,Word,T,P
0,Xylitol,0,0
1,for,0,0
2,prevention,0,0
3,of,0,0
4,acute,1,1
5,otitis,1,1
6,media,1,0
7,.,1,1
8,Switching,0,0
9,patients,1,1
10,with,1,1
11,asthma,1,1
12,from,0,0
13,chlorofluorocarbon,0,0
14,(,0,0
15,CFC,0,0
16,),0,0
17,albuterol,0,0
18,to,0,0
19,hydrofluoroalkane-134a,0,0
20,(,0,0
21,HFA,0,1
22,),0,0
23,albuterol,0,0
24,.,0,0
25,Chlorofluorocarbon,0,0
26,(,0,0
27,CFC,0,0
28,),0,0
29,propellants,0,1
30,deplete,0,0
31,stratospheric,0,0
32,ozone,0,0
33,.,0,0
34,Production,0,0
35,and,0,0
36,use,0,0
37,of,0,0
38,CFCs,0,0
39,",",0,0
40,except,0,0
41,for,0,0
42,certain,0,0
43,critical,0,0
44,exemptions,0,1
45,",",0,0
46,has,0,0
47,been,0,0
48,prohibited,0,0
49,by,0,0
50,the,0,0
51,Montreal,0,1
52,Protocol,0,1
53,.,0,1
54,Use,0,0
55,of,0,0
56,CFCs,0,1
57,as,0,1
58,propellants,0,1
59,in,0,1
60,metered-dose,0,0
61,inhalers,0,1
62,(,0,1
63,MDIs,0,0
64,),0,0
65,is,0,0
66,still,0,0
67,allowed,0,0
68,",",0,0
69,but,0,0
70,the,0,0
71,U.S.,0,0
72,Food,0,1
73,and,0,0
74,Drug,0,0
75,Administration,0,0
76,is,0,0
77,planning,0,0
78,the,0,0
79,transition,0,0
80,to,0,0
81,alternative,0,0
82,propellants,0,0
83,for,0,0
84,use,0,0
85,in,0,0
86,MDIs,0,0
87,.,0,1
88,Hydrofluoroalkane-134a,0,0
89,(,0,0
90,HFA,0,1
91,),0,0
92,",",0,0
93,a,0,0
94,non-ozone-depleting,0,0
95,propellant,0,0
96,",",0,0
97,has,0,0
98,been,0,0
99,used,0,0
100,to,0,0
101,reformulate,0,0
102,albuterol,0,0
103,(,0,0
104,HFA,0,1
105,albuterol,0,1
106,),0,0
107,.,0,0
108,This,0,0
109,study,0,0
110,evaluates,0,0
111,whether,0,0
112,comparable,0,0
113,safety,0,0
114,and,0,0
115,efficacy,0,0
116,continues,0,0
117,for,0,0
118,12,0,0
119,weeks,0,0
120,after,0,1
121,patients,1,1
122,with,1,1
123,asthma,1,1
124,are,0,0
125,switched,0,0
126,from,0,0
127,CFC,0,0
128,albuterol,0,0
129,to,0,0
130,HFA,0,1
131,albuterol,0,0
132,.,0,1
133,Patients,1,1
134,with,1,1
135,asthma,1,1
136,stabilized,1,0
137,on,1,0
138,CFC,1,0
139,albuterol,1,0
140,during,0,0
141,a,0,0
142,12-week,0,0
143,safety,0,0
144,and,0,0
145,efficacy,0,0
146,trial,0,0
147,were,0,0
148,randomized,0,0
149,to,0,0
150,either,0,0
151,continue,0,0
152,receiving,0,0
153,CFC,0,0
154,albuterol,0,0
155,or,0,0
156,to,0,0
157,be,0,0
158,switched,0,0
159,to,0,0
160,receive,0,0
161,HFA,0,1
162,albuterol,0,0
163,in,0,0
164,a,0,0
165,yearlong,0,0
166,safety,0,0
167,and,0,0
168,efficacy,0,0
169,trial,0,0
170,.,0,0
171,Safety,0,0
172,and,0,0
173,efficacy,0,0
174,were,0,0
175,compared,0,0
176,over,0,0
177,the,0,0
178,first,0,0
179,12,0,0
180,weeks,0,0
181,of,0,0
182,the,0,0
183,yearlong,0,0
184,trial,0,0
185,between,0,1
186,patients,0,1
187,who,0,1
188,had,0,1
189,remained,0,1
190,on,0,0
191,CFC,0,0
192,albuterol,0,0
193,and,0,1
194,those,0,1
195,who,0,1
196,had,0,1
197,been,0,1
198,switched,0,0
199,to,0,0
200,HFA,0,1
201,albuterol,0,0
202,.,0,0
203,Bronchodilator,0,0
204,efficacy,0,0
205,was,0,0
206,evaluated,0,0
207,by,0,0
208,serial,0,0
209,spirometry,0,1
210,for,0,0
211,6,0,0
212,hr,0,0
213,after,0,0
214,the,0,0
215,patients,0,1
216,self-administered,0,1
217,the,0,0
218,study,0,0
219,drug,0,0
220,in,0,0
221,the,0,0
222,clinic,0,1
223,.,0,0
224,Safety,0,0
225,was,0,0
226,assessed,0,0
227,by,0,0
228,measuring,0,0
229,changes,0,0
230,in,0,1
231,pulse,0,0
232,rate,0,0
233,",",0,0
234,blood,0,0
235,pressure,0,0
236,",",0,0
237,and,0,0
238,electrocardiogram,0,0
239,(,0,0
240,ECG,0,1
241,),0,1
242,intervals,0,0
243,after,0,0
244,dosing,0,0
245,with,0,1
246,study,0,0
247,drug,0,0
248,",",0,0
249,monitoring,0,0
250,adverse,0,0
251,events,0,0
252,",",0,0
253,and,0,0
254,performing,0,0
255,prestudy,0,0
256,and,0,0
257,poststudy,0,0
258,laboratory,0,0
259,testing,0,0
260,and,0,0
261,physical,0,0
262,examinations,0,1
263,.,0,1
264,No,0,0
265,significant,0,0
266,differences,0,0
267,in,0,0
268,bronchodilator,0,0
269,efficacy,0,0
270,between,0,0
271,the,0,0
272,patients,0,1
273,continuing,0,0
274,to,0,0
275,receive,0,0
276,CFC,0,0
277,albuterol,0,0
278,and,0,0
279,those,0,0
280,switched,0,0
281,to,0,0
282,HFA,0,1
283,albuterol,0,0
284,were,0,0
285,found,0,0
286,in,0,0
287,the,0,0
288,12,0,0
289,weeks,0,0
290,after,0,0
291,the,0,0
292,switch,0,0
293,.,0,0
294,No,0,0
295,differences,0,0
296,between,0,0
297,the,0,0
298,two,0,0
299,products,0,0
300,were,0,1
301,found,0,0
302,for,0,0
303,changes,0,0
304,in,0,0
305,pulse,0,0
306,rate,0,0
307,",",0,0
308,blood,0,0
309,pressure,0,0
310,",",0,0
311,and,0,0
312,ECG,0,1
313,intervals,0,0
314,.,0,1
315,Adverse,0,0
316,event,0,0
317,profiles,0,0
318,were,0,1
319,similar,0,0
320,for,0,0
321,the,0,0
322,two,0,0
323,products,0,0
324,",",0,0
325,except,0,0
326,the,0,0
327,patients,0,1
328,remaining,0,0
329,on,0,0
330,CFC,0,0
331,albuterol,0,0
332,reported,0,0
333,increased,0,0
334,asthma,0,1
335,symptoms,0,0
336,and,0,0
337,rhinitis,0,1
338,significantly,0,0
339,more,0,0
340,often,0,0
341,than,0,0
342,the,0,0
343,patients,0,1
344,switched,0,0
345,to,0,0
346,HFA,0,1
347,albuterol,0,0
348,.,0,0
349,No,0,0
350,clinically,0,0
351,meaningful,0,0
352,changes,0,0
353,in,0,0
354,laboratory,0,0
355,tests,0,0
356,or,0,1
357,physical,0,1
358,examinations,0,0
359,were,0,1
360,found,0,0
361,in,0,0
362,either,0,0
363,treatment,0,0
364,group,0,0
365,.,0,0
366,Patients,1,1
367,with,1,1
368,asthma,1,1
369,switched,0,0
370,from,0,1
371,CFC,0,0
372,albuterol,0,0
373,to,0,0
374,HFA,0,1
375,albuterol,0,0
376,receive,0,0
377,comparable,0,0
378,bronchodilation,0,0
379,with,0,1
380,a,0,0
381,similar,0,0
382,safety,0,0
383,profile,0,0
384,as,0,0
385,those,0,0
386,continuing,0,0
387,to,0,0
388,receive,0,0
389,CFC,0,0
390,albuterol,0,0
391,.,0,1
392,Independent,0,1
393,prognostic,0,0
394,information,0,0
395,provided,0,0
396,by,0,0
397,sphygmomanometrically,0,0
398,determined,0,0
399,pulse,0,0
400,pressure,0,0
401,and,0,0
402,mean,0,1
403,arterial,0,1
404,pressure,0,0
405,in,0,0
406,patients,1,1
407,with,1,1
408,left,1,1
409,ventricular,1,1
410,dysfunction,1,1
411,.,1,0
412,OBJECTIVES,0,0
413,The,0,0
414,purpose,0,0
415,of,0,0
416,this,0,0
417,study,0,0
418,was,0,0
419,to,0,0
420,evaluate,0,0
421,the,0,0
422,relationship,0,0
423,of,0,0
424,baseline,0,0
425,pulse,0,0
426,pressure,0,0
427,and,0,0
428,mean,0,1
429,arterial,0,1
430,pressure,0,0
431,to,0,0
432,mortality,0,0
433,in,0,0
434,patients,1,1
435,with,1,1
436,left,1,1
437,ventricular,1,1
438,dysfunction,1,1
439,.,1,1
440,BACKGROUND,0,0
441,Increased,0,0
442,conduit,0,1
443,vessel,0,0
444,stiffness,0,0
445,increases,0,0
446,pulse,0,0
447,pressure,0,0
448,and,0,0
449,pulsatile,0,0
450,load,0,0
451,",",0,0
452,potentially,0,0
453,contributing,0,0
454,to,0,0
455,adverse,0,0
456,outcomes,0,0
457,in,0,0
458,patients,1,1
459,with,1,1
460,left,1,1
461,ventricular,1,1
462,dysfunction,1,1
463,.,1,1
464,METHODS,0,0
465,Pulse,0,0
466,and,0,0
467,mean,0,0
468,arterial,0,1
469,pressure,0,0
470,were,0,0
471,analyzed,0,0
472,for,0,0
473,their,0,0
474,effect,0,0
475,on,0,0
476,mortality,0,0
477,",",0,0
478,adjusting,0,0
479,for,0,0
480,other,0,0
481,modifiers,0,0
482,of,0,0
483,risk,0,0
484,",",0,0
485,using,0,0
486,Cox,0,0
487,proportional,0,0
488,hazards,0,0
489,regression,0,0
490,analysis,0,0
491,of,0,0
492,data,0,0
493,collected,0,1
494,from,0,1
495,"6,781",1,1
496,patients,1,1
497,randomized,1,1
498,into,1,1
499,the,1,0
500,Studies,1,0
501,of,1,1
502,Left,1,1
503,Ventricular,1,1
504,Dysfunction,1,1
505,trials,1,1
506,.,1,1
507,RESULTS,0,0
508,Pulse,0,0
509,and,0,0
510,mean,0,0
511,arterial,0,1
512,pressure,0,0
513,were,0,0
514,related,0,0
515,positively,0,0
516,to,0,0
517,each,0,0
518,other,0,0
519,",",0,0
520,age,0,1
521,",",0,0
522,ejection,0,0
523,fraction,0,0
524,and,0,0
525,prevalence,0,1
526,of,0,0
527,diabetes,0,1
528,and,0,0
529,hypertension,0,1
530,and,0,0
531,inversely,0,0
532,to,0,0
533,prior,0,0
534,myocardial,0,1
535,infarction,0,1
536,and,0,0
537,beta-adrenergic,0,0
538,blocking,0,0
539,agent,0,0
540,use,0,0
541,.,0,0
542,Higher,0,0
543,pulse,0,0
544,pressure,0,0
545,was,0,0
546,associated,0,0
547,with,0,1
548,increased,0,0
549,prevalence,0,1
550,of,0,0
551,female,0,1
552,gender,0,0
553,",",0,0
554,greater,0,0
555,calcium,0,0
556,channel,0,0
557,blocking,0,0
558,agent,0,0
559,",",0,0
560,digoxin,0,0
561,and,0,0
562,diuretic,0,0
563,use,0,0
564,",",0,0
565,lower,0,0
566,heart,0,1
567,rate,0,0
568,and,0,0
569,a,0,0
570,higher,0,0
571,rate,0,0
572,of,0,0
573,reported,0,0
574,smoking,0,1
575,history,0,1
576,.,0,0
577,Higher,0,0
578,mean,0,0
579,arterial,0,1
580,pressure,0,0
581,was,0,0
582,associated,0,0
583,with,0,1
584,higher,0,0
585,heart,0,1
586,rate,0,0
587,",",0,0
588,lower,0,0
589,calcium,0,0
590,channel,0,0
591,blocker,0,0
592,and,0,0
593,digoxin,0,0
594,use,0,0
595,and,0,0
596,lower,0,0
597,New,0,1
598,York,0,1
599,Heart,0,1
600,Association,0,0
601,functional,0,1
602,class,0,1
603,.,0,0
604,Over,0,0
605,a,0,0
606,61-month,0,0
607,follow-up,0,0
608,"1,582",0,1
609,deaths,0,0
610,(,0,1
611,"1,397",0,1
612,cardiovascular,0,1
613,),0,0
614,occurred,0,0
615,.,0,0
616,In,0,0
617,a,0,0
618,multivariate,0,0
619,analysis,0,0
620,adjusting,0,0
621,for,0,0
622,the,0,0
623,above,0,0
624,covariates,0,0
625,and,0,0
626,treatment,0,0
627,assignment,0,0
628,",",0,0
629,higher,0,0
630,pulse,0,0
631,pressure,0,0
632,remained,0,0
633,an,0,0
634,independent,0,0
635,predictor,0,0
636,of,0,0
637,total,0,1
638,and,0,0
639,cardiovascular,0,1
640,mortality,0,0
641,(,0,0
642,total,0,1
643,mortality,0,0
644,relative,0,0
645,risk,0,0
646,",",0,0
647,1.05,0,0
648,per,0,0
649,10,0,1
650,mm,0,0
651,Hg,0,0
652,increment,0,0
653,;,0,0
654,95,0,0
655,%,0,0
656,confidence,0,0
657,interval,0,0
658,",",0,0
659,1.01,0,0
660,to,0,0
661,1.10,0,0
662,;,0,0
663,p,0,0
664,=,0,0
665,0.02,0,0
666,),0,0
667,.,0,1
668,Mean,0,0
669,arterial,0,1
670,pressure,0,0
671,was,0,0
672,inversely,0,0
673,related,0,0
674,to,0,0
675,total,0,1
676,and,0,0
677,cardiovascular,0,1
678,mortality,0,0
679,(,0,0
680,total,0,1
681,mortality,0,0
682,relative,0,0
683,risk,0,0
684,",",0,0
685,0.89,0,0
686,;,0,0
687,95,0,0
688,%,0,0
689,confidence,0,0
690,interval,0,0
691,",",0,0
692,0.85,0,0
693,to,0,0
694,0.94,0,0
695,;,0,0
696,p,0,0
697,<,0,0
698,0.0001,0,0
699,),0,0
700,.,0,1
701,CONCLUSIONS,0,0
702,One,0,1
703,noninvasive,0,0
704,blood,0,0
705,pressure,0,0
706,measurement,0,0
707,provides,0,0
708,two,0,0
709,independent,0,0
710,prognostic,0,0
711,factors,0,0
712,for,0,0
713,survival,0,0
714,.,0,0
715,Increased,0,0
716,conduit,0,0
717,vessel,0,0
718,stiffness,0,0
719,",",0,0
720,as,0,0
721,assessed,0,0
722,by,0,0
723,pulse,0,0
724,pressure,0,0
725,",",0,0
726,may,0,0
727,contribute,0,0
728,to,0,0
729,increased,0,0
730,mortality,0,0
731,in,0,0
732,patients,0,1
733,with,0,1
734,left,0,1
735,ventricular,0,0
736,dysfunction,0,1
737,",",0,0
738,independent,0,0
739,of,0,0
740,mean,0,1
741,arterial,0,1
742,pressure,0,0
743,.,0,1
744,A,0,0
745,comparative,0,0
746,study,0,0
747,of,0,0
748,administration,0,0
749,methods,0,1
750,of,0,0
751,granisetron,0,0
752,injection,0,0
753,used,0,0
754,to,0,0
755,treat,0,0
756,nausea/vomiting,0,0
757,induced,0,0
758,by,0,0
759,cancer,0,1
760,chemotherapy,0,0
761,without,0,0
762,cisplatin,0,0
763,in,0,0
764,tumors,1,1
765,of,1,1
766,hematopoietic,1,1
767,organs,1,1
768,.,1,1
769,Keihanshin,0,1
770,Study,0,0
771,Group,0,1
772,of,0,0
773,Hematological,0,1
774,Malignancies,0,1
775,.,0,0
776,PURPOSE,0,0
777,The,0,0
778,antiemetic,0,0
779,effect,0,0
780,of,0,0
781,granisetron,0,0
782,injection,0,0
783,at,0,0
784,a,0,0
785,dose,0,0
786,of,0,0
787,40,0,1
788,microg/kg,0,0
789,used,0,0
790,in,0,0
791,the,0,0
792,treatment,0,0
793,of,0,0
794,nausea/vomiting,0,0
795,induced,0,0
796,by,0,0
797,multidrug,0,0
798,combined,0,0
799,cancer,0,1
800,chemotherapy,0,0
801,excluding,0,0
802,cisplatin,0,0
803,in,0,0
804,patients,1,1
805,with,1,1
806,tumors,1,1
807,of,1,1
808,hematopoietic,1,1
809,organs,1,1
810,was,0,0
811,evaluated,0,0
812,by,0,0
813,comparing,0,0
814,a,0,0
815,30-min,0,0
816,infusion,0,0
817,and,0,0
818,a,0,0
819,slow,0,0
820,intravenous,0,0
821,injection,0,0
822,given,0,0
823,over,0,0
824,30,0,1
825,s.,0,1
826,METHODS,0,0
827,A,0,1
828,two-group,0,0
829,random-allocation,0,0
830,comparative,0,0
831,study,0,0
832,was,0,0
833,performed,0,0
834,with,0,1
835,the,0,0
836,cooperation,0,0
837,of,0,0
838,multiple,1,0
839,institutions,1,1
840,using,1,0
841,a,1,0
842,central,1,0
843,registration,1,0
844,system,1,0
845,.,1,0
846,RESULTS,0,0
847,In,0,0
848,the,0,0
849,treatment,0,0
850,of,0,0
851,acute,0,1
852,clinical,0,0
853,symptoms,0,0
854,",",0,0
855,appetite,0,0
856,was,0,0
857,described,0,0
858,as,0,0
859,similar,0,0
860,to,0,0
861,that,0,0
862,during,0,0
863,good,0,0
864,health,0,1
865,by,0,0
866,61.1,0,0
867,%,0,0
868,of,0,0
869,patients,0,1
870,(,1,1
871,55/93,1,1
872,),1,0
873,in,0,0
874,the,0,0
875,instillation,0,0
876,group,0,0
877,and,0,0
878,by,0,0
879,47.3,0,0
880,%,0,0
881,(,1,1
882,44/93,1,1
883,),1,0
884,in,0,0
885,the,0,0
886,slow,0,0
887,injection,0,0
888,group,0,0
889,",",0,0
890,a,0,0
891,significant,0,0
892,advantage,0,0
893,in,0,0
894,the,0,0
895,infusion,0,0
896,group,0,0
897,.,0,0
898,However,0,0
899,",",0,0
900,no,0,0
901,significant,0,0
902,differences,0,0
903,in,0,0
904,the,0,0
905,number,0,0
906,of,0,0
907,episodes,0,0
908,of,0,0
909,vomiting,0,0
910,",",0,0
911,the,0,0
912,severity,0,0
913,of,0,0
914,nausea,0,0
915,or,0,1
916,clinical,0,0
917,efficacy,0,0
918,were,0,0
919,found,0,0
920,.,0,0
921,In,0,0
922,the,0,0
923,final,0,0
924,clinical,0,0
925,evaluation,0,0
926,and,0,0
927,assessment,0,0
928,of,0,0
929,usefulness,0,0
930,based,0,0
931,on,0,0
932,the,0,0
933,subjective,0,0
934,judgement,0,0
935,of,0,0
936,physicians,0,1
937,throughout,0,0
938,the,0,0
939,entire,0,0
940,therapeutic,0,0
941,period,0,0
942,",",0,0
943,no,0,0
944,differences,0,0
945,were,0,1
946,discernible,0,0
947,.,0,0
948,No,0,0
949,side,0,0
950,effects,0,0
951,were,0,0
952,reported,0,0
953,for,0,0
954,either,0,0
955,method,0,0
956,and,0,0
957,there,0,0
958,was,0,0
959,no,0,0
960,indication,0,0
961,of,0,0
962,a,0,0
963,sex,0,0
964,difference,0,0
965,concerning,0,0
966,efficacy,0,0
967,.,0,0
968,However,0,0
969,",",0,0
970,the,0,0
971,efficacy,0,0
972,in,0,0
973,patients,0,1
974,with,0,1
975,an,0,0
976,anemic,0,1
977,tendency,0,0
978,was,0,0
979,slightly,0,0
980,inferior,0,0
981,.,0,0
982,CONCLUSIONS,0,0
983,The,0,0
984,maintenance,0,0
985,of,0,0
986,appetite,0,0
987,during,0,0
988,the,0,0
989,administration,0,0
990,of,0,0
991,anticancer,0,0
992,drugs,0,0
993,is,0,0
994,very,0,0
995,important,0,0
996,to,0,0
997,maintain,0,0
998,patients,0,1
999,',0,1
1000,daily,0,0
1001,activities,0,0
1002,and,0,0
1003,quality,0,0
1004,of,0,0
1005,life,0,0
1006,.,0,0
1007,The,0,0
1008,present,0,0
1009,results,0,0
1010,support,0,0
1011,the,0,0
1012,usefulness,0,0
1013,of,0,0
1014,infusion,0,0
1015,of,0,0
1016,granisetron,0,0
1017,as,0,0
1018,an,0,0
1019,administration,0,0
1020,method,0,0
1021,during,0,0
1022,chemotherapy,0,0
1023,for,0,0
1024,malignant,0,1
1025,hemopathy,0,1
1026,.,0,1
1027,Treatment,0,0
1028,of,0,0
1029,polyarteritis,1,1
1030,nodosa,1,1
1031,and,1,0
1032,Churg-Strauss,1,1
1033,syndrome,1,1
1034,:,1,1
1035,indications,0,0
1036,of,0,0
1037,plasma,0,0
1038,exchanges,0,0
1039,.,0,1
1040,To,0,0
1041,define,0,0
1042,the,0,0
1043,most,0,0
1044,effective,0,0
1045,treatment,0,0
1046,for,0,0
1047,polyarteritis,1,1
1048,nodosa,1,1
1049,(,1,0
1050,PAN,1,1
1051,),1,0
1052,and,1,0
1053,Churg-Strauss,1,0
1054,syndrome,1,1
1055,(,1,0
1056,CSS,1,1
1057,),1,0
1058,",",0,0
1059,we,0,0
1060,undertook,0,0
1061,4,0,0
1062,consecutive,0,1
1063,prospective,0,1
1064,therapeutic,0,1
1065,trials,0,1
1066,including,0,1
1067,236,1,1
1068,patients,1,1
1069,and,0,0
1070,tried,0,0
1071,to,0,0
1072,answer,0,0
1073,several,0,0
1074,important,0,0
1075,questions,0,0
1076,:,0,1
1077,Should,0,0
1078,cyclophosphamide,0,0
1079,(,0,0
1080,CYC,0,0
1081,),0,0
1082,be,0,0
1083,given,0,0
1084,as,0,0
1085,the,0,0
1086,first-line,0,1
1087,treatment,0,1
1088,?,0,1
1089,What,0,0
1090,is,0,0
1091,the,0,0
1092,place,0,0
1093,of,0,0
1094,plasma,0,0
1095,exchanges,0,0
1096,(,0,1
1097,PE,0,1
1098,),0,0
1099,in,0,0
1100,the,0,0
1101,treatment,0,0
1102,of,0,0
1103,systemic,0,0
1104,vasculitis,0,1
1105,?,0,0
1106,and,0,0
1107,does,0,0
1108,hepatitis,0,1
1109,B,0,0
1110,virus,0,1
1111,(,0,0
1112,HBV,0,1
1113,),0,0
1114,related,0,0
1115,PAN,0,1
1116,require,0,1
1117,treatment,0,0
1118,?,0,0
1119,Our,0,0
1120,first,0,0
1121,randomized,0,0
1122,trial,0,0
1123,in,0,0
1124,71,1,1
1125,patients,1,1
1126,(,1,1
1127,1981-1983,1,1
1128,),1,0
1129,compared,1,0
1130,the,1,0
1131,association,1,0
1132,of,1,0
1133,CYC,1,0
1134,with,1,1
1135,corticosteroids,1,0
1136,(,1,1
1137,CS,1,0
1138,),1,0
1139,and,1,0
1140,PE,1,1
1141,to,1,0
1142,CS,1,0
1143,and,1,0
1144,PE,1,1
1145,",",1,0
1146,in,1,0
1147,order,1,0
1148,to,1,0
1149,evaluate,1,0
1150,the,1,0
1151,efficacy,1,0
1152,of,1,0
1153,CYC,1,0
1154,given,1,0
1155,as,1,0
1156,the,1,0
1157,first-line,1,1
1158,treatment,1,0
1159,to,1,0
1160,control,1,0
1161,disease,1,1
1162,activity,1,0
1163,and,1,0
1164,subsequent,1,0
1165,survival,1,0
1166,of,1,0
1167,PAN,1,1
1168,and,1,1
1169,CSS,1,1
1170,patients,1,1
1171,.,1,1
1172,Between,0,0
1173,December,1,1
1174,1983,1,1
1175,and,1,0
1176,December,1,1
1177,1988,1,1
1178,",",0,0
1179,we,0,0
1180,conducted,0,0
1181,two,0,0
1182,trials,0,0
1183,simultaneously,0,0
1184,:,0,1
1185,one,0,0
1186,aimed,0,0
1187,at,1,0
1188,patients,1,1
1189,without,1,1
1190,HBV,1,1
1191,markers,1,0
1192,and,1,0
1193,the,1,0
1194,second,1,0
1195,at,1,0
1196,patients,1,1
1197,with,1,1
1198,HBV,1,1
1199,markers,1,0
1200,.,1,1
1201,In,0,0
1202,78,1,1
1203,patients,1,1
1204,without,1,1
1205,HBV,1,1
1206,markers,1,0
1207,",",0,0
1208,we,0,0
1209,compared,0,0
1210,prednisone,0,0
1211,and,0,0
1212,PE,0,1
1213,to,0,0
1214,prednisone,0,0
1215,alone,0,0
1216,as,0,0
1217,the,0,0
1218,initial,0,0
1219,therapeutic,0,0
1220,regimen,0,0
1221,.,0,1
1222,In,0,0
1223,33,1,1
1224,patients,1,1
1225,with,1,1
1226,PAN,1,1
1227,related,1,0
1228,to,1,0
1229,HBV,1,0
1230,",",0,0
1231,a,0,0
1232,new,0,0
1233,therapeutic,0,0
1234,strategy,0,0
1235,was,0,0
1236,applied,0,0
1237,as,0,0
1238,an,0,0
1239,alternative,0,0
1240,to,0,0
1241,long-term,0,0
1242,steroid,0,0
1243,and,0,0
1244,immunosuppressive,0,1
1245,therapy,0,0
1246,:,0,1
1247,short-term,0,0
1248,steroid,0,0
1249,therapy,0,0
1250,and,0,0
1251,PE,0,1
1252,were,0,0
1253,used,0,0
1254,to,0,0
1255,control,0,0
1256,the,0,0
1257,evolution,0,0
1258,of,0,0
1259,PAN,0,1
1260,and,0,0
1261,anti-viral,0,0
1262,therapy,0,0
1263,was,0,0
1264,administered,0,0
1265,to,0,0
1266,suppress,0,0
1267,the,0,0
1268,etiological,0,0
1269,agent,0,0
1270,of,0,0
1271,the,0,0
1272,vasculitis,0,1
1273,.,0,0
1274,In,0,0
1275,the,0,0
1276,last,0,0
1277,protocol,0,0
1278,including,0,0
1279,56,1,1
1280,patients,1,1
1281,and,1,0
1282,addressed,1,0
1283,to,1,0
1284,severe,1,1
1285,PAN,1,1
1286,without,1,1
1287,HBV,1,1
1288,markers,1,0
1289,or,1,1
1290,CSS,1,1
1291,we,0,0
1292,have,0,0
1293,shown,0,0
1294,that,0,0
1295,PE,0,1
1296,did,0,0
1297,not,0,0
1298,improve,0,0
1299,the,0,0
1300,prognosis,0,0
1301,and,0,0
1302,control,0,0
1303,of,0,0
1304,the,0,0
1305,disease,0,1
1306,.,0,0
1307,Twelve,0,1
1308,years,0,1
1309,after,0,0
1310,the,0,0
1311,beginning,0,0
1312,of,0,0
1313,the,0,0
1314,trials,0,0
1315,on,0,0
1316,PAN,0,1
1317,and,0,1
1318,CSS,0,1
1319,patients,0,1
1320,",",0,0
1321,we,0,0
1322,think,0,0
1323,that,0,0
1324,the,0,0
1325,therapeutic,0,0
1326,strategy,0,0
1327,should,0,0
1328,be,0,0
1329,as,0,0
1330,follows,0,0
1331,:,0,0
1332,In,0,0
1333,PAN,0,1
1334,without,0,1
1335,HBV,0,1
1336,and,0,1
1337,CSS,0,1
1338,:,0,1
1339,prednisone,0,0
1340,in,0,0
1341,association,0,0
1342,with,0,1
1343,CYC,0,0
1344,improves,0,0
1345,the,0,0
1346,control,0,0
1347,of,0,0
1348,the,0,0
1349,disease,0,1
1350,despite,0,0
1351,infectious,0,1
1352,side,0,0
1353,effects,0,0
1354,which,0,0
1355,may,0,0
1356,be,0,0
1357,reduced,0,0
1358,by,0,0
1359,better,0,0
1360,CYC,0,0
1361,dose,0,0
1362,adaptation,0,0
1363,.,0,1
1364,In,0,0
1365,PAN,0,0
1366,related,0,0
1367,to,0,0
1368,HBV,0,1
1369,:,0,1
1370,The,0,0
1371,first-line,0,0
1372,treatment,0,0
1373,should,0,0
1374,be,0,0
1375,the,0,0
1376,association,0,0
1377,of,0,0
1378,anti-viral,0,0
1379,agents,0,0
1380,and,0,1
1381,PE,0,1
1382,.,0,0
1383,This,0,0
1384,treatment,0,0
1385,was,0,0
1386,effective,0,0
1387,and,0,0
1388,cured,0,0
1389,a,0,0
1390,majority,0,0
1391,of,0,0
1392,patients,0,1
1393,within,0,1
1394,2,0,1
1395,to,0,1
1396,3,0,1
1397,months,0,0
1398,;,0,1
1399,half,0,1
1400,of,0,0
1401,them,0,1
1402,seroconverted,0,1
1403,.,0,0
1404,The,0,0
1405,length,0,0
1406,of,0,0
1407,HBV,0,1
1408,infection,0,0
1409,before,0,0
1410,its,0,0
1411,diagnosis,0,1
1412,",",0,0
1413,delay,0,0
1414,before,0,0
1415,initiation,0,0
1416,of,0,0
1417,treatment,0,0
1418,and,0,0
1419,previous,0,0
1420,immunosuppressive,0,1
1421,therapy,0,0
1422,led,0,0
1423,to,0,0
1424,a,0,0
1425,poor,0,0
1426,seroconversion,0,0
1427,rate,0,0
1428,.,0,0
1429,The,0,0
1430,role,0,0
1431,of,0,0
1432,PE,0,1
1433,in,0,0
1434,the,0,0
1435,treatment,0,0
1436,of,0,0
1437,systemic,0,0
1438,necrotizing,0,1
1439,vasculitis,0,1
1440,:,0,1
1441,PE,0,1
1442,are,0,0
1443,obviously,0,0
1444,useful,0,0
1445,in,0,0
1446,PAN,1,1
1447,related,1,0
1448,to,1,0
1449,HBV,1,0
1450,where,0,0
1451,immune,0,0
1452,complex,0,0
1453,deposition,0,0
1454,has,0,0
1455,been,0,0
1456,demonstrated,0,0
1457,.,0,0
1458,When,0,0
1459,PAN,0,0
1460,is,0,0
1461,not,0,0
1462,related,0,0
1463,to,0,0
1464,HBV,0,0
1465,and,0,0
1466,in,0,0
1467,CSS,0,1
1468,",",0,0
1469,even,0,0
1470,in,0,0
1471,severe,0,1
1472,cases,0,1
1473,",",0,0
1474,there,0,0
1475,is,0,0
1476,presently,0,0
1477,no,0,0
1478,argument,0,0
1479,supporting,0,0
1480,systematic,0,0
1481,administration,0,0
1482,of,0,0
1483,PE,0,1
1484,at,0,0
1485,the,0,0
1486,time,0,0
1487,of,0,0
1488,diagnosis,0,1
1489,.,0,1
1490,Protocol,0,1
1491,for,0,0
1492,the,0,0
1493,Multicenter,0,1
1494,Acute,0,1
1495,Stroke,0,1
1496,Trial,0,1
1497,--,0,1
1498,thrombolysis,0,0
1499,study,0,0
1500,.,0,0
1501,The,0,0
1502,rationale,0,0
1503,for,0,0
1504,the,0,0
1505,Multicenter,0,1
1506,Acute,0,1
1507,Stroke,0,1
1508,Trial,0,1
1509,(,0,0
1510,MAST,0,0
1511,),0,0
1512,is,0,0
1513,presented,0,0
1514,in,0,0
1515,a,0,0
1516,companion,0,0
1517,article,0,0
1518,appearing,0,0
1519,in,0,0
1520,this,0,0
1521,issue,0,0
1522,.,0,0
1523,Acute,0,0
1524,ischaemic,0,1
1525,stroke,0,1
1526,is,0,0
1527,the,0,0
1528,third,0,0
1529,major,0,0
1530,cause,0,0
1531,of,0,0
1532,death,0,0
1533,in,0,0
1534,developed,0,0
1535,countries,0,1
1536,",",0,0
1537,and,0,0
1538,a,0,0
1539,major,0,0
1540,cause,0,0
1541,of,0,0
1542,disability,0,0
1543,.,0,0
1544,Despite,0,0
1545,a,0,0
1546,very,0,0
1547,poor,0,0
1548,prognosis,0,0
1549,",",0,0
1550,no,0,0
1551,treatment,0,0
1552,has,0,0
1553,demonstrated,0,0
1554,an,0,0
1555,efficacy,0,0
1556,in,0,0
1557,lowering,0,0
1558,the,0,0
1559,mortality,0,0
1560,and,0,0
1561,disability,0,0
1562,resulting,0,0
1563,from,0,0
1564,stroke,0,1
1565,events,0,0
1566,.,0,0
1567,Thrombolysis,0,0
1568,has,0,0
1569,been,0,0
1570,proven,0,0
1571,to,0,0
1572,reduce,0,0
1573,mortality,0,0
1574,in,0,0
1575,myocardial,0,1
1576,infarction,0,1
1577,",",0,0
1578,and,0,0
1579,it,0,0
1580,has,0,0
1581,been,0,0
1582,shown,0,0
1583,able,0,0
1584,to,0,0
1585,induce,0,0
1586,recanalisation,0,0
1587,when,0,0
1588,administered,0,0
1589,to,0,0
1590,acute,1,1
1591,stroke,1,1
1592,patients,1,1
1593,.,1,1
1594,A,0,0
1595,recent,0,0
1596,meta,0,0
1597,analysis,0,0
1598,of,0,0
1599,small-sized,0,0
1600,studies,0,0
1601,suggests,0,0
1602,that,0,0
1603,thrombolysis,0,0
1604,could,0,0
1605,offer,0,0
1606,some,0,0
1607,benefit,0,0
1608,to,0,0
1609,stroke,1,1
1610,patients,1,1
1611,",",0,0
1612,by,0,0
1613,reducing,0,0
1614,the,0,0
1615,mortality,0,0
1616,and,0,0
1617,severe,0,1
1618,invalidity,0,1
1619,by,0,0
1620,56,0,1
1621,%,0,0
1622,;,0,0
1623,these,0,0
1624,results,0,0
1625,need,0,0
1626,to,0,0
1627,be,0,0
1628,confirmed,0,0
1629,in,0,0
1630,adequately,0,0
1631,designed,0,0
1632,and,0,0
1633,sized,0,1
1634,studies,0,0
1635,.,0,1
1636,Effects,0,0
1637,of,0,1
1638,oral,0,0
1639,brovincamine,0,0
1640,on,0,0
1641,visual,0,0
1642,field,0,0
1643,damage,0,0
1644,in,0,0
1645,patients,1,1
1646,with,1,1
1647,normal-tension,1,1
1648,glaucoma,1,1
1649,with,1,1
1650,low-normal,1,1
1651,intraocular,1,1
1652,pressure,1,0
1653,.,1,1
1654,PURPOSE,0,0
1655,To,0,0
1656,prospectively,0,0
1657,study,0,0
1658,the,0,0
1659,effect,0,0
1660,of,0,0
1661,oral,0,0
1662,brovincamine,0,0
1663,",",0,0
1664,a,0,0
1665,relatively,0,0
1666,selective,0,0
1667,cerebral,0,1
1668,vasodilator,0,0
1669,",",0,0
1670,on,0,0
1671,further,0,0
1672,deterioration,0,0
1673,of,0,0
1674,visual,0,0
1675,field,0,0
1676,in,0,0
1677,patients,1,1
1678,with,1,1
1679,normal-tension,1,1
1680,glaucoma,1,1
1681,(,1,0
1682,NTG,1,0
1683,),1,0
1684,with,1,1
1685,low-normal,1,1
1686,intraocular,1,0
1687,pressure,1,0
1688,(,1,0
1689,IOP,1,0
1690,),1,1
1691,.,1,1
1692,METHODS,0,0
1693,Fifty-two,1,1
1694,patients,1,1
1695,with,1,1
1696,NTG,1,0
1697,(,1,0
1698,average,1,0
1699,age,1,1
1700,57.7,1,1
1701,years,1,1
1702,),1,1
1703,with,1,1
1704,an,1,0
1705,IOP,1,0
1706,that,1,0
1707,was,1,0
1708,consistently,1,0
1709,less,1,0
1710,than,1,0
1711,15,1,1
1712,mmHg,1,0
1713,were,1,1
1714,randomly,1,1
1715,assigned,1,0
1716,to,1,0
1717,receive,0,0
1718,oral,0,0
1719,brovincamine,0,0
1720,(,0,0
1721,20,0,1
1722,mg,0,0
1723,three,0,0
1724,times,0,0
1725,daily,0,0
1726,),0,0
1727,or,0,0
1728,to,0,0
1729,an,0,0
1730,untreated,0,1
1731,control,0,0
1732,group,0,0
1733,.,0,0
1734,The,0,0
1735,groups,0,0
1736,were,0,0
1737,prospectively,0,1
1738,followed,0,0
1739,for,0,0
1740,2,0,0
1741,years,0,1
1742,with,0,1
1743,visual,0,0
1744,field,0,0
1745,examinations,0,0
1746,every,0,0
1747,4,0,0
1748,months,0,0
1749,",",0,0
1750,using,0,0
1751,the,0,0
1752,30-2,0,0
1753,Humphrey,0,1
1754,perimeter,0,0
1755,program,0,1
1756,.,0,0
1757,Changes,0,0
1758,in,0,0
1759,mean,0,1
1760,deviation,0,0
1761,(,0,0
1762,MD,0,0
1763,),0,0
1764,",",0,0
1765,corrected,0,0
1766,pattern,0,1
1767,standard,0,0
1768,deviation,0,0
1769,(,0,0
1770,CPSD,0,0
1771,),0,0
1772,",",0,0
1773,and,0,0
1774,total,0,1
1775,deviation,0,0
1776,(,0,0
1777,TD,0,0
1778,),0,0
1779,at,0,0
1780,74,0,1
1781,test,0,0
1782,points,0,0
1783,were,0,0
1784,analyzed,0,0
1785,using,0,0
1786,regression,0,0
1787,analysis,0,0
1788,with,0,1
1789,linear,0,0
1790,mixed,0,0
1791,model,0,0
1792,.,0,1
1793,Data,0,0
1794,from,0,1
1795,one,0,1
1796,eye,0,0
1797,without,0,1
1798,media,0,0
1799,opacity,0,0
1800,of,0,0
1801,each,0,0
1802,subject,0,0
1803,were,0,0
1804,analyzed,0,0
1805,.,0,0
1806,RESULTS,0,0
1807,There,0,0
1808,were,0,0
1809,no,0,0
1810,differences,0,0
1811,between,0,0
1812,groups,0,0
1813,in,0,1
1814,age,0,1
1815,;,0,0
1816,sex,0,0
1817,distribution,0,0
1818,;,0,0
1819,refraction,0,0
1820,;,0,0
1821,blood,0,0
1822,pressure,0,0
1823,;,0,0
1824,baseline,0,0
1825,IOP,0,0
1826,;,0,0
1827,MD,0,0
1828,",",0,0
1829,CPSD,0,0
1830,",",0,0
1831,or,0,0
1832,TD,0,0
1833,at,0,0
1834,each,0,0
1835,point,0,0
1836,.,0,0
1837,Changes,0,0
1838,in,0,0
1839,MD,0,0
1840,(,0,0
1841,standard,0,0
1842,error,0,0
1843,[,0,0
1844,SE,0,1
1845,],0,1
1846,),0,0
1847,during,0,0
1848,the,0,0
1849,study,0,0
1850,period,0,0
1851,were,0,0
1852,-0.778,0,0
1853,(,0,1
1854,0.178,0,0
1855,),0,0
1856,and,0,0
1857,-0.071,0,0
1858,(,0,0
1859,0.195,0,0
1860,),0,0
1861,dB/year,0,0
1862,in,0,0
1863,the,0,0
1864,control,0,0
1865,and,0,0
1866,brovincamine,0,0
1867,groups,0,0
1868,",",0,0
1869,respectively,0,0
1870,;,0,0
1871,change,0,0
1872,in,0,0
1873,the,0,0
1874,control,0,0
1875,group,0,0
1876,was,0,0
1877,significantly,0,0
1878,more,0,0
1879,negative,0,0
1880,than,0,0
1881,in,0,0
1882,the,0,0
1883,brovincamine,0,0
1884,group,0,0
1885,.,0,0
1886,Change,0,0
1887,in,0,0
1888,CPSD,0,0
1889,(,0,1
1890,SE,0,1
1891,),0,0
1892,was,0,0
1893,0.032,0,0
1894,(,0,1
1895,0.015,0,0
1896,),0,1
1897,and,0,0
1898,0.004,0,0
1899,(,0,0
1900,0.016,0,0
1901,),0,0
1902,dB/year,0,0
1903,in,0,0
1904,the,0,0
1905,control,0,0
1906,and,0,0
1907,brovincamine,0,0
1908,groups,0,0
1909,",",0,0
1910,respectively,0,0
1911,.,0,0
1912,Change,0,0
1913,in,0,0
1914,the,0,0
1915,control,0,0
1916,group,0,0
1917,was,0,0
1918,significantly,0,0
1919,positive,0,0
1920,",",0,0
1921,but,0,0
1922,the,0,0
1923,intergroup,0,0
1924,difference,0,0
1925,was,0,0
1926,not,0,0
1927,significant,0,0
1928,.,0,0
1929,Change,0,0
1930,in,0,0
1931,TD,0,0
1932,was,0,0
1933,significantly,0,0
1934,negative,0,0
1935,at,0,0
1936,six,0,1
1937,test,0,0
1938,points,0,0
1939,in,0,0
1940,the,0,0
1941,control,0,0
1942,group,0,0
1943,",",0,0
1944,whereas,0,0
1945,no,0,0
1946,points,0,0
1947,showed,0,0
1948,a,0,0
1949,significant,0,0
1950,trend,0,0
1951,in,0,0
1952,the,0,0
1953,brovincamine,0,0
1954,group,0,0
1955,;,0,0
1956,the,0,0
1957,intergroup,0,0
1958,difference,0,0
1959,was,0,0
1960,significant,0,0
1961,.,0,1
1962,The,0,0
1963,average,0,0
1964,IOP,0,0
1965,was,0,0
1966,13.2,0,0
1967,mmHg,0,0
1968,and,0,0
1969,13.1,0,0
1970,mmHg,0,0
1971,in,0,0
1972,the,0,0
1973,control,0,0
1974,and,0,0
1975,brovincamine,0,0
1976,groups,0,0
1977,",",0,0
1978,respectively,0,0
1979,",",0,0
1980,and,0,0
1981,there,0,0
1982,was,0,0
1983,no,0,0
1984,significant,0,0
1985,intergroup,0,0
1986,difference,0,0
1987,.,0,1
1988,CONCLUSION,0,0
1989,Oral,0,0
1990,brovincamine,0,0
1991,may,0,0
1992,retard,0,0
1993,further,0,0
1994,visual,0,0
1995,field,0,0
1996,deterioration,0,0
1997,in,0,0
1998,patients,1,1
1999,with,1,1
2000,NTG,1,1
2001,who,1,1
2002,have,1,1
2003,low-normal,1,1
2004,IOP,1,0
2005,.,1,1
2006,Isradipine,0,0
2007,",",0,0
2008,raised,0,0
2009,glycosylated,0,0
2010,haemoglobin,0,0
2011,",",0,0
2012,and,0,0
2013,risk,1,0
2014,of,1,0
2015,cardiovascular,1,1
2016,events,1,0
2017,.,1,1
2018,Thrombolysis,0,0
2019,is,0,0
2020,superior,0,0
2021,to,0,0
2022,heparin,0,0
2023,for,0,0
2024,non-obstructive,1,1
2025,mitral,1,1
2026,mechanical,1,1
2027,valve,1,1
2028,thrombosis,1,1
2029,.,1,1
2030,BACKGROUND,0,0
2031,AND,0,0
2032,AIM,0,0
2033,OF,0,0
2034,THE,0,0
2035,STUDY,0,0
2036,Non-obstructive,1,1
2037,prosthetic,1,1
2038,valve,1,1
2039,thrombosis,1,1
2040,(,1,0
2041,PVT,1,0
2042,),1,0
2043,is,0,0
2044,a,0,0
2045,unique,0,0
2046,subset,0,1
2047,that,0,0
2048,features,0,0
2049,clinical,0,0
2050,presentation,0,0
2051,without,0,1
2052,heart,0,1
2053,failure,0,1
2054,",",0,0
2055,and,0,0
2056,may,0,0
2057,be,0,0
2058,asymptomatic,0,1
2059,.,0,0
2060,Thrombolysis,0,0
2061,has,0,0
2062,been,0,0
2063,accepted,0,0
2064,for,0,0
2065,obstructive,0,1
2066,PVT,0,0
2067,",",0,0
2068,but,0,0
2069,treatment,0,0
2070,strategies,0,0
2071,of,0,0
2072,non-obstructive,0,1
2073,PVT,0,0
2074,are,0,0
2075,controversial,0,0
2076,.,0,0
2077,This,0,0
2078,study,0,0
2079,compared,0,0
2080,the,0,0
2081,efficacy,0,0
2082,and,0,0
2083,safety,0,0
2084,of,0,0
2085,thrombolysis,0,0
2086,and,0,0
2087,heparin,0,0
2088,treatment,0,0
2089,in,0,0
2090,these,0,0
2091,patients,0,1
2092,.,0,1
2093,METHODS,0,0
2094,Between,0,0
2095,1993,0,1
2096,and,0,0
2097,1998,0,1
2098,",",0,0
2099,20,1,1
2100,consecutive,1,1
2101,patients,1,1
2102,were,1,1
2103,found,1,0
2104,by,1,0
2105,multiplane,1,0
2106,transesophageal,1,1
2107,echocardiography,1,0
2108,(,1,0
2109,TEE,1,0
2110,),1,0
2111,to,1,0
2112,have,1,0
2113,non-obstructive,1,1
2114,PVT,1,0
2115,.,1,1
2116,TEE,0,0
2117,was,0,0
2118,performed,0,0
2119,for,0,0
2120,peripheral,0,0
2121,embolism,0,1
2122,in,0,0
2123,two,0,0
2124,patients,0,1
2125,",",0,0
2126,stroke,0,1
2127,or,0,1
2128,transient,0,0
2129,ischemic,0,1
2130,attack,0,1
2131,in,0,0
2132,six,0,0
2133,",",0,0
2134,stroke,0,1
2135,and,0,0
2136,fever,0,1
2137,in,0,0
2138,two,0,0
2139,",",0,0
2140,fever,0,1
2141,in,0,0
2142,one,0,0
2143,patient,0,0
2144,",",0,0
2145,as,0,0
2146,a,0,0
2147,routine,0,0
2148,postoperative,0,0
2149,examination,0,1
2150,in,0,0
2151,two,0,0
2152,patients,0,1
2153,",",0,0
2154,and,0,0
2155,for,0,0
2156,other,0,0
2157,reasons,0,0
2158,in,0,1
2159,seven,0,1
2160,.,0,1
2161,Patients,0,1
2162,were,0,0
2163,allocated,0,1
2164,to,0,0
2165,two,0,0
2166,groups,0,0
2167,:,0,1
2168,group,0,0
2169,I,0,1
2170,(,0,0
2171,n,0,1
2172,=,0,0
2173,8,0,0
2174,),0,0
2175,received,0,0
2176,streptokinase-mediated,0,0
2177,fibrinolysis,0,0
2178,;,0,0
2179,group,0,0
2180,II,0,1
2181,(,0,0
2182,n,0,1
2183,=,0,0
2184,12,0,1
2185,),0,0
2186,received,0,1
2187,intravenous,0,0
2188,heparin,0,0
2189,by,0,0
2190,infusion,0,0
2191,.,0,1
2192,Treatment,0,0
2193,was,0,0
2194,monitored,0,0
2195,using,0,0
2196,TEE,0,0
2197,.,0,1
2198,RESULTS,0,0
2199,There,0,0
2200,was,0,0
2201,no,0,0
2202,difference,0,0
2203,between,0,0
2204,patient,0,1
2205,groups,0,0
2206,with,0,1
2207,regard,0,0
2208,to,0,0
2209,sex,0,0
2210,",",0,0
2211,age,0,1
2212,",",0,0
2213,type,0,1
2214,of,0,0
2215,prosthesis,0,1
2216,and,0,0
2217,time,0,0
2218,since,0,0
2219,operation,0,0
2220,",",0,0
2221,though,0,0
2222,anticoagulant,0,0
2223,status,0,0
2224,was,0,0
2225,more,0,0
2226,often,0,0
2227,inadequate,0,0
2228,in,0,0
2229,group,0,1
2230,II,0,1
2231,.,0,0
2232,By,0,0
2233,TEE,0,0
2234,",",0,0
2235,valve,0,1
2236,motion,0,0
2237,was,0,0
2238,normal,0,1
2239,in,0,0
2240,all,0,1
2241,patients,0,1
2242,.,0,0
2243,In,0,0
2244,group,0,0
2245,I,0,1
2246,",",0,0
2247,all,0,0
2248,thrombi,0,0
2249,were,0,0
2250,mobile,0,1
2251,and,0,0
2252,5-13,0,1
2253,mm,0,0
2254,in,0,0
2255,diameter,0,0
2256,;,0,0
2257,in,0,0
2258,group,0,0
2259,II,0,1
2260,",",0,0
2261,all,0,0
2262,thrombi,0,0
2263,but,0,0
2264,three,0,0
2265,were,0,0
2266,mobile,0,1
2267,and,0,0
2268,3-18,0,1
2269,mm,0,0
2270,in,0,0
2271,diameter,0,0
2272,.,0,0
2273,In,0,0
2274,group,0,0
2275,I,0,1
2276,",",0,0
2277,thrombolysis,0,0
2278,was,0,0
2279,successful,0,0
2280,in,0,0
2281,all,0,0
2282,patients,0,1
2283,",",0,0
2284,without,0,1
2285,complications,0,0
2286,",",0,0
2287,within,0,0
2288,6-72,0,0
2289,h.,0,1
2290,In,0,0
2291,group,0,0
2292,II,0,1
2293,",",0,0
2294,heparin,0,0
2295,treatment,0,0
2296,was,0,0
2297,successful,0,0
2298,in,0,0
2299,six,0,1
2300,patients,0,1
2301,in,0,1
2302,3-32,0,1
2303,days,0,0
2304,.,0,1
2305,In,0,0
2306,one,0,0
2307,patient,0,1
2308,",",0,0
2309,seven,0,1
2310,days,0,0
2311,',0,1
2312,of,0,0
2313,unsuccessful,0,1
2314,heparin,0,0
2315,was,0,0
2316,followed,0,0
2317,by,0,0
2318,two,0,0
2319,months,0,0
2320,',0,1
2321,successful,0,0
2322,coumarin,0,1
2323,therapy,0,0
2324,.,0,0
2325,Among,0,1
2326,five,0,1
2327,unsuccessful,0,1
2328,cases,0,1
2329,",",0,0
2330,the,0,0
2331,thrombus,0,0
2332,size,0,0
2333,increased,0,0
2334,in,0,0
2335,four,0,1
2336,(,0,1
2337,three,0,0
2338,became,0,0
2339,obstructive,0,1
2340,in,0,0
2341,7-35,0,1
2342,days,0,1
2343,),0,1
2344,;,0,1
2345,all,0,0
2346,four,0,0
2347,patients,0,1
2348,were,0,1
2349,switched,0,0
2350,to,0,0
2351,fibrinolysis,0,0
2352,",",0,0
2353,which,0,0
2354,was,0,0
2355,successful,0,0
2356,without,0,1
2357,complications,0,0
2358,in,0,0
2359,12-60,0,0
2360,h.,0,1
2361,The,0,0
2362,fifth,0,0
2363,patient,0,0
2364,developed,0,0
2365,a,0,0
2366,stroke,0,1
2367,after,0,0
2368,nine,0,1
2369,days,0,0
2370,of,0,0
2371,heparin,0,0
2372,treatment,0,0
2373,and,0,0
2374,was,0,0
2375,subsequently,0,0
2376,operated,0,1
2377,on,0,0
2378,.,0,1
2379,CONCLUSIONS,0,0
2380,Non-obstructive,0,1
2381,PVT,0,0
2382,may,0,0
2383,be,0,0
2384,asymptomatic,0,1
2385,in,0,0
2386,one-third,0,1
2387,of,0,0
2388,patients,0,1
2389,.,0,1
2390,Thrombolysis,0,0
2391,is,0,0
2392,an,0,0
2393,efficient,0,0
2394,and,0,0
2395,safe,0,0
2396,treatment,0,0
2397,",",0,0
2398,and,0,0
2399,may,0,0
2400,be,0,0
2401,first-line,0,0
2402,therapy,0,0
2403,if,0,0
2404,there,0,0
2405,is,0,0
2406,no,0,0
2407,contraindication,0,0
2408,.,0,0
2409,Heparin,0,0
2410,treatment,0,0
2411,was,0,0
2412,successful,0,0
2413,in,0,0
2414,about,0,0
2415,one-half,0,0
2416,of,0,0
2417,our,0,0
2418,cases,0,1
2419,in,0,0
2420,the,0,0
2421,presence,0,0
2422,of,0,0
2423,sessile,0,1
2424,or,0,1
2425,small,0,0
2426,thrombi,0,1
2427,and,0,0
2428,inadequate,0,1
2429,anticoagulant,0,0
2430,status,0,0
2431,.,0,0
2432,In,0,0
2433,unsuccessful,0,1
2434,cases,0,1
2435,",",0,0
2436,thrombi,0,1
2437,became,0,0
2438,obstructive,0,1
2439,or,0,1
2440,caused,0,0
2441,stroke,0,1
2442,during,0,0
2443,heparin,0,0
2444,therapy,0,0
2445,",",0,0
2446,the,0,0
2447,adequate,0,0
2448,duration,0,0
2449,of,0,0
2450,which,0,0
2451,remains,0,0
2452,unclear,0,0
2453,.,0,0
2454,Effect,0,0
2455,of,0,0
2456,total,0,1
2457,androgen,0,0
2458,ablation,0,1
2459,on,0,0
2460,pathologic,0,0
2461,stage,0,1
2462,and,0,0
2463,resection,0,1
2464,limit,0,0
2465,status,0,0
2466,of,0,0
2467,prostate,1,1
2468,cancer,1,1
2469,.,1,1
2470,Initial,0,0
2471,results,0,0
2472,of,0,0
2473,the,0,0
2474,Italian,1,1
2475,PROSIT,1,0
2476,study,1,1
2477,.,1,0
2478,The,0,0
2479,likelihood,0,0
2480,of,0,0
2481,finding,0,0
2482,organ-confined,0,1
2483,untreated,0,1
2484,prostate,0,1
2485,cancer,0,1
2486,(,0,0
2487,PCa,0,0
2488,),0,0
2489,by,0,0
2490,pathological,0,0
2491,examination,0,0
2492,at,0,0
2493,the,0,0
2494,time,0,0
2495,of,0,0
2496,radical,0,0
2497,prostatectomy,0,1
2498,(,0,0
2499,RP,0,0
2500,),0,0
2501,is,0,0
2502,only,0,0
2503,50,0,0
2504,%,0,0
2505,in,0,0
2506,patients,0,1
2507,with,0,1
2508,clinically,0,0
2509,organ-confined,0,1
2510,disease,0,1
2511,.,0,0
2512,In,0,0
2513,addition,0,0
2514,",",0,0
2515,tumour,0,0
2516,is,0,0
2517,present,0,0
2518,at,0,0
2519,the,0,0
2520,resection,0,1
2521,margin,0,0
2522,in,0,0
2523,approximately,0,1
2524,30,0,0
2525,%,0,0
2526,of,0,0
2527,clinical,0,0
2528,T2,0,1
2529,(,0,0
2530,clinical,0,0
2531,stage,0,1
2532,B,0,1
2533,),0,1
2534,cases,0,1
2535,.,0,1
2536,The,0,0
2537,issue,0,0
2538,of,0,0
2539,clinical,0,0
2540,understaging,0,0
2541,and,0,0
2542,of,0,0
2543,resection,0,1
2544,limit,0,0
2545,positivity,0,0
2546,have,0,0
2547,led,0,0
2548,to,0,0
2549,the,0,0
2550,development,0,0
2551,of,0,0
2552,novel,0,0
2553,management,0,1
2554,practices,0,0
2555,",",0,0
2556,including,0,0
2557,neoadjuvant,0,0
2558,hormonal,0,1
2559,therapy,0,0
2560,(,0,0
2561,NHT,0,0
2562,),0,0
2563,.,0,0
2564,The,0,0
2565,optimal,0,0
2566,duration,0,0
2567,of,0,0
2568,NHT,0,0
2569,is,0,0
2570,unknown,0,0
2571,.,0,0
2572,We,0,0
2573,undertook,0,0
2574,the,0,0
2575,present,0,0
2576,analysis,0,0
2577,to,0,0
2578,evaluate,0,0
2579,the,0,0
2580,effect,0,0
2581,of,0,0
2582,NHT,0,0
2583,on,0,0
2584,pathologic,0,0
2585,stage,0,1
2586,of,0,0
2587,PCa,0,0
2588,and,0,0
2589,resection,0,1
2590,limit,0,0
2591,status,0,0
2592,in,0,0
2593,patients,1,1
2594,with,1,1
2595,prostate,1,1
2596,cancer,1,1
2597,and,1,0
2598,treated,1,1
2599,with,1,1
2600,total,1,1
2601,androgen,1,0
2602,ablation,1,1
2603,either,1,0
2604,for,1,0
2605,three,1,0
2606,or,1,1
2607,six,1,1
2608,months,1,0
2609,before,1,1
2610,RP,1,1
2611,.,1,1
2612,Between,1,0
2613,January,1,1
2614,1996,1,1
2615,and,1,0
2616,February,1,1
2617,1998,1,1
2618,",",1,0
2619,259,1,1
2620,men,1,1
2621,with,1,1
2622,prostate,1,1
2623,cancer,1,1
2624,underwent,1,1
2625,radical,1,0
2626,retropubic,1,1
2627,prostatectomy,1,1
2628,and,1,0
2629,bilateral,1,0
2630,pelvic,1,1
2631,node,1,1
2632,dissection,1,1
2633,in,1,0
2634,the,1,0
2635,26,1,1
2636,centres,1,1
2637,participating,1,1
2638,in,1,0
2639,the,1,0
2640,Italian,1,1
2641,randomised,1,0
2642,prospective,1,1
2643,PROSIT,1,0
2644,study,1,1
2645,.,1,0
2646,Whole,0,0
2647,mount,0,0
2648,sectioning,0,0
2649,of,0,0
2650,the,0,0
2651,complete,0,0
2652,RP,0,0
2653,specimens,0,1
2654,was,0,0
2655,adopted,0,0
2656,in,0,0
2657,each,0,0
2658,centre,0,1
2659,for,0,0
2660,accurately,0,0
2661,evaluating,0,0
2662,the,0,0
2663,pathologic,0,0
2664,stage,0,1
2665,and,0,0
2666,resection,0,1
2667,limit,0,0
2668,status,0,0
2669,.,0,0
2670,By,0,0
2671,February,0,1
2672,1998,0,1
2673,",",0,0
2674,haematoxylin,0,0
2675,and,0,0
2676,eosin,0,0
2677,stained,0,0
2678,sections,0,1
2679,from,0,1
2680,155,0,1
2681,RP,0,1
2682,specimens,0,1
2683,had,0,1
2684,been,0,0
2685,received,0,0
2686,and,0,0
2687,evaluated,0,0
2688,by,0,0
2689,the,0,0
2690,reviewing,0,0
2691,pathologist,0,1
2692,(,0,0
2693,RM,0,1
2694,),0,1
2695,.,0,1
2696,64,0,1
2697,cases,0,0
2698,had,0,1
2699,not,0,0
2700,been,0,0
2701,treated,0,0
2702,with,0,1
2703,total,0,1
2704,androgen,0,0
2705,ablation,0,1
2706,(,0,0
2707,e.g,0,0
2708,.,0,1
2709,NHT,0,0
2710,),0,0
2711,before,0,0
2712,RP,0,0
2713,was,0,0
2714,performed,0,0
2715,",",0,0
2716,whereas,0,0
2717,58,0,1
2718,and,0,1
2719,33,0,1
2720,had,0,1
2721,been,0,0
2722,treated,0,1
2723,for,0,0
2724,three,0,0
2725,and,0,1
2726,six,0,1
2727,months,0,0
2728,",",0,0
2729,respectively,0,0
2730,.,0,0
2731,114,1,1
2732,patients,1,1
2733,were,0,1
2734,clinical,0,0
2735,stage,0,1
2736,B,0,1
2737,whereas,0,0
2738,41,0,1
2739,were,0,1
2740,clinical,0,0
2741,stage,0,1
2742,C.,0,0
2743,After,0,0
2744,three,0,0
2745,months,0,0
2746,of,0,0
2747,total,0,1
2748,androgen,0,0
2749,ablation,0,1
2750,",",0,0
2751,pathological,0,0
2752,stage,0,1
2753,B,0,0
2754,was,0,0
2755,more,0,0
2756,prevalent,0,0
2757,among,0,0
2758,patients,0,1
2759,with,0,1
2760,clinical,0,0
2761,B,0,1
2762,tumours,0,1
2763,",",0,0
2764,compared,0,0
2765,with,0,1
2766,untreated,0,1
2767,patients,0,1
2768,(,0,1
2769,57,0,1
2770,%,0,0
2771,in,0,0
2772,treated,0,1
2773,patients,0,1
2774,vs.,0,0
2775,36,0,1
2776,%,0,0
2777,in,0,0
2778,untreated,0,1
2779,),0,1
2780,.,0,0
2781,The,0,0
2782,percentage,0,0
2783,of,0,0
2784,cancers,0,1
2785,with,0,1
2786,negative,0,1
2787,margins,0,0
2788,was,0,0
2789,statistically,0,0
2790,significantly,0,0
2791,greater,0,0
2792,in,0,0
2793,patients,0,1
2794,treated,0,1
2795,with,0,1
2796,neoadjuvant,0,0
2797,therapy,0,0
2798,than,0,0
2799,those,0,0
2800,treated,0,1
2801,with,0,1
2802,immediate,0,0
2803,surgery,0,1
2804,alone,0,0
2805,(,0,0
2806,69,0,1
2807,%,0,0
2808,vs.,0,0
2809,42,0,1
2810,%,0,0
2811,",",0,0
2812,respectively,0,0
2813,),0,0
2814,.,0,0
2815,After,0,0
2816,six,0,1
2817,months,0,0
2818,of,0,0
2819,NHT,0,0
2820,therapy,0,0
2821,the,0,0
2822,proportion,0,0
2823,of,0,0
2824,patients,0,1
2825,with,0,1
2826,pathological,0,1
2827,stage,0,1
2828,B,0,1
2829,(,0,0
2830,67,0,1
2831,%,0,0
2832,vs.,0,0
2833,36,0,1
2834,%,0,0
2835,",",0,0
2836,respectively,0,0
2837,),0,0
2838,and,0,0
2839,negative,0,1
2840,margins,0,0
2841,was,0,0
2842,greater,0,0
2843,than,0,0
2844,after,0,0
2845,3,0,0
2846,months,0,0
2847,(,0,1
2848,92,0,1
2849,%,0,0
2850,vs.,0,0
2851,42,0,1
2852,%,0,0
2853,",",0,0
2854,respectively,0,0
2855,),0,0
2856,.,0,0
2857,For,0,0
2858,clinical,0,0
2859,C,0,0
2860,tumours,0,1
2861,",",0,0
2862,the,0,0
2863,prevalence,0,0
2864,of,0,0
2865,pathological,0,0
2866,stage,0,1
2867,B,0,1
2868,and,0,0
2869,negative,0,0
2870,margins,0,0
2871,in,0,0
2872,the,0,0
2873,patients,0,1
2874,treated,0,1
2875,for,0,0
2876,either,0,0
2877,3,0,0
2878,or,0,1
2879,6,0,0
2880,months,0,0
2881,was,0,0
2882,not,0,0
2883,as,0,0
2884,high,0,0
2885,as,0,0
2886,in,0,0
2887,the,0,0
2888,clinical,0,0
2889,B,0,0
2890,tumours,0,1
2891,",",0,0
2892,when,0,0
2893,compared,0,0
2894,with,0,0
2895,the,0,0
2896,untreated,0,1
2897,group,0,0
2898,(,0,0
2899,pathological,0,0
2900,stage,0,1
2901,B,0,1
2902,:,0,1
2903,31,0,1
2904,%,0,0
2905,and,0,0
2906,33,0,1
2907,%,0,0
2908,vs.,0,0
2909,6,0,0
2910,%,0,0
2911,in,0,0
2912,the,0,0
2913,clinical,0,0
2914,C,0,0
2915,cases,0,1
2916,",",0,0
2917,respectively,0,0
2918,.,0,0
2919,Negative,0,0
2920,margins,0,1
2921,:,0,1
2922,56,0,1
2923,%,0,0
2924,and,0,0
2925,67,0,1
2926,%,0,0
2927,vs.,0,0
2928,31,0,1
2929,%,0,0
2930,",",0,0
2931,respectively,0,0
2932,),0,0
2933,.,0,0
2934,The,0,0
2935,initial,0,0
2936,results,0,0
2937,of,0,0
2938,this,0,0
2939,study,0,0
2940,suggest,0,0
2941,that,0,0
2942,total,0,1
2943,androgen,0,0
2944,ablation,0,1
2945,before,0,0
2946,RP,0,0
2947,is,0,0
2948,beneficial,0,0
2949,in,0,0
2950,men,0,1
2951,with,0,1
2952,clinical,0,0
2953,stage,0,1
2954,B,0,0
2955,because,0,0
2956,of,0,0
2957,the,0,0
2958,significant,0,0
2959,pathological,0,0
2960,downstaging,0,0
2961,and,0,0
2962,decrease,0,0
2963,in,0,0
2964,the,0,0
2965,number,0,0
2966,of,0,0
2967,positive,0,0
2968,margins,0,0
2969,in,0,0
2970,the,0,0
2971,RP,0,0
2972,specimens,0,0
2973,.,0,1
2974,These,0,0
2975,two,0,0
2976,effects,0,0
2977,are,0,0
2978,more,0,0
2979,pronounced,0,0
2980,after,0,0
2981,six,0,1
2982,months,0,0
2983,of,0,0
2984,NHT,0,0
2985,than,0,0
2986,after,0,0
2987,three,0,1
2988,months,0,0
2989,of,0,1
2990,therapy,0,0
2991,.,0,0
2992,The,0,0
2993,same,0,0
2994,degree,0,0
2995,of,0,0
2996,beneficial,0,0
2997,effects,0,0
2998,are,0,0
2999,not,0,0
3000,observed,0,0
3001,in,0,0
3002,clinical,0,0
3003,C,0,0
3004,tumours,0,1
3005,.,0,1
3006,Problem-solving,0,0
3007,counseling,0,0
3008,for,0,0
3009,caregivers,0,1
3010,of,0,0
3011,the,0,0
3012,cognitively,0,1
3013,impaired,0,1
3014,:,0,1
3015,effective,0,0
3016,for,0,1
3017,whom,0,1
3018,?,0,1
3019,BACKGROUND,0,0
3020,Individualized,0,0
3021,problem-solving,0,0
3022,counseling,0,0
3023,for,0,0
3024,caregivers,0,1
3025,of,0,0
3026,cognitively,0,1
3027,impaired,0,1
3028,relatives,0,1
3029,is,0,0
3030,thought,0,0
3031,to,0,0
3032,help,0,0
3033,caregivers,0,1
3034,cope,0,0
3035,with,0,1
3036,the,0,0
3037,stress,0,0
3038,and,0,0
3039,burden,0,0
3040,of,0,0
3041,caregiving,0,0
3042,.,0,1
3043,Few,0,0
3044,studies,0,0
3045,have,0,0
3046,shown,0,0
3047,the,0,0
3048,effectiveness,0,0
3049,of,0,0
3050,counseling,0,0
3051,for,0,0
3052,these,0,0
3053,caregivers,0,1
3054,.,0,1
3055,OBJECTIVES,0,0
3056,To,0,0
3057,determine,0,0
3058,the,0,0
3059,effectiveness,0,0
3060,of,0,0
3061,individualized,0,0
3062,problem-solving,0,0
3063,counseling,0,0
3064,by,0,0
3065,nurses,0,1
3066,for,0,1
3067,caregivers,0,1
3068,and,0,1
3069,the,0,0
3070,expenditures,0,0
3071,of,0,0
3072,health,0,1
3073,care,0,1
3074,utilization,0,0
3075,.,0,1
3076,METHOD,0,0
3077,Caregivers,1,1
3078,(,1,0
3079,n,1,1
3080,=,1,0
3081,77,1,1
3082,),1,0
3083,of,1,0
3084,the,1,0
3085,cognitively,1,1
3086,impaired,1,0
3087,living,1,1
3088,at,1,0
3089,home,1,0
3090,were,0,0
3091,randomized,0,0
3092,to,0,0
3093,receive,0,0
3094,nurse,0,0
3095,counseling,0,0
3096,or,0,1
3097,not,0,0
3098,.,0,0
3099,Psychosocial,0,0
3100,adjustment,0,0
3101,to,0,0
3102,their,0,0
3103,relative,0,0
3104,'s,0,0
3105,illness,0,1
3106,",",0,0
3107,psychological,0,0
3108,distress,0,0
3109,",",0,0
3110,burden,0,0
3111,",",0,0
3112,coping,0,0
3113,skills,0,0
3114,",",0,0
3115,and,0,0
3116,expenditures,0,0
3117,were,0,0
3118,measured,0,0
3119,after,0,0
3120,6,0,0
3121,months,0,0
3122,and,0,1
3123,1,0,1
3124,year,0,1
3125,.,0,1
3126,RESULTS,0,0
3127,Although,0,0
3128,on,0,0
3129,average,0,0
3130,",",0,0
3131,all,0,0
3132,caregivers,0,1
3133,receiving,0,1
3134,nurse,0,1
3135,counseling,0,0
3136,indicated,0,0
3137,no,0,0
3138,improvement,0,0
3139,in,0,0
3140,psychosocial,0,1
3141,adjustment,0,0
3142,to,0,0
3143,their,0,0
3144,relative,0,0
3145,'s,0,0
3146,illness,0,1
3147,",",0,0
3148,psychological,0,0
3149,distress,0,0
3150,",",0,0
3151,or,0,0
3152,caregiver,0,0
3153,burden,0,0
3154,",",0,0
3155,they,0,0
3156,found,0,0
3157,counseling,0,0
3158,very,0,0
3159,helpful,0,0
3160,and,0,0
3161,it,0,0
3162,was,0,0
3163,effective,0,0
3164,for,0,0
3165,a,0,0
3166,subgroup,0,1
3167,of,0,0
3168,caregivers,0,1
3169,.,0,1
3170,Those,0,1
3171,with,0,0
3172,poor,0,0
3173,logical,0,0
3174,analysis,0,0
3175,coping,0,0
3176,skills,0,0
3177,at,0,1
3178,baseline,0,0
3179,had,0,1
3180,decreased,0,0
3181,psychological,0,0
3182,distress,0,1
3183,(,0,0
3184,F,0,1
3185,(,0,1
3186,"1,53",0,1
3187,),0,1
3188,=,0,0
3189,9.7,0,0
3190,",",0,0
3191,p,0,0
3192,=,0,0
3193,.003,0,0
3194,),0,0
3195,and,0,0
3196,improved,0,0
3197,psychosocial,0,0
3198,adjustment,0,0
3199,(,0,0
3200,F,0,1
3201,(,0,1
3202,"1,53",0,1
3203,),0,1
3204,=,0,0
3205,4.7,0,0
3206,",",0,0
3207,p,0,0
3208,=,0,0
3209,.035,0,0
3210,),0,0
3211,after,0,0
3212,1,0,0
3213,year,0,1
3214,.,0,1
3215,Caregivers,0,0
3216,in,0,0
3217,control,0,1
3218,and,0,0
3219,counseling,0,0
3220,groups,0,0
3221,whose,0,1
3222,relatives,0,1
3223,entered,0,1
3224,a,0,0
3225,nursing,0,1
3226,home,0,0
3227,improved,0,0
3228,their,0,0
3229,psychosocial,0,1
3230,adjustment,0,0
3231,23,0,1
3232,%,0,0
3233,on,0,0
3234,average,0,0
3235,whereas,0,0
3236,those,0,1
3237,continuing,0,0
3238,to,0,0
3239,live,0,0
3240,in,0,0
3241,the,0,0
3242,community,0,0
3243,decreased,0,0
3244,by,0,0
3245,8,0,0
3246,%,0,0
3247,.,0,1
3248,Almost,0,0
3249,half,0,1
3250,as,0,0
3251,many,0,1
3252,relatives,0,1
3253,entered,0,1
3254,nursing,0,1
3255,homes,0,1
3256,in,0,0
3257,the,0,0
3258,counseling,0,0
3259,group,0,0
3260,(,0,0
3261,n,0,1
3262,=,0,0
3263,9,0,0
3264,vs.,0,0
3265,n,0,1
3266,=,0,0
3267,5,0,1
3268,),0,0
3269,but,0,0
3270,these,0,0
3271,compared,0,0
3272,to,0,0
3273,control,0,0
3274,group,0,0
3275,relatives,0,1
3276,had,0,1
3277,greater,0,0
3278,annualized,0,0
3279,per,0,0
3280,person,0,1
3281,expenditures,0,0
3282,for,0,0
3283,health,0,1
3284,and,0,0
3285,social,0,0
3286,services,0,1
3287,(,0,1
3288,Cdn,0,1
3289,$,0,0
3290,"23,437",0,1
3291,vs.,0,0
3292,Cdn,0,1
3293,$,0,0
3294,"15,151",0,1
3295,),0,0
3296,.,0,1
3297,CONCLUSIONS,0,0
3298,Caregivers,0,1
3299,found,0,0
3300,nurse,0,1
3301,counseling,0,0
3302,most,0,0
3303,helpful,0,0
3304,.,0,0
3305,Those,0,0
3306,indicating,0,0
3307,infrequent,0,0
3308,use,0,0
3309,of,0,0
3310,logical,0,0
3311,analysis,0,0
3312,coping,0,0
3313,skills,0,0
3314,showed,0,0
3315,benefits,0,0
3316,.,0,1
3317,A,0,0
3318,randomized,0,0
3319,phase,0,1
3320,II,0,1
3321,trial,0,0
3322,of,0,0
3323,5-fluorouracil,0,0
3324,",",0,0
3325,with,0,1
3326,or,0,0
3327,without,0,1
3328,human,0,0
3329,interferon-beta,0,0
3330,",",0,0
3331,for,0,0
3332,advanced,1,1
3333,colorectal,1,1
3334,cancer,1,1
3335,.,1,0
3336,This,0,0
3337,study,0,0
3338,compared,0,0
3339,the,0,0
3340,efficacy,0,0
3341,and,0,0
3342,safety,0,0
3343,of,0,0
3344,5-fluorouracil,0,0
3345,(,0,1
3346,5-FU,0,0
3347,),0,0
3348,monotherapy,0,0
3349,to,0,0
3350,that,0,0
3351,of,0,0
3352,5-FU,0,0
3353,combined,0,0
3354,with,0,1
3355,natural,0,0
3356,human,0,1
3357,interferon-beta,0,0
3358,(,0,0
3359,IFN-beta,0,0
3360,),0,0
3361,in,0,0
3362,patients,1,1
3363,with,1,1
3364,unresectable,1,1
3365,",",1,0
3366,advanced,1,1
3367,colorectal,1,1
3368,carcinoma,1,1
3369,.,1,1
3370,Forty-nine,1,1
3371,chemotherapy-naive,1,1
3372,patients,1,1
3373,were,1,1
3374,randomized,1,1
3375,to,0,0
3376,5-FU,0,0
3377,alone,0,0
3378,or,0,0
3379,to,0,0
3380,the,0,0
3381,combination,0,0
3382,.,0,0
3383,All,0,0
3384,patients,0,1
3385,received,0,1
3386,750,0,1
3387,mg,0,0
3388,m,0,1
3389,(,0,1
3390,-2,0,0
3391,),0,0
3392,day,0,0
3393,(,0,0
3394,-1,0,0
3395,),0,0
3396,5-FU,0,0
3397,for,0,0
3398,5,0,0
3399,days,0,0
3400,by,0,0
3401,continuous,0,0
3402,intravenous,0,0
3403,(,0,1
3404,i.v,0,0
3405,.,0,1
3406,),0,0
3407,infusion,0,0
3408,",",0,0
3409,followed,0,0
3410,after,0,0
3411,day,0,0
3412,15,0,1
3413,by,0,0
3414,a,0,0
3415,weekly,0,0
3416,i.v,0,0
3417,.,0,0
3418,bolus,0,0
3419,of,0,0
3420,750,0,1
3421,mg,0,0
3422,m,0,1
3423,(,0,1
3424,-2,0,0
3425,),0,1
3426,.,0,1
3427,IFN-beta,0,0
3428,was,0,0
3429,injected,0,0
3430,intramuscularly,0,0
3431,three,0,0
3432,times,0,0
3433,weekly,0,0
3434,at,0,0
3435,9,0,0
3436,M,0,0
3437,IU,0,0
3438,.,0,1
3439,Treatment,0,0
3440,continued,0,0
3441,for,0,0
3442,52,0,1
3443,weeks,0,0
3444,",",0,0
3445,or,0,1
3446,until,0,0
3447,disease,0,1
3448,progression,0,0
3449,or,0,1
3450,intolerable,0,0
3451,toxicity,0,0
3452,.,0,1
3453,Clinical,0,0
3454,endpoints,0,0
3455,were,0,1
3456,tumor,0,1
3457,response,0,0
3458,",",0,0
3459,time,0,0
3460,to,0,0
3461,progression,0,0
3462,",",0,0
3463,survival,0,0
3464,and,0,0
3465,toxicity,0,0
3466,.,0,0
3467,The,0,0
3468,addition,0,0
3469,of,0,0
3470,IFN-3,0,1
3471,to,0,0
3472,5-FU,0,0
3473,significantly,0,0
3474,improved,0,0
3475,response,0,0
3476,rate,0,0
3477,(,0,0
3478,33.3,0,0
3479,%,0,0
3480,vs,0,0
3481,4.5,0,0
3482,%,0,0
3483,for,0,0
3484,evaluable,0,1
3485,patients,0,1
3486,;,0,1
3487,P,0,0
3488,=,0,0
3489,0.021,0,0
3490,),0,0
3491,",",0,0
3492,time,0,0
3493,to,0,0
3494,progression,0,0
3495,(,0,0
3496,median,0,1
3497,7.2,0,1
3498,vs,0,0
3499,4.2,0,1
3500,months,0,1
3501,;,0,1
3502,P,0,0
3503,=,0,0
3504,0.0435,0,0
3505,),0,0
3506,",",0,0
3507,and,0,0
3508,survival,0,0
3509,time,0,0
3510,(,0,1
3511,median,0,1
3512,15.9,0,1
3513,vs,0,0
3514,7.2,0,1
3515,months,0,1
3516,;,0,1
3517,P,0,0
3518,=,0,0
3519,0.038,0,0
3520,),0,0
3521,without,0,1
3522,significantly,0,0
3523,increasing,0,0
3524,toxicity,0,0
3525,compared,0,0
3526,to,0,0
3527,5-FU,0,0
3528,alone,0,0
3529,.,0,1
3530,Cumulative,0,0
3531,5-FU,0,0
3532,dose,0,0
3533,was,0,0
3534,higher,0,0
3535,with,0,1
3536,combined,0,0
3537,therapy,0,0
3538,(,0,0
3539,P,0,0
3540,<,0,0
3541,0.001,0,0
3542,),0,1
3543,:,0,1
3544,more,0,0
3545,patients,0,1
3546,receiving,0,1
3547,monotherapy,0,1
3548,discontinued,0,0
3549,treatment,0,0
3550,because,0,0
3551,of,0,0
3552,disease,0,1
3553,progression,0,0
3554,.,0,1
3555,Fever,0,0
3556,was,0,0
3557,more,0,0
3558,frequent,0,0
3559,with,0,0
3560,combined,0,0
3561,therapy,0,0
3562,(,0,0
3563,P,0,0
3564,=,0,0
3565,0.008,0,0
3566,),0,1
3567,;,0,0
3568,there,0,0
3569,were,0,0
3570,no,0,0
3571,other,0,0
3572,differences,0,0
3573,in,0,1
3574,toxicity,0,0
3575,.,0,0
3576,The,0,0
3577,only,0,0
3578,grade,0,1
3579,IV,0,0
3580,toxicity,0,0
3581,observed,0,0
3582,was,0,0
3583,neutropenia,0,0
3584,(,0,1
3585,two,0,0
3586,patients,0,1
3587,per,0,1
3588,group,0,1
3589,),0,0
3590,.,0,0
3591,A,0,0
3592,randomized,0,0
3593,phase,0,1
3594,III,0,0
3595,trial,0,0
3596,has,0,0
3597,been,0,0
3598,initiated,0,0
3599,to,0,0
3600,confirm,0,0
3601,the,0,0
3602,synergy,0,0
3603,between,0,0
3604,5-FU,0,0
3605,and,0,1
3606,IFN-beta,0,0
3607,.,0,1
3608,Comparison,0,0
3609,of,0,0
3610,the,0,0
3611,relative,0,0
3612,efficacy,0,0
3613,of,0,0
3614,formoterol,0,0
3615,and,0,0
3616,salmeterol,0,0
3617,in,0,0
3618,asthmatic,1,1
3619,patients,1,1
3620,.,1,1
3621,Studies,0,0
3622,performed,0,0
3623,on,0,0
3624,airway,0,1
3625,smooth,0,1
3626,muscle,0,0
3627,in,0,0
3628,vitro,0,0
3629,have,0,0
3630,indicated,0,0
3631,that,0,0
3632,salmeterol,0,0
3633,is,0,0
3634,a,0,0
3635,partial,0,0
3636,agonist,0,0
3637,on,0,0
3638,the,0,0
3639,beta2-receptor,0,0
3640,in,0,0
3641,comparison,0,0
3642,to,0,0
3643,formoterol,0,0
3644,.,0,0
3645,In,0,0
3646,the,0,0
3647,present,0,0
3648,study,0,0
3649,we,0,0
3650,evaluated,0,0
3651,whether,0,0
3652,these,0,0
3653,pharmacological,0,0
3654,differences,0,0
3655,between,0,0
3656,salmeterol,0,0
3657,and,0,0
3658,formoterol,0,0
3659,also,0,0
3660,are,0,0
3661,applicable,0,0
3662,to,0,0
3663,asthmatic,1,1
3664,patients,1,1
3665,.,1,1
3666,The,0,0
3667,protective,0,0
3668,effects,0,0
3669,by,0,0
3670,increasing,0,0
3671,cumulative,0,0
3672,doses,0,0
3673,of,0,0
3674,formoterol,0,0
3675,(,0,0
3676,12,0,0
3677,",",0,0
3678,60,0,1
3679,",",0,0
3680,120,0,1
3681,micrograms,0,0
3682,),0,1
3683,and,0,0
3684,salmeterol,0,0
3685,(,0,0
3686,50,0,1
3687,",",0,0
3688,250,0,0
3689,",",0,0
3690,500,0,0
3691,micrograms,0,0
3692,),0,1
3693,on,0,0
3694,methacholine-induced,0,0
3695,bronchoconstriction,0,1
3696,were,0,0
3697,evaluated,0,0
3698,in,0,0
3699,a,0,0
3700,double-blind,0,0
3701,",",0,0
3702,crossover,0,0
3703,",",0,0
3704,placebo-controlled,0,0
3705,design,0,0
3706,.,0,1
3707,Patients,1,1
3708,were,0,0
3709,regularly,0,0
3710,treated,0,1
3711,with,0,1
3712,salbutamol,0,0
3713,200,0,1
3714,micrograms,0,0
3715,twice,0,0
3716,daily,0,0
3717,during,0,0
3718,the,0,0
3719,study,0,0
3720,period,0,0
3721,",",0,0
3722,to,0,0
3723,avoid,0,0
3724,variability,0,0
3725,in,0,0
3726,beta2-adrenoceptor,0,0
3727,tolerance,0,0
3728,.,0,0
3729,S-potassium,0,0
3730,",",0,0
3731,heart,0,1
3732,rate,0,0
3733,corrected,0,0
3734,Q-T,0,0
3735,interval,0,0
3736,(,0,0
3737,Q-Tc,0,0
3738,),0,0
3739,",",0,0
3740,and,0,0
3741,tremor,0,1
3742,score,0,0
3743,were,0,0
3744,followed,0,0
3745,as,0,0
3746,measures,0,0
3747,of,0,1
3748,systemic,0,1
3749,effects,0,0
3750,.,0,1
3751,Formoterol,0,0
3752,dose-dependently,0,0
3753,protected,0,0
3754,against,0,0
3755,methacholine,0,0
3756,responsiveness,0,0
3757,(,0,0
3758,4.6,0,0
3759,doubling,0,0
3760,doses,0,0
3761,after,0,1
3762,120,0,1
3763,micrograms,0,0
3764,),0,1
3765,.,0,1
3766,Salmeterol,0,0
3767,",",0,0
3768,however,0,0
3769,",",0,0
3770,showed,0,0
3771,a,0,0
3772,flatter,0,0
3773,dose-response,0,0
3774,curve,0,0
3775,",",0,0
3776,and,0,0
3777,a,0,0
3778,significantly,0,0
3779,weaker,0,0
3780,maximal,0,0
3781,protective,0,0
3782,effect,0,0
3783,(,0,0
3784,2.8,0,0
3785,doubling,0,0
3786,doses,0,0
3787,after,0,1
3788,250,0,1
3789,micrograms,0,0
3790,),0,1
3791,.,0,1
3792,Formoterol,0,0
3793,caused,0,0
3794,a,0,0
3795,significantly,0,0
3796,higher,0,0
3797,tremor,0,0
3798,score,0,0
3799,and,0,0
3800,a,0,0
3801,larger,0,0
3802,drop,0,0
3803,in,0,0
3804,S-potassium,0,0
3805,than,0,0
3806,salmeterol,0,0
3807,at,0,0
3808,the,0,0
3809,highest,0,0
3810,doses,0,0
3811,.,0,1
3812,These,0,0
3813,data,0,0
3814,show,0,0
3815,that,0,0
3816,salmeterol,0,0
3817,is,0,0
3818,a,0,0
3819,partial,0,0
3820,agonist,0,0
3821,on,0,0
3822,the,0,0
3823,beta2-receptor,0,0
3824,in,0,0
3825,relation,0,0
3826,to,0,0
3827,formoterol,0,0
3828,in,0,0
3829,human,0,1
3830,airways,0,1
3831,in,0,1
3832,vivo,0,0
3833,.,0,1
3834,Further,0,0
3835,studies,0,0
3836,are,0,0
3837,required,0,0
3838,to,0,0
3839,document,0,0
3840,the,0,0
3841,clinical,0,0
3842,consequences,0,0
3843,of,0,0
3844,this,0,0
3845,finding,0,0
3846,",",0,0
3847,for,0,0
3848,example,0,0
3849,in,0,0
3850,severe,1,1
3851,asthmatic,1,1
3852,patients,1,1
3853,.,1,1
3854,Moderate-intensity,0,0
3855,exercise,0,0
3856,training,0,0
3857,with,0,1
3858,elements,0,0
3859,of,0,0
3860,step,0,0
3861,aerobics,0,1
3862,in,0,0
3863,patients,1,1
3864,with,1,1
3865,severe,1,1
3866,chronic,1,1
3867,heart,1,1
3868,failure,1,1
3869,.,1,0
3870,OBJECTIVE,0,0
3871,To,0,0
3872,evaluate,0,0
3873,whether,0,0
3874,a,0,0
3875,specific,0,0
3876,program,0,0
3877,of,0,0
3878,moderate-intensity,0,1
3879,step,0,0
3880,aerobics,0,0
3881,training,0,0
3882,may,0,0
3883,be,0,0
3884,sufficient,0,0
3885,to,0,0
3886,improve,0,0
3887,the,0,0
3888,exercise,0,0
3889,tolerance,0,0
3890,of,0,0
3891,patients,1,1
3892,with,1,1
3893,severe,1,1
3894,chronic,1,1
3895,heart,1,1
3896,failure,1,1
3897,.,1,0
3898,PATIENTS,0,0
3899,Twenty-six,1,1
3900,patients,1,1
3901,(,1,1
3902,22,1,1
3903,men,1,1
3904,",",1,1
3905,4,1,0
3906,women,1,1
3907,;,1,1
3908,mean,1,1
3909,+/-,1,0
3910,SD,1,0
3911,age,1,1
3912,",",1,0
3913,54,1,1
3914,+/-,1,0
3915,9yrs,1,1
3916,),1,0
3917,with,1,1
3918,a,1,0
3919,history,1,1
3920,of,1,0
3921,severe,1,1
3922,chronic,1,1
3923,heart,1,1
3924,failure,1,1
3925,(,1,0
3926,left,1,1
3927,ventricular,1,0
3928,ejection,1,1
3929,fraction,1,1
3930,of,1,0
3931,18,1,1
3932,%,1,0
3933,+/-,1,0
3934,8,1,0
3935,%,1,0
3936,),1,1
3937,.,1,1
3938,STUDY,0,0
3939,DESIGN,0,0
3940,Prospective,0,0
3941,",",0,0
3942,randomized,0,0
3943,",",0,0
3944,controlled,0,0
3945,trial,0,0
3946,.,0,1
3947,Patients,0,1
3948,were,0,0
3949,randomized,0,1
3950,into,0,0
3951,exercise,0,0
3952,and,0,0
3953,control,0,1
3954,groups,0,0
3955,.,0,1
3956,All,0,1
3957,patients,0,1
3958,underwent,0,1
3959,a,0,0
3960,clinical,0,0
3961,examination,0,0
3962,and,0,0
3963,a,0,0
3964,ramp,0,0
3965,pattern,0,1
3966,cycle,0,0
3967,exercise,0,0
3968,test,0,0
3969,before,0,0
3970,and,0,0
3971,after,0,0
3972,the,0,0
3973,observation,0,0
3974,period,0,0
3975,.,0,0
3976,The,0,0
3977,exercise,0,0
3978,group,0,0
3979,underwent,0,1
3980,a,0,0
3981,moderate-intensity,0,0
3982,(,0,0
3983,50,0,0
3984,%,0,0
3985,of,0,0
3986,peak,0,0
3987,oxygen,0,0
3988,uptake,0,0
3989,),0,0
3990,12-week,0,0
3991,training,0,0
3992,program,0,0
3993,",",0,0
3994,progressing,0,0
3995,to,0,0
3996,100,0,0
3997,minutes,0,0
3998,per,0,0
3999,week,0,0
4000,of,0,0
4001,step,0,0
4002,aerobics,0,1
4003,and,0,1
4004,50,0,1
4005,minutes,0,0
4006,per,0,0
4007,week,0,0
4008,of,0,0
4009,cycling,0,0
4010,.,0,0
4011,The,0,0
4012,control,0,0
4013,group,0,0
4014,did,0,0
4015,not,0,0
4016,perform,0,0
4017,a,0,0
4018,training,0,0
4019,program,0,0
4020,.,0,1
4021,MAIN,0,0
4022,OUTCOME,0,0
4023,MEASURES,0,0
4024,Peak,0,0
4025,oxygen,0,0
4026,uptake,0,0
4027,",",0,0
4028,peak,0,0
4029,workload,0,0
4030,",",0,0
4031,percent,0,0
4032,of,0,0
4033,predicted,0,0
4034,power,0,0
4035,ability,0,0
4036,.,0,0
4037,RESULTS,0,0
4038,Significant,0,0
4039,increases,0,0
4040,in,0,0
4041,peak,0,0
4042,oxygen,0,0
4043,uptake,0,0
4044,(,0,0
4045,15,0,1
4046,+/-,0,0
4047,3.4,0,1
4048,to,0,1
4049,18.5,0,0
4050,+/-,0,0
4051,2.9mL/kg/min,0,0
4052,;,0,1
4053,p,0,0
4054,=,0,0
4055,.001,0,0
4056,),0,0
4057,",",0,0
4058,peak,0,0
4059,workload,0,0
4060,(,0,0
4061,77,0,1
4062,+/-,0,0
4063,26,0,1
4064,to,0,1
4065,99,0,1
4066,+/-,0,0
4067,31,0,1
4068,watts,0,1
4069,;,0,0
4070,p,0,0
4071,=,0,0
4072,.000,0,0
4073,),0,0
4074,",",0,0
4075,and,0,0
4076,percent,0,0
4077,of,0,0
4078,predicted,0,0
4079,power,0,0
4080,ability,0,0
4081,(,0,0
4082,43,0,1
4083,%,0,0
4084,+/-,0,0
4085,10,0,0
4086,%,0,0
4087,to,0,0
4088,56,0,1
4089,%,0,0
4090,+/-,0,0
4091,13,0,1
4092,%,0,0
4093,;,0,0
4094,p,0,0
4095,=,0,0
4096,.000,0,0
4097,),0,0
4098,were,0,0
4099,observed,0,0
4100,in,0,0
4101,the,0,0
4102,exercise,0,0
4103,group,0,0
4104,.,0,0
4105,No,0,0
4106,significant,0,0
4107,changes,0,0
4108,in,0,0
4109,baseline,0,0
4110,parameters,0,0
4111,occurred,0,0
4112,in,0,0
4113,the,0,0
4114,control,0,0
4115,group,0,0
4116,.,0,0
4117,There,0,0
4118,were,0,0
4119,no,0,0
4120,critical,0,0
4121,changes,0,0
4122,in,0,0
4123,heart,0,1
4124,rate,0,0
4125,or,0,0
4126,blood,0,0
4127,pressure,0,0
4128,in,0,0
4129,either,0,0
4130,group,0,0
4131,.,0,0
4132,CONCLUSION,0,0
4133,Moderate-intensity,0,0
4134,step,0,0
4135,aerobics,0,0
4136,training,0,0
4137,significantly,0,0
4138,increases,0,0
4139,peak,0,0
4140,oxygen,0,0
4141,uptake,0,0
4142,and,0,0
4143,peak,0,0
4144,workloads,0,0
4145,in,0,1
4146,patients,1,1
4147,with,1,1
4148,severe,1,1
4149,chronic,1,1
4150,heart,1,1
4151,failure,1,1
4152,.,1,1
4153,Treatment,0,0
4154,of,0,0
4155,hypertensive,1,1
4156,and,1,1
4157,hypercholesterolaemic,1,1
4158,patients,1,1
4159,in,0,0
4160,general,0,1
4161,practice,0,0
4162,.,0,0
4163,The,0,0
4164,effect,0,0
4165,of,0,0
4166,captopril,0,0
4167,",",0,0
4168,atenolol,0,0
4169,and,0,0
4170,pravastatin,0,0
4171,combined,0,0
4172,with,0,1
4173,life,0,0
4174,style,0,0
4175,intervention,0,0
4176,.,0,0
4177,OBJECTIVE,0,0
4178,To,0,0
4179,elucidate,0,0
4180,the,0,0
4181,effect,0,0
4182,on,0,0
4183,blood,0,0
4184,pressure,0,0
4185,and,0,0
4186,blood,0,0
4187,lipids,0,0
4188,of,0,0
4189,an,0,0
4190,angiotensin,0,0
4191,converting,0,0
4192,enzyme,0,0
4193,inhibitor,0,0
4194,(,0,0
4195,captopril,0,0
4196,),0,0
4197,",",0,0
4198,and,0,0
4199,a,0,0
4200,beta-receptor,0,0
4201,blocking,0,0
4202,agent,0,0
4203,(,0,0
4204,atenolol,0,0
4205,),0,0
4206,",",0,0
4207,given,0,0
4208,alone,0,0
4209,or,0,0
4210,in,0,0
4211,combination,0,0
4212,with,0,1
4213,a,0,0
4214,cholesterol,0,0
4215,reducing,0,0
4216,drug,0,0
4217,",",0,0
4218,the,0,0
4219,beta-hydroxy-methylglutaryl-coenzyme,0,0
4220,A,0,0
4221,reductase,0,0
4222,inhibitor,0,0
4223,pravastatin,0,0
4224,",",0,0
4225,in,0,1
4226,patients,1,1
4227,who,1,1
4228,were,1,1
4229,also,1,0
4230,encouraged,1,0
4231,to,1,0
4232,improve,1,0
4233,their,1,0
4234,lifestyle,1,1
4235,.,1,0
4236,DESIGN,0,0
4237,A,0,0
4238,longitudinal,0,0
4239,study,0,0
4240,consisting,0,1
4241,of,0,0
4242,three,0,1
4243,phases,0,0
4244,.,0,1
4245,I,0,1
4246,:,0,1
4247,Lifestyle,0,0
4248,intervention,0,0
4249,alone,0,0
4250,.,0,0
4251,II,0,0
4252,:,0,1
4253,Continued,0,1
4254,lifestyle,0,1
4255,intervention,0,0
4256,combined,0,0
4257,with,0,1
4258,captopril,0,0
4259,or,0,1
4260,atenolol,0,0
4261,.,0,1
4262,III,0,0
4263,:,0,1
4264,Continued,0,1
4265,lifestyle,0,1
4266,intervention,0,0
4267,combined,0,0
4268,with,0,1
4269,the,0,0
4270,same,0,0
4271,drugs,0,0
4272,as,0,0
4273,in,0,0
4274,phase,0,1
4275,II,0,1
4276,and,0,0
4277,in,0,0
4278,addition,0,0
4279,pravastatin,0,0
4280,or,0,1
4281,placebo,0,0
4282,.,0,0
4283,SETTING,0,1
4284,Fifty-four,1,1
4285,general,1,1
4286,practice,1,0
4287,surgeries,1,1
4288,in,1,1
4289,Norway,1,1
4290,.,1,1
4291,PARTICIPANTS,0,0
4292,Hypertensive,1,1
4293,patients,1,1
4294,",",1,1
4295,210,1,1
4296,females,1,1
4297,and,1,1
4298,160,1,1
4299,males,1,1
4300,",",1,0
4301,treated,1,1
4302,or,1,0
4303,untreated,1,1
4304,with,1,1
4305,antihypertensive,1,0
4306,drugs,1,0
4307,with,1,1
4308,a,1,0
4309,sitting,1,0
4310,diastolic,1,0
4311,blood,1,0
4312,pressure,1,0
4313,between,1,0
4314,95,1,0
4315,and,1,0
4316,115,1,1
4317,mmHg,1,0
4318,and,1,0
4319,a,1,0
4320,serum,1,0
4321,total,1,1
4322,cholesterol,1,0
4323,between,1,0
4324,6.5,1,0
4325,mmol/l,1,0
4326,(,1,1
4327,7.0,1,1
4328,for,1,0
4329,those,1,1
4330,age,1,1
4331,60-67,1,1
4332,years,1,1
4333,),1,1
4334,and,1,0
4335,9.0,1,0
4336,mmol/l,1,0
4337,.,1,0
4338,RESULTS,0,0
4339,The,0,0
4340,antihypertensive,0,0
4341,effect,0,0
4342,of,0,0
4343,captopril,0,0
4344,and,0,0
4345,atenolol,0,0
4346,was,0,0
4347,not,0,0
4348,influenced,0,0
4349,by,0,0
4350,concurrent,0,0
4351,administration,0,0
4352,of,0,0
4353,pravastatin,0,0
4354,.,0,0
4355,The,0,0
4356,effect,0,0
4357,of,0,0
4358,pravastatin,0,0
4359,was,0,0
4360,not,0,0
4361,limited,0,0
4362,by,0,0
4363,concurrent,0,0
4364,medication,0,0
4365,with,0,1
4366,captopril,0,0
4367,or,0,1
4368,atenolol,0,0
4369,.,0,0
4370,Improvement,0,0
4371,in,0,0
4372,lifestyle,0,1
4373,seemed,0,0
4374,to,0,0
4375,reduce,0,0
4376,the,0,0
4377,need,0,0
4378,for,0,0
4379,supplementary,0,0
4380,treatment,0,0
4381,with,0,1
4382,diuretics,0,0
4383,.,0,1
4384,CONCLUSION,0,0
4385,Pravastatin,0,0
4386,can,0,0
4387,be,0,0
4388,used,0,0
4389,in,0,0
4390,combination,0,0
4391,with,0,1
4392,captopril,0,0
4393,or,0,0
4394,atenolol,0,0
4395,in,0,0
4396,the,0,0
4397,treatment,0,0
4398,of,0,0
4399,hypertensive,1,1
4400,and,1,1
4401,hypercholesterolaemic,1,1
4402,patients,1,1
4403,.,1,1
4404,Effects,0,0
4405,of,0,0
4406,amlodipine,0,0
4407,and,0,0
4408,enalapril,0,0
4409,on,0,0
4410,platelet,1,0
4411,function,1,0
4412,in,1,0
4413,patients,1,1
4414,with,1,1
4415,mild,1,1
4416,to,1,0
4417,moderate,1,1
4418,hypertension,1,1
4419,.,1,0
4420,OBJECTIVE,0,0
4421,The,0,0
4422,aim,0,0
4423,of,0,0
4424,this,0,0
4425,study,0,0
4426,was,0,0
4427,to,0,0
4428,compare,0,0
4429,the,0,0
4430,effect,0,0
4431,of,0,0
4432,amlodipine,0,0
4433,and,0,0
4434,enalapril,0,0
4435,on,0,0
4436,platelet,0,0
4437,aggregation,0,0
4438,",",0,0
4439,and,0,0
4440,platelet,0,0
4441,production,0,0
4442,of,0,0
4443,malondialdehyde,0,0
4444,in,0,0
4445,patients,1,1
4446,with,1,1
4447,mild,1,1
4448,to,1,0
4449,moderate,1,1
4450,arterial,1,1
4451,hypertension,1,1
4452,.,1,1
4453,PATIENTS,0,0
4454,AND,0,0
4455,METHODS,0,0
4456,A,0,0
4457,parallel,0,0
4458,",",0,0
4459,double-blind,0,0
4460,",",0,0
4461,placebo-controlled,0,0
4462,study,0,0
4463,was,0,0
4464,carried,0,0
4465,out,0,0
4466,in,0,0
4467,24,1,1
4468,patients,1,1
4469,(,1,1
4470,2,1,1
4471,groups,1,0
4472,of,1,1
4473,12,1,1
4474,patients,1,1
4475,each,1,1
4476,),1,0
4477,.,1,0
4478,Initially,0,0
4479,all,0,0
4480,patients,0,1
4481,received,0,0
4482,placebo,0,0
4483,for,0,1
4484,four,0,1
4485,weeks,0,0
4486,;,0,0
4487,then,0,0
4488,amlodipine,0,0
4489,",",0,0
4490,5,0,0
4491,mg,0,0
4492,daily,0,0
4493,or,0,1
4494,enalapril,0,0
4495,20,0,1
4496,mg,0,0
4497,daily,0,0
4498,taken,0,0
4499,once,0,0
4500,a,0,0
4501,day,0,0
4502,at,0,0
4503,7,0,1
4504,am,0,0
4505,.,0,0
4506,Dosage,0,0
4507,was,0,0
4508,doubled,0,0
4509,after,0,0
4510,4,0,0
4511,weeks,0,0
4512,when,0,0
4513,diastolic,0,1
4514,blood,0,0
4515,pressure,0,0
4516,was,0,0
4517,>,0,1
4518,90,0,0
4519,mmHg,0,0
4520,in,0,0
4521,sitting,0,0
4522,position,0,0
4523,",",0,0
4524,the,0,0
4525,treatment,0,0
4526,was,0,0
4527,continued,0,0
4528,for,0,0
4529,12,0,1
4530,weeks,0,0
4531,.,0,1
4532,At,0,0
4533,the,0,0
4534,end,0,0
4535,of,0,0
4536,placebo,0,0
4537,and,0,0
4538,active,0,1
4539,phases,0,0
4540,a,0,0
4541,platelet,0,0
4542,aggregation,0,0
4543,test,0,0
4544,",",0,0
4545,using,0,0
4546,adenosine,0,0
4547,diphosphate,0,0
4548,",",0,0
4549,collagen,0,0
4550,and,0,0
4551,adrenaline,0,0
4552,",",0,0
4553,and,0,0
4554,a,0,0
4555,platelet,0,0
4556,malondialdehyde,0,0
4557,production,0,0
4558,test,0,0
4559,",",0,0
4560,either,0,0
4561,in,0,0
4562,basal,0,0
4563,conditions,0,0
4564,(,0,1
4565,MDA-basal,0,0
4566,),0,0
4567,and,0,0
4568,after,0,0
4569,the,0,0
4570,stimulation,0,0
4571,of,0,0
4572,arachidonic,0,0
4573,acid,0,0
4574,pathway,0,0
4575,by,0,0
4576,adding,0,0
4577,ethylmaleimide,0,0
4578,(,0,0
4579,MDA-activated,0,0
4580,),0,0
4581,were,0,0
4582,carried,0,0
4583,out,0,0
4584,.,0,0
4585,RESULTS,0,0
4586,Blood,0,0
4587,pressure,0,0
4588,was,0,0
4589,reduced,0,0
4590,by,0,0
4591,both,0,0
4592,agents,0,0
4593,",",0,0
4594,enalapril,0,0
4595,and,0,0
4596,amlodipine,0,0
4597,.,0,1
4598,Enalapril,0,0
4599,controlled,0,0
4600,58.3,0,0
4601,%,0,0
4602,of,0,0
4603,hypertensive,1,1
4604,patients,1,1
4605,with,0,1
4606,an,0,0
4607,average,0,0
4608,dosage,0,0
4609,of,0,0
4610,31.7,0,0
4611,mg/daily,0,0
4612,.,0,1
4613,Amlodipine,0,0
4614,controlled,0,0
4615,75,0,0
4616,%,0,0
4617,of,0,0
4618,patients,0,1
4619,with,0,1
4620,a,0,0
4621,dosage,0,0
4622,of,0,0
4623,7.1,0,0
4624,mg/daily,0,0
4625,.,0,0
4626,Platelet,0,0
4627,aggregation,0,0
4628,was,0,0
4629,reduced,0,0
4630,by,0,0
4631,amlodipine,0,0
4632,in,0,0
4633,15.9,0,0
4634,%,0,0
4635,for,0,0
4636,ADP,0,0
4637,(,0,1
4638,10,0,0
4639,microM,0,0
4640,),0,1
4641,;,0,0
4642,17.4,0,0
4643,%,0,0
4644,for,0,0
4645,collagen,0,0
4646,(,0,0
4647,2,0,0
4648,microg/ml,0,0
4649,),0,0
4650,and,0,0
4651,19.9,0,0
4652,%,0,0
4653,for,0,0
4654,adrenaline,0,0
4655,(,0,0
4656,2,0,0
4657,microM,0,0
4658,),0,0
4659,(,0,0
4660,p,0,0
4661,<,0,0
4662,0.025,0,0
4663,),0,0
4664,.,0,0
4665,Meanwhile,0,0
4666,enalapril,0,0
4667,slightly,0,0
4668,increased,0,0
4669,platelet,0,0
4670,aggregation,0,0
4671,by,0,0
4672,6.7,0,0
4673,%,0,0
4674,",",0,0
4675,1.3,0,0
4676,%,0,0
4677,and,0,0
4678,5.6,0,0
4679,%,0,0
4680,for,0,0
4681,the,0,0
4682,three,0,0
4683,agents,0,0
4684,",",0,0
4685,respectively,0,0
4686,(,0,0
4687,p,0,0
4688,>,0,1
4689,0.05,0,0
4690,",",0,0
4691,ns,0,0
4692,),0,0
4693,.,0,1
4694,Malondialdehyde,0,0
4695,was,0,0
4696,reduced,0,0
4697,by,0,0
4698,amlodipine,0,0
4699,in,0,0
4700,45.33,0,0
4701,%,0,0
4702,(,0,0
4703,p,0,0
4704,<,0,0
4705,0.05,0,0
4706,),0,0
4707,for,0,0
4708,MDA-basal,0,0
4709,;,0,1
4710,3.76,0,0
4711,%,0,0
4712,(,0,0
4713,p,0,0
4714,>,0,1
4715,0.05,0,0
4716,),0,0
4717,for,0,0
4718,MDA-activated,0,0
4719,;,0,0
4720,and,0,0
4721,the,0,0
4722,ratio,0,0
4723,MDA-basal,0,0
4724,:,0,1
4725,MDA-activated,0,0
4726,in,0,0
4727,36.79,0,0
4728,%,0,0
4729,(,0,0
4730,p,0,0
4731,<,0,0
4732,0.005,0,0
4733,),0,0
4734,.,0,0
4735,Meanwhile,0,0
4736,enalapril,0,0
4737,increased,0,0
4738,MDA-basal,0,0
4739,in,0,0
4740,2.89,0,0
4741,%,0,0
4742,;,0,0
4743,MDA-activated,0,0
4744,in,0,0
4745,3.58,0,0
4746,%,0,0
4747,and,0,0
4748,reduced,0,0
4749,the,0,0
4750,ratio,0,0
4751,MDA-basal,0,0
4752,:,0,1
4753,MDA-activated,0,0
4754,",",0,0
4755,in,0,0
4756,10.34,0,0
4757,%,0,0
4758,(,0,0
4759,p,0,0
4760,>,0,1
4761,0.05,0,0
4762,),0,1
4763,.,0,1
4764,CONCLUSION,0,0
4765,Both,0,0
4766,agents,0,0
4767,",",0,0
4768,enalapril,0,0
4769,and,0,0
4770,amlodipine,0,0
4771,",",0,0
4772,reduced,0,0
4773,blood,0,0
4774,pressure,0,0
4775,",",0,0
4776,but,0,0
4777,only,0,0
4778,amlodipine,0,0
4779,reduced,0,0
4780,platelet,0,0
4781,aggregation,0,0
4782,and,0,0
4783,platelet,0,0
4784,production,0,0
4785,of,0,0
4786,malondialdehyde,0,0
4787,",",0,0
4788,indicating,0,0
4789,its,0,0
4790,action,0,0
4791,on,0,0
4792,the,0,0
4793,arachidonic,0,0
4794,acid,0,0
4795,metabolic,0,1
4796,pathway,0,0
4797,.,0,1
4798,Continued,0,1
4799,improvement,0,0
4800,in,0,0
4801,pressure-flow,0,0
4802,parameters,0,0
4803,in,0,1
4804,men,1,1
4805,receiving,1,1
4806,finasteride,1,0
4807,for,1,0
4808,2,1,1
4809,years,1,1
4810,.,1,1
4811,Finasteride,0,0
4812,Urodynamics,0,0
4813,Study,0,1
4814,Group,0,1
4815,.,0,1
4816,OBJECTIVES,0,0
4817,To,0,0
4818,assess,0,0
4819,the,0,0
4820,long-term,0,0
4821,effects,0,0
4822,of,0,0
4823,finasteride,0,0
4824,on,0,0
4825,pressure-flow,0,0
4826,parameters,0,0
4827,in,0,1
4828,men,1,1
4829,with,1,1
4830,urodynamically,1,1
4831,documented,1,0
4832,bladder,1,1
4833,outflow,1,0
4834,obstruction,1,1
4835,(,1,0
4836,BOO,1,1
4837,),1,1
4838,.,1,1
4839,METHODS,0,0
4840,One,1,1
4841,hundred,1,1
4842,twenty-one,1,1
4843,men,1,1
4844,with,1,1
4845,benign,1,1
4846,prostatic,1,1
4847,enlargement,1,1
4848,(,1,0
4849,BPE,1,0
4850,),1,0
4851,and,1,0
4852,lower,1,0
4853,urinary,1,0
4854,tract,1,1
4855,symptoms,1,0
4856,(,1,1
4857,LUTS,1,1
4858,),1,0
4859,underwent,0,1
4860,a,0,0
4861,pressure-flow,0,0
4862,study,0,0
4863,(,0,0
4864,PFS,0,0
4865,),0,0
4866,at,0,0
4867,1,0,0
4868,of,0,0
4869,11,0,1
4870,clinical,0,1
4871,centers,0,1
4872,.,0,1
4873,The,0,0
4874,PFS,0,0
4875,technique,0,0
4876,was,0,0
4877,standardized,0,0
4878,",",0,0
4879,and,0,0
4880,all,0,0
4881,tracings,0,0
4882,were,0,0
4883,read,0,0
4884,by,0,0
4885,a,0,0
4886,single,0,0
4887,reader,0,0
4888,unaware,0,1
4889,of,0,0
4890,the,0,0
4891,treatment,0,0
4892,group,0,0
4893,.,0,1
4894,Patients,1,1
4895,who,1,1
4896,were,1,1
4897,obstructed,1,1
4898,according,1,0
4899,to,1,0
4900,a,1,0
4901,modified,1,0
4902,Abrams-Griffiths,1,0
4903,nomogram,1,0
4904,were,0,1
4905,randomized,0,1
4906,to,0,0
4907,5,0,0
4908,mg,0,0
4909,finasteride,0,0
4910,(,0,0
4911,n,0,1
4912,=,0,0
4913,81,0,1
4914,),0,0
4915,or,0,1
4916,placebo,0,0
4917,(,0,0
4918,n,0,1
4919,=,0,0
4920,40,0,1
4921,),0,0
4922,for,0,0
4923,12,0,1
4924,months,0,0
4925,;,0,1
4926,all,0,1
4927,patients,0,1
4928,continuing,0,0
4929,into,0,0
4930,an,0,0
4931,open,0,1
4932,extension,0,0
4933,received,0,0
4934,finasteride,0,0
4935,during,0,0
4936,the,0,0
4937,second,0,0
4938,12,0,0
4939,months,0,0
4940,of,0,1
4941,therapy,0,1
4942,.,0,1
4943,Results,0,0
4944,of,0,0
4945,the,0,0
4946,initial,0,0
4947,12-month,0,0
4948,study,0,0
4949,demonstrated,0,0
4950,the,0,0
4951,benefit,0,0
4952,of,0,0
4953,finasteride,0,0
4954,treatment,0,0
4955,on,0,0
4956,PFS,0,0
4957,parameters,0,0
4958,.,0,1
4959,To,0,0
4960,examine,0,0
4961,the,0,0
4962,continuing,0,0
4963,effects,0,0
4964,over,0,0
4965,time,0,0
4966,",",0,0
4967,an,0,0
4968,analysis,0,0
4969,of,0,0
4970,the,0,0
4971,data,0,0
4972,from,0,1
4973,54,0,1
4974,patients,0,1
4975,who,0,1
4976,completed,0,1
4977,24,0,1
4978,months,0,0
4979,of,0,0
4980,treatment,0,0
4981,with,0,1
4982,finasteride,0,0
4983,is,0,0
4984,provided,0,0
4985,.,0,0
4986,RESULTS,0,0
4987,Detrusor,0,1
4988,pressure,0,0
4989,at,0,0
4990,maximum,0,0
4991,flow,0,0
4992,(,0,0
4993,PdetQmax,0,0
4994,),0,0
4995,continued,0,0
4996,to,0,0
4997,decrease,0,0
4998,during,0,0
4999,the,0,0
5000,second,0,0
5001,12,0,0
5002,months,0,0
5003,of,0,0
5004,therapy,0,0
5005,(,0,0
5006,decreases,0,0
5007,of,0,0
5008,5.3,0,0
5009,and,0,0
5010,11.7,0,0
5011,cm,0,1
5012,H2O,0,0
5013,at,0,1
5014,months,0,0
5015,12,0,1
5016,and,0,1
5017,24,0,0
5018,",",0,0
5019,respectively,0,0
5020,),0,0
5021,.,0,0
5022,The,0,0
5023,percentage,0,0
5024,of,0,0
5025,patients,0,1
5026,obstructed,0,1
5027,by,0,0
5028,Abrams-Griffiths,0,0
5029,classification,0,1
5030,decreased,0,0
5031,from,0,0
5032,76.2,0,0
5033,%,0,0
5034,at,0,0
5035,baseline,0,0
5036,to,0,0
5037,66.7,0,0
5038,%,0,0
5039,at,0,0
5040,month,0,0
5041,12,0,0
5042,and,0,0
5043,59.6,0,0
5044,%,0,0
5045,at,0,0
5046,month,0,0
5047,24,0,0
5048,.,0,0
5049,An,0,0
5050,intention-to-treat,0,0
5051,analysis,0,0
5052,yielded,0,0
5053,similar,0,0
5054,results,0,0
5055,.,0,1
5056,CONCLUSIONS,0,0
5057,Finasteride,0,0
5058,improves,0,0
5059,urodynamic,0,1
5060,measures,0,0
5061,of,0,0
5062,obstruction,0,1
5063,in,0,0
5064,men,1,1
5065,with,1,1
5066,BPE,1,0
5067,and,1,0
5068,LUTS,1,0
5069,",",0,0
5070,with,0,1
5071,continued,0,0
5072,improvement,0,0
5073,during,0,0
5074,the,0,0
5075,second,0,0
5076,12,0,0
5077,months,0,0
5078,of,0,1
5079,therapy,0,1
5080,.,0,1
5081,Befriending,0,1
5082,as,0,0
5083,an,0,0
5084,intervention,0,0
5085,for,0,0
5086,chronic,1,1
5087,depression,1,1
5088,among,1,0
5089,women,1,1
5090,in,1,0
5091,an,1,0
5092,inner,1,1
5093,city,1,1
5094,.,1,1
5095,2,0,0
5096,:,0,1
5097,Role,0,0
5098,of,0,0
5099,fresh-start,0,1
5100,experiences,0,0
5101,and,0,1
5102,baseline,0,0
5103,psychosocial,0,1
5104,factors,0,0
5105,in,0,0
5106,remission,1,1
5107,from,1,1
5108,depression,1,1
5109,.,1,1
5110,BACKGROUND,0,0
5111,Volunteer,0,1
5112,befriending,0,0
5113,promoted,0,0
5114,remission,1,0
5115,of,1,0
5116,chronic,1,1
5117,depression,1,0
5118,when,0,0
5119,clinical,0,0
5120,and,0,0
5121,other,0,0
5122,treatment,0,0
5123,variables,0,0
5124,were,0,1
5125,controlled,0,0
5126,.,0,0
5127,AIMS,0,0
5128,To,0,0
5129,examine,0,0
5130,the,0,0
5131,role,0,0
5132,of,0,0
5133,other,0,0
5134,psychosocial,0,1
5135,factors,0,0
5136,relevant,0,0
5137,for,0,0
5138,outcome,0,0
5139,.,0,1
5140,METHOD,0,0
5141,Factors,0,1
5142,measured,0,0
5143,at,0,1
5144,baseline,0,0
5145,interview,0,0
5146,were,0,0
5147,examined,0,0
5148,in,0,0
5149,multivariate,0,0
5150,analyses,0,0
5151,along,0,0
5152,with,0,1
5153,psychosocial,0,1
5154,factors,0,0
5155,occurring,0,1
5156,during,0,0
5157,follow-up,0,0
5158,",",0,0
5159,such,0,0
5160,as,0,0
5161,'fresh-start,0,1
5162,',0,1
5163,experiences,0,0
5164,and,0,1
5165,new,0,1
5166,severe,0,1
5167,events,0,0
5168,and,0,1
5169,difficulties,0,1
5170,.,0,1
5171,RESULTS,0,0
5172,Fresh-start,0,0
5173,experiences,0,0
5174,and,0,0
5175,a,0,0
5176,standard,0,0
5177,attachment,0,0
5178,style,0,0
5179,were,0,0
5180,found,0,0
5181,to,0,0
5182,enhance,0,0
5183,chances,0,0
5184,of,0,0
5185,remission,0,0
5186,",",0,0
5187,with,0,1
5188,new,0,0
5189,severe,0,1
5190,stressors,0,0
5191,and,0,0
5192,markedly,0,0
5193,poor,0,0
5194,coping,0,0
5195,strategies,0,0
5196,liable,0,1
5197,to,0,0
5198,prevent,0,0
5199,it,0,0
5200,",",0,0
5201,with,0,0
5202,volunteer,0,1
5203,befriending,0,0
5204,continuing,0,0
5205,to,0,0
5206,play,0,0
5207,a,0,0
5208,role,0,0
5209,.,0,0
5210,CONCLUSIONS,0,0
5211,The,0,0
5212,positive,0,0
5213,result,0,0
5214,reported,0,0
5215,in,0,0
5216,the,0,0
5217,preceding,0,0
5218,paper,0,0
5219,is,0,0
5220,unlikely,0,0
5221,to,0,0
5222,be,0,0
5223,an,0,0
5224,artefact,0,0
5225,.,0,0
5226,However,0,0
5227,",",0,0
5228,fresh-start,0,0
5229,experiences,0,0
5230,",",0,0
5231,absence,0,0
5232,of,0,0
5233,new,0,0
5234,severe,0,1
5235,stressors,0,0
5236,and,0,1
5237,standard,0,0
5238,attachment,0,0
5239,style,0,0
5240,were,0,0
5241,more,0,0
5242,important,0,0
5243,predictors,0,0
5244,of,0,0
5245,remission,0,1
5246,.,0,0
5247,This,0,0
5248,knowledge,0,0
5249,might,0,0
5250,profitably,0,0
5251,be,0,0
5252,incorporated,0,0
5253,into,0,0
5254,the,0,0
5255,evaluation,0,0
5256,of,0,0
5257,existing,0,0
5258,treatments,0,0
5259,.,0,1
5260,The,0,0
5261,impact,0,0
5262,of,0,0
5263,schizophrenic,1,1
5264,patient,1,0
5265,functionality,0,0
5266,on,0,0
5267,service,0,1
5268,utilization,0,0
5269,and,0,0
5270,cost,0,0
5271,.,0,0
5272,Based,0,0
5273,on,0,0
5274,a,0,0
5275,presentation,0,0
5276,by,0,0
5277,Sandra,0,1
5278,L.,0,1
5279,Tunis,0,1
5280,",",0,0
5281,PhD,0,0
5282,.,0,0
5283,With,0,0
5284,the,0,0
5285,advent,0,0
5286,of,0,0
5287,atypical,0,1
5288,agents,0,0
5289,in,0,0
5290,the,0,0
5291,treatment,0,0
5292,of,0,0
5293,schizophrenia,0,1
5294,",",0,0
5295,physicians,0,1
5296,and,0,0
5297,policy,0,0
5298,makers,0,0
5299,must,0,0
5300,consider,0,0
5301,the,0,0
5302,costs,0,0
5303,that,0,0
5304,may,0,0
5305,accompany,0,0
5306,greater,0,0
5307,clinical,0,0
5308,efficacy,0,0
5309,.,0,0
5310,Analyses,0,0
5311,reveal,0,0
5312,that,0,0
5313,olanzapine,0,0
5314,shows,0,0
5315,a,0,0
5316,greater,0,0
5317,clinical,0,0
5318,cost,0,0
5319,effectiveness,0,0
5320,",",0,0
5321,as,0,0
5322,well,0,0
5323,as,0,0
5324,a,0,0
5325,greater,0,0
5326,functional,0,0
5327,cost,0,0
5328,effectiveness,0,0
5329,",",0,0
5330,than,0,0
5331,haloperidol,0,0
5332,",",0,0
5333,and,0,0
5334,that,0,0
5335,functional,0,1
5336,outcomes,0,0
5337,",",0,0
5338,in,0,0
5339,particular,0,0
5340,",",0,0
5341,show,0,0
5342,promise,0,0
5343,as,0,0
5344,important,0,0
5345,measures,0,0
5346,of,0,0
5347,effectiveness,0,0
5348,.,0,1
5349,Functional,0,0
5350,outcomes,0,0
5351,can,0,0
5352,help,0,0
5353,differentiate,0,0
5354,medications,0,0
5355,and,0,0
5356,can,0,0
5357,be,0,0
5358,used,0,0
5359,to,0,0
5360,help,0,0
5361,demonstrate,0,0
5362,the,0,0
5363,cost,0,0
5364,effectiveness,0,0
5365,of,0,0
5366,atypical,0,1
5367,agents,0,0
5368,.,0,1
5369,Mental,0,0
5370,health,0,0
5371,and,0,0
5372,physical,0,0
5373,health,0,0
5374,functioning,0,0
5375,",",0,0
5376,as,0,0
5377,well,0,0
5378,as,0,0
5379,work,0,0
5380,status,0,0
5381,",",0,0
5382,are,0,0
5383,all,0,0
5384,measures,0,0
5385,of,0,0
5386,functioning,0,0
5387,that,0,0
5388,have,0,0
5389,been,0,0
5390,used,0,0
5391,to,0,0
5392,evaluate,0,0
5393,treatment,0,0
5394,strategies,0,0
5395,.,0,0
5396,When,0,0
5397,comparing,0,0
5398,olanzapine,0,0
5399,with,0,1
5400,haloperidol,0,0
5401,",",0,0
5402,cost,0,0
5403,savings,0,0
5404,are,0,0
5405,seen,0,0
5406,throughout,0,0
5407,the,0,0
5408,treatment,0,0
5409,period,0,0
5410,(,0,0
5411,1,0,0
5412,year,0,0
5413,),0,0
5414,",",0,0
5415,with,0,1
5416,physical,0,0
5417,functioning,0,0
5418,most,0,0
5419,highly,0,0
5420,affected,0,0
5421,over,0,0
5422,time,0,0
5423,.,0,1
5424,Functional,0,0
5425,outcomes,0,0
5426,can,0,0
5427,therefore,0,0
5428,serve,0,0
5429,2,0,0
5430,purposes,0,0
5431,:,0,1
5432,to,0,0
5433,enhance,0,0
5434,compliance,0,0
5435,by,0,0
5436,improving,0,0
5437,health-related,0,0
5438,quality,0,0
5439,of,0,0
5440,life,0,0
5441,and,0,0
5442,to,0,0
5443,assist,0,0
5444,in,0,0
5445,making,0,0
5446,both,0,0
5447,treatment,0,0
5448,and,0,0
5449,formulary,0,0
5450,decisions,0,0
5451,.,0,1
5452,The,0,0
5453,effect,0,0
5454,of,0,0
5455,Cys,0,1
5456,LT1,0,0
5457,receptor,0,0
5458,blockade,0,0
5459,on,0,0
5460,airway,1,1
5461,responses,1,0
5462,to,1,0
5463,allergen,1,0
5464,.,1,1
5465,STUDY,0,0
5466,OBJECTIVE,0,0
5467,To,0,0
5468,evaluate,0,0
5469,the,0,0
5470,effect,0,0
5471,of,0,0
5472,a,0,0
5473,potent,0,0
5474,experimental,0,0
5475,leukotriene,0,0
5476,receptor,0,0
5477,antagonist,0,0
5478,",",0,0
5479,MK-571,0,0
5480,",",0,0
5481,on,0,0
5482,airway,1,1
5483,responses,1,0
5484,to,1,0
5485,inhaled,1,0
5486,allergen,1,0
5487,.,1,0
5488,DESIGN,0,0
5489,Randomized,0,0
5490,",",0,0
5491,double-blind,0,0
5492,",",0,0
5493,placebo-controlled,0,0
5494,",",0,0
5495,crossover,0,0
5496,trial,0,0
5497,.,0,1
5498,SETTING,0,1
5499,Clinical,0,0
5500,research,0,0
5501,center,0,1
5502,.,0,1
5503,SUBJECTS,0,0
5504,Eight,1,0
5505,male,1,1
5506,volunteers,1,1
5507,with,1,1
5508,allergic,1,1
5509,asthma,1,1
5510,.,1,1
5511,INTERVENTIONS,0,0
5512,An,0,0
5513,intravenous,0,0
5514,loading,0,0
5515,dose,0,0
5516,was,0,0
5517,followed,0,0
5518,by,0,0
5519,an,0,0
5520,8-hour,0,0
5521,infusion,0,0
5522,of,0,0
5523,MK-571,0,0
5524,or,0,1
5525,placebo,0,0
5526,",",0,0
5527,with,0,1
5528,a,0,0
5529,7-,0,0
5530,to,0,0
5531,14-day,0,0
5532,washout,0,0
5533,between,0,0
5534,treatments,0,0
5535,.,0,1
5536,Allergen,0,0
5537,challenge,0,0
5538,was,0,0
5539,performed,0,0
5540,after,0,0
5541,the,0,0
5542,loading,0,0
5543,dose,0,0
5544,and,0,0
5545,a,0,0
5546,histamine,0,0
5547,challenge,0,0
5548,was,0,0
5549,performed,0,0
5550,before,0,0
5551,and,0,0
5552,24,0,1
5553,hours,0,0
5554,after,0,0
5555,allergen,0,1
5556,.,0,1
5557,MEASUREMENTS,0,0
5558,AND,0,0
5559,MAIN,0,0
5560,RESULTS,0,0
5561,Forced,0,1
5562,expiratory,0,0
5563,volume,0,0
5564,in,0,0
5565,1,0,0
5566,second,0,0
5567,was,0,0
5568,measured,0,0
5569,serially,0,0
5570,.,0,0
5571,MK-571,0,0
5572,provided,0,0
5573,about,0,0
5574,50,0,1
5575,%,0,0
5576,protection,0,0
5577,during,0,0
5578,maximum,0,0
5579,early,0,1
5580,and,0,1
5581,late,0,1
5582,responses,0,0
5583,compared,0,0
5584,with,0,1
5585,placebo,0,0
5586,(,0,0
5587,p=0.005,0,0
5588,),0,0
5589,",",0,0
5590,but,0,0
5591,airway,0,1
5592,obstruction,0,1
5593,persisted,0,0
5594,8-24,0,0
5595,hours,0,0
5596,after,0,0
5597,allergen,0,0
5598,on,0,0
5599,both,0,0
5600,treatment,0,0
5601,days,0,0
5602,.,0,1
5603,Airway,0,0
5604,responsiveness,0,0
5605,to,0,0
5606,histamine,0,0
5607,was,0,0
5608,not,0,0
5609,significantly,0,0
5610,attenuated,0,0
5611,at,0,0
5612,24,0,1
5613,hours,0,0
5614,.,0,1
5615,CONCLUSION,0,0
5616,Blocking,0,0
5617,Cys,0,1
5618,LT1,0,1
5619,receptors,0,0
5620,for,0,1
5621,8,0,1
5622,hours,0,0
5623,attenuated,0,0
5624,the,0,0
5625,early,0,0
5626,and,0,0
5627,late,0,1
5628,responses,0,0
5629,but,0,0
5630,did,0,0
5631,not,0,0
5632,interrupt,0,0
5633,the,0,0
5634,cascade,0,0
5635,of,0,0
5636,events,0,0
5637,leading,0,0
5638,to,0,0
5639,subsequent,0,0
5640,allergen-induced,0,0
5641,airway,0,1
5642,obstruction,0,1
5643,and,0,0
5644,hyperreactivity,0,1
5645,.,0,1
5646,Effect,0,0
5647,of,0,0
5648,guided,0,0
5649,imagery,0,0
5650,on,0,0
5651,length,0,0
5652,of,0,0
5653,stay,0,0
5654,",",0,0
5655,pain,0,0
5656,and,0,0
5657,anxiety,0,0
5658,in,0,0
5659,cardiac,1,1
5660,surgery,1,1
5661,patients,1,1
5662,.,1,1
5663,Intra-luminal,0,1
5664,nicotine,0,0
5665,reduces,0,0
5666,smooth,0,1
5667,muscle,0,0
5668,tone,0,0
5669,and,0,0
5670,contractile,0,0
5671,activity,0,0
5672,in,0,0
5673,the,0,0
5674,distal,0,1
5675,large,0,1
5676,bowel,0,1
5677,.,0,1
5678,BACKGROUND,0,0
5679,Nicotine,0,0
5680,may,0,0
5681,be,0,0
5682,of,0,0
5683,therapeutic,0,0
5684,value,0,0
5685,in,0,0
5686,ulcerative,1,1
5687,colitis,1,1
5688,(,1,0
5689,UC,1,0
5690,),1,0
5691,",",0,0
5692,although,0,0
5693,its,0,0
5694,mechanism,0,0
5695,of,0,0
5696,action,0,0
5697,has,0,0
5698,not,0,0
5699,been,0,0
5700,established,0,0
5701,.,0,0
5702,OBJECTIVE,0,0
5703,To,0,0
5704,examine,0,0
5705,the,0,0
5706,effect,0,0
5707,of,0,0
5708,a,0,0
5709,solution,0,0
5710,of,0,0
5711,nicotine,0,0
5712,on,0,0
5713,sustained,0,0
5714,resting,0,0
5715,pressure,0,0
5716,(,0,0
5717,tone,0,0
5718,),0,0
5719,and,0,0
5720,contractile,0,1
5721,activity,0,0
5722,in,0,0
5723,the,0,0
5724,human,0,1
5725,colon,0,1
5726,.,0,1
5727,METHODS,0,0
5728,Ten,1,1
5729,healthy,1,1
5730,volunteers,1,1
5731,",",1,0
5732,and,1,0
5733,seven,1,1
5734,with,1,1
5735,UC,1,0
5736,in,1,0
5737,symptomatic,1,1
5738,remission,1,0
5739,took,1,1
5740,part,1,0
5741,;,1,0
5742,all,1,0
5743,were,1,0
5744,non-smokers,1,1
5745,.,1,1
5746,All,0,1
5747,17,1,1
5748,subjects,1,1
5749,were,0,1
5750,given,0,0
5751,nicotine,0,0
5752,or,0,1
5753,placebo,0,0
5754,solution,0,0
5755,on,0,0
5756,two,0,0
5757,separate,0,0
5758,occasions,0,0
5759,in,0,0
5760,a,0,0
5761,randomized,0,0
5762,sequence,0,0
5763,.,0,0
5764,A,0,0
5765,water-perfused,0,0
5766,manometry,0,0
5767,catheter,0,0
5768,",",0,0
5769,with,0,1
5770,openings,0,0
5771,at,0,1
5772,5,0,1
5773,",",0,0
5774,10,0,0
5775,and,0,0
5776,15,0,1
5777,cm,0,1
5778,from,0,0
5779,the,0,0
5780,tip,0,0
5781,",",0,0
5782,was,0,0
5783,placed,0,0
5784,by,0,0
5785,rigid,0,1
5786,sigmoidoscopy,0,1
5787,in,0,0
5788,the,0,0
5789,recto-sigmoid,0,1
5790,region,0,1
5791,.,0,1
5792,Baseline,0,0
5793,tone,0,0
5794,and,0,0
5795,activity,0,0
5796,were,0,0
5797,measured,0,0
5798,for,0,0
5799,15,0,1
5800,min,0,0
5801,prior,0,1
5802,to,0,0
5803,instillation,0,0
5804,of,0,0
5805,20,0,0
5806,ml,0,0
5807,of,0,0
5808,saline,0,0
5809,alone,0,0
5810,or,0,1
5811,with,0,1
5812,nicotine,0,0
5813,",",0,0
5814,1.2,0,0
5815,mg,0,0
5816,",",0,0
5817,at,0,0
5818,pH,0,0
5819,4.5,0,1
5820,.,0,1
5821,Observations,0,0
5822,were,0,0
5823,made,0,0
5824,over,0,0
5825,the,0,0
5826,subsequent,0,0
5827,15-20,0,1
5828,min,0,0
5829,.,0,1
5830,RESULTS,0,0
5831,Baseline,0,0
5832,spontaneous,0,0
5833,activity,0,0
5834,in,0,0
5835,all,0,0
5836,subjects,0,1
5837,showed,0,0
5838,both,0,0
5839,high-,0,0
5840,and,0,0
5841,low-frequency,0,0
5842,components,0,0
5843,;,0,1
5844,in,0,1
5845,three,0,0
5846,patients,0,1
5847,with,0,1
5848,UC,0,0
5849,",",0,0
5850,the,0,0
5851,low-frequency,0,0
5852,activity,0,0
5853,was,0,0
5854,of,0,0
5855,high,0,1
5856,amplitude,0,0
5857,.,0,0
5858,The,0,0
5859,nicotine,0,0
5860,reduced,0,0
5861,both,0,0
5862,tone,0,0
5863,and,0,0
5864,activity,0,0
5865,in,0,0
5866,all,0,0
5867,subjects,0,1
5868,",",0,0
5869,with,0,1
5870,reduction,0,0
5871,or,0,0
5872,abolition,0,0
5873,of,0,0
5874,the,0,0
5875,large,0,1
5876,contractions,0,0
5877,in,0,1
5878,UC,0,0
5879,.,0,0
5880,Tone,0,0
5881,in,0,0
5882,all,0,0
5883,17,1,1
5884,subjects,1,1
5885,was,0,0
5886,reduced,0,0
5887,significantly,0,0
5888,at,0,0
5889,3,0,0
5890,min,0,0
5891,after,0,0
5892,nicotine,0,0
5893,(,0,0
5894,P,0,0
5895,=,0,0
5896,0.000015,0,0
5897,",",0,0
5898,sign,0,0
5899,test,0,0
5900,),0,1
5901,;,0,0
5902,the,0,0
5903,rate,0,0
5904,of,0,0
5905,recovery,0,0
5906,varied,0,0
5907,in,0,0
5908,individuals,0,1
5909,.,0,1
5910,Results,0,0
5911,from,0,1
5912,normals,0,1
5913,and,0,1
5914,UC,0,0
5915,did,0,0
5916,not,0,0
5917,differ,0,0
5918,significantly,0,0
5919,from,0,0
5920,each,0,0
5921,other,0,0
5922,.,0,0
5923,No,0,0
5924,significant,0,0
5925,change,0,0
5926,in,0,0
5927,tone,0,0
5928,or,0,1
5929,activity,0,0
5930,was,0,0
5931,observed,0,0
5932,with,0,1
5933,the,0,0
5934,saline,0,0
5935,solution,0,0
5936,.,0,1
5937,CONCLUSION,0,0
5938,Intra-luminal,0,0
5939,nicotine,0,0
5940,significantly,0,0
5941,reduces,0,0
5942,both,0,0
5943,smooth,0,0
5944,muscle,0,0
5945,tone,0,0
5946,and,0,0
5947,contractile,0,0
5948,activity,0,0
5949,in,0,0
5950,the,0,0
5951,recto-sigmoid,0,1
5952,colon,0,1
5953,in,0,0
5954,both,0,0
5955,normal,1,1
5956,subjects,1,1
5957,and,1,1
5958,patients,1,1
5959,with,1,1
5960,UC,1,1
5961,.,1,1
5962,Standard-dose,0,0
5963,lansoprazole,0,0
5964,is,0,0
5965,more,0,0
5966,effective,0,0
5967,than,0,0
5968,high-dose,0,0
5969,ranitidine,0,0
5970,in,0,0
5971,achieving,0,0
5972,endoscopic,0,0
5973,healing,0,0
5974,and,0,0
5975,symptom,0,0
5976,relief,0,0
5977,in,0,0
5978,patients,1,1
5979,with,1,1
5980,moderately,1,1
5981,severe,1,1
5982,reflux,1,1
5983,oesophagitis,1,1
5984,.,1,0
5985,The,0,0
5986,Dutch,0,0
5987,Lansoprazole,0,0
5988,Study,0,1
5989,Group,0,1
5990,.,0,1
5991,BACKGROUND,0,0
5992,In,0,0
5993,the,0,0
5994,treatment,0,0
5995,of,0,0
5996,reflux,0,1
5997,oesophagitis,0,1
5998,",",0,0
5999,H2-receptor,0,0
6000,antagonists,0,0
6001,are,0,0
6002,still,0,0
6003,widely,0,0
6004,used,0,0
6005,in,0,0
6006,spite,0,0
6007,of,0,0
6008,the,0,0
6009,apparent,0,0
6010,higher,0,0
6011,efficacy,0,0
6012,of,0,0
6013,proton,0,0
6014,pump,0,0
6015,inhibitors,0,0
6016,.,0,1
6017,In,0,0
6018,an,0,0
6019,attempt,0,0
6020,to,0,0
6021,compensate,0,0
6022,for,0,0
6023,the,0,0
6024,lower,0,0
6025,efficacy,0,0
6026,",",0,0
6027,H2-receptor,0,0
6028,antagonists,0,0
6029,are,0,0
6030,now,0,0
6031,increasingly,0,0
6032,being,0,0
6033,used,0,0
6034,at,0,0
6035,a,0,0
6036,higher,0,0
6037,dose,0,0
6038,.,0,0
6039,OBJECTIVE,0,0
6040,To,0,0
6041,assess,0,0
6042,whether,0,0
6043,or,0,0
6044,not,0,0
6045,standard-dose,0,0
6046,lansoprazole,0,0
6047,(,0,0
6048,30,0,0
6049,mg,0,0
6050,o.d,0,1
6051,.,0,0
6052,),0,0
6053,is,0,0
6054,more,0,0
6055,effective,0,0
6056,than,0,0
6057,high-dose,0,0
6058,ranitidine,0,0
6059,(,0,0
6060,300,0,0
6061,mg,0,0
6062,b.d,0,1
6063,.,0,0
6064,),0,0
6065,in,0,0
6066,moderately,0,1
6067,severe,0,1
6068,reflux,0,1
6069,oesophagitis,0,1
6070,(,0,0
6071,grades,0,1
6072,II-III,0,1
6073,),0,1
6074,.,0,1
6075,METHODS,0,0
6076,Lansoprazole,0,0
6077,or,0,1
6078,ranitidine,0,0
6079,was,0,0
6080,given,0,0
6081,to,0,0
6082,133,1,1
6083,patients,1,1
6084,for,0,1
6085,4-8,0,1
6086,weeks,0,0
6087,in,0,0
6088,a,0,0
6089,double-blind,0,0
6090,",",0,0
6091,randomized,0,0
6092,",",0,0
6093,parallel,0,0
6094,group,0,0
6095,",",0,0
6096,multicentre,0,0
6097,trial,0,0
6098,.,0,0
6099,RESULTS,0,0
6100,The,0,0
6101,percentage,0,0
6102,of,0,0
6103,patients,0,1
6104,with,0,1
6105,endoscopically-verified,0,1
6106,healing,0,0
6107,was,0,0
6108,significantly,0,0
6109,higher,0,0
6110,on,0,0
6111,lansoprazole,0,0
6112,than,0,0
6113,on,0,0
6114,ranitidine,0,0
6115,both,0,0
6116,after,0,0
6117,4,0,0
6118,weeks,0,0
6119,(,0,1
6120,79,0,1
6121,%,0,0
6122,vs.,0,0
6123,42,0,1
6124,%,0,0
6125,),0,0
6126,and,0,0
6127,8,0,0
6128,weeks,0,0
6129,(,0,1
6130,91,0,1
6131,%,0,0
6132,vs.,0,0
6133,66,0,1
6134,%,0,0
6135,),0,0
6136,",",0,0
6137,though,0,0
6138,smoking,0,0
6139,had,0,1
6140,a,0,0
6141,negative,0,0
6142,impact,0,0
6143,on,0,0
6144,oesophagitis,0,1
6145,healing,0,0
6146,with,0,1
6147,lansoprazole,0,0
6148,.,0,1
6149,Heartburn,0,0
6150,",",0,0
6151,retrosternal,0,1
6152,pain,0,0
6153,and,0,0
6154,belching,0,0
6155,improved,0,0
6156,significantly,0,0
6157,better,0,0
6158,with,0,0
6159,lansoprazole,0,0
6160,than,0,0
6161,with,0,1
6162,ranitidine,0,0
6163,",",0,0
6164,as,0,0
6165,did,0,0
6166,the,0,0
6167,patient-rated,0,0
6168,overall,0,0
6169,symptom,0,1
6170,severity,0,0
6171,.,0,0
6172,Relief,0,0
6173,of,0,0
6174,heartburn,0,1
6175,appeared,0,0
6176,somewhat,0,0
6177,faster,0,0
6178,with,0,0
6179,ranitidine,0,0
6180,",",0,0
6181,but,0,0
6182,was,0,0
6183,more,0,0
6184,pronounced,0,0
6185,with,0,0
6186,lansoprazole,0,0
6187,.,0,0
6188,The,0,0
6189,number,0,0
6190,of,0,0
6191,patients,0,1
6192,with,0,1
6193,adverse,0,0
6194,events,0,0
6195,was,0,0
6196,similar,0,0
6197,in,0,0
6198,both,0,0
6199,treatment,0,0
6200,groups,0,0
6201,.,0,1
6202,CONCLUSION,0,0
6203,Standard-dose,0,0
6204,lansoprazole,0,0
6205,is,0,0
6206,better,0,0
6207,than,0,0
6208,high-dose,0,0
6209,ranitidine,0,0
6210,in,0,0
6211,moderately,0,1
6212,severe,0,1
6213,reflux,0,1
6214,oesophagitis,0,1
6215,.,0,1
6216,Partial,0,1
6217,depletion,0,0
6218,of,0,0
6219,tissue,0,0
6220,factor,0,0
6221,pathway,0,0
6222,inhibitor,0,0
6223,during,0,0
6224,subcutaneous,0,0
6225,administration,0,0
6226,of,0,0
6227,unfractionated,0,0
6228,heparin,0,0
6229,",",0,0
6230,but,0,0
6231,not,0,0
6232,with,0,1
6233,two,0,0
6234,low,0,1
6235,molecular,0,0
6236,weight,0,1
6237,heparins,0,0
6238,.,0,1
6239,Tissue,0,0
6240,factor,0,0
6241,pathway,0,0
6242,inhibitor,0,0
6243,(,0,0
6244,TFPI,0,0
6245,),0,0
6246,is,0,0
6247,released,0,0
6248,to,0,0
6249,circulating,0,0
6250,blood,0,0
6251,after,0,0
6252,intravenous,0,0
6253,(,0,1
6254,i.v,0,0
6255,.,0,1
6256,),0,0
6257,and,0,0
6258,subcutaneous,0,0
6259,(,0,0
6260,s.c.,0,1
6261,),0,0
6262,injections,0,0
6263,of,0,0
6264,heparins,0,0
6265,",",0,0
6266,and,0,0
6267,may,0,0
6268,thus,0,0
6269,contribute,0,0
6270,to,0,0
6271,the,0,0
6272,antithrombotic,0,0
6273,effect,0,0
6274,of,0,0
6275,heparins,0,0
6276,.,0,1
6277,We,0,0
6278,have,0,0
6279,recently,0,0
6280,shown,0,0
6281,that,0,0
6282,total,0,1
6283,TFPI,0,1
6284,activity,0,0
6285,",",0,0
6286,plasma,0,0
6287,free,0,0
6288,TFPI,0,1
6289,antigen,0,0
6290,",",0,0
6291,and,0,0
6292,heparin,0,0
6293,releasable,0,1
6294,TFPI,0,1
6295,were,0,0
6296,partially,0,0
6297,depleted,0,0
6298,during,0,0
6299,repeated,0,0
6300,and,0,0
6301,continuous,0,0
6302,i.v,0,0
6303,.,0,0
6304,infusion,0,0
6305,of,0,0
6306,unfractionated,0,0
6307,heparin,0,0
6308,(,0,0
6309,UFH,0,0
6310,),0,0
6311,",",0,0
6312,but,0,0
6313,not,0,0
6314,during,0,0
6315,s.c.,0,0
6316,treatment,0,0
6317,with,0,1
6318,a,0,0
6319,low,0,0
6320,molecular,0,0
6321,weight,0,0
6322,heparin,0,0
6323,(,0,0
6324,LMWH,0,1
6325,),0,0
6326,.,0,0
6327,The,0,0
6328,difference,0,0
6329,may,0,0
6330,be,0,0
6331,attributed,0,0
6332,to,0,0
6333,a,0,0
6334,different,0,0
6335,mode,0,0
6336,of,0,0
6337,action,0,0
6338,or,0,1
6339,the,0,0
6340,different,0,0
6341,mode,0,0
6342,of,0,0
6343,administration,0,0
6344,.,0,0
6345,In,0,0
6346,the,0,0
6347,present,0,0
6348,randomized,0,0
6349,cross-over,0,0
6350,study,0,0
6351,",",0,0
6352,s.c.,0,0
6353,administration,0,0
6354,of,0,0
6355,therapeutic,0,0
6356,doses,0,0
6357,of,0,1
6358,UFH,0,0
6359,was,0,0
6360,compared,0,0
6361,with,0,1
6362,s.c.,0,0
6363,administration,0,0
6364,of,0,0
6365,two,0,0
6366,LMWHs,0,0
6367,.,0,1
6368,12,1,0
6369,healthy,1,1
6370,male,1,1
6371,volunteers,1,1
6372,were,0,0
6373,treated,0,1
6374,for,0,0
6375,3,0,0
6376,d,0,1
6377,with,0,1
6378,UFH,0,0
6379,",",0,0
6380,250,0,0
6381,U/kg,0,0
6382,twice,0,0
6383,daily,0,0
6384,",",0,0
6385,dalteparin,0,0
6386,",",0,0
6387,200,0,0
6388,U/kg,0,0
6389,once,0,0
6390,daily,0,0
6391,",",0,0
6392,and,0,0
6393,enoxaparin,0,0
6394,",",0,0
6395,1.5,0,0
6396,mg/kg,0,0
6397,once,0,0
6398,daily,0,0
6399,.,0,1
6400,Six,1,0
6401,participants,1,1
6402,were,0,1
6403,also,0,0
6404,treated,0,1
6405,with,0,0
6406,UFH,0,0
6407,",",0,0
6408,300,0,0
6409,U/kg,0,0
6410,once,0,0
6411,daily,0,0
6412,.,0,0
6413,On,0,0
6414,day,0,0
6415,5,0,0
6416,a,0,0
6417,single,0,0
6418,dose,0,0
6419,of,0,0
6420,either,0,0
6421,drug,0,0
6422,was,0,0
6423,given,0,0
6424,.,0,1
6425,Peak,0,0
6426,levels,0,0
6427,of,0,0
6428,total,0,1
6429,TFPI,0,1
6430,activity,0,0
6431,and,0,0
6432,free,0,0
6433,TFPI,0,1
6434,antigen,0,0
6435,were,0,0
6436,detected,0,0
6437,1,0,0
6438,h,0,0
6439,after,0,0
6440,injection,0,0
6441,",",0,0
6442,whereas,0,0
6443,maximal,0,0
6444,prolongation,0,0
6445,of,0,0
6446,activated,0,0
6447,partial,0,1
6448,thromboplastin,0,0
6449,time,0,0
6450,(,0,0
6451,APTT,0,0
6452,),0,0
6453,and,0,0
6454,peak,0,0
6455,levels,0,0
6456,of,0,1
6457,anti-factor,0,0
6458,Xa,0,0
6459,activity,0,0
6460,and,0,0
6461,anti-factor,0,0
6462,IIa,0,0
6463,activity,0,0
6464,were,0,0
6465,detected,0,0
6466,after,0,0
6467,4,0,0
6468,h.,0,1
6469,On,0,0
6470,UFH,0,0
6471,administered,0,0
6472,twice,0,0
6473,daily,0,0
6474,",",0,0
6475,free,0,0
6476,TFPI,0,1
6477,antigen,0,0
6478,decreased,0,0
6479,by,0,0
6480,44,0,1
6481,%,0,0
6482,from,0,1
6483,baseline,0,0
6484,level,0,0
6485,before,0,0
6486,the,0,0
6487,first,0,0
6488,injection,0,0
6489,on,0,0
6490,day,0,0
6491,1,0,0
6492,to,0,0
6493,pre-injection,0,0
6494,level,0,0
6495,on,0,0
6496,day,0,0
6497,5,0,0
6498,.,0,1
6499,On,0,0
6500,UFH,0,0
6501,administered,0,0
6502,once,0,0
6503,daily,0,0
6504,",",0,0
6505,basal,0,0
6506,free,0,0
6507,TFPI,0,1
6508,antigen,0,0
6509,decreased,0,0
6510,by,0,0
6511,50,0,1
6512,%,0,0
6513,",",0,0
6514,56,0,1
6515,%,0,0
6516,and,0,0
6517,27,0,1
6518,%,0,0
6519,on,0,0
6520,day,0,0
6521,2,0,0
6522,",",0,0
6523,3,0,0
6524,and,0,0
6525,5,0,0
6526,respectively,0,0
6527,",",0,0
6528,compared,0,0
6529,with,0,1
6530,day,0,0
6531,1,0,0
6532,.,0,1
6533,Minimal,0,0
6534,depletion,0,0
6535,of,0,0
6536,TFPI,0,1
6537,was,0,0
6538,detected,0,0
6539,during,0,0
6540,treatment,0,0
6541,with,0,1
6542,LMWHs,0,0
6543,.,0,0
6544,The,0,0
6545,study,0,0
6546,demonstrates,0,0
6547,the,0,0
6548,different,0,0
6549,modes,0,0
6550,of,0,0
6551,action,0,0
6552,of,0,0
6553,LMWHs,0,0
6554,and,0,0
6555,UFH,0,0
6556,and,0,0
6557,may,0,0
6558,help,0,0
6559,to,0,0
6560,explain,0,0
6561,the,0,0
6562,superior,0,0
6563,antithrombotic,0,0
6564,efficacy,0,0
6565,of,0,0
6566,LMWHs,0,0
6567,.,0,1
6568,Early,0,1
6569,immunisation,0,1
6570,with,0,1
6571,hepatitis,0,1
6572,B,0,1
6573,vaccine,0,0
6574,:,0,1
6575,a,0,0
6576,five-year,0,0
6577,study,0,0
6578,.,0,1
6579,We,0,0
6580,evaluated,0,0
6581,the,0,0
6582,response,0,0
6583,to,0,0
6584,the,0,0
6585,recombinant,0,0
6586,Hepatitis,0,1
6587,B,0,0
6588,vaccine,0,0
6589,using,0,0
6590,an,0,0
6591,accelerated,0,0
6592,schedule,0,0
6593,versus,0,0
6594,the,0,0
6595,traditional,0,0
6596,schedule,0,0
6597,by,0,0
6598,studying,0,0
6599,the,0,0
6600,immunologic,0,0
6601,memory,0,0
6602,induced,0,0
6603,in,0,0
6604,200,1,0
6605,children,1,1
6606,with,1,1
6607,HBs-Ag,1,1
6608,negative,1,1
6609,mothers,1,1
6610,.,1,1
6611,At,0,0
6612,seroconversion,0,0
6613,",",0,0
6614,the,0,0
6615,traditional,0,0
6616,schedule,0,0
6617,presented,0,0
6618,a,0,0
6619,higher,0,0
6620,percentage,0,0
6621,of,0,0
6622,children,1,1
6623,with,1,1
6624,serum,1,0
6625,HBs-Ag,1,0
6626,concentrations,1,0
6627,over,1,0
6628,100,1,1
6629,mIU/ml,1,0
6630,than,1,0
6631,the,1,0
6632,accelerated,1,0
6633,schedule,1,0
6634,.,1,1
6635,After,0,0
6636,five,0,1
6637,years,0,1
6638,this,0,0
6639,difference,0,0
6640,was,0,0
6641,no,0,0
6642,longer,0,0
6643,statistically,0,0
6644,significant,0,0
6645,and,0,1
6646,children,1,1
6647,who,1,1
6648,presented,1,1
6649,anti-HBsAg,1,1
6650,concentrations,1,0
6651,below,1,0
6652,10,1,1
6653,mUI/ml,1,0
6654,received,0,0
6655,an,0,0
6656,additional,0,0
6657,booster,0,0
6658,dose,0,0
6659,which,0,0
6660,stimulated,0,0
6661,the,0,0
6662,antibody,0,0
6663,concentration,0,0
6664,to,0,0
6665,exceed,0,0
6666,100,0,0
6667,mIU/ml,0,0
6668,in,0,0
6669,all,0,1
6670,cases,0,1
6671,.,0,1
6672,Recombinant,0,0
6673,HBV,0,1
6674,vaccine,0,0
6675,induced,0,0
6676,better,0,0
6677,long,0,0
6678,term,0,0
6679,immunologic,0,0
6680,memory,0,0
6681,when,0,0
6682,it,0,0
6683,was,0,0
6684,administered,0,0
6685,earlier,0,1
6686,.,0,0
6687,Focal,0,1
6688,therapeutic,0,0
6689,efficacy,0,0
6690,of,0,0
6691,transcatheter,0,1
6692,arterial,0,1
6693,infusion,0,0
6694,of,0,0
6695,styrene,0,0
6696,maleic,0,0
6697,acid,0,0
6698,neocarzinostatin,0,0
6699,for,0,0
6700,hepatocellular,0,1
6701,carcinoma,0,1
6702,.,0,1
6703,We,0,0
6704,evaluated,0,0
6705,the,0,0
6706,focal,0,1
6707,therapeutic,0,0
6708,effect,0,0
6709,of,0,0
6710,oily,0,0
6711,carcinostatic,0,1
6712,agents,0,0
6713,administered,0,0
6714,by,0,0
6715,transcatheter,0,1
6716,arterial,0,1
6717,infusion,0,0
6718,(,0,0
6719,TAI,0,0
6720,),0,0
6721,as,0,0
6722,the,0,0
6723,initial,0,0
6724,therapy,0,0
6725,in,0,0
6726,patients,1,1
6727,with,1,1
6728,hepatocellular,1,1
6729,carcinoma,1,1
6730,in,0,0
6731,a,0,0
6732,randomized,0,0
6733,controlled,0,0
6734,clinical,0,0
6735,trial,0,1
6736,.,0,1
6737,Group,1,0
6738,A,1,0
6739,(,1,1
6740,19,1,1
6741,patients,1,1
6742,),1,1
6743,received,0,1
6744,4,0,0
6745,mg,0,0
6746,of,0,0
6747,styrene,0,0
6748,maleic,0,0
6749,acid,0,0
6750,neocarzinostatin,0,0
6751,in,0,0
6752,4,0,0
6753,ml,0,0
6754,of,0,0
6755,Lipiodol,0,0
6756,",",0,0
6757,and,0,0
6758,group,1,0
6759,B,1,1
6760,(,1,1
6761,18,1,1
6762,patients,1,1
6763,),1,1
6764,received,0,1
6765,100,0,0
6766,mg,0,0
6767,of,0,0
6768,epirubicin,0,0
6769,in,0,0
6770,4,0,0
6771,ml,0,0
6772,of,0,0
6773,Lipiodol,0,0
6774,via,0,0
6775,the,0,0
6776,tumor,0,0
6777,feeding,0,0
6778,arteries,0,0
6779,as,0,0
6780,peripherally,0,0
6781,as,0,0
6782,possible,0,0
6783,.,0,0
6784,The,0,0
6785,grade,0,0
6786,of,0,0
6787,Lipiodol,0,0
6788,accumulation,0,0
6789,and,0,0
6790,the,0,0
6791,tumor,0,0
6792,regression,0,0
6793,rate,0,0
6794,were,0,0
6795,determined,0,0
6796,2,0,0
6797,weeks,0,0
6798,after,0,0
6799,TAI,0,0
6800,by,0,0
6801,computerized,0,0
6802,tomography,0,0
6803,.,0,1
6804,Adverse,0,0
6805,effects,0,0
6806,within,0,1
6807,2,0,1
6808,weeks,0,0
6809,after,0,1
6810,TAI,0,0
6811,were,0,0
6812,evaluated,0,0
6813,by,0,0
6814,subjective,0,0
6815,signs,0,1
6816,and,0,1
6817,symptoms,0,1
6818,such,0,0
6819,as,0,0
6820,fever,0,1
6821,(,0,0
6822,maximum,0,0
6823,body,0,1
6824,temperature,0,0
6825,),0,0
6826,and,0,0
6827,the,0,0
6828,frequency,0,0
6829,of,0,0
6830,shaking,0,0
6831,chills,0,0
6832,and,0,1
6833,abdominal,0,1
6834,pain,0,0
6835,",",0,0
6836,and,0,0
6837,by,0,0
6838,biochemical,0,0
6839,parameters,0,0
6840,such,0,0
6841,as,0,0
6842,albumin,0,0
6843,",",0,0
6844,prothrombin,0,0
6845,time,0,0
6846,",",0,0
6847,and,0,0
6848,aspartate,0,0
6849,and,0,0
6850,alanine,0,1
6851,aminotransferases,0,0
6852,.,0,1
6853,Lipiodol,0,0
6854,accumulation,0,0
6855,in,0,0
6856,the,0,0
6857,tumor,0,0
6858,was,0,0
6859,significantly,0,0
6860,greater,0,0
6861,in,0,0
6862,group,0,0
6863,A,0,1
6864,(,0,1
6865,12/19,0,0
6866,;,0,1
6867,63.2,0,0
6868,%,0,0
6869,showing,0,0
6870,grade,0,1
6871,IV,0,1
6872,Lipiodol,0,0
6873,accumulation,0,0
6874,),0,0
6875,than,0,0
6876,in,0,0
6877,group,0,1
6878,B,0,1
6879,(,0,1
6880,3/18,0,1
6881,;,0,1
6882,16.7,0,1
6883,%,0,0
6884,showing,0,0
6885,grade,0,1
6886,IV,0,1
6887,),0,0
6888,(,0,0
6889,P,0,0
6890,<,0,0
6891,0.05,0,0
6892,),0,0
6893,.,0,0
6894,The,0,0
6895,tumor,0,0
6896,regression,0,0
6897,rate,0,0
6898,was,0,0
6899,also,0,0
6900,significantly,0,0
6901,greater,0,0
6902,in,0,0
6903,group,0,0
6904,A,0,1
6905,(,0,1
6906,8/17,0,0
6907,;,0,1
6908,47.1,0,1
6909,%,0,0
6910,showing,0,0
6911,more,0,0
6912,than,0,0
6913,25,0,0
6914,%,0,0
6915,tumor,0,1
6916,regression,0,0
6917,),0,0
6918,than,0,0
6919,in,0,0
6920,group,0,1
6921,B,0,1
6922,(,0,1
6923,1/13,0,0
6924,;,0,1
6925,7.7,0,0
6926,%,0,0
6927,showing,0,0
6928,more,0,0
6929,than,0,0
6930,25,0,0
6931,%,0,0
6932,tumor,0,1
6933,regression,0,0
6934,),0,0
6935,(,0,0
6936,P,0,0
6937,<,0,0
6938,0.05,0,0
6939,),0,0
6940,.,0,0
6941,Although,0,0
6942,clinically,0,0
6943,significant,0,0
6944,elevations,0,0
6945,of,0,1
6946,aminotransferases,0,0
6947,and,0,1
6948,reductions,0,0
6949,of,0,0
6950,cholinesterase,0,0
6951,",",0,0
6952,and,0,0
6953,shaking,0,0
6954,chills,0,0
6955,were,0,0
6956,observed,0,0
6957,more,0,0
6958,often,0,0
6959,in,0,0
6960,group,0,0
6961,A,0,0
6962,than,0,0
6963,in,0,0
6964,group,0,1
6965,B,0,1
6966,(,0,0
6967,P,0,0
6968,<,0,0
6969,0.0001,0,0
6970,),0,0
6971,",",0,0
6972,these,0,0
6973,factors,0,0
6974,had,0,1
6975,little,0,0
6976,influence,0,0
6977,on,0,0
6978,the,0,0
6979,clinical,0,0
6980,outcome,0,0
6981,.,0,1
6982,Our,0,0
6983,results,0,0
6984,suggest,0,0
6985,that,0,0
6986,styrene,0,0
6987,maleic,0,0
6988,acid,0,0
6989,neocarzinostatin,0,0
6990,in,0,0
6991,Lipiodol,0,0
6992,exerts,0,0
6993,a,0,0
6994,more,0,0
6995,favorable,0,0
6996,focal,0,1
6997,therapeutic,0,0
6998,effect,0,0
6999,than,0,0
7000,does,0,0
7001,epirubicin,0,0
7002,in,0,0
7003,Lipiodol,0,0
7004,in,0,0
7005,the,0,0
7006,initial,0,0
7007,treatment,0,0
7008,of,0,0
7009,hepatocellular,0,1
7010,carcinoma,0,1
7011,.,0,1
7012,[,0,0
7013,Administration,0,0
7014,of,0,0
7015,tobramycin,0,0
7016,aerosols,0,1
7017,in,0,1
7018,patients,1,1
7019,with,1,1
7020,nosocomial,1,1
7021,pneumonia,1,1
7022,:,1,1
7023,a,0,0
7024,preliminary,0,0
7025,study,0,0
7026,],0,1
7027,.,0,0
7028,OBJECTIVE,0,0
7029,The,0,0
7030,aim,0,0
7031,of,0,0
7032,this,0,0
7033,study,0,0
7034,was,0,0
7035,to,0,0
7036,assess,0,0
7037,renal,0,1
7038,and,0,0
7039,respiratory,0,1
7040,tolerance,0,0
7041,of,0,0
7042,aerosolized,0,0
7043,tobramycin,0,0
7044,in,0,0
7045,intubated,1,1
7046,and,1,0
7047,mechanically,1,1
7048,ventilated,1,1
7049,patients,1,1
7050,with,1,1
7051,nosocomial,1,1
7052,pneumonia,1,1
7053,.,1,1
7054,PATIENTS,0,0
7055,AND,0,0
7056,METHODS,0,0
7057,This,0,0
7058,was,0,0
7059,a,0,0
7060,multicenter,0,0
7061,",",0,0
7062,randomized,0,0
7063,",",0,0
7064,double-blind,0,0
7065,",",0,0
7066,placebo,0,0
7067,controlled,0,0
7068,study,0,0
7069,.,0,0
7070,Thirty-eight,1,1
7071,mechanically,1,0
7072,ventilated,1,1
7073,patients,1,1
7074,with,1,1
7075,documented,1,1
7076,nosocomial,1,0
7077,pneumonia,1,1
7078,were,1,0
7079,included,1,1
7080,.,1,1
7081,Patients,0,1
7082,treated,0,1
7083,with,0,1
7084,intravenous,0,0
7085,betalactam,0,0
7086,and,0,1
7087,tobramycin,0,0
7088,were,0,0
7089,randomly,0,1
7090,allocated,0,0
7091,to,0,0
7092,receive,0,0
7093,aerosolized,0,0
7094,tobramycin,0,0
7095,(,0,0
7096,6,0,0
7097,mg/kg/day,0,0
7098,",",0,0
7099,n,0,1
7100,=,0,0
7101,21,0,1
7102,),0,0
7103,or,0,1
7104,placebo,0,0
7105,(,0,0
7106,n,0,1
7107,=,0,0
7108,17,0,1
7109,),0,0
7110,.,0,0
7111,The,0,0
7112,aerosol,0,0
7113,was,0,0
7114,administered,0,0
7115,via,0,0
7116,a,0,0
7117,pneumatic,0,0
7118,nebulizer,0,0
7119,once,0,0
7120,a,0,0
7121,day,0,0
7122,for,0,0
7123,5,0,1
7124,days,0,0
7125,.,0,1
7126,RESULTS,0,0
7127,Respiratory,1,1
7128,tolerance,1,0
7129,was,1,0
7130,good,1,0
7131,in,1,0
7132,all,1,0
7133,but,1,0
7134,two,1,0
7135,patients,1,1
7136,.,1,1
7137,No,0,0
7138,acute,0,1
7139,renal,0,1
7140,failure,0,1
7141,occurred,0,0
7142,.,0,0
7143,By,0,0
7144,day,0,0
7145,10,0,0
7146,",",0,0
7147,7,0,1
7148,patients,0,1
7149,in,0,0
7150,the,0,0
7151,tobramycin,0,0
7152,group,0,0
7153,(,0,0
7154,35,0,1
7155,%,0,0
7156,),0,0
7157,had,0,0
7158,been,0,0
7159,extubated,0,1
7160,versus,0,0
7161,3,0,0
7162,in,0,0
7163,the,0,0
7164,placebo,0,0
7165,group,0,0
7166,(,0,0
7167,18.5,0,0
7168,%,0,0
7169,",",0,0
7170,p,0,0
7171,=,0,0
7172,0.18,0,0
7173,),0,0
7174,.,0,0
7175,By,0,0
7176,day,0,0
7177,28,0,1
7178,",",0,0
7179,6,0,0
7180,patients,0,1
7181,had,0,1
7182,died,0,1
7183,(,0,0
7184,2,0,0
7185,in,0,0
7186,the,0,0
7187,tobramycin,0,0
7188,group,0,0
7189,and,0,0
7190,4,0,0
7191,in,0,0
7192,the,0,0
7193,placebo,0,0
7194,group,0,0
7195,",",0,0
7196,p,0,0
7197,=,0,0
7198,0.23,0,0
7199,),0,0
7200,.,0,1
7201,CONCLUSION,0,0
7202,Aerosolized,0,0
7203,tobramycin,0,0
7204,was,0,0
7205,well,0,0
7206,tolerated,0,0
7207,in,0,0
7208,ventilated,1,1
7209,patients,1,1
7210,with,1,1
7211,documented,1,1
7212,nosocomial,1,1
7213,pneumonia,1,1
7214,.,1,1
7215,Growth,0,0
7216,hormone,0,0
7217,(,0,0
7218,GH,0,0
7219,),0,0
7220,responses,0,0
7221,to,0,0
7222,GH-releasing,0,0
7223,hormone,0,0
7224,alone,0,0
7225,or,0,0
7226,combined,0,0
7227,with,0,1
7228,arginine,0,0
7229,in,0,0
7230,patients,1,1
7231,with,1,1
7232,adrenal,1,1
7233,incidentaloma,1,1
7234,:,1,1
7235,evidence,0,0
7236,for,0,0
7237,enhanced,0,0
7238,somatostatinergic,0,0
7239,tone,0,0
7240,.,0,1
7241,Spontaneous,0,0
7242,and,0,0
7243,stimulated,0,0
7244,GH,0,0
7245,secretion,0,0
7246,is,0,0
7247,blunted,0,0
7248,in,0,0
7249,hypercortisolemic,0,1
7250,states,0,1
7251,due,0,1
7252,to,0,0
7253,increased,0,0
7254,hypothalamic,0,0
7255,somatostatinergic,0,0
7256,tone,0,0
7257,.,0,0
7258,However,0,0
7259,",",0,0
7260,no,0,0
7261,data,0,0
7262,are,0,0
7263,available,0,0
7264,on,0,0
7265,the,0,0
7266,characteristics,0,0
7267,of,0,0
7268,GH,0,0
7269,secretion,0,0
7270,in,0,0
7271,patients,1,1
7272,with,1,1
7273,incidentally,1,1
7274,discovered,1,0
7275,adrenal,1,1
7276,adenomas,1,1
7277,.,1,0
7278,They,0,0
7279,represent,0,0
7280,an,0,0
7281,interesting,0,0
7282,model,0,0
7283,for,0,0
7284,studying,0,0
7285,GH,0,0
7286,secretion,0,0
7287,",",0,0
7288,as,0,0
7289,a,0,0
7290,slight,0,0
7291,degree,0,0
7292,of,0,0
7293,cortisol,0,0
7294,excess,0,0
7295,may,0,0
7296,frequently,0,0
7297,be,0,0
7298,observed,0,0
7299,in,0,0
7300,such,0,0
7301,patients,1,1
7302,who,1,1
7303,do,1,1
7304,not,1,0
7305,present,1,0
7306,with,1,0
7307,any,1,0
7308,clear,1,0
7309,Cushingoid,1,1
7310,sign,1,0
7311,.,1,0
7312,In,0,0
7313,the,0,0
7314,present,0,0
7315,study,0,0
7316,",",0,0
7317,10,1,0
7318,patients,1,1
7319,(,1,1
7320,3,1,1
7321,men,1,1
7322,and,1,1
7323,7,1,1
7324,women,1,1
7325,",",1,0
7326,aged,1,1
7327,48-63,1,1
7328,yr,1,1
7329,),1,0
7330,with,1,1
7331,an,1,0
7332,adrenal,1,1
7333,mass,1,0
7334,discovered,1,0
7335,serendipitously,1,0
7336,underwent,0,1
7337,",",0,0
7338,on,0,0
7339,separate,0,0
7340,occasions,0,0
7341,",",0,0
7342,a,0,0
7343,GHRH,0,0
7344,injection,0,0
7345,alone,0,0
7346,or,0,0
7347,combined,0,0
7348,with,0,1
7349,an,0,0
7350,infusion,0,0
7351,of,0,0
7352,the,0,0
7353,functional,0,0
7354,somatostatin,0,0
7355,antagonist,0,0
7356,",",0,0
7357,arginine,0,0
7358,.,0,0
7359,Thirteen,1,1
7360,age-matched,1,1
7361,healthy,1,1
7362,volunteers,1,1
7363,served,1,1
7364,as,1,0
7365,controls,1,1
7366,.,1,1
7367,Briefly,0,0
7368,",",0,0
7369,arginine,0,0
7370,(,0,0
7371,30,0,0
7372,g,0,1
7373,),0,0
7374,was,0,0
7375,infused,0,0
7376,from,0,0
7377,-30,0,0
7378,to,0,0
7379,0,0,0
7380,min,0,0
7381,",",0,0
7382,and,0,0
7383,GHRH,0,1
7384,(,0,0
7385,100,0,0
7386,microg,0,0
7387,),0,0
7388,was,0,0
7389,injected,0,0
7390,as,0,0
7391,a,0,0
7392,bolus,0,0
7393,at,0,0
7394,0,0,0
7395,min,0,0
7396,",",0,0
7397,with,0,1
7398,measurement,0,0
7399,of,0,0
7400,serum,0,0
7401,GH,0,0
7402,[,0,0
7403,immunoradiometric,0,0
7404,assay,0,0
7405,(,0,0
7406,IRMA,0,0
7407,),0,0
7408,],0,0
7409,every,0,0
7410,15,0,0
7411,min,0,0
7412,for,0,0
7413,150,0,0
7414,min,0,0
7415,.,0,1
7416,Plasma,0,0
7417,IGF-I,0,0
7418,(,0,0
7419,RIA,0,1
7420,after,0,0
7421,acid-ethanol,0,0
7422,extraction,0,1
7423,),0,0
7424,was,0,0
7425,measured,0,0
7426,in,0,0
7427,a,0,0
7428,morning,0,0
7429,sample,0,1
7430,.,0,0
7431,The,0,0
7432,diagnosis,0,1
7433,of,0,0
7434,cortical,0,0
7435,adenoma,0,1
7436,was,0,0
7437,based,0,0
7438,on,0,0
7439,computed,0,0
7440,tomography,0,0
7441,features,0,0
7442,and,0,0
7443,pattern,0,1
7444,of,0,0
7445,uptake,0,0
7446,on,0,0
7447,adrenal,0,1
7448,scintigraphy,0,1
7449,.,0,1
7450,Patients,1,1
7451,with,1,1
7452,obesity,1,1
7453,and/or,1,1
7454,diabetes,1,1
7455,were,1,1
7456,excluded,1,1
7457,.,1,0
7458,The,0,0
7459,study,0,0
7460,design,0,0
7461,included,0,0
7462,also,0,0
7463,an,0,0
7464,endocrine,0,1
7465,work-up,0,0
7466,aimed,0,0
7467,to,0,0
7468,study,0,0
7469,the,0,0
7470,hypothalamic-pituitary-adrenal,0,0
7471,axis,0,0
7472,[,0,0
7473,urinary,0,0
7474,free,0,0
7475,cortisol,0,0
7476,(,0,0
7477,UFC,0,0
7478,),0,0
7479,excretion,0,0
7480,",",0,0
7481,serum,0,0
7482,cortisol,0,0
7483,at,0,0
7484,0800,0,0
7485,h,0,0
7486,",",0,0
7487,plasma,0,0
7488,ACTH,0,1
7489,at,0,0
7490,0800,0,0
7491,h,0,0
7492,",",0,0
7493,morning,0,0
7494,cortisol,0,0
7495,after,0,0
7496,overnight,0,1
7497,1,0,0
7498,mg,0,0
7499,dexamethasone,0,0
7500,],0,0
7501,.,0,0
7502,Five,0,0
7503,of,0,0
7504,10,0,1
7505,patients,0,1
7506,showed,0,0
7507,abnormalities,0,1
7508,of,0,0
7509,the,0,0
7510,hypothalamic-pituitary-adrenal,0,0
7511,axis,0,0
7512,",",0,0
7513,including,0,0
7514,borderline,0,1
7515,or,0,1
7516,increased,0,0
7517,UFC,0,0
7518,excretion,0,0
7519,in,0,0
7520,4,0,0
7521,of,0,0
7522,them,0,1
7523,accompanied,0,0
7524,by,0,0
7525,blunted,0,0
7526,ACTH,0,1
7527,in,0,1
7528,2,0,1
7529,cases,0,1
7530,and,0,0
7531,failure,0,1
7532,of,0,0
7533,cortisol,0,0
7534,to,0,0
7535,suppress,0,0
7536,after,0,0
7537,dexamethasone,0,0
7538,in,0,1
7539,1,0,0
7540,;,0,0
7541,the,0,0
7542,fifth,0,0
7543,patient,0,0
7544,displayed,0,0
7545,low,0,0
7546,ACTH,0,1
7547,and,0,0
7548,resistance,0,0
7549,to,0,0
7550,dexamethasone,0,0
7551,suppression,0,0
7552,.,0,0
7553,However,0,0
7554,",",0,0
7555,all,0,0
7556,patients,0,1
7557,had,0,1
7558,a,0,0
7559,unilateral,0,1
7560,uptake,0,0
7561,of,0,0
7562,the,0,0
7563,tracer,0,0
7564,on,0,0
7565,the,0,0
7566,side,0,0
7567,of,0,0
7568,the,0,0
7569,mass,0,0
7570,with,0,0
7571,suppression,0,0
7572,of,0,0
7573,the,0,0
7574,contralateral,0,0
7575,normal,0,1
7576,adrenal,0,1
7577,gland,0,1
7578,.,0,0
7579,As,0,0
7580,a,0,0
7581,group,0,0
7582,",",0,0
7583,the,0,0
7584,patients,0,1
7585,displayed,0,0
7586,greater,0,0
7587,UFC,0,0
7588,excretion,0,0
7589,and,0,0
7590,lower,0,0
7591,ACTH,0,1
7592,concentrations,0,0
7593,than,0,0
7594,the,0,0
7595,controls,0,1
7596,.,0,1
7597,GH,0,0
7598,release,0,0
7599,after,0,0
7600,GHRH,0,1
7601,treatment,0,0
7602,was,0,0
7603,blunted,0,0
7604,in,0,0
7605,patients,1,1
7606,bearing,1,1
7607,adrenal,1,1
7608,incidentaloma,1,1
7609,compared,0,0
7610,with,0,1
7611,controls,0,1
7612,(,0,1
7613,GH,0,0
7614,peak,0,0
7615,",",0,0
7616,5.7,0,0
7617,+/-,0,0
7618,5.2,0,0
7619,vs.,0,0
7620,18.0,0,0
7621,+/-,0,0
7622,7.0,0,1
7623,microg/L,0,0
7624,;,0,1
7625,P,0,0
7626,<,0,0
7627,0.0001,0,0
7628,),0,0
7629,",",0,0
7630,whereas,0,0
7631,GHRH,0,1
7632,plus,0,0
7633,arginine,0,0
7634,was,0,0
7635,able,0,0
7636,to,0,0
7637,elicit,0,0
7638,a,0,0
7639,comparable,0,0
7640,response,0,0
7641,in,0,0
7642,the,0,0
7643,2,0,0
7644,groups,0,0
7645,(,0,1
7646,GH,0,0
7647,peak,0,0
7648,",",0,0
7649,33.5,0,0
7650,+/-,0,0
7651,20.3,0,1
7652,vs.,0,0
7653,33.7,0,0
7654,+/-,0,0
7655,17.5,0,0
7656,microg/L,0,0
7657,;,0,1
7658,P,0,0
7659,=,0,0
7660,NS,0,0
7661,),0,0
7662,.,0,0
7663,The,0,0
7664,ratio,0,0
7665,between,0,0
7666,GH,0,0
7667,peaks,0,0
7668,after,0,0
7669,GHRH,0,1
7670,plus,0,0
7671,arginine,0,0
7672,and,0,0
7673,after,0,0
7674,GHRH,0,1
7675,plus,0,0
7676,saline,0,0
7677,was,0,0
7678,significantly,0,0
7679,greater,0,0
7680,in,0,0
7681,patients,0,1
7682,than,0,0
7683,in,0,1
7684,controls,0,1
7685,(,0,1
7686,751,0,1
7687,+/-,0,0
7688,531,0,1
7689,%,0,0
7690,vs.,0,0
7691,81,0,1
7692,+/-,0,0
7693,45,0,1
7694,%,0,0
7695,;,0,1
7696,P,0,0
7697,=,0,0
7698,0.0001,0,0
7699,),0,1
7700,.,0,1
7701,Similar,0,0
7702,data,0,0
7703,were,0,1
7704,obtained,0,0
7705,when,0,0
7706,comparing,0,0
7707,GH,0,0
7708,area,0,0
7709,under,0,0
7710,the,0,0
7711,curve,0,0
7712,after,0,0
7713,GHRH,0,1
7714,plus,0,0
7715,saline,0,0
7716,or,0,1
7717,GHRH,0,0
7718,plus,0,0
7719,arginine,0,0
7720,between,0,0
7721,the,0,0
7722,2,0,0
7723,groups,0,0
7724,.,0,1
7725,In,0,0
7726,summary,0,0
7727,",",0,0
7728,the,0,0
7729,present,0,0
7730,data,0,0
7731,suggest,0,0
7732,that,0,0
7733,in,0,0
7734,patients,1,1
7735,with,1,1
7736,incidental,1,1
7737,adrenal,1,1
7738,adenomas,1,1
7739,the,0,0
7740,GH,0,0
7741,response,0,0
7742,to,0,0
7743,GHRH,0,0
7744,is,0,0
7745,blunted,0,0
7746,due,0,0
7747,to,0,0
7748,increased,0,0
7749,somatostatinergic,0,0
7750,tone,0,0
7751,",",0,0
7752,as,0,0
7753,it,0,0
7754,can,0,0
7755,be,0,0
7756,restored,0,0
7757,to,0,0
7758,normal,0,1
7759,by,0,0
7760,pretreatment,0,0
7761,with,0,1
7762,the,0,0
7763,functional,0,0
7764,somatostatin,0,0
7765,antagonist,0,0
7766,arginine,0,0
7767,.,0,0
7768,The,0,0
7769,blunted,0,0
7770,GH,0,0
7771,release,0,0
7772,to,0,0
7773,GHRH,0,0
7774,may,0,0
7775,be,0,0
7776,an,0,0
7777,early,0,0
7778,and,0,0
7779,long,0,1
7780,lasting,0,0
7781,sign,0,0
7782,of,0,0
7783,autonomous,0,1
7784,cortisol,0,0
7785,secretion,0,0
7786,by,0,0
7787,the,0,0
7788,adrenal,0,1
7789,adenoma,0,1
7790,.,0,1
7791,A,0,0
7792,comparison,0,0
7793,of,0,0
7794,local,0,0
7795,anaesthetics,0,0
7796,for,0,0
7797,venepuncture,1,0
7798,.,1,1
7799,AIM,0,0
7800,To,0,0
7801,compare,0,0
7802,the,0,0
7803,effectiveness,0,0
7804,of,0,0
7805,EMLA,0,0
7806,cream,0,0
7807,and,0,0
7808,Ametop,0,0
7809,gel,0,0
7810,in,0,0
7811,providing,0,0
7812,analgesia,0,0
7813,for,0,0
7814,venous,1,1
7815,cannulation,1,1
7816,.,1,1
7817,METHODS,0,0
7818,Single,0,0
7819,blind,0,0
7820,study,0,0
7821,in,0,0
7822,120,1,1
7823,children,1,1
7824,.,1,1
7825,RESULTS,0,0
7826,Both,0,0
7827,anaesthetic,0,0
7828,agents,0,0
7829,produced,0,0
7830,adequate,0,1
7831,analgesia,0,0
7832,.,0,0
7833,However,0,0
7834,",",0,0
7835,Ametop,0,0
7836,gel,0,0
7837,was,0,0
7838,more,0,0
7839,effective,0,0
7840,",",0,0
7841,with,0,0
7842,a,0,0
7843,statistically,0,0
7844,significant,0,0
7845,difference,0,0
7846,in,0,0
7847,the,0,0
7848,pain,0,0
7849,scores,0,0
7850,of,0,0
7851,the,0,0
7852,two,0,0
7853,groups,0,0
7854,(,0,1
7855,p,0,0
7856,<,0,0
7857,0.05,0,0
7858,),0,1
7859,.,0,1
7860,Auditory,0,0
7861,integration,0,0
7862,training,0,0
7863,for,0,0
7864,children,1,1
7865,with,1,1
7866,autism,1,1
7867,:,1,1
7868,no,0,0
7869,behavioral,0,0
7870,benefits,0,0
7871,detected,0,0
7872,.,0,1
7873,Auditory,0,0
7874,integration,0,0
7875,training,0,0
7876,and,0,0
7877,a,0,0
7878,control,0,0
7879,treatment,0,0
7880,were,0,0
7881,provided,0,0
7882,for,0,0
7883,16,1,1
7884,children,1,1
7885,with,1,1
7886,autism,1,1
7887,in,0,0
7888,a,0,0
7889,crossover,0,0
7890,experimental,0,0
7891,design,0,1
7892,.,0,1
7893,Measures,0,0
7894,",",0,0
7895,blind,0,0
7896,to,0,0
7897,treatment,0,0
7898,order,0,0
7899,",",0,0
7900,included,0,0
7901,parent,0,0
7902,and,0,0
7903,teacher,0,1
7904,ratings,0,0
7905,of,0,0
7906,behavior,0,0
7907,",",0,0
7908,direct,0,0
7909,observational,0,1
7910,recordings,0,0
7911,",",0,0
7912,IQ,0,1
7913,",",0,0
7914,language,0,0
7915,",",0,0
7916,and,0,0
7917,social/adaptive,0,0
7918,tests,0,0
7919,.,0,1
7920,Significant,0,0
7921,differences,0,0
7922,tended,0,0
7923,to,0,0
7924,show,0,0
7925,that,0,0
7926,the,0,0
7927,control,0,0
7928,condition,0,0
7929,was,0,0
7930,superior,0,0
7931,on,0,0
7932,parent-rated,0,0
7933,measures,0,0
7934,of,0,0
7935,hyperactivity,0,1
7936,and,0,0
7937,on,0,0
7938,direct,0,0
7939,observational,0,1
7940,measures,0,0
7941,of,0,0
7942,ear-occlusion,0,1
7943,.,0,0
7944,No,0,0
7945,differences,0,0
7946,were,0,0
7947,detected,0,0
7948,on,0,0
7949,teacher-rated,0,0
7950,measures,0,0
7951,.,0,1
7952,Children,0,1
7953,'s,0,1
7954,IQs,0,1
7955,and,0,1
7956,language,0,0
7957,comprehension,0,0
7958,did,0,0
7959,not,0,0
7960,increase,0,0
7961,",",0,0
7962,but,0,0
7963,adaptive/social,0,0
7964,behavior,0,0
7965,scores,0,0
7966,and,0,0
7967,expressive,0,1
7968,language,0,0
7969,quotients,0,1
7970,decreased,0,0
7971,.,0,0
7972,The,0,0
7973,majority,0,0
7974,of,0,0
7975,parents,1,1
7976,(,0,1
7977,56,0,1
7978,%,0,0
7979,),0,0
7980,were,0,0
7981,unable,0,0
7982,to,0,0
7983,report,0,0
7984,in,0,0
7985,retrospect,0,0
7986,when,0,0
7987,their,0,0
7988,child,0,0
7989,had,0,0
7990,received,0,0
7991,auditory,0,0
7992,integration,0,0
7993,training,0,0
7994,.,0,0
7995,No,0,0
7996,individual,0,0
7997,child,1,1
7998,was,0,0
7999,identified,0,0
8000,as,0,0
8001,benefiting,0,0
8002,clinically,0,0
8003,or,0,0
8004,educationally,0,0
8005,from,0,0
8006,the,0,0
8007,treatment,0,0
8008,.,0,0
8009,Antisaccade,0,0
8010,and,0,0
8011,smooth,0,1
8012,pursuit,0,0
8013,eye,0,0
8014,movements,0,0
8015,in,0,0
8016,healthy,1,1
8017,subjects,1,1
8018,receiving,1,1
8019,sertraline,1,0
8020,and,1,0
8021,lorazepam,1,0
8022,.,1,1
8023,Patients,1,1
8024,suffering,1,1
8025,from,1,1
8026,some,1,0
8027,psychiatric,1,1
8028,and,1,0
8029,neurological,1,1
8030,disorders,1,1
8031,demonstrate,0,0
8032,abnormally,0,0
8033,high,0,0
8034,levels,0,0
8035,of,0,0
8036,saccadic,0,0
8037,distractibility,0,0
8038,when,0,0
8039,carrying,0,0
8040,out,0,0
8041,the,0,0
8042,antisaccade,0,0
8043,task,0,0
8044,.,0,0
8045,This,0,0
8046,has,0,0
8047,been,0,0
8048,particularly,0,0
8049,thoroughly,0,0
8050,demonstrated,0,0
8051,in,0,0
8052,patients,1,1
8053,with,1,1
8054,schizophrenia,1,1
8055,.,1,0
8056,A,0,0
8057,large,0,0
8058,body,0,0
8059,of,0,0
8060,evidence,0,0
8061,has,0,0
8062,been,0,0
8063,accumulated,0,0
8064,from,0,0
8065,studies,0,0
8066,of,0,1
8067,patients,0,1
8068,which,0,0
8069,suggests,0,0
8070,that,0,0
8071,such,0,0
8072,eye,0,0
8073,movement,0,0
8074,abnormalities,0,0
8075,may,0,0
8076,arise,0,0
8077,from,0,0
8078,frontal,0,0
8079,lobe,0,1
8080,dysfunction,0,1
8081,.,0,0
8082,The,0,0
8083,psychopharmacology,0,0
8084,of,0,0
8085,saccadic,0,0
8086,distractibility,0,0
8087,is,0,0
8088,less,0,0
8089,well,0,0
8090,understood,0,0
8091,",",0,0
8092,but,0,0
8093,is,0,0
8094,relevant,0,0
8095,both,0,0
8096,to,0,0
8097,interpreting,0,0
8098,patient,0,1
8099,studies,0,0
8100,and,0,0
8101,to,0,0
8102,establishing,0,0
8103,the,0,0
8104,neurological,0,0
8105,basis,0,0
8106,of,0,0
8107,their,0,1
8108,findings,0,0
8109,.,0,1
8110,Twenty,1,1
8111,healthy,1,1
8112,subjects,1,1
8113,received,0,1
8114,lorazepam,0,0
8115,0.5,0,0
8116,mg,0,0
8117,",",0,0
8118,1,0,0
8119,mg,0,0
8120,and,0,0
8121,2,0,0
8122,mg,0,0
8123,",",0,0
8124,sertraline,0,0
8125,50,0,0
8126,mg,0,0
8127,and,0,0
8128,placebo,0,0
8129,in,0,0
8130,a,0,0
8131,balanced,0,0
8132,",",0,0
8133,repeated,0,0
8134,measures,0,0
8135,study,0,1
8136,design,0,1
8137,.,0,0
8138,Antisaccade,0,0
8139,",",0,0
8140,no-saccade,0,0
8141,",",0,0
8142,visually,0,0
8143,guided,0,0
8144,saccade,0,0
8145,and,0,0
8146,smooth,0,1
8147,pursuit,0,0
8148,tasks,0,0
8149,were,0,0
8150,carried,0,0
8151,out,0,0
8152,and,0,0
8153,the,0,0
8154,effects,0,0
8155,of,0,0
8156,practice,0,1
8157,and,0,0
8158,drugs,0,0
8159,measured,0,0
8160,.,0,1
8161,Lorazepam,0,0
8162,increased,0,0
8163,direction,0,0
8164,errors,0,0
8165,in,0,0
8166,the,0,0
8167,antisaccade,0,0
8168,and,0,0
8169,no-saccade,0,0
8170,tasks,0,0
8171,in,0,0
8172,a,0,0
8173,dose-dependent,0,0
8174,manner,0,0
8175,.,0,1
8176,Sertraline,0,0
8177,had,0,0
8178,no,0,0
8179,effect,0,0
8180,on,0,0
8181,these,0,0
8182,measures,0,0
8183,.,0,1
8184,Correlation,0,0
8185,showed,0,0
8186,a,0,0
8187,statistically,0,0
8188,significant,0,0
8189,",",0,0
8190,but,0,0
8191,rather,0,0
8192,weak,0,0
8193,",",0,0
8194,association,0,0
8195,between,0,0
8196,direction,0,0
8197,errors,0,0
8198,and,0,0
8199,smooth,0,1
8200,pursuit,0,0
8201,measures,0,0
8202,.,0,1
8203,Practice,0,0
8204,was,0,0
8205,shown,0,0
8206,to,0,0
8207,have,0,0
8208,a,0,0
8209,powerful,0,0
8210,effect,0,0
8211,on,0,0
8212,antisaccade,0,0
8213,direction,0,0
8214,errors,0,0
8215,.,0,0
8216,This,0,0
8217,study,0,0
8218,supports,0,0
8219,our,0,0
8220,previous,0,0
8221,work,0,0
8222,by,0,0
8223,confirming,0,0
8224,that,0,0
8225,lorazepam,0,0
8226,reliably,0,0
8227,worsens,0,0
8228,saccadic,0,0
8229,distractibility,0,0
8230,",",0,0
8231,in,0,0
8232,contrast,0,0
8233,to,0,0
8234,other,0,0
8235,psychotropic,0,1
8236,drugs,0,0
8237,such,0,0
8238,as,0,0
8239,sertraline,0,0
8240,and,0,0
8241,chlorpromazine,0,0
8242,.,0,0
8243,Our,0,0
8244,results,0,0
8245,also,0,0
8246,suggest,0,0
8247,that,0,0
8248,other,0,0
8249,studies,0,0
8250,in,0,0
8251,this,0,0
8252,field,0,0
8253,",",0,0
8254,particularly,0,0
8255,those,0,0
8256,using,0,0
8257,parallel,0,0
8258,groups,0,0
8259,design,0,0
8260,",",0,0
8261,should,0,0
8262,take,0,0
8263,account,0,0
8264,of,0,0
8265,practice,0,1
8266,effects,0,0
8267,.,0,1
8268,[,0,0
8269,Improving,0,0
8270,wound,1,0
8271,healing,1,0
8272,after,1,0
8273,nose,1,1
8274,surgery,1,1
8275,by,0,0
8276,combined,0,0
8277,administration,0,0
8278,of,0,0
8279,xylometazoline,0,0
8280,and,0,1
8281,dexpanthenol,0,0
8282,],0,1
8283,.,0,1
8284,BACKGROUND,0,0
8285,The,0,0
8286,aim,0,0
8287,of,0,0
8288,this,0,0
8289,study,0,0
8290,was,0,0
8291,the,0,0
8292,examination,0,0
8293,of,0,0
8294,efficacy,0,0
8295,and,0,0
8296,tolerability,0,0
8297,of,0,0
8298,an,0,0
8299,application-form,0,0
8300,of,0,0
8301,the,0,0
8302,new,0,0
8303,combination,0,0
8304,of,0,0
8305,Xylometazoline,0,0
8306,with,0,1
8307,Dexpanthenol,0,0
8308,(,0,1
8309,Nasic,0,1
8310,),0,0
8311,versus,0,0
8312,Xylometazoline,0,0
8313,alone,0,0
8314,.,0,0
8315,PATIENTS,0,0
8316,AND,0,0
8317,METHODS,0,0
8318,Randomized,0,0
8319,verum,0,0
8320,controlled,0,0
8321,parallel-group-comparison,0,0
8322,of,0,0
8323,two,0,0
8324,weeks,0,0
8325,treatment,0,0
8326,of,0,0
8327,a,0,0
8328,nasal-spray,0,1
8329,.,0,1
8330,61,1,1
8331,inpatients,1,1
8332,with,1,1
8333,the,1,0
8334,diagnosis,1,1
8335,Rhinitis,1,1
8336,following,1,0
8337,nasal,1,0
8338,operation,1,1
8339,were,0,0
8340,included,0,0
8341,in,0,0
8342,this,0,0
8343,study,0,0
8344,and,0,0
8345,30,0,1
8346,patients,0,1
8347,were,0,1
8348,treated,0,1
8349,with,0,1
8350,verum,0,0
8351,and,0,0
8352,placebo,0,0
8353,each,0,0
8354,.,0,0
8355,The,0,0
8356,assessment,0,0
8357,of,0,0
8358,nasal-breathing-resistance,0,0
8359,according,0,1
8360,to,0,0
8361,scores,0,0
8362,was,0,0
8363,defined,0,0
8364,as,0,0
8365,target-parameter,0,0
8366,.,0,1
8367,Confirmatory,0,0
8368,statistical,0,0
8369,analysis,0,0
8370,was,0,0
8371,carried,0,0
8372,out,0,0
8373,according,0,0
8374,to,0,0
8375,Wilcoxon-Mann-Whitney-U,0,0
8376,two-sided,0,0
8377,at,0,0
8378,alpha,0,0
8379,<,0,0
8380,or,0,1
8381,=,0,0
8382,0.05,0,0
8383,.,0,1
8384,MAIN,0,0
8385,OUTCOME,0,0
8386,MEASURE,0,0
8387,The,0,0
8388,superiority,0,0
8389,of,0,0
8390,the,0,0
8391,combination,0,0
8392,of,0,0
8393,Xylometazoline-Dexpanthenol,0,0
8394,nasal-spray,0,1
8395,versus,0,0
8396,Xylometazoline,0,0
8397,nasal,0,0
8398,spray,0,0
8399,could,0,0
8400,be,0,0
8401,proven,0,0
8402,for,0,0
8403,the,0,0
8404,target-parameter,0,0
8405,as,0,0
8406,clinically,0,0
8407,relevant,0,0
8408,and,0,0
8409,statistically,0,0
8410,significant,0,0
8411,.,0,0
8412,The,0,0
8413,clinically,0,0
8414,proven,0,0
8415,efficacy,0,0
8416,is,0,0
8417,emphasized,0,0
8418,by,0,0
8419,good,0,0
8420,tolerability,0,0
8421,of,0,0
8422,both,0,0
8423,treatments,0,0
8424,.,0,1
8425,Due,0,0
8426,to,0,0
8427,easy,0,0
8428,handling,0,0
8429,of,0,0
8430,the,0,0
8431,nasal-spray,0,0
8432,a,0,0
8433,good,0,0
8434,compliance,0,0
8435,was,0,0
8436,confirmed,0,0
8437,.,0,1
8438,CONCLUSION,0,0
8439,Distinct,0,0
8440,improvement,0,0
8441,of,0,0
8442,symptoms,0,0
8443,in,0,1
8444,patients,1,1
8445,following,1,0
8446,nasal,1,1
8447,operations,1,1
8448,underlines,0,0
8449,the,0,0
8450,efficacy,0,0
8451,of,0,0
8452,both,0,0
8453,medications,0,0
8454,.,0,0
8455,With,0,0
8456,respect,0,0
8457,to,0,0
8458,the,0,0
8459,tolerability,0,0
8460,therapy,0,0
8461,with,0,1
8462,the,0,0
8463,combination,0,0
8464,is,0,0
8465,more,0,0
8466,beneficial,0,0
8467,in,0,0
8468,comparison,0,0
8469,to,0,0
8470,the,0,0
8471,alternative,0,0
8472,therapy,0,0
8473,.,0,0
8474,The,0,0
8475,result,0,0
8476,of,0,0
8477,this,0,0
8478,controlled,0,0
8479,clinical,0,0
8480,study,0,0
8481,confirms,0,0
8482,that,0,0
8483,the,0,0
8484,combination,0,0
8485,Xylometazoline-Dexpanthenol,0,0
8486,is,0,0
8487,an,0,0
8488,enlargement,0,0
8489,and,0,0
8490,improvement,0,0
8491,of,0,0
8492,effective,0,0
8493,medicinal,0,1
8494,treatment,0,0
8495,of,0,0
8496,rhinitis,1,1
8497,following,1,0
8498,nasal,1,0
8499,operation,1,0
8500,in,0,0
8501,comparison,0,0
8502,to,0,0
8503,therapy,0,0
8504,with,0,1
8505,Xylometazoline,0,0
8506,alone,0,0
8507,.,0,0
8508,Lack,0,0
8509,of,0,0
8510,effect,0,0
8511,of,0,0
8512,a,0,0
8513,low-fat,0,0
8514,",",0,0
8515,high-fiber,0,0
8516,diet,0,0
8517,on,0,0
8518,the,0,0
8519,recurrence,0,0
8520,of,0,0
8521,colorectal,0,1
8522,adenomas,0,1
8523,.,0,1
8524,Polyp,0,0
8525,Prevention,0,1
8526,Trial,0,1
8527,Study,0,1
8528,Group,0,1
8529,.,0,1
8530,BACKGROUND,0,0
8531,We,0,0
8532,tested,0,0
8533,the,0,0
8534,hypothesis,0,0
8535,that,0,0
8536,dietary,0,0
8537,intervention,0,0
8538,can,0,0
8539,inhibit,0,0
8540,the,0,0
8541,development,0,0
8542,of,0,0
8543,recurrent,0,1
8544,colorectal,0,1
8545,adenomas,0,0
8546,",",0,0
8547,which,0,0
8548,are,0,0
8549,precursors,0,0
8550,of,0,0
8551,most,0,0
8552,large-bowel,0,1
8553,cancers,0,1
8554,.,0,1
8555,METHODS,0,0
8556,We,0,0
8557,randomly,0,1
8558,assigned,0,1
8559,2079,1,1
8560,men,1,1
8561,and,1,1
8562,women,1,1
8563,who,1,1
8564,were,1,1
8565,35,1,1
8566,years,1,1
8567,of,1,0
8568,age,1,1
8569,or,1,1
8570,older,1,1
8571,and,1,1
8572,who,1,1
8573,had,1,1
8574,had,1,1
8575,one,1,0
8576,or,1,0
8577,more,1,0
8578,histologically,1,1
8579,confirmed,1,0
8580,colorectal,1,1
8581,adenomas,1,1
8582,removed,1,0
8583,within,1,0
8584,six,1,1
8585,months,1,0
8586,before,1,0
8587,randomization,1,1
8588,to,0,0
8589,one,0,1
8590,of,0,0
8591,two,0,1
8592,groups,0,0
8593,:,0,1
8594,an,0,0
8595,intervention,0,0
8596,group,0,0
8597,given,0,0
8598,intensive,0,0
8599,counseling,0,0
8600,and,0,0
8601,assigned,0,0
8602,to,0,0
8603,follow,0,0
8604,a,0,0
8605,diet,0,0
8606,that,0,0
8607,was,0,0
8608,low,0,0
8609,in,0,0
8610,fat,0,0
8611,(,0,0
8612,20,0,0
8613,percent,0,1
8614,of,0,0
8615,total,0,1
8616,calories,0,1
8617,),0,1
8618,and,0,0
8619,high,0,0
8620,in,0,0
8621,fiber,0,0
8622,(,0,0
8623,18,0,1
8624,g,0,1
8625,of,0,0
8626,dietary,0,0
8627,fiber,0,0
8628,per,0,0
8629,1000,0,0
8630,kcal,0,1
8631,),0,0
8632,and,0,0
8633,fruits,0,1
8634,and,0,1
8635,vegetables,0,0
8636,(,0,1
8637,3.5,0,1
8638,servings,0,0
8639,per,0,1
8640,1000,0,0
8641,kcal,0,1
8642,),0,0
8643,",",0,0
8644,and,0,0
8645,a,0,0
8646,control,0,0
8647,group,0,0
8648,given,0,0
8649,a,0,0
8650,standard,0,0
8651,brochure,0,0
8652,on,0,0
8653,healthy,0,1
8654,eating,0,0
8655,and,0,0
8656,assigned,0,0
8657,to,0,0
8658,follow,0,0
8659,their,0,0
8660,usual,0,1
8661,diet,0,1
8662,.,0,1
8663,Subjects,0,0
8664,entered,0,1
8665,the,0,0
8666,study,0,0
8667,after,0,0
8668,undergoing,0,1
8669,complete,0,0
8670,colonoscopy,0,1
8671,and,0,0
8672,removal,0,0
8673,of,0,0
8674,adenomatous,0,1
8675,polyps,0,1
8676,;,0,1
8677,they,0,0
8678,remained,0,0
8679,in,0,0
8680,the,0,0
8681,study,0,0
8682,for,0,0
8683,approximately,0,1
8684,four,0,1
8685,years,0,1
8686,",",0,0
8687,undergoing,0,1
8688,colonoscopy,0,1
8689,one,0,1
8690,and,0,0
8691,four,0,1
8692,years,0,1
8693,after,0,0
8694,randomization,0,1
8695,.,0,0
8696,RESULTS,0,0
8697,A,1,0
8698,total,1,1
8699,of,1,0
8700,1905,1,1
8701,of,1,0
8702,the,1,0
8703,randomized,1,1
8704,subjects,1,1
8705,(,1,1
8706,91.6,1,0
8707,percent,1,1
8708,),1,0
8709,completed,1,1
8710,the,1,0
8711,study,1,0
8712,.,1,0
8713,Of,0,0
8714,the,0,0
8715,958,0,1
8716,subjects,0,1
8717,in,0,0
8718,the,0,0
8719,intervention,0,0
8720,group,0,0
8721,and,0,0
8722,the,0,0
8723,947,0,0
8724,in,0,0
8725,the,0,0
8726,control,0,1
8727,group,0,1
8728,who,0,1
8729,completed,0,1
8730,the,0,1
8731,study,0,0
8732,",",0,0
8733,39.7,0,0
8734,percent,0,0
8735,and,0,0
8736,39.5,0,0
8737,percent,0,0
8738,",",0,0
8739,respectively,0,0
8740,",",0,0
8741,had,0,0
8742,at,0,0
8743,least,0,1
8744,one,0,1
8745,recurrent,0,1
8746,adenoma,0,1
8747,;,0,0
8748,the,0,0
8749,unadjusted,0,0
8750,risk,0,0
8751,ratio,0,0
8752,was,0,0
8753,1.00,0,0
8754,(,0,0
8755,95,0,0
8756,percent,0,0
8757,confidence,0,0
8758,interval,0,0
8759,",",0,0
8760,0.90,0,0
8761,to,0,0
8762,1.12,0,0
8763,),0,0
8764,.,0,1
8765,Among,0,1
8766,subjects,0,1
8767,with,0,1
8768,recurrent,0,1
8769,adenomas,0,1
8770,",",0,0
8771,the,0,0
8772,mean,0,0
8773,(,0,0
8774,+/-SE,0,0
8775,),0,0
8776,number,0,0
8777,of,0,0
8778,such,0,0
8779,lesions,0,1
8780,was,0,0
8781,1.85+/-0.08,0,0
8782,in,0,0
8783,the,0,0
8784,intervention,0,0
8785,group,0,0
8786,and,0,0
8787,1.84+/-0.07,0,0
8788,in,0,0
8789,the,0,0
8790,control,0,0
8791,group,0,0
8792,.,0,0
8793,The,0,0
8794,rate,0,0
8795,of,0,0
8796,recurrence,0,0
8797,of,0,0
8798,large,0,1
8799,adenomas,0,1
8800,(,0,0
8801,with,0,1
8802,a,0,0
8803,maximal,0,0
8804,diameter,0,0
8805,of,0,0
8806,at,0,0
8807,least,0,1
8808,1,0,0
8809,cm,0,1
8810,),0,0
8811,and,0,0
8812,advanced,0,1
8813,adenomas,0,1
8814,(,0,0
8815,defined,0,0
8816,as,0,0
8817,lesions,0,1
8818,that,0,0
8819,had,0,1
8820,a,0,0
8821,maximal,0,0
8822,diameter,0,0
8823,of,0,0
8824,at,0,0
8825,least,0,1
8826,1,0,0
8827,cm,0,1
8828,or,0,1
8829,at,0,0
8830,least,0,1
8831,25,0,1
8832,percent,0,1
8833,villous,0,1
8834,elements,0,1
8835,or,0,1
8836,evidence,0,0
8837,of,0,0
8838,high-grade,0,1
8839,dysplasia,0,1
8840,",",0,0
8841,including,0,0
8842,carcinoma,0,1
8843,),0,0
8844,did,0,0
8845,not,0,0
8846,differ,0,0
8847,significantly,0,0
8848,between,0,0
8849,the,0,0
8850,two,0,0
8851,groups,0,0
8852,.,0,1
8853,CONCLUSIONS,0,0
8854,Adopting,0,0
8855,a,0,0
8856,diet,0,0
8857,that,0,0
8858,is,0,0
8859,low,0,0
8860,in,0,0
8861,fat,0,0
8862,and,0,0
8863,high,0,0
8864,in,0,0
8865,fiber,0,0
8866,",",0,0
8867,fruits,0,0
8868,",",0,0
8869,and,0,0
8870,vegetables,0,0
8871,does,0,0
8872,not,0,0
8873,influence,0,0
8874,the,0,0
8875,risk,0,0
8876,of,0,0
8877,recurrence,0,0
8878,of,0,0
8879,colorectal,0,1
8880,adenomas,0,1
8881,.,0,1
8882,Human,0,1
8883,motor,0,0
8884,responses,0,0
8885,to,0,0
8886,simultaneous,0,0
8887,aversive,0,0
8888,stimulation,0,0
8889,and,0,0
8890,failure,0,1
8891,on,0,0
8892,a,0,0
8893,valued,0,0
8894,task,0,0
8895,.,0,0
8896,The,0,0
8897,effects,0,0
8898,of,0,0
8899,presentation,0,1
8900,of,0,0
8901,an,0,0
8902,aversive,0,0
8903,stimulus,0,0
8904,and,0,0
8905,simultaneous,0,0
8906,failure,0,1
8907,on,0,0
8908,a,0,0
8909,bogus,0,1
8910,intelligence,0,0
8911,test,0,0
8912,upon,0,0
8913,a,0,0
8914,subject,0,0
8915,'s,0,1
8916,aggressive,0,1
8917,reactions,0,0
8918,were,0,1
8919,studied,0,1
8920,.,0,0
8921,The,0,0
8922,subject,1,0
8923,'s,1,0
8924,fist,1,0
8925,clenching,1,0
8926,was,0,0
8927,used,0,0
8928,as,0,0
8929,an,0,0
8930,indicator,0,0
8931,of,0,0
8932,aggression,0,1
8933,.,0,1
8934,Four,0,0
8935,conditions,0,0
8936,",",0,0
8937,generated,0,0
8938,by,0,0
8939,the,0,0
8940,combinations,0,0
8941,of,0,0
8942,two,0,0
8943,kinds,0,0
8944,of,0,0
8945,stimulus,0,0
8946,delivered,0,0
8947,to,0,0
8948,the,0,0
8949,subjects,0,1
8950,(,0,0
8951,aversive,0,0
8952,or,0,1
8953,nonaversive,0,0
8954,),0,0
8955,and,0,0
8956,two,0,0
8957,outcomes,0,0
8958,of,0,0
8959,the,0,0
8960,task,0,0
8961,(,0,0
8962,failure,0,1
8963,or,0,1
8964,success,0,0
8965,),0,0
8966,",",0,0
8967,were,0,0
8968,investigated,0,0
8969,.,0,1
8970,20,1,0
8971,female,1,1
8972,and,1,1
8973,20,1,1
8974,male,1,1
8975,students,1,1
8976,(,1,1
8977,ages,1,1
8978,:,1,1
8979,17-34,1,1
8980,years,1,1
8981,),1,1
8982,were,0,0
8983,instructed,0,0
8984,",",0,0
8985,upon,0,0
8986,the,0,0
8987,reception,0,0
8988,of,0,0
8989,an,0,0
8990,aversive,0,0
8991,or,0,1
8992,nonaversive,0,0
8993,acoustic,0,0
8994,signal,0,0
8995,",",0,0
8996,to,0,0
8997,press,0,0
8998,with,0,1
8999,the,0,0
9000,right,0,0
9001,hand,0,0
9002,a,0,0
9003,device,0,0
9004,that,0,0
9005,displayed,0,0
9006,a,0,0
9007,slide,0,0
9008,.,0,0
9009,Each,0,0
9010,slide,0,0
9011,presented,0,0
9012,an,0,0
9013,item,0,0
9014,from,0,0
9015,an,0,0
9016,intelligence,0,0
9017,test,0,0
9018,",",0,0
9019,to,0,0
9020,which,0,0
9021,the,0,0
9022,subjects,0,1
9023,were,0,0
9024,either,0,0
9025,allowed,0,0
9026,to,0,0
9027,answer,0,0
9028,successfully,0,0
9029,(,0,0
9030,success,0,0
9031,),0,0
9032,or,0,0
9033,not,0,0
9034,(,0,0
9035,failure,0,1
9036,),0,0
9037,.,0,0
9038,Failure,0,0
9039,increased,0,0
9040,the,0,0
9041,subject,0,0
9042,'s,0,1
9043,autonomic,0,0
9044,arousal,0,0
9045,",",0,0
9046,as,0,0
9047,measured,0,0
9048,by,0,0
9049,photoplethysmographic,0,0
9050,sensors,0,0
9051,",",0,0
9052,in,0,0
9053,all,0,0
9054,stimulation,0,0
9055,conditions,0,0
9056,",",0,0
9057,but,0,0
9058,only,0,0
9059,the,0,0
9060,condition,0,0
9061,with,0,1
9062,aversive,0,0
9063,stimulation,0,0
9064,increased,0,0
9065,the,0,0
9066,speed,0,0
9067,of,0,0
9068,clenching,0,0
9069,.,0,0
9070,This,0,0
9071,was,0,0
9072,interpreted,0,0
9073,as,0,0
9074,indicating,0,0
9075,subject,0,0
9076,'s,0,1
9077,tendencies,0,0
9078,to,0,1
9079,aggression,0,1
9080,.,0,0
9081,These,0,0
9082,results,0,0
9083,are,0,0
9084,discussed,0,0
9085,in,0,0
9086,relation,0,0
9087,to,0,0
9088,the,0,0
9089,effects,0,0
9090,of,0,0
9091,frustration,0,0
9092,.,0,1
9093,Language,0,0
9094,",",0,0
9095,speech,0,0
9096,sound,0,0
9097,production,0,0
9098,",",0,0
9099,and,0,0
9100,cognition,0,0
9101,in,0,0
9102,three-year-old,1,1
9103,children,1,1
9104,in,1,0
9105,relation,1,0
9106,to,1,0
9107,otitis,1,1
9108,media,1,0
9109,in,1,0
9110,their,1,1
9111,first,1,0
9112,three,1,0
9113,years,1,1
9114,of,1,1
9115,life,1,0
9116,.,1,0
9117,OBJECTIVE,0,0
9118,As,0,0
9119,part,0,0
9120,of,0,0
9121,a,0,0
9122,prospective,0,0
9123,study,0,0
9124,of,0,0
9125,possible,0,0
9126,effects,0,0
9127,of,0,0
9128,early-life,0,1
9129,otitis,0,1
9130,media,0,0
9131,on,0,0
9132,speech,0,0
9133,",",0,0
9134,language,0,0
9135,",",0,0
9136,cognitive,0,0
9137,",",0,0
9138,and,0,0
9139,psychosocial,0,0
9140,development,0,0
9141,",",0,0
9142,we,0,0
9143,tested,0,0
9144,relationships,0,0
9145,between,0,0
9146,children,0,1
9147,'s,0,1
9148,cumulative,0,0
9149,duration,0,0
9150,of,0,0
9151,middle,0,1
9152,ear,0,1
9153,effusion,0,1
9154,(,0,0
9155,MEE,0,0
9156,),0,0
9157,in,0,0
9158,their,0,1
9159,first,0,0
9160,3,0,0
9161,years,0,1
9162,of,0,0
9163,life,0,0
9164,and,0,0
9165,their,0,0
9166,scores,0,0
9167,on,0,0
9168,measures,0,0
9169,of,0,0
9170,language,0,0
9171,",",0,0
9172,speech,0,0
9173,sound,0,0
9174,production,0,0
9175,",",0,0
9176,and,0,0
9177,cognition,0,0
9178,at,0,0
9179,3,0,0
9180,years,0,1
9181,of,0,1
9182,age,0,1
9183,.,0,1
9184,METHODS,0,0
9185,We,1,0
9186,enrolled,1,1
9187,6350,1,1
9188,healthy,1,1
9189,infants,1,1
9190,by,1,1
9191,2,1,1
9192,months,1,0
9193,of,1,1
9194,age,1,1
9195,who,1,1
9196,presented,1,1
9197,for,1,1
9198,primary,1,1
9199,care,1,1
9200,at,1,0
9201,1,1,0
9202,of,1,0
9203,2,1,1
9204,urban,1,1
9205,hospitals,1,1
9206,or,1,1
9207,1,1,1
9208,of,1,0
9209,2,1,1
9210,small,1,1
9211,town/rural,1,1
9212,and,1,1
9213,4,1,0
9214,suburban,1,1
9215,private,1,1
9216,pediatric,1,1
9217,practices,1,1
9218,.,1,1
9219,We,0,0
9220,intensively,0,0
9221,monitored,0,0
9222,the,0,0
9223,children,0,1
9224,'s,0,1
9225,middle,0,1
9226,ear,0,1
9227,status,0,0
9228,by,0,0
9229,pneumatic,0,0
9230,otoscopy,0,0
9231,",",0,0
9232,supplemented,0,0
9233,by,0,0
9234,tympanometry,0,0
9235,",",0,0
9236,throughout,0,0
9237,their,0,0
9238,first,0,0
9239,3,0,0
9240,years,0,1
9241,of,0,1
9242,life,0,0
9243,;,0,0
9244,we,0,0
9245,monitored,0,0
9246,the,0,0
9247,validity,0,0
9248,of,0,0
9249,the,0,0
9250,otoscopic,0,1
9251,observations,0,0
9252,on,0,0
9253,an,0,0
9254,ongoing,0,0
9255,basis,0,0
9256,;,0,0
9257,and,0,0
9258,we,0,0
9259,treated,0,1
9260,children,0,1
9261,for,0,0
9262,otitis,0,1
9263,media,0,0
9264,according,0,1
9265,to,0,0
9266,specified,0,1
9267,guidelines,0,0
9268,.,0,1
9269,Children,1,1
9270,who,1,1
9271,met,1,1
9272,specified,1,1
9273,minimum,1,0
9274,criteria,1,1
9275,regarding,1,0
9276,the,1,0
9277,persistence,1,0
9278,of,1,0
9279,MEE,1,1
9280,became,1,0
9281,eligible,1,1
9282,for,1,0
9283,a,1,0
9284,clinical,1,0
9285,trial,1,0
9286,in,0,0
9287,which,0,0
9288,they,0,1
9289,were,0,0
9290,assigned,0,0
9291,randomly,0,1
9292,to,0,0
9293,undergo,0,1
9294,tympanostomy,0,0
9295,tube,0,0
9296,placement,0,0
9297,either,0,0
9298,promptly,0,0
9299,or,0,0
9300,after,0,0
9301,a,0,0
9302,defined,0,0
9303,extended,0,0
9304,period,0,0
9305,if,0,0
9306,MEE,0,1
9307,remained,0,0
9308,present,0,0
9309,.,0,0
9310,From,1,1
9311,among,1,0
9312,those,1,0
9313,remaining,1,0
9314,",",1,0
9315,we,1,0
9316,selected,1,1
9317,randomly,1,0
9318,",",1,0
9319,within,1,0
9320,sociodemographic,1,0
9321,strata,1,0
9322,",",1,0
9323,a,1,0
9324,sample,1,1
9325,of,1,0
9326,241,1,1
9327,children,1,1
9328,who,1,1
9329,represented,1,1
9330,a,1,1
9331,spectrum,1,1
9332,of,1,0
9333,MEE,1,0
9334,experience,1,0
9335,from,1,0
9336,having,1,1
9337,no,1,0
9338,MEE,1,0
9339,to,1,0
9340,having,1,1
9341,MEE,1,0
9342,whose,1,1
9343,cumulative,1,0
9344,duration,1,0
9345,fell,1,0
9346,just,1,0
9347,short,1,0
9348,of,1,0
9349,meeting,1,0
9350,randomization,1,1
9351,criteria,1,1
9352,.,1,1
9353,In,1,0
9354,subjects,1,1
9355,so,1,0
9356,selected,1,1
9357,",",1,0
9358,the,1,0
9359,estimated,1,0
9360,duration,1,0
9361,of,1,0
9362,MEE,1,0
9363,ranged,1,0
9364,from,1,0
9365,none,1,0
9366,to,1,0
9367,65.6,1,0
9368,%,1,0
9369,of,1,0
9370,the,1,0
9371,first,1,0
9372,year,1,0
9373,of,1,0
9374,life,1,0
9375,and,1,0
9376,44.8,1,0
9377,%,1,0
9378,of,1,0
9379,the,1,0
9380,first,1,0
9381,3,1,0
9382,years,1,1
9383,of,1,1
9384,life,1,0
9385,.,1,0
9386,In,0,0
9387,these,0,0
9388,241,1,1
9389,children,1,1
9390,we,0,0
9391,assessed,0,0
9392,language,0,0
9393,development,0,0
9394,",",0,0
9395,speech,0,0
9396,sound,0,0
9397,production,0,0
9398,",",0,0
9399,and,0,0
9400,cognition,0,0
9401,at,0,0
9402,3,0,0
9403,years,0,1
9404,of,0,0
9405,age,0,1
9406,",",0,0
9407,using,0,0
9408,both,0,0
9409,formal,0,0
9410,tests,0,0
9411,and,0,1
9412,conversational,0,0
9413,samples,0,0
9414,.,0,1
9415,RESULTS,0,0
9416,We,0,0
9417,found,0,0
9418,weak,0,0
9419,to,0,0
9420,moderate,0,1
9421,",",0,0
9422,statistically,0,0
9423,significant,0,0
9424,negative,0,0
9425,correlations,0,0
9426,between,0,0
9427,children,0,1
9428,'s,0,1
9429,cumulative,0,0
9430,durations,0,0
9431,of,0,0
9432,MEE,0,1
9433,in,0,0
9434,their,0,0
9435,first,0,0
9436,year,0,0
9437,of,0,0
9438,life,0,0
9439,or,0,1
9440,in,0,0
9441,age,0,1
9442,periods,0,0
9443,that,0,0
9444,included,0,1
9445,their,0,0
9446,first,0,0
9447,year,0,0
9448,of,0,0
9449,life,0,0
9450,",",0,0
9451,and,0,0
9452,their,0,0
9453,scores,0,0
9454,on,0,0
9455,formal,0,1
9456,tests,0,0
9457,of,0,0
9458,receptive,0,1
9459,vocabulary,0,0
9460,and,0,0
9461,verbal,0,0
9462,aspects,0,0
9463,of,0,0
9464,cognition,0,0
9465,at,0,0
9466,3,0,0
9467,years,0,1
9468,of,0,1
9469,age,0,1
9470,.,0,0
9471,However,0,0
9472,",",0,0
9473,the,0,0
9474,percent,0,0
9475,of,0,0
9476,variance,0,0
9477,in,0,0
9478,these,0,0
9479,scores,0,0
9480,explained,0,0
9481,by,0,0
9482,time,0,0
9483,with,0,1
9484,MEE,0,0
9485,in,0,0
9486,the,0,0
9487,first,0,0
9488,year,0,0
9489,of,0,0
9490,life,0,0
9491,beyond,0,0
9492,that,0,0
9493,explained,0,0
9494,by,0,0
9495,sociodemographic,0,1
9496,variables,0,0
9497,ranged,0,0
9498,only,0,0
9499,from,0,0
9500,1.2,0,0
9501,%,0,0
9502,to,0,0
9503,2.9,0,0
9504,%,0,0
9505,",",0,0
9506,and,0,0
9507,the,0,0
9508,negative,0,0
9509,correlations,0,0
9510,were,0,1
9511,concentrated,0,0
9512,in,0,0
9513,the,0,0
9514,subgroup,0,1
9515,of,0,0
9516,children,0,1
9517,whose,0,1
9518,families,0,1
9519,had,0,1
9520,private,0,1
9521,health,0,1
9522,insurance,0,1
9523,(,0,0
9524,rather,0,0
9525,than,0,0
9526,Medicaid,0,1
9527,),0,1
9528,.,0,0
9529,We,0,0
9530,found,0,0
9531,no,0,0
9532,significant,0,0
9533,correlations,0,0
9534,in,0,0
9535,the,0,0
9536,study,0,0
9537,population,0,1
9538,as,0,0
9539,a,0,0
9540,whole,0,0
9541,or,0,0
9542,in,0,0
9543,any,0,0
9544,subgroup,0,0
9545,between,0,0
9546,time,0,0
9547,with,0,1
9548,MEE,0,1
9549,during,0,0
9550,antecedent,0,0
9551,periods,0,0
9552,and,0,1
9553,children,0,1
9554,'s,0,1
9555,scores,0,0
9556,on,0,1
9557,measures,0,0
9558,of,0,1
9559,spontaneous,0,1
9560,expressive,0,0
9561,language,0,0
9562,",",0,0
9563,speech,0,0
9564,sound,0,0
9565,production,0,0
9566,",",0,0
9567,or,0,0
9568,other,0,0
9569,measured,0,0
9570,aspects,0,0
9571,of,0,0
9572,cognition,0,0
9573,.,0,0
9574,In,0,0
9575,contrast,0,0
9576,",",0,0
9577,by,0,0
9578,wide,0,1
9579,margins,0,0
9580,",",0,0
9581,scores,0,0
9582,on,0,0
9583,all,0,1
9584,measures,0,0
9585,were,0,0
9586,consistently,0,0
9587,highest,0,0
9588,among,0,0
9589,the,0,0
9590,most,0,0
9591,socioeconomically,0,1
9592,advantaged,0,1
9593,children,0,1
9594,and,0,0
9595,lowest,0,0
9596,among,0,0
9597,the,0,0
9598,most,0,0
9599,socioeconomically,0,1
9600,disadvantaged,0,1
9601,children,0,1
9602,.,0,1
9603,CONCLUSIONS,0,0
9604,Our,0,0
9605,findings,0,0
9606,suggest,0,0
9607,either,0,0
9608,that,0,0
9609,persistent,1,1
9610,early-life,1,1
9611,MEE,1,0
9612,actually,0,0
9613,causes,0,0
9614,later,0,0
9615,small,0,0
9616,",",0,0
9617,circumscribed,0,1
9618,impairments,0,0
9619,of,0,0
9620,receptive,0,1
9621,language,0,0
9622,and,0,0
9623,verbal,0,0
9624,aspects,0,0
9625,of,0,0
9626,cognition,0,0
9627,in,0,0
9628,certain,0,0
9629,groups,0,0
9630,of,0,1
9631,children,0,1
9632,or,0,1
9633,that,0,0
9634,unidentified,0,0
9635,",",0,0
9636,confounding,0,0
9637,factors,0,0
9638,predispose,0,1
9639,children,0,1
9640,both,0,0
9641,to,0,0
9642,early-life,0,0
9643,otitis,0,1
9644,media,0,0
9645,and,0,0
9646,to,0,1
9647,certain,0,0
9648,types,0,0
9649,of,0,0
9650,developmental,0,1
9651,impairment,0,1
9652,.,0,1
9653,Findings,0,0
9654,in,0,0
9655,the,0,0
9656,randomized,0,0
9657,clinical,0,0
9658,trial,0,0
9659,component,0,0
9660,of,0,0
9661,the,0,0
9662,larger,0,0
9663,study,0,0
9664,should,0,0
9665,help,0,0
9666,distinguish,0,0
9667,between,0,0
9668,causality,0,0
9669,and,0,0
9670,confounding,0,0
9671,as,0,0
9672,explanations,0,0
9673,for,0,0
9674,our,0,0
9675,findings.language,0,0
9676,",",0,0
9677,speech,0,0
9678,",",0,0
9679,cognition,0,0
9680,",",0,0
9681,development,0,0
9682,",",0,0
9683,otitis,0,1
9684,media,0,0
9685,",",0,0
9686,middle,0,1
9687,ear,0,1
9688,effusion,0,1
9689,.,0,1
9690,Does,0,0
9691,waiting,0,0
9692,matter,0,0
9693,?,0,0
9694,A,0,0
9695,randomized,0,0
9696,controlled,0,0
9697,trial,0,0
9698,of,0,0
9699,new,1,0
9700,non-urgent,1,1
9701,rheumatology,1,1
9702,out-patient,1,1
9703,referrals,1,1
9704,.,1,1
9705,OBJECTIVE,0,0
9706,To,0,0
9707,examine,0,0
9708,the,0,0
9709,effect,0,0
9710,of,0,0
9711,waiting,0,1
9712,times,0,0
9713,on,0,0
9714,the,0,0
9715,health,0,0
9716,status,0,0
9717,of,0,0
9718,patients,1,1
9719,referred,1,1
9720,for,1,0
9721,a,1,0
9722,non-urgent,1,0
9723,rheumatology,1,1
9724,opinion,1,0
9725,.,1,0
9726,METHODS,0,0
9727,The,0,0
9728,study,0,0
9729,was,0,0
9730,a,0,0
9731,randomized,0,0
9732,controlled,0,0
9733,clinical,0,0
9734,study,0,0
9735,evaluating,0,0
9736,a,1,0
9737,'fast,1,0
9738,track,1,0
9739,',1,0
9740,appointment,1,0
9741,with,1,1
9742,a,1,0
9743,6-week,1,0
9744,target,1,0
9745,waiting,1,1
9746,time,1,0
9747,against,1,0
9748,an,1,0
9749,'ordinary,1,1
9750,',1,0
9751,appointment,1,0
9752,in,1,0
9753,the,1,0
9754,main,1,0
9755,city,1,1
9756,out-patient,1,0
9757,clinic,1,1
9758,of,1,0
9759,the,1,0
9760,rheumatology,1,1
9761,service,1,1
9762,for,1,0
9763,the,1,0
9764,Lothian,1,1
9765,and,1,0
9766,Borders,1,1
9767,region,1,1
9768,(,1,1
9769,population,1,1
9770,approximately,1,1
9771,1,1,0
9772,million,1,1
9773,),1,1
9774,.,1,1
9775,Health,0,0
9776,status,0,0
9777,was,0,0
9778,measured,0,0
9779,using,0,0
9780,the,0,0
9781,SF12,0,0
9782,physical,0,0
9783,and,0,0
9784,mental,0,1
9785,summary,0,0
9786,component,0,0
9787,T-scores,0,0
9788,and,0,0
9789,pain,0,1
9790,was,0,0
9791,measured,0,0
9792,with,0,1
9793,a,0,0
9794,100,0,0
9795,mm,0,0
9796,visual,0,0
9797,analogue,0,0
9798,pain,0,1
9799,scale,0,0
9800,.,0,1
9801,Secondary,0,0
9802,outcomes,0,0
9803,were,0,1
9804,health,0,1
9805,utility,0,0
9806,and,0,0
9807,perceived,0,0
9808,health,0,0
9809,both,0,0
9810,measured,0,0
9811,with,0,1
9812,the,0,0
9813,EuroQol,0,0
9814,instrument,0,0
9815,",",0,0
9816,mental,0,1
9817,health,0,0
9818,measured,0,0
9819,with,0,1
9820,the,0,0
9821,Hospital,0,1
9822,Anxiety,0,0
9823,and,0,0
9824,Depression,0,0
9825,scale,0,0
9826,",",0,0
9827,disability,0,0
9828,with,0,1
9829,the,0,0
9830,modified,0,0
9831,Health,0,0
9832,Assessment,0,0
9833,Questionnaire,0,0
9834,and,0,0
9835,economic,0,0
9836,costs,0,0
9837,measured,0,0
9838,from,0,1
9839,a,0,0
9840,societal,0,0
9841,perspective,0,0
9842,.,0,1
9843,RESULTS,0,0
9844,Mean,0,1
9845,waiting,0,1
9846,times,0,0
9847,were,0,1
9848,43,0,1
9849,days,0,0
9850,(,0,1
9851,sigma,0,0
9852,=,0,0
9853,+/-16,0,0
9854,),0,0
9855,and,0,0
9856,105,0,1
9857,days,0,0
9858,(,0,1
9859,sigma,0,0
9860,=,0,0
9861,+/-51,0,0
9862,),0,0
9863,for,0,0
9864,'fast,0,0
9865,track,0,0
9866,',0,0
9867,and,0,0
9868,'ordinary,0,1
9869,',0,1
9870,appointments,0,0
9871,",",0,1
9872,respectively,0,0
9873,.,0,0
9874,Both,0,0
9875,groups,0,0
9876,showed,0,0
9877,significant,0,0
9878,improvements,0,0
9879,in,0,1
9880,mean,0,1
9881,[,0,0
9882,95,0,0
9883,%,0,0
9884,confidence,0,0
9885,interval,0,0
9886,(,0,0
9887,CI,0,0
9888,),0,0
9889,],0,0
9890,scores,0,0
9891,for,0,0
9892,pain,0,1
9893,:,0,1
9894,11,0,0
9895,(,0,0
9896,7,0,0
9897,",",0,0
9898,16,0,1
9899,),0,0
9900,(,0,0
9901,P,0,0
9902,<,0,0
9903,0.001,0,0
9904,),0,1
9905,;,0,0
9906,physical,0,0
9907,health,0,1
9908,status,0,1
9909,:,0,1
9910,4,0,0
9911,(,0,0
9912,2,0,0
9913,",",0,0
9914,5,0,0
9915,),0,0
9916,(,0,0
9917,P,0,0
9918,<,0,0
9919,0.001,0,0
9920,),0,1
9921,;,0,0
9922,mental,0,1
9923,health,0,1
9924,status,0,1
9925,:,0,1
9926,2,0,0
9927,(,0,0
9928,0.1,0,0
9929,",",0,0
9930,4,0,0
9931,),0,0
9932,(,0,0
9933,P,0,0
9934,<,0,0
9935,0.02,0,0
9936,),0,1
9937,;,0,0
9938,and,0,0
9939,health,0,1
9940,utility,0,0
9941,:,0,1
9942,0.11,0,0
9943,(,0,0
9944,0.07,0,0
9945,",",0,0
9946,0.16,0,0
9947,),0,0
9948,(,0,0
9949,P,0,0
9950,<,0,0
9951,0.001,0,0
9952,),0,0
9953,by,0,0
9954,the,0,0
9955,end,0,0
9956,of,0,0
9957,the,0,0
9958,15-month,0,0
9959,period,0,0
9960,of,0,0
9961,the,0,0
9962,study,0,0
9963,",",0,0
9964,but,0,0
9965,there,0,0
9966,was,0,0
9967,no,0,0
9968,significant,0,0
9969,difference,0,0
9970,between,0,0
9971,either,0,0
9972,arm,0,0
9973,of,0,0
9974,the,0,0
9975,study,0,0
9976,.,0,0
9977,CONCLUSIONS,0,0
9978,Rationing,0,0
9979,by,0,0
9980,delay,0,0
9981,was,0,0
9982,not,0,0
9983,detrimental,0,0
9984,to,0,0
9985,either,0,0
9986,mental,0,1
9987,or,0,1
9988,physical,0,0
9989,health,0,1
9990,and,0,0
9991,patients,0,1
9992,in,0,0
9993,both,0,0
9994,arms,0,0
9995,of,0,0
9996,the,0,0
9997,study,0,0
9998,showed,0,0
9999,significant,0,0
10000,and,0,0
10001,similar,0,0
10002,improvement,0,0
10003,in,0,0
10004,health,0,1
10005,by,0,0
10006,15,0,1
10007,months,0,0
10008,.,0,1
10009,Expenditure,0,0
10010,of,0,0
10011,resources,0,0
10012,on,0,0
10013,waiting,0,1
10014,times,0,0
10015,without,0,1
10016,regard,0,0
10017,to,0,0
10018,clinical,0,0
10019,outcomes,0,0
10020,is,0,0
10021,likely,0,0
10022,to,0,0
10023,be,0,0
10024,wasteful,0,0
10025,and,0,0
10026,additional,0,0
10027,resources,0,0
10028,should,0,0
10029,be,0,0
10030,directed,0,0
10031,at,0,0
10032,achieving,0,0
10033,the,0,0
10034,greatest,0,0
10035,clinical,0,0
10036,benefit,0,0
10037,.,0,0
10038,More,0,0
10039,research,0,0
10040,into,0,0
10041,effective,0,0
10042,methods,0,1
10043,of,0,0
10044,controlling,0,0
10045,demand,0,0
10046,and,0,0
10047,better,0,0
10048,identification,0,0
10049,of,0,0
10050,those,0,1
10051,who,0,1
10052,would,0,0
10053,benefit,0,0
10054,from,0,0
10055,access,0,0
10056,to,0,0
10057,specialist,0,1
10058,care,0,0
10059,is,0,0
10060,needed,0,0
10061,.,0,0
10062,The,0,0
10063,effectiveness,0,0
10064,of,0,0
10065,omeprazole,0,0
10066,",",0,0
10067,clarithromycin,0,0
10068,and,0,0
10069,tinidazole,0,0
10070,in,0,0
10071,eradicating,0,0
10072,Helicobacter,0,1
10073,pylori,0,0
10074,in,0,0
10075,a,0,0
10076,community,0,0
10077,screen,0,0
10078,and,0,0
10079,treat,0,0
10080,programme,0,0
10081,.,0,1
10082,Leeds,0,0
10083,Help,0,0
10084,Study,0,1
10085,Group,0,1
10086,.,0,1
10087,INTRODUCTION,0,0
10088,Helicobacter,0,1
10089,pylori,0,0
10090,screening,0,0
10091,and,0,0
10092,treatment,0,0
10093,has,0,0
10094,been,0,0
10095,proposed,0,0
10096,as,0,0
10097,a,0,0
10098,cost-effective,0,0
10099,method,0,0
10100,of,0,0
10101,preventing,0,0
10102,gastric,0,1
10103,cancer,0,1
10104,.,0,1
10105,AIM,0,0
10106,To,0,0
10107,assess,0,0
10108,",",0,0
10109,in,0,0
10110,a,0,0
10111,randomized,0,0
10112,controlled,0,0
10113,trial,0,0
10114,",",0,0
10115,the,0,0
10116,efficacy,0,0
10117,of,0,0
10118,therapy,0,0
10119,in,0,0
10120,eradicating,0,0
10121,H.,0,1
10122,pylori,0,0
10123,as,0,0
10124,part,0,0
10125,of,0,0
10126,a,0,0
10127,screening,0,0
10128,programme,0,0
10129,",",0,0
10130,and,0,0
10131,to,0,0
10132,report,0,0
10133,the,0,0
10134,adverse,0,0
10135,events,0,0
10136,associated,0,0
10137,with,0,1
10138,this,0,0
10139,strategy,0,0
10140,.,0,1
10141,METHODS,0,0
10142,Subjects,1,1
10143,between,1,0
10144,the,1,1
10145,ages,1,1
10146,of,1,0
10147,40-49,1,1
10148,years,1,1
10149,were,1,1
10150,randomly,1,1
10151,selected,1,1
10152,from,1,0
10153,the,1,0
10154,lists,1,0
10155,of,1,0
10156,36,1,1
10157,primary,1,1
10158,care,1,1
10159,centres,1,1
10160,.,1,1
10161,Participants,0,1
10162,attended,0,1
10163,their,0,1
10164,local,0,0
10165,practice,0,0
10166,and,0,0
10167,H.,0,1
10168,pylori,0,0
10169,status,0,0
10170,was,0,0
10171,determined,0,0
10172,by,0,0
10173,13C-urea,0,0
10174,breath,0,0
10175,test,0,0
10176,.,0,0
10177,Infected,0,1
10178,subjects,0,1
10179,were,0,0
10180,randomized,0,1
10181,to,0,0
10182,receive,0,0
10183,omeprazole,0,0
10184,20,0,0
10185,mg,0,0
10186,b.d.,0,0
10187,",",0,0
10188,clarithromycin,0,0
10189,250,0,0
10190,mg,0,0
10191,b.d,0,1
10192,.,0,0
10193,and,0,0
10194,tinidazole,0,0
10195,500,0,0
10196,mg,0,0
10197,b.d,0,0
10198,.,0,0
10199,for,0,0
10200,7,0,0
10201,days,0,0
10202,(,0,1
10203,OCT,0,0
10204,),0,0
10205,or,0,1
10206,identical,0,0
10207,placebos,0,0
10208,.,0,1
10209,Eradication,0,0
10210,was,0,0
10211,determined,0,0
10212,by,0,0
10213,a,0,0
10214,13C-urea,0,0
10215,breath,0,0
10216,test,0,0
10217,6,0,0
10218,months,0,0
10219,and,0,1
10220,2,0,1
10221,years,0,1
10222,after,0,0
10223,the,0,0
10224,first,0,0
10225,visit,0,0
10226,.,0,1
10227,Successful,0,0
10228,eradication,0,0
10229,was,0,0
10230,defined,0,0
10231,as,0,0
10232,two,0,0
10233,negative,0,1
10234,13C-urea,0,0
10235,breath,0,0
10236,tests,0,0
10237,or,0,1
10238,one,0,1
10239,negative,0,0
10240,and,0,1
10241,one,0,1
10242,missing,0,0
10243,test,0,0
10244,.,0,1
10245,Adverse,0,0
10246,events,0,0
10247,and,0,1
10248,compliance,0,0
10249,were,0,0
10250,assessed,0,0
10251,at,0,0
10252,the,0,0
10253,6-month,0,0
10254,visit,0,0
10255,.,0,0
10256,RESULTS,0,0
10257,A,1,0
10258,total,1,1
10259,of,1,0
10260,32,1,1
10261,929,1,1
10262,subjects,1,1
10263,were,1,1
10264,invited,1,1
10265,to,1,0
10266,attend,1,1
10267,",",1,0
10268,8407,1,1
10269,were,1,0
10270,evaluable,1,1
10271,",",1,0
10272,and,1,0
10273,2329,1,1
10274,(,1,0
10275,28,1,1
10276,%,1,0
10277,),1,0
10278,of,1,0
10279,these,1,0
10280,were,1,0
10281,H.,1,1
10282,pylori-positive,1,1
10283,.,1,0
10284,A,1,0
10285,total,1,1
10286,of,1,0
10287,1161,1,1
10288,subjects,1,1
10289,were,0,1
10290,randomized,0,1
10291,to,0,0
10292,OCT,0,0
10293,and,0,0
10294,1163,0,1
10295,to,0,0
10296,placebo,0,0
10297,;,0,0
10298,over,0,0
10299,80,0,1
10300,%,0,0
10301,returned,0,0
10302,for,0,0
10303,a,0,0
10304,repeat,0,0
10305,13C-urea,0,0
10306,breath,0,0
10307,test,0,0
10308,on,0,0
10309,at,0,0
10310,least,0,1
10311,one,0,1
10312,occasion,0,0
10313,.,0,0
10314,The,0,0
10315,eradication,0,0
10316,rates,0,0
10317,in,0,0
10318,those,0,1
10319,allocated,0,0
10320,to,0,0
10321,OCT,0,0
10322,were,0,0
10323,as,0,0
10324,follows,0,0
10325,:,0,0
10326,intention-to-treat,0,0
10327,",",0,0
10328,710,0,0
10329,out,0,0
10330,of,0,0
10331,1161,0,1
10332,(,0,1
10333,61,0,1
10334,%,0,0
10335,;,0,1
10336,95,0,0
10337,%,0,0
10338,confidence,0,0
10339,interval,0,0
10340,:,0,1
10341,58-64,0,1
10342,%,0,0
10343,),0,1
10344,;,0,0
10345,evaluable,0,1
10346,710,0,1
10347,out,0,1
10348,of,0,0
10349,967,0,1
10350,(,0,1
10351,73,0,1
10352,%,0,0
10353,;,0,1
10354,95,0,0
10355,%,0,0
10356,CI,0,0
10357,:,0,1
10358,71-76,0,1
10359,%,0,0
10360,),0,1
10361,;,0,0
10362,took,0,0
10363,all,0,0
10364,medication,0,0
10365,645,0,1
10366,out,0,0
10367,of,0,0
10368,769,0,1
10369,(,0,1
10370,84,0,1
10371,%,0,0
10372,;,0,1
10373,95,0,0
10374,%,0,0
10375,CI,0,0
10376,:,0,1
10377,81-87,0,0
10378,%,0,0
10379,),0,0
10380,.,0,1
10381,Adverse,0,0
10382,events,0,0
10383,occurred,0,0
10384,in,0,0
10385,45,0,1
10386,%,0,0
10387,of,0,0
10388,the,0,0
10389,treatment,0,0
10390,group,0,0
10391,and,0,0
10392,in,0,0
10393,18,0,1
10394,%,0,0
10395,of,0,0
10396,the,0,0
10397,placebo,0,0
10398,group,0,0
10399,(,0,0
10400,relative,0,0
10401,risk,0,1
10402,2.5,0,0
10403,;,0,0
10404,95,0,0
10405,%,0,0
10406,CI,0,0
10407,:,0,1
10408,2.1-2.9,0,1
10409,),0,0
10410,.,0,0
10411,Compliance,0,0
10412,",",0,0
10413,male,0,1
10414,gender,0,0
10415,",",0,0
10416,no,0,0
10417,antibiotic,0,0
10418,prescription,0,0
10419,in,0,0
10420,the,0,0
10421,subsequent,0,0
10422,2,0,0
10423,years,0,1
10424,and,0,0
10425,experiencing,0,0
10426,a,0,0
10427,bitter,0,0
10428,taste,0,0
10429,with,0,1
10430,the,0,0
10431,medication,0,0
10432,were,0,0
10433,independently,0,0
10434,associated,0,0
10435,with,0,0
10436,treatment,0,0
10437,success,0,0
10438,.,0,0
10439,CONCLUSIONS,0,0
10440,The,0,0
10441,OCT,0,0
10442,regimen,0,0
10443,has,0,0
10444,an,0,0
10445,eradication,0,0
10446,rate,0,0
10447,of,0,0
10448,61,0,1
10449,%,0,0
10450,in,0,0
10451,intention-to-treat,0,0
10452,analysis,0,0
10453,and,0,0
10454,is,0,0
10455,therefore,0,0
10456,less,0,0
10457,successful,0,0
10458,in,0,0
10459,treating,0,0
10460,H.,0,1
10461,pylori,0,0
10462,as,0,0
10463,part,0,0
10464,of,0,0
10465,a,0,0
10466,screening,0,0
10467,programme,0,0
10468,compared,0,0
10469,with,0,1
10470,hospital,0,1
10471,studies,0,0
10472,in,0,1
10473,dyspeptic,1,1
10474,patients,1,1
10475,.,1,1
10476,Response,0,0
10477,of,0,0
10478,pre-core,1,0
10479,mutant,1,0
10480,chronic,1,1
10481,hepatitis,1,1
10482,B,1,0
10483,infection,1,0
10484,to,0,0
10485,lamivudine,0,0
10486,.,0,0
10487,The,0,0
10488,proportion,0,0
10489,of,0,0
10490,chronic,0,1
10491,liver,0,1
10492,disease,0,1
10493,associated,0,0
10494,with,0,1
10495,the,0,0
10496,pre-core,1,0
10497,mutant,1,0
10498,of,1,0
10499,hepatitis,1,1
10500,B,1,1
10501,virus,1,1
10502,(,1,0
10503,HBV,1,1
10504,),1,0
10505,infection,1,0
10506,is,0,0
10507,increasing,0,0
10508,",",0,0
10509,particularly,0,0
10510,in,0,0
10511,Mediterranean,1,1
10512,Europe,1,1
10513,and,1,0
10514,in,1,0
10515,Asia,1,0
10516,.,1,1
10517,The,0,0
10518,pre-core,1,0
10519,mutant,1,0
10520,HBV,1,1
10521,is,0,0
10522,unable,0,0
10523,to,0,0
10524,produce,0,0
10525,hepatitis,0,1
10526,B,0,0
10527,e,0,0
10528,antigen,0,0
10529,(,0,0
10530,HBeAg,0,1
10531,),0,0
10532,",",0,0
10533,so,0,0
10534,that,0,0
10535,patients,1,1
10536,with,1,1
10537,this,1,0
10538,variant,1,0
10539,do,0,0
10540,not,0,0
10541,present,0,0
10542,with,0,1
10543,HBV,0,0
10544,characterised,0,0
10545,by,0,0
10546,HBeAg,0,1
10547,in,0,0
10548,the,0,0
10549,serum,0,0
10550,.,0,0
10551,Pre-core,0,0
10552,mutant,0,0
10553,chronic,0,1
10554,hepatitis,0,1
10555,B,0,0
10556,infection,0,0
10557,usually,0,0
10558,proceeds,0,0
10559,to,0,0
10560,serious,0,0
10561,liver,0,1
10562,disease,0,1
10563,.,0,1
10564,Wild-type,0,0
10565,HBV,0,0
10566,infection,0,0
10567,may,0,0
10568,be,0,0
10569,mild,0,1
10570,and,0,0
10571,respond,0,0
10572,relatively,0,0
10573,well,0,0
10574,to,0,0
10575,interferon,0,0
10576,(,0,0
10577,IFN,0,1
10578,),0,0
10579,alpha,0,0
10580,therapy,0,0
10581,",",0,0
10582,but,0,0
10583,IFN,0,1
10584,alpha,0,0
10585,is,0,0
10586,not,0,0
10587,an,0,0
10588,effective,0,0
10589,therapeutic,0,0
10590,option,0,0
10591,in,0,0
10592,pre-core,0,0
10593,mutant,0,0
10594,hepatitis,0,1
10595,B,0,0
10596,infection,0,0
10597,and,0,0
10598,new,0,0
10599,therapeutic,0,0
10600,options,0,0
10601,are,0,0
10602,needed,0,0
10603,.,0,1
10604,Clinical,0,0
10605,data,0,0
10606,show,0,0
10607,that,0,0
10608,lamivudine,0,0
10609,is,0,0
10610,an,0,0
10611,effective,0,0
10612,treatment,0,0
10613,for,0,0
10614,patients,1,1
10615,with,1,1
10616,pre-core,1,0
10617,mutant,1,0
10618,hepatitis,1,1
10619,B,1,0
10620,.,1,0
10621,There,0,0
10622,is,0,0
10623,profound,0,0
10624,suppression,0,0
10625,of,0,0
10626,HBV,0,1
10627,replication,0,0
10628,and,0,0
10629,improvement,0,0
10630,in,0,0
10631,indicators,0,0
10632,of,0,0
10633,liver,0,1
10634,disease,0,1
10635,in,0,0
10636,most,0,0
10637,patients,0,1
10638,.,0,1
10639,In,0,0
10640,conclusion,0,0
10641,",",0,0
10642,lamivudine,0,0
10643,is,0,0
10644,suitable,0,0
10645,for,0,0
10646,treatment,0,0
10647,of,0,0
10648,a,0,0
10649,wide,0,1
10650,range,0,0
10651,of,0,0
10652,patients,1,1
10653,with,1,1
10654,chronic,1,1
10655,hepatitis,1,1
10656,B,1,0
10657,",",1,0
10658,including,1,0
10659,those,1,0
10660,with,1,1
10661,pre-core,1,0
10662,mutant,1,0
10663,HBV,1,1
10664,infection,1,1
10665,.,1,1
10666,Clinical,0,0
10667,pathway,0,0
10668,for,0,0
10669,fractured,1,0
10670,neck,1,1
10671,of,1,0
10672,femur,1,1
10673,:,1,1
10674,a,0,0
10675,prospective,0,0
10676,",",0,0
10677,controlled,0,0
10678,study,0,0
10679,.,0,0
10680,OBJECTIVE,0,0
10681,To,0,0
10682,assess,0,0
10683,outcomes,0,0
10684,of,0,0
10685,using,0,0
10686,a,0,0
10687,clinical,0,0
10688,pathway,0,0
10689,for,0,0
10690,managing,0,0
10691,patients,1,1
10692,with,1,1
10693,fractured,1,1
10694,neck,1,1
10695,of,1,0
10696,femur,1,1
10697,.,1,1
10698,DESIGN,0,0
10699,Prospective,0,0
10700,",",0,0
10701,pseudorandomised,0,0
10702,",",0,0
10703,controlled,0,0
10704,trial,0,0
10705,.,0,0
10706,SETTING,0,1
10707,St,1,0
10708,Vincent,1,1
10709,'s,1,1
10710,Hospital,1,1
10711,",",1,0
10712,Melbourne,1,1
10713,",",1,0
10714,Victoria,1,1
10715,(,1,0
10716,a,1,0
10717,tertiary,1,1
10718,referral,1,1
10719,",",1,0
10720,university,1,1
10721,teaching,1,0
10722,hospital,1,1
10723,),1,0
10724,",",1,0
10725,1,1,0
10726,October,1,1
10727,1997,1,1
10728,to,1,0
10729,30,1,1
10730,November,1,1
10731,1998,1,1
10732,.,1,0
10733,PARTICIPANTS,0,0
10734,111,1,1
10735,patients,1,1
10736,(,1,1
10737,80,1,1
10738,women,1,1
10739,and,1,1
10740,31,1,1
10741,men,1,1
10742,;,1,1
10743,mean,1,1
10744,age,1,1
10745,",",1,0
10746,81,1,1
10747,years,1,1
10748,),1,1
10749,admitted,1,1
10750,via,1,0
10751,the,1,0
10752,emergency,1,1
10753,department,1,1
10754,with,1,1
10755,a,1,0
10756,primary,1,0
10757,diagnosis,1,1
10758,of,1,0
10759,fractured,1,0
10760,neck,1,1
10761,of,1,0
10762,femur,1,1
10763,.,1,1
10764,INTERVENTIONS,0,0
10765,Management,0,0
10766,guided,0,0
10767,by,0,0
10768,a,0,0
10769,clinical,0,0
10770,pathway,0,0
10771,(,0,1
10772,55,0,1
10773,patients,0,1
10774,),0,1
10775,or,0,1
10776,established,0,0
10777,standard,0,0
10778,of,0,0
10779,care,0,1
10780,(,0,0
10781,control,0,0
10782,group,0,0
10783,",",0,0
10784,56,0,1
10785,patients,0,1
10786,),0,1
10787,.,0,1
10788,MAIN,0,0
10789,OUTCOME,0,0
10790,MEASURES,0,0
10791,Timing,0,0
10792,of,0,0
10793,referrals,0,0
10794,and,0,0
10795,discharge,0,1
10796,planning,0,0
10797,;,0,0
10798,total,0,1
10799,length,0,0
10800,of,0,0
10801,stay,0,0
10802,;,0,0
10803,and,0,0
10804,complication,0,0
10805,and,0,0
10806,readmission,0,0
10807,rates,0,0
10808,within,0,1
10809,28,0,1
10810,days,0,0
10811,of,0,1
10812,discharge,0,1
10813,.,0,1
10814,RESULTS,0,0
10815,Patients,0,1
10816,managed,0,1
10817,according,0,1
10818,to,0,0
10819,the,0,0
10820,clinical,0,0
10821,pathway,0,0
10822,had,0,0
10823,a,0,0
10824,shorter,0,0
10825,total,0,1
10826,stay,0,0
10827,(,0,0
10828,6.6,0,0
10829,versus,0,0
10830,8.0,0,1
10831,days,0,0
10832,;,0,1
10833,P,0,0
10834,=,0,0
10835,0.03,0,0
10836,),0,0
10837,",",0,0
10838,even,0,0
10839,if,0,0
10840,assessment,0,0
10841,for,0,0
10842,placement,0,0
10843,by,0,0
10844,the,0,0
10845,Aged,0,0
10846,Care,0,1
10847,Assessment,0,0
10848,Service,0,1
10849,was,0,0
10850,required,0,0
10851,(,0,0
10852,9.5,0,0
10853,versus,0,0
10854,13.6,0,1
10855,days,0,0
10856,;,0,1
10857,P,0,0
10858,=,0,0
10859,0.03,0,0
10860,),0,0
10861,.,0,0
10862,There,0,0
10863,were,0,0
10864,no,0,0
10865,significant,0,0
10866,differences,0,0
10867,in,0,0
10868,complication,0,0
10869,and,0,0
10870,readmission,0,0
10871,rates,0,0
10872,between,0,0
10873,pathway,0,0
10874,and,0,0
10875,control,1,0
10876,patients,1,1
10877,(,0,0
10878,complication,0,0
10879,rates,0,0
10880,",",0,0
10881,24,0,0
10882,%,0,0
10883,versus,0,0
10884,36,0,1
10885,%,0,0
10886,;,0,0
10887,P,0,0
10888,=,0,0
10889,0.40,0,0
10890,;,0,0
10891,readmission,0,0
10892,rates,0,0
10893,",",0,0
10894,4,0,0
10895,%,0,0
10896,versus,0,0
10897,11,0,1
10898,%,0,0
10899,;,0,1
10900,P,0,0
10901,=,0,0
10902,0.28,0,0
10903,),0,1
10904,.,0,1
10905,CONCLUSION,0,0
10906,Coordinated,0,0
10907,multidisciplinary,0,0
10908,care,0,1
10909,of,0,0
10910,patients,1,1
10911,with,1,1
10912,fractured,1,1
10913,neck,1,1
10914,of,1,0
10915,femur,1,1
10916,reduces,0,0
10917,length,0,0
10918,of,0,0
10919,stay,0,0
10920,without,0,1
10921,increasing,0,0
10922,complications,0,0
10923,.,0,1
10924,Comparison,0,0
10925,of,0,0
10926,high,0,1
10927,and,0,0
10928,low,0,0
10929,dose,0,0
10930,of,0,0
10931,the,0,0
10932,inhaled,0,0
10933,steroid,0,0
10934,",",0,0
10935,budesonide,0,0
10936,",",0,0
10937,as,0,0
10938,an,0,0
10939,initial,0,0
10940,treatment,0,0
10941,in,0,0
10942,newly,1,1
10943,detected,1,0
10944,asthma,1,1
10945,.,1,0
10946,The,0,0
10947,importance,0,0
10948,of,0,0
10949,early,0,0
10950,initiation,0,0
10951,of,0,0
10952,inhaled,0,0
10953,steroids,0,0
10954,even,0,0
10955,in,0,0
10956,mild,0,1
10957,asthma,0,1
10958,has,0,0
10959,been,0,0
10960,documented,0,0
10961,in,0,0
10962,several,0,0
10963,studies,0,0
10964,.,0,0
10965,It,0,0
10966,is,0,0
10967,not,0,0
10968,",",0,0
10969,however,0,0
10970,",",0,0
10971,clear,0,0
10972,whether,0,0
10973,the,0,0
10974,treatment,0,0
10975,should,0,0
10976,be,0,0
10977,started,0,0
10978,with,0,0
10979,a,0,0
10980,high,0,0
10981,or,0,0
10982,a,0,0
10983,low,0,0
10984,dose,0,0
10985,of,0,0
10986,the,0,0
10987,inhaled,0,0
10988,steroid,0,0
10989,.,0,0
10990,We,0,0
10991,have,0,0
10992,compared,0,0
10993,the,0,0
10994,effects,0,0
10995,of,0,0
10996,high,0,1
10997,and,0,0
10998,low,0,1
10999,dose,0,0
11000,inhaled,0,0
11001,steroid,0,0
11002,",",0,0
11003,budesonide,0,0
11004,",",0,0
11005,in,0,0
11006,patients,1,1
11007,with,1,1
11008,newly,1,1
11009,detected,1,0
11010,asthma,1,1
11011,.,1,0
11012,We,0,0
11013,studied,0,0
11014,101,1,1
11015,adult,1,1
11016,patients,1,1
11017,with,1,1
11018,newly,1,1
11019,detected,1,0
11020,bronchial,1,1
11021,asthma,1,1
11022,who,1,1
11023,were,1,1
11024,without,1,1
11025,inhaled,1,0
11026,steroid,1,0
11027,or,1,0
11028,any,1,0
11029,regular,1,0
11030,pharmacological,1,0
11031,treatment,1,0
11032,for,1,0
11033,their,1,0
11034,asthma,1,1
11035,.,1,0
11036,The,0,0
11037,patients,0,1
11038,were,0,0
11039,randomly,0,1
11040,allocated,0,1
11041,to,0,0
11042,two,0,0
11043,treatment,0,1
11044,groups,0,1
11045,:,0,1
11046,one,0,1
11047,to,0,0
11048,receive,0,0
11049,800,0,0
11050,microg,0,0
11051,inhaled,0,0
11052,budesonide,0,0
11053,per,0,0
11054,day,0,0
11055,and,0,0
11056,the,0,0
11057,other,0,0
11058,to,0,0
11059,receive,0,0
11060,200,0,0
11061,microg,0,0
11062,inhaled,0,0
11063,budesonide,0,0
11064,per,0,0
11065,day,0,0
11066,.,0,0
11067,The,0,0
11068,drugs,0,0
11069,were,0,0
11070,given,0,0
11071,with,0,1
11072,a,0,0
11073,Turbuhaler,0,0
11074,dry,0,1
11075,powder,0,0
11076,inhaler,0,0
11077,.,0,0
11078,During,0,0
11079,the,0,0
11080,3-month,0,0
11081,treatment,0,0
11082,period,0,0
11083,",",0,0
11084,no,0,0
11085,significant,0,0
11086,differences,0,0
11087,between,0,0
11088,the,0,0
11089,treatment,0,0
11090,groups,0,0
11091,were,0,0
11092,noted,0,0
11093,in,0,0
11094,morning,0,0
11095,or,0,1
11096,evening,0,0
11097,PEF,0,0
11098,values,0,0
11099,",",0,0
11100,in,0,0
11101,spirometric,0,0
11102,parameters,0,0
11103,",",0,0
11104,in,0,0
11105,asthmatic,0,1
11106,symptoms,0,0
11107,or,0,1
11108,in,0,0
11109,the,0,0
11110,use,0,0
11111,of,0,0
11112,rescue,0,0
11113,beta2-agonists,0,0
11114,.,0,0
11115,The,0,0
11116,decrease,0,0
11117,in,0,0
11118,bronchial,0,1
11119,hyperresponsiveness,0,0
11120,was,0,0
11121,",",0,0
11122,however,0,0
11123,",",0,0
11124,more,0,0
11125,marked,0,0
11126,in,0,0
11127,the,0,0
11128,high,0,0
11129,dose,0,0
11130,budesonide,0,0
11131,group,0,0
11132,",",0,0
11133,reaching,0,0
11134,a,0,0
11135,borderline,0,0
11136,significance,0,0
11137,(,0,0
11138,P=0.10,0,0
11139,high,0,1
11140,vs.,0,0
11141,low,0,0
11142,dose,0,0
11143,budesonide,0,0
11144,),0,0
11145,.,0,0
11146,In,0,0
11147,addition,0,0
11148,",",0,0
11149,in,0,0
11150,serum,0,0
11151,markers,0,0
11152,of,0,0
11153,asthmatic,0,1
11154,inflammation,0,0
11155,significant,0,0
11156,differences,0,0
11157,were,0,1
11158,shown,0,0
11159,between,0,0
11160,the,0,0
11161,treatment,0,0
11162,groups,0,0
11163,.,0,0
11164,The,0,0
11165,decrease,0,0
11166,in,0,0
11167,the,0,0
11168,number,0,0
11169,of,0,0
11170,blood,0,0
11171,eosinophils,0,0
11172,during,0,0
11173,the,0,0
11174,treatment,0,0
11175,was,0,0
11176,more,0,0
11177,marked,0,0
11178,in,0,0
11179,the,0,0
11180,high,0,0
11181,dose,0,0
11182,budesonide,0,0
11183,group,0,0
11184,(,0,0
11185,P=0.02,0,0
11186,;,0,0
11187,high,0,1
11188,vs.,0,0
11189,low,0,1
11190,dose,0,0
11191,budesonide,0,0
11192,),0,0
11193,.,0,0
11194,In,0,0
11195,serum,0,0
11196,ECP,0,0
11197,no,0,0
11198,change,0,0
11199,was,0,0
11200,observed,0,0
11201,in,0,0
11202,the,0,0
11203,low,0,0
11204,dose,0,0
11205,budesonide,0,0
11206,group,0,0
11207,",",0,0
11208,but,0,0
11209,a,0,0
11210,marked,0,0
11211,decrease,0,0
11212,in,0,0
11213,the,0,0
11214,high-dose,0,0
11215,budesonide,0,0
11216,group,0,0
11217,(,0,0
11218,P=0.008,0,0
11219,;,0,0
11220,high,0,1
11221,vs.,0,0
11222,low,0,1
11223,dose,0,0
11224,budesonide,0,0
11225,),0,0
11226,.,0,0
11227,The,0,0
11228,change,0,0
11229,was,0,0
11230,even,0,0
11231,more,0,0
11232,marked,0,0
11233,with,0,1
11234,regard,0,0
11235,to,0,0
11236,serum,0,0
11237,EPX,0,0
11238,(,0,0
11239,P=0.005,0,0
11240,;,0,0
11241,high,0,1
11242,vs.,0,0
11243,low,0,1
11244,dose,0,0
11245,budesonide,0,0
11246,),0,0
11247,.,0,0
11248,Our,0,0
11249,results,0,0
11250,support,0,0
11251,the,0,0
11252,view,0,0
11253,that,0,0
11254,the,0,0
11255,treatment,0,0
11256,of,0,0
11257,newly,0,1
11258,detected,0,0
11259,asthma,0,1
11260,should,0,0
11261,be,0,0
11262,started,0,0
11263,with,0,0
11264,a,0,0
11265,high,0,0
11266,dose,0,0
11267,of,0,0
11268,inhaled,0,0
11269,steroid,0,1
11270,.,0,0
11271,The,0,0
11272,low,0,0
11273,dose,0,0
11274,may,0,0
11275,not,0,0
11276,be,0,0
11277,enough,0,0
11278,to,0,0
11279,suppress,0,0
11280,asthmatic,0,1
11281,inflammation,0,0
11282,despite,0,0
11283,good,0,0
11284,clinical,0,0
11285,primary,0,1
11286,response,0,0
11287,.,0,1
11288,5-fluorouracil,0,0
11289,plus,0,0
11290,folinic,0,0
11291,acid,0,0
11292,with,0,1
11293,or,0,0
11294,without,0,1
11295,ifosfamide,0,0
11296,in,0,0
11297,advanced,0,1
11298,colorectal,0,1
11299,cancer,0,1
11300,:,0,1
11301,a,0,0
11302,phase,0,0
11303,II,0,0
11304,randomized,0,1
11305,trial,0,0
11306,.,0,0
11307,AIM,0,0
11308,This,0,0
11309,phase,0,0
11310,II,0,0
11311,trial,0,0
11312,evaluated,0,0
11313,the,0,0
11314,biomodulation,0,0
11315,of,0,0
11316,5-fluorouracil,0,0
11317,(,0,1
11318,5-FU,0,0
11319,),0,0
11320,plus,0,0
11321,folinic,0,0
11322,acid,0,0
11323,(,0,0
11324,FA,0,0
11325,),0,0
11326,with,0,1
11327,or,0,1
11328,without,0,1
11329,ifosfamide,0,0
11330,(,0,1
11331,IFO,0,1
11332,),0,0
11333,in,0,0
11334,chemotherapy-naive,1,1
11335,patients,1,1
11336,with,1,1
11337,colorectal,1,1
11338,cancer,1,1
11339,.,1,1
11340,PATIENTS,0,0
11341,AND,0,0
11342,METHODS,0,0
11343,Forty-eight,1,1
11344,patients,1,1
11345,were,1,0
11346,randomized,1,1
11347,to,0,0
11348,receive,0,0
11349,:,0,1
11350,FA,0,0
11351,(,0,0
11352,25,0,0
11353,mg/m2,0,0
11354,iv,0,0
11355,bolus,0,0
11356,days,0,0
11357,1,0,1
11358,to,0,1
11359,3,0,0
11360,),0,0
11361,",",0,0
11362,followed,0,0
11363,by,0,0
11364,5-FU,0,0
11365,(,0,1
11366,750,0,0
11367,mg/m2,0,0
11368,iv,0,0
11369,bolus,0,0
11370,days,0,0
11371,1,0,1
11372,to,0,1
11373,3,0,0
11374,),0,0
11375,",",0,0
11376,arm,0,0
11377,A,0,0
11378,;,0,0
11379,or,0,1
11380,FA,0,0
11381,(,0,0
11382,25,0,0
11383,mg/m2,0,0
11384,iv,0,0
11385,bolus,0,0
11386,days,0,0
11387,1,0,1
11388,to,0,1
11389,3,0,0
11390,),0,0
11391,",",0,0
11392,followed,0,0
11393,by,0,0
11394,5-FU,0,0
11395,(,0,1
11396,750,0,0
11397,mg/m2,0,0
11398,iv,0,0
11399,bolus,0,0
11400,days,0,0
11401,1,0,1
11402,to,0,1
11403,3,0,0
11404,),0,0
11405,plus,0,0
11406,IFO,0,1
11407,(,0,0
11408,"2,000",0,0
11409,mg/m2,0,0
11410,in,0,0
11411,1000,0,0
11412,mL,0,0
11413,5,0,0
11414,%,0,0
11415,dextrose,0,0
11416,in,0,0
11417,a,0,0
11418,2-hr,0,0
11419,infusion,0,0
11420,",",0,0
11421,days,0,0
11422,1,0,0
11423,to,0,1
11424,3,0,0
11425,),0,0
11426,",",0,0
11427,arm,0,0
11428,B.,0,0
11429,Mesna,0,1
11430,was,0,0
11431,added,0,0
11432,during,0,0
11433,and,0,0
11434,after,0,0
11435,IFO,0,0
11436,to,0,0
11437,prevent,0,0
11438,hemorrhagic,0,0
11439,cystitis,0,1
11440,.,0,1
11441,Treatment,0,0
11442,was,0,0
11443,repeated,0,0
11444,every,0,0
11445,21,0,1
11446,days,0,0
11447,in,0,0
11448,both,0,0
11449,arms,0,0
11450,.,0,1
11451,RESULTS,0,0
11452,Forty-five,1,1
11453,patients,1,1
11454,were,1,1
11455,assessable,1,1
11456,for,1,0
11457,response,1,0
11458,:,1,1
11459,in,0,0
11460,arm,0,0
11461,A,0,0
11462,",",0,0
11463,5,0,0
11464,patients,0,1
11465,achieved,0,0
11466,a,0,0
11467,partial,0,0
11468,response,0,0
11469,(,0,0
11470,overall,0,0
11471,response,0,0
11472,",",0,0
11473,25,0,0
11474,%,0,0
11475,),0,0
11476,",",0,0
11477,and,0,0
11478,in,0,0
11479,arm,0,0
11480,B,0,1
11481,",",0,0
11482,2,0,0
11483,patients,0,1
11484,achieved,0,0
11485,a,0,0
11486,complete,0,0
11487,and,0,0
11488,1,0,0
11489,a,0,0
11490,partial,0,0
11491,response,0,0
11492,(,0,0
11493,overall,0,0
11494,response,0,0
11495,",",0,0
11496,12,0,0
11497,%,0,0
11498,),0,0
11499,.,0,0
11500,Time,0,0
11501,to,0,0
11502,failure,0,1
11503,was,0,0
11504,3.5,0,1
11505,months,0,0
11506,(,0,0
11507,range,0,0
11508,",",0,0
11509,1-38,0,0
11510,),0,0
11511,in,0,0
11512,patients,0,1
11513,treated,0,1
11514,with,0,1
11515,5-FU,0,0
11516,plus,0,0
11517,FA,0,0
11518,",",0,0
11519,and,0,0
11520,3,0,0
11521,months,0,0
11522,(,0,0
11523,range,0,0
11524,",",0,0
11525,1-21,0,0
11526,),0,0
11527,in,0,0
11528,patients,0,1
11529,treated,0,1
11530,with,0,1
11531,the,0,0
11532,IFO,0,0
11533,combination,0,0
11534,.,0,0
11535,The,0,0
11536,median,0,0
11537,survival,0,0
11538,time,0,0
11539,was,0,0
11540,13.5,0,0
11541,months,0,0
11542,(,0,0
11543,range,0,0
11544,",",0,0
11545,1-49,0,0
11546,months,0,0
11547,),0,1
11548,in,0,0
11549,arm,0,0
11550,A,0,0
11551,and,0,0
11552,16,0,1
11553,months,0,0
11554,(,0,0
11555,range,0,0
11556,",",0,0
11557,1-43,0,0
11558,months,0,0
11559,),0,1
11560,in,0,0
11561,arm,0,1
11562,B,0,1
11563,.,0,0
11564,Diarrhea,0,0
11565,",",0,0
11566,stomatitis,0,1
11567,and,0,0
11568,vomiting,0,0
11569,were,0,0
11570,the,0,0
11571,most,0,0
11572,common,0,0
11573,nonhematologic,0,1
11574,toxicities,0,0
11575,in,0,0
11576,both,0,0
11577,arms,0,0
11578,.,0,0
11579,The,0,0
11580,most,0,0
11581,notable,0,0
11582,hematologic,0,1
11583,toxicity,0,0
11584,was,0,0
11585,leukopenia,0,1
11586,;,0,0
11587,15,0,0
11588,%,0,0
11589,and,0,0
11590,20,0,0
11591,%,0,0
11592,of,0,0
11593,patients,0,1
11594,experienced,0,1
11595,grade,0,1
11596,4,0,0
11597,in,0,0
11598,arm,0,0
11599,A,0,0
11600,and,0,0
11601,arm,0,0
11602,B,0,0
11603,",",0,0
11604,respectively,0,0
11605,.,0,0
11606,CONCLUSIONS,0,0
11607,IFO,0,0
11608,does,0,0
11609,not,0,0
11610,increase,0,0
11611,the,0,0
11612,activity,0,0
11613,of,0,0
11614,the,0,0
11615,5-FU,0,0
11616,plus,0,0
11617,FA,0,0
11618,combination,0,0
11619,in,0,0
11620,advanced,0,1
11621,colorectal,0,1
11622,cancer,0,1
11623,.,0,1
11624,Physostigmine,0,0
11625,reverses,0,0
11626,propofol-induced,0,0
11627,unconsciousness,0,0
11628,and,0,0
11629,attenuation,0,0
11630,of,0,0
11631,the,0,0
11632,auditory,0,0
11633,steady,0,0
11634,state,0,0
11635,response,0,0
11636,and,0,0
11637,bispectral,0,0
11638,index,0,0
11639,in,0,0
11640,human,1,1
11641,volunteers,1,1
11642,.,1,1
11643,BACKGROUND,0,0
11644,It,0,0
11645,is,0,0
11646,postulated,0,0
11647,that,0,0
11648,alteration,0,0
11649,of,0,0
11650,central,0,0
11651,cholinergic,0,0
11652,transmission,0,0
11653,plays,0,0
11654,an,0,0
11655,important,0,0
11656,role,0,0
11657,in,0,0
11658,the,0,0
11659,mechanism,0,0
11660,by,0,0
11661,which,0,0
11662,anesthetics,0,0
11663,produce,0,0
11664,unconsciousness,0,1
11665,.,0,0
11666,The,0,0
11667,authors,0,0
11668,investigated,0,0
11669,the,0,0
11670,effect,0,0
11671,of,0,0
11672,altering,0,0
11673,central,0,1
11674,cholinergic,0,0
11675,transmission,0,0
11676,",",0,0
11677,by,0,0
11678,physostigmine,0,0
11679,and,0,0
11680,scopolamine,0,0
11681,",",0,0
11682,on,0,0
11683,unconsciousness,0,0
11684,produced,0,0
11685,by,0,0
11686,propofol,0,0
11687,.,0,1
11688,METHODS,0,0
11689,Propofol,0,1
11690,was,0,0
11691,administered,0,0
11692,to,0,0
11693,American,1,1
11694,Society,1,1
11695,of,1,0
11696,Anesthesiologists,1,1
11697,physical,1,0
11698,status,1,1
11699,1,1,0
11700,(,1,0
11701,n,1,1
11702,=,1,0
11703,17,1,1
11704,),1,1
11705,volunteers,1,1
11706,with,0,1
11707,use,0,0
11708,of,0,0
11709,a,0,0
11710,computer-controlled,0,0
11711,infusion,0,0
11712,pump,0,0
11713,at,0,0
11714,increasing,0,0
11715,concentrations,0,0
11716,until,0,1
11717,unconsciousness,0,1
11718,resulted,0,0
11719,(,0,0
11720,inability,0,0
11721,to,0,0
11722,respond,0,0
11723,to,0,0
11724,verbal,0,0
11725,commands,0,0
11726,",",0,0
11727,abolition,0,0
11728,of,0,0
11729,spontaneous,0,0
11730,movement,0,0
11731,),0,0
11732,.,0,0
11733,Central,0,0
11734,nervous,0,0
11735,system,0,0
11736,function,0,0
11737,was,0,0
11738,assessed,0,0
11739,by,0,0
11740,use,0,0
11741,of,0,0
11742,the,0,0
11743,Auditory,0,0
11744,Steady,0,0
11745,State,0,0
11746,Response,0,0
11747,(,0,0
11748,ASSR,0,0
11749,),0,0
11750,and,0,0
11751,Bispectral,0,0
11752,Index,0,0
11753,(,0,0
11754,BIS,0,0
11755,),0,0
11756,analysis,0,0
11757,of,0,0
11758,electrooculogram,0,0
11759,.,0,1
11760,During,0,0
11761,continuous,0,0
11762,administration,0,0
11763,of,0,0
11764,propofol,0,0
11765,",",0,0
11766,reversal,0,0
11767,of,0,0
11768,unconsciousness,0,0
11769,produced,0,0
11770,by,0,0
11771,physostigmine,0,0
11772,(,0,0
11773,28,0,1
11774,microgram/kg,0,0
11775,),0,0
11776,and,0,0
11777,block,0,0
11778,of,0,0
11779,this,0,0
11780,reversal,0,0
11781,by,0,0
11782,scopolamine,0,0
11783,(,0,0
11784,8.6,0,0
11785,microgram/kg,0,0
11786,),0,0
11787,were,0,0
11788,evaluated,0,0
11789,.,0,1
11790,RESULTS,0,0
11791,Propofol,0,1
11792,produced,0,0
11793,unconsciousness,0,0
11794,at,0,0
11795,a,0,0
11796,plasma,0,0
11797,concentration,0,0
11798,of,0,0
11799,3.2,0,0
11800,+/-,0,0
11801,0.8,0,1
11802,(,0,1
11803,+/-,0,0
11804,SD,0,1
11805,),0,0
11806,microgram/ml,0,0
11807,(,0,0
11808,n,0,1
11809,=,0,0
11810,17,0,1
11811,),0,0
11812,.,0,1
11813,Unconsciousness,0,0
11814,was,0,0
11815,associated,0,0
11816,with,0,1
11817,reductions,0,0
11818,in,0,0
11819,ASSR,0,1
11820,(,0,1
11821,0.10,0,0
11822,+/-,0,0
11823,0.08,0,0
11824,microV,0,0
11825,[,0,0
11826,awake,0,1
11827,baseline,0,0
11828,0.32,0,0
11829,+/-,0,0
11830,0.18,0,0
11831,microV,0,0
11832,],0,0
11833,",",0,0
11834,P,0,0
11835,<,0,0
11836,0.001,0,0
11837,),0,0
11838,and,0,0
11839,BIS,0,0
11840,(,0,0
11841,55.7,0,1
11842,+/-,0,0
11843,8.8,0,0
11844,[,0,0
11845,awake,0,1
11846,baseline,0,0
11847,92.4,0,0
11848,+/-,0,0
11849,3.9,0,0
11850,],0,0
11851,",",0,0
11852,P,0,0
11853,<,0,0
11854,0.001,0,0
11855,),0,1
11856,.,0,1
11857,Physostigmine,0,0
11858,restored,0,0
11859,consciousness,0,0
11860,in,0,0
11861,9,0,0
11862,of,0,1
11863,11,0,1
11864,subjects,0,1
11865,",",0,0
11866,with,0,1
11867,concomitant,0,0
11868,increases,0,0
11869,in,0,0
11870,ASSR,0,1
11871,(,0,1
11872,0.38,0,0
11873,+/-,0,0
11874,0.17,0,0
11875,microV,0,0
11876,",",0,0
11877,P,0,0
11878,<,0,0
11879,0.01,0,0
11880,),0,0
11881,and,0,0
11882,BIS,0,0
11883,(,0,0
11884,75.3,0,0
11885,+/-,0,0
11886,8.3,0,0
11887,",",0,0
11888,P,0,0
11889,<,0,0
11890,0.001,0,0
11891,),0,0
11892,.,0,0
11893,In,0,0
11894,all,0,0
11895,subjects,0,1
11896,(,0,0
11897,n,0,1
11898,=,0,0
11899,6,0,0
11900,),0,0
11901,scopolamine,0,0
11902,blocked,0,0
11903,the,0,0
11904,physostigmine-induced,0,0
11905,reversal,0,0
11906,of,0,0
11907,unconsciousness,0,0
11908,and,0,0
11909,the,0,0
11910,increase,0,0
11911,of,0,0
11912,the,0,0
11913,ASSR,0,0
11914,and,0,0
11915,BIS,0,0
11916,(,0,0
11917,ASSR,0,0
11918,and,0,0
11919,BIS,0,0
11920,during,0,0
11921,propofol-induced,0,0
11922,unconsciousness,0,1
11923,:,0,1
11924,0.09,0,0
11925,+/-,0,0
11926,0.09,0,0
11927,microV,0,0
11928,and,0,0
11929,58.2,0,0
11930,+/-,0,0
11931,7.5,0,0
11932,",",0,0
11933,respectively,0,0
11934,;,0,0
11935,ASSR,0,0
11936,and,0,0
11937,BIS,0,0
11938,after,0,0
11939,physostigmine,0,0
11940,administration,0,0
11941,:,0,1
11942,0.08,0,0
11943,+/-,0,0
11944,0.06,0,0
11945,microV,0,0
11946,and,0,0
11947,56.8,0,1
11948,+/-,0,0
11949,6.7,0,0
11950,",",0,0
11951,respectively,0,0
11952,",",0,0
11953,NS,0,0
11954,),0,0
11955,.,0,0
11956,CONCLUSIONS,0,0
11957,These,0,0
11958,findings,0,0
11959,suggest,0,0
11960,that,0,0
11961,the,0,0
11962,unconsciousness,0,0
11963,produced,0,0
11964,by,0,0
11965,propofol,0,0
11966,is,0,0
11967,mediated,0,0
11968,at,0,0
11969,least,0,0
11970,in,0,0
11971,part,0,0
11972,via,0,0
11973,interruption,0,0
11974,of,0,0
11975,central,0,0
11976,cholinergic,0,0
11977,muscarinic,0,0
11978,transmission,0,0
11979,.,0,1
11980,Influence,0,0
11981,of,0,0
11982,asimadoline,0,0
11983,",",0,0
11984,a,0,0
11985,new,0,0
11986,kappa-opioid,0,0
11987,receptor,0,0
11988,agonist,0,0
11989,",",0,0
11990,on,0,0
11991,tubular,0,0
11992,water,0,0
11993,absorption,0,0
11994,and,0,0
11995,vasopressin,1,0
11996,secretion,1,0
11997,in,1,0
11998,man,1,1
11999,.,1,0
12000,AIMS,0,0
12001,The,0,0
12002,purpose,0,0
12003,of,0,0
12004,the,0,0
12005,study,0,0
12006,was,0,0
12007,to,0,0
12008,investigate,0,0
12009,the,0,0
12010,effects,0,0
12011,of,0,0
12012,asimadoline,0,0
12013,",",0,0
12014,a,0,0
12015,new,0,0
12016,kappa-opioid,0,0
12017,agonist,0,0
12018,",",0,0
12019,on,0,0
12020,renal,0,1
12021,function,0,0
12022,and,0,0
12023,on,0,0
12024,hormones,0,0
12025,related,0,0
12026,to,0,0
12027,body,0,1
12028,fluid,0,0
12029,balance,0,0
12030,as,0,0
12031,well,0,0
12032,as,0,0
12033,its,0,0
12034,tolerability,0,0
12035,in,0,0
12036,healthy,1,1
12037,subjects,1,1
12038,.,1,1
12039,METHODS,0,0
12040,In,0,0
12041,a,0,0
12042,placebo-controlled,0,0
12043,",",0,0
12044,randomised,0,0
12045,",",0,0
12046,double-blind,0,0
12047,crossover,0,0
12048,design,0,0
12049,we,0,0
12050,studied,0,0
12051,the,0,0
12052,effects,0,0
12053,of,0,0
12054,single,0,0
12055,oral,0,0
12056,doses,0,0
12057,of,0,0
12058,1,0,0
12059,",",0,0
12060,5,0,0
12061,",",0,0
12062,and,0,0
12063,10,0,0
12064,mg,0,0
12065,of,0,0
12066,asimadoline,0,0
12067,",",0,0
12068,in,0,0
12069,24,1,0
12070,healthy,1,1
12071,volunteers,1,1
12072,.,1,1
12073,Two,0,0
12074,hour,0,0
12075,control,0,1
12076,urine,0,0
12077,collections,0,0
12078,were,0,1
12079,followed,0,0
12080,by,0,0
12081,2,0,1
12082,h,0,0
12083,postdose,0,0
12084,urine,0,1
12085,collections,0,0
12086,and,0,0
12087,subsequently,0,0
12088,2.5,0,0
12089,%,0,0
12090,saline,0,0
12091,was,0,0
12092,given,0,0
12093,i.v,0,0
12094,.,0,0
12095,at,0,0
12096,a,0,0
12097,rate,0,0
12098,of,0,0
12099,0.3,0,0
12100,ml,0,0
12101,min,0,0
12102,(,0,1
12103,-1,0,0
12104,),0,0
12105,kg,0,0
12106,(,0,0
12107,-1,0,0
12108,),0,0
12109,during,0,0
12110,another,0,0
12111,2,0,0
12112,h,0,0
12113,urine,0,0
12114,collection,0,0
12115,.,0,1
12116,Blood,0,0
12117,was,0,0
12118,obtained,0,0
12119,hourly,0,0
12120,.,0,0
12121,Arginine-vasopressin,0,0
12122,(,0,0
12123,AVP,0,0
12124,),0,0
12125,",",0,0
12126,atrial,0,1
12127,natriuretic,0,0
12128,peptide,0,0
12129,(,0,0
12130,alpha-hANP,0,0
12131,),0,0
12132,",",0,0
12133,endothelin,0,0
12134,(,0,0
12135,ET-1,0,0
12136,),0,0
12137,and,0,0
12138,cAMP,0,0
12139,were,0,0
12140,determined,0,0
12141,by,0,0
12142,r.i.a,0,0
12143,.,0,1
12144,or,0,0
12145,ELISA,0,1
12146,.,0,1
12147,RESULTS,0,0
12148,GC-MS,0,1
12149,measurements,0,0
12150,revealed,0,0
12151,Cmax,0,0
12152,values,0,0
12153,of,0,0
12154,asimadoline,0,0
12155,in,0,0
12156,plasma,0,0
12157,ranging,0,1
12158,from,0,1
12159,18,0,1
12160,ng,0,0
12161,ml,0,0
12162,(,0,0
12163,-1,0,0
12164,),0,0
12165,at,0,0
12166,the,0,0
12167,1,0,0
12168,mg,0,0
12169,dose,0,0
12170,",",0,0
12171,91,0,0
12172,ng,0,0
12173,ml,0,0
12174,(,0,0
12175,-1,0,0
12176,),0,0
12177,at,0,0
12178,the,0,0
12179,5,0,0
12180,mg,0,0
12181,dose,0,0
12182,",",0,0
12183,to,0,0
12184,214,0,1
12185,ng,0,0
12186,ml,0,0
12187,(,0,0
12188,-1,0,0
12189,),0,0
12190,at,0,0
12191,the,0,0
12192,10,0,0
12193,mg,0,0
12194,dose,0,0
12195,after,0,0
12196,an,0,0
12197,average,0,0
12198,of,0,0
12199,1.1-1.4,0,1
12200,h.,0,1
12201,Without,0,1
12202,effects,0,0
12203,on,0,0
12204,blood,0,0
12205,pressure,0,0
12206,",",0,0
12207,heart,0,1
12208,rate,0,0
12209,",",0,0
12210,GFR,0,1
12211,or,0,1
12212,urine,0,0
12213,electrolyte,0,0
12214,excretion,0,0
12215,",",0,0
12216,urine,0,0
12217,volume,0,0
12218,increased,0,0
12219,after,0,0
12220,1-2,0,0
12221,h,0,0
12222,after,0,0
12223,administration,0,0
12224,of,0,0
12225,5,0,0
12226,and,0,1
12227,10,0,1
12228,mg,0,0
12229,asimadoline,0,0
12230,from,0,0
12231,3.3+/-1.3,0,0
12232,to,0,0
12233,5.6+/-1.4,0,0
12234,(,0,0
12235,P,0,0
12236,<,0,0
12237,0.05,0,0
12238,),0,0
12239,and,0,0
12240,from,0,1
12241,3.2,0,0
12242,+/-1.6,0,1
12243,to,0,0
12244,5.5+/-2.2,0,0
12245,ml,0,0
12246,min,0,0
12247,(,0,0
12248,-1,0,0
12249,),0,0
12250,(,0,0
12251,P,0,0
12252,<,0,0
12253,0.01,0,0
12254,),0,0
12255,",",0,0
12256,respectively,0,0
12257,.,0,0
12258,CH2O,0,0
12259,rose,0,0
12260,from,0,0
12261,0.2+/-1.5,0,0
12262,to,0,0
12263,2.0+/-1.6,0,0
12264,(,0,0
12265,P,0,0
12266,<,0,0
12267,0.05,0,0
12268,),0,0
12269,and,0,0
12270,from,0,0
12271,0.6+/-1.6,0,0
12272,to,0,0
12273,3.0+/-1.6,0,0
12274,ml,0,0
12275,min,0,0
12276,(,0,0
12277,-1,0,0
12278,),0,0
12279,(,0,0
12280,P,0,0
12281,<,0,0
12282,0.01,0,0
12283,),0,1
12284,.,0,1
12285,Urinary,0,0
12286,excretion,0,0
12287,of,0,0
12288,AVP,0,0
12289,was,0,0
12290,suppressed,0,0
12291,only,0,0
12292,with,0,1
12293,the,0,0
12294,10,0,0
12295,mg,0,0
12296,dose,0,0
12297,from,0,1
12298,46+/-23,0,0
12299,to,0,0
12300,25+/-15,0,0
12301,fmol,0,0
12302,min,0,0
12303,(,0,0
12304,-1,0,0
12305,),0,0
12306,(,0,0
12307,P,0,0
12308,<,0,0
12309,0.05,0,0
12310,),0,0
12311,without,0,1
12312,and,0,0
12313,from,0,1
12314,410+/-206,0,1
12315,to,0,0
12316,181+/-125,0,0
12317,fmol,0,0
12318,min,0,0
12319,(,0,0
12320,-1,0,0
12321,),0,0
12322,(,0,0
12323,P,0,0
12324,<,0,0
12325,0.05,0,0
12326,),0,0
12327,with,0,1
12328,stimulation,0,0
12329,by,0,0
12330,2.5,0,0
12331,%,0,0
12332,saline,0,0
12333,.,0,1
12334,Plasma,0,0
12335,AVP,0,0
12336,was,0,0
12337,suppressed,0,0
12338,only,0,0
12339,by,0,0
12340,the,0,0
12341,10,0,0
12342,mg,0,0
12343,dose,0,0
12344,of,0,0
12345,asimadoline,0,0
12346,in,0,0
12347,six,0,1
12348,of,0,1
12349,eight,0,1
12350,subjects,0,1
12351,during,0,0
12352,the,0,0
12353,2.5,0,0
12354,%,0,0
12355,saline,0,0
12356,infusion,0,0
12357,.,0,1
12358,Changes,0,0
12359,in,0,0
12360,the,0,0
12361,alpha-hANP,0,0
12362,or,0,1
12363,ET-1,0,0
12364,systems,0,0
12365,were,0,1
12366,not,0,0
12367,affected,0,0
12368,by,0,0
12369,asimadoline,0,0
12370,.,0,1
12371,CONCLUSIONS,0,0
12372,Asimadoline,0,0
12373,is,0,0
12374,diuretic,0,0
12375,in,0,0
12376,man,0,1
12377,after,0,0
12378,single,0,0
12379,doses,0,0
12380,of,0,1
12381,5,0,1
12382,or,0,1
12383,10,0,0
12384,mg,0,0
12385,probably,0,0
12386,through,0,0
12387,a,0,0
12388,direct,0,0
12389,effect,0,0
12390,at,0,0
12391,the,0,0
12392,renal,0,1
12393,tubular,0,0
12394,level,0,0
12395,.,0,0
12396,Suppression,0,0
12397,of,0,0
12398,AVP,0,0
12399,secretion,0,0
12400,was,0,0
12401,observed,0,0
12402,only,0,0
12403,at,0,0
12404,the,0,0
12405,highest,0,0
12406,dose,0,0
12407,level,0,0
12408,of,0,0
12409,10,0,0
12410,mg,0,0
12411,of,0,0
12412,asimadoline,0,0
12413,.,0,1
12414,Uvulopalatopharyngoplasty,0,1
12415,versus,0,0
12416,laser,0,0
12417,assisted,0,1
12418,uvulopalatoplasty,0,1
12419,for,0,0
12420,the,0,0
12421,treatment,0,0
12422,of,0,0
12423,snoring,1,1
12424,:,1,1
12425,an,0,0
12426,objective,0,0
12427,randomised,0,0
12428,clinical,0,0
12429,trial,0,0
12430,.,0,0
12431,This,0,0
12432,study,0,0
12433,was,0,0
12434,designed,0,0
12435,to,0,0
12436,evaluate,0,0
12437,objectively,0,0
12438,the,0,0
12439,clinical,0,0
12440,effectiveness,0,0
12441,of,0,0
12442,surgery,0,1
12443,for,0,0
12444,snoring,0,1
12445,and,0,0
12446,to,0,0
12447,compare,0,0
12448,the,0,0
12449,results,0,0
12450,of,0,0
12451,conventional,0,1
12452,uvulopalatopharyngoplasty,0,1
12453,(,0,1
12454,UPPP,0,1
12455,),0,0
12456,and,0,0
12457,laser,0,0
12458,assisted,0,0
12459,uvulopalatoplasty,0,1
12460,(,0,0
12461,LAUP,0,0
12462,),0,0
12463,in,0,0
12464,the,0,0
12465,treatment,0,0
12466,of,0,0
12467,snoring,0,1
12468,.,0,1
12469,Patients,1,1
12470,who,1,1
12471,had,1,1
12472,been,1,1
12473,referred,1,1
12474,for,1,0
12475,investigation,1,0
12476,and,1,0
12477,treatment,1,0
12478,of,1,0
12479,their,1,0
12480,snoring,1,1
12481,were,1,0
12482,randomly,1,1
12483,allocated,1,0
12484,to,1,0
12485,receive,1,0
12486,either,1,0
12487,UPPP,1,0
12488,or,1,1
12489,LAUP,1,0
12490,.,1,1
12491,Forty-seven,1,1
12492,patients,1,1
12493,with,1,1
12494,confirmed,1,1
12495,palatal,1,1
12496,flutter,1,1
12497,had,1,0
12498,surgery,1,1
12499,and,1,0
12500,all,1,0
12501,of,1,0
12502,them,1,0
12503,had,1,1
12504,a,1,0
12505,preoperative,1,0
12506,and,1,0
12507,postoperative,1,0
12508,objective,1,0
12509,assessment,1,0
12510,of,1,0
12511,their,1,0
12512,snoring,1,1
12513,loudness,1,0
12514,and,1,0
12515,duration,1,0
12516,in,1,0
12517,the,1,0
12518,home,1,0
12519,.,1,0
12520,The,0,0
12521,recording,0,0
12522,device,0,0
12523,(,0,0
12524,Snore,0,1
12525,Box,0,0
12526,),0,0
12527,is,0,0
12528,simple,0,0
12529,for,0,0
12530,the,0,0
12531,patient,0,0
12532,to,0,0
12533,operate,0,0
12534,",",0,0
12535,portable,0,0
12536,with,0,1
12537,a,0,0
12538,built,0,0
12539,in,0,0
12540,microphone,0,0
12541,",",0,0
12542,and,0,0
12543,able,0,0
12544,to,0,0
12545,produce,0,0
12546,objective,0,0
12547,results,0,0
12548,",",0,0
12549,which,0,0
12550,can,0,0
12551,be,0,0
12552,automatically,0,0
12553,analysed,0,0
12554,.,0,0
12555,Of,0,0
12556,the,0,0
12557,38,0,1
12558,patients,0,1
12559,",",0,1
12560,who,0,1
12561,had,0,1
12562,technically,0,1
12563,valid,0,0
12564,recordings,0,0
12565,",",0,1
12566,22,0,1
12567,underwent,0,1
12568,LAUP,0,0
12569,and,0,1
12570,16,0,1
12571,UPPP,0,1
12572,.,0,0
12573,Overall,0,0
12574,the,0,0
12575,mean,0,0
12576,postoperative,0,0
12577,Snore,0,1
12578,Index,0,0
12579,(,0,0
12580,SI,0,1
12581,),0,0
12582,was,0,0
12583,less,0,0
12584,than,0,0
12585,the,0,0
12586,preoperative,0,0
12587,SI,0,0
12588,(,0,1
12589,P,0,0
12590,<,0,0
12591,0.0001,0,0
12592,),0,0
12593,",",0,0
12594,the,0,0
12595,average,0,0
12596,difference,0,0
12597,being,0,0
12598,78.2,0,0
12599,snores/h,0,1
12600,.,0,0
12601,There,0,0
12602,was,0,0
12603,no,0,0
12604,significant,0,0
12605,difference,0,0
12606,between,0,0
12607,the,0,0
12608,LAUP,0,0
12609,and,0,0
12610,UPPP,0,0
12611,regarding,0,0
12612,the,0,0
12613,fall,0,0
12614,in,0,0
12615,the,0,0
12616,SI,0,0
12617,.,0,0
12618,This,0,0
12619,study,0,0
12620,is,0,0
12621,the,0,0
12622,first,0,0
12623,objective,0,0
12624,comparative,0,0
12625,study,0,0
12626,to,0,0
12627,demonstrate,0,0
12628,the,0,0
12629,effectiveness,0,0
12630,of,0,0
12631,snoring,0,1
12632,surgery,0,1
12633,.,0,1
12634,Onset/offset,0,1
12635,characteristics,0,0
12636,and,0,0
12637,intubating,0,1
12638,conditions,0,0
12639,of,0,1
12640,rapacuronium,0,1
12641,:,0,1
12642,a,0,0
12643,comparison,0,0
12644,with,0,1
12645,rocuronium,0,0
12646,.,0,1
12647,We,0,0
12648,compared,0,0
12649,onset,0,0
12650,and,0,0
12651,offset,0,0
12652,of,0,0
12653,action,0,0
12654,and,0,0
12655,tracheal,1,1
12656,intubating,1,0
12657,conditions,1,0
12658,after,0,0
12659,rapacuronium,0,0
12660,and,0,0
12661,rocuronium,0,0
12662,in,0,0
12663,60,1,1
12664,patients,1,1
12665,in,0,0
12666,a,0,0
12667,randomized,0,0
12668,",",0,0
12669,assessor-blinded,0,0
12670,study,0,0
12671,.,0,0
12672,Following,0,0
12673,induction,0,0
12674,of,0,0
12675,anaesthesia,0,1
12676,with,0,1
12677,propofol,0,0
12678,2.5,0,0
12679,mg,0,0
12680,kg-1,0,0
12681,",",0,0
12682,either,0,0
12683,rapacuronium,0,0
12684,1.5,0,0
12685,mg,0,0
12686,kg-1,0,0
12687,(,0,0
12688,n,0,1
12689,=,0,0
12690,30,0,1
12691,),0,0
12692,or,0,1
12693,rocuronium,0,0
12694,0.6,0,0
12695,mg,0,0
12696,kg-1,0,0
12697,(,0,0
12698,n,0,1
12699,=,0,0
12700,30,0,1
12701,),0,0
12702,was,0,0
12703,administered,0,0
12704,to,0,0
12705,facilitate,0,0
12706,tracheal,0,1
12707,intubation,0,0
12708,.,0,1
12709,Anaesthesia,0,0
12710,was,0,0
12711,maintained,0,0
12712,with,0,1
12713,either,0,0
12714,a,0,0
12715,propofol,0,0
12716,infusion,0,0
12717,(,0,1
12718,100,0,0
12719,micrograms,0,0
12720,kg-1,0,1
12721,min-1,0,0
12722,),0,0
12723,or,0,1
12724,sevoflurane,0,0
12725,(,0,0
12726,1,0,0
12727,%,0,0
12728,end-tidal,0,0
12729,),0,0
12730,with,0,1
12731,66,0,1
12732,%,0,0
12733,nitrous,0,0
12734,oxide,0,0
12735,(,0,0
12736,N2O,0,1
12737,),0,0
12738,",",0,0
12739,n,0,1
12740,=,0,0
12741,15,0,0
12742,in,0,0
12743,each,0,0
12744,subgroup,0,1
12745,.,0,0
12746,Neuromuscular,0,1
12747,monitoring,0,0
12748,was,0,0
12749,performed,0,0
12750,using,0,0
12751,an,0,0
12752,electromyographic,0,0
12753,(,0,0
12754,EMG,0,0
12755,),0,0
12756,device,0,0
12757,(,0,0
12758,Datex,0,1
12759,Relaxograph,0,1
12760,),0,0
12761,.,0,0
12762,The,0,0
12763,lag,0,0
12764,times,0,0
12765,(,0,1
12766,mean,0,1
12767,42,0,1
12768,(,0,1
12769,SD,0,1
12770,11,0,1
12771,),0,0
12772,s,0,0
12773,and,0,0
12774,44,0,1
12775,(,0,0
12776,16,0,1
12777,),0,0
12778,s,0,0
12779,),0,0
12780,",",0,0
12781,maximum,0,0
12782,block,0,0
12783,(,0,0
12784,99,0,1
12785,(,0,1
12786,2,0,0
12787,),0,0
12788,%,0,0
12789,and,0,0
12790,98,0,1
12791,(,0,0
12792,3,0,0
12793,),0,0
12794,%,0,0
12795,),0,0
12796,and,0,0
12797,intubating,0,0
12798,conditions,0,0
12799,at,0,1
12800,60,0,1
12801,s,0,0
12802,(,0,0
12803,good-to-excellent,0,0
12804,in,0,0
12805,86,0,1
12806,%,0,0
12807,and,0,0
12808,84,0,1
12809,%,0,0
12810,of,0,0
12811,patients,0,1
12812,),0,1
12813,were,0,1
12814,similar,0,0
12815,for,0,0
12816,rapacuronium,0,0
12817,and,0,0
12818,rocuronium,0,0
12819,",",0,0
12820,respectively,0,0
12821,.,0,0
12822,The,0,0
12823,onset,0,0
12824,time,0,0
12825,of,0,0
12826,rapacuronium,0,0
12827,was,0,0
12828,shorter,0,0
12829,than,0,0
12830,rocuronium,0,0
12831,(,0,0
12832,87,0,1
12833,(,0,1
12834,20,0,1
12835,),0,1
12836,vs,0,0
12837,141,0,1
12838,(,0,0
12839,65,0,1
12840,),0,0
12841,s,0,0
12842,",",0,0
12843,P,0,0
12844,<,0,0
12845,0.001,0,0
12846,),0,0
12847,",",0,0
12848,and,0,0
12849,the,0,0
12850,degree,0,0
12851,of,0,0
12852,block,0,0
12853,at,0,0
12854,60,0,1
12855,s,0,0
12856,was,0,0
12857,greater,0,0
12858,(,0,0
12859,69,0,1
12860,(,0,1
12861,26,0,1
12862,),0,1
12863,vs,0,0
12864,50,0,1
12865,(,0,0
12866,27,0,1
12867,),0,0
12868,%,0,0
12869,",",0,0
12870,P,0,0
12871,<,0,0
12872,0.05,0,0
12873,),0,1
12874,.,0,1
12875,Twenty-five,0,1
12876,per,0,0
12877,cent,0,0
12878,recovery,0,0
12879,was,0,0
12880,shorter,0,0
12881,with,0,1
12882,rapacuronium,0,0
12883,than,0,0
12884,rocuronium,0,0
12885,during,0,0
12886,propofol,0,0
12887,(,0,0
12888,15.0,0,0
12889,(,0,1
12890,3.2,0,0
12891,),0,1
12892,vs,0,0
12893,39.1,0,0
12894,(,0,0
12895,14.2,0,0
12896,),0,0
12897,min,0,0
12898,",",0,0
12899,P,0,0
12900,<,0,0
12901,0.001,0,0
12902,),0,0
12903,and,0,0
12904,sevoflurane,0,0
12905,(,0,0
12906,15.1,0,0
12907,(,0,1
12908,4.2,0,0
12909,),0,1
12910,vs,0,0
12911,47.8,0,0
12912,(,0,0
12913,19.0,0,0
12914,),0,0
12915,min,0,0
12916,",",0,0
12917,P,0,0
12918,<,0,0
12919,0.001,0,0
12920,),0,0
12921,anaesthesia,0,1
12922,.,0,0
12923,We,0,0
12924,conclude,0,0
12925,that,0,0
12926,rapacuronium,0,0
12927,1.5,0,0
12928,mg,0,0
12929,kg-1,0,0
12930,had,0,0
12931,a,0,0
12932,more,0,0
12933,rapid,0,0
12934,onset,0,0
12935,",",0,0
12936,similar,0,0
12937,intubating,0,0
12938,conditions,0,0
12939,",",0,0
12940,and,0,0
12941,shorter,0,0
12942,recovery,0,0
12943,times,0,0
12944,than,0,0
12945,rocuronium,0,0
12946,0.6,0,0
12947,mg,0,0
12948,kg-1,0,0
12949,.,0,1
12950,Analysis,0,0
12951,of,0,0
12952,treatment,0,0
12953,in,0,0
12954,childhood,1,1
12955,leukaemia,1,1
12956,.,1,1
12957,I.,0,0
12958,Predisposition,0,0
12959,to,0,0
12960,methotrexate-induced,0,0
12961,neutropenia,0,0
12962,after,1,0
12963,craniospinal,1,0
12964,irradiation,1,0
12965,.,1,1
12966,Report,0,0
12967,to,0,0
12968,the,0,0
12969,Medical,0,1
12970,Research,0,0
12971,Council,0,0
12972,of,0,0
12973,the,0,0
12974,Working,0,1
12975,Party,0,1
12976,on,0,0
12977,Leukaemia,1,1
12978,in,1,0
12979,Childhood,1,1
12980,.,1,0
12981,The,0,0
12982,degree,0,0
12983,of,0,0
12984,drug-induced,0,1
12985,neutropenia,0,0
12986,resulting,0,0
12987,from,0,1
12988,a,0,0
12989,controlled,0,0
12990,trial,0,0
12991,(,0,0
12992,UKALL,0,0
12993,I,0,1
12994,),0,0
12995,of,0,0
12996,treatment,0,0
12997,in,0,0
12998,acute,1,1
12999,lymphoblastic,1,1
13000,leukaemia,1,1
13001,was,0,0
13002,analysed,0,0
13003,.,0,0
13004,The,0,0
13005,main,0,0
13006,agent,0,0
13007,associated,0,0
13008,with,0,1
13009,severe,0,1
13010,neutropenia,0,0
13011,was,0,0
13012,methotrexate,0,0
13013,",",0,0
13014,and,0,0
13015,methotrexate-induced,0,0
13016,neutropenia,0,0
13017,was,0,0
13018,significantly,0,0
13019,greater,0,0
13020,in,0,1
13021,patients,1,1
13022,who,1,1
13023,had,1,1
13024,received,1,1
13025,craniospinal,1,0
13026,irradiation,1,0
13027,.,1,0
13028,The,0,0
13029,synergistic,0,0
13030,toxic,0,0
13031,effect,0,0
13032,of,0,0
13033,irradiation,0,0
13034,followed,0,0
13035,by,0,0
13036,methotrexate,0,0
13037,treatment,0,0
13038,seems,0,0
13039,to,0,0
13040,have,0,0
13041,contributed,0,0
13042,to,0,0
13043,three,0,0
13044,of,0,0
13045,the,0,0
13046,five,0,1
13047,deaths,0,0
13048,which,0,0
13049,occurred,0,0
13050,in,0,0
13051,complete,0,0
13052,remission,0,0
13053,in,0,0
13054,this,0,0
13055,trial,0,0
13056,;,0,0
13057,all,0,0
13058,deaths,0,0
13059,in,0,0
13060,remission,0,0
13061,occurred,0,0
13062,in,0,1
13063,patients,0,1
13064,who,0,1
13065,had,0,1
13066,received,0,1
13067,central,0,0
13068,nervous,0,0
13069,system,0,0
13070,prophylaxis,0,0
13071,.,0,0
13072,Analysis,0,0
13073,of,0,1
13074,patients,0,1
13075,who,0,1
13076,subsequently,0,1
13077,relapsed,0,1
13078,compared,0,0
13079,with,0,1
13080,those,0,0
13081,still,0,0
13082,in,0,0
13083,remission,0,0
13084,after,0,0
13085,18,0,1
13086,months,0,0
13087,of,0,0
13088,treatment,0,0
13089,indicated,0,0
13090,that,0,0
13091,the,0,0
13092,former,0,0
13093,",",0,0
13094,on,0,0
13095,average,0,0
13096,",",0,0
13097,had,0,0
13098,slightly,0,0
13099,lower,0,0
13100,neutrophil,0,0
13101,counts,0,0
13102,.,0,0
13103,This,0,0
13104,suggests,0,0
13105,that,0,0
13106,the,0,0
13107,children,1,1
13108,who,0,1
13109,relapsed,0,1
13110,did,0,1
13111,not,0,0
13112,receive,0,0
13113,any,0,0
13114,less,0,0
13115,aggressive,0,0
13116,treatment,0,0
13117,than,0,1
13118,those,0,1
13119,who,0,1
13120,remained,0,1
13121,in,0,1
13122,remission,0,1
13123,.,0,1
13124,Beta,0,0
13125,radiation,0,0
13126,as,0,0
13127,an,0,0
13128,adjunct,0,0
13129,to,0,0
13130,low-risk,1,1
13131,trabeculectomy,1,1
13132,.,1,1
13133,PURPOSE,0,0
13134,To,0,0
13135,assess,0,0
13136,a,0,0
13137,single,0,0
13138,dose,0,0
13139,of,0,0
13140,intraoperative,0,0
13141,beta,0,0
13142,radiation,0,0
13143,used,0,0
13144,to,0,0
13145,enhance,0,0
13146,the,0,0
13147,success,0,0
13148,rate,0,0
13149,of,0,0
13150,trabeculectomy,0,0
13151,in,0,0
13152,a,0,0
13153,population,1,1
13154,of,1,0
13155,low-risk,1,1
13156,glaucoma,1,1
13157,patients,1,1
13158,in,1,1
13159,whom,1,1
13160,antimetabolites,1,0
13161,might,1,0
13162,not,1,0
13163,be,1,0
13164,indicated,1,0
13165,.,1,0
13166,METHODS,0,0
13167,A,0,0
13168,prospective,0,0
13169,randomized,0,0
13170,trial,0,0
13171,of,0,0
13172,65,1,1
13173,eyes,1,1
13174,was,1,0
13175,designed,1,0
13176,",",1,0
13177,with,1,1
13178,31,1,1
13179,eyes,1,1
13180,receiving,1,1
13181,750,1,1
13182,rads,1,0
13183,of,1,0
13184,intraoperative,1,0
13185,beta,1,0
13186,radiation,1,0
13187,(,1,0
13188,group,1,0
13189,1,1,0
13190,),1,0
13191,",",1,0
13192,and,1,0
13193,34,1,1
13194,eyes,1,1
13195,receiving,1,1
13196,no,1,0
13197,supplementation,1,0
13198,(,1,0
13199,group,1,0
13200,2,1,1
13201,),1,0
13202,.,1,1
13203,RESULTS,0,0
13204,Mean,0,1
13205,follow-up,0,0
13206,time,0,0
13207,was,0,0
13208,24,0,1
13209,months,0,0
13210,.,0,1
13211,Mean,0,1
13212,postoperative,0,0
13213,intraocular,0,0
13214,pressure,0,0
13215,was,0,0
13216,12.2,0,0
13217,mmHg,0,0
13218,in,0,0
13219,group,0,0
13220,1,0,0
13221,",",0,0
13222,and,0,0
13223,13.7,0,0
13224,mmHg,0,0
13225,in,0,0
13226,group,0,0
13227,2,0,0
13228,(,0,0
13229,P,0,0
13230,=,0,0
13231,0.16,0,0
13232,),0,1
13233,.,0,1
13234,Mean,0,0
13235,decrease,0,0
13236,in,0,0
13237,intraocular,0,0
13238,pressure,0,0
13239,was,0,0
13240,10.3,0,0
13241,mmHg,0,0
13242,in,0,0
13243,group,0,0
13244,1,0,0
13245,",",0,0
13246,and,0,0
13247,9.3,0,0
13248,mmHg,0,0
13249,in,0,0
13250,group,0,0
13251,2,0,0
13252,(,0,0
13253,P,0,0
13254,=,0,0
13255,0.49,0,0
13256,),0,0
13257,.,0,1
13258,The,0,0
13259,two,0,0
13260,groups,0,0
13261,were,0,0
13262,not,0,0
13263,significantly,0,0
13264,different,0,0
13265,in,0,0
13266,terms,0,0
13267,of,0,1
13268,surgical,0,1
13269,complications,0,0
13270,.,0,1
13271,CONCLUSION,0,0
13272,For,0,0
13273,this,0,0
13274,population,0,1
13275,of,0,0
13276,low-risk,1,1
13277,patients,1,1
13278,",",0,0
13279,there,0,0
13280,was,0,0
13281,no,0,0
13282,significant,0,0
13283,difference,0,0
13284,in,0,0
13285,outcome,0,0
13286,after,0,0
13287,applications,0,0
13288,of,0,0
13289,a,0,1
13290,single,0,0
13291,intraoperative,0,0
13292,dose,0,0
13293,of,0,0
13294,beta,0,0
13295,radiation,0,1
13296,.,0,1
13297,Tromethamine,0,0
13298,buffer,0,0
13299,modifies,0,0
13300,the,0,0
13301,depressant,0,0
13302,effect,0,0
13303,of,0,0
13304,permissive,0,0
13305,hypercapnia,0,1
13306,on,0,0
13307,myocardial,0,1
13308,contractility,0,0
13309,in,0,0
13310,patients,1,1
13311,with,1,1
13312,acute,1,1
13313,respiratory,1,1
13314,distress,1,1
13315,syndrome,1,1
13316,.,1,0
13317,In,0,0
13318,patients,1,1
13319,with,1,1
13320,acute,1,1
13321,respiratory,1,1
13322,distress,1,1
13323,syndrome,1,1
13324,(,1,0
13325,ARDS,1,1
13326,),1,0
13327,",",0,0
13328,permissive,0,0
13329,hypercapnia,0,1
13330,is,0,0
13331,a,0,0
13332,strategy,0,0
13333,to,0,0
13334,decrease,0,0
13335,airway,0,1
13336,pressures,0,0
13337,to,0,0
13338,prevent,0,0
13339,ventilator-induced,0,0
13340,lung,0,1
13341,damage,0,0
13342,by,0,0
13343,lowering,0,0
13344,tidal,0,1
13345,volumes,0,1
13346,and,0,0
13347,tolerating,0,0
13348,higher,0,0
13349,arterial,0,1
13350,carbon,0,0
13351,dioxide,0,0
13352,tension,0,0
13353,.,0,0
13354,However,0,0
13355,",",0,0
13356,in,0,0
13357,experimental,0,0
13358,studies,0,0
13359,hypercapnia,0,1
13360,impairs,0,0
13361,myocardial,0,1
13362,contractility,0,0
13363,and,0,0
13364,hemodynamic,0,0
13365,function,0,0
13366,.,0,1
13367,We,0,0
13368,investigated,0,0
13369,the,0,0
13370,effect,0,0
13371,of,0,0
13372,short-term,0,0
13373,permissive,0,0
13374,hypercapnia,0,1
13375,on,0,0
13376,myocardial,0,1
13377,contractility,0,0
13378,and,0,0
13379,hemodynamics,0,0
13380,in,0,0
13381,patients,1,1
13382,with,1,1
13383,ARDS,1,1
13384,.,1,1
13385,We,0,0
13386,hypothesized,0,0
13387,that,0,0
13388,the,0,0
13389,administration,0,0
13390,of,0,0
13391,tromethamine,0,0
13392,(,0,0
13393,THAM,0,0
13394,),0,0
13395,",",0,0
13396,a,0,0
13397,buffer,0,0
13398,which,0,0
13399,does,0,0
13400,not,0,0
13401,increase,0,0
13402,carbon,0,0
13403,dioxide,0,0
13404,production,0,0
13405,",",0,0
13406,would,0,0
13407,modify,0,0
13408,these,0,0
13409,changes,0,0
13410,.,0,1
13411,In,0,0
13412,12,1,0
13413,patients,1,1
13414,with,1,1
13415,ARDS,1,1
13416,",",0,0
13417,permissive,0,0
13418,hypercapnia,0,1
13419,was,0,0
13420,implemented,0,0
13421,for,0,0
13422,2,0,0
13423,h,0,0
13424,with,0,1
13425,a,0,0
13426,target,0,0
13427,Pa,0,0
13428,(,0,0
13429,CO,0,0
13430,(,0,1
13431,2,0,0
13432,),0,0
13433,),0,0
13434,of,0,0
13435,80,0,1
13436,mm,0,1
13437,Hg,0,0
13438,.,0,1
13439,Patients,0,1
13440,were,0,0
13441,randomized,0,1
13442,to,0,0
13443,have,0,0
13444,respiratory,0,1
13445,acidosis,0,0
13446,corrected,0,0
13447,by,0,0
13448,THAM,0,0
13449,(,0,0
13450,pH-corrected,0,0
13451,group,0,0
13452,),0,0
13453,",",0,0
13454,or,0,0
13455,not,0,0
13456,corrected,0,0
13457,(,0,0
13458,pH-uncorrected,0,0
13459,group,0,1
13460,),0,0
13461,.,0,1
13462,Hemodynamic,0,0
13463,responses,0,0
13464,were,0,0
13465,measured,0,0
13466,",",0,0
13467,and,0,0
13468,transesophageal,0,1
13469,echocardiography,0,0
13470,(,0,0
13471,TEE,0,0
13472,),0,0
13473,was,0,0
13474,used,0,0
13475,to,0,0
13476,determine,0,0
13477,myocardial,0,1
13478,contractility,0,0
13479,.,0,1
13480,Permissive,0,0
13481,hypercapnia,0,1
13482,resulted,0,0
13483,in,0,0
13484,significant,0,0
13485,decreases,0,0
13486,in,0,1
13487,systemic,0,0
13488,vascular,0,0
13489,resistance,0,0
13490,(,0,0
13491,SVR,0,0
13492,),0,0
13493,and,0,0
13494,increases,0,0
13495,in,0,0
13496,cardiac,0,1
13497,output,0,0
13498,(,0,0
13499,Q,0,1
13500,),0,1
13501,.,0,0
13502,Myocardial,0,0
13503,contractility,0,0
13504,decreased,0,0
13505,in,0,0
13506,both,0,0
13507,groups,0,0
13508,but,0,0
13509,significantly,0,0
13510,less,0,0
13511,in,0,0
13512,the,0,0
13513,pH-corrected,0,0
13514,group,0,0
13515,(,0,0
13516,approximately,0,0
13517,10,0,0
13518,%,0,0
13519,),0,0
13520,than,0,0
13521,in,0,0
13522,the,0,0
13523,pH-uncorrected,0,0
13524,group,0,0
13525,(,0,0
13526,approximately,0,0
13527,18,0,1
13528,%,0,0
13529,",",0,0
13530,p,0,0
13531,<,0,0
13532,0.05,0,0
13533,),0,1
13534,.,0,1
13535,Mean,0,0
13536,arterial,0,1
13537,pressure,0,0
13538,decreased,0,0
13539,and,0,0
13540,mean,0,1
13541,pulmonary,0,1
13542,arterial,0,1
13543,pressure,0,0
13544,increased,0,0
13545,significantly,0,0
13546,only,0,0
13547,in,0,0
13548,the,0,0
13549,pH-uncorrected,0,0
13550,group,0,0
13551,.,0,0
13552,All,0,0
13553,values,0,0
13554,returned,0,0
13555,to,0,0
13556,baseline,0,0
13557,conditions,0,0
13558,1,0,0
13559,h,0,0
13560,after,0,0
13561,permissive,0,0
13562,hypercapnia,0,1
13563,was,0,0
13564,terminated,0,0
13565,.,0,0
13566,Our,0,0
13567,study,0,0
13568,demonstrates,0,0
13569,a,0,0
13570,reversible,0,0
13571,depression,0,1
13572,of,0,0
13573,myocardial,0,1
13574,contractility,0,0
13575,and,0,0
13576,hemodynamic,0,0
13577,alterations,0,0
13578,during,0,0
13579,rapid,0,1
13580,permissive,0,0
13581,hypercapnia,0,1
13582,which,0,0
13583,were,0,0
13584,attenuated,0,0
13585,by,0,0
13586,buffering,0,0
13587,with,0,1
13588,THAM,0,1
13589,.,0,0
13590,This,0,0
13591,may,0,0
13592,have,0,0
13593,applicability,0,0
13594,to,0,0
13595,the,0,0
13596,clinical,0,0
13597,strategy,0,0
13598,of,0,0
13599,permissive,0,0
13600,hypercapnia,0,1
13601,and,0,0
13602,allow,0,0
13603,the,0,0
13604,benefit,0,0
13605,of,0,0
13606,decreased,0,0
13607,airway,0,1
13608,pressures,0,0
13609,to,0,0
13610,be,0,0
13611,realized,0,0
13612,while,0,0
13613,minimizing,0,0
13614,the,0,0
13615,adverse,0,0
13616,hemodynamic,0,0
13617,effects,0,0
13618,of,0,0
13619,hypercapnic,0,1
13620,acidosis,0,0
13621,.,0,1
13622,Randomized,0,0
13623,trial,0,0
13624,of,0,0
13625,fenretinide,0,0
13626,in,0,0
13627,superficial,1,1
13628,bladder,1,1
13629,cancer,1,1
13630,using,0,0
13631,DNA,0,0
13632,flow,0,0
13633,cytometry,0,0
13634,as,0,0
13635,an,0,0
13636,intermediate,0,0
13637,end,0,0
13638,point,0,0
13639,.,0,1
13640,Retinoids,0,0
13641,have,0,0
13642,shown,0,0
13643,a,0,0
13644,potential,0,0
13645,activity,0,0
13646,in,0,0
13647,preventing,0,0
13648,tumor,0,0
13649,recurrence,0,0
13650,in,0,0
13651,superficial,1,1
13652,bladder,1,1
13653,cancer,1,1
13654,.,1,0
13655,We,0,0
13656,assessed,0,0
13657,the,0,0
13658,activity,0,0
13659,of,0,0
13660,the,0,0
13661,synthetic,0,0
13662,retinoid,0,0
13663,fenretinide,0,0
13664,in,0,0
13665,superficial,0,1
13666,bladder,0,1
13667,cancer,0,1
13668,using,0,0
13669,DNA,0,0
13670,flow,0,0
13671,cytometry,0,0
13672,and,0,0
13673,conventional,0,0
13674,cytology,0,1
13675,as,0,0
13676,surrogate,0,0
13677,biomarkers,0,0
13678,.,0,1
13679,A,0,0
13680,total,1,1
13681,of,1,0
13682,99,1,1
13683,subjects,1,1
13684,with,1,1
13685,resected,1,1
13686,superficial,1,1
13687,bladder,1,1
13688,cancer,1,1
13689,(,1,0
13690,pTa,1,0
13691,",",1,0
13692,pT1,1,0
13693,),1,0
13694,were,0,0
13695,randomized,0,0
13696,to,0,0
13697,either,0,0
13698,fenretinide,0,0
13699,(,0,0
13700,200,0,0
13701,mg,0,0
13702,day,0,0
13703,p.o,0,1
13704,.,0,0
13705,for,0,0
13706,24,0,0
13707,months,0,0
13708,),0,1
13709,or,0,1
13710,no,0,0
13711,intervention,0,0
13712,.,0,0
13713,Cystoscopy,0,0
13714,and,0,0
13715,bladder,0,1
13716,washing,0,0
13717,for,0,0
13718,DNA,0,0
13719,flow,0,0
13720,cytometry,0,0
13721,end,0,0
13722,points,0,0
13723,(,0,0
13724,proportion,0,0
13725,of,0,0
13726,DNA,0,0
13727,aneuploid,0,0
13728,histograms,0,0
13729,",",0,0
13730,hyperdiploid,0,0
13731,fraction,0,0
13732,",",0,0
13733,and,0,0
13734,percentage,0,0
13735,of,0,0
13736,apoptotic,0,0
13737,cells,0,0
13738,),0,1
13739,and,0,0
13740,proportion,0,0
13741,of,0,0
13742,abnormal,0,0
13743,cytological,0,0
13744,examinations,0,1
13745,were,0,1
13746,repeated,0,0
13747,every,0,0
13748,4,0,0
13749,months,0,0
13750,for,0,0
13751,up,0,0
13752,to,0,1
13753,36,0,1
13754,months,0,0
13755,.,0,1
13756,The,0,0
13757,primary,0,0
13758,study,0,0
13759,end,0,0
13760,point,0,0
13761,was,0,0
13762,the,0,0
13763,proportion,0,0
13764,of,0,0
13765,DNA,0,0
13766,aneuploid,0,1
13767,histograms,0,0
13768,after,0,1
13769,12,0,1
13770,months,0,0
13771,.,0,1
13772,This,0,0
13773,figure,0,0
13774,was,0,0
13775,48.9,0,0
13776,%,0,0
13777,in,0,0
13778,the,0,0
13779,fenretinide,0,0
13780,arm,0,0
13781,and,0,0
13782,41.9,0,0
13783,%,0,0
13784,in,0,0
13785,the,0,0
13786,control,0,0
13787,arm,0,0
13788,(,0,0
13789,odds,0,0
13790,ratio,0,0
13791,",",0,1
13792,1.16,0,0
13793,;,0,0
13794,95,0,0
13795,%,0,0
13796,confidence,0,0
13797,interval,0,0
13798,",",0,0
13799,0.44-3.07,0,0
13800,),0,0
13801,.,0,0
13802,There,0,0
13803,was,0,0
13804,no,0,0
13805,difference,0,0
13806,in,0,0
13807,any,0,0
13808,other,0,0
13809,response,0,0
13810,biomarker,0,0
13811,between,0,0
13812,the,0,0
13813,two,0,0
13814,groups,0,0
13815,up,0,0
13816,to,0,0
13817,36,0,1
13818,months,0,0
13819,",",0,0
13820,nor,0,0
13821,was,0,0
13822,any,0,0
13823,biomarker,0,0
13824,able,0,0
13825,to,0,0
13826,predict,0,0
13827,recurrence,0,0
13828,risk,0,0
13829,.,0,0
13830,Recurrence-free,0,0
13831,survival,0,0
13832,was,0,0
13833,comparable,0,0
13834,between,0,0
13835,the,0,0
13836,arms,0,0
13837,(,0,1
13838,27,0,1
13839,events,0,0
13840,in,0,0
13841,the,0,0
13842,fenretinide,0,0
13843,arm,0,0
13844,versus,0,0
13845,21,0,1
13846,in,0,0
13847,the,0,0
13848,control,0,0
13849,arm,0,0
13850,;,0,0
13851,P,0,0
13852,=,0,0
13853,0.36,0,0
13854,),0,1
13855,.,0,0
13856,Twelve,0,0
13857,subjects,0,1
13858,in,0,0
13859,the,0,0
13860,fenretinide,0,0
13861,arm,0,0
13862,complained,0,0
13863,of,0,0
13864,diminished,0,0
13865,dark,0,0
13866,adaptability,0,0
13867,",",0,0
13868,and,0,0
13869,nine,0,1
13870,subjects,0,1
13871,in,0,0
13872,the,0,0
13873,fenretinide,0,0
13874,arm,0,0
13875,versus,0,0
13876,one,0,0
13877,control,0,1
13878,subject,0,0
13879,had,0,1
13880,mild,0,1
13881,dermatological,0,1
13882,alterations,0,0
13883,.,0,1
13884,We,0,0
13885,conclude,0,0
13886,that,0,0
13887,fenretinide,0,0
13888,showed,0,0
13889,a,0,0
13890,lack,0,0
13891,of,0,0
13892,effect,0,0
13893,on,0,0
13894,the,0,0
13895,DNA,0,0
13896,content,0,0
13897,distribution,0,0
13898,and,0,0
13899,the,0,0
13900,morphology,0,1
13901,of,0,0
13902,urothelial,0,1
13903,cells,0,0
13904,obtained,0,0
13905,in,0,0
13906,serial,0,0
13907,bladder,0,1
13908,washings,0,0
13909,.,0,1
13910,Recurrence-free,0,0
13911,survival,0,0
13912,was,0,0
13913,comparable,0,0
13914,between,0,0
13915,groups,0,0
13916,.,0,1
13917,Because,0,0
13918,our,0,0
13919,data,0,0
13920,are,0,0
13921,hampered,0,0
13922,by,0,0
13923,the,0,0
13924,lack,0,0
13925,of,0,0
13926,predictivity,0,0
13927,of,0,0
13928,the,0,0
13929,selected,0,1
13930,biomarkers,0,0
13931,",",0,0
13932,additional,0,0
13933,studies,0,0
13934,are,0,0
13935,necessary,0,0
13936,to,0,0
13937,assess,0,0
13938,the,0,0
13939,activity,0,0
13940,of,0,0
13941,fenretinide,0,0
13942,in,0,0
13943,preventing,0,0
13944,bladder,1,1
13945,cancer,1,1
13946,.,1,1
13947,Efficacy,0,0
13948,and,0,0
13949,safety,0,0
13950,of,0,0
13951,recombinant,0,0
13952,human,0,1
13953,nerve,0,0
13954,growth,0,0
13955,factor,0,0
13956,in,0,0
13957,patients,1,1
13958,with,1,1
13959,diabetic,1,1
13960,polyneuropathy,1,1
13961,:,1,1
13962,A,0,0
13963,randomized,0,0
13964,controlled,0,0
13965,trial,0,0
13966,.,0,0
13967,rhNGF,0,0
13968,Clinical,0,0
13969,Investigator,0,0
13970,Group,0,1
13971,.,0,1
13972,CONTEXT,0,0
13973,Nerve,0,0
13974,growth,0,0
13975,factor,0,0
13976,is,0,0
13977,a,0,0
13978,neurotrophic,0,0
13979,factor,0,0
13980,that,0,0
13981,promotes,0,0
13982,the,0,0
13983,survival,0,0
13984,of,0,0
13985,small,0,1
13986,fiber,0,1
13987,sensory,0,1
13988,neurons,0,1
13989,and,0,1
13990,sympathetic,0,0
13991,neurons,0,0
13992,in,0,0
13993,the,0,0
13994,peripheral,0,0
13995,nervous,0,0
13996,system,0,0
13997,.,0,1
13998,Recombinant,0,0
13999,human,0,0
14000,nerve,0,0
14001,growth,0,0
14002,factor,0,0
14003,(,0,0
14004,rhNGF,0,0
14005,),0,0
14006,has,0,0
14007,demonstrated,0,0
14008,efficacy,0,0
14009,as,0,0
14010,treatment,0,0
14011,for,0,0
14012,peripheral,0,0
14013,neuropathy,0,1
14014,in,0,0
14015,experimental,0,0
14016,models,0,0
14017,and,0,0
14018,phase,0,1
14019,2,0,0
14020,clinical,0,0
14021,trials,0,1
14022,.,0,1
14023,OBJECTIVE,0,0
14024,To,0,0
14025,evaluate,0,0
14026,the,0,0
14027,efficacy,0,0
14028,and,0,0
14029,safety,0,0
14030,of,0,0
14031,a,0,0
14032,12-month,0,0
14033,regimen,0,0
14034,of,0,0
14035,rhNGF,0,0
14036,in,0,0
14037,patients,1,1
14038,with,1,1
14039,diabetic,1,1
14040,polyneuropathy,1,1
14041,.,1,1
14042,DESIGN,0,0
14043,Randomized,0,0
14044,",",0,0
14045,double-blind,0,0
14046,",",0,0
14047,placebo-controlled,0,0
14048,phase,0,1
14049,3,0,0
14050,trial,0,0
14051,conducted,0,0
14052,from,0,1
14053,July,0,0
14054,1997,0,1
14055,through,0,0
14056,May,0,1
14057,1999,0,1
14058,.,0,0
14059,SETTING,0,1
14060,Eighty-four,1,1
14061,outpatient,1,1
14062,centers,1,1
14063,throughout,1,0
14064,the,1,1
14065,United,1,1
14066,States,1,0
14067,.,1,1
14068,PATIENTS,0,0
14069,A,1,0
14070,total,1,1
14071,of,1,0
14072,1019,1,1
14073,men,1,1
14074,and,1,1
14075,women,1,1
14076,aged,1,1
14077,18,1,1
14078,to,1,1
14079,74,1,1
14080,years,1,1
14081,with,1,1
14082,either,1,1
14083,type,1,1
14084,1,1,0
14085,or,1,1
14086,type,1,1
14087,2,1,0
14088,diabetes,1,1
14089,and,1,0
14090,a,1,0
14091,sensory,1,0
14092,polyneuropathy,1,1
14093,attributable,1,0
14094,to,1,1
14095,diabetes,1,1
14096,.,1,1
14097,INTERVENTIONS,0,0
14098,Patients,0,1
14099,were,0,1
14100,randomly,0,1
14101,assigned,0,0
14102,to,0,0
14103,receive,0,0
14104,either,0,0
14105,rhNGF,0,0
14106,",",0,0
14107,0.1,0,0
14108,microg/kg,0,0
14109,(,0,0
14110,n,0,1
14111,=,0,0
14112,504,0,1
14113,),0,0
14114,",",0,0
14115,or,0,0
14116,placebo,0,0
14117,(,0,0
14118,n,0,1
14119,=,0,0
14120,515,0,1
14121,),0,0
14122,by,0,0
14123,subcutaneous,0,0
14124,injection,0,0
14125,3,0,0
14126,times,0,0
14127,per,0,0
14128,week,0,0
14129,for,0,0
14130,48,0,1
14131,weeks,0,0
14132,.,0,1
14133,Patients,0,1
14134,were,0,0
14135,assessed,0,0
14136,at,0,0
14137,baseline,0,0
14138,",",0,0
14139,12,0,0
14140,weeks,0,0
14141,",",0,1
14142,24,0,1
14143,weeks,0,0
14144,",",0,0
14145,and,0,0
14146,48,0,1
14147,weeks,0,0
14148,.,0,1
14149,MAIN,0,0
14150,OUTCOME,0,0
14151,MEASURES,0,0
14152,The,0,0
14153,primary,0,0
14154,outcome,0,0
14155,measure,0,0
14156,was,0,0
14157,a,0,0
14158,change,0,0
14159,in,0,0
14160,neuropathy,0,1
14161,between,0,0
14162,baseline,0,0
14163,and,0,0
14164,week,0,0
14165,48,0,0
14166,",",0,0
14167,demonstrated,0,0
14168,by,0,0
14169,the,0,0
14170,Neuropathy,0,1
14171,Impairment,0,0
14172,Score,0,1
14173,for,0,0
14174,the,0,0
14175,Lower,0,0
14176,Limbs,0,0
14177,",",0,0
14178,compared,0,0
14179,between,0,0
14180,the,0,0
14181,2,0,0
14182,groups,0,0
14183,.,0,1
14184,Secondary,0,0
14185,outcome,0,0
14186,measures,0,0
14187,included,0,1
14188,quantitative,0,0
14189,sensory,0,1
14190,tests,0,0
14191,using,0,0
14192,the,0,0
14193,CASE,0,0
14194,IV,0,0
14195,System,0,1
14196,",",0,0
14197,the,0,0
14198,Neuropathy,0,1
14199,Symptom,0,0
14200,and,0,0
14201,Change,0,0
14202,questionnaire,0,0
14203,",",0,0
14204,the,0,0
14205,Patient,0,0
14206,Benefit,0,0
14207,Questionnaire,0,0
14208,(,0,0
14209,PBQ,0,0
14210,),0,0
14211,",",0,0
14212,and,0,0
14213,a,0,0
14214,global,0,0
14215,symptom,0,0
14216,assessment,0,0
14217,",",0,0
14218,as,0,0
14219,well,0,0
14220,as,0,0
14221,nerve,0,0
14222,conduction,0,1
14223,studies,0,0
14224,and,0,0
14225,occurrence,0,0
14226,of,0,0
14227,new,0,0
14228,plantar,0,1
14229,foot,0,1
14230,ulcers,0,1
14231,.,0,1
14232,Patients,0,1
14233,also,0,0
14234,were,0,0
14235,evaluated,0,0
14236,for,0,0
14237,presence,0,0
14238,of,0,0
14239,adverse,0,0
14240,events,0,0
14241,.,0,1
14242,RESULTS,0,0
14243,Among,0,1
14244,patients,0,1
14245,who,0,1
14246,received,0,1
14247,rhNGF,0,1
14248,",",0,0
14249,418,0,1
14250,(,0,0
14251,83,0,1
14252,%,0,0
14253,),0,0
14254,completed,0,1
14255,the,0,0
14256,regimen,0,0
14257,compared,0,0
14258,with,0,1
14259,461,0,1
14260,(,0,1
14261,90,0,0
14262,%,0,1
14263,),0,1
14264,who,0,1
14265,received,0,1
14266,placebo,0,1
14267,.,0,0
14268,Administration,0,0
14269,of,0,0
14270,rhNGF,0,0
14271,was,0,0
14272,safe,0,0
14273,",",0,0
14274,with,0,1
14275,few,0,0
14276,adverse,0,0
14277,events,0,0
14278,attributed,0,0
14279,to,0,0
14280,treatment,0,0
14281,apart,0,0
14282,from,0,0
14283,injection,0,0
14284,site,0,0
14285,pain/hyperalgesia,0,0
14286,and,0,0
14287,other,0,0
14288,pain,0,1
14289,syndromes,0,0
14290,.,0,0
14291,However,0,0
14292,",",0,0
14293,neither,0,0
14294,the,0,0
14295,primary,0,0
14296,end,0,0
14297,point,0,0
14298,(,0,0
14299,P,0,0
14300,=.25,0,0
14301,),0,0
14302,nor,0,0
14303,most,0,0
14304,of,0,0
14305,the,0,0
14306,secondary,0,0
14307,end,0,0
14308,points,0,0
14309,demonstrated,0,0
14310,a,0,0
14311,significant,0,0
14312,benefit,0,0
14313,of,0,0
14314,rhNGF,0,0
14315,.,0,1
14316,Exceptions,0,0
14317,were,0,0
14318,the,0,0
14319,global,0,0
14320,symptom,0,0
14321,assessment,0,0
14322,(,0,0
14323,P,0,0
14324,=.03,0,0
14325,),0,0
14326,and,0,0
14327,2,0,0
14328,of,0,0
14329,32,0,1
14330,comparisons,0,0
14331,within,0,1
14332,the,0,0
14333,PBQ,0,0
14334,",",0,0
14335,which,0,0
14336,showed,0,0
14337,a,0,0
14338,modest,0,0
14339,but,0,0
14340,significant,0,0
14341,benefit,0,0
14342,of,0,0
14343,rhNGF,0,0
14344,(,0,0
14345,P,0,0
14346,=.05,0,0
14347,for,0,0
14348,severity,0,0
14349,of,0,0
14350,pain,0,0
14351,in,0,0
14352,the,0,0
14353,legs,0,0
14354,and,0,0
14355,P,0,0
14356,=.003,0,0
14357,for,0,0
14358,6-month,0,0
14359,symptoms,0,0
14360,in,0,0
14361,the,0,0
14362,feet,0,0
14363,and,0,0
14364,legs,0,0
14365,),0,1
14366,.,0,1
14367,CONCLUSION,0,0
14368,Unlike,0,0
14369,previous,0,0
14370,phase,0,1
14371,2,0,0
14372,trials,0,0
14373,",",0,0
14374,this,0,0
14375,phase,0,0
14376,3,0,0
14377,clinical,0,0
14378,trial,0,0
14379,failed,0,0
14380,to,0,0
14381,demonstrate,0,0
14382,a,0,0
14383,significant,0,0
14384,beneficial,0,0
14385,effect,0,0
14386,of,0,0
14387,rhNGF,0,0
14388,on,0,0
14389,diabetic,0,1
14390,polyneuropathy,0,1
14391,.,0,1
14392,JAMA,0,0
14393,.,0,1
14394,2000,0,1
14395,;,0,0
14396,284:2215-2221,0,1
14397,.,0,1
14398,Oral,0,0
14399,ciprofloxacin,0,0
14400,vs.,0,0
14401,intramuscular,0,0
14402,ceftriaxone,0,0
14403,as,0,0
14404,empiric,0,0
14405,treatment,0,0
14406,of,0,0
14407,acute,1,1
14408,invasive,1,1
14409,diarrhea,1,1
14410,in,1,0
14411,children,1,1
14412,.,1,1
14413,BACKGROUND,0,0
14414,Acute,0,0
14415,invasive,0,1
14416,diarrhea,0,1
14417,is,0,0
14418,a,0,0
14419,potentially,0,0
14420,serious,0,0
14421,condition,0,0
14422,in,0,0
14423,children,1,1
14424,.,1,1
14425,Because,0,0
14426,of,0,0
14427,the,0,0
14428,increasing,0,0
14429,resistance,0,0
14430,of,0,0
14431,enteric,0,0
14432,pathogens,0,0
14433,to,0,0
14434,commonly,0,1
14435,used,0,0
14436,oral,0,0
14437,antibiotics,0,0
14438,",",0,0
14439,intramuscular,0,0
14440,ceftriaxone,0,0
14441,has,0,0
14442,become,0,0
14443,the,0,0
14444,routine,0,0
14445,drug,0,0
14446,in,0,0
14447,the,0,0
14448,treatment,0,0
14449,of,0,0
14450,acute,0,1
14451,invasive,0,1
14452,diarrhea,0,1
14453,requiring,0,0
14454,an,0,0
14455,emergency,0,1
14456,visit,0,0
14457,in,0,0
14458,southern,0,1
14459,Israel,0,1
14460,.,0,0
14461,The,0,0
14462,inconvenience,0,0
14463,of,0,0
14464,this,0,0
14465,parenteral,0,0
14466,regimen,0,0
14467,created,0,0
14468,an,0,0
14469,increased,0,0
14470,need,0,0
14471,for,0,0
14472,oral,0,0
14473,pediatric,0,1
14474,formulations,0,0
14475,for,0,0
14476,the,0,0
14477,treatment,0,0
14478,of,0,0
14479,invasive,0,1
14480,diarrhea,0,1
14481,.,0,1
14482,OBJECTIVES,0,0
14483,To,0,0
14484,evaluate,0,0
14485,the,0,0
14486,efficacy,0,0
14487,and,0,0
14488,safety,0,0
14489,of,0,0
14490,a,0,0
14491,suspension,0,0
14492,formulation,0,0
14493,of,0,0
14494,ciprofloxacin,0,0
14495,in,0,0
14496,the,0,0
14497,treatment,0,0
14498,of,0,0
14499,acute,1,1
14500,invasive,1,1
14501,diarrhea,1,1
14502,in,1,0
14503,infants,1,1
14504,and,1,1
14505,children,1,1
14506,.,1,1
14507,PATIENTS,0,0
14508,AND,0,0
14509,METHODS,0,0
14510,From,1,1
14511,July,1,1
14512,1996,1,1
14513,through,1,0
14514,December,1,1
14515,1997,1,1
14516,",",1,0
14517,201,1,1
14518,evaluable,1,1
14519,children,1,1
14520,ages,1,1
14521,6,1,0
14522,months,1,0
14523,to,1,1
14524,10,1,1
14525,years,1,1
14526,(,1,1
14527,35,1,1
14528,%,1,0
14529,<,1,0
14530,1,1,0
14531,year,1,1
14532,;,1,1
14533,70,1,1
14534,%,1,0
14535,<,1,0
14536,3,1,0
14537,years,1,1
14538,),1,1
14539,presenting,1,1
14540,with,1,1
14541,acute,1,1
14542,invasive,1,1
14543,diarrhea,1,1
14544,at,1,0
14545,the,1,0
14546,Pediatric,1,1
14547,Emergency,1,1
14548,Room,1,1
14549,were,0,0
14550,randomized,0,0
14551,to,0,0
14552,receive,0,0
14553,either,0,0
14554,ciprofloxacin,0,0
14555,suspension,0,0
14556,(,0,0
14557,10,0,0
14558,mg/kg,0,0
14559,twice,0,0
14560,a,0,0
14561,day,0,0
14562,+,0,0
14563,im,0,1
14564,placebo,0,0
14565,;,0,0
14566,n,0,1
14567,=,0,0
14568,95,0,0
14569,),0,0
14570,or,0,0
14571,im,0,0
14572,ceftriaxone,0,0
14573,(,0,0
14574,50,0,1
14575,mg/kg/day,0,0
14576,+,0,0
14577,placebo,0,0
14578,suspension,0,0
14579,;,0,0
14580,n,0,1
14581,=,0,0
14582,106,0,1
14583,),0,0
14584,for,0,0
14585,3,0,0
14586,days,0,0
14587,in,0,0
14588,a,0,0
14589,double,0,0
14590,blind,0,0
14591,manner,0,0
14592,.,0,1
14593,Stool,0,0
14594,cultures,0,0
14595,for,0,0
14596,Shigella,0,0
14597,",",0,0
14598,Salmonella,0,1
14599,",",0,0
14600,Campylobacter,0,0
14601,spp,0,0
14602,.,0,0
14603,and,0,0
14604,diarrheagenic,0,1
14605,Escherichia,0,0
14606,coli,0,0
14607,were,0,0
14608,obtained,0,0
14609,on,0,0
14610,Days,0,1
14611,1,0,0
14612,",",0,0
14613,3,0,0
14614,",",0,0
14615,4,0,0
14616,to,0,0
14617,5,0,0
14618,and,0,0
14619,21,0,1
14620,+/-,0,0
14621,5,0,1
14622,.,0,1
14623,Clinical,0,0
14624,response,0,0
14625,and,0,0
14626,safety,0,0
14627,were,0,0
14628,assessed,0,0
14629,on,0,0
14630,Days,0,1
14631,1,0,0
14632,",",0,0
14633,2,0,0
14634,",",0,0
14635,3,0,0
14636,",",0,0
14637,4,0,0
14638,to,0,0
14639,5,0,0
14640,and,0,0
14641,21,0,1
14642,+/-,0,0
14643,5,0,1
14644,.,0,1
14645,RESULTS,0,0
14646,We,0,0
14647,isolated,0,1
14648,127,1,1
14649,pathogens,1,1
14650,from,1,1
14651,121,1,1
14652,(,1,1
14653,60,1,1
14654,%,1,0
14655,),1,1
14656,patients,1,1
14657,:,1,1
14658,73,0,1
14659,(,0,0
14660,57,0,1
14661,%,0,0
14662,),0,1
14663,Shigella,0,0
14664,;,0,1
14665,23,0,1
14666,(,0,0
14667,18,0,1
14668,%,0,0
14669,),0,1
14670,Salmonella,0,1
14671,;,0,1
14672,18,0,1
14673,(,0,0
14674,14,0,0
14675,%,0,0
14676,),0,1
14677,E.,0,1
14678,coli,0,0
14679,;,0,1
14680,and,0,0
14681,13,0,1
14682,(,0,0
14683,10,0,1
14684,%,0,0
14685,),0,1
14686,Campylobacter,0,0
14687,.,0,1
14688,Overall,0,0
14689,bacteriologic,0,0
14690,eradication,0,0
14691,on,0,0
14692,Day,0,1
14693,4,0,0
14694,to,0,0
14695,5,0,0
14696,was,0,0
14697,99,0,1
14698,%,0,0
14699,for,0,0
14700,Shigella,0,0
14701,",",0,0
14702,77,0,0
14703,%,0,0
14704,for,0,0
14705,Salmonella,0,1
14706,and,0,0
14707,77,0,1
14708,%,0,0
14709,for,0,0
14710,Campylobacter,0,0
14711,",",0,0
14712,with,0,0
14713,no,0,0
14714,difference,0,0
14715,between,0,0
14716,the,0,0
14717,2,0,0
14718,groups,0,0
14719,.,0,1
14720,Clinical,0,0
14721,cure,0,0
14722,or,0,1
14723,improvement,0,0
14724,was,0,0
14725,observed,0,0
14726,in,0,0
14727,100,0,0
14728,and,0,0
14729,99,0,1
14730,%,0,0
14731,of,0,0
14732,the,0,0
14733,ciprofloxacin,0,0
14734,and,0,0
14735,ceftriaxone,0,0
14736,groups,0,0
14737,",",0,0
14738,respectively,0,0
14739,.,0,0
14740,Serum,0,0
14741,ciprofloxacin,0,0
14742,values,0,0
14743,determined,0,0
14744,on,0,0
14745,Day,0,1
14746,3,0,0
14747,of,0,0
14748,the,0,0
14749,treatment,0,0
14750,were,0,0
14751,higher,0,0
14752,in,0,0
14753,the,0,0
14754,majority,0,0
14755,of,0,0
14756,patients,0,1
14757,than,0,0
14758,were,0,1
14759,the,0,0
14760,MIC50,0,0
14761,and,0,0
14762,MIC90,0,0
14763,values,0,0
14764,for,0,0
14765,the,0,0
14766,Shigella,0,0
14767,and,0,0
14768,Salmonella,0,1
14769,spp,0,0
14770,.,0,0
14771,isolated,0,0
14772,.,0,0
14773,Possible,0,0
14774,drug-related,0,0
14775,adverse,0,0
14776,events,0,0
14777,occurred,0,0
14778,in,0,1
14779,13,0,1
14780,patients,0,1
14781,[,0,0
14782,ciprofloxacin,0,0
14783,",",0,0
14784,8,0,0
14785,(,0,0
14786,8,0,0
14787,%,0,0
14788,),0,1
14789,;,0,0
14790,ceftriaxone,0,0
14791,",",0,0
14792,5,0,0
14793,(,0,0
14794,4.7,0,0
14795,%,0,0
14796,),0,0
14797,],0,0
14798,and,0,0
14799,were,0,0
14800,mild,0,1
14801,and,0,1
14802,transient,0,0
14803,.,0,0
14804,Joint,0,0
14805,examination,0,0
14806,was,0,0
14807,normal,0,1
14808,during,0,0
14809,and,0,0
14810,after,0,0
14811,completion,0,0
14812,of,0,0
14813,therapy,0,0
14814,in,0,0
14815,all,0,1
14816,patients,0,1
14817,.,0,1
14818,CONCLUSION,0,0
14819,Oral,0,0
14820,ciprofloxacin,0,0
14821,was,0,0
14822,as,0,0
14823,safe,0,0
14824,and,0,0
14825,effective,0,0
14826,as,0,0
14827,intramuscular,0,0
14828,ceftriaxone,0,0
14829,for,0,0
14830,the,0,0
14831,empiric,0,0
14832,treatment,0,0
14833,of,0,0
14834,acute,0,1
14835,invasive,0,1
14836,diarrhea,0,1
14837,in,0,0
14838,ambulatory,1,1
14839,pediatric,1,1
14840,patients,1,1
14841,requiring,1,1
14842,an,1,0
14843,emergency,1,1
14844,room,1,0
14845,visit,1,0
14846,.,1,1
14847,Measurement,0,0
14848,of,0,0
14849,peptidase,0,0
14850,activity,0,0
14851,and,0,0
14852,evaluation,0,0
14853,of,0,0
14854,effectiveness,0,0
14855,of,0,0
14856,administration,0,0
14857,of,0,0
14858,minocycline,0,0
14859,for,0,0
14860,treatment,0,0
14861,of,0,0
14862,dogs,1,1
14863,with,1,1
14864,periodontitis,1,1
14865,.,1,0
14866,OBJECTIVE,0,0
14867,To,0,0
14868,determine,0,0
14869,clinical,0,0
14870,",",0,0
14871,enzymatic,0,0
14872,",",0,0
14873,and,0,0
14874,microbiologic,0,0
14875,effects,0,0
14876,of,0,0
14877,controlled-release,0,0
14878,localized,0,1
14879,administration,0,0
14880,of,0,0
14881,minocycline,0,0
14882,on,0,0
14883,dogs,1,1
14884,with,1,1
14885,periodontitis,1,1
14886,.,1,1
14887,ANIMALS,0,0
14888,Five,1,0
14889,adult,1,1
14890,Beagles,1,1
14891,with,1,1
14892,periodontitis,1,1
14893,.,1,1
14894,PROCEDURE,0,0
14895,After,0,0
14896,tooth,0,0
14897,scaling,0,0
14898,and,0,0
14899,root,0,0
14900,planing,0,0
14901,",",0,0
14902,2,0,0
14903,treatment,0,0
14904,",",0,0
14905,1,0,0
14906,placebo,0,0
14907,",",0,0
14908,and,0,0
14909,1,0,0
14910,control,0,0
14911,site,0,0
14912,were,0,0
14913,selected,0,1
14914,for,0,0
14915,each,0,0
14916,dog,0,1
14917,.,0,0
14918,Treatment,0,0
14919,sites,0,0
14920,(,0,1
14921,n,0,1
14922,=,0,0
14923,10,0,1
14924,),0,0
14925,received,0,0
14926,a,0,0
14927,periodontal,0,0
14928,formulation,0,0
14929,of,0,0
14930,minocycline,0,0
14931,hydrochloride,0,0
14932,",",0,0
14933,placebo,0,0
14934,sites,0,0
14935,(,0,1
14936,5,0,1
14937,),0,0
14938,received,0,0
14939,ointment,0,0
14940,without,0,1
14941,minocycline,0,0
14942,",",0,0
14943,and,0,0
14944,control,0,0
14945,sites,0,0
14946,(,0,0
14947,5,0,1
14948,),0,0
14949,did,0,0
14950,not,0,0
14951,receive,0,0
14952,ointment,0,0
14953,.,0,0
14954,Treatments,0,0
14955,were,0,0
14956,administered,0,0
14957,4,0,0
14958,times,0,0
14959,at,0,1
14960,weekly,0,0
14961,intervals,0,0
14962,.,0,1
14963,Peptidase,0,0
14964,activity,0,0
14965,and,0,0
14966,clinical,0,0
14967,and,0,0
14968,microbiologic,0,1
14969,effects,0,0
14970,were,0,1
14971,evaluated,0,0
14972,and,0,0
14973,compared,0,0
14974,among,0,0
14975,sites,0,0
14976,for,0,1
14977,17,0,1
14978,weeks,0,0
14979,.,0,1
14980,RESULTS,0,0
14981,Bleeding,0,0
14982,of,0,0
14983,the,0,0
14984,gums,0,0
14985,on,0,0
14986,probing,0,0
14987,(,0,0
14988,BOP,0,1
14989,),0,0
14990,and,0,0
14991,pocket,0,0
14992,depth,0,0
14993,(,0,0
14994,PD,0,1
14995,),0,0
14996,improved,0,0
14997,at,0,0
14998,the,0,0
14999,treatment,0,0
15000,site,0,0
15001,and,0,0
15002,were,0,0
15003,maintained,0,0
15004,for,0,0
15005,13,0,1
15006,weeks,0,0
15007,after,0,0
15008,treatment,0,0
15009,.,0,0
15010,However,0,0
15011,",",0,0
15012,BOP,0,0
15013,and,0,0
15014,PD,0,1
15015,in,0,0
15016,placebo,0,0
15017,and,0,0
15018,control,0,1
15019,sites,0,0
15020,increased,0,0
15021,from,0,1
15022,weeks,0,0
15023,9,0,1
15024,to,0,1
15025,17,0,1
15026,Peptidase,0,0
15027,activity,0,0
15028,in,0,0
15029,the,0,0
15030,periodontal,0,0
15031,pocket,0,0
15032,decreased,0,0
15033,noticeably,0,0
15034,from,0,0
15035,week,0,0
15036,1,0,0
15037,to,0,0
15038,17,0,1
15039,",",0,0
15040,compared,0,0
15041,with,0,1
15042,baseline,0,0
15043,values,0,0
15044,for,0,0
15045,the,0,0
15046,treatment,0,0
15047,site,0,0
15048,.,0,0
15049,However,0,0
15050,",",0,0
15051,peptidase,0,0
15052,activity,0,0
15053,for,0,0
15054,placebo,0,0
15055,and,0,0
15056,control,0,1
15057,sites,0,0
15058,increased,0,0
15059,and,0,0
15060,were,0,0
15061,above,0,0
15062,baseline,0,0
15063,values,0,0
15064,on,0,0
15065,week,0,0
15066,9,0,0
15067,and,0,0
15068,week,0,0
15069,13,0,0
15070,",",0,0
15071,respectively,0,0
15072,.,0,0
15073,Total,0,0
15074,bacterial,0,0
15075,counts,0,0
15076,decreased,0,0
15077,by,0,0
15078,90,0,0
15079,%,0,0
15080,for,0,0
15081,treatment,0,0
15082,sites,0,0
15083,and,0,0
15084,remained,0,0
15085,at,0,0
15086,that,0,0
15087,value,0,0
15088,for,0,0
15089,13,0,1
15090,weeks,0,0
15091,.,0,1
15092,However,0,0
15093,",",0,0
15094,for,0,0
15095,placebo,0,0
15096,and,0,0
15097,control,0,0
15098,sites,0,0
15099,",",0,0
15100,bacterial,0,0
15101,counts,0,0
15102,increased,0,0
15103,and,0,0
15104,reached,0,0
15105,the,0,0
15106,baseline,0,0
15107,value,0,0
15108,on,0,0
15109,week,0,0
15110,17,0,1
15111,.,0,1
15112,CONCLUSIONS,0,0
15113,AND,0,0
15114,CLINICAL,0,1
15115,RELEVANCE,0,0
15116,Increased,0,0
15117,peptidase,0,0
15118,activity,0,0
15119,is,0,0
15120,correlated,0,0
15121,with,0,0
15122,the,0,0
15123,progression,0,0
15124,of,0,0
15125,periodontitis,1,1
15126,in,1,0
15127,dogs,1,1
15128,.,1,1
15129,Treatment,0,0
15130,with,0,0
15131,minocycline,0,0
15132,",",0,0
15133,using,0,0
15134,a,0,0
15135,localized,0,0
15136,delivery,0,0
15137,system,0,0
15138,",",0,0
15139,was,0,0
15140,effective,0,0
15141,in,0,0
15142,dogs,0,1
15143,for,0,0
15144,at,0,1
15145,least,0,1
15146,13,0,1
15147,weeks,0,0
15148,after,0,0
15149,cessation,0,1
15150,of,0,0
15151,drug,0,0
15152,administration,0,0
15153,.,0,1
15154,Effect,0,0
15155,of,0,0
15156,secretin,0,0
15157,on,0,0
15158,children,1,1
15159,with,1,1
15160,autism,1,1
15161,:,1,1
15162,a,0,0
15163,randomized,0,0
15164,controlled,0,0
15165,trial,0,0
15166,.,0,0
15167,To,0,0
15168,determine,0,0
15169,the,0,0
15170,effect,0,0
15171,of,0,0
15172,intravenous,0,0
15173,porcine,0,0
15174,secretin,0,0
15175,on,0,0
15176,autistic,0,1
15177,behaviours,0,0
15178,in,0,1
15179,children,1,1
15180,aged,1,1
15181,2,1,1
15182,to,1,1
15183,7,1,1
15184,years,1,1
15185,",",0,0
15186,the,0,0
15187,effects,0,0
15188,of,0,0
15189,secretin,0,0
15190,on,0,0
15191,(,0,0
15192,1,0,0
15193,),0,0
15194,performance,0,0
15195,on,0,0
15196,a,0,0
15197,standardized,0,0
15198,language,0,0
15199,measure,0,0
15200,",",0,0
15201,and,0,0
15202,(,0,0
15203,2,0,0
15204,),0,0
15205,autistic,0,1
15206,behaviours,0,0
15207,",",0,0
15208,as,0,0
15209,rated,0,0
15210,by,0,0
15211,parents,0,1
15212,and,0,0
15213,child,0,1
15214,development,0,0
15215,professionals,0,0
15216,was,0,0
15217,examined,0,0
15218,.,0,0
15219,Employing,0,0
15220,a,0,0
15221,randomized,0,0
15222,",",0,0
15223,double-blind,0,0
15224,",",0,0
15225,placebo-controlled,0,0
15226,design,0,0
15227,",",0,0
15228,95,1,0
15229,participants,1,1
15230,were,0,1
15231,assigned,0,1
15232,to,0,0
15233,one,0,1
15234,of,0,0
15235,two,0,0
15236,groups,0,0
15237,and,0,0
15238,administered,0,0
15239,a,0,0
15240,single,0,0
15241,dose,0,0
15242,of,0,0
15243,either,0,0
15244,secretin,0,0
15245,or,0,0
15246,placebo,0,0
15247,.,0,0
15248,A,0,0
15249,follow-up,0,0
15250,assessment,0,0
15251,was,0,0
15252,conducted,0,1
15253,3,0,0
15254,weeks,0,0
15255,after,0,0
15256,the,0,0
15257,injection,0,0
15258,.,0,0
15259,No,0,0
15260,significant,0,0
15261,differences,0,0
15262,in,0,0
15263,language,0,0
15264,or,0,1
15265,autistic,0,1
15266,behaviour,0,0
15267,measures,0,0
15268,were,0,0
15269,observed,0,0
15270,at,0,0
15271,the,0,0
15272,3-week,0,0
15273,follow-up,0,0
15274,between,0,0
15275,the,0,0
15276,groups,0,0
15277,.,0,0
15278,Also,0,0
15279,",",0,0
15280,there,0,0
15281,was,0,0
15282,no,0,0
15283,significant,0,0
15284,difference,0,0
15285,in,0,0
15286,the,0,0
15287,proportion,0,0
15288,of,0,1
15289,individuals,0,1
15290,who,0,1
15291,improved,0,0
15292,by,0,1
15293,>,0,1
15294,or,0,1
15295,=,0,0
15296,6,0,0
15297,points,0,0
15298,on,0,0
15299,the,0,0
15300,language,0,0
15301,measure,0,0
15302,at,0,0
15303,follow-up,0,0
15304,.,0,0
15305,This,0,0
15306,study,0,0
15307,showed,0,0
15308,no,0,0
15309,significant,0,0
15310,effects,0,0
15311,of,0,0
15312,secretin,0,0
15313,on,0,0
15314,children,1,1
15315,with,1,1
15316,autism,1,1
15317,.,1,1
15318,Our,0,0
15319,results,0,0
15320,are,0,0
15321,consistent,0,0
15322,with,0,1
15323,a,0,0
15324,systematic,0,0
15325,review,0,0
15326,of,0,0
15327,randomized,0,1
15328,controlled,0,0
15329,trials,0,0
15330,evaluating,0,0
15331,the,0,0
15332,effect,0,0
15333,of,0,0
15334,secretin,0,0
15335,in,0,0
15336,children,1,1
15337,with,1,1
15338,autism,1,1
15339,.,1,1
15340,A,1,0
15341,randomized,1,0
15342,trial,1,0
15343,in,1,0
15344,simultaneous,1,0
15345,pancreas-kidney,1,1
15346,transplantation,1,1
15347,:,1,1
15348,portal,0,0
15349,versus,0,0
15350,systemic,0,0
15351,venous,0,0
15352,drainage,0,1
15353,of,0,0
15354,the,0,0
15355,pancreas,0,1
15356,allograft,0,1
15357,.,0,1
15358,Cardiovascular,0,1
15359,effects,0,0
15360,of,0,0
15361,tamoxifen,0,1
15362,in,0,0
15363,women,1,1
15364,with,1,1
15365,and,1,0
15366,without,1,1
15367,heart,1,1
15368,disease,1,1
15369,:,1,1
15370,breast,0,1
15371,cancer,0,1
15372,prevention,0,0
15373,trial,0,0
15374,.,0,1
15375,National,0,0
15376,Surgical,0,1
15377,Adjuvant,0,0
15378,Breast,0,1
15379,and,0,0
15380,Bowel,0,0
15381,Project,0,1
15382,Breast,0,1
15383,Cancer,0,1
15384,Prevention,0,1
15385,Trial,0,1
15386,Investigators,0,1
15387,.,0,1
15388,BACKGROUND,0,0
15389,The,0,0
15390,overall,0,0
15391,effect,0,0
15392,of,0,0
15393,prophylactic,0,0
15394,tamoxifen,0,1
15395,in,0,0
15396,women,0,1
15397,depends,0,0
15398,on,0,0
15399,the,0,0
15400,balance,0,0
15401,between,0,0
15402,the,0,0
15403,effects,0,0
15404,of,0,0
15405,the,0,0
15406,drug,0,0
15407,",",0,0
15408,which,0,0
15409,include,0,0
15410,preventing,0,0
15411,breast,0,1
15412,cancer,0,1
15413,and,0,0
15414,altering,0,0
15415,cardiovascular,0,1
15416,risk,0,0
15417,.,0,0
15418,In,0,0
15419,a,0,0
15420,recent,0,0
15421,clinical,0,0
15422,trial,0,0
15423,",",0,0
15424,postmenopausal,0,1
15425,estrogen-progestin,0,0
15426,therapy,0,0
15427,was,0,0
15428,shown,0,0
15429,to,0,0
15430,increase,0,0
15431,the,0,0
15432,risk,0,0
15433,of,0,0
15434,early,0,1
15435,cardiovascular,0,1
15436,events,0,0
15437,among,0,1
15438,women,1,1
15439,with,1,1
15440,a,1,0
15441,history,1,1
15442,of,1,0
15443,coronary,1,1
15444,heart,1,1
15445,disease,1,1
15446,(,1,0
15447,CHD,1,1
15448,),1,0
15449,.,1,0
15450,The,0,0
15451,cardiovascular,0,0
15452,effects,0,0
15453,of,0,0
15454,tamoxifen,0,1
15455,in,0,0
15456,women,1,1
15457,with,1,1
15458,and,1,0
15459,without,1,1
15460,CHD,1,0
15461,are,0,0
15462,not,0,0
15463,known,0,0
15464,.,0,0
15465,The,0,0
15466,National,0,0
15467,Surgical,0,1
15468,Adjuvant,0,0
15469,Breast,0,1
15470,and,0,0
15471,Bowel,0,0
15472,Project,0,1
15473,Breast,0,1
15474,Cancer,0,1
15475,Prevention,0,1
15476,Trial,0,1
15477,(,0,0
15478,BCPT,0,1
15479,),0,0
15480,is,0,0
15481,the,0,0
15482,only,0,0
15483,clinical,0,0
15484,trial,0,0
15485,that,0,0
15486,provides,0,0
15487,data,0,0
15488,to,0,0
15489,assess,0,0
15490,the,0,0
15491,cardiovascular,0,0
15492,effects,0,0
15493,of,0,0
15494,tamoxifen,0,1
15495,in,0,0
15496,women,0,1
15497,with,0,1
15498,and,0,0
15499,without,0,1
15500,CHD,0,1
15501,.,0,1
15502,METHODS,0,0
15503,A,0,0
15504,total,0,1
15505,of,0,0
15506,13,1,1
15507,388,1,1
15508,women,1,1
15509,at,1,0
15510,increased,1,0
15511,risk,1,0
15512,for,1,0
15513,breast,1,1
15514,cancer,1,1
15515,were,0,0
15516,randomly,0,1
15517,assigned,0,0
15518,in,0,0
15519,the,0,0
15520,BCPT,0,1
15521,to,0,0
15522,receive,0,0
15523,either,0,0
15524,tamoxifen,0,0
15525,(,0,0
15526,20,0,0
15527,mg/day,0,0
15528,),0,0
15529,or,0,1
15530,placebo,0,0
15531,.,0,0
15532,Cardiovascular,1,0
15533,follow-up,1,0
15534,was,1,0
15535,available,1,0
15536,for,1,0
15537,13,1,1
15538,194,1,1
15539,women,1,1
15540,",",1,0
15541,1048,1,1
15542,of,1,1
15543,whom,1,1
15544,had,1,1
15545,prior,1,1
15546,clinical,1,0
15547,CHD,1,1
15548,.,1,1
15549,Fatal,0,0
15550,and,0,0
15551,nonfatal,0,0
15552,myocardial,0,1
15553,infarction,0,1
15554,",",0,0
15555,unstable,0,1
15556,angina,0,1
15557,",",0,0
15558,and,0,0
15559,severe,0,1
15560,angina,0,1
15561,were,0,0
15562,tabulated,0,0
15563,(,0,0
15564,mean,0,1
15565,follow-up,0,0
15566,:,0,1
15567,49,0,1
15568,months,0,0
15569,),0,1
15570,.,0,1
15571,All,0,0
15572,statistical,0,0
15573,tests,0,0
15574,were,0,1
15575,two-sided,0,0
15576,.,0,1
15577,RESULTS,0,0
15578,Cardiovascular,0,0
15579,event,0,0
15580,rates,0,0
15581,were,0,0
15582,not,0,0
15583,statistically,0,0
15584,significantly,0,0
15585,different,0,0
15586,between,0,0
15587,women,0,1
15588,assigned,0,1
15589,to,0,0
15590,receive,0,0
15591,tamoxifen,0,0
15592,and,0,0
15593,those,0,0
15594,assigned,0,0
15595,to,0,0
15596,receive,0,0
15597,placebo,0,0
15598,",",0,0
15599,independent,0,0
15600,of,0,0
15601,pre-existing,0,1
15602,CHD,0,1
15603,.,0,1
15604,Among,0,1
15605,women,0,1
15606,without,0,1
15607,CHD,0,1
15608,(,0,0
15609,6074,0,1
15610,on,0,0
15611,tamoxifen,0,1
15612,versus,0,0
15613,6072,0,1
15614,on,0,0
15615,placebo,0,0
15616,),0,0
15617,",",0,0
15618,risk,0,0
15619,ratios,0,0
15620,(,0,1
15621,95,0,0
15622,%,0,0
15623,confidence,0,0
15624,intervals,0,0
15625,[,0,0
15626,CIs,0,0
15627,],0,1
15628,),0,0
15629,for,0,0
15630,tamoxifen,0,1
15631,users,0,1
15632,were,0,1
15633,1.75,0,1
15634,(,0,0
15635,0.44,0,0
15636,to,0,0
15637,8.13,0,0
15638,),0,0
15639,for,0,0
15640,fatal,0,1
15641,myocardial,0,1
15642,infarction,0,1
15643,",",0,0
15644,1.11,0,0
15645,(,0,0
15646,0.55,0,0
15647,to,0,0
15648,2.28,0,0
15649,),0,0
15650,for,0,0
15651,nonfatal,0,0
15652,myocardial,0,1
15653,infarction,0,1
15654,",",0,0
15655,0.69,0,0
15656,(,0,0
15657,0.29,0,0
15658,to,0,0
15659,1.57,0,0
15660,),0,0
15661,for,0,0
15662,unstable,0,1
15663,angina,0,1
15664,",",0,0
15665,and,0,0
15666,0.83,0,0
15667,(,0,0
15668,0.32,0,0
15669,to,0,0
15670,2.10,0,0
15671,),0,0
15672,for,0,0
15673,severe,0,1
15674,angina,0,1
15675,.,0,1
15676,In,0,0
15677,women,0,1
15678,with,0,1
15679,CHD,0,1
15680,(,0,0
15681,516,0,1
15682,on,0,0
15683,tamoxifen,0,1
15684,versus,0,0
15685,532,0,1
15686,on,0,0
15687,placebo,0,0
15688,),0,0
15689,",",0,0
15690,risk,0,0
15691,ratios,0,0
15692,(,0,1
15693,95,0,0
15694,%,0,0
15695,CIs,0,0
15696,),0,0
15697,for,0,0
15698,tamoxifen,0,1
15699,users,0,1
15700,were,0,1
15701,0.00,0,0
15702,(,0,0
15703,0,0,0
15704,to,0,0
15705,1.58,0,0
15706,),0,0
15707,for,0,0
15708,fatal,0,1
15709,myocardial,0,1
15710,infarction,0,1
15711,",",0,0
15712,1.25,0,0
15713,(,0,0
15714,0.32,0,0
15715,to,0,0
15716,5.18,0,0
15717,),0,0
15718,for,0,0
15719,nonfatal,0,0
15720,myocardial,0,1
15721,infarction,0,1
15722,",",0,0
15723,2.26,0,0
15724,(,0,0
15725,0.87,0,0
15726,to,0,0
15727,6.55,0,0
15728,),0,0
15729,for,0,0
15730,unstable,0,1
15731,angina,0,1
15732,",",0,0
15733,and,0,0
15734,1.39,0,0
15735,(,0,0
15736,0.23,0,0
15737,to,0,0
15738,9.47,0,0
15739,),0,0
15740,for,0,0
15741,severe,0,1
15742,angina,0,1
15743,.,0,0
15744,There,0,0
15745,was,0,0
15746,no,0,0
15747,evidence,0,0
15748,that,0,0
15749,the,0,0
15750,lack,0,0
15751,of,0,0
15752,association,0,0
15753,between,0,0
15754,tamoxifen,0,0
15755,and,0,0
15756,cardiovascular,0,1
15757,events,0,0
15758,was,0,0
15759,related,0,0
15760,to,0,0
15761,an,0,0
15762,early,0,0
15763,increase,0,0
15764,in,0,0
15765,risk,0,0
15766,that,0,0
15767,may,0,0
15768,have,0,0
15769,been,0,0
15770,offset,0,0
15771,by,0,0
15772,a,0,0
15773,late,0,0
15774,decrease,0,0
15775,in,0,0
15776,risk,0,0
15777,.,0,0
15778,CONCLUSION,0,0
15779,When,0,0
15780,used,0,0
15781,for,0,0
15782,breast,0,1
15783,cancer,0,1
15784,prevention,0,0
15785,in,0,0
15786,women,1,1
15787,with,1,1
15788,or,1,1
15789,without,1,1
15790,heart,1,1
15791,disease,1,1
15792,",",0,0
15793,tamoxifen,0,0
15794,is,0,0
15795,not,0,0
15796,associated,0,0
15797,with,0,1
15798,beneficial,0,0
15799,or,0,1
15800,adverse,0,0
15801,cardiovascular,0,1
15802,effects,0,0
15803,.,0,1
15804,Sertraline,0,0
15805,treatment,0,0
15806,of,0,0
15807,generalized,1,1
15808,social,1,0
15809,phobia,1,1
15810,:,1,1
15811,a,0,0
15812,20-week,0,0
15813,",",0,0
15814,double-blind,0,0
15815,",",0,0
15816,placebo-controlled,0,0
15817,study,0,0
15818,.,0,0
15819,OBJECTIVE,0,0
15820,The,0,0
15821,authors,0,0
15822,evaluated,0,0
15823,the,0,0
15824,efficacy,0,0
15825,",",0,0
15826,safety,0,0
15827,",",0,0
15828,and,0,0
15829,tolerability,0,0
15830,of,0,0
15831,sertraline,0,0
15832,",",0,0
15833,a,0,0
15834,selective,0,0
15835,serotonin,0,0
15836,reuptake,0,0
15837,inhibitor,0,0
15838,",",0,0
15839,in,0,0
15840,the,0,0
15841,treatment,0,0
15842,of,0,0
15843,generalized,0,1
15844,social,0,0
15845,phobia,0,1
15846,.,0,1
15847,METHOD,0,0
15848,Adult,1,1
15849,outpatients,1,1
15850,with,1,1
15851,generalized,1,1
15852,social,1,0
15853,phobia,1,1
15854,(,1,0
15855,N=204,1,1
15856,),1,0
15857,from,1,1
15858,10,1,1
15859,Canadian,1,1
15860,centers,1,1
15861,were,0,1
15862,randomly,0,1
15863,assigned,0,0
15864,to,0,0
15865,receive,0,0
15866,sertraline,0,0
15867,or,0,0
15868,placebo,0,0
15869,in,0,0
15870,a,0,0
15871,2:1,0,1
15872,ratio,0,0
15873,for,0,0
15874,a,0,0
15875,20-week,0,0
15876,double-blind,0,0
15877,study,0,0
15878,following,0,0
15879,a,0,0
15880,1-week,0,0
15881,",",0,0
15882,single-blind,0,0
15883,",",0,0
15884,placebo,0,0
15885,run-in,0,0
15886,.,0,0
15887,The,0,0
15888,initial,0,0
15889,dose,0,0
15890,of,0,0
15891,sertraline,0,0
15892,was,0,0
15893,50,0,0
15894,mg/day,0,0
15895,with,0,1
15896,increases,0,0
15897,of,0,1
15898,50,0,1
15899,mg/day,0,0
15900,every,0,0
15901,3,0,0
15902,weeks,0,0
15903,permitted,0,0
15904,after,0,0
15905,the,0,0
15906,fourth,0,0
15907,week,0,0
15908,of,0,0
15909,treatment,0,0
15910,(,0,0
15911,dosing,0,0
15912,was,0,0
15913,flexible,0,0
15914,up,0,0
15915,to,0,0
15916,a,0,0
15917,maximum,0,0
15918,of,0,0
15919,200,0,0
15920,mg/day,0,1
15921,),0,0
15922,.,0,0
15923,Primary,0,0
15924,efficacy,0,0
15925,assessments,0,0
15926,were,0,0
15927,the,0,0
15928,percentage,0,0
15929,of,0,0
15930,patients,0,1
15931,rated,0,1
15932,much,0,0
15933,or,0,1
15934,very,0,0
15935,much,0,0
15936,improved,0,0
15937,on,0,0
15938,the,0,0
15939,Clinical,0,0
15940,Global,0,1
15941,Impression,0,0
15942,(,0,0
15943,CGI,0,1
15944,),0,0
15945,improvement,0,0
15946,item,0,0
15947,and,0,0
15948,the,0,0
15949,mean,0,0
15950,changes,0,0
15951,from,0,1
15952,baseline,0,0
15953,to,0,0
15954,study,0,0
15955,endpoint,0,0
15956,in,0,0
15957,total,0,1
15958,score,0,0
15959,on,0,0
15960,the,0,0
15961,social,0,0
15962,phobia,0,1
15963,subscale,0,0
15964,of,0,0
15965,the,0,0
15966,Marks,0,1
15967,Fear,0,0
15968,Questionnaire,0,0
15969,and,0,0
15970,total,0,1
15971,score,0,0
15972,on,0,0
15973,the,0,0
15974,Brief,0,0
15975,Social,0,0
15976,Phobia,0,1
15977,Scale,0,0
15978,.,0,1
15979,RESULTS,0,0
15980,In,0,0
15981,intent-to-treat,0,0
15982,endpoint,0,0
15983,analyses,0,0
15984,of,0,0
15985,203,0,1
15986,of,0,0
15987,the,0,0
15988,patients,0,1
15989,",",0,0
15990,significantly,0,0
15991,more,0,0
15992,of,0,0
15993,the,0,0
15994,134,1,1
15995,patients,1,1
15996,given,1,0
15997,sertraline,1,0
15998,(,0,0
15999,N=71,0,0
16000,[,0,0
16001,53,0,1
16002,%,0,0
16003,],0,0
16004,),0,0
16005,than,0,0
16006,of,0,0
16007,the,0,0
16008,69,1,1
16009,patients,1,1
16010,receiving,1,1
16011,placebo,1,0
16012,(,0,0
16013,N=20,0,0
16014,[,0,0
16015,29,0,1
16016,%,0,0
16017,],0,1
16018,),0,0
16019,were,0,0
16020,considered,0,0
16021,responders,0,0
16022,according,0,1
16023,to,0,0
16024,their,0,0
16025,CGI,0,1
16026,improvement,0,0
16027,scores,0,0
16028,at,0,0
16029,the,0,0
16030,end,0,0
16031,of,0,0
16032,treatment,0,0
16033,.,0,0
16034,The,0,0
16035,mean,0,0
16036,reductions,0,0
16037,in,0,0
16038,the,0,0
16039,social,0,0
16040,phobia,0,1
16041,subscale,0,0
16042,of,0,0
16043,the,0,0
16044,Marks,0,1
16045,Fear,0,0
16046,Questionnaire,0,0
16047,and,0,0
16048,in,0,0
16049,the,0,0
16050,total,0,1
16051,score,0,0
16052,on,0,0
16053,the,0,0
16054,Brief,0,0
16055,Social,0,0
16056,Phobia,0,1
16057,Scale,0,0
16058,were,0,1
16059,32.6,0,0
16060,%,0,0
16061,and,0,0
16062,34.3,0,0
16063,%,0,0
16064,in,0,0
16065,the,0,0
16066,sertraline,0,0
16067,group,0,0
16068,and,0,0
16069,10.8,0,0
16070,%,0,0
16071,and,0,0
16072,18.6,0,0
16073,%,0,0
16074,in,0,0
16075,the,0,0
16076,placebo,0,0
16077,group,0,0
16078,",",0,0
16079,respectively,0,0
16080,.,0,0
16081,Analysis,0,0
16082,of,0,0
16083,covariance,0,0
16084,showed,0,0
16085,superiority,0,0
16086,of,0,0
16087,sertraline,0,0
16088,over,0,0
16089,placebo,0,0
16090,on,0,0
16091,all,0,0
16092,primary,0,0
16093,and,0,0
16094,secondary,0,1
16095,efficacy,0,0
16096,measures,0,0
16097,.,0,1
16098,Sertraline,0,0
16099,was,0,0
16100,well,0,0
16101,tolerated,0,0
16102,:,0,1
16103,103,0,1
16104,(,0,0
16105,76,0,1
16106,%,0,0
16107,),0,0
16108,of,0,0
16109,the,0,0
16110,135,0,1
16111,sertraline-treated,0,1
16112,patients,0,1
16113,and,0,1
16114,54,0,1
16115,(,0,0
16116,78,0,1
16117,%,0,0
16118,),0,0
16119,of,0,0
16120,the,0,0
16121,69,0,1
16122,placebo-treated,0,0
16123,patients,0,1
16124,completed,0,1
16125,the,0,0
16126,study,0,0
16127,.,0,0
16128,CONCLUSIONS,0,0
16129,Sertraline,0,0
16130,is,0,0
16131,an,0,0
16132,effective,0,0
16133,treatment,0,0
16134,for,0,0
16135,patients,0,1
16136,with,0,1
16137,generalized,0,1
16138,social,0,0
16139,phobia,0,1
16140,.,0,1
16141,Perioperative,0,0
16142,blood,0,0
16143,transfusions,0,0
16144,",",0,0
16145,with,0,1
16146,or,0,0
16147,without,0,1
16148,allogeneic,0,1
16149,leucocytes,0,0
16150,",",0,0
16151,relate,0,0
16152,to,0,0
16153,survival,0,0
16154,",",0,0
16155,not,0,0
16156,to,0,0
16157,cancer,0,1
16158,recurrence,0,0
16159,.,0,1
16160,BACKGROUND,0,0
16161,Perioperative,0,0
16162,blood,0,0
16163,transfusions,0,0
16164,are,0,0
16165,reported,0,0
16166,to,0,0
16167,be,0,0
16168,related,0,0
16169,to,0,0
16170,cancer,0,1
16171,recurrence,0,0
16172,and,0,0
16173,reduced,0,0
16174,survival,0,0
16175,.,0,1
16176,Different,0,0
16177,underlying,0,0
16178,mechanisms,0,0
16179,have,0,1
16180,been,0,0
16181,proposed,0,0
16182,",",0,0
16183,and,0,0
16184,allogeneic,0,1
16185,leucocytes,0,0
16186,in,0,0
16187,transfused,0,1
16188,blood,0,0
16189,have,0,0
16190,been,0,0
16191,suggested,0,0
16192,to,0,0
16193,contribute,0,0
16194,to,0,0
16195,this,0,0
16196,phenomenon,0,0
16197,.,0,0
16198,METHODS,0,0
16199,Packed,0,0
16200,red,0,1
16201,cells,0,0
16202,without,0,1
16203,buffy,0,0
16204,coat,0,0
16205,(,0,0
16206,PC,0,0
16207,group,0,1
16208,),0,0
16209,were,0,0
16210,compared,0,0
16211,with,0,1
16212,filtered,0,0
16213,",",0,0
16214,leucoreduced,0,0
16215,",",0,0
16216,red,0,1
16217,cells,0,0
16218,(,0,1
16219,LD,0,0
16220,group,0,0
16221,),0,0
16222,in,0,0
16223,a,0,0
16224,randomized,0,0
16225,trial,1,0
16226,of,1,0
16227,697,1,1
16228,patients,1,1
16229,with,1,1
16230,colorectal,1,1
16231,carcinoma,1,1
16232,.,1,1
16233,Five-year,0,0
16234,survival,0,0
16235,and,0,0
16236,cancer,0,1
16237,recurrence,0,0
16238,rates,0,0
16239,were,0,0
16240,determined,0,0
16241,",",0,0
16242,with,0,1
16243,special,0,0
16244,emphasis,0,0
16245,on,0,0
16246,the,0,0
16247,location,0,0
16248,of,0,0
16249,recurrence,0,0
16250,.,0,0
16251,RESULTS,0,0
16252,The,0,0
16253,intention-to-treat,0,0
16254,analysis,0,0
16255,showed,0,0
16256,a,0,0
16257,survival,0,0
16258,rate,0,0
16259,of,0,0
16260,63.6,0,0
16261,per,0,0
16262,cent,0,0
16263,in,0,0
16264,the,0,0
16265,PC,0,0
16266,group,0,0
16267,and,0,0
16268,65.3,0,0
16269,per,0,0
16270,cent,0,0
16271,in,0,0
16272,the,0,0
16273,LD,0,0
16274,group,0,0
16275,(,0,0
16276,P,0,0
16277,=,0,0
16278,0.69,0,0
16279,),0,0
16280,",",0,0
16281,with,0,1
16282,recurrence,0,0
16283,rates,0,0
16284,of,0,0
16285,27.8,0,1
16286,and,0,0
16287,27.9,0,0
16288,per,0,0
16289,cent,0,0
16290,respectively,0,0
16291,.,0,0
16292,The,0,0
16293,observational,0,0
16294,analysis,0,0
16295,showed,0,0
16296,a,0,0
16297,significant,0,0
16298,difference,0,0
16299,in,0,0
16300,survival,0,0
16301,between,0,0
16302,transfused,0,0
16303,and,0,0
16304,non-transfused,0,1
16305,patients,0,1
16306,(,0,1
16307,59.6,0,1
16308,versus,0,0
16309,72.9,0,0
16310,per,0,0
16311,cent,0,1
16312,;,0,1
16313,P,0,0
16314,<,0,0
16315,0.001,0,0
16316,),0,0
16317,.,0,0
16318,The,0,0
16319,difference,0,0
16320,in,0,0
16321,cancer,0,1
16322,recurrence,0,0
16323,rate,0,0
16324,between,0,0
16325,transfused,0,0
16326,and,0,0
16327,non-transfused,0,1
16328,patients,0,1
16329,was,0,0
16330,not,0,0
16331,statistically,0,0
16332,significant,0,0
16333,(,0,0
16334,29.8,0,0
16335,versus,0,0
16336,24.3,0,0
16337,per,0,0
16338,cent,0,1
16339,;,0,1
16340,P,0,0
16341,=,0,0
16342,0.13,0,0
16343,),0,1
16344,.,0,1
16345,Local,0,0
16346,recurrences,0,0
16347,were,0,0
16348,more,0,0
16349,frequent,0,0
16350,in,0,0
16351,transfused,0,1
16352,than,0,0
16353,non-transfused,0,1
16354,patients,0,1
16355,(,0,1
16356,11.9,0,1
16357,versus,0,0
16358,7.6,0,0
16359,per,0,0
16360,cent,0,1
16361,;,0,1
16362,P,0,0
16363,=,0,0
16364,0.09,0,0
16365,),0,1
16366,.,0,1
16367,CONCLUSION,0,0
16368,Leucocyte,0,0
16369,depletion,0,0
16370,of,0,0
16371,perioperative,0,0
16372,transfused,0,0
16373,blood,0,0
16374,has,0,0
16375,no,0,0
16376,effect,0,0
16377,on,0,0
16378,long-term,0,0
16379,survival,0,0
16380,and/or,0,0
16381,cancer,0,1
16382,recurrence,0,0
16383,.,0,0
16384,Perioperative,0,0
16385,blood,0,0
16386,transfusions,0,0
16387,are,0,0
16388,associated,0,0
16389,with,0,1
16390,impaired,0,1
16391,survival,0,0
16392,",",0,0
16393,but,0,0
16394,not,0,0
16395,with,0,0
16396,cancer,0,1
16397,recurrence,0,0
16398,.,0,0
16399,The,0,0
16400,slight,0,0
16401,increase,0,0
16402,in,0,0
16403,local,0,0
16404,recurrence,0,0
16405,rate,0,0
16406,in,0,0
16407,transfused,1,0
16408,patients,1,1
16409,appears,0,0
16410,to,0,0
16411,be,0,0
16412,related,0,0
16413,to,0,0
16414,complicated,0,0
16415,",",0,0
16416,in,0,0
16417,particular,0,0
16418,rectal,0,1
16419,",",0,0
16420,surgery,0,1
16421,.,0,0
16422,The,0,0
16423,effect,0,0
16424,of,0,0
16425,aging,0,1
16426,on,0,0
16427,circulating,0,0
16428,levels,0,0
16429,of,0,0
16430,proinflammatory,0,0
16431,cytokines,0,0
16432,during,0,0
16433,septic,1,1
16434,shock,1,1
16435,.,1,1
16436,Norasept,0,0
16437,II,0,1
16438,Study,0,1
16439,Investigators,0,1
16440,.,0,1
16441,BACKGROUND,0,0
16442,As,0,0
16443,the,0,0
16444,proportion,0,0
16445,of,0,0
16446,the,0,0
16447,population,0,1
16448,that,0,0
16449,is,0,0
16450,older,0,1
16451,continues,0,0
16452,to,0,0
16453,rise,0,0
16454,",",0,0
16455,infection,0,0
16456,in,0,0
16457,older,1,1
16458,people,1,1
16459,has,0,0
16460,become,0,0
16461,an,0,0
16462,important,0,0
16463,healthcare,0,0
16464,problem,0,0
16465,.,0,0
16466,Although,0,0
16467,aging,0,1
16468,is,0,0
16469,associated,0,0
16470,with,0,1
16471,multiple,0,0
16472,abnormalities,0,1
16473,in,0,0
16474,immune,0,0
16475,function,0,0
16476,",",0,0
16477,the,0,0
16478,effect,0,0
16479,of,0,0
16480,aging,0,1
16481,on,0,0
16482,the,0,0
16483,production,0,0
16484,of,0,0
16485,proinflammatory,0,0
16486,cytokines,0,0
16487,has,0,0
16488,not,0,0
16489,been,0,0
16490,well,0,0
16491,studied,0,0
16492,under,0,0
16493,conditions,0,0
16494,of,0,0
16495,clinical,0,0
16496,stress,0,0
16497,.,0,0
16498,OBJECTIVES,0,0
16499,The,0,0
16500,aim,0,0
16501,of,0,0
16502,this,0,0
16503,study,0,0
16504,was,0,0
16505,to,0,0
16506,examine,0,0
16507,the,0,0
16508,effect,0,0
16509,of,0,0
16510,aging,0,1
16511,on,0,0
16512,circulating,0,0
16513,levels,0,0
16514,of,0,0
16515,the,0,0
16516,proinflammatory,0,0
16517,cytokines,0,0
16518,in,0,0
16519,a,0,0
16520,large,0,1
16521,cohort,0,1
16522,of,0,0
16523,septic,1,1
16524,shock,1,1
16525,patients,1,1
16526,.,1,1
16527,We,0,0
16528,hypothesized,0,0
16529,that,0,0
16530,aging,0,1
16531,would,0,0
16532,be,0,0
16533,associated,0,0
16534,with,0,0
16535,a,0,0
16536,diminished,0,0
16537,proinflammatory,0,0
16538,cytokine,0,0
16539,response,0,0
16540,to,0,0
16541,sepsis,0,1
16542,.,0,1
16543,DESIGN,0,0
16544,Patients,1,1
16545,with,1,1
16546,septic,1,1
16547,shock,1,1
16548,who,1,1
16549,were,1,1
16550,enrolled,1,1
16551,in,1,0
16552,the,1,0
16553,placebo,1,0
16554,limb,1,0
16555,of,1,0
16556,the,1,0
16557,North,1,1
16558,American,1,1
16559,Sepsis,1,1
16560,Trial,1,1
16561,(,1,0
16562,NORASEPT,1,0
16563,II,1,1
16564,),1,0
16565,study,0,0
16566,were,0,0
16567,analyzed,0,0
16568,.,0,0
16569,SETTING,0,0
16570,The,0,0
16571,intensive,0,1
16572,care,0,1
16573,units,0,0
16574,of,0,1
16575,105,0,1
16576,hospitals,0,1
16577,in,0,0
16578,the,0,1
16579,United,0,1
16580,States,0,0
16581,and,0,1
16582,Canada,0,1
16583,.,0,1
16584,PARTICIPANTS,0,0
16585,Nine,1,1
16586,hundred,1,1
16587,and,1,0
16588,thirty,1,1
16589,patients,1,1
16590,presenting,1,1
16591,to,1,0
16592,hospital,1,1
16593,within,1,0
16594,12,1,0
16595,hours,1,0
16596,of,1,0
16597,the,1,0
16598,onset,1,0
16599,of,1,0
16600,septic,1,1
16601,shock,1,1
16602,.,1,1
16603,MEASUREMENTS,0,0
16604,Interleukin-6,0,0
16605,(,0,0
16606,IL-6,0,0
16607,),0,0
16608,",",0,0
16609,tumor,0,0
16610,necrosis,0,0
16611,factor-alpha,0,0
16612,(,0,0
16613,TNF-alpha,0,0
16614,),0,0
16615,",",0,0
16616,soluble,0,0
16617,tumor,0,0
16618,necrosis,0,0
16619,factor-receptor-55,0,0
16620,(,0,0
16621,sTNF-R55,0,1
16622,),0,0
16623,",",0,0
16624,and,0,0
16625,soluble,0,0
16626,tumor,0,1
16627,necrosis,0,0
16628,factor-receptor-75,0,0
16629,(,0,0
16630,sTNF-R75,0,1
16631,),0,1
16632,concentrations,0,0
16633,were,0,0
16634,measured,0,0
16635,at,0,0
16636,enrollment,0,1
16637,.,0,0
16638,The,0,0
16639,study,0,0
16640,population,1,1
16641,was,1,0
16642,broken,1,0
16643,down,1,0
16644,into,1,0
16645,five,1,1
16646,age,1,1
16647,groups,1,0
16648,as,1,0
16649,follows,1,0
16650,:,1,0
16651,less,1,0
16652,than,1,0
16653,50,1,1
16654,years,1,1
16655,(,1,1
16656,group,1,1
16657,one,1,1
16658,),1,0
16659,",",1,0
16660,50,1,1
16661,to,1,0
16662,64,1,1
16663,years,1,1
16664,(,1,1
16665,group,1,1
16666,two,1,0
16667,),1,0
16668,",",1,0
16669,65,1,1
16670,to,1,0
16671,74,1,1
16672,years,1,1
16673,(,1,1
16674,group,1,1
16675,three,1,0
16676,),1,0
16677,",",1,0
16678,75,1,1
16679,to,1,0
16680,84,1,1
16681,years,1,1
16682,(,1,1
16683,group,1,1
16684,four,1,1
16685,),1,0
16686,",",1,0
16687,and,1,0
16688,85,1,0
16689,or,1,1
16690,older,1,1
16691,(,1,0
16692,group,1,0
16693,five,1,1
16694,),1,0
16695,.,1,0
16696,Clinical,0,0
16697,",",0,0
16698,demographic,0,0
16699,",",0,0
16700,and,0,0
16701,cytokine,0,0
16702,data,0,0
16703,were,0,0
16704,extracted,0,1
16705,to,0,0
16706,describe,0,0
16707,each,0,0
16708,age,0,1
16709,group,0,0
16710,.,0,1
16711,RESULTS,0,0
16712,Data,0,0
16713,were,0,0
16714,available,0,0
16715,for,0,0
16716,930,1,1
16717,patients,1,1
16718,.,1,1
16719,The,0,0
16720,patients,1,1
16721,',1,1
16722,mean,1,1
16723,age,1,1
16724,(,1,0
16725,+/-,1,0
16726,SD,1,1
16727,),1,1
16728,was,1,0
16729,59,1,1
16730,+/-,1,0
16731,17,1,1
16732,years,1,1
16733,(,1,0
16734,range,1,1
16735,",",1,0
16736,18,1,1
16737,to,1,0
16738,102,1,1
16739,),1,0
16740,.,1,0
16741,There,0,0
16742,were,0,0
16743,280,1,1
16744,patients,1,1
16745,in,1,1
16746,group,1,1
16747,one,1,1
16748,",",1,0
16749,242,1,1
16750,in,1,0
16751,group,1,1
16752,two,1,0
16753,",",1,0
16754,210,1,1
16755,in,1,0
16756,group,1,1
16757,three,1,0
16758,",",1,0
16759,150,1,0
16760,in,1,0
16761,group,1,1
16762,four,1,0
16763,",",1,0
16764,and,1,0
16765,48,1,0
16766,in,1,0
16767,group,1,1
16768,five,1,1
16769,.,1,0
16770,The,0,0
16771,primary,0,1
16772,diagnoses,0,1
16773,;,0,1
16774,clinical,0,1
16775,characteristics,0,0
16776,;,0,1
16777,and,0,0
16778,IL-6,0,0
16779,",",0,0
16780,sTNF-R55,0,0
16781,",",0,0
16782,and,0,0
16783,sTNF-R75,0,1
16784,levels,0,0
16785,were,0,1
16786,similar,0,0
16787,among,0,0
16788,the,0,0
16789,five,0,1
16790,age,0,1
16791,groups,0,0
16792,.,0,1
16793,The,0,0
16794,TNF-alpha,0,0
16795,levels,0,0
16796,were,0,0
16797,significantly,0,0
16798,higher,0,0
16799,",",0,0
16800,however,0,0
16801,",",0,0
16802,in,0,0
16803,the,0,0
16804,oldest,0,1
16805,group,0,0
16806,of,0,0
16807,patients,0,1
16808,(,0,1
16809,group,0,1
16810,five,0,1
16811,),0,0
16812,.,0,0
16813,The,0,0
16814,28-day,0,0
16815,survival,0,0
16816,was,0,0
16817,49,0,1
16818,%,0,0
16819,in,0,0
16820,patients,0,1
16821,over,0,0
16822,the,0,0
16823,age,0,1
16824,of,0,0
16825,75,0,1
16826,and,0,0
16827,58,0,1
16828,%,0,0
16829,in,0,0
16830,those,0,0
16831,under,0,0
16832,75,0,1
16833,years,0,1
16834,(,0,1
16835,P,0,0
16836,=,0,0
16837,.03,0,0
16838,),0,0
16839,.,0,0
16840,There,0,0
16841,was,0,0
16842,no,0,0
16843,gender,0,0
16844,difference,0,0
16845,in,0,0
16846,survival,0,0
16847,or,0,1
16848,cytokine,0,0
16849,levels,0,0
16850,.,0,1
16851,CONCLUSIONS,0,0
16852,Contrary,0,0
16853,to,0,0
16854,our,0,0
16855,expectations,0,0
16856,",",0,0
16857,we,0,0
16858,found,0,0
16859,that,0,0
16860,aging,0,1
16861,was,0,0
16862,not,0,0
16863,associated,0,0
16864,with,0,0
16865,a,0,0
16866,decline,0,0
16867,in,0,0
16868,the,0,0
16869,circulating,0,0
16870,levels,0,0
16871,of,0,0
16872,proinflammatory,0,0
16873,cytokines,0,0
16874,.,0,1
16875,Effect,0,0
16876,of,0,0
16877,antipyretic,0,0
16878,drugs,0,0
16879,in,0,1
16880,children,1,1
16881,with,1,1
16882,malaria,1,1
16883,.,1,0
16884,A,0,0
16885,comparison,0,0
16886,of,0,0
16887,different,0,0
16888,antipyretics,0,0
16889,in,0,1
16890,children,1,1
16891,with,1,1
16892,malaria,1,1
16893,showed,0,0
16894,a,0,0
16895,small,0,0
16896,effect,0,0
16897,of,0,0
16898,naproxen,0,0
16899,",",0,0
16900,but,0,0
16901,not,0,0
16902,of,0,0
16903,metamizol,0,0
16904,",",0,0
16905,on,0,0
16906,the,0,0
16907,reduction,0,0
16908,of,0,0
16909,fever,0,1
16910,peaks,0,0
16911,.,0,1
16912,Antipyretic,0,0
16913,treatment,0,0
16914,had,0,0
16915,no,0,0
16916,effect,0,0
16917,on,0,0
16918,fever,0,0
16919,clearance,0,0
16920,and,0,0
16921,therefore,0,0
16922,should,0,0
16923,be,0,0
16924,used,0,0
16925,cautiously,0,0
16926,in,0,0
16927,the,0,0
16928,treatment,1,0
16929,of,1,0
16930,malaria,1,1
16931,.,1,1
16932,Effect,0,0
16933,of,0,0
16934,protein,0,0
16935,ingestion,0,0
16936,on,0,0
16937,the,0,0
16938,glucose,0,0
16939,appearance,0,0
16940,rate,0,0
16941,in,0,0
16942,people,1,1
16943,with,1,1
16944,type,1,1
16945,2,1,1
16946,diabetes,1,1
16947,.,1,1
16948,Amino,0,0
16949,acids,0,0
16950,derived,0,0
16951,from,0,1
16952,ingested,0,1
16953,protein,0,0
16954,are,0,0
16955,potential,0,0
16956,substrates,0,0
16957,for,0,0
16958,gluconeogenesis,0,0
16959,.,0,0
16960,However,0,0
16961,",",0,0
16962,several,0,0
16963,laboratories,0,1
16964,have,0,0
16965,reported,0,0
16966,that,0,0
16967,protein,0,0
16968,ingestion,0,0
16969,does,0,0
16970,not,0,0
16971,result,0,0
16972,in,0,0
16973,an,0,0
16974,increase,0,0
16975,in,0,0
16976,the,0,0
16977,circulating,0,0
16978,glucose,0,0
16979,concentration,0,0
16980,in,0,0
16981,people,0,1
16982,with,0,1
16983,or,0,1
16984,without,0,1
16985,type,1,1
16986,2,1,1
16987,diabetes,1,1
16988,.,1,1
16989,The,0,0
16990,reason,0,0
16991,for,0,0
16992,this,0,0
16993,has,0,0
16994,remained,0,0
16995,unclear,0,0
16996,.,0,1
16997,In,0,0
16998,people,0,1
16999,without,0,1
17000,diabetes,0,1
17001,it,0,0
17002,seems,0,0
17003,to,0,0
17004,be,0,0
17005,due,0,0
17006,to,0,0
17007,less,0,0
17008,glucose,0,0
17009,being,0,0
17010,produced,0,0
17011,and,0,0
17012,entering,0,1
17013,the,0,0
17014,circulation,0,0
17015,than,0,0
17016,the,0,0
17017,calculated,0,0
17018,theoretical,0,0
17019,amount,0,0
17020,.,0,0
17021,Therefore,0,0
17022,",",0,0
17023,we,0,0
17024,were,0,0
17025,interested,0,0
17026,in,0,0
17027,determining,0,0
17028,whether,0,0
17029,this,0,0
17030,also,0,0
17031,was,0,0
17032,the,0,0
17033,case,0,0
17034,in,0,0
17035,people,1,1
17036,with,1,1
17037,type,1,1
17038,2,1,1
17039,diabetes,1,1
17040,.,1,1
17041,Ten,1,1
17042,male,1,1
17043,subjects,1,1
17044,with,1,1
17045,untreated,1,1
17046,type,1,1
17047,2,1,1
17048,diabetes,1,1
17049,were,0,1
17050,given,0,0
17051,",",0,0
17052,in,0,0
17053,random,0,0
17054,sequence,0,0
17055,",",0,0
17056,50,0,0
17057,g,0,0
17058,protein,0,0
17059,in,0,0
17060,the,0,0
17061,form,0,0
17062,of,0,0
17063,very,0,0
17064,lean,0,0
17065,beef,0,0
17066,or,0,0
17067,only,0,0
17068,water,0,0
17069,at,0,0
17070,0800,0,0
17071,h,0,0
17072,and,0,0
17073,studied,0,0
17074,over,0,0
17075,the,0,0
17076,subsequent,0,0
17077,8,0,0
17078,h.,0,1
17079,Protein,0,0
17080,ingestion,0,0
17081,resulted,0,0
17082,in,0,0
17083,an,0,0
17084,increase,0,0
17085,in,0,0
17086,circulating,0,0
17087,insulin,0,0
17088,",",0,0
17089,C-peptide,0,0
17090,",",0,0
17091,glucagon,0,0
17092,",",0,0
17093,alpha,0,0
17094,amino,0,0
17095,and,0,0
17096,urea,0,0
17097,nitrogen,0,0
17098,",",0,0
17099,and,0,0
17100,triglycerides,0,0
17101,;,0,0
17102,a,0,0
17103,decrease,0,0
17104,in,0,0
17105,nonesterified,0,0
17106,fatty,0,0
17107,acids,0,0
17108,;,0,1
17109,and,0,0
17110,a,0,0
17111,modest,0,0
17112,increase,0,0
17113,in,0,0
17114,respiratory,0,1
17115,quotient,0,1
17116,.,0,0
17117,The,0,0
17118,total,0,0
17119,amount,0,0
17120,of,0,0
17121,protein,0,0
17122,deaminated,0,0
17123,and,0,0
17124,the,0,0
17125,amino,0,0
17126,groups,0,0
17127,incorporated,0,0
17128,into,0,1
17129,urea,0,0
17130,was,0,0
17131,calculated,0,0
17132,to,0,0
17133,be,0,0
17134,approximately,0,0
17135,20-23,0,1
17136,g.,0,0
17137,The,0,0
17138,net,0,0
17139,amount,0,0
17140,of,0,0
17141,glucose,0,0
17142,estimated,0,0
17143,to,0,0
17144,be,0,0
17145,produced,0,0
17146,",",0,0
17147,based,0,0
17148,on,0,0
17149,the,0,0
17150,quantity,0,0
17151,of,0,0
17152,amino,0,0
17153,acids,0,0
17154,deaminated,0,0
17155,",",0,0
17156,was,0,0
17157,approximately,0,0
17158,11-13,0,1
17159,g.,0,0
17160,However,0,0
17161,",",0,0
17162,the,0,0
17163,amount,0,0
17164,of,0,0
17165,glucose,0,0
17166,appearing,0,0
17167,in,0,0
17168,the,0,0
17169,circulation,0,0
17170,was,0,0
17171,only,0,0
17172,approximately,0,0
17173,2,0,0
17174,g.,0,0
17175,The,0,0
17176,peripheral,0,0
17177,plasma,0,0
17178,glucose,0,0
17179,concentration,0,0
17180,decreased,0,0
17181,by,0,0
17182,approximately,0,1
17183,1,0,0
17184,mM,0,0
17185,after,0,0
17186,ingestion,0,0
17187,of,0,0
17188,either,0,0
17189,protein,0,0
17190,or,0,0
17191,water,0,0
17192,",",0,0
17193,confirming,0,0
17194,that,0,0
17195,ingested,0,1
17196,protein,0,0
17197,does,0,0
17198,not,0,0
17199,result,0,0
17200,in,0,0
17201,a,0,0
17202,net,0,0
17203,increase,0,0
17204,in,0,0
17205,glucose,0,0
17206,concentration,0,0
17207,",",0,0
17208,and,0,0
17209,results,0,0
17210,in,0,0
17211,only,0,0
17212,a,0,0
17213,modest,0,0
17214,increase,0,0
17215,in,0,0
17216,the,0,0
17217,rate,0,0
17218,of,0,0
17219,glucose,0,0
17220,disappearance,0,0
17221,.,0,1
17222,Central,0,0
17223,nervous,0,0
17224,system,0,0
17225,serotonin,0,0
17226,function,0,0
17227,and,0,0
17228,cardiovascular,0,1
17229,responses,0,0
17230,to,0,0
17231,stress,0,0
17232,.,0,0
17233,OBJECTIVE,0,0
17234,The,0,0
17235,objective,0,0
17236,of,0,0
17237,this,0,0
17238,study,0,0
17239,was,0,0
17240,to,0,0
17241,evaluate,0,0
17242,the,0,0
17243,impact,0,0
17244,of,0,0
17245,indices,0,0
17246,of,0,1
17247,central,0,1
17248,nervous,0,0
17249,system,0,0
17250,(,0,0
17251,CNS,0,0
17252,),0,0
17253,serotonin,0,0
17254,function,0,0
17255,on,0,0
17256,cardiovascular,0,1
17257,reactivity,0,1
17258,to,0,0
17259,mental,0,1
17260,stress,0,0
17261,.,0,1
17262,METHODS,0,0
17263,Lumbar,0,1
17264,puncture,0,0
17265,was,0,0
17266,performed,0,0
17267,on,0,0
17268,54,1,1
17269,healthy,1,1
17270,volunteers,1,1
17271,to,1,0
17272,obtain,0,0
17273,cerebrospinal,0,0
17274,fluid,0,0
17275,(,0,0
17276,CSF,0,1
17277,),0,0
17278,for,0,0
17279,determination,0,0
17280,of,0,0
17281,5-hydroxyindoleacetic,0,0
17282,acid,0,0
17283,(,0,0
17284,5HIAA,0,0
17285,),0,1
17286,levels,0,0
17287,.,0,1
17288,Genotypes,0,0
17289,were,0,0
17290,determined,0,0
17291,with,0,1
17292,respect,0,0
17293,to,0,0
17294,a,0,0
17295,functional,0,0
17296,polymorphism,0,0
17297,of,0,0
17298,the,0,0
17299,serotonin,0,0
17300,transporter,0,0
17301,gene,0,0
17302,promoter,0,0
17303,region,0,1
17304,(,0,0
17305,5HTTLPR,0,0
17306,),0,1
17307,.,0,1
17308,Subjects,0,1
17309,then,0,0
17310,underwent,0,1
17311,mental,0,1
17312,stress,0,0
17313,testing,0,0
17314,.,0,1
17315,RESULTS,0,0
17316,Persons,1,1
17317,with,1,1
17318,one,1,1
17319,or,1,1
17320,two,1,0
17321,long,1,0
17322,(,1,0
17323,l,1,0
17324,),1,1
17325,5HTTLPR,1,0
17326,alleles,1,0
17327,had,0,1
17328,CSF,0,1
17329,levels,0,0
17330,of,0,0
17331,the,0,0
17332,major,0,0
17333,serotonin,0,0
17334,metabolite,0,0
17335,",",0,0
17336,5HIAA,0,0
17337,",",0,0
17338,that,0,0
17339,were,0,0
17340,50,0,1
17341,%,0,0
17342,higher,0,0
17343,than,0,0
17344,those,0,0
17345,of,0,0
17346,persons,0,1
17347,with,0,1
17348,the,0,0
17349,s/s,0,0
17350,5HTTLPR,1,0
17351,genotype,1,0
17352,.,1,1
17353,Persons,0,1
17354,with,0,1
17355,one,0,1
17356,or,0,1
17357,two,0,0
17358,l,0,0
17359,alleles,0,0
17360,or,0,1
17361,higher,0,0
17362,CSF,0,1
17363,5HIAA,0,0
17364,levels,0,0
17365,also,0,0
17366,exhibited,0,0
17367,greater,0,0
17368,blood,0,0
17369,pressure,0,0
17370,and,0,0
17371,heart,0,1
17372,rate,0,0
17373,responses,0,0
17374,to,0,0
17375,a,0,0
17376,mental,0,1
17377,stress,0,0
17378,protocol,0,0
17379,.,0,0
17380,CONCLUSIONS,0,0
17381,These,0,0
17382,findings,0,0
17383,suggest,0,0
17384,the,0,0
17385,5HTTLPR,0,0
17386,polymorphism,0,0
17387,affects,0,0
17388,CNS,0,0
17389,serotonin,0,0
17390,function,0,0
17391,",",0,0
17392,and,0,0
17393,they,0,0
17394,are,0,0
17395,consistent,0,0
17396,with,0,1
17397,the,0,0
17398,general,0,1
17399,hypothesis,0,0
17400,that,0,0
17401,CNS,0,0
17402,serotonin,0,0
17403,function,0,0
17404,is,0,0
17405,involved,0,0
17406,in,0,0
17407,the,0,0
17408,regulation,0,0
17409,of,0,0
17410,potentially,0,0
17411,health-damaging,0,0
17412,biobehavioral,0,1
17413,characteristics,0,0
17414,.,0,1
17415,In,0,0
17416,particular,0,0
17417,",",0,0
17418,the,0,0
17419,l,0,0
17420,allele,0,0
17421,could,0,0
17422,contribute,0,0
17423,",",0,0
17424,through,0,0
17425,its,0,0
17426,association,0,0
17427,with,0,1
17428,increased,0,0
17429,cardiovascular,0,1
17430,reactivity,0,0
17431,to,0,0
17432,stress,0,0
17433,",",0,0
17434,to,0,0
17435,increased,0,0
17436,risk,0,0
17437,of,0,0
17438,cardiovascular,0,1
17439,disease,0,1
17440,.,0,1
17441,Interferential,0,1
17442,therapy,0,0
17443,electrode,0,0
17444,placement,0,0
17445,technique,0,0
17446,in,0,0
17447,acute,1,1
17448,low,1,0
17449,back,1,1
17450,pain,1,1
17451,:,1,1
17452,a,0,0
17453,preliminary,0,0
17454,investigation,0,0
17455,.,0,0
17456,OBJECTIVE,0,0
17457,To,0,0
17458,determine,0,0
17459,the,0,0
17460,efficacy,0,0
17461,of,0,0
17462,interferential,0,0
17463,therapy,0,0
17464,(,0,0
17465,IFT,0,1
17466,),0,0
17467,electrode,0,0
17468,placement,0,0
17469,technique,0,0
17470,compared,0,0
17471,with,0,1
17472,a,0,0
17473,control,0,0
17474,treatment,0,0
17475,in,0,0
17476,subjects,1,1
17477,with,1,1
17478,acute,1,1
17479,low,1,0
17480,back,1,1
17481,pain,1,0
17482,(,1,0
17483,LBP,1,1
17484,),1,1
17485,.,1,1
17486,DESIGN,0,0
17487,Single-blind,0,0
17488,",",0,0
17489,randomized,0,0
17490,",",0,0
17491,controlled,0,0
17492,trial,0,0
17493,with,0,1
17494,a,0,0
17495,3-month,0,0
17496,follow-up,0,0
17497,.,0,1
17498,SETTING,0,1
17499,Outpatient,1,0
17500,physiotherapy,1,0
17501,departments,1,1
17502,in,1,0
17503,hospital,1,1
17504,and,1,0
17505,university,1,1
17506,settings,1,0
17507,.,1,0
17508,PATIENTS,0,0
17509,A,0,0
17510,random,0,0
17511,sample,0,1
17512,of,0,0
17513,60,1,1
17514,eligible,1,1
17515,patients,1,1
17516,with,1,1
17517,back,1,1
17518,pain,1,1
17519,(,1,1
17520,28,1,1
17521,men,1,1
17522,",",1,1
17523,32,1,1
17524,women,1,1
17525,),1,1
17526,were,1,0
17527,recruited,1,1
17528,by,1,0
17529,general,1,1
17530,practitioners,1,1
17531,and,1,1
17532,self-referral,1,1
17533,for,0,0
17534,physiotherapy,0,0
17535,treatment,0,0
17536,and,0,0
17537,randomly,0,1
17538,assigned,0,0
17539,to,0,0
17540,1,0,0
17541,of,0,0
17542,3,0,1
17543,groups,0,0
17544,.,0,1
17545,INTERVENTIONS,0,0
17546,(,0,0
17547,1,0,0
17548,),0,1
17549,IFT,0,1
17550,painful,0,0
17551,area,0,0
17552,and,0,0
17553,The,0,0
17554,Back,0,0
17555,Book,0,0
17556,",",0,0
17557,(,0,0
17558,2,0,0
17559,),0,1
17560,IFT,0,1
17561,spinal,0,1
17562,nerve,0,0
17563,and,0,0
17564,The,0,0
17565,Back,0,0
17566,Book,0,0
17567,",",0,0
17568,and,0,0
17569,(,0,0
17570,3,0,0
17571,),0,0
17572,Control,0,0
17573,",",0,0
17574,The,0,0
17575,Back,0,0
17576,Book,0,0
17577,only,0,0
17578,.,0,0
17579,Standardized,0,0
17580,IFT,0,1
17581,stimulation,0,0
17582,parameters,0,0
17583,were,0,1
17584,used,0,0
17585,:,0,1
17586,carrier,0,0
17587,frequency,0,0
17588,3.85,0,0
17589,kHz,0,1
17590,;,0,1
17591,140,0,1
17592,Hz,0,0
17593,constant,0,0
17594,;,0,0
17595,pulse,0,0
17596,duration,0,0
17597,130,0,1
17598,micros,0,0
17599,;,0,1
17600,30,0,1
17601,minutes,0,0
17602,',0,1
17603,duration,0,0
17604,.,0,1
17605,MAIN,0,0
17606,OUTCOME,0,0
17607,MEASURES,0,0
17608,Pain,0,1
17609,Rating,0,0
17610,Index,0,0
17611,",",0,0
17612,Roland-Morris,0,1
17613,Disability,0,0
17614,Questionnaire,0,0
17615,(,0,0
17616,RMDQ,0,0
17617,),0,0
17618,",",0,0
17619,and,0,0
17620,EuroQol,0,0
17621,were,0,0
17622,completed,0,1
17623,by,0,0
17624,subjects,0,1
17625,pretreatment,0,0
17626,",",0,0
17627,at,0,0
17628,discharge,0,0
17629,",",0,0
17630,and,0,0
17631,3-month,0,0
17632,follow-up,0,0
17633,.,0,1
17634,RESULTS,0,0
17635,All,0,1
17636,groups,0,0
17637,had,0,1
17638,significant,0,0
17639,improvements,0,0
17640,in,0,0
17641,all,0,1
17642,outcomes,0,0
17643,at,0,0
17644,follow-up,0,0
17645,.,0,1
17646,Subjects,0,0
17647,managed,0,1
17648,by,0,0
17649,IFT,0,1
17650,spinal,0,1
17651,nerve,0,0
17652,and,0,0
17653,The,0,0
17654,Back,0,0
17655,Book,0,0
17656,displayed,0,0
17657,both,0,0
17658,a,0,0
17659,statistically,0,0
17660,significant,0,0
17661,(,0,0
17662,p,0,0
17663,=,0,0
17664,.030,0,0
17665,),0,0
17666,and,0,0
17667,clinically,0,0
17668,meaningful,0,0
17669,reduction,0,0
17670,in,0,0
17671,functional,0,0
17672,disability,0,1
17673,(,0,0
17674,RMDQ,0,0
17675,),0,0
17676,",",0,0
17677,compared,0,0
17678,with,0,0
17679,management,0,0
17680,via,0,0
17681,IFT,0,1
17682,painful,0,0
17683,area,0,0
17684,and,0,0
17685,The,0,0
17686,Back,0,0
17687,Book,0,0
17688,combined,0,0
17689,or,0,0
17690,The,0,0
17691,Back,0,0
17692,Book,0,0
17693,alone,0,0
17694,.,0,0
17695,CONCLUSIONS,0,0
17696,The,0,0
17697,findings,0,0
17698,showed,0,0
17699,that,0,0
17700,IFT,0,1
17701,electrode,0,0
17702,placement,0,0
17703,technique,0,0
17704,affects,0,0
17705,LBP-specific,0,0
17706,functional,0,0
17707,disability,0,0
17708,",",0,0
17709,providing,0,0
17710,preliminary,0,0
17711,implications,0,0
17712,for,0,1
17713,future,0,0
17714,clinical,0,1
17715,studies,0,0
17716,.,0,1
17717,Children,1,1
17718,with,1,1
17719,persistent,1,1
17720,conduct,1,1
17721,problems,1,1
17722,who,1,1
17723,dropout,1,1
17724,of,1,1
17725,treatment,1,0
17726,.,1,1
17727,Dropout,0,0
17728,of,0,0
17729,treatment,0,0
17730,is,0,0
17731,one,0,0
17732,of,0,0
17733,the,0,0
17734,key,0,0
17735,issues,0,0
17736,in,0,0
17737,outcome,0,0
17738,in,0,0
17739,a,0,0
17740,child,1,0
17741,and,1,0
17742,adolescent,1,1
17743,mental,1,1
17744,health,1,1
17745,service,1,1
17746,.,1,0
17747,We,0,0
17748,report,0,0
17749,two,0,0
17750,studies,0,0
17751,focusing,0,0
17752,on,0,0
17753,the,0,0
17754,treatment,0,0
17755,process,0,0
17756,and,0,0
17757,the,0,0
17758,dropout,0,0
17759,rate,0,0
17760,of,0,0
17761,children,1,1
17762,with,1,1
17763,persistent,1,1
17764,conduct,1,0
17765,problems,1,1
17766,presenting,1,1
17767,to,1,0
17768,a,1,0
17769,community,1,0
17770,mental,1,1
17771,health,1,0
17772,service,1,1
17773,",",0,0
17774,using,0,0
17775,a,0,0
17776,prospective,0,0
17777,design,0,0
17778,.,0,0
17779,The,0,0
17780,first,1,0
17781,study,1,0
17782,included,1,1
17783,32,1,1
17784,children,1,1
17785,and,0,0
17786,used,0,0
17787,a,0,0
17788,randomised,0,0
17789,controlled,0,0
17790,treatment,0,0
17791,design,0,0
17792,comparing,0,0
17793,a,0,0
17794,CBT,0,0
17795,approach,0,0
17796,with,0,1
17797,conjoint,0,0
17798,family,0,1
17799,therapy,0,0
17800,and,0,0
17801,an,0,0
17802,eclectic,0,1
17803,approach,0,0
17804,.,0,0
17805,The,0,0
17806,overall,0,0
17807,dropout,0,0
17808,rate,0,0
17809,was,0,0
17810,36,0,1
17811,%,0,0
17812,.,0,1
17813,Dropout,0,0
17814,occurred,0,0
17815,significantly,0,0
17816,less,0,0
17817,frequently,0,0
17818,in,0,0
17819,the,0,0
17820,CBT,0,0
17821,group,0,0
17822,.,0,0
17823,The,0,0
17824,dropout,0,0
17825,group,0,0
17826,was,0,0
17827,associated,0,0
17828,with,0,1
17829,mothers,1,1
17830,who,1,1
17831,were,1,1
17832,younger,1,1
17833,and,1,0
17834,less,1,0
17835,educated,1,0
17836,",",0,0
17837,a,0,0
17838,poorer,0,0
17839,rating,0,0
17840,by,0,0
17841,the,0,0
17842,clinicians,0,0
17843,at,0,0
17844,the,0,0
17845,last,0,0
17846,meeting,0,0
17847,",",0,0
17848,parental,0,0
17849,dissatisfaction,0,0
17850,with,0,1
17851,the,0,0
17852,treatment,0,0
17853,service,0,1
17854,and,0,0
17855,perception,0,0
17856,that,0,0
17857,the,0,0
17858,treatment,0,0
17859,was,0,0
17860,less,0,0
17861,organised,0,0
17862,and,0,0
17863,having,0,1
17864,less,0,0
17865,behavioural,0,1
17866,tasks,0,0
17867,.,0,1
17868,In,0,0
17869,the,0,0
17870,second,0,0
17871,study,0,0
17872,we,0,0
17873,used,0,0
17874,a,0,0
17875,naturalistic,0,0
17876,follow-up,0,0
17877,design,0,1
17878,.,0,1
17879,Forty-six,1,1
17880,children,1,1
17881,were,1,1
17882,included,1,1
17883,.,1,0
17884,The,0,0
17885,overall,0,0
17886,dropout,0,0
17887,rate,0,0
17888,was,0,0
17889,48,0,0
17890,%,0,0
17891,.,0,0
17892,Again,0,0
17893,",",0,0
17894,the,0,0
17895,children,1,1
17896,who,1,1
17897,defaulted,1,1
17898,were,0,1
17899,rated,0,0
17900,by,0,0
17901,clinicians,0,0
17902,as,0,0
17903,less,0,0
17904,likely,0,0
17905,to,0,0
17906,have,0,0
17907,improved,0,0
17908,and,0,0
17909,dropout,0,0
17910,was,0,0
17911,also,0,0
17912,significantly,0,0
17913,associated,0,0
17914,with,0,1
17915,parental,0,0
17916,perception,0,0
17917,of,0,0
17918,a,0,0
17919,less,0,0
17920,organised,0,0
17921,treatment,0,0
17922,.,0,0
17923,In,0,0
17924,both,0,0
17925,studies,0,0
17926,dropout,0,0
17927,usually,0,0
17928,occurred,0,0
17929,after,0,0
17930,assessment,0,0
17931,and,0,0
17932,at,0,0
17933,the,0,0
17934,early,0,0
17935,phase,0,0
17936,of,0,0
17937,treatment,0,0
17938,.,0,1
17939,Double,0,0
17940,hearing,0,1
17941,protection,0,0
17942,and,0,0
17943,speech,0,0
17944,intelligibility-room,0,0
17945,for,0,0
17946,improvement,0,0
17947,.,0,1
17948,INTRODUCTION,0,0
17949,Double,0,0
17950,hearing,0,1
17951,protection,0,0
17952,is,0,0
17953,used,0,0
17954,in,0,0
17955,many,0,0
17956,air,0,1
17957,forces,0,0
17958,around,0,0
17959,the,0,0
17960,world,0,0
17961,for,0,0
17962,protection,0,0
17963,in,0,0
17964,noisy,0,1
17965,aircraft,0,1
17966,environments,0,0
17967,",",0,0
17968,particularly,0,0
17969,in,0,0
17970,helicopters,0,1
17971,.,0,1
17972,The,0,0
17973,usual,0,0
17974,combination,0,0
17975,is,0,0
17976,foam,0,0
17977,ear,0,1
17978,plugs,0,1
17979,under,0,0
17980,headset,0,0
17981,or,0,1
17982,helmet,0,0
17983,muffs,0,1
17984,.,0,1
17985,Much,0,1
17986,of,0,0
17987,the,0,0
17988,research,0,0
17989,that,0,0
17990,spurred,0,0
17991,the,0,0
17992,introduction,0,0
17993,of,0,0
17994,foam,0,0
17995,earplugs,0,1
17996,indicated,0,0
17997,little,0,0
17998,change,0,0
17999,in,0,0
18000,speech,0,0
18001,intelligibility,0,0
18002,in,0,0
18003,persons,0,1
18004,with,0,1
18005,normal,0,1
18006,hearing,0,1
18007,.,0,0
18008,However,0,0
18009,",",0,0
18010,aircrew,0,0
18011,often,0,0
18012,complain,0,1
18013,about,0,0
18014,having,0,1
18015,to,0,0
18016,maximize,0,0
18017,intercom,0,0
18018,volume,0,0
18019,for,0,0
18020,speech,0,0
18021,understanding,0,0
18022,",",0,0
18023,causing,0,0
18024,a,0,0
18025,situation,0,0
18026,with,0,0
18027,no,0,0
18028,reserve,0,0
18029,volume,0,0
18030,and,0,0
18031,bad,0,0
18032,sound,0,1
18033,quality,0,0
18034,.,0,0
18035,In,0,0
18036,recent,0,0
18037,years,0,1
18038,",",0,1
18039,further,0,0
18040,developments,0,0
18041,have,0,0
18042,included,0,1
18043,so-called,0,1
18044,hi-fi,0,0
18045,plugs,0,1
18046,and,0,1
18047,custom,0,1
18048,made,0,0
18049,ear,0,1
18050,plugs,0,0
18051,which,0,0
18052,are,0,0
18053,claimed,0,0
18054,to,0,0
18055,improve,0,0
18056,speech,0,0
18057,communication,0,0
18058,.,0,0
18059,The,0,0
18060,aim,0,0
18061,of,0,0
18062,the,0,0
18063,present,0,0
18064,project,0,0
18065,was,0,0
18066,to,0,0
18067,investigate,0,0
18068,different,0,0
18069,types,0,0
18070,of,0,0
18071,ear,0,1
18072,plugs,0,1
18073,and,0,0
18074,their,0,0
18075,effect,0,0
18076,on,0,0
18077,speech,0,0
18078,intelligibility,0,0
18079,in,0,0
18080,helicopter,0,1
18081,noise,0,0
18082,.,0,0
18083,METHODS,0,0
18084,Each,1,0
18085,of,1,0
18086,nine,1,1
18087,normal-hearing,1,1
18088,pilot,1,1
18089,subjects,1,1
18090,were,1,0
18091,placed,1,1
18092,in,0,0
18093,an,0,0
18094,environment,0,0
18095,of,0,0
18096,recorded,0,0
18097,helicopter,0,1
18098,noise,0,0
18099,from,0,0
18100,a,0,0
18101,BO-105,1,0
18102,helicopter,1,1
18103,.,1,1
18104,Speech,0,0
18105,audiometry,0,0
18106,was,0,0
18107,performed,0,0
18108,under,0,0
18109,four,0,1
18110,different,0,1
18111,conditions,0,1
18112,:,0,1
18113,headset,0,0
18114,only,0,0
18115,",",0,0
18116,and,0,0
18117,three,0,0
18118,different,0,0
18119,ear,0,1
18120,plugs,0,0
18121,worn,0,0
18122,under,0,0
18123,the,0,0
18124,headset,0,0
18125,.,0,0
18126,Fitting,0,0
18127,of,0,0
18128,the,0,0
18129,ear,0,1
18130,plugs,0,0
18131,was,0,0
18132,performed,0,0
18133,by,0,0
18134,an,0,0
18135,ear,0,0
18136,",",0,0
18137,nose,0,0
18138,and,0,0
18139,throat,0,1
18140,specialist,0,1
18141,to,0,0
18142,ensure,0,0
18143,similar,0,0
18144,conditions,0,0
18145,.,0,1
18146,The,0,0
18147,sequence,0,0
18148,of,0,0
18149,test,0,0
18150,conditions,0,0
18151,was,0,0
18152,randomized,0,1
18153,and,0,0
18154,double-blind,0,0
18155,.,0,0
18156,In,0,0
18157,addition,0,0
18158,",",0,0
18159,a,0,0
18160,subjective,0,0
18161,rating,0,0
18162,scale,0,0
18163,was,0,0
18164,used,0,0
18165,.,0,1
18166,RESULTS,0,0
18167,Wearing,0,0
18168,foam,0,0
18169,ear,0,1
18170,plugs,0,1
18171,under,0,0
18172,the,0,0
18173,headset,0,0
18174,decreased,0,0
18175,speech,0,0
18176,intelligibility,0,0
18177,dramatically,0,0
18178,.,0,0
18179,The,0,0
18180,hi-fi,0,0
18181,plug,0,0
18182,was,0,0
18183,somewhat,0,0
18184,better,0,0
18185,than,0,0
18186,foam,0,0
18187,plugs,0,0
18188,",",0,0
18189,and,0,0
18190,the,0,0
18191,custom,0,0
18192,made,0,0
18193,ear,0,1
18194,plug,0,0
18195,provided,0,0
18196,a,0,0
18197,speech,0,0
18198,intelligibility,0,0
18199,close,0,0
18200,to,0,0
18201,the,0,0
18202,headset-only,0,0
18203,situation,0,0
18204,.,0,1
18205,Subjective,0,0
18206,rating,0,0
18207,scores,0,0
18208,coincided,0,0
18209,with,0,1
18210,these,0,0
18211,findings,0,0
18212,.,0,0
18213,DISCUSSION,0,0
18214,In,0,0
18215,helicopter,0,1
18216,noise,0,0
18217,",",0,0
18218,custom,0,0
18219,made,0,0
18220,ear,0,1
18221,plugs,0,0
18222,may,0,0
18223,provide,0,0
18224,a,0,0
18225,much,0,0
18226,improved,0,0
18227,speech,0,0
18228,intelligibility,0,0
18229,over,0,0
18230,conventional,0,1
18231,plugs,0,0
18232,when,0,0
18233,worn,0,0
18234,under,0,0
18235,a,0,0
18236,headset,0,0
18237,",",0,0
18238,while,0,0
18239,maintaining,0,0
18240,improved,0,0
18241,noise,0,0
18242,protection,0,0
18243,over,0,0
18244,the,0,0
18245,headset-alone,0,0
18246,situation,0,0
18247,.,0,1
18248,Custom,0,0
18249,made,0,0
18250,ear,0,1
18251,plugs,0,0
18252,might,0,0
18253,therefore,0,0
18254,be,0,0
18255,a,0,0
18256,good,0,0
18257,alternative,0,0
18258,to,0,0
18259,other,0,0
18260,forms,0,0
18261,of,0,0
18262,enhanced,0,0
18263,noise,0,0
18264,protection,0,0
18265,in,0,0
18266,helicopters,0,1
18267,.,0,1
18268,Physiologic,0,0
18269,modeling,0,0
18270,of,0,0
18271,the,0,0
18272,intravenous,0,0
18273,glucose,0,0
18274,tolerance,0,0
18275,test,0,0
18276,in,0,0
18277,type,1,1
18278,2,1,1
18279,diabetes,1,1
18280,:,1,1
18281,a,0,0
18282,new,0,0
18283,approach,0,0
18284,to,0,0
18285,the,0,0
18286,insulin,0,0
18287,compartment,0,0
18288,.,0,0
18289,The,0,0
18290,minimal,0,0
18291,model,0,0
18292,of,0,0
18293,Bergman,0,1
18294,et,0,0
18295,al,0,0
18296,has,0,0
18297,been,0,0
18298,used,0,0
18299,to,0,0
18300,yield,0,0
18301,estimates,0,0
18302,of,0,0
18303,insulin,0,0
18304,sensitivity,0,0
18305,(,0,0
18306,Si,0,0
18307,),0,0
18308,and,0,0
18309,glucose,0,0
18310,effectiveness,0,0
18311,(,0,0
18312,Sg,0,0
18313,),0,0
18314,in,0,0
18315,type,0,1
18316,2,0,0
18317,diabetes,0,1
18318,by,0,0
18319,incorporating,0,0
18320,exogenous,0,0
18321,insulin,0,0
18322,protocols,0,0
18323,into,0,0
18324,the,0,0
18325,regular,0,0
18326,intravenous,0,0
18327,glucose,0,0
18328,tolerance,0,0
18329,test,0,0
18330,(,0,0
18331,IVGTT,0,1
18332,),0,0
18333,.,0,0
18334,These,0,0
18335,estimates,0,0
18336,",",0,0
18337,however,0,0
18338,",",0,0
18339,are,0,0
18340,influenced,0,0
18341,by,0,0
18342,the,0,0
18343,degree,0,0
18344,to,0,0
18345,which,0,0
18346,the,0,0
18347,dose,0,0
18348,of,0,0
18349,exogenous,0,0
18350,insulin,0,0
18351,is,0,0
18352,greater,0,0
18353,than,0,0
18354,the,0,0
18355,physiologic,0,0
18356,response,0,0
18357,to,0,0
18358,a,0,0
18359,glucose,0,0
18360,load,0,0
18361,.,0,0
18362,Moreover,0,0
18363,",",0,0
18364,most,0,0
18365,studies,0,0
18366,have,0,0
18367,related,0,0
18368,to,0,0
18369,type,1,1
18370,2,1,0
18371,diabetes,1,1
18372,subjects,1,1
18373,whose,0,1
18374,diabetes,0,1
18375,was,0,0
18376,relatively,0,0
18377,mild,0,1
18378,in,0,0
18379,terms,0,0
18380,of,0,1
18381,therapeutic,0,1
18382,requirements,0,1
18383,.,0,1
18384,To,0,0
18385,develop,0,0
18386,a,0,0
18387,minimal,0,0
18388,disturbance,0,0
18389,approach,0,0
18390,in,0,0
18391,estimating,0,0
18392,Si,0,0
18393,and,0,0
18394,Sg,0,0
18395,in,0,0
18396,type,0,1
18397,2,0,0
18398,diabetes,0,1
18399,",",0,0
18400,we,0,0
18401,have,0,0
18402,used,0,0
18403,a,0,0
18404,reduced,0,0
18405,glucose,0,0
18406,load,0,0
18407,(,0,0
18408,200,0,0
18409,mg/kg,0,0
18410,),0,0
18411,and,0,0
18412,a,0,0
18413,physiologic,0,0
18414,insulin,0,0
18415,infusion,0,0
18416,throughout,0,0
18417,the,0,0
18418,IVGTT,0,0
18419,in,0,0
18420,a,0,0
18421,series,0,0
18422,of,0,0
18423,8,1,0
18424,patients,1,1
18425,",",1,0
18426,5,1,1
18427,of,1,1
18428,whom,1,1
18429,were,1,1
18430,insulin-requiring,1,1
18431,.,1,1
18432,Data,0,0
18433,from,0,0
18434,this,0,0
18435,approach,0,0
18436,were,0,0
18437,analyzed,0,0
18438,using,0,0
18439,the,0,0
18440,modelling,0,0
18441,program,0,0
18442,CONSAM,0,0
18443,to,0,0
18444,apply,0,0
18445,the,0,0
18446,Bergman,0,1
18447,model,0,0
18448,",",0,0
18449,either,0,0
18450,unmodified,0,0
18451,(,0,0
18452,BMM,0,0
18453,),0,0
18454,",",0,0
18455,or,0,0
18456,incorporating,0,0
18457,an,0,0
18458,additional,0,0
18459,delay,0,0
18460,element,0,0
18461,between,0,0
18462,the,0,0
18463,plasma,0,0
18464,and,0,0
18465,remote,0,0
18466,insulin,0,0
18467,compartments,0,0
18468,(,0,1
18469,MMD,0,1
18470,),0,0
18471,.,0,0
18472,Application,0,0
18473,of,0,0
18474,the,0,0
18475,MMD,0,0
18476,and,0,0
18477,extension,0,0
18478,of,0,0
18479,the,0,0
18480,IVGTT,0,1
18481,from,0,0
18482,3,0,0
18483,to,0,1
18484,5,0,1
18485,hours,0,0
18486,improved,0,0
18487,successful,0,0
18488,resolution,0,0
18489,of,0,0
18490,Si,0,0
18491,and,0,0
18492,Sg,0,1
18493,from,0,1
18494,37.5,0,0
18495,%,0,0
18496,(,0,0
18497,BMM,0,0
18498,",",0,0
18499,3-hour,0,0
18500,IVGTT,0,1
18501,),0,1
18502,to,0,0
18503,100,0,0
18504,%,0,0
18505,(,0,0
18506,MMD,0,0
18507,",",0,0
18508,5-hour,0,0
18509,IVGTT,0,1
18510,),0,1
18511,.,0,1
18512,Si,0,0
18513,was,0,0
18514,reduced,0,0
18515,in,0,0
18516,these,0,0
18517,type,0,1
18518,2,0,0
18519,diabetes,0,1
18520,patients,0,1
18521,compared,0,0
18522,with,0,1
18523,normal,0,1
18524,subjects,0,1
18525,(,0,1
18526,1.86,0,0
18527,+/-,0,0
18528,0.60,0,0
18529,v.,0,0
18530,8.65,0,0
18531,+/-,0,0
18532,2.27,0,0
18533,min,0,0
18534,(,0,0
18535,-1,0,0
18536,),0,0
18537,x,0,0
18538,microU,0,0
18539,(,0,0
18540,-1,0,0
18541,),0,0
18542,x,0,0
18543,mL,0,0
18544,x,0,0
18545,10,0,1
18546,(,0,0
18547,4,0,0
18548,),0,1
18549,P,0,0
18550,<,0,0
18551,.01,0,0
18552,),0,0
18553,.,0,0
18554,The,0,0
18555,results,0,0
18556,were,0,0
18557,validated,0,0
18558,in,0,0
18559,the,0,0
18560,type,1,1
18561,2,1,0
18562,diabetes,1,1
18563,group,1,1
18564,using,0,0
18565,a,0,0
18566,2-stage,0,1
18567,euglycemic,0,0
18568,clamp,0,0
18569,(,0,0
18570,(,0,0
18571,Si,0,0
18572,),0,0
18573,CLAMP,0,0
18574,=,0,0
18575,2.02,0,0
18576,+/-,0,0
18577,0.42,0,0
18578,min,0,0
18579,(,0,0
18580,-1,0,0
18581,),0,0
18582,x,0,0
18583,microU,0,0
18584,(,0,0
18585,-1,0,0
18586,),0,0
18587,x,0,0
18588,mL,0,0
18589,x,0,0
18590,10,0,1
18591,(,0,0
18592,4,0,0
18593,),0,1
18594,P,0,0
18595,>,0,1
18596,.4,0,0
18597,),0,1
18598,.,0,1
18599,Sg,0,0
18600,was,0,0
18601,not,0,0
18602,significantly,0,0
18603,reduced,0,0
18604,(,0,0
18605,2.00,0,0
18606,+/-,0,0
18607,0.25,0,0
18608,type,0,1
18609,2,0,1
18610,diabetes,0,1
18611,v.,0,0
18612,1.55,0,0
18613,+/-,0,0
18614,0.26,0,0
18615,normal,0,1
18616,min,0,0
18617,(,0,0
18618,-1,0,0
18619,),0,0
18620,x,0,0
18621,10,0,0
18622,(,0,0
18623,2,0,1
18624,),0,1
18625,),0,1
18626,.,0,1
18627,Data,0,0
18628,from,0,0
18629,a,0,0
18630,group,0,0
18631,of,0,0
18632,normal,1,1
18633,nondiabetic,1,1
18634,subjects,1,1
18635,was,0,0
18636,then,0,0
18637,analyzed,0,0
18638,using,0,0
18639,the,0,0
18640,MMD,0,0
18641,",",0,0
18642,but,0,0
18643,this,0,0
18644,approach,0,0
18645,did,0,0
18646,not,0,0
18647,enhance,0,0
18648,the,0,0
18649,fit,0,0
18650,of,0,0
18651,the,0,0
18652,model,0,0
18653,compared,0,0
18654,with,0,1
18655,the,0,0
18656,BMM,0,0
18657,.,0,0
18658,This,0,0
18659,result,0,0
18660,indicates,0,0
18661,that,0,0
18662,the,0,0
18663,delay,0,0
18664,in,0,0
18665,insulin,0,0
18666,action,0,0
18667,in,0,0
18668,type,0,1
18669,2,0,0
18670,diabetes,0,1
18671,represents,0,0
18672,an,0,0
18673,abnormality,0,0
18674,whereby,0,0
18675,the,0,0
18676,onset,0,0
18677,of,0,0
18678,insulin,0,0
18679,action,0,0
18680,can,0,0
18681,not,0,0
18682,be,0,0
18683,described,0,0
18684,as,0,0
18685,a,0,0
18686,single,0,0
18687,phase,0,0
18688,in,0,0
18689,the,0,0
18690,transfer,0,0
18691,of,0,0
18692,insulin,0,0
18693,from,0,0
18694,plasma,0,0
18695,to,0,0
18696,the,0,0
18697,remote,0,0
18698,compartment,0,0
18699,.,0,0
18700,It,0,0
18701,is,0,0
18702,postulated,0,0
18703,that,0,0
18704,the,0,0
18705,physiologic,0,0
18706,basis,0,0
18707,for,0,0
18708,this,0,0
18709,delayed,0,0
18710,action,0,0
18711,may,0,0
18712,relate,0,0
18713,to,0,0
18714,transcapillary,0,0
18715,endothelial,0,0
18716,transfer,0,0
18717,of,0,0
18718,insulin,0,0
18719,",",0,0
18720,this,0,0
18721,process,0,0
18722,limiting,0,0
18723,the,0,0
18724,rate,0,0
18725,of,0,0
18726,onset,0,1
18727,of,0,0
18728,insulin,0,0
18729,action,0,0
18730,.,0,1
18731,Comments,0,0
18732,on,0,0
18733,Comparison,0,0
18734,of,0,0
18735,gastrointestinal,0,1
18736,tolerance,0,0
18737,feeding,0,0
18738,proctocols,0,1
18739,in,0,0
18740,critically,1,1
18741,ill,1,1
18742,patients,1,1
18743,:,1,1
18744,a,0,0
18745,prospective,0,0
18746,",",0,0
18747,randomized,1,0
18748,controlled,1,0
18749,clinical,1,0
18750,trial,1,1
18751,.,0,1
18752,[,0,0
18753,Clinical,0,0
18754,and,0,0
18755,experimental,0,0
18756,research,0,0
18757,of,0,0
18758,Epimedium,0,0
18759,brevicornum,0,1
18760,in,0,0
18761,relieving,1,0
18762,neuroendocrino-immunological,1,1
18763,effect,1,0
18764,inhibited,0,0
18765,by,0,0
18766,exogenous,0,0
18767,glucocorticoid,0,0
18768,],0,0
18769,.,0,0
18770,OBJECTIVE,0,0
18771,To,0,0
18772,study,0,0
18773,protective,0,0
18774,effect,0,0
18775,of,0,0
18776,Epimedium,0,0
18777,brevicornum,0,1
18778,(,0,0
18779,EB,0,0
18780,),0,0
18781,on,0,0
18782,hypothalamus-pituitary-adrenal-thymus,0,0
18783,(,0,0
18784,HPAT,0,0
18785,),0,0
18786,axis,0,0
18787,inhibited,0,0
18788,by,0,0
18789,exogenous,0,0
18790,glucocorticoid,0,0
18791,.,0,0
18792,METHODS,0,0
18793,In,0,0
18794,clinical,0,0
18795,research,0,0
18796,",",0,0
18797,variation,0,0
18798,of,0,0
18799,cortisol,0,0
18800,",",0,0
18801,adrenocorticotrophin,0,0
18802,(,0,0
18803,ACTH,0,1
18804,),0,0
18805,",",0,0
18806,lymphocyte,0,0
18807,proliferative,0,1
18808,reaction,0,1
18809,were,0,0
18810,observed,0,0
18811,before,0,0
18812,and,0,0
18813,after,0,0
18814,medication,0,0
18815,in,0,0
18816,65,1,1
18817,patients,1,1
18818,took,1,1
18819,prednisone,1,0
18820,",",1,0
18821,and,1,0
18822,were,1,0
18823,randomly,1,1
18824,divided,1,1
18825,into,1,0
18826,Fufang,1,0
18827,prednisone,1,0
18828,group,1,0
18829,(,1,0
18830,mixture,1,0
18831,of,1,0
18832,prednisone,1,0
18833,and,1,0
18834,EB,1,0
18835,),1,0
18836,and,1,0
18837,prednisone,1,0
18838,group,1,0
18839,.,1,0
18840,An,0,0
18841,experimental,0,0
18842,model,0,0
18843,of,0,0
18844,HPAT,0,0
18845,axis,0,0
18846,inhibited,0,0
18847,by,0,0
18848,corticosterone,0,0
18849,(,0,0
18850,CORT,0,1
18851,),0,0
18852,was,0,0
18853,established,0,0
18854,to,0,0
18855,observe,0,0
18856,the,0,0
18857,effect,0,0
18858,of,0,0
18859,EB,0,0
18860,on,0,0
18861,relevant,0,0
18862,indices,0,0
18863,of,0,0
18864,HPAT,0,0
18865,axis,0,0
18866,.,0,0
18867,RESULTS,0,0
18868,The,0,0
18869,level,0,0
18870,of,0,0
18871,ACTH,0,1
18872,and,0,0
18873,CORT,0,0
18874,in,0,0
18875,plasma,0,0
18876,decreased,0,0
18877,and,0,0
18878,lymphocyte,0,0
18879,proliferative,0,1
18880,reaction,0,0
18881,reduced,0,0
18882,in,0,0
18883,patients,0,1
18884,(,0,1
18885,P,0,0
18886,<,0,0
18887,0.05,0,0
18888,),0,0
18889,.,0,1
18890,In,0,0
18891,experimental,0,0
18892,study,0,0
18893,",",0,0
18894,monoaminic,0,1
18895,transmitters,0,0
18896,activated,0,0
18897,in,0,0
18898,hypothalamus,0,0
18899,;,0,0
18900,weight,0,0
18901,of,0,0
18902,pituitary,0,1
18903,",",0,0
18904,adrenal,0,1
18905,and,0,0
18906,thymus,0,0
18907,decreased,0,0
18908,;,0,0
18909,number,0,0
18910,of,0,0
18911,CRH,0,1
18912,positive,0,1
18913,neurons,0,1
18914,in,0,1
18915,hypothalamic,0,1
18916,paraventricular,0,0
18917,nucleus,0,0
18918,",",0,0
18919,CRH,0,1
18920,positive,0,0
18921,neurofibrilin,0,1
18922,median,0,0
18923,eminence,0,0
18924,and,0,0
18925,anterior,0,1
18926,pituitary,0,1
18927,ACTH,0,1
18928,positive,0,1
18929,secretory,0,1
18930,cells,0,0
18931,decreased,0,0
18932,;,0,1
18933,adrenal,0,1
18934,fasciculate,0,0
18935,zone,0,1
18936,and,0,0
18937,thymus,0,0
18938,cortex,0,0
18939,atrophies,0,1
18940,;,0,1
18941,NK,0,0
18942,cell,0,1
18943,cytotoxicity,0,0
18944,and,0,0
18945,the,0,0
18946,level,0,0
18947,of,0,0
18948,IL-2,0,0
18949,and,0,0
18950,gamma-IFN,0,0
18951,which,0,0
18952,were,0,0
18953,produced,0,0
18954,by,0,0
18955,lymphocytes,0,0
18956,reduced,0,0
18957,in,0,0
18958,CORT-rats,0,0
18959,(,0,1
18960,P,0,0
18961,<,0,0
18962,0.05,0,0
18963,),0,0
18964,.,0,0
18965,There,0,0
18966,were,0,0
18967,significant,0,0
18968,difference,0,0
18969,between,0,0
18970,Fufang,0,0
18971,prednisone,0,0
18972,group,0,0
18973,(,0,0
18974,clinical,0,0
18975,research,0,1
18976,),0,0
18977,or,0,1
18978,EB,0,0
18979,group,0,0
18980,(,0,0
18981,experimental,0,0
18982,research,0,1
18983,),0,0
18984,and,0,0
18985,CORT,0,1
18986,control,0,1
18987,groups,0,0
18988,",",0,0
18989,P,0,0
18990,<,0,0
18991,0.05,0,0
18992,.,0,0
18993,CONCLUSION,0,0
18994,EB,0,0
18995,could,0,0
18996,relieve,0,0
18997,neuroendocrino-immunological,0,0
18998,effect,0,0
18999,inhibited,0,0
19000,by,0,0
19001,exogenous,0,0
19002,glucocorticoid,0,0
19003,.,0,1
19004,Dose,0,0
19005,response,0,0
19006,effect,0,0
19007,of,0,0
19008,cyclical,0,0
19009,medroxyprogesterone,0,0
19010,on,0,0
19011,blood,0,0
19012,pressure,0,0
19013,in,0,0
19014,postmenopausal,1,1
19015,women,1,1
19016,.,1,1
19017,OBJECTIVE,0,0
19018,This,0,0
19019,study,0,0
19020,was,0,0
19021,designed,0,0
19022,to,0,0
19023,compare,0,0
19024,with,0,1
19025,placebo,0,0
19026,the,0,0
19027,dose-response,0,0
19028,effect,0,0
19029,of,0,0
19030,cyclical,0,0
19031,doses,0,0
19032,of,0,0
19033,the,0,0
19034,C21,0,0
19035,progestogen,0,0
19036,",",0,0
19037,medroxyprogesterone,0,0
19038,acetate,0,0
19039,(,0,0
19040,MPA,0,0
19041,),0,0
19042,on,0,0
19043,blood,0,0
19044,pressure,0,0
19045,(,0,0
19046,BP,0,0
19047,),0,0
19048,when,0,0
19049,administered,0,0
19050,to,0,0
19051,normotensive,1,1
19052,postmenopausal,1,1
19053,women,1,1
19054,receiving,1,1
19055,a,1,0
19056,fixed,1,0
19057,mid-range,1,1
19058,daily,1,0
19059,dose,1,0
19060,of,1,0
19061,conjugated,1,0
19062,equine,1,1
19063,oestrogen,1,0
19064,(,1,0
19065,CEE,1,0
19066,),1,1
19067,.,1,0
19068,MATERIALS,0,0
19069,AND,0,0
19070,METHODS,0,0
19071,Twenty,1,1
19072,normotensive,1,1
19073,postmenopausal,1,1
19074,women,1,1
19075,(,1,0
19076,median,1,1
19077,age,1,1
19078,53,1,1
19079,years,1,1
19080,),1,1
19081,participated,0,1
19082,in,0,0
19083,the,0,0
19084,study,0,0
19085,which,0,0
19086,used,0,0
19087,a,0,0
19088,double-blind,0,0
19089,crossover,0,0
19090,design,0,0
19091,.,0,0
19092,There,0,0
19093,were,0,0
19094,four,0,0
19095,randomised,0,0
19096,treatment,0,0
19097,phases,0,0
19098,",",0,0
19099,each,0,0
19100,of,0,0
19101,4,0,0
19102,weeks,0,0
19103,duration,0,0
19104,.,0,1
19105,The,0,0
19106,four,0,0
19107,blinded,0,0
19108,treatments,0,0
19109,were,0,1
19110,MPA,0,0
19111,2.5,0,0
19112,mg,0,0
19113,",",0,0
19114,MPA,0,0
19115,5,0,0
19116,mg,0,0
19117,",",0,0
19118,MPA,0,0
19119,10,0,0
19120,mg,0,0
19121,and,0,0
19122,matching,0,0
19123,placebo,0,0
19124,",",0,0
19125,taken,0,0
19126,for,0,0
19127,the,0,0
19128,last,0,0
19129,14,0,0
19130,days,0,0
19131,of,0,0
19132,each,0,1
19133,28,0,0
19134,day,0,0
19135,treatment,0,0
19136,cycle,0,0
19137,.,0,1
19138,CEE,0,0
19139,0.625,0,0
19140,mg,0,0
19141,was,0,0
19142,also,0,0
19143,administered,0,0
19144,once,0,0
19145,daily,0,0
19146,as,0,0
19147,open,0,1
19148,labelled,0,0
19149,tablets,0,0
19150,to,0,0
19151,all,0,1
19152,subjects,0,1
19153,throughout,0,0
19154,the,0,0
19155,study,0,0
19156,.,0,0
19157,Clinic,0,0
19158,BP,0,0
19159,was,0,0
19160,measured,0,0
19161,weekly,0,0
19162,with,0,1
19163,the,0,0
19164,mean,0,0
19165,values,0,0
19166,of,0,1
19167,weeks,0,0
19168,3,0,1
19169,and,0,1
19170,4,0,0
19171,of,0,0
19172,each,0,0
19173,phase,0,0
19174,used,0,0
19175,for,0,0
19176,analysis,0,0
19177,.,0,1
19178,Ambulatory,0,1
19179,BP,0,0
19180,was,0,0
19181,performed,0,0
19182,in,0,0
19183,the,0,0
19184,final,0,0
19185,week,0,0
19186,of,0,0
19187,each,0,0
19188,phase,0,0
19189,.,0,0
19190,RESULTS,0,0
19191,Compared,0,0
19192,with,0,1
19193,the,0,0
19194,placebo,0,0
19195,phase,0,0
19196,",",0,0
19197,end,0,0
19198,of,0,0
19199,phase,0,1
19200,clinic,0,1
19201,BP,0,0
19202,was,0,0
19203,unchanged,0,0
19204,by,0,0
19205,any,0,0
19206,of,0,0
19207,the,0,0
19208,progestogen,0,0
19209,treatments,0,0
19210,.,0,0
19211,There,0,0
19212,was,0,0
19213,a,0,0
19214,dose-dependent,0,0
19215,decrease,0,0
19216,in,0,0
19217,ambulatory,0,1
19218,daytime,0,1
19219,diastolic,0,1
19220,and,0,0
19221,mean,0,1
19222,arterial,0,1
19223,BP,0,0
19224,with,0,1
19225,the,0,0
19226,progestogen,0,0
19227,treatments,0,0
19228,compared,0,0
19229,with,0,1
19230,placebo,0,0
19231,(,0,0
19232,P,0,0
19233,<,0,0
19234,0.05,0,0
19235,),0,1
19236,.,0,1
19237,CONCLUSION,0,0
19238,In,0,0
19239,a,0,0
19240,regimen,0,0
19241,of,0,0
19242,postmenopausal,0,1
19243,hormone,0,0
19244,replacement,0,0
19245,therapy,0,0
19246,with,0,1
19247,a,0,0
19248,fixed,0,0
19249,mid-range,0,1
19250,daily,0,0
19251,dose,0,0
19252,of,0,0
19253,CEE,0,0
19254,combined,0,0
19255,with,0,1
19256,a,0,0
19257,cyclical,0,0
19258,regimen,0,0
19259,of,0,0
19260,a,0,0
19261,C21,0,1
19262,progestogen,0,0
19263,spanning,0,1
19264,the,0,0
19265,current,0,0
19266,clinical,0,0
19267,dose,0,0
19268,range,0,0
19269,",",0,0
19270,the,0,0
19271,progestogen,0,0
19272,has,0,0
19273,either,0,0
19274,no,0,0
19275,effect,0,0
19276,or,0,0
19277,a,0,0
19278,small,0,0
19279,dose-dependent,0,0
19280,reduction,0,0
19281,in,0,0
19282,clinic,0,1
19283,and,0,0
19284,ambulatory,0,0
19285,BPs,0,0
19286,over,0,0
19287,one,0,1
19288,treatment,0,0
19289,cycle,0,0
19290,.,0,1
19291,Why,0,0
19292,were,0,0
19293,the,0,0
19294,results,0,0
19295,of,0,0
19296,the,0,0
19297,Heart,0,1
19298,Outcomes,0,0
19299,Prevention,0,1
19300,Evaluation,0,0
19301,(,0,0
19302,HOPE,0,0
19303,),0,0
19304,trial,0,0
19305,so,0,0
19306,astounding,0,0
19307,?,0,0
19308,The,0,0
19309,Heart,0,0
19310,Outcomes,0,0
19311,Prevention,0,1
19312,Evaluation,0,0
19313,(,0,0
19314,HOPE,0,0
19315,),0,0
19316,study,0,0
19317,was,0,0
19318,important,0,0
19319,because,0,0
19320,it,0,0
19321,showed,0,0
19322,the,0,0
19323,benefits,0,0
19324,of,0,0
19325,ramipril,0,0
19326,-,0,0
19327,an,0,0
19328,angiotensin-converting,0,0
19329,enzyme,0,0
19330,(,0,0
19331,ACE,0,1
19332,),0,1
19333,inhibitor,0,0
19334,-,0,0
19335,in,0,0
19336,patients,1,1
19337,at,1,1
19338,high,1,1
19339,risk,1,0
19340,for,1,0
19341,cardiovascular,1,1
19342,events,1,0
19343,.,1,1
19344,Treatment,0,0
19345,with,0,0
19346,ramipril,0,0
19347,significantly,0,0
19348,reduced,0,0
19349,the,0,0
19350,rates,0,0
19351,of,0,0
19352,death,0,0
19353,",",0,0
19354,myocardial,0,1
19355,infarction,0,1
19356,",",0,0
19357,stroke,0,1
19358,",",0,0
19359,coronary,0,1
19360,revascularization,0,0
19361,",",0,0
19362,cardiac,0,1
19363,arrest,0,1
19364,and,0,0
19365,heart,0,1
19366,failure,0,1
19367,",",0,0
19368,as,0,0
19369,well,0,0
19370,as,0,0
19371,the,0,0
19372,risk,0,0
19373,of,0,0
19374,diabetes-related,0,0
19375,complications,0,0
19376,and,0,1
19377,of,0,0
19378,diabetes,0,1
19379,itself,0,0
19380,.,0,1
19381,The,0,0
19382,effects,0,0
19383,of,0,0
19384,therapy,0,0
19385,with,0,1
19386,vitamin,0,0
19387,E,0,0
19388,were,0,0
19389,also,0,0
19390,evaluated,0,0
19391,",",0,0
19392,but,0,0
19393,no,0,0
19394,statistical,0,0
19395,benefits,0,0
19396,were,0,1
19397,shown,0,0
19398,.,0,0
19399,The,0,0
19400,benefits,0,0
19401,of,0,0
19402,ACE,0,1
19403,inhibitor,0,0
19404,therapy,0,0
19405,that,0,0
19406,were,0,0
19407,observed,0,0
19408,were,0,0
19409,likely,0,0
19410,due,0,0
19411,to,0,0
19412,a,0,0
19413,variety,0,0
19414,of,0,0
19415,mechanisms,0,0
19416,",",0,0
19417,not,0,0
19418,just,0,0
19419,a,0,0
19420,reduction,0,0
19421,in,0,0
19422,blood,0,0
19423,pressure,0,0
19424,.,0,1
19425,Treating,0,0
19426,the,0,0
19427,substance-abusing,1,1
19428,suicidal,1,0
19429,patient,1,1
19430,.,1,0
19431,Studies,0,0
19432,concerning,0,0
19433,the,0,0
19434,treatment,0,0
19435,of,0,0
19436,substance-abusing,1,1
19437,suicidal,1,1
19438,patients,1,1
19439,are,0,0
19440,scarce,0,0
19441,despite,0,0
19442,the,0,0
19443,frequent,0,0
19444,presence,0,0
19445,of,0,0
19446,suicidal,0,0
19447,behavior,0,0
19448,among,0,0
19449,this,0,0
19450,population,0,1
19451,.,0,0
19452,Indeed,0,0
19453,",",0,0
19454,suicidality,0,0
19455,(,0,0
19456,ideation,0,0
19457,or,0,1
19458,behavior,0,0
19459,),0,0
19460,is,0,0
19461,generally,0,0
19462,an,0,0
19463,exclusion,0,0
19464,criterion,0,0
19465,for,0,0
19466,participation,0,0
19467,in,0,0
19468,treatment,0,0
19469,studies,0,0
19470,of,0,0
19471,subjects,1,1
19472,with,1,1
19473,alcohol,1,1
19474,or,1,1
19475,drug,1,0
19476,abuse,1,1
19477,.,1,0
19478,Consequently,0,0
19479,",",0,0
19480,to,0,0
19481,date,0,0
19482,",",0,0
19483,little,0,0
19484,is,0,0
19485,known,0,0
19486,about,0,0
19487,the,0,0
19488,optimal,0,0
19489,treatment,0,0
19490,of,0,0
19491,this,0,0
19492,population,0,1
19493,.,0,0
19494,The,0,0
19495,first,0,0
19496,study,0,0
19497,involving,0,1
19498,substance-abusing,1,1
19499,suicidal,1,1
19500,patients,1,1
19501,was,0,0
19502,an,0,0
19503,open-label,0,0
19504,trial,0,0
19505,conducted,0,0
19506,in,0,0
19507,the,0,0
19508,early,0,1
19509,1990s,0,0
19510,.,0,0
19511,This,0,0
19512,study,0,0
19513,involved,0,0
19514,12,1,0
19515,patients,1,1
19516,",",1,0
19517,all,1,1
19518,of,1,0
19519,whom,1,1
19520,demonstrated,1,1
19521,recent,1,1
19522,suicidal,1,1
19523,ideations,1,0
19524,and,1,1
19525,had,1,1
19526,made,1,0
19527,a,1,0
19528,lifetime,1,0
19529,suicide,1,1
19530,attempt,1,0
19531,.,1,0
19532,The,0,0
19533,results,0,0
19534,of,0,0
19535,that,0,0
19536,open-label,0,0
19537,study,0,0
19538,demonstrated,0,0
19539,significant,0,0
19540,within-group,0,0
19541,improvement,0,0
19542,in,0,0
19543,both,0,0
19544,depressive,0,0
19545,symptoms,0,0
19546,(,0,1
19547,including,0,1
19548,suicidal,0,0
19549,ideations,0,0
19550,),0,1
19551,and,0,0
19552,level,0,0
19553,of,0,0
19554,drinking,0,0
19555,.,0,0
19556,However,0,0
19557,",",0,0
19558,substantial,0,0
19559,residual,0,0
19560,depressive,0,0
19561,symptoms,0,0
19562,and,0,0
19563,drinking,0,0
19564,persisted,0,0
19565,at,0,0
19566,the,0,0
19567,end,0,0
19568,of,0,0
19569,the,0,0
19570,trial,0,0
19571,.,0,0
19572,Also,0,0
19573,",",0,0
19574,because,0,0
19575,no,0,0
19576,placebo,0,0
19577,control,0,0
19578,group,0,0
19579,was,0,0
19580,utilized,0,0
19581,",",0,0
19582,the,0,0
19583,authors,0,0
19584,of,0,0
19585,that,0,0
19586,study,0,0
19587,could,0,0
19588,not,0,0
19589,rule,0,0
19590,out,0,0
19591,the,0,0
19592,possibility,0,0
19593,that,0,0
19594,the,0,0
19595,apparent,0,0
19596,therapeutic,0,0
19597,effect,0,0
19598,from,0,1
19599,fluoxetine,0,0
19600,was,0,0
19601,the,0,0
19602,result,0,0
19603,of,0,0
19604,the,0,0
19605,placebo,0,0
19606,effect,0,0
19607,.,0,0
19608,To,0,0
19609,date,0,0
19610,",",0,0
19611,only,0,0
19612,one,0,0
19613,double-blind,0,0
19614,",",0,0
19615,placebo-controlled,0,0
19616,study,0,0
19617,of,0,0
19618,subjects,1,1
19619,with,1,1
19620,alcohol,1,1
19621,or,1,1
19622,substance,1,0
19623,abuse,1,0
19624,has,0,0
19625,included,0,0
19626,substantial,0,0
19627,numbers,0,0
19628,of,0,1
19629,suicidal,0,1
19630,patients,0,1
19631,.,0,1
19632,The,0,0
19633,study,0,0
19634,involved,0,0
19635,51,1,1
19636,subjects,1,1
19637,",",1,1
19638,of,1,1
19639,whom,1,1
19640,20,1,1
19641,(,1,1
19642,39,1,1
19643,%,1,0
19644,),1,0
19645,had,1,0
19646,made,1,0
19647,a,1,0
19648,suicide,1,1
19649,attempt,1,0
19650,in,1,0
19651,the,1,0
19652,current,1,0
19653,depressive,1,0
19654,episode,1,1
19655,",",1,0
19656,31,1,1
19657,(,1,0
19658,61,1,1
19659,%,1,0
19660,),1,0
19661,had,1,0
19662,made,1,0
19663,a,1,0
19664,suicide,1,1
19665,attempt,1,0
19666,in,1,0
19667,their,1,0
19668,lifetime,1,0
19669,",",1,0
19670,and,1,0
19671,46,1,1
19672,(,1,0
19673,90,1,0
19674,%,1,0
19675,),1,0
19676,had,1,0
19677,reported,1,0
19678,suicidal,1,0
19679,ideations,1,0
19680,in,1,0
19681,the,1,0
19682,week,1,0
19683,before,1,0
19684,hospitalization,1,0
19685,.,1,0
19686,The,0,0
19687,results,0,0
19688,of,0,0
19689,that,0,0
19690,double-blind,0,0
19691,",",0,0
19692,placebo-controlled,0,0
19693,study,0,0
19694,suggest,0,0
19695,that,0,0
19696,fluoxetine,0,0
19697,was,0,0
19698,effective,0,0
19699,in,0,0
19700,decreasing,0,0
19701,but,0,0
19702,not,0,0
19703,eliminating,0,0
19704,both,0,0
19705,the,0,0
19706,depressive,0,0
19707,symptoms,0,0
19708,(,0,0
19709,including,0,1
19710,suicidal,0,0
19711,ideations,0,0
19712,),0,1
19713,and,0,0
19714,the,0,0
19715,level,0,0
19716,of,0,0
19717,alcohol,0,1
19718,consumption,0,0
19719,among,0,0
19720,a,0,0
19721,study,0,0
19722,group,0,0
19723,of,0,0
19724,subjects,0,1
19725,with,0,1
19726,comorbid,0,1
19727,major,0,1
19728,depressive,0,0
19729,disorder,0,1
19730,and,0,0
19731,alcohol,0,0
19732,dependence,0,0
19733,",",0,0
19734,many,0,1
19735,of,0,1
19736,whom,0,1
19737,displayed,0,1
19738,suicidal,0,1
19739,ideations,0,0
19740,.,0,1
19741,A,0,0
19742,secondary,0,0
19743,data,0,0
19744,analysis,0,0
19745,from,0,0
19746,that,0,0
19747,study,0,0
19748,suggested,0,0
19749,that,0,0
19750,cigarette,0,0
19751,smoking,0,0
19752,is,0,0
19753,also,0,0
19754,significantly,0,0
19755,decreased,0,0
19756,by,0,0
19757,fluoxetine,0,0
19758,",",0,0
19759,but,0,0
19760,the,0,0
19761,magnitude,0,0
19762,of,0,0
19763,the,0,0
19764,decrease,0,0
19765,is,0,0
19766,limited,0,0
19767,and,0,0
19768,few,0,0
19769,of,0,0
19770,these,0,0
19771,patients,0,1
19772,totally,0,1
19773,quit,0,1
19774,smoking,0,0
19775,with,0,1
19776,fluoxetine,0,0
19777,treatment,0,0
19778,alone,0,0
19779,.,0,0
19780,Another,0,0
19781,secondary,0,0
19782,data,0,0
19783,analysis,0,0
19784,from,0,0
19785,that,0,0
19786,study,0,0
19787,suggested,0,0
19788,that,0,0
19789,marijuana,0,0
19790,smoking,0,0
19791,was,0,0
19792,also,0,0
19793,significantly,0,0
19794,decreased,0,0
19795,in,0,0
19796,a,0,0
19797,subgroup,0,1
19798,of,0,1
19799,subjects,0,1
19800,who,0,1
19801,demonstrated,0,1
19802,cannabis,0,1
19803,abuse,0,1
19804,and,0,0
19805,that,0,0
19806,the,0,0
19807,magnitude,0,0
19808,of,0,0
19809,this,0,0
19810,improvement,0,0
19811,was,0,0
19812,robust,0,0
19813,.,0,1
19814,A,0,0
19815,third,0,0
19816,secondary,0,1
19817,data,0,0
19818,analysis,0,0
19819,from,0,0
19820,that,0,0
19821,study,0,0
19822,suggested,0,0
19823,that,0,0
19824,cocaine,0,0
19825,abuse,0,0
19826,acts,0,0
19827,as,0,0
19828,a,0,0
19829,predictor,0,0
19830,of,0,0
19831,poor,0,0
19832,outcome,0,0
19833,for,0,0
19834,both,0,0
19835,depressive,0,0
19836,symptoms,0,0
19837,(,0,0
19838,including,0,0
19839,suicidality,0,0
19840,),0,0
19841,and,0,0
19842,level,0,0
19843,of,0,0
19844,alcohol,0,1
19845,use,0,0
19846,in,0,0
19847,this,0,0
19848,population,0,1
19849,.,0,0
19850,The,0,0
19851,results,0,0
19852,of,0,0
19853,a,0,1
19854,1-year,0,0
19855,naturalistic,0,0
19856,follow-up,0,0
19857,study,0,0
19858,involving,0,1
19859,the,0,0
19860,patients,0,1
19861,from,0,0
19862,that,0,0
19863,study,0,0
19864,suggest,0,0
19865,that,0,0
19866,the,0,0
19867,benefits,0,0
19868,of,0,0
19869,fluoxetine,0,0
19870,in,0,0
19871,decreasing,0,0
19872,depressive,0,0
19873,symptoms,0,0
19874,and,0,0
19875,level,0,0
19876,of,0,0
19877,drinking,0,0
19878,persist,0,0
19879,1,0,0
19880,year,0,0
19881,after,0,0
19882,entering,0,1
19883,the,0,0
19884,treatment,0,0
19885,program,0,0
19886,.,0,0
19887,To,0,0
19888,date,0,0
19889,",",0,0
19890,no,0,0
19891,other,0,0
19892,double-blind,0,0
19893,",",0,0
19894,placebo-controlled,0,0
19895,studies,0,0
19896,involving,0,1
19897,substantial,0,0
19898,numbers,0,0
19899,of,0,0
19900,substance-abusing,1,1
19901,suicidal,1,1
19902,patients,1,1
19903,have,0,0
19904,been,0,0
19905,reported,0,0
19906,to,0,0
19907,either,0,0
19908,confirm,0,0
19909,or,0,0
19910,refute,0,0
19911,these,0,0
19912,findings,0,0
19913,.,0,1
19914,Further,0,0
19915,studies,0,0
19916,are,0,0
19917,clearly,0,0
19918,warranted,0,0
19919,to,0,0
19920,evaluate,0,0
19921,the,0,0
19922,efficacy,0,0
19923,of,0,0
19924,various,0,0
19925,pharmacotherapeutic,0,1
19926,agents,0,0
19927,and,0,1
19928,various,0,0
19929,psychotherapies,0,0
19930,in,0,0
19931,the,0,0
19932,treatment,0,0
19933,of,0,0
19934,substance-abusing,1,1
19935,suicidal,1,1
19936,patients,1,1
19937,.,1,1
19938,Gabapentin,0,0
19939,but,0,0
19940,not,0,0
19941,vigabatrin,0,0
19942,is,0,0
19943,effective,0,0
19944,in,0,0
19945,the,0,0
19946,treatment,0,0
19947,of,0,0
19948,acquired,1,0
19949,nystagmus,1,0
19950,in,1,0
19951,multiple,1,0
19952,sclerosis,1,1
19953,:,1,1
19954,How,0,0
19955,valid,0,0
19956,is,0,0
19957,the,0,0
19958,GABAergic,0,0
19959,hypothesis,0,0
19960,?,0,0
19961,Acquired,0,0
19962,nystagmus,0,0
19963,occurs,0,0
19964,frequently,0,0
19965,in,0,0
19966,patients,1,1
19967,with,1,1
19968,multiple,1,0
19969,sclerosis,1,1
19970,and,0,0
19971,is,0,0
19972,often,0,0
19973,the,0,0
19974,cause,0,0
19975,of,0,0
19976,illusory,0,0
19977,motion,0,0
19978,of,0,0
19979,the,0,0
19980,environment,0,0
19981,(,0,0
19982,oscillopsia,0,0
19983,),0,0
19984,",",0,0
19985,and,0,0
19986,blurring,0,0
19987,of,0,0
19988,vision,0,0
19989,.,0,0
19990,Based,0,0
19991,primarily,0,0
19992,on,0,0
19993,the,0,0
19994,beneficial,0,0
19995,effect,0,0
19996,of,0,0
19997,gabapentin,0,0
19998,on,0,0
19999,acquired,0,0
20000,pendular,0,0
20001,nystagmus,0,0
20002,(,0,0
20003,APN,0,0
20004,),0,0
20005,",",0,0
20006,a,0,0
20007,GABAergic,0,0
20008,mechanism,0,0
20009,in,0,0
20010,controlling,0,0
20011,nystagmus,0,0
20012,has,0,0
20013,been,0,0
20014,hypothesised,0,0
20015,.,0,0
20016,If,0,0
20017,increasing,0,0
20018,GABA,0,0
20019,concentrations,0,0
20020,in,0,0
20021,the,0,0
20022,CNS,0,0
20023,are,0,0
20024,critical,0,0
20025,for,0,0
20026,the,0,0
20027,treatment,0,0
20028,of,0,0
20029,nystagmus,0,0
20030,",",0,0
20031,then,0,0
20032,a,0,0
20033,selective,0,0
20034,GABAergic,0,0
20035,drug,0,0
20036,should,0,0
20037,be,0,0
20038,highly,0,0
20039,successful,0,0
20040,.,0,0
20041,However,0,0
20042,",",0,0
20043,as,0,0
20044,gabapentin,0,0
20045,is,0,0
20046,not,0,0
20047,a,0,0
20048,selective,0,0
20049,GABAergic,0,0
20050,agent,0,0
20051,",",0,0
20052,vigabatrin,0,0
20053,",",0,0
20054,a,0,0
20055,pure,0,0
20056,GABAergic,0,0
20057,medication,0,0
20058,",",0,0
20059,and,0,0
20060,gabapentin,0,0
20061,",",0,0
20062,were,0,0
20063,compared,0,0
20064,in,0,0
20065,a,0,0
20066,single,0,0
20067,blind,0,0
20068,cross,0,1
20069,over,0,0
20070,trial,0,0
20071,in,0,0
20072,eight,1,1
20073,patients,1,1
20074,with,1,1
20075,definite,1,1
20076,multiple,1,0
20077,sclerosis,1,1
20078,.,1,1
20079,Patients,0,1
20080,were,0,0
20081,randomly,0,1
20082,assigned,0,0
20083,to,0,0
20084,begin,0,0
20085,with,0,1
20086,gabapentin,0,0
20087,(,0,0
20088,1200,0,0
20089,mg,0,0
20090,daily,0,0
20091,),0,0
20092,or,0,0
20093,vigabatrin,0,1
20094,(,0,0
20095,2000,0,1
20096,mg,0,0
20097,daily,0,0
20098,),0,0
20099,.,0,0
20100,Neuro-ophthalmological,0,0
20101,and,0,0
20102,electro-oculographic,0,0
20103,(,0,0
20104,EOG,0,1
20105,),0,1
20106,evaluations,0,0
20107,were,0,1
20108,performed,0,0
20109,four,0,1
20110,and,0,0
20111,three,0,0
20112,times,0,0
20113,",",0,0
20114,respectively,0,0
20115,.,0,0
20116,Treatment,0,0
20117,efficacy,0,0
20118,was,0,0
20119,based,0,0
20120,on,0,0
20121,improving,0,0
20122,visual,0,0
20123,acuity,0,0
20124,and,0,0
20125,EOG,0,0
20126,indices,0,0
20127,(,0,0
20128,amplitude,0,0
20129,or,0,0
20130,frequency,0,0
20131,of,0,0
20132,nystagmus,0,0
20133,",",0,0
20134,or,0,0
20135,both,0,0
20136,),0,0
20137,by,0,0
20138,at,0,0
20139,least,0,1
20140,50,0,1
20141,%,0,0
20142,of,0,0
20143,pretreatment,0,0
20144,values,0,0
20145,.,0,1
20146,Three,1,0
20147,out,1,0
20148,of,1,1
20149,eight,1,1
20150,patients,1,1
20151,dropped,1,0
20152,out,1,0
20153,due,1,0
20154,to,1,0
20155,adverse,1,0
20156,effects,1,0
20157,.,1,1
20158,In,0,0
20159,the,0,0
20160,remaining,0,0
20161,five,0,1
20162,patients,0,1
20163,gabapentin,0,0
20164,improved,0,0
20165,symptomatic,0,1
20166,pendular,0,0
20167,or,0,1
20168,gaze,0,0
20169,evoked,0,0
20170,jerk,0,0
20171,nystagmus,0,0
20172,in,0,0
20173,four,0,1
20174,.,0,1
20175,Three,1,1
20176,patients,1,1
20177,decided,1,0
20178,to,1,0
20179,continue,1,0
20180,gabapentin,1,0
20181,therapy,1,0
20182,.,1,0
20183,Importantly,0,0
20184,",",0,0
20185,vigabatrin,0,0
20186,proved,0,0
20187,useful,0,0
20188,in,0,0
20189,only,0,0
20190,one,0,0
20191,out,0,0
20192,of,0,1
20193,five,0,1
20194,patients,0,1
20195,",",0,0
20196,suggesting,0,0
20197,that,0,0
20198,gabapentin,0,0
20199,effectiveness,0,0
20200,may,0,0
20201,be,0,0
20202,related,0,0
20203,to,0,0
20204,additional,0,0
20205,non-GABAergic,0,0
20206,mechanisms,0,0
20207,of,0,0
20208,action,0,0
20209,.,0,0
20210,Interaction,0,0
20211,with,0,1
20212,cerebral,0,1
20213,glutamate,0,0
20214,transmission,0,0
20215,by,0,0
20216,inhibition,0,0
20217,of,0,0
20218,NMDA,0,0
20219,receptor,0,0
20220,might,0,0
20221,be,0,0
20222,an,0,0
20223,alternative,0,0
20224,hypothesis,0,0
20225,for,0,0
20226,the,0,0
20227,therapeutic,0,0
20228,action,0,0
20229,of,0,0
20230,gabapentin,0,0
20231,.,0,1
20232,Uncomplicated,0,0
20233,moderate,0,1
20234,coronary,1,1
20235,artery,1,1
20236,dissections,1,1
20237,after,0,0
20238,balloon,0,1
20239,angioplasty,0,1
20240,:,0,1
20241,good,0,0
20242,outcome,0,0
20243,without,0,1
20244,stenting,0,1
20245,.,0,1
20246,OBJECTIVE,0,0
20247,To,0,0
20248,study,0,0
20249,the,0,0
20250,relation,0,0
20251,between,0,0
20252,moderate,0,1
20253,coronary,0,1
20254,dissections,0,1
20255,",",0,0
20256,coronary,0,1
20257,flow,0,0
20258,velocity,0,0
20259,reserve,0,1
20260,(,0,0
20261,CFVR,0,0
20262,),0,0
20263,",",0,0
20264,and,0,0
20265,long,0,0
20266,term,0,1
20267,outcome,0,0
20268,.,0,1
20269,METHODS,0,0
20270,523,1,1
20271,patients,1,1
20272,undergoing,1,1
20273,balloon,1,0
20274,angioplasty,1,1
20275,and,1,0
20276,sequential,1,0
20277,intracoronary,1,1
20278,Doppler,1,1
20279,measurements,1,0
20280,were,0,0
20281,examined,0,0
20282,as,0,0
20283,part,0,0
20284,of,0,0
20285,the,0,0
20286,DEBATE,0,0
20287,II,0,1
20288,trial,0,0
20289,(,0,0
20290,Doppler,0,0
20291,endpoints,0,0
20292,balloon,0,0
20293,angioplasty,0,0
20294,trial,0,0
20295,Europe,0,1
20296,),0,0
20297,.,0,0
20298,After,1,0
20299,successful,1,0
20300,balloon,1,0
20301,angioplasty,1,1
20302,",",0,0
20303,patients,0,1
20304,were,0,0
20305,randomised,0,0
20306,to,0,0
20307,stenting,0,0
20308,or,0,0
20309,no,0,0
20310,further,0,0
20311,treatment,0,0
20312,.,0,1
20313,Dissections,0,0
20314,were,0,0
20315,graded,0,0
20316,at,0,0
20317,the,0,0
20318,core,0,0
20319,laboratory,0,0
20320,by,0,0
20321,two,0,0
20322,observers,0,1
20323,and,0,0
20324,divided,0,1
20325,into,0,1
20326,four,0,1
20327,categories,0,1
20328,:,0,1
20329,none,0,0
20330,",",0,0
20331,mild,0,1
20332,(,0,0
20333,type,0,1
20334,A-B,0,1
20335,),0,0
20336,",",0,0
20337,moderate,0,1
20338,(,0,0
20339,type,0,1
20340,C,0,0
20341,),0,0
20342,",",0,0
20343,severe,0,1
20344,(,0,0
20345,types,0,0
20346,D,0,0
20347,to,0,1
20348,F,0,1
20349,),0,1
20350,.,0,1
20351,Patients,1,1
20352,with,1,1
20353,severe,1,1
20354,dissections,1,1
20355,(,1,1
20356,n,1,1
20357,=,1,0
20358,128,1,1
20359,),1,0
20360,or,1,1
20361,without,1,1
20362,available,1,0
20363,reference,1,0
20364,vessel,1,0
20365,CFVR,1,0
20366,(,1,0
20367,n,1,1
20368,=,1,0
20369,139,1,1
20370,),1,0
20371,were,1,0
20372,excluded,1,0
20373,.,1,0
20374,The,0,0
20375,remaining,1,0
20376,256,1,1
20377,patients,1,1
20378,were,0,1
20379,divided,0,1
20380,into,0,1
20381,two,0,0
20382,groups,0,0
20383,according,0,1
20384,to,0,0
20385,the,0,0
20386,presence,0,0
20387,(,0,0
20388,group,0,0
20389,A,0,0
20390,",",0,0
20391,n,0,1
20392,=,0,0
20393,45,0,1
20394,),0,0
20395,or,0,1
20396,absence,0,0
20397,(,0,0
20398,group,0,0
20399,B,0,0
20400,",",0,0
20401,n,0,1
20402,=,0,0
20403,211,0,1
20404,),0,0
20405,of,0,0
20406,moderate,0,1
20407,dissection,0,1
20408,.,0,1
20409,RESULTS,0,0
20410,Following,0,0
20411,balloon,0,0
20412,angioplasty,0,0
20413,",",0,0
20414,there,0,0
20415,was,0,0
20416,no,0,0
20417,difference,0,0
20418,in,0,0
20419,CFVR,0,0
20420,between,0,0
20421,the,0,0
20422,two,0,0
20423,groups,0,0
20424,.,0,1
20425,At,0,0
20426,12,0,0
20427,months,0,0
20428,follow,0,0
20429,up,0,0
20430,",",0,0
20431,a,0,0
20432,higher,0,0
20433,rate,0,0
20434,of,0,0
20435,major,0,1
20436,adverse,0,0
20437,cardiac,0,1
20438,events,0,0
20439,was,0,0
20440,observed,0,0
20441,overall,0,0
20442,in,0,0
20443,group,0,0
20444,A,0,0
20445,than,0,0
20446,in,0,0
20447,group,0,1
20448,B,0,1
20449,(,0,0
20450,10,0,1
20451,(,0,0
20452,22,0,1
20453,%,0,0
20454,),0,0
20455,v,0,0
20456,23,0,1
20457,(,0,0
20458,11,0,0
20459,%,0,0
20460,),0,0
20461,",",0,0
20462,p,0,0
20463,=,0,0
20464,0.041,0,0
20465,),0,0
20466,.,0,0
20467,However,0,0
20468,",",0,0
20469,the,0,0
20470,risk,0,0
20471,of,0,0
20472,major,0,1
20473,adverse,0,0
20474,events,0,0
20475,was,0,0
20476,similar,0,0
20477,in,0,0
20478,the,0,0
20479,subgroups,0,0
20480,receiving,0,1
20481,balloon,0,0
20482,angioplasty,0,1
20483,(,0,0
20484,group,0,0
20485,A,0,0
20486,",",0,0
20487,6,0,0
20488,(,0,0
20489,19,0,1
20490,%,0,0
20491,),0,0
20492,v,0,0
20493,group,0,0
20494,B,0,0
20495,",",0,0
20496,16,0,1
20497,(,0,0
20498,16,0,1
20499,%,0,0
20500,),0,0
20501,",",0,0
20502,NS,0,0
20503,),0,0
20504,.,0,0
20505,Among,0,1
20506,group,0,0
20507,A,0,1
20508,patients,0,1
20509,",",0,0
20510,the,0,0
20511,adverse,0,0
20512,events,0,0
20513,risk,0,1
20514,was,0,0
20515,greater,0,0
20516,in,0,0
20517,those,0,0
20518,randomised,0,0
20519,to,0,0
20520,stenting,0,1
20521,(,0,0
20522,odds,0,0
20523,ratios,0,0
20524,6.603,0,0
20525,v,0,0
20526,1.197,0,0
20527,",",0,0
20528,p,0,0
20529,=,0,0
20530,0.046,0,0
20531,),0,0
20532,",",0,0
20533,whereas,0,0
20534,there,0,0
20535,was,0,0
20536,no,0,0
20537,difference,0,0
20538,in,0,0
20539,risk,0,0
20540,if,0,0
20541,the,0,0
20542,group,0,0
20543,was,0,0
20544,analysed,0,0
20545,according,0,0
20546,to,0,0
20547,whether,0,0
20548,the,0,0
20549,CFVR,0,0
20550,was,0,0
20551,<,0,0
20552,2.5,0,0
20553,or,0,1
20554,>,0,1
20555,/=,0,1
20556,2.5,0,0
20557,after,0,0
20558,balloon,0,0
20559,angioplasty,0,1
20560,.,0,1
20561,CONCLUSIONS,0,0
20562,Moderate,0,1
20563,dissections,0,1
20564,left,0,1
20565,untreated,0,1
20566,result,0,0
20567,in,0,0
20568,no,0,0
20569,increased,0,0
20570,risk,0,0
20571,of,0,0
20572,major,0,1
20573,adverse,0,0
20574,cardiac,0,1
20575,events,0,0
20576,.,0,1
20577,Additional,0,0
20578,stenting,0,0
20579,does,0,0
20580,not,0,0
20581,improve,0,0
20582,the,0,0
20583,long,0,0
20584,term,0,0
20585,outcome,0,0
20586,.,0,1
20587,Famotidine,0,0
20588,treatment,0,0
20589,of,0,0
20590,children,1,1
20591,with,1,1
20592,autistic,1,1
20593,spectrum,1,1
20594,disorders,1,1
20595,:,1,1
20596,pilot,0,0
20597,research,0,0
20598,using,0,0
20599,single,0,0
20600,subject,0,0
20601,research,0,1
20602,design,0,0
20603,.,0,0
20604,Using,0,0
20605,single,0,0
20606,subject,0,0
20607,research,0,0
20608,design,0,0
20609,",",0,0
20610,we,0,0
20611,performed,0,0
20612,pilot,0,0
20613,research,0,0
20614,to,0,0
20615,evaluate,0,0
20616,the,0,0
20617,safety,0,0
20618,and,0,0
20619,efficacy,0,0
20620,of,0,0
20621,famotidine,0,0
20622,for,0,0
20623,the,0,0
20624,treatment,0,0
20625,of,0,0
20626,children,1,1
20627,with,1,1
20628,autistic,1,1
20629,spectrum,1,1
20630,disorders,1,1
20631,.,1,1
20632,We,0,0
20633,studied,0,0
20634,9,1,0
20635,Caucasian,1,1
20636,boys,1,1
20637,",",1,1
20638,3.8-8.1,1,0
20639,years,1,1
20640,old,1,1
20641,",",1,0
20642,with,1,1
20643,a,1,0
20644,DSM-IV,1,0
20645,diagnosis,1,1
20646,of,1,0
20647,a,1,0
20648,pervasive,1,1
20649,developmental,1,0
20650,disorder,1,1
20651,",",1,0
20652,living,1,1
20653,with,1,1
20654,their,1,1
20655,families,1,1
20656,",",1,0
20657,receiving,1,1
20658,no,1,0
20659,chronic,1,1
20660,medications,1,0
20661,",",1,0
20662,and,1,0
20663,without,1,1
20664,significant,1,0
20665,gastrointestinal,1,1
20666,symptoms,1,1
20667,.,1,1
20668,The,0,0
20669,dose,0,0
20670,of,0,0
20671,oral,0,0
20672,famotidine,0,0
20673,was,0,0
20674,2,0,0
20675,mg/kg/day,0,0
20676,(,0,0
20677,given,0,0
20678,in,0,0
20679,two,0,0
20680,divided,0,1
20681,doses,0,0
20682,),0,1
20683,;,0,0
20684,the,0,0
20685,maximum,0,0
20686,total,0,1
20687,daily,0,0
20688,dose,0,0
20689,was,0,0
20690,100,0,0
20691,mg,0,0
20692,.,0,1
20693,Using,0,0
20694,single-subject,0,0
20695,research,0,0
20696,analysis,0,0
20697,and,0,0
20698,medication,0,0
20699,given,0,0
20700,in,0,0
20701,a,0,0
20702,randomized,0,0
20703,",",0,0
20704,double-blind,0,0
20705,",",0,0
20706,placebo-controlled,0,0
20707,",",0,0
20708,cross-over,0,0
20709,design,0,0
20710,",",0,0
20711,4,0,0
20712,of,0,0
20713,9,0,1
20714,children,0,1
20715,randomized,0,1
20716,(,0,1
20717,44,0,1
20718,%,0,0
20719,),0,0
20720,had,0,0
20721,evidence,0,0
20722,of,0,0
20723,behavioral,0,0
20724,improvement,0,0
20725,.,0,1
20726,Primary,0,0
20727,efficacy,0,0
20728,was,0,0
20729,based,0,0
20730,on,0,0
20731,data,0,0
20732,kept,0,0
20733,by,0,0
20734,primary,0,1
20735,caregivers,0,1
20736,",",0,0
20737,including,0,0
20738,a,0,0
20739,daily,0,0
20740,diary,0,0
20741,;,0,1
20742,daily,0,0
20743,visual,0,0
20744,analogue,0,0
20745,scales,0,0
20746,of,0,0
20747,affection,0,1
20748,",",0,0
20749,reciting,0,0
20750,",",0,0
20751,or,0,1
20752,aspects,0,0
20753,of,0,0
20754,social,0,1
20755,interaction,0,0
20756,;,0,1
20757,Aberrant,0,1
20758,Behavior,0,1
20759,Checklists,0,0
20760,(,0,0
20761,ABC,0,0
20762,",",0,0
20763,Aman,0,1
20764,),0,0
20765,;,0,0
20766,and,0,0
20767,Clinical,0,0
20768,Global,0,1
20769,Improvement,0,0
20770,scales,0,0
20771,.,0,1
20772,Children,1,1
20773,with,1,1
20774,marked,1,0
20775,stereotypy,1,0
20776,(,1,0
20777,meaningless,1,0
20778,",",1,0
20779,repetitive,1,0
20780,behaviors,1,0
20781,),1,0
20782,did,0,0
20783,not,0,0
20784,respond,0,0
20785,.,0,0
20786,Our,1,0
20787,subjects,1,1
20788,did,1,0
20789,not,1,0
20790,have,1,0
20791,prominent,1,0
20792,gastrointestinal,1,1
20793,symptoms,1,0
20794,and,0,1
20795,endoscopy,0,1
20796,was,0,0
20797,not,0,0
20798,part,0,0
20799,of,0,0
20800,our,0,0
20801,protocol,0,0
20802,;,0,0
20803,thus,0,0
20804,",",0,0
20805,we,0,0
20806,can,0,0
20807,not,0,0
20808,exclude,0,0
20809,the,0,0
20810,possibility,0,0
20811,that,0,0
20812,our,0,0
20813,subjects,0,1
20814,improved,0,0
20815,due,0,0
20816,to,0,0
20817,the,0,0
20818,effective,0,0
20819,treatment,0,0
20820,of,0,0
20821,asymptomatic,0,1
20822,esophagitis,0,1
20823,.,0,0
20824,The,0,0
20825,use,0,0
20826,of,0,0
20827,famotidine,0,0
20828,for,0,0
20829,the,0,0
20830,treatment,0,0
20831,of,0,0
20832,children,1,1
20833,with,1,1
20834,autistic,1,1
20835,spectrum,1,1
20836,disorders,1,1
20837,warrants,0,0
20838,further,0,0
20839,investigation,0,0
20840,.,0,1
20841,Comparison,0,0
20842,of,0,0
20843,thiopentone/guaifenesin,0,0
20844,",",0,0
20845,ketamine/guaifenesin,0,0
20846,and,0,0
20847,ketamine/midazolam,0,0
20848,for,0,0
20849,the,0,0
20850,induction,0,0
20851,of,0,0
20852,horses,1,1
20853,to,1,0
20854,be,1,0
20855,anaesthetised,1,1
20856,with,1,1
20857,isoflurane,1,0
20858,.,1,1
20859,Forty-eight,1,1
20860,horses,1,1
20861,subjected,1,0
20862,to,1,0
20863,elective,1,1
20864,surgery,1,1
20865,were,0,0
20866,randomly,0,1
20867,assigned,0,1
20868,to,0,0
20869,three,1,0
20870,groups,1,0
20871,of,1,1
20872,16,1,1
20873,horses,1,1
20874,.,1,1
20875,After,0,0
20876,premedication,0,0
20877,with,0,1
20878,0.1,0,0
20879,mg/kg,0,0
20880,acepromazine,0,0
20881,intramuscularly,0,0
20882,and,0,0
20883,0.6,0,0
20884,mg/kg,0,0
20885,xylazine,0,0
20886,intravenously,0,1
20887,",",0,0
20888,anaesthesia,0,0
20889,was,0,0
20890,induced,0,0
20891,either,0,0
20892,with,0,1
20893,2,0,0
20894,g,0,1
20895,thiopentone,0,0
20896,in,0,0
20897,500,0,0
20898,ml,0,0
20899,of,0,0
20900,a,0,0
20901,10,0,0
20902,per,0,0
20903,cent,0,0
20904,guaifenesin,0,0
20905,solution,0,0
20906,",",0,0
20907,given,0,0
20908,intravenously,0,0
20909,at,0,0
20910,a,0,0
20911,dose,0,0
20912,of,0,0
20913,1,0,0
20914,ml/kg,0,0
20915,(,0,1
20916,group,0,1
20917,TG,0,0
20918,),0,0
20919,",",0,0
20920,or,0,1
20921,with,0,1
20922,100,0,0
20923,mg/kg,0,0
20924,guaifenesin,0,1
20925,and,0,0
20926,2.2,0,0
20927,mg/kg,0,0
20928,ketamine,0,0
20929,given,0,0
20930,intravenously,0,0
20931,(,0,0
20932,group,0,0
20933,KG,0,0
20934,),0,0
20935,",",0,0
20936,or,0,1
20937,with,0,1
20938,0.06,0,0
20939,mg/kg,0,0
20940,midazolam,0,0
20941,",",0,0
20942,and,0,0
20943,2.2,0,0
20944,mg/kg,0,0
20945,ketamine,0,0
20946,given,0,0
20947,intravenously,0,0
20948,(,0,0
20949,group,0,0
20950,KM,0,0
20951,),0,0
20952,.,0,1
20953,Anaesthesia,0,0
20954,was,0,0
20955,maintained,0,0
20956,with,0,1
20957,isoflurane,0,0
20958,.,0,0
20959,The,0,0
20960,mean,0,0
20961,(,0,0
20962,sd,0,0
20963,),0,0
20964,end,0,0
20965,tidal,0,1
20966,isoflurane,0,0
20967,concentration,0,0
20968,(,0,0
20969,per,0,0
20970,cent,0,1
20971,),0,0
20972,needed,0,0
20973,to,0,0
20974,maintain,0,0
20975,a,0,0
20976,light,0,0
20977,surgical,0,0
20978,anaesthesia,0,1
20979,(,0,0
20980,stage,0,1
20981,III,0,0
20982,",",0,0
20983,plane,0,0
20984,2,0,0
20985,),0,0
20986,was,0,0
20987,significantly,0,0
20988,lower,0,0
20989,in,0,0
20990,group,0,0
20991,KM,0,0
20992,(,0,0
20993,0.91,0,0
20994,[,0,0
20995,0.03,0,0
20996,],0,0
20997,),0,0
20998,than,0,0
20999,in,0,0
21000,groups,0,0
21001,TG,0,0
21002,(,0,1
21003,1.11,0,0
21004,[,0,0
21005,0.03,0,0
21006,],0,0
21007,),0,0
21008,and,0,0
21009,KG,0,0
21010,(,0,0
21011,1.14,0,0
21012,[,0,0
21013,0.03,0,0
21014,],0,0
21015,),0,0
21016,.,0,0
21017,The,0,0
21018,mean,0,0
21019,(,0,0
21020,sd,0,0
21021,),0,0
21022,arterial,0,1
21023,pressure,0,0
21024,(,0,0
21025,mmHg,0,0
21026,),0,0
21027,was,0,0
21028,significantly,0,0
21029,lower,0,0
21030,in,0,0
21031,group,0,0
21032,KG,0,0
21033,(,0,0
21034,67.4,0,0
21035,[,0,0
21036,2.07,0,0
21037,],0,0
21038,),0,0
21039,than,0,0
21040,in,0,0
21041,groups,0,0
21042,TC,0,1
21043,(,0,1
21044,75.6,0,0
21045,[,0,0
21046,2.23,0,0
21047,],0,0
21048,),0,0
21049,and,0,0
21050,KM,0,0
21051,(,0,0
21052,81.0,0,0
21053,[,0,0
21054,2.16,0,0
21055,],0,0
21056,),0,0
21057,.,0,0
21058,There,0,0
21059,were,0,0
21060,no,0,0
21061,significant,0,0
21062,differences,0,0
21063,in,0,0
21064,the,0,0
21065,logarithm,0,0
21066,of,0,0
21067,the,0,0
21068,heart,0,1
21069,rate,0,0
21070,",",0,0
21071,recovery,0,0
21072,time,0,0
21073,or,0,0
21074,quality,0,0
21075,of,0,0
21076,recovery,0,0
21077,between,0,0
21078,the,0,0
21079,three,0,0
21080,induction,0,1
21081,groups,0,0
21082,.,0,0
21083,However,0,0
21084,",",0,0
21085,pronounced,0,0
21086,ataxia,0,1
21087,was,0,0
21088,observed,0,0
21089,in,0,0
21090,the,0,0
21091,horses,0,1
21092,of,0,0
21093,group,0,1
21094,KM,0,0
21095,",",0,0
21096,especially,0,0
21097,after,0,0
21098,periods,0,0
21099,of,0,0
21100,anaesthesia,0,1
21101,lasting,0,0
21102,less,0,0
21103,than,0,0
21104,75,0,1
21105,minutes,0,0
21106,.,0,1
21107,Comparison,0,0
21108,of,0,0
21109,tropisetron,0,0
21110,and,0,0
21111,granisetron,0,0
21112,in,0,0
21113,the,0,0
21114,control,0,0
21115,of,0,0
21116,nausea,0,0
21117,and,0,0
21118,vomiting,0,0
21119,in,0,0
21120,children,1,1
21121,receiving,1,1
21122,combined,1,0
21123,cancer,1,1
21124,chemotherapy,1,1
21125,.,1,0
21126,Tropisetron,0,0
21127,and,0,0
21128,granisetron,0,0
21129,are,0,0
21130,selective,0,0
21131,serotonin,0,0
21132,(,0,0
21133,5-HT3,0,0
21134,),0,0
21135,antagonists,0,0
21136,that,0,0
21137,have,0,0
21138,been,0,0
21139,proven,0,0
21140,effective,0,0
21141,in,0,0
21142,the,0,0
21143,prevention,0,0
21144,of,0,0
21145,nausea,0,0
21146,and,0,0
21147,vomiting,0,0
21148,in,0,0
21149,adults,1,1
21150,and,1,1
21151,children,1,1
21152,receiving,1,1
21153,cancer,1,1
21154,chemotherapy,1,1
21155,.,1,0
21156,This,0,0
21157,prospective,0,0
21158,",",0,0
21159,randomised,0,0
21160,study,0,0
21161,was,0,0
21162,designed,0,0
21163,to,0,0
21164,compare,0,0
21165,the,0,0
21166,efficacy,0,0
21167,of,0,0
21168,the,0,0
21169,two,0,0
21170,agents,0,0
21171,in,0,0
21172,the,0,0
21173,prevention,0,0
21174,of,0,0
21175,vomiting,0,0
21176,and,0,0
21177,nausea,0,0
21178,in,0,0
21179,children,1,1
21180,receiving,1,1
21181,highly,1,0
21182,emetogenic,1,1
21183,chemotherapy,1,0
21184,for,1,0
21185,various,1,0
21186,malignancies,1,1
21187,.,1,1
21188,A,0,0
21189,total,1,1
21190,of,1,0
21191,51,1,1
21192,children,1,1
21193,(,1,1
21194,mean,1,1
21195,age,1,1
21196,:,1,1
21197,7.7,1,0
21198,+/-,1,0
21199,4.8,1,0
21200,year,1,1
21201,),1,0
21202,were,1,0
21203,studied,1,1
21204,in,0,0
21205,133,0,1
21206,chemotherapy,0,1
21207,cycles,0,0
21208,.,0,1
21209,In,0,0
21210,66,0,1
21211,chemotherapy,0,1
21212,cycles,0,0
21213,",",0,0
21214,the,0,0
21215,children,0,1
21216,received,0,0
21217,tropisetron,0,0
21218,as,0,0
21219,an,0,0
21220,antiemetic,0,0
21221,agent,0,0
21222,in,0,0
21223,a,0,0
21224,dose,0,0
21225,of,0,0
21226,0.2,0,0
21227,mg/kg/24,0,0
21228,h,0,0
21229,intravenously,0,1
21230,and,0,0
21231,",",0,0
21232,in,0,0
21233,67,0,1
21234,cycles,0,0
21235,",",0,0
21236,they,0,0
21237,received,0,0
21238,granisetron,0,0
21239,40,0,1
21240,micrograms/kg/24,0,0
21241,h,0,0
21242,intravenously,0,0
21243,before,0,0
21244,cytotoxic,0,0
21245,drug,0,0
21246,administration,0,0
21247,during,0,0
21248,the,0,0
21249,days,0,0
21250,they,0,0
21251,received,0,0
21252,chemotherapy,0,0
21253,.,0,0
21254,The,0,0
21255,response,0,0
21256,per,0,0
21257,24,0,0
21258,h,0,0
21259,of,0,0
21260,chemotherapy,0,0
21261,was,0,0
21262,defined,0,0
21263,as,0,0
21264,complete,0,0
21265,(,0,0
21266,no,0,0
21267,nausea,0,0
21268,and,0,0
21269,vomiting,0,0
21270,),0,0
21271,",",0,0
21272,partial,0,0
21273,(,0,0
21274,1-4,0,1
21275,events,0,0
21276,of,0,0
21277,vomiting,0,1
21278,and/or,0,0
21279,nausea,0,0
21280,),0,0
21281,",",0,0
21282,and,0,0
21283,failure,0,1
21284,(,0,0
21285,more,0,0
21286,than,0,0
21287,4,0,0
21288,events,0,0
21289,of,0,0
21290,vomiting,0,1
21291,and/or,0,0
21292,nausea,0,0
21293,),0,0
21294,.,0,0
21295,Efficacy,0,0
21296,of,0,0
21297,antiemetic,0,0
21298,therapy,0,0
21299,was,0,0
21300,evaluated,0,0
21301,as,0,0
21302,acute,0,1
21303,(,0,1
21304,Day,0,1
21305,1,0,0
21306,),0,0
21307,and,0,0
21308,overall,0,0
21309,was,0,0
21310,based,0,0
21311,on,0,0
21312,the,0,0
21313,worst,0,0
21314,day,0,0
21315,during,0,0
21316,the,0,0
21317,chemotherapy,0,0
21318,.,0,0
21319,Complete,0,0
21320,control,0,0
21321,of,0,0
21322,acute,0,1
21323,vomiting,0,0
21324,was,0,0
21325,achieved,0,0
21326,in,0,0
21327,74,0,1
21328,%,0,0
21329,of,0,0
21330,tropisetron,0,0
21331,and,0,0
21332,88,0,0
21333,%,0,0
21334,of,0,0
21335,granisetron,0,0
21336,patients,0,1
21337,(,0,1
21338,P,0,0
21339,=,0,0
21340,0.04,0,0
21341,),0,0
21342,",",0,0
21343,and,0,0
21344,complete,0,0
21345,control,0,0
21346,of,0,0
21347,acute,0,1
21348,nausea,0,0
21349,in,0,0
21350,56,0,1
21351,%,0,0
21352,and,0,0
21353,82,0,1
21354,%,0,0
21355,respectively,0,0
21356,(,0,0
21357,p,0,0
21358,=,0,0
21359,0.002,0,0
21360,),0,1
21361,.,0,1
21362,Overall,0,0
21363,response,0,0
21364,by,0,0
21365,means,0,0
21366,of,0,0
21367,complete,0,1
21368,control,0,1
21369,of,0,0
21370,both,0,0
21371,vomiting,0,0
21372,and,0,0
21373,nausea,0,0
21374,during,0,0
21375,the,0,0
21376,whole,0,0
21377,therapy,0,0
21378,period,0,0
21379,was,0,0
21380,29,0,1
21381,%,0,0
21382,of,0,0
21383,tropisetron,0,0
21384,group,0,0
21385,and,0,0
21386,55,0,1
21387,%,0,0
21388,of,0,0
21389,granisetron,0,0
21390,group,0,0
21391,(,0,0
21392,p,0,0
21393,=,0,0
21394,0.007,0,0
21395,),0,0
21396,.,0,0
21397,The,0,0
21398,statistical,0,0
21399,analysis,0,0
21400,(,0,0
21401,depending,0,0
21402,on,0,0
21403,the,0,0
21404,emetogenicity,0,0
21405,of,0,0
21406,the,0,0
21407,chemotherapy,0,1
21408,cycles,0,0
21409,),0,1
21410,showed,0,0
21411,increased,0,0
21412,efficacy,0,0
21413,of,0,0
21414,granisetron,0,0
21415,in,0,0
21416,highly,0,0
21417,(,0,0
21418,grade,0,1
21419,3,0,0
21420,),0,0
21421,emetogenic,0,1
21422,chemotherapy,0,1
21423,cycles,0,0
21424,(,0,1
21425,p,0,0
21426,=,0,0
21427,0.002,0,0
21428,),0,0
21429,",",0,0
21430,whereas,0,0
21431,there,0,0
21432,was,0,0
21433,no,0,0
21434,difference,0,0
21435,in,0,0
21436,the,0,0
21437,very,0,0
21438,highly,0,0
21439,emetogenic,0,1
21440,cycles,0,0
21441,(,0,1
21442,p,0,0
21443,=,0,0
21444,0.7,0,1
21445,),0,0
21446,.,0,0
21447,Also,0,0
21448,",",0,0
21449,granisetron,0,0
21450,was,0,0
21451,found,0,0
21452,to,0,0
21453,be,0,0
21454,more,0,0
21455,effective,0,0
21456,than,0,0
21457,tropisetron,0,0
21458,",",0,0
21459,especially,0,0
21460,in,0,0
21461,patients,0,1
21462,heavier,0,1
21463,than,0,0
21464,25,0,0
21465,kg,0,1
21466,(,0,0
21467,p,0,0
21468,=,0,0
21469,0.02,0,0
21470,),0,0
21471,.,0,0
21472,The,0,0
21473,adverse,0,0
21474,reactions,0,0
21475,were,0,1
21476,few,0,0
21477,and,0,1
21478,mild,0,1
21479,.,0,0
21480,There,0,0
21481,were,0,0
21482,no,0,0
21483,differences,0,0
21484,in,0,0
21485,the,0,0
21486,tolerability,0,0
21487,of,0,0
21488,the,0,0
21489,two,0,0
21490,antiemetic,0,0
21491,therapy,0,1
21492,modalities,0,0
21493,.,0,1
21494,In,0,0
21495,conclusion,0,0
21496,",",0,0
21497,granisetron,0,0
21498,was,0,0
21499,found,0,0
21500,to,0,0
21501,be,0,0
21502,more,0,0
21503,effective,0,0
21504,than,0,0
21505,tropisetron,0,0
21506,in,0,0
21507,controlling,0,0
21508,nausea,0,0
21509,and,0,0
21510,vomiting,0,0
21511,in,0,0
21512,children,1,1
21513,receiving,1,1
21514,highly,1,0
21515,emetogenic,1,1
21516,chemotherapy,1,0
21517,.,1,0
21518,This,0,0
21519,increased,0,0
21520,antiemetic,0,0
21521,efficacy,0,0
21522,of,0,0
21523,ganisetron,0,0
21524,might,0,0
21525,have,0,0
21526,been,0,0
21527,related,0,0
21528,to,0,0
21529,maximal,0,0
21530,dose,0,0
21531,differences,0,0
21532,according,0,1
21533,to,0,0
21534,body,0,1
21535,weight,0,0
21536,.,0,1
21537,Dose,0,0
21538,dependent,0,1
21539,pharmacokinetics,0,0
21540,of,0,1
21541,theophylline,0,0
21542,:,0,1
21543,Michaelis-Menten,0,0
21544,parameters,0,0
21545,for,0,0
21546,its,0,0
21547,major,0,1
21548,metabolic,0,1
21549,pathways,0,0
21550,.,0,1
21551,Dose,0,0
21552,Dependency,0,0
21553,for,0,0
21554,pharmacokinetics,0,0
21555,of,0,0
21556,theophylline,0,0
21557,and,0,0
21558,the,0,0
21559,formation,0,0
21560,of,0,0
21561,its,0,0
21562,major,0,1
21563,metabolites,0,0
21564,",",0,0
21565,3-methylxanthine,0,0
21566,(,0,0
21567,3-MX,0,1
21568,),0,1
21569,;,0,0
21570,1-methyluric,0,0
21571,acid,0,0
21572,(,0,0
21573,1-MU,0,0
21574,),0,1
21575,;,0,0
21576,"1,3-dimethyluric",0,0
21577,acid,0,0
21578,(,0,0
21579,DMU,0,0
21580,),0,0
21581,",",0,0
21582,were,0,0
21583,examined,0,0
21584,by,0,0
21585,administering,0,0
21586,three,0,0
21587,single,0,0
21588,oral,0,0
21589,doses,0,0
21590,(,0,1
21591,250,0,0
21592,",",0,0
21593,375,0,0
21594,",",0,0
21595,500,0,0
21596,mg,0,0
21597,),0,0
21598,of,0,0
21599,theophylline,0,0
21600,to,0,0
21601,six,1,1
21602,healthy,1,1
21603,adult,1,1
21604,volunteers,1,1
21605,.,1,0
21606,The,0,0
21607,serum,0,0
21608,and,0,0
21609,urine,0,0
21610,concentrations,0,0
21611,of,0,0
21612,theophylline,0,0
21613,and,0,0
21614,the,0,0
21615,metabolites,0,0
21616,in,0,0
21617,serum,0,0
21618,and,0,0
21619,urine,0,0
21620,were,0,0
21621,determined,0,0
21622,by,0,0
21623,high-performance,0,0
21624,liquid,0,0
21625,chromatography,0,0
21626,.,0,0
21627,Total,0,0
21628,clearance,0,0
21629,of,0,0
21630,theophylline,0,0
21631,decreased,0,0
21632,and,0,0
21633,its,0,0
21634,half,0,1
21635,life,0,0
21636,increased,0,0
21637,over,0,0
21638,the,0,0
21639,range,0,0
21640,of,0,0
21641,doses,0,0
21642,administered,0,0
21643,(,0,1
21644,p,0,0
21645,<,0,0
21646,0.01,0,0
21647,),0,0
21648,.,0,0
21649,There,0,0
21650,was,0,0
21651,a,0,0
21652,significant,0,0
21653,dose,0,0
21654,related,0,0
21655,decrease,0,0
21656,in,0,0
21657,the,0,0
21658,fractional,0,0
21659,recovery,0,0
21660,of,0,0
21661,3-MX,0,0
21662,and,0,0
21663,1-MU,0,0
21664,(,0,0
21665,p,0,0
21666,<,0,0
21667,0.001,0,0
21668,),0,0
21669,and,0,0
21670,a,0,0
21671,dose,0,0
21672,related,0,0
21673,increase,0,0
21674,in,0,0
21675,fractional,0,0
21676,excretion,0,0
21677,of,0,0
21678,DMU,0,0
21679,and,0,0
21680,unchanged,0,0
21681,theophylline,0,0
21682,(,0,0
21683,p,0,0
21684,<,0,0
21685,0.01,0,0
21686,and,0,0
21687,p,0,0
21688,<,0,0
21689,0.001,0,0
21690,respectively,0,0
21691,),0,0
21692,.,0,0
21693,No,0,0
21694,significant,0,0
21695,dose,0,0
21696,related,0,0
21697,changes,0,0
21698,were,0,0
21699,observed,0,0
21700,in,0,0
21701,the,0,0
21702,renal,0,1
21703,clearance,0,0
21704,of,0,0
21705,3-MX,0,0
21706,",",0,0
21707,1-MU,0,0
21708,and,0,0
21709,DMU,0,0
21710,",",0,0
21711,indicating,0,0
21712,linear,0,0
21713,urinary,0,1
21714,excretion,0,0
21715,kinetics,0,0
21716,of,0,0
21717,the,0,0
21718,metabolites,0,0
21719,.,0,1
21720,Theophylline,0,0
21721,metabolic,0,0
21722,clearance,0,0
21723,to,0,0
21724,3-MX,0,0
21725,as,0,0
21726,well,0,0
21727,as,0,0
21728,to,0,0
21729,1-MU,0,0
21730,decreased,0,0
21731,with,0,1
21732,increasing,0,0
21733,dose,0,0
21734,but,0,0
21735,clearance,0,0
21736,to,0,0
21737,DMU,0,0
21738,remained,0,0
21739,unnaffected,0,1
21740,by,0,0
21741,the,0,0
21742,size,0,0
21743,of,0,0
21744,dose,0,0
21745,.,0,0
21746,The,0,0
21747,individual,0,0
21748,Michaelis-Menten,0,0
21749,parameters,0,0
21750,Km,0,1
21751,and,0,1
21752,Vmax,0,0
21753,were,0,0
21754,estimated,0,0
21755,for,0,0
21756,six,1,1
21757,subjects,1,1
21758,receiving,0,1
21759,three,0,1
21760,different,0,0
21761,single,0,0
21762,doses,0,0
21763,.,0,1
21764,The,0,0
21765,Km,0,0
21766,values,0,0
21767,for,0,0
21768,theophylline,0,0
21769,metabolism,0,0
21770,to,0,0
21771,3-MX,0,0
21772,",",0,0
21773,1-MU,0,0
21774,and,0,0
21775,DMU,0,0
21776,were,0,0
21777,2.4+/-0.6,0,0
21778,",",0,0
21779,5.1+/-1.8+/-,0,0
21780,and,0,0
21781,112.3+/-36.8,0,0
21782,mg/L,0,0
21783,respectively,0,0
21784,and,0,0
21785,the,0,0
21786,Vmax,0,0
21787,values,0,0
21788,were,0,1
21789,3.5+/-0.7,0,0
21790,",",0,0
21791,7.5+/-2.6,0,0
21792,and,0,0
21793,112.3+/-36.8,0,0
21794,mg/hr,0,0
21795,respectively,0,0
21796,.,0,0
21797,The,0,0
21798,Km,0,0
21799,values,0,0
21800,for,0,0
21801,the,0,0
21802,N-demethylation,0,0
21803,pathways,0,0
21804,(,0,1
21805,3MX,0,0
21806,and,0,0
21807,1-MU,0,0
21808,),0,0
21809,were,0,0
21810,lower,0,0
21811,corresponding,0,0
21812,to,0,0
21813,therapeutic,0,0
21814,serum,0,0
21815,concentrations,0,0
21816,of,0,0
21817,drug,0,0
21818,.,0,0
21819,These,0,0
21820,results,0,0
21821,suggest,0,0
21822,that,0,0
21823,the,0,0
21824,elimination,0,0
21825,kinetics,0,0
21826,of,0,0
21827,theophylline,0,0
21828,is,0,0
21829,nonlinear,0,0
21830,in,0,0
21831,the,0,0
21832,human,0,0
21833,in,0,0
21834,the,0,0
21835,therapeutic,0,0
21836,range,0,0
21837,of,0,0
21838,serum,0,0
21839,concenntrations,0,0
21840,and,0,0
21841,can,0,0
21842,be,0,0
21843,explained,0,0
21844,by,0,0
21845,saturable,0,0
21846,formation,0,0
21847,kinetics,0,0
21848,of,0,0
21849,3-MX,0,1
21850,and,0,1
21851,1-MU,0,0
21852,.,0,0
21853,In,0,0
21854,contrast,0,0
21855,to,0,0
21856,previous,0,0
21857,studies,0,0
21858,we,0,0
21859,did,0,0
21860,n't,0,0
21861,find,0,0
21862,obvious,0,0
21863,indication,0,0
21864,for,0,0
21865,nonlinear,0,0
21866,formation,0,0
21867,of,0,0
21868,DMU,0,0
21869,at,0,0
21870,therapeutic,0,0
21871,concentration,0,0
21872,range,0,1
21873,.,0,1
21874,Epidural,0,0
21875,analgesia,0,0
21876,compared,0,0
21877,with,0,1
21878,intravenous,0,0
21879,morphine,0,0
21880,patient-controlled,0,0
21881,analgesia,0,1
21882,:,0,1
21883,postoperative,0,0
21884,outcome,0,0
21885,measures,0,0
21886,after,0,0
21887,mastectomy,1,1
21888,with,1,1
21889,immediate,1,0
21890,TRAM,1,1
21891,flap,1,1
21892,breast,1,1
21893,reconstruction,1,1
21894,.,1,1
21895,BACKGROUND,0,0
21896,AND,0,0
21897,OBJECTIVES,0,0
21898,Epidural,0,0
21899,analgesia,0,0
21900,has,0,0
21901,been,0,0
21902,shown,0,0
21903,to,0,0
21904,provide,0,0
21905,superior,0,0
21906,pain,0,0
21907,control,0,0
21908,compared,0,0
21909,with,0,1
21910,intravenous,0,0
21911,(,0,1
21912,IV,0,1
21913,),0,1
21914,opioids,0,0
21915,after,0,0
21916,major,0,1
21917,surgical,0,1
21918,procedures,0,1
21919,.,0,1
21920,In,0,0
21921,this,0,0
21922,study,0,0
21923,",",0,0
21924,we,0,0
21925,compared,0,0
21926,the,0,0
21927,effect,0,0
21928,of,0,0
21929,epidural,0,0
21930,analgesia,0,0
21931,and,0,0
21932,IV,0,0
21933,morphine,0,0
21934,patient-controlled,0,0
21935,analgesia,0,0
21936,(,0,0
21937,PCA,0,1
21938,),0,0
21939,on,0,0
21940,pain,0,0
21941,relief,0,0
21942,",",0,0
21943,duration,0,0
21944,of,0,0
21945,hospitalization,0,0
21946,",",0,0
21947,oral,0,0
21948,nutrition,0,0
21949,",",0,0
21950,ambulation,0,0
21951,",",0,0
21952,and,0,0
21953,side,0,0
21954,effects,0,0
21955,in,0,0
21956,patients,1,1
21957,undergoing,1,1
21958,a,1,0
21959,major,1,0
21960,surgical,1,0
21961,procedure,1,0
21962,(,1,0
21963,i.e.,1,0
21964,",",0,0
21965,unilateral,1,1
21966,mastectomy,1,1
21967,with,1,1
21968,immediate,1,0
21969,transverse,1,0
21970,rectus,1,1
21971,abdominis,1,0
21972,musculocutaneous,1,0
21973,flap,1,1
21974,reconstruction,1,1
21975,),1,0
21976,.,1,0
21977,METHODS,0,0
21978,Eighteen,1,1
21979,patients,1,1
21980,were,0,1
21981,prospectively,0,1
21982,randomized,0,0
21983,to,0,0
21984,receive,0,0
21985,either,0,0
21986,epidural,0,0
21987,analgesia,0,0
21988,or,0,1
21989,PCA,0,1
21990,during,0,0
21991,the,0,0
21992,postoperative,0,0
21993,period,0,0
21994,.,0,0
21995,The,0,0
21996,intensity,0,0
21997,of,0,0
21998,pain,0,1
21999,was,0,0
22000,assessed,0,0
22001,daily,0,0
22002,by,0,0
22003,a,0,0
22004,100-mm,0,0
22005,visual,0,0
22006,analog,0,0
22007,scale,0,0
22008,.,0,0
22009,The,0,0
22010,total,0,0
22011,length,0,0
22012,of,0,0
22013,hospital,0,1
22014,stay,0,0
22015,",",0,0
22016,time,0,0
22017,to,0,0
22018,ambulation,0,0
22019,",",0,0
22020,and,0,0
22021,time,0,0
22022,to,0,0
22023,oral,0,0
22024,nutrition,0,0
22025,were,0,0
22026,recorded,0,0
22027,.,0,0
22028,RESULTS,0,0
22029,The,0,0
22030,epidural,0,0
22031,group,0,0
22032,had,0,0
22033,significantly,0,0
22034,lower,0,0
22035,pain,0,0
22036,scores,0,0
22037,at,0,0
22038,3,0,0
22039,evaluation,0,0
22040,times,0,0
22041,through,0,0
22042,postoperative,0,0
22043,day,0,0
22044,number,0,0
22045,4,0,0
22046,(,0,0
22047,P,0,0
22048,<,0,0
22049,.05,0,0
22050,),0,0
22051,.,0,0
22052,The,0,0
22053,total,0,0
22054,length,0,0
22055,of,0,0
22056,hospitalization,0,0
22057,for,0,0
22058,the,0,0
22059,epidural,0,0
22060,group,0,0
22061,(,0,0
22062,median,0,0
22063,",",0,0
22064,101,0,1
22065,hours,0,0
22066,),0,0
22067,was,0,0
22068,significantly,0,0
22069,less,0,0
22070,than,0,0
22071,the,0,0
22072,PCA,0,1
22073,group,0,0
22074,(,0,0
22075,median,0,0
22076,",",0,0
22077,126,0,1
22078,hours,0,0
22079,;,0,1
22080,P,0,0
22081,=,0,0
22082,.0498,0,0
22083,),0,0
22084,.,0,0
22085,The,0,0
22086,time,0,0
22087,to,0,0
22088,first,0,0
22089,ambulation,0,0
22090,",",0,0
22091,time,0,0
22092,to,0,0
22093,first,0,0
22094,bowel,0,1
22095,sounds,0,0
22096,",",0,0
22097,time,0,0
22098,to,0,0
22099,tolerating,0,0
22100,oral,0,0
22101,nutrition,0,0
22102,",",0,0
22103,incidence,0,0
22104,of,0,0
22105,nausea/vomiting,0,0
22106,or,0,0
22107,pruritus,0,0
22108,",",0,0
22109,and,0,0
22110,time,0,0
22111,to,0,0
22112,first,0,0
22113,flatus,0,0
22114,were,0,0
22115,not,0,0
22116,statistically,0,0
22117,different,0,0
22118,between,0,0
22119,the,0,0
22120,groups,0,0
22121,.,0,1
22122,CONCLUSIONS,0,0
22123,These,0,0
22124,results,0,0
22125,show,0,0
22126,that,0,0
22127,epidural,0,0
22128,analgesia,0,0
22129,compared,0,0
22130,with,0,1
22131,PCA,0,1
22132,offered,0,0
22133,improved,0,0
22134,pain,0,1
22135,control,0,0
22136,after,0,0
22137,breast,0,1
22138,reconstruction,0,1
22139,with,0,1
22140,immediate,0,0
22141,transverse,0,0
22142,rectus,0,1
22143,abdominis,0,0
22144,musculocutaneous,0,0
22145,flap,0,1
22146,reconstruction,0,1
22147,.,0,0
22148,It,0,0
22149,also,0,0
22150,resulted,0,0
22151,in,0,0
22152,a,0,0
22153,25-hour,0,0
22154,reduction,0,0
22155,in,0,0
22156,time,0,0
22157,of,0,0
22158,hospitalization,0,1
22159,.,0,1
22160,Evaluation,0,0
22161,of,0,0
22162,a,0,0
22163,new,0,0
22164,computer,0,0
22165,intervention,0,0
22166,to,0,0
22167,teach,0,0
22168,people,1,1
22169,with,1,1
22170,autism,1,1
22171,or,1,1
22172,Asperger,1,1
22173,syndrome,1,1
22174,to,0,0
22175,recognize,0,0
22176,and,0,0
22177,predict,0,0
22178,emotions,0,0
22179,in,0,0
22180,others,0,0
22181,.,0,1
22182,This,0,0
22183,randomized,0,0
22184,controlled,0,0
22185,trial,0,0
22186,looked,0,0
22187,at,0,0
22188,the,0,0
22189,effect,0,0
22190,of,0,0
22191,a,0,0
22192,new,0,0
22193,computer,0,0
22194,program,0,0
22195,designed,0,0
22196,to,0,0
22197,teach,0,0
22198,people,1,1
22199,with,1,1
22200,autistic,1,1
22201,spectrum,1,1
22202,disorders,1,1
22203,to,0,0
22204,better,0,0
22205,recognize,0,0
22206,and,0,0
22207,predict,0,0
22208,emotional,0,0
22209,responses,0,0
22210,in,0,1
22211,others,0,1
22212,.,0,1
22213,Two,1,1
22214,groups,1,0
22215,of,1,1
22216,11,1,1
22217,children,1,1
22218,(,1,1
22219,age,1,1
22220,12-18,1,1
22221,),1,0
22222,with,1,1
22223,autism,1,1
22224,or,1,1
22225,Asperger,1,1
22226,syndrome,1,1
22227,at,1,0
22228,two,1,0
22229,special,1,1
22230,schools,1,1
22231,participated,1,1
22232,:,1,1
22233,one,0,1
22234,group,0,0
22235,used,0,0
22236,the,0,0
22237,computer,0,0
22238,program,0,0
22239,for,0,0
22240,10,0,1
22241,half-hour,0,0
22242,sessions,0,0
22243,over,0,0
22244,2,0,1
22245,weeks,0,0
22246,.,0,1
22247,Within-program,0,0
22248,data,0,0
22249,showed,0,0
22250,a,0,0
22251,significant,0,0
22252,reduction,0,0
22253,in,0,0
22254,errors,0,0
22255,made,0,0
22256,from,0,1
22257,first,0,0
22258,to,0,0
22259,last,0,0
22260,use,0,0
22261,.,0,1
22262,Students,0,0
22263,were,0,0
22264,assessed,0,0
22265,pre-,0,0
22266,and,0,0
22267,post-intervention,0,0
22268,using,0,0
22269,facial,0,0
22270,expression,0,0
22271,photographs,0,0
22272,",",0,0
22273,cartoons,0,0
22274,depicting,0,0
22275,emotion-laden,0,1
22276,situations,0,0
22277,",",0,0
22278,and,0,0
22279,non-literal,0,1
22280,stories,0,0
22281,.,0,1
22282,Scores,0,0
22283,were,0,0
22284,not,0,0
22285,related,0,0
22286,to,0,0
22287,age,0,1
22288,or,0,1
22289,verbal,0,0
22290,ability,0,0
22291,.,0,0
22292,The,0,0
22293,experimental,0,0
22294,group,0,0
22295,made,0,0
22296,gains,0,0
22297,relative,0,0
22298,to,0,0
22299,the,0,0
22300,control,0,0
22301,group,0,0
22302,on,0,0
22303,all,0,0
22304,three,0,0
22305,measures,0,0
22306,.,0,1
22307,Gains,0,0
22308,correlated,0,0
22309,significantly,0,0
22310,with,0,1
22311,the,0,0
22312,number,0,0
22313,of,0,0
22314,times,0,0
22315,the,0,0
22316,computer,0,0
22317,program,0,0
22318,was,0,0
22319,used,0,0
22320,and,0,0
22321,results,0,0
22322,suggest,0,0
22323,positive,0,1
22324,effects,0,0
22325,.,0,1
22326,Further,0,0
22327,research,0,0
22328,could,0,0
22329,assess,0,0
22330,whether,0,0
22331,these,0,0
22332,gains,0,0
22333,generalized,0,1
22334,into,0,1
22335,real,0,0
22336,life,0,0
22337,or,0,1
22338,improved,0,0
22339,performance,0,0
22340,on,0,0
22341,theory,0,0
22342,of,0,0
22343,mind,0,1
22344,measures,0,0
22345,.,0,1
22346,Absence,0,0
22347,of,0,0
22348,cervical,0,1
22349,radiation,0,0
22350,myelitis,0,1
22351,after,0,0
22352,hyperfractionated,0,0
22353,radiation,0,0
22354,therapy,0,0
22355,with,0,1
22356,and,0,0
22357,without,0,1
22358,concurrent,0,0
22359,chemotherapy,0,0
22360,for,0,0
22361,locally,1,1
22362,advanced,1,1
22363,",",1,0
22364,unresectable,1,1
22365,",",1,0
22366,nonmetastatic,1,1
22367,squamous,1,1
22368,cell,1,1
22369,carcinoma,1,1
22370,of,1,0
22371,the,1,0
22372,head,1,1
22373,and,1,0
22374,neck,1,1
22375,.,1,0
22376,PURPOSE,0,0
22377,To,0,0
22378,evaluate,0,0
22379,the,0,0
22380,risk,0,0
22381,of,0,0
22382,developing,0,0
22383,radiation,0,0
22384,myelitis,0,1
22385,after,0,0
22386,a,0,0
22387,cervical,0,1
22388,spinal,0,1
22389,cord,0,1
22390,dose,0,0
22391,of,0,0
22392,50.6,0,0
22393,Gy,0,1
22394,given,0,0
22395,via,0,0
22396,1.1,0,0
22397,Gy,0,1
22398,b.i.d,0,0
22399,.,0,0
22400,fractionation,0,0
22401,during,0,0
22402,a,0,0
22403,prospective,0,0
22404,",",0,0
22405,randomised,0,0
22406,trial,0,0
22407,of,0,0
22408,hyperfractionated,0,0
22409,radiation,0,0
22410,therapy,0,0
22411,(,0,0
22412,HFX,0,0
22413,RT,0,1
22414,),0,0
22415,to,0,0
22416,a,0,0
22417,total,0,1
22418,dose,0,0
22419,of,0,0
22420,77,0,1
22421,Gy,0,1
22422,given,0,0
22423,in,0,0
22424,70,0,1
22425,fractions,0,1
22426,of,0,1
22427,1.1,0,0
22428,Gy,0,0
22429,b.i.d.,0,0
22430,",",0,0
22431,with,0,0
22432,and,0,0
22433,without,0,1
22434,concurrent,0,0
22435,low-dose,0,0
22436,",",0,0
22437,daily,0,0
22438,cisplatin,0,0
22439,(,0,0
22440,CDDP,0,1
22441,),0,0
22442,for,0,0
22443,head,1,1
22444,and,1,0
22445,neck,1,1
22446,cancer,1,1
22447,.,1,0
22448,METHODS,0,0
22449,Of,0,1
22450,130,1,1
22451,patients,1,1
22452,with,1,1
22453,locally,1,1
22454,advanced,1,1
22455,",",1,0
22456,unresectable,1,1
22457,",",1,0
22458,nonmetastatic,1,1
22459,squamous,1,1
22460,cell,1,1
22461,carcinoma,1,1
22462,of,1,0
22463,the,1,0
22464,head,1,1
22465,and,1,0
22466,neck,1,1
22467,(,1,0
22468,SCC,1,0
22469,H,1,1
22470,&,1,1
22471,N,1,1
22472,),1,1
22473,who,0,1
22474,entered,0,1
22475,a,0,1
22476,prospective,0,0
22477,",",0,0
22478,randomised,0,0
22479,trial,0,0
22480,",",0,0
22481,101,0,1
22482,patients,0,1
22483,received,0,1
22484,50.6,0,1
22485,Gy,0,0
22486,to,0,0
22487,a,0,0
22488,portion,0,0
22489,of,0,0
22490,their,0,0
22491,spinal,0,1
22492,cord,0,1
22493,and,0,0
22494,survived,0,1
22495,>,0,1
22496,1,0,0
22497,year,0,1
22498,following,0,0
22499,the,0,0
22500,beginning,0,0
22501,of,0,0
22502,therapy,0,0
22503,.,0,1
22504,Forty-five,0,1
22505,patients,0,1
22506,were,0,1
22507,treated,0,1
22508,with,0,1
22509,HFX,0,0
22510,RT,0,1
22511,alone,0,0
22512,and,0,0
22513,fifty-six,0,1
22514,patients,0,1
22515,also,0,0
22516,received,0,1
22517,CDDP,0,1
22518,.,0,1
22519,RESULTS,0,0
22520,None,0,0
22521,of,0,0
22522,these,0,0
22523,101,0,1
22524,patients,0,1
22525,developed,0,1
22526,cervical,0,1
22527,radiation,0,1
22528,myelitis,0,1
22529,.,0,0
22530,Therefore,0,0
22531,",",0,0
22532,it,0,0
22533,was,0,0
22534,not,0,0
22535,possible,0,0
22536,to,0,0
22537,investigate,0,0
22538,the,0,0
22539,influence,0,0
22540,of,0,0
22541,potentially,0,0
22542,contributing,0,0
22543,factors,0,0
22544,on,0,0
22545,the,0,0
22546,occurrence,0,0
22547,of,0,0
22548,radiation,0,0
22549,myelitis,0,1
22550,",",0,0
22551,such,0,0
22552,as,0,0
22553,interfraction,0,0
22554,interval,0,0
22555,",",0,0
22556,cord,0,0
22557,length,0,0
22558,",",0,0
22559,and,0,0
22560,administration,0,0
22561,of,0,0
22562,concurrent,0,0
22563,CDDP,0,1
22564,.,0,1
22565,CONCLUSIONS,0,0
22566,Given,0,0
22567,the,0,0
22568,increasing,0,0
22569,number,0,0
22570,of,0,0
22571,studies,0,0
22572,with,0,1
22573,both,0,0
22574,altered,0,0
22575,fractionated,0,0
22576,regimens,0,0
22577,and,0,0
22578,concurrent,0,0
22579,radio-chemotherapy,0,0
22580,in,0,0
22581,SCC,0,0
22582,H,0,1
22583,&,0,1
22584,N,0,1
22585,",",0,0
22586,new,0,0
22587,studies,0,0
22588,with,0,1
22589,more,0,0
22590,patients,0,1
22591,are,0,0
22592,needed,0,0
22593,to,0,0
22594,gain,0,0
22595,better,0,0
22596,insight,0,0
22597,into,0,0
22598,the,0,0
22599,risks,0,0
22600,of,0,0
22601,developing,0,1
22602,cervical,0,1
22603,radiation,0,1
22604,myelitis,0,1
22605,.,0,1
22606,Relationship,0,0
22607,between,0,0
22608,endogenous,0,0
22609,estrogen,0,1
22610,concentrations,0,0
22611,and,0,0
22612,serum,0,0
22613,cholesteryl,0,0
22614,ester,0,0
22615,transfer,0,0
22616,protein,0,0
22617,concentrations,0,0
22618,in,1,0
22619,Chinese,1,1
22620,women,1,1
22621,.,1,1
22622,BACKGROUND,0,0
22623,CETP,0,0
22624,plays,0,0
22625,an,0,0
22626,important,0,0
22627,role,0,0
22628,in,0,0
22629,HDL,0,0
22630,metabolism,0,0
22631,and,0,0
22632,in,0,0
22633,the,0,0
22634,reverse,0,0
22635,cholesterol,0,0
22636,transport,0,0
22637,pathway,0,0
22638,.,0,0
22639,METHODS,0,0
22640,The,0,0
22641,relationship,0,0
22642,between,0,0
22643,the,0,0
22644,changes,0,0
22645,of,0,0
22646,endogenous,0,0
22647,estrogen,0,0
22648,and,0,0
22649,the,0,0
22650,concentration,0,0
22651,of,0,0
22652,cholesteryl,0,0
22653,ester,0,0
22654,transfer,0,0
22655,protein,0,0
22656,(,0,0
22657,CETP,0,0
22658,),0,0
22659,in,0,0
22660,the,0,0
22661,serum,0,0
22662,of,0,0
22663,Chinese,1,1
22664,women,1,1
22665,was,0,0
22666,investigated,0,0
22667,.,0,1
22668,Serum,0,0
22669,concentrations,0,0
22670,of,0,0
22671,estradiol,0,0
22672,(,0,0
22673,E,0,0
22674,(,0,1
22675,2,0,0
22676,),0,0
22677,),0,0
22678,",",0,0
22679,follicle-stimulating,0,0
22680,hormone,0,0
22681,(,0,0
22682,FSH,0,0
22683,),0,0
22684,",",0,0
22685,CETP,0,0
22686,and,0,0
22687,lipid,0,0
22688,profile,0,0
22689,were,0,0
22690,determined,0,0
22691,in,0,0
22692,196,1,1
22693,Chinese,1,1
22694,women,1,1
22695,(,1,1
22696,52,1,1
22697,premenopausal,1,1
22698,with,1,1
22699,ages,1,1
22700,ranging,1,1
22701,from,1,1
22702,18,1,1
22703,to,1,1
22704,40,1,1
22705,years,1,1
22706,",",1,1
22707,57,1,1
22708,perimenopausal,1,1
22709,from,1,1
22710,41,1,1
22711,to,1,1
22712,60,1,1
22713,years,1,1
22714,",",1,0
22715,and,1,0
22716,87,1,1
22717,postmenopausal,1,1
22718,from,1,1
22719,61,1,1
22720,to,1,1
22721,81,1,1
22722,years,1,1
22723,),1,1
22724,.,1,1
22725,RESULTS,0,0
22726,Serum,0,1
22727,CETP,0,0
22728,concentration,0,0
22729,was,0,0
22730,significantly,0,0
22731,lower,0,0
22732,in,0,0
22733,postmenopausal,0,1
22734,women,0,1
22735,compared,0,0
22736,with,0,1
22737,those,0,0
22738,in,0,0
22739,perimenopausal,0,1
22740,and,0,0
22741,premenopausal,0,1
22742,women,0,1
22743,(,0,1
22744,1.39+/-1.06,0,0
22745,",",0,0
22746,2.36+/-1.50,0,0
22747,and,0,0
22748,2.31+/-1.25,0,0
22749,mg/l,0,0
22750,",",0,0
22751,respectively,0,0
22752,",",0,0
22753,P,0,0
22754,<,0,0
22755,0.0001,0,0
22756,),0,0
22757,.,0,0
22758,Even,0,0
22759,in,0,0
22760,the,0,0
22761,women,1,1
22762,around,1,0
22763,the,1,0
22764,menopausal,1,1
22765,",",0,0
22766,CETP,0,0
22767,concentration,0,0
22768,in,0,0
22769,postmenopause,0,1
22770,was,0,0
22771,significantly,0,0
22772,lower,0,0
22773,than,0,0
22774,that,0,0
22775,in,0,0
22776,premenopause,0,1
22777,(,0,0
22778,1.93+/-1.33,0,0
22779,vs.,0,0
22780,3.42+/-1.35,0,0
22781,mg/l,0,0
22782,",",0,0
22783,P,0,0
22784,<,0,0
22785,0.01,0,0
22786,),0,0
22787,.,0,0
22788,In,0,0
22789,addition,0,0
22790,",",0,0
22791,CETP,0,0
22792,concentration,0,0
22793,had,0,0
22794,a,0,0
22795,highly,0,0
22796,positive,0,0
22797,correlation,0,0
22798,with,0,1
22799,serum,0,0
22800,concentration,0,0
22801,of,0,0
22802,E,0,0
22803,(,0,1
22804,2,0,0
22805,),0,0
22806,(,0,0
22807,r=0.243,0,0
22808,",",0,0
22809,P,0,0
22810,<,0,0
22811,0.001,0,0
22812,),0,0
22813,",",0,0
22814,while,0,0
22815,negative,0,0
22816,correlation,0,0
22817,of,0,0
22818,CETP,0,0
22819,concentration,0,0
22820,with,0,1
22821,serum,0,0
22822,concentration,0,0
22823,of,0,0
22824,FSH,0,0
22825,was,0,0
22826,found,0,0
22827,(,0,0
22828,r=-0.273,0,0
22829,",",0,0
22830,P,0,0
22831,<,0,0
22832,0.001,0,0
22833,),0,1
22834,.,0,1
22835,CONCLUSIONS,0,0
22836,Estrogen,0,0
22837,may,0,0
22838,affect,0,0
22839,the,0,0
22840,concentration,0,0
22841,of,0,0
22842,CETP,0,0
22843,.,0,1
22844,Methodological,0,0
22845,issues,0,0
22846,in,0,0
22847,designing,0,0
22848,a,0,0
22849,multisite,0,0
22850,trial,0,0
22851,of,0,0
22852,risperidone,0,0
22853,in,0,0
22854,children,1,1
22855,and,1,1
22856,adolescents,1,1
22857,with,1,1
22858,autism,1,1
22859,.,1,0
22860,OBJECTIVE,0,0
22861,To,0,0
22862,describe,0,0
22863,the,0,0
22864,methodological,0,0
22865,challenges,0,0
22866,and,0,1
22867,decisions,0,0
22868,made,0,0
22869,in,0,0
22870,developing,0,0
22871,a,0,0
22872,multisite,0,0
22873,",",0,0
22874,controlled,0,0
22875,study,0,0
22876,of,0,0
22877,risperidone,0,0
22878,in,0,0
22879,children,1,1
22880,and,1,1
22881,adolescents,1,1
22882,with,1,1
22883,autism,1,1
22884,.,1,1
22885,METHODS,0,0
22886,Review,0,0
22887,the,0,0
22888,design,0,0
22889,considerations,0,0
22890,for,0,0
22891,clinical,0,0
22892,trials,0,1
22893,in,0,1
22894,children,1,1
22895,with,1,1
22896,autistic,1,1
22897,disorder,1,1
22898,accompanied,1,0
22899,by,1,0
22900,severe,1,1
22901,tantrums,1,1
22902,",",1,0
22903,aggressive,1,1
22904,and/or,1,0
22905,self-injurious,1,1
22906,behaviors,1,0
22907,.,1,1
22908,These,0,0
22909,design,0,0
22910,considerations,0,0
22911,include,0,0
22912,the,0,0
22913,definition,0,0
22914,of,0,0
22915,inclusion,0,1
22916,criteria,0,1
22917,that,0,0
22918,are,0,0
22919,relevant,0,0
22920,to,0,0
22921,clinical,0,0
22922,practice,0,0
22923,and,0,0
22924,matching,0,0
22925,study,0,0
22926,design,0,0
22927,to,0,0
22928,the,0,0
22929,goal,0,0
22930,of,0,0
22931,evaluating,0,0
22932,short-,0,0
22933,and,0,1
22934,long-term,0,1
22935,effects,0,0
22936,.,0,1
22937,Additional,0,0
22938,ethical,0,0
22939,and,0,0
22940,scientific,0,0
22941,issues,0,0
22942,concern,0,0
22943,the,0,0
22944,length,0,0
22945,of,0,0
22946,trial,0,0
22947,and,0,0
22948,sample,0,1
22949,size,0,0
22950,.,0,0
22951,RESULTS,0,0
22952,We,0,0
22953,undertook,0,0
22954,a,0,0
22955,short-term,0,0
22956,",",0,0
22957,placebo-controlled,0,0
22958,study,0,0
22959,to,0,0
22960,evaluate,0,0
22961,the,0,0
22962,efficacy,0,0
22963,and,0,0
22964,safety,0,0
22965,of,0,0
22966,risperidone,0,0
22967,in,0,0
22968,children,1,1
22969,and,1,1
22970,adolescents,1,1
22971,with,1,1
22972,autistic,1,1
22973,disorder,1,1
22974,.,1,0
22975,This,0,0
22976,trial,0,0
22977,design,0,0
22978,was,0,0
22979,followed,0,0
22980,by,0,0
22981,an,0,0
22982,extended,0,0
22983,open-label,0,0
22984,maintenance,0,0
22985,on,0,0
22986,risperidone,0,0
22987,to,0,0
22988,confirm,0,0
22989,durability,0,0
22990,of,0,0
22991,treatment,0,0
22992,effects,0,0
22993,and,0,0
22994,to,0,0
22995,monitor,0,0
22996,safety,0,0
22997,.,0,0
22998,Finally,0,0
22999,",",0,0
23000,a,0,0
23001,placebo-controlled,0,0
23002,discontinuation,0,0
23003,study,0,0
23004,tested,0,0
23005,the,0,0
23006,need,0,0
23007,for,0,0
23008,continuous,0,0
23009,treatment,0,0
23010,.,0,0
23011,CONCLUSIONS,0,0
23012,In,0,0
23013,the,0,0
23014,absence,0,0
23015,of,0,0
23016,standard,0,0
23017,pharmacological,0,0
23018,treatment,0,0
23019,for,0,0
23020,children,0,1
23021,with,0,1
23022,autistic,0,1
23023,disorder,0,1
23024,",",0,0
23025,a,0,0
23026,placebo-controlled,0,0
23027,study,0,0
23028,remains,0,0
23029,the,0,0
23030,most,0,0
23031,appropriate,0,0
23032,method,0,0
23033,of,0,0
23034,testing,0,0
23035,efficacy,0,0
23036,and,0,0
23037,safety,0,0
23038,.,0,0
23039,The,0,0
23040,clinical,0,0
23041,relevance,0,0
23042,of,0,0
23043,this,0,0
23044,study,0,0
23045,is,0,0
23046,enhanced,0,0
23047,by,0,0
23048,the,0,0
23049,addition,0,0
23050,of,0,0
23051,an,0,0
23052,extended,0,0
23053,maintenance,0,0
23054,phase,0,0
23055,followed,0,0
23056,by,0,0
23057,a,0,0
23058,placebo,0,0
23059,discontinuation,0,0
23060,.,0,1
23061,[,0,0
23062,Efficacy,0,0
23063,and,0,0
23064,immune,0,0
23065,memory,0,0
23066,of,0,0
23067,plasma-derived,0,0
23068,hepatitis,1,1
23069,B,1,1
23070,vaccine,1,0
23071,11,1,0
23072,years,1,1
23073,after,1,0
23074,primary,1,1
23075,immunization,1,1
23076,],1,0
23077,.,0,0
23078,OBJECTIVE,0,0
23079,To,0,0
23080,evaluate,0,0
23081,the,0,0
23082,long-term,0,0
23083,efficacy,0,0
23084,of,0,0
23085,hepatitis,1,1
23086,B,1,1
23087,vaccine,1,0
23088,10,1,1
23089,years,1,1
23090,after,1,0
23091,primary,1,1
23092,immunization,1,1
23093,to,0,0
23094,provide,0,0
23095,scientific,0,0
23096,basis,0,0
23097,for,0,0
23098,the,0,0
23099,time,0,0
23100,of,0,0
23101,revaccination,0,1
23102,.,0,1
23103,METHODS,0,0
23104,The,0,0
23105,study,0,0
23106,was,0,0
23107,strictly,0,0
23108,designed,0,0
23109,with,0,0
23110,randomization,0,0
23111,",",0,0
23112,double-blinding,0,0
23113,",",0,0
23114,and,0,0
23115,placebo-controlled,0,0
23116,method,0,0
23117,to,0,0
23118,observe,0,0
23119,the,1,0
23120,efficacy,1,0
23121,and,1,0
23122,immune,1,0
23123,memory,1,0
23124,11,1,1
23125,years,1,1
23126,following,1,0
23127,hepatitis,1,1
23128,B,1,1
23129,vaccination,1,1
23130,.,1,1
23131,RESULTS,0,0
23132,Immunogenicity,0,0
23133,and,0,0
23134,protective,0,0
23135,rate,0,0
23136,of,0,0
23137,vaccine,0,0
23138,were,0,0
23139,still,0,0
23140,kept,0,0
23141,well,0,0
23142,11,0,0
23143,years,0,1
23144,after,0,0
23145,immunization,0,1
23146,with,0,1
23147,a,0,0
23148,protective,0,0
23149,rate,0,0
23150,against,0,0
23151,HBV,0,1
23152,infection,0,1
23153,of,0,0
23154,73.5,0,0
23155,%,0,0
23156,.,0,0
23157,But,0,0
23158,",",0,0
23159,there,0,0
23160,was,0,0
23161,no,0,0
23162,significant,0,0
23163,difference,0,0
23164,in,0,0
23165,HBV,0,1
23166,infection,0,1
23167,rates,0,0
23168,between,0,0
23169,vaccine,1,0
23170,group,1,0
23171,and,1,0
23172,placebo-controlled,1,0
23173,group,1,0
23174,(,0,0
23175,7.89,0,0
23176,%,0,0
23177,vs.,0,0
23178,13.25,0,0
23179,%,0,0
23180,",",0,0
23181,P,0,0
23182,>,0,1
23183,0.1,0,0
23184,),0,1
23185,nine,0,1
23186,to,0,1
23187,11,0,1
23188,years,0,1
23189,following,0,0
23190,immunization,0,1
23191,.,0,0
23192,There,0,0
23193,still,0,0
23194,existed,0,0
23195,immune,0,0
23196,memory,0,0
23197,11,0,1
23198,years,0,1
23199,after,0,0
23200,immunization,0,1
23201,",",0,0
23202,but,0,0
23203,it,0,0
23204,was,0,0
23205,significantly,0,0
23206,weaker,0,0
23207,than,0,0
23208,that,0,0
23209,within,0,0
23210,the,0,0
23211,first,0,0
23212,10,0,0
23213,years,0,1
23214,after,0,0
23215,immunization,0,1
23216,.,0,0
23217,CONCLUSION,0,0
23218,The,0,0
23219,efficacy,0,0
23220,of,0,0
23221,the,0,0
23222,vaccine,0,0
23223,had,0,0
23224,begun,0,0
23225,to,0,0
23226,drop,0,0
23227,11,0,0
23228,years,0,1
23229,after,0,0
23230,immunization,0,1
23231,",",0,0
23232,which,0,0
23233,should,0,0
23234,be,0,0
23235,followed,0,0
23236,up,0,0
23237,further,0,0
23238,to,0,0
23239,reach,0,0
23240,a,0,0
23241,clear,0,0
23242,conclusion,0,0
23243,.,0,1
23244,Effectiveness,0,0
23245,of,0,0
23246,two,0,0
23247,quadruple,0,0
23248,",",0,0
23249,tetracycline-,0,0
23250,or,0,0
23251,clarithromycin-containing,0,0
23252,",",0,0
23253,second-line,0,0
23254,",",0,0
23255,Helicobacter,1,1
23256,pylori,1,0
23257,eradication,0,0
23258,therapies,0,0
23259,.,0,1
23260,BACKGROUND,0,0
23261,There,0,0
23262,are,0,0
23263,no,0,0
23264,guidelines,0,0
23265,on,0,0
23266,second-line,0,1
23267,therapies,0,0
23268,for,0,0
23269,Helicobacter,0,1
23270,pylori,0,1
23271,eradication,0,0
23272,failures,0,0
23273,of,0,0
23274,omeprazole-clarithromycin-amoxicillin,0,0
23275,triple,0,0
23276,therapy,0,0
23277,.,0,1
23278,AIM,0,0
23279,To,0,0
23280,compare,0,0
23281,the,0,0
23282,efficacy,0,0
23283,of,0,0
23284,two,0,0
23285,second-line,0,1
23286,therapies,0,0
23287,for,0,1
23288,persistent,0,1
23289,H.,0,1
23290,pylori,0,1
23291,infection,0,0
23292,.,0,0
23293,METHODS,0,0
23294,Over,0,0
23295,a,0,0
23296,6-year,1,0
23297,period,1,0
23298,",",1,0
23299,patients,1,1
23300,with,1,1
23301,persistent,1,1
23302,H.,1,1
23303,pylori,1,0
23304,infection,1,0
23305,following,1,0
23306,omeprazole-clarithromycin-amoxicillin,1,0
23307,eradication,1,0
23308,therapy,1,0
23309,were,0,0
23310,randomized,0,0
23311,to,0,0
23312,receive,0,0
23313,omeprazole,0,0
23314,",",0,0
23315,20,0,0
23316,mg,0,0
23317,twice,0,0
23318,daily,0,0
23319,",",0,0
23320,bismuth,0,0
23321,",",0,0
23322,120,0,1
23323,mg,0,0
23324,four,0,1
23325,times,0,0
23326,daily,0,0
23327,",",0,0
23328,metronidazole,0,0
23329,",",0,0
23330,500,0,0
23331,mg,0,0
23332,twice,0,0
23333,daily,0,0
23334,",",0,0
23335,and,0,0
23336,either,0,0
23337,tetracycline,0,0
23338,",",0,0
23339,500,0,0
23340,mg,0,0
23341,four,0,1
23342,times,0,0
23343,daily,0,0
23344,",",0,0
23345,or,0,0
23346,clarithromycin,0,0
23347,",",0,0
23348,500,0,0
23349,mg,0,0
23350,twice,0,0
23351,daily,0,0
23352,",",0,0
23353,given,0,0
23354,for,0,0
23355,7,0,1
23356,days,0,0
23357,.,0,1
23358,Before,0,0
23359,therapy,0,0
23360,",",0,0
23361,patients,0,1
23362,underwent,0,1
23363,endoscopy,0,1
23364,with,0,1
23365,biopsies,0,0
23366,for,0,0
23367,histology,0,0
23368,",",0,0
23369,culture,0,0
23370,and,0,0
23371,antibiotic,0,0
23372,susceptibility,0,0
23373,tests,0,0
23374,.,0,1
23375,H.,0,0
23376,pylori,0,0
23377,infection,0,1
23378,was,0,0
23379,confirmed,0,0
23380,by,0,0
23381,histology,0,0
23382,.,0,1
23383,RESULTS,0,0
23384,Of,0,0
23385,the,0,0
23386,95,1,0
23387,randomized,1,1
23388,patients,1,1
23389,",",1,0
23390,88,1,1
23391,(,1,0
23392,93,1,1
23393,%,1,0
23394,),1,0
23395,completed,1,1
23396,the,1,0
23397,study,1,0
23398,.,1,0
23399,Age,0,0
23400,",",0,0
23401,sex,0,0
23402,",",0,0
23403,smoking,0,0
23404,",",0,0
23405,ulcer/non-ulcer,0,1
23406,dyspepsia,0,1
23407,ratio,0,0
23408,and,0,0
23409,antibiotic,0,0
23410,resistance,0,0
23411,were,0,0
23412,not,0,0
23413,significantly,0,0
23414,different,0,0
23415,between,0,0
23416,the,0,0
23417,treatment,0,0
23418,groups,0,0
23419,.,0,1
23420,On,0,0
23421,intention-to-treat,0,0
23422,analysis,0,0
23423,",",0,0
23424,eradication,0,0
23425,was,0,0
23426,achieved,0,0
23427,in,0,0
23428,41,0,1
23429,of,0,0
23430,the,0,0
23431,49,0,1
23432,patients,0,1
23433,(,0,1
23434,84,0,1
23435,%,0,0
23436,;,0,1
23437,95,0,0
23438,%,0,0
23439,confidence,0,0
23440,interval,0,0
23441,",",0,0
23442,70.4-92.7,0,0
23443,%,0,0
23444,),0,0
23445,and,0,0
23446,27,0,1
23447,of,0,0
23448,the,0,0
23449,46,0,1
23450,patients,0,1
23451,(,0,1
23452,59,0,1
23453,%,0,0
23454,;,0,1
23455,95,0,0
23456,%,0,0
23457,confidence,0,0
23458,interval,0,0
23459,",",0,0
23460,43.3-73.0,0,0
23461,%,0,0
23462,),0,0
23463,of,0,0
23464,the,0,0
23465,tetracycline-,0,0
23466,and,0,0
23467,clarithromycin-containing,0,0
23468,groups,0,0
23469,",",0,0
23470,respectively,0,0
23471,(,0,0
23472,P=0.007,0,0
23473,),0,0
23474,.,0,0
23475,On,0,0
23476,multivariate,0,0
23477,regression,0,0
23478,analysis,0,0
23479,",",0,0
23480,the,0,0
23481,sensitivity,0,0
23482,of,0,0
23483,H.,0,1
23484,pylori,0,0
23485,to,0,0
23486,metronidazole,0,0
23487,had,0,0
23488,a,0,0
23489,likelihood,0,0
23490,ratio,0,0
23491,of,0,0
23492,5.2,0,0
23493,(,0,1
23494,P=0.022,0,0
23495,),0,0
23496,",",0,0
23497,followed,0,0
23498,by,0,0
23499,the,0,0
23500,type,0,1
23501,of,0,0
23502,quadruple,0,0
23503,therapy,0,0
23504,(,0,0
23505,likelihood,0,0
23506,ratio,0,0
23507,",",0,0
23508,4.4,0,0
23509,;,0,0
23510,P=0.036,0,0
23511,),0,0
23512,.,0,1
23513,CONCLUSIONS,0,0
23514,Tetracycline-containing,0,0
23515,quadruple,0,0
23516,rescue,0,0
23517,therapy,0,0
23518,is,0,0
23519,highly,0,0
23520,effective,0,0
23521,in,0,0
23522,treating,0,1
23523,H.,0,1
23524,pylori,0,1
23525,eradication,0,0
23526,failures,0,0
23527,of,0,0
23528,the,0,0
23529,omeprazole-amoxicillin-clarithromycin,0,0
23530,regimen,0,0
23531,.,0,1
23532,Supervisor,1,1
23533,tolerance-responsiveness,1,0
23534,to,0,0
23535,substance,0,0
23536,abuse,0,0
23537,and,0,0
23538,workplace,0,0
23539,prevention,0,0
23540,training,0,0
23541,:,0,1
23542,use,0,0
23543,of,0,0
23544,a,0,0
23545,cognitive,0,0
23546,mapping,0,0
23547,tool,0,0
23548,.,0,0
23549,Supervisor,1,0
23550,tolerance-responsiveness,1,0
23551,",",0,0
23552,referring,0,0
23553,to,0,0
23554,the,0,0
23555,attitudes,0,0
23556,and,0,0
23557,behaviors,0,0
23558,associated,0,0
23559,with,0,1
23560,either,0,0
23561,ignoring,0,0
23562,or,0,0
23563,taking,0,1
23564,proactive,0,0
23565,steps,0,1
23566,with,0,1
23567,troubled,1,1
23568,employees,1,1
23569,",",0,0
23570,was,0,0
23571,investigated,0,0
23572,in,0,0
23573,two,0,0
23574,studies,0,0
23575,.,0,1
23576,The,0,0
23577,studies,0,0
23578,were,0,0
23579,conducted,0,0
23580,to,0,0
23581,help,0,0
23582,examine,0,0
23583,",",0,0
23584,understand,0,0
23585,and,0,0
23586,improve,0,0
23587,supervisor,1,0
23588,responsiveness,1,0
23589,to,1,0
23590,employee,1,0
23591,substance,1,1
23592,abuse,1,1
23593,.,1,1
23594,Study,0,0
23595,1,0,0
23596,examined,0,0
23597,supervisor,1,0
23598,response,1,0
23599,to,1,0
23600,and,1,0
23601,tolerance,1,0
23602,of,1,0
23603,coworker,1,0
23604,substance,1,0
23605,use,1,0
23606,and,0,0
23607,ways,0,0
23608,of,0,0
23609,interfacing,0,0
23610,with,0,1
23611,the,0,0
23612,Employee,1,1
23613,Assistance,1,0
23614,Program,1,0
23615,(,1,0
23616,EAP,1,1
23617,),1,0
23618,in,1,0
23619,two,1,0
23620,workplaces,1,1
23621,(,1,1
23622,n,1,1
23623,=,1,0
23624,244,1,1
23625,and,1,0
23626,107,1,1
23627,),1,0
23628,.,1,1
23629,These,0,0
23630,surveys,0,0
23631,suggested,0,0
23632,that,0,0
23633,engaging,0,1
23634,supervisors,0,0
23635,in,0,0
23636,a,0,0
23637,dialogue,0,0
23638,about,0,0
23639,tolerance,0,0
23640,might,0,0
23641,improve,0,0
23642,their,0,0
23643,willingness,0,0
23644,to,0,0
23645,use,0,0
23646,the,0,0
23647,EAP,0,0
23648,.,0,1
23649,Study,0,0
23650,2,0,0
23651,was,0,0
23652,a,0,0
23653,randomized,0,0
23654,control,0,0
23655,field,0,0
23656,experiment,0,0
23657,that,0,0
23658,assessed,0,0
23659,a,0,0
23660,team-oriented,0,0
23661,training,0,0
23662,.,0,0
23663,This,0,0
23664,training,0,0
23665,adopted,0,0
23666,a,0,0
23667,cognitive,0,0
23668,mapping,0,0
23669,technique,0,0
23670,to,0,0
23671,help,0,0
23672,improve,0,0
23673,supervisor,0,0
23674,responsiveness,0,0
23675,.,0,1
23676,Supervisors,1,0
23677,receiving,1,0
23678,this,1,0
23679,training,1,0
23680,(,1,0
23681,n,1,1
23682,=,1,0
23683,29,1,1
23684,),1,0
23685,were,0,0
23686,more,0,0
23687,likely,0,0
23688,to,0,0
23689,improve,0,0
23690,on,0,0
23691,several,0,0
23692,dimensions,0,0
23693,of,0,0
23694,responsiveness,0,0
23695,(,0,0
23696,e.g,0,0
23697,.,0,0
23698,likely,0,0
23699,to,0,0
23700,contact,0,0
23701,the,0,0
23702,EAP,0,0
23703,),0,0
23704,than,0,0
23705,were,0,1
23706,supervisors,1,1
23707,who,1,1
23708,received,1,1
23709,a,1,1
23710,more,1,0
23711,didactic,1,0
23712,",",1,0
23713,informational,1,0
23714,training,1,0
23715,(,1,0
23716,n,1,1
23717,=,1,0
23718,23,1,1
23719,),1,0
23720,or,1,1
23721,a,1,0
23722,no-training,1,0
23723,control,1,0
23724,group,1,0
23725,(,1,0
23726,n,1,1
23727,=,1,0
23728,17,1,1
23729,),1,1
23730,.,1,1
23731,Trained,1,0
23732,supervisors,1,0
23733,also,0,0
23734,showed,0,0
23735,increases,0,0
23736,in,0,0
23737,their,0,1
23738,own,0,1
23739,help-seeking,0,0
23740,behavior,0,0
23741,.,0,1
23742,Procedures,0,0
23743,and,0,0
23744,maps,0,1
23745,from,0,0
23746,the,0,0
23747,mapping,0,0
23748,activity,0,0
23749,(,0,0
23750,two-stage,0,0
23751,conversational,0,0
23752,mapping,0,0
23753,),0,0
23754,are,0,0
23755,described,0,0
23756,.,0,0
23757,Overall,0,0
23758,",",0,0
23759,results,0,0
23760,indicate,0,0
23761,that,0,0
23762,while,0,0
23763,supervisor,0,0
23764,tolerance,0,0
23765,of,0,0
23766,coworker,0,0
23767,substance,0,0
23768,use,0,0
23769,inhibits,0,0
23770,EAP,0,0
23771,utilization,0,0
23772,",",0,0
23773,it,0,0
23774,may,0,0
23775,be,0,0
23776,possible,0,0
23777,to,0,0
23778,address,0,0
23779,this,0,0
23780,tolerance,0,0
23781,using,0,0
23782,team-oriented,0,0
23783,prevention,0,0
23784,training,0,0
23785,in,0,0
23786,the,0,0
23787,work-site,0,1
23788,.,0,1
23789,The,0,0
23790,interaction,0,0
23791,between,0,0
23792,propofol,0,0
23793,and,0,0
23794,clonidine,0,0
23795,for,0,0
23796,loss,0,0
23797,of,0,0
23798,consciousness,0,0
23799,.,0,1
23800,UNLABELLED,0,0
23801,Clonidine,0,0
23802,premedication,0,0
23803,reduces,0,0
23804,the,0,0
23805,intraoperative,0,0
23806,requirement,0,0
23807,for,0,0
23808,opioids,0,0
23809,and,0,1
23810,volatile,0,0
23811,anesthetics,0,0
23812,.,0,1
23813,Clonidine,0,0
23814,also,0,0
23815,reduces,0,0
23816,the,0,0
23817,induction,0,0
23818,dose,0,0
23819,of,0,0
23820,IV,0,1
23821,anesthetics,0,0
23822,.,0,0
23823,There,0,0
23824,is,0,0
23825,no,0,0
23826,information,0,0
23827,",",0,0
23828,however,0,0
23829,",",0,0
23830,regarding,0,0
23831,the,0,0
23832,effect,0,0
23833,of,0,0
23834,oral,0,0
23835,clonidine,0,0
23836,premedication,0,0
23837,on,0,0
23838,the,0,0
23839,propofol,0,0
23840,blood,0,0
23841,concentrations,0,0
23842,required,0,0
23843,for,0,0
23844,loss,0,0
23845,of,0,0
23846,consciousness,0,0
23847,",",0,0
23848,and,0,0
23849,the,0,0
23850,interaction,0,0
23851,between,0,0
23852,propofol,0,0
23853,and,0,0
23854,clonidine,0,0
23855,.,0,0
23856,We,0,0
23857,randomly,0,0
23858,administered,0,0
23859,target,0,0
23860,effect-site,0,0
23861,concentrations,0,0
23862,of,0,0
23863,propofol,0,0
23864,ranging,0,1
23865,from,0,0
23866,0.5,0,0
23867,to,0,1
23868,5,0,1
23869,.,0,1
23870,0,0,0
23871,microg/mL,0,0
23872,by,0,0
23873,using,0,0
23874,computer-assisted,0,0
23875,target-controlled,0,0
23876,infusion,0,0
23877,to,0,0
23878,3,1,0
23879,groups,1,0
23880,of,1,1
23881,healthy,1,1
23882,male,1,1
23883,patients,1,1
23884,:,1,1
23885,Control,1,1
23886,(,1,0
23887,n,1,1
23888,=,1,0
23889,35,1,1
23890,),1,0
23891,",",1,0
23892,2.5,1,0
23893,microg/kg,1,0
23894,Clonidine,1,0
23895,(,1,0
23896,n,1,1
23897,=,1,0
23898,36,1,1
23899,),1,0
23900,",",1,0
23901,and,1,0
23902,5.0,1,0
23903,microg/kg,1,0
23904,Clonidine,1,0
23905,(,1,1
23906,n,1,1
23907,=,1,0
23908,36,1,1
23909,),1,1
23910,groups,1,0
23911,.,1,1
23912,Nothing,0,0
23913,was,0,0
23914,administered,0,0
23915,to,0,0
23916,the,0,0
23917,Control,0,0
23918,group,0,0
23919,.,0,0
23920,Clonidine,0,0
23921,(,0,0
23922,2.5,0,0
23923,or,0,1
23924,5.0,0,0
23925,microg/kg,0,0
23926,),0,0
23927,was,0,0
23928,administered,0,0
23929,orally,0,0
23930,90,0,0
23931,min,0,0
23932,before,0,0
23933,the,0,0
23934,induction,0,0
23935,of,0,0
23936,anesthesia,0,0
23937,in,0,0
23938,the,0,0
23939,Clonidine,0,0
23940,groups,0,0
23941,.,0,1
23942,After,0,0
23943,equilibration,0,0
23944,between,0,0
23945,the,0,0
23946,blood,0,0
23947,and,0,0
23948,effect-site,0,0
23949,for,0,0
23950,15,0,0
23951,min,0,0
23952,",",0,0
23953,a,0,0
23954,verbal,0,0
23955,command,0,0
23956,to,0,0
23957,open,0,1
23958,their,0,0
23959,eyes,0,1
23960,was,0,0
23961,given,0,0
23962,two,0,0
23963,times,0,0
23964,to,0,1
23965,the,0,0
23966,patients,0,1
23967,.,0,1
23968,Arterial,0,0
23969,blood,0,0
23970,samples,0,0
23971,for,0,0
23972,analysis,0,0
23973,of,0,0
23974,the,0,0
23975,serum,0,0
23976,propofol,0,0
23977,and,0,0
23978,clonidine,0,0
23979,concentrations,0,0
23980,were,0,0
23981,taken,0,0
23982,immediately,0,0
23983,before,0,0
23984,verbal,0,0
23985,commands,0,0
23986,were,0,1
23987,given,0,0
23988,.,0,1
23989,Measured,0,0
23990,serum,0,0
23991,propofol,0,0
23992,concentrations,0,0
23993,in,0,0
23994,equilibrium,0,0
23995,with,0,1
23996,the,0,0
23997,effect-site,0,0
23998,at,0,0
23999,which,0,0
24000,50,0,1
24001,%,0,0
24002,of,0,0
24003,the,0,0
24004,patients,0,1
24005,did,0,0
24006,not,0,0
24007,respond,0,0
24008,to,0,0
24009,verbal,0,0
24010,commands,0,0
24011,(,0,0
24012,EC50,0,0
24013,for,0,0
24014,loss,0,0
24015,of,0,0
24016,consciousness,0,0
24017,),0,0
24018,were,0,0
24019,determined,0,0
24020,by,0,0
24021,logistic,0,0
24022,regression,0,0
24023,.,0,0
24024,The,0,0
24025,EC50,0,0
24026,+/-,0,0
24027,SE,0,1
24028,values,0,0
24029,in,0,0
24030,the,0,0
24031,Control,0,0
24032,",",0,0
24033,2.5,0,0
24034,microg/kg,0,0
24035,Clonidine,0,0
24036,",",0,0
24037,and,0,0
24038,5.0,0,0
24039,microg/kg,0,0
24040,Clonidine,0,0
24041,groups,0,0
24042,were,0,1
24043,2.67,0,0
24044,+/-,0,0
24045,0.18,0,0
24046,",",0,0
24047,1.31,0,0
24048,+/-,0,0
24049,0.12,0,0
24050,",",0,0
24051,and,0,0
24052,0.91,0,0
24053,+/-,0,0
24054,0.13,0,0
24055,microg/mL,0,0
24056,",",0,0
24057,respectively,0,0
24058,.,0,0
24059,The,0,0
24060,EC50,0,0
24061,in,0,0
24062,the,0,0
24063,2.5,0,0
24064,and,0,0
24065,5.0,0,0
24066,microg/kg,0,0
24067,clonidine,0,0
24068,groups,0,0
24069,was,0,0
24070,significantly,0,0
24071,smaller,0,0
24072,than,0,0
24073,that,0,0
24074,in,0,0
24075,the,0,0
24076,Control,0,0
24077,group,0,0
24078,(,0,0
24079,P,0,0
24080,<,0,0
24081,0.001,0,0
24082,),0,0
24083,.,0,0
24084,The,0,0
24085,use,0,0
24086,of,0,0
24087,a,0,0
24088,response,0,0
24089,surface,0,0
24090,modeling,0,0
24091,analysis,0,0
24092,indicated,0,0
24093,that,0,0
24094,there,0,0
24095,was,0,0
24096,an,0,0
24097,additive,0,0
24098,interaction,0,0
24099,between,0,0
24100,measured,0,0
24101,arterial,0,1
24102,propofol,0,0
24103,and,0,0
24104,clonidine,0,0
24105,concentrations,0,0
24106,in,0,0
24107,relation,0,0
24108,to,0,0
24109,loss,0,0
24110,of,0,0
24111,consciousness,0,0
24112,.,0,0
24113,These,0,0
24114,results,0,0
24115,indicate,0,0
24116,that,0,0
24117,propofol,0,0
24118,and,0,0
24119,clonidine,0,0
24120,act,0,0
24121,additively,0,0
24122,for,0,0
24123,loss,0,0
24124,of,0,0
24125,consciousness,0,0
24126,.,0,1
24127,IMPLICATIONS,0,0
24128,Oral,0,0
24129,clonidine,0,0
24130,2.5,0,0
24131,and,0,0
24132,5.0,0,0
24133,microg/kg,0,0
24134,premedication,0,0
24135,decreases,0,0
24136,the,0,0
24137,propofol,0,0
24138,concentration,0,0
24139,required,0,0
24140,for,0,0
24141,loss,0,0
24142,of,0,0
24143,consciousness,0,0
24144,.,0,1
24145,Detection,0,0
24146,of,0,0
24147,recurrent,1,1
24148,or,1,1
24149,persistent,1,1
24150,nasopharyngeal,1,1
24151,carcinomas,1,1
24152,after,1,0
24153,radiotherapy,1,1
24154,with,0,1
24155,technetium-99m,0,0
24156,methoxyisobutylisonitrile,0,0
24157,single,0,0
24158,photon,0,0
24159,emission,0,1
24160,computed,0,0
24161,tomography,0,0
24162,and,0,0
24163,computed,0,0
24164,tomography,0,0
24165,:,0,1
24166,comparison,0,0
24167,with,0,1
24168,18-fluoro-2-deoxyglucose,0,1
24169,positron,0,1
24170,emission,0,1
24171,tomography,0,0
24172,.,0,0
24173,BACKGROUND,0,0
24174,The,0,0
24175,diagnostic,0,0
24176,accuracy,0,0
24177,of,0,0
24178,technetium-99m,0,0
24179,methoxyisobutylisonitrile,0,0
24180,(,0,0
24181,Tc-MIBI,0,1
24182,),0,0
24183,single,0,0
24184,photon,0,0
24185,emission,0,1
24186,computed,0,0
24187,tomography,0,0
24188,(,0,0
24189,SPECT,0,0
24190,),0,0
24191,and,0,0
24192,computed,0,0
24193,tomography,0,0
24194,(,0,0
24195,CT,0,0
24196,),0,0
24197,of,0,0
24198,the,0,0
24199,head,0,1
24200,and,0,0
24201,neck,0,1
24202,for,0,0
24203,differentiating,0,0
24204,recurrent,0,1
24205,or,0,1
24206,residual,1,0
24207,nasopharyngeal,1,1
24208,carcinomas,1,1
24209,(,1,0
24210,NPC,1,0
24211,),1,0
24212,from,0,1
24213,benign,0,1
24214,lesions,0,1
24215,after,0,0
24216,radiotherapy,0,1
24217,was,0,0
24218,compared,0,0
24219,with,0,1
24220,positron,0,0
24221,emission,0,1
24222,tomography,0,0
24223,(,0,0
24224,PET,0,0
24225,),0,0
24226,with,0,1
24227,18-fluoro-2-deoxyglucose,0,1
24228,(,0,1
24229,FDG,0,0
24230,),0,1
24231,.,0,1
24232,METHODS,0,0
24233,Thirty,1,1
24234,six,1,1
24235,NPC,1,1
24236,patients,1,1
24237,underwent,1,1
24238,head,1,1
24239,and,1,0
24240,neck,1,1
24241,CT,1,0
24242,",",1,0
24243,Tc-MIBI,1,0
24244,SPECT,1,0
24245,",",1,0
24246,and,1,0
24247,FDG-PET,1,0
24248,four,1,1
24249,months,1,0
24250,after,1,0
24251,radiotherapy,1,1
24252,to,0,0
24253,differentiate,0,0
24254,recurrent,0,1
24255,or,0,0
24256,residual,0,0
24257,NPC,0,0
24258,from,0,1
24259,benign,0,1
24260,lesions,0,1
24261,.,0,1
24262,Histopathologic,0,1
24263,examinations,0,0
24264,of,0,1
24265,nasopharyngeal,0,1
24266,biopsies,0,1
24267,were,0,1
24268,performed,0,0
24269,for,0,0
24270,all,0,0
24271,36,1,1
24272,patients,1,1
24273,.,1,1
24274,No,1,0
24275,patients,1,1
24276,had,1,1
24277,multiple,1,0
24278,foci,1,1
24279,of,1,0
24280,NPC,1,0
24281,.,1,1
24282,RESULTS,0,0
24283,Based,0,0
24284,on,0,0
24285,biopsy,0,1
24286,results,0,0
24287,",",0,0
24288,the,0,0
24289,sensitivity,0,0
24290,",",0,0
24291,specificity,0,0
24292,",",0,0
24293,and,0,0
24294,accuracy,0,0
24295,of,0,0
24296,CT,0,0
24297,for,0,0
24298,differentiating,0,0
24299,recurrent,0,1
24300,or,0,1
24301,residual,0,0
24302,NPC,0,0
24303,from,0,1
24304,benign,0,1
24305,lesions,0,1
24306,were,0,1
24307,73,0,1
24308,%,0,0
24309,",",0,0
24310,88,0,0
24311,%,0,0
24312,",",0,0
24313,and,0,0
24314,83,0,0
24315,%,0,0
24316,",",0,0
24317,respectively,0,0
24318,.,0,0
24319,The,0,0
24320,sensitivity,0,0
24321,",",0,0
24322,specificity,0,0
24323,",",0,0
24324,and,0,0
24325,accuracy,0,0
24326,of,0,0
24327,Tc-MIBI,0,1
24328,SPECT,0,1
24329,were,0,1
24330,73,0,1
24331,%,0,0
24332,",",0,0
24333,96,0,0
24334,%,0,0
24335,",",0,0
24336,and,0,0
24337,89,0,1
24338,%,0,0
24339,",",0,0
24340,respectively,0,0
24341,.,0,0
24342,The,0,0
24343,sensitivity,0,0
24344,",",0,0
24345,specificity,0,0
24346,",",0,0
24347,and,0,0
24348,accuracy,0,0
24349,of,0,0
24350,FDG-PET,0,0
24351,were,0,1
24352,100,0,0
24353,%,0,0
24354,",",0,0
24355,96,0,0
24356,%,0,0
24357,",",0,0
24358,and,0,0
24359,97,0,0
24360,%,0,0
24361,",",0,0
24362,respectively,0,0
24363,.,0,0
24364,Combination,0,0
24365,CT,0,0
24366,and,0,0
24367,Tc-MIBI,0,0
24368,SPECT,0,1
24369,for,0,0
24370,28,0,1
24371,NPC,0,1
24372,patients,0,1
24373,with,0,1
24374,congruent,0,1
24375,results,0,0
24376,showed,0,0
24377,the,0,0
24378,same,0,0
24379,sensitivity,0,0
24380,",",0,0
24381,specificity,0,0
24382,",",0,0
24383,and,0,0
24384,accuracy,0,0
24385,of,0,0
24386,100,0,0
24387,%,0,0
24388,",",0,0
24389,96,0,0
24390,%,0,0
24391,",",0,0
24392,and,0,0
24393,96,0,0
24394,%,0,0
24395,",",0,0
24396,respectively,0,0
24397,",",0,0
24398,as,0,0
24399,FDG-PET,0,0
24400,for,0,0
24401,differentiating,0,0
24402,recurrent,0,1
24403,or,0,1
24404,residual,0,0
24405,NPC,0,0
24406,from,0,1
24407,benign,0,1
24408,lesions,0,1
24409,.,0,1
24410,In,0,0
24411,eight,0,1
24412,patients,0,1
24413,with,0,1
24414,incongruent,0,0
24415,results,0,0
24416,between,0,0
24417,CT,0,1
24418,and,0,0
24419,Tc-MIBI,0,0
24420,SPECT,0,0
24421,",",0,0
24422,FDG-PET,0,0
24423,correctly,0,0
24424,differentiated,0,0
24425,two,0,0
24426,benign,0,1
24427,lesions,0,1
24428,and,0,1
24429,six,0,1
24430,recurrent,0,1
24431,or,0,1
24432,residual,0,0
24433,NPCs,0,0
24434,.,0,1
24435,CONCLUSIONS,0,0
24436,In,0,0
24437,detecting,0,0
24438,recurrent,0,1
24439,or,0,1
24440,residual,0,0
24441,NPC,0,0
24442,",",0,0
24443,FDG-PET,0,0
24444,is,0,0
24445,the,0,0
24446,best,0,0
24447,tool,0,0
24448,.,0,0
24449,However,0,0
24450,",",0,0
24451,combined,0,0
24452,use,0,0
24453,of,0,0
24454,CT,0,0
24455,and,0,0
24456,Tc-MIBI,0,0
24457,SPECT,0,0
24458,can,0,0
24459,result,0,0
24460,in,0,0
24461,the,0,0
24462,same,0,0
24463,accuracy,0,0
24464,as,0,0
24465,FDG-PET,0,0
24466,.,0,1
24467,Short-term,0,0
24468,intravenous,0,0
24469,antibiotic,0,0
24470,treatment,0,0
24471,of,0,0
24472,acute,1,1
24473,hematogenous,1,1
24474,bone,1,0
24475,and,1,0
24476,joint,1,0
24477,infection,1,1
24478,in,1,1
24479,children,1,1
24480,:,1,1
24481,a,0,0
24482,prospective,0,0
24483,randomized,0,0
24484,trial,0,0
24485,.,0,1
24486,Thirty-three,1,1
24487,cases,1,1
24488,of,1,1
24489,acute,1,1
24490,hematogenous,1,1
24491,bone,1,0
24492,or,1,1
24493,joint,1,0
24494,infection,1,1
24495,in,1,0
24496,children,1,1
24497,were,0,1
24498,randomly,0,1
24499,treated,0,1
24500,with,0,1
24501,short-term,0,0
24502,(,0,1
24503,7,0,1
24504,days,0,0
24505,for,0,0
24506,joint,0,1
24507,infection,0,1
24508,",",0,0
24509,10,0,0
24510,days,0,0
24511,for,0,0
24512,bone,0,0
24513,infection,0,1
24514,),0,0
24515,or,0,1
24516,long-term,0,0
24517,(,0,1
24518,14,0,1
24519,days,0,0
24520,and,0,1
24521,21,0,1
24522,days,0,0
24523,",",0,0
24524,respectively,0,0
24525,),0,0
24526,intravenous,0,0
24527,antibiotics,0,0
24528,after,0,0
24529,surgical,0,1
24530,drainage,0,1
24531,.,0,0
24532,The,0,0
24533,treatment,0,0
24534,outcome,0,0
24535,was,0,0
24536,measured,0,0
24537,through,0,0
24538,a,0,0
24539,detailed,0,0
24540,scoring,0,0
24541,system,0,0
24542,that,0,0
24543,included,0,0
24544,the,0,0
24545,ability,0,0
24546,to,0,0
24547,eradicate,0,0
24548,infection,0,0
24549,",",0,0
24550,the,0,0
24551,functional,0,0
24552,status,0,0
24553,of,0,0
24554,the,0,0
24555,limb,0,0
24556,",",0,0
24557,and,0,0
24558,the,0,0
24559,radiographic,0,0
24560,appearance,0,0
24561,of,0,0
24562,the,0,0
24563,bone,0,0
24564,and,0,0
24565,joint,0,0
24566,.,0,0
24567,The,0,0
24568,results,0,0
24569,were,0,0
24570,similar,0,0
24571,in,0,0
24572,both,0,0
24573,groups,0,0
24574,",",0,0
24575,showing,0,0
24576,the,0,0
24577,added,0,0
24578,benefit,0,0
24579,of,0,0
24580,a,0,0
24581,shorter,0,0
24582,hospital,0,0
24583,stay,0,0
24584,for,0,0
24585,children,1,1
24586,with,1,1
24587,blood-borne,1,1
24588,musculoskeletal,1,1
24589,infection,1,1
24590,.,1,0
24591,The,0,0
24592,use,0,0
24593,of,0,0
24594,this,0,0
24595,scoring,0,0
24596,system,0,0
24597,in,0,0
24598,choosing,0,0
24599,the,0,0
24600,route,0,0
24601,of,0,0
24602,antibiotic,0,0
24603,administration,0,0
24604,is,0,0
24605,recommended,0,0
24606,.,0,0
24607,Do,0,0
24608,colonic,0,0
24609,short-chain,0,0
24610,fatty,0,0
24611,acids,0,0
24612,contribute,0,0
24613,to,0,0
24614,the,0,0
24615,long-term,0,0
24616,adaptation,0,0
24617,of,0,0
24618,blood,0,0
24619,lipids,0,0
24620,in,0,0
24621,subjects,1,1
24622,with,1,1
24623,type,1,1
24624,2,1,1
24625,diabetes,1,1
24626,consuming,1,0
24627,a,1,0
24628,high-fiber,1,0
24629,diet,1,0
24630,?,0,0
24631,BACKGROUND,0,0
24632,We,0,0
24633,recently,0,1
24634,obtained,0,0
24635,evidence,0,0
24636,of,0,0
24637,long-term,0,0
24638,adaptation,0,0
24639,of,0,0
24640,blood,0,0
24641,lipids,0,0
24642,to,0,0
24643,changes,0,0
24644,in,0,0
24645,intakes,0,0
24646,of,0,0
24647,carbohydrate,0,0
24648,and,0,0
24649,fiber,0,0
24650,in,0,0
24651,subjects,1,1
24652,with,1,1
24653,type,1,1
24654,2,1,1
24655,diabetes,1,1
24656,.,1,1
24657,OBJECTIVE,0,0
24658,We,0,0
24659,determined,0,0
24660,the,0,0
24661,effect,0,0
24662,of,0,0
24663,increased,0,0
24664,carbohydrate,0,0
24665,and,0,0
24666,fiber,0,0
24667,intakes,0,0
24668,on,0,0
24669,serum,0,0
24670,short-chain,0,0
24671,fatty,0,0
24672,acids,0,0
24673,(,0,1
24674,SCFAs,0,1
24675,),0,0
24676,and,0,0
24677,the,0,0
24678,relation,0,0
24679,between,0,0
24680,changes,0,0
24681,in,0,0
24682,serum,0,0
24683,acetate,0,0
24684,and,0,0
24685,changes,0,0
24686,in,0,0
24687,blood,0,0
24688,lipids,0,0
24689,.,0,0
24690,DESIGN,0,0
24691,Subjects,1,1
24692,with,1,0
24693,type,1,1
24694,2,1,1
24695,diabetes,1,1
24696,(,1,1
24697,n,1,1
24698,=,1,0
24699,62,1,1
24700,),1,0
24701,were,0,0
24702,randomly,0,1
24703,assigned,0,0
24704,to,0,0
24705,receive,0,0
24706,approximately,0,0
24707,10,0,0
24708,%,0,0
24709,of,0,0
24710,energy,0,0
24711,from,0,1
24712,low-fiber,0,0
24713,breakfast,0,0
24714,cereal,0,1
24715,(,0,0
24716,LF,0,0
24717,diet,0,1
24718,),0,0
24719,",",0,0
24720,high-fiber,0,0
24721,breakfast,0,0
24722,cereal,0,1
24723,(,0,0
24724,HF,0,0
24725,diet,0,1
24726,),0,0
24727,",",0,0
24728,or,0,0
24729,monounsaturated,0,0
24730,fatty,0,0
24731,acids,0,0
24732,(,0,1
24733,MUFA,0,0
24734,diet,0,1
24735,),0,0
24736,for,0,0
24737,6,0,1
24738,mo,0,1
24739,.,0,1
24740,RESULTS,0,0
24741,Carbohydrate,0,0
24742,intakes,0,0
24743,were,0,0
24744,higher,0,0
24745,in,0,0
24746,the,0,0
24747,LF,0,0
24748,and,0,0
24749,HF,0,1
24750,groups,0,0
24751,than,0,0
24752,in,0,0
24753,the,0,0
24754,MUFA,0,0
24755,group,0,0
24756,(,0,0
24757,54,0,1
24758,%,0,0
24759,compared,0,0
24760,with,0,1
24761,43,0,1
24762,%,0,0
24763,),0,0
24764,",",0,0
24765,and,0,0
24766,more,0,0
24767,fiber,0,0
24768,was,0,0
24769,consumed,0,0
24770,by,0,0
24771,the,0,0
24772,HF,0,0
24773,group,0,0
24774,(,0,0
24775,approximately,0,1
24776,50,0,1
24777,g/d,0,0
24778,),0,1
24779,than,0,0
24780,by,0,0
24781,the,0,0
24782,LF,0,0
24783,or,0,1
24784,MUFA,0,0
24785,group,0,0
24786,(,0,0
24787,approximately,0,0
24788,23,0,1
24789,g/d,0,0
24790,),0,0
24791,.,0,0
24792,Fasting,0,0
24793,serum,0,0
24794,SCFAs,0,1
24795,did,0,0
24796,not,0,0
24797,change,0,0
24798,significantly,0,0
24799,over,0,0
24800,the,0,0
24801,first,0,0
24802,3,0,0
24803,mo,0,1
24804,.,0,1
24805,Between,0,0
24806,3,0,0
24807,and,0,0
24808,6,0,0
24809,mo,0,1
24810,",",0,0
24811,serum,0,0
24812,acetate,0,0
24813,tended,0,0
24814,(,0,0
24815,NS,0,0
24816,),0,0
24817,to,0,0
24818,decrease,0,0
24819,in,0,0
24820,the,0,0
24821,LF,0,0
24822,group,0,0
24823,(,0,0
24824,from,0,1
24825,69,0,1
24826,+/-,0,0
24827,4,0,0
24828,to,0,1
24829,59,0,1
24830,+/-,0,0
24831,5,0,1
24832,micromol/L,0,0
24833,),0,0
24834,and,0,0
24835,increase,0,0
24836,in,0,0
24837,the,0,0
24838,HF,0,0
24839,group,0,0
24840,(,0,0
24841,from,0,1
24842,100,0,1
24843,+/-,0,0
24844,18,0,1
24845,to,0,1
24846,107,0,1
24847,+/-,0,0
24848,17,0,1
24849,micromol/L,0,0
24850,),0,0
24851,",",0,0
24852,with,0,1
24853,no,0,0
24854,significant,0,0
24855,change,0,0
24856,in,0,0
24857,the,0,0
24858,MUFA,0,0
24859,group,0,0
24860,.,0,0
24861,Serum,0,0
24862,butyrate,0,0
24863,did,0,0
24864,not,0,0
24865,change,0,0
24866,significantly,0,0
24867,in,0,0
24868,the,0,0
24869,LF,0,0
24870,or,0,1
24871,MUFA,0,0
24872,group,0,0
24873,but,0,0
24874,increased,0,0
24875,in,0,0
24876,the,0,0
24877,HF,0,0
24878,group,0,0
24879,(,0,0
24880,from,0,1
24881,2.5,0,0
24882,+/-,0,0
24883,0.5,0,0
24884,to,0,1
24885,3.1,0,0
24886,+/-,0,0
24887,0.6,0,1
24888,micromol/L,0,0
24889,;,0,1
24890,P,0,0
24891,<,0,0
24892,0.001,0,0
24893,),0,1
24894,.,0,1
24895,Changes,0,0
24896,in,0,0
24897,serum,0,0
24898,acetate,0,0
24899,from,0,0
24900,0,0,0
24901,to,0,1
24902,3,0,1
24903,mo,0,0
24904,were,0,1
24905,not,0,0
24906,related,0,0
24907,to,0,0
24908,changes,0,0
24909,in,0,1
24910,lipids,0,0
24911,.,0,1
24912,However,0,0
24913,",",0,0
24914,changes,0,0
24915,in,0,0
24916,serum,0,0
24917,acetate,0,0
24918,from,0,0
24919,3,0,0
24920,to,0,1
24921,6,0,0
24922,mo,0,0
24923,were,0,1
24924,positively,0,0
24925,related,0,0
24926,to,0,0
24927,changes,0,0
24928,in,0,0
24929,the,0,0
24930,ratio,0,0
24931,of,0,0
24932,total,0,1
24933,to,0,0
24934,HDL,0,0
24935,cholesterol,0,0
24936,(,0,0
24937,P,0,0
24938,=,0,0
24939,0.041,0,0
24940,),0,0
24941,and,0,0
24942,in,0,0
24943,fasting,0,0
24944,(,0,0
24945,P,0,0
24946,=,0,0
24947,0.013,0,0
24948,),0,0
24949,and,0,0
24950,postprandial,0,0
24951,(,0,0
24952,P,0,0
24953,=,0,0
24954,0.016,0,0
24955,),0,1
24956,triacylglycerols,0,0
24957,.,0,1
24958,CONCLUSIONS,0,0
24959,In,0,0
24960,subjects,1,1
24961,with,1,1
24962,type,1,1
24963,2,1,1
24964,diabetes,1,1
24965,",",0,1
24966,changes,0,0
24967,in,0,0
24968,serum,0,0
24969,SCFAs,0,1
24970,in,0,0
24971,response,0,0
24972,to,0,0
24973,changes,0,0
24974,in,0,0
24975,carbohydrate,0,0
24976,and,0,0
24977,fiber,0,0
24978,intakes,0,0
24979,took,0,1
24980,many,0,1
24981,months,0,0
24982,to,0,0
24983,occur,0,0
24984,",",0,0
24985,and,0,0
24986,the,0,0
24987,changes,0,0
24988,in,0,0
24989,serum,0,0
24990,acetate,0,0
24991,were,0,0
24992,significantly,0,0
24993,related,0,0
24994,to,0,0
24995,the,0,0
24996,long-term,0,0
24997,adaptive,0,0
24998,changes,0,0
24999,in,0,0
25000,blood,0,0
25001,lipids,0,0
25002,.,0,1
25003,Can,0,0
25004,sedation,0,0
25005,reduce,0,0
25006,the,0,0
25007,cardiac,0,0
25008,stress,0,0
25009,during,0,0
25010,gastrointestinal,0,1
25011,endoscopy,0,1
25012,?,0,0
25013,A,0,0
25014,study,0,0
25015,with,0,1
25016,non-invasive,0,0
25017,automated,0,0
25018,cardiac,0,1
25019,flow,0,0
25020,measurement,0,0
25021,by,0,0
25022,color,0,1
25023,Doppler,0,0
25024,echocardiography,0,0
25025,.,0,1
25026,BACKGROUND,0,0
25027,Upper,1,0
25028,gastrointestinal,1,1
25029,endoscopy,1,1
25030,(,1,0
25031,UGIE,1,0
25032,),1,0
25033,may,0,0
25034,cause,0,0
25035,some,0,0
25036,cardiac,0,1
25037,stress,0,0
25038,.,0,0
25039,The,0,0
25040,effect,0,0
25041,of,0,0
25042,sedation,0,0
25043,on,0,0
25044,hemodynamics,0,0
25045,during,0,0
25046,UGIE,0,0
25047,has,0,0
25048,not,0,0
25049,been,0,0
25050,fully,0,0
25051,studied,0,0
25052,",",0,0
25053,and,0,0
25054,therefore,0,0
25055,the,0,0
25056,aim,0,0
25057,of,0,0
25058,this,0,0
25059,study,0,0
25060,was,0,0
25061,to,0,0
25062,clarify,0,0
25063,whether,0,0
25064,or,0,0
25065,not,0,0
25066,sedation,0,0
25067,can,0,0
25068,reduce,0,0
25069,cardiac,0,0
25070,stress,0,0
25071,dufing,0,0
25072,UGIE,0,0
25073,.,0,1
25074,METHODS,0,0
25075,Eight,1,0
25076,normal,1,1
25077,male,1,1
25078,volunteers,1,1
25079,undergoing,1,1
25080,UGIE,1,0
25081,with,1,1
25082,sedation,1,1
25083,(,1,0
25084,0.1,1,0
25085,mg/kg,1,0
25086,of,1,0
25087,midazolam,1,0
25088,),1,0
25089,and,1,0
25090,without,1,1
25091,it,1,0
25092,(,1,1
25093,two,1,0
25094,endoscopies,1,1
25095,per,1,0
25096,volunteer,1,1
25097,in,1,0
25098,random,1,1
25099,order,1,0
25100,),1,0
25101,were,0,0
25102,monitored,0,0
25103,throughout,0,0
25104,the,0,0
25105,procedure,0,0
25106,by,0,0
25107,means,0,0
25108,of,0,0
25109,electrocardiogram,0,0
25110,",",0,0
25111,blood,0,0
25112,pressure,0,0
25113,and,0,0
25114,peripheral,0,0
25115,oxygen,0,0
25116,saturation,0,0
25117,(,0,0
25118,SpO2,0,1
25119,),0,1
25120,.,0,0
25121,Cardiac,0,0
25122,output,0,0
25123,was,0,0
25124,measured,0,0
25125,at,0,0
25126,six,0,1
25127,points,0,0
25128,before,0,0
25129,",",0,0
25130,during,0,0
25131,and,0,0
25132,after,0,0
25133,endoscopy,0,1
25134,from,0,0
25135,automated,0,0
25136,cardiac,0,1
25137,flow,0,0
25138,measurement,0,0
25139,by,0,0
25140,color,0,1
25141,Doppler,0,0
25142,echocardiography,0,0
25143,.,0,0
25144,Serum,0,0
25145,norepinephrine,0,0
25146,",",0,0
25147,epinephrine,0,0
25148,",",0,0
25149,dopamine,0,0
25150,and,0,0
25151,ACTH,0,1
25152,concentrations,0,0
25153,were,0,0
25154,measured,0,0
25155,before,0,0
25156,and,0,0
25157,after,0,0
25158,the,0,0
25159,examination,0,0
25160,.,0,0
25161,RESULTS,0,0
25162,No,0,0
25163,significant,0,0
25164,differences,0,0
25165,in,0,0
25166,heart,0,1
25167,rate,0,0
25168,",",0,0
25169,systolic,0,0
25170,blood,0,0
25171,pressure,0,0
25172,",",0,0
25173,rate-pressure,0,0
25174,product,0,0
25175,",",0,0
25176,cardiac,0,1
25177,output,0,0
25178,and,0,0
25179,left,0,1
25180,ventricular,0,0
25181,work,0,0
25182,index,0,0
25183,were,0,0
25184,observed,0,0
25185,between,0,0
25186,the,0,0
25187,sedated,0,1
25188,and,0,0
25189,non-sedated,0,1
25190,groups,0,0
25191,.,0,1
25192,SpO2,0,0
25193,hardly,0,0
25194,changed,0,0
25195,during,0,0
25196,endoscopy,0,1
25197,in,0,0
25198,the,0,0
25199,non-sedated,0,1
25200,group,0,0
25201,",",0,0
25202,but,0,0
25203,decreased,0,0
25204,slightly,0,0
25205,in,0,0
25206,the,0,0
25207,sedated,0,1
25208,group,0,0
25209,(,0,0
25210,P,0,0
25211,=,0,0
25212,0.075,0,0
25213,),0,0
25214,.,0,0
25215,Although,0,0
25216,all,0,0
25217,serum,0,0
25218,catecholamine,0,0
25219,concentration,0,0
25220,changes,0,0
25221,were,0,1
25222,within,0,1
25223,normal,0,1
25224,limits,0,0
25225,in,0,0
25226,both,0,0
25227,groups,0,0
25228,",",0,0
25229,after,0,0
25230,endoscopy,0,0
25231,only,0,0
25232,epinephrine,0,0
25233,concentration,0,0
25234,was,0,0
25235,significantly,0,0
25236,lower,0,0
25237,in,0,0
25238,the,0,0
25239,sedated,0,1
25240,group,0,0
25241,than,0,0
25242,in,0,0
25243,the,0,0
25244,non-sedated,0,1
25245,group,0,0
25246,(,0,0
25247,P,0,0
25248,=,0,0
25249,0.0027,0,0
25250,),0,1
25251,.,0,1
25252,CONCLUSIONS,0,0
25253,Conscious,0,0
25254,sedation,0,0
25255,with,0,0
25256,midazolam,0,0
25257,does,0,0
25258,not,0,0
25259,reduce,0,0
25260,the,0,0
25261,cardiac,0,0
25262,stress,0,0
25263,during,0,0
25264,UGIE,0,0
25265,.,0,1
25266,The,0,0
25267,effects,0,0
25268,of,0,0
25269,physical,0,0
25270,and,0,0
25271,emotional,0,0
25272,status,0,0
25273,on,0,0
25274,adherence,0,0
25275,to,0,0
25276,a,0,0
25277,low-fat,0,0
25278,dietary,0,0
25279,pattern,0,1
25280,in,0,0
25281,the,0,0
25282,Women,0,1
25283,'s,0,1
25284,Health,0,0
25285,Initiative,0,1
25286,.,0,1
25287,OBJECTIVE,0,0
25288,To,0,0
25289,examine,0,0
25290,whether,0,0
25291,the,0,0
25292,effects,0,0
25293,of,0,0
25294,physical,0,0
25295,and,0,0
25296,emotional,0,0
25297,status,0,0
25298,on,0,0
25299,adherance,0,0
25300,to,0,0
25301,a,0,0
25302,low-fat,1,0
25303,(,1,0
25304,20,1,1
25305,%,1,0
25306,energy,1,0
25307,),1,0
25308,dietary,1,0
25309,pattern,1,1
25310,are,0,0
25311,mediated,0,0
25312,by,0,0
25313,participation,0,0
25314,in,0,0
25315,an,0,0
25316,intervention,0,0
25317,program,0,0
25318,(,0,0
25319,attending,0,1
25320,sessions,0,0
25321,and,0,1
25322,self-monitoring,0,0
25323,),0,0
25324,.,0,0
25325,DESIGN,0,0
25326,The,0,0
25327,Baron,0,0
25328,and,0,0
25329,Kenny,0,1
25330,mediator,0,0
25331,model,0,0
25332,",",0,0
25333,a,0,0
25334,series,0,0
25335,of,0,0
25336,4,0,0
25337,regression,0,0
25338,analyses,0,0
25339,",",0,0
25340,was,0,0
25341,used,0,0
25342,to,0,0
25343,evaluate,0,0
25344,whether,0,0
25345,:,0,1
25346,a,0,0
25347,),0,0
25348,physical,0,0
25349,and,0,0
25350,emotional,0,0
25351,status,0,0
25352,predicted,0,0
25353,program,0,0
25354,participation,0,0
25355,",",0,0
25356,b,0,0
25357,),0,0
25358,program,0,0
25359,participation,0,0
25360,predicted,0,0
25361,dietary,0,0
25362,adherence,0,0
25363,",",0,0
25364,c,0,0
25365,),0,0
25366,physical,0,0
25367,and,0,0
25368,emotional,0,0
25369,status,0,1
25370,factors,0,0
25371,predicted,0,0
25372,dietary,0,0
25373,adherence,0,0
25374,",",0,0
25375,and,0,0
25376,",",0,0
25377,ultimately,0,0
25378,d,0,0
25379,),0,0
25380,the,0,0
25381,effects,0,0
25382,of,0,0
25383,physical,0,0
25384,and,0,0
25385,emotional,0,0
25386,status,0,0
25387,on,0,0
25388,dietary,0,0
25389,adherence,0,0
25390,were,0,0
25391,mediated,0,0
25392,by,0,0
25393,program,0,0
25394,participation,0,0
25395,.,0,1
25396,SUBJECTS/SETTING,0,0
25397,Data,1,1
25398,from,1,1
25399,"13,277",1,1
25400,postmenopausal,1,1
25401,women,1,1
25402,randomly,1,1
25403,assigned,1,1
25404,to,1,0
25405,the,1,0
25406,low-fat,1,0
25407,intervention,1,0
25408,arm,1,0
25409,of,1,0
25410,the,1,0
25411,Women,1,1
25412,'s,1,1
25413,Health,1,0
25414,Initiative,1,1
25415,Dietary,1,1
25416,Modification,1,1
25417,Trial,1,1
25418,.,1,1
25419,INTERVENTION,0,0
25420,The,0,0
25421,nutrition,0,0
25422,goals,0,0
25423,for,0,0
25424,women,0,1
25425,randomly,0,1
25426,assigned,0,1
25427,to,0,0
25428,the,0,0
25429,low-fat,0,0
25430,intervention,0,0
25431,were,0,0
25432,to,0,0
25433,reduce,0,0
25434,total,0,1
25435,fat,0,0
25436,intake,0,0
25437,to,0,0
25438,20,0,0
25439,%,0,0
25440,or,0,0
25441,less,0,0
25442,of,0,0
25443,energy,0,0
25444,from,0,1
25445,fat,0,0
25446,and,0,0
25447,to,0,0
25448,consume,0,1
25449,5,0,0
25450,or,0,0
25451,more,0,0
25452,fruit/vegetable,0,0
25453,servings,0,0
25454,daily,0,0
25455,and,0,0
25456,6,0,0
25457,or,0,1
25458,more,0,0
25459,grain,0,0
25460,servings,0,0
25461,daily,0,0
25462,.,0,1
25463,MAIN,0,0
25464,OUTCOME,0,0
25465,MEASURES,0,0
25466,Year,1,1
25467,1,1,0
25468,program,1,0
25469,participation,1,0
25470,(,1,0
25471,degree,1,0
25472,of,1,0
25473,attending,1,1
25474,group,1,1
25475,sessions,1,0
25476,and,1,0
25477,submitting,1,0
25478,fat,1,0
25479,scores,1,0
25480,),1,1
25481,and,1,0
25482,adherence,1,0
25483,to,1,0
25484,the,1,0
25485,low-fat,1,0
25486,dietary,1,0
25487,pattern,1,1
25488,(,0,0
25489,percent,0,0
25490,energy,0,0
25491,from,0,0
25492,fat,0,0
25493,),0,0
25494,as,0,0
25495,predicted,0,0
25496,by,0,0
25497,baseline,0,0
25498,physical,0,0
25499,and,0,0
25500,emotional,0,0
25501,status,0,1
25502,(,0,0
25503,eight,0,1
25504,SF-36,0,0
25505,Health,0,0
25506,Survey,0,0
25507,subscales,0,0
25508,),0,0
25509,.,0,0
25510,RESULTS,0,0
25511,Participating,0,1
25512,in,0,0
25513,the,0,0
25514,dietary,0,0
25515,intervention,0,0
25516,program,0,0
25517,reduced,0,0
25518,(,0,0
25519,mediated,0,0
25520,),0,0
25521,the,0,0
25522,negative,0,0
25523,effect,0,0
25524,of,0,0
25525,poorer,0,0
25526,mental,0,1
25527,health,0,0
25528,on,0,0
25529,dietary,0,0
25530,adherence,0,0
25531,by,0,0
25532,15,0,1
25533,%,0,0
25534,.,0,1
25535,Additional,0,0
25536,findings,0,0
25537,included,0,1
25538,that,0,0
25539,a,0,0
25540,10,0,0
25541,%,0,0
25542,increase,0,0
25543,in,0,0
25544,physical,0,0
25545,functioning,0,0
25546,increased,0,0
25547,session,0,0
25548,attendance,0,0
25549,by,0,0
25550,0.4,0,0
25551,%,0,0
25552,(,0,0
25553,P,0,0
25554,<,0,0
25555,.001,0,0
25556,),0,0
25557,and,0,0
25558,a,0,0
25559,10,0,0
25560,%,0,0
25561,increase,0,0
25562,in,0,0
25563,mental,0,1
25564,health,0,1
25565,predicted,0,0
25566,a,0,0
25567,decrease,0,0
25568,in,0,0
25569,percent,0,0
25570,energy,0,0
25571,from,0,0
25572,fat,0,0
25573,of,0,0
25574,0.3,0,0
25575,%,0,0
25576,(,0,0
25577,P,0,0
25578,<,0,0
25579,.001,0,0
25580,),0,1
25581,.,0,0
25582,Program,0,0
25583,participation,0,0
25584,had,0,0
25585,a,0,0
25586,marked,0,0
25587,effect,0,0
25588,on,0,0
25589,dietary,0,0
25590,adherence,0,0
25591,:,0,1
25592,a,0,0
25593,10,0,0
25594,%,0,0
25595,increase,0,0
25596,in,0,0
25597,session,0,0
25598,attendance,0,0
25599,predicted,0,0
25600,a,0,0
25601,1.2,0,0
25602,%,0,0
25603,decrease,0,0
25604,in,0,0
25605,percent,0,0
25606,energy,0,0
25607,from,0,0
25608,fat,0,0
25609,(,0,1
25610,P,0,0
25611,<,0,0
25612,.001,0,0
25613,),0,1
25614,.,0,1
25615,APPLICATIONS/CONCLUSIONS,0,0
25616,Understanding,0,0
25617,and,0,0
25618,using,0,0
25619,instruments,0,0
25620,to,0,0
25621,assess,0,0
25622,the,0,0
25623,physical,0,0
25624,and,0,0
25625,emotional,0,0
25626,status,0,0
25627,of,0,0
25628,a,0,0
25629,target,0,0
25630,population,0,0
25631,will,0,0
25632,help,0,0
25633,dietetic,0,1
25634,professionals,0,0
25635,promote,0,0
25636,healthful,0,0
25637,dietary,0,0
25638,change,0,0
25639,and,0,0
25640,maintenance,0,0
25641,.,0,1
25642,Double-blind,0,0
25643,placebo-controlled,0,0
25644,trial,0,0
25645,of,0,0
25646,aprindine,0,0
25647,and,0,0
25648,digoxin,0,0
25649,for,0,0
25650,the,0,0
25651,prevention,0,0
25652,of,0,0
25653,symptomatic,1,1
25654,atrial,1,1
25655,fibrillation,1,1
25656,.,1,0
25657,A,0,0
25658,multicenter,0,0
25659,",",0,0
25660,placebo-controlled,0,0
25661,",",0,0
25662,randomized,0,0
25663,",",0,0
25664,double-blind,0,0
25665,trial,0,0
25666,compared,0,0
25667,the,0,0
25668,preventive,0,0
25669,effect,0,0
25670,of,0,0
25671,aprindine,0,0
25672,and,0,0
25673,digoxin,0,0
25674,on,0,0
25675,the,0,0
25676,recurrence,0,0
25677,of,0,0
25678,atrial,1,1
25679,fibrillation,1,1
25680,(,1,0
25681,AF,1,0
25682,),1,0
25683,with,0,1
25684,placebo,0,0
25685,",",0,0
25686,and,0,0
25687,also,0,0
25688,compare,0,0
25689,the,0,0
25690,effectiveness,0,0
25691,of,0,0
25692,these,0,0
25693,2,0,0
25694,drugs,0,0
25695,in,0,0
25696,the,0,0
25697,prevention,0,0
25698,of,0,0
25699,AF,0,1
25700,.,0,1
25701,Patients,1,1
25702,with,1,1
25703,symptomatic,1,1
25704,paroxysmal,1,1
25705,or,1,1
25706,persistent,1,1
25707,AF,1,1
25708,who,1,1
25709,had,1,1
25710,converted,1,1
25711,to,1,0
25712,sinus,1,1
25713,rhythm,1,1
25714,(,1,0
25715,SR,1,0
25716,),1,0
25717,were,0,0
25718,randomly,0,1
25719,assigned,0,0
25720,aprindine,0,0
25721,(,0,0
25722,40,0,1
25723,mg/day,0,0
25724,),0,0
25725,",",0,0
25726,digoxin,0,0
25727,(,0,0
25728,0.25,0,0
25729,mg/day,0,0
25730,),0,0
25731,or,0,0
25732,placebo,0,0
25733,and,0,0
25734,followed,0,0
25735,up,0,0
25736,on,0,0
25737,an,0,0
25738,outpatient,0,1
25739,basis,0,0
25740,every,0,0
25741,2,0,0
25742,weeks,0,0
25743,for,0,1
25744,6,0,1
25745,months,0,0
25746,.,0,1
25747,Of,1,0
25748,the,1,0
25749,141,1,1
25750,patients,1,1
25751,from,1,1
25752,36,1,1
25753,participating,1,1
25754,centers,1,1
25755,",",1,1
25756,47,1,1
25757,were,1,0
25758,given,1,0
25759,aprindine,1,0
25760,",",1,0
25761,47,1,0
25762,digoxin,1,0
25763,",",1,0
25764,and,1,0
25765,47,1,1
25766,were,1,0
25767,on,1,0
25768,placebo,1,0
25769,.,1,0
25770,After,0,0
25771,the,0,0
25772,6-month,0,0
25773,follow-up,0,0
25774,",",0,0
25775,the,0,0
25776,Kaplan-Meier,0,0
25777,estimates,0,0
25778,of,0,0
25779,the,0,0
25780,percentage,0,0
25781,of,0,0
25782,patients,0,1
25783,remaining,0,1
25784,free,0,1
25785,of,0,0
25786,recurrent,0,1
25787,symptomatic,0,1
25788,AF,0,1
25789,on,0,0
25790,aprindine,0,0
25791,",",0,0
25792,digoxin,0,0
25793,and,0,0
25794,placebo,0,0
25795,were,0,0
25796,33.3,0,0
25797,%,0,0
25798,",",0,0
25799,29.2,0,0
25800,%,0,0
25801,and,0,0
25802,21.5,0,0
25803,%,0,0
25804,",",0,0
25805,respectively,0,0
25806,.,0,0
25807,In,0,0
25808,patients,0,1
25809,remaining,0,1
25810,in,0,0
25811,SR,0,0
25812,for,0,0
25813,15,0,1
25814,days,0,0
25815,after,0,0
25816,from,0,1
25817,the,0,0
25818,start,0,0
25819,of,0,0
25820,follow-up,0,0
25821,",",0,0
25822,freedom,0,0
25823,from,0,0
25824,recurrence,0,0
25825,was,0,0
25826,significantly,0,0
25827,more,0,0
25828,prevalent,0,0
25829,in,0,0
25830,the,0,0
25831,aprindine,0,0
25832,group,0,0
25833,than,0,0
25834,in,0,0
25835,the,0,0
25836,placebo,0,0
25837,group,0,0
25838,(,0,0
25839,p=0.0414,0,0
25840,),0,0
25841,",",0,0
25842,but,0,0
25843,there,0,0
25844,was,0,0
25845,no,0,0
25846,significant,0,0
25847,difference,0,0
25848,between,0,0
25849,the,0,0
25850,digoxin,0,0
25851,and,0,0
25852,placebo,0,0
25853,groups,0,0
25854,.,0,0
25855,The,0,0
25856,rate,0,0
25857,of,0,0
25858,adverse,0,0
25859,events,0,0
25860,was,0,0
25861,similar,0,0
25862,in,0,0
25863,the,0,0
25864,3,0,0
25865,groups,0,0
25866,.,0,1
25867,In,0,0
25868,conclusion,0,0
25869,",",0,0
25870,neither,0,0
25871,aprindine,0,0
25872,nor,0,0
25873,digoxin,0,0
25874,had,0,0
25875,a,0,0
25876,significant,0,0
25877,effect,0,0
25878,on,0,0
25879,preventing,0,0
25880,relapse,0,0
25881,of,0,0
25882,symptomatic,0,1
25883,AF,0,1
25884,;,0,0
25885,however,0,0
25886,",",0,0
25887,recurrence,0,0
25888,of,0,0
25889,AF,0,0
25890,occurred,0,0
25891,later,0,0
25892,with,0,0
25893,aprindine,0,0
25894,than,0,0
25895,with,0,1
25896,placebo,0,0
25897,or,0,1
25898,digoxin,0,0
25899,.,0,1
25900,Monitoring,0,0
25901,tumour,0,1
25902,cells,0,0
25903,in,0,0
25904,the,0,0
25905,peripheral,0,0
25906,blood,0,0
25907,of,0,0
25908,small,1,1
25909,cell,1,1
25910,lung,1,1
25911,cancer,1,1
25912,patients,1,1
25913,.,1,1
25914,BACKGROUND,0,0
25915,Flow,0,0
25916,cytometry,0,0
25917,was,0,0
25918,used,0,0
25919,to,0,0
25920,enumerate,0,0
25921,tumour,0,1
25922,cells,0,0
25923,in,0,1
25924,longitudinal,0,1
25925,studies,0,0
25926,of,0,0
25927,peripheral,0,1
25928,blood,0,0
25929,from,0,1
25930,small,1,1
25931,cell,1,1
25932,lung,1,1
25933,cancer,1,1
25934,(,1,0
25935,SCLC,1,0
25936,),1,0
25937,patients,1,1
25938,",",0,0
25939,together,0,0
25940,with,0,1
25941,magnetic,0,0
25942,bead,0,0
25943,selection,0,0
25944,to,0,0
25945,isolate,0,0
25946,and,0,0
25947,identify,0,0
25948,these,0,0
25949,cells,0,0
25950,.,0,0
25951,As,0,0
25952,part,0,0
25953,of,0,0
25954,a,0,0
25955,trial,0,0
25956,",",0,0
25957,11,1,0
25958,patients,1,1
25959,received,1,0
25960,either,1,0
25961,standard,1,0
25962,(,1,0
25963,four,1,0
25964,weekly,1,0
25965,),1,0
25966,chemotherapy,1,0
25967,with,1,1
25968,ifosfamide,1,0
25969,",",1,0
25970,carboplatin,1,0
25971,",",1,0
25972,and,1,0
25973,etoposide,1,0
25974,(,1,0
25975,ICE,1,0
25976,),1,0
25977,or,1,0
25978,accelerated,1,0
25979,(,1,0
25980,two,1,0
25981,weekly,1,0
25982,),1,0
25983,ICE,1,0
25984,with,1,1
25985,filgrastim,1,0
25986,(,1,0
25987,granulocyte,1,0
25988,colony-stimulating,0,0
25989,factor,0,0
25990,[,0,0
25991,G-CSF,0,1
25992,],0,1
25993,),0,0
25994,and,0,0
25995,autologous,0,0
25996,stem,0,1
25997,cell,0,1
25998,support,0,0
25999,.,0,1
26000,METHODS,0,0
26001,Fresh,0,0
26002,venous,0,1
26003,blood,0,0
26004,was,0,0
26005,taken,0,0
26006,throughout,0,0
26007,treatment,0,0
26008,and,0,0
26009,follow-up,0,0
26010,.,0,1
26011,Aliquots,0,0
26012,were,0,0
26013,stained,0,0
26014,with,0,1
26015,a,0,0
26016,tumour-specific,0,0
26017,antibody,0,0
26018,against,0,0
26019,epithelial,0,0
26020,tissue,0,0
26021,(,0,0
26022,Ber,0,1
26023,EP4,0,0
26024,),0,0
26025,",",0,0
26026,verified,0,0
26027,as,0,0
26028,a,0,0
26029,good,0,0
26030,marker,0,0
26031,of,0,0
26032,SCLC,0,0
26033,cells,0,0
26034,by,0,0
26035,immunohistochemistry,0,1
26036,.,0,1
26037,Matched,0,1
26038,samples,0,0
26039,labelled,0,0
26040,with,0,1
26041,Ber,0,1
26042,EP4,0,1
26043,were,0,0
26044,separated,0,0
26045,magnetically,0,0
26046,by,0,0
26047,adding,0,0
26048,a,0,0
26049,secondary,0,0
26050,bead-antibody,0,0
26051,conjugate,0,0
26052,for,0,0
26053,confirmation,0,0
26054,of,0,0
26055,tumour,0,0
26056,cell,0,1
26057,identity,0,0
26058,.,0,1
26059,RESULTS,0,0
26060,Circulating,0,0
26061,tumour,0,1
26062,cells,0,0
26063,were,0,1
26064,detected,0,0
26065,and,0,0
26066,monitored,0,0
26067,throughout,0,0
26068,treatment,0,0
26069,periods,0,0
26070,.,0,1
26071,An,0,0
26072,initial,0,0
26073,rise,0,0
26074,in,0,0
26075,circulating,0,0
26076,cells,0,0
26077,after,0,0
26078,the,0,0
26079,first,0,0
26080,cycle,0,0
26081,was,0,0
26082,followed,0,0
26083,by,0,0
26084,a,0,0
26085,fall,0,0
26086,in,0,0
26087,both,0,0
26088,treatment,0,0
26089,arms,0,0
26090,to,0,0
26091,baseline,0,0
26092,levels,0,0
26093,set,0,0
26094,by,0,0
26095,normal,0,1
26096,controls,0,1
26097,.,0,1
26098,This,0,0
26099,was,0,0
26100,achieved,0,0
26101,by,0,0
26102,week,0,0
26103,12,0,0
26104,in,0,0
26105,the,0,0
26106,accelerated,0,0
26107,treatment,0,0
26108,arm,0,0
26109,and,0,0
26110,by,0,0
26111,week,0,0
26112,24,0,0
26113,in,0,0
26114,the,0,0
26115,standard,0,0
26116,arm,0,0
26117,.,0,1
26118,CONCLUSIONS,0,0
26119,Flow,0,0
26120,cytometry,0,0
26121,and,0,0
26122,magnetic,0,0
26123,bead,0,0
26124,isolation,0,0
26125,can,0,0
26126,be,0,0
26127,used,0,0
26128,to,0,0
26129,identify,0,0
26130,changes,0,0
26131,in,0,0
26132,numbers,0,0
26133,of,0,0
26134,circulating,0,0
26135,tumour,0,1
26136,cells,0,0
26137,in,0,1
26138,patients,0,1
26139,undergoing,0,1
26140,chemotherapy,0,1
26141,for,0,0
26142,SCLC,0,0
26143,and,0,0
26144,thereafter,0,0
26145,during,0,0
26146,follow-up,0,0
26147,periods,0,0
26148,.,0,1
26149,Absence,0,0
26150,of,0,0
26151,tumour,0,0
26152,cells,0,0
26153,may,0,0
26154,indicate,0,0
26155,a,0,0
26156,more,0,0
26157,favourable,0,0
26158,patient,0,0
26159,group,0,1
26160,who,0,1
26161,would,0,0
26162,benefit,0,0
26163,from,0,0
26164,a,0,0
26165,more,0,0
26166,intense,0,0
26167,course,0,0
26168,of,0,0
26169,treatment,0,0
26170,.,0,1
26171,Walking,0,0
26172,trials,0,0
26173,in,0,1
26174,postmenopausal,1,1
26175,women,1,1
26176,:,1,1
26177,effect,0,0
26178,of,0,0
26179,one,0,1
26180,vs,0,0
26181,two,0,0
26182,daily,0,0
26183,bouts,0,0
26184,on,0,0
26185,aerobic,0,1
26186,fitness,0,1
26187,.,0,0
26188,We,0,0
26189,compared,0,0
26190,the,0,0
26191,effects,0,0
26192,of,0,0
26193,one,0,1
26194,vs,0,0
26195,two,0,0
26196,daily,0,0
26197,bouts,0,0
26198,of,0,0
26199,walking,0,0
26200,on,0,0
26201,aerobic,0,1
26202,fitness,0,1
26203,and,0,0
26204,body,0,0
26205,composition,0,0
26206,in,0,0
26207,postmenopausal,1,1
26208,women,1,1
26209,.,1,1
26210,One,1,1
26211,hundred,1,1
26212,and,1,1
26213,thirty-four,1,1
26214,subjects,1,1
26215,were,1,1
26216,randomized,1,1
26217,into,1,0
26218,exercise,1,0
26219,groups,1,0
26220,or,1,1
26221,a,1,0
26222,control,1,0
26223,group,1,0
26224,and,1,0
26225,130,1,1
26226,completed,1,1
26227,the,1,0
26228,study,1,0
26229,.,1,0
26230,The,0,0
26231,subjects,0,1
26232,walked,0,0
26233,5,0,0
26234,d/week,0,0
26235,for,0,0
26236,15,0,1
26237,weeks,0,0
26238,at,0,1
26239,65,0,1
26240,%,0,0
26241,of,0,0
26242,their,0,0
26243,maximal,0,0
26244,aerobic,0,0
26245,power,0,0
26246,expending,0,0
26247,300,0,0
26248,kcal,0,1
26249,(,0,1
26250,1255,0,1
26251,kJ,0,0
26252,),0,0
26253,in,0,0
26254,exercise,0,0
26255,in,0,0
26256,one,0,1
26257,(,0,1
26258,Group,0,1
26259,S1,0,1
26260,),0,0
26261,or,0,1
26262,two,0,0
26263,daily,0,0
26264,sessions,0,0
26265,(,0,1
26266,Group,0,1
26267,S2,0,0
26268,),0,1
26269,.,0,0
26270,VO,0,0
26271,(,0,0
26272,2max,0,0
26273,),0,0
26274,was,0,0
26275,measured,0,0
26276,in,0,0
26277,a,0,0
26278,direct,0,0
26279,maximal,0,0
26280,treadmill,0,0
26281,test,0,0
26282,.,0,0
26283,Body,0,0
26284,mass,0,0
26285,index,0,0
26286,(,0,0
26287,BMI,0,1
26288,),0,0
26289,was,0,0
26290,calculated,0,0
26291,and,0,0
26292,the,0,0
26293,percentage,0,0
26294,of,0,0
26295,body,0,1
26296,fat,0,0
26297,(,0,0
26298,fat,0,0
26299,%,0,0
26300,),0,0
26301,estimated,0,0
26302,using,0,0
26303,skinfold,0,0
26304,measurements,0,0
26305,.,0,1
26306,The,0,0
26307,net,0,0
26308,change,0,0
26309,in,0,0
26310,the,0,0
26311,VO,0,0
26312,(,0,0
26313,2max,0,0
26314,),0,1
26315,was,0,0
26316,2.5,0,0
26317,mL,0,0
26318,min/kg,0,0
26319,(,0,0
26320,95,0,0
26321,%,0,0
26322,CI,0,0
26323,1.5,0,0
26324,",",0,0
26325,3.5,0,1
26326,),0,0
26327,(,0,0
26328,8.7,0,0
26329,%,0,0
26330,),0,0
26331,in,0,0
26332,Group,0,1
26333,S1,0,1
26334,and,0,0
26335,2.5,0,0
26336,mL,0,0
26337,min/kg,0,0
26338,(,0,0
26339,95,0,0
26340,%,0,0
26341,CI,0,0
26342,1.5,0,0
26343,",",0,0
26344,3.5,0,1
26345,),0,0
26346,(,0,0
26347,8.8,0,0
26348,%,0,0
26349,),0,0
26350,in,0,0
26351,Group,0,1
26352,S2,0,0
26353,.,0,0
26354,The,0,0
26355,net,0,0
26356,change,0,0
26357,in,0,0
26358,body,0,1
26359,mass,0,1
26360,was,0,0
26361,-1.2,0,0
26362,kg,0,1
26363,(,0,0
26364,95,0,0
26365,%,0,0
26366,CI-1.9,0,0
26367,",",0,0
26368,-0.5,0,0
26369,),0,0
26370,in,0,0
26371,Group,0,1
26372,S1,0,1
26373,and,0,0
26374,-1.1,0,0
26375,kg,0,1
26376,(,0,0
26377,95,0,0
26378,%,0,0
26379,CI,0,0
26380,-1.8,0,0
26381,",",0,0
26382,-0.4,0,0
26383,),0,0
26384,in,0,0
26385,Group,0,1
26386,S2,0,0
26387,.,0,0
26388,The,0,0
26389,net,0,0
26390,fat,0,0
26391,%,0,0
26392,change,0,0
26393,was,0,0
26394,-2.1,0,0
26395,%,0,0
26396,(,0,0
26397,95,0,0
26398,%,0,0
26399,CI-2.7,0,0
26400,",",0,0
26401,-1.4,0,0
26402,),0,0
26403,in,0,0
26404,Group,0,1
26405,S1,0,1
26406,and,0,0
26407,-1.7,0,0
26408,%,0,0
26409,(,0,0
26410,95,0,0
26411,%,0,0
26412,CI-2.3,0,0
26413,",",0,0
26414,-1.0,0,0
26415,),0,0
26416,in,0,0
26417,Group,0,1
26418,S2,0,0
26419,.,0,1
26420,Exercise,0,0
26421,improved,0,0
26422,the,0,0
26423,maximal,0,0
26424,aerobic,0,0
26425,power,0,0
26426,and,0,0
26427,body,0,0
26428,composition,0,0
26429,equally,0,0
26430,when,0,0
26431,walking,0,0
26432,was,0,0
26433,performed,0,0
26434,in,0,0
26435,one,0,1
26436,or,0,1
26437,two,0,0
26438,daily,0,0
26439,bouts,0,0
26440,.,0,1
26441,Cyclosporine,0,1
26442,inhibition,0,0
26443,of,0,0
26444,P-glycoprotein,0,1
26445,in,0,0
26446,chronic,1,1
26447,myeloid,1,1
26448,leukemia,1,1
26449,blast,1,0
26450,phase,1,1
26451,.,1,0
26452,Chronic,0,0
26453,myeloid,0,1
26454,leukemia,0,1
26455,blast,0,0
26456,phase,0,0
26457,(,0,0
26458,CML-BP,0,0
26459,),0,0
26460,cells,0,0
26461,commonly,0,1
26462,express,0,0
26463,the,0,0
26464,multidrug,0,0
26465,transporter,0,0
26466,",",0,0
26467,P-glycoprotein,0,0
26468,(,0,0
26469,Pgp,0,1
26470,),0,0
26471,.,0,0
26472,To,0,0
26473,determine,0,0
26474,whether,0,0
26475,Pgp,0,0
26476,inhibition,0,0
26477,improves,0,0
26478,treatment,0,0
26479,outcome,0,0
26480,in,0,0
26481,CML-BP,0,0
26482,",",0,0
26483,the,0,0
26484,Southwest,0,1
26485,Oncology,0,1
26486,Group,0,1
26487,performed,0,0
26488,a,0,0
26489,randomized,0,0
26490,",",0,0
26491,controlled,0,0
26492,trial,0,0
26493,testing,0,0
26494,the,0,0
26495,benefit,0,0
26496,of,0,0
26497,the,0,0
26498,Pgp,0,0
26499,modulator,0,0
26500,",",0,0
26501,cyclosporin,0,0
26502,A,0,0
26503,(,0,0
26504,CsA,0,1
26505,),0,1
26506,.,0,1
26507,Seventy-three,1,1
26508,eligible,1,1
26509,patients,1,1
26510,were,0,1
26511,assigned,0,1
26512,to,0,0
26513,treatment,0,0
26514,with,0,1
26515,cytarabine,0,0
26516,and,0,0
26517,infusional,0,0
26518,daunorubicin,0,0
26519,with,0,1
26520,or,0,1
26521,without,0,1
26522,intravenous,0,0
26523,CsA,0,1
26524,.,0,0
26525,Treatment,0,0
26526,with,0,1
26527,CsA,0,0
26528,yielded,0,0
26529,no,0,0
26530,improvement,0,0
26531,in,0,0
26532,treatment,0,0
26533,outcome,0,0
26534,as,0,0
26535,measured,0,0
26536,by,0,0
26537,the,0,0
26538,frequency,0,0
26539,of,0,0
26540,induction,0,0
26541,resistance,0,0
26542,(,0,0
26543,68,0,1
26544,%,0,0
26545,vs,0,0
26546,53,0,1
26547,%,0,0
26548,),0,0
26549,",",0,0
26550,rate,0,0
26551,of,0,0
26552,complete,0,0
26553,remission,0,1
26554,or,0,1
26555,restored,0,0
26556,chronic,0,1
26557,phase,0,1
26558,(,0,0
26559,CR/CP,0,0
26560,",",0,0
26561,8,0,0
26562,%,0,0
26563,vs,0,0
26564,30,0,1
26565,%,0,0
26566,),0,0
26567,",",0,0
26568,and,0,0
26569,survival,0,0
26570,(,0,0
26571,3,0,0
26572,vs,0,0
26573,5,0,1
26574,months,0,0
26575,),0,1
26576,.,0,1
26577,Blast,0,0
26578,expression,0,0
26579,of,0,0
26580,Pgp,0,1
26581,(,0,1
26582,63,0,1
26583,%,0,0
26584,),0,0
26585,and,0,0
26586,LRP,0,1
26587,(,0,0
26588,71,0,1
26589,%,0,0
26590,),0,0
26591,was,0,0
26592,common,0,0
26593,",",0,0
26594,whereas,0,0
26595,only,0,0
26596,Pgp,0,1
26597,adversely,0,0
26598,impacted,0,0
26599,the,0,0
26600,rate,0,0
26601,of,0,0
26602,CR/CP,0,0
26603,(,0,1
26604,P,0,0
26605,=.025,0,0
26606,),0,0
26607,.,0,0
26608,We,0,0
26609,conclude,0,0
26610,that,0,0
26611,Pgp,0,0
26612,has,0,0
26613,prognostic,0,0
26614,relevance,0,0
26615,in,0,0
26616,CML-BP,0,0
26617,but,0,0
26618,that,0,0
26619,the,0,0
26620,modulation,0,0
26621,of,0,0
26622,Pgp,0,1
26623,function,0,0
26624,with,0,1
26625,CsA,0,1
26626,as,0,0
26627,applied,0,0
26628,in,0,0
26629,this,0,0
26630,trial,0,0
26631,is,0,0
26632,ineffective,0,0
26633,.,0,0
26634,Local,0,1
26635,warming,0,0
26636,and,0,0
26637,insertion,0,0
26638,of,0,0
26639,peripheral,0,1
26640,venous,0,1
26641,cannulas,0,0
26642,:,0,1
26643,single,0,0
26644,blinded,0,0
26645,prospective,0,0
26646,randomised,0,0
26647,controlled,0,0
26648,trial,0,0
26649,and,0,0
26650,single,0,0
26651,blinded,0,0
26652,randomised,0,0
26653,crossover,0,0
26654,trial,0,0
26655,.,0,0
26656,OBJECTIVE,0,0
26657,To,0,0
26658,determine,0,0
26659,whether,0,0
26660,local,0,0
26661,warming,0,0
26662,of,0,0
26663,the,0,0
26664,lower,0,0
26665,arm,0,0
26666,and,0,0
26667,hand,0,0
26668,facilitates,0,0
26669,peripheral,0,1
26670,venous,0,0
26671,cannulation,0,1
26672,.,0,1
26673,DESIGN,0,0
26674,Single,0,0
26675,blinded,0,0
26676,prospective,0,0
26677,randomised,0,0
26678,controlled,0,0
26679,trial,0,0
26680,and,0,0
26681,single,0,0
26682,blinded,0,0
26683,randomised,0,0
26684,crossover,0,0
26685,trial,0,0
26686,.,0,0
26687,SETTING,0,1
26688,Neurosurgical,1,1
26689,unit,1,0
26690,and,1,0
26691,haematology,1,1
26692,ward,1,1
26693,of,1,0
26694,university,1,1
26695,hospital,1,1
26696,.,1,0
26697,PARTICIPANTS,0,0
26698,100,1,0
26699,neurosurgical,1,1
26700,patients,1,1
26701,and,1,1
26702,40,1,1
26703,patients,1,1
26704,with,1,1
26705,leukaemia,1,1
26706,who,1,1
26707,required,1,1
26708,chemotherapy,1,1
26709,.,1,1
26710,INTERVENTIONS,0,0
26711,Neurosurgical,0,1
26712,patients,0,1
26713,',0,1
26714,hands,0,0
26715,and,0,1
26716,forearms,0,1
26717,were,0,0
26718,covered,0,0
26719,for,0,0
26720,15,0,1
26721,minutes,0,0
26722,with,0,1
26723,a,0,0
26724,carbon,0,0
26725,fibre,0,0
26726,heating,0,0
26727,mitt,0,1
26728,.,0,1
26729,Patients,0,1
26730,were,0,0
26731,assigned,0,1
26732,randomly,0,1
26733,to,0,0
26734,active,0,0
26735,warming,0,0
26736,at,0,0
26737,52,0,1
26738,degrees,0,0
26739,C,0,0
26740,or,0,1
26741,passive,0,0
26742,insulation,0,0
26743,(,0,0
26744,heater,0,0
26745,not,0,0
26746,activated,0,0
26747,),0,0
26748,.,0,0
26749,The,0,0
26750,same,0,0
26751,warming,0,0
26752,system,0,0
26753,was,0,0
26754,used,0,0
26755,for,0,0
26756,10,0,1
26757,minutes,0,0
26758,in,0,1
26759,patients,0,1
26760,with,0,1
26761,leukaemia,0,1
26762,.,0,1
26763,They,0,0
26764,were,0,0
26765,assigned,0,0
26766,randomly,0,1
26767,to,0,0
26768,active,0,0
26769,warming,0,0
26770,or,0,1
26771,passive,0,0
26772,insulation,0,0
26773,on,0,0
26774,day,0,0
26775,1,0,0
26776,and,0,0
26777,given,0,0
26778,alternative,0,0
26779,treatment,0,0
26780,during,0,0
26781,the,0,0
26782,subsequent,0,0
26783,visit,0,0
26784,.,0,1
26785,MAIN,0,0
26786,OUTCOME,0,0
26787,MEASURES,0,0
26788,PRIMARY,0,0
26789,:,0,1
26790,success,0,0
26791,rate,0,0
26792,for,0,0
26793,insertion,0,0
26794,of,0,0
26795,18,0,1
26796,gauge,0,0
26797,cannula,0,0
26798,into,0,0
26799,vein,0,0
26800,on,0,0
26801,back,0,1
26802,of,0,0
26803,hand,0,0
26804,.,0,1
26805,SECONDARY,0,0
26806,:,0,1
26807,time,0,0
26808,required,0,0
26809,for,0,0
26810,successful,0,0
26811,cannulation,0,1
26812,.,0,0
26813,RESULTS,0,0
26814,In,0,0
26815,neurosurgical,0,1
26816,patients,0,1
26817,",",0,0
26818,it,0,0
26819,took,0,1
26820,36,0,1
26821,seconds,0,0
26822,(,0,1
26823,95,0,0
26824,%,0,0
26825,confidence,0,0
26826,interval,0,0
26827,31,0,1
26828,to,0,0
26829,40,0,1
26830,seconds,0,0
26831,),0,1
26832,to,0,0
26833,insert,0,0
26834,a,0,0
26835,cannula,0,0
26836,in,0,0
26837,the,0,0
26838,active,0,0
26839,warming,0,0
26840,group,0,0
26841,and,0,0
26842,62,0,1
26843,(,0,0
26844,50,0,1
26845,to,0,0
26846,74,0,1
26847,),0,0
26848,seconds,0,0
26849,in,0,0
26850,the,0,0
26851,passive,0,0
26852,insulation,0,0
26853,group,0,0
26854,(,0,0
26855,P=0.002,0,0
26856,),0,1
26857,.,0,0
26858,Three,0,1
26859,(,0,0
26860,6,0,0
26861,%,0,0
26862,),0,0
26863,first,0,0
26864,attempts,0,0
26865,failed,0,0
26866,in,0,0
26867,the,0,0
26868,active,0,0
26869,warming,0,0
26870,group,0,0
26871,compared,0,0
26872,with,0,1
26873,14,0,1
26874,(,0,1
26875,28,0,1
26876,%,0,0
26877,),0,0
26878,in,0,0
26879,the,0,0
26880,passive,0,0
26881,insulation,0,0
26882,group,0,0
26883,(,0,0
26884,P=0.008,0,0
26885,),0,0
26886,.,0,0
26887,The,0,0
26888,crossover,0,0
26889,study,0,0
26890,in,0,0
26891,patients,0,1
26892,with,0,1
26893,leukaemia,0,1
26894,showed,0,0
26895,that,0,0
26896,insertion,0,0
26897,time,0,0
26898,was,0,0
26899,reduced,0,0
26900,by,0,0
26901,20,0,1
26902,seconds,0,0
26903,(,0,1
26904,8,0,0
26905,to,0,0
26906,32,0,1
26907,",",0,0
26908,P=0.013,0,0
26909,),0,0
26910,with,0,1
26911,active,0,1
26912,warming,0,0
26913,and,0,0
26914,that,0,0
26915,failure,0,1
26916,rates,0,0
26917,at,0,0
26918,first,0,0
26919,attempt,0,0
26920,were,0,0
26921,6,0,0
26922,%,0,0
26923,with,0,1
26924,warming,0,0
26925,and,0,0
26926,30,0,1
26927,%,0,0
26928,with,0,1
26929,passive,0,0
26930,insulation,0,0
26931,(,0,0
26932,P,0,0
26933,<,0,0
26934,0.001,0,0
26935,),0,1
26936,.,0,1
26937,CONCLUSIONS,0,0
26938,Local,0,0
26939,warming,0,0
26940,facilitates,0,0
26941,the,0,0
26942,insertion,0,0
26943,of,0,0
26944,peripheral,0,1
26945,venous,0,1
26946,cannulas,0,0
26947,",",0,0
26948,reducing,0,0
26949,both,0,0
26950,time,0,0
26951,and,0,0
26952,number,0,0
26953,of,0,0
26954,attempts,0,0
26955,required,0,0
26956,.,0,0
26957,This,0,0
26958,may,0,0
26959,decrease,0,0
26960,the,0,0
26961,time,0,0
26962,staff,0,0
26963,spend,0,0
26964,inserting,0,0
26965,cannulas,0,0
26966,",",0,0
26967,reduce,0,0
26968,supply,0,0
26969,costs,0,0
26970,",",0,0
26971,and,0,0
26972,improve,0,0
26973,patient,0,0
26974,satisfaction,0,0
26975,.,0,1
26976,14,0,1
26977,day,0,0
26978,endoscopy,0,1
26979,study,0,0
26980,comparing,0,0
26981,risedronate,0,0
26982,and,0,0
26983,alendronate,0,0
26984,in,0,0
26985,postmenopausal,1,1
26986,women,1,1
26987,stratified,1,1
26988,by,1,0
26989,Helicobacter,1,1
26990,pylori,1,1
26991,status,1,1
26992,.,1,1
26993,OBJECTIVE,0,0
26994,Bisphosphonates,0,0
26995,are,0,0
26996,effective,0,0
26997,treatment,0,0
26998,for,0,0
26999,osteoporosis,0,1
27000,but,0,0
27001,have,0,0
27002,been,0,0
27003,associated,0,0
27004,with,0,1
27005,gastrointestinal,0,1
27006,(,0,1
27007,GI,0,0
27008,),0,0
27009,mucosal,0,0
27010,injury,0,1
27011,.,0,0
27012,This,0,0
27013,study,0,0
27014,compared,0,0
27015,the,0,0
27016,incidence,0,0
27017,of,0,0
27018,gastric,0,1
27019,ulcers,0,1
27020,after,0,0
27021,treatment,0,0
27022,with,0,1
27023,risedronate,0,0
27024,",",0,0
27025,a,0,0
27026,pyridinyl,0,0
27027,bisphosphonate,0,0
27028,",",0,0
27029,or,0,0
27030,alendronate,0,0
27031,",",0,0
27032,a,0,0
27033,primary,0,0
27034,amino,0,0
27035,bisphosphonate,0,0
27036,",",0,0
27037,in,0,0
27038,healthy,1,1
27039,postmenopausal,1,1
27040,women,1,1
27041,stratified,1,1
27042,by,1,0
27043,Helicobacter,1,1
27044,pylori,1,1
27045,status,1,1
27046,.,1,1
27047,METHODS,0,0
27048,Subjects,0,1
27049,were,0,1
27050,randomized,0,1
27051,to,0,0
27052,receive,0,0
27053,risedronate,0,0
27054,5,0,0
27055,mg,0,0
27056,(,0,0
27057,n,0,1
27058,=,0,0
27059,318,0,1
27060,),0,0
27061,or,0,1
27062,alendronate,0,0
27063,10,0,0
27064,mg,0,0
27065,(,0,0
27066,n,0,1
27067,=,0,0
27068,317,0,1
27069,),0,0
27070,daily,0,0
27071,for,0,0
27072,14,0,1
27073,days,0,0
27074,.,0,1
27075,Endoscopy,0,0
27076,and,0,0
27077,evaluator-blind,0,1
27078,assessments,0,0
27079,of,0,0
27080,the,0,0
27081,esophageal,0,1
27082,",",0,0
27083,gastric,0,0
27084,",",0,0
27085,and,0,0
27086,duodenal,0,1
27087,mucosa,0,1
27088,were,0,0
27089,performed,0,0
27090,at,0,0
27091,baseline,0,0
27092,and,0,0
27093,on,0,0
27094,Days,0,1
27095,8,0,0
27096,and,0,1
27097,15,0,1
27098,.,0,1
27099,RESULTS,0,0
27100,Overall,0,0
27101,",",0,0
27102,gastric,0,1
27103,ulcers,0,1
27104,>,0,1
27105,or,0,1
27106,=,0,0
27107,3,0,0
27108,mm,0,0
27109,were,0,1
27110,observed,0,0
27111,in,0,0
27112,18,0,1
27113,(,0,1
27114,6.0,0,0
27115,%,0,0
27116,),0,0
27117,of,0,0
27118,300,0,0
27119,evaluable,0,1
27120,subjects,0,1
27121,in,0,0
27122,the,0,0
27123,risedronate,0,0
27124,group,0,0
27125,and,0,0
27126,36,0,1
27127,(,0,0
27128,12.1,0,0
27129,%,0,0
27130,),0,0
27131,of,0,0
27132,297,0,1
27133,in,0,0
27134,the,0,0
27135,alendronate,0,0
27136,group,0,0
27137,during,0,0
27138,treatment,0,0
27139,(,0,0
27140,p,0,0
27141,=,0,0
27142,0.013,0,0
27143,),0,0
27144,.,0,1
27145,On,0,0
27146,Day,0,0
27147,8,0,0
27148,",",0,0
27149,the,0,0
27150,incidences,0,0
27151,of,0,0
27152,gastric,0,1
27153,ulcers,0,1
27154,in,0,0
27155,the,0,0
27156,risedronate,0,0
27157,and,0,0
27158,alendronate,0,0
27159,groups,0,0
27160,were,0,1
27161,3.6,0,0
27162,%,0,0
27163,and,0,0
27164,6.6,0,0
27165,%,0,0
27166,",",0,0
27167,respectively,0,0
27168,(,0,0
27169,p,0,0
27170,=,0,0
27171,0.133,0,0
27172,),0,0
27173,",",0,0
27174,and,0,0
27175,on,0,0
27176,Day,0,1
27177,15,0,1
27178,",",0,0
27179,they,0,0
27180,were,0,0
27181,3.3,0,0
27182,%,0,0
27183,and,0,0
27184,8.7,0,0
27185,%,0,0
27186,(,0,0
27187,p,0,0
27188,=,0,0
27189,0.008,0,0
27190,),0,0
27191,.,0,0
27192,The,0,0
27193,incidence,0,0
27194,of,0,0
27195,gastric,0,1
27196,ulcers,0,1
27197,was,0,0
27198,not,0,0
27199,affected,0,0
27200,by,0,0
27201,H.,0,1
27202,pylori,0,1
27203,status,0,1
27204,.,0,0
27205,Mean,0,0
27206,gastric,0,1
27207,endoscopy,0,1
27208,scores,0,0
27209,at,0,1
27210,Days,0,1
27211,8,0,0
27212,and,0,0
27213,15,0,1
27214,were,0,0
27215,significantly,0,0
27216,lower,0,0
27217,in,0,0
27218,the,0,0
27219,risedronate,0,0
27220,group,0,0
27221,than,0,0
27222,in,0,0
27223,the,0,0
27224,alendronate,0,0
27225,group,0,0
27226,(,0,0
27227,p,0,0
27228,<,0,0
27229,0.001,0,0
27230,),0,1
27231,.,0,1
27232,Mean,0,0
27233,esophageal,0,1
27234,and,0,0
27235,duodenal,0,1
27236,endoscopy,0,1
27237,scores,0,0
27238,were,0,1
27239,similar,0,0
27240,in,0,0
27241,the,0,0
27242,2,0,0
27243,groups,0,0
27244,at,0,1
27245,Days,0,1
27246,8,0,0
27247,and,0,1
27248,15,0,1
27249,.,0,0
27250,When,0,0
27251,the,0,0
27252,treatment,0,0
27253,groups,0,0
27254,were,0,0
27255,combined,0,0
27256,",",0,0
27257,gastric,0,1
27258,endoscopy,0,1
27259,scores,0,0
27260,were,0,0
27261,significantly,0,0
27262,higher,0,0
27263,among,0,0
27264,H.,0,1
27265,pylori,0,1
27266,negative,0,0
27267,than,0,0
27268,H.,0,1
27269,pylori,0,1
27270,positive,0,0
27271,subjects,0,1
27272,at,0,1
27273,Days,0,1
27274,8,0,0
27275,and,0,0
27276,15,0,1
27277,(,0,0
27278,p,0,0
27279,<,0,0
27280,0.05,0,0
27281,),0,0
27282,.,0,1
27283,Upper,0,0
27284,GI,0,0
27285,adverse,0,0
27286,events,0,0
27287,were,0,1
27288,reported,0,0
27289,by,0,0
27290,18,0,1
27291,(,0,1
27292,5.7,0,0
27293,%,0,0
27294,),0,0
27295,subjects,0,1
27296,in,0,0
27297,the,0,0
27298,risedronate,0,0
27299,group,0,0
27300,(,0,0
27301,19,0,1
27302,events,0,0
27303,),0,1
27304,and,0,0
27305,28,0,1
27306,(,0,0
27307,8.8,0,0
27308,%,0,0
27309,),0,0
27310,subjects,0,1
27311,in,0,0
27312,the,0,0
27313,alendronate,0,0
27314,group,0,0
27315,(,0,0
27316,32,0,1
27317,events,0,0
27318,),0,1
27319,.,0,1
27320,Symptoms,0,0
27321,did,0,0
27322,not,0,0
27323,predict,0,0
27324,the,0,0
27325,presence,0,0
27326,of,0,0
27327,mucosal,0,0
27328,damage,0,0
27329,.,0,1
27330,CONCLUSION,0,0
27331,Risedronate,0,0
27332,was,0,0
27333,associated,0,0
27334,with,0,1
27335,a,0,0
27336,significantly,0,0
27337,lower,0,0
27338,incidence,0,0
27339,of,0,0
27340,gastric,0,1
27341,ulcers,0,1
27342,than,0,0
27343,alendronate,0,0
27344,.,0,1
27345,H.,0,0
27346,pylori,0,0
27347,infection,0,0
27348,did,0,0
27349,not,0,0
27350,increase,0,0
27351,the,0,0
27352,incidence,0,0
27353,of,0,0
27354,bisphosphonate,0,0
27355,related,0,0
27356,gastric,0,1
27357,ulcers,0,1
27358,.,0,1
27359,The,0,0
27360,findings,0,0
27361,from,0,1
27362,this,0,0
27363,14,0,0
27364,day,0,0
27365,study,0,0
27366,in,0,0
27367,healthy,0,1
27368,volunteers,0,1
27369,support,0,0
27370,the,0,0
27371,hypothesis,0,0
27372,that,0,0
27373,bisphosphonates,0,0
27374,may,0,0
27375,differ,0,0
27376,from,0,0
27377,one,0,0
27378,another,0,0
27379,in,0,0
27380,their,0,0
27381,potential,0,0
27382,to,0,0
27383,produce,0,0
27384,upper,0,1
27385,GI,0,0
27386,mucosal,0,0
27387,damage,0,0
27388,.,0,1
27389,Multimodal,0,0
27390,evaluation,0,0
27391,of,0,0
27392,risperidone,0,0
27393,for,0,0
27394,destructive,0,1
27395,behavior,0,0
27396,:,0,1
27397,functional,0,0
27398,analysis,0,0
27399,",",0,0
27400,direct,0,0
27401,observations,0,0
27402,",",0,0
27403,rating,0,0
27404,scales,0,0
27405,",",0,0
27406,and,0,0
27407,psychiatric,0,1
27408,impressions,0,0
27409,.,0,1
27410,Risperidone,0,0
27411,",",0,0
27412,an,0,0
27413,atypical,0,0
27414,neuroleptic,0,0
27415,",",0,0
27416,has,0,0
27417,become,0,0
27418,a,0,0
27419,popular,0,0
27420,option,0,0
27421,for,0,0
27422,treating,0,0
27423,destructive,0,1
27424,behaviors,0,0
27425,of,0,1
27426,persons,1,1
27427,with,1,1
27428,developmental,1,1
27429,disabilities,1,1
27430,.,1,1
27431,A,0,0
27432,few,0,0
27433,studies,0,0
27434,have,0,1
27435,been,0,0
27436,conducted,0,0
27437,that,0,0
27438,evaluate,0,0
27439,the,0,0
27440,effects,0,0
27441,of,0,0
27442,risperidone,0,0
27443,on,0,0
27444,destructive,0,1
27445,behavior,0,0
27446,;,0,0
27447,however,0,0
27448,",",0,0
27449,none,0,0
27450,of,0,0
27451,these,0,0
27452,studies,0,0
27453,have,0,0
27454,combined,0,0
27455,objective,0,0
27456,measures,0,0
27457,with,0,1
27458,rating,0,0
27459,scales,0,0
27460,to,0,0
27461,evaluate,0,0
27462,the,0,0
27463,effects,0,0
27464,of,0,0
27465,risperidone,0,0
27466,on,0,0
27467,destructive,0,0
27468,behavior,0,0
27469,across,0,0
27470,home,0,0
27471,and,0,0
27472,clinical,0,0
27473,settings,0,0
27474,.,0,1
27475,This,0,0
27476,study,0,0
27477,evaluated,0,0
27478,the,0,0
27479,wide,0,0
27480,range,0,0
27481,of,0,0
27482,effects,0,0
27483,of,0,0
27484,risperidone,0,0
27485,on,0,0
27486,destructive,0,0
27487,behavior,0,0
27488,of,0,0
27489,2,1,0
27490,persons,1,1
27491,with,1,1
27492,developmental,1,1
27493,disabilities,1,1
27494,using,0,1
27495,weekly,0,0
27496,functional,0,1
27497,analysis,0,0
27498,sessions,0,0
27499,",",0,0
27500,daily,0,0
27501,observations,0,0
27502,",",0,0
27503,hourly,0,0
27504,home,0,0
27505,data,0,0
27506,",",0,0
27507,weekly,0,0
27508,rating,0,0
27509,scales,0,0
27510,",",0,0
27511,and,0,0
27512,monthly,0,0
27513,psychiatric,0,1
27514,impressions,0,0
27515,.,0,1
27516,Results,0,0
27517,indicate,0,0
27518,that,0,0
27519,risperidone,0,0
27520,does,0,0
27521,decrease,0,0
27522,destructive,0,0
27523,behavior,0,0
27524,and,0,0
27525,that,0,0
27526,",",0,0
27527,for,0,0
27528,the,0,0
27529,most,0,0
27530,part,0,0
27531,",",0,0
27532,all,0,0
27533,of,0,0
27534,the,0,0
27535,various,0,0
27536,measures,0,0
27537,yielded,0,0
27538,similar,0,0
27539,results,0,0
27540,.,0,1
27541,Examining,0,0
27542,possible,0,0
27543,gender,0,1
27544,differences,0,0
27545,among,0,1
27546,cocaine-dependent,1,1
27547,outpatients,1,1
27548,.,1,1
27549,Potential,0,0
27550,differences,0,0
27551,in,0,1
27552,sociodemographics,0,1
27553,",",0,0
27554,drug,0,0
27555,use,0,0
27556,",",0,0
27557,and,0,0
27558,measures,0,0
27559,of,0,0
27560,treatment,0,0
27561,outcome,0,0
27562,were,0,0
27563,examined,0,0
27564,among,0,0
27565,137,1,1
27566,male,1,1
27567,and,1,0
27568,51,1,1
27569,female,1,1
27570,cocaine-dependent,1,1
27571,outpatients,1,1
27572,.,1,1
27573,More,1,1
27574,women,1,1
27575,than,1,0
27576,men,1,1
27577,were,1,1
27578,unemployed,1,1
27579,",",1,0
27580,received,1,0
27581,public,1,1
27582,assistance,1,0
27583,",",1,0
27584,and,1,0
27585,were,1,0
27586,living,1,1
27587,with,1,1
27588,their,1,1
27589,children,1,1
27590,.,1,1
27591,Women,0,1
27592,reported,0,0
27593,fewer,0,0
27594,years,0,1
27595,of,0,0
27596,regular,0,0
27597,cocaine,0,0
27598,use,0,0
27599,",",0,0
27600,spending,0,0
27601,less,0,0
27602,money,0,0
27603,per,0,0
27604,week,0,0
27605,on,0,0
27606,cocaine,0,0
27607,",",0,0
27608,less,0,0
27609,prior,0,0
27610,treatment,0,0
27611,for,0,0
27612,cocaine,0,0
27613,abuse,0,0
27614,",",0,0
27615,and,0,0
27616,were,0,0
27617,more,0,0
27618,likely,0,0
27619,than,0,0
27620,men,0,1
27621,to,0,0
27622,test,0,0
27623,positive,0,0
27624,for,0,0
27625,cocaine,0,0
27626,at,0,0
27627,intake,0,0
27628,.,0,0
27629,With,0,0
27630,respect,0,0
27631,to,0,0
27632,other,0,0
27633,drug,0,0
27634,use,0,0
27635,",",0,0
27636,fewer,0,0
27637,women,0,1
27638,than,0,0
27639,men,0,1
27640,reported,0,0
27641,using,0,0
27642,sedatives,0,0
27643,and,0,1
27644,tested,0,0
27645,positive,0,0
27646,for,0,0
27647,sedatives,0,0
27648,at,0,1
27649,intake,0,0
27650,.,0,1
27651,Women,0,1
27652,reported,0,0
27653,a,0,0
27654,lower,0,0
27655,frequency,0,0
27656,of,0,0
27657,alcohol,0,1
27658,use,0,0
27659,before,0,0
27660,intake,0,0
27661,",",0,0
27662,and,0,0
27663,fewer,0,0
27664,women,0,1
27665,than,0,0
27666,men,0,1
27667,met,0,1
27668,criteria,0,1
27669,for,0,0
27670,cannabis,0,1
27671,dependence,0,0
27672,.,0,0
27673,Men,0,1
27674,and,0,0
27675,women,0,1
27676,experienced,0,0
27677,comparable,0,0
27678,improvement,0,0
27679,during,0,0
27680,the,0,0
27681,course,0,0
27682,of,0,0
27683,treatment,0,0
27684,and,0,0
27685,follow-up,0,0
27686,.,0,1
27687,Home,0,1
27688,sleep,0,1
27689,studies,0,0
27690,in,0,0
27691,the,0,0
27692,assessment,0,0
27693,of,0,0
27694,sleep,1,0
27695,apnea/hypopnea,1,1
27696,syndrome,1,1
27697,.,1,0
27698,OBJECTIVE,0,0
27699,To,0,0
27700,determine,0,0
27701,the,0,0
27702,clinical,0,0
27703,utility,0,0
27704,of,0,0
27705,a,0,0
27706,limited,0,0
27707,sleep-recording,0,0
27708,device,0,0
27709,used,0,0
27710,unsupervised,0,0
27711,in,0,0
27712,the,0,0
27713,patient,0,0
27714,'s,0,0
27715,home,0,0
27716,",",0,0
27717,compared,0,0
27718,with,0,1
27719,in-laboratory,0,0
27720,",",0,0
27721,fully,0,0
27722,supervised,0,0
27723,polysomnography,0,1
27724,for,0,0
27725,the,0,0
27726,diagnosis,0,1
27727,of,0,0
27728,sleep,1,0
27729,apnea/hypopnea,1,1
27730,syndrome,1,1
27731,(,1,0
27732,SAHS,1,0
27733,),1,0
27734,",",0,0
27735,and,0,0
27736,to,0,0
27737,assess,0,0
27738,its,0,0
27739,impact,0,0
27740,on,0,0
27741,costs,0,0
27742,.,0,1
27743,DESIGN,0,0
27744,Prospective,0,0
27745,case,0,0
27746,study,0,0
27747,.,0,0
27748,SETTING,0,0
27749,The,0,0
27750,sleep-disorders,0,1
27751,unit,0,0
27752,of,0,0
27753,a,0,0
27754,tertiary,0,1
27755,referral,0,1
27756,university,0,1
27757,hospital,0,1
27758,.,0,0
27759,PATIENTS,0,0
27760,Fifty-five,1,1
27761,patients,1,1
27762,suspected,1,1
27763,of,1,0
27764,having,1,1
27765,SAHS,1,0
27766,and,1,0
27767,living,1,1
27768,within,1,0
27769,30,1,1
27770,km,1,0
27771,of,1,0
27772,our,1,0
27773,laboratory,1,0
27774,.,1,1
27775,METHODS,0,0
27776,Patients,1,1
27777,were,1,1
27778,studied,1,1
27779,first,1,0
27780,in,1,0
27781,their,1,0
27782,homes,1,1
27783,with,0,1
27784,the,0,0
27785,limited,0,0
27786,sleep-recording,0,0
27787,device,0,0
27788,.,0,1
27789,Polysomnography,0,1
27790,was,0,0
27791,performed,0,0
27792,within,0,0
27793,30,0,1
27794,days,0,0
27795,of,0,0
27796,the,0,0
27797,first,0,0
27798,study,0,0
27799,.,0,1
27800,Both,0,0
27801,studies,0,0
27802,were,0,0
27803,read,0,0
27804,by,0,0
27805,independent,0,1
27806,investigators,0,0
27807,blinded,0,0
27808,to,0,0
27809,the,0,0
27810,results,0,0
27811,of,0,0
27812,the,0,0
27813,other,0,0
27814,study,0,0
27815,.,0,1
27816,Diagnoses,0,0
27817,and,0,0
27818,therapeutic,0,1
27819,decisions,0,0
27820,regarding,0,0
27821,the,0,0
27822,use,0,0
27823,of,0,0
27824,continuous,0,0
27825,positive,0,0
27826,airway,0,1
27827,pressure,0,0
27828,obtained,0,0
27829,from,0,0
27830,the,0,0
27831,home,0,0
27832,and,0,0
27833,laboratory,0,0
27834,studies,0,0
27835,were,0,1
27836,compared,0,0
27837,.,0,0
27838,Agreement,0,0
27839,between,0,0
27840,the,0,0
27841,home,0,0
27842,and,0,0
27843,laboratory,0,0
27844,study,0,1
27845,recordings,0,0
27846,was,0,0
27847,also,0,0
27848,assessed,0,0
27849,using,0,0
27850,receiver,0,0
27851,operating,0,1
27852,characteristic,0,0
27853,(,0,1
27854,ROC,0,1
27855,),0,1
27856,curves,0,0
27857,and,0,1
27858,Bland-Altman,0,1
27859,analysis,0,0
27860,.,0,1
27861,One,0,0
27862,half,0,1
27863,of,0,0
27864,the,0,0
27865,home,0,1
27866,studies,0,0
27867,were,0,0
27868,randomly,0,1
27869,assigned,0,0
27870,to,0,0
27871,be,0,0
27872,performed,0,0
27873,with,0,0
27874,a,0,0
27875,sleep,0,0
27876,technician,0,0
27877,'s,0,1
27878,set,0,0
27879,up,0,0
27880,of,0,0
27881,the,0,0
27882,equipment,0,0
27883,in,0,0
27884,the,0,0
27885,patient,0,0
27886,'s,0,0
27887,home,0,0
27888,(,0,1
27889,group,0,0
27890,1,0,0
27891,),0,0
27892,",",0,0
27893,and,0,0
27894,the,0,0
27895,other,0,0
27896,half,0,1
27897,with,0,1
27898,the,0,0
27899,patient,0,0
27900,'s,0,1
27901,own,0,1
27902,setup,0,0
27903,of,0,0
27904,the,0,0
27905,sleep-recording,0,0
27906,device,0,0
27907,(,0,0
27908,group,0,0
27909,2,0,0
27910,),0,0
27911,",",0,0
27912,after,0,0
27913,an,0,0
27914,instruction,0,0
27915,period,0,0
27916,in,0,0
27917,the,0,0
27918,hospital,0,1
27919,.,0,0
27920,An,0,0
27921,economic,0,0
27922,analysis,0,0
27923,was,0,0
27924,performed,0,0
27925,",",0,0
27926,considering,0,0
27927,the,0,0
27928,cost,0,0
27929,of,0,0
27930,repeating,0,0
27931,studies,0,0
27932,in,0,1
27933,cases,0,1
27934,with,0,1
27935,faulty,0,0
27936,or,0,1
27937,inconclusive,0,0
27938,home,0,1
27939,studies,0,0
27940,(,0,0
27941,these,0,0
27942,patients,0,1
27943,should,0,0
27944,undergo,0,1
27945,polysomnography,0,1
27946,as,0,0
27947,a,0,0
27948,second,0,0
27949,step,0,0
27950,),0,0
27951,.,0,1
27952,RESULTS,0,0
27953,Seven,0,0
27954,percent,0,0
27955,of,0,0
27956,the,0,0
27957,home,0,0
27958,studies,0,0
27959,in,0,0
27960,group,0,1
27961,1,0,0
27962,",",0,0
27963,and,0,0
27964,33,0,1
27965,%,0,0
27966,in,0,0
27967,group,0,1
27968,2,0,0
27969,produced,0,0
27970,no,0,0
27971,interpretable,0,0
27972,data,0,0
27973,because,0,0
27974,of,0,1
27975,artifacts,0,0
27976,(,0,1
27977,p,0,0
27978,<,0,0
27979,0.05,0,0
27980,),0,1
27981,.,0,1
27982,Sixteen,0,1
27983,percent,0,0
27984,of,0,0
27985,the,0,0
27986,home,0,0
27987,study,0,0
27988,findings,0,0
27989,were,0,1
27990,inconclusive,0,0
27991,.,0,0
27992,The,0,0
27993,diagnosis,0,0
27994,obtained,0,0
27995,from,0,0
27996,the,0,0
27997,limited,0,0
27998,sleep-recording,0,0
27999,device,0,0
28000,and,0,0
28001,polysomnography,0,1
28002,agreed,0,0
28003,in,0,0
28004,75,0,1
28005,%,0,0
28006,of,0,0
28007,the,0,0
28008,interpretable,0,0
28009,home,0,1
28010,studies,0,0
28011,(,0,1
28012,89,0,1
28013,%,0,0
28014,",",0,0
28015,if,0,0
28016,inconclusive,0,0
28017,home,0,1
28018,studies,0,0
28019,were,0,1
28020,excluded,0,1
28021,),0,0
28022,.,0,0
28023,The,0,0
28024,area,0,0
28025,under,0,0
28026,the,0,0
28027,ROC,0,1
28028,curve,0,0
28029,for,0,0
28030,the,0,0
28031,home,0,1
28032,study-derived,0,0
28033,parameters,0,0
28034,was,0,0
28035,between,0,0
28036,0.84,0,0
28037,and,0,0
28038,0.89,0,0
28039,",",0,0
28040,compared,0,0
28041,with,0,1
28042,polysomnography,0,1
28043,.,0,0
28044,There,0,0
28045,was,0,0
28046,no,0,0
28047,bias,0,0
28048,between,0,0
28049,home,0,0
28050,and,0,0
28051,polysomnography,0,1
28052,studies,0,0
28053,in,0,0
28054,the,0,0
28055,Bland-Altman,0,1
28056,plot,0,0
28057,.,0,0
28058,The,0,0
28059,cost,0,0
28060,per,0,0
28061,study,0,0
28062,of,0,0
28063,home,0,1
28064,study,0,1
28065,recordings,0,0
28066,was,0,0
28067,less,0,0
28068,expensive,0,0
28069,than,0,0
28070,that,0,0
28071,of,0,0
28072,polysomnography,0,1
28073,(,0,0
28074,143.86,0,0
28075,euros,0,0
28076,),0,0
28077,",",0,0
28078,either,0,0
28079,with,0,1
28080,(,0,0
28081,93.08,0,0
28082,euros,0,1
28083,),0,0
28084,or,0,0
28085,without,0,1
28086,(,0,1
28087,129.97,0,0
28088,euros,0,1
28089,),0,1
28090,intervention,0,0
28091,of,0,0
28092,the,0,0
28093,technician,0,0
28094,in,0,0
28095,the,0,0
28096,patient,0,0
28097,'s,0,1
28098,home,0,1
28099,.,0,1
28100,CONCLUSION,0,0
28101,Home,0,1
28102,sleep,0,1
28103,studies,0,0
28104,are,0,0
28105,a,0,0
28106,viable,0,0
28107,form,0,0
28108,of,0,0
28109,diagnosing,0,0
28110,SAHS,0,0
28111,",",0,0
28112,and,0,0
28113,are,0,0
28114,less,0,0
28115,expensive,0,0
28116,than,0,0
28117,polysomnography,0,1
28118,.,0,0
28119,Intervention,0,0
28120,of,0,0
28121,a,0,0
28122,sleep,0,0
28123,technician,0,0
28124,in,0,0
28125,the,0,0
28126,patient,0,0
28127,'s,0,1
28128,home,0,0
28129,was,0,0
28130,the,0,0
28131,least,0,0
28132,expensive,0,0
28133,strategy,0,0
28134,",",0,0
28135,because,0,0
28136,of,0,0
28137,the,0,0
28138,high,0,0
28139,percentages,0,0
28140,of,0,1
28141,faulty,0,0
28142,studies,0,0
28143,with,0,1
28144,the,0,0
28145,patient,0,0
28146,'s,0,1
28147,own,0,1
28148,setup,0,0
28149,of,0,0
28150,the,0,0
28151,equipment,0,0
28152,",",0,0
28153,when,0,0
28154,using,0,0
28155,the,0,0
28156,limited,0,0
28157,sleep-recording,0,0
28158,device,0,0
28159,.,0,1
28160,A,0,0
28161,randomized,0,0
28162,trial,0,0
28163,of,0,0
28164,continuous,0,0
28165,subcutaneous,0,0
28166,insulin,0,0
28167,infusion,0,0
28168,and,0,0
28169,intensive,0,0
28170,injection,0,0
28171,therapy,0,0
28172,in,0,0
28173,type,1,1
28174,1,1,0
28175,diabetes,1,1
28176,for,1,1
28177,patients,1,1
28178,with,1,1
28179,long-standing,1,1
28180,poor,1,1
28181,glycemic,1,0
28182,control,1,1
28183,.,1,1
28184,OBJECTIVE,0,0
28185,To,0,0
28186,assess,0,0
28187,in,0,0
28188,a,0,0
28189,randomized,0,0
28190,crossover,0,0
28191,trial,0,0
28192,the,0,0
28193,efficacy,0,0
28194,of,0,0
28195,continuous,0,0
28196,subcutaneous,0,0
28197,insulin,0,0
28198,infusion,0,0
28199,in,0,0
28200,improving,0,0
28201,glycemic,0,0
28202,control,0,1
28203,and,0,0
28204,health-related,0,0
28205,quality,0,0
28206,of,0,0
28207,life,0,0
28208,in,0,0
28209,type,1,1
28210,1,1,1
28211,diabetic,1,1
28212,patients,1,1
28213,with,1,1
28214,long-standing,1,1
28215,poor,1,1
28216,glycemic,1,0
28217,control,1,1
28218,.,1,1
28219,RESEARCH,0,0
28220,DESIGN,0,0
28221,AND,0,0
28222,METHODS,0,0
28223,A,1,0
28224,total,1,1
28225,of,1,0
28226,79,1,1
28227,patients,1,1
28228,in,1,1
28229,11,1,1
28230,Dutch,1,1
28231,centers,1,1
28232,were,0,0
28233,randomized,0,1
28234,to,0,0
28235,16,0,1
28236,weeks,0,0
28237,of,0,1
28238,continuous,0,0
28239,subcutaneous,0,0
28240,insulin,0,0
28241,infusion,0,0
28242,followed,0,0
28243,by,0,0
28244,16,0,1
28245,weeks,0,0
28246,intensive,0,1
28247,injection,0,0
28248,therapy,0,0
28249,or,0,0
28250,the,0,0
28251,reverse,0,0
28252,order,0,0
28253,.,0,1
28254,Glycemic,0,0
28255,control,0,0
28256,was,0,0
28257,assessed,0,0
28258,by,0,0
28259,HbA,0,0
28260,(,0,1
28261,1c,0,0
28262,),0,0
28263,",",0,0
28264,self-reported,0,0
28265,hypoglycemic,0,1
28266,events,0,0
28267,",",0,0
28268,and,0,0
28269,blood,0,0
28270,glucose,0,0
28271,memory,0,0
28272,meter,0,0
28273,read,0,0
28274,outs,0,0
28275,.,0,1
28276,Changes,0,0
28277,in,0,0
28278,quality,0,0
28279,of,0,0
28280,life,0,0
28281,were,0,0
28282,assessed,0,0
28283,by,0,0
28284,self-report,0,1
28285,questionnaires,0,0
28286,administered,0,0
28287,at,0,0
28288,baseline,0,0
28289,and,0,0
28290,16,0,1
28291,weeks,0,0
28292,.,0,1
28293,RESULTS,0,0
28294,As,0,0
28295,the,0,0
28296,drop-out,0,0
28297,rate,0,0
28298,after,0,0
28299,crossover,0,0
28300,was,0,0
28301,high,0,1
28302,(,0,0
28303,17,0,1
28304,of,0,0
28305,79,0,1
28306,patients,0,1
28307,[,0,0
28308,22,0,1
28309,%,0,0
28310,],0,0
28311,),0,0
28312,",",0,0
28313,we,0,0
28314,analyzed,0,0
28315,the,0,0
28316,trial,0,0
28317,as,0,0
28318,a,0,0
28319,parallel,0,0
28320,clinical,0,0
28321,trial,0,0
28322,",",0,0
28323,using,0,0
28324,data,0,0
28325,of,0,0
28326,the,0,0
28327,first,0,0
28328,half,0,1
28329,of,0,0
28330,the,0,0
28331,crossover,0,0
28332,phase,0,0
28333,only,0,0
28334,.,0,0
28335,At,0,0
28336,16,0,1
28337,weeks,0,0
28338,",",0,1
28339,mean,0,1
28340,HbA,0,0
28341,(,0,1
28342,1c,0,0
28343,),0,1
28344,was,0,0
28345,0.84,0,0
28346,%,0,0
28347,(,0,0
28348,95,0,0
28349,%,0,0
28350,CI,0,0
28351,-1.31,0,0
28352,to,0,0
28353,-0.36,0,0
28354,),0,0
28355,lower,0,0
28356,in,0,0
28357,the,0,0
28358,continuous,0,0
28359,subcutaneous,0,0
28360,insulin,0,0
28361,infusion,0,0
28362,group,0,0
28363,compared,0,0
28364,with,0,1
28365,the,0,0
28366,insulin,0,0
28367,injection,0,0
28368,group,0,0
28369,(,0,0
28370,P,0,0
28371,=,0,0
28372,0.002,0,0
28373,),0,0
28374,.,0,0
28375,Stability,0,0
28376,of,0,0
28377,blood,0,0
28378,glucose,0,0
28379,self-measurement,0,0
28380,values,0,0
28381,",",0,0
28382,expressed,0,0
28383,as,0,0
28384,SD,0,0
28385,of,0,0
28386,the,0,0
28387,nine-point,0,0
28388,blood,0,0
28389,glucose,0,0
28390,profiles,0,0
28391,",",0,0
28392,improved,0,0
28393,in,0,0
28394,the,0,0
28395,insulin,0,0
28396,pump,0,0
28397,group,0,0
28398,by,0,0
28399,29.3,0,1
28400,+/-,0,0
28401,41.1,0,0
28402,vs.,0,0
28403,8.2,0,0
28404,+/-,0,0
28405,36.5,0,1
28406,%,0,0
28407,in,0,0
28408,the,0,0
28409,injection,0,0
28410,group,0,0
28411,(,0,0
28412,P,0,0
28413,=,0,0
28414,0.039,0,0
28415,),0,0
28416,.,0,0
28417,The,0,0
28418,number,0,0
28419,of,0,0
28420,mild,0,1
28421,hypoglycemic,0,1
28422,episodes,0,0
28423,per,0,1
28424,patient-week,0,0
28425,was,0,0
28426,0.99,0,0
28427,(,0,0
28428,95,0,0
28429,%,0,0
28430,CI,0,0
28431,0.11-1.87,0,0
28432,),0,0
28433,higher,0,0
28434,in,0,0
28435,the,0,0
28436,insulin,0,0
28437,pump,0,0
28438,group,0,0
28439,(,0,0
28440,P,0,0
28441,=,0,0
28442,0.028,0,0
28443,),0,1
28444,.,0,1
28445,Weight,0,1
28446,gain,0,0
28447,was,0,0
28448,similar,0,0
28449,in,0,0
28450,both,0,0
28451,groups,0,0
28452,.,0,1
28453,Scores,0,0
28454,on,0,0
28455,the,0,0
28456,Short-Form,0,0
28457,36-Item,0,0
28458,subscales,0,0
28459,'general,0,1
28460,health,0,1
28461,',0,1
28462,and,0,0
28463,'mental,0,0
28464,health,0,1
28465,',0,0
28466,improved,0,0
28467,in,0,0
28468,the,0,0
28469,continuous,0,0
28470,subcutaneous,0,0
28471,insulin,0,0
28472,infusion,0,0
28473,group,0,0
28474,",",0,0
28475,compared,0,0
28476,with,0,1
28477,stable,0,1
28478,values,0,0
28479,in,0,0
28480,the,0,0
28481,injection,0,0
28482,group,0,0
28483,(,0,0
28484,P,0,0
28485,=,0,0
28486,0.048,0,0
28487,and,0,0
28488,0.050,0,0
28489,",",0,0
28490,respectively,0,0
28491,),0,0
28492,.,0,0
28493,CONCLUSIONS,0,0
28494,Continuous,0,0
28495,subcutaneous,0,0
28496,insulin,0,0
28497,infusion,0,0
28498,improves,0,0
28499,glycemic,0,0
28500,control,0,0
28501,and,0,0
28502,some,0,0
28503,aspects,0,0
28504,of,0,0
28505,health-related,0,0
28506,quality,0,0
28507,of,0,0
28508,life,0,0
28509,in,0,0
28510,patients,1,1
28511,with,1,1
28512,a,1,0
28513,history,1,1
28514,of,1,0
28515,long-term,1,0
28516,poor,1,1
28517,glycemic,1,0
28518,control,1,1
28519,.,1,1
28520,Effect,0,0
28521,of,0,0
28522,nitazoxanide,0,0
28523,on,0,0
28524,morbidity,0,0
28525,and,0,0
28526,mortality,0,0
28527,in,0,0
28528,Zambian,1,1
28529,children,1,1
28530,with,1,1
28531,cryptosporidiosis,1,1
28532,:,1,1
28533,a,0,0
28534,randomised,0,0
28535,controlled,0,0
28536,trial,0,0
28537,.,0,1
28538,BACKGROUND,0,0
28539,Cryptosporidiosis,1,1
28540,in,1,0
28541,children,1,1
28542,in,1,0
28543,developing,1,0
28544,countries,1,0
28545,causes,0,0
28546,persistent,0,1
28547,diarrhoea,0,0
28548,and,0,0
28549,malnutrition,0,1
28550,and,0,0
28551,is,0,0
28552,associated,0,0
28553,with,0,0
28554,increased,0,0
28555,mortality,0,0
28556,",",0,0
28557,but,0,0
28558,there,0,0
28559,is,0,0
28560,no,0,0
28561,effective,0,0
28562,treatment,0,0
28563,.,0,1
28564,We,0,0
28565,aimed,0,0
28566,to,0,0
28567,assess,0,0
28568,the,0,0
28569,effect,0,0
28570,of,0,0
28571,nitazoxanide-a,0,0
28572,new,0,1
28573,broad-spectrum,0,1
28574,antiparasitic,0,1
28575,drug-on,0,0
28576,morbidity,0,0
28577,and,0,0
28578,mortality,0,0
28579,in,0,0
28580,Zambian,1,1
28581,children,1,1
28582,with,1,1
28583,diarrhoea,1,1
28584,due,1,0
28585,to,1,0
28586,Cryptosporidium,1,1
28587,parvum,1,0
28588,.,1,1
28589,METHODS,0,0
28590,Children,1,1
28591,with,1,1
28592,cryptosporidial,1,1
28593,diarrhoea,1,1
28594,who,1,1
28595,were,1,1
28596,admitted,1,1
28597,to,1,0
28598,the,1,0
28599,University,1,1
28600,Teaching,1,0
28601,Hospital,1,1
28602,",",1,0
28603,Lusaka,1,1
28604,",",1,0
28605,Zambia,1,0
28606,",",1,0
28607,between,1,0
28608,November,1,1
28609,",",1,0
28610,2000,1,1
28611,",",1,0
28612,and,1,0
28613,July,1,0
28614,",",1,0
28615,2001,1,1
28616,",",1,0
28617,and,1,0
28618,whose,1,1
28619,parents,1,1
28620,consented,1,1
28621,to,1,0
28622,their,1,0
28623,having,1,0
28624,an,1,0
28625,HIV,1,0
28626,test,1,0
28627,were,1,0
28628,randomly,1,1
28629,assigned,1,0
28630,nitazoxanide,1,0
28631,(,1,0
28632,100,1,0
28633,mg,1,0
28634,twice,1,0
28635,daily,1,0
28636,orally,1,0
28637,for,1,0
28638,3,1,0
28639,days,1,0
28640,),1,1
28641,or,1,1
28642,placebo,1,0
28643,.,1,0
28644,The,0,0
28645,primary,0,0
28646,endpoint,0,0
28647,was,0,0
28648,clinical,0,0
28649,response,0,0
28650,on,0,0
28651,day,0,0
28652,7,0,0
28653,after,0,0
28654,the,0,0
28655,start,0,0
28656,of,0,0
28657,treatment,0,0
28658,.,0,1
28659,Secondary,0,0
28660,endpoints,0,0
28661,included,0,1
28662,parasitological,0,0
28663,response,0,0
28664,by,0,0
28665,day,0,0
28666,10,0,0
28667,and,0,0
28668,mortality,0,0
28669,at,0,0
28670,day,0,0
28671,8,0,0
28672,.,0,1
28673,Analysis,0,0
28674,was,0,0
28675,by,0,0
28676,intention,0,0
28677,to,0,0
28678,treat,0,0
28679,",",0,0
28680,with,0,0
28681,exclusion,0,1
28682,of,0,0
28683,patients,0,1
28684,subsequently,0,0
28685,found,0,0
28686,to,0,0
28687,be,0,0
28688,negative,0,0
28689,for,0,0
28690,C,1,0
28691,parvum,1,0
28692,or,1,1
28693,co-infected,1,0
28694,at,1,0
28695,baseline,1,0
28696,.,1,0
28697,The,0,0
28698,trial,0,0
28699,was,0,0
28700,stratified,0,1
28701,by,0,0
28702,HIV,0,1
28703,serology,0,1
28704,.,0,1
28705,FINDINGS,0,0
28706,50,1,1
28707,HIV-seropositive,1,1
28708,and,1,1
28709,50,1,1
28710,HIV-seronegative,1,1
28711,children,1,1
28712,were,0,1
28713,recruited,0,1
28714,for,0,0
28715,the,0,0
28716,study,0,0
28717,",",0,0
28718,four,0,1
28719,of,0,1
28720,whom,0,1
28721,were,0,1
28722,subsequently,0,1
28723,excluded,0,0
28724,.,0,0
28725,In,0,0
28726,HIV-seronegative,0,1
28727,children,0,1
28728,",",0,0
28729,diarrhoea,0,0
28730,resolved,0,0
28731,in,0,0
28732,14,0,1
28733,(,0,1
28734,56,0,1
28735,%,0,0
28736,),0,0
28737,of,0,0
28738,25,0,0
28739,receiving,0,1
28740,nitazoxanide,0,0
28741,and,0,0
28742,5,0,0
28743,(,0,0
28744,23,0,1
28745,%,0,0
28746,),0,0
28747,of,0,0
28748,22,0,1
28749,receiving,0,1
28750,placebo,0,0
28751,(,0,0
28752,difference,0,0
28753,33,0,1
28754,%,0,0
28755,",",0,0
28756,95,0,0
28757,%,0,0
28758,CI,0,0
28759,7-59,0,1
28760,;,0,0
28761,p=0.037,0,0
28762,),0,0
28763,.,0,0
28764,C,0,0
28765,parvum,0,0
28766,was,0,0
28767,eradicated,0,0
28768,from,0,0
28769,stool,0,0
28770,in,0,0
28771,13,0,1
28772,(,0,1
28773,52,0,1
28774,%,0,0
28775,),0,0
28776,of,0,0
28777,25,0,1
28778,receiving,0,1
28779,nitazoxanide,0,0
28780,and,0,0
28781,three,0,0
28782,(,0,0
28783,14,0,0
28784,%,0,0
28785,),0,0
28786,of,0,0
28787,22,0,1
28788,receiving,0,1
28789,placebo,0,0
28790,(,0,0
28791,38,0,1
28792,%,0,0
28793,",",0,0
28794,95,0,0
28795,%,0,0
28796,CI,0,0
28797,14-63,0,1
28798,;,0,0
28799,p=0.007,0,0
28800,),0,0
28801,.,0,1
28802,Four,0,0
28803,children,0,1
28804,(,0,1
28805,18,0,1
28806,%,0,0
28807,),0,0
28808,of,0,0
28809,22,0,1
28810,in,0,0
28811,the,0,0
28812,placebo,0,0
28813,group,0,0
28814,had,0,0
28815,died,0,1
28816,by,0,0
28817,day,0,0
28818,8,0,0
28819,",",0,0
28820,compared,0,0
28821,with,0,0
28822,none,0,0
28823,of,0,0
28824,25,0,0
28825,in,0,0
28826,the,0,0
28827,nitazoxanide,0,0
28828,group,0,0
28829,(,0,0
28830,-18,0,0
28831,%,0,0
28832,",",0,0
28833,-34,0,0
28834,to,0,0
28835,2,0,0
28836,;,0,0
28837,p=0.041,0,0
28838,),0,0
28839,.,0,1
28840,HIV-seropositive,0,1
28841,children,0,1
28842,did,0,0
28843,not,0,0
28844,benefit,0,0
28845,from,0,0
28846,nitazoxanide,0,0
28847,.,0,1
28848,Nitazoxanide,0,0
28849,was,0,0
28850,not,0,0
28851,significantly,0,0
28852,associated,0,0
28853,with,0,1
28854,adverse,0,0
28855,events,0,0
28856,in,0,0
28857,either,0,1
28858,stratum,0,0
28859,.,0,0
28860,INTERPRETATION,0,0
28861,A,0,0
28862,3-day,0,0
28863,course,0,0
28864,of,0,0
28865,nitazoxanide,0,0
28866,significantly,0,0
28867,improved,0,0
28868,the,0,0
28869,resolution,0,0
28870,of,0,0
28871,diarrhoea,0,0
28872,",",0,0
28873,parasitological,0,0
28874,eradication,0,0
28875,",",0,0
28876,and,0,0
28877,mortality,0,0
28878,in,0,0
28879,HIV-seronegative,0,1
28880,",",0,0
28881,but,0,0
28882,not,0,0
28883,HIV-seropositive,0,1
28884,",",0,0
28885,children,0,1
28886,.,0,1
28887,Determinants,0,0
28888,of,0,1
28889,serum,0,0
28890,creatinine,0,0
28891,trajectory,0,0
28892,in,0,0
28893,acute,1,1
28894,contrast,1,0
28895,nephropathy,1,1
28896,.,1,0
28897,The,0,0
28898,aim,0,0
28899,of,0,0
28900,this,0,0
28901,study,0,0
28902,was,0,0
28903,to,0,0
28904,describe,0,0
28905,the,0,0
28906,trajectory,0,0
28907,of,0,0
28908,creatinine,0,0
28909,(,0,0
28910,Cr,0,0
28911,),0,0
28912,rise,0,0
28913,and,0,0
28914,its,0,0
28915,determinants,0,0
28916,after,1,0
28917,exposure,1,0
28918,to,1,0
28919,radiocontrast,1,0
28920,media,1,0
28921,.,1,1
28922,Included,0,0
28923,were,0,0
28924,98,1,1
28925,subjects,1,1
28926,who,1,1
28927,underwent,1,1
28928,cardiac,1,1
28929,catheterization,1,1
28930,and,0,0
28931,were,0,0
28932,randomized,0,0
28933,to,0,0
28934,forced,0,0
28935,diuresis,0,0
28936,with,0,1
28937,i.v,0,0
28938,.,0,0
28939,crystalloid,0,0
28940,",",0,0
28941,furosemide,0,0
28942,",",0,0
28943,mannitol,0,0
28944,(,0,0
28945,if,0,0
28946,pulmonary,0,1
28947,capillary,0,0
28948,wedge,0,1
28949,pressure,0,0
28950,was,0,0
28951,<,0,0
28952,20,0,1
28953,mmHg,0,0
28954,),0,0
28955,",",0,0
28956,and,0,0
28957,low,0,0
28958,dose,0,0
28959,dopamine,0,0
28960,versus,0,0
28961,intravenous,0,0
28962,crystalloid,0,0
28963,and,0,0
28964,matching,0,0
28965,placebos,0,0
28966,.,0,1
28967,Baseline,0,0
28968,and,0,0
28969,postcatheterization,0,1
28970,serum,0,0
28971,Cr,0,0
28972,levels,0,0
28973,were,0,0
28974,analyzed,0,0
28975,in,0,0
28976,a,0,0
28977,longitudinal,0,0
28978,fashion,0,0
28979,",",0,0
28980,allowing,0,0
28981,for,0,0
28982,differences,0,0
28983,in,0,0
28984,the,0,0
28985,time,0,0
28986,between,0,0
28987,blood,0,0
28988,draws,0,0
28989,",",0,0
28990,to,0,0
28991,determine,0,0
28992,the,0,0
28993,different,0,0
28994,critical,0,0
28995,trajectories,0,1
28996,of,0,0
28997,serum,0,0
28998,Cr,0,0
28999,.,0,0
29000,The,1,0
29001,mean,1,0
29002,age,1,1
29003,",",1,0
29004,baseline,1,0
29005,serum,1,0
29006,Cr,1,0
29007,",",1,0
29008,and,1,0
29009,Cr,1,0
29010,clearance,1,0
29011,(,1,0
29012,CrCl,1,0
29013,),1,0
29014,were,1,0
29015,69.3,1,0
29016,+/-,1,0
29017,10.8,1,0
29018,years,1,1
29019,",",1,1
29020,2.5,1,0
29021,+/-,1,0
29022,0.9,1,0
29023,mg/dL,1,0
29024,",",1,0
29025,and,1,0
29026,31.4,1,0
29027,+/-,1,0
29028,12.1,1,0
29029,mL/min,1,0
29030,",",1,0
29031,respectively,1,0
29032,.,1,0
29033,The,0,0
29034,clinically,0,0
29035,driven,0,0
29036,postprocedural,0,0
29037,observation,0,0
29038,time,0,0
29039,was,0,0
29040,5.5,0,0
29041,+/-,0,0
29042,5.1,0,1
29043,days,0,0
29044,(,0,1
29045,range,0,1
29046,19,0,1
29047,hours,0,0
29048,and,0,1
29049,one,0,1
29050,Cr,0,0
29051,value,0,0
29052,to,0,0
29053,25.7,0,0
29054,days,0,0
29055,and,0,1
29056,18,0,1
29057,values,0,0
29058,),0,1
29059,.,0,1
29060,The,0,0
29061,mean,0,0
29062,maximum,0,0
29063,Cr,0,0
29064,was,0,0
29065,3.3,0,0
29066,+/-,0,0
29067,1.4,0,0
29068,",",0,0
29069,range,0,0
29070,1.7-8.7,0,0
29071,mg/dL,0,0
29072,),0,0
29073,.,0,1
29074,Longitudinal,0,0
29075,models,0,0
29076,support,0,0
29077,baseline,0,0
29078,Cr,0,0
29079,clearance,0,0
29080,predictions,0,0
29081,for,0,0
29082,the,0,0
29083,change,0,0
29084,in,0,0
29085,Cr,0,0
29086,at,0,1
29087,24,0,1
29088,hours,0,0
29089,",",0,0
29090,time,0,0
29091,as,0,0
29092,the,0,0
29093,determinant,0,0
29094,of,0,0
29095,Cr,0,0
29096,trajectory,0,0
29097,",",0,0
29098,and,0,0
29099,requisite,0,0
29100,monitoring,0,0
29101,.,0,0
29102,For,0,0
29103,any,0,0
29104,given,0,0
29105,individual,0,0
29106,",",0,0
29107,a,0,0
29108,rise,0,0
29109,in,0,0
29110,Cr,0,0
29111,of,0,0
29112,<,0,0
29113,or,0,1
29114,=,0,0
29115,0.5,0,0
29116,mg/dL,0,0
29117,in,0,0
29118,the,0,0
29119,first,0,0
29120,24,0,0
29121,hours,0,0
29122,after,0,0
29123,contrast,0,0
29124,exposure,0,0
29125,predicted,0,0
29126,a,0,0
29127,favorable,0,0
29128,outcome,0,0
29129,.,0,1
29130,Baseline,0,0
29131,renal,0,1
29132,function,0,0
29133,is,0,0
29134,the,0,0
29135,major,0,0
29136,determinant,0,0
29137,of,0,0
29138,the,0,0
29139,rate,0,0
29140,of,0,0
29141,rise,0,0
29142,",",0,0
29143,height,0,0
29144,",",0,0
29145,and,0,0
29146,duration,0,0
29147,of,0,0
29148,Cr,0,0
29149,trajectory,0,0
29150,after,0,0
29151,contrast,0,0
29152,exposure,0,0
29153,.,0,0
29154,Length,0,0
29155,of,0,0
29156,observation,0,0
29157,and,0,0
29158,frequency,0,0
29159,of,0,0
29160,laboratory,0,0
29161,measures,0,0
29162,can,0,0
29163,be,0,0
29164,anticipated,0,0
29165,from,0,0
29166,these,0,0
29167,models,0,0
29168,.,0,1
29169,Direct,0,0
29170,aortic,0,1
29171,cannulation,0,1
29172,in,0,0
29173,minimally,1,1
29174,invasive,1,1
29175,mitral-valve,1,1
29176,operations,1,1
29177,.,1,1
29178,The,0,0
29179,minimally,0,0
29180,invasive,0,1
29181,Port-Access,0,0
29182,(,0,0
29183,Heartport,0,1
29184,",",0,0
29185,Redwood,0,1
29186,City,0,0
29187,",",0,0
29188,CA,0,1
29189,),0,0
29190,approach,0,0
29191,in,0,0
29192,mitral-valve,0,1
29193,operations,0,1
29194,originally,0,1
29195,required,0,0
29196,femoral,0,1
29197,arterial,0,1
29198,cannulation,0,1
29199,",",0,0
29200,which,0,0
29201,is,0,0
29202,considered,0,0
29203,a,0,0
29204,disadvantage,0,0
29205,",",0,0
29206,especially,0,0
29207,in,0,0
29208,patients,1,1
29209,with,1,1
29210,peripheral,1,1
29211,vessel,1,0
29212,disease,1,1
29213,.,1,0
29214,In,0,0
29215,this,0,0
29216,study,0,0
29217,20,1,1
29218,patients,1,1
29219,were,1,1
29220,prospectively,1,1
29221,randomized,1,0
29222,into,1,0
29223,2,1,0
29224,groups,1,0
29225,",",1,0
29226,to,1,0
29227,undergo,1,1
29228,either,1,0
29229,standard,1,0
29230,femoral,1,1
29231,(,1,0
29232,group,1,0
29233,A,1,1
29234,),1,0
29235,or,1,1
29236,direct,1,0
29237,aortic,1,1
29238,cannulation,1,1
29239,(,1,0
29240,group,1,0
29241,B,1,1
29242,),1,0
29243,.,1,0
29244,Pre-,0,0
29245,and,0,0
29246,postoperative,0,0
29247,data,0,0
29248,as,0,0
29249,well,0,0
29250,as,0,0
29251,markers,0,0
29252,for,0,0
29253,myocardial,0,1
29254,damage,0,0
29255,were,0,0
29256,assessed,0,0
29257,.,0,0
29258,Postoperatively,0,0
29259,",",0,0
29260,patients,0,1
29261,of,0,0
29262,group,0,1
29263,B,0,1
29264,showed,0,0
29265,lower,0,0
29266,levels,0,0
29267,of,0,0
29268,damage,0,0
29269,",",0,0
29270,indicating,0,0
29271,that,0,0
29272,direct,0,0
29273,aortic,0,1
29274,cannulation,0,0
29275,might,0,0
29276,provide,0,0
29277,better,0,0
29278,myocardial,0,1
29279,protection,0,0
29280,.,0,0
29281,Furthermore,0,0
29282,",",0,0
29283,the,0,0
29284,direct,0,0
29285,aortic,0,1
29286,cannulation,0,0
29287,technique,0,0
29288,may,0,0
29289,eliminate,0,0
29290,complications,0,0
29291,associated,0,0
29292,with,0,1
29293,the,0,0
29294,standard,0,0
29295,femoral,0,1
29296,artery,0,1
29297,cannulation,0,1
29298,.,0,1
29299,A,0,0
29300,pilot,0,0
29301,randomised,0,0
29302,control,0,0
29303,trial,0,0
29304,of,0,0
29305,a,0,0
29306,parent,0,0
29307,training,0,0
29308,intervention,0,0
29309,for,0,0
29310,pre-school,1,1
29311,children,1,1
29312,with,1,1
29313,autism,1,1
29314,.,1,1
29315,Preliminary,0,0
29316,findings,0,0
29317,and,0,1
29318,methodological,0,1
29319,challenges,0,0
29320,.,0,1
29321,Few,0,0
29322,attempts,0,0
29323,have,0,1
29324,been,0,0
29325,made,0,0
29326,to,0,0
29327,conduct,0,0
29328,randomised,0,0
29329,control,0,0
29330,trials,0,0
29331,(,0,1
29332,RCTs,0,0
29333,),0,0
29334,of,0,0
29335,interventions,0,0
29336,for,0,1
29337,pre-school,1,1
29338,children,1,1
29339,with,1,1
29340,autism,1,1
29341,.,1,0
29342,We,0,0
29343,report,0,0
29344,findings,0,0
29345,of,0,0
29346,a,0,0
29347,pilot,0,0
29348,RCT,0,0
29349,for,0,0
29350,a,0,0
29351,parent,0,0
29352,training,0,0
29353,intervention,0,0
29354,with,0,1
29355,a,0,0
29356,focus,0,0
29357,on,0,0
29358,the,0,0
29359,development,0,0
29360,of,0,0
29361,joint,0,1
29362,attention,0,0
29363,skills,0,0
29364,and,0,0
29365,joint,0,1
29366,action,0,0
29367,routines,0,0
29368,.,0,1
29369,Twenty-four,1,1
29370,children,1,1
29371,meeting,1,1
29372,ICD-10,1,0
29373,criteria,1,1
29374,for,1,0
29375,childhood,1,1
29376,autism,1,1
29377,(,1,0
29378,mean,1,0
29379,age,1,1
29380,=,1,0
29381,23,1,1
29382,months,1,0
29383,),1,1
29384,were,0,0
29385,identified,0,0
29386,using,0,0
29387,the,0,0
29388,CHAT,0,0
29389,screen,0,0
29390,and,0,0
29391,randomised,0,0
29392,to,0,0
29393,the,0,0
29394,parent,0,0
29395,training,0,0
29396,group,0,0
29397,or,0,1
29398,to,0,0
29399,local,0,0
29400,services,0,1
29401,only,0,0
29402,.,0,0
29403,A,0,0
29404,follow-up,0,0
29405,was,0,0
29406,conducted,0,1
29407,12,0,0
29408,months,0,0
29409,later,0,1
29410,(,0,0
29411,mean,0,0
29412,age,0,1
29413,=,0,0
29414,35,0,1
29415,months,0,0
29416,),0,1
29417,.,0,0
29418,There,0,0
29419,was,0,0
29420,some,0,0
29421,evidence,0,0
29422,that,0,0
29423,the,0,0
29424,parent,1,0
29425,training,1,0
29426,group,1,0
29427,made,0,0
29428,more,0,0
29429,progress,0,0
29430,in,0,0
29431,language,0,0
29432,development,0,0
29433,than,0,0
29434,the,0,0
29435,local,0,0
29436,services,0,1
29437,group,0,1
29438,.,0,0
29439,However,0,0
29440,",",0,0
29441,the,0,0
29442,present,0,0
29443,pilot,0,0
29444,study,0,0
29445,was,0,0
29446,compromised,0,0
29447,by,0,0
29448,several,0,0
29449,factors,0,0
29450,:,0,1
29451,a,0,0
29452,reliance,0,0
29453,on,0,0
29454,parental,0,0
29455,report,0,0
29456,to,0,0
29457,measure,0,0
29458,language,0,0
29459,",",0,0
29460,non-matching,0,0
29461,of,0,0
29462,the,0,0
29463,groups,0,0
29464,on,0,0
29465,initial,0,0
29466,IQ,0,1
29467,",",0,0
29468,and,0,0
29469,a,0,0
29470,lack,0,0
29471,of,0,0
29472,systematic,0,0
29473,checking,0,0
29474,regarding,0,0
29475,the,0,0
29476,implementation,0,0
29477,of,0,0
29478,the,0,0
29479,parent,0,0
29480,training,0,0
29481,intervention,0,0
29482,.,0,0
29483,Furthermore,0,0
29484,",",0,0
29485,three,1,0
29486,parents,1,1
29487,in,1,0
29488,the,1,0
29489,local,1,0
29490,services,1,1
29491,group,1,1
29492,commenced,0,1
29493,intensive,0,0
29494,",",0,0
29495,home-based,0,0
29496,behavioural,0,0
29497,intervention,0,0
29498,during,0,0
29499,the,0,0
29500,course,0,0
29501,of,0,0
29502,the,0,0
29503,study,0,0
29504,.,0,0
29505,The,0,0
29506,difficulties,0,0
29507,encountered,0,0
29508,in,0,0
29509,the,0,0
29510,conduct,0,0
29511,of,0,0
29512,RCTs,0,0
29513,for,0,0
29514,pre-school,1,1
29515,children,1,1
29516,with,1,1
29517,autism,1,1
29518,are,0,0
29519,discussed,0,0
29520,.,0,1
29521,Methodological,0,0
29522,challenges,0,0
29523,and,0,1
29524,strategies,0,0
29525,for,0,0
29526,future,0,0
29527,well-designed,0,0
29528,RCTs,0,0
29529,for,0,0
29530,autism,0,1
29531,interventions,0,0
29532,are,0,0
29533,highlighted,0,0
29534,.,0,1
29535,Variance,0,0
29536,in,0,0
29537,albumin,0,0
29538,loading,0,0
29539,in,0,0
29540,exchange,1,0
29541,transfusions,1,0
29542,.,1,1
29543,To,0,0
29544,assess,0,0
29545,the,0,0
29546,rationale,0,0
29547,of,0,0
29548,albumin,0,0
29549,priming,0,0
29550,prior,0,0
29551,to,0,0
29552,exchange,0,0
29553,transfusions,0,0
29554,",",0,0
29555,42,1,1
29556,hyperbilirubinemic,1,1
29557,infants,1,1
29558,who,1,1
29559,required,1,1
29560,exchange,1,1
29561,transfusions,1,0
29562,were,0,0
29563,randomly,0,1
29564,assigned,0,1
29565,to,0,0
29566,one,0,1
29567,of,0,0
29568,two,0,1
29569,groups,0,0
29570,.,0,1
29571,Group,0,0
29572,I,0,0
29573,consisted,0,1
29574,of,0,0
29575,15,1,1
29576,infants,1,1
29577,who,0,1
29578,were,0,1
29579,given,0,1
29580,intravenously,0,1
29581,1,0,0
29582,gm/kg,0,0
29583,of,0,0
29584,salt-poor,0,0
29585,human,0,1
29586,serum,0,0
29587,albumin,0,0
29588,one,0,0
29589,hour,0,0
29590,before,0,0
29591,the,0,0
29592,exchanges,0,0
29593,.,0,1
29594,Group,0,0
29595,II,0,0
29596,",",0,0
29597,which,0,0
29598,consisted,0,1
29599,of,0,0
29600,27,0,1
29601,infants,0,1
29602,",",0,0
29603,received,0,0
29604,simple,0,0
29605,exchanges,0,0
29606,.,0,1
29607,No,0,0
29608,statistical,0,0
29609,differences,0,0
29610,were,0,1
29611,found,0,0
29612,in,0,0
29613,variations,0,0
29614,in,0,0
29615,reserve,0,1
29616,albumin-binding,0,0
29617,capacity,0,0
29618,",",0,0
29619,bilirubin,0,0
29620,",",0,0
29621,albumin,0,0
29622,",",0,0
29623,or,0,0
29624,red,0,1
29625,cell,0,0
29626,bilirubin,0,0
29627,at,0,0
29628,pre,0,0
29629,and,0,0
29630,one-hour,0,0
29631,post,0,0
29632,albumin,0,0
29633,infusion,0,0
29634,in,0,0
29635,the,0,0
29636,primed,0,1
29637,infants,0,1
29638,.,0,1
29639,The,0,0
29640,amount,0,0
29641,of,0,0
29642,bilirubin,0,0
29643,removed,0,0
29644,per,0,0
29645,kilogram,0,0
29646,is,0,0
29647,directly,0,0
29648,correlated,0,0
29649,to,0,0
29650,plasma,0,0
29651,bilirubin,0,0
29652,concentration,0,0
29653,(,0,0
29654,r=0.87,0,0
29655,),0,0
29656,.,0,0
29657,No,0,0
29658,significant,0,0
29659,difference,0,0
29660,in,0,0
29661,efficiency,0,0
29662,on,0,0
29663,bilirubin,0,0
29664,removal,0,0
29665,was,0,0
29666,seen,0,0
29667,between,0,0
29668,the,0,0
29669,two,0,0
29670,groups,0,0
29671,.,0,1
29672,Beneficial,0,0
29673,effects,0,0
29674,of,0,0
29675,albumin,0,0
29676,therapy,0,0
29677,was,0,0
29678,apparent,0,0
29679,only,0,0
29680,in,0,0
29681,those,0,0
29682,infants,1,1
29683,with,1,1
29684,low,1,1
29685,RABC,1,1
29686,as,0,0
29687,determined,0,0
29688,by,0,0
29689,the,0,0
29690,sephadex,0,0
29691,gel,0,0
29692,filtration,0,0
29693,technique,0,0
29694,.,0,1
29695,Long-term,0,0
29696,use,0,0
29697,of,0,0
29698,Viozan,0,0
29699,(,0,1
29700,sibenadet,0,0
29701,HCl,0,0
29702,),0,1
29703,in,0,0
29704,patients,1,1
29705,with,1,1
29706,chronic,1,1
29707,obstructive,1,1
29708,pulmonary,1,1
29709,disease,1,1
29710,:,1,1
29711,results,0,0
29712,of,0,0
29713,a,0,0
29714,1-year,0,0
29715,study,0,0
29716,.,0,1
29717,Viozan,0,0
29718,(,0,0
29719,sibenadet,0,0
29720,HCl,0,0
29721,",",0,0
29722,AR-C68397AA,0,0
29723,),0,0
29724,is,0,0
29725,a,0,0
29726,novel,0,0
29727,dual,0,1
29728,D2,0,0
29729,dopamine,0,0
29730,receptor,0,0
29731,",",0,0
29732,beta2-adrenoceptor,0,0
29733,agonist,0,0
29734,that,0,0
29735,has,0,0
29736,been,0,0
29737,investigated,0,0
29738,for,0,0
29739,efficacy,0,0
29740,in,0,0
29741,alleviating,0,0
29742,the,0,0
29743,symptoms,0,0
29744,of,0,0
29745,chronic,0,1
29746,obstructive,0,1
29747,pulmonary,0,1
29748,disease,0,1
29749,(,0,0
29750,COPD,0,1
29751,),0,0
29752,.,0,0
29753,The,0,0
29754,slowly,0,0
29755,progressive,0,0
29756,nature,0,0
29757,of,0,0
29758,this,0,0
29759,disease,0,1
29760,means,0,0
29761,that,0,0
29762,patients,0,1
29763,will,0,0
29764,require,0,1
29765,ongoing,0,0
29766,therapeutic,0,0
29767,management,0,1
29768,for,0,0
29769,many,0,0
29770,years,0,1
29771,",",0,0
29772,or,0,1
29773,even,0,0
29774,decades,0,0
29775,.,0,0
29776,With,0,1
29777,such,0,0
29778,long-term,0,0
29779,treatment,0,0
29780,",",0,0
29781,the,0,0
29782,safety,0,0
29783,profile,0,0
29784,of,0,0
29785,new,0,0
29786,agents,0,0
29787,will,0,0
29788,be,0,0
29789,of,0,0
29790,paramount,0,0
29791,importance,0,0
29792,.,0,0
29793,As,0,0
29794,part,0,0
29795,of,0,0
29796,the,0,0
29797,large-scale,0,0
29798,assessment,0,0
29799,of,0,0
29800,sibenadet,0,0
29801,",",0,0
29802,a,0,0
29803,12-month,0,0
29804,safety,0,0
29805,study,0,0
29806,has,0,0
29807,been,0,0
29808,conducted,0,0
29809,.,0,0
29810,Following,0,0
29811,completion,0,0
29812,of,0,0
29813,a,0,0
29814,2-week,0,0
29815,baseline,0,0
29816,period,0,0
29817,",",0,0
29818,435,1,1
29819,adults,1,1
29820,with,1,1
29821,stable,1,1
29822,",",1,0
29823,symptomatic,1,1
29824,",",1,0
29825,smoking-related,1,1
29826,COPD,1,0
29827,were,1,0
29828,randomized,1,0
29829,to,0,0
29830,receive,0,0
29831,either,0,0
29832,500,0,0
29833,microg,0,0
29834,sibenadet,0,0
29835,or,0,0
29836,placebo,0,0
29837,delivered,0,0
29838,via,0,0
29839,pressurized,0,0
29840,metered,0,0
29841,dose,0,0
29842,inhaler,0,0
29843,(,0,0
29844,pMDI,0,0
29845,),0,0
29846,",",0,0
29847,three,0,0
29848,times,0,0
29849,daily,0,0
29850,for,0,0
29851,52,0,1
29852,weeks,0,0
29853,.,0,1
29854,Sibenadet,0,0
29855,therapy,0,0
29856,was,0,0
29857,generally,0,0
29858,well,0,0
29859,tolerated,0,0
29860,",",0,0
29861,with,0,1
29862,the,0,0
29863,only,0,0
29864,notable,0,0
29865,differences,0,0
29866,seen,0,0
29867,in,0,0
29868,the,0,0
29869,incidence,0,0
29870,of,0,0
29871,tremor,0,1
29872,and,0,0
29873,taste,0,0
29874,of,0,0
29875,treatment,0,0
29876,(,0,0
29877,16.9,0,0
29878,%,0,0
29879,vs.,0,0
29880,4.1,0,0
29881,%,0,0
29882,and,0,0
29883,14.5,0,0
29884,%,0,0
29885,vs.,0,0
29886,4.1,0,0
29887,%,0,0
29888,in,0,0
29889,the,0,0
29890,sibenadet,0,0
29891,and,0,0
29892,placebo,0,0
29893,groups,0,0
29894,respectively,0,0
29895,),0,0
29896,.,0,0
29897,There,0,0
29898,were,0,0
29899,a,0,0
29900,total,0,1
29901,of,0,0
29902,79,1,1
29903,patients,1,1
29904,with,1,1
29905,serious,1,0
29906,adverse,1,0
29907,events,1,0
29908,(,1,1
29909,SAEs,1,0
29910,),1,0
29911,",",1,0
29912,43,1,1
29913,(,1,0
29914,14.8,1,0
29915,%,1,0
29916,),1,0
29917,in,1,0
29918,the,1,0
29919,sibenadet,1,0
29920,pMDI,1,0
29921,group,1,0
29922,and,1,0
29923,36,1,1
29924,(,1,0
29925,24.8,1,0
29926,%,1,0
29927,),1,0
29928,in,1,0
29929,the,1,0
29930,placebo,1,0
29931,group,1,0
29932,.,1,0
29933,No,0,0
29934,clinically,0,0
29935,significant,0,0
29936,abnormal,0,0
29937,laboratory,0,0
29938,values,0,0
29939,or,0,1
29940,overall,0,0
29941,differences,0,0
29942,between,0,0
29943,treatment,0,1
29944,groups,0,0
29945,were,0,1
29946,noted,0,0
29947,.,0,0
29948,Similarly,0,0
29949,",",0,0
29950,there,0,0
29951,were,0,0
29952,no,0,0
29953,clinically,0,0
29954,significant,0,0
29955,differences,0,0
29956,between,0,0
29957,the,0,0
29958,two,0,0
29959,treatment,0,0
29960,groups,0,0
29961,for,0,0
29962,cardiac,0,1
29963,variables,0,0
29964,",",0,0
29965,or,0,1
29966,in,0,0
29967,vital,0,1
29968,signs,0,1
29969,.,0,1
29970,The,0,0
29971,secondary,0,0
29972,variables,0,0
29973,showed,0,0
29974,no,0,0
29975,notable,0,0
29976,differences,0,0
29977,with,0,1
29978,respect,0,0
29979,to,0,0
29980,lung,0,1
29981,function,0,0
29982,",",0,0
29983,exacerbations,0,1
29984,or,0,1
29985,health-related,0,0
29986,quality,0,0
29987,of,0,0
29988,life,0,0
29989,.,0,1
29990,Due,0,0
29991,to,0,0
29992,the,0,0
29993,effective,0,0
29994,beta2-agonist,0,0
29995,properties,0,0
29996,",",0,0
29997,patients,0,1
29998,in,0,0
29999,the,0,0
30000,sibenadet,0,0
30001,group,0,0
30002,did,0,0
30003,",",0,0
30004,however,0,0
30005,",",0,0
30006,report,0,0
30007,reduced,0,0
30008,rescue,0,0
30009,medication,0,0
30010,usage,0,0
30011,at,0,0
30012,all,0,1
30013,timepoints,0,0
30014,.,0,0
30015,While,0,0
30016,the,0,0
30017,results,0,0
30018,of,0,0
30019,this,0,0
30020,study,0,0
30021,show,0,0
30022,that,0,0
30023,",",0,0
30024,overall,0,0
30025,",",0,0
30026,sibenadet,0,0
30027,therapy,0,0
30028,was,0,0
30029,well,0,0
30030,tolerated,0,0
30031,",",0,0
30032,the,0,0
30033,lack,0,0
30034,of,0,0
30035,sustained,0,0
30036,benefit,0,0
30037,reported,0,0
30038,in,0,0
30039,large-scale,0,0
30040,clinical,0,0
30041,efficacy,0,0
30042,studies,0,0
30043,means,0,0
30044,that,0,0
30045,sibenadet,0,0
30046,development,0,0
30047,will,0,0
30048,not,0,0
30049,be,0,0
30050,continued,0,0
30051,.,0,0
30052,Development,0,0
30053,of,0,0
30054,renal,0,1
30055,disease,0,1
30056,in,0,0
30057,people,1,1
30058,at,1,1
30059,high,1,1
30060,cardiovascular,1,1
30061,risk,1,1
30062,:,1,1
30063,results,0,0
30064,of,0,0
30065,the,0,0
30066,HOPE,0,0
30067,randomized,0,0
30068,study,0,0
30069,.,0,0
30070,In,0,0
30071,people,1,1
30072,with,1,1
30073,diabetes,1,1
30074,",",0,0
30075,renal,0,1
30076,disease,0,1
30077,tends,0,0
30078,to,0,0
30079,progress,0,0
30080,from,0,0
30081,microalbuminuria,0,0
30082,to,0,0
30083,clinical,0,0
30084,proteinuria,0,1
30085,to,0,0
30086,renal,0,1
30087,insufficiency,0,1
30088,.,0,1
30089,Little,0,0
30090,evidence,0,0
30091,has,0,0
30092,been,0,0
30093,published,0,0
30094,for,0,0
30095,the,0,0
30096,nondiabetic,1,1
30097,population,1,1
30098,.,1,0
30099,This,0,0
30100,study,0,0
30101,retrospectively,0,1
30102,analyzed,0,0
30103,changes,0,0
30104,of,0,0
30105,proteinuria,0,1
30106,over,0,0
30107,4.5,0,0
30108,yr,0,1
30109,in,0,0
30110,the,0,0
30111,HOPE,0,0
30112,(,0,0
30113,Heart,0,1
30114,Outcomes,0,0
30115,and,0,0
30116,Prevention,0,1
30117,Evaluation,0,0
30118,),0,0
30119,study,0,0
30120,",",0,0
30121,which,0,0
30122,compared,0,0
30123,ramipril,0,0
30124,'s,0,1
30125,effects,0,0
30126,to,0,0
30127,placebo,0,0
30128,in,0,0
30129,9297,1,1
30130,participants,1,1
30131,",",1,0
30132,including,1,0
30133,3577,1,1
30134,with,1,1
30135,diabetes,1,1
30136,and,1,1
30137,1956,1,1
30138,with,1,1
30139,microalbuminuria,1,1
30140,.,1,0
30141,This,0,0
30142,report,0,0
30143,is,0,0
30144,restricted,1,0
30145,to,1,0
30146,7674,1,1
30147,participants,1,1
30148,with,1,1
30149,albuminuria,1,1
30150,data,1,0
30151,at,1,1
30152,baseline,1,0
30153,and,1,0
30154,at,1,0
30155,follow-up,1,0
30156,.,1,1
30157,Inclusion,0,0
30158,criteria,0,1
30159,were,0,1
30160,known,0,0
30161,vascular,0,0
30162,disease,0,1
30163,or,0,0
30164,diabetes,0,1
30165,plus,0,0
30166,one,0,0
30167,other,0,0
30168,cardiovascular,0,1
30169,risk,0,0
30170,factor,0,0
30171,",",0,0
30172,exclusion,0,1
30173,criteria,0,1
30174,included,0,1
30175,heart,0,1
30176,failure,0,1
30177,or,0,0
30178,known,0,0
30179,impaired,0,1
30180,left,0,1
30181,ventricular,0,0
30182,function,0,0
30183,",",0,0
30184,dipstick-positive,0,0
30185,proteinuria,0,0
30186,(,0,1
30187,>,0,1
30188,1+,0,1
30189,),0,0
30190,",",0,0
30191,and,0,0
30192,serum,0,0
30193,creatinine,0,0
30194,>,0,1
30195,2.3,0,0
30196,mg/dl,0,0
30197,(,0,0
30198,200,0,0
30199,microM,0,0
30200,),0,1
30201,.,0,0
30202,Baseline,0,0
30203,microalbuminuria,0,0
30204,predicted,0,0
30205,subsequent,0,0
30206,clinical,0,0
30207,proteinuria,0,1
30208,for,0,0
30209,the,0,0
30210,study,0,0
30211,participants,0,1
30212,overall,0,0
30213,(,0,1
30214,adjusted,0,0
30215,odds,0,0
30216,ratio,0,0
30217,[,0,0
30218,OR,0,0
30219,],0,1
30220,",",0,0
30221,17.5,0,0
30222,;,0,0
30223,95,0,0
30224,%,0,0
30225,confidence,0,0
30226,interval,0,0
30227,[,0,0
30228,CI,0,0
30229,],0,1
30230,",",0,0
30231,12.6,0,0
30232,to,0,0
30233,24.4,0,0
30234,),0,0
30235,",",0,0
30236,in,0,0
30237,participants,0,1
30238,without,0,1
30239,diabetes,0,1
30240,(,0,1
30241,OR,0,0
30242,",",0,1
30243,16.7,0,1
30244,;,0,0
30245,95,0,0
30246,%,0,0
30247,CI,0,0
30248,",",0,0
30249,8.6,0,0
30250,to,0,0
30251,32.4,0,0
30252,),0,0
30253,",",0,0
30254,and,0,0
30255,in,0,0
30256,participants,0,1
30257,with,0,1
30258,diabetes,0,1
30259,(,0,1
30260,OR,0,0
30261,",",0,1
30262,18.2,0,0
30263,;,0,0
30264,95,0,0
30265,%,0,0
30266,CI,0,0
30267,",",0,0
30268,12.4,0,0
30269,to,0,0
30270,26.7,0,0
30271,),0,0
30272,.,0,0
30273,Any,0,1
30274,progression,0,0
30275,of,0,0
30276,albuminuria,0,1
30277,(,0,0
30278,defined,0,0
30279,as,0,0
30280,new,0,0
30281,microalbuminuria,0,1
30282,or,0,1
30283,new,0,1
30284,clinical,0,0
30285,proteinuria,0,1
30286,),0,0
30287,occurred,0,0
30288,in,0,0
30289,1859,0,1
30290,participants,0,1
30291,;,0,1
30292,1542,0,1
30293,developed,0,0
30294,new,0,0
30295,microalbuminuria,0,0
30296,",",0,0
30297,and,0,0
30298,317,0,1
30299,participants,0,1
30300,developed,0,1
30301,clinical,0,0
30302,proteinuria,0,1
30303,.,0,1
30304,Ramipril,0,0
30305,reduced,0,0
30306,the,0,0
30307,risk,0,0
30308,for,0,0
30309,any,0,0
30310,progression,0,0
30311,(,0,0
30312,OR,0,0
30313,",",0,1
30314,0.87,0,0
30315,;,0,0
30316,95,0,0
30317,%,0,0
30318,CI,0,0
30319,",",0,0
30320,0.78,0,0
30321,to,0,0
30322,0.97,0,0
30323,;,0,1
30324,P,0,0
30325,=,0,0
30326,0.0146,0,0
30327,),0,1
30328,.,0,1
30329,People,0,1
30330,without,0,1
30331,and,0,1
30332,with,0,1
30333,diabetes,0,1
30334,who,0,1
30335,are,0,1
30336,at,0,1
30337,high,0,0
30338,risk,0,0
30339,for,0,0
30340,cardiovascular,0,1
30341,disease,0,1
30342,are,0,0
30343,also,0,0
30344,at,0,0
30345,risk,0,0
30346,for,0,0
30347,a,0,0
30348,progressive,0,0
30349,rise,0,0
30350,in,0,0
30351,albuminuria,0,1
30352,.,0,1
30353,Microalbuminuria,0,0
30354,itself,0,0
30355,predicts,0,0
30356,clinical,0,0
30357,proteinuria,0,0
30358,in,0,0
30359,nondiabetic,1,1
30360,and,1,0
30361,in,1,0
30362,diabetic,1,1
30363,people,1,1
30364,.,1,1
30365,Ramipril,0,0
30366,prevents,0,0
30367,or,0,1
30368,delays,0,0
30369,the,0,0
30370,progression,0,0
30371,of,0,0
30372,albuminuria,0,1
30373,.,0,1
30374,Gastrointestinal,0,1
30375,safety,0,0
30376,of,0,0
30377,NO-aspirin,0,0
30378,(,0,1
30379,NCX-4016,0,1
30380,),0,0
30381,in,0,0
30382,healthy,1,1
30383,human,1,1
30384,volunteers,1,1
30385,:,1,1
30386,a,0,0
30387,proof,0,0
30388,of,0,0
30389,concept,0,0
30390,endoscopic,0,0
30391,study,0,0
30392,.,0,0
30393,BACKGROUND,0,0
30394,AND,0,0
30395,AIMS,0,1
30396,NCX-4016,0,0
30397,is,0,0
30398,a,0,0
30399,nitric,0,0
30400,oxide-releasing,0,0
30401,derivative,0,0
30402,of,0,0
30403,aspirin,0,0
30404,with,0,1
30405,antiplatelet,0,1
30406,activity,0,0
30407,.,0,0
30408,The,0,0
30409,aim,0,0
30410,of,0,0
30411,this,0,0
30412,study,0,0
30413,was,0,0
30414,to,0,0
30415,investigate,0,0
30416,the,0,0
30417,effect,0,0
30418,of,0,0
30419,NCX-4016,0,1
30420,on,0,0
30421,gastrointestinal,0,1
30422,mucosa,0,1
30423,and,0,0
30424,platelet,0,0
30425,functions,0,0
30426,in,0,0
30427,healthy,1,1
30428,human,1,1
30429,volunteers,1,1
30430,.,1,1
30431,METHODS,0,0
30432,This,0,0
30433,was,0,0
30434,a,0,0
30435,parallel-group,0,0
30436,",",0,0
30437,double-blind,0,0
30438,",",0,0
30439,placebo-controlled,0,0
30440,study,0,0
30441,.,0,1
30442,Forty,1,1
30443,healthy,1,1
30444,subjects,1,1
30445,were,0,1
30446,randomly,0,1
30447,allocated,0,0
30448,to,0,0
30449,receive,0,0
30450,7,0,1
30451,days,0,0
30452,of,0,0
30453,treatment,0,0
30454,with,0,1
30455,NCX-4016,0,1
30456,(,0,1
30457,400,0,0
30458,and,0,0
30459,800,0,0
30460,mg,0,0
30461,twice,0,0
30462,daily,0,0
30463,),0,0
30464,",",0,0
30465,equimolar,0,0
30466,doses,0,0
30467,of,0,0
30468,aspirin,0,0
30469,(,0,0
30470,200,0,0
30471,and,0,0
30472,420,0,1
30473,mg,0,0
30474,twice,0,0
30475,daily,0,0
30476,),0,0
30477,",",0,0
30478,or,0,1
30479,placebo,0,0
30480,.,0,0
30481,Upper,0,0
30482,endoscopies,0,0
30483,were,0,0
30484,performed,0,0
30485,before,0,0
30486,and,0,0
30487,at,0,0
30488,the,0,0
30489,end,0,0
30490,of,0,0
30491,the,0,0
30492,treatment,0,0
30493,period,0,0
30494,",",0,0
30495,and,0,0
30496,gastroduodenal,0,1
30497,lesions,0,1
30498,were,0,1
30499,graded,0,0
30500,using,0,0
30501,a,0,0
30502,predefined,0,0
30503,scoring,0,0
30504,system,0,0
30505,.,0,0
30506,Basal,0,0
30507,and,0,0
30508,posttreatment,0,0
30509,platelet,0,0
30510,aggregation,0,0
30511,in,0,0
30512,response,0,0
30513,to,0,0
30514,arachidonic,0,0
30515,acid,0,0
30516,(,0,0
30517,AA,0,0
30518,),0,0
30519,and,0,0
30520,serum,0,0
30521,thromboxane,0,0
30522,(,0,0
30523,TX,0,0
30524,),0,0
30525,B,0,1
30526,(,0,1
30527,2,0,0
30528,),0,0
30529,and,0,0
30530,AA-stimulated,0,0
30531,platelet,0,0
30532,TXB,0,1
30533,(,0,0
30534,2,0,0
30535,),0,0
30536,production,0,0
30537,were,0,0
30538,investigated,0,0
30539,.,0,1
30540,RESULTS,0,0
30541,Mucosal,0,1
30542,endoscopic,0,0
30543,injury,0,1
30544,score,0,0
30545,on,0,0
30546,day,0,0
30547,7,0,1
30548,was,0,0
30549,0.63,0,0
30550,+/-,0,0
30551,0.16,0,0
30552,in,0,0
30553,the,0,0
30554,placebo,0,0
30555,group,0,0
30556,and,0,0
30557,11.0,0,0
30558,+/-,0,0
30559,3.0,0,0
30560,and,0,1
30561,16.1,0,0
30562,+/-,0,0
30563,1.6,0,0
30564,in,0,0
30565,healthy,1,1
30566,volunteers,1,1
30567,treated,0,1
30568,with,0,1
30569,200,0,0
30570,and,0,0
30571,420,0,1
30572,mg,0,0
30573,aspirin,0,0
30574,twice,0,0
30575,daily,0,0
30576,(,0,0
30577,P,0,0
30578,<,0,0
30579,0.0001,0,0
30580,vs.,0,0
30581,placebo,0,0
30582,),0,0
30583,.,0,0
30584,NCX-4016,0,0
30585,was,0,0
30586,virtually,0,0
30587,devoid,0,0
30588,of,0,0
30589,gastric,0,1
30590,and,0,0
30591,duodenal,0,1
30592,toxicity,0,0
30593,",",0,0
30594,resulting,0,0
30595,in,0,0
30596,a,0,0
30597,total,0,1
30598,gastric,0,1
30599,and,0,0
30600,duodenal,0,1
30601,endoscopic,0,0
30602,score,0,0
30603,of,0,0
30604,1.38,0,0
30605,+/-,0,0
30606,0.3,0,0
30607,and,0,1
30608,1.25,0,0
30609,+/-,0,0
30610,0.5,0,0
30611,(,0,0
30612,P,0,0
30613,<,0,0
30614,0.0001,0,0
30615,vs.,0,0
30616,aspirin,0,0
30617,",",0,0
30618,not,0,0
30619,significant,0,0
30620,vs.,0,0
30621,placebo,0,0
30622,),0,0
30623,.,0,0
30624,NCX-4016,0,0
30625,inhibited,0,0
30626,AA-induced,0,0
30627,platelet,0,0
30628,aggregation,0,0
30629,as,0,0
30630,well,0,0
30631,as,0,0
30632,serum,0,0
30633,TXB,0,1
30634,(,0,0
30635,2,0,0
30636,),0,0
30637,and,0,0
30638,platelet,0,0
30639,TXB,0,0
30640,(,0,0
30641,2,0,0
30642,),0,0
30643,generation,0,0
30644,induced,0,0
30645,by,0,0
30646,AA,0,0
30647,to,0,0
30648,the,0,0
30649,same,0,0
30650,extent,0,0
30651,as,0,0
30652,aspirin,0,0
30653,(,0,0
30654,not,0,0
30655,significant,0,0
30656,vs.,0,0
30657,aspirin,0,0
30658,),0,0
30659,.,0,0
30660,CONCLUSIONS,0,0
30661,In,0,0
30662,this,0,0
30663,study,0,0
30664,",",0,0
30665,we,0,0
30666,have,0,0
30667,proven,0,0
30668,the,0,0
30669,concept,0,0
30670,that,0,0
30671,addition,0,0
30672,of,0,0
30673,an,0,0
30674,NO-donating,0,0
30675,moiety,0,0
30676,to,0,0
30677,aspirin,0,0
30678,results,0,0
30679,in,0,0
30680,a,0,0
30681,new,0,0
30682,chemical,0,0
30683,entity,0,0
30684,that,0,0
30685,maintains,0,0
30686,cyclooxygenase-1,0,0
30687,and,0,0
30688,platelet,0,0
30689,inhibitory,0,0
30690,activity,0,0
30691,while,0,0
30692,nearly,0,0
30693,avoiding,0,0
30694,gastrointestinal,0,1
30695,damage,0,1
30696,.,0,1
30697,Clonidine,0,0
30698,premedication,0,0
30699,improves,0,0
30700,metabolic,0,0
30701,control,0,0
30702,in,0,0
30703,type,1,1
30704,2,1,1
30705,diabetic,1,1
30706,patients,1,1
30707,during,1,0
30708,ophthalmic,1,1
30709,surgery,1,1
30710,.,1,0
30711,BACKGROUND,0,0
30712,In,0,0
30713,stressful,0,0
30714,conditions,0,0
30715,",",0,0
30716,increasing,0,0
30717,blood,0,0
30718,glucose,0,0
30719,concentrations,0,0
30720,are,0,0
30721,closely,0,0
30722,related,0,0
30723,to,0,0
30724,an,0,0
30725,increase,0,0
30726,in,0,0
30727,catecholamines,0,0
30728,and,0,0
30729,cortisol,0,0
30730,release,0,0
30731,.,0,0
30732,Clonidine,0,0
30733,",",0,0
30734,a,0,0
30735,centrally,0,0
30736,acting,0,0
30737,alpha,0,0
30738,(,0,1
30739,2,0,0
30740,),0,0
30741,-adrenoceptor,0,0
30742,agonist,0,0
30743,",",0,0
30744,has,0,0
30745,neuroendocrine,0,0
30746,effects,0,0
30747,",",0,0
30748,including,0,0
30749,inhibition,0,0
30750,of,0,0
30751,sympathoadrenal,0,0
30752,activity,0,0
30753,.,0,0
30754,We,0,0
30755,therefore,0,0
30756,evaluated,0,0
30757,the,0,0
30758,effect,0,0
30759,of,0,0
30760,clonidine,0,0
30761,on,0,0
30762,blood,0,0
30763,glucose,0,0
30764,control,0,0
30765,and,0,0
30766,insulin,0,0
30767,requirements,0,0
30768,during,0,0
30769,ophthalmic,0,1
30770,surgery,0,1
30771,when,0,0
30772,given,0,0
30773,as,0,0
30774,premedication,0,0
30775,in,0,0
30776,type,1,1
30777,2,1,1
30778,diabetic,1,1
30779,patients,1,1
30780,.,1,1
30781,METHODS,0,0
30782,After,0,0
30783,randomization,0,0
30784,",",0,0
30785,patients,0,1
30786,were,0,0
30787,premedicated,0,1
30788,with,0,1
30789,clonidine,0,0
30790,or,0,1
30791,flunitrazepam,0,0
30792,(,0,0
30793,control,0,1
30794,),0,1
30795,.,0,0
30796,Patients,0,1
30797,were,0,1
30798,given,0,0
30799,insulin,0,0
30800,by,0,0
30801,continuous,0,0
30802,i.v,0,0
30803,.,0,0
30804,infusion,0,0
30805,to,0,0
30806,maintain,0,0
30807,blood,0,0
30808,glucose,0,0
30809,in,0,0
30810,the,0,0
30811,range,0,0
30812,5.5-11.1,0,0
30813,mmol,0,0
30814,litre,0,0
30815,(,0,0
30816,-1,0,0
30817,),0,1
30818,.,0,1
30819,Blood,0,0
30820,glucose,0,0
30821,concentrations,0,0
30822,were,0,1
30823,measured,0,0
30824,every,0,0
30825,15,0,0
30826,min,0,0
30827,during,0,0
30828,surgery,0,1
30829,",",0,0
30830,and,0,0
30831,hourly,0,0
30832,for,0,0
30833,6,0,0
30834,h,0,0
30835,after,0,0
30836,surgery,0,1
30837,.,0,1
30838,Plasma,0,0
30839,C-peptide,0,0
30840,and,0,0
30841,counter-regulatory,0,0
30842,hormones,0,0
30843,were,0,1
30844,also,0,0
30845,measured,0,0
30846,.,0,0
30847,RESULTS,0,0
30848,Glycaemia,0,0
30849,was,0,0
30850,significantly,0,0
30851,lower,0,0
30852,in,0,0
30853,the,0,0
30854,clonidine,0,0
30855,group,0,0
30856,(,0,0
30857,P,0,0
30858,<,0,0
30859,0.01,0,0
30860,),0,0
30861,and,0,0
30862,the,0,0
30863,median,0,0
30864,amount,0,0
30865,of,0,0
30866,insulin,0,0
30867,administered,0,0
30868,was,0,0
30869,significantly,0,0
30870,reduced,0,0
30871,:,0,0
30872,clonidine,0,0
30873,group,0,0
30874,9.0,0,0
30875,(,0,0
30876,interquartile,0,0
30877,range,0,1
30878,5.1,0,0
30879,),0,1
30880,units,0,0
30881,;,0,1
30882,control,0,1
30883,18.6,0,0
30884,(,0,0
30885,10.2,0,0
30886,),0,1
30887,units,0,0
30888,;,0,1
30889,P,0,0
30890,<,0,0
30891,0.01,0,0
30892,),0,1
30893,.,0,1
30894,Plasma,0,0
30895,catecholamine,0,0
30896,concentrations,0,0
30897,were,0,1
30898,lower,0,0
30899,in,0,0
30900,patients,0,1
30901,given,0,0
30902,clonidine,0,0
30903,(,0,0
30904,P,0,0
30905,<,0,0
30906,0.05,0,0
30907,),0,0
30908,but,0,0
30909,there,0,0
30910,was,0,0
30911,no,0,0
30912,difference,0,0
30913,in,0,0
30914,cortisol,0,0
30915,concentrations,0,0
30916,.,0,1
30917,CONCLUSION,0,0
30918,Premedication,0,0
30919,of,0,0
30920,type,1,1
30921,2,1,1
30922,diabetic,1,1
30923,patients,1,1
30924,with,0,1
30925,clonidine,0,0
30926,90,0,0
30927,min,0,0
30928,before,0,0
30929,surgery,0,1
30930,improves,0,0
30931,blood,0,0
30932,glucose,0,0
30933,control,0,0
30934,and,0,0
30935,decreases,0,0
30936,insulin,0,0
30937,requirements,0,0
30938,during,0,0
30939,ophthalmic,0,1
30940,surgery,0,1
30941,.,0,1
30942,Multiple,0,0
30943,risk,0,0
30944,factor,0,0
30945,intervention,0,0
30946,reduces,0,0
30947,cardiovascular,0,0
30948,risk,0,0
30949,in,0,0
30950,hypertensive,1,1
30951,patients,1,1
30952,with,1,1
30953,echolucent,1,1
30954,plaques,1,1
30955,in,1,0
30956,the,1,0
30957,carotid,1,1
30958,artery,1,1
30959,.,1,0
30960,OBJECTIVE,0,0
30961,In,0,0
30962,a,0,0
30963,previously,0,0
30964,published,0,0
30965,randomized,0,0
30966,6-year,0,0
30967,study,0,0
30968,we,0,0
30969,observed,0,0
30970,that,0,0
30971,multiple,0,0
30972,risk,0,0
30973,factor,0,0
30974,intervention,0,0
30975,reduced,0,0
30976,cardiovascular,0,0
30977,risk,0,0
30978,in,0,0
30979,high-risk,1,1
30980,hypertensive,1,1
30981,men,1,1
30982,",",0,0
30983,and,0,0
30984,that,0,0
30985,this,0,0
30986,effect,0,0
30987,was,0,0
30988,confined,0,0
30989,to,0,0
30990,patients,1,1
30991,with,1,1
30992,carotid,1,1
30993,artery,1,1
30994,plaques,1,1
30995,.,1,0
30996,Hypothetically,0,0
30997,",",0,0
30998,the,0,0
30999,underlying,0,0
31000,mechanism,0,0
31001,might,0,0
31002,have,0,0
31003,been,0,0
31004,a,0,0
31005,stabilization,0,0
31006,of,0,0
31007,echolucent,0,1
31008,",",0,0
31009,instable,0,1
31010,",",0,0
31011,rupture-prone,0,1
31012,plaques,0,1
31013,.,0,1
31014,The,0,0
31015,aim,0,0
31016,of,0,0
31017,the,0,0
31018,present,0,0
31019,study,0,0
31020,was,0,0
31021,to,0,0
31022,examine,0,0
31023,plaque,0,0
31024,characteristics,0,0
31025,by,0,0
31026,B-mode,0,1
31027,ultrasound,0,0
31028,in,0,0
31029,the,0,0
31030,previous,0,0
31031,intervention,0,0
31032,study,0,0
31033,",",0,0
31034,and,0,0
31035,also,0,0
31036,to,0,0
31037,investigate,0,0
31038,the,0,0
31039,relationship,0,0
31040,between,0,0
31041,plaque,0,0
31042,characteristics,0,0
31043,at,0,0
31044,baseline,0,0
31045,and,0,0
31046,cardiovascular,0,1
31047,events,0,0
31048,during,0,0
31049,the,0,0
31050,6-year,0,0
31051,follow-up,0,0
31052,in,0,0
31053,the,0,0
31054,two,0,0
31055,randomization,0,1
31056,groups,0,0
31057,.,0,1
31058,METHODS,0,0
31059,High,0,0
31060,resolution,0,0
31061,B-mode,0,1
31062,ultrasound,0,0
31063,was,0,0
31064,used,0,0
31065,to,0,0
31066,characterize,0,0
31067,plaque,0,0
31068,echogenicity,0,0
31069,in,0,0
31070,four,0,1
31071,subgroups,0,0
31072,-,0,1
31073,dominantly,0,0
31074,echolucent,0,0
31075,",",0,0
31076,substantially,0,0
31077,echolucent,0,0
31078,",",0,0
31079,dominantly,0,0
31080,echogenic,0,0
31081,",",0,0
31082,and,0,0
31083,uniformly,0,0
31084,echogenic,0,1
31085,.,0,0
31086,RESULTS,0,0
31087,In,0,0
31088,the,0,0
31089,usual,1,0
31090,care,1,1
31091,group,1,0
31092,17,1,1
31093,of,1,0
31094,32,1,1
31095,(,1,1
31096,53,1,1
31097,%,1,0
31098,),1,0
31099,patients,1,1
31100,with,1,1
31101,echolucent,1,1
31102,plaques,1,1
31103,at,1,1
31104,baseline,1,0
31105,suffered,0,1
31106,from,0,0
31107,a,0,0
31108,combined,0,0
31109,end-point,0,0
31110,(,0,0
31111,any,0,0
31112,death,0,0
31113,or,0,0
31114,nonfatal,0,0
31115,myocardial,0,1
31116,infarction,0,1
31117,or,0,1
31118,nonfatal,0,0
31119,stroke,0,1
31120,),0,0
31121,during,0,0
31122,follow-up,0,0
31123,compared,0,0
31124,with,0,1
31125,seven,0,1
31126,of,0,0
31127,28,0,1
31128,(,0,1
31129,25,0,1
31130,%,0,0
31131,),0,0
31132,patients,0,1
31133,in,0,0
31134,the,0,0
31135,intervention,0,0
31136,group,0,0
31137,(,0,0
31138,P,0,0
31139,=,0,0
31140,0.036,0,0
31141,),0,0
31142,.,0,0
31143,The,0,0
31144,corresponding,0,0
31145,numbers,0,0
31146,in,0,1
31147,patients,0,1
31148,with,0,1
31149,echogenic,0,1
31150,plaques,0,1
31151,were,0,1
31152,n,0,1
31153,=,0,0
31154,4/13,0,0
31155,(,0,1
31156,31,0,1
31157,%,0,0
31158,),0,0
31159,and,0,0
31160,n,0,1
31161,=,0,0
31162,4/17,0,0
31163,(,0,0
31164,24,0,0
31165,%,0,0
31166,),0,0
31167,",",0,0
31168,respectively,0,0
31169,(,0,0
31170,NS,0,0
31171,),0,0
31172,.,0,0
31173,In,0,0
31174,the,0,0
31175,usual,0,0
31176,care,0,1
31177,group,0,0
31178,11,0,0
31179,of,0,0
31180,33,0,1
31181,(,0,1
31182,33,0,1
31183,%,0,0
31184,),0,0
31185,patients,0,1
31186,with,0,1
31187,no,0,0
31188,plaques,0,0
31189,suffered,0,1
31190,from,0,1
31191,a,0,0
31192,combined,0,0
31193,end-point,0,0
31194,during,0,0
31195,follow-up,0,0
31196,compared,0,0
31197,with,0,1
31198,11,0,0
31199,of,0,0
31200,30,0,1
31201,(,0,1
31202,37,0,1
31203,%,0,0
31204,),0,0
31205,in,0,0
31206,the,0,0
31207,intervention,0,0
31208,group,0,0
31209,.,0,0
31210,CONCLUSION,0,0
31211,Our,0,0
31212,data,0,0
31213,indicate,0,0
31214,that,0,0
31215,the,0,0
31216,beneficial,0,0
31217,effect,0,0
31218,of,0,0
31219,the,0,0
31220,multiple,0,0
31221,risk,0,0
31222,intervention,0,0
31223,programme,0,0
31224,was,0,0
31225,confined,0,0
31226,to,0,0
31227,those,0,0
31228,patients,0,1
31229,with,0,1
31230,echolucent,0,1
31231,plaques,0,1
31232,.,0,1
31233,The,0,0
31234,data,0,0
31235,have,0,0
31236,to,0,0
31237,be,0,0
31238,confirmed,0,0
31239,with,0,0
31240,a,0,0
31241,large-scale,0,0
31242,trial,0,0
31243,.,0,1
31244,Effect,0,0
31245,of,0,0
31246,postural,0,0
31247,supports,0,0
31248,on,0,0
31249,neuromotor,0,1
31250,function,0,0
31251,in,0,0
31252,very,1,0
31253,preterm,1,1
31254,infants,1,1
31255,to,1,0
31256,term,1,1
31257,equivalent,1,0
31258,age,1,1
31259,.,1,0
31260,OBJECTIVE,0,0
31261,To,0,0
31262,determine,0,0
31263,the,0,0
31264,effect,0,0
31265,of,0,0
31266,a,0,0
31267,postural,0,0
31268,support,0,0
31269,nappy,0,0
31270,and/or,0,0
31271,a,0,0
31272,postural,0,0
31273,support,0,0
31274,roll,0,0
31275,on,0,0
31276,neuromotor,1,1
31277,function,1,0
31278,in,1,0
31279,very,1,0
31280,preterm,1,1
31281,infants,1,1
31282,when,0,0
31283,nursed,0,1
31284,prone,0,0
31285,to,0,0
31286,term,0,0
31287,equivalent,0,0
31288,age,0,1
31289,.,0,1
31290,METHODS,0,0
31291,A,0,0
31292,randomized,0,0
31293,observer,0,0
31294,blind,0,1
31295,controlled,0,0
31296,trial,0,0
31297,of,0,0
31298,123,1,1
31299,very,1,0
31300,preterm,1,1
31301,infants,1,1
31302,was,1,0
31303,conducted,1,0
31304,in,1,0
31305,the,1,0
31306,neonatal,1,1
31307,intensive,1,0
31308,care,1,1
31309,unit,1,0
31310,of,1,0
31311,the,1,0
31312,sole,1,0
31313,tertiary,1,1
31314,referral,1,1
31315,centre,1,1
31316,in,1,0
31317,Western,1,1
31318,Australia,1,1
31319,.,1,1
31320,Infants,1,1
31321,were,1,0
31322,stratified,1,1
31323,by,1,0
31324,gestational,1,1
31325,age,1,1
31326,(,1,1
31327,<,1,0
31328,29,1,1
31329,weeks,1,0
31330,or,1,1
31331,29-30,1,1
31332,weeks,1,0
31333,),1,0
31334,",",0,0
31335,then,0,0
31336,randomized,0,0
31337,into,0,0
31338,one,0,1
31339,of,0,0
31340,three,0,0
31341,intervention,0,1
31342,groups,0,0
31343,:,0,1
31344,postural,0,0
31345,support,0,0
31346,nappy,0,0
31347,",",0,0
31348,postural,0,0
31349,support,0,0
31350,nappy,0,0
31351,and,0,0
31352,postural,0,0
31353,support,0,0
31354,roll,0,0
31355,",",0,0
31356,or,0,0
31357,disposable,0,0
31358,nappy,0,0
31359,and,0,0
31360,postural,0,0
31361,support,0,0
31362,roll,0,0
31363,.,0,1
31364,Interventions,0,0
31365,started,0,0
31366,when,0,0
31367,infants,0,1
31368,were,0,0
31369,stable,0,1
31370,and,0,0
31371,ceased,0,0
31372,when,0,0
31373,routine,0,0
31374,side-lying,0,0
31375,commenced,0,1
31376,.,0,0
31377,Measurements,0,0
31378,of,0,0
31379,shoulder,0,1
31380,and,0,0
31381,hip,0,1
31382,posture,0,0
31383,were,0,0
31384,performed,0,0
31385,pre-intervention,0,0
31386,",",0,0
31387,5,0,0
31388,weeks,0,0
31389,post-intervention,0,0
31390,and,0,0
31391,term,0,0
31392,postmenstrual,0,1
31393,age,0,1
31394,.,0,1
31395,RESULTS,0,0
31396,Infants,0,1
31397,nursed,0,1
31398,with,0,1
31399,a,0,0
31400,postural,0,0
31401,support,0,0
31402,roll,0,0
31403,and,0,0
31404,a,0,0
31405,postural,0,0
31406,support,0,0
31407,nappy,0,0
31408,demonstrated,0,0
31409,improved,0,0
31410,hip,0,1
31411,posture,0,0
31412,to,0,0
31413,term,0,0
31414,equivalent,0,0
31415,age,0,1
31416,compared,0,0
31417,with,0,1
31418,infants,0,1
31419,nursed,0,1
31420,with,0,1
31421,either,0,0
31422,a,0,0
31423,postural,0,0
31424,support,0,0
31425,roll,0,0
31426,only,0,0
31427,",",0,0
31428,or,0,0
31429,a,0,0
31430,postural,0,0
31431,support,0,0
31432,nappy,0,0
31433,only,0,0
31434,.,0,1
31435,Infants,0,1
31436,nursed,0,0
31437,with,0,1
31438,a,0,0
31439,postural,0,0
31440,support,0,0
31441,roll,0,0
31442,either,0,0
31443,with,0,0
31444,or,0,0
31445,without,0,1
31446,a,0,0
31447,postural,0,0
31448,support,0,0
31449,nappy,0,0
31450,demonstrated,0,0
31451,improved,0,0
31452,shoulder,0,1
31453,posture,0,0
31454,to,0,0
31455,term,0,0
31456,equivalent,0,0
31457,age,0,1
31458,.,0,1
31459,CONCLUSIONS,0,0
31460,Combined,0,0
31461,use,0,0
31462,of,0,0
31463,a,0,0
31464,postural,0,0
31465,support,0,0
31466,roll,0,0
31467,and,0,0
31468,a,0,0
31469,postural,0,0
31470,support,0,0
31471,nappy,0,0
31472,while,0,0
31473,very,0,0
31474,preterm,0,1
31475,infants,0,1
31476,are,0,0
31477,nursed,0,1
31478,prone,0,0
31479,improves,0,0
31480,hip,0,1
31481,posture,0,0
31482,up,0,0
31483,to,0,0
31484,term,0,1
31485,postmenstrual,0,1
31486,age,0,1
31487,.,0,0
31488,Use,0,0
31489,of,0,0
31490,a,0,0
31491,postural,0,0
31492,support,0,0
31493,roll,0,0
31494,improves,0,0
31495,shoulder,0,0
31496,posture,0,0
31497,up,0,0
31498,to,0,0
31499,term,0,1
31500,equivalent,0,0
31501,age,0,1
31502,.,0,1
31503,Comparative,0,0
31504,clinical,0,0
31505,and,0,1
31506,microbiological,0,0
31507,effects,0,0
31508,of,0,1
31509,subgingival,0,1
31510,metronidazole,0,0
31511,application,0,0
31512,in,0,0
31513,adult,1,1
31514,periodontitis,1,1
31515,;,1,0
31516,12-months,0,0
31517,results,0,0
31518,.,0,1
31519,The,0,0
31520,aim,0,0
31521,of,0,0
31522,the,0,0
31523,present,0,0
31524,study,0,0
31525,was,0,0
31526,to,0,0
31527,evaluate,0,0
31528,the,0,0
31529,clinical,0,0
31530,and,0,0
31531,microbiological,0,0
31532,effects,0,0
31533,of,0,0
31534,subgingival,0,0
31535,application,0,0
31536,of,0,0
31537,25,0,1
31538,%,0,0
31539,metronidazole,0,0
31540,dental,0,1
31541,gel,0,0
31542,as,0,0
31543,an,0,0
31544,adjunct,0,0
31545,to,0,0
31546,scaling,0,0
31547,and,0,0
31548,root,0,0
31549,planing,0,0
31550,(,0,0
31551,SRP,0,0
31552,),0,0
31553,in,0,0
31554,the,0,0
31555,treatment,0,0
31556,of,0,0
31557,adult,1,1
31558,periodontitis,1,1
31559,.,1,0
31560,Eighty,1,0
31561,teeth,1,1
31562,in,1,0
31563,18,1,1
31564,patients,1,1
31565,were,0,1
31566,evaluated,0,0
31567,using,0,0
31568,a,0,0
31569,split,0,0
31570,mouth,0,0
31571,design,0,0
31572,.,0,0
31573,The,0,0
31574,test,0,0
31575,teeth,0,1
31576,received,0,0
31577,SRP,0,0
31578,and,0,0
31579,a,0,0
31580,25,0,0
31581,%,0,0
31582,metronidazole,0,0
31583,gel,0,0
31584,applied,0,0
31585,subgingivally,0,0
31586,on,0,0
31587,days,0,0
31588,0,0,0
31589,and,0,1
31590,7,0,1
31591,.,0,0
31592,The,0,0
31593,control,0,0
31594,teeth,0,1
31595,received,0,0
31596,SRP,0,0
31597,only,0,0
31598,.,0,0
31599,Clinical,0,0
31600,and,0,0
31601,microbiological,0,0
31602,examinations,0,0
31603,were,0,1
31604,carried,0,0
31605,out,0,0
31606,before,0,0
31607,treatment,0,0
31608,and,0,0
31609,on,0,0
31610,weeks,0,0
31611,1,0,1
31612,",",0,0
31613,3,0,0
31614,",",0,0
31615,7,0,0
31616,",",0,0
31617,13,0,1
31618,",",0,0
31619,26,0,1
31620,",",0,0
31621,38,0,1
31622,and,0,0
31623,52,0,1
31624,of,0,0
31625,the,0,0
31626,experimental,0,0
31627,period,0,0
31628,.,0,1
31629,Colony,0,0
31630,forming,0,0
31631,units,0,0
31632,of,0,0
31633,Porphyromonas,0,0
31634,gingivalis,0,0
31635,and,0,0
31636,Prevotella,0,0
31637,intermedia,0,1
31638,/,0,0
31639,Prevotella,0,0
31640,nigrescens,0,1
31641,were,0,1
31642,determined,0,0
31643,.,0,0
31644,Both,0,0
31645,treatments,0,0
31646,provided,0,0
31647,significant,0,0
31648,improvements,0,0
31649,in,0,0
31650,all,0,0
31651,the,0,0
31652,clinical,0,0
31653,and,0,0
31654,microbiological,0,0
31655,parameters,0,0
31656,(,0,1
31657,P,0,0
31658,<,0,0
31659,0.05,0,0
31660,),0,0
31661,.,0,0
31662,However,0,0
31663,",",0,0
31664,none,0,0
31665,of,0,0
31666,the,0,0
31667,differences,0,0
31668,between,0,0
31669,the,0,0
31670,study,0,0
31671,groups,0,0
31672,were,0,0
31673,statistically,0,0
31674,significant,0,0
31675,(,0,0
31676,P,0,0
31677,>,0,1
31678,0.05,0,0
31679,),0,0
31680,.,0,0
31681,As,0,0
31682,a,0,0
31683,conclusion,0,0
31684,",",0,0
31685,the,0,0
31686,present,0,0
31687,study,0,0
31688,does,0,0
31689,not,0,0
31690,provide,0,0
31691,evidence,0,0
31692,in,0,0
31693,favour,0,0
31694,of,0,0
31695,the,0,0
31696,routine,0,0
31697,use,0,0
31698,of,0,0
31699,adjunctive,0,0
31700,metronidazole,0,0
31701,dental,0,1
31702,gel,0,0
31703,in,0,0
31704,the,0,0
31705,treatment,0,0
31706,of,0,0
31707,adult,1,1
31708,periodontitis,1,1
31709,.,1,1
31710,A,0,0
31711,single,0,0
31712,nasal,0,0
31713,allergen,0,0
31714,challenge,0,0
31715,increases,0,0
31716,induced,0,0
31717,sputum,0,0
31718,inflammatory,0,0
31719,markers,0,0
31720,in,0,1
31721,non-asthmatic,1,1
31722,subjects,1,1
31723,with,1,1
31724,seasonal,1,1
31725,allergic,1,1
31726,rhinitis,1,1
31727,:,1,1
31728,correlation,0,0
31729,with,0,1
31730,plasma,0,0
31731,interleukin-5,0,0
31732,.,0,1
31733,BACKGROUND,0,0
31734,Seasonal,0,0
31735,allergic,0,1
31736,rhinitis,0,1
31737,(,0,0
31738,SAR,0,0
31739,),0,0
31740,is,0,0
31741,a,0,0
31742,risk,1,0
31743,factor,1,0
31744,for,1,0
31745,asthma,1,1
31746,in,1,0
31747,affected,1,0
31748,individuals,1,1
31749,.,1,1
31750,Nasal,0,0
31751,allergic,0,1
31752,inflammation,0,0
31753,enhances,0,0
31754,bone-marrow,0,0
31755,eosinophil,0,0
31756,production,0,0
31757,",",0,0
31758,mainly,0,0
31759,via,0,0
31760,IL-5,0,0
31761,",",0,0
31762,and,0,0
31763,rhinitis,0,1
31764,patients,0,1
31765,have,0,0
31766,increased,0,0
31767,airway,0,1
31768,inflammation,0,0
31769,during,0,0
31770,the,0,0
31771,pollen,0,0
31772,season,0,0
31773,.,0,0
31774,OBJECTIVE,0,0
31775,To,0,0
31776,assess,0,0
31777,the,0,0
31778,impact,0,0
31779,of,0,0
31780,nasal,0,0
31781,allergy,0,1
31782,on,0,0
31783,sputum,0,0
31784,inflammatory,0,0
31785,markers,0,0
31786,.,0,1
31787,METHODS,0,0
31788,In,0,0
31789,an,0,0
31790,open-labelled,0,0
31791,",",0,0
31792,randomized,0,0
31793,",",0,0
31794,placebo-controlled,0,0
31795,cross-over,0,0
31796,study,0,0
31797,with,0,1
31798,16,1,1
31799,non-asthmatic,1,1
31800,SAR,1,0
31801,patients,1,1
31802,(,1,1
31803,median,1,1
31804,age,1,1
31805,25,1,1
31806,years,1,1
31807,",",1,1
31808,56,1,1
31809,%,1,0
31810,males,1,1
31811,),1,0
31812,",",0,0
31813,the,0,0
31814,effect,0,0
31815,of,0,0
31816,a,0,0
31817,single,0,0
31818,nasal,0,0
31819,allergen,0,0
31820,challenge,0,0
31821,performed,0,0
31822,out,0,0
31823,of,0,0
31824,season,0,0
31825,on,0,0
31826,induced,0,0
31827,sputum,0,0
31828,inflammatory,0,0
31829,parameters,0,0
31830,was,0,0
31831,evaluated,0,0
31832,.,0,1
31833,SAR,1,0
31834,patients,1,1
31835,were,1,1
31836,identified,1,0
31837,by,1,0
31838,history,1,1
31839,",",1,0
31840,skin-prick,1,0
31841,test,1,0
31842,and,1,0
31843,specific,1,0
31844,IgE,1,1
31845,.,1,1
31846,All,1,0
31847,patients,1,1
31848,had,1,1
31849,normal,1,1
31850,lung,1,1
31851,function/bronchial,1,0
31852,hyper-responsiveness,1,0
31853,out,1,0
31854,of,1,0
31855,season,1,0
31856,and,1,0
31857,a,1,0
31858,negative,1,0
31859,asthma/wheezing,1,1
31860,history,1,1
31861,.,1,1
31862,Sputum,0,1
31863,cells,0,0
31864,and,0,1
31865,supernatant,0,0
31866,levels,0,0
31867,of,0,0
31868,ECP,0,0
31869,",",0,0
31870,sICAM,0,0
31871,",",0,0
31872,IL-5,0,0
31873,and,0,0
31874,IL-10,0,0
31875,",",0,0
31876,and,0,0
31877,plasma,0,0
31878,levels,0,0
31879,of,0,0
31880,IL-5,0,0
31881,and,0,0
31882,ECP,0,0
31883,",",0,0
31884,were,0,0
31885,measured,0,0
31886,before,0,0
31887,and,0,0
31888,24,0,0
31889,h,0,0
31890,after,0,0
31891,nasal,0,0
31892,allergen,0,0
31893,challenge,0,0
31894,.,0,0
31895,After,0,0
31896,a,0,0
31897,washout,0,0
31898,period,0,0
31899,of,0,0
31900,at,0,0
31901,least,0,1
31902,4,0,0
31903,weeks,0,0
31904,",",0,0
31905,the,0,0
31906,procedure,0,0
31907,was,0,0
31908,repeated,0,0
31909,with,0,1
31910,placebo,0,0
31911,challenge,0,0
31912,(,0,0
31913,diluent,0,0
31914,),0,0
31915,.,0,1
31916,RESULTS,0,0
31917,Nasal,0,0
31918,allergen,0,0
31919,challenge,0,0
31920,led,0,0
31921,to,0,0
31922,an,0,0
31923,increase,0,0
31924,in,0,0
31925,sputum,0,0
31926,ECP,0,0
31927,(,0,0
31928,pre,0,0
31929,=,0,0
31930,60,0,1
31931,+/-,0,0
31932,12,0,0
31933,",",0,0
31934,post,0,0
31935,=,0,0
31936,212,0,1
31937,+/-,0,0
31938,63,0,1
31939,micro,0,0
31940,g/L,0,0
31941,",",0,0
31942,P,0,0
31943,=,0,0
31944,0.02,0,0
31945,vs.,0,0
31946,placebo,0,0
31947,),0,0
31948,",",0,0
31949,and,0,0
31950,sICAM,0,0
31951,(,0,0
31952,4.8,0,0
31953,+/-,0,0
31954,2.7,0,0
31955,to,0,1
31956,6.5,0,0
31957,+/-,0,0
31958,2.9,0,0
31959,ng/mL,0,0
31960,",",0,0
31961,P,0,0
31962,=,0,0
31963,0.02,0,0
31964,vs.,0,0
31965,placebo,0,0
31966,),0,0
31967,",",0,0
31968,whereas,0,0
31969,IL-10,0,0
31970,decreased,0,0
31971,after,0,0
31972,provocation,0,0
31973,(,0,0
31974,44,0,1
31975,+/-,0,0
31976,11,0,1
31977,to,0,1
31978,29,0,1
31979,+/-,0,0
31980,6,0,0
31981,pg/mL,0,0
31982,",",0,0
31983,P,0,0
31984,=,0,0
31985,0.06,0,0
31986,vs.,0,0
31987,placebo,0,0
31988,),0,0
31989,.,0,1
31990,Sputum,0,1
31991,IL-5,0,0
31992,was,0,0
31993,undetectable,0,0
31994,in,0,0
31995,all,0,1
31996,patients,0,1
31997,.,0,0
31998,The,0,0
31999,absolute,0,0
32000,number,0,0
32001,of,0,0
32002,blood,0,0
32003,and,0,0
32004,sputum,0,0
32005,eosinophils,0,0
32006,did,0,0
32007,not,0,0
32008,change,0,0
32009,significantly,0,0
32010,after,0,0
32011,allergen,0,0
32012,or,0,1
32013,placebo,0,0
32014,challenge,0,0
32015,(,0,0
32016,P,0,0
32017,>,0,1
32018,0.07,0,0
32019,",",0,0
32020,both,0,0
32021,comparisons,0,0
32022,),0,0
32023,.,0,1
32024,Plasma,0,0
32025,levels,0,0
32026,of,0,0
32027,IL-5,0,0
32028,increased,0,0
32029,after,0,0
32030,allergen,0,0
32031,challenge,0,0
32032,(,0,0
32033,8.7,0,0
32034,+/-,0,0
32035,2.9,0,0
32036,to,0,1
32037,14.5,0,0
32038,+/-,0,0
32039,3.9,0,0
32040,pg/mL,0,0
32041,",",0,0
32042,P,0,0
32043,=,0,0
32044,0.001,0,0
32045,),0,0
32046,",",0,0
32047,and,0,0
32048,the,0,0
32049,increase,0,0
32050,in,0,0
32051,plasma,0,0
32052,IL-5,0,0
32053,was,0,0
32054,positively,0,0
32055,correlated,0,0
32056,with,0,0
32057,the,0,0
32058,rise,0,0
32059,in,0,0
32060,sputum,0,0
32061,ECP,0,0
32062,in,0,0
32063,a,0,0
32064,subgroup,0,1
32065,of,0,0
32066,'responders,0,0
32067,',0,1
32068,(,0,0
32069,n,0,1
32070,=,0,0
32071,12,0,0
32072,",",0,0
32073,r,0,0
32074,=,0,0
32075,0.71,0,0
32076,",",0,0
32077,P,0,0
32078,=,0,0
32079,0.01,0,0
32080,),0,0
32081,.,0,0
32082,CONCLUSIONS,0,0
32083,A,0,0
32084,single,0,0
32085,nasal,0,0
32086,allergen,0,0
32087,challenge,0,0
32088,in,0,0
32089,SAR,1,0
32090,patients,1,1
32091,increased,0,0
32092,markers,0,0
32093,of,0,0
32094,allergic,0,1
32095,inflammation,0,0
32096,in,0,0
32097,the,0,0
32098,lower,0,0
32099,respiratory,0,0
32100,tract,0,0
32101,",",0,0
32102,possibly,0,0
32103,via,0,0
32104,pronounced,0,0
32105,activation,0,0
32106,of,0,0
32107,inflammatory,0,0
32108,cells,0,0
32109,through,0,0
32110,circulating,0,0
32111,immediate-type,0,1
32112,reaction,0,1
32113,cytokines,0,0
32114,like,0,0
32115,IL-5,0,0
32116,.,0,1
32117,These,0,0
32118,findings,0,0
32119,may,0,0
32120,provide,0,0
32121,additional,0,0
32122,explanatory,0,0
32123,data,0,0
32124,for,0,0
32125,the,0,0
32126,high,0,0
32127,susceptibility,0,0
32128,of,0,0
32129,SAR,1,0
32130,patients,1,1
32131,to,0,0
32132,incident,0,1
32133,asthma,0,1
32134,.,0,0
32135,Conscious,0,0
32136,analgesia/sedation,0,1
32137,with,0,1
32138,remifentanil,0,0
32139,and,0,0
32140,propofol,0,0
32141,versus,0,0
32142,total,0,1
32143,intravenous,0,0
32144,anesthesia,0,1
32145,with,0,1
32146,fentanyl,0,0
32147,",",0,0
32148,midazolam,0,0
32149,",",0,0
32150,and,0,0
32151,propofol,0,0
32152,for,0,0
32153,outpatient,1,1
32154,colonoscopy,1,1
32155,.,1,1
32156,BACKGROUND,0,0
32157,This,0,0
32158,study,0,0
32159,tested,0,0
32160,the,0,0
32161,hypothesis,0,0
32162,that,0,0
32163,",",0,0
32164,for,0,0
32165,colonoscopy,0,0
32166,",",0,0
32167,analgesia/sedation,0,0
32168,with,0,1
32169,remifentanil,0,0
32170,and,0,0
32171,propofol,0,0
32172,might,0,0
32173,be,0,0
32174,more,0,0
32175,effective,0,0
32176,compared,0,0
32177,with,0,1
32178,anesthesia,0,1
32179,by,0,0
32180,intravenous,0,0
32181,administration,0,0
32182,of,0,0
32183,midazolam,0,0
32184,",",0,0
32185,fentanyl,0,0
32186,",",0,0
32187,and,0,0
32188,propofol,0,0
32189,.,0,0
32190,METHODS,0,0
32191,In,0,0
32192,a,0,0
32193,prospective,0,0
32194,",",0,0
32195,randomized,0,0
32196,trial,0,0
32197,",",0,0
32198,100,1,0
32199,adult,1,1
32200,patients,1,1
32201,received,0,0
32202,either,0,0
32203,conscious,0,0
32204,analgesia/sedation,0,0
32205,(,1,0
32206,Sedation,1,0
32207,group,1,1
32208,),1,0
32209,or,0,1
32210,total,0,1
32211,intravenous,0,0
32212,anesthesia,0,1
32213,(,1,0
32214,TIVA,1,0
32215,group,1,1
32216,),1,0
32217,.,0,0
32218,Analgesia/sedation,0,0
32219,was,0,0
32220,achieved,0,0
32221,by,0,0
32222,infusion,0,0
32223,of,0,0
32224,remifentanil,0,0
32225,(,0,0
32226,0.20,0,0
32227,to,0,0
32228,0.25,0,0
32229,microg/kg/min,0,0
32230,),0,0
32231,and,0,0
32232,propofol,0,0
32233,in,0,0
32234,titrated,0,0
32235,doses,0,0
32236,.,0,1
32237,TIVA,0,0
32238,was,0,0
32239,induced,0,0
32240,by,0,0
32241,intravenous,0,0
32242,administration,0,0
32243,of,0,0
32244,fentanyl,0,0
32245,(,0,0
32246,2,0,0
32247,microg/kg,0,0
32248,),0,0
32249,",",0,0
32250,midazolam,0,0
32251,(,0,0
32252,0.05,0,0
32253,mg/kg,0,0
32254,),0,0
32255,and,0,0
32256,propofol,0,0
32257,(,0,0
32258,dosage,0,0
32259,titrated,0,0
32260,),0,0
32261,.,0,1
32262,Cardiorespiratory,0,0
32263,parameters,0,0
32264,and,0,1
32265,bispectral,0,0
32266,index,0,0
32267,were,0,0
32268,monitored,0,0
32269,and,0,0
32270,recorded,0,0
32271,.,0,0
32272,The,0,0
32273,quality,0,0
32274,of,0,0
32275,the,0,0
32276,analgesia,0,0
32277,was,0,0
32278,assessed,0,0
32279,with,0,1
32280,a,0,0
32281,Numerical,0,0
32282,Pain,0,0
32283,Rating,0,0
32284,Scale,0,0
32285,(,0,0
32286,NRS,0,0
32287,),0,1
32288,;,0,0
32289,recovery,0,0
32290,level,0,0
32291,and,0,0
32292,return,0,0
32293,of,0,0
32294,psychomotor,0,0
32295,efficiency,0,0
32296,were,0,0
32297,evaluated,0,0
32298,with,0,0
32299,",",0,0
32300,respectively,0,0
32301,",",0,0
32302,the,0,0
32303,Aldrete,0,0
32304,scale,0,0
32305,and,0,0
32306,a,0,0
32307,Modified,0,0
32308,Post,0,1
32309,Anesthesia,0,0
32310,Discharge,0,0
32311,Scoring,0,0
32312,(,0,0
32313,MPADS,0,0
32314,),0,0
32315,system,0,0
32316,.,0,0
32317,RESULTS,0,0
32318,Both,1,0
32319,groups,1,0
32320,of,1,0
32321,50,1,1
32322,patients,1,1
32323,were,1,1
32324,comparable,1,0
32325,with,1,1
32326,respect,1,0
32327,to,1,0
32328,demographic,1,0
32329,data,1,0
32330,",",1,0
32331,initial,1,0
32332,parameters,1,0
32333,",",1,0
32334,and,1,0
32335,duration,1,0
32336,of,1,0
32337,colonoscopy,1,1
32338,.,1,0
32339,All,0,0
32340,patients,0,1
32341,in,0,0
32342,the,0,0
32343,TIVA,0,0
32344,group,0,0
32345,found,0,0
32346,the,0,0
32347,colonoscopy,0,0
32348,painless,0,1
32349,(,0,0
32350,NRS,0,0
32351,score,0,0
32352,0,0,0
32353,),0,0
32354,.,0,0
32355,In,0,0
32356,the,0,0
32357,Sedation,0,0
32358,group,0,0
32359,",",0,0
32360,the,0,0
32361,average,0,0
32362,pain,0,0
32363,intensity,0,0
32364,score,0,0
32365,was,0,0
32366,0.4,0,0
32367,(,0,1
32368,0.8,0,1
32369,),0,0
32370,.,0,0
32371,There,0,0
32372,was,0,0
32373,a,0,0
32374,marked,0,0
32375,difference,0,0
32376,between,0,0
32377,the,0,0
32378,Sedation,0,0
32379,and,0,0
32380,TIVA,0,0
32381,groups,0,0
32382,with,0,1
32383,respect,0,0
32384,to,0,0
32385,the,0,0
32386,time,0,0
32387,from,0,0
32388,the,0,0
32389,end,0,0
32390,of,0,0
32391,the,0,0
32392,procedure,0,0
32393,until,0,0
32394,the,0,0
32395,maximum,0,0
32396,MPADS,0,0
32397,score,0,0
32398,was,0,0
32399,reached,0,0
32400,:,0,1
32401,respectively,0,0
32402,",",0,0
32403,-6.9,0,0
32404,(,0,0
32405,4.0,0,0
32406,),0,1
32407,versus,0,0
32408,25.7,0,0
32409,(,0,0
32410,8.4,0,0
32411,),0,1
32412,minutes,0,0
32413,(,0,1
32414,p,0,0
32415,<,0,0
32416,0.001,0,0
32417,),0,0
32418,.,0,0
32419,In,0,0
32420,the,0,0
32421,TIVA,0,0
32422,group,0,0
32423,",",0,0
32424,changes,0,0
32425,in,0,0
32426,mean,0,1
32427,arterial,0,1
32428,pressure,0,0
32429,and,0,0
32430,heart,0,1
32431,rate,0,0
32432,and,0,0
32433,signs,0,0
32434,of,0,0
32435,respiratory,0,1
32436,depression,0,1
32437,were,0,0
32438,significant,0,0
32439,(,0,1
32440,p,0,0
32441,<,0,0
32442,0.05,0,0
32443,),0,1
32444,.,0,1
32445,CONCLUSIONS,0,0
32446,Combined,0,0
32447,administration,0,0
32448,of,0,0
32449,remifentanil,0,0
32450,and,0,0
32451,propofol,0,0
32452,for,0,0
32453,colonoscopy,0,0
32454,provides,0,0
32455,sufficient,0,0
32456,analgesia,0,0
32457,",",0,0
32458,satisfactory,0,0
32459,hemodynamic,0,0
32460,stability,0,0
32461,",",0,0
32462,minor,0,0
32463,respiratory,0,1
32464,depression,0,1
32465,",",0,0
32466,and,0,0
32467,rapid,0,0
32468,recovery,0,0
32469,",",0,0
32470,and,0,0
32471,allows,0,0
32472,patients,0,1
32473,to,0,0
32474,be,0,0
32475,discharged,0,1
32476,approximately,0,0
32477,15,0,1
32478,minutes,0,0
32479,after,0,0
32480,the,0,0
32481,procedure,0,0
32482,.,0,0
32483,Effects,0,0
32484,of,0,0
32485,ezetimibe,0,0
32486,",",0,0
32487,a,0,0
32488,new,0,0
32489,cholesterol,0,0
32490,absorption,0,0
32491,inhibitor,0,0
32492,",",0,0
32493,on,0,0
32494,plasma,0,0
32495,lipids,0,0
32496,in,0,1
32497,patients,1,1
32498,with,1,1
32499,primary,1,1
32500,hypercholesterolemia,1,1
32501,.,1,0
32502,AIMS,0,0
32503,This,0,0
32504,randomized,0,0
32505,",",0,0
32506,double-blind,0,0
32507,",",0,0
32508,placebo-controlled,0,0
32509,",",0,0
32510,parallel-group,0,0
32511,study,0,0
32512,evaluated,0,0
32513,the,0,0
32514,safety,0,0
32515,and,0,0
32516,efficacy,0,0
32517,of,0,0
32518,ezetimibe,0,0
32519,10,0,0
32520,mg/day,0,0
32521,in,0,0
32522,patients,1,1
32523,with,1,1
32524,primary,1,1
32525,hypercholesterolemia,1,1
32526,.,1,1
32527,METHODS,0,0
32528,AND,0,0
32529,RESULTS,0,0
32530,Following,0,0
32531,dietary,0,0
32532,stabilization,0,0
32533,",",0,0
32534,a,0,0
32535,2-12-week,0,0
32536,washout,0,0
32537,period,0,0
32538,",",0,0
32539,and,0,0
32540,a,0,0
32541,4-week,0,0
32542,",",0,0
32543,single-blind,0,0
32544,",",0,0
32545,placebo,0,0
32546,lead-in,0,0
32547,period,0,0
32548,",",0,0
32549,827,1,1
32550,patients,1,1
32551,with,1,1
32552,baseline,1,0
32553,low-density,1,0
32554,lipoprotein,1,0
32555,cholesterol,1,0
32556,(,1,0
32557,LDL-C,1,1
32558,),1,0
32559,>,1,1
32560,or,1,0
32561,=3.36,1,0
32562,mmol/l,1,0
32563,(,1,0
32564,130,1,1
32565,mg/dl,1,0
32566,),1,0
32567,to,1,0
32568,<,1,0
32569,or,1,0
32570,=6.47,1,0
32571,mmol/l,1,0
32572,(,1,0
32573,250,1,0
32574,mg/dl,1,0
32575,),1,0
32576,and,1,0
32577,triglycerides,1,0
32578,<,1,0
32579,or,1,0
32580,=3.95,1,0
32581,mmol/l,1,0
32582,(,1,0
32583,350,1,1
32584,mg/dl,1,0
32585,),1,0
32586,were,0,0
32587,randomized,0,1
32588,3:1,0,1
32589,to,0,0
32590,receive,0,0
32591,ezetimibe,0,0
32592,10,0,0
32593,mg,0,0
32594,or,0,0
32595,placebo,0,0
32596,orally,0,0
32597,once,0,0
32598,daily,0,0
32599,in,0,0
32600,the,0,0
32601,morning,0,0
32602,for,0,0
32603,12,0,1
32604,weeks,0,0
32605,.,0,1
32606,The,0,0
32607,primary,0,0
32608,efficacy,0,0
32609,endpoint,0,0
32610,was,0,0
32611,percentage,0,0
32612,reduction,0,0
32613,in,0,0
32614,direct,0,0
32615,plasma,0,0
32616,LDL-C.,0,1
32617,Ezetimibe,0,1
32618,reduced,0,0
32619,direct,0,0
32620,LDL-C,0,1
32621,by,0,0
32622,a,0,0
32623,mean,0,0
32624,of,0,0
32625,17.7,0,0
32626,%,0,0
32627,from,0,0
32628,baseline,0,0
32629,to,0,0
32630,endpoint,0,0
32631,",",0,0
32632,compared,0,0
32633,with,0,0
32634,an,0,0
32635,increase,0,0
32636,of,0,0
32637,0.8,0,0
32638,%,0,0
32639,with,0,1
32640,placebo,0,0
32641,(,0,0
32642,P,0,0
32643,<,0,0
32644,0.01,0,0
32645,),0,0
32646,.,0,0
32647,Response,0,0
32648,to,0,0
32649,ezetimibe,0,0
32650,was,0,0
32651,generally,0,0
32652,consistent,0,0
32653,across,0,0
32654,all,0,1
32655,subgroups,0,0
32656,analyzed,0,0
32657,.,0,1
32658,Ezetimibe,0,0
32659,also,0,0
32660,significantly,0,0
32661,improved,0,0
32662,levels,0,0
32663,of,0,0
32664,plasma,0,0
32665,total,0,1
32666,cholesterol,0,0
32667,",",0,0
32668,apolipoprotein,0,0
32669,B,0,0
32670,",",0,0
32671,high-density,0,0
32672,lipoprotein,0,0
32673,(,0,0
32674,2,0,0
32675,),0,0
32676,-cholesterol,0,0
32677,and,0,0
32678,lipoprotein,0,0
32679,(,0,0
32680,a,0,0
32681,),0,0
32682,",",0,0
32683,and,0,0
32684,elicited,0,0
32685,a,0,0
32686,trend,0,0
32687,toward,0,0
32688,lower,0,0
32689,triglyceride,0,0
32690,levels,0,0
32691,.,0,1
32692,Ezetimibe,0,0
32693,did,0,0
32694,not,0,0
32695,alter,0,0
32696,the,0,0
32697,serum,0,0
32698,concentrations,0,0
32699,of,0,0
32700,lipid-soluble,0,0
32701,vitamins,0,0
32702,or,0,1
32703,significantly,0,0
32704,affect,0,0
32705,baseline,0,0
32706,or,0,1
32707,stimulated,0,0
32708,cortisol,0,0
32709,production,0,0
32710,.,0,1
32711,Ezetimibe,0,0
32712,was,0,0
32713,well,0,0
32714,tolerated,0,0
32715,",",0,0
32716,with,0,0
32717,a,0,0
32718,safety,0,0
32719,profile,0,0
32720,similar,0,0
32721,to,0,0
32722,that,0,0
32723,of,0,0
32724,placebo,0,0
32725,.,0,1
32726,CONCLUSIONS,0,0
32727,Ezetimibe,0,0
32728,",",0,0
32729,which,0,0
32730,significantly,0,0
32731,reduces,0,0
32732,LDL-C,0,0
32733,and,0,0
32734,favorably,0,0
32735,affects,0,0
32736,other,0,0
32737,lipid,0,0
32738,variables,0,0
32739,",",0,0
32740,may,0,0
32741,provide,0,0
32742,a,0,0
32743,well,0,0
32744,tolerated,0,0
32745,and,0,0
32746,effective,0,0
32747,new,0,0
32748,option,0,0
32749,for,0,0
32750,lipid,0,0
32751,management,0,1
32752,in,0,0
32753,the,0,0
32754,future,0,0
32755,.,0,0
32756,The,0,0
32757,utility,0,0
32758,of,0,0
32759,laparoscopy,0,1
32760,in,0,0
32761,the,0,0
32762,diagnosis,0,1
32763,of,0,0
32764,acute,1,1
32765,appendicitis,1,1
32766,in,1,0
32767,women,1,1
32768,of,1,0
32769,reproductive,1,1
32770,age,1,1
32771,.,1,1
32772,AIM,0,0
32773,To,0,0
32774,see,0,0
32775,whether,0,0
32776,laparoscopy,0,0
32777,improves,0,0
32778,the,0,0
32779,accuracy,0,0
32780,of,0,0
32781,a,0,0
32782,clinical,0,0
32783,diagnosis,0,1
32784,of,0,0
32785,acute,1,1
32786,appendicitis,1,1
32787,in,1,0
32788,women,1,1
32789,of,1,0
32790,reproductive,1,1
32791,age,1,1
32792,",",0,0
32793,and,0,0
32794,to,0,0
32795,determine,0,0
32796,what,0,0
32797,the,0,1
32798,long-term,0,1
32799,sequelae,0,0
32800,are,0,0
32801,of,0,0
32802,not,0,0
32803,removing,0,0
32804,an,0,0
32805,appendix,0,0
32806,deemed,0,0
32807,at,0,0
32808,laparoscopy,0,1
32809,to,0,0
32810,be,0,0
32811,normal,0,1
32812,.,0,0
32813,METHOD,0,0
32814,The,0,0
32815,initial,0,0
32816,part,0,0
32817,of,0,0
32818,the,0,0
32819,study,0,0
32820,was,0,0
32821,undertaken,0,0
32822,during,0,0
32823,1991-1992,1,1
32824,.,1,1
32825,Female,1,1
32826,patients,1,1
32827,between,1,0
32828,16,1,1
32829,and,1,1
32830,45,1,1
32831,years,1,1
32832,were,0,1
32833,eligible,0,1
32834,for,0,0
32835,inclusion,0,1
32836,once,0,0
32837,a,0,0
32838,clinical,0,0
32839,decision,0,0
32840,had,0,1
32841,been,0,0
32842,made,0,0
32843,to,0,0
32844,perform,0,0
32845,an,0,0
32846,appendicectomy,0,0
32847,for,0,0
32848,suspected,1,1
32849,acute,1,1
32850,appendicitis,1,1
32851,.,1,0
32852,Following,0,0
32853,consent,0,0
32854,",",0,0
32855,patients,0,1
32856,were,0,0
32857,randomized,0,1
32858,into,0,1
32859,two,0,0
32860,groups,0,1
32861,.,0,1
32862,One,0,1
32863,group,0,0
32864,had,0,1
32865,open,0,1
32866,appendicectomy,0,1
32867,",",0,0
32868,as,0,0
32869,planned,0,0
32870,.,0,0
32871,The,0,0
32872,other,0,0
32873,group,0,0
32874,had,0,0
32875,laparoscopy,0,1
32876,",",0,0
32877,followed,0,0
32878,by,0,0
32879,open,0,1
32880,appendicectomy,0,1
32881,only,0,0
32882,if,0,0
32883,the,0,0
32884,appendix,0,1
32885,was,0,0
32886,seen,0,0
32887,to,0,0
32888,be,0,0
32889,inflamed,0,1
32890,or,0,0
32891,was,0,0
32892,not,0,0
32893,visualized,0,0
32894,.,0,0
32895,The,0,0
32896,end,0,0
32897,points,0,0
32898,for,0,0
32899,the,0,0
32900,study,0,0
32901,were,0,0
32902,the,0,0
32903,clinical,0,0
32904,outcomes,0,0
32905,of,0,0
32906,all,0,1
32907,patients,0,1
32908,",",0,0
32909,and,0,0
32910,the,0,0
32911,results,0,0
32912,of,0,0
32913,histology,0,0
32914,",",0,0
32915,where,0,0
32916,appropriate,0,0
32917,.,0,0
32918,An,0,0
32919,attempt,0,0
32920,was,0,0
32921,made,0,0
32922,to,0,0
32923,contact,0,0
32924,all,0,0
32925,patients,0,1
32926,at,0,0
32927,10,0,1
32928,years,0,1
32929,to,0,0
32930,determine,0,0
32931,whether,0,0
32932,they,0,0
32933,had,0,1
32934,had,0,0
32935,a,0,0
32936,subsequent,0,0
32937,appendicectomy,0,1
32938,",",0,0
32939,or,0,0
32940,had,0,0
32941,been,0,0
32942,diagnosed,0,1
32943,with,0,1
32944,another,0,0
32945,abdominal,0,0
32946,condition,0,0
32947,that,0,0
32948,might,0,0
32949,be,0,0
32950,relevant,0,0
32951,to,0,0
32952,the,0,0
32953,initial,0,0
32954,presentation,0,0
32955,in,0,0
32956,1991-1992,0,1
32957,.,0,1
32958,RESULTS,0,0
32959,Laparoscopic,0,0
32960,assessment,0,0
32961,was,0,0
32962,correct,0,0
32963,in,0,0
32964,all,0,0
32965,cases,0,0
32966,in,0,0
32967,which,0,0
32968,the,0,0
32969,appendix,0,0
32970,was,0,0
32971,visualized,0,0
32972,.,0,0
32973,Diagnostic,0,0
32974,accuracy,0,0
32975,was,0,0
32976,improved,0,0
32977,from,0,1
32978,75,0,1
32979,%,0,0
32980,to,0,0
32981,97,0,1
32982,%,0,0
32983,.,0,1
32984,Laparoscopy,0,1
32985,was,0,0
32986,associated,0,0
32987,with,0,1
32988,no,0,0
32989,added,0,0
32990,complications,0,0
32991,",",0,0
32992,no,0,0
32993,increase,0,0
32994,in,0,0
32995,hospital,0,1
32996,stay,0,0
32997,in,0,1
32998,patients,0,1
32999,who,0,1
33000,went,0,1
33001,on,0,1
33002,to,0,0
33003,appendicectomy,0,1
33004,",",0,0
33005,and,0,0
33006,a,0,0
33007,reduction,0,0
33008,in,0,0
33009,hospital,0,1
33010,stay,0,0
33011,for,0,0
33012,those,0,1
33013,who,0,1
33014,underwent,0,1
33015,laparoscopy,0,1
33016,alone,0,0
33017,.,0,0
33018,No,0,0
33019,patients,0,1
33020,developed,0,0
33021,a,0,0
33022,problem,0,0
33023,over,0,0
33024,the,0,0
33025,10-year,0,0
33026,follow-up,0,0
33027,period,0,0
33028,from,0,0
33029,having,0,1
33030,a,0,0
33031,normal-looking,0,0
33032,appendix,0,0
33033,not,0,0
33034,removed,0,0
33035,at,0,0
33036,laparoscopy,0,1
33037,.,0,1
33038,CONCLUSION,0,0
33039,Laparoscopic,0,0
33040,assessment,0,0
33041,of,0,0
33042,the,0,0
33043,appendix,0,0
33044,is,0,0
33045,reliable,0,0
33046,",",0,0
33047,and,0,0
33048,to,0,0
33049,leave,0,0
33050,a,0,0
33051,normal-looking,0,0
33052,appendix,0,1
33053,at,0,0
33054,laparoscopy,0,0
33055,does,0,0
33056,not,0,0
33057,appear,0,0
33058,to,0,0
33059,cause,0,0
33060,any,0,0
33061,long-term,0,0
33062,problems,0,1
33063,.,0,1
33064,Preservative-free,0,0
33065,ocular,0,1
33066,hydrating,0,0
33067,agents,0,0
33068,in,0,1
33069,symptomatic,1,1
33070,contact,1,0
33071,lens,1,1
33072,wearers,1,0
33073,:,1,1
33074,saline,0,0
33075,versus,0,0
33076,PVP,0,1
33077,solution,0,0
33078,.,0,0
33079,PURPOSE,0,0
33080,To,0,0
33081,compare,0,0
33082,two,0,0
33083,preservative-free,0,0
33084,hydrating,0,0
33085,agents,0,0
33086,",",0,0
33087,in,0,0
33088,multidose,0,0
33089,(,0,0
33090,ABAK,0,0
33091,),0,0
33092,bottles,0,0
33093,",",0,0
33094,in,0,0
33095,contact,1,0
33096,lens,1,1
33097,wearers,1,1
33098,experiencing,1,0
33099,symptoms,1,1
33100,of,1,0
33101,ocular,1,1
33102,dryness,1,0
33103,.,1,1
33104,METHODS,0,0
33105,The,0,0
33106,endpoint,0,0
33107,of,0,0
33108,this,0,0
33109,4-week,0,0
33110,multicenter,0,0
33111,",",0,0
33112,randomized,0,0
33113,",",0,0
33114,double-blind,0,0
33115,",",0,0
33116,parallel-group,0,0
33117,study,0,0
33118,comparing,0,0
33119,a,0,0
33120,2,0,0
33121,%,0,0
33122,polyvinylpyrrolidone,0,0
33123,(,0,0
33124,PVP,0,1
33125,),0,0
33126,solution,0,0
33127,with,0,1
33128,a,0,0
33129,0.9,0,0
33130,%,0,0
33131,NaCl,0,1
33132,solution,0,0
33133,was,0,0
33134,to,0,0
33135,assess,0,0
33136,ocular,0,1
33137,discomfort,0,0
33138,using,0,0
33139,a,0,0
33140,visual,0,0
33141,analog,0,0
33142,scale,0,0
33143,.,0,0
33144,A,0,0
33145,biomicroscopic,0,0
33146,examination,0,0
33147,and,0,0
33148,a,0,0
33149,test,0,0
33150,of,0,0
33151,tolerability,0,0
33152,on,0,0
33153,instillation,0,0
33154,were,0,0
33155,also,0,0
33156,performed,0,0
33157,",",0,0
33158,and,0,0
33159,adverse,0,0
33160,events,0,0
33161,were,0,1
33162,recorded,0,0
33163,.,0,1
33164,RESULTS,0,0
33165,Thirty-nine,1,1
33166,subjects,1,1
33167,were,1,1
33168,enrolled,1,1
33169,(,1,0
33170,23,1,1
33171,PVP,1,1
33172,;,1,1
33173,16,1,1
33174,NaCl,1,1
33175,),1,1
33176,.,1,0
33177,The,0,0
33178,average,1,0
33179,age,1,1
33180,was,1,0
33181,30,1,1
33182,;,1,1
33183,subjects,1,1
33184,were,1,0
33185,predominantly,1,1
33186,female,1,1
33187,",",1,0
33188,and,1,0
33189,mostly,1,0
33190,wore,1,0
33191,frequent-replacement,1,0
33192,contact,1,0
33193,lenses,1,1
33194,.,1,1
33195,They,1,0
33196,were,1,0
33197,all,1,0
33198,exposed,1,0
33199,to,1,0
33200,environmental,1,1
33201,factors,1,0
33202,such,1,0
33203,as,1,0
33204,routine,1,0
33205,use,1,0
33206,of,1,0
33207,video,1,0
33208,monitors,1,0
33209,or,1,1
33210,air,1,1
33211,conditioning,1,0
33212,.,1,0
33213,The,0,0
33214,two,0,0
33215,groups,0,0
33216,were,0,1
33217,similar,0,0
33218,at,0,0
33219,baseline,0,0
33220,(,0,0
33221,D0,0,0
33222,),0,0
33223,.,0,0
33224,Both,0,0
33225,PVP,0,0
33226,and,0,0
33227,NaCl,0,0
33228,improved,0,0
33229,the,0,0
33230,comfort,0,0
33231,of,0,0
33232,contact,0,0
33233,lens,0,1
33234,wear,0,1
33235,(,0,0
33236,P,0,0
33237,=,0,0
33238,0.0003,0,0
33239,),0,0
33240,",",0,0
33241,with,0,1
33242,no,0,0
33243,difference,0,0
33244,between,0,0
33245,them,0,1
33246,(,0,0
33247,P,0,0
33248,=,0,0
33249,0.25,0,0
33250,),0,0
33251,.,0,0
33252,The,0,0
33253,mean,0,0
33254,daily,0,0
33255,duration,0,0
33256,of,0,0
33257,lens,0,1
33258,wear,0,1
33259,and,0,0
33260,the,0,0
33261,daily,0,0
33262,number,0,0
33263,of,0,0
33264,instillations,0,0
33265,to,0,0
33266,relieve,0,0
33267,discomfort,0,0
33268,(,0,0
33269,4.2,0,0
33270,+/-,0,0
33271,2.0,0,0
33272,for,0,0
33273,PVP,0,1
33274,ABAK,0,1
33275,;,0,1
33276,4.6,0,0
33277,+/-,0,0
33278,1.9,0,0
33279,for,0,0
33280,NaCl,0,1
33281,ABAK,0,0
33282,),0,0
33283,were,0,0
33284,comparable,0,0
33285,.,0,0
33286,However,0,0
33287,",",0,0
33288,PVP,0,1
33289,use,0,0
33290,led,0,0
33291,to,0,0
33292,more,0,0
33293,favorable,0,0
33294,evolution,0,0
33295,of,0,0
33296,fluorescein-staining,0,0
33297,corneal,0,0
33298,punctuations,0,0
33299,(,0,1
33300,P,0,0
33301,=,0,0
33302,0.028,0,0
33303,),0,0
33304,.,0,1
33305,Safety,0,0
33306,was,0,0
33307,good,0,0
33308,",",0,0
33309,with,0,1
33310,minimal,0,0
33311,adverse,0,0
33312,events,0,0
33313,considered,0,1
33314,unrelated,0,1
33315,to,0,0
33316,the,0,0
33317,products,0,0
33318,.,0,1
33319,Lens,0,0
33320,wettability,0,0
33321,was,0,0
33322,excellent,0,0
33323,",",0,0
33324,and,0,0
33325,there,0,0
33326,were,0,0
33327,no,0,0
33328,clinically,0,0
33329,relevant,0,0
33330,deposits,0,1
33331,.,0,1
33332,Most,0,0
33333,subjects,0,1
33334,also,0,0
33335,found,0,0
33336,the,0,0
33337,ABAK,0,0
33338,bottles,0,0
33339,convenient,0,0
33340,.,0,1
33341,CONCLUSIONS,0,0
33342,Ocular,0,0
33343,hydration,0,0
33344,improves,0,0
33345,comfort,0,0
33346,in,0,0
33347,contact,0,0
33348,lens,0,1
33349,wearers,0,1
33350,.,0,0
33351,NaCl,0,0
33352,is,0,0
33353,an,0,0
33354,appropriate,0,0
33355,first-line,0,1
33356,treatment,0,0
33357,",",0,0
33358,but,0,0
33359,for,0,0
33360,subjects,0,1
33361,with,0,1
33362,fluorescein-staining,0,0
33363,punctuations,0,0
33364,",",0,0
33365,lubrication,0,0
33366,with,0,0
33367,PVP,0,1
33368,is,0,0
33369,preferable,0,0
33370,.,0,0
33371,Changing,0,1
33372,Childbirth,1,1
33373,:,1,1
33374,a,0,0
33375,pilot,0,0
33376,project,0,0
33377,.,0,0
33378,OBJECTIVE,0,0
33379,To,0,0
33380,compare,0,0
33381,the,0,0
33382,outcomes,0,0
33383,of,0,0
33384,an,0,0
33385,adapted,0,0
33386,pilot,0,0
33387,Changing,0,1
33388,Childbirth,0,1
33389,initiative,0,1
33390,providing,0,0
33391,continuity,0,0
33392,of,0,0
33393,care,0,1
33394,by,0,0
33395,a,0,0
33396,group,1,0
33397,of,1,0
33398,known,1,0
33399,midwives,1,1
33400,with,1,1
33401,traditional,1,1
33402,maternity,1,1
33403,care,1,1
33404,.,1,1
33405,DESIGN,0,0
33406,Between-groups,0,0
33407,trial,0,0
33408,to,0,0
33409,compare,0,0
33410,levels,0,0
33411,of,0,0
33412,satisfaction,0,0
33413,and,0,0
33414,clinical,0,0
33415,outcomes,0,0
33416,for,0,1
33417,two,1,0
33418,groups,1,0
33419,of,1,1
33420,women,1,1
33421,",",1,0
33422,cared,1,1
33423,for,1,0
33424,either,1,0
33425,under,1,0
33426,this,1,0
33427,Changing,1,0
33428,Childbirth,1,0
33429,scheme,1,0
33430,or,1,0
33431,the,1,0
33432,traditional,1,0
33433,model,1,0
33434,of,1,0
33435,care,1,1
33436,.,1,1
33437,METHOD,0,0
33438,Of,0,0
33439,the,0,0
33440,200,1,1
33441,women,1,1
33442,who,1,1
33443,agreed,1,1
33444,to,1,1
33445,participate,1,1
33446,in,1,0
33447,the,1,0
33448,project,1,0
33449,",",1,0
33450,100,1,0
33451,were,1,0
33452,randomly,1,1
33453,allocated,1,0
33454,to,1,0
33455,the,1,0
33456,pilot,1,0
33457,scheme,1,0
33458,and,1,0
33459,100,1,0
33460,to,1,0
33461,the,1,0
33462,traditional,1,0
33463,care,1,1
33464,package,1,0
33465,.,1,0
33466,During,0,0
33467,the,0,0
33468,postpartum,0,1
33469,period,0,0
33470,",",0,0
33471,information,0,0
33472,was,0,0
33473,collected,0,0
33474,via,0,0
33475,a,0,0
33476,questionnaire,0,0
33477,about,0,0
33478,participants,0,1
33479,',0,1
33480,levels,0,0
33481,of,0,1
33482,satisfaction,0,0
33483,with,0,1
33484,a,0,0
33485,variety,0,0
33486,of,0,0
33487,aspects,0,0
33488,of,0,0
33489,care,0,1
33490,provided,0,0
33491,during,0,0
33492,the,0,0
33493,antenatal,0,0
33494,",",0,0
33495,delivery,0,0
33496,and,0,0
33497,postpartum,0,1
33498,periods,0,0
33499,.,0,1
33500,Data,0,0
33501,about,0,0
33502,clinical,0,0
33503,outcomes,0,0
33504,for,0,0
33505,the,0,0
33506,two,0,0
33507,groups,0,0
33508,were,0,1
33509,also,0,0
33510,obtained,0,0
33511,.,0,0
33512,RESULTS,0,0
33513,Women,0,1
33514,in,0,0
33515,the,0,0
33516,pilot,0,0
33517,group,0,0
33518,had,0,0
33519,significantly,0,0
33520,more,0,0
33521,continuity,0,0
33522,of,0,0
33523,care,0,1
33524,throughout,0,0
33525,each,0,0
33526,of,0,0
33527,the,0,0
33528,three,0,0
33529,periods,0,0
33530,",",0,0
33531,were,0,0
33532,generally,0,0
33533,more,0,0
33534,satisfied,0,0
33535,with,0,0
33536,their,0,0
33537,care,0,1
33538,",",0,0
33539,felt,0,0
33540,that,0,0
33541,they,0,0
33542,had,0,1
33543,more,0,0
33544,choice,0,0
33545,over,0,0
33546,a,0,0
33547,variety,0,0
33548,of,0,0
33549,aspects,0,0
33550,of,0,0
33551,care,0,1
33552,and,0,0
33553,experienced,0,0
33554,no,0,0
33555,compromise,0,0
33556,in,0,0
33557,clinical,0,0
33558,outcomes,0,0
33559,(,0,0
33560,P,0,0
33561,=,0,0
33562,0.05,0,0
33563,or,0,0
33564,less,0,0
33565,in,0,0
33566,each,0,0
33567,case,0,0
33568,),0,0
33569,.,0,1
33570,IMPLICATIONS,0,0
33571,FOR,0,0
33572,PRACTICE,0,1
33573,Many,0,1
33574,previous,0,0
33575,attempts,0,0
33576,to,0,0
33577,introduce,0,0
33578,the,0,0
33579,Changing,0,0
33580,Childbirth,0,0
33581,initiative,0,1
33582,have,0,0
33583,revealed,0,0
33584,significant,0,0
33585,problems,0,1
33586,",",0,0
33587,particularly,0,0
33588,with,0,0
33589,regard,0,0
33590,to,0,0
33591,the,0,0
33592,continuity,0,0
33593,of,0,0
33594,carer,0,0
33595,requirement,0,0
33596,.,0,0
33597,Taking,0,0
33598,account,0,0
33599,of,0,0
33600,local,0,0
33601,health,0,1
33602,care,0,1
33603,needs,0,0
33604,and,0,0
33605,existing,0,0
33606,provision,0,0
33607,",",0,0
33608,the,0,0
33609,present,0,0
33610,study,0,0
33611,adapted,0,0
33612,this,0,0
33613,concept,0,0
33614,to,0,0
33615,continuity,0,0
33616,of,0,0
33617,care,0,1
33618,.,0,0
33619,This,0,0
33620,did,0,0
33621,not,0,0
33622,apparently,0,0
33623,affect,0,0
33624,any,0,0
33625,of,0,0
33626,the,0,0
33627,guiding,0,0
33628,principles,0,0
33629,contained,0,0
33630,in,0,0
33631,the,0,0
33632,original,0,0
33633,document,0,0
33634,",",0,0
33635,and,0,0
33636,yet,0,0
33637,enhanced,0,0
33638,satisfaction,0,0
33639,.,0,0
33640,It,0,0
33641,would,0,0
33642,appear,0,0
33643,that,0,0
33644,the,0,0
33645,Changing,0,0
33646,Childbirth,0,0
33647,agenda,0,0
33648,can,0,0
33649,be,0,0
33650,adapted,0,0
33651,and,0,0
33652,integrated,0,0
33653,with,0,1
33654,local,0,0
33655,health,0,1
33656,care,0,1
33657,situations,0,0
33658,without,0,1
33659,sacrificing,0,0
33660,any,0,0
33661,of,0,0
33662,the,0,0
33663,overarching,0,0
33664,principles,0,0
33665,.,0,1
33666,A,0,0
33667,proof,0,0
33668,of,0,0
33669,concept,0,0
33670,study,0,0
33671,to,0,0
33672,evaluate,0,0
33673,putative,0,0
33674,benefits,0,0
33675,of,0,0
33676,montelukast,0,0
33677,in,0,0
33678,moderate,1,1
33679,persistent,1,1
33680,asthmatics,1,1
33681,.,1,1
33682,AIMS,0,1
33683,Whether,0,0
33684,chronic,0,1
33685,dosing,0,0
33686,with,0,1
33687,montelukast,0,0
33688,confers,0,0
33689,benefit,0,0
33690,in,0,0
33691,patients,1,1
33692,with,1,1
33693,moderate,1,1
33694,to,1,0
33695,severe,1,1
33696,asthma,1,1
33697,remains,0,0
33698,to,0,0
33699,be,0,0
33700,fully,0,0
33701,established,0,0
33702,.,0,0
33703,A,0,0
33704,proof,0,0
33705,of,0,0
33706,concept,0,0
33707,study,0,0
33708,was,0,0
33709,performed,0,0
33710,evaluating,0,0
33711,putative,0,0
33712,benefits,0,0
33713,with,0,1
33714,montelukast,0,0
33715,in,0,0
33716,moderate,1,1
33717,persistent,1,1
33718,asthmatics,1,1
33719,who,0,1
33720,were,0,1
33721,taken,0,0
33722,off,0,0
33723,inhaled,0,0
33724,corticosteroids,0,0
33725,(,0,1
33726,ICS,0,0
33727,),0,0
33728,and,0,0
33729,switched,0,0
33730,to,0,0
33731,salmeterol,0,0
33732,.,0,0
33733,The,0,0
33734,latter,0,0
33735,was,0,0
33736,done,0,0
33737,to,0,0
33738,dissociate,0,0
33739,the,0,0
33740,effects,0,0
33741,of,0,0
33742,montelukast,0,0
33743,from,0,1
33744,ICS,0,0
33745,.,0,1
33746,METHODS,0,0
33747,Twenty,1,1
33748,moderate,1,1
33749,to,1,0
33750,severe,1,1
33751,persistent,1,1
33752,asthmatics,1,1
33753,completed,0,1
33754,a,0,0
33755,randomized,0,0
33756,double-blind,0,0
33757,crossover,0,1
33758,study,0,0
33759,.,0,1
33760,Subjects,0,0
33761,received,0,0
33762,montelukast,0,0
33763,10,0,0
33764,mg,0,0
33765,daily,0,0
33766,or,0,1
33767,placebo,0,0
33768,for,0,0
33769,2,0,0
33770,weeks,0,0
33771,each,0,1
33772,.,0,0
33773,This,0,0
33774,was,0,0
33775,preceded,0,0
33776,by,0,0
33777,a,0,0
33778,2-week,0,0
33779,run-in,0,0
33780,when,0,0
33781,ICS,0,0
33782,were,0,0
33783,discontinued,0,0
33784,and,0,0
33785,salmeterol,0,0
33786,started,0,0
33787,",",0,0
33788,and,0,0
33789,used,0,0
33790,on,0,0
33791,a,0,0
33792,regular,0,0
33793,basis,0,0
33794,throughout,0,0
33795,the,0,0
33796,study,0,0
33797,.,0,0
33798,Measurements,0,0
33799,were,0,0
33800,made,0,0
33801,after,0,0
33802,run-in,0,0
33803,and,0,0
33804,after,0,0
33805,both,0,0
33806,randomized,0,1
33807,treatments,0,0
33808,.,0,1
33809,RESULTS,0,0
33810,There,0,0
33811,were,0,0
33812,no,0,0
33813,significant,0,0
33814,sequence,0,0
33815,effects,0,0
33816,for,0,0
33817,responses,0,0
33818,as,0,0
33819,to,0,0
33820,whether,0,0
33821,placebo,0,0
33822,or,0,1
33823,montelukast,0,0
33824,were,0,0
33825,given,0,0
33826,first,0,0
33827,or,0,1
33828,second,0,0
33829,.,0,1
33830,Methacholine,0,0
33831,PD20,0,0
33832,values,0,0
33833,after,0,0
33834,run-in,0,0
33835,",",0,0
33836,first,0,0
33837,and,0,0
33838,second,0,0
33839,placebo,0,0
33840,were,0,0
33841,63,0,1
33842,micro,0,0
33843,g,0,0
33844,",",0,0
33845,60,0,1
33846,micro,0,0
33847,g,0,1
33848,and,0,0
33849,64,0,1
33850,micro,0,0
33851,g,0,0
33852,",",0,0
33853,respectively,0,0
33854,(,0,0
33855,corresponding,0,0
33856,to,0,0
33857,2,0,0
33858,",",0,0
33859,4,0,0
33860,and,0,0
33861,6,0,0
33862,weeks,0,0
33863,of,0,0
33864,ICS,0,0
33865,washout,0,0
33866,",",0,0
33867,respectively,0,0
33868,),0,0
33869,.,0,0
33870,Lung,0,0
33871,function,0,0
33872,deteriorated,0,0
33873,pre,0,0
33874,vs,0,0
33875,post,0,0
33876,run-in,0,0
33877,",",0,0
33878,which,0,0
33879,was,0,0
33880,significant,0,0
33881,(,0,1
33882,P,0,0
33883,<,0,0
33884,0.05,0,0
33885,),0,0
33886,for,0,0
33887,FEF25-75,0,0
33888,%,0,0
33889,predicted,0,0
33890,.,0,1
33891,Montelukast,0,0
33892,conferred,0,0
33893,significant,0,0
33894,(,0,1
33895,P,0,0
33896,<,0,0
33897,0.05,0,0
33898,),0,1
33899,improvements,0,0
33900,as,0,0
33901,change,0,0
33902,from,0,0
33903,post,0,0
33904,run-in,0,0
33905,compared,0,0
33906,with,0,1
33907,placebo,0,0
33908,in,0,0
33909,methacholine,0,0
33910,PD20,0,0
33911,",",0,0
33912,FEV1,0,0
33913,%,0,0
33914,predicted,0,0
33915,",",0,0
33916,FEF25-75,0,0
33917,%,0,0
33918,predicted,0,0
33919,",",0,0
33920,diurnal,0,0
33921,peak,0,0
33922,expiratory,0,0
33923,flow,0,0
33924,",",0,0
33925,symptoms,0,0
33926,and,0,0
33927,salbutamol,0,0
33928,use,0,0
33929,.,0,0
33930,For,0,0
33931,the,0,0
33932,primary,0,0
33933,outcome,0,0
33934,of,0,0
33935,methacholine,0,0
33936,PD20,0,0
33937,",",0,0
33938,this,0,0
33939,amounted,0,0
33940,to,0,0
33941,a,0,0
33942,1.6-fold,0,0
33943,difference,0,0
33944,(,0,0
33945,95,0,0
33946,%,0,0
33947,CI,0,0
33948,1.1,0,0
33949,",",0,0
33950,2.5,0,0
33951,),0,0
33952,.,0,1
33953,CONCLUSIONS,0,0
33954,In,0,0
33955,moderate,0,1
33956,persistent,0,1
33957,asthmatics,0,1
33958,switched,0,0
33959,from,0,1
33960,taking,0,1
33961,ICS,0,0
33962,to,0,0
33963,salmeterol,0,0
33964,alone,0,0
33965,",",0,0
33966,adding,0,0
33967,montelukast,0,0
33968,conferred,0,0
33969,significant,0,0
33970,benefits,0,0
33971,on,0,0
33972,all,0,1
33973,parameters,0,0
33974,of,0,0
33975,asthma,0,1
33976,control,0,1
33977,.,0,1
33978,Further,0,0
33979,studies,0,0
33980,are,0,0
33981,indicated,0,0
33982,to,0,0
33983,evaluate,0,0
33984,whether,0,0
33985,montelukast,0,0
33986,exhibits,0,0
33987,additive,0,0
33988,effects,0,0
33989,to,0,1
33990,ICS/long-acting,0,0
33991,beta2-adrenoceptor,0,0
33992,agonist,0,1
33993,combination,0,0
33994,inhalers,0,0
33995,upon,0,0
33996,clinically,0,1
33997,important,0,0
33998,outcomes,0,0
33999,.,0,1
34000,Pethidine,0,0
34001,versus,0,0
34002,tramadol,0,0
34003,for,0,0
34004,pain,1,0
34005,relief,1,0
34006,during,1,0
34007,labor,1,1
34008,.,1,0
34009,OBJECTIVE,0,0
34010,To,0,0
34011,evaluate,0,0
34012,and,0,0
34013,compare,0,0
34014,the,0,0
34015,analgesic,0,0
34016,efficacy,0,0
34017,and,0,0
34018,adverse,0,0
34019,effects,0,0
34020,of,0,0
34021,tramadol,0,0
34022,and,0,0
34023,pethidine,0,0
34024,in,0,0
34025,labor,0,1
34026,.,0,1
34027,METHOD,0,0
34028,Fifty-nine,1,1
34029,full,1,1
34030,term,1,1
34031,parturients,1,1
34032,were,1,0
34033,randomly,1,1
34034,assigned,1,1
34035,to,1,0
34036,one,1,1
34037,of,1,0
34038,two,1,0
34039,groups,1,0
34040,in,1,1
34041,active,1,1
34042,labor,1,1
34043,.,1,1
34044,Group,0,0
34045,1,0,0
34046,received,0,1
34047,100,0,0
34048,mg,0,0
34049,pethidine,0,1
34050,;,0,0
34051,group,0,0
34052,2,0,0
34053,",",0,0
34054,100,0,0
34055,mg,0,0
34056,tramadol,0,0
34057,",",0,0
34058,intramuscularly,0,0
34059,.,0,0
34060,Analgesic,0,0
34061,efficacy,0,0
34062,",",0,0
34063,maternal,0,0
34064,side,0,0
34065,effects,0,0
34066,",",0,0
34067,changes,0,0
34068,in,0,0
34069,the,0,0
34070,blood,0,0
34071,pressure,0,0
34072,",",0,0
34073,heart,0,1
34074,rate,0,0
34075,",",0,0
34076,and,0,0
34077,duration,0,0
34078,of,0,0
34079,labor,0,1
34080,were,0,0
34081,assessed,0,0
34082,.,0,0
34083,RESULT,0,0
34084,At,0,0
34085,30,0,1
34086,and,0,1
34087,60,0,1
34088,min,0,0
34089,after,0,0
34090,drug,0,0
34091,administration,0,0
34092,",",0,0
34093,pain,0,0
34094,relief,0,0
34095,was,0,0
34096,greater,0,0
34097,in,0,0
34098,the,0,0
34099,pethidine,0,0
34100,group,0,0
34101,than,0,0
34102,in,0,0
34103,tramadol,0,0
34104,group,0,1
34105,.,0,0
34106,The,0,0
34107,incidence,0,0
34108,of,0,0
34109,nausea,0,0
34110,and,0,0
34111,fatigue,0,0
34112,was,0,0
34113,higher,0,0
34114,in,0,0
34115,the,0,0
34116,tramadol,0,0
34117,group,0,0
34118,.,0,0
34119,Following,0,0
34120,drug,0,0
34121,administration,0,0
34122,the,0,0
34123,decrease,0,0
34124,in,0,0
34125,systolic,0,1
34126,and,0,0
34127,diastolic,0,1
34128,blood,0,0
34129,pressure,0,0
34130,and,0,0
34131,the,0,0
34132,increase,0,0
34133,in,0,0
34134,heart,0,1
34135,rate,0,0
34136,were,0,0
34137,statistically,0,0
34138,significant,0,0
34139,in,0,0
34140,both,0,0
34141,groups,0,0
34142,.,0,0
34143,No,0,0
34144,significant,0,0
34145,difference,0,0
34146,was,0,0
34147,found,0,0
34148,between,0,0
34149,the,0,0
34150,groups,0,0
34151,when,0,0
34152,compared,0,0
34153,for,0,0
34154,duration,0,0
34155,of,0,0
34156,labor,0,1
34157,and,0,0
34158,Apgar,0,1
34159,scores,0,0
34160,.,0,1
34161,None,0,0
34162,of,0,0
34163,the,0,0
34164,neonates,0,1
34165,developed,0,0
34166,respiratory,0,1
34167,depression,0,1
34168,.,0,1
34169,CONCLUSION,0,0
34170,Pethidine,0,0
34171,seems,0,0
34172,to,0,0
34173,be,0,0
34174,a,0,0
34175,better,0,0
34176,alternative,0,0
34177,than,0,0
34178,tramadol,0,0
34179,in,0,0
34180,obstetric,0,1
34181,analgesia,0,0
34182,because,0,0
34183,of,0,0
34184,its,0,0
34185,superiority,0,0
34186,in,0,0
34187,analgesic,0,0
34188,efficacy,0,0
34189,and,0,0
34190,low,0,0
34191,incidence,0,0
34192,of,0,0
34193,maternal,0,1
34194,side,0,0
34195,effects,0,0
34196,.,0,1
34197,Randomized,0,0
34198,comparison,0,0
34199,of,0,0
34200,interferon,0,0
34201,alpha,0,0
34202,and,0,0
34203,hydroxyurea,0,0
34204,with,0,1
34205,hydroxyurea,0,0
34206,monotherapy,0,1
34207,in,0,0
34208,chronic,0,1
34209,myeloid,0,1
34210,leukemia,0,1
34211,(,0,0
34212,CML-study,0,1
34213,II,0,1
34214,),0,1
34215,:,0,1
34216,prolongation,0,0
34217,of,0,0
34218,survival,0,0
34219,by,0,0
34220,the,0,0
34221,combination,0,0
34222,of,0,0
34223,interferon,0,0
34224,alpha,0,0
34225,and,0,0
34226,hydroxyurea,0,0
34227,.,0,0
34228,The,0,0
34229,optimum,0,0
34230,treatment,0,0
34231,conditions,0,0
34232,of,0,0
34233,interferon,0,0
34234,(,0,0
34235,IFN,0,1
34236,),0,0
34237,alpha,0,0
34238,therapy,0,0
34239,in,0,0
34240,chronic,0,1
34241,myeloid,0,1
34242,leukemia,0,1
34243,(,0,0
34244,CML,0,1
34245,),0,0
34246,are,0,0
34247,still,0,0
34248,controversial,0,0
34249,.,0,0
34250,To,0,0
34251,evaluate,0,0
34252,the,0,0
34253,role,0,0
34254,of,0,0
34255,hydroxyurea,0,0
34256,(,0,0
34257,HU,0,0
34258,),0,0
34259,for,0,0
34260,the,0,0
34261,outcome,0,0
34262,of,0,0
34263,IFN,0,1
34264,therapy,0,0
34265,",",0,0
34266,we,0,0
34267,conducted,0,0
34268,a,0,0
34269,randomized,0,0
34270,trial,0,0
34271,to,0,0
34272,compare,0,0
34273,the,0,0
34274,combination,0,0
34275,of,0,0
34276,IFN,0,1
34277,and,0,0
34278,HU,0,0
34279,vs,0,0
34280,HU,0,0
34281,monotherapy,0,0
34282,(,0,0
34283,CML-study,0,1
34284,II,0,1
34285,),0,0
34286,.,0,0
34287,From,1,1
34288,February,1,1
34289,1991,1,1
34290,to,1,0
34291,December,1,1
34292,1994,1,1
34293,",",1,0
34294,376,1,1
34295,patients,1,1
34296,with,1,1
34297,newly,1,1
34298,diagnosed,1,1
34299,CML,1,1
34300,in,1,0
34301,chronic,1,1
34302,phase,1,1
34303,were,0,0
34304,randomized,0,0
34305,.,0,0
34306,In,0,0
34307,all,0,0
34308,",",0,0
34309,340,1,1
34310,patients,1,1
34311,were,1,1
34312,Ph/BCR-ABL,1,0
34313,positive,1,0
34314,and,1,0
34315,evaluable,1,1
34316,.,1,1
34317,Randomization,0,0
34318,was,0,0
34319,unbalanced,0,0
34320,1:2,0,1
34321,in,0,0
34322,favor,0,0
34323,of,0,0
34324,the,0,0
34325,combination,0,0
34326,therapy,0,0
34327,",",0,0
34328,since,0,0
34329,study,0,1
34330,conditions,0,0
34331,were,0,1
34332,identical,0,0
34333,to,0,0
34334,the,0,0
34335,previous,0,0
34336,CML-study,0,1
34337,I,0,1
34338,and,0,0
34339,it,0,0
34340,had,0,0
34341,been,0,0
34342,planned,0,0
34343,in,0,0
34344,advance,0,0
34345,to,0,0
34346,add,0,0
34347,the,0,0
34348,HU,0,0
34349,patients,0,1
34350,of,0,0
34351,study,0,1
34352,I,0,1
34353,(,0,0
34354,n=194,0,1
34355,),0,0
34356,to,0,0
34357,the,0,0
34358,HU,0,0
34359,control,0,0
34360,group,0,0
34361,.,0,0
34362,Therefore,0,0
34363,",",0,0
34364,a,1,0
34365,total,1,1
34366,of,1,0
34367,534,1,1
34368,patients,1,1
34369,were,1,1
34370,evaluable,1,1
34371,(,1,1
34372,226,1,1
34373,patients,1,1
34374,with,1,1
34375,IFN/HU,1,1
34376,and,1,1
34377,308,1,1
34378,patients,1,1
34379,with,1,1
34380,HU,1,1
34381,),1,1
34382,.,1,1
34383,Analyses,0,0
34384,were,0,0
34385,according,0,1
34386,to,0,0
34387,intention-to-treat,0,0
34388,.,0,0
34389,Median,0,0
34390,observation,0,0
34391,time,0,0
34392,of,0,0
34393,nontransplanted,1,1
34394,living,1,1
34395,patients,1,1
34396,was,0,0
34397,7.6,0,0
34398,years,0,1
34399,(,0,1
34400,7.9,0,1
34401,years,0,1
34402,for,0,0
34403,IFN/HU,0,1
34404,and,0,1
34405,7.3,0,0
34406,years,0,1
34407,for,0,1
34408,HU,0,1
34409,),0,1
34410,.,0,0
34411,The,0,0
34412,risk,0,0
34413,profile,0,0
34414,(,0,0
34415,new,0,0
34416,CML,0,1
34417,score,0,0
34418,),0,0
34419,was,0,0
34420,available,0,0
34421,for,0,0
34422,532,0,1
34423,patients,0,1
34424,:,0,1
34425,200,0,1
34426,patients,0,1
34427,(,0,1
34428,38,0,1
34429,%,0,0
34430,),0,0
34431,were,0,0
34432,low,0,0
34433,",",0,0
34434,239,0,1
34435,patients,0,1
34436,(,0,1
34437,45,0,1
34438,%,0,0
34439,),0,0
34440,intermediate,0,0
34441,",",0,0
34442,and,0,0
34443,93,0,1
34444,patients,0,1
34445,(,0,1
34446,17,0,1
34447,%,0,0
34448,),0,0
34449,high,0,1
34450,risk,0,1
34451,.,0,1
34452,Complete,0,0
34453,hematologic,0,1
34454,response,0,0
34455,rates,0,0
34456,were,0,0
34457,higher,0,0
34458,in,0,0
34459,IFN/HU-treated,0,0
34460,patients,0,1
34461,(,0,1
34462,59,0,1
34463,vs,0,0
34464,32,0,1
34465,%,0,0
34466,),0,0
34467,.,0,0
34468,Of,0,0
34469,169,0,1
34470,evaluable,0,1
34471,IFN/HU-treated,0,0
34472,patients,0,1
34473,(,0,1
34474,75,0,1
34475,%,0,0
34476,),0,0
34477,",",0,0
34478,104,0,1
34479,patients,0,1
34480,(,0,1
34481,62,0,1
34482,%,0,0
34483,),0,0
34484,achieved,0,0
34485,a,0,0
34486,cytogenetic,0,0
34487,response,0,0
34488,that,0,0
34489,was,0,0
34490,complete,0,0
34491,in,0,0
34492,12,0,0
34493,%,0,0
34494,(,0,0
34495,n=21,0,1
34496,),0,0
34497,",",0,0
34498,major,0,0
34499,in,0,0
34500,14,0,0
34501,%,0,0
34502,(,0,0
34503,n=24,0,1
34504,),0,0
34505,",",0,0
34506,and,0,0
34507,at,0,0
34508,least,0,0
34509,minimal,0,0
34510,in,0,0
34511,35,0,1
34512,%,0,0
34513,(,0,0
34514,n=59,0,1
34515,),0,0
34516,.,0,0
34517,Of,0,0
34518,the,0,0
34519,534,1,1
34520,patients,1,1
34521,",",0,1
34522,105,0,1
34523,(,0,0
34524,20,0,1
34525,%,0,0
34526,),0,0
34527,underwent,0,1
34528,allogeneic,0,1
34529,stem,0,1
34530,cell,0,0
34531,transplantation,0,1
34532,in,0,0
34533,first,0,0
34534,chronic,0,1
34535,phase,0,1
34536,.,0,0
34537,In,0,0
34538,the,0,0
34539,low-risk,0,1
34540,group,0,0
34541,",",0,0
34542,65,0,1
34543,of,0,0
34544,200,0,1
34545,patients,0,1
34546,were,0,1
34547,transplanted,0,1
34548,(,0,0
34549,33,0,1
34550,%,0,0
34551,),0,0
34552,",",0,0
34553,30,0,1
34554,(,0,0
34555,13,0,1
34556,%,0,0
34557,),0,0
34558,in,0,0
34559,the,0,0
34560,intermediate-risk,0,1
34561,group,0,0
34562,",",0,0
34563,and,0,0
34564,nine,0,1
34565,(,0,0
34566,10,0,1
34567,%,0,0
34568,),0,0
34569,in,0,0
34570,the,0,0
34571,high-risk,0,1
34572,group,0,0
34573,.,0,0
34574,Duration,0,0
34575,of,0,0
34576,chronic,0,1
34577,phase,0,1
34578,was,0,0
34579,55,0,1
34580,months,0,0
34581,for,0,0
34582,IFN/HU,0,1
34583,and,0,1
34584,41,0,1
34585,months,0,0
34586,for,0,0
34587,HU,0,0
34588,(,0,1
34589,P,0,0
34590,<,0,0
34591,0.0001,0,0
34592,),0,1
34593,.,0,1
34594,Median,0,0
34595,survival,0,0
34596,was,0,0
34597,64,0,1
34598,months,0,0
34599,for,0,0
34600,IFN/HU,0,1
34601,and,0,1
34602,53,0,1
34603,months,0,0
34604,for,0,1
34605,HU-treated,0,1
34606,patients,0,1
34607,(,0,1
34608,P=0.0063,0,0
34609,),0,0
34610,.,0,0
34611,We,0,0
34612,conclude,0,0
34613,that,0,0
34614,IFN,0,1
34615,in,0,0
34616,combination,0,0
34617,with,0,1
34618,HU,0,0
34619,achieves,0,0
34620,a,0,0
34621,significant,0,0
34622,long-term,0,0
34623,survival,0,0
34624,advantage,0,0
34625,over,0,0
34626,HU,0,0
34627,monotherapy,0,1
34628,.,0,0
34629,In,0,0
34630,view,0,0
34631,of,0,0
34632,the,0,0
34633,data,0,0
34634,of,0,0
34635,CML-study,0,1
34636,I,0,1
34637,",",0,0
34638,these,0,0
34639,results,0,0
34640,suggest,0,0
34641,that,0,0
34642,IFN/HU,0,0
34643,is,0,0
34644,also,0,0
34645,superior,0,0
34646,to,0,0
34647,IFN,0,1
34648,alone,0,0
34649,.,0,0
34650,HU,0,0
34651,should,0,0
34652,be,0,0
34653,combined,0,0
34654,with,0,1
34655,IFN,0,1
34656,in,0,0
34657,IFN-based,0,0
34658,therapies,0,0
34659,and,0,1
34660,for,0,0
34661,comparisons,0,0
34662,with,0,1
34663,new,0,1
34664,therapies,0,1
34665,.,0,1
34666,Investigation,0,0
34667,of,0,0
34668,erosion,0,0
34669,and,0,0
34670,abrasion,0,0
34671,on,0,0
34672,enamel,0,0
34673,and,0,0
34674,dentine,0,1
34675,:,0,1
34676,a,0,0
34677,model,0,0
34678,in,0,0
34679,situ,0,0
34680,using,0,0
34681,toothpastes,0,1
34682,of,0,0
34683,different,0,0
34684,abrasivity,0,0
34685,.,0,1
34686,BACKGROUND,0,0
34687,Studies,0,0
34688,in,0,1
34689,vitro,0,0
34690,suggest,0,0
34691,that,0,0
34692,abrasion,0,0
34693,and,0,0
34694,erosion,0,0
34695,may,0,0
34696,act,0,0
34697,synergistically,0,0
34698,to,0,0
34699,produce,0,0
34700,wear,0,0
34701,of,0,0
34702,enamel,0,0
34703,and,0,0
34704,dentine,0,1
34705,.,0,0
34706,Methods,0,0
34707,in,0,0
34708,situ,0,0
34709,are,0,0
34710,recently,0,0
34711,available,0,0
34712,to,0,0
34713,study,0,0
34714,separately,0,0
34715,erosion,0,0
34716,and,0,0
34717,abrasion,0,0
34718,of,0,0
34719,dental,0,1
34720,tissues,0,1
34721,.,0,1
34722,The,0,0
34723,aim,0,0
34724,of,0,0
34725,this,0,0
34726,study,0,0
34727,was,0,0
34728,to,0,0
34729,combine,0,0
34730,two,0,0
34731,in,0,0
34732,situ,0,0
34733,protocols,0,0
34734,to,0,0
34735,study,0,0
34736,the,0,0
34737,interplay,0,0
34738,between,0,0
34739,erosion,0,0
34740,and,0,0
34741,abrasion,0,0
34742,of,0,0
34743,enamel,0,0
34744,and,0,0
34745,dentine,0,1
34746,.,0,0
34747,METHOD,0,0
34748,The,0,0
34749,study,0,0
34750,was,0,0
34751,a,0,0
34752,single-blind,0,0
34753,",",0,0
34754,randomised,0,0
34755,",",0,0
34756,five-treatment,0,0
34757,cross-over,0,0
34758,design,0,0
34759,involving,0,1
34760,15,1,1
34761,healthy,1,1
34762,volunteers,1,1
34763,.,1,1
34764,During,0,0
34765,each,0,0
34766,10-day,0,0
34767,study,0,0
34768,period,0,0
34769,",",0,0
34770,subjects,1,1
34771,wore,1,1
34772,from,1,0
34773,0900,1,0
34774,to,1,0
34775,1700,1,0
34776,h,1,0
34777,an,1,0
34778,upper,1,0
34779,removable,1,0
34780,acrylic,1,0
34781,appliance,1,1
34782,holding,1,0
34783,one,1,1
34784,polished,1,0
34785,enamel,1,1
34786,and,1,0
34787,one,1,0
34788,polished,1,0
34789,dentine,1,1
34790,specimen,1,0
34791,.,1,1
34792,The,0,0
34793,specimen,0,0
34794,treatment,0,0
34795,regimens,0,0
34796,were,0,1
34797,:,0,1
34798,1,0,0
34799,.,0,0
34800,Drinking,0,0
34801,water,0,0
34802,and,0,0
34803,brushing,0,0
34804,with,0,1
34805,toothpaste,0,1
34806,A,0,1
34807,.,0,1
34808,2,0,0
34809,.,0,0
34810,Drinking,0,0
34811,water,0,0
34812,and,0,0
34813,brushing,0,0
34814,with,0,1
34815,toothpaste,0,1
34816,B,0,1
34817,.,0,1
34818,3,0,0
34819,.,0,0
34820,Drinking,0,0
34821,orange,0,0
34822,juice,0,0
34823,.,0,1
34824,4,0,0
34825,.,0,0
34826,Drinking,0,0
34827,orange,0,0
34828,juice,0,0
34829,and,0,0
34830,brushing,0,0
34831,with,0,1
34832,toothpaste,0,1
34833,A,0,1
34834,.,0,1
34835,5,0,0
34836,.,0,0
34837,Drinking,0,0
34838,orange,0,0
34839,juice,0,0
34840,and,0,0
34841,brushing,0,0
34842,with,0,1
34843,toothpaste,0,1
34844,B,0,1
34845,.,0,0
34846,Drinking,0,0
34847,and,0,0
34848,brushing,0,0
34849,times,0,0
34850,were,0,1
34851,around,0,0
34852,0900,0,0
34853,",",0,0
34854,1100,0,1
34855,",",0,0
34856,1300,0,1
34857,and,0,0
34858,1500,0,1
34859,h.,0,1
34860,Drinks,0,0
34861,were,0,0
34862,consumed,0,1
34863,as,0,0
34864,250,0,0
34865,ml,0,0
34866,over,0,0
34867,10,0,1
34868,min,0,0
34869,and,0,1
34870,brushing,0,0
34871,ex,0,0
34872,vivo,0,0
34873,for,0,0
34874,1,0,0
34875,min,0,0
34876,to,0,1
34877,each,0,1
34878,specimen,0,0
34879,.,0,0
34880,Measurement,0,0
34881,of,0,0
34882,tissue,0,0
34883,loss,0,0
34884,was,0,0
34885,made,0,0
34886,on,0,0
34887,days,0,0
34888,5,0,1
34889,and,0,1
34890,10,0,0
34891,of,0,0
34892,each,0,0
34893,period,0,0
34894,using,0,0
34895,a,0,0
34896,profilometer,0,0
34897,.,0,0
34898,RESULTS,0,0
34899,All,0,1
34900,treatments,0,0
34901,produced,0,0
34902,increasing,0,0
34903,tissue,0,0
34904,loss,0,0
34905,over,0,0
34906,time,0,0
34907,",",0,0
34908,which,0,0
34909,was,0,0
34910,considerably,0,0
34911,greater,0,0
34912,for,0,0
34913,dentine,0,0
34914,than,0,0
34915,enamel,0,0
34916,.,0,0
34917,For,0,0
34918,enamel,0,0
34919,",",0,0
34920,the,0,0
34921,data,0,0
34922,at,0,1
34923,days,0,0
34924,5,0,1
34925,and,0,1
34926,10,0,0
34927,showed,0,0
34928,a,0,0
34929,significant,0,0
34930,effect,0,0
34931,for,0,0
34932,erosion,0,0
34933,(,0,0
34934,i.e,0,0
34935,.,0,0
34936,orange,0,0
34937,juice,0,0
34938,was,0,0
34939,significantly,0,0
34940,more,0,0
34941,erosive,0,0
34942,than,0,0
34943,water,0,0
34944,),0,0
34945,",",0,0
34946,but,0,0
34947,no,0,0
34948,significant,0,0
34949,effect,0,0
34950,for,0,0
34951,abrasion,0,0
34952,(,0,0
34953,i.e,0,0
34954,.,0,0
34955,no,0,0
34956,significant,0,0
34957,difference,0,0
34958,between,0,0
34959,the,0,0
34960,two,0,0
34961,toothpaste,0,0
34962,treatments,0,0
34963,),0,1
34964,.,0,1
34965,The,0,0
34966,combined,0,0
34967,orange,0,0
34968,juice,0,0
34969,and,0,0
34970,toothpaste,0,1
34971,effects,0,0
34972,were,0,1
34973,directional,0,0
34974,for,0,0
34975,synergy,0,0
34976,but,0,0
34977,did,0,0
34978,not,0,0
34979,reach,0,0
34980,significance,0,0
34981,.,0,0
34982,For,0,0
34983,dentine,0,0
34984,at,0,0
34985,day,0,0
34986,10,0,0
34987,",",0,0
34988,many,0,0
34989,specimens,0,0
34990,exceeded,0,0
34991,the,0,0
34992,50,0,0
34993,microm,0,0
34994,set,0,0
34995,limit,0,0
34996,of,0,0
34997,the,0,0
34998,profilometer,0,0
34999,and,0,0
35000,only,0,0
35001,day,0,0
35002,5,0,0
35003,data,0,0
35004,were,0,1
35005,considered,0,0
35006,.,0,0
35007,There,0,0
35008,were,0,0
35009,significant,0,0
35010,effects,0,0
35011,for,0,0
35012,erosion,0,0
35013,(,0,0
35014,orange,0,0
35015,juice,0,0
35016,produced,0,0
35017,significantly,0,0
35018,more,0,0
35019,erosion,0,0
35020,than,0,0
35021,water,0,0
35022,),0,0
35023,and,0,0
35024,for,0,0
35025,abrasion,0,0
35026,(,0,0
35027,paste,0,0
35028,A,0,0
35029,was,0,0
35030,significantly,0,0
35031,more,0,0
35032,abrasive,0,0
35033,to,0,0
35034,dentine,0,1
35035,than,0,0
35036,paste,0,0
35037,B,0,1
35038,),0,0
35039,.,0,0
35040,The,0,0
35041,synergy,0,0
35042,effect,0,0
35043,could,0,0
35044,not,0,0
35045,be,0,0
35046,examined,0,0
35047,for,0,0
35048,dentine,0,1
35049,due,0,0
35050,to,0,0
35051,the,0,0
35052,truncation,0,0
35053,effect,0,0
35054,as,0,0
35055,the,0,0
35056,set,0,0
35057,limit,0,0
35058,of,0,0
35059,the,0,0
35060,profilometer,0,0
35061,was,0,0
35062,exceeded,0,0
35063,.,0,1
35064,CONCLUSIONS,0,0
35065,Erosion,0,0
35066,increases,0,0
35067,the,0,0
35068,susceptibility,0,0
35069,of,0,0
35070,enamel,0,0
35071,to,0,0
35072,toothpaste,0,0
35073,abrasion,0,0
35074,.,0,0
35075,Dentine,0,0
35076,is,0,0
35077,considerably,0,0
35078,more,0,0
35079,susceptible,0,0
35080,than,0,0
35081,enamel,0,0
35082,to,0,0
35083,erosion,0,0
35084,and,0,0
35085,abrasion,0,0
35086,alone,0,0
35087,or,0,0
35088,combined,0,0
35089,.,0,0
35090,Dentine,0,0
35091,loss,0,0
35092,appears,0,0
35093,to,0,0
35094,correlate,0,0
35095,with,0,1
35096,toothpaste,0,0
35097,abrasivity,0,0
35098,(,0,0
35099,RDA,0,0
35100,value,0,0
35101,),0,0
35102,.,0,1
35103,Efficacy,0,0
35104,and,0,0
35105,tolerability,0,0
35106,of,0,0
35107,donepezil,0,0
35108,in,0,0
35109,vascular,1,0
35110,dementia,1,1
35111,:,1,1
35112,positive,0,0
35113,results,0,0
35114,of,0,0
35115,a,0,0
35116,24-week,0,0
35117,",",0,0
35118,multicenter,0,0
35119,",",0,0
35120,international,0,0
35121,",",0,0
35122,randomized,0,0
35123,",",0,0
35124,placebo-controlled,0,0
35125,clinical,0,0
35126,trial,0,1
35127,.,0,1
35128,BACKGROUND,0,0
35129,AND,0,0
35130,PURPOSE,0,0
35131,Clinical,0,0
35132,observations,0,0
35133,suggest,0,0
35134,that,0,0
35135,patients,1,1
35136,with,1,1
35137,vascular,1,0
35138,dementia,1,1
35139,(,1,0
35140,VaD,1,0
35141,),1,0
35142,may,0,0
35143,benefit,0,0
35144,from,0,0
35145,treatment,0,0
35146,with,0,1
35147,cholinesterase,0,0
35148,inhibitors,0,0
35149,.,0,0
35150,This,0,0
35151,study,0,0
35152,evaluated,0,0
35153,the,0,0
35154,efficacy,0,0
35155,and,0,0
35156,safety,0,0
35157,of,0,0
35158,donepezil,0,0
35159,for,0,0
35160,relieving,0,0
35161,symptoms,0,0
35162,of,0,0
35163,dementia,0,1
35164,in,0,0
35165,VaD,0,0
35166,.,0,1
35167,METHODS,0,0
35168,Patients,1,1
35169,(,1,1
35170,n=603,1,1
35171,;,1,1
35172,mean,1,0
35173,age,1,1
35174,",",1,0
35175,73.9,1,0
35176,years,1,1
35177,;,1,1
35178,55.2,1,1
35179,%,1,0
35180,men,1,1
35181,),1,1
35182,with,1,1
35183,probable,1,1
35184,(,1,1
35185,70.5,1,0
35186,%,1,0
35187,),1,0
35188,or,1,1
35189,possible,1,0
35190,(,1,0
35191,29.5,1,1
35192,%,1,0
35193,),1,0
35194,VaD,1,0
35195,",",1,0
35196,according,1,0
35197,to,1,0
35198,criteria,1,1
35199,of,1,0
35200,the,1,0
35201,National,1,0
35202,Institute,1,1
35203,of,1,0
35204,Neurological,1,1
35205,Disorders,1,1
35206,and,1,0
35207,Stroke,1,1
35208,(,1,0
35209,NINDS,1,1
35210,),1,0
35211,and,1,0
35212,the,1,0
35213,Association,1,0
35214,Internationale,1,0
35215,pour,1,0
35216,la,1,0
35217,Recherche,1,0
35218,et,1,1
35219,l'Enseignement,1,0
35220,en,1,0
35221,Neurosciences,1,1
35222,(,1,0
35223,AIREN,1,0
35224,),1,0
35225,",",0,0
35226,were,0,0
35227,randomized,0,0
35228,to,0,0
35229,24,0,0
35230,weeks,0,0
35231,of,0,0
35232,treatment,0,0
35233,with,0,1
35234,donepezil,0,0
35235,5,0,0
35236,mg/d,0,0
35237,(,0,0
35238,n=198,0,1
35239,),0,0
35240,",",0,0
35241,donepezil,0,0
35242,10,0,0
35243,mg/d,0,0
35244,(,0,0
35245,5,0,0
35246,mg/d,0,0
35247,for,0,0
35248,first,0,0
35249,28,0,1
35250,days,0,0
35251,;,0,1
35252,n=206,0,1
35253,),0,0
35254,",",0,0
35255,or,0,0
35256,placebo,0,0
35257,(,0,0
35258,n=199,0,1
35259,),0,1
35260,.,0,1
35261,Analyses,0,0
35262,were,0,0
35263,based,0,0
35264,on,0,0
35265,the,0,0
35266,intent-to-treat,0,0
35267,population,0,1
35268,.,0,0
35269,RESULTS,0,0
35270,At,0,0
35271,week,0,0
35272,24,0,0
35273,",",0,0
35274,both,0,0
35275,donepezil,0,0
35276,groups,0,0
35277,showed,0,0
35278,significant,0,0
35279,improvement,0,0
35280,in,0,0
35281,cognition,0,0
35282,versus,0,0
35283,placebo,0,0
35284,on,0,0
35285,the,0,0
35286,Alzheimer,0,1
35287,'s,0,1
35288,Disease,0,1
35289,Assessment,0,0
35290,Scale-cognitive,0,0
35291,subscale,0,0
35292,(,0,0
35293,mean,0,0
35294,change,0,0
35295,from,0,0
35296,baseline,0,0
35297,score,0,0
35298,effect,0,0
35299,size,0,0
35300,:,0,1
35301,donepezil,0,0
35302,5,0,0
35303,mg/d,0,0
35304,",",0,0
35305,-1.90,0,0
35306,;,0,1
35307,P=0.001,0,0
35308,;,0,0
35309,donepezil,0,0
35310,10,0,0
35311,mg/d,0,0
35312,",",0,0
35313,-2.33,0,0
35314,;,0,0
35315,P,0,0
35316,<,0,0
35317,0.001,0,0
35318,),0,1
35319,.,0,1
35320,Significant,0,0
35321,improvements,0,0
35322,in,0,1
35323,patients,0,1
35324,',0,1
35325,global,0,0
35326,function,0,0
35327,were,0,0
35328,seen,0,0
35329,versus,0,0
35330,placebo,0,0
35331,at,0,0
35332,week,0,0
35333,24,0,0
35334,(,0,0
35335,observed,0,0
35336,cases,0,1
35337,),0,0
35338,",",0,0
35339,on,0,0
35340,the,0,0
35341,Clinician,0,0
35342,'s,0,1
35343,Interview-Based,0,0
35344,Impression,0,1
35345,of,0,0
35346,Change-Plus,0,0
35347,version,0,0
35348,only,0,0
35349,for,0,0
35350,patients,0,1
35351,on,0,0
35352,donepezil,0,0
35353,5,0,0
35354,mg/d,0,0
35355,(,0,0
35356,P=0.014,0,0
35357,),0,0
35358,",",0,0
35359,and,0,0
35360,on,0,0
35361,the,0,0
35362,Sum,0,0
35363,of,0,0
35364,the,0,0
35365,Boxes,0,0
35366,of,0,0
35367,the,0,0
35368,Clinical,0,0
35369,Dementia,0,1
35370,Rating,0,0
35371,only,0,0
35372,for,0,0
35373,patients,0,1
35374,on,0,0
35375,10,0,1
35376,mg/d,0,0
35377,(,0,0
35378,P=0.007,0,0
35379,),0,1
35380,.,0,1
35381,Donepezil-treated,0,0
35382,patients,0,1
35383,showed,0,0
35384,significant,0,0
35385,benefits,0,0
35386,in,0,1
35387,activities,0,0
35388,of,0,0
35389,daily,0,0
35390,living,0,1
35391,over,0,0
35392,placebo,0,0
35393,on,0,0
35394,the,0,0
35395,Alzheimer,0,1
35396,'s,0,1
35397,Disease,0,1
35398,Functional,0,1
35399,Assessment,0,0
35400,and,0,0
35401,Change,0,0
35402,Scale,0,0
35403,(,0,0
35404,mean,0,0
35405,change,0,0
35406,from,0,0
35407,baseline,0,0
35408,score,0,0
35409,effect,0,0
35410,size,0,0
35411,at,0,0
35412,week,0,0
35413,24,0,1
35414,:,0,1
35415,donepezil,0,0
35416,5,0,0
35417,mg/d,0,0
35418,",",0,0
35419,-1.31,0,0
35420,",",0,0
35421,P=0.02,0,0
35422,;,0,0
35423,donepezil,0,0
35424,10,0,0
35425,mg/d,0,0
35426,",",0,0
35427,-1.31,0,0
35428,",",0,0
35429,P=0.02,0,0
35430,),0,0
35431,.,0,1
35432,Donepezil,0,0
35433,was,0,0
35434,well,0,0
35435,tolerated,0,0
35436,.,0,0
35437,Withdrawal,0,0
35438,rates,0,0
35439,due,0,1
35440,to,0,1
35441,adverse,0,0
35442,events,0,0
35443,were,0,1
35444,relatively,0,0
35445,low,0,0
35446,(,0,0
35447,placebo,0,0
35448,",",0,0
35449,11.1,0,0
35450,%,0,0
35451,;,0,0
35452,donepezil,0,0
35453,5,0,0
35454,mg/d,0,0
35455,",",0,0
35456,11.1,0,0
35457,%,0,0
35458,;,0,0
35459,donepezil,0,0
35460,10,0,0
35461,mg/d,0,0
35462,",",0,0
35463,21.8,0,0
35464,%,0,0
35465,;,0,0
35466,P=0.005,0,0
35467,versus,0,0
35468,placebo,0,0
35469,),0,0
35470,.,0,0
35471,CONCLUSIONS,0,0
35472,These,0,0
35473,data,0,0
35474,demonstrate,0,0
35475,that,0,0
35476,donepezil,0,0
35477,is,0,0
35478,an,0,0
35479,effective,0,0
35480,and,0,0
35481,well-tolerated,0,0
35482,treatment,0,0
35483,for,0,0
35484,VaD,0,0
35485,and,0,0
35486,show,0,0
35487,it,0,0
35488,may,0,0
35489,have,0,0
35490,an,0,0
35491,important,0,0
35492,place,0,0
35493,in,0,0
35494,the,0,0
35495,management,0,0
35496,of,0,0
35497,this,0,0
35498,condition,0,0
35499,.,0,0
35500,T,0,1
35501,lymphocyte,0,1
35502,subsets,0,0
35503,and,0,1
35504,NK,0,0
35505,cell,0,0
35506,cytotoxicity,0,0
35507,in,0,0
35508,chronic,1,1
35509,hemodialysis,1,1
35510,patients,1,1
35511,.,1,0
35512,The,0,0
35513,effect,0,0
35514,of,0,0
35515,recombinant,0,0
35516,human,0,1
35517,erythropoietin,0,0
35518,(,0,0
35519,rHu-EPO,0,0
35520,),0,1
35521,treatment,0,0
35522,.,0,0
35523,We,0,0
35524,investigated,0,0
35525,subpopulations,0,0
35526,of,0,1
35527,T,0,1
35528,lymphocytes,0,0
35529,",",0,0
35530,NK,0,0
35531,cell,0,0
35532,number,0,0
35533,and,0,0
35534,cytotoxic,0,0
35535,activity,0,0
35536,in,0,0
35537,14,1,1
35538,chronic,1,1
35539,uremic,1,1
35540,patients,1,1
35541,on,1,0
35542,regular,1,0
35543,hemodialysis,1,1
35544,treatment,1,0
35545,.,1,0
35546,We,0,0
35547,observed,0,0
35548,a,0,0
35549,significantly,0,0
35550,decreased,0,0
35551,absolute,0,0
35552,lymphocyte,0,0
35553,number,0,0
35554,and,0,0
35555,percentage,0,0
35556,of,0,0
35557,CD3,0,1
35558,cells,0,0
35559,.,0,1
35560,Relative,0,0
35561,numbers,0,0
35562,of,0,1
35563,CD16,0,1
35564,cells,0,0
35565,were,0,0
35566,significantly,0,0
35567,elevated,0,0
35568,",",0,0
35569,but,0,0
35570,NK,0,0
35571,cell,0,1
35572,cytotoxic,0,0
35573,activity,0,0
35574,was,0,0
35575,within,0,0
35576,a,0,0
35577,normal,0,1
35578,range,0,0
35579,.,0,1
35580,Nine,1,0
35581,patients,1,1
35582,with,1,1
35583,chronic,1,1
35584,renal,1,1
35585,anemia,1,1
35586,on,1,0
35587,maintenance,1,0
35588,hemodialysis,1,1
35589,were,0,0
35590,enrolled,0,1
35591,in,0,0
35592,rHu-EPO,0,0
35593,treatment,0,0
35594,trial,0,0
35595,.,0,0
35596,The,0,0
35597,treatment,0,0
35598,was,0,0
35599,continued,0,0
35600,till,0,1
35601,the,0,0
35602,hematocrit,0,0
35603,level,0,0
35604,reached,0,0
35605,30,0,1
35606,%,0,0
35607,.,0,0
35608,Each,0,0
35609,of,0,0
35610,the,0,0
35611,patients,1,1
35612,had,1,0
35613,corrected,0,0
35614,anemia,0,1
35615,and,0,0
35616,well-being,0,0
35617,.,0,0
35618,After,0,0
35619,12,0,0
35620,weeks,0,0
35621,of,0,0
35622,the,0,0
35623,treatment,0,0
35624,we,0,0
35625,observed,0,0
35626,in,0,0
35627,these,0,0
35628,patients,0,1
35629,decreases,0,0
35630,in,0,1
35631,CD3,0,1
35632,",",0,0
35633,CD4,0,1
35634,",",0,0
35635,CD8,0,0
35636,and,0,0
35637,CD16,0,1
35638,cell,0,1
35639,numbers,0,0
35640,and,0,0
35641,elevation,0,0
35642,of,0,0
35643,CD4/CD8,0,1
35644,ratio,0,0
35645,.,0,0
35646,Cytotoxic,0,0
35647,activity,0,0
35648,of,0,0
35649,NK,0,0
35650,cells,0,0
35651,did,0,0
35652,not,0,0
35653,change,0,0
35654,significantly,0,0
35655,.,0,0
35656,Presented,0,0
35657,results,0,0
35658,indicate,0,0
35659,that,0,0
35660,chronic,1,1
35661,hemodialysis,1,1
35662,patients,1,1
35663,have,0,0
35664,significantly,0,0
35665,diminished,0,0
35666,lymphocyte,0,0
35667,number,0,0
35668,.,0,1
35669,rHu,0,0
35670,EPO,0,0
35671,treatment,0,0
35672,affects,0,0
35673,the,0,0
35674,T,0,0
35675,lymphocyte,0,0
35676,subsets,0,0
35677,inducing,0,0
35678,a,0,0
35679,deep,0,0
35680,decrease,0,0
35681,of,0,0
35682,CD8,0,1
35683,and,0,0
35684,CD16,0,0
35685,cell,0,1
35686,percentage,0,0
35687,leading,0,0
35688,to,0,0
35689,normalisation,0,0
35690,of,0,0
35691,the,0,0
35692,CD4/CD8,0,0
35693,ratio,0,0
35694,.,0,1
35695,Shorter,0,0
35696,treatment,0,0
35697,for,0,0
35698,vaginal,1,1
35699,candidosis,1,1
35700,:,1,1
35701,comparison,0,0
35702,between,0,0
35703,single-dose,0,0
35704,oral,0,0
35705,fluconazole,0,0
35706,and,0,0
35707,three-day,0,0
35708,treatment,0,0
35709,with,0,1
35710,local,0,0
35711,miconazole,0,0
35712,.,0,0
35713,Fluconazole,0,0
35714,is,0,0
35715,an,0,0
35716,effective,0,0
35717,",",0,0
35718,simple,0,0
35719,and,0,0
35720,safe,0,0
35721,",",0,0
35722,although,0,0
35723,slightly,0,0
35724,expensive,0,0
35725,",",0,0
35726,agent,0,0
35727,for,0,0
35728,the,0,0
35729,treatment,0,0
35730,of,0,0
35731,vaginal,1,1
35732,candidosis,1,1
35733,.,1,1
35734,Single-dose,0,0
35735,fluconazole,0,0
35736,(,0,0
35737,150,0,0
35738,mg,0,0
35739,),0,0
35740,administered,0,0
35741,orally,0,0
35742,in,0,0
35743,capsule,0,0
35744,form,0,0
35745,was,0,0
35746,compared,0,0
35747,with,0,1
35748,three-day,0,0
35749,local,0,0
35750,treatment,0,0
35751,with,0,1
35752,miconazole,0,0
35753,pessaries,0,0
35754,in,0,0
35755,the,0,0
35756,treatment,1,0
35757,of,1,0
35758,vaginal,1,1
35759,candidosis,1,1
35760,in,1,0
35761,a,1,0
35762,randomized,1,0
35763,study,1,0
35764,in,1,0
35765,Finland,1,1
35766,.,1,1
35767,Cure,0,0
35768,rates,0,0
35769,were,0,1
35770,good,0,0
35771,(,0,1
35772,>,0,1
35773,80,0,1
35774,%,0,0
35775,),0,0
35776,in,0,0
35777,randomized,0,1
35778,patient,0,1
35779,groups,0,0
35780,assessed,0,0
35781,both,0,0
35782,clinically,0,0
35783,and,0,0
35784,by,0,0
35785,the,0,0
35786,results,0,0
35787,of,0,0
35788,yeast,0,1
35789,cultures,0,0
35790,.,0,1
35791,Oral,0,0
35792,administration,0,0
35793,was,0,0
35794,preferred,0,0
35795,to,0,0
35796,local,0,0
35797,therapy,0,0
35798,by,0,0
35799,patients,0,1
35800,in,0,0
35801,both,0,0
35802,the,0,0
35803,miconazole,0,0
35804,and,0,0
35805,fluconazole,0,0
35806,groups,0,0
35807,.,0,1
35808,For,0,0
35809,the,0,0
35810,time,0,0
35811,being,0,0
35812,",",0,0
35813,fluconazole,0,0
35814,is,0,0
35815,not,0,0
35816,recommended,0,0
35817,for,0,0
35818,use,0,0
35819,during,0,0
35820,pregnancy,0,1
35821,or,0,1
35822,lactation,0,0
35823,.,0,1
35824,The,0,0
35825,adrenocorticotrophic,0,0
35826,hormone,0,0
35827,(,0,0
35828,4-9,0,1
35829,),0,0
35830,analog,0,0
35831,ORG,0,0
35832,2766,0,1
35833,benefits,0,0
35834,autistic,1,1
35835,children,1,1
35836,:,1,1
35837,report,0,0
35838,on,0,0
35839,a,0,0
35840,second,0,0
35841,controlled,0,0
35842,clinical,0,0
35843,trial,0,0
35844,.,0,0
35845,In,0,0
35846,a,0,0
35847,second,0,0
35848,controlled,0,0
35849,crossover,0,0
35850,trial,0,0
35851,",",0,0
35852,20,1,1
35853,autistic,1,1
35854,children,1,1
35855,received,1,1
35856,40,1,1
35857,mg/day,1,0
35858,of,1,0
35859,the,1,0
35860,neuropeptide,1,0
35861,ORG,1,0
35862,2766,1,0
35863,",",1,0
35864,a,1,0
35865,synthetic,1,0
35866,analog,1,0
35867,of,1,0
35868,ACTH,1,1
35869,(,1,1
35870,4-9,1,1
35871,),1,0
35872,",",1,0
35873,for,1,0
35874,8,1,0
35875,weeks,1,0
35876,.,1,1
35877,Parents,0,0
35878,',0,1
35879,checklist,0,0
35880,ratings,0,0
35881,(,0,1
35882,ABC,0,0
35883,),0,0
35884,as,0,0
35885,well,0,0
35886,as,0,0
35887,clinicians,0,0
35888,',0,1
35889,ratings,0,0
35890,(,0,1
35891,CGI,0,1
35892,),0,0
35893,pointed,0,0
35894,to,0,0
35895,significant,0,0
35896,improvements,0,0
35897,after,0,0
35898,the,0,0
35899,course,0,0
35900,of,0,0
35901,treatment,0,0
35902,;,0,1
35903,improvements,0,0
35904,were,0,0
35905,clearest,0,0
35906,on,0,0
35907,the,0,0
35908,ABC,0,0
35909,social,0,0
35910,withdrawal,0,0
35911,subscale,0,0
35912,.,0,0
35913,The,0,0
35914,analysis,0,0
35915,of,0,0
35916,individual,0,0
35917,target,0,0
35918,symptoms,0,0
35919,and,0,0
35920,the,0,0
35921,parents,0,1
35922,',0,1
35923,treatment,0,0
35924,preferences,0,0
35925,substantiated,0,0
35926,the,0,0
35927,beneficial,0,0
35928,effects,0,0
35929,of,0,1
35930,ORG,0,0
35931,2766,0,1
35932,.,0,0
35933,In,0,0
35934,an,0,0
35935,ethologically,0,0
35936,analyzed,0,0
35937,playroom,0,0
35938,session,0,0
35939,",",0,0
35940,ORG,0,0
35941,2766,0,1
35942,treatment,0,0
35943,was,0,0
35944,associated,0,0
35945,with,0,1
35946,an,0,0
35947,improvement,0,0
35948,in,0,0
35949,the,0,0
35950,children,0,1
35951,'s,0,1
35952,play,0,0
35953,behavior,0,0
35954,and,0,0
35955,a,0,0
35956,significant,0,0
35957,increase,0,0
35958,in,0,0
35959,the,0,0
35960,social,0,0
35961,interaction,0,0
35962,between,0,0
35963,child,0,1
35964,and,0,0
35965,experimenter,0,0
35966,.,0,0
35967,Gaze,0,0
35968,coordination,0,0
35969,between,0,0
35970,child,0,1
35971,and,0,0
35972,experimenter,0,0
35973,also,0,0
35974,was,0,0
35975,improved,0,0
35976,.,0,1
35977,Role,0,0
35978,of,0,0
35979,memory,0,0
35980,B-cell,0,0
35981,responses,0,0
35982,in,0,0
35983,serum,0,0
35984,and,0,0
35985,mucosal,0,0
35986,fluids,0,0
35987,of,0,0
35988,swine,0,1
35989,for,0,0
35990,protective,0,0
35991,immunity,0,0
35992,against,0,0
35993,pseudorabies,0,1
35994,virus,0,1
35995,.,0,0
35996,We,0,0
35997,examined,0,0
35998,primary,0,1
35999,and,0,0
36000,memory,0,0
36001,isotype-specific,0,0
36002,antibody,0,0
36003,responses,0,0
36004,directed,0,0
36005,against,0,1
36006,pseudorabies,0,1
36007,virus,0,1
36008,in,0,0
36009,serum,0,0
36010,and,0,0
36011,mucosal,0,0
36012,fluids,0,0
36013,of,0,1
36014,pigs,1,1
36015,with,1,1
36016,and,1,0
36017,without,1,1
36018,passively,1,0
36019,acquired,1,0
36020,maternal,1,0
36021,antibody,1,0
36022,",",0,0
36023,and,0,0
36024,we,0,0
36025,studied,0,0
36026,the,0,0
36027,relationship,0,0
36028,between,0,0
36029,these,0,0
36030,responses,0,0
36031,and,0,0
36032,protection,0,0
36033,against,0,0
36034,virus,0,1
36035,challenge,0,0
36036,.,0,1
36037,Pigs,1,0
36038,were,0,0
36039,inoculated,0,0
36040,intranasally,0,0
36041,with,0,1
36042,the,0,0
36043,virulent,0,1
36044,NIA-3,0,0
36045,strain,0,0
36046,or,0,0
36047,the,0,0
36048,avirulent,0,1
36049,Bartha,0,1
36050,strain,0,0
36051,",",0,0
36052,or,0,0
36053,they,0,0
36054,were,0,0
36055,inoculated,0,0
36056,IM,0,1
36057,with,0,1
36058,an,0,0
36059,inactivated,0,0
36060,vaccine,0,0
36061,containing,0,0
36062,the,0,0
36063,Phylaxia,0,1
36064,strain,0,0
36065,.,0,1
36066,Ten,0,1
36067,weeks,0,0
36068,later,0,1
36069,",",0,0
36070,all,0,0
36071,pigs,0,0
36072,were,0,0
36073,challenge-exposed,0,0
36074,intranasally,0,0
36075,with,0,1
36076,strain,0,0
36077,NIA-3,0,0
36078,.,0,0
36079,Only,0,0
36080,pigs,0,0
36081,that,0,0
36082,were,0,0
36083,without,0,1
36084,passively,0,0
36085,acquired,0,0
36086,antibody,0,0
36087,at,0,0
36088,the,0,0
36089,time,0,0
36090,they,0,0
36091,were,0,0
36092,inoculated,0,0
36093,with,0,1
36094,virulent,0,1
36095,virus,0,1
36096,appeared,0,0
36097,to,0,0
36098,have,0,0
36099,complete,0,0
36100,protective,0,0
36101,immunity,0,0
36102,against,0,0
36103,challenge,0,0
36104,exposure,0,0
36105,",",0,0
36106,as,0,0
36107,evidenced,0,0
36108,by,0,0
36109,lack,0,0
36110,of,0,0
36111,clinical,0,0
36112,signs,0,1
36113,of,0,1
36114,pseudorabies,0,1
36115,and,0,0
36116,lack,0,0
36117,of,0,0
36118,virus,0,1
36119,excretion,0,0
36120,.,0,0
36121,In,0,0
36122,contrast,0,0
36123,",",0,0
36124,pigs,1,1
36125,inoculated,1,0
36126,with,1,1
36127,strain,1,0
36128,Bartha,1,1
36129,or,1,1
36130,with,1,1
36131,the,1,0
36132,inactivated,1,0
36133,vaccine,1,0
36134,developed,0,0
36135,fever,0,0
36136,",",0,0
36137,had,0,0
36138,a,0,0
36139,period,0,0
36140,of,0,0
36141,growth,0,0
36142,arrest,0,0
36143,",",0,0
36144,and,0,0
36145,excreted,0,0
36146,virus,0,1
36147,after,0,0
36148,challenge,0,0
36149,exposure,0,0
36150,.,0,0
36151,In,0,0
36152,pigs,0,1
36153,without,0,1
36154,passively,0,1
36155,acquired,0,0
36156,antibody,0,0
36157,",",0,0
36158,intranasal,0,0
36159,inoculation,0,0
36160,with,0,1
36161,strains,0,0
36162,NIA-3,0,0
36163,or,0,1
36164,Bartha,0,1
36165,was,0,0
36166,followed,0,0
36167,by,0,0
36168,primary,0,1
36169,IgM,0,1
36170,and,0,1
36171,IgA,0,0
36172,responses,0,0
36173,in,0,0
36174,serum,0,0
36175,and,0,0
36176,in,0,0
36177,oropharyngeal,0,1
36178,fluid,0,0
36179,as,0,0
36180,well,0,0
36181,as,0,0
36182,primary,0,1
36183,IgG1,0,0
36184,and,0,1
36185,IgG2,0,1
36186,responses,0,0
36187,in,0,0
36188,serum,0,0
36189,.,0,1
36190,Intramuscular,0,0
36191,inoculation,0,0
36192,with,0,1
36193,the,0,0
36194,inactivated,0,0
36195,vaccine,0,0
36196,induced,0,0
36197,primary,0,1
36198,serum,0,0
36199,IgM,0,0
36200,",",0,0
36201,IgG1,0,0
36202,",",0,0
36203,and,0,0
36204,IgG2,0,0
36205,responses,0,0
36206,",",0,0
36207,but,0,0
36208,no,0,0
36209,mucosal,0,0
36210,responses,0,0
36211,.,0,0
36212,Challenge,0,0
36213,exposure,0,0
36214,of,0,0
36215,pigs,0,1
36216,that,0,0
36217,had,0,1
36218,been,0,0
36219,inoculated,0,0
36220,with,0,1
36221,the,0,0
36222,Bartha,0,1
36223,strain,0,0
36224,or,0,0
36225,the,0,0
36226,inactivated,0,0
36227,vaccine,0,0
36228,was,0,0
36229,followed,0,0
36230,by,0,0
36231,clear,0,0
36232,memory,0,0
36233,responses,0,0
36234,in,0,0
36235,serum,0,0
36236,and,0,0
36237,in,0,0
36238,oropharyngeal,0,1
36239,fluid,0,0
36240,.,0,0
36241,In,0,0
36242,contrast,0,0
36243,",",0,0
36244,challenge,0,0
36245,exposure,0,0
36246,of,0,0
36247,pigs,0,1
36248,that,0,0
36249,had,0,1
36250,been,0,0
36251,inoculated,0,0
36252,by,0,0
36253,the,0,0
36254,virulent,0,1
36255,NIA-3,0,0
36256,strain,0,0
36257,was,0,0
36258,not,0,0
36259,followed,0,0
36260,by,0,0
36261,memory,0,0
36262,responses,0,0
36263,.,0,1
36264,(,0,0
36265,ABSTRACT,0,0
36266,TRUNCATED,0,1
36267,AT,0,1
36268,250,0,0
36269,WORDS,0,1
36270,),0,1
36271,Long-term,0,0
36272,anticoagulant,0,0
36273,treatment,0,0
36274,after,0,0
36275,acute,0,1
36276,myocardial,0,1
36277,infarction,0,1
36278,.,0,0
36279,The,0,0
36280,Warfarin,0,0
36281,Re-Infarction,0,1
36282,Study,0,0
36283,.,0,1
36284,High,0,0
36285,levels,0,0
36286,of,0,0
36287,fibrinogen,0,0
36288,and,0,0
36289,clotting,0,0
36290,factor,0,0
36291,VII,0,0
36292,are,0,0
36293,associated,0,0
36294,with,0,1
36295,an,0,0
36296,increased,0,0
36297,risk,0,0
36298,for,0,0
36299,subsequent,0,0
36300,death,0,0
36301,and,0,0
36302,cardiovascular,0,0
36303,disease,0,1
36304,in,0,0
36305,apparently,1,1
36306,healthy,1,1
36307,individuals,1,1
36308,.,1,0
36309,Furthermore,0,0
36310,",",0,0
36311,pathoanatomic,0,0
36312,studies,0,0
36313,and,0,1
36314,coronary,0,1
36315,angiography,0,0
36316,have,0,0
36317,confirmed,0,0
36318,a,0,0
36319,relationship,0,0
36320,between,0,0
36321,coronary,0,1
36322,thrombus,0,0
36323,formation,0,0
36324,and,0,0
36325,acute,0,1
36326,Q-wave,0,0
36327,infarction,0,1
36328,.,0,1
36329,Effective,0,0
36330,antithrombotic,0,0
36331,agents,0,0
36332,may,0,0
36333,prevent,0,0
36334,or,0,0
36335,limit,0,0
36336,thrombus,0,0
36337,formation,0,0
36338,and,0,0
36339,events,0,0
36340,related,0,0
36341,to,0,0
36342,thrombosis,0,0
36343,.,0,0
36344,The,0,0
36345,Warfarin,0,0
36346,Re-Infarction,0,1
36347,Study,0,0
36348,(,0,0
36349,WARIS,0,0
36350,),0,0
36351,studied,0,0
36352,the,0,0
36353,effect,0,0
36354,of,0,0
36355,warfarin,0,0
36356,in,0,0
36357,survivors,1,1
36358,of,1,1
36359,acute,1,1
36360,myocardial,1,1
36361,infarction,1,1
36362,.,1,1
36363,Patients,1,1
36364,aged,1,1
36365,75,1,1
36366,years,1,1
36367,or,1,1
36368,less,1,0
36369,were,0,0
36370,randomized,0,0
36371,in,0,0
36372,a,0,0
36373,double-blind,0,0
36374,",",0,0
36375,placebo-controlled,0,0
36376,study,0,0
36377,to,0,0
36378,test,0,0
36379,whether,0,0
36380,long-term,0,0
36381,treatment,0,0
36382,with,0,1
36383,warfarin,0,0
36384,reduces,0,0
36385,the,0,0
36386,risk,0,0
36387,of,0,0
36388,death,0,0
36389,",",0,0
36390,reinfarction,0,0
36391,",",0,0
36392,and,0,0
36393,thromboembolic,0,0
36394,morbidity,0,0
36395,.,0,0
36396,A,1,0
36397,total,1,1
36398,of,1,0
36399,1918,1,1
36400,patients,1,1
36401,were,1,1
36402,screened,1,1
36403,for,1,0
36404,participation,1,0
36405,;,1,1
36406,1214,1,1
36407,were,1,0
36408,recruited,1,1
36409,.,1,0
36410,The,0,0
36411,mean,0,0
36412,follow-up,0,0
36413,was,0,0
36414,37,0,1
36415,months,0,0
36416,.,0,1
36417,Analyzed,0,0
36418,on,0,0
36419,an,0,0
36420,intention-to-treat,0,0
36421,basis,0,0
36422,",",0,0
36423,123,0,1
36424,(,0,0
36425,20,0,1
36426,%,0,0
36427,),0,0
36428,in,0,0
36429,the,0,0
36430,placebo,0,0
36431,group,0,0
36432,died,0,1
36433,",",0,0
36434,versus,0,0
36435,94,0,1
36436,(,0,0
36437,15,0,1
36438,%,0,0
36439,),0,0
36440,in,0,0
36441,the,0,0
36442,warfarin,0,0
36443,group,0,0
36444,",",0,0
36445,a,0,0
36446,risk,0,0
36447,reduction,0,0
36448,of,0,0
36449,24,0,0
36450,%,0,0
36451,(,0,0
36452,P,0,0
36453,=,0,0
36454,0.026,0,0
36455,),0,0
36456,.,0,1
36457,Considering,0,0
36458,patients,0,1
36459,on,0,0
36460,treatment,0,0
36461,or,0,1
36462,within,0,0
36463,28,0,1
36464,days,0,0
36465,after,0,0
36466,discontinuing,0,0
36467,the,0,0
36468,test,0,0
36469,medication,0,0
36470,",",0,0
36471,92,0,0
36472,in,0,0
36473,the,0,0
36474,placebo,0,0
36475,group,0,0
36476,died,0,1
36477,",",0,0
36478,as,0,0
36479,compared,0,0
36480,with,0,1
36481,60,0,1
36482,of,0,0
36483,the,0,0
36484,warfarin-treated,0,1
36485,patients,0,1
36486,",",0,0
36487,a,0,0
36488,risk,0,0
36489,reduction,0,0
36490,of,0,0
36491,35,0,1
36492,%,0,0
36493,(,0,0
36494,P,0,0
36495,=,0,0
36496,0.005,0,0
36497,),0,0
36498,.,0,1
36499,Relapsing,0,0
36500,myocardial,0,1
36501,infarction,0,1
36502,(,0,0
36503,fatal,0,1
36504,and,0,0
36505,nonfatal,0,0
36506,),0,0
36507,was,0,0
36508,reduced,0,0
36509,by,0,0
36510,43,0,1
36511,%,0,0
36512,(,0,0
36513,P,0,0
36514,=,0,0
36515,0.0001,0,0
36516,),0,0
36517,.,0,0
36518,The,0,0
36519,incidence,0,0
36520,of,0,0
36521,cerebrovascular,0,1
36522,attacks,0,0
36523,was,0,0
36524,lower,0,0
36525,in,0,0
36526,the,0,0
36527,warfarin,0,0
36528,group,0,0
36529,(,0,0
36530,16,0,1
36531,patients,0,1
36532,),0,1
36533,than,0,0
36534,the,0,0
36535,placebo,0,0
36536,group,0,0
36537,(,0,0
36538,41,0,1
36539,patients,0,1
36540,),0,0
36541,",",0,0
36542,a,0,0
36543,highly,0,0
36544,significant,0,0
36545,reduction,0,0
36546,of,0,0
36547,61,0,1
36548,%,0,0
36549,(,0,0
36550,P,0,0
36551,=,0,0
36552,0.0003,0,0
36553,),0,1
36554,.,0,1
36555,Serious,0,0
36556,bleeding,0,0
36557,occurred,0,0
36558,in,0,0
36559,11,0,1
36560,patients,0,1
36561,taking,0,1
36562,warfarin,0,0
36563,",",0,0
36564,an,0,0
36565,incidence,0,0
36566,of,0,0
36567,0.6,0,0
36568,%,0,0
36569,per,0,0
36570,year,0,0
36571,.,0,0
36572,In,0,0
36573,conclusion,0,0
36574,",",0,0
36575,long-term,0,0
36576,anticoagulant,0,0
36577,therapy,0,0
36578,may,0,0
36579,be,0,0
36580,recommended,0,0
36581,after,0,0
36582,acute,0,1
36583,myocardial,0,1
36584,infarction,0,1
36585,.,0,1
36586,Effect,0,0
36587,of,0,0
36588,enalapril,0,0
36589,on,0,0
36590,myocardial,0,1
36591,infarction,0,1
36592,and,0,0
36593,unstable,0,1
36594,angina,0,1
36595,in,0,0
36596,patients,1,1
36597,with,1,1
36598,low,1,1
36599,ejection,1,1
36600,fractions,1,0
36601,.,1,0
36602,An,0,0
36603,association,0,0
36604,between,0,0
36605,raised,0,0
36606,renin,0,0
36607,levels,0,0
36608,and,0,0
36609,myocardial,0,1
36610,infarction,0,1
36611,has,0,0
36612,been,0,0
36613,reported,0,0
36614,.,0,0
36615,We,0,0
36616,studied,0,0
36617,the,0,0
36618,effects,0,0
36619,of,0,0
36620,enalapril,0,0
36621,",",0,0
36622,an,0,0
36623,angiotensin-converting,0,0
36624,enzyme,0,0
36625,(,0,0
36626,ACE,0,1
36627,),0,0
36628,inhibitor,0,0
36629,",",0,0
36630,on,0,0
36631,the,0,0
36632,development,0,0
36633,of,0,0
36634,myocardial,0,1
36635,infarction,0,1
36636,and,0,0
36637,unstable,0,1
36638,angina,0,1
36639,in,0,0
36640,6797,1,1
36641,patients,1,1
36642,with,1,1
36643,ejection,1,1
36644,fractions,1,0
36645,<,1,0
36646,or,1,1
36647,=,1,0
36648,0.35,1,0
36649,enrolled,1,1
36650,into,1,0
36651,the,1,0
36652,two,1,0
36653,Studies,1,0
36654,of,1,1
36655,Left,1,1
36656,Ventricular,1,1
36657,Dysfunction,1,1
36658,(,1,0
36659,SOLVD,1,1
36660,),1,1
36661,trials,1,0
36662,.,1,1
36663,Patients,0,1
36664,were,0,0
36665,randomly,0,1
36666,assigned,0,0
36667,to,0,0
36668,placebo,0,0
36669,(,0,0
36670,n,0,1
36671,=,0,0
36672,3401,0,1
36673,),0,0
36674,or,0,1
36675,enalapril,0,0
36676,(,0,0
36677,n,0,1
36678,=,0,0
36679,3396,0,1
36680,),0,0
36681,at,0,0
36682,doses,0,0
36683,of,0,1
36684,2.5-20,0,0
36685,mg,0,0
36686,per,0,0
36687,day,0,0
36688,in,0,0
36689,two,0,0
36690,concurrent,0,0
36691,double-blind,0,0
36692,trials,0,0
36693,with,0,1
36694,the,0,0
36695,same,0,0
36696,protocol,0,0
36697,.,0,1
36698,Patients,1,1
36699,with,1,1
36700,heart,1,1
36701,failure,1,1
36702,entered,1,0
36703,the,1,0
36704,treatment,1,0
36705,trial,1,0
36706,(,1,0
36707,n,1,1
36708,=,1,0
36709,2569,1,1
36710,),1,0
36711,and,1,0
36712,those,1,0
36713,without,1,0
36714,heart,1,1
36715,failure,1,1
36716,entered,1,0
36717,the,1,0
36718,prevention,1,0
36719,trial,1,0
36720,(,1,0
36721,n,1,1
36722,=,1,0
36723,4228,1,1
36724,),1,0
36725,.,1,1
36726,Follow-up,0,0
36727,averaged,0,0
36728,40,0,1
36729,months,0,0
36730,.,0,1
36731,In,0,0
36732,each,0,0
36733,trial,0,0
36734,there,0,0
36735,were,0,0
36736,significant,0,0
36737,reductions,0,0
36738,in,0,0
36739,the,0,0
36740,number,0,0
36741,of,0,0
36742,patients,0,1
36743,developing,0,1
36744,myocardial,0,1
36745,infarction,0,1
36746,(,0,0
36747,treatment,0,0
36748,trial,0,1
36749,:,0,1
36750,158,0,1
36751,placebo,0,0
36752,vs,0,0
36753,127,0,1
36754,enalapril,0,0
36755,",",0,0
36756,p,0,0
36757,<,0,0
36758,0.02,0,0
36759,;,0,0
36760,prevention,0,1
36761,trial,0,1
36762,:,0,1
36763,204,0,1
36764,vs,0,0
36765,161,0,1
36766,p,0,0
36767,<,0,0
36768,0.01,0,0
36769,),0,0
36770,or,0,1
36771,unstable,0,1
36772,angina,0,1
36773,(,0,0
36774,240,0,1
36775,vs,0,0
36776,187,0,1
36777,p,0,0
36778,<,0,0
36779,0.001,0,0
36780,;,0,0
36781,355,0,1
36782,vs,0,0
36783,312,0,1
36784,",",0,0
36785,p,0,0
36786,<,0,0
36787,0.05,0,0
36788,),0,1
36789,.,0,0
36790,Combined,0,0
36791,",",0,0
36792,there,0,0
36793,were,0,0
36794,362,1,1
36795,placebo,1,0
36796,group,1,1
36797,patients,0,1
36798,with,0,1
36799,myocardial,0,1
36800,infarction,0,1
36801,compared,0,0
36802,with,0,1
36803,288,0,1
36804,in,0,0
36805,the,0,0
36806,enalapril,0,0
36807,group,0,0
36808,(,0,0
36809,risk,0,0
36810,reduction,0,0
36811,23,0,1
36812,%,0,0
36813,",",0,0
36814,95,0,0
36815,%,0,0
36816,CI,0,0
36817,11-34,0,1
36818,%,0,0
36819,;,0,0
36820,p,0,0
36821,<,0,0
36822,0.001,0,0
36823,),0,0
36824,.,0,1
36825,595,1,0
36826,placebo,1,0
36827,group,1,1
36828,patients,0,1
36829,developed,0,1
36830,unstable,0,1
36831,angina,0,1
36832,compared,0,0
36833,with,0,1
36834,499,0,1
36835,in,0,0
36836,the,0,0
36837,enalapril,0,0
36838,group,0,0
36839,(,0,0
36840,risk,0,0
36841,reduction,0,0
36842,20,0,0
36843,%,0,0
36844,",",0,0
36845,95,0,0
36846,%,0,0
36847,CI,0,0
36848,9-29,0,0
36849,%,0,0
36850,",",0,0
36851,p,0,0
36852,<,0,0
36853,0.001,0,0
36854,),0,0
36855,.,0,0
36856,There,0,0
36857,was,0,0
36858,also,0,0
36859,a,0,0
36860,reduction,0,0
36861,in,0,0
36862,cardiac,0,1
36863,deaths,0,0
36864,(,0,1
36865,711,0,1
36866,placebo,0,0
36867,",",0,0
36868,615,0,1
36869,enalapril,0,0
36870,;,0,0
36871,p,0,0
36872,<,0,0
36873,0.003,0,0
36874,),0,0
36875,",",0,0
36876,so,0,0
36877,that,0,0
36878,the,0,0
36879,reduction,0,0
36880,in,0,0
36881,the,0,0
36882,combined,0,0
36883,endpoint,0,0
36884,of,0,0
36885,deaths,0,0
36886,",",0,0
36887,myocardial,0,1
36888,infarction,0,1
36889,",",0,0
36890,and,0,0
36891,unstable,0,1
36892,angina,0,1
36893,was,0,0
36894,highly,0,0
36895,significant,0,0
36896,(,0,0
36897,20,0,1
36898,%,0,0
36899,risk,0,0
36900,reduction,0,0
36901,",",0,0
36902,95,0,0
36903,%,0,0
36904,CI,0,0
36905,14-26,0,1
36906,%,0,0
36907,;,0,0
36908,p,0,0
36909,<,0,0
36910,0.0001,0,0
36911,),0,0
36912,.,0,1
36913,Enalapril,0,0
36914,treatment,0,0
36915,significantly,0,0
36916,reduced,0,0
36917,myocardial,0,1
36918,infarction,0,1
36919,",",0,0
36920,unstable,0,1
36921,angina,0,1
36922,",",0,0
36923,and,0,0
36924,cardiac,0,1
36925,mortality,0,0
36926,in,0,0
36927,patients,1,1
36928,with,1,1
36929,low,1,1
36930,ejection,1,1
36931,fractions,1,1
36932,.,1,1
36933,[,0,0
36934,Platelet,0,0
36935,serotonin,0,0
36936,in,0,0
36937,infantile,1,1
36938,autism,1,1
36939,.,1,1
36940,Cross-over,0,0
36941,effects,0,0
36942,of,0,0
36943,a,0,0
36944,dopamine,0,0
36945,agonist,0,0
36946,and,0,0
36947,an,0,0
36948,antagonist,0,0
36949,],0,0
36950,.,0,0
36951,In,0,0
36952,infantile,1,1
36953,autism,1,1
36954,",",0,0
36955,the,0,0
36956,serotoninergic,0,0
36957,(,0,0
36958,5-HT,0,0
36959,),0,0
36960,hypothesis,0,0
36961,is,0,0
36962,corroborated,0,0
36963,by,0,0
36964,biological,0,0
36965,dosages,0,0
36966,and,0,1
36967,therapeutic,0,0
36968,effects,0,0
36969,of,0,0
36970,fenfluramine,0,0
36971,which,0,0
36972,decrease,0,0
36973,blood,0,0
36974,serotonin,0,0
36975,.,0,0
36976,However,0,0
36977,other,0,0
36978,drugs,0,0
36979,",",0,0
36980,such,0,0
36981,as,0,0
36982,dopaminergic,0,0
36983,agonists,0,1
36984,or,0,1
36985,antagonists,0,0
36986,",",0,0
36987,have,0,0
36988,therapeutic,0,0
36989,effects,0,0
36990,.,0,0
36991,Therefore,0,0
36992,",",0,0
36993,we,0,0
36994,tested,0,0
36995,the,0,0
36996,hypothesis,0,0
36997,that,0,0
36998,two,0,0
36999,dopaminergic,0,0
37000,(,0,0
37001,DA,0,0
37002,),0,1
37003,drugs,0,0
37004,have,0,0
37005,a,0,0
37006,similar,0,0
37007,5-HT,0,0
37008,effect,0,0
37009,underlying,0,0
37010,the,0,0
37011,therapeutic,0,0
37012,efficiency,0,0
37013,.,0,1
37014,We,0,0
37015,evaluated,0,0
37016,in,0,0
37017,a,0,0
37018,randomized,0,0
37019,",",0,0
37020,double-blind,0,0
37021,and,0,0
37022,cross-over,0,0
37023,study,0,0
37024,",",0,0
37025,the,0,0
37026,effects,0,0
37027,of,0,0
37028,a,0,0
37029,DA,0,0
37030,agonist,0,0
37031,(,0,0
37032,bromocriptine,0,1
37033,),0,0
37034,and,0,0
37035,a,0,0
37036,DA,0,0
37037,antagonist,0,0
37038,(,0,0
37039,amisulpride,0,0
37040,),0,0
37041,on,0,0
37042,platelet,0,0
37043,5-HT,0,0
37044,in,0,0
37045,infantile,1,1
37046,autism,1,1
37047,.,1,0
37048,The,0,0
37049,prolactinemia,0,0
37050,",",0,0
37051,reflecting,0,0
37052,the,0,0
37053,DA,0,0
37054,action,0,0
37055,",",0,0
37056,has,0,0
37057,been,0,0
37058,also,0,0
37059,measured,0,0
37060,.,0,0
37061,Nine,1,0
37062,children,1,1
37063,",",1,0
37064,aged,1,1
37065,from,1,0
37066,4,1,0
37067,to,1,1
37068,13,1,1
37069,years,1,1
37070,",",1,0
37071,according,1,1
37072,to,1,0
37073,the,1,0
37074,DSM,1,0
37075,III,1,1
37076,for,1,0
37077,infantile,1,1
37078,autism,1,1
37079,",",0,0
37080,received,0,0
37081,either,0,0
37082,drug,0,0
37083,in,0,0
37084,a,0,0
37085,random,0,0
37086,order,0,0
37087,during,0,0
37088,four,0,1
37089,weeks,0,0
37090,with,0,1
37091,an,0,0
37092,in-between,0,0
37093,placebo,0,0
37094,period,0,0
37095,of,0,0
37096,six,0,1
37097,weeks,0,0
37098,.,0,1
37099,The,0,0
37100,dosages,0,0
37101,of,0,0
37102,platelet,0,1
37103,5-HT,0,0
37104,and,0,0
37105,serum,0,0
37106,prolactin,0,0
37107,were,0,0
37108,carried,0,0
37109,out,0,0
37110,at,0,0
37111,the,0,0
37112,beginning,0,0
37113,and,0,0
37114,at,0,0
37115,the,0,0
37116,end,0,0
37117,of,0,0
37118,every,0,0
37119,phase,0,0
37120,of,0,0
37121,treatment,0,0
37122,(,0,0
37123,active,0,1
37124,or,0,1
37125,placebo,0,0
37126,),0,0
37127,with,0,1
37128,radioenzymology,0,1
37129,and,0,0
37130,radioimmunoassay,0,0
37131,methods,0,1
37132,respectively,0,0
37133,.,0,0
37134,The,0,0
37135,principal,0,0
37136,results,0,0
37137,on,0,0
37138,serum,0,0
37139,prolactin,0,0
37140,show,0,0
37141,neither,0,0
37142,order,0,0
37143,x,0,0
37144,treatment,0,0
37145,interaction,0,0
37146,",",0,0
37147,nor,0,0
37148,order,0,0
37149,effect,0,0
37150,but,0,0
37151,a,0,0
37152,significant,0,0
37153,treatment,0,0
37154,effect,0,0
37155,(,0,0
37156,p,0,0
37157,<,0,0
37158,0.01,0,0
37159,),0,1
37160,:,0,1
37161,amisulpride,0,0
37162,increases,0,0
37163,serum,0,0
37164,prolactin,0,0
37165,whereas,0,0
37166,bromocriptine,0,0
37167,decreases,0,0
37168,according,0,0
37169,to,0,0
37170,the,0,0
37171,usual,0,0
37172,data,0,0
37173,.,0,0
37174,About,0,0
37175,platelet,0,0
37176,5-HT,0,0
37177,",",0,0
37178,there,0,0
37179,is,0,0
37180,neither,0,0
37181,order,0,0
37182,x,0,0
37183,treatment,0,0
37184,interaction,0,0
37185,",",0,0
37186,nor,0,0
37187,treatment,0,0
37188,effect,0,0
37189,but,0,0
37190,a,0,0
37191,significant,0,0
37192,order,0,0
37193,effect,0,0
37194,(,0,0
37195,p,0,0
37196,<,0,0
37197,0.01,0,0
37198,),0,0
37199,.,0,1
37200,Both,0,0
37201,drugs,0,0
37202,increase,0,0
37203,platelet,0,0
37204,5-HT,0,0
37205,in,0,0
37206,the,0,0
37207,first,0,0
37208,phase,0,0
37209,of,0,0
37210,treatment,0,0
37211,.,0,0
37212,This,0,0
37213,order,0,0
37214,effect,0,0
37215,could,0,0
37216,be,0,0
37217,explained,0,0
37218,by,0,0
37219,a,0,0
37220,remanent,0,0
37221,effect,0,0
37222,of,0,0
37223,amisulpride,0,0
37224,after,0,0
37225,6,0,0
37226,wash-out,0,0
37227,weeks,0,0
37228,.,0,1
37229,(,0,0
37230,ABSTRACT,0,0
37231,TRUNCATED,0,1
37232,AT,0,1
37233,250,0,0
37234,WORDS,0,1
37235,),0,1
37236,Iloprost,0,0
37237,in,0,0
37238,cardiopulmonary,0,1
37239,bypass,0,1
37240,procedures,0,0
37241,.,0,0
37242,The,0,0
37243,inhibition,0,0
37244,of,0,0
37245,platelet,0,0
37246,aggregation,0,0
37247,during,0,0
37248,cardiopulmonary,1,1
37249,bypass,1,1
37250,and,0,0
37251,effects,0,0
37252,on,0,0
37253,post-operative,1,0
37254,placebo-controlled,1,0
37255,study,1,1
37256,of,1,0
37257,145,1,1
37258,patients,1,1
37259,.,1,1
37260,Significant,0,0
37261,preservation,0,0
37262,of,0,0
37263,platelet,0,1
37264,numbers,0,0
37265,and,0,0
37266,function,0,0
37267,were,0,0
37268,shown,0,0
37269,without,0,1
37270,significant,0,0
37271,haemodynamic,0,0
37272,problems,0,1
37273,",",0,0
37274,but,0,0
37275,no,0,0
37276,effect,0,0
37277,on,0,0
37278,cerebral,0,1
37279,deficits,0,0
37280,could,0,0
37281,be,0,0
37282,found,0,0
37283,.,0,0
37284,The,0,0
37285,use,0,0
37286,of,0,0
37287,iloprost,0,0
37288,in,0,0
37289,patients,1,1
37290,with,1,1
37291,severe,1,1
37292,thrombocytopenia,1,1
37293,seems,0,0
37294,justified,0,0
37295,",",0,0
37296,but,0,0
37297,the,0,0
37298,clinical,0,0
37299,benefits,0,0
37300,from,0,1
37301,its,0,0
37302,use,0,0
37303,in,0,0
37304,routine,0,0
37305,cardiopulmonary,0,1
37306,bypass,0,1
37307,remain,0,0
37308,to,0,0
37309,be,0,0
37310,shown,0,0
37311,.,0,0
37312,Cone,0,0
37313,biopsy,0,0
37314,:,0,1
37315,has,0,0
37316,endocervical,0,0
37317,sampling,0,0
37318,a,0,0
37319,role,0,0
37320,?,0,0
37321,OBJECTIVE,0,0
37322,To,0,0
37323,investigate,0,0
37324,the,0,0
37325,sensitivity,0,0
37326,",",0,0
37327,specificity,0,0
37328,and,0,0
37329,predictive,0,0
37330,value,0,0
37331,of,0,0
37332,endocervical,0,0
37333,sampling,0,0
37334,in,0,0
37335,women,1,1
37336,with,1,1
37337,abnormal,1,1
37338,cervical,1,1
37339,smears,1,1
37340,.,1,1
37341,DESIGN,0,0
37342,A,0,0
37343,randomized,0,0
37344,study,0,0
37345,of,0,0
37346,two,0,0
37347,methods,0,1
37348,of,0,0
37349,endocervical,0,1
37350,sampling,0,0
37351,.,0,1
37352,SETTING,0,1
37353,Colposcopy,1,0
37354,clinic,1,1
37355,at,1,0
37356,Aberdeen,1,1
37357,Royal,1,1
37358,Infirmary,1,1
37359,.,1,1
37360,SUBJECTS,0,0
37361,100,1,0
37362,women,1,1
37363,with,1,1
37364,abnormal,1,1
37365,cervical,1,1
37366,smears,1,0
37367,selected,1,1
37368,for,1,0
37369,cone,1,0
37370,biopsy,1,0
37371,according,1,0
37372,to,1,0
37373,current,1,0
37374,colposcopy,1,1
37375,criteria,1,1
37376,.,1,1
37377,INTERVENTIONS,0,0
37378,53,0,1
37379,women,0,1
37380,were,0,1
37381,randomized,0,1
37382,to,0,0
37383,have,0,0
37384,endocervical,0,0
37385,sampling,0,0
37386,with,0,1
37387,the,0,0
37388,Kevorkian,0,1
37389,curette,0,0
37390,and,0,0
37391,47,0,1
37392,to,0,0
37393,have,0,0
37394,sampling,0,0
37395,with,0,1
37396,the,0,0
37397,Medscand,0,0
37398,endocervical,0,0
37399,brush,0,0
37400,.,0,1
37401,MAIN,0,0
37402,OUTCOME,0,0
37403,MEASURES,0,0
37404,Cytology,0,1
37405,and,0,0
37406,histology,0,0
37407,results,0,0
37408,from,0,1
37409,endocervical,0,1
37410,sampling,0,0
37411,compared,0,0
37412,with,0,1
37413,cone,0,0
37414,biopsy,0,1
37415,histology,0,0
37416,.,0,0
37417,RESULTS,0,0
37418,The,0,0
37419,overall,0,0
37420,sensitivity,0,0
37421,of,0,0
37422,endocervical,0,0
37423,sampling,0,0
37424,was,0,0
37425,56,0,1
37426,%,0,0
37427,",",0,0
37428,with,0,1
37429,a,0,0
37430,false,0,0
37431,negative,0,0
37432,rate,0,0
37433,of,0,0
37434,44,0,1
37435,%,0,0
37436,and,0,0
37437,a,0,0
37438,negative,0,0
37439,predictive,0,0
37440,value,0,0
37441,of,0,0
37442,26,0,1
37443,%,0,0
37444,.,0,1
37445,CONCLUSIONS,0,0
37446,Endocervical,0,0
37447,sampling,0,0
37448,should,0,0
37449,not,0,0
37450,influence,0,0
37451,management,0,0
37452,when,0,0
37453,colposcopy,0,0
37454,is,0,0
37455,unsatisfactory,0,0
37456,.,0,0
37457,Isoflurane,0,0
37458,and,0,0
37459,propofol,0,0
37460,for,0,0
37461,long-term,0,0
37462,sedation,0,0
37463,in,0,0
37464,the,0,0
37465,intensive,0,0
37466,care,0,1
37467,unit,0,0
37468,.,0,0
37469,A,0,0
37470,crossover,0,0
37471,study,0,0
37472,.,0,0
37473,Propofol,0,0
37474,and,0,0
37475,isoflurane,0,0
37476,have,0,0
37477,been,0,0
37478,reported,0,0
37479,recently,0,1
37480,to,0,0
37481,offer,0,0
37482,better,0,0
37483,sedation,0,0
37484,than,0,0
37485,alternative,0,0
37486,agents,0,0
37487,in,0,1
37488,patients,1,1
37489,who,1,1
37490,require,1,1
37491,long-term,1,1
37492,ventilation,1,0
37493,in,1,0
37494,the,1,0
37495,Intensive,1,1
37496,Care,1,1
37497,Unit,1,0
37498,.,1,0
37499,This,0,0
37500,is,0,0
37501,the,0,0
37502,first,0,0
37503,report,0,0
37504,of,0,0
37505,a,0,0
37506,direct,0,0
37507,comparison,0,0
37508,between,0,0
37509,propofol,0,0
37510,and,0,0
37511,isoflurane,0,0
37512,.,0,1
37513,Twenty-four,1,1
37514,patients,1,1
37515,predicted,1,0
37516,to,1,0
37517,require,1,0
37518,artificial,1,0
37519,ventilation,1,0
37520,for,1,0
37521,at,1,0
37522,least,1,1
37523,48,1,1
37524,h,1,0
37525,were,0,1
37526,entered,0,1
37527,into,0,0
37528,a,0,0
37529,randomised,0,0
37530,crossover,0,0
37531,study,0,0
37532,to,0,0
37533,monitor,0,0
37534,sedation,0,0
37535,quality,0,0
37536,and,0,0
37537,time,0,0
37538,to,0,0
37539,recovery,0,0
37540,from,0,0
37541,sedation,0,0
37542,.,0,0
37543,There,0,0
37544,were,0,0
37545,no,0,0
37546,significant,0,0
37547,differences,0,0
37548,between,0,0
37549,the,0,0
37550,two,0,0
37551,agents,0,0
37552,in,0,0
37553,either,0,0
37554,end-point,0,0
37555,",",0,0
37556,with,0,1
37557,over,0,0
37558,95,0,0
37559,%,0,0
37560,optimal,0,0
37561,sedation,0,0
37562,achieved,0,0
37563,by,0,0
37564,the,0,0
37565,use,0,0
37566,of,0,0
37567,each,0,0
37568,drug,0,0
37569,.,0,0
37570,Few,0,0
37571,adverse,0,0
37572,events,0,0
37573,were,0,1
37574,noted,0,0
37575,.,0,1
37576,Technological,0,0
37577,advances,0,0
37578,in,0,0
37579,the,0,0
37580,administration,0,0
37581,of,0,0
37582,volatile,0,0
37583,agents,0,0
37584,as,0,0
37585,long-term,0,1
37586,sedatives,0,0
37587,in,0,0
37588,the,0,0
37589,Intensive,0,1
37590,Care,0,0
37591,Unit,0,0
37592,may,0,0
37593,facilitate,0,0
37594,their,0,0
37595,more,0,0
37596,widespread,0,0
37597,use,0,0
37598,.,0,1
37599,Interferon,0,0
37600,alfa,0,0
37601,in,0,0
37602,acute,1,1
37603,posttransfusion,1,0
37604,hepatitis,1,1
37605,C,1,0
37606,:,1,1
37607,a,0,0
37608,randomized,0,0
37609,",",0,0
37610,controlled,0,0
37611,trial,0,0
37612,.,0,1
37613,The,0,0
37614,relationship,0,0
37615,between,0,0
37616,the,0,0
37617,response,0,0
37618,of,0,0
37619,Plasmodium,1,1
37620,falciparum,1,1
37621,malaria,1,1
37622,to,1,0
37623,mefloquine,1,1
37624,in,1,0
37625,African,1,1
37626,children,1,1
37627,and,0,0
37628,its,0,0
37629,sensitivity,0,0
37630,in,0,0
37631,vitro,0,0
37632,.,0,0
37633,The,0,0
37634,clinical,0,0
37635,efficacy,0,0
37636,of,0,0
37637,two,0,0
37638,doses,0,0
37639,of,0,0
37640,mefloquine,0,1
37641,(,0,0
37642,15,0,1
37643,and,0,0
37644,25,0,1
37645,mg/kg,0,0
37646,body,0,1
37647,weight,0,0
37648,),0,0
37649,was,0,0
37650,evaluated,0,0
37651,in,0,0
37652,85,1,1
37653,children,1,1
37654,suffering,1,1
37655,from,1,1
37656,acute,1,1
37657,symptomatic,1,1
37658,falciparum,1,1
37659,malaria,1,1
37660,.,1,0
37661,The,0,0
37662,cure,0,0
37663,rate,0,0
37664,on,0,0
37665,day,0,0
37666,28,0,1
37667,was,0,0
37668,100,0,0
37669,%,0,0
37670,in,0,0
37671,both,0,0
37672,groups,0,0
37673,.,0,0
37674,There,0,0
37675,was,0,0
37676,no,0,0
37677,significant,0,0
37678,difference,0,0
37679,(,0,0
37680,P,0,0
37681,>,0,1
37682,0.05,0,0
37683,),0,0
37684,in,0,0
37685,the,0,0
37686,mean,0,0
37687,parasite,0,0
37688,and,0,0
37689,fever,0,1
37690,clearance,0,0
37691,times,0,0
37692,in,0,0
37693,both,0,0
37694,groups,0,0
37695,(,0,0
37696,48.5,0,1
37697,+/-,0,0
37698,14.6,0,1
37699,and,0,1
37700,32.0,0,1
37701,+/-,0,0
37702,12.7,0,0
37703,h,0,0
37704,respectively,0,0
37705,for,0,0
37706,the,0,0
37707,25,0,0
37708,mg/kg,0,0
37709,group,0,0
37710,and,0,0
37711,49.0,0,0
37712,+/-,0,0
37713,15.1,0,0
37714,and,0,1
37715,30.0,0,1
37716,+/-,0,0
37717,13.3,0,0
37718,h,0,0
37719,respectively,0,0
37720,for,0,0
37721,the,0,0
37722,15,0,1
37723,mg/kg,0,0
37724,group,0,1
37725,),0,1
37726,.,0,0
37727,There,0,0
37728,was,0,0
37729,also,0,0
37730,no,0,0
37731,significant,0,0
37732,difference,0,0
37733,(,0,0
37734,P,0,0
37735,>,0,1
37736,0.05,0,0
37737,),0,0
37738,in,0,0
37739,these,0,0
37740,values,0,0
37741,between,0,0
37742,children,1,1
37743,with,1,1
37744,hyperparasitaemia,1,1
37745,(,0,0
37746,53.6,0,1
37747,+/-,0,0
37748,11.1,0,0
37749,and,0,1
37750,36.0,0,0
37751,+/-,0,0
37752,17.0,0,0
37753,h,0,0
37754,respectively,0,0
37755,),0,0
37756,and,0,0
37757,those,1,0
37758,without,1,0
37759,hyperparasitaemia,1,1
37760,(,0,0
37761,49.1,0,1
37762,+/-,0,0
37763,13.6,0,0
37764,and,0,1
37765,31.8,0,1
37766,+/-,0,0
37767,14.6,0,1
37768,h,0,0
37769,respectively,0,0
37770,),0,0
37771,.,0,0
37772,Recurrence,0,0
37773,of,0,0
37774,parasitaemia,0,0
37775,was,0,0
37776,observed,0,0
37777,after,0,0
37778,day,0,0
37779,30,0,1
37780,in,0,0
37781,2,0,1
37782,patients,0,1
37783,in,0,0
37784,the,0,0
37785,15,0,0
37786,mg/kg,0,0
37787,group,0,0
37788,and,0,0
37789,in,0,0
37790,1,0,0
37791,patient,0,1
37792,in,0,0
37793,the,0,0
37794,25,0,0
37795,mg/kg,0,0
37796,group,0,0
37797,.,0,0
37798,In,0,0
37799,vitro,0,0
37800,",",0,0
37801,3,0,0
37802,of,0,0
37803,21,0,1
37804,isolates,0,1
37805,showed,0,0
37806,reduced,0,0
37807,susceptibility,0,0
37808,to,0,0
37809,mefloquine,0,0
37810,",",0,0
37811,with,0,1
37812,minimum,0,0
37813,inhibitory,0,0
37814,concentrations,0,0
37815,(,0,1
37816,MIC,0,1
37817,),0,0
37818,>,0,1
37819,67,0,1
37820,nM/litre,0,0
37821,.,0,0
37822,The,0,0
37823,MIC,0,0
37824,and,0,0
37825,50,0,0
37826,%,0,0
37827,",",0,0
37828,90,0,0
37829,%,0,0
37830,and,0,0
37831,99,0,1
37832,%,0,0
37833,inhibitory,0,0
37834,concentrations,0,0
37835,were,0,1
37836,200.8,0,0
37837,",",0,0
37838,6.27,0,0
37839,",",0,0
37840,31.7,0,0
37841,and,0,0
37842,119.6,0,0
37843,nM/litre,0,0
37844,respectively,0,0
37845,.,0,1
37846,Four,0,0
37847,of,0,0
37848,22,0,1
37849,isolates,0,1
37850,were,0,1
37851,resistant,0,1
37852,to,0,0
37853,chloroquine,0,0
37854,(,0,0
37855,MIC,0,0
37856,>,0,1
37857,108,0,1
37858,nM/litre,0,0
37859,),0,0
37860,.,0,0
37861,Isolates,0,0
37862,that,0,0
37863,showed,0,0
37864,low,0,0
37865,sensitivity,0,0
37866,to,0,0
37867,mefloquine,0,0
37868,in,0,0
37869,vitro,0,0
37870,were,0,0
37871,sensitive,0,0
37872,to,0,0
37873,chloroquine,0,0
37874,in,0,0
37875,vitro,0,0
37876,",",0,0
37877,and,0,0
37878,the,0,0
37879,4,0,0
37880,that,0,0
37881,were,0,0
37882,resistant,0,1
37883,to,0,0
37884,chloroquine,0,0
37885,were,0,0
37886,sensitive,0,0
37887,to,0,0
37888,mefloquine,0,1
37889,.,0,0
37890,Irrespective,0,0
37891,of,0,0
37892,MIC,0,0
37893,and,0,0
37894,dose,0,0
37895,of,0,0
37896,mefloquine,0,0
37897,",",0,0
37898,parasitaemia,0,0
37899,cleared,0,0
37900,in,0,0
37901,all,0,0
37902,subjects,0,1
37903,in,0,0
37904,96,0,1
37905,h,0,0
37906,or,0,1
37907,less,0,0
37908,.,0,0
37909,(,0,0
37910,ABSTRACT,0,0
37911,TRUNCATED,0,1
37912,AT,0,1
37913,250,0,0
37914,WORDS,0,1
37915,),0,1
37916,Controlled,0,0
37917,study,0,0
37918,on,0,0
37919,the,0,0
37920,therapeutic,0,0
37921,efficacy,0,0
37922,of,0,0
37923,propionyl-L-carnitine,0,0
37924,in,0,0
37925,patients,1,1
37926,with,1,1
37927,congestive,1,1
37928,heart,1,1
37929,failure,1,1
37930,.,1,0
37931,A,0,0
37932,double-blind,0,0
37933,phase,0,1
37934,II,0,1
37935,study,0,0
37936,of,0,0
37937,propionyl-L-carnitine,0,0
37938,(,0,1
37939,CAS,0,0
37940,17298-37-2,0,0
37941,),0,0
37942,versus,0,0
37943,placebo,0,0
37944,was,0,0
37945,carried,0,0
37946,out,0,0
37947,on,0,0
37948,a,0,0
37949,group,0,0
37950,of,0,0
37951,60,1,1
37952,patients,1,1
37953,with,1,1
37954,mild,1,1
37955,to,1,0
37956,moderate,1,1
37957,(,1,0
37958,II,1,0
37959,and,1,0
37960,III,1,1
37961,NYHA,1,1
37962,class,1,1
37963,),1,0
37964,congestive,1,1
37965,heart,1,1
37966,failure,1,1
37967,.,1,0
37968,The,1,0
37969,group,1,0
37970,was,1,0
37971,made,1,0
37972,up,1,0
37973,of,1,0
37974,men,1,1
37975,and,1,1
37976,women,1,1
37977,aged,1,1
37978,between,1,0
37979,48,1,1
37980,and,1,1
37981,73,1,1
37982,years,1,1
37983,in,1,1
37984,chronic,1,1
37985,treatment,1,0
37986,with,1,1
37987,digitalis,1,0
37988,and,1,0
37989,diuretics,1,0
37990,for,1,0
37991,at,1,1
37992,least,1,1
37993,3,1,0
37994,months,1,1
37995,and,1,1
37996,who,1,1
37997,still,1,1
37998,displayed,1,1
37999,symptoms,1,0
38000,.,1,1
38001,Thirty,0,1
38002,of,0,0
38003,these,0,0
38004,patients,0,1
38005,were,0,0
38006,chosen,0,0
38007,randomly,0,1
38008,and,0,0
38009,for,0,0
38010,180,0,1
38011,days,0,0
38012,",",0,1
38013,500,0,0
38014,mg,0,0
38015,of,0,0
38016,propionyl-L-carnitine,0,0
38017,was,0,0
38018,orally,0,0
38019,administered,0,0
38020,",",0,0
38021,3,0,0
38022,times,0,0
38023,a,0,0
38024,day,0,0
38025,in,0,0
38026,addition,0,0
38027,to,0,0
38028,their,0,0
38029,usual,0,1
38030,treatment,0,0
38031,.,0,0
38032,At,0,0
38033,basal,0,0
38034,conditions,0,0
38035,and,0,1
38036,after,0,0
38037,30,0,1
38038,",",0,0
38039,90,0,0
38040,and,0,0
38041,180,0,1
38042,days,0,0
38043,the,0,0
38044,maximum,0,0
38045,exercise,0,0
38046,time,0,0
38047,was,0,0
38048,evaluated,0,0
38049,using,0,0
38050,an,0,0
38051,exercise,0,0
38052,tolerance,0,0
38053,test,0,0
38054,performed,0,0
38055,on,0,0
38056,an,0,0
38057,ergometer,0,0
38058,bicycle,0,0
38059,and,0,0
38060,the,0,0
38061,left,0,1
38062,ventricular,0,0
38063,ejection,0,1
38064,fraction,0,0
38065,was,0,0
38066,tested,0,0
38067,by,0,0
38068,means,0,0
38069,of,0,0
38070,bidimensional,0,0
38071,echocardiography,0,0
38072,.,0,1
38073,After,0,0
38074,one,0,0
38075,month,0,0
38076,of,0,0
38077,treatment,0,0
38078,",",0,0
38079,the,0,0
38080,patients,0,1
38081,treated,0,1
38082,with,0,1
38083,propionyl-L-carnitine,0,0
38084,",",0,0
38085,compared,0,0
38086,to,0,0
38087,the,0,0
38088,control,0,0
38089,group,0,0
38090,",",0,0
38091,showed,0,0
38092,significant,0,0
38093,increases,0,0
38094,in,0,0
38095,the,0,0
38096,values,0,0
38097,of,0,0
38098,both,0,0
38099,tests,0,0
38100,",",0,0
38101,increases,0,0
38102,which,0,0
38103,became,0,0
38104,even,0,0
38105,more,0,0
38106,evident,0,0
38107,after,0,0
38108,90,0,1
38109,and,0,1
38110,180,0,1
38111,days,0,0
38112,.,0,1
38113,At,0,0
38114,the,0,0
38115,stated,0,0
38116,times,0,0
38117,the,0,0
38118,increases,0,0
38119,in,0,0
38120,the,0,0
38121,maximum,0,0
38122,exercise,0,0
38123,time,0,0
38124,were,0,0
38125,16.4,0,0
38126,%,0,0
38127,",",0,0
38128,22.9,0,0
38129,%,0,0
38130,",",0,0
38131,and,0,0
38132,25.9,0,0
38133,%,0,0
38134,",",0,0
38135,respectively,0,0
38136,.,0,0
38137,The,0,0
38138,ventricular,0,0
38139,ejection,0,1
38140,fraction,0,0
38141,increased,0,0
38142,by,0,0
38143,8.4,0,0
38144,%,0,0
38145,",",0,0
38146,11.6,0,0
38147,%,0,0
38148,and,0,0
38149,13.6,0,0
38150,%,0,0
38151,",",0,0
38152,respectively,0,0
38153,.,0,0
38154,On,0,0
38155,the,0,0
38156,basis,0,0
38157,of,0,0
38158,these,0,0
38159,results,0,0
38160,",",0,0
38161,having,0,1
38162,studied,0,0
38163,the,0,0
38164,particular,0,0
38165,mechanism,0,0
38166,of,0,0
38167,action,0,0
38168,of,0,0
38169,propionyl-L-carnitine,0,0
38170,the,0,0
38171,authors,0,0
38172,conclude,0,0
38173,that,0,0
38174,it,0,0
38175,represents,0,0
38176,a,0,0
38177,drug,0,0
38178,of,0,0
38179,undoubted,0,0
38180,therapeutic,0,0
38181,interest,0,0
38182,in,0,0
38183,patients,1,1
38184,with,1,1
38185,congestive,1,1
38186,heart,1,1
38187,failure,1,1
38188,",",0,0
38189,in,0,0
38190,whom,0,1
38191,it,0,1
38192,could,0,0
38193,be,0,0
38194,efficaciously,0,0
38195,administered,0,0
38196,along,0,0
38197,with,0,1
38198,a,0,0
38199,standard,0,0
38200,pharmacological,0,0
38201,therapy,0,0
38202,.,0,1
38203,A,0,0
38204,prospective,0,0
38205,",",0,0
38206,placebo-controlled,0,0
38207,",",0,0
38208,randomized,0,0
38209,trial,0,0
38210,of,0,0
38211,intravenous,0,0
38212,streptokinase,0,0
38213,and,0,0
38214,angioplasty,0,1
38215,versus,0,0
38216,lone,0,1
38217,angioplasty,0,1
38218,therapy,0,0
38219,of,0,0
38220,acute,0,1
38221,myocardial,0,1
38222,infarction,0,1
38223,.,0,0
38224,BACKGROUND,0,0
38225,The,0,0
38226,value,0,0
38227,of,0,0
38228,routine,0,0
38229,administration,0,0
38230,of,0,0
38231,intravenous,0,0
38232,thrombolytic,0,1
38233,agents,0,0
38234,during,0,0
38235,percutaneous,0,1
38236,transluminal,0,1
38237,coronary,0,1
38238,angioplasty,0,1
38239,(,0,0
38240,PTCA,0,0
38241,),0,0
38242,therapy,0,0
38243,of,0,0
38244,acute,0,1
38245,myocardial,0,1
38246,infarction,0,1
38247,(,0,0
38248,MI,0,0
38249,),0,0
38250,has,0,0
38251,not,0,0
38252,been,0,0
38253,determined,0,0
38254,.,0,0
38255,Therefore,0,0
38256,",",0,0
38257,we,0,0
38258,prospectively,0,1
38259,randomized,0,1
38260,122,1,1
38261,patients,1,1
38262,with,1,1
38263,evolving,1,0
38264,MI,1,0
38265,to,1,0
38266,PTCA,1,0
38267,therapy,1,0
38268,with,1,1
38269,or,1,1
38270,without,1,1
38271,adjunctive,1,0
38272,intravenous,1,0
38273,streptokinase,1,0
38274,therapy,1,0
38275,.,1,0
38276,METHODS,0,0
38277,AND,0,0
38278,RESULTS,0,0
38279,Patients,1,1
38280,with,1,1
38281,ECG,1,1
38282,ST,1,1
38283,segment,1,1
38284,elevation,1,1
38285,who,1,1
38286,presented,1,1
38287,within,1,1
38288,4,1,0
38289,hours,1,0
38290,of,1,0
38291,symptom,1,1
38292,onset,1,1
38293,",",1,0
38294,had,1,0
38295,no,1,0
38296,contraindication,1,0
38297,to,1,0
38298,thrombolytic,1,0
38299,therapy,1,0
38300,",",1,0
38301,and,1,0
38302,were,1,0
38303,not,1,0
38304,in,1,0
38305,cardiogenic,1,1
38306,shock,1,1
38307,were,1,0
38308,enrolled,1,1
38309,.,1,0
38310,They,0,0
38311,were,0,0
38312,treated,0,0
38313,immediately,0,0
38314,with,0,1
38315,intravenous,0,0
38316,heparin,0,0
38317,(,0,1
38318,"10,000",0,1
38319,units,0,0
38320,),0,1
38321,and,0,0
38322,oral,0,0
38323,aspirin,0,0
38324,(,0,0
38325,325,0,1
38326,mg,0,0
38327,),0,0
38328,and,0,0
38329,randomized,0,0
38330,to,0,0
38331,treatment,0,0
38332,with,0,1
38333,placebo,0,0
38334,or,0,1
38335,streptokinase,0,0
38336,(,0,0
38337,1.5,0,0
38338,M,0,0
38339,units,0,0
38340,),0,0
38341,administered,0,0
38342,intravenously,0,1
38343,over,0,0
38344,30,0,1
38345,minutes,0,0
38346,.,0,1
38347,Patients,0,1
38348,then,0,0
38349,were,0,0
38350,taken,0,0
38351,immediately,0,0
38352,to,0,0
38353,the,0,0
38354,catheterization,0,0
38355,laboratory,0,0
38356,",",0,0
38357,and,0,0
38358,those,0,0
38359,with,0,1
38360,suitable,0,0
38361,coronary,0,1
38362,anatomy,0,0
38363,underwent,0,1
38364,immediate,0,0
38365,PTCA,0,0
38366,.,0,1
38367,Subsequent,0,0
38368,clinical,0,0
38369,course,0,0
38370,",",0,0
38371,serial,0,0
38372,radionuclide,0,0
38373,ventriculography,0,0
38374,",",0,0
38375,and,0,0
38376,6-month,0,0
38377,repeat,0,0
38378,angiography,0,0
38379,were,0,0
38380,analyzed,0,0
38381,.,0,0
38382,A,0,0
38383,total,0,1
38384,of,0,0
38385,106,1,1
38386,patients,1,1
38387,were,1,1
38388,treated,1,1
38389,with,1,1
38390,PTCA,1,0
38391,.,1,1
38392,Use,0,0
38393,of,0,0
38394,PTCA,0,0
38395,was,0,0
38396,similar,0,0
38397,for,0,0
38398,placebo,0,0
38399,(,0,0
38400,92,0,1
38401,%,0,0
38402,),0,0
38403,and,0,0
38404,streptokinase,0,0
38405,(,0,0
38406,83,0,1
38407,%,0,0
38408,),0,1
38409,groups,0,0
38410,.,0,1
38411,Angioplasty,0,0
38412,was,0,0
38413,successful,0,0
38414,in,0,0
38415,95,0,0
38416,%,0,0
38417,of,0,0
38418,patients,0,1
38419,",",0,0
38420,with,0,1
38421,no,0,0
38422,difference,0,0
38423,in,0,0
38424,placebo,0,0
38425,(,0,0
38426,93,0,1
38427,%,0,0
38428,),0,0
38429,and,0,0
38430,streptokinase,0,0
38431,(,0,0
38432,98,0,1
38433,%,0,0
38434,),0,1
38435,groups,0,0
38436,.,0,1
38437,Serial,0,0
38438,radionuclide,0,0
38439,ventriculography,0,0
38440,demonstrated,0,0
38441,no,0,0
38442,difference,0,0
38443,in,0,0
38444,24-hour,0,1
38445,(,0,1
38446,52,0,1
38447,+/-,0,0
38448,12,0,0
38449,%,0,0
38450,versus,0,0
38451,50,0,1
38452,+/-,0,0
38453,12,0,1
38454,%,0,0
38455,),0,0
38456,or,0,1
38457,6-week,0,0
38458,(,0,0
38459,51,0,1
38460,+/-,0,0
38461,12,0,0
38462,%,0,0
38463,versus,0,0
38464,51,0,1
38465,+/-,0,0
38466,13,0,1
38467,%,0,0
38468,),0,0
38469,ejection,0,1
38470,fraction,0,1
38471,values,0,0
38472,for,0,0
38473,placebo,0,0
38474,and,0,0
38475,streptokinase,0,0
38476,groups,0,0
38477,",",0,0
38478,respectively,0,0
38479,.,0,0
38480,Contrast,0,0
38481,ventriculography,0,0
38482,demonstrated,0,0
38483,improvement,0,0
38484,in,0,0
38485,immediate,0,0
38486,(,0,0
38487,54,0,1
38488,+/-,0,0
38489,12,0,1
38490,%,0,0
38491,),0,0
38492,versus,0,0
38493,6-month,0,0
38494,(,0,0
38495,60,0,1
38496,+/-,0,0
38497,15,0,1
38498,%,0,0
38499,",",0,0
38500,p,0,0
38501,<,0,0
38502,0.05,0,0
38503,),0,1
38504,values,0,0
38505,for,0,0
38506,the,0,0
38507,overall,0,0
38508,group,0,0
38509,.,0,0
38510,No,0,0
38511,differences,0,0
38512,in,0,0
38513,6-month,0,1
38514,values,0,0
38515,were,0,1
38516,present,0,0
38517,(,0,1
38518,58,0,1
38519,+/-,0,0
38520,15,0,1
38521,%,0,0
38522,versus,0,0
38523,62,0,1
38524,+/-,0,0
38525,15,0,1
38526,%,0,0
38527,",",0,0
38528,p,0,0
38529,=,0,0
38530,NS,0,0
38531,),0,0
38532,for,0,0
38533,placebo,0,0
38534,and,0,0
38535,streptokinase,0,0
38536,groups,0,0
38537,",",0,0
38538,respectively,0,0
38539,.,0,0
38540,Coronary,0,1
38541,angiography,0,0
38542,was,0,0
38543,performed,0,0
38544,in,0,0
38545,75,0,1
38546,%,0,0
38547,of,0,0
38548,the,0,0
38549,90,0,0
38550,patients,0,1
38551,eligible,0,1
38552,for,0,0
38553,restudy,0,1
38554,.,0,1
38555,Arterial,0,0
38556,patency,0,0
38557,was,0,0
38558,87,0,1
38559,%,0,0
38560,at,0,0
38561,6,0,0
38562,months,0,0
38563,",",0,0
38564,and,0,0
38565,coronary,0,1
38566,restenosis,0,0
38567,was,0,0
38568,present,0,0
38569,in,0,0
38570,38,0,1
38571,%,0,0
38572,of,0,0
38573,patients,0,1
38574,.,0,1
38575,No,0,0
38576,differences,0,0
38577,in,0,0
38578,chronic,0,1
38579,patency,0,0
38580,or,0,1
38581,restenosis,0,0
38582,were,0,0
38583,detected,0,0
38584,for,0,0
38585,the,0,0
38586,two,0,0
38587,treatment,0,0
38588,groups,0,0
38589,.,0,1
38590,Although,0,0
38591,adjunctive,0,0
38592,intravenous,0,0
38593,streptokinase,0,0
38594,therapy,0,0
38595,did,0,0
38596,not,0,0
38597,improve,0,0
38598,outcome,0,0
38599,",",0,0
38600,it,0,0
38601,did,0,0
38602,complicate,0,0
38603,the,0,0
38604,hospital,0,0
38605,course,0,0
38606,.,0,1
38607,Hospitalization,0,0
38608,was,0,0
38609,longer,0,0
38610,(,0,0
38611,9.3,0,0
38612,+/-,0,0
38613,5.0,0,0
38614,versus,0,0
38615,7.7,0,0
38616,+/-,0,0
38617,4.4,0,0
38618,days,0,0
38619,",",0,0
38620,p,0,0
38621,=,0,0
38622,0.046,0,0
38623,),0,0
38624,and,0,0
38625,more,0,0
38626,costly,0,0
38627,(,0,0
38628,$,0,0
38629,"25,191",0,1
38630,+/-,0,0
38631,"15,368",0,1
38632,versus,0,0
38633,$,0,0
38634,"19,643",0,1
38635,+/-,0,0
38636,"7,250",0,1
38637,",",0,0
38638,p,0,0
38639,<,0,0
38640,0.02,0,0
38641,),0,0
38642,.,0,0
38643,Transfusion,0,0
38644,rate,0,0
38645,was,0,0
38646,higher,0,0
38647,(,0,0
38648,39,0,1
38649,%,0,0
38650,versus,0,0
38651,8,0,0
38652,%,0,0
38653,",",0,0
38654,p,0,0
38655,=,0,0
38656,0.0001,0,0
38657,),0,0
38658,and,0,0
38659,need,0,0
38660,for,0,0
38661,emergency,0,1
38662,coronary,0,1
38663,bypass,0,1
38664,surgery,0,1
38665,was,0,0
38666,greater,0,0
38667,(,0,0
38668,10.3,0,0
38669,%,0,0
38670,versus,0,0
38671,1.6,0,0
38672,%,0,0
38673,",",0,0
38674,p,0,0
38675,=,0,0
38676,0.03,0,0
38677,),0,0
38678,for,0,0
38679,the,0,0
38680,streptokinase-treated,0,0
38681,patients,0,1
38682,.,0,1
38683,CONCLUSIONS,0,0
38684,Adjunctive,0,0
38685,intravenous,0,0
38686,streptokinase,0,0
38687,therapy,0,0
38688,does,0,0
38689,not,0,0
38690,enhance,0,0
38691,early,0,0
38692,preservation,0,0
38693,of,0,0
38694,ventricular,0,0
38695,function,0,0
38696,",",0,0
38697,improve,0,0
38698,arterial,0,1
38699,patency,0,0
38700,rates,0,0
38701,",",0,0
38702,or,0,1
38703,lower,0,0
38704,restenosis,0,0
38705,rates,0,0
38706,after,0,0
38707,PTCA,0,0
38708,therapy,0,0
38709,of,0,0
38710,acute,0,1
38711,MI,0,1
38712,.,0,1
38713,Hospital,0,0
38714,course,0,0
38715,is,0,0
38716,longer,0,0
38717,",",0,0
38718,more,0,0
38719,expensive,0,0
38720,",",0,0
38721,and,0,0
38722,more,0,0
38723,complicated,0,0
38724,.,0,0
38725,For,0,0
38726,these,0,0
38727,reasons,0,0
38728,",",0,0
38729,PTCA,0,0
38730,therapy,0,0
38731,of,0,0
38732,acute,0,1
38733,MI,0,0
38734,should,0,0
38735,not,0,0
38736,be,0,0
38737,routinely,0,0
38738,performed,0,0
38739,with,0,1
38740,adjunctive,0,0
38741,intravenous,0,0
38742,streptokinase,0,0
38743,therapy,0,0
38744,.,0,1
38745,Leukocyte-depleted,1,0
38746,reperfusion,1,0
38747,of,1,0
38748,transplanted,1,1
38749,human,1,1
38750,hearts,1,1
38751,:,1,1
38752,a,0,0
38753,randomized,0,0
38754,",",0,0
38755,double-blind,0,0
38756,clinical,0,0
38757,trial,0,1
38758,.,0,1
38759,Standard,0,0
38760,methods,0,1
38761,of,0,0
38762,myocardial,0,1
38763,preservation,0,0
38764,for,0,0
38765,heart,0,1
38766,transplantation,0,1
38767,have,0,0
38768,generally,0,0
38769,provided,0,0
38770,good,0,0
38771,results,0,0
38772,.,0,1
38773,Preservation,0,0
38774,times,0,0
38775,beyond,0,0
38776,3,0,0
38777,hours,0,0
38778,",",0,0
38779,however,0,0
38780,",",0,0
38781,have,0,0
38782,been,0,0
38783,associated,0,0
38784,with,0,1
38785,decreased,0,0
38786,survival,0,0
38787,.,0,1
38788,Leukocyte-mediated,0,0
38789,reperfusion,0,0
38790,injury,0,0
38791,is,0,0
38792,partly,0,0
38793,responsible,0,0
38794,for,0,0
38795,decreased,0,0
38796,graft,0,0
38797,function,0,0
38798,after,0,0
38799,prolonged,0,0
38800,graft,0,1
38801,ischemia,0,1
38802,.,0,0
38803,Leukocyte-depleted,0,0
38804,reperfusion,0,0
38805,has,0,0
38806,been,0,0
38807,shown,0,0
38808,experimentally,0,0
38809,to,0,0
38810,improve,0,0
38811,cardiac,0,1
38812,function,0,0
38813,after,0,0
38814,cold,0,0
38815,ischemic,0,1
38816,arrest,0,1
38817,.,0,0
38818,To,0,0
38819,determine,0,0
38820,the,0,0
38821,efficacy,0,0
38822,and,0,0
38823,safety,0,0
38824,of,0,0
38825,leukocyte-depleted,0,0
38826,reperfusion,0,0
38827,",",0,0
38828,20,1,1
38829,patients,1,1
38830,were,1,1
38831,enrolled,1,1
38832,in,1,0
38833,a,1,0
38834,randomized,1,0
38835,",",1,0
38836,double-blind,1,0
38837,clinical,1,0
38838,trial,1,0
38839,to,1,0
38840,be,1,0
38841,treated,1,1
38842,with,1,0
38843,either,1,0
38844,warm,1,1
38845,whole,1,0
38846,blood,1,0
38847,reperfusion,1,0
38848,(,1,0
38849,group,1,0
38850,I,1,1
38851,;,1,0
38852,n,1,1
38853,=,1,0
38854,9,1,0
38855,),1,0
38856,or,0,1
38857,warm,0,1
38858,leukocyte-depleted,0,0
38859,blood,0,0
38860,reperfusion,0,0
38861,(,1,0
38862,group,1,1
38863,II,1,1
38864,;,1,0
38865,n,1,1
38866,=,1,0
38867,11,1,1
38868,),1,0
38869,.,1,0
38870,Reperfusion,0,0
38871,with,0,1
38872,leukocyte-depleted,0,0
38873,blood,0,0
38874,or,0,1
38875,whole,0,0
38876,blood,0,0
38877,was,0,0
38878,carried,0,0
38879,out,0,0
38880,for,0,0
38881,10,0,1
38882,minutes,0,0
38883,",",0,0
38884,with,0,1
38885,enriched,0,0
38886,cardioplegic,0,1
38887,solution,0,0
38888,added,0,0
38889,for,0,0
38890,the,0,0
38891,first,0,0
38892,3,0,0
38893,minutes,0,0
38894,of,0,1
38895,reperfusion,0,0
38896,.,0,0
38897,The,0,0
38898,mean,0,0
38899,donor,0,0
38900,and,0,0
38901,recipient,0,0
38902,age,0,1
38903,and,0,0
38904,the,0,0
38905,ischemic,0,1
38906,time,0,0
38907,(,0,0
38908,142,0,1
38909,versus,0,0
38910,153,0,1
38911,minutes,0,0
38912,),0,0
38913,were,0,0
38914,not,0,0
38915,significantly,0,0
38916,different,0,0
38917,between,0,0
38918,the,0,0
38919,two,0,0
38920,groups,0,0
38921,.,0,1
38922,Coronary,0,1
38923,sinus,0,0
38924,release,0,0
38925,of,0,0
38926,creatinine,0,0
38927,phosphokinase-MB,0,1
38928,5,0,1
38929,minutes,0,0
38930,after,0,0
38931,reperfusion,0,0
38932,was,0,0
38933,significantly,0,0
38934,less,0,0
38935,in,0,0
38936,group,0,0
38937,II,0,1
38938,(,0,0
38939,1.65,0,0
38940,EU/min,0,1
38941,),0,0
38942,than,0,0
38943,in,0,0
38944,group,0,0
38945,I,0,1
38946,(,0,0
38947,3.83,0,0
38948,units/min,0,0
38949,;,0,0
38950,p,0,0
38951,=,0,0
38952,0.05,0,0
38953,),0,0
38954,.,0,1
38955,Thromboxane,0,0
38956,B2,0,0
38957,release,0,0
38958,was,0,0
38959,also,0,0
38960,significantly,0,0
38961,less,0,0
38962,(,0,0
38963,p,0,0
38964,=,0,0
38965,0.05,0,0
38966,),0,0
38967,in,0,0
38968,group,0,0
38969,II,0,1
38970,(,0,0
38971,33.6,0,0
38972,pg/min,0,0
38973,),0,0
38974,than,0,0
38975,in,0,0
38976,group,0,0
38977,I,0,1
38978,(,0,0
38979,67.0,0,0
38980,pg/min,0,0
38981,),0,0
38982,.,0,0
38983,All,0,1
38984,hearts,0,0
38985,functioned,0,0
38986,adequately,0,0
38987,in,0,0
38988,both,0,0
38989,groups,0,0
38990,.,0,0
38991,The,0,0
38992,duration,0,0
38993,of,0,0
38994,inotropic,0,0
38995,support,0,0
38996,was,0,0
38997,shorter,0,0
38998,in,0,0
38999,group,0,0
39000,II,0,1
39001,than,0,0
39002,in,0,0
39003,group,0,0
39004,I,0,1
39005,",",0,0
39006,but,0,0
39007,the,0,0
39008,difference,0,0
39009,was,0,0
39010,not,0,0
39011,statistically,0,0
39012,significant,0,0
39013,.,0,1
39014,Postoperative,0,0
39015,hemodynamics,0,0
39016,",",0,0
39017,rejection,0,1
39018,episodes,0,0
39019,",",0,0
39020,and,0,0
39021,infectious,0,1
39022,complications,0,0
39023,were,0,0
39024,also,0,0
39025,not,0,0
39026,significantly,0,0
39027,different,0,0
39028,between,0,0
39029,groups,0,0
39030,in,0,0
39031,a,0,0
39032,mean,0,0
39033,follow-up,0,0
39034,of,0,0
39035,9,0,1
39036,months,0,0
39037,.,0,1
39038,Mean,0,1
39039,ejection,0,1
39040,fraction,0,1
39041,1,0,0
39042,month,0,0
39043,after,0,0
39044,operation,0,0
39045,was,0,0
39046,65,0,1
39047,%,0,0
39048,in,0,0
39049,both,0,0
39050,groups,0,0
39051,.,0,1
39052,One,0,1
39053,early,0,0
39054,death,0,0
39055,occurred,0,0
39056,at,0,0
39057,66,0,1
39058,days,0,0
39059,secondary,0,1
39060,to,0,1
39061,infection,0,1
39062,;,0,0
39063,two,0,0
39064,late,0,1
39065,deaths,0,0
39066,occurred,0,0
39067,in,0,0
39068,group,0,0
39069,II,0,1
39070,",",0,0
39071,both,0,0
39072,from,0,0
39073,rejection,0,1
39074,.,0,1
39075,Leukocyte-depleted,0,0
39076,reperfusion,0,0
39077,is,0,0
39078,safe,0,0
39079,and,0,0
39080,easily,0,0
39081,applied,0,0
39082,in,0,0
39083,the,0,0
39084,operating,0,0
39085,room,0,0
39086,.,0,0
39087,Furthermore,0,0
39088,",",0,0
39089,leukocyte-depleted,0,0
39090,reperfusion,0,0
39091,decreases,0,0
39092,biochemical,0,0
39093,evidence,0,0
39094,of,0,0
39095,reperfusion,0,0
39096,injury,0,1
39097,.,0,0
39098,Although,0,0
39099,not,0,0
39100,influencing,0,0
39101,postoperative,0,0
39102,cardiac,0,1
39103,function,0,0
39104,when,0,0
39105,the,0,0
39106,ischemic,0,0
39107,time,0,0
39108,is,0,0
39109,short,0,0
39110,",",0,0
39111,less,0,0
39112,than,0,0
39113,3,0,0
39114,hours,0,0
39115,",",0,0
39116,leukocyte-depleted,0,0
39117,reperfusion,0,0
39118,may,0,0
39119,prevent,0,0
39120,significant,0,0
39121,reperfusion,0,0
39122,injury,0,1
39123,and,0,0
39124,improve,0,0
39125,posttransplantation,0,0
39126,graft,0,0
39127,function,0,0
39128,when,0,0
39129,ischemic,0,1
39130,times,0,0
39131,are,0,0
39132,long,0,1
39133,.,0,1
39134,Safe,0,0
39135,extension,0,0
39136,of,0,0
39137,the,0,0
39138,ischemic,0,1
39139,time,0,0
39140,would,0,0
39141,expand,0,0
39142,the,0,0
39143,donor,0,0
39144,pool,0,0
39145,and,0,0
39146,allow,0,0
39147,for,0,0
39148,better,0,0
39149,crossmatching,0,1
39150,.,0,0
39151,Prophylaxis,0,1
39152,with,0,1
39153,meropenem,0,0
39154,of,0,0
39155,septic,0,1
39156,complications,0,0
39157,in,0,0
39158,acute,0,1
39159,pancreatitis,0,1
39160,:,0,1
39161,a,0,0
39162,randomized,0,0
39163,",",0,0
39164,controlled,0,0
39165,trial,0,0
39166,versus,0,0
39167,imipenem,0,0
39168,.,0,0
39169,OBJECTIVES,0,0
39170,Prophylactic,0,0
39171,antibiotics,0,0
39172,are,0,0
39173,helpful,0,0
39174,in,0,0
39175,decreasing,0,0
39176,the,0,0
39177,incidence,0,0
39178,of,0,0
39179,septic,0,1
39180,complications,0,0
39181,in,0,0
39182,acute,0,1
39183,pancreatitis,0,1
39184,.,0,0
39185,The,0,0
39186,aim,0,0
39187,of,0,0
39188,this,0,0
39189,study,0,0
39190,was,0,0
39191,to,0,0
39192,compare,0,0
39193,the,0,0
39194,efficacy,0,0
39195,of,0,0
39196,meropenem,0,0
39197,",",0,0
39198,a,0,0
39199,new,0,0
39200,carbapenem,0,0
39201,antibiotic,0,0
39202,",",0,0
39203,with,0,1
39204,that,0,0
39205,of,0,0
39206,imipenem,0,0
39207,",",0,0
39208,which,0,0
39209,is,0,0
39210,the,0,0
39211,standard,0,0
39212,prophylactic,0,0
39213,treatment,0,0
39214,in,0,0
39215,patients,1,1
39216,with,1,1
39217,severe,1,1
39218,acute,1,1
39219,pancreatitis,1,1
39220,.,1,1
39221,METHODS,0,0
39222,One,1,1
39223,hundred,1,1
39224,seventy-six,1,1
39225,patients,1,1
39226,with,1,1
39227,necrotizing,1,1
39228,pancreatitis,1,1
39229,were,0,0
39230,prospectively,0,0
39231,randomized,0,0
39232,to,0,0
39233,prophylactic,0,0
39234,treatment,0,0
39235,with,0,1
39236,0.5,0,0
39237,g,0,1
39238,meropenem,0,0
39239,t.i.d,0,0
39240,.,0,0
39241,intravenously,0,0
39242,or,0,0
39243,0.5,0,0
39244,g,0,1
39245,imipenem,0,0
39246,q.i.d,0,0
39247,.,0,0
39248,intravenously,0,0
39249,.,0,0
39250,The,0,0
39251,occurrence,0,0
39252,of,0,0
39253,infection,0,0
39254,of,0,0
39255,pancreatic,0,1
39256,necrosis,0,0
39257,",",0,0
39258,rate,0,0
39259,of,0,0
39260,extrapancreatic,0,1
39261,infections,0,1
39262,",",0,0
39263,systemic,0,0
39264,and,0,0
39265,local,0,0
39266,complications,0,0
39267,",",0,0
39268,need,0,0
39269,for,0,0
39270,surgery,0,1
39271,",",0,0
39272,mortality,0,0
39273,rate,0,0
39274,",",0,0
39275,and,0,0
39276,length,0,0
39277,of,0,0
39278,hospitalization,0,0
39279,were,0,0
39280,recorded,0,0
39281,for,0,0
39282,each,0,0
39283,group,0,0
39284,.,0,0
39285,When,0,0
39286,a,0,0
39287,septic,0,0
39288,complication,0,0
39289,of,0,0
39290,pancreatic,0,1
39291,necrosis,0,0
39292,was,0,0
39293,suspected,0,1
39294,",",0,0
39295,fine,0,0
39296,needle,0,0
39297,aspiration,0,0
39298,with,0,1
39299,cultures,0,0
39300,of,0,0
39301,the,0,0
39302,sample,0,1
39303,was,0,0
39304,performed,0,0
39305,.,0,0
39306,Surgery,0,0
39307,was,0,0
39308,performed,0,0
39309,in,0,0
39310,cases,0,1
39311,of,0,1
39312,verified,0,0
39313,infected,0,1
39314,necrosis,0,0
39315,.,0,1
39316,CONCLUSION,0,0
39317,No,0,0
39318,difference,0,0
39319,was,0,0
39320,observed,0,0
39321,between,0,0
39322,patients,1,1
39323,treated,1,1
39324,with,1,1
39325,meropenem,1,0
39326,and,1,0
39327,those,1,0
39328,treated,1,0
39329,with,1,0
39330,imipenem,1,0
39331,in,1,0
39332,terms,1,0
39333,of,1,0
39334,incidence,1,0
39335,of,1,0
39336,pancreatic,1,1
39337,infection,1,1
39338,(,1,0
39339,11.4,1,0
39340,%,1,0
39341,versus,1,0
39342,13.6,1,0
39343,%,1,0
39344,),1,0
39345,and,1,0
39346,extrapancreatic,1,1
39347,infections,1,1
39348,(,1,1
39349,21.6,1,0
39350,%,1,0
39351,versus,1,0
39352,23.9,1,0
39353,%,1,0
39354,),1,0
39355,and,1,0
39356,clinical,1,0
39357,outcome,1,0
39358,.,1,0
39359,Meropenem,0,0
39360,is,0,0
39361,as,0,0
39362,effective,0,0
39363,as,0,0
39364,imipenem,0,0
39365,in,0,0
39366,preventing,0,0
39367,septic,0,1
39368,complications,0,0
39369,of,0,1
39370,patients,0,1
39371,with,0,1
39372,severe,0,1
39373,acute,0,1
39374,pancreatitis,0,1
39375,.,0,1
39376,Remifentanil,0,0
39377,with,0,1
39378,morphine,0,0
39379,transitional,0,1
39380,analgesia,0,0
39381,shortens,0,0
39382,neurological,0,0
39383,recovery,0,0
39384,compared,0,0
39385,to,0,0
39386,fentanyl,0,0
39387,for,0,0
39388,supratentorial,0,1
39389,craniotomy,0,0
39390,.,0,1
39391,PURPOSE,0,0
39392,To,0,0
39393,compare,0,0
39394,the,0,0
39395,recovery,0,0
39396,profiles,0,0
39397,",",0,0
39398,efficacy,0,0
39399,and,0,0
39400,safety,0,0
39401,of,0,0
39402,remifentanil,0,0
39403,and,0,0
39404,morphine,0,0
39405,for,0,0
39406,transitional,0,1
39407,analgesia,0,0
39408,with,0,1
39409,fentanyl,0,0
39410,in,0,0
39411,patients,1,1
39412,undergoing,1,1
39413,elective,1,1
39414,craniotomy,1,0
39415,for,1,0
39416,supratentorial,1,1
39417,mass,1,1
39418,lesions,1,1
39419,.,1,1
39420,METHODS,0,0
39421,Ninety-one,1,1
39422,patients,1,1
39423,were,0,1
39424,enrolled,0,1
39425,in,0,0
39426,this,0,0
39427,prospective,0,0
39428,",",0,0
39429,randomized,0,0
39430,",",0,0
39431,multicentre,0,0
39432,study,0,0
39433,.,0,1
39434,Anesthesia,0,0
39435,was,0,0
39436,induced,0,0
39437,with,0,1
39438,thiopental,0,0
39439,and,0,0
39440,remifentanil,0,0
39441,(,0,0
39442,1.0,0,0
39443,micro,0,0
39444,g,0,1
39445,x,0,0
39446,kg,0,0
39447,(,0,0
39448,-1,0,0
39449,),0,0
39450,bolus,0,0
39451,and,0,0
39452,a,0,0
39453,1,0,0
39454,micro,0,0
39455,g,0,1
39456,x,0,0
39457,kg,0,0
39458,(,0,0
39459,-1,0,0
39460,),0,0
39461,x,0,0
39462,min,0,0
39463,(,0,0
39464,-1,0,0
39465,),0,0
39466,infusion,0,0
39467,),0,0
39468,or,0,0
39469,fentanyl,0,0
39470,(,0,0
39471,1,0,0
39472,micro,0,0
39473,g,0,1
39474,x,0,0
39475,kg,0,0
39476,(,0,0
39477,-1,0,0
39478,),0,0
39479,bolus,0,0
39480,and,0,0
39481,a,0,0
39482,1.0,0,0
39483,micro,0,0
39484,g,0,1
39485,x,0,0
39486,kg,0,0
39487,(,0,0
39488,-1,0,0
39489,),0,0
39490,x,0,0
39491,min,0,0
39492,(,0,0
39493,-1,0,0
39494,),0,0
39495,infusion,0,0
39496,),0,0
39497,.,0,0
39498,The,0,0
39499,opioid,0,0
39500,infusion,0,0
39501,continued,0,0
39502,until,0,0
39503,the,0,0
39504,level,0,0
39505,of,0,0
39506,anesthesia,0,1
39507,was,0,0
39508,deemed,0,0
39509,appropriate,0,0
39510,for,0,0
39511,intubation,0,1
39512,.,0,1
39513,Anesthesia,0,0
39514,was,0,0
39515,maintained,0,0
39516,with,0,1
39517,N,0,1
39518,(,0,1
39519,2,0,0
39520,),0,0
39521,O/O,0,0
39522,(,0,1
39523,2,0,0
39524,),0,0
39525,",",0,0
39526,isoflurane,0,0
39527,0.5,0,0
39528,MAC,0,0
39529,and,0,0
39530,remifentanil,0,0
39531,0.2,0,0
39532,micro,0,0
39533,g,0,1
39534,x,0,0
39535,kg,0,0
39536,(,0,0
39537,-1,0,0
39538,),0,0
39539,x,0,0
39540,min,0,0
39541,(,0,0
39542,-1,0,0
39543,),0,0
39544,or,0,1
39545,fentanyl,0,0
39546,0.04,0,0
39547,micro,0,0
39548,g,0,1
39549,x,0,0
39550,kg,0,0
39551,(,0,0
39552,-1,0,0
39553,),0,0
39554,x,0,0
39555,min,0,0
39556,(,0,0
39557,-1,0,0
39558,),0,0
39559,.,0,0
39560,At,0,0
39561,bone,0,0
39562,flap,0,1
39563,replacement,0,0
39564,",",0,0
39565,either,0,0
39566,morphine,0,0
39567,0.08,0,0
39568,mg,0,0
39569,x,0,0
39570,kg,0,0
39571,(,0,0
39572,-1,0,0
39573,),0,0
39574,(,0,0
39575,remifentanil,0,0
39576,group,0,1
39577,),0,0
39578,or,0,0
39579,saline,0,0
39580,(,0,0
39581,fentanyl,0,0
39582,group,0,1
39583,),0,0
39584,was,0,0
39585,given,0,0
39586,.,0,1
39587,RESULTS,0,0
39588,Systolic,0,1
39589,blood,0,0
39590,pressure,0,0
39591,was,0,0
39592,greater,0,0
39593,in,0,0
39594,those,0,0
39595,receiving,0,0
39596,fentanyl,0,0
39597,during,0,0
39598,induction,0,1
39599,(,0,0
39600,145.6,0,0
39601,+/-17.5,0,0
39602,mmHg,0,0
39603,vs,0,0
39604,128.8,0,0
39605,+/-18.3,0,1
39606,mmHg,0,0
39607,;,0,1
39608,P,0,0
39609,=,0,0
39610,0.006,0,0
39611,),0,0
39612,and,0,0
39613,intubation,0,0
39614,(,0,0
39615,126.9,0,0
39616,+/-17.1,0,0
39617,vs,0,0
39618,110.9,0,0
39619,+/-16.5,0,1
39620,mmHg,0,0
39621,;,0,1
39622,P,0,0
39623,<,0,0
39624,0.001,0,0
39625,),0,1
39626,.,0,1
39627,Median,0,0
39628,time,0,0
39629,to,0,0
39630,tracheal,0,1
39631,extubation,0,0
39632,was,0,0
39633,similar,0,0
39634,but,0,0
39635,less,0,0
39636,variable,0,0
39637,in,0,0
39638,the,0,0
39639,remifentanil,0,0
39640,group,0,0
39641,(,0,0
39642,remifentanil,0,0
39643,=,0,0
39644,8,0,0
39645,min,0,0
39646,:,0,1
39647,range,0,0
39648,=,0,0
39649,2-44,0,0
39650,min,0,0
39651,;,0,0
39652,fentanyl,0,0
39653,=,0,0
39654,8,0,0
39655,min,0,0
39656,:,0,1
39657,range,0,0
39658,=,0,0
39659,1-732,0,0
39660,min,0,0
39661,),0,0
39662,.,0,0
39663,The,0,0
39664,fentanyl,0,0
39665,patients,0,1
39666,required,0,0
39667,a,0,0
39668,longer,0,0
39669,time,0,0
39670,to,0,0
39671,achieve,0,0
39672,the,0,0
39673,first,0,0
39674,normal,0,1
39675,neurological,0,1
39676,score,0,0
39677,(,0,0
39678,fentanyl,0,0
39679,=,0,0
39680,38.0,0,0
39681,min,0,0
39682,;,0,0
39683,remifentanil,0,0
39684,=,0,0
39685,26.0,0,0
39686,min,0,0
39687,;,0,1
39688,P,0,0
39689,=,0,0
39690,0.035,0,0
39691,),0,0
39692,.,0,0
39693,Both,0,0
39694,the,0,0
39695,anesthesiologists,0,0
39696,and,0,0
39697,the,0,0
39698,recovery,0,0
39699,room,0,0
39700,nurses,0,1
39701,rated,0,0
39702,remifentanil,0,0
39703,better,0,0
39704,with,0,0
39705,respect,0,0
39706,to,0,0
39707,level,0,0
39708,of,0,0
39709,consciousness,0,0
39710,.,0,1
39711,Analgesics,0,0
39712,were,0,0
39713,required,0,0
39714,earlier,0,0
39715,in,0,0
39716,patients,0,1
39717,receiving,0,1
39718,remifentanil,0,0
39719,;,0,0
39720,median,0,0
39721,time,0,0
39722,0.5,0,0
39723,vs,0,0
39724,1.08,0,0
39725,hr,0,0
39726,",",0,0
39727,P,0,0
39728,<,0,0
39729,0.001,0,0
39730,.,0,0
39731,CONCLUSIONS,0,0
39732,Remifentanil,0,0
39733,is,0,0
39734,a,0,0
39735,suitable,0,0
39736,alternative,0,0
39737,to,0,0
39738,fentanyl,0,0
39739,in,0,0
39740,supratentorial,0,1
39741,craniotomy,0,0
39742,.,0,0
39743,Time,0,0
39744,to,0,0
39745,preoperative,0,0
39746,neurological,0,0
39747,recovery,0,0
39748,is,0,0
39749,faster,0,0
39750,and,0,0
39751,morphine,0,0
39752,provides,0,0
39753,some,0,0
39754,transitional,0,0
39755,analgesia,0,0
39756,without,0,1
39757,compromising,0,0
39758,the,0,0
39759,quality,0,0
39760,of,0,0
39761,recovery,0,0
39762,.,0,1
39763,Efficacy,0,0
39764,of,0,0
39765,azithromycin,0,0
39766,for,0,0
39767,the,0,0
39768,treatment,0,0
39769,of,0,0
39770,feline,1,1
39771,chlamydophilosis,1,1
39772,.,1,0
39773,The,0,0
39774,current,0,0
39775,recommended,0,0
39776,treatment,0,0
39777,for,0,0
39778,feline,1,1
39779,chlamydophilosis,1,0
39780,involves,0,0
39781,daily,0,0
39782,oral,0,0
39783,administration,0,0
39784,of,0,0
39785,antimicrobials,0,0
39786,to,0,0
39787,all,0,1
39788,cats,1,1
39789,within,1,0
39790,an,1,0
39791,affected,1,0
39792,group,1,0
39793,for,0,0
39794,a,0,0
39795,prolonged,0,0
39796,period,0,0
39797,of,0,0
39798,time,0,0
39799,(,0,0
39800,4-6,0,1
39801,weeks,0,0
39802,),0,1
39803,.,0,0
39804,Not,0,0
39805,surprisingly,0,0
39806,",",0,0
39807,owner,0,0
39808,compliance,0,0
39809,can,0,0
39810,be,0,0
39811,poor,0,0
39812,resulting,0,0
39813,in,0,0
39814,apparent,0,0
39815,treatment,0,0
39816,failure,0,1
39817,.,0,0
39818,Recent,0,0
39819,anecdotal,0,0
39820,evidence,0,0
39821,",",0,0
39822,supported,0,0
39823,by,0,0
39824,its,0,0
39825,efficacy,0,0
39826,in,0,0
39827,the,0,0
39828,treatment,0,0
39829,of,0,0
39830,Chlamydia,0,1
39831,trachomatis,0,1
39832,infection,0,0
39833,in,0,0
39834,humans,0,0
39835,",",0,0
39836,has,0,0
39837,suggested,0,0
39838,that,0,0
39839,azithromycin,0,0
39840,may,0,0
39841,offer,0,0
39842,an,0,0
39843,alternative,0,0
39844,by,0,0
39845,allowing,0,0
39846,less,0,0
39847,frequent,0,0
39848,dosing,0,0
39849,for,0,0
39850,a,0,0
39851,shorter,0,0
39852,duration,0,0
39853,.,0,0
39854,A,0,0
39855,clinical,0,0
39856,trial,0,0
39857,was,0,0
39858,designed,0,0
39859,to,0,0
39860,evaluate,0,0
39861,the,0,0
39862,efficacy,0,0
39863,of,0,0
39864,azithromycin,0,0
39865,for,0,0
39866,the,0,0
39867,treatment,0,0
39868,of,0,0
39869,chlamydia,1,1
39870,(,1,0
39871,Chlamydophila,1,1
39872,felis,1,1
39873,),1,0
39874,infection,1,0
39875,in,1,0
39876,cats,1,1
39877,.,1,1
39878,Whilst,0,0
39879,azithromycin,0,0
39880,",",0,0
39881,given,0,0
39882,at,0,0
39883,10-15,0,0
39884,mg/kg,0,0
39885,daily,0,0
39886,for,0,0
39887,3,0,0
39888,days,0,0
39889,and,0,0
39890,then,0,0
39891,twice,0,0
39892,weekly,0,0
39893,",",0,0
39894,provided,0,0
39895,a,0,0
39896,similar,0,0
39897,",",0,0
39898,rapid,0,0
39899,resolution,0,0
39900,of,0,0
39901,clinical,0,0
39902,signs,0,1
39903,and,0,1
39904,negative,0,0
39905,isolation,0,0
39906,scores,0,0
39907,as,0,0
39908,doxycycline,0,0
39909,",",0,0
39910,C,0,0
39911,felis,0,1
39912,was,0,0
39913,re-isolated,0,0
39914,in,0,0
39915,four,0,0
39916,out,0,0
39917,of,0,0
39918,the,0,0
39919,five,1,1
39920,cats,1,1
39921,treated,1,1
39922,.,1,1
39923,Furthermore,0,0
39924,",",0,0
39925,even,0,0
39926,daily,0,0
39927,administration,0,0
39928,of,0,0
39929,azithromycin,0,0
39930,to,0,0
39931,chronically,0,1
39932,infected,0,1
39933,cats,0,1
39934,was,0,0
39935,ineffective,0,0
39936,in,0,0
39937,clearing,0,0
39938,infection,0,1
39939,.,0,0
39940,The,0,0
39941,azithromycin,0,0
39942,protocols,0,0
39943,used,0,0
39944,here,0,0
39945,were,0,0
39946,therefore,0,0
39947,found,0,0
39948,to,0,0
39949,be,0,0
39950,unsuccessful,0,0
39951,in,0,0
39952,eliminating,0,0
39953,the,0,0
39954,carriage,0,0
39955,of,0,0
39956,this,0,0
39957,strain,0,0
39958,of,0,0
39959,C,0,0
39960,felis,0,1
39961,.,0,1
39962,Twenty-four,0,1
39963,vs.,0,0
39964,forty-eight,0,1
39965,weeks,0,0
39966,of,0,0
39967,re-therapy,0,0
39968,with,0,1
39969,interferon,0,0
39970,alpha,0,0
39971,2b,0,0
39972,and,0,0
39973,ribavirin,0,0
39974,in,0,0
39975,interferon,1,0
39976,alpha,1,0
39977,monotherapy,1,0
39978,relapsers,1,0
39979,with,1,1
39980,chronic,1,1
39981,hepatitis,1,1
39982,C.,1,0
39983,BACKGROUND/AIM,0,0
39984,Roughly,0,1
39985,50,0,1
39986,%,0,0
39987,of,0,0
39988,patients,0,1
39989,with,0,1
39990,chronic,0,1
39991,hepatitis,0,1
39992,C,0,0
39993,",",0,1
39994,who,0,1
39995,relapsed,0,1
39996,after,0,1
39997,a,0,0
39998,previous,0,0
39999,monotherapy,0,0
40000,with,0,1
40001,interferon,0,0
40002,alpha,0,0
40003,",",0,0
40004,will,0,0
40005,respond,0,0
40006,in,0,0
40007,a,0,0
40008,sustained,0,0
40009,fashion,0,0
40010,to,0,0
40011,24,0,0
40012,weeks,0,0
40013,of,0,0
40014,re-therapy,0,0
40015,with,0,1
40016,the,0,0
40017,combination,0,0
40018,of,0,0
40019,interferon,0,0
40020,alpha,0,0
40021,plus,0,0
40022,ribavirin,0,0
40023,.,0,0
40024,Whether,0,0
40025,prolonging,0,0
40026,treatment,0,0
40027,duration,0,0
40028,to,0,0
40029,48,0,0
40030,weeks,0,0
40031,will,0,0
40032,further,0,0
40033,increase,0,0
40034,sustained,0,0
40035,response,0,0
40036,rates,0,0
40037,remains,0,0
40038,ill,0,1
40039,defined,0,0
40040,.,0,0
40041,In,0,0
40042,this,0,0
40043,randomised,0,0
40044,controlled,0,0
40045,pilot,0,0
40046,trial,0,0
40047,we,0,0
40048,compared,0,0
40049,the,0,0
40050,efficacy,0,0
40051,and,0,0
40052,tolerability,0,0
40053,of,0,0
40054,a,0,0
40055,24,0,0
40056,week,0,0
40057,with,0,1
40058,that,0,0
40059,of,0,0
40060,a,0,0
40061,48,0,0
40062,week,0,0
40063,course,0,0
40064,of,0,0
40065,combination,0,0
40066,therapy,0,0
40067,with,0,1
40068,interferon,0,0
40069,alpha,0,0
40070,and,0,0
40071,ribavirin,0,0
40072,in,0,0
40073,interferon,1,0
40074,monotherapy,1,1
40075,relapsers,1,0
40076,with,1,1
40077,chronic,1,1
40078,hepatitis,1,1
40079,C.,1,0
40080,METHODS,0,0
40081,Interferon,1,0
40082,alpha,1,0
40083,monotherapy,1,0
40084,relapsers,1,0
40085,with,1,1
40086,chronic,1,1
40087,hepatitis,1,1
40088,C,1,0
40089,were,0,0
40090,randomised,0,0
40091,to,0,0
40092,receive,0,0
40093,interferon,0,0
40094,alpha,0,0
40095,2b,0,0
40096,(,0,0
40097,3,0,0
40098,x,0,1
40099,3,0,0
40100,MIU,0,0
40101,sc,0,1
40102,weekly,0,0
40103,),0,0
40104,and,0,0
40105,oral,0,0
40106,ribavirin,0,1
40107,(,0,1
40108,1000/1200,0,0
40109,mg,0,0
40110,po,0,0
40111,daily,0,0
40112,),0,0
40113,for,0,0
40114,either,0,1
40115,24,0,0
40116,weeks,0,0
40117,or,0,1
40118,48,0,1
40119,weeks,0,0
40120,.,0,1
40121,Virological,0,1
40122,response,0,0
40123,was,0,0
40124,evaluated,0,0
40125,by,0,0
40126,HCV,0,1
40127,RNA,0,1
40128,PCR,0,0
40129,at,0,0
40130,week,0,0
40131,10,0,1
40132,(,0,0
40133,initial,0,0
40134,response,0,0
40135,),0,0
40136,",",0,0
40137,at,0,0
40138,the,0,0
40139,end,0,0
40140,of,0,0
40141,treatment,0,0
40142,(,0,0
40143,end,0,0
40144,of-,0,0
40145,treatment,0,0
40146,response,0,0
40147,),0,0
40148,and,0,0
40149,at,0,0
40150,the,0,0
40151,end,0,0
40152,of,0,0
40153,24,0,1
40154,weeks,0,0
40155,follow-up,0,0
40156,(,0,1
40157,sustained,0,0
40158,response,0,0
40159,),0,0
40160,.,0,1
40161,Only,1,0
40162,patients,1,1
40163,with,1,1
40164,negative,1,1
40165,HCV,1,1
40166,RNA,1,1
40167,at,1,0
40168,week,1,0
40169,10,1,0
40170,continued,1,0
40171,treatment,1,0
40172,.,1,1
40173,Adverse,0,0
40174,events,0,0
40175,were,0,1
40176,recorded,0,0
40177,at,0,0
40178,regular,0,1
40179,intervals,0,0
40180,.,0,1
40181,RESULTS,0,0
40182,Thirty-seven,1,1
40183,patients,1,1
40184,were,1,0
40185,enrolled,1,1
40186,",",1,0
40187,19,1,1
40188,(,1,0
40189,6,1,0
40190,females,1,1
40191,",",1,0
40192,median,1,1
40193,age,1,1
40194,43,1,1
40195,),1,0
40196,in,1,0
40197,the,1,0
40198,24,1,0
40199,week,1,0
40200,and,1,0
40201,18,1,1
40202,(,1,1
40203,5,1,0
40204,females,1,1
40205,",",1,0
40206,median,1,1
40207,age,1,1
40208,40,1,1
40209,),1,0
40210,in,1,0
40211,the,1,0
40212,48,1,0
40213,week,1,0
40214,treatment,1,0
40215,arm,1,0
40216,.,1,1
40217,Baseline,1,0
40218,characteristics,1,0
40219,were,1,1
40220,similar,1,0
40221,in,1,0
40222,both,1,0
40223,groups,1,0
40224,.,1,0
40225,At,0,0
40226,treatment,0,0
40227,week,0,0
40228,10,0,0
40229,",",0,0
40230,12/19,0,0
40231,(,0,0
40232,63,0,1
40233,%,0,0
40234,),0,0
40235,in,0,0
40236,the,0,0
40237,24,0,0
40238,week,0,0
40239,group,0,0
40240,and,0,0
40241,14/18,0,0
40242,(,0,0
40243,78,0,1
40244,%,0,0
40245,),0,0
40246,patients,0,1
40247,in,0,0
40248,the,0,0
40249,48,0,0
40250,week,0,0
40251,group,0,0
40252,had,0,0
40253,lost,0,0
40254,HCV,0,1
40255,RNA,0,1
40256,in,0,0
40257,serum,0,0
40258,(,0,0
40259,p,0,0
40260,=,0,0
40261,0.33,0,0
40262,),0,0
40263,.,0,0
40264,All,0,0
40265,initial,0,0
40266,responders,0,0
40267,remained,0,0
40268,HCV,0,1
40269,RNA,0,1
40270,negative,0,0
40271,throughout,0,0
40272,the,0,0
40273,treatment,0,0
40274,period,0,0
40275,.,0,0
40276,Sustained,0,0
40277,response,0,0
40278,rates,0,0
40279,were,0,1
40280,10/19,0,0
40281,(,0,0
40282,53,0,1
40283,%,0,0
40284,),0,0
40285,in,0,0
40286,the,0,0
40287,24,0,0
40288,week,0,0
40289,group,0,0
40290,and,0,0
40291,13/18,0,0
40292,(,0,0
40293,72,0,1
40294,%,0,0
40295,),0,0
40296,in,0,0
40297,the,0,0
40298,48,0,0
40299,week,0,0
40300,group,0,0
40301,(,0,0
40302,p,0,0
40303,=,0,0
40304,0.31,0,0
40305,),0,1
40306,.,0,1
40307,Three,1,1
40308,patients,1,1
40309,discontinued,1,0
40310,treatment,1,0
40311,early,1,0
40312,(,1,0
40313,two,1,0
40314,due,1,0
40315,to,1,0
40316,moderate,1,1
40317,adverse,1,0
40318,events,1,0
40319,",",1,1
40320,one,1,1
40321,due,1,0
40322,to,1,0
40323,non-compliance,1,1
40324,),1,0
40325,.,1,1
40326,Dose,0,0
40327,modifications,0,0
40328,were,0,1
40329,necessary,0,0
40330,in,0,0
40331,9,0,0
40332,patients,0,1
40333,",",0,0
40334,4,0,0
40335,in,0,0
40336,the,0,0
40337,24,0,0
40338,week,0,0
40339,and,0,0
40340,5,0,0
40341,in,0,0
40342,the,0,0
40343,48,0,0
40344,week,0,0
40345,group,0,0
40346,for,0,0
40347,anaemia,0,1
40348,",",0,0
40349,neutropenia,0,0
40350,",",0,0
40351,nausea,0,0
40352,and,0,0
40353,depression,0,0
40354,",",0,0
40355,respectively,0,0
40356,.,0,0
40357,CONCLUSION,0,0
40358,Prolonging,0,0
40359,interferon,0,0
40360,/,0,0
40361,ribavirin,0,0
40362,combination,0,0
40363,therapy,0,0
40364,in,0,0
40365,interferon,0,0
40366,alpha,0,0
40367,monotherapy,0,0
40368,relapsers,0,0
40369,with,0,1
40370,chronic,0,1
40371,hepatitis,0,1
40372,C,0,0
40373,from,0,1
40374,24,0,1
40375,to,0,1
40376,48,0,0
40377,weeks,0,0
40378,may,0,0
40379,increase,0,0
40380,sustained,0,0
40381,response,0,0
40382,rates,0,0
40383,.,0,1
40384,Larger,0,0
40385,controlled,0,0
40386,trials,0,0
40387,using,0,0
40388,pegylated,0,0
40389,interferon,0,0
40390,alpha,0,0
40391,and,0,0
40392,ribavirin,0,0
40393,in,0,0
40394,relapsers,1,0
40395,with,1,1
40396,chronic,1,1
40397,hepatitis,1,1
40398,C,1,0
40399,seem,0,0
40400,warranted,0,0
40401,.,0,1
40402,Bupropion,0,1
40403,SR,0,0
40404,and,0,0
40405,counseling,0,0
40406,for,0,0
40407,smoking,1,1
40408,cessation,1,0
40409,in,0,0
40410,actual,0,0
40411,practice,0,1
40412,:,0,1
40413,predictors,0,0
40414,of,0,0
40415,outcome,0,0
40416,.,0,0
40417,To,0,0
40418,date,0,0
40419,",",0,0
40420,only,0,0
40421,one,0,0
40422,study,0,0
40423,has,0,0
40424,been,0,0
40425,published,0,0
40426,on,0,0
40427,individual,0,0
40428,characteristics,0,0
40429,associated,0,0
40430,with,0,1
40431,outcome,0,0
40432,following,0,0
40433,standard,0,0
40434,treatment,0,0
40435,with,0,1
40436,bupropion,0,0
40437,SR,0,0
40438,for,0,0
40439,smoking,0,1
40440,cessation,0,0
40441,.,0,0
40442,To,0,0
40443,investigate,0,0
40444,treatment,0,0
40445,outcome,0,0
40446,beyond,0,0
40447,the,0,0
40448,6-week,0,0
40449,end-of-treatment,0,0
40450,point,0,0
40451,",",0,0
40452,the,0,0
40453,present,0,0
40454,study,0,0
40455,examined,0,0
40456,characteristics,0,0
40457,associated,0,0
40458,with,0,0
40459,more,0,0
40460,clinically,0,0
40461,relevant,0,0
40462,smoking,0,1
40463,endpoints,0,0
40464,following,0,0
40465,treatment,0,0
40466,with,0,1
40467,bupropion,0,0
40468,SR,0,0
40469,in,0,0
40470,a,0,0
40471,large,0,1
40472,health,0,0
40473,care,0,1
40474,system,0,0
40475,.,0,0
40476,A,0,0
40477,total,1,1
40478,of,1,0
40479,"1,524",1,1
40480,smokers,1,1
40481,(,1,1
40482,649,1,1
40483,men,1,1
40484,and,1,1
40485,875,1,1
40486,women,1,1
40487,),1,1
40488,of,1,0
40489,average,1,1
40490,age,1,1
40491,45.1,1,1
40492,years,1,1
40493,were,0,1
40494,randomized,0,1
40495,to,0,0
40496,receive,0,0
40497,one,0,1
40498,of,0,0
40499,four,0,1
40500,combinations,0,0
40501,of,0,0
40502,bupropion,0,1
40503,SR,0,0
40504,(,0,0
40505,150,0,0
40506,or,0,1
40507,300,0,0
40508,mg,0,0
40509,),0,0
40510,and,0,0
40511,behavioral,0,0
40512,counseling,0,0
40513,(,0,0
40514,tailored,0,0
40515,mailings,0,0
40516,or,0,1
40517,proactive,0,0
40518,telephone,0,0
40519,counseling,0,0
40520,),0,0
40521,and,0,0
40522,assessed,0,0
40523,for,0,0
40524,point-prevalent,0,0
40525,smoking,0,1
40526,status,0,1
40527,at,0,0
40528,3,0,0
40529,and,0,1
40530,12,0,1
40531,months,0,0
40532,.,0,1
40533,Multiple,0,0
40534,logistic,0,0
40535,regression,0,0
40536,analyses,0,0
40537,of,0,0
40538,potential,0,0
40539,risk,0,1
40540,factors,0,0
40541,for,0,0
40542,12-month,0,0
40543,point-prevalent,0,0
40544,smoking,0,1
40545,and,0,0
40546,for,0,0
40547,persistent,0,1
40548,smoking,0,1
40549,(,0,0
40550,point-prevalent,0,0
40551,smoking,0,1
40552,at,0,0
40553,both,0,0
40554,follow-ups,0,0
40555,),0,0
40556,following,0,0
40557,treatment,0,0
40558,were,0,0
40559,conducted,0,0
40560,for,0,0
40561,men,0,1
40562,and,0,1
40563,women,0,1
40564,combined,0,0
40565,and,0,0
40566,separately,0,0
40567,.,0,0
40568,Risk,0,0
40569,factors,0,0
40570,for,0,0
40571,smoking,0,1
40572,at,0,0
40573,both,0,0
40574,endpoints,0,0
40575,in,0,0
40576,the,0,0
40577,combined,0,0
40578,sample,0,1
40579,included,0,1
40580,treatment,0,0
40581,with,0,1
40582,tailored,0,0
40583,mailings,0,0
40584,",",0,0
40585,female,0,1
40586,gender,0,0
40587,",",0,0
40588,younger,0,1
40589,age,0,1
40590,",",0,0
40591,higher,0,0
40592,levels,0,0
40593,of,0,0
40594,tobacco,0,1
40595,dependence,0,0
40596,",",0,0
40597,shorter,0,0
40598,previous,0,0
40599,quit,0,1
40600,attempts,0,0
40601,",",0,0
40602,previous,0,0
40603,use,0,0
40604,of,0,0
40605,nicotine,0,0
40606,replacement,0,1
40607,therapy,0,0
40608,",",0,0
40609,and,0,0
40610,report,0,0
40611,of,0,0
40612,current,0,0
40613,depressive,0,1
40614,symptoms,0,1
40615,or,0,1
40616,lifetime,0,1
40617,depression,0,1
40618,.,0,1
40619,Risk,0,0
40620,factors,0,0
40621,for,0,0
40622,smoking,0,1
40623,following,0,0
40624,treatment,0,0
40625,identified,0,1
40626,in,0,0
40627,women,0,1
40628,only,0,0
40629,included,0,1
40630,treatment,0,0
40631,with,0,1
40632,the,0,0
40633,lower,0,0
40634,dose,0,0
40635,of,0,0
40636,bupropion,0,0
40637,SR,0,0
40638,",",0,0
40639,younger,0,1
40640,age,0,1
40641,",",0,0
40642,and,0,0
40643,higher,0,0
40644,perceived,0,0
40645,stress,0,0
40646,",",0,0
40647,whereas,0,0
40648,those,0,0
40649,that,0,0
40650,were,0,0
40651,unique,0,0
40652,to,0,1
40653,men,0,1
40654,included,0,1
40655,the,0,0
40656,presence,0,0
40657,of,0,0
40658,lifetime,0,0
40659,depression,0,1
40660,.,0,0
40661,The,0,0
40662,results,0,0
40663,are,0,0
40664,discussed,0,0
40665,in,0,0
40666,terms,0,0
40667,of,0,0
40668,their,0,1
40669,implications,0,0
40670,for,0,0
40671,the,0,0
40672,need,0,0
40673,for,0,0
40674,more,0,0
40675,effective,0,0
40676,treatments,0,0
40677,in,0,0
40678,general,0,1
40679,",",0,0
40680,and,0,0
40681,the,0,0
40682,role,0,0
40683,of,0,0
40684,individual,0,0
40685,differences,0,0
40686,in,0,0
40687,the,0,0
40688,likelihood,0,0
40689,of,0,0
40690,returning,0,0
40691,to,0,0
40692,smoking,0,0
40693,following,0,0
40694,treatment,0,0
40695,for,0,0
40696,quitting,0,1
40697,.,0,1
40698,Long-term,0,0
40699,survival,0,0
40700,in,0,0
40701,a,0,0
40702,phase,0,0
40703,III,0,0
40704,",",0,0
40705,randomised,0,0
40706,study,0,0
40707,of,0,0
40708,topotecan,0,0
40709,versus,0,0
40710,paclitaxel,0,0
40711,in,0,0
40712,advanced,1,1
40713,epithelial,1,1
40714,ovarian,1,1
40715,carcinoma,1,1
40716,.,1,0
40717,BACKGROUND,0,0
40718,We,0,0
40719,have,0,0
40720,continued,0,0
40721,to,0,0
40722,monitor,0,0
40723,the,0,0
40724,survival,0,0
40725,of,0,0
40726,patients,1,1
40727,randomised,1,1
40728,in,1,0
40729,a,1,0
40730,previously,1,0
40731,reported,1,0
40732,multicentre,1,0
40733,phase,1,1
40734,III,1,1
40735,study,1,0
40736,of,1,0
40737,topotecan,1,0
40738,versus,1,0
40739,paclitaxel,1,0
40740,in,1,0
40741,patients,1,1
40742,with,1,1
40743,advanced,1,1
40744,epithelial,1,1
40745,ovarian,1,1
40746,cancer,1,1
40747,who,1,1
40748,had,1,1
40749,failed,1,1
40750,one,1,1
40751,prior,1,1
40752,platinum-based,1,1
40753,regimen,1,0
40754,.,1,1
40755,PATIENTS,0,0
40756,AND,0,0
40757,METHODS,0,0
40758,Patients,1,1
40759,with,1,1
40760,bidimensionally,1,1
40761,measurable,1,0
40762,disease,1,1
40763,were,1,0
40764,randomised,1,0
40765,to,0,0
40766,topotecan,0,0
40767,(,0,0
40768,1.5,0,0
40769,mg/m,0,0
40770,(,0,1
40771,2,0,0
40772,),0,0
40773,/day,0,0
40774,for,0,0
40775,5,0,1
40776,days,0,0
40777,),0,1
40778,or,0,1
40779,paclitaxel,0,0
40780,(,0,0
40781,175,0,1
40782,mg/m,0,0
40783,(,0,1
40784,2,0,0
40785,),0,0
40786,/day,0,0
40787,as,0,0
40788,a,0,0
40789,3-h,0,0
40790,infusion,0,0
40791,),0,0
40792,every,0,0
40793,21,0,1
40794,days,0,0
40795,.,0,1
40796,Patients,0,1
40797,were,0,0
40798,eligible,0,1
40799,for,0,0
40800,treatment,0,0
40801,with,0,1
40802,the,0,0
40803,alternate,0,0
40804,therapy,0,0
40805,at,0,0
40806,third,0,1
40807,line,0,0
40808,.,0,0
40809,The,0,0
40810,European,0,1
40811,Organisation,0,0
40812,for,0,0
40813,Research,0,0
40814,and,0,0
40815,Treatment,0,0
40816,of,0,0
40817,Cancer,0,1
40818,Quality,0,0
40819,of,0,0
40820,Life,0,0
40821,(,0,1
40822,EORTC,0,0
40823,QOL,0,0
40824,),0,0
40825,-C30,0,0
40826,questionnaire,0,0
40827,was,0,0
40828,also,0,0
40829,used,0,0
40830,to,0,0
40831,measure,0,0
40832,eight,0,1
40833,symptoms,0,0
40834,at,0,0
40835,baseline,0,0
40836,and,0,0
40837,during,0,0
40838,each,0,0
40839,course,0,0
40840,(,0,0
40841,pain,0,0
40842,",",0,0
40843,anorexia,0,1
40844,",",0,0
40845,diarrhoea,0,0
40846,",",0,0
40847,fatigue,0,0
40848,",",0,0
40849,nausea,0,0
40850,and,0,0
40851,vomiting,0,0
40852,",",0,0
40853,dyspnea,0,0
40854,",",0,0
40855,constipation,0,1
40856,and,0,0
40857,insomnia,0,1
40858,),0,0
40859,.,0,0
40860,RESULTS,0,0
40861,A,1,0
40862,total,1,1
40863,of,1,0
40864,226,1,1
40865,patients,1,1
40866,were,0,1
40867,evaluable,0,1
40868,for,0,0
40869,response,0,0
40870,.,0,1
40871,Demographic,0,0
40872,characteristics,0,0
40873,were,0,1
40874,similar,0,0
40875,in,0,0
40876,both,0,0
40877,treatment,0,0
40878,groups,0,0
40879,",",0,0
40880,as,0,0
40881,were,0,0
40882,results,0,0
40883,of,0,0
40884,the,0,0
40885,EORTC,0,0
40886,QOL-30,0,0
40887,questionnaire,0,0
40888,.,0,0
40889,For,0,0
40890,the,0,0
40891,topotecan,0,0
40892,group,0,0
40893,",",0,0
40894,median,0,0
40895,time,0,0
40896,to,0,0
40897,progression,0,0
40898,was,0,0
40899,18.9,0,0
40900,weeks,0,0
40901,(,0,0
40902,range,0,1
40903,<,0,0
40904,1,0,0
40905,to,0,0
40906,92.6+,0,0
40907,weeks,0,0
40908,;,0,1
40909,25,0,1
40910,%,0,0
40911,censored,0,0
40912,),0,0
40913,",",0,0
40914,and,0,0
40915,",",0,0
40916,for,0,0
40917,paclitaxel,0,0
40918,",",0,0
40919,14.7,0,0
40920,weeks,0,0
40921,(,0,0
40922,range,0,1
40923,<,0,0
40924,1,0,0
40925,to,0,0
40926,137.3+,0,1
40927,weeks,0,0
40928,;,0,1
40929,12.3,0,0
40930,%,0,0
40931,censored,0,1
40932,),0,0
40933,;,0,0
40934,P,0,0
40935,=,0,0
40936,0.076,0,0
40937,.,0,1
40938,At,0,0
40939,4,0,0
40940,years,0,1
40941,post-randomisation,0,1
40942,",",0,0
40943,median,0,0
40944,survival,0,0
40945,in,0,0
40946,the,0,0
40947,topotecan,0,0
40948,group,0,0
40949,was,0,0
40950,63.0,0,0
40951,weeks,0,0
40952,(,0,0
40953,range,0,1
40954,<,0,0
40955,1,0,0
40956,to,0,0
40957,238.4+,0,1
40958,weeks,0,0
40959,;,0,1
40960,20.5,0,0
40961,%,0,0
40962,censored,0,0
40963,),0,0
40964,and,0,0
40965,",",0,0
40966,for,0,0
40967,paclitaxel,0,0
40968,",",0,0
40969,53.0,0,0
40970,weeks,0,0
40971,(,0,0
40972,range,0,1
40973,<,0,0
40974,1,0,0
40975,to,0,0
40976,226.3+,0,1
40977,weeks,0,0
40978,;,0,1
40979,12.3,0,0
40980,%,0,0
40981,censored,0,1
40982,),0,0
40983,;,0,0
40984,P,0,0
40985,=,0,0
40986,0.44,0,0
40987,.,0,1
40988,CONCLUSION,0,0
40989,Topotecan,0,0
40990,continues,0,0
40991,to,0,0
40992,demonstrate,0,0
40993,comparable,0,0
40994,efficacy,0,0
40995,and,0,0
40996,survival,0,0
40997,to,0,0
40998,paclitaxel,0,0
40999,with,0,1
41000,manageable,0,0
41001,and,0,1
41002,non-cumulative,0,0
41003,haematological,0,1
41004,toxicity,0,0
41005,.,0,1
41006,Non-haematological,0,0
41007,toxicity,0,0
41008,was,0,0
41009,generally,0,0
41010,mild,0,1
41011,for,0,0
41012,both,0,0
41013,groups,0,0
41014,.,0,0
41015,The,0,0
41016,long-term,0,0
41017,survival,0,0
41018,rate,0,0
41019,indicates,0,0
41020,substantial,0,0
41021,therapeutic,0,0
41022,benefit,0,0
41023,for,0,0
41024,this,0,0
41025,group,1,0
41026,of,1,0
41027,patients,1,1
41028,receiving,1,1
41029,topotecan,1,0
41030,at,0,0
41031,relapse,1,0
41032,of,1,0
41033,ovarian,1,1
41034,cancer,1,1
41035,.,1,1
41036,[,0,0
41037,Combined,0,0
41038,preoperative,0,0
41039,xeloda,0,0
41040,and,0,0
41041,radiotherapy,0,1
41042,for,0,0
41043,lower,1,0
41044,rectal,1,1
41045,cancer,1,1
41046,],1,1
41047,.,0,1
41048,OBJECTIVE,0,0
41049,To,0,0
41050,evaluate,0,0
41051,the,0,0
41052,effect,0,0
41053,of,0,0
41054,combined,0,0
41055,preoperative,0,0
41056,xeloda,0,0
41057,and,0,0
41058,pelvic,0,1
41059,radiotherapy,0,1
41060,on,0,0
41061,locally,1,1
41062,advanced,1,1
41063,lower,1,0
41064,rectal,1,1
41065,cancer,1,1
41066,.,1,1
41067,METHODS,0,0
41068,Sixty,1,1
41069,lower,1,0
41070,rectal,1,1
41071,cancer,1,1
41072,patients,1,1
41073,were,0,0
41074,divided,0,1
41075,randomly,0,1
41076,into,0,0
41077,two,0,0
41078,groups,0,1
41079,.,0,1
41080,30,1,0
41081,patients,1,1
41082,(,0,1
41083,Group,0,1
41084,A,0,1
41085,),0,0
41086,were,0,0
41087,treated,0,1
41088,with,0,1
41089,operation,0,0
41090,alone,0,0
41091,and,0,0
41092,30,0,0
41093,patients,0,1
41094,(,0,1
41095,Group,0,1
41096,B,0,1
41097,),0,0
41098,were,0,0
41099,treated,0,1
41100,with,0,1
41101,xeloda,0,0
41102,and,0,0
41103,radiotherapy,0,1
41104,before,0,0
41105,operation,0,0
41106,.,0,0
41107,RESULTS,0,0
41108,The,0,0
41109,operative,0,0
41110,resection,0,1
41111,",",0,0
41112,anal,0,1
41113,preservation,0,0
41114,and,0,0
41115,local,0,0
41116,recurrence,0,0
41117,rates,0,0
41118,were,0,1
41119,86.66,0,0
41120,%,0,0
41121,",",0,0
41122,33.33,0,0
41123,%,0,0
41124,",",0,0
41125,15.38,0,0
41126,%,0,0
41127,in,0,0
41128,group,0,0
41129,A,0,1
41130,and,0,0
41131,100,0,0
41132,%,0,0
41133,",",0,0
41134,83.33,0,0
41135,%,0,0
41136,",",0,0
41137,0,0,0
41138,%,0,0
41139,in,0,0
41140,group,0,0
41141,B,0,1
41142,(,0,0
41143,P,0,0
41144,<,0,0
41145,0.05,0,0
41146,and,0,0
41147,P,0,0
41148,<,0,0
41149,0.01,0,0
41150,),0,1
41151,.,0,1
41152,CONCLUSION,0,0
41153,Combined,0,0
41154,preoperative,0,0
41155,xeloda,0,0
41156,and,0,0
41157,radiotherapy,0,1
41158,for,0,0
41159,lower,0,0
41160,rectal,0,1
41161,cancer,0,1
41162,is,0,0
41163,able,0,0
41164,to,0,0
41165,significantly,0,0
41166,improve,0,0
41167,the,0,0
41168,operative,0,0
41169,resection,0,1
41170,",",0,0
41171,anal,0,1
41172,preservation,0,0
41173,and,0,0
41174,decrease,0,0
41175,the,0,0
41176,local,0,0
41177,recurrence,0,0
41178,rates,0,0
41179,.,0,1
41180,Outcomes,1,0
41181,in,1,1
41182,patients,1,1
41183,with,1,1
41184,diabetes,1,1
41185,mellitus,1,1
41186,undergoing,1,1
41187,percutaneous,1,1
41188,coronary,1,1
41189,intervention,1,0
41190,in,1,0
41191,the,1,0
41192,current,1,0
41193,era,1,0
41194,:,1,1
41195,a,0,0
41196,report,0,0
41197,from,0,0
41198,the,0,0
41199,Prevention,0,0
41200,of,0,0
41201,REStenosis,0,1
41202,with,0,1
41203,Tranilast,0,0
41204,and,0,0
41205,its,0,0
41206,Outcomes,0,0
41207,(,0,0
41208,PRESTO,0,0
41209,),0,0
41210,trial,0,0
41211,.,0,1
41212,BACKGROUND,0,0
41213,Diabetes,0,1
41214,portends,0,0
41215,an,0,0
41216,adverse,0,0
41217,prognosis,0,0
41218,in,0,0
41219,patients,1,1
41220,undergoing,1,1
41221,percutaneous,1,1
41222,coronary,1,1
41223,intervention,1,0
41224,(,1,0
41225,PCI,1,0
41226,),1,0
41227,.,1,0
41228,Whether,0,0
41229,improvements,0,0
41230,in,0,0
41231,current,0,0
41232,clinical,0,0
41233,practice,0,0
41234,(,0,0
41235,stents,0,0
41236,",",0,0
41237,IIb/IIIa,0,0
41238,antagonists,0,0
41239,),0,0
41240,have,0,0
41241,resulted,0,0
41242,in,0,0
41243,substantial,0,0
41244,improvement,0,0
41245,of,0,0
41246,these,0,0
41247,outcomes,0,0
41248,remains,0,0
41249,an,0,0
41250,issue,0,0
41251,.,0,0
41252,The,0,0
41253,aim,0,0
41254,of,0,0
41255,this,0,0
41256,study,0,0
41257,was,0,0
41258,to,0,0
41259,determine,0,0
41260,the,0,0
41261,influence,0,0
41262,of,0,0
41263,diabetes,0,1
41264,on,0,0
41265,9-month,0,1
41266,outcomes,0,0
41267,of,0,1
41268,patients,1,1
41269,undergoing,1,1
41270,PCI,1,0
41271,in,1,0
41272,the,1,0
41273,current,1,0
41274,era,1,0
41275,.,1,1
41276,METHODS,0,0
41277,AND,0,0
41278,RESULTS,0,0
41279,The,1,0
41280,11,1,0
41281,482,1,1
41282,patients,1,1
41283,enrolled,1,1
41284,in,1,0
41285,the,1,0
41286,Prevention,1,0
41287,of,1,0
41288,REStenosis,1,1
41289,with,1,1
41290,Tranilast,1,0
41291,and,1,0
41292,its,1,0
41293,Outcomes,1,0
41294,(,1,0
41295,PRESTO,1,0
41296,),1,1
41297,Trial,1,0
41298,were,0,0
41299,stratified,0,1
41300,according,0,0
41301,to,0,0
41302,the,0,0
41303,presence,0,0
41304,(,0,0
41305,n=2694,0,1
41306,),0,0
41307,or,0,1
41308,absence,0,0
41309,(,0,0
41310,n=8798,0,1
41311,),0,0
41312,of,0,0
41313,diabetes,0,1
41314,.,0,1
41315,Diabetic,0,1
41316,patients,0,1
41317,were,0,1
41318,older,0,1
41319,;,0,0
41320,were,0,0
41321,more,0,0
41322,likely,0,0
41323,to,0,0
41324,be,0,0
41325,female,0,1
41326,;,0,0
41327,had,0,0
41328,a,0,0
41329,higher,0,0
41330,proportion,0,0
41331,of,0,0
41332,congestive,0,1
41333,failure,0,1
41334,",",0,0
41335,hypertension,0,1
41336,",",0,0
41337,prior,0,0
41338,CABG,0,0
41339,",",0,0
41340,and,0,0
41341,unstable,0,1
41342,angina,0,1
41343,;,0,0
41344,and,0,0
41345,had,0,0
41346,higher,0,0
41347,body,0,1
41348,mass,0,0
41349,index,0,0
41350,and,0,0
41351,lower,0,0
41352,ejection,0,1
41353,fraction,0,0
41354,than,0,0
41355,nondiabetic,0,1
41356,patients,0,1
41357,(,0,0
41358,P,0,0
41359,<,0,0
41360,0.01,0,0
41361,for,0,0
41362,all,0,1
41363,comparisons,0,0
41364,),0,0
41365,.,0,0
41366,The,0,0
41367,degree,0,0
41368,of,0,0
41369,multivessel,0,1
41370,disease,0,1
41371,was,0,0
41372,similar,0,0
41373,between,0,0
41374,the,0,0
41375,two,0,0
41376,groups,0,0
41377,.,0,1
41378,American,0,1
41379,College,0,1
41380,of,0,0
41381,Cardiology/American,0,1
41382,Heart,0,1
41383,Association,0,0
41384,type,0,1
41385,C,0,0
41386,lesions,0,1
41387,were,0,1
41388,more,0,0
41389,common,0,0
41390,in,0,0
41391,diabetic,0,1
41392,patients,0,1
41393,(,0,1
41394,17,0,1
41395,%,0,0
41396,versus,0,0
41397,15,0,0
41398,%,0,0
41399,",",0,0
41400,P,0,0
41401,<,0,0
41402,0.01,0,0
41403,),0,1
41404,.,0,1
41405,Angiographic,0,0
41406,and,0,0
41407,procedural,0,0
41408,success,0,0
41409,rates,0,0
41410,and,0,1
41411,in-hospital,0,0
41412,events,0,0
41413,were,0,1
41414,similar,0,0
41415,between,0,0
41416,the,0,0
41417,two,0,0
41418,groups,0,0
41419,.,0,1
41420,The,0,0
41421,primary,0,0
41422,end,0,0
41423,point,0,0
41424,of,0,0
41425,death,0,0
41426,",",0,0
41427,myocardial,0,1
41428,infarction,0,1
41429,",",0,0
41430,or,0,0
41431,target,0,0
41432,vessel,0,0
41433,revascularization,0,1
41434,(,0,0
41435,TVR,0,1
41436,),0,0
41437,was,0,0
41438,analyzed,0,0
41439,as,0,0
41440,time-to-first,0,0
41441,event,0,0
41442,within,0,1
41443,9,0,0
41444,months,0,0
41445,of,0,0
41446,the,0,0
41447,index,0,0
41448,PCI,0,0
41449,.,0,0
41450,After,0,0
41451,adjusting,0,0
41452,for,0,0
41453,certain,0,0
41454,baseline,0,0
41455,characteristics,0,0
41456,",",0,1
41457,diabetes,0,1
41458,was,0,0
41459,independently,0,0
41460,associated,0,0
41461,with,0,0
41462,death,0,0
41463,at,0,0
41464,9,0,0
41465,months,0,0
41466,(,0,1
41467,relative,0,0
41468,risk,0,1
41469,[,0,0
41470,RR,0,0
41471,],0,1
41472,",",0,0
41473,1.87,0,0
41474,;,0,0
41475,95,0,0
41476,%,0,0
41477,CI,0,0
41478,",",0,0
41479,1.31,0,0
41480,to,0,0
41481,2.68,0,0
41482,",",0,0
41483,P,0,0
41484,<,0,0
41485,0.01,0,0
41486,),0,0
41487,and,0,0
41488,with,0,1
41489,an,0,0
41490,increased,0,0
41491,likelihood,0,0
41492,of,0,0
41493,TVR,0,1
41494,(,0,0
41495,RR,0,0
41496,",",0,1
41497,1.27,0,0
41498,;,0,0
41499,95,0,0
41500,%,0,0
41501,CI,0,0
41502,",",0,0
41503,1.14,0,0
41504,to,0,0
41505,1.42,0,0
41506,",",0,0
41507,P,0,0
41508,<,0,0
41509,0.01,0,0
41510,),0,0
41511,",",0,0
41512,as,0,0
41513,well,0,0
41514,as,0,0
41515,the,0,0
41516,composite,0,0
41517,end,0,0
41518,point,0,0
41519,of,0,0
41520,death/myocardial,0,0
41521,infarction/TVR,0,1
41522,(,0,0
41523,RR,0,0
41524,",",0,1
41525,1.26,0,0
41526,;,0,0
41527,95,0,0
41528,%,0,0
41529,CI,0,0
41530,",",0,0
41531,1.13,0,0
41532,to,0,0
41533,1.40,0,0
41534,",",0,0
41535,P,0,0
41536,<,0,0
41537,0.01,0,0
41538,),0,1
41539,.,0,1
41540,CONCLUSIONS,0,0
41541,Despite,0,0
41542,advances,0,0
41543,in,0,1
41544,interventional,0,1
41545,techniques,0,0
41546,",",0,0
41547,diabetes,0,1
41548,remains,0,0
41549,a,0,0
41550,significant,0,0
41551,independent,0,0
41552,predictor,0,0
41553,of,0,0
41554,adverse,0,0
41555,events,0,0
41556,in,0,0
41557,the,0,0
41558,intermediate,0,0
41559,term,0,0
41560,after,0,0
41561,PCI,0,1
41562,.,0,1
41563,Comparison,0,0
41564,study,0,0
41565,of,0,0
41566,venlafaxine,0,0
41567,and,0,0
41568,paroxetine,0,0
41569,for,0,0
41570,the,0,0
41571,treatment,0,0
41572,of,0,0
41573,depression,1,1
41574,in,1,0
41575,elderly,1,1
41576,Chinese,1,1
41577,inpatients,1,1
41578,.,1,1
41579,Prospective,0,0
41580,",",0,0
41581,randomized,0,0
41582,trial,0,0
41583,of,0,0
41584,diclofenac,0,0
41585,and,0,0
41586,ketorolac,0,0
41587,after,0,0
41588,refractive,1,1
41589,surgery,1,1
41590,.,1,1
41591,PURPOSE,0,0
41592,To,0,0
41593,compare,0,0
41594,the,0,0
41595,effectiveness,0,0
41596,of,0,0
41597,diclofenac,0,0
41598,and,0,0
41599,ketorolac,0,0
41600,in,0,0
41601,relieving,0,0
41602,corneal,1,0
41603,pain,1,1
41604,after,1,0
41605,refractive,1,0
41606,surgery,1,1
41607,",",0,0
41608,and,0,0
41609,determine,0,0
41610,if,0,0
41611,there,0,0
41612,is,0,0
41613,a,0,0
41614,difference,0,0
41615,in,0,0
41616,stinging,0,0
41617,on,0,0
41618,instillation,0,0
41619,.,0,1
41620,METHODS,0,0
41621,Thirty,1,1
41622,patients,1,1
41623,were,0,0
41624,randomized,0,0
41625,prospectively,0,1
41626,to,0,0
41627,postoperative,0,0
41628,diclofenac,0,0
41629,in,0,0
41630,one,0,0
41631,eye,0,0
41632,and,0,0
41633,ketorolac,0,0
41634,in,0,0
41635,the,0,0
41636,other,0,0
41637,.,0,1
41638,Patients,0,1
41639,and,0,0
41640,surgeon,0,1
41641,did,0,0
41642,not,0,0
41643,know,0,0
41644,which,0,0
41645,medications,0,0
41646,were,0,1
41647,used,0,0
41648,.,0,1
41649,Ocular,0,0
41650,postoperative,0,0
41651,pain,0,1
41652,and,0,0
41653,discomfort,0,0
41654,on,0,0
41655,instillation,0,0
41656,of,0,0
41657,medication,0,0
41658,were,0,0
41659,measured,0,0
41660,after,0,0
41661,radial,0,0
41662,keratotomy,0,1
41663,with,0,1
41664,a,0,0
41665,visual,0,0
41666,analog,0,0
41667,scale,0,0
41668,and,0,0
41669,a,0,0
41670,questionnaire,0,0
41671,.,0,0
41672,RESULTS,0,0
41673,Both,0,0
41674,medications,0,0
41675,were,0,0
41676,highly,0,0
41677,effective,0,0
41678,in,0,0
41679,relieving,0,0
41680,pain,0,1
41681,.,0,0
41682,There,0,0
41683,was,0,0
41684,no,0,0
41685,significant,0,0
41686,difference,0,0
41687,in,0,0
41688,pain,0,0
41689,relief,0,0
41690,",",0,0
41691,or,0,0
41692,stinging,0,0
41693,on,0,0
41694,instillation,0,0
41695,(,0,0
41696,P,0,0
41697,=,0,0
41698,.29,0,0
41699,),0,1
41700,.,0,0
41701,CONCLUSION,0,0
41702,There,0,0
41703,was,0,0
41704,no,0,0
41705,statistical,0,0
41706,difference,0,0
41707,in,0,0
41708,the,0,0
41709,effectiveness,0,0
41710,of,0,0
41711,the,0,0
41712,medications,0,0
41713,on,0,0
41714,pain,0,1
41715,relief,0,0
41716,",",0,0
41717,or,0,0
41718,in,0,0
41719,stinging,0,0
41720,on,0,0
41721,instillation,0,0
41722,.,0,1
41723,Oscillatory,1,1
41724,potentials,1,0
41725,",",1,0
41726,retinopathy,1,1
41727,",",1,0
41728,and,1,0
41729,long-term,1,0
41730,glucose,1,0
41731,control,1,0
41732,in,1,0
41733,insulin-dependent,1,1
41734,diabetes,1,1
41735,.,1,1
41736,The,0,0
41737,main,0,0
41738,objective,0,0
41739,of,0,0
41740,the,0,0
41741,study,0,0
41742,was,0,0
41743,to,0,0
41744,assess,0,0
41745,effects,0,0
41746,of,0,0
41747,long-term,0,0
41748,lowering,0,0
41749,of,0,0
41750,glucosylated,0,0
41751,hemoglobin,0,0
41752,(,0,0
41753,HbA1,0,0
41754,%,0,0
41755,),0,0
41756,on,0,0
41757,neurosensory,0,0
41758,function,0,0
41759,in,0,0
41760,insulin-dependent,1,1
41761,diabetes,1,1
41762,.,1,1
41763,Individual,0,0
41764,(,0,0
41765,OP-1,0,0
41766,",",0,0
41767,OP-2,0,0
41768,",",0,0
41769,OP-3,0,0
41770,),0,0
41771,and,0,0
41772,summed,0,0
41773,(,0,0
41774,OP-sum,0,0
41775,),0,1
41776,amplitudes,0,0
41777,of,0,1
41778,oscillatory,0,1
41779,potentials,0,0
41780,(,0,1
41781,OPs,0,0
41782,),0,0
41783,of,0,0
41784,electroretinography,0,0
41785,were,0,0
41786,recorded,0,0
41787,at,0,0
41788,study,0,0
41789,start,0,1
41790,and,0,0
41791,7-years,0,1
41792,later,0,1
41793,in,0,0
41794,45,1,1
41795,patients,1,1
41796,(,0,1
41797,the,0,0
41798,Oslo,1,1
41799,study,0,0
41800,),0,0
41801,.,0,0
41802,As,0,0
41803,an,0,0
41804,overall,0,0
41805,7-year,0,0
41806,change,0,0
41807,",",0,0
41808,amplitudes,0,0
41809,of,0,0
41810,OP-2,0,0
41811,",",0,0
41812,OP-3,0,0
41813,and,0,0
41814,OP-sum,0,0
41815,were,0,0
41816,reduced,0,0
41817,(,0,0
41818,p,0,0
41819,<,0,0
41820,0.0001-0.01,0,0
41821,),0,0
41822,",",0,0
41823,retinopathy,0,1
41824,worsened,0,0
41825,(,0,0
41826,p,0,0
41827,=,0,0
41828,0.005,0,0
41829,),0,0
41830,",",0,0
41831,intraocular,0,0
41832,pressure,0,0
41833,decreased,0,0
41834,(,0,0
41835,p,0,0
41836,<,0,0
41837,0.001,0,0
41838,),0,0
41839,",",0,0
41840,systolic,0,0
41841,blood,0,0
41842,pressure,0,0
41843,increased,0,0
41844,(,0,0
41845,p,0,0
41846,<,0,0
41847,0.0002,0,0
41848,),0,0
41849,",",0,0
41850,and,0,0
41851,glycemic,0,0
41852,control,0,0
41853,improved,0,0
41854,from,0,0
41855,HbA1,0,0
41856,of,0,0
41857,11.2,0,0
41858,+/-,0,0
41859,2.2,0,0
41860,%,0,0
41861,at,0,0
41862,study,0,0
41863,start,0,1
41864,to,0,0
41865,a,0,0
41866,7-year,0,0
41867,cumulative,0,0
41868,mean,0,1
41869,of,0,0
41870,9.5,0,0
41871,+/-,0,0
41872,1.5,0,0
41873,%,0,0
41874,(,0,0
41875,p,0,0
41876,<,0,0
41877,0.0001,0,0
41878,),0,1
41879,.,0,1
41880,Multiple,0,0
41881,regression,0,0
41882,analysis,0,0
41883,did,0,0
41884,not,0,0
41885,identify,0,0
41886,any,0,0
41887,independent,0,0
41888,relations,0,0
41889,between,0,0
41890,change,0,0
41891,in,0,0
41892,OP-1,0,0
41893,",",0,0
41894,OP-2,0,0
41895,",",0,0
41896,OP-3,0,0
41897,",",0,0
41898,OP-sum,0,0
41899,and,0,0
41900,change,0,0
41901,in,0,0
41902,glycemic,0,0
41903,control,0,1
41904,or,0,1
41905,background,0,0
41906,variables,0,0
41907,",",0,0
41908,including,0,0
41909,change,0,0
41910,in,0,0
41911,age,0,1
41912,and,0,0
41913,duration,0,0
41914,of,0,0
41915,diabetes,0,1
41916,.,0,1
41917,However,0,0
41918,",",0,0
41919,cross-sectional,0,1
41920,observations,0,0
41921,at,0,1
41922,7,0,1
41923,years,0,1
41924,showed,0,0
41925,negative,0,1
41926,correlations,0,0
41927,between,0,0
41928,all,0,1
41929,OPs,0,0
41930,and,0,0
41931,age,0,1
41932,(,0,0
41933,p,0,0
41934,<,0,0
41935,0.0001-0.003,0,0
41936,),0,0
41937,",",0,0
41938,and,0,0
41939,between,0,0
41940,OP-3,0,0
41941,and,0,0
41942,duration,0,0
41943,(,0,0
41944,p,0,0
41945,=,0,0
41946,0.003,0,0
41947,),0,0
41948,and,0,0
41949,counts,0,0
41950,of,0,0
41951,microaneurysms,0,1
41952,(,0,1
41953,p,0,0
41954,=,0,0
41955,0.02,0,0
41956,),0,0
41957,.,0,0
41958,The,0,0
41959,data,0,0
41960,suggest,0,0
41961,that,0,0
41962,various,0,0
41963,clinical,0,0
41964,background,0,0
41965,variables,0,0
41966,may,0,0
41967,influence,0,0
41968,individual,0,0
41969,and,0,0
41970,summed,0,0
41971,amplitudes,0,0
41972,of,0,0
41973,OPs,0,0
41974,differently,0,0
41975,.,0,0
41976,Reduced,0,0
41977,neurosensory,0,0
41978,retinal,0,1
41979,function,0,0
41980,(,0,0
41981,OPs,0,0
41982,),0,0
41983,seemed,0,0
41984,to,0,0
41985,appear,0,0
41986,after,0,0
41987,7-years,0,1
41988,",",0,0
41989,independently,0,0
41990,of,0,0
41991,vascular,0,0
41992,defects,0,1
41993,of,0,0
41994,retinopathy,0,1
41995,and,0,0
41996,long-term,0,0
41997,improvement,0,0
41998,in,0,0
41999,glucose,0,0
42000,control,0,1
42001,.,0,1
42002,Rapid-sequence,0,0
42003,intubation,0,1
42004,of,0,0
42005,head,1,1
42006,trauma,1,1
42007,patients,1,1
42008,:,1,1
42009,prevention,0,1
42010,of,0,0
42011,fasciculations,0,0
42012,with,0,1
42013,pancuronium,0,0
42014,versus,0,0
42015,minidose,0,0
42016,succinylcholine,0,0
42017,.,0,1
42018,INTRODUCTION,0,0
42019,Fasciculations,0,0
42020,during,0,0
42021,rapid-sequence,0,0
42022,intubation,0,0
42023,may,0,0
42024,lead,0,0
42025,to,0,0
42026,increased,0,0
42027,intracranial,0,1
42028,pressure,0,0
42029,and,0,0
42030,emesis,0,0
42031,with,0,1
42032,aspiration,0,0
42033,.,0,1
42034,Standard,0,0
42035,rapid-sequence,0,0
42036,intubation,0,0
42037,requires,0,0
42038,a,0,0
42039,nondepolarizing,0,0
42040,blocking,0,0
42041,agent,0,0
42042,before,0,0
42043,succinylcholine,0,0
42044,administration,0,0
42045,.,0,1
42046,HYPOTHESIS,0,0
42047,Prevention,0,0
42048,of,0,0
42049,fasciculations,0,0
42050,during,0,0
42051,rapid-sequence,0,0
42052,intubation,0,1
42053,of,0,0
42054,head,1,1
42055,trauma,1,1
42056,patients,1,1
42057,can,0,0
42058,be,0,0
42059,accomplished,0,0
42060,as,0,0
42061,safely,0,0
42062,and,0,0
42063,effectively,0,0
42064,with,0,1
42065,minidose,0,0
42066,succinylcholine,0,0
42067,as,0,0
42068,with,0,1
42069,a,0,0
42070,defasciculating,0,0
42071,dose,0,0
42072,of,0,0
42073,pancuronium,0,0
42074,.,0,0
42075,DESIGN,0,0
42076,A,0,0
42077,prospective,0,0
42078,",",0,0
42079,randomized,0,0
42080,",",0,0
42081,double-blind,0,0
42082,study,0,0
42083,.,0,0
42084,SETTING,0,0
42085,An,0,0
42086,inner-city,1,1
42087,county,1,1
42088,trauma,1,1
42089,center,1,1
42090,with,1,1
42091,"70,000",1,1
42092,patient,1,1
42093,visits,1,0
42094,per,1,1
42095,year,1,1
42096,.,1,1
42097,PARTICIPANTS,0,0
42098,Sequential,1,0
42099,adult,1,1
42100,head,1,1
42101,trauma,1,1
42102,patients,1,1
42103,requiring,1,1
42104,rapid-sequence,1,1
42105,intubation,1,1
42106,who,1,1
42107,had,1,1
42108,no,1,1
42109,contraindications,1,0
42110,to,1,0
42111,succinylcholine,1,0
42112,or,1,0
42113,pancuronium,1,0
42114,.,1,0
42115,INTERVENTIONS,0,0
42116,Each,0,0
42117,head,1,1
42118,trauma,1,1
42119,patient,1,0
42120,requiring,0,1
42121,rapid-sequence,0,1
42122,intubation,0,1
42123,who,0,1
42124,met,0,1
42125,the,0,1
42126,inclusion,0,1
42127,criteria,0,1
42128,received,0,0
42129,standard,0,0
42130,rapid-sequence,0,0
42131,intubation,0,1
42132,maneuvers,0,0
42133,and,0,0
42134,lidocaine,0,0
42135,(,0,0
42136,1,0,0
42137,mg/kg,0,0
42138,),0,1
42139,IV,0,0
42140,.,0,1
42141,Patients,0,1
42142,were,0,0
42143,randomized,0,1
42144,to,0,0
42145,receive,0,0
42146,either,0,0
42147,minidose,0,0
42148,succinylcholine,0,0
42149,(,0,0
42150,0.1,0,0
42151,mg/kg,0,0
42152,),0,0
42153,or,0,0
42154,pancuronium,0,0
42155,(,0,0
42156,0.03,0,0
42157,mg/kg,0,0
42158,),0,1
42159,IV,0,0
42160,one,0,1
42161,minute,0,0
42162,prior,0,0
42163,to,0,0
42164,the,0,0
42165,full,0,0
42166,paralytic,0,1
42167,dose,0,0
42168,of,0,0
42169,succinylcholine,0,0
42170,(,0,0
42171,1.5,0,0
42172,mg/kg,0,0
42173,),0,1
42174,IV,0,0
42175,.,0,1
42176,Fasciculations,0,0
42177,were,0,0
42178,recorded,0,0
42179,using,0,0
42180,a,0,0
42181,graded,0,0
42182,visual,0,0
42183,scale,0,1
42184,.,0,0
42185,RESULTS,0,0
42186,Of,0,1
42187,46,1,1
42188,patients,1,1
42189,",",0,0
42190,eight,0,1
42191,of,0,0
42192,19,0,1
42193,(,0,1
42194,42,0,1
42195,%,0,0
42196,),0,0
42197,in,0,0
42198,the,0,0
42199,pancuronium,0,0
42200,group,0,0
42201,and,0,0
42202,six,0,1
42203,of,0,0
42204,27,0,1
42205,(,0,1
42206,22,0,1
42207,%,0,0
42208,),0,0
42209,in,0,0
42210,the,0,0
42211,succinylcholine,0,0
42212,group,0,0
42213,experienced,0,0
42214,fasciculations,0,0
42215,.,0,0
42216,No,0,0
42217,statistically,0,0
42218,significant,0,0
42219,difference,0,0
42220,in,0,0
42221,fasciculations,0,0
42222,was,0,0
42223,detected,0,0
42224,between,0,0
42225,the,0,0
42226,two,0,0
42227,groups,0,0
42228,using,0,1
42229,chi,0,0
42230,2,0,1
42231,analysis,0,0
42232,.,0,1
42233,Complete,0,0
42234,relaxation,0,0
42235,of,0,0
42236,the,0,0
42237,cords,0,0
42238,was,0,0
42239,present,0,0
42240,in,0,0
42241,all,0,0
42242,but,0,0
42243,two,0,0
42244,patients,0,1
42245,",",0,0
42246,one,0,1
42247,in,0,0
42248,each,0,0
42249,group,0,0
42250,.,0,0
42251,No,0,0
42252,patient,0,0
42253,in,0,0
42254,either,0,0
42255,group,0,0
42256,experienced,0,0
42257,emesis,0,0
42258,or,0,1
42259,significant,0,0
42260,dysrhythmias,0,0
42261,.,0,1
42262,CONCLUSION,0,0
42263,Pretreatment,0,0
42264,with,0,1
42265,minidose,0,0
42266,succinylcholine,0,0
42267,causes,0,0
42268,no,0,0
42269,greater,0,0
42270,incidence,0,0
42271,of,0,0
42272,fasciculations,0,0
42273,than,0,0
42274,pancuronium,0,0
42275,in,0,0
42276,rapid-sequence,0,0
42277,intubation,0,1
42278,of,0,0
42279,head,1,1
42280,trauma,1,1
42281,patients,1,1
42282,in,1,0
42283,an,1,0
42284,ED,1,0
42285,setting,1,1
42286,.,1,0
42287,Thus,0,0
42288,succinylcholine,0,0
42289,may,0,0
42290,be,0,0
42291,used,0,0
42292,as,0,0
42293,the,0,0
42294,sole,0,0
42295,paralytic,0,1
42296,agent,0,0
42297,in,0,0
42298,rapid-sequence,0,0
42299,intubation,0,1
42300,of,0,0
42301,head,0,1
42302,trauma,0,1
42303,patients,0,1
42304,.,0,1
42305,Body,1,1
42306,asymmetry,1,0
42307,affects,0,0
42308,conjugate,0,0
42309,lateral,0,0
42310,eye,0,0
42311,movement,0,0
42312,.,0,1
42313,A.,0,0
42314,H.,0,1
42315,Baker,0,1
42316,(,0,1
42317,1989,0,1
42318,),0,0
42319,and,0,0
42320,A.,0,0
42321,H.,0,1
42322,Baker,0,1
42323,and,0,0
42324,A.,0,0
42325,I.,0,0
42326,Ledner,0,0
42327,(,0,1
42328,1990,0,1
42329,),0,0
42330,reported,0,0
42331,that,0,0
42332,asymmetrical,0,0
42333,visual,0,0
42334,stimulation,0,0
42335,affects,0,0
42336,conjugate,1,0
42337,lateral,1,0
42338,eye,1,0
42339,movement,1,0
42340,(,1,0
42341,CLEM,1,0
42342,),1,0
42343,.,0,0
42344,In,0,0
42345,the,0,0
42346,present,0,0
42347,article,0,0
42348,",",0,0
42349,the,0,0
42350,authors,0,0
42351,explored,0,0
42352,whether,0,0
42353,asymmetrical,0,0
42354,body,0,1
42355,position,0,0
42356,similarly,0,0
42357,affects,0,0
42358,CLEM,0,0
42359,.,0,0
42360,The,0,0
42361,authors,1,0
42362,assessed,0,0
42363,CLEMs,0,0
42364,twice,0,0
42365,in,0,0
42366,a,0,0
42367,counterbalanced,0,0
42368,design,0,0
42369,.,0,0
42370,In,0,0
42371,the,0,0
42372,control,1,0
42373,(,1,0
42374,symmetric,1,1
42375,),1,0
42376,condition,1,0
42377,",",0,0
42378,each,0,0
42379,participant,1,0
42380,sat,0,0
42381,in,0,0
42382,a,0,0
42383,completely,0,0
42384,symmetrical,0,0
42385,position,0,0
42386,facing,0,0
42387,a,0,0
42388,wall,0,0
42389,devoid,0,0
42390,of,0,0
42391,any,0,0
42392,asymmetrical,0,0
42393,features,0,0
42394,.,0,1
42395,In,0,0
42396,the,0,0
42397,experimental,0,0
42398,(,0,0
42399,asymmetrical,0,0
42400,),0,0
42401,condition,0,0
42402,",",0,0
42403,half,0,1
42404,the,0,0
42405,participants,1,1
42406,rotated,0,0
42407,their,0,1
42408,heads,0,1
42409,68,0,1
42410,degrees,0,0
42411,clockwise,0,0
42412,relative,0,0
42413,to,0,0
42414,their,0,0
42415,bodies,0,1
42416,to,0,0
42417,face,0,0
42418,the,0,0
42419,experimenter,0,0
42420,",",0,0
42421,and,0,0
42422,the,0,0
42423,other,0,0
42424,half,0,1
42425,rotated,0,0
42426,their,0,1
42427,heads,0,1
42428,68,0,1
42429,degrees,0,0
42430,counterclockwise,0,0
42431,",",0,0
42432,also,0,0
42433,to,0,0
42434,face,0,0
42435,the,0,0
42436,experimenter,0,0
42437,.,0,0
42438,CLEM,0,0
42439,was,0,0
42440,predominantly,0,1
42441,toward,0,0
42442,the,0,0
42443,body,0,0
42444,'s,0,0
42445,position,0,0
42446,in,0,0
42447,the,0,0
42448,asymmetrical,0,0
42449,condition,0,0
42450,rather,0,0
42451,than,0,0
42452,toward,0,0
42453,the,0,0
42454,body,0,0
42455,'s,0,0
42456,position,0,0
42457,in,0,0
42458,the,0,0
42459,symmetrical,0,1
42460,condition,0,0
42461,.,0,1
42462,Plasma,0,1
42463,kinetics,0,0
42464,of,0,0
42465,zeaxanthin,0,0
42466,and,0,0
42467,3'-dehydro-lutein,0,0
42468,after,0,0
42469,multiple,0,1
42470,oral,0,0
42471,doses,0,0
42472,of,0,0
42473,synthetic,0,0
42474,zeaxanthin,0,0
42475,.,0,1
42476,BACKGROUND,0,0
42477,Zeaxanthin,0,0
42478,is,0,0
42479,hypothesized,0,0
42480,to,0,0
42481,reduce,0,0
42482,the,0,0
42483,risk,0,0
42484,of,0,0
42485,age-related,1,0
42486,macular,1,1
42487,degeneration,1,1
42488,;,1,0
42489,however,0,0
42490,",",0,0
42491,kinetic,0,0
42492,information,0,0
42493,is,0,0
42494,limited,0,0
42495,.,0,0
42496,OBJECTIVES,0,0
42497,The,0,0
42498,objective,0,0
42499,was,0,0
42500,to,0,0
42501,investigate,0,0
42502,the,0,0
42503,plasma,0,0
42504,kinetics,0,0
42505,of,0,0
42506,synthetic,0,0
42507,zeaxanthin,0,0
42508,after,0,0
42509,repeated,0,0
42510,oral,0,0
42511,doses,0,0
42512,and,0,0
42513,to,0,0
42514,assess,0,0
42515,the,0,0
42516,possible,0,0
42517,influence,0,0
42518,of,0,0
42519,other,0,0
42520,carotenoids,0,0
42521,on,0,0
42522,plasma,0,0
42523,zeaxanthin,0,0
42524,concentrations,0,0
42525,.,0,1
42526,DESIGN,0,0
42527,After,0,0
42528,a,0,0
42529,run-in,0,0
42530,of,0,0
42531,3,0,0
42532,d,0,1
42533,",",0,0
42534,20,1,1
42535,healthy,1,1
42536,volunteers,1,1
42537,assigned,0,1
42538,to,0,1
42539,2,0,1
42540,parallel,0,0
42541,dose,0,0
42542,groups,0,0
42543,received,0,0
42544,once,0,0
42545,daily,0,0
42546,oral,0,0
42547,doses,0,0
42548,of,0,0
42549,either,0,1
42550,1,0,0
42551,mg,0,0
42552,(,0,0
42553,1.76,0,0
42554,micro,0,0
42555,mol,0,0
42556,),0,0
42557,or,0,1
42558,10,0,0
42559,mg,0,0
42560,(,0,0
42561,17.6,0,0
42562,micro,0,0
42563,mol,0,0
42564,),0,0
42565,zeaxanthin,0,0
42566,for,0,0
42567,42,0,1
42568,d.,0,1
42569,Plasma,0,1
42570,concentration-time,0,0
42571,profiles,0,0
42572,on,0,0
42573,days,0,0
42574,1,0,1
42575,and,0,1
42576,42,0,1
42577,",",0,0
42578,concentrations,0,0
42579,immediately,0,0
42580,before,0,0
42581,zeaxanthin,0,0
42582,intake,0,0
42583,during,0,0
42584,the,0,0
42585,dosing,0,0
42586,period,0,0
42587,",",0,0
42588,and,0,0
42589,concentrations,0,0
42590,after,0,0
42591,the,0,0
42592,last,0,0
42593,dose,0,0
42594,until,0,0
42595,day,0,0
42596,76,0,1
42597,were,0,0
42598,monitored,0,1
42599,.,0,1
42600,RESULTS,0,0
42601,all-E-Zeaxanthin,0,0
42602,concentrations,0,0
42603,increased,0,0
42604,from,0,1
42605,0.048,0,0
42606,+/-,0,0
42607,0.026,0,0
42608,micro,0,0
42609,mol/L,0,0
42610,at,0,0
42611,baseline,0,0
42612,to,0,0
42613,0.20,0,0
42614,+/-,0,0
42615,0.07,0,0
42616,and,0,1
42617,0.92,0,0
42618,+/-,0,0
42619,0.28,0,0
42620,micro,0,0
42621,mol/L,0,0
42622,with,0,1
42623,1,0,0
42624,and,0,0
42625,10,0,0
42626,mg,0,0
42627,zeaxanthin,0,0
42628,",",0,0
42629,respectively,0,0
42630,.,0,0
42631,The,0,0
42632,dose-normalized,0,0
42633,bioavailability,0,0
42634,of,0,0
42635,all-E-zeaxanthin,0,0
42636,after,0,0
42637,the10-mg,0,0
42638,dose,0,0
42639,was,0,0
42640,40,0,1
42641,%,0,0
42642,lower,0,0
42643,(,0,0
42644,P,0,0
42645,<,0,0
42646,0.001,0,0
42647,),0,0
42648,than,0,0
42649,after,0,0
42650,the,0,0
42651,1-mg,0,0
42652,dose,0,0
42653,.,0,1
42654,Other,0,0
42655,kinetic,0,0
42656,parameters,0,0
42657,did,0,0
42658,not,0,0
42659,differ,0,0
42660,significantly,0,0
42661,between,0,0
42662,groups,0,0
42663,.,0,1
42664,After,0,0
42665,17,0,1
42666,d,0,0
42667,of,0,0
42668,dosing,0,0
42669,",",0,0
42670,>,0,1
42671,90,0,0
42672,%,0,0
42673,of,0,0
42674,steady,0,0
42675,state,0,1
42676,concentrations,0,0
42677,were,0,0
42678,reached,0,0
42679,",",0,0
42680,which,0,0
42681,was,0,0
42682,compatible,0,0
42683,with,0,1
42684,an,0,0
42685,effective,0,0
42686,half-life,0,0
42687,for,0,0
42688,accumulation,0,0
42689,of,0,0
42690,5,0,0
42691,d.,0,1
42692,The,0,0
42693,terminal,0,0
42694,elimination,0,0
42695,half-life,0,0
42696,was,0,0
42697,12,0,0
42698,+/-,0,0
42699,7,0,1
42700,d,0,1
42701,(,0,0
42702,n,0,1
42703,=,0,0
42704,20,0,1
42705,),0,0
42706,.,0,0
42707,The,0,0
42708,time,0,0
42709,course,0,0
42710,of,0,0
42711,plasma,0,0
42712,all-E-3-'dehydro-lutein,0,0
42713,concentrations,0,0
42714,resembled,0,0
42715,that,0,0
42716,of,0,0
42717,all-E-zeaxanthin,0,0
42718,.,0,0
42719,The,0,0
42720,data,0,0
42721,provided,0,0
42722,evidence,0,0
42723,that,0,0
42724,all-E-3-'dehydro-lutein,0,0
42725,was,0,0
42726,derived,0,0
42727,from,0,1
42728,all-E-zeaxanthin,0,0
42729,.,0,1
42730,Concentrations,0,0
42731,of,0,0
42732,other,0,1
42733,carotenoids,0,0
42734,were,0,1
42735,not,0,0
42736,affected,0,0
42737,.,0,0
42738,Zeaxanthin,0,0
42739,was,0,0
42740,well,0,0
42741,tolerated,0,0
42742,.,0,0
42743,CONCLUSION,0,0
42744,Long-term,0,0
42745,oral,0,0
42746,intake,0,0
42747,of,0,0
42748,1,0,0
42749,and,0,0
42750,10,0,0
42751,mg,0,0
42752,zeaxanthin,0,0
42753,as,0,0
42754,beadlets,0,0
42755,increases,0,0
42756,plasma,0,0
42757,zeaxanthin,0,0
42758,concentrations,0,0
42759,approximately,0,1
42760,4-,0,0
42761,and,0,0
42762,20-fold,0,0
42763,",",0,0
42764,respectively,0,0
42765,.,0,0
42766,Evidence,0,0
42767,that,0,0
42768,all-E-3-dehydro-lutein,0,0
42769,is,0,0
42770,formed,0,0
42771,from,0,0
42772,zeaxanthin,0,0
42773,was,0,0
42774,strong,0,0
42775,.,0,1
42776,A,0,0
42777,randomised,0,0
42778,controlled,0,0
42779,trial,0,0
42780,comparing,0,0
42781,Drawtex,0,0
42782,with,0,1
42783,standard,0,0
42784,dressings,0,0
42785,for,0,0
42786,exuding,1,1
42787,wounds,1,1
42788,.,1,1
42789,OBJECTIVE,0,0
42790,This,0,0
42791,randomised,0,0
42792,controlled,0,0
42793,clinical,0,0
42794,trial,0,0
42795,compared,0,0
42796,a,0,0
42797,capillary,0,0
42798,dressing,0,0
42799,(,0,0
42800,Drawtex,0,0
42801,",",0,0
42802,now,0,0
42803,rebranded,0,0
42804,as,0,0
42805,Vibriant,0,1
42806,RCD,0,1
42807,[,0,0
42808,Vibriant,0,1
42809,Technology,0,1
42810,Services,0,0
42811,],0,1
42812,),0,0
42813,with,0,1
42814,routine,0,0
42815,practice,0,0
42816,for,0,0
42817,exuding,1,1
42818,wounds,1,1
42819,greater,1,0
42820,than,1,0
42821,2.5,1,0
42822,x,1,1
42823,2.5,1,0
42824,cm,1,1
42825,.,1,1
42826,METHOD,0,0
42827,The,0,0
42828,target,1,0
42829,population,1,1
42830,was,1,0
42831,300,1,0
42832,control,1,1
42833,and,1,0
42834,300,1,0
42835,test,1,0
42836,subjects,1,1
42837,across,1,0
42838,three,1,1
42839,sites,1,0
42840,in,1,0
42841,the,1,0
42842,UK,1,1
42843,",",1,0
42844,but,1,0
42845,recruitment,1,0
42846,difficulties,1,0
42847,resulted,1,0
42848,in,1,0
42849,only,1,0
42850,125,1,0
42851,patients,1,1
42852,being,1,1
42853,evaluable,1,1
42854,.,1,1
42855,Wound,0,0
42856,progress,0,0
42857,was,0,0
42858,recorded,0,0
42859,by,0,0
42860,nurses,0,1
42861,',0,1
42862,perception,0,0
42863,of,0,0
42864,the,0,0
42865,progress,0,0
42866,of,0,0
42867,wound,0,0
42868,healing,0,0
42869,and,0,0
42870,by,0,0
42871,objective,0,0
42872,digital,0,0
42873,imaging,0,0
42874,.,0,0
42875,In,0,0
42876,the,0,0
42877,final,0,0
42878,analysis,0,0
42879,digital,0,0
42880,images,0,0
42881,were,0,1
42882,randomised,0,0
42883,(,0,0
42884,in,0,0
42885,time,0,0
42886,order,0,0
42887,),0,0
42888,and,0,0
42889,a,0,0
42890,panel,0,0
42891,of,0,1
42892,nurses,0,1
42893,who,0,1
42894,were,0,1
42895,not,0,1
42896,otherwise,0,0
42897,involved,0,0
42898,in,0,0
42899,the,0,0
42900,research,0,0
42901,project,0,0
42902,graded,0,0
42903,the,0,0
42904,wound,0,0
42905,'s,0,1
42906,progress,0,0
42907,.,0,1
42908,RESULTS,0,0
42909,After,0,0
42910,deconvolution,0,0
42911,of,0,0
42912,the,0,0
42913,data,0,0
42914,",",0,0
42915,the,0,0
42916,subjective,0,0
42917,(,0,0
42918,nurse,0,0
42919,perception,0,0
42920,),0,0
42921,method,0,0
42922,of,0,0
42923,evaluation,0,0
42924,determined,0,0
42925,that,0,0
42926,the,0,0
42927,new,0,0
42928,dressing,0,0
42929,resulted,0,0
42930,in,0,0
42931,wound,0,0
42932,improvement,0,0
42933,in,0,0
42934,12.7,0,0
42935,%,0,0
42936,more,0,0
42937,patients,0,1
42938,than,0,0
42939,did,0,0
42940,routine,0,0
42941,practice,0,0
42942,",",0,0
42943,but,0,0
42944,the,0,0
42945,blinded,0,0
42946,assessment,0,0
42947,method,0,0
42948,(,0,0
42949,based,0,0
42950,on,0,0
42951,the,0,0
42952,digital,0,0
42953,images,0,0
42954,),0,1
42955,showed,0,0
42956,that,0,0
42957,routine,0,0
42958,practice,0,0
42959,was,0,0
42960,better,0,0
42961,by,0,0
42962,6.6,0,0
42963,%,0,0
42964,.,0,1
42965,CONCLUSION,0,0
42966,Evaluation,0,0
42967,of,0,0
42968,wound,0,0
42969,progress,0,0
42970,is,0,0
42971,clearly,0,0
42972,difficult,0,0
42973,.,0,0
42974,Human,0,0
42975,nature,0,0
42976,makes,0,0
42977,us,0,0
42978,favour,0,0
42979,novelty,0,0
42980,if,0,0
42981,we,0,0
42982,believe,0,0
42983,it,0,0
42984,is,0,0
42985,going,0,0
42986,to,0,0
42987,be,0,0
42988,better,0,0
42989,.,0,0
42990,Making,0,0
42991,interpretation,0,0
42992,more,0,0
42993,objective,0,0
42994,removed,0,0
42995,that,0,0
42996,bias,0,0
42997,and,0,0
42998,did,0,0
42999,not,0,0
43000,demonstrate,0,0
43001,a,0,0
43002,significant,0,0
43003,advantage,0,0
43004,for,0,0
43005,the,0,0
43006,test,0,0
43007,dressing,0,0
43008,.,0,0
43009,The,0,0
43010,findings,0,0
43011,suggest,0,0
43012,that,0,0
43013,unblinded,0,0
43014,assessment,0,0
43015,by,0,0
43016,trial,0,0
43017,nurses,0,1
43018,is,0,0
43019,unacceptable,0,0
43020,on,0,0
43021,its,0,0
43022,own,0,1
43023,.,0,1
43024,Blinded,0,0
43025,assessments,0,0
43026,may,0,0
43027,miss,0,1
43028,finer,0,0
43029,nuances,0,0
43030,of,0,0
43031,wound,0,0
43032,progression,0,0
43033,",",0,0
43034,but,0,0
43035,are,0,0
43036,likely,0,0
43037,to,0,0
43038,be,0,0
43039,more,0,0
43040,accurate,0,0
43041,.,0,0
43042,The,0,0
43043,authors,0,0
43044,suggest,0,0
43045,that,0,0
43046,the,0,0
43047,true,0,0
43048,result,0,0
43049,lies,0,0
43050,somewhere,0,0
43051,in,0,0
43052,the,0,0
43053,middle,0,1
43054,",",0,0
43055,with,0,0
43056,the,0,0
43057,trial,0,0
43058,dressing,0,0
43059,likely,0,0
43060,to,0,0
43061,be,0,0
43062,as,0,0
43063,effective,0,0
43064,as,0,0
43065,",",0,0
43066,but,0,0
43067,not,0,0
43068,more,0,0
43069,effective,0,0
43070,than,0,0
43071,",",0,0
43072,a,0,0
43073,standard,0,0
43074,dressing,0,0
43075,.,0,1
43076,Retrograde,0,0
43077,tracing,0,0
43078,and,0,0
43079,electrophysiological,0,0
43080,findings,0,0
43081,of,0,0
43082,collateral,0,1
43083,sprouting,0,0
43084,after,1,0
43085,end-to-side,1,0
43086,neurorrhaphy,1,0
43087,.,1,0
43088,The,0,0
43089,aim,0,0
43090,of,0,0
43091,this,0,0
43092,study,0,0
43093,was,0,0
43094,to,0,0
43095,seek,0,0
43096,more,0,0
43097,potent,0,0
43098,evidences,0,0
43099,of,0,0
43100,collateral,0,1
43101,sprouting,0,0
43102,for,0,0
43103,both,0,0
43104,motor,0,0
43105,and,0,0
43106,sensory,0,0
43107,nerve,0,0
43108,fibres,0,0
43109,after,1,0
43110,end-to-side,1,0
43111,neurorrhaphy,1,0
43112,using,0,0
43113,a,0,0
43114,modified,0,0
43115,double-labelling,0,0
43116,retrograde,0,0
43117,tracing,0,0
43118,method,0,0
43119,and,0,0
43120,to,0,0
43121,investigate,0,0
43122,the,0,0
43123,function,0,0
43124,of,0,0
43125,regenerated,0,0
43126,motor,0,0
43127,axons,0,0
43128,with,0,1
43129,electrophysiological,0,1
43130,evaluation,0,0
43131,.,0,1
43132,Four,1,0
43133,groups,1,0
43134,(,1,1
43135,n=4,1,0
43136,for,1,0
43137,each,1,0
43138,group,1,0
43139,),1,0
43140,were,1,0
43141,used,1,0
43142,:,1,1
43143,end-to-end,1,0
43144,coaptation,1,0
43145,(,1,1
43146,six,1,1
43147,months,1,0
43148,postoperatively,1,0
43149,),1,0
43150,",",1,0
43151,end-to-side,1,0
43152,coaptation,1,0
43153,(,1,1
43154,four,1,1
43155,months,1,0
43156,and,1,1
43157,six,1,1
43158,months,1,0
43159,postoperatively,1,0
43160,),1,0
43161,and,1,0
43162,normal,1,1
43163,control,1,1
43164,.,1,1
43165,Two,0,0
43166,fluorescent,0,0
43167,tracers,0,1
43168,(,0,1
43169,true,0,0
43170,blue,0,1
43171,and,0,0
43172,diamidino,0,0
43173,yellow,0,1
43174,),0,0
43175,were,0,0
43176,applied,0,0
43177,to,0,0
43178,the,0,0
43179,proximal,0,1
43180,ends,0,0
43181,of,0,0
43182,tibial,0,1
43183,and,0,0
43184,common,0,0
43185,peroneal,0,1
43186,nerves,0,0
43187,",",0,0
43188,respectively,0,0
43189,after,0,0
43190,four,0,0
43191,or,0,1
43192,six,0,1
43193,months,0,0
43194,of,0,0
43195,nerve,0,0
43196,coaptation,0,0
43197,.,0,0
43198,Five,0,0
43199,days,0,0
43200,later,0,1
43201,",",0,0
43202,we,0,0
43203,only,0,0
43204,found,0,0
43205,single-labelled,0,0
43206,motor,0,0
43207,and,0,0
43208,sensory,0,0
43209,neurons,0,0
43210,in,0,0
43211,the,0,0
43212,normal,0,1
43213,and,0,0
43214,end-to-end,0,0
43215,coaptation,0,0
43216,groups,0,0
43217,",",0,0
43218,while,0,0
43219,some,0,0
43220,dual-labelled,0,0
43221,neurons,0,0
43222,can,0,0
43223,be,0,0
43224,identified,0,0
43225,in,0,0
43226,end-to-side,0,0
43227,coaptation,0,0
43228,groups,0,0
43229,.,0,1
43230,Four,0,0
43231,months,0,0
43232,after,0,0
43233,surgery,0,1
43234,",",0,0
43235,the,0,0
43236,motor,0,0
43237,nerve,0,0
43238,conduction,0,0
43239,velocity,0,0
43240,in,0,0
43241,end-to-side,0,0
43242,coaptation,0,0
43243,was,0,0
43244,significantly,0,0
43245,slower,0,0
43246,than,0,0
43247,in,0,0
43248,the,0,0
43249,normal,0,1
43250,control,0,0
43251,.,0,0
43252,But,0,0
43253,no,0,0
43254,difference,0,0
43255,was,0,0
43256,found,0,0
43257,in,0,0
43258,the,0,0
43259,sixth,0,0
43260,month,0,0
43261,.,0,0
43262,These,0,0
43263,results,0,0
43264,suggest,0,0
43265,that,0,0
43266,end-to-side,0,0
43267,neurorrhaphy,0,0
43268,can,0,0
43269,induce,0,0
43270,the,0,0
43271,functional,0,0
43272,collateral,0,0
43273,sprouting,0,0
43274,of,0,0
43275,both,0,0
43276,motor,0,0
43277,and,0,0
43278,sensory,0,0
43279,axons,0,0
43280,in,0,0
43281,the,0,0
43282,peripheral,0,0
43283,nerve,0,0
43284,.,0,1
43285,Strength,0,0
43286,of,0,0
43287,vital,0,0
43288,force,0,1
43289,in,0,0
43290,classical,0,1
43291,homeopathy,0,0
43292,:,0,1
43293,bio-psycho-social-spiritual,0,1
43294,correlates,0,0
43295,within,0,1
43296,a,0,1
43297,complex,0,0
43298,systems,0,0
43299,context,0,0
43300,.,0,1
43301,OBJECTIVE,0,0
43302,To,0,0
43303,explore,0,0
43304,associations,0,0
43305,between,0,0
43306,a,0,0
43307,global,0,0
43308,rating,0,0
43309,for,0,0
43310,the,0,0
43311,classical,0,0
43312,homeopathic,0,0
43313,construct,0,0
43314,of,0,0
43315,vital,0,0
43316,force,0,1
43317,and,0,0
43318,clinician,0,0
43319,and,0,0
43320,patient,0,1
43321,ratings,0,0
43322,on,0,0
43323,previously,0,1
43324,validated,0,0
43325,bio-psycho-social-spiritual,0,1
43326,questionnaires,0,0
43327,.,0,1
43328,METHODS,0,0
43329,Sixty-two,1,1
43330,(,1,1
43331,62,1,1
43332,),1,1
43333,community-recruited,1,1
43334,patients,1,1
43335,with,1,1
43336,fibromyalgia,1,1
43337,(,1,0
43338,FM,1,0
43339,),1,0
43340,were,0,0
43341,assessed,0,0
43342,at,0,0
43343,baseline,0,0
43344,prior,0,0
43345,to,0,0
43346,a,0,0
43347,clinical,0,0
43348,trial,0,0
43349,of,0,0
43350,individualized,0,0
43351,homeopathy,0,0
43352,.,0,1
43353,Two,1,0
43354,homeopaths,1,0
43355,jointly,1,0
43356,performed,1,0
43357,case-taking,1,0
43358,interviews,1,1
43359,.,1,1
43360,A,1,0
43361,conventional,1,0
43362,medical,1,0
43363,provider,1,0
43364,independently,1,0
43365,evaluated,1,0
43366,patients,1,1
43367,with,1,1
43368,a,1,0
43369,standardized,1,0
43370,history,1,1
43371,and,1,0
43372,physical,1,0
43373,examination,1,1
43374,.,1,1
43375,Homeopaths,0,0
43376,rated,0,0
43377,each,0,0
43378,patient,0,0
43379,'s,0,1
43380,vital,0,0
43381,force,0,1
43382,(,0,0
43383,five-point,0,0
43384,Likert,0,0
43385,scale,0,0
43386,",",0,0
43387,with,0,1
43388,1,0,0
43389,=,0,0
43390,very,0,0
43391,weak,0,0
43392,to,0,0
43393,5,0,0
43394,=,0,0
43395,very,0,1
43396,strong,0,0
43397,),0,0
43398,.,0,1
43399,Homeopaths,0,0
43400,and,0,0
43401,the,0,0
43402,conventional,0,0
43403,medical,0,1
43404,provider,0,0
43405,rated,0,0
43406,their,0,0
43407,Clinical,0,0
43408,Global,0,1
43409,Impression,0,0
43410,(,0,0
43411,CGI,0,1
43412,),0,0
43413,of,0,0
43414,the,0,0
43415,severity,0,0
43416,of,0,0
43417,illness,0,1
43418,(,0,1
43419,1,0,0
43420,=,0,1
43421,normal,0,1
43422,;,0,1
43423,7,0,0
43424,=,0,0
43425,among,0,0
43426,the,0,0
43427,most,0,0
43428,extremely,0,0
43429,ill,0,1
43430,),0,0
43431,.,0,1
43432,Patients,0,1
43433,completed,0,1
43434,self-rating,0,0
43435,scales,0,0
43436,on,0,0
43437,pain,0,1
43438,",",0,0
43439,global,0,0
43440,health,0,0
43441,",",0,0
43442,mood,0,0
43443,",",0,0
43444,quality,0,0
43445,of,0,0
43446,life,0,0
43447,",",0,0
43448,coping,0,0
43449,style,0,0
43450,",",0,0
43451,health,0,0
43452,locus,0,0
43453,of,0,0
43454,control,0,0
43455,",",0,0
43456,multidimensional,0,0
43457,well-being,0,0
43458,",",0,0
43459,spirituality,0,0
43460,",",0,0
43461,sense,0,0
43462,of,0,0
43463,coherence,0,0
43464,",",0,0
43465,positive,0,0
43466,states,0,1
43467,of,0,0
43468,mind,0,1
43469,",",0,0
43470,and,0,0
43471,social,0,0
43472,desirability,0,0
43473,.,0,1
43474,RESULTS,0,0
43475,Greater,0,0
43476,vital,0,0
43477,force,0,1
43478,ratings,0,0
43479,(,0,0
43480,mean,0,1
43481,2.9,0,0
43482,standard,0,0
43483,deviation,0,1
43484,[,0,0
43485,SD,0,1
43486,],0,1
43487,0.6,0,0
43488,),0,0
43489,correlated,0,0
43490,moderately,0,0
43491,(,0,0
43492,p,0,0
43493,<,0,0
43494,or,0,1
43495,=,0,0
43496,0.005,0,0
43497,),0,0
43498,with,0,1
43499,less,0,0
43500,severe,0,1
43501,CGI,0,1
43502,illness,0,1
43503,ratings,0,0
43504,by,0,0
43505,the,0,0
43506,homeopaths,0,0
43507,(,0,0
43508,r,0,0
43509,=-0.59,0,0
43510,),0,0
43511,",",0,0
43512,decreased,0,0
43513,patient-rated,0,0
43514,mental,0,1
43515,confusion,0,0
43516,(,0,0
43517,r,0,0
43518,=-0.43,0,0
43519,),0,0
43520,",",0,0
43521,higher,0,0
43522,vigor,0,0
43523,(,0,0
43524,r,0,0
43525,=,0,0
43526,0.38,0,0
43527,),0,0
43528,",",0,0
43529,and,0,0
43530,greater,0,0
43531,positive,0,0
43532,states,0,1
43533,of,0,0
43534,mind,0,1
43535,(,0,0
43536,r,0,0
43537,=,0,0
43538,0.36,0,0
43539,),0,1
43540,.,0,1
43541,Vital,0,0
43542,force,0,0
43543,also,0,0
43544,showed,0,0
43545,correlations,0,0
43546,(,0,1
43547,p,0,0
43548,<,0,0
43549,0.05,0,0
43550,),0,0
43551,with,0,1
43552,lower,0,0
43553,CGI,0,1
43554,ratings,0,0
43555,by,0,0
43556,the,0,0
43557,conventional,0,0
43558,medical,0,0
43559,provider,0,0
43560,(,0,0
43561,r,0,0
43562,=-0.32,0,0
43563,),0,0
43564,",",0,0
43565,better,0,0
43566,selfrated,0,0
43567,quality,0,0
43568,of,0,0
43569,life,0,0
43570,(,0,0
43571,r,0,0
43572,=,0,0
43573,0.33,0,0
43574,),0,0
43575,",",0,0
43576,lesser,0,0
43577,fatigue,0,0
43578,(,0,0
43579,r,0,0
43580,=-0.31,0,0
43581,),0,0
43582,",",0,0
43583,better,0,0
43584,global,0,0
43585,health,0,0
43586,(,0,0
43587,r,0,0
43588,=,0,0
43589,0.29,0,0
43590,),0,0
43591,",",0,0
43592,greater,0,0
43593,sense,0,0
43594,of,0,0
43595,coherence,0,0
43596,(,0,0
43597,r,0,0
43598,=,0,0
43599,0.28,0,0
43600,),0,0
43601,",",0,0
43602,powerful-others,0,0
43603,health,0,0
43604,locus,0,0
43605,of,0,0
43606,control,0,0
43607,(,0,0
43608,r,0,0
43609,=,0,0
43610,0.27,0,0
43611,),0,0
43612,",",0,0
43613,increased,0,0
43614,emotional,0,0
43615,well-being,0,0
43616,(,0,0
43617,r,0,0
43618,=,0,0
43619,0.27,0,0
43620,),0,0
43621,",",0,0
43622,and,0,0
43623,higher,0,0
43624,social,0,0
43625,desirability,0,0
43626,(,0,0
43627,r,0,0
43628,=,0,0
43629,0.27,0,0
43630,),0,0
43631,",",0,0
43632,but,0,0
43633,not,0,0
43634,with,0,0
43635,age,0,1
43636,",",0,0
43637,pain,0,0
43638,",",0,0
43639,or,0,0
43640,illness,0,1
43641,duration,0,0
43642,.,0,1
43643,CONCLUSION,0,0
43644,Homeopathic,0,0
43645,vital,0,0
43646,force,0,1
43647,ratings,0,0
43648,reflect,0,0
43649,better,0,0
43650,perceived,0,0
43651,mental,0,1
43652,function,0,0
43653,",",0,0
43654,energy,0,0
43655,",",0,0
43656,and,0,0
43657,positive,0,0
43658,dimensions,0,0
43659,of,0,0
43660,the,0,0
43661,individual,0,0
43662,",",0,0
43663,beyond,0,0
43664,absence,0,0
43665,of,0,0
43666,disease,0,1
43667,.,0,1
43668,Reflexive,0,0
43669,orienting,0,0
43670,in,0,0
43671,response,0,0
43672,to,0,0
43673,eye,0,0
43674,gaze,0,0
43675,and,0,0
43676,an,0,0
43677,arrow,0,0
43678,in,0,0
43679,children,1,1
43680,with,1,1
43681,and,1,0
43682,without,1,1
43683,autism,1,1
43684,.,1,1
43685,BACKGROUND,0,0
43686,This,0,0
43687,study,0,0
43688,investigated,0,0
43689,whether,0,0
43690,another,0,0
43691,person,0,1
43692,'s,0,1
43693,social,0,0
43694,attention,0,0
43695,",",0,0
43696,specifically,0,0
43697,the,0,0
43698,direction,0,0
43699,of,0,0
43700,their,0,0
43701,eye,0,0
43702,gaze,0,0
43703,",",0,0
43704,and,0,0
43705,a,0,0
43706,non-social,0,0
43707,directional,0,0
43708,cue,0,0
43709,",",0,0
43710,an,0,0
43711,arrow,0,0
43712,",",0,0
43713,triggered,0,0
43714,reflexive,0,0
43715,orienting,0,0
43716,in,0,0
43717,children,1,1
43718,with,1,1
43719,and,1,0
43720,without,1,1
43721,autism,1,1
43722,in,0,0
43723,an,0,0
43724,experimental,0,0
43725,situation,0,0
43726,.,0,1
43727,METHODS,0,0
43728,Children,1,1
43729,with,1,1
43730,autism,1,1
43731,and,1,0
43732,typically,1,1
43733,developed,1,0
43734,children,1,1
43735,participated,1,1
43736,in,0,0
43737,one,0,1
43738,of,0,1
43739,two,0,1
43740,experiments,0,0
43741,.,0,1
43742,Both,0,0
43743,experiments,0,0
43744,involved,0,0
43745,the,0,0
43746,localization,0,0
43747,of,0,0
43748,a,0,0
43749,target,0,0
43750,that,0,0
43751,appeared,0,0
43752,to,0,0
43753,the,0,0
43754,left,0,0
43755,or,0,0
43756,right,0,0
43757,of,0,0
43758,the,0,0
43759,fixation,0,0
43760,point,0,0
43761,.,0,0
43762,Before,0,0
43763,the,0,0
43764,target,0,0
43765,appeared,0,0
43766,",",0,0
43767,the,0,0
43768,participant,0,0
43769,'s,0,1
43770,attention,0,0
43771,was,0,0
43772,cued,0,0
43773,to,0,0
43774,the,0,0
43775,left,0,0
43776,or,0,0
43777,right,0,0
43778,by,0,0
43779,either,0,0
43780,an,0,0
43781,arrow,0,0
43782,or,0,0
43783,the,0,0
43784,direction,0,0
43785,of,0,0
43786,eye,0,0
43787,gaze,0,0
43788,on,0,0
43789,a,0,0
43790,computerized,0,0
43791,face,0,0
43792,.,0,1
43793,RESULTS,0,0
43794,Children,1,1
43795,with,1,1
43796,autism,1,1
43797,were,0,0
43798,slower,0,0
43799,to,0,0
43800,respond,0,0
43801,",",0,0
43802,which,0,0
43803,suggests,0,0
43804,a,0,0
43805,slight,0,0
43806,difference,0,0
43807,in,0,0
43808,the,0,0
43809,general,0,1
43810,cognitive,0,0
43811,ability,0,0
43812,of,0,0
43813,the,0,0
43814,groups,0,0
43815,.,0,0
43816,In,0,0
43817,Experiment,0,0
43818,1,0,0
43819,",",0,0
43820,although,0,0
43821,the,0,0
43822,participants,0,1
43823,were,0,0
43824,instructed,0,0
43825,to,0,0
43826,disregard,0,0
43827,the,0,0
43828,cue,0,0
43829,and,0,0
43830,the,0,0
43831,target,0,0
43832,was,0,0
43833,correctly,0,0
43834,cued,0,0
43835,in,0,0
43836,only,0,0
43837,50,0,0
43838,%,0,0
43839,of,0,0
43840,the,0,0
43841,trials,0,0
43842,",",0,0
43843,both,0,0
43844,groups,0,0
43845,of,0,0
43846,children,0,1
43847,responded,0,0
43848,significantly,0,0
43849,faster,0,0
43850,to,0,0
43851,cued,0,0
43852,targets,0,0
43853,than,0,0
43854,to,0,1
43855,uncued,0,0
43856,targets,0,0
43857,",",0,0
43858,regardless,0,0
43859,of,0,0
43860,the,0,0
43861,cue,0,0
43862,.,0,0
43863,In,0,0
43864,Experiment,0,0
43865,2,0,0
43866,",",0,0
43867,children,0,1
43868,were,0,0
43869,instructed,0,0
43870,to,0,0
43871,attend,0,1
43872,to,0,0
43873,the,0,0
43874,direction,0,0
43875,opposite,0,0
43876,that,0,0
43877,of,0,0
43878,the,0,0
43879,cues,0,0
43880,and,0,0
43881,the,0,0
43882,target,0,0
43883,was,0,0
43884,correctly,0,0
43885,cued,0,0
43886,in,0,0
43887,only,0,0
43888,20,0,0
43889,%,0,0
43890,of,0,0
43891,the,0,0
43892,trials,0,0
43893,.,0,0
43894,Typically,0,1
43895,developed,0,0
43896,children,0,1
43897,located,0,1
43898,targets,0,0
43899,cued,0,0
43900,by,0,0
43901,eye,0,0
43902,gaze,0,0
43903,more,0,0
43904,quickly,0,0
43905,",",0,0
43906,while,0,0
43907,the,0,0
43908,arrow,0,0
43909,cue,0,0
43910,did,0,0
43911,not,0,0
43912,trigger,0,0
43913,such,0,0
43914,reflexive,0,0
43915,orienting,0,0
43916,in,0,0
43917,these,0,0
43918,children,0,1
43919,.,0,0
43920,However,0,0
43921,",",0,0
43922,both,0,0
43923,social,0,0
43924,and,0,0
43925,non-social,0,0
43926,cues,0,0
43927,shifted,0,0
43928,attention,0,0
43929,to,0,0
43930,the,0,0
43931,cued,0,0
43932,location,0,0
43933,in,0,0
43934,children,0,1
43935,with,0,1
43936,autism,0,1
43937,.,0,1
43938,CONCLUSION,0,0
43939,These,0,0
43940,results,0,0
43941,indicate,0,0
43942,that,0,0
43943,eye,0,0
43944,gaze,0,0
43945,attracted,0,0
43946,attention,0,0
43947,more,0,0
43948,effectively,0,0
43949,than,0,0
43950,the,0,0
43951,arrow,0,0
43952,in,0,0
43953,typically,1,1
43954,developed,1,0
43955,children,1,1
43956,",",0,0
43957,while,0,0
43958,children,1,1
43959,with,1,1
43960,autism,1,1
43961,shifted,0,0
43962,their,0,0
43963,attention,0,0
43964,equally,0,0
43965,in,0,0
43966,response,0,0
43967,to,0,0
43968,eye,0,0
43969,gaze,0,0
43970,and,0,0
43971,arrow,0,0
43972,direction,0,0
43973,",",0,0
43974,failing,0,0
43975,to,0,0
43976,show,0,0
43977,preferential,0,0
43978,sensitivity,0,0
43979,to,0,0
43980,the,0,0
43981,social,0,0
43982,cue,0,0
43983,.,0,0
43984,Difficulty,0,0
43985,in,0,0
43986,shifting,0,0
43987,controlled,0,0
43988,attention,0,0
43989,to,0,0
43990,the,0,0
43991,instructed,0,0
43992,side,0,0
43993,was,0,0
43994,also,0,0
43995,found,0,0
43996,in,0,0
43997,children,1,1
43998,with,1,1
43999,autism,1,1
44000,.,1,1
44001,Increased,0,0
44002,repetitive,0,0
44003,behaviours,0,0
44004,and,0,1
44005,prolactin,0,0
44006,responsivity,0,0
44007,to,0,0
44008,oral,0,0
44009,m-chlorophenylpiperazine,0,0
44010,in,0,0
44011,adults,1,1
44012,with,1,1
44013,autism,1,1
44014,spectrum,1,1
44015,disorders,1,1
44016,.,1,0
44017,Autism,0,1
44018,is,0,0
44019,a,0,0
44020,neurodevelopmental,0,0
44021,disorder,0,1
44022,characterized,0,0
44023,by,0,0
44024,dysfunction,0,1
44025,in,0,0
44026,three,0,0
44027,primary,0,1
44028,behavioural,0,1
44029,domains,0,1
44030,:,0,1
44031,repetitive,0,0
44032,behaviours,0,0
44033,",",0,1
44034,social,0,0
44035,deficits,0,0
44036,",",0,0
44037,and,0,0
44038,language,0,0
44039,abnormalities,0,1
44040,.,0,0
44041,There,0,0
44042,is,0,0
44043,evidence,0,0
44044,that,0,0
44045,abnormalities,0,1
44046,exist,0,0
44047,in,0,0
44048,the,0,0
44049,serotonin,0,0
44050,(,0,0
44051,5-HT,0,0
44052,),0,0
44053,system,0,0
44054,in,0,0
44055,autism,0,1
44056,spectrum,0,1
44057,patients,0,1
44058,.,0,0
44059,Furthermore,0,0
44060,",",0,0
44061,5-HT,0,0
44062,is,0,0
44063,known,0,0
44064,to,0,0
44065,play,0,0
44066,a,0,0
44067,role,0,0
44068,in,0,0
44069,repetitive,0,0
44070,and,0,0
44071,social,0,0
44072,behaviours,0,0
44073,.,0,0
44074,This,0,0
44075,study,0,0
44076,examined,0,0
44077,the,0,0
44078,effect,0,0
44079,of,0,0
44080,m-chlorophenylpiperazine,0,0
44081,(,0,0
44082,m-CPP,0,1
44083,),0,0
44084,on,0,0
44085,repetitive,0,0
44086,behaviours,0,0
44087,and,0,1
44088,prolactin,0,0
44089,response,0,0
44090,in,0,0
44091,11,1,1
44092,adults,1,1
44093,with,1,1
44094,autism,1,1
44095,or,1,1
44096,Aspergers,1,1
44097,disorder,1,1
44098,and,1,0
44099,8,1,0
44100,age-,1,1
44101,and,1,1
44102,gender-matched,1,1
44103,healthy,1,1
44104,controls,1,1
44105,via,1,0
44106,randomized,1,1
44107,double-blind,1,0
44108,",",1,0
44109,m-CPP,1,0
44110,and,1,0
44111,placebo,1,0
44112,challenges,1,0
44113,.,1,1
44114,The,0,0
44115,primary,0,0
44116,outcome,0,0
44117,measure,0,0
44118,was,0,0
44119,an,0,0
44120,instrument,0,0
44121,rating,0,0
44122,six,0,1
44123,repetitive,0,0
44124,behaviours,0,0
44125,:,0,1
44126,need,0,0
44127,to,0,0
44128,know,0,0
44129,",",0,0
44130,repeating,0,0
44131,",",0,0
44132,ordering,0,0
44133,",",0,0
44134,need,0,0
44135,to,0,0
44136,tell/ask,0,0
44137,",",0,0
44138,self-injury,0,0
44139,",",0,0
44140,and,0,0
44141,touching,0,0
44142,.,0,0
44143,Patients,1,1
44144,with,1,1
44145,autism,1,1
44146,spectrum,1,1
44147,disorders,1,1
44148,showed,0,0
44149,a,0,0
44150,significant,0,0
44151,increase,0,0
44152,in,0,0
44153,repetitive,0,0
44154,behaviours,0,0
44155,at,0,0
44156,end-point,0,0
44157,following,0,0
44158,oral,0,0
44159,m-CPP,0,1
44160,in,0,0
44161,comparison,0,0
44162,to,0,0
44163,placebo,0,0
44164,.,0,0
44165,Additionally,0,0
44166,subjects,1,1
44167,with,1,0
44168,autism,1,1
44169,spectrum,1,1
44170,disorders,1,1
44171,showed,0,0
44172,a,0,0
44173,significantly,0,0
44174,increased,0,0
44175,prolactin,0,0
44176,response,0,0
44177,to,0,0
44178,m-CPP,0,0
44179,compared,0,0
44180,to,0,0
44181,normal,0,1
44182,controls,0,1
44183,",",0,0
44184,with,0,1
44185,neither,0,0
44186,group,0,0
44187,responding,0,0
44188,to,0,0
44189,placebo,0,0
44190,.,0,0
44191,This,0,0
44192,study,0,0
44193,provides,0,0
44194,further,0,0
44195,evidence,0,0
44196,for,0,0
44197,altered,0,1
44198,5-HT,0,0
44199,sensitivity,0,0
44200,in,0,0
44201,individuals,0,1
44202,with,0,1
44203,autism,0,1
44204,spectrum,0,1
44205,disorders,0,1
44206,",",0,0
44207,as,0,0
44208,well,0,0
44209,as,0,0
44210,a,0,0
44211,possible,0,0
44212,relationship,0,0
44213,between,0,0
44214,repetitive,0,0
44215,behaviours,0,0
44216,in,0,0
44217,autism,0,1
44218,spectrum,0,1
44219,disorders,0,1
44220,and,0,0
44221,abnormalities,0,1
44222,in,0,0
44223,the,0,0
44224,5-HT,0,0
44225,system,0,0
44226,.,0,1
44227,ROMEO,0,0
44228,:,0,1
44229,rethink,0,0
44230,organization,0,0
44231,to,0,0
44232,improve,0,0
44233,education,0,0
44234,and,0,0
44235,outcomes,0,0
44236,.,0,1
44237,AIMS,0,0
44238,Scarcity,0,1
44239,of,0,0
44240,resources,0,0
44241,",",0,0
44242,expertise,0,0
44243,and,0,0
44244,evidence-based,0,0
44245,models,0,0
44246,have,0,0
44247,so,0,0
44248,far,0,0
44249,limited,0,0
44250,delivery,0,0
44251,of,0,0
44252,patient-centred,0,0
44253,diabetes,0,1
44254,education,0,0
44255,.,0,1
44256,We,0,0
44257,have,0,0
44258,developed,0,0
44259,and,0,0
44260,validated,0,0
44261,a,0,0
44262,group,0,0
44263,care,0,0
44264,approach,0,0
44265,that,0,0
44266,is,0,0
44267,applicable,0,0
44268,to,0,0
44269,everyday,0,0
44270,clinical,0,0
44271,practice,0,0
44272,and,0,0
44273,cost-effective,0,0
44274,in,0,0
44275,improving,0,0
44276,metabolic,0,1
44277,control,0,0
44278,",",0,0
44279,knowledge,0,0
44280,of,0,0
44281,diabetes,0,1
44282,",",0,0
44283,health,0,1
44284,behaviours,0,0
44285,",",0,0
44286,and,0,0
44287,quality,0,0
44288,of,0,0
44289,life,0,0
44290,in,0,0
44291,Type,0,1
44292,2,0,1
44293,diabetes,0,1
44294,.,0,1
44295,A,0,0
44296,clinical,0,0
44297,trial,0,0
44298,(,0,0
44299,ROMEO,0,0
44300,),0,0
44301,was,0,0
44302,planned,0,0
44303,to,0,0
44304,evaluate,0,0
44305,applicability,0,0
44306,and,0,0
44307,reproducibility,0,0
44308,of,0,0
44309,group,0,0
44310,care,0,1
44311,in,0,0
44312,other,0,0
44313,outpatients,0,1
44314,facilities,0,1
44315,and,0,0
44316,assess,0,0
44317,its,0,0
44318,impact,0,0
44319,on,0,0
44320,a,0,0
44321,larger,1,0
44322,patient,1,0
44323,population,1,1
44324,.,1,1
44325,METHODS,0,0
44326,Multicentre,0,1
44327,",",0,0
44328,randomized,0,0
44329,",",0,0
44330,controlled,0,0
44331,clinical,0,0
44332,trial,0,0
44333,of,0,0
44334,group,0,0
44335,vs.,0,0
44336,individual,0,0
44337,care,0,1
44338,in,0,0
44339,the,0,0
44340,routine,0,0
44341,management,0,0
44342,of,0,0
44343,Type,0,1
44344,2,0,1
44345,diabetes,0,1
44346,.,0,1
44347,Nine,1,1
44348,hundred,1,1
44349,patient,1,0
44350,aged,1,1
44351,<,1,0
44352,80,1,1
44353,",",1,0
44354,with,1,1
44355,diabetes,1,1
44356,of,1,0
44357,>,1,1
44358,or,1,1
44359,=1,1,0
44360,year,1,0
44361,known,1,0
44362,duration,1,0
44363,",",1,0
44364,treated,1,0
44365,by,1,0
44366,either,1,0
44367,diet,1,0
44368,alone,1,0
44369,or,1,1
44370,diet,1,0
44371,and,1,0
44372,oral,1,0
44373,agents,1,0
44374,",",1,0
44375,will,1,0
44376,be,1,0
44377,recruited,1,1
44378,in,1,0
44379,15,1,1
44380,centres,1,1
44381,and,1,0
44382,followed,1,0
44383,for,1,0
44384,4,1,0
44385,years,1,1
44386,.,1,1
44387,Training,0,0
44388,of,0,0
44389,physicians,0,1
44390,",",0,1
44391,nurses,0,1
44392,and,0,1
44393,dietitians,0,1
44394,included,0,1
44395,preparation,0,0
44396,of,0,0
44397,operating,0,1
44398,manual,0,0
44399,and,0,0
44400,videos,0,0
44401,",",0,0
44402,interactive,0,0
44403,sessions,0,0
44404,",",0,0
44405,and,0,0
44406,evaluation,0,0
44407,of,0,0
44408,local,0,0
44409,facilities,0,1
44410,and,0,1
44411,resources,0,0
44412,.,0,1
44413,RESULTS,0,0
44414,PRIMARY,0,0
44415,MEASUREMENTS,0,0
44416,3-monthly,0,0
44417,HbA1c,0,0
44418,",",0,0
44419,fasting,0,0
44420,blood,0,0
44421,glucose,0,0
44422,",",0,0
44423,body,0,0
44424,weight,0,0
44425,",",0,0
44426,waist-hip,0,0
44427,ratio,0,0
44428,",",0,0
44429,yearly,0,0
44430,blood,0,0
44431,lipids,0,0
44432,",",0,0
44433,and,0,0
44434,bi-yearly,0,0
44435,assessment,0,0
44436,of,0,0
44437,knowledge,0,0
44438,of,0,0
44439,diabetes,0,1
44440,",",0,0
44441,health,0,1
44442,behaviours,0,0
44443,and,0,0
44444,quality,0,0
44445,of,0,0
44446,life,0,0
44447,.,0,1
44448,SECONDARY,0,0
44449,OUTCOMES,0,0
44450,systolic,0,1
44451,and,0,0
44452,diastolic,0,1
44453,blood,0,0
44454,pressure,0,0
44455,",",0,0
44456,evaluation,0,0
44457,of,0,0
44458,ECG,0,0
44459,for,0,0
44460,ischaemia,0,0
44461,and,0,0
44462,QT,0,0
44463,interval,0,0
44464,",",0,0
44465,hypoglycaemic,0,0
44466,and,0,0
44467,anti-hypertensive,0,0
44468,medication,0,0
44469,and,0,0
44470,cardiovascular,0,1
44471,events,0,0
44472,.,0,0
44473,Analysis,0,0
44474,will,0,0
44475,be,0,0
44476,by,0,0
44477,intention-to-treat,0,0
44478,.,0,1
44479,DISCUSSION,0,0
44480,If,0,0
44481,ROMEO,0,0
44482,confirms,0,0
44483,that,0,0
44484,group,0,0
44485,care,0,0
44486,can,0,0
44487,be,0,0
44488,successfully,0,0
44489,implemented,0,0
44490,in,0,0
44491,different,0,0
44492,clinics,0,1
44493,",",0,0
44494,a,0,0
44495,novel,0,0
44496,clinico-pedagogic,0,0
44497,tool,0,0
44498,will,0,0
44499,have,0,0
44500,been,0,0
44501,acquired,0,0
44502,to,0,0
44503,support,0,0
44504,patient-centred,0,0
44505,education,0,0
44506,",",0,0
44507,improve,0,0
44508,lifestyle,0,1
44509,and,0,0
44510,outcomes,0,0
44511,",",0,0
44512,support,0,0
44513,team,0,0
44514,work,0,0
44515,",",0,0
44516,enhance,0,0
44517,providers,0,0
44518,',0,1
44519,attitudes,0,0
44520,and,0,1
44521,competencies,0,0
44522,and,0,0
44523,ameliorate,0,0
44524,diabetes,0,1
44525,care,0,1
44526,organization,0,1
44527,.,0,1
44528,Weight,0,1
44529,and,0,0
44530,leptin,0,0
44531,changes,0,0
44532,among,0,1
44533,risperidone-treated,1,1
44534,youths,1,1
44535,with,1,1
44536,autism,1,1
44537,:,1,1
44538,6-month,0,0
44539,prospective,0,1
44540,data,0,0
44541,.,0,1
44542,OBJECTIVE,0,0
44543,The,0,0
44544,authors,0,0
44545,examined,0,0
44546,the,0,0
44547,developmental,0,0
44548,impact,0,0
44549,and,0,0
44550,temporal,0,0
44551,characteristics,0,0
44552,of,0,0
44553,risperidone-associated,0,0
44554,weight,0,1
44555,change,0,0
44556,.,0,1
44557,METHOD,0,0
44558,Weight,0,1
44559,change,0,0
44560,was,0,0
44561,measured,0,0
44562,for,0,0
44563,63,1,1
44564,children,1,1
44565,and,1,1
44566,adolescents,1,1
44567,with,1,1
44568,autism,1,1
44569,treated,1,1
44570,with,1,1
44571,risperidone,1,0
44572,for,1,0
44573,6,1,0
44574,months,1,0
44575,.,1,1
44576,Change,0,0
44577,in,0,0
44578,serum,0,0
44579,leptin,0,0
44580,levels,0,0
44581,after,0,1
44582,2,0,1
44583,months,0,0
44584,was,0,0
44585,examined,0,0
44586,as,0,0
44587,a,0,0
44588,predictor,0,0
44589,of,0,0
44590,final,0,0
44591,weight,0,0
44592,gain,0,0
44593,in,0,0
44594,mixed,0,0
44595,regression,0,0
44596,models,0,0
44597,that,0,0
44598,controlled,0,0
44599,for,0,0
44600,site,0,0
44601,",",0,0
44602,gender,0,0
44603,",",0,0
44604,age,0,1
44605,",",0,0
44606,and,0,0
44607,risperidone,0,0
44608,dose,0,0
44609,.,0,0
44610,RESULTS,0,0
44611,Age-,0,0
44612,and,0,0
44613,gender-standardized,0,0
44614,weight,0,0
44615,increased,0,0
44616,after,0,0
44617,6,0,0
44618,months,0,0
44619,of,0,0
44620,treatment,0,0
44621,(,0,1
44622,gross,0,0
44623,:,0,1
44624,mean=5.6,0,0
44625,kg,0,0
44626,[,0,0
44627,SD=3.9,0,0
44628,],0,1
44629,;,0,1
44630,standardized,0,0
44631,:,0,1
44632,mean=0.6,0,0
44633,z,0,0
44634,[,0,0
44635,SD=0.5,0,0
44636,],0,1
44637,),0,0
44638,and,0,0
44639,was,0,0
44640,positively,0,0
44641,correlated,0,0
44642,with,0,1
44643,weight,0,0
44644,gained,0,0
44645,after,0,0
44646,1,0,0
44647,month,0,0
44648,.,0,0
44649,Change,0,0
44650,in,0,0
44651,leptin,0,0
44652,levels,0,0
44653,after,0,1
44654,2,0,1
44655,months,0,0
44656,of,0,0
44657,treatment,0,0
44658,(,0,0
44659,mean=-0.3,0,0
44660,ng/ml,0,0
44661,",",0,0
44662,SD=6.2,0,0
44663,),0,0
44664,(,0,0
44665,N=48,0,0
44666,),0,0
44667,did,0,0
44668,not,0,0
44669,predict,0,0
44670,final,0,0
44671,weight,0,1
44672,gain,0,0
44673,.,0,1
44674,CONCLUSIONS,0,0
44675,Chronic,0,1
44676,risperidone,0,0
44677,exposure,0,0
44678,in,0,0
44679,children,0,1
44680,with,0,1
44681,autism,0,1
44682,causes,0,0
44683,weight,0,0
44684,gain,0,0
44685,in,0,0
44686,excess,0,0
44687,of,0,0
44688,developmentally,0,0
44689,expected,0,0
44690,norms,0,0
44691,that,0,0
44692,follows,0,0
44693,a,0,0
44694,curvilinear,0,0
44695,trajectory,0,0
44696,and,0,0
44697,decelerates,0,0
44698,over,0,0
44699,time,0,0
44700,.,0,1
44701,Serum,0,0
44702,leptin,0,0
44703,change,0,0
44704,does,0,0
44705,not,0,0
44706,reliably,0,0
44707,predict,0,0
44708,risperidone-associated,0,0
44709,weight,0,1
44710,gain,0,0
44711,.,0,1
44712,Clarithromycin,0,0
44713,reduces,0,0
44714,the,0,0
44715,severity,0,0
44716,of,0,0
44717,bronchial,0,1
44718,hyperresponsiveness,0,1
44719,in,0,0
44720,patients,1,1
44721,with,1,1
44722,asthma,1,1
44723,.,1,0
44724,A,0,0
44725,randomised,0,0
44726,double-blind,0,0
44727,placebo-controlled,0,0
44728,study,0,1
44729,was,0,0
44730,designed,0,0
44731,to,0,0
44732,evaluate,0,0
44733,the,0,0
44734,effects,0,0
44735,of,0,0
44736,a,0,0
44737,semisynthetic,0,0
44738,macrolide,0,0
44739,antibiotic,0,0
44740,",",0,0
44741,clarithromycin,0,0
44742,",",0,0
44743,on,0,0
44744,bronchial,0,1
44745,hyperresponsiveness,0,1
44746,to,0,0
44747,methacholine,0,0
44748,in,0,0
44749,patients,1,1
44750,with,1,1
44751,a,1,0
44752,diagnosis,1,1
44753,of,1,0
44754,asthma,1,1
44755,.,1,1
44756,Adult,1,1
44757,asthma,1,1
44758,patients,1,1
44759,undergoing,1,1
44760,treatment,1,0
44761,with,1,1
44762,budesonide,1,0
44763,400,1,0
44764,microg,1,0
44765,b.i.d,1,0
44766,.,1,0
44767,and,1,0
44768,salbutamol,1,0
44769,200,1,0
44770,microg,1,0
44771,p.r.n,1,0
44772,.,1,0
44773,less,1,0
44774,than,1,0
44775,twice,1,0
44776,weekly,1,0
44777,were,1,0
44778,studied,1,1
44779,.,1,0
44780,Arm,1,0
44781,A,1,0
44782,(,1,0
44783,16,1,1
44784,males/six,1,1
44785,females,1,1
44786,",",1,0
44787,aged,1,1
44788,48,1,0
44789,+/-,1,0
44790,16,1,1
44791,yrs,1,1
44792,),1,0
44793,received,1,0
44794,clarithromycin,1,0
44795,250,1,0
44796,mg,1,0
44797,b.i.d,1,0
44798,.,1,0
44799,for,1,0
44800,8,1,0
44801,weeks,1,0
44802,",",1,0
44803,arm,1,0
44804,B,1,0
44805,(,1,0
44806,eight,1,1
44807,males/12,1,1
44808,females,1,1
44809,",",1,0
44810,aged,1,1
44811,42,1,1
44812,+/-,1,0
44813,12,1,1
44814,yrs,1,1
44815,),1,0
44816,clarithromycin,0,0
44817,250,0,0
44818,mg,0,0
44819,t.id,0,1
44820,.,0,0
44821,and,0,0
44822,arm,0,0
44823,C,0,0
44824,(,0,1
44825,six,0,1
44826,males/15,0,1
44827,females,0,1
44828,",",0,0
44829,aged,0,1
44830,41,0,1
44831,+/-,0,0
44832,16,0,1
44833,yrs,0,1
44834,),0,0
44835,placebo,0,0
44836,dextrose,0,0
44837,tablets,0,0
44838,.,0,1
44839,Bronchial,0,1
44840,hyperresponsiveness,0,0
44841,was,0,0
44842,quantified,0,0
44843,by,0,0
44844,measurement,0,0
44845,of,0,0
44846,the,0,0
44847,provocative,0,0
44848,dose,0,0
44849,of,0,0
44850,methacholine,0,0
44851,causing,0,0
44852,a,0,0
44853,20,0,0
44854,%,0,0
44855,fall,0,0
44856,in,0,0
44857,forced,0,1
44858,expiratory,0,0
44859,volume,0,0
44860,in,0,0
44861,one,0,0
44862,second,0,0
44863,(,0,0
44864,PD20,0,1
44865,),0,1
44866,.,0,0
44867,Median,0,0
44868,(,0,0
44869,interquartile,0,0
44870,range,0,1
44871,),0,0
44872,PD20,0,0
44873,in,0,0
44874,the,0,0
44875,three,0,0
44876,groups,0,0
44877,before,0,0
44878,and,0,0
44879,after,0,0
44880,treatment,0,0
44881,with,0,1
44882,clarithromycin,0,0
44883,were,0,1
44884,:,0,1
44885,arm,0,0
44886,A,0,1
44887,:,0,1
44888,0.3,0,0
44889,(,0,0
44890,0.1-1,0,0
44891,),0,0
44892,and,0,0
44893,1.3,0,0
44894,(,0,0
44895,0.6-2,0,0
44896,),0,0
44897,mg,0,0
44898,;,0,0
44899,arm,0,0
44900,B,0,1
44901,:,0,1
44902,0.4,0,0
44903,(,0,0
44904,0.1-0.9,0,0
44905,),0,0
44906,and,0,0
44907,2,0,0
44908,(,0,0
44909,2-2,0,1
44910,),0,1
44911,mg,0,0
44912,;,0,0
44913,and,0,0
44914,arm,0,1
44915,C,0,0
44916,:,0,1
44917,0.4,0,0
44918,(,0,0
44919,0.1-0.9,0,0
44920,),0,0
44921,and,0,0
44922,0.3,0,0
44923,(,0,0
44924,0.1-0.6,0,0
44925,),0,0
44926,mg,0,0
44927,",",0,0
44928,respectively,0,0
44929,.,0,0
44930,Serum,0,0
44931,free,0,0
44932,cortisol,0,0
44933,levels,0,0
44934,were,0,0
44935,determined,0,0
44936,and,0,0
44937,remained,0,0
44938,unchanged,0,0
44939,from,0,0
44940,baseline,0,0
44941,in,0,0
44942,the,0,0
44943,clarithromycin-treated,1,1
44944,patients,1,1
44945,.,1,0
44946,It,0,0
44947,is,0,0
44948,concluded,0,0
44949,that,0,0
44950,clarithromycin,0,0
44951,reduces,0,0
44952,the,0,0
44953,degree,0,0
44954,of,0,0
44955,bronchial,0,1
44956,hyperresponsiveness,0,1
44957,in,0,0
44958,patients,1,1
44959,with,1,1
44960,asthma,1,1
44961,.,1,1
44962,Effect,0,0
44963,of,0,0
44964,simvastatin,0,0
44965,and,0,0
44966,fenofibrate,0,0
44967,on,0,0
44968,endothelium,0,0
44969,in,0,0
44970,Type,1,1
44971,2,1,1
44972,diabetes,1,1
44973,.,1,1
44974,Statins,0,0
44975,and,0,0
44976,fibrates,0,0
44977,influence,0,0
44978,endothelial,0,0
44979,activity,0,0
44980,and,0,0
44981,consequently,0,0
44982,atherogenesis,0,0
44983,but,0,0
44984,the,0,0
44985,mechanisms,0,0
44986,are,0,0
44987,not,0,0
44988,well,0,0
44989,understood,0,0
44990,.,0,0
44991,Twenty,1,1
44992,Type,1,1
44993,2,1,1
44994,diabetic,1,1
44995,patients,1,1
44996,with,1,1
44997,dyslipidemia,1,1
44998,were,1,0
44999,treated,1,1
45000,3,0,0
45001,months,0,0
45002,with,0,1
45003,simvastatin,0,0
45004,(,0,1
45005,20,0,1
45006,mg,0,0
45007,daily,0,0
45008,),0,0
45009,and,0,0
45010,then,0,0
45011,3,0,0
45012,months,0,0
45013,with,0,1
45014,fenofibrate,0,1
45015,(,0,1
45016,200,0,0
45017,mg,0,0
45018,daily,0,0
45019,),0,0
45020,with,0,1
45021,2,0,0
45022,months,0,0
45023,of,0,0
45024,wash-out,0,0
45025,between,0,0
45026,the,0,0
45027,two,0,0
45028,treatments,0,0
45029,.,0,1
45030,Laboratory,0,0
45031,parameters,0,0
45032,of,0,0
45033,oxidative,0,0
45034,stress,0,0
45035,",",0,0
45036,fibrinolysis,0,0
45037,and,0,0
45038,endothelial,0,0
45039,function,0,0
45040,were,0,0
45041,evaluated,0,0
45042,before,0,0
45043,and,0,0
45044,at,0,0
45045,the,0,0
45046,end,0,0
45047,of,0,0
45048,each,0,0
45049,treatment,0,0
45050,period,0,0
45051,.,0,0
45052,The,0,0
45053,significant,0,0
45054,decrease,0,0
45055,in,0,0
45056,serum,0,0
45057,total,0,1
45058,and,0,1
45059,LDL-cholesterol,0,0
45060,concentrations,0,0
45061,(,0,1
45062,P,0,0
45063,<,0,0
45064,0.0001,0,0
45065,),0,0
45066,caused,0,0
45067,by,0,0
45068,simvastatin,0,0
45069,was,0,0
45070,associated,0,0
45071,with,0,1
45072,an,0,0
45073,increase,0,0
45074,in,0,0
45075,serum,0,0
45076,N-acetyl-beta-glucosaminidase,0,1
45077,activity,0,0
45078,(,0,0
45079,P,0,0
45080,<,0,0
45081,0.001,0,0
45082,),0,0
45083,",",0,0
45084,ascorbic,0,0
45085,acid,0,0
45086,(,0,0
45087,P,0,0
45088,<,0,0
45089,0.001,0,0
45090,),0,0
45091,",",0,0
45092,plasminogen,0,0
45093,activator,0,0
45094,inhibitor,0,0
45095,(,0,0
45096,PAI-1,0,0
45097,),0,0
45098,(,0,0
45099,P,0,0
45100,<,0,0
45101,0.01,0,0
45102,),0,0
45103,",",0,0
45104,vonWillebrand,0,0
45105,factor,0,0
45106,(,0,0
45107,P,0,0
45108,<,0,0
45109,0.05,0,0
45110,),0,0
45111,",",0,0
45112,E-selectin,0,0
45113,(,0,0
45114,P,0,0
45115,<,0,0
45116,0.01,0,0
45117,),0,0
45118,and,0,0
45119,vascular,0,0
45120,endothelial,0,0
45121,growth,0,0
45122,factor,0,0
45123,(,0,0
45124,P,0,0
45125,<,0,0
45126,0.05,0,0
45127,),0,1
45128,concentrations,0,0
45129,and,0,0
45130,with,0,1
45131,a,0,0
45132,decrease,0,0
45133,in,0,0
45134,plasma,0,0
45135,glutathione,0,0
45136,(,0,0
45137,P,0,0
45138,<,0,0
45139,0.01,0,0
45140,),0,1
45141,levels,0,0
45142,.,0,1
45143,Fenofibrate,0,0
45144,caused,0,0
45145,a,0,0
45146,significant,0,0
45147,decrease,0,0
45148,in,0,0
45149,serum,0,0
45150,triglyceride,0,0
45151,concentration,0,0
45152,(,0,0
45153,P,0,0
45154,<,0,0
45155,0.0001,0,0
45156,),0,0
45157,associated,0,0
45158,with,0,1
45159,a,0,0
45160,decrease,0,0
45161,in,0,0
45162,plasma,0,0
45163,malondialdehyde,0,0
45164,(,0,0
45165,P,0,0
45166,<,0,0
45167,0.001,0,0
45168,),0,0
45169,and,0,0
45170,an,0,0
45171,increase,0,0
45172,in,0,0
45173,plasma,0,0
45174,PAI-1,0,1
45175,(,0,1
45176,P,0,0
45177,<,0,0
45178,0.05,0,0
45179,),0,0
45180,and,0,0
45181,P-selectin,0,0
45182,(,0,0
45183,P,0,0
45184,<,0,0
45185,0.05,0,0
45186,),0,1
45187,concentrations,0,0
45188,.,0,1
45189,We,0,0
45190,conclude,0,0
45191,that,0,0
45192,simvastatin,0,0
45193,and,0,0
45194,fenofibrate,0,0
45195,interact,0,0
45196,",",0,0
45197,by,0,0
45198,different,0,0
45199,mechanisms,0,0
45200,",",0,0
45201,with,0,1
45202,oxidative,0,0
45203,stress,0,0
45204,",",0,0
45205,a,0,0
45206,key,0,0
45207,factor,0,0
45208,in,0,0
45209,the,0,0
45210,modification,0,0
45211,of,0,0
45212,fibrinolysis,0,0
45213,and,0,0
45214,endothelial,0,0
45215,function,0,0
45216,in,0,0
45217,Type,0,1
45218,2,0,1
45219,diabetes,0,1
45220,.,0,1
45221,Chronic,0,1
45222,fatigue,0,0
45223,syndrome,0,1
45224,versus,0,0
45225,neuroendocrineimmune,0,1
45226,dysfunction,0,1
45227,syndrome,0,1
45228,:,0,1
45229,differential,0,0
45230,attributions,0,0
45231,.,0,1
45232,Since,0,0
45233,1988,0,1
45234,",",0,0
45235,when,0,0
45236,the,0,0
45237,term,0,0
45238,chronic,0,1
45239,fatigue,0,0
45240,syndrome,0,1
45241,(,0,0
45242,CFS,0,0
45243,),0,0
45244,was,0,0
45245,coined,0,0
45246,",",0,0
45247,considerable,0,0
45248,discussion,0,0
45249,has,0,0
45250,occurred,0,0
45251,about,0,0
45252,stigma,0,0
45253,associated,0,0
45254,with,0,1
45255,this,0,0
45256,diagnostic,0,0
45257,term,0,0
45258,.,0,0
45259,In,0,0
45260,particular,0,0
45261,",",0,0
45262,patients,1,1
45263,with,1,1
45264,CFS,1,0
45265,have,0,0
45266,felt,0,0
45267,that,0,0
45268,this,0,0
45269,term,0,0
45270,trivializes,0,0
45271,the,0,0
45272,serious,0,0
45273,nature,0,0
45274,of,0,0
45275,this,0,0
45276,disorder,0,1
45277,.,0,0
45278,A,0,0
45279,Name,0,0
45280,Change,0,0
45281,Work,0,0
45282,group,0,0
45283,",",0,0
45284,appointed,0,0
45285,by,0,0
45286,the,0,0
45287,CFS,0,0
45288,Coordinating,0,0
45289,Committee,0,1
45290,",",0,0
45291,developed,0,0
45292,an,0,0
45293,umbrella,0,1
45294,term,0,1
45295,:,0,1
45296,chronic,0,1
45297,neuroendocrineimmune,0,1
45298,dysfunction,0,1
45299,syndrome,0,1
45300,(,0,0
45301,CNDS,0,0
45302,),0,0
45303,",",0,0
45304,and,0,0
45305,proposed,0,0
45306,that,0,0
45307,there,0,0
45308,would,0,0
45309,be,0,0
45310,sub-types,0,0
45311,under,0,0
45312,this,0,0
45313,term,0,0
45314,",",0,0
45315,one,0,0
45316,being,0,0
45317,CFS,0,0
45318,.,0,1
45319,The,0,0
45320,present,0,0
45321,study,0,0
45322,examined,0,0
45323,attributions,0,0
45324,of,0,0
45325,this,0,0
45326,new,0,0
45327,umbrella,0,0
45328,term,0,0
45329,when,0,0
45330,compared,0,0
45331,with,0,0
45332,CFS,0,0
45333,.,0,1
45334,Nurses,0,0
45335,and,0,0
45336,physician,0,1
45337,assistants,0,0
45338,(,0,1
45339,PAs,0,1
45340,),0,0
45341,were,0,0
45342,presented,0,0
45343,a,0,0
45344,case,0,0
45345,study,0,0
45346,of,0,0
45347,a,0,0
45348,patient,1,0
45349,with,1,1
45350,symptoms,1,0
45351,of,1,1
45352,CFS,1,0
45353,.,1,1
45354,They,0,0
45355,were,0,0
45356,told,0,0
45357,that,0,0
45358,the,0,0
45359,patient,1,0
45360,had,1,0
45361,either,1,0
45362,chronic,1,1
45363,fatigue,1,0
45364,syndrome,1,1
45365,",",1,0
45366,chronic,1,1
45367,neuroendocrineimmune,1,1
45368,dysfunction,1,1
45369,syndrome,1,1
45370,",",1,0
45371,or,1,0
45372,chronic,1,1
45373,neuroendocrineimmune,1,1
45374,dysfunction,1,1
45375,syndrome,1,1
45376,",",0,0
45377,which,0,0
45378,had,0,0
45379,formerly,0,1
45380,been,0,0
45381,called,0,0
45382,chronic,0,1
45383,fatigue,0,0
45384,syndrome,0,1
45385,.,0,0
45386,The,0,0
45387,different,0,0
45388,terms,0,0
45389,led,0,0
45390,to,0,1
45391,different,0,0
45392,attributions,0,0
45393,",",0,0
45394,with,0,1
45395,PA,0,0
45396,respondents,0,1
45397,rating,0,0
45398,the,0,0
45399,CNDS,0,0
45400,label,0,0
45401,as,0,0
45402,more,0,0
45403,severe,0,1
45404,.,0,0
45405,Results,0,0
45406,suggest,0,0
45407,that,0,0
45408,a,0,0
45409,more,0,0
45410,medical,0,0
45411,sounding,0,0
45412,term,0,1
45413,(,0,0
45414,CNDS,0,0
45415,),0,0
45416,may,0,0
45417,lead,0,0
45418,to,0,0
45419,attributions,0,0
45420,that,0,0
45421,this,0,0
45422,syndrome,0,1
45423,is,0,0
45424,a,0,0
45425,more,0,0
45426,serious,0,0
45427,",",0,0
45428,disabling,0,1
45429,illness,0,1
45430,.,0,0
45431,The,0,0
45432,policy,0,0
45433,implications,0,0
45434,of,0,0
45435,these,0,0
45436,findings,0,0
45437,are,0,0
45438,discussed,0,0
45439,.,0,1
45440,An,0,0
45441,open,0,1
45442,and,0,0
45443,randomized,0,1
45444,study,0,0
45445,comparing,0,0
45446,the,0,0
45447,efficacy,0,0
45448,of,0,0
45449,standard,0,0
45450,danazol,0,0
45451,and,0,0
45452,modified,0,0
45453,triptorelin,0,0
45454,regimens,0,0
45455,for,0,0
45456,postoperative,1,0
45457,disease,1,1
45458,management,1,0
45459,of,1,0
45460,moderate,1,1
45461,to,1,0
45462,severe,1,1
45463,endometriosis,1,1
45464,.,1,0
45465,OBJECTIVE,0,0
45466,To,0,0
45467,compare,0,0
45468,the,0,0
45469,efficacy,0,0
45470,of,0,0
45471,danazol,0,0
45472,and,0,0
45473,triptorelin,0,0
45474,(,0,0
45475,Decapeptyl,0,0
45476,CR,0,0
45477,",",0,0
45478,Ferring,0,1
45479,",",0,0
45480,Kiel,0,1
45481,",",0,0
45482,Germany,0,1
45483,),0,0
45484,in,0,0
45485,the,0,0
45486,management,0,0
45487,of,0,0
45488,moderate,0,1
45489,and,0,0
45490,severe,0,1
45491,endometriosis,0,1
45492,in,0,0
45493,terms,0,0
45494,of,0,0
45495,symptom,0,1
45496,control,0,0
45497,and,0,0
45498,revised,0,1
45499,American,0,1
45500,Fertility,0,1
45501,Society,0,1
45502,(,0,0
45503,AFS,0,0
45504,),0,0
45505,score,0,0
45506,reduction,0,0
45507,",",0,0
45508,and,0,0
45509,to,0,0
45510,evaluate,0,0
45511,the,0,0
45512,hormonal,0,0
45513,profile,0,0
45514,of,0,0
45515,patients,1,1
45516,treated,1,1
45517,with,1,1
45518,triptorelin,1,0
45519,every,1,0
45520,6,1,0
45521,weeks,1,0
45522,.,1,1
45523,DESIGN,0,0
45524,Open,0,0
45525,and,0,0
45526,randomized,0,1
45527,trial,0,0
45528,.,0,0
45529,SETTING,0,1
45530,Kwong,1,1
45531,Wah,1,1
45532,Hospital,1,1
45533,",",1,0
45534,a,1,0
45535,large,1,1
45536,public,1,1
45537,hospital,1,1
45538,in,1,0
45539,an,1,0
45540,urban,1,1
45541,location,1,0
45542,(,1,0
45543,Hong,1,1
45544,Kong,1,1
45545,),1,1
45546,.,1,0
45547,PATIENT,0,0
45548,(,0,0
45549,S,0,0
45550,),0,1
45551,Forty,1,1
45552,patients,1,1
45553,after,1,0
45554,their,1,1
45555,first,1,0
45556,conservative,1,1
45557,operation,1,0
45558,for,1,0
45559,endometriosis,1,1
45560,",",1,0
45561,with,1,1
45562,surgical,1,0
45563,confirmation,1,0
45564,of,1,0
45565,revised,1,1
45566,AFS,1,0
45567,stage,1,1
45568,III,1,1
45569,or,1,1
45570,IV,1,0
45571,endometriosis,1,1
45572,.,1,0
45573,INTERVENTION,0,0
45574,(,0,0
45575,S,0,0
45576,),0,0
45577,Postoperative,0,0
45578,6,0,0
45579,months,0,0
45580,',0,1
45581,therapy,0,0
45582,of,0,0
45583,danazol,0,0
45584,or,0,1
45585,triptorelin,0,0
45586,every,0,0
45587,6,0,0
45588,weeks,0,0
45589,",",0,0
45590,postmedical,0,1
45591,therapy,0,0
45592,second-look,0,0
45593,laparoscopy,0,1
45594,.,0,1
45595,MAIN,0,0
45596,OUTCOME,0,0
45597,MEASURE,0,0
45598,(,0,0
45599,S,0,0
45600,),0,0
45601,Symptom,0,0
45602,control,0,1
45603,and,0,0
45604,patients,0,1
45605,',0,1
45606,tolerance,0,0
45607,during,0,0
45608,medical,0,0
45609,therapy,0,0
45610,",",0,0
45611,posttherapy,0,0
45612,revised,0,0
45613,AFS,0,0
45614,score,0,0
45615,",",0,0
45616,hormonal,0,0
45617,profile,0,0
45618,during,0,0
45619,triptorelin,0,0
45620,therapy,0,0
45621,.,0,1
45622,RESULT,0,0
45623,(,0,0
45624,S,0,0
45625,),0,0
45626,Pain,0,0
45627,control,0,1
45628,was,0,0
45629,similar,0,0
45630,between,0,0
45631,danazol,0,0
45632,and,0,0
45633,triptorelin,0,0
45634,therapy,0,0
45635,.,0,0
45636,There,0,0
45637,was,0,0
45638,less,0,0
45639,breakthrough,0,0
45640,bleeding,0,0
45641,with,0,1
45642,triptorelin,0,0
45643,.,0,1
45644,More,0,1
45645,patients,0,1
45646,failed,0,0
45647,to,0,0
45648,complete,0,0
45649,the,0,0
45650,whole,0,0
45651,course,0,0
45652,of,0,0
45653,danazol,0,0
45654,because,0,0
45655,of,0,0
45656,its,0,0
45657,side,0,0
45658,effects,0,0
45659,.,0,1
45660,The,0,0
45661,revised,0,0
45662,AFS,0,0
45663,score,0,0
45664,at,0,0
45665,second-look,0,0
45666,laparoscopy,0,1
45667,did,0,0
45668,not,0,0
45669,show,0,0
45670,a,0,0
45671,significant,0,0
45672,difference,0,0
45673,between,0,0
45674,the,0,0
45675,two,0,0
45676,medications,0,0
45677,.,0,1
45678,Adequate,0,0
45679,pituitary,0,1
45680,suppression,0,0
45681,was,0,0
45682,observed,0,0
45683,with,0,1
45684,injection,0,0
45685,of,0,0
45686,triptorelin,0,0
45687,every,0,0
45688,6,0,0
45689,weeks,0,0
45690,.,0,1
45691,CONCLUSION,0,0
45692,(,0,0
45693,S,0,0
45694,),0,0
45695,Lengthening,0,0
45696,of,0,0
45697,triptorelin,0,0
45698,administration,0,0
45699,intervals,0,0
45700,from,0,1
45701,4,0,0
45702,weeks,0,0
45703,to,0,1
45704,6,0,0
45705,weeks,0,0
45706,is,0,0
45707,effective,0,0
45708,in,0,0
45709,maintaining,0,0
45710,a,0,0
45711,hypoestrogenic,0,1
45712,state,0,1
45713,.,0,1
45714,Patients,0,0
45715,were,0,0
45716,more,0,0
45717,compliant,0,0
45718,with,0,0
45719,triptorelin,0,0
45720,than,0,0
45721,danazol,0,0
45722,.,0,0
45723,Thus,0,0
45724,",",0,0
45725,triptorelin,0,0
45726,injection,0,0
45727,every,0,0
45728,6,0,0
45729,weeks,0,0
45730,is,0,0
45731,more,0,0
45732,cost-effective,0,0
45733,than,0,0
45734,conventional,0,1
45735,regimens,0,0
45736,.,0,1
45737,Needle,0,0
45738,versus,0,0
45739,loop,0,1
45740,diathermy,0,0
45741,excision,0,0
45742,of,0,0
45743,the,0,0
45744,transformation,0,0
45745,zone,0,0
45746,for,0,0
45747,the,0,0
45748,treatment,0,0
45749,of,0,0
45750,cervical,1,1
45751,intraepithelial,1,1
45752,neoplasia,1,1
45753,:,1,1
45754,a,0,0
45755,randomised,0,0
45756,controlled,0,0
45757,trial,0,0
45758,.,0,0
45759,OBJECTIVE,0,0
45760,To,0,0
45761,determine,0,0
45762,whether,0,0
45763,lower,0,0
45764,rates,0,0
45765,or,0,1
45766,incomplete,0,1
45767,resection,0,1
45768,of,0,0
45769,cervical,1,1
45770,intraepithelial,1,1
45771,neoplasia,1,1
45772,(,1,0
45773,CIN,1,0
45774,),1,0
45775,may,0,0
45776,be,0,0
45777,achieved,0,0
45778,by,0,0
45779,needle,0,0
45780,excision,0,1
45781,of,0,0
45782,the,0,0
45783,transformation,0,0
45784,zone,0,0
45785,(,0,0
45786,NETZ,0,0
45787,),0,0
45788,than,0,0
45789,with,0,1
45790,loop,0,1
45791,excision,0,1
45792,(,0,0
45793,LLETZ,0,0
45794,),0,0
45795,.,0,0
45796,DESIGN,0,0
45797,A,0,0
45798,prospective,0,0
45799,randomised,0,0
45800,controlled,0,0
45801,trial,0,0
45802,.,0,0
45803,SETTING,0,0
45804,A,0,0
45805,gynaecological,1,1
45806,oncology,1,0
45807,centre,1,1
45808,and,1,0
45809,a,1,0
45810,teaching,1,0
45811,hospital,1,1
45812,in,1,0
45813,West,1,1
45814,London,1,1
45815,.,1,1
45816,POPULATION,0,0
45817,Four,1,0
45818,hundred,1,1
45819,and,1,1
45820,four,1,1
45821,women,1,1
45822,due,1,1
45823,to,1,0
45824,receive,1,0
45825,treatment,1,0
45826,for,1,0
45827,suspected,1,1
45828,CIN,1,1
45829,.,1,1
45830,METHODS,0,0
45831,Women,0,1
45832,were,0,0
45833,randomised,0,0
45834,to,0,0
45835,receive,0,0
45836,either,0,0
45837,LLETZ,0,0
45838,or,0,1
45839,NETZ,0,0
45840,.,0,1
45841,MAIN,0,0
45842,OUTCOME,0,0
45843,MEASURES,0,0
45844,The,0,0
45845,study,0,0
45846,was,0,0
45847,designed,0,0
45848,to,0,0
45849,demostrate,0,0
45850,a,0,0
45851,difference,0,0
45852,in,0,0
45853,the,0,0
45854,proportion,0,0
45855,of,0,0
45856,women,0,1
45857,with,0,1
45858,clear,0,0
45859,histological,0,0
45860,margins,0,1
45861,of,0,1
45862,82,0,1
45863,%,0,0
45864,for,0,0
45865,LLETZ,0,0
45866,compared,0,0
45867,to,0,0
45868,94,0,1
45869,%,0,0
45870,for,0,0
45871,NETZ,0,0
45872,with,0,1
45873,90,0,0
45874,%,0,0
45875,power,0,0
45876,at,0,0
45877,a,0,0
45878,5,0,0
45879,%,0,0
45880,significance,0,0
45881,level,0,0
45882,",",0,0
45883,allowing,0,0
45884,for,0,0
45885,absence,0,0
45886,of,0,0
45887,CIN,0,0
45888,in,0,0
45889,the,0,0
45890,treatment,0,0
45891,specimen,0,0
45892,in,0,0
45893,15,0,1
45894,%,0,0
45895,.,0,1
45896,RESULTS,0,0
45897,Four,1,0
45898,randomised,1,1
45899,women,1,1
45900,were,0,0
45901,excluded,0,0
45902,from,0,0
45903,the,0,0
45904,analysis,0,0
45905,",",0,0
45906,as,0,0
45907,they,0,0
45908,were,0,0
45909,ineligible,0,1
45910,for,0,0
45911,the,0,0
45912,study,0,0
45913,.,0,0
45914,Three,0,0
45915,hundred,0,1
45916,and,0,0
45917,forty-seven,0,1
45918,(,0,0
45919,87,0,1
45920,%,0,0
45921,),0,0
45922,had,0,0
45923,CIN,0,0
45924,in,0,0
45925,the,0,0
45926,treatment,0,0
45927,specimen,0,0
45928,and,0,0
45929,could,0,0
45930,be,0,0
45931,included,0,0
45932,in,0,0
45933,the,0,0
45934,analysis,0,0
45935,of,0,0
45936,excision,0,1
45937,margins,0,0
45938,.,0,1
45939,More,0,1
45940,women,0,1
45941,in,0,0
45942,the,0,0
45943,NETZ,0,0
45944,arm,0,0
45945,had,0,1
45946,clear,0,0
45947,histological,0,0
45948,margins,0,1
45949,(,0,1
45950,84.8,0,0
45951,%,0,0
45952,vs,0,0
45953,75,0,1
45954,%,0,0
45955,",",0,0
45956,(,0,0
45957,P=,0,1
45958,0.03,0,0
45959,),0,0
45960,.,0,0
45961,The,0,0
45962,median,0,0
45963,volume,0,0
45964,of,0,0
45965,specimens,0,0
45966,in,0,0
45967,the,0,0
45968,NETZ,0,0
45969,arm,0,0
45970,was,0,0
45971,739,0,1
45972,mm,0,0
45973,(,0,1
45974,3,0,0
45975,),0,0
45976,larger,0,0
45977,(,0,0
45978,P=,0,1
45979,0.33,0,0
45980,),0,0
45981,and,0,0
45982,they,0,0
45983,were,0,0
45984,less,0,0
45985,likely,0,0
45986,to,0,0
45987,be,0,0
45988,removed,0,0
45989,in,0,0
45990,multiple,0,0
45991,pieces,0,0
45992,(,0,1
45993,2.5,0,0
45994,%,0,0
45995,vs,0,0
45996,29.5,0,0
45997,%,0,0
45998,",",0,0
45999,RR,0,0
46000,0.09,0,0
46001,",",0,0
46002,95,0,0
46003,%,0,0
46004,CI,0,0
46005,0.04,0,0
46006,to,0,0
46007,0.20,0,0
46008,),0,0
46009,.,0,1
46010,Needle,0,0
46011,excision,0,0
46012,took,0,0
46013,longer,0,0
46014,to,0,0
46015,perform,0,0
46016,(,0,0
46017,median,0,0
46018,treatment,0,0
46019,time,0,0
46020,210,0,1
46021,vs,0,0
46022,90,0,1
46023,seconds,0,0
46024,",",0,1
46025,P,0,0
46026,<,0,0
46027,0.0001,0,0
46028,),0,0
46029,and,0,0
46030,surgeons,0,0
46031,more,0,0
46032,often,0,0
46033,reported,0,0
46034,the,0,0
46035,procedure,0,0
46036,as,0,0
46037,'difficult,0,0
46038,',0,1
46039,(,0,0
46040,9.5,0,0
46041,%,0,0
46042,vs,0,0
46043,3.0,0,0
46044,%,0,0
46045,",",0,0
46046,RR,0,0
46047,=,0,0
46048,3.17,0,0
46049,%,0,0
46050,",",0,0
46051,95,0,0
46052,%,0,0
46053,CI,0,0
46054,1.33,0,0
46055,to,0,0
46056,7.58,0,0
46057,),0,0
46058,.,0,0
46059,No,0,0
46060,difference,0,0
46061,in,0,0
46062,peri-operative,0,0
46063,or,0,1
46064,post-operative,0,0
46065,complication,0,0
46066,rates,0,0
46067,could,0,0
46068,be,0,0
46069,demonstrated,0,0
46070,between,0,0
46071,the,0,0
46072,two,0,0
46073,groups,0,0
46074,.,0,1
46075,CONCLUSION,0,0
46076,NETZ,0,0
46077,is,0,0
46078,more,0,0
46079,likely,0,0
46080,to,0,0
46081,produce,0,0
46082,a,0,0
46083,specimen,0,0
46084,in,0,0
46085,one,0,1
46086,piece,0,0
46087,and,0,0
46088,with,0,1
46089,clear,0,0
46090,margins,0,0
46091,compared,0,0
46092,to,0,1
46093,LLETZ,0,0
46094,.,0,1
46095,Chemotherapy,0,1
46096,for,0,0
46097,patients,1,1
46098,with,1,1
46099,non-small,1,1
46100,cell,1,1
46101,lung,1,1
46102,cancer,1,1
46103,:,1,1
46104,the,0,0
46105,surgical,0,0
46106,setting,0,1
46107,of,0,0
46108,the,0,0
46109,Big,0,0
46110,Lung,0,0
46111,Trial,0,1
46112,.,0,0
46113,OBJECTIVES,0,0
46114,The,0,0
46115,non-small,1,0
46116,cell,1,0
46117,lung,1,1
46118,cancer,1,1
46119,(,1,0
46120,NSCLC,1,0
46121,),1,0
46122,meta-analysis,0,0
46123,suggested,0,0
46124,a,0,0
46125,survival,0,0
46126,benefit,0,0
46127,for,0,0
46128,cisplatin-based,0,0
46129,chemotherapy,0,0
46130,when,0,0
46131,given,0,0
46132,in,0,0
46133,addition,0,0
46134,to,0,0
46135,surgery,0,1
46136,",",0,0
46137,radical,0,0
46138,radiotherapy,0,1
46139,or,0,1
46140,'best,0,0
46141,supportive,0,0
46142,care,0,1
46143,',0,1
46144,.,0,0
46145,However,0,0
46146,",",0,0
46147,it,0,0
46148,included,0,1
46149,many,0,0
46150,small,0,1
46151,trials,0,1
46152,and,0,1
46153,trials,0,0
46154,with,0,1
46155,differing,0,0
46156,eligibility,0,1
46157,criteria,0,1
46158,and,0,0
46159,chemotherapy,0,1
46160,regimens,0,0
46161,.,0,0
46162,The,0,0
46163,aim,0,0
46164,of,0,0
46165,the,0,0
46166,Big,0,0
46167,Lung,0,0
46168,Trial,0,0
46169,was,0,0
46170,therefore,0,0
46171,to,0,0
46172,run,0,0
46173,a,0,0
46174,large,0,1
46175,pragmatic,0,0
46176,trial,0,0
46177,to,0,0
46178,confirm,0,0
46179,the,0,0
46180,survival,0,0
46181,benefits,0,0
46182,seen,0,0
46183,in,0,0
46184,the,0,0
46185,meta-analysis,0,0
46186,.,0,0
46187,METHODS,0,0
46188,In,0,0
46189,the,0,0
46190,surgery,0,1
46191,setting,0,0
46192,",",0,0
46193,a,0,0
46194,total,0,1
46195,of,0,0
46196,381,1,1
46197,patients,1,1
46198,were,1,1
46199,randomised,1,0
46200,to,1,0
46201,chemotherapy,1,0
46202,(,1,0
46203,C,1,0
46204,",",1,0
46205,192,1,1
46206,patients,1,1
46207,),1,1
46208,or,1,1
46209,no,1,0
46210,chemotherapy,1,0
46211,(,1,0
46212,NoC,1,0
46213,",",1,0
46214,189,1,1
46215,patients,1,1
46216,),1,1
46217,.,1,1
46218,C,0,0
46219,was,0,0
46220,three,0,0
46221,3-weekly,0,0
46222,cycles,0,0
46223,of,0,0
46224,cisplatin/vindesine,0,0
46225,",",0,0
46226,mitomycin/ifosfamide/cisplatin,0,0
46227,",",0,0
46228,mitomycin/vinblastine/cisplatin,0,0
46229,or,0,0
46230,vinorelbine/cisplatin,0,0
46231,.,0,1
46232,RESULTS,0,0
46233,Chemotherapy,0,0
46234,was,0,0
46235,given,0,0
46236,before,0,0
46237,surgery,0,1
46238,in,0,0
46239,3,0,0
46240,%,0,0
46241,of,0,0
46242,patients,0,1
46243,whilst,0,0
46244,97,0,1
46245,%,0,0
46246,received,0,0
46247,adjuvant,0,0
46248,chemotherapy,0,1
46249,.,0,1
46250,Baseline,0,0
46251,characteristics,0,0
46252,were,0,1
46253,:,0,1
46254,median,0,0
46255,age,0,1
46256,61,0,1
46257,years,0,1
46258,",",0,1
46259,69,0,1
46260,%,0,0
46261,male,0,1
46262,",",0,0
46263,48,0,0
46264,%,0,0
46265,squamous,0,1
46266,cell,0,1
46267,",",0,0
46268,93,0,1
46269,%,0,0
46270,WHO,0,0
46271,PS,0,1
46272,0-1,0,0
46273,",",0,0
46274,27,0,1
46275,%,0,0
46276,stage,0,1
46277,I,0,1
46278,",",0,0
46279,38,0,1
46280,%,0,0
46281,stage,0,1
46282,II,0,0
46283,",",0,0
46284,and,0,0
46285,34,0,1
46286,%,0,0
46287,stage,0,1
46288,III,0,1
46289,.,0,1
46290,Complete,0,0
46291,resection,0,1
46292,was,0,0
46293,achieved,0,0
46294,in,0,0
46295,approximately,0,1
46296,95,0,0
46297,%,0,0
46298,of,0,0
46299,patients,0,1
46300,.,0,1
46301,In,0,0
46302,the,0,0
46303,C,0,0
46304,group,0,0
46305,",",0,0
46306,13,0,1
46307,%,0,0
46308,received,0,0
46309,no,0,0
46310,chemotherapy,0,0
46311,",",0,0
46312,21,0,1
46313,%,0,0
46314,one,0,1
46315,or,0,1
46316,two,0,0
46317,cycles,0,0
46318,",",0,0
46319,and,0,0
46320,64,0,1
46321,%,0,0
46322,all,0,1
46323,three,0,0
46324,cycles,0,0
46325,of,0,0
46326,their,0,1
46327,prescribed,0,0
46328,chemotherapy,0,1
46329,(,0,0
46330,60,0,1
46331,%,0,0
46332,of,0,0
46333,the,0,0
46334,latter,0,0
46335,with,0,1
46336,no,0,0
46337,delays,0,0
46338,or,0,1
46339,modification,0,0
46340,),0,0
46341,.,0,0
46342,30,0,0
46343,%,0,0
46344,had,0,1
46345,grade,0,1
46346,3/4,0,0
46347,toxicity,0,0
46348,",",0,0
46349,mainly,0,0
46350,haematological,0,0
46351,",",0,0
46352,nausea/vomiting,0,0
46353,and,0,0
46354,neutropenic,0,1
46355,fever,0,0
46356,",",0,0
46357,and,0,0
46358,six,0,1
46359,patients,0,1
46360,were,0,1
46361,reported,0,0
46362,as,0,0
46363,having,0,1
46364,a,0,0
46365,treatment-related,0,0
46366,death,0,0
46367,.,0,1
46368,198,0,1
46369,(,0,0
46370,52,0,1
46371,%,0,0
46372,),0,0
46373,of,0,0
46374,patients,0,1
46375,have,0,0
46376,died,0,1
46377,",",0,0
46378,but,0,0
46379,there,0,0
46380,is,0,0
46381,currently,0,0
46382,no,0,0
46383,evidence,0,0
46384,of,0,0
46385,a,0,0
46386,benefit,0,0
46387,in,0,0
46388,overall,0,0
46389,survival,0,0
46390,to,0,0
46391,the,0,0
46392,C,0,0
46393,group,0,0
46394,:,0,1
46395,HR,0,0
46396,1.02,0,0
46397,(,0,0
46398,95,0,0
46399,%,0,0
46400,CI,0,0
46401,0.77-1.35,0,0
46402,),0,0
46403,",",0,0
46404,P,0,0
46405,=,0,0
46406,0.90,0,0
46407,),0,0
46408,.,0,0
46409,CONCLUSIONS,0,0
46410,This,0,0
46411,trial,0,0
46412,has,0,0
46413,failed,0,0
46414,to,0,0
46415,observe,0,0
46416,a,0,0
46417,survival,0,0
46418,benefit,0,0
46419,with,0,1
46420,adjuvant,0,0
46421,chemotherapy,0,1
46422,following,0,0
46423,complete,0,0
46424,resection,0,1
46425,of,0,0
46426,stage,0,1
46427,I-III,0,0
46428,NSCLC,0,0
46429,.,0,0
46430,However,0,0
46431,",",0,0
46432,the,0,0
46433,hazard,0,0
46434,ratio,0,0
46435,and,0,0
46436,95,0,0
46437,%,0,0
46438,confidence,0,0
46439,intervals,0,0
46440,are,0,0
46441,consistent,0,0
46442,with,0,1
46443,the,0,0
46444,previously,0,0
46445,reported,0,0
46446,meta-analysis,0,0
46447,and,0,0
46448,two,0,0
46449,large,0,1
46450,recently,0,1
46451,reported,0,0
46452,trials,0,0
46453,",",0,0
46454,which,0,0
46455,suggest,0,0
46456,a,0,0
46457,small,0,0
46458,survival,0,0
46459,benefit,0,0
46460,with,0,1
46461,cisplatin-based,0,0
46462,chemotherapy,0,1
46463,.,0,1
46464,Effects,0,0
46465,of,0,0
46466,pioglitazone,0,0
46467,and,0,0
46468,glimepiride,0,0
46469,on,0,0
46470,glycemic,0,0
46471,control,0,1
46472,and,0,0
46473,insulin,0,0
46474,sensitivity,0,0
46475,in,0,0
46476,Mexican,1,1
46477,patients,1,1
46478,with,1,1
46479,type,1,1
46480,2,1,1
46481,diabetes,1,1
46482,mellitus,1,1
46483,:,1,1
46484,A,0,0
46485,multicenter,0,0
46486,",",0,0
46487,randomized,0,0
46488,",",0,0
46489,double-blind,0,0
46490,",",0,0
46491,parallel-group,0,0
46492,trial,0,0
46493,.,0,1
46494,BACKGROUND,0,0
46495,Pioglitazone,0,0
46496,and,0,0
46497,glimepiride,0,0
46498,improve,0,0
46499,glycemic,0,0
46500,control,0,0
46501,in,0,0
46502,patients,1,1
46503,with,1,1
46504,type,1,1
46505,2,1,1
46506,diabetes,1,1
46507,mellitus,1,1
46508,by,0,0
46509,different,0,0
46510,mechanisms,0,0
46511,.,0,0
46512,Pioglitazone,0,0
46513,is,0,0
46514,a,0,0
46515,thiazolidinedione,0,0
46516,that,0,0
46517,reduces,0,0
46518,insulin,0,0
46519,resistance,0,0
46520,",",0,0
46521,and,0,0
46522,glimepiride,0,0
46523,is,0,0
46524,a,0,0
46525,sulfonylurea,0,0
46526,insulin,0,0
46527,secretagogue,0,0
46528,.,0,0
46529,OBJECTIVE,0,0
46530,The,0,0
46531,goals,0,0
46532,of,0,0
46533,this,0,0
46534,study,0,0
46535,were,0,0
46536,to,0,0
46537,compare,0,0
46538,changes,0,0
46539,in,0,0
46540,measures,0,0
46541,of,0,0
46542,glycemic,0,0
46543,control,0,1
46544,and,0,0
46545,insulin,0,0
46546,sensitivity,0,0
46547,in,0,0
46548,Mexican,1,1
46549,patients,1,1
46550,with,1,1
46551,type,1,1
46552,2,1,1
46553,diabetes,1,1
46554,who,1,1
46555,received,1,1
46556,pioglitazone,1,1
46557,or,1,0
46558,glimepiride,1,0
46559,for,1,0
46560,1,1,0
46561,year,1,1
46562,.,1,1
46563,METHODS,0,0
46564,This,0,0
46565,was,0,0
46566,a,0,0
46567,multicenter,0,0
46568,",",0,0
46569,52-week,0,0
46570,",",0,0
46571,double-blind,0,0
46572,",",0,0
46573,parallel-group,0,0
46574,trial,0,0
46575,.,0,1
46576,Patients,0,1
46577,were,0,0
46578,randomized,0,1
46579,to,0,0
46580,receive,0,0
46581,monotherapy,0,0
46582,with,0,0
46583,either,0,0
46584,glimepiride,0,0
46585,(,0,0
46586,2,0,0
46587,mg,0,0
46588,QD,0,0
46589,initially,0,0
46590,),0,0
46591,or,0,0
46592,pioglitazone,0,0
46593,(,0,0
46594,15,0,1
46595,mg,0,0
46596,QD,0,0
46597,initially,0,1
46598,),0,0
46599,.,0,0
46600,Doses,0,0
46601,were,0,0
46602,titrated,0,0
46603,(,0,0
46604,maximal,0,0
46605,doses,0,0
46606,:,0,1
46607,pioglitazone,0,0
46608,45,0,1
46609,mg,0,0
46610,",",0,0
46611,glimepiride,0,0
46612,8,0,0
46613,mg,0,0
46614,),0,0
46615,to,0,0
46616,achieve,0,0
46617,glycemic,0,0
46618,targets,0,0
46619,(,0,0
46620,fasting,0,0
46621,blood,0,0
46622,glucose,0,0
46623,<,0,0
46624,or,0,1
46625,=7,0,1
46626,mmol/L,0,0
46627,and,0,0
46628,1-hour,0,0
46629,postprandial,0,0
46630,blood,0,0
46631,glucose,0,0
46632,<,0,0
46633,or,0,0
46634,=10,0,0
46635,mmol/L,0,0
46636,),0,0
46637,.,0,0
46638,Insulin,0,0
46639,sensitivity,0,0
46640,(,0,0
46641,primary,0,0
46642,end,0,0
46643,point,0,0
46644,),0,0
46645,was,0,0
46646,evaluated,0,0
46647,in,0,0
46648,terms,0,0
46649,of,0,0
46650,the,0,0
46651,Homeostasis,0,1
46652,Model,0,0
46653,Assessment,0,0
46654,for,0,0
46655,Insulin,0,0
46656,Sensitivity,0,0
46657,(,0,0
46658,HOMA-S,0,1
46659,),0,0
46660,",",0,0
46661,the,0,0
46662,Quantitative,0,0
46663,Insulin,0,0
46664,Sensitivity,0,0
46665,Check,0,0
46666,Index,0,0
46667,(,0,0
46668,QUICKI,0,1
46669,),0,0
46670,",",0,0
46671,and,0,0
46672,fasting,0,0
46673,serum,0,0
46674,insulin,0,0
46675,(,0,0
46676,FSI,0,0
46677,),0,1
46678,concentrations,0,0
46679,.,0,1
46680,Glycemic,0,0
46681,control,0,0
46682,was,0,0
46683,evaluated,0,0
46684,in,0,0
46685,terms,0,0
46686,of,0,0
46687,glycosylated,0,0
46688,hemoglobin,0,0
46689,(,0,0
46690,HbA,0,0
46691,(,0,1
46692,1c,0,0
46693,),0,1
46694,),0,1
46695,values,0,0
46696,and,0,0
46697,fasting,0,0
46698,plasma,0,0
46699,glucose,0,0
46700,(,0,0
46701,FPG,0,0
46702,),0,1
46703,concentrations,0,0
46704,.,0,1
46705,Patients,0,1
46706,were,0,0
46707,encouraged,0,0
46708,to,0,0
46709,maintain,0,0
46710,their,0,0
46711,individual,0,0
46712,diet,0,0
46713,and,0,0
46714,exercise,0,0
46715,regimens,0,0
46716,throughout,0,0
46717,the,0,0
46718,study,0,0
46719,.,0,0
46720,RESULTS,0,0
46721,Two,1,1
46722,hundred,1,1
46723,forty-four,1,1
46724,patients,1,1
46725,(,1,1
46726,125,1,1
46727,women,1,1
46728,",",1,1
46729,119,1,1
46730,men,1,1
46731,;,1,1
46732,all,1,0
46733,but,1,0
46734,1,1,0
46735,Hispanic,1,1
46736,),1,1
46737,were,1,0
46738,randomized,1,0
46739,to,0,0
46740,receive,0,0
46741,pioglitazone,0,0
46742,(,0,0
46743,n,0,1
46744,=,0,0
46745,121,0,1
46746,),0,0
46747,or,0,1
46748,glimepiride,0,0
46749,(,0,0
46750,n,0,1
46751,=,0,0
46752,123,0,1
46753,),0,0
46754,.,0,0
46755,In,0,0
46756,the,0,0
46757,intent-to-treat,0,0
46758,sample,0,1
46759,",",0,0
46760,pioglitazone,0,0
46761,and,0,0
46762,glimepirede,0,0
46763,produced,0,0
46764,comparable,0,0
46765,reductions,0,0
46766,in,0,0
46767,HbA,0,0
46768,(,0,1
46769,1c,0,0
46770,),0,0
46771,from,0,0
46772,baseline,0,0
46773,to,0,0
46774,the,0,0
46775,end,0,0
46776,of,0,0
46777,the,0,0
46778,study,0,0
46779,(,0,0
46780,-0.78,0,0
46781,%,0,0
46782,and,0,0
46783,-0.68,0,0
46784,%,0,0
46785,",",0,0
46786,respectively,0,0
46787,),0,0
46788,.,0,0
46789,The,0,0
46790,pioglitazone,0,0
46791,group,0,0
46792,had,0,0
46793,significantly,0,0
46794,higher,0,0
46795,HbA,0,0
46796,(,0,0
46797,1c,0,0
46798,),0,1
46799,values,0,0
46800,compared,0,0
46801,with,0,1
46802,the,0,0
46803,glimepiride,0,0
46804,group,0,0
46805,after,0,0
46806,12,0,0
46807,weeks,0,0
46808,of,0,0
46809,therapy,0,0
46810,(,0,0
46811,8.66,0,0
46812,%,0,0
46813,vs,0,0
46814,7.80,0,1
46815,%,0,0
46816,;,0,1
46817,P,0,0
46818,=,0,0
46819,0.007,0,0
46820,),0,0
46821,but,0,0
46822,had,0,0
46823,significantly,0,0
46824,lower,0,0
46825,values,0,0
46826,after,0,0
46827,52,0,1
46828,weeks,0,0
46829,(,0,1
46830,7.46,0,0
46831,%,0,0
46832,vs,0,0
46833,7.77,0,0
46834,%,0,0
46835,;,0,1
46836,P,0,0
46837,=,0,0
46838,0.027,0,0
46839,),0,0
46840,.,0,0
46841,Pioglitazone,0,0
46842,significantly,0,0
46843,reduced,0,0
46844,FPG,0,0
46845,compared,0,0
46846,with,0,1
46847,glimepiride,0,0
46848,(,0,0
46849,-0.6,0,0
46850,vs,0,0
46851,0.6,0,0
46852,mmol/L,0,0
46853,;,0,1
46854,P,0,0
46855,=,0,0
46856,0.01,0,0
46857,),0,1
46858,.,0,1
46859,Pioglitazone,0,0
46860,therapy,0,0
46861,was,0,0
46862,associated,0,0
46863,with,0,1
46864,significant,0,0
46865,increases,0,0
46866,in,0,0
46867,insulin,0,0
46868,sensitivity,0,0
46869,(,0,0
46870,reduced,0,0
46871,insulin,0,0
46872,resistance,0,0
46873,),0,0
46874,",",0,0
46875,whereas,0,0
46876,glimepiride,0,0
46877,had,0,0
46878,no,0,0
46879,effect,0,0
46880,.,0,0
46881,HOMA-S,0,0
46882,values,0,0
46883,changed,0,0
46884,18.0,0,0
46885,%,0,0
46886,for,0,0
46887,pioglitazone,0,0
46888,and,0,0
46889,-7.9,0,0
46890,%,0,0
46891,for,0,0
46892,glimepiride,0,0
46893,(,0,0
46894,P,0,0
46895,<,0,0
46896,0.001,0,0
46897,),0,0
46898,",",0,0
46899,QUICKI,0,0
46900,values,0,0
46901,changed,0,0
46902,a,0,0
46903,respective,0,0
46904,0.013,0,0
46905,and,0,0
46906,-0.007,0,0
46907,(,0,0
46908,P,0,0
46909,<,0,0
46910,0.001,0,0
46911,),0,0
46912,",",0,0
46913,and,0,0
46914,FSI,0,0
46915,values,0,0
46916,were,0,1
46917,-21.1,0,0
46918,and,0,0
46919,15.1,0,0
46920,pmol/L,0,0
46921,(,0,0
46922,P,0,0
46923,<,0,0
46924,0.001,0,0
46925,),0,0
46926,.,0,1
46927,Both,0,0
46928,drugs,0,0
46929,were,0,0
46930,well,0,0
46931,tolerated,0,0
46932,",",0,0
46933,with,0,1
46934,pioglitazone,0,0
46935,associated,0,0
46936,with,0,0
46937,more,0,0
46938,peripheral,0,0
46939,edema,0,0
46940,(,0,0
46941,number,0,0
46942,of,0,0
46943,treatment-emergent,0,1
46944,cases,0,1
46945,:,0,1
46946,35/121,0,1
46947,[,0,0
46948,28.9,0,0
46949,%,0,0
46950,],0,1
46951,vs,0,0
46952,17/123,0,1
46953,[,0,0
46954,13.8,0,0
46955,%,0,0
46956,],0,1
46957,;,0,0
46958,P,0,0
46959,=,0,0
46960,0.005,0,0
46961,),0,0
46962,and,0,0
46963,fewer,0,0
46964,hypoglycemic,0,1
46965,episodes,0,0
46966,(,0,1
46967,19,0,1
46968,[,0,0
46969,15.7,0,0
46970,%,0,0
46971,],0,1
46972,vs,0,0
46973,38,0,1
46974,[,0,0
46975,30.9,0,0
46976,%,0,0
46977,],0,1
46978,;,0,0
46979,P,0,0
46980,=,0,0
46981,0.024,0,0
46982,),0,0
46983,.,0,0
46984,The,0,0
46985,incidence,0,0
46986,of,0,0
46987,weight,0,0
46988,gain,0,0
46989,was,0,0
46990,not,0,0
46991,significantly,0,0
46992,different,0,0
46993,between,0,0
46994,treatment,0,1
46995,groups,0,0
46996,.,0,1
46997,CONCLUSIONS,0,0
46998,These,0,0
46999,data,0,0
47000,suggest,0,0
47001,that,0,0
47002,long-term,0,0
47003,treatment,0,0
47004,with,0,1
47005,pioglitazone,0,0
47006,enhances,0,0
47007,insulin,0,0
47008,sensitivity,0,0
47009,relative,0,0
47010,to,0,0
47011,glimepiride,0,0
47012,in,0,0
47013,Mexican,1,1
47014,patients,1,1
47015,with,1,1
47016,type,1,1
47017,2,1,1
47018,diabetes,1,1
47019,and,0,0
47020,that,0,0
47021,pioglitazone,0,0
47022,may,0,0
47023,have,0,0
47024,a,0,0
47025,more,0,0
47026,sustained,0,0
47027,antihyperglycemic,0,0
47028,effect,0,0
47029,.,0,1
47030,Registration,0,0
47031,accuracy,0,0
47032,of,0,0
47033,153Gd,0,0
47034,transmission,0,0
47035,images,0,0
47036,of,0,0
47037,the,0,0
47038,brain,0,0
47039,.,0,0
47040,PURPOSE,0,0
47041,The,0,0
47042,aim,0,0
47043,of,0,0
47044,the,0,0
47045,study,0,0
47046,was,0,0
47047,to,0,0
47048,determine,0,0
47049,the,0,0
47050,accuracy,0,0
47051,of,0,0
47052,non-rigid,0,1
47053,nine-parameter,0,0
47054,image,0,1
47055,registrations,0,0
47056,based,0,0
47057,on,0,0
47058,153Gd,0,0
47059,transmission,0,0
47060,computed,0,0
47061,tomography,0,0
47062,(,0,0
47063,TCT,0,0
47064,),0,0
47065,images,0,0
47066,as,0,0
47067,compared,0,0
47068,with,0,1
47069,those,0,0
47070,based,0,0
47071,on,0,0
47072,99mTc-ethyl,0,0
47073,cysteinate,0,0
47074,dimer,0,0
47075,(,0,0
47076,ECD,0,0
47077,),0,1
47078,images,0,0
47079,and,0,0
47080,to,0,0
47081,assess,0,0
47082,whether,0,0
47083,normalised,0,0
47084,mutual,0,0
47085,information,0,0
47086,(,0,0
47087,NMI,0,1
47088,),0,0
47089,or,0,0
47090,count,0,0
47091,difference,0,0
47092,(,0,0
47093,CD,0,1
47094,),0,0
47095,should,0,0
47096,be,0,0
47097,used,0,0
47098,.,0,0
47099,METHODS,0,0
47100,TCT,0,0
47101,and,0,0
47102,ECD,0,0
47103,data,0,0
47104,were,0,0
47105,acquired,0,1
47106,in,0,0
47107,25,1,0
47108,randomly,1,1
47109,selected,1,1
47110,patients,1,1
47111,.,1,1
47112,Emission,0,0
47113,images,0,0
47114,were,0,0
47115,registered,0,1
47116,to,0,0
47117,an,0,0
47118,ECD,0,0
47119,template,0,0
47120,with,0,1
47121,a,0,0
47122,CD,0,1
47123,cost,0,0
47124,function,0,0
47125,.,0,0
47126,The,0,0
47127,same,0,0
47128,registration,0,0
47129,parameters,0,0
47130,were,0,0
47131,applied,0,0
47132,to,0,0
47133,the,0,0
47134,transmission,0,0
47135,images,0,0
47136,to,0,0
47137,create,0,0
47138,a,0,0
47139,TCT,0,0
47140,template,0,0
47141,.,0,0
47142,All,0,0
47143,TCT,0,0
47144,images,0,0
47145,were,0,0
47146,registered,0,1
47147,to,0,0
47148,the,0,0
47149,TCT,0,0
47150,template,0,0
47151,and,0,0
47152,the,0,0
47153,same,0,0
47154,registration,0,0
47155,parameters,0,0
47156,were,0,0
47157,applied,0,0
47158,to,0,0
47159,the,0,0
47160,ECD,0,0
47161,images,0,0
47162,.,0,1
47163,The,0,0
47164,procedure,0,0
47165,was,0,0
47166,repeated,0,0
47167,with,0,1
47168,NMI,0,1
47169,as,0,0
47170,cost,0,0
47171,function,0,0
47172,.,0,0
47173,Accuracy,0,0
47174,of,0,0
47175,both,0,0
47176,ECD-based,0,0
47177,and,0,0
47178,TCT-based,0,0
47179,registrations,0,0
47180,was,0,0
47181,assessed,0,0
47182,by,0,0
47183,comparing,0,0
47184,the,0,0
47185,normalisation,0,0
47186,parameter,0,0
47187,values,0,0
47188,and,0,1
47189,regional,0,1
47190,activities,0,0
47191,in,0,0
47192,the,0,0
47193,spatially,0,0
47194,normalised,0,0
47195,ECD,0,0
47196,images,0,0
47197,",",0,0
47198,using,0,0
47199,a,0,0
47200,mixed-model,0,0
47201,analysis,0,0
47202,of,0,0
47203,variance,0,0
47204,(,0,0
47205,ANOVA,0,0
47206,),0,1
47207,.,0,0
47208,Scheffe,0,0
47209,post,0,0
47210,hoc,0,0
47211,tests,0,0
47212,were,0,1
47213,performed,0,0
47214,.,0,1
47215,RESULTS,0,0
47216,No,0,0
47217,significant,0,0
47218,differences,0,0
47219,were,0,1
47220,found,0,0
47221,between,0,0
47222,ECD/CD,0,1
47223,",",0,0
47224,ECD/NMI,0,1
47225,and,0,0
47226,TCT/CD,0,0
47227,",",0,0
47228,suggesting,0,0
47229,that,0,0
47230,ECD,0,0
47231,registration,0,0
47232,can,0,0
47233,be,0,0
47234,done,0,0
47235,with,0,0
47236,either,0,0
47237,CD,0,1
47238,or,0,0
47239,NMI,0,0
47240,",",0,0
47241,and,0,0
47242,that,0,0
47243,TCT,0,0
47244,registration,0,0
47245,using,0,0
47246,CD,0,0
47247,is,0,0
47248,equally,0,0
47249,as,0,0
47250,accurate,0,0
47251,as,0,0
47252,ECD,0,0
47253,registration,0,1
47254,.,0,0
47255,The,0,0
47256,accuracy,0,0
47257,of,0,0
47258,TCT,0,0
47259,registration,0,0
47260,with,0,1
47261,NMI,0,1
47262,was,0,0
47263,lower,0,0
47264,",",0,0
47265,with,0,1
47266,discrepancies,0,0
47267,occurring,0,1
47268,in,0,0
47269,the,0,0
47270,frontal,0,0
47271,inferior,0,0
47272,region,0,1
47273,and,0,0
47274,the,0,0
47275,cerebellum,0,0
47276,.,0,0
47277,The,0,0
47278,analysis,0,0
47279,of,0,0
47280,normalisation,0,0
47281,parameters,0,0
47282,indicated,0,0
47283,that,0,0
47284,z-scaling,0,0
47285,is,0,0
47286,underestimated,0,0
47287,and,0,0
47288,yz-rotation,0,0
47289,overestimated,0,0
47290,with,0,1
47291,TCT/NMI,0,0
47292,registration,0,1
47293,.,0,0
47294,CONCLUSION,0,0
47295,We,0,0
47296,conclude,0,0
47297,that,0,0
47298,ECD,0,0
47299,registrations,0,0
47300,with,0,1
47301,CD,0,1
47302,or,0,1
47303,NMI,0,0
47304,are,0,0
47305,as,0,0
47306,accurate,0,0
47307,as,0,0
47308,TCT,0,0
47309,registrations,0,0
47310,with,0,1
47311,CD,0,1
47312,and,0,0
47313,that,0,0
47314,TCT,0,0
47315,registrations,0,0
47316,with,0,1
47317,NMI,0,1
47318,should,0,0
47319,be,0,0
47320,avoided,0,0
47321,.,0,0
47322,Effect,0,0
47323,of,0,0
47324,the,0,0
47325,dietary,0,0
47326,approaches,0,0
47327,to,0,0
47328,stop,0,1
47329,hypertension,0,1
47330,diet,0,0
47331,and,0,0
47332,reduced,0,0
47333,sodium,0,0
47334,intake,0,0
47335,on,0,0
47336,blood,0,0
47337,pressure,0,0
47338,control,0,0
47339,.,0,0
47340,The,0,0
47341,authors,0,0
47342,hypothesized,0,0
47343,that,0,0
47344,the,0,0
47345,Dietary,0,0
47346,Approaches,0,0
47347,to,0,0
47348,Stop,0,0
47349,Hypertension,0,1
47350,(,0,0
47351,DASH,0,0
47352,),0,0
47353,diet,0,0
47354,and,0,0
47355,reduced,0,0
47356,sodium,0,0
47357,intake,0,0
47358,would,0,0
47359,control,0,0
47360,stage,0,1
47361,1,0,0
47362,hypertension,0,1
47363,and,0,0
47364,reduce,0,0
47365,high-normal,0,1
47366,blood,0,0
47367,pressure,0,0
47368,(,0,0
47369,BP,0,0
47370,),0,0
47371,to,0,0
47372,optimal,0,0
47373,levels,0,0
47374,.,0,1
47375,Adults,1,1
47376,with,1,1
47377,systolic,1,1
47378,BP,1,1
47379,120-159,1,1
47380,mm,1,0
47381,Hg,1,0
47382,and,1,0
47383,diastolic,1,1
47384,BP,1,0
47385,80-95,1,1
47386,mm,1,0
47387,Hg,1,0
47388,were,0,0
47389,randomly,0,1
47390,assigned,0,0
47391,to,0,0
47392,receive,0,0
47393,the,0,0
47394,DASH,0,0
47395,diet,0,0
47396,or,0,0
47397,a,0,0
47398,typical,0,1
47399,American,0,1
47400,(,0,0
47401,control,0,0
47402,),0,0
47403,diet,0,0
47404,",",0,0
47405,consuming,0,0
47406,three,0,0
47407,different,0,0
47408,sodium,0,0
47409,intakes,0,0
47410,(,0,0
47411,higher=142,0,0
47412,mmol/d,0,0
47413,",",0,0
47414,intermediate=107,0,0
47415,mmol/d,0,0
47416,",",0,0
47417,and,0,0
47418,lower=65,0,0
47419,mmol/d,0,0
47420,),0,0
47421,for,0,0
47422,30,0,1
47423,days,0,0
47424,each,0,1
47425,.,0,0
47426,BP,0,0
47427,control,0,0
47428,was,0,0
47429,defined,0,0
47430,as,0,0
47431,systolic,0,1
47432,BP,0,1
47433,<,0,0
47434,140,0,1
47435,mm,0,0
47436,Hg,0,0
47437,and,0,0
47438,diastolic,0,1
47439,BP,0,1
47440,<,0,0
47441,90,0,1
47442,mm,0,0
47443,Hg,0,0
47444,.,0,1
47445,Among,0,1
47446,subjects,1,1
47447,with,1,1
47448,hypertension,1,1
47449,at,1,0
47450,baseline,1,0
47451,",",0,0
47452,at,0,0
47453,higher,0,0
47454,sodium,0,0
47455,intake,0,0
47456,the,0,0
47457,DASH,0,0
47458,diet,0,0
47459,increased,0,0
47460,BP,0,0
47461,control,0,0
47462,two-fold,0,0
47463,over,0,0
47464,control,0,0
47465,(,0,0
47466,63,0,1
47467,%,0,0
47468,vs.,0,0
47469,32,0,1
47470,%,0,0
47471,;,0,1
47472,95,0,0
47473,%,0,0
47474,confidence,0,0
47475,interval,0,0
47476,",",0,0
47477,1.4-2.9,0,0
47478,),0,0
47479,.,0,0
47480,Reducing,0,0
47481,sodium,0,0
47482,intake,0,0
47483,in,0,0
47484,the,0,0
47485,control,0,0
47486,diet,0,0
47487,group,0,0
47488,increased,0,0
47489,BP,0,0
47490,control,0,1
47491,2.3-fold,0,0
47492,(,0,0
47493,74,0,1
47494,%,0,0
47495,vs.,0,0
47496,32,0,1
47497,%,0,0
47498,;,0,1
47499,95,0,0
47500,%,0,0
47501,confidence,0,0
47502,interval,0,0
47503,",",0,0
47504,1.7-3.2,0,0
47505,),0,0
47506,.,0,0
47507,The,0,0
47508,maximum,0,0
47509,BP,0,0
47510,control,0,0
47511,rate,0,0
47512,(,0,0
47513,84,0,1
47514,%,0,0
47515,),0,0
47516,was,0,0
47517,achieved,0,0
47518,with,0,1
47519,the,0,0
47520,DASH/lower,0,0
47521,sodium,0,0
47522,diet,0,0
47523,.,0,1
47524,BP,0,0
47525,became,0,0
47526,normal,0,1
47527,or,0,1
47528,optimal,0,0
47529,in,0,0
47530,71,0,1
47531,%,0,0
47532,of,0,0
47533,persons,0,1
47534,consuming,0,0
47535,the,0,0
47536,control/lower,0,0
47537,sodium,0,0
47538,diet,0,0
47539,and,0,0
47540,77,0,1
47541,%,0,0
47542,of,0,0
47543,persons,0,1
47544,consuming,0,0
47545,the,0,0
47546,DASH/lower,0,0
47547,sodium,0,0
47548,diet,0,0
47549,.,0,0
47550,Both,0,0
47551,the,0,0
47552,DASH,0,0
47553,diet,0,0
47554,and,0,0
47555,reduced,0,0
47556,sodium,0,0
47557,intake,0,0
47558,improved,0,0
47559,BP,0,0
47560,control,0,1
47561,.,0,1
47562,Effect,0,0
47563,of,0,0
47564,the,0,0
47565,motilin,0,0
47566,agonist,0,0
47567,KC,0,1
47568,11458,0,1
47569,on,0,0
47570,gastric,0,1
47571,emptying,0,0
47572,in,0,0
47573,diabetic,0,1
47574,gastroparesis,0,1
47575,.,0,1
47576,BACKGROUND,0,0
47577,KC,0,1
47578,11458,0,0
47579,",",0,0
47580,a,0,0
47581,motilin,0,0
47582,agonist,0,0
47583,without,0,1
47584,antibiotic,0,0
47585,properties,0,0
47586,",",0,0
47587,accelerates,0,0
47588,gastric,0,0
47589,emptying,0,0
47590,in,0,0
47591,animals,1,1
47592,and,1,1
47593,healthy,1,1
47594,humans,1,1
47595,.,1,1
47596,AIM,0,0
47597,To,0,0
47598,evaluate,0,0
47599,the,0,0
47600,acute,0,1
47601,effects,0,0
47602,of,0,1
47603,KC,0,1
47604,11458,0,1
47605,on,0,0
47606,gastric,0,1
47607,emptying,0,0
47608,in,0,0
47609,diabetic,0,1
47610,gastroparesis,0,1
47611,.,0,1
47612,METHODS,0,0
47613,Twenty-nine,1,1
47614,patients,1,1
47615,(,1,1
47616,6,1,0
47617,type,1,1
47618,1,1,0
47619,and,1,0
47620,23,1,1
47621,type,1,1
47622,2,1,0
47623,),1,0
47624,with,1,1
47625,gastroparesis,1,1
47626,underwent,0,1
47627,assessments,0,0
47628,of,0,1
47629,:,0,1
47630,(,0,0
47631,i,0,0
47632,),0,0
47633,gastric,0,0
47634,emptying,0,0
47635,of,0,0
47636,a,0,0
47637,solid/liquid,0,0
47638,meal,0,0
47639,using,0,0
47640,scintigraphy,0,0
47641,",",0,0
47642,(,0,0
47643,ii,0,0
47644,),0,0
47645,glycaemic,0,0
47646,control,0,0
47647,(,0,0
47648,blood,0,0
47649,glucose,0,0
47650,at,0,0
47651,0,0,0
47652,",",0,0
47653,30,0,0
47654,",",0,0
47655,60,0,1
47656,",",0,0
47657,90,0,0
47658,and,0,0
47659,120,0,1
47660,min,0,0
47661,during,0,0
47662,the,0,0
47663,gastric,0,1
47664,emptying,0,0
47665,measurement,0,0
47666,),0,0
47667,and,0,0
47668,(,0,0
47669,iii,0,0
47670,),0,0
47671,upper,0,0
47672,gastrointestinal,0,1
47673,and,0,0
47674,'meal-related,0,0
47675,',0,1
47676,symptoms,0,0
47677,(,0,0
47678,questionnaire,0,0
47679,),0,0
47680,",",0,0
47681,at,1,0
47682,baseline,1,0
47683,and,1,0
47684,after,1,0
47685,treatment,1,0
47686,with,1,1
47687,KC,1,1
47688,11458,1,1
47689,in,1,0
47690,a,1,0
47691,dose,1,0
47692,of,1,0
47693,8,1,0
47694,mg,1,0
47695,t.d.s.,1,0
47696,",",0,0
47697,or,1,0
47698,placebo,1,0
47699,for,1,0
47700,8,1,0
47701,days,1,0
47702,.,1,1
47703,RESULTS,0,0
47704,KC,0,1
47705,11458,0,0
47706,had,0,0
47707,no,0,0
47708,statistically,0,0
47709,significant,0,0
47710,or,0,0
47711,clinically,0,0
47712,relevant,0,0
47713,effect,0,0
47714,on,0,0
47715,gastric,0,1
47716,emptying,0,0
47717,of,0,0
47718,either,0,0
47719,the,0,0
47720,solid,0,0
47721,intragastric,0,0
47722,retention,0,0
47723,at,0,0
47724,100,0,0
47725,min,0,0
47726,(,0,0
47727,T100,0,0
47728,),0,0
47729,(,0,0
47730,P,0,0
47731,=,0,0
47732,0.87,0,0
47733,),0,0
47734,or,0,1
47735,liquid,0,0
47736,50,0,1
47737,%,0,0
47738,emptying,0,0
47739,time,0,0
47740,(,0,0
47741,T50,0,0
47742,),0,0
47743,(,0,0
47744,P,0,0
47745,=,0,0
47746,0.17,0,0
47747,),0,1
47748,components,0,0
47749,of,0,0
47750,the,0,0
47751,meal,0,0
47752,.,0,0
47753,KC,0,1
47754,11458,0,0
47755,slightly,0,0
47756,worsened,0,0
47757,(,0,0
47758,P,0,0
47759,=,0,0
47760,0.04,0,0
47761,),0,0
47762,upper,0,1
47763,gastrointestinal,0,1
47764,symptoms,0,0
47765,when,0,0
47766,compared,0,0
47767,with,0,0
47768,placebo,0,0
47769,.,0,0
47770,The,0,0
47771,magnitude,0,0
47772,of,0,0
47773,the,0,0
47774,change,0,0
47775,in,0,0
47776,solid,0,1
47777,gastric,0,1
47778,emptying,0,0
47779,correlated,0,0
47780,with,0,1
47781,the,0,0
47782,change,0,0
47783,in,0,0
47784,the,0,0
47785,blood,0,0
47786,glucose,0,0
47787,concentration,0,0
47788,(,0,0
47789,r,0,0
47790,=,0,0
47791,0.49,0,0
47792,;,0,0
47793,P,0,0
47794,<,0,0
47795,0.05,0,0
47796,),0,1
47797,.,0,1
47798,CONCLUSIONS,0,0
47799,KC,0,1
47800,11458,0,0
47801,",",0,0
47802,in,0,0
47803,a,0,0
47804,dose,0,0
47805,of,0,0
47806,8,0,0
47807,mg,0,0
47808,t.d.s,0,0
47809,.,0,0
47810,for,0,0
47811,8,0,0
47812,days,0,0
47813,",",0,0
47814,does,0,0
47815,not,0,0
47816,accelerate,0,0
47817,gastric,0,0
47818,emptying,0,0
47819,in,0,0
47820,patients,0,1
47821,with,0,1
47822,diabetic,0,1
47823,gastroparesis,0,1
47824,.,0,0
47825,The,0,0
47826,absence,0,0
47827,of,0,0
47828,efficacy,0,0
47829,may,0,0
47830,relate,0,0
47831,to,0,0
47832,an,0,0
47833,effect,0,0
47834,of,0,0
47835,hyperglycaemia,0,1
47836,.,0,1
47837,Gonadotropin-releasing,1,0
47838,hormone,1,0
47839,agonist,1,0
47840,with,1,1
47841,or,1,0
47842,without,1,1
47843,raloxifene,1,1
47844,:,1,1
47845,effects,0,0
47846,on,0,0
47847,cognition,0,0
47848,",",0,0
47849,mood,0,0
47850,",",0,0
47851,and,0,0
47852,quality,0,0
47853,of,0,0
47854,life,0,0
47855,.,0,1
47856,Caudal,0,0
47857,neostigmine,0,0
47858,with,0,0
47859,bupivacaine,0,0
47860,produces,0,0
47861,a,0,0
47862,dose-independent,0,0
47863,analgesic,0,0
47864,effect,0,0
47865,in,0,0
47866,children,1,1
47867,.,1,1
47868,PURPOSE,0,0
47869,To,0,0
47870,evaluate,0,0
47871,the,0,0
47872,analgesic,0,0
47873,efficacy,0,0
47874,and,0,0
47875,duration,0,0
47876,of,0,0
47877,varying,0,0
47878,doses,0,0
47879,of,0,0
47880,caudal,0,0
47881,neostigmine,0,0
47882,with,0,1
47883,plain,0,0
47884,bupivacaine,0,0
47885,and,0,0
47886,its,0,0
47887,side,0,0
47888,effects,0,0
47889,in,0,0
47890,children,1,1
47891,undergoing,1,1
47892,genito-urinary,1,1
47893,surgery,1,1
47894,.,1,0
47895,METHODS,0,0
47896,In,0,0
47897,a,0,0
47898,randomized,0,0
47899,double-blind,0,0
47900,prospective,0,1
47901,study,0,1
47902,80,1,1
47903,boys,1,1
47904,aged,1,1
47905,two,1,0
47906,to,1,0
47907,eight,1,1
47908,years,1,1
47909,scheduled,1,1
47910,for,1,0
47911,surgical,1,0
47912,repair,1,1
47913,of,1,0
47914,hypospadias,1,1
47915,were,1,0
47916,allocated,1,1
47917,randomly,1,1
47918,to,0,0
47919,one,0,0
47920,of,0,0
47921,four,0,1
47922,groups,0,0
47923,(,0,1
47924,n,0,1
47925,=,0,0
47926,20,0,0
47927,each,0,0
47928,),0,0
47929,and,0,0
47930,received,0,0
47931,either,0,0
47932,only,0,0
47933,caudal,1,0
47934,0.25,1,0
47935,%,1,0
47936,plain,1,0
47937,bupivacaine,1,0
47938,0.5,1,0
47939,mL.kg,1,0
47940,(,1,0
47941,-1,1,0
47942,),1,0
47943,(,1,0
47944,Group,1,1
47945,I,1,1
47946,),1,0
47947,or,0,1
47948,0.25,1,0
47949,%,1,0
47950,plain,1,0
47951,bupivacaine,1,0
47952,0.5,1,0
47953,mL.kg,1,0
47954,(,1,0
47955,-1,1,0
47956,),1,0
47957,with,1,1
47958,neostigmine,1,0
47959,(,1,0
47960,Groups,1,0
47961,II-IV,1,1
47962,),1,0
47963,in,0,0
47964,doses,0,0
47965,of,0,0
47966,2,0,1
47967,",",0,0
47968,3,0,0
47969,and,0,0
47970,4,0,0
47971,microg.kg,0,0
47972,(,0,0
47973,-1,0,0
47974,),0,0
47975,respectively,0,0
47976,.,0,0
47977,Postoperative,0,0
47978,pain,0,0
47979,was,0,0
47980,assessed,0,0
47981,for,0,0
47982,24,0,0
47983,hr,0,0
47984,using,0,0
47985,an,0,0
47986,objective,0,0
47987,pain,0,1
47988,score,0,0
47989,.,0,0
47990,Blood,0,0
47991,pressure,0,0
47992,",",0,0
47993,heart,0,1
47994,rate,0,0
47995,",",0,0
47996,oxygen,0,0
47997,saturation,0,0
47998,",",0,0
47999,total,0,1
48000,amount,0,0
48001,of,0,0
48002,analgesic,0,0
48003,consumed,0,1
48004,and,0,0
48005,adverse,0,0
48006,effects,0,0
48007,were,0,1
48008,also,0,0
48009,recorded,0,0
48010,.,0,0
48011,RESULTS,0,0
48012,The,0,0
48013,duration,0,0
48014,of,0,0
48015,postoperative,0,0
48016,analgesia,0,0
48017,in,0,0
48018,Group,0,1
48019,I,0,1
48020,(,0,0
48021,5.1,0,0
48022,+/-,0,0
48023,2.3,0,0
48024,hr,0,0
48025,),0,0
48026,was,0,0
48027,significantly,0,0
48028,shorter,0,0
48029,than,0,0
48030,in,0,0
48031,the,0,0
48032,other,0,0
48033,three,0,0
48034,groups,0,0
48035,(,0,1
48036,II,0,1
48037,-16.6,0,0
48038,+/-,0,0
48039,4.9,0,0
48040,hr,0,0
48041,;,0,1
48042,III,0,1
48043,-,0,1
48044,17.2,0,0
48045,+/-,0,0
48046,5.5,0,1
48047,hr,0,0
48048,;,0,1
48049,IV,0,1
48050,-,0,1
48051,17.0,0,0
48052,+/-,0,0
48053,5.8,0,0
48054,hr,0,0
48055,;,0,1
48056,P,0,0
48057,<,0,0
48058,0.05,0,0
48059,),0,1
48060,.,0,1
48061,Total,0,0
48062,analgesic,0,0
48063,(,0,0
48064,paracetamol,0,0
48065,),0,0
48066,consumption,0,0
48067,was,0,0
48068,significantly,0,0
48069,more,0,0
48070,in,0,0
48071,Group,0,0
48072,I,0,1
48073,(,0,0
48074,697.6,0,0
48075,+/-,0,0
48076,240.7,0,0
48077,mg,0,0
48078,),0,0
48079,than,0,0
48080,in,0,0
48081,the,0,0
48082,groups,0,0
48083,receiving,0,1
48084,caudal,0,0
48085,neostigmine,0,0
48086,(,0,1
48087,II,0,1
48088,-,0,1
48089,248.0,0,0
48090,+/-,0,0
48091,178.4,0,0
48092,;,0,1
48093,III,0,1
48094,-,0,1
48095,270.2,0,0
48096,+/-,0,0
48097,180.8,0,0
48098,and,0,1
48099,IV,0,1
48100,-230.6,0,0
48101,+/-,0,0
48102,166.9,0,1
48103,mg,0,0
48104,;,0,1
48105,P,0,0
48106,<,0,0
48107,0.05,0,0
48108,),0,1
48109,.,0,1
48110,Groups,0,0
48111,II,0,0
48112,",",0,0
48113,III,0,1
48114,and,0,0
48115,IV,0,0
48116,were,0,0
48117,comparable,0,0
48118,with,0,1
48119,regards,0,0
48120,to,0,0
48121,duration,0,0
48122,of,0,0
48123,postoperative,0,0
48124,analgesia,0,0
48125,and,0,0
48126,total,0,1
48127,analgesic,0,0
48128,consumption,0,0
48129,(,0,0
48130,P,0,0
48131,>,0,1
48132,0.05,0,0
48133,),0,0
48134,.,0,0
48135,Incidence,0,0
48136,of,0,0
48137,nausea,0,0
48138,and,0,0
48139,vomiting,0,0
48140,were,0,0
48141,comparable,0,0
48142,in,0,0
48143,all,0,1
48144,four,0,1
48145,groups,0,0
48146,.,0,1
48147,No,0,0
48148,significant,0,0
48149,alteration,0,0
48150,in,0,0
48151,vital,0,0
48152,signs,0,0
48153,or,0,1
48154,any,0,0
48155,other,0,0
48156,adverse,0,0
48157,effects,0,0
48158,were,0,1
48159,observed,0,0
48160,.,0,1
48161,CONCLUSIONS,0,0
48162,Caudal,0,0
48163,neostigmine,0,0
48164,(,0,0
48165,2,0,0
48166,",",0,0
48167,3,0,0
48168,and,0,0
48169,4,0,0
48170,microg.kg,0,0
48171,(,0,0
48172,-1,0,0
48173,),0,0
48174,),0,0
48175,with,0,0
48176,bupivacaine,0,0
48177,produces,0,0
48178,a,0,0
48179,dose-independent,0,0
48180,analgesic,0,0
48181,effect,0,0
48182,(,0,0
48183,approximately,0,0
48184,16-17,0,1
48185,hr,0,0
48186,),0,0
48187,in,0,0
48188,children,0,1
48189,as,0,0
48190,compared,0,0
48191,to,0,0
48192,those,0,0
48193,receiving,0,0
48194,caudal,0,0
48195,bupivacaine,0,0
48196,alone,0,0
48197,(,0,0
48198,approximately,0,0
48199,five,0,1
48200,hours,0,0
48201,),0,1
48202,and,0,0
48203,a,0,0
48204,reduction,0,0
48205,in,0,0
48206,postoperative,0,0
48207,rescue,0,0
48208,analgesic,0,0
48209,consumption,0,0
48210,without,0,1
48211,increasing,0,0
48212,the,0,0
48213,incidence,0,0
48214,of,0,0
48215,adverse,0,0
48216,effects,0,0
48217,.,0,1
48218,Peripheral,0,0
48219,arterial,0,1
48220,disease,0,1
48221,:,0,1
48222,therapeutic,0,0
48223,confidence,0,0
48224,of,0,0
48225,CT,0,1
48226,versus,0,0
48227,digital,0,0
48228,subtraction,0,0
48229,angiography,0,0
48230,and,0,0
48231,effects,0,0
48232,on,0,0
48233,additional,0,0
48234,imaging,0,1
48235,recommendations,0,0
48236,.,0,1
48237,PURPOSE,0,0
48238,To,0,0
48239,compare,0,0
48240,multi-detector,0,0
48241,row,0,0
48242,computed,0,0
48243,tomographic,0,0
48244,(,0,0
48245,CT,0,1
48246,),0,0
48247,angiography,0,0
48248,and,0,0
48249,digital,0,0
48250,subtraction,0,0
48251,angiography,0,0
48252,(,0,0
48253,DSA,0,1
48254,),0,0
48255,prior,0,0
48256,to,0,0
48257,revascularization,0,0
48258,in,0,0
48259,patients,1,1
48260,with,1,1
48261,symptomatic,1,1
48262,peripheral,1,1
48263,arterial,1,1
48264,disease,1,1
48265,for,0,0
48266,the,0,0
48267,purpose,0,0
48268,of,0,0
48269,assessing,0,0
48270,recommendations,0,0
48271,for,0,0
48272,additional,0,0
48273,imaging,0,0
48274,and,0,0
48275,physician,0,0
48276,confidence,0,0
48277,ratings,0,0
48278,for,0,0
48279,chosen,0,0
48280,therapy,0,0
48281,.,0,0
48282,MATERIALS,0,0
48283,AND,0,0
48284,METHODS,0,0
48285,In,0,0
48286,a,0,0
48287,randomized,0,0
48288,controlled,0,0
48289,trial,0,0
48290,",",0,0
48291,73,1,1
48292,patients,1,1
48293,were,1,1
48294,assigned,1,1
48295,to,1,0
48296,CT,1,0
48297,angiography,1,0
48298,",",1,0
48299,and,1,0
48300,72,1,0
48301,were,1,0
48302,assigned,1,1
48303,to,1,0
48304,DSA,1,1
48305,.,1,1
48306,Physician,0,0
48307,confidence,0,0
48308,in,0,0
48309,the,0,0
48310,treatment,0,0
48311,decision,0,0
48312,was,0,0
48313,measured,0,0
48314,as,0,0
48315,a,0,0
48316,continuous,0,0
48317,outcome,0,0
48318,on,0,0
48319,a,0,0
48320,scale,0,0
48321,of,0,0
48322,0-10,0,0
48323,(,0,0
48324,uncertain,0,0
48325,to,0,0
48326,certain,0,0
48327,),0,0
48328,and,0,0
48329,as,0,0
48330,a,0,0
48331,dichotomous,0,0
48332,outcome,0,0
48333,(,0,0
48334,further,0,0
48335,imaging,0,0
48336,recommended,0,0
48337,",",0,0
48338,yes,0,0
48339,or,0,0
48340,no,0,0
48341,),0,0
48342,.,0,0
48343,Mean,0,0
48344,confidence,0,0
48345,scores,0,0
48346,and,0,0
48347,additional,0,0
48348,imaging,0,1
48349,recommendations,0,0
48350,were,0,0
48351,compared,0,0
48352,between,0,0
48353,CT,0,0
48354,and,0,1
48355,DSA,0,1
48356,groups,0,0
48357,in,0,0
48358,an,0,0
48359,intention-to-diagnose-and-treat,0,0
48360,analysis,0,0
48361,.,0,0
48362,To,0,0
48363,detect,0,0
48364,trends,0,0
48365,in,0,0
48366,confidence,0,0
48367,",",0,0
48368,confidence,0,0
48369,scores,0,0
48370,were,0,0
48371,plotted,0,0
48372,over,0,0
48373,time,0,0
48374,",",0,0
48375,and,0,0
48376,multiple,0,0
48377,linear,0,0
48378,regression,0,0
48379,analysis,0,0
48380,was,0,0
48381,performed,0,0
48382,.,0,0
48383,To,0,0
48384,detect,0,0
48385,trends,0,0
48386,in,0,0
48387,additional,0,0
48388,imaging,0,1
48389,recommendations,0,0
48390,",",0,0
48391,logistic,0,0
48392,regression,0,0
48393,analysis,0,0
48394,was,0,0
48395,used,0,0
48396,.,0,1
48397,Data,0,0
48398,from,0,1
48399,eligible,0,1
48400,nonrandomized,0,1
48401,patients,0,1
48402,were,0,0
48403,analyzed,0,0
48404,separately,0,0
48405,.,0,0
48406,RESULTS,0,0
48407,No,0,0
48408,statistically,0,0
48409,significant,0,0
48410,difference,0,0
48411,in,0,0
48412,baseline,0,0
48413,characteristics,0,0
48414,between,0,0
48415,randomized,0,1
48416,groups,0,0
48417,was,0,0
48418,found,0,0
48419,.,0,1
48420,CT,0,0
48421,had,0,0
48422,a,0,0
48423,lower,0,0
48424,confidence,0,0
48425,score,0,0
48426,than,0,0
48427,did,0,0
48428,DSA,0,1
48429,(,0,0
48430,7.2,0,0
48431,vs,0,0
48432,8.2,0,0
48433,",",0,0
48434,P,0,0
48435,<,0,0
48436,.001,0,0
48437,),0,0
48438,.,0,0
48439,Further,0,0
48440,imaging,0,0
48441,was,0,0
48442,recommended,0,0
48443,more,0,0
48444,often,0,0
48445,after,0,0
48446,CT,0,0
48447,(,0,0
48448,25,0,1
48449,of,0,0
48450,71,0,1
48451,patients,0,1
48452,",",0,1
48453,35,0,1
48454,%,0,0
48455,),0,0
48456,than,0,0
48457,after,0,0
48458,DSA,0,1
48459,(,0,0
48460,nine,0,1
48461,of,0,0
48462,66,0,1
48463,patients,0,1
48464,",",0,1
48465,14,0,1
48466,%,0,0
48467,;,0,1
48468,P,0,0
48469,=,0,0
48470,.003,0,0
48471,),0,0
48472,.,0,0
48473,Analysis,0,0
48474,of,0,0
48475,trends,0,0
48476,demonstrated,0,0
48477,increasing,0,0
48478,(,0,0
48479,but,0,0
48480,not,0,0
48481,statistically,0,0
48482,significant,0,0
48483,),0,0
48484,confidence,0,0
48485,in,0,0
48486,CT,0,0
48487,and,0,0
48488,stable,0,1
48489,confidence,0,0
48490,in,0,0
48491,DSA,0,1
48492,.,0,1
48493,No,0,0
48494,significant,0,0
48495,difference,0,0
48496,was,0,0
48497,found,0,0
48498,in,0,0
48499,baseline,0,0
48500,characteristics,0,0
48501,between,0,0
48502,randomized,0,1
48503,and,0,0
48504,nonrandomized,0,1
48505,patients,0,1
48506,.,0,1
48507,Among,0,1
48508,nonrandomized,0,0
48509,patients,0,1
48510,",",0,0
48511,no,0,0
48512,significant,0,0
48513,difference,0,0
48514,in,0,0
48515,mean,0,0
48516,confidence,0,0
48517,score,0,0
48518,(,0,0
48519,8.2,0,0
48520,vs,0,0
48521,8.3,0,0
48522,",",0,0
48523,P,0,0
48524,=,0,0
48525,.26,0,0
48526,),0,0
48527,was,0,0
48528,found,0,0
48529,between,0,0
48530,CT,0,0
48531,(,0,1
48532,n,0,1
48533,=,0,0
48534,24,0,1
48535,),0,0
48536,and,0,0
48537,DSA,0,1
48538,(,0,0
48539,n,0,1
48540,=,0,0
48541,26,0,1
48542,),0,0
48543,.,0,0
48544,CONCLUSION,0,0
48545,With,0,1
48546,CT,0,0
48547,angiography,0,0
48548,",",0,0
48549,physician,0,0
48550,confidence,0,0
48551,decreases,0,0
48552,with,0,1
48553,an,0,0
48554,associated,0,0
48555,increase,0,0
48556,in,0,0
48557,additional,0,0
48558,imaging,0,0
48559,prior,0,0
48560,to,0,0
48561,revascularization,0,0
48562,in,0,0
48563,patients,1,1
48564,with,1,1
48565,symptomatic,1,1
48566,peripheral,1,1
48567,arterial,1,1
48568,disease,1,1
48569,.,1,0
48570,Given,0,0
48571,that,0,0
48572,CT,0,0
48573,is,0,0
48574,less,0,0
48575,invasive,0,0
48576,than,0,0
48577,DSA,0,1
48578,",",0,0
48579,results,0,0
48580,suggest,0,0
48581,that,0,0
48582,CT,0,0
48583,may,0,0
48584,replace,0,0
48585,DSA,0,1
48586,in,0,0
48587,selected,0,1
48588,cases,0,1
48589,.,0,1
48590,Parent,1,1
48591,management,1,0
48592,training,1,0
48593,and,1,0
48594,Asperger,1,1
48595,syndrome,1,1
48596,:,1,1
48597,a,0,0
48598,randomized,0,0
48599,controlled,0,0
48600,trial,0,0
48601,to,0,0
48602,evaluate,0,0
48603,a,0,0
48604,parent,1,0
48605,based,1,0
48606,intervention,0,0
48607,.,0,0
48608,This,0,0
48609,controlled,0,0
48610,trial,0,0
48611,of,0,0
48612,a,0,0
48613,parent,0,0
48614,management,0,0
48615,intervention,0,0
48616,aimed,0,0
48617,to,0,0
48618,increase,0,0
48619,parental,0,0
48620,competence,0,0
48621,in,0,0
48622,management,0,0
48623,of,0,0
48624,problem,0,0
48625,behaviours,0,0
48626,associated,0,0
48627,with,0,1
48628,Asperger,1,1
48629,syndrome,1,1
48630,.,1,0
48631,The,0,0
48632,intervention,0,0
48633,compared,0,0
48634,two,0,0
48635,formats,0,0
48636,",",0,0
48637,a,0,0
48638,1,0,0
48639,day,0,0
48640,workshop,0,1
48641,and,0,0
48642,six,0,1
48643,individual,0,0
48644,sessions,0,0
48645,.,0,1
48646,Measures,0,0
48647,were,0,0
48648,taken,0,0
48649,on,0,0
48650,three,0,1
48651,occasions,0,0
48652,:,0,1
48653,pre-intervention,0,0
48654,",",0,0
48655,at,0,0
48656,4,0,0
48657,weeks,0,0
48658,",",0,0
48659,and,0,0
48660,at,0,0
48661,3,0,0
48662,month,0,0
48663,follow-up,0,0
48664,.,0,0
48665,Variables,0,0
48666,of,0,0
48667,interest,0,0
48668,were,0,0
48669,number,0,0
48670,and,0,0
48671,intensity,0,0
48672,of,0,0
48673,problem,0,0
48674,behaviours,0,0
48675,",",0,0
48676,and,0,0
48677,parent,0,0
48678,evaluation,0,0
48679,of,0,0
48680,social,0,0
48681,interaction,0,1
48682,skills,0,0
48683,.,0,1
48684,Results,0,0
48685,showed,0,0
48686,parents,0,1
48687,reporting,0,0
48688,fewer,0,0
48689,and,0,0
48690,lower,0,0
48691,intensity,0,0
48692,of,0,0
48693,problem,0,0
48694,behaviours,0,0
48695,and,0,0
48696,increased,0,0
48697,social,0,0
48698,interactions,0,0
48699,at,0,1
48700,4,0,0
48701,weeks,0,0
48702,and,0,1
48703,3,0,1
48704,months,0,0
48705,.,0,1
48706,Results,0,0
48707,held,0,0
48708,across,0,0
48709,formats,0,0
48710,and,0,0
48711,suggest,0,0
48712,that,0,0
48713,parent,0,0
48714,management,0,0
48715,training,0,0
48716,can,0,0
48717,provide,0,0
48718,an,0,0
48719,effective,0,0
48720,intervention,0,0
48721,for,0,0
48722,parents,1,1
48723,of,1,0
48724,a,1,0
48725,child,1,0
48726,with,1,1
48727,Asperger,1,1
48728,syndrome,1,1
48729,.,1,0
48730,Group,0,0
48731,differences,0,0
48732,on,0,0
48733,outcome,0,0
48734,measures,0,0
48735,and,0,0
48736,in,0,0
48737,the,0,0
48738,use,0,0
48739,of,0,0
48740,strategies,0,0
48741,are,0,0
48742,discussed,0,0
48743,along,0,0
48744,with,0,1
48745,limitations,0,0
48746,of,0,0
48747,the,0,0
48748,study,0,0
48749,.,0,0
48750,Absorption,0,0
48751,of,0,0
48752,intramuscular,0,0
48753,phenobarbitone,0,0
48754,in,0,0
48755,children,1,1
48756,with,1,1
48757,severe,1,1
48758,falciparum,1,1
48759,malaria,1,1
48760,.,1,0
48761,The,0,0
48762,absorption,0,0
48763,of,0,0
48764,intramuscular,0,0
48765,phenobarbitone,0,0
48766,7,0,1
48767,mg.kg-1,0,0
48768,was,0,0
48769,studied,0,1
48770,in,0,0
48771,11,1,1
48772,Karen,1,1
48773,children,1,1
48774,aged,1,1
48775,between,1,0
48776,1.7,1,0
48777,and,1,0
48778,11,1,0
48779,y,1,1
48780,with,1,1
48781,severe,1,1
48782,falciparum,1,1
48783,malaria,1,1
48784,.,1,0
48785,Eight,1,0
48786,of,1,0
48787,the,1,0
48788,children,1,1
48789,were,1,1
48790,comatose,1,1
48791,.,1,1
48792,Clinical,0,0
48793,findings,0,0
48794,were,0,1
48795,compared,0,0
48796,with,0,1
48797,those,0,0
48798,in,0,0
48799,9,1,0
48800,further,1,0
48801,children,1,1
48802,with,1,1
48803,severe,1,1
48804,malaria,1,1
48805,of,1,0
48806,similar,1,0
48807,age,1,1
48808,range,1,1
48809,(,1,0
48810,four,1,1
48811,of,1,1
48812,whom,1,1
48813,were,1,1
48814,unconscious,1,1
48815,),1,1
48816,",",0,1
48817,who,0,1
48818,received,0,1
48819,an,0,1
48820,identical,0,0
48821,placebo,0,0
48822,.,0,1
48823,One,0,0
48824,child,0,1
48825,",",0,1
48826,who,0,1
48827,had,0,1
48828,received,0,1
48829,placebo,0,0
48830,",",0,0
48831,had,0,0
48832,repeated,0,0
48833,convulsions,0,0
48834,and,0,0
48835,died,0,1
48836,1,0,0
48837,h,0,0
48838,after,0,0
48839,admission,0,1
48840,to,0,0
48841,hospital,0,1
48842,.,0,0
48843,The,0,0
48844,remainder,0,0
48845,made,0,0
48846,an,0,0
48847,uncomplicated,0,1
48848,recovery,0,0
48849,.,0,0
48850,There,0,0
48851,were,0,0
48852,no,0,0
48853,convulsions,0,0
48854,subsequent,0,0
48855,to,0,0
48856,treatment,0,0
48857,",",0,0
48858,although,0,0
48859,the,0,0
48860,study,0,0
48861,was,0,0
48862,too,0,0
48863,small,0,0
48864,to,0,0
48865,assess,0,0
48866,anticonvulsant,0,0
48867,efficacy,0,0
48868,.,0,0
48869,There,0,0
48870,was,0,0
48871,no,0,0
48872,observable,0,0
48873,toxicity,0,0
48874,",",0,0
48875,but,0,0
48876,phenobarbitone,0,0
48877,recipients,0,1
48878,had,0,1
48879,a,0,0
48880,significant,0,0
48881,tendency,0,0
48882,to,0,0
48883,deepen,0,0
48884,in,0,0
48885,their,0,0
48886,level,0,0
48887,of,0,0
48888,coma,0,1
48889,or,0,1
48890,to,0,0
48891,become,0,0
48892,sleepy,0,0
48893,within,0,0
48894,the,0,0
48895,4,0,0
48896,h,0,0
48897,after,0,0
48898,drug,0,0
48899,administration,0,0
48900,.,0,1
48901,Phenobarbitone,0,0
48902,was,0,0
48903,rapidly,0,0
48904,absorbed,0,0
48905,",",0,0
48906,reaching,0,0
48907,a,0,0
48908,mean,0,0
48909,(,0,0
48910,range,0,0
48911,),0,0
48912,peak,0,0
48913,concentration,0,0
48914,of,0,0
48915,34.2,0,1
48916,[,0,0
48917,29.3-42.6,0,0
48918,],0,1
48919,mumol.l-1,0,0
48920,in,0,0
48921,a,0,0
48922,median,0,0
48923,(,0,0
48924,range,0,0
48925,),0,0
48926,of,0,0
48927,4,0,0
48928,(,0,1
48929,2.5-12,0,1
48930,),0,0
48931,h.,0,1
48932,These,0,1
48933,values,0,0
48934,are,0,0
48935,comparable,0,0
48936,to,0,0
48937,those,0,0
48938,previously,0,0
48939,reported,0,0
48940,in,0,0
48941,healthy,0,1
48942,children,0,1
48943,and,0,1
48944,in,0,0
48945,children,0,1
48946,with,0,1
48947,febrile,0,1
48948,convulsions,0,1
48949,.,0,1
48950,Intramuscular,0,0
48951,phenobarbitone,0,0
48952,is,0,0
48953,well,0,0
48954,absorbed,0,0
48955,in,0,0
48956,children,1,1
48957,with,1,1
48958,severe,1,1
48959,malaria,1,1
48960,;,1,1
48961,the,0,0
48962,optimum,0,0
48963,prophylactic,0,0
48964,anticonvulsant,0,0
48965,dose,0,0
48966,remains,0,0
48967,to,0,0
48968,be,0,0
48969,determined,0,0
48970,.,0,0
48971,Creon,0,0
48972,"10,000",0,0
48973,Minimicrospheres,0,0
48974,vs.,0,0
48975,Creon,0,0
48976,"8,000",0,1
48977,microspheres,0,0
48978,--,0,1
48979,an,0,0
48980,open,0,1
48981,randomised,0,0
48982,crossover,0,0
48983,preference,0,0
48984,study,0,0
48985,.,0,1
48986,Creon,0,0
48987,"10,000",0,0
48988,Minimicrospherestrade,0,0
48989,mark,0,0
48990,(,0,0
48991,Creon,0,0
48992,),0,1
48993,"10,000",0,0
48994,MMS,0,1
48995,),0,0
48996,is,0,0
48997,a,0,0
48998,pancreatic,0,1
48999,enzyme,0,0
49000,formulation,0,0
49001,that,0,0
49002,contains,0,0
49003,smaller,0,0
49004,spheres,0,0
49005,of,0,0
49006,pancreatin,0,0
49007,in,0,0
49008,a,0,0
49009,50,0,0
49010,%,0,0
49011,smaller,0,0
49012,capsule,0,0
49013,than,0,0
49014,conventional,0,1
49015,microspheres,0,0
49016,(,0,1
49017,Creon,0,1
49018,),0,1
49019,"8,000",0,1
49020,),0,0
49021,.,0,0
49022,This,0,0
49023,three-centre,1,0
49024,study,1,0
49025,investigated,1,0
49026,the,1,0
49027,preference,1,0
49028,of,1,0
49029,cystic,1,1
49030,fibrosis,1,1
49031,(,1,0
49032,CF,1,0
49033,),1,1
49034,patients,1,1
49035,for,0,0
49036,these,0,0
49037,products,0,0
49038,.,0,1
49039,In,0,0
49040,one,0,0
49041,centre,0,1
49042,",",0,0
49043,72,0,0
49044,h,0,0
49045,stool,0,0
49046,fat,0,0
49047,excretion,0,0
49048,and,0,0
49049,coefficient,0,0
49050,of,0,0
49051,fat,0,0
49052,absorption,0,0
49053,(,0,0
49054,CFA,0,0
49055,),0,0
49056,were,0,0
49057,also,0,0
49058,compared,0,0
49059,.,0,0
49060,Fifty-nine,1,1
49061,patients,1,1
49062,with,1,1
49063,a,1,0
49064,mean,1,0
49065,age,1,1
49066,10,1,1
49067,years,1,1
49068,(,1,0
49069,range,1,1
49070,3-17,1,1
49071,),1,0
49072,took,0,1
49073,Creon,0,0
49074,"8,000",0,1
49075,ms,0,1
49076,for,0,0
49077,14,0,1
49078,days,0,0
49079,and,0,0
49080,were,0,0
49081,then,0,0
49082,randomised,0,0
49083,to,0,0
49084,28,0,1
49085,days,0,0
49086,of,0,1
49087,Creon,0,1
49088,"8,000",0,1
49089,ms,0,0
49090,followed,0,0
49091,by,0,0
49092,28,0,1
49093,days,0,0
49094,of,0,1
49095,Creon,0,1
49096,"10,000",0,0
49097,MMS,0,1
49098,",",0,0
49099,or,0,0
49100,vice,0,0
49101,versa,0,0
49102,.,0,1
49103,Dosing,0,0
49104,was,0,0
49105,lipase,0,0
49106,for,0,0
49107,lipase,0,0
49108,according,0,1
49109,to,0,0
49110,the,0,0
49111,labelled,0,0
49112,declaration,0,0
49113,.,0,0
49114,At,0,0
49115,the,0,0
49116,end,0,0
49117,of,0,0
49118,the,0,0
49119,second,0,0
49120,treatment,0,0
49121,period,0,0
49122,",",0,0
49123,51,1,1
49124,of,1,0
49125,54,1,1
49126,patients,1,1
49127,who,1,1
49128,completed,1,1
49129,the,1,1
49130,study,1,0
49131,expressed,0,0
49132,a,0,0
49133,preference,0,0
49134,",",0,0
49135,with,0,0
49136,a,0,0
49137,statistically,0,0
49138,significant,0,0
49139,preference,0,0
49140,in,0,0
49141,favour,0,0
49142,of,0,0
49143,Creon,0,0
49144,"10,000",0,1
49145,MMS,0,1
49146,(,0,1
49147,47/51,0,1
49148,;,0,1
49149,87,0,1
49150,%,0,0
49151,),0,0
49152,vs.,0,0
49153,Creon,0,0
49154,"8,000",0,1
49155,ms,0,1
49156,(,0,1
49157,4/51,0,0
49158,;,0,1
49159,7.4,0,0
49160,%,0,0
49161,;,0,1
49162,P,0,0
49163,<,0,0
49164,0.0001,0,0
49165,),0,1
49166,.,0,1
49167,Stool,0,0
49168,fat,0,0
49169,(,0,0
49170,g/day,0,0
49171,),0,0
49172,and,0,0
49173,CFA,0,0
49174,(,0,0
49175,%,0,0
49176,),0,0
49177,were,0,0
49178,measured,0,0
49179,in,0,0
49180,24,0,0
49181,patients,0,1
49182,at,0,0
49183,the,0,0
49184,end,0,0
49185,of,0,0
49186,each,0,0
49187,treatment,0,0
49188,period,0,0
49189,:,0,1
49190,the,0,0
49191,products,0,0
49192,were,0,0
49193,therapeutically,0,0
49194,equivalent,0,0
49195,(,0,0
49196,Creon,0,0
49197,"10,000",0,1
49198,:,0,1
49199,8.4,0,0
49200,g/day,0,0
49201,",",0,0
49202,91.3,0,0
49203,%,0,0
49204,CFA,0,0
49205,;,0,1
49206,Creon,0,0
49207,"8,000",0,1
49208,:,0,1
49209,6.7,0,0
49210,g/day,0,0
49211,",",0,0
49212,93.5,0,0
49213,%,0,0
49214,CFA,0,0
49215,),0,0
49216,.,0,0
49217,Both,0,0
49218,products,0,0
49219,were,0,0
49220,well,0,0
49221,tolerated,0,0
49222,.,0,0
49223,In,0,0
49224,conclusion,0,0
49225,",",0,0
49226,in,0,0
49227,CF,1,0
49228,children,1,1
49229,we,0,0
49230,found,0,0
49231,a,0,0
49232,clear,0,0
49233,preference,0,0
49234,for,0,0
49235,Creon,0,0
49236,"10,000",0,1
49237,MMS,0,1
49238,compared,0,0
49239,with,0,1
49240,Creon,0,0
49241,"8,000",0,1
49242,ms,0,0
49243,with,0,1
49244,no,0,0
49245,difference,0,0
49246,in,0,0
49247,fat,0,0
49248,absorption,0,0
49249,between,0,0
49250,the,0,0
49251,two,0,0
49252,products,0,0
49253,.,0,1
49254,Creon,0,0
49255,"10,000s",0,0
49256,smaller,0,0
49257,capsules,0,0
49258,are,0,0
49259,easier,0,0
49260,to,0,0
49261,take,0,0
49262,and,0,0
49263,should,0,0
49264,aid,0,0
49265,patient,0,0
49266,compliance,0,0
49267,.,0,1
49268,Recurrent,1,1
49269,tuberculosis,1,1
49270,in,1,0
49271,the,1,0
49272,United,1,1
49273,States,1,0
49274,and,1,1
49275,Canada,1,1
49276,:,1,1
49277,relapse,0,0
49278,or,0,1
49279,reinfection,0,0
49280,?,0,0
49281,Recurrence,0,0
49282,of,0,0
49283,active,1,1
49284,tuberculosis,1,1
49285,after,1,0
49286,treatment,1,0
49287,can,0,0
49288,be,0,0
49289,due,0,0
49290,to,0,0
49291,relapse,0,0
49292,of,0,0
49293,infection,0,0
49294,with,0,1
49295,the,0,0
49296,same,0,0
49297,strain,0,0
49298,or,0,0
49299,reinfection,0,0
49300,with,0,1
49301,a,0,0
49302,new,0,0
49303,strain,0,0
49304,of,0,0
49305,Mycobacterium,0,1
49306,tuberculosis,0,1
49307,.,0,0
49308,The,0,0
49309,proportion,0,0
49310,of,0,0
49311,recurrent,0,1
49312,tuberculosis,0,1
49313,cases,0,1
49314,caused,0,0
49315,by,0,0
49316,reinfection,0,0
49317,has,0,0
49318,varied,0,0
49319,widely,0,0
49320,in,0,0
49321,previous,0,0
49322,studies,0,0
49323,.,0,1
49324,We,0,0
49325,evaluated,0,0
49326,cases,0,1
49327,of,0,0
49328,recurrent,0,1
49329,tuberculosis,0,1
49330,in,0,0
49331,two,0,0
49332,prospective,0,1
49333,clinical,0,1
49334,trials,0,1
49335,:,0,1
49336,a,0,0
49337,randomized,0,0
49338,study,0,0
49339,of,0,0
49340,two,0,0
49341,regimens,0,0
49342,for,0,0
49343,the,0,0
49344,last,0,0
49345,4,0,0
49346,months,0,0
49347,of,0,0
49348,treatment,0,0
49349,(,1,0
49350,n,1,1
49351,=,1,0
49352,"1,075",1,1
49353,),1,0
49354,and,0,0
49355,a,0,0
49356,study,0,0
49357,of,0,0
49358,a,0,0
49359,twice-weekly,0,0
49360,rifabutin-containing,0,0
49361,regimen,0,0
49362,for,0,0
49363,human,1,1
49364,immunodeficiency,1,1
49365,virus-infected,1,1
49366,tuberculosis,1,1
49367,(,1,0
49368,n,1,1
49369,=,1,0
49370,169,1,1
49371,),1,0
49372,.,1,0
49373,Isolates,0,0
49374,at,0,0
49375,diagnosis,0,1
49376,and,0,0
49377,from,0,1
49378,positive,0,0
49379,cultures,0,0
49380,after,0,0
49381,treatment,0,0
49382,completion,0,0
49383,underwent,0,1
49384,genotyping,0,0
49385,using,0,0
49386,IS6110,0,0
49387,(,0,0
49388,with,0,1
49389,secondary,0,0
49390,genotyping,0,0
49391,for,0,0
49392,isolates,0,0
49393,with,0,1
49394,less,0,0
49395,than,0,0
49396,six,0,1
49397,copies,0,0
49398,of,0,1
49399,IS6110,0,1
49400,),0,0
49401,.,0,0
49402,Of,0,0
49403,85,1,1
49404,patients,1,1
49405,having,1,1
49406,a,1,0
49407,positive,1,0
49408,culture,1,0
49409,after,1,0
49410,completing,1,0
49411,treatment,1,0
49412,",",0,0
49413,6,0,0
49414,(,0,0
49415,7.1,0,0
49416,%,0,0
49417,),0,0
49418,were,0,0
49419,classified,0,1
49420,as,0,0
49421,false-positive,0,0
49422,cultures,0,0
49423,by,0,0
49424,a,0,0
49425,review,0,0
49426,committee,0,0
49427,blinded,0,0
49428,to,0,0
49429,treatment,0,0
49430,assignment,0,0
49431,.,0,0
49432,Of,0,0
49433,the,0,0
49434,remaining,0,0
49435,75,0,1
49436,cases,0,1
49437,with,0,1
49438,recurrent,0,1
49439,tuberculosis,0,1
49440,and,0,0
49441,genotyping,0,0
49442,data,0,0
49443,available,0,0
49444,",",0,0
49445,72,0,1
49446,(,0,0
49447,96,0,1
49448,%,0,0
49449,;,0,1
49450,95,0,0
49451,%,0,0
49452,confidence,0,0
49453,interval,0,0
49454,",",0,0
49455,88.8-99.2,0,0
49456,%,0,0
49457,),0,0
49458,paired,0,0
49459,isolates,0,0
49460,had,0,1
49461,the,0,0
49462,same,0,0
49463,genotype,0,0
49464,;,0,0
49465,only,0,0
49466,3,0,0
49467,(,0,0
49468,4,0,0
49469,%,0,0
49470,;,0,1
49471,95,0,0
49472,%,0,0
49473,confidence,0,0
49474,interval,0,0
49475,",",0,0
49476,0.8-11.2,0,0
49477,%,0,0
49478,),0,0
49479,had,0,0
49480,a,0,0
49481,different,0,0
49482,genotype,0,0
49483,and,0,0
49484,were,0,0
49485,categorized,0,0
49486,as,0,0
49487,reinfection,0,0
49488,.,0,0
49489,We,0,0
49490,conclude,0,0
49491,that,0,0
49492,recurrent,1,1
49493,tuberculosis,1,1
49494,in,1,0
49495,the,1,0
49496,United,1,1
49497,States,1,0
49498,and,1,1
49499,Canada,1,1
49500,",",0,0
49501,countries,0,1
49502,with,0,1
49503,low,0,1
49504,rates,0,0
49505,of,0,0
49506,tuberculosis,0,1
49507,",",0,0
49508,is,0,0
49509,rarely,0,0
49510,due,0,0
49511,to,0,0
49512,reinfection,0,0
49513,with,0,1
49514,a,0,0
49515,new,0,0
49516,strain,0,0
49517,of,0,0
49518,M.,0,1
49519,tuberculosis,0,1
49520,.,0,1
49521,Total,0,1
49522,anthelmintic,0,0
49523,failure,0,1
49524,to,0,0
49525,control,0,1
49526,nematode,1,1
49527,parasites,1,0
49528,of,1,1
49529,small,1,1
49530,ruminants,1,1
49531,on,1,0
49532,government,1,1
49533,breeding,1,1
49534,farms,1,0
49535,in,1,0
49536,Sabah,1,1
49537,",",1,0
49538,East,1,0
49539,Malaysia,1,1
49540,.,1,1
49541,Government-owned,1,1
49542,small-ruminant,1,0
49543,breeding,1,1
49544,farms,1,0
49545,in,0,0
49546,Malaysia,0,1
49547,provide,0,0
49548,the,0,0
49549,source,0,0
49550,of,0,0
49551,sheep,0,1
49552,and,0,0
49553,goats,0,1
49554,to,0,0
49555,smallholder,0,1
49556,farmers,0,1
49557,in,0,0
49558,the,0,0
49559,country,0,0
49560,.,0,0
49561,In,0,0
49562,the,0,0
49563,eastern,1,1
49564,Malaysian,1,1
49565,state,1,1
49566,of,1,0
49567,Sabah,1,1
49568,",",0,0
49569,high-level,0,0
49570,stock,0,0
49571,losses,0,0
49572,have,0,0
49573,been,0,0
49574,recorded,0,0
49575,on,0,0
49576,these,0,0
49577,farms,0,0
49578,for,0,0
49579,several,0,0
49580,years,0,1
49581,",",0,0
49582,frequently,0,0
49583,accompanied,0,0
49584,by,0,0
49585,clinical,0,0
49586,signs,0,1
49587,indicating,0,0
49588,pathogenic,0,0
49589,levels,0,0
49590,of,0,1
49591,infections,0,1
49592,with,0,1
49593,the,0,0
49594,nematode,1,0
49595,parasite,1,0
49596,Haemonchus,1,0
49597,contortus,1,0
49598,.,1,0
49599,This,0,0
49600,suggests,0,0
49601,that,0,0
49602,their,0,0
49603,dependence,0,0
49604,on,0,0
49605,chemotherapy,0,0
49606,to,0,0
49607,control,0,1
49608,parasite,0,1
49609,infections,0,0
49610,had,0,1
49611,failed,0,0
49612,.,0,0
49613,Accordingly,0,0
49614,",",0,0
49615,tests,0,0
49616,for,0,0
49617,anthelmintic,0,0
49618,efficacy,0,0
49619,using,0,0
49620,the,0,0
49621,faecal,0,0
49622,egg,0,0
49623,count,0,0
49624,reduction,0,0
49625,test,0,0
49626,(,0,0
49627,FECRT,0,0
49628,),0,0
49629,on,0,0
49630,the,0,0
49631,range,0,0
49632,of,0,0
49633,drugs,0,0
49634,used,0,0
49635,to,0,0
49636,control,0,1
49637,nematode,0,1
49638,parasites,0,0
49639,were,0,1
49640,carried,0,0
49641,out,0,0
49642,on,0,0
49643,the,0,0
49644,five,0,1
49645,government,0,1
49646,small-ruminant,0,0
49647,breeding,0,1
49648,farms,0,0
49649,in,0,1
49650,Sabah,0,1
49651,.,0,1
49652,These,0,0
49653,tests,0,0
49654,showed,0,0
49655,a,0,0
49656,total,0,1
49657,failure,0,1
49658,of,0,0
49659,the,0,0
49660,benzimidazole,0,0
49661,",",0,0
49662,imidothiazole,0,0
49663,",",0,0
49664,macrocyclic,0,0
49665,lactone,0,0
49666,and,0,0
49667,salicylanilide,0,0
49668,groups,0,0
49669,of,0,1
49670,anthelmintics,0,0
49671,to,0,0
49672,control,0,1
49673,H.,0,1
49674,contortus,0,0
49675,infections,0,1
49676,of,0,0
49677,sheep,1,1
49678,and,1,0
49679,goats,1,1
49680,on,1,0
49681,all,1,1
49682,farms,1,0
49683,.,1,1
49684,Drastic,0,0
49685,changes,0,0
49686,in,0,0
49687,animal,0,1
49688,management,0,1
49689,need,0,0
49690,to,0,0
49691,be,0,0
49692,made,0,0
49693,in,0,0
49694,an,0,0
49695,attempt,0,0
49696,to,0,0
49697,deal,0,0
49698,with,0,1
49699,this,0,0
49700,situation,0,0
49701,",",0,0
49702,for,0,0
49703,which,0,0
49704,suggestions,0,0
49705,are,0,0
49706,made,0,0
49707,.,0,1
49708,Acid,0,0
49709,resistance,0,0
49710,of,0,0
49711,enamel,1,0
49712,subsurface,1,0
49713,lesions,1,0
49714,remineralized,1,0
49715,by,1,0
49716,a,1,0
49717,sugar-free,1,0
49718,chewing,1,0
49719,gum,1,0
49720,containing,1,0
49721,casein,1,0
49722,phosphopeptide-amorphous,1,0
49723,calcium,1,0
49724,phosphate,1,0
49725,.,1,0
49726,The,0,0
49727,aim,0,0
49728,of,0,0
49729,this,0,0
49730,clinical,0,0
49731,study,0,0
49732,was,0,0
49733,to,0,0
49734,investigate,0,0
49735,the,0,0
49736,acid,0,0
49737,resistance,0,0
49738,of,0,0
49739,enamel,1,1
49740,lesions,1,1
49741,remineralized,1,0
49742,in,1,0
49743,situ,1,0
49744,by,1,0
49745,a,1,0
49746,sugar-free,1,0
49747,chewing,1,0
49748,gum,1,0
49749,containing,1,0
49750,casein,1,0
49751,phosphopeptide-amorphous,1,0
49752,calcium,1,0
49753,phosphate,1,0
49754,nanocomplexes,1,0
49755,(,1,1
49756,CPP-ACP,1,0
49757,:,1,1
49758,Recaldent,1,1
49759,),1,0
49760,.,1,0
49761,The,0,0
49762,study,0,0
49763,utilized,0,0
49764,a,0,0
49765,double-blind,0,0
49766,",",0,0
49767,randomized,0,0
49768,",",0,0
49769,crossover,0,0
49770,design,0,0
49771,with,0,1
49772,two,0,1
49773,treatments,0,0
49774,:,0,1
49775,(,0,0
49776,i,0,0
49777,),0,0
49778,sugar-free,0,0
49779,gum,0,0
49780,containing,0,0
49781,18.8,0,0
49782,mg,0,0
49783,of,0,0
49784,CPP-ACP,0,0
49785,",",0,0
49786,and,0,0
49787,(,0,0
49788,ii,0,0
49789,),0,0
49790,sugar-free,0,0
49791,gum,0,0
49792,not,0,0
49793,containing,0,0
49794,CPP-ACP,0,0
49795,as,0,0
49796,control,0,1
49797,.,0,0
49798,Subjects,1,0
49799,wore,1,0
49800,removable,1,0
49801,palatal,1,0
49802,appliances,1,1
49803,with,1,1
49804,insets,1,1
49805,of,1,0
49806,human,1,1
49807,enamel,1,1
49808,containing,1,0
49809,demineralized,1,0
49810,subsurface,1,0
49811,lesions,1,1
49812,and,1,0
49813,chewed,1,0
49814,the,1,0
49815,gum,1,0
49816,for,1,0
49817,20,1,1
49818,min,1,0
49819,4,1,0
49820,times,1,0
49821,per,1,0
49822,day,1,0
49823,for,1,0
49824,14,1,1
49825,days,1,0
49826,.,1,1
49827,After,0,0
49828,each,0,0
49829,treatment,0,0
49830,the,0,0
49831,enamel,0,0
49832,slabs,0,0
49833,were,0,0
49834,removed,0,0
49835,and,0,0
49836,half,0,1
49837,of,0,0
49838,each,0,0
49839,lesion,0,0
49840,challenged,0,0
49841,with,0,1
49842,acid,0,0
49843,in,0,0
49844,vitro,0,0
49845,for,0,0
49846,8,0,0
49847,or,0,1
49848,16,0,1
49849,h.,0,0
49850,The,0,0
49851,level,0,0
49852,of,0,0
49853,remineralization,0,0
49854,was,0,0
49855,determined,0,0
49856,using,0,0
49857,microradiography,0,0
49858,.,0,0
49859,The,0,0
49860,gum,0,0
49861,containing,0,0
49862,CPP-ACP,0,0
49863,produced,0,0
49864,approximately,0,0
49865,twice,0,0
49866,the,0,0
49867,level,0,0
49868,of,0,0
49869,remineralization,0,0
49870,as,0,0
49871,the,0,0
49872,control,0,0
49873,sugar-free,0,0
49874,gum,0,0
49875,.,0,0
49876,The,0,0
49877,8-,0,0
49878,and,0,0
49879,16-hour,0,0
49880,acid,0,0
49881,challenge,0,0
49882,of,0,0
49883,the,0,0
49884,lesions,0,0
49885,remineralized,0,0
49886,with,0,1
49887,the,0,0
49888,control,0,0
49889,gum,0,0
49890,resulted,0,0
49891,in,0,0
49892,65.4,0,1
49893,and,0,0
49894,88.0,0,0
49895,%,0,0
49896,reductions,0,0
49897,",",0,0
49898,respectively,0,0
49899,",",0,0
49900,of,0,0
49901,deposited,0,0
49902,mineral,0,0
49903,",",0,0
49904,while,0,0
49905,for,0,0
49906,the,0,0
49907,CPP-ACP-remineralized,0,1
49908,lesions,0,0
49909,the,0,0
49910,corresponding,0,0
49911,reductions,0,0
49912,were,0,1
49913,30.5,0,0
49914,and,0,0
49915,41.8,0,1
49916,%,0,0
49917,.,0,0
49918,The,0,0
49919,acid,0,0
49920,challenge,0,0
49921,after,0,0
49922,in,0,0
49923,situ,0,0
49924,remineralization,0,0
49925,for,0,0
49926,both,0,0
49927,control,0,0
49928,and,0,0
49929,CPP-ACP-treated,0,0
49930,lesions,0,0
49931,resulted,0,0
49932,in,0,0
49933,demineralization,0,0
49934,underneath,0,0
49935,the,0,0
49936,remineralized,0,0
49937,zone,0,0
49938,",",0,0
49939,indicating,0,0
49940,that,0,0
49941,the,0,0
49942,remineralized,0,0
49943,mineral,0,0
49944,was,0,0
49945,more,0,0
49946,resistant,0,0
49947,to,0,0
49948,subsequent,0,0
49949,acid,0,0
49950,challenge,0,0
49951,.,0,0
49952,The,0,0
49953,results,0,0
49954,show,0,0
49955,that,0,0
49956,sugar-free,0,0
49957,gum,0,0
49958,containing,0,0
49959,CPP-ACP,0,0
49960,is,0,0
49961,superior,0,0
49962,to,0,0
49963,an,0,0
49964,equivalent,0,0
49965,gum,0,0
49966,not,0,0
49967,containing,0,0
49968,CPP-ACP,0,0
49969,in,0,0
49970,remineralization,0,0
49971,of,0,0
49972,enamel,0,0
49973,subsurface,0,0
49974,lesions,0,0
49975,in,0,0
49976,situ,0,0
49977,with,0,1
49978,mineral,0,0
49979,that,0,0
49980,is,0,0
49981,more,0,0
49982,resistant,0,0
49983,to,0,0
49984,subsequent,0,0
49985,acid,0,0
49986,challenge,0,0
49987,.,0,1
49988,Syncope,1,1
49989,Evaluation,0,0
49990,in,0,0
49991,the,0,0
49992,Emergency,0,1
49993,Department,0,1
49994,Study,0,0
49995,(,0,0
49996,SEEDS,0,1
49997,),0,1
49998,:,0,1
49999,a,0,0
50000,multidisciplinary,0,0
50001,approach,0,0
50002,to,0,0
50003,syncope,1,1
50004,management,0,0
50005,.,0,0
50006,BACKGROUND,0,0
50007,The,0,0
50008,primary,0,0
50009,aim,0,0
50010,and,0,0
50011,central,0,0
50012,hypothesis,0,0
50013,of,0,0
50014,the,0,0
50015,study,0,0
50016,are,0,0
50017,that,0,0
50018,a,0,0
50019,designated,0,0
50020,syncope,0,1
50021,unit,0,0
50022,in,0,0
50023,the,0,0
50024,emergency,0,1
50025,department,0,1
50026,improves,0,0
50027,diagnostic,0,0
50028,yield,0,0
50029,and,0,0
50030,reduces,0,0
50031,hospital,0,1
50032,admission,0,1
50033,for,0,0
50034,patients,1,1
50035,with,1,1
50036,syncope,1,1
50037,who,1,1
50038,are,1,0
50039,at,1,1
50040,intermediate,1,0
50041,risk,1,0
50042,for,1,0
50043,an,1,0
50044,adverse,1,0
50045,cardiovascular,1,1
50046,outcome,1,0
50047,.,1,1
50048,METHODS,0,0
50049,AND,0,0
50050,RESULTS,0,0
50051,In,0,0
50052,this,0,0
50053,prospective,0,0
50054,",",0,0
50055,randomized,0,0
50056,",",0,0
50057,single-center,1,1
50058,study,1,0
50059,",",1,0
50060,patients,1,1
50061,were,0,0
50062,randomly,0,1
50063,allocated,0,1
50064,to,0,0
50065,2,0,0
50066,treatment,0,1
50067,arms,0,0
50068,:,0,1
50069,syncope,0,1
50070,unit,0,0
50071,evaluation,0,0
50072,and,0,0
50073,standard,0,0
50074,care,0,1
50075,.,0,0
50076,The,0,0
50077,2,0,0
50078,groups,0,0
50079,were,0,1
50080,compared,0,0
50081,with,0,1
50082,chi2,0,0
50083,test,0,0
50084,for,0,0
50085,independence,0,0
50086,of,0,0
50087,categorical,0,0
50088,variables,0,0
50089,.,0,1
50090,Wilcoxon,0,0
50091,rank,0,0
50092,sum,0,0
50093,test,0,0
50094,was,0,0
50095,used,0,0
50096,for,0,0
50097,continuous,0,0
50098,variables,0,0
50099,.,0,1
50100,Survival,0,0
50101,was,0,0
50102,estimated,0,0
50103,with,0,1
50104,the,0,0
50105,Kaplan-Meier,0,0
50106,method,0,0
50107,.,0,1
50108,One,1,1
50109,hundred,1,1
50110,three,1,1
50111,consecutive,1,1
50112,patients,1,1
50113,(,1,1
50114,53,1,1
50115,women,1,1
50116,;,1,1
50117,mean,1,1
50118,age,1,1
50119,64+/-17,1,1
50120,years,1,1
50121,),1,1
50122,entered,1,1
50123,the,1,0
50124,study,1,0
50125,.,1,0
50126,Fifty-one,0,1
50127,patients,0,1
50128,were,0,1
50129,randomized,0,1
50130,to,0,0
50131,the,0,0
50132,syncope,0,1
50133,unit,0,0
50134,.,0,0
50135,For,0,0
50136,the,0,0
50137,syncope,0,1
50138,unit,0,0
50139,and,0,0
50140,standard,0,0
50141,care,0,1
50142,patients,0,1
50143,",",0,0
50144,the,0,0
50145,presumptive,0,0
50146,diagnosis,0,1
50147,was,0,0
50148,established,0,0
50149,in,0,0
50150,34,0,1
50151,(,0,1
50152,67,0,1
50153,%,0,0
50154,),0,0
50155,and,0,0
50156,5,0,0
50157,(,0,0
50158,10,0,1
50159,%,0,0
50160,),0,1
50161,patients,0,1
50162,(,0,1
50163,P,0,0
50164,<,0,0
50165,0.001,0,0
50166,),0,0
50167,",",0,0
50168,respectively,0,0
50169,",",0,0
50170,hospital,0,0
50171,admission,0,1
50172,was,0,0
50173,required,0,0
50174,for,0,0
50175,22,0,1
50176,(,0,1
50177,43,0,1
50178,%,0,0
50179,),0,0
50180,and,0,0
50181,51,0,1
50182,(,0,0
50183,98,0,1
50184,%,0,0
50185,),0,1
50186,patients,0,1
50187,(,0,1
50188,P,0,0
50189,<,0,0
50190,0.001,0,0
50191,),0,0
50192,",",0,0
50193,and,0,0
50194,total,0,1
50195,patient-hospital,0,1
50196,days,0,0
50197,were,0,1
50198,reduced,0,0
50199,from,0,1
50200,140,0,1
50201,to,0,1
50202,64,0,1
50203,.,0,1
50204,Actuarial,0,0
50205,survival,0,0
50206,was,0,0
50207,97,0,1
50208,%,0,0
50209,and,0,0
50210,90,0,0
50211,%,0,0
50212,(,0,0
50213,P=0.30,0,0
50214,),0,0
50215,",",0,0
50216,and,0,0
50217,survival,0,0
50218,free,0,0
50219,from,0,1
50220,recurrent,0,1
50221,syncope,0,1
50222,was,0,0
50223,88,0,0
50224,%,0,0
50225,and,0,0
50226,89,0,1
50227,%,0,0
50228,(,0,0
50229,P=0.72,0,0
50230,),0,0
50231,at,0,0
50232,2,0,0
50233,years,0,1
50234,for,0,0
50235,the,0,0
50236,syncope,0,1
50237,unit,0,0
50238,and,0,0
50239,standard,0,0
50240,care,0,1
50241,groups,0,0
50242,",",0,0
50243,respectively,0,0
50244,.,0,0
50245,CONCLUSIONS,0,0
50246,The,0,0
50247,novel,0,0
50248,syncope,0,1
50249,unit,0,0
50250,designed,0,0
50251,for,0,0
50252,this,0,0
50253,study,0,0
50254,significantly,0,0
50255,improved,0,0
50256,diagnostic,0,0
50257,yield,0,0
50258,in,0,0
50259,the,0,0
50260,emergency,0,1
50261,department,0,1
50262,and,0,0
50263,reduced,0,0
50264,hospital,0,1
50265,admission,0,1
50266,and,0,0
50267,total,0,1
50268,length,0,0
50269,of,0,0
50270,hospital,0,1
50271,stay,0,0
50272,without,0,1
50273,affecting,0,0
50274,recurrent,0,1
50275,syncope,0,1
50276,and,0,0
50277,all-cause,0,0
50278,mortality,0,0
50279,among,0,1
50280,intermediate-risk,1,1
50281,patients,1,1
50282,.,1,1
50283,Observations,0,0
50284,from,0,0
50285,the,0,0
50286,present,0,0
50287,study,0,0
50288,provide,0,0
50289,benchmark,0,0
50290,data,0,0
50291,for,0,0
50292,improving,0,0
50293,patient,0,0
50294,care,0,1
50295,and,0,0
50296,effectively,0,0
50297,utilizing,0,0
50298,healthcare,0,1
50299,resources,0,0
50300,.,0,1
50301,Abstinence,0,1
50302,incentive,0,1
50303,effects,0,0
50304,in,0,0
50305,a,0,1
50306,short-term,0,0
50307,outpatient,0,1
50308,detoxification,0,1
50309,program,0,0
50310,.,0,0
50311,Despite,0,0
50312,being,0,0
50313,widely,0,0
50314,available,0,0
50315,",",0,0
50316,outpatient,0,1
50317,detoxification,0,0
50318,has,0,0
50319,limited,0,0
50320,efficacy,0,0
50321,as,0,0
50322,a,0,0
50323,stand-alone,0,0
50324,treatment,0,0
50325,.,0,0
50326,This,0,0
50327,study,0,0
50328,examined,0,0
50329,whether,0,0
50330,abstinence-contingent,0,0
50331,incentives,0,0
50332,would,0,0
50333,improve,0,0
50334,outcomes,0,0
50335,for,0,0
50336,patients,1,1
50337,entering,1,1
50338,outpatient,1,1
50339,opiate,1,1
50340,detoxification,1,1
50341,.,1,1
50342,Participants,1,1
50343,(,1,0
50344,N,1,1
50345,=,1,0
50346,211,1,1
50347,),1,0
50348,received,0,0
50349,a,0,0
50350,100,0,0
50351,US,0,0
50352,dollars,0,0
50353,voucher,0,0
50354,on,0,0
50355,the,0,0
50356,last,0,0
50357,day,0,0
50358,of,0,0
50359,detoxification,0,1
50360,either,0,0
50361,contingent,0,0
50362,on,0,0
50363,opiate,0,1
50364,and,0,0
50365,cocaine,0,0
50366,abstinence,0,0
50367,or,0,0
50368,noncontingently,0,0
50369,.,0,0
50370,Urine,0,0
50371,samples,0,0
50372,were,0,1
50373,collected,0,0
50374,at,0,0
50375,intake,0,0
50376,",",0,0
50377,on,0,0
50378,Wednesday,0,1
50379,",",0,0
50380,Friday,0,0
50381,(,0,0
50382,the,0,0
50383,last,0,0
50384,day,0,0
50385,of,0,0
50386,detoxification,0,1
50387,),0,0
50388,",",0,0
50389,and,0,0
50390,the,0,0
50391,following,0,0
50392,Monday,0,1
50393,.,0,1
50394,Among,0,1
50395,contingent-voucher,0,0
50396,participants,0,1
50397,",",0,0
50398,31,0,1
50399,%,0,0
50400,were,0,0
50401,drug-free,0,1
50402,on,0,0
50403,Friday,0,0
50404,compared,0,0
50405,with,0,1
50406,18,0,1
50407,%,0,0
50408,of,0,0
50409,noncontingent,0,0
50410,controls,0,1
50411,(,0,1
50412,Z,0,0
50413,=,0,0
50414,2.4,0,0
50415,",",0,0
50416,p,0,0
50417,<,0,0
50418,.05,0,0
50419,),0,0
50420,.,0,0
50421,Few,0,0
50422,(,0,0
50423,12-13,0,1
50424,%,0,0
50425,),0,1
50426,participants,0,1
50427,tested,0,0
50428,negative,0,0
50429,on,0,0
50430,Monday,0,1
50431,.,0,1
50432,Results,0,0
50433,support,0,0
50434,the,0,0
50435,ability,0,0
50436,of,0,0
50437,vouchers,0,0
50438,to,0,0
50439,produce,0,0
50440,modest,0,0
50441,improvements,0,0
50442,in,0,0
50443,abstinence,0,1
50444,initiation,0,0
50445,rates,0,0
50446,during,0,0
50447,brief,0,0
50448,detoxification,0,1
50449,but,0,0
50450,suggest,0,0
50451,that,0,0
50452,additional,0,0
50453,interventions,0,0
50454,are,0,0
50455,needed,0,0
50456,to,0,0
50457,sustain,0,0
50458,improvements,0,0
50459,.,0,1
50460,Dual-task-related,0,0
50461,gait,0,0
50462,changes,0,0
50463,in,0,0
50464,transitionally,1,1
50465,frail,1,1
50466,older,1,1
50467,adults,1,1
50468,:,1,1
50469,the,0,0
50470,type,0,1
50471,of,0,0
50472,the,0,0
50473,walking-associated,0,0
50474,cognitive,0,0
50475,task,0,1
50476,matters,0,0
50477,.,0,1
50478,BACKGROUND,0,0
50479,Changes,0,0
50480,in,0,0
50481,gait,0,0
50482,patterns,0,1
50483,due,0,0
50484,to,0,0
50485,a,0,0
50486,simultaneously,0,0
50487,performed,0,0
50488,cognitive,0,0
50489,task,0,0
50490,have,0,0
50491,been,0,0
50492,reported,0,0
50493,previously,0,0
50494,and,0,0
50495,associated,0,0
50496,with,0,1
50497,an,0,0
50498,increased,0,0
50499,falling,1,0
50500,risk,1,0
50501,among,1,0
50502,older,1,1
50503,adults,1,1
50504,.,1,0
50505,Little,0,0
50506,is,0,0
50507,known,0,0
50508,whether,0,0
50509,the,0,0
50510,type,0,1
50511,of,0,0
50512,cognitive,0,0
50513,task,0,0
50514,performed,0,0
50515,while,0,0
50516,walking,0,0
50517,is,0,0
50518,important,0,0
50519,concerning,0,0
50520,possible,0,0
50521,gait,0,0
50522,interference,0,0
50523,in,0,0
50524,older,1,1
50525,fall-prone,1,1
50526,individuals,1,1
50527,.,1,1
50528,OBJECTIVE,0,0
50529,To,0,0
50530,quantify,0,0
50531,and,0,0
50532,compare,0,0
50533,the,0,0
50534,effects,0,0
50535,of,0,0
50536,two,0,1
50537,different,0,0
50538,cognitive,0,1
50539,tasks,0,0
50540,on,0,0
50541,gait,0,0
50542,in,0,0
50543,transitionally,1,1
50544,frail,1,1
50545,older,1,1
50546,adults,1,1
50547,.,1,1
50548,MEASUREMENTS,0,0
50549,Gait,0,0
50550,was,0,0
50551,tested,0,0
50552,in,0,0
50553,30,1,0
50554,transitionally,1,1
50555,frail,1,1
50556,older,1,1
50557,adults,1,1
50558,(,1,0
50559,mean,1,1
50560,age,1,1
50561,82.6,1,1
50562,+/-,1,0
50563,7.1,1,0
50564,years,1,1
50565,",",1,1
50566,90,1,0
50567,%,1,0
50568,female,1,1
50569,),1,0
50570,while,0,0
50571,either,0,0
50572,walking,1,0
50573,alone,1,0
50574,",",1,0
50575,performing,1,0
50576,a,1,0
50577,simple,1,0
50578,arithmetic,1,0
50579,task,1,0
50580,",",1,0
50581,or,1,0
50582,performing,1,0
50583,a,1,0
50584,task,1,0
50585,of,1,0
50586,verbal,1,0
50587,fluency,1,0
50588,.,1,1
50589,Walking,0,0
50590,time,0,0
50591,in,0,0
50592,seconds,0,0
50593,",",0,0
50594,number,0,0
50595,of,0,0
50596,steps,0,0
50597,",",0,0
50598,frequency,0,0
50599,of,0,0
50600,lateral,0,0
50601,line,0,0
50602,stepping-over,0,0
50603,",",0,0
50604,and,0,0
50605,stops,0,0
50606,were,0,1
50607,recorded,0,0
50608,.,0,0
50609,Health,0,0
50610,status,0,0
50611,was,0,0
50612,assessed,0,0
50613,using,0,0
50614,standard,0,0
50615,instruments,0,1
50616,of,0,0
50617,geriatric,0,1
50618,assessment,0,0
50619,.,0,0
50620,The,0,0
50621,classification,0,0
50622,of,0,0
50623,Speechley,0,1
50624,and,0,1
50625,Tinetti,0,0
50626,was,0,0
50627,used,0,0
50628,to,0,0
50629,define,0,0
50630,the,0,0
50631,participants,0,1
50632,',0,0
50633,degree,0,0
50634,of,0,0
50635,frailty,0,0
50636,.,0,1
50637,RESULTS,0,0
50638,Walking,0,0
50639,time,0,0
50640,and,0,0
50641,number,0,0
50642,of,0,0
50643,steps,0,0
50644,increased,0,0
50645,significantly,0,0
50646,under,0,0
50647,both,0,0
50648,dual-task,0,0
50649,conditions,0,0
50650,compared,0,0
50651,to,0,0
50652,walking,0,0
50653,alone,0,0
50654,(,0,0
50655,p,0,0
50656,<,0,0
50657,0.001,0,0
50658,),0,0
50659,without,0,1
50660,reaching,0,0
50661,a,0,0
50662,significant,0,0
50663,difference,0,0
50664,between,0,0
50665,the,0,0
50666,two,0,0
50667,dual-task,0,0
50668,conditions,0,0
50669,(,0,0
50670,respectively,0,0
50671,",",0,0
50672,p,0,0
50673,=,0,0
50674,0.131,0,0
50675,and,0,0
50676,p,0,0
50677,=,0,0
50678,0.407,0,0
50679,),0,0
50680,",",0,0
50681,whereas,0,0
50682,lateral,0,0
50683,gait,0,0
50684,instability,0,1
50685,(,0,0
50686,frequency,0,0
50687,of,0,0
50688,lateral,0,0
50689,line,0,0
50690,stepping-over,0,0
50691,),0,0
50692,increased,0,0
50693,significantly,0,0
50694,in,0,0
50695,association,0,0
50696,with,0,1
50697,counting,0,0
50698,backward,0,0
50699,(,0,0
50700,p,0,0
50701,=,0,0
50702,0.006,0,0
50703,),0,0
50704,but,0,0
50705,not,0,0
50706,with,0,1
50707,the,0,0
50708,verbal,0,0
50709,fluency,0,0
50710,task,0,0
50711,(,0,0
50712,p,0,0
50713,=,0,0
50714,1,0,1
50715,),0,1
50716,.,0,1
50717,CONCLUSION,0,0
50718,Among,0,1
50719,the,0,0
50720,studied,0,0
50721,sample,0,1
50722,of,0,0
50723,transitional,1,1
50724,older,1,1
50725,adults,1,1
50726,",",0,0
50727,a,0,0
50728,walking-,0,0
50729,associated,0,0
50730,arithmetic,0,0
50731,task,0,0
50732,significantly,0,0
50733,interfered,0,0
50734,with,0,1
50735,lateral,0,0
50736,gait,0,0
50737,stability,0,0
50738,",",0,0
50739,whereas,0,0
50740,no,0,0
50741,lateral,0,0
50742,gait,0,0
50743,deviations,0,0
50744,were,0,0
50745,seen,0,0
50746,in,0,0
50747,association,0,0
50748,with,0,1
50749,a,0,0
50750,verbal,0,0
50751,fluency,0,0
50752,task,0,0
50753,.,0,0
50754,We,0,0
50755,",",0,0
50756,therefore,0,0
50757,",",0,0
50758,suggest,0,0
50759,that,0,0
50760,the,0,0
50761,choice,0,0
50762,of,0,0
50763,the,0,0
50764,attention-splitting,0,0
50765,task,0,0
50766,in,0,0
50767,dual-task,0,0
50768,gait,0,0
50769,assessment,0,0
50770,among,0,0
50771,older,1,1
50772,adults,1,1
50773,must,0,0
50774,be,0,0
50775,made,0,0
50776,carefully,0,0
50777,.,0,0
50778,Comparative,0,0
50779,bioavailability,0,0
50780,of,0,0
50781,two,0,0
50782,formulations,0,0
50783,of,0,1
50784,terbinafine,0,0
50785,.,0,1
50786,Data,0,0
50787,from,0,0
50788,a,0,0
50789,cross-over,0,0
50790,",",0,0
50791,randomised,0,0
50792,",",0,0
50793,open-label,0,0
50794,bioequivalence,0,0
50795,study,0,0
50796,in,0,0
50797,healthy,1,1
50798,volunteers,1,1
50799,.,1,1
50800,An,0,0
50801,open-label,0,0
50802,",",0,0
50803,randomised,0,0
50804,",",0,0
50805,cross-over,0,0
50806,single,0,0
50807,dose,0,0
50808,study,0,0
50809,",",0,0
50810,using,0,0
50811,2,0,0
50812,periods,0,0
50813,x,0,1
50814,2,0,0
50815,sequences,0,0
50816,",",0,0
50817,with,0,1
50818,a,0,0
50819,minimum,0,0
50820,washout,0,0
50821,period,0,0
50822,of,0,0
50823,21,0,1
50824,days,0,0
50825,",",0,0
50826,was,0,0
50827,conducted,0,0
50828,in,0,0
50829,order,0,0
50830,to,0,0
50831,assess,0,0
50832,the,0,0
50833,comparative,0,0
50834,bioavailability,0,0
50835,of,0,0
50836,two,0,0
50837,formulations,0,0
50838,of,0,0
50839,terbinafine,0,0
50840,(,0,0
50841,CAS,0,0
50842,78628-80-5,0,1
50843,),0,1
50844,250,0,0
50845,mg,0,0
50846,tablets,0,0
50847,.,0,1
50848,Plasma,0,0
50849,samples,0,0
50850,were,0,0
50851,obtained,0,0
50852,at,0,0
50853,baseline,0,0
50854,",",0,0
50855,+0.333,0,0
50856,;,0,1
50857,0.667,0,0
50858,;,0,1
50859,1.00,0,0
50860,;,0,1
50861,1.33,0,0
50862,;,0,1
50863,1.67,0,0
50864,;,0,1
50865,2.00,0,0
50866,;,0,1
50867,2.33,0,0
50868,;,0,1
50869,2.67,0,0
50870,;,0,1
50871,3.00,0,0
50872,;,0,1
50873,3.50,0,0
50874,;,0,1
50875,4.00,0,0
50876,;,0,1
50877,6.00,0,0
50878,;,0,1
50879,8.00,0,0
50880,;,0,1
50881,12.0,0,0
50882,;,0,1
50883,24.0,0,1
50884,;,0,1
50885,36.0,0,1
50886,;,0,0
50887,48.0,0,0
50888,and,0,0
50889,72.0,0,0
50890,h,0,0
50891,post-administration,0,0
50892,.,0,1
50893,Terbinafine,0,0
50894,levels,0,0
50895,were,0,0
50896,determined,0,0
50897,by,0,0
50898,high,0,0
50899,pressure,0,0
50900,liquid,0,0
50901,chromatography,0,0
50902,with,0,1
50903,tandem,0,1
50904,mass,0,1
50905,detection,0,0
50906,(,0,0
50907,HPLC-MS/MS,0,0
50908,),0,0
50909,and,0,0
50910,the,0,0
50911,lower,0,0
50912,limit,0,0
50913,of,0,0
50914,quantification,0,0
50915,was,0,0
50916,set,0,0
50917,at,0,0
50918,9.99,0,0
50919,ng/mL,0,0
50920,.,0,0
50921,The,0,0
50922,pharmacokinetic,0,0
50923,parameters,0,0
50924,used,0,0
50925,for,0,0
50926,the,0,0
50927,bioequivalence,0,0
50928,assessment,0,0
50929,(,0,0
50930,AUClast,0,0
50931,",",0,0
50932,AUCinf,0,0
50933,and,0,0
50934,Cmax,0,0
50935,),0,0
50936,were,0,0
50937,determined,0,0
50938,from,0,0
50939,the,0,0
50940,terbinafine,0,0
50941,concentration,0,0
50942,data,0,0
50943,using,0,0
50944,non-compartmental,0,0
50945,analysis,0,0
50946,.,0,1
50947,Classical,0,0
50948,90,0,0
50949,%,0,0
50950,confidence,0,0
50951,intervals,0,0
50952,(,0,1
50953,90CI,0,1
50954,),0,0
50955,were,0,0
50956,calculated,0,0
50957,for,0,0
50958,the,0,0
50959,overall,0,0
50960,sample,0,1
50961,",",0,0
50962,and,0,0
50963,for,0,0
50964,males,1,1
50965,and,1,1
50966,females,1,1
50967,separately,0,0
50968,",",0,0
50969,and,0,0
50970,gender,0,1
50971,effects,0,0
50972,were,0,0
50973,investigated,0,0
50974,using,0,0
50975,an,0,0
50976,appropriate,0,0
50977,model,0,0
50978,.,0,0
50979,The,0,0
50980,results,0,0
50981,showed,0,0
50982,that,0,0
50983,overall,0,0
50984,classical,0,1
50985,90CI,0,1
50986,were,0,1
50987,96.08-105.40,0,0
50988,%,0,0
50989,for,0,0
50990,AUCinf,0,0
50991,",",0,0
50992,95.68-105.33,0,0
50993,for,0,0
50994,AUClast,0,1
50995,and,0,0
50996,88.24-112.83,0,0
50997,for,0,0
50998,Cmax,0,0
50999,",",0,0
51000,that,0,0
51001,is,0,0
51002,",",0,0
51003,all,0,0
51004,within,0,0
51005,the,0,0
51006,predefined,0,0
51007,ranges,0,0
51008,for,0,0
51009,bioequivalence,0,0
51010,acceptance,0,0
51011,.,0,0
51012,Separate,0,0
51013,gender,0,0
51014,analysis,0,0
51015,showed,0,0
51016,very,0,0
51017,similar,0,0
51018,results,0,0
51019,for,0,1
51020,males,1,1
51021,and,1,1
51022,females,1,1
51023,when,0,0
51024,analysed,0,0
51025,independently,0,0
51026,",",0,0
51027,and,0,0
51028,no,0,0
51029,gender,0,0
51030,effects,0,0
51031,were,0,0
51032,detected,0,0
51033,(,0,0
51034,p,0,0
51035,>,0,1
51036,0.05,0,0
51037,for,0,0
51038,all,0,0
51039,of,0,0
51040,the,0,0
51041,tested,0,0
51042,model,0,0
51043,effects,0,0
51044,),0,1
51045,.,0,0
51046,It,0,0
51047,may,0,0
51048,be,0,0
51049,therefore,0,0
51050,concluded,0,0
51051,that,0,0
51052,the,0,0
51053,evaluated,0,0
51054,formulations,0,0
51055,are,0,0
51056,bioequivalent,0,0
51057,in,0,0
51058,terms,0,0
51059,of,0,0
51060,rate,0,0
51061,and,0,0
51062,extent,0,0
51063,of,0,0
51064,absorption,0,0
51065,.,0,1
51066,Genetic,0,1
51067,polymorphisms,0,0
51068,of,0,0
51069,human,0,1
51070,flavin,0,0
51071,monooxygenase,0,0
51072,3,0,0
51073,in,0,0
51074,sulindac-mediated,0,0
51075,primary,0,1
51076,chemoprevention,0,1
51077,of,0,0
51078,familial,1,1
51079,adenomatous,1,1
51080,polyposis,1,1
51081,.,1,1
51082,PURPOSE,0,0
51083,Sulindac,0,0
51084,is,0,0
51085,a,0,0
51086,nonsteroidal,0,0
51087,anti-inflammatory,0,0
51088,drug,0,0
51089,(,0,0
51090,NSAID,0,0
51091,),0,0
51092,effective,0,0
51093,in,0,0
51094,regressing,0,0
51095,adenomas,0,1
51096,in,0,0
51097,patients,1,1
51098,with,1,1
51099,familial,1,1
51100,adenomatous,1,1
51101,polyposis,1,1
51102,(,1,0
51103,FAP,1,1
51104,),1,0
51105,.,1,0
51106,However,0,0
51107,",",0,0
51108,a,0,0
51109,recent,0,0
51110,randomized,0,0
51111,trial,0,0
51112,showed,0,0
51113,that,0,0
51114,sulindac,0,0
51115,",",0,0
51116,when,0,0
51117,compared,0,0
51118,with,0,0
51119,placebo,0,0
51120,",",0,0
51121,failed,0,0
51122,to,0,0
51123,prevent,0,0
51124,the,0,0
51125,development,0,0
51126,of,0,0
51127,adenomatous,0,1
51128,polyps,0,1
51129,in,0,0
51130,genotypically,0,1
51131,positive,0,0
51132,but,0,0
51133,phenotypically,0,1
51134,negative,0,0
51135,FAP,0,1
51136,patients,0,1
51137,.,0,1
51138,The,0,0
51139,present,0,0
51140,study,0,0
51141,determined,0,0
51142,whether,0,0
51143,polymorphisms,0,0
51144,in,0,0
51145,the,0,0
51146,gene,0,0
51147,encoding,0,0
51148,flavin,0,0
51149,monooxygenase,0,0
51150,3,0,0
51151,(,0,0
51152,FMO3,0,0
51153,),0,0
51154,",",0,0
51155,a,0,0
51156,hepatic,0,0
51157,microsomal,0,0
51158,enzyme,0,0
51159,that,0,0
51160,inactivates,0,0
51161,sulindac,0,0
51162,",",0,0
51163,played,0,0
51164,a,0,0
51165,role,0,0
51166,in,0,0
51167,determining,0,0
51168,the,0,0
51169,efficacy,0,0
51170,of,0,0
51171,sulindac,0,0
51172,in,0,0
51173,preventing,0,0
51174,polyposis,0,1
51175,in,0,0
51176,this,0,0
51177,cohort,0,1
51178,of,0,0
51179,FAP,1,1
51180,patients,1,1
51181,.,1,1
51182,EXPERIMENTAL,0,0
51183,DESIGN,0,0
51184,Genotyping,0,0
51185,was,0,0
51186,performed,0,0
51187,on,0,0
51188,seven,0,1
51189,established,0,1
51190,FMO3,0,0
51191,polymorphisms,0,0
51192,previously,0,1
51193,shown,0,0
51194,to,0,0
51195,have,0,0
51196,functional,0,0
51197,relevance-M66I,1,0
51198,",",1,0
51199,P153L,1,0
51200,",",1,0
51201,E158K,1,0
51202,",",1,0
51203,V257M,1,0
51204,",",1,0
51205,E305X,1,1
51206,",",1,0
51207,E308G,1,0
51208,",",1,0
51209,and,1,0
51210,R492W-in,1,0
51211,21,1,1
51212,and,1,0
51213,20,1,1
51214,FAP,1,1
51215,patients,1,1
51216,",",1,1
51217,who,1,1
51218,received,1,1
51219,sulindac,1,1
51220,and,1,0
51221,placebo,1,0
51222,",",1,0
51223,respectively,1,0
51224,.,1,0
51225,RESULTS,0,0
51226,None,0,0
51227,of,0,0
51228,the,0,0
51229,41,1,1
51230,patients,1,1
51231,exhibited,0,0
51232,heterozygous,0,1
51233,or,0,1
51234,homozygous,0,1
51235,M66I,0,0
51236,and,0,0
51237,R492W,0,0
51238,variant,0,1
51239,alleles,0,0
51240,",",0,0
51241,or,0,1
51242,homozygous,0,0
51243,P153L,0,0
51244,",",0,0
51245,V257M,0,0
51246,",",0,0
51247,and,0,0
51248,E305X,0,1
51249,variant,0,1
51250,alleles,0,0
51251,.,0,1
51252,Among,0,1
51253,sulindac-treated,1,0
51254,patients,1,1
51255,who,0,1
51256,did,0,1
51257,not,0,1
51258,develop,0,0
51259,adenomas,0,1
51260,(,0,0
51261,responders,0,0
51262,),0,1
51263,",",0,0
51264,4,0,0
51265,(,0,0
51266,33,0,1
51267,%,0,0
51268,),0,0
51269,were,0,0
51270,homozygous,0,0
51271,for,0,0
51272,E158K,0,0
51273,and,0,0
51274,2,0,0
51275,(,0,0
51276,17,0,1
51277,%,0,0
51278,),0,0
51279,were,0,0
51280,homozygous,0,0
51281,for,0,0
51282,E308G,0,0
51283,variant,0,1
51284,alleles,0,0
51285,.,0,1
51286,In,0,0
51287,contrast,0,0
51288,",",0,0
51289,none,0,0
51290,of,0,0
51291,the,0,0
51292,patients,1,1
51293,on,1,0
51294,sulindac,1,1
51295,who,0,1
51296,developed,0,1
51297,adenomas,0,1
51298,(,0,0
51299,nonresponders,0,0
51300,),0,0
51301,exhibited,0,0
51302,homozygosity,0,0
51303,for,0,0
51304,either,0,0
51305,of,0,0
51306,the,0,0
51307,two,0,0
51308,variant,0,1
51309,alleles,0,0
51310,.,0,1
51311,In,0,0
51312,addition,0,0
51313,",",0,0
51314,polymorphisms,0,0
51315,in,0,0
51316,the,0,0
51317,E158K,0,0
51318,or,0,1
51319,E308G,0,0
51320,allele,0,0
51321,were,0,0
51322,associated,0,0
51323,with,0,1
51324,a,0,0
51325,significant,0,0
51326,reduction,0,0
51327,in,0,0
51328,mucosal,0,0
51329,prostanoid,0,0
51330,levels,0,0
51331,in,0,1
51332,patients,0,1
51333,treated,0,1
51334,with,0,1
51335,sulindac,0,0
51336,.,0,1
51337,CONCLUSIONS,0,0
51338,Polymorphisms,0,0
51339,in,0,0
51340,FMO3,0,0
51341,",",0,0
51342,particularly,0,0
51343,at,0,0
51344,the,0,0
51345,E158K,0,0
51346,and,0,0
51347,E308G,0,0
51348,loci,0,0
51349,",",0,0
51350,may,0,0
51351,reduce,0,0
51352,activity,0,0
51353,in,0,0
51354,catabolizing,0,0
51355,sulindac,0,0
51356,and,0,0
51357,result,0,0
51358,in,0,0
51359,an,0,0
51360,increased,0,0
51361,efficacy,0,0
51362,to,0,0
51363,prevent,0,0
51364,polyposis,0,1
51365,in,0,0
51366,FAP,0,1
51367,.,0,1
51368,Slotted,0,0
51369,versus,0,0
51370,non-slotted,0,1
51371,locked,0,1
51372,intramedullary,0,1
51373,nailing,0,1
51374,for,0,0
51375,femoral,0,1
51376,shaft,0,1
51377,fractures,0,1
51378,.,0,0
51379,Experimentally,0,0
51380,",",0,0
51381,two,0,0
51382,slotted,0,0
51383,nails,0,1
51384,",",0,0
51385,the,0,0
51386,Grosse-Kempf,0,0
51387,nail,0,1
51388,and,0,0
51389,the,0,0
51390,AO/ASIF,0,1
51391,universal,0,0
51392,femoral,0,1
51393,nail,0,1
51394,",",0,0
51395,were,0,0
51396,compared,0,0
51397,to,0,0
51398,the,0,0
51399,non-slotted,0,0
51400,Grosse-Kempf,0,0
51401,nail,0,1
51402,and,0,0
51403,control,0,0
51404,bone,0,0
51405,using,0,0
51406,a,0,0
51407,cadaver,1,1
51408,femoral,1,1
51409,osteotomy,1,1
51410,.,1,0
51411,The,0,0
51412,stiffnesses,0,0
51413,and,0,0
51414,strengths,0,0
51415,of,0,0
51416,the,0,0
51417,osteotomies,0,1
51418,fixed,0,0
51419,with,0,1
51420,slotted,0,1
51421,nails,0,1
51422,in,0,1
51423,10-30,0,1
51424,degrees,0,0
51425,torsion,0,1
51426,were,0,1
51427,6-8,0,0
51428,%,0,0
51429,and,0,0
51430,the,0,0
51431,values,0,0
51432,of,0,0
51433,non-slotted,0,1
51434,nails,0,1
51435,40,0,1
51436,%,0,0
51437,of,0,0
51438,control,0,0
51439,bone,0,0
51440,.,0,0
51441,The,0,0
51442,maximal,0,0
51443,moments,0,0
51444,were,0,1
51445,14-18,0,1
51446,%,0,0
51447,and,0,0
51448,48,0,0
51449,%,0,0
51450,",",0,0
51451,respectively,0,0
51452,.,0,0
51453,In,0,0
51454,the,0,0
51455,clinical,0,0
51456,range,0,0
51457,of,0,0
51458,torsion,0,0
51459,",",0,0
51460,the,0,0
51461,implant-bone,0,0
51462,construct,0,0
51463,never,0,1
51464,failed,0,0
51465,or,0,0
51466,was,0,0
51467,deformed,0,0
51468,.,0,0
51469,Clinically,0,0
51470,",",0,0
51471,46,1,1
51472,femoral,1,1
51473,shaft,1,1
51474,fractures,1,1
51475,were,1,0
51476,randomized,1,1
51477,to,1,0
51478,treatment,1,0
51479,with,1,1
51480,Gross-Kempf,1,0
51481,nails,1,1
51482,",",1,0
51483,24,1,0
51484,with,1,1
51485,slotted,1,1
51486,nails,1,1
51487,and,1,0
51488,22,1,1
51489,with,1,1
51490,non-slotted,1,1
51491,nails,1,1
51492,.,1,1
51493,Four,0,0
51494,complications,0,0
51495,in,0,0
51496,the,0,0
51497,slotted,0,0
51498,nail,0,1
51499,group,0,0
51500,and,0,0
51501,three,0,0
51502,in,0,0
51503,the,0,0
51504,non-slotted,0,0
51505,nail,0,1
51506,group,0,0
51507,were,0,0
51508,considered,0,0
51509,to,0,0
51510,be,0,0
51511,independent,0,0
51512,of,0,0
51513,the,0,0
51514,choice,0,0
51515,of,0,0
51516,nail,0,1
51517,and,0,0
51518,did,0,0
51519,not,0,0
51520,affect,0,0
51521,the,0,0
51522,end,0,0
51523,result,0,0
51524,.,0,1
51525,Three,0,0
51526,splinterings,0,0
51527,of,0,0
51528,the,0,0
51529,distal,0,0
51530,fragment,0,0
51531,",",0,0
51532,one,0,0
51533,resulting,0,0
51534,in,0,0
51535,a,0,0
51536,change,0,0
51537,of,0,0
51538,the,0,0
51539,osteosynthesis,0,0
51540,implant,0,0
51541,to,0,0
51542,a,0,0
51543,condylar,0,1
51544,plate,0,0
51545,",",0,0
51546,were,0,0
51547,considered,0,0
51548,to,0,0
51549,result,0,0
51550,from,0,0
51551,the,0,0
51552,high,0,0
51553,stiffness,0,0
51554,of,0,0
51555,the,0,0
51556,non-slotted,0,1
51557,nail,0,1
51558,.,0,0
51559,Osteosynthesis,0,0
51560,of,0,0
51561,femoral,0,1
51562,shaft,0,1
51563,fractures,0,1
51564,using,0,0
51565,slotted,0,0
51566,nails,0,1
51567,has,0,0
51568,not,0,0
51569,resulted,0,0
51570,in,0,0
51571,healing,0,0
51572,disturbances,0,0
51573,",",0,0
51574,which,0,0
51575,could,0,0
51576,be,0,0
51577,accounted,0,0
51578,for,0,0
51579,by,0,0
51580,the,0,0
51581,high,0,0
51582,torsional,0,0
51583,elasticity,0,0
51584,of,0,0
51585,the,0,0
51586,nail,0,1
51587,;,0,0
51588,there,0,0
51589,seems,0,0
51590,to,0,0
51591,be,0,0
51592,no,0,0
51593,indication,0,0
51594,for,0,0
51595,high-stiffness,0,0
51596,nails,0,1
51597,in,0,0
51598,femoral,1,1
51599,fractures,1,1
51600,.,1,1
51601,Group-based,0,1
51602,HIV,0,1
51603,risk,0,0
51604,reduction,0,0
51605,intervention,0,0
51606,for,0,0
51607,adolescent,1,1
51608,girls,1,1
51609,:,1,1
51610,evidence,0,0
51611,of,0,0
51612,feasibility,0,0
51613,and,0,0
51614,efficacy,0,0
51615,.,0,0
51616,The,0,0
51617,purposes,0,0
51618,of,0,0
51619,this,0,0
51620,pilot,0,0
51621,study,0,0
51622,were,0,0
51623,(,0,0
51624,a,0,0
51625,),0,0
51626,to,0,0
51627,assess,0,0
51628,the,0,0
51629,feasibility,0,0
51630,of,0,0
51631,a,0,0
51632,community-based,0,1
51633,",",0,0
51634,small,0,1
51635,group,0,0
51636,HIV,0,1
51637,risk,0,0
51638,reduction,0,0
51639,intervention,0,0
51640,with,0,1
51641,adolescent,1,1
51642,girls,1,1
51643,",",0,0
51644,and,0,0
51645,(,0,0
51646,b,0,0
51647,),0,0
51648,to,0,0
51649,obtain,0,0
51650,preliminary,0,0
51651,evidence,0,0
51652,of,0,0
51653,the,0,0
51654,efficacy,0,0
51655,of,0,0
51656,this,0,0
51657,theoretically-guided,0,0
51658,intervention,0,0
51659,using,0,0
51660,a,0,0
51661,controlled,0,0
51662,design,0,0
51663,.,0,0
51664,The,0,0
51665,feasibility,0,0
51666,of,0,0
51667,the,0,0
51668,intervention,0,0
51669,was,0,0
51670,demonstrated,0,0
51671,by,0,0
51672,successfully,0,0
51673,implementing,0,0
51674,it,0,0
51675,with,0,1
51676,33,1,1
51677,sexually-active,1,1
51678,",",1,0
51679,single,1,0
51680,girls,1,1
51681,.,1,1
51682,Preliminary,0,0
51683,evidence,0,0
51684,of,0,0
51685,the,0,0
51686,efficacy,0,0
51687,of,0,0
51688,the,0,0
51689,intervention,0,0
51690,was,0,0
51691,obtained,0,0
51692,using,0,0
51693,a,0,0
51694,randomized,0,0
51695,trial,0,0
51696,with,0,1
51697,62,1,1
51698,sexually-active,1,1
51699,",",1,0
51700,single,1,0
51701,girls,1,1
51702,.,1,1
51703,Data,0,0
51704,obtained,0,0
51705,at,0,0
51706,a,0,0
51707,3-month,0,0
51708,follow-up,0,0
51709,assessment,0,0
51710,showed,0,0
51711,that,0,0
51712,girls,1,1
51713,who,0,1
51714,received,0,1
51715,the,0,1
51716,HIV-related,0,0
51717,intervention,0,0
51718,improved,0,0
51719,their,0,0
51720,HIV-related,0,0
51721,knowledge,0,0
51722,and,0,0
51723,enhanced,0,0
51724,their,0,0
51725,motivation,0,0
51726,for,0,0
51727,risk,0,0
51728,reduction,0,0
51729,compared,0,0
51730,to,0,1
51731,girls,0,1
51732,who,0,1
51733,received,0,1
51734,a,0,1
51735,control,0,0
51736,(,0,0
51737,health,0,0
51738,promotion,0,0
51739,),0,0
51740,intervention,0,0
51741,.,0,0
51742,Effect,0,0
51743,sizes,0,0
51744,suggest,0,0
51745,that,0,0
51746,the,0,0
51747,HIV,0,0
51748,intervention,0,0
51749,also,0,0
51750,reduced,0,0
51751,several,0,0
51752,risk,0,1
51753,behaviors,0,0
51754,(,0,0
51755,e.g.,0,0
51756,",",0,0
51757,vaginal,0,0
51758,sex,0,0
51759,without,0,1
51760,a,0,0
51761,condom,0,0
51762,",",0,0
51763,giving,0,0
51764,oral,0,0
51765,sex,0,0
51766,",",0,0
51767,and,0,0
51768,alcohol,0,0
51769,and,0,0
51770,drug,0,0
51771,use,0,0
51772,before,0,0
51773,sex,0,1
51774,),0,0
51775,.,0,0
51776,Challenges,0,0
51777,to,0,0
51778,implementation,0,0
51779,and,0,0
51780,suggestions,0,0
51781,for,0,0
51782,intervention,0,0
51783,enhancement,0,0
51784,are,0,0
51785,discussed,0,0
51786,.,0,1
51787,Evaluation,0,0
51788,of,0,0
51789,apical,0,0
51790,sealing,0,0
51791,ability,0,0
51792,and,0,0
51793,adaptation,0,0
51794,to,0,0
51795,dentine,0,1
51796,of,0,0
51797,two,0,0
51798,resin-based,0,0
51799,sealers,0,0
51800,.,0,1
51801,The,0,0
51802,purpose,0,0
51803,of,0,0
51804,this,0,0
51805,study,0,0
51806,was,0,0
51807,to,0,0
51808,evaluate,0,0
51809,the,0,0
51810,apical,0,0
51811,sealing,0,0
51812,ability,0,0
51813,and,0,0
51814,adaptation,0,0
51815,to,0,0
51816,dentine,0,1
51817,of,0,0
51818,two,0,0
51819,resin-based,0,0
51820,root,0,1
51821,canal,0,1
51822,sealers,0,0
51823,.,0,1
51824,The,1,0
51825,root,1,0
51826,canals,1,0
51827,of,1,0
51828,55,1,1
51829,human,1,1
51830,maxillary,1,1
51831,anterior,1,1
51832,teeth,1,1
51833,were,0,0
51834,prepared,0,0
51835,using,0,0
51836,a,0,0
51837,step-back,0,0
51838,technique,0,0
51839,and,0,0
51840,the,0,0
51841,smear,0,0
51842,layer,0,0
51843,removed,0,0
51844,with,0,1
51845,17,0,1
51846,%,0,0
51847,ethylenediaminetetraacetic,0,0
51848,acid,0,0
51849,.,0,0
51850,The,0,0
51851,teeth,0,1
51852,were,0,0
51853,divided,0,1
51854,into,0,1
51855,two,0,0
51856,groups,0,0
51857,of,0,1
51858,25,0,1
51859,teeth,0,1
51860,and,0,0
51861,the,0,0
51862,remaining,0,0
51863,five,0,1
51864,teeth,0,1
51865,served,0,1
51866,as,0,0
51867,control,0,0
51868,.,0,0
51869,Then,0,0
51870,the,0,0
51871,teeth,0,1
51872,were,0,0
51873,prepared,0,0
51874,and,0,0
51875,obturated,0,0
51876,with,0,1
51877,gutta-percha,0,0
51878,by,0,0
51879,a,0,0
51880,lateral,0,0
51881,condensation,0,0
51882,and,0,0
51883,either,0,0
51884,AH,0,0
51885,plus,0,0
51886,and,0,0
51887,EndoRez,0,0
51888,used,0,0
51889,as,0,0
51890,a,0,0
51891,sealer,0,0
51892,.,0,0
51893,Twenty,0,1
51894,teeth,0,1
51895,from,0,0
51896,each,0,0
51897,group,0,0
51898,were,0,0
51899,used,0,0
51900,for,0,0
51901,the,0,0
51902,apical,0,0
51903,leakage,0,0
51904,test,0,0
51905,and,0,0
51906,the,0,0
51907,remaining,0,0
51908,five,0,1
51909,teeth,0,1
51910,from,0,1
51911,each,0,0
51912,group,0,0
51913,were,0,0
51914,used,0,0
51915,for,0,0
51916,examination,0,0
51917,under,0,0
51918,the,0,0
51919,scanning,0,0
51920,electron,0,0
51921,microscope,0,0
51922,(,0,0
51923,SEM,0,0
51924,),0,0
51925,.,0,0
51926,For,0,0
51927,apical,0,0
51928,leakage,0,0
51929,test,0,0
51930,",",0,0
51931,teeth,0,1
51932,were,0,0
51933,covered,0,0
51934,with,0,1
51935,nail,0,1
51936,varnish,0,1
51937,and,0,0
51938,sticky,0,0
51939,wax,0,0
51940,to,0,0
51941,within,0,0
51942,1,0,0
51943,mm,0,0
51944,of,0,0
51945,the,0,0
51946,apical,0,0
51947,foramen,0,1
51948,and,0,0
51949,placed,0,1
51950,in,0,0
51951,2,0,0
51952,%,0,0
51953,methylene,0,0
51954,blue,0,1
51955,for,0,0
51956,7,0,1
51957,days,0,0
51958,.,0,1
51959,After,0,0
51960,this,0,0
51961,period,0,0
51962,",",0,0
51963,the,0,0
51964,teeth,0,1
51965,were,0,0
51966,sectioned,0,0
51967,longitudinally,0,1
51968,and,0,0
51969,apical,0,0
51970,leakage,0,0
51971,measurements,0,0
51972,made,0,0
51973,.,0,1
51974,The,0,0
51975,mean,0,0
51976,value,0,0
51977,of,0,0
51978,dye,0,0
51979,penetration,0,0
51980,for,0,0
51981,AH,0,0
51982,plus,0,0
51983,was,0,0
51984,2.87,0,0
51985,+/-,0,0
51986,0.43,0,0
51987,mm,0,0
51988,",",0,0
51989,while,0,0
51990,that,0,0
51991,of,0,0
51992,EndoRez,0,0
51993,was,0,0
51994,4.54,0,0
51995,+/-,0,0
51996,0.36,0,0
51997,mm,0,0
51998,.,0,0
51999,The,0,0
52000,difference,0,0
52001,between,0,0
52002,mean,0,0
52003,of,0,0
52004,dye,0,0
52005,penetration,0,0
52006,was,0,0
52007,statistically,0,0
52008,significant,0,0
52009,(,0,0
52010,P,0,0
52011,<,0,0
52012,0.01,0,0
52013,),0,0
52014,.,0,0
52015,The,0,0
52016,SEM,0,0
52017,examination,0,0
52018,showed,0,0
52019,both,0,0
52020,sealers,0,0
52021,had,0,0
52022,better,0,0
52023,adaptation,0,0
52024,and,0,0
52025,penetration,0,0
52026,in,0,0
52027,coronal,0,0
52028,and,0,1
52029,middle,0,1
52030,thirds,0,1
52031,than,0,0
52032,apical,0,0
52033,third,0,1
52034,of,0,0
52035,root,0,0
52036,canal,0,1
52037,.,0,0
52038,In,0,0
52039,apical,0,0
52040,third,0,1
52041,",",0,0
52042,AH,0,0
52043,plus,0,0
52044,was,0,0
52045,adapted,0,0
52046,better,0,0
52047,adpated,0,0
52048,to,0,0
52049,dentine,0,1
52050,than,0,0
52051,EndoRez,0,0
52052,.,0,1
52053,In,0,0
52054,conclusion,0,0
52055,",",0,0
52056,AH,0,0
52057,plus,0,0
52058,sealer,0,0
52059,has,0,0
52060,better,0,0
52061,apical,0,0
52062,sealing,0,0
52063,ability,0,0
52064,and,0,0
52065,adaptation,0,0
52066,to,0,0
52067,dentine,0,1
52068,than,0,0
52069,EndoRez,0,0
52070,sealer,0,0
52071,.,0,1
52072,[,0,0
52073,Relationship,0,0
52074,between,0,0
52075,sCD44v6,0,0
52076,expression,0,0
52077,and,0,0
52078,TCM,0,0
52079,differentiation,0,0
52080,type,0,1
52081,of,0,0
52082,gastric,1,1
52083,carcinoma,1,1
52084,patients,1,1
52085,and,0,0
52086,influence,0,0
52087,of,0,0
52088,weitai,0,0
52089,capsule,0,0
52090,on,0,0
52091,the,0,0
52092,expression,0,0
52093,],0,0
52094,.,0,1
52095,OBJECTIVE,0,0
52096,To,0,0
52097,explore,0,0
52098,the,0,0
52099,relationship,0,0
52100,of,0,0
52101,TCM,0,0
52102,type,0,1
52103,with,0,1
52104,serum,0,0
52105,level,0,0
52106,of,0,0
52107,soluble,0,0
52108,CD44v6,0,1
52109,(,0,0
52110,sCD44v6,0,0
52111,),0,0
52112,and,0,0
52113,different,0,0
52114,histologic,0,0
52115,parameters,0,0
52116,in,0,0
52117,gastric,1,1
52118,carcinoma,1,1
52119,patients,1,1
52120,and,0,0
52121,to,0,0
52122,observe,0,0
52123,the,0,0
52124,influence,0,0
52125,of,0,0
52126,Weitai,0,1
52127,capsule,0,0
52128,(,0,0
52129,WTC,0,0
52130,),0,0
52131,on,0,0
52132,the,0,0
52133,sCD44v6,0,0
52134,expression,0,0
52135,.,0,1
52136,METHODS,0,0
52137,TCM,0,0
52138,typing,0,0
52139,and,0,0
52140,sCD44v6,0,0
52141,expression,0,0
52142,were,0,0
52143,determined,0,0
52144,in,0,0
52145,all,1,0
52146,the,1,0
52147,enrolled,1,1
52148,patients,1,1
52149,(,1,1
52150,30,1,1
52151,in,1,0
52152,the,1,0
52153,control,1,0
52154,and,1,0
52155,32,1,1
52156,in,1,0
52157,the,1,0
52158,trial,1,0
52159,group,1,0
52160,),1,0
52161,before,1,0
52162,operation,1,0
52163,",",1,0
52164,and,1,0
52165,3-4,1,0
52166,courses,1,0
52167,of,1,0
52168,chemotherapy,1,1
52169,was,1,0
52170,applied,1,0
52171,to,1,0
52172,them,1,1
52173,from,1,1
52174,3-4,1,1
52175,weeks,1,0
52176,after,1,0
52177,operation,1,1
52178,.,1,0
52179,To,0,0
52180,the,0,0
52181,patients,0,1
52182,of,0,0
52183,trial,0,0
52184,group,0,0
52185,",",0,0
52186,oral,0,0
52187,administration,0,0
52188,of,0,0
52189,WTC,0,0
52190,was,0,0
52191,given,0,0
52192,additionally,0,0
52193,with,0,1
52194,4,0,0
52195,capsules,0,0
52196,",",0,1
52197,3,0,0
52198,times,0,0
52199,a,0,0
52200,day,0,0
52201,for,0,0
52202,consecutive,0,1
52203,3,0,1
52204,months,0,0
52205,.,0,1
52206,RESULTS,0,0
52207,sCD44v6,0,0
52208,was,0,0
52209,significantly,0,0
52210,positive,0,0
52211,correlated,0,0
52212,with,0,1
52213,the,0,0
52214,degree,0,0
52215,of,0,0
52216,cancer,0,1
52217,cell,0,0
52218,differentiation,0,0
52219,",",0,0
52220,infiltration,0,0
52221,and,0,0
52222,lymph,0,1
52223,node,0,1
52224,metastasis,0,1
52225,;,0,0
52226,(,0,0
52227,2,0,0
52228,),0,0
52229,Level,0,0
52230,of,0,0
52231,sCD44v6,0,0
52232,was,0,0
52233,the,0,0
52234,highest,0,0
52235,in,0,0
52236,patients,1,1
52237,of,1,0
52238,blood,1,0
52239,stasis,1,1
52240,type,1,1
52241,",",0,0
52242,as,0,0
52243,compared,0,0
52244,with,0,1
52245,that,0,0
52246,in,0,0
52247,the,0,0
52248,patients,1,1
52249,of,1,0
52250,Pi-deficiency,1,1
52251,type,1,1
52252,or,1,1
52253,of,1,0
52254,damp-heat,1,1
52255,type,1,1
52256,",",0,0
52257,the,0,0
52258,difference,0,0
52259,was,0,0
52260,significant,0,0
52261,;,0,1
52262,(,0,0
52263,3,0,0
52264,),0,0
52265,After,0,0
52266,ending,0,0
52267,treatment,0,0
52268,",",0,0
52269,level,0,0
52270,of,0,0
52271,sCD44v6,0,0
52272,in,0,0
52273,the,0,0
52274,trial,0,0
52275,group,0,0
52276,was,0,0
52277,significantly,0,0
52278,lower,0,0
52279,than,0,0
52280,that,0,0
52281,in,0,0
52282,the,0,0
52283,control,0,0
52284,group,0,0
52285,.,0,0
52286,CONCLUSION,0,0
52287,(,0,0
52288,1,0,0
52289,),0,0
52290,Serum,0,1
52291,level,0,0
52292,of,0,0
52293,sCD44v6,0,0
52294,could,0,0
52295,be,0,0
52296,taken,0,0
52297,as,0,0
52298,the,0,0
52299,criterion,0,0
52300,for,0,0
52301,evaluating,0,0
52302,the,0,0
52303,development,0,0
52304,and,0,0
52305,prognosis,0,0
52306,of,0,0
52307,gastric,0,1
52308,cancer,0,1
52309,",",0,0
52310,as,0,0
52311,well,0,0
52312,as,0,0
52313,the,0,0
52314,therapeutic,0,0
52315,target,0,0
52316,for,0,0
52317,anti-metastasis,0,0
52318,treatment,0,0
52319,;,0,0
52320,(,0,0
52321,2,0,0
52322,),0,0
52323,Serum,0,1
52324,level,0,0
52325,of,0,0
52326,sCD44v6,0,0
52327,is,0,0
52328,related,0,0
52329,to,0,0
52330,some,0,0
52331,extent,0,0
52332,with,0,1
52333,TCM,0,0
52334,type,0,1
52335,of,0,0
52336,blood,0,0
52337,stasis,0,1
52338,and,0,0
52339,Pi-deficiency,0,1
52340,;,0,0
52341,(,0,0
52342,3,0,0
52343,),0,1
52344,WTC,0,0
52345,combined,0,0
52346,with,0,0
52347,chemotherapy,0,0
52348,could,0,0
52349,further,0,0
52350,inhibit,0,0
52351,the,0,0
52352,expression,0,0
52353,of,0,0
52354,serum,0,0
52355,sCD44v6,0,0
52356,in,0,0
52357,gastric,0,1
52358,carcinoma,0,1
52359,patients,0,1
52360,.,0,1
52361,Phase,0,1
52362,I,0,1
52363,pharmacokinetic,0,0
52364,",",0,0
52365,food,0,0
52366,effect,0,0
52367,",",0,0
52368,and,0,0
52369,pharmacogenetic,0,0
52370,study,0,0
52371,of,0,0
52372,oral,0,0
52373,irinotecan,0,0
52374,given,0,0
52375,as,0,0
52376,semisolid,0,0
52377,matrix,0,0
52378,capsules,0,0
52379,in,0,0
52380,patients,1,1
52381,with,1,1
52382,solid,1,1
52383,tumors,1,1
52384,.,1,1
52385,PURPOSE,0,0
52386,To,0,0
52387,characterize,0,0
52388,the,0,0
52389,maximum-tolerated,0,0
52390,dose,0,0
52391,",",0,0
52392,recommended,0,0
52393,dose,0,0
52394,",",0,0
52395,dose-limiting,0,0
52396,toxicities,0,0
52397,(,0,1
52398,DLT,0,1
52399,),0,0
52400,",",0,0
52401,pharmacokinetic,0,0
52402,profile,0,0
52403,",",0,0
52404,and,0,0
52405,food,0,0
52406,effect,0,0
52407,of,0,0
52408,orally,0,0
52409,administered,0,0
52410,irinotecan,0,0
52411,formulated,0,0
52412,as,0,0
52413,new,0,0
52414,semisolid,0,0
52415,matrix,0,1
52416,capsules,0,0
52417,.,0,1
52418,EXPERIMENTAL,0,0
52419,DESIGN,0,0
52420,Irinotecan,0,0
52421,was,0,0
52422,given,0,0
52423,orally,0,0
52424,in,0,0
52425,fasted,1,0
52426,patients,1,1
52427,once,0,0
52428,daily,0,0
52429,for,0,0
52430,5,0,1
52431,consecutive,0,1
52432,days,0,0
52433,and,0,0
52434,repeated,0,0
52435,every,0,0
52436,3,0,0
52437,weeks,0,0
52438,.,0,1
52439,Patients,0,1
52440,were,0,0
52441,randomly,0,1
52442,assigned,0,0
52443,to,0,0
52444,take,0,0
52445,the,0,0
52446,drug,0,0
52447,along,0,0
52448,with,0,1
52449,a,0,0
52450,high-fat,0,0
52451,",",0,0
52452,high-calorie,0,0
52453,breakfast,0,0
52454,for,0,0
52455,the,0,0
52456,administration,0,0
52457,at,0,0
52458,day,0,0
52459,1,0,0
52460,of,0,0
52461,the,0,0
52462,first,0,0
52463,or,0,1
52464,second,0,0
52465,cycle,0,0
52466,.,0,1
52467,Dosages,0,0
52468,tested,0,0
52469,were,0,1
52470,70,0,1
52471,and,0,0
52472,80,0,1
52473,mg/m,0,0
52474,(,0,1
52475,2,0,0
52476,),0,1
52477,/day,0,0
52478,.,0,1
52479,RESULTS,0,0
52480,Twenty-five,1,1
52481,patients,1,1
52482,received,0,1
52483,101,0,1
52484,cycles,0,0
52485,of,0,0
52486,therapy,0,0
52487,(,0,1
52488,median,0,1
52489,two,0,0
52490,cycles,0,0
52491,",",0,0
52492,range,0,1
52493,1-15,0,1
52494,),0,0
52495,.,0,0
52496,During,0,0
52497,the,0,0
52498,first,0,0
52499,cycle,0,0
52500,",",0,0
52501,grade,0,1
52502,3,0,0
52503,delayed,0,0
52504,diarrhea,0,1
52505,and,0,0
52506,grade,0,1
52507,3,0,0
52508,fever,0,1
52509,were,0,0
52510,the,0,0
52511,DLTs,0,0
52512,at,0,0
52513,the,0,0
52514,dosage,0,0
52515,of,0,0
52516,80,0,1
52517,mg/m,0,0
52518,(,0,1
52519,2,0,0
52520,),0,0
52521,/day,0,0
52522,in,0,0
52523,three,0,0
52524,out,0,1
52525,of,0,1
52526,five,0,1
52527,patients,0,1
52528,.,0,1
52529,Hematologic,0,0
52530,and,0,0
52531,nonhematologic,0,1
52532,toxicities,0,0
52533,were,0,1
52534,mild,0,1
52535,to,0,0
52536,moderate,0,1
52537,.,0,0
52538,Exposure,0,0
52539,to,0,0
52540,the,0,0
52541,active,0,0
52542,metabolite,0,0
52543,SN-38,0,0
52544,was,0,0
52545,relatively,0,0
52546,high,0,0
52547,compared,0,0
52548,with,0,1
52549,i.v,0,0
52550,.,0,0
52551,infusion,0,0
52552,",",0,0
52553,but,0,0
52554,no,0,0
52555,relevant,0,0
52556,accumulation,0,0
52557,was,0,0
52558,observed,0,0
52559,.,0,1
52560,Food,0,0
52561,had,0,0
52562,no,0,0
52563,significant,0,0
52564,effect,0,0
52565,on,0,0
52566,irinotecan,0,0
52567,pharmacokinetics,0,0
52568,.,0,1
52569,One,0,1
52570,confirmed,0,0
52571,partial,0,1
52572,remission,0,1
52573,and,0,0
52574,10,0,0
52575,disease,0,1
52576,stabilizations,0,0
52577,were,0,0
52578,observed,0,0
52579,in,0,0
52580,previously,0,1
52581,treated,0,1
52582,patients,0,1
52583,.,0,0
52584,No,0,0
52585,association,0,0
52586,was,0,0
52587,found,0,0
52588,between,0,0
52589,the,0,0
52590,UGT1A1*28,0,0
52591,genotype,0,0
52592,and,0,0
52593,the,0,0
52594,risk,0,0
52595,of,0,0
52596,severe,0,1
52597,irinotecan-induced,0,0
52598,toxicity,0,0
52599,.,0,0
52600,CONCLUSIONS,0,0
52601,For,0,0
52602,oral,0,0
52603,irinotecan,0,0
52604,",",0,0
52605,a,0,0
52606,dose,0,0
52607,of,0,0
52608,70,0,1
52609,mg/m,0,0
52610,(,0,1
52611,2,0,0
52612,),0,0
52613,/day,0,0
52614,for,0,0
52615,5,0,1
52616,consecutive,0,1
52617,days,0,0
52618,every,0,0
52619,3,0,0
52620,weeks,0,0
52621,is,0,0
52622,recommended,0,0
52623,for,0,0
52624,further,0,0
52625,studies,0,0
52626,.,0,1
52627,Delayed,0,0
52628,diarrhea,0,1
52629,was,0,0
52630,the,0,0
52631,main,0,0
52632,DLT,0,1
52633,",",0,0
52634,similar,0,0
52635,to,0,0
52636,that,0,0
52637,observed,0,0
52638,with,0,0
52639,intravenously,0,1
52640,administered,0,0
52641,irinotecan,0,0
52642,.,0,0
52643,This,0,0
52644,study,0,0
52645,confirms,0,0
52646,that,0,0
52647,oral,0,0
52648,administration,0,0
52649,of,0,0
52650,irinotecan,0,0
52651,is,0,0
52652,feasible,0,0
52653,and,0,0
52654,may,0,0
52655,have,0,0
52656,favorable,0,0
52657,pharmacokinetic,0,0
52658,characteristics,0,0
52659,.,0,1
52660,Abacavir,0,0
52661,once,0,0
52662,or,0,0
52663,twice,0,0
52664,daily,0,0
52665,combined,0,0
52666,with,0,1
52667,once-daily,0,0
52668,lamivudine,0,1
52669,and,0,0
52670,efavirenz,0,1
52671,for,0,0
52672,the,0,0
52673,treatment,0,0
52674,of,0,0
52675,antiretroviral-naive,1,1
52676,HIV-infected,1,1
52677,adults,1,1
52678,:,1,1
52679,results,0,0
52680,of,0,0
52681,the,0,0
52682,Ziagen,0,0
52683,Once,0,0
52684,Daily,0,1
52685,in,0,0
52686,Antiretroviral,0,1
52687,Combination,0,0
52688,Study,0,0
52689,.,0,0
52690,The,0,0
52691,long,0,0
52692,intracellular,0,0
52693,half-life,0,0
52694,of,0,0
52695,abacavir,0,0
52696,(,0,0
52697,ABC,0,0
52698,),0,0
52699,supports,0,0
52700,its,0,0
52701,once-daily,0,0
52702,use,0,0
52703,",",0,0
52704,and,0,0
52705,this,0,0
52706,would,0,0
52707,be,0,0
52708,expected,0,0
52709,to,0,0
52710,simplify,0,0
52711,treatment,0,0
52712,if,0,0
52713,ABC,0,0
52714,could,0,0
52715,be,0,0
52716,given,0,0
52717,as,0,0
52718,part,0,0
52719,of,0,0
52720,a,0,0
52721,complete,0,0
52722,once-daily,0,0
52723,regimen,0,0
52724,.,0,1
52725,A,0,0
52726,randomized,0,0
52727,double-blind,0,0
52728,clinical,0,0
52729,trial,0,0
52730,compared,0,0
52731,the,0,0
52732,efficacy,0,0
52733,and,0,0
52734,safety,0,0
52735,of,0,0
52736,600,0,0
52737,mg,0,0
52738,of,0,0
52739,ABC,0,0
52740,administered,0,0
52741,once,0,0
52742,daily,0,0
52743,(,0,0
52744,n,0,1
52745,=,0,0
52746,384,0,1
52747,),0,0
52748,versus,0,0
52749,300,0,0
52750,mg,0,0
52751,of,0,0
52752,ABC,0,0
52753,administered,0,0
52754,twice,0,0
52755,daily,0,0
52756,(,0,0
52757,n,0,1
52758,=,0,0
52759,386,0,1
52760,),0,0
52761,in,0,0
52762,combination,0,0
52763,with,0,1
52764,300,0,0
52765,mg,0,0
52766,of,0,0
52767,lamivudine,0,1
52768,(,0,0
52769,3TC,0,0
52770,),0,1
52771,and,0,0
52772,600,0,0
52773,mg,0,0
52774,of,0,0
52775,efavirenz,0,1
52776,(,0,0
52777,EFV,0,1
52778,),0,0
52779,administered,0,0
52780,once,0,0
52781,daily,0,0
52782,in,0,0
52783,antiretroviral-naive,1,1
52784,patients,1,1
52785,over,1,0
52786,48,1,1
52787,weeks,1,0
52788,.,1,1
52789,The,0,0
52790,baseline,0,0
52791,median,0,0
52792,plasma,0,0
52793,HIV-1,0,1
52794,RNA,0,1
52795,level,0,0
52796,was,0,0
52797,4.89,0,0
52798,log10,0,0
52799,copies/mL,0,0
52800,(,0,0
52801,44,0,1
52802,%,0,0
52803,with,0,1
52804,viral,0,0
52805,load,0,0
52806,>,0,1
52807,"100,000",0,0
52808,copies/mL,0,0
52809,),0,0
52810,",",0,0
52811,and,0,0
52812,the,0,0
52813,median,0,0
52814,CD4,0,1
52815,cell,0,1
52816,count,0,0
52817,was,0,0
52818,262,0,1
52819,cells/mm,0,0
52820,.,0,1
52821,ABC,0,0
52822,administered,0,0
52823,once,0,0
52824,daily,0,0
52825,was,0,0
52826,non-inferior,0,0
52827,to,0,0
52828,the,0,0
52829,twice-daily,0,0
52830,regimen,0,0
52831,",",0,0
52832,with,0,1
52833,66,0,1
52834,%,0,0
52835,and,0,0
52836,68,0,1
52837,%,0,0
52838,of,0,0
52839,patients,0,1
52840,in,0,0
52841,these,0,0
52842,respective,0,0
52843,treatment,0,0
52844,arms,0,0
52845,achieving,0,0
52846,a,0,0
52847,confirmed,0,0
52848,plasma,0,0
52849,HIV-1,0,1
52850,RNA,0,1
52851,level,0,0
52852,<,0,0
52853,50,0,1
52854,copies/mL,0,0
52855,(,0,0
52856,95,0,0
52857,%,0,0
52858,confidence,0,0
52859,interval,0,0
52860,:,0,1
52861,-8.4,0,0
52862,%,0,0
52863,",",0,0
52864,4.9,0,0
52865,%,0,0
52866,),0,0
52867,.,0,0
52868,The,0,0
52869,ABC,0,0
52870,once-daily,0,0
52871,and,0,0
52872,twice-daily,0,0
52873,regimens,0,0
52874,were,0,1
52875,similar,0,0
52876,with,0,1
52877,respect,0,0
52878,to,0,0
52879,infrequency,0,0
52880,of,0,0
52881,virologic,0,0
52882,failure,0,1
52883,(,0,0
52884,10,0,0
52885,%,0,0
52886,vs.,0,0
52887,8,0,0
52888,%,0,0
52889,),0,0
52890,",",0,0
52891,emergence,0,0
52892,of,0,0
52893,resistance,0,0
52894,mutations,0,1
52895,",",0,0
52896,CD4,0,1
52897,cell,0,1
52898,increases,0,0
52899,from,0,1
52900,baseline,0,0
52901,(,0,0
52902,median,0,0
52903,",",0,0
52904,188,0,1
52905,vs.,0,0
52906,200,0,0
52907,cells/mm,0,0
52908,),0,0
52909,",",0,0
52910,safety,0,0
52911,profile,0,0
52912,",",0,0
52913,and,0,0
52914,incidence,0,0
52915,of,0,0
52916,ABC-related,0,0
52917,hypersensitivity,0,0
52918,reactions,0,0
52919,(,0,1
52920,9,0,0
52921,%,0,0
52922,vs.,0,0
52923,7,0,0
52924,%,0,0
52925,),0,1
52926,.,0,1
52927,ABC,0,0
52928,administered,0,0
52929,once,0,0
52930,daily,0,0
52931,in,0,0
52932,combination,0,0
52933,with,0,1
52934,3TC,0,0
52935,and,0,1
52936,EFV,0,1
52937,administered,0,0
52938,once,0,0
52939,daily,0,0
52940,was,0,0
52941,non-inferior,0,0
52942,to,0,0
52943,the,0,0
52944,ABC,0,0
52945,twice-daily,0,0
52946,dosing,0,0
52947,schedule,0,0
52948,when,0,0
52949,combined,0,0
52950,with,0,0
52951,3TC,0,0
52952,and,0,0
52953,EFV,0,1
52954,over,0,0
52955,48,0,1
52956,weeks,0,0
52957,.,0,1
52958,Effects,0,0
52959,of,0,1
52960,long-term,0,0
52961,vitamin,0,0
52962,E,0,0
52963,supplementation,0,0
52964,on,0,0
52965,cardiovascular,1,1
52966,events,1,0
52967,and,1,1
52968,cancer,1,1
52969,:,1,1
52970,a,0,0
52971,randomized,0,0
52972,controlled,0,0
52973,trial,0,0
52974,.,0,1
52975,CONTEXT,0,0
52976,Experimental,0,0
52977,and,0,0
52978,epidemiological,0,1
52979,data,0,0
52980,suggest,0,0
52981,that,0,0
52982,vitamin,0,0
52983,E,0,0
52984,supplementation,0,0
52985,may,0,0
52986,prevent,0,0
52987,cancer,1,1
52988,and,1,0
52989,cardiovascular,1,1
52990,events,1,0
52991,.,1,1
52992,Clinical,0,0
52993,trials,0,0
52994,have,0,0
52995,generally,0,0
52996,failed,0,0
52997,to,0,0
52998,confirm,0,0
52999,benefits,0,0
53000,",",0,0
53001,possibly,0,0
53002,due,0,0
53003,to,0,0
53004,their,0,0
53005,relatively,0,0
53006,short,0,0
53007,duration,0,0
53008,.,0,0
53009,OBJECTIVE,0,0
53010,To,0,0
53011,evaluate,0,0
53012,whether,0,0
53013,long-term,0,0
53014,supplementation,0,0
53015,with,0,1
53016,vitamin,0,0
53017,E,0,0
53018,decreases,0,0
53019,the,0,0
53020,risk,0,0
53021,of,0,0
53022,cancer,1,1
53023,",",1,0
53024,cancer,1,1
53025,death,1,0
53026,",",1,0
53027,and,1,0
53028,major,1,0
53029,cardiovascular,1,1
53030,events,1,0
53031,.,1,1
53032,DESIGN,0,0
53033,",",0,0
53034,SETTING,0,1
53035,",",0,0
53036,AND,0,0
53037,PATIENTS,0,0
53038,A,0,0
53039,randomized,0,0
53040,",",0,0
53041,double-blind,0,0
53042,",",0,0
53043,placebo-controlled,0,0
53044,international,1,0
53045,trial,0,0
53046,(,0,0
53047,the,0,0
53048,initial,0,0
53049,Heart,0,1
53050,Outcomes,0,0
53051,Prevention,0,1
53052,Evaluation,0,0
53053,[,0,0
53054,HOPE,0,1
53055,],0,1
53056,trial,0,0
53057,conducted,0,0
53058,between,0,0
53059,December,0,1
53060,21,0,1
53061,",",0,0
53062,1993,0,1
53063,",",0,0
53064,and,0,0
53065,April,0,0
53066,15,0,1
53067,",",0,0
53068,1999,0,1
53069,),0,0
53070,of,0,0
53071,patients,1,1
53072,at,1,1
53073,least,1,1
53074,55,1,1
53075,years,1,1
53076,old,1,1
53077,with,1,1
53078,vascular,1,0
53079,disease,1,1
53080,or,1,0
53081,diabetes,1,1
53082,mellitus,1,1
53083,was,1,0
53084,extended,1,0
53085,(,1,0
53086,HOPE-The,1,0
53087,Ongoing,1,0
53088,Outcomes,1,0
53089,[,1,0
53090,HOPE-TOO,1,1
53091,],1,1
53092,),1,0
53093,between,1,0
53094,April,1,0
53095,16,1,1
53096,",",1,0
53097,1999,1,1
53098,",",1,0
53099,and,1,0
53100,May,1,0
53101,26,1,1
53102,",",1,0
53103,2003,1,1
53104,.,1,0
53105,Of,0,0
53106,the,0,0
53107,initial,0,0
53108,267,1,1
53109,HOPE,1,1
53110,centers,1,1
53111,that,1,0
53112,had,1,1
53113,enrolled,1,1
53114,9541,1,1
53115,patients,1,1
53116,",",1,1
53117,174,1,1
53118,centers,1,1
53119,participated,1,1
53120,in,1,0
53121,the,1,0
53122,HOPE-TOO,1,0
53123,trial,1,0
53124,.,1,0
53125,Of,0,0
53126,7030,1,1
53127,patients,1,1
53128,enrolled,1,1
53129,at,1,0
53130,these,1,0
53131,centers,1,1
53132,",",1,0
53133,916,1,1
53134,were,1,0
53135,deceased,1,1
53136,at,1,0
53137,the,1,0
53138,beginning,1,0
53139,of,1,0
53140,the,1,0
53141,extension,1,0
53142,",",1,0
53143,1382,1,1
53144,refused,1,1
53145,participation,1,0
53146,",",1,0
53147,3994,1,1
53148,continued,1,0
53149,to,1,0
53150,take,1,0
53151,the,1,0
53152,study,1,0
53153,intervention,1,0
53154,",",1,0
53155,and,1,0
53156,738,1,1
53157,agreed,1,0
53158,to,1,0
53159,passive,1,0
53160,follow-up,1,0
53161,.,1,0
53162,Median,0,0
53163,duration,0,0
53164,of,0,0
53165,follow-up,0,0
53166,was,0,0
53167,7.0,0,1
53168,years,0,1
53169,.,0,1
53170,INTERVENTION,0,0
53171,Daily,0,0
53172,dose,0,0
53173,of,0,0
53174,natural,0,0
53175,source,0,1
53176,vitamin,0,0
53177,E,0,0
53178,(,0,0
53179,400,0,0
53180,IU,0,0
53181,),0,0
53182,or,0,0
53183,matching,0,0
53184,placebo,0,0
53185,.,0,1
53186,MAIN,0,0
53187,OUTCOME,0,0
53188,MEASURES,0,0
53189,Primary,0,1
53190,outcomes,0,0
53191,included,0,1
53192,cancer,0,1
53193,incidence,0,0
53194,",",0,0
53195,cancer,0,1
53196,deaths,0,0
53197,",",0,0
53198,and,0,0
53199,major,0,0
53200,cardiovascular,0,1
53201,events,0,0
53202,(,0,1
53203,myocardial,0,1
53204,infarction,0,1
53205,",",0,0
53206,stroke,0,1
53207,",",0,0
53208,and,0,0
53209,cardiovascular,0,0
53210,death,0,0
53211,),0,0
53212,.,0,1
53213,Secondary,0,0
53214,outcomes,0,0
53215,included,0,1
53216,heart,0,1
53217,failure,0,1
53218,",",0,0
53219,unstable,0,1
53220,angina,0,1
53221,",",0,0
53222,and,0,0
53223,revascularizations,0,1
53224,.,0,1
53225,RESULTS,0,0
53226,Among,0,1
53227,all,0,0
53228,HOPE,0,0
53229,patients,0,1
53230,",",0,0
53231,there,0,0
53232,were,0,0
53233,no,0,0
53234,significant,0,0
53235,differences,0,0
53236,in,0,0
53237,the,0,0
53238,primary,0,1
53239,analysis,0,0
53240,:,0,1
53241,for,0,0
53242,cancer,0,1
53243,incidence,0,0
53244,",",0,0
53245,there,0,0
53246,were,0,0
53247,552,0,0
53248,patients,0,1
53249,(,0,1
53250,11.6,0,0
53251,%,0,0
53252,),0,0
53253,in,0,0
53254,the,0,0
53255,vitamin,0,0
53256,E,0,0
53257,group,0,0
53258,vs,0,0
53259,586,0,1
53260,(,0,0
53261,12.3,0,0
53262,%,0,0
53263,),0,0
53264,in,0,0
53265,the,0,0
53266,placebo,0,0
53267,group,0,0
53268,(,0,0
53269,relative,0,0
53270,risk,0,1
53271,[,0,0
53272,RR,0,0
53273,],0,1
53274,",",0,0
53275,0.94,0,0
53276,;,0,0
53277,95,0,0
53278,%,0,0
53279,confidence,0,0
53280,interval,0,0
53281,[,0,0
53282,CI,0,0
53283,],0,0
53284,",",0,0
53285,0.84-1.06,0,0
53286,;,0,0
53287,P,0,0
53288,=,0,0
53289,.30,0,0
53290,),0,0
53291,;,0,0
53292,for,0,0
53293,cancer,0,1
53294,deaths,0,0
53295,",",0,0
53296,156,0,1
53297,(,0,0
53298,3.3,0,0
53299,%,0,0
53300,),0,0
53301,vs,0,0
53302,178,0,1
53303,(,0,0
53304,3.7,0,0
53305,%,0,0
53306,),0,0
53307,",",0,0
53308,respectively,0,0
53309,(,0,0
53310,RR,0,0
53311,",",0,1
53312,0.88,0,0
53313,;,0,0
53314,95,0,0
53315,%,0,0
53316,CI,0,0
53317,",",0,0
53318,0.71-1.09,0,0
53319,;,0,0
53320,P,0,0
53321,=,0,0
53322,.24,0,0
53323,),0,1
53324,;,0,0
53325,and,0,0
53326,for,0,0
53327,major,0,1
53328,cardiovascular,0,1
53329,events,0,0
53330,",",0,0
53331,1022,0,1
53332,(,0,0
53333,21.5,0,0
53334,%,0,0
53335,),0,0
53336,vs,0,0
53337,985,0,1
53338,(,0,0
53339,20.6,0,0
53340,%,0,0
53341,),0,0
53342,",",0,0
53343,respectively,0,0
53344,(,0,0
53345,RR,0,0
53346,",",0,1
53347,1.04,0,0
53348,;,0,0
53349,95,0,0
53350,%,0,0
53351,CI,0,0
53352,",",0,0
53353,0.96-1.14,0,0
53354,;,0,0
53355,P,0,0
53356,=,0,0
53357,.34,0,0
53358,),0,1
53359,.,0,1
53360,Patients,0,1
53361,in,0,0
53362,the,0,0
53363,vitamin,0,0
53364,E,0,0
53365,group,0,0
53366,had,0,0
53367,a,0,0
53368,higher,0,0
53369,risk,0,0
53370,of,0,0
53371,heart,0,1
53372,failure,0,1
53373,(,0,0
53374,RR,0,0
53375,",",0,1
53376,1.13,0,0
53377,;,0,0
53378,95,0,0
53379,%,0,0
53380,CI,0,0
53381,",",0,0
53382,1.01-1.26,0,0
53383,;,0,0
53384,P,0,0
53385,=,0,0
53386,.03,0,0
53387,),0,0
53388,and,0,0
53389,hospitalization,0,0
53390,for,0,0
53391,heart,0,1
53392,failure,0,1
53393,(,0,0
53394,RR,0,0
53395,",",0,1
53396,1.21,0,0
53397,;,0,0
53398,95,0,0
53399,%,0,0
53400,CI,0,0
53401,",",0,0
53402,1.00-1.47,0,0
53403,;,0,0
53404,P,0,0
53405,=,0,0
53406,.045,0,0
53407,),0,0
53408,.,0,0
53409,Similarly,0,0
53410,",",0,0
53411,among,0,0
53412,patients,0,1
53413,enrolled,0,1
53414,at,0,0
53415,the,0,0
53416,centers,0,1
53417,participating,0,1
53418,in,0,0
53419,the,0,0
53420,HOPE-TOO,0,0
53421,trial,0,0
53422,",",0,0
53423,there,0,0
53424,were,0,0
53425,no,0,0
53426,differences,0,0
53427,in,0,0
53428,cancer,0,1
53429,incidence,0,0
53430,",",0,0
53431,cancer,0,1
53432,deaths,0,0
53433,",",0,0
53434,and,0,0
53435,major,0,0
53436,cardiovascular,0,1
53437,events,0,0
53438,",",0,0
53439,but,0,0
53440,higher,0,0
53441,rates,0,0
53442,of,0,0
53443,heart,0,1
53444,failure,0,1
53445,and,0,0
53446,hospitalizations,0,0
53447,for,0,0
53448,heart,0,1
53449,failure,0,1
53450,.,0,0
53451,CONCLUSION,0,0
53452,In,0,0
53453,patients,1,1
53454,with,1,1
53455,vascular,1,0
53456,disease,1,1
53457,or,1,0
53458,diabetes,1,1
53459,mellitus,1,1
53460,",",0,0
53461,long-term,0,0
53462,vitamin,0,0
53463,E,0,0
53464,supplementation,0,0
53465,does,0,0
53466,not,0,0
53467,prevent,0,0
53468,cancer,0,1
53469,or,0,0
53470,major,0,1
53471,cardiovascular,0,1
53472,events,0,0
53473,and,0,0
53474,may,0,0
53475,increase,0,0
53476,the,0,0
53477,risk,0,0
53478,for,0,0
53479,heart,0,1
53480,failure,0,1
53481,.,0,1
53482,Stapled,0,0
53483,hemorrhoidopexy,0,1
53484,vs.,0,0
53485,Harmonic,0,0
53486,Scalpel,0,0
53487,hemorrhoidectomy,0,1
53488,:,0,1
53489,a,0,0
53490,randomized,0,0
53491,trial,0,0
53492,.,0,0
53493,PURPOSE,0,0
53494,A,0,0
53495,randomized,0,0
53496,trial,0,0
53497,was,0,0
53498,undertaken,0,0
53499,to,0,0
53500,evaluate,0,0
53501,and,0,0
53502,compare,0,0
53503,stapled,0,0
53504,hemorrhoidopexy,0,0
53505,with,0,1
53506,excisional,0,1
53507,hemorrhoidectomy,0,1
53508,in,0,0
53509,which,0,0
53510,the,0,0
53511,Harmonic,0,0
53512,Scalpel,0,0
53513,was,0,0
53514,used,0,0
53515,.,0,1
53516,METHODS,0,0
53517,Patients,1,1
53518,with,1,1
53519,Grade,1,1
53520,III,1,1
53521,hemorrhoids,1,1
53522,who,1,1
53523,were,1,1
53524,employed,1,1
53525,during,1,0
53526,the,1,0
53527,trial,1,0
53528,period,1,0
53529,were,0,0
53530,recruited,0,1
53531,and,0,0
53532,randomized,0,0
53533,into,0,1
53534,two,0,1
53535,groups,0,0
53536,:,0,1
53537,(,0,1
53538,1,0,0
53539,),0,1
53540,Harmonic,0,1
53541,Scalpel,0,0
53542,hemorrhoidectomy,0,0
53543,",",0,0
53544,and,0,0
53545,(,0,0
53546,2,0,0
53547,),0,0
53548,stapled,0,0
53549,hemorrhoidopexy,0,1
53550,.,0,0
53551,All,0,0
53552,operations,0,0
53553,were,0,0
53554,performed,0,0
53555,by,0,0
53556,a,0,0
53557,single,0,0
53558,surgeon,0,1
53559,.,0,0
53560,In,0,0
53561,the,0,0
53562,stapled,0,0
53563,group,0,0
53564,",",0,0
53565,the,0,0
53566,doughnut,0,0
53567,obtained,0,0
53568,was,0,0
53569,sent,0,1
53570,for,0,0
53571,histopathologic,0,0
53572,examination,0,0
53573,to,0,0
53574,determine,0,0
53575,whether,0,0
53576,smooth,0,1
53577,muscles,0,0
53578,were,0,1
53579,included,0,1
53580,in,0,0
53581,the,0,0
53582,specimen,0,0
53583,.,0,1
53584,Operative,0,0
53585,data,0,0
53586,and,0,0
53587,complications,0,0
53588,were,0,0
53589,recorded,0,0
53590,",",0,0
53591,and,0,0
53592,patients,0,1
53593,were,0,0
53594,followed,0,0
53595,up,0,0
53596,through,0,0
53597,a,0,0
53598,structured,0,0
53599,pro,0,0
53600,forma,0,0
53601,protocol,0,0
53602,.,0,0
53603,An,0,0
53604,independent,0,0
53605,assessor,0,0
53606,was,0,0
53607,assigned,0,0
53608,to,0,0
53609,obtain,0,0
53610,postoperative,0,0
53611,pain,0,1
53612,scores,0,0
53613,and,0,0
53614,satisfaction,0,0
53615,scores,0,0
53616,at,0,1
53617,six-month,0,1
53618,follow-up,0,0
53619,.,0,1
53620,Patients,0,1
53621,were,0,0
53622,also,0,0
53623,administered,0,0
53624,a,0,0
53625,simple,0,0
53626,questionnaire,0,0
53627,at,0,0
53628,follow-up,0,0
53629,to,0,0
53630,assess,0,0
53631,continence,0,0
53632,functions,0,0
53633,.,0,1
53634,RESULTS,0,0
53635,Over,1,0
53636,a,1,0
53637,20-month,1,0
53638,period,1,0
53639,",",1,0
53640,88,1,1
53641,patients,1,1
53642,were,1,1
53643,recruited,1,1
53644,.,1,0
53645,The,0,0
53646,two,0,0
53647,groups,0,0
53648,were,0,1
53649,matched,0,1
53650,for,0,0
53651,age,0,1
53652,and,0,0
53653,gender,0,0
53654,distribution,0,0
53655,.,0,0
53656,No,0,0
53657,significant,0,0
53658,difference,0,0
53659,was,0,0
53660,identified,0,0
53661,between,0,0
53662,the,0,0
53663,two,0,0
53664,groups,0,0
53665,in,0,1
53666,terms,0,0
53667,of,0,0
53668,operation,0,0
53669,time,0,0
53670,",",0,0
53671,blood,0,0
53672,loss,0,0
53673,",",0,0
53674,day,0,0
53675,of,0,0
53676,first,0,0
53677,bowel,0,1
53678,movement,0,0
53679,after,0,0
53680,surgery,0,1
53681,",",0,0
53682,and,0,0
53683,complication,0,0
53684,rates,0,0
53685,.,0,1
53686,Despite,0,0
53687,a,0,0
53688,similar,0,0
53689,parenteral,0,0
53690,and,0,0
53691,oral,0,0
53692,analgesic,0,0
53693,requirement,0,0
53694,",",0,0
53695,the,0,0
53696,stapled,0,0
53697,group,0,0
53698,had,0,0
53699,a,0,0
53700,significantly,0,0
53701,better,0,0
53702,pain,0,0
53703,score,0,0
53704,(,0,0
53705,P,0,0
53706,=,0,0
53707,0.002,0,0
53708,),0,1
53709,;,0,0
53710,these,0,0
53711,patients,0,1
53712,also,0,0
53713,had,0,0
53714,a,0,0
53715,significantly,0,0
53716,shorter,0,0
53717,length,0,0
53718,of,0,0
53719,stay,0,0
53720,(,0,0
53721,P,0,0
53722,=,0,0
53723,0.02,0,0
53724,),0,0
53725,",",0,0
53726,and,0,0
53727,on,0,0
53728,average,0,0
53729,resumed,0,0
53730,work,0,0
53731,nine,0,1
53732,days,0,0
53733,earlier,0,0
53734,than,0,0
53735,the,0,0
53736,group,0,0
53737,treated,0,0
53738,with,0,1
53739,the,0,0
53740,Harmonic,0,0
53741,Scalpel,0,0
53742,(,0,0
53743,6.7,0,0
53744,vs.,0,0
53745,15.6,0,0
53746,",",0,0
53747,P,0,0
53748,=,0,0
53749,0.002,0,0
53750,),0,0
53751,.,0,1
53752,Although,0,0
53753,88,0,0
53754,percent,0,1
53755,of,0,0
53756,doughnuts,0,0
53757,obtained,0,0
53758,in,0,0
53759,the,0,0
53760,stapled,0,0
53761,group,0,0
53762,contained,0,0
53763,some,0,0
53764,smooth,0,1
53765,muscle,0,0
53766,fibers,0,0
53767,",",0,0
53768,no,0,0
53769,association,0,0
53770,was,0,0
53771,found,0,0
53772,between,0,0
53773,smooth,0,1
53774,muscle,0,0
53775,incorporation,0,0
53776,and,0,0
53777,postoperative,0,0
53778,continence,0,0
53779,function,0,0
53780,",",0,0
53781,and,0,0
53782,as,0,0
53783,a,0,0
53784,whole,0,0
53785,the,0,0
53786,continence,0,0
53787,outcomes,0,0
53788,of,0,0
53789,the,0,0
53790,stapled,0,0
53791,group,0,0
53792,were,0,0
53793,similar,0,0
53794,to,0,0
53795,those,0,0
53796,after,0,0
53797,Harmonic,0,0
53798,Scalpel,0,1
53799,hemorrhoidectomy,0,1
53800,.,0,0
53801,Finally,0,0
53802,",",0,0
53803,at,0,0
53804,six-month,0,0
53805,follow-up,0,0
53806,",",0,1
53807,patients,0,1
53808,who,0,1
53809,underwent,0,1
53810,the,0,1
53811,stapled,0,0
53812,procedure,0,0
53813,had,0,0
53814,significantly,0,0
53815,better,0,0
53816,satisfaction,0,0
53817,scores,0,0
53818,(,0,1
53819,P,0,0
53820,=,0,0
53821,0.001,0,0
53822,),0,1
53823,.,0,1
53824,CONCLUSION,0,0
53825,Stapled,0,0
53826,hemorrhoidopexy,0,0
53827,is,0,0
53828,a,0,0
53829,safe,0,0
53830,and,0,0
53831,effective,0,0
53832,procedure,0,0
53833,for,0,0
53834,Grade,0,0
53835,III,0,1
53836,hemorrhoidal,0,1
53837,disease,0,1
53838,.,0,1
53839,Patients,0,1
53840,derive,0,0
53841,greater,0,0
53842,short-term,0,0
53843,benefits,0,0
53844,of,0,0
53845,reduced,0,0
53846,pain,0,1
53847,",",0,0
53848,shorter,0,0
53849,length,0,0
53850,of,0,0
53851,stay,0,0
53852,",",0,0
53853,and,0,0
53854,earlier,0,0
53855,resumption,0,0
53856,to,0,0
53857,work,0,0
53858,.,0,0
53859,Long-term,0,0
53860,follow-up,0,0
53861,is,0,0
53862,necessary,0,0
53863,to,0,0
53864,determine,0,0
53865,whether,0,0
53866,these,0,0
53867,initial,0,0
53868,results,0,0
53869,are,0,0
53870,lasting,0,0
53871,.,0,1
53872,Dairy,0,1
53873,products,0,0
53874,do,0,0
53875,not,0,0
53876,lead,0,0
53877,to,0,0
53878,alterations,0,0
53879,in,0,0
53880,body,0,1
53881,weight,0,0
53882,or,0,1
53883,fat,0,0
53884,mass,0,1
53885,in,0,0
53886,young,1,1
53887,women,1,1
53888,in,0,0
53889,a,0,0
53890,1-y,0,0
53891,intervention,0,0
53892,.,0,1
53893,BACKGROUND,0,0
53894,Previous,0,1
53895,results,0,0
53896,suggested,0,0
53897,that,0,0
53898,increased,0,0
53899,intake,0,0
53900,of,0,0
53901,dairy,0,1
53902,calcium,0,0
53903,is,0,0
53904,associated,0,0
53905,with,0,0
53906,reduced,0,0
53907,weight,0,1
53908,and,0,0
53909,fat,0,0
53910,mass,0,1
53911,.,0,0
53912,OBJECTIVE,0,0
53913,The,0,0
53914,purpose,0,0
53915,of,0,0
53916,this,0,0
53917,study,0,0
53918,was,0,0
53919,to,0,0
53920,determine,0,0
53921,whether,0,0
53922,long-term,0,0
53923,increases,0,0
53924,in,0,0
53925,consumption,0,0
53926,of,0,0
53927,dairy,0,1
53928,calcium,0,0
53929,alter,0,0
53930,body,0,0
53931,weight,0,0
53932,and,0,0
53933,fat,0,0
53934,mass,0,1
53935,in,0,0
53936,young,1,1
53937,",",1,0
53938,healthy,1,1
53939,women,1,1
53940,.,1,1
53941,DESIGN,0,0
53942,We,0,0
53943,used,0,0
53944,a,0,0
53945,randomized,0,0
53946,",",0,0
53947,1-y,0,0
53948,intervention,0,0
53949,for,0,0
53950,dairy,0,1
53951,calcium,0,0
53952,.,0,1
53953,Subjects,1,1
53954,were,1,1
53955,155,1,1
53956,young,1,1
53957,(,1,1
53958,aged,1,1
53959,18-30,1,1
53960,y,1,1
53961,),1,0
53962,",",1,0
53963,healthy,1,1
53964,",",1,0
53965,normal-weight,1,1
53966,women,1,1
53967,with,1,1
53968,intake,1,0
53969,of,1,0
53970,dietary,1,0
53971,calcium,1,0
53972,<,1,0
53973,800,1,0
53974,mg/d,1,0
53975,and,1,0
53976,energy,1,0
53977,intake,1,0
53978,<,1,0
53979,/=,1,1
53980,2200,1,1
53981,kcal/d,1,0
53982,.,1,1
53983,Women,0,1
53984,were,0,0
53985,randomly,0,1
53986,assigned,0,1
53987,to,0,0
53988,1,0,0
53989,of,0,0
53990,3,0,1
53991,groups,0,1
53992,:,0,1
53993,1,0,1
53994,),0,1
53995,control,0,1
53996,:,0,1
53997,continue,0,0
53998,established,0,0
53999,dietary,0,0
54000,intake,0,1
54001,;,0,1
54002,2,0,0
54003,),0,0
54004,medium,0,0
54005,dairy,0,1
54006,:,0,1
54007,substitute,0,0
54008,dairy,0,1
54009,products,0,0
54010,to,0,0
54011,achieve,0,0
54012,intake,0,0
54013,of,0,0
54014,calcium,0,0
54015,of,0,0
54016,approximately,0,0
54017,1000-1100,0,0
54018,mg/d,0,0
54019,and,0,0
54020,maintain,0,0
54021,isocaloric,0,0
54022,intake,0,0
54023,;,0,1
54024,3,0,0
54025,),0,0
54026,high,0,1
54027,dairy,0,1
54028,:,0,1
54029,substitute,0,0
54030,dairy,0,1
54031,products,0,0
54032,to,0,0
54033,achieve,0,0
54034,intake,0,0
54035,of,0,0
54036,calcium,0,0
54037,of,0,0
54038,1300-1400,0,1
54039,mg/d,0,0
54040,and,0,0
54041,maintain,0,0
54042,isocaloric,0,0
54043,intake,0,0
54044,.,0,0
54045,The,0,0
54046,main,0,0
54047,outcome,0,0
54048,measures,0,0
54049,were,0,1
54050,1-y,0,0
54051,changes,0,0
54052,in,0,0
54053,body,0,1
54054,weight,0,0
54055,(,0,0
54056,in,0,0
54057,kg,0,1
54058,),0,0
54059,and,0,0
54060,fat,0,0
54061,mass,0,0
54062,(,0,0
54063,in,0,0
54064,kg,0,1
54065,),0,1
54066,.,0,1
54067,One,1,1
54068,hundred,1,1
54069,thirty-five,1,1
54070,women,1,1
54071,completed,1,1
54072,the,1,0
54073,trial,1,0
54074,.,1,0
54075,RESULTS,0,0
54076,Mean,0,1
54077,intakes,0,0
54078,of,0,0
54079,calcium,0,0
54080,during,0,0
54081,the,0,0
54082,intervention,0,0
54083,were,0,0
54084,742.4,0,0
54085,+/-,0,0
54086,321.5,0,0
54087,",",0,0
54088,1026.4,0,0
54089,+/-,0,0
54090,311.3,0,0
54091,",",0,0
54092,and,0,0
54093,1131.29,0,0
54094,+/-,0,0
54095,337.2,0,0
54096,mg/d,0,0
54097,for,0,0
54098,the,0,0
54099,control,0,0
54100,",",0,0
54101,medium-dairy,0,0
54102,",",0,0
54103,and,0,0
54104,high-dairy,0,0
54105,groups,0,0
54106,",",0,0
54107,respectively,0,0
54108,(,0,0
54109,P,0,0
54110,<,0,0
54111,0.0001,0,0
54112,),0,0
54113,.,0,0
54114,No,0,0
54115,significant,0,0
54116,differences,0,0
54117,were,0,1
54118,observed,0,0
54119,in,0,0
54120,the,0,0
54121,mean,0,0
54122,1-y,0,0
54123,change,0,0
54124,in,0,0
54125,body,0,0
54126,weight,0,0
54127,between,0,0
54128,the,0,0
54129,control,0,0
54130,",",0,0
54131,medium-dairy,0,0
54132,",",0,0
54133,and,0,0
54134,high-dairy,0,0
54135,groups,0,0
54136,(,0,1
54137,0.8,0,1
54138,+/-,0,0
54139,2.8,0,0
54140,",",0,0
54141,0.7,0,0
54142,+/-,0,0
54143,3.0,0,0
54144,",",0,0
54145,and,0,0
54146,1.5,0,0
54147,+/-,0,0
54148,4.1,0,0
54149,kg,0,0
54150,",",0,0
54151,respectively,0,0
54152,;,0,0
54153,P,0,0
54154,=,0,0
54155,0.45,0,0
54156,),0,0
54157,.,0,0
54158,No,0,0
54159,significant,0,0
54160,differences,0,0
54161,were,0,1
54162,observed,0,0
54163,in,0,0
54164,the,0,0
54165,mean,0,0
54166,1-y,0,0
54167,change,0,0
54168,in,0,0
54169,fat,0,0
54170,mass,0,1
54171,between,0,0
54172,the,0,0
54173,control,0,0
54174,",",0,0
54175,medium-dairy,0,0
54176,",",0,0
54177,and,0,0
54178,high-dairy,0,0
54179,groups,0,0
54180,(,0,1
54181,-0.5,0,0
54182,+/-,0,0
54183,2.5,0,0
54184,",",0,0
54185,0.3,0,0
54186,+/-,0,0
54187,2.7,0,0
54188,",",0,0
54189,and,0,0
54190,0.5,0,0
54191,+/-,0,0
54192,3.5,0,1
54193,kg,0,0
54194,",",0,0
54195,respectively,0,0
54196,;,0,0
54197,P,0,0
54198,=,0,0
54199,0.26,0,0
54200,),0,1
54201,.,0,1
54202,CONCLUSION,0,0
54203,Increased,0,0
54204,intake,0,0
54205,of,0,0
54206,dairy,0,1
54207,products,0,0
54208,does,0,0
54209,not,0,0
54210,alter,0,0
54211,body,0,0
54212,weight,0,0
54213,or,0,1
54214,fat,0,0
54215,mass,0,1
54216,in,0,0
54217,young,1,1
54218,",",1,0
54219,healthy,1,1
54220,women,1,1
54221,over,0,0
54222,1,0,1
54223,y,0,1
54224,.,0,1
54225,Combined,0,0
54226,chemotherapy,0,0
54227,and,0,0
54228,radiotherapy,0,1
54229,compared,0,0
54230,with,0,1
54231,radiotherapy,0,1
54232,alone,0,0
54233,in,0,0
54234,patients,1,1
54235,with,1,1
54236,cancer,1,1
54237,of,1,0
54238,the,1,0
54239,esophagus,1,1
54240,.,1,0
54241,BACKGROUND,0,0
54242,The,0,0
54243,efficacy,0,0
54244,of,0,0
54245,conventional,0,0
54246,treatment,0,0
54247,with,0,1
54248,surgery,0,1
54249,and,0,0
54250,radiation,0,0
54251,for,0,0
54252,cancer,0,1
54253,of,0,0
54254,the,0,0
54255,esophagus,0,0
54256,is,0,0
54257,limited,0,0
54258,.,0,0
54259,The,0,0
54260,median,0,0
54261,survival,0,0
54262,is,0,0
54263,less,0,0
54264,than,0,0
54265,10,0,0
54266,months,0,0
54267,",",0,0
54268,and,0,0
54269,less,0,0
54270,than,0,0
54271,10,0,0
54272,percent,0,1
54273,of,0,0
54274,patients,0,1
54275,survive,0,1
54276,for,0,0
54277,5,0,1
54278,years,0,1
54279,.,0,1
54280,Recent,0,1
54281,studies,0,0
54282,have,0,0
54283,suggested,0,0
54284,that,0,0
54285,combined,0,0
54286,chemotherapy,0,1
54287,and,0,0
54288,radiation,0,0
54289,therapy,0,0
54290,may,0,0
54291,result,0,0
54292,in,0,0
54293,improved,0,0
54294,survival,0,0
54295,.,0,1
54296,METHODS,0,0
54297,This,0,0
54298,phase,0,0
54299,III,0,0
54300,prospective,0,0
54301,",",0,0
54302,randomized,0,0
54303,",",0,0
54304,and,0,0
54305,stratified,0,1
54306,trial,0,0
54307,was,0,0
54308,undertaken,0,0
54309,to,0,0
54310,evaluate,0,0
54311,the,0,0
54312,efficacy,0,0
54313,of,0,0
54314,four,0,1
54315,courses,0,0
54316,of,0,0
54317,combined,0,0
54318,fluorouracil,0,0
54319,(,0,0
54320,1000,0,0
54321,mg,0,0
54322,per,0,0
54323,square,0,0
54324,meter,0,0
54325,of,0,0
54326,body-surface,0,0
54327,area,0,0
54328,daily,0,0
54329,for,0,0
54330,four,0,1
54331,days,0,0
54332,),0,1
54333,and,0,0
54334,cisplatin,0,0
54335,(,0,0
54336,75,0,0
54337,mg,0,0
54338,per,0,0
54339,square,0,0
54340,meter,0,0
54341,on,0,0
54342,the,0,0
54343,first,0,0
54344,day,0,0
54345,),0,0
54346,plus,0,0
54347,5000,0,1
54348,cGy,0,0
54349,of,0,0
54350,radiation,0,0
54351,therapy,0,0
54352,",",0,0
54353,as,0,0
54354,compared,0,0
54355,with,0,1
54356,6400,0,0
54357,cGy,0,0
54358,of,0,0
54359,radiation,0,0
54360,therapy,0,0
54361,alone,0,0
54362,",",0,0
54363,in,0,0
54364,patients,0,1
54365,with,0,1
54366,squamous-cell,0,1
54367,carcinoma,0,1
54368,or,0,0
54369,adenocarcinoma,0,1
54370,of,0,0
54371,the,0,0
54372,thoracic,0,1
54373,esophagus,0,1
54374,.,0,0
54375,The,0,0
54376,trial,0,0
54377,was,0,0
54378,stopped,0,0
54379,after,0,0
54380,the,0,0
54381,accumulated,0,0
54382,results,0,0
54383,in,0,1
54384,121,1,1
54385,patients,1,1
54386,demonstrated,1,0
54387,a,1,0
54388,significant,1,0
54389,advantage,1,0
54390,for,1,0
54391,survival,1,0
54392,in,1,0
54393,the,1,1
54394,patients,1,1
54395,who,1,1
54396,received,1,1
54397,chemotherapy,1,1
54398,and,1,0
54399,radiation,1,0
54400,therapy,1,0
54401,.,1,0
54402,RESULTS,0,0
54403,The,0,0
54404,median,0,0
54405,survival,0,0
54406,was,0,0
54407,8.9,0,0
54408,months,0,0
54409,in,0,0
54410,the,0,0
54411,radiation-treated,0,0
54412,patients,0,1
54413,",",0,0
54414,as,0,0
54415,compared,0,0
54416,with,0,1
54417,12.5,0,0
54418,months,0,0
54419,in,0,0
54420,the,0,0
54421,patients,0,1
54422,treated,0,1
54423,with,0,1
54424,chemotherapy,0,0
54425,and,0,0
54426,radiation,0,0
54427,therapy,0,0
54428,.,0,0
54429,In,0,0
54430,the,0,0
54431,former,0,0
54432,group,0,0
54433,",",0,0
54434,the,0,0
54435,survival,0,0
54436,rates,0,0
54437,at,0,0
54438,12,0,1
54439,and,0,1
54440,24,0,1
54441,months,0,0
54442,were,0,1
54443,33,0,1
54444,percent,0,1
54445,and,0,0
54446,10,0,0
54447,percent,0,0
54448,",",0,0
54449,respectively,0,0
54450,",",0,0
54451,whereas,0,0
54452,they,0,0
54453,were,0,1
54454,50,0,1
54455,percent,0,1
54456,and,0,0
54457,38,0,1
54458,percent,0,0
54459,in,0,0
54460,the,0,0
54461,patients,0,1
54462,receiving,0,1
54463,combined,0,0
54464,therapy,0,0
54465,(,0,0
54466,P,0,0
54467,less,0,0
54468,than,0,0
54469,0.001,0,0
54470,),0,1
54471,.,0,1
54472,Seven,1,0
54473,patients,1,1
54474,in,1,0
54475,the,1,0
54476,radiotherapy,1,1
54477,group,1,0
54478,and,1,0
54479,25,1,0
54480,in,1,0
54481,the,1,0
54482,combined-therapy,1,0
54483,group,1,0
54484,were,0,0
54485,alive,0,1
54486,at,0,0
54487,the,0,0
54488,time,0,0
54489,of,0,0
54490,the,0,0
54491,analysis,0,0
54492,.,0,0
54493,The,0,0
54494,patients,0,1
54495,who,0,1
54496,received,0,1
54497,combined,0,1
54498,treatment,0,0
54499,had,0,1
54500,fewer,0,0
54501,local,0,0
54502,(,0,0
54503,P,0,0
54504,less,0,0
54505,than,0,0
54506,0.02,0,0
54507,),0,0
54508,and,0,0
54509,fewer,0,0
54510,distant,0,0
54511,(,0,0
54512,P,0,0
54513,less,0,0
54514,than,0,0
54515,0.01,0,0
54516,),0,1
54517,recurrences,0,1
54518,.,0,1
54519,Severe,0,1
54520,and,0,0
54521,life-threatening,0,1
54522,side,0,0
54523,effects,0,0
54524,occurred,0,0
54525,in,0,0
54526,44,0,1
54527,percent,0,1
54528,and,0,0
54529,20,0,0
54530,percent,0,0
54531,",",0,0
54532,respectively,0,0
54533,",",0,0
54534,of,0,0
54535,the,0,1
54536,patients,0,1
54537,who,0,1
54538,received,0,1
54539,combined,0,1
54540,therapy,0,0
54541,",",0,0
54542,as,0,0
54543,compared,0,0
54544,with,0,1
54545,25,0,0
54546,percent,0,1
54547,and,0,0
54548,3,0,0
54549,percent,0,0
54550,of,0,0
54551,those,0,0
54552,treated,0,0
54553,with,0,0
54554,radiation,0,0
54555,alone,0,0
54556,.,0,0
54557,CONCLUSIONS,0,0
54558,Concurrent,0,0
54559,therapy,0,0
54560,with,0,1
54561,cisplatin,0,0
54562,and,0,0
54563,fluorouracil,0,0
54564,and,0,0
54565,radiation,0,0
54566,is,0,0
54567,superior,0,0
54568,to,0,0
54569,radiation,0,0
54570,therapy,0,0
54571,alone,0,0
54572,in,0,0
54573,patients,0,1
54574,with,0,1
54575,localized,0,1
54576,carcinoma,0,1
54577,of,0,0
54578,the,0,0
54579,esophagus,0,0
54580,",",0,0
54581,as,0,0
54582,measured,0,0
54583,by,0,0
54584,control,0,0
54585,of,0,0
54586,local,0,0
54587,tumors,0,1
54588,",",0,1
54589,distant,0,1
54590,metastases,0,1
54591,",",0,0
54592,and,0,0
54593,survival,0,0
54594,",",0,0
54595,but,0,0
54596,at,0,0
54597,the,0,0
54598,cost,0,0
54599,of,0,0
54600,increased,0,0
54601,side,0,0
54602,effects,0,0
54603,.,0,1
54604,Treatment,0,0
54605,outcome,0,0
54606,of,0,0
54607,appliance,0,0
54608,therapy,0,0
54609,in,0,0
54610,temporomandibular,1,1
54611,disorder,1,1
54612,patients,1,1
54613,with,1,1
54614,myofascial,1,0
54615,pain,1,1
54616,after,1,0
54617,6,1,0
54618,and,1,1
54619,12,1,1
54620,months,1,0
54621,.,1,1
54622,AIM,0,0
54623,To,0,0
54624,compare,0,0
54625,the,0,0
54626,long-term,0,0
54627,effect,0,0
54628,of,0,0
54629,treatment,0,0
54630,with,0,1
54631,a,0,0
54632,stabilization,0,0
54633,appliance,0,0
54634,(,0,0
54635,group,0,0
54636,T,0,1
54637,),0,0
54638,and,0,0
54639,treatment,0,0
54640,with,0,1
54641,a,0,0
54642,control,0,0
54643,appliance,0,0
54644,(,0,0
54645,group,0,0
54646,C,0,0
54647,),0,0
54648,in,0,0
54649,temporomandibular,1,1
54650,disorder,1,1
54651,(,1,0
54652,TMD,1,0
54653,),1,1
54654,patients,1,1
54655,with,1,1
54656,myofascial,1,1
54657,pain,1,1
54658,.,1,0
54659,METHODS,0,0
54660,In,0,0
54661,this,0,0
54662,controlled,0,0
54663,trial,0,0
54664,",",0,0
54665,60,1,1
54666,patients,1,1
54667,(,1,1
54668,mean,1,1
54669,age,1,1
54670,29,1,1
54671,years,1,1
54672,),1,1
54673,with,1,1
54674,myofascial,1,0
54675,pain,1,1
54676,were,1,0
54677,evaluated,1,0
54678,after,1,0
54679,10,1,1
54680,weeks,1,0
54681,of,1,0
54682,treatment,1,0
54683,with,1,1
54684,either,1,0
54685,a,1,0
54686,stabilization,1,0
54687,appliance,1,0
54688,or,1,0
54689,a,1,0
54690,control,1,0
54691,appliance,1,0
54692,.,1,1
54693,All,0,0
54694,60,1,1
54695,patients,1,1
54696,were,0,1
54697,then,0,0
54698,assigned,0,1
54699,to,0,0
54700,1,0,0
54701,of,0,0
54702,3,0,1
54703,groups,0,0
54704,according,0,1
54705,to,0,0
54706,demand,0,0
54707,for,0,0
54708,treatment,0,0
54709,.,0,1
54710,Seventeen,0,0
54711,patients,0,1
54712,from,0,1
54713,group,0,1
54714,C,0,0
54715,requested,0,0
54716,another,0,0
54717,appliance,0,0
54718,and,0,0
54719,were,0,0
54720,given,0,0
54721,a,0,0
54722,stabilization,0,0
54723,appliance,0,0
54724,",",0,0
54725,thus,0,0
54726,creating,0,0
54727,a,0,0
54728,mixed,0,0
54729,group,0,0
54730,(,0,0
54731,group,0,0
54732,M,0,0
54733,),0,0
54734,.,0,0
54735,RESULTS,0,0
54736,A,0,0
54737,significant,0,0
54738,difference,0,0
54739,in,0,0
54740,improvement,0,0
54741,of,0,0
54742,overall,0,0
54743,subjective,0,0
54744,symptoms,0,0
54745,in,0,0
54746,an,0,0
54747,intent-to-treat,0,0
54748,analysis,0,0
54749,between,0,0
54750,groups,0,0
54751,T,0,1
54752,and,0,1
54753,C,0,0
54754,was,0,0
54755,found,0,0
54756,at,0,0
54757,the,0,0
54758,follow-ups,0,0
54759,.,0,0
54760,In,0,0
54761,a,0,0
54762,survival,0,0
54763,analysis,0,0
54764,of,0,0
54765,treatment,0,0
54766,compliance,0,0
54767,",",0,0
54768,a,0,0
54769,significant,0,0
54770,difference,0,0
54771,was,0,0
54772,found,0,0
54773,between,0,0
54774,groups,0,0
54775,T,0,1
54776,and,0,0
54777,C.,0,0
54778,At,0,0
54779,the,0,0
54780,6-,0,0
54781,and,0,0
54782,12-month,0,0
54783,follow-ups,0,0
54784,",",0,0
54785,a,0,0
54786,significant,0,0
54787,reduction,0,0
54788,in,0,0
54789,myofascial,0,0
54790,pain,0,0
54791,",",0,0
54792,as,0,0
54793,measured,0,0
54794,on,0,0
54795,a,0,0
54796,visual,0,0
54797,analog,0,0
54798,scale,0,0
54799,",",0,0
54800,was,0,0
54801,found,0,0
54802,in,0,0
54803,all,0,0
54804,three,0,0
54805,groups,0,0
54806,.,0,1
54807,A,0,0
54808,significant,0,0
54809,decrease,0,0
54810,in,0,0
54811,frequency,0,0
54812,and,0,0
54813,intensity,0,0
54814,of,0,0
54815,myofascial,0,0
54816,pain,0,1
54817,was,0,0
54818,found,0,0
54819,in,0,0
54820,group,0,0
54821,T,0,1
54822,at,0,0
54823,the,0,0
54824,follow-ups,0,0
54825,.,0,0
54826,A,0,0
54827,significant,0,0
54828,decrease,0,0
54829,in,0,0
54830,number,0,0
54831,of,0,0
54832,tender,0,0
54833,sites,0,0
54834,on,0,0
54835,the,0,0
54836,masticatory,0,1
54837,muscles,0,0
54838,was,0,0
54839,found,0,0
54840,in,0,0
54841,group,0,0
54842,T,0,1
54843,at,0,0
54844,the,0,0
54845,follow-ups,0,0
54846,.,0,0
54847,CONCLUSION,0,0
54848,The,0,0
54849,results,0,0
54850,support,0,0
54851,the,0,0
54852,conclusion,0,0
54853,that,0,0
54854,the,0,0
54855,positive,0,0
54856,treatment,0,0
54857,outcome,0,0
54858,obtained,0,0
54859,by,0,0
54860,use,0,0
54861,of,0,0
54862,a,0,0
54863,stabilization,0,0
54864,appliance,0,0
54865,to,0,0
54866,alleviate,0,0
54867,the,0,0
54868,signs,0,0
54869,and,0,0
54870,symptoms,0,1
54871,in,0,0
54872,patients,1,1
54873,with,1,1
54874,myofascial,1,1
54875,pain,1,1
54876,persisted,0,0
54877,after,0,0
54878,6,0,0
54879,and,0,1
54880,12,0,1
54881,months,0,0
54882,.,0,1
54883,Most,0,0
54884,patients,0,1
54885,in,0,1
54886,groups,0,0
54887,T,0,1
54888,and,0,1
54889,M,0,0
54890,reported,0,0
54891,positive,0,0
54892,changes,0,0
54893,in,0,1
54894,overall,0,0
54895,subjective,0,0
54896,symptoms,0,0
54897,in,0,0
54898,this,0,0
54899,trial,0,0
54900,.,0,0
54901,We,0,0
54902,therefore,0,0
54903,recommend,0,0
54904,use,0,0
54905,of,0,0
54906,the,0,0
54907,stabilization,0,0
54908,appliance,0,0
54909,in,0,0
54910,the,0,0
54911,treatment,0,0
54912,of,0,0
54913,TMD,1,0
54914,patients,1,1
54915,with,1,1
54916,myofascial,1,1
54917,pain,1,1
54918,.,1,1
54919,Problem-based,0,1
54920,learning,0,0
54921,:,0,1
54922,is,0,0
54923,anatomy,0,0
54924,a,0,0
54925,casualty,0,1
54926,?,0,0
54927,INTRODUCTION,0,0
54928,The,0,0
54929,teaching,0,0
54930,of,0,0
54931,medical,0,0
54932,anatomy,0,0
54933,is,0,0
54934,changing,0,0
54935,.,0,0
54936,Medical,0,1
54937,schools,0,1
54938,worldwide,0,0
54939,are,0,0
54940,moving,0,0
54941,away,0,0
54942,from,0,0
54943,dissection,0,0
54944,and,0,0
54945,lectures,0,0
54946,to,0,0
54947,a,0,0
54948,more,0,0
54949,integrated,0,0
54950,course,0,0
54951,",",0,0
54952,where,0,0
54953,basic,0,0
54954,science,0,0
54955,and,0,0
54956,clinical,0,0
54957,skills,0,0
54958,are,0,0
54959,taught,0,0
54960,simultaneously,0,0
54961,.,0,1
54962,Medical,1,0
54963,students,1,1
54964,on,0,0
54965,these,0,0
54966,integrated,0,0
54967,courses,0,0
54968,have,0,0
54969,reported,0,0
54970,a,0,0
54971,lack,0,0
54972,of,0,0
54973,confidence,0,0
54974,in,0,0
54975,their,0,0
54976,basic,0,0
54977,science,0,0
54978,knowledge,0,0
54979,",",0,0
54980,especially,0,0
54981,concerning,0,0
54982,anatomy,0,0
54983,.,0,0
54984,Our,0,0
54985,aim,0,0
54986,was,0,0
54987,to,0,0
54988,perform,0,0
54989,a,0,0
54990,randomised,0,0
54991,controlled,0,0
54992,trial,0,0
54993,(,0,0
54994,RCT,0,0
54995,),0,0
54996,to,0,0
54997,compare,0,0
54998,anatomical,0,0
54999,knowledge,0,0
55000,of,0,0
55001,two,1,0
55002,groups,1,0
55003,of,1,1
55004,second-year,1,1
55005,medical,1,1
55006,students,1,1
55007,",",1,0
55008,the,1,0
55009,first,1,0
55010,group,1,0
55011,taught,1,0
55012,on,1,0
55013,a,1,0
55014,traditional,1,0
55015,course,1,0
55016,",",1,0
55017,the,1,0
55018,second,1,0
55019,on,1,0
55020,an,1,0
55021,integrated,1,0
55022,course,1,0
55023,.,1,1
55024,MATERIALS,0,0
55025,AND,0,0
55026,METHODS,0,0
55027,Testing,0,0
55028,was,0,0
55029,done,0,0
55030,using,0,0
55031,a,0,0
55032,Questionnaire,0,0
55033,in,0,0
55034,a,0,0
55035,True/False,0,0
55036,format,0,0
55037,.,0,0
55038,There,0,0
55039,were,0,0
55040,80,1,0
55041,students,1,1
55042,in,1,0
55043,each,1,1
55044,group,1,0
55045,.,1,0
55046,There,0,0
55047,was,0,0
55048,no,0,0
55049,penalty,0,0
55050,for,0,0
55051,an,0,0
55052,incorrect,0,0
55053,answer,0,0
55054,.,0,0
55055,The,0,0
55056,test,0,0
55057,was,0,0
55058,performed,0,0
55059,under,0,0
55060,examination,0,1
55061,conditions,0,1
55062,.,0,1
55063,Papers,0,1
55064,were,0,0
55065,marked,0,0
55066,under,0,0
55067,blind,0,1
55068,conditions,0,1
55069,.,0,1
55070,Results,0,0
55071,were,0,0
55072,analysed,0,0
55073,using,0,0
55074,a,0,0
55075,Student,0,0
55076,'s,0,1
55077,t,0,0
55078,test,0,0
55079,analysis,0,0
55080,.,0,0
55081,RESULTS,0,0
55082,Those,0,1
55083,students,0,1
55084,taught,0,0
55085,on,0,0
55086,a,0,0
55087,traditional,0,0
55088,course,0,0
55089,exhibited,0,0
55090,a,0,0
55091,significantly,0,0
55092,higher,0,0
55093,level,0,0
55094,of,0,0
55095,basic,0,0
55096,anatomical,0,0
55097,knowledge,0,0
55098,(,0,0
55099,p,0,0
55100,<,0,0
55101,0.001,0,0
55102,),0,0
55103,than,0,0
55104,those,0,0
55105,taught,0,0
55106,on,0,0
55107,an,0,0
55108,integrated,0,0
55109,course,0,0
55110,.,0,0
55111,The,0,0
55112,students,0,1
55113,taught,0,0
55114,on,0,0
55115,an,0,0
55116,integrated,0,0
55117,course,0,0
55118,showed,0,0
55119,a,0,0
55120,much,0,0
55121,greater,0,0
55122,range,0,0
55123,of,0,0
55124,results,0,0
55125,.,0,1
55126,CONCLUSIONS,0,0
55127,Students,0,0
55128,taught,0,1
55129,on,0,0
55130,a,0,0
55131,traditional,0,0
55132,course,0,0
55133,have,0,0
55134,a,0,0
55135,higher,0,0
55136,level,0,0
55137,of,0,0
55138,anatomical,0,0
55139,knowledge,0,0
55140,than,0,0
55141,those,0,0
55142,taught,0,0
55143,on,0,0
55144,an,0,0
55145,integrated,0,0
55146,course,0,0
55147,.,0,1
55148,Our,0,0
55149,results,0,0
55150,differ,0,0
55151,from,0,1
55152,previous,0,1
55153,studies,0,0
55154,done,0,0
55155,in,0,0
55156,Europe,0,1
55157,which,0,0
55158,show,0,0
55159,no,0,0
55160,difference,0,0
55161,between,0,0
55162,the,0,0
55163,courses,0,0
55164,.,0,1
55165,Treatment,0,0
55166,of,0,0
55167,peri-implantitis,0,0
55168,by,0,0
55169,the,0,0
55170,Vector,0,0
55171,system,0,0
55172,.,0,0
55173,AIM,0,0
55174,To,0,0
55175,compare,0,0
55176,the,0,0
55177,effectiveness,0,0
55178,of,0,0
55179,treatment,0,0
55180,of,0,0
55181,peri-implantitis,0,0
55182,with,0,1
55183,a,0,0
55184,novel,0,0
55185,ultrasonic,0,0
55186,device,0,0
55187,",",0,0
55188,the,0,0
55189,Vector,0,0
55190,system,0,0
55191,",",0,0
55192,with,0,0
55193,that,0,0
55194,of,0,0
55195,subgingival,0,0
55196,debridement,0,1
55197,with,0,1
55198,carbon,0,0
55199,fiber,0,1
55200,curettes,0,0
55201,.,0,1
55202,MATERIAL,0,0
55203,AND,0,0
55204,METHODS,0,0
55205,The,0,0
55206,study,0,0
55207,",",0,0
55208,comprising,0,1
55209,11,1,0
55210,patients,1,1
55211,with,1,1
55212,at,1,1
55213,least,1,1
55214,two,1,0
55215,screw,1,1
55216,type,1,1
55217,implants,1,0
55218,with,1,1
55219,bleeding,1,1
55220,on,1,0
55221,probing,1,0
55222,(,1,0
55223,BOP,1,1
55224,),1,0
55225,",",1,0
55226,probing,1,0
55227,pocket,1,0
55228,depth,1,0
55229,(,1,0
55230,PPD,1,1
55231,),1,0
55232,>,1,1
55233,or,1,1
55234,=5,1,1
55235,mm,1,0
55236,",",1,0
55237,and,1,0
55238,at,1,0
55239,least,1,1
55240,1.5,1,0
55241,mm,1,0
55242,radiographic,1,1
55243,bone,1,0
55244,loss,1,0
55245,and,1,0
55246,exposed,1,0
55247,implant,1,0
55248,threads,1,0
55249,",",0,0
55250,was,0,0
55251,carried,0,0
55252,out,0,0
55253,as,0,0
55254,a,0,0
55255,single,0,0
55256,blind,0,0
55257,randomized,0,1
55258,clinical,0,0
55259,trial,0,0
55260,.,0,0
55261,At,0,0
55262,baseline,0,0
55263,one,0,1
55264,randomly,0,1
55265,chosen,0,0
55266,implant,0,0
55267,in,0,0
55268,each,0,0
55269,patient,0,0
55270,was,0,0
55271,treated,0,1
55272,by,0,0
55273,the,0,0
55274,Vector,0,0
55275,system,0,0
55276,(,0,0
55277,test,0,0
55278,),0,0
55279,while,0,0
55280,the,0,0
55281,other,0,0
55282,implant,0,0
55283,(,0,0
55284,control,0,1
55285,),0,0
55286,was,0,0
55287,treated,0,1
55288,by,0,0
55289,submucosal,0,1
55290,debridement,0,1
55291,with,0,1
55292,a,0,0
55293,carbon,0,0
55294,fiber,0,0
55295,curette,0,0
55296,.,0,0
55297,After,0,0
55298,3,0,0
55299,months,0,0
55300,",",0,0
55301,the,0,0
55302,same,0,0
55303,treatments,0,0
55304,were,0,1
55305,repeated,0,0
55306,.,0,0
55307,Plaque,0,0
55308,",",0,0
55309,BOP,0,0
55310,",",0,0
55311,and,0,0
55312,PPD,0,1
55313,were,0,0
55314,recorded,0,0
55315,on,0,0
55316,all,0,0
55317,implant,0,0
55318,surfaces,0,0
55319,at,0,0
55320,baseline,0,0
55321,",",0,0
55322,and,0,0
55323,after,0,0
55324,3,0,0
55325,and,0,1
55326,6,0,0
55327,months,0,0
55328,.,0,1
55329,Bone,0,0
55330,levels,0,0
55331,were,0,0
55332,recorded,0,0
55333,on,0,0
55334,radiographs,0,0
55335,taken,0,0
55336,prior,0,0
55337,to,0,0
55338,the,0,0
55339,start,0,0
55340,of,0,0
55341,the,0,0
55342,study,0,0
55343,",",0,0
55344,and,0,0
55345,after,0,0
55346,6,0,0
55347,months,0,0
55348,.,0,1
55349,RESULTS,0,0
55350,Oral,0,0
55351,hygiene,0,0
55352,around,0,0
55353,both,0,0
55354,test,0,0
55355,and,0,0
55356,control,0,1
55357,implants,0,0
55358,was,0,0
55359,improved,0,0
55360,at,0,0
55361,3,0,0
55362,and,0,1
55363,6,0,0
55364,months,0,0
55365,compared,0,0
55366,with,0,1
55367,baseline,0,0
55368,.,0,1
55369,At,0,0
55370,6,0,0
55371,months,0,0
55372,",",0,0
55373,four,0,1
55374,of,0,0
55375,the,0,0
55376,Vector-treated,0,1
55377,sites,0,0
55378,",",0,0
55379,and,0,0
55380,only,0,0
55381,one,0,0
55382,site,0,0
55383,treated,0,1
55384,with,0,1
55385,curettes,0,0
55386,",",0,0
55387,had,0,1
55388,stopped,0,0
55389,to,0,0
55390,bleed,0,1
55391,.,0,0
55392,In,0,0
55393,neither,0,0
55394,the,0,0
55395,test,0,0
55396,nor,0,0
55397,the,0,0
55398,control,0,0
55399,group,0,0
55400,",",0,0
55401,were,0,0
55402,there,0,0
55403,any,0,0
55404,differences,0,0
55405,between,0,0
55406,baseline,0,0
55407,and,0,0
55408,6,0,0
55409,months,0,0
55410,regarding,0,0
55411,PPD,0,1
55412,and,0,0
55413,bone,0,0
55414,levels,0,0
55415,.,0,1
55416,CONCLUSION,0,0
55417,Although,0,0
55418,there,0,0
55419,was,0,0
55420,a,0,0
55421,greater,0,0
55422,reduction,0,0
55423,in,0,0
55424,the,0,0
55425,number,0,0
55426,of,0,0
55427,sites,0,0
55428,with,0,1
55429,BOP,0,1
55430,following,0,0
55431,treatment,0,0
55432,with,0,1
55433,the,0,0
55434,Vector,0,0
55435,system,0,0
55436,than,0,0
55437,following,0,0
55438,instrumentation,0,0
55439,with,0,1
55440,carbon,0,0
55441,fiber,0,0
55442,curettes,0,0
55443,",",0,0
55444,there,0,0
55445,was,0,0
55446,no,0,0
55447,significant,0,0
55448,difference,0,0
55449,between,0,0
55450,the,0,0
55451,two,0,0
55452,methods,0,1
55453,.,0,1
55454,Automatic,1,0
55455,detection,1,0
55456,of,1,0
55457,red,1,1
55458,lesions,1,1
55459,in,1,0
55460,digital,1,0
55461,color,1,1
55462,fundus,1,1
55463,photographs,1,0
55464,.,1,0
55465,The,0,0
55466,robust,0,0
55467,detection,0,0
55468,of,0,0
55469,red,0,1
55470,lesions,0,1
55471,in,0,0
55472,digital,1,0
55473,color,1,1
55474,fundus,1,0
55475,photographs,1,0
55476,is,0,0
55477,a,0,0
55478,critical,0,0
55479,step,0,0
55480,in,0,0
55481,the,0,0
55482,development,0,0
55483,of,0,0
55484,automated,0,0
55485,screening,0,1
55486,systems,0,0
55487,for,0,0
55488,diabetic,1,1
55489,retinopathy,1,1
55490,.,1,0
55491,In,0,0
55492,this,0,0
55493,paper,0,0
55494,",",0,0
55495,a,0,0
55496,novel,0,0
55497,red,0,1
55498,lesion,0,0
55499,detection,0,0
55500,method,0,0
55501,is,0,0
55502,presented,0,0
55503,based,0,0
55504,on,0,0
55505,a,0,0
55506,hybrid,0,0
55507,approach,0,0
55508,",",0,0
55509,combining,0,0
55510,prior,0,1
55511,works,0,0
55512,by,0,0
55513,Spencer,0,1
55514,et,0,1
55515,al,0,0
55516,.,0,0
55517,(,0,0
55518,1996,0,1
55519,),0,0
55520,and,0,0
55521,Frame,0,0
55522,et,0,1
55523,al,0,0
55524,.,0,0
55525,(,0,0
55526,1998,0,1
55527,),0,1
55528,with,0,1
55529,two,0,0
55530,important,0,0
55531,new,0,1
55532,contributions,0,0
55533,.,0,1
55534,The,0,0
55535,first,0,0
55536,contribution,0,0
55537,is,0,0
55538,a,0,0
55539,new,0,0
55540,red,0,1
55541,lesion,0,0
55542,candidate,0,0
55543,detection,0,0
55544,system,0,0
55545,based,0,0
55546,on,0,0
55547,pixel,0,0
55548,classification,0,1
55549,.,0,0
55550,Using,0,0
55551,this,0,0
55552,technique,0,0
55553,",",0,0
55554,vasculature,0,0
55555,and,0,0
55556,red,0,1
55557,lesions,0,1
55558,are,0,0
55559,separated,0,0
55560,from,0,0
55561,the,0,0
55562,background,0,0
55563,of,0,0
55564,the,0,0
55565,image,0,0
55566,.,0,0
55567,After,0,0
55568,removal,0,0
55569,of,0,0
55570,the,0,0
55571,connected,0,0
55572,vasculature,0,0
55573,the,0,0
55574,remaining,0,0
55575,objects,0,0
55576,are,0,0
55577,considered,0,0
55578,possible,0,0
55579,red,0,1
55580,lesions,0,1
55581,.,0,1
55582,Second,0,0
55583,",",0,0
55584,an,0,0
55585,extensive,0,0
55586,number,0,0
55587,of,0,0
55588,new,0,0
55589,features,0,1
55590,are,0,0
55591,added,0,0
55592,to,0,0
55593,those,0,0
55594,proposed,0,0
55595,by,0,0
55596,Spencer-Frame,0,1
55597,.,0,1
55598,The,0,0
55599,detected,0,0
55600,candidate,0,0
55601,objects,0,0
55602,are,0,0
55603,classified,0,0
55604,using,0,0
55605,all,0,0
55606,features,0,0
55607,and,0,0
55608,a,0,0
55609,k-nearest,0,0
55610,neighbor,0,0
55611,classifier,0,0
55612,.,0,0
55613,An,0,0
55614,extensive,0,0
55615,evaluation,0,0
55616,was,0,0
55617,performed,0,0
55618,on,0,0
55619,a,0,0
55620,test,0,0
55621,set,0,0
55622,composed,0,1
55623,of,0,0
55624,images,0,0
55625,representative,0,1
55626,of,0,0
55627,those,0,0
55628,normally,0,0
55629,found,0,0
55630,in,0,0
55631,a,0,0
55632,screening,0,0
55633,set,0,0
55634,.,0,0
55635,When,0,0
55636,determining,0,0
55637,whether,0,0
55638,an,0,0
55639,image,0,0
55640,contains,0,0
55641,red,0,1
55642,lesions,0,0
55643,the,0,0
55644,system,0,0
55645,achieves,0,0
55646,a,0,0
55647,sensitivity,0,0
55648,of,0,0
55649,100,0,0
55650,%,0,0
55651,at,0,0
55652,a,0,0
55653,specificity,0,0
55654,of,0,0
55655,87,0,1
55656,%,0,0
55657,.,0,0
55658,The,0,0
55659,method,0,0
55660,is,0,0
55661,compared,0,0
55662,with,0,0
55663,several,0,0
55664,different,0,0
55665,automatic,0,1
55666,systems,0,0
55667,and,0,0
55668,is,0,0
55669,shown,0,0
55670,to,0,0
55671,outperform,0,0
55672,them,0,1
55673,all,0,0
55674,.,0,0
55675,Performance,0,0
55676,is,0,0
55677,close,0,0
55678,to,0,0
55679,that,0,0
55680,of,0,0
55681,a,0,0
55682,human,0,0
55683,expert,0,0
55684,examining,0,0
55685,the,0,0
55686,images,0,0
55687,for,0,0
55688,the,0,0
55689,presence,0,0
55690,of,0,0
55691,red,0,1
55692,lesions,0,1
55693,.,0,1
55694,Use,0,0
55695,of,0,0
55696,an,0,0
55697,inspiratory,0,0
55698,impedance,0,0
55699,threshold,0,0
55700,device,0,0
55701,on,0,0
55702,a,0,0
55703,facemask,0,0
55704,and,0,0
55705,endotracheal,0,1
55706,tube,0,0
55707,to,0,0
55708,reduce,0,0
55709,intrathoracic,0,1
55710,pressures,0,0
55711,during,0,0
55712,the,0,0
55713,decompression,0,0
55714,phase,0,0
55715,of,0,0
55716,active,1,1
55717,compression-decompression,1,1
55718,cardiopulmonary,1,1
55719,resuscitation,1,1
55720,.,1,1
55721,INTRODUCTION,0,0
55722,Use,0,0
55723,of,0,0
55724,an,0,0
55725,inspiratory,0,0
55726,impedance,0,0
55727,threshold,0,0
55728,device,0,0
55729,(,0,0
55730,ITD,0,0
55731,),0,0
55732,significantly,0,0
55733,increases,0,0
55734,coronary,0,1
55735,perfusion,0,0
55736,pressures,0,0
55737,and,0,0
55738,survival,0,0
55739,in,0,0
55740,patients,1,1
55741,ventilated,1,1
55742,with,1,1
55743,an,1,0
55744,endotracheal,1,1
55745,tube,1,0
55746,(,1,0
55747,ETT,1,0
55748,),1,0
55749,during,1,0
55750,active,1,1
55751,compression-decompression,1,1
55752,cardiopulmonary,1,1
55753,resuscitation,1,1
55754,.,1,1
55755,We,0,0
55756,tested,0,0
55757,the,0,0
55758,hypothesis,0,0
55759,that,0,0
55760,the,0,0
55761,ITD,0,0
55762,could,0,0
55763,lower,0,0
55764,intratracheal,0,0
55765,pressures,0,0
55766,when,0,0
55767,attached,0,0
55768,to,0,0
55769,either,0,0
55770,a,0,0
55771,facemask,0,0
55772,or,0,1
55773,ETT,0,1
55774,.,0,1
55775,METHODS,0,0
55776,An,0,0
55777,active,0,0
55778,and,0,0
55779,sham,0,0
55780,ITD,0,0
55781,were,0,0
55782,randomly,0,1
55783,applied,0,0
55784,first,0,0
55785,to,0,0
55786,a,0,0
55787,facemask,0,0
55788,and,0,0
55789,then,0,0
55790,to,0,0
55791,an,0,0
55792,ETT,0,0
55793,during,0,0
55794,active,1,1
55795,compression-decompression,1,1
55796,cardiopulmonary,1,1
55797,resuscitation,1,1
55798,in,1,0
55799,13,1,1
55800,out-of-hospital,1,1
55801,cardiac,1,1
55802,arrest,1,1
55803,patients,1,1
55804,in,0,0
55805,a,0,0
55806,randomized,0,0
55807,",",0,0
55808,double-blinded,0,0
55809,",",0,0
55810,prospective,0,0
55811,clinical,0,0
55812,trial,0,1
55813,.,0,0
55814,The,0,0
55815,compression-to-bag-valve,0,0
55816,ventilation,0,0
55817,ratio,0,0
55818,was,0,0
55819,15:2,0,0
55820,.,0,1
55821,Airway,0,0
55822,pressures,0,0
55823,(,0,0
55824,surrogate,0,0
55825,for,0,0
55826,intrathoracic,0,1
55827,pressure,0,0
55828,),0,0
55829,were,0,0
55830,measured,0,0
55831,with,0,1
55832,a,0,0
55833,pressure,0,0
55834,transducer,0,0
55835,.,0,0
55836,A,0,0
55837,sham,0,0
55838,and,0,0
55839,an,0,0
55840,active,0,1
55841,ITD,0,0
55842,were,0,0
55843,used,0,0
55844,for,0,0
55845,1,0,0
55846,min,0,0
55847,each,0,0
55848,in,0,0
55849,a,0,0
55850,randomized,0,0
55851,order,0,0
55852,",",0,0
55853,first,0,0
55854,on,0,0
55855,a,0,0
55856,facemask,0,0
55857,and,0,0
55858,then,0,0
55859,on,0,0
55860,an,0,0
55861,ETT,0,0
55862,.,0,1
55863,Statistical,0,0
55864,analyses,0,0
55865,were,0,1
55866,made,0,0
55867,using,0,0
55868,Friedman,0,0
55869,'s,0,1
55870,and,0,0
55871,Wilcoxon,0,0
55872,'s,0,1
55873,rank-sum,0,0
55874,tests,0,0
55875,.,0,1
55876,RESULTS,0,0
55877,For,0,0
55878,the,0,0
55879,primary,0,0
55880,end,0,0
55881,point,0,0
55882,",",0,0
55883,mean,0,0
55884,+/-,0,0
55885,sd,0,1
55886,maximum,0,0
55887,negative,0,0
55888,intrathoracic,0,1
55889,pressures,0,0
55890,(,0,0
55891,mm,0,0
55892,Hg,0,0
55893,),0,0
55894,during,0,0
55895,the,0,0
55896,decompression,0,0
55897,phase,0,0
55898,of,0,0
55899,cardiopulmonary,0,1
55900,resuscitation,0,1
55901,were,0,1
55902,-1.0,0,0
55903,+/-,0,0
55904,0.73,0,0
55905,mm,0,0
55906,Hg,0,0
55907,with,0,1
55908,a,0,0
55909,sham,0,0
55910,vs.,0,0
55911,-4.6,0,0
55912,+/-,0,0
55913,3.7,0,0
55914,mm,0,0
55915,Hg,0,0
55916,with,0,1
55917,an,0,0
55918,active,0,0
55919,ITD,0,0
55920,on,0,0
55921,the,0,0
55922,facemask,0,0
55923,(,0,0
55924,p,0,0
55925,=,0,0
55926,.003,0,0
55927,),0,0
55928,and,0,0
55929,-1.3,0,0
55930,+/-,0,0
55931,1.3,0,0
55932,mm,0,0
55933,Hg,0,0
55934,with,0,1
55935,a,0,0
55936,sham,0,0
55937,ITD,0,0
55938,vs.,0,0
55939,-7.3,0,0
55940,+/-,0,0
55941,4.5,0,0
55942,mm,0,0
55943,Hg,0,0
55944,with,0,1
55945,an,0,0
55946,active,0,1
55947,ITD,0,0
55948,on,0,0
55949,an,0,0
55950,ETT,0,0
55951,(,0,0
55952,p,0,0
55953,=,0,0
55954,.0009,0,0
55955,),0,1
55956,.,0,0
55957,Decompression,0,0
55958,phase,0,0
55959,airway,0,1
55960,pressures,0,0
55961,with,0,1
55962,the,0,0
55963,facemask,0,0
55964,and,0,0
55965,ETT,0,0
55966,were,0,0
55967,not,0,0
55968,statistically,0,0
55969,different,0,0
55970,.,0,0
55971,CONCLUSIONS,0,0
55972,Use,0,0
55973,of,0,0
55974,an,0,0
55975,active,0,1
55976,ITD,0,0
55977,attached,0,0
55978,to,0,0
55979,a,0,0
55980,facemask,0,0
55981,or,0,0
55982,an,0,0
55983,ETT,0,0
55984,resulted,0,0
55985,in,0,0
55986,a,0,0
55987,significantly,0,0
55988,lower,0,0
55989,negative,0,0
55990,intratracheal,0,0
55991,pressure,0,0
55992,during,0,0
55993,the,0,0
55994,decompression,0,0
55995,phase,0,0
55996,of,0,0
55997,active,0,1
55998,compression-decompression,0,1
55999,cardiopulmonary,0,1
56000,resuscitation,0,0
56001,when,0,0
56002,compared,0,0
56003,with,0,0
56004,controls,0,1
56005,.,0,1
56006,Airway,0,0
56007,pressures,0,0
56008,with,0,0
56009,an,0,0
56010,ITD,0,0
56011,on,0,0
56012,either,0,0
56013,a,0,0
56014,facemask,0,0
56015,or,0,0
56016,ETT,0,0
56017,were,0,1
56018,similar,0,0
56019,.,0,1
56020,The,0,0
56021,ITD-facemask,0,0
56022,combination,0,0
56023,was,0,0
56024,practical,0,0
56025,and,0,0
56026,enables,0,0
56027,rapid,0,0
56028,deployment,0,0
56029,of,0,0
56030,this,0,0
56031,life-saving,0,0
56032,technology,0,0
56033,.,0,1
56034,Uterine,0,0
56035,incision,0,0
56036,closure,0,1
56037,at,0,0
56038,caesarean,0,1
56039,section,0,1
56040,:,0,1
56041,a,0,0
56042,randomised,0,0
56043,comparative,0,0
56044,study,0,0
56045,of,0,0
56046,intraperitoneal,0,0
56047,closure,0,1
56048,and,0,0
56049,closure,0,1
56050,after,0,0
56051,temporary,0,0
56052,exteriorisation,0,0
56053,.,0,0
56054,BACKGROUND,0,0
56055,The,0,0
56056,safety,0,0
56057,of,0,0
56058,the,0,0
56059,technique,0,0
56060,of,0,0
56061,uterine,0,1
56062,exteriorization,0,0
56063,at,0,0
56064,caesarean,0,1
56065,section,0,1
56066,though,0,0
56067,popular,0,0
56068,among,0,1
56069,obstetricians,0,1
56070,",",0,0
56071,remains,0,0
56072,controversial,0,0
56073,.,0,0
56074,OBJECTIVE,0,0
56075,To,0,0
56076,evaluate,0,0
56077,the,0,0
56078,influence,0,0
56079,of,0,0
56080,exteriorization,0,0
56081,of,0,0
56082,uterus,0,1
56083,during,0,0
56084,uterine,0,1
56085,repair,0,1
56086,on,0,0
56087,caesarean,0,1
56088,morbidity,0,0
56089,.,0,1
56090,METHODS,0,0
56091,A,0,0
56092,randomized,0,1
56093,comparative,0,0
56094,study,0,1
56095,of,0,0
56096,136,1,1
56097,women,1,1
56098,undergoing,1,1
56099,primary,1,1
56100,caesarean,1,1
56101,delivery,1,0
56102,at,1,0
56103,Havana,1,0
56104,Specialist,1,1
56105,Hospital,1,1
56106,Lagos,1,1
56107,Nigeria,1,1
56108,.,1,1
56109,Data,0,0
56110,on,0,0
56111,operation,0,0
56112,time,0,0
56113,",",0,0
56114,estimated,0,0
56115,blood,0,0
56116,loss,0,0
56117,",",0,0
56118,postoperative,0,0
56119,morbidities,0,0
56120,were,0,1
56121,collected,0,0
56122,and,0,0
56123,analysed,0,0
56124,with,0,1
56125,comparison,0,0
56126,between,0,0
56127,the,0,0
56128,two,0,0
56129,groups,0,0
56130,using,0,0
56131,chi,0,0
56132,square,0,0
56133,",",0,0
56134,Fischer,0,0
56135,'s,0,1
56136,exact,0,0
56137,test,0,0
56138,and,0,0
56139,t-test,0,0
56140,as,0,0
56141,appropriate,0,0
56142,.,0,0
56143,RESULTS,0,0
56144,The,0,0
56145,mean,0,0
56146,operative,0,0
56147,time,0,0
56148,",",0,0
56149,estimated,0,0
56150,blood,0,0
56151,loss,0,0
56152,",",0,0
56153,transfusion,0,0
56154,rate,0,0
56155,and,0,0
56156,postoperative,0,0
56157,anemia,0,1
56158,rate,0,0
56159,were,0,0
56160,significantly,0,0
56161,less,0,0
56162,in,0,0
56163,the,0,0
56164,exteriorized,0,0
56165,group,0,0
56166,than,0,0
56167,the,0,0
56168,intraperitoneal,0,0
56169,group,0,0
56170,(,0,0
56171,p,0,0
56172,=,0,0
56173,0.000,0,0
56174,",",0,0
56175,"0.009,0.048",0,0
56176,0.038,0,0
56177,and,0,0
56178,0.028,0,0
56179,respectively,0,0
56180,),0,0
56181,",",0,0
56182,but,0,0
56183,not,0,0
56184,in,0,0
56185,other,0,0
56186,outcome,0,0
56187,measures,0,0
56188,.,0,1
56189,CONCLUSION,0,0
56190,With,0,1
56191,shorter,0,0
56192,operative,0,0
56193,time,0,0
56194,",",0,0
56195,less,0,0
56196,blood,0,0
56197,loss,0,0
56198,and,0,0
56199,similar,0,0
56200,morbidity,0,0
56201,profile,0,0
56202,exteriorization,0,0
56203,of,0,0
56204,uterus,0,1
56205,during,0,0
56206,caesarean,0,1
56207,section,0,0
56208,seems,0,0
56209,to,0,0
56210,be,0,0
56211,preferred,0,0
56212,except,0,0
56213,where,0,0
56214,it,0,0
56215,is,0,0
56216,not,0,0
56217,possible,0,0
56218,because,0,0
56219,of,0,0
56220,adhesions,0,0
56221,and,0,1
56222,surgeons,0,1
56223,inexperience,0,0
56224,.,0,1
56225,Are,0,1
56226,brand-name,0,0
56227,and,0,0
56228,generic,0,0
56229,warfarin,0,0
56230,interchangeable,0,0
56231,?,0,0
56232,Multiple,0,0
56233,n-of-1,0,0
56234,randomized,0,0
56235,",",0,0
56236,crossover,0,1
56237,trials,0,0
56238,.,0,1
56239,BACKGROUND,0,0
56240,Warfarin,0,0
56241,is,0,0
56242,a,0,0
56243,commonly,0,0
56244,used,0,0
56245,anticoagulant,0,0
56246,in,0,0
56247,North,0,1
56248,America,0,1
56249,.,0,1
56250,Several,0,0
56251,generic,0,0
56252,formulations,0,0
56253,have,0,1
56254,been,0,0
56255,approved,0,0
56256,",",0,0
56257,raising,0,0
56258,concern,0,0
56259,over,0,0
56260,the,0,0
56261,safety,0,0
56262,and,0,0
56263,efficacy,0,0
56264,of,0,0
56265,these,0,0
56266,products,0,0
56267,compared,0,0
56268,with,0,1
56269,brand-name,0,0
56270,Coumadin,0,1
56271,.,0,1
56272,OBJECTIVE,0,0
56273,To,0,0
56274,ensure,0,0
56275,that,0,0
56276,generic,0,0
56277,warfarin,0,0
56278,products,0,0
56279,can,0,0
56280,be,0,0
56281,safely,0,0
56282,interchanged,0,0
56283,with,0,1
56284,Coumadin,0,1
56285,.,0,1
56286,METHODS,0,0
56287,Multiple,0,0
56288,n-of-1,0,0
56289,randomized,0,0
56290,",",0,0
56291,double-blind,0,0
56292,",",0,0
56293,crossover,0,0
56294,trials,0,0
56295,switched,0,0
56296,outpatients,1,1
56297,(,1,1
56298,N,1,1
56299,=,1,0
56300,7,1,1
56301,),1,0
56302,between,0,0
56303,a,0,0
56304,generic,0,0
56305,warfarin,0,0
56306,formulation,0,0
56307,(,0,0
56308,Apo-warfarin,0,0
56309,),0,0
56310,and,0,0
56311,Coumadin,0,1
56312,over,0,0
56313,30,0,1
56314,weeks,0,0
56315,.,0,1
56316,Study,1,0
56317,patients,1,1
56318,took,1,1
56319,each,1,0
56320,drug,1,0
56321,for,1,0
56322,five,1,1
56323,3-week,1,0
56324,periods,1,0
56325,",",1,0
56326,with,1,1
56327,international,1,0
56328,normalized,1,0
56329,ratio,1,0
56330,(,1,0
56331,INR,1,0
56332,),1,0
56333,measurements,1,0
56334,taken,1,0
56335,twice,1,0
56336,per,1,0
56337,period,1,0
56338,.,1,1
56339,Inter-,0,0
56340,and,0,0
56341,intrapatient,0,0
56342,differences,0,0
56343,between,0,0
56344,generic,0,0
56345,warfarin,0,0
56346,and,0,0
56347,Coumadin,0,1
56348,were,0,0
56349,compared,0,0
56350,",",0,0
56351,and,0,0
56352,overall,0,0
56353,study,0,0
56354,patient,0,1
56355,results,0,0
56356,were,0,0
56357,compared,0,0
56358,with,0,1
56359,those,0,0
56360,of,0,0
56361,a,0,0
56362,Coumadin,0,0
56363,control,0,0
56364,group,0,0
56365,.,0,0
56366,RESULTS,0,0
56367,There,0,0
56368,were,0,0
56369,no,0,0
56370,differences,0,0
56371,between,0,0
56372,warfarin,0,1
56373,products,0,0
56374,in,0,0
56375,terms,0,0
56376,of,0,1
56377,mean,0,1
56378,INR,0,1
56379,results,0,0
56380,or,0,1
56381,number,0,0
56382,of,0,0
56383,dosage,0,0
56384,adjustments,0,0
56385,required,0,0
56386,.,0,0
56387,There,0,0
56388,also,0,0
56389,was,0,0
56390,no,0,0
56391,difference,0,0
56392,in,0,0
56393,INR,0,0
56394,variation,0,0
56395,based,0,0
56396,on,0,0
56397,warfarin,0,0
56398,formulation,0,0
56399,(,0,0
56400,p,0,0
56401,>,0,1
56402,0.69,0,0
56403,),0,0
56404,",",0,0
56405,nor,0,0
56406,was,0,0
56407,a,0,0
56408,patient,0,0
56409,and,0,0
56410,warfarin,0,0
56411,interaction,0,0
56412,found,0,0
56413,(,0,0
56414,p,0,0
56415,>,0,1
56416,0.81,0,0
56417,),0,0
56418,.,0,0
56419,The,0,0
56420,INR,0,0
56421,results,0,0
56422,were,0,0
56423,not,0,0
56424,influenced,0,0
56425,by,0,0
56426,whether,0,0
56427,patients,0,1
56428,were,0,1
56429,maintained,0,0
56430,on,0,0
56431,Coumadin,0,1
56432,only,0,0
56433,(,0,0
56434,control,0,0
56435,group,0,0
56436,),0,0
56437,or,0,0
56438,interchanged,0,0
56439,between,0,0
56440,Coumadin,0,1
56441,and,0,0
56442,generic,0,0
56443,warfarin,0,0
56444,(,0,0
56445,p,0,0
56446,=,0,0
56447,0.98,0,0
56448,),0,0
56449,.,0,0
56450,CONCLUSIONS,0,0
56451,It,0,0
56452,appears,0,0
56453,that,0,0
56454,patients,0,1
56455,can,0,0
56456,safely,0,0
56457,and,0,0
56458,effectively,0,0
56459,switch,0,0
56460,between,0,0
56461,generic,0,0
56462,warfarin,0,0
56463,and,0,0
56464,Coumadin,0,1
56465,.,0,1
56466,A,0,0
56467,short-term,0,0
56468,cognitive,0,0
56469,group,0,0
56470,treatment,0,0
56471,program,0,0
56472,gives,0,0
56473,substantial,0,0
56474,weight,0,0
56475,reduction,0,0
56476,up,0,0
56477,to,0,0
56478,18,0,1
56479,months,0,0
56480,from,0,1
56481,the,0,0
56482,end,0,0
56483,of,0,0
56484,treatment,0,0
56485,.,0,0
56486,A,0,0
56487,randomized,0,0
56488,controlled,0,0
56489,trial,0,1
56490,.,0,0
56491,OBJECTIVE,0,0
56492,To,0,0
56493,describe,0,0
56494,and,0,0
56495,evaluate,0,0
56496,long-term,0,0
56497,efficacy,0,0
56498,(,0,1
56499,18,0,1
56500,months,0,0
56501,from,0,1
56502,the,0,0
56503,end,0,0
56504,of,0,0
56505,treatment,0,0
56506,),0,0
56507,of,0,0
56508,a,0,0
56509,new,0,0
56510,cognitive,0,0
56511,short-term,0,0
56512,weight,0,0
56513,reducing,0,0
56514,treatment,0,0
56515,program,0,0
56516,for,0,0
56517,obese,1,1
56518,patients,1,1
56519,.,1,1
56520,SUBJECTS,0,0
56521,One,1,1
56522,hundred,1,1
56523,and,1,1
56524,five,1,1
56525,obese,1,1
56526,[,1,0
56527,Body,1,1
56528,Mass,1,0
56529,Index,1,0
56530,(,1,0
56531,BMI,1,1
56532,),1,0
56533,>,1,1
56534,or,1,1
56535,=,1,0
56536,30,1,1
56537,],1,1
56538,patients,1,1
56539,participated,1,1
56540,in,1,0
56541,the,1,0
56542,study,1,0
56543,.,1,0
56544,Of,0,0
56545,these,0,0
56546,",",0,0
56547,62,1,0
56548,took,1,0
56549,part,1,0
56550,in,1,0
56551,the,1,0
56552,treatment,1,0
56553,program,1,0
56554,and,1,0
56555,43,1,1
56556,served,1,0
56557,as,1,0
56558,controls,1,1
56559,.,1,1
56560,METHOD,0,0
56561,From,0,1
56562,an,0,0
56563,obesity,1,1
56564,unit,1,0
56565,'s,1,1
56566,waiting,1,0
56567,list,1,0
56568,",",0,0
56569,the,0,0
56570,patients,0,1
56571,were,0,0
56572,randomly,0,1
56573,assigned,0,0
56574,to,0,0
56575,either,0,0
56576,a,0,0
56577,treatment,0,0
56578,group,0,0
56579,or,0,0
56580,remained,0,0
56581,in,0,0
56582,the,0,0
56583,waiting,0,0
56584,list,0,0
56585,to,0,0
56586,serve,0,0
56587,as,0,0
56588,a,0,0
56589,control,0,0
56590,group,0,0
56591,.,0,0
56592,The,0,0
56593,treatment,0,0
56594,group,0,0
56595,participated,0,1
56596,in,0,0
56597,a,0,0
56598,10-week,0,0
56599,(,0,0
56600,30,0,1
56601,hours,0,0
56602,),0,1
56603,cognitive,0,0
56604,group,0,0
56605,treatment,0,0
56606,program,0,0
56607,.,0,0
56608,All,0,0
56609,participants,0,1
56610,were,0,0
56611,weighed,0,0
56612,at,0,0
56613,the,0,0
56614,outset,0,0
56615,of,0,0
56616,the,0,0
56617,study,0,0
56618,",",0,0
56619,directly,0,0
56620,after,0,0
56621,treatment,0,0
56622,and,0,0
56623,at,0,0
56624,a,0,0
56625,6-,0,0
56626,",",0,0
56627,12-,0,0
56628,and,0,0
56629,18-month,0,0
56630,post-treatment,0,0
56631,follow-up,0,0
56632,without,0,1
56633,any,0,0
56634,booster,0,0
56635,treatment,0,0
56636,after,0,0
56637,the,0,0
56638,10-week,0,0
56639,program,0,0
56640,.,0,1
56641,RESULTS,0,0
56642,Fifty-seven,1,1
56643,(,1,0
56644,92,1,1
56645,%,1,0
56646,),1,1
56647,patients,1,1
56648,completed,1,1
56649,treatment,1,0
56650,.,1,0
56651,For,0,0
56652,the,0,0
56653,34,0,1
56654,(,0,0
56655,60,0,1
56656,%,0,0
56657,),0,1
56658,patients,0,1
56659,who,0,1
56660,participated,0,1
56661,in,0,1
56662,the,0,0
56663,study,0,0
56664,18,0,1
56665,months,0,0
56666,after,0,0
56667,treatment,0,0
56668,was,0,0
56669,terminated,0,0
56670,",",0,0
56671,the,0,0
56672,mean,0,0
56673,weight,0,0
56674,loss,0,0
56675,at,0,0
56676,treatment,0,0
56677,'s,0,1
56678,end,0,0
56679,was,0,0
56680,8.5,0,0
56681,kg,0,1
56682,(,0,0
56683,SD=16.1,0,0
56684,),0,1
56685,.,0,1
56686,Eighteen,0,1
56687,months,0,0
56688,later,0,1
56689,their,0,0
56690,mean,0,0
56691,weight,0,0
56692,loss,0,0
56693,was,0,0
56694,10.4,0,0
56695,kg,0,1
56696,(,0,0
56697,SD=10.8,0,0
56698,),0,0
56699,.,0,0
56700,The,0,0
56701,control,0,0
56702,patients,0,1
56703,(,0,0
56704,n=31.72,0,1
56705,%,0,0
56706,),0,0
56707,that,0,0
56708,participated,0,1
56709,in,0,0
56710,the,0,0
56711,study,0,0
56712,during,0,0
56713,the,0,0
56714,same,0,0
56715,period,0,0
56716,increased,0,0
56717,in,0,0
56718,weight,0,1
56719,by,0,0
56720,2.3,0,0
56721,kg,0,1
56722,(,0,1
56723,SD=7.0,0,0
56724,),0,0
56725,.,0,0
56726,The,0,0
56727,weight,0,0
56728,difference,0,0
56729,between,0,0
56730,the,0,0
56731,treatment,0,0
56732,and,0,0
56733,control,0,0
56734,group,0,0
56735,at,0,0
56736,the,0,0
56737,18-month,0,0
56738,follow-up,0,0
56739,was,0,0
56740,highly,0,0
56741,significant,0,0
56742,(,0,0
56743,p,0,0
56744,<,0,0
56745,0.001,0,0
56746,),0,0
56747,.,0,0
56748,CONCLUSION,0,0
56749,The,0,0
56750,cognitive,0,0
56751,group,0,0
56752,treatment,0,0
56753,program,0,0
56754,was,0,0
56755,highly,0,0
56756,acceptable,0,0
56757,among,0,0
56758,the,0,0
56759,participants,0,1
56760,and,0,0
56761,was,0,0
56762,completed,0,1
56763,by,0,0
56764,nearly,0,0
56765,all,0,0
56766,the,0,0
56767,patients,0,1
56768,.,0,0
56769,The,0,0
56770,10-week,0,0
56771,treatment,0,0
56772,program,0,0
56773,resulted,0,0
56774,in,0,0
56775,satisfactory,0,0
56776,weight,0,1
56777,loss,0,0
56778,.,0,0
56779,The,0,0
56780,weight,0,0
56781,difference,0,0
56782,between,0,0
56783,the,0,0
56784,treatment,0,0
56785,group,0,0
56786,and,0,0
56787,controls,0,1
56788,was,0,0
56789,nearly,0,0
56790,the,0,0
56791,same,0,0
56792,at,0,0
56793,18,0,1
56794,months,0,0
56795,after,0,0
56796,end,0,0
56797,of,0,0
56798,treatment,0,0
56799,as,0,0
56800,at,0,0
56801,six,0,1
56802,months,0,0
56803,.,0,1
56804,The,0,0
56805,study,0,0
56806,",",0,0
56807,therefore,0,0
56808,",",0,0
56809,does,0,0
56810,not,0,0
56811,provide,0,0
56812,support,0,0
56813,for,0,0
56814,the,0,0
56815,contention,0,0
56816,that,0,0
56817,a,0,0
56818,lengthy,0,0
56819,therapy,0,0
56820,for,0,0
56821,obesity,0,1
56822,is,0,0
56823,necessary,0,0
56824,if,0,0
56825,treatment,0,0
56826,results,0,0
56827,are,0,0
56828,lasting,0,0
56829,.,0,1
56830,Combined,0,0
56831,therapy,0,0
56832,for,0,0
56833,obese,1,1
56834,type,1,1
56835,2,1,1
56836,diabetes,1,1
56837,:,1,1
56838,suppertime,0,1
56839,mixed,0,0
56840,insulin,0,0
56841,with,0,1
56842,daytime,0,1
56843,sulfonylurea,0,1
56844,.,0,0
56845,Combined,0,0
56846,insulin,0,0
56847,and,0,0
56848,sulfonylurea,0,0
56849,therapy,0,0
56850,for,0,0
56851,type,0,1
56852,2,0,0
56853,diabetes,0,1
56854,may,0,0
56855,improve,0,0
56856,the,0,0
56857,effectiveness,0,0
56858,of,0,0
56859,a,0,0
56860,single,0,0
56861,injection,0,0
56862,of,0,0
56863,insulin,0,0
56864,",",0,0
56865,thereby,0,0
56866,postponing,0,0
56867,the,0,0
56868,need,0,0
56869,for,0,0
56870,multiple,0,1
56871,injections,0,0
56872,.,0,1
56873,This,0,0
56874,concept,0,0
56875,was,0,0
56876,tested,0,0
56877,in,0,0
56878,21,1,1
56879,obese,1,1
56880,subjects,1,1
56881,imperfectly,1,1
56882,controlled,1,0
56883,by,1,0
56884,20,1,1
56885,mg,1,0
56886,of,1,1
56887,glyburide,1,0
56888,daily,1,0
56889,in,0,0
56890,a,0,0
56891,double,0,0
56892,masked,0,0
56893,",",0,0
56894,placebo-controlled,0,0
56895,",",0,0
56896,parallel,0,0
56897,design,0,0
56898,",",0,0
56899,16-week,0,0
56900,protocol,0,0
56901,.,0,1
56902,Premixed,0,0
56903,70,0,1
56904,%,0,0
56905,NPH/30,0,0
56906,%,0,0
56907,Regular,0,0
56908,insulin,0,0
56909,was,0,0
56910,taken,0,0
56911,before,0,0
56912,supper,0,0
56913,",",0,0
56914,and,0,0
56915,the,0,0
56916,dosage,0,0
56917,was,0,0
56918,adjusted,0,0
56919,weekly,0,0
56920,by,0,0
56921,an,0,0
56922,algorithm,0,0
56923,seeking,0,0
56924,nearly,0,0
56925,normal,0,1
56926,fasting,0,0
56927,glycemia,0,0
56928,.,0,1
56929,Eleven,1,0
56930,subjects,1,1
56931,using,1,0
56932,insulin,1,0
56933,plus,1,0
56934,10,1,1
56935,mg,1,0
56936,glyburide,1,0
56937,before,0,0
56938,breakfast,0,0
56939,had,0,1
56940,lower,0,0
56941,mean,0,0
56942,fasting,0,0
56943,glucose,0,0
56944,at,0,0
56945,10-16,0,1
56946,weeks,0,0
56947,than,0,1
56948,10,0,1
56949,subjects,0,1
56950,using,0,0
56951,insulin,0,0
56952,with,0,1
56953,placebo,0,0
56954,(,0,0
56955,mean,0,1
56956,+/-,0,0
56957,SEM,0,1
56958,;,0,1
56959,5.9,0,0
56960,+/-,0,0
56961,0.3,0,0
56962,versus,0,0
56963,7.5,0,0
56964,+/-,0,0
56965,0.7,0,0
56966,mmol/L,0,0
56967,;,0,0
56968,p,0,0
56969,less,0,0
56970,than,0,0
56971,0.05,0,0
56972,),0,0
56973,",",0,0
56974,and,0,0
56975,had,0,0
56976,a,0,0
56977,greater,0,0
56978,decrement,0,0
56979,of,0,0
56980,glycosylated,0,0
56981,hemoglobin,0,0
56982,from,0,1
56983,baseline,0,0
56984,values,0,0
56985,(,0,1
56986,1.3,0,0
56987,+/-,0,0
56988,0.1,0,0
56989,versus,0,0
56990,0.8,0,1
56991,+/-,0,0
56992,0.2,0,0
56993,%,0,0
56994,A1,0,0
56995,",",0,0
56996,p,0,0
56997,less,0,0
56998,than,0,0
56999,0.05,0,0
57000,),0,0
57001,.,0,1
57002,After,0,0
57003,16,0,1
57004,weeks,0,0
57005,the,0,0
57006,combined,0,0
57007,therapy,0,0
57008,group,0,0
57009,used,0,0
57010,half,0,1
57011,as,0,0
57012,much,0,0
57013,insulin,0,0
57014,as,0,0
57015,the,0,0
57016,insulin-only,0,0
57017,group,0,0
57018,(,0,0
57019,50,0,1
57020,+/-,0,0
57021,5,0,1
57022,versus,0,0
57023,101,0,1
57024,+/-,0,0
57025,13,0,1
57026,units/d,0,0
57027,;,0,0
57028,p,0,0
57029,less,0,0
57030,than,0,0
57031,0.01,0,0
57032,),0,1
57033,.,0,1
57034,Fasting,0,0
57035,serum,0,0
57036,free,0,1
57037,insulin,0,0
57038,values,0,0
57039,increased,0,0
57040,58,0,1
57041,%,0,0
57042,from,0,0
57043,baseline,0,0
57044,after,0,0
57045,insulin,0,0
57046,therapy,0,0
57047,in,0,0
57048,the,0,0
57049,insulin-only,0,0
57050,group,0,0
57051,(,0,0
57052,p,0,0
57053,less,0,0
57054,than,0,0
57055,0.05,0,0
57056,),0,1
57057,but,0,0
57058,did,0,0
57059,not,0,0
57060,increase,0,0
57061,with,0,1
57062,combined,0,0
57063,therapy,0,0
57064,.,0,1
57065,Weight,0,1
57066,gain,0,0
57067,was,0,0
57068,similar,0,0
57069,in,0,0
57070,the,0,0
57071,two,0,0
57072,groups,0,0
57073,.,0,1
57074,These,0,0
57075,data,0,0
57076,support,0,0
57077,this,0,0
57078,form,0,0
57079,of,0,0
57080,combined,0,0
57081,therapy,0,0
57082,as,0,0
57083,one,0,0
57084,option,0,0
57085,for,0,0
57086,treating,0,0
57087,obese,1,1
57088,persons,1,1
57089,with,1,1
57090,type,1,1
57091,2,1,0
57092,diabetes,1,1
57093,no,0,0
57094,longer,0,0
57095,responsive,0,0
57096,to,0,0
57097,oral,0,0
57098,therapy,0,0
57099,alone,0,0
57100,.,0,0
57101,Inhibition,0,0
57102,of,0,0
57103,awake,0,0
57104,sympathetic,0,0
57105,nerve,0,0
57106,activity,0,0
57107,of,0,0
57108,heart,1,1
57109,failure,1,1
57110,patients,1,1
57111,with,1,1
57112,obstructive,1,1
57113,sleep,1,0
57114,apnea,1,1
57115,by,0,0
57116,nocturnal,0,1
57117,continuous,0,0
57118,positive,0,0
57119,airway,0,1
57120,pressure,0,0
57121,.,0,0
57122,OBJECTIVES,0,0
57123,This,0,0
57124,study,0,0
57125,was,0,0
57126,designed,0,0
57127,to,0,0
57128,determine,0,0
57129,whether,0,0
57130,reductions,0,0
57131,in,0,0
57132,morning,0,0
57133,systolic,0,1
57134,blood,0,0
57135,pressure,0,0
57136,(,0,0
57137,BP,0,0
57138,),0,0
57139,elicited,0,0
57140,by,0,0
57141,treatment,0,0
57142,of,0,0
57143,moderate,0,1
57144,to,0,0
57145,severe,0,1
57146,obstructive,0,1
57147,sleep,0,0
57148,apnea,0,1
57149,(,0,0
57150,OSA,0,1
57151,),0,0
57152,in,0,0
57153,heart,1,1
57154,failure,1,1
57155,(,1,0
57156,HF,1,1
57157,),1,1
57158,patients,1,1
57159,are,0,0
57160,associated,0,0
57161,with,0,1
57162,a,0,0
57163,reduction,0,0
57164,in,0,0
57165,sympathetic,0,0
57166,vasoconstrictor,0,0
57167,tone,0,0
57168,.,0,1
57169,BACKGROUND,0,0
57170,Daytime,0,0
57171,muscle,0,0
57172,sympathetic,0,0
57173,nerve,0,0
57174,activity,0,0
57175,(,0,0
57176,MSNA,0,0
57177,),0,0
57178,is,0,0
57179,elevated,0,0
57180,in,0,0
57181,HF,1,1
57182,patients,1,1
57183,with,1,1
57184,coexisting,1,1
57185,OSA,1,1
57186,.,1,1
57187,In,0,0
57188,our,0,0
57189,recent,0,0
57190,randomized,0,0
57191,trial,0,0
57192,in,0,0
57193,HF,0,0
57194,",",0,0
57195,abolition,0,0
57196,of,0,0
57197,OSA,0,1
57198,by,0,0
57199,continuous,0,0
57200,positive,0,0
57201,airway,0,1
57202,pressure,0,0
57203,(,0,0
57204,CPAP,0,1
57205,),0,0
57206,increased,0,0
57207,left,0,1
57208,ventricular,0,0
57209,ejection,0,1
57210,fraction,0,0
57211,(,0,0
57212,LVEF,0,1
57213,),0,0
57214,and,0,0
57215,lowered,0,0
57216,morning,0,0
57217,systolic,0,1
57218,BP,0,0
57219,.,0,1
57220,METHODS,0,0
57221,Muscle,0,0
57222,sympathetic,0,0
57223,nerve,0,0
57224,activity,0,0
57225,",",0,0
57226,BP,0,0
57227,",",0,0
57228,and,0,0
57229,heart,0,1
57230,rate,0,0
57231,(,0,0
57232,HR,0,0
57233,),0,0
57234,of,0,0
57235,medically,1,1
57236,treated,1,1
57237,HF,1,0
57238,patients,1,1
57239,(,1,0
57240,EF,1,0
57241,<,1,0
57242,45,1,1
57243,%,1,0
57244,),1,0
57245,and,1,0
57246,OSA,1,1
57247,(,1,0
57248,apnea-hypopnea,1,1
57249,index,1,0
57250,>,1,1
57251,or,1,1
57252,=20/h,1,0
57253,of,1,0
57254,sleep,1,1
57255,),1,0
57256,were,0,0
57257,recorded,0,0
57258,on,0,0
57259,the,0,0
57260,morning,0,0
57261,after,0,0
57262,overnight,0,0
57263,polysomnography,0,1
57264,",",0,0
57265,and,0,0
57266,again,0,0
57267,one,0,0
57268,month,0,0
57269,after,0,0
57270,patients,0,1
57271,were,0,1
57272,randomly,0,1
57273,allocated,0,1
57274,nocturnal,0,0
57275,CPAP,0,1
57276,treatment,0,0
57277,or,0,0
57278,no,0,0
57279,CPAP,0,0
57280,(,0,0
57281,control,0,1
57282,),0,0
57283,.,0,0
57284,RESULTS,0,0
57285,In,1,0
57286,nine,1,1
57287,control,1,1
57288,patients,1,1
57289,",",0,0
57290,there,0,0
57291,were,0,0
57292,no,0,0
57293,significant,0,0
57294,changes,0,0
57295,in,0,0
57296,the,0,0
57297,severity,0,0
57298,of,0,0
57299,OSA,0,1
57300,",",0,0
57301,MSNA,0,0
57302,",",0,0
57303,systolic,0,0
57304,BP,0,0
57305,",",0,0
57306,or,0,1
57307,HR,0,0
57308,.,0,0
57309,In,0,0
57310,contrast,0,0
57311,",",0,0
57312,in,0,0
57313,the,0,0
57314,8,1,0
57315,CPAP-treated,1,0
57316,patients,1,1
57317,",",0,1
57318,OSA,0,1
57319,was,0,0
57320,attenuated,0,0
57321,",",0,0
57322,and,0,0
57323,there,0,0
57324,were,0,0
57325,significant,0,0
57326,reductions,0,0
57327,in,0,1
57328,daytime,0,1
57329,MSNA,0,1
57330,(,0,0
57331,from,0,1
57332,58,0,1
57333,+/-,0,0
57334,4,0,0
57335,bursts/min,0,0
57336,to,0,0
57337,48,0,1
57338,+/-,0,0
57339,5,0,1
57340,bursts/min,0,1
57341,;,0,1
57342,84,0,1
57343,+/-,0,0
57344,4,0,0
57345,bursts/100,0,0
57346,heart,0,1
57347,beats,0,1
57348,to,0,0
57349,72,0,0
57350,+/-,0,0
57351,5,0,1
57352,bursts/100,0,0
57353,heart,0,1
57354,beats,0,1
57355,;,0,0
57356,p,0,0
57357,<,0,0
57358,0.001,0,0
57359,and,0,0
57360,p,0,0
57361,=,0,0
57362,0.003,0,0
57363,",",0,0
57364,respectively,0,0
57365,),0,0
57366,",",0,0
57367,systolic,0,1
57368,BP,0,0
57369,(,0,0
57370,from,0,1
57371,135,0,1
57372,+/-,0,0
57373,5,0,1
57374,mm,0,0
57375,Hg,0,0
57376,to,0,0
57377,120,0,1
57378,+/-,0,0
57379,6,0,0
57380,mm,0,0
57381,Hg,0,0
57382,",",0,0
57383,p,0,0
57384,=,0,0
57385,0.03,0,0
57386,),0,0
57387,",",0,0
57388,and,0,0
57389,HR,0,0
57390,(,0,0
57391,from,0,1
57392,69,0,1
57393,+/-,0,0
57394,2,0,0
57395,min,0,0
57396,(,0,0
57397,-1,0,0
57398,),0,0
57399,to,0,0
57400,66,0,1
57401,+/-,0,0
57402,2,0,0
57403,min,0,0
57404,(,0,0
57405,-1,0,0
57406,),0,1
57407,;,0,0
57408,p,0,0
57409,=,0,0
57410,0.013,0,0
57411,),0,0
57412,.,0,1
57413,CONCLUSIONS,0,0
57414,Treatment,1,0
57415,of,1,0
57416,coexisting,1,1
57417,OSA,1,1
57418,by,1,0
57419,CPAP,1,1
57420,in,1,0
57421,HF,1,1
57422,patients,1,1
57423,lowers,0,0
57424,daytime,0,1
57425,MSNA,0,1
57426,",",0,0
57427,systolic,0,0
57428,BP,0,0
57429,",",0,0
57430,and,0,0
57431,HR,0,0
57432,.,0,0
57433,Inhibition,0,0
57434,of,0,0
57435,increased,0,0
57436,central,0,1
57437,sympathetic,0,0
57438,vasoconstrictor,0,0
57439,outflow,0,0
57440,is,0,0
57441,one,0,0
57442,mechanism,0,0
57443,by,0,0
57444,which,0,0
57445,nocturnal,0,1
57446,CPAP,0,1
57447,reduces,0,0
57448,awake,0,1
57449,BP,0,0
57450,in,0,0
57451,HF,1,1
57452,patients,1,1
57453,with,1,1
57454,moderate,1,1
57455,to,1,0
57456,severe,1,1
57457,OSA,1,1
57458,.,1,1
57459,Montelukast,0,0
57460,treatment,0,0
57461,of,0,0
57462,moderate,0,1
57463,to,0,0
57464,severe,1,1
57465,atopic,1,1
57466,dermatitis,1,1
57467,in,1,0
57468,adults,1,1
57469,:,1,1
57470,a,0,0
57471,randomized,0,0
57472,",",0,0
57473,double-blind,0,0
57474,",",0,0
57475,placebo-controlled,0,0
57476,trial,0,0
57477,.,0,0
57478,In,0,0
57479,a,0,0
57480,randomized,0,0
57481,",",0,0
57482,double-blind,0,0
57483,",",0,0
57484,placebo-controlled,0,0
57485,4-week,0,0
57486,trial,0,0
57487,",",0,0
57488,59,1,1
57489,patients,1,1
57490,with,1,1
57491,moderate,1,1
57492,to,1,0
57493,severe,1,1
57494,atopic,1,1
57495,dermatitis,1,1
57496,were,0,0
57497,treated,0,0
57498,orally,0,0
57499,with,0,1
57500,10,0,0
57501,mg,0,0
57502,of,0,0
57503,the,0,0
57504,leukotriene,0,0
57505,antagonist,0,0
57506,montelukast,0,0
57507,.,0,1
57508,Forty-seven,1,1
57509,patients,1,1
57510,completed,1,1
57511,the,1,0
57512,study,1,0
57513,.,1,0
57514,No,0,0
57515,difference,0,0
57516,in,0,0
57517,efficacy,0,0
57518,was,0,0
57519,seen,0,0
57520,among,0,1
57521,patients,0,1
57522,who,0,1
57523,received,0,1
57524,montelukast,0,1
57525,and,0,0
57526,the,0,0
57527,group,0,0
57528,given,0,0
57529,a,0,0
57530,placebo,0,0
57531,.,0,0
57532,Anti-Xa,0,0
57533,effect,0,0
57534,of,0,0
57535,a,0,0
57536,low,0,0
57537,molecular,0,0
57538,weight,0,0
57539,heparin,0,0
57540,(,0,0
57541,dalteparin,0,0
57542,),0,0
57543,does,0,0
57544,not,0,0
57545,accumulate,0,0
57546,in,0,0
57547,extended,0,0
57548,duration,0,0
57549,therapy,0,0
57550,for,0,0
57551,venous,1,0
57552,thromboembolism,1,1
57553,in,1,0
57554,cancer,1,1
57555,patients,1,1
57556,.,1,1
57557,Many,0,1
57558,patients,1,1
57559,with,1,1
57560,venous,1,1
57561,thromboembolism,1,1
57562,are,0,0
57563,being,0,0
57564,treated,0,1
57565,with,0,1
57566,low,0,1
57567,molecular,0,0
57568,weight,0,0
57569,heparin,0,0
57570,for,0,0
57571,extended,0,1
57572,periods,0,0
57573,of,0,0
57574,time,0,0
57575,.,0,0
57576,It,0,0
57577,is,0,0
57578,not,0,0
57579,certain,0,0
57580,if,0,0
57581,it,0,0
57582,is,0,0
57583,necessary,0,0
57584,to,0,0
57585,assess,0,0
57586,anti-Xa,0,0
57587,levels,0,0
57588,for,0,0
57589,extended,0,1
57590,treatment,0,0
57591,periods,0,0
57592,.,0,0
57593,This,0,0
57594,study,0,0
57595,is,0,0
57596,a,0,0
57597,prospective,0,0
57598,assessment,0,0
57599,of,0,0
57600,anti-Xa,0,0
57601,levels,0,0
57602,in,0,1
57603,patients,1,1
57604,on,1,0
57605,long-term,1,0
57606,therapy,1,0
57607,for,1,0
57608,acute,1,1
57609,venous,1,1
57610,thromboembolism,1,1
57611,who,1,1
57612,have,1,1
57613,active,1,1
57614,cancer,1,1
57615,.,1,1
57616,Consecutive,1,1
57617,consenting,1,1
57618,patients,1,1
57619,from,1,1
57620,one,1,1
57621,center,1,1
57622,in,1,0
57623,a,1,0
57624,multicenter,1,0
57625,trial,1,0
57626,that,0,0
57627,compared,0,0
57628,6,0,0
57629,months,0,0
57630,of,0,1
57631,low,0,1
57632,molecular,0,0
57633,weight,0,0
57634,heparin,0,0
57635,with,0,1
57636,oral,0,0
57637,anticoagulant,0,0
57638,therapy,0,0
57639,were,0,0
57640,treated,0,1
57641,with,0,1
57642,therapeutic,0,0
57643,doses,0,0
57644,of,0,0
57645,dalteparin,0,1
57646,(,0,1
57647,200,0,0
57648,IU,0,0
57649,per,0,0
57650,kilogram,0,0
57651,),0,0
57652,subcutaneously,0,0
57653,daily,0,0
57654,.,0,1
57655,Anti-Xa,0,0
57656,levels,0,0
57657,were,0,1
57658,assessed,0,0
57659,at,0,0
57660,the,0,0
57661,end,0,0
57662,of,0,0
57663,weeks,0,0
57664,1,0,1
57665,and,0,1
57666,"4,4-6",0,0
57667,hours,0,0
57668,after,0,0
57669,injection,0,0
57670,of,0,0
57671,dalteparin,0,0
57672,.,0,1
57673,Patients,0,1
57674,were,0,0
57675,followed,0,0
57676,for,0,0
57677,bleeding,0,0
57678,and,0,0
57679,recurrent,0,1
57680,venous,0,0
57681,thromboembolism,0,1
57682,.,0,0
57683,There,0,0
57684,were,0,0
57685,24,1,1
57686,patients,1,1
57687,who,1,1
57688,had,1,1
57689,anti-Xa,1,1
57690,levels,1,0
57691,measured,0,0
57692,at,0,1
57693,weeks,0,0
57694,1,0,1
57695,and,0,1
57696,4,0,0
57697,.,0,1
57698,Two,0,1
57699,other,0,0
57700,patients,0,1
57701,had,0,1
57702,week,0,0
57703,1,0,1
57704,measurements,0,0
57705,performed,0,0
57706,but,0,0
57707,died,0,1
57708,before,0,0
57709,the,0,0
57710,week,0,0
57711,4,0,0
57712,sample,0,1
57713,was,0,0
57714,collected,0,0
57715,due,0,0
57716,to,0,0
57717,their,0,0
57718,underlying,0,0
57719,cancer,0,1
57720,.,0,0
57721,The,0,0
57722,mean,0,0
57723,anti-Xa,0,0
57724,levels,0,0
57725,at,0,1
57726,weeks,0,0
57727,1,0,1
57728,and,0,1
57729,4,0,0
57730,were,0,0
57731,1.11,0,0
57732,and,0,1
57733,1.03,0,0
57734,anti-Xa,0,0
57735,units/ml,0,0
57736,respectively,0,0
57737,(,0,0
57738,P=0.13,0,0
57739,),0,0
57740,.,0,0
57741,These,0,0
57742,results,0,0
57743,suggest,0,0
57744,that,0,0
57745,for,0,0
57746,patients,1,1
57747,with,1,1
57748,active,1,1
57749,cancer,1,1
57750,receiving,0,1
57751,extended,0,0
57752,duration,0,0
57753,therapy,0,0
57754,with,0,1
57755,low,0,1
57756,molecular,0,0
57757,weight,0,0
57758,heparin,0,0
57759,(,0,0
57760,dalteparin,0,0
57761,),0,0
57762,there,0,0
57763,is,0,0
57764,no,0,0
57765,accumulation,0,0
57766,of,0,0
57767,anti-Xa,0,0
57768,effect,0,0
57769,over,0,0
57770,the,0,0
57771,first,0,0
57772,month,0,0
57773,of,0,0
57774,therapy,0,0
57775,.,0,0
57776,Monitoring,0,0
57777,of,0,0
57778,anti-Xa,0,0
57779,levels,0,0
57780,in,0,0
57781,this,0,0
57782,situation,0,0
57783,is,0,0
57784,usually,0,0
57785,not,0,0
57786,required,0,0
57787,.,0,0
57788,The,0,0
57789,effect,0,0
57790,of,0,0
57791,venlafaxine,0,0
57792,on,0,0
57793,ongoing,0,0
57794,and,0,0
57795,experimentally,0,0
57796,induced,0,0
57797,pain,0,0
57798,in,0,0
57799,neuropathic,1,1
57800,pain,1,1
57801,patients,1,1
57802,:,1,1
57803,a,0,0
57804,double,0,0
57805,blind,0,0
57806,",",0,0
57807,placebo,0,0
57808,controlled,0,0
57809,study,0,0
57810,.,0,0
57811,BACKGROUND,0,0
57812,AND,0,0
57813,AIM,0,0
57814,The,0,0
57815,aim,0,0
57816,of,0,0
57817,this,0,0
57818,randomized,0,0
57819,double,0,0
57820,blind,0,1
57821,placebo,0,0
57822,controlled,0,0
57823,study,0,0
57824,was,0,0
57825,to,0,0
57826,investigate,0,0
57827,the,0,0
57828,effectiveness,0,0
57829,and,0,0
57830,the,0,0
57831,safety,0,0
57832,of,0,0
57833,venlafaxine,0,0
57834,XR,0,1
57835,75,0,1
57836,and,0,0
57837,150,0,0
57838,mg,0,0
57839,on,0,0
57840,ongoing,0,0
57841,pain,0,0
57842,and,0,0
57843,on,0,0
57844,quantitative,0,0
57845,sensory,0,1
57846,tests,0,0
57847,in,0,1
57848,60,1,1
57849,patients,1,1
57850,with,1,1
57851,neuropathic,1,1
57852,pain,1,1
57853,for,1,0
57854,8,1,0
57855,weeks,1,0
57856,.,1,1
57857,METHODS,0,0
57858,Evaluation,0,0
57859,parameters,0,0
57860,consisted,0,1
57861,of,0,0
57862,ongoing,0,0
57863,pain,0,1
57864,intensity,0,0
57865,(,0,0
57866,VAS,0,1
57867,),0,0
57868,",",0,0
57869,patient,0,0
57870,satisfaction,0,0
57871,",",0,0
57872,side,0,0
57873,effects,0,0
57874,",",0,0
57875,global,0,0
57876,efficacy,0,0
57877,and,0,0
57878,tolerance,0,0
57879,.,0,0
57880,Quantitative,0,0
57881,sensory,0,0
57882,measurements,0,0
57883,taken,0,0
57884,from,0,1
57885,the,0,0
57886,affected,0,0
57887,area,0,0
57888,before,0,0
57889,and,0,0
57890,after,0,0
57891,the,0,0
57892,drug,0,0
57893,treatment,0,0
57894,included,0,1
57895,pin-prick,0,0
57896,hyperalgesia,0,0
57897,",",0,0
57898,allodynia,0,0
57899,",",0,0
57900,detection,0,0
57901,and,0,0
57902,pain,0,1
57903,thresholds,0,0
57904,to,0,0
57905,electrical,0,0
57906,and,0,0
57907,heat,0,0
57908,stimuli,0,0
57909,",",0,0
57910,temporal,0,0
57911,summation,0,0
57912,of,0,0
57913,repetitive,0,0
57914,electrical,0,0
57915,and,0,0
57916,heat,0,0
57917,stimuli,0,0
57918,.,0,0
57919,RESULTS,1,0
57920,A,1,0
57921,total,1,1
57922,of,1,0
57923,55,1,1
57924,patients,1,1
57925,completed,1,1
57926,the,1,0
57927,study,1,0
57928,.,1,0
57929,VAS,0,0
57930,scores,0,0
57931,decreased,0,0
57932,significantly,0,0
57933,compared,0,0
57934,to,0,0
57935,the,0,0
57936,baseline,0,0
57937,measurements,0,0
57938,in,0,0
57939,all,0,1
57940,groups,0,0
57941,.,0,0
57942,There,0,0
57943,was,0,0
57944,no,0,0
57945,significant,0,0
57946,difference,0,0
57947,between,0,0
57948,the,0,0
57949,groups,1,0
57950,regarding,1,0
57951,pain,1,1
57952,intensity,1,0
57953,and,1,0
57954,escape,1,0
57955,medication,1,0
57956,.,1,0
57957,The,0,0
57958,areas,0,0
57959,of,0,0
57960,allodynia,0,1
57961,and,0,0
57962,pin-prick,0,0
57963,hyperalgesia,0,0
57964,decreased,0,0
57965,significantly,0,0
57966,in,0,0
57967,venlafaxine,0,0
57968,groups,0,0
57969,compared,0,0
57970,to,0,0
57971,the,0,0
57972,placebo,0,0
57973,.,0,0
57974,There,0,0
57975,was,0,0
57976,no,0,0
57977,significant,0,0
57978,difference,0,0
57979,between,0,0
57980,the,0,0
57981,groups,0,0
57982,regarding,0,0
57983,the,0,0
57984,detection,0,0
57985,thresholds,0,0
57986,(,0,0
57987,electrical,0,0
57988,and,0,0
57989,heat,0,0
57990,),0,0
57991,.,0,0
57992,The,0,0
57993,pain,0,0
57994,threshold,0,0
57995,and,0,0
57996,the,0,0
57997,summation,0,0
57998,threshold,0,0
57999,to,0,0
58000,electrical,0,0
58001,stimuli,0,0
58002,and,0,0
58003,the,0,0
58004,summation,0,0
58005,threshold,0,0
58006,to,0,0
58007,heat,0,0
58008,stimuli,0,0
58009,increased,0,0
58010,significantly,0,0
58011,following,0,0
58012,treatment,0,0
58013,in,0,0
58014,both,0,0
58015,venlafaxine,0,0
58016,groups,0,0
58017,.,0,1
58018,In,0,0
58019,addition,0,0
58020,",",0,0
58021,the,0,0
58022,degree,0,0
58023,of,0,0
58024,the,0,0
58025,temporal,0,0
58026,summation,0,0
58027,to,0,0
58028,electrical,0,0
58029,and,0,0
58030,heat,0,0
58031,stimuli,0,0
58032,decreased,0,0
58033,significantly,0,0
58034,following,0,0
58035,treatment,0,0
58036,in,0,0
58037,both,0,0
58038,venlafaxine,0,0
58039,groups,0,0
58040,compared,0,0
58041,to,0,0
58042,the,0,0
58043,placebo,0,0
58044,.,0,0
58045,CONCLUSION,0,0
58046,The,0,0
58047,study,0,0
58048,showed,0,0
58049,significant,0,0
58050,effect,0,0
58051,of,0,0
58052,venlafaxine,0,0
58053,in,0,0
58054,the,0,0
58055,manifestations,0,0
58056,of,0,0
58057,hyperalgesia,0,0
58058,and,0,0
58059,temporal,0,0
58060,summation,0,0
58061,",",0,0
58062,but,0,0
58063,not,0,0
58064,on,0,0
58065,the,0,0
58066,ongoing,0,0
58067,pain,0,1
58068,intensity,0,0
58069,.,0,0
58070,Furthermore,0,0
58071,",",0,0
58072,the,0,0
58073,quantitative,0,0
58074,sensory,0,0
58075,tests,0,0
58076,provided,0,0
58077,complementing,0,0
58078,information,0,0
58079,to,0,0
58080,the,0,0
58081,clinical,0,0
58082,measures,0,0
58083,.,0,1
58084,The,0,0
58085,assessment,0,0
58086,of,0,0
58087,erythema,0,0
58088,and,0,0
58089,thickness,0,0
58090,on,0,0
58091,burn,0,1
58092,related,0,0
58093,scars,0,0
58094,during,0,0
58095,pressure,0,0
58096,garment,0,0
58097,therapy,0,0
58098,as,0,0
58099,a,0,0
58100,preventive,0,0
58101,measure,0,0
58102,for,0,0
58103,hypertrophic,0,1
58104,scarring,0,0
58105,.,0,0
58106,The,0,0
58107,aim,0,0
58108,of,0,0
58109,this,0,0
58110,study,0,0
58111,was,0,0
58112,threefold,0,0
58113,:,0,1
58114,(,0,0
58115,1,0,0
58116,),0,0
58117,Assess,0,0
58118,the,0,0
58119,pressure,0,0
58120,loss,0,0
58121,of,0,0
58122,two,0,0
58123,types,0,0
58124,of,0,0
58125,pressure,0,0
58126,garments,0,0
58127,that,0,0
58128,are,0,0
58129,used,0,0
58130,in,0,0
58131,the,0,0
58132,treatment,0,0
58133,of,0,0
58134,hypertrophic,1,1
58135,scars,1,1
58136,after,1,0
58137,burn,1,1
58138,injury,1,1
58139,",",0,0
58140,(,0,0
58141,2,0,0
58142,),0,0
58143,investigate,0,0
58144,the,0,0
58145,influence,0,0
58146,of,0,0
58147,two,0,0
58148,different,0,0
58149,levels,0,0
58150,of,0,0
58151,compression,0,0
58152,on,0,0
58153,erythema,0,0
58154,and,0,0
58155,thickness,0,0
58156,of,0,0
58157,burn,0,1
58158,scars,0,0
58159,and,0,0
58160,(,0,1
58161,3,0,0
58162,),0,0
58163,examine,0,0
58164,the,0,0
58165,association,0,0
58166,between,0,0
58167,erythema,0,0
58168,and,0,0
58169,thickness,0,0
58170,.,0,0
58171,The,0,0
58172,study,0,0
58173,was,0,0
58174,a,0,0
58175,prospective,0,0
58176,trial,0,0
58177,in,0,0
58178,which,0,0
58179,76,1,1
58180,burn,1,1
58181,scars,1,1
58182,in,1,1
58183,60,1,1
58184,patients,1,1
58185,were,1,1
58186,objectively,0,0
58187,assessed,0,0
58188,with,0,0
58189,the,0,0
58190,Minolta,0,0
58191,Chromameter,0,0
58192,CR-300,0,0
58193,for,0,0
58194,erythema,0,0
58195,and,0,0
58196,with,0,1
58197,the,0,0
58198,Dermascan,0,0
58199,C,0,0
58200,for,0,0
58201,thickness,0,0
58202,of,0,0
58203,the,0,0
58204,scar,0,0
58205,over,0,0
58206,a,0,0
58207,period,0,0
58208,of,0,0
58209,3,0,0
58210,months,0,0
58211,.,0,1
58212,Each,0,0
58213,patient,0,0
58214,was,0,0
58215,randomly,0,1
58216,assigned,0,0
58217,to,0,0
58218,a,0,0
58219,normal,0,0
58220,or,0,0
58221,lower,0,0
58222,compression,0,0
58223,class,0,0
58224,treatment,0,0
58225,",",0,0
58226,with,0,1
58227,respectively,0,0
58228,mean,0,1
58229,values,0,0
58230,of,0,1
58231,15,0,1
58232,and,0,0
58233,10,0,0
58234,mmHg,0,0
58235,pressure,0,0
58236,after,0,0
58237,wearing,0,0
58238,the,0,0
58239,garment,0,0
58240,for,0,0
58241,1,0,0
58242,month,0,0
58243,.,0,1
58244,Measurements,0,0
58245,for,0,0
58246,both,0,0
58247,parameters,0,0
58248,were,0,0
58249,taken,0,0
58250,at,0,0
58251,0,0,0
58252,",",0,0
58253,1,0,0
58254,",",0,0
58255,2,0,0
58256,and,0,0
58257,3,0,0
58258,months,0,0
58259,of,0,1
58260,treatment,0,0
58261,.,0,1
58262,Pressure,0,0
58263,garments,0,0
58264,with,0,1
58265,normal,0,1
58266,compression,0,0
58267,did,0,0
58268,lose,0,0
58269,significantly,0,0
58270,more,0,0
58271,compression,0,0
58272,over,0,0
58273,1,0,0
58274,month,0,0
58275,(,0,0
58276,4.82,0,0
58277,mmHg,0,0
58278,),0,0
58279,than,0,0
58280,did,0,0
58281,the,0,0
58282,garments,0,0
58283,from,0,0
58284,the,0,0
58285,low,0,0
58286,compression,0,0
58287,class,0,1
58288,(,0,0
58289,2.57,0,0
58290,mmHg,0,0
58291,),0,1
58292,.,0,1
58293,Scars,0,0
58294,that,0,0
58295,were,0,0
58296,treated,0,1
58297,with,0,1
58298,garments,0,0
58299,from,0,1
58300,a,0,0
58301,normal,0,1
58302,compression,0,0
58303,class,0,1
58304,did,0,0
58305,score,0,0
58306,significantly,0,0
58307,better,0,0
58308,for,0,0
58309,thickness,0,0
58310,compared,0,0
58311,to,0,0
58312,the,0,0
58313,low,0,0
58314,compression,0,0
58315,class,0,1
58316,.,0,0
58317,The,0,0
58318,difference,0,0
58319,in,0,0
58320,thickness,0,0
58321,was,0,0
58322,most,0,0
58323,evident,0,0
58324,at,0,0
58325,1,0,0
58326,month,0,0
58327,.,0,1
58328,Thereafter,0,0
58329,no,0,0
58330,further,0,0
58331,significant,0,0
58332,improvement,0,0
58333,between,0,0
58334,the,0,0
58335,two,0,0
58336,different,0,0
58337,treatments,0,0
58338,over,0,0
58339,time,0,0
58340,could,0,0
58341,be,0,0
58342,obtained,0,0
58343,.,0,0
58344,This,0,0
58345,difference,0,0
58346,was,0,0
58347,not,0,0
58348,found,0,0
58349,for,0,0
58350,erythema,0,0
58351,.,0,1
58352,Positive,0,0
58353,correlations,0,0
58354,could,0,0
58355,be,0,0
58356,found,0,0
58357,between,0,0
58358,erythema,0,0
58359,and,0,0
58360,thickness,0,0
58361,values,0,0
58362,at,0,0
58363,all,0,0
58364,of,0,0
58365,the,0,0
58366,three,0,0
58367,test,0,0
58368,points,0,0
58369,while,0,0
58370,changes,0,0
58371,in,0,0
58372,erythema,0,0
58373,and,0,0
58374,thickness,0,0
58375,only,0,0
58376,correlated,0,0
58377,significantly,0,0
58378,after,0,0
58379,the,0,0
58380,first,0,0
58381,month,0,0
58382,.,0,0
58383,The,0,0
58384,pattern,0,0
58385,of,0,0
58386,change,0,0
58387,of,0,0
58388,both,0,0
58389,parameters,0,0
58390,correlated,0,0
58391,at,0,0
58392,a,0,0
58393,high,0,0
58394,level,0,0
58395,of,0,0
58396,significance,0,0
58397,after,0,0
58398,3,0,0
58399,months,0,0
58400,of,0,1
58401,treatment,0,0
58402,.,0,0
58403,These,0,0
58404,data,0,0
58405,suggest,0,0
58406,that,0,0
58407,pressure,0,0
58408,garments,0,0
58409,that,0,0
58410,deliver,0,0
58411,a,0,0
58412,pressure,0,0
58413,of,0,0
58414,at,0,0
58415,least,0,1
58416,15,0,1
58417,mmHg,0,0
58418,pressure,0,0
58419,tend,0,0
58420,to,0,0
58421,accelerate,0,0
58422,scar,0,0
58423,maturation,0,0
58424,and,0,0
58425,that,0,0
58426,measurements,0,0
58427,of,0,0
58428,the,0,0
58429,pattern,0,0
58430,of,0,0
58431,change,0,0
58432,of,0,0
58433,the,0,0
58434,erythema,0,0
58435,can,0,0
58436,be,0,0
58437,used,0,0
58438,to,0,0
58439,predict,0,0
58440,changes,0,0
58441,in,0,0
58442,scar,0,0
58443,thickness,0,0
58444,and,0,0
58445,vice,0,0
58446,versa,0,0
58447,.,0,1
58448,Prospective,0,0
58449,",",0,0
58450,randomized,0,0
58451,comparison,0,0
58452,of,0,0
58453,transperitoneal,0,1
58454,versus,0,0
58455,retroperitoneal,0,1
58456,laparoscopic,0,1
58457,adrenalectomy,0,1
58458,.,0,1
58459,PURPOSE,0,0
58460,We,0,0
58461,report,0,0
58462,a,0,0
58463,prospective,0,0
58464,",",0,0
58465,randomized,0,0
58466,comparison,0,0
58467,of,0,0
58468,transperitoneal,0,1
58469,laparoscopic,0,1
58470,adrenalectomy,0,1
58471,(,0,0
58472,TLA,0,1
58473,),0,0
58474,vs,0,0
58475,retroperitoneal,0,1
58476,laparoscopic,0,1
58477,adrenalectomy,0,1
58478,(,0,0
58479,RLA,0,0
58480,),0,0
58481,for,0,0
58482,adrenal,0,1
58483,lesions,0,1
58484,with,0,1
58485,long-term,0,0
58486,followup,0,1
58487,.,0,1
58488,MATERIALS,0,0
58489,AND,0,0
58490,METHODS,0,0
58491,Between,1,1
58492,December,1,1
58493,1997,1,1
58494,and,1,0
58495,November,1,1
58496,1999,1,1
58497,",",1,0
58498,57,1,1
58499,consecutive,1,1
58500,eligible,1,1
58501,patients,1,1
58502,with,1,1
58503,surgical,1,1
58504,adrenal,1,1
58505,disease,1,1
58506,were,0,0
58507,prospectively,0,0
58508,randomized,0,0
58509,to,0,0
58510,undergo,0,1
58511,TLA,0,1
58512,(,0,0
58513,25,0,1
58514,),0,0
58515,or,0,1
58516,RLA,0,0
58517,(,0,0
58518,32,0,1
58519,),0,1
58520,.,0,1
58521,Study,1,0
58522,exclusion,1,1
58523,criteria,1,1
58524,were,1,1
58525,patient,1,1
58526,age,1,1
58527,greater,1,0
58528,than,1,0
58529,80,1,1
58530,years,1,1
58531,",",1,0
58532,body,1,1
58533,mass,1,0
58534,index,1,0
58535,greater,1,0
58536,than,1,0
58537,40,1,0
58538,",",1,0
58539,bilateral,1,0
58540,adrenalectomy,1,1
58541,and,1,0
58542,significant,1,0
58543,prior,1,1
58544,abdominal,1,1
58545,surgery,1,1
58546,in,1,0
58547,the,1,0
58548,quadrant,1,0
58549,of,1,0
58550,interest,1,0
58551,.,1,1
58552,Mean,0,0
58553,followup,0,0
58554,was,0,0
58555,5.96,0,0
58556,years,0,1
58557,in,0,0
58558,the,0,0
58559,2,0,0
58560,groups,0,0
58561,.,0,1
58562,RESULTS,0,0
58563,The,0,0
58564,groups,0,0
58565,were,0,0
58566,matched,0,1
58567,in,0,0
58568,regard,0,0
58569,to,0,0
58570,patient,0,0
58571,age,0,1
58572,(,0,0
58573,p,0,0
58574,=,0,0
58575,0.84,0,0
58576,),0,0
58577,",",0,0
58578,body,0,0
58579,mass,0,0
58580,index,0,0
58581,(,0,0
58582,p,0,0
58583,=,0,0
58584,0.43,0,0
58585,),0,0
58586,",",0,0
58587,American,0,1
58588,Society,0,1
58589,of,0,0
58590,Anesthesiologists,0,1
58591,class,0,1
58592,(,0,0
58593,p,0,0
58594,=,0,0
58595,0.81,0,0
58596,),0,0
58597,and,0,0
58598,laterality,0,0
58599,(,0,0
58600,p,0,0
58601,=,0,0
58602,0.12,0,0
58603,),0,1
58604,.,0,1
58605,Median,0,0
58606,adrenal,0,1
58607,mass,0,1
58608,size,0,0
58609,was,0,0
58610,2.7,0,0
58611,cm,0,1
58612,(,0,0
58613,range,0,0
58614,1,0,0
58615,to,0,0
58616,9,0,0
58617,),0,0
58618,in,0,0
58619,the,0,0
58620,TLA,0,0
58621,group,0,0
58622,and,0,0
58623,2.6,0,0
58624,cm,0,1
58625,(,0,0
58626,range,0,0
58627,0.5,0,0
58628,to,0,0
58629,6,0,0
58630,),0,0
58631,in,0,0
58632,the,0,0
58633,RLA,0,0
58634,group,0,0
58635,(,0,0
58636,p,0,0
58637,=,0,0
58638,0.83,0,0
58639,),0,1
58640,.,0,1
58641,TLA,0,0
58642,was,0,0
58643,comparable,0,0
58644,to,0,0
58645,RLA,0,0
58646,in,0,0
58647,terms,0,0
58648,of,0,0
58649,operative,0,0
58650,time,0,0
58651,(,0,0
58652,130,0,1
58653,vs,0,0
58654,126.5,0,0
58655,minutes,0,0
58656,",",0,0
58657,p,0,0
58658,=,0,0
58659,0.64,0,0
58660,),0,0
58661,",",0,0
58662,estimated,0,0
58663,blood,0,0
58664,loss,0,0
58665,(,0,0
58666,p,0,0
58667,=,0,0
58668,0.92,0,0
58669,),0,0
58670,",",0,0
58671,specimen,0,0
58672,weight,0,0
58673,(,0,1
58674,p,0,0
58675,=,0,0
58676,0.81,0,0
58677,),0,0
58678,",",0,0
58679,analgesic,0,0
58680,requirements,0,0
58681,(,0,1
58682,p,0,0
58683,=,0,0
58684,0.25,0,0
58685,),0,0
58686,",",0,0
58687,hospital,0,1
58688,stay,0,0
58689,(,0,0
58690,p,0,0
58691,=,0,0
58692,0.56,0,0
58693,),0,0
58694,and,0,0
58695,the,0,0
58696,complication,0,0
58697,rate,0,0
58698,(,0,0
58699,p,0,0
58700,=,0,0
58701,0.58,0,0
58702,),0,1
58703,.,0,1
58704,One,0,0
58705,case,0,0
58706,per,0,0
58707,group,0,0
58708,was,0,0
58709,electively,0,1
58710,converted,0,0
58711,to,0,0
58712,open,0,1
58713,surgery,0,1
58714,.,0,0
58715,Pathology,0,0
58716,data,0,0
58717,on,0,0
58718,the,0,0
58719,intact,0,0
58720,extracted,0,1
58721,specimens,0,1
58722,were,0,1
58723,similar,0,0
58724,between,0,0
58725,the,0,0
58726,groups,0,0
58727,.,0,0
58728,Averaged,0,0
58729,convalescence,0,0
58730,was,0,0
58731,4.7,0,0
58732,weeks,0,0
58733,in,0,0
58734,the,0,0
58735,TLA,0,0
58736,group,0,0
58737,and,0,0
58738,2.3,0,0
58739,weeks,0,0
58740,in,0,0
58741,the,0,0
58742,RLA,0,0
58743,group,0,0
58744,(,0,0
58745,p,0,0
58746,=,0,0
58747,0.02,0,0
58748,),0,0
58749,.,0,0
58750,During,0,0
58751,a,0,0
58752,mean,0,0
58753,followup,0,0
58754,of,0,0
58755,6,0,0
58756,years,0,1
58757,2,0,1
58758,patients,0,1
58759,in,0,0
58760,the,0,0
58761,TLA,0,0
58762,group,0,0
58763,had,0,0
58764,a,0,0
58765,late,0,0
58766,complication,0,0
58767,(,0,0
58768,port,0,0
58769,site,0,0
58770,hernia,0,1
58771,),0,0
58772,.,0,0
58773,Mortality,0,0
58774,occurred,0,0
58775,in,0,0
58776,5,0,1
58777,patients,0,1
58778,",",0,0
58779,including,0,0
58780,1,0,0
58781,with,0,1
58782,TLA,0,1
58783,and,0,0
58784,4,0,0
58785,with,0,1
58786,RLA,0,0
58787,",",0,0
58788,during,0,0
58789,the,0,0
58790,6-year,0,0
58791,followup,0,0
58792,.,0,0
58793,CONCLUSIONS,0,0
58794,For,0,0
58795,most,0,0
58796,benign,0,1
58797,adrenal,0,1
58798,lesions,0,1
58799,requiring,0,1
58800,surgery,0,1
58801,laparoscopic,0,1
58802,adrenalectomy,0,0
58803,can,0,0
58804,be,0,0
58805,performed,0,0
58806,safely,0,0
58807,and,0,0
58808,effectively,0,0
58809,by,0,0
58810,the,0,0
58811,transperitoneal,0,1
58812,or,0,0
58813,the,0,0
58814,retroperitoneal,0,1
58815,approach,0,0
58816,.,0,1
58817,Determinants,0,0
58818,of,0,0
58819,the,0,0
58820,effect,0,0
58821,of,0,0
58822,estrogen,0,0
58823,on,0,0
58824,the,0,0
58825,progression,0,0
58826,of,0,0
58827,subclinical,0,1
58828,atherosclerosis,0,1
58829,:,0,1
58830,Estrogen,0,0
58831,in,0,0
58832,the,0,0
58833,Prevention,0,0
58834,of,0,0
58835,Atherosclerosis,0,1
58836,Trial,0,1
58837,.,0,0
58838,OBJECTIVE,0,0
58839,To,0,0
58840,determine,0,0
58841,the,0,0
58842,extent,0,0
58843,to,0,0
58844,which,0,0
58845,the,0,0
58846,estrogen-induced,0,0
58847,changes,0,0
58848,in,0,1
58849,lipids,0,0
58850,and,0,1
58851,markers,0,0
58852,of,0,0
58853,carbohydrate,0,0
58854,metabolism,0,0
58855,explain,0,0
58856,the,0,0
58857,beneficial,0,0
58858,effect,0,0
58859,of,0,0
58860,estrogen,0,0
58861,therapy,0,0
58862,on,0,0
58863,the,0,0
58864,progression,0,0
58865,of,0,0
58866,carotid,0,1
58867,artery,0,1
58868,intima-media,0,0
58869,thickness,0,0
58870,(,0,0
58871,IMT,0,0
58872,),0,0
58873,in,0,0
58874,postmenopausal,1,1
58875,women,1,1
58876,.,1,1
58877,DESIGN,0,0
58878,A,0,0
58879,randomized,0,0
58880,",",0,0
58881,double-blind,0,0
58882,",",0,0
58883,placebo-controlled,0,0
58884,",",0,0
58885,single-center,0,1
58886,trial,0,0
58887,enrolling,0,1
58888,222,1,1
58889,postmenopausal,1,1
58890,women,1,1
58891,45,1,1
58892,years,1,1
58893,and,1,0
58894,older,1,1
58895,without,1,1
58896,cardiovascular,1,0
58897,disease,1,1
58898,and,1,0
58899,with,1,1
58900,low-density,1,0
58901,lipoprotein,1,0
58902,(,1,0
58903,LDL,1,0
58904,),1,0
58905,cholesterol,1,0
58906,levels,1,0
58907,of,1,0
58908,3.37,1,0
58909,mmol/L,1,0
58910,or,1,1
58911,greater,1,0
58912,(,1,0
58913,>,1,0
58914,or,1,1
58915,=,1,0
58916,130,1,1
58917,mg/dL,1,0
58918,),1,0
58919,.,1,0
58920,Intervention,0,0
58921,was,0,0
58922,unopposed,0,0
58923,micronized,0,0
58924,17beta-estradiol,0,0
58925,versus,0,0
58926,placebo,0,0
58927,.,0,1
58928,Measurements,0,0
58929,were,0,0
58930,made,0,0
58931,using,0,0
58932,high-resolution,0,0
58933,B-mode,0,1
58934,ultrasonography,0,0
58935,to,0,0
58936,measure,0,0
58937,carotid,0,1
58938,artery,0,1
58939,IMT,0,0
58940,at,0,0
58941,baseline,0,0
58942,and,0,0
58943,every,0,0
58944,6,0,0
58945,months,0,0
58946,on-trial,0,0
58947,.,0,1
58948,RESULTS,0,0
58949,Progression,0,0
58950,of,0,0
58951,carotid,0,1
58952,IMT,0,0
58953,was,0,0
58954,inversely,0,0
58955,related,0,0
58956,to,0,0
58957,on-trial,0,0
58958,high-density,0,0
58959,lipoprotein,0,0
58960,(,0,0
58961,HDL,0,0
58962,),0,0
58963,cholesterol,0,0
58964,(,0,0
58965,P,0,0
58966,=,0,0
58967,0.04,0,0
58968,),0,0
58969,and,0,0
58970,was,0,0
58971,directly,0,0
58972,related,0,0
58973,to,0,0
58974,on-trial,0,0
58975,LDL-cholesterol,0,0
58976,(,0,1
58977,P,0,0
58978,=,0,0
58979,0.005,0,0
58980,),0,1
58981,.,0,0
58982,Compared,0,0
58983,with,0,0
58984,placebo,0,0
58985,",",0,0
58986,women,0,1
58987,randomized,0,0
58988,to,0,0
58989,estradiol,0,0
58990,showed,0,0
58991,a,0,0
58992,higher,0,0
58993,mean,0,0
58994,on-trial,0,0
58995,HDL-cholesterol,0,0
58996,level,0,0
58997,and,0,0
58998,a,0,0
58999,lower,0,0
59000,mean,0,0
59001,on-trial,0,0
59002,LDL-cholesterol,0,0
59003,level,0,0
59004,.,0,0
59005,In,0,0
59006,contrast,0,0
59007,",",0,0
59008,fasting,0,0
59009,glucose,0,0
59010,",",0,0
59011,insulin,0,0
59012,",",0,0
59013,and,0,0
59014,hemoglobin,0,0
59015,A1C,0,0
59016,were,0,0
59017,lowered,0,0
59018,and,0,0
59019,insulin,0,0
59020,sensitivity,0,0
59021,increased,0,0
59022,with,0,1
59023,estradiol,0,0
59024,therapy,0,0
59025,",",0,0
59026,but,0,0
59027,the,0,0
59028,changes,0,0
59029,were,0,0
59030,not,0,0
59031,related,0,0
59032,to,0,0
59033,carotid,0,1
59034,IMT,0,0
59035,progression,0,0
59036,.,0,1
59037,On-trial,0,0
59038,HDL-cholesterol,0,0
59039,and,0,0
59040,LDL-cholesterol,0,0
59041,were,0,0
59042,significant,0,0
59043,independent,0,1
59044,determinants,0,0
59045,of,0,0
59046,carotid,0,1
59047,IMT,0,0
59048,progression,0,0
59049,",",0,0
59050,jointly,0,0
59051,explaining,0,0
59052,30,0,0
59053,%,0,0
59054,of,0,0
59055,the,0,0
59056,treatment,0,0
59057,effect,0,0
59058,of,0,0
59059,unopposed,0,0
59060,estrogen,0,0
59061,on,0,0
59062,the,0,0
59063,progression,0,0
59064,of,0,0
59065,carotid,0,1
59066,IMT,0,0
59067,.,0,1
59068,CONCLUSION,0,0
59069,Unopposed,0,0
59070,17beta-estradiol,0,0
59071,reduced,0,0
59072,carotid,0,1
59073,IMT,0,0
59074,progression,0,0
59075,in,0,0
59076,postmenopausal,1,1
59077,women,1,1
59078,in,0,0
59079,part,0,1
59080,by,0,0
59081,increasing,0,0
59082,HDL-cholesterol,0,0
59083,and,0,0
59084,decreasing,0,0
59085,LDL-cholesterol,0,0
59086,.,0,1
59087,Although,0,0
59088,women,1,1
59089,randomized,0,1
59090,to,0,0
59091,estradiol,0,0
59092,showed,0,0
59093,improvement,0,0
59094,in,0,0
59095,all,0,0
59096,the,0,0
59097,markers,0,0
59098,of,0,0
59099,carbohydrate,0,0
59100,metabolism,0,0
59101,",",0,0
59102,these,0,0
59103,factors,0,0
59104,did,0,0
59105,not,0,0
59106,play,0,0
59107,a,0,0
59108,significant,0,0
59109,role,0,0
59110,in,0,0
59111,carotid,0,1
59112,IMT,0,0
59113,progression,0,0
59114,.,0,1
59115,Superior,0,0
59116,efficacy,0,0
59117,of,0,0
59118,clopidogrel,0,1
59119,plus,0,0
59120,acetylsalicylic,0,0
59121,acid,0,0
59122,compared,0,0
59123,with,0,1
59124,extended-release,0,0
59125,dipyridamole,0,0
59126,plus,0,0
59127,acetylsalicylic,0,0
59128,acid,0,0
59129,in,0,0
59130,preventing,0,0
59131,arterial,0,1
59132,thrombogenesis,0,0
59133,in,0,0
59134,healthy,1,1
59135,volunteers,1,1
59136,.,1,1
59137,INTRODUCTION,0,0
59138,Recent,0,0
59139,ex,0,0
59140,vivo,0,0
59141,platelet,0,0
59142,aggregometry,0,0
59143,data,0,0
59144,indicate,0,0
59145,that,0,0
59146,clopidogrel,0,1
59147,75,0,1
59148,mg/day,0,0
59149,plus,0,0
59150,acetylsalicylic,0,0
59151,acid,0,0
59152,(,0,0
59153,ASA,0,1
59154,),0,1
59155,75,0,0
59156,mg/day,0,0
59157,is,0,0
59158,a,0,0
59159,more,0,0
59160,potent,0,0
59161,antiplatelet,0,0
59162,regimen,0,0
59163,than,0,0
59164,the,0,0
59165,marketed,0,0
59166,combination,0,0
59167,of,0,0
59168,dipyridamole+ASA,0,0
59169,.,0,0
59170,The,0,0
59171,present,0,0
59172,study,0,0
59173,was,0,0
59174,designed,0,0
59175,to,0,0
59176,assess,0,0
59177,the,0,0
59178,antithrombotic,0,0
59179,effect,0,0
59180,of,0,0
59181,both,0,0
59182,dual,0,1
59183,antiplatelet,0,1
59184,regimens,0,0
59185,using,0,0
59186,a,0,0
59187,human,0,0
59188,ex,0,0
59189,vivo,0,0
59190,model,0,0
59191,of,0,0
59192,arterial,0,1
59193,thrombosis,0,1
59194,.,0,1
59195,MATERIALS,0,0
59196,AND,0,0
59197,METHODS,0,0
59198,This,0,0
59199,was,0,0
59200,a,0,0
59201,randomized,0,0
59202,",",0,0
59203,double-blind,0,0
59204,",",0,0
59205,placebo-controlled,0,0
59206,",",0,0
59207,crossover,0,0
59208,study,0,0
59209,.,0,0
59210,During,0,0
59211,two,0,0
59212,10-day,0,0
59213,treatment,0,1
59214,periods,0,0
59215,separated,0,0
59216,by,0,0
59217,a,0,0
59218,14-day,0,0
59219,washout,0,0
59220,period,0,0
59221,",",0,0
59222,23,1,1
59223,healthy,1,1
59224,male,1,1
59225,volunteers,1,1
59226,received,0,0
59227,once-daily,0,0
59228,clopidogrel,0,1
59229,75,0,0
59230,mg,0,0
59231,plus,0,0
59232,acetylsalicylic,0,0
59233,acid,0,0
59234,75,0,1
59235,mg,0,0
59236,",",0,0
59237,or,0,0
59238,twice-daily,0,0
59239,extended-release,0,0
59240,dipyridamole,0,0
59241,200,0,0
59242,mg,0,0
59243,plus,0,0
59244,acetylsalicylic,0,0
59245,acid,0,0
59246,25,0,1
59247,mg,0,0
59248,.,0,1
59249,Assessments,0,0
59250,were,0,0
59251,made,0,0
59252,at,0,0
59253,baseline,0,0
59254,and,0,0
59255,on,0,0
59256,Day,0,1
59257,10,0,1
59258,of,0,0
59259,each,0,0
59260,period,0,0
59261,.,0,0
59262,Arterial,0,0
59263,thrombus,0,0
59264,formation,0,0
59265,was,0,0
59266,induced,0,0
59267,ex,0,0
59268,vivo,0,0
59269,by,0,0
59270,exposing,0,0
59271,a,0,0
59272,collagen-coated,0,0
59273,surface,0,0
59274,in,0,0
59275,a,0,0
59276,parallel-plate,0,0
59277,perfusion,0,0
59278,chamber,0,0
59279,to,0,0
59280,native,0,0
59281,blood,0,0
59282,for,0,0
59283,3,0,0
59284,min,0,0
59285,(,0,0
59286,arterial,0,1
59287,wall,0,1
59288,shear,0,0
59289,rate,0,0
59290,2600,0,0
59291,s,0,0
59292,(,0,0
59293,-1,0,0
59294,),0,1
59295,),0,0
59296,.,0,0
59297,Total,0,0
59298,platelet,0,0
59299,and,0,0
59300,fibrin,0,0
59301,deposition,0,0
59302,was,0,0
59303,determined,0,0
59304,by,0,0
59305,immunoenzymatic,0,1
59306,methods,0,1
59307,.,0,1
59308,RESULTS,0,0
59309,Compared,0,0
59310,with,0,1
59311,baseline,0,0
59312,values,0,0
59313,",",0,0
59314,the,0,0
59315,mean,0,0
59316,inhibition,0,0
59317,of,0,0
59318,total,0,1
59319,platelet,0,1
59320,deposition,0,0
59321,was,0,0
59322,63.9+/-5.9,0,0
59323,%,0,0
59324,with,0,1
59325,clopidogrel,0,1
59326,plus,0,0
59327,acetylsalicylic,0,0
59328,acid,0,0
59329,",",0,0
59330,compared,0,0
59331,with,0,1
59332,18.4+/-5.6,0,0
59333,%,0,0
59334,for,0,0
59335,extended-release,0,0
59336,dipyridamole,0,0
59337,plus,0,0
59338,acetylsalicylic,0,0
59339,acid,0,0
59340,(,0,0
59341,67,0,1
59342,%,0,0
59343,reduction,0,0
59344,;,0,0
59345,95,0,0
59346,%,0,0
59347,CI,0,0
59348,",",0,0
59349,49-79,0,1
59350,%,0,0
59351,;,0,0
59352,p,0,0
59353,<,0,0
59354,0.0001,0,0
59355,),0,0
59356,.,0,1
59357,Corresponding,0,0
59358,figures,0,0
59359,for,0,0
59360,fibrin,0,0
59361,deposition,0,1
59362,were,0,0
59363,64.9+/-4.8,0,0
59364,%,0,0
59365,and,0,0
59366,18.3+/-9.7,0,0
59367,%,0,0
59368,",",0,0
59369,respectively,0,0
59370,(,0,0
59371,58,0,1
59372,%,0,0
59373,reduction,0,0
59374,;,0,0
59375,95,0,0
59376,%,0,0
59377,CI,0,0
59378,",",0,0
59379,45-67,0,1
59380,%,0,0
59381,;,0,0
59382,p,0,0
59383,<,0,0
59384,0.0001,0,0
59385,),0,0
59386,.,0,1
59387,Both,0,0
59388,treatments,0,0
59389,were,0,0
59390,well,0,0
59391,tolerated,0,0
59392,.,0,0
59393,CONCLUSIONS,0,0
59394,Clopidogrel,0,1
59395,plus,0,0
59396,acetylsalicylic,0,0
59397,acid,0,0
59398,showed,0,0
59399,significantly,0,0
59400,superior,0,0
59401,antithrombotic,0,0
59402,efficacy,0,0
59403,compared,0,0
59404,with,0,1
59405,extended-release,0,0
59406,dipyridamole,0,0
59407,plus,0,0
59408,acetylsalicylic,0,0
59409,acid,0,0
59410,in,0,0
59411,preventing,0,0
59412,arterial,0,1
59413,thrombogenesis,0,0
59414,in,0,0
59415,humans,0,1
59416,.,0,1
59417,Autism-Spectrum,0,1
59418,Quotient-Japanese,0,0
59419,version,0,0
59420,and,0,0
59421,its,0,0
59422,short,0,0
59423,forms,0,0
59424,for,0,0
59425,screening,1,1
59426,normally,1,1
59427,intelligent,1,0
59428,persons,1,1
59429,with,1,1
59430,pervasive,1,1
59431,developmental,1,1
59432,disorders,1,1
59433,.,1,1
59434,A,0,0
59435,Japanese,0,0
59436,version,0,0
59437,of,0,0
59438,the,0,0
59439,Autism,0,1
59440,Spectrum,0,1
59441,Quotient,0,0
59442,(,0,0
59443,AQ,0,1
59444,),0,0
59445,",",0,0
59446,AQ-J,0,0
59447,was,0,0
59448,administered,0,0
59449,to,0,0
59450,25,1,0
59451,normally,1,1
59452,intelligent,1,0
59453,high-functioning,1,1
59454,pervasive,1,1
59455,developmental,1,1
59456,disorder,1,1
59457,(,1,0
59458,HPDD,1,0
59459,),1,1
59460,patients,1,1
59461,(,1,1
59462,mean,1,1
59463,age,1,1
59464,",",1,0
59465,24.2,1,0
59466,years,1,1
59467,;,1,1
59468,24,1,0
59469,male,1,1
59470,",",1,0
59471,one,1,0
59472,female,1,1
59473,),1,0
59474,and,1,0
59475,215,1,1
59476,controls,1,1
59477,(,1,1
59478,mean,1,1
59479,age,1,1
59480,",",1,0
59481,30.4,1,0
59482,years,1,1
59483,;,1,1
59484,86,1,1
59485,male,1,1
59486,",",1,0
59487,129,1,1
59488,female,1,1
59489,),1,0
59490,randomly,1,1
59491,selected,1,1
59492,from,1,0
59493,the,1,0
59494,general,1,1
59495,population,1,1
59496,.,1,0
59497,The,0,0
59498,AQ-J,0,0
59499,had,0,1
59500,satisfactory,0,0
59501,internal,0,1
59502,consistency,0,0
59503,reliability,0,0
59504,(,0,0
59505,Cronbach,0,0
59506,'s,0,1
59507,alpha,0,0
59508,>,0,1
59509,0.70,0,0
59510,in,0,0
59511,the,0,0
59512,two,0,0
59513,groups,0,0
59514,),0,1
59515,",",0,0
59516,test-retest,0,0
59517,reliability,0,0
59518,",",0,0
59519,and,0,0
59520,discriminant,0,0
59521,validity,0,0
59522,[,0,0
59523,i.e,0,0
59524,.,0,0
59525,the,0,0
59526,AQ-J,0,0
59527,score,0,0
59528,was,0,0
59529,significantly,0,0
59530,higher,0,0
59531,in,0,0
59532,the,0,0
59533,HPDD,0,0
59534,(,0,0
59535,mean,0,0
59536,",",0,0
59537,29.6,0,0
59538,),0,0
59539,than,0,0
59540,controls,0,1
59541,(,0,0
59542,mean,0,1
59543,",",0,0
59544,22.2,0,0
59545,),0,0
59546,],0,0
59547,.,0,0
59548,At,0,0
59549,a,0,0
59550,cut-off,0,0
59551,of,0,0
59552,26,0,1
59553,",",0,0
59554,the,0,0
59555,AQ-J,0,0
59556,had,0,0
59557,satisfactory,0,0
59558,sensitivity,0,0
59559,",",0,0
59560,specificity,0,0
59561,",",0,0
59562,and,0,0
59563,negative,0,0
59564,predictive,0,0
59565,value,0,0
59566,",",0,0
59567,but,0,0
59568,it,0,0
59569,had,0,1
59570,low,0,0
59571,positive,0,0
59572,predictive,0,0
59573,value,0,0
59574,(,0,0
59575,0.24,0,0
59576,),0,0
59577,possibly,0,0
59578,due,0,0
59579,to,0,0
59580,the,0,0
59581,facts,0,0
59582,that,0,0
59583,the,0,0
59584,25,0,1
59585,mild,0,1
59586,HPDD,0,1
59587,patients,0,1
59588,scored,0,0
59589,lower,0,0
59590,and,0,0
59591,the,0,0
59592,controls,0,0
59593,scored,0,0
59594,higher,0,0
59595,on,0,0
59596,the,0,0
59597,AQ-J,0,0
59598,than,0,0
59599,British,0,1
59600,counterparts,0,1
59601,on,0,0
59602,the,0,0
59603,AQ,0,1
59604,.,0,0
59605,The,0,0
59606,AQ-J-21,0,0
59607,(,0,0
59608,consisting,0,1
59609,of,0,0
59610,21,0,1
59611,items,0,0
59612,significantly,0,0
59613,associated,0,0
59614,with,0,1
59615,HPDD,0,0
59616,diagnosis,0,1
59617,),0,0
59618,and,0,0
59619,the,0,0
59620,AQ-J-10,0,0
59621,(,0,0
59622,consisting,0,1
59623,of,0,0
59624,10,0,1
59625,of,0,0
59626,the,0,0
59627,21,0,1
59628,items,0,0
59629,with,0,1
59630,an,0,0
59631,effect,0,0
59632,size,0,0
59633,>,0,1
59634,0.17,0,0
59635,),0,0
59636,had,0,0
59637,higher,0,0
59638,",",0,0
59639,although,0,0
59640,not,0,0
59641,satisfactory,0,0
59642,",",0,0
59643,positive,0,0
59644,predictive,0,0
59645,values,0,0
59646,of,0,1
59647,0.35,0,0
59648,and,0,0
59649,0.46,0,0
59650,at,0,0
59651,cut-offs,0,0
59652,of,0,1
59653,12,0,1
59654,and,0,0
59655,7,0,0
59656,",",0,0
59657,respectively,0,0
59658,",",0,0
59659,than,0,0
59660,the,0,0
59661,AQ-J,0,0
59662,.,0,0
59663,The,0,0
59664,AQ-J,0,0
59665,and,0,0
59666,two,0,0
59667,short,0,0
59668,forms,0,0
59669,are,0,0
59670,useful,0,0
59671,not,0,0
59672,to,0,0
59673,predict,0,0
59674,but,0,0
59675,to,0,0
59676,rule,0,0
59677,out,0,0
59678,mild,0,1
59679,HPDD,0,0
59680,",",0,0
59681,the,0,0
59682,most,0,0
59683,difficult,0,0
59684,part,0,0
59685,of,0,0
59686,HPDD,0,0
59687,to,0,0
59688,be,0,0
59689,distinguished,0,0
59690,from,0,0
59691,non-PDD,0,1
59692,conditions,0,0
59693,",",0,0
59694,in,0,0
59695,persons,0,1
59696,scoring,0,1
59697,under,0,0
59698,the,0,0
59699,cut-offs,0,0
59700,and,0,0
59701,to,0,0
59702,consider,0,0
59703,professionals,0,0
59704,',0,0
59705,examination,0,1
59706,of,0,0
59707,HPDD,0,0
59708,in,0,0
59709,persons,0,1
59710,scoring,0,1
59711,over,0,0
59712,them,0,1
59713,",",0,0
59714,because,0,0
59715,their,0,0
59716,negative,0,1
59717,predictive,0,0
59718,values,0,0
59719,were,0,1
59720,satisfactory,0,0
59721,.,0,1
59722,Reactivation,0,0
59723,of,0,0
59724,unstable,1,1
59725,angina,1,1
59726,after,0,0
59727,the,0,0
59728,discontinuation,0,0
59729,of,0,0
59730,heparin,0,0
59731,.,0,1
59732,BACKGROUND,0,0
59733,Heparin,0,0
59734,is,0,0
59735,an,0,0
59736,effective,0,0
59737,",",0,0
59738,widely,0,0
59739,used,0,0
59740,treatment,0,0
59741,for,0,0
59742,unstable,1,1
59743,angina,1,1
59744,.,1,1
59745,Among,0,1
59746,patients,1,1
59747,enrolled,0,1
59748,in,0,0
59749,a,0,0
59750,double-blind,0,0
59751,",",0,0
59752,randomized,0,0
59753,",",0,0
59754,placebo-controlled,0,0
59755,trial,0,0
59756,comparing,0,0
59757,intravenous,0,0
59758,heparin,0,0
59759,",",0,0
59760,aspirin,0,0
59761,",",0,0
59762,both,0,0
59763,treatments,0,0
59764,",",0,0
59765,and,0,0
59766,neither,0,0
59767,during,0,0
59768,the,0,0
59769,acute,0,1
59770,phase,0,0
59771,of,0,0
59772,unstable,0,1
59773,angina,0,1
59774,",",0,0
59775,we,0,0
59776,encountered,0,0
59777,patients,0,1
59778,in,0,1
59779,whom,0,1
59780,unstable,0,1
59781,angina,0,1
59782,was,0,0
59783,reactivated,0,0
59784,after,0,0
59785,heparin,0,0
59786,was,0,0
59787,discontinued,0,0
59788,.,0,0
59789,METHODS,0,0
59790,The,1,0
59791,study,1,0
59792,population,1,1
59793,included,1,1
59794,403,1,1
59795,of,1,0
59796,the,1,0
59797,original,1,1
59798,479,1,1
59799,patients,1,1
59800,in,1,0
59801,the,1,1
59802,trial,1,1
59803,who,1,1
59804,had,1,1
59805,completed,1,1
59806,six,1,1
59807,days,1,0
59808,of,1,0
59809,blinded,1,0
59810,therapy,1,0
59811,without,1,1
59812,refractory,1,1
59813,angina,1,1
59814,or,1,1
59815,myocardial,1,1
59816,infarction,1,1
59817,.,1,0
59818,After,0,0
59819,the,0,0
59820,discontinuation,0,0
59821,of,0,0
59822,therapy,0,0
59823,",",0,0
59824,clinical,0,0
59825,events,0,0
59826,",",0,0
59827,including,0,0
59828,reactivation,0,0
59829,of,0,0
59830,unstable,0,1
59831,angina,0,1
59832,and,0,0
59833,myocardial,0,1
59834,infarction,0,1
59835,occurring,0,0
59836,within,0,0
59837,96,0,1
59838,hours,0,0
59839,after,0,0
59840,hospitalization,0,1
59841,",",0,0
59842,were,0,0
59843,closely,0,0
59844,monitored,0,0
59845,.,0,0
59846,RESULTS,0,0
59847,Early,0,0
59848,reactivation,0,0
59849,occurred,0,0
59850,in,0,0
59851,14,0,0
59852,of,0,0
59853,the,0,0
59854,107,0,1
59855,patients,0,1
59856,who,0,1
59857,received,0,1
59858,heparin,0,1
59859,alone,0,0
59860,",",0,0
59861,as,0,0
59862,compared,0,0
59863,with,0,1
59864,only,0,0
59865,5,0,0
59866,patients,0,1
59867,in,0,0
59868,each,0,0
59869,of,0,0
59870,the,0,0
59871,other,0,0
59872,three,0,0
59873,study,0,1
59874,groups,0,0
59875,(,0,0
59876,P,0,0
59877,less,0,0
59878,than,0,0
59879,0.01,0,0
59880,),0,1
59881,.,0,1
59882,These,0,0
59883,reactivations,0,0
59884,required,0,0
59885,urgent,0,0
59886,intervention,0,0
59887,(,0,0
59888,thrombolysis,0,0
59889,",",0,0
59890,angioplasty,0,0
59891,",",0,0
59892,or,0,0
59893,coronary-bypass,0,1
59894,surgery,0,1
59895,),0,0
59896,in,0,0
59897,11,0,1
59898,patients,0,1
59899,treated,0,1
59900,with,0,1
59901,heparin,0,0
59902,alone,0,0
59903,",",0,0
59904,but,0,0
59905,in,0,0
59906,only,0,0
59907,2,0,0
59908,patients,0,1
59909,in,0,0
59910,the,0,0
59911,other,0,0
59912,groups,0,0
59913,combined,0,0
59914,(,0,0
59915,P,0,0
59916,less,0,0
59917,than,0,0
59918,0.01,0,0
59919,),0,1
59920,.,0,1
59921,Four,0,0
59922,of,0,0
59923,the,0,0
59924,six,0,1
59925,patients,0,1
59926,who,0,1
59927,had,0,1
59928,a,0,1
59929,myocardial,0,1
59930,infarction,0,1
59931,during,0,0
59932,a,0,0
59933,reactivation,0,0
59934,of,0,0
59935,their,0,0
59936,disease,0,1
59937,were,0,0
59938,in,0,0
59939,the,0,0
59940,heparin,0,0
59941,group,0,0
59942,.,0,0
59943,Reactivations,0,0
59944,in,0,0
59945,this,0,0
59946,group,0,0
59947,occurred,0,0
59948,in,0,0
59949,a,0,0
59950,cluster,0,0
59951,a,0,0
59952,mean,0,0
59953,(,0,0
59954,+/-,0,0
59955,SD,0,0
59956,),0,1
59957,of,0,0
59958,9.5,0,0
59959,+/-,0,0
59960,5,0,1
59961,hours,0,0
59962,after,0,0
59963,the,0,0
59964,discontinuation,0,0
59965,of,0,0
59966,the,0,0
59967,study,0,0
59968,drug,0,0
59969,but,0,0
59970,were,0,0
59971,randomly,0,1
59972,distributed,0,0
59973,over,0,0
59974,the,0,0
59975,initial,0,0
59976,96,0,1
59977,hours,0,0
59978,in,0,0
59979,the,0,0
59980,other,0,0
59981,three,0,0
59982,groups,0,0
59983,.,0,1
59984,CONCLUSIONS,0,0
59985,Although,0,0
59986,heparin,0,0
59987,is,0,0
59988,beneficial,0,0
59989,in,0,0
59990,treating,0,0
59991,unstable,0,1
59992,angina,0,1
59993,",",0,0
59994,the,0,0
59995,disease,0,0
59996,process,0,0
59997,may,0,0
59998,be,0,0
59999,reactivated,0,0
60000,within,0,0
60001,hours,0,0
60002,of,0,0
60003,the,0,0
60004,discontinuation,0,0
60005,of,0,0
60006,this,0,0
60007,drug,0,0
60008,.,0,0
60009,Concomitant,0,0
60010,therapy,0,0
60011,with,0,0
60012,aspirin,0,0
60013,may,0,0
60014,prevent,0,0
60015,this,0,0
60016,withdrawal,0,0
60017,phenomenon,0,0
60018,.,0,1
60019,Hydrogen,0,0
60020,peroxide,0,0
60021,mouth,0,1
60022,rinse,0,0
60023,:,0,1
60024,an,0,0
60025,analgesic,0,0
60026,post-tonsillectomy,1,0
60027,.,1,0
60028,OBJECTIVE,0,0
60029,To,0,0
60030,compare,0,0
60031,the,0,0
60032,analgesic,0,0
60033,efficacy,0,0
60034,of,0,0
60035,hydrogen,0,0
60036,peroxide,0,0
60037,(,0,0
60038,H2O2,0,0
60039,),0,0
60040,mouth,0,0
60041,rinse,0,0
60042,with,0,1
60043,control,0,0
60044,for,0,0
60045,post-tonsillectomy,0,0
60046,pain,0,1
60047,management,0,1
60048,.,0,1
60049,DESIGN,0,0
60050,Double-blinded,0,0
60051,",",0,0
60052,prospective,0,0
60053,",",0,0
60054,randomized,0,0
60055,",",0,0
60056,controlled,0,0
60057,clinical,0,0
60058,trial,0,1
60059,.,0,1
60060,PATIENTS,0,0
60061,AND,0,0
60062,METHODS,0,0
60063,Thirty-seven,1,1
60064,patients,1,1
60065,from,1,1
60066,5,1,1
60067,to,1,1
60068,14,1,1
60069,years,1,1
60070,old,1,1
60071,undergoing,1,1
60072,electrocautery,1,0
60073,tonsillectomy,1,1
60074,were,0,0
60075,randomized,0,0
60076,to,0,0
60077,either,0,0
60078,the,0,0
60079,H2O2,0,0
60080,mouth,1,0
60081,rinse,1,0
60082,or,0,0
60083,the,0,0
60084,water,1,0
60085,rinse,1,0
60086,(,1,0
60087,control,1,0
60088,),1,0
60089,group,0,0
60090,.,0,1
60091,For,0,0
60092,14,0,0
60093,days,0,0
60094,",",0,1
60095,patients,0,1
60096,recorded,0,0
60097,pain,0,1
60098,levels,0,0
60099,twice,0,0
60100,daily,0,0
60101,using,0,0
60102,a,0,0
60103,visual,0,0
60104,analogue,0,0
60105,scale,0,0
60106,.,0,1
60107,Analgesic,0,0
60108,uses,0,0
60109,",",0,0
60110,as,0,0
60111,well,0,0
60112,as,0,0
60113,any,0,0
60114,complications,0,0
60115,",",0,0
60116,were,0,0
60117,also,0,0
60118,noted,0,0
60119,by,0,0
60120,the,0,0
60121,patients,0,1
60122,.,0,1
60123,RESULTS,0,0
60124,Thirty-seven,0,1
60125,patients,0,1
60126,completed,0,1
60127,the,0,0
60128,study,0,0
60129,",",0,0
60130,21,0,1
60131,in,0,0
60132,the,0,0
60133,treatment,1,0
60134,group,1,0
60135,and,0,0
60136,16,0,1
60137,in,0,0
60138,the,0,0
60139,control,1,0
60140,group,1,0
60141,.,1,0
60142,Mean,0,1
60143,postoperative,0,0
60144,days,0,0
60145,of,0,0
60146,pain,0,1
60147,were,0,1
60148,10.3,0,0
60149,and,0,0
60150,8.3,0,0
60151,",",0,0
60152,respectively,0,0
60153,",",0,0
60154,and,0,0
60155,differed,0,0
60156,significantly,0,0
60157,(,0,0
60158,p,0,0
60159,=,0,0
60160,.008,0,0
60161,),0,0
60162,.,0,1
60163,Mean,0,1
60164,postoperative,0,0
60165,days,0,0
60166,of,0,0
60167,analgesic,0,0
60168,use,0,0
60169,were,0,0
60170,9.0,0,0
60171,and,0,0
60172,6.7,0,0
60173,",",0,0
60174,respectively,0,0
60175,",",0,0
60176,and,0,0
60177,differed,0,0
60178,significantly,0,0
60179,(,0,0
60180,p,0,0
60181,=,0,0
60182,.005,0,0
60183,),0,0
60184,.,0,0
60185,Only,0,0
60186,one,0,0
60187,incidence,0,0
60188,of,0,0
60189,postoperative,0,0
60190,hemorrhage,0,1
60191,occurred,0,0
60192,in,0,0
60193,the,0,0
60194,study,0,0
60195,group,0,0
60196,.,0,0
60197,CONCLUSION,0,0
60198,In,0,0
60199,our,0,0
60200,study,0,0
60201,",",0,0
60202,the,0,0
60203,H2O2,0,0
60204,mouth,0,0
60205,rinse,0,0
60206,does,0,0
60207,not,0,0
60208,provide,0,0
60209,a,0,0
60210,better,0,0
60211,analgesic,0,0
60212,effect,0,0
60213,than,0,0
60214,the,0,0
60215,water,0,0
60216,rinse,0,0
60217,for,0,0
60218,post-tonsillectomy,0,0
60219,pain,0,1
60220,relief,0,0
60221,.,0,1
60222,[,0,0
60223,A,0,0
60224,randomized,0,0
60225,study,0,0
60226,of,0,0
60227,prophylactic,0,0
60228,intravesical,0,0
60229,instillation,0,0
60230,of,0,0
60231,pirarubicin,0,0
60232,(,0,0
60233,THP,0,0
60234,),0,0
60235,prior,0,0
60236,to,0,0
60237,transurethral,1,1
60238,resection,1,1
60239,of,1,0
60240,superficial,1,1
60241,bladder,1,1
60242,cancer,1,1
60243,],1,1
60244,.,0,1
60245,A,0,0
60246,prospective,0,0
60247,randomized,0,1
60248,study,0,0
60249,was,0,0
60250,conducted,0,0
60251,to,0,0
60252,evaluate,0,0
60253,the,0,0
60254,efficacy,0,0
60255,of,0,0
60256,prophylactic,1,0
60257,intravesical,1,0
60258,instillation,1,0
60259,of,1,0
60260,pirarubicin,1,0
60261,(,1,0
60262,THP,1,0
60263,),1,0
60264,prior,1,0
60265,to,1,0
60266,transurethral,1,1
60267,resection,1,1
60268,(,1,0
60269,TUR,1,0
60270,),1,0
60271,of,1,0
60272,superficial,1,1
60273,bladder,1,1
60274,cancer,1,1
60275,.,1,0
60276,A,0,0
60277,total,0,1
60278,of,0,0
60279,63,1,1
60280,patients,1,1
60281,were,0,1
60282,randomized,0,1
60283,into,0,1
60284,two,0,0
60285,groups,0,0
60286,",",0,0
60287,the,0,0
60288,THP,0,0
60289,group,0,0
60290,and,0,0
60291,the,0,0
60292,control,0,0
60293,group,0,0
60294,.,0,0
60295,In,0,0
60296,the,0,0
60297,THP,0,0
60298,group,0,0
60299,",",0,0
60300,30,0,0
60301,mg,0,0
60302,of,0,0
60303,THP,0,0
60304,dissolved,0,0
60305,in,0,0
60306,50,0,1
60307,ml,0,0
60308,saline,0,0
60309,was,0,0
60310,administered,0,0
60311,4,0,0
60312,times,0,0
60313,intravesically,0,0
60314,for,0,0
60315,4,0,0
60316,consecutive,0,1
60317,days,0,0
60318,before,0,1
60319,TUR,0,1
60320,.,0,1
60321,In,0,0
60322,the,0,0
60323,control,0,0
60324,group,0,0
60325,",",0,0
60326,no,0,0
60327,instillation,0,0
60328,was,0,0
60329,performed,0,0
60330,before,0,0
60331,TUR,0,0
60332,.,0,1
60333,The,0,0
60334,patients,0,1
60335,were,0,0
60336,followed,0,0
60337,by,0,0
60338,cystoscopy,0,0
60339,and,0,0
60340,urinary,0,0
60341,cytology,0,1
60342,every,0,0
60343,3,0,0
60344,months,0,0
60345,.,0,1
60346,The,0,0
60347,non-recurrence,0,0
60348,rates,0,0
60349,in,0,0
60350,the,0,0
60351,THP,0,0
60352,group,0,0
60353,and,0,0
60354,control,0,0
60355,group,0,0
60356,were,0,0
60357,54.1,0,0
60358,%,0,0
60359,versus,0,0
60360,37.6,0,0
60361,%,0,0
60362,at,0,0
60363,1,0,0
60364,year,0,1
60365,and,0,0
60366,40.4,0,0
60367,%,0,0
60368,versus,0,0
60369,26.8,0,0
60370,%,0,0
60371,at,0,0
60372,2,0,0
60373,years,0,1
60374,",",0,0
60375,respectively,0,0
60376,(,0,0
60377,P,0,0
60378,=,0,0
60379,0.086,0,0
60380,),0,0
60381,.,0,0
60382,Time,0,0
60383,to,0,0
60384,recurrence,0,0
60385,for,0,0
60386,tumors,0,1
60387,larger,0,0
60388,than,0,0
60389,1,0,0
60390,cm,0,1
60391,was,0,0
60392,significantly,0,0
60393,longer,0,0
60394,in,0,0
60395,the,0,0
60396,THP,0,0
60397,group,0,0
60398,(,0,0
60399,P,0,0
60400,=,0,0
60401,0.0137,0,0
60402,),0,0
60403,.,0,0
60404,Time,0,0
60405,to,0,0
60406,recurrence,0,0
60407,for,0,0
60408,single,0,0
60409,and,0,0
60410,grade,0,1
60411,1+2,0,0
60412,tumors,0,1
60413,tended,0,0
60414,to,0,0
60415,be,0,0
60416,longer,0,0
60417,in,0,0
60418,the,0,0
60419,THP,0,0
60420,group,0,0
60421,(,0,0
60422,P,0,0
60423,=,0,0
60424,0.09,0,0
60425,",",0,0
60426,P,0,0
60427,=,0,0
60428,0.079,0,0
60429,),0,0
60430,.,0,0
60431,No,0,0
60432,significant,0,0
60433,adverse,0,0
60434,effects,0,0
60435,were,0,1
60436,observed,0,0
60437,in,0,0
60438,any,0,0
60439,patient,0,0
60440,.,0,0
60441,Our,0,0
60442,findings,0,0
60443,suggest,0,0
60444,that,0,0
60445,intravesical,0,0
60446,THP,0,0
60447,instillation,0,0
60448,prior,0,0
60449,to,0,0
60450,TUR,0,0
60451,would,0,0
60452,be,0,0
60453,effective,0,0
60454,for,0,0
60455,patients,0,1
60456,with,0,1
60457,single,0,0
60458,",",0,0
60459,low,0,0
60460,grade,0,1
60461,lesions,0,0
60462,larger,0,0
60463,than,0,0
60464,1,0,0
60465,cm,0,1
60466,of,0,0
60467,superficial,1,1
60468,bladder,1,1
60469,cancer,1,1
60470,.,1,1
60471,[,0,0
60472,Effect,0,0
60473,of,0,0
60474,branch,0,0
60475,chain,0,0
60476,amino,0,0
60477,acid,0,0
60478,enriched,0,0
60479,formula,0,0
60480,on,0,0
60481,postoperative,0,0
60482,fatigue,0,0
60483,and,0,0
60484,nutritional,0,0
60485,status,0,0
60486,after,1,0
60487,digestive,1,1
60488,surgery,1,1
60489,],1,0
60490,.,0,0
60491,OBJECTIVE,0,0
60492,To,0,0
60493,evaluate,0,0
60494,the,0,0
60495,effect,0,0
60496,of,0,0
60497,branch,0,0
60498,chain,0,0
60499,amino,0,0
60500,acid,0,0
60501,(,0,0
60502,BCAA,0,0
60503,),0,0
60504,enriched,0,0
60505,formula,0,0
60506,on,0,0
60507,nutritional,0,0
60508,status,0,1
60509,and,0,0
60510,postoperative,0,0
60511,fatigue,0,0
60512,for,0,0
60513,digestive,1,1
60514,surgery,1,1
60515,patients,1,1
60516,.,1,1
60517,METHODS,0,0
60518,Forty,1,1
60519,patients,1,1
60520,who,1,1
60521,underwent,1,1
60522,digestive,1,1
60523,surgery,1,1
60524,were,0,0
60525,randomly,0,1
60526,received,0,0
60527,parenteral,0,0
60528,nutrition,0,0
60529,with,0,1
60530,either,0,0
60531,BCAA,0,0
60532,enriched,0,0
60533,(,0,0
60534,study,0,0
60535,group,0,0
60536,",",0,0
60537,n=20,0,1
60538,),0,0
60539,or,0,0
60540,routine,0,0
60541,amino,0,0
60542,acid,0,0
60543,(,0,0
60544,control,0,0
60545,group,0,0
60546,",",0,0
60547,n=20,0,1
60548,),0,0
60549,for,0,0
60550,seven,0,1
60551,consecutive,0,1
60552,days,0,0
60553,.,0,1
60554,Nitrogen,0,0
60555,balance,0,0
60556,",",0,0
60557,serum,0,0
60558,total,0,1
60559,protein,0,0
60560,",",0,0
60561,albumin,0,0
60562,",",0,0
60563,prealbumin,0,0
60564,",",0,0
60565,transferrin,0,0
60566,",",0,0
60567,retinol,0,0
60568,binding,0,0
60569,protein,0,0
60570,and,0,0
60571,postoperative,0,0
60572,fatigue,0,0
60573,score,0,0
60574,were,0,0
60575,monitored,0,0
60576,during,0,0
60577,the,0,0
60578,postoperative,0,0
60579,period,0,0
60580,.,0,0
60581,RESULTS,0,0
60582,The,0,0
60583,cumulative,0,0
60584,postoperative,0,0
60585,fatigue,0,1
60586,scores,0,0
60587,were,0,0
60588,lower,0,0
60589,in,0,0
60590,BCAA,0,0
60591,group,0,0
60592,than,0,0
60593,that,0,0
60594,in,0,0
60595,the,0,0
60596,control,0,0
60597,group,0,0
60598,at,0,0
60599,the,0,0
60600,4th,0,0
60601,",",0,0
60602,5th,0,1
60603,and,0,0
60604,7th,0,0
60605,day,0,0
60606,after,0,0
60607,operation,0,0
60608,(,0,0
60609,P,0,0
60610,<,0,0
60611,0.05,0,0
60612,),0,1
60613,.,0,1
60614,Patients,0,1
60615,achieved,0,0
60616,positive,0,0
60617,nitrogen,0,0
60618,balance,0,0
60619,2,0,0
60620,days,0,0
60621,earlier,0,0
60622,in,0,0
60623,the,0,0
60624,study,0,0
60625,group,0,0
60626,than,0,0
60627,that,0,0
60628,in,0,0
60629,the,0,0
60630,control,0,0
60631,group,0,0
60632,",",0,0
60633,but,0,0
60634,there,0,0
60635,was,0,0
60636,no,0,0
60637,significant,0,0
60638,difference,0,0
60639,in,0,0
60640,cumulative,0,0
60641,nitrogen,0,0
60642,balance,0,0
60643,between,0,0
60644,the,0,0
60645,two,0,0
60646,groups,0,0
60647,.,0,0
60648,There,0,0
60649,was,0,0
60650,no,0,0
60651,significant,0,0
60652,difference,0,0
60653,in,0,0
60654,elevation,0,0
60655,of,0,0
60656,serum,0,0
60657,total,0,1
60658,protein,0,0
60659,",",0,0
60660,albumin,0,0
60661,",",0,0
60662,prealbumin,0,0
60663,",",0,0
60664,transferrin,0,0
60665,at,0,0
60666,the,0,0
60667,7th,0,0
60668,day,0,0
60669,after,0,0
60670,operation,0,0
60671,between,0,0
60672,the,0,0
60673,two,0,0
60674,groups,0,0
60675,(,0,1
60676,P,0,0
60677,>,0,1
60678,0.05,0,0
60679,),0,0
60680,",",0,0
60681,compared,0,0
60682,with,0,0
60683,those,0,0
60684,at,0,0
60685,the,0,0
60686,first,0,0
60687,day,0,0
60688,after,0,0
60689,operation,0,0
60690,.,0,0
60691,The,0,0
60692,serum,0,0
60693,level,0,0
60694,of,0,0
60695,retinol,0,0
60696,binding,0,0
60697,protein,0,0
60698,was,0,0
60699,higher,0,0
60700,in,0,0
60701,BCAA-enriched,0,0
60702,group,0,0
60703,than,0,0
60704,that,0,0
60705,in,0,0
60706,the,0,0
60707,control,0,0
60708,group,0,0
60709,(,0,0
60710,P=0.004,0,0
60711,),0,1
60712,.,0,1
60713,CONCLUSION,0,0
60714,TPN,0,0
60715,with,0,1
60716,BCAA,0,0
60717,enriched,0,0
60718,formula,0,0
60719,can,0,0
60720,reduce,0,0
60721,postoperative,0,0
60722,fatigue,0,0
60723,score,0,0
60724,and,0,0
60725,improve,0,0
60726,the,0,0
60727,nutritional,0,0
60728,status,0,0
60729,for,0,0
60730,digestive,1,1
60731,surgery,1,1
60732,patients,1,1
60733,.,1,1
60734,[,0,0
60735,Study,0,0
60736,on,0,0
60737,classification,0,0
60738,and,0,0
60739,treatment,0,0
60740,of,0,0
60741,vulvovaginal,1,1
60742,candidiasis,1,1
60743,],1,0
60744,.,0,0
60745,OBJECTIVE,0,0
60746,To,0,0
60747,determine,0,0
60748,the,0,0
60749,clinical,0,0
60750,manifestations,0,0
60751,of,0,0
60752,vulvovaginal,1,1
60753,candidiasis,1,1
60754,(,1,0
60755,VVC,1,0
60756,),1,0
60757,and,0,0
60758,to,0,0
60759,study,0,0
60760,the,0,0
60761,mycologic,0,0
60762,eradication,0,0
60763,rate,0,0
60764,of,0,0
60765,different,0,0
60766,miconazole,0,0
60767,treatment,0,0
60768,courses,0,0
60769,for,0,0
60770,VVC,0,1
60771,.,0,1
60772,METHODS,0,0
60773,Three,1,1
60774,hundred,1,1
60775,cases,1,1
60776,of,1,1
60777,VVC,1,1
60778,were,1,1
60779,recruited,1,1
60780,.,1,1
60781,The,0,0
60782,Candidas,0,1
60783,were,0,1
60784,cultured,0,0
60785,.,0,0
60786,A,0,0
60787,prospective,0,0
60788,and,0,0
60789,randomized,0,1
60790,study,0,0
60791,was,0,0
60792,performed,0,0
60793,to,0,0
60794,compare,0,0
60795,the,0,0
60796,treatment,0,0
60797,effect,0,0
60798,of,0,0
60799,3,0,0
60800,day,0,0
60801,miconazole,0,0
60802,(,0,0
60803,400,0,0
60804,mg/d,0,0
60805,),0,0
60806,",",0,0
60807,6,0,0
60808,day,0,0
60809,miconazole,0,0
60810,(,0,0
60811,400,0,0
60812,mg/d,0,0
60813,),0,0
60814,",",0,0
60815,and,0,0
60816,7,0,0
60817,day,0,0
60818,miconazole,0,0
60819,(,0,0
60820,200,0,0
60821,mg/d,0,0
60822,),0,0
60823,for,0,0
60824,uncomplicated,0,1
60825,and,0,0
60826,complicated,0,1
60827,VVC,0,0
60828,.,0,1
60829,RESULTS,0,0
60830,Among,0,1
60831,300,1,0
60832,cases,1,1
60833,of,1,0
60834,VVC,1,1
60835,",",0,0
60836,uncomplicated,0,0
60837,",",0,0
60838,complicated,0,0
60839,and,0,0
60840,recurrent,0,1
60841,VVC,0,0
60842,were,0,1
60843,56.0,0,0
60844,%,0,0
60845,",",0,0
60846,44.0,0,0
60847,%,0,0
60848,and,0,0
60849,9.7,0,0
60850,%,0,0
60851,(,0,1
60852,29/300,0,0
60853,),0,0
60854,respectively,0,0
60855,.,0,1
60856,C.,0,0
60857,albicans,0,0
60858,was,0,0
60859,isolated,0,1
60860,most,0,0
60861,frequently,0,0
60862,90.3,0,0
60863,%,0,0
60864,(,0,1
60865,271/300,0,0
60866,),0,0
60867,",",0,0
60868,followed,0,0
60869,by,0,0
60870,C.,0,0
60871,glabrata,0,1
60872,(,0,0
60873,7.3,0,0
60874,%,0,0
60875,),0,0
60876,",",0,0
60877,C.,0,0
60878,tropicalis,0,0
60879,(,0,0
60880,1.3,0,0
60881,%,0,0
60882,),0,0
60883,",",0,0
60884,C.,0,0
60885,krusei,0,1
60886,(,0,0
60887,0.7,0,0
60888,%,0,0
60889,),0,0
60890,",",0,0
60891,and,0,0
60892,C.,0,0
60893,parapsilosis,0,1
60894,(,0,0
60895,0.3,0,0
60896,%,0,0
60897,),0,0
60898,.,0,0
60899,Mycologic,0,0
60900,eradication,0,0
60901,rate,0,0
60902,of,0,0
60903,3,0,0
60904,day,0,0
60905,",",0,0
60906,6,0,0
60907,day,0,0
60908,and,0,0
60909,7,0,0
60910,day,0,0
60911,miconazole,0,0
60912,courses,0,0
60913,for,0,0
60914,uncomplicated,0,1
60915,VVC,0,0
60916,at,0,0
60917,day,0,0
60918,14,0,1
60919,was,0,0
60920,96.0,0,0
60921,%,0,0
60922,",",0,0
60923,93.5,0,0
60924,%,0,0
60925,and,0,0
60926,98.0,0,0
60927,%,0,0
60928,",",0,0
60929,respectively,0,0
60930,(,0,0
60931,P,0,0
60932,>,0,1
60933,0.05,0,0
60934,),0,1
60935,.,0,1
60936,Eradication,0,0
60937,rate,0,0
60938,of,0,0
60939,3,0,0
60940,day,0,0
60941,",",0,0
60942,6,0,0
60943,day,0,0
60944,and,0,0
60945,7,0,0
60946,day,0,0
60947,miconazole,0,0
60948,courses,0,0
60949,for,0,0
60950,complicated,0,1
60951,VVC,0,0
60952,at,0,0
60953,day,0,0
60954,14,0,1
60955,was,0,0
60956,86.7,0,0
60957,%,0,0
60958,",",0,0
60959,92.5,0,0
60960,%,0,0
60961,",",0,0
60962,and,0,0
60963,86.4,0,0
60964,%,0,0
60965,",",0,0
60966,respectively,0,0
60967,(,0,0
60968,P,0,0
60969,>,0,1
60970,0.05,0,0
60971,),0,1
60972,.,0,1
60973,Eradication,0,0
60974,rate,0,0
60975,of,0,0
60976,3,0,0
60977,day,0,0
60978,",",0,0
60979,6,0,0
60980,day,0,0
60981,and,0,0
60982,7,0,0
60983,day,0,0
60984,miconazole,0,0
60985,courses,0,0
60986,for,0,0
60987,uncomplicated,0,1
60988,VVC,0,0
60989,at,0,0
60990,day,0,0
60991,35,0,1
60992,was,0,0
60993,93.8,0,0
60994,%,0,0
60995,",",0,0
60996,95.3,0,0
60997,%,0,0
60998,",",0,0
60999,and,0,0
61000,89.8,0,0
61001,%,0,0
61002,",",0,0
61003,respectively,0,0
61004,(,0,0
61005,P,0,0
61006,>,0,1
61007,0.05,0,0
61008,),0,1
61009,.,0,1
61010,Eradication,0,0
61011,rate,0,0
61012,of,0,0
61013,3,0,0
61014,day,0,0
61015,",",0,0
61016,6,0,0
61017,day,0,0
61018,and,0,0
61019,7,0,0
61020,day,0,0
61021,miconazole,0,0
61022,courses,0,0
61023,for,0,0
61024,complicated,0,1
61025,VVC,0,0
61026,at,0,0
61027,day,0,0
61028,35,0,1
61029,was,0,0
61030,89.7,0,0
61031,%,0,0
61032,",",0,0
61033,97.3,0,0
61034,%,0,0
61035,and,0,0
61036,86.8,0,0
61037,%,0,0
61038,",",0,0
61039,respectively,0,0
61040,(,0,0
61041,P,0,0
61042,>,0,1
61043,0.05,0,0
61044,),0,1
61045,.,0,1
61046,CONCLUSION,0,0
61047,Treatment,0,0
61048,of,0,0
61049,VVC,0,0
61050,should,0,0
61051,be,0,0
61052,individualized,0,0
61053,",",0,0
61054,and,0,0
61055,women,1,1
61056,with,1,1
61057,complicated,1,1
61058,VVC,1,1
61059,achieve,0,0
61060,superior,0,0
61061,mycologic,0,0
61062,eradication,0,0
61063,by,0,0
61064,a,0,0
61065,6,0,0
61066,day,0,0
61067,miconazole,0,0
61068,course,0,0
61069,.,0,1
61070,Treatment,0,0
61071,of,0,0
61072,anal,1,1
61073,fissures,1,0
61074,using,0,0
61075,a,0,0
61076,combination,0,0
61077,of,0,0
61078,minoxidil,0,0
61079,and,0,0
61080,lignocaine,0,0
61081,:,0,1
61082,a,0,0
61083,randomized,0,0
61084,",",0,0
61085,double-blind,0,0
61086,trial,0,0
61087,.,0,1
61088,AIM,0,0
61089,Anal,0,1
61090,fissures,0,0
61091,are,0,0
61092,associated,0,0
61093,with,0,1
61094,hypertonia,0,0
61095,of,0,0
61096,the,0,0
61097,internal,0,0
61098,anal,0,1
61099,sphincter,0,1
61100,and,0,0
61101,pain,0,1
61102,.,0,0
61103,We,0,0
61104,evaluated,0,0
61105,the,0,0
61106,efficacy,0,0
61107,of,0,0
61108,local,0,0
61109,application,0,0
61110,of,0,0
61111,a,0,0
61112,combination,0,0
61113,of,0,0
61114,minoxidil,0,0
61115,and,0,0
61116,lignocaine,0,0
61117,in,0,0
61118,healing,0,0
61119,anal,0,1
61120,fissures,0,0
61121,.,0,1
61122,METHODS,0,0
61123,In,0,0
61124,this,0,0
61125,prospective,0,0
61126,",",0,0
61127,randomized,0,0
61128,",",0,0
61129,double-blind,0,0
61130,study,0,0
61131,",",0,0
61132,90,1,0
61133,patients,1,1
61134,with,1,1
61135,anal,1,1
61136,fissure,1,0
61137,were,1,0
61138,recruited,1,1
61139,.,1,1
61140,Patients,0,1
61141,received,0,0
61142,local,0,0
61143,applications,0,0
61144,of,0,1
61145,ointments,0,0
61146,containing,0,0
61147,5,0,0
61148,%,0,0
61149,lignocaine,0,0
61150,(,0,0
61151,n=28,0,1
61152,),0,0
61153,",",0,0
61154,0.5,0,0
61155,%,0,0
61156,minoxidil,0,0
61157,(,0,0
61158,n=36,0,1
61159,),0,0
61160,",",0,0
61161,or,0,0
61162,both,0,0
61163,(,0,0
61164,n=26,0,1
61165,),0,0
61166,.,0,0
61167,Healing,0,0
61168,of,0,0
61169,anal,0,1
61170,fissure,0,0
61171,at,0,0
61172,6,0,0
61173,weeks,0,0
61174,was,0,0
61175,used,0,0
61176,as,0,0
61177,the,0,0
61178,primary,0,1
61179,end-point,0,0
61180,.,0,1
61181,RESULTS,0,0
61182,Rates,0,0
61183,of,0,1
61184,complete,0,1
61185,healing,0,0
61186,of,0,0
61187,fissure,0,0
61188,were,0,0
61189,similar,0,0
61190,in,0,0
61191,the,0,0
61192,three,0,0
61193,groups,0,0
61194,(,0,0
61195,lignocaine,0,0
61196,alone,0,0
61197,8/27,0,0
61198,",",0,0
61199,minoxidil,0,0
61200,alone,0,0
61201,10/34,0,0
61202,",",0,0
61203,combination,0,0
61204,7/22,0,0
61205,;,0,0
61206,p=ns,0,0
61207,),0,0
61208,.,0,0
61209,Mean,0,0
61210,(,0,0
61211,SD,0,0
61212,),0,0
61213,time,0,0
61214,taken,0,0
61215,for,0,0
61216,complete,0,0
61217,healing,0,0
61218,with,0,1
61219,combination,0,0
61220,treatment,0,0
61221,[,0,0
61222,1.9,0,0
61223,(,0,0
61224,0.6,0,0
61225,),0,1
61226,weeks,0,0
61227,],0,0
61228,was,0,0
61229,significantly,0,0
61230,shorter,0,0
61231,than,0,0
61232,that,0,0
61233,with,0,0
61234,minoxidil,0,0
61235,alone,0,0
61236,(,0,0
61237,3.1,0,0
61238,[,0,0
61239,1.7,0,0
61240,],0,1
61241,weeks,0,0
61242,;,0,1
61243,p=0.001,0,0
61244,),0,0
61245,or,0,0
61246,with,0,1
61247,lignocaine,0,0
61248,alone,0,0
61249,(,0,0
61250,3.3,0,0
61251,[,0,0
61252,0.8,0,1
61253,],0,1
61254,weeks,0,0
61255,;,0,1
61256,p=0.002,0,0
61257,),0,0
61258,.,0,0
61259,Rates,0,0
61260,of,0,0
61261,pain,0,1
61262,relief,0,0
61263,were,0,0
61264,similar,0,0
61265,in,0,0
61266,the,0,0
61267,three,0,0
61268,groups,0,0
61269,.,0,1
61270,Stoppage,0,0
61271,of,0,0
61272,bleeding,0,0
61273,occurred,0,0
61274,more,0,0
61275,often,0,0
61276,with,0,0
61277,combination,0,0
61278,treatment,0,0
61279,than,0,0
61280,with,0,1
61281,lignocaine,0,0
61282,alone,0,0
61283,.,0,0
61284,No,0,0
61285,patient,0,0
61286,had,0,0
61287,systemic,0,0
61288,or,0,1
61289,local,0,0
61290,side,0,0
61291,effects,0,0
61292,.,0,1
61293,CONCLUSION,0,0
61294,Combination,0,0
61295,treatment,0,0
61296,with,0,1
61297,minoxidil,0,0
61298,and,0,0
61299,lignocaine,0,0
61300,helps,0,0
61301,in,0,0
61302,faster,0,0
61303,healing,0,0
61304,of,0,0
61305,anal,0,1
61306,fissures,0,0
61307,and,0,0
61308,provides,0,0
61309,better,0,0
61310,symptomatic,0,0
61311,relief,0,0
61312,than,0,0
61313,either,0,0
61314,drug,0,0
61315,alone,0,0
61316,.,0,0
61317,Effects,0,0
61318,of,0,1
61319,glucose-insulin-potassium,0,0
61320,infusion,0,0
61321,on,0,0
61322,ST-elevation,1,1
61323,myocardial,1,1
61324,infarction,1,1
61325,in,1,0
61326,patients,1,1
61327,treated,1,1
61328,with,1,1
61329,thrombolytic,1,1
61330,therapy,1,0
61331,.,1,0
61332,The,0,0
61333,role,0,0
61334,of,0,0
61335,glucose-insulin-potassium,0,0
61336,(,0,0
61337,GIK,0,1
61338,),0,0
61339,infusion,0,0
61340,in,0,0
61341,the,0,0
61342,management,0,0
61343,of,0,0
61344,acute,0,1
61345,myocardial,0,1
61346,infarction,0,1
61347,is,0,0
61348,not,0,0
61349,well,0,0
61350,established,0,0
61351,.,0,0
61352,This,0,0
61353,prospective,0,0
61354,",",0,0
61355,randomized,0,0
61356,study,0,0
61357,comprised,0,1
61358,120,1,1
61359,patients,1,1
61360,who,1,1
61361,had,1,1
61362,ST-elevation,1,1
61363,myocardial,1,1
61364,infarction,1,1
61365,that,1,0
61366,was,1,0
61367,treated,1,1
61368,within,1,0
61369,12,1,0
61370,hours,1,0
61371,from,1,1
61372,symptom,1,1
61373,onset,1,1
61374,with,0,1
61375,a,0,0
61376,high,0,0
61377,dose,0,0
61378,of,0,0
61379,GIK,0,1
61380,(,0,1
61381,25,0,0
61382,%,0,0
61383,glucose,0,0
61384,",",0,0
61385,50,0,0
61386,IU,0,0
61387,of,0,0
61388,soluble,0,0
61389,insulin,0,0
61390,per,0,0
61391,liter,0,0
61392,",",0,0
61393,and,0,0
61394,80,0,1
61395,mmol,0,0
61396,of,0,0
61397,potassium,0,0
61398,chloride,0,0
61399,per,0,0
61400,liter,0,0
61401,at,0,0
61402,1,0,0
61403,ml/kg/hour,0,0
61404,over,0,0
61405,24,0,1
61406,hours,0,0
61407,),0,1
61408,as,0,0
61409,adjunct,0,0
61410,to,0,0
61411,thrombolytic,0,0
61412,therapy,0,0
61413,(,0,0
61414,1.5,0,0
61415,MU,0,0
61416,of,0,0
61417,streptokinase/30,0,0
61418,to,0,0
61419,60,0,1
61420,minutes,0,0
61421,;,0,1
61422,GIK,0,1
61423,group,0,0
61424,),0,0
61425,or,0,1
61426,thrombolytic,0,0
61427,therapy,0,0
61428,alone,0,0
61429,(,0,0
61430,control,0,0
61431,group,0,1
61432,),0,0
61433,.,0,0
61434,The,0,0
61435,primary,0,0
61436,end,0,0
61437,point,0,0
61438,of,0,0
61439,the,0,0
61440,study,0,0
61441,was,0,0
61442,the,0,0
61443,rate,0,0
61444,of,0,0
61445,major,0,1
61446,adverse,0,0
61447,cardiac,0,1
61448,events,0,0
61449,(,0,1
61450,MACEs,0,0
61451,),0,0
61452,at,0,0
61453,1,0,0
61454,month,0,0
61455,",",0,0
61456,defined,0,0
61457,as,0,0
61458,a,0,0
61459,composite,0,0
61460,of,0,0
61461,cardiac,0,1
61462,death,0,0
61463,",",0,0
61464,reinfarction,0,0
61465,",",0,0
61466,serious,0,0
61467,arrhythmias,0,1
61468,(,0,0
61469,ventricular,0,0
61470,fibrillation,0,1
61471,and/or,0,0
61472,tachycardia,0,1
61473,),0,0
61474,",",0,0
61475,and,0,0
61476,severe,0,1
61477,heart,0,1
61478,failure,0,1
61479,.,0,0
61480,The,0,0
61481,secondary,0,0
61482,end,0,0
61483,points,0,0
61484,were,0,0
61485,the,0,0
61486,rate,0,0
61487,of,0,0
61488,MACEs,0,0
61489,at,0,0
61490,1,0,0
61491,year,0,0
61492,and,0,0
61493,improvement,0,0
61494,in,0,0
61495,left,0,1
61496,ventricular,0,1
61497,systolic,0,1
61498,function,0,0
61499,.,0,0
61500,The,0,0
61501,incidence,0,0
61502,of,0,0
61503,MACEs,0,0
61504,at,0,0
61505,1,0,0
61506,month,0,0
61507,was,0,0
61508,significantly,0,0
61509,lower,0,0
61510,in,0,0
61511,the,0,0
61512,GIK,0,0
61513,group,0,0
61514,(,0,0
61515,10,0,0
61516,%,0,0
61517,vs,0,0
61518,32.5,0,0
61519,%,0,0
61520,",",0,0
61521,relative,0,0
61522,risk,0,0
61523,0.24,0,0
61524,",",0,0
61525,95,0,0
61526,%,0,0
61527,confidence,0,0
61528,interval,0,0
61529,0.09,0,0
61530,to,0,0
61531,0.63,0,0
61532,",",0,0
61533,p,0,0
61534,=,0,0
61535,0.0043,0,0
61536,),0,1
61537,.,0,1
61538,Patients,0,1
61539,in,0,0
61540,the,0,0
61541,GIK,0,1
61542,group,0,0
61543,had,0,1
61544,significant,0,0
61545,decreases,0,0
61546,in,0,0
61547,ventricular,0,1
61548,tachycardia,0,1
61549,and/or,0,0
61550,fibrillation,0,1
61551,(,0,0
61552,1.3,0,0
61553,%,0,0
61554,vs,0,0
61555,15.0,0,0
61556,%,0,0
61557,",",0,0
61558,p,0,0
61559,=,0,0
61560,0.003,0,0
61561,),0,0
61562,and,0,0
61563,severe,0,1
61564,heart,0,1
61565,failure,0,1
61566,(,0,0
61567,3,0,0
61568,%,0,0
61569,vs,0,0
61570,12.5,0,0
61571,%,0,0
61572,",",0,0
61573,p,0,0
61574,=,0,0
61575,0.031,0,0
61576,),0,0
61577,.,0,0
61578,The,0,0
61579,rate,0,0
61580,of,0,0
61581,MACEs,0,0
61582,at,0,0
61583,1,0,0
61584,year,0,0
61585,was,0,0
61586,also,0,0
61587,significantly,0,0
61588,lower,0,0
61589,in,0,0
61590,the,0,0
61591,GIK,0,0
61592,group,0,0
61593,(,0,0
61594,13,0,1
61595,%,0,0
61596,vs,0,0
61597,40.0,0,0
61598,%,0,0
61599,",",0,0
61600,relative,0,0
61601,risk,0,0
61602,0.22,0,0
61603,",",0,0
61604,95,0,0
61605,%,0,0
61606,confidence,0,0
61607,interval,0,0
61608,0.09,0,0
61609,to,0,0
61610,0.55,0,0
61611,",",0,0
61612,p,0,0
61613,=,0,0
61614,0.0012,0,0
61615,),0,0
61616,.,0,1
61617,After,0,0
61618,1,0,0
61619,year,0,0
61620,",",0,0
61621,there,0,0
61622,was,0,0
61623,a,0,0
61624,significant,0,0
61625,improvement,0,0
61626,in,0,0
61627,left,0,1
61628,ventricular,0,0
61629,ejection,0,1
61630,fraction,0,0
61631,in,0,0
61632,the,0,0
61633,GIK,0,0
61634,group,0,0
61635,(,0,0
61636,from,0,1
61637,48,0,1
61638,+/-,0,0
61639,8,0,0
61640,%,0,0
61641,to,0,0
61642,51,0,1
61643,+/-,0,0
61644,10,0,1
61645,%,0,0
61646,",",0,0
61647,p,0,0
61648,<,0,0
61649,0.01,0,0
61650,),0,0
61651,",",0,0
61652,which,0,0
61653,was,0,0
61654,not,0,0
61655,observed,0,0
61656,in,0,0
61657,the,0,0
61658,control,0,0
61659,group,0,0
61660,.,0,0
61661,In,0,0
61662,conclusion,0,0
61663,",",0,0
61664,high-dose,0,0
61665,GIK,0,1
61666,",",0,0
61667,used,0,0
61668,as,0,0
61669,an,0,0
61670,adjunct,0,0
61671,to,0,0
61672,thrombolytic,0,0
61673,therapy,0,0
61674,",",0,0
61675,was,0,0
61676,safe,0,0
61677,and,0,0
61678,improved,0,0
61679,clinical,0,0
61680,outcome,0,0
61681,at,0,0
61682,1,0,0
61683,month,0,0
61684,.,0,0
61685,The,0,0
61686,beneficial,0,0
61687,effect,0,0
61688,of,0,0
61689,GIK,0,1
61690,infusion,0,0
61691,was,0,0
61692,maintained,0,0
61693,up,0,0
61694,to,0,0
61695,1,0,0
61696,year,0,1
61697,.,0,1
61698,Over,0,0
61699,time,0,0
61700,relationships,0,0
61701,between,0,0
61702,early,1,1
61703,adolescent,1,1
61704,and,1,0
61705,peer,1,0
61706,substance,0,1
61707,use,0,0
61708,.,0,0
61709,Peer,0,0
61710,and,0,0
61711,adolescent,0,1
61712,substance,0,0
61713,use,0,0
61714,are,0,0
61715,highly,0,0
61716,correlated,0,0
61717,",",0,0
61718,but,0,0
61719,this,0,0
61720,relationship,0,0
61721,is,0,0
61722,not,0,0
61723,fully,0,0
61724,understood,0,0
61725,.,0,0
61726,In,0,0
61727,particular,0,0
61728,",",0,0
61729,the,0,0
61730,relative,0,0
61731,contributions,0,0
61732,of,0,0
61733,selection,0,0
61734,and,0,0
61735,socialization,0,0
61736,to,0,0
61737,substance,0,0
61738,use,0,0
61739,progression,0,0
61740,have,0,0
61741,not,0,0
61742,been,0,0
61743,established,0,0
61744,.,0,1
61745,Students,1,0
61746,(,1,0
61747,n=2453,1,1
61748,),1,0
61749,in,1,0
61750,the,1,0
61751,seven,1,1
61752,middle,1,1
61753,schools,1,1
61754,in,1,1
61755,one,1,1
61756,school,1,1
61757,district,1,1
61758,were,1,0
61759,assessed,1,0
61760,at,1,0
61761,school,1,1
61762,at,1,0
61763,the,1,0
61764,beginning,1,0
61765,and,1,0
61766,end,1,0
61767,of,1,0
61768,the,1,0
61769,sixth,1,0
61770,",",1,0
61771,seventh,1,0
61772,",",1,0
61773,eighth,1,1
61774,grade,1,1
61775,and,1,0
61776,beginning,1,0
61777,of,1,0
61778,the,1,0
61779,9th,1,1
61780,grade,1,1
61781,.,1,1
61782,Self-reported,1,0
61783,smoking,1,0
61784,and,1,0
61785,drinking,1,0
61786,and,1,0
61787,the,1,0
61788,number,1,0
61789,of,1,0
61790,substance,1,1
61791,using,1,0
61792,friends,1,0
61793,were,1,1
61794,assessed,1,0
61795,5,1,0
61796,times,1,0
61797,over,1,0
61798,3,1,1
61799,years,1,1
61800,.,1,1
61801,The,0,0
61802,relationship,0,0
61803,between,0,0
61804,peer,0,0
61805,and,0,0
61806,adolescent,0,1
61807,substance,0,0
61808,use,0,0
61809,were,0,0
61810,assessed,0,0
61811,in,0,0
61812,parallel,0,0
61813,processes,0,0
61814,as,0,0
61815,part,0,1
61816,of,0,0
61817,an,0,0
61818,autoregressive,0,0
61819,latent,0,0
61820,trajectory,0,0
61821,model,0,0
61822,.,0,0
61823,Substance,0,0
61824,use,0,0
61825,and,0,0
61826,the,0,0
61827,number,0,0
61828,of,0,0
61829,substance,0,1
61830,using,0,0
61831,friends,0,0
61832,increased,0,0
61833,in,0,0
61834,linear,0,0
61835,fashion,0,0
61836,from,0,1
61837,T1,0,0
61838,to,0,1
61839,T5,0,0
61840,.,0,1
61841,Initial,0,0
61842,substance,0,0
61843,use,0,0
61844,predicted,0,0
61845,an,0,0
61846,increase,0,0
61847,in,0,0
61848,the,0,0
61849,number,0,0
61850,of,0,0
61851,substance,0,1
61852,using,0,0
61853,friends,0,0
61854,over,0,0
61855,time,0,0
61856,",",0,0
61857,indicating,0,0
61858,an,0,0
61859,effect,0,0
61860,of,0,0
61861,selection,0,0
61862,",",0,0
61863,and,0,0
61864,the,0,0
61865,initial,0,0
61866,number,0,0
61867,of,0,0
61868,substance,0,1
61869,using,0,0
61870,friends,0,0
61871,predicted,0,0
61872,substance,0,1
61873,use,0,0
61874,progression,0,0
61875,",",0,0
61876,providing,0,0
61877,evidence,0,0
61878,of,0,0
61879,socialization,0,0
61880,.,0,0
61881,The,0,0
61882,magnitudes,0,0
61883,of,0,0
61884,these,0,0
61885,relationships,0,0
61886,were,0,1
61887,similar,0,0
61888,.,0,1
61889,Bivariate,0,0
61890,",",0,0
61891,lagged,0,0
61892,autoregressive,0,0
61893,analyses,0,0
61894,of,0,0
61895,the,0,0
61896,successive,0,0
61897,relationships,0,0
61898,from,0,1
61899,one,0,1
61900,assessment,0,0
61901,to,0,0
61902,the,0,0
61903,next,0,0
61904,showed,0,0
61905,consistent,0,0
61906,",",0,0
61907,significant,0,0
61908,associations,0,0
61909,from,0,1
61910,peer,0,1
61911,use,0,0
61912,to,0,0
61913,adolescent,0,1
61914,substance,0,1
61915,use,0,0
61916,.,0,0
61917,The,0,0
61918,association,0,0
61919,from,0,0
61920,adolescent,0,1
61921,to,0,0
61922,peer,0,0
61923,use,0,0
61924,was,0,0
61925,significant,0,0
61926,only,0,0
61927,from,0,0
61928,7th,0,0
61929,to,0,0
61930,8th,0,1
61931,grade,0,1
61932,.,0,1
61933,The,0,0
61934,findings,0,0
61935,provide,0,0
61936,evidence,0,0
61937,of,0,0
61938,reciprocal,0,0
61939,influences,0,0
61940,",",0,0
61941,but,0,0
61942,socialization,0,0
61943,was,0,0
61944,a,0,0
61945,more,0,0
61946,consistent,0,0
61947,influence,0,0
61948,than,0,0
61949,selection,0,0
61950,.,0,1
61951,Pathology,0,1
61952,parameters,0,0
61953,and,0,0
61954,adjuvant,0,0
61955,tamoxifen,0,0
61956,response,0,0
61957,in,0,0
61958,a,0,0
61959,randomised,0,0
61960,premenopausal,1,1
61961,breast,1,1
61962,cancer,1,1
61963,trial,0,0
61964,.,0,1
61965,BACKGROUND,0,0
61966,Subgroups,0,0
61967,of,0,0
61968,breast,0,1
61969,cancer,0,1
61970,that,0,0
61971,have,0,0
61972,an,0,0
61973,impaired,0,0
61974,response,0,0
61975,to,0,0
61976,endocrine,0,1
61977,treatment,0,0
61978,",",0,0
61979,despite,0,0
61980,hormone,0,0
61981,receptor,0,0
61982,positivity,0,0
61983,",",0,0
61984,are,0,0
61985,still,0,0
61986,poorly,0,0
61987,defined,0,0
61988,.,0,0
61989,Breast,0,0
61990,cancer,0,1
61991,can,0,0
61992,be,0,0
61993,subdivided,0,1
61994,according,0,0
61995,to,0,0
61996,standard,0,1
61997,pathological,0,1
61998,parameters,0,0
61999,including,0,1
62000,histological,0,0
62001,type,0,1
62002,",",0,0
62003,grade,0,0
62004,",",0,0
62005,and,0,0
62006,assessment,0,0
62007,of,0,0
62008,proliferation,0,0
62009,.,0,0
62010,These,0,0
62011,parameters,0,0
62012,are,0,0
62013,the,0,0
62014,net,0,0
62015,result,0,0
62016,of,0,0
62017,combinations,0,0
62018,of,0,1
62019,genetic,0,1
62020,alterations,0,0
62021,effecting,0,0
62022,tumour,0,1
62023,behaviour,0,0
62024,and,0,0
62025,could,0,0
62026,potentially,0,0
62027,reflect,0,0
62028,subtypes,0,0
62029,that,0,0
62030,respond,0,0
62031,differently,0,0
62032,to,0,0
62033,endocrine,0,1
62034,treatment,0,0
62035,.,0,0
62036,AIMS,0,0
62037,To,0,0
62038,investigate,0,0
62039,the,0,0
62040,usefulness,0,0
62041,of,0,0
62042,these,0,0
62043,parameters,0,0
62044,as,0,0
62045,predictors,0,0
62046,of,0,0
62047,the,0,0
62048,response,0,0
62049,to,0,0
62050,tamoxifen,0,0
62051,in,0,0
62052,premenopausal,1,1
62053,women,1,1
62054,with,1,1
62055,breast,1,1
62056,cancer,1,1
62057,.,1,1
62058,MATERIALS/METHODS,0,0
62059,Clinically,0,0
62060,established,0,0
62061,pathological,0,1
62062,parameters,0,0
62063,were,0,1
62064,assessed,0,0
62065,and,0,0
62066,related,0,0
62067,to,0,0
62068,the,0,0
62069,tamoxifen,0,0
62070,response,0,0
62071,in,0,0
62072,500,1,0
62073,available,1,0
62074,tumour,1,1
62075,specimens,1,1
62076,from,1,1
62077,564,1,1
62078,premenopausal,1,1
62079,patients,1,1
62080,with,1,1
62081,breast,1,1
62082,cancer,1,1
62083,randomised,0,0
62084,to,0,0
62085,either,0,0
62086,two,0,0
62087,years,0,1
62088,of,0,0
62089,tamoxifen,0,1
62090,or,0,0
62091,no,0,0
62092,treatment,0,0
62093,with,0,1
62094,14,0,1
62095,years,0,1
62096,of,0,0
62097,follow,0,0
62098,up,0,0
62099,.,0,0
62100,Proliferation,0,0
62101,was,0,0
62102,further,0,0
62103,evaluated,0,0
62104,by,0,0
62105,immunohistochemical,0,0
62106,Ki-67,0,0
62107,expression,0,0
62108,.,0,1
62109,RESULTS,0,0
62110,Oestrogen,0,0
62111,receptor,0,1
62112,positive,0,0
62113,ductal,0,1
62114,carcinomas,0,1
62115,responded,0,1
62116,as,0,0
62117,expected,0,0
62118,to,0,0
62119,tamoxifen,0,0
62120,",",0,0
62121,whereas,0,0
62122,the,0,0
62123,difference,0,0
62124,in,0,0
62125,recurrence,0,0
62126,free,0,0
62127,survival,0,0
62128,between,0,0
62129,control,0,0
62130,and,0,0
62131,tamoxifen,0,0
62132,treated,0,1
62133,patients,0,1
62134,was,0,0
62135,less,0,0
62136,apparent,0,0
62137,in,0,0
62138,the,0,0
62139,relatively,0,0
62140,few,0,0
62141,lobular,0,1
62142,carcinomas,0,1
62143,.,0,0
62144,For,0,0
62145,histological,0,0
62146,grade,0,1
62147,",",0,0
62148,there,0,0
62149,was,0,0
62150,no,0,0
62151,obvious,0,0
62152,difference,0,0
62153,in,0,0
62154,treatment,0,0
62155,response,0,0
62156,between,0,0
62157,the,0,0
62158,groups,0,0
62159,.,0,0
62160,The,0,0
62161,relation,0,0
62162,between,0,0
62163,proliferation,0,0
62164,and,0,0
62165,tamoxifen,0,0
62166,response,0,0
62167,seemed,0,0
62168,to,0,0
62169,be,0,0
62170,more,0,0
62171,complex,0,0
62172,",",0,0
62173,with,0,1
62174,a,0,0
62175,clear,0,0
62176,response,0,0
62177,in,0,0
62178,tumours,0,1
62179,with,0,1
62180,high,0,1
62181,and,0,0
62182,low,0,0
62183,proliferation,0,0
62184,",",0,0
62185,whereas,0,0
62186,tumours,0,1
62187,with,0,1
62188,intermediate,0,0
62189,proliferation,0,0
62190,defined,0,0
62191,by,0,0
62192,Ki-67,0,0
62193,responded,0,0
62194,more,0,0
62195,poorly,0,0
62196,.,0,0
62197,CONCLUSIONS,0,0
62198,Clinically,0,0
62199,established,0,0
62200,pathology,0,1
62201,parameters,0,0
62202,seem,0,0
62203,to,0,0
62204,mirror,0,0
62205,the,0,0
62206,endocrine,0,1
62207,treatment,0,0
62208,response,0,0
62209,and,0,0
62210,could,0,0
62211,potentially,0,0
62212,be,0,0
62213,valuable,0,0
62214,in,0,0
62215,future,0,0
62216,treatment,0,0
62217,decisions,0,0
62218,for,0,0
62219,patients,1,1
62220,with,1,1
62221,breast,1,1
62222,cancer,1,1
62223,.,1,1
62224,Efficacy,0,0
62225,of,0,0
62226,nebulized,0,0
62227,flunisolide,0,0
62228,combined,0,0
62229,with,0,1
62230,salbutamol,0,0
62231,and,0,0
62232,ipratropium,0,0
62233,bromide,0,0
62234,in,0,0
62235,stable,1,1
62236,patients,1,1
62237,with,1,1
62238,moderate-to-severe,1,1
62239,chronic,1,1
62240,obstructive,1,1
62241,pulmonary,1,1
62242,disease,1,1
62243,.,1,0
62244,BACKGROUND,0,0
62245,The,0,0
62246,efficacy,0,0
62247,of,0,0
62248,nebulized,0,0
62249,corticosteroids,0,0
62250,in,0,0
62251,the,0,0
62252,prevention,0,0
62253,of,0,0
62254,exacerbation,0,1
62255,of,0,0
62256,chronic,1,1
62257,obstructive,1,1
62258,pulmonary,1,1
62259,disease,1,1
62260,(,1,0
62261,COPD,1,0
62262,),1,0
62263,has,0,0
62264,been,0,0
62265,poorly,0,0
62266,studied,0,0
62267,.,0,0
62268,OBJECTIVE,0,0
62269,To,0,0
62270,evaluate,0,0
62271,the,0,0
62272,efficacy,0,0
62273,and,0,0
62274,tolerability,0,0
62275,of,0,0
62276,nebulized,0,0
62277,flunisolide,0,0
62278,(,0,0
62279,1,0,0
62280,mg,0,0
62281,),0,0
62282,+,0,0
62283,salbutamol/ipratropium,0,0
62284,bromide,0,0
62285,(,0,0
62286,"1,875/375",0,0
62287,microg,0,0
62288,),0,0
62289,b.i.d,0,0
62290,.,0,0
62291,in,0,0
62292,comparison,0,0
62293,with,0,1
62294,placebo,0,0
62295,+,0,0
62296,salbutamol/ipratropium,0,0
62297,bromide,0,0
62298,.,0,0
62299,METHODS,0,0
62300,This,0,0
62301,was,0,0
62302,a,0,0
62303,randomized,0,0
62304,",",0,0
62305,parallel-group,0,0
62306,",",0,0
62307,double-blind,0,0
62308,study,0,0
62309,on,0,0
62310,114,1,1
62311,patients,1,1
62312,with,1,1
62313,COPD,1,1
62314,of,1,0
62315,moderate-to-severe,1,1
62316,degree,1,0
62317,.,1,0
62318,The,0,0
62319,main,0,0
62320,outcome,0,0
62321,was,0,0
62322,the,0,0
62323,frequency,0,0
62324,of,0,0
62325,severe,0,1
62326,exacerbations,0,1
62327,over,0,0
62328,a,0,0
62329,6-month,0,0
62330,period,0,0
62331,.,0,0
62332,Before,0,0
62333,and,0,0
62334,after,0,0
62335,treatment,0,0
62336,",",0,0
62337,respiratory,0,1
62338,symptoms,0,0
62339,",",0,0
62340,forced,0,1
62341,expiratory,0,0
62342,volume,0,0
62343,in,0,0
62344,1,0,0
62345,s,0,0
62346,(,0,0
62347,FEV,0,0
62348,(,0,1
62349,1,0,0
62350,),0,0
62351,),0,0
62352,",",0,0
62353,shuttle,0,0
62354,walking,0,0
62355,test,0,0
62356,distance,0,0
62357,and,0,0
62358,St.,0,1
62359,George,0,1
62360,'s,0,1
62361,Respiratory,0,1
62362,Questionnaire,0,1
62363,scores,0,0
62364,were,0,1
62365,evaluated,0,0
62366,.,0,0
62367,RESULTS,0,0
62368,The,0,0
62369,total,0,0
62370,number,0,0
62371,of,0,0
62372,exacerbations,0,1
62373,was,0,0
62374,slightly,0,0
62375,lower,0,0
62376,in,0,0
62377,the,0,0
62378,flunisolide,0,0
62379,group,0,0
62380,compared,0,0
62381,to,0,0
62382,the,0,0
62383,placebo,0,0
62384,group,0,0
62385,(,0,0
62386,19,0,1
62387,vs.,0,0
62388,34,0,1
62389,",",0,0
62390,p,0,0
62391,=,0,0
62392,0.054,0,0
62393,),0,1
62394,;,0,0
62395,the,0,0
62396,number,0,0
62397,of,0,0
62398,patients,0,1
62399,experiencing,0,0
62400,at,0,0
62401,least,0,1
62402,one,0,0
62403,exacerbation,0,1
62404,during,0,0
62405,the,0,0
62406,study,0,0
62407,was,0,0
62408,also,0,0
62409,decreased,0,0
62410,(,0,0
62411,16,0,1
62412,vs.,0,0
62413,26,0,1
62414,",",0,0
62415,p,0,0
62416,=,0,0
62417,0.059,0,0
62418,),0,0
62419,.,0,1
62420,In,0,0
62421,particular,0,0
62422,",",0,0
62423,type,0,1
62424,3,0,0
62425,Anthonisens,0,0
62426,'s,0,1
62427,exacerbations,0,1
62428,were,0,1
62429,significantly,0,0
62430,reduced,0,0
62431,by,0,0
62432,flunisolide,0,0
62433,(,0,0
62434,p,0,0
62435,=,0,0
62436,0.044,0,0
62437,),0,0
62438,.,0,0
62439,In,0,0
62440,the,0,0
62441,placebo,0,0
62442,group,0,0
62443,",",0,0
62444,scores,0,0
62445,were,0,0
62446,higher,0,0
62447,than,0,0
62448,in,0,0
62449,the,0,0
62450,flunisolide,0,0
62451,group,0,0
62452,but,0,0
62453,nonsignificant,0,0
62454,for,0,0
62455,dyspnea,0,0
62456,",",0,0
62457,cough,0,0
62458,",",0,0
62459,sputum,0,0
62460,amount,0,0
62461,and,0,0
62462,purulence,0,0
62463,.,0,0
62464,FEV,0,0
62465,(,0,0
62466,1,0,0
62467,),0,0
62468,was,0,0
62469,significantly,0,0
62470,increased,0,0
62471,compared,0,0
62472,to,0,0
62473,baseline,0,0
62474,in,0,0
62475,both,0,0
62476,groups,0,0
62477,",",0,0
62478,and,0,0
62479,the,0,0
62480,area,0,0
62481,under,0,0
62482,the,0,0
62483,FEV,0,0
62484,(,0,0
62485,1,0,0
62486,),0,0
62487,-time,0,0
62488,curve,0,0
62489,during,0,0
62490,the,0,0
62491,6-month,0,0
62492,period,0,0
62493,was,0,0
62494,significantly,0,0
62495,greater,0,0
62496,in,0,0
62497,the,0,0
62498,flunisolide,0,0
62499,group,0,0
62500,(,0,0
62501,5.2,0,0
62502,+/-,0,0
62503,10.6,0,0
62504,vs.,0,0
62505,2.1,0,0
62506,+/-,0,0
62507,5.0,0,0
62508,",",0,0
62509,flunisolide,0,0
62510,vs.,0,0
62511,placebo,0,0
62512,",",0,0
62513,respectively,0,0
62514,;,0,0
62515,p,0,0
62516,=,0,0
62517,0.047,0,0
62518,),0,0
62519,.,0,1
62520,For,0,0
62521,shuttle,0,0
62522,walking,0,0
62523,test,0,0
62524,distance,0,0
62525,and,0,0
62526,scores,0,0
62527,of,0,0
62528,the,0,0
62529,St.,0,1
62530,George,0,1
62531,'s,0,1
62532,Respiratory,0,1
62533,Questionnaire,0,0
62534,",",0,0
62535,no,0,0
62536,significant,0,0
62537,difference,0,0
62538,between,0,0
62539,the,0,0
62540,baseline,0,0
62541,evaluation,0,0
62542,and,0,0
62543,the,0,0
62544,end,0,0
62545,of,0,0
62546,the,0,0
62547,study,0,0
62548,was,0,0
62549,observed,0,0
62550,in,0,0
62551,both,0,0
62552,groups,0,0
62553,.,0,1
62554,CONCLUSIONS,0,0
62555,Nebulized,0,0
62556,flunisolide,0,0
62557,is,0,0
62558,a,0,0
62559,good,0,0
62560,alternative,0,0
62561,to,0,0
62562,other,0,0
62563,inhaled,0,0
62564,corticosteroids,0,0
62565,when,0,0
62566,added,0,0
62567,to,0,0
62568,nebulized,0,0
62569,salbutamol/ipratropium,0,0
62570,bromide,0,0
62571,in,0,0
62572,the,0,0
62573,long-term,0,0
62574,treatment,0,0
62575,of,0,0
62576,moderate-to-severe,1,1
62577,COPD,1,1
62578,patients,1,1
62579,.,1,1
62580,Comparative,0,0
62581,speed,0,0
62582,of,0,0
62583,kill,0,0
62584,of,0,0
62585,selamectin,0,0
62586,",",0,0
62587,imidacloprid,0,0
62588,",",0,0
62589,and,0,0
62590,fipronil-,0,0
62591,(,0,0
62592,S,0,0
62593,),0,0
62594,-methoprene,0,0
62595,spot-on,0,0
62596,formulations,0,0
62597,against,0,1
62598,fleas,1,1
62599,on,1,1
62600,cats,1,1
62601,.,1,1
62602,The,0,0
62603,speed,0,0
62604,of,0,0
62605,kill,0,0
62606,of,0,0
62607,selamectin,0,0
62608,",",0,0
62609,imidacloprid,0,0
62610,",",0,0
62611,and,0,0
62612,fipronil-,0,0
62613,(,0,0
62614,S,0,0
62615,),0,0
62616,-methoprene,0,0
62617,against,0,0
62618,Ctenocephalides,0,1
62619,felis,0,1
62620,infestations,0,1
62621,on,0,0
62622,cats,1,1
62623,for,0,1
62624,one,0,1
62625,month,0,0
62626,following,0,0
62627,a,0,0
62628,single,0,0
62629,treatment,0,0
62630,was,0,0
62631,evaluated,0,0
62632,.,0,1
62633,Eighty,1,1
62634,cats,1,1
62635,were,1,0
62636,randomly,1,1
62637,allocated,1,0
62638,so,0,0
62639,that,0,0
62640,there,0,0
62641,were,0,1
62642,20,0,0
62643,cats,0,1
62644,in,0,1
62645,four,0,1
62646,different,0,0
62647,treatment,0,1
62648,groups,0,0
62649,.,0,1
62650,On,0,0
62651,Days,0,1
62652,-2,0,1
62653,",",0,1
62654,7,0,0
62655,",",0,0
62656,14,0,0
62657,",",0,0
62658,21,0,1
62659,",",0,0
62660,and,0,0
62661,28,0,0
62662,",",0,0
62663,each,0,0
62664,cat,0,0
62665,was,0,0
62666,infested,0,1
62667,with,0,1
62668,100,0,0
62669,adult,0,1
62670,C.,0,0
62671,felis,0,1
62672,from,0,0
62673,the,0,0
62674,Kansas,1,1
62675,1,1,0
62676,flea,1,0
62677,strain,1,0
62678,.,1,0
62679,Following,0,0
62680,initial,0,0
62681,application,0,0
62682,only,0,0
62683,imidacloprid,0,0
62684,had,0,0
62685,caused,0,0
62686,a,0,0
62687,significant,0,0
62688,reduction,0,0
62689,in,0,0
62690,adult,0,1
62691,fleas,0,1
62692,on,0,0
62693,treated,0,1
62694,cats,0,1
62695,within,0,1
62696,6,0,0
62697,hours,0,0
62698,",",0,0
62699,but,0,0
62700,by,0,0
62701,24,0,1
62702,hours,0,0
62703,all,0,1
62704,three,0,0
62705,formulations,0,0
62706,had,0,1
62707,killed,0,0
62708,96.7,0,0
62709,%,0,0
62710,of,0,0
62711,the,0,0
62712,fleas,0,0
62713,.,0,1
62714,At,0,0
62715,7,0,0
62716,days,0,0
62717,post,0,1
62718,treatment,0,0
62719,",",0,0
62720,all,0,0
62721,three,0,0
62722,formulations,0,0
62723,reduced,0,0
62724,flea,0,1
62725,populations,0,1
62726,within,0,1
62727,6,0,0
62728,and,0,1
62729,24,0,1
62730,hours,0,0
62731,by,0,0
62732,68.4,0,0
62733,%,0,0
62734,and,0,0
62735,99.4,0,0
62736,%,0,0
62737,",",0,0
62738,respectively,0,0
62739,.,0,0
62740,At,0,0
62741,21,0,1
62742,and,0,1
62743,28,0,1
62744,days,0,0
62745,after,0,0
62746,treatment,0,0
62747,",",0,0
62748,none,0,0
62749,of,0,0
62750,the,0,0
62751,formulations,0,0
62752,killed,0,0
62753,significant,0,0
62754,numbers,0,0
62755,of,0,1
62756,fleas,0,1
62757,as,0,0
62758,compared,0,0
62759,to,0,0
62760,controls,0,1
62761,within,0,1
62762,6,0,0
62763,hours,0,0
62764,of,0,1
62765,infestation,0,1
62766,.,0,1
62767,At,0,0
62768,28,0,1
62769,days,0,0
62770,after,0,0
62771,treatment,0,0
62772,",",0,0
62773,selamectin,0,0
62774,",",0,0
62775,fipronil-,0,0
62776,(,0,0
62777,S,0,0
62778,),0,0
62779,-methoprene,0,0
62780,",",0,0
62781,and,0,0
62782,imidacloprid,0,0
62783,had,0,1
62784,killed,0,0
62785,99.0,0,0
62786,%,0,0
62787,",",0,0
62788,86.4,0,0
62789,%,0,0
62790,",",0,0
62791,and,0,0
62792,72.6,0,0
62793,%,0,0
62794,of,0,0
62795,the,0,0
62796,fleas,0,0
62797,within,0,1
62798,48,0,1
62799,hours,0,0
62800,of,0,0
62801,infestation,0,1
62802,",",0,0
62803,respectively,0,0
62804,.,0,0
62805,This,0,0
62806,study,0,0
62807,demonstrates,0,0
62808,that,0,0
62809,the,0,0
62810,speed,0,0
62811,of,0,0
62812,kill,0,0
62813,of,0,0
62814,residual,0,0
62815,flea,0,1
62816,products,0,0
62817,on,0,0
62818,cats,1,1
62819,decreases,0,0
62820,throughout,0,0
62821,the,0,0
62822,month,0,0
62823,following,0,0
62824,application,0,0
62825,.,0,0
62826,It,0,0
62827,also,0,0
62828,demonstrated,0,0
62829,that,0,0
62830,selamectin,0,0
62831,provided,0,0
62832,the,0,0
62833,highest,0,0
62834,level,0,0
62835,of,0,0
62836,residual,0,0
62837,activity,0,0
62838,on,0,0
62839,cats,1,1
62840,against,0,1
62841,the,0,0
62842,Kansas,0,1
62843,1,0,0
62844,flea,0,0
62845,strain,0,0
62846,.,0,1
62847,Divalproex,0,0
62848,sodium,0,0
62849,vs.,0,0
62850,placebo,0,0
62851,in,0,0
62852,the,0,0
62853,treatment,0,0
62854,of,0,0
62855,repetitive,0,0
62856,behaviours,0,0
62857,in,0,0
62858,autism,1,1
62859,spectrum,1,1
62860,disorder,1,1
62861,.,1,0
62862,Autism,0,0
62863,is,0,0
62864,a,0,0
62865,neurodevelopmental,0,0
62866,disorder,0,1
62867,characterized,0,0
62868,by,0,0
62869,impairment,0,1
62870,in,0,0
62871,three,0,0
62872,core,0,1
62873,symptom,0,1
62874,domains,0,0
62875,:,0,1
62876,socialization,0,0
62877,",",0,0
62878,communication,0,0
62879,",",0,0
62880,and,0,0
62881,repetitive/stereotyped,0,1
62882,behaviours,0,0
62883,.,0,1
62884,Other,0,0
62885,associated,0,0
62886,symptom,0,1
62887,domains,0,0
62888,are,0,0
62889,also,0,0
62890,affected,0,0
62891,including,0,0
62892,impulsivity/aggression,0,0
62893,",",0,0
62894,self-injury,0,0
62895,",",0,0
62896,anxiety,0,0
62897,",",0,0
62898,and,0,0
62899,mood,0,0
62900,lability,0,0
62901,.,0,0
62902,Divalproex,0,0
62903,has,0,0
62904,been,0,0
62905,shown,0,0
62906,to,0,0
62907,have,0,0
62908,efficacy,0,0
62909,in,0,0
62910,treating,0,0
62911,epilepsy,0,1
62912,",",0,0
62913,bipolar,0,0
62914,disorder,0,1
62915,",",0,0
62916,mood,0,0
62917,lability,0,0
62918,",",0,0
62919,and,0,0
62920,impulsive,0,0
62921,aggression,0,1
62922,.,0,0
62923,The,0,0
62924,present,0,0
62925,study,0,0
62926,evaluated,0,0
62927,the,0,0
62928,use,0,0
62929,of,0,0
62930,divalproex,0,0
62931,in,0,0
62932,the,0,0
62933,treatment,0,0
62934,of,0,0
62935,repetitive,0,0
62936,",",0,0
62937,compulsive-like,1,1
62938,symptoms,1,0
62939,of,1,0
62940,autism,1,1
62941,spectrum,1,1
62942,disorder,1,1
62943,(,1,0
62944,ASD,1,1
62945,),1,1
62946,.,1,1
62947,Thirteen,1,1
62948,individuals,1,1
62949,with,1,1
62950,ASD,1,1
62951,participated,0,1
62952,in,0,0
62953,an,0,0
62954,8-wk,0,0
62955,",",0,0
62956,double-blind,0,0
62957,",",0,0
62958,placebo-controlled,0,0
62959,trial,0,0
62960,of,0,0
62961,divalproex,0,0
62962,sodium,0,0
62963,vs.,0,0
62964,placebo,0,0
62965,.,0,0
62966,There,0,0
62967,was,0,0
62968,a,0,0
62969,significant,0,0
62970,group,0,0
62971,difference,0,0
62972,on,0,0
62973,improvement,0,0
62974,in,0,0
62975,repetitive,0,0
62976,behaviours,0,0
62977,as,0,0
62978,measured,0,0
62979,by,0,0
62980,the,0,0
62981,Children,0,1
62982,'s,0,1
62983,Yale-Brown,0,0
62984,Obsessive,0,1
62985,Compulsive,0,1
62986,Scale,0,0
62987,(,0,0
62988,C-YBOCS,0,0
62989,),0,0
62990,(,0,0
62991,p=0.037,0,0
62992,),0,0
62993,and,0,0
62994,a,0,0
62995,large,0,1
62996,effect,0,0
62997,size,0,0
62998,(,0,0
62999,d=1.616,0,0
63000,),0,0
63001,.,0,0
63002,This,0,0
63003,study,0,0
63004,provides,0,0
63005,preliminary,0,0
63006,support,0,0
63007,for,0,0
63008,the,0,0
63009,use,0,0
63010,of,0,0
63011,divalproex,0,0
63012,in,0,0
63013,treating,0,0
63014,repetitive,0,0
63015,behaviours,0,0
63016,in,0,1
63017,ASD,1,1
63018,.,1,1
63019,Further,0,0
63020,research,0,0
63021,is,0,0
63022,needed,0,0
63023,to,0,0
63024,evaluate,0,0
63025,the,0,0
63026,specificity,0,0
63027,and,0,0
63028,mechanism,0,0
63029,of,0,0
63030,action,0,0
63031,of,0,0
63032,these,0,0
63033,findings,0,0
63034,.,0,1
63035,Phytase,0,0
63036,and,0,0
63037,1alpha-hydroxycholecalciferol,0,0
63038,supplementation,0,0
63039,of,0,0
63040,broiler,1,1
63041,chickens,1,1
63042,during,1,0
63043,the,1,0
63044,starting,1,0
63045,and,1,0
63046,growing/finishing,1,1
63047,phases,1,0
63048,.,1,1
63049,Supplemental,0,0
63050,1alpha-hydroxycholecalciferol,0,0
63051,(,0,1
63052,1alpha-OHD3,0,0
63053,),0,0
63054,has,0,0
63055,been,0,0
63056,shown,0,0
63057,to,0,0
63058,have,0,0
63059,qualitatively,0,0
63060,similar,0,0
63061,and,0,0
63062,quantitatively,0,0
63063,additive,0,0
63064,effects,0,0
63065,to,0,1
63066,exogenous,0,0
63067,phytase,0,0
63068,.,0,1
63069,Two,0,0
63070,experiments,0,0
63071,were,0,1
63072,conducted,0,1
63073,from,0,1
63074,0,0,0
63075,to,0,0
63076,35,0,1
63077,d,0,0
63078,in,0,0
63079,floor,0,1
63080,pens,0,0
63081,to,0,0
63082,determine,0,0
63083,the,0,0
63084,additive,0,0
63085,effect,0,0
63086,of,0,0
63087,phytase,0,0
63088,and,0,0
63089,1alpha-OHD3,0,0
63090,when,0,0
63091,supplemented,0,0
63092,to,0,0
63093,Ca-,0,1
63094,and,0,0
63095,P-deficient,0,1
63096,diets,0,0
63097,.,0,1
63098,In,0,0
63099,both,0,0
63100,experiments,0,0
63101,",",0,0
63102,at,1,0
63103,least,1,1
63104,4,1,0
63105,replicates,1,0
63106,per,1,0
63107,treatment,1,0
63108,(,1,1
63109,50,1,1
63110,chicks,1,1
63111,per,1,1
63112,replicate,1,1
63113,),1,0
63114,were,1,0
63115,used,1,0
63116,.,1,1
63117,Corn-soybean-meal-and,1,0
63118,soybean-oil-based,1,0
63119,diets,1,0
63120,were,1,1
63121,fed,1,0
63122,and,1,0
63123,birds,1,1
63124,were,1,0
63125,raised,1,0
63126,in,1,0
63127,a,1,0
63128,house,1,1
63129,impervious,1,0
63130,to,1,0
63131,ultraviolet,1,0
63132,light,1,0
63133,.,1,0
63134,During,0,0
63135,the,0,0
63136,starter,0,0
63137,phase,0,0
63138,(,0,0
63139,ST,0,1
63140,),0,0
63141,",",0,0
63142,from,0,0
63143,0,0,0
63144,to,0,0
63145,18,0,1
63146,d,0,0
63147,",",0,0
63148,chicks,0,0
63149,were,0,0
63150,fed,0,0
63151,a,0,0
63152,23,0,0
63153,%,0,0
63154,CP,0,0
63155,diet,0,1
63156,containing,0,0
63157,0.60,0,0
63158,%,0,0
63159,Ca,0,1
63160,and,0,0
63161,0.47,0,0
63162,%,0,0
63163,total,0,1
63164,P,0,0
63165,(,0,0
63166,tP,0,0
63167,),0,0
63168,.,0,0
63169,During,0,0
63170,the,0,0
63171,grower/finisher,0,0
63172,phase,0,0
63173,(,0,0
63174,GF,0,0
63175,),0,0
63176,",",0,0
63177,from,0,0
63178,19,0,1
63179,to,0,0
63180,35,0,1
63181,d,0,0
63182,",",0,0
63183,birds,0,1
63184,were,0,0
63185,fed,0,0
63186,a,0,0
63187,19,0,1
63188,%,0,0
63189,CP,0,0
63190,diet,0,1
63191,containing,0,0
63192,0.30,0,0
63193,%,0,0
63194,Ca,0,1
63195,and,0,0
63196,0.37,0,0
63197,%,0,0
63198,tP,0,0
63199,.,0,0
63200,A,0,0
63201,combination,0,0
63202,of,0,0
63203,"1,000",0,0
63204,phytase,0,0
63205,units/kg,0,0
63206,of,0,0
63207,Natuphos,0,0
63208,phytase,0,0
63209,and,0,0
63210,5,0,0
63211,microg/kg,0,0
63212,of,0,0
63213,1alpha-OHD3,0,0
63214,(,0,1
63215,P+1A,0,0
63216,),0,0
63217,was,0,0
63218,supplemented,0,0
63219,to,0,0
63220,some,0,0
63221,of,0,0
63222,the,0,0
63223,feed,0,0
63224,during,0,0
63225,the,0,0
63226,ST,0,1
63227,and,0,0
63228,GF,0,0
63229,.,0,1
63230,Diets,0,0
63231,containing,0,0
63232,adequate,0,0
63233,Ca,0,1
63234,and,0,0
63235,P,0,0
63236,were,0,0
63237,also,0,0
63238,fed,0,0
63239,during,0,0
63240,the,0,0
63241,ST,0,1
63242,(,0,0
63243,0.90,0,0
63244,%,0,0
63245,Ca,0,1
63246,",",0,0
63247,0.68,0,0
63248,%,0,0
63249,tP,0,0
63250,),0,0
63251,and,0,0
63252,GF,0,0
63253,(,0,0
63254,0.80,0,0
63255,%,0,0
63256,Ca,0,1
63257,",",0,0
63258,0.67,0,0
63259,%,0,0
63260,tP,0,0
63261,),0,0
63262,.,0,0
63263,Performance,0,0
63264,characteristics,0,0
63265,and,0,0
63266,the,0,0
63267,incidence,0,0
63268,of,0,0
63269,rickets,0,1
63270,and,0,1
63271,tibial,0,1
63272,dyschondroplasia,0,1
63273,were,0,0
63274,measured,0,0
63275,at,0,0
63276,18,0,1
63277,and,0,0
63278,35,0,1
63279,d.,0,1
63280,In,0,0
63281,experiment,0,0
63282,1,0,0
63283,",",0,0
63284,unsupplemented,0,0
63285,chicks,0,0
63286,performed,0,0
63287,well,0,0
63288,but,0,0
63289,had,0,0
63290,considerable,0,0
63291,leg,0,1
63292,problems,0,1
63293,.,0,1
63294,Chicks,0,1
63295,fed,0,0
63296,P+1A,0,0
63297,during,0,0
63298,the,0,0
63299,ST,0,1
63300,or,0,1
63301,GF,0,0
63302,did,0,0
63303,not,0,0
63304,perform,0,0
63305,as,0,0
63306,well,0,0
63307,as,0,0
63308,birds,0,1
63309,fed,0,1
63310,P+1A,0,0
63311,throughout,0,0
63312,.,0,1
63313,Birds,0,0
63314,fed,0,0
63315,P+1A,0,0
63316,throughout,0,0
63317,performed,0,0
63318,as,0,0
63319,well,0,0
63320,birds,0,1
63321,fed,0,0
63322,the,0,0
63323,adequate,0,0
63324,diets,0,0
63325,without,0,1
63326,any,0,0
63327,indication,0,0
63328,of,0,0
63329,leg,0,0
63330,problems,0,1
63331,.,0,1
63332,In,0,0
63333,experiment,0,0
63334,2,0,0
63335,",",0,0
63336,unsupplemented,0,0
63337,birds,0,1
63338,performed,0,0
63339,similarly,0,0
63340,to,0,0
63341,unsupplemented,0,0
63342,birds,1,1
63343,in,1,1
63344,experiment,1,1
63345,1,1,0
63346,.,1,0
63347,However,0,0
63348,",",0,0
63349,chicks,0,0
63350,fed,0,0
63351,the,0,0
63352,supplements,0,0
63353,or,0,1
63354,the,0,0
63355,control,0,0
63356,diets,0,0
63357,did,0,0
63358,not,0,0
63359,perform,0,0
63360,as,0,0
63361,well,0,0
63362,or,0,0
63363,accumulate,0,0
63364,as,0,0
63365,much,0,0
63366,bone,0,0
63367,ash,0,1
63368,as,0,0
63369,birds,1,1
63370,in,1,1
63371,experiment,1,0
63372,1,1,0
63373,",",0,0
63374,although,0,0
63375,the,0,0
63376,diets,0,0
63377,were,0,0
63378,formulated,0,0
63379,identically,0,0
63380,in,0,0
63381,both,0,0
63382,experiments,0,0
63383,.,0,1
63384,Diets,0,0
63385,with,0,1
63386,as,0,0
63387,little,0,0
63388,as,0,0
63389,0.30,0,0
63390,%,0,0
63391,Ca,0,1
63392,and,0,0
63393,0.37,0,0
63394,%,0,0
63395,tP,0,0
63396,appear,0,0
63397,to,0,0
63398,be,0,0
63399,adequate,0,0
63400,for,0,0
63401,broilers,0,0
63402,older,0,1
63403,than,0,0
63404,18,0,1
63405,d,0,1
63406,if,0,0
63407,supplemented,0,0
63408,with,0,1
63409,the,0,0
63410,correct,0,0
63411,amounts,0,0
63412,of,0,0
63413,phytase,0,0
63414,and,0,0
63415,1alpha-OHD3,0,0
63416,.,0,0
63417,However,0,0
63418,",",0,0
63419,there,0,0
63420,are,0,0
63421,unknown,0,0
63422,variables,0,0
63423,that,0,0
63424,may,0,0
63425,limit,0,0
63426,the,0,0
63427,potential,0,0
63428,of,0,0
63429,broilers,0,0
63430,in,0,1
63431,terms,0,0
63432,of,0,0
63433,bone,0,0
63434,mineralization,0,0
63435,and,0,0
63436,bone,0,0
63437,pathology,0,1
63438,",",0,0
63439,even,0,0
63440,when,0,0
63441,adequate,0,0
63442,diets,0,0
63443,are,0,0
63444,fed,0,0
63445,.,0,1
63446,Albendazole,0,0
63447,trial,0,1
63448,at,0,0
63449,15,0,1
63450,or,0,1
63451,30,0,1
63452,mg/kg/day,0,0
63453,for,0,0
63454,subarachnoid,1,1
63455,and,1,0
63456,intraventricular,1,1
63457,cysticercosis,1,1
63458,.,1,1
63459,Thirty-six,1,1
63460,patients,1,1
63461,with,1,1
63462,subarachnoid,1,1
63463,and,1,0
63464,intraventricular,1,1
63465,cysticercosis,1,1
63466,were,0,0
63467,randomly,0,1
63468,assigned,0,0
63469,to,0,0
63470,receive,0,0
63471,albendazole,0,0
63472,at,0,0
63473,15,0,1
63474,or,0,1
63475,30,0,1
63476,mg/kg/day,0,0
63477,plus,0,0
63478,dexamethasone,0,0
63479,for,0,0
63480,8,0,0
63481,days,0,0
63482,.,0,1
63483,Results,0,0
63484,favored,0,0
63485,a,0,0
63486,higher,0,0
63487,dose,0,0
63488,",",0,0
63489,with,0,0
63490,larger,0,0
63491,cyst,0,1
63492,reduction,0,0
63493,on,0,0
63494,MRI,0,0
63495,at,0,0
63496,90,0,1
63497,and,0,1
63498,180,0,1
63499,days,0,0
63500,and,0,1
63501,higher,0,0
63502,albendazole,0,0
63503,sulfoxide,0,0
63504,levels,0,0
63505,in,0,0
63506,plasma,0,0
63507,.,0,0
63508,An,0,0
63509,albendazole,0,0
63510,course,0,0
63511,at,0,0
63512,30,0,1
63513,mg/kg/day,0,0
63514,combined,0,0
63515,with,0,1
63516,corticosteroids,0,0
63517,is,0,0
63518,safe,0,0
63519,and,0,0
63520,more,0,0
63521,effective,0,0
63522,than,0,0
63523,the,0,0
63524,usual,0,1
63525,dose,0,0
63526,.,0,0
63527,A,0,0
63528,single,0,0
63529,treatment,0,0
63530,was,0,0
63531,insufficient,0,0
63532,in,0,0
63533,intraventricular,0,1
63534,and,0,1
63535,giant,0,1
63536,cysts,0,1
63537,.,0,1
63538,The,0,0
63539,impact,0,0
63540,of,0,0
63541,emotional,0,0
63542,distress,0,1
63543,on,0,0
63544,HIV,1,1
63545,risk,1,0
63546,reduction,1,0
63547,among,1,1
63548,women,1,1
63549,.,1,1
63550,This,0,0
63551,study,0,0
63552,evaluated,0,0
63553,whether,0,0
63554,333,1,1
63555,seronegative,1,1
63556,African,1,1
63557,American,1,1
63558,female,1,1
63559,drug,1,0
63560,users,1,1
63561,(,1,1
63562,aged,1,1
63563,18-59,1,1
63564,years,1,1
63565,),1,1
63566,participating,1,1
63567,in,1,0
63568,an,1,0
63569,HIV,1,0
63570,intervention,1,0
63571,and,1,0
63572,with,1,1
63573,higher,1,0
63574,levels,1,0
63575,of,1,0
63576,emotional,1,0
63577,distress,1,0
63578,",",1,0
63579,specifically,1,0
63580,symptoms,1,0
63581,of,1,0
63582,depression,1,1
63583,and,1,0
63584,anxiety,1,0
63585,",",0,0
63586,reduced,0,0
63587,HIV,0,1
63588,risk,0,1
63589,behaviors,0,0
63590,to,0,0
63591,a,0,0
63592,lesser,0,0
63593,extent,0,0
63594,than,0,0
63595,those,0,0
63596,with,0,1
63597,lower,0,0
63598,levels,0,0
63599,of,0,0
63600,emotional,0,0
63601,distress,0,1
63602,.,0,1
63603,Participants,1,1
63604,were,0,0
63605,recruited,1,1
63606,between,1,0
63607,June,1,1
63608,1998,1,1
63609,and,1,0
63610,January,1,1
63611,2001,1,1
63612,from,1,1
63613,inner-city,1,1
63614,Atlanta,1,1
63615,(,1,0
63616,Georgia,1,1
63617,",",1,0
63618,U.S.,1,0
63619,),1,0
63620,neighborhoods,1,1
63621,and,0,0
63622,were,0,0
63623,randomly,1,1
63624,assigned,1,1
63625,to,1,0
63626,one,1,1
63627,of,1,0
63628,two,1,0
63629,enhanced,1,0
63630,gender-specific,1,0
63631,and,1,0
63632,culturally,1,1
63633,specific,1,0
63634,HIV,1,1
63635,intervention,1,0
63636,conditions,1,0
63637,or,0,1
63638,to,0,0
63639,the,0,0
63640,NIDA,0,0
63641,standard,0,0
63642,condition,0,0
63643,.,0,1
63644,Participants,0,1
63645,were,0,0
63646,interviewed,0,1
63647,at,0,0
63648,baseline,0,0
63649,",",0,0
63650,post-intervention,0,0
63651,and,0,0
63652,at,0,0
63653,6-month,0,0
63654,follow-up,0,0
63655,with,0,1
63656,a,0,0
63657,structured,0,0
63658,questionnaire,0,0
63659,including,0,0
63660,information,0,0
63661,on,0,0
63662,sociodemographics,0,0
63663,",",0,0
63664,sexual,0,1
63665,and,0,0
63666,drug-using,0,1
63667,behavior,0,0
63668,",",0,0
63669,and,0,0
63670,psychosocial,0,1
63671,characteristics,0,0
63672,.,0,1
63673,Despite,0,0
63674,a,0,0
63675,significant,0,0
63676,decline,0,0
63677,in,0,0
63678,symptoms,0,0
63679,of,0,0
63680,emotional,0,0
63681,distress,0,1
63682,during,0,0
63683,the,0,0
63684,study,0,0
63685,period,0,0
63686,",",0,0
63687,the,0,0
63688,women,0,1
63689,in,0,0
63690,this,0,0
63691,sample,0,1
63692,reported,0,0
63693,high,0,1
63694,levels,0,0
63695,of,0,0
63696,depressive,0,0
63697,and,0,0
63698,anxiety,0,0
63699,symptoms,0,0
63700,at,0,0
63701,baseline,0,0
63702,and,0,0
63703,6-month,0,0
63704,follow-up,0,0
63705,.,0,1
63706,Higher,0,0
63707,levels,0,0
63708,of,0,0
63709,emotional,0,0
63710,distress,0,1
63711,were,0,0
63712,positively,0,0
63713,associated,0,0
63714,with,0,1
63715,post-intervention,0,0
63716,sexual,0,1
63717,and,0,0
63718,drug-taking,0,1
63719,risk,0,1
63720,.,0,1
63721,Women,0,1
63722,in,0,0
63723,both,0,0
63724,enhanced,0,0
63725,intervention,0,0
63726,conditions,0,0
63727,reduced,0,0
63728,their,0,1
63729,sexual,0,1
63730,and,0,0
63731,drug-taking,0,0
63732,risks,0,0
63733,more,0,0
63734,than,0,0
63735,women,0,1
63736,in,0,0
63737,the,0,0
63738,standard,0,0
63739,intervention,0,0
63740,.,0,0
63741,Those,0,0
63742,in,0,0
63743,the,0,0
63744,motivation,0,0
63745,intervention,0,0
63746,arm,0,0
63747,experienced,0,0
63748,a,0,0
63749,greater,0,0
63750,reduction,0,0
63751,in,0,0
63752,depressive,0,0
63753,symptoms,0,0
63754,",",0,0
63755,accompanied,0,0
63756,by,0,0
63757,a,0,0
63758,greater,0,0
63759,reduction,0,0
63760,in,0,0
63761,sexual,0,0
63762,risk,0,1
63763,behavior,0,0
63764,.,0,1
63765,Findings,0,0
63766,suggest,0,0
63767,the,0,0
63768,need,0,0
63769,for,0,0
63770,effective,0,0
63771,interventions,0,0
63772,and,0,1
63773,mental,0,1
63774,health,0,1
63775,resources,0,0
63776,among,0,1
63777,subgroups,0,0
63778,of,0,1
63779,high-risk,1,1
63780,women,1,1
63781,who,1,1
63782,may,1,0
63783,be,1,0
63784,most,1,0
63785,resistant,1,0
63786,to,1,0
63787,behavioral,1,0
63788,change,1,0
63789,.,1,1
63790,Similar,0,0
63791,compliance,0,0
63792,and,0,0
63793,effect,0,0
63794,of,0,0
63795,treatment,0,0
63796,in,0,0
63797,chronic,1,1
63798,hepatitis,1,1
63799,C,1,0
63800,resulting,1,0
63801,from,1,0
63802,intravenous,1,0
63803,drug,1,0
63804,use,1,0
63805,in,0,0
63806,comparison,0,0
63807,with,0,1
63808,other,0,0
63809,infection,0,1
63810,causes,0,0
63811,.,0,1
63812,OBJECTIVES,0,0
63813,There,0,0
63814,is,0,0
63815,some,0,0
63816,reluctance,0,0
63817,to,0,0
63818,treat,0,0
63819,intravenous,1,0
63820,drug,1,0
63821,users,1,1
63822,(,1,1
63823,IVDUs,1,0
63824,),1,0
63825,with,1,1
63826,chronic,1,1
63827,hepatitis,1,1
63828,C,1,0
63829,(,1,0
63830,CHC,1,0
63831,),1,0
63832,because,0,0
63833,of,0,0
63834,presumed,0,1
63835,lower,0,0
63836,compliance,0,0
63837,and,0,0
63838,response,0,0
63839,to,0,0
63840,antiviral,0,0
63841,therapy,0,0
63842,.,0,1
63843,We,0,0
63844,intended,0,0
63845,to,0,0
63846,evaluate,0,0
63847,the,0,0
63848,compliance,0,0
63849,and,0,0
63850,response,0,0
63851,to,0,0
63852,antiviral,0,0
63853,treatment,0,0
63854,for,0,0
63855,CHC,0,0
63856,in,0,0
63857,IVDUs,0,0
63858,compared,0,0
63859,with,0,1
63860,non-IVDUs,0,1
63861,.,0,0
63862,METHODS,0,0
63863,A,0,0
63864,retrospective,0,0
63865,cohort,0,1
63866,study,0,1
63867,--,0,1
63868,secondary,0,0
63869,analysis,0,0
63870,of,0,0
63871,the,0,0
63872,results,0,0
63873,of,0,0
63874,a,0,0
63875,treatment,1,0
63876,trial,1,0
63877,--,1,1
63878,was,1,0
63879,performed,1,0
63880,in,1,0
63881,Belgium,1,1
63882,and,1,0
63883,The,1,0
63884,Netherlands,1,1
63885,.,1,0
63886,A,1,0
63887,total,1,1
63888,of,1,0
63889,406,1,1
63890,previously,1,1
63891,untreated,1,1
63892,CHC,1,0
63893,patients,1,1
63894,",",1,0
63895,including,1,0
63896,98,1,1
63897,(,1,1
63898,24,1,0
63899,%,1,0
63900,),1,0
63901,IVDUs,1,0
63902,",",0,0
63903,were,0,0
63904,studied,0,0
63905,for,0,0
63906,compliance,0,0
63907,(,0,0
63908,presentation,0,0
63909,at,0,0
63910,the,0,0
63911,end,0,0
63912,of,0,0
63913,treatment,0,0
63914,),0,0
63915,",",0,0
63916,complete,0,0
63917,response,0,0
63918,(,0,0
63919,alanine,0,0
63920,aminotransferase,0,0
63921,within,0,0
63922,normal,0,1
63923,limits,0,0
63924,and,0,0
63925,serum,0,0
63926,hepatitis,0,1
63927,C,0,0
63928,virus,0,1
63929,polymerase,0,0
63930,chain,0,0
63931,reaction,0,0
63932,negative,0,0
63933,),0,0
63934,at,0,0
63935,the,0,0
63936,end,0,0
63937,of,0,0
63938,therapy,0,0
63939,and,0,0
63940,sustained,0,0
63941,virological,0,0
63942,response,0,0
63943,(,0,0
63944,SVR,0,0
63945,),0,1
63946,.,0,1
63947,RESULTS,0,0
63948,Non-compliance,0,0
63949,(,0,1
63950,8.2,0,0
63951,%,0,0
63952,),0,0
63953,in,0,0
63954,IVDUs,0,0
63955,was,0,0
63956,not,0,0
63957,different,0,0
63958,from,0,0
63959,non-IVDUs,0,1
63960,(,0,1
63961,6.8,0,0
63962,%,0,0
63963,),0,0
63964,(,0,0
63965,relative,0,0
63966,risk=1.20,0,0
63967,;,0,0
63968,95,0,0
63969,%,0,0
63970,confidence,0,0
63971,interval=0.55-2.62,0,0
63972,),0,0
63973,.,0,0
63974,Complete,0,0
63975,response,0,0
63976,after,0,0
63977,controlling,0,0
63978,for,0,0
63979,hepatitis,0,1
63980,C,0,0
63981,virus,0,1
63982,was,0,0
63983,similar,0,0
63984,(,0,0
63985,relative,0,0
63986,risk=1.19,0,0
63987,;,0,0
63988,95,0,0
63989,%,0,0
63990,confidence,0,0
63991,interval=0.89-1.60,0,0
63992,),0,0
63993,.,0,0
63994,Controlling,0,0
63995,for,0,0
63996,treatment,0,0
63997,arm,0,0
63998,",",0,0
63999,age,0,1
64000,",",0,0
64001,sex,0,0
64002,",",0,0
64003,presence,0,0
64004,of,0,0
64005,cirrhosis,0,1
64006,or,0,1
64007,hepatitis,0,1
64008,C,0,0
64009,virus,0,1
64010,viral,0,0
64011,load,0,0
64012,before,0,0
64013,treatment,0,0
64014,did,0,0
64015,not,0,0
64016,change,0,0
64017,these,0,0
64018,results,0,0
64019,.,0,0
64020,There,0,0
64021,was,0,0
64022,a,0,0
64023,marginally,0,0
64024,significant,0,0
64025,difference,0,0
64026,in,0,0
64027,the,0,0
64028,sustained,0,0
64029,virological,0,0
64030,response,0,0
64031,between,0,0
64032,IVDUs,0,0
64033,(,0,1
64034,46.6,0,1
64035,%,0,0
64036,),0,0
64037,and,0,0
64038,non-IVDUs,0,1
64039,(,0,0
64040,34.6,0,0
64041,%,0,0
64042,),0,0
64043,(,0,0
64044,relative,0,0
64045,risk=1.35,0,0
64046,;,0,0
64047,95,0,0
64048,%,0,0
64049,confidence,0,0
64050,interval=1.00-1.81,0,0
64051,),0,0
64052,",",0,0
64053,also,0,0
64054,disappearing,0,0
64055,after,0,0
64056,adjusting,0,0
64057,for,0,0
64058,genotype,0,0
64059,.,0,0
64060,No,0,0
64061,difference,0,0
64062,in,0,0
64063,compliance,0,0
64064,or,0,1
64065,sustained,0,0
64066,virological,0,0
64067,response,0,0
64068,was,0,0
64069,found,0,0
64070,between,0,0
64071,active,0,1
64072,and,0,1
64073,non-active,0,1
64074,IVDUs,0,0
64075,or,0,1
64076,between,0,0
64077,IVDU,0,1
64078,patients,0,1
64079,in,0,0
64080,or,0,1
64081,without,0,1
64082,a,0,0
64083,methadone,0,0
64084,maintenance,0,0
64085,program,0,0
64086,.,0,0
64087,CONCLUSIONS,0,0
64088,In,0,0
64089,this,0,0
64090,group,0,0
64091,of,0,0
64092,Benelux,1,0
64093,patients,1,1
64094,",",0,0
64095,IVDUs,0,0
64096,showed,0,0
64097,similar,0,0
64098,compliance,0,0
64099,and,0,0
64100,response,0,0
64101,to,0,0
64102,treatment,0,0
64103,with,0,1
64104,interferon,0,0
64105,and,0,0
64106,ribavirin,0,0
64107,compared,0,0
64108,with,0,1
64109,other,0,0
64110,patients,0,1
64111,with,0,1
64112,CHC,0,0
64113,infection,0,1
64114,.,0,0
64115,Therefore,0,0
64116,",",0,0
64117,it,0,0
64118,is,0,0
64119,no,0,0
64120,longer,0,0
64121,justifiable,0,0
64122,to,0,0
64123,withhold,0,0
64124,treatment,0,0
64125,to,0,0
64126,chronic,1,1
64127,hepatitis,1,1
64128,C,1,1
64129,patients,1,1
64130,who,1,1
64131,use,1,1
64132,intravenous,1,1
64133,drugs,1,0
64134,.,1,1
64135,Perceptual,0,0
64136,wind-up,0,0
64137,in,0,0
64138,the,0,0
64139,human,1,0
64140,oesophagus,1,1
64141,is,0,0
64142,enhanced,0,0
64143,by,0,0
64144,central,0,1
64145,sensitisation,0,1
64146,.,0,1
64147,BACKGROUND,0,0
64148,Oesophageal,0,1
64149,acid,0,0
64150,infusion,0,0
64151,induces,0,0
64152,enhanced,0,0
64153,pain,0,1
64154,hypersensitivity,0,0
64155,in,0,0
64156,non-acid,0,1
64157,exposed,0,1
64158,upper,0,1
64159,oesophagus,0,1
64160,(,0,0
64161,secondary,0,0
64162,hyperalgesia,0,0
64163,),0,0
64164,in,0,0
64165,patients,0,1
64166,with,0,1
64167,non-cardiac,0,1
64168,chest,0,0
64169,pain,0,0
64170,",",0,0
64171,thus,0,0
64172,suggesting,0,0
64173,central,0,0
64174,sensitisation,0,1
64175,contributes,0,0
64176,to,0,0
64177,visceral,0,1
64178,pain,0,0
64179,hypersensitivity,0,0
64180,in,0,0
64181,functional,0,1
64182,gut,0,1
64183,disorders,0,1
64184,(,0,1
64185,FGD,0,1
64186,),0,1
64187,.,0,1
64188,Perceptual,0,0
64189,wind-up,0,0
64190,(,0,0
64191,increased,0,0
64192,pain,0,1
64193,perception,0,0
64194,to,0,0
64195,constant,0,0
64196,intensity,0,0
64197,sensory,0,0
64198,stimuli,0,0
64199,at,0,0
64200,frequencies,0,0
64201,>,0,1
64202,or=0.3,0,0
64203,Hz,0,0
64204,),0,0
64205,is,0,0
64206,used,0,0
64207,as,0,0
64208,a,0,0
64209,proxy,0,0
64210,for,0,0
64211,central,0,0
64212,sensitisation,0,0
64213,to,0,0
64214,investigate,0,0
64215,pain,0,1
64216,syndromes,0,0
64217,where,0,0
64218,pain,0,0
64219,hypersensitivity,0,0
64220,is,0,0
64221,important,0,0
64222,(,0,0
64223,for,0,0
64224,example,0,0
64225,",",0,0
64226,fibromyalgia,0,1
64227,),0,0
64228,.,0,0
64229,AIMS,0,0
64230,Wind-up,0,0
64231,in,0,0
64232,central,0,1
64233,sensitisation,0,0
64234,induced,0,0
64235,human,0,1
64236,visceral,0,1
64237,pain,0,0
64238,hypersensitivity,0,0
64239,has,0,0
64240,not,0,0
64241,been,0,0
64242,explored,0,0
64243,.,0,0
64244,We,0,0
64245,hypothesised,0,0
64246,that,0,0
64247,if,0,0
64248,wind-up,0,0
64249,is,0,0
64250,a,0,0
64251,proxy,0,0
64252,for,0,0
64253,central,0,0
64254,sensitisation,0,0
64255,induced,0,0
64256,human,0,1
64257,visceral,0,1
64258,pain,0,1
64259,hypersensitivity,0,0
64260,",",0,0
64261,then,0,0
64262,oesophageal,0,0
64263,wind-up,0,0
64264,should,0,0
64265,be,0,0
64266,enhanced,0,0
64267,by,0,0
64268,secondary,0,1
64269,hyperalgesia,0,0
64270,.,0,0
64271,METHODS,0,0
64272,In,0,0
64273,eight,1,1
64274,healthy,1,1
64275,volunteers,1,1
64276,(,1,1
64277,seven,1,1
64278,males,1,1
64279,;,1,1
64280,mean,1,1
64281,age,1,1
64282,32,1,1
64283,years,1,1
64284,),1,0
64285,",",0,0
64286,perception,0,0
64287,at,0,0
64288,pain,0,0
64289,threshold,0,0
64290,to,0,0
64291,a,0,0
64292,train,0,0
64293,of,0,0
64294,20,0,1
64295,electrical,0,0
64296,stimuli,0,0
64297,applied,0,0
64298,to,0,0
64299,the,0,0
64300,hand,0,0
64301,and,0,0
64302,upper,0,0
64303,oesophagus,0,1
64304,(,0,0
64305,UO,0,0
64306,),0,0
64307,at,0,0
64308,either,0,1
64309,0.1,0,0
64310,Hz,0,0
64311,(,0,0
64312,control,0,0
64313,),0,0
64314,or,0,1
64315,2,0,0
64316,Hz,0,0
64317,was,0,0
64318,determined,0,0
64319,before,0,0
64320,and,0,0
64321,one,0,0
64322,hour,0,0
64323,after,0,0
64324,a,0,0
64325,30,0,0
64326,minute,0,0
64327,lower,0,0
64328,oesophageal,0,1
64329,acid,0,0
64330,infusion,0,0
64331,.,0,1
64332,RESULTS,0,0
64333,Wind-up,0,0
64334,occurred,0,0
64335,only,0,0
64336,with,0,1
64337,the,0,0
64338,2,0,0
64339,Hz,0,0
64340,train,0,0
64341,in,0,0
64342,the,0,0
64343,UO,0,0
64344,and,0,0
64345,hand,0,0
64346,(,0,0
64347,both,0,0
64348,p=0.01,0,0
64349,),0,0
64350,.,0,0
64351,Following,0,0
64352,acid,0,0
64353,infusion,0,0
64354,",",0,0
64355,pain,0,0
64356,threshold,0,0
64357,decreased,0,0
64358,(,0,0
64359,17,0,1
64360,(,0,1
64361,4,0,0
64362,),0,1
64363,%,0,0
64364,;,0,0
64365,p=0.01,0,0
64366,),0,0
64367,in,0,0
64368,the,0,0
64369,UO,0,0
64370,",",0,0
64371,suggesting,0,0
64372,the,0,0
64373,presence,0,0
64374,of,0,0
64375,secondary,0,1
64376,hyperalgesia,0,0
64377,.,0,0
64378,Wind-up,0,0
64379,to,0,0
64380,the,0,0
64381,2,0,0
64382,Hz,0,0
64383,train,0,0
64384,increased,0,0
64385,in,0,0
64386,the,0,0
64387,UO,0,0
64388,(,0,0
64389,wind-up,0,0
64390,ratio,0,0
64391,1.4,0,0
64392,(,0,0
64393,0.1,0,0
64394,),0,1
64395,to,0,0
64396,1.6,0,0
64397,(,0,0
64398,0.1,0,1
64399,),0,1
64400,;,0,0
64401,p=0.03,0,0
64402,),0,0
64403,but,0,0
64404,not,0,0
64405,in,0,0
64406,the,0,0
64407,hand,0,0
64408,(,0,0
64409,wind-up,0,0
64410,ratio,0,0
64411,1.3,0,0
64412,(,0,0
64413,0.1,0,0
64414,),0,1
64415,and,0,0
64416,1.3,0,0
64417,(,0,0
64418,0.1,0,1
64419,),0,1
64420,;,0,0
64421,p=0.3,0,0
64422,),0,0
64423,CONCLUSION,0,0
64424,Enhanced,0,0
64425,wind-up,0,0
64426,after,0,0
64427,secondary,0,0
64428,oesophageal,0,1
64429,hyperalgesia,0,0
64430,suggests,0,0
64431,that,0,0
64432,visceral,0,0
64433,pain,0,1
64434,hypersensitivity,0,0
64435,induced,0,0
64436,by,0,0
64437,central,0,0
64438,sensitisation,0,1
64439,results,0,0
64440,from,0,1
64441,increased,0,0
64442,central,0,1
64443,neuronal,0,1
64444,excitability,0,0
64445,.,0,0
64446,Wind-up,0,0
64447,may,0,0
64448,offer,0,0
64449,new,0,0
64450,opportunities,0,0
64451,to,0,0
64452,investigate,0,0
64453,the,0,0
64454,contribution,0,0
64455,of,0,0
64456,central,0,1
64457,neuronal,0,1
64458,changes,0,0
64459,to,0,1
64460,symptoms,0,1
64461,in,0,1
64462,FGD,0,1
64463,.,0,1
64464,Phase,0,1
64465,III,0,1
64466,study,0,0
64467,of,0,0
64468,two,0,0
64469,different,0,0
64470,dosing,0,0
64471,schedules,0,0
64472,of,0,0
64473,erythropoietin,0,1
64474,in,0,0
64475,anemic,1,1
64476,patients,1,1
64477,with,1,1
64478,cancer,1,1
64479,.,1,1
64480,PURPOSE,0,0
64481,To,0,0
64482,compare,0,0
64483,maintenance,0,0
64484,epoetin,0,0
64485,alfa,0,0
64486,administered,0,0
64487,once,0,0
64488,every,0,0
64489,3,0,0
64490,weeks,0,0
64491,with,0,1
64492,continued,0,0
64493,weekly,0,0
64494,epoetin,0,0
64495,alfa,0,0
64496,for,0,0
64497,patients,1,1
64498,with,1,1
64499,cancer-associated,1,1
64500,anemia,1,1
64501,.,1,1
64502,PATIENTS,0,0
64503,AND,0,0
64504,METHODS,0,0
64505,Eligible,1,1
64506,patients,1,1
64507,were,1,1
64508,randomly,1,1
64509,assigned,1,0
64510,at,1,0
64511,enrollment,1,1
64512,to,0,0
64513,receive,0,0
64514,three,0,0
64515,weekly,0,0
64516,doses,0,0
64517,of,0,0
64518,epoetin,0,0
64519,alfa,0,0
64520,"40,000",0,0
64521,U,0,0
64522,subcutaneously,0,0
64523,(,0,0
64524,SC,0,0
64525,),0,0
64526,",",0,0
64527,followed,0,0
64528,by,0,0
64529,either,0,0
64530,standard,0,0
64531,weekly,0,0
64532,epoetin,0,0
64533,alfa,0,0
64534,(,0,0
64535,40K,0,1
64536,arm,0,1
64537,),0,0
64538,or,0,1
64539,"120,000",0,0
64540,U,0,0
64541,of,0,0
64542,epoetin,0,0
64543,alfa,0,0
64544,(,0,0
64545,120K,0,0
64546,arm,0,1
64547,),0,0
64548,SC,0,0
64549,every,0,0
64550,3,0,0
64551,weeks,0,0
64552,for,0,1
64553,18,0,1
64554,additional,0,1
64555,weeks,0,0
64556,.,0,1
64557,RESULTS,0,0
64558,Three,1,1
64559,hundred,1,1
64560,sixty-five,1,1
64561,patients,1,1
64562,were,1,1
64563,enrolled,1,1
64564,.,1,1
64565,One,1,1
64566,hundred,1,1
64567,eighty-three,1,1
64568,patients,1,1
64569,were,1,1
64570,assigned,1,1
64571,to,1,0
64572,the,1,0
64573,40K,1,1
64574,arm,1,0
64575,",",1,0
64576,and,1,0
64577,182,1,1
64578,were,1,0
64579,assigned,1,1
64580,to,1,0
64581,the,1,0
64582,120K,1,0
64583,arm,1,0
64584,.,1,0
64585,There,0,0
64586,was,0,0
64587,no,0,0
64588,difference,0,0
64589,in,0,0
64590,the,0,0
64591,proportion,0,0
64592,of,0,0
64593,patients,0,1
64594,requiring,0,1
64595,transfusions,0,0
64596,during,0,0
64597,the,0,0
64598,study,0,0
64599,(,0,0
64600,23,0,1
64601,%,0,0
64602,in,0,0
64603,40K,0,1
64604,arm,0,1
64605,and,0,0
64606,18,0,1
64607,%,0,0
64608,in,0,0
64609,120K,0,0
64610,arm,0,0
64611,",",0,0
64612,P,0,0
64613,=,0,0
64614,.22,0,0
64615,),0,0
64616,or,0,0
64617,specifically,0,0
64618,during,0,0
64619,the,0,0
64620,maintenance,0,0
64621,phase,0,0
64622,(,0,0
64623,13,0,1
64624,%,0,0
64625,in,0,0
64626,40K,0,1
64627,arm,0,1
64628,v,0,0
64629,15,0,0
64630,%,0,0
64631,in,0,0
64632,120K,0,0
64633,arm,0,0
64634,",",0,0
64635,P,0,0
64636,=,0,0
64637,.58,0,0
64638,),0,1
64639,.,0,0
64640,Patients,0,1
64641,randomly,0,1
64642,assigned,0,1
64643,to,0,0
64644,the,0,0
64645,40K,0,1
64646,arm,0,0
64647,were,0,0
64648,more,0,0
64649,likely,0,0
64650,to,0,0
64651,have,0,0
64652,a,0,0
64653,>,0,0
64654,or,0,0
64655,=,0,0
64656,2,0,0
64657,or,0,1
64658,>,0,1
64659,or,0,1
64660,=,0,0
64661,3,0,0
64662,g/dL,0,0
64663,hemoglobin,0,0
64664,(,0,0
64665,Hb,0,0
64666,),0,0
64667,increment,0,0
64668,",",0,0
64669,were,0,0
64670,more,0,0
64671,likely,0,0
64672,to,0,0
64673,have,0,0
64674,a,0,0
64675,drug,0,0
64676,dose,0,0
64677,held,0,0
64678,because,0,0
64679,of,0,0
64680,high,0,1
64681,Hb,0,0
64682,",",0,0
64683,and,0,0
64684,had,0,0
64685,higher,0,0
64686,mean,0,1
64687,end-of-study,0,0
64688,Hb,0,0
64689,levels,0,0
64690,.,0,1
64691,Toxicities,0,0
64692,",",0,0
64693,including,0,0
64694,thromboembolism,0,0
64695,",",0,0
64696,and,0,0
64697,overall,0,0
64698,survival,0,0
64699,were,0,1
64700,similar,0,0
64701,.,0,1
64702,Patients,0,1
64703,in,0,0
64704,the,0,0
64705,40K,0,1
64706,arm,0,0
64707,had,0,0
64708,a,0,0
64709,higher,0,0
64710,global,0,0
64711,quality,0,0
64712,of,0,0
64713,life,0,0
64714,(,0,0
64715,QOL,0,0
64716,),0,0
64717,at,0,0
64718,baseline,0,0
64719,for,0,0
64720,unclear,0,0
64721,reasons,0,0
64722,",",0,1
64723,whereas,0,0
64724,patients,0,1
64725,in,0,0
64726,the,0,0
64727,120K,0,0
64728,arm,0,0
64729,had,0,0
64730,a,0,0
64731,greater,0,0
64732,global,0,0
64733,QOL,0,0
64734,improvement,0,0
64735,during,0,0
64736,the,0,0
64737,study,0,0
64738,",",0,0
64739,so,0,0
64740,end-of-study,0,0
64741,QOL,0,0
64742,was,0,0
64743,equivalent,0,0
64744,.,0,0
64745,CONCLUSION,0,0
64746,After,0,0
64747,three,0,0
64748,weekly,0,0
64749,doses,0,0
64750,of,0,0
64751,epoetin,0,0
64752,alfa,0,0
64753,"40,000",0,0
64754,U,0,0
64755,",",0,0
64756,a,0,0
64757,dose,0,0
64758,of,0,0
64759,"120,000",0,0
64760,U,0,0
64761,can,0,0
64762,be,0,0
64763,administered,0,0
64764,safely,0,0
64765,once,0,0
64766,every,0,0
64767,3,0,0
64768,weeks,0,0
64769,without,0,1
64770,increasing,0,0
64771,transfusion,0,0
64772,needs,0,0
64773,or,0,1
64774,sacrificing,0,0
64775,QOL,0,0
64776,.,0,1
64777,The,0,0
64778,Hb,0,0
64779,increment,0,0
64780,is,0,0
64781,somewhat,0,0
64782,greater,0,0
64783,with,0,1
64784,continued,0,0
64785,weekly,0,0
64786,epoetin,0,0
64787,alfa,0,0
64788,.,0,0
64789,Lack,0,0
64790,of,0,0
64791,blinding,0,0
64792,as,0,0
64793,a,0,0
64794,result,0,0
64795,of,0,0
64796,different,0,0
64797,treatment,0,0
64798,schedules,0,0
64799,may,0,0
64800,have,0,0
64801,confounded,0,0
64802,results,0,0
64803,.,0,1
64804,Nurse-led,0,1
64805,cardiac,0,1
64806,clinics,0,1
64807,for,0,0
64808,adults,1,1
64809,with,1,1
64810,coronary,1,1
64811,heart,1,1
64812,disease,1,1
64813,.,1,0
64814,This,0,0
64815,information,0,0
64816,on,0,0
64817,best,0,0
64818,practice,0,0
64819,is,0,0
64820,based,0,0
64821,on,0,0
64822,a,0,0
64823,systematic,0,0
64824,review,0,0
64825,of,0,0
64826,research,0,0
64827,",",0,0
64828,published,0,0
64829,by,0,0
64830,Blackwell,0,0
64831,Publishing,0,0
64832,Asia,0,0
64833,and,0,0
64834,conducted,0,0
64835,by,0,0
64836,the,0,0
64837,Centre,0,0
64838,for,0,0
64839,Evidence-based,0,0
64840,Nursing,0,1
64841,South,0,1
64842,Australia,0,1
64843,",",0,0
64844,a,0,0
64845,collaborating,0,0
64846,centre,0,1
64847,of,0,0
64848,the,0,0
64849,Joanna,0,1
64850,Briggs,0,1
64851,Institute,0,1
64852,(,0,0
64853,JBI,0,1
64854,),0,0
64855,.,0,0
64856,The,0,0
64857,primary,0,0
64858,references,0,0
64859,on,0,0
64860,which,0,0
64861,this,0,0
64862,information,0,0
64863,is,0,0
64864,based,0,0
64865,are,0,0
64866,provided,0,0
64867,in,0,0
64868,the,0,0
64869,systematic,0,0
64870,review,0,0
64871,report,0,0
64872,available,0,0
64873,online,0,0
64874,via,0,0
64875,Blackwell,0,0
64876,Synergy,0,1
64877,www.blackwell-synergy.com,0,0
64878,and,0,0
64879,to,0,0
64880,members,0,1
64881,of,0,0
64882,the,0,0
64883,institute,0,1
64884,via,0,0
64885,the,0,0
64886,web,0,1
64887,site,0,0
64888,:,0,1
64889,www.joannabriggs.edu.au,0,0
64890,.,0,0
64891,This,0,0
64892,information,0,0
64893,sheet,0,0
64894,covers,0,0
64895,the,0,0
64896,following,0,0
64897,:,0,1
64898,Nurse-led,0,0
64899,education,0,0
64900,and,0,0
64901,self-help,0,0
64902,.,0,0
64903,Education,0,0
64904,and,0,0
64905,motivational,0,0
64906,interview,0,1
64907,.,0,1
64908,Audit,0,0
64909,and,0,0
64910,recall,0,0
64911,.,0,0
64912,Secondary,0,0
64913,prevention,0,0
64914,.,0,1
64915,Clinical,0,0
64916,usefulness,0,0
64917,of,0,0
64918,serum,0,0
64919,prostate,0,1
64920,specific,0,0
64921,antigen,0,0
64922,for,0,0
64923,the,0,0
64924,detection,0,0
64925,of,0,0
64926,prostate,1,1
64927,cancer,1,1
64928,is,0,0
64929,preserved,0,0
64930,in,0,0
64931,men,1,1
64932,receiving,1,1
64933,the,1,0
64934,dual,1,1
64935,5alpha-reductase,1,0
64936,inhibitor,1,0
64937,dutasteride,1,0
64938,.,1,0
64939,PURPOSE,0,0
64940,We,0,0
64941,determined,0,0
64942,whether,0,0
64943,the,0,0
64944,decrease,0,0
64945,in,0,0
64946,serum,0,0
64947,PSA,0,0
64948,seen,0,0
64949,with,0,1
64950,5alpha-reductase,0,0
64951,inhibitors,0,0
64952,affects,0,0
64953,the,0,0
64954,clinical,0,0
64955,usefulness,0,0
64956,of,0,0
64957,PSA,0,0
64958,for,0,0
64959,prostate,0,1
64960,cancer,0,1
64961,screening,0,1
64962,using,0,0
64963,data,0,0
64964,from,0,1
64965,2,0,1
64966,dutasteride,0,1
64967,benign,0,1
64968,prostatic,0,1
64969,hyperplasia,0,1
64970,studies,0,0
64971,.,0,1
64972,MATERIALS,0,0
64973,AND,0,0
64974,METHODS,0,0
64975,A,1,0
64976,total,1,1
64977,of,1,0
64978,"2,802",1,1
64979,men,1,1
64980,50,1,1
64981,years,1,1
64982,or,1,1
64983,older,1,1
64984,with,1,1
64985,a,1,0
64986,clinical,1,0
64987,diagnosis,1,1
64988,of,1,0
64989,benign,1,1
64990,prostatic,1,1
64991,hyperplasia,1,1
64992,",",1,0
64993,no,1,0
64994,history,1,0
64995,of,1,0
64996,prostate,1,1
64997,cancer,1,1
64998,",",1,0
64999,PSA,1,0
65000,1.5,1,0
65001,to,1,1
65002,10,1,1
65003,ng/ml,1,0
65004,",",1,0
65005,prostate,1,1
65006,volume,1,0
65007,30,1,0
65008,cc,1,0
65009,or,1,0
65010,greater,1,0
65011,",",1,0
65012,an,1,0
65013,American,1,1
65014,Urological,1,0
65015,Association,1,0
65016,symptom,1,0
65017,score,1,0
65018,of,1,0
65019,12,1,0
65020,or,1,1
65021,greater,1,0
65022,and,1,0
65023,peak,1,0
65024,urinary,1,0
65025,flow,1,0
65026,rate,1,0
65027,15,1,0
65028,ml,1,0
65029,per,1,0
65030,second,1,0
65031,or,1,1
65032,less,1,0
65033,were,1,0
65034,randomized,1,0
65035,to,1,0
65036,0.5,1,0
65037,mg,1,0
65038,dutasteride,1,1
65039,daily,1,0
65040,or,1,0
65041,matching,1,0
65042,placebo,1,0
65043,for,0,0
65044,24,0,1
65045,months,0,0
65046,.,0,1
65047,Increases,0,0
65048,in,0,0
65049,PSA,0,1
65050,from,0,1
65051,baseline,0,0
65052,and,0,0
65053,the,0,0
65054,maximum,0,0
65055,increase,0,0
65056,from,0,1
65057,nadir,0,0
65058,to,0,0
65059,month,0,0
65060,24,0,0
65061,were,0,0
65062,compared,0,0
65063,between,0,0
65064,the,0,0
65065,groups,0,0
65066,and,0,0
65067,analyzed,0,0
65068,by,0,0
65069,prostate,0,1
65070,cancer,0,1
65071,status,0,0
65072,",",0,0
65073,as,0,0
65074,determined,0,0
65075,by,0,0
65076,PSA,0,1
65077,driven,0,0
65078,biopsy,0,0
65079,and,0,0
65080,an,0,0
65081,advised,0,0
65082,cutoff,0,0
65083,of,0,0
65084,more,0,0
65085,than,0,0
65086,4,0,0
65087,ng/ml,0,0
65088,after,0,0
65089,doubling,0,0
65090,to,0,0
65091,correct,0,0
65092,for,0,0
65093,dutasteride,0,0
65094,treatment,0,0
65095,with,0,1
65096,sensitivity,0,0
65097,and,0,0
65098,specificity,0,0
65099,calculated,0,0
65100,for,0,0
65101,each,0,0
65102,.,0,0
65103,RESULTS,0,0
65104,In,0,0
65105,placebo,0,0
65106,treated,0,1
65107,men,0,1
65108,without,0,1
65109,prostate,0,1
65110,cancer,0,1
65111,there,0,0
65112,was,0,0
65113,an,0,0
65114,8.3,0,0
65115,%,0,0
65116,median,0,0
65117,increase,0,0
65118,in,0,0
65119,PSA,0,0
65120,at,0,0
65121,month,0,0
65122,24,0,0
65123,compared,0,0
65124,with,0,1
65125,-59.5,0,0
65126,%,0,0
65127,in,0,1
65128,those,0,1
65129,who,0,1
65130,received,0,1
65131,dutasteride,0,1
65132,",",0,0
65133,using,0,0
65134,doubled,0,0
65135,values,0,0
65136,to,0,0
65137,correct,0,0
65138,for,0,0
65139,dutasteride,0,0
65140,treatment,0,0
65141,.,0,0
65142,In,0,0
65143,those,0,0
65144,with,0,1
65145,prostate,0,1
65146,cancer,0,1
65147,these,0,0
65148,changes,0,0
65149,were,0,1
65150,23.8,0,0
65151,%,0,0
65152,and,0,0
65153,-37.2,0,0
65154,%,0,0
65155,",",0,0
65156,respectively,0,0
65157,.,0,0
65158,Using,0,0
65159,the,0,0
65160,upper,0,0
65161,PSA,0,0
65162,limit,0,0
65163,of,0,0
65164,4,0,0
65165,ng/ml,0,0
65166,sensitivity,0,0
65167,for,0,0
65168,prostate,0,1
65169,cancer,0,1
65170,in,0,0
65171,men,0,1
65172,receiving,0,1
65173,dutasteride,0,0
65174,vs,0,0
65175,placebo,0,0
65176,was,0,0
65177,0.737,0,0
65178,vs,0,0
65179,0.804,0,0
65180,",",0,0
65181,while,0,0
65182,specificity,0,0
65183,was,0,0
65184,0.671,0,0
65185,vs,0,0
65186,0.578,0,0
65187,.,0,1
65188,Using,0,0
65189,a,0,0
65190,PSA,0,0
65191,increase,0,0
65192,from,0,0
65193,nadir,0,0
65194,of,0,0
65195,0.8,0,0
65196,ng/ml,0,0
65197,the,0,0
65198,sensitivity,0,0
65199,of,0,0
65200,dutasteride,0,0
65201,was,0,0
65202,0.548,0,0
65203,and,0,0
65204,its,0,0
65205,specificity,0,0
65206,was,0,0
65207,0.795,0,0
65208,.,0,0
65209,CONCLUSIONS,0,0
65210,A,0,0
65211,doubling,0,0
65212,factor,0,0
65213,is,0,0
65214,effective,0,0
65215,for,0,0
65216,maintaining,0,0
65217,the,0,0
65218,sensitivity,0,0
65219,and,0,0
65220,specificity,0,0
65221,of,0,0
65222,PSA,0,0
65223,for,0,0
65224,prostate,0,1
65225,cancer,0,1
65226,detection,0,0
65227,in,0,0
65228,men,0,1
65229,on,0,0
65230,dutasteride,0,0
65231,.,0,0
65232,Increases,0,0
65233,in,0,0
65234,serum,0,0
65235,PSA,0,1
65236,in,0,0
65237,men,0,1
65238,receiving,0,1
65239,dutasteride,0,0
65240,should,0,0
65241,be,0,0
65242,considered,0,0
65243,suspicious,0,1
65244,and,0,0
65245,serial,0,1
65246,PSA,0,0
65247,measurements,0,0
65248,should,0,0
65249,be,0,0
65250,used,0,0
65251,to,0,0
65252,evaluate,0,0
65253,changes,0,0
65254,from,0,1
65255,nadir,0,0
65256,.,0,1
65257,Antiarrhythmic,0,0
65258,efficacy,0,0
65259,of,0,0
65260,azimilide,0,0
65261,in,0,0
65262,patients,1,1
65263,with,1,1
65264,atrial,1,1
65265,fibrillation,1,1
65266,.,1,0
65267,Maintenance,0,0
65268,of,0,0
65269,sinus,0,1
65270,rhythm,0,1
65271,after,1,0
65272,conversion,1,0
65273,to,1,0
65274,sinus,1,1
65275,rhythm,1,1
65276,.,1,0
65277,BACKGROUND,0,0
65278,Azimilide,0,0
65279,dihydrochloride,0,0
65280,(,0,0
65281,azimilide,0,0
65282,),0,0
65283,is,0,0
65284,an,0,0
65285,investigational,0,0
65286,antiarrhythmic,0,0
65287,drug,0,0
65288,that,0,0
65289,has,0,0
65290,been,0,0
65291,tested,0,0
65292,in,0,0
65293,patients,0,1
65294,with,0,1
65295,a,0,0
65296,variety,0,0
65297,of,0,0
65298,arrhythmias,0,1
65299,.,0,1
65300,In,0,0
65301,patients,1,1
65302,with,1,1
65303,atrial,1,1
65304,fibrillation,1,1
65305,",",0,0
65306,it,0,0
65307,has,0,0
65308,shown,0,0
65309,excellent,0,0
65310,efficacy,0,0
65311,in,0,0
65312,some,0,0
65313,previous,0,0
65314,trials,0,0
65315,and,0,1
65316,minimal,0,0
65317,efficacy,0,0
65318,in,0,0
65319,others,0,0
65320,.,0,1
65321,METHODS,0,0
65322,Patients,1,1
65323,who,1,1
65324,had,1,1
65325,symptomatic,1,1
65326,atrial,1,1
65327,fibrillation,1,1
65328,for,1,0
65329,>,1,1
65330,48,1,1
65331,hours,1,0
65332,but,1,0
65333,<,1,0
65334,6,1,0
65335,months,1,0
65336,were,1,1
65337,eligible,1,1
65338,for,0,0
65339,this,0,0
65340,multicenter,0,0
65341,",",0,0
65342,randomized,0,0
65343,",",0,0
65344,placebo-controlled,0,0
65345,clinical,0,0
65346,trial,0,1
65347,.,0,1
65348,Patients,1,1
65349,were,1,0
65350,admitted,1,1
65351,to,1,0
65352,a,1,0
65353,hospital,1,0
65354,and,0,0
65355,randomly,1,1
65356,assigned,1,0
65357,to,1,0
65358,receive,1,0
65359,either,1,0
65360,azimilide,1,0
65361,125,1,0
65362,mg,1,0
65363,or,1,1
65364,a,1,0
65365,matched,1,1
65366,placebo,1,0
65367,twice,1,0
65368,daily,1,0
65369,for,1,0
65370,3,1,0
65371,days,1,0
65372,and,1,0
65373,then,1,0
65374,once,1,0
65375,daily,1,0
65376,.,1,1
65377,Patients,1,1
65378,who,1,1
65379,were,1,1
65380,in,1,1
65381,sinus,1,1
65382,rhythm,1,1
65383,spontaneously,1,0
65384,or,1,0
65385,had,1,0
65386,sinus,1,1
65387,rhythm,1,1
65388,restored,1,0
65389,by,1,0
65390,electric,1,0
65391,cardioversion,1,1
65392,on,1,0
65393,day,1,0
65394,4,1,0
65395,were,1,0
65396,discharged,1,1
65397,from,1,0
65398,the,1,0
65399,hospital,1,1
65400,.,1,0
65401,Recurrence,0,0
65402,of,0,0
65403,atrial,0,1
65404,fibrillation,0,1
65405,was,0,0
65406,documented,0,0
65407,by,0,0
65408,electrocardiogram,0,0
65409,.,0,0
65410,In,0,0
65411,the,0,0
65412,primary,0,0
65413,efficacy,0,0
65414,analysis,0,0
65415,",",0,0
65416,time,0,0
65417,to,0,0
65418,recurrence,0,0
65419,in,0,0
65420,the,0,0
65421,2,0,0
65422,treatment,0,0
65423,groups,0,0
65424,was,0,0
65425,compared,0,0
65426,with,0,1
65427,the,0,0
65428,log-rank,0,0
65429,test,0,0
65430,in,0,0
65431,the,0,0
65432,subgroup,0,1
65433,of,0,0
65434,patients,1,1
65435,with,1,1
65436,structural,1,0
65437,heart,1,1
65438,disease,1,1
65439,.,1,1
65440,Safety,0,0
65441,was,0,0
65442,assessed,0,0
65443,as,0,0
65444,deaths,0,0
65445,",",0,1
65446,adverse,0,0
65447,events,0,0
65448,",",0,0
65449,and,0,0
65450,serious,0,0
65451,adverse,0,0
65452,events,0,0
65453,.,0,1
65454,RESULTS,0,0
65455,A,0,0
65456,total,0,1
65457,of,0,0
65458,446,1,1
65459,patients,1,1
65460,were,1,1
65461,randomized,1,1
65462,in,1,0
65463,the,1,0
65464,study,1,0
65465,;,1,0
65466,314,1,1
65467,were,1,0
65468,in,1,0
65469,the,1,0
65470,subgroup,1,1
65471,with,1,1
65472,structural,1,0
65473,heart,1,1
65474,disease,1,1
65475,.,1,0
65476,The,0,0
65477,median,0,0
65478,time,0,0
65479,to,0,0
65480,arrhythmia,0,0
65481,recurrence,0,0
65482,in,0,0
65483,both,0,0
65484,treatment,0,0
65485,groups,0,0
65486,with,0,1
65487,structural,0,0
65488,heart,0,1
65489,disease,0,1
65490,was,0,0
65491,13,0,1
65492,days,0,0
65493,",",0,0
65494,and,0,0
65495,the,0,0
65496,difference,0,0
65497,between,0,0
65498,treatments,0,0
65499,was,0,0
65500,not,0,0
65501,significant,0,0
65502,(,0,0
65503,P,0,0
65504,=,0,0
65505,.4596,0,0
65506,",",0,0
65507,n,0,1
65508,=,0,0
65509,314,0,1
65510,),0,0
65511,.,0,0
65512,The,0,0
65513,relative,0,0
65514,risk,0,0
65515,for,0,0
65516,recurrence,0,0
65517,(,0,0
65518,placebo,0,0
65519,:,0,1
65520,azimilide,0,0
65521,),0,0
65522,was,0,0
65523,1.104,0,0
65524,(,0,0
65525,95,0,0
65526,%,0,0
65527,CI,0,0
65528,0.849-1.436,0,0
65529,),0,0
65530,.,0,0
65531,There,0,0
65532,was,0,0
65533,1,0,0
65534,death,0,0
65535,in,0,0
65536,the,0,0
65537,placebo,0,0
65538,group,0,0
65539,and,0,0
65540,3,0,0
65541,in,0,0
65542,the,0,0
65543,azimilide,0,0
65544,group,0,0
65545,.,0,1
65546,CONCLUSIONS,0,0
65547,Azimilide,0,0
65548,did,0,0
65549,not,0,0
65550,demonstrate,0,0
65551,clinically,0,0
65552,important,0,0
65553,or,0,0
65554,statistically,0,0
65555,significant,0,0
65556,efficacy,0,0
65557,in,0,0
65558,reducing,0,0
65559,the,0,0
65560,risk,0,0
65561,for,0,0
65562,arrhythmia,0,1
65563,recurrence,0,0
65564,in,0,0
65565,patients,1,1
65566,with,1,1
65567,structural,1,0
65568,heart,1,1
65569,disease,1,1
65570,who,1,1
65571,were,1,1
65572,in,1,1
65573,atrial,1,1
65574,fibrillation,1,1
65575,and,1,0
65576,converted,1,0
65577,to,1,0
65578,sinus,1,1
65579,rhythm,1,1
65580,.,1,0
65581,Decompressive,0,1
65582,craniectomy,0,1
65583,in,0,0
65584,traumatic,1,1
65585,brain,1,1
65586,injury,1,1
65587,:,1,1
65588,the,0,0
65589,randomized,0,0
65590,multicenter,0,0
65591,RESCUEicp,0,0
65592,study,0,0
65593,(,0,0
65594,www.RESCUEicp.com,0,0
65595,),0,0
65596,.,0,0
65597,The,0,0
65598,RESCUEicp,0,0
65599,(,0,0
65600,Randomized,0,0
65601,Evaluation,0,0
65602,of,0,0
65603,Surgery,0,1
65604,with,0,1
65605,Craniectomy,0,0
65606,for,0,0
65607,Uncontrollable,0,0
65608,Elevation,0,0
65609,of,0,0
65610,intracranial,0,1
65611,pressure,0,0
65612,),0,0
65613,study,0,0
65614,has,0,0
65615,been,0,0
65616,established,0,0
65617,to,0,0
65618,determine,0,0
65619,whether,0,0
65620,decompressive,0,0
65621,craniectomy,0,1
65622,has,0,0
65623,a,0,0
65624,role,0,0
65625,in,0,0
65626,the,0,0
65627,management,0,0
65628,of,0,0
65629,patients,1,1
65630,with,1,1
65631,traumatic,1,1
65632,brain,1,0
65633,injury,1,1
65634,and,1,0
65635,raised,1,0
65636,intracranial,1,1
65637,pressure,1,0
65638,that,1,0
65639,does,1,0
65640,not,1,0
65641,respond,1,0
65642,to,1,0
65643,initial,1,0
65644,treatment,1,0
65645,measures,1,0
65646,.,1,1
65647,We,0,0
65648,describe,0,0
65649,the,0,0
65650,concept,0,0
65651,of,0,0
65652,decompressive,0,0
65653,craniectomy,0,1
65654,in,0,0
65655,traumatic,0,1
65656,brain,0,0
65657,injury,0,1
65658,and,0,0
65659,the,0,0
65660,rationale,0,0
65661,and,0,0
65662,protocol,0,0
65663,of,0,0
65664,the,0,0
65665,RESCUEicp,0,0
65666,study,0,0
65667,.,0,1
65668,Endurance,0,0
65669,training,0,0
65670,has,0,0
65671,little,0,0
65672,effect,0,0
65673,on,0,0
65674,active,0,1
65675,muscle,0,0
65676,free,0,0
65677,fatty,0,0
65678,acid,0,0
65679,",",0,0
65680,lipoprotein,0,0
65681,cholesterol,0,0
65682,",",0,0
65683,or,0,0
65684,triglyceride,0,0
65685,net,0,0
65686,balances,0,0
65687,.,0,1
65688,We,0,0
65689,evaluated,0,0
65690,the,0,0
65691,hypothesis,0,0
65692,that,0,0
65693,net,0,0
65694,leg,0,0
65695,total,0,1
65696,FFA,0,0
65697,",",0,0
65698,LDL-C,0,0
65699,",",0,0
65700,and,0,0
65701,TG,0,0
65702,uptake,0,0
65703,and,0,0
65704,HDL-C,0,0
65705,release,0,0
65706,during,0,0
65707,moderate-intensity,0,0
65708,cycling,0,0
65709,exercise,0,0
65710,would,0,0
65711,be,0,0
65712,increased,0,0
65713,following,0,0
65714,endurance,0,0
65715,training,0,0
65716,.,0,0
65717,Eight,1,0
65718,sedentary,1,1
65719,men,1,1
65720,(,1,1
65721,26,1,1
65722,+/-,1,0
65723,1,1,0
65724,yr,1,1
65725,",",1,0
65726,77.4,1,0
65727,+/-,1,0
65728,3.7,1,0
65729,kg,1,1
65730,),1,0
65731,were,1,0
65732,studied,1,0
65733,in,0,0
65734,the,0,0
65735,postprandial,0,0
65736,state,0,0
65737,during,0,0
65738,90,0,1
65739,min,0,0
65740,of,0,0
65741,rest,0,0
65742,and,0,0
65743,60,0,1
65744,min,0,0
65745,of,0,0
65746,exercise,0,0
65747,twice,0,0
65748,before,0,0
65749,(,0,0
65750,45,0,1
65751,%,0,0
65752,and,0,0
65753,65,0,1
65754,%,0,0
65755,V,0,0
65756,(,0,0
65757,O2,0,0
65758,peak,0,0
65759,),0,0
65760,),0,0
65761,and,0,0
65762,twice,0,0
65763,after,0,0
65764,9,0,0
65765,wk,0,0
65766,of,0,0
65767,endurance,0,0
65768,training,0,0
65769,(,0,0
65770,55,0,1
65771,%,0,0
65772,and,0,0
65773,65,0,1
65774,%,0,0
65775,posttraining,0,0
65776,V,0,0
65777,(,0,0
65778,O2,0,0
65779,peak,0,0
65780,),0,1
65781,),0,0
65782,.,0,1
65783,Measurements,0,0
65784,across,0,0
65785,an,0,0
65786,exercising,0,0
65787,leg,0,0
65788,were,0,0
65789,taken,0,0
65790,to,0,0
65791,be,0,0
65792,a,0,0
65793,surrogate,0,0
65794,for,0,0
65795,active,0,1
65796,skeletal,0,0
65797,muscle,0,0
65798,.,0,0
65799,To,0,0
65800,determine,0,0
65801,limb,0,0
65802,lipid,0,0
65803,exchange,0,0
65804,",",0,0
65805,femoral,0,1
65806,arterial,0,1
65807,and,0,0
65808,venous,0,0
65809,blood,0,0
65810,samples,0,0
65811,drawn,0,0
65812,simultaneously,0,0
65813,at,0,0
65814,rest,0,0
65815,and,0,0
65816,during,0,0
65817,exercise,0,0
65818,were,0,0
65819,analyzed,0,0
65820,for,0,0
65821,total,0,1
65822,and,0,1
65823,individual,0,0
65824,FFA,0,0
65825,(,0,0
65826,e.g.,0,0
65827,",",0,0
65828,palmitate,0,0
65829,",",0,0
65830,oleate,0,0
65831,),0,0
65832,",",0,0
65833,LDL-C,0,0
65834,",",0,0
65835,HDL-C,0,0
65836,",",0,0
65837,and,0,0
65838,TG,0,0
65839,concentrations,0,0
65840,",",0,0
65841,and,0,0
65842,limb,0,0
65843,blood,0,0
65844,flow,0,0
65845,was,0,0
65846,determined,0,0
65847,by,0,0
65848,thermodilution,0,0
65849,.,0,0
65850,The,0,0
65851,transition,0,0
65852,from,0,0
65853,rest,0,0
65854,to,0,0
65855,exercise,0,0
65856,resulted,0,0
65857,in,0,0
65858,a,0,0
65859,shift,0,0
65860,from,0,0
65861,net,0,0
65862,leg,0,0
65863,total,0,1
65864,FFA,0,0
65865,release,0,0
65866,(,0,0
65867,-44,0,0
65868,+/-,0,0
65869,16,0,1
65870,micromol/min,0,0
65871,),0,0
65872,to,0,0
65873,uptake,0,0
65874,(,0,0
65875,193,0,1
65876,+/-,0,0
65877,49,0,1
65878,micromol/min,0,0
65879,),0,0
65880,that,0,0
65881,was,0,0
65882,unaffected,0,0
65883,by,0,0
65884,either,0,0
65885,exercise,0,0
65886,intensity,0,0
65887,or,0,0
65888,endurance,0,0
65889,training,0,0
65890,.,0,0
65891,The,0,0
65892,relative,0,0
65893,net,0,0
65894,leg,0,0
65895,release,0,0
65896,and,0,0
65897,uptake,0,0
65898,of,0,0
65899,individual,0,0
65900,FFA,0,0
65901,closely,0,0
65902,resembled,0,0
65903,their,0,0
65904,relative,0,0
65905,abundances,0,0
65906,in,0,0
65907,the,0,0
65908,plasma,0,0
65909,with,0,1
65910,approximately,0,1
65911,21,0,1
65912,and,0,0
65913,41,0,1
65914,%,0,0
65915,of,0,0
65916,net,0,0
65917,leg,0,0
65918,total,0,1
65919,FFA,0,0
65920,uptake,0,0
65921,during,0,0
65922,exercise,0,0
65923,accounted,0,0
65924,for,0,0
65925,by,0,0
65926,palmitate,0,0
65927,and,0,0
65928,oleate,0,0
65929,",",0,0
65930,respectively,0,0
65931,.,0,0
65932,Endurance,0,0
65933,training,0,0
65934,resulted,0,0
65935,in,0,0
65936,significant,0,0
65937,changes,0,0
65938,in,0,1
65939,arterial,0,1
65940,concentrations,0,0
65941,of,0,0
65942,HDL-C,0,0
65943,(,0,1
65944,49,0,1
65945,+/-,0,0
65946,5,0,1
65947,vs.,0,0
65948,52,0,1
65949,+/-,0,0
65950,5,0,0
65951,mg/dl,0,0
65952,",",0,0
65953,pre,0,0
65954,vs.,0,0
65955,post,0,0
65956,),0,0
65957,and,0,0
65958,LDL-C,0,1
65959,(,0,0
65960,82,0,1
65961,+/-,0,0
65962,9,0,1
65963,vs.,0,0
65964,76,0,1
65965,+/-,0,0
65966,9,0,0
65967,mg/dl,0,0
65968,",",0,0
65969,pre,0,0
65970,vs.,0,0
65971,post,0,0
65972,),0,0
65973,",",0,0
65974,but,0,0
65975,there,0,0
65976,was,0,0
65977,no,0,0
65978,net,0,0
65979,TG,0,0
65980,or,0,1
65981,LDL-C,0,0
65982,uptake,0,0
65983,or,0,1
65984,HDL-C,0,0
65985,release,0,0
65986,across,0,0
65987,the,0,0
65988,resting,0,0
65989,or,0,0
65990,active,0,0
65991,leg,0,0
65992,before,0,0
65993,or,0,1
65994,after,0,0
65995,endurance,0,0
65996,training,0,0
65997,.,0,0
65998,In,0,0
65999,conclusion,0,0
66000,",",0,0
66001,endurance,0,0
66002,training,0,0
66003,favorably,0,0
66004,affects,0,0
66005,blood,0,0
66006,lipoprotein,0,0
66007,profiles,0,0
66008,",",0,0
66009,even,0,0
66010,in,1,0
66011,young,1,1
66012,",",1,0
66013,healthy,1,1
66014,normolipidemic,1,1
66015,men,1,1
66016,",",0,0
66017,but,0,0
66018,muscle,0,0
66019,contractions,0,0
66020,per,0,0
66021,se,0,0
66022,have,0,0
66023,little,0,0
66024,effect,0,0
66025,on,0,0
66026,net,0,0
66027,leg,0,0
66028,LDL-C,0,0
66029,",",0,0
66030,or,0,0
66031,TG,0,0
66032,uptake,0,0
66033,or,0,0
66034,HDL-C,0,0
66035,release,0,0
66036,during,0,0
66037,moderate-intensity,0,0
66038,cycling,0,0
66039,exercise,0,0
66040,.,0,0
66041,Therefore,0,0
66042,",",0,0
66043,the,0,0
66044,favorable,0,0
66045,effects,0,0
66046,of,0,0
66047,physical,0,0
66048,activity,0,0
66049,on,0,0
66050,the,0,0
66051,lipid,0,0
66052,profiles,0,0
66053,of,0,0
66054,young,1,1
66055,",",1,0
66056,healthy,1,1
66057,normolipidemic,1,1
66058,men,1,1
66059,in,1,0
66060,the,1,0
66061,postprandial,1,0
66062,state,1,0
66063,are,0,0
66064,not,0,0
66065,attributable,0,0
66066,to,0,0
66067,changes,0,0
66068,in,0,0
66069,HDL-C,0,0
66070,or,0,1
66071,LDL-C,0,0
66072,exchange,0,0
66073,across,0,0
66074,active,0,1
66075,skeletal,0,0
66076,muscle,0,0
66077,.,0,1
66078,Local,0,1
66079,immunotherapy,0,0
66080,by,0,0
66081,inhalation,0,0
66082,of,0,0
66083,a,0,0
66084,powder,0,0
66085,extract,0,0
66086,in,0,0
66087,asthma,0,1
66088,due,0,0
66089,to,0,0
66090,house,0,1
66091,dust,0,1
66092,mite,0,1
66093,Dermatophagoides,0,1
66094,pteronyssinus,0,1
66095,:,0,1
66096,a,0,0
66097,double-blind,0,0
66098,comparison,0,0
66099,with,0,1
66100,parenteral,0,0
66101,immunotherapy,0,1
66102,.,0,0
66103,To,0,0
66104,verify,0,0
66105,the,0,0
66106,efficacy,0,0
66107,and,0,0
66108,the,0,0
66109,tolerability,0,0
66110,of,0,0
66111,local,0,0
66112,immunotherapy,0,1
66113,(,0,0
66114,LI,0,0
66115,),0,0
66116,by,0,0
66117,inhalation,0,0
66118,of,0,0
66119,a,0,0
66120,powder,0,0
66121,extract,0,0
66122,of,0,0
66123,house,0,1
66124,dust,0,1
66125,mite,0,1
66126,(,0,0
66127,HDM,0,0
66128,),0,0
66129,",",0,0
66130,in,0,0
66131,comparison,0,0
66132,with,0,1
66133,parenteral,0,0
66134,immunotherapy,0,1
66135,(,0,0
66136,PI,0,0
66137,),0,0
66138,by,0,0
66139,injection,0,0
66140,",",0,0
66141,10,1,0
66142,patients,1,1
66143,with,1,1
66144,asthma,1,1
66145,due,1,1
66146,to,1,1
66147,HDM,1,0
66148,were,0,0
66149,studied,0,0
66150,in,0,0
66151,a,0,0
66152,blind,0,0
66153,fashion,0,0
66154,.,0,1
66155,5,0,0
66156,patients,0,1
66157,(,0,1
66158,Group,0,1
66159,A,0,1
66160,),0,0
66161,underwent,0,1
66162,LI,0,0
66163,and,0,0
66164,subcutaneous,0,0
66165,injections,0,0
66166,of,0,0
66167,placebo,0,0
66168,",",0,0
66169,5,0,0
66170,patients,0,1
66171,(,0,1
66172,Group,0,1
66173,B,0,1
66174,),0,0
66175,underwent,0,1
66176,PI,0,0
66177,and,0,0
66178,inhalation,0,0
66179,of,0,0
66180,lactose,0,0
66181,for,0,0
66182,6,0,0
66183,months,0,0
66184,.,0,1
66185,In,0,0
66186,both,0,0
66187,groups,0,0
66188,each,0,0
66189,inhalation,0,0
66190,was,0,0
66191,preceded,0,0
66192,by,0,0
66193,premedication,0,0
66194,with,0,1
66195,disodium,0,0
66196,cromoglycate,0,0
66197,(,0,0
66198,DSCG,0,0
66199,),0,0
66200,(,0,0
66201,40,0,1
66202,mg,0,0
66203,),0,0
66204,.,0,0
66205,In,0,0
66206,Group,0,1
66207,A,0,1
66208,a,0,0
66209,significant,0,0
66210,decrease,0,0
66211,in,0,0
66212,symptoms,0,0
66213,score,0,0
66214,and,0,0
66215,in,0,0
66216,peak,0,0
66217,expiratory,0,0
66218,flow,0,0
66219,(,0,0
66220,PEF,0,1
66221,),0,0
66222,-derived,0,0
66223,parameters,0,0
66224,was,0,0
66225,observed,0,0
66226,already,0,0
66227,after,0,0
66228,3,0,0
66229,months,0,0
66230,of,0,0
66231,treatment,0,0
66232,",",0,0
66233,and,0,0
66234,2,0,0
66235,patients,0,1
66236,lost,0,1
66237,the,0,0
66238,late,0,0
66239,component,0,0
66240,of,0,0
66241,the,0,0
66242,bronchial,0,1
66243,response,0,0
66244,to,0,0
66245,the,0,0
66246,challenge,0,0
66247,with,0,1
66248,HDM,0,0
66249,.,0,1
66250,No,0,0
66251,significant,0,0
66252,variation,0,0
66253,was,0,0
66254,found,0,0
66255,in,0,0
66256,bronchial,0,1
66257,responsiveness,0,0
66258,to,0,0
66259,methacholine,0,0
66260,and,0,0
66261,ultrasonically,0,0
66262,nebulized,0,0
66263,distilled,0,0
66264,water,0,0
66265,(,0,0
66266,UNDW,0,0
66267,),0,0
66268,and,0,0
66269,in,0,0
66270,immunologic,0,0
66271,humoral,0,0
66272,and,0,1
66273,cellular,0,0
66274,parameters,0,0
66275,in,0,0
66276,peripheral,0,1
66277,blood,0,0
66278,after,0,0
66279,treatment,0,0
66280,in,0,0
66281,either,0,0
66282,group,0,0
66283,.,0,0
66284,No,0,0
66285,local,0,0
66286,important,0,0
66287,adverse,0,0
66288,reactions,0,0
66289,were,0,1
66290,observed,0,0
66291,in,0,0
66292,Group,0,1
66293,A,0,1
66294,and,0,0
66295,no,0,0
66296,systemic,0,0
66297,side,0,0
66298,effects,0,0
66299,were,0,0
66300,observed,0,0
66301,in,0,0
66302,either,0,0
66303,group,0,0
66304,.,0,0
66305,We,0,0
66306,conclude,0,0
66307,that,0,0
66308,LI,0,0
66309,is,0,0
66310,as,0,0
66311,effective,0,0
66312,as,0,0
66313,PI,0,0
66314,",",0,0
66315,but,0,0
66316,more,0,0
66317,rapid,0,0
66318,in,0,0
66319,its,0,0
66320,action,0,0
66321,",",0,0
66322,in,0,0
66323,the,0,0
66324,treatment,0,0
66325,of,0,0
66326,asthma,0,1
66327,due,0,1
66328,to,0,1
66329,HDM,0,0
66330,.,0,0
66331,Moreover,0,0
66332,",",0,0
66333,LI,0,0
66334,is,0,0
66335,locally,0,0
66336,well,0,0
66337,tolerated,0,0
66338,",",0,0
66339,providing,0,0
66340,DSCG,0,0
66341,is,0,0
66342,inhaled,0,0
66343,before,0,0
66344,each,0,0
66345,therapeutic,0,0
66346,inhalation,0,0
66347,",",0,0
66348,and,0,0
66349,does,0,0
66350,not,0,0
66351,induce,0,0
66352,systemic,0,0
66353,side,0,0
66354,effects,0,0
66355,.,0,1
66356,Joint,0,0
66357,attention,0,0
66358,and,0,0
66359,symbolic,0,0
66360,play,0,0
66361,in,0,0
66362,young,1,1
66363,children,1,1
66364,with,1,1
66365,autism,1,1
66366,:,1,1
66367,a,0,0
66368,randomized,0,0
66369,controlled,0,0
66370,intervention,0,0
66371,study,0,0
66372,.,0,1
66373,BACKGROUND,0,0
66374,Delays,0,0
66375,and,0,1
66376,deficits,0,1
66377,in,0,0
66378,joint,0,1
66379,attention,0,0
66380,and,0,0
66381,symbolic,0,0
66382,play,0,0
66383,constitute,0,0
66384,two,0,0
66385,important,0,0
66386,developmental,0,1
66387,problems,0,1
66388,in,0,0
66389,young,1,1
66390,children,1,1
66391,with,1,1
66392,autism,1,1
66393,.,1,0
66394,These,0,0
66395,areas,0,0
66396,of,0,0
66397,deficit,0,1
66398,have,0,0
66399,been,0,0
66400,well,0,0
66401,studied,0,0
66402,in,0,0
66403,autism,0,1
66404,but,0,0
66405,have,0,0
66406,rarely,0,0
66407,been,0,0
66408,the,0,0
66409,focus,0,0
66410,of,0,0
66411,treatment,0,0
66412,efforts,0,0
66413,(,0,0
66414,see,0,0
66415,Kasari,0,0
66416,",",0,0
66417,Freeman,0,0
66418,",",0,0
66419,&,0,0
66420,Paparella,0,1
66421,",",0,0
66422,2001,0,1
66423,),0,0
66424,.,0,0
66425,In,0,0
66426,this,0,0
66427,study,0,0
66428,",",0,0
66429,we,0,0
66430,examine,0,0
66431,the,0,0
66432,efficacy,0,0
66433,of,0,0
66434,targeted,0,0
66435,interventions,0,0
66436,of,0,0
66437,joint,0,1
66438,attention,0,0
66439,and,0,0
66440,symbolic,0,0
66441,play,0,0
66442,.,0,1
66443,METHODS,0,0
66444,Participants,1,1
66445,were,1,1
66446,58,1,1
66447,children,1,1
66448,with,1,1
66449,autism,1,1
66450,aged,1,1
66451,3,1,0
66452,and,1,0
66453,4,1,0
66454,years,1,1
66455,(,1,1
66456,46,1,1
66457,boys,1,1
66458,),1,1
66459,.,1,1
66460,Children,0,1
66461,were,0,0
66462,randomized,0,0
66463,to,0,0
66464,a,0,0
66465,joint,0,0
66466,attention,0,0
66467,intervention,0,0
66468,",",0,0
66469,a,0,0
66470,symbolic,0,0
66471,play,0,0
66472,intervention,0,0
66473,",",0,0
66474,or,0,0
66475,control,0,0
66476,group,0,0
66477,.,0,1
66478,Interventions,0,0
66479,were,0,0
66480,conducted,0,1
66481,30,0,1
66482,minutes,0,0
66483,daily,0,0
66484,for,0,0
66485,5-6,0,1
66486,weeks,0,0
66487,.,0,1
66488,Both,0,0
66489,structured,0,0
66490,assessments,0,0
66491,of,0,0
66492,joint,0,1
66493,attention,0,0
66494,and,0,0
66495,play,0,0
66496,skills,0,0
66497,and,0,1
66498,mother-child,0,1
66499,interactions,0,0
66500,were,0,1
66501,collected,0,0
66502,pre,0,0
66503,and,0,0
66504,post,0,0
66505,intervention,0,0
66506,by,0,0
66507,independent,0,1
66508,assessors,0,0
66509,.,0,1
66510,RESULTS,0,0
66511,Results,0,0
66512,indicate,0,0
66513,that,0,0
66514,both,0,0
66515,intervention,0,0
66516,groups,0,0
66517,improved,0,0
66518,significantly,0,0
66519,over,0,0
66520,the,0,0
66521,control,0,0
66522,group,0,0
66523,on,0,0
66524,certain,0,0
66525,behaviors,0,0
66526,.,0,1
66527,Children,0,1
66528,in,0,0
66529,the,0,0
66530,joint,0,0
66531,attention,0,0
66532,intervention,0,0
66533,initiated,0,0
66534,significantly,0,0
66535,more,0,0
66536,showing,0,0
66537,and,0,0
66538,responsiveness,0,0
66539,to,0,0
66540,joint,0,0
66541,attention,0,0
66542,on,0,0
66543,the,0,0
66544,structured,0,0
66545,joint,0,0
66546,attention,0,0
66547,assessment,0,0
66548,and,0,0
66549,more,0,0
66550,child-initiated,0,0
66551,joint,0,0
66552,attention,0,0
66553,in,0,0
66554,the,0,0
66555,mother-child,0,1
66556,interaction,0,0
66557,.,0,0
66558,The,0,0
66559,children,0,1
66560,in,0,0
66561,the,0,0
66562,play,0,0
66563,group,0,0
66564,showed,0,0
66565,more,0,0
66566,diverse,0,1
66567,types,0,0
66568,of,0,0
66569,symbolic,0,0
66570,play,0,0
66571,in,0,0
66572,interaction,0,0
66573,with,0,1
66574,their,0,0
66575,mothers,0,1
66576,and,0,0
66577,higher,0,0
66578,play,0,0
66579,levels,0,0
66580,on,0,0
66581,both,0,0
66582,the,0,0
66583,play,0,0
66584,assessment,0,0
66585,and,0,0
66586,in,0,0
66587,interaction,0,0
66588,with,0,1
66589,their,0,1
66590,mothers,0,1
66591,.,0,0
66592,CONCLUSIONS,0,0
66593,This,0,0
66594,randomized,0,0
66595,controlled,0,0
66596,trial,0,0
66597,provides,0,0
66598,promising,0,0
66599,data,0,0
66600,on,0,0
66601,the,0,0
66602,specificity,0,0
66603,and,0,0
66604,generalizability,0,0
66605,of,0,0
66606,joint,0,0
66607,attention,0,0
66608,and,0,0
66609,play,0,0
66610,interventions,0,0
66611,for,0,0
66612,young,1,1
66613,children,1,1
66614,with,1,1
66615,autism,1,1
66616,.,1,1
66617,Future,0,0
66618,studies,0,0
66619,need,0,0
66620,to,0,0
66621,examine,0,0
66622,the,0,0
66623,long-term,0,0
66624,effects,0,0
66625,of,0,0
66626,these,0,0
66627,early,0,0
66628,interventions,0,0
66629,on,0,0
66630,children,0,1
66631,'s,0,1
66632,development,0,0
66633,.,0,1
66634,Thermal,0,0
66635,welding,0,0
66636,versus,0,0
66637,bipolar,0,1
66638,tonsillectomy,0,1
66639,:,0,1
66640,a,0,0
66641,comparative,0,0
66642,study,0,0
66643,.,0,1
66644,OBJECTIVE,0,0
66645,To,0,0
66646,compare,0,0
66647,thermal,0,0
66648,welding,0,0
66649,tonsillectomy,0,1
66650,(,0,0
66651,TWT,0,1
66652,),0,0
66653,with,0,1
66654,bipolar,0,1
66655,electrocautery,0,0
66656,tonsillectomy,0,1
66657,(,0,0
66658,BET,0,1
66659,),0,0
66660,procedure,0,0
66661,.,0,1
66662,STUDY,0,0
66663,DESIGN,0,0
66664,AND,0,0
66665,SETTING,0,1
66666,A,0,1
66667,prospective,0,0
66668,randomized,0,1
66669,study,0,0
66670,was,0,0
66671,conducted,0,0
66672,on,0,0
66673,150,1,0
66674,consecutive,1,1
66675,adult,1,1
66676,patients,1,1
66677,undergoing,1,1
66678,tonsillectomy,1,1
66679,.,1,1
66680,Indications,1,0
66681,included,1,1
66682,chronic,1,1
66683,tonsillitis,1,1
66684,and,1,0
66685,obstructive,1,1
66686,sleep,1,0
66687,apnea,1,1
66688,syndrome,1,1
66689,.,1,0
66690,Exclusion,1,0
66691,criteria,1,1
66692,included,1,1
66693,peritonsillar,1,1
66694,abscess,1,1
66695,history,1,1
66696,",",1,0
66697,bleeding,1,0
66698,disorders,1,1
66699,",",1,0
66700,and,1,0
66701,any,1,0
66702,other,1,0
66703,procedure,1,0
66704,together,1,0
66705,with,1,1
66706,tonsillectomy,1,1
66707,.,1,1
66708,Patients,0,1
66709,were,0,0
66710,randomly,0,1
66711,assigned,0,0
66712,to,0,0
66713,TWT,0,1
66714,or,0,1
66715,BET,0,1
66716,groups,0,0
66717,.,0,1
66718,Intraoperative,0,0
66719,bleeding,0,0
66720,",",0,0
66721,operative,0,0
66722,time,0,0
66723,",",0,0
66724,postoperative,0,0
66725,pain,0,0
66726,",",0,0
66727,complication,0,0
66728,rates,0,0
66729,",",0,0
66730,and,0,0
66731,return,0,0
66732,to,0,0
66733,normal,0,1
66734,diet,0,1
66735,were,0,1
66736,evaluated,0,0
66737,.,0,0
66738,RESULTS,0,0
66739,In,0,0
66740,the,0,0
66741,TWT,0,0
66742,group,0,0
66743,there,0,0
66744,was,0,0
66745,no,0,0
66746,measurable,0,0
66747,intraoperative,0,0
66748,bleeding,0,0
66749,",",0,0
66750,while,0,0
66751,mean,0,0
66752,bleeding,0,1
66753,for,0,0
66754,BET,0,1
66755,group,0,1
66756,was,0,0
66757,16,0,1
66758,mL,0,0
66759,.,0,0
66760,No,0,0
66761,significant,0,0
66762,difference,0,0
66763,regarding,0,0
66764,mean,0,1
66765,operative,0,0
66766,time,0,0
66767,was,0,0
66768,noticed,0,0
66769,.,0,1
66770,Mean,0,0
66771,postoperative,0,0
66772,pain,0,1
66773,score,0,0
66774,and,0,0
66775,mean,0,0
66776,time,0,0
66777,for,0,0
66778,return,0,0
66779,to,0,0
66780,normal,0,1
66781,diet,0,0
66782,were,0,0
66783,significantly,0,0
66784,lower,0,0
66785,in,0,0
66786,the,0,0
66787,TWT,0,1
66788,group,0,0
66789,.,0,0
66790,Primary,0,0
66791,hemorrhage,0,1
66792,occurred,0,0
66793,in,0,0
66794,1,0,0
66795,subject,0,0
66796,of,0,0
66797,the,0,0
66798,BET,0,1
66799,group,0,0
66800,.,0,1
66801,Secondary,0,0
66802,postoperative,0,0
66803,hemorrhage,0,1
66804,was,0,0
66805,noticed,0,0
66806,in,0,0
66807,1,0,0
66808,subject,0,0
66809,of,0,0
66810,the,0,0
66811,TWT,0,0
66812,group,0,0
66813,and,0,0
66814,3,0,0
66815,subjects,0,1
66816,of,0,0
66817,the,0,0
66818,BET,0,1
66819,group,0,0
66820,.,0,1
66821,CONCLUSION,0,0
66822,Thermal,0,0
66823,welding,0,0
66824,tonsillectomy,0,1
66825,procedure,0,0
66826,provides,0,0
66827,sufficient,0,0
66828,hemostasis,0,0
66829,",",0,0
66830,lower,0,0
66831,postoperative,0,0
66832,pain,0,0
66833,",",0,0
66834,and,0,0
66835,quick,0,0
66836,return,0,0
66837,to,0,0
66838,normal,0,1
66839,diet,0,1
66840,.,0,1
66841,EBM,0,0
66842,RATING,0,1
66843,A-1b,0,1
66844,.,0,1
66845,Greater,0,0
66846,knowledge,0,0
66847,gain,0,0
66848,with,0,1
66849,structured,0,0
66850,than,0,0
66851,student-directed,0,0
66852,learning,0,0
66853,in,0,0
66854,Child,1,1
66855,Health,1,0
66856,:,1,1
66857,cluster,0,0
66858,randomized,0,0
66859,trial,0,0
66860,.,0,0
66861,The,0,0
66862,aim,0,0
66863,of,0,0
66864,this,0,0
66865,study,0,0
66866,was,0,0
66867,to,0,0
66868,detect,0,0
66869,a,0,0
66870,difference,0,0
66871,in,0,0
66872,knowledge,0,0
66873,gain,0,0
66874,between,0,0
66875,students,1,1
66876,receiving,1,1
66877,structured,1,0
66878,versus,1,0
66879,student-directed,1,0
66880,learning,1,0
66881,for,1,0
66882,the,1,0
66883,two-week,1,0
66884,Child,1,1
66885,Health,1,0
66886,outpatient,1,1
66887,module,1,0
66888,.,1,0
66889,A,1,0
66890,total,1,1
66891,of,1,0
66892,138,1,1
66893,phase,1,1
66894,3,1,0
66895,(,1,0
66896,year,1,1
66897,4,1,0
66898,),1,1
66899,medical,1,1
66900,students,1,1
66901,in,1,1
66902,10,1,1
66903,two-week,1,0
66904,paediatric,1,1
66905,outpatient,1,1
66906,blocks,1,0
66907,at,1,0
66908,the,1,0
66909,Department,1,1
66910,of,1,0
66911,Child,1,1
66912,Health,1,0
66913,",",1,0
66914,University,1,1
66915,of,1,0
66916,Dundee,1,1
66917,",",1,0
66918,Scotland,1,1
66919,",",0,0
66920,were,0,0
66921,randomized,0,0
66922,to,0,0
66923,student-directed,0,0
66924,or,0,1
66925,structured,0,0
66926,learning,0,0
66927,between,0,0
66928,January,0,1
66929,and,0,1
66930,December,0,1
66931,2002,0,1
66932,.,0,1
66933,Pre-,0,0
66934,and,0,0
66935,post-course,0,0
66936,tests,0,0
66937,were,0,1
66938,administered,0,0
66939,at,0,0
66940,the,0,0
66941,start,0,0
66942,and,0,0
66943,the,0,0
66944,end,0,0
66945,of,0,0
66946,the,0,0
66947,attachment,0,0
66948,;,0,0
66949,129,1,1
66950,students,1,1
66951,sat,1,1
66952,both,1,0
66953,tests,1,0
66954,.,1,1
66955,Results,0,0
66956,are,0,0
66957,presented,0,0
66958,as,0,0
66959,mean,0,1
66960,scores,0,0
66961,with,0,1
66962,standard,0,1
66963,deviations,0,0
66964,or,0,1
66965,95,0,0
66966,%,0,0
66967,confidence,0,0
66968,intervals,0,0
66969,(,0,1
66970,CI,0,0
66971,),0,0
66972,in,0,0
66973,parentheses,0,0
66974,.,0,1
66975,The,0,0
66976,primary,0,0
66977,outcome,0,0
66978,measure,0,0
66979,was,0,0
66980,gain,0,0
66981,in,0,0
66982,knowledge,0,0
66983,of,0,0
66984,the,0,0
66985,Child,0,1
66986,Health,0,0
66987,core,0,0
66988,curriculum,0,0
66989,that,0,0
66990,is,0,0
66991,covered,0,0
66992,in,0,0
66993,the,0,0
66994,outpatient,0,1
66995,setting,0,1
66996,.,0,0
66997,Although,0,0
66998,pre-course,0,0
66999,scores,0,0
67000,were,0,1
67001,similar,0,0
67002,(,0,1
67003,student-directed,0,0
67004,25.3,0,1
67005,(,0,1
67006,7.3,0,0
67007,),0,1
67008,;,0,0
67009,structured,0,0
67010,24.8,0,0
67011,(,0,0
67012,7.5,0,0
67013,),0,1
67014,),0,0
67015,the,0,0
67016,structured,0,0
67017,approach,0,0
67018,resulted,0,0
67019,in,0,0
67020,higher,0,0
67021,post-course,0,0
67022,scores,0,0
67023,in,0,0
67024,comparison,0,0
67025,with,0,1
67026,the,0,0
67027,student-directed,0,0
67028,approach,0,0
67029,(,0,1
67030,student-directed,0,0
67031,41.8,0,1
67032,(,0,1
67033,9.4,0,0
67034,),0,1
67035,;,0,0
67036,structured,0,0
67037,53.8,0,1
67038,(,0,0
67039,8.8,0,0
67040,),0,1
67041,;,0,0
67042,p,0,0
67043,<,0,0
67044,0.01,0,0
67045,),0,0
67046,.,0,1
67047,Knowledge,0,0
67048,gain,0,0
67049,showed,0,0
67050,significant,0,0
67051,differences,0,0
67052,between,0,0
67053,the,0,0
67054,two,0,0
67055,learning,0,0
67056,approaches,0,0
67057,(,0,1
67058,student-directed,0,1
67059,16.5,0,0
67060,(,0,1
67061,3.7,0,1
67062,),0,1
67063,;,0,0
67064,structured,0,0
67065,29.1,0,1
67066,(,0,0
67067,3.8,0,0
67068,),0,0
67069,",",0,0
67070,difference,0,0
67071,=,0,0
67072,12.6,0,0
67073,(,0,0
67074,95,0,0
67075,%,0,0
67076,CI,0,0
67077,11.3,0,0
67078,to,0,0
67079,13.9,0,0
67080,),0,1
67081,),0,0
67082,.,0,1
67083,Low,0,0
67084,pre-course,0,0
67085,scores,0,0
67086,or,0,1
67087,gender,0,0
67088,did,0,0
67089,not,0,0
67090,affect,0,0
67091,knowledge,0,0
67092,gain,0,0
67093,.,0,0
67094,In,0,0
67095,the,0,0
67096,Child,0,1
67097,Health,0,0
67098,outpatient,0,1
67099,setting,0,1
67100,",",0,0
67101,the,0,0
67102,'traditional,0,0
67103,',0,1
67104,structured,0,0
67105,approach,0,1
67106,led,0,0
67107,to,0,0
67108,significantly,0,0
67109,greater,0,0
67110,knowledge,0,0
67111,gain,0,0
67112,in,0,0
67113,comparison,0,0
67114,with,0,1
67115,the,0,0
67116,'novel,0,0
67117,',0,1
67118,student-directed,0,0
67119,approach,0,1
67120,.,0,0
67121,The,0,0
67122,findings,0,0
67123,emphasize,0,0
67124,the,0,0
67125,importance,0,0
67126,of,0,0
67127,careful,0,0
67128,evaluation,0,0
67129,of,0,0
67130,novel,0,0
67131,medical,0,1
67132,education,0,0
67133,strategies,0,0
67134,before,0,0
67135,their,0,0
67136,implementation,0,0
67137,in,0,0
67138,medical,0,1
67139,schools,0,1
67140,",",0,0
67141,and,0,0
67142,the,0,0
67143,need,0,0
67144,for,0,0
67145,further,0,0
67146,research,0,0
67147,to,0,0
67148,define,0,0
67149,the,0,0
67150,effective,0,0
67151,methods,0,1
67152,for,0,0
67153,delivering,0,0
67154,medical,0,1
67155,education,0,0
67156,in,0,0
67157,Child,0,1
67158,Health,0,0
67159,.,0,1
67160,Effects,0,0
67161,of,0,1
67162,two,0,1
67163,different,0,0
67164,short-term,0,0
67165,training,0,0
67166,programs,0,0
67167,on,0,0
67168,the,0,0
67169,physical,0,0
67170,and,0,0
67171,technical,0,0
67172,abilities,0,0
67173,of,0,0
67174,adolescent,1,1
67175,basketball,1,1
67176,players,1,0
67177,.,1,0
67178,This,0,0
67179,study,0,0
67180,evaluated,0,0
67181,and,0,0
67182,compared,0,0
67183,the,0,0
67184,effectiveness,0,0
67185,of,0,0
67186,two,0,0
67187,different,0,0
67188,off-season,0,0
67189,",",0,0
67190,short-term,0,0
67191,basketball,0,1
67192,training,0,0
67193,programs,0,0
67194,on,0,0
67195,physical,0,0
67196,and,0,1
67197,technical,0,0
67198,abilities,0,0
67199,of,0,0
67200,young,1,1
67201,basketball,1,1
67202,players,1,0
67203,.,1,1
67204,Twenty-seven,1,1
67205,adolescent,1,1
67206,basketball,1,1
67207,players,1,0
67208,(,1,1
67209,14.7+/-0.5,1,0
67210,years,1,1
67211,;,1,1
67212,Tanner,1,1
67213,stage,1,1
67214,:,1,1
67215,3.5+/-0.5,1,0
67216,),1,0
67217,were,0,0
67218,randomly,0,1
67219,divided,0,0
67220,into,0,0
67221,a,0,0
67222,specialized,0,1
67223,basketball,0,1
67224,training,0,0
67225,group,0,0
67226,(,0,0
67227,SP,0,0
67228,",",0,0
67229,n=10,0,1
67230,),0,0
67231,",",0,0
67232,a,0,0
67233,mixed,0,0
67234,basketball,0,1
67235,plus,0,0
67236,conditioning,0,0
67237,training,0,0
67238,group,0,0
67239,(,0,0
67240,MX,0,0
67241,",",0,0
67242,n=10,0,1
67243,),0,0
67244,and,0,0
67245,a,0,0
67246,control,0,0
67247,group,0,0
67248,(,0,0
67249,n=7,0,1
67250,),0,0
67251,.,0,0
67252,Training,0,0
67253,included,0,1
67254,five,0,1
67255,sessions,0,0
67256,per,0,0
67257,week,0,0
67258,(,0,0
67259,100-120,0,0
67260,min,0,0
67261,each,0,1
67262,),0,0
67263,and,0,0
67264,was,0,0
67265,performed,0,0
67266,for,0,0
67267,4,0,0
67268,weeks,0,0
67269,.,0,1
67270,Maximal,0,0
67271,oxygen,0,0
67272,uptake,0,0
67273,was,0,0
67274,similarly,0,0
67275,improved,0,0
67276,after,0,0
67277,SP,0,1
67278,(,0,1
67279,4.9+/-1.8,0,0
67280,%,0,0
67281,),0,0
67282,and,0,0
67283,MX,0,0
67284,(,0,0
67285,4.9+/-1.4,0,0
67286,%,0,0
67287,),0,0
67288,",",0,0
67289,but,0,0
67290,there,0,0
67291,was,0,0
67292,no,0,0
67293,effect,0,0
67294,on,0,0
67295,ventilatory,0,0
67296,threshold,0,0
67297,.,0,0
67298,Peak,0,0
67299,and,0,0
67300,mean,0,0
67301,power,0,0
67302,output,0,0
67303,measured,0,0
67304,during,0,0
67305,the,0,0
67306,Wingate,0,0
67307,test,0,0
67308,were,0,0
67309,also,0,0
67310,improved,0,0
67311,by,0,0
67312,a,0,0
67313,similar,0,0
67314,magnitude,0,0
67315,after,0,0
67316,SP,0,1
67317,(,0,1
67318,21+/-5,0,0
67319,%,0,0
67320,),0,0
67321,and,0,0
67322,MX,0,0
67323,(,0,0
67324,15+/-6,0,0
67325,%,0,0
67326,),0,1
67327,.,0,0
67328,Trunk,0,0
67329,muscle,0,0
67330,endurance,0,0
67331,was,0,0
67332,equally,0,0
67333,increased,0,0
67334,(,0,0
67335,SP,0,1
67336,:,0,1
67337,23+/-4,0,0
67338,%,0,0
67339,",",0,0
67340,MX,0,0
67341,:,0,1
67342,25+/-5,0,0
67343,%,0,0
67344,),0,0
67345,",",0,0
67346,but,0,0
67347,arms,0,0
67348,endurance,0,1
67349,was,0,0
67350,improved,0,0
67351,significantly,0,0
67352,more,0,0
67353,after,0,0
67354,MX,0,0
67355,(,0,1
67356,50+/-11,0,1
67357,%,0,0
67358,),0,0
67359,compared,0,0
67360,to,0,0
67361,SP,0,1
67362,(,0,0
67363,11+/-14,0,0
67364,%,0,0
67365,",",0,0
67366,p,0,0
67367,<,0,0
67368,0.05,0,0
67369,),0,0
67370,.,0,0
67371,Performance,0,0
67372,in,0,0
67373,four,0,1
67374,basketball,0,1
67375,technical,0,0
67376,skills,0,0
67377,was,0,0
67378,similarly,0,0
67379,increased,0,0
67380,(,0,0
67381,by,0,0
67382,17-27,0,1
67383,%,0,0
67384,),0,0
67385,in,0,0
67386,both,0,0
67387,groups,0,0
67388,",",0,0
67389,with,0,1
67390,a,0,0
67391,tendency,0,0
67392,for,0,0
67393,greater,0,0
67394,improvement,0,0
67395,of,0,0
67396,the,0,0
67397,SP,0,1
67398,groups,0,0
67399,in,0,0
67400,the,0,0
67401,technical,0,0
67402,skills,0,0
67403,of,0,0
67404,shooting,0,0
67405,and,0,0
67406,passing,0,0
67407,.,0,0
67408,These,0,0
67409,results,0,0
67410,indicate,0,0
67411,that,0,0
67412,a,0,0
67413,SP,0,0
67414,basketball,0,1
67415,training,0,0
67416,program,0,0
67417,",",0,0
67418,performed,0,0
67419,exclusively,0,1
67420,on-court,0,0
67421,was,0,0
67422,as,0,0
67423,effective,0,0
67424,as,0,0
67425,a,0,0
67426,MX,0,0
67427,training,0,0
67428,program,0,0
67429,in,0,0
67430,terms,0,0
67431,of,0,0
67432,aerobic,0,1
67433,and,0,0
67434,anaerobic,0,0
67435,fitness,0,1
67436,improvement,0,0
67437,.,0,0
67438,Furthermore,0,0
67439,",",0,0
67440,the,0,0
67441,decrease,0,0
67442,of,0,0
67443,the,0,0
67444,total,0,1
67445,on-court,0,0
67446,training,0,0
67447,time,0,0
67448,in,0,0
67449,the,0,0
67450,MX,0,0
67451,group,0,0
67452,resulted,0,0
67453,in,0,0
67454,a,0,0
67455,tendency,0,0
67456,for,0,0
67457,a,0,0
67458,smaller,0,0
67459,improvement,0,0
67460,of,0,0
67461,basketball,0,1
67462,technical,0,0
67463,skills,0,0
67464,.,0,1
67465,In,0,0
67466,conclusion,0,0
67467,",",0,0
67468,both,0,0
67469,SP,0,0
67470,and,0,0
67471,MX,0,0
67472,training,0,0
67473,are,0,0
67474,equally,0,0
67475,effective,0,0
67476,in,0,0
67477,order,0,0
67478,to,0,0
67479,limit,0,0
67480,and/or,0,0
67481,reverse,0,0
67482,the,0,0
67483,detraining,0,0
67484,effects,0,0
67485,that,0,0
67486,occur,0,0
67487,during,0,0
67488,the,0,0
67489,off-season,0,0
67490,in,0,0
67491,basketball,0,1
67492,.,0,1
67493,Specific,0,1
67494,immunoglobulin,0,1
67495,for,0,0
67496,treatment,0,0
67497,of,0,0
67498,whooping,1,1
67499,cough,1,1
67500,.,1,1
67501,Immunoglobulin,0,0
67502,treatment,0,0
67503,for,0,0
67504,whooping,0,1
67505,cough,0,1
67506,(,0,0
67507,pertussis,0,0
67508,),0,0
67509,is,0,0
67510,widely,0,0
67511,believed,0,0
67512,to,0,0
67513,be,0,0
67514,ineffective,0,0
67515,although,0,0
67516,there,0,0
67517,are,0,0
67518,sound,0,0
67519,reasons,0,0
67520,for,0,0
67521,regarding,0,0
67522,the,0,0
67523,condition,0,0
67524,as,0,0
67525,a,0,0
67526,toxin-induced,0,0
67527,disease,0,1
67528,.,0,1
67529,We,0,0
67530,wondered,0,0
67531,whether,0,0
67532,the,0,0
67533,lack,0,0
67534,of,0,0
67535,success,0,0
67536,with,0,1
67537,pertussis,0,0
67538,immunoglobulins,0,0
67539,might,0,0
67540,be,0,0
67541,attributable,0,0
67542,to,0,0
67543,inadequate,0,1
67544,dose,0,0
67545,",",0,0
67546,so,0,0
67547,we,0,0
67548,designed,0,0
67549,a,0,0
67550,randomised,0,0
67551,",",0,0
67552,double-blind,0,0
67553,",",0,0
67554,placebo-controlled,0,0
67555,trial,0,0
67556,of,0,0
67557,two,0,0
67558,immunoglobulin,0,1
67559,preparations,0,0
67560,.,0,1
67561,The,0,0
67562,study,0,0
67563,was,0,0
67564,conducted,0,0
67565,at,0,0
67566,three,1,0
67567,Swedish,1,1
67568,hospitals,1,1
67569,.,1,1
67570,We,0,0
67571,enrolled,0,1
67572,73,1,1
67573,children,1,1
67574,aged,1,1
67575,less,1,0
67576,than,1,0
67577,36,1,1
67578,months,1,1
67579,who,1,1
67580,were,1,1
67581,admitted,1,1
67582,with,1,1
67583,a,1,0
67584,clinical,1,0
67585,diagnosis,1,1
67586,of,1,0
67587,whooping,1,1
67588,cough,1,1
67589,.,1,0
67590,On,0,0
67591,admission,0,0
67592,they,0,1
67593,were,0,0
67594,assigned,0,1
67595,to,0,0
67596,one,0,1
67597,of,0,0
67598,three,0,1
67599,groups,0,0
67600,:,0,1
67601,(,0,0
67602,a,0,0
67603,),0,0
67604,monocomponent,0,0
67605,pertussis,0,0
67606,toxoid,0,0
67607,vaccine,0,0
67608,;,0,0
67609,(,0,0
67610,b,0,0
67611,),0,0
67612,two-component,0,0
67613,acellular,0,0
67614,vaccine,0,0
67615,also,0,0
67616,containing,0,0
67617,filamentous,0,0
67618,haemagglutinin,0,1
67619,;,0,0
67620,or,0,0
67621,(,0,0
67622,c,0,1
67623,),0,0
67624,20,0,0
67625,%,0,0
67626,albumin,0,0
67627,solution,0,0
67628,(,0,0
67629,placebo,0,0
67630,),0,0
67631,.,0,0
67632,The,0,0
67633,immunoglobulins,0,0
67634,had,0,1
67635,a,0,0
67636,high,0,0
67637,antitoxin,0,0
67638,content,0,0
67639,and,0,0
67640,had,0,0
67641,been,0,0
67642,raised,0,0
67643,with,0,1
67644,acellular,0,0
67645,pertussis,0,1
67646,vaccines,0,0
67647,.,0,1
67648,Diagnosis,0,0
67649,of,0,0
67650,pertussis,0,0
67651,was,0,0
67652,confirmed,0,0
67653,by,0,0
67654,laboratory,0,0
67655,tests,0,0
67656,and,0,0
67657,the,0,0
67658,follow-up,0,0
67659,was,0,0
67660,completed,0,1
67661,in,0,0
67662,67,0,1
67663,children,0,1
67664,.,0,1
67665,The,0,0
67666,main,0,0
67667,study,0,0
67668,group,0,0
67669,consisted,0,1
67670,of,0,0
67671,47,1,1
67672,children,1,1
67673,with,1,1
67674,less,1,0
67675,than,1,0
67676,or,1,0
67677,equal,1,0
67678,to,1,0
67679,14,1,1
67680,days,1,0
67681,of,1,0
67682,disease,1,1
67683,before,1,0
67684,therapy,1,0
67685,.,1,0
67686,Duration,0,0
67687,of,0,0
67688,whoops,0,0
67689,post-treatment,0,0
67690,was,0,0
67691,8.7,0,0
67692,days,0,0
67693,(,0,1
67694,95,0,0
67695,%,0,0
67696,Cl,0,0
67697,4.8,0,0
67698,",",0,0
67699,12.6,0,0
67700,),0,0
67701,in,0,0
67702,the,0,0
67703,33,0,1
67704,children,0,1
67705,receiving,0,1
67706,immunoglobulin,0,1
67707,vs,0,0
67708,20.6,0,0
67709,(,0,0
67710,95,0,0
67711,%,0,0
67712,Cl,0,0
67713,11.9,0,0
67714,",",0,0
67715,29.3,0,0
67716,),0,0
67717,in,0,0
67718,the,0,0
67719,14,0,0
67720,receiving,0,0
67721,placebo,0,0
67722,(,0,0
67723,p,0,0
67724,=,0,0
67725,0.0041,0,0
67726,),0,1
67727,.,0,1
67728,Mean,0,0
67729,number,0,0
67730,of,0,0
67731,whoops,0,0
67732,during,0,0
67733,the,0,0
67734,first,0,0
67735,week,0,0
67736,of,0,0
67737,follow-up,0,0
67738,was,0,0
67739,also,0,0
67740,significantly,0,0
67741,reduced,0,0
67742,(,0,0
67743,p,0,0
67744,=,0,0
67745,0.0196,0,0
67746,),0,0
67747,.,0,1
67748,We,0,0
67749,found,0,0
67750,that,0,0
67751,early,0,1
67752,treatment,0,0
67753,was,0,0
67754,important,0,0
67755,",",0,0
67756,since,0,0
67757,the,0,0
67758,effect,0,0
67759,on,0,0
67760,duration,0,0
67761,of,0,0
67762,whoops,0,0
67763,was,0,0
67764,most,0,0
67765,pronounced,0,0
67766,when,0,0
67767,disease,0,1
67768,duration,0,0
67769,before,0,0
67770,treatment,0,0
67771,was,0,0
67772,less,0,0
67773,than,0,0
67774,or,0,0
67775,equal,0,0
67776,to,0,0
67777,7,0,1
67778,days,0,0
67779,.,0,0
67780,There,0,0
67781,were,0,0
67782,no,0,0
67783,significant,0,0
67784,differences,0,0
67785,between,0,0
67786,the,0,0
67787,two,0,0
67788,immunoglobulin,0,1
67789,preparations,0,0
67790,.,0,1
67791,High-dose,0,0
67792,specific,0,0
67793,pertussis,0,0
67794,immunoglobulin,0,0
67795,with,0,1
67796,a,0,0
67797,high,0,0
67798,antitoxin,0,0
67799,concentration,0,0
67800,has,0,0
67801,a,0,0
67802,beneficial,0,0
67803,effect,0,0
67804,in,0,0
67805,the,0,0
67806,treatment,0,0
67807,of,0,0
67808,whooping,0,1
67809,cough,0,1
67810,.,0,1
67811,The,0,0
67812,efficacy,0,0
67813,of,0,0
67814,early,0,1
67815,continuous,0,0
67816,positive,0,0
67817,airway,0,1
67818,pressure,0,0
67819,therapy,0,0
67820,in,0,0
67821,patients,1,1
67822,with,1,1
67823,acute,1,1
67824,cardiogenic,1,1
67825,pulmonary,1,1
67826,edema,1,0
67827,.,1,0
67828,Although,0,0
67829,continuous,0,0
67830,positive,0,0
67831,airway,0,1
67832,pressure,0,0
67833,(,0,0
67834,CPAP,0,1
67835,),0,0
67836,therapy,0,0
67837,using,0,0
67838,a,0,0
67839,face,0,0
67840,mask,0,0
67841,is,0,0
67842,known,0,0
67843,to,0,0
67844,improve,0,0
67845,oxygenation,0,0
67846,",",0,0
67847,the,0,0
67848,intrapulmonary,0,0
67849,shunt,0,0
67850,reduction,0,0
67851,remains,0,0
67852,unsettled,0,0
67853,.,0,0
67854,Our,0,0
67855,study,0,0
67856,was,0,0
67857,designed,0,0
67858,to,0,0
67859,explore,0,0
67860,this,0,0
67861,issue,0,0
67862,.,0,0
67863,From,1,1
67864,1985,1,1
67865,to,1,1
67866,1987,1,1
67867,80,1,1
67868,patients,1,1
67869,with,1,1
67870,acute,1,1
67871,cardiogenic,1,1
67872,pulmonary,1,1
67873,edema,1,0
67874,were,0,0
67875,randomly,0,1
67876,chosen,0,0
67877,to,0,0
67878,receive,0,0
67879,either,0,0
67880,serial,0,0
67881,CPAP,0,0
67882,therapy,0,0
67883,or,0,1
67884,high-flow,0,0
67885,face,0,0
67886,mask,0,0
67887,oxygen,0,0
67888,therapy,0,0
67889,without,0,1
67890,CPAP,0,1
67891,(,0,0
67892,control,0,0
67893,),0,0
67894,for,0,0
67895,the,0,0
67896,purpose,0,0
67897,of,0,0
67898,evaluating,0,0
67899,the,0,0
67900,efficacy,0,0
67901,of,0,0
67902,CPAP,0,1
67903,therapy,0,0
67904,.,0,0
67905,After,0,0
67906,screening,0,0
67907,for,0,0
67908,exclusion,0,1
67909,",",0,0
67910,only,1,0
67911,55,1,1
67912,patients,1,1
67913,were,1,1
67914,included,1,1
67915,in,0,0
67916,the,0,0
67917,first,0,0
67918,3-hour,0,0
67919,investigation,0,0
67920,period,0,0
67921,.,0,0
67922,PaO2,0,0
67923,in,0,0
67924,the,0,0
67925,CPAP,0,0
67926,group,0,0
67927,showed,0,0
67928,a,0,0
67929,significant,0,0
67930,increase,0,0
67931,by,0,0
67932,the,0,0
67933,end,0,0
67934,of,0,0
67935,the,0,0
67936,initial,0,0
67937,study,0,0
67938,;,0,0
67939,whereas,0,0
67940,intrapulmonary,0,0
67941,shunt,0,0
67942,and,0,0
67943,alveolar-arterial,0,0
67944,oxygen,0,0
67945,tension,0,0
67946,gradient,0,1
67947,AaDO2,0,0
67948,revealed,0,0
67949,simultaneously,0,0
67950,a,0,0
67951,significant,0,0
67952,reduction,0,0
67953,.,0,0
67954,Conversely,0,0
67955,",",0,0
67956,neither,0,0
67957,PaO2,0,0
67958,nor,0,0
67959,intrapulmonary,0,0
67960,shunt,0,0
67961,(,0,0
67962,or,0,1
67963,AaDO2,0,0
67964,),0,0
67965,in,0,0
67966,the,0,0
67967,control,0,0
67968,group,0,0
67969,demonstrated,0,0
67970,any,0,0
67971,significant,0,0
67972,beneficial,0,0
67973,changes,0,0
67974,.,0,1
67975,As,0,0
67976,for,0,0
67977,cardiovascular,0,1
67978,function,0,0
67979,",",0,0
67980,only,0,0
67981,the,0,0
67982,CPAP,0,0
67983,therapy,0,0
67984,achieved,0,0
67985,a,0,0
67986,significant,0,0
67987,reduction,0,0
67988,in,0,0
67989,rate,0,0
67990,pressure,0,0
67991,product,0,0
67992,in,0,0
67993,contrast,0,0
67994,to,0,0
67995,the,0,0
67996,control,0,0
67997,(,0,0
67998,face,0,0
67999,mask,0,0
68000,),0,0
68001,therapy,0,0
68002,alone,0,0
68003,.,0,0
68004,In,0,0
68005,terms,0,0
68006,of,0,0
68007,therapeutic,0,0
68008,failure,0,1
68009,",",0,0
68010,10,0,0
68011,patients,0,1
68012,in,0,0
68013,the,0,0
68014,control,0,0
68015,group,0,0
68016,failed,0,0
68017,.,0,0
68018,However,0,0
68019,",",0,0
68020,in,0,0
68021,the,0,0
68022,CPAP,0,0
68023,group,0,0
68024,only,0,0
68025,5,0,0
68026,patients,0,1
68027,had,0,1
68028,failed,0,0
68029,at,0,0
68030,the,0,0
68031,end,0,0
68032,of,0,0
68033,the,0,0
68034,first,0,0
68035,3-hour,0,0
68036,study,0,1
68037,period,0,0
68038,.,0,0
68039,Overall,0,0
68040,",",0,0
68041,the,0,0
68042,cumulative,0,0
68043,therapeutic,0,0
68044,failure,0,1
68045,rate,0,0
68046,was,0,0
68047,28,0,1
68048,%,0,0
68049,in,0,0
68050,the,0,0
68051,CPAP,0,0
68052,group,0,0
68053,and,0,0
68054,60,0,1
68055,%,0,0
68056,in,0,0
68057,the,0,0
68058,control,0,0
68059,group,0,0
68060,during,0,0
68061,a,0,0
68062,6-hour,0,0
68063,observation,0,0
68064,study,0,0
68065,.,0,0
68066,However,0,0
68067,",",0,0
68068,there,0,0
68069,was,0,0
68070,no,0,0
68071,significant,0,0
68072,difference,0,0
68073,between,0,0
68074,the,0,0
68075,two,0,0
68076,groups,0,0
68077,in,0,1
68078,24-hour,0,1
68079,hospital,0,1
68080,mortality,0,0
68081,.,0,0
68082,(,0,0
68083,ABSTRACT,0,0
68084,TRUNCATED,0,1
68085,AT,0,1
68086,250,0,0
68087,WORDS,0,1
68088,),0,1
68089,Nuclear,0,1
68090,fragments,0,1
68091,and,0,1
68092,holes,0,1
68093,in,0,0
68094,grading,1,1
68095,of,1,0
68096,breast,1,1
68097,cancer,1,1
68098,aspirates,1,1
68099,.,1,0
68100,[,0,0
68101,Pilot,0,1
68102,results,0,0
68103,of,0,0
68104,using,0,0
68105,tamsulone-FS,0,1
68106,in,0,0
68107,patients,1,1
68108,with,1,1
68109,prostatic,1,1
68110,adenoma,1,1
68111,according,0,1
68112,to,0,0
68113,the,0,0
68114,results,0,0
68115,of,0,0
68116,a,0,0
68117,randomized,0,0
68118,multicenter,1,0
68119,comparative,0,0
68120,trial,0,0
68121,],0,1
68122,.,0,1
68123,Tamsulone-FS,0,0
68124,--,0,0
68125,a,0,0
68126,novel,0,0
68127,Russian,0,1
68128,alpha1A/D-adrenoblocker,0,0
68129,(,0,0
68130,Farm-Syntez,0,1
68131,),0,1
68132,--,0,1
68133,was,0,0
68134,studied,0,0
68135,in,0,0
68136,a,0,0
68137,randomized,0,0
68138,multicenter,0,0
68139,comparative,0,0
68140,trial,0,0
68141,in,0,0
68142,patients,1,1
68143,with,1,1
68144,prostatic,1,1
68145,adenoma,1,1
68146,.,1,1
68147,Pilot,0,1
68148,results,0,0
68149,agreed,0,1
68150,with,0,1
68151,other,0,0
68152,trials,0,0
68153,published,0,1
68154,in,0,0
68155,the,0,0
68156,literature,0,0
68157,and,0,0
68158,demonstrated,0,0
68159,tamsulone-FS,0,0
68160,efficacy,0,0
68161,and,0,0
68162,safety,0,0
68163,for,0,0
68164,management,0,0
68165,of,0,0
68166,lower,0,0
68167,urinary,0,1
68168,tract,0,1
68169,symptoms,0,0
68170,caused,0,0
68171,by,0,0
68172,prostatic,0,1
68173,adenoma,0,1
68174,.,0,0
68175,The,0,0
68176,efficacy,0,0
68177,and,0,0
68178,safety,0,0
68179,of,0,0
68180,tamsulone-FS,0,0
68181,was,0,0
68182,comparable,0,0
68183,to,0,0
68184,those,0,0
68185,of,0,0
68186,omnik,0,1
68187,.,0,0
68188,This,0,0
68189,drug,0,0
68190,can,0,0
68191,be,0,0
68192,recommended,0,0
68193,for,0,0
68194,wide,0,1
68195,clinical,0,0
68196,practice,0,0
68197,in,0,0
68198,prostatic,0,1
68199,adenoma,0,1
68200,.,0,0
68201,It,0,0
68202,is,0,0
68203,registered,0,0
68204,by,0,0
68205,Roszdravnadzor,0,1
68206,(,0,1
68207,certificate,0,1
68208,N,0,1
68209,LC-000859,0,0
68210,of,0,0
68211,03.11.2005,0,1
68212,),0,1
68213,and,0,0
68214,allowed,0,0
68215,for,0,0
68216,production,0,0
68217,and,0,0
68218,sale,0,0
68219,.,0,1
68220,A,0,0
68221,comparative,0,0
68222,study,0,0
68223,of,0,0
68224,the,0,0
68225,pharmacokinetics,0,0
68226,of,0,0
68227,ibuprofen,0,0
68228,arginate,0,0
68229,versus,0,0
68230,dexibuprofen,0,0
68231,in,0,0
68232,healthy,1,1
68233,volunteers,1,1
68234,.,1,1
68235,OBJECTIVE,0,0
68236,Ibuprofen,0,0
68237,arginate,0,0
68238,is,0,0
68239,a,0,0
68240,salt,0,0
68241,formulation,0,0
68242,of,0,0
68243,ibuprofen,0,0
68244,designed,0,0
68245,to,0,0
68246,reach,0,0
68247,target,0,0
68248,concentrations,0,0
68249,rapidly,0,0
68250,.,0,0
68251,The,0,0
68252,primary,0,0
68253,objective,0,0
68254,of,0,0
68255,this,0,0
68256,study,0,0
68257,was,0,0
68258,to,0,0
68259,compare,0,0
68260,the,0,0
68261,12-h,0,0
68262,pharmacokinetic,0,0
68263,profile,0,0
68264,of,0,0
68265,S,0,0
68266,(,0,1
68267,+,0,0
68268,),0,0
68269,-ibuprofen,0,0
68270,following,0,0
68271,administration,0,0
68272,of,0,0
68273,single,0,0
68274,doses,0,0
68275,of,0,0
68276,ibuprofen,0,0
68277,arginate,0,0
68278,(,0,0
68279,600,0,0
68280,mg,0,0
68281,),0,0
68282,and,0,0
68283,dexibuprofen,0,0
68284,(,0,0
68285,400,0,0
68286,mg,0,0
68287,),0,0
68288,in,0,0
68289,healthy,1,1
68290,volunteers,1,1
68291,.,1,1
68292,METHODS,0,0
68293,Twenty-four,1,1
68294,volunteers,1,1
68295,were,1,1
68296,recruited,1,1
68297,into,1,0
68298,an,1,0
68299,open-label,1,0
68300,",",1,0
68301,randomised,1,0
68302,",",1,0
68303,two-period,1,0
68304,",",1,0
68305,single-centre,1,1
68306,study,1,0
68307,with,0,1
68308,crossover,0,0
68309,design,0,0
68310,.,0,0
68311,RESULTS,0,0
68312,Both,0,0
68313,treatments,0,0
68314,were,0,0
68315,well,0,0
68316,tolerated,0,0
68317,.,0,0
68318,Ibuprofen,0,0
68319,arginate,0,0
68320,and,0,0
68321,dexibuprofen,0,0
68322,showed,0,0
68323,similar,0,0
68324,bioavailability,0,0
68325,for,0,0
68326,S,0,0
68327,(,0,1
68328,+,0,0
68329,),0,0
68330,-ibuprofen,0,0
68331,.,0,0
68332,Compared,0,0
68333,with,0,0
68334,dexibuprofen,0,0
68335,",",0,0
68336,ibuprofen,0,0
68337,arginate,0,0
68338,demonstrated,0,0
68339,a,0,0
68340,45,0,1
68341,%,0,0
68342,higher,0,0
68343,maximum,0,0
68344,concentration,0,0
68345,(,0,0
68346,C,0,0
68347,(,0,0
68348,max,0,0
68349,),0,0
68350,),0,0
68351,",",0,0
68352,and,0,0
68353,a,0,0
68354,time,0,0
68355,to,0,0
68356,peak,0,0
68357,concentration,0,0
68358,(,0,0
68359,T,0,0
68360,(,0,0
68361,max,0,0
68362,),0,1
68363,),0,0
68364,2,0,0
68365,h,0,0
68366,sooner,0,1
68367,.,0,1
68368,CONCLUSION,0,0
68369,Ibuprofen,0,0
68370,arginate,0,0
68371,approaches,0,0
68372,maximum,0,0
68373,concentrations,0,0
68374,of,0,0
68375,S,0,0
68376,(,0,1
68377,+,0,0
68378,),0,0
68379,-ibuprofen,0,0
68380,faster,0,0
68381,and,0,0
68382,higher,0,0
68383,than,0,0
68384,dexibuprofen,0,0
68385,.,0,1
68386,Studies,0,1
68387,on,0,0
68388,leptin,0,0
68389,and,0,0
68390,leptin,0,0
68391,receptor,0,0
68392,gene,0,0
68393,expression,0,0
68394,in,0,0
68395,myometrium,1,0
68396,and,1,0
68397,uterine,1,1
68398,myomas,1,1
68399,of,1,0
68400,gnRH,1,0
68401,analogue-treated,1,0
68402,women,1,1
68403,.,1,1
68404,AIM,0,0
68405,To,0,0
68406,test,0,0
68407,if,0,0
68408,treatment,0,0
68409,with,0,1
68410,GnRH,0,0
68411,analogue,0,0
68412,",",0,0
68413,which,0,0
68414,leads,0,0
68415,to,0,0
68416,a,0,0
68417,significant,0,0
68418,reduction,0,0
68419,in,0,0
68420,myoma,0,1
68421,volume,0,0
68422,",",0,0
68423,changes,0,0
68424,expression,0,0
68425,of,0,0
68426,leptin,0,0
68427,genes,0,0
68428,and,0,0
68429,gene,0,0
68430,coding,0,0
68431,leptin,0,0
68432,receptor,0,1
68433,isoforms,0,0
68434,in,0,0
68435,uterine,0,1
68436,myomas,0,1
68437,and,0,0
68438,in,0,0
68439,the,0,0
68440,surrounding,0,0
68441,unaltered,0,0
68442,myometrium,0,0
68443,.,0,1
68444,METHODS,0,0
68445,Using,0,0
68446,RT-PCR,0,0
68447,",",0,0
68448,expression,0,0
68449,of,0,0
68450,leptin,0,0
68451,genes,0,0
68452,and,0,0
68453,leptin,0,0
68454,receptor,0,0
68455,genes,0,0
68456,was,0,0
68457,studied,0,1
68458,in,0,0
68459,myomas,0,1
68460,and,0,0
68461,in,0,0
68462,the,0,0
68463,surrounding,0,0
68464,myometrium,0,0
68465,in,0,0
68466,women,1,1
68467,with,1,1
68468,uterine,1,1
68469,myomas,1,1
68470,",",1,0
68471,untreated,1,1
68472,or,1,0
68473,treated,1,1
68474,with,1,1
68475,GnRH,1,0
68476,analogue,1,0
68477,.,1,0
68478,In,0,0
68479,the,0,0
68480,randomly,0,1
68481,selected,0,1
68482,cases,0,0
68483,presence,0,0
68484,of,0,0
68485,leptin,0,0
68486,protein,0,0
68487,and,0,0
68488,of,0,0
68489,leptin,0,0
68490,receptor,0,1
68491,proteins,0,0
68492,was,0,0
68493,examined,0,0
68494,also,0,0
68495,by,0,0
68496,Western,0,1
68497,blotting,0,0
68498,.,0,1
68499,RESULTS,0,0
68500,Expression,0,0
68501,of,0,0
68502,leptin,0,0
68503,genes,0,0
68504,was,0,0
68505,demonstrated,0,0
68506,both,0,0
68507,in,0,0
68508,myomas,0,1
68509,and,0,0
68510,in,0,0
68511,the,0,0
68512,surrounding,0,0
68513,myometrium,0,0
68514,",",0,0
68515,and,0,0
68516,a,0,0
68517,similar,0,0
68518,pattern,0,1
68519,of,0,0
68520,expression,0,0
68521,was,0,0
68522,found,0,0
68523,for,0,0
68524,leptin,0,0
68525,receptor,0,1
68526,isoforms,0,0
68527,.,0,1
68528,The,0,0
68529,results,0,0
68530,of,0,0
68531,RT-PCR,0,0
68532,were,0,0
68533,confirmed,0,0
68534,by,0,0
68535,Western,0,1
68536,blotting,0,0
68537,",",0,0
68538,which,0,0
68539,documented,0,0
68540,the,0,0
68541,identical,0,0
68542,distribution,0,0
68543,of,0,0
68544,leptin,0,0
68545,proteins,0,0
68546,and,0,0
68547,leptin,0,0
68548,receptor,0,0
68549,proteins,0,0
68550,in,0,0
68551,studied,0,1
68552,tissues,0,1
68553,.,0,1
68554,Treatment,0,0
68555,with,0,1
68556,GnRH,0,0
68557,analogue,0,0
68558,had,0,0
68559,no,0,0
68560,effect,0,0
68561,on,0,0
68562,the,0,0
68563,expression,0,0
68564,pattern,0,1
68565,of,0,0
68566,studied,0,1
68567,genes,0,0
68568,.,0,1
68569,CONCLUSION,0,0
68570,The,0,0
68571,results,0,0
68572,of,0,0
68573,the,0,0
68574,present,0,0
68575,study,0,0
68576,on,0,0
68577,the,0,0
68578,administration,0,0
68579,of,0,0
68580,GnRH,0,0
68581,analogue,0,0
68582,to,0,0
68583,females,1,1
68584,with,1,1
68585,myomas,1,1
68586,suggest,0,0
68587,that,0,0
68588,no,0,0
68589,direct,0,0
68590,or,0,1
68591,immediate,0,0
68592,inter-relationship,0,0
68593,exists,0,0
68594,between,0,0
68595,expression,0,0
68596,of,0,0
68597,leptin,0,0
68598,genes,0,0
68599,in,0,0
68600,uterine,0,1
68601,myomas,0,1
68602,on,0,0
68603,one,0,0
68604,hand,0,0
68605,and,0,0
68606,estrogen,0,0
68607,",",0,0
68608,progesterone,0,0
68609,and,0,0
68610,leptin,0,0
68611,levels,0,0
68612,in,0,0
68613,the,0,0
68614,blood,0,0
68615,on,0,0
68616,the,0,0
68617,other,0,0
68618,.,0,0
68619,Expression,0,0
68620,seems,0,0
68621,to,0,0
68622,be,0,0
68623,of,0,0
68624,a,0,0
68625,more,0,0
68626,durable,0,0
68627,nature,0,0
68628,but,0,0
68629,factors,0,0
68630,that,0,0
68631,induce,0,0
68632,such,0,0
68633,expression,0,0
68634,remain,0,0
68635,unknown,0,0
68636,.,0,1
68637,Enhanced,0,0
68638,baroreceptor,0,0
68639,control,0,0
68640,of,0,0
68641,the,0,0
68642,cardiovascular,0,0
68643,system,0,0
68644,by,0,0
68645,polyunsaturated,0,0
68646,Fatty,0,1
68647,acids,0,0
68648,in,0,0
68649,heart,1,1
68650,failure,1,1
68651,patients,1,1
68652,.,1,1
68653,OBJECTIVES,0,0
68654,The,0,0
68655,intention,0,0
68656,of,0,0
68657,this,0,0
68658,study,0,0
68659,was,0,0
68660,to,0,0
68661,test,0,0
68662,the,0,0
68663,hypothesis,0,0
68664,that,0,0
68665,",",0,0
68666,in,0,0
68667,heart,1,1
68668,failure,1,1
68669,patients,1,1
68670,",",0,0
68671,dietary,0,0
68672,supplementation,0,0
68673,of,0,0
68674,polyunsaturated,0,0
68675,fatty,0,0
68676,acids,0,0
68677,(,0,1
68678,PUFA,0,0
68679,),0,0
68680,enhances,0,0
68681,arterial,0,0
68682,baroreceptor,0,0
68683,control,0,0
68684,of,0,0
68685,the,0,0
68686,cardiovascular,0,1
68687,system,0,0
68688,.,0,1
68689,BACKGROUND,0,0
68690,Administration,0,0
68691,of,0,0
68692,PUFA,0,0
68693,reduces,0,0
68694,the,0,0
68695,risk,0,0
68696,of,0,0
68697,life-threatening,0,1
68698,arrhythmias,0,1
68699,in,0,1
68700,patients,1,1
68701,surviving,1,1
68702,myocardial,1,1
68703,infarction,1,1
68704,.,1,0
68705,This,0,0
68706,might,0,0
68707,result,0,0
68708,from,0,0
68709,potentiation,0,0
68710,of,0,0
68711,arterial,0,1
68712,baroreflexes,0,0
68713,",",0,0
68714,but,0,0
68715,whether,0,0
68716,or,0,0
68717,not,0,0
68718,PUFA,0,0
68719,enhance,0,0
68720,baroreflex,0,0
68721,function,0,0
68722,has,0,0
68723,never,0,0
68724,been,0,0
68725,studied,0,0
68726,in,0,0
68727,humans,1,1
68728,.,1,1
68729,METHODS,0,0
68730,Patients,1,1
68731,with,1,1
68732,post-myocardial,1,1
68733,infarction,1,1
68734,left,1,1
68735,ventricular,1,0
68736,dysfunction,1,1
68737,underwent,0,1
68738,beat-to-beat,0,0
68739,blood,0,0
68740,pressure,0,0
68741,(,0,0
68742,BP,0,0
68743,),0,0
68744,(,0,0
68745,Finapres,0,0
68746,",",0,0
68747,Ohmeda,0,0
68748,Inc.,0,0
68749,",",0,0
68750,Englewood,0,0
68751,",",0,0
68752,Colorado,0,1
68753,),0,0
68754,and,0,0
68755,R-R,0,0
68756,interval,0,0
68757,(,0,0
68758,electrocardiogram,0,0
68759,),0,0
68760,recording,0,0
68761,;,0,0
68762,baroreceptor,0,0
68763,reflexes,0,0
68764,were,0,0
68765,assessed,0,0
68766,from,0,0
68767,the,0,0
68768,bradycardic,0,0
68769,and,0,0
68770,depressor,0,0
68771,responses,0,0
68772,to,0,0
68773,graded,0,0
68774,neck,0,1
68775,suction,0,0
68776,(,0,0
68777,NS,0,0
68778,),0,0
68779,as,0,0
68780,well,0,0
68781,as,0,0
68782,by,0,0
68783,computation,0,0
68784,of,0,0
68785,the,0,0
68786,alpha,0,0
68787,spontaneous,0,0
68788,baroreflex,0,0
68789,sensitivity,0,0
68790,index,0,0
68791,.,0,1
68792,Assessments,0,0
68793,were,0,0
68794,repeated,0,0
68795,after,0,0
68796,prolonged,0,0
68797,treatment,0,0
68798,with,0,1
68799,PUFA,0,0
68800,(,0,1
68801,2,0,0
68802,g/die,0,0
68803,",",0,0
68804,n,0,1
68805,=,0,0
68806,15,0,1
68807,),0,0
68808,or,0,1
68809,placebo,0,0
68810,(,0,0
68811,n,0,1
68812,=,0,0
68813,10,0,1
68814,),0,1
68815,.,0,1
68816,RESULTS,0,0
68817,Baseline,0,0
68818,BP,0,0
68819,and,0,0
68820,R-R,0,0
68821,interval,0,0
68822,were,0,0
68823,unaffected,0,0
68824,by,0,0
68825,PUFA,0,0
68826,.,0,1
68827,Both,0,0
68828,reflex,0,0
68829,depressor,0,0
68830,and,0,0
68831,bradycardic,0,0
68832,responses,0,0
68833,to,0,1
68834,NS,0,0
68835,increased,0,0
68836,after,0,0
68837,PUFA,0,0
68838,(,0,0
68839,respectively,0,0
68840,from,0,0
68841,-0.09,0,0
68842,+/-,0,0
68843,0.01,0,0
68844,to,0,0
68845,-0.16,0,0
68846,+/-,0,0
68847,0.01,0,0
68848,mm,0,1
68849,Hg,0,0
68850,x,0,0
68851,mm,0,0
68852,Hg,0,0
68853,(,0,0
68854,-1,0,0
68855,),0,0
68856,",",0,0
68857,p,0,0
68858,<,0,0
68859,0.01,0,0
68860,",",0,0
68861,and,0,0
68862,from,0,0
68863,1.25,0,0
68864,+/-,0,0
68865,0.9,0,0
68866,to,0,1
68867,1.76,0,0
68868,+/-,0,0
68869,1.1,0,0
68870,ms,0,1
68871,x,0,0
68872,mm,0,0
68873,Hg,0,0
68874,(,0,0
68875,-1,0,0
68876,),0,0
68877,",",0,0
68878,p,0,0
68879,<,0,0
68880,0.04,0,0
68881,),0,0
68882,but,0,0
68883,not,0,0
68884,after,0,0
68885,placebo,0,0
68886,.,0,0
68887,The,0,0
68888,spontaneous,0,0
68889,baroreflex,0,0
68890,sensitivity,0,0
68891,increased,0,0
68892,in,0,0
68893,the,0,0
68894,PUFA,0,0
68895,(,0,0
68896,from,0,1
68897,8.99,0,0
68898,+/-,0,0
68899,1.4,0,0
68900,to,0,1
68901,12.2,0,0
68902,+/-,0,0
68903,1.2,0,0
68904,ms,0,1
68905,x,0,0
68906,mm,0,0
68907,Hg,0,0
68908,(,0,0
68909,-1,0,0
68910,),0,0
68911,",",0,0
68912,p,0,0
68913,<,0,0
68914,0.02,0,0
68915,),0,0
68916,but,0,0
68917,not,0,0
68918,in,0,0
68919,the,0,0
68920,placebo,0,0
68921,group,0,0
68922,.,0,0
68923,Polyunsaturated,0,0
68924,fatty,0,0
68925,acids,0,0
68926,(,0,0
68927,but,0,0
68928,not,0,0
68929,placebo,0,0
68930,),0,0
68931,treatment,0,0
68932,also,0,0
68933,significantly,0,0
68934,increased,0,0
68935,R-R,0,0
68936,interval,0,0
68937,total,0,1
68938,variance,0,0
68939,and,0,0
68940,low-frequency,0,0
68941,and,0,0
68942,high-frequency,0,0
68943,spectral,0,0
68944,powers,0,1
68945,.,0,1
68946,CONCLUSIONS,0,0
68947,Dietary,0,0
68948,PUFA,0,0
68949,supplementation,0,0
68950,markedly,0,0
68951,potentiates,0,0
68952,baroreflex,0,0
68953,function,0,0
68954,and,0,0
68955,enhances,0,0
68956,heart,0,1
68957,rate,0,0
68958,variability,0,0
68959,in,0,0
68960,patients,1,1
68961,with,1,1
68962,stable,1,1
68963,congestive,1,1
68964,heart,1,1
68965,failure,1,1
68966,.,1,1
68967,Endocrine,0,1
68968,response,0,0
68969,to,0,0
68970,cataract,1,1
68971,surgery,1,1
68972,under,1,0
68973,total,1,1
68974,intravenous,1,0
68975,anaesthesia,1,1
68976,",",1,0
68977,local,1,0
68978,anaesthesia,1,1
68979,under,1,0
68980,sedation,1,0
68981,or,1,1
68982,local,1,0
68983,anaesthesia,1,1
68984,alone,1,0
68985,:,1,1
68986,a,0,0
68987,comparative,0,0
68988,study,0,0
68989,.,0,1
68990,Effect,0,0
68991,of,0,0
68992,patient,1,0
68993,withdrawal,1,0
68994,on,1,0
68995,a,1,0
68996,study,1,0
68997,evaluating,0,0
68998,pharmacist,0,0
68999,management,0,1
69000,of,0,0
69001,hypertension,0,1
69002,.,0,1
69003,STUDY,0,0
69004,OBJECTIVES,0,0
69005,To,0,0
69006,examine,0,0
69007,potential,0,0
69008,threats,0,0
69009,to,0,1
69010,internal,0,1
69011,and,0,0
69012,external,0,0
69013,study,0,0
69014,validity,0,0
69015,caused,0,0
69016,by,0,0
69017,differential,1,0
69018,patient,1,0
69019,withdrawal,1,0
69020,from,1,0
69021,a,1,0
69022,randomized,1,0
69023,controlled,1,0
69024,trial,1,0
69025,evaluating,1,0
69026,pharmacist,1,0
69027,management,1,1
69028,of,1,0
69029,hypertension,1,1
69030,",",1,0
69031,to,1,0
69032,compare,1,0
69033,the,1,0
69034,characteristics,1,0
69035,of,1,1
69036,patients,1,1
69037,who,1,1
69038,withdrew,1,1
69039,with,1,1
69040,those,1,0
69041,of,1,1
69042,patients,1,1
69043,who,1,1
69044,completed,1,1
69045,the,1,1
69046,study,1,0
69047,",",1,0
69048,and,1,0
69049,to,1,0
69050,identify,1,0
69051,characteristics,1,0
69052,that,1,0
69053,predispose,1,1
69054,patients,1,1
69055,to,1,0
69056,withdraw,1,0
69057,from,1,0
69058,hypertension,1,1
69059,management,1,1
69060,.,1,1
69061,DESIGN,0,0
69062,Prospective,0,0
69063,",",0,0
69064,randomized,0,0
69065,",",0,0
69066,comparative,0,0
69067,study,0,0
69068,.,0,1
69069,SETTING,0,1
69070,Network,0,0
69071,of,0,0
69072,primary,0,1
69073,care,0,1
69074,clinics,0,1
69075,.,0,1
69076,PATIENTS,0,0
69077,Four,1,0
69078,hundred,1,1
69079,sixty-three,1,1
69080,patients,1,1
69081,with,1,1
69082,a,1,0
69083,diagnosis,1,1
69084,of,1,0
69085,hypertension,1,1
69086,and,1,0
69087,a,1,0
69088,last,1,0
69089,documented,1,0
69090,systolic,1,1
69091,blood,1,0
69092,pressure,1,0
69093,of,1,0
69094,160,1,1
69095,mm,1,0
69096,Hg,1,0
69097,or,1,1
69098,greater,1,0
69099,and/or,1,0
69100,diastolic,1,1
69101,blood,1,0
69102,pressure,1,0
69103,of,1,0
69104,100,1,0
69105,mm,1,0
69106,Hg,1,0
69107,or,1,1
69108,greater,1,0
69109,.,1,1
69110,INTERVENTION,0,0
69111,Patients,1,1
69112,were,1,1
69113,randomly,1,1
69114,allocated,1,0
69115,to,1,0
69116,the,1,0
69117,pharmacist,1,0
69118,intervention,1,0
69119,or,1,1
69120,usual-care,1,0
69121,(,1,0
69122,control,1,1
69123,),1,0
69124,group,1,0
69125,.,1,0
69126,Those,1,0
69127,in,1,0
69128,the,1,0
69129,pharmacist,1,0
69130,intervention,1,0
69131,group,1,0
69132,were,0,0
69133,collaboratively,0,0
69134,managed,0,1
69135,by,0,0
69136,a,0,0
69137,primary,0,0
69138,care,0,1
69139,clinical,0,0
69140,pharmacy,0,0
69141,specialist,0,1
69142,and,0,0
69143,their,0,0
69144,primary,0,0
69145,care,0,1
69146,provider,0,0
69147,.,0,0
69148,Patients,1,1
69149,in,1,0
69150,the,1,0
69151,control,1,0
69152,group,1,0
69153,received,0,0
69154,usual,0,1
69155,care,0,1
69156,from,0,0
69157,only,0,0
69158,their,0,0
69159,primary,0,0
69160,care,0,1
69161,provider,0,0
69162,.,0,0
69163,MEASUREMENTS,0,0
69164,AND,0,0
69165,MAIN,0,0
69166,RESULTS,0,0
69167,Of,0,1
69168,the,0,0
69169,463,1,1
69170,patients,1,1
69171,",",1,1
69172,191,1,1
69173,(,1,0
69174,41,1,1
69175,%,1,0
69176,),1,0
69177,withdrew,1,0
69178,from,1,0
69179,the,1,0
69180,study,1,0
69181,after,1,0
69182,randomization,1,0
69183,and,1,0
69184,272,1,1
69185,(,1,0
69186,59,1,1
69187,%,1,0
69188,),1,0
69189,completed,1,1
69190,the,1,0
69191,study,1,0
69192,.,1,1
69193,Patients,1,1
69194,who,1,1
69195,withdrew,1,1
69196,from,1,1
69197,the,1,0
69198,pharmacist,1,0
69199,intervention,1,0
69200,group,1,0
69201,were,1,0
69202,similar,1,0
69203,to,1,1
69204,patients,1,1
69205,who,1,1
69206,withdrew,1,1
69207,from,1,1
69208,the,1,0
69209,usual-care,1,0
69210,group,1,0
69211,with,0,1
69212,respect,0,0
69213,to,0,0
69214,age,0,1
69215,",",0,0
69216,sex,0,0
69217,",",0,0
69218,insurance,0,1
69219,status,0,0
69220,",",0,0
69221,and,0,0
69222,chronic,0,1
69223,conditions,0,1
69224,.,0,1
69225,Patients,1,1
69226,who,1,1
69227,smoked,1,1
69228,or,1,1
69229,had,1,1
69230,commercial,1,0
69231,insurance,1,0
69232,were,1,0
69233,more,1,0
69234,likely,1,0
69235,to,1,0
69236,withdraw,1,0
69237,from,1,0
69238,the,1,0
69239,study,1,0
69240,than,1,0
69241,the,1,0
69242,other,1,0
69243,participants,1,1
69244,.,1,0
69245,However,0,0
69246,",",0,0
69247,multivariate,0,0
69248,analysis,0,0
69249,of,0,0
69250,all,0,0
69251,variables,0,0
69252,",",0,0
69253,when,0,0
69254,adjusted,0,0
69255,for,0,0
69256,the,0,0
69257,effect,0,0
69258,of,0,0
69259,the,0,0
69260,intervention,0,0
69261,",",0,0
69262,revealed,0,0
69263,that,0,0
69264,insurance,0,1
69265,status,0,0
69266,was,0,0
69267,the,0,0
69268,only,0,0
69269,variable,0,0
69270,associated,0,0
69271,with,0,1
69272,a,0,0
69273,heightened,0,0
69274,probability,0,0
69275,of,0,0
69276,withdrawal,0,0
69277,(,0,0
69278,p=0.002,0,0
69279,),0,0
69280,.,0,0
69281,CONCLUSION,0,0
69282,Although,0,0
69283,this,0,0
69284,study,0,0
69285,had,0,0
69286,a,0,0
69287,high,0,0
69288,withdrawal,0,0
69289,rate,0,0
69290,",",0,0
69291,between-group,1,0
69292,patient,1,1
69293,characteristics,1,0
69294,remained,1,0
69295,balanced,1,0
69296,.,1,0
69297,Therefore,0,0
69298,",",0,0
69299,internal,0,0
69300,validity,0,0
69301,was,0,0
69302,preserved,0,0
69303,",",0,0
69304,and,0,0
69305,outcomes,0,0
69306,from,0,0
69307,the,0,0
69308,study,0,0
69309,groups,0,0
69310,could,0,0
69311,be,0,0
69312,reliably,0,0
69313,compared,0,0
69314,.,0,0
69315,A,0,0
69316,lack,0,0
69317,of,0,0
69318,significant,0,0
69319,differences,0,0
69320,between,0,1
69321,patients,1,1
69322,who,1,1
69323,withdrew,1,1
69324,versus,1,1
69325,those,1,1
69326,who,1,1
69327,completed,1,1
69328,",",1,1
69329,with,1,1
69330,the,1,0
69331,exception,1,0
69332,of,1,0
69333,insurance,1,1
69334,status,1,0
69335,",",1,0
69336,suggests,1,0
69337,that,1,0
69338,external,1,0
69339,validity,1,0
69340,was,1,0
69341,not,1,0
69342,jeopardized,1,0
69343,.,1,0
69344,Neuropsychological,0,1
69345,effects,0,0
69346,of,0,0
69347,risperidone,0,0
69348,in,0,0
69349,children,1,1
69350,with,1,1
69351,pervasive,1,1
69352,developmental,1,1
69353,disorders,1,1
69354,:,1,1
69355,a,0,0
69356,blinded,0,0
69357,discontinuation,0,0
69358,study,0,1
69359,.,0,1
69360,OBJECTIVE,0,0
69361,Little,0,0
69362,is,0,0
69363,known,0,0
69364,about,0,0
69365,the,0,0
69366,neuropsychological,0,1
69367,effects,0,0
69368,of,0,0
69369,risperidone,0,0
69370,in,0,0
69371,children,1,1
69372,with,1,1
69373,pervasive,1,1
69374,developmental,1,1
69375,disorders,1,1
69376,.,1,1
69377,METHOD,0,0
69378,Twenty-four,1,1
69379,children,1,1
69380,(,1,1
69381,aged,1,1
69382,5-17,1,1
69383,years,1,1
69384,),1,1
69385,with,1,1
69386,pervasive,1,1
69387,developmental,1,1
69388,disorders,1,1
69389,and,1,1
69390,co-morbid,1,1
69391,disruptive,1,1
69392,behavior,1,1
69393,who,1,1
69394,responded,1,1
69395,favorably,1,1
69396,to,1,0
69397,open-label,1,0
69398,treatment,1,0
69399,with,1,1
69400,risperidone,1,0
69401,as,1,0
69402,part,1,0
69403,of,1,0
69404,a,1,0
69405,previously,1,0
69406,described,1,0
69407,controlled,1,0
69408,discontinuation,1,0
69409,study,1,0
69410,completed,0,1
69411,two,0,0
69412,different,0,0
69413,computerized,0,1
69414,attention,0,0
69415,tasks,0,0
69416,at,0,0
69417,baseline,0,0
69418,",",0,0
69419,weeks,0,0
69420,4,0,0
69421,",",0,0
69422,8,0,0
69423,",",0,0
69424,and,0,0
69425,24,0,0
69426,of,0,0
69427,open-label,0,0
69428,treatment,0,0
69429,",",0,0
69430,and,0,0
69431,",",0,0
69432,at,0,0
69433,8,0,0
69434,weeks,0,0
69435,after,0,0
69436,random,0,1
69437,assignment,0,0
69438,to,0,0
69439,either,0,0
69440,placebo,0,0
69441,or,0,0
69442,risperidone,0,0
69443,.,0,0
69444,The,0,0
69445,primary,0,0
69446,efficacy,0,0
69447,measures,0,0
69448,were,0,1
69449,response,0,0
69450,latencies,0,0
69451,to,0,0
69452,visually,0,0
69453,presented,0,0
69454,stimuli,0,0
69455,requiring,0,1
69456,two,0,0
69457,different,0,0
69458,types,0,0
69459,of,0,0
69460,attention-controlled,0,0
69461,processing,0,0
69462,",",0,0
69463,i.e.,0,0
69464,",",0,0
69465,focused,0,0
69466,and,0,0
69467,divided,0,1
69468,attention,0,0
69469,.,0,0
69470,RESULTS,0,0
69471,About,0,0
69472,half,0,1
69473,of,0,0
69474,the,0,0
69475,clinical,0,0
69476,responders,0,0
69477,did,0,0
69478,not,0,0
69479,produce,0,0
69480,valid,0,0
69481,performance,0,0
69482,measures,0,0
69483,.,0,0
69484,These,0,0
69485,could,0,0
69486,be,0,0
69487,shown,0,0
69488,to,0,0
69489,be,0,0
69490,of,0,0
69491,younger,0,1
69492,mental,0,1
69493,age,0,1
69494,and,0,0
69495,less,0,0
69496,adaptive,0,0
69497,as,0,0
69498,measured,0,0
69499,by,0,0
69500,the,0,0
69501,Vineland,0,1
69502,Behavior,0,1
69503,Scales,0,0
69504,.,0,0
69505,For,0,0
69506,the,0,0
69507,valid,0,0
69508,task,0,0
69509,performers,0,0
69510,divided,0,1
69511,attention,0,0
69512,(,0,0
69513,serial,0,0
69514,search,0,0
69515,in,0,0
69516,working,0,0
69517,memory,0,0
69518,),0,0
69519,was,0,0
69520,shown,0,0
69521,to,0,0
69522,regress,0,0
69523,in,0,0
69524,the,0,0
69525,placebo,0,0
69526,group,0,0
69527,(,0,0
69528,n,0,1
69529,=,0,0
69530,7,0,1
69531,),0,0
69532,",",0,0
69533,while,0,0
69534,in,0,0
69535,the,0,0
69536,risperidone,0,0
69537,group,0,0
69538,(,0,0
69539,n,0,1
69540,=,0,0
69541,7,0,1
69542,),0,0
69543,there,0,0
69544,was,0,0
69545,further,0,0
69546,improvement,0,0
69547,.,0,0
69548,No,0,0
69549,such,0,0
69550,group,0,0
69551,difference,0,0
69552,was,0,0
69553,found,0,0
69554,for,0,0
69555,focused,0,0
69556,attention,0,0
69557,.,0,0
69558,CONCLUSIONS,0,0
69559,The,0,0
69560,study,0,0
69561,suggests,0,0
69562,a,0,0
69563,beneficial,0,0
69564,effect,0,0
69565,of,0,0
69566,risperidone,0,0
69567,after,0,0
69568,several,0,0
69569,months,0,0
69570,of,0,0
69571,treatment,0,0
69572,",",0,0
69573,enhancing,0,0
69574,divided,0,0
69575,attention,0,0
69576,in,0,0
69577,children,1,1
69578,with,1,1
69579,pervasive,1,1
69580,developmental,1,1
69581,disorders,1,1
69582,.,1,1
69583,[,0,0
69584,The,0,0
69585,effects,0,0
69586,of,0,0
69587,antidepressant,0,0
69588,treatment,0,0
69589,on,0,0
69590,efficacy,0,0
69591,of,0,0
69592,antihypertensive,0,0
69593,therapy,0,0
69594,in,0,0
69595,elderly,1,1
69596,hypertension,1,1
69597,],1,1
69598,.,0,1
69599,OBJECTIVE,0,0
69600,To,0,0
69601,explore,0,0
69602,the,0,0
69603,effect,0,0
69604,of,0,0
69605,antidepressant,0,0
69606,treatment,0,0
69607,on,0,0
69608,antihypertensive,0,0
69609,therapy,0,0
69610,of,0,0
69611,senile,1,1
69612,hypertension,1,1
69613,.,1,1
69614,METHODS,0,0
69615,138,1,1
69616,cases,1,1
69617,of,1,0
69618,senile,1,1
69619,hypertension,1,1
69620,complicating,1,0
69621,with,1,1
69622,depression,1,1
69623,were,1,0
69624,studied,1,1
69625,.,1,1
69626,103,1,1
69627,senile,1,1
69628,hypertensive,1,1
69629,patients,1,1
69630,without,1,1
69631,depression,1,1
69632,in,1,0
69633,the,1,0
69634,same,1,0
69635,period,1,0
69636,served,1,0
69637,as,1,0
69638,controls,1,1
69639,.,1,1
69640,The,0,0
69641,patients,0,1
69642,were,0,0
69643,randomly,0,1
69644,divided,0,1
69645,into,0,0
69646,3,0,0
69647,groups,0,0
69648,as,0,0
69649,A,0,1
69650,",",0,0
69651,B,0,0
69652,and,0,0
69653,C,0,0
69654,for,0,0
69655,study,0,1
69656,.,0,1
69657,12.5,0,0
69658,mg/d,0,0
69659,hydrochlorothiazide,0,0
69660,and,0,0
69661,30,0,1
69662,mg/d,0,0
69663,release-controlling,0,0
69664,tablets,0,0
69665,of,0,0
69666,nifedipine,0,0
69667,were,0,0
69668,orally,0,0
69669,administrated,0,0
69670,as,0,0
69671,basic,0,0
69672,antihypertensive,0,0
69673,medication,0,0
69674,each,0,0
69675,group,0,0
69676,.,0,0
69677,Besides,0,0
69678,",",0,0
69679,20,0,0
69680,mg/d,0,0
69681,fluoxetine,0,0
69682,was,0,0
69683,additionally,0,0
69684,given,0,0
69685,to,0,0
69686,groups,0,0
69687,A,0,1
69688,and,0,1
69689,one,0,0
69690,tablet,0,0
69691,of,0,0
69692,almitrine,0,0
69693,l/d,0,0
69694,and,0,0
69695,20,0,0
69696,mg,0,0
69697,oryzanol,0,0
69698,3/d,0,0
69699,were,0,0
69700,given,0,0
69701,to,0,0
69702,group,0,0
69703,B,0,0
69704,.,0,0
69705,The,0,0
69706,treatment,0,0
69707,lasted,0,0
69708,12,0,1
69709,weeks,0,0
69710,.,0,1
69711,RESULTS,0,0
69712,In,0,0
69713,comparison,0,0
69714,with,0,1
69715,pre-treatment,0,0
69716,",",0,0
69717,the,0,0
69718,blood,0,0
69719,pressure,0,0
69720,at,0,0
69721,base,0,0
69722,line,0,0
69723,in,0,0
69724,sitting,0,0
69725,position,0,0
69726,and,0,0
69727,the,0,0
69728,average,0,0
69729,circadian,0,0
69730,SBP,0,1
69731,and,0,0
69732,DBP,0,1
69733,monitored,0,0
69734,with,0,1
69735,24-hour,0,0
69736,ambulatory,0,1
69737,blood,0,0
69738,pressure,0,0
69739,monitoring,0,0
69740,(,0,0
69741,ABPM,0,0
69742,),0,0
69743,was,0,0
69744,remarkably,0,0
69745,decreased,0,0
69746,in,0,0
69747,group,0,0
69748,A,0,1
69749,with,0,1
69750,statistical,0,0
69751,significance,0,0
69752,(,0,0
69753,P,0,0
69754,<,0,0
69755,0.01,0,0
69756,),0,0
69757,.,0,0
69758,These,0,0
69759,blood,0,0
69760,pressure,0,0
69761,parameters,0,0
69762,in,0,0
69763,group,0,1
69764,B,0,0
69765,were,0,0
69766,also,0,0
69767,decreased,0,0
69768,as,0,0
69769,compared,0,0
69770,ith,0,0
69771,the,0,0
69772,pretreatment,0,0
69773,level,0,0
69774,brt,0,0
69775,with,0,1
69776,less,0,0
69777,statistical,0,0
69778,significance,0,0
69779,(,0,0
69780,P,0,0
69781,>,0,1
69782,0.05,0,0
69783,),0,0
69784,.,0,1
69785,It,0,0
69786,was,0,0
69787,also,0,0
69788,noted,0,0
69789,tha,0,0
69790,with,0,1
69791,the,0,0
69792,addition,0,0
69793,of,0,0
69794,antidepressant,0,0
69795,fluoxetine,0,0
69796,",",0,0
69797,the,0,0
69798,manifestations,0,0
69799,of,0,0
69800,depression,0,1
69801,ere,0,0
69802,alleviated,0,0
69803,as,0,0
69804,shown,0,0
69805,by,0,0
69806,Hamilton,0,1
69807,depression,0,1
69808,(,0,0
69809,HAMD,0,0
69810,),0,0
69811,scale,0,0
69812,.,0,1
69813,untoward,0,0
69814,reactions,0,0
69815,such,0,0
69816,as,0,0
69817,nausea,0,0
69818,",",0,0
69819,perspiration,0,0
69820,and,0,0
69821,skin,0,0
69822,rash,0,0
69823,were,0,0
69824,noted,0,0
69825,in,0,0
69826,a,0,0
69827,few,0,0
69828,patients,0,1
69829,",",0,0
69830,but,0,0
69831,none,0,0
69832,withdrew,0,0
69833,from,0,0
69834,the,0,0
69835,study,0,0
69836,.,0,0
69837,CONCLUSIONS,0,0
69838,Antidepressant,0,0
69839,and,0,0
69840,antianxiety,0,0
69841,treatment,0,0
69842,is,0,0
69843,of,0,0
69844,benefit,0,0
69845,to,0,0
69846,the,0,0
69847,antihypertensive,0,0
69848,therapy,0,0
69849,in,0,0
69850,senile,0,1
69851,hypertensive,0,1
69852,patients,0,1
69853,with,0,1
69854,complications,0,0
69855,of,0,0
69856,depression,0,1
69857,and/or,0,0
69858,anxiety,0,0
69859,neurosis,0,1
69860,.,0,0
69861,Based,0,0
69862,on,0,0
69863,the,0,0
69864,results,0,0
69865,of,0,0
69866,this,0,0
69867,study,0,0
69868,",",0,0
69869,it,0,0
69870,is,0,0
69871,suggested,0,0
69872,that,0,0
69873,routine,0,0
69874,administration,0,0
69875,of,0,0
69876,antidepressants,0,0
69877,and,0,1
69878,antianxiety,0,0
69879,drugs,0,0
69880,should,0,0
69881,be,0,0
69882,carried,0,0
69883,out,0,0
69884,in,0,0
69885,senile,1,1
69886,hypertensive,1,1
69887,patients,1,1
69888,complicating,0,1
69889,with,0,1
69890,depression,0,1
69891,or,0,1
69892,anxiety,0,0
69893,.,0,1
69894,The,0,0
69895,instruction,0,0
69896,to,0,0
69897,refrain,0,0
69898,from,0,0
69899,blinking,0,0
69900,affects,0,0
69901,auditory,0,0
69902,P3,0,1
69903,and,0,1
69904,N1,0,0
69905,amplitudes,0,0
69906,.,0,1
69907,Often,0,0
69908,subjects,0,1
69909,have,0,0
69910,been,0,0
69911,instructed,0,0
69912,to,0,0
69913,refrain,0,0
69914,from,0,0
69915,blinking,0,0
69916,lest,0,0
69917,their,0,1
69918,evoked,0,0
69919,EEG,0,0
69920,potentials,0,0
69921,should,0,0
69922,be,0,0
69923,distorted,0,0
69924,.,0,0
69925,We,0,0
69926,studied,0,0
69927,whether,0,0
69928,these,0,0
69929,very,0,0
69930,instructions,0,0
69931,have,0,0
69932,any,0,0
69933,impact,0,0
69934,on,0,0
69935,P3,0,1
69936,amplitude,0,0
69937,.,0,1
69938,Two,0,0
69939,tones,0,0
69940,were,0,1
69941,presented,0,1
69942,in,0,0
69943,random,0,1
69944,order,0,0
69945,",",0,0
69946,and,0,0
69947,subjects,0,1
69948,had,0,1
69949,to,0,0
69950,count,0,0
69951,the,0,0
69952,high-pitched,0,0
69953,tones,0,0
69954,.,0,1
69955,Half,1,0
69956,the,1,0
69957,subjects,1,1
69958,were,1,0
69959,instructed,1,0
69960,not,1,0
69961,to,1,0
69962,blink,1,0
69963,",",0,0
69964,whereas,0,0
69965,this,0,0
69966,instruction,0,0
69967,was,0,0
69968,omitted,0,0
69969,for,0,0
69970,the,0,0
69971,other,0,0
69972,subjects,0,1
69973,.,0,1
69974,Target,0,0
69975,tones,0,0
69976,evoked,0,0
69977,larger,0,0
69978,P3s,0,0
69979,than,0,0
69980,non-targets,0,0
69981,in,0,0
69982,the,0,0
69983,latter,0,0
69984,group,0,0
69985,but,0,0
69986,not,0,0
69987,in,0,0
69988,the,0,0
69989,former,0,0
69990,",",0,0
69991,in,0,0
69992,particular,0,0
69993,not,0,0
69994,in,0,0
69995,those,0,0
69996,subjects,0,1
69997,that,0,0
69998,actually,0,0
69999,blinked,0,0
70000,rarely,0,0
70001,.,0,0
70002,The,0,0
70003,groups,0,0
70004,also,0,0
70005,differed,0,0
70006,in,0,0
70007,their,0,0
70008,N1,0,0
70009,amplitudes,0,0
70010,.,0,1
70011,These,0,0
70012,findings,0,0
70013,might,0,0
70014,be,0,0
70015,relevant,0,0
70016,to,0,0
70017,P3,0,1
70018,studies,0,0
70019,working,0,1
70020,with,0,1
70021,patients,0,1
70022,and,0,1
70023,controls,0,1
70024,:,0,1
70025,the,0,0
70026,harder,0,0
70027,some,0,0
70028,frequently,0,0
70029,blinking,0,0
70030,subjects,0,1
70031,try,0,0
70032,to,0,0
70033,refrain,0,0
70034,from,0,0
70035,blinking,0,0
70036,",",0,0
70037,the,0,0
70038,smaller,0,0
70039,might,0,0
70040,become,0,0
70041,their,0,0
70042,P3,0,1
70043,amplitudes,0,0
70044,.,0,1
70045,Omitting,0,0
70046,the,0,0
70047,instruction,0,0
70048,and,0,0
70049,using,0,0
70050,off-line,0,0
70051,blink,0,0
70052,subtraction,0,0
70053,procedures,0,0
70054,seems,0,0
70055,a,0,0
70056,viable,0,0
70057,alternative,0,0
70058,.,0,0
70059,This,0,0
70060,study,0,0
70061,was,0,0
70062,actually,0,0
70063,motivated,0,0
70064,by,0,0
70065,discrepant,0,1
70066,findings,0,0
70067,on,0,0
70068,the,0,0
70069,effects,0,0
70070,of,0,0
70071,the,0,0
70072,preceding,0,0
70073,tone,0,0
70074,sequence,0,0
70075,on,0,0
70076,P3,0,1
70077,.,0,1
70078,These,0,0
70079,discrepancies,0,0
70080,could,0,0
70081,be,0,0
70082,largely,0,0
70083,resolved,0,0
70084,by,0,0
70085,the,0,0
70086,instructional,0,0
70087,variable,0,0
70088,",",0,0
70089,in,0,0
70090,conjunction,0,0
70091,with,0,1
70092,different,0,0
70093,tone,0,0
70094,intensities,0,0
70095,.,0,0
70096,It,0,0
70097,is,0,0
70098,suggested,0,0
70099,that,0,0
70100,subjects,0,1
70101,who,0,1
70102,are,0,1
70103,discouraged,0,1
70104,from,0,0
70105,blinking,0,0
70106,try,0,0
70107,to,0,0
70108,protect,0,0
70109,themselves,0,0
70110,against,0,0
70111,the,0,0
70112,arousing,0,0
70113,effects,0,0
70114,of,0,0
70115,stimuli,0,1
70116,.,0,1
70117,Topical,0,1
70118,retapamulin,0,0
70119,ointment,0,0
70120,(,0,0
70121,1,0,0
70122,%,0,0
70123,",",0,0
70124,wt/wt,0,0
70125,),0,0
70126,twice,0,0
70127,daily,0,0
70128,for,0,0
70129,5,0,0
70130,days,0,0
70131,versus,0,0
70132,oral,0,0
70133,cephalexin,0,0
70134,twice,0,0
70135,daily,0,0
70136,for,0,0
70137,10,0,0
70138,days,0,0
70139,in,0,0
70140,the,0,0
70141,treatment,0,0
70142,of,0,0
70143,secondarily,1,0
70144,infected,1,1
70145,dermatitis,1,1
70146,:,1,1
70147,results,0,0
70148,of,0,0
70149,a,0,0
70150,randomized,0,0
70151,controlled,0,0
70152,trial,0,0
70153,.,0,1
70154,BACKGROUND,0,0
70155,New,0,1
70156,antibacterial,0,0
70157,agents,0,0
70158,with,0,1
70159,activity,0,0
70160,against,0,1
70161,pathogenic,0,0
70162,strains,0,0
70163,resistant,0,1
70164,to,0,0
70165,established,0,0
70166,antibiotics,0,0
70167,are,0,0
70168,needed,0,0
70169,to,0,0
70170,treat,0,0
70171,patients,1,1
70172,with,1,1
70173,secondarily,1,1
70174,infected,1,1
70175,dermatitis,1,1
70176,(,1,0
70177,SID,1,1
70178,),1,0
70179,.,1,0
70180,OBJECTIVE,0,0
70181,We,0,0
70182,sought,0,0
70183,to,0,0
70184,determine,0,0
70185,the,0,0
70186,clinical,0,0
70187,safety,0,0
70188,and,0,0
70189,efficacy,0,0
70190,of,0,0
70191,topical,0,0
70192,retapamulin,0,0
70193,ointment,0,0
70194,1,0,0
70195,%,0,0
70196,versus,0,0
70197,oral,0,0
70198,cephalexin,0,0
70199,for,0,0
70200,the,0,0
70201,treatment,0,0
70202,of,0,0
70203,SID,0,1
70204,.,0,1
70205,METHODS,0,0
70206,Patients,1,1
70207,with,1,1
70208,SID,1,1
70209,were,0,0
70210,randomly,0,1
70211,assigned,0,0
70212,to,0,0
70213,retapamulin,0,0
70214,ointment,0,0
70215,1,0,0
70216,%,0,0
70217,(,0,0
70218,twice,0,0
70219,daily,0,0
70220,[,0,0
70221,bid,0,0
70222,],0,0
70223,),0,0
70224,for,0,0
70225,5,0,1
70226,days,0,0
70227,",",0,0
70228,or,0,1
70229,oral,0,0
70230,cephalexin,0,0
70231,(,0,0
70232,500,0,0
70233,mg,0,0
70234,bid,0,0
70235,),0,0
70236,for,0,0
70237,10,0,1
70238,days,0,0
70239,.,0,1
70240,The,0,0
70241,primary,0,0
70242,efficacy,0,0
70243,end,0,0
70244,point,0,0
70245,was,0,0
70246,clinical,0,0
70247,response,0,0
70248,at,0,0
70249,follow-up,0,0
70250,.,0,1
70251,Secondary,0,0
70252,outcomes,0,0
70253,included,0,1
70254,microbiologic,0,0
70255,response,0,0
70256,at,0,0
70257,follow-up,0,0
70258,",",0,0
70259,safety,0,0
70260,",",0,0
70261,and,0,0
70262,compliance,0,0
70263,.,0,1
70264,RESULTS,0,0
70265,Retapamulin,0,0
70266,was,0,0
70267,as,0,0
70268,effective,0,0
70269,as,0,0
70270,cephalexin,0,0
70271,(,0,0
70272,clinical,0,0
70273,success,0,0
70274,rates,0,0
70275,at,0,1
70276,follow-up,0,1
70277,:,0,1
70278,85.9,0,0
70279,%,0,0
70280,and,0,0
70281,89.7,0,0
70282,%,0,0
70283,",",0,0
70284,respectively,0,0
70285,),0,0
70286,.,0,0
70287,Microbiologic,0,0
70288,success,0,0
70289,rates,0,0
70290,at,0,1
70291,follow-up,0,0
70292,were,0,1
70293,87.2,0,0
70294,%,0,0
70295,for,0,0
70296,retapamulin,0,0
70297,and,0,0
70298,91.8,0,0
70299,%,0,0
70300,for,0,0
70301,cephalexin,0,0
70302,.,0,1
70303,Retapamulin,0,0
70304,was,0,0
70305,well,0,0
70306,tolerated,0,0
70307,and,0,0
70308,the,0,0
70309,topical,0,0
70310,formulation,0,0
70311,was,0,0
70312,preferred,0,0
70313,over,0,0
70314,the,0,0
70315,oral,0,0
70316,drug,0,0
70317,.,0,1
70318,LIMITATIONS,0,0
70319,An,0,0
70320,imbalance,0,0
70321,existed,0,0
70322,in,0,0
70323,the,0,0
70324,number,0,0
70325,of,0,0
70326,patients,0,1
70327,with,0,1
70328,the,0,0
70329,clinical,0,0
70330,outcome,0,0
70331,unable,0,0
70332,to,0,0
70333,determine,0,0
70334,(,0,0
70335,15,0,0
70336,retapamulin,0,0
70337,",",0,0
70338,2,0,0
70339,cephalexin,0,0
70340,),0,0
70341,",",0,0
70342,mainly,0,0
70343,because,0,0
70344,of,0,0
70345,their,0,0
70346,failure,0,1
70347,to,0,0
70348,attend,0,1
70349,the,0,0
70350,study,0,0
70351,visit,0,0
70352,.,0,0
70353,If,0,0
70354,those,0,1
70355,who,0,1
70356,failed,0,1
70357,to,0,1
70358,attend,0,1
70359,visits,0,0
70360,(,0,1
70361,who,0,1
70362,did,0,1
70363,not,0,1
70364,withdraw,0,0
70365,as,0,0
70366,a,0,0
70367,result,0,0
70368,of,0,0
70369,drug-related,0,1
70370,events,0,0
70371,),0,1
70372,are,0,0
70373,removed,0,0
70374,from,0,0
70375,the,0,0
70376,analysis,0,0
70377,",",0,0
70378,the,0,0
70379,clinical,0,0
70380,success,0,0
70381,rates,0,0
70382,are,0,0
70383,89.9,0,0
70384,%,0,0
70385,for,0,0
70386,retapamulin,0,0
70387,and,0,0
70388,89.7,0,0
70389,%,0,0
70390,for,0,0
70391,cephalexin,0,0
70392,.,0,1
70393,CONCLUSIONS,0,0
70394,Retapamulin,0,0
70395,ointment,0,0
70396,1,0,0
70397,%,0,0
70398,(,0,0
70399,bid,0,0
70400,),0,0
70401,for,0,0
70402,5,0,1
70403,days,0,0
70404,was,0,0
70405,as,0,0
70406,effective,0,0
70407,as,0,0
70408,oral,0,0
70409,cephalexin,0,0
70410,(,0,0
70411,bid,0,0
70412,),0,0
70413,for,0,0
70414,10,0,1
70415,days,0,0
70416,in,0,0
70417,treatment,0,0
70418,of,0,0
70419,patients,1,1
70420,with,1,1
70421,SID,1,1
70422,",",0,0
70423,and,0,0
70424,was,0,0
70425,well,0,0
70426,tolerated,0,0
70427,.,0,0
70428,New,0,1
70429,hope,0,0
70430,for,0,0
70431,children,1,1
70432,with,1,1
70433,Kawasaki,1,1
70434,disease,1,1
70435,.,1,0
70436,Kawasaki,0,1
70437,disease,0,1
70438,is,0,0
70439,now,0,0
70440,the,0,0
70441,most,0,0
70442,common,0,0
70443,cause,0,0
70444,of,0,0
70445,acquired,1,0
70446,heart,1,1
70447,disease,1,1
70448,in,1,0
70449,America,1,0
70450,'s,1,1
70451,children,1,1
70452,.,1,1
70453,It,0,0
70454,is,0,0
70455,an,0,0
70456,acute,0,0
70457,febrile,0,0
70458,illness,0,1
70459,that,0,0
70460,may,0,0
70461,cause,0,0
70462,coronary,0,1
70463,artery,0,1
70464,aneurysm,0,0
70465,formation,0,0
70466,in,0,0
70467,infected,1,1
70468,children,1,1
70469,.,1,1
70470,The,0,0
70471,results,0,0
70472,of,0,0
70473,a,0,0
70474,multicenter,0,0
70475,",",0,0
70476,randomized,0,0
70477,trial,0,0
70478,on,0,0
70479,the,0,0
70480,effect,0,0
70481,of,0,0
70482,intravenous,0,0
70483,administration,0,0
70484,of,0,0
70485,gamma,0,0
70486,globulin,0,0
70487,(,0,0
70488,IVGG,0,0
70489,),0,0
70490,plus,0,0
70491,aspirin,0,0
70492,versus,0,0
70493,aspirin,0,0
70494,alone,0,0
70495,upon,0,0
70496,coronary,0,1
70497,aneurysm,0,1
70498,formation,0,0
70499,show,0,0
70500,a,0,0
70501,decrease,0,0
70502,in,0,0
70503,coronary,0,1
70504,aneurysm,0,1
70505,formation,0,0
70506,from,0,0
70507,the,0,0
70508,usual,0,1
70509,20,0,0
70510,%,0,0
70511,-30,0,0
70512,%,0,0
70513,to,0,0
70514,3,0,0
70515,%,0,0
70516,.,0,1
70517,Administration,0,0
70518,of,0,0
70519,IVGG,0,0
70520,presents,0,0
70521,some,0,0
70522,unique,0,0
70523,challenges,0,0
70524,for,0,1
70525,nurses,0,1
70526,.,0,1
70527,Also,0,0
70528,",",0,0
70529,the,0,0
70530,pediatric,0,1
70531,nurse,0,0
70532,must,0,0
70533,educate,0,0
70534,parents,0,1
70535,and,0,0
70536,children,1,1
70537,about,0,0
70538,this,0,0
70539,disease,0,1
70540,to,0,0
70541,prepare,0,0
70542,them,0,0
70543,for,0,0
70544,discharge,0,0
70545,and,0,0
70546,long-term,0,0
70547,follow-up,0,0
70548,care,0,1
70549,.,0,1
70550,Effect,0,0
70551,of,0,0
70552,daily,0,0
70553,etidronate,0,0
70554,on,0,0
70555,the,0,0
70556,osteolysis,0,0
70557,of,0,0
70558,multiple,0,0
70559,myeloma,0,1
70560,.,0,1
70561,Progressive,0,0
70562,bone,0,0
70563,disease,0,1
70564,in,0,0
70565,multiple,0,0
70566,myeloma,0,1
70567,frequently,0,0
70568,leads,0,0
70569,to,0,0
70570,osteolysis,0,0
70571,",",0,0
70572,bone,0,0
70573,resorption,0,0
70574,",",0,0
70575,pathologic,0,0
70576,fractures,0,1
70577,",",0,0
70578,vertebral,0,1
70579,compression,0,0
70580,",",0,0
70581,and,0,0
70582,hypercalcemia,0,1
70583,.,0,0
70584,We,0,0
70585,conducted,0,0
70586,a,0,0
70587,double-blind,0,0
70588,study,0,0
70589,in,0,0
70590,173,1,1
70591,newly,1,1
70592,diagnosed,1,1
70593,multiple,1,0
70594,myeloma,1,1
70595,patients,1,1
70596,of,1,0
70597,etidronate,1,0
70598,disodium,1,0
70599,(,1,0
70600,EHDP,1,0
70601,),1,0
70602,",",1,0
70603,a,1,0
70604,diphosphonate,1,0
70605,compound,1,0
70606,that,1,0
70607,reduces,1,0
70608,bone,1,0
70609,resorption,1,0
70610,by,1,0
70611,inhibiting,1,0
70612,osteoclastic,1,0
70613,activity,1,0
70614,.,1,0
70615,The,0,0
70616,patients,0,1
70617,were,0,0
70618,randomly,0,1
70619,assigned,0,0
70620,to,0,0
70621,receive,0,0
70622,oral,0,0
70623,EHDP,0,1
70624,5,0,0
70625,mg/kg/d,0,0
70626,or,0,0
70627,placebo,0,0
70628,until,0,0
70629,death,0,0
70630,or,0,1
70631,discontinuation,0,0
70632,due,0,0
70633,to,0,0
70634,intolerance,0,1
70635,or,0,0
70636,refusal,0,0
70637,.,0,0
70638,The,0,0
70639,extent,0,0
70640,of,0,0
70641,vertebral,0,1
70642,deformity,0,1
70643,was,0,0
70644,measured,0,0
70645,by,0,0
70646,a,0,0
70647,vertebral,0,0
70648,index,0,0
70649,as,0,0
70650,well,0,0
70651,as,0,0
70652,height,0,0
70653,.,0,0
70654,The,0,0
70655,frequency,0,0
70656,of,0,0
70657,pathologic,0,1
70658,fractures,0,1
70659,",",0,0
70660,hypercalcemia,0,1
70661,",",0,0
70662,and,0,0
70663,bone,0,0
70664,pain,0,0
70665,was,0,0
70666,regularly,0,0
70667,assessed,0,0
70668,",",0,0
70669,as,0,0
70670,well,0,0
70671,as,0,0
70672,size,0,0
70673,and,0,0
70674,number,0,0
70675,of,0,0
70676,osteolytic,0,1
70677,lesions,0,1
70678,.,0,1
70679,All,0,1
70680,patients,0,1
70681,received,0,0
70682,melphalan,0,1
70683,and,0,0
70684,prednisone,0,0
70685,daily,0,0
70686,for,0,1
70687,4,0,0
70688,days,0,0
70689,every,0,0
70690,4,0,0
70691,weeks,0,0
70692,as,0,0
70693,the,0,0
70694,primary,0,0
70695,chemotherapy,0,0
70696,for,0,0
70697,their,0,0
70698,disease,0,1
70699,.,0,0
70700,Although,0,0
70701,the,0,0
70702,repeated,0,0
70703,measures,0,0
70704,analysis,0,0
70705,showed,0,0
70706,a,0,0
70707,significant,0,0
70708,height,0,0
70709,loss,0,0
70710,",",0,0
70711,there,0,0
70712,was,0,0
70713,no,0,0
70714,difference,0,0
70715,between,0,0
70716,treatment,0,0
70717,arms,0,0
70718,(,0,1
70719,P,0,0
70720,=,0,0
70721,.98,0,0
70722,),0,0
70723,.,0,0
70724,There,0,0
70725,was,0,0
70726,no,0,0
70727,significant,0,0
70728,difference,0,0
70729,in,0,0
70730,bone,0,0
70731,pain,0,1
70732,",",0,0
70733,episodes,0,0
70734,of,0,0
70735,hypercalcemia,0,1
70736,",",0,0
70737,or,0,0
70738,development,0,0
70739,of,0,0
70740,pathologic,0,1
70741,fractures,0,1
70742,.,0,1
70743,Patients,1,1
70744,on,1,0
70745,EHDP,1,1
70746,showed,0,0
70747,less,0,0
70748,deterioration,0,0
70749,in,0,0
70750,their,0,0
70751,vertebral,0,1
70752,index,0,0
70753,",",0,0
70754,but,0,0
70755,this,0,0
70756,difference,0,0
70757,only,0,0
70758,approached,0,0
70759,statistical,0,0
70760,significance,0,0
70761,(,0,0
70762,P,0,0
70763,=,0,0
70764,.07,0,0
70765,),0,0
70766,.,0,0
70767,We,0,0
70768,conclude,0,0
70769,that,0,0
70770,EHDP,0,1
70771,therapy,0,0
70772,used,0,0
70773,in,0,0
70774,this,0,0
70775,dosage,0,0
70776,schedule,0,0
70777,does,0,0
70778,not,0,0
70779,have,0,0
70780,a,0,0
70781,clinically,0,0
70782,significant,0,0
70783,impact,0,0
70784,in,0,0
70785,multiple,0,0
70786,myeloma,0,1
70787,.,0,1
70788,The,0,0
70789,use,0,0
70790,of,0,0
70791,the,0,0
70792,Antenatal,0,0
70793,Psychosocial,0,1
70794,Health,0,0
70795,Assessment,0,0
70796,(,0,0
70797,ALPHA,0,0
70798,),0,0
70799,tool,0,0
70800,in,0,0
70801,the,0,0
70802,detection,0,0
70803,of,0,0
70804,psychosocial,0,1
70805,risk,0,1
70806,factors,0,0
70807,for,0,0
70808,postpartum,0,1
70809,depression,0,1
70810,:,0,1
70811,a,0,0
70812,randomized,0,0
70813,controlled,0,0
70814,trial,0,0
70815,.,0,0
70816,OBJECTIVE,0,0
70817,Eliciting,0,0
70818,known,0,0
70819,risk,0,0
70820,factors,0,0
70821,for,0,0
70822,postpartum,0,1
70823,depression,0,1
70824,(,0,0
70825,PPD,0,1
70826,),0,0
70827,during,0,0
70828,pregnancy,0,0
70829,may,0,0
70830,enable,0,0
70831,primary,0,0
70832,health,0,0
70833,care,0,1
70834,providers,0,0
70835,to,0,0
70836,identify,0,0
70837,women,0,1
70838,at,0,0
70839,increased,0,0
70840,risk,0,0
70841,of,0,0
70842,becoming,0,0
70843,depressed,0,1
70844,.,0,0
70845,The,0,0
70846,purpose,0,0
70847,of,0,0
70848,this,0,0
70849,study,0,0
70850,was,0,0
70851,to,0,0
70852,examine,0,0
70853,how,0,0
70854,well,0,0
70855,the,0,0
70856,Antenatal,0,0
70857,Psychosocial,0,1
70858,Health,0,0
70859,Assessment,0,0
70860,(,0,0
70861,ALPHA,0,0
70862,),0,0
70863,form,0,0
70864,identified,0,0
70865,antenatal,0,1
70866,risk,0,0
70867,factors,0,0
70868,for,0,0
70869,PPD,0,1
70870,",",0,0
70871,compared,0,0
70872,with,0,1
70873,routine,0,0
70874,care,0,1
70875,",",0,0
70876,in,0,0
70877,a,0,0
70878,sample,0,1
70879,of,0,0
70880,pregnant,1,1
70881,women,1,1
70882,.,1,1
70883,METHODS,0,0
70884,A,0,0
70885,randomized,0,0
70886,controlled,0,0
70887,trial,0,0
70888,was,0,0
70889,conducted,0,0
70890,to,0,0
70891,assess,0,0
70892,the,0,0
70893,effectiveness,0,0
70894,of,0,0
70895,the,0,0
70896,ALPHA,0,0
70897,form,0,0
70898,in,0,0
70899,detecting,0,0
70900,antenatal,0,1
70901,risk,0,1
70902,factors,0,0
70903,associated,0,0
70904,with,0,1
70905,the,0,0
70906,adverse,0,0
70907,postpartum,0,1
70908,outcomes,0,0
70909,of,0,0
70910,postpartum,0,1
70911,depression,0,1
70912,",",0,0
70913,intimate,0,0
70914,partner,0,0
70915,violence,0,0
70916,",",0,0
70917,child,0,0
70918,abuse,0,0
70919,",",0,0
70920,and,0,0
70921,couple,0,0
70922,dysfunction,0,1
70923,.,0,0
70924,The,1,0
70925,participants,1,1
70926,were,1,1
70927,primary,1,1
70928,antenatal,1,1
70929,care,1,1
70930,providers,1,1
70931,--,1,1
70932,family,1,1
70933,physicians,1,1
70934,",",1,0
70935,obstetricians,1,1
70936,",",1,0
70937,and,1,1
70938,midwives,1,0
70939,--,1,1
70940,from,1,1
70941,four,1,1
70942,diverse,1,1
70943,communities,1,1
70944,in,1,1
70945,Ontario,1,1
70946,.,1,1
70947,These,0,0
70948,providers,0,0
70949,were,0,0
70950,matched,0,1
70951,and,0,0
70952,then,0,0
70953,randomly,0,0
70954,allocated,0,0
70955,into,0,0
70956,the,0,0
70957,intervention,0,0
70958,group,0,0
70959,",",0,1
70960,who,0,1
70961,used,0,0
70962,the,0,1
70963,ALPHA,0,0
70964,form,0,0
70965,",",0,0
70966,or,0,0
70967,into,0,0
70968,the,0,0
70969,control,0,0
70970,group,0,0
70971,",",0,1
70972,who,0,1
70973,administered,0,1
70974,usual,0,1
70975,care,0,1
70976,.,0,0
70977,In,1,0
70978,total,1,1
70979,",",1,0
70980,227,1,1
70981,pregnant,1,1
70982,women,1,1
70983,were,1,1
70984,recruited,1,1
70985,:,1,1
70986,98,1,1
70987,in,1,0
70988,the,1,0
70989,ALPHA,1,0
70990,group,1,0
70991,and,1,0
70992,129,1,1
70993,in,1,0
70994,the,1,0
70995,control,1,0
70996,group,1,0
70997,.,1,0
70998,The,0,0
70999,data,0,0
71000,presented,0,0
71001,in,0,0
71002,this,0,0
71003,paper,0,0
71004,are,0,0
71005,from,0,0
71006,a,0,0
71007,secondary,0,0
71008,analysis,0,0
71009,focusing,0,0
71010,on,0,0
71011,PPD,0,1
71012,as,0,0
71013,the,0,0
71014,outcome,0,0
71015,.,0,1
71016,RESULTS,0,0
71017,Providers,0,1
71018,randomized,0,1
71019,to,0,1
71020,the,0,0
71021,ALPHA,0,0
71022,group,0,0
71023,identified,0,0
71024,a,0,0
71025,statistically,0,0
71026,significantly,0,0
71027,higher,0,0
71028,proportion,0,0
71029,of,0,0
71030,women,0,1
71031,with,0,1
71032,antenatal,0,1
71033,psychosocial,0,1
71034,risk,0,1
71035,factors,0,0
71036,for,0,0
71037,PPD,0,1
71038,(,0,1
71039,36,0,1
71040,%,0,0
71041,vs.,0,0
71042,26,0,1
71043,%,0,0
71044,),0,0
71045,and,0,0
71046,a,0,0
71047,significantly,0,0
71048,higher,0,0
71049,number,0,0
71050,of,0,0
71051,risk,0,0
71052,factors,0,0
71053,per,0,0
71054,woman,0,1
71055,compared,0,0
71056,with,0,1
71057,the,0,0
71058,control,0,0
71059,group,0,0
71060,(,0,0
71061,mean,0,1
71062,2.1,0,0
71063,vs.1.8,0,0
71064,),0,0
71065,(,0,0
71066,z,0,0
71067,=,0,0
71068,-1.96,0,0
71069,",",0,0
71070,P,0,0
71071,=,0,0
71072,0.05,0,0
71073,),0,1
71074,.,0,1
71075,Providers,0,0
71076,in,0,0
71077,the,0,0
71078,ALPHA,0,0
71079,group,0,0
71080,also,0,0
71081,identified,0,0
71082,significantly,0,0
71083,more,0,0
71084,women,0,1
71085,having,0,1
71086,a,0,0
71087,previous,0,0
71088,history,0,1
71089,of,0,0
71090,depression,0,1
71091,(,0,0
71092,16,0,1
71093,%,0,0
71094,vs.,0,0
71095,6,0,0
71096,%,0,0
71097,),0,0
71098,(,0,0
71099,chi2,0,0
71100,=,0,0
71101,5.243,0,0
71102,",",0,0
71103,df,0,0
71104,=,0,0
71105,1,0,0
71106,",",0,0
71107,P,0,0
71108,=,0,0
71109,0.03,0,0
71110,),0,0
71111,and,0,0
71112,[,0,0
71113,having,0,1
71114,],0,0
71115,witnessed,0,0
71116,or,0,1
71117,experienced,0,0
71118,abuse,0,1
71119,as,0,0
71120,a,0,0
71121,child,0,1
71122,(,0,0
71123,17,0,1
71124,%,0,0
71125,vs.,0,0
71126,3,0,0
71127,%,0,0
71128,),0,0
71129,(,0,0
71130,chi2,0,0
71131,=,0,0
71132,12.488,0,0
71133,",",0,0
71134,df,0,0
71135,=,0,0
71136,1,0,0
71137,",",0,0
71138,P,0,0
71139,=,0,0
71140,0.0005,0,0
71141,),0,0
71142,",",0,0
71143,which,0,0
71144,are,0,0
71145,both,0,0
71146,established,0,0
71147,risk,0,0
71148,factors,0,0
71149,for,0,0
71150,PPD,0,1
71151,.,0,1
71152,CONCLUSION,0,0
71153,The,0,0
71154,ALPHA,0,0
71155,provides,0,0
71156,a,0,0
71157,systematic,0,0
71158,means,0,0
71159,of,0,0
71160,eliciting,0,0
71161,antenatal,0,1
71162,psychosocial,0,1
71163,risk,0,1
71164,factors,0,0
71165,for,0,0
71166,PPD,0,1
71167,for,0,0
71168,primary,0,1
71169,care,0,1
71170,providers,0,0
71171,",",0,0
71172,and,0,0
71173,it,0,0
71174,may,0,0
71175,be,0,0
71176,particularly,0,0
71177,useful,0,0
71178,for,0,0
71179,raising,0,0
71180,and,0,0
71181,discussing,0,0
71182,sensitive,0,0
71183,issues,0,0
71184,.,0,1
71185,The,0,0
71186,detection,0,0
71187,of,0,0
71188,depressive,0,0
71189,symptomatology,0,0
71190,during,0,0
71191,pregnancy,0,0
71192,remains,0,0
71193,problematic,0,0
71194,",",0,0
71195,however,0,0
71196,",",0,0
71197,and,0,0
71198,detection,0,0
71199,may,0,0
71200,be,0,0
71201,improved,0,0
71202,by,0,0
71203,administering,0,0
71204,a,0,0
71205,simple,0,0
71206,standardized,0,0
71207,measure,0,0
71208,of,0,0
71209,depressive,0,0
71210,symptomatology,0,0
71211,during,0,0
71212,routine,0,0
71213,antenatal,0,1
71214,care,0,1
71215,.,0,1
71216,A,0,0
71217,double-blind,0,0
71218,placebo-controlled,0,0
71219,trial,0,0
71220,of,0,0
71221,zonisamide,0,0
71222,(,0,0
71223,zonegran,0,0
71224,),0,0
71225,in,0,0
71226,the,0,0
71227,treatment,0,0
71228,of,0,0
71229,essential,0,1
71230,tremor,0,1
71231,.,0,1
71232,Medical,0,0
71233,therapy,0,0
71234,for,0,0
71235,essential,1,0
71236,tremor,1,1
71237,(,1,0
71238,ET,1,0
71239,),1,0
71240,",",0,0
71241,a,0,0
71242,common,0,0
71243,movement,0,0
71244,disorder,0,1
71245,",",0,0
71246,is,0,0
71247,often,0,0
71248,inadequate,0,0
71249,.,0,0
71250,We,0,0
71251,performed,0,0
71252,a,0,0
71253,double-blind,0,0
71254,placebo-controlled,0,0
71255,randomized,0,1
71256,trial,0,0
71257,to,0,0
71258,evaluate,0,0
71259,the,0,0
71260,efficacy,0,0
71261,and,0,0
71262,tolerability,0,0
71263,of,0,0
71264,zonisamide,0,0
71265,(,0,0
71266,ZNS,0,0
71267,),0,0
71268,",",0,0
71269,an,0,0
71270,antiepileptic,0,0
71271,agent,0,0
71272,",",0,0
71273,in,0,0
71274,treating,0,0
71275,ET,0,0
71276,.,0,1
71277,Twenty,1,1
71278,patients,1,1
71279,(,1,1
71280,mean,1,1
71281,age,1,1
71282,",",1,0
71283,60,1,1
71284,+/-,1,0
71285,15,1,1
71286,years,1,1
71287,),1,1
71288,with,1,1
71289,ET,1,0
71290,were,0,0
71291,randomized,0,0
71292,to,0,0
71293,receive,0,0
71294,ZNS,0,0
71295,or,0,1
71296,placebo,0,0
71297,.,0,1
71298,ZNS,0,0
71299,was,0,0
71300,initiated,0,0
71301,at,0,0
71302,a,0,0
71303,dosage,0,0
71304,of,0,0
71305,100,0,0
71306,mg/day,0,0
71307,and,0,0
71308,escalated,0,0
71309,to,0,0
71310,200,0,0
71311,mg/day,0,0
71312,at,0,1
71313,day,0,1
71314,14,0,1
71315,.,0,1
71316,Patients,0,1
71317,were,0,0
71318,evaluated,0,0
71319,by,0,0
71320,accelerometry,0,0
71321,and,0,0
71322,the,0,0
71323,Fahn-Tolosa-Marin,0,0
71324,(,0,0
71325,FTM,0,0
71326,),0,0
71327,rating,0,0
71328,scale,0,0
71329,at,0,0
71330,baseline,0,0
71331,and,0,1
71332,days,0,0
71333,14,0,1
71334,and,0,1
71335,28,0,0
71336,",",0,0
71337,as,0,0
71338,well,0,0
71339,as,0,0
71340,the,0,0
71341,Clinical,0,0
71342,Global,0,1
71343,Impression,0,0
71344,(,0,0
71345,CGI-C,0,0
71346,),0,0
71347,scale,0,0
71348,at,0,0
71349,day,0,0
71350,28,0,1
71351,.,0,0
71352,At,0,0
71353,endpoint,0,0
71354,",",0,0
71355,subjects,0,1
71356,assigned,0,1
71357,to,0,0
71358,ZNS,0,0
71359,were,0,0
71360,taking,0,0
71361,a,0,0
71362,mean,0,0
71363,dosage,0,0
71364,of,0,0
71365,160,0,1
71366,+/-,0,0
71367,50,0,1
71368,mg/day,0,0
71369,.,0,0
71370,There,0,0
71371,were,0,0
71372,no,0,0
71373,significant,0,0
71374,improvements,0,0
71375,in,0,0
71376,the,0,0
71377,FTM,0,0
71378,total,0,1
71379,score,0,0
71380,or,0,1
71381,its,0,0
71382,subsections,0,0
71383,.,0,1
71384,Tremor,0,0
71385,amplitude,0,0
71386,as,0,0
71387,assessed,0,0
71388,by,0,0
71389,accelerometry,0,0
71390,significantly,0,0
71391,improved,0,0
71392,in,0,0
71393,the,0,0
71394,ZNS,0,0
71395,group,0,0
71396,compared,0,0
71397,to,0,0
71398,the,0,0
71399,placebo,0,0
71400,group,0,0
71401,at,0,0
71402,endpoint,0,0
71403,relative,0,0
71404,to,0,0
71405,baseline,0,0
71406,(,0,0
71407,-0.50,0,0
71408,+/-,0,0
71409,0.72,0,0
71410,vs.,0,0
71411,0.30,0,0
71412,+/-,0,0
71413,0.79,0,0
71414,m/s,0,1
71415,(,0,1
71416,2,0,1
71417,),0,1
71418,;,0,1
71419,P,0,0
71420,=,0,0
71421,0.03,0,0
71422,),0,0
71423,.,0,0
71424,On,0,0
71425,the,0,0
71426,CGI-C,0,0
71427,",",0,0
71428,60,0,1
71429,%,0,0
71430,(,0,0
71431,n,0,1
71432,=,0,0
71433,6,0,0
71434,),0,0
71435,of,0,0
71436,patients,0,1
71437,in,0,0
71438,the,0,0
71439,ZNS,0,0
71440,group,0,0
71441,felt,0,0
71442,that,0,0
71443,their,0,0
71444,tremor,0,1
71445,was,0,0
71446,unchanged,0,0
71447,",",0,0
71448,while,0,0
71449,the,0,0
71450,remaining,0,0
71451,patients,0,1
71452,felt,0,0
71453,that,0,0
71454,their,0,0
71455,tremor,0,1
71456,was,0,0
71457,minimally,0,0
71458,improved,0,0
71459,.,0,0
71460,Thirty,0,0
71461,percent,0,0
71462,(,0,0
71463,n,0,1
71464,=,0,0
71465,3,0,0
71466,),0,0
71467,of,0,0
71468,patients,0,1
71469,taking,0,1
71470,ZNS,0,0
71471,discontinued,0,0
71472,the,0,0
71473,study,0,0
71474,due,0,0
71475,to,0,0
71476,side,0,0
71477,effects,0,0
71478,(,0,0
71479,fatigue,0,0
71480,",",0,0
71481,headache,0,0
71482,",",0,0
71483,paresthesias,0,0
71484,),0,0
71485,while,0,0
71486,taking,0,1
71487,100,0,0
71488,mg,0,0
71489,per,0,0
71490,day,0,0
71491,.,0,1
71492,ZNS,0,0
71493,did,0,0
71494,not,0,0
71495,provide,0,0
71496,significant,0,0
71497,improvements,0,0
71498,in,0,0
71499,clinical,0,0
71500,rating,0,0
71501,scales,0,0
71502,at,0,0
71503,study,0,1
71504,endpoint,0,0
71505,compared,0,0
71506,to,0,0
71507,placebo,0,0
71508,and,0,0
71509,was,0,0
71510,only,0,0
71511,modestly,0,0
71512,well,0,0
71513,tolerated,0,0
71514,.,0,0
71515,ZNS,0,0
71516,was,0,0
71517,effective,0,0
71518,in,0,0
71519,reducing,0,0
71520,tremor,0,1
71521,amplitude,0,0
71522,as,0,0
71523,measured,0,0
71524,by,0,0
71525,accelerometry,0,0
71526,.,0,1
71527,Treating,0,0
71528,anxiety,1,1
71529,disorders,1,1
71530,in,1,0
71531,children,1,1
71532,with,1,1
71533,high,1,1
71534,functioning,1,0
71535,autism,1,1
71536,spectrum,1,1
71537,disorders,1,1
71538,:,1,1
71539,a,0,0
71540,controlled,0,0
71541,trial,0,0
71542,.,0,0
71543,A,0,0
71544,family-based,0,0
71545,",",0,0
71546,cognitive,0,0
71547,behavioural,0,0
71548,treatment,0,0
71549,for,0,0
71550,anxiety,0,0
71551,in,0,0
71552,47,1,1
71553,children,1,1
71554,with,1,1
71555,comorbid,1,1
71556,anxiety,1,1
71557,disorders,1,1
71558,and,1,1
71559,High,1,1
71560,Functioning,1,0
71561,Autism,1,1
71562,Spectrum,1,1
71563,Disorder,1,1
71564,(,1,0
71565,HFA,1,1
71566,),1,0
71567,was,0,0
71568,evaluated,0,0
71569,.,0,1
71570,Treatment,0,0
71571,involved,0,0
71572,12,0,0
71573,weekly,0,0
71574,group,0,1
71575,sessions,0,0
71576,and,0,0
71577,was,0,0
71578,compared,0,0
71579,with,0,1
71580,a,0,0
71581,waiting,0,0
71582,list,0,0
71583,condition,0,0
71584,.,0,0
71585,Changes,0,0
71586,between,0,0
71587,pre-,0,0
71588,and,0,0
71589,post-treatment,0,0
71590,were,0,0
71591,examined,0,0
71592,using,0,0
71593,clinical,0,0
71594,interviews,0,1
71595,as,0,0
71596,well,0,0
71597,as,0,0
71598,child-,0,0
71599,",",0,0
71600,parent-,0,0
71601,and,0,0
71602,teacher-report,0,0
71603,measures,0,0
71604,.,0,1
71605,Following,0,0
71606,treatment,0,0
71607,",",0,0
71608,71.4,0,0
71609,%,0,0
71610,of,0,0
71611,the,0,0
71612,treated,0,1
71613,participants,0,1
71614,no,0,0
71615,longer,0,0
71616,fulfilled,0,1
71617,diagnostic,0,0
71618,criteria,0,1
71619,for,0,0
71620,an,0,0
71621,anxiety,0,0
71622,disorder,0,1
71623,.,0,0
71624,Comparisons,0,0
71625,between,0,0
71626,the,0,0
71627,two,0,0
71628,conditions,0,0
71629,indicated,0,0
71630,significant,0,0
71631,reductions,0,0
71632,in,0,0
71633,anxiety,0,1
71634,symptoms,0,0
71635,as,0,0
71636,measured,0,0
71637,by,0,0
71638,self-report,0,0
71639,",",0,0
71640,parent,0,0
71641,report,0,0
71642,and,0,0
71643,teacher,0,1
71644,report,0,0
71645,.,0,0
71646,Discussion,0,0
71647,focuses,0,0
71648,on,0,0
71649,the,0,0
71650,implications,0,0
71651,for,0,0
71652,the,0,0
71653,use,0,0
71654,of,0,0
71655,cognitive,0,0
71656,behaviour,0,0
71657,therapy,0,0
71658,with,0,1
71659,HFA,1,1
71660,children,1,1
71661,",",0,0
71662,for,0,0
71663,theory,0,0
71664,of,0,0
71665,mind,0,0
71666,research,0,0
71667,and,0,0
71668,for,0,0
71669,further,0,0
71670,research,0,0
71671,on,0,0
71672,the,0,0
71673,treatment,0,0
71674,components,0,0
71675,.,0,1
71676,Do,0,0
71677,readers,1,0
71678,with,1,1
71679,autism,1,1
71680,make,0,0
71681,bridging,0,0
71682,inferences,0,0
71683,from,0,1
71684,world,0,1
71685,knowledge,0,0
71686,?,0,0
71687,Individuals,1,0
71688,with,1,1
71689,autism,1,1
71690,frequently,0,1
71691,show,0,0
71692,impairments,0,0
71693,in,0,0
71694,text,0,0
71695,reading,0,1
71696,comprehension,0,0
71697,.,0,0
71698,This,0,0
71699,often,0,0
71700,is,0,0
71701,attributed,0,0
71702,to,0,0
71703,poor,0,0
71704,ability,0,0
71705,to,0,0
71706,draw,0,0
71707,inferences,0,0
71708,during,0,0
71709,reading,0,0
71710,and,0,0
71711,to,0,0
71712,inadequate,0,1
71713,access,0,0
71714,to,0,0
71715,relevant,0,0
71716,knowledge,0,0
71717,.,0,0
71718,The,0,0
71719,current,0,0
71720,study,0,0
71721,tested,0,0
71722,this,0,0
71723,hypothesis,0,0
71724,by,0,0
71725,measuring,0,0
71726,the,0,0
71727,time,0,0
71728,taken,0,0
71729,to,0,0
71730,read,0,0
71731,the,0,0
71732,same,0,0
71733,question,0,0
71734,",",0,0
71735,relating,0,0
71736,to,0,0
71737,either,0,0
71738,physical,0,0
71739,or,0,1
71740,social,0,0
71741,world,0,0
71742,knowledge,0,0
71743,",",0,0
71744,when,0,0
71745,it,0,0
71746,was,0,0
71747,either,0,0
71748,relevant,0,0
71749,or,0,1
71750,irrelevant,0,0
71751,to,0,0
71752,the,0,0
71753,bridging,0,0
71754,inference,0,0
71755,evoked,0,0
71756,by,0,0
71757,a,0,0
71758,preceding,0,0
71759,two-sentence,0,0
71760,vignette,0,0
71761,.,0,0
71762,In,0,0
71763,the,0,0
71764,study,0,0
71765,",",0,0
71766,16,1,1
71767,normally,1,1
71768,developing,1,0
71769,adolescents,1,1
71770,and,1,1
71771,16,1,1
71772,adolescents,1,1
71773,with,1,1
71774,autism,1,1
71775,were,0,0
71776,matched,0,1
71777,on,0,0
71778,word,0,0
71779,reading,0,0
71780,accuracy,0,0
71781,",",0,0
71782,chronological,0,0
71783,age,0,1
71784,",",0,0
71785,and,0,0
71786,vocabulary,0,0
71787,but,0,0
71788,differed,0,0
71789,significantly,0,0
71790,in,0,0
71791,text,0,0
71792,comprehension,0,0
71793,.,0,0
71794,A,0,0
71795,strong,0,0
71796,priming,0,0
71797,effect,0,0
71798,was,0,0
71799,found,0,0
71800,",",0,0
71801,robust,0,0
71802,over,0,0
71803,participants,0,1
71804,and,0,1
71805,over,0,0
71806,items,0,0
71807,;,0,1
71808,participants,0,1
71809,read,0,0
71810,those,0,0
71811,questions,0,0
71812,that,0,0
71813,were,0,1
71814,relevant,0,0
71815,to,0,0
71816,the,0,0
71817,inference,0,0
71818,evoked,0,0
71819,by,0,0
71820,the,0,0
71821,vignette,0,0
71822,faster,0,0
71823,than,0,0
71824,they,0,0
71825,read,0,0
71826,those,0,0
71827,questions,0,0
71828,that,0,0
71829,were,0,0
71830,irrelevant,0,0
71831,",",0,0
71832,and,0,0
71833,no,0,0
71834,interaction,0,0
71835,with,0,0
71836,group,0,0
71837,membership,0,0
71838,or,0,0
71839,type,0,1
71840,of,0,0
71841,knowledge,0,0
71842,was,0,0
71843,found,0,0
71844,.,0,0
71845,This,0,0
71846,indicates,0,0
71847,that,0,0
71848,readers,1,0
71849,with,1,1
71850,autism,1,1
71851,",",0,0
71852,just,0,0
71853,like,0,0
71854,controls,0,1
71855,",",0,0
71856,were,0,0
71857,activating,0,0
71858,appropriate,0,0
71859,world,0,1
71860,knowledge,0,0
71861,primed,0,0
71862,by,0,0
71863,implicit,0,0
71864,inferences,0,0
71865,while,0,0
71866,reading,0,1
71867,the,0,0
71868,vignettes,0,0
71869,.,0,0
71870,Thus,0,0
71871,",",0,0
71872,the,0,0
71873,comprehension,0,0
71874,problems,0,1
71875,in,0,0
71876,these,0,0
71877,readers,0,0
71878,can,0,0
71879,not,0,0
71880,be,0,0
71881,attributed,0,0
71882,to,0,0
71883,an,0,0
71884,inability,0,0
71885,to,0,0
71886,make,0,0
71887,implicit,0,0
71888,inferences,0,0
71889,or,0,1
71890,to,0,0
71891,draw,0,0
71892,on,0,0
71893,relevant,0,0
71894,world,0,1
71895,knowledge,0,0
71896,.,0,0
71897,Instead,0,0
71898,",",0,0
71899,we,0,0
71900,suggest,0,0
71901,that,0,0
71902,these,0,0
71903,problems,0,0
71904,must,0,0
71905,be,0,0
71906,sought,0,0
71907,at,0,0
71908,a,0,0
71909,higher,0,0
71910,level,0,0
71911,of,0,0
71912,text,0,0
71913,processing,0,0
71914,.,0,1
71915,Role,0,0
71916,of,0,0
71917,diltiazem,0,0
71918,in,0,0
71919,the,0,0
71920,treatment,0,0
71921,of,0,0
71922,silent,0,0
71923,myocardial,0,1
71924,ischemia,0,1
71925,.,0,1
71926,Silent,0,0
71927,myocardial,0,1
71928,ischemia,0,1
71929,is,0,0
71930,a,0,0
71931,frequent,0,0
71932,finding,0,0
71933,when,0,0
71934,Holter,0,1
71935,monitoring,0,0
71936,is,0,0
71937,done,0,0
71938,in,0,0
71939,patients,1,1
71940,with,1,1
71941,advanced,1,1
71942,coronary,1,1
71943,disease,1,1
71944,.,1,1
71945,Silent,0,0
71946,ischemia,0,0
71947,is,0,0
71948,associated,0,0
71949,with,0,0
71950,a,0,0
71951,worse,0,0
71952,prognosis,0,0
71953,in,0,0
71954,patients,0,1
71955,with,0,1
71956,stable,0,1
71957,or,0,1
71958,unstable,0,1
71959,angina,0,1
71960,",",0,0
71961,survivors,0,1
71962,of,0,0
71963,myocardial,0,1
71964,infarction,0,1
71965,",",0,0
71966,and,0,0
71967,populations,0,0
71968,at,0,0
71969,risk,0,1
71970,for,0,0
71971,coronary,0,1
71972,disease,0,1
71973,.,0,1
71974,Whether,0,0
71975,medical,0,0
71976,therapy,0,0
71977,for,0,0
71978,silent,0,0
71979,ischemia,0,1
71980,improves,0,0
71981,prognosis,0,0
71982,is,0,0
71983,not,0,0
71984,known,0,0
71985,.,0,0
71986,In,0,0
71987,a,0,0
71988,randomized,0,0
71989,",",0,0
71990,placebo-controlled,0,0
71991,",",0,0
71992,multicenter,0,0
71993,trial,0,0
71994,of,0,0
71995,60,1,1
71996,patients,1,1
71997,with,1,1
71998,documented,1,1
71999,coronary,1,1
72000,disease,1,1
72001,",",1,0
72002,positive,1,0
72003,exercise,1,0
72004,tests,1,0
72005,",",1,0
72006,and,1,0
72007,ischemic,1,1
72008,episodes,1,0
72009,on,1,0
72010,Holter,1,1
72011,monitoring,1,0
72012,",",0,0
72013,long-acting,0,0
72014,diltiazem,0,0
72015,reduced,0,0
72016,ischemic,0,1
72017,episodes,0,1
72018,by,0,0
72019,50,0,1
72020,%,0,0
72021,compared,0,0
72022,to,0,0
72023,placebo,0,0
72024,",",0,0
72025,from,0,0
72026,a,0,0
72027,mean,0,0
72028,of,0,0
72029,5.6,0,0
72030,to,0,0
72031,2.8,0,0
72032,(,0,0
72033,p,0,0
72034,less,0,0
72035,than,0,0
72036,0.0001,0,0
72037,),0,1
72038,.,0,1
72039,Efficacy,0,0
72040,was,0,0
72041,maintained,0,0
72042,over,0,0
72043,24,0,1
72044,h,0,0
72045,and,0,0
72046,diltiazem,0,0
72047,also,0,0
72048,significantly,0,0
72049,improved,0,0
72050,exercise,0,0
72051,test,0,0
72052,parameters,0,0
72053,.,0,1
72054,Three,0,1
72055,smaller,0,0
72056,studies,0,0
72057,also,0,0
72058,demonstrated,0,0
72059,that,0,0
72060,diltiazem,0,0
72061,effectively,0,0
72062,reduces,0,0
72063,ambulatory,0,0
72064,ischemia,0,0
72065,;,0,0
72066,however,0,0
72067,",",0,0
72068,results,0,0
72069,with,0,1
72070,nifedipine,0,0
72071,are,0,0
72072,conflicting,0,0
72073,",",0,0
72074,with,0,1
72075,several,0,0
72076,studies,0,0
72077,showing,0,0
72078,no,0,0
72079,benefit,0,0
72080,.,0,0
72081,In,0,0
72082,contrast,0,0
72083,",",0,0
72084,beta-blockers,0,0
72085,reliably,0,0
72086,reduce,0,0
72087,ischemic,0,1
72088,episodes,0,0
72089,.,0,1
72090,The,0,0
72091,role,0,0
72092,of,0,0
72093,medical,0,0
72094,therapy,0,0
72095,for,0,0
72096,silent,0,0
72097,ischemia,0,1
72098,will,0,0
72099,be,0,0
72100,clarified,0,0
72101,only,0,0
72102,when,0,0
72103,its,0,0
72104,effect,0,0
72105,upon,0,0
72106,morbidity,0,0
72107,and,0,0
72108,mortality,0,0
72109,are,0,0
72110,determined,0,0
72111,.,0,1
72112,[,0,0
72113,Effect,0,0
72114,of,0,0
72115,ulinastatin,0,0
72116,on,0,0
72117,inflammatory,1,0
72118,responses,1,0
72119,induced,1,0
72120,by,1,0
72121,oesophagectomy,1,1
72122,],1,1
72123,.,0,1
72124,OBJECTIVE,0,0
72125,To,0,0
72126,examine,0,0
72127,the,0,0
72128,effect,0,0
72129,of,0,0
72130,ulinastatin,0,0
72131,(,0,0
72132,UTI,0,0
72133,),0,0
72134,on,0,0
72135,the,0,0
72136,inflammatory,1,0
72137,responses,1,0
72138,induced,1,0
72139,by,1,0
72140,oesophagectomy,1,1
72141,.,1,1
72142,METHODS,0,0
72143,Forty,1,1
72144,patients,1,1
72145,with,1,1
72146,esophageal,1,1
72147,cancer,1,1
72148,(,1,0
72149,without,1,1
72150,serious,1,0
72151,hypertension,1,1
72152,",",1,0
72153,heart,1,1
72154,disease,1,1
72155,",",1,0
72156,or,1,0
72157,respiratory,1,1
72158,function,1,0
72159,impairment,1,0
72160,",",1,0
72161,including,1,0
72162,34,1,1
72163,men,1,1
72164,and,1,1
72165,6,1,1
72166,women,1,1
72167,aged,1,1
72168,46,1,1
72169,to,1,1
72170,70,1,1
72171,years,1,1
72172,),1,1
72173,scheduled,1,1
72174,for,1,0
72175,oesophagectomy,1,1
72176,via,1,0
72177,left,1,1
72178,thoracotomy,1,1
72179,were,1,0
72180,randomly,1,1
72181,divided,1,0
72182,into,1,0
72183,control,1,0
72184,group,1,0
72185,(,1,0
72186,n=20,1,1
72187,),1,0
72188,and,1,0
72189,UTI,1,0
72190,group,1,0
72191,(,1,0
72192,n=20,1,1
72193,),1,0
72194,.,1,0
72195,Anesthesia,0,0
72196,induction,0,0
72197,and,0,0
72198,perioperative,0,0
72199,management,0,0
72200,followed,0,0
72201,the,0,0
72202,same,0,0
72203,protocols,0,0
72204,in,0,0
72205,the,0,0
72206,two,0,0
72207,groups,0,0
72208,",",0,0
72209,and,0,0
72210,in,0,0
72211,UTI,0,0
72212,group,0,0
72213,",",0,0
72214,patients,0,1
72215,received,0,1
72216,5000,0,1
72217,U/kg,0,1
72218,UTI,0,1
72219,while,0,0
72220,those,0,0
72221,in,0,0
72222,the,0,0
72223,control,0,0
72224,group,0,0
72225,were,0,0
72226,given,0,0
72227,the,0,0
72228,same,0,0
72229,volume,0,0
72230,of,0,0
72231,saline,0,0
72232,.,0,0
72233,Before,0,0
72234,operation,0,0
72235,(,0,0
72236,T,0,1
72237,(,0,1
72238,1,0,0
72239,),0,0
72240,),0,0
72241,",",0,0
72242,10,0,0
72243,min,0,0
72244,after,0,0
72245,recovery,0,0
72246,of,0,0
72247,two-lung,0,0
72248,ventilation,0,1
72249,(,0,0
72250,T,0,1
72251,(,0,1
72252,2,0,0
72253,),0,0
72254,),0,0
72255,",",0,0
72256,and,0,0
72257,24,0,0
72258,h,0,0
72259,(,0,0
72260,T,0,1
72261,(,0,1
72262,3,0,0
72263,),0,1
72264,),0,0
72265,and,0,0
72266,48,0,0
72267,h,0,0
72268,(,0,0
72269,T,0,1
72270,(,0,1
72271,4,0,0
72272,),0,0
72273,),0,0
72274,after,0,0
72275,operation,0,0
72276,",",0,0
72277,the,0,0
72278,venous,0,0
72279,blood,0,0
72280,sample,0,1
72281,was,0,0
72282,taken,0,0
72283,from,0,0
72284,the,0,0
72285,internal,0,0
72286,jugular,0,1
72287,vein,0,1
72288,and,0,0
72289,the,0,0
72290,plasma,0,0
72291,was,0,0
72292,separated,0,0
72293,and,0,0
72294,stored,0,0
72295,at,0,0
72296,-70,0,1
72297,degrees,0,0
72298,C,0,0
72299,for,0,0
72300,later,0,0
72301,analysis,0,0
72302,of,0,0
72303,IL-6,0,0
72304,and,0,0
72305,IL-8,0,0
72306,with,0,1
72307,enzyme-linked,0,0
72308,immunosorbent,0,0
72309,assay,0,0
72310,(,0,0
72311,ELISA,0,1
72312,),0,0
72313,.,0,0
72314,The,0,0
72315,bronchoalveoar,0,0
72316,lavage,0,0
72317,fluid,0,0
72318,(,0,0
72319,BAFL,0,0
72320,),0,0
72321,was,0,0
72322,also,0,0
72323,collected,0,0
72324,at,0,0
72325,T,0,1
72326,(,0,1
72327,1,0,0
72328,),0,0
72329,and,0,0
72330,T,0,1
72331,(,0,0
72332,2,0,0
72333,),0,0
72334,for,0,0
72335,IL-6,0,0
72336,and,0,0
72337,IL-8,0,0
72338,detection,0,0
72339,.,0,1
72340,RESULTS,0,0
72341,IL-6,0,0
72342,",",0,0
72343,IL-8,0,0
72344,levels,0,0
72345,in,0,0
72346,the,0,0
72347,plasma,0,0
72348,and,0,0
72349,BALF,0,0
72350,collected,0,0
72351,at,0,0
72352,T,0,1
72353,(,0,1
72354,2,0,0
72355,),0,0
72356,-T,0,0
72357,(,0,0
72358,4,0,0
72359,),0,0
72360,increased,0,0
72361,significantly,0,0
72362,as,0,0
72363,compared,0,0
72364,with,0,1
72365,those,0,0
72366,in,0,0
72367,samples,0,0
72368,collected,0,1
72369,at,0,0
72370,T,0,1
72371,(,0,1
72372,1,0,0
72373,),0,0
72374,",",0,0
72375,and,0,0
72376,their,0,0
72377,peak,0,0
72378,concentration,0,0
72379,inplasma,0,0
72380,and,0,0
72381,BALF,0,0
72382,samples,0,0
72383,were,0,1
72384,similar,0,0
72385,.,0,1
72386,IL-6,0,0
72387,and,0,0
72388,IL-8,0,0
72389,levels,0,0
72390,in,0,0
72391,the,0,0
72392,UTI,0,0
72393,group,0,0
72394,were,0,0
72395,significantly,0,0
72396,lower,0,0
72397,than,0,0
72398,those,0,0
72399,in,0,0
72400,the,0,0
72401,control,0,0
72402,group,0,0
72403,during,0,0
72404,the,0,0
72405,time,0,0
72406,points,0,0
72407,of,0,0
72408,T,0,1
72409,(,0,1
72410,2,0,0
72411,),0,0
72412,-T,0,0
72413,(,0,0
72414,4,0,0
72415,),0,1
72416,.,0,1
72417,CONCLUSION,0,0
72418,Inflammatory,0,0
72419,responses,0,0
72420,occur,0,0
72421,during,0,0
72422,and,0,0
72423,after,0,0
72424,oesophagectomy,0,1
72425,",",0,0
72426,which,0,0
72427,can,0,0
72428,be,0,0
72429,inhibited,0,0
72430,with,0,1
72431,UTI,0,1
72432,.,0,1
72433,Developmental,0,1
72434,disabilities,0,1
72435,modification,0,0
72436,of,0,0
72437,the,0,0
72438,Children,0,1
72439,'s,0,1
72440,Global,0,1
72441,Assessment,0,0
72442,Scale,0,0
72443,.,0,1
72444,BACKGROUND,0,0
72445,Interventions,0,0
72446,for,0,0
72447,pervasive,1,1
72448,developmental,1,1
72449,disorders,1,1
72450,(,1,1
72451,PDD,1,1
72452,),1,0
72453,aim,0,0
72454,to,0,0
72455,alleviate,0,0
72456,symptoms,0,0
72457,and,0,0
72458,improve,0,0
72459,functioning,0,0
72460,.,0,0
72461,To,0,0
72462,measure,0,0
72463,global,0,0
72464,functioning,0,0
72465,in,0,0
72466,treatment,0,0
72467,studies,0,0
72468,",",0,0
72469,the,0,0
72470,Children,0,1
72471,'s,0,1
72472,Global,0,1
72473,Assessment,0,0
72474,Scale,0,0
72475,was,0,0
72476,modified,0,0
72477,and,0,0
72478,psychometric,0,0
72479,properties,0,0
72480,of,0,0
72481,the,0,0
72482,revised,0,0
72483,version,0,0
72484,(,0,0
72485,DD-CGAS,0,0
72486,),0,0
72487,were,0,0
72488,assessed,0,0
72489,in,0,0
72490,children,1,1
72491,with,1,1
72492,PDD,1,1
72493,.,1,1
72494,METHODS,0,0
72495,Developmental,0,1
72496,disabilities-relevant,0,1
72497,descriptors,0,0
72498,were,0,1
72499,developed,0,0
72500,for,0,0
72501,the,0,0
72502,DD-CGAS,0,0
72503,",",0,0
72504,and,0,0
72505,administration,0,0
72506,procedures,0,0
72507,were,0,0
72508,established,0,0
72509,to,0,0
72510,enhance,0,0
72511,rater,0,0
72512,consistency,0,0
72513,.,0,0
72514,Ratings,0,0
72515,of,0,0
72516,clinical,0,0
72517,case,0,1
72518,vignettes,0,0
72519,were,0,0
72520,used,0,0
72521,to,0,0
72522,assess,0,0
72523,inter-rater,0,0
72524,reliability,0,0
72525,and,0,0
72526,temporal,0,0
72527,stability,0,0
72528,.,0,1
72529,Validity,0,0
72530,was,0,0
72531,assessed,0,0
72532,by,0,0
72533,correlating,0,0
72534,the,0,0
72535,DD-CGAS,0,0
72536,with,0,1
72537,measures,0,0
72538,of,0,0
72539,functioning,0,1
72540,and,0,0
72541,symptoms,0,0
72542,in,0,1
72543,83,1,1
72544,youngsters,1,1
72545,with,1,1
72546,PDD,1,1
72547,.,1,1
72548,Sensitivity,0,0
72549,to,0,0
72550,change,0,0
72551,was,0,0
72552,assessed,0,0
72553,by,0,0
72554,comparing,0,0
72555,change,0,0
72556,from,0,0
72557,baseline,0,0
72558,to,0,0
72559,post-treatment,0,0
72560,with,0,1
72561,change,0,0
72562,on,0,0
72563,the,0,0
72564,Aberrant,0,1
72565,Behavior,0,1
72566,Checklist-Irritability,0,0
72567,and,0,0
72568,Clinical,0,0
72569,Global,0,1
72570,Impressions-Improvement,0,0
72571,subscale,0,0
72572,scores,0,0
72573,in,0,0
72574,a,0,0
72575,subset,0,1
72576,of,0,0
72577,14,0,1
72578,children,0,1
72579,.,0,1
72580,RESULTS,0,0
72581,Inter-rater,0,0
72582,reliability,0,0
72583,(,0,0
72584,intraclass,0,0
72585,correlation,0,0
72586,coefficient,0,0
72587,[,0,0
72588,ICC,0,1
72589,],0,1
72590,=,0,0
72591,.79,0,0
72592,),0,0
72593,and,0,0
72594,temporal,0,0
72595,stability,0,0
72596,(,0,0
72597,average,0,0
72598,ICC,0,1
72599,=,0,0
72600,.86,0,0
72601,),0,0
72602,were,0,0
72603,excellent,0,0
72604,.,0,1
72605,The,0,0
72606,DD-CGAS,0,0
72607,scores,0,0
72608,correlated,0,0
72609,with,0,1
72610,measures,0,0
72611,of,0,0
72612,functioning,0,1
72613,and,0,0
72614,symptoms,0,0
72615,with,0,1
72616,moderate,0,1
72617,to,0,0
72618,large,0,1
72619,effect,0,0
72620,sizes,0,0
72621,.,0,0
72622,Changes,0,0
72623,on,0,0
72624,the,0,0
72625,DD-CGAS,0,0
72626,correlated,0,0
72627,with,0,1
72628,changes,0,0
72629,on,0,0
72630,the,0,0
72631,Aberrant,0,1
72632,Behavior,0,1
72633,Checklist-I,0,0
72634,(,0,0
72635,r,0,0
72636,=,0,0
72637,-.71,0,0
72638,),0,0
72639,and,0,0
72640,Global,0,1
72641,Impressions,0,0
72642,Scale-I,0,1
72643,(,0,0
72644,r,0,0
72645,=,0,0
72646,-.52,0,0
72647,),0,0
72648,.,0,0
72649,The,0,0
72650,pre-post,0,0
72651,DD-CGAS,0,0
72652,change,0,0
72653,had,0,0
72654,an,0,0
72655,effect,0,0
72656,size,0,0
72657,of,0,0
72658,.72,0,0
72659,.,0,0
72660,CONCLUSIONS,0,0
72661,The,0,0
72662,DD-CGAS,0,0
72663,is,0,0
72664,a,0,0
72665,reliable,0,0
72666,instrument,0,0
72667,with,0,1
72668,apparent,0,0
72669,convergent,0,0
72670,validity,0,0
72671,for,0,0
72672,measuring,0,0
72673,global,0,0
72674,functioning,0,0
72675,of,0,0
72676,children,1,1
72677,with,1,1
72678,PDD,1,1
72679,in,0,0
72680,treatment,0,0
72681,studies,0,0
72682,.,0,1
72683,Desmopressin,0,0
72684,in,0,0
72685,the,0,0
72686,treatment,0,0
72687,of,0,0
72688,nocturia,1,0
72689,:,1,1
72690,a,0,0
72691,double-blind,0,0
72692,",",0,0
72693,placebo-controlled,0,0
72694,study,0,0
72695,.,0,1
72696,OBJECTIVES,0,0
72697,To,0,0
72698,investigate,0,0
72699,efficacy,0,0
72700,",",0,0
72701,safety,0,0
72702,",",0,0
72703,and,0,0
72704,impact,0,0
72705,on,0,0
72706,quality,0,0
72707,of,0,0
72708,sleep,0,0
72709,of,0,0
72710,desmopressin,0,0
72711,in,0,0
72712,the,0,0
72713,treatment,0,0
72714,of,0,0
72715,nocturia,0,0
72716,.,0,1
72717,METHODS,0,0
72718,Adults,1,1
72719,aged,1,1
72720,>,1,1
72721,or,1,1
72722,=18,1,1
72723,yr,1,1
72724,with,1,1
72725,nocturia,1,0
72726,(,1,1
72727,>,1,1
72728,or,1,0
72729,=2,1,0
72730,voids/night,1,0
72731,),1,0
72732,received,0,0
72733,desmopressin,0,0
72734,tablets,0,0
72735,(,0,1
72736,0.1,0,0
72737,",",0,0
72738,0.2,0,0
72739,",",0,0
72740,or,0,1
72741,0.4,0,0
72742,mg,0,0
72743,),0,0
72744,during,0,0
72745,a,0,0
72746,3-wk,0,0
72747,dose-titration,0,0
72748,period,0,0
72749,.,0,0
72750,Patients,0,0
72751,should,0,0
72752,show,0,0
72753,sufficient,0,0
72754,response,0,0
72755,during,0,0
72756,the,0,0
72757,dose-titration,0,0
72758,period,0,0
72759,(,0,0
72760,>,0,1
72761,or,0,1
72762,=20,0,1
72763,%,0,0
72764,reduction,0,0
72765,in,0,0
72766,nocturnal,0,1
72767,diuresis,0,1
72768,),0,0
72769,and,0,0
72770,a,0,0
72771,return,0,0
72772,of,0,0
72773,nocturnal,0,0
72774,diuresis,0,0
72775,to,0,0
72776,>,0,0
72777,or,0,0
72778,=80,0,1
72779,%,0,0
72780,of,0,0
72781,baseline,0,0
72782,levels,0,0
72783,during,0,0
72784,washout,0,0
72785,.,0,1
72786,Eligible,0,0
72787,patients,0,1
72788,then,0,0
72789,entered,0,1
72790,a,0,0
72791,3-wk,0,0
72792,double-blind,0,0
72793,treatment,0,0
72794,period,0,0
72795,and,0,0
72796,received,0,0
72797,either,0,0
72798,desmopressin,0,0
72799,or,0,1
72800,placebo,0,0
72801,.,0,0
72802,RESULTS,0,0
72803,127,1,1
72804,patients,1,1
72805,were,1,1
72806,randomised,1,0
72807,to,0,0
72808,either,0,0
72809,desmopressin,0,0
72810,(,0,0
72811,n=61,0,1
72812,),0,0
72813,or,0,1
72814,placebo,0,0
72815,(,0,0
72816,n=66,0,1
72817,),0,1
72818,.,0,1
72819,Twenty,0,1
72820,(,0,0
72821,33,0,1
72822,%,0,0
72823,),0,1
72824,desmopressin-treated,0,0
72825,patients,0,1
72826,compared,0,0
72827,with,0,1
72828,seven,0,1
72829,(,0,1
72830,11,0,0
72831,%,0,0
72832,),0,1
72833,placebo-treated,0,0
72834,patients,0,1
72835,showed,0,0
72836,a,0,0
72837,clinical,0,0
72838,response,0,0
72839,",",0,0
72840,defined,0,0
72841,as,0,0
72842,a,0,0
72843,>,0,1
72844,or,0,0
72845,=50,0,1
72846,%,0,0
72847,reduction,0,0
72848,in,0,0
72849,the,0,0
72850,number,0,0
72851,of,0,0
72852,nocturnal,0,1
72853,voids,0,0
72854,compared,0,0
72855,with,0,1
72856,baseline,0,0
72857,(,0,0
72858,p=0.0014,0,0
72859,),0,0
72860,.,0,0
72861,Compared,0,0
72862,with,0,0
72863,placebo,0,0
72864,",",0,0
72865,desmopressin,0,0
72866,resulted,0,0
72867,in,0,0
72868,a,0,0
72869,significant,0,0
72870,reduction,0,0
72871,in,0,0
72872,the,0,0
72873,mean,0,0
72874,number,0,0
72875,of,0,0
72876,nocturnal,0,1
72877,voids,0,0
72878,(,0,1
72879,39,0,1
72880,%,0,0
72881,reduction,0,0
72882,with,0,1
72883,desmopressin,0,0
72884,vs.,0,0
72885,15,0,0
72886,%,0,0
72887,with,0,1
72888,placebo,0,0
72889,;,0,0
72890,absolute,0,0
72891,difference,0,0
72892,-0.84,0,0
72893,",",0,0
72894,p,0,0
72895,<,0,0
72896,0.0001,0,0
72897,),0,0
72898,and,0,0
72899,duration,0,0
72900,of,0,0
72901,the,0,0
72902,first,0,0
72903,sleep,0,0
72904,period,0,0
72905,(,0,0
72906,prolonged,0,0
72907,by,0,0
72908,108,0,1
72909,min,0,0
72910,with,0,1
72911,desmopressin,0,0
72912,vs.,0,0
72913,41,0,1
72914,min,0,0
72915,with,0,1
72916,placebo,0,0
72917,;,0,0
72918,p,0,0
72919,<,0,0
72920,0.0001,0,0
72921,),0,0
72922,.,0,0
72923,Quality,0,0
72924,of,0,0
72925,sleep,0,0
72926,was,0,0
72927,also,0,0
72928,improved,0,0
72929,with,0,0
72930,desmopressin,0,0
72931,versus,0,0
72932,placebo,0,0
72933,(,0,0
72934,statistically,0,0
72935,significant,0,0
72936,for,0,0
72937,one,0,1
72938,of,0,0
72939,the,0,0
72940,two,0,0
72941,parameters,0,0
72942,evaluated,0,1
72943,),0,1
72944,.,0,1
72945,Adverse,0,0
72946,events,0,0
72947,were,0,1
72948,mainly,0,1
72949,mild,0,1
72950,.,0,0
72951,CONCLUSIONS,0,0
72952,Oral,0,0
72953,desmopressin,0,0
72954,tablets,0,0
72955,provide,0,0
72956,an,0,0
72957,effective,0,0
72958,and,0,0
72959,well-tolerated,0,0
72960,treatment,0,0
72961,for,0,0
72962,nocturia,0,0
72963,.,0,0
72964,Compared,0,0
72965,with,0,0
72966,placebo,0,0
72967,",",0,0
72968,nocturnal,0,0
72969,voiding,0,0
72970,frequency,0,0
72971,is,0,0
72972,reduced,0,0
72973,",",0,0
72974,duration,0,0
72975,of,0,0
72976,the,0,0
72977,first,0,0
72978,sleep,0,0
72979,period,0,0
72980,is,0,0
72981,increased,0,0
72982,",",0,0
72983,and,0,0
72984,sleep,0,0
72985,quality,0,0
72986,may,0,0
72987,be,0,0
72988,improved,0,0
72989,.,0,0
72990,Effectiveness,0,0
72991,of,0,0
72992,aromatherapy,0,0
72993,massage,0,0
72994,in,0,0
72995,the,0,0
72996,management,0,0
72997,of,0,0
72998,anxiety,1,0
72999,and,1,0
73000,depression,1,1
73001,in,1,0
73002,patients,1,1
73003,with,1,1
73004,cancer,1,1
73005,:,1,1
73006,a,0,0
73007,multicenter,0,0
73008,randomized,0,0
73009,controlled,0,0
73010,trial,0,0
73011,.,0,0
73012,PURPOSE,0,0
73013,To,0,0
73014,test,0,0
73015,the,0,0
73016,effectiveness,0,0
73017,of,0,0
73018,supplementing,0,0
73019,usual,0,1
73020,supportive,0,0
73021,care,0,1
73022,with,0,1
73023,aromatherapy,0,0
73024,massage,0,0
73025,in,0,0
73026,the,0,0
73027,management,0,0
73028,of,0,0
73029,anxiety,1,0
73030,and,1,0
73031,depression,1,1
73032,in,1,0
73033,cancer,1,1
73034,patients,1,1
73035,through,0,0
73036,a,0,0
73037,pragmatic,0,0
73038,two-arm,0,0
73039,randomized,0,1
73040,controlled,0,0
73041,trial,0,0
73042,in,0,0
73043,four,0,1
73044,United,1,1
73045,Kingdom,1,1
73046,cancer,0,1
73047,centers,0,1
73048,and,0,0
73049,a,0,0
73050,hospice,0,1
73051,.,0,0
73052,PATIENTS,0,0
73053,AND,0,0
73054,METHODS,0,0
73055,Two,1,1
73056,hundred,1,1
73057,eighty-eight,1,1
73058,cancer,1,1
73059,patients,1,1
73060,",",1,0
73061,referred,1,1
73062,to,1,0
73063,complementary,1,0
73064,therapy,1,0
73065,services,1,1
73066,with,1,1
73067,clinical,1,0
73068,anxiety,1,1
73069,and/or,1,0
73070,depression,1,1
73071,",",0,0
73072,were,0,0
73073,allocated,0,0
73074,randomly,0,1
73075,to,0,0
73076,a,0,0
73077,course,0,0
73078,of,0,0
73079,aromatherapy,0,0
73080,massage,0,0
73081,or,0,1
73082,usual,0,1
73083,supportive,0,0
73084,care,0,1
73085,alone,0,0
73086,.,0,1
73087,RESULTS,0,0
73088,Patients,0,1
73089,who,0,1
73090,received,0,1
73091,aromatherapy,0,1
73092,massage,0,0
73093,had,0,1
73094,no,0,0
73095,significant,0,0
73096,improvement,0,0
73097,in,0,0
73098,clinical,0,0
73099,anxiety,0,1
73100,and/or,0,0
73101,depression,0,1
73102,compared,0,0
73103,with,0,1
73104,those,0,0
73105,receiving,0,0
73106,usual,0,0
73107,care,0,1
73108,at,0,0
73109,10,0,1
73110,weeks,0,0
73111,postrandomization,0,0
73112,(,0,1
73113,odds,0,0
73114,ratio,0,0
73115,[,0,0
73116,OR,0,0
73117,],0,1
73118,",",0,0
73119,1.3,0,0
73120,;,0,0
73121,95,0,0
73122,%,0,0
73123,CI,0,0
73124,",",0,0
73125,0.9,0,0
73126,to,0,0
73127,1.7,0,0
73128,;,0,1
73129,P,0,0
73130,=,0,0
73131,.1,0,0
73132,),0,0
73133,",",0,0
73134,but,0,0
73135,did,0,0
73136,at,0,0
73137,6,0,0
73138,weeks,0,0
73139,postrandomization,0,0
73140,(,0,0
73141,OR,0,0
73142,",",0,1
73143,1.4,0,0
73144,;,0,0
73145,95,0,0
73146,%,0,0
73147,CI,0,0
73148,",",0,0
73149,1.1,0,0
73150,to,0,0
73151,1.9,0,0
73152,;,0,1
73153,P,0,0
73154,=,0,0
73155,.01,0,0
73156,),0,1
73157,.,0,1
73158,Patients,0,1
73159,receiving,0,1
73160,aromatherapy,0,0
73161,massage,0,0
73162,also,0,0
73163,described,0,0
73164,greater,0,0
73165,improvement,0,0
73166,in,0,0
73167,self-reported,0,0
73168,anxiety,0,1
73169,at,0,0
73170,both,0,0
73171,6,0,0
73172,and,0,0
73173,10,0,1
73174,weeks,0,0
73175,postrandomization,0,0
73176,(,0,0
73177,OR,0,0
73178,",",0,1
73179,3.4,0,0
73180,;,0,0
73181,95,0,0
73182,%,0,0
73183,CI,0,0
73184,",",0,0
73185,0.2,0,0
73186,to,0,0
73187,6.7,0,0
73188,;,0,1
73189,P,0,0
73190,=,0,0
73191,.04,0,0
73192,and,0,0
73193,OR,0,0
73194,",",0,0
73195,3.4,0,0
73196,;,0,0
73197,95,0,0
73198,%,0,0
73199,CI,0,0
73200,",",0,0
73201,0.2,0,0
73202,to,0,0
73203,6.6,0,0
73204,;,0,1
73205,P,0,0
73206,=,0,0
73207,.04,0,0
73208,),0,0
73209,",",0,0
73210,respectively,0,0
73211,.,0,0
73212,CONCLUSION,0,0
73213,Aromatherapy,0,0
73214,massage,0,0
73215,does,0,0
73216,not,0,0
73217,appear,0,0
73218,to,0,0
73219,confer,0,0
73220,benefit,0,0
73221,on,0,0
73222,cancer,1,1
73223,patients,1,1
73224,',1,1
73225,anxiety,0,0
73226,and/or,0,0
73227,depression,0,1
73228,in,0,0
73229,the,0,0
73230,long-term,0,0
73231,",",0,0
73232,but,0,0
73233,is,0,0
73234,associated,0,0
73235,with,0,0
73236,clinically,0,0
73237,important,0,0
73238,benefit,0,0
73239,up,0,0
73240,to,0,0
73241,2,0,0
73242,weeks,0,0
73243,after,0,0
73244,the,0,0
73245,intervention,0,0
73246,.,0,0
73247,Stage,1,1
73248,II,1,1
73249,carcinoma,1,1
73250,of,1,0
73251,the,1,0
73252,ovary,1,1
73253,:,1,1
73254,an,0,0
73255,analysis,0,0
73256,of,0,0
73257,survival,0,0
73258,after,0,0
73259,comprehensive,0,1
73260,surgical,0,1
73261,staging,0,1
73262,and,0,0
73263,adjuvant,0,0
73264,therapy,0,0
73265,.,0,1
73266,Ninety-three,1,1
73267,women,1,1
73268,with,1,1
73269,FIGO,1,1
73270,stage,1,1
73271,II,1,1
73272,epithelial,1,1
73273,ovarian,1,1
73274,carcinoma,1,1
73275,underwent,0,1
73276,comprehensive,0,1
73277,surgical,0,1
73278,staging,0,1
73279,and,0,0
73280,were,0,0
73281,randomized,0,0
73282,prospectively,0,1
73283,to,0,0
73284,therapy,0,0
73285,consisting,0,0
73286,of,0,0
73287,either,0,0
73288,intraperitoneal,0,0
73289,radioactive,0,0
73290,phosphorus,0,0
73291,or,0,1
73292,oral,0,0
73293,melphalan,0,1
73294,.,0,0
73295,No,0,0
73296,patient,0,0
73297,had,0,0
73298,gross,0,0
73299,residual,0,0
73300,disease,0,1
73301,at,0,0
73302,the,0,0
73303,time,0,0
73304,of,0,0
73305,randomization,0,1
73306,.,0,1
73307,Ten,0,0
73308,of,0,0
73309,the,0,0
73310,forty-five,1,1
73311,women,1,1
73312,treated,1,1
73313,with,1,1
73314,melphalan,1,0
73315,experienced,0,0
73316,severe,0,1
73317,bone,0,0
73318,marrow,0,1
73319,depression,0,1
73320,at,0,0
73321,some,0,0
73322,time,0,0
73323,during,0,0
73324,therapy,0,0
73325,and,0,0
73326,two,0,0
73327,women,0,1
73328,expired,0,1
73329,from,0,1
73330,leukemia,0,1
73331,.,0,1
73332,Four,0,0
73333,of,0,0
73334,the,0,0
73335,forty-eight,1,1
73336,women,1,1
73337,treated,1,1
73338,with,1,1
73339,intraperitoneal,1,0
73340,phosphorus,1,0
73341,required,0,0
73342,surgical,0,0
73343,reexploration,0,1
73344,for,0,0
73345,intestinal,0,0
73346,obstruction,0,1
73347,or,0,1
73348,bowel,0,1
73349,injury,0,1
73350,.,0,1
73351,Twenty-one,0,1
73352,women,0,1
73353,died,0,1
73354,of,0,0
73355,their,0,0
73356,disease,0,1
73357,.,0,1
73358,Survival,0,0
73359,was,0,0
73360,not,0,0
73361,statistically,0,0
73362,different,0,0
73363,between,0,0
73364,the,0,0
73365,two,0,0
73366,treatment,0,0
73367,arms,0,0
73368,.,0,1
73369,The,0,0
73370,5-year,0,0
73371,actuarial,0,0
73372,survival,0,0
73373,was,0,0
73374,78,0,1
73375,%,0,0
73376,.,0,1
73377,Pathological,0,1
73378,features,0,1
73379,and,0,1
73380,inhaled,0,0
73381,corticosteroid,0,0
73382,response,0,0
73383,of,0,0
73384,eosinophilic,1,1
73385,and,1,0
73386,non-eosinophilic,1,1
73387,asthma,1,1
73388,.,1,1
73389,BACKGROUND,0,0
73390,Non-eosinophilic,0,0
73391,asthma,0,1
73392,is,0,0
73393,a,0,0
73394,potentially,0,0
73395,important,0,0
73396,clinicopathological,0,0
73397,phenotype,0,1
73398,since,0,0
73399,there,0,0
73400,is,0,0
73401,evidence,0,0
73402,that,0,0
73403,it,0,0
73404,responds,0,0
73405,poorly,0,0
73406,to,0,0
73407,inhaled,0,0
73408,corticosteroid,0,0
73409,therapy,0,0
73410,.,0,0
73411,However,0,0
73412,",",0,0
73413,little,0,0
73414,is,0,0
73415,known,0,0
73416,about,0,0
73417,the,0,0
73418,underlying,0,0
73419,airway,0,1
73420,immunopathology,0,0
73421,and,0,0
73422,there,0,0
73423,are,0,0
73424,no,0,0
73425,data,0,0
73426,from,0,1
73427,placebo-controlled,0,1
73428,studies,0,0
73429,examining,0,0
73430,the,0,0
73431,effect,0,0
73432,of,0,0
73433,inhaled,0,0
73434,corticosteroids,0,0
73435,.,0,1
73436,METHODS,0,0
73437,Airway,0,0
73438,immunopathology,0,0
73439,was,0,0
73440,investigated,0,0
73441,using,0,0
73442,induced,0,0
73443,sputum,0,0
73444,",",0,0
73445,bronchial,0,1
73446,biopsies,0,0
73447,",",0,0
73448,bronchial,0,1
73449,wash,0,0
73450,and,0,0
73451,bronchoalveolar,0,1
73452,lavage,0,1
73453,in,0,0
73454,12,1,0
73455,patients,1,1
73456,with,1,1
73457,symptomatic,1,1
73458,eosinophilic,1,1
73459,asthma,1,1
73460,",",1,0
73461,11,1,0
73462,patients,1,1
73463,with,1,1
73464,non-eosinophilic,1,1
73465,asthma,1,1
73466,and,1,0
73467,10,1,1
73468,healthy,1,1
73469,controls,1,1
73470,.,1,1
73471,The,0,0
73472,patients,1,1
73473,with,1,1
73474,non-eosinophilic,1,1
73475,asthma,1,1
73476,and,1,0
73477,6,1,0
73478,different,1,0
73479,patients,1,1
73480,with,1,1
73481,eosinophilic,1,1
73482,asthma,1,1
73483,entered,0,1
73484,a,0,0
73485,randomised,0,0
73486,",",0,0
73487,double-blind,0,0
73488,",",0,0
73489,placebo-controlled,0,0
73490,crossover,0,0
73491,study,0,0
73492,in,0,0
73493,which,0,0
73494,the,0,0
73495,effects,0,0
73496,of,0,0
73497,inhaled,0,1
73498,mometasone,0,0
73499,400,0,0
73500,microg,0,0
73501,once,0,0
73502,daily,0,0
73503,for,0,0
73504,8,0,0
73505,weeks,0,0
73506,on,0,0
73507,airway,0,1
73508,responsiveness,0,0
73509,and,0,0
73510,asthma,0,1
73511,quality,0,0
73512,of,0,0
73513,life,0,0
73514,were,0,0
73515,investigated,0,0
73516,.,0,1
73517,RESULTS,0,0
73518,Patients,1,1
73519,with,1,1
73520,non-eosinophilic,1,1
73521,asthma,1,1
73522,had,0,0
73523,absence,0,0
73524,of,0,0
73525,eosinophils,0,0
73526,in,0,0
73527,the,0,0
73528,mucosa,0,1
73529,(,0,0
73530,median,0,0
73531,4.4,0,0
73532,cells/mm,0,0
73533,(,0,1
73534,2,0,0
73535,),0,1
73536,vs,0,0
73537,23,0,1
73538,cells/mm,0,0
73539,(,0,1
73540,2,0,0
73541,),0,0
73542,in,0,0
73543,eosinophilic,0,1
73544,asthma,0,1
73545,and,0,0
73546,0,0,0
73547,cells/mm,0,0
73548,(,0,1
73549,2,0,0
73550,),0,0
73551,in,0,0
73552,normal,0,1
73553,controls,0,1
73554,;,0,0
73555,p,0,0
73556,=,0,0
73557,0.03,0,0
73558,),0,0
73559,and,0,0
73560,normal,0,1
73561,subepithelial,0,1
73562,layer,0,0
73563,thickness,0,0
73564,(,0,0
73565,5.8,0,0
73566,microm,0,0
73567,vs,0,0
73568,10.3,0,0
73569,microm,0,0
73570,in,0,0
73571,eosinophilic,0,1
73572,asthma,0,1
73573,and,0,0
73574,5.1,0,0
73575,microm,0,0
73576,in,0,0
73577,controls,0,1
73578,",",0,0
73579,p,0,0
73580,=,0,0
73581,0.002,0,0
73582,),0,0
73583,.,0,1
73584,Non-eosinophilic,1,0
73585,and,1,0
73586,eosinophilic,1,1
73587,asthma,1,1
73588,groups,1,0
73589,had,0,1
73590,increased,0,0
73591,mast,0,0
73592,cell,0,0
73593,numbers,0,0
73594,in,0,0
73595,the,0,0
73596,airway,0,1
73597,smooth,0,1
73598,muscle,0,0
73599,compared,0,0
73600,with,0,1
73601,normal,0,1
73602,controls,0,1
73603,(,0,1
73604,9,0,0
73605,vs,0,0
73606,8,0,0
73607,vs,0,0
73608,0,0,0
73609,cells/mm,0,0
73610,(,0,1
73611,2,0,0
73612,),0,0
73613,",",0,0
73614,p,0,0
73615,=,0,0
73616,0.016,0,0
73617,),0,1
73618,.,0,0
73619,Compared,0,0
73620,with,0,0
73621,placebo,0,0
73622,",",0,0
73623,8,0,0
73624,weeks,0,0
73625,of,0,0
73626,treatment,0,0
73627,with,0,1
73628,inhaled,0,0
73629,mometasone,0,0
73630,led,0,0
73631,to,0,0
73632,less,0,0
73633,improvement,0,0
73634,in,0,0
73635,methacholine,0,0
73636,PC,0,0
73637,(,0,0
73638,20,0,1
73639,),0,1
73640,(,0,0
73641,0.5,0,0
73642,vs,0,0
73643,5.5,0,0
73644,doubling,0,0
73645,concentrations,0,0
73646,",",0,1
73647,95,0,0
73648,%,0,0
73649,CI,0,0
73650,of,0,0
73651,difference,0,0
73652,1.1,0,0
73653,to,0,1
73654,9.1,0,0
73655,;,0,0
73656,p,0,0
73657,=,0,0
73658,0.018,0,0
73659,),0,0
73660,and,0,0
73661,asthma,0,1
73662,quality,0,0
73663,of,0,0
73664,life,0,0
73665,(,0,0
73666,0.2,0,0
73667,vs,0,0
73668,1.0,0,0
73669,points,0,0
73670,",",0,1
73671,95,0,0
73672,%,0,0
73673,CI,0,0
73674,of,0,0
73675,difference,0,0
73676,0.27,0,0
73677,to,0,1
73678,1.43,0,0
73679,;,0,0
73680,p,0,0
73681,=,0,0
73682,0.008,0,0
73683,),0,0
73684,.,0,1
73685,CONCLUSIONS,0,0
73686,Non-eosinophilic,0,0
73687,asthma,0,1
73688,represents,0,0
73689,a,0,0
73690,pathologically,0,0
73691,distinct,0,0
73692,disease,0,1
73693,phenotype,0,0
73694,which,0,0
73695,is,0,0
73696,characterised,0,0
73697,by,0,0
73698,the,0,0
73699,absence,0,0
73700,of,0,0
73701,airway,0,1
73702,eosinophilia,0,1
73703,",",0,0
73704,normal,0,1
73705,subepithelial,0,1
73706,layer,0,0
73707,thickness,0,0
73708,and,0,0
73709,a,0,0
73710,poor,0,0
73711,short-term,0,0
73712,response,0,0
73713,to,0,0
73714,treatment,0,0
73715,with,0,1
73716,inhaled,0,0
73717,corticosteroids,0,1
73718,.,0,1
73719,Immediately,0,0
73720,restored,0,0
73721,",",0,0
73722,single-tapered,0,0
73723,implants,1,0
73724,in,1,0
73725,the,1,0
73726,anterior,1,1
73727,maxilla,1,1
73728,:,1,1
73729,prosthodontic,0,1
73730,and,0,0
73731,aesthetic,0,1
73732,outcomes,0,0
73733,after,0,1
73734,1,0,1
73735,year,0,1
73736,.,0,1
73737,BACKGROUND,0,0
73738,Conventional,0,1
73739,implant,0,1
73740,protocols,0,0
73741,advocate,0,0
73742,a,0,0
73743,two-stage,0,0
73744,technique,0,0
73745,with,0,1
73746,a,0,0
73747,load-free,0,0
73748,",",0,0
73749,submerged,0,0
73750,healing,0,0
73751,period,0,1
73752,.,0,1
73753,Recent,0,0
73754,studies,0,0
73755,suggest,0,0
73756,that,0,0
73757,immediate,0,0
73758,restoration,0,0
73759,of,0,0
73760,single,0,0
73761,implants,0,0
73762,may,0,0
73763,be,0,0
73764,a,0,0
73765,viable,0,0
73766,treatment,0,0
73767,option,0,0
73768,.,0,0
73769,PURPOSE,0,0
73770,The,0,0
73771,purpose,0,0
73772,of,0,0
73773,this,0,0
73774,study,0,0
73775,was,0,0
73776,to,0,0
73777,evaluate,0,0
73778,prosthodontic,1,1
73779,and,1,0
73780,aesthetic,1,1
73781,peri-implant,1,0
73782,mucosal,0,0
73783,outcomes,0,0
73784,of,0,0
73785,immediately,1,0
73786,restored,1,0
73787,",",1,0
73788,Southern,1,1
73789,single-tapered,1,0
73790,implants,1,1
73791,in,1,0
73792,the,1,0
73793,anterior,1,1
73794,maxilla,1,1
73795,after,1,0
73796,1,1,0
73797,year,1,1
73798,.,1,1
73799,MATERIALS,0,0
73800,AND,0,0
73801,METHODS,0,0
73802,Participants,1,1
73803,(,1,0
73804,mean,1,1
73805,age,1,1
73806,:,1,1
73807,43.25,1,0
73808,years,1,1
73809,;,1,1
73810,range,1,1
73811,:,1,1
73812,23-71,1,1
73813,years,1,1
73814,),1,1
73815,satisfying,1,0
73816,specified,1,0
73817,inclusion,1,1
73818,criteria,1,1
73819,were,0,0
73820,randomly,0,1
73821,allocated,0,0
73822,to,0,0
73823,conventional,0,0
73824,two-stage,0,0
73825,restoration,0,0
73826,(,0,0
73827,control,0,0
73828,group,0,0
73829,;,0,0
73830,n=14,0,1
73831,),0,0
73832,and,0,0
73833,immediate,0,0
73834,restoration,0,0
73835,groups,0,0
73836,(,0,0
73837,test,0,0
73838,group,0,0
73839,;,0,0
73840,n,0,1
73841,=14,0,1
73842,),0,0
73843,in,0,0
73844,a,0,0
73845,randomized,0,0
73846,controlled,0,0
73847,clinical,0,0
73848,trial,0,1
73849,.,0,0
73850,Tapered,0,0
73851,",",0,0
73852,roughened-surface,0,0
73853,Southern,0,1
73854,implants,0,1
73855,were,0,1
73856,placed,0,1
73857,using,0,0
73858,a,0,0
73859,standardized,0,0
73860,technique,0,0
73861,",",0,0
73862,and,0,0
73863,implant,0,0
73864,level,0,0
73865,bone,0,0
73866,impressions,0,0
73867,were,0,1
73868,made,0,0
73869,.,0,1
73870,Provisional,0,0
73871,screw-retained,0,0
73872,crowns,0,0
73873,",",0,0
73874,out,0,0
73875,of,0,0
73876,occlusion,0,1
73877,",",0,0
73878,were,0,0
73879,placed,0,0
73880,at,0,0
73881,second-stage,0,1
73882,surgery,0,1
73883,after,0,0
73884,26,0,1
73885,weeks,0,0
73886,for,0,0
73887,the,0,0
73888,conventional,0,0
73889,restoration,0,0
73890,group,0,0
73891,",",0,0
73892,and,0,0
73893,within,0,0
73894,4,0,0
73895,hours,0,0
73896,of,0,0
73897,implant,0,0
73898,placement,0,0
73899,for,0,0
73900,the,0,0
73901,immediate,0,0
73902,restoration,0,0
73903,group,0,0
73904,.,0,0
73905,Both,0,0
73906,groups,0,0
73907,had,0,1
73908,definitive,0,1
73909,screw-retained,0,0
73910,metal-ceramic,0,1
73911,crowns,0,1
73912,placed,0,1
73913,in,0,0
73914,occlusion,0,1
73915,8,0,0
73916,weeks,0,0
73917,later,0,1
73918,.,0,1
73919,Peri-implant,0,0
73920,mucosal,0,0
73921,response,0,0
73922,and,0,0
73923,papilla,0,0
73924,index,0,0
73925,were,0,0
73926,recorded,0,0
73927,4,0,0
73928,weeks,0,0
73929,after,0,1
73930,definitive,0,1
73931,crown,0,0
73932,placement,0,0
73933,to,0,0
73934,allow,0,0
73935,for,0,0
73936,mucosal,0,0
73937,maturation,0,0
73938,and,0,0
73939,at,0,0
73940,1,0,0
73941,year,0,1
73942,.,0,1
73943,Prosthodontic,0,0
73944,and,0,0
73945,aesthetic,0,1
73946,outcomes,0,0
73947,were,0,1
73948,assessed,0,0
73949,using,0,0
73950,established,0,0
73951,criteria,0,1
73952,.,0,0
73953,RESULTS,0,0
73954,There,0,0
73955,were,0,0
73956,no,0,0
73957,significant,0,0
73958,differences,0,0
73959,within,0,0
73960,",",0,0
73961,or,0,0
73962,between,0,0
73963,",",0,0
73964,the,0,0
73965,control,0,0
73966,and,0,0
73967,test,0,0
73968,groups,0,0
73969,for,0,0
73970,age,0,1
73971,",",0,0
73972,gender,0,0
73973,",",0,0
73974,bone,0,0
73975,quality,0,0
73976,or,0,0
73977,quantity,0,0
73978,",",0,0
73979,implant,0,0
73980,stability,0,0
73981,measurements,0,0
73982,at,0,0
73983,surgery,0,1
73984,",",0,0
73985,or,0,0
73986,implant,0,0
73987,length,0,0
73988,.,0,0
73989,There,0,0
73990,were,0,0
73991,no,0,0
73992,significant,0,0
73993,differences,0,0
73994,in,0,0
73995,the,0,0
73996,implant,0,0
73997,success,0,0
73998,rate,0,0
73999,as,0,0
74000,determined,0,0
74001,by,0,0
74002,radiographic,0,1
74003,bone,0,0
74004,loss,0,0
74005,and,0,0
74006,stability,0,0
74007,tests,0,0
74008,after,0,0
74009,1,0,1
74010,year,0,1
74011,.,0,0
74012,There,0,0
74013,were,0,0
74014,no,0,0
74015,significant,0,0
74016,differences,0,0
74017,in,0,0
74018,prosthodontic,0,1
74019,maintenance,0,0
74020,",",0,0
74021,peri-implant,0,0
74022,mucosal,0,0
74023,response,0,0
74024,",",0,0
74025,and,0,0
74026,papilla,0,0
74027,index,0,0
74028,between,0,0
74029,the,0,0
74030,two,0,0
74031,groups,0,0
74032,over,0,0
74033,1,0,1
74034,year,0,1
74035,.,0,1
74036,CONCLUSIONS,0,0
74037,Tapered,0,0
74038,",",0,0
74039,roughened-surface,0,0
74040,implants,0,0
74041,immediately,0,0
74042,restored,0,0
74043,with,0,1
74044,single,0,0
74045,provisional,0,1
74046,crowns,0,1
74047,at,0,0
74048,surgery,0,1
74049,and,0,0
74050,definitive,0,1
74051,crowns,0,1
74052,8,0,1
74053,weeks,0,0
74054,later,0,1
74055,were,0,0
74056,as,0,0
74057,prosthodontically,0,1
74058,and,0,0
74059,aesthetically,0,0
74060,successful,0,0
74061,as,0,0
74062,conventionally,0,0
74063,restored,0,0
74064,two-stage,0,0
74065,implants,0,0
74066,during,0,0
74067,the,0,0
74068,first,0,0
74069,year,0,0
74070,of,0,0
74071,service,0,1
74072,.,0,1
74073,Restoring,0,0
74074,single,0,0
74075,implants,0,0
74076,immediately,0,0
74077,with,0,1
74078,screw-retained,0,0
74079,crowns,0,0
74080,is,0,0
74081,an,0,0
74082,efficient,0,0
74083,procedure,0,0
74084,",",0,0
74085,but,0,0
74086,the,0,0
74087,short-term,0,0
74088,outcome,0,0
74089,is,0,0
74090,by,0,0
74091,no,0,0
74092,means,0,0
74093,superior,0,0
74094,to,0,0
74095,a,0,0
74096,conventional,0,0
74097,two-stage,0,0
74098,approach,0,1
74099,.,0,1
74100,p16,0,0
74101,(,0,0
74102,INK4a,0,0
74103,),0,0
74104,Expression,0,0
74105,does,0,0
74106,not,0,0
74107,predict,0,0
74108,the,0,0
74109,outcome,0,0
74110,of,0,0
74111,cervical,0,1
74112,intraepithelial,0,1
74113,neoplasia,0,1
74114,grade,0,1
74115,2,0,0
74116,.,0,1
74117,Spontaneous,0,0
74118,regression,0,0
74119,of,0,0
74120,cervical,0,1
74121,intraepithelial,0,1
74122,neoplasia,0,1
74123,grade,0,1
74124,2,0,0
74125,(,0,0
74126,CIN2,0,0
74127,),0,0
74128,lesions,0,0
74129,has,0,0
74130,been,0,0
74131,recognized,0,0
74132,since,0,0
74133,1955,0,1
74134,",",0,0
74135,but,0,0
74136,predictors,0,0
74137,of,0,0
74138,this,0,0
74139,are,0,0
74140,poorly,0,0
74141,understood,0,0
74142,.,0,0
74143,Among,0,1
74144,the,0,0
74145,predictive,0,0
74146,markers,0,0
74147,studied,0,1
74148,",",0,0
74149,p16,0,0
74150,(,0,0
74151,INK4a,0,0
74152,),0,0
74153,has,0,0
74154,been,0,0
74155,suggested,0,0
74156,to,0,0
74157,be,0,0
74158,of,0,0
74159,some,0,0
74160,value,0,0
74161,in,0,0
74162,monitoring,0,0
74163,the,0,0
74164,diagnosis,0,1
74165,of,0,0
74166,CIN2,0,0
74167,.,0,1
74168,In,0,0
74169,this,0,0
74170,clinical,0,0
74171,trial,0,0
74172,",",0,0
74173,90,1,0
74174,Brazilian,1,1
74175,women,1,1
74176,",",1,0
74177,diagnosed,1,1
74178,to,1,0
74179,CIN2,1,0
74180,and,1,0
74181,high-risk,1,1
74182,human,1,1
74183,papillomavirus,1,1
74184,infection,1,0
74185,",",1,0
74186,were,1,0
74187,randomized,1,0
74188,into,1,1
74189,two,1,0
74190,groups,1,0
74191,of,1,0
74192,equal,1,1
74193,size,1,1
74194,:,1,1
74195,45,1,1
74196,women,1,1
74197,whose,1,1
74198,lesions,1,1
74199,were,1,0
74200,excised,1,1
74201,and,1,0
74202,45,1,1
74203,women,1,1
74204,subjected,1,0
74205,to,1,0
74206,prospective,1,0
74207,follow-up,1,0
74208,at,1,0
74209,3-month,1,0
74210,intervals,1,0
74211,at,1,0
74212,least,1,1
74213,for,1,0
74214,1,1,0
74215,year,1,1
74216,(,1,1
74217,mean,1,1
74218,6.8,1,0
74219,months,1,1
74220,),1,1
74221,.,1,1
74222,p16,0,0
74223,(,0,0
74224,INK4a,0,0
74225,),0,0
74226,expression,0,0
74227,was,0,0
74228,analyzed,0,0
74229,in,0,0
74230,paraffin-embedded,0,1
74231,sections,0,1
74232,using,0,0
74233,immunohistochemical,0,0
74234,staining,0,0
74235,.,0,0
74236,Among,0,1
74237,the,0,0
74238,45,1,1
74239,women,1,1
74240,in,0,0
74241,the,0,0
74242,follow-up,0,0
74243,group,0,0
74244,",",0,0
74245,42,0,1
74246,%,0,0
74247,experienced,0,0
74248,spontaneous,0,0
74249,regression,0,0
74250,",",0,0
74251,11,0,0
74252,%,0,0
74253,showed,0,0
74254,persistence,0,0
74255,",",0,0
74256,22,0,1
74257,%,0,0
74258,progressed,0,0
74259,to,0,0
74260,CIN3,0,1
74261,",",0,0
74262,and,0,0
74263,20,0,0
74264,%,0,0
74265,had,0,1
74266,partial,0,0
74267,regression,0,0
74268,to,0,0
74269,CIN1,0,0
74270,or,0,1
74271,ASCUS,0,0
74272,(,0,0
74273,atypical,0,1
74274,squamous,0,1
74275,cell,0,1
74276,undetermined,0,1
74277,signifiance,0,0
74278,),0,0
74279,.,0,0
74280,p16,0,0
74281,(,0,0
74282,INK4a,0,0
74283,),0,0
74284,expression,0,0
74285,was,0,0
74286,detected,0,0
74287,in,0,0
74288,68.9,0,0
74289,%,0,0
74290,of,0,0
74291,the,0,0
74292,patients,0,1
74293,.,0,0
74294,In,0,0
74295,univariate,0,0
74296,survival,0,0
74297,(,0,0
74298,Cox,0,0
74299,),0,0
74300,analysis,0,0
74301,",",0,0
74302,no,0,0
74303,significant,0,0
74304,difference,0,0
74305,in,0,0
74306,regression,0,0
74307,was,0,0
74308,obtained,0,0
74309,between,0,0
74310,p16,0,1
74311,(,0,0
74312,INK4a,0,0
74313,),0,0
74314,-negative,0,1
74315,and,0,0
74316,-positive,0,1
74317,CIN2,0,0
74318,lesions,0,1
74319,(,0,0
74320,adjusted,0,0
74321,HR,0,0
74322,=,0,1
74323,1.1,0,0
74324,;,0,1
74325,95,0,0
74326,%,0,0
74327,CI,0,0
74328,0.6-2.0,0,0
74329,),0,0
74330,.,0,0
74331,In,0,0
74332,conclusion,0,0
74333,",",0,0
74334,p16,0,0
74335,(,0,0
74336,INK4a,0,0
74337,),0,0
74338,expression,0,0
74339,could,0,0
74340,be,0,0
74341,useful,0,0
74342,in,0,0
74343,the,0,0
74344,diagnosis,0,1
74345,of,0,0
74346,CIN2,0,0
74347,.,0,0
74348,However,0,0
74349,",",0,0
74350,it,0,0
74351,failed,0,0
74352,to,0,0
74353,predict,0,0
74354,the,0,0
74355,outcome,0,0
74356,of,0,0
74357,CIN2,0,0
74358,.,0,0
74359,Because,0,0
74360,of,0,0
74361,its,0,0
74362,high,0,1
74363,spontaneous,0,0
74364,regression,0,0
74365,rate,0,0
74366,",",0,0
74367,follow-up,0,0
74368,could,0,0
74369,be,0,0
74370,considered,0,0
74371,as,0,0
74372,a,0,0
74373,management,0,0
74374,option,0,0
74375,of,0,0
74376,CIN2,0,0
74377,in,0,0
74378,young,0,1
74379,and,0,1
74380,compliant,0,1
74381,women,0,1
74382,.,0,1
74383,Enhanced,0,0
74384,inotropic,0,0
74385,state,0,0
74386,of,0,0
74387,the,0,0
74388,failing,0,0
74389,left,0,0
74390,ventricle,0,0
74391,by,0,0
74392,cardiac,0,1
74393,contractility,0,0
74394,modulation,0,0
74395,electrical,0,0
74396,signals,0,0
74397,is,0,0
74398,not,0,0
74399,associated,0,0
74400,with,0,1
74401,increased,0,0
74402,myocardial,0,1
74403,oxygen,0,0
74404,consumption,0,0
74405,.,0,1
74406,BACKGROUND,0,0
74407,Previous,0,1
74408,studies,0,0
74409,in,0,1
74410,patients,1,1
74411,and,1,1
74412,in,1,0
74413,dogs,1,1
74414,with,1,1
74415,experimentally,1,1
74416,induced,1,0
74417,heart,1,1
74418,failure,1,1
74419,(,1,0
74420,HF,1,1
74421,),1,0
74422,showed,0,0
74423,that,0,0
74424,electrical,0,0
74425,signals,0,0
74426,applied,0,0
74427,to,0,0
74428,the,0,0
74429,failing,0,0
74430,myocardium,0,1
74431,during,0,0
74432,the,0,0
74433,absolute,0,0
74434,refractory,0,1
74435,period,0,0
74436,improved,0,0
74437,left,0,1
74438,ventricular,0,0
74439,(,0,0
74440,LV,0,1
74441,),0,0
74442,function,0,0
74443,.,0,0
74444,We,0,0
74445,examined,0,0
74446,the,0,0
74447,effects,0,0
74448,these,0,0
74449,same,0,0
74450,cardiac,0,1
74451,contractility,0,0
74452,modulating,0,0
74453,(,0,0
74454,CCM,0,1
74455,),0,1
74456,electrical,0,0
74457,signals,0,0
74458,on,0,0
74459,myocardial,0,1
74460,oxygen,0,0
74461,consumption,0,0
74462,(,0,0
74463,MVO,0,1
74464,(,0,1
74465,2,0,0
74466,),0,0
74467,),0,0
74468,in,0,0
74469,both,1,0
74470,patients,1,1
74471,and,1,0
74472,dogs,1,1
74473,with,1,1
74474,chronic,1,1
74475,HF,1,1
74476,.,1,1
74477,METHODS,0,0
74478,AND,0,0
74479,RESULTS,0,0
74480,Six,1,1
74481,dogs,1,1
74482,with,1,1
74483,microembolizations-induced,1,0
74484,HF,1,1
74485,and,1,1
74486,9,1,0
74487,HF,1,1
74488,patients,1,1
74489,underwent,1,1
74490,CCM,1,1
74491,leads,1,0
74492,and,1,0
74493,generator,1,0
74494,(,1,0
74495,OPTIMIZER,1,0
74496,II,1,1
74497,),1,0
74498,implantation,1,0
74499,.,1,0
74500,After,0,0
74501,baseline,0,0
74502,measurements,0,0
74503,",",0,0
74504,CCM,0,1
74505,signals,0,0
74506,were,0,0
74507,delivered,0,0
74508,continuously,0,0
74509,for,0,0
74510,2,0,0
74511,hours,0,0
74512,in,0,1
74513,dogs,0,1
74514,and,0,1
74515,for,0,0
74516,30,0,1
74517,minutes,0,0
74518,in,0,1
74519,patients,0,1
74520,.,0,1
74521,MVO,0,1
74522,(,0,0
74523,2,0,0
74524,),0,0
74525,was,0,0
74526,measured,0,0
74527,before,0,0
74528,and,0,0
74529,after,0,0
74530,CCM,0,1
74531,therapy,0,0
74532,.,0,0
74533,In,0,0
74534,dogs,0,1
74535,",",0,0
74536,CCM,0,1
74537,therapy,0,0
74538,increased,0,0
74539,LV,0,0
74540,ejection,0,1
74541,fraction,0,0
74542,at,0,0
74543,2,0,0
74544,hours,0,0
74545,(,0,1
74546,26,0,1
74547,+/-,0,0
74548,1,0,1
74549,versus,0,0
74550,31,0,1
74551,+/-,0,0
74552,2,0,0
74553,%,0,0
74554,",",0,0
74555,P,0,0
74556,=,0,0
74557,.001,0,0
74558,),0,0
74559,without,0,1
74560,increasing,0,0
74561,MVO,0,1
74562,(,0,1
74563,2,0,0
74564,),0,1
74565,(,0,1
74566,257,0,1
74567,+/-,0,0
74568,41,0,1
74569,versus,0,0
74570,180,0,1
74571,+/-,0,0
74572,34,0,1
74573,micromol/min,0,0
74574,),0,0
74575,.,0,0
74576,In,0,0
74577,patients,0,1
74578,",",0,0
74579,CCM,0,1
74580,therapy,0,0
74581,increased,0,0
74582,LV,0,0
74583,peak,0,0
74584,+dP/dt,0,0
74585,by,0,0
74586,10.1,0,0
74587,+/-,0,0
74588,1.5,0,0
74589,%,0,0
74590,.,0,0
74591,As,0,0
74592,with,0,1
74593,dogs,0,1
74594,",",0,0
74595,the,0,0
74596,increase,0,0
74597,in,0,0
74598,LV,0,0
74599,function,0,0
74600,after,0,0
74601,30,0,1
74602,minutes,0,0
74603,of,0,0
74604,CCM,0,1
74605,therapy,0,0
74606,was,0,0
74607,not,0,0
74608,associated,0,0
74609,with,0,1
74610,increased,0,0
74611,MVO,0,1
74612,(,0,0
74613,2,0,0
74614,),0,1
74615,(,0,1
74616,13.6,0,0
74617,+/-,0,0
74618,9.7,0,1
74619,versus,0,0
74620,12.5,0,0
74621,+/-,0,0
74622,7.2,0,0
74623,mL,0,0
74624,O,0,0
74625,(,0,0
74626,2,0,0
74627,),0,0
74628,/min,0,0
74629,),0,0
74630,.,0,0
74631,CONCLUSIONS,0,0
74632,The,0,0
74633,study,0,0
74634,results,0,0
74635,suggest,0,0
74636,that,0,0
74637,unlike,0,0
74638,cAMP-dependent,0,0
74639,positive,0,1
74640,inotropic,0,0
74641,drugs,0,0
74642,",",0,0
74643,the,0,0
74644,increase,0,0
74645,in,0,0
74646,LV,0,0
74647,function,0,0
74648,during,0,0
74649,CCM,0,0
74650,therapy,0,0
74651,is,0,0
74652,elicited,0,0
74653,without,0,0
74654,increasing,0,0
74655,MVO,0,1
74656,(,0,1
74657,2,0,0
74658,),0,1
74659,.,0,1
74660,Effects,0,0
74661,of,0,0
74662,application,0,0
74663,in,0,0
74664,spring,0,1
74665,of,0,0
74666,urea,0,0
74667,fertiliser,0,1
74668,on,0,0
74669,aspects,0,0
74670,of,0,0
74671,reproductive,0,1
74672,performance,0,0
74673,of,0,0
74674,pasture-fed,1,1
74675,dairy,1,1
74676,cows,1,1
74677,.,1,1
74678,AIMS,0,0
74679,To,0,0
74680,assess,0,0
74681,if,0,0
74682,raising,0,0
74683,concentrations,0,0
74684,of,0,0
74685,crude,0,0
74686,protein,0,0
74687,(,0,0
74688,CP,0,0
74689,),0,0
74690,in,0,0
74691,pasture,0,0
74692,in,0,0
74693,spring,0,1
74694,by,0,0
74695,the,0,0
74696,frequent,0,0
74697,application,0,0
74698,of,0,0
74699,urea,0,0
74700,fertiliser,0,0
74701,would,0,0
74702,affect,0,0
74703,ovarian,0,1
74704,follicular,0,1
74705,dynamics,0,0
74706,",",0,0
74707,luteal,0,0
74708,function,0,0
74709,",",0,0
74710,onset,0,0
74711,of,0,0
74712,oestrus,0,0
74713,and,0,0
74714,reproductive,0,1
74715,performance,0,0
74716,of,0,0
74717,dairy,1,1
74718,cows,1,1
74719,under,1,0
74720,farming,1,1
74721,conditions,1,0
74722,in,1,1
74723,New,1,1
74724,Zealand,1,1
74725,.,1,1
74726,METHODS,0,0
74727,Spring-calved,1,1
74728,dairy,1,1
74729,cows,1,1
74730,were,1,0
74731,grazed,1,0
74732,for,1,0
74733,101,1,1
74734,days,1,0
74735,in,1,1
74736,paddocks,1,1
74737,that,1,0
74738,were,1,0
74739,either,1,0
74740,not,1,0
74741,fertilised,1,0
74742,(,1,0
74743,Control,1,1
74744,;,1,0
74745,n=20,1,1
74746,),1,0
74747,during,1,0
74748,the,1,0
74749,course,1,0
74750,of,1,0
74751,the,1,0
74752,study,1,0
74753,",",1,0
74754,or,1,0
74755,were,1,0
74756,fertilised,1,0
74757,with,1,1
74758,40-50,1,0
74759,kg,1,1
74760,nitrogen,1,0
74761,(,1,1
74762,N,1,1
74763,),1,0
74764,/ha,1,0
74765,every,1,0
74766,4-6,1,0
74767,weeks,1,0
74768,(,1,1
74769,High-N,1,1
74770,;,1,0
74771,n=20,1,1
74772,),1,0
74773,.,1,0
74774,Similar,0,0
74775,generous,0,0
74776,pasture,0,1
74777,allowances,0,1
74778,were,0,0
74779,offered,0,0
74780,to,0,0
74781,both,0,0
74782,groups,0,0
74783,.,0,1
74784,Concentrations,0,0
74785,of,0,0
74786,CP,0,1
74787,in,0,0
74788,pasture,0,0
74789,",",0,0
74790,urea,0,0
74791,in,0,0
74792,serum,0,0
74793,and,0,0
74794,progesterone,0,0
74795,in,0,0
74796,milk,0,1
74797,were,0,0
74798,measured,0,0
74799,.,0,0
74800,Ovarian,0,0
74801,follicular,0,1
74802,and,0,0
74803,luteal,0,0
74804,dynamics,0,0
74805,were,0,1
74806,determined,0,0
74807,using,0,0
74808,ultrasonography,0,0
74809,.,0,1
74810,Oestrous,0,0
74811,behaviour,0,0
74812,and,0,0
74813,the,0,0
74814,number,0,0
74815,",",0,0
74816,time,0,0
74817,and,0,0
74818,outcome,0,0
74819,of,0,0
74820,inseminations,0,0
74821,were,0,1
74822,also,0,0
74823,recorded,0,0
74824,.,0,0
74825,RESULTS,0,0
74826,Mean,0,1
74827,concentrations,0,0
74828,of,0,0
74829,CP,0,1
74830,in,0,0
74831,pasture,0,0
74832,and,0,0
74833,urea,0,0
74834,in,0,0
74835,serum,0,0
74836,was,0,0
74837,higher,0,0
74838,in,0,0
74839,the,0,0
74840,High-N,0,0
74841,than,0,0
74842,the,0,0
74843,Control,0,0
74844,group,0,0
74845,(,0,0
74846,25.2,0,0
74847,vs,0,0
74848,21.6,0,1
74849,and,0,0
74850,8.3,0,0
74851,vs,0,0
74852,5.4,0,0
74853,mmol/L,0,0
74854,for,0,0
74855,CP,0,0
74856,and,0,0
74857,urea,0,0
74858,",",0,0
74859,respectively,0,0
74860,;,0,0
74861,p,0,0
74862,<,0,0
74863,0.001,0,0
74864,),0,1
74865,.,0,1
74866,Intervals,0,0
74867,between,0,0
74868,calving,0,1
74869,and,0,0
74870,first,0,0
74871,oestrus,0,0
74872,",",0,0
74873,first,0,0
74874,insemination,0,0
74875,and,0,0
74876,conception,0,0
74877,",",0,0
74878,the,0,0
74879,time,0,0
74880,of,0,0
74881,first,0,0
74882,emergence,0,0
74883,of,0,0
74884,a,0,0
74885,dominant,0,0
74886,follicle,0,0
74887,",",0,0
74888,milk,0,0
74889,progesterone,0,0
74890,concentration,0,0
74891,",",0,0
74892,and,0,0
74893,the,0,0
74894,diameter,0,0
74895,of,0,0
74896,the,0,0
74897,corpus,0,0
74898,luteum,0,0
74899,(,0,0
74900,CL,0,0
74901,),0,0
74902,in,0,0
74903,the,0,0
74904,first,0,0
74905,luteal,0,0
74906,phase,0,1
74907,did,0,0
74908,not,0,0
74909,differ,0,0
74910,significantly,0,0
74911,between,0,0
74912,groups,0,0
74913,.,0,1
74914,The,0,0
74915,interval,0,0
74916,from,0,0
74917,calving,0,1
74918,to,0,0
74919,first,0,0
74920,ovulation,0,0
74921,tended,0,0
74922,(,0,0
74923,p=0.10,0,0
74924,),0,0
74925,to,0,0
74926,be,0,0
74927,lower,0,0
74928,and,0,0
74929,the,0,0
74930,diameter,0,0
74931,of,0,0
74932,the,0,0
74933,dominant,0,0
74934,follicle,0,1
74935,of,0,0
74936,the,0,0
74937,oestrous,0,0
74938,cycle,0,0
74939,at,0,0
74940,which,0,0
74941,cows,0,1
74942,conceived,0,0
74943,was,0,0
74944,greater,0,0
74945,(,0,0
74946,p=0.02,0,0
74947,),0,0
74948,in,0,0
74949,Control,0,1
74950,than,0,0
74951,High-N,0,1
74952,cows,0,1
74953,.,0,0
74954,CONCLUSIONS,0,0
74955,The,0,0
74956,use,0,0
74957,of,0,0
74958,large,0,1
74959,amounts,0,0
74960,of,0,0
74961,urea,0,0
74962,fertiliser,0,0
74963,during,0,0
74964,spring,0,1
74965,and,0,0
74966,the,0,0
74967,consequent,0,0
74968,increases,0,0
74969,in,0,0
74970,concentrations,0,0
74971,of,0,0
74972,CP,0,1
74973,in,0,0
74974,pasture,0,0
74975,and,0,0
74976,urea,0,0
74977,in,0,0
74978,serum,0,0
74979,did,0,0
74980,not,0,0
74981,negatively,0,0
74982,affect,0,0
74983,any,0,0
74984,of,0,0
74985,the,0,0
74986,parameters,0,0
74987,of,0,0
74988,reproductive,0,1
74989,performance,0,0
74990,of,0,0
74991,pasture-fed,1,1
74992,dairy,1,1
74993,cows,1,1
74994,that,0,0
74995,were,0,0
74996,assessed,0,0
74997,in,0,0
74998,this,0,0
74999,study,0,0
75000,.,0,0
75001,Temporal,0,0
75002,judgements,0,0
75003,of,0,0
75004,internal,0,1
75005,and,0,1
75006,external,0,0
75007,events,0,0
75008,in,0,1
75009,persons,1,1
75010,with,1,1
75011,and,1,0
75012,without,1,1
75013,autism,1,1
75014,.,1,0
75015,When,0,0
75016,participants,0,1
75017,make,0,0
75018,judgments,0,0
75019,about,0,0
75020,the,0,0
75021,onset,0,0
75022,of,0,0
75023,self-initiated,0,0
75024,movements,0,0
75025,they,0,1
75026,typically,0,1
75027,report,0,0
75028,the,0,0
75029,movement,0,0
75030,occurred,0,0
75031,earlier,0,0
75032,than,0,0
75033,it,0,0
75034,had,0,1
75035,[,0,0
75036,Obhi,0,0
75037,",",0,0
75038,S.,0,0
75039,S.,0,0
75040,",",0,0
75041,&,0,0
75042,Haggard,0,1
75043,",",0,0
75044,P.,0,1
75045,(,0,0
75046,2004,0,1
75047,),0,1
75048,.,0,0
75049,Free,0,0
75050,will,0,0
75051,and,0,0
75052,free,0,0
75053,wo,0,0
75054,n't,0,0
75055,.,0,0
75056,American,0,0
75057,Scientific,0,0
75058,",",0,0
75059,92,0,0
75060,",",0,0
75061,358-365.,0,0
75062,],0,1
75063,.,0,1
75064,One,0,0
75065,interpretation,0,0
75066,is,0,0
75067,that,0,0
75068,feed-forward,0,0
75069,processes,0,0
75070,lead,0,0
75071,to,0,0
75072,awareness,0,0
75073,of,0,0
75074,the,0,0
75075,movement,0,0
75076,prior,0,0
75077,to,0,0
75078,execution,0,0
75079,.,0,0
75080,Because,0,0
75081,individuals,1,1
75082,with,1,1
75083,autism,1,1
75084,experience,0,0
75085,reduced,0,0
75086,preparatory,0,0
75087,activity,0,0
75088,prior,0,0
75089,to,0,0
75090,a,0,0
75091,voluntary,0,0
75092,movement,0,0
75093,",",0,0
75094,the,0,0
75095,present,0,0
75096,study,0,0
75097,sought,0,0
75098,to,0,0
75099,determine,0,0
75100,whether,0,0
75101,these,0,0
75102,anticipatory,0,0
75103,biases,0,0
75104,are,0,0
75105,exhibited,0,0
75106,by,0,0
75107,persons,1,1
75108,with,1,1
75109,autism,1,1
75110,.,1,1
75111,Participants,0,1
75112,watched,0,1
75113,a,0,0
75114,dot,0,0
75115,move,0,0
75116,in,0,0
75117,a,0,0
75118,circle,0,0
75119,and,0,0
75120,pressed,0,0
75121,the,0,0
75122,spacebar,0,0
75123,any,0,0
75124,time,0,0
75125,after,0,0
75126,one,0,1
75127,revolution,0,1
75128,.,0,0
75129,A,0,0
75130,tone,0,0
75131,either,0,0
75132,followed,0,0
75133,the,0,0
75134,participants,0,1
75135,',0,1
75136,voluntary,0,1
75137,movement,0,0
75138,or,0,1
75139,was,0,0
75140,computer,0,0
75141,generated,0,0
75142,.,0,0
75143,Participants,0,1
75144,in,0,0
75145,both,0,0
75146,groups,0,0
75147,made,0,0
75148,anticipatory,0,0
75149,judgements,0,0
75150,regarding,0,0
75151,movement,0,0
75152,initiation,0,0
75153,(,0,0
75154,approximately,0,0
75155,100,0,0
75156,ms,0,1
75157,),0,0
75158,.,0,0
75159,When,0,0
75160,the,0,0
75161,movement,0,0
75162,and,0,0
75163,tone,0,0
75164,occurred,0,0
75165,together,0,0
75166,this,0,0
75167,anticipatory,0,0
75168,bias,0,0
75169,was,0,0
75170,also,0,0
75171,present,0,0
75172,",",0,0
75173,regardless,0,0
75174,of,0,0
75175,which,0,0
75176,event,0,0
75177,participants,0,1
75178,focused,0,0
75179,on,0,0
75180,.,0,1
75181,Individuals,1,0
75182,with,1,1
75183,autism,1,1
75184,appear,0,0
75185,to,0,0
75186,have,0,0
75187,access,0,0
75188,to,0,0
75189,a,0,0
75190,similar,0,0
75191,representation,0,0
75192,of,0,0
75193,voluntary,0,1
75194,movements,0,0
75195,",",0,0
75196,however,0,0
75197,this,0,0
75198,representation,0,0
75199,may,0,0
75200,be,0,0
75201,more,0,0
75202,variable,0,0
75203,.,0,0
75204,Women,1,1
75205,'s,1,1
75206,responses,1,0
75207,to,1,1
75208,information,1,0
75209,on,1,0
75210,mammographic,1,1
75211,breast,1,1
75212,density,1,0
75213,.,1,0
75214,The,0,0
75215,objective,0,0
75216,of,0,0
75217,this,0,0
75218,study,0,0
75219,was,0,0
75220,to,0,0
75221,determine,0,0
75222,the,0,0
75223,negative,0,0
75224,and,0,0
75225,positive,0,0
75226,outcomes,0,0
75227,of,0,0
75228,providing,0,0
75229,mammographic,0,1
75230,breast,0,1
75231,density,0,0
75232,(,0,0
75233,MBD,0,1
75234,),0,0
75235,information,0,0
75236,to,0,0
75237,participants,1,1
75238,of,1,0
75239,a,1,0
75240,screening,1,1
75241,program,1,0
75242,.,1,0
75243,A,0,0
75244,randomized,0,0
75245,experiment,0,0
75246,was,0,0
75247,conducted,0,0
75248,with,0,1
75249,a,0,0
75250,sample,1,1
75251,of,1,0
75252,618,1,1
75253,women,1,1
75254,50,1,1
75255,years,1,1
75256,or,1,1
75257,older,1,1
75258,with,1,1
75259,MBD,1,1
75260,greater,1,0
75261,than,1,0
75262,50,1,0
75263,%,1,0
75264,of,1,0
75265,breast,1,1
75266,volume,1,0
75267,.,1,0
75268,The,0,0
75269,intervention,0,0
75270,consisted,0,0
75271,of,0,0
75272,reporting,0,0
75273,the,0,0
75274,presence,0,0
75275,of,0,0
75276,MBD,0,1
75277,in,0,0
75278,the,0,0
75279,screening,0,0
75280,mammography,0,1
75281,results,0,0
75282,letter,0,0
75283,that,0,0
75284,was,0,0
75285,sent,0,0
75286,along,0,0
75287,with,0,1
75288,an,0,0
75289,information,0,0
75290,pamphlet,0,0
75291,.,0,0
75292,Compared,0,0
75293,to,0,0
75294,the,0,0
75295,controls,0,0
75296,",",0,0
75297,more,0,0
75298,women,0,1
75299,in,0,0
75300,the,0,0
75301,intervention,0,0
75302,group,0,0
75303,described,0,0
75304,the,0,0
75305,term,0,0
75306,breast,0,1
75307,density,0,0
75308,correctly,0,0
75309,and,0,0
75310,recognized,0,0
75311,it,0,0
75312,as,0,0
75313,a,0,0
75314,risk,0,0
75315,factor,0,0
75316,for,0,0
75317,breast,0,1
75318,cancer,0,1
75319,.,0,0
75320,Although,0,0
75321,at,0,0
75322,the,0,0
75323,4-week,0,0
75324,follow-up,0,0
75325,the,0,0
75326,intervention,0,0
75327,group,0,0
75328,indicated,0,0
75329,that,0,0
75330,they,0,0
75331,were,0,0
75332,very,0,0
75333,likely,0,0
75334,to,0,0
75335,have,0,0
75336,an,0,0
75337,annual,0,0
75338,clinical,0,0
75339,breast,0,1
75340,examination,0,0
75341,more,0,0
75342,frequently,0,0
75343,than,0,0
75344,controls,0,0
75345,",",0,0
75346,no,0,0
75347,differences,0,0
75348,were,0,0
75349,detected,0,0
75350,at,0,0
75351,6,0,0
75352,months,0,0
75353,.,0,0
75354,There,0,0
75355,were,0,0
75356,no,0,0
75357,significant,0,0
75358,differences,0,0
75359,on,0,0
75360,other,0,0
75361,behavioural,0,0
75362,or,0,1
75363,psychological,0,0
75364,measures,0,0
75365,",",0,0
75366,although,0,0
75367,at,0,0
75368,the,0,0
75369,4-week,0,0
75370,follow-up,0,0
75371,the,0,0
75372,control,0,0
75373,group,0,0
75374,perceived,0,0
75375,their,0,0
75376,risk,0,0
75377,for,0,0
75378,breast,0,1
75379,cancer,0,1
75380,",",0,0
75381,relative,0,0
75382,to,0,0
75383,other,0,0
75384,women,0,1
75385,their,0,0
75386,age,0,1
75387,",",0,0
75388,as,0,0
75389,a,0,0
75390,lot,0,0
75391,lower,0,0
75392,than,0,0
75393,did,0,0
75394,women,0,1
75395,in,0,0
75396,the,0,0
75397,intervention,0,0
75398,group,0,0
75399,.,0,0
75400,The,0,0
75401,results,0,0
75402,demonstrate,0,0
75403,a,0,0
75404,feasible,0,0
75405,and,0,0
75406,non-threatening,0,0
75407,way,0,0
75408,to,0,0
75409,provide,0,0
75410,women,0,1
75411,with,0,1
75412,important,0,0
75413,personalized,0,0
75414,information,0,0
75415,about,0,0
75416,breast,0,1
75417,cancer,0,1
75418,risk,0,0
75419,.,0,1
75420,Dissociation,0,0
75421,between,0,0
75422,cortical,0,0
75423,activation,0,0
75424,and,0,0
75425,cognitive,0,0
75426,performance,0,0
75427,under,0,0
75428,pharmacological,0,0
75429,blood,0,0
75430,pressure,0,0
75431,elevation,0,0
75432,in,0,0
75433,chronic,0,1
75434,hypotension,0,0
75435,.,0,0
75436,The,0,0
75437,present,0,0
75438,study,0,0
75439,explored,0,0
75440,the,0,0
75441,impact,0,0
75442,of,0,0
75443,pharmacological,0,0
75444,blood,0,0
75445,pressure,0,0
75446,elevation,0,0
75447,on,0,0
75448,cortical,0,0
75449,activation,0,0
75450,and,0,0
75451,reaction,0,0
75452,time,0,0
75453,in,0,0
75454,chronic,1,1
75455,hypotension,1,1
75456,.,1,1
75457,Effects,0,0
75458,of,0,0
75459,the,0,0
75460,sympathomimetic,0,0
75461,etilefrine,0,0
75462,were,0,0
75463,investigated,0,0
75464,in,0,0
75465,50,1,1
75466,hypotensive,1,0
75467,persons,1,1
75468,based,0,0
75469,on,0,0
75470,a,0,0
75471,randomized,0,0
75472,",",0,0
75473,placebo-controlled,0,0
75474,double,0,0
75475,blind,0,1
75476,design,0,0
75477,.,0,0
75478,As,0,0
75479,an,0,0
75480,indicator,0,0
75481,of,0,0
75482,cortical,0,0
75483,excitability,0,0
75484,",",0,0
75485,the,0,0
75486,contingent,0,0
75487,negative,0,0
75488,variation,0,0
75489,(,0,0
75490,CNV,0,0
75491,),0,0
75492,",",0,0
75493,induced,0,0
75494,by,0,0
75495,a,0,0
75496,constant,0,0
75497,foreperiod,0,0
75498,reaction,0,0
75499,time,0,0
75500,task,0,0
75501,",",0,0
75502,was,0,0
75503,assessed,0,0
75504,at,0,0
75505,frontal,0,0
75506,(,0,0
75507,F3,0,0
75508,",",0,0
75509,Fz,0,0
75510,",",0,0
75511,F4,0,0
75512,),0,0
75513,and,0,0
75514,central,0,0
75515,(,0,0
75516,C3,0,1
75517,",",0,0
75518,Cz,0,0
75519,",",0,0
75520,C4,0,0
75521,),0,0
75522,scalp,0,1
75523,sites,0,0
75524,.,0,1
75525,Etilefrine,0,0
75526,provoked,0,0
75527,a,0,0
75528,decrease,0,0
75529,in,0,0
75530,the,0,0
75531,frontal,0,0
75532,and,0,0
75533,central,0,1
75534,CNV,0,0
75535,.,0,1
75536,In,0,0
75537,contrast,0,0
75538,",",0,0
75539,shorter,0,0
75540,reaction,0,0
75541,times,0,0
75542,were,0,1
75543,observed,0,0
75544,following,0,0
75545,drug,0,0
75546,administration,0,0
75547,.,0,0
75548,The,0,0
75549,degree,0,0
75550,of,0,0
75551,pharmacologically,0,0
75552,induced,0,0
75553,blood,0,0
75554,pressure,0,0
75555,elevation,0,0
75556,was,0,0
75557,correlated,0,0
75558,to,0,0
75559,CNV,0,0
75560,attrition,0,0
75561,as,0,0
75562,well,0,0
75563,as,0,0
75564,to,0,0
75565,performance,0,0
75566,enhancement,0,0
75567,.,0,1
75568,Inhibitory,0,0
75569,effects,0,0
75570,of,0,0
75571,baroreceptor,0,0
75572,activation,0,0
75573,on,0,0
75574,cortical,0,0
75575,excitability,0,0
75576,and,0,0
75577,enhanced,0,0
75578,cerebral,0,1
75579,blood,0,0
75580,flow,0,0
75581,are,0,0
75582,considered,0,0
75583,to,0,0
75584,be,0,0
75585,involved,0,0
75586,in,0,0
75587,mediating,0,0
75588,the,0,0
75589,effects,0,0
75590,of,0,0
75591,blood,0,0
75592,pressure,0,0
75593,elevation,0,0
75594,on,0,0
75595,cerebral,0,1
75596,functioning,0,1
75597,.,0,1
75598,Implications,0,0
75599,for,0,0
75600,the,0,0
75601,treatment,0,0
75602,of,0,0
75603,chronic,0,1
75604,hypotension,0,0
75605,are,0,0
75606,discussed,0,0
75607,.,0,1
75608,Randomized,0,0
75609,trial,0,0
75610,of,0,0
75611,an,0,0
75612,allogeneic,0,1
75613,melanoma,0,1
75614,lysate,0,0
75615,vaccine,0,0
75616,with,0,1
75617,low-dose,0,0
75618,interferon,0,0
75619,Alfa-2b,0,0
75620,compared,0,0
75621,with,0,1
75622,high-dose,0,0
75623,interferon,0,0
75624,Alfa-2b,0,0
75625,for,0,0
75626,Resected,1,1
75627,stage,1,1
75628,III,1,1
75629,cutaneous,1,1
75630,melanoma,1,1
75631,.,1,1
75632,PURPOSE,0,0
75633,To,0,0
75634,compare,0,0
75635,the,0,0
75636,overall,0,0
75637,survival,0,0
75638,(,0,0
75639,OS,0,0
75640,),0,0
75641,of,0,0
75642,patients,1,1
75643,with,1,1
75644,resected,1,1
75645,stage,1,1
75646,III,1,1
75647,melanoma,1,1
75648,administered,0,0
75649,active,0,1
75650,specific,0,0
75651,immunotherapy,0,0
75652,and,0,0
75653,low-dose,0,0
75654,interferon,0,0
75655,alfa-2b,0,0
75656,(,0,0
75657,IFN-alpha-2b,0,0
75658,),0,0
75659,with,0,1
75660,the,0,0
75661,OS,0,0
75662,achieved,0,0
75663,using,0,0
75664,high-dose,0,0
75665,IFN-alpha-2b,0,0
75666,.,0,1
75667,PATIENTS,0,0
75668,AND,0,0
75669,METHODS,0,0
75670,An,0,0
75671,Ad,1,1
75672,Hoc,1,1
75673,Melanoma,1,1
75674,Working,1,1
75675,Group,1,1
75676,of,1,0
75677,25,1,1
75678,investigators,1,0
75679,treated,1,1
75680,604,1,1
75681,patients,1,1
75682,from,1,1
75683,April,1,1
75684,1997,1,1
75685,to,1,0
75686,January,1,1
75687,2003,1,1
75688,.,1,1
75689,Patients,0,1
75690,were,0,0
75691,stratified,0,1
75692,by,0,0
75693,sex,0,0
75694,and,0,0
75695,number,0,0
75696,of,0,0
75697,nodes,0,1
75698,and,0,0
75699,were,0,0
75700,randomly,0,1
75701,assigned,0,0
75702,to,0,0
75703,receive,0,0
75704,either,0,0
75705,2,0,0
75706,years,0,1
75707,of,0,0
75708,treatment,0,0
75709,with,0,1
75710,active,0,1
75711,specific,0,0
75712,immunotherapy,0,0
75713,with,0,1
75714,allogeneic,0,1
75715,melanoma,0,1
75716,lysates,0,0
75717,and,0,1
75718,low-dose,0,0
75719,IFN-alpha-2b,0,0
75720,(,0,1
75721,arm,0,1
75722,1,0,0
75723,),0,0
75724,or,0,1
75725,high-dose,0,0
75726,IFN-alpha-2b,0,0
75727,alone,0,0
75728,for,0,0
75729,1,0,0
75730,year,0,0
75731,(,0,0
75732,arm,0,0
75733,2,0,1
75734,),0,1
75735,.,0,1
75736,Active,0,0
75737,specific,0,0
75738,immunotherapy,0,0
75739,was,0,0
75740,injected,0,0
75741,subcutaneously,0,0
75742,(,0,0
75743,SC,0,0
75744,),0,0
75745,weekly,0,0
75746,for,0,0
75747,4,0,0
75748,weeks,0,0
75749,",",0,0
75750,at,0,0
75751,week,0,0
75752,8,0,0
75753,",",0,0
75754,and,0,0
75755,bimonthly,0,0
75756,thereafter,0,0
75757,.,0,0
75758,IFN-alpha-2b,0,0
75759,SC,0,0
75760,was,0,0
75761,begun,0,0
75762,on,0,0
75763,week,0,0
75764,4,0,0
75765,and,0,0
75766,continued,0,0
75767,thrice,0,0
75768,weekly,0,0
75769,at,0,0
75770,5,0,0
75771,MU/m2,0,1
75772,for,0,0
75773,2,0,1
75774,years,0,1
75775,.,0,1
75776,IFN-alpha-2b,0,0
75777,in,0,0
75778,arm,0,1
75779,2,0,0
75780,was,0,0
75781,administered,0,0
75782,according,0,0
75783,to,0,0
75784,the,0,0
75785,Eastern,0,1
75786,Cooperative,0,1
75787,Oncology,0,1
75788,Group,0,1
75789,1684,0,1
75790,study,0,1
75791,regimen,0,0
75792,.,0,1
75793,RESULTS,0,0
75794,Median,0,1
75795,follow-up,0,0
75796,time,0,0
75797,was,0,0
75798,32,0,1
75799,months,0,0
75800,for,0,0
75801,all,0,1
75802,patients,0,1
75803,and,0,0
75804,42,0,1
75805,months,0,0
75806,for,0,0
75807,surviving,0,1
75808,patients,0,1
75809,.,0,1
75810,Median,0,0
75811,OS,0,0
75812,time,0,0
75813,exceeds,0,0
75814,84,0,1
75815,months,0,0
75816,in,0,1
75817,arm,0,1
75818,1,0,0
75819,and,0,0
75820,is,0,0
75821,83,0,0
75822,months,0,0
75823,in,0,1
75824,arm,0,1
75825,2,0,0
75826,(,0,0
75827,P,0,0
75828,=,0,0
75829,.56,0,0
75830,),0,0
75831,.,0,1
75832,Five-year,0,0
75833,OS,0,0
75834,rate,0,0
75835,is,0,0
75836,61,0,0
75837,%,0,0
75838,in,0,0
75839,arm,0,0
75840,1,0,0
75841,and,0,0
75842,57,0,1
75843,%,0,0
75844,in,0,0
75845,arm,0,1
75846,2,0,0
75847,.,0,0
75848,Estimated,0,0
75849,5-year,0,0
75850,relapse-free,0,0
75851,survival,0,0
75852,(,0,0
75853,RFS,0,0
75854,),0,0
75855,rate,0,0
75856,is,0,0
75857,50,0,0
75858,%,0,0
75859,in,0,0
75860,arm,0,0
75861,1,0,0
75862,and,0,0
75863,48,0,0
75864,%,0,0
75865,in,0,0
75866,arm,0,0
75867,2,0,0
75868,",",0,0
75869,with,0,1
75870,median,0,1
75871,RFS,0,1
75872,times,0,0
75873,of,0,0
75874,58,0,1
75875,and,0,1
75876,50,0,1
75877,months,0,0
75878,",",0,0
75879,respectively,0,0
75880,.,0,0
75881,The,0,0
75882,incidence,0,0
75883,of,0,0
75884,serious,0,0
75885,adverse,0,0
75886,events,0,0
75887,as,0,0
75888,a,0,0
75889,result,0,0
75890,of,0,0
75891,treatment,0,0
75892,was,0,0
75893,the,0,0
75894,same,0,0
75895,in,0,0
75896,both,0,0
75897,arms,0,0
75898,",",0,0
75899,but,0,0
75900,more,0,0
75901,severe,0,1
75902,neuropsychiatric,0,1
75903,toxicity,0,0
75904,was,0,0
75905,seen,0,0
75906,in,0,0
75907,arm,0,1
75908,2,0,0
75909,.,0,1
75910,CONCLUSION,0,0
75911,OS,0,0
75912,and,0,0
75913,RFS,0,0
75914,achieved,0,0
75915,by,0,0
75916,active,0,1
75917,specific,0,0
75918,immunotherapy,0,0
75919,and,0,0
75920,low-dose,0,0
75921,IFN-alpha-2b,0,0
75922,were,0,0
75923,indistinguishable,0,0
75924,from,0,1
75925,those,0,0
75926,achieved,0,0
75927,by,0,0
75928,high-dose,0,0
75929,IFN-alpha-2b,0,0
75930,.,0,1
75931,Long,0,1
75932,RFS,0,0
75933,and,0,0
75934,OS,0,0
75935,times,0,0
75936,were,0,0
75937,observed,0,0
75938,in,0,0
75939,both,0,0
75940,treatment,0,0
75941,arms,0,0
75942,.,0,1
75943,Using,0,0
75944,the,0,0
75945,demand-control,0,0
75946,model,0,0
75947,of,0,0
75948,job,0,0
75949,strain,0,0
75950,to,0,0
75951,predict,0,0
75952,caregiver,0,0
75953,burden,0,0
75954,and,0,0
75955,caregiver,0,0
75956,satisfaction,0,0
75957,in,0,0
75958,the,0,0
75959,informal,1,0
75960,caregivers,1,1
75961,of,1,0
75962,heart,1,1
75963,failure,1,1
75964,patients,1,1
75965,.,1,1
75966,OBJECTIVES,0,0
75967,The,0,0
75968,demand-control,0,0
75969,(,0,0
75970,D-C,0,1
75971,),0,0
75972,model,0,0
75973,of,0,0
75974,job,0,0
75975,strain,0,0
75976,has,0,0
75977,generated,0,0
75978,a,0,0
75979,considerable,0,0
75980,body,0,1
75981,of,0,0
75982,empirical,0,0
75983,support,0,0
75984,in,0,0
75985,predicting,0,0
75986,psychological,0,0
75987,health,0,1
75988,outcomes,0,0
75989,in,0,0
75990,the,0,0
75991,context,0,0
75992,of,0,0
75993,work,0,0
75994,.,0,0
75995,This,0,0
75996,study,0,0
75997,aimed,0,0
75998,to,0,0
75999,extend,0,0
76000,previous,0,0
76001,work,0,0
76002,using,0,0
76003,the,0,0
76004,D-C,0,0
76005,model,0,0
76006,of,0,0
76007,job,0,0
76008,strain,0,0
76009,to,0,0
76010,predict,0,0
76011,caregiver,0,0
76012,burden,0,0
76013,and,0,0
76014,satisfaction,0,0
76015,in,0,0
76016,the,0,0
76017,informal,1,0
76018,caregivers,1,1
76019,of,1,1
76020,patients,1,1
76021,with,1,1
76022,heart,1,1
76023,failure,1,1
76024,.,1,0
76025,DESIGN,0,0
76026,AND,0,0
76027,METHOD,0,0
76028,Data,0,1
76029,were,0,0
76030,gathered,0,1
76031,from,0,1
76032,60,1,1
76033,caregiver/patient,1,0
76034,dyads,1,1
76035,in,1,0
76036,a,1,0
76037,cross-sectional,1,1
76038,design,1,0
76039,.,1,1
76040,Patients,1,1
76041,with,1,1
76042,chronic,1,1
76043,stable,1,1
76044,heart,1,1
76045,failure,1,1
76046,were,1,0
76047,recruited,1,1
76048,from,1,1
76049,out-patient,1,1
76050,clinics,1,1
76051,.,1,1
76052,The,0,0
76053,dependent,0,0
76054,variables,0,0
76055,were,0,1
76056,caregiver,0,0
76057,burden,0,0
76058,and,0,0
76059,satisfaction,0,0
76060,.,0,0
76061,Demand,0,0
76062,and,0,0
76063,control,0,0
76064,were,0,0
76065,measured,0,0
76066,using,0,0
76067,both,0,0
76068,patient-,0,0
76069,and,0,0
76070,caregiver-derived,0,0
76071,measures,0,0
76072,.,0,1
76073,RESULTS,0,0
76074,The,0,0
76075,D-C,0,0
76076,model,0,0
76077,accounted,0,0
76078,for,0,0
76079,15,0,1
76080,and,0,0
76081,19,0,1
76082,%,0,0
76083,of,0,0
76084,the,0,0
76085,variance,0,0
76086,in,0,0
76087,caregiver,0,0
76088,burden,0,0
76089,",",0,0
76090,after,0,0
76091,controlling,0,0
76092,for,0,0
76093,age,0,1
76094,",",0,0
76095,gender,0,0
76096,and,0,0
76097,relationship,0,0
76098,to,0,0
76099,the,0,0
76100,patient,0,0
76101,.,0,0
76102,Lower,0,0
76103,control,0,0
76104,was,0,0
76105,associated,0,0
76106,with,0,1
76107,higher,0,0
76108,burden,0,0
76109,.,0,0
76110,The,0,0
76111,D-C,0,0
76112,model,0,0
76113,did,0,0
76114,not,0,0
76115,predict,0,0
76116,caregiver,0,0
76117,satisfaction,0,0
76118,.,0,0
76119,CONCLUSION,0,0
76120,The,0,0
76121,D-C,0,0
76122,model,0,0
76123,was,0,0
76124,associated,0,0
76125,with,0,1
76126,caregiver,0,0
76127,burden,0,0
76128,",",0,0
76129,but,0,0
76130,not,0,0
76131,satisfaction,0,0
76132,in,0,0
76133,caregivers,0,1
76134,",",0,0
76135,with,0,1
76136,control,0,0
76137,being,0,0
76138,the,0,0
76139,dominant,0,0
76140,predictor,0,0
76141,.,0,1
76142,Research,0,0
76143,linking,0,0
76144,the,0,0
76145,theory,0,0
76146,and,0,0
76147,findings,0,0
76148,from,0,1
76149,job,0,0
76150,strain,0,0
76151,and,0,0
76152,informal,0,0
76153,caregiving,0,0
76154,studies,0,0
76155,may,0,0
76156,elucidate,0,0
76157,both,0,0
76158,fields,0,0
76159,of,0,0
76160,research,0,1
76161,.,0,0
76162,Using,0,0
76163,the,0,0
76164,demand-control,0,0
76165,model,0,0
76166,of,0,0
76167,job,0,0
76168,strain,0,0
76169,to,0,0
76170,predict,0,0
76171,caregiver,0,0
76172,burden,0,0
76173,and,0,0
76174,caregiver,0,0
76175,satisfaction,0,0
76176,in,0,0
76177,the,0,0
76178,informal,1,0
76179,caregivers,1,1
76180,of,1,0
76181,heart,1,1
76182,failure,1,1
76183,patients,1,1
76184,.,1,1
76185,A,0,0
76186,comparison,0,0
76187,of,0,0
76188,acceptance-,0,0
76189,and,0,1
76190,control-based,0,0
76191,strategies,0,0
76192,for,0,0
76193,coping,0,0
76194,with,0,1
76195,food,0,1
76196,cravings,0,0
76197,:,0,1
76198,an,0,0
76199,analog,0,0
76200,study,0,0
76201,.,0,0
76202,The,0,0
76203,present,0,0
76204,study,0,0
76205,utilized,0,0
76206,an,0,0
76207,analog,0,0
76208,paradigm,0,0
76209,to,0,0
76210,investigate,0,0
76211,the,0,0
76212,effectiveness,0,0
76213,of,0,0
76214,two,0,0
76215,strategies,0,0
76216,for,0,0
76217,coping,0,0
76218,with,0,1
76219,food,0,0
76220,cravings,0,0
76221,",",0,0
76222,which,0,0
76223,was,0,0
76224,theorized,0,0
76225,to,0,0
76226,be,0,0
76227,critical,0,0
76228,to,0,0
76229,the,0,0
76230,maintenance,0,0
76231,of,0,0
76232,weight,0,1
76233,loss,0,0
76234,.,0,1
76235,Ninety-eight,1,1
76236,undergraduate,1,1
76237,students,1,1
76238,were,1,1
76239,given,1,0
76240,transparent,1,0
76241,boxes,1,0
76242,of,1,0
76243,chocolate,1,1
76244,Hershey,1,0
76245,'s,1,1
76246,Kisses,1,0
76247,and,0,1
76248,instructed,0,0
76249,to,0,0
76250,keep,0,0
76251,the,0,0
76252,chocolates,0,0
76253,with,0,1
76254,them,0,1
76255,",",0,0
76256,but,0,0
76257,not,0,0
76258,to,0,0
76259,eat,0,0
76260,them,0,0
76261,",",0,0
76262,for,0,0
76263,48,0,0
76264,h.,0,1
76265,Before,0,0
76266,receiving,0,0
76267,the,0,0
76268,Kisses,0,0
76269,",",0,0
76270,participants,0,1
76271,were,0,0
76272,randomized,0,1
76273,to,0,0
76274,receive,0,0
76275,either,0,0
76276,(,0,0
76277,a,0,0
76278,),0,0
76279,no,0,0
76280,intervention,0,0
76281,",",0,0
76282,(,0,0
76283,b,0,0
76284,),0,0
76285,instruction,0,0
76286,in,0,0
76287,control-based,0,0
76288,coping,0,0
76289,strategies,0,0
76290,such,0,0
76291,as,0,0
76292,distraction,0,0
76293,and,0,0
76294,cognitive,0,0
76295,restructuring,0,0
76296,",",0,0
76297,or,0,0
76298,(,0,0
76299,c,0,1
76300,),0,0
76301,instruction,0,0
76302,in,0,0
76303,acceptance-based,0,0
76304,strategies,0,0
76305,such,0,0
76306,as,0,0
76307,experiential,0,0
76308,acceptance,0,0
76309,and,0,0
76310,defusion,0,0
76311,techniques,0,0
76312,.,0,1
76313,Measures,0,0
76314,included,0,1
76315,the,0,0
76316,Power,0,1
76317,of,0,0
76318,Food,0,1
76319,Scale,0,0
76320,(,0,1
76321,PFS,0,0
76322,;,0,0
76323,a,0,0
76324,measure,0,0
76325,of,0,0
76326,psychological,0,0
76327,sensitivity,0,0
76328,to,0,0
76329,the,0,0
76330,food,0,0
76331,environment,0,0
76332,),0,0
76333,",",0,0
76334,self-report,0,0
76335,ratings,0,0
76336,of,0,0
76337,chocolate,0,1
76338,cravings,0,0
76339,and,0,0
76340,surreptitiously,0,0
76341,recorded,0,0
76342,chocolate,0,0
76343,consumption,0,0
76344,.,0,1
76345,Results,0,0
76346,suggested,0,0
76347,that,0,0
76348,the,0,0
76349,effect,0,0
76350,of,0,0
76351,the,0,0
76352,intervention,0,0
76353,depended,0,0
76354,on,0,0
76355,baseline,0,0
76356,PFS,0,0
76357,levels,0,0
76358,",",0,0
76359,such,0,0
76360,that,0,0
76361,acceptance-based,0,0
76362,strategies,0,0
76363,were,0,1
76364,associated,0,0
76365,with,0,1
76366,better,0,0
76367,outcomes,0,0
76368,(,0,0
76369,cravings,0,0
76370,",",0,0
76371,consumption,0,0
76372,),0,0
76373,among,0,0
76374,those,0,0
76375,reporting,0,0
76376,the,0,0
76377,highest,0,0
76378,susceptibility,0,0
76379,to,0,0
76380,the,0,0
76381,presence,0,0
76382,of,0,0
76383,food,0,0
76384,",",0,0
76385,but,0,0
76386,greater,0,0
76387,cravings,0,0
76388,among,0,1
76389,those,0,1
76390,who,0,1
76391,scored,0,1
76392,lowest,0,1
76393,on,0,0
76394,the,0,0
76395,PFS,0,0
76396,.,0,0
76397,It,0,0
76398,was,0,0
76399,observed,0,0
76400,that,0,0
76401,craving,0,0
76402,self-report,0,1
76403,measures,0,0
76404,predicted,0,0
76405,chocolate,0,0
76406,consumption,0,0
76407,",",0,0
76408,and,0,0
76409,baseline,0,0
76410,PFS,0,0
76411,levels,0,0
76412,predicted,0,0
76413,both,0,0
76414,cravings,0,0
76415,and,0,0
76416,consumption,0,0
76417,.,0,1
76418,Results,0,0
76419,are,0,0
76420,discussed,0,0
76421,in,0,0
76422,terms,0,0
76423,of,0,0
76424,the,0,0
76425,implications,0,0
76426,for,0,0
76427,weight,0,1
76428,loss,0,0
76429,maintenance,0,0
76430,strategies,0,0
76431,.,0,1
76432,Comparison,0,0
76433,of,0,0
76434,split-course,0,0
76435,radiation,0,0
76436,therapy,0,0
76437,and,0,0
76438,continuous,0,0
76439,radiation,0,0
76440,therapy,0,0
76441,for,0,0
76442,unresectable,1,1
76443,bronchogenic,1,1
76444,carcinoma,1,1
76445,:,1,1
76446,5,0,0
76447,year,0,1
76448,results,0,0
76449,.,0,1
76450,One,1,1
76451,hundred,1,1
76452,and,1,1
76453,eighty-eight,1,1
76454,patients,1,1
76455,with,1,1
76456,inoperable,1,1
76457,or,1,1
76458,unresectable,1,1
76459,bronchogenic,1,1
76460,carcinoma,1,1
76461,were,0,0
76462,stratified,0,1
76463,by,0,0
76464,cell,0,0
76465,type,0,1
76466,",",0,0
76467,TNM,0,0
76468,staging,0,0
76469,",",0,0
76470,and,0,0
76471,prior,0,0
76472,surgery,0,1
76473,and,0,0
76474,then,0,0
76475,randomized,0,0
76476,into,0,0
76477,two,0,0
76478,treatment,0,1
76479,groups,0,0
76480,:,0,1
76481,continuous,0,0
76482,radiation,0,0
76483,therapy,0,0
76484,and,0,0
76485,split-course,0,0
76486,radiation,0,0
76487,therapy,0,0
76488,.,0,0
76489,There,0,0
76490,was,0,0
76491,no,0,0
76492,difference,0,0
76493,in,0,0
76494,clinical,0,0
76495,or,0,1
76496,objective,0,0
76497,improvement,0,0
76498,in,0,0
76499,the,0,0
76500,two,0,0
76501,groups,0,0
76502,.,0,1
76503,Survival,0,0
76504,rates,0,0
76505,for,0,0
76506,cases,0,1
76507,of,0,0
76508,squamous,0,1
76509,cell,0,1
76510,carcinoma,0,1
76511,",",0,0
76512,small,0,0
76513,cell,0,0
76514,carcinoma,0,1
76515,",",0,0
76516,and,0,0
76517,adrenocarcinoma,0,1
76518,were,0,0
76519,the,0,0
76520,same,0,0
76521,after,0,0
76522,both,0,0
76523,regimens,0,0
76524,of,0,0
76525,therapy,0,0
76526,.,0,1
76527,Split-course,0,0
76528,therapy,0,0
76529,resulted,0,0
76530,in,0,0
76531,a,0,0
76532,significantly,0,0
76533,better,0,0
76534,survival,0,0
76535,rate,0,0
76536,in,0,0
76537,cases,0,1
76538,of,0,0
76539,large,0,1
76540,cell,0,1
76541,carcinoma,0,1
76542,but,0,0
76543,the,0,0
76544,number,0,0
76545,of,0,0
76546,cases,0,1
76547,was,0,0
76548,small,0,1
76549,.,0,0
76550,We,0,0
76551,doubt,0,0
76552,that,0,0
76553,the,0,0
76554,difference,0,0
76555,is,0,0
76556,clinically,0,0
76557,significant,0,0
76558,.,0,0
76559,Objective,0,0
76560,roentgenographic,0,0
76561,response,0,0
76562,was,0,0
76563,accompanied,0,0
76564,by,0,0
76565,improved,0,0
76566,survival,0,0
76567,in,0,0
76568,squamous,0,1
76569,cell,0,1
76570,carcinoma,0,1
76571,",",0,0
76572,but,0,0
76573,not,0,0
76574,in,0,0
76575,the,0,0
76576,other,0,0
76577,three,0,0
76578,cell,0,1
76579,types,0,0
76580,.,0,1
76581,Split-course,0,0
76582,radiation,0,0
76583,therapy,0,0
76584,is,0,0
76585,superior,0,0
76586,to,0,0
76587,continuous,0,0
76588,radiation,0,0
76589,therapy,0,0
76590,because,0,0
76591,it,0,0
76592,is,0,0
76593,better,0,0
76594,tolerated,0,0
76595,by,0,0
76596,the,0,0
76597,patient,0,0
76598,and,0,0
76599,because,0,0
76600,re-examination,0,0
76601,of,0,0
76602,the,0,0
76603,patient,0,0
76604,prior,0,0
76605,to,0,0
76606,the,0,0
76607,second,0,0
76608,half,0,1
76609,of,0,0
76610,split-course,0,0
76611,therapy,0,0
76612,permits,0,0
76613,the,0,0
76614,detection,0,0
76615,of,0,0
76616,new,0,0
76617,metastatic,0,1
76618,disease,0,1
76619,that,0,0
76620,has,0,0
76621,become,0,0
76622,manifest,0,0
76623,during,0,0
76624,the,0,0
76625,rest,0,0
76626,period,0,0
76627,and,0,0
76628,spares,0,0
76629,the,0,0
76630,patient,0,0
76631,the,0,0
76632,futile,0,0
76633,second,0,0
76634,half,0,1
76635,of,0,0
76636,radiation,0,0
76637,therapy,0,0
76638,.,0,1
76639,A,0,0
76640,randomized,0,0
76641,",",0,0
76642,double-blind,0,0
76643,",",0,0
76644,phase,0,1
76645,II,0,0
76646,study,0,0
76647,of,0,0
76648,two,0,0
76649,doses,0,0
76650,of,0,0
76651,pemetrexed,0,0
76652,as,0,0
76653,first-line,0,1
76654,chemotherapy,0,1
76655,for,0,0
76656,advanced,1,1
76657,breast,1,1
76658,cancer,1,1
76659,.,1,1
76660,PURPOSE,0,0
76661,Pemetrexed,0,0
76662,has,0,0
76663,shown,0,0
76664,varied,0,0
76665,response,0,0
76666,rates,0,0
76667,in,0,0
76668,advanced,1,1
76669,breast,1,1
76670,cancer,1,1
76671,.,1,0
76672,This,0,0
76673,randomized,0,0
76674,",",0,0
76675,double-blind,0,0
76676,",",0,0
76677,phase,0,1
76678,II,0,1
76679,study,0,0
76680,was,0,0
76681,conducted,0,0
76682,to,0,0
76683,assess,0,0
76684,the,0,0
76685,efficacy,0,0
76686,and,0,0
76687,safety,0,0
76688,of,0,0
76689,two,0,0
76690,doses,0,0
76691,of,0,0
76692,pemetrexed,0,0
76693,in,0,0
76694,a,0,0
76695,homogeneous,0,1
76696,population,0,1
76697,.,0,0
76698,A,0,0
76699,secondary,0,0
76700,objective,0,0
76701,was,0,0
76702,to,0,0
76703,identify,0,0
76704,molecular,0,0
76705,biomarkers,0,0
76706,correlating,0,0
76707,with,0,1
76708,response,0,0
76709,and,0,0
76710,toxicity,0,0
76711,.,0,1
76712,EXPERIMENTAL,0,0
76713,DESIGN,0,0
76714,Patients,1,1
76715,with,1,1
76716,newly,1,1
76717,diagnosed,1,1
76718,metastatic,1,1
76719,breast,1,1
76720,cancer,1,1
76721,or,1,0
76722,locally,1,1
76723,recurrent,1,1
76724,breast,1,1
76725,cancer,1,1
76726,received,0,0
76727,600,0,0
76728,mg/m,0,0
76729,(,0,1
76730,2,0,0
76731,),0,0
76732,(,0,0
76733,P600,0,0
76734,arm,0,1
76735,),0,0
76736,or,0,1
76737,900,0,1
76738,mg/m,0,0
76739,(,0,1
76740,2,0,0
76741,),0,0
76742,(,0,0
76743,P900,0,0
76744,arm,0,0
76745,),0,0
76746,of,0,0
76747,pemetrexed,0,0
76748,on,0,0
76749,day,0,0
76750,1,0,0
76751,of,0,0
76752,a,0,0
76753,21-day,0,0
76754,cycle,0,0
76755,.,0,0
76756,All,0,0
76757,patients,0,1
76758,received,0,0
76759,folic,0,0
76760,acid,0,0
76761,and,0,0
76762,vitamin,0,0
76763,B,0,1
76764,(,0,0
76765,12,0,0
76766,),0,1
76767,supplementation,0,0
76768,.,0,0
76769,RESULTS,0,0
76770,The,1,0
76771,P600,1,0
76772,(,1,0
76773,47,1,1
76774,patients,1,1
76775,),1,1
76776,and,1,0
76777,P900,1,0
76778,(,1,1
76779,45,1,1
76780,patients,1,1
76781,),1,1
76782,arms,0,0
76783,had,0,1
76784,response,0,0
76785,rates,0,0
76786,of,0,0
76787,17.0,0,0
76788,%,0,0
76789,(,0,0
76790,95,0,0
76791,%,0,0
76792,confidence,0,0
76793,interval,0,0
76794,",",0,0
76795,7.7-30.8,0,0
76796,%,0,0
76797,),0,0
76798,and,0,0
76799,15.6,0,0
76800,%,0,0
76801,(,0,0
76802,95,0,0
76803,%,0,0
76804,confidence,0,0
76805,interval,0,0
76806,",",0,0
76807,6.5-29.5,0,0
76808,%,0,0
76809,),0,0
76810,with,0,1
76811,approximately,0,1
76812,50,0,1
76813,%,0,0
76814,stable,0,1
76815,disease,0,1
76816,per,0,0
76817,arm,0,0
76818,",",0,0
76819,median,0,0
76820,progression-free,0,0
76821,survival,0,0
76822,of,0,0
76823,4.2,0,0
76824,and,0,1
76825,4.1,0,0
76826,months,0,0
76827,",",0,0
76828,and,0,0
76829,median,0,0
76830,times,0,0
76831,to,0,0
76832,tumor,0,0
76833,progression,0,0
76834,of,0,0
76835,4.2,0,0
76836,and,0,1
76837,4.6,0,0
76838,months,0,0
76839,",",0,0
76840,respectively,0,0
76841,.,0,0
76842,Both,0,0
76843,arms,0,0
76844,exhibited,0,0
76845,minimal,0,0
76846,toxicity,0,0
76847,(,0,1
76848,grade,0,1
76849,3/4,0,0
76850,neutropenia,0,1
76851,<,0,0
76852,20,0,0
76853,%,0,0
76854,",",0,0
76855,leukopenia,0,0
76856,<,0,0
76857,9,0,0
76858,%,0,0
76859,",",0,0
76860,and,0,0
76861,other,0,0
76862,toxicities,0,0
76863,<,0,0
76864,5,0,0
76865,%,0,0
76866,),0,0
76867,.,0,0
76868,Tumor,0,0
76869,samples,0,0
76870,from,0,1
76871,49,0,1
76872,patients,0,1
76873,were,0,1
76874,assessed,0,0
76875,for,0,0
76876,the,0,0
76877,expression,0,0
76878,levels,0,0
76879,of,0,0
76880,12,0,1
76881,pemetrexed-related,0,0
76882,genes,0,0
76883,.,0,1
76884,Folylpolyglutamate,0,0
76885,synthetase,0,0
76886,and,0,0
76887,thymidine,0,0
76888,phosphorylase,0,0
76889,correlated,0,0
76890,with,0,1
76891,efficacy,0,0
76892,.,0,0
76893,Best,0,0
76894,response,0,0
76895,rates,0,0
76896,and,0,0
76897,median,0,0
76898,time,0,0
76899,to,0,0
76900,tumor,0,0
76901,progression,0,0
76902,for,0,0
76903,high,0,1
76904,versus,0,0
76905,low,0,0
76906,thymidine,0,0
76907,phosphorylase,0,0
76908,expression,0,0
76909,were,0,0
76910,27.6,0,0
76911,%,0,0
76912,versus,0,0
76913,6.3,0,0
76914,%,0,0
76915,(,0,0
76916,P,0,0
76917,=,0,0
76918,0.023,0,0
76919,),0,0
76920,and,0,0
76921,5.4,0,0
76922,versus,0,0
76923,1.9,0,0
76924,months,0,0
76925,(,0,1
76926,P,0,0
76927,=,0,0
76928,0.076,0,0
76929,),0,0
76930,",",0,0
76931,and,0,0
76932,for,0,0
76933,folylpolyglutamate,0,0
76934,synthetase,0,0
76935,were,0,0
76936,37.5,0,0
76937,%,0,0
76938,versus,0,0
76939,10.0,0,0
76940,%,0,0
76941,(,0,0
76942,P,0,0
76943,=,0,0
76944,0.115,0,0
76945,),0,0
76946,and,0,0
76947,8.6,0,1
76948,versus,0,0
76949,3.0,0,0
76950,months,0,0
76951,(,0,1
76952,P,0,0
76953,=,0,0
76954,0.019,0,0
76955,),0,0
76956,",",0,0
76957,respectively,0,0
76958,.,0,0
76959,gamma-Glutamyl,0,0
76960,hydrolase,0,1
76961,expression,0,0
76962,correlated,0,0
76963,with,0,1
76964,grade,0,1
76965,3/4,0,1
76966,toxicities,0,0
76967,:,0,1
76968,78.6,0,1
76969,%,0,0
76970,for,0,0
76971,high,0,1
76972,versus,0,0
76973,27.3,0,0
76974,%,0,0
76975,for,0,0
76976,low,0,1
76977,gamma-glutamyl,0,0
76978,hydrolase,0,1
76979,(,0,0
76980,P,0,0
76981,=,0,0
76982,0.024,0,0
76983,),0,0
76984,.,0,0
76985,CONCLUSION,0,0
76986,The,0,0
76987,two,0,0
76988,pemetrexed,0,0
76989,doses,0,0
76990,yielded,0,0
76991,similar,0,0
76992,efficacy,0,0
76993,and,0,0
76994,safety,0,0
76995,profiles,0,0
76996,.,0,1
76997,Exploratory,0,0
76998,biomarker,0,0
76999,analysis,0,0
77000,identified,0,0
77001,efficacy,0,0
77002,and,0,0
77003,toxicity,0,0
77004,correlations,0,0
77005,and,0,1
77006,warrants,0,0
77007,further,0,0
77008,evaluation,0,0
77009,.,0,1
77010,A,0,0
77011,prospective,0,0
77012,",",0,0
77013,randomized,0,0
77014,trial,0,0
77015,of,0,0
77016,clear,0,0
77017,liquids,0,1
77018,versus,0,0
77019,low-fat,0,0
77020,solid,0,1
77021,diet,0,1
77022,as,0,0
77023,the,0,0
77024,initial,0,0
77025,meal,0,0
77026,in,0,0
77027,mild,1,1
77028,acute,1,1
77029,pancreatitis,1,1
77030,.,1,1
77031,BACKGROUND,0,0
77032,&,0,1
77033,AIMS,0,1
77034,Patients,1,1
77035,recovering,1,1
77036,from,1,1
77037,mild,1,1
77038,acute,1,1
77039,pancreatitis,1,1
77040,typically,0,1
77041,receive,0,0
77042,a,0,0
77043,clear,0,0
77044,liquid,0,0
77045,diet,0,0
77046,(,0,0
77047,CLD,0,0
77048,),0,0
77049,when,0,0
77050,ready,0,0
77051,to,0,0
77052,initiate,0,0
77053,oral,0,0
77054,nutrition,0,0
77055,.,0,1
77056,Patient,0,0
77057,discharge,0,0
77058,then,0,0
77059,depends,0,0
77060,on,0,0
77061,their,0,0
77062,successful,0,0
77063,advancement,0,1
77064,to,0,0
77065,solid,0,1
77066,food,0,0
77067,.,0,0
77068,We,0,0
77069,hypothesized,0,0
77070,that,0,0
77071,initiating,0,0
77072,oral,0,0
77073,nutrition,0,0
77074,with,0,1
77075,a,0,0
77076,low-fat,0,0
77077,solid,0,1
77078,diet,0,1
77079,(,0,0
77080,LFSD,0,1
77081,),0,0
77082,after,0,0
77083,mild,0,1
77084,pancreatitis,0,1
77085,would,0,0
77086,be,0,0
77087,well,0,0
77088,tolerated,0,0
77089,and,0,0
77090,would,0,0
77091,result,0,0
77092,in,0,0
77093,a,0,0
77094,shorter,0,0
77095,length,0,0
77096,of,0,0
77097,hospitalization,0,0
77098,(,0,0
77099,LOH,0,0
77100,),0,1
77101,.,0,1
77102,METHODS,0,0
77103,Patients,1,1
77104,with,1,1
77105,mild,1,1
77106,pancreatitis,1,1
77107,were,0,1
77108,randomized,0,1
77109,to,0,0
77110,a,0,0
77111,CLD,0,0
77112,or,0,1
77113,LFSD,0,0
77114,when,0,0
77115,they,0,0
77116,were,0,0
77117,ready,0,0
77118,to,0,0
77119,resume,0,0
77120,oral,0,0
77121,nutrition,0,0
77122,.,0,1
77123,Decisions,0,0
77124,about,0,0
77125,diet,0,1
77126,advancement,0,1
77127,and,0,0
77128,hospital,0,1
77129,discharge,0,0
77130,were,0,0
77131,at,0,0
77132,the,0,0
77133,discretion,0,0
77134,of,0,0
77135,the,0,0
77136,medical,0,0
77137,team,0,0
77138,",",0,0
77139,without,0,0
77140,input,0,0
77141,from,0,0
77142,study,0,0
77143,team,0,0
77144,members,0,1
77145,.,0,1
77146,Patients,0,1
77147,were,0,0
77148,monitored,0,0
77149,daily,0,0
77150,for,0,0
77151,recurrence,0,0
77152,of,0,0
77153,pain,0,0
77154,",",0,0
77155,need,0,0
77156,to,0,0
77157,stop,0,0
77158,feeding,0,0
77159,",",0,0
77160,post-refeeding,0,0
77161,LOH,0,0
77162,(,0,0
77163,primary,0,1
77164,end,0,0
77165,point,0,0
77166,),0,0
77167,",",0,0
77168,and,0,0
77169,for,0,0
77170,28,0,1
77171,days,0,0
77172,post-refeeding,0,0
77173,to,0,0
77174,capture,0,0
77175,re-admission,0,0
77176,rates,0,0
77177,.,0,1
77178,RESULTS,0,0
77179,We,0,0
77180,randomized,0,1
77181,121,1,1
77182,patients,1,1
77183,:,1,1
77184,66,1,1
77185,to,1,0
77186,CLD,1,0
77187,and,1,0
77188,55,1,1
77189,to,1,0
77190,LFSD,1,1
77191,.,1,0
77192,The,0,0
77193,number,0,0
77194,of,0,0
77195,patients,0,1
77196,requiring,0,1
77197,cessation,0,0
77198,of,0,0
77199,feeding,0,0
77200,because,0,0
77201,of,0,0
77202,pain,0,1
77203,or,0,1
77204,nausea,0,0
77205,was,0,0
77206,similar,0,0
77207,in,0,0
77208,both,0,0
77209,groups,0,0
77210,(,0,0
77211,6,0,0
77212,%,0,0
77213,for,0,0
77214,CLD,0,0
77215,",",0,0
77216,11,0,0
77217,%,0,0
77218,for,0,0
77219,LFSD,0,1
77220,;,0,1
77221,P,0,0
77222,=,0,0
77223,.51,0,0
77224,),0,0
77225,.,0,0
77226,The,0,0
77227,median,0,0
77228,LOH,0,0
77229,after,0,0
77230,refeeding,0,0
77231,was,0,0
77232,identical,0,0
77233,in,0,0
77234,both,0,0
77235,groups,0,0
77236,(,0,0
77237,1-day,0,0
77238,interquartile,0,0
77239,range,0,0
77240,",",0,0
77241,1-2,0,0
77242,;,0,0
77243,P,0,0
77244,=,0,0
77245,.77,0,0
77246,),0,1
77247,.,0,1
77248,Patients,0,1
77249,in,0,0
77250,the,0,0
77251,LFSD,0,0
77252,arm,0,0
77253,consumed,0,0
77254,significantly,0,0
77255,more,0,0
77256,calories,0,0
77257,and,0,0
77258,grams,0,0
77259,of,0,0
77260,fat,0,0
77261,than,0,0
77262,those,0,0
77263,in,0,0
77264,the,0,0
77265,CLD,0,0
77266,arm,0,0
77267,during,0,0
77268,their,0,0
77269,first,0,0
77270,meal,0,0
77271,and,0,0
77272,on,0,0
77273,study,0,0
77274,day,0,0
77275,1,0,0
77276,.,0,0
77277,There,0,0
77278,was,0,0
77279,no,0,0
77280,difference,0,0
77281,in,0,0
77282,the,0,0
77283,28-day,0,0
77284,re-admission,0,0
77285,rates,0,0
77286,between,0,0
77287,the,0,0
77288,2,0,0
77289,arms,0,0
77290,.,0,1
77291,CONCLUSIONS,0,0
77292,Initiating,0,0
77293,oral,0,0
77294,nutrition,0,0
77295,after,0,0
77296,mild,0,1
77297,acute,0,1
77298,pancreatitis,0,1
77299,with,0,1
77300,an,0,0
77301,LFSD,0,0
77302,appeared,0,0
77303,safe,0,0
77304,and,0,0
77305,provided,0,0
77306,more,0,0
77307,calories,0,0
77308,than,0,0
77309,a,0,0
77310,CLD,0,0
77311,",",0,0
77312,but,0,0
77313,did,0,0
77314,not,0,0
77315,result,0,0
77316,in,0,0
77317,a,0,0
77318,shorter,0,0
77319,LOH,0,0
77320,.,0,1
77321,[,0,0
77322,Intravenous,0,0
77323,treatment,0,0
77324,of,0,0
77325,postpartum,1,1
77326,anemia,0,1
77327,with,0,1
77328,trivalent,0,1
77329,ferrum,0,0
77330,preparation,0,0
77331,],0,1
77332,.,0,0
77333,AIM,0,0
77334,OF,0,0
77335,THE,0,0
77336,STUDY,0,0
77337,To,0,0
77338,assess,0,0
77339,the,0,0
77340,effectivity,0,0
77341,and,0,0
77342,safeness,0,0
77343,of,0,0
77344,intravenous,0,0
77345,treatment,0,0
77346,of,0,0
77347,pospartal,0,0
77348,anemia,0,1
77349,with,0,1
77350,trivalent,0,1
77351,ferrum,0,1
77352,preparation,0,0
77353,.,0,0
77354,TYPE,0,0
77355,OF,0,0
77356,THE,0,0
77357,STUDY,0,0
77358,Prospective,0,0
77359,randomized,0,1
77360,study,0,0
77361,.,0,1
77362,SETTING,0,1
77363,Department,1,1
77364,of,1,0
77365,Obstetric,1,1
77366,and,1,1
77367,Gynecology,1,1
77368,2nd,1,1
77369,Medical,1,1
77370,Faculty,1,0
77371,Charles,1,1
77372,University,1,1
77373,and,1,0
77374,Teaching,1,0
77375,Hospital,1,1
77376,Motol,1,0
77377,",",1,0
77378,Prague,1,1
77379,",",1,0
77380,and,1,0
77381,Department,1,1
77382,of,1,0
77383,Obstetric,1,1
77384,and,1,1
77385,Gynecology,1,1
77386,1st,1,1
77387,Medical,1,1
77388,Faculty,1,0
77389,and,1,0
77390,Teaching,1,0
77391,Hospital,1,1
77392,Bulovka,1,1
77393,",",1,0
77394,Prague,1,1
77395,.,1,1
77396,METHODS,0,0
77397,500,0,0
77398,mg,0,0
77399,of,0,0
77400,sacharose,0,0
77401,ferric,0,0
77402,oxide,0,0
77403,(,0,0
77404,Venofer,0,0
77405,),0,0
77406,was,0,0
77407,intravenously,0,0
77408,administered,0,0
77409,in,0,0
77410,two,0,0
77411,days,0,0
77412,regimen,0,1
77413,to,0,1
77414,50,1,1
77415,women,1,1
77416,with,1,1
77417,clinical,1,0
77418,and,1,1
77419,lab,1,0
77420,signs,1,0
77421,of,1,0
77422,postpartal,1,1
77423,anemia,1,1
77424,.,1,0
77425,The,0,0
77426,effect,0,0
77427,of,0,0
77428,administered,0,0
77429,drug,0,0
77430,was,0,0
77431,determined,0,0
77432,by,0,0
77433,comparsion,0,0
77434,of,0,0
77435,values,0,0
77436,of,0,0
77437,red,0,1
77438,blood,0,0
77439,count,0,0
77440,recovered,0,0
77441,before,0,0
77442,the,0,0
77443,treatment,0,0
77444,",",0,0
77445,2nd,0,0
77446,or,0,1
77447,3rd,0,0
77448,day,0,0
77449,post,0,0
77450,administration,0,0
77451,and,0,0
77452,two,0,0
77453,weeks,0,0
77454,later,0,1
77455,.,0,0
77456,The,0,0
77457,serum,0,0
77458,values,0,0
77459,of,0,0
77460,soluble,0,0
77461,transferrin,0,0
77462,receptors,0,0
77463,and,0,1
77464,ferritin,0,0
77465,were,0,0
77466,observed,0,0
77467,as,0,0
77468,markers,0,0
77469,of,0,0
77470,iron,0,0
77471,cell,0,1
77472,saturation,0,0
77473,and,0,0
77474,body,0,1
77475,iron,0,0
77476,reserves,0,0
77477,",",0,0
77478,too,0,0
77479,.,0,0
77480,Integral,0,0
77481,part,0,0
77482,of,0,0
77483,the,0,0
77484,study,0,0
77485,was,0,0
77486,the,0,0
77487,monitoring,0,0
77488,of,0,0
77489,adverse,0,0
77490,events,0,0
77491,during,0,0
77492,the,0,0
77493,treatment,0,0
77494,.,0,0
77495,RESULTS,0,0
77496,Venofer,0,0
77497,came,0,1
77498,in,0,0
77499,sight,0,0
77500,as,0,0
77501,effective,0,0
77502,drug,0,0
77503,in,0,0
77504,the,0,0
77505,treatment,0,0
77506,of,0,0
77507,pospartal,0,1
77508,anemia,0,1
77509,and,0,0
77510,could,0,0
77511,become,0,0
77512,as,0,0
77513,the,0,0
77514,alternative,0,0
77515,to,0,0
77516,blood,0,0
77517,transfusion,0,0
77518,in,0,0
77519,mid-severe,0,1
77520,cases,0,1
77521,.,0,0
77522,It,0,0
77523,should,0,0
77524,be,0,0
77525,emphasized,0,0
77526,that,0,0
77527,we,0,0
77528,have,0,0
77529,not,0,0
77530,encountered,0,0
77531,any,0,0
77532,serious,0,0
77533,adverse,0,0
77534,event,0,0
77535,with,0,1
77536,intravenous,0,0
77537,trivalent,0,1
77538,saccharose,0,0
77539,ferric,0,0
77540,oxide,0,0
77541,treatment,0,0
77542,.,0,1
77543,Parenteral,0,1
77544,nutrition,0,0
77545,and,0,0
77546,protein,0,0
77547,sparing,0,0
77548,after,0,0
77549,surgery,0,1
77550,:,0,1
77551,do,0,0
77552,we,0,0
77553,need,0,0
77554,glucose,0,0
77555,?,0,0
77556,Although,0,0
77557,capable,0,0
77558,of,0,0
77559,inducing,0,0
77560,an,0,0
77561,anabolic,0,0
77562,state,0,0
77563,after,0,0
77564,surgery,0,1
77565,",",0,0
77566,parenteral,0,0
77567,nutrition,0,0
77568,",",0,0
77569,including,0,0
77570,glucose,0,0
77571,",",0,0
77572,leads,0,0
77573,to,0,0
77574,hyperglycemia,0,0
77575,.,0,0
77576,Even,0,0
77577,moderate,0,1
77578,increases,0,0
77579,in,0,0
77580,blood,0,0
77581,glucose,0,0
77582,are,0,0
77583,associated,0,0
77584,with,0,1
77585,poor,0,1
77586,surgical,0,1
77587,outcome,0,0
77588,.,0,1
77589,We,0,0
77590,examined,0,0
77591,the,0,0
77592,hypothesis,0,0
77593,that,0,0
77594,amino,0,0
77595,acids,0,0
77596,",",0,0
77597,in,0,0
77598,the,0,0
77599,absence,0,0
77600,of,0,0
77601,glucose,0,0
77602,supply,0,0
77603,",",0,0
77604,spare,0,0
77605,protein,0,0
77606,while,0,0
77607,preventing,0,0
77608,hyperglycemia,0,1
77609,.,0,0
77610,In,0,0
77611,this,0,0
77612,prospective,0,0
77613,study,0,0
77614,",",0,0
77615,14,1,0
77616,patients,1,1
77617,with,1,1
77618,colonic,1,1
77619,cancer,1,1
77620,were,0,0
77621,randomly,0,1
77622,assigned,0,0
77623,to,0,0
77624,undergo,0,1
77625,a,0,0
77626,6-hour,0,0
77627,stable,0,1
77628,isotope,0,0
77629,infusion,0,0
77630,study,0,0
77631,(,0,0
77632,3,0,0
77633,hours,0,0
77634,of,0,0
77635,fasting,0,0
77636,followed,0,0
77637,by,0,0
77638,3-hour,0,0
77639,infusions,0,0
77640,of,0,0
77641,amino,0,0
77642,acids,0,0
77643,",",0,0
77644,Travasol,0,0
77645,[,0,0
77646,Baxter,0,1
77647,",",0,0
77648,Montreal,0,0
77649,",",0,0
77650,Canada,0,1
77651,],0,0
77652,10,0,0
77653,%,0,0
77654,at,0,0
77655,0.02,0,0
77656,mL.kg,0,1
77657,(,0,0
77658,-1,0,0
77659,),0,0
77660,.min,0,0
77661,(,0,0
77662,-1,0,0
77663,),0,0
77664,",",0,0
77665,with,0,1
77666,or,0,0
77667,without,0,1
77668,glucose,0,0
77669,at,0,0
77670,4,0,0
77671,mg.kg,0,0
77672,(,0,0
77673,-1,0,0
77674,),0,0
77675,.min,0,0
77676,(,0,0
77677,-1,0,0
77678,),0,0
77679,),0,0
77680,on,0,0
77681,the,0,0
77682,second,0,0
77683,day,0,0
77684,after,0,0
77685,colorectal,0,1
77686,surgery,0,1
77687,.,0,1
77688,Protein,0,0
77689,breakdown,0,0
77690,",",0,0
77691,protein,0,0
77692,oxidation,0,0
77693,",",0,0
77694,protein,0,0
77695,balance,0,0
77696,",",0,0
77697,and,0,0
77698,glucose,0,0
77699,production,0,0
77700,were,0,0
77701,assessed,0,0
77702,by,0,0
77703,stable,0,1
77704,isotope,0,0
77705,tracer,0,1
77706,kinetics,0,0
77707,using,0,0
77708,l-,0,0
77709,[,0,0
77710,1-,0,0
77711,(,0,1
77712,13,0,1
77713,),0,1
77714,C,0,0
77715,],0,1
77716,leucine,0,0
77717,and,0,0
77718,[,0,0
77719,"6,6-",0,0
77720,(,0,1
77721,2,0,1
77722,),0,1
77723,H2,0,0
77724,],0,1
77725,glucose,0,0
77726,.,0,0
77727,Circulating,0,0
77728,concentrations,0,0
77729,of,0,0
77730,glucose,0,0
77731,",",0,0
77732,cortisol,0,0
77733,",",0,0
77734,insulin,0,0
77735,",",0,0
77736,and,0,0
77737,glucagon,0,0
77738,were,0,0
77739,determined,0,0
77740,.,0,0
77741,The,0,0
77742,administration,0,0
77743,of,0,0
77744,amino,0,0
77745,acids,0,0
77746,increased,0,0
77747,protein,0,0
77748,balance,0,0
77749,from,0,1
77750,-16+/-4,0,0
77751,micromol.kg,0,0
77752,(,0,0
77753,-1,0,0
77754,),0,0
77755,.h,0,0
77756,(,0,0
77757,-1,0,0
77758,),0,0
77759,in,0,0
77760,the,0,0
77761,fasted,0,0
77762,state,0,0
77763,to,0,0
77764,16+/-3,0,0
77765,micromol.kg,0,0
77766,(,0,0
77767,-1,0,0
77768,),0,0
77769,.h,0,0
77770,(,0,0
77771,-1,0,0
77772,),0,1
77773,.,0,0
77774,Combined,0,0
77775,infusion,0,0
77776,of,0,0
77777,amino,0,0
77778,acids,0,0
77779,and,0,0
77780,glucose,0,0
77781,increased,0,0
77782,protein,0,0
77783,balance,0,0
77784,from,0,0
77785,-17+/-7,0,0
77786,to,0,0
77787,7+/-5,0,0
77788,micromol.kg,0,0
77789,(,0,0
77790,-1,0,0
77791,),0,0
77792,.h,0,0
77793,(,0,0
77794,-1,0,0
77795,),0,0
77796,.,0,0
77797,The,0,0
77798,increase,0,0
77799,in,0,0
77800,protein,0,0
77801,balance,0,0
77802,during,0,0
77803,nutrition,0,0
77804,was,0,0
77805,comparable,0,0
77806,in,0,0
77807,the,0,0
77808,2,0,0
77809,groups,0,0
77810,(,0,1
77811,P=.07,0,0
77812,),0,1
77813,.,0,0
77814,Combined,0,0
77815,administration,0,0
77816,of,0,0
77817,amino,0,0
77818,acids,0,0
77819,and,0,0
77820,glucose,0,0
77821,decreased,0,0
77822,endogenous,0,0
77823,glucose,0,0
77824,production,0,0
77825,(,0,0
77826,P=.001,0,0
77827,),0,0
77828,and,0,0
77829,stimulated,0,0
77830,insulin,0,0
77831,secretion,0,0
77832,(,0,0
77833,P=.001,0,0
77834,),0,0
77835,to,0,0
77836,a,0,0
77837,greater,0,0
77838,extent,0,0
77839,than,0,0
77840,the,0,0
77841,administration,0,0
77842,of,0,0
77843,amino,0,0
77844,acids,0,0
77845,alone,0,0
77846,.,0,1
77847,Hyperglycemia,0,0
77848,(,0,0
77849,blood,0,0
77850,glucose,0,0
77851,",",0,0
77852,10.1+/-1.9,0,0
77853,micromol/L,0,0
77854,),0,0
77855,occurred,0,0
77856,only,0,0
77857,in,0,0
77858,the,0,0
77859,presence,0,0
77860,of,0,0
77861,glucose,0,0
77862,infusion,0,0
77863,.,0,0
77864,In,0,0
77865,summary,0,0
77866,",",0,0
77867,excluding,0,0
77868,glucose,0,0
77869,from,0,0
77870,a,0,0
77871,short-term,0,0
77872,feeding,0,0
77873,protocol,0,0
77874,does,0,0
77875,not,0,0
77876,diminish,0,0
77877,the,0,0
77878,protein-sparing,0,0
77879,effect,0,0
77880,of,0,0
77881,amino,0,0
77882,acids,0,0
77883,and,0,1
77884,avoids,0,0
77885,hyperglycemia,0,1
77886,.,0,1
77887,Efficacy,0,0
77888,of,0,0
77889,amantadine,0,0
77890,on,0,0
77891,quality,0,0
77892,of,0,0
77893,life,0,0
77894,in,0,0
77895,patients,1,1
77896,with,1,1
77897,chronic,1,1
77898,hepatitis,1,1
77899,C,1,0
77900,treated,1,1
77901,with,1,1
77902,interferon-alpha,1,0
77903,and,1,1
77904,ribavirin,1,1
77905,:,1,1
77906,results,0,0
77907,from,0,1
77908,a,0,0
77909,randomized,0,0
77910,",",0,0
77911,placebo-controlled,0,0
77912,",",0,0
77913,double-blind,0,0
77914,trial,0,0
77915,.,0,0
77916,AIM,0,0
77917,The,0,0
77918,aim,0,0
77919,of,0,0
77920,this,0,0
77921,study,0,0
77922,was,0,0
77923,to,0,0
77924,investigate,0,0
77925,whether,0,0
77926,amantadine,0,1
77927,reduces,0,0
77928,deterioration,0,0
77929,of,0,0
77930,quality,0,0
77931,of,0,0
77932,life,0,0
77933,in,0,0
77934,patients,1,1
77935,with,1,1
77936,chronic,1,1
77937,hepatitis,1,1
77938,C,1,0
77939,during,1,0
77940,and,1,0
77941,after,1,0
77942,treatment,1,0
77943,with,1,1
77944,interferon-alpha,1,0
77945,(,1,1
77946,IFN-alpha,1,0
77947,),1,0
77948,and,1,0
77949,ribavirin,1,1
77950,.,1,0
77951,PATIENTS,0,0
77952,AND,0,0
77953,METHODS,0,0
77954,In,0,0
77955,this,0,0
77956,randomized,0,0
77957,",",0,0
77958,prospective,0,0
77959,",",0,0
77960,placebo-controlled,0,0
77961,",",0,0
77962,multicenter,0,0
77963,trial,0,0
77964,",",0,0
77965,previously,1,0
77966,untreated,1,1
77967,patients,1,1
77968,with,1,1
77969,chronic,1,1
77970,hepatitis,1,1
77971,C,1,0
77972,were,0,0
77973,treated,0,1
77974,with,0,1
77975,IFN-alpha,0,0
77976,plus,0,0
77977,ribavirin,0,1
77978,[,0,0
77979,17,0,1
77980,],0,0
77981,and,0,0
77982,randomized,0,0
77983,for,0,0
77984,treatment,0,0
77985,with,0,1
77986,amantadine,0,1
77987,(,0,0
77988,200,0,0
77989,mg/day,0,0
77990,",",0,0
77991,orally,0,0
77992,",",0,0
77993,n=136,0,1
77994,),0,0
77995,or,0,0
77996,placebo,0,0
77997,(,0,0
77998,n=131,0,1
77999,),0,0
78000,.,0,0
78001,Quality,0,0
78002,of,0,0
78003,life,0,0
78004,was,0,0
78005,assessed,0,0
78006,with,0,1
78007,the,0,0
78008,'Profile,0,0
78009,of,0,0
78010,Mood,0,1
78011,States,0,0
78012,',0,1
78013,scale,0,1
78014,and,0,0
78015,the,0,0
78016,'Everyday,0,0
78017,Life,0,0
78018,',0,1
78019,questionnaire,0,0
78020,at,0,0
78021,baseline,0,0
78022,",",0,0
78023,treatment,0,0
78024,week,0,0
78025,(,0,0
78026,TW,0,0
78027,),0,0
78028,8,0,0
78029,",",0,0
78030,TW24,0,0
78031,",",0,0
78032,TW48,0,0
78033,",",0,0
78034,and,0,0
78035,at,0,0
78036,follow-up,0,0
78037,.,0,1
78038,RESULTS,0,0
78039,Early,0,0
78040,during,0,0
78041,treatment,0,0
78042,at,0,0
78043,TW8,0,0
78044,",",0,0
78045,quality,0,0
78046,of,0,0
78047,life,0,0
78048,was,0,0
78049,not,0,0
78050,different,0,0
78051,between,0,0
78052,patients,1,1
78053,in,1,0
78054,the,1,0
78055,control,1,0
78056,and,1,0
78057,the,1,0
78058,amantadine,1,0
78059,group,1,0
78060,.,1,0
78061,At,0,0
78062,TW24,0,0
78063,",",0,0
78064,the,0,0
78065,control,0,0
78066,group,0,0
78067,but,0,0
78068,not,0,0
78069,the,0,0
78070,amantadine,0,0
78071,group,0,0
78072,",",0,0
78073,however,0,0
78074,",",0,0
78075,showed,0,0
78076,significant,0,0
78077,deterioration,0,0
78078,of,0,0
78079,the,0,0
78080,modalities,0,0
78081,depression,0,1
78082,",",0,0
78083,fatigue,0,0
78084,",",0,0
78085,and,0,0
78086,vigor,0,0
78087,compared,0,0
78088,with,0,1
78089,baseline,0,0
78090,.,0,0
78091,Especially,0,0
78092,",",0,0
78093,nonresponders,0,0
78094,in,0,0
78095,the,0,0
78096,amantadine,0,0
78097,group,0,0
78098,showed,0,0
78099,significantly,0,0
78100,lower,0,0
78101,deterioration,0,0
78102,of,0,0
78103,depression,0,1
78104,",",0,0
78105,anger,0,0
78106,",",0,0
78107,mind,0,0
78108,function,0,0
78109,",",0,0
78110,everyday,0,0
78111,life,0,0
78112,",",0,0
78113,and,0,0
78114,zest,0,0
78115,for,0,0
78116,life,0,0
78117,than,0,0
78118,those,0,0
78119,in,0,0
78120,the,0,0
78121,placebo,0,0
78122,group,0,0
78123,.,0,0
78124,After,0,0
78125,treatment,0,0
78126,",",0,0
78127,the,0,0
78128,beneficial,0,0
78129,effects,0,0
78130,of,0,0
78131,amantadine,0,1
78132,disappeared,0,0
78133,.,0,0
78134,CONCLUSION,0,0
78135,The,0,0
78136,addition,0,0
78137,of,0,0
78138,amantadine,0,1
78139,to,0,0
78140,IFN-alpha,0,0
78141,plus,0,0
78142,ribavirin,0,0
78143,combination,0,0
78144,therapy,0,0
78145,may,0,0
78146,reduce,0,0
78147,deterioration,0,0
78148,of,0,0
78149,depression,0,1
78150,",",0,0
78151,fatigue,0,0
78152,",",0,0
78153,and,0,0
78154,vigor,0,0
78155,during,0,0
78156,treatment,0,0
78157,but,0,0
78158,does,0,0
78159,not,0,0
78160,affect,0,0
78161,quality,0,0
78162,of,0,0
78163,life,0,0
78164,after,0,0
78165,treatment,0,0
78166,.,0,1
78167,Eight,0,0
78168,in-office,0,0
78169,tooth,0,1
78170,whitening,0,0
78171,systems,0,0
78172,evaluated,0,0
78173,in,0,0
78174,vivo,0,0
78175,:,0,1
78176,a,0,0
78177,pilot,0,0
78178,study,0,0
78179,.,0,0
78180,This,0,0
78181,in,0,0
78182,vivo,0,0
78183,pilot,0,0
78184,study,0,0
78185,evaluated,0,0
78186,eight,0,1
78187,products,0,0
78188,with,0,1
78189,hydrogen,0,0
78190,peroxide,0,0
78191,(,0,0
78192,HP,0,0
78193,),0,1
78194,concentrations,0,0
78195,ranging,0,1
78196,from,0,1
78197,15,0,1
78198,%,0,0
78199,to,0,0
78200,35,0,1
78201,%,0,0
78202,.,0,0
78203,The,0,0
78204,treatment,0,0
78205,contact,0,0
78206,time,0,0
78207,varied,0,0
78208,from,0,1
78209,15,0,1
78210,minutes,0,0
78211,to,0,1
78212,60,0,1
78213,minutes,0,0
78214,.,0,1
78215,Patients,1,1
78216,were,0,0
78217,evaluated,0,0
78218,for,0,0
78219,color,0,0
78220,at,0,0
78221,baseline,0,0
78222,",",0,0
78223,immediately,1,0
78224,after,1,0
78225,treatment,1,0
78226,and,0,0
78227,at,0,0
78228,one,0,1
78229,",",0,0
78230,two,0,0
78231,",",0,0
78232,four,0,1
78233,and,0,0
78234,six,0,1
78235,weeks,0,0
78236,after,0,0
78237,treatment,0,0
78238,using,0,0
78239,a,0,0
78240,colorimeter,0,0
78241,",",0,0
78242,shade,0,0
78243,guide,0,0
78244,and,0,0
78245,photos,0,0
78246,.,0,1
78247,All,0,1
78248,eight,0,1
78249,products,0,0
78250,were,0,1
78251,effective,0,0
78252,in,0,0
78253,bleaching,0,0
78254,teeth,0,1
78255,.,0,1
78256,Colorimeter,0,0
78257,data,0,0
78258,for,0,0
78259,deltaE,0,0
78260,immediately,0,0
78261,after,0,0
78262,treatment,0,0
78263,was,0,0
78264,6.77,0,0
78265,.,0,1
78266,At,0,0
78267,one,0,0
78268,and,0,1
78269,six,0,1
78270,weeks,0,0
78271,after,0,0
78272,bleaching,0,0
78273,",",0,0
78274,there,0,0
78275,were,0,0
78276,51,0,0
78277,%,0,0
78278,and,0,0
78279,65,0,1
78280,%,0,0
78281,reductions,0,0
78282,in,0,0
78283,deltaE,0,0
78284,",",0,0
78285,respectively,0,0
78286,.,0,0
78287,A,0,0
78288,randomized,0,0
78289,",",0,0
78290,controlled,0,0
78291,trial,0,0
78292,of,0,0
78293,a,0,0
78294,home-based,0,0
78295,intervention,0,0
78296,program,0,0
78297,for,0,0
78298,children,1,1
78299,with,1,1
78300,autism,1,1
78301,and,1,0
78302,developmental,1,1
78303,delay,1,0
78304,.,1,0
78305,OBJECTIVE,0,0
78306,This,0,0
78307,study,0,0
78308,aimed,0,0
78309,to,0,0
78310,(,0,0
78311,1,0,0
78312,),0,0
78313,investigate,0,0
78314,whether,0,0
78315,provision,0,0
78316,of,0,0
78317,a,0,0
78318,home-based,0,0
78319,program,0,0
78320,in,0,0
78321,addition,0,0
78322,to,0,0
78323,a,0,0
78324,center-based,0,0
78325,program,0,0
78326,improves,0,0
78327,development,0,0
78328,in,0,0
78329,young,1,1
78330,children,1,1
78331,with,1,1
78332,disabilities,1,1
78333,and,1,1
78334,coping,1,0
78335,abilities,1,0
78336,of,1,0
78337,their,1,1
78338,families,1,1
78339,and,1,0
78340,(,1,1
78341,2,1,0
78342,),1,0
78343,describe,1,0
78344,the,1,0
78345,characteristics,1,0
78346,of,1,0
78347,children,1,1
78348,and,1,1
78349,families,1,1
78350,who,1,1
78351,benefit,1,0
78352,most,1,0
78353,from,1,0
78354,the,1,0
78355,intervention,1,0
78356,.,1,0
78357,METHODS,0,0
78358,Fifty-nine,1,1
78359,children,1,1
78360,",",1,0
78361,aged,1,1
78362,3-5,1,0
78363,years,1,1
78364,",",1,0
78365,with,1,1
78366,no,1,0
78367,cerebral,1,1
78368,palsy,1,1
78369,",",0,0
78370,participated,0,1
78371,in,0,0
78372,the,0,0
78373,study,0,0
78374,.,0,0
78375,Half,0,0
78376,of,0,0
78377,the,0,0
78378,group,0,0
78379,was,0,0
78380,randomized,0,0
78381,to,0,0
78382,receive,0,0
78383,an,0,0
78384,additional,0,0
78385,program,0,0
78386,in,0,0
78387,their,0,1
78388,homes,0,1
78389,.,0,1
78390,A,1,0
78391,special,1,0
78392,education,1,0
78393,teacher,1,1
78394,provided,1,0
78395,40,1,1
78396,visits,1,0
78397,over,1,0
78398,12,1,1
78399,months,1,0
78400,working,1,1
78401,with,1,1
78402,the,1,0
78403,families,1,1
78404,to,0,0
78405,help,0,0
78406,generalize,0,0
78407,skills,0,0
78408,to,0,0
78409,the,0,0
78410,home,0,0
78411,environment,0,0
78412,and,0,0
78413,assist,0,0
78414,with,0,1
78415,their,0,1
78416,concerns,0,0
78417,.,0,1
78418,All,0,1
78419,children,0,1
78420,were,0,0
78421,assessed,0,0
78422,before,0,0
78423,and,0,0
78424,after,0,0
78425,the,0,0
78426,intervention,0,0
78427,",",0,0
78428,and,0,0
78429,families,0,1
78430,completed,0,1
78431,questionnaires,0,0
78432,assessing,0,0
78433,family,0,1
78434,stress,0,0
78435,",",0,0
78436,support,0,0
78437,",",0,0
78438,and,0,0
78439,empowerment,0,0
78440,on,0,0
78441,both,0,0
78442,occasions,0,0
78443,.,0,1
78444,Differences,0,0
78445,in,0,0
78446,change,0,0
78447,over,0,0
78448,time,0,0
78449,and,0,0
78450,between,0,0
78451,the,0,0
78452,intervention,0,0
78453,and,0,0
78454,control,0,0
78455,group,0,0
78456,were,0,0
78457,analyzed,0,0
78458,by,0,0
78459,repeated,0,0
78460,measures,0,0
78461,and,0,0
78462,the,0,0
78463,association,0,0
78464,between,0,0
78465,characteristics,0,0
78466,of,0,1
78467,children,0,1
78468,and,0,1
78469,families,0,1
78470,with,0,1
78471,improved,0,0
78472,outcome,0,0
78473,by,0,0
78474,multivariate,0,0
78475,analysis,0,0
78476,of,0,0
78477,variance,0,0
78478,.,0,1
78479,RESULTS,0,0
78480,Change,0,0
78481,in,0,0
78482,cognitive,0,0
78483,development,0,0
78484,and,0,0
78485,behavior,0,0
78486,(,0,0
78487,in,0,0
78488,the,0,0
78489,centers,0,1
78490,),0,0
78491,over,0,0
78492,time,0,0
78493,favored,0,0
78494,the,0,1
78495,children,0,1
78496,who,0,1
78497,received,0,1
78498,the,0,1
78499,extra,0,0
78500,intervention,0,0
78501,(,0,0
78502,p,0,0
78503,=,0,0
78504,.007,0,0
78505,and,0,0
78506,p,0,0
78507,=,0,0
78508,.007,0,0
78509,",",0,0
78510,respectively,0,0
78511,),0,0
78512,.,0,0
78513,The,0,0
78514,groups,0,0
78515,did,0,0
78516,not,0,0
78517,differ,0,0
78518,on,0,0
78519,any,0,0
78520,of,0,0
78521,the,0,0
78522,family,0,1
78523,measures,0,0
78524,of,0,0
78525,change,0,0
78526,.,0,1
78527,Multivariate,0,0
78528,analysis,0,0
78529,of,0,0
78530,variance,0,0
78531,revealed,0,0
78532,more,0,0
78533,improvement,0,0
78534,for,0,0
78535,children,0,1
78536,in,0,0
78537,the,0,0
78538,intervention,0,0
78539,group,0,0
78540,from,0,0
78541,higher,0,0
78542,than,0,0
78543,lower,0,0
78544,stressed,0,0
78545,families,0,1
78546,.,0,1
78547,CONCLUSIONS,0,0
78548,Results,0,0
78549,suggest,0,0
78550,the,0,0
78551,need,0,0
78552,for,0,0
78553,daily,0,0
78554,reinforcement,0,0
78555,of,0,0
78556,skills,0,0
78557,learned,0,0
78558,at,0,0
78559,the,0,0
78560,center-based,0,0
78561,program,0,0
78562,and,0,0
78563,the,0,0
78564,importance,0,0
78565,of,0,0
78566,involving,0,1
78567,families,0,1
78568,",",0,0
78569,especially,0,0
78570,those,0,0
78571,with,0,0
78572,few,0,0
78573,resources,0,0
78574,and,0,0
78575,relatively,0,0
78576,high,0,0
78577,stress,0,0
78578,.,0,1
78579,Sodium,0,0
78580,bicarbonate,0,0
78581,",",0,0
78582,N-acetylcysteine,0,0
78583,",",0,0
78584,and,0,0
78585,saline,0,0
78586,for,0,0
78587,prevention,0,0
78588,of,0,0
78589,radiocontrast-induced,1,0
78590,nephropathy,1,1
78591,.,1,0
78592,A,0,0
78593,comparison,0,0
78594,of,0,0
78595,3,0,0
78596,regimens,0,0
78597,for,0,0
78598,protecting,0,0
78599,contrast-induced,0,0
78600,nephropathy,0,1
78601,in,0,0
78602,patients,1,1
78603,undergoing,1,1
78604,coronary,1,1
78605,procedures,1,1
78606,.,1,1
78607,A,0,0
78608,single-center,1,0
78609,prospective,0,0
78610,controlled,0,0
78611,trial,0,0
78612,.,0,1
78613,BACKGROUND,0,0
78614,Several,0,0
78615,protective,0,0
78616,therapies,0,0
78617,have,0,1
78618,been,0,0
78619,developed,0,0
78620,to,0,0
78621,prevent,0,0
78622,contrast-induced,0,0
78623,nephropathy,0,1
78624,(,0,1
78625,CIN,0,1
78626,),0,0
78627,.,0,0
78628,We,0,0
78629,aimed,0,0
78630,to,0,0
78631,investigate,0,0
78632,the,0,0
78633,efficacy,0,0
78634,of,0,0
78635,sodium,0,0
78636,bicarbonate,0,0
78637,by,0,0
78638,comparing,0,0
78639,2,0,1
78640,other,0,0
78641,regimens,0,0
78642,",",0,0
78643,including,0,0
78644,combination,0,0
78645,of,0,0
78646,N-acetylcysteine,0,0
78647,(,0,1
78648,NAC,0,0
78649,),0,0
78650,plus,0,0
78651,sodium,0,0
78652,chloride,0,0
78653,and,0,0
78654,sodium,0,0
78655,chloride,0,0
78656,alone,0,0
78657,",",0,0
78658,to,0,0
78659,prevent,0,0
78660,CIN,0,0
78661,in,0,0
78662,patients,1,1
78663,undergoing,1,1
78664,cardiovascular,1,1
78665,procedures,1,1
78666,.,1,1
78667,METHODS,0,0
78668,We,1,0
78669,prospectively,1,1
78670,enrolled,1,1
78671,264,1,1
78672,patients,1,1
78673,who,1,1
78674,were,1,1
78675,scheduled,1,1
78676,for,1,0
78677,cardiovascular,1,1
78678,procedures,1,1
78679,and,1,0
78680,had,1,1
78681,a,1,0
78682,baseline,1,0
78683,creatinine,1,0
78684,level,1,0
78685,>,1,1
78686,1.2,1,0
78687,mg/dL,1,0
78688,.,1,1
78689,The,0,0
78690,patients,0,1
78691,were,0,0
78692,assigned,0,1
78693,1,0,0
78694,of,0,0
78695,3,0,1
78696,prophylactic,0,1
78697,regimens,0,0
78698,:,0,1
78699,infusion,0,0
78700,of,0,0
78701,sodium,0,0
78702,bicarbonate,0,0
78703,",",0,0
78704,sodium,0,0
78705,chloride,0,0
78706,",",0,0
78707,sodium,0,0
78708,chloride,0,0
78709,plus,0,0
78710,oral,0,0
78711,NAC,0,1
78712,(,0,0
78713,600,0,0
78714,mg,0,0
78715,bid,0,0
78716,),0,0
78717,.,0,0
78718,Contrast-induced,0,0
78719,nephropathy,0,1
78720,was,0,0
78721,defined,0,0
78722,as,0,0
78723,an,0,0
78724,increase,0,0
78725,in,0,0
78726,serum,0,0
78727,creatinine,0,0
78728,level,0,0
78729,>,0,1
78730,25,0,0
78731,%,0,0
78732,or,0,1
78733,0.5,0,0
78734,mg/dL,0,0
78735,after,0,1
78736,48,0,1
78737,hours,0,0
78738,.,0,1
78739,RESULTS,0,0
78740,There,0,0
78741,were,0,0
78742,no,0,0
78743,significant,0,0
78744,differences,0,0
78745,among,0,1
78746,groups,0,0
78747,regarding,0,0
78748,baseline,0,0
78749,demographic,0,0
78750,properties,0,0
78751,and,0,1
78752,nephropathy,0,1
78753,risk,0,1
78754,factors,0,0
78755,.,0,0
78756,The,0,0
78757,change,0,0
78758,in,0,0
78759,creatinine,0,0
78760,clearance,0,0
78761,was,0,0
78762,significantly,0,0
78763,better,0,0
78764,in,0,0
78765,the,0,0
78766,sodium,0,0
78767,bicarbonate,0,0
78768,group,0,0
78769,than,0,0
78770,other,0,0
78771,2,0,1
78772,groups,0,0
78773,(,0,1
78774,P,0,0
78775,=,0,0
78776,.007,0,0
78777,),0,0
78778,.,0,0
78779,The,0,0
78780,incidence,0,0
78781,of,0,0
78782,CIN,0,0
78783,was,0,0
78784,significantly,0,0
78785,lower,0,0
78786,in,0,0
78787,the,0,0
78788,sodium,0,0
78789,bicarbonate,0,0
78790,group,0,0
78791,(,0,0
78792,4.5,0,0
78793,%,0,0
78794,),0,0
78795,compared,0,0
78796,with,0,1
78797,sodium,0,0
78798,chloride,0,0
78799,alone,0,0
78800,(,0,0
78801,13.6,0,0
78802,%,0,0
78803,",",0,0
78804,P,0,0
78805,=,0,0
78806,.036,0,0
78807,),0,0
78808,and,0,0
78809,tended,0,0
78810,to,0,0
78811,be,0,0
78812,lower,0,0
78813,than,0,0
78814,in,0,0
78815,the,0,0
78816,combination,0,0
78817,group,0,0
78818,(,0,0
78819,12.5,0,0
78820,%,0,0
78821,",",0,0
78822,P,0,0
78823,=,0,0
78824,.059,0,0
78825,),0,0
78826,.,0,0
78827,After,0,0
78828,adjusting,0,0
78829,the,0,0
78830,Mehran,0,0
78831,nephropathy,0,1
78832,risk,0,0
78833,score,0,0
78834,",",0,0
78835,the,0,0
78836,risk,0,0
78837,of,0,0
78838,CIN,0,0
78839,significantly,0,0
78840,reduced,0,0
78841,with,0,0
78842,sodium,0,0
78843,bicarbonate,0,0
78844,compared,0,0
78845,with,0,1
78846,sodium,0,0
78847,chloride,0,0
78848,alone,0,0
78849,(,0,0
78850,adjusted,0,0
78851,risk,0,0
78852,ratio,0,0
78853,0.29,0,0
78854,",",0,0
78855,P,0,0
78856,=,0,0
78857,.043,0,0
78858,),0,1
78859,.,0,1
78860,CONCLUSIONS,0,0
78861,Hydration,0,0
78862,with,0,1
78863,sodium,0,0
78864,bicarbonate,0,0
78865,provides,0,0
78866,better,0,0
78867,protection,0,0
78868,against,0,0
78869,CIN,0,0
78870,than,0,0
78871,the,0,0
78872,sodium,0,0
78873,chloride,0,0
78874,infusion,0,0
78875,does,0,0
78876,alone,0,0
78877,.,0,0
78878,Combination,0,0
78879,therapy,0,0
78880,of,0,0
78881,NAC,0,0
78882,plus,0,0
78883,sodium,0,0
78884,chloride,0,0
78885,did,0,0
78886,not,0,0
78887,offer,0,0
78888,additional,0,0
78889,benefit,0,0
78890,over,0,0
78891,hydration,0,0
78892,with,0,1
78893,sodium,0,0
78894,chloride,0,0
78895,alone,0,0
78896,.,0,0
78897,[,0,0
78898,Clinical,0,0
78899,study,0,0
78900,of,0,0
78901,the,0,0
78902,efficacy,0,0
78903,of,0,0
78904,and,0,0
78905,tolerance,0,0
78906,to,0,0
78907,nimesulide,0,0
78908,in,0,0
78909,suppository,0,0
78910,formulation,0,0
78911,in,0,0
78912,pain-inflammatory,0,1
78913,pathologies,0,1
78914,of,0,0
78915,the,0,0
78916,ear,0,0
78917,",",0,0
78918,nose,0,0
78919,",",0,0
78920,and,0,0
78921,throat,0,1
78922,],0,0
78923,.,0,0
78924,The,0,0
78925,efficacy,0,0
78926,and,0,0
78927,tolerability,0,0
78928,of,0,0
78929,a,0,0
78930,new,0,0
78931,pharmaceutical,0,0
78932,form,0,0
78933,of,0,0
78934,the,0,0
78935,non-steroid,0,0
78936,anti-inflammatory,0,0
78937,drug,0,0
78938,.,0,1
78939,Nimesulide,0,0
78940,have,0,0
78941,been,0,0
78942,studied,0,0
78943,in,0,0
78944,a,0,0
78945,double,0,0
78946,blind,0,0
78947,study,0,0
78948,compared,0,0
78949,with,0,1
78950,flurbiprofen,0,0
78951,",",0,0
78952,in,0,0
78953,98,1,1
78954,patients,1,1
78955,aged,1,1
78956,between,1,0
78957,18,1,1
78958,and,1,0
78959,75,1,1
78960,suffering,1,1
78961,from,1,1
78962,pain-inflammatory,1,1
78963,pathologies,1,1
78964,of,1,0
78965,ENT,1,0
78966,nature,1,0
78967,.,1,0
78968,Both,0,0
78969,drugs,0,0
78970,",",0,0
78971,administered,0,0
78972,in,0,0
78973,a,0,0
78974,dose,0,0
78975,of,0,0
78976,one,0,0
78977,suppository,0,0
78978,twice,0,0
78979,a,0,0
78980,day,0,0
78981,for,0,0
78982,7,0,1
78983,days,0,0
78984,",",0,0
78985,showed,0,0
78986,marked,0,0
78987,anti-inflammatory,0,0
78988,",",0,0
78989,analgesic,0,0
78990,and,0,0
78991,antipyretic,0,0
78992,activity,0,0
78993,and,0,0
78994,produced,0,0
78995,a,0,0
78996,significant,0,0
78997,",",0,0
78998,progressive,0,0
78999,improvement,0,0
79000,in,0,0
79001,the,0,0
79002,typical,0,1
79003,symptoms,0,0
79004,of,0,0
79005,the,0,0
79006,inflammatory,0,0
79007,state,0,0
79008,up,0,0
79009,to,0,0
79010,their,0,0
79011,complete,0,0
79012,remission,0,0
79013,.,0,1
79014,Nimesulide,0,0
79015,evidenced,0,0
79016,greater,0,0
79017,speed,0,0
79018,and,0,0
79019,duration,0,0
79020,of,0,0
79021,therapeutic,0,0
79022,action,0,0
79023,.,0,0
79024,Assessment,0,0
79025,on,0,0
79026,the,0,0
79027,effectiveness,0,0
79028,and,0,0
79029,tolerability,0,0
79030,as,0,0
79031,expressed,0,0
79032,separately,0,0
79033,by,0,0
79034,the,0,0
79035,physician,0,0
79036,and,0,0
79037,patient,0,0
79038,were,0,0
79039,positive,0,0
79040,in,0,0
79041,almost,0,0
79042,all,0,0
79043,cases,0,0
79044,of,0,0
79045,both,0,0
79046,treatments,0,0
79047,.,0,1
79048,A,0,1
79049,randomized,0,1
79050,controlled,0,0
79051,trial,0,0
79052,of,0,0
79053,a,0,0
79054,health-promotion,0,0
79055,programme,0,0
79056,and,0,0
79057,its,0,0
79058,effect,0,0
79059,on,0,0
79060,ADL,0,1
79061,dependence,0,0
79062,and,0,0
79063,self-reported,0,0
79064,health,0,1
79065,problems,0,1
79066,for,0,0
79067,the,1,0
79068,elderly,1,1
79069,visually,1,0
79070,impaired,1,1
79071,.,1,0
79072,BACKGROUND,0,0
79073,Ageing,0,0
79074,with,0,1
79075,visual,0,0
79076,impairment,0,0
79077,is,0,0
79078,associated,0,0
79079,with,0,0
79080,a,0,0
79081,high,0,0
79082,degree,0,0
79083,of,0,0
79084,disability,0,0
79085,whereby,0,0
79086,age-related,0,0
79087,macular,0,0
79088,degeneration,0,1
79089,in,0,0
79090,particular,0,0
79091,causes,0,0
79092,dependence,0,0
79093,in,0,0
79094,activities,0,0
79095,of,0,0
79096,daily,0,0
79097,living,0,1
79098,(,0,0
79099,ADL,0,1
79100,),0,0
79101,even,0,0
79102,at,0,0
79103,an,0,0
79104,early,0,0
79105,stage,0,1
79106,.,0,1
79107,AIMS,0,0
79108,To,0,0
79109,compare,0,0
79110,an,0,0
79111,activity-based,0,0
79112,",",0,0
79113,health-promotion,0,0
79114,programme,0,0
79115,with,0,1
79116,an,0,0
79117,individual,0,0
79118,programme,0,0
79119,",",0,0
79120,targeting,0,0
79121,the,1,0
79122,elderly,1,1
79123,with,1,1
79124,age-related,1,0
79125,macular,1,1
79126,degeneration,1,1
79127,concerning,0,0
79128,the,0,0
79129,effect,0,0
79130,on,0,0
79131,the,0,0
79132,development,0,0
79133,of,0,0
79134,dependence,0,0
79135,in,0,0
79136,ADL,0,1
79137,",",0,0
79138,general,0,1
79139,health,0,0
79140,",",0,0
79141,and,0,0
79142,self-reported,0,0
79143,health,0,1
79144,problems,0,1
79145,.,0,0
79146,METHODS,0,0
79147,A,0,0
79148,randomized,0,0
79149,controlled,0,0
79150,study,0,0
79151,with,0,1
79152,a,0,0
79153,28-month,0,0
79154,follow-up,0,0
79155,.,0,0
79156,A,1,0
79157,total,1,1
79158,of,1,0
79159,229,1,1
79160,persons,1,1
79161,were,1,1
79162,randomized,1,1
79163,to,1,0
79164,the,1,0
79165,study,1,0
79166,and,0,0
79167,131,0,0
79168,(,0,0
79169,57,0,1
79170,%,0,0
79171,),0,0
79172,were,0,0
79173,followed,0,0
79174,up,0,0
79175,(,0,0
79176,individual,0,0
79177,intervention,0,0
79178,n=69,0,1
79179,",",0,0
79180,health-promotion,0,0
79181,programme,0,0
79182,n=62,0,1
79183,),0,0
79184,at,0,0
79185,28-month,0,1
79186,.,0,0
79187,RESULTS,0,0
79188,The,0,0
79189,health-promotion,0,0
79190,group,0,0
79191,maintained,0,0
79192,their,0,0
79193,ADL,0,1
79194,level,0,0
79195,despite,0,0
79196,a,0,0
79197,significant,0,0
79198,decrease,0,0
79199,in,0,0
79200,visual,0,0
79201,acuity,0,0
79202,",",0,0
79203,while,0,0
79204,the,0,0
79205,individual,0,0
79206,intervention,0,0
79207,group,0,0
79208,increased,0,0
79209,its,0,0
79210,dependence,0,0
79211,in,0,0
79212,ADL,0,1
79213,.,0,1
79214,General,0,0
79215,health,0,0
79216,systematically,0,0
79217,dropped,0,0
79218,to,0,0
79219,a,0,0
79220,lower,0,0
79221,level,0,0
79222,in,0,0
79223,both,0,0
79224,groups,0,0
79225,",",0,0
79226,but,0,0
79227,participants,0,1
79228,from,0,0
79229,the,0,0
79230,health-promotion,0,0
79231,group,0,0
79232,reported,0,0
79233,fewer,0,0
79234,health,0,1
79235,problems,0,1
79236,.,0,0
79237,There,0,0
79238,were,0,0
79239,significantly,0,0
79240,fewer,0,0
79241,reports,0,0
79242,of,0,0
79243,tiredness,0,0
79244,and,0,0
79245,dizziness,0,0
79246,among,0,0
79247,the,0,0
79248,health-promotion,0,0
79249,participants,0,1
79250,.,0,0
79251,CONCLUSION,0,0
79252,The,0,0
79253,health-promotion,0,0
79254,programme,0,0
79255,seems,0,0
79256,to,0,0
79257,have,0,0
79258,slowed,0,0
79259,down,0,0
79260,the,0,0
79261,disablement,0,0
79262,process,0,0
79263,among,0,0
79264,elderly,1,1
79265,with,1,1
79266,decreased,1,0
79267,vision,1,0
79268,by,0,0
79269,enabling,0,0
79270,them,0,1
79271,to,0,0
79272,maintain,0,0
79273,their,0,0
79274,ADL,0,1
79275,level,0,0
79276,and,0,0
79277,by,0,0
79278,reducing,0,0
79279,self-reported,0,0
79280,health,0,1
79281,problems,0,1
79282,for,0,0
79283,at,0,1
79284,least,0,1
79285,28,0,1
79286,months,0,0
79287,following,0,0
79288,intervention,0,0
79289,.,0,1
79290,Transcutaneous,0,0
79291,electrical,0,0
79292,nerve,0,0
79293,stimulation,0,0
79294,combined,0,0
79295,with,0,1
79296,task-related,0,0
79297,training,0,0
79298,improves,0,0
79299,lower,0,0
79300,limb,0,0
79301,functions,0,0
79302,in,0,0
79303,subjects,1,1
79304,with,1,1
79305,chronic,1,1
79306,stroke,1,1
79307,.,1,1
79308,BACKGROUND,0,0
79309,AND,0,0
79310,PURPOSE,0,0
79311,Previous,0,1
79312,studies,0,0
79313,have,0,0
79314,shown,0,0
79315,that,0,0
79316,repeated,0,0
79317,sensory,0,0
79318,inputs,0,0
79319,could,0,0
79320,enhance,0,0
79321,brain,0,0
79322,plasticity,0,0
79323,and,0,0
79324,cortical,0,0
79325,motor,0,0
79326,output,0,0
79327,.,0,0
79328,The,0,0
79329,purpose,0,0
79330,of,0,0
79331,this,0,0
79332,study,0,0
79333,was,0,0
79334,to,0,0
79335,investigate,0,0
79336,whether,0,0
79337,combining,0,0
79338,electrically,0,0
79339,induced,0,0
79340,sensory,0,0
79341,inputs,0,0
79342,through,0,0
79343,transcutaneous,0,0
79344,electrical,0,0
79345,nerve,0,0
79346,stimulation,0,0
79347,(,0,0
79348,TENS,0,0
79349,),0,0
79350,with,0,1
79351,task-related,0,0
79352,training,0,0
79353,(,0,0
79354,TRT,0,1
79355,),0,0
79356,in,0,0
79357,a,0,0
79358,home-based,0,0
79359,program,0,0
79360,would,0,0
79361,augment,0,0
79362,voluntary,0,0
79363,motor,0,0
79364,output,0,0
79365,in,0,0
79366,chronic,1,1
79367,stroke,1,1
79368,survivors,1,0
79369,better,0,0
79370,than,0,0
79371,either,0,0
79372,treatment,0,0
79373,alone,0,0
79374,or,0,0
79375,no,0,0
79376,treatment,0,0
79377,.,0,0
79378,METHODS,0,0
79379,Eighty-eight,1,1
79380,patients,1,1
79381,with,1,1
79382,stroke,1,1
79383,were,0,0
79384,assigned,0,0
79385,randomly,0,1
79386,to,0,0
79387,receive,0,0
79388,a,0,0
79389,home-based,0,0
79390,program,0,0
79391,of,0,0
79392,(,0,0
79393,1,0,0
79394,),0,0
79395,TENS,0,0
79396,",",0,0
79397,(,0,0
79398,2,0,0
79399,),0,0
79400,TENS+TRT,0,0
79401,",",0,0
79402,(,0,0
79403,3,0,0
79404,),0,0
79405,placebo,0,0
79406,TENS+TRT,0,0
79407,",",0,0
79408,or,0,0
79409,(,0,0
79410,4,0,0
79411,),0,0
79412,no,0,0
79413,treatment,0,0
79414,(,0,0
79415,control,0,1
79416,),0,1
79417,5,0,0
79418,days,0,0
79419,a,0,0
79420,week,0,0
79421,for,0,0
79422,4,0,0
79423,weeks,0,0
79424,.,0,1
79425,Outcome,0,0
79426,measurements,0,0
79427,included,0,1
79428,Composite,0,0
79429,Spasticity,0,1
79430,Scale,0,0
79431,",",0,0
79432,peak,0,0
79433,torques,0,0
79434,generated,0,0
79435,during,0,0
79436,maximum,0,0
79437,isometric,0,1
79438,voluntary,0,1
79439,contraction,0,1
79440,of,0,0
79441,ankle,0,1
79442,dorsiflexors,0,1
79443,and,0,1
79444,plantarflexors,0,0
79445,",",0,0
79446,and,0,0
79447,gait,0,0
79448,velocity,0,0
79449,recorded,0,0
79450,at,0,0
79451,baseline,0,0
79452,",",0,0
79453,after,0,0
79454,2,0,0
79455,and,0,1
79456,4,0,0
79457,weeks,0,0
79458,of,0,0
79459,treatment,0,0
79460,",",0,0
79461,and,0,0
79462,4,0,0
79463,weeks,0,0
79464,after,0,0
79465,treatment,0,0
79466,ended,0,1
79467,.,0,0
79468,RESULTS,0,0
79469,When,0,0
79470,compared,0,0
79471,with,0,0
79472,TENS,0,0
79473,",",0,0
79474,the,0,0
79475,combined,0,0
79476,TENS+TRT,0,0
79477,group,0,0
79478,showed,0,0
79479,significantly,0,0
79480,greater,0,0
79481,improvement,0,0
79482,in,0,0
79483,ankle,0,1
79484,dorsiflexion,0,0
79485,torque,0,0
79486,at,0,0
79487,follow-up,0,0
79488,and,0,0
79489,in,0,0
79490,ankle,0,1
79491,plantarflexion,0,0
79492,torque,0,0
79493,at,0,0
79494,week,0,0
79495,2,0,0
79496,and,0,0
79497,follow-up,0,0
79498,(,0,0
79499,P,0,0
79500,<,0,0
79501,0.01,0,0
79502,),0,0
79503,.,0,0
79504,When,0,0
79505,compared,0,0
79506,with,0,0
79507,placebo+TRT,0,0
79508,",",0,0
79509,the,0,0
79510,TENS+TRT,0,0
79511,group,0,0
79512,produced,0,0
79513,earlier,0,0
79514,and,0,0
79515,greater,0,0
79516,reduction,0,0
79517,of,0,0
79518,plantarflexor,0,0
79519,spasticity,0,0
79520,and,0,0
79521,improvement,0,0
79522,in,0,0
79523,ankle,0,1
79524,dorsiflexion,0,0
79525,torque,0,0
79526,at,0,0
79527,week,0,0
79528,2,0,0
79529,(,0,0
79530,P,0,0
79531,<,0,0
79532,0.01,0,0
79533,),0,0
79534,.,0,0
79535,When,0,0
79536,compared,0,0
79537,with,0,0
79538,all,0,0
79539,3,0,0
79540,groups,0,0
79541,",",0,0
79542,the,0,0
79543,TENS+TRT,0,0
79544,group,0,0
79545,showed,0,0
79546,significantly,0,0
79547,greater,0,0
79548,improvement,0,0
79549,in,0,0
79550,gait,0,0
79551,velocity,0,0
79552,(,0,0
79553,P,0,0
79554,<,0,0
79555,0.01,0,0
79556,),0,1
79557,.,0,1
79558,CONCLUSIONS,0,0
79559,In,0,0
79560,patients,1,1
79561,with,1,1
79562,chronic,1,1
79563,stroke,1,1
79564,",",0,0
79565,20,0,0
79566,sessions,0,0
79567,of,0,0
79568,a,0,1
79569,combined,0,0
79570,TENS+TRT,0,0
79571,home-based,0,0
79572,program,0,0
79573,decreased,0,0
79574,plantarflexor,0,0
79575,spasticity,0,0
79576,",",0,0
79577,improved,0,0
79578,dorsiflexor,0,0
79579,and,0,0
79580,plantarflexor,0,0
79581,strength,0,0
79582,",",0,0
79583,and,0,0
79584,increased,0,0
79585,gait,0,0
79586,velocity,0,0
79587,significantly,0,0
79588,more,0,0
79589,than,0,0
79590,TENS,0,0
79591,alone,0,0
79592,",",0,0
79593,placebo+TRT,0,0
79594,",",0,0
79595,or,0,0
79596,no,0,0
79597,treatment,0,0
79598,.,0,0
79599,Such,0,0
79600,improvements,0,0
79601,can,0,0
79602,even,0,0
79603,be,0,0
79604,maintained,0,0
79605,4,0,0
79606,weeks,0,0
79607,after,0,0
79608,treatment,0,0
79609,ended,0,1
79610,.,0,1
79611,Tubeless,0,0
79612,percutaneous,0,1
79613,nephrolithotomy,0,1
79614,:,0,1
79615,safe,0,0
79616,even,0,0
79617,in,0,0
79618,supracostal,0,0
79619,access,0,0
79620,.,0,0
79621,PURPOSE,0,0
79622,This,0,0
79623,study,0,0
79624,was,0,0
79625,designed,0,0
79626,to,0,0
79627,determine,0,0
79628,the,0,0
79629,outcome,0,0
79630,and,0,0
79631,safety,0,0
79632,of,0,0
79633,tubeless,0,0
79634,percutaneous,0,1
79635,nephrolithotomy,0,1
79636,(,0,0
79637,PCNL,0,1
79638,),0,0
79639,in,0,0
79640,the,0,0
79641,treatment,0,0
79642,of,0,0
79643,renal,1,1
79644,calculi,1,1
79645,.,1,1
79646,PATIENTS,0,0
79647,AND,0,0
79648,METHODS,0,0
79649,Between,1,1
79650,November,1,1
79651,2005,1,1
79652,and,1,0
79653,March,1,1
79654,2006,1,1
79655,",",1,0
79656,48,1,1
79657,patients,1,1
79658,were,1,1
79659,randomized,1,1
79660,to,1,0
79661,either,1,0
79662,an,1,0
79663,18F,1,1
79664,Re-entry,1,0
79665,nephrostomy,1,1
79666,tube,1,0
79667,(,1,0
79668,group,1,0
79669,1,1,0
79670,),1,0
79671,or,1,1
79672,a,1,0
79673,6F,1,0
79674,Double-J,1,0
79675,stent,1,0
79676,(,1,0
79677,group,1,0
79678,2,1,1
79679,),1,0
79680,.,1,1
79681,The,0,0
79682,two,0,0
79683,groups,0,0
79684,were,0,1
79685,well,0,0
79686,matched,0,1
79687,for,0,0
79688,age,0,1
79689,",",0,0
79690,sex,0,0
79691,",",0,0
79692,stone,0,0
79693,size,0,0
79694,",",0,0
79695,stone,0,0
79696,laterality,0,0
79697,",",0,0
79698,and,0,0
79699,number,0,0
79700,of,0,0
79701,previous,0,0
79702,renal,0,1
79703,procedures,0,1
79704,.,0,1
79705,All,0,1
79706,PCNL,0,1
79707,procedures,0,0
79708,were,0,0
79709,performed,0,0
79710,by,0,0
79711,the,0,0
79712,same,0,0
79713,surgeon,0,1
79714,.,0,1
79715,Postoperative,0,0
79716,visual,0,0
79717,analog,0,0
79718,pain,0,1
79719,scale,0,0
79720,(,0,0
79721,VAS,0,0
79722,),0,0
79723,scores,0,0
79724,at,0,0
79725,8,0,0
79726,and,0,1
79727,24,0,1
79728,hours,0,0
79729,and,0,1
79730,14,0,1
79731,days,0,0
79732,after,0,0
79733,surgery,0,1
79734,",",0,0
79735,in-hospital,0,0
79736,analgesic,0,0
79737,use,0,0
79738,",",0,0
79739,length,0,0
79740,of,0,0
79741,hospital,0,1
79742,stay,0,0
79743,",",0,0
79744,success,0,0
79745,rate,0,0
79746,",",0,0
79747,blood,0,0
79748,transfusion,0,0
79749,rate,0,0
79750,",",0,0
79751,and,0,0
79752,postoperative,0,0
79753,complications,0,0
79754,were,0,1
79755,compared,0,0
79756,for,0,0
79757,the,0,0
79758,two,0,0
79759,groups,0,0
79760,.,0,1
79761,RESULTS,0,0
79762,The,0,0
79763,mean,0,0
79764,hospital,0,1
79765,stays,0,0
79766,in,0,1
79767,groups,0,0
79768,1,0,1
79769,and,0,1
79770,2,0,0
79771,were,0,0
79772,3.1,0,0
79773,and,0,1
79774,1.6,0,0
79775,days,0,0
79776,",",0,0
79777,respectively,0,0
79778,(,0,0
79779,P,0,0
79780,=,0,0
79781,0.003,0,0
79782,),0,0
79783,.,0,0
79784,The,0,0
79785,mean,0,0
79786,VAS,0,0
79787,scores,0,0
79788,8,0,0
79789,and,0,0
79790,24,0,1
79791,hours,0,0
79792,after,0,0
79793,surgery,0,1
79794,were,0,0
79795,significantly,0,0
79796,lower,0,0
79797,in,0,0
79798,group,0,0
79799,2,0,0
79800,than,0,0
79801,in,0,0
79802,group,0,1
79803,1,0,0
79804,(,0,0
79805,P,0,0
79806,=,0,0
79807,0.001,0,0
79808,),0,0
79809,.,0,0
79810,The,0,0
79811,postoperative,0,0
79812,analgesic,0,0
79813,requirement,0,1
79814,(,0,0
79815,diclofenac,0,0
79816,sodium,0,0
79817,),0,0
79818,was,0,0
79819,significantly,0,0
79820,higher,0,0
79821,in,0,0
79822,group,0,0
79823,1,0,0
79824,(,0,0
79825,263,0,1
79826,mg,0,0
79827,),0,0
79828,than,0,0
79829,in,0,0
79830,group,0,1
79831,2,0,0
79832,(,0,0
79833,120,0,1
79834,mg,0,0
79835,;,0,1
79836,P,0,0
79837,=,0,0
79838,0.02,0,0
79839,),0,0
79840,.,0,0
79841,The,0,0
79842,rate,0,0
79843,of,0,0
79844,blood,0,0
79845,transfusion,0,0
79846,in,0,0
79847,the,0,0
79848,two,0,0
79849,groups,0,0
79850,was,0,0
79851,similar,0,0
79852,(,0,1
79853,P,0,0
79854,=,0,0
79855,NS,0,0
79856,),0,0
79857,.,0,0
79858,There,0,0
79859,was,0,0
79860,no,0,0
79861,difference,0,0
79862,between,0,0
79863,the,0,0
79864,groups,0,0
79865,in,0,0
79866,VAS,0,1
79867,scores,0,0
79868,on,0,0
79869,postoperative,0,0
79870,day,0,1
79871,14,0,0
79872,.,0,0
79873,The,0,0
79874,number,0,0
79875,of,0,0
79876,supracostal,0,1
79877,accesses,0,1
79878,was,0,0
79879,significantly,0,0
79880,higher,0,0
79881,in,0,0
79882,group,0,0
79883,2,0,0
79884,than,0,0
79885,in,0,0
79886,group,0,1
79887,1,0,0
79888,(,0,0
79889,P,0,0
79890,=,0,0
79891,0.02,0,0
79892,),0,0
79893,.,0,0
79894,The,0,0
79895,stone-free,0,0
79896,rates,0,0
79897,and,0,1
79898,the,0,0
79899,numbers,0,0
79900,of,0,0
79901,patients,0,1
79902,with,0,1
79903,insignificant,0,0
79904,residual,0,0
79905,fragments,0,1
79906,were,0,1
79907,similar,0,0
79908,in,0,0
79909,the,0,0
79910,two,0,0
79911,groups,0,0
79912,.,0,0
79913,There,0,0
79914,was,0,0
79915,no,0,0
79916,urine,0,0
79917,leakage,0,0
79918,or,0,0
79919,formation,0,0
79920,of,0,0
79921,urinoma,0,0
79922,in,0,0
79923,patients,0,1
79924,with,0,1
79925,Double-J,0,0
79926,stents,0,1
79927,.,0,1
79928,CONCLUSION,0,0
79929,Tubeless,0,0
79930,PCNL,0,1
79931,is,0,0
79932,safe,0,0
79933,and,0,0
79934,effective,0,0
79935,even,0,0
79936,after,0,0
79937,supracostal,0,0
79938,access,0,0
79939,and,0,0
79940,is,0,0
79941,associated,0,0
79942,with,0,0
79943,less,0,0
79944,postoperative,0,0
79945,pain,0,0
79946,and,0,0
79947,a,0,0
79948,shorter,0,0
79949,hospital,0,1
79950,stay,0,0
79951,.,0,1
79952,Covariation,0,0
79953,of,0,0
79954,adolescent,1,1
79955,physical,1,0
79956,activity,1,0
79957,and,0,0
79958,dietary,0,0
79959,behaviors,0,0
79960,over,0,0
79961,12,0,1
79962,months,0,0
79963,.,0,1
79964,PURPOSE,0,0
79965,This,0,0
79966,study,0,0
79967,examined,0,0
79968,covariation,0,0
79969,among,0,0
79970,changes,0,0
79971,in,0,0
79972,dietary,0,0
79973,",",0,0
79974,physical,0,0
79975,activity,0,0
79976,",",0,0
79977,and,0,0
79978,sedentary,0,1
79979,behaviors,0,0
79980,over,0,0
79981,12,0,1
79982,months,0,0
79983,among,0,1
79984,adolescents,1,1
79985,participating,1,1
79986,in,1,0
79987,a,1,0
79988,health,1,0
79989,behavior,1,0
79990,intervention,1,0
79991,.,1,0
79992,Evidence,0,0
79993,of,0,0
79994,covariation,0,0
79995,among,0,0
79996,behaviors,0,0
79997,would,0,0
79998,suggest,0,0
79999,multi-behavior,0,0
80000,interventions,0,0
80001,could,0,0
80002,have,0,1
80003,synergistic,0,0
80004,effects,0,0
80005,.,0,1
80006,METHODS,0,0
80007,Prospective,0,0
80008,analyses,0,0
80009,were,0,1
80010,conducted,0,0
80011,with,0,1
80012,baseline,0,0
80013,and,0,0
80014,12-month,0,0
80015,assessments,0,0
80016,from,0,1
80017,a,0,0
80018,randomized,0,0
80019,controlled,0,0
80020,trial,0,0
80021,to,0,0
80022,promote,0,0
80023,improved,0,0
80024,diet,0,0
80025,",",0,0
80026,physical,0,0
80027,activity,0,0
80028,",",0,0
80029,and,0,0
80030,sedentary,0,1
80031,behaviors,0,0
80032,(,0,1
80033,experimental,0,0
80034,condition,0,0
80035,),0,0
80036,or,0,1
80037,SUN,0,1
80038,protection,0,0
80039,behaviors,0,0
80040,(,0,0
80041,comparison,0,0
80042,condition,0,0
80043,),0,1
80044,.,0,1
80045,Participants,1,1
80046,were,1,1
80047,adolescent,1,1
80048,girls,1,1
80049,and,1,1
80050,boys,1,1
80051,(,1,1
80052,N,1,1
80053,=,1,0
80054,878,1,1
80055,),1,0
80056,aged,1,1
80057,11-15,1,1
80058,years,1,1
80059,on,1,0
80060,entry,1,1
80061,.,1,0
80062,The,0,0
80063,main,0,0
80064,outcomes,0,0
80065,were,0,1
80066,:,0,1
80067,diet,0,0
80068,",",0,0
80069,based,0,0
80070,on,0,0
80071,multiple,0,0
80072,24-hour,0,1
80073,recalls,0,0
80074,(,0,1
80075,total,0,1
80076,fat,0,0
80077,",",0,0
80078,grams,0,0
80079,of,0,0
80080,fiber,0,0
80081,",",0,0
80082,servings,0,0
80083,of,0,0
80084,fruit,0,1
80085,and,0,0
80086,vegetables,0,0
80087,",",0,0
80088,total,0,1
80089,calories,0,1
80090,),0,1
80091,;,0,1
80092,average,0,0
80093,daily,0,0
80094,energy,0,0
80095,expenditure,0,0
80096,(,0,0
80097,kcals/kg,0,0
80098,),0,0
80099,based,0,0
80100,on,0,0
80101,7-day,0,0
80102,physical,0,0
80103,activity,0,0
80104,recall,0,0
80105,interviews,0,1
80106,;,0,1
80107,daily,0,0
80108,minutes,0,0
80109,of,0,1
80110,moderate-vigorous,0,1
80111,physical,0,0
80112,activity,0,0
80113,minutes,0,0
80114,from,0,1
80115,accelerometery,0,1
80116,;,0,0
80117,and,0,0
80118,self-reported,0,0
80119,daily,0,0
80120,hours,0,0
80121,of,0,0
80122,sedentary,0,1
80123,behavior,0,0
80124,.,0,1
80125,RESULTS,0,0
80126,Covariation,0,0
80127,was,0,0
80128,found,0,0
80129,between,0,0
80130,fat,0,0
80131,and,0,0
80132,calories,0,0
80133,(,0,0
80134,r,0,0
80135,=,0,0
80136,.16,0,0
80137,),0,0
80138,",",0,0
80139,fiber,0,0
80140,and,0,0
80141,calories,0,0
80142,(,0,0
80143,r,0,0
80144,=,0,0
80145,.53,0,0
80146,),0,0
80147,",",0,0
80148,fiber,0,0
80149,and,0,0
80150,fruit/vegetables,0,0
80151,(,0,0
80152,r,0,0
80153,=,0,0
80154,.53,0,0
80155,),0,0
80156,",",0,0
80157,calories,0,0
80158,and,0,0
80159,fruit/vegetables,0,0
80160,(,0,0
80161,r,0,0
80162,=,0,0
80163,.34,0,0
80164,),0,0
80165,",",0,0
80166,and,0,0
80167,fruit,0,1
80168,and,0,0
80169,vegetables,0,0
80170,and,0,0
80171,sedentary,0,1
80172,behavior,0,0
80173,(,0,0
80174,r,0,0
80175,=,0,0
80176,-.12,0,0
80177,),0,0
80178,for,0,0
80179,the,0,0
80180,total,0,1
80181,sample,0,1
80182,(,0,0
80183,all,0,0
80184,p,0,0
80185,values,0,0
80186,<,0,0
80187,.01,0,0
80188,),0,0
80189,.,0,0
80190,The,0,0
80191,pattern,0,0
80192,of,0,0
80193,findings,0,0
80194,was,0,0
80195,similar,0,0
80196,for,0,0
80197,most,0,0
80198,subgroups,0,0
80199,defined,0,0
80200,by,0,0
80201,gender,0,0
80202,and,0,0
80203,study,0,0
80204,condition,0,0
80205,.,0,0
80206,CONCLUSIONS,0,0
80207,The,0,0
80208,strongest,0,0
80209,covariation,0,0
80210,was,0,0
80211,observed,0,0
80212,for,0,0
80213,diet,0,1
80214,variables,0,0
80215,that,0,0
80216,are,0,0
80217,inherently,0,0
80218,related,0,0
80219,(,0,0
80220,calories,0,0
80221,and,0,0
80222,fat,0,0
80223,",",0,0
80224,fiber,0,0
80225,",",0,0
80226,and,0,0
80227,fruit/vegetables,0,0
80228,),0,1
80229,.,0,1
80230,Little,0,0
80231,covariation,0,0
80232,was,0,0
80233,detected,0,0
80234,within,0,0
80235,or,0,1
80236,between,0,0
80237,other,0,0
80238,diet,0,1
80239,",",0,0
80240,physical,0,0
80241,activity,0,0
80242,and,0,0
80243,sedentary,0,1
80244,behavior,0,0
80245,domains,0,0
80246,suggesting,0,0
80247,that,0,0
80248,interventions,0,0
80249,to,0,0
80250,improve,0,0
80251,these,0,0
80252,behaviors,0,0
80253,in,0,0
80254,adolescents,1,1
80255,need,0,0
80256,to,0,0
80257,include,0,0
80258,specific,0,0
80259,program,0,0
80260,components,0,0
80261,for,0,0
80262,each,0,0
80263,target,0,0
80264,behavior,0,0
80265,of,0,0
80266,interest,0,0
80267,.,0,1
80268,Cost-effectiveness,0,0
80269,of,0,0
80270,clopidogrel,0,1
80271,in,0,0
80272,acute,1,1
80273,coronary,1,1
80274,syndromes,1,0
80275,in,1,1
80276,Canada,1,1
80277,:,1,1
80278,a,0,0
80279,long-term,0,0
80280,analysis,0,0
80281,based,0,0
80282,on,0,0
80283,the,0,0
80284,CURE,0,0
80285,trial,0,0
80286,.,0,1
80287,BACKGROUND,0,0
80288,Cardiovascular,0,0
80289,diseases,0,1
80290,account,0,0
80291,for,0,0
80292,nearly,0,0
80293,20,0,0
80294,%,0,0
80295,of,0,0
80296,all,0,0
80297,hospitalizations,0,0
80298,in,0,0
80299,Canada,0,1
80300,and,0,0
80301,consume,0,1
80302,12,0,0
80303,%,0,0
80304,of,0,0
80305,the,0,0
80306,total,0,1
80307,cost,0,0
80308,of,0,0
80309,all,0,1
80310,illnesses,0,1
80311,.,0,0
80312,With,0,0
80313,increasing,0,0
80314,trends,0,0
80315,of,0,0
80316,cardiovascular,0,1
80317,disease,0,1
80318,and,0,0
80319,increasing,0,0
80320,costs,0,0
80321,of,0,0
80322,care,0,1
80323,",",0,0
80324,development,0,0
80325,of,0,0
80326,cost-effective,0,0
80327,strategies,0,0
80328,is,0,0
80329,vital,0,0
80330,.,0,0
80331,The,0,0
80332,Clopidogrel,0,0
80333,in,0,0
80334,Unstable,0,1
80335,angina,0,1
80336,to,0,0
80337,prevent,0,0
80338,Recurrent,0,1
80339,Events,0,0
80340,(,0,1
80341,CURE,0,1
80342,),0,0
80343,trial,0,0
80344,demonstrated,0,0
80345,the,0,0
80346,effectiveness,0,0
80347,of,0,0
80348,clopidogrel,0,1
80349,plus,0,0
80350,acetylsalicylic,0,0
80351,acid,0,0
80352,(,0,0
80353,ASA,0,1
80354,),0,0
80355,compared,0,0
80356,with,0,1
80357,ASA,0,0
80358,alone,0,0
80359,in,0,0
80360,reducing,0,0
80361,cardiovascular,0,1
80362,events,0,0
80363,in,0,1
80364,patients,1,1
80365,with,1,1
80366,acute,1,1
80367,coronary,1,1
80368,syndromes,1,0
80369,and,1,0
80370,",",1,0
80371,in,1,0
80372,addition,1,0
80373,",",1,0
80374,patients,1,1
80375,undergoing,1,1
80376,percutaneous,1,1
80377,coronary,1,1
80378,intervention,1,0
80379,in,1,0
80380,the,1,0
80381,Percutaneous,1,1
80382,Coronary,1,1
80383,Intervention,1,1
80384,in,1,0
80385,CURE,1,0
80386,(,1,1
80387,PCI-CURE,1,0
80388,),1,0
80389,trial,1,0
80390,.,1,0
80391,OBJECTIVE,0,0
80392,To,0,0
80393,assess,0,0
80394,the,0,0
80395,cost-effectiveness,0,0
80396,of,0,0
80397,clopidogrel,0,1
80398,in,0,0
80399,the,0,0
80400,Canadian,1,1
80401,health,1,0
80402,care,1,1
80403,system,1,0
80404,.,1,1
80405,METHODS,0,0
80406,Estimates,0,0
80407,of,0,0
80408,hospitalization,0,1
80409,costs,0,0
80410,were,0,0
80411,based,0,0
80412,on,0,0
80413,the,0,0
80414,2003,0,1
80415,cost,0,0
80416,schedules,0,0
80417,released,0,0
80418,by,0,0
80419,the,0,0
80420,Health,0,0
80421,Funding,0,0
80422,and,0,0
80423,Costing,0,0
80424,Branch,0,1
80425,of,0,0
80426,the,0,0
80427,Alberta,0,1
80428,Health,0,0
80429,and,0,0
80430,Wellness,0,0
80431,",",0,0
80432,as,0,0
80433,well,0,0
80434,as,0,0
80435,on,0,0
80436,the,0,0
80437,Case,0,0
80438,Mix,0,0
80439,Group,0,1
80440,classification,0,1
80441,system,0,0
80442,.,0,0
80443,Life,0,0
80444,expectancy,0,0
80445,beyond,0,0
80446,the,0,0
80447,trial,0,0
80448,was,0,0
80449,estimated,0,0
80450,from,0,0
80451,the,0,0
80452,Saskatchewan,0,1
80453,Health,0,0
80454,Database,0,1
80455,.,0,1
80456,Cost-effectiveness,0,0
80457,was,0,0
80458,expressed,0,0
80459,as,0,0
80460,the,0,0
80461,incremental,0,0
80462,cost-effectiveness,0,0
80463,ratio,0,0
80464,",",0,0
80465,and,0,0
80466,bootstrap,0,0
80467,methods,0,1
80468,were,0,0
80469,used,0,0
80470,to,0,0
80471,estimate,0,0
80472,the,0,0
80473,joint,0,0
80474,distribution,0,0
80475,of,0,0
80476,costs,0,0
80477,and,0,1
80478,effectiveness,0,0
80479,.,0,1
80480,RESULTS,0,0
80481,Clopidogrel,0,1
80482,was,0,0
80483,shown,0,0
80484,to,0,0
80485,be,0,0
80486,cost-effective,0,0
80487,",",0,0
80488,with,0,1
80489,incremental,0,0
80490,cost-effectiveness,0,0
80491,ratios,0,0
80492,less,0,0
80493,than,0,0
80494,$,0,0
80495,"10,000",0,0
80496,per,0,0
80497,event,0,0
80498,prevented,0,0
80499,and,0,0
80500,less,0,0
80501,than,0,0
80502,$,0,0
80503,"4,000",0,0
80504,per,0,0
80505,life-year,0,0
80506,gained,0,0
80507,.,0,0
80508,The,0,0
80509,probability,0,0
80510,of,0,0
80511,clopidogrel,0,1
80512,resulting,0,0
80513,in,0,0
80514,cost,0,0
80515,per,0,0
80516,life-year,0,0
80517,gained,0,0
80518,of,0,0
80519,less,0,0
80520,than,0,0
80521,$,0,0
80522,"20,000",0,0
80523,was,0,0
80524,0.975,0,0
80525,for,0,0
80526,CURE,1,1
80527,patients,1,1
80528,and,0,0
80529,0.904,0,0
80530,for,0,0
80531,PCI-CURE,1,1
80532,patients,1,1
80533,.,1,1
80534,CONCLUSIONS,0,0
80535,The,0,0
80536,economic,0,0
80537,analysis,0,0
80538,demonstrated,0,0
80539,that,0,0
80540,clopidogrel,0,1
80541,combination,0,0
80542,therapy,0,0
80543,is,0,0
80544,not,0,0
80545,only,0,0
80546,cost-effective,0,0
80547,as,0,0
80548,antiplatelet,0,1
80549,therapy,0,0
80550,compared,0,0
80551,with,0,1
80552,ASA,0,0
80553,alone,0,0
80554,",",0,0
80555,but,0,0
80556,it,0,0
80557,is,0,0
80558,also,0,0
80559,cost-effective,0,0
80560,compared,0,0
80561,with,0,1
80562,other,0,0
80563,commonly,0,1
80564,used,0,0
80565,and,0,0
80566,openly,0,0
80567,reimbursed,0,1
80568,cardiovascular,0,1
80569,therapies,0,0
80570,in,0,0
80571,the,0,0
80572,Canadian,0,1
80573,health,0,0
80574,care,0,1
80575,system,0,0
80576,.,0,1
80577,Comparison,0,0
80578,of,0,0
80579,two,0,0
80580,sedation,0,1
80581,techniques,0,0
80582,in,0,0
80583,patients,1,1
80584,undergoing,1,1
80585,surgical,1,1
80586,procedures,1,1
80587,under,1,0
80588,regional,1,1
80589,anaesthesia,1,1
80590,.,1,1
80591,OBJECTIVE,0,0
80592,Intraoperative,0,0
80593,comfort,0,0
80594,and,0,0
80595,patient,0,0
80596,satisfaction,0,0
80597,during,0,0
80598,surgical,0,1
80599,procedures,0,1
80600,under,0,0
80601,regional,0,0
80602,anaesthesia,0,1
80603,can,0,0
80604,be,0,0
80605,improved,0,0
80606,with,0,0
80607,the,0,0
80608,use,0,0
80609,of,0,0
80610,supplemental,0,0
80611,intravenous,0,0
80612,sedation,0,1
80613,.,0,0
80614,The,0,0
80615,authors,0,0
80616,conducted,0,0
80617,a,0,0
80618,study,0,0
80619,to,0,0
80620,compare,0,0
80621,two,0,0
80622,sedation,0,0
80623,techniques,0,0
80624,for,0,0
80625,surgical,0,1
80626,procedures,0,0
80627,performed,0,0
80628,under,0,0
80629,regional,0,0
80630,anaesthesia,0,1
80631,",",0,0
80632,i.e.,0,0
80633,",",0,0
80634,midazolam,0,0
80635,and,0,0
80636,pethidine,0,0
80637,combination,0,0
80638,compared,0,0
80639,with,0,1
80640,midazolam,0,0
80641,and,0,0
80642,tramadol,0,0
80643,combination,0,0
80644,.,0,1
80645,METHODS,0,0
80646,Forty,1,1
80647,adult,1,1
80648,American,1,1
80649,Society,1,1
80650,of,1,0
80651,Anaesthesiologists,1,1
80652,(,1,1
80653,ASA,1,1
80654,),1,0
80655,grade,1,1
80656,1-111,1,0
80657,patients,1,1
80658,",",1,0
80659,aged,1,1
80660,between,1,0
80661,40-65,1,1
80662,years,1,1
80663,undergoing,1,1
80664,surgery,1,1
80665,under,1,0
80666,regional,1,0
80667,anaesthesia,1,1
80668,(,1,0
80669,sub-arachnoid,1,1
80670,block,1,0
80671,),1,0
80672,were,1,0
80673,included,1,1
80674,.,1,0
80675,The,0,0
80676,patients,0,1
80677,were,0,0
80678,randomly,0,1
80679,divided,0,1
80680,into,0,0
80681,two,0,0
80682,groups,0,0
80683,.,0,1
80684,All,0,1
80685,patients,0,1
80686,received,0,0
80687,standardized,0,0
80688,premedication,0,0
80689,",",0,0
80690,intraoperative,0,0
80691,monitoring,0,0
80692,and,0,0
80693,oxygen,0,0
80694,therapy,0,0
80695,.,0,1
80696,Group,0,0
80697,A,0,1
80698,patients,0,1
80699,received,0,1
80700,midazolam,0,1
80701,0.03,0,0
80702,mg/kg,0,0
80703,followed,0,0
80704,by,0,0
80705,pethidine,0,0
80706,20,0,0
80707,mg,0,0
80708,intravenously,0,0
80709,",",0,0
80710,and,0,0
80711,group,0,0
80712,B,0,1
80713,patients,0,1
80714,received,0,1
80715,midazolam,0,1
80716,0.03,0,0
80717,mg/kg,0,0
80718,followed,0,0
80719,by,0,0
80720,tramadol,0,0
80721,20,0,0
80722,mg,0,0
80723,intravenously,0,0
80724,after,0,0
80725,the,0,0
80726,institution,0,1
80727,of,0,0
80728,regional,0,1
80729,anaesthesia,0,1
80730,.,0,1
80731,Monitoring,0,0
80732,included,0,0
80733,ECG,0,0
80734,",",0,0
80735,blood,0,0
80736,pressure,0,0
80737,",",0,0
80738,respiratory,0,0
80739,rate,0,0
80740,",",0,0
80741,oxygen,0,0
80742,saturation,0,0
80743,and,0,0
80744,sedation,0,0
80745,score,0,0
80746,.,0,0
80747,Complications,0,0
80748,",",0,0
80749,if,0,0
80750,any,0,0
80751,",",0,0
80752,were,0,0
80753,recorded,0,0
80754,.,0,0
80755,Monitoring,0,0
80756,was,0,0
80757,continued,0,0
80758,during,0,0
80759,the,0,0
80760,recovery,0,0
80761,room,0,0
80762,stay,0,0
80763,.,0,0
80764,All,0,0
80765,patients,0,1
80766,were,0,0
80767,interviewed,0,1
80768,in,0,0
80769,the,0,0
80770,evening,0,0
80771,and,0,0
80772,time,0,0
80773,of,0,0
80774,ambulation,0,0
80775,and,0,0
80776,rating,0,0
80777,of,0,0
80778,OR,0,0
80779,experience,0,0
80780,was,0,0
80781,noted,0,0
80782,.,0,1
80783,RESULTS,0,0
80784,Data,0,1
80785,analysis,0,0
80786,showed,0,0
80787,no,0,0
80788,significant,0,0
80789,difference,0,0
80790,between,0,0
80791,pethidine,0,0
80792,and,0,0
80793,tramadol,0,0
80794,for,0,0
80795,all,0,0
80796,the,0,0
80797,haemodynamic,0,0
80798,variables,0,0
80799,(,0,1
80800,p,0,0
80801,=,0,0
80802,>,0,1
80803,0.05,0,0
80804,),0,0
80805,.,0,0
80806,There,0,0
80807,was,0,0
80808,also,0,0
80809,no,0,0
80810,significant,0,0
80811,difference,0,0
80812,in,0,0
80813,patient,0,0
80814,'s,0,1
80815,and,0,0
80816,surgeon,0,1
80817,'s,0,1
80818,assessment,0,0
80819,of,0,0
80820,their,0,0
80821,experience,0,0
80822,.,0,1
80823,Complications,0,0
80824,and,0,0
80825,recovery,0,0
80826,characteristics,0,0
80827,also,0,0
80828,did,0,0
80829,not,0,0
80830,show,0,0
80831,any,0,0
80832,significant,0,0
80833,difference,0,0
80834,.,0,1
80835,CONCLUSION,0,0
80836,Midazolam-tramadol,0,0
80837,combination,0,0
80838,may,0,0
80839,be,0,0
80840,used,0,0
80841,as,0,0
80842,an,0,0
80843,alternative,0,0
80844,to,0,0
80845,midazolam-pethidine,0,0
80846,combination,0,0
80847,for,0,0
80848,sedation,0,0
80849,during,0,0
80850,surgical,0,1
80851,procedures,0,0
80852,performed,0,0
80853,under,0,0
80854,regional,0,1
80855,anaesthesia,0,1
80856,.,0,1
80857,Transthoracic,0,1
80858,versus,0,0
80859,transesophageal,0,1
80860,cardioversion,0,0
80861,of,0,0
80862,atrial,0,1
80863,fibrillation,0,1
80864,under,0,0
80865,light,0,1
80866,sedation,0,1
80867,:,0,1
80868,a,0,0
80869,prospective,0,0
80870,randomized,0,0
80871,trial,0,0
80872,.,0,0
80873,BACKGROUND,0,0
80874,Electrical,1,0
80875,cardioversion,1,1
80876,(,1,0
80877,ECV,1,1
80878,),1,0
80879,of,1,0
80880,atrial,1,1
80881,fibrillation,1,1
80882,(,1,0
80883,AF,1,0
80884,),1,0
80885,is,0,0
80886,limited,0,0
80887,by,0,0
80888,a,0,0
80889,5-10,0,0
80890,%,0,0
80891,failure,0,1
80892,rate,0,0
80893,and,0,0
80894,by,0,0
80895,the,0,0
80896,expense,0,0
80897,arising,0,0
80898,from,0,0
80899,a,0,0
80900,perceived,0,0
80901,need,0,0
80902,for,0,0
80903,general,0,1
80904,anesthesia,0,1
80905,.,0,0
80906,A,0,0
80907,transesophageal,0,0
80908,approach,0,0
80909,using,0,0
80910,light,0,0
80911,sedation,0,0
80912,has,0,0
80913,been,0,0
80914,proposed,0,0
80915,as,0,0
80916,a,0,0
80917,means,0,0
80918,of,0,0
80919,augmenting,0,0
80920,the,0,0
80921,success,0,0
80922,rate,0,0
80923,and,0,0
80924,avoiding,0,0
80925,the,0,0
80926,need,0,0
80927,for,0,0
80928,general,0,1
80929,anesthesia,0,1
80930,.,0,1
80931,We,0,0
80932,hypothesized,0,0
80933,that,0,0
80934,the,0,0
80935,high,0,0
80936,rate,0,0
80937,of,0,0
80938,success,0,0
80939,and,0,0
80940,the,0,0
80941,lower,0,0
80942,energy,0,0
80943,requirement,0,0
80944,associated,0,0
80945,with,0,1
80946,biphasic,0,0
80947,cardioversion,0,0
80948,might,0,0
80949,eliminate,0,0
80950,any,0,0
80951,advantage,0,0
80952,of,0,0
80953,the,0,0
80954,transesophageal,0,1
80955,approach,0,0
80956,.,0,1
80957,METHODS,0,0
80958,We,0,0
80959,randomly,0,1
80960,assigned,0,0
80961,60,1,1
80962,patients,1,1
80963,attending,1,1
80964,for,1,0
80965,ECV,1,1
80966,of,1,0
80967,persistent,1,1
80968,AF,1,1
80969,to,1,0
80970,a,1,0
80971,transesophageal,1,0
80972,or,1,0
80973,a,1,0
80974,transthoracic,1,1
80975,approach,1,0
80976,.,1,0
80977,Sedation,0,0
80978,of,0,0
80979,moderate,0,1
80980,depth,0,0
80981,was,0,0
80982,achieved,0,0
80983,with,0,1
80984,intravenous,0,1
80985,midazolam,0,0
80986,.,0,1
80987,The,0,0
80988,dose,0,0
80989,of,0,0
80990,midazolam,0,0
80991,was,0,0
80992,titrated,0,0
80993,in,0,0
80994,the,0,0
80995,same,0,0
80996,manner,0,0
80997,in,0,0
80998,both,0,0
80999,groups,0,0
81000,.,0,1
81001,RESULTS,0,0
81002,Sinus,0,0
81003,rhythm,0,1
81004,was,0,0
81005,restored,0,0
81006,in,0,0
81007,29/30,0,0
81008,patients,0,1
81009,(,0,1
81010,97,0,1
81011,%,0,0
81012,),0,0
81013,in,0,0
81014,each,0,0
81015,group,0,0
81016,using,0,0
81017,a,0,0
81018,similar,0,0
81019,number,0,0
81020,of,0,0
81021,shocks,0,0
81022,for,0,0
81023,both,0,0
81024,groups,0,0
81025,(,0,0
81026,1.3,0,0
81027,+/-,0,0
81028,0.6,0,0
81029,transesophageal,0,1
81030,vs,0,0
81031,1.4,0,0
81032,+/-,0,0
81033,0.7,0,0
81034,transthoracic,0,1
81035,",",0,0
81036,P,0,0
81037,=,0,0
81038,NS,0,0
81039,),0,0
81040,with,0,1
81041,a,0,0
81042,similar,0,0
81043,procedure,0,0
81044,duration,0,0
81045,(,0,0
81046,14.1,0,0
81047,+/-,0,0
81048,8.2,0,0
81049,minutes,0,0
81050,vs,0,0
81051,13.8,0,1
81052,+/-,0,0
81053,7.5,0,0
81054,minutes,0,0
81055,",",0,1
81056,P,0,0
81057,=,0,0
81058,NS,0,0
81059,),0,0
81060,.,0,0
81061,Both,0,0
81062,groups,0,0
81063,received,0,0
81064,similar,0,0
81065,doses,0,0
81066,of,0,0
81067,midazolam,0,1
81068,(,0,0
81069,4.2,0,0
81070,+/-,0,0
81071,2.7,0,0
81072,mg,0,0
81073,vs,0,0
81074,4.4,0,0
81075,+/-,0,0
81076,2.8,0,0
81077,mg,0,0
81078,",",0,0
81079,P,0,0
81080,=,0,0
81081,NS,0,0
81082,),0,0
81083,and,0,0
81084,both,0,0
81085,reported,0,0
81086,a,0,0
81087,similar,0,0
81088,discomfort,0,0
81089,score,0,0
81090,in,0,0
81091,(,0,0
81092,0.9,0,0
81093,+/-,0,0
81094,1.3,0,0
81095,vs,0,0
81096,1.1,0,1
81097,+/-,0,0
81098,1.8,0,0
81099,",",0,0
81100,P,0,0
81101,=,0,0
81102,NS,0,0
81103,),0,0
81104,.,0,0
81105,No,0,0
81106,complication,0,0
81107,occurred,0,0
81108,in,0,0
81109,either,0,0
81110,group,0,0
81111,.,0,0
81112,CONCLUSION,0,0
81113,AF,0,0
81114,may,0,0
81115,be,0,0
81116,cardioverted,0,0
81117,safely,0,0
81118,and,0,0
81119,effectively,0,0
81120,by,0,0
81121,either,0,0
81122,a,0,0
81123,transthoracic,0,1
81124,or,0,0
81125,a,0,0
81126,transesophageal,0,1
81127,approach,0,0
81128,.,0,0
81129,The,0,0
81130,use,0,0
81131,of,0,0
81132,sedation,0,0
81133,of,0,0
81134,moderate,0,1
81135,depth,0,0
81136,renders,0,0
81137,cardioversion,0,1
81138,by,0,0
81139,either,0,0
81140,approach,0,0
81141,acceptable,0,0
81142,.,0,0
81143,As,0,0
81144,transesophageal,0,0
81145,ECV,0,0
81146,shows,0,0
81147,no,0,0
81148,clear,0,0
81149,advantage,0,0
81150,",",0,0
81151,transthoracic,0,1
81152,cardioversion,0,0
81153,should,0,0
81154,remain,0,0
81155,the,0,0
81156,approach,0,0
81157,of,0,0
81158,first,0,0
81159,choice,0,1
81160,.,0,1
81161,Short-term,0,0
81162,aerobic,0,1
81163,exercise,0,0
81164,training,0,0
81165,in,0,0
81166,obese,1,1
81167,humans,1,1
81168,with,1,1
81169,type,1,1
81170,2,1,1
81171,diabetes,1,1
81172,mellitus,1,1
81173,improves,0,0
81174,whole-body,0,0
81175,insulin,0,0
81176,sensitivity,0,0
81177,through,0,0
81178,gains,0,0
81179,in,0,0
81180,peripheral,0,0
81181,",",0,0
81182,not,0,0
81183,hepatic,0,0
81184,insulin,0,0
81185,sensitivity,0,0
81186,.,0,0
81187,CONTEXT,0,0
81188,Short-term,0,0
81189,aerobic,0,0
81190,exercise,0,0
81191,training,0,0
81192,can,0,0
81193,improve,0,0
81194,whole-body,0,0
81195,insulin,0,0
81196,sensitivity,0,0
81197,in,0,0
81198,humans,1,0
81199,with,1,1
81200,type,1,1
81201,2,1,1
81202,diabetes,1,1
81203,mellitus,1,1
81204,;,1,0
81205,however,0,0
81206,",",0,0
81207,the,0,0
81208,contributions,0,0
81209,of,0,0
81210,peripheral,0,1
81211,and,0,1
81212,hepatic,0,1
81213,tissues,0,0
81214,to,0,0
81215,these,0,0
81216,improvements,0,0
81217,are,0,0
81218,not,0,0
81219,known,0,0
81220,.,0,0
81221,OBJECTIVE,0,0
81222,Our,0,0
81223,objective,0,0
81224,was,0,0
81225,to,0,0
81226,determine,0,0
81227,the,0,0
81228,effect,0,0
81229,of,0,0
81230,7-d,0,0
81231,aerobic,0,1
81232,exercise,0,0
81233,training,0,0
81234,on,0,0
81235,peripheral,0,1
81236,and,0,0
81237,hepatic,0,0
81238,insulin,0,0
81239,sensitivity,0,0
81240,during,0,0
81241,isoglycemic/hyperinsulinemic,0,0
81242,clamp,0,0
81243,conditions,0,0
81244,.,0,1
81245,DESIGN,0,0
81246,Subjects,0,1
81247,were,0,1
81248,randomly,0,1
81249,assigned,0,1
81250,to,0,0
81251,one,0,1
81252,of,0,0
81253,two,0,1
81254,groups,0,0
81255,.,0,1
81256,The,0,0
81257,energy,0,0
81258,balance,0,0
81259,group,0,0
81260,consumed,0,0
81261,an,0,0
81262,isocaloric,0,0
81263,diet,0,0
81264,consisting,0,1
81265,of,0,0
81266,50,0,1
81267,%,0,0
81268,carbohydrate,0,0
81269,",",0,0
81270,30,0,0
81271,%,0,0
81272,fat,0,0
81273,",",0,0
81274,and,0,0
81275,20,0,0
81276,%,0,0
81277,protein,0,0
81278,for,0,0
81279,15,0,1
81280,d.,0,1
81281,The,0,0
81282,energy,0,0
81283,balance,0,0
81284,plus,0,0
81285,exercise,0,0
81286,group,0,0
81287,consumed,0,0
81288,a,0,0
81289,similar,0,0
81290,diet,0,0
81291,over,0,0
81292,the,0,0
81293,15,0,0
81294,d,0,0
81295,and,0,0
81296,performed,0,0
81297,50-min,0,0
81298,of,0,0
81299,treadmill,0,0
81300,walking,0,0
81301,at,0,0
81302,70,0,1
81303,%,0,0
81304,of,0,0
81305,maximum,0,0
81306,oxygen,0,0
81307,consumption,0,0
81308,maximum,0,0
81309,during,0,0
81310,the,0,0
81311,second,0,0
81312,7,0,0
81313,d,0,0
81314,of,0,0
81315,the,0,0
81316,15-d,0,0
81317,study,0,0
81318,period,0,0
81319,.,0,0
81320,Each,0,0
81321,subject,0,0
81322,underwent,0,1
81323,an,0,0
81324,initial,0,0
81325,isoglycemic/hyperinsulinemic,0,0
81326,clamp,0,0
81327,after,0,0
81328,1-wk,0,0
81329,dietary,0,0
81330,control,0,1
81331,and,0,0
81332,a,0,0
81333,second,0,0
81334,clamp,0,0
81335,after,0,0
81336,completing,0,0
81337,the,0,0
81338,study,0,0
81339,.,0,0
81340,SETTING,0,0
81341,The,1,0
81342,study,1,0
81343,was,1,0
81344,performed,1,0
81345,at,1,0
81346,Ohio,1,1
81347,State,1,0
81348,University,1,1
81349,'s,1,1
81350,General,1,1
81351,Clinical,1,0
81352,Research,1,1
81353,Center,1,1
81354,.,1,0
81355,PARTICIPANTS,0,0
81356,There,1,0
81357,were,1,0
81358,18,1,0
81359,obese,1,1
81360,",",1,0
81361,mildly,1,1
81362,diabetic,1,1
81363,humans,1,0
81364,included,1,1
81365,in,1,0
81366,the,1,0
81367,study,1,0
81368,.,1,0
81369,INTERVENTION,0,0
81370,Aerobic,0,1
81371,exercise,0,0
81372,training,0,0
81373,was,0,0
81374,performed,0,0
81375,for,0,0
81376,7,0,0
81377,d.,0,1
81378,MAIN,0,0
81379,OUTCOME,0,0
81380,MEASURES,0,0
81381,Whole-body,0,0
81382,",",0,0
81383,peripheral,0,0
81384,",",0,0
81385,and,0,0
81386,hepatic,0,0
81387,insulin,0,0
81388,sensitivity,0,0
81389,were,0,0
81390,measured,0,0
81391,.,0,1
81392,RESULTS,0,0
81393,Exercise,0,0
81394,training,0,0
81395,did,0,0
81396,not,0,0
81397,have,0,0
81398,an,0,0
81399,impact,0,0
81400,on,0,0
81401,peripheral,0,1
81402,glucose,0,0
81403,uptake,0,0
81404,or,0,1
81405,endogenous,0,0
81406,glucose,0,0
81407,production,0,0
81408,during,0,0
81409,the,0,0
81410,basal,0,0
81411,state,0,0
81412,or,0,1
81413,low-dose,0,0
81414,insulin,0,0
81415,.,0,0
81416,Likewise,0,0
81417,",",0,0
81418,it,0,0
81419,did,0,0
81420,not,0,0
81421,alter,0,0
81422,endogenous,0,0
81423,glucose,0,0
81424,production,0,0
81425,during,0,0
81426,high-dose,0,0
81427,insulin,0,0
81428,.,0,0
81429,However,0,0
81430,",",0,0
81431,1-wk,0,0
81432,of,0,0
81433,exercise,0,0
81434,training,0,0
81435,increased,0,0
81436,both,0,0
81437,whole-body,0,0
81438,(,0,0
81439,P,0,0
81440,<,0,0
81441,0.05,0,0
81442,),0,0
81443,and,0,0
81444,peripheral,0,0
81445,insulin,0,0
81446,sensitivity,0,0
81447,(,0,0
81448,P,0,0
81449,<,0,0
81450,0.0001,0,0
81451,),0,0
81452,during,0,0
81453,high-dose,0,0
81454,insulin,0,0
81455,.,0,1
81456,CONCLUSION,0,0
81457,Improvements,0,0
81458,to,0,1
81459,whole,0,0
81460,body,0,1
81461,insulin,0,0
81462,sensitivity,0,0
81463,after,0,0
81464,short-term,0,0
81465,aerobic,0,1
81466,exercise,0,0
81467,training,0,0
81468,are,0,0
81469,due,0,0
81470,to,0,0
81471,gains,0,0
81472,in,0,0
81473,peripheral,0,0
81474,",",0,0
81475,not,0,0
81476,heptic,0,1
81477,insulin,0,0
81478,sensitivity,0,0
81479,.,0,1
81480,Risperidone,0,0
81481,versus,0,0
81482,haloperidol,0,0
81483,in,1,0
81484,children,1,1
81485,and,1,1
81486,adolescents,1,1
81487,with,1,1
81488,AD,1,1
81489,:,0,1
81490,a,0,0
81491,randomized,0,0
81492,",",0,0
81493,controlled,0,0
81494,",",0,0
81495,double-blind,0,0
81496,trial,0,0
81497,.,0,0
81498,OBJECTIVE,0,0
81499,The,0,0
81500,aim,0,0
81501,of,0,0
81502,the,0,0
81503,study,0,0
81504,was,0,0
81505,to,0,0
81506,compare,0,0
81507,safety,0,0
81508,",",0,0
81509,efficacy,0,0
81510,and,0,0
81511,tolerability,0,0
81512,of,0,0
81513,risperidone,0,0
81514,with,0,1
81515,haloperidol,0,0
81516,in,0,0
81517,the,0,0
81518,treatment,0,0
81519,of,0,0
81520,Autistic,1,1
81521,Disorder,1,1
81522,(,1,1
81523,AD,1,0
81524,),1,1
81525,.,0,0
81526,METHOD,0,0
81527,This,0,0
81528,study,0,0
81529,was,0,0
81530,designed,0,0
81531,as,0,0
81532,a,0,0
81533,double-blind,0,0
81534,",",0,0
81535,prospective,0,0
81536,",",0,0
81537,for,0,0
81538,a,0,0
81539,12-week,0,0
81540,period,0,0
81541,.,0,0
81542,A,1,0
81543,total,1,1
81544,of,1,0
81545,30,1,1
81546,subjects,1,1
81547,",",1,0
81548,between,1,0
81549,the,1,0
81550,ages,1,1
81551,of,1,0
81552,8,1,1
81553,and,1,0
81554,18,1,1
81555,with,1,1
81556,AD,1,0
81557,based,1,0
81558,on,1,0
81559,DSM,1,1
81560,IV,1,1
81561,criteria,1,1
81562,",",1,0
81563,were,1,0
81564,included,1,0
81565,in,1,0
81566,the,1,0
81567,study,1,0
81568,.,1,0
81569,Behavioral,0,0
81570,Rating,0,0
81571,Scales,0,0
81572,were,0,1
81573,performed,0,0
81574,by,0,0
81575,the,0,0
81576,investigators,0,0
81577,and,0,0
81578,the,0,0
81579,parents,0,1
81580,.,0,1
81581,Safety,0,0
81582,assessment,0,0
81583,included,0,1
81584,vital,0,0
81585,signs,0,0
81586,",",0,0
81587,electrocardiogram,0,0
81588,",",0,0
81589,electroencephalogram,0,0
81590,",",0,0
81591,adverse,0,0
81592,events,0,0
81593,",",0,0
81594,laboratory,0,0
81595,tests,0,0
81596,",",0,0
81597,extrapyramidal,0,0
81598,symptoms,0,0
81599,and,0,0
81600,the,0,0
81601,side,0,0
81602,effects,0,0
81603,.,0,1
81604,Both,0,0
81605,treatments,0,0
81606,were,0,0
81607,applied,0,0
81608,in,0,0
81609,a,0,0
81610,once,0,0
81611,daily,0,0
81612,dosage,0,0
81613,regimen,0,0
81614,of,0,0
81615,0.01-0.08,0,0
81616,mg/kg/day,0,0
81617,.,0,0
81618,RESULTS,0,0
81619,The,0,0
81620,reduction,0,0
81621,from,0,0
81622,baseline,0,0
81623,in,0,0
81624,Ritvo-Freeman,0,0
81625,Real,0,1
81626,Life,0,0
81627,Rating,0,0
81628,Scale,0,0
81629,(,0,0
81630,RF-RLRS,0,0
81631,),0,0
81632,",",0,0
81633,sensory,0,0
81634,motor,0,0
81635,(,0,0
81636,subscale,0,0
81637,I,0,1
81638,),0,0
81639,and,0,0
81640,language,0,0
81641,(,0,0
81642,subscale,0,0
81643,V,0,0
81644,),0,1
81645,scores,0,0
81646,were,0,1
81647,significant,0,0
81648,in,0,0
81649,risperidone,0,0
81650,group,0,0
81651,(,0,0
81652,P,0,0
81653,<,0,0
81654,0.05,0,0
81655,),0,1
81656,.,0,0
81657,Compared,0,0
81658,to,0,0
81659,haloperidol,0,0
81660,",",0,0
81661,risperidone,0,0
81662,led,0,0
81663,to,0,0
81664,a,0,0
81665,significantly,0,0
81666,greater,0,0
81667,reduction,0,0
81668,in,0,0
81669,the,0,0
81670,Aberrant,0,1
81671,Behavior,0,1
81672,Checklist,0,0
81673,(,0,0
81674,ABC,0,0
81675,),0,0
81676,and,0,0
81677,Turgay,0,1
81678,DSM-IV,0,1
81679,Pervasive,0,1
81680,Developmental,0,1
81681,Disorder,0,1
81682,(,0,0
81683,PDD,0,0
81684,),0,0
81685,scale,0,0
81686,scores,0,0
81687,(,0,1
81688,P,0,0
81689,<,0,0
81690,0.05,0,0
81691,and,0,0
81692,P,0,0
81693,<,0,0
81694,0.01,0,0
81695,),0,0
81696,.,0,0
81697,There,0,0
81698,was,0,0
81699,a,0,0
81700,greater,0,0
81701,increase,0,0
81702,of,0,0
81703,prolactin,0,0
81704,in,0,0
81705,the,0,0
81706,risperidone,0,0
81707,group,0,0
81708,",",0,0
81709,while,0,0
81710,alanine,0,0
81711,amino,0,0
81712,transferase,0,0
81713,(,0,0
81714,ALT,0,1
81715,),0,0
81716,had,0,0
81717,further,0,0
81718,increased,0,0
81719,in,0,0
81720,the,0,0
81721,haloperidol,0,0
81722,group,0,0
81723,.,0,0
81724,Sensory,0,0
81725,motor,0,0
81726,behaviors,0,0
81727,(,0,0
81728,subscale,0,0
81729,I,0,1
81730,),0,0
81731,and,0,0
81732,language,0,0
81733,at,0,0
81734,the,0,0
81735,end,0,0
81736,of,0,0
81737,the,0,0
81738,12th,0,0
81739,week,0,0
81740,",",0,0
81741,RF-RLRS,0,0
81742,sensory,0,0
81743,motor,0,0
81744,and,0,0
81745,language,0,0
81746,subscale,0,0
81747,scores,0,0
81748,decreased,0,0
81749,in,0,0
81750,the,0,0
81751,risperidone,0,0
81752,group,0,0
81753,further,0,0
81754,than,0,0
81755,the,0,0
81756,other,0,0
81757,group,0,0
81758,(,0,0
81759,P,0,0
81760,<,0,0
81761,0.05,0,0
81762,),0,1
81763,.,0,1
81764,CONCLUSIONS,0,0
81765,Risperidone,0,0
81766,was,0,0
81767,found,0,0
81768,to,0,0
81769,be,0,0
81770,more,0,0
81771,effective,0,0
81772,than,0,0
81773,haloperidol,0,0
81774,in,0,0
81775,the,0,0
81776,treatment,0,0
81777,of,0,0
81778,behavioral,0,0
81779,symptoms,0,0
81780,",",0,0
81781,impulsivity,0,0
81782,",",0,0
81783,language,0,0
81784,skills,0,0
81785,",",0,0
81786,and,0,0
81787,impaired,0,1
81788,social,0,0
81789,relations,0,0
81790,in,0,1
81791,children,1,1
81792,with,1,1
81793,AD,1,0
81794,.,1,1
81795,These,0,0
81796,results,0,0
81797,demonstrated,0,0
81798,that,0,0
81799,both,0,0
81800,drugs,0,0
81801,were,0,0
81802,safe,0,0
81803,and,0,0
81804,well,0,0
81805,tolerated,0,0
81806,in,0,0
81807,the,0,0
81808,treatment,0,0
81809,of,0,0
81810,AD,0,0
81811,.,0,1
81812,Can,0,0
81813,analysis,0,0
81814,of,0,0
81815,the,0,0
81816,bispectral,0,0
81817,index,0,0
81818,prove,0,0
81819,helpful,0,0
81820,when,0,0
81821,monitoring,0,0
81822,titration,0,0
81823,of,0,0
81824,doses,0,0
81825,of,0,0
81826,midazolam,0,0
81827,and,0,0
81828,ketamine,0,0
81829,for,0,0
81830,sedation,0,0
81831,during,0,0
81832,paediatric,1,1
81833,cardiac,1,1
81834,catheterization,1,1
81835,.,1,0
81836,OBJECTIVE,0,0
81837,We,0,0
81838,investigated,0,0
81839,the,0,0
81840,use,0,0
81841,of,0,0
81842,the,0,0
81843,bispectral,0,0
81844,index,0,0
81845,for,0,0
81846,monitoring,0,0
81847,sedation,0,0
81848,during,0,0
81849,cardiac,0,1
81850,catheterization,0,1
81851,.,0,0
81852,The,0,0
81853,scores,0,0
81854,for,0,0
81855,the,0,0
81856,bispectral,0,0
81857,index,0,0
81858,may,0,0
81859,not,0,0
81860,reflect,0,0
81861,correct,0,0
81862,values,0,0
81863,in,0,1
81864,children,0,1
81865,",",0,0
81866,but,0,0
81867,may,0,0
81868,be,0,0
81869,helpful,0,0
81870,during,0,0
81871,titration,0,0
81872,of,0,0
81873,sedatives,0,0
81874,such,0,0
81875,as,0,0
81876,midazolam,0,0
81877,and,0,0
81878,ketamine,0,0
81879,.,0,0
81880,METHODS,0,0
81881,We,0,0
81882,conducted,0,0
81883,a,0,0
81884,prospective,0,0
81885,randomized,0,0
81886,clinical,0,0
81887,trial,0,0
81888,in,0,0
81889,126,1,1
81890,patients,1,1
81891,scheduled,1,1
81892,for,1,0
81893,cardiac,1,1
81894,catheterization,1,1
81895,in,1,0
81896,a,1,0
81897,teaching,1,1
81898,hospital,1,1
81899,.,1,1
81900,They,1,0
81901,ranged,1,0
81902,in,1,0
81903,age,1,1
81904,from,1,1
81905,4,1,0
81906,months,1,0
81907,to,1,1
81908,15,1,1
81909,years,1,1
81910,.,1,1
81911,In,0,0
81912,66,0,1
81913,patients,0,1
81914,",",0,0
81915,sedation,0,0
81916,was,0,0
81917,performed,0,0
81918,without,0,1
81919,use,0,0
81920,of,0,0
81921,the,0,0
81922,bispectral,0,0
81923,index,0,0
81924,",",0,0
81925,while,0,0
81926,the,0,0
81927,index,0,0
81928,was,0,0
81929,used,0,0
81930,in,0,0
81931,the,0,0
81932,other,0,0
81933,60,0,1
81934,patients,0,1
81935,.,0,1
81936,The,0,0
81937,data,0,0
81938,collected,0,0
81939,included,0,1
81940,heart,0,1
81941,rate,0,0
81942,",",0,0
81943,mean,0,0
81944,arterial,0,0
81945,pressure,0,0
81946,",",0,0
81947,respiratory,0,0
81948,rate,0,0
81949,",",0,0
81950,saturation,0,0
81951,of,0,0
81952,oxygen,0,0
81953,",",0,0
81954,amount,0,0
81955,of,0,0
81956,sedatives,0,0
81957,",",0,0
81958,awakening,0,0
81959,time,0,0
81960,and,0,0
81961,adverse,0,0
81962,effects,0,0
81963,.,0,1
81964,We,0,0
81965,subdivided,0,1
81966,the,0,0
81967,patients,0,1
81968,into,0,1
81969,age-related,0,0
81970,groups,0,0
81971,for,0,0
81972,each,0,1
81973,parameter,0,0
81974,.,0,0
81975,RESULTS,0,0
81976,The,0,0
81977,demographic,0,0
81978,data,0,0
81979,were,0,0
81980,not,0,0
81981,statistically,0,0
81982,different,0,0
81983,.,0,0
81984,Monitoring,0,0
81985,with,0,0
81986,the,0,0
81987,bispectral,0,0
81988,index,0,0
81989,in,0,0
81990,those,0,0
81991,aged,0,1
81992,from,0,0
81993,1,0,0
81994,to,0,1
81995,3,0,1
81996,years,0,1
81997,revealed,0,0
81998,use,0,0
81999,of,0,0
82000,lower,0,0
82001,doses,0,0
82002,of,0,0
82003,midazolam,0,0
82004,",",0,0
82005,at,0,0
82006,2.09,0,0
82007,mg,0,0
82008,per,0,0
82009,kg,0,1
82010,per,0,0
82011,hr,0,0
82012,",",0,0
82013,with,0,1
82014,standard,0,0
82015,deviation,0,0
82016,of,0,0
82017,0.36,0,0
82018,",",0,0
82019,and,0,0
82020,similarly,0,0
82021,lowers,0,0
82022,doses,0,0
82023,of,0,0
82024,ketamine,0,0
82025,",",0,0
82026,at,0,0
82027,2.07,0,0
82028,mg,0,0
82029,per,0,0
82030,kg,0,1
82031,per,0,0
82032,hr,0,0
82033,",",0,0
82034,with,0,1
82035,standard,0,0
82036,deviation,0,0
82037,of,0,0
82038,0.22,0,0
82039,",",0,0
82040,the,0,0
82041,values,0,0
82042,in,0,0
82043,those,0,1
82044,not,0,0
82045,monitored,0,0
82046,being,0,0
82047,2.93,0,0
82048,",",0,0
82049,with,0,1
82050,standard,0,0
82051,deviation,0,0
82052,of,0,0
82053,0.45,0,0
82054,",",0,0
82055,and,0,0
82056,2.96,0,0
82057,with,0,1
82058,standard,0,0
82059,deviation,0,0
82060,of,0,0
82061,0.51,0,0
82062,respectively,0,0
82063,",",0,0
82064,these,0,0
82065,difference,0,0
82066,being,0,0
82067,statistically,0,0
82068,significant,0,0
82069,(,0,0
82070,p,0,0
82071,=,0,0
82072,0.001,0,0
82073,and,0,0
82074,p,0,0
82075,=,0,0
82076,0.04,0,0
82077,",",0,0
82078,respectively,0,0
82079,),0,0
82080,.,0,0
82081,In,0,0
82082,those,0,0
82083,aged,1,1
82084,from,1,0
82085,3,1,0
82086,to,1,1
82087,6,1,0
82088,years,1,1
82089,of,1,0
82090,age,1,1
82091,",",0,0
82092,dosage,0,0
82093,of,0,0
82094,midazolam,0,0
82095,was,0,0
82096,2.09,0,0
82097,",",0,0
82098,with,0,1
82099,deviation,0,0
82100,of,0,0
82101,0.36,0,0
82102,",",0,0
82103,and,0,0
82104,of,0,0
82105,ketamine,0,0
82106,1.78,0,0
82107,",",0,0
82108,with,0,1
82109,deviation,0,0
82110,of,0,0
82111,0.27,0,0
82112,",",0,0
82113,following,0,0
82114,use,0,0
82115,of,0,0
82116,the,0,0
82117,bispectral,0,0
82118,index,0,0
82119,",",0,0
82120,compared,0,0
82121,to,0,0
82122,2.89,0,0
82123,with,0,1
82124,deviation,0,0
82125,of,0,0
82126,0.28,0,0
82127,",",0,0
82128,and,0,0
82129,2.62,0,0
82130,with,0,1
82131,deviation,0,0
82132,of,0,0
82133,0.69,0,0
82134,respectively,0,0
82135,",",0,0
82136,when,0,0
82137,the,0,0
82138,bispectral,0,0
82139,index,0,0
82140,was,0,0
82141,not,0,0
82142,used,0,0
82143,",",0,0
82144,these,0,0
82145,again,0,0
82146,being,0,0
82147,significant,0,0
82148,differences,0,0
82149,(,0,1
82150,p,0,0
82151,=,0,0
82152,0.033,0,0
82153,and,0,0
82154,p,0,0
82155,=,0,0
82156,0.04,0,0
82157,),0,0
82158,.,0,1
82159,The,0,0
82160,requirements,0,0
82161,for,0,0
82162,respiratory,0,1
82163,support,0,0
82164,and,0,0
82165,adverse,0,0
82166,effects,0,0
82167,were,0,0
82168,also,0,0
82169,significantly,0,0
82170,lower,0,0
82171,when,0,0
82172,using,0,0
82173,the,0,0
82174,bispectral,0,0
82175,index,0,0
82176,(,0,0
82177,p,0,0
82178,less,0,0
82179,than,0,0
82180,0.05,0,0
82181,),0,1
82182,.,0,0
82183,No,0,0
82184,significant,0,0
82185,difference,0,0
82186,was,0,0
82187,found,0,0
82188,regarding,0,0
82189,dosages,0,0
82190,at,0,1
82191,the,0,0
82192,ages,0,1
82193,of,0,0
82194,4,0,0
82195,months,0,0
82196,to,0,1
82197,1,0,0
82198,year,0,0
82199,",",0,0
82200,and,0,0
82201,6,0,0
82202,to,0,0
82203,15,0,1
82204,years,0,1
82205,.,0,1
82206,The,0,0
82207,awakening,0,0
82208,time,0,0
82209,",",0,0
82210,however,0,0
82211,",",0,0
82212,was,0,0
82213,shorter,0,0
82214,with,0,1
82215,use,0,0
82216,of,0,0
82217,the,0,0
82218,index,0,0
82219,in,0,0
82220,those,0,0
82221,aged,0,1
82222,from,0,0
82223,1,0,0
82224,to,0,1
82225,6,0,0
82226,years,0,1
82227,.,0,1
82228,CONCLUSIONS,0,0
82229,When,0,0
82230,using,0,0
82231,the,0,0
82232,bispectral,0,0
82233,index,0,0
82234,for,0,0
82235,monitoring,0,0
82236,sedation,0,0
82237,during,0,0
82238,catheterization,0,1
82239,in,0,0
82240,children,1,1
82241,",",0,0
82242,we,0,0
82243,noted,0,0
82244,decreased,0,0
82245,need,0,0
82246,for,0,0
82247,doses,0,0
82248,of,0,0
82249,midazolam,0,0
82250,and,0,0
82251,ketamine,0,0
82252,",",0,0
82253,a,0,0
82254,lower,0,0
82255,need,0,0
82256,for,0,0
82257,respiratory,0,1
82258,support,0,0
82259,and,0,0
82260,less,0,0
82261,adverse,0,0
82262,effects,0,0
82263,.,0,1
82264,The,0,0
82265,effect,0,0
82266,of,0,0
82267,coenzyme,0,0
82268,Q10,0,0
82269,on,0,0
82270,microcirculatory,0,0
82271,endothelial,0,0
82272,function,0,0
82273,of,0,0
82274,subjects,1,1
82275,with,1,1
82276,type,1,1
82277,2,1,1
82278,diabetes,1,1
82279,mellitus,1,1
82280,.,1,1
82281,Impact,0,0
82282,of,0,0
82283,a,0,0
82284,controlled,0,0
82285,heated,0,0
82286,breathing,0,0
82287,tube,0,0
82288,humidifier,0,0
82289,on,0,0
82290,sleep,0,0
82291,quality,0,0
82292,during,0,0
82293,CPAP,1,0
82294,therapy,1,0
82295,in,1,0
82296,a,1,0
82297,cool,1,0
82298,sleeping,1,0
82299,environment,1,0
82300,.,1,0
82301,There,0,0
82302,are,0,0
82303,conflicting,0,0
82304,data,0,0
82305,on,0,0
82306,the,0,0
82307,effect,0,0
82308,of,0,0
82309,adding,0,0
82310,a,0,0
82311,heated,0,0
82312,humidifier,0,0
82313,to,0,0
82314,nasal,0,0
82315,continuous,0,0
82316,positive,0,0
82317,airway,0,1
82318,pressure,0,0
82319,(,0,0
82320,CPAP,0,1
82321,),0,0
82322,therapy,0,0
82323,for,0,0
82324,patients,1,1
82325,with,1,1
82326,obstructive,1,1
82327,sleep,1,1
82328,apnoea,1,1
82329,syndrome,1,1
82330,(,1,0
82331,OSAS,1,0
82332,),1,0
82333,.,1,0
82334,The,0,0
82335,effects,0,0
82336,of,0,0
82337,heated,0,0
82338,humidification,0,0
82339,on,0,0
82340,sleep,0,0
82341,quality,0,0
82342,and,0,0
82343,treatment,0,0
82344,side-effects,0,0
82345,for,0,1
82346,patients,0,1
82347,who,0,1
82348,prefer,0,1
82349,a,0,1
82350,cold,0,0
82351,bedroom,0,0
82352,environment,0,0
82353,have,0,0
82354,not,0,0
82355,been,0,0
82356,studied,0,0
82357,.,0,0
82358,A,0,0
82359,randomised,0,0
82360,",",0,0
82361,controlled,0,0
82362,crossover,0,0
82363,trial,0,0
82364,involving,0,1
82365,19,1,1
82366,patients,1,1
82367,with,1,1
82368,a,1,0
82369,first-ever,1,1
82370,diagnosis,1,1
82371,of,1,0
82372,OSAS,1,0
82373,measured,0,0
82374,the,0,0
82375,effect,0,0
82376,of,0,0
82377,conventional,0,0
82378,heated,0,0
82379,humidification,0,0
82380,added,0,0
82381,to,0,0
82382,CPAP,0,0
82383,compared,0,0
82384,with,0,1
82385,a,0,0
82386,controlled,0,0
82387,heated,0,0
82388,breathing,0,0
82389,tube,0,0
82390,humidifier,0,0
82391,(,0,0
82392,ThermoSmart,0,0
82393,(,0,0
82394,R,0,1
82395,),0,1
82396,;,0,0
82397,Fisher,0,0
82398,and,0,0
82399,Paykel,0,1
82400,Healthcare,0,0
82401,",",0,0
82402,Auckland,0,1
82403,",",0,0
82404,New,0,1
82405,Zealand,0,1
82406,),0,0
82407,on,0,0
82408,sleep,0,1
82409,quality,0,0
82410,.,0,0
82411,During,0,0
82412,the,0,0
82413,night,0,0
82414,in,0,0
82415,the,0,0
82416,sleep,0,0
82417,laboratory,0,0
82418,at,0,0
82419,a,0,0
82420,mean,0,0
82421,room,0,0
82422,temperature,0,0
82423,of,0,0
82424,14,0,1
82425,degrees,0,0
82426,C,0,0
82427,",",0,0
82428,less,0,0
82429,condensation,0,0
82430,formed,0,0
82431,with,0,1
82432,the,0,0
82433,controlled,0,0
82434,heated,0,0
82435,breathing,0,0
82436,tube,0,0
82437,humidifier,0,0
82438,(,0,0
82439,1.9,0,0
82440,mL,0,0
82441,versus,0,0
82442,35.3,0,0
82443,mL,0,0
82444,),0,0
82445,in,0,0
82446,the,0,0
82447,delivery,0,0
82448,system,0,0
82449,.,0,0
82450,In,0,0
82451,addition,0,0
82452,",",0,0
82453,the,0,0
82454,total,0,1
82455,sleep,0,0
82456,time,0,0
82457,",",0,0
82458,time,0,0
82459,spent,0,0
82460,in,0,0
82461,sleep,0,1
82462,stages,0,1
82463,3,0,1
82464,and,0,1
82465,4,0,0
82466,",",0,0
82467,and,0,0
82468,rapid,0,0
82469,eye,0,0
82470,movement,0,0
82471,sleep,0,1
82472,phases,0,0
82473,were,0,0
82474,significantly,0,0
82475,longer,0,0
82476,and,0,0
82477,the,0,0
82478,overall,0,0
82479,side-effect,0,0
82480,score,0,0
82481,was,0,0
82482,lower,0,0
82483,than,0,0
82484,with,0,1
82485,conventional,0,1
82486,heated,0,0
82487,humidification,0,1
82488,.,0,1
82489,Patients,0,1
82490,on,0,0
82491,nasal,0,1
82492,continuous,0,0
82493,positive,0,0
82494,airway,0,1
82495,pressure,0,0
82496,desiring,0,1
82497,a,0,0
82498,cool,0,0
82499,bedroom,0,0
82500,temperature,0,0
82501,could,0,0
82502,benefit,0,0
82503,from,0,0
82504,controlled,0,0
82505,heated,0,0
82506,breathing,0,0
82507,tube,0,0
82508,humidification,0,0
82509,technology,0,0
82510,(,0,0
82511,with,0,1
82512,inputs,0,0
82513,from,0,1
82514,ambient,0,0
82515,temperature,0,0
82516,",",0,0
82517,set,0,0
82518,pressure,0,0
82519,and,0,0
82520,flow,0,0
82521,),0,0
82522,.,0,1
82523,Randomized,0,0
82524,",",0,0
82525,comparative,0,0
82526,study,0,0
82527,of,0,0
82528,the,0,0
82529,efficacy,0,0
82530,and,0,0
82531,safety,0,0
82532,of,0,0
82533,artesunate,0,0
82534,plus,0,0
82535,amodiaquine,0,0
82536,",",0,0
82537,administered,0,0
82538,as,0,0
82539,a,0,0
82540,single,0,0
82541,daily,0,0
82542,intake,0,0
82543,versus,0,0
82544,two,0,0
82545,daily,0,0
82546,intakes,0,0
82547,in,0,0
82548,the,0,0
82549,treatment,0,0
82550,of,0,0
82551,uncomplicated,1,1
82552,falciparum,1,1
82553,malaria,1,1
82554,.,1,1
82555,BACKGROUND,0,0
82556,Artesunate,0,0
82557,plus,0,0
82558,amodiaquine,0,0
82559,is,0,0
82560,a,0,0
82561,coblistered,0,0
82562,ACT,0,0
82563,",",0,0
82564,given,0,0
82565,as,0,0
82566,a,0,0
82567,single,0,0
82568,daily,0,0
82569,intake,0,0
82570,.,0,0
82571,It,0,0
82572,has,0,0
82573,been,0,0
82574,suggested,0,0
82575,that,0,0
82576,",",0,0
82577,in,0,0
82578,view,0,0
82579,of,0,0
82580,the,0,0
82581,number,0,0
82582,of,0,0
82583,tablets,0,0
82584,to,0,0
82585,be,0,0
82586,taken,0,0
82587,(,0,0
82588,particularly,0,0
82589,in,0,0
82590,adults,0,1
82591,),0,0
82592,",",0,0
82593,it,0,0
82594,may,0,0
82595,be,0,0
82596,possible,0,0
82597,to,0,0
82598,improve,0,0
82599,compliance,0,0
82600,by,0,0
82601,allowing,0,0
82602,patients,0,1
82603,to,0,0
82604,divide,0,0
82605,the,0,0
82606,daily,0,0
82607,dose,0,0
82608,.,0,0
82609,The,0,0
82610,objectives,0,0
82611,of,0,0
82612,this,0,0
82613,randomized,0,0
82614,",",0,0
82615,comparative,0,0
82616,",",0,0
82617,open-label,0,0
82618,",",0,0
82619,multicentre,1,0
82620,study,1,0
82621,",",1,0
82622,conducted,1,0
82623,in,1,0
82624,Senegal,1,1
82625,and,1,0
82626,in,1,0
82627,Cameroon,1,1
82628,in,1,0
82629,2005,1,1
82630,",",0,0
82631,was,0,0
82632,to,0,0
82633,demonstrate,0,0
82634,the,0,0
82635,non-inferiority,0,0
82636,and,0,0
82637,to,0,0
82638,compare,0,0
82639,the,0,0
82640,safety,0,0
82641,of,0,0
82642,artesunate,0,0
82643,plus,0,0
82644,amodiaquine,0,0
82645,",",0,0
82646,as,0,0
82647,a,0,0
82648,single,0,0
82649,daily,0,0
82650,intake,0,0
82651,versus,0,0
82652,two,0,0
82653,daily,0,0
82654,intakes,0,0
82655,.,0,1
82656,METHODS,0,0
82657,A,0,0
82658,three-day,0,0
82659,treatment,0,0
82660,period,0,0
82661,and,0,0
82662,14-day,0,0
82663,follow-up,0,0
82664,period,0,0
82665,was,0,0
82666,performed,0,0
82667,in,0,0
82668,any,1,0
82669,subject,1,0
82670,weighting,1,0
82671,more,1,0
82672,than,1,0
82673,10,1,0
82674,kg,1,0
82675,",",1,0
82676,presenting,1,1
82677,with,1,0
82678,a,1,0
82679,malaria,1,1
82680,paroxysm,1,0
82681,confirmed,1,0
82682,by,1,0
82683,parasitaemia,1,0
82684,>,1,1
82685,or,1,1
82686,=,1,0
82687,"1,000/microl",1,0
82688,",",1,0
82689,after,1,0
82690,informed,1,0
82691,consent,1,1
82692,.,1,1
82693,Patients,0,1
82694,were,0,0
82695,randomly,0,1
82696,allocated,0,1
82697,into,0,0
82698,one,0,0
82699,of,0,0
82700,the,0,0
82701,two,0,0
82702,regimens,0,0
82703,",",0,0
82704,with,0,1
82705,dosage,0,0
82706,according,0,1
82707,to,0,0
82708,bodyweight,0,0
82709,range,0,1
82710,.,0,0
82711,All,0,0
82712,products,0,0
82713,were,0,0
82714,administered,0,0
82715,by,0,0
82716,an,0,0
82717,authorized,0,1
82718,person,0,0
82719,",",0,0
82720,blinded,0,0
82721,to,0,0
82722,both,0,0
82723,the,0,0
82724,investigating,0,0
82725,physician,0,0
82726,and,0,0
82727,the,0,0
82728,biologist,0,0
82729,.,0,0
82730,The,0,0
82731,primary,0,0
82732,endpoint,0,0
82733,was,0,0
82734,an,0,0
82735,adequate,0,0
82736,response,0,0
82737,to,0,0
82738,treatment,0,0
82739,on,0,0
82740,D14,0,0
82741,(,0,0
82742,WHO,0,0
82743,definition,0,0
82744,),0,0
82745,.,0,0
82746,The,0,0
82747,two-sided,0,0
82748,90,0,0
82749,%,0,0
82750,confidence,0,0
82751,interval,0,0
82752,of,0,0
82753,the,0,0
82754,difference,0,0
82755,was,0,0
82756,calculated,0,0
82757,on,0,0
82758,intent,0,0
82759,to,0,0
82760,treat,0,0
82761,(,0,0
82762,ITT,0,0
82763,),0,1
82764,population,0,1
82765,;,0,0
82766,the,0,0
82767,acceptance,0,0
82768,limit,0,0
82769,for,0,0
82770,non-inferiority,0,0
82771,was,0,0
82772,3,0,0
82773,%,0,0
82774,.,0,0
82775,The,0,0
82776,safety,0,0
82777,was,0,0
82778,evaluated,0,0
82779,by,0,0
82780,incidence,0,0
82781,of,0,0
82782,adverse,0,0
82783,events,0,0
82784,.,0,1
82785,RESULTS,0,0
82786,Three-hundred,1,1
82787,and,1,0
82788,sixteen,1,1
82789,patients,1,1
82790,were,1,1
82791,included,1,1
82792,in,1,0
82793,the,1,0
82794,study,1,0
82795,.,1,0
82796,The,0,0
82797,two,0,0
82798,patient,0,1
82799,groups,0,0
82800,were,0,0
82801,strictly,0,0
82802,comparable,0,0
82803,on,0,0
82804,D0,0,0
82805,.,0,1
82806,The,0,0
82807,adequate,0,0
82808,responses,0,0
82809,to,0,1
82810,treatment,0,0
82811,were,0,0
82812,similar,0,0
82813,for,0,0
82814,the,0,0
82815,two,0,0
82816,treatment,0,0
82817,regimens,0,0
82818,on,0,0
82819,D14,0,1
82820,",",0,0
82821,PCR-corrected,0,0
82822,(,0,0
82823,"99,4",0,0
82824,%,0,0
82825,in,0,0
82826,the,0,0
82827,one-daily,0,0
82828,intake,0,0
82829,group,0,0
82830,versus,0,0
82831,"99,3",0,0
82832,%,0,0
82833,in,0,0
82834,the,0,0
82835,comparative,0,0
82836,group,0,0
82837,),0,0
82838,.,0,0
82839,The,0,0
82840,statistical,0,0
82841,analyses,0,0
82842,demonstrated,0,0
82843,the,0,0
82844,non-inferiority,0,0
82845,of,0,0
82846,administering,0,0
82847,artesunate/amodiaquine,0,0
82848,as,0,0
82849,two,0,0
82850,intakes,0,0
82851,.,0,1
82852,The,0,0
82853,drug,0,0
82854,was,0,0
82855,well,0,0
82856,tolerated,0,0
82857,.,0,0
82858,The,0,0
82859,main,0,0
82860,adverse,0,0
82861,events,0,0
82862,were,0,1
82863,gastrointestinal,0,1
82864,disorders,0,1
82865,(,0,1
82866,2.5,0,0
82867,%,0,0
82868,),0,0
82869,and,0,0
82870,pruritus,0,0
82871,(,0,0
82872,2.5,0,0
82873,%,0,0
82874,),0,1
82875,;,0,0
82876,safety,0,0
82877,profiles,0,0
82878,were,0,1
82879,similar,0,0
82880,in,0,0
82881,the,0,0
82882,two,0,0
82883,groups,0,0
82884,.,0,1
82885,CONCLUSION,0,0
82886,This,0,0
82887,pilot,0,0
82888,study,0,0
82889,confirms,0,0
82890,the,0,0
82891,efficacy,0,0
82892,and,0,0
82893,good,0,0
82894,tolerability,0,0
82895,of,0,0
82896,artesunate,0,0
82897,plus,0,0
82898,amodiaquine,0,0
82899,",",0,0
82900,administrated,0,0
82901,either,0,0
82902,in,0,0
82903,one,0,0
82904,or,0,1
82905,in,0,0
82906,two,0,0
82907,daily,0,0
82908,intakes,0,1
82909,.,0,1
82910,Comparison,0,0
82911,of,0,0
82912,the,0,0
82913,therapeutic,0,0
82914,effects,0,0
82915,of,0,0
82916,epoetin,0,0
82917,zeta,0,0
82918,to,0,0
82919,epoetin,0,0
82920,alfa,0,0
82921,in,0,0
82922,the,0,0
82923,maintenance,1,0
82924,phase,1,0
82925,of,1,0
82926,renal,1,1
82927,anaemia,1,1
82928,treatment,1,0
82929,.,1,0
82930,OBJECTIVE,0,0
82931,To,0,0
82932,evaluate,0,0
82933,the,0,0
82934,therapeutic,0,0
82935,efficacy,0,0
82936,and,0,0
82937,safety,0,0
82938,of,0,0
82939,epoetin,0,0
82940,zeta,0,0
82941,",",0,0
82942,compared,0,0
82943,with,0,1
82944,epoetin,0,0
82945,alfa,0,0
82946,",",0,0
82947,in,0,0
82948,maintaining,0,0
82949,target,0,0
82950,haemoglobin,0,1
82951,(,0,0
82952,Hb,0,0
82953,),0,1
82954,concentrations,0,0
82955,in,0,0
82956,patients,1,1
82957,with,1,1
82958,anaemia,1,1
82959,and,1,0
82960,chronic,1,1
82961,kidney,1,1
82962,disease,1,1
82963,(,1,0
82964,CKD,1,1
82965,),1,0
82966,maintained,1,0
82967,on,1,0
82968,haemodialysis,1,1
82969,.,1,1
82970,METHODS,0,0
82971,Patients,0,1
82972,received,0,1
82973,epoetin,0,0
82974,zeta,0,0
82975,or,0,1
82976,epoetin,0,0
82977,alfa,0,0
82978,intravenously,0,0
82979,",",0,0
82980,1-3,0,0
82981,times/week,0,0
82982,for,0,0
82983,12,0,0
82984,weeks,0,0
82985,",",0,0
82986,then,0,0
82987,the,0,0
82988,alternative,0,0
82989,treatment,0,0
82990,for,0,0
82991,12,0,0
82992,weeks,0,0
82993,",",0,0
82994,in,0,0
82995,this,0,0
82996,double-blind,0,0
82997,",",0,0
82998,crossover,0,0
82999,",",0,0
83000,phase,0,0
83001,III,0,1
83002,trial,0,0
83003,.,0,1
83004,Eligible,1,0
83005,patients,1,1
83006,were,1,1
83007,18-75,1,1
83008,years,1,1
83009,old,1,1
83010,with,1,1
83011,CKD,1,1
83012,stage,1,1
83013,5,1,0
83014,maintained,1,0
83015,on,1,0
83016,haemodialysis,1,0
83017,.,1,1
83018,Patients,0,1
83019,had,0,0
83020,received,0,0
83021,epoetin,0,0
83022,for,0,0
83023,>,0,1
83024,or,0,1
83025,=,0,0
83026,3,0,0
83027,months,0,0
83028,upon,0,0
83029,study,0,1
83030,entry,0,0
83031,and,0,0
83032,had,0,0
83033,achieved,0,0
83034,a,0,0
83035,target,0,0
83036,Hb,0,0
83037,level,0,0
83038,of,0,0
83039,10.5-12.5,0,0
83040,g/dL,0,0
83041,with,0,1
83042,a,0,0
83043,stable,0,1
83044,epoetin,0,0
83045,dose,0,0
83046,.,0,1
83047,MAIN,0,0
83048,OUTCOME,0,0
83049,MEASURES,0,0
83050,Primary,0,1
83051,efficacy,0,0
83052,endpoints,0,0
83053,were,0,1
83054,intra-individual,0,0
83055,differences,0,0
83056,(,0,1
83057,test-reference,0,0
83058,),0,0
83059,in,0,0
83060,mean,0,1
83061,Hb,0,0
83062,levels,0,0
83063,and,0,1
83064,mean,0,1
83065,weekly,0,0
83066,dose/kg,0,0
83067,of,0,0
83068,body,0,1
83069,weight,0,0
83070,.,0,0
83071,Safety,0,0
83072,endpoints,0,0
83073,included,0,1
83074,occurrence,0,0
83075,of,0,0
83076,neutralizing,0,0
83077,anti-erythro,0,0
83078,poietin,0,0
83079,antibodies,0,0
83080,",",0,0
83081,tolerability,0,0
83082,",",0,0
83083,and,0,0
83084,adverse,0,0
83085,events,0,0
83086,(,0,1
83087,AEs,0,0
83088,),0,1
83089,.,0,0
83090,RESULTS,0,0
83091,In,1,0
83092,total,1,1
83093,",",1,1
83094,313,1,1
83095,patients,1,1
83096,were,1,1
83097,randomized,1,1
83098,to,0,0
83099,receive,0,0
83100,epoetin,0,0
83101,zeta,0,0
83102,(,0,0
83103,n,0,1
83104,=,0,0
83105,155,0,1
83106,),0,0
83107,or,0,1
83108,epoetin,0,0
83109,alfa,0,0
83110,(,0,0
83111,n,0,1
83112,=,0,0
83113,158,0,1
83114,),0,1
83115,;,0,1
83116,146,0,1
83117,and,0,0
83118,145,0,1
83119,patients,0,1
83120,(,0,0
83121,respectively,0,0
83122,),0,0
83123,switched,0,0
83124,treatment,0,0
83125,after,0,0
83126,12,0,1
83127,weeks,0,0
83128,.,0,1
83129,Mean,0,1
83130,(,0,0
83131,range,0,1
83132,),0,0
83133,Hb,0,0
83134,levels,0,0
83135,were,0,1
83136,11.35,0,0
83137,(,0,1
83138,8.96-14.22,0,0
83139,),0,0
83140,g/dL,0,0
83141,and,0,0
83142,11.54,0,0
83143,(,0,0
83144,8.74-13.84,0,0
83145,),0,0
83146,g/dL,0,0
83147,for,0,0
83148,patients,0,1
83149,receiving,0,1
83150,epoetin,0,0
83151,zeta,0,0
83152,and,0,0
83153,epoetin,0,0
83154,alfa,0,0
83155,",",0,0
83156,respectively,0,0
83157,(,0,0
83158,95,0,0
83159,%,0,0
83160,confidence,0,0
83161,interval,0,0
83162,[,0,0
83163,CI,0,0
83164,],0,1
83165,[,0,0
83166,test-reference,0,0
83167,],0,1
83168,:,0,1
83169,0.09-0.28,0,0
83170,g/dL,0,0
83171,",",0,0
83172,within,0,0
83173,the,0,0
83174,predefined,0,0
83175,equivalence,0,0
83176,range,0,1
83177,of,0,0
83178,+/-0.6,0,0
83179,g/dL,0,0
83180,),0,0
83181,.,0,0
83182,Mean,0,0
83183,(,0,0
83184,range,0,1
83185,),0,0
83186,weekly,0,0
83187,doses,0,0
83188,were,0,1
83189,92.68,0,0
83190,(,0,0
83191,12.74-398.41,0,0
83192,),0,0
83193,IU/kg/wk,0,0
83194,and,0,0
83195,92.58,0,0
83196,(,0,0
83197,10.53-393.07,0,0
83198,),0,0
83199,IU/kg/wk,0,0
83200,for,0,0
83201,patients,0,1
83202,receiving,0,1
83203,epoetin,0,0
83204,zeta,0,0
83205,and,0,0
83206,epoetin,0,0
83207,alfa,0,0
83208,",",0,0
83209,respectively,0,0
83210,(,0,0
83211,95,0,0
83212,%,0,0
83213,CI,0,0
83214,[,0,0
83215,test-reference,0,0
83216,],0,0
83217,:,0,1
83218,-4.67,0,0
83219,and,0,0
83220,4.29,0,0
83221,IU/kg/wk,0,0
83222,",",0,0
83223,within,0,0
83224,the,0,0
83225,equivalence,0,0
83226,range,0,0
83227,of,0,0
83228,+/-45.00,0,0
83229,IU/kg/wk,0,0
83230,),0,1
83231,.,0,0
83232,Patients,0,1
83233,underwent,0,1
83234,minor,0,0
83235,nominal,0,0
83236,dose,0,0
83237,adjustments,0,0
83238,during,0,0
83239,treatment,0,0
83240,crossover,0,1
83241,.,0,0
83242,AE,0,0
83243,profile,0,0
83244,was,0,0
83245,similar,0,0
83246,for,0,0
83247,both,0,0
83248,products,0,0
83249,;,0,0
83250,the,0,0
83251,most,0,0
83252,commonly,0,0
83253,reported,0,0
83254,AEs,0,0
83255,were,0,1
83256,infections,0,1
83257,and,0,1
83258,infestations,0,0
83259,(,0,1
83260,in,0,0
83261,26.5,0,0
83262,%,0,0
83263,of,0,0
83264,patients,0,1
83265,receiving,0,1
83266,epoetin,0,0
83267,zeta,0,0
83268,and,0,0
83269,23.6,0,0
83270,%,0,0
83271,receiving,0,1
83272,epoetin,0,0
83273,alfa,0,0
83274,),0,0
83275,.,0,0
83276,No,0,0
83277,patients,0,1
83278,developed,0,0
83279,neutralizing,0,1
83280,anti-erythropoietin,0,0
83281,antibodies,0,0
83282,.,0,1
83283,CONCLUSIONS,0,0
83284,Epoetin,0,0
83285,zeta,0,0
83286,is,0,0
83287,therapeutically,0,0
83288,equivalent,0,0
83289,to,0,0
83290,epoetin,0,0
83291,alfa,0,0
83292,in,0,0
83293,the,0,0
83294,maintenance,0,0
83295,of,0,0
83296,target,0,0
83297,Hb,0,0
83298,levels,0,0
83299,in,0,0
83300,patients,1,1
83301,with,1,1
83302,renal,1,1
83303,anaemia,1,1
83304,.,1,0
83305,No,0,0
83306,unexpected,0,0
83307,AEs,0,0
83308,were,0,1
83309,seen,0,0
83310,.,0,1
83311,The,0,0
83312,impact,0,0
83313,of,0,0
83314,fasting,0,0
83315,and,0,0
83316,treatment,0,0
83317,omission,0,0
83318,on,0,0
83319,susceptibility,0,0
83320,to,0,0
83321,hypoglycaemia,0,0
83322,in,0,0
83323,children,1,1
83324,and,1,1
83325,adolescents,1,1
83326,with,1,1
83327,GH,1,0
83328,and,1,0
83329,cortisol,1,0
83330,insufficiency,1,1
83331,.,1,1
83332,OBJECTIVE,0,0
83333,Hypoglycaemia,0,0
83334,may,0,0
83335,be,0,0
83336,a,0,0
83337,frequent,0,0
83338,occurrence,0,0
83339,in,0,0
83340,young,1,1
83341,GH,1,0
83342,deficient,1,1
83343,patients,1,1
83344,and,0,0
83345,so,0,0
83346,we,0,0
83347,studied,0,0
83348,the,0,0
83349,response,0,0
83350,to,0,0
83351,fasting,0,0
83352,in,0,0
83353,children,1,1
83354,and,1,1
83355,adolescents,1,1
83356,with,1,1
83357,GH,1,0
83358,and/or,1,0
83359,cortisol,1,0
83360,deficiency,1,1
83361,.,1,1
83362,METHODS,0,0
83363,A,1,0
83364,total,1,1
83365,of,1,0
83366,20,1,1
83367,patients,1,1
83368,(,1,1
83369,2-18,1,1
83370,years,1,1
83371,),1,1
83372,fasted,1,1
83373,for,1,0
83374,14,1,0
83375,h,1,0
83376,(,1,0
83377,22.00-12.00,1,0
83378,h,1,0
83379,),1,0
83380,on,1,0
83381,two,1,0
83382,occasions,1,0
83383,as,0,0
83384,part,0,1
83385,of,0,0
83386,a,0,0
83387,randomized,0,0
83388,cross-over,0,0
83389,study,0,1
83390,.,0,1
83391,Fourteen,1,1
83392,had,1,0
83393,pituitary,1,1
83394,hormone,1,0
83395,deficiency,1,1
83396,(,1,0
83397,PHD,1,0
83398,),1,0
83399,including,1,0
83400,GH,1,0
83401,deficiency,1,1
83402,(,1,0
83403,GHD,1,0
83404,),1,0
83405,.,1,0
83406,Of,1,0
83407,the,1,0
83408,14,1,0
83409,patients,1,1
83410,",",1,1
83411,seven,1,1
83412,were,1,0
83413,ACTH,1,1
83414,sufficient,1,0
83415,(,1,0
83416,PHDC+,1,1
83417,),1,0
83418,and,1,0
83419,seven,1,1
83420,ACTH,1,1
83421,deficient,1,1
83422,(,1,0
83423,PHDC-,1,0
83424,),1,1
83425,.,1,1
83426,Six,1,0
83427,had,1,0
83428,primary,1,1
83429,adrenal,1,1
83430,failure,1,1
83431,(,1,0
83432,PAF,1,1
83433,),1,1
83434,.,1,0
83435,Subjects,0,1
83436,administered,0,0
83437,or,0,1
83438,omitted,0,0
83439,their,0,0
83440,normal,0,1
83441,dose,0,0
83442,of,0,0
83443,evening,0,0
83444,GH,0,0
83445,and/or,0,0
83446,morning,0,0
83447,hydrocortisone,0,0
83448,.,0,0
83449,Glucose,0,0
83450,",",0,0
83451,insulin,0,0
83452,",",0,0
83453,GH,0,0
83454,",",0,0
83455,cortisol,0,0
83456,",",0,0
83457,ketones,0,0
83458,and,0,1
83459,catecholamines,0,1
83460,were,0,0
83461,measured,0,0
83462,at,0,0
83463,04.00,0,0
83464,h,0,0
83465,and,0,0
83466,regularly,0,0
83467,from,0,0
83468,07.00,0,0
83469,to,0,1
83470,12.00,0,0
83471,h.,0,1
83472,Insulin,0,1
83473,sensitivity,0,0
83474,was,0,0
83475,assessed,0,0
83476,by,0,0
83477,HOMA,0,0
83478,and,0,0
83479,hypoglycaemia,0,0
83480,defined,0,0
83481,as,0,0
83482,a,0,0
83483,blood,0,0
83484,glucose,0,0
83485,(,0,0
83486,BG,0,1
83487,),0,0
83488,<,0,0
83489,/=,0,1
83490,3.3,0,0
83491,mmol/l,0,0
83492,.,0,1
83493,RESULTS,0,0
83494,BG,0,1
83495,was,0,0
83496,related,0,0
83497,to,0,0
83498,age,0,1
83499,and,0,0
83500,body,0,0
83501,mass,0,0
83502,index,0,0
83503,on,0,0
83504,treatment,0,0
83505,but,0,0
83506,no,0,0
83507,subject,0,0
83508,became,0,0
83509,hypoglycaemic,0,0
83510,on,0,0
83511,or,0,1
83512,off,0,0
83513,therapy,0,0
83514,prior,0,1
83515,to,0,0
83516,07.00,0,0
83517,h.,0,1
83518,Five,0,1
83519,children,0,1
83520,(,0,1
83521,aged,0,1
83522,3,0,0
83523,",",0,0
83524,4,0,0
83525,",",0,0
83526,7,0,0
83527,",",0,0
83528,8,0,0
83529,and,0,0
83530,11,0,1
83531,years,0,1
83532,),0,1
83533,were,0,1
83534,hypoglycaemic,0,0
83535,between,0,0
83536,07.00,0,0
83537,and,0,1
83538,12.00,0,0
83539,h,0,0
83540,off,0,0
83541,treatment,0,0
83542,.,0,0
83543,There,0,0
83544,was,0,0
83545,a,0,0
83546,positive,0,0
83547,relationship,0,0
83548,between,0,0
83549,GH,0,0
83550,AUC,0,0
83551,and,0,0
83552,minimum,0,0
83553,BG,0,1
83554,in,0,0
83555,patients,0,1
83556,with,0,1
83557,PHD,0,1
83558,on,0,0
83559,treatment,0,0
83560,(,0,0
83561,r,0,0
83562,(,0,0
83563,2,0,0
83564,),0,1
83565,=,0,0
83566,0.45,0,0
83567,",",0,0
83568,P,0,0
83569,=,0,0
83570,0.012,0,0
83571,),0,0
83572,with,0,1
83573,increased,0,0
83574,insulin,0,0
83575,sensitivity,0,0
83576,off,0,0
83577,treatment,0,0
83578,.,0,0
83579,Increased,0,0
83580,cortisol,0,0
83581,levels,0,0
83582,were,0,0
83583,seen,0,0
83584,in,0,0
83585,PHDC+,0,1
83586,patients,0,1
83587,off,0,0
83588,GH,0,0
83589,(,0,0
83590,P,0,0
83591,<,0,0
83592,0.001,0,0
83593,),0,0
83594,.,0,0
83595,A,0,0
83596,negative,0,0
83597,relationship,0,0
83598,was,0,0
83599,observed,0,0
83600,between,0,0
83601,minimum,0,0
83602,BG,0,1
83603,and,0,0
83604,adrenaline,0,0
83605,(,0,0
83606,r,0,0
83607,(,0,0
83608,2,0,0
83609,),0,1
83610,=,0,0
83611,0.37,0,0
83612,",",0,0
83613,P,0,0
83614,=,0,0
83615,0.01,0,0
83616,),0,0
83617,",",0,0
83618,ketone,0,0
83619,bodies,0,1
83620,(,0,0
83621,r,0,0
83622,(,0,0
83623,2,0,0
83624,),0,0
83625,=,0,0
83626,-0.20,0,0
83627,",",0,0
83628,P,0,0
83629,=,0,0
83630,0.05,0,0
83631,),0,0
83632,and,0,0
83633,NEFA,0,0
83634,(,0,0
83635,r,0,0
83636,(,0,0
83637,2,0,0
83638,),0,0
83639,=,0,0
83640,-0.35,0,0
83641,",",0,0
83642,P,0,0
83643,=,0,0
83644,0.02,0,0
83645,),0,1
83646,.,0,1
83647,Noradrenaline,0,0
83648,levels,0,0
83649,were,0,1
83650,reduced,0,0
83651,in,0,0
83652,patients,1,1
83653,with,1,1
83654,PHDC-,1,1
83655,.,1,1
83656,Low,0,0
83657,BMI,0,0
83658,(,0,0
83659,on,0,0
83660,treatment,0,0
83661,),0,0
83662,and,0,0
83663,young,0,1
83664,age,0,1
83665,(,0,0
83666,off,0,0
83667,treatment,0,0
83668,),0,0
83669,were,0,0
83670,determinants,0,0
83671,of,0,1
83672,low,0,1
83673,BG,0,1
83674,levels,0,0
83675,in,0,0
83676,a,0,0
83677,multiple,0,0
83678,regression,0,0
83679,model,0,0
83680,.,0,1
83681,CONCLUSIONS,0,0
83682,Unrecognized,0,0
83683,overnight,0,0
83684,hypoglycaemia,0,0
83685,in,0,0
83686,children,1,1
83687,and,1,1
83688,adolescents,1,1
83689,on,0,0
83690,pituitary,0,1
83691,hormone,0,0
83692,replacement,0,0
83693,is,0,0
83694,uncommon,0,0
83695,but,0,0
83696,BG,0,1
83697,levels,0,0
83698,quickly,0,0
83699,become,0,0
83700,abnormal,0,0
83701,when,0,0
83702,treatment,0,0
83703,and,0,0
83704,meals,0,0
83705,are,0,0
83706,omitted,0,0
83707,.,0,0
83708,The,0,0
83709,insulin,0,0
83710,antagonistic,0,0
83711,actions,0,0
83712,of,0,0
83713,GH,0,0
83714,are,0,0
83715,important,0,0
83716,in,0,0
83717,preventing,0,0
83718,hypoglycaemia,0,0
83719,.,0,1
83720,Patients,1,1
83721,with,1,1
83722,PHD,1,1
83723,have,0,0
83724,altered,0,0
83725,sympathetic,0,0
83726,nerve,0,0
83727,activity,0,0
83728,.,0,1
83729,[,1,0
83730,4,1,0
83731,years,1,1
83732,',1,1
83733,experience,1,0
83734,with,1,1
83735,a,1,0
83736,balloon-expandable,1,1
83737,endoprosthesis,1,1
83738,.,1,1
83739,Experimental,1,0
83740,and,1,0
83741,clinical,1,0
83742,application,1,0
83743,],1,1
83744,.,0,0
83745,During,0,0
83746,a,0,0
83747,4-year,0,0
83748,period,0,0
83749,of,0,0
83750,clinical,0,0
83751,application,0,0
83752,of,0,0
83753,the,0,0
83754,balloon-expandable,0,1
83755,Palmaz,0,1
83756,stent,0,0
83757,",",0,0
83758,a,0,0
83759,randomized,0,0
83760,trial,0,0
83761,comparing,0,0
83762,stent,0,0
83763,implantation,0,1
83764,and,0,0
83765,traditional,0,0
83766,balloon,0,0
83767,angioplasty,0,1
83768,of,0,0
83769,iliac,1,1
83770,arteries,1,1
83771,in,1,1
83772,arterial,1,1
83773,occlusive,1,1
83774,disease,1,1
83775,was,0,0
83776,started,0,0
83777,.,0,0
83778,The,0,0
83779,first,0,0
83780,long-term,0,0
83781,results,0,0
83782,",",0,0
83783,recorded,0,0
83784,after,0,0
83785,2,0,0
83786,years,0,1
83787,",",0,0
83788,indicate,0,0
83789,statistically,0,0
83790,significant,0,0
83791,differences,0,0
83792,in,0,0
83793,the,0,0
83794,complication,0,0
83795,rate,0,0
83796,(,0,0
83797,after,0,0
83798,stenting,1,1
83799,2/62,1,0
83800,and,0,0
83801,after,0,0
83802,angioplasty,1,1
83803,5/69,1,0
83804,),1,0
83805,and,0,0
83806,patency,0,0
83807,(,0,0
83808,greater,0,0
83809,than,0,0
83810,or,0,0
83811,equal,0,0
83812,to,0,0
83813,70,0,1
83814,%,0,0
83815,of,0,0
83816,original,0,1
83817,lumen,0,0
83818,size,0,0
83819,upon,0,0
83820,stent,0,0
83821,implantation,0,1
83822,or,0,1
83823,balloon,0,0
83824,inflation,0,0
83825,:,0,1
83826,95,0,0
83827,%,0,0
83828,after,0,0
83829,stenting,0,1
83830,and,0,0
83831,72,0,1
83832,%,0,0
83833,after,0,0
83834,angioplasty,0,1
83835,),0,0
83836,.,0,0
83837,Clinical,0,0
83838,improvement,0,0
83839,after,0,0
83840,2,0,1
83841,years,0,1
83842,was,0,0
83843,89,0,1
83844,%,0,0
83845,after,0,0
83846,stenting,0,1
83847,and,0,0
83848,70,0,1
83849,%,0,0
83850,after,0,0
83851,angioplasty,0,1
83852,.,0,1
83853,Parallel,0,0
83854,to,0,0
83855,the,0,0
83856,clinical,1,0
83857,trials,1,0
83858,",",0,0
83859,experimental,0,0
83860,canine,1,0
83861,artery,0,1
83862,stenting,0,1
83863,was,0,0
83864,performed,0,0
83865,to,0,0
83866,evaluate,0,0
83867,differences,0,0
83868,in,0,0
83869,the,0,0
83870,long-term,0,0
83871,patency,0,0
83872,of,0,0
83873,stents,0,1
83874,exposed,0,1
83875,to,0,0
83876,restricted,0,0
83877,flow,0,0
83878,.,0,1
83879,Significant,0,0
83880,differences,0,0
83881,in,0,0
83882,neointimal,0,1
83883,healing,0,0
83884,were,0,0
83885,found,0,0
83886,between,0,0
83887,normally,0,1
83888,perfused,0,1
83889,stents,0,0
83890,and,0,0
83891,stents,0,1
83892,with,0,1
83893,artificially,0,1
83894,reduced,0,0
83895,flow,0,0
83896,:,0,1
83897,during,0,0
83898,the,0,0
83899,total,0,1
83900,observation,0,0
83901,period,0,0
83902,of,0,0
83903,6,0,0
83904,months,0,0
83905,the,0,0
83906,neointimal,0,0
83907,height,0,0
83908,was,0,0
83909,up,0,0
83910,to,0,0
83911,200,0,0
83912,%,0,0
83913,higher,0,0
83914,in,0,0
83915,flow-restricted,0,0
83916,stents,0,1
83917,",",0,0
83918,while,0,0
83919,the,0,0
83920,histological,0,0
83921,composition,0,0
83922,of,0,0
83923,the,0,0
83924,neointima,0,0
83925,was,0,0
83926,the,0,0
83927,same,0,0
83928,as,0,0
83929,with,0,1
83930,normally,0,1
83931,perfused,0,1
83932,stents,0,1
83933,.,0,1
83934,Prognosis,0,1
83935,of,0,0
83936,advanced,1,1
83937,hepatocellular,1,1
83938,carcinoma,1,1
83939,:,1,1
83940,comparison,0,0
83941,of,0,0
83942,three,0,0
83943,staging,0,1
83944,systems,0,0
83945,in,0,1
83946,two,0,1
83947,French,1,1
83948,clinical,1,1
83949,trials,1,1
83950,.,1,1
83951,OBJECTIVE,0,0
83952,The,0,0
83953,objective,0,0
83954,of,0,0
83955,this,0,0
83956,study,0,0
83957,was,0,0
83958,to,0,0
83959,assess,0,0
83960,the,0,0
83961,performance,0,0
83962,of,0,0
83963,three,0,0
83964,staging,0,1
83965,systems,0,0
83966,[,0,0
83967,Okuda,0,0
83968,",",0,0
83969,Cancer,1,0
83970,of,1,0
83971,the,1,0
83972,Liver,1,0
83973,Italian,1,1
83974,Program,1,0
83975,(,1,1
83976,CLIP,1,0
83977,),1,0
83978,and,0,0
83979,Barcelona,1,1
83980,Clinic,1,0
83981,Liver,1,1
83982,Cancer,1,1
83983,group,1,0
83984,(,1,0
83985,BCLC,1,0
83986,),1,0
83987,],1,0
83988,",",0,0
83989,for,0,0
83990,predicting,0,0
83991,survival,0,0
83992,in,0,0
83993,patients,1,1
83994,with,1,1
83995,hepatocellular,1,1
83996,carcinoma,1,1
83997,(,1,0
83998,HCC,1,0
83999,),1,0
84000,and,0,0
84001,to,0,0
84002,explore,0,0
84003,how,0,0
84004,to,0,0
84005,improve,0,0
84006,prognostic,0,0
84007,classification,0,0
84008,among,0,1
84009,French,1,1
84010,patients,1,1
84011,with,1,1
84012,HCC,1,0
84013,whose,1,1
84014,main,1,0
84015,etiology,1,0
84016,is,1,0
84017,alcoholic,1,1
84018,cirrhosis,1,1
84019,.,1,1
84020,METHODS,0,0
84021,We,1,0
84022,have,1,0
84023,pooled,1,0
84024,two,1,0
84025,randomized,1,1
84026,clinical,1,0
84027,trials,1,0
84028,in,1,0
84029,palliative,1,1
84030,condition,1,0
84031,from,1,0
84032,the,1,0
84033,F?d?ration,1,0
84034,Francophone,1,1
84035,de,1,1
84036,Cancerologie,1,1
84037,Digestive,1,1
84038,.,1,1
84039,They,1,0
84040,had,1,0
84041,included,1,1
84042,416,1,1
84043,and,1,0
84044,122,1,1
84045,patients,1,1
84046,.,1,1
84047,Performances,0,0
84048,of,0,0
84049,Okuda,0,0
84050,",",0,0
84051,CLIP,0,0
84052,and,0,0
84053,BCLC,0,0
84054,scores,0,0
84055,have,0,0
84056,been,0,0
84057,compared,0,0
84058,using,0,0
84059,Akaike,0,0
84060,information,0,0
84061,criterion,0,0
84062,",",0,0
84063,discriminatory,0,0
84064,ability,0,0
84065,(,0,0
84066,Harrell,0,1
84067,'s,0,1
84068,C,0,0
84069,and,0,1
84070,the,0,0
84071,Royston,0,1
84072,'s,0,1
84073,D,0,0
84074,statistics,0,0
84075,),0,0
84076,",",0,0
84077,monotonicity,0,0
84078,of,0,0
84079,gradients,0,0
84080,and,0,1
84081,predictive,0,0
84082,accuracy,0,0
84083,(,0,0
84084,Schemper,0,1
84085,statistics,0,0
84086,Vs,0,1
84087,),0,1
84088,.,0,0
84089,To,0,0
84090,explore,0,0
84091,how,0,0
84092,to,0,0
84093,improve,0,0
84094,classifications,0,0
84095,",",0,0
84096,univariate,0,0
84097,and,0,0
84098,multivariate,0,0
84099,Cox,0,0
84100,model,0,0
84101,analyses,0,0
84102,were,0,0
84103,carried,0,0
84104,out,0,0
84105,.,0,0
84106,RESULTS,0,0
84107,The,0,0
84108,pooled,0,0
84109,database,0,1
84110,included,1,1
84111,538,1,1
84112,patients,1,1
84113,.,1,1
84114,The,0,0
84115,median,0,0
84116,survival,0,0
84117,was,0,0
84118,5.3,0,0
84119,months,0,0
84120,(,0,1
84121,95,0,0
84122,%,0,0
84123,confidence,0,0
84124,interval,0,0
84125,4.6-6.2,0,0
84126,),0,0
84127,.,0,0
84128,For,0,0
84129,all,0,0
84130,statistics,0,0
84131,CLIP,0,0
84132,staging,0,1
84133,system,0,0
84134,had,0,0
84135,a,0,0
84136,better,0,0
84137,prognostic,0,0
84138,ability,0,0
84139,.,0,1
84140,Performances,0,0
84141,of,0,0
84142,all,0,1
84143,staging,0,0
84144,systems,0,0
84145,were,0,1
84146,rather,0,0
84147,disappointing,0,0
84148,.,0,0
84149,World,0,0
84150,Health,0,0
84151,Organization,0,1
84152,performance,0,0
84153,status,0,0
84154,(,0,0
84155,WHO,0,0
84156,PS,0,1
84157,),0,0
84158,for,0,0
84159,CLIP,0,0
84160,or,0,1
84161,alpha-fetoprotein,0,0
84162,for,0,0
84163,BCLC,0,0
84164,allowed,0,0
84165,a,0,0
84166,significant,0,0
84167,improvement,0,0
84168,of,0,0
84169,prognostic,0,0
84170,information,0,0
84171,.,0,1
84172,CONCLUSION,0,0
84173,Our,0,0
84174,results,0,0
84175,indicate,0,0
84176,that,0,0
84177,CLIP,0,0
84178,staging,0,0
84179,seems,0,0
84180,to,0,0
84181,be,0,0
84182,most,0,0
84183,adapted,0,0
84184,to,0,0
84185,palliative,0,0
84186,setting,0,1
84187,and,0,0
84188,that,0,0
84189,it,0,0
84190,could,0,0
84191,be,0,0
84192,better,0,0
84193,by,0,0
84194,associating,0,0
84195,WHO,0,0
84196,PS,0,1
84197,.,0,1
84198,Closure,0,0
84199,of,0,0
84200,the,0,0
84201,femoral,0,1
84202,artery,0,1
84203,after,1,0
84204,cardiac,1,1
84205,catheterization,1,1
84206,:,1,1
84207,a,0,0
84208,comparison,0,0
84209,of,0,0
84210,Angio-Seal,0,0
84211,",",0,0
84212,StarClose,0,0
84213,",",0,0
84214,and,0,0
84215,manual,0,0
84216,compression,0,0
84217,.,0,1
84218,OBJECTIVES,0,0
84219,To,0,0
84220,compare,0,0
84221,Angio-Seal,0,0
84222,(,0,0
84223,AS,0,1
84224,),0,0
84225,and,0,0
84226,StarClose,0,0
84227,(,0,0
84228,SC,0,0
84229,),0,0
84230,and,0,0
84231,manual,0,0
84232,compression,0,0
84233,(,0,0
84234,MC,0,1
84235,),0,0
84236,on,0,0
84237,efficacy,0,0
84238,of,0,0
84239,hemostasis,0,0
84240,",",0,0
84241,complication,0,0
84242,rate,0,0
84243,",",0,0
84244,safety,0,0
84245,of,0,0
84246,early,0,0
84247,mobilization,0,0
84248,",",0,0
84249,and,0,0
84250,patient,0,0
84251,comfort,0,0
84252,.,0,1
84253,BACKGROUND,0,0
84254,Closure,0,0
84255,of,0,0
84256,the,0,0
84257,femoral,0,1
84258,artery,0,1
84259,after,0,0
84260,cardiac,0,1
84261,catheterization,0,0
84262,can,0,0
84263,be,0,0
84264,obtained,0,0
84265,through,0,0
84266,different,0,0
84267,methods,0,1
84268,.,0,1
84269,Today,0,0
84270,",",0,0
84271,physicians,0,0
84272,can,0,0
84273,choose,0,1
84274,from,0,0
84275,a,0,0
84276,number,0,0
84277,of,0,0
84278,different,0,0
84279,devices,0,0
84280,to,0,0
84281,achieve,0,0
84282,arterial,0,1
84283,closure,0,1
84284,.,0,0
84285,METHODS,0,0
84286,In,0,0
84287,a,0,0
84288,prospective,0,0
84289,trial,0,0
84290,450,1,1
84291,patients,1,1
84292,were,0,1
84293,randomized,0,1
84294,to,0,0
84295,AS,0,1
84296,",",0,0
84297,SC,0,0
84298,",",0,0
84299,or,0,1
84300,MC,0,1
84301,.,0,1
84302,Patients,0,1
84303,were,0,0
84304,mobilized,0,1
84305,1,0,0
84306,to,0,0
84307,2,0,0
84308,hr,0,0
84309,after,0,0
84310,device,0,0
84311,placement,0,0
84312,",",0,0
84313,and,0,0
84314,6,0,0
84315,hr,0,0
84316,after,0,0
84317,MC,0,1
84318,.,0,1
84319,Data,0,0
84320,were,0,0
84321,collected,0,0
84322,during,0,0
84323,hospital,0,1
84324,admission,0,1
84325,and,0,0
84326,by,0,0
84327,telephone,0,0
84328,at,0,0
84329,one,0,0
84330,month,0,0
84331,after,0,0
84332,hospital,0,1
84333,discharge,0,1
84334,.,0,1
84335,RESULTS,0,0
84336,Devices,0,1
84337,were,0,1
84338,used,0,0
84339,in,0,0
84340,138/150,0,0
84341,allocated,0,1
84342,to,0,0
84343,AS,0,1
84344,and,0,0
84345,124/150,0,0
84346,allocated,0,1
84347,to,0,0
84348,SC,0,1
84349,patients,0,1
84350,(,0,1
84351,92,0,1
84352,%,0,0
84353,vs.,0,0
84354,83,0,0
84355,%,0,0
84356,",",0,0
84357,P,0,0
84358,=,0,0
84359,0.015,0,0
84360,),0,1
84361,Patients,0,1
84362,with,0,1
84363,MC,0,1
84364,experienced,0,0
84365,more,0,0
84366,pain,0,0
84367,during,0,0
84368,sheath,0,0
84369,removal,0,0
84370,than,0,0
84371,patients,0,1
84372,receiving,0,1
84373,a,0,0
84374,device,0,0
84375,",",0,0
84376,and,0,0
84377,rated,0,0
84378,their,0,0
84379,period,0,0
84380,of,0,0
84381,bed,0,0
84382,rest,0,0
84383,as,0,0
84384,less,0,0
84385,comfortable,0,0
84386,.,0,0
84387,Oozing,0,0
84388,and,0,0
84389,need,0,0
84390,for,0,0
84391,pressure,0,0
84392,bandage,0,0
84393,at,0,0
84394,the,0,0
84395,puncture,0,0
84396,site,0,0
84397,were,0,0
84398,observed,0,0
84399,in,0,0
84400,37,0,1
84401,AS,0,1
84402,patients,0,1
84403,and,0,1
84404,57,0,1
84405,SC,0,1
84406,patients,0,1
84407,(,0,1
84408,25,0,1
84409,%,0,0
84410,vs.,0,0
84411,38,0,1
84412,%,0,0
84413,",",0,0
84414,P,0,0
84415,=,0,0
84416,0.002,0,0
84417,),0,1
84418,.,0,1
84419,Hematoma,0,0
84420,occurred,0,0
84421,in,0,0
84422,15,0,1
84423,AS,0,1
84424,patients,0,1
84425,",",0,0
84426,in,0,0
84427,17,0,1
84428,SC,0,1
84429,patients,0,1
84430,",",0,0
84431,and,0,0
84432,in,0,0
84433,14,0,1
84434,MC,0,1
84435,patients,0,1
84436,(,0,1
84437,11,0,1
84438,vs.,0,0
84439,14,0,1
84440,vs.,0,0
84441,9,0,0
84442,%,0,0
84443,",",0,0
84444,ns,0,0
84445,),0,0
84446,.,0,0
84447,CONCLUSION,0,0
84448,There,0,0
84449,is,0,0
84450,no,0,0
84451,difference,0,0
84452,in,0,0
84453,safety,0,0
84454,between,0,0
84455,the,0,0
84456,three,0,0
84457,methods,0,1
84458,of,0,0
84459,arterial,0,1
84460,closure,0,1
84461,.,0,1
84462,SC,0,0
84463,was,0,0
84464,more,0,0
84465,often,0,0
84466,not,0,0
84467,used,0,0
84468,or,0,0
84469,successfully,0,0
84470,deployed,0,0
84471,.,0,0
84472,SC,0,0
84473,patients,0,1
84474,more,0,0
84475,often,0,0
84476,had,0,0
84477,continuing,0,0
84478,oozing,0,0
84479,.,0,1
84480,On,0,0
84481,patient,0,0
84482,comfort,0,0
84483,",",0,0
84484,closure,0,1
84485,devices,0,0
84486,performed,0,0
84487,better,0,0
84488,than,0,0
84489,MC,0,1
84490,.,0,1
84491,Early,0,0
84492,ambulation,0,0
84493,in,0,0
84494,patients,0,1
84495,with,0,1
84496,a,0,0
84497,closure,0,0
84498,device,0,0
84499,is,0,0
84500,safe,0,0
84501,.,0,0
84502,AS,0,0
84503,is,0,0
84504,the,0,0
84505,preferred,0,0
84506,method,0,0
84507,of,0,0
84508,arterial,0,1
84509,closure,0,1
84510,after,0,0
84511,cardiac,0,1
84512,catheterization,0,1
84513,.,0,1
84514,Bevacizumab-augmented,0,0
84515,retinal,0,1
84516,laser,0,0
84517,photocoagulation,0,0
84518,in,0,0
84519,proliferative,1,1
84520,diabetic,1,1
84521,retinopathy,1,1
84522,:,1,1
84523,a,0,0
84524,randomized,0,0
84525,double-masked,0,0
84526,clinical,0,0
84527,trial,0,1
84528,.,0,1
84529,PURPOSE,0,0
84530,To,0,0
84531,evaluate,0,0
84532,the,0,0
84533,additional,0,0
84534,therapeutic,0,0
84535,effect,0,0
84536,of,0,0
84537,single,0,0
84538,intravitreal,0,0
84539,bevacizumab,0,0
84540,injection,0,0
84541,on,0,0
84542,standard,0,0
84543,laser,0,0
84544,treatment,0,0
84545,in,0,0
84546,the,0,0
84547,management,0,0
84548,of,0,0
84549,proliferative,0,1
84550,diabetic,0,1
84551,retinopathy,0,1
84552,.,0,1
84553,METHODS,0,0
84554,A,0,0
84555,prospective,0,0
84556,",",0,0
84557,fellow-eye,0,1
84558,sham,0,0
84559,controlled,0,0
84560,clinical,0,0
84561,trial,0,0
84562,was,0,0
84563,conducted,0,0
84564,on,0,0
84565,80,1,1
84566,eyes,1,1
84567,of,1,1
84568,40,1,1
84569,high-risk,1,1
84570,characteristic,1,0
84571,proliferative,1,1
84572,diabetic,1,1
84573,retinopathy,1,1
84574,type,1,1
84575,II,1,1
84576,diabetics,1,1
84577,.,1,1
84578,All,0,1
84579,cases,0,0
84580,received,0,0
84581,standard,0,0
84582,laser,0,0
84583,treatment,0,0
84584,according,0,0
84585,to,0,0
84586,Early,0,1
84587,Treatment,0,0
84588,Diabetic,0,1
84589,Retinopathy,0,1
84590,Study,0,0
84591,protocol,0,0
84592,.,0,1
84593,Avastin-assigned,0,0
84594,eyes,0,1
84595,received,0,1
84596,1.25,0,0
84597,mg,0,0
84598,intravitreal,0,0
84599,bevacizumab,0,0
84600,(,0,0
84601,Genentech,0,0
84602,Inc.,0,0
84603,",",0,0
84604,San,0,0
84605,Francisco,0,1
84606,",",0,0
84607,CA,0,0
84608,),0,0
84609,on,0,0
84610,the,0,0
84611,first,0,0
84612,session,0,0
84613,of,0,0
84614,their,0,0
84615,laser,0,1
84616,treatments,0,0
84617,.,0,1
84618,Fluorescein,0,0
84619,angiography,0,0
84620,was,0,0
84621,performed,0,0
84622,at,0,0
84623,baseline,0,0
84624,and,0,0
84625,at,0,0
84626,weeks,0,0
84627,6,0,1
84628,and,0,1
84629,16,0,1
84630,",",0,0
84631,and,0,0
84632,proliferative,0,0
84633,diabetic,0,1
84634,retinopathy,0,1
84635,regression,0,0
84636,was,0,0
84637,evaluated,0,0
84638,in,0,0
84639,a,0,0
84640,masked,0,1
84641,fashion,0,0
84642,.,0,0
84643,RESULTS,0,0
84644,The,1,0
84645,median,1,0
84646,age,1,1
84647,was,1,0
84648,52,1,1
84649,years,1,1
84650,(,1,1
84651,range,1,1
84652,:,1,1
84653,39-68,1,1
84654,),1,0
84655,and,1,0
84656,30,1,0
84657,%,1,0
84658,of,1,0
84659,the,1,0
84660,participants,1,1
84661,were,1,1
84662,male,1,1
84663,.,1,1
84664,All,0,1
84665,patients,0,1
84666,were,0,0
84667,followed,0,0
84668,for,0,0
84669,16,0,1
84670,weeks,0,0
84671,.,0,1
84672,A,0,0
84673,total,0,1
84674,of,0,0
84675,87.5,0,0
84676,%,0,0
84677,of,0,0
84678,Avastin-injected,0,0
84679,eyes,0,1
84680,and,0,1
84681,25,0,1
84682,%,0,0
84683,of,0,0
84684,sham,0,0
84685,group,0,0
84686,showed,0,0
84687,complete,0,0
84688,regression,0,0
84689,at,0,0
84690,week,0,0
84691,6,0,0
84692,of,0,0
84693,follow-up,0,0
84694,(,0,0
84695,p,0,0
84696,<,0,0
84697,0.005,0,0
84698,),0,0
84699,.,0,0
84700,However,0,0
84701,",",0,0
84702,at,0,0
84703,week,0,0
84704,16,0,1
84705,",",0,0
84706,PDR,0,1
84707,recurred,0,0
84708,in,0,0
84709,a,0,0
84710,sizable,0,0
84711,number,0,0
84712,of,0,0
84713,the,0,0
84714,Avastin-treated,0,0
84715,eyes,0,1
84716,",",0,0
84717,and,0,0
84718,the,0,0
84719,complete,0,0
84720,regression,0,0
84721,rate,0,0
84722,in,0,0
84723,the,0,0
84724,two,0,0
84725,groups,0,0
84726,became,0,1
84727,identical,0,1
84728,(,0,0
84729,25,0,1
84730,%,0,0
84731,;,0,0
84732,p=1.000,0,0
84733,),0,0
84734,;,0,0
84735,partial,0,1
84736,regression,0,0
84737,rates,0,0
84738,were,0,1
84739,70,0,1
84740,%,0,0
84741,vs,0,0
84742,65,0,1
84743,%,0,0
84744,.,0,0
84745,In,0,0
84746,the,0,0
84747,subgroup,0,1
84748,of,0,0
84749,Avastin-treated,0,0
84750,eyes,0,1
84751,",",0,0
84752,multivariate,0,0
84753,analysis,0,0
84754,identified,0,0
84755,hemoglobin,0,0
84756,A1c,0,1
84757,as,0,0
84758,the,0,0
84759,strongest,0,0
84760,predictor,0,0
84761,of,0,0
84762,proliferative,0,1
84763,diabetic,0,1
84764,retinopathy,0,1
84765,recurrence,0,0
84766,(,0,0
84767,p=0.033,0,0
84768,),0,0
84769,.,0,1
84770,CONCLUSIONS,0,0
84771,Intravitreal,0,0
84772,bevacizumab,0,0
84773,remarkably,0,0
84774,augmented,0,0
84775,the,0,0
84776,short-term,0,0
84777,response,0,0
84778,to,0,0
84779,scatter,0,0
84780,panretinal,0,0
84781,laser,0,0
84782,photocoagulation,0,0
84783,in,0,0
84784,high-risk,0,1
84785,characteristic,0,0
84786,proliferative,0,1
84787,diabetic,0,1
84788,retinopathy,0,1
84789,but,0,0
84790,the,0,0
84791,effect,0,0
84792,was,0,0
84793,short-lived,0,0
84794,",",0,0
84795,as,0,0
84796,many,0,0
84797,of,0,0
84798,the,0,0
84799,eyes,0,1
84800,showed,0,0
84801,rapid,0,0
84802,recurrence,0,0
84803,.,0,1
84804,Alternative,0,0
84805,dosing,0,0
84806,(,0,0
84807,multiple,0,0
84808,and/or,0,0
84809,periodic,0,1
84810,intravitreal,0,0
84811,Avastin,0,0
84812,injections,0,0
84813,),0,0
84814,is,0,0
84815,recommended,0,0
84816,for,0,0
84817,further,0,0
84818,evaluation,0,0
84819,.,0,1
84820,Desogestrel,0,0
84821,and,0,0
84822,gestodene,0,0
84823,in,0,0
84824,oral,0,0
84825,contraceptives,0,1
84826,:,0,1
84827,12,0,1
84828,months,0,0
84829,',0,1
84830,assessment,0,0
84831,of,0,0
84832,carbohydrate,0,0
84833,and,0,0
84834,lipoprotein,0,0
84835,metabolism,0,0
84836,.,0,1
84837,We,0,0
84838,examined,0,0
84839,the,0,0
84840,influence,0,0
84841,on,0,0
84842,carbohydrate,0,0
84843,and,0,0
84844,lipoprotein,0,0
84845,metabolism,0,0
84846,of,0,0
84847,oral,0,0
84848,contraceptives,0,1
84849,(,0,1
84850,OCs,0,0
84851,),0,0
84852,containing,0,0
84853,two,0,0
84854,new,0,1
84855,third-generation,0,1
84856,progestogens,0,0
84857,",",0,0
84858,desogestrel,0,0
84859,and,0,0
84860,gestodene,0,0
84861,.,0,0
84862,This,0,0
84863,was,0,0
84864,a,0,0
84865,prospective,0,0
84866,randomized,0,0
84867,study,0,0
84868,in,0,0
84869,which,0,0
84870,monophasic,0,0
84871,combinations,0,0
84872,of,0,1
84873,20,0,1
84874,micrograms,0,0
84875,ethinyl,0,0
84876,estradiol,0,0
84877,(,0,0
84878,E2,0,1
84879,),0,0
84880,and,0,0
84881,150,0,0
84882,micrograms,0,0
84883,desogestrel,0,0
84884,or,0,1
84885,30,0,1
84886,micrograms,0,0
84887,ethinyl,0,0
84888,E2,0,1
84889,plus,0,0
84890,75,0,1
84891,micrograms,0,0
84892,gestodene,0,1
84893,were,0,0
84894,administered,0,0
84895,to,0,0
84896,15,1,1
84897,and,1,0
84898,19,1,1
84899,healthy,1,1
84900,women,1,1
84901,",",1,0
84902,respectively,1,0
84903,.,1,0
84904,An,0,0
84905,oral,0,0
84906,glucose,0,0
84907,tolerance,0,0
84908,test,0,0
84909,including,0,0
84910,measurement,0,0
84911,of,0,0
84912,insulin,0,0
84913,response,0,0
84914,was,0,0
84915,performed,0,0
84916,before,0,0
84917,treatment,0,0
84918,and,0,0
84919,after,0,0
84920,3,0,0
84921,",",0,0
84922,6,0,0
84923,",",0,0
84924,and,0,0
84925,12,0,0
84926,months,0,0
84927,of,0,1
84928,treatment,0,0
84929,.,0,0
84930,We,0,0
84931,also,0,0
84932,determined,0,0
84933,fasting,0,0
84934,plasma,0,0
84935,concentrations,0,0
84936,of,0,0
84937,total,0,1
84938,cholesterol,0,0
84939,;,0,0
84940,high-density,0,0
84941,lipoprotein,0,0
84942,cholesterol,0,0
84943,",",0,0
84944,including,0,0
84945,the,0,0
84946,subfractions,0,0
84947,high-density,0,0
84948,lipoprotein2,0,0
84949,cholesterol,0,0
84950,and,0,0
84951,high-density,0,0
84952,lipoprotein3,0,0
84953,cholesterol,0,0
84954,;,0,0
84955,low-density,0,0
84956,lipoprotein,0,0
84957,cholesterol,0,0
84958,;,0,0
84959,very,0,0
84960,low-density,0,0
84961,lipoprotein,0,0
84962,cholesterol,0,0
84963,;,0,0
84964,and,0,0
84965,triglycerides,0,0
84966,.,0,1
84967,A,0,0
84968,transient,0,0
84969,deterioration,0,0
84970,of,0,0
84971,glucose,0,0
84972,tolerance,0,0
84973,was,0,0
84974,observed,0,0
84975,despite,0,0
84976,unchanged,0,0
84977,levels,0,0
84978,of,0,0
84979,insulin,0,0
84980,after,0,0
84981,treatment,0,0
84982,with,0,1
84983,both,0,0
84984,compounds,0,0
84985,for,0,0
84986,3,0,1
84987,months,0,0
84988,.,0,1
84989,In,0,0
84990,both,0,0
84991,groups,0,0
84992,plasma,0,0
84993,levels,0,0
84994,of,0,0
84995,triglycerides,0,0
84996,",",0,0
84997,very,0,0
84998,low-density,0,0
84999,lipoprotein,0,0
85000,cholesterol,0,0
85001,",",0,0
85002,and,0,0
85003,high-density,0,0
85004,lipoprotein,0,0
85005,cholesterol,0,0
85006,increased,0,0
85007,significantly,0,0
85008,after,0,0
85009,3,0,0
85010,months,0,0
85011,.,0,1
85012,After,0,0
85013,12,0,0
85014,months,0,0
85015,",",0,0
85016,a,0,0
85017,significant,0,0
85018,increase,0,0
85019,in,0,0
85020,the,0,0
85021,high-density,0,0
85022,lipoprotein,0,0
85023,cholesterol/total,0,0
85024,cholesterol,0,0
85025,ratio,0,0
85026,was,0,0
85027,observed,0,0
85028,in,0,0
85029,the,0,0
85030,ethinyl,0,0
85031,E2-desogestrel,0,0
85032,group,0,0
85033,",",0,0
85034,and,0,0
85035,no,0,0
85036,persistent,0,1
85037,changes,0,0
85038,in,0,0
85039,low-density,0,0
85040,lipoprotein,0,0
85041,cholesterol,0,0
85042,could,0,0
85043,be,0,0
85044,demonstrated,0,0
85045,in,0,0
85046,any,0,0
85047,of,0,0
85048,the,0,0
85049,groups,0,0
85050,.,0,1
85051,Our,0,0
85052,results,0,0
85053,indicate,0,0
85054,that,0,0
85055,treatment,0,0
85056,with,0,1
85057,either,0,0
85058,compound,0,0
85059,for,0,0
85060,12,0,0
85061,months,0,0
85062,has,0,0
85063,no,0,0
85064,effect,0,0
85065,on,0,0
85066,carbohydrate,0,0
85067,or,0,1
85068,lipoprotein,0,0
85069,metabolism,0,0
85070,known,0,0
85071,to,0,0
85072,increase,0,0
85073,the,0,0
85074,risk,0,0
85075,of,0,0
85076,cardiovascular,0,1
85077,disease,0,1
85078,.,0,1
85079,Once-daily,0,0
85080,amoxicillin,0,0
85081,versus,0,0
85082,twice-daily,0,0
85083,penicillin,0,0
85084,V,0,0
85085,in,0,0
85086,group,0,1
85087,A,0,1
85088,beta-haemolytic,1,1
85089,streptococcal,1,1
85090,pharyngitis,1,1
85091,.,1,1
85092,BACKGROUND,0,0
85093,Rheumatic,0,1
85094,fever,0,0
85095,is,0,0
85096,a,0,0
85097,preventable,0,0
85098,chronic,0,1
85099,disease,0,1
85100,preceded,0,0
85101,by,0,0
85102,group,1,0
85103,A,1,1
85104,beta-haemolytic,1,0
85105,streptococcal,1,1
85106,(,1,0
85107,GABHS,1,0
85108,),1,0
85109,pharyngitis,1,1
85110,.,1,0
85111,OBJECTIVE,0,0
85112,To,0,0
85113,test,0,0
85114,the,0,0
85115,non-inferiority,0,0
85116,of,0,0
85117,once-daily,0,0
85118,(,0,1
85119,QD,0,0
85120,),0,0
85121,oral,0,0
85122,amoxicillin,0,0
85123,to,0,0
85124,the,0,0
85125,recommended,0,0
85126,twice-daily,0,0
85127,(,0,0
85128,BID,0,1
85129,),0,0
85130,oral,0,0
85131,penicillin,0,0
85132,V,0,0
85133,in,0,0
85134,GABHS,0,0
85135,pharyngitis,0,1
85136,.,0,0
85137,METHODS,0,0
85138,This,0,0
85139,was,0,0
85140,a,0,0
85141,randomised,0,0
85142,non-inferiority,0,0
85143,trial,0,0
85144,carried,0,0
85145,out,0,0
85146,in,0,0
85147,a,0,0
85148,school-based,1,0
85149,clinic,1,1
85150,in,1,0
85151,New,1,1
85152,Zealand,1,1
85153,.,1,1
85154,Children,1,1
85155,presenting,1,1
85156,with,1,1
85157,GABHS,1,0
85158,pharyngitis,1,1
85159,were,0,0
85160,randomised,0,0
85161,to,0,0
85162,oral,0,0
85163,amoxicillin,0,0
85164,1500,0,1
85165,mg,0,0
85166,QD,0,0
85167,(,0,0
85168,or,0,1
85169,750,0,0
85170,mg,0,0
85171,if,0,0
85172,bodyweight,0,0
85173,was,0,0
85174,<,0,0
85175,or=30,0,1
85176,kg,0,1
85177,),0,0
85178,or,0,0
85179,to,0,0
85180,oral,0,0
85181,penicillin,0,1
85182,V,0,0
85183,500,0,0
85184,mg,0,0
85185,BID,0,1
85186,(,0,0
85187,or,0,1
85188,250,0,0
85189,mg,0,0
85190,if,0,0
85191,bodyweight,0,0
85192,was,0,0
85193,<,0,0
85194,or=20,0,1
85195,kg,0,1
85196,),0,0
85197,for,0,0
85198,10,0,1
85199,days,0,0
85200,.,0,1
85201,Observed,0,0
85202,medication,0,0
85203,and,0,0
85204,weekend,0,0
85205,diary,0,0
85206,cards,0,0
85207,were,0,1
85208,used,0,0
85209,to,0,0
85210,monitor,0,0
85211,adherence,0,0
85212,.,0,0
85213,OUTCOME,0,0
85214,Eradication,0,0
85215,of,0,0
85216,GABHS,0,0
85217,",",0,0
85218,determined,0,0
85219,with,0,1
85220,follow-up,0,0
85221,throat,0,1
85222,cultures,0,0
85223,on,0,0
85224,days,0,0
85225,3-6,0,1
85226,",",0,0
85227,12-16,0,1
85228,and,0,0
85229,26-36,0,1
85230,.,0,1
85231,GABHS,0,0
85232,isolates,0,0
85233,were,0,0
85234,serotyped,0,1
85235,to,0,0
85236,distinguish,0,0
85237,bacteriological,0,0
85238,treatment,0,0
85239,failures,0,0
85240,(,0,0
85241,and,0,1
85242,relapses,0,0
85243,),0,1
85244,from,0,1
85245,new,0,1
85246,acquisitions,0,0
85247,.,0,1
85248,Non-inferiority,0,0
85249,was,0,0
85250,defined,0,0
85251,as,0,0
85252,an,0,0
85253,upper,0,1
85254,95,0,0
85255,%,0,0
85256,confidence,0,0
85257,limit,0,0
85258,(,0,0
85259,CL,0,0
85260,),0,0
85261,for,0,0
85262,the,0,0
85263,difference,0,0
85264,in,0,0
85265,success,0,0
85266,of,0,0
85267,eradication,0,0
85268,in,0,0
85269,the,0,0
85270,amoxicillin,0,0
85271,and,0,0
85272,penicillin,0,0
85273,V,0,0
85274,treatment,0,0
85275,groups,0,0
85276,of,0,0
85277,<,0,0
85278,or=10,0,1
85279,%,0,0
85280,.,0,0
85281,RESULTS,0,0
85282,353,1,1
85283,children,1,1
85284,with,1,1
85285,positive,1,0
85286,throat,1,1
85287,swabs,1,1
85288,for,1,0
85289,GABHS,1,0
85290,were,1,0
85291,randomised,1,0
85292,to,0,0
85293,amoxicillin,0,0
85294,(,0,0
85295,n,0,1
85296,=,0,0
85297,177,0,1
85298,),0,0
85299,or,0,1
85300,penicillin,0,0
85301,V,0,0
85302,(,0,1
85303,n,0,1
85304,=,0,0
85305,176,0,1
85306,),0,0
85307,.,0,0
85308,The,0,0
85309,upper,0,0
85310,95,0,0
85311,%,0,0
85312,CL,0,0
85313,for,0,0
85314,the,0,0
85315,differences,0,0
85316,in,0,0
85317,positive,0,1
85318,cultures,0,0
85319,between,0,0
85320,the,0,0
85321,antibiotics,0,0
85322,was,0,0
85323,4.9,0,0
85324,%,0,0
85325,at,0,1
85326,days,0,0
85327,3-6,0,1
85328,",",0,0
85329,6.5,0,0
85330,%,0,0
85331,at,0,1
85332,days,0,0
85333,12-16,0,1
85334,and,0,1
85335,8.5,0,0
85336,%,0,0
85337,at,0,0
85338,days,0,0
85339,26-36,0,1
85340,.,0,1
85341,Treatment,0,0
85342,failures,0,0
85343,(,0,0
85344,including,0,1
85345,relapses,0,0
85346,),0,1
85347,occurred,0,0
85348,at,0,0
85349,each,0,0
85350,visit,0,0
85351,in,0,0
85352,5.8,0,0
85353,%,0,0
85354,",",0,0
85355,12.7,0,0
85356,%,0,0
85357,and,0,0
85358,10.7,0,0
85359,%,0,0
85360,of,0,0
85361,amoxicillin,0,0
85362,recipients,0,1
85363,and,0,0
85364,6.2,0,0
85365,%,0,0
85366,",",0,0
85367,11.9,0,0
85368,%,0,0
85369,and,0,0
85370,11.3,0,0
85371,%,0,0
85372,of,0,0
85373,penicillin,0,0
85374,V,0,0
85375,recipients,0,1
85376,",",0,0
85377,respectively,0,0
85378,.,0,0
85379,No,0,0
85380,significant,0,0
85381,differences,0,0
85382,in,0,0
85383,resolution,0,0
85384,of,0,0
85385,symptoms,0,0
85386,were,0,1
85387,noted,0,0
85388,between,0,0
85389,treatment,0,0
85390,groups,0,0
85391,.,0,1
85392,One,0,1
85393,case,0,0
85394,of,0,0
85395,unsubstantiated,0,0
85396,acute,0,1
85397,rheumatic,0,1
85398,fever,0,1
85399,occurred,0,0
85400,after,0,0
85401,7,0,1
85402,days,0,0
85403,of,0,1
85404,amoxicillin,0,0
85405,.,0,0
85406,CONCLUSION,0,0
85407,In,0,0
85408,this,0,0
85409,adequately,0,0
85410,powered,0,0
85411,study,0,0
85412,",",0,0
85413,once-daily,0,0
85414,oral,0,0
85415,amoxicillin,0,0
85416,is,0,0
85417,not,0,0
85418,inferior,0,0
85419,to,0,0
85420,twice-daily,0,0
85421,penicillin,0,0
85422,V,0,0
85423,for,0,0
85424,the,0,0
85425,treatment,0,0
85426,and,0,0
85427,eradication,0,0
85428,of,0,0
85429,GABHS,1,0
85430,in,1,0
85431,children,1,1
85432,with,1,1
85433,pharyngitis,1,1
85434,.,1,1
85435,Pentoxifylline,0,0
85436,to,0,0
85437,treat,0,0
85438,radiation,1,0
85439,proctitis,1,1
85440,:,1,1
85441,a,0,0
85442,small,0,0
85443,and,0,0
85444,inconclusive,0,0
85445,randomised,0,0
85446,trial,0,0
85447,.,0,0
85448,This,0,0
85449,prospective,0,0
85450,randomised,0,0
85451,controlled,0,0
85452,study,1,0
85453,of,1,0
85454,40,1,1
85455,patients,1,1
85456,could,0,0
85457,not,0,0
85458,show,0,0
85459,a,0,0
85460,statistically,0,0
85461,significant,0,0
85462,advantage,0,0
85463,with,0,1
85464,6,0,0
85465,months,0,0
85466,of,0,0
85467,pentoxifylline,0,0
85468,compared,0,0
85469,with,0,1
85470,standard,0,0
85471,measures,0,0
85472,for,0,1
85473,late,0,1
85474,radiation-induced,0,0
85475,rectal,0,1
85476,bleeding,0,0
85477,.,0,0
85478,However,0,0
85479,",",0,0
85480,a,0,0
85481,modest,0,0
85482,benefit,0,0
85483,can,0,0
85484,not,0,0
85485,be,0,0
85486,excluded,0,0
85487,and,0,0
85488,larger,0,0
85489,randomised,0,0
85490,placebo-controlled,0,0
85491,trials,0,0
85492,with,0,1
85493,longer,0,0
85494,durations,0,0
85495,of,0,0
85496,pentoxifylline,0,0
85497,treatment,0,0
85498,may,0,0
85499,be,0,0
85500,justified,0,0
85501,.,0,0
85502,Resource,0,1
85503,utilization,0,0
85504,and,0,0
85505,economic,0,0
85506,costs,0,0
85507,of,0,0
85508,care,0,1
85509,based,0,0
85510,on,0,0
85511,a,0,0
85512,randomized,0,0
85513,trial,0,0
85514,of,0,0
85515,vacuum-assisted,0,0
85516,closure,0,1
85517,therapy,0,0
85518,in,0,0
85519,the,0,0
85520,treatment,0,0
85521,of,0,0
85522,diabetic,1,1
85523,foot,1,1
85524,wounds,1,1
85525,.,1,1
85526,BACKGROUND,0,0
85527,To,0,0
85528,evaluate,0,0
85529,resource,0,0
85530,utilization,0,0
85531,and,0,0
85532,direct,0,0
85533,economic,0,0
85534,costs,0,0
85535,of,0,0
85536,care,0,1
85537,for,0,0
85538,patients,1,1
85539,treated,1,1
85540,with,1,1
85541,negative-pressure,1,0
85542,wound,1,0
85543,therapy,1,0
85544,(,1,0
85545,NPWT,1,0
85546,),1,0
85547,",",0,0
85548,using,0,0
85549,the,0,0
85550,Vacuum-Assisted,0,0
85551,Closure,0,1
85552,(,0,1
85553,V.A.C,0,0
85554,.,0,1
85555,),0,0
85556,system,0,0
85557,",",0,0
85558,compared,0,0
85559,to,0,0
85560,standard,0,0
85561,moist,0,1
85562,wound,0,0
85563,therapy,0,0
85564,(,0,0
85565,MWT,0,1
85566,),0,0
85567,.,0,0
85568,METHODS,0,0
85569,A,0,0
85570,total,0,1
85571,of,0,0
85572,162,1,1
85573,diabetic,1,1
85574,patients,1,1
85575,with,1,1
85576,post-amputation,1,1
85577,wounds,1,1
85578,(,1,0
85579,up,1,0
85580,to,1,0
85581,the,1,0
85582,trans-metatarsal,1,0
85583,level,1,0
85584,),1,0
85585,entered,0,1
85586,a,0,0
85587,16-week,0,0
85588,",",0,0
85589,randomized,0,1
85590,clinical,0,0
85591,trial,0,1
85592,.,0,1
85593,Patients,1,1
85594,randomized,1,0
85595,to,1,1
85596,V.A.C,1,0
85597,.,1,0
85598,(,1,0
85599,n,1,1
85600,=,1,0
85601,77,1,1
85602,),1,0
85603,received,1,0
85604,therapy,1,0
85605,with,1,1
85606,dressing,1,0
85607,changes,1,0
85608,every,0,0
85609,48,0,1
85610,hours,0,0
85611,.,0,1
85612,Control,1,0
85613,patients,1,1
85614,(,1,1
85615,n,1,1
85616,=,1,0
85617,85,1,1
85618,),1,0
85619,received,1,0
85620,standard,1,1
85621,MWT,1,1
85622,.,1,1
85623,Resource,0,0
85624,utilization,0,0
85625,",",0,0
85626,procedures,0,0
85627,",",0,0
85628,and,0,0
85629,direct,0,0
85630,costs,0,0
85631,were,0,1
85632,calculated,0,0
85633,and,0,0
85634,analyzed,0,0
85635,in,0,0
85636,this,0,0
85637,post,0,0
85638,hoc,0,0
85639,retrospective,0,1
85640,study,0,0
85641,.,0,0
85642,RESULTS,0,0
85643,There,0,0
85644,was,0,0
85645,no,0,0
85646,difference,0,0
85647,between,0,0
85648,groups,1,0
85649,for,0,0
85650,in-patient,1,1
85651,hospital,1,1
85652,stay,1,0
85653,(,0,0
85654,number,0,0
85655,of,0,0
85656,admissions,0,1
85657,or,0,1
85658,length,0,0
85659,of,0,0
85660,stay,0,0
85661,),0,0
85662,.,0,0
85663,More,0,0
85664,surgical,0,0
85665,procedures,0,0
85666,(,0,0
85667,including,0,0
85668,debridement,0,1
85669,),0,0
85670,were,0,0
85671,required,0,0
85672,in,0,0
85673,the,0,0
85674,MWT,0,0
85675,group,0,0
85676,(,0,0
85677,120,0,1
85678,vs,0,0
85679,43,0,1
85680,NPWT,0,0
85681,",",0,0
85682,P,0,0
85683,<,0,0
85684,.001,0,0
85685,),0,0
85686,.,0,0
85687,The,0,0
85688,average,0,0
85689,number,0,0
85690,of,0,0
85691,dressing,0,0
85692,changes,0,0
85693,performed,0,0
85694,per,0,0
85695,patient,0,1
85696,was,0,0
85697,118.0,0,0
85698,(,0,0
85699,range,0,1
85700,12-226,0,0
85701,),0,0
85702,for,0,0
85703,MWT,0,1
85704,versus,0,0
85705,41,0,1
85706,(,0,0
85707,6-140,0,1
85708,),0,0
85709,for,0,0
85710,NPWT,0,0
85711,(,0,1
85712,P,0,0
85713,=,0,0
85714,.0001,0,0
85715,),0,0
85716,.,0,0
85717,The,0,0
85718,MWT,0,0
85719,group,0,0
85720,had,0,1
85721,11,0,0
85722,(,0,0
85723,range,0,1
85724,0-106,0,1
85725,),0,0
85726,outpatient,0,1
85727,treatment,0,0
85728,visits,0,0
85729,during,0,0
85730,the,0,0
85731,study,0,0
85732,versus,0,0
85733,4,0,0
85734,(,0,0
85735,range,0,1
85736,0-47,0,1
85737,),0,0
85738,in,0,0
85739,the,0,0
85740,NPWT,0,0
85741,group,0,0
85742,(,0,0
85743,P,0,0
85744,<,0,0
85745,.05,0,0
85746,),0,0
85747,.,0,0
85748,The,0,0
85749,average,0,0
85750,direct,0,0
85751,cost,0,0
85752,per,0,0
85753,patient,1,0
85754,treated,0,1
85755,for,0,0
85756,8,0,0
85757,weeks,0,0
85758,or,0,1
85759,longer,0,0
85760,(,0,0
85761,independent,0,0
85762,of,0,0
85763,clinical,0,0
85764,outcome,0,0
85765,),0,0
85766,was,0,0
85767,$,0,0
85768,"27,270",0,0
85769,and,0,0
85770,$,0,0
85771,"36,096",0,1
85772,in,0,0
85773,the,0,0
85774,NPWT,0,0
85775,and,0,0
85776,MWT,0,1
85777,groups,0,0
85778,",",0,0
85779,respectively,0,0
85780,.,0,0
85781,The,0,0
85782,average,0,0
85783,total,0,1
85784,cost,0,0
85785,to,0,0
85786,achieve,0,0
85787,healing,0,0
85788,was,0,0
85789,$,0,0
85790,"25,954",0,1
85791,for,0,0
85792,patients,0,1
85793,treated,0,1
85794,with,0,1
85795,NPWT,0,0
85796,(,0,1
85797,n,0,1
85798,=,0,0
85799,43,0,1
85800,),0,0
85801,compared,0,0
85802,with,0,1
85803,$,0,0
85804,"38,806",0,1
85805,for,0,0
85806,the,0,0
85807,MWT,0,0
85808,group,0,0
85809,(,0,0
85810,n,0,1
85811,=,0,0
85812,33,0,1
85813,),0,1
85814,.,0,1
85815,CONCLUSION,0,0
85816,Treatment,0,0
85817,of,0,0
85818,diabetic,1,1
85819,patients,1,1
85820,with,1,1
85821,post,1,0
85822,amputation,1,0
85823,wounds,1,1
85824,using,0,0
85825,NPWT,0,0
85826,resulted,0,0
85827,in,0,0
85828,lower,0,0
85829,resource,0,0
85830,utilization,0,0
85831,and,0,0
85832,a,0,0
85833,greater,0,0
85834,proportion,0,0
85835,of,0,0
85836,patients,0,1
85837,obtaining,0,0
85838,wound,0,0
85839,healing,0,0
85840,at,0,0
85841,a,0,0
85842,lower,0,0
85843,overall,0,0
85844,cost,0,0
85845,of,0,0
85846,care,0,0
85847,when,0,0
85848,compared,0,0
85849,to,0,0
85850,MWT,0,1
85851,.,0,1
85852,Evaluation,0,0
85853,of,0,0
85854,a,0,0
85855,device,0,0
85856,to,0,0
85857,facilitate,0,0
85858,female,1,1
85859,urethral,0,1
85860,catheterization,0,1
85861,.,0,1
85862,Urethral,0,0
85863,catheterization,0,0
85864,is,0,0
85865,a,0,0
85866,skilled,0,0
85867,procedure,0,0
85868,that,0,0
85869,nurses,1,1
85870,in,1,0
85871,hospital,1,1
85872,settings,1,0
85873,perform,0,1
85874,routinely,0,0
85875,.,0,0
85876,The,0,0
85877,opening,0,0
85878,of,0,0
85879,the,0,0
85880,female,0,1
85881,urethra,0,0
85882,is,0,0
85883,located,0,0
85884,within,0,0
85885,the,0,0
85886,vulvar,0,1
85887,vestibule,0,0
85888,",",0,0
85889,making,0,0
85890,insertion,0,0
85891,of,0,0
85892,urinary,0,1
85893,catheters,0,1
85894,into,0,1
85895,females,1,1
85896,a,0,0
85897,greater,0,0
85898,technical,0,0
85899,challenge,0,0
85900,than,0,0
85901,in,0,0
85902,males,0,1
85903,.,0,1
85904,Researchers,0,0
85905,evaluated,0,0
85906,whether,0,0
85907,a,0,0
85908,new,0,0
85909,device,0,0
85910,might,0,0
85911,decrease,0,0
85912,the,0,0
85913,time,0,0
85914,required,0,0
85915,for,0,0
85916,catheter,0,0
85917,insertion,0,0
85918,",",0,0
85919,increase,0,0
85920,the,0,0
85921,likelihood,0,0
85922,of,0,0
85923,inserting,0,0
85924,the,0,0
85925,catheter,0,0
85926,on,0,0
85927,the,0,0
85928,first,0,0
85929,attempt,0,0
85930,(,0,0
85931,improved,0,0
85932,accuracy,0,0
85933,),0,0
85934,",",0,0
85935,and,0,0
85936,reduce,0,0
85937,patient,0,0
85938,discomfort,0,0
85939,.,0,1
85940,Comments,0,0
85941,about,0,0
85942,the,0,0
85943,device,0,0
85944,from,0,0
85945,both,0,0
85946,patients,0,1
85947,and,0,0
85948,nurses,0,1
85949,also,0,0
85950,are,0,0
85951,reported,0,0
85952,.,0,1
85953,Does,0,0
85954,3-day,0,0
85955,course,0,0
85956,of,0,0
85957,oral,0,0
85958,amoxycillin,0,0
85959,benefit,0,0
85960,children,1,1
85961,of,1,0
85962,non-severe,1,1
85963,pneumonia,1,1
85964,with,1,1
85965,wheeze,1,0
85966,:,1,1
85967,a,0,0
85968,multicentric,0,0
85969,randomised,0,0
85970,controlled,0,0
85971,trial,0,0
85972,.,0,0
85973,BACKGROUND,0,0
85974,WHO-defined,0,0
85975,pneumonias,0,1
85976,",",0,0
85977,treated,0,1
85978,with,0,1
85979,antibiotics,0,0
85980,",",0,0
85981,are,0,0
85982,responsible,0,0
85983,for,0,0
85984,a,0,0
85985,significant,0,0
85986,proportion,0,0
85987,of,0,0
85988,childhood,0,1
85989,morbidity,0,0
85990,and,0,0
85991,mortality,0,0
85992,in,0,0
85993,the,0,0
85994,developing,1,0
85995,countries,1,0
85996,.,1,1
85997,Since,0,0
85998,substantial,0,0
85999,proportion,0,0
86000,pneumonias,0,1
86001,have,0,0
86002,a,0,0
86003,viral,0,0
86004,etiology,0,0
86005,",",0,0
86006,where,0,0
86007,children,0,1
86008,are,0,0
86009,more,0,0
86010,likely,0,0
86011,to,0,0
86012,present,0,0
86013,with,0,1
86014,wheeze,0,0
86015,",",0,0
86016,there,0,0
86017,is,0,0
86018,a,0,0
86019,concern,0,0
86020,that,0,0
86021,currently,0,1
86022,antibiotics,0,0
86023,are,0,0
86024,being,0,0
86025,over-prescribed,0,0
86026,for,0,0
86027,it,0,0
86028,.,0,0
86029,Hence,0,0
86030,the,0,0
86031,current,0,0
86032,trial,0,0
86033,was,0,0
86034,conducted,0,0
86035,with,0,1
86036,the,0,0
86037,objective,0,0
86038,to,0,0
86039,show,0,0
86040,the,0,0
86041,therapeutic,0,0
86042,equivalence,0,0
86043,of,0,0
86044,two,0,0
86045,treatments,0,0
86046,(,0,1
86047,placebo,0,0
86048,and,0,0
86049,amoxycillin,0,0
86050,),0,0
86051,for,0,0
86052,children,1,1
86053,presenting,1,1
86054,with,1,1
86055,non-severe,1,1
86056,pneumonia,1,1
86057,with,1,1
86058,wheeze,1,1
86059,",",1,1
86060,who,1,1
86061,have,1,1
86062,persistent,1,1
86063,fast,1,0
86064,breathing,1,0
86065,after,1,0
86066,nebulisation,1,0
86067,with,1,1
86068,salbutamol,1,0
86069,",",1,0
86070,and,1,0
86071,have,1,0
86072,normal,1,0
86073,chest,1,0
86074,radiograph,1,1
86075,.,1,0
86076,METHODOLOGY,0,0
86077,This,0,0
86078,multi-centric,0,0
86079,",",0,0
86080,randomised,0,0
86081,placebo,0,0
86082,controlled,0,0
86083,double,0,0
86084,blind,0,1
86085,clinical,0,0
86086,trial,0,0
86087,intended,0,0
86088,to,0,0
86089,investigate,0,0
86090,equivalent,0,0
86091,efficacy,0,0
86092,of,0,0
86093,placebo,0,0
86094,and,0,0
86095,amoxicillin,0,0
86096,and,0,0
86097,was,0,0
86098,conducted,0,0
86099,in,0,0
86100,ambulatory,0,1
86101,care,0,1
86102,settings,0,0
86103,in,0,0
86104,eight,1,1
86105,government,1,1
86106,hospitals,1,1
86107,in,1,1
86108,India,1,1
86109,.,1,1
86110,Participants,1,1
86111,were,1,1
86112,children,1,1
86113,aged,1,1
86114,2-59,1,1
86115,months,1,0
86116,of,1,0
86117,age,1,1
86118,",",0,1
86119,who,0,1
86120,received,0,1
86121,either,0,1
86122,oral,0,0
86123,amoxycillin,0,0
86124,(,0,0
86125,31-54,0,0
86126,mg/Kg/day,0,0
86127,",",0,0
86128,in,0,0
86129,three,0,0
86130,divided,0,1
86131,doses,0,0
86132,for,0,1
86133,three,0,1
86134,days,0,0
86135,),0,1
86136,or,0,1
86137,placebo,0,0
86138,",",0,0
86139,and,0,0
86140,standard,0,0
86141,bronchodilator,0,0
86142,therapy,0,0
86143,.,0,0
86144,Primary,0,0
86145,outcome,0,0
86146,was,0,0
86147,clinical,0,0
86148,failure,0,1
86149,on,0,0
86150,or,0,1
86151,before,0,0
86152,day-,0,0
86153,4,0,0
86154,.,0,1
86155,PRINCIPAL,0,0
86156,FINDINGS,0,0
86157,We,0,0
86158,randomized,0,1
86159,836,1,1
86160,cases,1,1
86161,in,1,0
86162,placebo,1,0
86163,and,1,0
86164,835,1,1
86165,in,1,0
86166,amoxycillin,1,0
86167,group,1,0
86168,.,1,1
86169,Clinical,0,0
86170,failures,0,0
86171,occurred,0,0
86172,in,0,0
86173,201,0,1
86174,(,0,1
86175,24.0,0,0
86176,%,0,0
86177,),0,0
86178,on,0,0
86179,placebo,0,0
86180,and,0,0
86181,166,0,1
86182,(,0,0
86183,19.9,0,0
86184,%,0,0
86185,),0,0
86186,on,0,0
86187,amoxycillin,0,0
86188,(,0,0
86189,risk,0,0
86190,difference,0,0
86191,4.2,0,0
86192,%,0,0
86193,in,0,0
86194,favour,0,0
86195,of,0,0
86196,antibiotic,0,0
86197,",",0,0
86198,95,0,0
86199,%,0,0
86200,CI,0,0
86201,:,0,1
86202,0.2,0,0
86203,to,0,0
86204,8.1,0,0
86205,),0,0
86206,.,0,0
86207,Adherence,0,0
86208,for,0,0
86209,both,0,0
86210,placebo,0,0
86211,and,0,0
86212,amoxycillin,0,0
86213,was,0,0
86214,>,0,1
86215,96,0,1
86216,%,0,0
86217,and,0,0
86218,98.9,0,0
86219,%,0,0
86220,subjects,0,1
86221,were,0,0
86222,followed,0,0
86223,up,0,0
86224,on,0,0
86225,day-,0,0
86226,4,0,0
86227,.,0,1
86228,Clinical,0,0
86229,failure,0,1
86230,was,0,0
86231,associated,0,0
86232,with,0,1
86233,(,0,0
86234,i,0,0
86235,),0,0
86236,placebo,0,0
86237,treatment,0,0
86238,(,0,0
86239,adjusted,0,0
86240,OR,0,0
86241,=,0,0
86242,1.28,0,0
86243,",",0,0
86244,95,0,0
86245,%,0,0
86246,CI,0,0
86247,:,0,1
86248,1.01,0,0
86249,to1.62,0,0
86250,),0,0
86251,",",0,0
86252,(,0,0
86253,ii,0,0
86254,),0,0
86255,excess,0,0
86256,respiratory,0,1
86257,rate,0,0
86258,of,0,0
86259,>,0,1
86260,10,0,1
86261,breaths,0,0
86262,per,0,0
86263,minute,0,0
86264,(,0,0
86265,adjusted,0,0
86266,OR,0,0
86267,=,0,0
86268,1.51,0,0
86269,",",0,0
86270,95,0,0
86271,%,0,0
86272,CI,0,0
86273,:,0,1
86274,1.19,0,0
86275,",",0,0
86276,1.92,0,0
86277,),0,0
86278,",",0,0
86279,(,0,0
86280,iii,0,0
86281,),0,0
86282,vomiting,0,0
86283,at,0,0
86284,enrolment,0,1
86285,(,0,0
86286,adjusted,0,0
86287,OR,0,0
86288,=,0,0
86289,1.49,0,0
86290,",",0,0
86291,95,0,0
86292,%,0,0
86293,CI,0,0
86294,:,0,1
86295,1.13,0,0
86296,",",0,0
86297,1.96,0,0
86298,),0,0
86299,",",0,0
86300,(,0,0
86301,iv,0,0
86302,),0,0
86303,history,0,1
86304,of,0,0
86305,use,0,0
86306,of,0,0
86307,broncho-dilators,0,1
86308,(,0,1
86309,adjusted,0,0
86310,OR,0,0
86311,=,0,0
86312,1.71,0,0
86313,",",0,0
86314,95,0,0
86315,%,0,0
86316,CI,0,0
86317,:,0,1
86318,1.30,0,0
86319,",",0,0
86320,2.24,0,0
86321,),0,0
86322,and,0,0
86323,(,0,0
86324,v,0,0
86325,),0,0
86326,non-adherence,0,0
86327,(,0,0
86328,adjusted,0,0
86329,OR,0,0
86330,=,0,0
86331,8.06,0,0
86332,",",0,0
86333,95,0,0
86334,%,0,0
86335,CI,0,0
86336,:,0,1
86337,4.36,0,0
86338,",",0,0
86339,14.92,0,0
86340,),0,0
86341,.,0,1
86342,CONCLUSIONS,0,0
86343,Treating,0,0
86344,children,1,1
86345,with,1,1
86346,non-severe,1,1
86347,pneumonia,1,1
86348,and,1,0
86349,wheeze,1,0
86350,with,0,1
86351,a,0,0
86352,placebo,0,0
86353,is,0,0
86354,not,0,0
86355,equivalent,0,0
86356,to,0,0
86357,treatment,0,0
86358,with,0,1
86359,oral,0,0
86360,amoxycillin,0,0
86361,.,0,1
86362,TRIAL,0,0
86363,REGISTRATION,0,0
86364,ClinicalTrials.gov,0,1
86365,NCT00407394,0,1
86366,.,0,1
86367,Omega-3/omega-6,0,0
86368,fatty,0,0
86369,acids,0,0
86370,for,0,0
86371,attention,0,0
86372,deficit,0,0
86373,hyperactivity,0,1
86374,disorder,0,1
86375,:,0,1
86376,a,0,0
86377,randomized,0,0
86378,placebo-controlled,0,0
86379,trial,0,1
86380,in,0,0
86381,children,1,1
86382,and,1,1
86383,adolescents,1,1
86384,.,1,1
86385,OBJECTIVE,0,0
86386,The,0,0
86387,aim,0,0
86388,of,0,0
86389,the,0,0
86390,study,0,0
86391,was,0,0
86392,to,0,0
86393,assess,0,0
86394,omega,0,0
86395,3/6,0,0
86396,fatty,0,0
86397,acids,0,0
86398,(,0,0
86399,eye,0,0
86400,q,0,0
86401,),0,0
86402,in,0,0
86403,attention,0,0
86404,deficit,0,0
86405,hyperactivity,0,1
86406,disorder,0,1
86407,(,0,0
86408,ADHD,0,0
86409,),0,0
86410,.,0,0
86411,METHOD,0,0
86412,The,0,0
86413,study,0,0
86414,included,0,0
86415,a,0,0
86416,randomized,0,0
86417,",",0,0
86418,3-month,0,0
86419,",",0,0
86420,omega,0,0
86421,3/6,0,0
86422,placebo-controlled,0,0
86423,",",0,0
86424,one-way,0,0
86425,crossover,0,0
86426,trial,0,0
86427,with,0,1
86428,75,1,1
86429,children,1,1
86430,and,1,1
86431,adolescents,1,1
86432,(,1,1
86433,8-18,1,1
86434,years,1,1
86435,),1,1
86436,",",0,0
86437,followed,0,0
86438,by,0,0
86439,3,0,0
86440,months,0,0
86441,with,0,1
86442,omega,0,0
86443,3/6,0,0
86444,for,0,0
86445,all,0,0
86446,.,0,0
86447,Investigator-rated,0,0
86448,ADHD,0,0
86449,Rating,0,0
86450,Scale-IV,0,1
86451,and,0,0
86452,Clinical,0,0
86453,Global,0,1
86454,Impression,0,0
86455,(,0,0
86456,CGI,0,1
86457,),0,0
86458,scale,0,0
86459,were,0,1
86460,outcome,0,0
86461,measures,0,0
86462,.,0,1
86463,RESULTS,0,0
86464,A,0,0
86465,majority,0,0
86466,did,0,0
86467,not,0,0
86468,respond,0,0
86469,to,0,0
86470,omega,0,0
86471,3/6,0,0
86472,treatment,0,0
86473,.,0,0
86474,However,0,0
86475,",",0,0
86476,a,0,0
86477,subgroup,0,0
86478,of,0,0
86479,26,0,1
86480,%,0,0
86481,responded,0,1
86482,with,0,1
86483,more,0,0
86484,than,0,0
86485,25,0,0
86486,%,0,0
86487,reduction,0,0
86488,of,0,0
86489,ADHD,0,0
86490,symptoms,0,0
86491,and,0,0
86492,a,0,0
86493,drop,0,0
86494,of,0,0
86495,CGI,0,1
86496,scores,0,0
86497,to,0,0
86498,the,0,0
86499,near-normal,0,0
86500,range,0,0
86501,.,0,1
86502,After,0,0
86503,6,0,0
86504,months,0,0
86505,",",0,1
86506,47,0,1
86507,%,0,0
86508,of,0,0
86509,all,0,0
86510,showed,0,0
86511,such,0,0
86512,improvement,0,0
86513,.,0,1
86514,Responders,1,0
86515,tended,1,0
86516,to,1,0
86517,have,1,0
86518,ADHD,1,0
86519,inattentive,1,0
86520,subtype,1,1
86521,and,1,0
86522,comorbid,1,1
86523,neurodevelopmental,1,1
86524,disorders,1,1
86525,.,1,1
86526,CONCLUSION,0,0
86527,A,1,0
86528,subgroup,1,0
86529,of,1,0
86530,children,1,1
86531,and,1,1
86532,adolescents,1,1
86533,with,1,1
86534,ADHD,1,0
86535,",",0,0
86536,characterized,0,0
86537,by,0,0
86538,inattention,0,0
86539,and,0,0
86540,associated,0,0
86541,neurodevelopmental,0,1
86542,disorders,0,1
86543,",",0,0
86544,treated,0,1
86545,with,0,1
86546,omega,0,0
86547,3/6,0,1
86548,fatty,0,0
86549,acids,0,0
86550,for,0,1
86551,6,0,1
86552,months,0,0
86553,responded,0,1
86554,with,0,1
86555,meaningful,0,0
86556,reduction,0,0
86557,of,0,0
86558,ADHD,0,0
86559,symptoms,0,1
86560,.,0,1
86561,Immunoenhanced,0,0
86562,enteral,0,1
86563,nutrition,0,0
86564,formulas,0,0
86565,in,0,0
86566,head,1,1
86567,and,1,0
86568,neck,1,1
86569,cancer,1,1
86570,surgery,1,1
86571,:,1,1
86572,a,0,0
86573,prospective,0,0
86574,",",0,0
86575,randomized,0,1
86576,clinical,0,0
86577,trial,0,1
86578,.,0,1
86579,INTRODUCTION,0,0
86580,Significant,0,0
86581,malnutrition,0,1
86582,exists,0,0
86583,in,0,0
86584,a,0,0
86585,high,0,0
86586,percentage,0,0
86587,of,0,0
86588,patients,1,1
86589,with,1,1
86590,head,1,1
86591,and,1,0
86592,neck,1,1
86593,cancer,1,1
86594,.,1,0
86595,Malnutrition,0,0
86596,is,0,0
86597,associated,0,0
86598,with,0,0
86599,defects,0,1
86600,in,0,0
86601,immune,0,0
86602,function,0,0
86603,that,0,0
86604,may,0,0
86605,impair,0,0
86606,the,0,0
86607,host,0,0
86608,response,0,0
86609,to,0,0
86610,malignancy,0,1
86611,.,0,0
86612,Malnutrition,0,0
86613,and,0,0
86614,immunosupression,0,0
86615,make,0,0
86616,patients,0,1
86617,highly,0,0
86618,susceptible,0,0
86619,to,0,0
86620,postoperative,0,0
86621,infections,0,1
86622,and,0,1
86623,complications,0,0
86624,.,0,1
86625,OBJECTIVES,0,0
86626,Compare,0,0
86627,two,0,0
86628,immunoenhanced,0,0
86629,enteral,0,1
86630,nutritions,0,0
86631,with,0,1
86632,a,0,0
86633,control,0,0
86634,diet,0,0
86635,",",0,0
86636,and,0,0
86637,evaluate,0,0
86638,the,0,0
86639,effect,0,0
86640,in,0,0
86641,postoperative,0,0
86642,infections,0,1
86643,",",0,0
86644,length,0,0
86645,of,0,0
86646,stay,0,0
86647,and,0,0
86648,inflammatory,0,0
86649,markers,0,0
86650,.,0,1
86651,PATIENTS,0,0
86652,A,1,0
86653,population,1,1
86654,of,1,0
86655,44,1,1
86656,patients,1,1
86657,with,1,1
86658,oral,1,0
86659,and,1,0
86660,laryngeal,1,1
86661,cancer,1,1
86662,was,1,0
86663,enrolled,1,1
86664,in,1,0
86665,a,1,0
86666,randomized,1,0
86667,trial,1,0
86668,.,1,0
86669,At,0,0
86670,surgery,0,1
86671,",",0,0
86672,patients,0,1
86673,were,0,0
86674,randomly,0,1
86675,allocated,0,1
86676,to,0,0
86677,three,0,1
86678,groups,0,0
86679,:,0,1
86680,(,0,0
86681,group,0,0
86682,I,0,1
86683,),0,1
86684,;,0,0
86685,patients,0,1
86686,receiving,0,1
86687,an,0,0
86688,arginine-enhanced,0,0
86689,formula,0,0
86690,(,0,0
86691,group,0,0
86692,II,0,1
86693,),0,1
86694,;,0,0
86695,patients,0,1
86696,receiving,0,1
86697,a,0,0
86698,standard,0,0
86699,polymeric,0,0
86700,formula,0,0
86701,",",0,0
86702,and,0,0
86703,(,0,0
86704,group,0,0
86705,III,0,1
86706,),0,0
86707,patients,0,1
86708,receiving,0,1
86709,an,0,0
86710,arginine,0,0
86711,",",0,0
86712,RNA,0,1
86713,and,0,0
86714,omega-3,0,0
86715,fatty,0,0
86716,acids,0,0
86717,enhanced,0,0
86718,formula,0,0
86719,",",0,0
86720,in,0,0
86721,an,0,0
86722,isonitrogenous,0,0
86723,way,0,0
86724,.,0,0
86725,RESULTS,0,0
86726,The,0,0
86727,duration,0,0
86728,of,0,0
86729,enteral,0,1
86730,nutrition,0,0
86731,in,0,0
86732,the,0,0
86733,three,0,0
86734,groups,0,0
86735,was,0,0
86736,similar,0,0
86737,with,0,1
86738,an,0,0
86739,average,0,0
86740,duration,0,0
86741,of,0,0
86742,"14,5",0,0
86743,+/-,0,0
86744,8,0,1
86745,days,0,0
86746,.,0,1
86747,The,0,0
86748,length,0,0
86749,of,0,0
86750,postoperative,0,0
86751,stay,0,0
86752,was,0,0
86753,similar,0,0
86754,",",0,0
86755,with,0,1
86756,an,0,0
86757,average,0,0
86758,of,0,0
86759,"19,8",0,0
86760,+/-,0,0
86761,"8,5",0,1
86762,days,0,0
86763,.,0,1
86764,Wound,0,0
86765,infections,0,0
86766,and,0,1
86767,general,0,1
86768,infections,0,0
86769,were,0,0
86770,more,0,0
86771,frequent,0,0
86772,in,0,0
86773,the,0,0
86774,control,0,0
86775,group,0,0
86776,.,0,1
86777,Fistula,0,0
86778,rates,0,0
86779,were,0,0
86780,not,0,0
86781,improved,0,0
86782,in,0,0
86783,the,0,0
86784,enhanced,0,0
86785,diet,0,1
86786,groups,0,0
86787,.,0,1
86788,No,0,0
86789,significant,0,0
86790,intergroup,0,0
86791,differences,0,0
86792,in,0,0
86793,the,0,0
86794,trend,0,0
86795,of,0,0
86796,the,0,0
86797,two,0,0
86798,plasma,0,0
86799,proteins,0,0
86800,(,0,0
86801,albumin,0,0
86802,",",0,0
86803,transferrin,0,0
86804,),0,0
86805,",",0,0
86806,lymphocytes,0,0
86807,",",0,0
86808,weight,0,0
86809,",",0,0
86810,IL-6,0,0
86811,",",0,0
86812,CPR,0,0
86813,and,0,0
86814,TNFalpha,0,0
86815,were,0,0
86816,detected,0,0
86817,.,0,0
86818,The,0,0
86819,control,0,0
86820,group,0,0
86821,showed,0,0
86822,the,0,0
86823,highest,0,0
86824,levels,0,0
86825,of,0,0
86826,TNFalpha,0,0
86827,at,0,0
86828,the,0,0
86829,fourteenth,0,0
86830,postoperative,0,0
86831,day,0,0
86832,.,0,1
86833,Gastrointestinal,0,0
86834,tolerance,0,0
86835,and,0,0
86836,diarrhoea,0,0
86837,rate,0,0
86838,were,0,0
86839,similar,0,0
86840,in,0,0
86841,all,0,0
86842,the,0,0
86843,patients,0,1
86844,.,0,1
86845,CONCLUSIONS,0,0
86846,Immunoenhanced,0,0
86847,enteral,0,1
86848,nutrition,0,1
86849,formulas,0,0
86850,improved,0,0
86851,the,0,0
86852,infection,0,0
86853,rate,0,0
86854,in,0,0
86855,the,0,0
86856,postoperative,0,0
86857,of,0,0
86858,head,1,1
86859,and,1,0
86860,neck,1,1
86861,cancer,1,1
86862,patients,1,1
86863,.,1,1
86864,In,0,0
86865,the,0,0
86866,fistula,0,0
86867,rates,0,0
86868,",",0,0
86869,we,0,0
86870,observed,0,0
86871,that,0,0
86872,technical,0,0
86873,problems,0,1
86874,and,0,1
86875,nutritional,0,0
86876,status,0,0
86877,might,0,0
86878,have,0,0
86879,played,0,0
86880,an,0,0
86881,equally,0,0
86882,important,0,0
86883,role,0,0
86884,",",0,0
86885,and,0,0
86886,therefore,0,0
86887,the,0,0
86888,positive,0,0
86889,effect,0,0
86890,of,0,0
86891,immunonutrition,0,0
86892,in,0,0
86893,this,0,0
86894,parameter,0,0
86895,might,0,0
86896,have,0,0
86897,been,0,0
86898,overestimated,0,0
86899,.,0,1
86900,Atypical,0,1
86901,recruitment,0,0
86902,of,0,0
86903,medial,0,0
86904,prefrontal,0,0
86905,cortex,0,0
86906,in,0,0
86907,autism,1,1
86908,spectrum,1,1
86909,disorders,1,1
86910,:,1,1
86911,an,0,0
86912,fMRI,0,0
86913,study,0,0
86914,of,0,0
86915,two,0,0
86916,executive,0,0
86917,function,0,0
86918,tasks,0,0
86919,.,0,1
86920,Recent,0,1
86921,studies,0,0
86922,have,0,0
86923,suggested,0,0
86924,an,0,0
86925,uneven,0,0
86926,profile,0,0
86927,of,0,0
86928,executive,0,0
86929,dysfunction,0,1
86930,in,0,0
86931,autism,1,1
86932,spectrum,1,1
86933,disorders,1,1
86934,(,1,1
86935,ASD,1,1
86936,),1,0
86937,.,1,0
86938,For,0,0
86939,example,0,0
86940,",",0,0
86941,some,0,0
86942,authors,0,0
86943,have,0,0
86944,reported,0,0
86945,deficits,0,0
86946,on,0,0
86947,newly,0,1
86948,developed,0,0
86949,tests,0,0
86950,of,0,0
86951,executive,0,0
86952,function,0,0
86953,sensitive,0,0
86954,to,0,0
86955,rostral,0,0
86956,prefrontal,0,0
86957,function,0,0
86958,",",0,0
86959,despite,0,0
86960,spared,0,0
86961,",",0,0
86962,or,0,0
86963,even,0,0
86964,superior,0,0
86965,",",0,0
86966,performance,0,0
86967,on,0,0
86968,other,0,0
86969,tests,0,0
86970,.,0,1
86971,We,0,0
86972,investigated,0,0
86973,the,0,0
86974,performance,0,0
86975,of,0,0
86976,a,0,0
86977,group,0,0
86978,of,0,0
86979,high-functioning,1,1
86980,participants,1,1
86981,with,1,1
86982,ASD,1,1
86983,(,1,1
86984,N=15,1,1
86985,),1,0
86986,and,1,0
86987,an,1,0
86988,age-,1,1
86989,and,1,0
86990,IQ-matched,1,1
86991,control,1,0
86992,group,1,0
86993,(,1,0
86994,N=18,1,1
86995,),1,0
86996,on,0,0
86997,two,0,0
86998,executive,0,0
86999,function,0,0
87000,tests,0,0
87001,",",0,0
87002,whilst,0,0
87003,undergoing,0,1
87004,functional,0,1
87005,magnetic,0,0
87006,resonance,0,0
87007,imaging,0,0
87008,(,0,0
87009,fMRI,0,0
87010,),0,0
87011,.,0,0
87012,Behaviourally,0,0
87013,",",0,0
87014,there,0,0
87015,were,0,0
87016,no,0,0
87017,significant,0,0
87018,differences,0,0
87019,between,0,0
87020,the,0,0
87021,two,0,0
87022,groups,0,0
87023,.,0,1
87024,In,0,0
87025,a,0,0
87026,classical,0,0
87027,test,0,0
87028,of,0,0
87029,executive,0,0
87030,function,0,0
87031,(,0,0
87032,random,0,1
87033,response,0,0
87034,generation,0,0
87035,),0,0
87036,",",0,0
87037,BOLD,0,0
87038,signal,0,0
87039,differed,0,0
87040,between,0,0
87041,the,0,0
87042,groups,0,0
87043,in,0,0
87044,the,0,0
87045,cerebellum,0,0
87046,but,0,0
87047,not,0,0
87048,in,0,0
87049,the,0,0
87050,frontal,0,0
87051,lobes,0,0
87052,.,0,0
87053,However,0,0
87054,",",0,0
87055,on,0,0
87056,a,0,0
87057,new,0,0
87058,test,0,0
87059,of,0,0
87060,executive,0,0
87061,function,0,0
87062,(,0,0
87063,selection,0,0
87064,between,0,0
87065,stimulus-oriented,0,0
87066,and,0,0
87067,stimulus-independent,0,0
87068,thought,0,0
87069,),0,0
87070,",",0,0
87071,the,0,0
87072,ASD,0,1
87073,group,0,0
87074,exhibited,0,0
87075,significantly,0,0
87076,greater,0,0
87077,signal-change,0,0
87078,in,0,0
87079,medial,0,0
87080,rostral,0,0
87081,prefrontal,0,0
87082,cortex,0,0
87083,(,0,0
87084,especially,0,0
87085,Brodmann,0,0
87086,Area,0,0
87087,10,0,1
87088,),0,0
87089,in,0,0
87090,the,0,0
87091,comparison,0,0
87092,of,0,0
87093,stimulus-oriented,0,0
87094,versus,0,0
87095,stimulus-independent,0,0
87096,attention,0,0
87097,.,0,0
87098,In,0,0
87099,addition,0,0
87100,",",0,0
87101,the,0,0
87102,new,0,0
87103,test,0,0
87104,(,0,0
87105,but,0,0
87106,not,0,0
87107,the,0,0
87108,classical,0,0
87109,test,0,0
87110,),0,0
87111,provided,0,0
87112,evidence,0,0
87113,for,0,0
87114,abnormal,0,0
87115,functional,0,1
87116,organisation,0,0
87117,of,0,0
87118,medial,0,0
87119,prefrontal,0,0
87120,cortex,0,0
87121,in,0,0
87122,ASD,1,1
87123,.,1,1
87124,These,0,0
87125,results,0,0
87126,underline,0,0
87127,the,0,0
87128,heterogeneity,0,0
87129,of,0,0
87130,different,0,0
87131,tests,0,0
87132,of,0,0
87133,executive,0,0
87134,function,0,0
87135,",",0,0
87136,and,0,0
87137,suggest,0,0
87138,that,0,0
87139,executive,0,0
87140,functioning,0,0
87141,in,0,0
87142,ASD,1,1
87143,is,0,0
87144,associated,0,0
87145,with,0,0
87146,task-specific,0,0
87147,functional,0,1
87148,change,0,0
87149,.,0,1
87150,[,0,0
87151,Radiotherapy,0,1
87152,of,0,0
87153,malignant,1,1
87154,brain,1,0
87155,gliomas,1,1
87156,using,0,0
87157,teniposide,0,0
87158,],0,1
87159,.,0,0
87160,Efficacy,0,0
87161,of,0,0
87162,radiochemotherapy,0,0
87163,of,0,0
87164,malignantly-converted,1,0
87165,brain,1,0
87166,gliomas,1,1
87167,using,0,0
87168,teniposide,0,0
87169,was,0,0
87170,evaluated,0,0
87171,in,0,0
87172,a,0,0
87173,randomized,0,0
87174,prospective,0,0
87175,study,0,1
87176,.,0,0
87177,Combined,0,0
87178,use,0,0
87179,of,0,0
87180,cytostatics,0,0
87181,and,0,1
87182,irradiation,0,0
87183,appeared,0,0
87184,safe,0,0
87185,",",0,0
87186,tolerable,0,0
87187,and,0,0
87188,significantly,0,0
87189,more,0,0
87190,effective,0,0
87191,than,0,0
87192,radiotherapy,0,1
87193,alone,0,0
87194,as,0,0
87195,assessed,0,0
87196,by,0,0
87197,local,0,0
87198,control,0,1
87199,of,0,0
87200,tumor,0,0
87201,and,0,0
87202,survival,0,0
87203,.,0,1
87204,A,0,0
87205,comparison,0,0
87206,of,0,0
87207,single-dose,0,0
87208,versus,0,0
87209,conventional-dose,0,0
87210,antibiotic,0,0
87211,treatment,0,0
87212,of,0,0
87213,bacteriuria,1,1
87214,in,1,0
87215,elderly,1,1
87216,women,1,1
87217,.,1,1
87218,The,0,0
87219,efficacy,0,0
87220,of,0,0
87221,single-dose,0,0
87222,antibiotic,0,0
87223,therapy,0,0
87224,for,0,0
87225,the,0,0
87226,treatment,0,0
87227,of,0,0
87228,bacteriuria,1,1
87229,in,1,0
87230,a,1,0
87231,group,1,0
87232,of,1,0
87233,non-catheterized,1,1
87234,elderly,1,1
87235,women,1,1
87236,was,0,0
87237,compared,0,0
87238,with,0,1
87239,that,0,0
87240,of,0,0
87241,conventional,0,0
87242,7-10,0,1
87243,day,0,0
87244,courses,0,0
87245,of,0,0
87246,antibiotic,0,1
87247,therapy,0,0
87248,.,0,1
87249,Thirty-one,1,1
87250,women,1,1
87251,received,1,1
87252,single-dose,1,0
87253,treatment,1,0
87254,and,1,0
87255,22,1,1
87256,conventional-dose,1,0
87257,treatment,1,0
87258,.,1,0
87259,The,0,0
87260,cure,0,0
87261,rates,0,0
87262,at,0,0
87263,1,0,1
87264,and,0,1
87265,6,0,0
87266,weeks,0,0
87267,for,0,0
87268,the,0,0
87269,single-dose,0,0
87270,treatments,0,0
87271,were,0,1
87272,52,0,1
87273,%,0,0
87274,and,0,0
87275,38,0,1
87276,%,0,0
87277,",",0,0
87278,respectively,0,0
87279,",",0,0
87280,and,0,0
87281,the,0,0
87282,cure,0,0
87283,rates,0,0
87284,for,0,0
87285,the,0,0
87286,conventional-dose,0,0
87287,treatments,0,0
87288,at,0,1
87289,1,0,1
87290,and,0,1
87291,6,0,0
87292,weeks,0,0
87293,were,0,1
87294,59,0,1
87295,%,0,0
87296,and,0,0
87297,52,0,1
87298,%,0,0
87299,",",0,0
87300,respectively,0,0
87301,.,0,0
87302,It,0,0
87303,is,0,0
87304,concluded,0,0
87305,that,0,0
87306,there,0,0
87307,may,0,0
87308,be,0,0
87309,a,0,0
87310,place,0,0
87311,for,0,0
87312,the,0,0
87313,use,0,0
87314,of,0,0
87315,single-dose,0,0
87316,antibiotic,0,0
87317,therapy,0,0
87318,for,0,0
87319,the,0,0
87320,treatment,0,0
87321,of,0,0
87322,selected,1,1
87323,elderly,1,1
87324,women,1,1
87325,with,1,1
87326,bacteriuria,1,1
87327,",",0,0
87328,but,0,0
87329,larger,0,0
87330,studies,0,0
87331,are,0,0
87332,needed,0,0
87333,.,0,1
87334,Use,0,0
87335,of,0,0
87336,topical,0,0
87337,selamectin,0,0
87338,for,0,0
87339,the,0,0
87340,treatment,0,0
87341,of,0,0
87342,Syphacia,1,1
87343,muris,1,1
87344,infection,1,0
87345,in,1,0
87346,laboratory,1,0
87347,rats,1,1
87348,.,1,1
87349,Efficacy,0,0
87350,of,0,0
87351,selamectin,0,0
87352,was,0,0
87353,studied,0,0
87354,in,0,0
87355,naturally,1,1
87356,acquired,1,0
87357,S.,1,1
87358,muris,1,1
87359,infections,1,1
87360,in,0,1
87361,rats,1,1
87362,.,1,1
87363,Fourty-eight,1,1
87364,S.,1,1
87365,muris-positive,1,1
87366,rats,1,1
87367,were,0,1
87368,divided,0,1
87369,into,0,1
87370,six,0,1
87371,treated,0,1
87372,and,0,1
87373,two,0,0
87374,control,0,1
87375,groups,0,0
87376,.,0,1
87377,Selamectin,0,0
87378,(,0,0
87379,6,0,0
87380,mg/kg,0,0
87381,),0,0
87382,was,0,0
87383,applied,0,0
87384,topically,0,0
87385,to,0,0
87386,the,0,0
87387,skin,0,0
87388,in,0,0
87389,a,0,0
87390,single,0,0
87391,spot,0,0
87392,at,0,0
87393,the,0,0
87394,base,0,0
87395,of,0,0
87396,the,0,0
87397,neck,0,1
87398,in,0,0
87399,the,0,0
87400,treatment,0,0
87401,group,0,0
87402,.,0,0
87403,The,0,0
87404,rats,0,0
87405,of,0,0
87406,treated,0,1
87407,and,0,0
87408,control,0,1
87409,groups,0,0
87410,were,0,0
87411,necropsied,0,1
87412,on,0,0
87413,the,0,0
87414,24th,0,0
87415,day,0,0
87416,after,0,0
87417,the,0,0
87418,treatment,0,0
87419,.,0,0
87420,Topical,0,0
87421,selamectin,0,0
87422,was,0,0
87423,found,0,0
87424,to,0,0
87425,be,0,0
87426,40.7-63.3,0,0
87427,%,0,0
87428,effective,0,0
87429,(,0,0
87430,based,0,0
87431,on,0,0
87432,egg,0,0
87433,per,0,0
87434,gram,0,0
87435,method,0,0
87436,),0,0
87437,in,0,0
87438,eliminating,0,0
87439,S.,0,1
87440,muris,0,0
87441,infection,0,1
87442,in,0,0
87443,rats,0,1
87444,.,0,1
87445,The,0,0
87446,efficacy,0,0
87447,of,0,0
87448,the,0,0
87449,treatment,0,0
87450,against,0,0
87451,S.,0,1
87452,muris,0,1
87453,(,0,0
87454,based,0,0
87455,on,0,0
87456,adult,0,1
87457,worm,0,0
87458,counts,0,0
87459,),0,0
87460,in,0,0
87461,male,1,1
87462,and,1,0
87463,female,1,1
87464,rats,1,1
87465,was,0,0
87466,35.14-58.88,0,0
87467,%,0,0
87468,",",0,0
87469,respectively,0,0
87470,(,0,0
87471,mean,0,0
87472,48.39,0,1
87473,%,0,0
87474,),0,1
87475,.,0,1
87476,In,0,1
87477,school-aged,1,1
87478,children,1,1
87479,a,0,0
87480,combination,0,0
87481,of,0,0
87482,galacto-oligosaccharides,0,0
87483,and,0,1
87484,Lactobacillus,0,0
87485,GG,0,0
87486,increases,0,0
87487,bifidobacteria,0,0
87488,more,0,0
87489,than,0,0
87490,Lactobacillus,0,0
87491,GG,0,0
87492,on,0,0
87493,its,0,0
87494,own,0,1
87495,.,0,0
87496,The,0,0
87497,aim,0,0
87498,of,0,0
87499,this,0,0
87500,study,0,0
87501,was,0,0
87502,to,0,0
87503,compare,0,0
87504,a,0,0
87505,combination,0,0
87506,of,0,0
87507,Lactobacillus,0,0
87508,GG,0,0
87509,(,0,0
87510,LGG,0,0
87511,),0,0
87512,and,0,0
87513,galacto-oligosaccharides,0,0
87514,(,0,1
87515,GOS,0,0
87516,),0,0
87517,with,0,1
87518,LGG,0,0
87519,on,0,0
87520,its,0,0
87521,own,0,1
87522,",",0,0
87523,and,0,0
87524,their,0,0
87525,effects,0,0
87526,on,0,0
87527,the,0,0
87528,intestinal,0,0
87529,microbiota,0,0
87530,in,0,0
87531,school-aged,1,1
87532,children,1,1
87533,.,1,1
87534,The,0,0
87535,randomized,0,0
87536,",",0,0
87537,double-blinded,0,0
87538,",",0,0
87539,crossover,0,0
87540,study,0,0
87541,comprised,0,1
87542,30,1,1
87543,healthy,1,1
87544,children,1,1
87545,.,1,0
87546,There,0,0
87547,were,0,0
87548,two,0,0
87549,3-week,0,0
87550,study,0,1
87551,periods,0,0
87552,with,0,1
87553,a,0,1
87554,4-week,0,0
87555,wash-out,0,0
87556,period,0,0
87557,in,0,0
87558,between,0,0
87559,.,0,1
87560,The,0,0
87561,children,0,1
87562,ingested,0,1
87563,daily,0,0
87564,65,0,1
87565,ml,0,0
87566,of,0,0
87567,milk-based,0,0
87568,fruit,0,1
87569,juice,0,0
87570,containing,0,0
87571,either,0,0
87572,LGG,0,0
87573,alone,0,0
87574,(,0,0
87575,6.5,0,0
87576,x,0,0
87577,10,0,1
87578,(,0,0
87579,9,0,1
87580,),0,1
87581,CFU,0,1
87582,),0,0
87583,or,0,1
87584,LGG,0,0
87585,plus,0,0
87586,2,0,0
87587,g,0,1
87588,of,0,0
87589,GOS,0,0
87590,.,0,1
87591,Symptom,0,0
87592,diaries,0,0
87593,were,0,0
87594,filled,0,1
87595,during,0,0
87596,the,0,0
87597,study,0,0
87598,periods,0,0
87599,.,0,1
87600,Fecal,0,0
87601,samples,0,0
87602,were,0,1
87603,collected,0,0
87604,at,0,0
87605,the,0,0
87606,beginning,0,0
87607,and,0,0
87608,end,0,0
87609,of,0,0
87610,both,0,0
87611,study,0,0
87612,periods,0,0
87613,.,0,1
87614,At,0,0
87615,the,0,0
87616,end,0,0
87617,of,0,0
87618,both,0,0
87619,study,0,0
87620,periods,0,0
87621,",",0,0
87622,the,0,0
87623,amount,0,0
87624,of,0,0
87625,bifidobacteria,0,0
87626,was,0,0
87627,significantly,0,0
87628,greater,0,0
87629,after,0,0
87630,the,0,0
87631,ingestion,0,0
87632,of,0,0
87633,LGG,0,0
87634,+,0,0
87635,GOS,0,0
87636,compared,0,0
87637,with,0,1
87638,LGG,0,0
87639,alone,0,0
87640,(,0,0
87641,geometric,0,0
87642,mean,0,1
87643,9.33,0,0
87644,x,0,0
87645,10,0,1
87646,(,0,0
87647,9,0,0
87648,),0,1
87649,vs.,0,0
87650,4.28,0,0
87651,x,0,0
87652,10,0,1
87653,(,0,0
87654,9,0,1
87655,),0,0
87656,CFU/g,0,0
87657,",",0,0
87658,p,0,0
87659,<,0,0
87660,0.001,0,0
87661,),0,0
87662,.,0,0
87663,No,0,0
87664,significant,0,0
87665,differences,0,0
87666,were,0,1
87667,seen,0,0
87668,in,0,0
87669,the,0,0
87670,amount,0,0
87671,of,0,0
87672,lactobacilli,0,0
87673,or,0,1
87674,LGG,0,0
87675,",",0,0
87676,nor,0,0
87677,did,0,0
87678,gastrointestinal,0,1
87679,symptoms,0,0
87680,",",0,0
87681,defecation,0,1
87682,frequency,0,0
87683,",",0,0
87684,consistency,0,0
87685,of,0,0
87686,stools,0,0
87687,or,0,1
87688,ease,0,0
87689,of,0,0
87690,defecation,0,1
87691,differ,0,0
87692,between,0,0
87693,the,0,0
87694,two,0,0
87695,study,0,1
87696,periods,0,0
87697,.,0,1
87698,Ingestion,0,0
87699,of,0,0
87700,LGG,0,0
87701,combined,0,0
87702,with,0,1
87703,2,0,0
87704,g,0,1
87705,of,0,0
87706,GOS,0,0
87707,increased,0,0
87708,the,0,0
87709,bifidobacteria,0,0
87710,more,0,0
87711,than,0,0
87712,LGG,0,0
87713,on,0,0
87714,its,0,0
87715,own,0,1
87716,and,0,0
87717,thus,0,0
87718,GOS,0,0
87719,clearly,0,0
87720,has,0,0
87721,a,0,0
87722,prebiotic,0,0
87723,effect,0,0
87724,in,0,0
87725,children,1,1
87726,.,1,1
87727,The,0,0
87728,children,1,1
87729,tolerated,0,0
87730,well,0,0
87731,a,0,0
87732,daily,0,0
87733,intake,0,0
87734,of,0,0
87735,2,0,0
87736,g,0,1
87737,of,0,0
87738,GOS,0,0
87739,.,0,1
87740,Best,0,0
87741,evidence,0,0
87742,in,0,0
87743,critical,0,0
87744,care,0,1
87745,medicine,0,1
87746,.,0,1
87747,Steroids,0,0
87748,to,0,0
87749,prevent,0,0
87750,post-extubation,0,0
87751,airway,0,1
87752,obstruction,0,1
87753,in,0,0
87754,adult,1,1
87755,critically,1,0
87756,ill,1,1
87757,patients,1,1
87758,.,1,1
87759,The,0,0
87760,effect,0,0
87761,of,0,0
87762,cyclosporin,0,0
87763,administered,0,0
87764,during,0,0
87765,a,0,0
87766,third-party,1,0
87767,blood,1,0
87768,transfusion,1,0
87769,protocol,1,0
87770,on,0,0
87771,humoral,0,0
87772,immune,0,0
87773,responses,0,0
87774,.,0,1
87775,Antigen,1,0
87776,pre-treatment,1,0
87777,in,1,0
87778,animals,1,1
87779,undoubtedly,0,0
87780,prolongs,0,0
87781,graft,0,0
87782,survival,0,0
87783,.,0,0
87784,In,0,0
87785,man,0,0
87786,",",0,0
87787,however,0,0
87788,",",0,0
87789,routine,0,0
87790,pre-transplantation,1,1
87791,blood,1,0
87792,transfusions,1,0
87793,have,0,0
87794,recently,0,1
87795,become,0,0
87796,controversial,0,0
87797,",",0,0
87798,principally,0,0
87799,because,0,0
87800,of,0,0
87801,the,0,0
87802,adverse,0,0
87803,effect,0,0
87804,of,0,0
87805,transfusion-induced,0,0
87806,sensitisation,0,0
87807,on,0,0
87808,graft,0,0
87809,survival,0,0
87810,rates,0,0
87811,.,0,1
87812,We,0,0
87813,have,0,0
87814,monitored,0,0
87815,the,0,0
87816,effect,0,0
87817,of,0,0
87818,cyclosporin,0,0
87819,administered,0,0
87820,during,0,0
87821,a,0,0
87822,planned,1,0
87823,programme,1,0
87824,of,1,0
87825,third-party,1,0
87826,blood,1,0
87827,transfusions,1,0
87828,on,0,0
87829,the,0,0
87830,development,0,0
87831,of,0,0
87832,both,0,0
87833,cytotoxic,0,0
87834,and,0,0
87835,anti-idiotypic,0,0
87836,antibodies,0,0
87837,.,0,1
87838,A,0,0
87839,total,0,1
87840,of,0,0
87841,24,1,1
87842,patients,1,1
87843,were,1,1
87844,recruited,1,1
87845,to,1,0
87846,the,1,0
87847,study,1,0
87848,;,1,0
87849,ten,1,1
87850,received,1,0
87851,cyclosporin,1,0
87852,with,1,1
87853,blood,1,0
87854,transfusions,1,0
87855,(,1,1
87856,BT,1,0
87857,),1,0
87858,(,1,0
87859,group,1,1
87860,1,1,0
87861,),1,0
87862,",",1,0
87863,14,1,0
87864,received,1,0
87865,BT,1,0
87866,alone,1,0
87867,(,1,0
87868,group,1,0
87869,2,1,1
87870,),1,0
87871,.,0,1
87872,Anti-HLA,0,0
87873,antibodies,0,0
87874,developed,0,1
87875,in,0,0
87876,3,0,0
87877,of,0,1
87878,9,0,1
87879,patients,0,1
87880,in,0,1
87881,group,0,1
87882,1,0,0
87883,and,0,0
87884,8,0,0
87885,of,0,0
87886,12,0,1
87887,patients,0,1
87888,in,0,1
87889,group,0,1
87890,2,0,0
87891,(,0,0
87892,P,0,0
87893,less,0,0
87894,than,0,0
87895,0.05,0,0
87896,),0,1
87897,.,0,1
87898,Anti-idiotypic,0,0
87899,antibody,0,0
87900,activity,0,0
87901,was,0,0
87902,detectable,0,0
87903,in,0,0
87904,9,0,1
87905,of,0,1
87906,9,0,1
87907,patients,0,1
87908,in,0,1
87909,group,0,1
87910,1,0,0
87911,and,0,0
87912,7,0,1
87913,of,0,0
87914,12,0,1
87915,patients,0,1
87916,in,0,1
87917,group,0,1
87918,2,0,0
87919,(,0,0
87920,P,0,0
87921,less,0,0
87922,than,0,0
87923,0.006,0,0
87924,),0,1
87925,.,0,0
87926,The,0,0
87927,mechanism,0,0
87928,by,0,0
87929,which,0,0
87930,cyclosporin,0,0
87931,can,0,0
87932,prevent,0,0
87933,an,0,0
87934,anti-HLA,0,0
87935,antibody,0,0
87936,response,0,0
87937,and,0,0
87938,promote,0,0
87939,an,0,0
87940,anti-idiotypic,0,0
87941,response,0,0
87942,is,0,0
87943,unclear,0,0
87944,.,0,0
87945,Cognitive,0,1
87946,effects,0,0
87947,of,0,0
87948,risperidone,0,0
87949,in,0,0
87950,children,1,1
87951,with,1,1
87952,autism,1,1
87953,and,1,0
87954,irritable,1,1
87955,behavior,1,0
87956,.,1,0
87957,OBJECTIVE,0,0
87958,The,0,0
87959,objective,0,0
87960,of,0,0
87961,this,0,0
87962,research,0,0
87963,was,0,0
87964,to,0,0
87965,explore,0,0
87966,the,0,0
87967,effects,0,0
87968,of,0,0
87969,risperidone,0,0
87970,on,0,0
87971,cognitive,0,1
87972,processes,0,0
87973,in,0,1
87974,children,1,1
87975,with,1,1
87976,autism,1,1
87977,and,1,0
87978,irritable,1,1
87979,behavior,1,0
87980,.,1,1
87981,METHOD,0,0
87982,Thirty-eight,1,1
87983,children,1,1
87984,",",1,0
87985,ages,1,1
87986,5-17,1,1
87987,years,1,1
87988,with,1,1
87989,autism,1,1
87990,and,1,0
87991,severe,1,1
87992,behavioral,1,0
87993,disturbance,1,0
87994,",",0,0
87995,were,0,0
87996,randomly,0,1
87997,assigned,0,0
87998,to,0,0
87999,risperidone,0,0
88000,(,0,0
88001,0.5,0,0
88002,to,0,0
88003,3.5,0,1
88004,mg/day,0,0
88005,),0,0
88006,or,0,0
88007,placebo,0,0
88008,for,0,0
88009,8,0,0
88010,weeks,0,0
88011,.,0,1
88012,This,1,0
88013,sample,1,1
88014,of,1,0
88015,38,1,1
88016,was,1,0
88017,a,1,0
88018,subset,1,1
88019,of,1,0
88020,101,1,1
88021,subjects,1,1
88022,who,1,1
88023,participated,1,1
88024,in,1,1
88025,the,1,0
88026,clinical,1,0
88027,trial,1,1
88028,;,1,1
88029,63,1,1
88030,were,1,0
88031,unable,1,0
88032,to,1,0
88033,perform,1,0
88034,the,1,0
88035,cognitive,1,0
88036,tasks,1,0
88037,.,1,1
88038,A,0,0
88039,double-blind,0,0
88040,placebo-controlled,0,0
88041,parallel,0,0
88042,groups,0,0
88043,design,0,0
88044,was,0,0
88045,used,0,0
88046,.,0,1
88047,Dependent,0,0
88048,measures,0,0
88049,included,0,1
88050,tests,0,0
88051,of,0,0
88052,sustained,0,0
88053,attention,0,0
88054,",",0,0
88055,verbal,0,0
88056,learning,0,0
88057,",",0,0
88058,hand-eye,0,0
88059,coordination,0,0
88060,",",0,0
88061,and,0,0
88062,spatial,0,0
88063,memory,0,0
88064,assessed,0,0
88065,before,0,0
88066,",",0,0
88067,during,0,0
88068,",",0,0
88069,and,0,0
88070,after,0,0
88071,the,0,0
88072,8-week,0,0
88073,treatment,0,0
88074,.,0,1
88075,Changes,0,0
88076,in,0,0
88077,performance,0,0
88078,were,0,0
88079,compared,0,0
88080,by,0,0
88081,repeated,0,0
88082,measures,0,0
88083,ANOVA,0,0
88084,.,0,1
88085,RESULTS,0,0
88086,Twenty-nine,1,1
88087,boys,1,1
88088,and,1,1
88089,9,1,1
88090,girls,1,1
88091,with,1,1
88092,autism,1,1
88093,and,1,0
88094,severe,1,1
88095,behavioral,1,0
88096,disturbance,1,0
88097,and,1,0
88098,a,1,0
88099,mental,1,1
88100,age,1,1
88101,>,1,1
88102,or=18,1,1
88103,months,1,0
88104,completed,1,1
88105,the,1,0
88106,cognitive,1,0
88107,part,1,0
88108,of,1,0
88109,the,1,0
88110,study,1,0
88111,.,1,0
88112,No,0,0
88113,decline,0,0
88114,in,0,0
88115,performance,0,0
88116,occurred,0,0
88117,with,0,1
88118,risperidone,0,0
88119,.,0,0
88120,Performance,0,0
88121,on,0,0
88122,a,0,0
88123,cancellation,0,0
88124,task,0,0
88125,(,0,0
88126,number,0,0
88127,of,0,0
88128,correct,0,0
88129,detections,0,0
88130,),0,1
88131,and,0,0
88132,a,0,0
88133,verbal,0,0
88134,learning,0,0
88135,task,0,0
88136,(,0,0
88137,word,0,0
88138,recognition,0,1
88139,),0,0
88140,was,0,0
88141,better,0,0
88142,on,0,0
88143,risperidone,0,0
88144,than,0,0
88145,on,0,0
88146,placebo,0,0
88147,(,0,0
88148,without,0,0
88149,correction,0,0
88150,for,0,0
88151,multiplicity,0,0
88152,),0,0
88153,.,0,0
88154,Equivocal,0,0
88155,improvement,0,0
88156,also,0,0
88157,occurred,0,0
88158,on,0,0
88159,a,0,0
88160,spatial,0,0
88161,memory,0,0
88162,task,0,0
88163,.,0,0
88164,There,0,0
88165,were,0,0
88166,no,0,0
88167,significant,0,0
88168,differences,0,0
88169,between,0,0
88170,treatment,0,0
88171,conditions,0,0
88172,on,0,0
88173,the,0,0
88174,Purdue,0,0
88175,Pegboard,0,0
88176,(,0,0
88177,hand-eye,0,0
88178,coordination,0,0
88179,),0,0
88180,task,0,0
88181,or,0,1
88182,the,0,0
88183,Analog,0,0
88184,Classroom,0,1
88185,Task,0,0
88186,(,0,0
88187,timed,0,0
88188,math,0,0
88189,test,0,0
88190,),0,0
88191,.,0,1
88192,CONCLUSION,0,0
88193,Risperidone,0,0
88194,given,0,0
88195,to,0,0
88196,children,1,1
88197,with,1,1
88198,autism,1,1
88199,at,0,0
88200,doses,0,0
88201,up,0,0
88202,to,0,0
88203,3.5,0,0
88204,mg,0,0
88205,for,0,0
88206,up,0,0
88207,to,0,1
88208,8,0,0
88209,weeks,0,0
88210,appears,0,0
88211,to,0,0
88212,have,0,0
88213,no,0,0
88214,detrimental,0,0
88215,effect,0,0
88216,on,0,0
88217,cognitive,0,0
88218,performance,0,0
88219,.,0,1
88220,Comparison,0,0
88221,of,0,0
88222,amantadine,0,0
88223,and,0,0
88224,desipramine,0,0
88225,combined,0,0
88226,with,0,1
88227,psychotherapy,0,0
88228,for,0,0
88229,treatment,0,0
88230,of,0,0
88231,cocaine,1,0
88232,dependence,1,0
88233,.,1,0
88234,We,0,0
88235,conducted,0,0
88236,a,0,0
88237,single-blind,0,0
88238,",",0,0
88239,random,0,0
88240,assignment,0,0
88241,",",0,0
88242,placebo-controlled,0,0
88243,",",0,0
88244,12-week,0,0
88245,comparison,0,0
88246,of,0,0
88247,desipramine,0,0
88248,hydrochloride,0,0
88249,and,0,0
88250,amantadine,0,0
88251,hydrochloride,0,0
88252,as,0,0
88253,adjunctive,0,0
88254,treatments,0,0
88255,to,0,0
88256,counseling,0,0
88257,for,0,0
88258,cocaine,0,1
88259,dependence,0,0
88260,.,0,1
88261,Subjects,1,1
88262,were,1,1
88263,54,1,1
88264,outpatients,1,1
88265,who,1,1
88266,met,1,1
88267,DSM,1,1
88268,III-R,1,0
88269,criteria,1,1
88270,for,1,0
88271,active,1,1
88272,cocaine,1,0
88273,dependence,1,1
88274,and,1,1
88275,who,1,1
88276,completed,1,1
88277,a,1,1
88278,minimum,1,0
88279,of,1,0
88280,2,1,0
88281,weeks,1,0
88282,of,1,1
88283,treatment,1,0
88284,.,1,1
88285,Subjects,0,0
88286,treated,0,1
88287,with,0,1
88288,fixed,0,0
88289,doses,0,0
88290,of,0,1
88291,200,0,1
88292,mg/day,0,0
88293,desipramine,0,0
88294,(,0,0
88295,N,0,1
88296,=,0,0
88297,17,0,1
88298,),0,0
88299,",",0,0
88300,400,0,0
88301,mg/day,0,0
88302,amantadine-placebo,0,0
88303,(,0,1
88304,N,0,1
88305,=,0,0
88306,16,0,1
88307,),0,0
88308,",",0,0
88309,and,0,0
88310,placebo,0,0
88311,(,0,0
88312,N,0,1
88313,=,0,0
88314,21,0,1
88315,),0,0
88316,did,1,0
88317,not,1,0
88318,differ,1,0
88319,for,1,0
88320,lifetime,1,0
88321,cocaine,1,0
88322,use,1,0
88323,",",1,0
88324,lifetime,1,0
88325,histories,1,0
88326,of,1,0
88327,psychopathology,1,1
88328,",",1,0
88329,admission,1,0
88330,scores,1,0
88331,on,1,0
88332,psychometric,1,0
88333,assessments,1,0
88334,",",1,0
88335,and,1,1
88336,sociodemographics,1,0
88337,.,1,0
88338,All,0,0
88339,treatment,0,0
88340,groups,0,0
88341,demonstrated,0,0
88342,dramatic,0,0
88343,and,0,1
88344,persistent,0,1
88345,decreases,0,0
88346,in,0,0
88347,cocaine,0,0
88348,use,0,0
88349,",",0,0
88350,craving,0,0
88351,for,0,0
88352,cocaine,0,0
88353,",",0,0
88354,and,0,0
88355,psychiatric,0,1
88356,symptoms,0,0
88357,consequent,0,0
88358,to,0,0
88359,treatment,0,0
88360,.,0,0
88361,Although,0,0
88362,there,0,0
88363,was,0,0
88364,a,0,0
88365,trend,0,0
88366,for,0,0
88367,more,0,0
88368,dropouts,0,0
88369,by,0,0
88370,subjects,0,1
88371,taking,0,1
88372,desipramine,0,0
88373,",",0,0
88374,there,0,0
88375,were,0,0
88376,no,0,0
88377,significant,0,0
88378,differences,0,0
88379,among,0,1
88380,treatment,0,0
88381,groups,0,0
88382,regarding,0,0
88383,retention,0,0
88384,in,0,0
88385,treatment,0,0
88386,",",0,0
88387,craving,0,0
88388,for,0,0
88389,cocaine,0,0
88390,",",0,0
88391,and,0,0
88392,decreased,0,0
88393,cocaine,0,0
88394,use,0,0
88395,confirmed,0,0
88396,by,0,0
88397,urine,0,0
88398,toxicology,0,0
88399,.,0,0
88400,There,0,0
88401,was,0,0
88402,a,0,0
88403,trend,0,0
88404,for,0,0
88405,subjects,0,1
88406,treated,0,1
88407,with,0,1
88408,desipramine,0,0
88409,to,0,0
88410,maintain,0,0
88411,longer,0,0
88412,periods,0,0
88413,of,0,0
88414,cocaine,0,1
88415,abstinence,0,0
88416,.,0,0
88417,Mean,0,0
88418,plasma,0,0
88419,concentration,0,0
88420,of,0,0
88421,desipramine,0,0
88422,in,0,0
88423,a,0,0
88424,subsample,0,1
88425,of,0,0
88426,our,0,0
88427,subjects,0,1
88428,was,0,0
88429,less,0,0
88430,than,0,0
88431,that,0,0
88432,recommended,0,0
88433,for,0,0
88434,treatment,0,0
88435,of,0,0
88436,depression,0,0
88437,",",0,0
88438,thus,0,0
88439,the,0,0
88440,dosage,0,0
88441,of,0,0
88442,desipramine,0,0
88443,may,0,0
88444,have,0,0
88445,been,0,0
88446,subtherapeutic,0,0
88447,.,0,1
88448,Placebo-controlled,0,0
88449,trial,0,0
88450,evaluating,0,0
88451,safety,0,0
88452,with,0,1
88453,12-months,0,0
88454,continuous,0,0
88455,use,0,0
88456,of,0,0
88457,6,0,0
88458,%,0,0
88459,hydrogen,0,0
88460,peroxide,0,0
88461,whitening,0,0
88462,strips,0,0
88463,.,0,1
88464,OBJECTIVE,0,0
88465,To,0,0
88466,assess,0,0
88467,the,0,0
88468,safety,0,0
88469,and,0,0
88470,tolerability,0,0
88471,of,0,0
88472,6,0,0
88473,%,0,0
88474,hydrogen,0,0
88475,peroxide,0,0
88476,whitening,0,0
88477,strips,0,0
88478,over,0,0
88479,12,0,1
88480,months,0,0
88481,.,0,1
88482,METHODS,0,0
88483,80,1,1
88484,adults,1,1
88485,were,1,1
88486,randomly,1,1
88487,assigned,1,0
88488,equally,0,0
88489,to,0,0
88490,one,0,0
88491,of,0,0
88492,two,0,1
88493,treatments,0,1
88494,:,0,1
88495,6,0,0
88496,%,0,0
88497,hydrogen,0,0
88498,peroxide,0,0
88499,strips,0,0
88500,or,0,1
88501,placebo,0,0
88502,strips,0,0
88503,.,0,1
88504,Strips,0,0
88505,were,0,1
88506,worn,0,1
88507,5,0,0
88508,min,0,0
88509,daily,0,0
88510,for,0,0
88511,12,0,0
88512,months,0,0
88513,.,0,1
88514,Safety,0,0
88515,and,0,0
88516,tolerability,0,0
88517,were,0,0
88518,assessed,0,0
88519,via,0,0
88520,oral,0,0
88521,status,0,1
88522,interviews,0,1
88523,and,0,1
88524,oral,0,0
88525,examinations,0,0
88526,at,0,0
88527,baseline,0,0
88528,and,0,0
88529,after,0,0
88530,1,0,0
88531,",",0,0
88532,2,0,0
88533,",",0,0
88534,3,0,0
88535,",",0,0
88536,6,0,0
88537,",",0,0
88538,9,0,0
88539,",",0,0
88540,and,0,0
88541,12,0,0
88542,months,0,0
88543,of,0,1
88544,use,0,0
88545,.,0,1
88546,RESULTS,0,0
88547,Tooth,0,0
88548,sensitivity,0,0
88549,and,0,0
88550,oral,0,0
88551,irritation,0,0
88552,were,0,0
88553,the,0,0
88554,two,0,0
88555,most,0,0
88556,common,0,1
88557,adverse,0,0
88558,events,0,0
88559,.,0,1
88560,After,0,0
88561,12,0,0
88562,months,0,0
88563,use,0,0
88564,",",0,0
88565,tooth,0,0
88566,sensitivity,0,0
88567,was,0,0
88568,reported,0,0
88569,by,0,0
88570,10,0,0
88571,%,0,0
88572,of,0,0
88573,subjects,0,1
88574,in,0,0
88575,the,0,0
88576,6,0,0
88577,%,0,0
88578,strip,0,0
88579,group,0,0
88580,with,0,1
88581,a,0,0
88582,95,0,0
88583,%,0,0
88584,confidence,0,0
88585,interval,0,0
88586,(,0,0
88587,CI,0,0
88588,),0,0
88589,of,0,0
88590,(,0,0
88591,2.8,0,0
88592,%,0,0
88593,",",0,0
88594,23.7,0,0
88595,%,0,0
88596,),0,0
88597,and,0,0
88598,5,0,0
88599,%,0,0
88600,of,0,0
88601,subjects,0,1
88602,in,0,0
88603,the,0,0
88604,placebo,0,0
88605,group,0,0
88606,with,0,1
88607,a,0,0
88608,95,0,0
88609,%,0,0
88610,CI,0,0
88611,of,0,0
88612,(,0,0
88613,0.6,0,0
88614,%,0,0
88615,",",0,0
88616,16.9,0,0
88617,%,0,0
88618,),0,0
88619,.,0,0
88620,The,0,0
88621,occurrence,0,0
88622,of,0,0
88623,reported,0,0
88624,oral,0,0
88625,irritation,0,1
88626,was,0,0
88627,0,0,0
88628,%,0,0
88629,in,0,0
88630,the,0,0
88631,6,0,0
88632,%,0,0
88633,strip,0,0
88634,group,0,0
88635,with,0,1
88636,a,0,0
88637,95,0,0
88638,%,0,0
88639,CI,0,0
88640,of,0,0
88641,(,0,0
88642,0,0,0
88643,%,0,0
88644,",",0,0
88645,8.8,0,0
88646,%,0,0
88647,),0,0
88648,and,0,0
88649,2.5,0,0
88650,%,0,0
88651,in,0,0
88652,the,0,0
88653,placebo,0,0
88654,strip,0,0
88655,group,0,0
88656,with,0,1
88657,a,0,0
88658,95,0,0
88659,%,0,0
88660,CI,0,0
88661,of,0,0
88662,(,0,0
88663,0.1,0,0
88664,%,0,0
88665,",",0,0
88666,13.2,0,0
88667,%,0,0
88668,),0,0
88669,.,0,0
88670,The,0,0
88671,occurrence,0,0
88672,of,0,0
88673,observed,0,0
88674,oral,0,0
88675,irritation,0,0
88676,was,0,0
88677,also,0,0
88678,similar,0,0
88679,between,0,0
88680,groups,0,0
88681,.,0,1
88682,The,0,0
88683,groups,0,0
88684,did,0,0
88685,not,0,0
88686,differ,0,0
88687,significantly,0,0
88688,(,0,0
88689,p,0,0
88690,>,0,1
88691,0.67,0,0
88692,),0,0
88693,for,0,0
88694,the,0,0
88695,percent,0,0
88696,of,0,0
88697,subjects,0,1
88698,with,0,1
88699,each,0,0
88700,type,0,1
88701,of,0,0
88702,adverse,0,0
88703,event,0,0
88704,.,0,0
88705,In,0,0
88706,the,0,0
88707,6,0,0
88708,%,0,0
88709,strip,0,0
88710,group,0,0
88711,",",0,0
88712,two,0,0
88713,subjects,0,1
88714,discontinued,0,0
88715,product,0,0
88716,use,0,0
88717,due,0,0
88718,to,0,0
88719,an,0,0
88720,adverse,0,0
88721,event,0,0
88722,(,0,0
88723,tooth,0,0
88724,sensitivity,0,0
88725,),0,0
88726,compared,0,0
88727,to,0,0
88728,no,0,0
88729,subjects,0,1
88730,in,0,0
88731,the,0,0
88732,placebo,0,0
88733,group,0,0
88734,.,0,1
88735,Groups,0,0
88736,did,0,0
88737,not,0,0
88738,differ,0,0
88739,significantly,0,0
88740,(,0,0
88741,p,0,0
88742,>,0,1
88743,0.49,0,0
88744,),0,0
88745,with,0,1
88746,respect,0,0
88747,to,0,0
88748,this,0,0
88749,outcome,0,0
88750,.,0,0
88751,CONCLUSION,0,0
88752,Use,0,0
88753,of,0,0
88754,6,0,0
88755,%,0,0
88756,hydrogen,0,0
88757,peroxide,0,0
88758,whitening,0,0
88759,strips,0,0
88760,over,0,0
88761,12,0,1
88762,months,0,0
88763,resulted,0,0
88764,in,0,0
88765,a,0,0
88766,safety,0,0
88767,profile,0,0
88768,similar,0,0
88769,to,0,0
88770,that,0,0
88771,seen,0,0
88772,with,0,1
88773,placebo,0,0
88774,strips,0,0
88775,.,0,1
88776,[,0,0
88777,No,0,0
88778,effect,0,0
88779,of,0,0
88780,spironolactone,0,0
88781,on,0,0
88782,bulimia,0,1
88783,nervosa,0,1
88784,symptoms,0,0
88785,],0,1
88786,.,0,1
88787,Some,0,0
88788,case,0,0
88789,reports,0,0
88790,mention,0,0
88791,that,0,0
88792,Spironolactone,0,0
88793,",",0,0
88794,a,0,0
88795,mineral,0,0
88796,corticoid,0,0
88797,antagonist,0,0
88798,and,0,0
88799,aldosterone,0,0
88800,antagonist,0,0
88801,",",0,0
88802,reduces,0,0
88803,binging,0,0
88804,in,0,0
88805,patients,1,1
88806,with,1,1
88807,bulimia,1,1
88808,nervosa,1,1
88809,.,1,0
88810,Therefore,0,0
88811,",",0,0
88812,we,0,0
88813,decided,0,0
88814,to,0,0
88815,study,0,0
88816,these,0,0
88817,findings,0,0
88818,by,0,0
88819,using,0,0
88820,a,0,0
88821,randomized,0,0
88822,",",0,0
88823,double-blind,0,0
88824,",",0,0
88825,placebo,0,0
88826,controlled,0,0
88827,study,0,0
88828,design,0,0
88829,.,0,0
88830,In,0,0
88831,one,0,0
88832,study,0,0
88833,arm,0,0
88834,",",0,0
88835,patients,1,1
88836,with,1,1
88837,bulimia,1,1
88838,nervosa,1,1
88839,were,0,1
88840,treated,0,1
88841,with,0,1
88842,150,0,0
88843,mg,0,0
88844,Spironolactone,0,0
88845,per,0,1
88846,day,0,0
88847,;,0,0
88848,in,0,0
88849,the,0,0
88850,other,0,0
88851,arm,0,0
88852,",",0,0
88853,patients,0,1
88854,received,0,0
88855,a,0,0
88856,placebo,0,0
88857,for,0,0
88858,a,0,0
88859,total,0,1
88860,of,0,0
88861,8,0,0
88862,weeks,0,0
88863,.,0,1
88864,The,0,0
88865,target,0,0
88866,variables,0,0
88867,were,0,0
88868,the,0,0
88869,number,0,0
88870,of,0,0
88871,binges,0,0
88872,and,0,0
88873,the,0,0
88874,bulimia,0,1
88875,scale,0,0
88876,of,0,0
88877,the,0,0
88878,Eating,0,0
88879,Disorder,0,1
88880,Inventory,0,1
88881,.,0,0
88882,The,1,0
88883,study,1,0
88884,included,1,1
88885,93,1,1
88886,patients,1,1
88887,.,1,1
88888,The,0,0
88889,results,0,0
88890,show,0,0
88891,that,0,0
88892,the,0,0
88893,number,0,0
88894,of,0,0
88895,binges,0,0
88896,and,0,1
88897,the,0,0
88898,scores,0,0
88899,on,0,0
88900,the,0,0
88901,bulimia,0,1
88902,scale,0,0
88903,decreased,0,0
88904,somewhat,0,0
88905,",",0,0
88906,but,0,0
88907,this,0,0
88908,occurred,0,0
88909,in,0,0
88910,both,0,0
88911,groups,0,0
88912,.,0,1
88913,We,0,0
88914,were,0,0
88915,not,0,0
88916,able,0,0
88917,to,0,0
88918,show,0,0
88919,any,0,0
88920,significant,0,0
88921,statistical,0,0
88922,differences,0,0
88923,between,0,0
88924,the,0,0
88925,Spironolactone,0,0
88926,group,0,0
88927,and,0,0
88928,the,0,0
88929,placebo,0,0
88930,group,0,0
88931,.,0,1
88932,Additional,0,0
88933,evaluations,0,0
88934,",",0,0
88935,executed,0,1
88936,with,0,1
88937,data,0,0
88938,from,0,1
88939,the,0,0
88940,Symptom-Check-List,0,0
88941,(,0,0
88942,SCL-90R,0,1
88943,),0,0
88944,and,0,0
88945,with,0,1
88946,other,0,0
88947,scales,0,0
88948,from,0,1
88949,the,0,0
88950,EDI-2,0,0
88951,also,0,0
88952,showed,0,0
88953,no,0,0
88954,effect,0,0
88955,of,0,0
88956,Spironolactone,0,0
88957,.,0,1
88958,Therefore,0,0
88959,",",0,0
88960,a,0,0
88961,treatment,0,0
88962,with,0,0
88963,Spironolactone,0,0
88964,seems,0,0
88965,to,0,0
88966,have,0,0
88967,no,0,0
88968,effect,0,0
88969,on,0,0
88970,bulimia,0,1
88971,nervosa,0,1
88972,symptoms,0,0
88973,.,0,1
88974,Beneficial,0,0
88975,effects,0,0
88976,of,0,0
88977,a,0,0
88978,diabetes,0,1
88979,specific,0,0
88980,formula,0,0
88981,on,0,0
88982,insulin,0,0
88983,sensitivity,0,0
88984,and,0,0
88985,free,0,0
88986,fatty,0,0
88987,acid,0,0
88988,in,0,0
88989,patients,1,1
88990,with,1,1
88991,type,1,1
88992,2,1,1
88993,diabetes,1,1
88994,mellitus,1,1
88995,.,1,0
88996,BACKGROUND,0,0
88997,This,0,0
88998,prospective,0,0
88999,",",0,0
89000,randomized,0,0
89001,",",0,0
89002,controlled,0,0
89003,study,0,0
89004,was,0,0
89005,designed,0,0
89006,to,0,0
89007,investigate,0,0
89008,the,0,0
89009,effects,0,0
89010,of,0,0
89011,a,0,0
89012,diabetes,0,1
89013,specific,0,0
89014,formula,0,0
89015,(,0,0
89016,Diason,0,0
89017,low,0,1
89018,energy,0,0
89019,:,0,1
89020,313.8,0,0
89021,kJ/100,0,0
89022,ml,0,0
89023,),0,0
89024,",",0,0
89025,compared,0,0
89026,with,0,1
89027,a,0,0
89028,standard,0,0
89029,formula,0,0
89030,",",0,0
89031,on,0,0
89032,insulin,0,0
89033,sensitivity,0,0
89034,",",0,0
89035,serum,0,0
89036,C,0,0
89037,peptide,0,0
89038,",",0,0
89039,serum,0,0
89040,lipids,0,0
89041,and,0,1
89042,free,0,1
89043,fatty,0,0
89044,acid,0,0
89045,(,0,0
89046,FFA,0,0
89047,),0,0
89048,in,0,0
89049,type,1,1
89050,2,1,1
89051,diabetics,1,1
89052,.,1,1
89053,METHODS,0,0
89054,In,0,0
89055,total,0,1
89056,of,0,0
89057,71,1,1
89058,type,1,1
89059,2,1,1
89060,diabetics,1,1
89061,completed,1,1
89062,the,1,0
89063,study,1,0
89064,.,1,0
89065,Enteral,0,0
89066,formulas,0,0
89067,were,0,0
89068,given,0,0
89069,orally,0,0
89070,as,0,0
89071,the,0,0
89072,sole,0,0
89073,source,0,0
89074,of,0,0
89075,nutrition,0,0
89076,to,0,0
89077,the,0,0
89078,subjects,0,1
89079,for,0,0
89080,6,0,1
89081,days,0,0
89082,.,0,1
89083,Venous,0,1
89084,blood,0,0
89085,samples,0,0
89086,(,0,0
89087,0.5,0,0
89088,",",0,0
89089,1,0,0
89090,",",0,0
89091,2,0,0
89092,",",0,0
89093,3,0,0
89094,hours,0,0
89095,),0,1
89096,were,0,0
89097,collected,0,0
89098,at,0,0
89099,day-7,0,0
89100,after,0,0
89101,a,0,0
89102,75,0,1
89103,g,0,1
89104,oral,0,0
89105,glucose,0,0
89106,tolerance,0,0
89107,test,0,0
89108,(,0,0
89109,OGTT,0,0
89110,),0,0
89111,",",0,0
89112,day,0,0
89113,1,0,0
89114,after,0,0
89115,a,0,0
89116,standard,0,0
89117,test,0,0
89118,meal,0,0
89119,(,0,0
89120,1673.6,0,0
89121,kJ,0,0
89122,),0,0
89123,and,0,0
89124,after,0,0
89125,6,0,0
89126,days,0,0
89127,of,0,0
89128,either,0,0
89129,the,0,0
89130,test,0,0
89131,diabetes,0,1
89132,specific,0,0
89133,formula,0,0
89134,or,0,1
89135,a,0,0
89136,standard,0,0
89137,formula,0,0
89138,.,0,1
89139,Plasma,0,0
89140,glucose,0,0
89141,",",0,0
89142,serum,0,0
89143,insulin,0,0
89144,",",0,0
89145,C,0,0
89146,peptide,0,0
89147,and,0,0
89148,lipids,0,0
89149,were,0,1
89150,measured,0,0
89151,.,0,0
89152,RESULTS,0,0
89153,After,0,0
89154,the,0,0
89155,intervention,0,0
89156,period,0,0
89157,",",0,0
89158,the,0,0
89159,diabetes,0,1
89160,specific,0,0
89161,formula,0,0
89162,resulted,0,0
89163,in,0,0
89164,a,0,0
89165,significantly,0,0
89166,lower,0,0
89167,postprandial,0,0
89168,rise,0,0
89169,in,0,0
89170,blood,0,0
89171,glucose,0,0
89172,concentrations,0,0
89173,at,0,1
89174,0.5,0,0
89175,hour,0,0
89176,(,0,0
89177,P,0,0
89178,<,0,0
89179,0.05,0,0
89180,),0,0
89181,and,0,0
89182,1,0,0
89183,hour,0,0
89184,(,0,0
89185,P,0,0
89186,<,0,0
89187,0.01,0,0
89188,),0,0
89189,;,0,0
89190,significantly,0,0
89191,lower,0,0
89192,peak,0,0
89193,height,0,0
89194,of,0,0
89195,plasma,0,0
89196,glucose,0,0
89197,(,0,0
89198,P,0,0
89199,=,0,0
89200,0.05,0,0
89201,),0,0
89202,;,0,0
89203,significantly,0,0
89204,lower,0,0
89205,plasma,0,0
89206,insulin,0,0
89207,concentrations,0,0
89208,at,0,0
89209,0.5,0,0
89210,hour,0,0
89211,(,0,0
89212,P,0,0
89213,<,0,0
89214,0.01,0,0
89215,),0,0
89216,",",0,0
89217,1,0,0
89218,hour,0,0
89219,(,0,0
89220,P,0,0
89221,<,0,0
89222,0.01,0,0
89223,),0,0
89224,and,0,1
89225,2,0,0
89226,hours,0,0
89227,(,0,1
89228,P,0,0
89229,<,0,0
89230,0.01,0,0
89231,),0,1
89232,;,0,0
89233,and,0,0
89234,a,0,0
89235,significantly,0,0
89236,lower,0,0
89237,plasma,0,0
89238,insulin,0,0
89239,peak,0,0
89240,compared,0,0
89241,to,0,0
89242,controls,0,1
89243,;,0,0
89244,both,0,0
89245,OGTT,0,0
89246,and,0,0
89247,a,0,0
89248,standard,0,0
89249,test,0,0
89250,meal,0,0
89251,(,0,0
89252,P,0,0
89253,<,0,0
89254,0.05,0,0
89255,),0,0
89256,.,0,0
89257,The,0,0
89258,glucose,0,0
89259,and,0,0
89260,insulin,0,0
89261,area,0,0
89262,under,0,0
89263,the,0,0
89264,curve,0,0
89265,after,0,0
89266,the,0,0
89267,diabetes,0,1
89268,specific,0,0
89269,formula,0,0
89270,compared,0,0
89271,to,0,0
89272,the,0,0
89273,standard,0,0
89274,formula,0,0
89275,were,0,0
89276,significantly,0,0
89277,lower,0,0
89278,.,0,0
89279,The,0,0
89280,C,0,0
89281,peptide,0,0
89282,level,0,0
89283,was,0,0
89284,lower,0,0
89285,after,0,0
89286,6,0,0
89287,days,0,0
89288,of,0,0
89289,both,0,0
89290,nutrition,0,0
89291,formulas,0,0
89292,compare,0,0
89293,to,0,0
89294,75,0,1
89295,g,0,0
89296,OGTT,0,0
89297,",",0,0
89298,but,0,0
89299,not,0,0
89300,different,0,0
89301,from,0,0
89302,the,0,0
89303,standard,0,0
89304,mixed,0,0
89305,meal,0,0
89306,.,0,0
89307,Both,0,0
89308,formulas,0,0
89309,were,0,0
89310,well,0,0
89311,tolerated,0,0
89312,.,0,0
89313,CONCLUSIONS,0,0
89314,In,0,0
89315,summary,0,0
89316,the,0,0
89317,diabetes,0,1
89318,specific,0,0
89319,formula,0,0
89320,with,0,1
89321,a,0,0
89322,relatively,0,0
89323,high,0,0
89324,monounsaturated,0,0
89325,fatty,0,0
89326,acid,0,0
89327,and,0,0
89328,high,0,0
89329,multi,0,0
89330,fiber,0,0
89331,proportion,0,0
89332,significantly,0,0
89333,improved,0,0
89334,glycemic,0,0
89335,control,0,0
89336,.,0,0
89337,On,0,0
89338,top,0,0
89339,of,0,0
89340,this,0,0
89341,",",0,0
89342,the,0,0
89343,insulin,0,0
89344,sensitivity,0,0
89345,(,0,0
89346,HOMA-IS,0,0
89347,),0,0
89348,was,0,0
89349,significantly,0,0
89350,improved,0,0
89351,and,0,0
89352,may,0,0
89353,therefore,0,0
89354,directly,0,0
89355,improve,0,0
89356,the,0,0
89357,impact,0,0
89358,on,0,0
89359,long,0,1
89360,term,0,1
89361,complications,0,0
89362,.,0,0
89363,The,0,0
89364,disease,0,1
89365,specific,0,0
89366,formula,0,0
89367,should,0,0
89368,therefore,0,0
89369,be,0,0
89370,the,0,0
89371,preferred,0,0
89372,option,0,0
89373,to,0,0
89374,be,0,0
89375,used,0,0
89376,by,0,0
89377,diabetic,1,1
89378,and,1,1
89379,hyperglycemic,1,1
89380,patients,1,1
89381,in,1,0
89382,need,1,0
89383,of,1,0
89384,nutritional,1,0
89385,support,1,0
89386,.,1,1
89387,A,0,0
89388,prospective,0,0
89389,study,0,0
89390,on,0,0
89391,the,0,0
89392,clinical,0,0
89393,performance,0,0
89394,of,0,0
89395,polysiloxane,0,0
89396,soft,0,1
89397,liners,0,0
89398,:,0,1
89399,one-year,0,0
89400,results,0,0
89401,.,0,1
89402,OBJECTIVE,0,0
89403,The,0,0
89404,aim,0,0
89405,of,0,0
89406,the,0,0
89407,present,0,0
89408,study,0,0
89409,was,0,0
89410,to,0,0
89411,evaluate,0,0
89412,the,0,0
89413,clinical,0,0
89414,performance,0,0
89415,of,0,0
89416,four,0,0
89417,denture,0,0
89418,soft,0,1
89419,liners,0,0
89420,up,0,0
89421,to,0,0
89422,12,0,1
89423,months,0,0
89424,.,0,1
89425,MATERIALS,0,0
89426,AND,0,0
89427,METHODS,0,0
89428,Thirty-three,1,1
89429,edentulous,1,1
89430,patients,1,1
89431,who,1,1
89432,experienced,1,1
89433,difficulties,1,1
89434,when,1,0
89435,using,1,0
89436,hard,1,0
89437,denture,1,1
89438,bases,1,0
89439,because,1,0
89440,of,1,0
89441,changes,1,0
89442,in,1,1
89443,denture-supporting,1,1
89444,tissues,1,1
89445,were,0,1
89446,accepted,0,0
89447,for,0,0
89448,the,0,0
89449,study,0,0
89450,and,0,0
89451,randomly,0,1
89452,received,0,0
89453,Molloplast,0,0
89454,B,0,0
89455,",",0,0
89456,GC,0,0
89457,Reline,0,0
89458,Soft,0,1
89459,",",0,0
89460,Silagum,0,1
89461,Comfort,0,0
89462,",",0,0
89463,or,0,1
89464,Mollosil,0,0
89465,Plus,0,1
89466,relines,0,0
89467,.,0,1
89468,Performance,0,0
89469,of,0,0
89470,the,0,0
89471,materials,0,1
89472,was,0,0
89473,evaluated,0,0
89474,using,0,0
89475,nine,0,1
89476,criteria,0,1
89477,at,0,1
89478,3,0,0
89479,",",0,0
89480,6,0,0
89481,",",0,0
89482,and,0,0
89483,12,0,1
89484,months,0,0
89485,:,0,1
89486,physical,0,0
89487,integrity,0,0
89488,",",0,0
89489,surface,0,0
89490,detail,0,0
89491,",",0,0
89492,adhesion,0,0
89493,",",0,0
89494,color,0,0
89495,",",0,0
89496,odor,0,0
89497,",",0,0
89498,plaque,0,0
89499,accumulation,0,0
89500,",",0,0
89501,resilience,0,0
89502,",",0,0
89503,hygiene,0,0
89504,",",0,0
89505,and,0,0
89506,mucosal,0,0
89507,condition,0,0
89508,.,0,0
89509,A,0,0
89510,four-point,0,0
89511,categorized,0,0
89512,scale,0,0
89513,(,0,0
89514,1=poor,0,0
89515,",",0,0
89516,2=fair,0,0
89517,",",0,0
89518,3=good,0,0
89519,",",0,0
89520,4=excellent,0,0
89521,),0,0
89522,was,0,0
89523,used,0,0
89524,.,0,0
89525,Unscheduled,0,0
89526,maintenance,0,0
89527,events,0,0
89528,and,0,0
89529,the,0,0
89530,presence,0,0
89531,of,0,0
89532,fungal,0,1
89533,colonization,0,0
89534,were,0,0
89535,also,0,0
89536,recorded,0,0
89537,.,0,0
89538,RESULTS,0,0
89539,The,1,0
89540,percentage,1,0
89541,of,1,0
89542,patients,1,1
89543,available,1,0
89544,at,1,1
89545,3,1,0
89546,",",1,0
89547,6,1,0
89548,",",1,0
89549,and,1,0
89550,12,1,0
89551,months,1,0
89552,were,1,1
89553,91,1,1
89554,%,1,0
89555,",",1,0
89556,91,1,0
89557,%,1,0
89558,",",1,0
89559,and,1,0
89560,66,1,1
89561,%,1,0
89562,.,1,1
89563,Main,0,0
89564,reasons,0,0
89565,for,0,0
89566,dropouts,0,0
89567,and,0,1
89568,discontinuation,0,0
89569,were,0,0
89570,fractured,0,0
89571,dentures,0,0
89572,and,0,0
89573,patient,0,1
89574,dissatisfaction,0,0
89575,.,0,1
89576,At,0,0
89577,6,0,0
89578,months,0,0
89579,",",0,1
89580,96,0,1
89581,%,0,0
89582,of,0,0
89583,the,0,0
89584,performance,0,0
89585,scores,0,0
89586,were,0,1
89587,good,0,0
89588,or,0,1
89589,excellent,0,0
89590,and,0,0
89591,the,0,0
89592,largest,0,0
89593,changes,0,0
89594,were,0,0
89595,observed,0,0
89596,for,0,0
89597,physical,0,0
89598,integrity,0,0
89599,",",0,0
89600,surface,0,0
89601,detail,0,0
89602,",",0,0
89603,color,0,0
89604,",",0,0
89605,and,0,0
89606,fungal,0,1
89607,colonization,0,0
89608,.,0,1
89609,Fungal,0,0
89610,colonization,0,0
89611,was,0,0
89612,the,0,0
89613,most,0,0
89614,commonly,0,0
89615,observed,0,0
89616,problem,0,0
89617,and,0,0
89618,was,0,0
89619,the,0,0
89620,only,0,0
89621,reason,0,0
89622,of,0,0
89623,failure,0,1
89624,at,0,0
89625,12,0,1
89626,months,0,0
89627,.,0,1
89628,CONCLUSIONS,0,0
89629,The,0,0
89630,clinical,0,0
89631,performance,0,0
89632,of,0,0
89633,all,0,0
89634,soft,0,1
89635,liners,0,0
89636,was,0,0
89637,slightly,0,0
89638,impaired,0,1
89639,over,0,0
89640,the,0,0
89641,12-month,0,0
89642,observation,0,0
89643,.,0,0
89644,Except,0,0
89645,for,0,0
89646,cases,0,1
89647,showing,0,0
89648,extensive,0,1
89649,fungal,0,1
89650,colonization,0,0
89651,",",0,0
89652,the,0,0
89653,observed,0,0
89654,changes,0,0
89655,in,0,0
89656,clinical,0,0
89657,performance,0,0
89658,did,0,0
89659,not,0,0
89660,necessitate,0,0
89661,remaking,0,0
89662,of,0,0
89663,the,0,0
89664,dentures,0,0
89665,.,0,1
89666,Mollosil,0,0
89667,Plus,0,1
89668,showed,0,0
89669,a,0,0
89670,performance,0,0
89671,comparable,0,0
89672,to,0,0
89673,that,0,0
89674,of,0,0
89675,Molloplast,0,0
89676,B,0,0
89677,",",0,0
89678,and,0,0
89679,the,0,0
89680,other,0,0
89681,materials,0,0
89682,had,0,1
89683,slightly,0,0
89684,lower,0,0
89685,performance,0,0
89686,especially,0,0
89687,in,0,0
89688,terms,0,0
89689,of,0,0
89690,fungal,0,1
89691,colonization,0,0
89692,.,0,1
89693,Treatment,0,0
89694,of,0,0
89695,posterior,1,0
89696,uveitis,1,1
89697,with,0,1
89698,a,0,0
89699,fluocinolone,0,0
89700,acetonide,0,0
89701,implant,0,0
89702,:,0,1
89703,three-year,0,0
89704,clinical,0,0
89705,trial,0,1
89706,results,0,0
89707,.,0,1
89708,OBJECTIVES,0,0
89709,To,0,0
89710,evaluate,0,0
89711,the,0,0
89712,safety,0,0
89713,and,0,0
89714,efficacy,0,0
89715,of,0,0
89716,0.59-mg,0,0
89717,and,0,0
89718,2.1-mg,0,0
89719,fluocinolone,0,0
89720,acetonide,0,0
89721,(,0,0
89722,FA,0,0
89723,),0,1
89724,intravitreous,0,0
89725,implants,0,1
89726,in,0,1
89727,noninfectious,1,1
89728,posterior,1,1
89729,uveitis,1,1
89730,.,1,0
89731,DESIGN,0,0
89732,A,0,0
89733,3-year,0,0
89734,",",0,0
89735,multicenter,0,0
89736,",",0,0
89737,randomized,0,0
89738,",",0,0
89739,historically,0,0
89740,controlled,0,0
89741,trial,0,0
89742,of,0,0
89743,the,0,0
89744,0.59-mg,1,0
89745,FA,1,0
89746,intravitreous,1,0
89747,implant,1,0
89748,in,1,0
89749,110,1,1
89750,patients,1,1
89751,and,1,0
89752,the,1,0
89753,2.1-mg,1,0
89754,FA,1,0
89755,intravitreous,1,0
89756,implant,1,0
89757,in,1,0
89758,168,1,1
89759,patients,1,1
89760,.,1,1
89761,MAIN,0,0
89762,OUTCOME,0,0
89763,MEASURES,0,0
89764,Recurrence,0,0
89765,rate,0,0
89766,",",0,0
89767,vision,0,0
89768,",",0,0
89769,and,0,0
89770,complications,0,0
89771,.,0,1
89772,RESULTS,0,0
89773,Uveitis,0,1
89774,recurrence,0,0
89775,was,0,0
89776,reduced,0,0
89777,in,0,0
89778,implanted,0,1
89779,eyes,0,1
89780,from,0,1
89781,62,0,1
89782,%,0,0
89783,(,0,0
89784,during,0,0
89785,the,0,0
89786,1-year,0,0
89787,preimplantation,0,1
89788,period,0,0
89789,),0,0
89790,to,0,0
89791,4,0,0
89792,%,0,0
89793,",",0,0
89794,10,0,0
89795,%,0,0
89796,",",0,0
89797,and,0,0
89798,20,0,0
89799,%,0,0
89800,during,0,0
89801,the,0,0
89802,1-,0,0
89803,",",0,0
89804,2-,0,0
89805,",",0,0
89806,and,0,0
89807,3-year,0,0
89808,postimplantation,0,1
89809,periods,0,0
89810,",",0,0
89811,respectively,0,0
89812,",",0,0
89813,for,0,0
89814,the,0,0
89815,0.59-mg,0,0
89816,dose,0,0
89817,group,0,0
89818,(,0,0
89819,P,0,0
89820,<,0,0
89821,.01,0,0
89822,),0,0
89823,and,0,0
89824,from,0,1
89825,58,0,1
89826,%,0,0
89827,to,0,0
89828,7,0,0
89829,%,0,0
89830,",",0,0
89831,17,0,0
89832,%,0,0
89833,",",0,0
89834,and,0,0
89835,41,0,1
89836,%,0,0
89837,",",0,0
89838,respectively,0,0
89839,",",0,0
89840,for,0,0
89841,the,0,0
89842,2.1-mg,0,0
89843,dose,0,0
89844,group,0,0
89845,(,0,0
89846,P,0,0
89847,<,0,0
89848,.01,0,0
89849,),0,0
89850,.,0,0
89851,More,0,0
89852,implanted,0,0
89853,eyes,0,1
89854,than,0,1
89855,nonimplanted,0,1
89856,eyes,0,1
89857,had,0,1
89858,improved,0,0
89859,visual,0,0
89860,acuity,0,0
89861,(,0,0
89862,P,0,0
89863,<,0,0
89864,.01,0,0
89865,),0,1
89866,.,0,0
89867,Implanted,0,0
89868,eyes,0,1
89869,had,0,1
89870,higher,0,0
89871,incidences,0,0
89872,of,0,0
89873,intraocular,0,0
89874,pressure,0,0
89875,elevation,0,0
89876,(,0,0
89877,>,0,0
89878,or,0,1
89879,=,0,0
89880,10,0,1
89881,mm,0,0
89882,Hg,0,1
89883,),0,1
89884,than,0,0
89885,nonimplanted,0,1
89886,eyes,0,1
89887,(,0,1
89888,P,0,0
89889,<,0,0
89890,.01,0,0
89891,),0,0
89892,",",0,0
89893,and,0,0
89894,glaucoma,0,1
89895,surgery,0,1
89896,was,0,0
89897,required,0,0
89898,in,0,0
89899,40,0,1
89900,%,0,0
89901,of,0,0
89902,implanted,0,1
89903,eyes,0,1
89904,vs,0,0
89905,2,0,0
89906,%,0,0
89907,of,0,0
89908,nonimplanted,0,1
89909,eyes,0,1
89910,(,0,1
89911,P,0,0
89912,<,0,0
89913,.01,0,0
89914,),0,1
89915,.,0,0
89916,Cataracts,0,1
89917,were,0,1
89918,extracted,0,1
89919,in,0,0
89920,93,0,1
89921,%,0,0
89922,of,0,0
89923,phakic,0,1
89924,implanted,0,1
89925,eyes,0,1
89926,vs,0,0
89927,20,0,0
89928,%,0,0
89929,of,0,0
89930,phakic,0,1
89931,nonimplanted,0,1
89932,eyes,0,1
89933,(,0,1
89934,P,0,0
89935,<,0,0
89936,.01,0,0
89937,),0,0
89938,.,0,0
89939,CONCLUSIONS,0,0
89940,The,0,0
89941,FA,0,0
89942,implant,0,0
89943,significantly,0,0
89944,reduced,0,0
89945,uveitis,0,1
89946,recurrence,0,0
89947,and,0,0
89948,improved,0,0
89949,or,0,0
89950,stabilized,0,0
89951,visual,0,0
89952,acuity,0,0
89953,in,0,0
89954,subjects,1,1
89955,with,1,1
89956,noninfectious,1,1
89957,posterior,1,1
89958,uveitis,1,1
89959,.,1,1
89960,Most,0,0
89961,subjects,0,1
89962,required,0,0
89963,cataract,0,1
89964,extraction,0,0
89965,",",0,0
89966,and,0,0
89967,a,0,0
89968,significant,0,0
89969,proportion,0,0
89970,required,0,0
89971,intraocular,0,0
89972,pressure-lowering,0,0
89973,surgery,0,1
89974,.,0,1
89975,APPLICATION,0,0
89976,TO,0,0
89977,CLINICAL,0,1
89978,PRACTICE,0,1
89979,The,0,0
89980,FA,0,0
89981,implant,0,0
89982,provides,0,0
89983,an,0,0
89984,alternative,0,0
89985,therapy,0,0
89986,for,0,0
89987,prolonged,0,0
89988,control,0,1
89989,of,0,0
89990,inflammation,0,0
89991,in,0,0
89992,noninfectious,0,1
89993,posterior,0,1
89994,uveitis,0,1
89995,.,0,1
89996,TRIAL,0,0
89997,REGISTRATION,0,0
89998,clinicaltrials.gov,0,1
89999,Identifier,0,1
90000,:,0,1
90001,NCT00407082,0,0
90002,.,0,1
90003,Cemented,0,1
90004,CeraOne,0,1
90005,and,0,0
90006,porcelain,0,1
90007,fused,0,0
90008,to,0,0
90009,TiAdapt,0,0
90010,abutment,0,0
90011,single-implant,1,0
90012,crown,1,1
90013,restorations,0,1
90014,:,0,1
90015,a,0,0
90016,10-year,0,0
90017,comparative,0,0
90018,follow-up,0,0
90019,study,0,1
90020,.,0,1
90021,BACKGROUND,0,0
90022,Long-term,0,0
90023,data,0,0
90024,comparing,0,0
90025,cemented,0,1
90026,and,0,0
90027,noncemented,0,1
90028,single-implant,0,0
90029,restorations,0,0
90030,has,0,0
90031,not,0,0
90032,been,0,0
90033,reported,0,0
90034,.,0,0
90035,AIM,0,0
90036,To,0,0
90037,compare,0,0
90038,clinical,0,0
90039,and,0,0
90040,radiographic,0,1
90041,performance,0,0
90042,of,0,0
90043,single-implant,1,0
90044,crown,1,1
90045,restorations,1,1
90046,made,0,0
90047,by,0,0
90048,either,0,0
90049,directly,0,0
90050,baked,0,0
90051,porcelain,0,1
90052,to,0,0
90053,custom-made,0,1
90054,TiAdapt,0,0
90055,titanium,0,0
90056,abutments,0,0
90057,(,0,1
90058,Nobel,0,1
90059,Biocare,0,1
90060,AB,0,1
90061,",",0,0
90062,G?teborg,0,1
90063,",",0,0
90064,Sweden,0,1
90065,),0,0
90066,(,0,0
90067,test,0,0
90068,),0,0
90069,or,0,1
90070,cement,0,0
90071,crowns,0,1
90072,onto,0,0
90073,CeraOne,0,1
90074,(,0,1
90075,Nobel,0,1
90076,Biocare,0,1
90077,AB,0,1
90078,),0,1
90079,abutments,0,0
90080,(,0,1
90081,control,0,1
90082,),0,0
90083,after,0,0
90084,10,0,1
90085,years,0,1
90086,in,0,1
90087,function,0,0
90088,.,0,1
90089,MATERIALS,0,0
90090,AND,0,0
90091,METHODS,1,0
90092,Altogether,1,0
90093,",",1,0
90094,35,1,1
90095,consecutive,1,1
90096,patients,1,1
90097,were,1,1
90098,provided,1,0
90099,with,1,1
90100,41,1,1
90101,turned,1,0
90102,single,1,0
90103,Br?nemark,1,1
90104,System,1,1
90105,implants,1,1
90106,(,1,1
90107,Nobel,1,1
90108,Biocare,1,1
90109,AB,1,1
90110,),1,0
90111,in,1,0
90112,the,1,0
90113,partially,1,0
90114,edentulous,1,1
90115,upper,1,1
90116,jaw,1,1
90117,.,1,0
90118,By,1,0
90119,random,1,0
90120,",",1,0
90121,15,1,0
90122,and,1,0
90123,20,1,1
90124,patients,1,1
90125,were,1,1
90126,provided,1,0
90127,with,1,1
90128,18,1,1
90129,test,1,0
90130,and,1,0
90131,23,1,1
90132,control,1,1
90133,implant,1,0
90134,crowns,1,0
90135,",",1,0
90136,respectively,1,0
90137,.,1,0
90138,Thereafter,0,0
90139,",",0,0
90140,clinical,0,0
90141,and,0,0
90142,radiographic,0,1
90143,data,0,0
90144,were,0,1
90145,collected,0,0
90146,and,0,0
90147,compared,0,0
90148,between,0,0
90149,the,0,0
90150,two,0,0
90151,groups,0,0
90152,.,0,1
90153,RESULTS,0,0
90154,None,0,0
90155,of,0,0
90156,the,0,0
90157,implants,0,0
90158,were,0,0
90159,found,0,0
90160,loose,0,0
90161,during,0,0
90162,the,0,0
90163,follow-up,0,0
90164,period,0,0
90165,(,0,0
90166,100,0,0
90167,%,0,0
90168,),0,0
90169,.,0,0
90170,Few,0,0
90171,clinical,0,0
90172,problems,0,1
90173,were,0,0
90174,observed,0,0
90175,",",0,0
90176,and,0,0
90177,the,0,0
90178,overall,0,0
90179,average,0,0
90180,marginal,0,1
90181,bone,0,0
90182,loss,0,0
90183,was,0,0
90184,0.26,0,0
90185,mm,0,0
90186,(,0,1
90187,SD,0,0
90188,0.64,0,0
90189,),0,0
90190,during,0,0
90191,10,0,1
90192,years,0,1
90193,in,0,1
90194,function,0,0
90195,.,0,0
90196,After,0,0
90197,the,0,0
90198,final,0,0
90199,tightening,0,0
90200,of,0,0
90201,the,0,0
90202,crowns,0,0
90203,",",0,0
90204,no,0,0
90205,significant,0,0
90206,differences,0,0
90207,were,0,1
90208,observed,0,0
90209,between,0,0
90210,the,0,0
90211,test,0,0
90212,and,0,0
90213,control,0,0
90214,groups,0,0
90215,(,0,1
90216,p,0,0
90217,>,0,1
90218,.05,0,0
90219,),0,0
90220,.,0,0
90221,The,0,0
90222,head,0,0
90223,of,0,0
90224,the,0,0
90225,implants,0,0
90226,was,0,0
90227,placed,0,1
90228,on,0,0
90229,an,0,0
90230,average,0,0
90231,6.3,0,0
90232,mm,0,0
90233,(,0,1
90234,SD,0,0
90235,2.24,0,0
90236,),0,0
90237,below,0,0
90238,the,0,0
90239,cement/enamel,0,0
90240,junction,0,0
90241,of,0,0
90242,the,0,0
90243,adjacent,0,0
90244,teeth,0,1
90245,(,0,0
90246,range,0,1
90247,2.5-10.0,0,0
90248,mm,0,1
90249,),0,1
90250,.,0,0
90251,Implants,0,0
90252,with,0,1
90253,reported,0,0
90254,mechanical,0,1
90255,and/or,0,1
90256,mucosal,0,0
90257,problems,0,1
90258,or,0,1
90259,placed,0,0
90260,more,0,0
90261,apically,0,0
90262,in,0,0
90263,relation,0,0
90264,to,0,0
90265,the,0,0
90266,adjacent,0,0
90267,teeth,0,1
90268,did,0,0
90269,not,0,0
90270,present,0,0
90271,more,0,0
90272,bone,0,0
90273,loss,0,0
90274,as,0,0
90275,compared,0,0
90276,with,0,1
90277,implants,0,0
90278,with,0,1
90279,no,0,0
90280,problems,0,1
90281,or,0,0
90282,placed,0,0
90283,more,0,0
90284,coronally,0,0
90285,",",0,0
90286,respectively,0,0
90287,(,0,0
90288,p,0,0
90289,>,0,1
90290,.05,0,0
90291,),0,1
90292,.,0,0
90293,CONCLUSIONS,0,0
90294,There,0,0
90295,seems,0,0
90296,to,0,0
90297,be,0,0
90298,no,0,0
90299,obvious,0,0
90300,clinical,0,0
90301,or,0,1
90302,radiographic,0,1
90303,differences,0,0
90304,between,0,0
90305,the,0,0
90306,test,0,0
90307,and,0,0
90308,control,0,1
90309,single-implant,0,0
90310,restorations,0,1
90311,during,0,1
90312,10,0,1
90313,years,0,1
90314,of,0,1
90315,follow-up,0,0
90316,.,0,1
90317,Occasionally,0,0
90318,",",0,0
90319,some,0,0
90320,restorations,0,0
90321,presented,0,1
90322,loose,0,1
90323,abutment,0,0
90324,screws,0,0
90325,and/or,0,1
90326,fistulas,0,1
90327,during,0,0
90328,follow-up,0,0
90329,.,0,0
90330,This,0,0
90331,implies,0,0
90332,a,0,0
90333,certain,0,0
90334,need,0,0
90335,for,0,0
90336,maintenance,0,0
90337,where,0,0
90338,a,0,0
90339,one-piece,0,0
90340,single-implant,0,0
90341,protocol,0,0
90342,(,0,0
90343,test,0,0
90344,),0,0
90345,allows,0,0
90346,both,0,0
90347,for,0,0
90348,a,0,0
90349,simple,0,0
90350,clinical,0,0
90351,procedure,0,0
90352,at,0,0
90353,placement,0,0
90354,without,0,1
90355,cementation,0,0
90356,problems,0,1
90357,",",0,0
90358,as,0,0
90359,well,0,0
90360,as,0,0
90361,for,0,0
90362,an,0,0
90363,easy,0,0
90364,and,0,0
90365,simple,0,0
90366,maintenance,0,0
90367,of,0,0
90368,installed,0,0
90369,single,0,0
90370,implant,0,1
90371,crowns,0,1
90372,in,0,0
90373,long-term,0,0
90374,function,0,0
90375,.,0,1
90376,Psychological,0,1
90377,mediators,0,0
90378,of,0,0
90379,bupropion,0,0
90380,sustained-release,0,0
90381,treatment,0,0
90382,for,0,0
90383,smoking,0,1
90384,cessation,0,0
90385,.,0,0
90386,AIM,0,0
90387,The,0,0
90388,study,0,0
90389,aimed,0,0
90390,to,0,0
90391,test,0,0
90392,simultaneously,0,0
90393,our,0,0
90394,understanding,0,0
90395,of,0,0
90396,the,0,0
90397,effects,0,0
90398,of,0,0
90399,bupropion,0,0
90400,sustained-release,0,0
90401,(,0,0
90402,SR,0,0
90403,),0,0
90404,treatment,0,0
90405,on,0,0
90406,putative,0,1
90407,mediators,0,0
90408,and,0,0
90409,our,0,0
90410,understanding,0,0
90411,of,0,0
90412,determinants,0,0
90413,of,0,0
90414,post-quit,0,0
90415,abstinence,0,0
90416,",",0,0
90417,including,0,0
90418,withdrawal,0,0
90419,distress,0,0
90420,",",0,0
90421,cigarette,0,0
90422,craving,0,0
90423,",",0,0
90424,positive,0,0
90425,affect,0,0
90426,and,0,0
90427,subjective,0,0
90428,reactions,0,0
90429,to,0,1
90430,cigarettes,0,1
90431,smoked,0,0
90432,during,0,0
90433,a,0,0
90434,lapse,0,0
90435,.,0,0
90436,The,0,0
90437,specificity,0,0
90438,of,0,0
90439,bupropion,0,0
90440,SR,0,0
90441,effects,0,0
90442,was,0,0
90443,also,0,0
90444,tested,0,0
90445,in,0,0
90446,exploratory,0,1
90447,analyses,0,0
90448,.,0,1
90449,DESIGN,0,0
90450,Data,0,0
90451,from,0,0
90452,a,0,0
90453,randomized,0,0
90454,",",0,0
90455,placebo-controlled,0,0
90456,clinical,0,0
90457,trial,0,0
90458,of,0,0
90459,bupropion,0,0
90460,SR,0,0
90461,were,0,0
90462,submitted,0,0
90463,to,0,0
90464,mediation,0,0
90465,analyses,0,0
90466,.,0,1
90467,SETTING,0,1
90468,Center,1,1
90469,for,1,0
90470,Tobacco,1,1
90471,Research,1,1
90472,and,1,0
90473,Intervention,1,0
90474,",",1,0
90475,Madison,1,1
90476,",",1,0
90477,WI,1,0
90478,",",1,0
90479,USA,1,0
90480,.,1,0
90481,PARTICIPANTS,0,0
90482,A,1,0
90483,total,1,1
90484,of,1,0
90485,403,1,1
90486,adult,1,1
90487,",",1,0
90488,daily,1,0
90489,smokers,1,1
90490,without,1,1
90491,contraindications,1,0
90492,to,1,0
90493,bupropion,1,0
90494,SR,1,0
90495,use,1,0
90496,.,1,0
90497,INTERVENTION,0,0
90498,Participants,0,1
90499,were,0,0
90500,assigned,0,1
90501,randomly,0,1
90502,to,0,0
90503,receive,0,0
90504,a,0,0
90505,9-week,0,0
90506,course,0,0
90507,of,0,0
90508,bupropion,0,0
90509,SR,0,0
90510,or,0,1
90511,placebo,0,0
90512,pill,0,0
90513,and,0,0
90514,to,0,0
90515,receive,0,0
90516,eight,0,1
90517,brief,0,0
90518,individual,0,0
90519,counseling,0,1
90520,sessions,0,0
90521,or,0,1
90522,no,0,0
90523,counseling,0,0
90524,.,0,0
90525,MEASUREMENTS,0,0
90526,Ecological,0,0
90527,momentary,0,0
90528,assessment,0,0
90529,ratings,0,0
90530,of,0,0
90531,smoking,0,1
90532,behavior,0,0
90533,and,0,0
90534,putative,0,1
90535,mediators,0,0
90536,were,0,1
90537,collected,0,1
90538,pre-,0,0
90539,and,0,0
90540,post-quit,0,0
90541,.,0,1
90542,FINDINGS,0,0
90543,Results,0,0
90544,of,0,0
90545,structural,0,0
90546,equation,0,0
90547,and,0,0
90548,hierarchical,0,0
90549,linear,0,0
90550,models,0,0
90551,did,0,0
90552,not,0,0
90553,support,0,0
90554,the,0,0
90555,hypothesis,0,0
90556,that,0,0
90557,bupropion,0,0
90558,SR,0,0
90559,treatment,0,0
90560,improves,0,0
90561,short-term,0,0
90562,abstinence,0,0
90563,by,0,0
90564,reducing,0,0
90565,withdrawal,0,0
90566,distress,0,1
90567,or,0,0
90568,affecting,0,0
90569,the,0,0
90570,subjective,0,0
90571,effects,0,0
90572,of,0,0
90573,a,0,0
90574,lapse,0,0
90575,cigarette,0,0
90576,",",0,0
90577,but,0,0
90578,provided,0,0
90579,partial,0,0
90580,support,0,0
90581,for,0,0
90582,mediation,0,0
90583,by,0,0
90584,cigarette,0,1
90585,craving,0,0
90586,reduction,0,0
90587,and,0,0
90588,enhanced,0,0
90589,positive,0,0
90590,affect,0,0
90591,.,0,1
90592,Bupropion,0,0
90593,SR,0,0
90594,effects,0,0
90595,on,0,0
90596,point-prevalence,0,0
90597,abstinence,0,0
90598,at,0,0
90599,1,0,0
90600,month,0,0
90601,post-quit,0,0
90602,were,0,0
90603,also,0,0
90604,mediated,0,0
90605,partially,0,0
90606,by,0,0
90607,enhanced,0,0
90608,motivation,0,0
90609,to,0,0
90610,quit,0,0
90611,and,0,0
90612,self-efficacy,0,0
90613,.,0,1
90614,CONCLUSIONS,0,0
90615,Results,0,0
90616,provided,0,0
90617,some,0,0
90618,support,0,0
90619,for,0,0
90620,models,0,0
90621,of,0,0
90622,bupropion,0,1
90623,SR,0,0
90624,treatment,0,0
90625,and,0,0
90626,relapse,0,0
90627,and,0,0
90628,suggested,0,0
90629,that,0,0
90630,motivational,0,0
90631,processes,0,0
90632,may,0,0
90633,partially,0,0
90634,account,0,0
90635,for,0,0
90636,bupropion,0,0
90637,SR,0,0
90638,efficacy,0,0
90639,.,0,1
90640,CASTLE,0,0
90641,data,1,0
90642,show,1,0
90643,no,1,0
90644,gender,1,0
90645,differences,1,0
90646,.,1,1
90647,Methotrexate,0,0
90648,in,0,0
90649,the,0,0
90650,treatment,0,0
90651,of,0,0
90652,steroid-dependent,1,1
90653,asthma,1,1
90654,.,1,0
90655,A,0,0
90656,double-blind,0,0
90657,",",0,0
90658,placebo-controlled,0,0
90659,",",0,0
90660,crossover,0,0
90661,study,0,0
90662,was,0,0
90663,designed,0,0
90664,to,0,0
90665,compare,0,0
90666,steroid,0,0
90667,requirements,0,0
90668,between,0,0
90669,placebo,0,0
90670,and,0,0
90671,methotrexate,0,0
90672,(,0,0
90673,MTX,0,0
90674,),0,0
90675,treatment,0,0
90676,in,0,0
90677,subjects,1,1
90678,with,1,1
90679,corticosteroid-requiring,1,1
90680,asthma,1,1
90681,.,1,1
90682,Subjects,0,0
90683,began,0,1
90684,with,0,1
90685,a,0,0
90686,steroid,0,0
90687,taper,0,0
90688,and,0,0
90689,then,0,0
90690,were,0,0
90691,randomized,0,0
90692,to,0,0
90693,a,0,0
90694,3-month,0,0
90695,trial,0,0
90696,of,0,0
90697,drug,0,0
90698,or,0,1
90699,placebo,0,0
90700,therapy,0,0
90701,.,0,1
90702,Subjects,0,1
90703,received,0,0
90704,15,0,1
90705,mg,0,0
90706,of,0,0
90707,MTX,0,0
90708,a,0,0
90709,week,0,0
90710,or,0,0
90711,identical,0,0
90712,placebo,0,0
90713,.,0,0
90714,A,0,0
90715,1-month,0,0
90716,washout,0,0
90717,period,0,0
90718,was,0,0
90719,completed,0,1
90720,before,0,0
90721,the,0,0
90722,crossover,0,0
90723,trial,0,0
90724,.,0,1
90725,Symptom,0,0
90726,scores,0,0
90727,",",0,0
90728,peak,0,0
90729,flow,0,0
90730,rates,0,0
90731,",",0,0
90732,spirometry,0,1
90733,",",0,0
90734,and,0,0
90735,beta-agonist,0,0
90736,frequency,0,0
90737,were,0,0
90738,closely,0,0
90739,monitored,0,0
90740,.,0,0
90741,Ten,1,1
90742,subjects,1,1
90743,completed,1,1
90744,the,1,0
90745,study,1,0
90746,.,1,0
90747,The,0,0
90748,average,0,0
90749,dose,0,0
90750,of,0,0
90751,prednisone,0,0
90752,during,0,0
90753,the,0,0
90754,placebo-treatment,0,0
90755,period,0,0
90756,was,0,0
90757,11.97,0,0
90758,mg/day,0,0
90759,compared,0,0
90760,to,0,0
90761,8.37,0,0
90762,mg/day,0,0
90763,while,0,1
90764,subjects,0,1
90765,were,0,1
90766,taking,0,1
90767,MTX,0,0
90768,.,0,1
90769,This,0,0
90770,was,0,0
90771,a,0,0
90772,30,0,0
90773,%,0,0
90774,reduction,0,0
90775,in,0,0
90776,daily,0,0
90777,steroid,0,0
90778,requirement,0,0
90779,(,0,0
90780,p,0,0
90781,less,0,0
90782,than,0,0
90783,0.01,0,0
90784,),0,1
90785,.,0,1
90786,Symptom,0,0
90787,scores,0,0
90788,and,0,1
90789,spirometry,0,1
90790,did,0,0
90791,not,0,0
90792,differ,0,0
90793,between,0,0
90794,the,0,0
90795,crossover,0,0
90796,trials,0,0
90797,",",0,0
90798,and,0,0
90799,overall,0,0
90800,clinical,0,0
90801,status,0,0
90802,was,0,0
90803,not,0,0
90804,altered,0,1
90805,.,0,0
90806,Complications,0,0
90807,from,0,1
90808,MTX,0,0
90809,were,0,1
90810,mild,0,1
90811,and,0,0
90812,included,0,0
90813,anorexia,0,1
90814,",",0,0
90815,alopecia,0,0
90816,",",0,0
90817,and,0,0
90818,stomatitis,0,1
90819,.,0,0
90820,All,0,0
90821,complications,0,0
90822,resolved,0,0
90823,with,0,1
90824,dose,0,0
90825,reduction,0,0
90826,or,0,0
90827,when,0,0
90828,MTX,0,0
90829,was,0,0
90830,stopped,0,0
90831,at,0,0
90832,the,0,0
90833,end,0,0
90834,of,0,0
90835,the,0,0
90836,study,0,0
90837,.,0,0
90838,No,0,0
90839,subjects,0,1
90840,withdrew,0,0
90841,from,0,0
90842,the,0,0
90843,study,0,0
90844,because,0,0
90845,of,0,0
90846,MTX,0,0
90847,complications,0,0
90848,.,0,1
90849,Low-dose,0,0
90850,MTX,0,0
90851,significantly,0,0
90852,reduced,0,0
90853,the,0,0
90854,steroid,0,0
90855,requirement,0,0
90856,in,0,0
90857,this,0,0
90858,group,0,0
90859,of,0,0
90860,subjects,1,1
90861,with,1,1
90862,steroid-dependent,1,1
90863,asthma,1,1
90864,.,1,0
90865,This,0,0
90866,reduction,0,0
90867,in,0,0
90868,steroid,0,0
90869,requirement,0,1
90870,was,0,0
90871,obtained,0,0
90872,without,0,1
90873,altering,0,0
90874,clinical,0,0
90875,status,0,0
90876,and,0,0
90877,without,0,1
90878,significant,0,0
90879,complication,0,0
90880,.,0,1
90881,Monitoring,0,0
90882,of,0,0
90883,the,0,0
90884,central,0,0
90885,pulse,0,0
90886,pressure,0,0
90887,is,0,0
90888,useful,0,0
90889,for,0,0
90890,detecting,0,0
90891,cardiac,0,1
90892,overload,0,1
90893,during,0,0
90894,antiadrenergic,0,0
90895,treatment,0,0
90896,:,0,1
90897,the,1,0
90898,Japan,1,0
90899,Morning,1,0
90900,Surge,1,1
90901,1,1,0
90902,study,1,1
90903,.,1,1
90904,OBJECTIVE,0,0
90905,Lowering,0,0
90906,of,0,0
90907,the,0,0
90908,central,0,0
90909,pulse,0,0
90910,pressure,0,0
90911,(,0,0
90912,PP,0,0
90913,),0,0
90914,has,0,0
90915,been,0,0
90916,shown,0,0
90917,to,0,0
90918,contribute,0,0
90919,to,0,0
90920,an,0,0
90921,improvement,0,0
90922,of,0,0
90923,the,0,0
90924,cardiac,0,1
90925,damage,0,0
90926,beyond,0,0
90927,that,0,0
90928,of,0,0
90929,lowering,0,0
90930,the,0,0
90931,brachial,0,1
90932,PP,0,0
90933,.,0,1
90934,We,0,0
90935,assessed,0,0
90936,the,0,0
90937,hypothesis,0,0
90938,that,0,0
90939,the,0,0
90940,change,0,0
90941,in,0,0
90942,the,0,0
90943,central,0,0
90944,PP,0,0
90945,is,0,0
90946,more,0,0
90947,useful,0,0
90948,than,0,0
90949,that,0,0
90950,in,0,0
90951,the,0,0
90952,brachial,0,0
90953,PP,0,0
90954,in,0,0
90955,the,0,0
90956,assessment,0,0
90957,of,0,0
90958,the,0,0
90959,change,0,0
90960,in,0,0
90961,cardiac,0,1
90962,load,0,0
90963,.,0,1
90964,METHODS,0,0
90965,We,0,0
90966,studied,0,1
90967,434,1,1
90968,treated,1,1
90969,hypertensive,1,1
90970,patients,1,1
90971,whose,1,1
90972,home,1,1
90973,systolic,1,0
90974,blood,1,0
90975,pressure,1,0
90976,was,1,0
90977,135,1,1
90978,mmHg,1,0
90979,or,1,1
90980,higher,1,0
90981,.,1,0
90982,They,1,0
90983,were,0,0
90984,followed,0,0
90985,for,0,0
90986,6,0,0
90987,months,0,0
90988,after,0,0
90989,allocation,0,0
90990,to,0,0
90991,either,0,0
90992,a,0,0
90993,control,0,0
90994,group,0,0
90995,or,0,0
90996,an,0,0
90997,added,0,0
90998,treatment,0,0
90999,group,0,0
91000,(,0,0
91001,doxazosin,0,0
91002,1-4,0,1
91003,mg,0,0
91004,and,0,0
91005,atenolol,0,0
91006,when,0,0
91007,needed,0,0
91008,),0,0
91009,.,0,0
91010,We,0,0
91011,measured,0,0
91012,the,0,0
91013,brachial,0,0
91014,and,0,0
91015,central,0,0
91016,(,0,0
91017,carotid,0,1
91018,),0,0
91019,blood,0,0
91020,pressure,0,0
91021,simultaneously,0,0
91022,using,0,0
91023,a,0,0
91024,validated,0,0
91025,device,0,0
91026,",",0,0
91027,and,0,0
91028,the,0,0
91029,B-type,0,0
91030,natriuretic,0,0
91031,peptide,0,0
91032,at,0,0
91033,baseline,0,0
91034,and,0,0
91035,at,0,0
91036,the,0,0
91037,sixth,0,0
91038,month,0,0
91039,of,0,0
91040,treatment,0,0
91041,.,0,1
91042,RESULTS,0,0
91043,In,0,0
91044,the,0,0
91045,added,0,0
91046,treatment,0,0
91047,group,0,0
91048,",",0,0
91049,the,0,0
91050,brachial,0,0
91051,systolic,0,0
91052,blood,0,0
91053,pressure,0,0
91054,was,0,0
91055,successfully,0,0
91056,reduced,0,0
91057,",",0,0
91058,but,0,0
91059,the,0,0
91060,central,0,0
91061,PP,0,0
91062,increased,0,0
91063,significantly,0,0
91064,",",0,0
91065,whereas,0,0
91066,the,0,0
91067,other,0,0
91068,blood,0,0
91069,pressure,0,0
91070,parameters,0,0
91071,did,0,0
91072,not,0,0
91073,change,0,0
91074,from,0,0
91075,the,0,0
91076,baseline,0,0
91077,.,0,0
91078,In,0,0
91079,the,0,0
91080,added,0,0
91081,treatment,0,0
91082,group,0,0
91083,",",0,0
91084,the,0,0
91085,change,0,0
91086,in,0,0
91087,the,0,0
91088,B-type,0,0
91089,natriuretic,0,0
91090,peptide,0,0
91091,was,0,0
91092,significantly,0,0
91093,correlated,0,0
91094,with,0,0
91095,the,0,0
91096,change,0,0
91097,in,0,0
91098,the,0,0
91099,brachial,0,0
91100,PP,0,0
91101,(,0,0
91102,r,0,0
91103,=,0,0
91104,0.18,0,0
91105,),0,0
91106,",",0,0
91107,central,0,0
91108,systolic,0,1
91109,blood,0,0
91110,pressure,0,0
91111,(,0,0
91112,r,0,0
91113,=,0,0
91114,0.18,0,0
91115,),0,0
91116,",",0,0
91117,central,0,0
91118,PP,0,0
91119,(,0,0
91120,r,0,0
91121,=,0,0
91122,0.26,0,0
91123,),0,0
91124,",",0,0
91125,and,0,0
91126,PP,0,0
91127,amplification,0,0
91128,(,0,0
91129,r,0,0
91130,=,0,0
91131,-0.22,0,0
91132,),0,0
91133,even,0,0
91134,after,0,0
91135,adjusting,0,0
91136,for,0,0
91137,the,0,0
91138,confounding,0,0
91139,factors,0,0
91140,.,0,0
91141,The,0,0
91142,correlation,0,0
91143,with,0,0
91144,the,0,0
91145,central,0,0
91146,PP,0,0
91147,was,0,0
91148,stronger,0,0
91149,than,0,0
91150,with,0,1
91151,the,0,0
91152,brachial,0,0
91153,PP,0,0
91154,(,0,1
91155,P,0,0
91156,=,0,0
91157,0.018,0,0
91158,),0,0
91159,or,0,1
91160,central,0,0
91161,systolic,0,1
91162,blood,0,0
91163,pressure,0,0
91164,(,0,0
91165,P,0,0
91166,=,0,0
91167,0.002,0,0
91168,),0,0
91169,",",0,0
91170,and,0,0
91171,these,0,0
91172,relationships,0,0
91173,were,0,0
91174,essentially,0,0
91175,the,0,0
91176,same,0,0
91177,even,0,0
91178,after,0,0
91179,adjustment,0,0
91180,for,0,0
91181,the,0,0
91182,use,0,0
91183,of,0,0
91184,atenolol,0,0
91185,or,0,0
91186,the,0,0
91187,change,0,0
91188,in,0,0
91189,heart,0,1
91190,rate,0,0
91191,.,0,0
91192,CONCLUSION,0,0
91193,This,0,0
91194,study,0,0
91195,showed,0,0
91196,that,0,0
91197,the,0,0
91198,central,0,0
91199,PP,0,0
91200,measurement,0,0
91201,may,0,0
91202,be,0,0
91203,more,0,0
91204,important,0,0
91205,to,0,0
91206,assess,0,0
91207,cardiac,0,1
91208,load,0,0
91209,than,0,0
91210,the,0,0
91211,brachial,0,0
91212,PP,0,0
91213,during,0,0
91214,antiadrenergic,0,0
91215,treatment,0,0
91216,.,0,1
91217,Development,0,0
91218,of,0,0
91219,autistic,1,1
91220,children,1,1
91221,based,0,0
91222,on,0,0
91223,maternal,0,1
91224,responses,0,0
91225,to,0,0
91226,the,0,0
91227,Autism,0,1
91228,Behavior,0,1
91229,Checklist,0,0
91230,.,0,1
91231,BACKGROUND,0,0
91232,language,0,0
91233,and,0,0
91234,speech-language,0,1
91235,intervention,0,0
91236,.,0,1
91237,AIM,0,0
91238,to,0,0
91239,evaluate,0,0
91240,the,0,0
91241,development,0,0
91242,process,0,0
91243,of,0,0
91244,autistic,1,1
91245,children,1,1
91246,",",0,0
91247,in,0,0
91248,a,0,0
91249,direct,0,0
91250,and,0,0
91251,indirect,0,0
91252,intervention,0,0
91253,context,0,0
91254,based,0,0
91255,on,0,0
91256,the,0,0
91257,responses,0,0
91258,of,0,0
91259,mothers,0,1
91260,to,0,0
91261,the,0,0
91262,Autism,0,1
91263,Behavior,0,1
91264,Checklist,0,0
91265,.,0,1
91266,METHOD,0,0
91267,the,0,0
91268,research,0,0
91269,sample,0,1
91270,consisted,0,1
91271,of,0,0
91272,11,1,1
91273,mothers,1,1
91274,of,1,1
91275,children,1,1
91276,diagnosed,1,1
91277,",",1,0
91278,according,1,0
91279,to,1,0
91280,the,1,0
91281,criteria,1,1
91282,established,1,0
91283,by,1,0
91284,the,1,0
91285,DSM,1,1
91286,IVtr,1,0
91287,(,1,0
91288,APA,1,1
91289,",",1,0
91290,2002,1,1
91291,),1,0
91292,",",1,0
91293,with,1,1
91294,autism,1,1
91295,(,1,0
91296,six,1,1
91297,),1,0
91298,and,1,0
91299,with,1,1
91300,Asperger,1,1
91301,Syndrome,1,1
91302,(,1,1
91303,five,1,1
91304,),1,1
91305,and,1,1
91306,who,1,1
91307,were,1,1
91308,seen,1,1
91309,at,1,0
91310,the,1,0
91311,Investigation,1,0
91312,Laboratory,1,1
91313,of,1,0
91314,Global,1,1
91315,Developmental,1,1
91316,Disorders,1,1
91317,of,1,0
91318,the,1,0
91319,Federal,1,0
91320,University,1,1
91321,of,1,0
91322,S?o,1,1
91323,Paulo,1,1
91324,.,1,1
91325,These,0,0
91326,children,0,1
91327,were,0,0
91328,randomly,0,1
91329,divided,0,1
91330,into,0,0
91331,two,0,1
91332,groups,0,1
91333,:,0,1
91334,Six,0,1
91335,were,0,0
91336,receiving,0,1
91337,both,0,0
91338,direct,0,0
91339,and,0,0
91340,indirect,0,0
91341,intervention,0,0
91342,(,0,0
91343,TG,0,0
91344,),0,0
91345,",",0,0
91346,and,0,0
91347,five,0,1
91348,were,0,0
91349,receiving,0,1
91350,indirect,0,0
91351,intervention,0,0
91352,exclusively,0,1
91353,(,0,0
91354,OG,0,0
91355,),0,0
91356,.,0,0
91357,The,0,0
91358,Autism,0,1
91359,Behavior,0,1
91360,Checklist,0,0
91361,(,0,0
91362,Krug,0,0
91363,et,0,0
91364,al.,0,0
91365,",",0,0
91366,1993,0,1
91367,),0,0
91368,was,0,0
91369,used,0,0
91370,",",0,0
91371,adapted,0,0
91372,to,0,0
91373,the,1,0
91374,Portuguese,1,0
91375,language,1,0
91376,by,0,0
91377,Marteleto,0,1
91378,(,0,1
91379,2003,0,1
91380,),0,0
91381,.,0,0
91382,This,0,0
91383,behavior,0,0
91384,checklist,0,0
91385,(,0,1
91386,57,0,1
91387,items,0,0
91388,),0,0
91389,allows,0,0
91390,the,0,0
91391,detailed,0,0
91392,description,0,0
91393,of,0,0
91394,non-adaptable,0,0
91395,characteristics,0,0
91396,regarding,0,0
91397,the,0,0
91398,following,0,0
91399,areas,0,0
91400,:,0,1
91401,sensory,0,0
91402,",",0,0
91403,use,0,0
91404,of,0,0
91405,the,0,0
91406,body,0,0
91407,and,0,0
91408,object,0,0
91409,",",0,0
91410,Language,0,0
91411,",",0,0
91412,Psycho-social,0,1
91413,and,0,0
91414,Relational,0,0
91415,.,0,0
91416,The,0,0
91417,questionnaire,0,0
91418,was,0,0
91419,filled,0,0
91420,in,0,0
91421,during,0,0
91422,an,0,0
91423,interview,0,0
91424,on,0,0
91425,three,0,1
91426,occasions,0,0
91427,:,0,1
91428,at,0,0
91429,the,0,0
91430,beginning,0,0
91431,of,0,0
91432,intervention,0,0
91433,",",0,0
91434,after,0,0
91435,six,0,1
91436,months,0,0
91437,and,0,0
91438,at,0,0
91439,the,0,0
91440,end,0,0
91441,of,0,0
91442,12,0,1
91443,months,0,0
91444,.,0,1
91445,RESULTS,0,0
91446,after,0,0
91447,statistical,0,0
91448,analysis,0,0
91449,it,0,0
91450,was,0,0
91451,observed,0,0
91452,that,0,0
91453,there,0,0
91454,was,0,0
91455,a,0,0
91456,greater,0,0
91457,development,0,0
91458,in,0,0
91459,the,0,0
91460,total,0,1
91461,scores,0,0
91462,and,0,0
91463,in,0,0
91464,the,0,0
91465,areas,0,0
91466,of,0,0
91467,language,0,0
91468,",",0,0
91469,psycho-social,0,0
91470,and,0,0
91471,relational,0,0
91472,for,0,0
91473,the,0,0
91474,TG,0,0
91475,.,0,0
91476,This,0,0
91477,suggests,0,0
91478,a,0,0
91479,greater,0,0
91480,development,0,0
91481,pattern,0,0
91482,during,0,0
91483,the,0,0
91484,studied,0,0
91485,period,0,0
91486,for,0,0
91487,this,0,0
91488,group,0,0
91489,.,0,0
91490,CONCLUSION,0,0
91491,the,1,0
91492,mothers,1,1
91493,of,0,0
91494,both,0,0
91495,groups,0,0
91496,observed,0,0
91497,behavioral,0,1
91498,changes,0,0
91499,.,0,1
91500,The,0,0
91501,better,0,0
91502,scores,0,0
91503,observed,0,0
91504,for,0,0
91505,the,0,0
91506,TG,0,0
91507,is,0,0
91508,probably,0,0
91509,related,0,0
91510,to,0,0
91511,the,0,0
91512,effectiveness,0,0
91513,of,0,0
91514,direct,0,0
91515,intervention,0,0
91516,",",0,0
91517,and,0,0
91518,not,0,0
91519,to,0,0
91520,the,0,0
91521,lack,0,0
91522,of,0,0
91523,attention,0,0
91524,of,1,0
91525,parents,1,1
91526,in,0,0
91527,the,0,0
91528,OG,0,0
91529,in,0,0
91530,recognizing,0,0
91531,behavioral,0,1
91532,changes,0,0
91533,in,0,0
91534,their,0,1
91535,children,0,1
91536,.,0,1
91537,Need,0,0
91538,the,0,0
91539,thumb,0,0
91540,be,0,0
91541,immobilised,0,0
91542,in,0,0
91543,scaphoid,1,1
91544,fractures,1,1
91545,?,0,0
91546,A,0,0
91547,randomised,0,0
91548,prospective,0,0
91549,trial,0,1
91550,.,0,0
91551,Immobilisation,0,0
91552,of,0,0
91553,the,0,0
91554,thumb,0,0
91555,is,0,0
91556,widely,0,0
91557,believed,0,0
91558,to,0,0
91559,be,0,0
91560,important,0,0
91561,in,0,0
91562,the,0,0
91563,management,0,0
91564,of,0,0
91565,fractures,1,1
91566,of,1,0
91567,the,1,0
91568,carpal,1,1
91569,scaphoid,1,1
91570,.,1,0
91571,To,0,0
91572,assess,0,0
91573,the,0,0
91574,need,0,0
91575,for,0,0
91576,this,0,0
91577,",",0,0
91578,we,0,0
91579,randomly,0,1
91580,allocated,0,1
91581,392,1,1
91582,fresh,1,1
91583,fractures,1,1
91584,for,0,0
91585,treatment,0,0
91586,by,0,0
91587,either,0,0
91588,a,0,0
91589,forearm,0,0
91590,gauntlet,0,0
91591,(,0,0
91592,Colles,0,1
91593,',0,1
91594,),0,0
91595,cast,0,0
91596,",",0,0
91597,leaving,0,0
91598,the,0,0
91599,thumb,0,1
91600,free,0,0
91601,",",0,0
91602,or,0,0
91603,by,0,0
91604,a,0,0
91605,conventional,0,0
91606,'scaphoid,0,1
91607,',0,1
91608,plaster,0,0
91609,incorporating,0,0
91610,the,0,0
91611,thumb,0,0
91612,as,0,0
91613,far,0,0
91614,as,0,0
91615,its,0,0
91616,interphalangeal,0,1
91617,joint,0,0
91618,.,0,0
91619,In,0,0
91620,the,0,0
91621,292,1,1
91622,fractures,1,1
91623,which,0,0
91624,were,0,0
91625,followed,0,0
91626,for,0,0
91627,six,0,1
91628,months,0,0
91629,",",0,0
91630,the,0,0
91631,incidence,0,0
91632,of,0,0
91633,nonunion,0,1
91634,was,0,0
91635,independent,0,0
91636,of,0,0
91637,the,0,0
91638,type,0,1
91639,of,0,0
91640,cast,0,0
91641,used,0,0
91642,.,0,1
91643,Treatment,0,0
91644,with,0,1
91645,the,0,0
91646,dipeptidyl,0,0
91647,peptidase-4,0,0
91648,inhibitor,0,0
91649,vildagliptin,0,0
91650,improves,0,0
91651,fasting,0,0
91652,islet-cell,0,0
91653,function,0,0
91654,in,0,0
91655,subjects,1,1
91656,with,1,1
91657,type,1,1
91658,2,1,1
91659,diabetes,1,1
91660,.,1,1
91661,CONTEXT,0,0
91662,Dipeptidyl,0,0
91663,peptidase,0,0
91664,4,0,0
91665,(,0,0
91666,DPP-4,0,0
91667,),0,1
91668,inhibitors,0,0
91669,are,0,0
91670,proposed,0,0
91671,to,0,0
91672,lower,0,0
91673,blood,0,0
91674,glucose,0,0
91675,in,0,0
91676,type,1,1
91677,2,1,1
91678,diabetes,1,1
91679,mellitus,1,1
91680,(,1,1
91681,T2DM,1,0
91682,),1,0
91683,by,0,0
91684,prolonging,0,0
91685,the,0,0
91686,activity,0,0
91687,of,0,0
91688,the,0,0
91689,circulating,0,0
91690,incretins,0,0
91691,",",0,0
91692,glucose-dependent,0,0
91693,insulinotropic,0,0
91694,polypeptide,0,0
91695,(,0,0
91696,GIP,0,1
91697,),0,0
91698,and,0,0
91699,glucagon-like,0,0
91700,peptide,0,0
91701,1,0,0
91702,(,0,0
91703,GLP-1,0,1
91704,),0,1
91705,.,0,0
91706,Consistent,0,0
91707,with,0,0
91708,this,0,0
91709,mechanism,0,0
91710,of,0,0
91711,action,0,0
91712,",",0,0
91713,DPP-4,0,0
91714,inhibitors,0,0
91715,improve,0,0
91716,glucose,0,0
91717,tolerance,0,0
91718,after,0,0
91719,meals,0,0
91720,by,0,0
91721,increasing,0,0
91722,insulin,0,0
91723,and,0,0
91724,reducing,0,0
91725,glucagon,0,0
91726,levels,0,0
91727,in,0,0
91728,the,0,0
91729,plasma,0,0
91730,.,0,0
91731,However,0,0
91732,",",0,0
91733,DPP-4,0,0
91734,inhibitors,0,0
91735,also,0,0
91736,reduce,0,0
91737,fasting,0,0
91738,blood,0,0
91739,glucose,0,0
91740,",",0,0
91741,an,0,0
91742,unexpected,0,0
91743,effect,0,0
91744,because,0,0
91745,circulating,0,0
91746,levels,0,0
91747,of,0,1
91748,active,0,1
91749,GIP,0,1
91750,and,0,0
91751,GLP-1,0,1
91752,are,0,0
91753,low,0,0
91754,in,0,0
91755,the,0,0
91756,postabsorptive,0,0
91757,state,0,0
91758,.,0,0
91759,OBJECTIVE,0,0
91760,The,0,0
91761,objective,0,0
91762,of,0,0
91763,the,0,0
91764,study,0,0
91765,was,0,0
91766,to,0,0
91767,examine,0,0
91768,the,0,0
91769,effects,0,0
91770,of,0,0
91771,DPP-4,0,0
91772,inhibition,0,0
91773,on,0,0
91774,fasting,0,0
91775,islet,0,1
91776,function,0,0
91777,.,0,0
91778,DESIGN,0,0
91779,We,0,0
91780,conducted,0,0
91781,a,0,0
91782,randomized,0,0
91783,",",0,0
91784,double-blind,0,0
91785,",",0,0
91786,placebo-controlled,0,0
91787,trial,0,0
91788,.,0,0
91789,SETTING,0,0
91790,The,0,0
91791,study,0,0
91792,was,0,0
91793,performed,0,0
91794,in,0,0
91795,General,1,1
91796,Clinical,1,0
91797,Research,1,0
91798,Centers,1,1
91799,at,1,1
91800,two,1,1
91801,University,1,1
91802,Hospitals,1,1
91803,.,1,1
91804,SUBJECTS,0,0
91805,Forty-one,1,1
91806,subjects,1,1
91807,with,1,1
91808,T2DM,1,0
91809,were,0,0
91810,treated,0,1
91811,with,0,1
91812,metformin,0,0
91813,or,0,0
91814,diet,0,0
91815,",",0,0
91816,having,0,1
91817,good,0,0
91818,glycemic,0,0
91819,control,0,1
91820,with,0,1
91821,glycosylated,0,0
91822,hemoglobin,0,0
91823,values,0,0
91824,of,0,0
91825,6.2-7.5,0,1
91826,%,0,0
91827,.,0,1
91828,INTERVENTION,0,0
91829,Subjects,0,1
91830,were,0,1
91831,treated,0,1
91832,with,0,1
91833,vildagliptin,0,0
91834,(,0,0
91835,50,0,0
91836,mg,0,0
91837,twice,0,0
91838,daily,0,0
91839,),0,0
91840,or,0,0
91841,placebo,0,0
91842,for,0,0
91843,3,0,0
91844,months,0,0
91845,",",0,0
91846,followed,0,0
91847,by,0,0
91848,a,0,0
91849,2-wk,0,0
91850,washout,0,0
91851,.,0,1
91852,Major,0,0
91853,Outcome,0,0
91854,Measure,0,0
91855,:,0,1
91856,We,0,0
91857,measured,0,0
91858,insulin,0,0
91859,secretion,0,0
91860,in,0,0
91861,response,0,0
91862,to,0,0
91863,iv,0,0
91864,glucose,0,0
91865,and,0,0
91866,arginine,0,0
91867,before,0,0
91868,and,0,0
91869,after,0,0
91870,treatment,0,0
91871,and,0,0
91872,after,0,0
91873,drug,0,0
91874,washout,0,0
91875,.,0,0
91876,RESULTS,0,0
91877,There,0,0
91878,were,0,0
91879,small,0,0
91880,and,0,1
91881,comparable,0,0
91882,reductions,0,0
91883,in,0,0
91884,glycosylated,0,0
91885,hemoglobin,0,0
91886,in,0,0
91887,both,0,0
91888,groups,0,0
91889,over,0,0
91890,3,0,1
91891,months,0,0
91892,.,0,1
91893,Vildagliptin,0,0
91894,increased,0,0
91895,fasting,0,0
91896,GLP-1,0,1
91897,levels,0,0
91898,in,0,1
91899,subjects,0,1
91900,taking,0,1
91901,metformin,0,0
91902,",",0,0
91903,but,0,0
91904,not,0,0
91905,those,0,0
91906,managed,0,0
91907,with,0,1
91908,diet,0,0
91909,",",0,0
91910,and,0,0
91911,raised,0,0
91912,active,0,1
91913,GIP,0,1
91914,levels,0,0
91915,slightly,0,0
91916,.,0,1
91917,DPP-4,0,0
91918,inhibitor,0,0
91919,treatment,0,0
91920,improved,0,0
91921,the,0,0
91922,acute,0,1
91923,insulin,0,0
91924,and,0,0
91925,C-peptide,0,0
91926,responses,0,0
91927,to,0,0
91928,glucose,0,0
91929,(,0,0
91930,50,0,1
91931,and,0,0
91932,100,0,0
91933,%,0,0
91934,respectively,0,0
91935,;,0,0
91936,P,0,0
91937,<,0,0
91938,0.05,0,0
91939,),0,0
91940,and,0,0
91941,increased,0,0
91942,the,0,0
91943,slope,0,0
91944,of,0,0
91945,the,0,0
91946,C-peptide,0,0
91947,response,0,0
91948,to,0,0
91949,glucose,0,0
91950,(,0,0
91951,33,0,1
91952,%,0,0
91953,;,0,1
91954,P,0,0
91955,=,0,0
91956,0.023,0,0
91957,),0,1
91958,.,0,1
91959,CONCLUSION,0,0
91960,Vildagliptin,0,0
91961,improves,0,0
91962,islet,0,0
91963,function,0,0
91964,in,0,0
91965,T2DM,0,0
91966,under,0,0
91967,fasting,0,0
91968,conditions,0,0
91969,.,0,0
91970,This,0,0
91971,suggests,0,0
91972,that,0,0
91973,DPP-4,0,0
91974,inhibition,0,0
91975,has,0,0
91976,metabolic,0,0
91977,benefits,0,0
91978,in,0,0
91979,addition,0,0
91980,to,0,0
91981,enhancing,0,0
91982,meal-induced,0,0
91983,GLP-1,0,1
91984,and,0,0
91985,GIP,0,1
91986,activity,0,0
91987,.,0,1
91988,Comparison,0,0
91989,of,0,0
91990,40,0,1
91991,milliliters,0,0
91992,of,0,1
91993,0.25,0,0
91994,%,0,0
91995,intrapleural,0,0
91996,bupivacaine,0,0
91997,with,0,1
91998,epinephrine,0,0
91999,with,0,1
92000,20,0,1
92001,milliliters,0,0
92002,of,0,1
92003,0.5,0,0
92004,%,0,0
92005,intrapleural,0,0
92006,bupivacaine,0,0
92007,with,0,1
92008,epinephrine,0,0
92009,after,0,0
92010,cholecystectomy,0,1
92011,.,0,0
92012,To,0,0
92013,determine,0,0
92014,the,0,0
92015,influence,0,0
92016,of,0,0
92017,the,0,0
92018,volume,0,0
92019,of,0,0
92020,local,0,0
92021,anesthetic,0,0
92022,injected,0,0
92023,for,0,0
92024,intrapleural,0,0
92025,analgesia,0,0
92026,",",0,0
92027,40,1,1
92028,patients,1,1
92029,undergoing,1,1
92030,cholecystectomy,1,1
92031,were,1,1
92032,randomly,1,1
92033,allocated,1,1
92034,to,1,0
92035,two,1,0
92036,groups,1,0
92037,of,1,1
92038,20,1,1
92039,patients,1,1
92040,each,1,1
92041,.,1,1
92042,One,1,0
92043,group,1,0
92044,received,0,0
92045,40,0,1
92046,mL,0,0
92047,of,0,0
92048,0.25,0,0
92049,%,0,0
92050,bupivacaine,0,0
92051,with,0,1
92052,epinephrine,0,0
92053,injected,0,0
92054,intrapleurally,0,0
92055,postoperatively,0,0
92056,.,0,0
92057,The,1,0
92058,other,1,0
92059,group,1,0
92060,received,0,0
92061,20,0,0
92062,mL,0,0
92063,of,0,0
92064,0.5,0,0
92065,%,0,0
92066,bupivacaine,0,0
92067,with,0,1
92068,epinephrine,0,0
92069,.,0,0
92070,The,0,0
92071,onset,0,0
92072,time,0,0
92073,of,0,0
92074,analgesia,0,0
92075,was,0,0
92076,nearly,0,0
92077,the,0,0
92078,same,0,0
92079,in,0,0
92080,both,0,0
92081,groups,0,0
92082,and,0,0
92083,within,0,1
92084,25,0,1
92085,min,0,0
92086,all,0,1
92087,patients,1,1
92088,were,0,0
92089,nearly,0,0
92090,pain,0,1
92091,free,0,0
92092,.,0,1
92093,Our,0,0
92094,data,0,0
92095,demonstrate,0,0
92096,that,0,0
92097,100,0,0
92098,mg,0,0
92099,of,0,0
92100,bupivacaine,0,0
92101,with,0,1
92102,epinephrine,0,0
92103,elicits,0,0
92104,effective,0,0
92105,analgesia,0,0
92106,after,0,0
92107,cholecystectomy,0,1
92108,.,0,0
92109,There,0,0
92110,are,0,0
92111,only,0,0
92112,minor,0,0
92113,differences,0,0
92114,between,0,0
92115,20,0,1
92116,and,0,0
92117,40,0,1
92118,mL,0,0
92119,with,0,1
92120,regard,0,0
92121,to,0,0
92122,pain,0,1
92123,relief,0,0
92124,.,0,0
92125,The,0,0
92126,authors,0,0
92127,conclude,0,0
92128,that,0,0
92129,the,0,0
92130,volume,0,0
92131,of,0,0
92132,local,0,0
92133,anesthetic,0,0
92134,within,0,0
92135,the,0,0
92136,range,0,0
92137,of,0,0
92138,20-40,0,1
92139,mL,0,0
92140,in,0,0
92141,an,0,0
92142,adult,0,1
92143,has,0,0
92144,little,0,0
92145,influence,0,0
92146,on,0,0
92147,the,0,0
92148,extent,0,0
92149,or,0,0
92150,duration,0,0
92151,of,0,0
92152,intrapleural,0,0
92153,analgesia,0,0
92154,.,0,1
92155,A,0,0
92156,controlled,0,0
92157,study,0,0
92158,of,0,0
92159,the,0,0
92160,effect,0,0
92161,of,0,0
92162,cognitive-behavioural,0,0
92163,group,0,0
92164,therapy,0,0
92165,for,0,0
92166,pathological,1,1
92167,gamblers,1,1
92168,.,1,1
92169,As,0,0
92170,the,0,0
92171,number,0,0
92172,of,0,0
92173,pathological,1,0
92174,gamblers,1,1
92175,has,0,0
92176,increased,0,0
92177,recently,0,0
92178,",",0,0
92179,the,0,0
92180,need,0,0
92181,for,0,0
92182,effective,0,0
92183,treatment,0,0
92184,has,0,0
92185,become,0,0
92186,more,0,0
92187,evident,0,0
92188,.,0,0
92189,The,0,0
92190,aim,0,0
92191,of,0,0
92192,this,0,0
92193,study,0,0
92194,was,0,0
92195,to,0,0
92196,evaluate,0,0
92197,the,0,0
92198,effectiveness,0,0
92199,of,0,0
92200,a,0,0
92201,short-term,0,0
92202,cognitive-behavioural,0,0
92203,group,0,0
92204,therapy,0,0
92205,programme,0,0
92206,for,0,0
92207,pathological,1,1
92208,gamblers,1,1
92209,.,1,1
92210,Fourteen,1,1
92211,subjects,1,1
92212,(,1,1
92213,three,1,1
92214,females,1,1
92215,and,1,1
92216,11,1,1
92217,males,1,1
92218,),1,1
92219,",",1,1
92220,who,1,1
92221,met,1,1
92222,the,1,1
92223,criteria,1,1
92224,for,1,0
92225,pathological,1,1
92226,gambling,1,1
92227,in,1,0
92228,accordance,1,0
92229,with,1,1
92230,the,1,0
92231,Diagnostic,1,0
92232,and,1,0
92233,Statistical,1,0
92234,Manual,1,1
92235,of,1,0
92236,Mental,1,1
92237,Disorders,1,1
92238,IV,1,0
92239,",",0,0
92240,were,0,0
92241,randomly,0,1
92242,assigned,0,0
92243,to,0,0
92244,a,0,0
92245,Treatment,0,0
92246,Group,0,0
92247,(,0,0
92248,n=7,0,1
92249,),0,0
92250,or,0,0
92251,a,0,0
92252,waiting,0,1
92253,list,0,0
92254,Control,0,1
92255,Group,0,1
92256,(,0,0
92257,n=7,0,1
92258,),0,0
92259,.,0,0
92260,An,0,0
92261,experimental,0,0
92262,design,0,0
92263,with,0,1
92264,three,0,0
92265,repeated,0,0
92266,measures,0,0
92267,was,0,0
92268,used,0,0
92269,(,0,0
92270,pre-treatment,0,0
92271,",",0,0
92272,post-treatment/post-waiting,0,0
92273,list,0,0
92274,and,0,0
92275,follow-up,0,0
92276,),0,0
92277,.,0,0
92278,The,0,0
92279,dependent,0,0
92280,variables,0,0
92281,were,0,1
92282,DSM-IV,0,1
92283,Criteria,0,1
92284,for,0,0
92285,Pathological,0,1
92286,Gambling,0,0
92287,",",0,0
92288,Money,0,0
92289,Spent,0,0
92290,on,0,0
92291,Gambling,0,0
92292,During,0,0
92293,the,0,0
92294,Last,0,0
92295,Week,0,0
92296,and,0,0
92297,Gamblers,0,1
92298,Inventory,0,1
92299,of,0,1
92300,Negative,0,1
92301,Consequences,0,0
92302,.,0,1
92303,The,0,0
92304,Treatment,0,0
92305,Group,0,0
92306,improved,0,0
92307,on,0,0
92308,the,0,0
92309,DSM-IV,0,0
92310,Criteria,0,1
92311,for,0,0
92312,Pathological,0,1
92313,Gambling,0,0
92314,",",0,0
92315,but,0,0
92316,did,0,0
92317,not,0,0
92318,show,0,0
92319,a,0,0
92320,significant,0,0
92321,improvement,0,0
92322,on,0,0
92323,Money,0,0
92324,Spent,0,0
92325,on,0,0
92326,Gambling,0,0
92327,During,0,0
92328,the,0,0
92329,Last,0,0
92330,week,0,0
92331,from,0,1
92332,pre-treatment,0,0
92333,to,0,1
92334,post-treatment,0,0
92335,.,0,0
92336,Combining,0,0
92337,both,0,0
92338,groups,0,0
92339,at,0,0
92340,3-months,0,0
92341,follow-up,0,0
92342,",",0,0
92343,there,0,0
92344,was,0,0
92345,a,0,0
92346,significant,0,0
92347,improvement,0,0
92348,on,0,0
92349,all,0,0
92350,three,0,0
92351,variables,0,0
92352,from,0,1
92353,pre-treatment,0,0
92354,to,0,1
92355,follow-up,0,0
92356,.,0,0
92357,The,0,0
92358,results,0,0
92359,of,0,0
92360,this,0,0
92361,controlled,0,0
92362,study,0,0
92363,indicate,0,0
92364,that,0,0
92365,a,0,0
92366,short-term,0,0
92367,cognitive-behavioural,0,0
92368,group,0,0
92369,treatment,0,0
92370,for,0,0
92371,pathological,1,1
92372,gamblers,1,1
92373,had,0,1
92374,an,0,0
92375,effect,0,0
92376,.,0,0
92377,Phosphate,0,0
92378,binder,0,0
92379,impact,0,0
92380,on,0,0
92381,bone,0,0
92382,remodeling,0,0
92383,and,0,0
92384,coronary,0,1
92385,calcification,0,1
92386,--,0,1
92387,results,0,0
92388,from,0,1
92389,the,0,0
92390,BRiC,0,1
92391,study,0,0
92392,.,0,0
92393,BACKGROUND,0,0
92394,AND,0,0
92395,AIMS,0,1
92396,Calcium-containing,0,1
92397,phosphate,0,0
92398,binders,0,0
92399,have,0,0
92400,been,0,0
92401,shown,0,0
92402,to,0,0
92403,increase,0,0
92404,the,0,0
92405,progression,0,0
92406,of,0,0
92407,vascular,0,0
92408,calcification,0,1
92409,in,0,0
92410,hemodialysis,1,1
92411,patients,1,1
92412,.,1,0
92413,This,0,0
92414,is,0,0
92415,a,0,0
92416,prospective,0,0
92417,study,0,0
92418,that,0,0
92419,compares,0,0
92420,the,0,0
92421,effects,0,0
92422,of,0,0
92423,calcium,0,0
92424,acetate,0,0
92425,and,0,0
92426,sevelamer,0,0
92427,on,0,0
92428,coronary,0,1
92429,calcification,0,1
92430,(,0,0
92431,CAC,0,0
92432,),0,0
92433,and,0,0
92434,bone,0,0
92435,histology,0,0
92436,.,0,1
92437,METHODS,0,0
92438,101,1,1
92439,hemodialysis,1,1
92440,patients,1,1
92441,were,1,0
92442,randomized,1,1
92443,for,0,0
92444,each,0,0
92445,phosphate,0,0
92446,binder,0,0
92447,and,0,0
92448,submitted,0,0
92449,to,0,0
92450,multislice,0,0
92451,coronary,0,1
92452,tomographies,0,0
92453,and,0,1
92454,bone,0,0
92455,biopsies,0,0
92456,at,0,0
92457,entry,0,1
92458,and,0,0
92459,12,0,1
92460,months,0,0
92461,.,0,1
92462,RESULTS,0,0
92463,The,1,0
92464,71,1,1
92465,patients,1,1
92466,who,1,1
92467,concluded,1,0
92468,the,1,1
92469,study,1,0
92470,had,1,0
92471,similar,1,0
92472,baseline,1,0
92473,characteristics,1,0
92474,.,1,1
92475,On,0,0
92476,follow-up,0,0
92477,",",0,0
92478,the,0,0
92479,sevelamer,0,0
92480,group,0,0
92481,had,0,0
92482,higher,0,0
92483,levels,0,0
92484,of,0,0
92485,intact,0,1
92486,parathyroid,0,1
92487,hormone,0,1
92488,(,0,0
92489,498,0,1
92490,+/-,0,0
92491,352,0,1
92492,vs.,0,0
92493,326,0,1
92494,+/-,0,0
92495,236,0,1
92496,pg/ml,0,0
92497,",",0,0
92498,p,0,0
92499,=,0,0
92500,0.017,0,0
92501,),0,0
92502,",",0,0
92503,bone,0,0
92504,alkaline,0,0
92505,phosphatase,0,0
92506,(,0,0
92507,38,0,1
92508,+/-,0,0
92509,24,0,1
92510,vs.,0,0
92511,28,0,1
92512,+/-,0,0
92513,15,0,1
92514,U/l,0,0
92515,",",0,0
92516,p,0,0
92517,=,0,0
92518,0.03,0,0
92519,),0,0
92520,and,0,0
92521,deoxypyridinoline,0,0
92522,(,0,0
92523,135,0,1
92524,+/-,0,0
92525,107,0,1
92526,vs.,0,0
92527,89,0,1
92528,+/-,0,0
92529,71,0,1
92530,nmol/l,0,0
92531,",",0,0
92532,p,0,0
92533,=,0,0
92534,0.03,0,0
92535,),0,0
92536,and,0,0
92537,lower,0,0
92538,LDL,0,0
92539,cholesterol,0,0
92540,(,0,0
92541,74,0,1
92542,+/-,0,0
92543,21,0,1
92544,vs.,0,0
92545,91,0,1
92546,+/-,0,0
92547,28,0,1
92548,mg/dl,0,0
92549,",",0,0
92550,p,0,0
92551,=,0,0
92552,0.015,0,0
92553,),0,1
92554,.,0,1
92555,Phosphorus,0,0
92556,(,0,0
92557,5.8,0,0
92558,+/-,0,0
92559,1.0,0,0
92560,vs.,0,0
92561,6,0,0
92562,+/-,0,0
92563,1.0,0,0
92564,mg/dl,0,0
92565,",",0,0
92566,p,0,0
92567,=,0,0
92568,0.47,0,0
92569,),0,0
92570,and,0,0
92571,calcium,0,0
92572,(,0,0
92573,1.27,0,0
92574,+/-,0,0
92575,0.07,0,0
92576,vs.,0,0
92577,1.23,0,0
92578,+/-,0,0
92579,0.08,0,0
92580,mmol/l,0,0
92581,",",0,0
92582,p,0,0
92583,=,0,0
92584,0.68,0,0
92585,),0,1
92586,levels,0,0
92587,did,0,0
92588,not,0,0
92589,differ,0,0
92590,between,0,0
92591,groups,0,0
92592,.,0,1
92593,CAC,0,0
92594,progression,0,0
92595,(,0,0
92596,35,0,1
92597,vs.,0,0
92598,24,0,0
92599,%,0,0
92600,",",0,0
92601,p,0,0
92602,=,0,0
92603,0.94,0,0
92604,),0,0
92605,and,0,0
92606,bone,0,0
92607,histological,0,0
92608,diagnosis,0,1
92609,at,0,0
92610,baseline,0,0
92611,and,0,0
92612,12,0,0
92613,months,0,0
92614,were,0,1
92615,similar,0,0
92616,in,0,0
92617,both,0,0
92618,groups,0,0
92619,.,0,1
92620,Patients,0,1
92621,of,0,0
92622,the,0,0
92623,sevelamer,0,0
92624,group,0,0
92625,with,0,1
92626,a,0,0
92627,high,0,0
92628,turnover,0,0
92629,at,0,0
92630,baseline,0,0
92631,had,0,0
92632,an,0,0
92633,increase,0,0
92634,in,0,0
92635,bone,0,0
92636,resorption,0,0
92637,(,0,0
92638,eroded,0,0
92639,surface,0,0
92640,",",0,0
92641,ES/BS,0,0
92642,=,0,0
92643,9.0,0,0
92644,+/-,0,0
92645,5.9,0,0
92646,vs.,0,0
92647,13.1,0,0
92648,+/-,0,0
92649,9.5,0,0
92650,%,0,0
92651,",",0,0
92652,p,0,0
92653,=,0,0
92654,0.05,0,0
92655,),0,0
92656,",",0,0
92657,whereas,0,0
92658,patients,0,1
92659,of,0,0
92660,both,0,0
92661,groups,0,0
92662,with,0,1
92663,low,0,1
92664,turnover,0,0
92665,at,0,0
92666,baseline,0,0
92667,had,0,0
92668,an,0,0
92669,improvement,0,0
92670,in,0,0
92671,bone,0,0
92672,formation,0,0
92673,rate,0,0
92674,(,0,0
92675,BFR/BS,0,0
92676,=,0,0
92677,0.015,0,0
92678,+/-,0,0
92679,0.016,0,0
92680,vs.,0,0
92681,0.062,0,0
92682,+/-,0,0
92683,0.078,0,0
92684,",",0,0
92685,p,0,0
92686,=,0,0
92687,0.003,0,0
92688,for,0,0
92689,calcium,0,0
92690,and,0,0
92691,0.017,0,0
92692,+/-,0,0
92693,0.016,0,0
92694,vs.,0,0
92695,0.071,0,0
92696,+/-,0,0
92697,0.084,0,0
92698,microm,0,0
92699,(,0,1
92700,3,0,0
92701,),0,0
92702,/microm,0,0
92703,(,0,0
92704,2,0,0
92705,),0,0
92706,/day,0,0
92707,",",0,0
92708,p,0,0
92709,=,0,0
92710,0.010,0,0
92711,for,0,0
92712,sevelamer,0,0
92713,),0,0
92714,.,0,0
92715,CONCLUSIONS,0,0
92716,There,0,0
92717,was,0,0
92718,no,0,0
92719,difference,0,0
92720,in,0,0
92721,CAC,0,0
92722,progression,0,0
92723,or,0,1
92724,changes,0,0
92725,in,0,0
92726,bone,0,0
92727,remodeling,0,0
92728,between,0,0
92729,the,0,0
92730,calcium,0,0
92731,and,0,0
92732,the,0,0
92733,sevelamer,0,0
92734,groups,0,0
92735,.,0,1
92736,Comparing,0,0
92737,two,0,0
92738,web-based,1,0
92739,smoking,1,1
92740,cessation,1,1
92741,programs,1,1
92742,:,1,1
92743,randomized,0,1
92744,controlled,0,0
92745,trial,0,0
92746,.,0,1
92747,BACKGROUND,0,0
92748,Smoking,0,0
92749,cessation,0,0
92750,remains,0,0
92751,a,0,0
92752,significant,0,0
92753,public,0,1
92754,health,0,1
92755,problem,0,0
92756,.,0,1
92757,Innovative,0,0
92758,interventions,0,0
92759,that,0,0
92760,use,0,0
92761,the,0,0
92762,Internet,0,0
92763,have,0,0
92764,begun,0,0
92765,to,0,0
92766,emerge,0,0
92767,that,0,0
92768,offer,0,0
92769,great,0,0
92770,promise,0,0
92771,in,0,0
92772,reaching,0,0
92773,large,0,1
92774,numbers,0,0
92775,of,0,1
92776,participants,0,1
92777,and,0,1
92778,encouraging,0,0
92779,widespread,0,0
92780,behavior,0,0
92781,change,0,0
92782,.,0,0
92783,To,0,0
92784,date,0,0
92785,",",0,0
92786,the,0,0
92787,relatively,0,0
92788,few,0,0
92789,controlled,0,0
92790,trials,0,0
92791,of,0,0
92792,Web-based,0,0
92793,smoking,0,1
92794,cessation,0,1
92795,programs,0,0
92796,have,0,0
92797,been,0,0
92798,limited,0,0
92799,by,0,0
92800,short,0,0
92801,follow-up,0,1
92802,intervals,0,0
92803,.,0,1
92804,OBJECTIVE,0,0
92805,We,0,0
92806,describe,0,0
92807,the,0,0
92808,6-month,0,0
92809,follow-up,0,0
92810,results,0,0
92811,of,0,0
92812,a,0,0
92813,randomized,0,0
92814,controlled,0,0
92815,trial,0,0
92816,in,0,0
92817,which,0,0
92818,participants,1,1
92819,recruited,1,1
92820,online,1,0
92821,were,0,0
92822,randomly,0,1
92823,assigned,0,0
92824,to,0,0
92825,either,0,0
92826,a,0,0
92827,Web-based,0,0
92828,smoking,0,0
92829,cessation,0,0
92830,program,0,0
92831,(,0,0
92832,Quit,0,1
92833,Smoking,0,1
92834,Network,0,1
92835,;,0,1
92836,QSN,0,0
92837,),0,0
92838,or,0,0
92839,a,0,0
92840,Web-based,0,0
92841,exercise,0,0
92842,enhancement,0,0
92843,program,0,0
92844,(,0,0
92845,Active,0,0
92846,Lives,0,1
92847,),0,0
92848,adapted,0,0
92849,somewhat,0,0
92850,to,0,0
92851,encourage,0,0
92852,smoking,0,0
92853,cessation,0,0
92854,.,0,1
92855,METHODS,0,0
92856,The,0,0
92857,study,0,0
92858,was,0,0
92859,a,0,0
92860,two-arm,0,0
92861,randomized,0,0
92862,controlled,0,0
92863,trial,0,0
92864,that,0,0
92865,compared,0,0
92866,two,0,0
92867,Web-based,0,0
92868,smoking,0,1
92869,cessation,0,1
92870,programs,0,1
92871,:,0,1
92872,(,0,1
92873,1,0,0
92874,),0,0
92875,the,0,0
92876,QSN,0,0
92877,intervention,0,0
92878,condition,0,0
92879,presented,0,1
92880,cognitive-behavioral,0,0
92881,strategies,0,0
92882,",",0,0
92883,and,0,0
92884,(,0,0
92885,2,0,0
92886,),0,0
92887,the,0,0
92888,Active,0,0
92889,Lives,0,1
92890,control,0,0
92891,condition,0,0
92892,provided,0,0
92893,participants,0,1
92894,with,0,1
92895,guidance,0,0
92896,in,0,0
92897,developing,0,0
92898,a,0,0
92899,physical,0,0
92900,activity,0,0
92901,program,0,0
92902,to,0,0
92903,assist,0,0
92904,them,0,0
92905,with,0,1
92906,quitting,0,0
92907,.,0,0
92908,The,0,0
92909,QSN,0,0
92910,condition,0,0
92911,provided,0,0
92912,smoking,0,0
92913,cessation,0,0
92914,information,0,0
92915,and,0,0
92916,behavior,0,0
92917,change,0,0
92918,strategies,0,0
92919,while,0,0
92920,the,0,0
92921,Active,0,0
92922,Lives,0,1
92923,condition,0,0
92924,provided,0,0
92925,participants,0,1
92926,with,0,1
92927,physical,0,0
92928,activity,0,0
92929,recommendations,0,0
92930,and,0,0
92931,goal,0,0
92932,setting,0,1
92933,.,0,0
92934,The,0,0
92935,QSN,0,0
92936,condition,0,0
92937,was,0,0
92938,designed,0,0
92939,to,0,0
92940,be,0,0
92941,more,0,0
92942,engaging,0,0
92943,(,0,0
92944,eg,0,0
92945,",",0,0
92946,it,0,0
92947,included,0,1
92948,multimedia,0,0
92949,components,0,0
92950,),0,1
92951,and,0,0
92952,to,0,0
92953,present,0,0
92954,much,0,0
92955,greater,0,0
92956,content,0,0
92957,than,0,0
92958,is,0,0
92959,typically,0,0
92960,found,0,0
92961,in,0,0
92962,smoking,0,1
92963,cessation,0,1
92964,programs,0,1
92965,.,0,1
92966,RESULTS,0,0
92967,Contrary,0,0
92968,to,0,0
92969,our,0,0
92970,hypotheses,0,0
92971,",",0,0
92972,no,0,0
92973,between-condition,0,0
92974,differences,0,0
92975,in,0,0
92976,smoking,0,1
92977,abstinence,0,0
92978,were,0,0
92979,found,0,0
92980,at,0,0
92981,3-,0,0
92982,and,0,1
92983,6-month,0,0
92984,follow-up,0,0
92985,assessments,0,0
92986,.,0,1
92987,While,0,0
92988,participants,0,1
92989,in,0,0
92990,the,0,0
92991,QSN,0,0
92992,intervention,0,0
92993,condition,0,0
92994,spent,0,0
92995,more,0,0
92996,time,0,0
92997,than,0,0
92998,controls,0,1
92999,visiting,0,1
93000,the,0,0
93001,online,0,0
93002,program,0,0
93003,",",0,0
93004,the,0,0
93005,median,0,0
93006,number,0,0
93007,of,0,0
93008,1.0,0,0
93009,visit,0,0
93010,in,0,0
93011,each,0,0
93012,condition,0,0
93013,and,0,0
93014,the,0,0
93015,substantial,0,0
93016,attrition,0,1
93017,(,0,0
93018,60.8,0,1
93019,%,0,0
93020,at,0,0
93021,the,0,0
93022,6-month,0,0
93023,follow-up,0,0
93024,),0,0
93025,indicate,0,0
93026,that,0,0
93027,participants,0,1
93028,were,0,0
93029,not,0,0
93030,as,0,0
93031,engaged,0,0
93032,as,0,0
93033,we,0,0
93034,had,0,1
93035,expected,0,0
93036,.,0,1
93037,CONCLUSIONS,0,0
93038,Contrary,0,0
93039,to,0,0
93040,our,0,0
93041,hypothesis,0,0
93042,",",0,0
93043,our,0,0
93044,test,0,0
93045,of,0,0
93046,two,0,0
93047,Web-based,0,0
93048,smoking,0,1
93049,cessation,0,1
93050,conditions,0,0
93051,",",0,0
93052,an,0,0
93053,intervention,0,0
93054,and,0,0
93055,an,0,0
93056,attention,0,0
93057,placebo,0,0
93058,control,0,0
93059,",",0,0
93060,failed,0,0
93061,to,0,0
93062,show,0,0
93063,differences,0,0
93064,at,0,0
93065,3-,0,1
93066,and,0,1
93067,6-month,0,0
93068,assessments,0,0
93069,.,0,1
93070,We,0,0
93071,explored,0,0
93072,possible,0,0
93073,reasons,0,0
93074,for,0,0
93075,this,0,0
93076,finding,0,0
93077,",",0,0
93078,including,0,0
93079,limited,0,0
93080,engagement,0,1
93081,of,0,0
93082,participants,0,1
93083,and,0,0
93084,simplifying,0,0
93085,program,0,0
93086,content,0,0
93087,and,0,0
93088,architecture,0,0
93089,.,0,0
93090,Future,0,0
93091,research,0,0
93092,needs,0,0
93093,to,0,0
93094,address,0,0
93095,methods,0,1
93096,to,0,0
93097,improve,0,0
93098,participant,0,0
93099,engagement,0,0
93100,in,0,0
93101,online,0,0
93102,smoking,0,1
93103,cessation,0,1
93104,programs,0,1
93105,.,0,1
93106,Possible,0,0
93107,approaches,0,0
93108,in,0,0
93109,this,0,0
93110,regard,0,0
93111,can,0,0
93112,include,0,0
93113,new,0,0
93114,informed,0,0
93115,consent,0,1
93116,procedures,0,0
93117,that,0,0
93118,better,0,0
93119,explain,0,0
93120,the,0,0
93121,roles,0,0
93122,and,0,0
93123,responsibilities,0,0
93124,of,0,0
93125,being,0,0
93126,a,0,0
93127,research,0,0
93128,participant,0,0
93129,",",0,0
93130,new,0,0
93131,program,0,1
93132,designs,0,0
93133,that,0,0
93134,add,0,0
93135,more,0,0
93136,vitality,0,0
93137,(,0,0
93138,changing,0,0
93139,content,0,0
93140,from,0,0
93141,visit,0,0
93142,to,0,0
93143,visit,0,0
93144,),0,0
93145,",",0,0
93146,and,0,0
93147,new,0,0
93148,types,0,0
93149,of,0,1
93150,reminders,0,0
93151,pushed,0,0
93152,out,0,0
93153,to,0,0
93154,participants,0,1
93155,to,0,0
93156,encourage,0,0
93157,return,0,0
93158,visits,0,0
93159,.,0,0
93160,Simplifying,0,0
93161,program,0,0
93162,content,0,0
93163,through,0,0
93164,a,0,0
93165,combination,0,0
93166,of,0,0
93167,enhanced,0,0
93168,tailoring,0,0
93169,and,0,0
93170,information,0,0
93171,architecture,0,0
93172,also,0,0
93173,merits,0,0
93174,further,0,0
93175,research,0,0
93176,attention,0,0
93177,.,0,1
93178,Stepping,0,0
93179,Stones,0,1
93180,Triple,0,0
93181,P,0,0
93182,:,0,1
93183,an,0,0
93184,RCT,0,0
93185,of,0,0
93186,a,0,0
93187,parenting,0,0
93188,program,0,0
93189,with,0,1
93190,parents,1,1
93191,of,1,0
93192,a,1,0
93193,child,1,0
93194,diagnosed,1,1
93195,with,1,1
93196,an,1,0
93197,autism,1,1
93198,spectrum,1,1
93199,disorder,1,1
93200,.,1,0
93201,Whilst,0,0
93202,the,0,0
93203,Triple,0,0
93204,P,0,0
93205,Positive,0,1
93206,Parenting,0,0
93207,Program,0,0
93208,has,0,0
93209,a,0,0
93210,large,0,0
93211,evidence,0,0
93212,base,0,0
93213,(,0,0
93214,Sanders,0,1
93215,",",0,0
93216,Clinical,0,0
93217,Child,0,1
93218,and,0,0
93219,Family,0,1
93220,Psychology,0,1
93221,Review,0,0
93222,2:71-90,0,1
93223,",",0,1
93224,1999,0,1
93225,;,0,0
93226,Sanders,0,1
93227,",",0,0
93228,Journal,0,1
93229,of,0,0
93230,Consulting,0,1
93231,and,0,0
93232,Clinical,0,0
93233,Psychology,0,0
93234,68:624-640,0,1
93235,",",0,0
93236,2000,0,1
93237,),0,0
93238,and,0,0
93239,preliminary,0,0
93240,evidence,0,0
93241,indicates,0,0
93242,that,0,0
93243,Stepping,0,0
93244,Stones,0,1
93245,Triple,0,0
93246,P,0,0
93247,is,0,0
93248,also,0,0
93249,efficacious,0,0
93250,(,0,0
93251,Roberts,0,1
93252,",",0,0
93253,Journal,0,1
93254,of,0,0
93255,Clinical,0,0
93256,Child,0,1
93257,and,0,0
93258,Adolescent,0,1
93259,Psychology,0,0
93260,",",0,0
93261,35,0,1
93262,(,0,0
93263,2,0,0
93264,),0,0
93265,:180-193,0,1
93266,",",0,0
93267,2006,0,1
93268,),0,0
93269,",",0,0
93270,to,0,0
93271,date,0,0
93272,Stepping,0,0
93273,Stones,0,0
93274,has,0,0
93275,not,0,0
93276,been,0,0
93277,evaluated,0,0
93278,with,0,1
93279,the,0,0
93280,ASD,0,1
93281,population,0,1
93282,.,0,1
93283,Fifty-nine,1,1
93284,families,1,1
93285,with,1,1
93286,a,1,0
93287,child,1,0
93288,with,1,1
93289,ASD,1,1
93290,aged,1,1
93291,between,1,0
93292,2,1,0
93293,and,1,1
93294,9,1,0
93295,participated,1,1
93296,in,0,0
93297,this,0,0
93298,randomized,0,0
93299,controlled,0,0
93300,trial,0,0
93301,.,0,0
93302,The,0,0
93303,results,0,0
93304,demonstrate,0,0
93305,significant,0,0
93306,improvements,0,0
93307,in,0,1
93308,parental,1,1
93309,reports,1,0
93310,of,1,0
93311,child,1,1
93312,behaviour,1,0
93313,and,1,0
93314,parenting,1,0
93315,styles,1,0
93316,with,1,1
93317,the,1,0
93318,treatment,1,0
93319,effects,1,0
93320,for,1,0
93321,child,1,1
93322,behaviour,1,0
93323,",",1,0
93324,parental,1,0
93325,over,1,0
93326,reactivity,1,0
93327,and,1,0
93328,parental,1,0
93329,verbosity,1,0
93330,being,0,0
93331,maintained,0,0
93332,at,0,0
93333,follow-up,0,0
93334,6,0,0
93335,months,0,0
93336,later,0,0
93337,.,0,0
93338,Further,0,0
93339,",",0,0
93340,the,0,0
93341,results,0,0
93342,suggest,0,0
93343,significant,0,0
93344,improvements,0,0
93345,in,0,0
93346,parental,0,0
93347,satisfaction,0,0
93348,and,0,0
93349,conflict,0,0
93350,about,0,0
93351,parenting,0,0
93352,as,0,0
93353,well,0,0
93354,as,0,0
93355,a,0,0
93356,sleeper,0,1
93357,effect,0,0
93358,for,0,0
93359,parental,0,0
93360,efficacy,0,0
93361,.,0,0
93362,The,0,0
93363,results,0,0
93364,indicate,0,0
93365,that,0,0
93366,Stepping,0,0
93367,Stones,0,1
93368,Triple,0,0
93369,P,0,0
93370,is,0,0
93371,a,0,0
93372,promising,0,0
93373,intervention,0,0
93374,for,0,0
93375,parents,1,1
93376,of,1,1
93377,children,1,1
93378,with,1,1
93379,ASD,1,1
93380,.,1,1
93381,Limitations,0,0
93382,and,0,0
93383,future,0,0
93384,research,0,0
93385,are,0,0
93386,also,0,0
93387,addressed,0,0
93388,.,0,0
93389,Effect,0,0
93390,of,0,0
93391,diltiazem,0,0
93392,on,0,0
93393,symptomatic,1,1
93394,and,1,1
93395,asymptomatic,1,1
93396,episodes,1,0
93397,of,1,0
93398,ST,1,1
93399,segment,1,0
93400,depression,1,1
93401,occurring,1,0
93402,during,1,0
93403,daily,1,0
93404,life,1,0
93405,and,1,0
93406,during,1,0
93407,exercise,1,0
93408,.,1,1
93409,BACKGROUND,0,0
93410,Silent,0,0
93411,myocardial,0,1
93412,ischemia,0,0
93413,is,0,0
93414,an,0,0
93415,adverse,0,0
93416,prognostic,0,0
93417,marker,0,0
93418,in,0,0
93419,patients,1,1
93420,with,1,1
93421,coronary,1,1
93422,disease,1,1
93423,;,1,0
93424,however,0,0
93425,",",0,0
93426,controlled,0,0
93427,data,0,0
93428,on,0,0
93429,the,0,0
93430,effect,0,0
93431,of,0,0
93432,treatment,0,0
93433,are,0,0
93434,sparse,0,0
93435,and,0,0
93436,contradictory,0,0
93437,",",0,0
93438,and,0,0
93439,the,0,0
93440,relations,0,0
93441,among,0,0
93442,the,0,0
93443,occurrence,0,0
93444,of,0,0
93445,ST,0,1
93446,segment,0,0
93447,depression,0,1
93448,",",0,0
93449,drug,0,0
93450,efficacy,0,0
93451,",",0,0
93452,and,0,0
93453,heart,0,1
93454,rate,0,0
93455,are,0,0
93456,unclear,0,0
93457,.,0,1
93458,METHODS,0,0
93459,AND,0,0
93460,RESULTS,0,0
93461,Sixty,1,1
93462,patients,1,1
93463,with,1,1
93464,stable,1,1
93465,coronary,1,1
93466,artery,1,1
93467,disease,1,1
93468,",",1,0
93469,a,1,0
93470,positive,1,0
93471,treadmill,1,0
93472,exercise,1,0
93473,test,1,0
93474,and,1,0
93475,asymptomatic,1,1
93476,ST,1,1
93477,segment,1,0
93478,depression,1,1
93479,on,1,0
93480,ambulatory,1,1
93481,electrocardiographic,1,1
93482,recording,1,0
93483,were,1,0
93484,assessed,1,0
93485,in,1,0
93486,a,1,0
93487,multicenter,1,0
93488,",",1,0
93489,double-blind,1,0
93490,",",1,0
93491,placebo-controlled,1,0
93492,",",1,0
93493,cross-over,1,0
93494,trial,1,0
93495,.,1,1
93496,Treadmill,0,0
93497,exercise,0,0
93498,tests,0,0
93499,and,0,1
93500,72-hour,0,0
93501,electrocardiographic,0,1
93502,recordings,0,0
93503,were,0,1
93504,obtained,0,0
93505,at,0,0
93506,the,0,0
93507,end,0,0
93508,of,0,0
93509,two,0,0
93510,2-week,0,0
93511,treatment,0,0
93512,periods,0,0
93513,with,0,1
93514,sustained-release,0,0
93515,diltiazem,0,0
93516,180,0,1
93517,mg,0,0
93518,b.i.d,0,0
93519,.,0,0
93520,or,0,0
93521,equivalent,0,0
93522,placebo,0,0
93523,.,0,1
93524,Episodes,0,0
93525,of,0,0
93526,asymptomatic,0,1
93527,ST,0,1
93528,depression,0,1
93529,decreased,0,0
93530,by,0,0
93531,50,0,1
93532,%,0,0
93533,or,0,0
93534,more,0,0
93535,in,0,0
93536,70,0,1
93537,%,0,0
93538,of,0,0
93539,the,0,0
93540,patients,0,1
93541,from,0,0
93542,a,0,0
93543,median,0,0
93544,number,0,0
93545,of,0,0
93546,4.5,0,0
93547,(,0,0
93548,range,0,0
93549,",",0,0
93550,0-19,0,1
93551,),0,0
93552,to,0,0
93553,1.5,0,0
93554,(,0,0
93555,range,0,0
93556,",",0,0
93557,0-13,0,0
93558,),0,0
93559,(,0,0
93560,p,0,0
93561,=,0,0
93562,0.0001,0,0
93563,),0,1
93564,;,0,0
93565,their,0,0
93566,cumulative,0,0
93567,duration,0,0
93568,also,0,0
93569,decreased,0,0
93570,from,0,0
93571,78.5,0,0
93572,(,0,0
93573,range,0,0
93574,",",0,0
93575,0-60,0,0
93576,),0,0
93577,to,0,0
93578,24.5,0,0
93579,(,0,0
93580,range,0,0
93581,",",0,0
93582,0-411,0,0
93583,),0,0
93584,minutes,0,0
93585,(,0,1
93586,p,0,0
93587,=,0,0
93588,0.001,0,0
93589,),0,0
93590,.,0,0
93591,No,0,0
93592,circadian,0,0
93593,variation,0,0
93594,was,0,0
93595,found,0,0
93596,in,0,0
93597,the,0,0
93598,efficacy,0,0
93599,of,0,0
93600,diltiazem,0,0
93601,.,0,0
93602,The,0,0
93603,occurrence,0,0
93604,of,0,0
93605,ischemic,0,1
93606,type,0,1
93607,ST,0,1
93608,segment,0,0
93609,depression,0,1
93610,was,0,0
93611,modulated,0,0
93612,by,0,0
93613,changes,0,0
93614,in,0,0
93615,heart,0,1
93616,rate,0,0
93617,rather,0,0
93618,than,0,0
93619,by,0,0
93620,absolute,0,0
93621,heart,0,1
93622,rate,0,0
93623,.,0,0
93624,Diltiazem,0,0
93625,also,0,0
93626,improved,0,0
93627,exercise,0,0
93628,test,0,0
93629,end,0,0
93630,points,0,0
93631,but,0,0
93632,to,0,0
93633,a,0,0
93634,lesser,0,0
93635,extent,0,0
93636,.,0,0
93637,Time,0,0
93638,to,0,0
93639,ST,0,1
93640,segment,0,0
93641,depression,0,1
93642,increased,0,0
93643,to,0,0
93644,341,0,1
93645,+/-,0,0
93646,148,0,1
93647,from,0,1
93648,296,0,1
93649,+/-,0,0
93650,154,0,1
93651,seconds,0,0
93652,(,0,1
93653,p,0,0
93654,=,0,0
93655,0.005,0,0
93656,),0,0
93657,.,0,0
93658,Although,0,0
93659,less,0,0
93660,frequent,0,0
93661,with,0,1
93662,diltiazem,0,0
93663,administration,0,0
93664,(,0,0
93665,45,0,1
93666,versus,0,0
93667,54,0,1
93668,patients,0,1
93669,",",0,0
93670,p,0,0
93671,less,0,0
93672,than,0,0
93673,0.03,0,0
93674,),0,0
93675,",",0,0
93676,exercise-induced,0,0
93677,ST,0,1
93678,depression,0,0
93679,was,0,0
93680,more,0,0
93681,often,0,0
93682,asymptomatic,0,1
93683,(,0,0
93684,98,0,1
93685,%,0,0
93686,versus,0,0
93687,72,0,0
93688,%,0,0
93689,of,0,0
93690,patients,0,1
93691,",",0,0
93692,p,0,0
93693,less,0,0
93694,than,0,0
93695,0.0001,0,0
93696,),0,1
93697,.,0,1
93698,CONCLUSIONS,0,0
93699,Diltiazem,0,0
93700,reduces,0,0
93701,the,0,0
93702,frequency,0,0
93703,and,0,0
93704,severity,0,0
93705,of,0,0
93706,ischemic,0,1
93707,type,0,1
93708,ST,0,1
93709,depression,0,1
93710,in,0,0
93711,patients,1,1
93712,with,1,1
93713,stable,1,1
93714,coronary,1,1
93715,artery,1,1
93716,disease,1,1
93717,.,1,1
93718,Comparison,0,0
93719,of,0,0
93720,propofol,0,0
93721,",",0,0
93722,droperidol,0,0
93723,",",0,0
93724,and,0,0
93725,metoclopramide,0,0
93726,for,0,0
93727,prophylaxis,1,0
93728,of,1,0
93729,postoperative,1,0
93730,nausea,1,0
93731,and,1,0
93732,vomiting,1,0
93733,after,1,0
93734,breast,1,1
93735,cancer,1,1
93736,surgery,1,1
93737,:,1,1
93738,a,0,0
93739,prospective,0,0
93740,",",0,0
93741,randomized,0,0
93742,",",0,0
93743,double-blind,0,0
93744,",",0,0
93745,placebo-controlled,0,0
93746,study,0,0
93747,in,0,0
93748,Japanese,1,1
93749,patients,1,1
93750,.,1,1
93751,BACKGROUND,0,0
93752,Breast,0,1
93753,cancer,0,1
93754,surgery,0,1
93755,performed,0,0
93756,with,0,1
93757,the,0,0
93758,patient,1,0
93759,under,1,0
93760,general,1,1
93761,anesthesia,1,0
93762,has,0,0
93763,been,0,0
93764,associated,0,0
93765,with,0,0
93766,a,0,0
93767,relatively,0,0
93768,high,0,0
93769,incidence,0,0
93770,of,0,0
93771,postoperative,0,0
93772,nausea,0,0
93773,and,0,0
93774,vomiting,0,0
93775,(,0,0
93776,PONV,0,0
93777,),0,0
93778,.,0,0
93779,Between,0,0
93780,60,0,1
93781,%,0,0
93782,and,0,0
93783,80,0,1
93784,%,0,0
93785,of,0,1
93786,patients,1,1
93787,who,0,1
93788,undergo,0,1
93789,mastectomy,0,1
93790,(,0,0
93791,with,0,1
93792,axillary,0,1
93793,dissection,0,1
93794,),0,0
93795,experience,0,0
93796,PONV,0,0
93797,.,0,0
93798,We,0,0
93799,previously,0,0
93800,reported,0,0
93801,that,0,0
93802,propofol,0,0
93803,at,0,0
93804,a,0,0
93805,subhypnotic,0,0
93806,dose,0,0
93807,of,0,0
93808,0.5,0,0
93809,mg/kg,0,0
93810,was,0,0
93811,more,0,0
93812,effective,0,0
93813,than,0,0
93814,placebo,0,0
93815,in,0,0
93816,preventing,0,0
93817,PONV,0,0
93818,in,0,1
93819,women,0,1
93820,who,0,1
93821,undergo,0,1
93822,mastectomy,0,1
93823,.,0,0
93824,OBJECTIVE,0,0
93825,The,0,0
93826,purpose,0,0
93827,of,0,0
93828,this,0,0
93829,study,0,0
93830,was,0,0
93831,to,0,0
93832,compare,0,0
93833,the,0,0
93834,efficacy,0,0
93835,of,0,0
93836,a,0,0
93837,subhypnotic,0,0
93838,dose,0,0
93839,of,0,0
93840,propofol,0,0
93841,with,0,1
93842,the,0,0
93843,conventional,0,0
93844,antiemetics,0,0
93845,droperidol,0,0
93846,and,0,0
93847,metoclopramide,0,0
93848,for,0,0
93849,the,0,0
93850,prophylaxis,0,0
93851,of,0,0
93852,PONV,0,0
93853,after,0,0
93854,breast,1,1
93855,cancer,1,1
93856,surgery,1,1
93857,in,1,0
93858,Japanese,1,1
93859,patients,1,1
93860,.,1,1
93861,METHODS,0,0
93862,In,0,0
93863,this,0,0
93864,prospective,0,0
93865,",",0,0
93866,randomized,0,0
93867,",",0,0
93868,double-blind,0,0
93869,",",0,0
93870,placebo-controlled,0,0
93871,study,0,0
93872,",",0,0
93873,Japanese,1,1
93874,women,1,1
93875,were,0,1
93876,randomized,0,1
93877,to,0,0
93878,1,0,0
93879,of,0,0
93880,4,0,0
93881,groups,0,0
93882,to,0,0
93883,receive,0,0
93884,IV,0,0
93885,administration,0,0
93886,of,0,0
93887,propofol,0,0
93888,0.5,0,0
93889,mg/kg,0,0
93890,",",0,0
93891,droperidol,0,0
93892,20,0,0
93893,microg/kg,0,0
93894,",",0,0
93895,metoclopramide,0,0
93896,0.2,0,0
93897,mg/kg,0,0
93898,",",0,0
93899,or,0,0
93900,placebo,0,0
93901,(,0,0
93902,isotonic,0,0
93903,saline,0,0
93904,),0,0
93905,immediately,0,0
93906,after,0,0
93907,skin,0,0
93908,suture,0,0
93909,.,0,0
93910,A,0,0
93911,standard,0,0
93912,general,0,1
93913,anesthetic,0,0
93914,technique,0,0
93915,",",0,0
93916,including,0,0
93917,sevoflurane,0,0
93918,and,0,0
93919,air,0,1
93920,in,0,0
93921,oxygen,0,0
93922,",",0,0
93923,was,0,0
93924,used,0,0
93925,.,0,0
93926,All,0,0
93927,episodes,0,0
93928,of,0,0
93929,PONV,0,0
93930,during,0,0
93931,the,0,0
93932,first,0,0
93933,24,0,0
93934,hours,0,0
93935,after,0,0
93936,anesthesia,0,1
93937,administration,0,0
93938,were,0,0
93939,recorded,0,0
93940,by,0,0
93941,an,0,1
93942,investigator,0,1
93943,who,0,1
93944,was,0,0
93945,blinded,0,1
93946,to,0,0
93947,treatment,0,0
93948,assignment,0,0
93949,.,0,0
93950,The,0,0
93951,investigator,0,0
93952,questioned,0,0
93953,the,0,0
93954,patients,0,1
93955,as,0,0
93956,to,0,0
93957,whether,0,0
93958,they,0,0
93959,experienced,0,0
93960,extrapyramidal,0,0
93961,symptoms,0,0
93962,.,0,1
93963,To,0,0
93964,maintain,0,0
93965,the,0,0
93966,integrity,0,0
93967,of,0,0
93968,the,0,0
93969,study,0,0
93970,results,0,0
93971,",",0,0
93972,none,0,0
93973,of,0,0
93974,the,0,0
93975,patients,0,1
93976,received,0,0
93977,preanesthetic,0,0
93978,medication,0,0
93979,.,0,0
93980,RESULTS,0,0
93981,A,1,0
93982,total,1,1
93983,of,1,0
93984,100,1,0
93985,women,1,1
93986,(,1,1
93987,mean,1,1
93988,[,1,0
93989,SD,1,1
93990,],1,0
93991,age,1,1
93992,",",1,0
93993,52,1,1
93994,[,1,0
93995,7,1,1
93996,],1,1
93997,years,1,1
93998,;,1,1
93999,height,1,0
94000,",",1,0
94001,154,1,1
94002,[,1,0
94003,6,1,0
94004,],1,1
94005,cm,1,1
94006,;,1,0
94007,weight,1,0
94008,",",1,0
94009,54,1,1
94010,[,1,0
94011,7,1,1
94012,],1,1
94013,kg,1,1
94014,),1,0
94015,were,1,0
94016,included,1,1
94017,in,1,0
94018,the,1,0
94019,study,1,0
94020,.,1,0
94021,Each,0,0
94022,study,0,0
94023,group,0,0
94024,comprised,0,1
94025,25,0,1
94026,patients,0,1
94027,.,0,0
94028,There,0,0
94029,were,0,0
94030,no,0,0
94031,significant,0,0
94032,differences,0,0
94033,between,0,0
94034,treatment,0,0
94035,groups,0,0
94036,with,0,1
94037,regard,0,0
94038,to,0,0
94039,patient,0,0
94040,demographics,0,0
94041,",",0,0
94042,surgery,0,1
94043,type,0,1
94044,",",0,0
94045,or,0,0
94046,awakening,0,0
94047,time,0,0
94048,.,0,1
94049,The,0,0
94050,prevalences,0,0
94051,of,0,0
94052,PONV,0,1
94053,0,0,0
94054,to,0,1
94055,24,0,1
94056,hours,0,0
94057,after,0,0
94058,anesthesia,0,1
94059,were,0,1
94060,28,0,1
94061,%,0,0
94062,with,0,1
94063,propofol,0,0
94064,(,0,0
94065,P,0,0
94066,=,0,0
94067,0.005,0,0
94068,),0,0
94069,",",0,0
94070,32,0,1
94071,%,0,0
94072,with,0,1
94073,droperidol,0,0
94074,(,0,0
94075,P,0,0
94076,=,0,0
94077,0.011,0,0
94078,),0,0
94079,",",0,0
94080,and,0,0
94081,60,0,1
94082,%,0,0
94083,with,0,1
94084,metoclopramide,0,1
94085,(,0,0
94086,P,0,0
94087,=,0,0
94088,NS,0,0
94089,),0,0
94090,",",0,0
94091,compared,0,0
94092,with,0,1
94093,placebo,0,0
94094,(,0,0
94095,68,0,1
94096,%,0,0
94097,),0,0
94098,.,0,0
94099,No,0,0
94100,significant,0,0
94101,difference,0,0
94102,in,0,0
94103,the,0,0
94104,prevalence,0,1
94105,of,0,0
94106,PONV,0,0
94107,was,0,0
94108,found,0,0
94109,between,0,0
94110,patients,0,1
94111,receiving,0,1
94112,propofol,0,0
94113,and,0,0
94114,those,0,0
94115,receiving,0,0
94116,droperidol,0,0
94117,",",0,0
94118,and,0,0
94119,propofol,0,0
94120,and,0,0
94121,droperidol,0,0
94122,were,0,0
94123,associated,0,0
94124,with,0,1
94125,significantly,0,0
94126,lower,0,0
94127,prevalences,0,0
94128,of,0,0
94129,PONV,0,0
94130,compared,0,0
94131,with,0,1
94132,metoclopramide,0,1
94133,(,0,0
94134,P,0,0
94135,=,0,0
94136,0.022,0,0
94137,and,0,0
94138,P,0,0
94139,=,0,0
94140,0.043,0,0
94141,",",0,0
94142,respectively,0,0
94143,),0,0
94144,.,0,0
94145,Extrapyramidal,0,0
94146,symptoms,0,0
94147,were,0,0
94148,not,0,0
94149,reported,0,0
94150,in,0,0
94151,any,0,0
94152,of,0,0
94153,the,0,0
94154,groups,0,0
94155,.,0,0
94156,CONCLUSIONS,0,0
94157,The,0,0
94158,prevalences,0,0
94159,of,0,0
94160,PONV,0,0
94161,were,0,0
94162,not,0,0
94163,significantly,0,0
94164,different,0,0
94165,between,0,0
94166,propofol,0,0
94167,0.5,0,0
94168,mg/kg,0,0
94169,and,0,0
94170,droperidol,0,0
94171,20,0,1
94172,microg/kg,0,0
94173,0,0,0
94174,to,0,0
94175,24,0,1
94176,hours,0,0
94177,after,0,0
94178,anesthesia,0,1
94179,in,0,0
94180,this,0,0
94181,small,0,0
94182,",",0,0
94183,select,0,0
94184,group,0,0
94185,of,0,0
94186,Japanese,0,1
94187,women,0,1
94188,who,0,1
94189,underwent,0,1
94190,breast,0,1
94191,cancer,0,1
94192,surgery,0,1
94193,.,0,0
94194,The,0,0
94195,prevalences,0,0
94196,of,0,0
94197,PONV,0,0
94198,were,0,0
94199,significantly,0,0
94200,lower,0,0
94201,with,0,0
94202,propofol,0,0
94203,and,0,0
94204,droperidol,0,0
94205,compared,0,0
94206,with,0,1
94207,metoclopramide,0,1
94208,0.2,0,0
94209,mg/kg,0,0
94210,and,0,0
94211,placebo,0,0
94212,.,0,1
94213,Prevention,0,0
94214,of,0,0
94215,postoperative,0,0
94216,hypocalcemia,0,0
94217,with,0,1
94218,routine,0,0
94219,oral,0,0
94220,calcium,0,0
94221,and,0,0
94222,vitamin,0,0
94223,D,0,0
94224,supplements,0,0
94225,in,0,0
94226,patients,1,1
94227,with,1,1
94228,differentiated,1,1
94229,papillary,1,1
94230,thyroid,1,1
94231,carcinoma,1,1
94232,undergoing,1,1
94233,total,1,1
94234,thyroidectomy,1,1
94235,plus,1,0
94236,central,1,0
94237,neck,1,1
94238,dissection,1,1
94239,.,1,1
94240,BACKGROUND,0,0
94241,Routine,0,0
94242,oral,0,0
94243,calcium,0,0
94244,and,0,0
94245,vitamin,0,0
94246,D,0,0
94247,supplementation,0,0
94248,may,0,0
94249,prevent,0,0
94250,hypocalcemic,0,0
94251,crisis,0,0
94252,",",0,0
94253,but,0,0
94254,its,0,0
94255,efficacy,0,0
94256,has,0,0
94257,not,0,0
94258,been,0,0
94259,studied,0,0
94260,in,0,0
94261,patients,1,1
94262,undergoing,1,1
94263,thyroidectomy,1,1
94264,plus,1,0
94265,central,1,1
94266,neck,1,1
94267,dissection,1,1
94268,(,1,0
94269,CND,1,0
94270,),1,0
94271,.,1,0
94272,The,0,0
94273,authors,0,0
94274,therefore,0,0
94275,prospectively,0,0
94276,evaluated,0,0
94277,the,0,0
94278,clinical,0,0
94279,usefulness,0,0
94280,of,0,0
94281,routine,0,0
94282,oral,0,0
94283,calcium,0,0
94284,and,0,0
94285,vitamin,0,0
94286,D,0,0
94287,supplementation,0,0
94288,for,0,0
94289,prevention,0,0
94290,of,0,0
94291,hypocalcemia,0,0
94292,after,0,0
94293,total,0,1
94294,thyroidectomy,0,1
94295,and,0,0
94296,CND,0,0
94297,.,0,0
94298,METHODS,0,0
94299,Of,0,1
94300,197,1,1
94301,patients,1,1
94302,with,1,1
94303,differentiated,1,1
94304,papillary,1,1
94305,thyroid,1,1
94306,carcinoma,1,1
94307,",",0,0
94308,49,0,1
94309,underwent,0,1
94310,total,0,1
94311,thyroidectomy,0,1
94312,alone,0,0
94313,",",0,0
94314,and,0,0
94315,148,0,1
94316,underwent,0,1
94317,total,0,1
94318,thyroidectomy,0,1
94319,plus,0,0
94320,CND,0,0
94321,.,0,0
94322,The,0,0
94323,latter,0,0
94324,were,0,0
94325,randomized,0,1
94326,to,0,0
94327,oral,0,0
94328,calcium,0,0
94329,(,0,0
94330,3,0,0
94331,g/day,0,0
94332,),0,0
94333,plus,0,0
94334,vitamin,0,0
94335,D,0,0
94336,(,0,1
94337,1,0,0
94338,mg/day,0,0
94339,),0,0
94340,(,0,0
94341,Group,0,1
94342,A,0,0
94343,",",0,0
94344,n=49,0,1
94345,),0,0
94346,",",0,0
94347,calcium,0,0
94348,alone,0,0
94349,(,0,0
94350,Group,0,0
94351,B,0,0
94352,",",0,0
94353,n=49,0,1
94354,),0,0
94355,",",0,0
94356,or,0,0
94357,no,0,0
94358,supplements,0,0
94359,(,0,0
94360,Group,0,1
94361,C,0,0
94362,",",0,0
94363,n=50,0,1
94364,),0,0
94365,.,0,0
94366,Hypocalcemic,0,0
94367,symptoms,0,0
94368,",",0,0
94369,serum,0,0
94370,calcium,0,0
94371,",",0,0
94372,and,0,0
94373,parathyroid,0,0
94374,hormone,0,0
94375,(,0,0
94376,PTH,0,0
94377,),0,1
94378,levels,0,0
94379,were,0,0
94380,compared,0,0
94381,among,0,0
94382,the,0,0
94383,groups,0,0
94384,.,0,1
94385,RESULTS,0,0
94386,Group,0,1
94387,C,0,0
94388,had,0,0
94389,significantly,0,0
94390,higher,0,0
94391,incidences,0,0
94392,of,0,0
94393,symptomatic,0,1
94394,(,0,1
94395,26.0,0,0
94396,%,0,0
94397,vs,0,0
94398,6.1,0,1
94399,%,0,0
94400,;,0,1
94401,P,0,0
94402,<,0,0
94403,.015,0,0
94404,),0,0
94405,and,0,0
94406,laboratory,0,0
94407,(,0,0
94408,44.0,0,0
94409,%,0,0
94410,vs,0,0
94411,14.3,0,0
94412,%,0,0
94413,;,0,1
94414,P,0,0
94415,<,0,0
94416,.015,0,0
94417,),0,0
94418,hypocalcemia,0,0
94419,than,0,0
94420,the,0,0
94421,group,0,0
94422,without,0,1
94423,CND,0,0
94424,.,0,1
94425,The,0,0
94426,incidences,0,0
94427,of,0,0
94428,symptomatic,0,1
94429,and,0,0
94430,laboratory,0,0
94431,hypocalcemia,0,0
94432,were,0,0
94433,significantly,0,0
94434,decreased,0,0
94435,in,0,0
94436,Groups,0,0
94437,A,0,1
94438,(,0,0
94439,2.0,0,0
94440,%,0,0
94441,and,0,0
94442,8.2,0,0
94443,%,0,0
94444,",",0,0
94445,respectively,0,0
94446,),0,0
94447,and,0,0
94448,B,0,1
94449,(,0,0
94450,12.2,0,0
94451,%,0,0
94452,and,0,0
94453,24.5,0,0
94454,%,0,0
94455,",",0,0
94456,respectively,0,0
94457,),0,0
94458,(,0,0
94459,P,0,0
94460,<,0,0
94461,.05,0,0
94462,),0,1
94463,.,0,0
94464,Serum,0,0
94465,calcium,0,0
94466,levels,0,0
94467,decreased,0,0
94468,in,0,0
94469,most,0,0
94470,patients,0,1
94471,after,0,0
94472,surgery,0,1
94473,",",0,0
94474,but,0,0
94475,recovered,0,0
94476,earliest,0,0
94477,in,0,0
94478,Group,0,1
94479,A.,0,0
94480,Hypercalcemia,0,1
94481,and,0,0
94482,PTH,0,0
94483,inhibition,0,0
94484,did,0,0
94485,not,0,0
94486,occur,0,0
94487,in,0,0
94488,gs,0,0
94489,A,0,1
94490,and,0,0
94491,B,0,1
94492,.,0,1
94493,CONCLUSIONS,0,0
94494,Compared,0,0
94495,with,0,1
94496,total,0,1
94497,thyroidectomy,0,1
94498,alone,0,0
94499,",",0,0
94500,CND,0,0
94501,significantly,0,0
94502,increases,0,0
94503,the,0,0
94504,rate,0,0
94505,of,0,0
94506,postoperative,0,0
94507,hypocalcemia,0,0
94508,",",0,0
94509,which,0,0
94510,can,0,0
94511,be,0,0
94512,prevented,0,0
94513,by,0,0
94514,routine,0,0
94515,postoperative,0,0
94516,supplementation,0,0
94517,with,0,1
94518,oral,0,0
94519,calcium,0,0
94520,and,0,0
94521,vitamin,0,0
94522,D,0,0
94523,.,0,1
94524,Detection,0,0
94525,of,0,0
94526,traumatic,0,1
94527,arthrotomy,0,1
94528,of,0,0
94529,the,0,0
94530,knee,0,1
94531,using,0,0
94532,the,0,0
94533,saline,0,0
94534,solution,0,0
94535,load,0,0
94536,test,0,0
94537,.,0,0
94538,BACKGROUND,0,0
94539,The,0,0
94540,saline,0,0
94541,solution,0,0
94542,load,0,0
94543,test,0,0
94544,helps,0,0
94545,to,0,0
94546,determine,0,0
94547,if,0,0
94548,a,0,0
94549,wound,0,0
94550,extends,0,0
94551,into,0,0
94552,the,0,0
94553,knee,0,1
94554,joint,0,0
94555,.,0,0
94556,Little,0,0
94557,is,0,0
94558,known,0,0
94559,about,0,0
94560,the,0,0
94561,volume,0,0
94562,of,0,0
94563,injected,0,0
94564,intra-articular,0,0
94565,saline,0,0
94566,solution,0,0
94567,that,0,0
94568,is,0,0
94569,needed,0,0
94570,to,0,0
94571,effectively,0,0
94572,rule,0,0
94573,in,0,0
94574,or,0,0
94575,rule,0,0
94576,out,0,0
94577,a,0,0
94578,traumatic,0,1
94579,arthrotomy,0,1
94580,of,0,0
94581,the,0,0
94582,knee,0,1
94583,.,0,0
94584,The,0,0
94585,purpose,0,0
94586,of,0,0
94587,the,0,0
94588,present,0,0
94589,study,0,0
94590,was,0,0
94591,to,0,0
94592,determine,0,0
94593,the,0,0
94594,appropriate,0,0
94595,volume,0,0
94596,and,0,0
94597,needle,0,0
94598,location,0,1
94599,for,0,0
94600,the,0,0
94601,diagnosis,0,1
94602,of,0,0
94603,a,0,0
94604,traumatic,0,1
94605,knee,0,1
94606,arthrotomy,0,1
94607,and,0,0
94608,to,0,0
94609,assess,0,0
94610,the,0,0
94611,effect,0,0
94612,of,0,0
94613,associated,0,0
94614,variables,0,0
94615,",",0,0
94616,including,0,0
94617,knee,0,1
94618,circumference,0,0
94619,",",0,0
94620,body,0,0
94621,mass,0,0
94622,index,0,0
94623,",",0,0
94624,and,0,0
94625,sex,0,0
94626,.,0,1
94627,METHODS,0,0
94628,Fifty-six,1,1
94629,consecutive,1,1
94630,patients,1,1
94631,scheduled,1,1
94632,for,1,0
94633,knee,1,1
94634,arthroscopy,1,1
94635,were,0,0
94636,enrolled,0,1
94637,.,0,0
94638,A,0,0
94639,standard,0,0
94640,inferolateral,0,0
94641,arthroscopic,0,1
94642,portal,0,0
94643,was,0,0
94644,made,0,0
94645,with,0,1
94646,a,0,0
94647,single,0,0
94648,stab,0,1
94649,incision,0,0
94650,with,0,1
94651,use,0,0
94652,of,0,0
94653,a,0,0
94654,number-11,0,0
94655,blade,0,0
94656,.,0,1
94657,Injection,0,0
94658,sites,0,0
94659,were,0,0
94660,randomized,0,1
94661,to,0,0
94662,either,0,0
94663,a,0,0
94664,superomedial,0,0
94665,or,0,0
94666,inferomedial,0,0
94667,location,0,1
94668,.,0,0
94669,The,0,0
94670,injection,0,0
94671,of,0,0
94672,normal,0,1
94673,saline,0,0
94674,solution,0,0
94675,at,0,0
94676,a,0,0
94677,rate,0,0
94678,of,0,0
94679,5,0,0
94680,mL/sec,0,0
94681,through,0,0
94682,an,0,0
94683,18-gauge,0,0
94684,needle,0,0
94685,was,0,0
94686,continued,0,0
94687,while,0,0
94688,the,0,0
94689,knee,0,1
94690,was,0,0
94691,moved,0,0
94692,through,0,0
94693,a,0,0
94694,range,0,0
94695,of,0,0
94696,motion,0,0
94697,until,0,0
94698,fluid,0,0
94699,extravasated,0,0
94700,from,0,1
94701,the,0,0
94702,iatrogenic,0,0
94703,laceration,0,0
94704,.,0,0
94705,The,0,0
94706,volume,0,0
94707,of,0,0
94708,injected,0,0
94709,fluid,0,0
94710,was,0,0
94711,recorded,0,0
94712,.,0,0
94713,RESULTS,0,0
94714,The,0,0
94715,study,0,0
94716,group,0,0
94717,included,0,1
94718,thirty-one,1,1
94719,female,1,1
94720,patients,1,1
94721,and,1,0
94722,twenty-five,1,1
94723,male,1,1
94724,patients,1,1
94725,with,1,1
94726,a,1,1
94727,combined,1,0
94728,average,1,0
94729,age,1,1
94730,of,1,0
94731,fifty,1,1
94732,years,1,1
94733,and,1,0
94734,an,1,0
94735,average,1,0
94736,body,1,0
94737,mass,1,0
94738,index,1,0
94739,of,1,0
94740,30.9,1,0
94741,.,1,1
94742,In,0,0
94743,order,0,0
94744,to,0,0
94745,effectively,0,0
94746,diagnose,0,0
94747,50,0,0
94748,%,0,0
94749,of,0,0
94750,the,0,0
94751,arthrotomies,0,1
94752,",",0,0
94753,75,0,1
94754,mL,0,0
94755,of,0,0
94756,injected,0,0
94757,fluid,0,0
94758,was,0,0
94759,needed,0,0
94760,;,0,0
94761,the,0,0
94762,volumes,0,0
94763,that,0,0
94764,were,0,0
94765,needed,0,0
94766,in,0,0
94767,order,0,0
94768,to,0,0
94769,effectively,0,0
94770,diagnose,0,0
94771,75,0,0
94772,%,0,0
94773,",",0,0
94774,90,0,0
94775,%,0,0
94776,",",0,0
94777,95,0,0
94778,%,0,0
94779,",",0,0
94780,and,0,0
94781,99,0,0
94782,%,0,0
94783,of,0,0
94784,the,0,0
94785,arthrotomies,0,1
94786,were,0,0
94787,110,0,1
94788,",",0,0
94789,145,0,1
94790,",",0,0
94791,155,0,1
94792,",",0,0
94793,and,0,0
94794,175,0,1
94795,mL,0,0
94796,",",0,0
94797,respectively,0,0
94798,.,0,0
94799,The,0,0
94800,mean,0,0
94801,volumes,0,0
94802,of,0,0
94803,injected,0,0
94804,fluid,0,0
94805,needed,0,0
94806,for,0,0
94807,a,0,0
94808,positive,0,0
94809,result,0,0
94810,at,0,0
94811,the,0,0
94812,inferomedial,0,0
94813,and,0,0
94814,superomedial,0,1
94815,needle,0,0
94816,locations,0,0
94817,were,0,1
94818,64.0,0,1
94819,and,0,0
94820,95.2,0,0
94821,mL,0,0
94822,",",0,0
94823,respectively,0,0
94824,;,0,0
94825,this,0,0
94826,difference,0,0
94827,was,0,0
94828,significant,0,0
94829,(,0,1
94830,p,0,0
94831,=,0,0
94832,0.01,0,0
94833,),0,0
94834,.,0,0
94835,There,0,0
94836,was,0,0
94837,no,0,0
94838,correlation,0,0
94839,between,0,0
94840,necessary,0,0
94841,injection,0,0
94842,volume,0,0
94843,and,0,0
94844,sex,0,0
94845,",",0,0
94846,body,0,0
94847,mass,0,0
94848,index,0,0
94849,",",0,0
94850,or,0,0
94851,knee,0,1
94852,circumference,0,0
94853,.,0,0
94854,CONCLUSIONS,0,0
94855,In,0,0
94856,order,0,0
94857,to,0,0
94858,detect,0,0
94859,95,0,0
94860,%,0,0
94861,of,0,0
94862,1-cm,0,1
94863,inferolateral,0,1
94864,arthrotomies,0,1
94865,of,0,0
94866,the,0,0
94867,knee,0,1
94868,with,0,0
94869,use,0,0
94870,of,0,0
94871,the,0,0
94872,saline,0,0
94873,solution,0,0
94874,load,0,0
94875,test,0,0
94876,",",0,0
94877,155,0,1
94878,mL,0,0
94879,must,0,0
94880,be,0,0
94881,injected,0,0
94882,.,0,0
94883,An,0,0
94884,inferomedial,0,0
94885,injection,0,0
94886,location,0,0
94887,requires,0,0
94888,significantly,0,0
94889,less,0,0
94890,fluid,0,0
94891,than,0,0
94892,a,0,0
94893,superomedial,0,0
94894,injection,0,0
94895,location,0,0
94896,does,0,0
94897,for,0,0
94898,the,0,0
94899,diagnosis,0,1
94900,of,0,0
94901,inferolateral,0,0
94902,arthrotomies,0,1
94903,of,0,0
94904,the,0,0
94905,knee,0,1
94906,.,0,0
94907,Recommendations,0,1
94908,for,0,1
94909,implementing,0,0
94910,stereotactic,0,0
94911,radiotherapy,0,1
94912,in,0,0
94913,peripheral,1,1
94914,stage,1,1
94915,IA,1,1
94916,non-small,1,1
94917,cell,1,0
94918,lung,1,1
94919,cancer,1,1
94920,:,1,1
94921,report,0,0
94922,from,0,0
94923,the,0,0
94924,Quality,0,0
94925,Assurance,0,0
94926,Working,0,1
94927,Party,0,1
94928,of,0,0
94929,the,0,0
94930,randomised,0,0
94931,phase,0,1
94932,III,0,1
94933,ROSEL,0,1
94934,study,0,1
94935,.,0,1
94936,BACKGROUND,0,0
94937,A,0,0
94938,phase,0,1
94939,III,0,1
94940,multi-centre,0,0
94941,randomised,0,0
94942,trial,0,0
94943,(,0,0
94944,ROSEL,0,1
94945,),0,0
94946,has,0,0
94947,been,0,0
94948,initiated,0,0
94949,to,0,0
94950,establish,0,0
94951,the,0,0
94952,role,0,0
94953,of,0,0
94954,stereotactic,0,0
94955,radiotherapy,0,1
94956,in,0,0
94957,patients,1,1
94958,with,1,1
94959,operable,1,1
94960,stage,1,1
94961,IA,1,1
94962,lung,1,1
94963,cancer,1,1
94964,.,1,0
94965,Due,0,0
94966,to,0,0
94967,rapid,0,0
94968,changes,0,0
94969,in,0,0
94970,radiotherapy,0,1
94971,technology,0,0
94972,and,0,0
94973,evolving,0,0
94974,techniques,0,0
94975,for,0,0
94976,image-guided,0,1
94977,delivery,0,0
94978,",",0,0
94979,guidelines,0,0
94980,had,0,1
94981,to,0,0
94982,be,0,0
94983,developed,0,0
94984,in,0,0
94985,order,0,0
94986,to,0,0
94987,ensure,0,0
94988,uniformity,0,0
94989,in,0,0
94990,implementation,0,0
94991,of,0,0
94992,stereotactic,0,0
94993,radiotherapy,0,1
94994,in,0,0
94995,this,0,0
94996,multi-centre,0,0
94997,study,0,0
94998,.,0,1
94999,METHODS/DESIGN,0,0
95000,A,0,0
95001,Quality,0,0
95002,Assurance,0,1
95003,Working,0,1
95004,Party,0,1
95005,was,0,0
95006,formed,0,0
95007,by,0,0
95008,radiation,0,0
95009,oncologists,0,1
95010,and,0,1
95011,clinical,0,0
95012,physicists,0,1
95013,from,0,1
95014,both,0,0
95015,academic,0,1
95016,as,0,0
95017,well,0,0
95018,as,0,0
95019,non-academic,0,1
95020,hospitals,0,1
95021,that,0,0
95022,had,0,1
95023,already,0,0
95024,implemented,0,0
95025,stereotactic,0,0
95026,radiotherapy,0,1
95027,for,0,0
95028,lung,0,1
95029,cancer,0,1
95030,.,0,0
95031,A,0,0
95032,literature,0,0
95033,survey,0,1
95034,was,0,0
95035,conducted,0,0
95036,and,0,0
95037,consensus,0,1
95038,meetings,0,0
95039,were,0,1
95040,held,0,0
95041,in,0,0
95042,which,0,0
95043,both,0,0
95044,the,0,0
95045,knowledge,0,0
95046,from,0,0
95047,the,0,0
95048,literature,0,0
95049,and,0,0
95050,clinical,0,0
95051,experience,0,0
95052,were,0,0
95053,pooled,0,0
95054,.,0,0
95055,In,0,0
95056,addition,0,0
95057,",",0,0
95058,a,1,0
95059,planning,1,0
95060,study,1,0
95061,was,1,0
95062,performed,1,0
95063,in,1,0
95064,26,1,1
95065,stage,1,1
95066,I,1,1
95067,patients,1,1
95068,",",1,0
95069,of,1,0
95070,which,1,0
95071,22,1,1
95072,were,1,0
95073,stage,1,1
95074,1A,1,1
95075,",",0,0
95076,in,0,0
95077,order,0,0
95078,to,0,0
95079,develop,0,0
95080,and,0,0
95081,evaluate,0,0
95082,the,0,0
95083,planning,0,0
95084,guidelines,0,0
95085,.,0,1
95086,Plans,0,0
95087,were,0,0
95088,optimised,0,0
95089,according,0,1
95090,to,0,0
95091,parameters,0,0
95092,adopted,0,0
95093,from,0,1
95094,RTOG,0,0
95095,trials,0,0
95096,using,0,0
95097,both,0,0
95098,an,0,0
95099,algorithm,0,0
95100,with,0,0
95101,a,0,0
95102,simple,0,0
95103,homogeneity,0,0
95104,correction,0,0
95105,(,0,0
95106,Type,0,1
95107,A,0,1
95108,),0,0
95109,and,0,0
95110,a,0,0
95111,more,0,0
95112,advanced,0,0
95113,algorithm,0,0
95114,(,0,0
95115,Type,0,1
95116,B,0,1
95117,),0,1
95118,.,0,0
95119,Dose,0,0
95120,conformity,0,0
95121,requirements,0,0
95122,were,0,0
95123,then,0,0
95124,formulated,0,0
95125,based,0,0
95126,on,0,0
95127,these,0,0
95128,results,0,0
95129,.,0,1
95130,CONCLUSION,0,0
95131,Based,0,0
95132,on,0,0
95133,current,0,0
95134,literature,0,0
95135,and,0,0
95136,expert,0,0
95137,experience,0,0
95138,",",0,0
95139,guidelines,0,0
95140,were,0,0
95141,formulated,0,0
95142,for,0,0
95143,this,0,0
95144,phase,0,0
95145,III,0,0
95146,study,0,0
95147,of,0,0
95148,stereotactic,0,0
95149,radiotherapy,0,1
95150,versus,0,0
95151,surgery,0,1
95152,.,0,0
95153,These,0,0
95154,guidelines,0,0
95155,can,0,0
95156,serve,0,0
95157,to,0,0
95158,facilitate,0,0
95159,the,0,0
95160,design,0,0
95161,of,0,0
95162,future,0,0
95163,multi-centre,0,1
95164,clinical,0,0
95165,trials,0,0
95166,of,0,0
95167,stereotactic,0,1
95168,radiotherapy,0,1
95169,in,0,0
95170,other,0,0
95171,patient,0,1
95172,groups,0,0
95173,and,0,0
95174,aid,0,0
95175,a,0,0
95176,more,0,0
95177,uniform,0,0
95178,implementation,0,0
95179,of,0,0
95180,this,0,0
95181,technique,0,0
95182,outside,0,0
95183,clinical,0,0
95184,trials,0,1
95185,.,0,1
95186,Ondansetron,0,0
95187,has,0,0
95188,similar,0,0
95189,clinical,0,0
95190,efficacy,0,0
95191,against,0,0
95192,both,0,0
95193,nausea,0,0
95194,and,0,0
95195,vomiting,0,0
95196,.,0,0
95197,Ondansetron,0,0
95198,is,0,0
95199,widely,0,0
95200,believed,0,0
95201,to,0,0
95202,prevent,0,0
95203,postoperative,0,0
95204,vomiting,0,0
95205,more,0,0
95206,effectively,0,0
95207,than,0,0
95208,nausea,0,0
95209,.,0,1
95210,We,1,0
95211,analysed,1,0
95212,data,1,0
95213,from,1,1
95214,5161,1,1
95215,patients,1,1
95216,undergoing,1,1
95217,general,1,1
95218,anaesthesia,1,1
95219,who,0,1
95220,were,0,1
95221,randomly,0,1
95222,stratified,0,1
95223,to,0,0
95224,receive,0,0
95225,a,0,0
95226,combination,0,0
95227,of,0,0
95228,six,0,1
95229,interventions,0,0
95230,",",0,0
95231,one,0,1
95232,of,0,0
95233,which,0,0
95234,was,0,0
95235,4,0,0
95236,mg,0,0
95237,ondansetron,0,0
95238,vs,0,0
95239,placebo,0,0
95240,.,0,0
95241,For,0,0
95242,the,0,0
95243,purpose,0,0
95244,of,0,0
95245,this,0,0
95246,study,0,0
95247,a,0,0
95248,20,0,0
95249,%,0,0
95250,difference,0,0
95251,in,0,0
95252,the,0,0
95253,relative,0,0
95254,risks,0,0
95255,for,0,0
95256,the,0,0
95257,two,0,0
95258,outcomes,0,0
95259,was,0,0
95260,considered,0,0
95261,clinically,0,0
95262,relevant,0,0
95263,.,0,0
95264,Nausea,0,0
95265,was,0,0
95266,reduced,0,0
95267,from,0,1
95268,38,0,1
95269,%,0,0
95270,(,0,1
95271,969/2585,0,0
95272,),0,0
95273,in,0,0
95274,the,0,0
95275,control,0,0
95276,to,0,0
95277,28,0,1
95278,%,0,0
95279,(,0,1
95280,715/2576,0,0
95281,),0,0
95282,in,0,0
95283,the,0,0
95284,ondansetron,0,0
95285,group,0,0
95286,",",0,0
95287,corresponding,0,0
95288,to,0,0
95289,a,0,0
95290,relative,0,0
95291,risk,0,0
95292,of,0,0
95293,0.74,0,0
95294,",",0,0
95295,or,0,0
95296,a,0,0
95297,relative,0,0
95298,risk,0,0
95299,reduction,0,0
95300,of,0,0
95301,26,0,1
95302,%,0,0
95303,.,0,1
95304,Vomiting,0,0
95305,was,0,0
95306,reduced,0,0
95307,from,0,1
95308,17,0,1
95309,%,0,0
95310,(,0,1
95311,441/2585,0,1
95312,),0,1
95313,to,0,0
95314,11,0,0
95315,%,0,0
95316,(,0,1
95317,293/2576,0,0
95318,),0,0
95319,",",0,0
95320,corresponding,0,0
95321,to,0,0
95322,a,0,0
95323,relative,0,0
95324,risk,0,0
95325,of,0,0
95326,0.67,0,0
95327,",",0,0
95328,or,0,0
95329,a,0,0
95330,relative,0,0
95331,risk,0,0
95332,reduction,0,0
95333,of,0,0
95334,33,0,1
95335,%,0,0
95336,.,0,0
95337,The,0,0
95338,relative,0,0
95339,risks,0,0
95340,of,0,1
95341,0.67,0,0
95342,and,0,1
95343,0.74,0,0
95344,were,0,0
95345,clinically,0,0
95346,similar,0,0
95347,and,0,0
95348,the,0,0
95349,difference,0,0
95350,between,0,0
95351,them,0,0
95352,did,0,0
95353,not,0,0
95354,reach,0,0
95355,statistical,0,0
95356,significance,0,0
95357,.,0,0
95358,We,0,0
95359,thus,0,0
95360,conclude,0,0
95361,that,0,0
95362,ondansetron,0,0
95363,prevents,0,0
95364,postoperative,1,0
95365,nausea,1,0
95366,and,1,0
95367,postoperative,1,0
95368,vomiting,1,0
95369,equally,0,0
95370,well,0,0
95371,.,0,0
95372,An,0,0
95373,emergency,0,1
95374,clinical,0,0
95375,pathway,0,0
95376,for,0,0
95377,stroke,1,1
95378,patients,1,1
95379,--,1,1
95380,results,1,0
95381,of,0,0
95382,a,0,0
95383,cluster,0,0
95384,randomised,0,0
95385,trial,0,0
95386,(,0,0
95387,isrctn41456865,0,1
95388,),0,0
95389,.,0,1
95390,BACKGROUND,0,0
95391,Emergency,0,1
95392,Clinical,0,0
95393,Pathways,0,1
95394,(,0,0
95395,ECP,0,0
95396,),0,0
95397,for,0,0
95398,stroke,0,1
95399,have,0,0
95400,never,0,0
95401,been,0,0
95402,tested,0,0
95403,in,0,0
95404,randomized,0,1
95405,controlled,0,0
95406,trials,0,0
95407,(,0,1
95408,RCTs,0,1
95409,),0,0
95410,.,0,0
95411,OBJECTIVE,0,0
95412,To,0,0
95413,evaluate,0,0
95414,the,0,0
95415,effectiveness,0,0
95416,of,0,0
95417,an,0,0
95418,ECP,0,0
95419,for,0,0
95420,stroke,1,1
95421,patients,1,1
95422,in,1,0
95423,Latium,1,1
95424,(,1,1
95425,Italy,1,1
95426,),1,0
95427,emergency,1,1
95428,system,1,0
95429,.,1,0
95430,METHODS,0,0
95431,cluster-RCT,0,0
95432,designed,0,0
95433,to,0,0
95434,compare,0,0
95435,stroke,1,1
95436,patient,1,1
95437,referrals,1,1
95438,by,1,0
95439,Emergency,1,1
95440,Medical,1,1
95441,Service,1,1
95442,(,1,0
95443,EMS,1,0
95444,),1,0
95445,and,1,0
95446,Emergency,1,1
95447,Room,1,1
95448,(,1,0
95449,ER,1,1
95450,),1,0
95451,health,1,1
95452,professionals,1,0
95453,trained,1,1
95454,in,1,0
95455,the,1,0
95456,ECP,1,0
95457,",",1,0
95458,with,1,0
95459,those,1,0
95460,of,1,0
95461,non-trained,1,0
95462,EMS,1,0
95463,and,1,1
95464,ER,1,1
95465,controls,1,1
95466,.,1,1
95467,Primary,0,1
95468,outcome,0,0
95469,measure,0,0
95470,was,0,0
95471,the,0,0
95472,proportion,0,0
95473,of,0,0
95474,eligible,1,1
95475,(,1,0
95476,aged,1,1
95477,<,1,0
95478,/=,1,1
95479,80,1,1
95480,and,1,0
95481,symptom,1,1
95482,onset,1,0
95483,<,1,0
95484,/=,1,1
95485,6,1,0
95486,hours,1,0
95487,),1,1
95488,stroke,1,1
95489,patients,1,1
95490,referred,1,1
95491,to,1,0
95492,a,1,0
95493,stroke,1,1
95494,unit,1,0
95495,(,1,0
95496,SU,1,1
95497,),1,0
95498,.,1,0
95499,Intention,0,0
95500,to,0,0
95501,treat,0,0
95502,(,0,0
95503,ITT,0,0
95504,),0,0
95505,and,0,0
95506,per-protocol,0,0
95507,(,0,0
95508,PP,0,1
95509,),0,1
95510,analyses,0,0
95511,were,0,0
95512,performed,0,0
95513,",",0,0
95514,and,0,0
95515,risk,0,0
95516,ratios,0,0
95517,(,0,1
95518,RR,0,0
95519,),0,0
95520,adjusted,0,0
95521,by,0,0
95522,age,0,1
95523,",",0,0
95524,gender,0,0
95525,and,0,0
95526,area,0,0
95527,",",0,0
95528,were,0,0
95529,calculated,0,0
95530,.,0,1
95531,RESULTS,0,0
95532,2656,1,0
95533,patients,1,1
95534,in,1,0
95535,the,1,0
95536,intervention,1,0
95537,arm,1,0
95538,and,1,0
95539,2239,1,1
95540,in,1,0
95541,the,1,0
95542,control,1,0
95543,arm,1,0
95544,required,0,0
95545,assistance,0,0
95546,;,0,0
95547,78.3,0,0
95548,%,0,0
95549,of,0,0
95550,the,0,0
95551,former,0,0
95552,and,0,0
95553,80.6,0,0
95554,%,0,0
95555,of,0,0
95556,the,0,0
95557,latter,0,0
95558,were,0,0
95559,admitted,0,1
95560,to,0,0
95561,hospitals,0,1
95562,",",0,0
95563,and,0,0
95564,respectively,0,0
95565,74.8,0,0
95566,%,0,0
95567,and,0,0
95568,78.3,0,0
95569,%,0,0
95570,were,0,0
95571,confirmed,0,0
95572,strokes,0,1
95573,.,0,1
95574,Of,0,0
95575,the,0,0
95576,eligible,0,1
95577,confirmed,0,0
95578,strokes,0,1
95579,",",0,0
95580,106/434,0,1
95581,(,0,0
95582,24.4,0,0
95583,%,0,0
95584,),0,0
95585,in,0,0
95586,the,0,0
95587,intervention,0,0
95588,arm,0,0
95589,and,0,0
95590,43/328,0,0
95591,(,0,0
95592,13.1,0,0
95593,%,0,0
95594,),0,0
95595,in,0,0
95596,the,0,0
95597,control,0,0
95598,arm,0,0
95599,were,0,0
95600,referred,0,1
95601,to,0,0
95602,the,0,0
95603,SU,0,1
95604,in,0,0
95605,the,0,0
95606,ITT,0,0
95607,analysis,0,0
95608,(,0,0
95609,RR,0,0
95610,=,0,1
95611,2.01,0,0
95612,;,0,1
95613,95,0,0
95614,%,0,0
95615,CI,0,0
95616,:,0,1
95617,0.79-4.00,0,0
95618,),0,0
95619,",",0,0
95620,and,0,0
95621,respectively,0,0
95622,105/243,0,0
95623,(,0,0
95624,43.2,0,1
95625,%,0,0
95626,),0,0
95627,and,0,0
95628,43/311,0,0
95629,(,0,0
95630,13.8,0,0
95631,%,0,0
95632,),0,0
95633,in,0,0
95634,the,0,0
95635,PP,0,0
95636,analysis,0,0
95637,(,0,0
95638,RR,0,0
95639,=,0,1
95640,3.21,0,0
95641,;,0,1
95642,95,0,0
95643,%,0,0
95644,CI,0,0
95645,:,0,1
95646,1.62-4.98,0,0
95647,),0,0
95648,.,0,1
95649,Of,0,0
95650,patients,0,1
95651,suitable,0,0
95652,for,0,0
95653,i.v,0,0
95654,.,0,0
95655,thrombolysis,0,0
95656,",",0,0
95657,15/175,0,0
95658,(,0,0
95659,8.6,0,1
95660,%,0,0
95661,),0,0
95662,in,0,0
95663,the,0,0
95664,intervention,0,0
95665,arm,0,0
95666,and,0,0
95667,2/115,0,0
95668,(,0,0
95669,1.7,0,0
95670,%,0,0
95671,),0,0
95672,in,0,0
95673,the,0,0
95674,control,0,0
95675,arm,0,0
95676,received,0,0
95677,thrombolysis,0,0
95678,(,0,0
95679,p,0,0
95680,=,0,0
95681,0.02,0,0
95682,),0,0
95683,in,0,0
95684,the,0,0
95685,ITT,0,0
95686,analysis,0,0
95687,",",0,0
95688,and,0,0
95689,respectively,0,0
95690,15/99,0,0
95691,(,0,0
95692,15.1,0,0
95693,%,0,0
95694,),0,0
95695,and,0,0
95696,2/107,0,0
95697,(,0,0
95698,1.9,0,0
95699,%,0,0
95700,),0,0
95701,(,0,0
95702,p,0,0
95703,=,0,0
95704,0.001,0,0
95705,),0,0
95706,in,0,0
95707,the,0,0
95708,PP,0,0
95709,analysis,0,0
95710,.,0,0
95711,CONCLUSION,0,0
95712,Our,0,0
95713,data,0,0
95714,suggest,0,0
95715,potenti,0,0
95716,efficiency,0,0
95717,and,0,0
95718,feasibility,0,0
95719,of,0,0
95720,an,0,0
95721,ECP,0,0
95722,.,0,0
95723,The,0,0
95724,integration,0,0
95725,of,0,0
95726,EMS,0,0
95727,and,0,0
95728,ERs,0,1
95729,with,0,1
95730,SU,0,1
95731,networks,0,0
95732,for,0,0
95733,organised,0,1
95734,acute,0,1
95735,stroke,0,1
95736,care,0,0
95737,is,0,0
95738,feasible,0,0
95739,and,0,0
95740,may,0,0
95741,ameliorate,0,0
95742,the,0,0
95743,quality,0,0
95744,of,0,0
95745,care,0,1
95746,for,0,0
95747,stroke,1,1
95748,patients,1,1
95749,.,1,1
95750,TRIAL,0,0
95751,REGISTRATION,0,0
95752,Current,0,1
95753,Controlled,0,1
95754,Trials,0,0
95755,(,0,0
95756,ISRCTN41456865,0,0
95757,),0,1
95758,.,0,1
95759,Approval,0,1
95760,summary,0,0
95761,:,0,1
95762,imatinib,0,0
95763,mesylate,0,0
95764,in,0,0
95765,the,0,0
95766,treatment,0,0
95767,of,0,0
95768,metastatic,1,1
95769,and/or,1,1
95770,unresectable,1,1
95771,malignant,1,1
95772,gastrointestinal,1,1
95773,stromal,1,1
95774,tumors,1,1
95775,.,1,1
95776,The,0,0
95777,purpose,0,0
95778,of,0,0
95779,the,0,0
95780,present,0,0
95781,application,0,0
95782,was,0,0
95783,to,0,0
95784,fulfill,0,0
95785,a,0,0
95786,postmarketing,0,0
95787,commitment,0,0
95788,to,0,0
95789,provide,0,0
95790,long-term,0,0
95791,efficacy,0,0
95792,and,0,0
95793,safety,0,0
95794,data,0,0
95795,on,0,0
95796,treatment,0,0
95797,with,0,1
95798,imatinib,0,0
95799,mesylate,0,0
95800,(,0,1
95801,Gleevec,0,1
95802,;,0,1
95803,Novartis,0,0
95804,Pharmaceuticals,0,0
95805,",",0,0
95806,East,0,0
95807,Hanover,0,1
95808,",",0,0
95809,NJ,0,0
95810,),0,0
95811,in,0,0
95812,patients,1,1
95813,with,1,1
95814,CD117,1,0
95815,(,1,1
95816,+,1,0
95817,),1,1
95818,unresectable,1,1
95819,and/or,1,1
95820,metastatic,1,1
95821,malignant,1,1
95822,gastrointestinal,1,1
95823,stromal,1,0
95824,tumors,1,1
95825,(,1,1
95826,GISTs,1,1
95827,),1,0
95828,.,1,0
95829,In,0,0
95830,addition,0,0
95831,",",0,0
95832,this,0,0
95833,application,0,0
95834,also,0,0
95835,provides,0,0
95836,evidence,0,0
95837,to,0,0
95838,support,0,0
95839,a,0,0
95840,change,0,0
95841,in,0,0
95842,the,0,0
95843,label,0,0
95844,to,0,0
95845,allow,0,0
95846,for,0,0
95847,an,0,0
95848,escalation,0,0
95849,of,0,0
95850,imatinib,0,0
95851,dosing,0,0
95852,to,0,0
95853,800,0,0
95854,mg/day,0,0
95855,for,0,0
95856,patients,1,1
95857,with,1,1
95858,progressive,1,1
95859,disease,1,1
95860,on,1,0
95861,a,1,0
95862,lower,1,0
95863,dose,1,0
95864,.,1,0
95865,Two,0,0
95866,open-label,0,0
95867,",",0,0
95868,controlled,0,0
95869,",",0,0
95870,multicenter,0,0
95871,",",0,0
95872,intergroup,0,0
95873,",",0,0
95874,international,0,0
95875,",",0,0
95876,randomized,0,0
95877,phase,0,1
95878,III,0,1
95879,studies,0,0
95880,were,0,1
95881,submitted,0,1
95882,--,0,1
95883,one,0,0
95884,conducted,0,0
95885,by,0,0
95886,the,0,0
95887,European,1,1
95888,Organization,1,0
95889,for,1,0
95890,Research,1,0
95891,and,1,0
95892,Treatment,1,0
95893,of,1,0
95894,Cancer,1,1
95895,(,1,1
95896,n,1,1
95897,=,1,0
95898,946,1,1
95899,),1,0
95900,and,1,0
95901,the,1,0
95902,other,1,0
95903,by,1,0
95904,the,1,0
95905,Southwest,1,1
95906,Oncology,1,1
95907,Group,1,1
95908,(,1,0
95909,n,1,1
95910,=,1,0
95911,746,1,1
95912,),1,0
95913,.,1,1
95914,These,0,0
95915,studies,0,0
95916,compared,0,0
95917,400,0,0
95918,mg/day,0,0
95919,of,0,0
95920,imatinib,0,0
95921,with,0,1
95922,800,0,0
95923,mg/day,0,0
95924,of,0,0
95925,imatinib,0,0
95926,.,0,0
95927,A,0,0
95928,combined,0,0
95929,analysis,0,0
95930,of,0,0
95931,the,0,0
95932,two,0,0
95933,studies,0,0
95934,was,0,0
95935,prospectively,0,1
95936,defined,0,0
95937,and,0,0
95938,agreed,0,0
95939,to,0,0
95940,by,0,0
95941,both,0,0
95942,groups,0,0
95943,.,0,0
95944,Both,0,0
95945,protocols,0,0
95946,allowed,0,0
95947,patients,0,1
95948,randomized,0,1
95949,to,0,0
95950,the,0,0
95951,400-mg/day,0,0
95952,imatinib,0,0
95953,arm,0,0
95954,to,0,0
95955,cross,0,0
95956,over,0,0
95957,to,0,0
95958,800,0,0
95959,mg/day,0,0
95960,imatinib,0,0
95961,at,0,0
95962,progression,0,0
95963,.,0,1
95964,Objective,0,0
95965,responses,0,0
95966,were,0,1
95967,achieved,0,0
95968,in,0,0
95969,>,0,1
95970,50,0,1
95971,%,0,0
95972,of,0,0
95973,patients,0,1
95974,receiving,0,1
95975,either,0,0
95976,imatinib,0,1
95977,dose,0,0
95978,.,0,0
95979,The,0,0
95980,median,0,0
95981,progression-free,0,0
95982,survival,0,0
95983,time,0,0
95984,was,0,0
95985,approximately,0,1
95986,20,0,1
95987,months,0,0
95988,and,0,0
95989,the,0,0
95990,median,0,0
95991,overall,0,0
95992,survival,0,0
95993,(,0,0
95994,OS,0,0
95995,),0,0
95996,time,0,0
95997,was,0,0
95998,approximately,0,1
95999,49,0,1
96000,months,0,0
96001,.,0,1
96002,In,0,0
96003,the,0,0
96004,combined,0,0
96005,analysis,0,0
96006,",",0,0
96007,347,0,1
96008,patients,0,1
96009,crossed,0,1
96010,over,0,0
96011,to,0,0
96012,800,0,0
96013,mg/day,0,0
96014,imatinib,0,0
96015,at,0,0
96016,the,0,0
96017,time,0,0
96018,of,0,0
96019,progression,0,0
96020,.,0,0
96021,The,0,0
96022,median,0,0
96023,OS,0,0
96024,time,0,0
96025,after,0,0
96026,crossover,0,0
96027,was,0,0
96028,14.3,0,0
96029,months,0,0
96030,.,0,1
96031,The,0,0
96032,most,0,0
96033,common,0,0
96034,adverse,0,0
96035,events,0,0
96036,(,0,1
96037,AEs,0,0
96038,),0,0
96039,were,0,0
96040,fluid,0,0
96041,retention,0,0
96042,",",0,0
96043,nausea,0,0
96044,",",0,0
96045,fatigue,0,0
96046,",",0,0
96047,skin,0,0
96048,rash,0,0
96049,",",0,0
96050,gastrointestinal,0,1
96051,complaints,0,0
96052,",",0,0
96053,and,0,0
96054,myalgia,0,1
96055,.,0,0
96056,The,0,0
96057,most,0,0
96058,common,0,0
96059,laboratory,0,0
96060,abnormality,0,1
96061,was,0,0
96062,anemia,0,1
96063,.,0,0
96064,Most,0,0
96065,often,0,0
96066,the,0,0
96067,AEs,0,0
96068,were,0,0
96069,of,0,0
96070,mild-to-moderate,0,1
96071,severity,0,0
96072,.,0,1
96073,Fluid,0,0
96074,retention,0,0
96075,events,0,0
96076,and,0,0
96077,skin,0,1
96078,rash,0,0
96079,were,0,0
96080,numerically,0,0
96081,reported,0,0
96082,more,0,0
96083,often,0,0
96084,in,0,0
96085,the,0,0
96086,800-mg/day,0,0
96087,treatment,0,0
96088,cohort,0,1
96089,of,0,0
96090,patients,0,1
96091,.,0,1
96092,Comparison,0,0
96093,of,0,0
96094,injection,1,0
96095,comfort,1,0
96096,of,0,0
96097,a,0,0
96098,new,0,0
96099,category,0,0
96100,of,0,0
96101,cohesive,1,0
96102,hyaluronic,1,0
96103,acid,1,0
96104,filler,1,0
96105,with,0,1
96106,preincorporated,0,0
96107,lidocaine,0,0
96108,and,0,0
96109,a,0,0
96110,hyaluronic,0,0
96111,acid,0,0
96112,filler,0,0
96113,alone,0,0
96114,.,0,0
96115,BACKGROUND,0,0
96116,A,0,0
96117,smooth,0,0
96118,",",0,0
96119,cohesive,0,0
96120,",",0,0
96121,24-mg/mL,0,0
96122,hyaluronic,0,0
96123,acid,0,0
96124,(,0,0
96125,HA,0,1
96126,),0,0
96127,gel,0,0
96128,with,0,1
96129,uniform,0,0
96130,consistency,0,0
96131,",",0,0
96132,even,0,0
96133,flow,0,0
96134,characteristics,0,0
96135,",",0,0
96136,and,0,0
96137,extended,0,0
96138,duration,0,0
96139,was,0,0
96140,designed,0,0
96141,for,0,0
96142,injection,0,0
96143,into,0,0
96144,the,0,0
96145,mid,0,0
96146,to,0,0
96147,deep,0,0
96148,dermis,0,0
96149,.,0,0
96150,OBJECTIVE,0,0
96151,To,0,0
96152,compare,0,0
96153,injection,0,0
96154,pain,0,0
96155,of,0,0
96156,a,0,0
96157,HA,0,1
96158,gel,0,0
96159,with,0,1
96160,preincorporated,0,0
96161,lidocaine,0,0
96162,with,0,1
96163,that,0,0
96164,with,0,1
96165,a,0,0
96166,non-lidocaine,0,0
96167,formulation,0,0
96168,.,0,1
96169,METHODS,0,0
96170,&,0,1
96171,MATERIALS,0,0
96172,This,0,0
96173,double-blind,0,0
96174,study,0,0
96175,at,0,0
96176,three,1,1
96177,centers,1,1
96178,enrolled,1,1
96179,60,1,1
96180,subjects,1,1
96181,",",1,0
96182,injected,1,0
96183,with,1,1
96184,both,1,0
96185,products,1,0
96186,",",1,0
96187,randomly,1,1
96188,assigned,1,0
96189,to,1,0
96190,left,1,1
96191,or,1,1
96192,right,1,1
96193,nasolabial,1,0
96194,fold,1,1
96195,.,1,0
96196,The,0,0
96197,injecting,0,0
96198,physician,0,0
96199,assessed,0,0
96200,severity,0,0
96201,of,0,0
96202,pain,0,0
96203,and,0,0
96204,ease,0,0
96205,of,0,0
96206,injection,0,0
96207,.,0,1
96208,Subjects,1,0
96209,used,1,0
96210,a,1,0
96211,visual,1,0
96212,analog,1,0
96213,scale,1,0
96214,(,1,0
96215,0-10,1,0
96216,),1,0
96217,for,1,0
96218,pain,1,1
96219,assessment,1,0
96220,.,1,1
96221,Adverse,0,0
96222,events,0,0
96223,were,0,1
96224,recorded,0,0
96225,.,0,1
96226,RESULTS,0,0
96227,Physician,0,0
96228,assessment,0,0
96229,of,0,0
96230,injection,0,0
96231,pain,0,1
96232,was,0,0
96233,none,0,0
96234,or,0,0
96235,mild,0,1
96236,in,0,0
96237,81,0,1
96238,%,0,0
96239,of,0,0
96240,HA,0,1
96241,gel,0,0
96242,injections,0,0
96243,with,0,1
96244,preincorporated,0,0
96245,lidocaine,0,0
96246,and,0,0
96247,36,0,1
96248,%,0,0
96249,of,0,0
96250,HA-alone,0,0
96251,injections,0,0
96252,(,0,1
96253,p,0,0
96254,<,0,0
96255,.001,0,0
96256,),0,1
96257,.,0,0
96258,Mean,0,0
96259,pain,0,0
96260,assessment,0,0
96261,by,0,0
96262,subjects,0,1
96263,was,0,0
96264,3.6,0,0
96265,for,0,0
96266,HA+lidocaine,0,0
96267,and,0,0
96268,5.8,0,0
96269,for,0,0
96270,HA,0,1
96271,alone,0,0
96272,(,0,0
96273,p,0,0
96274,<,0,0
96275,.001,0,0
96276,),0,0
96277,.,0,0
96278,Ninety-five,0,1
96279,percent,0,0
96280,of,0,0
96281,the,0,0
96282,injections,0,0
96283,were,0,0
96284,considered,0,0
96285,easy,0,0
96286,or,0,1
96287,very,0,0
96288,easy,0,0
96289,;,0,0
96290,a,0,0
96291,greater,0,0
96292,percentage,0,0
96293,of,0,0
96294,HA+lidocaine,0,0
96295,injections,0,0
96296,were,0,0
96297,rated,0,0
96298,very,0,0
96299,easy,0,0
96300,.,0,0
96301,Mild,0,0
96302,to,0,0
96303,moderate,0,1
96304,adverse,0,0
96305,events,0,0
96306,were,0,1
96307,reported,0,0
96308,for,0,0
96309,both,0,0
96310,products,0,0
96311,.,0,0
96312,CONCLUSION,0,0
96313,The,0,0
96314,smooth,0,0
96315,",",0,0
96316,cohesive,0,0
96317,HA,0,1
96318,gel,0,0
96319,with,0,1
96320,preincorporated,0,0
96321,lidocaine,0,0
96322,increased,0,0
96323,subject,0,0
96324,comfort,0,0
96325,during,0,0
96326,treatment,0,0
96327,and,0,0
96328,improved,0,0
96329,the,0,0
96330,injection,0,0
96331,experience,0,0
96332,.,0,1
96333,Using,0,0
96334,a,0,0
96335,laryngeal,0,1
96336,tube,0,0
96337,suction-device,0,0
96338,(,0,0
96339,LTS-D,0,0
96340,),0,0
96341,reduces,0,0
96342,the,0,0
96343,no,0,0
96344,flow,0,0
96345,time,0,0
96346,in,0,0
96347,a,0,0
96348,single,0,0
96349,rescuer,0,0
96350,manikin,0,0
96351,study,0,0
96352,.,0,0
96353,BACKGROUND,0,0
96354,In,0,0
96355,2005,0,1
96356,",",0,0
96357,the,0,0
96358,European,0,1
96359,Resuscitation,0,1
96360,Council,0,0
96361,and,0,0
96362,the,0,0
96363,American,0,1
96364,Heart,0,1
96365,Association,0,0
96366,published,0,1
96367,new,0,0
96368,guidelines,0,0
96369,for,0,1
96370,Advanced,0,1
96371,Life,0,1
96372,Support,0,1
96373,.,0,1
96374,One,0,1
96375,of,0,0
96376,the,0,0
96377,points,0,0
96378,was,0,0
96379,to,0,0
96380,reduce,0,0
96381,the,0,0
96382,time,0,0
96383,without,0,0
96384,chest,0,0
96385,compressions,0,0
96386,in,0,0
96387,the,0,0
96388,first,0,0
96389,phase,0,0
96390,of,0,0
96391,cardiac,0,1
96392,arrest,0,1
96393,.,0,0
96394,OBJECTIVE,0,0
96395,We,0,0
96396,evaluated,0,0
96397,in,0,0
96398,a,0,0
96399,manikin,0,0
96400,model,0,0
96401,whether,0,0
96402,using,0,0
96403,the,0,0
96404,single-use,0,0
96405,laryngeal,0,1
96406,tube,0,0
96407,with,0,1
96408,suction,0,0
96409,option,0,0
96410,(,0,0
96411,LTS-D,0,0
96412,),0,0
96413,instead,0,0
96414,of,0,0
96415,endotracheal,0,1
96416,intubation,0,1
96417,(,0,0
96418,ET,0,0
96419,),0,0
96420,and,0,0
96421,bag-mask-valve,0,1
96422,ventilation,0,0
96423,(,0,0
96424,BMV,0,0
96425,),0,0
96426,for,0,0
96427,emergency,0,1
96428,airway,0,1
96429,management,0,0
96430,could,0,0
96431,reduce,0,0
96432,the,0,0
96433,no-flow,0,0
96434,time,0,0
96435,(,0,0
96436,NFT,0,1
96437,),0,0
96438,.,0,0
96439,The,0,0
96440,NFT,0,0
96441,is,0,0
96442,defined,0,0
96443,as,0,0
96444,the,0,0
96445,time,0,0
96446,during,0,0
96447,resuscitation,0,0
96448,when,0,0
96449,no,0,0
96450,chest,0,0
96451,compressions,0,0
96452,take,0,0
96453,place,0,0
96454,.,0,0
96455,METHODS,0,0
96456,A,0,0
96457,randomized,1,0
96458,",",1,0
96459,prospective,1,0
96460,study,1,0
96461,was,1,0
96462,undertaken,1,0
96463,with,1,1
96464,150,1,1
96465,volunteers,1,1
96466,who,1,1
96467,performed,1,1
96468,management,1,1
96469,of,1,0
96470,a,1,0
96471,standardized,1,0
96472,simulated,1,0
96473,cardiac,1,1
96474,arrest,1,1
96475,in,1,0
96476,a,1,0
96477,manikin,1,0
96478,.,1,0
96479,Every,0,0
96480,participant,0,0
96481,was,0,0
96482,randomized,0,0
96483,to,0,0
96484,one,0,1
96485,of,0,0
96486,three,0,0
96487,different,0,0
96488,airway,0,1
96489,management,0,1
96490,groups,0,0
96491,(,0,0
96492,LTS-D,0,0
96493,vs,0,0
96494,.,0,0
96495,ET,0,0
96496,vs.,0,0
96497,BMV,0,0
96498,),0,1
96499,.,0,0
96500,RESULTS,0,0
96501,The,0,0
96502,LTS-D,0,0
96503,was,0,0
96504,inserted,0,0
96505,significantly,0,0
96506,faster,0,0
96507,than,0,0
96508,the,0,0
96509,ET,0,0
96510,tube,0,0
96511,(,0,0
96512,15,0,0
96513,s,0,0
96514,vs.,0,0
96515,44,0,1
96516,s,0,0
96517,",",0,0
96518,respectively,0,0
96519,",",0,0
96520,p,0,0
96521,<,0,0
96522,0.01,0,0
96523,),0,0
96524,.,0,0
96525,During,0,0
96526,the,0,0
96527,cardiac,0,1
96528,arrest,0,0
96529,simulation,0,0
96530,",",0,0
96531,establishing,0,0
96532,and,0,0
96533,performing,0,0
96534,ventilation,0,0
96535,took,0,1
96536,an,0,0
96537,average,0,0
96538,of,0,0
96539,57,0,1
96540,s,0,0
96541,with,0,1
96542,the,0,0
96543,LTS-D,0,0
96544,compared,0,0
96545,to,0,0
96546,116,0,1
96547,s,0,0
96548,with,0,1
96549,ET,0,0
96550,and,0,0
96551,111,0,0
96552,s,0,0
96553,with,0,1
96554,the,0,0
96555,BMV,0,0
96556,.,0,0
96557,Using,0,0
96558,the,0,0
96559,LTS-D,0,0
96560,significantly,0,0
96561,reduced,0,0
96562,NFT,0,0
96563,compared,0,0
96564,to,0,0
96565,ET,0,0
96566,and,0,0
96567,the,0,0
96568,BMV,0,0
96569,(,0,0
96570,125,0,0
96571,s,0,0
96572,vs.,0,0
96573,207,0,1
96574,s,0,0
96575,vs.,0,0
96576,160,0,1
96577,s,0,0
96578,;,0,0
96579,p,0,0
96580,<,0,0
96581,0.01,0,0
96582,),0,0
96583,.,0,0
96584,CONCLUSIONS,0,0
96585,In,0,0
96586,our,0,0
96587,manikin,0,0
96588,study,0,0
96589,",",0,0
96590,NFT,0,0
96591,was,0,0
96592,reduced,0,0
96593,significantly,0,0
96594,when,0,0
96595,the,0,0
96596,LTS-D,0,0
96597,was,0,0
96598,used,0,0
96599,when,0,0
96600,compared,0,0
96601,to,0,0
96602,ET,0,0
96603,and,0,0
96604,BMV,0,0
96605,.,0,0
96606,The,0,0
96607,results,0,0
96608,of,0,0
96609,our,0,0
96610,manikin,0,0
96611,study,0,0
96612,suggest,0,0
96613,that,0,0
96614,for,0,0
96615,personnel,0,1
96616,not,0,0
96617,experienced,0,0
96618,in,0,0
96619,tracheal,0,1
96620,intubation,0,0
96621,",",0,0
96622,the,0,0
96623,LTS-D,0,0
96624,offers,0,0
96625,a,0,0
96626,good,0,0
96627,alternative,0,0
96628,to,0,0
96629,ET,0,0
96630,and,0,0
96631,BMV,0,0
96632,to,0,0
96633,manage,0,0
96634,the,0,0
96635,airway,0,0
96636,during,0,0
96637,resuscitation,0,1
96638,",",0,0
96639,and,0,0
96640,to,0,0
96641,avoid,0,0
96642,the,0,0
96643,failure,0,1
96644,to,0,0
96645,achieve,0,0
96646,tracheal,0,1
96647,intubation,0,0
96648,with,0,1
96649,the,0,0
96650,ET,0,0
96651,",",0,0
96652,and,0,0
96653,the,0,0
96654,failure,0,1
96655,to,0,0
96656,achieve,0,0
96657,adequate,0,0
96658,ventilation,0,0
96659,with,0,1
96660,the,0,0
96661,BMV,0,0
96662,.,0,1
96663,Intensive,0,1
96664,insulin,0,0
96665,therapy,0,0
96666,on,0,0
96667,infection,0,0
96668,rate,0,0
96669,",",0,0
96670,days,0,0
96671,in,0,0
96672,NICU,0,0
96673,",",0,0
96674,in-hospital,0,0
96675,mortality,0,0
96676,and,0,0
96677,neurological,0,0
96678,outcome,0,0
96679,in,0,0
96680,severe,1,1
96681,traumatic,1,1
96682,brain,1,0
96683,injury,1,1
96684,patients,1,1
96685,:,1,1
96686,a,0,0
96687,randomized,0,0
96688,controlled,0,0
96689,trial,0,0
96690,.,0,1
96691,OBJECTIVES,0,0
96692,Evaluate,0,0
96693,the,0,0
96694,impact,0,0
96695,of,0,0
96696,an,0,0
96697,intensive,0,0
96698,insulin,0,0
96699,therapy,0,0
96700,and,0,0
96701,conventional,0,0
96702,glucose,0,0
96703,control,0,0
96704,protocol,0,0
96705,during,0,0
96706,staying,0,0
96707,in,0,0
96708,neurological,0,1
96709,intensive,0,1
96710,care,0,1
96711,unit,0,0
96712,(,0,0
96713,NICU,0,0
96714,),0,0
96715,on,0,0
96716,infection,0,0
96717,rate,0,0
96718,",",0,0
96719,days,0,0
96720,in,0,0
96721,NICU,0,0
96722,",",0,0
96723,in-hospital,0,0
96724,mortality,0,0
96725,and,0,0
96726,long-term,0,0
96727,neurological,0,1
96728,outcome,0,0
96729,in,0,0
96730,severe,1,1
96731,traumatic,1,1
96732,brain,1,0
96733,injury,1,1
96734,(,1,0
96735,TBI,1,1
96736,),1,1
96737,patients,1,1
96738,.,1,1
96739,METHODS,0,0
96740,A,0,0
96741,total,0,1
96742,of,0,0
96743,240,1,1
96744,patients,1,1
96745,with,1,1
96746,severe,1,1
96747,TBI,1,1
96748,(,1,0
96749,GCS,1,0
96750,score,1,0
96751,3-8,1,1
96752,),1,0
96753,admitted,1,1
96754,to,1,0
96755,NICU,1,0
96756,were,0,0
96757,prospectively,0,0
96758,enrolled,0,1
96759,and,0,0
96760,randomly,0,1
96761,assigned,0,0
96762,either,0,0
96763,to,0,0
96764,conventional,0,0
96765,insulin,0,0
96766,therapy,0,0
96767,or,0,0
96768,to,0,0
96769,intensive,0,0
96770,insulin,0,0
96771,therapy,0,0
96772,.,0,0
96773,Patients,0,1
96774,in,0,0
96775,intensive,0,1
96776,glucose,0,0
96777,control,0,1
96778,group,0,0
96779,(,0,0
96780,n=121,0,1
96781,),0,0
96782,received,0,0
96783,continuous,0,0
96784,insulin,0,0
96785,infusion,0,0
96786,to,0,0
96787,maintain,0,0
96788,glucose,0,0
96789,levels,0,0
96790,between,0,0
96791,4.4,0,1
96792,m,0,1
96793,mol/l,0,0
96794,(,0,1
96795,80,0,1
96796,mg/dl,0,0
96797,),0,0
96798,and,0,0
96799,6.1,0,0
96800,m,0,1
96801,mol/l,0,0
96802,(,0,0
96803,110,0,1
96804,mg/dl,0,0
96805,),0,1
96806,.,0,0
96807,Patients,0,1
96808,in,0,0
96809,the,0,0
96810,conventional,0,0
96811,treatment,0,0
96812,group,0,0
96813,(,0,0
96814,n=119,0,1
96815,),0,0
96816,were,0,0
96817,not,0,0
96818,given,0,0
96819,insulin,0,0
96820,unless,0,0
96821,glucose,0,0
96822,levels,0,0
96823,were,0,1
96824,greater,0,0
96825,than,0,0
96826,11.1,0,0
96827,m,0,1
96828,mol/l,0,0
96829,(,0,0
96830,200mg/dl,0,0
96831,),0,0
96832,.,0,1
96833,Both,0,0
96834,groups,0,0
96835,were,0,0
96836,treated,0,1
96837,with,0,1
96838,insulin,0,0
96839,infusion,0,0
96840,to,0,0
96841,maintain,0,0
96842,normoglycemia,0,0
96843,after,0,0
96844,leaving,0,0
96845,NICU,0,1
96846,.,0,1
96847,Comparison,0,0
96848,was,0,0
96849,made,0,0
96850,against,0,0
96851,conventional,0,0
96852,insulin,0,0
96853,therapy,0,0
96854,using,0,0
96855,a,0,0
96856,randomized,0,0
96857,trial,0,0
96858,design,0,0
96859,.,0,0
96860,The,0,0
96861,primary,0,0
96862,outcomes,0,0
96863,is,0,0
96864,the,0,0
96865,mortality,0,0
96866,rate,0,0
96867,at,0,0
96868,6,0,0
96869,months,0,0
96870,follow-up,0,0
96871,.,0,0
96872,The,0,0
96873,second,0,0
96874,outcomes,0,0
96875,including,0,1
96876,ICU,0,0
96877,infection,0,0
96878,rate,0,0
96879,",",0,0
96880,duration,0,0
96881,of,0,0
96882,ICU,0,0
96883,stay,0,0
96884,",",0,0
96885,in-hospital,0,0
96886,mortality,0,0
96887,rate,0,0
96888,and,0,0
96889,neurologic,0,1
96890,outcome,0,0
96891,at,0,0
96892,6,0,0
96893,months,0,0
96894,follow-up,0,0
96895,.,0,1
96896,RESULTS,0,0
96897,There,0,0
96898,was,0,0
96899,no,0,0
96900,significant,0,0
96901,difference,0,0
96902,in,0,0
96903,gender,1,1
96904,(,1,0
96905,66,1,1
96906,%,1,0
96907,vs.,1,0
96908,67,1,1
96909,%,1,0
96910,male,1,1
96911,),1,0
96912,",",1,0
96913,age,1,1
96914,(,1,0
96915,46+/-11,1,1
96916,years,1,1
96917,vs.,1,0
96918,45+/-10,1,1
96919,years,1,1
96920,),1,1
96921,",",1,0
96922,APACHE,1,0
96923,II,1,1
96924,score,1,0
96925,(,1,0
96926,30,1,1
96927,vs.,1,0
96928,29,1,1
96929,),1,0
96930,",",1,0
96931,TISS-28,1,0
96932,score,1,0
96933,(,1,0
96934,47,1,1
96935,vs.,1,0
96936,46,1,1
96937,),1,0
96938,",",1,0
96939,and,1,0
96940,Glasgow,1,1
96941,Coma,1,1
96942,Score,1,1
96943,(,1,0
96944,GCS,1,1
96945,",",1,0
96946,5.3,1,0
96947,vs.,1,0
96948,5.3,1,0
96949,),1,0
96950,between,0,0
96951,the,0,0
96952,two,0,0
96953,groups,0,0
96954,.,0,1
96955,Overall,0,0
96956,mortality,0,0
96957,rates,0,0
96958,at,0,1
96959,6,0,1
96960,months,0,0
96961,follow-up,0,0
96962,were,0,1
96963,similar,0,0
96964,in,0,0
96965,the,0,0
96966,2,0,0
96967,groups,0,0
96968,(,0,1
96969,61,0,1
96970,of,0,0
96971,117,0,1
96972,",",0,0
96973,52.1,0,0
96974,%,0,0
96975,vs.,0,0
96976,62,0,1
96977,of,0,0
96978,116,0,1
96979,",",0,0
96980,53.4,0,1
96981,%,0,0
96982,;,0,1
96983,P=0.8,0,0
96984,),0,0
96985,.,0,0
96986,The,0,0
96987,infection,0,0
96988,rate,0,0
96989,during,0,0
96990,the,0,0
96991,study,0,0
96992,was,0,0
96993,significantly,0,0
96994,higher,0,0
96995,in,0,1
96996,patients,0,1
96997,who,0,1
96998,received,0,1
96999,conventional,0,1
97000,insulin,0,0
97001,therapy,0,0
97002,than,0,0
97003,that,0,0
97004,in,0,1
97005,patients,0,1
97006,who,0,1
97007,received,0,1
97008,intensive,0,1
97009,insulin,0,0
97010,therapy,0,0
97011,(,0,0
97012,46.2,0,0
97013,%,0,0
97014,vs.,0,0
97015,31.4,0,0
97016,%,0,0
97017,;,0,1
97018,P,0,0
97019,<,0,0
97020,0.05,0,0
97021,),0,0
97022,.,0,1
97023,The,0,0
97024,days,0,0
97025,stay,0,0
97026,in,0,0
97027,NICU,0,0
97028,was,0,0
97029,shorter,0,0
97030,in,0,0
97031,intensive,0,0
97032,insulin,0,0
97033,control,0,0
97034,group,0,0
97035,than,0,0
97036,that,0,0
97037,in,0,0
97038,conventional,0,0
97039,therapy,0,0
97040,group,0,0
97041,[,0,0
97042,4.2,0,0
97043,days,0,0
97044,vs.,0,0
97045,5.6,0,0
97046,days,0,0
97047,(,0,1
97048,medians,0,0
97049,),0,1
97050,P,0,0
97051,<,0,0
97052,0.05,0,0
97053,],0,1
97054,.,0,1
97055,The,0,0
97056,in-hospital,0,0
97057,mortality,0,0
97058,during,0,0
97059,the,0,0
97060,study,0,0
97061,was,0,0
97062,similar,0,0
97063,in,0,0
97064,conventional,0,1
97065,and,0,0
97066,intensive,0,1
97067,therapy,0,0
97068,groups,0,0
97069,(,0,0
97070,34,0,1
97071,of,0,0
97072,119,0,1
97073,",",0,0
97074,28.6,0,0
97075,%,0,0
97076,vs.,0,0
97077,35,0,1
97078,of,0,0
97079,121,0,1
97080,",",0,0
97081,28.9,0,0
97082,%,0,0
97083,in,0,0
97084,the,0,0
97085,conventional,0,0
97086,and,0,0
97087,intensive,0,1
97088,insulin,0,0
97089,therapy,0,1
97090,groups,0,0
97091,;,0,1
97092,P=0.85,0,0
97093,),0,0
97094,.,0,0
97095,The,0,0
97096,neurologic,0,0
97097,outcome,0,0
97098,according,0,1
97099,to,0,0
97100,Glasgow,0,1
97101,Outcome,0,0
97102,Score,0,1
97103,(,0,0
97104,GOS,0,0
97105,),0,0
97106,at,0,0
97107,6,0,0
97108,months,0,0
97109,(,0,1
97110,GOS,0,0
97111,5,0,1
97112,and,0,0
97113,4,0,0
97114,),0,0
97115,was,0,0
97116,better,0,0
97117,in,0,0
97118,the,0,0
97119,intensive,0,0
97120,insulin,0,0
97121,therapy,0,0
97122,group,0,0
97123,(,0,0
97124,34,0,1
97125,of,0,0
97126,117,0,1
97127,",",0,0
97128,29.1,0,0
97129,%,0,0
97130,),0,0
97131,than,0,0
97132,that,0,0
97133,in,0,0
97134,the,0,0
97135,conventional,0,0
97136,therapy,0,0
97137,group,0,0
97138,(,0,0
97139,26,0,1
97140,of,0,0
97141,116,0,1
97142,",",0,0
97143,22.4,0,0
97144,%,0,0
97145,",",0,0
97146,P,0,0
97147,<,0,0
97148,0.05,0,0
97149,),0,1
97150,.,0,1
97151,CONCLUSIONS,0,0
97152,Mortality,0,0
97153,rates,0,0
97154,at,0,1
97155,6,0,1
97156,months,0,0
97157,follow-up,0,0
97158,are,0,0
97159,not,0,0
97160,affected,0,0
97161,by,0,0
97162,intensive,0,1
97163,glucose,0,0
97164,control,0,1
97165,in,0,0
97166,patients,1,1
97167,with,1,1
97168,severe,1,1
97169,TBI,1,1
97170,.,1,1
97171,Intensive,0,0
97172,insulin,0,0
97173,therapy,0,0
97174,decreases,0,0
97175,infection,0,0
97176,rate,0,0
97177,and,0,0
97178,days,0,0
97179,in,0,0
97180,NICU,0,0
97181,and,0,0
97182,improves,0,0
97183,the,0,0
97184,neurological,0,0
97185,outcome,0,0
97186,at,0,0
97187,6,0,0
97188,months,0,0
97189,follow-up,0,0
97190,",",0,0
97191,while,0,0
97192,has,0,0
97193,no,0,0
97194,obvious,0,0
97195,influence,0,0
97196,on,0,0
97197,in-hospital,0,0
97198,mortality,0,0
97199,of,0,0
97200,severe,1,1
97201,TBI,1,1
97202,patients,1,1
97203,.,1,1
97204,Effect,0,0
97205,of,0,0
97206,broccoli,0,0
97207,intake,0,0
97208,on,0,0
97209,markers,0,0
97210,related,0,0
97211,to,0,0
97212,oxidative,0,0
97213,stress,0,0
97214,and,0,0
97215,cancer,0,1
97216,risk,0,0
97217,in,0,0
97218,healthy,1,1
97219,smokers,1,1
97220,and,1,1
97221,nonsmokers,1,1
97222,.,1,1
97223,Cruciferous,0,1
97224,vegetables,0,0
97225,(,0,1
97226,CVs,0,1
97227,),0,0
97228,have,0,0
97229,been,0,0
97230,widely,0,0
97231,studied,0,0
97232,for,0,0
97233,their,0,0
97234,anticarcinogenic,0,0
97235,properties,0,0
97236,.,0,1
97237,The,0,0
97238,aim,0,0
97239,of,0,0
97240,the,0,0
97241,present,0,0
97242,study,0,0
97243,was,0,0
97244,to,0,0
97245,evaluate,0,0
97246,the,0,0
97247,protective,0,0
97248,effect,0,0
97249,of,0,0
97250,broccoli,0,0
97251,intake,0,0
97252,in,0,0
97253,smokers,1,1
97254,and,1,1
97255,nonsmokers,1,1
97256,.,1,1
97257,Twenty,1,1
97258,young,1,1
97259,healthy,1,1
97260,males,1,1
97261,(,1,1
97262,10,1,1
97263,smokers,1,1
97264,and,1,1
97265,10,1,1
97266,nonsmokers,1,1
97267,),1,1
97268,were,0,0
97269,randomized,0,0
97270,in,0,0
97271,a,0,0
97272,cross-over,0,0
97273,design,0,0
97274,and,0,0
97275,received,0,0
97276,a,0,0
97277,portion,0,0
97278,of,0,0
97279,broccoli,0,0
97280,(,0,0
97281,200,0,0
97282,g,0,1
97283,),0,0
97284,or,0,0
97285,maintained,0,0
97286,a,0,0
97287,controlled,0,0
97288,diet,0,0
97289,for,0,0
97290,10,0,1
97291,days,0,0
97292,each,0,1
97293,.,0,0
97294,The,0,0
97295,two,0,0
97296,periods,0,0
97297,were,0,1
97298,separated,0,0
97299,by,0,0
97300,a,0,0
97301,wash-out,0,0
97302,period,0,0
97303,(,0,1
97304,20,0,1
97305,days,0,0
97306,),0,1
97307,.,0,1
97308,Blood,0,0
97309,samples,0,0
97310,were,0,0
97311,collected,0,1
97312,at,0,0
97313,0,0,0
97314,",",0,0
97315,10,0,0
97316,",",0,0
97317,30,0,0
97318,",",0,0
97319,and,0,0
97320,40,0,1
97321,days,0,0
97322,and,0,0
97323,used,0,0
97324,for,0,0
97325,the,0,0
97326,evaluation,0,0
97327,of,0,0
97328,DNA,0,0
97329,damage,0,0
97330,",",0,0
97331,insulin-like,0,0
97332,growth,0,0
97333,factor-I,0,0
97334,(,0,0
97335,IGF-I,0,1
97336,),0,0
97337,and,0,0
97338,histone,0,0
97339,deacetylase,0,0
97340,(,0,0
97341,HDAC,0,0
97342,),0,1
97343,.,0,1
97344,Ex,0,0
97345,vivo,0,0
97346,protection,0,0
97347,from,0,1
97348,H,0,1
97349,(,0,1
97350,2,0,0
97351,),0,0
97352,O,0,0
97353,(,0,1
97354,2,0,0
97355,),0,0
97356,-induced,0,0
97357,DNA,0,0
97358,damage,0,0
97359,and,0,0
97360,endogenous,0,0
97361,DNA,0,0
97362,damage,0,0
97363,were,0,0
97364,evaluated,0,0
97365,in,0,0
97366,lymphocytes,0,0
97367,by,0,0
97368,means,0,0
97369,of,0,0
97370,the,0,0
97371,comet,0,0
97372,assay,0,0
97373,.,0,1
97374,Strand,0,0
97375,breaks,0,0
97376,decreased,0,0
97377,significantly,0,0
97378,after,0,0
97379,the,0,0
97380,broccoli,0,0
97381,diet,0,0
97382,in,0,0
97383,smokers,0,1
97384,as,0,0
97385,well,0,0
97386,as,0,0
97387,in,0,0
97388,nonsmokers,0,1
97389,(,0,1
97390,-22.2,0,0
97391,%,0,0
97392,;,0,1
97393,P,0,0
97394,<,0,0
97395,0.0001,0,0
97396,),0,0
97397,",",0,0
97398,whereas,0,0
97399,oxidized,0,0
97400,purines,0,0
97401,decreased,0,0
97402,significantly,0,0
97403,only,0,0
97404,in,0,0
97405,smokers,0,1
97406,(,0,1
97407,-51.0,0,0
97408,%,0,0
97409,;,0,1
97410,P,0,0
97411,<,0,0
97412,0.0001,0,0
97413,),0,1
97414,.,0,1
97415,Broccoli,0,0
97416,intake,0,0
97417,did,0,0
97418,not,0,0
97419,modify,0,0
97420,HDAC,0,0
97421,activity,0,0
97422,and,0,0
97423,IGF-I,0,1
97424,serum,0,0
97425,levels,0,0
97426,.,0,1
97427,Our,0,0
97428,results,0,0
97429,strengthen,0,0
97430,the,0,0
97431,importance,0,0
97432,of,0,0
97433,consuming,0,0
97434,CVs,0,0
97435,to,0,0
97436,increase,0,0
97437,cell,0,0
97438,protection,0,0
97439,against,0,0
97440,DNA,0,0
97441,damage,0,0
97442,.,0,0
97443,Future,0,0
97444,investigation,0,0
97445,",",0,0
97446,with,0,1
97447,different,0,0
97448,amount,0,0
97449,of,0,0
97450,broccoli,0,0
97451,and/or,0,1
97452,different,0,0
97453,time,0,0
97454,of,0,0
97455,exposure,0,0
97456,",",0,0
97457,is,0,0
97458,needed,0,0
97459,to,0,0
97460,understand,0,0
97461,the,0,0
97462,lack,0,0
97463,of,0,0
97464,effect,0,0
97465,on,0,0
97466,HDAC,0,0
97467,activity,0,0
97468,and,0,0
97469,IGF-I,0,1
97470,levels,0,0
97471,.,0,1
97472,Acute,0,1
97473,and,0,0
97474,short-term,0,0
97475,effects,0,0
97476,of,0,0
97477,secondhand,0,0
97478,smoke,0,1
97479,on,0,0
97480,lung,0,1
97481,function,0,0
97482,and,0,0
97483,cytokine,0,0
97484,production,0,0
97485,.,0,0
97486,RATIONALE,0,0
97487,The,0,0
97488,acute,0,1
97489,effect,0,0
97490,of,0,0
97491,secondhand,0,0
97492,smoke,0,1
97493,(,0,0
97494,SHS,0,0
97495,),0,0
97496,on,0,0
97497,lung,0,1
97498,function,0,0
97499,and,0,0
97500,the,0,0
97501,duration,0,0
97502,of,0,0
97503,system,0,0
97504,disruption,0,0
97505,remain,0,0
97506,unknown,0,0
97507,.,0,1
97508,OBJECTIVES,0,0
97509,To,0,0
97510,assess,0,0
97511,the,0,0
97512,SHS,0,0
97513,effects,0,0
97514,and,0,0
97515,their,0,0
97516,duration,0,0
97517,on,0,0
97518,lung,0,1
97519,function,0,0
97520,and,0,0
97521,inflammatory,0,0
97522,markers,0,0
97523,.,0,1
97524,METHODS,0,0
97525,In,0,0
97526,a,0,0
97527,randomized,0,0
97528,single-blind,0,0
97529,crossover,0,0
97530,experiment,0,0
97531,data,0,0
97532,were,0,0
97533,obtained,0,0
97534,from,0,1
97535,16,1,1
97536,(,1,1
97537,8,1,0
97538,women,1,1
97539,),1,1
97540,nonsmoking,1,1
97541,adults,1,1
97542,at,0,0
97543,baseline,0,0
97544,and,0,0
97545,at,0,0
97546,0,0,0
97547,",",0,0
97548,1,0,0
97549,",",0,0
97550,and,0,0
97551,3,0,0
97552,hours,0,0
97553,after,0,0
97554,a,0,1
97555,1-hour,0,0
97556,SHS,0,0
97557,exposure,0,0
97558,set,0,0
97559,at,0,0
97560,bar/restaurant,0,1
97561,SHS,0,1
97562,levels,0,0
97563,.,0,1
97564,MEASUREMENTS,0,0
97565,AND,0,0
97566,MAIN,0,0
97567,RESULTS,0,0
97568,Serum,0,1
97569,and,0,0
97570,urine,0,0
97571,cotinine,0,0
97572,",",0,0
97573,lung,0,1
97574,function,0,0
97575,",",0,0
97576,and,0,0
97577,cytokines,0,0
97578,IL-4,0,0
97579,",",0,0
97580,IL-5,0,0
97581,",",0,0
97582,IL-6,0,0
97583,",",0,0
97584,tumor,0,0
97585,necrosis,0,0
97586,factor,0,0
97587,(,0,0
97588,TNF,0,0
97589,),0,0
97590,-alpha,0,0
97591,",",0,0
97592,and,0,0
97593,IFN-gamma,0,0
97594,.,0,1
97595,At,0,0
97596,0,0,0
97597,hours,0,0
97598,most,0,0
97599,lung,0,1
97600,function,0,0
97601,parameters,0,0
97602,were,0,0
97603,significantly,0,0
97604,reduced,0,0
97605,(,0,0
97606,indicative,0,0
97607,:,0,1
97608,FEV,0,0
97609,(,0,0
97610,1,0,0
97611,),0,0
97612,",",0,0
97613,4.3,0,0
97614,+/-,0,0
97615,0.4,0,0
97616,vs.,0,0
97617,3.8,0,1
97618,+/-,0,0
97619,0.3,0,0
97620,L,0,0
97621,;,0,1
97622,FEV,0,0
97623,(,0,0
97624,1,0,0
97625,),0,0
97626,/FVC,0,0
97627,",",0,0
97628,0.9,0,0
97629,+/-,0,0
97630,0.1,0,0
97631,vs.,0,0
97632,0.8,0,1
97633,+/-,0,0
97634,0.1,0,1
97635,;,0,1
97636,P,0,0
97637,<,0,0
97638,0.05,0,0
97639,),0,0
97640,but,0,0
97641,at,0,0
97642,3,0,0
97643,hours,0,0
97644,they,0,1
97645,were,0,0
97646,at,0,0
97647,baseline,0,0
97648,levels,0,0
97649,.,0,1
97650,In,0,0
97651,contrast,0,0
97652,",",0,0
97653,cotinine,0,0
97654,(,0,0
97655,serum,0,0
97656,",",0,0
97657,8.9,0,0
97658,+/-,0,0
97659,3.2,0,0
97660,vs.,0,0
97661,35.5,0,1
97662,+/-,0,0
97663,10.2,0,0
97664,ng,0,0
97665,x,0,0
97666,ml,0,0
97667,(,0,0
97668,-1,0,0
97669,),0,0
97670,),0,0
97671,",",0,0
97672,IL-4,0,0
97673,(,0,0
97674,41.3,0,1
97675,+/-,0,0
97676,5.8,0,0
97677,vs.,0,0
97678,44.2,0,1
97679,+/-,0,0
97680,4.5,0,0
97681,pg,0,0
97682,x,0,0
97683,ml,0,0
97684,(,0,0
97685,-1,0,0
97686,),0,0
97687,),0,0
97688,",",0,0
97689,IL-5,0,0
97690,(,0,0
97691,36.1,0,1
97692,+/-,0,0
97693,3.2,0,0
97694,vs.,0,0
97695,60.1,0,1
97696,+/-,0,0
97697,7.0,0,1
97698,pg,0,0
97699,x,0,0
97700,ml,0,0
97701,(,0,0
97702,-1,0,0
97703,),0,0
97704,),0,0
97705,",",0,0
97706,IL-6,0,0
97707,(,0,0
97708,2.5,0,0
97709,+/-,0,0
97710,0.3,0,0
97711,vs.,0,0
97712,7.6,0,0
97713,+/-,0,0
97714,1.4,0,0
97715,pg,0,0
97716,x,0,0
97717,ml,0,0
97718,(,0,0
97719,-1,0,0
97720,),0,0
97721,),0,0
97722,and,0,0
97723,IFN-gamma,0,0
97724,(,0,0
97725,0.3,0,0
97726,+/-,0,0
97727,0.2,0,0
97728,vs.,0,0
97729,0.6,0,0
97730,+/-,0,0
97731,0.2,0,0
97732,IU,0,0
97733,x,0,0
97734,ml,0,0
97735,(,0,0
97736,-1,0,0
97737,),0,0
97738,),0,0
97739,at,0,0
97740,3,0,1
97741,hours,0,0
97742,were,0,1
97743,higher,0,0
97744,than,0,0
97745,at,0,0
97746,baseline,0,0
97747,(,0,0
97748,P,0,0
97749,<,0,0
97750,0.05,0,0
97751,),0,1
97752,.,0,1
97753,IL-4,0,0
97754,and,0,0
97755,TNF-alpha,0,0
97756,increased,0,0
97757,only,0,0
97758,in,0,0
97759,men,0,1
97760,",",0,0
97761,whereas,0,0
97762,IL-5,0,0
97763,",",0,0
97764,IL-6,0,0
97765,",",0,0
97766,and,0,0
97767,IFN-gamma,0,0
97768,were,0,0
97769,different,0,0
97770,between,0,0
97771,sexes,0,1
97772,after,0,0
97773,exposure,0,0
97774,(,0,0
97775,P,0,0
97776,<,0,0
97777,0.05,0,0
97778,),0,0
97779,.,0,0
97780,Regression,0,0
97781,analyses,0,0
97782,revealed,0,0
97783,inverse,0,0
97784,associations,0,0
97785,of,0,0
97786,FEV,0,0
97787,(,0,1
97788,1,0,0
97789,),0,0
97790,and,0,0
97791,FEV,0,0
97792,(,0,0
97793,1,0,0
97794,),0,0
97795,/FVC,0,0
97796,ratio,0,0
97797,with,0,1
97798,IL-5,0,0
97799,(,0,1
97800,P,0,0
97801,<,0,0
97802,0.05,0,0
97803,),0,0
97804,in,0,0
97805,men,0,1
97806,and,0,1
97807,with,0,1
97808,IL-5,0,0
97809,(,0,1
97810,P,0,0
97811,=,0,0
97812,0.01,0,0
97813,),0,0
97814,",",0,0
97815,IL-6,0,0
97816,(,0,0
97817,P,0,0
97818,<,0,0
97819,0.001,0,0
97820,),0,0
97821,",",0,0
97822,IFN-gamma,0,0
97823,(,0,0
97824,P,0,0
97825,=,0,0
97826,0.034,0,0
97827,),0,0
97828,and,0,0
97829,serum,0,0
97830,cotinine,0,1
97831,(,0,0
97832,P,0,0
97833,<,0,0
97834,0.001,0,0
97835,),0,0
97836,in,0,0
97837,women,0,1
97838,.,0,1
97839,CONCLUSIONS,0,0
97840,We,0,0
97841,conclude,0,0
97842,that,0,0
97843,1,0,0
97844,hour,0,0
97845,of,0,0
97846,SHS,0,0
97847,exposure,0,0
97848,at,0,0
97849,bar/restaurant,0,1
97850,levels,0,0
97851,is,0,0
97852,accompanied,0,0
97853,by,0,0
97854,significant,0,0
97855,decrements,0,0
97856,on,0,0
97857,lung,0,1
97858,function,0,0
97859,and,0,0
97860,marked,0,0
97861,increases,0,0
97862,in,0,1
97863,inflammatory,0,0
97864,cytokines,0,0
97865,",",0,0
97866,particularly,0,0
97867,in,0,0
97868,men,0,1
97869,.,0,0
97870,More,0,0
97871,importantly,0,0
97872,",",0,0
97873,whereas,0,0
97874,most,0,0
97875,smoke-induced,0,1
97876,effects,0,0
97877,on,0,0
97878,lung,0,1
97879,function,0,0
97880,appear,0,0
97881,to,0,0
97882,recede,0,0
97883,within,0,0
97884,60,0,1
97885,minutes,0,0
97886,",",0,1
97887,inflammatory,0,0
97888,cytokines,0,0
97889,remain,0,0
97890,elevated,0,0
97891,for,0,0
97892,at,0,0
97893,least,0,1
97894,3,0,0
97895,hours,0,0
97896,after,0,0
97897,exposure,0,0
97898,to,0,0
97899,SHS,0,0
97900,.,0,1
97901,Neuromuscular,0,1
97902,excitability,0,0
97903,changes,0,0
97904,in,0,0
97905,the,0,0
97906,vastus,0,0
97907,medialis,0,0
97908,following,0,0
97909,anterior,1,1
97910,cruciate,1,1
97911,ligament,1,1
97912,reconstruction,1,1
97913,.,1,1
97914,PURPOSE,0,0
97915,Quadriceps,0,0
97916,weakness,0,0
97917,following,0,0
97918,anterior,1,1
97919,cruciate,1,1
97920,ligament,1,1
97921,reconstruction,1,1
97922,(,1,0
97923,ACLR,1,0
97924,),1,0
97925,is,0,0
97926,prevalent,0,0
97927,despite,0,0
97928,intensive,0,1
97929,rehabilitation,0,1
97930,.,0,1
97931,Diminished,0,0
97932,neuromuscular,0,0
97933,excitability,0,0
97934,is,0,0
97935,one,0,0
97936,potential,0,0
97937,factor,0,0
97938,that,0,0
97939,may,0,0
97940,limit,0,0
97941,muscular,0,0
97942,recovery,0,0
97943,following,0,0
97944,injury,0,1
97945,or,0,1
97946,surgery,0,1
97947,.,0,0
97948,The,0,0
97949,H-reflex,0,0
97950,provides,0,0
97951,a,0,0
97952,measure,0,0
97953,of,0,0
97954,alpha,0,0
97955,motorneuron,0,1
97956,(,0,0
97957,neuromuscular,0,1
97958,),0,0
97959,excitability,0,0
97960,in,0,0
97961,the,0,0
97962,sensory-motor,0,0
97963,pathway,0,0
97964,of,0,0
97965,the,0,0
97966,respective,0,0
97967,muscle,0,0
97968,and,0,0
97969,nerve,0,0
97970,.,0,0
97971,To,0,0
97972,date,0,0
97973,the,0,0
97974,vastus,0,0
97975,medialis,0,0
97976,(,0,0
97977,VM,0,1
97978,),0,0
97979,and,0,0
97980,soleus,0,1
97981,(,0,0
97982,SOL,0,0
97983,),0,0
97984,H-reflexes,0,0
97985,have,0,0
97986,been,0,0
97987,examined,0,0
97988,primarily,0,0
97989,in,0,0
97990,control,0,0
97991,subjects,1,1
97992,with,1,1
97993,induced,1,1
97994,knee,1,1
97995,joint,1,1
97996,effusion,1,1
97997,.,1,0
97998,This,0,0
97999,prospective,0,0
98000,",",0,0
98001,randomized,0,1
98002,clinical,0,0
98003,trial,0,0
98004,evaluated,0,0
98005,the,0,0
98006,affect,0,0
98007,of,0,0
98008,ACLR,0,0
98009,",",0,0
98010,utilizing,0,0
98011,hamsting,0,0
98012,(,0,0
98013,HS,0,1
98014,),0,0
98015,or,0,1
98016,bone-patellar,0,1
98017,tendon-bone,0,0
98018,(,0,0
98019,BTB,0,0
98020,),0,0
98021,autograft,0,0
98022,",",0,0
98023,on,0,0
98024,VM,0,1
98025,and,0,0
98026,SOL,0,0
98027,H-reflex,0,0
98028,latency,0,0
98029,and,0,0
98030,amplitude,0,0
98031,in,0,0
98032,twenty,1,1
98033,subjects,1,1
98034,.,1,1
98035,METHODS,0,0
98036,Preoperatively,0,0
98037,bilateral,0,0
98038,VM,0,1
98039,and,0,0
98040,SOL,0,0
98041,H-reflex,0,0
98042,tests,0,0
98043,were,0,1
98044,conducted,0,1
98045,.,0,0
98046,VM,0,0
98047,and,0,0
98048,SOL,0,0
98049,H-reflexes,0,0
98050,were,0,0
98051,subsequently,0,0
98052,conducted,0,0
98053,on,0,0
98054,the,0,0
98055,involved,0,0
98056,lower,0,0
98057,extremity,0,1
98058,at,0,0
98059,1,0,0
98060,and,0,1
98061,3,0,0
98062,months,0,0
98063,post,0,1
98064,surgery,0,1
98065,.,0,0
98066,At,0,0
98067,each,0,0
98068,test,0,0
98069,session,0,0
98070,subjects,1,1
98071,completed,0,1
98072,visual,0,0
98073,analog,0,0
98074,scales,0,0
98075,and,0,0
98076,knee,0,1
98077,girth,0,1
98078,was,0,0
98079,measured,0,0
98080,.,0,0
98081,RESULTS,0,0
98082,The,0,0
98083,VM,0,0
98084,H-reflex,0,0
98085,amplitude,0,0
98086,increased,0,0
98087,in,0,0
98088,the,0,0
98089,HS,0,0
98090,group,0,0
98091,at,0,0
98092,3,0,0
98093,months,0,0
98094,compared,0,0
98095,to,0,0
98096,1-month,0,0
98097,post,0,0
98098,surgery,0,1
98099,(,0,0
98100,p,0,0
98101,<,0,0
98102,.05,0,0
98103,),0,0
98104,.,0,1
98105,Significant,0,0
98106,changes,0,0
98107,over,0,0
98108,time,0,0
98109,were,0,0
98110,also,0,0
98111,noted,0,0
98112,in,0,0
98113,the,0,0
98114,visual,0,0
98115,analog,0,0
98116,pain,0,1
98117,and,0,0
98118,functional,0,1
98119,scales,0,0
98120,and,0,0
98121,the,0,0
98122,mid-patella,0,0
98123,girth,0,1
98124,.,0,0
98125,CONCLUSIONS,0,0
98126,The,0,0
98127,increased,0,0
98128,VM,0,1
98129,H-reflex,0,0
98130,amplitude,0,0
98131,at,0,0
98132,3,0,0
98133,months,0,0
98134,following,0,0
98135,HS,0,1
98136,autograft,0,1
98137,ACLR,0,0
98138,demonstrates,0,0
98139,an,0,0
98140,increase,0,0
98141,in,0,0
98142,VM,0,1
98143,neuromuscular,0,1
98144,excitability,0,0
98145,.,0,1
98146,Increased,0,0
98147,VM,0,1
98148,neuromuscular,0,1
98149,excitability,0,0
98150,was,0,0
98151,not,0,0
98152,evident,0,0
98153,in,0,0
98154,patients,0,1
98155,following,0,0
98156,BTB,0,0
98157,reconstruction,0,1
98158,.,0,0
98159,The,0,0
98160,increased,0,0
98161,neuromuscular,0,1
98162,excitability,0,0
98163,",",0,0
98164,observed,0,0
98165,only,0,0
98166,in,0,0
98167,the,0,0
98168,HS,0,0
98169,group,0,0
98170,",",0,0
98171,warrants,0,0
98172,consideration,0,0
98173,when,0,0
98174,selecting,0,0
98175,graft,0,0
98176,type,0,1
98177,for,0,0
98178,patients,1,1
98179,with,1,1
98180,extensive,1,1
98181,preoperative,1,1
98182,quadriceps,1,1
98183,dysfunction,1,1
98184,.,1,1
98185,FDA,0,1
98186,review,0,0
98187,of,0,0
98188,a,0,0
98189,panitumumab,0,0
98190,(,0,0
98191,Vectibix,0,0
98192,),0,0
98193,clinical,0,0
98194,trial,0,0
98195,for,0,0
98196,first-line,0,1
98197,treatment,0,0
98198,of,0,0
98199,metastatic,1,1
98200,colorectal,1,1
98201,cancer,1,1
98202,.,1,1
98203,On,0,0
98204,September,0,1
98205,27,0,1
98206,",",0,0
98207,2006,0,1
98208,",",0,0
98209,the,0,0
98210,U.S.,0,0
98211,Food,0,1
98212,and,0,0
98213,Drug,0,0
98214,Administration,0,0
98215,granted,0,0
98216,accelerated,0,0
98217,approval,0,0
98218,to,0,0
98219,panitumumab,0,0
98220,(,0,0
98221,Vectibix,0,0
98222,;,0,0
98223,Amgen,0,0
98224,",",0,0
98225,Inc.,0,0
98226,",",0,0
98227,Thousand,0,1
98228,Oaks,0,0
98229,",",0,0
98230,CA,0,0
98231,),0,0
98232,for,0,0
98233,the,0,0
98234,treatment,0,0
98235,of,0,0
98236,patients,1,1
98237,with,1,1
98238,epidermal,1,1
98239,growth,1,0
98240,factor,1,0
98241,receptor-expressing,1,0
98242,",",1,0
98243,metastatic,1,1
98244,colorectal,1,1
98245,carcinoma,1,1
98246,with,1,1
98247,disease,1,1
98248,progression,1,0
98249,on,1,0
98250,or,1,1
98251,following,1,0
98252,fluoropyrimidine-,1,0
98253,",",1,0
98254,oxaliplatin-,1,0
98255,",",1,0
98256,and,1,0
98257,irinotecan-containing,1,0
98258,chemotherapy,1,1
98259,regimens,1,0
98260,.,1,1
98261,Accelerated,0,0
98262,approval,0,0
98263,was,0,0
98264,based,0,0
98265,on,0,0
98266,demonstration,0,0
98267,of,0,0
98268,a,0,0
98269,beneficial,0,0
98270,effect,0,0
98271,on,0,0
98272,progression-free,0,0
98273,survival,0,0
98274,(,0,0
98275,PFS,0,0
98276,),0,0
98277,.,0,0
98278,The,0,0
98279,present,0,0
98280,submission,0,0
98281,summarizes,0,0
98282,a,0,0
98283,second,0,0
98284,clinical,0,0
98285,trial,0,0
98286,",",0,0
98287,to,0,0
98288,be,0,0
98289,included,0,0
98290,in,0,0
98291,the,0,0
98292,panitumumab,0,0
98293,package,0,0
98294,insert,0,0
98295,in,0,0
98296,June,0,1
98297,2008,0,1
98298,",",0,0
98299,of,0,0
98300,chemotherapy,0,0
98301,and,0,0
98302,bevacizumab,0,0
98303,with,0,1
98304,and,0,0
98305,without,0,1
98306,panitumumab,0,0
98307,in,0,0
98308,the,0,0
98309,first-line,0,0
98310,treatment,0,0
98311,of,0,0
98312,patients,1,1
98313,with,1,1
98314,metastatic,1,1
98315,colorectal,1,1
98316,cancer,1,1
98317,.,1,0
98318,The,0,0
98319,study,0,0
98320,was,0,0
98321,closed,0,0
98322,when,0,0
98323,inferior,0,0
98324,PFS,0,0
98325,and,0,0
98326,greater,0,0
98327,toxicity,0,0
98328,were,0,0
98329,demonstrated,0,0
98330,at,0,0
98331,the,0,0
98332,time,0,0
98333,of,0,0
98334,the,0,0
98335,planned,0,0
98336,interim,0,0
98337,efficacy,0,0
98338,analysis,0,0
98339,.,0,1
98340,Patients,1,1
98341,receiving,1,0
98342,panitumumab,1,0
98343,in,0,0
98344,combination,0,0
98345,with,0,1
98346,bevacizumab,0,0
98347,and,0,0
98348,chemotherapy,0,0
98349,experienced,0,0
98350,a,0,0
98351,higher,0,0
98352,incidence,0,0
98353,of,0,0
98354,death,0,0
98355,(,0,0
98356,9,0,0
98357,%,0,0
98358,versus,0,0
98359,4,0,0
98360,%,0,0
98361,),0,0
98362,and,0,0
98363,a,0,0
98364,higher,0,0
98365,risk,0,0
98366,for,0,0
98367,grade,0,1
98368,3,0,0
98369,and,0,0
98370,4,0,0
98371,toxicities,0,0
98372,than,0,1
98373,patients,1,1
98374,receiving,1,1
98375,bevacizumab,1,0
98376,and,1,0
98377,chemotherapy,1,0
98378,alone,1,0
98379,.,1,0
98380,The,0,0
98381,incidences,0,0
98382,of,0,0
98383,any,0,1
98384,Common,0,1
98385,Terminology,0,0
98386,Criteria,0,1
98387,for,0,0
98388,Adverse,0,0
98389,Events,0,0
98390,grade,0,1
98391,3,0,0
98392,and,0,1
98393,4,0,0
98394,adverse,0,0
98395,events,0,0
98396,(,0,1
98397,AEs,0,0
98398,),0,0
98399,were,0,0
98400,87,0,1
98401,%,0,0
98402,and,0,0
98403,72,0,0
98404,%,0,0
98405,in,0,0
98406,the,0,0
98407,panitumumab,0,0
98408,and,0,0
98409,control,0,0
98410,groups,0,0
98411,",",0,0
98412,respectively,0,0
98413,.,0,0
98414,Grade,0,0
98415,3,0,0
98416,and,0,0
98417,4,0,0
98418,AEs,0,0
98419,occurring,0,0
98420,more,0,0
98421,commonly,0,0
98422,in,0,0
98423,panitumumab-treated,0,0
98424,patients,0,1
98425,included,0,1
98426,rash/acneiform,0,0
98427,dermatitis,0,1
98428,",",0,0
98429,diarrhea,0,1
98430,",",0,0
98431,dehydration,0,0
98432,",",0,0
98433,primarily,0,0
98434,resulting,0,0
98435,from,0,0
98436,diarrhea,0,1
98437,",",0,0
98438,hypokalemia,0,0
98439,",",0,0
98440,stomatitis/mucositis,0,0
98441,",",0,0
98442,and,0,0
98443,pulmonary,0,1
98444,embolism,0,1
98445,.,0,0
98446,The,0,0
98447,addition,0,0
98448,of,0,0
98449,panitumumab,0,0
98450,to,0,0
98451,bevacizumab,0,0
98452,and,0,0
98453,chemotherapy,0,0
98454,for,0,0
98455,the,0,0
98456,first-line,0,0
98457,treatment,0,0
98458,of,0,0
98459,metastatic,1,1
98460,colorectal,1,1
98461,cancer,1,1
98462,was,0,0
98463,harmful,0,0
98464,when,0,0
98465,compared,0,0
98466,with,0,0
98467,bevacizumab,0,0
98468,and,0,0
98469,chemotherapy,0,0
98470,alone,0,0
98471,.,0,0
98472,The,0,0
98473,use,0,0
98474,of,0,0
98475,panitumumab,0,0
98476,in,0,0
98477,this,0,0
98478,setting,0,0
98479,can,0,0
98480,not,0,0
98481,be,0,0
98482,recommended,0,0
98483,.,0,0
98484,Mastication,0,0
98485,and,0,0
98486,late,0,1
98487,mandibular,0,1
98488,fracture,0,1
98489,after,0,0
98490,surgery,0,1
98491,of,0,0
98492,impacted,1,0
98493,third,1,1
98494,molars,1,1
98495,associated,1,0
98496,with,1,1
98497,no,1,0
98498,gross,1,0
98499,pathology,1,1
98500,.,1,0
98501,PURPOSE,0,0
98502,This,0,0
98503,study,0,0
98504,was,0,0
98505,undertaken,0,0
98506,with,0,1
98507,the,0,0
98508,null,0,0
98509,hypothesis,0,0
98510,that,0,0
98511,in,0,0
98512,patients,1,1
98513,",",1,0
98514,fully,1,0
98515,denate,1,0
98516,or,1,0
98517,with,1,1
98518,1,1,0
98519,or,1,1
98520,2,1,1
98521,teeth,1,1
98522,missing,1,0
98523,and,1,0
98524,older,1,1
98525,than,1,0
98526,25,1,0
98527,years,1,1
98528,",",0,0
98529,mastication,0,0
98530,does,0,0
98531,not,0,0
98532,affect,0,0
98533,late,0,0
98534,mandibular,0,1
98535,fracture,0,1
98536,after,1,0
98537,surgical,1,0
98538,removal,1,0
98539,of,1,0
98540,impacted,1,0
98541,third,1,1
98542,molars,1,1
98543,(,1,1
98544,M3s,1,1
98545,),1,0
98546,associated,1,0
98547,with,1,1
98548,no,1,0
98549,gross,1,0
98550,pathology,1,1
98551,.,1,1
98552,MATERIALS,0,0
98553,AND,0,0
98554,METHODS,0,0
98555,Five,1,0
98556,hundred,1,1
98557,sixty,1,1
98558,patients,1,1
98559,",",1,0
98560,fully,1,0
98561,dentate,1,0
98562,or,1,0
98563,with,1,1
98564,1,1,0
98565,or,1,1
98566,2,1,1
98567,teeth,1,1
98568,missing,1,0
98569,and,1,0
98570,older,1,1
98571,than,1,0
98572,25,1,1
98573,years,1,1
98574,who,1,1
98575,had,1,1
98576,no,1,1
98577,gross,1,0
98578,pathology,1,1
98579,associated,1,0
98580,with,1,1
98581,their,1,0
98582,impacted,1,0
98583,lower,1,0
98584,M3s,1,0
98585,",",0,0
98586,were,0,0
98587,recruited,0,1
98588,in,0,0
98589,this,0,0
98590,study,0,0
98591,.,0,0
98592,They,0,0
98593,were,0,0
98594,operated,0,1
98595,on,0,0
98596,under,0,0
98597,local,0,0
98598,anesthesia,0,1
98599,using,0,0
98600,a,0,0
98601,standard,0,0
98602,technique,0,0
98603,and,0,0
98604,randomly,0,1
98605,assigned,0,0
98606,into,0,0
98607,2,0,0
98608,groups,0,0
98609,for,0,0
98610,nonroutine,0,0
98611,(,0,0
98612,NR,0,1
98613,group,0,1
98614,),0,0
98615,and,0,0
98616,routine,0,0
98617,(,0,0
98618,R,0,1
98619,group,0,1
98620,),0,0
98621,postoperative,0,0
98622,instructions,0,0
98623,.,0,1
98624,In,0,0
98625,the,0,0
98626,NR,0,0
98627,group,0,0
98628,",",0,0
98629,patients,0,1
98630,were,0,0
98631,postoperatively,0,0
98632,educated,0,0
98633,in,0,0
98634,the,0,0
98635,possibility,0,0
98636,of,0,0
98637,mandibular,0,1
98638,fracture,0,1
98639,and,0,0
98640,were,0,0
98641,given,0,0
98642,an,0,0
98643,emphasis,0,0
98644,on,0,0
98645,the,0,0
98646,necessity,0,0
98647,of,0,0
98648,limiting,0,0
98649,mastication,0,0
98650,to,0,0
98651,a,0,0
98652,soft,0,0
98653,diet,0,0
98654,for,0,0
98655,4,0,0
98656,weeks,0,0
98657,.,0,1
98658,In,0,0
98659,the,0,0
98660,R,0,1
98661,group,0,0
98662,",",0,0
98663,patients,0,1
98664,were,0,0
98665,given,0,0
98666,no,0,0
98667,such,0,0
98668,education,0,0
98669,or,0,1
98670,emphasis,0,0
98671,.,0,1
98672,Patients,0,1
98673,were,0,0
98674,followed,0,0
98675,up,0,0
98676,for,0,0
98677,2,0,0
98678,months,0,0
98679,",",0,0
98680,and,0,0
98681,data,0,0
98682,concerning,0,0
98683,patients,0,1
98684,',0,1
98685,age,0,1
98686,and,0,1
98687,gender,0,1
98688,;,0,0
98689,tooth,0,0
98690,position,0,0
98691,",",0,0
98692,angulation,0,0
98693,",",0,0
98694,and,0,0
98695,depth,0,0
98696,;,0,0
98697,date,0,0
98698,and,0,0
98699,site,0,0
98700,of,0,0
98701,surgery,0,1
98702,;,0,0
98703,and,0,0
98704,occurrence,0,0
98705,of,0,0
98706,late,0,1
98707,mandibular,0,1
98708,fracture,0,1
98709,were,0,0
98710,recorded,0,0
98711,and,0,0
98712,statistically,0,0
98713,analyzed,0,0
98714,.,0,0
98715,A,0,0
98716,value,0,0
98717,of,0,0
98718,P,0,0
98719,less,0,0
98720,than,0,0
98721,.05,0,0
98722,was,0,0
98723,considered,0,0
98724,statistically,0,0
98725,significant,0,0
98726,.,0,0
98727,RESULTS,0,0
98728,In,0,0
98729,no,0,0
98730,patient,0,0
98731,group,0,0
98732,was,0,0
98733,there,0,0
98734,a,0,0
98735,late,0,0
98736,mandibular,0,1
98737,fracture,0,1
98738,recorded,0,0
98739,.,0,0
98740,All,0,0
98741,patients,0,1
98742,completed,0,1
98743,the,0,0
98744,follow-up,0,0
98745,period,0,0
98746,",",0,0
98747,and,0,0
98748,most,0,0
98749,of,0,0
98750,the,0,0
98751,R,0,1
98752,group,0,0
98753,patients,0,1
98754,had,0,1
98755,normal,0,1
98756,eating,0,1
98757,habits,0,1
98758,10,0,1
98759,to,0,1
98760,14,0,1
98761,days,0,0
98762,after,0,0
98763,surgery,0,1
98764,.,0,0
98765,In,0,0
98766,no,0,0
98767,patient,0,0
98768,group,0,0
98769,was,0,0
98770,there,0,0
98771,a,0,0
98772,statistically,0,0
98773,significant,0,0
98774,difference,0,0
98775,in,0,0
98776,relation,0,0
98777,to,0,0
98778,gender,0,0
98779,(,0,0
98780,P,0,0
98781,=,0,0
98782,.735,0,0
98783,),0,0
98784,",",0,0
98785,site,0,0
98786,of,0,0
98787,surgery,0,1
98788,(,0,0
98789,P,0,0
98790,=,0,0
98791,.552,0,0
98792,),0,0
98793,",",0,0
98794,class,0,1
98795,horizontal,0,0
98796,space,0,0
98797,available,0,0
98798,(,0,0
98799,P,0,0
98800,=,0,0
98801,.427,0,0
98802,),0,0
98803,",",0,0
98804,class,0,1
98805,highest,0,0
98806,portion,0,0
98807,of,0,0
98808,the,0,0
98809,M3,0,1
98810,crown,0,0
98811,(,0,0
98812,P,0,0
98813,=,0,0
98814,.424,0,0
98815,),0,0
98816,",",0,0
98817,angulations,0,0
98818,of,0,0
98819,the,0,0
98820,teeth,0,1
98821,(,0,0
98822,P,0,0
98823,=,0,0
98824,.925,0,0
98825,),0,0
98826,",",0,0
98827,and,0,0
98828,severity,0,0
98829,of,0,0
98830,impaction,0,1
98831,(,0,0
98832,P,0,0
98833,=,0,0
98834,.445,0,0
98835,),0,1
98836,.,0,0
98837,CONCLUSIONS,0,0
98838,In,0,0
98839,patients,1,1
98840,",",1,0
98841,fully,1,0
98842,dentate,1,0
98843,or,1,0
98844,with,1,1
98845,1,1,0
98846,or,1,1
98847,2,1,1
98848,teeth,1,1
98849,missing,1,0
98850,and,1,0
98851,older,1,1
98852,than,1,0
98853,25,1,1
98854,years,1,1
98855,who,1,1
98856,have,1,1
98857,no,1,1
98858,jawbone,1,1
98859,atrophy,1,1
98860,and,1,0
98861,no,1,0
98862,systemic,1,0
98863,problems,1,0
98864,that,1,0
98865,may,1,0
98866,impair,1,0
98867,bone,1,0
98868,strength,1,0
98869,",",0,0
98870,mastication,0,0
98871,seems,0,0
98872,not,0,0
98873,to,0,0
98874,affect,0,0
98875,late,0,1
98876,mandibular,0,1
98877,fracture,0,1
98878,after,0,0
98879,surgical,0,0
98880,removal,0,0
98881,of,0,0
98882,impacted,0,0
98883,M3s,0,1
98884,associated,0,0
98885,with,0,1
98886,no,0,0
98887,gross,0,0
98888,pathology,0,1
98889,.,0,0
98890,The,0,0
98891,remote,0,0
98892,possible,0,0
98893,risk,0,0
98894,of,0,0
98895,the,0,0
98896,late,0,0
98897,fracture,0,1
98898,shown,0,0
98899,in,0,0
98900,our,0,0
98901,patients,0,1
98902,indicates,0,0
98903,the,0,0
98904,need,0,0
98905,for,0,0
98906,no,0,0
98907,special,0,1
98908,precautions,0,0
98909,.,0,1
98910,Acute,0,1
98911,effects,0,0
98912,of,0,0
98913,decaffeinated,0,0
98914,coffee,0,0
98915,and,0,0
98916,the,0,0
98917,major,0,0
98918,coffee,0,0
98919,components,0,0
98920,chlorogenic,0,0
98921,acid,0,0
98922,and,0,0
98923,trigonelline,0,0
98924,on,0,0
98925,glucose,1,0
98926,tolerance,1,1
98927,.,1,1
98928,OBJECTIVE,0,0
98929,Coffee,0,0
98930,consumption,0,0
98931,has,0,0
98932,been,0,0
98933,associated,0,0
98934,with,0,1
98935,lower,0,0
98936,risk,0,0
98937,of,0,0
98938,type,1,1
98939,2,1,1
98940,diabetes,1,1
98941,.,1,1
98942,We,0,0
98943,evaluated,0,0
98944,the,0,0
98945,acute,0,1
98946,effects,0,0
98947,of,0,0
98948,decaffeinated,0,0
98949,coffee,0,0
98950,and,0,0
98951,the,0,0
98952,major,0,0
98953,coffee,0,0
98954,components,0,0
98955,chlorogenic,0,0
98956,acid,0,0
98957,and,0,0
98958,trigonelline,0,0
98959,on,0,0
98960,glucose,0,0
98961,tolerance,0,1
98962,.,0,1
98963,RESEARCH,0,0
98964,DESIGN,0,0
98965,AND,0,0
98966,METHODS,0,0
98967,We,0,0
98968,conducted,0,0
98969,a,0,0
98970,randomized,0,0
98971,crossover,0,0
98972,trial,0,0
98973,of,0,0
98974,the,0,0
98975,effects,0,0
98976,of,0,0
98977,12,0,1
98978,g,0,1
98979,decaffeinated,0,0
98980,coffee,0,0
98981,",",0,0
98982,1,0,0
98983,g,0,0
98984,chlorogenic,0,0
98985,acid,0,0
98986,",",0,0
98987,500,0,0
98988,mg,0,0
98989,trigonelline,0,0
98990,",",0,0
98991,and,0,0
98992,placebo,0,0
98993,(,0,0
98994,1,0,0
98995,g,0,1
98996,mannitol,0,0
98997,),0,0
98998,on,0,0
98999,glucose,0,0
99000,and,0,0
99001,insulin,0,0
99002,concentrations,0,0
99003,during,0,0
99004,a,0,1
99005,2-h,0,0
99006,oral,0,0
99007,glucose,0,0
99008,tolerance,0,0
99009,test,0,0
99010,(,0,0
99011,OGTT,0,0
99012,),0,0
99013,in,0,0
99014,15,1,1
99015,overweight,1,1
99016,men,1,1
99017,.,1,1
99018,RESULTS,0,0
99019,Chlorogenic,0,0
99020,acid,0,0
99021,and,0,0
99022,trigonelline,0,0
99023,ingestion,0,0
99024,significantly,0,0
99025,reduced,0,0
99026,glucose,0,0
99027,(,0,0
99028,-0.7,0,0
99029,mmol/l,0,0
99030,",",0,0
99031,P,0,0
99032,=,0,0
99033,0.007,0,0
99034,",",0,0
99035,and,0,0
99036,-0.5,0,0
99037,mmol/l,0,0
99038,",",0,0
99039,P,0,0
99040,=,0,0
99041,0.024,0,0
99042,",",0,0
99043,respectively,0,0
99044,),0,0
99045,and,0,0
99046,insulin,0,0
99047,(,0,0
99048,-73,0,0
99049,pmol/l,0,0
99050,",",0,0
99051,P,0,0
99052,=,0,0
99053,0.038,0,0
99054,",",0,0
99055,and,0,0
99056,-117,0,0
99057,pmol/l,0,0
99058,",",0,0
99059,P,0,0
99060,=,0,0
99061,0.007,0,0
99062,),0,1
99063,concentrations,0,0
99064,15,0,1
99065,min,0,0
99066,following,0,0
99067,an,0,0
99068,OGTT,0,0
99069,compared,0,0
99070,with,0,1
99071,placebo,0,0
99072,.,0,0
99073,None,0,0
99074,of,0,0
99075,the,0,0
99076,treatments,0,0
99077,affected,0,0
99078,insulin,0,0
99079,or,0,1
99080,glucose,0,0
99081,area,0,0
99082,under,0,0
99083,the,0,0
99084,curve,0,0
99085,values,0,0
99086,during,0,0
99087,the,0,0
99088,OGTT,0,0
99089,compared,0,0
99090,with,0,1
99091,placebo,0,0
99092,.,0,1
99093,CONCLUSIONS,0,0
99094,Chlorogenic,0,0
99095,acid,0,0
99096,and,0,0
99097,trigonelline,0,0
99098,reduced,0,0
99099,early,0,0
99100,glucose,0,0
99101,and,0,0
99102,insulin,0,0
99103,responses,0,0
99104,during,0,0
99105,an,0,1
99106,OGTT,0,0
99107,.,0,1
99108,The,0,0
99109,SNRI,0,0
99110,venlafaxine,0,0
99111,improves,0,0
99112,emotional,0,0
99113,unawareness,0,0
99114,in,0,0
99115,patients,1,1
99116,with,1,1
99117,post-stroke,1,1
99118,depression,1,1
99119,.,1,1
99120,OBJECTIVE,0,0
99121,Patients,1,1
99122,with,1,1
99123,stroke,1,1
99124,have,0,0
99125,a,0,0
99126,high,0,0
99127,prevalence,0,0
99128,of,0,0
99129,depression,0,1
99130,and,0,0
99131,unawareness,0,0
99132,of,0,0
99133,emotions,0,0
99134,or,0,1
99135,alexithymia,0,0
99136,.,0,0
99137,Here,0,0
99138,we,0,0
99139,investigated,0,0
99140,the,0,0
99141,effects,0,0
99142,of,0,0
99143,the,0,0
99144,serotoninergic,0,0
99145,and,0,0
99146,noradrenergic,0,0
99147,reuptake,0,0
99148,inhibitor,0,0
99149,(,0,0
99150,SNRI,0,0
99151,),0,0
99152,venlafaxine,0,0
99153,in,0,0
99154,comparison,0,0
99155,with,0,1
99156,the,0,0
99157,SSRI,0,0
99158,fluoxetine,0,0
99159,on,0,0
99160,alexithymia,0,0
99161,severity,0,0
99162,in,0,0
99163,patients,1,1
99164,with,1,1
99165,DSM-IV,1,1
99166,post-stroke,1,1
99167,major,1,1
99168,depressive-like,1,0
99169,episode,1,1
99170,(,1,0
99171,PSD,1,1
99172,),1,1
99173,.,1,1
99174,METHODS,0,0
99175,Fifty,1,1
99176,inpatients,1,1
99177,with,1,1
99178,first-ever,1,1
99179,stroke,1,1
99180,and,1,0
99181,PSD,1,1
99182,were,1,0
99183,consecutively,1,1
99184,enrolled,1,1
99185,in,0,0
99186,this,0,0
99187,randomized,0,0
99188,open-label,0,0
99189,study,0,1
99190,.,0,1
99191,Twenty-five,0,1
99192,were,0,0
99193,treated,0,1
99194,with,0,1
99195,the,0,0
99196,SNRI,0,0
99197,venlafaxine,0,0
99198,SR,0,0
99199,(,0,0
99200,75-150,0,0
99201,mg/die,0,0
99202,),0,0
99203,",",0,0
99204,and,0,0
99205,25,0,0
99206,with,0,1
99207,the,0,0
99208,SSRI,0,0
99209,fluoxetine,0,0
99210,(,0,0
99211,20-40,0,1
99212,mg/die,0,0
99213,),0,0
99214,.,0,0
99215,All,0,1
99216,patients,0,1
99217,were,0,0
99218,assessed,0,0
99219,at,0,0
99220,day,0,0
99221,0,0,0
99222,",",0,0
99223,and,0,0
99224,after,0,0
99225,1,0,0
99226,",",0,0
99227,2,0,0
99228,",",0,0
99229,4,0,0
99230,",",0,0
99231,6,0,0
99232,",",0,0
99233,and,0,0
99234,8,0,0
99235,weeks,0,0
99236,",",0,0
99237,using,0,0
99238,the,0,0
99239,Mini-Mental,0,1
99240,State,0,0
99241,Examination,0,1
99242,",",0,0
99243,the,0,0
99244,Hamilton,0,1
99245,Depression,0,0
99246,Rating,0,0
99247,Scale,0,0
99248,",",0,0
99249,and,0,0
99250,the,0,0
99251,Toronto,0,1
99252,Alexithymia,0,0
99253,Scale,0,0
99254,(,0,0
99255,TAS-20,0,1
99256,),0,1
99257,.,0,1
99258,RESULTS,0,0
99259,Patients,0,1
99260,treated,0,1
99261,with,0,1
99262,fluoxetine,0,0
99263,and,0,0
99264,those,0,0
99265,treated,0,0
99266,with,0,1
99267,venlafaxine,0,0
99268,showed,0,0
99269,similar,0,0
99270,improvement,0,0
99271,in,0,0
99272,depressive,0,1
99273,symptoms,0,0
99274,.,0,0
99275,However,0,0
99276,",",0,0
99277,patients,0,1
99278,treated,0,1
99279,with,0,1
99280,venlafaxine,0,0
99281,had,0,0
99282,a,0,0
99283,greater,0,0
99284,improvement,0,0
99285,on,0,0
99286,alexithymia,0,0
99287,severity,0,0
99288,than,0,0
99289,those,0,0
99290,treated,0,0
99291,with,0,1
99292,fluoxetine,0,0
99293,.,0,0
99294,The,0,0
99295,effect,0,0
99296,of,0,0
99297,venlafaxine,0,0
99298,on,0,0
99299,unawareness,0,0
99300,of,0,0
99301,emotions,0,0
99302,was,0,0
99303,evident,0,0
99304,in,0,0
99305,patients,0,1
99306,with,0,1
99307,alexithymia,0,0
99308,(,0,0
99309,TAS-20,0,1
99310,>,0,1
99311,or=,0,1
99312,61,0,1
99313,),0,0
99314,at,0,0
99315,the,0,0
99316,baseline,0,0
99317,and,0,0
99318,in,0,0
99319,those,0,0
99320,without,0,0
99321,alexithymia,0,0
99322,(,0,0
99323,TAS-20,0,1
99324,<,0,0
99325,61,0,1
99326,),0,1
99327,.,0,1
99328,CONCLUSIONS,0,0
99329,Antidepressants,0,0
99330,acting,0,0
99331,on,0,0
99332,both,0,0
99333,the,0,0
99334,serotoninergic,0,0
99335,and,0,0
99336,noradrenergic,0,0
99337,systems,0,0
99338,might,0,0
99339,represent,0,0
99340,a,0,0
99341,valid,0,0
99342,resource,0,0
99343,not,0,0
99344,only,0,0
99345,for,0,0
99346,the,0,0
99347,treatment,0,0
99348,of,0,0
99349,depression,0,1
99350,but,0,0
99351,also,0,0
99352,for,0,0
99353,improving,0,0
99354,emotional,0,0
99355,unawareness,0,0
99356,in,0,0
99357,stroke,1,1
99358,patients,1,1
99359,.,1,1
99360,Evaluation,0,0
99361,of,0,0
99362,electrofunctional,0,0
99363,data,0,0
99364,following,0,0
99365,argon-laser,0,0
99366,trabeculoplasty,0,0
99367,in,0,0
99368,primary,0,1
99369,open-angle,0,1
99370,glaucoma,0,1
99371,.,0,0
99372,To,0,0
99373,establish,0,0
99374,whether,0,0
99375,or,0,0
99376,not,0,0
99377,glaucomatous,0,0
99378,damage,0,0
99379,is,0,0
99380,reversible,0,0
99381,",",0,0
99382,we,0,0
99383,obtained,0,0
99384,pattern-reversal,0,0
99385,electroretinograms,0,0
99386,(,0,1
99387,PERGs,0,1
99388,),0,0
99389,and,0,0
99390,visual,0,0
99391,evoked,0,0
99392,potentials,0,0
99393,(,0,1
99394,VEPs,0,0
99395,),0,0
99396,in,0,0
99397,25,1,1
99398,eyes,1,1
99399,of,1,1
99400,25,1,1
99401,patients,1,1
99402,suffering,1,1
99403,from,1,1
99404,bilateral,1,1
99405,primary,1,1
99406,open-angle,1,1
99407,glaucoma,1,1
99408,(,1,0
99409,POAG,1,0
99410,),1,0
99411,before,1,0
99412,and,1,0
99413,after,1,0
99414,argon-laser,1,0
99415,trabeculoplasty,1,1
99416,.,1,0
99417,The,0,0
99418,laser,0,0
99419,treatment,0,0
99420,was,0,0
99421,carried,0,0
99422,out,0,0
99423,in,0,0
99424,only,0,0
99425,one,0,1
99426,eye,0,0
99427,chosen,0,0
99428,at,0,0
99429,random,0,0
99430,",",0,0
99431,and,0,0
99432,the,0,0
99433,fellow,0,0
99434,eye,0,0
99435,was,0,0
99436,used,0,0
99437,as,0,0
99438,a,0,0
99439,control,0,0
99440,.,0,0
99441,In,0,0
99442,the,0,0
99443,present,0,0
99444,study,0,0
99445,we,0,0
99446,intended,0,0
99447,to,0,0
99448,verify,0,0
99449,the,0,0
99450,possibility,0,0
99451,of,0,0
99452,using,0,0
99453,electrofunctional,0,0
99454,techniques,0,0
99455,to,0,0
99456,determine,0,0
99457,the,0,0
99458,two,0,0
99459,distinct,0,0
99460,and,0,0
99461,",",0,0
99462,probably,0,0
99463,",",0,0
99464,consecutive,0,1
99465,glaucomatous,0,1
99466,alterations,0,0
99467,occurring,0,1
99468,in,0,0
99469,ganglion,0,1
99470,cells,0,0
99471,:,0,1
99472,functional,0,1
99473,(,0,0
99474,reversible,0,0
99475,),0,0
99476,and,0,0
99477,anatomical,0,0
99478,(,0,0
99479,irreversible,0,1
99480,),0,0
99481,.,0,0
99482,The,0,0
99483,results,0,0
99484,obtained,0,0
99485,indicate,0,0
99486,that,0,0
99487,glaucomatous,0,1
99488,damage,0,0
99489,is,0,0
99490,irreversible,0,0
99491,.,0,0
99492,We,0,0
99493,propose,0,0
99494,that,0,0
99495,such,0,0
99496,alterations,0,0
99497,differ,0,0
99498,very,0,0
99499,slightly,0,0
99500,and,0,0
99501,that,0,0
99502,the,0,0
99503,current,0,0
99504,electrofunctional,0,0
99505,techniques,0,0
99506,may,0,0
99507,not,0,0
99508,be,0,0
99509,sufficiently,0,0
99510,sophisticated,0,0
99511,to,0,0
99512,distinguish,0,0
99513,between,0,0
99514,them,0,1
99515,.,0,1
99516,Pulse,0,0
99517,oximeter,0,0
99518,perfusion,0,0
99519,index,0,0
99520,as,0,0
99521,an,0,0
99522,early,0,0
99523,indicator,0,0
99524,of,0,0
99525,sympathectomy,0,0
99526,after,0,0
99527,epidural,0,0
99528,anesthesia,0,1
99529,.,0,0
99530,BACKGROUND,0,0
99531,The,0,0
99532,pulse,0,0
99533,oximeter,0,0
99534,perfusion,0,0
99535,index,0,0
99536,(,0,0
99537,PI,0,0
99538,),0,0
99539,has,0,0
99540,been,0,0
99541,used,0,0
99542,to,0,0
99543,indicate,0,0
99544,sympathectomy-induced,0,0
99545,vasodilatation,0,0
99546,.,0,1
99547,We,0,0
99548,hypothesized,0,0
99549,that,0,0
99550,pulse,0,0
99551,oximeter,0,0
99552,PI,0,0
99553,provides,0,0
99554,an,0,0
99555,earlier,0,0
99556,and,0,0
99557,clearer,0,0
99558,indication,0,0
99559,of,0,0
99560,sympathectomy,0,0
99561,following,0,0
99562,epidural,0,0
99563,anesthesia,0,1
99564,than,0,0
99565,skin,0,1
99566,temperature,0,0
99567,and,0,0
99568,arterial,0,1
99569,pressure,0,0
99570,.,0,1
99571,METHODS,0,0
99572,Forty,1,1
99573,patients,1,1
99574,received,1,1
99575,lumbar,1,1
99576,epidural,1,1
99577,catheters,1,1
99578,.,1,1
99579,Patients,0,1
99580,were,0,0
99581,randomized,0,1
99582,to,0,0
99583,receive,0,0
99584,either,0,0
99585,10,0,0
99586,ml,0,0
99587,0.5,0,0
99588,%,0,0
99589,bupivacaine,0,0
99590,or,0,1
99591,10,0,1
99592,ml,0,0
99593,0.25,0,0
99594,%,0,0
99595,bupivacaine,0,0
99596,.,0,0
99597,PI,0,0
99598,in,0,0
99599,the,0,0
99600,toe,0,0
99601,",",0,0
99602,mean,0,0
99603,arterial,0,1
99604,pressure,0,0
99605,(,0,0
99606,MAP,0,0
99607,),0,0
99608,and,0,0
99609,toe,0,0
99610,temperature,0,0
99611,were,0,0
99612,all,0,0
99613,assessed,0,0
99614,at,0,0
99615,baseline,0,0
99616,and,0,0
99617,at,0,0
99618,5,0,0
99619,",",0,0
99620,10,0,0
99621,and,0,0
99622,20,0,1
99623,min,0,0
99624,following,0,0
99625,epidural,0,0
99626,anesthesia,0,1
99627,.,0,0
99628,The,0,0
99629,effect,0,0
99630,of,0,0
99631,epidural,0,0
99632,anesthesia,0,1
99633,over,0,0
99634,time,0,0
99635,was,0,0
99636,assessed,0,0
99637,by,0,0
99638,repeated,0,0
99639,measures,0,0
99640,analysis,0,0
99641,of,0,0
99642,variance,0,0
99643,.,0,0
99644,Additionally,0,0
99645,",",0,0
99646,we,0,0
99647,defined,0,0
99648,clinically,0,0
99649,evident,0,0
99650,sympathectomy,0,0
99651,criteria,0,1
99652,(,0,0
99653,a,0,0
99654,100,0,0
99655,%,0,0
99656,increase,0,0
99657,in,0,0
99658,the,0,0
99659,PI,0,0
99660,",",0,0
99661,a,0,0
99662,15,0,0
99663,%,0,0
99664,decrease,0,0
99665,in,0,0
99666,MAP,0,0
99667,and,0,0
99668,a,0,0
99669,1,0,0
99670,degrees,0,0
99671,C,0,0
99672,increase,0,0
99673,in,0,0
99674,toe,0,0
99675,temperature,0,1
99676,),0,0
99677,.,0,0
99678,The,0,0
99679,numbers,0,0
99680,of,0,0
99681,patients,0,1
99682,demonstrating,0,0
99683,these,0,0
99684,changes,0,0
99685,for,0,0
99686,each,0,0
99687,test,0,0
99688,were,0,0
99689,compared,0,0
99690,using,0,0
99691,the,0,0
99692,McNemar,0,0
99693,test,0,0
99694,for,0,0
99695,each,0,0
99696,time,0,0
99697,point,0,0
99698,.,0,0
99699,RESULTS,0,0
99700,Twenty-nine,1,1
99701,subjects,1,1
99702,had,0,1
99703,photoplethysmography,0,0
99704,signals,0,0
99705,that,0,0
99706,met,0,1
99707,a,0,0
99708,priori,0,0
99709,signal,0,0
99710,quality,0,0
99711,criteria,0,1
99712,for,0,0
99713,analysis,0,0
99714,.,0,1
99715,By,0,0
99716,20,0,0
99717,min,0,0
99718,",",0,1
99719,PI,0,0
99720,increased,0,0
99721,by,0,0
99722,326,0,1
99723,%,0,0
99724,",",0,0
99725,compared,0,0
99726,with,0,1
99727,a,0,0
99728,10,0,0
99729,%,0,0
99730,decrease,0,0
99731,and,0,0
99732,a,0,0
99733,3,0,0
99734,%,0,0
99735,increase,0,0
99736,in,0,0
99737,MAP,0,0
99738,and,0,0
99739,toe,0,0
99740,temperature,0,0
99741,",",0,0
99742,respectively,0,0
99743,.,0,0
99744,For,0,0
99745,PI,0,0
99746,15/29,0,0
99747,",",0,0
99748,26/29,0,0
99749,and,0,0
99750,29/29,0,0
99751,of,0,0
99752,the,0,0
99753,subjects,0,1
99754,met,0,1
99755,the,0,0
99756,sympathectomy,0,0
99757,criteria,0,1
99758,at,0,0
99759,5,0,1
99760,",",0,0
99761,10,0,0
99762,and,0,0
99763,20,0,0
99764,min,0,0
99765,",",0,0
99766,respectively,0,0
99767,",",0,0
99768,compared,0,0
99769,with,0,1
99770,4/29,0,0
99771,",",0,0
99772,6/29,0,0
99773,and,0,0
99774,18/29,0,0
99775,for,0,0
99776,MAP,0,1
99777,changes,0,0
99778,and,0,0
99779,3/29,0,0
99780,",",0,0
99781,8/29,0,0
99782,and,0,0
99783,14/29,0,0
99784,for,0,0
99785,toe,0,0
99786,temperature,0,1
99787,changes,0,0
99788,.,0,1
99789,CONCLUSIONS,0,0
99790,PI,0,0
99791,was,0,0
99792,an,0,0
99793,earlier,0,0
99794,",",0,0
99795,clearer,0,0
99796,and,0,0
99797,more,0,0
99798,sensitive,0,0
99799,indicator,0,0
99800,of,0,0
99801,the,0,0
99802,development,0,0
99803,of,0,0
99804,epidural-induced,0,0
99805,sympathectomy,0,0
99806,than,0,0
99807,either,0,0
99808,skin,0,0
99809,temperature,0,0
99810,or,0,1
99811,MAP,0,1
99812,.,0,1
99813,The,0,0
99814,influence,0,0
99815,of,0,0
99816,dietary,0,0
99817,fibre,0,0
99818,source,0,0
99819,and,0,0
99820,gender,0,0
99821,on,0,0
99822,the,0,0
99823,postprandial,0,0
99824,glucose,0,0
99825,and,0,0
99826,lipid,0,0
99827,response,0,0
99828,in,0,0
99829,healthy,1,1
99830,subjects,1,1
99831,.,1,1
99832,BACKGROUND,0,0
99833,Consumption,0,0
99834,of,0,0
99835,soluble,0,0
99836,dietary,0,0
99837,fibre,0,0
99838,is,0,0
99839,correlated,0,0
99840,with,0,0
99841,decreased,0,0
99842,postprandial,0,0
99843,glucose,0,0
99844,and,0,0
99845,insulin,0,0
99846,responses,0,0
99847,and,0,0
99848,hence,0,0
99849,has,0,0
99850,beneficial,0,0
99851,effects,0,0
99852,on,0,0
99853,the,0,0
99854,metabolic,0,1
99855,syndrome,0,1
99856,.,0,0
99857,AIM,0,0
99858,OF,0,0
99859,THE,0,0
99860,STUDY,0,0
99861,To,0,0
99862,investigate,0,0
99863,the,0,0
99864,effects,0,0
99865,on,0,0
99866,postprandial,0,0
99867,glucose,0,0
99868,",",0,0
99869,insulin,0,0
99870,and,0,0
99871,triglyceride,0,0
99872,concentrations,0,0
99873,of,0,1
99874,meals,0,1
99875,enriched,0,0
99876,with,0,1
99877,soluble,0,0
99878,dietary,0,0
99879,fibres,0,0
99880,from,0,1
99881,oats,0,1
99882,",",0,0
99883,rye,0,0
99884,bran,0,0
99885,",",0,0
99886,sugar,0,0
99887,beet,0,0
99888,fibre,0,0
99889,or,0,0
99890,a,0,0
99891,mixture,0,0
99892,of,0,0
99893,these,0,0
99894,three,0,0
99895,fibres,0,0
99896,.,0,1
99897,METHODS,0,0
99898,Thirteen,1,1
99899,healthy,1,1
99900,human,1,1
99901,volunteers,1,1
99902,(,1,1
99903,6,1,0
99904,men,1,1
99905,and,1,1
99906,7,1,1
99907,women,1,1
99908,",",1,0
99909,aged,1,1
99910,20-28,1,1
99911,years,1,1
99912,),1,1
99913,were,0,0
99914,included,0,1
99915,in,0,0
99916,the,0,0
99917,study,0,0
99918,.,0,0
99919,The,0,0
99920,subjects,0,1
99921,came,0,1
99922,to,0,0
99923,the,0,0
99924,study,0,0
99925,centre,0,0
99926,once,0,0
99927,a,0,0
99928,week,0,0
99929,after,0,0
99930,an,0,0
99931,overnight,0,0
99932,fast,0,0
99933,to,0,0
99934,ingest,0,1
99935,test,0,0
99936,meals,0,0
99937,and,0,0
99938,a,0,0
99939,control,0,0
99940,meal,0,0
99941,in,0,0
99942,random,0,1
99943,order,0,0
99944,.,0,0
99945,The,0,0
99946,meals,0,0
99947,contained,0,0
99948,either,0,0
99949,oat,0,1
99950,powder,0,0
99951,(,0,0
99952,62,0,0
99953,g,0,0
99954,",",0,0
99955,of,0,0
99956,which,0,0
99957,2.7,0,0
99958,soluble,0,0
99959,fibre,0,0
99960,),0,0
99961,",",0,0
99962,rye,0,0
99963,bran,0,0
99964,(,0,0
99965,31,0,1
99966,g,0,0
99967,",",0,0
99968,of,0,0
99969,which,0,0
99970,1.7,0,0
99971,g,0,1
99972,soluble,0,0
99973,fibre,0,0
99974,),0,0
99975,",",0,0
99976,sugar,0,0
99977,beet,0,0
99978,fibre,0,0
99979,(,0,0
99980,19,0,1
99981,g,0,0
99982,",",0,0
99983,of,0,0
99984,which,0,0
99985,5,0,0
99986,g,0,1
99987,soluble,0,0
99988,fibre,0,0
99989,),0,0
99990,",",0,0
99991,a,0,0
99992,mixture,0,0
99993,of,0,0
99994,these,0,0
99995,three,0,0
99996,fibres,0,0
99997,(,0,1
99998,74,0,1
99999,g,0,0
100000,",",0,0
100001,of,0,0
100002,which,0,0
100003,1.7,0,0
100004,g,0,1
100005,soluble,0,0
100006,fibre,0,0
100007,from,0,0
100008,each,0,0
100009,source,0,0
100010,",",0,0
100011,giving,0,0
100012,5,0,0
100013,g,0,1
100014,soluble,0,0
100015,fibre,0,0
100016,),0,0
100017,or,0,0
100018,no,0,0
100019,added,0,0
100020,fibre,0,0
100021,(,0,0
100022,control,0,0
100023,),0,0
100024,and,0,0
100025,were,0,0
100026,all,0,0
100027,adjusted,0,0
100028,to,0,0
100029,contain,0,0
100030,the,0,0
100031,same,0,0
100032,total,0,1
100033,amount,0,0
100034,of,0,0
100035,available,0,0
100036,carbohydrates,0,0
100037,.,0,1
100038,Blood,0,0
100039,samples,0,0
100040,were,0,0
100041,drawn,0,0
100042,before,0,0
100043,and,0,0
100044,every,0,0
100045,30,0,0
100046,min,0,0
100047,up,0,0
100048,to,0,0
100049,180,0,0
100050,min,0,0
100051,after,0,0
100052,the,0,0
100053,meals,0,0
100054,.,0,1
100055,RESULTS,0,0
100056,Meals,0,0
100057,with,0,1
100058,rye,0,0
100059,bran,0,0
100060,gave,0,0
100061,a,0,0
100062,lower,0,0
100063,postprandial,0,0
100064,glucose,0,0
100065,peak,0,0
100066,when,0,0
100067,compared,0,0
100068,with,0,0
100069,the,0,0
100070,control,0,0
100071,meal,0,0
100072,",",0,0
100073,and,0,0
100074,this,0,0
100075,effect,0,0
100076,was,0,0
100077,more,0,0
100078,pronounced,0,0
100079,in,0,0
100080,women,0,1
100081,compared,0,0
100082,to,0,1
100083,men,0,1
100084,.,0,1
100085,Oat,0,0
100086,powder,0,0
100087,",",0,0
100088,containing,0,0
100089,a,0,0
100090,low,0,0
100091,amount,0,0
100092,of,0,0
100093,total,0,1
100094,fibre,0,0
100095,and,0,0
100096,a,0,0
100097,high,0,0
100098,amount,0,0
100099,of,0,0
100100,carbohydrates,0,0
100101,in,0,0
100102,liquid,0,0
100103,matrix,0,0
100104,",",0,0
100105,gave,0,0
100106,a,0,0
100107,higher,0,0
100108,incremental,0,0
100109,glucose,0,0
100110,peak,0,0
100111,concentration,0,0
100112,compared,0,0
100113,to,0,0
100114,rye,0,0
100115,bran,0,0
100116,and,0,0
100117,sugar,0,0
100118,beet,0,0
100119,fibre,0,0
100120,and,0,0
100121,higher,0,0
100122,insulin,0,0
100123,incremental,0,0
100124,area,0,0
100125,under,0,0
100126,curve,0,0
100127,compared,0,0
100128,to,0,0
100129,control,0,0
100130,.,0,0
100131,The,0,0
100132,oat,0,0
100133,powder,0,0
100134,also,0,0
100135,influenced,0,0
100136,the,0,0
100137,effects,0,0
100138,of,0,0
100139,the,0,0
100140,mixed,0,0
100141,meal,0,0
100142,",",0,0
100143,diminishing,0,0
100144,the,0,0
100145,glucose-lowering,0,0
100146,effects,0,0
100147,.,0,1
100148,Postprandial,0,0
100149,triglyceride,0,0
100150,levels,0,0
100151,tended,0,0
100152,to,0,0
100153,be,0,0
100154,higher,0,0
100155,after,0,0
100156,all,0,0
100157,fibre-rich,0,0
100158,meals,0,0
100159,",",0,0
100160,but,0,0
100161,only,0,0
100162,significant,0,0
100163,for,0,0
100164,oat,0,1
100165,powder,0,0
100166,and,0,0
100167,the,0,0
100168,mixed,0,0
100169,meal,0,0
100170,when,0,0
100171,compared,0,0
100172,with,0,0
100173,the,0,0
100174,control,0,0
100175,meal,0,0
100176,.,0,1
100177,CONCLUSIONS,0,0
100178,Postprandial,0,0
100179,glucose,0,0
100180,",",0,0
100181,insulin,0,0
100182,and,0,0
100183,triglyceride,0,0
100184,concentrations,0,0
100185,are,0,0
100186,influenced,0,0
100187,by,0,0
100188,dietary,0,0
100189,fibre-rich,0,0
100190,meals,0,0
100191,",",0,0
100192,depending,0,0
100193,on,0,0
100194,fibre,0,0
100195,source,0,0
100196,",",0,0
100197,dose,0,0
100198,of,0,0
100199,soluble,0,0
100200,and,0,0
100201,total,0,1
100202,fibre,0,0
100203,and,0,0
100204,possibly,0,0
100205,gender,0,0
100206,.,0,0
100207,Effects,0,0
100208,of,0,1
100209,dietary,0,0
100210,coconut,0,0
100211,oil,0,0
100212,on,0,0
100213,the,0,0
100214,biochemical,0,0
100215,and,0,0
100216,anthropometric,0,1
100217,profiles,0,0
100218,of,0,1
100219,women,1,1
100220,presenting,1,1
100221,abdominal,1,1
100222,obesity,1,1
100223,.,1,0
100224,The,0,0
100225,effects,0,0
100226,of,0,0
100227,dietary,0,0
100228,supplementation,0,0
100229,with,0,1
100230,coconut,0,0
100231,oil,0,0
100232,on,0,0
100233,the,0,0
100234,biochemical,0,0
100235,and,0,0
100236,anthropometric,0,1
100237,profiles,0,0
100238,of,0,1
100239,women,1,1
100240,presenting,1,1
100241,waist,1,0
100242,circumferences,1,0
100243,(,1,1
100244,WC,1,1
100245,),1,0
100246,>,1,1
100247,88,1,0
100248,cm,1,1
100249,(,1,0
100250,abdominal,1,1
100251,obesity,1,1
100252,),1,0
100253,were,0,0
100254,investigated,0,0
100255,.,0,0
100256,The,0,0
100257,randomised,0,0
100258,",",0,0
100259,double-blind,0,0
100260,",",0,0
100261,clinical,0,0
100262,trial,0,0
100263,involved,0,0
100264,40,1,1
100265,women,1,1
100266,aged,1,1
100267,20-40,1,1
100268,years,1,1
100269,.,1,1
100270,Groups,0,0
100271,received,0,0
100272,daily,0,0
100273,dietary,0,0
100274,supplements,0,0
100275,comprising,0,1
100276,30,0,1
100277,mL,0,0
100278,of,0,0
100279,either,0,0
100280,soy,0,0
100281,bean,0,0
100282,oil,0,0
100283,(,0,0
100284,group,0,1
100285,S,0,0
100286,;,0,0
100287,n,0,1
100288,=,0,0
100289,20,0,1
100290,),0,0
100291,or,0,1
100292,coconut,0,0
100293,oil,0,0
100294,(,0,0
100295,group,0,1
100296,C,0,0
100297,;,0,0
100298,n,0,1
100299,=,0,0
100300,20,0,1
100301,),0,0
100302,over,0,0
100303,a,0,0
100304,12-week,0,0
100305,period,0,0
100306,",",0,0
100307,during,0,0
100308,which,0,0
100309,all,0,1
100310,subjects,0,1
100311,were,0,0
100312,instructed,0,0
100313,to,0,0
100314,follow,0,0
100315,a,0,0
100316,balanced,0,0
100317,hypocaloric,0,0
100318,diet,0,1
100319,and,0,0
100320,to,0,0
100321,walk,0,0
100322,for,0,0
100323,50,0,1
100324,min,0,0
100325,per,0,1
100326,day,0,0
100327,.,0,1
100328,Data,0,0
100329,were,0,0
100330,collected,0,1
100331,1,0,0
100332,week,0,0
100333,before,0,0
100334,(,0,0
100335,T1,0,0
100336,),0,0
100337,and,0,0
100338,1,0,0
100339,week,0,0
100340,after,0,0
100341,(,0,0
100342,T2,0,1
100343,),0,0
100344,dietary,0,0
100345,intervention,0,0
100346,.,0,1
100347,Energy,0,0
100348,intake,0,0
100349,and,0,0
100350,amount,0,0
100351,of,0,0
100352,carbohydrate,0,0
100353,ingested,0,1
100354,by,0,0
100355,both,0,0
100356,groups,0,0
100357,diminished,0,0
100358,over,0,0
100359,the,0,0
100360,trial,0,0
100361,",",0,0
100362,whereas,0,0
100363,the,0,0
100364,consumption,0,0
100365,of,0,0
100366,protein,0,0
100367,and,0,0
100368,fibre,0,0
100369,increased,0,0
100370,and,0,0
100371,lipid,0,0
100372,ingestion,0,0
100373,remained,0,0
100374,unchanged,0,0
100375,.,0,1
100376,At,0,0
100377,T1,0,0
100378,there,0,0
100379,were,0,0
100380,no,0,0
100381,differences,0,0
100382,in,0,0
100383,biochemical,0,0
100384,or,0,1
100385,anthropometric,0,1
100386,characteristics,0,0
100387,between,0,0
100388,the,0,0
100389,groups,0,0
100390,",",0,0
100391,whereas,0,0
100392,at,0,0
100393,T2,0,1
100394,group,0,1
100395,C,0,0
100396,presented,0,0
100397,a,0,0
100398,higher,0,0
100399,level,0,0
100400,of,0,0
100401,HDL,0,0
100402,(,0,1
100403,48.7,0,1
100404,+/-,0,0
100405,2.4,0,0
100406,vs.,0,0
100407,45.00,0,0
100408,+/-,0,0
100409,5.6,0,0
100410,;,0,1
100411,P,0,0
100412,=,0,0
100413,0.01,0,0
100414,),0,0
100415,and,0,0
100416,a,0,0
100417,lower,0,0
100418,LDL,0,0
100419,:,0,1
100420,HDL,0,0
100421,ratio,0,0
100422,(,0,0
100423,2.41,0,0
100424,+/-,0,0
100425,0.8,0,1
100426,vs.,0,0
100427,3.1,0,0
100428,+/-,0,0
100429,0.8,0,1
100430,;,0,1
100431,P,0,0
100432,=,0,0
100433,0.04,0,0
100434,),0,1
100435,.,0,0
100436,Reductions,0,0
100437,in,0,1
100438,BMI,0,1
100439,were,0,0
100440,observed,0,0
100441,in,0,0
100442,both,0,0
100443,groups,0,0
100444,at,0,0
100445,T2,0,1
100446,(,0,1
100447,P,0,0
100448,<,0,0
100449,0.05,0,0
100450,),0,0
100451,",",0,0
100452,but,0,0
100453,only,0,0
100454,group,0,0
100455,C,0,0
100456,exhibited,0,0
100457,a,0,0
100458,reduction,0,0
100459,in,0,0
100460,WC,0,1
100461,(,0,1
100462,P,0,0
100463,=,0,0
100464,0.005,0,0
100465,),0,1
100466,.,0,1
100467,Group,0,0
100468,S,0,0
100469,presented,0,0
100470,an,0,0
100471,increase,0,0
100472,(,0,0
100473,P,0,0
100474,<,0,0
100475,0.05,0,0
100476,),0,0
100477,in,0,0
100478,total,0,1
100479,cholesterol,0,0
100480,",",0,0
100481,LDL,0,0
100482,and,0,0
100483,LDL,0,1
100484,:,0,1
100485,HDL,0,0
100486,ratio,0,0
100487,",",0,1
100488,whilst,0,0
100489,HDL,0,1
100490,diminished,0,1
100491,(,0,0
100492,P,0,0
100493,=,0,0
100494,0.03,0,0
100495,),0,1
100496,.,0,1
100497,Such,0,1
100498,alterations,0,0
100499,were,0,1
100500,not,0,0
100501,observed,0,0
100502,in,0,0
100503,group,0,0
100504,C.,0,0
100505,It,0,0
100506,appears,0,0
100507,that,0,0
100508,dietetic,0,1
100509,supplementation,0,0
100510,with,0,1
100511,coconut,0,0
100512,oil,0,0
100513,does,0,0
100514,not,0,0
100515,cause,0,0
100516,dyslipidemia,0,0
100517,and,0,0
100518,seems,0,0
100519,to,0,0
100520,promote,0,0
100521,a,0,0
100522,reduction,0,0
100523,in,0,0
100524,abdominal,0,1
100525,obesity,0,1
100526,.,0,1
100527,Lack,0,1
100528,of,0,0
100529,efficacy,0,0
100530,of,0,0
100531,citalopram,0,0
100532,in,0,0
100533,children,1,1
100534,with,1,1
100535,autism,1,1
100536,spectrum,1,1
100537,disorders,1,1
100538,and,1,1
100539,high,1,1
100540,levels,1,0
100541,of,1,0
100542,repetitive,1,0
100543,behavior,1,0
100544,:,1,1
100545,citalopram,0,0
100546,ineffective,0,0
100547,in,0,0
100548,children,1,1
100549,with,1,1
100550,autism,1,1
100551,.,1,1
100552,CONTEXT,0,0
100553,Selective,0,0
100554,serotonin,0,0
100555,reuptake,0,0
100556,inhibitors,0,0
100557,are,0,0
100558,widely,0,0
100559,prescribed,0,0
100560,for,0,0
100561,children,1,1
100562,with,1,1
100563,autism,1,1
100564,spectrum,1,1
100565,disorders,1,1
100566,.,1,1
100567,OBJECTIVES,0,0
100568,To,0,0
100569,determine,0,0
100570,the,0,0
100571,efficacy,0,0
100572,and,0,0
100573,safety,0,0
100574,of,0,0
100575,citalopram,0,0
100576,hydrobromide,0,0
100577,therapy,0,0
100578,for,0,0
100579,repetitive,0,0
100580,behavior,0,0
100581,in,0,0
100582,children,1,1
100583,with,1,1
100584,autism,1,1
100585,spectrum,1,1
100586,disorders,1,1
100587,.,1,1
100588,DESIGN,0,0
100589,National,0,0
100590,Institutes,0,1
100591,of,0,1
100592,Health-sponsored,0,1
100593,randomized,0,1
100594,controlled,0,0
100595,trial,0,0
100596,.,0,0
100597,SETTING,0,1
100598,Six,1,0
100599,academic,1,1
100600,centers,1,1
100601,",",1,0
100602,including,1,0
100603,Mount,1,0
100604,Sinai,1,1
100605,School,1,1
100606,of,1,0
100607,Medicine,1,1
100608,",",1,0
100609,North,1,1
100610,Shore-Long,1,1
100611,Island,1,1
100612,Jewish,1,1
100613,Health,1,0
100614,System,1,1
100615,",",1,0
100616,University,1,1
100617,of,1,0
100618,North,1,1
100619,Carolina,1,1
100620,at,1,0
100621,Chapel,1,1
100622,Hill,1,0
100623,",",1,0
100624,University,1,1
100625,of,1,0
100626,California,1,1
100627,at,1,0
100628,Los,1,1
100629,Angeles,1,1
100630,",",1,0
100631,Yale,1,0
100632,University,1,1
100633,",",1,0
100634,and,1,0
100635,Dartmouth,1,1
100636,Medical,1,1
100637,School,1,1
100638,.,1,1
100639,PARTICIPANTS,0,0
100640,One,1,1
100641,hundred,1,1
100642,forty-nine,1,1
100643,volunteers,1,1
100644,5,1,1
100645,to,1,1
100646,17,1,1
100647,years,1,1
100648,old,1,1
100649,(,1,1
100650,mean,1,1
100651,[,1,0
100652,SD,1,1
100653,],1,0
100654,age,1,1
100655,",",1,0
100656,9.4,1,0
100657,[,1,0
100658,3.1,1,0
100659,],1,1
100660,years,1,1
100661,),1,1
100662,were,0,0
100663,randomized,0,0
100664,to,0,0
100665,receive,0,0
100666,citalopram,0,0
100667,(,0,0
100668,n,0,1
100669,=,0,0
100670,73,0,1
100671,),0,0
100672,or,0,1
100673,placebo,0,0
100674,(,0,0
100675,n,0,1
100676,=,0,0
100677,76,0,1
100678,),0,1
100679,.,0,1
100680,Participants,1,1
100681,had,1,1
100682,autistic,1,1
100683,spectrum,1,1
100684,disorders,1,1
100685,",",1,0
100686,Asperger,1,1
100687,disorder,1,1
100688,",",1,0
100689,or,1,0
100690,pervasive,1,1
100691,developmental,1,1
100692,disorder,1,1
100693,",",1,0
100694,not,1,0
100695,otherwise,1,1
100696,specified,1,0
100697,;,1,0
100698,had,1,0
100699,illness,1,1
100700,severity,1,0
100701,ratings,1,0
100702,of,1,0
100703,at,1,0
100704,least,1,1
100705,moderate,1,1
100706,on,1,0
100707,the,1,0
100708,Clinical,1,0
100709,Global,1,1
100710,Impressions,1,0
100711,",",1,0
100712,Severity,1,0
100713,of,1,0
100714,Illness,1,0
100715,Scale,1,0
100716,;,1,0
100717,and,1,0
100718,scored,1,0
100719,at,1,0
100720,least,1,1
100721,moderate,1,1
100722,on,1,0
100723,compulsive,1,1
100724,behaviors,1,0
100725,measured,1,0
100726,with,1,1
100727,the,1,0
100728,Children,1,1
100729,'s,1,1
100730,Yale-Brown,1,0
100731,Obsessive,1,1
100732,Compulsive,1,1
100733,Scales,1,0
100734,modified,1,0
100735,for,1,0
100736,pervasive,1,1
100737,developmental,1,1
100738,disorders,1,1
100739,.,1,1
100740,INTERVENTIONS,0,0
100741,Twelve,0,1
100742,weeks,0,0
100743,of,0,0
100744,citalopram,0,0
100745,hydrobromide,0,0
100746,(,0,0
100747,10,0,0
100748,mg/5,0,0
100749,mL,0,0
100750,),0,0
100751,or,0,1
100752,placebo,0,0
100753,.,0,0
100754,The,0,0
100755,mean,0,0
100756,(,0,0
100757,SD,0,0
100758,),0,0
100759,maximum,0,0
100760,dosage,0,0
100761,of,0,0
100762,citalopram,0,0
100763,hydrobromide,0,0
100764,was,0,0
100765,16.5,0,0
100766,(,0,1
100767,6.5,0,0
100768,),0,0
100769,mg/d,0,0
100770,by,0,0
100771,mouth,0,0
100772,(,0,0
100773,maximum,0,0
100774,",",0,0
100775,20,0,1
100776,mg/d,0,0
100777,),0,1
100778,.,0,1
100779,MAIN,0,0
100780,OUTCOME,0,0
100781,MEASURES,0,0
100782,Positive,0,1
100783,response,0,0
100784,was,0,0
100785,defined,0,0
100786,by,0,0
100787,a,0,0
100788,score,0,0
100789,of,0,0
100790,much,0,0
100791,improved,0,0
100792,or,0,1
100793,very,0,0
100794,much,0,0
100795,improved,0,0
100796,on,0,0
100797,the,0,0
100798,Clinical,0,0
100799,Global,0,1
100800,Impressions,0,0
100801,",",0,0
100802,Improvement,0,0
100803,subscale,0,0
100804,.,0,0
100805,An,0,0
100806,important,0,0
100807,secondary,0,0
100808,outcome,0,0
100809,was,0,0
100810,the,0,0
100811,score,0,0
100812,on,0,0
100813,the,0,0
100814,Children,0,1
100815,'s,0,1
100816,Yale-Brown,0,0
100817,Obsessive,0,1
100818,Compulsive,0,1
100819,Scales,0,0
100820,modified,0,0
100821,for,0,0
100822,pervasive,0,1
100823,developmental,0,1
100824,disorders,0,1
100825,.,0,1
100826,Adverse,0,0
100827,events,0,0
100828,were,0,1
100829,systematically,0,0
100830,elicited,0,0
100831,using,0,0
100832,the,0,0
100833,Safety,0,0
100834,Monitoring,0,0
100835,Uniform,0,1
100836,Report,0,1
100837,Form,0,1
100838,.,0,1
100839,RESULTS,0,0
100840,There,0,0
100841,was,0,0
100842,no,0,0
100843,significant,0,0
100844,difference,0,0
100845,in,0,0
100846,the,0,0
100847,rate,0,0
100848,of,0,0
100849,positive,0,0
100850,response,0,0
100851,on,0,0
100852,the,0,0
100853,Clinical,0,0
100854,Global,0,1
100855,Impressions,0,0
100856,",",0,0
100857,Improvement,0,0
100858,subscale,0,0
100859,between,0,0
100860,the,0,0
100861,citalopram-treated,0,0
100862,group,0,0
100863,(,0,0
100864,32.9,0,0
100865,%,0,0
100866,),0,0
100867,and,0,0
100868,the,0,0
100869,placebo,0,0
100870,group,0,0
100871,(,0,0
100872,34.2,0,0
100873,%,0,0
100874,),0,0
100875,(,0,0
100876,relative,0,0
100877,risk,0,0
100878,",",0,0
100879,0.96,0,0
100880,;,0,0
100881,95,0,0
100882,%,0,0
100883,confidence,0,0
100884,interval,0,0
100885,",",0,0
100886,0.61-1.51,0,0
100887,;,0,0
100888,P,0,0
100889,>,0,1
100890,.99,0,0
100891,),0,0
100892,.,0,0
100893,There,0,0
100894,was,0,0
100895,no,0,0
100896,difference,0,0
100897,in,0,0
100898,score,0,0
100899,reduction,0,0
100900,on,0,0
100901,the,0,0
100902,Children,0,1
100903,'s,0,1
100904,Yale-Brown,0,0
100905,Obsessive,0,1
100906,Compulsive,0,1
100907,Scales,0,0
100908,modified,0,0
100909,for,0,0
100910,pervasive,0,1
100911,developmental,0,1
100912,disorders,0,1
100913,from,0,1
100914,baseline,0,0
100915,(,0,0
100916,mean,0,1
100917,[,0,0
100918,SD,0,0
100919,],0,0
100920,",",0,0
100921,-2.0,0,0
100922,[,0,0
100923,3.4,0,0
100924,],0,0
100925,points,0,0
100926,for,0,0
100927,the,0,0
100928,citalopram-treated,0,0
100929,group,0,0
100930,and,0,0
100931,-1.9,0,0
100932,[,0,0
100933,2.5,0,0
100934,],0,1
100935,points,0,0
100936,for,0,0
100937,the,0,0
100938,placebo,0,0
100939,group,0,0
100940,;,0,0
100941,P,0,0
100942,=,0,0
100943,.81,0,0
100944,),0,1
100945,.,0,0
100946,Citalopram,0,0
100947,use,0,0
100948,was,0,0
100949,significantly,0,0
100950,more,0,0
100951,likely,0,0
100952,to,0,0
100953,be,0,0
100954,associated,0,0
100955,with,0,1
100956,adverse,0,0
100957,events,0,0
100958,",",0,0
100959,particularly,0,0
100960,increased,0,0
100961,energy,0,0
100962,level,0,0
100963,",",0,0
100964,impulsiveness,0,0
100965,",",0,0
100966,decreased,0,0
100967,concentration,0,0
100968,",",0,0
100969,hyperactivity,0,0
100970,",",0,0
100971,stereotypy,0,0
100972,",",0,0
100973,diarrhea,0,1
100974,",",0,0
100975,insomnia,0,0
100976,",",0,0
100977,and,0,0
100978,dry,0,1
100979,skin,0,0
100980,or,0,1
100981,pruritus,0,0
100982,.,0,1
100983,CONCLUSION,0,0
100984,Results,0,0
100985,of,0,0
100986,this,0,0
100987,trial,0,0
100988,do,0,0
100989,not,0,0
100990,support,0,0
100991,the,0,0
100992,use,0,0
100993,of,0,0
100994,citalopram,0,0
100995,for,0,0
100996,the,0,0
100997,treatment,0,0
100998,of,0,0
100999,repetitive,0,0
101000,behavior,0,0
101001,in,0,0
101002,children,0,1
101003,and,0,1
101004,adolescents,0,1
101005,with,0,1
101006,autism,0,1
101007,spectrum,0,1
101008,disorders,0,1
101009,.,0,1
101010,Trial,0,0
101011,Registration,0,0
101012,clinicaltrials.gov,0,1
101013,Identifier,0,1
101014,:,0,1
101015,NCT00086645,0,0
101016,.,0,1
101017,Loss,0,0
101018,of,0,0
101019,bone,0,0
101020,mineral,0,1
101021,density,0,0
101022,after,0,0
101023,antiretroviral,0,1
101024,therapy,0,0
101025,initiation,0,0
101026,",",0,0
101027,independent,0,0
101028,of,0,0
101029,antiretroviral,0,1
101030,regimen,0,0
101031,.,0,1
101032,BACKGROUND,0,0
101033,Decreased,0,0
101034,bone,0,0
101035,mineral,0,1
101036,density,0,0
101037,(,0,0
101038,BMD,0,0
101039,),0,0
101040,has,0,0
101041,been,0,0
101042,described,0,0
101043,in,0,0
101044,HIV-infected,1,1
101045,patients,1,1
101046,initiating,1,1
101047,antiretroviral,1,1
101048,therapy,1,0
101049,(,1,0
101050,ART,1,0
101051,),1,0
101052,",",0,0
101053,but,0,0
101054,the,0,0
101055,contributions,0,0
101056,of,0,0
101057,ART,0,1
101058,and,0,0
101059,immunologic,0,0
101060,and/or,0,1
101061,virologic,0,0
101062,factors,0,0
101063,remain,0,0
101064,unclear,0,0
101065,.,0,1
101066,METHODS,0,0
101067,We,0,0
101068,compared,0,0
101069,total,0,1
101070,BMD,0,0
101071,changes,0,0
101072,over,0,0
101073,96,0,1
101074,weeks,0,0
101075,in,0,1
101076,106,1,1
101077,ART-naive,1,1
101078,HIV-infected,1,1
101079,subjects,1,1
101080,who,1,1
101081,were,1,1
101082,randomized,1,1
101083,to,1,0
101084,receive,1,0
101085,efavirenz,1,1
101086,(,1,0
101087,EFV,1,1
101088,),1,0
101089,+,1,0
101090,zidovudine/lamivudine,1,0
101091,(,1,0
101092,n,1,1
101093,=,1,0
101094,32,1,1
101095,),1,0
101096,or,1,1
101097,lopinavir/ritonavir,1,0
101098,(,1,0
101099,LPV/r,1,0
101100,),1,0
101101,+,1,0
101102,zidovudine/lamivudine,1,0
101103,induction,1,0
101104,(,1,0
101105,n,1,1
101106,=,1,0
101107,74,1,1
101108,),1,0
101109,for,1,0
101110,24-48,1,0
101111,weeks,1,0
101112,followed,1,0
101113,by,1,0
101114,LPV/r,1,0
101115,monotherapy,1,1
101116,.,1,0
101117,We,0,0
101118,also,0,0
101119,sought,0,0
101120,to,0,0
101121,identify,0,0
101122,factors,0,0
101123,associated,0,0
101124,with,0,1
101125,BMD,0,0
101126,loss,0,0
101127,",",0,0
101128,including,0,0
101129,markers,0,0
101130,of,0,0
101131,systemic,0,0
101132,inflammation,0,0
101133,[,0,0
101134,soluble,0,0
101135,tumor,0,1
101136,necrosis,0,0
101137,factor-alpha,0,0
101138,receptors,0,0
101139,(,0,0
101140,sTNFR,0,0
101141,I,0,1
101142,and,0,0
101143,II,0,1
101144,),0,0
101145,],0,0
101146,.,0,0
101147,RESULTS,0,0
101148,After,0,0
101149,96,0,1
101150,weeks,0,0
101151,",",0,0
101152,the,0,0
101153,mean,0,0
101154,percent,0,0
101155,change,0,0
101156,from,0,0
101157,baseline,0,0
101158,in,0,0
101159,total,0,1
101160,BMD,0,1
101161,was,0,0
101162,-2.5,0,0
101163,%,0,0
101164,(,0,0
101165,LPV/r,0,0
101166,),0,0
101167,and,0,0
101168,-2.3,0,0
101169,%,0,0
101170,(,0,0
101171,EFV,0,1
101172,),0,0
101173,(,0,0
101174,P,0,0
101175,<,0,0
101176,0.01,0,0
101177,for,0,0
101178,within-group,0,0
101179,changes,0,0
101180,in,0,0
101181,either,0,1
101182,arm,0,0
101183,;,0,0
101184,P,0,0
101185,=,0,0
101186,0.86,0,0
101187,for,0,0
101188,between-group,0,0
101189,differences,0,0
101190,),0,1
101191,.,0,0
101192,No,0,0
101193,alteration,0,0
101194,in,0,0
101195,the,0,0
101196,rate,0,0
101197,of,0,0
101198,BMD,0,0
101199,change,0,0
101200,was,0,0
101201,observed,0,0
101202,upon,0,0
101203,simplification,0,0
101204,to,0,0
101205,LPV/r,0,0
101206,monotherapy,0,0
101207,.,0,0
101208,Although,0,0
101209,soluble,0,0
101210,tumor,0,1
101211,necrosis,0,0
101212,factor-alpha,0,0
101213,receptor,0,1
101214,II,0,1
101215,concentrations,0,0
101216,at,0,0
101217,baseline,0,0
101218,and,0,0
101219,24,0,1
101220,weeks,0,0
101221,were,0,1
101222,at,0,0
101223,least,0,0
101224,marginally,0,0
101225,associated,0,0
101226,with,0,1
101227,subsequent,0,0
101228,changes,0,0
101229,in,0,0
101230,BMD,0,1
101231,(,0,1
101232,P,0,0
101233,=,0,0
101234,0.06,0,0
101235,and,0,0
101236,P,0,0
101237,=,0,0
101238,0.028,0,0
101239,",",0,0
101240,respectively,0,0
101241,),0,0
101242,",",0,0
101243,these,0,0
101244,associations,0,0
101245,were,0,0
101246,no,0,0
101247,longer,0,0
101248,significant,0,0
101249,after,0,0
101250,adjustment,0,0
101251,for,0,0
101252,CD4,0,1
101253,T,0,1
101254,cell,0,1
101255,count,0,0
101256,.,0,0
101257,Subjects,1,0
101258,with,1,1
101259,lower,1,0
101260,baseline,1,0
101261,CD4,1,1
101262,T,1,1
101263,cell,1,0
101264,count,1,0
101265,",",1,0
101266,non-black,1,1
101267,race,1,0
101268,",",1,0
101269,and,1,0
101270,higher,1,0
101271,baseline,1,0
101272,glucose,1,0
101273,demonstrated,0,0
101274,a,0,0
101275,higher,0,0
101276,risk,0,0
101277,for,0,0
101278,>,0,1
101279,5,0,0
101280,%,0,0
101281,decrease,0,0
101282,in,0,0
101283,BMD,0,0
101284,.,0,1
101285,CONCLUSIONS,0,0
101286,Similar,0,0
101287,decreases,0,0
101288,in,0,0
101289,BMD,0,1
101290,over,0,0
101291,96,0,1
101292,weeks,0,0
101293,occurred,0,0
101294,in,0,0
101295,ART-naive,1,1
101296,subjects,1,1
101297,receiving,0,1
101298,either,0,1
101299,EFV-based,0,0
101300,regimen,0,0
101301,or,0,1
101302,LPV/r-based,0,0
101303,regimen,0,0
101304,",",0,0
101305,which,0,0
101306,was,0,0
101307,not,0,0
101308,altered,0,0
101309,by,0,0
101310,simplification,0,0
101311,to,0,0
101312,LPV/r,0,0
101313,monotherapy,0,0
101314,and,0,0
101315,was,0,0
101316,unrelated,0,1
101317,to,0,0
101318,markers,0,0
101319,of,0,0
101320,tumor,0,1
101321,necrosis,0,0
101322,factor-alpha,0,0
101323,activity,0,0
101324,.,0,1
101325,Leucocyte,0,0
101326,depletion,0,0
101327,of,0,0
101328,perioperative,0,0
101329,blood,0,0
101330,transfusion,0,0
101331,does,0,0
101332,not,0,0
101333,affect,0,0
101334,long-term,0,0
101335,survival,0,0
101336,and,0,0
101337,recurrence,0,0
101338,in,0,0
101339,patients,1,1
101340,with,1,1
101341,gastrointestinal,1,1
101342,cancer,1,1
101343,.,1,1
101344,BACKGROUND,0,0
101345,Perioperative,0,0
101346,red,0,1
101347,blood,0,0
101348,cell,0,1
101349,(,0,0
101350,RBC,0,0
101351,),0,0
101352,transfusion,0,0
101353,may,0,0
101354,be,0,0
101355,associated,0,0
101356,with,0,0
101357,a,0,0
101358,poor,0,0
101359,prognosis,0,0
101360,in,0,0
101361,cancer,0,1
101362,surgery,0,1
101363,.,0,1
101364,Allogeneic,0,0
101365,leucocytes,0,0
101366,are,0,0
101367,assumed,0,0
101368,to,0,0
101369,play,0,0
101370,a,0,0
101371,causal,0,0
101372,role,0,0
101373,.,0,0
101374,This,0,0
101375,study,0,0
101376,evaluated,0,0
101377,the,0,0
101378,long-term,0,0
101379,effect,0,0
101380,of,0,0
101381,transfusion,0,0
101382,with,0,1
101383,leucocyte-depleted,0,0
101384,(,0,1
101385,LD,0,0
101386,),0,0
101387,blood,0,0
101388,in,0,0
101389,patients,1,1
101390,with,1,1
101391,gastrointestinal,1,1
101392,cancer,1,1
101393,.,1,1
101394,METHODS,0,0
101395,The,0,0
101396,Transfusion,0,1
101397,Associated,0,0
101398,Complications,0,0
101399,=,0,0
101400,Transfusion,0,1
101401,Induced,0,1
101402,Complications,0,0
101403,?,0,0
101404,(,0,0
101405,TACTIC,0,0
101406,),0,0
101407,study,0,0
101408,is,0,0
101409,a,0,0
101410,multicentre,0,0
101411,randomized,0,0
101412,controlled,0,0
101413,trial,0,0
101414,evaluating,0,0
101415,the,0,0
101416,short-term,0,0
101417,benefits,0,0
101418,of,0,0
101419,LD,0,0
101420,versus,0,0
101421,non-LD,0,1
101422,RBC,0,0
101423,transfusions,0,0
101424,.,0,1
101425,The,0,0
101426,present,0,0
101427,study,0,0
101428,evaluated,0,0
101429,5-year,0,0
101430,survival,0,0
101431,and,0,0
101432,cancer,0,1
101433,recurrence,0,0
101434,among,1,0
101435,512,1,1
101436,patients,1,1
101437,with,1,1
101438,gastrointestinal,1,1
101439,cancer,1,1
101440,included,1,1
101441,in,1,0
101442,the,1,0
101443,TACTIC,1,0
101444,study,1,0
101445,.,1,0
101446,RESULTS,0,0
101447,Some,0,0
101448,89.2,1,0
101449,per,1,0
101450,cent,1,0
101451,of,1,0
101452,patients,1,1
101453,had,1,1
101454,a,1,0
101455,primary,1,0
101456,tumour,1,0
101457,and,1,0
101458,79.7,1,0
101459,per,1,0
101460,cent,1,0
101461,underwent,1,1
101462,surgery,1,1
101463,with,1,1
101464,curative,1,1
101465,intent,1,1
101466,;,1,1
101467,243,1,1
101468,patients,1,1
101469,received,1,1
101470,perioperative,1,0
101471,RBC,1,0
101472,transfusion,1,0
101473,(,1,0
101474,median,1,1
101475,3,1,1
101476,units,1,1
101477,),1,1
101478,.,1,1
101479,The,0,0
101480,5-year,0,0
101481,overall,0,0
101482,survival,0,0
101483,rate,0,0
101484,of,0,0
101485,patients,0,1
101486,with,0,1
101487,any,0,0
101488,type,0,1
101489,of,0,0
101490,gastrointestinal,0,1
101491,cancer,0,1
101492,was,0,0
101493,50.8,0,0
101494,per,0,0
101495,cent,0,0
101496,in,0,0
101497,the,0,0
101498,LD,1,0
101499,group,1,0
101500,and,0,0
101501,45.8,0,1
101502,per,0,0
101503,cent,0,0
101504,in,0,0
101505,the,0,0
101506,non-LD,1,1
101507,group,1,0
101508,(,0,0
101509,P,0,0
101510,=,0,0
101511,0.191,0,0
101512,),0,0
101513,.,0,1
101514,Corresponding,0,0
101515,5-year,0,0
101516,disease-free,0,0
101517,survival,0,0
101518,rates,0,0
101519,were,0,1
101520,60.0,0,0
101521,and,0,0
101522,56.6,0,1
101523,per,0,0
101524,cent,0,0
101525,(,0,0
101526,P,0,0
101527,=,0,0
101528,0.482,0,0
101529,),0,0
101530,",",0,0
101531,and,0,0
101532,recurrence,0,0
101533,rates,0,0
101534,32.9,0,1
101535,and,0,1
101536,34.3,0,0
101537,per,0,0
101538,cent,0,0
101539,(,0,0
101540,P,0,0
101541,=,0,0
101542,0.864,0,0
101543,),0,1
101544,.,0,1
101545,CONCLUSION,0,0
101546,Leucocyte,0,0
101547,depletion,0,0
101548,is,0,0
101549,not,0,0
101550,associated,0,0
101551,with,0,1
101552,better,0,0
101553,long-term,0,0
101554,survival,0,0
101555,and,0,0
101556,lower,0,0
101557,recurrence,0,0
101558,rates,0,0
101559,in,0,0
101560,patients,1,1
101561,with,1,1
101562,gastrointestinal,1,1
101563,cancer,1,1
101564,.,1,1
101565,A,0,0
101566,randomized,0,0
101567,double-blind,0,0
101568,placebo-controlled,0,0
101569,study,0,0
101570,of,0,0
101571,the,0,0
101572,long-term,0,0
101573,efficacy,0,0
101574,and,0,0
101575,safety,0,0
101576,of,0,0
101577,diethylpropion,0,0
101578,in,0,0
101579,the,0,0
101580,treatment,0,0
101581,of,0,0
101582,obese,1,1
101583,subjects,1,1
101584,.,1,1
101585,OBJECTIVE,0,0
101586,To,0,0
101587,evaluate,0,0
101588,the,0,0
101589,efficacy,0,0
101590,of,0,0
101591,diethylpropion,0,0
101592,on,0,0
101593,a,0,0
101594,long-term,0,0
101595,basis,0,0
101596,",",0,0
101597,with,0,0
101598,emphasis,0,0
101599,in,0,0
101600,cardiovascular,0,1
101601,and,0,0
101602,psychiatric,0,1
101603,safety,0,0
101604,aspects,0,0
101605,.,0,1
101606,DESIGN,0,0
101607,Randomized,0,0
101608,",",0,0
101609,double-blind,0,0
101610,",",0,0
101611,placebo-controlled,0,0
101612,trial,0,0
101613,.,0,1
101614,MEASUREMENTS,0,0
101615,Following,0,0
101616,a,0,0
101617,2-week,0,0
101618,screening,0,0
101619,period,0,0
101620,",",0,0
101621,69,1,1
101622,obese,1,1
101623,healthy,1,1
101624,adults,1,1
101625,received,1,1
101626,a,1,0
101627,hypocaloric,1,0
101628,diet,1,0
101629,and,0,0
101630,were,0,0
101631,randomized,0,0
101632,to,0,0
101633,diethylpropion,0,0
101634,50,0,1
101635,mg,0,0
101636,BID,0,1
101637,(,0,1
101638,n=37,0,1
101639,),0,0
101640,or,0,0
101641,placebo,0,0
101642,(,0,0
101643,n=32,0,1
101644,),0,1
101645,for,0,0
101646,6,0,1
101647,months,0,0
101648,.,0,1
101649,After,0,0
101650,this,0,0
101651,period,0,0
101652,",",0,0
101653,all,0,0
101654,participants,0,1
101655,received,0,0
101656,diethylpropion,0,0
101657,in,0,0
101658,an,0,0
101659,open-label,0,0
101660,extension,0,0
101661,for,0,0
101662,an,0,0
101663,additional,0,0
101664,6,0,0
101665,months,0,0
101666,.,0,1
101667,The,0,0
101668,primary,0,0
101669,outcome,0,0
101670,was,0,0
101671,percentage,0,0
101672,change,0,0
101673,in,0,0
101674,body,0,1
101675,weight,0,1
101676,.,0,0
101677,Electrocardiogram,0,0
101678,(,0,0
101679,ECG,0,0
101680,),0,0
101681,",",0,0
101682,echocardiography,0,0
101683,and,0,0
101684,clinical,0,0
101685,chemistry,0,0
101686,were,0,0
101687,performed,0,0
101688,at,0,0
101689,baseline,0,0
101690,and,0,0
101691,every,0,0
101692,6,0,0
101693,months,0,0
101694,.,0,1
101695,Psychiatric,0,1
101696,evaluation,0,0
101697,and,0,0
101698,application,0,0
101699,of,0,0
101700,Hamilton,0,1
101701,rating,0,0
101702,scales,0,0
101703,for,0,0
101704,depression,0,1
101705,and,0,0
101706,anxiety,0,0
101707,were,0,0
101708,also,0,0
101709,performed,0,0
101710,by,0,0
101711,experienced,0,0
101712,psychiatrists,0,1
101713,at,0,0
101714,baseline,0,0
101715,and,0,0
101716,every,0,0
101717,3,0,0
101718,months,0,0
101719,.,0,1
101720,RESULTS,0,0
101721,After,0,0
101722,6,0,0
101723,months,0,0
101724,",",0,0
101725,the,0,0
101726,diethylpropion,0,0
101727,group,0,0
101728,lost,0,0
101729,an,0,0
101730,average,0,0
101731,of,0,0
101732,9.8,0,0
101733,%,0,0
101734,(,0,0
101735,s.d,0,1
101736,.,0,1
101737,6.9,0,0
101738,%,0,0
101739,),0,0
101740,of,0,0
101741,initial,0,0
101742,body,0,1
101743,weight,0,0
101744,vs,0,0
101745,3.2,0,0
101746,%,0,0
101747,(,0,0
101748,3.7,0,0
101749,%,0,0
101750,),0,0
101751,in,0,0
101752,the,0,0
101753,placebo,0,0
101754,group,0,0
101755,(,0,0
101756,P,0,0
101757,<,0,0
101758,0.0001,0,0
101759,),0,0
101760,.,0,0
101761,From,0,0
101762,baseline,0,0
101763,to,0,0
101764,month,0,0
101765,12,0,0
101766,",",0,0
101767,the,0,0
101768,mean,0,0
101769,weight,0,0
101770,loss,0,0
101771,produced,0,0
101772,by,0,0
101773,diethylpropion,0,0
101774,was,0,0
101775,10.6,0,0
101776,%,0,0
101777,(,0,0
101778,8.3,0,0
101779,%,0,0
101780,),0,1
101781,.,0,0
101782,Participants,0,1
101783,in,0,0
101784,the,0,0
101785,placebo,0,0
101786,group,0,1
101787,who,0,1
101788,were,0,1
101789,switched,0,1
101790,to,0,0
101791,diethylpropion,0,0
101792,after,0,0
101793,6,0,0
101794,months,0,0
101795,lost,0,0
101796,an,0,0
101797,average,0,0
101798,of,0,0
101799,7.0,0,0
101800,%,0,0
101801,(,0,0
101802,7.7,0,0
101803,%,0,0
101804,),0,0
101805,of,0,0
101806,initial,0,0
101807,body,0,1
101808,weight,0,0
101809,.,0,0
101810,The,0,0
101811,difference,0,0
101812,between,0,0
101813,groups,0,0
101814,at,0,1
101815,month,0,1
101816,12,0,0
101817,was,0,0
101818,not,0,0
101819,significant,0,0
101820,(,0,0
101821,P=0.07,0,0
101822,),0,0
101823,.,0,0
101824,No,0,0
101825,differences,0,0
101826,in,0,0
101827,blood,0,0
101828,pressure,0,0
101829,",",0,0
101830,pulse,0,0
101831,rate,0,0
101832,",",0,0
101833,ECG,0,0
101834,and,0,0
101835,psychiatric,0,1
101836,evaluation,0,0
101837,were,0,0
101838,observed,0,0
101839,.,0,0
101840,Dry,0,0
101841,mouth,0,0
101842,and,0,0
101843,insomnia,0,0
101844,were,0,0
101845,the,0,0
101846,most,0,0
101847,frequent,0,0
101848,adverse,0,0
101849,events,0,0
101850,.,0,1
101851,CONCLUSION,0,0
101852,Diethylpropion,0,0
101853,plus,0,0
101854,diet,0,0
101855,produced,0,0
101856,sustained,0,0
101857,and,0,0
101858,clinically,0,0
101859,significant,0,0
101860,weight,0,0
101861,loss,0,0
101862,over,0,0
101863,1,0,0
101864,year,0,1
101865,.,0,0
101866,It,0,0
101867,seems,0,0
101868,to,0,0
101869,be,0,0
101870,safe,0,0
101871,in,0,0
101872,relation,0,0
101873,to,0,0
101874,cardiovascular,0,1
101875,and,0,0
101876,psychiatric,0,1
101877,aspects,0,0
101878,in,0,0
101879,a,0,0
101880,well-selected,1,1
101881,population,1,1
101882,.,1,1
101883,Preparation,0,0
101884,and,0,0
101885,immune,0,0
101886,activity,0,0
101887,analysis,0,0
101888,of,0,0
101889,H5N1,1,0
101890,subtype,1,1
101891,avian,1,1
101892,influenza,1,1
101893,virus,1,1
101894,recombinant,1,0
101895,protein-based,1,0
101896,vaccine,1,0
101897,.,1,1
101898,Avian,0,0
101899,influenza,0,0
101900,is,0,0
101901,a,0,0
101902,severe,0,1
101903,disease,0,1
101904,among,0,0
101905,farmed,1,1
101906,poultry,1,1
101907,and,1,0
101908,free-living,1,1
101909,birds,1,1
101910,and,0,0
101911,a,0,0
101912,constant,0,0
101913,threat,0,0
101914,to,0,0
101915,the,0,0
101916,commercial,1,0
101917,chicken,1,0
101918,industry,1,0
101919,around,0,0
101920,the,0,0
101921,world,0,0
101922,.,0,0
101923,Hemagglutinin,0,0
101924,(,0,0
101925,HA,0,1
101926,),0,0
101927,is,0,0
101928,the,0,0
101929,major,0,0
101930,immunogen,0,0
101931,on,0,0
101932,the,0,0
101933,envelope,0,0
101934,of,0,0
101935,influenza,0,1
101936,A,0,0
101937,virus,0,1
101938,and,0,0
101939,is,0,0
101940,the,0,0
101941,predominant,0,0
101942,inducer,0,0
101943,of,0,0
101944,neutralizing,0,0
101945,antibody,0,0
101946,.,0,0
101947,To,0,0
101948,obtain,0,0
101949,the,0,0
101950,bioactive,0,0
101951,antigen,0,0
101952,proteins,0,0
101953,in,0,0
101954,large,0,1
101955,quantities,0,0
101956,",",0,0
101957,a,0,0
101958,new,0,0
101959,protein,0,0
101960,expression,0,0
101961,vector,0,0
101962,pBCX,0,1
101963,was,0,0
101964,constructed,0,0
101965,",",0,0
101966,which,0,0
101967,is,0,0
101968,based,0,0
101969,on,0,0
101970,the,0,0
101971,pET32a,0,0
101972,vector,0,0
101973,.,0,0
101974,The,0,0
101975,HA,0,1
101976,gene,0,0
101977,of,0,0
101978,the,0,0
101979,H5N1,0,0
101980,subtype,0,1
101981,of,0,0
101982,avian,0,1
101983,influenza,0,1
101984,virus,0,1
101985,(,0,0
101986,AIV,0,1
101987,),0,0
101988,was,0,0
101989,inserted,0,0
101990,into,0,0
101991,the,0,0
101992,pBCX,1,0
101993,vector,1,0
101994,and,0,0
101995,expressed,0,0
101996,efficiently,0,0
101997,in,0,0
101998,Escherichia,0,0
101999,coli,0,0
102000,BL21,0,0
102001,(,0,0
102002,DE3,0,1
102003,),0,1
102004,.,0,0
102005,Fused,0,0
102006,expression,0,0
102007,of,0,0
102008,the,0,0
102009,exogenous,0,0
102010,gene,0,0
102011,and,0,0
102012,msyB,0,0
102013,produced,0,0
102014,a,0,0
102015,97-kDa,0,0
102016,msyB-HA,0,0
102017,fusion,0,0
102018,protein,0,0
102019,.,0,0
102020,Sodium,0,0
102021,dodecyl,0,0
102022,sulfate-PAGE,0,0
102023,combined,0,0
102024,with,0,1
102025,scanning,0,0
102026,analysis,0,0
102027,demonstrated,0,0
102028,that,0,0
102029,the,0,0
102030,msyB-HA,0,0
102031,fusion,0,0
102032,protein,0,0
102033,accounted,0,0
102034,for,0,0
102035,29.5,0,0
102036,%,0,0
102037,of,0,0
102038,the,0,0
102039,total,0,1
102040,bacterial,0,0
102041,protein,0,0
102042,",",0,0
102043,90.5,0,0
102044,%,0,0
102045,being,0,0
102046,soluble,0,0
102047,.,0,1
102048,The,0,0
102049,msyB-HA,0,0
102050,fusion,0,0
102051,protein,0,0
102052,was,0,0
102053,purified,0,0
102054,with,0,1
102055,nondenaturing,0,0
102056,50,0,1
102057,%,0,0
102058,Ni-NTA,0,0
102059,column,0,0
102060,chromatography,0,0
102061,",",0,0
102062,and,0,0
102063,the,0,0
102064,result,0,0
102065,showed,0,0
102066,that,0,0
102067,24,0,0
102068,mg,0,0
102069,of,0,0
102070,purified,0,0
102071,msyB-HA,0,0
102072,fusion,0,0
102073,protein,0,0
102074,could,0,0
102075,be,0,0
102076,obtained,0,0
102077,from,0,0
102078,1,0,0
102079,L,0,0
102080,of,0,0
102081,induced,0,0
102082,expression,0,0
102083,bacterial,0,0
102084,culture,0,0
102085,medium,0,0
102086,.,0,0
102087,The,0,0
102088,comparative,0,0
102089,results,0,0
102090,in,0,0
102091,the,0,0
102092,present,0,0
102093,study,0,0
102094,showed,0,0
102095,that,0,0
102096,pBCX,0,1
102097,was,0,0
102098,superior,0,0
102099,to,0,0
102100,pET32a,0,0
102101,as,0,0
102102,a,0,0
102103,protein,0,0
102104,expression,0,0
102105,vector,0,0
102106,.,0,0
102107,Western,0,0
102108,blotting,0,0
102109,showed,0,0
102110,the,0,0
102111,recombinant,0,0
102112,msyB-HA,0,0
102113,(,0,0
102114,rHA,0,0
102115,),0,0
102116,to,0,0
102117,have,0,0
102118,better,0,0
102119,antigenic,0,0
102120,activity,0,0
102121,",",0,0
102122,which,0,0
102123,may,0,0
102124,be,0,0
102125,the,0,0
102126,result,0,0
102127,from,0,0
102128,the,0,0
102129,better,0,0
102130,posttranslation,0,0
102131,protein,0,0
102132,modification,0,0
102133,and,0,0
102134,folding,0,0
102135,in,0,0
102136,the,0,0
102137,pBCX,0,0
102138,expression,0,0
102139,system,0,0
102140,.,0,0
102141,With,0,0
102142,the,0,0
102143,rHA,0,0
102144,fusion,0,0
102145,protein,0,0
102146,as,0,0
102147,antigen,0,0
102148,",",0,0
102149,we,0,0
102150,successfully,0,0
102151,prepared,0,0
102152,and,0,0
102153,screened,0,1
102154,specific,0,0
102155,monoclonal,0,0
102156,antibodys,0,1
102157,against,0,0
102158,the,0,0
102159,H5N1,0,0
102160,subtype,0,1
102161,AIV,0,0
102162,",",0,0
102163,which,0,0
102164,indicated,0,0
102165,that,0,0
102166,the,0,0
102167,rHA,0,0
102168,had,0,0
102169,antigen,0,0
102170,epitopes,0,0
102171,and,0,1
102172,biofunctions,0,0
102173,.,0,1
102174,The,0,0
102175,immune,0,0
102176,test,0,0
102177,confirmed,0,0
102178,that,0,0
102179,the,0,0
102180,rHA,0,0
102181,protein,0,0
102182,vaccine,0,0
102183,could,0,0
102184,also,0,0
102185,induce,0,0
102186,high,0,0
102187,neutralizing,0,0
102188,antibodies,0,0
102189,",",0,0
102190,and,0,0
102191,the,0,0
102192,AIV,0,0
102193,challenge,0,0
102194,test,0,0
102195,proved,0,0
102196,that,0,0
102197,the,0,0
102198,rHA,0,0
102199,protein-based,0,0
102200,vaccine,0,0
102201,could,0,0
102202,prevent,0,0
102203,the,0,0
102204,corresponding,0,0
102205,infection,0,0
102206,.,0,0
102207,This,0,0
102208,study,0,0
102209,demonstrates,0,0
102210,that,0,0
102211,the,0,0
102212,recombinant,0,0
102213,HA,0,1
102214,protein,0,0
102215,produced,0,0
102216,by,0,0
102217,the,0,0
102218,pBCX,0,0
102219,expression,0,0
102220,system,0,0
102221,could,0,0
102222,be,0,0
102223,used,0,0
102224,as,0,0
102225,a,0,0
102226,recombinant,0,0
102227,protein-based,0,0
102228,vaccine,0,0
102229,and,0,0
102230,has,0,0
102231,potential,0,0
102232,for,0,0
102233,further,0,0
102234,development,0,0
102235,for,0,0
102236,diagnosis,0,1
102237,.,0,1
102238,Excimer,0,1
102239,laser,0,0
102240,trabeculotomy,0,0
102241,vs,0,0
102242,180,0,1
102243,degrees,0,0
102244,selective,0,1
102245,laser,0,0
102246,trabeculoplasty,0,0
102247,in,0,0
102248,primary,0,1
102249,open-angle,0,1
102250,glaucoma,0,1
102251,.,0,0
102252,A,0,0
102253,2-year,0,0
102254,randomized,0,0
102255,",",0,0
102256,controlled,0,0
102257,trial,0,0
102258,.,0,0
102259,PURPOSE,0,0
102260,To,0,0
102261,compare,0,0
102262,the,0,0
102263,effectiveness,0,0
102264,and,0,0
102265,safety,0,0
102266,of,0,0
102267,excimer,0,0
102268,laser,0,0
102269,trabeculotomy,0,0
102270,(,0,0
102271,ELT,0,0
102272,),0,0
102273,ab,0,1
102274,interno,0,0
102275,vs,0,0
102276,selective,0,1
102277,laser,0,0
102278,trabeculoplasty,0,0
102279,(,0,0
102280,SLT,0,0
102281,),0,0
102282,over,0,0
102283,24,0,1
102284,months,0,0
102285,of,0,0
102286,follow-up,0,0
102287,in,0,0
102288,patients,1,1
102289,with,1,1
102290,primary,1,1
102291,open-angle,1,1
102292,glaucoma,1,1
102293,(,1,0
102294,POAG,1,0
102295,),1,0
102296,refractory,1,1
102297,to,1,0
102298,medical,1,1
102299,therapy,1,0
102300,.,1,1
102301,PATIENTS,0,0
102302,AND,0,0
102303,METHODS,0,0
102304,This,0,0
102305,prospective,0,0
102306,",",0,0
102307,randomized,0,0
102308,study,0,0
102309,included,0,1
102310,30,1,1
102311,consecutive,1,1
102312,eyes,1,1
102313,assigned,0,1
102314,randomly,0,1
102315,to,0,0
102316,either,0,0
102317,ELT,0,0
102318,or,0,1
102319,SLT,0,1
102320,group,0,0
102321,.,0,1
102322,ELT,0,0
102323,was,0,0
102324,carried,0,0
102325,out,0,0
102326,using,0,0
102327,a,0,0
102328,XeCl,0,0
102329,Excimer,0,0
102330,Laser,0,1
102331,with,0,1
102332,an,0,0
102333,emission,0,1
102334,wavelength,0,0
102335,of,0,0
102336,308,0,1
102337,nm,0,0
102338,.,0,1
102339,Eight,0,0
102340,spots,0,0
102341,were,0,1
102342,equally,0,0
102343,distributed,0,0
102344,at,0,0
102345,a,0,0
102346,distance,0,0
102347,of,0,0
102348,500,0,0
102349,microm,0,0
102350,from,0,1
102351,one,0,0
102352,another,0,0
102353,over,0,0
102354,the,0,0
102355,anterior,0,1
102356,trabeculum,0,1
102357,.,0,0
102358,The,0,0
102359,SLT,0,0
102360,patients,0,1
102361,were,0,1
102362,treated,0,1
102363,with,0,1
102364,a,0,0
102365,frequency-doubled,0,0
102366,q-switched,0,1
102367,neodymium,0,1
102368,:,0,1
102369,yytrium-aluminum-garnet,0,1
102370,laser,0,0
102371,(,0,1
102372,wavelength,0,0
102373,532,0,1
102374,nm,0,0
102375,),0,0
102376,.,0,0
102377,Approximately,0,0
102378,50,0,0
102379,adjacent,0,0
102380,",",0,0
102381,but,0,0
102382,not,0,0
102383,overlapping,0,0
102384,",",0,0
102385,laser,0,1
102386,spots,0,0
102387,were,0,1
102388,distributed,0,1
102389,over,0,0
102390,180,0,1
102391,degrees,0,0
102392,of,0,0
102393,the,0,0
102394,trabecular,0,0
102395,meshwork,0,0
102396,",",0,0
102397,using,0,0
102398,an,0,0
102399,energy,0,0
102400,level,0,0
102401,ranging,0,0
102402,from,0,0
102403,0.7,0,0
102404,to,0,1
102405,1.0,0,0
102406,mJ,0,0
102407,per,0,1
102408,pulse,0,0
102409,.,0,0
102410,The,0,0
102411,main,0,0
102412,outcome,0,0
102413,measure,0,0
102414,was,0,0
102415,intraocular,0,0
102416,pressure,0,0
102417,(,0,0
102418,IOP,0,0
102419,),0,0
102420,lowering,0,0
102421,after,0,0
102422,ELT,0,0
102423,and,0,1
102424,SLT,0,1
102425,.,0,1
102426,Success,0,0
102427,was,0,0
102428,defined,0,0
102429,as,0,0
102430,>,0,1
102431,or=20,0,1
102432,%,0,0
102433,reduction,0,0
102434,in,0,0
102435,IOP,0,0
102436,without,0,1
102437,further,0,0
102438,glaucoma,0,1
102439,intervention,0,0
102440,.,0,0
102441,RESULTS,0,0
102442,At,0,0
102443,24,0,1
102444,months,0,0
102445,",",0,0
102446,complete,0,1
102447,success,0,0
102448,rates,0,0
102449,were,0,1
102450,53.3,0,1
102451,%,0,0
102452,for,0,0
102453,the,0,0
102454,ELT,0,0
102455,group,0,0
102456,and,0,0
102457,40,0,1
102458,%,0,0
102459,for,0,0
102460,the,0,0
102461,SLT,0,0
102462,group,0,0
102463,(,0,0
102464,P=0.35,0,0
102465,",",0,0
102466,Fisher,0,0
102467,'s,0,1
102468,exact,0,0
102469,test,0,0
102470,),0,1
102471,;,0,0
102472,qualified,0,1
102473,success,0,0
102474,rates,0,0
102475,were,0,1
102476,33.3,0,0
102477,%,0,0
102478,for,0,0
102479,the,0,0
102480,ELT,0,0
102481,and,0,0
102482,26.6,0,0
102483,%,0,0
102484,for,0,0
102485,the,0,0
102486,SLT,0,0
102487,group,0,0
102488,(,0,0
102489,P=0.5,0,0
102490,",",0,0
102491,Fisher,0,0
102492,'s,0,1
102493,exact,0,0
102494,test,0,0
102495,),0,0
102496,.Mean,0,1
102497,IOP,0,0
102498,decreased,0,0
102499,from,0,0
102500,25.0+/-1.9,0,0
102501,to,0,0
102502,17.6+/-2.2,0,0
102503,mmHg,0,0
102504,(,0,0
102505,-29.6,0,0
102506,%,0,0
102507,;,0,1
102508,P,0,0
102509,<,0,0
102510,0.0001,0,0
102511,),0,0
102512,in,0,0
102513,the,0,0
102514,ELT,0,0
102515,group,0,0
102516,and,0,0
102517,from,0,0
102518,23.9+/-0.9,0,0
102519,to,0,0
102520,19.1+/-1.8,0,0
102521,mmHg,0,0
102522,(,0,0
102523,-21,0,0
102524,%,0,0
102525,;,0,1
102526,P,0,0
102527,<,0,0
102528,0.0001,0,0
102529,),0,0
102530,in,0,0
102531,the,0,0
102532,SLT,0,0
102533,group,0,0
102534,.,0,1
102535,CONCLUSIONS,0,0
102536,Both,0,0
102537,ELT,0,0
102538,and,0,0
102539,SLT,0,0
102540,proved,0,0
102541,to,0,0
102542,be,0,0
102543,effective,0,0
102544,techniques,0,0
102545,in,0,0
102546,the,0,0
102547,treatment,0,0
102548,of,0,0
102549,POAG,0,0
102550,refractory,0,1
102551,to,0,0
102552,medical,0,1
102553,therapy,0,0
102554,.,0,1
102555,Efficacy,0,0
102556,of,0,0
102557,prepackaged,0,0
102558,",",0,0
102559,low,0,0
102560,residual,0,0
102561,test,0,0
102562,meals,0,1
102563,with,0,1
102564,4L,0,0
102565,polyethylene,0,0
102566,glycol,0,0
102567,versus,0,0
102568,a,0,0
102569,clear,0,0
102570,liquid,0,0
102571,diet,0,1
102572,with,0,1
102573,4L,0,0
102574,polyethylene,0,0
102575,glycol,0,0
102576,bowel,0,1
102577,preparation,0,0
102578,:,0,1
102579,a,0,0
102580,randomized,0,0
102581,trial,0,0
102582,.,0,1
102583,BACKGROUND,0,0
102584,AND,0,0
102585,STUDY,0,0
102586,AIMS,0,1
102587,A,0,1
102588,prepackaged,0,0
102589,low,0,1
102590,residue,0,0
102591,one-day,0,1
102592,diet,0,1
102593,(,0,0
102594,breakfast,0,0
102595,",",0,0
102596,lunch,0,0
102597,and,0,0
102598,dinner,0,1
102599,),0,0
102600,has,0,0
102601,been,0,0
102602,recently,0,0
102603,developed,0,0
102604,to,0,0
102605,improve,0,0
102606,patient,1,0
102607,tolerance,0,0
102608,for,0,0
102609,bowel,0,1
102610,preparation,0,0
102611,prior,0,0
102612,to,0,0
102613,colonoscopy,0,0
102614,.,0,0
102615,The,0,0
102616,aims,0,0
102617,of,0,0
102618,this,0,0
102619,study,0,0
102620,were,0,0
102621,to,0,0
102622,evaluate,0,0
102623,the,0,0
102624,efficacy,0,0
102625,and,0,0
102626,tolerability,0,0
102627,of,0,0
102628,bowel,0,1
102629,preparation,0,0
102630,protocols,0,0
102631,based,0,0
102632,on,0,0
102633,a,0,0
102634,low,0,0
102635,residue,0,0
102636,diet,0,1
102637,and,0,0
102638,4L,0,0
102639,polyethylene,0,0
102640,glycol,0,0
102641,(,0,0
102642,PEG,0,1
102643,),0,0
102644,solution,0,0
102645,",",0,0
102646,and,0,0
102647,to,0,0
102648,compare,0,0
102649,these,0,0
102650,new,0,0
102651,options,0,0
102652,with,0,1
102653,the,0,0
102654,traditional,0,0
102655,liquid,0,0
102656,diet,0,0
102657,and,0,0
102658,the,0,0
102659,PEG,0,0
102660,4L,0,0
102661,lavage,0,1
102662,.,0,1
102663,METHODS,0,0
102664,A,1,0
102665,total,1,1
102666,of,1,0
102667,214,1,1
102668,patients,1,1
102669,(,1,1
102670,mean,1,1
102671,age,1,1
102672,:,1,1
102673,54.1,1,1
102674,years,1,1
102675,;,1,1
102676,120,1,1
102677,male,1,1
102678,",",1,0
102679,94,1,1
102680,female,1,1
102681,),1,0
102682,from,1,0
102683,four,1,1
102684,university,1,1
102685,hospitals,1,1
102686,were,0,0
102687,included,0,1
102688,in,0,0
102689,the,0,0
102690,analysis,0,0
102691,.,0,0
102692,Patients,0,1
102693,were,0,0
102694,randomized,0,1
102695,to,0,0
102696,receive,0,0
102697,a,0,0
102698,clear,0,0
102699,liquid,0,0
102700,diet,0,0
102701,and,0,0
102702,the,0,0
102703,PEG,0,0
102704,4L,0,0
102705,regimen,0,0
102706,(,1,1
102707,106,1,1
102708,patients,1,1
102709,),1,1
102710,or,0,1
102711,the,0,0
102712,low,0,0
102713,residue,0,0
102714,test,0,0
102715,meals,0,0
102716,and,0,0
102717,the,0,0
102718,PEG,0,0
102719,4L,0,0
102720,regimen,0,0
102721,(,0,1
102722,TM-PEG,0,1
102723,4L,0,0
102724,",",0,0
102725,108,0,1
102726,patients,0,1
102727,),0,1
102728,.,0,0
102729,The,0,0
102730,colon,0,1
102731,cleansing,0,0
102732,efficacy,0,0
102733,of,0,0
102734,the,0,0
102735,different,0,0
102736,preparations,0,0
102737,was,0,0
102738,rated,0,0
102739,using,0,0
102740,the,0,0
102741,Ottawa,0,1
102742,bowel,0,1
102743,preparation,0,0
102744,scale,0,0
102745,.,0,1
102746,RESULTS,0,0
102747,No,0,0
102748,significant,0,0
102749,differences,0,0
102750,were,0,1
102751,observed,0,0
102752,between,0,0
102753,the,0,0
102754,treatment,0,0
102755,groups,0,0
102756,according,0,1
102757,to,0,0
102758,the,0,0
102759,Ottawa,0,1
102760,cleansing,0,0
102761,scale,0,0
102762,findings,0,0
102763,(,0,1
102764,PEG,0,1
102765,4L,0,0
102766,:,0,1
102767,2.97,0,0
102768,vs,0,0
102769,TM-PEG,0,1
102770,4L,0,0
102771,:,0,1
102772,2.46,0,0
102773,",",0,0
102774,P,0,0
102775,=,0,0
102776,0.063,0,0
102777,),0,0
102778,.,0,0
102779,The,0,0
102780,overall,0,0
102781,tolerability,0,0
102782,was,0,0
102783,higher,0,0
102784,in,0,0
102785,the,0,0
102786,TM-PEG,0,0
102787,4L,0,0
102788,group,0,0
102789,than,0,0
102790,in,0,0
102791,the,0,0
102792,PEG,0,1
102793,4L,0,0
102794,group,0,0
102795,(,0,0
102796,P,0,0
102797,=,0,0
102798,0.036,0,0
102799,),0,0
102800,.,0,0
102801,No,0,0
102802,difference,0,0
102803,was,0,0
102804,found,0,0
102805,when,0,0
102806,the,0,0
102807,two,0,0
102808,groups,0,0
102809,were,0,1
102810,compared,0,0
102811,with,0,1
102812,regard,0,0
102813,to,0,0
102814,adverse,0,0
102815,events,0,0
102816,(,0,1
102817,P,0,0
102818,=,0,0
102819,0.599,0,0
102820,),0,0
102821,.,0,0
102822,CONCLUSIONS,0,0
102823,A,0,0
102824,prepackaged,0,0
102825,low,0,1
102826,residue,0,0
102827,one-day,0,1
102828,diet,0,1
102829,provided,0,0
102830,cleansing,0,0
102831,efficacy,0,0
102832,similar,0,0
102833,to,0,0
102834,that,0,0
102835,of,0,0
102836,a,0,0
102837,clear,0,0
102838,liquid,0,0
102839,diet,0,0
102840,and,0,0
102841,offered,0,0
102842,the,0,0
102843,benefit,0,0
102844,of,0,0
102845,improved,0,0
102846,tolerability,0,0
102847,compared,0,0
102848,to,0,0
102849,the,0,0
102850,conventional,0,0
102851,PEG,0,1
102852,4L,0,0
102853,regimen,0,0
102854,.,0,1
102855,Prognostic,0,1
102856,value,0,0
102857,of,0,0
102858,postoperative,0,0
102859,CEA,0,0
102860,clearance,0,0
102861,in,0,0
102862,rectal,1,1
102863,cancer,1,1
102864,patients,1,1
102865,with,1,1
102866,high,1,1
102867,preoperative,1,1
102868,CEA,1,1
102869,levels,1,0
102870,.,1,1
102871,PURPOSE,0,0
102872,We,0,0
102873,determined,0,0
102874,the,0,0
102875,prognostic,0,0
102876,value,0,0
102877,of,0,0
102878,carcinoembryonic,0,0
102879,antigen,0,0
102880,(,0,0
102881,CEA,0,0
102882,),0,0
102883,clearance,0,0
102884,after,0,0
102885,tumor,0,0
102886,resection,0,1
102887,with,0,1
102888,serial,0,0
102889,evaluation,0,0
102890,of,0,0
102891,postoperative,0,0
102892,CEA,0,0
102893,levels,0,0
102894,in,0,0
102895,rectal,1,1
102896,cancer,1,1
102897,.,1,1
102898,METHODS,0,0
102899,Between,1,0
102900,1994,1,1
102901,and,1,0
102902,2004,1,1
102903,",",1,0
102904,we,1,0
102905,retrospectively,1,1
102906,reviewed,1,1
102907,122,1,1
102908,patients,1,1
102909,with,1,1
102910,rectal,1,1
102911,cancer,1,1
102912,whose,1,1
102913,serum,1,0
102914,CEA,1,0
102915,levels,1,0
102916,were,1,0
102917,measured,1,0
102918,on,1,0
102919,the,1,0
102920,preoperative,1,0
102921,day,1,0
102922,and,1,0
102923,postoperative,1,0
102924,days,1,0
102925,7,1,1
102926,and,1,1
102927,30,1,1
102928,.,1,1
102929,Patients,1,1
102930,with,1,1
102931,preoperative,1,1
102932,CEA,1,0
102933,levels,1,0
102934,<,1,0
102935,5.0,1,0
102936,ng/ml,1,0
102937,were,1,1
102938,excluded,1,1
102939,.,1,0
102940,An,0,0
102941,exponential,0,0
102942,trend,0,0
102943,line,0,0
102944,was,0,0
102945,drawn,0,0
102946,using,0,0
102947,the,0,0
102948,three,0,0
102949,CEA,0,0
102950,values,0,0
102951,.,0,1
102952,Patients,1,1
102953,were,1,0
102954,categorized,1,1
102955,into,1,1
102956,three,1,1
102957,groups,1,0
102958,based,1,0
102959,on,1,0
102960,R,1,1
102961,(,1,1
102962,2,1,0
102963,),1,1
102964,values,1,0
102965,calculated,0,0
102966,through,0,0
102967,trend,0,0
102968,line,0,0
102969,",",0,0
102970,which,0,0
102971,indicates,0,0
102972,the,0,0
102973,correlation,0,0
102974,coefficient,0,0
102975,between,0,0
102976,exponential,0,0
102977,graph,0,0
102978,and,0,0
102979,measured,0,0
102980,CEA,0,0
102981,values,0,0
102982,:,0,1
102983,exponential,1,0
102984,decrease,1,0
102985,group,1,0
102986,(,0,0
102987,group,0,1
102988,1,0,1
102989,:,0,1
102990,0.9,0,0
102991,<,0,0
102992,R,0,1
102993,(,0,0
102994,2,0,0
102995,),0,0
102996,<,0,0
102997,or,0,1
102998,=,0,0
102999,1.0,0,0
103000,),0,0
103001,",",0,0
103002,nearly,1,0
103003,exponential,1,0
103004,decrease,1,0
103005,group,1,0
103006,(,0,0
103007,group,0,1
103008,2,0,1
103009,:,0,1
103010,0.5,0,0
103011,<,0,0
103012,R,0,1
103013,(,0,0
103014,2,0,0
103015,),0,0
103016,<,0,0
103017,or,0,1
103018,=,0,0
103019,0.9,0,0
103020,),0,0
103021,",",0,0
103022,and,0,0
103023,randomized,1,0
103024,clearance,1,0
103025,group,1,0
103026,(,0,0
103027,group,0,1
103028,3,0,0
103029,:,0,1
103030,0.5,0,0
103031,<,0,0
103032,or,0,1
103033,=,0,0
103034,R,0,1
103035,(,0,0
103036,2,0,0
103037,),0,1
103038,),0,0
103039,.,0,0
103040,We,0,0
103041,then,0,0
103042,analyzed,0,0
103043,the,0,0
103044,CEA,0,0
103045,clearance,0,0
103046,pattern,0,1
103047,as,0,0
103048,a,0,0
103049,prognostic,0,0
103050,indicator,0,0
103051,.,0,0
103052,RESULTS,0,0
103053,With,0,1
103054,a,0,0
103055,median,0,0
103056,follow-up,0,0
103057,of,0,0
103058,57,0,1
103059,months,0,0
103060,",",0,0
103061,the,0,0
103062,5-year,0,0
103063,overall,0,0
103064,survival,0,0
103065,was,0,0
103066,62.3,0,0
103067,%,0,0
103068,vs.,0,0
103069,48.1,0,0
103070,%,0,0
103071,vs.,0,0
103072,25,0,0
103073,%,0,0
103074,and,0,0
103075,the,0,0
103076,5-year,0,0
103077,disease-free,0,0
103078,survival,0,0
103079,was,0,0
103080,58.6,0,1
103081,%,0,0
103082,vs.,0,0
103083,52.7,0,0
103084,%,0,0
103085,vs.,0,0
103086,25,0,0
103087,%,0,0
103088,among,0,1
103089,groups,0,0
103090,1,0,1
103091,",",0,0
103092,2,0,0
103093,",",0,0
103094,and,0,0
103095,3,0,0
103096,(,0,0
103097,P,0,0
103098,=,0,0
103099,0.014,0,0
103100,",",0,0
103101,P,0,0
103102,=,0,0
103103,0.027,0,0
103104,",",0,0
103105,respectively,0,0
103106,),0,0
103107,in,0,0
103108,patients,1,1
103109,with,1,1
103110,stage,1,1
103111,III,1,1
103112,rectal,1,1
103113,cancer,1,1
103114,.,1,0
103115,For,0,0
103116,those,0,0
103117,with,0,1
103118,stage,0,1
103119,II,0,1
103120,rectal,0,1
103121,cancer,0,1
103122,",",0,0
103123,the,0,0
103124,5-year,0,0
103125,overall,0,0
103126,survival,0,0
103127,rate,0,0
103128,of,0,0
103129,group,0,1
103130,1,0,0
103131,was,0,0
103132,significantly,0,0
103133,better,0,0
103134,than,0,0
103135,groups,0,0
103136,2,0,1
103137,and,0,1
103138,3,0,0
103139,(,0,0
103140,88.8,0,0
103141,%,0,0
103142,vs.,0,0
103143,74.1,0,0
103144,%,0,0
103145,",",0,0
103146,respectively,0,0
103147,",",0,0
103148,P,0,0
103149,=,0,0
103150,0.021,0,0
103151,),0,0
103152,.,0,0
103153,CONCLUSIONS,0,0
103154,The,0,0
103155,postoperative,0,0
103156,pattern,0,1
103157,of,0,0
103158,CEA,0,0
103159,clearance,0,0
103160,is,0,0
103161,a,0,0
103162,useful,0,0
103163,prognostic,0,0
103164,determinant,0,0
103165,in,0,0
103166,patients,1,1
103167,with,1,1
103168,rectal,1,1
103169,cancer,1,1
103170,.,1,1
103171,Patients,1,1
103172,with,1,1
103173,a,1,0
103174,randomized,1,0
103175,pattern,1,1
103176,of,1,0
103177,CEA,1,0
103178,clearance,1,0
103179,after,0,0
103180,tumor,0,0
103181,resection,0,1
103182,should,0,0
103183,be,0,0
103184,regarded,0,0
103185,as,0,0
103186,having,0,1
103187,the,0,0
103188,possibility,0,0
103189,of,0,0
103190,a,0,0
103191,persistent,0,1
103192,CEA,0,0
103193,source,0,0
103194,and,0,0
103195,may,0,0
103196,require,0,0
103197,consideration,0,0
103198,of,0,0
103199,intensive,0,1
103200,follow-up,0,0
103201,or,0,1
103202,adjuvant,0,0
103203,therapy,0,0
103204,.,0,1
103205,Clinical,0,0
103206,effects,0,0
103207,of,0,1
103208,nanocrystalline,0,0
103209,hydroxyapatite,0,0
103210,paste,0,0
103211,in,0,0
103212,the,0,0
103213,treatment,0,0
103214,of,0,0
103215,intrabony,0,1
103216,periodontal,0,1
103217,defects,0,1
103218,:,0,1
103219,a,0,0
103220,randomized,0,0
103221,controlled,0,0
103222,clinical,0,0
103223,study,0,0
103224,.,0,0
103225,The,0,0
103226,purpose,0,0
103227,of,0,0
103228,the,0,0
103229,present,0,0
103230,randomized,0,0
103231,controlled,0,0
103232,clinical,0,0
103233,study,0,0
103234,was,0,0
103235,to,0,0
103236,compare,0,0
103237,the,0,0
103238,clinical,0,0
103239,outcomes,0,0
103240,of,0,0
103241,papilla,0,1
103242,preservation,0,0
103243,flap,0,0
103244,surgery,0,1
103245,with,0,1
103246,or,0,0
103247,without,0,1
103248,the,0,0
103249,application,0,0
103250,of,0,0
103251,a,0,0
103252,novel,0,0
103253,nanocrystalline,0,0
103254,hydroxyapatite,0,0
103255,(,0,0
103256,nano-HA,0,0
103257,),0,0
103258,bone,0,0
103259,graft,0,0
103260,substitute,0,0
103261,.,0,1
103262,Fourteen,1,1
103263,patients,1,1
103264,with,1,1
103265,paired,1,0
103266,intrabony,1,1
103267,periodontal,1,1
103268,defects,1,1
103269,of,1,1
103270,?,1,1
103271,4,1,0
103272,mm,1,0
103273,participated,1,1
103274,in,1,0
103275,this,0,0
103276,split-mouth,0,1
103277,design,0,0
103278,study,0,0
103279,.,0,0
103280,The,0,0
103281,defects,0,0
103282,in,0,0
103283,each,0,0
103284,subject,0,0
103285,were,0,0
103286,randomly,0,1
103287,selected,0,1
103288,to,0,0
103289,receive,0,0
103290,nano-HA,0,0
103291,paste,0,0
103292,in,0,0
103293,conjunction,0,0
103294,with,0,1
103295,papilla,0,1
103296,preservation,0,0
103297,flaps,0,1
103298,or,0,1
103299,papilla,0,1
103300,preservation,0,0
103301,flaps,0,1
103302,alone,0,0
103303,.,0,0
103304,Probing,0,0
103305,bone,0,0
103306,levels,0,0
103307,(,0,1
103308,PBL,0,0
103309,),0,0
103310,from,0,0
103311,a,0,0
103312,customized,0,0
103313,acrylic,0,0
103314,stent,0,0
103315,and,0,0
103316,probing,0,0
103317,pocket,0,0
103318,depths,0,1
103319,(,0,1
103320,PPD,0,1
103321,),0,0
103322,were,0,0
103323,measured,0,0
103324,at,0,0
103325,baseline,0,0
103326,and,0,0
103327,again,0,0
103328,6,0,0
103329,months,0,0
103330,following,0,0
103331,surgery,0,1
103332,.,0,1
103333,No,0,0
103334,differences,0,0
103335,in,0,0
103336,any,0,0
103337,of,0,0
103338,the,0,0
103339,investigated,0,0
103340,parameters,0,0
103341,were,0,1
103342,observed,0,0
103343,at,0,0
103344,baseline,0,0
103345,between,0,0
103346,the,0,0
103347,two,0,0
103348,groups,0,0
103349,.,0,1
103350,Healing,0,0
103351,was,0,0
103352,uneventful,0,0
103353,in,0,0
103354,all,0,1
103355,patients,0,1
103356,.,0,0
103357,Both,0,0
103358,treatments,0,0
103359,resulted,0,0
103360,in,0,0
103361,significant,0,0
103362,improvements,0,0
103363,between,0,0
103364,baseline,0,0
103365,and,0,0
103366,6,0,0
103367,months,0,0
103368,(,0,1
103369,p,0,0
103370,<,0,0
103371,0.05,0,0
103372,),0,0
103373,.,0,1
103374,At,0,0
103375,6,0,0
103376,months,0,0
103377,after,0,0
103378,therapy,0,0
103379,",",0,0
103380,the,0,0
103381,sites,0,0
103382,treated,0,1
103383,with,0,1
103384,nano-HA,0,0
103385,paste,0,0
103386,showed,0,0
103387,a,0,0
103388,reduction,0,0
103389,in,0,0
103390,mean,0,1
103391,PPD,0,1
103392,from,0,1
103393,8.3,0,0
103394,?,0,1
103395,1.2,0,0
103396,to,0,0
103397,4.0,0,0
103398,?,0,0
103399,1.1,0,0
103400,mm,0,0
103401,and,0,0
103402,a,0,0
103403,gain,0,0
103404,in,0,0
103405,PBL,0,0
103406,of,0,1
103407,4.3,0,0
103408,?,0,1
103409,1.4,0,0
103410,mm,0,0
103411,",",0,0
103412,whereas,0,0
103413,in,0,0
103414,the,0,0
103415,control,0,0
103416,group,0,0
103417,",",0,0
103418,the,0,0
103419,mean,0,0
103420,PPD,0,0
103421,changed,0,0
103422,from,0,1
103423,7.9,0,1
103424,?,0,1
103425,1.2,0,0
103426,mm,0,0
103427,to,0,1
103428,5.0,0,0
103429,?,0,0
103430,1.2,0,0
103431,mm,0,0
103432,and,0,0
103433,PBL,0,0
103434,gain,0,0
103435,was,0,0
103436,2.6,0,0
103437,?,0,1
103438,1.4,0,0
103439,mm,0,0
103440,.,0,1
103441,Results,0,0
103442,demonstrated,0,0
103443,statistically,0,0
103444,greater,0,0
103445,PPD,0,0
103446,reduction,0,0
103447,and,0,0
103448,PBL,0,0
103449,gain,0,0
103450,(,0,0
103451,p,0,0
103452,<,0,0
103453,0.05,0,0
103454,),0,0
103455,in,0,0
103456,the,0,0
103457,test,0,0
103458,group,0,0
103459,as,0,0
103460,compared,0,0
103461,with,0,1
103462,the,0,0
103463,control,0,0
103464,group,0,0
103465,.,0,0
103466,In,0,0
103467,conclusion,0,0
103468,",",0,0
103469,after,0,0
103470,6,0,0
103471,months,0,0
103472,",",0,0
103473,the,0,0
103474,treatment,0,0
103475,of,0,0
103476,intrabony,0,1
103477,periodontal,0,1
103478,defects,0,1
103479,with,0,1
103480,a,0,0
103481,nano-HA,0,0
103482,paste,0,0
103483,leads,0,0
103484,to,0,0
103485,significantly,0,0
103486,improved,0,0
103487,clinical,0,0
103488,outcomes,0,0
103489,when,0,0
103490,compared,0,0
103491,with,0,0
103492,papilla,0,0
103493,preservation,0,0
103494,flap,0,0
103495,surgery,0,1
103496,alone,0,0
103497,.,0,0
103498,Clinical,0,0
103499,trial,0,0
103500,of,0,0
103501,tooth,0,0
103502,whitening,0,0
103503,with,0,1
103504,6,0,0
103505,%,0,0
103506,hydrogen,0,0
103507,peroxide,0,0
103508,whitening,0,0
103509,strips,0,0
103510,and,0,1
103511,two,0,0
103512,whitening,0,1
103513,dentifrices,0,0
103514,.,0,1
103515,PURPOSE,0,0
103516,To,0,0
103517,compare,0,0
103518,tooth,0,0
103519,whitening,0,0
103520,with,0,1
103521,6,0,0
103522,%,0,0
103523,hydrogen,0,0
103524,peroxide,0,0
103525,whitening,0,0
103526,strips,0,0
103527,and,0,1
103528,two,0,0
103529,whitening,0,0
103530,dentifrices,0,0
103531,in,0,0
103532,a,0,0
103533,12-week,0,0
103534,randomized,0,0
103535,controlled,0,0
103536,trial,0,0
103537,at,0,0
103538,a,0,0
103539,Belgian,1,1
103540,dental,1,1
103541,school,1,1
103542,.,1,0
103543,METHODS,0,0
103544,After,0,0
103545,informed,0,0
103546,consent,0,1
103547,",",0,0
103548,46,1,1
103549,healthy,1,1
103550,adults,1,1
103551,were,1,1
103552,randomly,1,1
103553,assigned,1,1
103554,to,0,0
103555,one,0,1
103556,of,0,0
103557,three,0,0
103558,strip,0,0
103559,+,0,0
103560,dentifrice,0,0
103561,treatment,0,0
103562,groups,0,0
103563,.,0,1
103564,Subjects,0,1
103565,received,0,0
103566,either,0,1
103567,6,0,0
103568,%,0,0
103569,hydrogen,0,0
103570,peroxide,0,0
103571,whitening,0,0
103572,strips,0,0
103573,(,0,1
103574,Crest,0,0
103575,Whitestrips,0,0
103576,),0,0
103577,and,0,0
103578,an,0,0
103579,anticavity,0,0
103580,toothpaste,0,0
103581,(,0,0
103582,Crest,0,0
103583,Cavity,0,1
103584,Protection,0,1
103585,),0,0
103586,",",0,0
103587,placebo,0,0
103588,strips,0,0
103589,and,0,0
103590,a,0,0
103591,sodium,0,0
103592,fluoride,0,0
103593,(,0,0
103594,NaF,0,0
103595,),0,0
103596,whitening,0,0
103597,dentifrice,0,0
103598,(,0,0
103599,Mentadent,0,0
103600,Whitening,0,0
103601,Toothpaste,0,0
103602,),0,0
103603,or,0,1
103604,placebo,0,0
103605,strips,0,0
103606,and,0,0
103607,a,0,0
103608,sodium,0,0
103609,monofluorophosphate,0,0
103610,(,0,0
103611,MFP,0,1
103612,),0,0
103613,whitening,0,0
103614,dentifrice,0,0
103615,(,0,0
103616,Rembrandt,0,1
103617,Low,0,1
103618,Abrasion,0,1
103619,Whitening,0,0
103620,Toothpaste,0,0
103621,),0,1
103622,.,0,0
103623,Strip,0,0
103624,use,0,0
103625,(,0,0
103626,peroxide,0,0
103627,or,0,1
103628,placebo,0,0
103629,),0,0
103630,was,0,0
103631,for,0,0
103632,30,0,1
103633,minutes,0,0
103634,",",0,0
103635,twice,0,0
103636,daily,0,0
103637,for,0,0
103638,2,0,0
103639,weeks,0,0
103640,",",0,0
103641,while,0,0
103642,dentifrice,0,0
103643,use,0,0
103644,was,0,0
103645,at,0,0
103646,least,0,1
103647,twice,0,0
103648,daily,0,0
103649,for,0,0
103650,12,0,0
103651,weeks,0,0
103652,.,0,1
103653,Efficacy,0,0
103654,was,0,0
103655,measured,0,0
103656,from,0,1
103657,standardized,0,0
103658,digital,0,0
103659,images,0,0
103660,of,0,0
103661,the,0,0
103662,maxillary,0,1
103663,facial,0,0
103664,tooth,0,1
103665,surfaces,0,0
103666,",",0,0
103667,while,0,0
103668,safety,0,0
103669,was,0,0
103670,evaluated,0,0
103671,from,0,0
103672,oral,0,0
103673,examination,0,0
103674,and,0,0
103675,interview,0,0
103676,.,0,1
103677,Treatments,0,0
103678,were,0,0
103679,compared,0,0
103680,after,0,0
103681,2,0,0
103682,weeks,0,0
103683,(,0,1
103684,strip,0,0
103685,use,0,0
103686,),0,0
103687,and,0,0
103688,12,0,0
103689,weeks,0,0
103690,(,0,1
103691,dentifrice,0,0
103692,use,0,0
103693,),0,0
103694,using,0,0
103695,analysis,0,0
103696,of,0,0
103697,covariance,0,0
103698,.,0,1
103699,RESULTS,0,0
103700,All,0,1
103701,subjects,0,1
103702,completed,0,1
103703,the,0,0
103704,12-week,0,0
103705,evaluation,0,0
103706,.,0,0
103707,Adjusting,0,0
103708,for,0,0
103709,baseline,0,0
103710,and,0,0
103711,age,0,1
103712,",",0,0
103713,the,0,0
103714,peroxide,0,0
103715,strip,0,0
103716,group,0,0
103717,had,0,1
103718,-2.45,0,0
103719,Deltab*,0,0
103720,",",0,0
103721,2.39,0,0
103722,DeltaL*,0,0
103723,",",0,0
103724,and,0,0
103725,-0.96,0,0
103726,Deltaa*,0,0
103727,at,0,1
103728,Week,0,1
103729,2,0,1
103730,.,0,1
103731,Between-group,0,0
103732,comparisons,0,0
103733,demonstrated,0,0
103734,significant,0,0
103735,(,0,1
103736,P,0,0
103737,<,0,0
103738,0.0001,0,0
103739,),0,1
103740,reductions,0,0
103741,in,0,0
103742,yellowness,0,0
103743,and,0,0
103744,redness,0,0
103745,",",0,0
103746,and,0,0
103747,increased,0,0
103748,brightness,0,0
103749,favoring,0,0
103750,the,0,0
103751,peroxide,0,0
103752,strip,0,0
103753,group,0,0
103754,.,0,0
103755,The,0,0
103756,peroxide,0,0
103757,strip,0,0
103758,group,0,0
103759,demonstrated,0,0
103760,95,0,0
103761,%,0,0
103762,+,0,0
103763,color,0,0
103764,retention,0,0
103765,(,0,0
103766,Deltab*,0,0
103767,&,0,1
103768,DeltaL*,0,0
103769,),0,0
103770,at,0,0
103771,Week,0,1
103772,12,0,0
103773,",",0,0
103774,differing,0,0
103775,significantly,0,0
103776,(,0,0
103777,P,0,0
103778,<,0,0
103779,0.0001,0,0
103780,),0,0
103781,versus,0,0
103782,either,0,0
103783,of,0,0
103784,the,0,0
103785,continuously,0,0
103786,used,0,0
103787,whitening,0,0
103788,dentifrices,0,0
103789,.,0,0
103790,There,0,0
103791,were,0,0
103792,no,0,0
103793,significant,0,0
103794,(,0,0
103795,P,0,0
103796,>,0,1
103797,0.18,0,0
103798,),0,1
103799,differences,0,0
103800,between,0,0
103801,the,0,0
103802,whitening,0,0
103803,dentifrice,0,0
103804,groups,0,0
103805,at,0,0
103806,any,0,1
103807,timepoints,0,0
103808,.,0,0
103809,All,0,1
103810,treatments,0,0
103811,were,0,0
103812,well-tolerated,0,0
103813,",",0,0
103814,with,0,1
103815,minor,0,0
103816,tooth,0,0
103817,sensitivity,0,0
103818,and,0,0
103819,oral,0,0
103820,irritation,0,0
103821,representing,0,0
103822,the,0,0
103823,most,0,0
103824,common,0,0
103825,findings,0,0
103826,.,0,1
103827,Depiction,0,0
103828,of,0,0
103829,hypervascular,1,1
103830,hepatocellular,1,1
103831,carcinoma,1,1
103832,with,0,1
103833,64-MDCT,0,1
103834,:,0,1
103835,comparison,0,0
103836,of,0,0
103837,moderate-,0,0
103838,and,0,0
103839,high-concentration,0,0
103840,contrast,0,0
103841,material,0,1
103842,with,0,1
103843,and,0,0
103844,without,0,1
103845,saline,0,0
103846,flush,0,0
103847,.,0,0
103848,OBJECTIVE,0,0
103849,The,0,0
103850,purpose,0,0
103851,of,0,0
103852,this,0,0
103853,study,0,0
103854,was,0,0
103855,to,0,0
103856,evaluate,0,0
103857,prospectively,0,0
103858,the,0,0
103859,depiction,0,0
103860,of,0,0
103861,hypervascular,0,1
103862,hepatocellular,0,1
103863,carcinoma,0,1
103864,on,0,0
103865,64-MDCT,0,1
103866,scans,0,0
103867,obtained,0,0
103868,with,0,1
103869,contrast,0,0
103870,agents,0,0
103871,of,0,0
103872,varying,0,1
103873,iodine,0,1
103874,concentrations,0,0
103875,administered,0,0
103876,with,0,1
103877,and,0,0
103878,without,0,1
103879,saline,0,0
103880,flush,0,0
103881,.,0,1
103882,SUBJECTS,0,0
103883,AND,0,0
103884,METHODS,0,0
103885,The,1,0
103886,study,1,0
103887,included,1,1
103888,149,1,1
103889,patients,1,1
103890,",",1,1
103891,among,1,1
103892,whom,1,1
103893,36,1,1
103894,patients,1,1
103895,with,1,1
103896,hypervascular,1,1
103897,hepatocellular,1,1
103898,carcinoma,1,1
103899,were,1,0
103900,identified,1,0
103901,.,1,1
103902,Patients,0,1
103903,were,0,0
103904,randomly,0,1
103905,assigned,0,1
103906,to,0,0
103907,one,0,1
103908,of,0,0
103909,three,0,1
103910,protocols,0,0
103911,:,0,1
103912,A,0,0
103913,",",0,0
103914,contrast,0,0
103915,material,0,1
103916,of,0,0
103917,300,0,0
103918,mg,0,0
103919,I/mL,0,1
103920,;,0,1
103921,B,0,0
103922,",",0,0
103923,370,0,1
103924,mg,0,0
103925,I/mL,0,1
103926,;,0,0
103927,C,0,0
103928,",",0,0
103929,370,0,1
103930,mg,0,0
103931,I/mL,0,1
103932,plus,0,0
103933,saline,0,0
103934,flush,0,0
103935,.,0,0
103936,In,0,0
103937,all,0,0
103938,protocols,0,0
103939,",",0,0
103940,the,0,0
103941,same,0,0
103942,iodine,0,0
103943,load,0,0
103944,per,0,0
103945,kilogram,0,0
103946,of,0,0
103947,body,0,1
103948,weight,0,1
103949,(,0,0
103950,516,0,1
103951,mg/kg,0,0
103952,),0,0
103953,was,0,0
103954,administered,0,0
103955,for,0,0
103956,the,0,0
103957,same,0,0
103958,injection,0,0
103959,duration,0,0
103960,(,0,0
103961,30,0,1
103962,seconds,0,0
103963,),0,1
103964,.,0,1
103965,Enhancement,0,0
103966,values,0,0
103967,in,0,0
103968,the,0,0
103969,aorta,0,0
103970,",",0,0
103971,liver,0,0
103972,",",0,0
103973,and,0,0
103974,portal,0,0
103975,vein,0,1
103976,and,0,0
103977,tumor-liver,0,1
103978,contrast,0,0
103979,were,0,0
103980,measured,0,0
103981,at,0,0
103982,multiphase,0,1
103983,CT,0,1
103984,.,0,1
103985,RESULTS,0,0
103986,Aortic,0,1
103987,enhancement,0,0
103988,was,0,0
103989,significantly,0,0
103990,different,0,0
103991,between,0,0
103992,protocols,0,0
103993,A,0,1
103994,and,0,1
103995,B,0,0
103996,(,0,0
103997,p,0,0
103998,=,0,0
103999,0.04,0,0
104000,",",0,0
104001,p,0,0
104002,<,0,0
104003,0.0001,0,0
104004,),0,0
104005,and,0,0
104006,protocols,0,0
104007,B,0,0
104008,and,0,0
104009,C,0,0
104010,(,0,0
104011,p,0,0
104012,=,0,0
104013,0.02,0,0
104014,",",0,0
104015,p,0,0
104016,<,0,0
104017,0.001,0,0
104018,),0,0
104019,in,0,0
104020,the,0,0
104021,first,0,0
104022,and,0,0
104023,second,0,1
104024,phases,0,0
104025,.,0,1
104026,Portal,0,0
104027,venous,0,0
104028,enhancement,0,0
104029,was,0,0
104030,significantly,0,0
104031,different,0,0
104032,between,0,0
104033,protocols,0,0
104034,B,0,1
104035,and,0,1
104036,C,0,0
104037,(,0,0
104038,p,0,0
104039,=,0,0
104040,0.02,0,0
104041,),0,0
104042,in,0,0
104043,the,0,0
104044,first,0,0
104045,phase,0,0
104046,and,0,0
104047,between,0,0
104048,protocols,0,0
104049,B,0,1
104050,and,0,1
104051,C,0,0
104052,and,0,0
104053,protocols,0,0
104054,A,0,0
104055,and,0,0
104056,C,0,0
104057,(,0,0
104058,p,0,0
104059,<,0,0
104060,0.01,0,0
104061,",",0,0
104062,p,0,0
104063,=,0,0
104064,0.02,0,0
104065,),0,0
104066,in,0,0
104067,the,0,0
104068,second,0,0
104069,phase,0,1
104070,.,0,1
104071,Tumor-liver,0,0
104072,contrast,0,0
104073,was,0,0
104074,significantly,0,0
104075,different,0,0
104076,between,0,0
104077,protocols,0,0
104078,A,0,1
104079,and,0,1
104080,B,0,0
104081,(,0,0
104082,p,0,0
104083,=,0,0
104084,0.03,0,0
104085,",",0,0
104086,p,0,0
104087,=,0,0
104088,0.02,0,0
104089,),0,0
104090,and,0,0
104091,protocols,0,0
104092,B,0,0
104093,and,0,0
104094,C,0,0
104095,(,0,0
104096,p,0,0
104097,=,0,0
104098,0.03,0,0
104099,",",0,0
104100,p,0,0
104101,=,0,0
104102,0.04,0,0
104103,),0,0
104104,in,0,0
104105,the,0,0
104106,first,0,0
104107,and,0,0
104108,second,0,1
104109,phases,0,0
104110,but,0,0
104111,not,0,0
104112,between,0,0
104113,protocols,0,0
104114,A,0,1
104115,and,0,1
104116,C.,0,0
104117,There,0,0
104118,was,0,0
104119,no,0,0
104120,significant,0,0
104121,difference,0,0
104122,in,0,0
104123,hepatic,0,0
104124,enhancement,0,0
104125,among,0,0
104126,the,0,0
104127,three,0,0
104128,protocols,0,0
104129,.,0,1
104130,CONCLUSION,0,0
104131,Use,0,0
104132,of,0,0
104133,moderate,0,1
104134,concentration,0,0
104135,was,0,0
104136,more,0,0
104137,effective,0,0
104138,than,0,0
104139,use,0,0
104140,of,0,0
104141,a,0,0
104142,high,0,0
104143,concentration,0,0
104144,of,0,0
104145,contrast,0,0
104146,material,0,1
104147,for,0,0
104148,depiction,0,0
104149,of,0,0
104150,hepatocellular,0,1
104151,carcinoma,0,1
104152,.,0,0
104153,Adding,0,0
104154,a,0,0
104155,saline,0,0
104156,flush,0,0
104157,to,0,0
104158,the,0,0
104159,high-concentration,0,0
104160,protocol,0,0
104161,eliminated,0,0
104162,the,0,0
104163,difference,0,0
104164,in,0,0
104165,depiction,0,0
104166,of,0,0
104167,hepatocellular,0,1
104168,carcinoma,0,1
104169,between,0,0
104170,the,0,0
104171,moderate-,0,0
104172,and,0,0
104173,high-concentration,0,0
104174,protocols,0,0
104175,.,0,1
104176,Randomized,0,0
104177,",",0,0
104178,placebo-controlled,0,0
104179,",",0,0
104180,crossover,0,0
104181,study,0,0
104182,of,0,0
104183,methylphenidate,0,0
104184,for,0,0
104185,attention-deficit/hyperactivity,0,1
104186,disorder,0,1
104187,symptoms,0,0
104188,in,1,0
104189,preschoolers,1,1
104190,with,1,1
104191,developmental,1,1
104192,disorders,1,1
104193,.,1,1
104194,OBJECTIVE,0,0
104195,The,0,0
104196,aim,0,0
104197,of,0,0
104198,this,0,0
104199,study,0,0
104200,was,0,0
104201,to,0,0
104202,investigate,0,0
104203,the,0,0
104204,short-term,0,0
104205,efficacy,0,0
104206,and,0,0
104207,safety,0,0
104208,of,0,0
104209,methylphenidate,0,0
104210,(,0,0
104211,MPH,0,0
104212,),0,0
104213,to,0,0
104214,treat,0,0
104215,attention-deficit/hyperactivity,0,1
104216,disorder,0,1
104217,(,0,0
104218,ADHD,0,0
104219,),0,1
104220,symptoms,0,0
104221,in,0,0
104222,an,0,0
104223,understudied,1,0
104224,population,1,1
104225,of,1,0
104226,preschoolers,1,1
104227,with,1,1
104228,pervasive,1,1
104229,developmental,1,1
104230,disorder,1,1
104231,(,1,0
104232,PDD,1,0
104233,),1,0
104234,or,1,1
104235,intellectual,1,1
104236,disability,1,0
104237,(,1,0
104238,ID,1,1
104239,),1,1
104240,.,1,1
104241,METHODS,0,0
104242,Fourteen,1,1
104243,preschoolers,1,1
104244,with,1,1
104245,developmental,1,1
104246,disorders,1,1
104247,(,1,1
104248,DD,1,0
104249,",",1,0
104250,n,1,1
104251,=,1,0
104252,14,1,0
104253,;,1,0
104254,PDD,1,0
104255,",",1,0
104256,n,1,1
104257,=,1,0
104258,12,1,0
104259,;,1,0
104260,ID,1,0
104261,",",1,0
104262,n,1,1
104263,=,1,0
104264,2,1,1
104265,),1,0
104266,underwent,0,1
104267,MPH,0,0
104268,titration,0,0
104269,in,0,0
104270,a,0,0
104271,single-blind,0,0
104272,manner,0,0
104273,followed,0,0
104274,by,0,0
104275,a,0,0
104276,4-week,0,0
104277,double-blind,0,0
104278,crossover,0,1
104279,phase,0,0
104280,.,0,0
104281,Each,0,0
104282,child,0,0
104283,was,0,0
104284,administered,0,0
104285,placebo,0,0
104286,for,0,0
104287,2,0,0
104288,weeks,0,0
104289,and,0,1
104290,optimal,0,0
104291,dose,0,0
104292,for,0,0
104293,2,0,1
104294,weeks,0,0
104295,.,0,1
104296,The,0,0
104297,primary,0,0
104298,outcome,0,0
104299,measure,0,0
104300,was,0,0
104301,the,0,0
104302,Diagnostic,0,0
104303,and,0,0
104304,Statistical,0,0
104305,Manual,0,1
104306,of,0,0
104307,Mental,0,1
104308,Disorders,0,1
104309,",",0,0
104310,4,0,0
104311,(,0,0
104312,th,0,0
104313,),0,0
104314,edition,0,1
104315,(,0,0
104316,DSM-IV,0,1
104317,),0,0
104318,ADHD,0,0
104319,subscale,0,0
104320,of,0,0
104321,the,0,0
104322,Conners,0,1
104323,',0,0
104324,Parent,0,1
104325,Rating,0,0
104326,Scale-Revised,0,0
104327,(,0,1
104328,CPRS-R-DSM-IV-ADHD,0,1
104329,),0,1
104330,.,0,1
104331,RESULTS,0,0
104332,MPH,0,0
104333,improved,0,0
104334,parent-rated,0,0
104335,ADHD,0,0
104336,symptoms,0,0
104337,of,0,0
104338,the,0,1
104339,preschoolers,0,1
104340,;,0,0
104341,50,0,1
104342,%,0,0
104343,were,0,0
104344,rated,0,0
104345,as,0,0
104346,responders,0,0
104347,.,0,1
104348,The,0,0
104349,CPRS-R-DSM-IV-ADHD,0,0
104350,subscale,0,0
104351,was,0,0
104352,significant,0,0
104353,for,0,0
104354,the,0,0
104355,PDD,1,0
104356,subgroup,1,1
104357,(,0,0
104358,p,0,0
104359,=,0,0
104360,0.005,0,0
104361,",",0,0
104362,Cohen,0,0
104363,d,0,1
104364,=,0,0
104365,0.97,0,0
104366,),0,0
104367,and,0,0
104368,marginally,0,0
104369,significant,0,0
104370,for,0,0
104371,the,0,0
104372,entire,0,0
104373,DD,0,0
104374,sample,0,1
104375,(,0,0
104376,p,0,0
104377,=,0,0
104378,0.08,0,0
104379,",",0,0
104380,Cohen,0,0
104381,d,0,1
104382,=,0,0
104383,0.50,0,0
104384,),0,0
104385,.,0,0
104386,Half,0,0
104387,of,0,0
104388,the,0,0
104389,preschoolers,1,1
104390,experienced,0,0
104391,side,0,0
104392,effects,0,0
104393,with,0,1
104394,MPH,0,0
104395,",",0,0
104396,including,0,0
104397,reports,0,0
104398,of,0,0
104399,increased,0,0
104400,stereotypic,0,1
104401,behavior,0,0
104402,",",0,0
104403,upset,0,0
104404,stomach,0,0
104405,",",0,0
104406,sleep-related,0,0
104407,difficulties,0,0
104408,",",0,0
104409,and,0,0
104410,emotional,0,0
104411,lability,0,1
104412,.,0,1
104413,One,0,1
104414,child,0,0
104415,discontinued,0,0
104416,during,0,0
104417,titration,0,0
104418,due,0,0
104419,to,0,0
104420,side,0,0
104421,effects,0,0
104422,.,0,0
104423,CONCLUSION,0,0
104424,The,0,0
104425,predominant,0,0
104426,direction,0,0
104427,of,0,0
104428,response,0,0
104429,in,0,0
104430,these,0,0
104431,preschoolers,1,1
104432,with,1,1
104433,both,1,0
104434,ADHD,1,0
104435,and,1,0
104436,PDD/ID,1,0
104437,favored,0,0
104438,MPH,0,0
104439,",",0,0
104440,even,0,0
104441,though,0,0
104442,the,0,0
104443,response,0,0
104444,was,0,0
104445,more,0,0
104446,subtle,0,0
104447,and,0,0
104448,variable,0,0
104449,than,0,0
104450,in,0,0
104451,older,0,1
104452,and,0,0
104453,typically,0,1
104454,developing,0,0
104455,children,0,1
104456,.,0,1
104457,Due,0,0
104458,to,0,0
104459,high,0,1
104460,rates,0,0
104461,of,0,1
104462,adverse,0,0
104463,effects,0,0
104464,",",0,0
104465,preschoolers,0,1
104466,should,0,0
104467,be,0,0
104468,monitored,0,0
104469,closely,0,0
104470,.,0,0
104471,[,0,0
104472,Effects,0,0
104473,of,0,1
104474,auditory,0,0
104475,integrative,0,0
104476,training,0,0
104477,on,0,0
104478,autistic,1,1
104479,children,1,1
104480,],1,1
104481,.,0,0
104482,OBJECTIVE,0,0
104483,To,0,0
104484,explore,0,0
104485,the,0,0
104486,short-term,0,0
104487,treatment,0,0
104488,effect,0,0
104489,of,0,0
104490,the,0,0
104491,auditory,0,0
104492,integrative,0,0
104493,training,0,0
104494,on,0,0
104495,autistic,1,1
104496,children,1,1
104497,and,0,0
104498,provide,0,0
104499,them,0,1
104500,with,0,1
104501,clinical,0,0
104502,support,0,0
104503,for,0,0
104504,rehabilitative,0,1
104505,treatment,0,0
104506,.,0,1
104507,METHODS,0,0
104508,A,1,0
104509,total,1,1
104510,of,1,0
104511,81,1,1
104512,cases,1,1
104513,of,1,1
104514,autistic,1,1
104515,children,1,1
104516,were,0,1
104517,selected,0,1
104518,through,0,0
104519,the,0,0
104520,standard,0,0
104521,of,0,0
104522,DSM-4,0,0
104523,and,0,0
104524,clinical,0,0
104525,case,0,0
104526,study,0,0
104527,was,0,0
104528,used,0,0
104529,.,0,0
104530,They,0,0
104531,were,0,0
104532,divided,1,0
104533,randomly,1,1
104534,into,1,0
104535,experimental,1,0
104536,group,1,0
104537,and,1,0
104538,control,1,0
104539,one,1,0
104540,",",0,0
104541,and,0,0
104542,respectively,0,0
104543,received,0,0
104544,auditory,0,0
104545,integrative,0,0
104546,training,0,0
104547,and,0,0
104548,no,0,0
104549,training,0,0
104550,based,0,0
104551,on,0,0
104552,the,0,0
104553,multiple,0,0
104554,therapies,0,0
104555,.,0,1
104556,The,0,0
104557,patients,0,1
104558,were,0,0
104559,investigated,0,0
104560,using,0,0
104561,clinical,0,0
104562,manifestation,0,1
104563,and,0,0
104564,Autism,0,1
104565,Behavior,0,1
104566,Checklist,0,0
104567,(,0,0
104568,ABC,0,0
104569,),0,0
104570,and,0,0
104571,intelligence,0,0
104572,quotient,0,0
104573,(,0,0
104574,IQ,0,1
104575,),0,0
104576,before,0,0
104577,and,0,0
104578,after,0,0
104579,six,0,1
104580,months,0,0
104581,of,0,1
104582,treatment,0,0
104583,.,0,0
104584,The,0,0
104585,effect,0,0
104586,was,0,0
104587,evaluated,0,0
104588,through,0,0
104589,the,0,0
104590,changes,0,0
104591,of,0,0
104592,clinical,0,0
104593,manifestations,0,1
104594,and,0,1
104595,scores,0,0
104596,of,0,0
104597,ABC,0,1
104598,and,0,1
104599,IQ,0,1
104600,.,0,0
104601,The,0,0
104602,changes,0,0
104603,of,0,0
104604,scores,0,0
104605,of,0,1
104606,IQ,0,1
104607,were,0,0
104608,determined,0,0
104609,with,0,1
104610,Gesell,0,1
104611,and,0,0
104612,WPPSI,0,0
104613,or,0,1
104614,WISC-R,0,1
104615,.,0,1
104616,RESULTS,0,0
104617,Compared,0,0
104618,with,0,1
104619,40,1,1
104620,patients,1,1
104621,of,1,0
104622,the,1,0
104623,control,1,0
104624,group,1,0
104625,after,1,0
104626,the,1,0
104627,six,1,1
104628,months,1,0
104629,of,1,0
104630,the,1,0
104631,auditory,1,0
104632,integrative,1,0
104633,training,1,0
104634,",",1,0
104635,41,1,1
104636,of,1,0
104637,the,1,0
104638,experimental,1,0
104639,group,1,0
104640,had,0,0
104641,greatly,0,0
104642,improved,0,0
104643,in,0,0
104644,many,0,0
104645,aspects,0,0
104646,",",0,0
104647,such,0,0
104648,as,0,0
104649,the,0,0
104650,disorders,0,1
104651,of,0,0
104652,their,0,0
104653,language,0,0
104654,",",0,0
104655,social,0,0
104656,interactions,0,0
104657,and,0,1
104658,typical,0,1
104659,behavior,0,0
104660,symptoms,0,0
104661,while,0,0
104662,they,0,1
104663,had,0,0
104664,not,0,0
104665,changed,0,0
104666,in,0,0
104667,their,0,0
104668,abnormal,0,1
104669,behaviors,0,0
104670,.,0,1
104671,The,0,0
104672,scores,0,0
104673,of,0,0
104674,IQ,0,1
104675,or,0,1
104676,DQ,0,1
104677,had,0,0
104678,increased,0,0
104679,and,0,0
104680,scores,0,0
104681,of,0,0
104682,ABC,0,1
104683,had,0,1
104684,dropped,0,0
104685,.,0,0
104686,The,0,0
104687,differences,0,0
104688,between,0,0
104689,the,0,0
104690,two,1,0
104691,groups,1,0
104692,were,0,1
104693,greatly,0,0
104694,significant,0,0
104695,in,0,0
104696,statistics,0,0
104697,(,0,1
104698,P,0,0
104699,<,0,0
104700,0.01,0,0
104701,),0,0
104702,.,0,0
104703,The,0,0
104704,decreasing,0,0
104705,level,0,0
104706,of,0,0
104707,both,0,0
104708,ABC,0,0
104709,scores,0,0
104710,and,0,0
104711,the,0,0
104712,increasing,0,0
104713,level,0,0
104714,of,0,0
104715,the,0,0
104716,IQ,0,1
104717,scores,0,0
104718,were,0,0
104719,negatively,0,0
104720,correlated,0,0
104721,with,0,0
104722,age,0,1
104723,",",0,0
104724,and,0,0
104725,the,0,0
104726,decreasing,0,0
104727,level,0,0
104728,of,0,0
104729,ABC,0,0
104730,scores,0,0
104731,was,0,0
104732,in,0,0
104733,line,0,0
104734,regression,0,0
104735,(,0,0
104736,positive,0,0
104737,correlation,0,0
104738,),0,0
104739,with,0,1
104740,base,0,0
104741,IQ,0,1
104742,.,0,1
104743,CONCLUSION,0,0
104744,The,0,0
104745,treatment,0,0
104746,of,0,0
104747,auditory,0,0
104748,integrative,0,0
104749,training,0,0
104750,(,0,0
104751,AIT,0,0
104752,),0,0
104753,could,0,0
104754,greatly,0,0
104755,improve,0,0
104756,on,0,0
104757,language,0,0
104758,disorders,0,1
104759,",",0,0
104760,the,0,0
104761,difficulties,0,0
104762,of,0,0
104763,social,0,1
104764,interactions,0,0
104765,",",0,0
104766,typical,0,1
104767,behavior,0,0
104768,symptoms,0,0
104769,and,0,1
104770,developmental,0,1
104771,levels,0,0
104772,",",0,0
104773,therefore,0,0
104774,it,0,0
104775,is,0,0
104776,positive,0,0
104777,to,0,0
104778,the,0,0
104779,autistic,1,1
104780,children,1,1
104781,in,0,0
104782,its,0,0
104783,short-term,0,0
104784,treatment,0,0
104785,effect,0,0
104786,.,0,1
104787,Phase,0,1
104788,III,0,1
104789,",",0,0
104790,randomised,0,0
104791,",",0,0
104792,multicentre,0,0
104793,trial,0,0
104794,of,0,0
104795,maintenance,0,0
104796,immunotherapy,0,0
104797,with,0,1
104798,low-dose,0,0
104799,interleukin-2,0,0
104800,and,0,0
104801,interferon-alpha,0,0
104802,for,0,0
104803,metastatic,1,1
104804,renal,1,1
104805,cell,1,1
104806,cancer,1,1
104807,.,1,0
104808,This,0,0
104809,is,0,0
104810,the,0,0
104811,first,0,0
104812,phase,0,1
104813,III,0,1
104814,randomised,0,0
104815,trial,0,0
104816,to,0,0
104817,evaluate,0,0
104818,maintenance,0,0
104819,immunotherapy,0,0
104820,in,0,0
104821,metastatic,1,1
104822,renal,1,1
104823,cell,1,1
104824,cancer,1,1
104825,(,0,0
104826,mRCC,0,0
104827,),0,0
104828,.,0,1
104829,Patients,1,1
104830,were,0,0
104831,randomised,0,0
104832,to,0,0
104833,receive,0,0
104834,treatment,0,0
104835,with,0,0
104836,a,0,0
104837,4-week,0,0
104838,cycle,0,0
104839,of,0,0
104840,subcutaneous,0,0
104841,low,0,1
104842,doses,0,0
104843,IL-2,0,1
104844,+,0,0
104845,IFN,0,1
104846,in,0,1
104847,months,0,0
104848,1,0,1
104849,",",0,0
104850,3,0,0
104851,and,0,0
104852,5,0,0
104853,",",0,0
104854,and,0,0
104855,then,0,0
104856,every,0,0
104857,3,0,0
104858,months,0,0
104859,until,0,0
104860,the,0,0
104861,first,0,0
104862,documented,0,0
104863,disease,0,1
104864,progression,0,0
104865,(,0,0
104866,arm,0,0
104867,A,0,0
104868,",",0,0
104869,suspension,0,0
104870,),0,0
104871,",",0,0
104872,or,0,0
104873,the,0,0
104874,same,0,0
104875,regimen,0,0
104876,",",0,0
104877,with,0,1
104878,chronic,0,1
104879,maintenance,0,0
104880,of,0,0
104881,immunotherapy,0,0
104882,",",0,0
104883,regardless,0,0
104884,of,0,0
104885,tumour,0,0
104886,response,0,0
104887,",",0,0
104888,until,0,0
104889,death,0,0
104890,or,0,1
104891,intolerable,0,0
104892,toxicity,0,0
104893,(,0,0
104894,arm,0,0
104895,B,0,0
104896,",",0,0
104897,maintenance,0,0
104898,),0,0
104899,.,0,0
104900,The,0,0
104901,primary,0,0
104902,endpoint,0,0
104903,was,0,0
104904,overall,0,0
104905,survival,0,0
104906,(,0,0
104907,OS,0,0
104908,),0,1
104909,;,0,0
104910,secondary,0,1
104911,endpoints,0,0
104912,were,0,1
104913,time,0,0
104914,from,0,0
104915,first,0,0
104916,progression,0,0
104917,to,0,0
104918,death,0,0
104919,(,0,0
104920,TFPTD,0,1
104921,),0,0
104922,and,0,0
104923,tolerability,0,0
104924,.,0,1
104925,One,1,1
104926,hundred,1,1
104927,and,1,1
104928,eighty-three,1,1
104929,patients,1,1
104930,were,1,1
104931,enrolled,1,1
104932,between,1,0
104933,January,1,1
104934,1998,1,1
104935,and,1,0
104936,November,1,1
104937,2003,1,1
104938,.,1,0
104939,After,0,0
104940,a,0,0
104941,median,0,0
104942,follow-up,0,0
104943,of,0,0
104944,53.9,0,1
104945,months,0,0
104946,",",0,0
104947,response,0,0
104948,rate,0,0
104949,",",0,0
104950,median,0,0
104951,OS,0,0
104952,and,0,0
104953,median,0,1
104954,TFPTD,0,1
104955,were,0,1
104956,14.7,0,0
104957,%,0,0
104958,(,0,0
104959,6.3,0,0
104960,%,0,0
104961,CR,0,0
104962,),0,0
104963,versus,0,0
104964,11.3,0,0
104965,%,0,0
104966,(,0,0
104967,5.5,0,0
104968,%,0,0
104969,CR,0,0
104970,),0,0
104971,",",0,0
104972,14,0,0
104973,versus,0,0
104974,14,0,1
104975,months,0,0
104976,",",0,1
104977,6,0,0
104978,versus,0,0
104979,5,0,0
104980,months,0,0
104981,",",0,0
104982,in,0,0
104983,arms,0,0
104984,A,0,1
104985,and,0,0
104986,B,0,0
104987,",",0,0
104988,respectively,0,0
104989,with,0,0
104990,no,0,0
104991,significant,0,0
104992,differences,0,0
104993,between,0,0
104994,the,0,0
104995,groups,0,0
104996,.,0,1
104997,Cox,0,0
104998,regression,0,0
104999,analysis,0,0
105000,showed,0,0
105001,that,0,0
105002,the,0,0
105003,use,0,0
105004,of,0,0
105005,chemotherapy,0,0
105006,after,0,0
105007,first,0,0
105008,progression,0,0
105009,(,0,1
105010,HR,0,0
105011,0.54,0,0
105012,;,0,1
105013,95,0,0
105014,%,0,0
105015,CI,0,0
105016,0.35-0.86,0,0
105017,;,0,0
105018,p,0,0
105019,=,0,0
105020,0.008,0,0
105021,),0,0
105022,",",0,0
105023,PS,0,1
105024,=,0,0
105025,0,0,0
105026,(,0,0
105027,HR,0,0
105028,0.53,0,0
105029,;,0,1
105030,95,0,0
105031,%,0,0
105032,CI,0,0
105033,0.35-0.81,0,0
105034,;,0,0
105035,p,0,0
105036,=,0,0
105037,0.001,0,0
105038,),0,0
105039,and,0,0
105040,female,0,1
105041,gender,0,1
105042,(,0,1
105043,HR,0,0
105044,0.63,0,0
105045,;,0,1
105046,95,0,0
105047,%,0,0
105048,CI,0,0
105049,0.41-0.98,0,0
105050,;,0,0
105051,p,0,0
105052,=,0,0
105053,0.038,0,0
105054,),0,0
105055,were,0,0
105056,significantly,0,0
105057,associated,0,0
105058,with,0,0
105059,a,0,0
105060,longer,0,0
105061,TFPTD,0,0
105062,;,0,0
105063,treatment,0,0
105064,arm,0,0
105065,was,0,0
105066,not,0,0
105067,significant,0,0
105068,(,0,0
105069,HR,0,0
105070,0.88,0,0
105071,;,0,1
105072,95,0,0
105073,%,0,0
105074,CI,0,0
105075,0.60-1.31,0,0
105076,;,0,0
105077,p,0,0
105078,=,0,0
105079,0.54,0,0
105080,),0,0
105081,.,0,1
105082,Toxicity,0,0
105083,was,0,0
105084,mainly,0,0
105085,limited,0,0
105086,to,0,0
105087,WHO,0,0
105088,grades,0,1
105089,1,0,0
105090,or,0,1
105091,2,0,0
105092,.,0,1
105093,Chronic,0,1
105094,maintenance,0,0
105095,immunotherapy,0,0
105096,after,0,0
105097,disease,0,1
105098,progression,0,0
105099,is,0,0
105100,feasible,0,0
105101,",",0,0
105102,but,0,0
105103,does,0,0
105104,not,0,0
105105,significantly,0,0
105106,increase,0,0
105107,OS,0,0
105108,or,0,0
105109,the,0,0
105110,TFPTD,0,1
105111,.,0,1
105112,A,0,0
105113,placebo-controlled,0,0
105114,",",0,0
105115,fixed-dose,0,0
105116,study,0,0
105117,of,0,0
105118,aripiprazole,0,0
105119,in,0,0
105120,children,1,1
105121,and,1,1
105122,adolescents,1,1
105123,with,1,1
105124,irritability,1,0
105125,associated,1,0
105126,with,1,1
105127,autistic,1,1
105128,disorder,1,1
105129,.,1,0
105130,OBJECTIVE,0,0
105131,To,0,0
105132,evaluate,0,0
105133,the,0,0
105134,short-term,0,0
105135,efficacy,0,0
105136,and,0,0
105137,safety,0,0
105138,of,0,0
105139,aripiprazole,0,0
105140,in,0,0
105141,the,0,0
105142,treatment,0,0
105143,of,0,0
105144,irritability,0,0
105145,in,0,0
105146,children,1,1
105147,and,1,1
105148,adolescents,1,1
105149,with,1,1
105150,autistic,1,1
105151,disorder,1,1
105152,.,1,1
105153,METHOD,0,0
105154,Two,1,1
105155,hundred,1,1
105156,eighteen,1,1
105157,children,1,1
105158,and,1,1
105159,adolescents,1,1
105160,(,1,1
105161,aged,1,1
105162,6-17,1,1
105163,years,1,1
105164,),1,1
105165,with,1,1
105166,a,1,0
105167,diagnosis,1,1
105168,of,1,0
105169,autistic,1,1
105170,disorder,1,1
105171,",",1,0
105172,and,1,0
105173,with,1,1
105174,behaviors,1,0
105175,such,1,0
105176,as,1,0
105177,tantrums,1,1
105178,",",1,0
105179,aggression,1,1
105180,",",1,0
105181,self-injurious,1,1
105182,behavior,1,0
105183,",",1,0
105184,or,1,0
105185,a,1,0
105186,combination,1,0
105187,of,1,0
105188,these,1,0
105189,symptoms,1,0
105190,",",0,0
105191,were,0,0
105192,randomized,0,0
105193,1:1:1:1,0,0
105194,to,0,0
105195,aripiprazole,0,0
105196,(,0,0
105197,5,0,0
105198,",",0,0
105199,10,0,0
105200,",",0,0
105201,or,0,1
105202,15,0,0
105203,mg/day,0,0
105204,),0,0
105205,or,0,0
105206,placebo,0,0
105207,in,0,0
105208,this,0,0
105209,8-week,0,0
105210,double-blind,0,0
105211,",",0,0
105212,randomized,0,0
105213,",",0,0
105214,placebo-controlled,0,0
105215,",",0,0
105216,parallel-group,0,0
105217,study,0,0
105218,.,0,1
105219,Efficacy,0,0
105220,was,0,0
105221,evaluated,0,0
105222,using,0,0
105223,the,0,0
105224,caregiver-rated,0,0
105225,Aberrant,0,1
105226,Behavior,0,1
105227,Checklist,0,0
105228,Irritability,0,0
105229,subscale,0,0
105230,(,0,0
105231,primary,0,0
105232,efficacy,0,0
105233,measure,0,0
105234,),0,0
105235,and,0,0
105236,the,0,0
105237,clinician-rated,0,0
105238,Clinical,0,0
105239,Global,0,1
105240,Impressions-Improvement,0,0
105241,score,0,0
105242,.,0,0
105243,Safety,0,0
105244,and,0,0
105245,tolerability,0,0
105246,were,0,0
105247,also,0,0
105248,assessed,0,0
105249,.,0,0
105250,RESULTS,0,0
105251,At,0,0
105252,week,0,0
105253,8,0,0
105254,",",0,0
105255,all,0,0
105256,aripiprazole,0,0
105257,doses,0,0
105258,produced,0,0
105259,significantly,0,0
105260,greater,0,0
105261,improvement,0,0
105262,than,0,0
105263,placebo,0,0
105264,in,0,0
105265,mean,0,1
105266,Aberrant,0,1
105267,Behavior,0,1
105268,Checklist,0,0
105269,Irritability,0,0
105270,subscale,0,0
105271,scores,0,0
105272,(,0,1
105273,5,0,0
105274,mg/day,0,0
105275,",",0,0
105276,-12.4,0,0
105277,;,0,0
105278,10,0,0
105279,mg/day,0,0
105280,",",0,0
105281,-13.2,0,0
105282,;,0,0
105283,15,0,0
105284,mg/day,0,0
105285,",",0,0
105286,-14.4,0,0
105287,;,0,0
105288,versus,0,0
105289,placebo,0,0
105290,",",0,0
105291,-8.4,0,0
105292,;,0,0
105293,all,0,0
105294,p,0,0
105295,<,0,0
105296,.05,0,0
105297,),0,0
105298,.,0,0
105299,All,0,0
105300,aripiprazole,0,0
105301,doses,0,0
105302,demonstrated,0,0
105303,significantly,0,0
105304,greater,0,0
105305,improvements,0,0
105306,in,0,0
105307,mean,0,1
105308,Clinical,0,0
105309,Global,0,1
105310,Impressions-Improvement,0,0
105311,score,0,0
105312,than,0,0
105313,placebo,0,0
105314,at,0,0
105315,week,0,0
105316,8,0,0
105317,.,0,1
105318,Discontinuation,0,0
105319,rates,0,0
105320,due,0,1
105321,to,0,1
105322,adverse,0,0
105323,events,0,0
105324,were,0,0
105325,as,0,0
105326,follows,0,0
105327,:,0,0
105328,placebo,0,0
105329,7.7,0,0
105330,%,0,0
105331,",",0,0
105332,aripiprazole,0,0
105333,5,0,1
105334,mg/day,0,1
105335,9.4,0,0
105336,%,0,0
105337,",",0,0
105338,10,0,0
105339,mg/day,0,0
105340,13.6,0,0
105341,%,0,0
105342,",",0,0
105343,and,0,0
105344,15,0,1
105345,mg/day,0,0
105346,7.4,0,0
105347,%,0,0
105348,.,0,0
105349,The,0,0
105350,most,0,0
105351,common,0,0
105352,adverse,0,0
105353,event,0,0
105354,leading,0,0
105355,to,0,0
105356,discontinuation,0,0
105357,was,0,0
105358,sedation,0,0
105359,.,0,0
105360,There,0,0
105361,were,0,0
105362,two,0,0
105363,serious,0,0
105364,adverse,0,0
105365,events,0,0
105366,:,0,1
105367,presyncope,0,1
105368,(,0,0
105369,5,0,0
105370,mg/day,0,0
105371,),0,0
105372,and,0,0
105373,aggression,0,1
105374,(,0,0
105375,10,0,0
105376,mg/day,0,1
105377,),0,0
105378,.,0,0
105379,At,0,0
105380,week,0,0
105381,8,0,0
105382,",",0,0
105383,mean,0,0
105384,weight,0,0
105385,change,0,0
105386,(,0,0
105387,last,0,0
105388,observation,0,0
105389,carried,0,0
105390,forward,0,0
105391,),0,0
105392,was,0,0
105393,as,0,0
105394,follows,0,0
105395,:,0,0
105396,placebo,0,0
105397,+0.3,0,0
105398,kg,0,0
105399,",",0,0
105400,aripiprazole,0,0
105401,5,0,0
105402,mg/day,0,0
105403,+1.3,0,0
105404,kg,0,1
105405,",",0,0
105406,10,0,0
105407,mg/day,0,0
105408,+1.3,0,0
105409,kg,0,0
105410,",",0,0
105411,and,0,0
105412,15,0,0
105413,mg/day,0,0
105414,+1.5,0,0
105415,kg,0,1
105416,;,0,0
105417,all,0,0
105418,p,0,0
105419,<,0,0
105420,.05,0,0
105421,versus,0,0
105422,placebo,0,0
105423,.,0,1
105424,CONCLUSIONS,0,0
105425,Aripiprazole,0,0
105426,was,0,0
105427,efficacious,0,0
105428,and,0,0
105429,generally,0,0
105430,safe,0,0
105431,and,0,0
105432,well,0,0
105433,tolerated,0,0
105434,in,0,0
105435,the,0,0
105436,treatment,0,0
105437,of,0,0
105438,children,1,1
105439,and,1,1
105440,adolescents,1,1
105441,with,1,1
105442,irritability,1,0
105443,associated,1,0
105444,with,1,1
105445,autistic,1,1
105446,disorder,1,1
105447,.,1,1
105448,Efficacy,0,0
105449,and,0,0
105450,long-term,0,0
105451,tolerability,0,0
105452,of,0,0
105453,sublingual,0,0
105454,fentanyl,0,0
105455,orally,0,0
105456,disintegrating,0,0
105457,tablet,0,0
105458,in,0,0
105459,the,0,0
105460,treatment,0,0
105461,of,0,0
105462,breakthrough,0,0
105463,cancer,0,1
105464,pain,0,1
105465,.,0,1
105466,BACKGROUND,0,0
105467,AND,0,0
105468,OBJECTIVES,0,0
105469,Breakthrough,0,0
105470,cancer,0,1
105471,pain,0,1
105472,(,0,0
105473,BTcP,0,0
105474,),0,0
105475,represents,0,0
105476,an,0,0
105477,important,0,0
105478,clinical,0,0
105479,challenge,0,0
105480,in,0,0
105481,the,0,0
105482,care,0,1
105483,of,0,0
105484,patients,1,1
105485,with,1,1
105486,cancer,1,1
105487,.,1,0
105488,This,0,0
105489,trial,0,0
105490,evaluated,0,0
105491,the,0,0
105492,efficacy,0,0
105493,and,0,0
105494,long-term,0,0
105495,tolerability,0,0
105496,of,0,0
105497,a,0,0
105498,sublingual,0,0
105499,formulation,0,0
105500,of,0,0
105501,the,0,0
105502,fast-acting,0,0
105503,opioid,0,0
105504,fentanyl,0,0
105505,",",0,0
105506,for,0,0
105507,the,0,0
105508,treatment,0,0
105509,of,0,0
105510,BTcP,0,1
105511,in,0,0
105512,opioid-tolerant,1,1
105513,patients,1,1
105514,with,1,1
105515,cancer,1,1
105516,.,1,1
105517,RESEARCH,0,0
105518,DESIGN,0,0
105519,AND,0,0
105520,METHODS,0,0
105521,This,0,0
105522,was,0,0
105523,a,0,0
105524,randomized,0,0
105525,",",0,0
105526,placebo-controlled,0,0
105527,",",0,0
105528,multi-center,0,0
105529,",",0,0
105530,phase,0,1
105531,III,0,0
105532,trial,0,0
105533,",",0,0
105534,conducted,1,0
105535,in,1,0
105536,opioid-tolerant,1,1
105537,male,1,1
105538,and,1,0
105539,female,1,1
105540,patients,1,1
105541,(,1,0
105542,aged,1,1
105543,>,1,1
105544,or,1,1
105545,=17,1,1
105546,years,1,1
105547,),1,1
105548,with,1,1
105549,BTcP,1,1
105550,.,1,0
105551,The,0,0
105552,study,0,0
105553,was,0,0
105554,conducted,0,0
105555,at,0,0
105556,36,0,1
105557,centers,0,1
105558,across,0,0
105559,the,0,0
105560,USA,0,0
105561,.,0,0
105562,The,0,0
105563,study,0,0
105564,comprised,0,1
105565,a,0,0
105566,2-week,0,0
105567,open-label,0,0
105568,titration,0,0
105569,phase,0,0
105570,",",0,0
105571,followed,0,0
105572,by,0,0
105573,a,0,0
105574,double-blind,0,0
105575,efficacy,0,0
105576,phase,0,0
105577,",",0,0
105578,during,0,0
105579,which,0,0
105580,patients,0,1
105581,received,0,0
105582,sublingual,0,0
105583,fentanyl,0,0
105584,citrate,0,0
105585,orally,0,0
105586,disintegrating,0,0
105587,tablet,0,0
105588,(,0,0
105589,sublingual,0,0
105590,fentanyl,0,0
105591,ODT,0,0
105592,),0,0
105593,or,0,0
105594,placebo,0,0
105595,",",0,0
105596,in,0,0
105597,a,0,0
105598,random,0,1
105599,order,0,0
105600,.,0,0
105601,The,0,0
105602,primary,0,0
105603,efficacy,0,0
105604,endpoint,0,0
105605,was,0,0
105606,the,0,0
105607,sum,0,0
105608,of,0,0
105609,pain,0,0
105610,intensity,0,0
105611,difference,0,0
105612,(,0,0
105613,SPID,0,1
105614,),0,0
105615,over,0,0
105616,30,0,1
105617,min,0,0
105618,post-administration,0,0
105619,.,0,1
105620,Secondary,0,0
105621,efficacy,0,0
105622,endpoints,0,0
105623,included,0,1
105624,pain,0,1
105625,intensity,0,0
105626,difference,0,0
105627,(,0,0
105628,PID,0,0
105629,),0,0
105630,and,0,0
105631,pain,0,0
105632,relief,0,0
105633,(,0,0
105634,PR,0,0
105635,),0,0
105636,throughout,0,0
105637,the,0,0
105638,60-min,0,0
105639,post-dose,0,0
105640,assessment,0,0
105641,period,0,0
105642,.,0,0
105643,Following,0,0
105644,efficacy,0,0
105645,evaluation,0,0
105646,",",0,0
105647,patients,0,1
105648,entered,0,1
105649,a,0,0
105650,long-term,0,0
105651,safety,0,0
105652,phase,0,0
105653,of,0,0
105654,up,0,0
105655,to,0,1
105656,12,0,1
105657,months,0,0
105658,.,0,1
105659,Adverse,0,0
105660,events,0,0
105661,were,0,1
105662,recorded,0,0
105663,throughout,0,0
105664,the,0,0
105665,study,0,0
105666,.,0,0
105667,[,0,0
105668,CLINICAL,0,0
105669,TRIAL,0,0
105670,REGISTRATION,0,0
105671,NCT00262678,0,1
105672,],0,1
105673,RESULTS,0,0
105674,A,0,0
105675,total,0,1
105676,of,0,0
105677,131,1,1
105678,patients,1,1
105679,entered,1,1
105680,the,1,0
105681,titration,1,0
105682,phase,1,0
105683,",",1,0
105684,of,1,1
105685,whom,1,1
105686,61,1,1
105687,were,1,1
105688,included,1,1
105689,in,1,0
105690,the,1,0
105691,primary,1,0
105692,efficacy,1,0
105693,analysis,1,0
105694,.,1,0
105695,Sublingual,0,0
105696,fentanyl,0,0
105697,ODT,0,0
105698,provided,0,0
105699,significant,0,0
105700,improvements,0,0
105701,in,0,0
105702,SPID,0,1
105703,relative,0,0
105704,to,0,0
105705,placebo,0,0
105706,at,0,0
105707,30,0,0
105708,min,0,0
105709,(,0,0
105710,49.5,0,1
105711,vs.,0,0
105712,36.6,0,0
105713,",",0,0
105714,p,0,0
105715,=,0,0
105716,0.0004,0,0
105717,),0,0
105718,and,0,1
105719,60,0,1
105720,min,0,0
105721,post-administration,0,0
105722,(,0,1
105723,143.0,0,0
105724,vs.,0,0
105725,104.5,0,0
105726,",",0,0
105727,p,0,0
105728,=,0,0
105729,0.0002,0,0
105730,),0,0
105731,.,0,0
105732,Furthermore,0,0
105733,",",0,0
105734,sublingual,0,0
105735,fentanyl,0,0
105736,ODT,0,0
105737,provided,0,0
105738,significant,0,0
105739,improvements,0,0
105740,in,0,0
105741,PID,0,0
105742,and,0,0
105743,PR,0,0
105744,compared,0,0
105745,to,0,0
105746,placebo,0,0
105747,",",0,0
105748,from,0,0
105749,10,0,1
105750,min,0,0
105751,post-dose,0,0
105752,(,0,1
105753,p,0,0
105754,=,0,0
105755,0.0055,0,0
105756,and,0,0
105757,p,0,0
105758,=,0,0
105759,0.049,0,0
105760,for,0,0
105761,PID,0,0
105762,and,0,0
105763,PR,0,0
105764,",",0,0
105765,respectively,0,0
105766,),0,0
105767,.,0,0
105768,Patient,0,0
105769,recruitment,0,0
105770,was,0,0
105771,stopped,0,0
105772,early,0,0
105773,",",0,0
105774,due,0,0
105775,to,0,0
105776,positive,0,0
105777,interim,0,0
105778,analysis,0,0
105779,results,0,0
105780,(,0,0
105781,significant,0,0
105782,at,0,0
105783,prespecified,0,0
105784,level,0,0
105785,",",0,0
105786,p,0,0
105787,<,0,0
105788,or,0,1
105789,=,0,0
105790,0.0414,0,0
105791,),0,0
105792,.,0,0
105793,Overall,0,0
105794,",",0,0
105795,sublingual,0,0
105796,fentanyl,0,0
105797,ODT,0,0
105798,was,0,0
105799,well-tolerated,0,0
105800,both,0,0
105801,systemically,0,0
105802,and,0,0
105803,sublingually,0,0
105804,",",0,0
105805,with,0,1
105806,41,0,1
105807,patients,0,1
105808,experiencing,0,0
105809,>,0,1
105810,or,0,1
105811,=1,0,0
105812,study,0,0
105813,drug-related,0,0
105814,adverse,0,0
105815,event,0,0
105816,(,0,0
105817,AE,0,0
105818,),0,0
105819,.,0,0
105820,The,0,0
105821,most,0,0
105822,common,0,0
105823,AEs,0,0
105824,included,0,1
105825,nausea,0,0
105826,(,0,0
105827,12.2,0,0
105828,%,0,0
105829,),0,0
105830,",",0,0
105831,vomiting,0,0
105832,(,0,0
105833,5.3,0,0
105834,%,0,0
105835,),0,0
105836,and,0,0
105837,somnolence,0,1
105838,(,0,0
105839,4.6,0,0
105840,%,0,0
105841,),0,1
105842,.,0,1
105843,One,0,1
105844,serious,0,0
105845,AE,0,0
105846,(,0,0
105847,mild,0,1
105848,affect,0,0
105849,lability,0,0
105850,),0,0
105851,was,0,0
105852,considered,0,0
105853,possibly,0,0
105854,related,0,0
105855,to,0,0
105856,study,0,0
105857,medication,0,0
105858,.,0,0
105859,The,0,0
105860,observed,0,0
105861,pattern,0,1
105862,of,0,0
105863,AEs,0,0
105864,was,0,0
105865,consistent,0,0
105866,with,0,1
105867,that,0,0
105868,previously,0,0
105869,observed,0,0
105870,with,0,1
105871,fentanyl,0,0
105872,.,0,1
105873,CONCLUSIONS,0,0
105874,Sublingual,0,0
105875,fentanyl,0,0
105876,ODT,0,0
105877,was,0,0
105878,efficacious,0,0
105879,and,0,0
105880,well-tolerated,0,0
105881,for,0,0
105882,the,0,0
105883,treatment,0,0
105884,of,0,0
105885,BTcP,0,1
105886,in,0,0
105887,opioid-tolerant,1,1
105888,patients,1,1
105889,with,1,1
105890,cancer,1,1
105891,.,1,1
105892,Sublingual,0,0
105893,fentanyl,0,0
105894,ODT,0,0
105895,provided,0,0
105896,significant,0,0
105897,improvements,0,0
105898,in,0,0
105899,pain,0,1
105900,intensity,0,0
105901,compared,0,0
105902,to,0,0
105903,placebo,0,0
105904,",",0,0
105905,from,0,0
105906,10,0,0
105907,min,0,0
105908,post-administration,0,0
105909,and,0,0
105910,throughout,0,0
105911,the,0,0
105912,60-min,0,0
105913,post-dose,0,0
105914,assessment,0,0
105915,period,0,0
105916,.,0,0
105917,Sublingual,0,0
105918,fentanyl,0,0
105919,ODT,0,0
105920,was,0,0
105921,well,0,0
105922,tolerated,0,0
105923,over,0,0
105924,12,0,0
105925,months,0,0
105926,of,0,1
105927,treatment,0,1
105928,.,0,1
105929,Direct,0,0
105930,evidence,0,0
105931,for,0,0
105932,spinal,0,1
105933,cord,0,1
105934,involvement,0,0
105935,in,0,0
105936,placebo,0,0
105937,analgesia,0,0
105938,.,0,0
105939,Placebo,0,0
105940,analgesia,0,0
105941,is,0,0
105942,a,0,0
105943,prime,0,0
105944,example,0,0
105945,of,0,0
105946,the,0,0
105947,impact,0,0
105948,that,0,0
105949,psychological,0,0
105950,factors,0,0
105951,have,0,0
105952,on,0,0
105953,pain,0,1
105954,perception,0,0
105955,.,0,0
105956,We,0,0
105957,used,0,0
105958,functional,0,0
105959,magnetic,0,0
105960,resonance,0,0
105961,imaging,0,0
105962,of,0,0
105963,the,0,0
105964,human,0,1
105965,spinal,0,1
105966,cord,0,1
105967,to,0,0
105968,test,0,0
105969,the,0,0
105970,hypothesis,0,0
105971,that,0,0
105972,placebo,0,0
105973,analgesia,0,0
105974,results,0,0
105975,in,0,0
105976,a,0,0
105977,reduction,0,0
105978,of,0,0
105979,nociceptive,1,0
105980,processing,1,0
105981,in,1,0
105982,the,1,0
105983,spinal,1,1
105984,cord,1,1
105985,.,1,0
105986,In,0,0
105987,line,0,0
105988,with,0,1
105989,behavioral,0,1
105990,data,0,0
105991,that,0,0
105992,show,0,0
105993,decreased,1,0
105994,pain,1,1
105995,responses,1,0
105996,under,1,0
105997,placebo,1,0
105998,",",0,0
105999,pain-related,0,0
106000,activity,0,0
106001,in,0,0
106002,the,0,0
106003,spinal,0,0
106004,cord,0,0
106005,is,0,0
106006,strongly,0,0
106007,reduced,0,0
106008,under,0,0
106009,placebo,0,0
106010,.,0,0
106011,These,0,0
106012,results,0,0
106013,provide,0,0
106014,direct,0,0
106015,evidence,0,0
106016,for,0,0
106017,spinal,0,1
106018,inhibition,0,0
106019,as,0,0
106020,one,0,0
106021,mechanism,0,0
106022,of,0,0
106023,placebo,0,0
106024,analgesia,0,0
106025,and,0,0
106026,highlight,0,0
106027,that,0,0
106028,psychological,0,0
106029,factors,0,0
106030,can,0,0
106031,act,0,0
106032,on,0,0
106033,the,0,0
106034,earliest,0,0
106035,stages,0,0
106036,of,0,0
106037,pain,0,1
106038,processing,0,0
106039,in,0,0
106040,the,0,0
106041,central,0,0
106042,nervous,0,0
106043,system,0,0
106044,.,0,1
106045,Enhancing,0,0
106046,antiepileptic,0,0
106047,drug,0,0
106048,adherence,0,0
106049,:,0,1
106050,a,0,0
106051,randomized,0,0
106052,controlled,0,0
106053,trial,0,0
106054,.,0,0
106055,Suboptimal,0,0
106056,adherence,0,0
106057,to,0,0
106058,antiepileptic,0,0
106059,drug,0,0
106060,(,0,0
106061,AED,0,0
106062,),0,0
106063,treatment,0,0
106064,is,0,0
106065,commonplace,0,0
106066,",",0,0
106067,and,0,0
106068,increases,0,0
106069,the,0,0
106070,risk,0,0
106071,of,0,0
106072,status,0,0
106073,epilepticus,0,1
106074,and,0,0
106075,sudden,0,0
106076,unexplained,0,1
106077,death,0,0
106078,in,0,0
106079,epilepsy,0,1
106080,.,0,0
106081,This,0,0
106082,randomized,0,0
106083,controlled,0,0
106084,trial,0,0
106085,was,0,0
106086,designed,0,0
106087,to,0,0
106088,demonstrate,0,0
106089,whether,0,0
106090,an,0,0
106091,implementation,0,0
106092,intention,0,0
106093,intervention,0,0
106094,involving,0,0
106095,the,0,0
106096,completion,0,0
106097,of,0,0
106098,a,0,0
106099,simple,0,0
106100,self-administered,0,1
106101,questionnaire,0,0
106102,linking,0,0
106103,the,0,0
106104,intention,0,0
106105,of,0,0
106106,taking,0,0
106107,medication,0,0
106108,with,0,1
106109,a,0,0
106110,particular,0,0
106111,time,0,0
106112,",",0,0
106113,place,0,0
106114,",",0,0
106115,and,0,0
106116,other,0,0
106117,activity,0,0
106118,can,0,0
106119,improve,0,0
106120,AED,0,0
106121,treatment,0,0
106122,schedule,0,0
106123,adherence,0,0
106124,.,0,0
106125,Of,0,0
106126,the,0,0
106127,81,1,1
106128,patients,1,1
106129,with,1,1
106130,epilepsy,1,1
106131,who,0,1
106132,were,0,1
106133,randomized,0,1
106134,",",0,0
106135,69,1,1
106136,completed,1,1
106137,a,1,0
106138,1-month,1,0
106139,monitoring,1,0
106140,period,1,0
106141,with,0,1
106142,an,0,0
106143,objective,0,0
106144,measure,0,0
106145,of,0,0
106146,tablet,0,0
106147,taking,0,0
106148,(,0,0
106149,electronic,0,1
106150,registration,0,0
106151,of,0,0
106152,pill,0,0
106153,bottle,0,1
106154,openings,0,0
106155,",",0,1
106156,Medication,0,1
106157,Event,0,0
106158,Monitoring,0,0
106159,System,0,1
106160,[,0,0
106161,MEMS,0,0
106162,],0,1
106163,),0,0
106164,.,0,0
106165,Intervention,0,0
106166,participants,0,1
106167,showed,0,0
106168,improved,0,0
106169,adherence,0,0
106170,relative,0,0
106171,to,0,0
106172,controls,0,1
106173,on,0,0
106174,all,0,0
106175,three,0,0
106176,outcomes,0,0
106177,:,0,1
106178,doses,0,0
106179,taken,0,0
106180,in,0,0
106181,total,0,1
106182,(,0,1
106183,93.4,0,0
106184,%,0,0
106185,vs.,0,0
106186,79.1,0,0
106187,%,0,0
106188,),0,0
106189,",",0,0
106190,days,0,0
106191,on,0,0
106192,which,0,0
106193,correct,0,0
106194,dose,0,0
106195,was,0,0
106196,taken,0,0
106197,(,0,0
106198,88.7,0,0
106199,%,0,0
106200,vs.,0,0
106201,65.3,0,0
106202,%,0,0
106203,),0,0
106204,",",0,0
106205,and,0,0
106206,doses,0,0
106207,taken,0,0
106208,on,0,0
106209,schedule,0,0
106210,(,0,0
106211,78.8,0,0
106212,%,0,0
106213,vs.,0,0
106214,55.3,0,0
106215,%,0,0
106216,),0,0
106217,(,0,0
106218,P,0,0
106219,<,0,0
106220,0.01,0,0
106221,),0,0
106222,.,0,0
106223,The,0,0
106224,implementation,0,0
106225,intention,0,0
106226,intervention,0,0
106227,may,0,0
106228,be,0,0
106229,an,0,0
106230,easy-to-administer,0,0
106231,and,0,0
106232,effective,0,0
106233,means,0,0
106234,of,0,0
106235,promoting,0,0
106236,AED,0,0
106237,adherence,0,0
106238,.,0,1
106239,Sustained,0,1
106240,effect,0,0
106241,of,0,0
106242,SQ-standardized,0,0
106243,grass,0,1
106244,allergy,0,1
106245,immunotherapy,0,0
106246,tablet,0,0
106247,on,0,0
106248,rhinoconjunctivitis,0,1
106249,quality,0,0
106250,of,0,0
106251,life,0,0
106252,.,0,0
106253,BACKGROUND,0,0
106254,The,0,0
106255,prevalence,0,1
106256,of,0,0
106257,allergic,0,1
106258,rhinoconjunctivitis,0,1
106259,has,0,0
106260,increased,0,0
106261,significantly,0,0
106262,over,0,0
106263,the,0,0
106264,past,0,0
106265,decades,0,0
106266,with,0,1
106267,grass,0,1
106268,pollen,0,0
106269,being,0,0
106270,a,0,0
106271,common,0,0
106272,trigger,0,0
106273,.,0,0
106274,The,0,0
106275,impact,0,0
106276,of,0,0
106277,allergy,0,1
106278,on,0,0
106279,patient,0,0
106280,'s,0,1
106281,quality,0,0
106282,of,0,0
106283,life,0,0
106284,is,0,0
106285,substantial,0,0
106286,.,0,0
106287,AIM,0,0
106288,To,0,0
106289,investigate,0,0
106290,the,0,0
106291,sustained,0,0
106292,effect,0,0
106293,on,0,0
106294,quality,0,0
106295,of,0,0
106296,life,0,0
106297,during,0,0
106298,the,0,0
106299,grass,0,1
106300,pollen,0,0
106301,season,0,0
106302,1,0,0
106303,year,0,0
106304,after,0,0
106305,3,0,0
106306,years,0,1
106307,of,0,0
106308,treatment,0,0
106309,with,0,1
106310,the,0,0
106311,SQ-standardized,0,0
106312,grass,0,1
106313,allergy,0,1
106314,immunotherapy,0,0
106315,tablet,0,0
106316,(,0,0
106317,AIT,0,0
106318,),0,0
106319,",",0,0
106320,Graza,0,0
106321,(,0,0
106322,Phleum,0,1
106323,pratense,0,0
106324,"75,000",0,0
106325,SQ-T/2800,0,0
106326,BAU,0,1
106327,;,0,0
106328,ALK,0,0
106329,",",0,0
106330,Denmark,0,1
106331,),0,0
106332,.,0,0
106333,METHODS,0,0
106334,The,0,0
106335,trial,0,0
106336,was,0,0
106337,a,0,0
106338,randomized,0,0
106339,",",0,0
106340,parallel-group,0,0
106341,",",0,0
106342,double-blind,0,0
106343,",",0,0
106344,placebo-controlled,0,0
106345,trial,0,0
106346,in,0,0
106347,adult,1,1
106348,subjects,1,1
106349,with,1,1
106350,a,1,0
106351,history,1,1
106352,of,1,0
106353,moderate-severe,1,1
106354,grass,1,1
106355,pollen,1,0
106356,induced,1,0
106357,rhinoconjunctivitis,1,0
106358,inadequately,1,1
106359,controlled,1,0
106360,by,1,0
106361,symptomatic,1,1
106362,medications,1,0
106363,.,1,1
106364,Subjects,1,1
106365,received,0,0
106366,3,0,0
106367,years,0,1
106368,of,0,0
106369,grass,0,1
106370,AIT,0,0
106371,(,0,0
106372,n,0,1
106373,=,0,0
106374,157,0,1
106375,),0,0
106376,or,0,1
106377,placebo,0,0
106378,(,0,0
106379,n,0,1
106380,=,0,0
106381,126,0,1
106382,),0,0
106383,",",0,0
106384,followed,0,0
106385,by,0,0
106386,1,0,0
106387,year,0,0
106388,of,0,0
106389,follow-up,0,0
106390,.,0,0
106391,Quality,0,0
106392,of,0,0
106393,life,0,0
106394,assessments,0,0
106395,were,0,0
106396,based,0,0
106397,on,0,0
106398,the,0,0
106399,standardized,0,0
106400,rhinoconjunctivitis,0,0
106401,quality,0,0
106402,of,0,0
106403,life,0,0
106404,questionnaire,0,0
106405,(,0,0
106406,RQLQ,0,0
106407,(,0,0
106408,S,0,0
106409,),0,1
106410,),0,1
106411,;,0,0
106412,completed,0,1
106413,weekly,0,0
106414,during,0,0
106415,the,0,0
106416,entire,0,0
106417,grass,0,1
106418,pollen,0,0
106419,season,0,0
106420,.,0,0
106421,RESULTS,0,0
106422,During,0,0
106423,follow-up,0,0
106424,",",0,0
106425,the,0,0
106426,overall,0,0
106427,RQLQ,0,0
106428,(,0,1
106429,S,0,0
106430,),0,0
106431,score,0,0
106432,for,0,0
106433,the,0,0
106434,entire,0,0
106435,grass,0,1
106436,pollen,0,0
106437,season,0,0
106438,was,0,0
106439,significantly,0,0
106440,improved,0,0
106441,in,0,0
106442,the,0,0
106443,active,0,0
106444,group,0,0
106445,(,0,0
106446,relative,0,0
106447,difference,0,0
106448,to,0,0
106449,placebo,0,0
106450,:,0,1
106451,23,0,0
106452,%,0,0
106453,",",0,0
106454,P,0,0
106455,=,0,0
106456,0.004,0,0
106457,),0,0
106458,.,0,0
106459,The,0,0
106460,improvement,0,0
106461,was,0,0
106462,higher,0,0
106463,during,0,0
106464,the,0,0
106465,peak,0,0
106466,pollen,0,0
106467,season,0,0
106468,(,0,0
106469,28,0,0
106470,%,0,0
106471,",",0,0
106472,P,0,0
106473,=,0,0
106474,0.001,0,0
106475,),0,0
106476,.,0,0
106477,The,0,0
106478,treatment,0,0
106479,effect,0,0
106480,of,0,0
106481,grass,0,1
106482,AIT,0,0
106483,during,0,0
106484,the,0,0
106485,follow-up,0,0
106486,year,0,0
106487,and,0,0
106488,the,0,0
106489,previous,0,0
106490,three,0,0
106491,treatment,0,0
106492,years,0,1
106493,was,0,0
106494,similar,0,0
106495,.,0,1
106496,Improvements,0,0
106497,were,0,0
106498,found,0,0
106499,in,0,0
106500,all,0,0
106501,seven,0,1
106502,RQLQ,0,0
106503,(,0,1
106504,S,0,0
106505,),0,0
106506,domains,0,0
106507,.,0,0
106508,The,0,0
106509,RQLQ,0,0
106510,(,0,0
106511,S,0,0
106512,),0,0
106513,as,0,0
106514,a,0,0
106515,function,0,0
106516,of,0,0
106517,the,0,0
106518,weekly,0,0
106519,average,0,0
106520,pollen,0,0
106521,counts,0,0
106522,showed,0,0
106523,a,0,0
106524,clear,0,0
106525,separation,0,0
106526,between,0,0
106527,the,0,0
106528,treatment,0,0
106529,groups,0,0
106530,(,0,1
106531,P,0,0
106532,<,0,0
106533,0.001,0,0
106534,),0,1
106535,.,0,1
106536,CONCLUSION,0,0
106537,In,0,0
106538,subjects,0,1
106539,inadequately,0,1
106540,controlled,0,0
106541,by,0,0
106542,symptomatic,0,1
106543,medications,0,0
106544,",",0,0
106545,grass,0,1
106546,AIT,0,0
106547,provided,0,0
106548,sustained,0,0
106549,and,0,0
106550,clinically,0,0
106551,relevant,0,0
106552,improvements,0,0
106553,in,0,0
106554,rhinoconjunctivitis,0,1
106555,quality,0,0
106556,of,0,0
106557,life,0,0
106558,compared,0,0
106559,to,0,0
106560,placebo,0,0
106561,.,0,0
106562,The,0,0
106563,effect,0,0
106564,increased,0,0
106565,with,0,1
106566,increasing,0,0
106567,grass,0,1
106568,pollen,0,0
106569,exposure,0,0
106570,.,0,1
106571,Conjugated,0,0
106572,equine,0,1
106573,estrogen,0,0
106574,influence,0,0
106575,on,0,0
106576,mammographic,0,1
106577,density,0,0
106578,in,0,0
106579,postmenopausal,1,1
106580,women,1,1
106581,in,1,0
106582,a,1,0
106583,substudy,1,0
106584,of,1,0
106585,the,1,0
106586,women,1,1
106587,'s,1,1
106588,health,1,1
106589,initiative,1,1
106590,randomized,1,0
106591,trial,1,0
106592,.,1,1
106593,PURPOSE,0,0
106594,Increased,0,0
106595,mammographic,0,1
106596,density,0,0
106597,is,0,0
106598,associated,0,0
106599,with,0,0
106600,increased,0,0
106601,breast,0,1
106602,cancer,0,1
106603,risk,0,0
106604,and,0,0
106605,reduced,0,0
106606,sensitivity,0,0
106607,of,0,0
106608,screening,0,1
106609,mammography,0,1
106610,and,0,0
106611,is,0,0
106612,related,0,0
106613,to,0,0
106614,hormone,0,0
106615,exposure,0,0
106616,.,0,0
106617,However,0,0
106618,",",0,0
106619,the,0,0
106620,effects,0,0
106621,of,0,0
106622,conjugated,0,0
106623,equine,0,1
106624,estrogens,0,0
106625,(,0,1
106626,CEEs,0,1
106627,),0,0
106628,alone,0,0
106629,on,0,0
106630,mammographic,0,1
106631,density,0,0
106632,in,0,0
106633,diverse,1,1
106634,racial/ethnic,1,1
106635,populations,1,1
106636,are,0,0
106637,not,0,0
106638,established,0,0
106639,.,0,0
106640,We,0,0
106641,examined,0,0
106642,the,0,0
106643,effect,0,0
106644,of,0,0
106645,CEE,0,0
106646,alone,0,0
106647,on,0,0
106648,mammographic,0,1
106649,density,0,0
106650,in,0,0
106651,a,0,0
106652,subsample,1,1
106653,of,1,0
106654,the,1,0
106655,Women,1,1
106656,'s,1,1
106657,Health,1,0
106658,Initiative,1,1
106659,(,1,0
106660,WHI,1,0
106661,),1,0
106662,clinical,1,0
106663,trial,1,1
106664,participants,1,1
106665,.,1,1
106666,PATIENTS,0,0
106667,AND,0,0
106668,METHODS,0,0
106669,In,0,0
106670,the,0,0
106671,WHI,0,0
106672,trial,0,0
106673,",",0,0
106674,women,1,1
106675,were,0,0
106676,randomly,0,1
106677,assigned,0,0
106678,to,0,0
106679,daily,0,0
106680,CEE,0,0
106681,0.625,0,0
106682,mg,0,0
106683,or,0,1
106684,placebo,0,0
106685,.,0,0
106686,The,0,0
106687,effect,0,0
106688,of,0,0
106689,CEE,0,0
106690,on,0,0
106691,mammographic,0,1
106692,percent,0,1
106693,density,0,0
106694,was,0,0
106695,determined,0,0
106696,over,0,0
106697,1,0,0
106698,and,0,1
106699,2,0,0
106700,years,0,1
106701,in,0,0
106702,a,0,1
106703,stratified,0,1
106704,random,1,0
106705,sample,1,1
106706,of,1,0
106707,435,1,1
106708,racially,1,1
106709,and,1,0
106710,ethnically,1,1
106711,diverse,1,1
106712,participants,1,1
106713,from,1,1
106714,15,1,1
106715,of,1,0
106716,40,1,1
106717,WHI,1,0
106718,clinics,1,1
106719,.,1,1
106720,RESULTS,0,0
106721,Use,0,0
106722,of,0,0
106723,CEE,0,0
106724,resulted,0,0
106725,in,0,0
106726,mean,0,1
106727,increase,0,0
106728,in,0,0
106729,mammographic,0,1
106730,percent,0,1
106731,density,0,0
106732,of,0,0
106733,1.6,0,0
106734,percentage,0,0
106735,points,0,0
106736,(,0,1
106737,95,0,0
106738,%,0,0
106739,CI,0,0
106740,",",0,0
106741,0.8,0,0
106742,to,0,0
106743,2.4,0,0
106744,),0,0
106745,at,0,0
106746,year,0,1
106747,1,0,0
106748,compared,0,0
106749,with,0,1
106750,a,0,0
106751,mean,0,0
106752,decrease,0,0
106753,of,0,0
106754,1.0,0,0
106755,percentage,0,0
106756,point,0,0
106757,(,0,0
106758,95,0,0
106759,%,0,0
106760,CI,0,0
106761,",",0,0
106762,-1.7,0,0
106763,to,0,0
106764,-0.4,0,0
106765,),0,0
106766,in,0,0
106767,the,0,0
106768,placebo,0,0
106769,group,0,0
106770,(,0,0
106771,P,0,0
106772,<,0,0
106773,.001,0,0
106774,),0,0
106775,.,0,0
106776,The,0,0
106777,effect,0,0
106778,persisted,0,0
106779,for,0,0
106780,2,0,0
106781,years,0,1
106782,",",0,0
106783,with,0,1
106784,a,0,0
106785,mean,0,0
106786,increase,0,0
106787,of,0,0
106788,1.7,0,0
106789,percentage,0,0
106790,points,0,0
106791,(,0,1
106792,95,0,0
106793,%,0,0
106794,CI,0,0
106795,",",0,0
106796,0.7,0,0
106797,to,0,0
106798,2.7,0,0
106799,),0,0
106800,versus,0,0
106801,a,0,0
106802,mean,0,0
106803,decrease,0,0
106804,of,0,0
106805,1.2,0,0
106806,percentage,0,0
106807,points,0,0
106808,(,0,1
106809,95,0,0
106810,%,0,0
106811,CI,0,0
106812,",",0,0
106813,-1.8,0,0
106814,to,0,0
106815,-0.5,0,0
106816,;,0,0
106817,P,0,0
106818,<,0,0
106819,.001,0,0
106820,),0,0
106821,in,0,0
106822,the,0,0
106823,hormone,0,0
106824,and,0,0
106825,placebo,0,0
106826,groups,0,0
106827,",",0,0
106828,respectively,0,0
106829,.,0,0
106830,These,0,0
106831,effects,0,0
106832,were,0,0
106833,greater,0,0
106834,in,0,0
106835,women,1,1
106836,age,1,1
106837,60,1,1
106838,to,1,0
106839,79,1,1
106840,years,1,1
106841,(,0,1
106842,P,0,0
106843,=,0,0
106844,.03,0,0
106845,for,0,0
106846,interaction,0,0
106847,across,0,0
106848,age,0,1
106849,),0,0
106850,.,0,1
106851,CONCLUSION,0,0
106852,Use,0,0
106853,of,0,0
106854,CEE,0,0
106855,results,0,0
106856,in,0,0
106857,a,0,0
106858,modest,0,0
106859,but,0,0
106860,statistically,0,0
106861,significant,0,0
106862,increase,0,0
106863,in,0,0
106864,mammographic,0,1
106865,density,0,0
106866,that,0,0
106867,is,0,0
106868,sustained,0,0
106869,over,0,0
106870,at,0,0
106871,least,0,1
106872,a,0,0
106873,2-year,0,0
106874,period,0,0
106875,.,0,0
106876,The,0,0
106877,clinical,0,0
106878,significance,0,0
106879,of,0,0
106880,the,0,0
106881,CEE,0,0
106882,effect,0,0
106883,on,0,0
106884,mammographic,0,1
106885,density,0,0
106886,remains,0,0
106887,to,0,0
106888,be,0,0
106889,determined,0,0
106890,.,0,0
106891,First-line,0,0
106892,cisplatin,0,0
106893,with,0,1
106894,docetaxel,0,0
106895,or,0,0
106896,vinorelbine,0,0
106897,in,0,0
106898,patients,1,1
106899,with,1,1
106900,advanced,1,1
106901,non-small-cell,1,1
106902,lung,1,1
106903,cancer,1,1
106904,:,1,1
106905,a,0,0
106906,quality,1,0
106907,of,1,0
106908,life,1,0
106909,directed,1,0
106910,phase,1,1
106911,II,1,1
106912,randomized,1,0
106913,trial,1,0
106914,of,1,0
106915,Gruppo,1,1
106916,Oncologico,1,1
106917,Italia,1,1
106918,Meridionale,1,0
106919,.,1,1
106920,BACKGROUND,0,0
106921,Quality,0,0
106922,of,0,0
106923,life,0,0
106924,(,0,0
106925,QoL,0,0
106926,),0,0
106927,has,0,0
106928,gained,0,0
106929,greater,0,0
106930,importance,0,0
106931,in,0,0
106932,the,0,0
106933,management,0,0
106934,of,0,0
106935,metastatic,1,1
106936,non-small-cell,1,1
106937,lung,1,1
106938,cancer,1,1
106939,due,0,0
106940,to,0,0
106941,the,0,0
106942,palliative,0,0
106943,nature,0,0
106944,of,0,0
106945,treatment,0,0
106946,.,0,1
106947,Docetaxel,0,0
106948,(,0,0
106949,DCT,0,1
106950,),0,0
106951,and,0,0
106952,cisplatin,0,0
106953,(,0,0
106954,CDDP,0,1
106955,),0,0
106956,doublet,0,0
106957,has,0,0
106958,been,0,0
106959,reported,0,0
106960,to,0,0
106961,be,0,0
106962,associated,0,0
106963,to,0,0
106964,a,0,0
106965,better,0,0
106966,QoL,0,0
106967,than,0,0
106968,the,0,0
106969,weekly,0,0
106970,vinorelbine,0,0
106971,(,0,0
106972,VNR,0,1
106973,),0,0
106974,and,0,0
106975,CDDP,0,1
106976,regimen,0,0
106977,.,0,0
106978,Recently,0,0
106979,a,0,0
106980,newer,0,0
106981,more,0,0
106982,tolerated,0,0
106983,schedule,0,0
106984,of,0,0
106985,the,0,0
106986,VNR/CDDP,0,0
106987,regimen,0,0
106988,has,0,0
106989,been,0,0
106990,published,0,0
106991,and,0,0
106992,is,0,0
106993,widely,0,0
106994,employed,0,0
106995,in,0,0
106996,medical,0,1
106997,practice,0,0
106998,.,0,0
106999,The,0,0
107000,impact,0,0
107001,of,0,0
107002,these,0,0
107003,regimens,0,0
107004,on,0,0
107005,patients,0,1
107006,',0,1
107007,QoL,0,0
107008,as,0,0
107009,well,0,0
107010,as,0,0
107011,symptoms,0,0
107012,control,0,1
107013,and,0,0
107014,type,0,1
107015,and,0,0
107016,grading,0,0
107017,chemo-related,0,0
107018,side-effects,0,0
107019,has,0,0
107020,been,0,0
107021,compared,0,0
107022,prospectically,0,0
107023,.,0,1
107024,METHODS,0,0
107025,Patients,1,1
107026,received,0,1
107027,CDDP,0,1
107028,75,0,1
107029,mg/m,0,0
107030,(,0,1
107031,2,0,0
107032,),0,0
107033,plus,0,0
107034,DCT,0,1
107035,75,0,1
107036,mg/m,0,0
107037,(,0,1
107038,2,0,0
107039,),0,0
107040,on,0,0
107041,day,0,0
107042,1,0,0
107043,every,0,0
107044,weeks,0,0
107045,(,0,0
107046,arm,0,1
107047,A,0,1
107048,),0,0
107049,or,0,1
107050,CDDP,0,1
107051,80,0,1
107052,mg/m,0,0
107053,(,0,1
107054,2,0,0
107055,),0,0
107056,on,0,0
107057,day,0,0
107058,1,0,0
107059,plus,0,0
107060,VNR,0,1
107061,30,0,1
107062,mg/m,0,0
107063,(,0,1
107064,2,0,0
107065,),0,1
107066,day,0,0
107067,1,0,0
107068,and,0,0
107069,8,0,0
107070,every,0,0
107071,3,0,0
107072,weeks,0,0
107073,(,0,1
107074,arm,0,1
107075,B,0,1
107076,),0,0
107077,.,0,1
107078,G-CSF,0,0
107079,and/or,0,0
107080,EPO,0,0
107081,were,0,0
107082,employed,0,0
107083,as,0,0
107084,needed,0,0
107085,.,0,1
107086,Health-related,0,0
107087,QoL,0,0
107088,was,0,0
107089,assessed,0,0
107090,at,0,0
107091,entry,0,0
107092,and,0,0
107093,after,0,0
107094,every,0,0
107095,cycle,0,0
107096,by,0,0
107097,the,0,0
107098,EORTC-QLQ-C30,0,0
107099,and,0,0
107100,LC13,0,0
107101,questionnaires,0,0
107102,",",0,0
107103,toxicity,0,0
107104,by,0,0
107105,the,0,0
107106,NCI-NCCN,0,0
107107,CTC,0,0
107108,vs,0,0
107109,2,0,0
107110,",",0,0
107111,and,0,0
107112,intent-to-treat,0,0
107113,objective,0,0
107114,response,0,0
107115,by,0,0
107116,the,0,0
107117,Recist,0,0
107118,criteria,0,1
107119,.,0,0
107120,RESULTS,0,0
107121,The,0,0
107122,QoL,0,0
107123,questionnaires,0,0
107124,were,0,0
107125,completed,0,1
107126,by,0,0
107127,37,1,1
107128,pts,1,1
107129,(,1,1
107130,88,1,1
107131,%,1,0
107132,),1,0
107133,in,1,0
107134,the,1,0
107135,DCT/CDDP,1,0
107136,arm,1,0
107137,and,0,0
107138,39,1,1
107139,pts,1,1
107140,(,1,1
107141,87,1,1
107142,%,1,0
107143,),1,0
107144,in,1,0
107145,the,1,0
107146,VNR/CDDP,1,0
107147,one,1,1
107148,.,1,1
107149,Baseline,0,0
107150,mean,0,1
107151,scores,0,0
107152,and,0,1
107153,rates,0,0
107154,at,0,0
107155,which,0,0
107156,pts,0,1
107157,failed,0,0
107158,to,0,0
107159,complete,0,0
107160,QoL,0,0
107161,assessment,0,0
107162,were,0,0
107163,similar,0,0
107164,in,0,0
107165,the,0,0
107166,two,0,0
107167,arms,0,0
107168,.,0,1
107169,Global,0,0
107170,health,0,0
107171,status,0,0
107172,of,0,0
107173,the,0,0
107174,EORTC,0,0
107175,QLQ-C30,0,0
107176,scale,0,0
107177,and,0,0
107178,specific,0,0
107179,symptoms,0,0
107180,control,0,1
107181,(,0,0
107182,LC13,0,0
107183,module,0,0
107184,),0,0
107185,improved,0,0
107186,during,0,0
107187,treatment,0,0
107188,without,0,0
107189,any,0,0
107190,statistically,0,0
107191,significant,0,0
107192,difference,0,0
107193,between,0,0
107194,the,0,0
107195,two,0,0
107196,arms,0,0
107197,.,0,1
107198,Emotional,0,0
107199,functioning,0,0
107200,remained,0,0
107201,stable,0,1
107202,in,0,0
107203,both,0,0
107204,groups,0,0
107205,during,0,0
107206,treatment,0,0
107207,",",0,0
107208,whereas,0,0
107209,physical,0,0
107210,and,0,0
107211,role,0,0
107212,improved,0,0
107213,slightly,0,0
107214,.,0,0
107215,In,0,0
107216,the,0,0
107217,DCT/CDDP,0,0
107218,arm,0,0
107219,14,0,1
107220,pts,0,1
107221,(,0,1
107222,33,0,1
107223,%,0,0
107224,;,0,1
107225,95,0,0
107226,%,0,0
107227,CL,0,0
107228,24-40,0,1
107229,%,0,0
107230,),0,0
107231,had,0,0
107232,PR,0,0
107233,",",0,0
107234,and,0,0
107235,10,0,0
107236,(,0,0
107237,24,0,0
107238,%,0,0
107239,),0,0
107240,SD,0,0
107241,for,0,0
107242,a,0,0
107243,57,0,1
107244,%,0,0
107245,TGCR,0,0
107246,.,0,0
107247,In,0,0
107248,the,0,0
107249,VNR/CDDP,0,0
107250,arm,0,0
107251,12,0,0
107252,pts,0,1
107253,(,0,1
107254,27,0,1
107255,%,0,0
107256,),0,0
107257,achieved,0,0
107258,PR,0,0
107259,",",0,0
107260,18,0,1
107261,(,0,0
107262,41,0,1
107263,%,0,0
107264,),0,0
107265,SD,0,0
107266,a,0,0
107267,68,0,0
107268,%,0,0
107269,TGCR,0,0
107270,.,0,1
107271,Differences,0,0
107272,were,0,0
107273,not,0,0
107274,statistically,0,0
107275,significant,0,0
107276,.,0,0
107277,Median,0,0
107278,time-to-progression,0,0
107279,was,0,0
107280,4.2,0,0
107281,months,0,0
107282,in,0,0
107283,the,0,0
107284,DCT/CDDP,0,0
107285,arm,0,0
107286,and,0,0
107287,4.5,0,0
107288,months,0,0
107289,in,0,0
107290,the,0,0
107291,VNR/CDDP,0,0
107292,one,0,0
107293,",",0,0
107294,and,0,0
107295,median,0,0
107296,overall,0,0
107297,survival,0,0
107298,was,0,0
107299,12.1,0,0
107300,(,0,0
107301,range,0,1
107302,1-26+,0,1
107303,months,0,0
107304,),0,1
107305,and,0,1
107306,12.5,0,0
107307,months,0,0
107308,(,0,0
107309,range,0,1
107310,1-28+,0,0
107311,months,0,0
107312,),0,1
107313,for,0,0
107314,DCT/CDDP,0,0
107315,and,0,1
107316,VNR/CDDP,0,0
107317,arms,0,0
107318,",",0,0
107319,respectively,0,0
107320,.,0,0
107321,Febrile,0,0
107322,neutropenia,0,0
107323,rate,0,0
107324,was,0,0
107325,higher,0,0
107326,in,0,0
107327,the,0,0
107328,VNR/CDDP,0,0
107329,arm,0,0
107330,(,0,0
107331,p=0.02,0,0
107332,),0,0
107333,as,0,0
107334,well,0,0
107335,as,0,0
107336,G3-4,0,0
107337,anemia,0,1
107338,(,0,0
107339,p=0.005,0,0
107340,),0,0
107341,and,0,0
107342,G-CSF/EPO,0,0
107343,use,0,0
107344,(,0,0
107345,p=0.019,0,0
107346,),0,0
107347,.,0,1
107348,CONCLUSIONS,0,0
107349,Global,0,1
107350,and,0,0
107351,specific,0,0
107352,health-related,0,0
107353,QoL,0,0
107354,data,0,0
107355,similar,0,0
107356,in,0,0
107357,both,0,0
107358,treatment,0,0
107359,groups,0,0
107360,with,0,1
107361,no,0,0
107362,statistically,0,0
107363,significant,0,0
107364,difference,0,0
107365,.,0,1
107366,Efficacy,0,0
107367,measures,0,0
107368,",",0,0
107369,overall,0,0
107370,response,0,0
107371,rate,0,0
107372,",",0,0
107373,time-to-progression,0,0
107374,and,0,0
107375,overall,0,0
107376,survival,0,0
107377,were,0,0
107378,equivalent,0,0
107379,in,0,0
107380,both,0,0
107381,arms,0,0
107382,.,0,0
107383,However,0,0
107384,",",0,0
107385,severe,0,1
107386,anemia,0,1
107387,and,0,0
107388,febrile,0,0
107389,neutropenia,0,0
107390,are,0,0
107391,statistically,0,0
107392,more,0,0
107393,frequent,0,0
107394,in,0,0
107395,the,0,0
107396,VNR/CDDP,0,0
107397,arm,0,0
107398,than,0,0
107399,in,0,0
107400,the,0,0
107401,DCT/CDDP,0,0
107402,one,0,0
107403,.,0,0
107404,These,0,0
107405,data,0,0
107406,should,0,0
107407,be,0,0
107408,considered,0,0
107409,in,0,0
107410,treatment,0,0
107411,decision-making,0,0
107412,for,0,0
107413,pts,1,1
107414,with,1,1
107415,advanced,1,1
107416,non-small-cell,1,1
107417,lung,1,1
107418,cancer,1,1
107419,and,0,0
107420,for,0,0
107421,the,0,0
107422,design,0,0
107423,of,0,0
107424,future,0,0
107425,trials,0,0
107426,with,0,1
107427,chemotherapy,0,1
107428,plus,0,0
107429,biologics,0,0
107430,.,0,1
107431,A,0,0
107432,placebo-controlled,0,0
107433,trial,0,0
107434,of,0,0
107435,maintenance,0,0
107436,therapy,0,0
107437,with,0,1
107438,fluconazole,0,0
107439,after,1,0
107440,treatment,1,0
107441,of,1,0
107442,cryptococcal,1,1
107443,meningitis,1,1
107444,in,1,0
107445,the,1,0
107446,acquired,1,0
107447,immunodeficiency,1,1
107448,syndrome,1,1
107449,.,1,1
107450,California,0,1
107451,Collaborative,0,1
107452,Treatment,0,0
107453,Group,0,1
107454,.,0,1
107455,BACKGROUND,0,0
107456,AND,0,0
107457,METHODS,0,0
107458,In,0,0
107459,patients,1,1
107460,with,1,1
107461,the,1,0
107462,acquired,1,0
107463,immunodeficiency,1,1
107464,syndrome,1,1
107465,(,1,0
107466,AIDS,1,1
107467,),1,0
107468,",",0,0
107469,the,0,0
107470,rate,0,0
107471,of,0,0
107472,relapse,0,0
107473,after,0,0
107474,primary,0,1
107475,treatment,0,0
107476,for,0,0
107477,cryptococcal,0,0
107478,meningitis,0,1
107479,remains,0,0
107480,high,0,0
107481,.,0,0
107482,We,0,0
107483,conducted,0,0
107484,a,0,0
107485,controlled,0,0
107486,",",0,0
107487,double-blind,0,0
107488,trial,0,0
107489,to,0,0
107490,evaluate,0,0
107491,the,0,0
107492,efficacy,0,0
107493,of,0,0
107494,maintenance,0,0
107495,therapy,0,0
107496,with,0,1
107497,fluconazole,0,0
107498,.,0,0
107499,At,0,0
107500,entry,0,0
107501,into,0,0
107502,the,0,0
107503,study,0,0
107504,",",0,0
107505,all,1,0
107506,participants,1,1
107507,had,1,1
107508,sterile,1,0
107509,cultures,1,0
107510,of,1,0
107511,cerebrospinal,1,0
107512,fluid,1,0
107513,",",1,0
107514,blood,1,0
107515,",",1,0
107516,and,1,0
107517,urine,1,0
107518,after,1,0
107519,following,1,0
107520,a,1,0
107521,standardized,1,0
107522,course,1,0
107523,of,1,0
107524,therapy,1,0
107525,for,1,0
107526,culture-proved,1,1
107527,cryptococcal,1,1
107528,meningitis,1,1
107529,.,1,0
107530,The,0,0
107531,patients,0,1
107532,were,0,0
107533,randomly,0,1
107534,assigned,0,0
107535,to,0,0
107536,take,0,0
107537,either,0,0
107538,fluconazole,0,0
107539,or,0,0
107540,placebo,0,0
107541,as,0,0
107542,maintenance,0,0
107543,therapy,0,0
107544,.,0,0
107545,The,0,0
107546,dose,0,0
107547,of,0,0
107548,fluconazole,0,0
107549,was,0,0
107550,100,0,0
107551,mg,0,0
107552,daily,0,0
107553,in,0,0
107554,the,0,0
107555,first,0,0
107556,phase,0,0
107557,of,0,0
107558,study,0,0
107559,and,0,0
107560,200,0,0
107561,mg,0,0
107562,daily,0,0
107563,in,0,0
107564,the,0,0
107565,second,0,0
107566,phase,0,1
107567,.,0,0
107568,RESULTS,0,0
107569,Of,1,1
107570,84,1,1
107571,patients,1,1
107572,initially,1,1
107573,enrolled,1,1
107574,",",1,0
107575,16,1,1
107576,(,1,0
107577,19,1,1
107578,percent,1,1
107579,),1,0
107580,were,1,0
107581,found,1,0
107582,to,1,0
107583,have,1,0
107584,silent,1,0
107585,",",1,0
107586,persistent,1,1
107587,infection,1,0
107588,on,1,0
107589,the,1,0
107590,basis,1,0
107591,of,1,0
107592,cultures,1,0
107593,that,1,0
107594,became,1,0
107595,positive,1,0
107596,after,1,0
107597,entry,1,0
107598,into,1,0
107599,the,1,0
107600,study,1,0
107601,;,1,0
107602,7,1,1
107603,other,1,0
107604,patients,1,1
107605,were,1,1
107606,lost,1,1
107607,to,1,0
107608,follow-up,1,0
107609,shortly,1,0
107610,after,1,0
107611,entry,1,0
107612,.,0,0
107613,Of,0,0
107614,the,0,0
107615,remaining,1,0
107616,61,1,1
107617,patients,1,1
107618,",",0,0
107619,10,0,1
107620,of,0,0
107621,27,0,1
107622,assigned,0,1
107623,to,0,0
107624,placebo,0,0
107625,(,0,0
107626,37,0,1
107627,percent,0,1
107628,),0,0
107629,and,0,0
107630,1,0,0
107631,of,0,0
107632,34,0,1
107633,assigned,0,1
107634,to,0,0
107635,fluconazole,0,0
107636,(,0,0
107637,3,0,0
107638,percent,0,1
107639,),0,0
107640,had,0,0
107641,a,0,0
107642,recurrence,0,0
107643,of,0,0
107644,cryptococcal,0,1
107645,infection,0,1
107646,at,0,0
107647,any,0,0
107648,site,0,0
107649,(,0,0
107650,difference,0,0
107651,in,0,0
107652,risk,0,0
107653,",",0,0
107654,34,0,1
107655,percent,0,1
107656,;,0,1
107657,95,0,0
107658,percent,0,0
107659,confidence,0,0
107660,interval,0,0
107661,",",0,0
107662,15,0,0
107663,to,0,0
107664,53,0,1
107665,),0,0
107666,.,0,0
107667,Of,0,0
107668,the,0,0
107669,11,0,0
107670,recurrent,0,1
107671,infections,0,1
107672,",",0,0
107673,7,0,1
107674,were,0,0
107675,detected,0,0
107676,in,0,0
107677,urine,0,0
107678,obtained,0,0
107679,after,0,0
107680,prostatic,0,1
107681,massage,0,0
107682,.,0,0
107683,There,0,0
107684,were,0,0
107685,four,0,0
107686,recurrent,0,1
107687,meningeal,0,0
107688,infections,0,0
107689,in,0,0
107690,the,0,0
107691,patients,0,1
107692,taking,0,0
107693,placebo,0,0
107694,",",0,0
107695,but,0,0
107696,none,0,0
107697,in,0,0
107698,those,0,0
107699,taking,0,0
107700,fluconazole,0,0
107701,(,0,1
107702,mean,0,0
107703,duration,0,0
107704,of,0,0
107705,follow-up,0,0
107706,",",0,0
107707,164,0,1
107708,days,0,0
107709,),0,1
107710,(,0,1
107711,P,0,0
107712,=,0,0
107713,0.03,0,0
107714,),0,0
107715,.,0,0
107716,In,0,0
107717,multivariate,0,0
107718,analyses,0,0
107719,",",0,0
107720,the,0,0
107721,best,0,0
107722,predictors,0,0
107723,of,0,0
107724,recurrence-free,0,1
107725,survival,0,0
107726,were,0,0
107727,fluconazole,0,0
107728,treatment,0,0
107729,(,0,0
107730,P,0,0
107731,=,0,1
107732,0.02,0,0
107733,;,0,0
107734,relative,0,0
107735,hazard,0,0
107736,",",0,0
107737,13.2,0,0
107738,),0,0
107739,",",0,0
107740,a,0,0
107741,lower,0,0
107742,serum,0,0
107743,cryptococcal-antigen,0,0
107744,titer,0,0
107745,(,0,0
107746,P,0,0
107747,=,0,1
107748,0.05,0,0
107749,;,0,0
107750,relative,0,0
107751,hazard,0,0
107752,",",0,0
107753,1.2,0,0
107754,),0,0
107755,",",0,0
107756,and,0,0
107757,more,0,0
107758,prolonged,0,0
107759,primary,0,0
107760,therapy,0,0
107761,with,0,1
107762,flucytosine,0,0
107763,(,0,0
107764,P,0,0
107765,=,0,1
107766,0.09,0,0
107767,;,0,0
107768,relative,0,0
107769,hazard,0,0
107770,",",0,0
107771,1.1,0,0
107772,),0,0
107773,.,0,1
107774,Survival,0,0
107775,and,0,0
107776,toxicity,0,0
107777,were,0,0
107778,similar,0,0
107779,in,0,0
107780,the,0,0
107781,two,0,0
107782,maintenance-treatment,0,1
107783,groups,0,0
107784,.,0,1
107785,CONCLUSIONS,0,0
107786,In,0,0
107787,patients,1,1
107788,with,1,1
107789,AIDS,1,1
107790,",",0,0
107791,silent,0,0
107792,persistent,0,1
107793,infection,0,0
107794,is,0,0
107795,common,0,0
107796,after,0,0
107797,clinically,0,0
107798,successful,0,0
107799,treatment,0,0
107800,for,0,0
107801,cryptococcal,0,1
107802,meningitis,0,1
107803,.,0,1
107804,Maintenance,0,0
107805,therapy,0,0
107806,with,0,0
107807,fluconazole,0,0
107808,is,0,0
107809,highly,0,0
107810,effective,0,0
107811,in,0,0
107812,preventing,0,0
107813,recurrent,0,1
107814,cryptococcal,0,1
107815,infection,0,1
107816,.,0,1
107817,Low-frequency,0,0
107818,repetitive,0,0
107819,transcranial,0,0
107820,magnetic,0,0
107821,stimulation,0,0
107822,(,0,0
107823,rTMS,0,0
107824,),0,0
107825,affects,0,0
107826,event-related,0,0
107827,potential,0,0
107828,measures,0,0
107829,of,0,0
107830,novelty,0,0
107831,processing,0,0
107832,in,0,0
107833,autism,1,1
107834,.,1,0
107835,In,0,0
107836,our,0,0
107837,previous,0,0
107838,study,0,0
107839,on,0,0
107840,individuals,1,1
107841,with,1,1
107842,autism,1,1
107843,spectrum,1,1
107844,disorder,1,1
107845,(,1,0
107846,ASD,1,1
107847,),1,0
107848,(,0,0
107849,Sokhadze,0,1
107850,et,0,0
107851,al.,0,0
107852,",",0,0
107853,Appl,0,0
107854,Psychophysiol,0,1
107855,Biofeedback,0,0
107856,34:37-51,0,1
107857,",",0,0
107858,2009a,0,1
107859,),0,0
107860,we,0,0
107861,reported,0,0
107862,abnormalities,0,1
107863,in,0,0
107864,the,0,0
107865,attention-orienting,0,0
107866,frontal,0,0
107867,event-related,0,0
107868,potentials,0,0
107869,(,0,1
107870,ERP,0,0
107871,),0,0
107872,and,0,0
107873,the,0,0
107874,sustained-attention,0,0
107875,centro-parietal,0,0
107876,ERPs,0,0
107877,in,0,0
107878,a,0,0
107879,visual,0,0
107880,oddball,0,0
107881,experiment,0,0
107882,.,0,0
107883,These,0,0
107884,results,0,0
107885,suggest,0,0
107886,that,0,0
107887,individuals,1,1
107888,with,1,1
107889,autism,1,1
107890,over-process,0,0
107891,information,0,0
107892,needed,0,0
107893,for,0,0
107894,the,0,0
107895,successful,0,0
107896,differentiation,0,0
107897,of,0,0
107898,target,0,0
107899,and,0,0
107900,novel,0,0
107901,stimuli,0,0
107902,.,0,1
107903,In,0,0
107904,the,0,0
107905,present,0,0
107906,study,0,0
107907,we,0,0
107908,examine,0,0
107909,the,0,0
107910,effects,0,0
107911,of,0,0
107912,low-frequency,0,0
107913,",",0,0
107914,repetitive,0,0
107915,Transcranial,0,0
107916,Magnetic,0,0
107917,Stimulation,0,0
107918,(,0,0
107919,rTMS,0,0
107920,),0,0
107921,on,0,0
107922,novelty,0,0
107923,processing,0,0
107924,as,0,0
107925,well,0,0
107926,as,0,0
107927,behavior,0,0
107928,and,0,0
107929,social,0,0
107930,functioning,0,0
107931,in,0,0
107932,13,1,1
107933,individuals,1,1
107934,with,1,1
107935,ASD,1,1
107936,.,1,1
107937,Our,0,0
107938,hypothesis,0,0
107939,was,0,0
107940,that,0,0
107941,low-frequency,0,0
107942,rTMS,0,0
107943,application,0,0
107944,to,0,0
107945,dorsolateral,0,0
107946,prefrontal,0,0
107947,cortex,0,0
107948,(,0,0
107949,DLFPC,0,1
107950,),0,0
107951,would,0,0
107952,result,0,0
107953,in,0,0
107954,an,0,0
107955,alteration,0,0
107956,of,0,0
107957,the,0,0
107958,cortical,0,0
107959,excitatory/inhibitory,0,0
107960,balance,0,0
107961,through,0,0
107962,the,0,0
107963,activation,0,0
107964,of,0,0
107965,inhibitory,0,0
107966,GABAergic,0,1
107967,double,0,0
107968,bouquet,0,1
107969,interneurons,0,1
107970,.,0,1
107971,We,0,0
107972,expected,0,0
107973,to,0,0
107974,find,0,0
107975,post-TMS,0,0
107976,differences,0,0
107977,in,0,0
107978,amplitude,0,0
107979,and,0,0
107980,latency,0,0
107981,of,0,0
107982,early,0,0
107983,and,0,1
107984,late,0,1
107985,ERP,0,0
107986,components,0,0
107987,.,0,1
107988,The,0,0
107989,results,0,0
107990,of,0,0
107991,our,0,0
107992,current,0,0
107993,study,0,0
107994,validate,0,0
107995,the,0,0
107996,use,0,0
107997,of,0,0
107998,low-frequency,0,0
107999,rTMS,0,0
108000,as,0,0
108001,a,0,0
108002,modulatory,0,0
108003,tool,0,0
108004,that,0,0
108005,altered,0,0
108006,the,0,0
108007,disrupted,0,0
108008,ratio,0,0
108009,of,0,0
108010,cortical,0,0
108011,excitation,0,0
108012,to,0,0
108013,inhibition,0,0
108014,in,0,0
108015,autism,0,1
108016,.,0,0
108017,After,0,0
108018,rTMS,0,0
108019,the,0,0
108020,parieto-occipital,0,0
108021,P50,0,1
108022,amplitude,0,0
108023,decreased,0,0
108024,to,0,0
108025,novel,0,0
108026,distracters,0,0
108027,but,0,0
108028,not,0,0
108029,to,0,0
108030,targets,0,0
108031,;,0,0
108032,also,0,0
108033,the,0,0
108034,amplitude,0,0
108035,and,0,0
108036,latency,0,0
108037,to,0,0
108038,targets,0,0
108039,increased,0,0
108040,for,0,0
108041,the,0,0
108042,frontal,0,0
108043,P50,0,1
108044,while,0,0
108045,decreasing,0,0
108046,to,0,0
108047,non-target,0,0
108048,stimuli,0,0
108049,.,0,1
108050,Low-frequency,0,0
108051,rTMS,0,0
108052,minimized,0,0
108053,early,0,1
108054,cortical,0,0
108055,responses,0,0
108056,to,0,0
108057,irrelevant,0,0
108058,stimuli,0,0
108059,and,0,0
108060,increased,0,0
108061,responses,0,0
108062,to,0,0
108063,relevant,0,0
108064,stimuli,0,0
108065,.,0,0
108066,Improved,0,0
108067,selectivity,0,0
108068,in,0,0
108069,early,0,1
108070,cortical,0,0
108071,responses,0,0
108072,lead,0,0
108073,to,0,0
108074,better,0,0
108075,stimulus,0,0
108076,differentiation,0,0
108077,at,0,0
108078,later-stage,0,1
108079,responses,0,0
108080,as,0,0
108081,was,0,0
108082,made,0,0
108083,evident,0,0
108084,by,0,0
108085,our,0,0
108086,P3b,0,0
108087,and,0,0
108088,P3a,0,0
108089,component,0,0
108090,findings,0,0
108091,.,0,1
108092,These,0,0
108093,results,0,0
108094,indicate,0,0
108095,a,0,0
108096,significant,0,0
108097,change,0,0
108098,in,0,0
108099,early,0,0
108100,",",0,0
108101,middle-latency,0,0
108102,and,0,0
108103,late,0,1
108104,ERP,0,0
108105,components,0,0
108106,at,0,0
108107,the,0,0
108108,frontal,0,0
108109,",",0,0
108110,centro-parietal,0,0
108111,",",0,0
108112,and,0,0
108113,parieto-occipital,0,0
108114,regions,0,0
108115,of,0,0
108116,interest,0,0
108117,in,0,0
108118,response,0,0
108119,to,0,0
108120,target,0,0
108121,and,0,0
108122,distracter,0,0
108123,stimuli,0,0
108124,as,0,0
108125,a,0,0
108126,result,0,0
108127,of,0,0
108128,rTMS,0,0
108129,treatment,0,0
108130,.,0,0
108131,Overall,0,0
108132,",",0,0
108133,our,0,0
108134,preliminary,0,0
108135,results,0,0
108136,show,0,0
108137,that,0,0
108138,rTMS,0,0
108139,may,0,0
108140,prove,0,0
108141,to,0,0
108142,be,0,0
108143,an,0,0
108144,important,0,0
108145,research,0,0
108146,tool,0,0
108147,or,0,0
108148,treatment,0,0
108149,modality,0,0
108150,in,0,0
108151,addressing,0,0
108152,the,0,0
108153,stimulus,0,0
108154,hypersensitivity,0,0
108155,characteristic,0,0
108156,of,0,0
108157,autism,0,1
108158,spectrum,0,1
108159,disorders,0,1
108160,.,0,1
108161,Different,0,1
108162,therapeutic,0,0
108163,modalities,0,0
108164,for,0,0
108165,treatment,0,0
108166,of,0,0
108167,melasma,0,1
108168,.,0,1
108169,BACKGROUND,0,0
108170,Chemical,0,0
108171,peels,0,1
108172,and,0,0
108173,topical,0,0
108174,depigmenting,0,0
108175,agents,0,0
108176,have,0,0
108177,become,0,0
108178,a,0,0
108179,popular,0,0
108180,modality,0,0
108181,in,0,0
108182,the,0,0
108183,treatment,0,0
108184,of,0,0
108185,melasma,0,1
108186,.,0,1
108187,AIMS,0,0
108188,To,0,0
108189,compare,0,0
108190,the,0,0
108191,clinical,0,0
108192,efficacy,0,0
108193,of,0,0
108194,trichloroacetic,0,0
108195,acid,0,0
108196,peel,0,1
108197,20,0,0
108198,%,0,0
108199,vs,0,0
108200,.,0,0
108201,Jessner,0,0
108202,'s,0,0
108203,solution,0,0
108204,peel,0,1
108205,vs.,0,0
108206,the,0,0
108207,topical,0,0
108208,mixture,0,0
108209,of,0,0
108210,hydroquinone,0,0
108211,2,0,0
108212,%,0,0
108213,and,0,0
108214,kojic,0,0
108215,acid,0,0
108216,.,0,0
108217,PATIENTS,0,0
108218,AND,0,0
108219,METHODS,0,0
108220,Forty,1,1
108221,five,1,1
108222,patients,1,1
108223,with,1,1
108224,melasma,1,1
108225,were,1,1
108226,randomly,1,1
108227,assigned,1,1
108228,into,1,0
108229,three,1,0
108230,groups,1,0
108231,of,1,1
108232,fifteen,1,1
108233,patients,1,1
108234,each,1,1
108235,.,1,1
108236,Group,0,0
108237,A,0,0
108238,received,0,0
108239,Jessner,0,0
108240,'s,0,1
108241,solution,0,0
108242,peel,0,0
108243,",",0,0
108244,group,0,0
108245,B,0,0
108246,received,0,0
108247,trichloroacetic,0,0
108248,acid,0,0
108249,peel,0,1
108250,20,0,0
108251,%,0,0
108252,",",0,0
108253,and,0,0
108254,group,0,0
108255,C,0,0
108256,received,0,0
108257,topical,0,0
108258,hydroquinone,0,0
108259,2,0,0
108260,%,0,0
108261,and,0,0
108262,kojic,0,0
108263,acid,0,0
108264,.,0,0
108265,All,0,0
108266,patients,0,1
108267,were,0,0
108268,seen,0,0
108269,in,0,0
108270,follow-up,0,0
108271,period,0,1
108272,after,0,0
108273,16,0,1
108274,weeks,0,0
108275,;,0,1
108276,clinical,0,0
108277,evaluation,0,0
108278,using,0,0
108279,Melasma,0,1
108280,Area,0,0
108281,and,0,0
108282,Severity,0,0
108283,Index,0,0
108284,(,0,0
108285,MASI,0,0
108286,),0,0
108287,score,0,0
108288,and,0,0
108289,photography,0,0
108290,were,0,0
108291,recorded,0,0
108292,before,0,0
108293,and,0,0
108294,after,0,0
108295,treatment,0,0
108296,and,0,0
108297,after,0,0
108298,16,0,1
108299,weeks,0,0
108300,.,0,1
108301,RESULTS,0,0
108302,There,0,0
108303,was,0,0
108304,a,0,0
108305,decrease,0,0
108306,in,0,0
108307,MASI,0,0
108308,score,0,0
108309,in,0,0
108310,all,0,0
108311,three,0,0
108312,groups,0,0
108313,after,0,0
108314,treatment,0,0
108315,and,0,0
108316,after,0,0
108317,follow-up,0,0
108318,period,0,0
108319,but,0,0
108320,after,0,0
108321,treatment,0,0
108322,MASI,0,0
108323,score,0,0
108324,was,0,0
108325,statistically,0,0
108326,significantly,0,0
108327,lower,0,0
108328,in,0,0
108329,group,0,0
108330,A,0,0
108331,than,0,0
108332,group,0,0
108333,C,0,0
108334,(,0,0
108335,P,0,0
108336,=,0,0
108337,0.01,0,0
108338,),0,0
108339,",",0,0
108340,and,0,0
108341,it,0,0
108342,was,0,0
108343,also,0,0
108344,statistically,0,0
108345,significantly,0,0
108346,lower,0,0
108347,in,0,0
108348,group,0,0
108349,B,0,1
108350,than,0,0
108351,group,0,0
108352,C,0,0
108353,(,0,0
108354,P,0,0
108355,<,0,0
108356,0.001,0,0
108357,),0,0
108358,but,0,0
108359,there,0,0
108360,was,0,0
108361,no,0,0
108362,statistically,0,0
108363,significant,0,0
108364,difference,0,0
108365,between,0,0
108366,groups,0,0
108367,A,0,1
108368,and,0,1
108369,B,0,0
108370,.,0,0
108371,After,0,0
108372,the,0,0
108373,follow-up,0,0
108374,period,0,0
108375,",",0,0
108376,MASI,0,0
108377,score,0,0
108378,was,0,0
108379,statistically,0,0
108380,significantly,0,0
108381,lower,0,0
108382,in,0,0
108383,group,0,0
108384,A,0,0
108385,than,0,0
108386,group,0,0
108387,C,0,0
108388,(,0,0
108389,P,0,0
108390,<,0,0
108391,0.001,0,0
108392,),0,0
108393,",",0,0
108394,statistically,0,0
108395,significantly,0,0
108396,lower,0,0
108397,in,0,0
108398,group,0,0
108399,B,0,1
108400,than,0,0
108401,group,0,0
108402,C,0,0
108403,(,0,0
108404,P,0,0
108405,<,0,0
108406,0.001,0,0
108407,),0,0
108408,",",0,0
108409,and,0,0
108410,statistically,0,0
108411,significantly,0,0
108412,lower,0,0
108413,in,0,0
108414,group,0,0
108415,B,0,1
108416,than,0,0
108417,group,0,0
108418,A,0,1
108419,(,0,0
108420,P,0,0
108421,=,0,0
108422,0.035,0,0
108423,),0,0
108424,.,0,0
108425,The,0,0
108426,statistical,0,0
108427,analysis,0,0
108428,was,0,0
108429,done,0,0
108430,through,0,0
108431,one-way,0,0
108432,anova,0,0
108433,followed,0,0
108434,by,0,0
108435,least,0,1
108436,significant,0,0
108437,difference,0,0
108438,(,0,0
108439,LSD,0,0
108440,),0,1
108441,.,0,1
108442,CONCLUSION,0,0
108443,Trichloroacetic,0,0
108444,acid,0,0
108445,20,0,1
108446,%,0,0
108447,showed,0,0
108448,better,0,0
108449,results,0,0
108450,than,0,0
108451,Jessner,0,1
108452,'s,0,1
108453,solution,0,0
108454,as,0,0
108455,peeling,0,0
108456,agent,0,0
108457,and,0,0
108458,hydroquinone,0,0
108459,2,0,0
108460,%,0,0
108461,with,0,1
108462,kojic,0,0
108463,acid,0,0
108464,as,0,0
108465,a,0,0
108466,topical,0,0
108467,agent,0,0
108468,in,0,0
108469,the,0,0
108470,treatment,0,0
108471,of,0,0
108472,melasma,1,1
108473,.,1,1
108474,Efficiency,0,0
108475,of,0,0
108476,anaferon,0,0
108477,in,0,0
108478,complex,0,0
108479,therapy,0,0
108480,of,0,0
108481,genital,1,1
108482,herpes,1,1
108483,.,1,1
108484,We,0,0
108485,studied,0,0
108486,clinical,0,0
108487,efficiency,0,0
108488,and,0,0
108489,IFN-inducing,0,0
108490,activity,0,0
108491,of,0,0
108492,anaferon,0,0
108493,in,0,0
108494,chronic,1,1
108495,recurrent,1,1
108496,genital,1,1
108497,herpes,1,1
108498,with,1,1
108499,high,1,1
108500,incidence,1,0
108501,of,1,0
108502,relapses,1,0
108503,.,1,1
108504,The,0,0
108505,use,0,0
108506,of,0,0
108507,anaferon,0,0
108508,in,0,0
108509,complex,0,1
108510,therapy,0,0
108511,reduced,0,0
108512,the,0,0
108513,duration,0,0
108514,of,0,0
108515,intoxication,0,1
108516,symptoms,0,0
108517,and,0,1
108518,local,0,0
108519,symptoms,0,0
108520,",",0,0
108521,shortened,0,0
108522,the,0,0
108523,duration,0,0
108524,of,0,0
108525,the,0,0
108526,relapse,0,0
108527,",",0,0
108528,activated,0,0
108529,expression,0,0
108530,of,0,0
108531,IFN-gamma,0,0
108532,mRNA,0,0
108533,",",0,0
108534,and,0,0
108535,improved,0,0
108536,IFN-gamma-producing,0,0
108537,capacity,0,0
108538,of,0,0
108539,blood,0,0
108540,leukocytes,0,0
108541,.,0,1
108542,Stress,0,1
108543,reduction,0,0
108544,prolongs,0,0
108545,life,0,0
108546,in,0,0
108547,women,1,1
108548,with,1,1
108549,coronary,1,1
108550,disease,1,1
108551,:,1,1
108552,the,0,0
108553,Stockholm,0,1
108554,Women,0,1
108555,'s,0,1
108556,Intervention,0,1
108557,Trial,0,1
108558,for,0,0
108559,Coronary,0,1
108560,Heart,0,1
108561,Disease,0,1
108562,(,0,0
108563,SWITCHD,0,0
108564,),0,1
108565,.,0,1
108566,BACKGROUND,0,0
108567,Psychosocial,0,0
108568,stress,0,0
108569,may,0,0
108570,increase,0,0
108571,risk,0,0
108572,and,0,0
108573,worsen,0,0
108574,prognosis,0,0
108575,of,0,0
108576,coronary,1,1
108577,heart,1,1
108578,disease,1,1
108579,in,1,0
108580,women,1,1
108581,.,1,1
108582,Interventions,0,0
108583,that,0,0
108584,counteract,0,0
108585,women,0,1
108586,'s,0,1
108587,psychosocial,0,1
108588,stress,0,0
108589,have,0,0
108590,not,0,0
108591,previously,0,0
108592,been,0,0
108593,presented,0,0
108594,.,0,0
108595,This,0,0
108596,study,0,0
108597,implemented,0,0
108598,a,0,0
108599,stress,0,0
108600,reduction,0,0
108601,program,0,0
108602,for,0,0
108603,women,1,1
108604,and,0,0
108605,investigated,0,0
108606,its,0,0
108607,ability,0,0
108608,to,0,0
108609,improve,0,0
108610,survival,0,0
108611,in,0,0
108612,women,1,1
108613,coronary,1,1
108614,patients,1,1
108615,.,1,1
108616,METHODS,0,0
108617,AND,0,0
108618,RESULTS,0,0
108619,Two,1,1
108620,hundred,1,1
108621,thirty-seven,1,1
108622,consecutive,1,1
108623,women,1,1
108624,patients,1,1
108625,",",1,1
108626,aged,1,1
108627,75,1,1
108628,years,1,1
108629,or,1,1
108630,younger,1,1
108631,",",1,0
108632,hospitalized,1,1
108633,for,1,0
108634,acute,1,1
108635,myocardial,1,1
108636,infarction,1,1
108637,",",1,0
108638,coronary,1,1
108639,artery,1,1
108640,bypass,1,1
108641,grafting,1,0
108642,",",1,0
108643,or,1,0
108644,percutaneous,1,1
108645,coronary,1,1
108646,intervention,1,0
108647,were,0,0
108648,randomized,0,0
108649,to,0,0
108650,a,0,0
108651,group-based,0,0
108652,psychosocial,0,0
108653,intervention,0,0
108654,program,0,0
108655,or,0,1
108656,usual,0,1
108657,care,0,1
108658,.,0,1
108659,Initiated,0,0
108660,4,0,0
108661,months,0,0
108662,after,0,0
108663,hospitalization,0,0
108664,",",0,0
108665,intervention,0,0
108666,groups,0,0
108667,of,0,0
108668,4,0,0
108669,to,0,1
108670,8,0,0
108671,women,0,1
108672,met,0,1
108673,for,0,0
108674,a,0,0
108675,total,0,1
108676,of,0,0
108677,20,0,1
108678,sessions,0,0
108679,that,0,0
108680,were,0,0
108681,spread,0,0
108682,over,0,0
108683,a,0,0
108684,year,0,0
108685,.,0,0
108686,We,0,0
108687,provided,0,0
108688,education,0,0
108689,about,0,0
108690,risk,0,0
108691,factors,0,0
108692,",",0,0
108693,relaxation,0,0
108694,training,0,0
108695,techniques,0,0
108696,",",0,0
108697,methods,0,1
108698,for,0,0
108699,self-monitoring,0,0
108700,and,0,0
108701,cognitive,0,0
108702,restructuring,0,0
108703,",",0,0
108704,with,0,0
108705,an,0,0
108706,emphasis,0,0
108707,on,0,0
108708,coping,0,0
108709,with,0,1
108710,stress,0,0
108711,exposure,0,0
108712,from,0,0
108713,family,0,1
108714,and,0,0
108715,work,0,0
108716,",",0,0
108717,and,0,0
108718,self-care,0,0
108719,and,0,0
108720,compliance,0,0
108721,with,0,1
108722,clinical,0,0
108723,advice,0,0
108724,.,0,0
108725,From,0,0
108726,randomization,0,0
108727,until,0,0
108728,end,0,0
108729,of,0,0
108730,follow-up,0,0
108731,(,0,0
108732,mean,0,0
108733,duration,0,0
108734,",",0,0
108735,7.1,0,0
108736,years,0,1
108737,),0,1
108738,",",0,0
108739,25,0,1
108740,women,0,1
108741,(,0,1
108742,20,0,1
108743,%,0,0
108744,),0,0
108745,in,0,0
108746,the,0,0
108747,usual,0,0
108748,care,0,1
108749,and,0,0
108750,8,0,0
108751,women,0,1
108752,(,0,1
108753,7,0,1
108754,%,0,0
108755,),0,0
108756,in,0,0
108757,the,0,0
108758,stress,0,0
108759,reduction,0,0
108760,died,0,1
108761,",",0,0
108762,yielding,0,0
108763,an,0,0
108764,almost,0,0
108765,3-fold,0,0
108766,protective,0,0
108767,effect,0,0
108768,of,0,0
108769,the,0,0
108770,intervention,0,0
108771,(,0,0
108772,odds,0,0
108773,ratio,0,0
108774,",",0,1
108775,0.33,0,0
108776,;,0,0
108777,95,0,0
108778,%,0,0
108779,CI,0,0
108780,",",0,0
108781,0.15,0,0
108782,to,0,0
108783,0.74,0,0
108784,;,0,1
108785,P=0.007,0,0
108786,),0,0
108787,.,0,0
108788,Introducing,0,0
108789,baseline,0,0
108790,measures,0,0
108791,of,0,1
108792,clinical,0,1
108793,prognostic,0,0
108794,factors,0,0
108795,",",0,0
108796,including,0,0
108797,use,0,0
108798,of,0,0
108799,aspirin,0,0
108800,",",0,0
108801,beta-blockers,0,0
108802,",",0,0
108803,angiotensin-converting,0,0
108804,enzyme,0,0
108805,inhibitors,0,0
108806,",",0,0
108807,calcium-channel,0,0
108808,blockers,0,0
108809,",",0,0
108810,and,0,0
108811,statins,0,0
108812,into,0,0
108813,multivariate,0,0
108814,models,0,0
108815,confirmed,0,0
108816,the,0,0
108817,unadjusted,0,0
108818,results,0,0
108819,(,0,1
108820,P=0.009,0,0
108821,),0,1
108822,.,0,0
108823,CONCLUSIONS,0,0
108824,Although,0,0
108825,mechanisms,0,0
108826,remain,0,0
108827,unclear,0,0
108828,",",0,0
108829,a,0,0
108830,group-based,0,0
108831,psychosocial,0,0
108832,intervention,0,0
108833,program,0,0
108834,for,0,0
108835,women,1,1
108836,with,1,1
108837,coronary,1,1
108838,heart,1,1
108839,disease,1,1
108840,may,0,0
108841,prolong,0,0
108842,lives,0,0
108843,independent,0,0
108844,of,0,1
108845,other,0,0
108846,prognostic,0,1
108847,factors,0,0
108848,.,0,1
108849,Improved,0,0
108850,adherence,0,0
108851,with,0,1
108852,once-daily,0,0
108853,versus,0,0
108854,twice-daily,0,0
108855,dosing,0,0
108856,of,0,0
108857,mometasone,0,0
108858,furoate,0,0
108859,administered,0,0
108860,via,0,0
108861,a,0,0
108862,dry,0,1
108863,powder,0,0
108864,inhaler,0,0
108865,:,0,1
108866,a,0,0
108867,randomized,0,0
108868,open-label,0,0
108869,study,0,1
108870,.,0,1
108871,BACKGROUND,0,0
108872,Poor,0,1
108873,adherence,0,0
108874,with,0,1
108875,prescribed,0,0
108876,asthma,0,1
108877,medication,0,0
108878,is,0,0
108879,a,0,0
108880,major,0,0
108881,barrier,0,0
108882,to,0,0
108883,positive,0,0
108884,treatment,0,0
108885,outcomes,0,0
108886,.,0,0
108887,This,0,0
108888,study,0,0
108889,was,0,0
108890,designed,0,0
108891,to,0,0
108892,determine,0,0
108893,the,0,0
108894,effect,0,0
108895,of,0,0
108896,a,0,0
108897,once-daily,0,0
108898,administration,0,0
108899,of,0,0
108900,mometasone,0,0
108901,furoate,0,0
108902,administered,0,0
108903,via,0,0
108904,a,0,0
108905,dry,0,1
108906,powder,0,0
108907,inhaler,0,0
108908,(,0,0
108909,MF-DPI,0,1
108910,),0,0
108911,on,0,0
108912,treatment,0,0
108913,adherence,0,0
108914,compared,0,0
108915,with,0,1
108916,a,0,0
108917,twice-daily,0,0
108918,administration,0,0
108919,.,0,1
108920,METHODS,0,0
108921,This,0,0
108922,was,0,0
108923,a,0,0
108924,12-week,0,0
108925,open-label,0,0
108926,study,0,0
108927,designed,0,0
108928,to,0,0
108929,mimic,0,0
108930,an,0,0
108931,actual,0,0
108932,clinical,0,0
108933,setting,0,1
108934,in,1,0
108935,patients,1,1
108936,>,1,1
108937,or=12,1,1
108938,years,1,1
108939,old,1,1
108940,with,1,1
108941,mild-to-moderate,1,1
108942,persistent,1,1
108943,asthma,1,1
108944,.,1,1
108945,Patients,0,1
108946,were,0,0
108947,randomized,0,1
108948,to,0,0
108949,receive,0,0
108950,MF-DPI,0,1
108951,400,0,0
108952,microg,0,0
108953,once-daily,0,0
108954,in,0,0
108955,the,0,0
108956,evening,0,0
108957,or,0,1
108958,MF-DPI,0,1
108959,200,0,0
108960,microg,0,0
108961,twice-daily,0,0
108962,.,0,1
108963,Adherence,0,0
108964,was,0,0
108965,assessed,0,0
108966,primarily,0,1
108967,using,0,0
108968,the,0,0
108969,number,0,0
108970,of,0,0
108971,actual,0,0
108972,administered,0,0
108973,doses,0,0
108974,reported,0,0
108975,from,0,0
108976,the,0,0
108977,device,0,0
108978,counter,0,0
108979,divided,0,0
108980,by,0,0
108981,the,0,0
108982,number,0,0
108983,of,0,0
108984,scheduled,0,1
108985,doses,0,0
108986,.,0,1
108987,Self-reports,0,0
108988,were,0,0
108989,also,0,0
108990,used,0,0
108991,to,0,0
108992,determine,0,0
108993,adherence,0,0
108994,.,0,0
108995,Health-related,0,0
108996,quality,0,0
108997,of,0,0
108998,life,0,0
108999,",",0,0
109000,healthcare,0,0
109001,resource,0,0
109002,utilization,0,0
109003,",",0,0
109004,and,0,0
109005,days,0,0
109006,missed,0,1
109007,from,0,1
109008,work,0,0
109009,or,0,1
109010,school,0,1
109011,were,0,0
109012,also,0,0
109013,reported,0,0
109014,.,0,0
109015,RESULTS,0,0
109016,1233,1,1
109017,patients,1,1
109018,were,1,1
109019,randomized,1,1
109020,.,1,0
109021,The,0,0
109022,mean,0,0
109023,adherence,0,0
109024,rates,0,0
109025,",",0,0
109026,as,0,0
109027,measured,0,0
109028,by,0,0
109029,the,0,0
109030,automatic,0,0
109031,dose,0,0
109032,counter,0,0
109033,",",0,0
109034,were,0,0
109035,significantly,0,0
109036,better,0,0
109037,(,0,0
109038,P,0,0
109039,<,0,0
109040,0.001,0,0
109041,),0,0
109042,with,0,1
109043,MF-DPI,0,1
109044,400,0,0
109045,microg,0,0
109046,once-daily,0,0
109047,in,0,0
109048,the,0,0
109049,evening,0,0
109050,(,0,0
109051,93.3,0,0
109052,%,0,0
109053,),0,0
109054,than,0,0
109055,with,0,1
109056,MF-DPI,0,1
109057,200,0,0
109058,microg,0,0
109059,twice-daily,0,0
109060,(,0,0
109061,89.5,0,0
109062,%,0,0
109063,),0,0
109064,.,0,0
109065,Mean,0,0
109066,adherence,0,0
109067,rates,0,0
109068,based,0,0
109069,on,0,0
109070,self-reports,0,0
109071,were,0,0
109072,also,0,0
109073,significantly,0,0
109074,better,0,0
109075,(,0,0
109076,P,0,0
109077,<,0,0
109078,0.001,0,0
109079,),0,0
109080,with,0,1
109081,MF-DPI,0,1
109082,400,0,0
109083,microg,0,0
109084,QD,0,0
109085,PM,0,1
109086,(,0,0
109087,97.2,0,0
109088,%,0,0
109089,),0,0
109090,than,0,0
109091,with,0,1
109092,MF-DPI,0,1
109093,200,0,0
109094,microg,0,0
109095,twice-daily,0,0
109096,(,0,0
109097,95.3,0,0
109098,%,0,0
109099,),0,0
109100,.,0,0
109101,Adherence,0,0
109102,rates,0,0
109103,were,0,0
109104,lower,0,0
109105,in,0,0
109106,adolescents,0,1
109107,(,0,1
109108,12-17,0,1
109109,years,0,1
109110,old,0,1
109111,),0,1
109112,.,0,1
109113,Health-related,0,0
109114,quality,0,0
109115,of,0,0
109116,life,0,0
109117,improved,0,0
109118,by,0,0
109119,20,0,0
109120,%,0,0
109121,in,0,0
109122,patients,0,1
109123,using,0,0
109124,MF-DPI,0,0
109125,once-daily,0,0
109126,in,0,0
109127,the,0,0
109128,evening,0,0
109129,and,0,0
109130,by,0,0
109131,14,0,0
109132,%,0,0
109133,in,0,0
109134,patients,0,1
109135,using,0,1
109136,MF-DPI,0,1
109137,twice-daily,0,0
109138,.,0,1
109139,Very,0,0
109140,few,0,0
109141,(,0,0
109142,<,0,0
109143,8,0,0
109144,%,0,0
109145,),0,1
109146,patients,0,1
109147,missed,0,1
109148,work/school,0,1
109149,.,0,1
109150,CONCLUSION,0,0
109151,Mean,0,1
109152,adherence,0,0
109153,rates,0,0
109154,were,0,0
109155,greater,0,0
109156,with,0,1
109157,a,0,0
109158,once-daily,0,0
109159,dosing,0,0
109160,regimen,0,0
109161,of,0,0
109162,MF-DPI,0,1
109163,than,0,0
109164,with,0,1
109165,a,0,0
109166,twice-daily,0,0
109167,dosing,0,0
109168,regimen.This,0,0
109169,trial,0,0
109170,was,0,0
109171,completed,0,1
109172,prior,0,0
109173,to,0,0
109174,the,0,0
109175,ISMJE,0,0
109176,requirements,0,0
109177,for,0,0
109178,trial,0,1
109179,registration,0,1
109180,.,0,1
109181,Monitoring,0,0
109182,acute,0,1
109183,effects,0,0
109184,on,0,0
109185,athletic,0,1
109186,performance,0,0
109187,with,0,1
109188,mixed,0,0
109189,linear,0,0
109190,modeling,0,0
109191,.,0,0
109192,UNLABELLED,0,0
109193,There,0,0
109194,is,0,0
109195,a,0,0
109196,need,0,0
109197,for,0,0
109198,a,0,0
109199,sophisticated,0,0
109200,approach,0,0
109201,to,0,0
109202,track,0,0
109203,athletic,0,0
109204,performance,0,0
109205,and,0,0
109206,to,0,0
109207,quantify,0,0
109208,factors,0,0
109209,affecting,0,0
109210,it,0,0
109211,in,0,0
109212,practical,0,0
109213,settings,0,1
109214,.,0,1
109215,PURPOSE,0,0
109216,To,0,0
109217,demonstrate,0,0
109218,the,0,0
109219,application,0,0
109220,of,0,0
109221,mixed,0,0
109222,linear,0,0
109223,modeling,0,0
109224,for,0,0
109225,monitoring,0,0
109226,athletic,0,1
109227,performance,0,0
109228,.,0,1
109229,METHODS,0,0
109230,Elite,1,0
109231,sprint,1,0
109232,and,1,0
109233,middle-distance,1,0
109234,swimmers,1,1
109235,(,1,1
109236,three,1,1
109237,females,1,1
109238,and,1,1
109239,six,1,1
109240,males,1,1
109241,;,1,1
109242,aged,1,1
109243,21-26,1,1
109244,yr,1,1
109245,),1,0
109246,performed,1,0
109247,6-13,1,1
109248,time,1,0
109249,trials,1,0
109250,in,1,0
109251,training,1,0
109252,and,1,0
109253,competition,1,0
109254,in,1,0
109255,the,1,0
109256,9,1,0
109257,wk,1,0
109258,before,1,0
109259,and,1,0
109260,including,1,0
109261,Olympic-qualifying,1,1
109262,trials,1,0
109263,",",1,0
109264,all,1,0
109265,in,1,0
109266,their,1,0
109267,specialty,1,1
109268,event,1,0
109269,.,1,0
109270,We,0,0
109271,included,0,0
109272,a,0,0
109273,double-blind,0,0
109274,",",0,0
109275,randomized,0,0
109276,",",0,0
109277,diet-controlled,0,0
109278,crossover,0,0
109279,intervention,0,0
109280,",",0,0
109281,in,0,0
109282,which,0,0
109283,the,0,0
109284,swimmers,0,0
109285,consumed,0,1
109286,caffeine,0,1
109287,(,0,0
109288,5,0,0
109289,mg,0,0
109290,x,0,0
109291,kg,0,0
109292,(,0,0
109293,-1,0,0
109294,),0,0
109295,body,0,1
109296,mass,0,1
109297,),0,0
109298,or,0,1
109299,placebo,0,0
109300,.,0,0
109301,The,0,0
109302,swimmers,0,0
109303,also,0,0
109304,knowingly,0,1
109305,consumed,0,0
109306,varying,0,0
109307,doses,0,0
109308,of,0,0
109309,caffeine,0,1
109310,in,0,0
109311,some,0,0
109312,time,0,0
109313,trials,0,0
109314,.,0,1
109315,We,0,0
109316,used,0,0
109317,mixed,0,0
109318,linear,0,0
109319,modeling,0,0
109320,of,0,0
109321,log-transformed,0,0
109322,swim,0,0
109323,time,0,0
109324,to,0,0
109325,quantify,0,0
109326,effects,0,0
109327,on,0,0
109328,performance,0,0
109329,in,0,0
109330,training,0,0
109331,versus,0,0
109332,competition,0,0
109333,",",0,0
109334,in,0,0
109335,morning,0,0
109336,versus,0,0
109337,evening,0,0
109338,swims,0,0
109339,",",0,0
109340,and,0,0
109341,with,0,0
109342,use,0,0
109343,of,0,0
109344,caffeine,0,0
109345,.,0,1
109346,Predictor,0,0
109347,variables,0,0
109348,were,0,0
109349,coded,0,1
109350,as,0,0
109351,0,0,0
109352,or,0,1
109353,1,0,0
109354,to,0,0
109355,represent,0,0
109356,absence,0,0
109357,or,0,0
109358,presence,0,0
109359,",",0,0
109360,respectively,0,0
109361,",",0,0
109362,of,0,0
109363,each,0,0
109364,condition,0,0
109365,and,0,0
109366,were,0,0
109367,included,0,1
109368,as,0,0
109369,fixed,0,1
109370,effects,0,0
109371,.,0,1
109372,The,0,0
109373,date,0,0
109374,of,0,0
109375,each,0,0
109376,performance,0,0
109377,test,0,0
109378,was,0,0
109379,included,0,0
109380,as,0,0
109381,a,0,0
109382,continuous,0,0
109383,linear,0,0
109384,fixed,0,0
109385,effect,0,0
109386,and,0,0
109387,interacted,0,0
109388,with,0,1
109389,the,0,0
109390,random,0,0
109391,effect,0,0
109392,for,0,0
109393,the,0,0
109394,athlete,0,0
109395,to,0,0
109396,represent,0,0
109397,individual,0,0
109398,differences,0,0
109399,in,0,1
109400,linear,0,0
109401,trends,0,0
109402,in,0,1
109403,performance,0,0
109404,.,0,1
109405,RESULTS,0,0
109406,Most,0,0
109407,effects,0,0
109408,were,0,0
109409,clear,0,0
109410,",",0,0
109411,owing,0,0
109412,to,0,0
109413,the,0,0
109414,high,0,0
109415,reliability,0,0
109416,of,0,0
109417,performance,0,0
109418,times,0,0
109419,in,0,0
109420,training,0,0
109421,and,0,0
109422,competition,0,0
109423,(,0,0
109424,typical,0,1
109425,errors,0,0
109426,of,0,1
109427,0.9,0,0
109428,%,0,0
109429,and,0,0
109430,0.8,0,0
109431,%,0,0
109432,",",0,0
109433,respectively,0,0
109434,),0,0
109435,.,0,0
109436,Performance,0,0
109437,time,0,0
109438,improved,0,0
109439,linearly,0,0
109440,by,0,0
109441,0.8,0,0
109442,%,0,0
109443,per,0,0
109444,4,0,0
109445,wk,0,1
109446,.,0,1
109447,The,0,0
109448,swimmers,0,0
109449,performed,0,0
109450,substantially,0,0
109451,better,0,0
109452,in,0,0
109453,evenings,0,0
109454,versus,0,0
109455,mornings,0,1
109456,and,0,0
109457,in,0,0
109458,competition,0,0
109459,versus,0,0
109460,training,0,0
109461,.,0,0
109462,A,0,0
109463,100-mg,0,0
109464,dose,0,0
109465,of,0,0
109466,caffeine,0,0
109467,enhanced,0,0
109468,performance,0,0
109469,in,0,0
109470,training,0,0
109471,and,0,0
109472,competition,0,0
109473,by,0,0
109474,approximately,0,1
109475,1.3,0,0
109476,%,0,0
109477,.,0,0
109478,There,0,0
109479,were,0,0
109480,substantial,0,0
109481,but,0,0
109482,unclear,0,0
109483,individual,0,0
109484,responses,0,0
109485,to,0,0
109486,training,0,0
109487,and,0,0
109488,caffeine,0,0
109489,(,0,0
109490,SD,0,0
109491,of,0,0
109492,0.3,0,0
109493,%,0,0
109494,and,0,0
109495,0.8,0,0
109496,%,0,0
109497,",",0,0
109498,respectively,0,0
109499,),0,0
109500,.,0,0
109501,CONCLUSIONS,0,0
109502,Mixed,0,1
109503,linear,0,0
109504,modeling,0,0
109505,can,0,0
109506,be,0,0
109507,applied,0,0
109508,successfully,0,0
109509,to,0,0
109510,monitor,0,0
109511,factors,0,0
109512,affecting,0,0
109513,performance,0,0
109514,in,0,0
109515,a,0,0
109516,squad,0,0
109517,of,0,0
109518,elite,1,1
109519,athletes,1,1
109520,.,1,1
109521,PROCLAIM,0,0
109522,:,0,1
109523,pilot,0,0
109524,study,0,0
109525,to,0,0
109526,examine,0,0
109527,the,0,0
109528,effects,0,0
109529,of,0,0
109530,clopidogrel,0,1
109531,on,0,0
109532,inflammatory,0,0
109533,markers,0,0
109534,in,0,1
109535,patients,1,1
109536,with,1,1
109537,metabolic,1,1
109538,syndrome,1,1
109539,receiving,1,1
109540,low-dose,1,0
109541,aspirin,1,0
109542,.,1,1
109543,Metabolic,0,0
109544,syndrome,0,1
109545,is,0,0
109546,associated,0,0
109547,with,0,0
109548,intravascular,0,0
109549,inflammation,0,0
109550,",",0,0
109551,as,0,0
109552,determined,0,0
109553,by,0,0
109554,increased,0,0
109555,levels,0,0
109556,of,0,0
109557,inflammatory,0,0
109558,biomarkers,0,0
109559,and,0,0
109560,an,0,0
109561,increased,0,0
109562,risk,0,0
109563,of,0,0
109564,ischemic,0,1
109565,atherothrombotic,0,1
109566,events,0,0
109567,.,0,0
109568,Evidence,0,0
109569,suggests,0,0
109570,that,0,0
109571,atherothrombosis,0,0
109572,and,0,0
109573,intravascular,0,0
109574,inflammation,0,0
109575,share,0,0
109576,predictive,0,0
109577,biomarkers,0,0
109578,",",0,0
109579,including,0,0
109580,high-sensitivity,0,0
109581,C-reactive,0,0
109582,protein,0,0
109583,",",0,0
109584,CD40,0,0
109585,ligand,0,0
109586,",",0,0
109587,P-selectin,0,0
109588,",",0,0
109589,and,0,0
109590,N-terminal,0,0
109591,pro-brain,0,0
109592,natriuretic,0,1
109593,peptide,0,0
109594,.,0,1
109595,Patients,1,1
109596,who,1,1
109597,had,1,1
109598,metabolic,1,1
109599,syndrome,1,1
109600,were,0,0
109601,randomized,0,0
109602,to,0,0
109603,receive,0,0
109604,clopidogrel,0,1
109605,75,0,0
109606,mg/day,0,0
109607,plus,0,0
109608,aspirin,0,0
109609,81,0,1
109610,mg/day,0,0
109611,(,0,0
109612,n,0,1
109613,=,0,0
109614,89,0,1
109615,),0,0
109616,or,0,1
109617,placebo,0,0
109618,plus,0,0
109619,aspirin,0,0
109620,81,0,1
109621,mg/day,0,0
109622,(,0,0
109623,n,0,1
109624,=,0,0
109625,92,0,1
109626,),0,0
109627,for,0,0
109628,9,0,1
109629,weeks,0,0
109630,to,0,0
109631,assess,0,0
109632,the,0,0
109633,efficacy,0,0
109634,of,0,0
109635,each,0,0
109636,treatment,0,0
109637,in,0,0
109638,suppression,0,0
109639,of,0,0
109640,inflammatory,0,0
109641,markers,0,0
109642,.,0,1
109643,Change,0,0
109644,from,0,0
109645,baseline,0,0
109646,in,0,0
109647,the,0,0
109648,levels,0,0
109649,of,0,0
109650,high-sensitivity,0,0
109651,C-reactive,0,0
109652,protein,0,0
109653,",",0,0
109654,CD40,0,0
109655,ligand,0,0
109656,",",0,0
109657,P-selectin,0,0
109658,",",0,0
109659,and,0,0
109660,N-terminal,0,0
109661,pro-brain,0,0
109662,natriuretic,0,1
109663,peptide,0,0
109664,at,0,0
109665,6,0,0
109666,weeks,0,0
109667,was,0,0
109668,assessed,0,0
109669,to,0,0
109670,evaluate,0,0
109671,each,0,0
109672,treatment,0,0
109673,.,0,0
109674,There,0,0
109675,was,0,0
109676,a,0,0
109677,significant,0,0
109678,difference,0,0
109679,at,0,0
109680,Week,0,1
109681,6,0,0
109682,in,0,0
109683,model-adjusted,0,0
109684,CD40-ligand,0,0
109685,levels,0,0
109686,in,0,0
109687,favor,0,0
109688,of,0,0
109689,clopidogrel,0,1
109690,plus,0,0
109691,aspirin,0,0
109692,compared,0,0
109693,with,0,1
109694,placebo,0,0
109695,plus,0,0
109696,aspirin,0,0
109697,in,0,0
109698,both,0,0
109699,the,0,0
109700,intent-to-treat,0,0
109701,population,0,1
109702,(,0,0
109703,difference,0,0
109704,between,0,0
109705,least-squares,0,0
109706,means,0,0
109707,=,0,1
109708,-186.5,0,0
109709,;,0,0
109710,95,0,0
109711,%,0,0
109712,confidence,0,0
109713,interval,0,0
109714,",",0,0
109715,-342.3,0,0
109716,to,0,0
109717,-30.8,0,0
109718,;,0,0
109719,P,0,0
109720,=,0,0
109721,0.02,0,0
109722,),0,0
109723,and,0,0
109724,the,0,0
109725,per-protocol,0,0
109726,population,0,1
109727,(,0,0
109728,P,0,0
109729,=,0,0
109730,0.05,0,0
109731,),0,0
109732,.,0,0
109733,No,0,0
109734,significant,0,0
109735,differences,0,0
109736,were,0,1
109737,observed,0,0
109738,between,0,0
109739,the,0,0
109740,treatment,0,0
109741,arms,0,0
109742,for,0,0
109743,high-sensitivity,0,0
109744,C-reactive,0,0
109745,protein,0,0
109746,",",0,0
109747,P-selectin,0,0
109748,",",0,0
109749,and,0,0
109750,N-terminal,0,0
109751,pro-brain,0,0
109752,natriuretic,0,1
109753,peptide,0,0
109754,.,0,0
109755,There,0,0
109756,were,0,0
109757,no,0,0
109758,deaths,0,0
109759,or,0,1
109760,serious,0,0
109761,adverse,0,0
109762,events,0,0
109763,in,0,0
109764,either,0,0
109765,treatment,0,0
109766,arm,0,0
109767,.,0,0
109768,Data,0,0
109769,from,0,0
109770,this,0,0
109771,study,0,0
109772,suggest,0,0
109773,that,0,0
109774,clopidogrel,0,0
109775,can,0,0
109776,decrease,0,0
109777,the,0,0
109778,expression,0,0
109779,of,0,0
109780,the,0,0
109781,CD40-ligand,0,0
109782,biomarker,0,0
109783,.,0,1
109784,Pazopanib,0,1
109785,in,0,0
109786,locally,1,1
109787,advanced,1,1
109788,or,1,0
109789,metastatic,1,1
109790,renal,1,1
109791,cell,1,1
109792,carcinoma,1,1
109793,:,1,1
109794,results,0,0
109795,of,0,0
109796,a,0,0
109797,randomized,0,0
109798,phase,0,1
109799,III,0,1
109800,trial,0,0
109801,.,0,1
109802,PURPOSE,0,0
109803,Pazopanib,0,1
109804,is,0,0
109805,an,0,0
109806,oral,0,0
109807,angiogenesis,0,0
109808,inhibitor,0,0
109809,targeting,0,0
109810,vascular,0,0
109811,endothelial,0,0
109812,growth,0,0
109813,factor,0,0
109814,receptor,0,0
109815,",",0,0
109816,platelet-derived,0,0
109817,growth,0,0
109818,factor,0,0
109819,receptor,0,0
109820,",",0,0
109821,and,0,0
109822,c-Kit,0,0
109823,.,0,0
109824,This,0,0
109825,randomized,0,0
109826,",",0,0
109827,double-blind,0,0
109828,",",0,0
109829,placebo-controlled,0,0
109830,phase,0,1
109831,III,0,1
109832,study,0,0
109833,evaluated,0,0
109834,efficacy,0,0
109835,and,0,0
109836,safety,0,0
109837,of,0,0
109838,pazopanib,0,1
109839,monotherapy,0,1
109840,in,0,0
109841,treatment-naive,1,1
109842,and,1,1
109843,cytokine-pretreated,1,0
109844,patients,1,1
109845,with,1,1
109846,advanced,1,1
109847,renal,1,1
109848,cell,1,1
109849,carcinoma,1,1
109850,(,1,0
109851,RCC,1,0
109852,),1,1
109853,.,1,0
109854,PATIENTS,0,0
109855,AND,0,0
109856,METHODS,0,0
109857,Adult,1,1
109858,patients,1,1
109859,with,1,1
109860,measurable,1,0
109861,",",1,0
109862,locally,1,0
109863,advanced,1,1
109864,",",1,0
109865,and/or,1,0
109866,metastatic,1,1
109867,RCC,1,0
109868,were,0,0
109869,randomly,0,1
109870,assigned,0,1
109871,2:1,0,1
109872,to,0,0
109873,receive,0,0
109874,oral,0,0
109875,pazopanib,0,1
109876,or,0,1
109877,placebo,0,0
109878,.,0,0
109879,The,0,0
109880,primary,0,0
109881,end,0,0
109882,point,0,0
109883,was,0,0
109884,progression-free,0,0
109885,survival,0,0
109886,(,0,0
109887,PFS,0,0
109888,),0,1
109889,.,0,0
109890,Secondary,0,0
109891,end,0,0
109892,points,0,0
109893,included,0,1
109894,overall,0,0
109895,survival,0,0
109896,",",0,0
109897,tumor,0,0
109898,response,0,0
109899,rate,0,0
109900,(,0,0
109901,Response,0,0
109902,Evaluation,0,0
109903,Criteria,0,1
109904,in,0,0
109905,Solid,0,1
109906,Tumors,0,1
109907,),0,0
109908,",",0,0
109909,and,0,0
109910,safety,0,0
109911,.,0,1
109912,Radiographic,0,0
109913,assessments,0,0
109914,of,0,1
109915,tumors,0,1
109916,were,0,1
109917,independently,0,1
109918,reviewed,0,1
109919,.,0,0
109920,Results,0,0
109921,Of,1,1
109922,435,1,1
109923,patients,1,1
109924,enrolled,1,1
109925,",",1,0
109926,233,1,1
109927,were,1,0
109928,treatment,1,0
109929,naive,1,1
109930,(,1,0
109931,54,1,1
109932,%,1,0
109933,),1,0
109934,and,1,0
109935,202,1,1
109936,were,1,0
109937,cytokine,1,0
109938,pretreated,1,0
109939,(,1,0
109940,46,1,1
109941,%,1,0
109942,),1,1
109943,.,1,1
109944,PFS,0,0
109945,was,0,0
109946,significantly,0,0
109947,prolonged,0,0
109948,with,0,1
109949,pazopanib,0,1
109950,compared,0,0
109951,with,0,1
109952,placebo,0,0
109953,in,0,0
109954,the,0,0
109955,overall,0,0
109956,study,0,0
109957,population,0,1
109958,(,0,0
109959,median,0,0
109960,",",0,0
109961,PFS,0,0
109962,9.2,0,0
109963,v,0,0
109964,4.2,0,1
109965,months,0,0
109966,;,0,1
109967,hazard,0,0
109968,ratio,0,0
109969,[,0,0
109970,HR,0,0
109971,],0,1
109972,",",0,0
109973,0.46,0,0
109974,;,0,0
109975,95,0,0
109976,%,0,0
109977,CI,0,0
109978,",",0,0
109979,0.34,0,0
109980,to,0,0
109981,0.62,0,0
109982,;,0,1
109983,P,0,0
109984,<,0,0
109985,.0001,0,0
109986,),0,0
109987,",",0,0
109988,the,0,0
109989,treatment-naive,0,1
109990,subpopulation,0,1
109991,(,0,0
109992,median,0,1
109993,PFS,0,0
109994,11.1,0,0
109995,v,0,0
109996,2.8,0,1
109997,months,0,0
109998,;,0,1
109999,HR,0,0
110000,",",0,0
110001,0.40,0,0
110002,;,0,0
110003,95,0,0
110004,%,0,0
110005,CI,0,0
110006,",",0,0
110007,0.27,0,0
110008,to,0,0
110009,0.60,0,0
110010,;,0,1
110011,P,0,0
110012,<,0,0
110013,.0001,0,0
110014,),0,0
110015,",",0,0
110016,and,0,0
110017,the,0,0
110018,cytokine-pretreated,0,0
110019,subpopulation,0,1
110020,(,0,0
110021,median,0,0
110022,PFS,0,0
110023,",",0,0
110024,7.4,0,0
110025,v,0,0
110026,4.2,0,1
110027,months,0,0
110028,;,0,1
110029,HR,0,0
110030,",",0,0
110031,0.54,0,0
110032,;,0,0
110033,95,0,0
110034,%,0,0
110035,CI,0,0
110036,",",0,0
110037,0.35,0,0
110038,to,0,0
110039,0.84,0,0
110040,;,0,1
110041,P,0,0
110042,<,0,0
110043,.001,0,0
110044,),0,0
110045,.,0,0
110046,The,0,0
110047,objective,0,0
110048,response,0,0
110049,rate,0,0
110050,was,0,0
110051,30,0,0
110052,%,0,0
110053,with,0,1
110054,pazopanib,0,1
110055,compared,0,0
110056,with,0,1
110057,3,0,0
110058,%,0,0
110059,with,0,1
110060,placebo,0,0
110061,(,0,0
110062,P,0,0
110063,<,0,0
110064,.001,0,0
110065,),0,0
110066,.,0,0
110067,The,0,0
110068,median,0,0
110069,duration,0,0
110070,of,0,0
110071,response,0,0
110072,was,0,0
110073,longer,0,0
110074,than,0,0
110075,1,0,0
110076,year,0,1
110077,.,0,0
110078,The,0,0
110079,most,0,0
110080,common,0,0
110081,adverse,0,0
110082,events,0,0
110083,were,0,0
110084,diarrhea,0,1
110085,",",0,0
110086,hypertension,0,1
110087,",",0,0
110088,hair,0,1
110089,color,0,0
110090,changes,0,0
110091,",",0,0
110092,nausea,0,0
110093,",",0,0
110094,anorexia,0,1
110095,",",0,0
110096,and,0,0
110097,vomiting,0,0
110098,.,0,0
110099,There,0,0
110100,was,0,0
110101,no,0,0
110102,evidence,0,0
110103,of,0,0
110104,clinically,0,0
110105,important,0,0
110106,differences,0,0
110107,in,0,0
110108,quality,0,0
110109,of,0,0
110110,life,0,0
110111,for,0,0
110112,pazopanib,0,1
110113,versus,0,0
110114,placebo,0,0
110115,.,0,1
110116,CONCLUSION,0,0
110117,Pazopanib,0,1
110118,demonstrated,0,0
110119,significant,0,0
110120,improvement,0,0
110121,in,0,0
110122,PFS,0,0
110123,and,0,0
110124,tumor,0,0
110125,response,0,0
110126,compared,0,0
110127,with,0,1
110128,placebo,0,0
110129,in,0,0
110130,treatment-naive,1,1
110131,and,1,1
110132,cytokine-pretreated,1,0
110133,patients,1,1
110134,with,1,1
110135,advanced,1,1
110136,and/or,1,1
110137,metastatic,1,1
110138,RCC,1,0
110139,.,1,1
110140,Oral,0,0
110141,6-mercaptopurine,0,0
110142,versus,0,0
110143,oral,0,0
110144,6-thioguanine,0,0
110145,and,0,0
110146,veno-occlusive,0,1
110147,disease,0,1
110148,in,1,0
110149,children,1,1
110150,with,1,1
110151,standard-risk,1,1
110152,acute,1,1
110153,lymphoblastic,1,1
110154,leukemia,1,1
110155,:,1,1
110156,report,0,0
110157,of,0,0
110158,the,0,0
110159,Children,0,1
110160,'s,0,1
110161,Oncology,0,1
110162,Group,0,1
110163,CCG-1952,0,1
110164,clinical,0,0
110165,trial,0,0
110166,.,0,0
110167,The,0,0
110168,Children,1,1
110169,'s,1,1
110170,Cancer,1,1
110171,Group,1,1
110172,1952,1,1
110173,(,1,0
110174,CCG-1952,1,1
110175,),1,0
110176,clinical,0,0
110177,trial,0,0
110178,studied,0,0
110179,the,0,0
110180,substitution,0,0
110181,of,0,0
110182,oral,0,0
110183,6-thioguanine,0,0
110184,(,0,1
110185,TG,0,0
110186,),0,0
110187,for,0,0
110188,6-mercaptopurine,0,0
110189,(,0,1
110190,MP,0,0
110191,),0,0
110192,and,0,0
110193,triple,0,0
110194,intrathecal,0,0
110195,therapy,0,0
110196,(,0,0
110197,ITT,0,1
110198,),0,0
110199,for,0,0
110200,intrathecal,0,0
110201,methotrexate,0,0
110202,(,0,0
110203,IT-MTX,0,0
110204,),0,0
110205,in,0,0
110206,the,0,0
110207,treatment,0,0
110208,of,0,0
110209,standard-risk,1,1
110210,acute,1,1
110211,lymphoblastic,1,1
110212,leukemia,1,1
110213,.,1,0
110214,After,1,0
110215,remission,1,0
110216,induction,1,0
110217,",",1,0
110218,2027,1,1
110219,patients,1,1
110220,were,0,1
110221,randomized,0,1
110222,to,0,0
110223,receive,0,0
110224,MP,0,0
110225,(,0,0
110226,n,0,1
110227,=,0,0
110228,1010,0,1
110229,),0,0
110230,or,0,1
110231,TG,0,0
110232,(,0,0
110233,n,0,1
110234,=,0,0
110235,1017,0,1
110236,),0,0
110237,and,0,0
110238,IT-MTX,0,0
110239,(,0,0
110240,n,0,1
110241,=,0,0
110242,1018,0,1
110243,),0,0
110244,or,0,1
110245,ITT,0,1
110246,(,0,0
110247,n,0,1
110248,=,0,0
110249,1009,0,1
110250,),0,0
110251,.,0,1
110252,The,0,0
110253,results,0,0
110254,of,0,0
110255,the,0,0
110256,thiopurine,0,0
110257,comparison,0,0
110258,are,0,0
110259,as,0,0
110260,follows,0,0
110261,.,0,0
110262,The,0,0
110263,estimated,0,0
110264,7-year,0,0
110265,event-free,0,0
110266,survival,0,0
110267,(,0,0
110268,EFS,0,0
110269,),0,0
110270,for,0,0
110271,subjects,0,1
110272,randomized,0,1
110273,to,0,0
110274,TG,0,0
110275,was,0,0
110276,84.1,0,0
110277,%,0,0
110278,(,0,1
110279,+/-,0,0
110280,1.8,0,0
110281,%,0,0
110282,),0,0
110283,and,0,0
110284,to,0,0
110285,MP,0,0
110286,was,0,0
110287,79.0,0,0
110288,%,0,0
110289,(,0,1
110290,+/-,0,0
110291,2.1,0,0
110292,%,0,0
110293,;,0,1
110294,P,0,0
110295,=,0,0
110296,.004,0,0
110297,log,0,0
110298,rank,0,0
110299,),0,0
110300,",",0,0
110301,although,0,0
110302,overall,0,0
110303,survival,0,0
110304,was,0,0
110305,91.9,0,0
110306,%,0,0
110307,(,0,1
110308,+/-,0,0
110309,1.4,0,0
110310,%,0,0
110311,),0,0
110312,and,0,0
110313,91.2,0,0
110314,%,0,0
110315,(,0,1
110316,+/-,0,0
110317,1.5,0,0
110318,%,0,0
110319,),0,0
110320,",",0,0
110321,respectively,0,0
110322,(,0,0
110323,P,0,0
110324,=,0,0
110325,.6,0,1
110326,log,0,0
110327,rank,0,0
110328,),0,0
110329,.,0,0
110330,The,0,0
110331,TG,0,0
110332,starting,0,0
110333,dose,0,0
110334,was,0,0
110335,reduced,0,0
110336,from,0,1
110337,60,0,1
110338,to,0,0
110339,50,0,1
110340,mg/m,0,0
110341,(,0,1
110342,2,0,0
110343,),0,0
110344,per,0,0
110345,day,0,0
110346,after,0,0
110347,recognition,0,0
110348,of,0,0
110349,hepatic,0,0
110350,veno-occlusive,0,1
110351,disease,0,1
110352,(,0,0
110353,VOD,0,0
110354,),0,0
110355,.,0,0
110356,A,0,0
110357,total,0,1
110358,of,0,0
110359,257,1,1
110360,patients,1,1
110361,on,0,0
110362,TG,0,0
110363,(,0,1
110364,25,0,1
110365,%,0,0
110366,),0,0
110367,developed,0,0
110368,VOD,0,0
110369,or,0,0
110370,disproportionate,0,0
110371,thrombocytopenia,0,1
110372,and,0,0
110373,switched,0,0
110374,to,0,0
110375,MP,0,0
110376,.,0,1
110377,Once,0,0
110378,portal,0,0
110379,hypertension,0,1
110380,occurred,0,0
110381,",",0,0
110382,all,0,0
110383,subjects,0,1
110384,on,0,0
110385,TG,0,0
110386,were,0,0
110387,changed,0,0
110388,to,0,0
110389,MP,0,0
110390,.,0,0
110391,The,0,0
110392,benefit,0,0
110393,of,0,0
110394,randomization,0,0
110395,to,0,0
110396,TG,0,0
110397,over,0,0
110398,MP,0,0
110399,",",0,0
110400,as,0,0
110401,measured,0,0
110402,by,0,0
110403,EFS,0,0
110404,",",0,0
110405,was,0,0
110406,evident,0,0
110407,primarily,0,1
110408,in,0,1
110409,boys,0,1
110410,who,0,1
110411,began,0,1
110412,TG,0,1
110413,at,0,0
110414,60,0,1
110415,mg/m,0,0
110416,(,0,1
110417,2,0,0
110418,),0,0
110419,(,0,0
110420,relative,0,0
110421,hazard,0,0
110422,rate,0,0
110423,[,0,0
110424,RHR,0,0
110425,],0,1
110426,0.65,0,0
110427,",",0,0
110428,P,0,0
110429,=,0,0
110430,.002,0,0
110431,),0,0
110432,.,0,0
110433,The,0,0
110434,toxicities,0,0
110435,of,0,0
110436,TG,0,0
110437,preclude,0,0
110438,its,0,0
110439,protracted,0,0
110440,use,0,0
110441,as,0,0
110442,given,0,0
110443,in,0,0
110444,this,0,0
110445,study,0,0
110446,.,0,0
110447,This,0,0
110448,study,0,0
110449,is,0,0
110450,registered,0,0
110451,at,0,0
110452,http,0,0
110453,:,0,1
110454,//clinicaltrials.gov,0,0
110455,as,0,0
110456,NCT00002744,0,1
110457,.,0,1
110458,A,0,0
110459,randomized,0,0
110460,",",0,0
110461,double-blind,0,0
110462,",",0,0
110463,placebo-controlled,0,0
110464,",",0,0
110465,phase,0,0
110466,I,0,0
110467,study,0,0
110468,of,0,0
110469,MEDI-545,0,0
110470,",",0,0
110471,an,0,0
110472,anti-interferon-alfa,0,0
110473,monoclonal,0,0
110474,antibody,0,0
110475,",",0,0
110476,in,0,0
110477,subjects,1,1
110478,with,1,1
110479,chronic,1,1
110480,psoriasis,1,1
110481,.,1,1
110482,BACKGROUND,0,0
110483,Interferon-alfa,0,0
110484,(,0,0
110485,IFN-alpha,0,0
110486,),0,0
110487,has,0,0
110488,been,0,0
110489,implicated,0,0
110490,in,0,0
110491,the,0,0
110492,pathogenesis,0,0
110493,of,0,0
110494,psoriasis,0,1
110495,.,0,0
110496,OBJECTIVE,0,0
110497,To,0,0
110498,evaluate,0,0
110499,the,0,0
110500,safety,0,0
110501,profile,0,0
110502,of,0,0
110503,MEDI-545,0,0
110504,",",0,0
110505,a,0,0
110506,fully,0,0
110507,human,0,0
110508,anti-IFN-alpha,0,0
110509,monoclonal,0,0
110510,antibody,0,0
110511,and,0,0
110512,to,0,0
110513,explore,0,0
110514,its,0,0
110515,effect,0,0
110516,on,0,0
110517,the,0,0
110518,involvement,0,0
110519,of,0,0
110520,type,0,1
110521,I,0,1
110522,IFN-alpha,0,0
110523,activity,0,0
110524,in,0,0
110525,the,0,0
110526,maintenance,0,0
110527,of,0,0
110528,established,0,0
110529,plaque,0,0
110530,psoriasis,0,1
110531,.,0,0
110532,METHODS,0,0
110533,We,0,0
110534,conducted,0,0
110535,an,0,0
110536,18-week,0,0
110537,",",0,0
110538,randomized,0,0
110539,",",0,0
110540,double-blind,0,0
110541,",",0,0
110542,placebo-controlled,0,0
110543,",",0,0
110544,dose-escalating,0,0
110545,study,0,0
110546,in,0,0
110547,36,1,1
110548,subjects,1,1
110549,with,1,1
110550,chronic,1,1
110551,plaque,1,0
110552,psoriasis,1,1
110553,.,1,0
110554,Subjects,0,1
110555,received,0,0
110556,one,0,0
110557,intravenous,0,0
110558,dose,0,0
110559,of,0,0
110560,MEDI-545,0,0
110561,(,0,0
110562,0.3-30.0,0,0
110563,mg/kg,0,0
110564,),0,0
110565,or,0,1
110566,placebo,0,0
110567,.,0,1
110568,Study,0,0
110569,outcomes,0,0
110570,were,0,0
110571,safety,0,0
110572,profile,0,0
110573,",",0,0
110574,pharmacokinetics,0,0
110575,",",0,0
110576,immunogenicity,0,0
110577,",",0,0
110578,and,0,0
110579,clinical,0,0
110580,effects,0,0
110581,.,0,1
110582,RESULTS,0,0
110583,There,0,0
110584,was,0,0
110585,no,0,0
110586,difference,0,0
110587,in,0,0
110588,adverse,0,0
110589,events,0,0
110590,between,0,0
110591,MEDI-545,0,0
110592,and,0,0
110593,placebo,0,0
110594,.,0,1
110595,Two,0,0
110596,serious,0,0
110597,adverse,0,0
110598,events,0,0
110599,were,0,1
110600,reported,0,0
110601,;,0,1
110602,one,0,1
110603,drug-related,0,0
110604,hypotensive,0,0
110605,infusion,0,0
110606,reaction,0,0
110607,occurred,0,0
110608,in,0,0
110609,one,0,1
110610,subject,0,0
110611,in,0,0
110612,the,0,0
110613,30.0,0,1
110614,mg/kg,0,0
110615,MEDI-545,0,0
110616,dose,0,0
110617,group,0,0
110618,",",0,0
110619,causing,0,0
110620,discontinuation,0,0
110621,of,0,0
110622,study,0,0
110623,drug,0,0
110624,in,0,0
110625,that,0,0
110626,subject,0,0
110627,and,0,0
110628,study,0,0
110629,dismissal,0,0
110630,of,0,0
110631,the,0,0
110632,other,0,0
110633,subjects,0,1
110634,in,0,0
110635,the,0,0
110636,same,0,0
110637,cohort,0,1
110638,;,0,0
110639,and,0,0
110640,a,0,0
110641,myocardial,0,1
110642,infarction,0,1
110643,occurred,0,0
110644,in,0,0
110645,one,0,1
110646,subject,0,0
110647,in,0,0
110648,the,0,0
110649,10,0,0
110650,mg/kg,0,0
110651,MEDI-545,0,0
110652,dose,0,0
110653,group,0,0
110654,",",0,0
110655,which,0,0
110656,was,0,0
110657,considered,0,0
110658,to,0,0
110659,be,0,0
110660,unrelated,0,1
110661,to,0,0
110662,treatment,0,0
110663,.,0,1
110664,MEDI-545,0,0
110665,was,0,0
110666,nonimmunogenic,0,0
110667,",",0,0
110668,had,0,0
110669,a,0,0
110670,half-life,0,0
110671,of,0,0
110672,21,0,1
110673,days,0,0
110674,",",0,0
110675,showed,0,0
110676,no,0,0
110677,significant,0,0
110678,inhibition,0,0
110679,of,0,0
110680,the,0,0
110681,type,0,1
110682,I,0,1
110683,IFN,0,1
110684,gene,0,0
110685,signature,0,0
110686,",",0,0
110687,and,0,0
110688,had,0,0
110689,no,0,0
110690,clinical,0,0
110691,activity,0,0
110692,.,0,0
110693,LIMITATIONS,0,0
110694,The,0,0
110695,study,0,0
110696,addressed,0,0
110697,only,0,0
110698,IFN-alpha,0,0
110699,and,0,0
110700,chronic,0,1
110701,psoriatic,0,1
110702,lesions,0,1
110703,.,0,1
110704,CONCLUSION,0,0
110705,The,0,0
110706,safety,0,0
110707,profile,0,0
110708,of,0,0
110709,MEDI-545,0,0
110710,supports,0,0
110711,further,0,0
110712,clinical,0,0
110713,development,0,0
110714,.,0,0
110715,IFN-alpha,0,0
110716,does,0,0
110717,not,0,0
110718,appear,0,0
110719,to,0,0
110720,be,0,0
110721,significantly,0,0
110722,involved,0,0
110723,in,0,0
110724,the,0,0
110725,maintenance,0,0
110726,of,0,0
110727,established,0,0
110728,plaque,0,0
110729,psoriasis,0,1
110730,.,0,1
110731,Reducing,0,0
110732,polycystic,1,1
110733,liver,1,1
110734,volume,1,0
110735,in,1,0
110736,ADPKD,1,1
110737,:,1,1
110738,effects,0,0
110739,of,0,0
110740,somatostatin,0,0
110741,analogue,0,0
110742,octreotide,0,0
110743,.,0,1
110744,BACKGROUND,0,0
110745,AND,0,0
110746,OBJECTIVES,0,0
110747,No,0,0
110748,medical,0,0
110749,treatment,0,0
110750,is,0,0
110751,available,0,0
110752,for,0,0
110753,polycystic,0,1
110754,liver,0,1
110755,disease,0,1
110756,",",0,0
110757,a,0,0
110758,frequent,0,0
110759,manifestation,0,1
110760,of,0,0
110761,autosomal-dominant,1,1
110762,polycystic,1,1
110763,kidney,1,1
110764,disease,1,1
110765,(,1,0
110766,ADPKD,1,0
110767,),1,0
110768,.,1,0
110769,In,0,0
110770,a,0,0
110771,prospective,0,0
110772,",",0,0
110773,randomized,0,0
110774,",",0,0
110775,double-blind,0,0
110776,",",0,0
110777,crossover,0,0
110778,study,0,0
110779,",",0,0
110780,6,0,0
110781,months,0,0
110782,of,0,0
110783,octreotide,0,0
110784,(,0,0
110785,40,0,1
110786,mg,0,0
110787,every,0,0
110788,28,0,1
110789,days,0,0
110790,),0,1
110791,therapy,0,0
110792,limited,0,0
110793,kidney,0,1
110794,volume,0,0
110795,growth,0,0
110796,more,0,0
110797,effectively,0,0
110798,than,0,0
110799,placebo,0,0
110800,in,0,0
110801,12,1,0
110802,patients,1,1
110803,with,1,1
110804,ADPKD,1,1
110805,.,1,1
110806,DESIGN,0,0
110807,",",0,0
110808,SETTING,0,1
110809,",",0,0
110810,PARTICIPANTS,0,0
110811,",",0,0
110812,&,0,0
110813,MEASUREMENTS,0,0
110814,In,0,0
110815,this,0,0
110816,secondary,0,0
110817,",",0,0
110818,post,0,0
110819,hoc,0,0
110820,analysis,0,0
110821,of,0,0
110822,the,0,0
110823,above,0,0
110824,study,0,0
110825,",",0,0
110826,octreotide-induced,0,0
110827,changes,0,0
110828,in,0,0
110829,liver,0,1
110830,volumes,0,0
110831,compared,0,0
110832,with,0,1
110833,placebo,0,0
110834,and,0,0
110835,the,0,0
110836,relationship,0,0
110837,between,0,0
110838,concomitant,0,0
110839,changes,0,0
110840,in,0,0
110841,liver,0,1
110842,and,0,0
110843,kidney,0,1
110844,volumes,0,0
110845,were,0,1
110846,evaluated,0,0
110847,.,0,0
110848,Those,0,0
110849,analyzing,0,0
110850,liver,0,1
110851,and,0,0
110852,kidney,0,1
110853,volumes,0,0
110854,were,0,0
110855,blinded,0,0
110856,to,0,0
110857,treatment,0,0
110858,.,0,1
110859,RESULTS,0,0
110860,Liver,0,0
110861,volumes,0,0
110862,significantly,0,0
110863,decreased,0,0
110864,from,0,0
110865,1595,0,1
110866,+/-,0,0
110867,478,0,1
110868,ml,0,0
110869,to,0,0
110870,1524,0,1
110871,+/-,0,0
110872,453,0,1
110873,ml,0,0
110874,with,0,1
110875,octreotide,0,0
110876,whereas,0,0
110877,they,0,0
110878,did,0,0
110879,not,0,0
110880,appreciably,0,0
110881,change,0,0
110882,with,0,1
110883,placebo,0,0
110884,.,0,1
110885,Changes,0,0
110886,in,0,0
110887,liver,0,1
110888,volumes,0,0
110889,were,0,0
110890,significantly,0,0
110891,different,0,0
110892,between,0,0
110893,the,0,0
110894,two,0,0
110895,treatment,0,0
110896,periods,0,0
110897,(,0,1
110898,-71,0,0
110899,+/-,0,0
110900,57,0,1
110901,ml,0,0
110902,versus,0,0
110903,+14,0,0
110904,+/-,0,0
110905,85,0,1
110906,ml,0,0
110907,),0,0
110908,.,0,0
110909,Octreotide-induced,0,0
110910,liver,0,1
110911,volume,0,0
110912,reduction,0,0
110913,was,0,0
110914,fully,0,0
110915,explained,0,0
110916,by,0,0
110917,a,0,0
110918,reduction,0,0
110919,in,0,0
110920,parenchyma,0,0
110921,volume,0,0
110922,from,0,1
110923,1506,0,1
110924,+/-,0,0
110925,431,0,1
110926,ml,0,0
110927,to,0,0
110928,1432,0,1
110929,+/-,0,0
110930,403,0,1
110931,ml,0,0
110932,.,0,1
110933,Changes,0,0
110934,in,0,0
110935,liver,0,1
110936,volumes,0,0
110937,were,0,0
110938,significantly,0,0
110939,correlated,0,0
110940,with,0,1
110941,concomitant,0,0
110942,changes,0,0
110943,in,0,0
110944,kidney,0,1
110945,volumes,0,0
110946,(,0,0
110947,r,0,0
110948,=,0,0
110949,0.67,0,0
110950,),0,0
110951,during,0,0
110952,octreotide,0,0
110953,but,0,0
110954,not,0,0
110955,during,0,0
110956,placebo,0,0
110957,treatment,0,0
110958,.,0,1
110959,Liver,0,0
110960,and,0,0
110961,kidney,0,1
110962,volume,0,0
110963,changes,0,0
110964,significantly,0,0
110965,differed,0,0
110966,with,0,1
110967,both,0,0
110968,treatments,0,0
110969,(,0,0
110970,octreotide,0,0
110971,:,0,1
110972,-71,0,0
110973,+/-,0,0
110974,57,0,1
110975,ml,0,0
110976,versus,0,0
110977,+71,0,0
110978,+/-,0,0
110979,107,0,1
110980,;,0,1
110981,placebo,0,0
110982,:,0,1
110983,+14,0,0
110984,+/-,0,0
110985,85,0,1
110986,ml,0,0
110987,versus,0,0
110988,+162,0,0
110989,+/-,0,0
110990,114,0,1
110991,),0,0
110992,",",0,0
110993,but,0,0
110994,net,0,0
110995,reductions,0,0
110996,in,0,0
110997,liver,0,1
110998,(,0,0
110999,-85,0,1
111000,+/-,0,0
111001,103,0,1
111002,ml,0,0
111003,),0,0
111004,and,0,0
111005,kidney,0,1
111006,(,0,0
111007,-91,0,0
111008,+/-,0,0
111009,125,0,1
111010,ml,0,0
111011,),0,0
111012,volume,0,0
111013,growth,0,0
111014,on,0,0
111015,octreotide,0,0
111016,versus,0,0
111017,placebo,0,0
111018,were,0,0
111019,similar,0,0
111020,.,0,1
111021,CONCLUSIONS,0,0
111022,Octreotide,0,0
111023,therapy,0,0
111024,reduces,0,0
111025,liver,0,1
111026,volumes,0,1
111027,in,0,0
111028,patients,0,1
111029,with,0,1
111030,ADPKD,0,0
111031,and,0,0
111032,is,0,0
111033,safe,0,0
111034,.,0,0
111035,Final,0,1
111036,analysis,0,0
111037,of,0,0
111038,the,0,0
111039,UKLG,0,0
111040,LY02,0,1
111041,trial,0,0
111042,comparing,0,0
111043,6-8,0,1
111044,cycles,0,0
111045,of,0,0
111046,CHOP,0,0
111047,with,0,1
111048,3,0,0
111049,cycles,0,0
111050,of,0,1
111051,CHOP,0,0
111052,followed,0,0
111053,by,0,0
111054,a,0,0
111055,BEAM,0,0
111056,autograft,0,0
111057,in,0,0
111058,patients,1,1
111059,<,1,0
111060,65,1,1
111061,years,1,1
111062,with,1,1
111063,poor,1,1
111064,prognosis,1,0
111065,histologically,1,1
111066,aggressive,1,1
111067,NHL,1,1
111068,.,1,0
111069,This,0,0
111070,trial,0,0
111071,involved,0,0
111072,457,1,1
111073,patients,1,1
111074,and,0,0
111075,sought,0,0
111076,to,0,0
111077,assess,0,0
111078,the,0,0
111079,value,0,0
111080,of,0,0
111081,early,0,0
111082,intensification,0,0
111083,with,0,1
111084,autologous,0,0
111085,transplantation,0,1
111086,in,0,0
111087,patients,1,1
111088,with,1,1
111089,poor,1,1
111090,prognosis,1,0
111091,histologically,1,1
111092,aggressive,1,1
111093,non-Hodgkin,1,1
111094,lymphoma,1,1
111095,(,1,0
111096,NHL,1,1
111097,),1,0
111098,showing,1,0
111099,a,1,0
111100,response,1,0
111101,to,1,0
111102,initial,1,0
111103,CHOP,1,0
111104,(,1,0
111105,cyclophosphamide,1,0
111106,",",0,0
111107,doxorubicin,0,0
111108,",",0,0
111109,vincristine,0,0
111110,",",0,0
111111,prednisolone,0,0
111112,),0,0
111113,chemotherapy,0,0
111114,.,0,0
111115,Randomization,0,0
111116,was,0,0
111117,made,0,0
111118,at,0,0
111119,the,0,0
111120,time,0,0
111121,of,0,0
111122,diagnosis,0,1
111123,with,0,1
111124,223,0,1
111125,assigned,0,1
111126,to,0,0
111127,continuing,0,0
111128,CHOP,0,0
111129,and,0,0
111130,234,0,1
111131,to,0,0
111132,3,0,0
111133,cycles,0,0
111134,of,0,1
111135,CHOP,0,0
111136,followed,0,0
111137,by,0,0
111138,a,0,0
111139,BEAM,0,0
111140,(,0,0
111141,carmustine,0,0
111142,",",0,0
111143,etoposide,0,0
111144,",",0,0
111145,cytarabine,0,0
111146,",",0,0
111147,melphalan,0,0
111148,),0,0
111149,autograft,0,0
111150,.,0,0
111151,Analysis,0,0
111152,was,0,0
111153,on,0,0
111154,an,0,0
111155,intention,0,0
111156,to,0,0
111157,treat,0,0
111158,basis,0,0
111159,.,0,0
111160,After,0,0
111161,the,0,0
111162,initial,0,0
111163,three,0,0
111164,cycles,0,0
111165,of,0,1
111166,CHOP,0,0
111167,19,0,1
111168,%,0,0
111169,of,0,0
111170,the,0,0
111171,whole,0,0
111172,group,0,0
111173,were,0,0
111174,in,0,0
111175,complete,0,0
111176,response,0,0
111177,(,0,0
111178,CR,0,0
111179,),0,0
111180,and,0,0
111181,53,0,1
111182,%,0,0
111183,in,0,0
111184,partial,0,0
111185,remission,0,1
111186,(,0,0
111187,PR,0,0
111188,),0,0
111189,.,0,0
111190,At,0,0
111191,the,0,0
111192,end,0,0
111193,of,0,0
111194,treatment,0,0
111195,86,0,1
111196,%,0,0
111197,of,0,0
111198,patients,0,1
111199,in,0,0
111200,the,0,0
111201,CHOP,0,0
111202,arm,0,0
111203,had,0,0
111204,responded,0,1
111205,with,0,1
111206,58,0,1
111207,%,0,0
111208,in,0,0
111209,CR,0,0
111210,.,0,1
111211,In,0,0
111212,the,0,0
111213,high-dose,0,0
111214,therapy,0,0
111215,arm,0,0
111216,the,0,0
111217,overall,0,0
111218,response,0,0
111219,rate,0,0
111220,was,0,0
111221,83,0,0
111222,%,0,0
111223,with,0,1
111224,64,0,1
111225,%,0,0
111226,in,0,0
111227,CR,0,0
111228,(,0,0
111229,difference,0,0
111230,between,0,0
111231,arms,0,0
111232,not,0,0
111233,significant,0,0
111234,),0,0
111235,.,0,0
111236,The,0,0
111237,progression-free,0,0
111238,survival,0,0
111239,(,0,0
111240,PFS,0,0
111241,),0,0
111242,and,0,0
111243,overall,0,0
111244,survival,0,0
111245,at,0,0
111246,5,0,0
111247,years,0,1
111248,for,0,0
111249,the,0,0
111250,continuing,0,0
111251,CHOP,0,0
111252,arm,0,1
111253,were,0,0
111254,38,0,1
111255,%,0,0
111256,and,0,0
111257,50,0,0
111258,%,0,0
111259,respectively,0,0
111260,",",0,0
111261,and,0,0
111262,for,0,0
111263,the,0,0
111264,autograft,0,0
111265,arm,0,0
111266,were,0,0
111267,44,0,1
111268,%,0,0
111269,and,0,0
111270,50,0,1
111271,%,0,0
111272,(,0,0
111273,differences,0,0
111274,not,0,0
111275,significant,0,0
111276,),0,0
111277,.,0,0
111278,Of,0,0
111279,the,0,0
111280,patients,0,1
111281,who,0,1
111282,attained,0,1
111283,CR,0,1
111284,and,0,0
111285,subsequently,0,0
111286,relapsed,0,0
111287,",",0,0
111288,there,0,0
111289,were,0,0
111290,no,0,0
111291,long-term,0,0
111292,survivors,0,1
111293,in,0,0
111294,the,0,0
111295,autograft,0,1
111296,recipients,0,1
111297,compared,0,0
111298,to,0,0
111299,46,0,1
111300,%,0,0
111301,of,0,0
111302,the,0,0
111303,continuing,0,0
111304,CHOP,0,0
111305,recipients,0,1
111306,(,0,1
111307,P,0,0
111308,=,0,0
111309,0.0008,0,0
111310,),0,0
111311,.,0,0
111312,In,0,0
111313,conclusion,0,0
111314,",",0,0
111315,no,0,0
111316,survival,0,0
111317,benefit,0,0
111318,was,0,0
111319,demonstrated,0,0
111320,for,0,0
111321,an,0,0
111322,early,0,0
111323,autograft,0,0
111324,in,0,0
111325,first,0,0
111326,response,0,0
111327,.,0,1
111328,RCT,0,0
111329,of,0,0
111330,a,0,0
111331,manualized,0,0
111332,social,0,0
111333,treatment,0,0
111334,for,0,0
111335,high-functioning,1,1
111336,autism,1,1
111337,spectrum,1,1
111338,disorders,1,1
111339,.,1,1
111340,This,0,0
111341,RCT,0,0
111342,examined,0,0
111343,the,0,0
111344,efficacy,0,0
111345,of,0,0
111346,a,0,0
111347,manualized,0,0
111348,social,0,0
111349,intervention,0,0
111350,for,0,0
111351,children,1,1
111352,with,1,1
111353,HFASDs,1,1
111354,.,1,1
111355,Participants,0,1
111356,were,0,0
111357,randomly,0,1
111358,assigned,0,0
111359,to,0,0
111360,treatment,0,0
111361,or,0,1
111362,wait-list,0,0
111363,conditions,0,0
111364,.,0,1
111365,Treatment,0,0
111366,included,0,0
111367,instruction,0,0
111368,and,0,0
111369,therapeutic,0,0
111370,activities,0,0
111371,targeting,0,0
111372,social,0,0
111373,skills,0,0
111374,",",0,0
111375,face-emotion,0,0
111376,recognition,0,0
111377,",",0,0
111378,interest,0,0
111379,expansion,0,0
111380,",",0,0
111381,and,0,0
111382,interpretation,0,0
111383,of,0,0
111384,non-literal,0,1
111385,language,0,0
111386,.,0,0
111387,A,0,0
111388,response-cost,0,0
111389,program,0,0
111390,was,0,0
111391,applied,0,0
111392,to,0,0
111393,reduce,0,0
111394,problem,0,0
111395,behaviors,0,0
111396,and,0,1
111397,foster,0,1
111398,skills,0,0
111399,acquisition,0,0
111400,.,0,1
111401,Significant,0,0
111402,treatment,0,0
111403,effects,0,0
111404,were,0,0
111405,found,0,0
111406,for,0,0
111407,five,0,1
111408,of,0,0
111409,seven,0,1
111410,primary,0,1
111411,outcome,0,0
111412,measures,0,0
111413,(,0,1
111414,parent,0,1
111415,ratings,0,0
111416,and,0,0
111417,direct,0,0
111418,child,0,1
111419,measures,0,0
111420,),0,1
111421,.,0,1
111422,Secondary,0,0
111423,measures,0,0
111424,based,0,0
111425,on,0,0
111426,staff,0,1
111427,ratings,0,0
111428,(,0,0
111429,treatment,0,0
111430,group,0,0
111431,only,0,0
111432,),0,0
111433,corroborated,0,0
111434,gains,0,0
111435,reported,0,0
111436,by,0,0
111437,parents,0,1
111438,.,0,1
111439,High,0,0
111440,levels,0,0
111441,of,0,0
111442,parent,0,0
111443,",",0,0
111444,child,0,0
111445,and,0,0
111446,staff,0,1
111447,satisfaction,0,0
111448,were,0,0
111449,reported,0,0
111450,",",0,0
111451,along,0,0
111452,with,0,1
111453,high,0,1
111454,levels,0,0
111455,of,0,0
111456,treatment,0,0
111457,fidelity,0,0
111458,.,0,0
111459,Standardized,0,0
111460,effect,0,0
111461,size,0,0
111462,estimates,0,0
111463,were,0,0
111464,primarily,0,1
111465,in,0,0
111466,the,0,0
111467,medium,0,0
111468,and,0,0
111469,large,0,1
111470,ranges,0,0
111471,and,0,0
111472,favored,0,0
111473,the,0,0
111474,treatment,0,0
111475,group,0,0
111476,.,0,1
111477,Effect,0,0
111478,of,0,0
111479,topical,0,0
111480,anesthesia,0,1
111481,and,0,0
111482,age,0,1
111483,on,0,0
111484,pain,0,1
111485,scores,0,0
111486,during,0,0
111487,retinopathy,0,1
111488,of,0,0
111489,prematurity,0,1
111490,screening,0,1
111491,.,0,0
111492,OBJECTIVE,0,0
111493,The,0,0
111494,efficacy,0,0
111495,of,0,0
111496,topical,0,0
111497,anesthesia,0,1
111498,during,0,0
111499,retinopathy,1,1
111500,of,1,0
111501,prematurity,1,1
111502,(,1,0
111503,ROP,1,0
111504,),1,0
111505,screening,0,0
111506,has,0,0
111507,been,0,0
111508,a,0,0
111509,controversial,0,0
111510,issue,0,0
111511,.,0,0
111512,To,0,0
111513,determine,0,0
111514,the,0,0
111515,efficacy,0,0
111516,of,0,0
111517,proparacaine,0,0
111518,eye,0,0
111519,drops,0,0
111520,(,0,1
111521,0.5,0,0
111522,%,0,0
111523,),0,0
111524,",",0,0
111525,we,0,0
111526,compared,0,0
111527,the,0,0
111528,Premature,0,1
111529,Infant,0,1
111530,Pain,0,1
111531,Profile,0,1
111532,(,0,0
111533,PIPP,0,0
111534,),0,0
111535,scores,0,0
111536,in,0,0
111537,40,1,1
111538,preterm,1,1
111539,infants,1,1
111540,undergoing,1,1
111541,ROP,1,1
111542,screening,1,1
111543,.,1,1
111544,STUDY,0,0
111545,DESIGN,0,0
111546,Prospective,0,0
111547,randomized,0,1
111548,double,0,0
111549,masked,0,1
111550,cross-over,0,1
111551,clinical,0,0
111552,trial,0,1
111553,.,0,0
111554,The,0,0
111555,study,0,0
111556,was,0,0
111557,conducted,0,0
111558,in,0,0
111559,the,0,0
111560,neonatal,1,1
111561,intensive,1,1
111562,units,1,0
111563,for,1,1
111564,infants,1,1
111565,undergoing,1,1
111566,routine,1,1
111567,ROP,1,1
111568,screening,1,1
111569,exams,1,0
111570,.,1,1
111571,Baseline,0,0
111572,PIPP,0,0
111573,scores,0,0
111574,and,0,0
111575,post-examination,0,0
111576,PIPP,0,0
111577,scores,0,0
111578,at,0,0
111579,1,0,0
111580,and,0,1
111581,5,0,1
111582,min,0,0
111583,were,0,1
111584,compared,0,0
111585,for,0,0
111586,:,0,1
111587,(,0,0
111588,1,0,0
111589,),0,0
111590,those,0,0
111591,receiving,0,0
111592,saline,0,0
111593,vs,0,0
111594,proparacaine,0,0
111595,eye,0,0
111596,drops,0,0
111597,(,0,1
111598,2,0,0
111599,),0,0
111600,first,0,0
111601,ROP,0,0
111602,screening,0,1
111603,vs,0,0
111604,second,0,1
111605,ROP,0,0
111606,screening,0,0
111607,",",0,0
111608,regardless,0,0
111609,of,0,0
111610,the,0,0
111611,type,0,1
111612,of,0,0
111613,eye,0,0
111614,drops,0,0
111615,used,0,0
111616,.,0,1
111617,Wilcoxon,0,0
111618,signed-ranks,0,0
111619,test,0,0
111620,was,0,0
111621,used,0,0
111622,to,0,0
111623,pair,0,1
111624,pain,0,1
111625,scores,0,0
111626,.,0,1
111627,RESULT,1,0
111628,Forty,1,1
111629,preterm,1,1
111630,infants,1,1
111631,were,1,0
111632,included,1,1
111633,in,1,0
111634,the,1,0
111635,study,1,0
111636,.,1,0
111637,Mean,0,0
111638,gestational,0,1
111639,age,0,1
111640,(,0,0
111641,GA,0,1
111642,),0,0
111643,at,0,0
111644,first,0,0
111645,and,0,1
111646,second,0,1
111647,examinations,0,1
111648,was,0,0
111649,33.3,0,0
111650,and,0,1
111651,35.3,0,0
111652,weeks,0,0
111653,",",0,0
111654,respectively,0,0
111655,.,0,0
111656,Proparacaine,0,0
111657,use,0,0
111658,significantly,0,0
111659,lowered,0,0
111660,mean,0,0
111661,PIPP,0,0
111662,scores,0,0
111663,(,0,1
111664,P=0.027,0,0
111665,),0,0
111666,and,0,0
111667,delta,0,0
111668,scores,0,0
111669,(,0,1
111670,P=0.013,0,0
111671,),0,0
111672,at,0,0
111673,1,0,0
111674,min,0,0
111675,after,0,0
111676,examination,0,0
111677,",",0,0
111678,but,0,0
111679,there,0,0
111680,was,0,0
111681,no,0,0
111682,difference,0,0
111683,at,0,0
111684,5,0,0
111685,min,0,0
111686,after,0,0
111687,examination,0,0
111688,.,0,1
111689,Second,0,0
111690,examinations,0,0
111691,showed,0,0
111692,significantly,0,0
111693,lower,0,0
111694,mean,0,0
111695,PIPP,0,0
111696,scores,0,0
111697,after,0,0
111698,examination,0,1
111699,(,0,0
111700,1,0,0
111701,min,0,0
111702,(,0,0
111703,P=0.003,0,0
111704,),0,0
111705,and,0,0
111706,5,0,0
111707,min,0,0
111708,(,0,0
111709,P=0.025,0,0
111710,),0,0
111711,),0,0
111712,",",0,0
111713,regardless,0,0
111714,of,0,0
111715,the,0,0
111716,type,0,1
111717,of,0,0
111718,drop,0,0
111719,used,0,0
111720,.,0,1
111721,CONCLUSION,0,0
111722,Proparacaine,0,0
111723,eye,0,0
111724,drops,0,0
111725,offer,0,0
111726,significant,0,0
111727,relief,0,0
111728,of,0,0
111729,pain,0,0
111730,that,0,0
111731,is,0,0
111732,apparently,0,0
111733,short,0,0
111734,lived,0,1
111735,.,0,1
111736,Significantly,0,0
111737,lower,0,0
111738,PIPP,0,0
111739,scores,0,0
111740,at,0,1
111741,second,0,1
111742,ROP,0,1
111743,examinations,0,0
111744,suggested,0,0
111745,that,0,0
111746,infants,0,1
111747,of,0,0
111748,older,0,1
111749,GA,0,0
111750,may,0,0
111751,have,0,0
111752,a,0,0
111753,greater,0,0
111754,ability,0,0
111755,to,0,0
111756,tolerate,0,0
111757,ROP,0,0
111758,screening,0,1
111759,.,0,0
111760,We,0,0
111761,recommend,0,0
111762,the,0,0
111763,use,0,0
111764,of,0,0
111765,proparacaine,0,0
111766,eye,0,0
111767,drops,0,0
111768,for,0,0
111769,the,0,0
111770,short,0,0
111771,term,0,0
111772,",",0,0
111773,immediate,0,0
111774,relief,0,0
111775,of,0,0
111776,pain,0,1
111777,during,0,0
111778,ROP,0,0
111779,screening,0,1
111780,in,1,0
111781,preterm,1,1
111782,infants,1,1
111783,of,1,0
111784,lesser,0,0
111785,GA,0,1
111786,.,0,0
111787,CD4+FOXP3+,0,1
111788,regulatory,0,0
111789,T,0,1
111790,cell,0,1
111791,depletion,0,0
111792,by,0,0
111793,low-dose,0,0
111794,cyclophosphamide,0,0
111795,prevents,0,0
111796,recurrence,0,0
111797,in,0,0
111798,patients,1,1
111799,with,1,1
111800,large,1,1
111801,condylomata,1,1
111802,acuminata,1,1
111803,after,1,0
111804,laser,1,1
111805,therapy,1,0
111806,.,1,0
111807,Condylomata,0,0
111808,acuminata,0,1
111809,(,0,0
111810,CA,0,1
111811,),0,0
111812,caused,0,0
111813,by,0,0
111814,human,0,1
111815,papillomavirus,0,1
111816,(,0,0
111817,HPV,0,0
111818,),0,0
111819,is,0,0
111820,a,0,0
111821,common,0,0
111822,sexually,0,1
111823,transmitted,0,0
111824,disease,0,1
111825,with,0,1
111826,half,0,1
111827,a,0,0
111828,million,0,0
111829,new,0,0
111830,cases,0,1
111831,diagnosed,0,1
111832,in,0,0
111833,the,0,0
111834,United,0,1
111835,States,0,0
111836,per,0,1
111837,year,0,1
111838,and,0,0
111839,the,0,0
111840,annual,0,0
111841,increase,0,0
111842,in,0,0
111843,incidence,0,0
111844,in,0,0
111845,China,0,1
111846,.,0,0
111847,Recurrence,0,0
111848,is,0,0
111849,a,0,0
111850,major,0,0
111851,challenge,0,0
111852,for,0,0
111853,CA,0,1
111854,treatment,0,0
111855,.,0,0
111856,Recently,0,0
111857,",",0,0
111858,we,0,0
111859,demonstrated,0,0
111860,that,0,0
111861,FOXP3,0,0
111862,(,0,1
111863,+,0,0
111864,),0,1
111865,regulatory,0,0
111866,T,0,1
111867,(,0,1
111868,Treg,0,0
111869,),0,1
111870,cells,0,0
111871,mediate,0,0
111872,the,0,0
111873,immunosuppression,0,0
111874,in,0,0
111875,large,0,1
111876,genital,0,1
111877,warts,0,1
111878,.,0,0
111879,Here,0,0
111880,",",0,0
111881,we,0,0
111882,further,0,0
111883,report,0,0
111884,that,0,0
111885,low-dose,0,0
111886,cyclophosphamide,0,0
111887,(,0,0
111888,CY,0,0
111889,),0,0
111890,",",0,0
111891,a,0,0
111892,conventional,0,0
111893,chemotherapy,0,0
111894,drug,0,0
111895,",",0,0
111896,can,0,0
111897,effectively,0,0
111898,prevent,0,0
111899,the,0,0
111900,recurrence,0,0
111901,of,0,0
111902,large,0,1
111903,CA,0,1
111904,in,0,0
111905,clinical,1,0
111906,patients,1,1
111907,after,1,0
111908,laser,1,1
111909,therapy,1,0
111910,.,1,0
111911,Surprisingly,0,0
111912,",",0,0
111913,although,0,0
111914,9,0,0
111915,out,0,1
111916,of,0,1
111917,52,1,1
111918,patients,1,1
111919,recur,0,0
111920,six,0,1
111921,weeks,0,0
111922,after,0,0
111923,the,0,0
111924,combination,0,0
111925,treatment,0,0
111926,",",0,0
111927,the,0,0
111928,re-administration,0,0
111929,of,0,0
111930,low-dose,0,0
111931,CY,0,0
111932,alone,0,0
111933,completely,0,0
111934,eliminates,0,0
111935,most,0,0
111936,recurred,0,0
111937,lesions,0,1
111938,.,0,1
111939,We,0,0
111940,provide,0,0
111941,evidence,0,0
111942,that,0,0
111943,low-dose,0,0
111944,CY,0,0
111945,not,0,0
111946,only,0,0
111947,depletes,0,0
111948,patients,0,1
111949,',0,1
111950,Treg,0,0
111951,cells,0,0
111952,and,0,1
111953,enhances,0,0
111954,function,0,0
111955,of,0,0
111956,HPV-specific,0,0
111957,T,0,1
111958,cells,0,0
111959,and,0,1
111960,NK,0,0
111961,cells,0,0
111962,in,0,0
111963,the,0,0
111964,periphery,0,0
111965,",",0,0
111966,but,0,0
111967,also,0,0
111968,ameliorates,0,0
111969,the,0,0
111970,immune,0,0
111971,milieu,0,0
111972,of,0,0
111973,the,0,0
111974,lesion,0,0
111975,site,0,0
111976,",",0,0
111977,leading,0,0
111978,to,0,0
111979,the,0,0
111980,elimination,0,0
111981,of,0,0
111982,remnant,0,1
111983,viruses,0,0
111984,.,0,1
111985,These,0,0
111986,findings,0,0
111987,have,0,0
111988,important,0,0
111989,clinical,0,0
111990,significance,0,0
111991,",",0,0
111992,and,0,0
111993,potentially,0,0
111994,lead,0,0
111995,to,0,0
111996,a,0,0
111997,therapeutic,0,0
111998,breakthrough,0,0
111999,for,0,0
112000,the,0,0
112001,treatment,0,0
112002,of,0,0
112003,CA,0,1
112004,.,0,1
112005,Metformin,0,0
112006,",",0,0
112007,naltrexone,0,0
112008,",",0,0
112009,or,0,0
112010,the,0,0
112011,combination,0,0
112012,of,0,0
112013,prednisolone,0,0
112014,and,0,0
112015,antiandrogenic,0,1
112016,oral,0,0
112017,contraceptives,0,1
112018,as,0,0
112019,first-line,0,1
112020,therapy,0,0
112021,in,0,0
112022,hyperinsulinemic,1,1
112023,women,1,1
112024,with,1,1
112025,polycystic,1,1
112026,ovary,1,1
112027,syndrome,1,1
112028,.,1,0
112029,To,0,0
112030,compare,0,0
112031,the,0,0
112032,short-term,0,0
112033,effects,0,0
112034,of,0,0
112035,metformin,0,0
112036,(,0,0
112037,M,0,0
112038,),0,0
112039,",",0,0
112040,naltrexone,0,0
112041,(,0,0
112042,N,0,1
112043,),0,0
112044,",",0,0
112045,and,0,0
112046,a,0,0
112047,combination,0,0
112048,of,0,0
112049,OC,0,1
112050,and,0,0
112051,prednisolone,0,0
112052,(,0,0
112053,OC/Pr,0,0
112054,),0,0
112055,on,0,0
112056,the,0,0
112057,metabolic,0,0
112058,state,0,0
112059,and,0,0
112060,the,0,0
112061,ovarian,0,1
112062,function,0,0
112063,of,0,0
112064,PCOS,1,0
112065,women,1,1
112066,",",0,0
112067,we,0,0
112068,randomized,0,1
112069,29,1,1
112070,women,1,1
112071,to,0,0
112072,a,0,0
112073,3-month,0,0
112074,course,0,0
112075,of,0,0
112076,therapy,0,0
112077,.,0,1
112078,We,0,0
112079,observed,0,0
112080,significant,0,0
112081,improvements,0,0
112082,in,0,0
112083,hyperandrogenemia,0,1
112084,and,0,0
112085,ovulation,0,0
112086,rates,0,0
112087,in,0,0
112088,PCOS,1,1
112089,women,1,1
112090,of,0,0
112091,all,0,1
112092,three,0,0
112093,groups,0,0
112094,",",0,0
112095,in,0,0
112096,the,0,0
112097,absence,0,0
112098,of,0,0
112099,changes,0,0
112100,in,0,0
112101,the,0,0
112102,metabolic,0,0
112103,state,0,0
112104,",",0,0
112105,suggesting,0,0
112106,that,0,0
112107,insulin,0,0
112108,resistance,0,0
112109,in,0,0
112110,PCOS,1,0
112111,patients,1,1
112112,is,0,0
112113,only,0,0
112114,one,0,0
112115,of,0,0
112116,several,0,0
112117,factors,0,0
112118,leading,0,0
112119,to,0,0
112120,hyperandrogenemic,0,1
112121,ovarian,0,1
112122,failure,0,1
112123,.,0,1
112124,Effects,0,0
112125,of,0,1
112126,10,0,1
112127,Hz,0,1
112128,repetitive,0,0
112129,transcranial,0,0
112130,magnetic,0,0
112131,stimulation,0,0
112132,(,0,0
112133,rTMS,0,0
112134,),0,0
112135,on,0,0
112136,clinical,0,0
112137,global,0,0
112138,impression,0,0
112139,in,0,0
112140,chronic,1,1
112141,schizophrenia,1,1
112142,.,1,0
112143,UNLABELLED,0,0
112144,We,0,0
112145,conducted,0,0
112146,a,0,0
112147,randomized,0,0
112148,",",0,0
112149,sham-controlled,0,0
112150,repetitive,0,0
112151,transcranial,0,0
112152,magnetic,0,0
112153,stimulation,0,0
112154,(,0,0
112155,rTMS,0,0
112156,),0,0
112157,study,0,0
112158,in,0,0
112159,chronic,1,1
112160,schizophrenia,1,1
112161,in-patients,1,1
112162,(,1,0
112163,n=35,1,1
112164,),1,0
112165,to,0,0
112166,evaluate,0,0
112167,the,0,0
112168,therapeutic,0,0
112169,efficacy,0,0
112170,of,0,0
112171,10,0,1
112172,Hz,0,1
112173,stimulation,0,0
112174,.,0,0
112175,Patients,1,1
112176,",",0,1
112177,who,0,1
112178,were,0,1
112179,on,0,1
112180,stable,1,1
112181,antipsychotic,1,0
112182,treatment,1,0
112183,",",0,0
112184,were,0,0
112185,randomly,0,1
112186,assigned,0,0
112187,to,0,0
112188,the,0,0
112189,active,0,0
112190,or,0,1
112191,sham,0,0
112192,condition,0,0
112193,.,0,0
112194,In,0,0
112195,the,0,0
112196,active,0,0
112197,rTMS,0,0
112198,group,0,0
112199,",",0,0
112200,ten,0,1
112201,sessions,0,0
112202,with,0,1
112203,a,0,0
112204,total,0,1
112205,of,0,0
112206,"10,000",0,1
112207,stimuli,0,0
112208,were,0,1
112209,applied,0,0
112210,over,0,0
112211,the,0,0
112212,left,0,1
112213,dorsolateral,0,0
112214,prefrontal,0,0
112215,cortex,0,0
112216,at,0,0
112217,110,0,1
112218,%,0,0
112219,of,0,0
112220,motor,0,0
112221,threshold,0,0
112222,.,0,0
112223,The,0,0
112224,sham,0,0
112225,group,0,0
112226,received,0,0
112227,corresponding,0,0
112228,sham,0,0
112229,stimulation,0,0
112230,.,0,1
112231,Clinical,0,0
112232,improvement,0,0
112233,was,0,0
112234,measured,0,0
112235,by,0,0
112236,the,0,0
112237,Clinical,0,0
112238,Global,0,1
112239,Impression,0,0
112240,scale,0,0
112241,(,0,0
112242,primary,0,0
112243,outcome,0,0
112244,measure,0,0
112245,),0,0
112246,",",0,0
112247,the,0,0
112248,Global,0,0
112249,Assessment,0,0
112250,of,0,0
112251,Functioning,0,0
112252,Scale,0,0
112253,(,0,0
112254,GAF,0,0
112255,),0,0
112256,and,0,0
112257,the,0,0
112258,Positive,0,1
112259,and,0,0
112260,Negative,0,1
112261,Symptom,0,1
112262,Scale,0,0
112263,(,0,1
112264,PANSS,0,1
112265,;,0,0
112266,secondary,0,0
112267,outcome,0,0
112268,measures,0,0
112269,),0,1
112270,.,0,1
112271,Between-group,0,0
112272,comparisons,0,0
112273,revealed,0,0
112274,no,0,0
112275,significant,0,0
112276,differences,0,0
112277,in,0,0
112278,clinical,0,0
112279,outcome,0,0
112280,variables,0,0
112281,.,0,0
112282,Only,0,0
112283,a,0,0
112284,subgroup,0,0
112285,of,0,0
112286,patients,0,1
112287,with,0,1
112288,pronounced,0,0
112289,negative,0,1
112290,symptoms,0,0
112291,developed,0,1
112292,some,0,0
112293,clinical,0,0
112294,improvement,0,0
112295,as,0,0
112296,indicated,0,0
112297,by,0,0
112298,significant,0,0
112299,changes,0,0
112300,in,0,0
112301,the,0,0
112302,GAF-scale,0,0
112303,.,0,0
112304,Besides,0,0
112305,there,0,0
112306,is,0,0
112307,some,0,0
112308,evidence,0,0
112309,for,0,0
112310,a,0,0
112311,more,0,0
112312,favourable,0,0
112313,clinical,0,0
112314,outcome,0,0
112315,within,0,0
112316,this,0,0
112317,subgroup,0,0
112318,after,0,0
112319,rTMS,0,0
112320,in,0,0
112321,the,0,0
112322,CGI-S,0,0
112323,and,0,0
112324,PANSS,0,0
112325,negative,0,0
112326,scale,0,0
112327,",",0,0
112328,too,0,0
112329,.,0,0
112330,In,0,0
112331,line,0,0
112332,with,0,1
112333,earlier,0,1
112334,investigations,0,0
112335,",",0,0
112336,our,0,0
112337,results,0,0
112338,suggest,0,0
112339,a,0,0
112340,moderate,0,1
112341,-,0,0
112342,potentially,0,0
112343,clinically,0,0
112344,relevant,0,0
112345,-,0,0
112346,treatment,0,0
112347,effect,0,0
112348,of,0,0
112349,prefrontal,0,0
112350,10,0,1
112351,Hz,0,0
112352,rTMS,0,0
112353,stimulation,0,0
112354,in,0,0
112355,chronic,1,1
112356,patients,1,1
112357,.,1,0
112358,However,0,0
112359,",",0,0
112360,in,0,0
112361,our,0,0
112362,study,0,0
112363,this,0,0
112364,beneficial,0,0
112365,effect,0,0
112366,was,0,0
112367,restricted,0,0
112368,to,0,0
112369,subjects,0,1
112370,with,0,1
112371,pronounced,0,0
112372,negative,0,1
112373,symptoms,0,1
112374,.,0,1
112375,CLINICAL,0,0
112376,TRIAL,0,0
112377,REGISTRATION,0,0
112378,INFORMATION,0,0
112379,ClinicalTrial.gov,0,1
112380,Identifier,0,1
112381,:,0,1
112382,NCT00169689,0,0
112383,",",0,0
112384,http,0,0
112385,:,0,1
112386,//www.clinicaltrials.gov,0,0
112387,.,0,1
112388,The,0,0
112389,pulsed-dye,0,0
112390,laser,0,0
112391,as,0,0
112392,an,0,0
112393,adjuvant,0,0
112394,treatment,0,0
112395,modality,0,0
112396,in,0,0
112397,acne,1,1
112398,vulgaris,1,1
112399,:,1,1
112400,a,0,0
112401,randomized,0,0
112402,controlled,0,0
112403,single-blinded,0,0
112404,trial,0,0
112405,.,0,1
112406,BACKGROUND,0,0
112407,Acne,0,0
112408,vulgaris,0,0
112409,is,0,0
112410,the,0,0
112411,most,0,0
112412,common,0,0
112413,skin,0,0
112414,disease,0,1
112415,and,0,0
112416,can,0,0
112417,pose,0,0
112418,a,0,0
112419,substantial,0,0
112420,therapeutic,0,0
112421,challenge,0,0
112422,.,0,0
112423,Recently,0,0
112424,",",0,0
112425,several,0,0
112426,phototherapeutic,0,0
112427,modalities,0,0
112428,",",0,0
112429,most,0,0
112430,notably,0,0
112431,pulsed-dye,0,0
112432,laser,0,0
112433,(,0,0
112434,PDL,0,1
112435,),0,0
112436,treatment,0,0
112437,",",0,0
112438,have,0,0
112439,been,0,0
112440,introduced,0,0
112441,",",0,0
112442,but,0,0
112443,the,0,0
112444,published,0,0
112445,results,0,0
112446,-,0,0
112447,albeit,0,0
112448,promising,0,0
112449,-,0,0
112450,are,0,0
112451,controversial,0,0
112452,.,0,1
112453,OBJECTIVES,0,0
112454,To,0,0
112455,assess,0,0
112456,the,0,0
112457,efficacy,0,0
112458,of,0,0
112459,an,0,0
112460,adjuvant,0,0
112461,PDL,0,1
112462,treatment,0,0
112463,when,0,0
112464,combined,0,0
112465,with,0,0
112466,a,0,0
112467,proven,0,0
112468,topical,0,0
112469,treatment,0,0
112470,[,0,0
112471,fixed-combination,0,0
112472,clindamycin,0,0
112473,1,0,0
112474,%,0,0
112475,-benzoyl,0,0
112476,peroxide,0,0
112477,5,0,0
112478,%,0,0
112479,hydrating,0,0
112480,gel,0,0
112481,(,0,0
112482,C/BPO,0,0
112483,),0,0
112484,],0,0
112485,.,0,1
112486,METHODS,0,0
112487,Eighty,1,1
112488,patients,1,1
112489,(,1,1
112490,38,1,1
112491,males,1,1
112492,and,1,1
112493,42,1,1
112494,females,1,1
112495,",",1,1
112496,mean,1,1
112497,+/-,1,0
112498,SD,1,1
112499,age,1,1
112500,19.7,1,0
112501,+/-,1,0
112502,5.9,1,0
112503,years,1,1
112504,),1,1
112505,were,0,0
112506,randomized,0,0
112507,in,0,0
112508,a,0,1
112509,1,0,0
112510,:,0,1
112511,2,0,0
112512,ratio,0,0
112513,to,0,0
112514,receive,0,0
112515,C/BPO,0,0
112516,alone,0,0
112517,or,0,0
112518,in,0,0
112519,combination,0,0
112520,with,0,1
112521,PDL,0,1
112522,treatment,0,0
112523,(,0,0
112524,wavelength,0,0
112525,585,0,1
112526,nm,0,0
112527,",",0,0
112528,energy,0,0
112529,fluence,0,0
112530,3,0,0
112531,J,0,0
112532,cm,0,1
112533,(,0,0
112534,-2,0,0
112535,),0,0
112536,",",0,0
112537,pulse,0,0
112538,duration,0,0
112539,0.35,0,0
112540,ms,0,0
112541,",",0,0
112542,spot,0,0
112543,size,0,0
112544,7,0,0
112545,mm,0,0
112546,),0,1
112547,.,0,1
112548,Patients,0,1
112549,were,0,0
112550,evaluated,0,0
112551,at,0,0
112552,baseline,0,0
112553,and,0,0
112554,at,0,0
112555,2,0,0
112556,and,0,1
112557,4,0,0
112558,weeks,0,0
112559,after,0,0
112560,initial,0,1
112561,treatment,0,0
112562,.,0,0
112563,The,0,0
112564,primary,0,0
112565,end,0,0
112566,points,0,0
112567,were,0,0
112568,the,0,0
112569,Investigator,0,0
112570,'s,0,1
112571,Static,0,0
112572,Global,0,1
112573,Assessment,0,0
112574,(,0,0
112575,ISGA,0,1
112576,),0,0
112577,score,0,0
112578,and,0,0
112579,lesion,0,0
112580,count,0,0
112581,;,0,0
112582,the,0,0
112583,secondary,0,0
112584,end,0,0
112585,point,0,0
112586,was,0,0
112587,the,0,0
112588,Dermatology,0,1
112589,Life,0,0
112590,Quality,0,0
112591,Index,0,0
112592,(,0,0
112593,DLQI,0,1
112594,),0,1
112595,.,0,1
112596,RESULTS,0,0
112597,Both,0,0
112598,groups,0,0
112599,showed,0,0
112600,a,0,0
112601,significant,0,0
112602,improvement,0,0
112603,during,0,0
112604,observation,0,0
112605,[,0,0
112606,ISGA,0,1
112607,27.1,0,0
112608,%,0,0
112609,(,0,0
112610,C/BPO,0,0
112611,),0,0
112612,and,0,0
112613,24.6,0,0
112614,%,0,0
112615,(,0,0
112616,C/BPO,0,0
112617,+,0,0
112618,laser,0,0
112619,),0,0
112620,",",0,0
112621,total,0,1
112622,lesion,0,0
112623,count,0,0
112624,9.2,0,0
112625,%,0,0
112626,and,0,0
112627,9.0,0,0
112628,%,0,0
112629,",",0,0
112630,inflammatory,0,0
112631,lesion,0,0
112632,count,0,0
112633,36.3,0,0
112634,%,0,0
112635,and,0,0
112636,36.9,0,0
112637,%,0,0
112638,",",0,0
112639,DLQI,0,0
112640,54.5,0,0
112641,%,0,0
112642,and,0,0
112643,42.5,0,0
112644,%,0,0
112645,],0,0
112646,",",0,0
112647,but,0,0
112648,there,0,0
112649,was,0,0
112650,no,0,0
112651,significant,0,0
112652,or,0,0
112653,otherwise,0,1
112654,appreciable,0,0
112655,difference,0,0
112656,between,0,0
112657,treatment,0,0
112658,modalities,0,0
112659,as,0,0
112660,far,0,0
112661,as,0,0
112662,the,0,0
112663,extent,0,0
112664,of,0,0
112665,improvement,0,0
112666,was,0,0
112667,concerned,0,0
112668,.,0,1
112669,Patients,0,0
112670,with,0,0
112671,more,0,0
112672,severe,0,1
112673,findings,0,0
112674,at,0,1
112675,baseline,0,0
112676,had,0,0
112677,a,0,0
112678,greater,0,0
112679,benefit,0,0
112680,from,0,0
112681,either,0,0
112682,therapy,0,1
112683,regimen,0,0
112684,.,0,1
112685,CONCLUSIONS,0,0
112686,Our,0,0
112687,findings,0,0
112688,do,0,0
112689,not,0,0
112690,support,0,0
112691,the,0,0
112692,concept,0,0
112693,of,0,0
112694,a,0,0
112695,substantial,0,0
112696,benefit,0,0
112697,of,0,0
112698,PDL,0,1
112699,treatment,0,0
112700,in,0,0
112701,acne,0,1
112702,vulgaris,0,1
112703,.,0,1
112704,The,0,0
112705,11-beta-hydroxysteroid,0,0
112706,dehydrogenase,0,0
112707,type,0,1
112708,1,0,0
112709,inhibitor,0,0
112710,INCB13739,0,0
112711,improves,0,0
112712,hyperglycemia,1,0
112713,in,1,0
112714,patients,1,1
112715,with,1,1
112716,type,1,1
112717,2,1,1
112718,diabetes,1,1
112719,inadequately,1,1
112720,controlled,1,0
112721,by,1,0
112722,metformin,1,0
112723,monotherapy,1,0
112724,.,1,0
112725,OBJECTIVE,0,0
112726,11-Beta-hydroxysteroid,0,0
112727,dehydrogenase,0,0
112728,type,0,1
112729,1,0,0
112730,(,0,0
112731,11betaHSD1,0,1
112732,),0,1
112733,converts,0,0
112734,inactive,0,1
112735,cortisone,0,0
112736,into,0,0
112737,active,0,1
112738,cortisol,0,0
112739,",",0,0
112740,thereby,0,0
112741,amplifying,0,0
112742,intracellular,0,0
112743,glucocorticoid,0,0
112744,action,0,0
112745,.,0,0
112746,The,0,0
112747,efficacy,0,0
112748,and,0,0
112749,safety,0,0
112750,of,0,0
112751,the,0,0
112752,11betaHSD1,0,0
112753,inhibitor,0,0
112754,INCB13739,0,1
112755,were,0,0
112756,assessed,0,0
112757,when,0,0
112758,added,0,0
112759,to,0,0
112760,ongoing,0,0
112761,metformin,0,0
112762,monotherapy,0,0
112763,in,0,0
112764,patients,1,1
112765,with,1,1
112766,type,1,1
112767,2,1,1
112768,diabetes,1,1
112769,exhibiting,1,1
112770,inadequate,1,1
112771,glycemic,1,0
112772,control,1,1
112773,(,1,1
112774,A1C,1,0
112775,7-11,1,1
112776,%,1,0
112777,),1,1
112778,.,1,1
112779,RESEARCH,0,0
112780,DESIGN,0,0
112781,AND,0,0
112782,METHODS,0,0
112783,This,0,0
112784,double-blind,0,0
112785,placebo-controlled,0,0
112786,paralleled,0,0
112787,study,0,0
112788,randomized,0,1
112789,302,1,1
112790,patients,1,1
112791,with,1,1
112792,type,1,1
112793,2,1,1
112794,diabetes,1,1
112795,(,1,1
112796,mean,1,1
112797,A1C,1,0
112798,8.3,1,0
112799,%,1,0
112800,),1,0
112801,on,1,0
112802,metformin,1,0
112803,monotherapy,1,0
112804,(,1,0
112805,mean,1,1
112806,1.5,1,0
112807,g/day,1,0
112808,),1,0
112809,to,0,0
112810,receive,0,0
112811,one,0,1
112812,of,0,0
112813,five,0,1
112814,INCB13739,0,1
112815,doses,0,0
112816,or,0,1
112817,placebo,0,0
112818,once,0,0
112819,daily,0,0
112820,for,0,0
112821,12,0,1
112822,weeks,0,0
112823,.,0,1
112824,The,0,0
112825,primary,0,0
112826,end,0,0
112827,point,0,0
112828,was,0,0
112829,the,0,0
112830,change,0,0
112831,in,0,0
112832,A1C,0,0
112833,at,0,0
112834,study,0,1
112835,end,0,0
112836,.,0,1
112837,Other,0,0
112838,end,0,0
112839,points,0,0
112840,included,0,1
112841,changes,0,0
112842,in,0,0
112843,fasting,0,0
112844,glucose,0,0
112845,",",0,0
112846,lipids,0,0
112847,",",0,0
112848,weight,0,0
112849,",",0,0
112850,adverse,0,0
112851,events,0,0
112852,",",0,0
112853,and,0,0
112854,safety,0,0
112855,.,0,0
112856,RESULTS,0,0
112857,After,0,0
112858,12,0,0
112859,weeks,0,0
112860,",",0,1
112861,200,0,0
112862,mg,0,0
112863,of,0,0
112864,INCB13739,0,1
112865,resulted,0,0
112866,in,0,0
112867,significant,0,0
112868,reductions,0,0
112869,in,0,0
112870,A1C,0,0
112871,(,0,0
112872,-0.6,0,0
112873,%,0,0
112874,),0,0
112875,",",0,0
112876,fasting,0,0
112877,plasma,0,0
112878,glucose,0,0
112879,(,0,0
112880,-24,0,0
112881,mg/dl,0,0
112882,),0,0
112883,",",0,0
112884,and,0,0
112885,homeostasis,0,0
112886,model,0,0
112887,assessment-insulin,0,0
112888,resistance,0,0
112889,(,0,0
112890,HOMA-IR,0,0
112891,),0,0
112892,(,0,0
112893,-24,0,0
112894,%,0,0
112895,),0,0
112896,compared,0,0
112897,with,0,1
112898,placebo,0,0
112899,.,0,1
112900,Total,0,0
112901,cholesterol,0,0
112902,",",0,0
112903,LDL,0,0
112904,cholesterol,0,0
112905,",",0,0
112906,and,0,0
112907,triglycerides,0,0
112908,were,0,0
112909,all,0,0
112910,significantly,0,0
112911,decreased,0,0
112912,in,0,0
112913,hyperlipidemic,0,1
112914,patients,0,1
112915,.,0,1
112916,Body,0,0
112917,weight,0,0
112918,decreased,0,0
112919,relative,0,0
112920,to,0,0
112921,placebo,0,0
112922,after,0,0
112923,INCB13739,0,1
112924,therapy,0,0
112925,.,0,0
112926,A,0,0
112927,reversible,0,0
112928,dose-dependent,0,0
112929,elevation,0,0
112930,in,0,0
112931,adrenocorticotrophic,0,1
112932,hormone,0,0
112933,",",0,0
112934,generally,0,0
112935,within,0,0
112936,the,0,0
112937,normal,0,1
112938,reference,0,0
112939,range,0,0
112940,",",0,0
112941,was,0,0
112942,observed,0,0
112943,.,0,1
112944,Basal,0,0
112945,cortisol,0,0
112946,homeostasis,0,0
112947,",",0,0
112948,testosterone,0,0
112949,in,0,0
112950,men,0,1
112951,",",0,0
112952,and,0,0
112953,free,0,0
112954,androgen,0,0
112955,index,0,0
112956,in,0,0
112957,women,0,1
112958,were,0,1
112959,unchanged,0,0
112960,by,0,0
112961,INCB13739,0,1
112962,.,0,1
112963,Adverse,0,0
112964,events,0,0
112965,were,0,1
112966,similar,0,0
112967,across,0,0
112968,all,0,0
112969,treatment,0,0
112970,groups,0,0
112971,.,0,1
112972,CONCLUSIONS,0,0
112973,INCB13739,0,0
112974,added,0,0
112975,to,0,0
112976,ongoing,0,0
112977,metformin,0,0
112978,therapy,0,0
112979,was,0,0
112980,efficacious,0,0
112981,and,0,0
112982,well,0,0
112983,tolerated,0,0
112984,in,0,0
112985,patients,1,1
112986,with,1,1
112987,type,1,1
112988,2,1,1
112989,diabetes,1,1
112990,who,1,1
112991,had,1,1
112992,inadequate,1,1
112993,glycemic,1,0
112994,control,1,1
112995,with,1,1
112996,metformin,1,0
112997,alone,1,0
112998,.,1,0
112999,11BetaHSD1,0,0
113000,inhibition,0,0
113001,offers,0,0
113002,a,0,0
113003,new,0,0
113004,potential,0,0
113005,approach,0,0
113006,to,0,0
113007,control,0,0
113008,glucose,0,0
113009,and,0,0
113010,cardiovascular,0,1
113011,risk,0,0
113012,factors,0,0
113013,in,0,0
113014,type,1,1
113015,2,1,1
113016,diabetes,1,1
113017,.,1,1
113018,Efficacy,0,0
113019,and,0,0
113020,safety,0,0
113021,of,0,0
113022,de,0,0
113023,novo,0,1
113024,or,0,1
113025,early,0,0
113026,everolimus,0,0
113027,with,0,1
113028,low,0,0
113029,cyclosporine,0,0
113030,in,0,0
113031,deceased-donor,1,1
113032,kidney,1,1
113033,transplant,1,1
113034,recipients,1,1
113035,at,1,0
113036,specified,1,0
113037,risk,1,0
113038,of,1,0
113039,delayed,1,0
113040,graft,1,1
113041,function,1,0
113042,:,1,1
113043,12-month,0,0
113044,results,0,0
113045,of,0,0
113046,a,0,0
113047,randomized,0,0
113048,",",0,0
113049,multicenter,0,0
113050,trial,0,0
113051,.,0,0
113052,Immediate,0,0
113053,or,0,0
113054,early,0,0
113055,use,0,0
113056,of,0,0
113057,proliferation,0,0
113058,signal,0,0
113059,inhibitor,0,0
113060,(,0,0
113061,PSI,0,0
113062,),0,0
113063,/mammalian,0,0
113064,target,0,0
113065,of,0,0
113066,rapamycin,0,0
113067,(,0,0
113068,mTOR,0,0
113069,),0,0
113070,inhibitor,0,0
113071,therapy,0,0
113072,can,0,0
113073,avoid,0,0
113074,high,0,0
113075,exposure,0,0
113076,to,0,0
113077,calcineurin,0,0
113078,inhibitors,0,0
113079,but,0,0
113080,concerns,0,0
113081,exist,0,0
113082,relating,0,0
113083,to,0,0
113084,the,0,0
113085,risk,0,0
113086,of,0,0
113087,delayed,0,0
113088,graft,0,0
113089,function,0,0
113090,(,0,0
113091,DGF,0,1
113092,),0,0
113093,and,0,0
113094,impaired,0,1
113095,wound,0,0
113096,healing,0,0
113097,with,0,1
113098,the,0,0
113099,mTOR,0,0
113100,sirolimus,0,0
113101,.,0,1
113102,CALLISTO,0,0
113103,was,0,0
113104,a,0,0
113105,12-month,0,0
113106,",",0,0
113107,prospective,0,0
113108,",",0,0
113109,multicenter,1,0
113110,",",0,0
113111,open-label,0,0
113112,study,0,0
113113,.,0,1
113114,Deceased-donor,1,0
113115,kidney,1,1
113116,transplant,1,1
113117,patients,1,1
113118,at,1,0
113119,protocol-specified,1,0
113120,risk,1,1
113121,of,1,0
113122,DGF,1,1
113123,were,0,0
113124,randomized,0,0
113125,to,0,0
113126,start,0,0
113127,everolimus,0,0
113128,on,0,0
113129,day,0,0
113130,1,0,0
113131,(,0,0
113132,immediate,0,0
113133,everolimus,0,0
113134,",",0,0
113135,IE,0,0
113136,;,0,0
113137,n,0,1
113138,=,0,0
113139,65,0,1
113140,),0,0
113141,or,0,1
113142,week,0,0
113143,5,0,0
113144,(,0,0
113145,delayed,0,0
113146,everolimus,0,0
113147,",",0,0
113148,DE,0,0
113149,;,0,0
113150,n,0,1
113151,=,0,0
113152,74,0,1
113153,),0,0
113154,.,0,0
113155,Incidence,0,0
113156,of,0,0
113157,the,0,0
113158,primary,0,0
113159,endpoint,0,0
113160,(,0,0
113161,biopsy-proven,0,1
113162,acute,0,1
113163,rejection,0,0
113164,",",0,0
113165,BPAR,0,1
113166,;,0,0
113167,graft,0,0
113168,loss,0,0
113169,",",0,0
113170,death,0,0
113171,",",0,0
113172,DGF,0,0
113173,",",0,0
113174,wound,0,0
113175,healing,0,0
113176,complications,0,0
113177,related,0,0
113178,to,0,0
113179,transplant,0,1
113180,surgery,0,1
113181,or,0,0
113182,loss,0,0
113183,to,0,0
113184,follow-up,0,0
113185,),0,0
113186,was,0,0
113187,64.6,0,0
113188,%,0,0
113189,and,0,0
113190,66.2,0,0
113191,%,0,0
113192,in,0,0
113193,the,0,0
113194,IE,0,0
113195,and,0,0
113196,DE,0,1
113197,groups,0,0
113198,",",0,0
113199,respectively,0,0
113200,",",0,0
113201,at,0,0
113202,month,0,0
113203,12,0,0
113204,(,0,0
113205,P,0,0
113206,=,0,0
113207,0.860,0,0
113208,),0,0
113209,.,0,0
113210,The,0,0
113211,overall,0,0
113212,incidence,0,0
113213,of,0,0
113214,BPAR,0,1
113215,was,0,0
113216,20.1,0,0
113217,%,0,0
113218,.,0,1
113219,Median,0,0
113220,estimated,0,0
113221,glomerular,0,1
113222,filtration,0,0
113223,rate,0,0
113224,was,0,0
113225,48,0,0
113226,ml/min/1.73,0,1
113227,m,0,1
113228,(,0,0
113229,2,0,0
113230,),0,1
113231,and,0,1
113232,49,0,1
113233,ml/min/1.73,0,1
113234,m,0,1
113235,(,0,1
113236,2,0,0
113237,),0,0
113238,in,0,0
113239,the,0,0
113240,IE,0,0
113241,and,0,0
113242,DE,0,1
113243,groups,0,0
113244,",",0,0
113245,respectively,0,0
113246,",",0,0
113247,at,0,0
113248,month,0,0
113249,12,0,1
113250,.,0,1
113251,DGF,0,0
113252,and,0,0
113253,wound,0,0
113254,healing,0,0
113255,complications,0,0
113256,were,0,1
113257,similar,0,0
113258,between,0,0
113259,groups,0,0
113260,.,0,1
113261,Adverse,0,0
113262,events,0,0
113263,led,0,0
113264,to,0,0
113265,study,0,0
113266,drug,0,0
113267,discontinuation,0,0
113268,in,1,0
113269,17,1,1
113270,IE,1,0
113271,patients,1,1
113272,(,1,1
113273,26.2,0,0
113274,%,0,0
113275,),0,0
113276,and,0,0
113277,28,0,1
113278,DE,0,1
113279,patients,0,1
113280,(,0,1
113281,37.8,0,0
113282,%,0,0
113283,),0,0
113284,(,0,0
113285,NS,0,0
113286,),0,0
113287,.,0,0
113288,In,0,0
113289,conclusion,0,0
113290,",",0,0
113291,introduction,0,0
113292,of,0,0
113293,everolimus,0,0
113294,immediately,0,0
113295,or,0,0
113296,early,0,0
113297,posttransplant,0,1
113298,in,1,0
113299,DGF-risk,1,0
113300,patients,1,1
113301,is,0,0
113302,associated,0,0
113303,with,0,0
113304,good,0,0
113305,efficacy,0,0
113306,",",0,0
113307,renal,0,1
113308,function,0,0
113309,and,0,0
113310,safety,0,0
113311,profile,0,0
113312,.,0,0
113313,There,0,0
113314,seems,0,0
113315,no,0,0
113316,benefit,0,0
113317,in,0,0
113318,delaying,0,0
113319,initiation,0,0
113320,of,0,0
113321,everolimus,0,1
113322,.,0,1
113323,Hematologic,1,1
113324,patients,1,1
113325,',1,1
113326,clinical,1,0
113327,and,1,1
113328,psychosocial,1,1
113329,experiences,1,0
113330,with,1,1
113331,implanted,1,1
113332,long-term,1,0
113333,central,1,1
113334,venous,1,1
113335,catheter,1,0
113336,:,1,1
113337,self-management,0,0
113338,versus,0,0
113339,professionally,0,0
113340,controlled,0,0
113341,care,0,0
113342,.,0,0
113343,BACKGROUND,0,0
113344,A,0,0
113345,significant,0,0
113346,decrease,0,0
113347,in,0,0
113348,catheter-related,0,0
113349,infections,0,1
113350,was,0,0
113351,demonstrated,0,0
113352,in,0,0
113353,our,0,0
113354,earlier,0,0
113355,randomized,0,0
113356,controlled,0,0
113357,trial,0,0
113358,of,0,0
113359,central,0,0
113360,venous,0,1
113361,catheter,0,0
113362,(,0,0
113363,CVC,0,0
113364,),0,0
113365,care,0,1
113366,in,0,0
113367,hematologic,1,1
113368,patients,1,1
113369,.,1,1
113370,OBJECTIVE,0,0
113371,This,0,0
113372,article,0,0
113373,focuses,0,0
113374,on,0,0
113375,patients,0,1
113376,',0,1
113377,clinical,0,0
113378,and,0,1
113379,psychosocial,0,1
113380,experiences,0,0
113381,with,0,1
113382,CVC,0,0
113383,self-care,0,0
113384,compared,0,0
113385,with,0,1
113386,professionally,0,0
113387,controlled,0,0
113388,CVC,0,0
113389,care,0,1
113390,.,0,1
113391,METHODS,0,0
113392,Eighty-two,1,1
113393,patients,1,1
113394,with,1,1
113395,tunneled,1,1
113396,CVCs,1,0
113397,were,0,0
113398,enrolled,0,1
113399,in,0,0
113400,the,0,0
113401,randomized,0,0
113402,controlled,0,0
113403,trial,0,0
113404,.,0,0
113405,The,0,0
113406,intervention,0,0
113407,group,0,0
113408,(,0,0
113409,n,0,1
113410,=,0,0
113411,42,0,1
113412,),0,0
113413,was,0,0
113414,trained,0,1
113415,to,0,0
113416,perform,0,0
113417,CVC,0,0
113418,self-care,0,0
113419,.,0,0
113420,The,0,0
113421,control,0,0
113422,group,0,0
113423,(,0,0
113424,n,0,1
113425,=,0,0
113426,40,0,1
113427,),0,0
113428,followed,0,0
113429,standard,0,0
113430,CVC,0,0
113431,procedure,0,0
113432,provided,0,0
113433,by,0,0
113434,nurses,0,1
113435,.,0,1
113436,Eighteen,0,1
113437,patients,0,1
113438,were,0,1
113439,selected,0,1
113440,for,0,0
113441,semistructured,0,1
113442,interviews,0,1
113443,focusing,0,0
113444,on,0,0
113445,patients,0,1
113446,',0,1
113447,clinical,0,0
113448,and,0,1
113449,psychosocial,0,1
113450,experiences,0,0
113451,with,0,1
113452,CVCs,0,0
113453,.,0,1
113454,RESULTS,0,0
113455,Methods,0,1
113456,of,0,0
113457,CVC,0,0
113458,care,0,1
113459,have,0,0
113460,different,0,0
113461,influences,0,0
113462,on,0,0
113463,the,0,0
113464,patients,0,1
113465,',0,1
113466,clinical,0,0
113467,and,0,1
113468,psychosocial,0,1
113469,outcomes,0,0
113470,",",0,0
113471,depending,0,0
113472,on,0,0
113473,whether,0,0
113474,they,0,1
113475,were,0,0
113476,hospitalized,0,1
113477,or,0,1
113478,outpatients,0,1
113479,.,0,1
113480,Central,0,0
113481,venous,0,0
113482,catheter,0,0
113483,was,0,0
113484,viewed,0,0
113485,as,0,0
113486,important,0,0
113487,because,0,0
113488,it,0,0
113489,was,0,0
113490,the,0,0
113491,main,0,0
113492,port,0,0
113493,of,0,0
113494,treatment,0,0
113495,toward,0,0
113496,a,0,0
113497,cure,0,0
113498,",",0,0
113499,although,0,0
113500,patients,0,1
113501,constantly,0,0
113502,fear,0,0
113503,complications,0,0
113504,.,0,1
113505,Central,0,0
113506,venous,0,0
113507,catheter,0,0
113508,self-care,0,0
113509,increased,0,0
113510,patients,0,1
113511,',0,1
113512,independence,0,0
113513,from,0,1
113514,health,0,1
113515,professionals,0,0
113516,and,0,0
113517,supported,0,0
113518,perceived,0,0
113519,self-efficacy,0,0
113520,and,0,0
113521,control,0,0
113522,.,0,0
113523,Central,0,0
113524,venous,0,0
113525,catheters,0,1
113526,cause,0,0
113527,psychosocial,0,1
113528,problems,0,1
113529,including,0,0
113530,altered,0,1
113531,body,0,1
113532,perception,0,0
113533,",",0,0
113534,sexual,0,0
113535,activity,0,0
113536,avoidance,0,0
113537,",",0,0
113538,and,0,0
113539,feeling,0,0
113540,stigmatized,0,1
113541,.,0,1
113542,CONCLUSIONS,0,0
113543,Patients,0,1
113544,experience,0,1
113545,increased,0,0
113546,perceived,0,0
113547,self-control,0,0
113548,and,0,0
113549,independence,0,0
113550,when,0,0
113551,individually,0,0
113552,supervised,0,0
113553,and,0,0
113554,trained,0,1
113555,in,0,0
113556,CVC,0,0
113557,self-management,0,0
113558,.,0,0
113559,Assuming,0,0
113560,ownership,0,0
113561,of,0,0
113562,CVC,0,0
113563,care,0,0
113564,can,0,0
113565,encourage,0,0
113566,patients,0,1
113567,to,0,0
113568,feel,0,0
113569,less,0,0
113570,inhibited,0,0
113571,about,0,0
113572,sexual,0,0
113573,activity,0,0
113574,and,0,0
113575,socialization,0,0
113576,.,0,1
113577,IMPLICATIONS,0,0
113578,FOR,0,0
113579,PRACTICE,0,1
113580,Placement,0,1
113581,of,0,0
113582,a,0,0
113583,tunneled,0,0
113584,CVC,0,0
113585,should,0,0
113586,engage,0,1
113587,nurses,0,1
113588,to,0,0
113589,organize,0,0
113590,individualized,0,0
113591,structured,0,0
113592,and,0,0
113593,supervised,0,0
113594,patient,0,0
113595,education,0,0
113596,.,0,1
113597,Stigma,0,0
113598,originating,0,0
113599,from,0,0
113600,CVCs,0,0
113601,should,0,0
113602,be,0,0
113603,carefully,0,0
113604,considered,0,0
113605,by,0,0
113606,health,0,1
113607,professionals,0,0
113608,when,0,0
113609,maintaining,0,0
113610,CVC,0,0
113611,insertion,0,0
113612,for,0,0
113613,longer,0,0
113614,periods,0,0
113615,.,0,1
113616,Central,0,0
113617,venous,0,0
113618,catheters,0,0
113619,should,0,0
113620,be,0,0
113621,removed,0,0
113622,whenever,0,0
113623,the,0,0
113624,potential,0,0
113625,risks,0,0
113626,exceed,0,0
113627,the,0,0
113628,catheter,0,0
113629,'s,0,1
113630,functional,0,0
113631,necessity,0,0
113632,.,0,1
113633,Field,0,0
113634,efficacy,0,0
113635,of,0,0
113636,an,0,0
113637,inactivated,0,0
113638,bivalent,0,0
113639,influenza,0,1
113640,vaccine,0,0
113641,in,0,0
113642,a,0,0
113643,multi-site,1,0
113644,swine,1,0
113645,production,1,0
113646,system,1,0
113647,during,1,0
113648,an,1,0
113649,outbreak,1,1
113650,of,1,0
113651,systemic,1,0
113652,porcine,1,0
113653,circovirus,1,1
113654,associated,1,0
113655,disease,1,1
113656,.,1,0
113657,Swine,0,0
113658,influenza,0,1
113659,(,0,0
113660,SI,0,0
113661,),0,0
113662,is,0,0
113663,a,0,0
113664,disease,0,0
113665,of,0,0
113666,significance,0,0
113667,for,0,0
113668,the,0,0
113669,swine,0,0
113670,industry,0,0
113671,",",0,0
113672,and,0,0
113673,vaccination,0,0
113674,is,0,0
113675,often,0,0
113676,recommended,0,0
113677,as,0,0
113678,a,0,0
113679,way,0,0
113680,to,0,0
113681,reduce,0,0
113682,its,0,0
113683,impact,0,0
113684,on,0,0
113685,production,0,0
113686,.,0,0
113687,The,0,0
113688,efficacy,0,0
113689,of,0,0
113690,SI,0,0
113691,vaccines,0,0
113692,is,0,0
113693,well,0,0
113694,established,0,0
113695,under,0,0
113696,experimental,0,0
113697,conditions,0,0
113698,",",0,0
113699,but,0,0
113700,information,0,0
113701,about,0,0
113702,field,0,0
113703,efficacy,0,0
113704,is,0,0
113705,scarce,0,0
113706,.,0,0
113707,The,0,0
113708,objective,0,0
113709,of,0,0
113710,this,0,0
113711,study,0,0
113712,was,0,0
113713,to,0,0
113714,evaluate,0,0
113715,the,0,0
113716,efficacy,0,0
113717,of,0,0
113718,a,0,0
113719,commercial,0,0
113720,inactivated,0,0
113721,bivalent,0,0
113722,(,0,0
113723,H1N1/H3N2,0,0
113724,),0,0
113725,vaccine,0,0
113726,under,0,0
113727,conditions,0,0
113728,of,0,0
113729,natural,0,0
113730,exposure,0,0
113731,to,0,0
113732,a,0,0
113733,field,0,0
113734,SI,0,0
113735,variant,0,1
113736,.,0,0
113737,To,0,0
113738,accomplish,0,0
113739,our,0,0
113740,goal,0,0
113741,we,0,0
113742,used,0,0
113743,a,0,0
113744,randomized,0,0
113745,",",0,0
113746,blinded,0,0
113747,",",0,0
113748,field,0,0
113749,trial,0,0
113750,in,0,0
113751,2,1,0
113752,cohorts,1,1
113753,of,1,0
113754,finisher,1,1
113755,pigs,1,1
113756,in,1,0
113757,a,1,0
113758,multi-site,1,0
113759,swine,1,0
113760,production,1,0
113761,system,1,0
113762,located,1,1
113763,in,1,0
113764,southern,1,1
113765,Ontario,1,1
113766,.,1,1
113767,During,0,0
113768,the,0,0
113769,trial,0,0
113770,",",0,0
113771,this,0,0
113772,herd,0,0
113773,experienced,0,0
113774,an,0,0
113775,outbreak,0,0
113776,of,0,0
113777,porcine,0,0
113778,circovirus,0,1
113779,associated,0,0
113780,disease,0,1
113781,(,0,0
113782,PCVAD,0,0
113783,),0,0
113784,.,0,0
113785,The,0,0
113786,efficacy,0,0
113787,of,0,0
113788,the,0,0
113789,SI,0,0
113790,vaccine,0,0
113791,was,0,0
113792,assessed,0,0
113793,through,0,0
113794,its,0,0
113795,effect,0,0
113796,on,0,0
113797,average,0,0
113798,daily,0,0
113799,weight,0,0
113800,gain,0,0
113801,",",0,0
113802,and,0,0
113803,serological,0,0
113804,responses,0,0
113805,to,0,0
113806,SI,0,0
113807,over,0,0
113808,time,0,0
113809,.,0,0
113810,The,0,0
113811,effect,0,0
113812,of,0,0
113813,vaccination,0,0
113814,on,0,0
113815,pig,0,0
113816,growth,0,0
113817,was,0,0
113818,different,0,0
113819,in,0,0
113820,the,0,0
113821,2,1,0
113822,cohorts,1,0
113823,.,1,1
113824,Weight,0,1
113825,gain,0,0
113826,was,0,0
113827,higher,0,0
113828,in,0,0
113829,vaccinated,0,0
113830,pigs,1,1
113831,than,0,0
113832,in,0,0
113833,control,0,1
113834,pigs,0,1
113835,in,0,1
113836,Cohort,0,1
113837,1,0,0
113838,",",0,0
113839,but,0,0
113840,was,0,0
113841,numerically,0,0
113842,higher,0,0
113843,for,0,0
113844,control,0,0
113845,pigs,0,1
113846,than,0,0
113847,for,0,1
113848,vaccinated,0,1
113849,pigs,0,1
113850,in,0,1
113851,Cohort,0,1
113852,2,0,0
113853,.,0,0
113854,Vaccination,0,0
113855,against,0,0
113856,swine,0,0
113857,influenza,0,0
113858,",",0,0
113859,in,0,0
113860,a,0,0
113861,herd,1,0
113862,experiencing,1,0
113863,an,1,0
113864,outbreak,1,1
113865,of,1,0
113866,PCVAD,1,0
113867,",",0,0
113868,was,0,0
113869,of,0,0
113870,questionable,0,0
113871,value,0,0
113872,.,0,1
113873,Non-pharmacological,0,0
113874,care,0,1
113875,for,0,0
113876,patients,1,1
113877,with,1,1
113878,generalized,1,1
113879,osteoarthritis,1,1
113880,:,1,1
113881,design,0,0
113882,of,0,0
113883,a,0,0
113884,randomized,0,0
113885,clinical,0,0
113886,trial,0,1
113887,.,0,1
113888,BACKGROUND,0,0
113889,Non-pharmacological,0,0
113890,treatment,0,0
113891,(,0,0
113892,NPT,0,0
113893,),0,0
113894,is,0,0
113895,a,0,0
113896,useful,0,0
113897,treatment,0,0
113898,option,0,0
113899,in,0,0
113900,the,0,0
113901,management,0,0
113902,of,0,0
113903,hip,0,1
113904,or,0,1
113905,knee,0,1
113906,osteoarthritis,0,1
113907,.,0,0
113908,To,0,0
113909,our,0,0
113910,knowledge,0,0
113911,however,0,0
113912,",",0,0
113913,no,0,0
113914,studies,0,0
113915,have,0,0
113916,investigated,0,0
113917,the,0,0
113918,effect,0,0
113919,of,0,0
113920,NPT,0,0
113921,in,0,0
113922,patients,1,1
113923,with,1,1
113924,generalized,1,1
113925,osteoarthritis,1,1
113926,(,1,0
113927,GOA,1,1
113928,),1,0
113929,.,1,0
113930,The,0,0
113931,primary,0,0
113932,aim,0,0
113933,of,0,0
113934,this,0,0
113935,study,0,0
113936,is,0,0
113937,to,0,0
113938,compare,0,0
113939,the,0,0
113940,effectiveness,0,0
113941,of,0,0
113942,two,0,0
113943,currently,0,1
113944,existing,0,0
113945,health,0,0
113946,care,0,1
113947,programs,0,0
113948,with,0,1
113949,different,0,0
113950,intensity,0,0
113951,and,0,0
113952,mode,0,0
113953,of,0,0
113954,delivery,0,0
113955,on,0,0
113956,daily,0,0
113957,functioning,0,0
113958,in,0,0
113959,patients,1,1
113960,with,1,1
113961,GOA,1,1
113962,.,1,1
113963,The,0,0
113964,secondary,0,0
113965,objective,0,0
113966,is,0,0
113967,to,0,0
113968,compare,0,0
113969,the,0,0
113970,cost-effectiveness,0,0
113971,of,0,0
113972,both,0,0
113973,interventions,0,0
113974,.,0,0
113975,METHODS/DESIGN,0,0
113976,In,0,0
113977,this,0,0
113978,randomized,0,0
113979,",",0,0
113980,single,0,0
113981,blind,0,0
113982,",",0,0
113983,clinical,0,0
113984,trial,0,0
113985,with,0,1
113986,active,0,1
113987,controls,0,1
113988,",",0,0
113989,we,1,0
113990,aim,1,0
113991,to,1,0
113992,include,1,0
113993,170,1,1
113994,patients,1,1
113995,with,1,1
113996,GOA,1,1
113997,.,1,1
113998,The,0,0
113999,experimental,0,0
114000,intervention,0,0
114001,consist,0,0
114002,of,0,0
114003,six,0,1
114004,self-management,0,0
114005,group,0,1
114006,sessions,0,0
114007,provided,0,0
114008,by,0,0
114009,a,0,0
114010,multi-disciplinary,0,0
114011,team,0,0
114012,(,0,0
114013,occupational,0,0
114014,therapist,0,0
114015,",",0,0
114016,physiotherapist,0,0
114017,",",0,0
114018,dietician,0,0
114019,and,0,0
114020,specialized,0,1
114021,nurse,0,1
114022,),0,0
114023,.,0,0
114024,The,0,0
114025,active,0,0
114026,control,0,0
114027,group,0,0
114028,consists,0,0
114029,of,0,0
114030,two,0,0
114031,group,0,1
114032,sessions,0,0
114033,and,0,1
114034,four,0,1
114035,sessions,0,0
114036,by,0,0
114037,telephone,0,0
114038,",",0,0
114039,provided,0,0
114040,by,0,0
114041,a,0,0
114042,specialized,0,1
114043,nurse,0,0
114044,and,0,0
114045,physiotherapist,0,0
114046,.,0,0
114047,Both,0,0
114048,therapies,0,0
114049,last,0,0
114050,six,0,1
114051,weeks,0,0
114052,.,0,1
114053,Main,0,0
114054,study,0,0
114055,outcome,0,0
114056,is,0,0
114057,daily,0,0
114058,functioning,0,0
114059,during,0,0
114060,the,0,0
114061,first,0,0
114062,year,0,0
114063,after,0,0
114064,the,0,0
114065,treatment,0,0
114066,",",0,0
114067,assessed,0,0
114068,on,0,0
114069,the,0,0
114070,Health,0,0
114071,Assessment,0,0
114072,Questionnaire,0,0
114073,.,0,1
114074,Secondary,0,0
114075,outcomes,0,0
114076,are,0,0
114077,health,0,1
114078,related,0,0
114079,quality,0,0
114080,of,0,0
114081,life,0,0
114082,",",0,0
114083,specific,0,0
114084,complaints,0,0
114085,",",0,0
114086,fatigue,0,0
114087,",",0,0
114088,and,0,0
114089,costs,0,0
114090,.,0,1
114091,Illness,0,0
114092,cognitions,0,0
114093,",",0,0
114094,global,0,0
114095,perceived,0,0
114096,effect,0,0
114097,and,0,0
114098,self-efficacy,0,0
114099,",",0,0
114100,will,0,0
114101,also,0,0
114102,be,0,0
114103,assessed,0,0
114104,for,0,0
114105,a,0,0
114106,responder,0,0
114107,analysis,0,0
114108,.,0,0
114109,Outcome,0,0
114110,assessments,0,0
114111,are,0,0
114112,performed,0,0
114113,directly,0,0
114114,after,0,0
114115,the,0,0
114116,intervention,0,0
114117,",",0,0
114118,after,0,0
114119,26,0,1
114120,weeks,0,0
114121,and,0,1
114122,after,0,1
114123,52,0,1
114124,weeks,0,0
114125,.,0,1
114126,DISCUSSION,0,0
114127,This,0,0
114128,article,0,0
114129,describes,0,0
114130,the,0,0
114131,design,0,0
114132,of,0,0
114133,a,0,0
114134,randomized,0,0
114135,",",0,0
114136,single,0,0
114137,blind,0,0
114138,",",0,0
114139,clinical,0,0
114140,trial,0,0
114141,with,0,1
114142,a,0,0
114143,one,0,0
114144,year,0,0
114145,follow,0,0
114146,up,0,0
114147,to,0,0
114148,compare,0,0
114149,the,0,0
114150,costs,0,0
114151,and,0,0
114152,effectiveness,0,0
114153,of,0,0
114154,two,0,0
114155,non-pharmacological,0,0
114156,interventions,0,0
114157,with,0,1
114158,different,0,0
114159,modes,0,0
114160,of,0,0
114161,delivery,0,1
114162,for,0,0
114163,patients,1,1
114164,with,1,1
114165,GOA,1,1
114166,.,1,1
114167,TRIAL,0,0
114168,REGISTRATION,0,0
114169,Dutch,0,1
114170,Trial,0,1
114171,Register,0,1
114172,NTR2137,0,0
114173,.,0,1
114174,Therapeutic,0,1
114175,effects,0,0
114176,of,0,0
114177,combined,0,0
114178,treatment,0,0
114179,using,0,0
114180,tetracycline-immobilized,0,0
114181,collagen,0,0
114182,film,0,0
114183,and,0,0
114184,root,0,0
114185,planing,0,0
114186,in,0,0
114187,periodontal,1,1
114188,furcation,1,1
114189,pockets,1,0
114190,.,1,1
114191,46,1,0
114192,upper,1,0
114193,and,1,0
114194,lower,1,0
114195,molars,1,1
114196,with,1,1
114197,furcation,1,1
114198,grade,1,1
114199,II,1,1
114200,involvement,1,0
114201,were,1,0
114202,selected,1,1
114203,from,1,1
114204,16,1,1
114205,patients,1,1
114206,with,1,1
114207,periodontal,1,1
114208,disease,1,1
114209,.,1,0
114210,The,0,0
114211,teeth,0,0
114212,were,0,0
114213,randomly,0,1
114214,allocated,0,0
114215,to,0,0
114216,the,0,0
114217,following,0,0
114218,groups,0,0
114219,according,0,1
114220,to,0,1
114221,treatment,0,0
114222,;,0,0
114223,(,0,0
114224,1,0,0
114225,),0,1
114226,4,0,0
114227,consecutive,0,1
114228,administrations,0,0
114229,of,0,1
114230,tetracycline-immobilized,0,0
114231,cross-linked,0,0
114232,collagen,0,0
114233,film,0,0
114234,(,0,0
114235,TC,0,0
114236,film,0,0
114237,),0,0
114238,at,0,0
114239,intervals,0,0
114240,of,0,1
114241,1,0,0
114242,week,0,0
114243,(,0,0
114244,TC,0,0
114245,group,0,1
114246,),0,0
114247,;,0,0
114248,(,0,0
114249,2,0,0
114250,),0,1
114251,1,0,0
114252,root,0,0
114253,planing,0,0
114254,treatment,0,0
114255,(,0,0
114256,RP,0,0
114257,group,0,1
114258,),0,0
114259,;,0,0
114260,(,0,0
114261,3,0,0
114262,),0,0
114263,combination,0,0
114264,treatment,0,0
114265,(,0,0
114266,TC,0,0
114267,+,0,0
114268,RP,0,0
114269,group,0,1
114270,),0,0
114271,;,0,0
114272,(,0,0
114273,4,0,0
114274,),0,0
114275,no,0,0
114276,treatment,0,0
114277,(,0,0
114278,control,0,0
114279,group,0,1
114280,),0,0
114281,.,0,0
114282,The,0,0
114283,therapeutic,0,0
114284,effects,0,0
114285,of,0,0
114286,each,0,0
114287,treatment,0,0
114288,were,0,0
114289,compared,0,0
114290,both,0,0
114291,clinically,0,0
114292,and,0,0
114293,microbiologically,0,0
114294,.,0,0
114295,Records,0,0
114296,of,0,0
114297,plaque,0,0
114298,index,0,0
114299,",",0,0
114300,gingival,0,0
114301,index,0,0
114302,",",0,0
114303,bleeding,0,0
114304,on,0,0
114305,probing,0,0
114306,",",0,0
114307,probing,0,0
114308,depth,0,0
114309,",",0,0
114310,probing,0,0
114311,attachment,0,0
114312,level,0,0
114313,and,0,0
114314,microscopic,0,0
114315,counts,0,0
114316,were,0,0
114317,obtained,0,0
114318,at,0,0
114319,0,0,0
114320,",",0,0
114321,4,0,0
114322,",",0,0
114323,6,0,0
114324,and,0,0
114325,8,0,1
114326,weeks,0,0
114327,.,0,1
114328,The,0,0
114329,results,0,0
114330,showed,0,0
114331,marked,0,0
114332,decreases,0,0
114333,in,0,0
114334,probing,0,0
114335,depth,0,0
114336,and,0,0
114337,density,0,0
114338,of,0,0
114339,micro-organisms,0,0
114340,in,0,0
114341,both,0,0
114342,the,0,0
114343,RP,0,0
114344,and,0,0
114345,TC,0,0
114346,+,0,0
114347,RP,0,1
114348,groups,0,0
114349,.,0,1
114350,In,0,0
114351,particular,0,0
114352,",",0,0
114353,the,0,0
114354,TC,0,0
114355,+,0,0
114356,RP,0,0
114357,group,0,0
114358,was,0,0
114359,characterized,0,0
114360,by,0,0
114361,a,0,0
114362,decreased,0,0
114363,rate,0,0
114364,of,0,0
114365,bleeding,0,0
114366,on,0,0
114367,pocket,0,0
114368,probing,0,0
114369,and,0,0
114370,an,0,0
114371,increased,0,0
114372,probing,0,0
114373,attachment,0,0
114374,gain,0,0
114375,.,0,0
114376,The,0,0
114377,above,0,0
114378,findings,0,0
114379,demonstrated,0,0
114380,that,0,0
114381,root,0,0
114382,planning,0,0
114383,is,0,0
114384,effective,0,0
114385,in,0,0
114386,the,0,0
114387,treatment,0,0
114388,of,0,0
114389,furcation,0,1
114390,involvement,0,0
114391,and,0,0
114392,that,0,0
114393,the,0,0
114394,effects,0,0
114395,are,0,0
114396,enhanced,0,0
114397,by,0,0
114398,the,0,0
114399,local,0,0
114400,administration,0,0
114401,of,0,0
114402,TC,0,0
114403,films,0,1
114404,.,0,1
114405,Anxiety,0,0
114406,disorders,0,1
114407,in,0,0
114408,typically,0,1
114409,developing,0,0
114410,youth,0,1
114411,:,0,1
114412,autism,0,1
114413,spectrum,0,1
114414,symptoms,0,0
114415,as,0,0
114416,a,0,0
114417,predictor,0,0
114418,of,0,0
114419,cognitive-behavioral,0,1
114420,treatment,0,0
114421,.,0,1
114422,Symptoms,0,0
114423,of,0,0
114424,autism,0,1
114425,spectrum,0,1
114426,disorder,0,1
114427,(,0,0
114428,ASD,0,1
114429,),0,0
114430,were,0,0
114431,assessed,0,0
114432,(,0,0
114433,Social,0,0
114434,Responsiveness,0,1
114435,Scale-Parent,0,1
114436,(,0,0
114437,SRS-P,0,0
114438,),0,1
114439,;,0,0
114440,coded,0,1
114441,in-session,0,0
114442,behavior,0,0
114443,),0,0
114444,in,0,0
114445,typically-developing,1,1
114446,",",1,0
114447,anxiety-disordered,1,1
114448,children,1,1
114449,(,1,1
114450,N,1,1
114451,=,1,0
114452,50,1,1
114453,),1,0
114454,treated,1,1
114455,with,0,1
114456,cognitive-behavioral,0,0
114457,therapy,0,0
114458,(,0,0
114459,CBT,0,0
114460,),0,0
114461,.,0,0
114462,Study,0,0
114463,1,0,0
114464,:,0,1
114465,children,1,1
114466,with,1,1
114467,moderate,1,1
114468,autistic,1,1
114469,symptomology,1,1
114470,(,1,0
114471,per,0,0
114472,SRS-P,0,0
114473,),0,0
114474,were,0,0
114475,significantly,0,0
114476,more,0,0
114477,likely,0,0
114478,to,0,0
114479,improve,0,0
114480,from,0,0
114481,family,0,1
114482,CBT,0,0
114483,(,0,0
114484,FCBT,0,0
114485,),0,0
114486,than,0,0
114487,individual,0,0
114488,CBT,0,0
114489,(,0,1
114490,ICBT,0,1
114491,;,0,0
114492,OR,0,0
114493,=,0,0
114494,8.67,0,0
114495,),0,0
114496,.,0,0
114497,Coded,0,0
114498,behavior,0,0
114499,did,0,0
114500,not,0,0
114501,predict,0,0
114502,outcome,0,0
114503,.,0,1
114504,Study,0,0
114505,2,0,0
114506,:,0,1
114507,CBT,0,0
114508,components,0,0
114509,were,0,1
114510,compared,0,0
114511,by,0,0
114512,treatment,0,0
114513,and,0,0
114514,ASD,0,1
114515,symptom,0,0
114516,status,0,0
114517,.,0,0
114518,At-home,0,0
114519,exposure,0,0
114520,completion,0,0
114521,was,0,0
114522,greater,0,0
114523,in,0,0
114524,FCBT,0,0
114525,and,0,0
114526,there,0,0
114527,was,0,0
114528,an,0,0
114529,interaction,0,0
114530,in,0,0
114531,child,0,1
114532,involvement,0,0
114533,for,0,0
114534,treatment,0,0
114535,and,0,0
114536,ASD,0,1
114537,status,0,0
114538,.,0,0
114539,Though,0,0
114540,both,0,0
114541,treatments,0,0
114542,reduced,0,0
114543,anxiety,0,0
114544,",",0,0
114545,FCBT,0,0
114546,outperformed,0,0
114547,ICBT,0,1
114548,for,0,0
114549,children,0,1
114550,with,0,1
114551,moderate,0,1
114552,ASD,0,1
114553,symptoms,0,0
114554,",",0,0
114555,a,0,0
114556,benefit,0,0
114557,potentially,0,0
114558,linked,0,0
114559,to,0,0
114560,more,0,0
114561,at-home,0,0
114562,exposures,0,0
114563,and,0,0
114564,greater,0,0
114565,child,0,0
114566,involvement,0,0
114567,in,0,0
114568,FCBT,0,1
114569,.,0,1
114570,Modest,0,0
114571,visceral,0,1
114572,fat,0,0
114573,gain,0,0
114574,causes,0,0
114575,endothelial,1,0
114576,dysfunction,1,0
114577,in,1,0
114578,healthy,1,1
114579,humans,1,1
114580,.,1,1
114581,OBJECTIVES,0,0
114582,The,0,0
114583,aim,0,0
114584,of,0,0
114585,this,0,0
114586,study,0,0
114587,was,0,0
114588,to,0,0
114589,determine,0,0
114590,the,0,0
114591,impact,0,0
114592,of,0,0
114593,fat,0,0
114594,gain,0,0
114595,and,0,0
114596,its,0,0
114597,distribution,0,0
114598,on,0,0
114599,endothelial,1,0
114600,function,1,0
114601,in,1,0
114602,lean,1,1
114603,healthy,1,1
114604,humans,1,1
114605,.,1,1
114606,BACKGROUND,0,0
114607,Endothelial,0,0
114608,dysfunction,0,0
114609,has,0,0
114610,been,0,0
114611,identified,0,0
114612,as,0,0
114613,an,0,0
114614,independent,0,0
114615,predictor,0,0
114616,of,0,0
114617,cardiovascular,0,1
114618,events,0,0
114619,.,0,1
114620,Whether,0,0
114621,fat,0,0
114622,gain,0,0
114623,impairs,0,0
114624,endothelial,0,0
114625,function,0,0
114626,is,0,0
114627,unknown,0,0
114628,.,0,0
114629,METHODS,0,0
114630,A,0,0
114631,randomized,0,0
114632,controlled,0,0
114633,study,0,0
114634,was,0,0
114635,conducted,0,0
114636,to,0,0
114637,assess,0,0
114638,the,0,0
114639,effects,0,0
114640,of,0,0
114641,fat,0,0
114642,gain,0,0
114643,on,0,0
114644,endothelial,0,0
114645,function,0,0
114646,.,0,1
114647,Forty-three,1,1
114648,normal-weight,1,1
114649,healthy,1,1
114650,volunteers,1,1
114651,were,1,1
114652,recruited,1,1
114653,(,1,0
114654,mean,1,1
114655,age,1,1
114656,29,1,1
114657,years,1,1
114658,;,1,1
114659,18,1,1
114660,women,1,1
114661,),1,1
114662,.,1,1
114663,Subjects,1,1
114664,were,0,0
114665,assigned,0,1
114666,to,0,0
114667,gain,0,0
114668,weight,0,0
114669,(,0,0
114670,approximately,0,1
114671,4,0,0
114672,kg,0,0
114673,),0,1
114674,(,0,1
114675,n=35,0,1
114676,),0,0
114677,or,0,1
114678,to,0,0
114679,maintain,0,0
114680,weight,0,0
114681,(,0,0
114682,n=8,0,1
114683,),0,1
114684,.,0,1
114685,Endothelial,0,0
114686,function,0,0
114687,(,0,0
114688,brachial,0,0
114689,artery,0,1
114690,flow-mediated,0,0
114691,dilation,0,1
114692,[,0,0
114693,FMD,0,0
114694,],0,1
114695,),0,0
114696,was,0,0
114697,measured,0,0
114698,at,0,0
114699,baseline,0,0
114700,",",0,0
114701,after,0,0
114702,fat,0,0
114703,gain,0,0
114704,(,0,1
114705,8,0,0
114706,weeks,0,0
114707,),0,0
114708,",",0,0
114709,and,0,0
114710,after,0,0
114711,weight,0,0
114712,loss,0,0
114713,(,0,1
114714,16,0,1
114715,weeks,0,0
114716,),0,1
114717,for,0,0
114718,fat,0,1
114719,gainers,0,0
114720,and,0,0
114721,at,0,0
114722,baseline,0,0
114723,and,0,0
114724,follow-up,0,0
114725,(,0,0
114726,8,0,0
114727,weeks,0,0
114728,),0,1
114729,for,0,0
114730,weight,0,1
114731,maintainers,0,0
114732,.,0,1
114733,Body,0,0
114734,composition,0,0
114735,was,0,0
114736,measured,0,0
114737,by,0,0
114738,dual-energy,0,0
114739,X-ray,0,1
114740,absorptiometry,0,1
114741,and,0,0
114742,abdominal,0,1
114743,computed,0,0
114744,tomographic,0,1
114745,scans,0,1
114746,.,0,1
114747,RESULTS,0,0
114748,After,0,0
114749,an,0,0
114750,average,0,0
114751,weight,0,0
114752,gain,0,0
114753,of,0,0
114754,4.1,0,0
114755,kg,0,0
114756,",",0,0
114757,fat,0,0
114758,gainers,0,0
114759,significantly,0,0
114760,increased,0,0
114761,their,0,0
114762,total,0,1
114763,",",0,0
114764,visceral,0,0
114765,",",0,0
114766,and,0,0
114767,subcutaneous,0,0
114768,fat,0,0
114769,.,0,1
114770,Blood,0,0
114771,pressure,0,0
114772,and,0,0
114773,overnight,0,0
114774,polysomnography,0,1
114775,did,0,0
114776,not,0,0
114777,change,0,0
114778,after,0,0
114779,fat,0,0
114780,gain,0,0
114781,or,0,1
114782,loss,0,0
114783,.,0,1
114784,FMD,0,0
114785,remained,0,0
114786,unchanged,0,0
114787,in,0,0
114788,weight,0,1
114789,maintainers,0,0
114790,.,0,1
114791,FMD,0,0
114792,decreased,0,0
114793,in,0,0
114794,fat,0,1
114795,gainers,0,0
114796,(,0,1
114797,9.1+/-3,0,0
114798,%,0,0
114799,vs.,0,0
114800,7.8+/-3.2,0,0
114801,%,0,0
114802,",",0,0
114803,p=0.003,0,0
114804,),0,0
114805,but,0,0
114806,recovered,0,0
114807,to,0,0
114808,baseline,0,0
114809,when,0,0
114810,subjects,0,1
114811,shed,0,0
114812,the,0,0
114813,gained,0,0
114814,weight,0,0
114815,.,0,0
114816,There,0,0
114817,was,0,0
114818,a,0,0
114819,significant,0,0
114820,correlation,0,0
114821,between,0,0
114822,the,0,0
114823,decrease,0,0
114824,in,0,0
114825,FMD,0,0
114826,and,0,0
114827,the,0,0
114828,increase,0,0
114829,in,0,0
114830,visceral,0,1
114831,fat,0,0
114832,gain,0,0
114833,(,0,0
114834,rho=-0.42,0,0
114835,",",0,0
114836,p=0.004,0,0
114837,),0,0
114838,",",0,0
114839,but,0,0
114840,not,0,0
114841,with,0,1
114842,subcutaneous,0,0
114843,fat,0,0
114844,gain,0,0
114845,(,0,0
114846,rho=-0.22,0,0
114847,",",0,0
114848,p=0.15,0,0
114849,),0,0
114850,.,0,0
114851,CONCLUSIONS,0,0
114852,In,0,0
114853,normal-weight,1,1
114854,healthy,1,1
114855,young,1,1
114856,subjects,1,1
114857,",",0,1
114858,modest,0,0
114859,fat,0,0
114860,gain,0,0
114861,results,0,0
114862,in,0,0
114863,impaired,0,1
114864,endothelial,0,0
114865,function,0,0
114866,",",0,0
114867,even,0,0
114868,in,0,0
114869,the,0,0
114870,absence,0,0
114871,of,0,0
114872,changes,0,0
114873,in,0,0
114874,blood,0,0
114875,pressure,0,0
114876,.,0,0
114877,Endothelial,0,0
114878,function,0,0
114879,recovers,0,0
114880,after,0,0
114881,weight,0,1
114882,loss,0,0
114883,.,0,0
114884,Increased,0,0
114885,visceral,0,0
114886,rather,0,0
114887,than,0,0
114888,subcutaneous,0,0
114889,fat,0,1
114890,predicts,0,0
114891,endothelial,0,1
114892,dysfunction,0,1
114893,.,0,0
114894,(,0,0
114895,Fat,0,0
114896,Gain,0,1
114897,and,0,0
114898,Cardiovascular,0,1
114899,Disease,0,1
114900,Mechanisms,0,0
114901,;,0,1
114902,NCT00589498,0,0
114903,),0,1
114904,.,0,1
114905,Eltrombopag,0,0
114906,for,0,0
114907,management,0,0
114908,of,0,0
114909,chronic,1,1
114910,immune,1,0
114911,thrombocytopenia,1,1
114912,(,0,0
114913,RAISE,0,1
114914,),0,1
114915,:,0,1
114916,a,0,0
114917,6-month,0,0
114918,",",0,0
114919,randomised,0,0
114920,",",0,0
114921,phase,0,0
114922,3,0,0
114923,study,0,0
114924,.,0,1
114925,BACKGROUND,0,0
114926,Eltrombopag,0,0
114927,is,0,0
114928,an,0,0
114929,oral,0,0
114930,thrombopoietin,0,0
114931,receptor,0,0
114932,agonist,0,0
114933,for,0,0
114934,the,0,0
114935,treatment,0,0
114936,of,0,0
114937,thrombocytopenia,0,1
114938,.,0,1
114939,We,0,0
114940,aimed,0,0
114941,to,0,0
114942,compare,0,0
114943,the,0,0
114944,response,0,0
114945,to,0,0
114946,once,0,0
114947,daily,0,0
114948,eltrombopag,0,0
114949,versus,0,0
114950,placebo,0,0
114951,in,0,0
114952,patients,1,1
114953,with,1,1
114954,chronic,1,1
114955,immune,1,0
114956,thrombocytopenia,1,1
114957,during,0,0
114958,a,0,0
114959,6-month,0,0
114960,period,0,0
114961,.,0,1
114962,METHODS,0,0
114963,We,0,0
114964,undertook,0,0
114965,a,0,0
114966,phase,0,0
114967,3,0,0
114968,",",0,0
114969,double-blind,0,0
114970,",",0,0
114971,placebo-controlled,0,0
114972,study,0,0
114973,in,0,0
114974,adults,1,1
114975,with,1,1
114976,previously,1,1
114977,treated,1,1
114978,immune,1,0
114979,thrombocytopenia,1,1
114980,of,1,0
114981,more,1,0
114982,than,1,0
114983,6,1,0
114984,months,1,0
114985,',1,1
114986,duration,1,0
114987,who,1,1
114988,had,1,1
114989,baseline,1,1
114990,platelet,1,0
114991,counts,1,0
114992,lower,1,0
114993,than,1,0
114994,"30,000",1,0
114995,per,1,0
114996,?L,1,0
114997,.,1,1
114998,Patients,0,1
114999,were,0,0
115000,randomly,0,1
115001,allocated,0,0
115002,(,0,0
115003,in,0,0
115004,a,0,0
115005,2:1,0,1
115006,ratio,0,0
115007,),0,0
115008,treatment,0,0
115009,with,0,1
115010,local,0,0
115011,standard,0,0
115012,of,0,0
115013,care,0,1
115014,plus,0,0
115015,50,0,1
115016,mg,0,0
115017,eltrombopag,0,0
115018,or,0,0
115019,matching,0,0
115020,placebo,0,0
115021,once,0,0
115022,daily,0,0
115023,for,0,0
115024,6,0,1
115025,months,0,0
115026,.,0,1
115027,Randomisation,0,0
115028,was,0,0
115029,done,0,0
115030,centrally,0,0
115031,with,0,1
115032,a,0,0
115033,computer-generated,0,0
115034,randomisation,0,0
115035,schedule,0,0
115036,and,0,0
115037,was,0,0
115038,stratified,0,1
115039,by,0,0
115040,baseline,0,0
115041,platelet,0,1
115042,count,0,0
115043,(,0,0
115044,?,0,0
115045,"15,000",0,0
115046,per,0,0
115047,?L,0,0
115048,),0,0
115049,",",0,0
115050,use,0,0
115051,of,0,0
115052,treatment,0,0
115053,for,0,0
115054,immune,0,0
115055,thrombocytopenia,0,1
115056,",",0,0
115057,and,0,0
115058,splenectomy,0,1
115059,status,1,1
115060,.,1,1
115061,Patients,1,1
115062,",",0,0
115063,investigators,0,0
115064,",",0,0
115065,and,0,0
115066,those,0,0
115067,assessing,0,0
115068,data,0,0
115069,were,0,1
115070,masked,0,1
115071,to,0,0
115072,allocation,0,0
115073,.,0,1
115074,Dose,0,0
115075,modifications,0,0
115076,were,0,1
115077,made,0,0
115078,on,0,0
115079,the,0,0
115080,basis,0,0
115081,of,0,0
115082,platelet,0,0
115083,response,0,0
115084,.,0,1
115085,Patients,0,1
115086,were,0,0
115087,assessed,0,0
115088,for,0,0
115089,response,0,0
115090,to,0,0
115091,treatment,0,0
115092,(,0,0
115093,defined,0,0
115094,as,0,0
115095,a,0,0
115096,platelet,0,0
115097,count,0,0
115098,of,0,0
115099,"50,000-400,000",0,0
115100,per,0,0
115101,?L,0,0
115102,),0,0
115103,weekly,0,0
115104,during,0,0
115105,the,0,0
115106,first,0,0
115107,6,0,0
115108,weeks,0,0
115109,and,0,0
115110,at,0,0
115111,least,0,0
115112,once,0,0
115113,every,0,0
115114,4,0,0
115115,weeks,0,0
115116,thereafter,0,0
115117,;,0,0
115118,the,0,0
115119,primary,0,0
115120,endpoint,0,0
115121,was,0,0
115122,the,0,0
115123,odds,0,0
115124,of,0,0
115125,response,0,0
115126,to,0,0
115127,eltrombopag,0,0
115128,versus,0,0
115129,placebo,0,0
115130,.,0,0
115131,Analysis,0,0
115132,was,0,0
115133,by,0,0
115134,intention,0,0
115135,to,0,0
115136,treat,0,0
115137,.,0,0
115138,This,0,0
115139,study,0,0
115140,is,0,0
115141,registered,0,0
115142,at,0,0
115143,ClinicalTrials.gov,0,0
115144,",",0,0
115145,number,0,0
115146,NCT00370331,0,0
115147,.,0,1
115148,FINDINGS,1,0
115149,Between,1,0
115150,Nov,1,0
115151,22,1,1
115152,",",1,0
115153,2006,1,1
115154,",",1,0
115155,and,1,0
115156,July,1,0
115157,31,1,1
115158,",",1,0
115159,2007,1,1
115160,",",1,0
115161,197,1,1
115162,patients,1,1
115163,were,1,1
115164,randomly,0,1
115165,allocated,0,0
115166,to,0,0
115167,treatment,0,0
115168,groups,0,0
115169,and,0,0
115170,were,0,0
115171,included,0,0
115172,in,0,0
115173,the,0,0
115174,intention-to-treat,0,0
115175,analysis,0,0
115176,(,0,0
115177,135,0,1
115178,eltrombopag,0,0
115179,",",0,0
115180,62,0,1
115181,placebo,0,0
115182,),0,1
115183,.,0,0
115184,106,0,1
115185,(,0,0
115186,79,0,1
115187,%,0,0
115188,),0,0
115189,patients,0,1
115190,in,0,0
115191,the,0,0
115192,eltrombopag,0,0
115193,group,0,0
115194,responded,0,1
115195,to,0,0
115196,treatment,0,0
115197,at,0,0
115198,least,0,0
115199,once,0,0
115200,during,0,0
115201,the,0,0
115202,study,0,0
115203,",",0,0
115204,compared,0,0
115205,with,0,1
115206,17,0,1
115207,(,0,1
115208,28,0,1
115209,%,0,0
115210,),0,0
115211,patients,0,1
115212,in,0,0
115213,the,0,0
115214,placebo,0,0
115215,group,0,0
115216,.,0,0
115217,The,0,0
115218,odds,0,0
115219,of,0,0
115220,responding,0,0
115221,were,0,0
115222,greater,0,0
115223,in,0,0
115224,patients,0,1
115225,in,0,0
115226,the,0,0
115227,eltrombopag,0,0
115228,group,0,0
115229,compared,0,0
115230,with,0,1
115231,those,0,0
115232,in,0,0
115233,the,0,0
115234,placebo,0,0
115235,group,0,0
115236,throughout,0,0
115237,the,0,0
115238,6-month,0,0
115239,treatment,0,0
115240,period,0,0
115241,(,0,0
115242,odds,0,0
115243,ratio,0,0
115244,8?2,0,0
115245,",",0,0
115246,99,0,1
115247,%,0,0
115248,CI,0,0
115249,3?59-18?73,0,1
115250,;,0,0
115251,p,0,0
115252,<,0,0
115253,0?0001,0,0
115254,),0,0
115255,.,0,1
115256,37,0,1
115257,(,0,0
115258,59,0,1
115259,%,0,0
115260,),0,1
115261,patients,0,1
115262,receiving,0,1
115263,eltrombopag,0,0
115264,reduced,0,0
115265,concomitant,0,0
115266,treatment,0,0
115267,versus,0,0
115268,ten,0,1
115269,(,0,0
115270,32,0,1
115271,%,0,0
115272,),0,1
115273,patients,0,1
115274,receiving,0,1
115275,placebo,0,0
115276,(,0,0
115277,p=0?016,0,0
115278,),0,1
115279,.,0,0
115280,24,0,0
115281,(,0,0
115282,18,0,1
115283,%,0,0
115284,),0,1
115285,patients,0,1
115286,receiving,0,1
115287,eltrombopag,0,0
115288,needed,0,0
115289,rescue,0,0
115290,treatment,0,0
115291,compared,0,0
115292,with,0,1
115293,25,0,1
115294,(,0,1
115295,40,0,1
115296,%,0,0
115297,),0,1
115298,patients,0,1
115299,receiving,0,1
115300,placebo,0,0
115301,(,0,0
115302,p=0?001,0,0
115303,),0,0
115304,.,0,0
115305,Three,0,1
115306,(,0,0
115307,2,0,0
115308,%,0,0
115309,),0,1
115310,patients,0,1
115311,receiving,0,1
115312,eltrombopag,0,0
115313,had,0,1
115314,thromboembolic,0,1
115315,events,0,0
115316,compared,0,0
115317,with,0,1
115318,none,0,0
115319,in,0,0
115320,patients,0,1
115321,on,0,0
115322,placebo,0,0
115323,.,0,1
115324,Nine,0,0
115325,(,0,0
115326,7,0,0
115327,%,0,0
115328,),0,1
115329,eltrombopag-treated,0,0
115330,patients,0,1
115331,and,0,1
115332,two,0,0
115333,(,0,0
115334,3,0,0
115335,%,0,0
115336,),0,0
115337,in,0,0
115338,the,0,0
115339,placebo,0,0
115340,group,0,0
115341,had,0,0
115342,mild,0,1
115343,increases,0,0
115344,in,0,0
115345,alanine,0,1
115346,aminotransferase,0,0
115347,concentration,0,0
115348,",",0,0
115349,and,0,0
115350,five,0,1
115351,(,0,0
115352,4,0,0
115353,%,0,0
115354,),0,1
115355,eltrombopag-treated,0,0
115356,patients,0,1
115357,(,0,0
115358,vs,0,0
115359,none,0,0
115360,allocated,0,1
115361,to,0,0
115362,placebo,0,0
115363,),0,0
115364,had,0,0
115365,increases,0,0
115366,in,0,0
115367,total,0,1
115368,bilirubin,0,0
115369,.,0,1
115370,Four,0,0
115371,(,0,0
115372,7,0,1
115373,%,0,0
115374,),0,1
115375,patients,0,1
115376,taking,0,1
115377,placebo,0,0
115378,had,0,1
115379,serious,0,0
115380,bleeding,0,1
115381,events,0,0
115382,",",0,0
115383,compared,0,0
115384,with,0,1
115385,one,0,0
115386,(,0,0
115387,<,0,0
115388,1,0,0
115389,%,0,0
115390,),0,0
115391,patient,0,0
115392,treated,0,1
115393,with,0,1
115394,eltrombopag,0,0
115395,.,0,1
115396,INTERPRETATION,0,0
115397,Eltrombopag,0,0
115398,is,0,0
115399,effective,0,0
115400,for,0,0
115401,management,0,1
115402,of,0,0
115403,chronic,0,1
115404,immune,0,0
115405,thrombocytopenia,0,1
115406,",",0,0
115407,and,0,0
115408,could,0,0
115409,be,0,0
115410,particularly,0,0
115411,beneficial,0,0
115412,for,1,1
115413,patients,1,1
115414,who,1,1
115415,have,1,1
115416,not,1,1
115417,responded,1,0
115418,to,1,0
115419,splenectomy,1,1
115420,or,1,1
115421,previous,1,0
115422,treatment,1,0
115423,.,1,0
115424,These,0,0
115425,benefits,0,0
115426,should,0,0
115427,be,0,0
115428,balanced,0,0
115429,with,0,0
115430,the,0,0
115431,potential,0,0
115432,risks,0,0
115433,associated,0,0
115434,with,0,1
115435,eltrombopag,0,0
115436,treatment,0,0
115437,.,0,1
115438,FUNDING,0,0
115439,GlaxoSmithKline,0,1
115440,.,0,1
115441,A,0,1
115442,cluster,0,0
115443,randomised,0,0
115444,trial,0,0
115445,to,0,0
115446,evaluate,0,0
115447,a,0,0
115448,physical,0,0
115449,activity,0,0
115450,intervention,0,0
115451,among,0,0
115452,3-5,1,0
115453,year,1,1
115454,old,1,1
115455,children,1,1
115456,attending,1,1
115457,long,1,0
115458,day,1,0
115459,care,1,1
115460,services,1,1
115461,:,1,1
115462,study,0,1
115463,protocol,0,0
115464,.,0,1
115465,BACKGROUND,0,0
115466,Young,1,1
115467,children,1,1
115468,are,0,0
115469,not,0,0
115470,participating,0,1
115471,in,0,0
115472,recommended,0,1
115473,levels,0,0
115474,of,0,0
115475,physical,0,0
115476,activity,0,0
115477,and,0,0
115478,exhibit,0,0
115479,high,0,1
115480,levels,0,0
115481,of,0,0
115482,sedentary,0,1
115483,behaviour,0,0
115484,.,0,1
115485,Childcare,0,1
115486,services,0,0
115487,provide,0,0
115488,access,0,0
115489,to,0,0
115490,large,0,1
115491,numbers,0,0
115492,of,0,1
115493,young,1,1
115494,children,1,1
115495,for,0,1
115496,prolonged,0,0
115497,periods,0,0
115498,",",0,0
115499,yet,0,0
115500,there,0,0
115501,is,0,0
115502,limited,0,0
115503,experimental,0,0
115504,evidence,0,0
115505,regarding,0,0
115506,the,0,0
115507,effectiveness,0,0
115508,of,0,0
115509,physical,0,0
115510,activity,0,0
115511,interventions,0,0
115512,implemented,0,0
115513,in,0,0
115514,this,0,0
115515,setting,0,1
115516,.,0,0
115517,The,0,0
115518,aim,0,0
115519,of,0,0
115520,this,0,0
115521,study,0,0
115522,is,0,0
115523,to,0,0
115524,assess,0,0
115525,the,0,0
115526,effectiveness,0,0
115527,and,0,0
115528,acceptability,0,0
115529,of,0,0
115530,a,0,0
115531,multi-component,0,0
115532,physical,0,0
115533,activity,0,0
115534,intervention,0,0
115535,",",0,0
115536,delivered,0,0
115537,by,0,0
115538,childcare,0,1
115539,service,0,1
115540,staff,0,0
115541,",",0,0
115542,in,0,0
115543,increasing,0,0
115544,the,0,0
115545,physical,0,0
115546,activity,0,0
115547,levels,0,0
115548,of,0,0
115549,children,1,1
115550,attending,1,1
115551,long,1,0
115552,day,1,0
115553,care,1,1
115554,services,1,1
115555,.,1,1
115556,METHODS/DESIGN,0,0
115557,The,0,0
115558,study,0,0
115559,will,0,0
115560,employ,0,0
115561,a,0,0
115562,cluster,0,0
115563,randomised,0,0
115564,controlled,0,0
115565,trial,0,0
115566,design,0,0
115567,.,0,1
115568,Three,1,0
115569,hundred,1,1
115570,children,1,1
115571,aged,1,1
115572,between,1,0
115573,3-5,1,1
115574,years,1,1
115575,from,1,1
115576,twenty,1,1
115577,randomly,1,1
115578,selected,1,1
115579,long,1,0
115580,day,1,0
115581,care,1,0
115582,services,1,1
115583,in,1,0
115584,the,1,0
115585,Hunter,1,0
115586,Region,1,1
115587,of,1,0
115588,New,1,1
115589,South,1,1
115590,Wales,1,0
115591,",",1,0
115592,Australia,1,1
115593,will,0,0
115594,be,0,0
115595,invited,0,1
115596,to,0,0
115597,participate,0,1
115598,in,0,0
115599,the,0,0
115600,trial,0,0
115601,.,0,0
115602,Ten,0,0
115603,of,0,0
115604,the,0,0
115605,20,0,0
115606,long,0,0
115607,day,0,0
115608,care,0,1
115609,services,0,0
115610,will,0,0
115611,be,0,0
115612,randomly,0,0
115613,allocated,0,0
115614,to,0,0
115615,deliver,0,0
115616,the,0,0
115617,intervention,0,0
115618,with,0,0
115619,the,0,0
115620,remaining,0,0
115621,ten,0,1
115622,services,0,1
115623,allocated,0,1
115624,to,0,0
115625,a,0,0
115626,wait,0,0
115627,list,0,0
115628,control,0,1
115629,group,0,0
115630,.,0,0
115631,The,0,0
115632,physical,0,0
115633,activity,0,0
115634,intervention,0,0
115635,will,0,0
115636,consist,0,0
115637,of,0,0
115638,a,0,0
115639,number,0,0
115640,of,0,0
115641,strategies,0,0
115642,including,0,1
115643,:,0,1
115644,delivering,0,0
115645,structured,0,0
115646,fundamental,0,0
115647,movement,0,0
115648,skill,0,0
115649,activities,0,0
115650,",",0,0
115651,increasing,0,0
115652,physical,0,0
115653,activity,0,0
115654,opportunities,0,0
115655,",",0,0
115656,increasing,0,0
115657,staff,0,0
115658,role,0,0
115659,modelling,0,0
115660,",",0,0
115661,providing,0,0
115662,children,0,1
115663,with,0,1
115664,a,0,0
115665,physical,0,0
115666,activity,0,0
115667,promoting,0,0
115668,indoor,0,1
115669,and,0,0
115670,outdoor,0,1
115671,environment,0,0
115672,and,0,0
115673,limiting,0,0
115674,children,0,1
115675,'s,0,1
115676,small,0,1
115677,screen,0,1
115678,recreation,0,0
115679,and,0,0
115680,sedentary,0,1
115681,behaviours,0,0
115682,.,0,1
115683,Intervention,0,0
115684,effectiveness,0,0
115685,will,0,0
115686,be,0,0
115687,measured,0,0
115688,via,0,0
115689,child,0,1
115690,physical,0,0
115691,activity,0,0
115692,levels,0,0
115693,during,0,0
115694,attendance,0,0
115695,at,0,0
115696,long,0,0
115697,day,0,0
115698,care,0,0
115699,.,0,0
115700,The,0,0
115701,study,0,0
115702,also,0,0
115703,seeks,0,0
115704,to,0,0
115705,determine,0,0
115706,the,0,0
115707,acceptability,0,0
115708,and,0,0
115709,extent,0,0
115710,of,0,0
115711,implementation,0,0
115712,of,0,0
115713,the,0,0
115714,intervention,0,0
115715,by,0,0
115716,services,0,1
115717,and,0,0
115718,their,0,0
115719,staff,0,1
115720,participating,0,1
115721,in,0,0
115722,the,0,0
115723,study,0,0
115724,.,0,0
115725,DISCUSSION,0,0
115726,The,0,0
115727,trial,0,0
115728,will,0,0
115729,address,0,0
115730,current,0,0
115731,gaps,0,0
115732,in,0,0
115733,the,0,0
115734,research,0,0
115735,evidence,0,0
115736,base,0,0
115737,and,0,0
115738,contribute,0,0
115739,to,0,0
115740,the,0,0
115741,design,0,0
115742,and,0,0
115743,delivery,0,0
115744,of,0,0
115745,future,0,0
115746,interventions,0,0
115747,promoting,0,0
115748,physical,0,0
115749,activity,0,0
115750,for,0,0
115751,young,1,1
115752,children,1,1
115753,in,1,0
115754,long,1,1
115755,day,1,0
115756,care,1,1
115757,settings,1,0
115758,.,1,1
115759,TRIAL,0,0
115760,REGISTRATION,0,0
115761,Australian,1,1
115762,New,1,1
115763,Zealand,1,1
115764,Clinical,1,0
115765,Trials,1,1
115766,Registry,1,1
115767,ACTRN12610000087055,0,1
115768,.,0,1
115769,A,0,1
115770,randomized,0,0
115771,trial,0,0
115772,of,0,0
115773,genetic,0,0
115774,and,0,0
115775,environmental,0,0
115776,risk,0,0
115777,assessment,0,0
115778,(,0,0
115779,GERA,0,0
115780,),0,0
115781,for,0,0
115782,colorectal,0,1
115783,cancer,0,1
115784,risk,0,0
115785,in,0,0
115786,primary,0,1
115787,care,0,1
115788,:,0,1
115789,trial,0,0
115790,design,0,0
115791,and,0,0
115792,baseline,0,0
115793,findings,0,0
115794,.,0,0
115795,PURPOSE,0,0
115796,This,0,0
115797,paper,0,0
115798,describes,0,0
115799,an,0,0
115800,ongoing,0,0
115801,randomized,0,0
115802,controlled,0,0
115803,trial,0,0
115804,designed,0,0
115805,to,0,0
115806,assess,0,0
115807,the,0,0
115808,impact,0,0
115809,of,0,0
115810,genetic,0,0
115811,and,0,0
115812,environmental,0,0
115813,risk,0,0
115814,assessment,0,0
115815,(,0,0
115816,GERA,0,0
115817,),0,0
115818,on,0,0
115819,colorectal,1,1
115820,cancer,1,1
115821,(,1,0
115822,CRC,1,0
115823,),1,0
115824,screening,0,1
115825,.,0,0
115826,METHODS,0,0
115827,The,0,0
115828,trial,0,0
115829,includes,0,0
115830,asymptomatic,1,1
115831,patients,1,1
115832,who,1,1
115833,are,1,1
115834,50-79years,1,1
115835,and,1,0
115836,are,1,0
115837,not,1,0
115838,up-to-date,1,0
115839,with,1,1
115840,CRC,1,1
115841,screening,1,1
115842,guidelines,1,0
115843,.,1,1
115844,Patients,0,1
115845,who,0,1
115846,responded,0,1
115847,to,0,1
115848,a,0,0
115849,baseline,0,0
115850,telephone,0,0
115851,survey,0,1
115852,are,0,0
115853,randomized,0,0
115854,to,0,0
115855,a,0,0
115856,GERA,1,0
115857,or,1,1
115858,Control,1,1
115859,group,1,0
115860,.,1,0
115861,GERA,0,0
115862,group,0,0
115863,participants,0,1
115864,meet,0,1
115865,with,0,1
115866,a,0,0
115867,nurse,0,0
115868,",",0,0
115869,decide,0,0
115870,whether,0,0
115871,to,0,0
115872,have,0,0
115873,a,0,0
115874,GERA,0,0
115875,blood,0,0
115876,test,0,0
115877,(,0,0
115878,a,0,0
115879,combination,0,0
115880,of,0,0
115881,genetic,0,0
115882,polymorphism,0,0
115883,and,0,0
115884,folate,0,0
115885,),0,0
115886,",",0,0
115887,and,0,0
115888,",",0,0
115889,if,0,0
115890,tested,0,0
115891,",",0,0
115892,receive,0,0
115893,GERA,0,0
115894,feedback,0,0
115895,.,0,0
115896,Follow-up,0,0
115897,telephone,0,0
115898,surveys,0,0
115899,are,0,0
115900,conducted,0,0
115901,at,0,0
115902,1,0,0
115903,and,0,1
115904,6months,0,0
115905,.,0,0
115906,A,0,0
115907,chart,0,0
115908,audit,0,0
115909,is,0,0
115910,performed,0,0
115911,at,0,0
115912,6months,0,0
115913,.,0,1
115914,RESULTS,0,0
115915,Of,1,1
115916,"2,223",1,1
115917,eligible,1,1
115918,patients,1,1
115919,",",1,0
115920,562,1,1
115921,(,1,0
115922,25,1,1
115923,%,1,0
115924,),1,0
115925,have,1,0
115926,enrolled,1,1
115927,.,1,1
115928,Patients,1,1
115929,who,1,1
115930,enrolled,1,1
115931,in,1,1
115932,the,1,0
115933,study,1,0
115934,were,1,0
115935,significantly,1,0
115936,younger,1,1
115937,than,1,0
115938,those,1,1
115939,who,1,1
115940,did,1,1
115941,not,1,1
115942,(,1,0
115943,p,1,0
115944,<,1,0
115945,0.001,1,0
115946,),1,1
115947,.,1,1
115948,Participants,1,1
115949,tended,1,0
115950,to,1,0
115951,be,1,0
115952,50-59years,1,1
115953,(,1,0
115954,64,1,1
115955,%,1,0
115956,),1,0
115957,",",1,0
115958,female,1,1
115959,(,1,0
115960,58,1,1
115961,%,1,0
115962,),1,0
115963,",",1,0
115964,white,1,1
115965,(,1,0
115966,52,1,1
115967,%,1,0
115968,),1,0
115969,",",1,0
115970,married,1,1
115971,(,1,0
115972,51,1,1
115973,%,1,0
115974,),1,0
115975,",",1,0
115976,and,1,0
115977,have,1,0
115978,more,1,0
115979,than,1,0
115980,a,1,0
115981,high,1,0
115982,school,1,1
115983,education,1,0
115984,(,1,0
115985,67,1,1
115986,%,1,0
115987,),1,0
115988,.,1,0
115989,At,0,0
115990,baseline,0,0
115991,",",0,0
115992,most,0,0
115993,participants,0,1
115994,had,0,1
115995,some,0,0
115996,knowledge,0,0
115997,of,0,0
115998,CRC,0,0
115999,screening,0,1
116000,and,0,0
116001,GERA,0,0
116002,",",0,0
116003,viewed,0,0
116004,CRC,0,0
116005,screening,0,0
116006,favorably,0,0
116007,",",0,0
116008,and,0,0
116009,reported,0,0
116010,that,0,0
116011,they,0,1
116012,had,0,1
116013,decided,0,0
116014,to,0,0
116015,do,0,0
116016,screening,0,1
116017,.,0,0
116018,Almost,0,0
116019,half,0,1
116020,had,0,1
116021,worries,0,0
116022,and,0,1
116023,concerns,0,0
116024,about,0,0
116025,CRC,0,1
116026,.,0,1
116027,CONCLUSIONS,0,0
116028,One,1,1
116029,in,1,0
116030,four,1,1
116031,eligible,1,1
116032,primary,1,1
116033,care,1,1
116034,patients,1,1
116035,enrolled,1,1
116036,in,1,0
116037,the,1,0
116038,study,1,0
116039,.,1,0
116040,Age,0,0
116041,was,0,0
116042,negatively,0,0
116043,associated,0,0
116044,with,0,1
116045,enrollment,0,1
116046,.,0,1
116047,Prospective,0,0
116048,analyses,0,0
116049,using,0,1
116050,data,0,0
116051,for,0,0
116052,all,0,0
116053,participants,0,1
116054,will,0,0
116055,provide,0,0
116056,more,0,0
116057,definitive,0,0
116058,information,0,0
116059,on,0,0
116060,GERA,0,0
116061,uptake,0,0
116062,and,0,0
116063,the,0,0
116064,impact,0,0
116065,of,0,0
116066,GERA,0,0
116067,feedback,0,0
116068,.,0,1
116069,Anti-angiogenic,0,0
116070,effects,0,0
116071,of,0,0
116072,epigallocatechin-3-gallate,0,0
116073,in,0,0
116074,human,0,1
116075,skin,0,1
116076,.,0,1
116077,Epigallocatechin-3-gallate,0,0
116078,(,0,0
116079,EGCG,0,0
116080,),0,0
116081,is,0,0
116082,the,0,0
116083,main,0,0
116084,polyphenol,0,0
116085,component,0,0
116086,of,0,0
116087,green,0,0
116088,tea,0,0
116089,.,0,0
116090,This,0,0
116091,compound,0,0
116092,exhibits,0,0
116093,antioxidant,0,0
116094,",",0,0
116095,immunomodulatory,0,0
116096,",",0,0
116097,photoprotective,0,0
116098,",",0,0
116099,anti-angiogenic,0,0
116100,",",0,0
116101,and,0,0
116102,anti-inflammatory,0,0
116103,properties,0,0
116104,.,0,1
116105,We,0,0
116106,conducted,0,0
116107,a,0,0
116108,small,0,0
116109,randomized,0,0
116110,",",0,0
116111,double,0,0
116112,blind,0,0
116113,",",0,0
116114,split,0,0
116115,face,0,0
116116,trial,0,0
116117,using,0,0
116118,a,0,0
116119,cream,0,0
116120,containing,0,0
116121,2.5,0,0
116122,%,0,0
116123,w/w,0,0
116124,of,0,0
116125,EGCG,0,0
116126,.,0,1
116127,Four,1,0
116128,healthy,1,1
116129,volunteers,1,1
116130,with,1,1
116131,significant,1,0
116132,erythema,1,0
116133,and,1,0
116134,telangiectasia,1,1
116135,on,1,0
116136,the,1,0
116137,face,1,0
116138,applied,0,0
116139,EGCG,0,0
116140,cream,0,0
116141,to,0,0
116142,one,0,0
116143,side,0,0
116144,of,0,0
116145,the,0,0
116146,face,0,0
116147,",",0,0
116148,and,0,0
116149,vehicle,0,0
116150,control,0,0
116151,cream,0,0
116152,to,0,0
116153,the,0,0
116154,other,0,0
116155,",",0,0
116156,twice,0,0
116157,daily,0,0
116158,for,0,0
116159,six,0,1
116160,weeks,0,0
116161,.,0,1
116162,After,0,0
116163,six,0,1
116164,weeks,0,0
116165,",",0,1
116166,biopsies,0,0
116167,were,0,0
116168,taken,0,0
116169,from,0,0
116170,EGCG,0,0
116171,and,0,0
116172,vehicle,0,0
116173,treated,0,1
116174,sites,0,0
116175,.,0,1
116176,Immunohistochemistry,0,0
116177,was,0,0
116178,used,0,0
116179,to,0,0
116180,measure,0,0
116181,VEGF,0,1
116182,and,0,0
116183,HIF-1,0,0
116184,?.,0,0
116185,HIF-1,0,0
116186,?,0,0
116187,expression,0,0
116188,was,0,0
116189,decreased,0,0
116190,in,0,0
116191,EGCG,0,0
116192,treated,0,1
116193,sites,0,0
116194,",",0,0
116195,such,0,0
116196,that,0,0
116197,28.4,0,0
116198,%,0,0
116199,of,0,0
116200,the,0,0
116201,epidermis,0,0
116202,showed,0,0
116203,positive,0,0
116204,staining,0,0
116205,in,0,0
116206,vehicle,0,0
116207,treated,0,1
116208,vs.,0,0
116209,13.8,0,0
116210,%,0,0
116211,in,0,0
116212,EGCG,0,0
116213,treated,0,1
116214,sites,0,0
116215,(,0,1
116216,p,0,0
116217,<,0,0
116218,0.001,0,0
116219,),0,0
116220,.,0,0
116221,A,0,0
116222,similar,0,0
116223,decrease,0,0
116224,in,0,0
116225,VEGF,0,1
116226,expression,0,0
116227,was,0,0
116228,found,0,0
116229,(,0,0
116230,6.7,0,0
116231,%,0,0
116232,in,0,0
116233,EGCG,0,0
116234,vs.,0,0
116235,11.0,0,0
116236,%,0,0
116237,in,0,0
116238,in,0,0
116239,vehicle-treated,0,0
116240,skin,0,0
116241,(,0,0
116242,p,0,0
116243,<,0,0
116244,0.005,0,0
116245,),0,1
116246,.,0,1
116247,EGCG,0,0
116248,topical,0,0
116249,treatments,0,0
116250,influence,0,0
116251,HIF-1,0,0
116252,?,0,0
116253,induction,0,0
116254,and,0,0
116255,VEGF,0,0
116256,expression,0,0
116257,and,0,0
116258,may,0,0
116259,serve,0,0
116260,as,0,0
116261,a,0,0
116262,potential,0,0
116263,agent,0,0
116264,in,0,0
116265,the,0,0
116266,prevention,0,0
116267,of,0,0
116268,telangiectasias,1,1
116269,.,1,1
116270,Action,0,0
116271,observation,0,0
116272,treatment,0,0
116273,improves,0,0
116274,recovery,0,0
116275,of,0,0
116276,postsurgical,1,0
116277,orthopedic,1,1
116278,patients,1,1
116279,:,1,1
116280,evidence,0,0
116281,for,0,0
116282,a,0,0
116283,top-down,0,0
116284,effect,0,0
116285,?,0,0
116286,OBJECTIVE,0,0
116287,To,0,0
116288,assess,0,0
116289,whether,0,0
116290,action,0,0
116291,observation,0,0
116292,treatment,0,0
116293,(,0,0
116294,AOT,0,1
116295,),0,0
116296,may,0,0
116297,also,0,0
116298,improve,0,0
116299,motor,0,0
116300,recovery,0,0
116301,in,0,0
116302,postsurgical,1,0
116303,orthopedic,1,1
116304,patients,1,1
116305,",",0,0
116306,in,0,0
116307,addition,0,0
116308,to,0,0
116309,conventional,0,0
116310,physiotherapy,0,0
116311,.,0,1
116312,DESIGN,0,0
116313,Randomized,0,0
116314,controlled,0,0
116315,trial,0,0
116316,.,0,1
116317,SETTING,0,1
116318,Department,0,1
116319,of,0,0
116320,rehabilitation,0,1
116321,.,0,1
116322,PARTICIPANTS,0,0
116323,Patients,1,1
116324,(,1,1
116325,N=60,1,1
116326,),1,0
116327,admitted,1,1
116328,to,1,0
116329,our,1,0
116330,department,1,1
116331,postorthopedic,1,0
116332,surgery,1,1
116333,were,0,0
116334,randomly,0,1
116335,assigned,0,0
116336,to,0,0
116337,either,0,0
116338,a,0,0
116339,case,0,0
116340,(,0,0
116341,n=30,0,1
116342,),0,0
116343,or,0,0
116344,control,0,0
116345,(,0,0
116346,n=30,0,1
116347,),0,1
116348,group,0,0
116349,.,0,0
116350,Exclusion,1,0
116351,criteria,1,1
116352,were,1,1
116353,age,1,1
116354,18,1,1
116355,years,1,1
116356,or,1,1
116357,younger,1,1
116358,and,1,0
116359,90,1,0
116360,years,1,1
116361,or,1,1
116362,older,1,1
116363,",",1,0
116364,Mini-Mental,1,0
116365,State,1,0
116366,Examination,1,1
116367,score,1,0
116368,of,1,0
116369,21,1,1
116370,of,1,0
116371,30,1,1
116372,or,1,1
116373,lower,1,0
116374,",",1,0
116375,no,1,0
116376,ambulating,1,0
116377,order,1,0
116378,",",1,0
116379,advanced,1,1
116380,vision,1,0
116381,impairment,1,0
116382,",",1,0
116383,malignancy,1,0
116384,",",1,0
116385,pneumonia,1,0
116386,",",1,0
116387,or,1,0
116388,heart,1,1
116389,failure,1,1
116390,.,1,1
116391,INTERVENTIONS,0,0
116392,All,0,1
116393,participants,0,1
116394,underwent,0,1
116395,conventional,1,1
116396,physiotherapy,1,0
116397,.,1,0
116398,In,0,0
116399,addition,0,0
116400,",",0,0
116401,patients,0,1
116402,in,0,0
116403,the,0,0
116404,case,0,0
116405,group,0,0
116406,were,0,0
116407,asked,0,0
116408,to,0,0
116409,observe,0,0
116410,video,0,0
116411,clips,0,0
116412,showing,0,0
116413,daily,0,0
116414,actions,0,0
116415,and,0,0
116416,to,0,0
116417,imitate,0,0
116418,them,0,0
116419,afterward,0,0
116420,.,0,0
116421,Patients,0,1
116422,in,0,0
116423,the,0,0
116424,control,0,0
116425,group,0,0
116426,were,0,0
116427,asked,0,0
116428,to,0,0
116429,observe,0,0
116430,video,0,0
116431,clips,0,0
116432,with,0,1
116433,no,0,0
116434,motor,0,0
116435,content,0,0
116436,and,0,0
116437,to,0,0
116438,execute,0,0
116439,the,0,0
116440,same,0,0
116441,actions,0,0
116442,as,0,0
116443,patients,0,1
116444,in,0,0
116445,the,0,0
116446,case,0,0
116447,group,0,0
116448,afterward,0,0
116449,.,0,1
116450,Participants,0,1
116451,were,0,0
116452,scored,0,0
116453,on,0,0
116454,functional,0,1
116455,scales,0,0
116456,at,0,0
116457,baseline,0,0
116458,and,0,0
116459,after,0,0
116460,treatment,0,0
116461,by,0,0
116462,a,0,0
116463,physician,0,0
116464,blinded,0,0
116465,to,0,0
116466,group,0,0
116467,assignment,0,0
116468,.,0,1
116469,MAIN,0,0
116470,OUTCOMES,0,0
116471,MEASURES,0,0
116472,Changes,0,0
116473,in,0,0
116474,FIM,0,0
116475,and,0,0
116476,Tinetti,0,0
116477,scale,0,0
116478,scores,0,0
116479,",",0,0
116480,and,0,0
116481,dependence,0,0
116482,on,0,0
116483,walking,0,0
116484,aids,0,1
116485,.,0,1
116486,RESULTS,0,0
116487,At,0,0
116488,baseline,0,0
116489,",",0,0
116490,groups,0,0
116491,did,0,0
116492,not,0,0
116493,differ,0,0
116494,in,0,0
116495,clinical,0,0
116496,and,0,0
116497,functional,0,1
116498,scale,0,1
116499,scores,0,0
116500,.,0,1
116501,After,0,0
116502,treatment,0,0
116503,",",0,0
116504,patients,0,1
116505,in,0,0
116506,the,0,0
116507,case,0,0
116508,group,0,0
116509,scored,0,0
116510,better,0,0
116511,than,0,0
116512,patients,0,1
116513,in,0,0
116514,the,0,0
116515,control,0,0
116516,group,0,0
116517,(,0,0
116518,FIM,0,0
116519,total,0,1
116520,score,0,0
116521,",",0,0
116522,P=.02,0,0
116523,;,0,0
116524,FIM,0,0
116525,motor,0,0
116526,subscore,0,0
116527,",",0,0
116528,P=.001,0,0
116529,;,0,0
116530,Tinetti,0,0
116531,scale,0,0
116532,score,0,0
116533,",",0,0
116534,P=.04,0,0
116535,),0,1
116536,;,0,0
116537,patients,0,1
116538,in,0,0
116539,the,0,0
116540,case,0,0
116541,group,0,0
116542,were,0,0
116543,assigned,0,0
116544,more,0,0
116545,frequently,0,0
116546,to,0,0
116547,1,0,0
116548,crutch,0,0
116549,(,0,0
116550,P=.01,0,1
116551,),0,1
116552,.,0,0
116553,CONCLUSIONS,0,0
116554,In,0,0
116555,addition,0,0
116556,to,0,0
116557,conventional,0,0
116558,physiotherapy,0,0
116559,",",0,0
116560,AOT,0,0
116561,is,0,0
116562,effective,0,0
116563,in,0,0
116564,the,0,0
116565,rehabilitation,0,0
116566,of,0,0
116567,postsurgical,1,0
116568,orthopedic,1,1
116569,patients,1,1
116570,.,1,1
116571,The,0,0
116572,present,0,0
116573,results,0,0
116574,strongly,0,0
116575,support,0,0
116576,top-down,0,0
116577,effects,0,0
116578,of,0,0
116579,this,0,0
116580,treatment,0,0
116581,in,0,0
116582,motor,0,0
116583,recovery,0,0
116584,",",0,0
116585,even,0,0
116586,in,0,0
116587,nonneurologic,1,1
116588,patients,1,1
116589,.,1,1
116590,The,0,0
116591,immediate,0,0
116592,efficacy,0,0
116593,of,0,0
116594,adjunctive,0,0
116595,doxycycline,0,0
116596,in,0,0
116597,treatment,0,0
116598,of,0,0
116599,localized,1,1
116600,juvenile,1,1
116601,periodontitis,1,1
116602,.,1,0
116603,A,0,0
116604,randomized,0,0
116605,",",0,0
116606,double-blind,0,0
116607,",",0,0
116608,placebo-controlled,0,0
116609,study,0,0
116610,on,0,0
116611,the,0,0
116612,immediate,0,0
116613,clinical,0,0
116614,and,0,0
116615,microbiological,0,0
116616,efficacy,0,0
116617,of,0,0
116618,doxycycline,0,0
116619,(,0,0
116620,100,0,0
116621,mg,0,0
116622,for,0,0
116623,14,0,1
116624,days,0,0
116625,),0,1
116626,was,0,0
116627,carried,0,0
116628,out,0,0
116629,to,0,0
116630,determine,0,0
116631,the,0,0
116632,benefit,0,0
116633,of,0,0
116634,adjunctive,0,0
116635,medication,0,0
116636,in,0,0
116637,16,1,1
116638,patients,1,1
116639,with,1,1
116640,localized,1,1
116641,juvenile,1,1
116642,periodontitis,1,1
116643,.,1,0
116644,Measurements,0,0
116645,of,0,0
116646,gingival,0,1
116647,fluid,0,0
116648,flow,0,0
116649,",",0,0
116650,probing,0,0
116651,depths,0,0
116652,",",0,0
116653,bleeding,0,0
116654,on,0,0
116655,probing,0,0
116656,and,0,0
116657,suppuration,0,1
116658,were,0,0
116659,determined,0,0
116660,at,0,0
116661,2,0,0
116662,periodontal,0,1
116663,sites,0,0
116664,with,0,1
116665,and,0,1
116666,2,0,0
116667,without,0,1
116668,radiographic,0,1
116669,attachment,0,0
116670,loss,0,0
116671,",",0,0
116672,at,0,0
116673,weeks,0,0
116674,0,0,0
116675,",",0,0
116676,1,0,0
116677,",",0,0
116678,3,0,0
116679,and,0,0
116680,8,0,0
116681,.,0,1
116682,Subgingival,0,0
116683,bacterial,0,0
116684,samples,0,0
116685,were,0,1
116686,taken,0,0
116687,with,0,1
116688,curettes,0,0
116689,from,0,1
116690,the,0,0
116691,same,0,0
116692,sites,0,0
116693,.,0,1
116694,Spirochaetes,0,0
116695,were,0,0
116696,searched,0,1
116697,for,0,0
116698,by,0,0
116699,dark-field,0,0
116700,microscopy,0,0
116701,.,0,1
116702,Actinobacillus,0,0
116703,actinomycetemcomitans,0,0
116704,",",0,0
116705,pigmented,0,1
116706,and,0,0
116707,non-pigmented,0,0
116708,Bacteroides,0,0
116709,spp.,0,1
116710,",",0,0
116711,Capnocytophaga,0,0
116712,",",0,0
116713,Fusobacterium,0,0
116714,and,0,0
116715,Actinomyces,0,1
116716,spp,0,0
116717,.,0,0
116718,were,0,0
116719,cultured,0,0
116720,on,0,0
116721,various,0,0
116722,selective,0,1
116723,and,0,1
116724,non-selective,0,0
116725,media,0,0
116726,.,0,1
116727,Bacterial,0,0
116728,species,0,0
116729,found,0,0
116730,at,0,0
116731,least,0,1
116732,in,0,0
116733,50,0,1
116734,%,0,0
116735,of,0,0
116736,the,0,0
116737,patients,0,1
116738,and,0,0
116739,comprising,0,1
116740,on,0,0
116741,average,0,1
116742,5,0,0
116743,%,0,0
116744,or,0,0
116745,more,0,0
116746,of,0,0
116747,the,0,0
116748,cultivable,0,0
116749,flora,0,1
116750,were,0,1
116751,included,0,1
116752,in,0,0
116753,the,0,0
116754,analysis,0,0
116755,.,0,0
116756,Neither,0,0
116757,short-term,0,0
116758,clinical,0,0
116759,nor,0,0
116760,microbiological,0,0
116761,efficacy,0,0
116762,beyond,0,0
116763,that,0,0
116764,of,0,0
116765,a,0,0
116766,course,0,0
116767,of,0,0
116768,mechanical,0,0
116769,debridement,0,1
116770,alone,0,0
116771,was,0,0
116772,found,0,0
116773,by,0,0
116774,using,0,0
116775,systemic,0,0
116776,medication,0,0
116777,with,0,1
116778,doxycycline,0,0
116779,in,0,0
116780,patients,1,1
116781,with,1,1
116782,localized,1,1
116783,juvenile,1,1
116784,periodontitis,1,1
116785,.,1,1
116786,Tetracaine/adrenaline/cocaine,0,0
116787,for,0,0
116788,local,1,0
116789,anesthesia,1,1
116790,.,1,1
116791,The,0,0
116792,use,0,0
116793,of,0,0
116794,vitamin,0,0
116795,E,0,0
116796,for,0,0
116797,the,0,0
116798,prevention,0,0
116799,of,0,0
116800,chemotherapy-induced,0,1
116801,peripheral,0,1
116802,neuropathy,0,1
116803,:,0,1
116804,results,0,0
116805,of,0,0
116806,a,0,0
116807,randomized,0,0
116808,phase,0,1
116809,III,0,1
116810,clinical,0,0
116811,trial,0,1
116812,.,0,1
116813,BACKGROUND,0,0
116814,Chemotherapy-induced,0,0
116815,peripheral,0,1
116816,neuropathy,0,1
116817,(,0,0
116818,CIPN,0,0
116819,),0,0
116820,continues,0,0
116821,to,0,0
116822,be,0,0
116823,a,0,0
116824,substantial,0,0
116825,problem,0,0
116826,for,0,0
116827,many,0,0
116828,cancer,1,1
116829,patients,1,1
116830,.,1,1
116831,Pursuant,0,0
116832,to,0,0
116833,promising,0,0
116834,appearing,0,0
116835,pilot,0,0
116836,data,0,0
116837,",",0,0
116838,the,0,0
116839,current,0,0
116840,study,0,0
116841,evaluated,0,0
116842,the,0,0
116843,use,0,0
116844,of,0,0
116845,vitamin,0,0
116846,E,0,0
116847,for,0,0
116848,the,0,0
116849,prevention,0,0
116850,of,0,0
116851,CIPN,0,0
116852,.,0,1
116853,METHODS,0,0
116854,A,0,0
116855,phase,0,0
116856,III,0,0
116857,",",0,0
116858,randomized,0,0
116859,",",0,0
116860,double-blind,0,0
116861,",",0,0
116862,placebo-controlled,0,0
116863,study,0,0
116864,was,0,0
116865,conducted,0,0
116866,in,0,0
116867,patients,1,1
116868,undergoing,1,1
116869,therapy,1,0
116870,with,1,1
116871,neurotoxic,1,0
116872,chemotherapy,1,0
116873,",",0,0
116874,utilizing,0,0
116875,twice,0,0
116876,daily,0,0
116877,dosing,0,0
116878,of,0,0
116879,vitamin,0,0
116880,E,0,0
116881,(,0,0
116882,400,0,0
116883,mg,0,0
116884,),0,0
116885,/placebo,0,0
116886,.,0,0
116887,The,0,0
116888,primary,0,0
116889,endpoint,0,0
116890,was,0,0
116891,the,0,0
116892,incidence,0,0
116893,of,0,0
116894,grade,0,1
116895,2+,0,0
116896,sensory,0,0
116897,neuropathy,0,1
116898,(,0,0
116899,SN,0,0
116900,),0,0
116901,toxicity,0,0
116902,(,0,0
116903,CTCAE,0,0
116904,v,0,0
116905,3.0,0,0
116906,),0,0
116907,in,0,0
116908,each,0,0
116909,treatment,0,0
116910,arm,0,0
116911,",",0,0
116912,analyzed,0,0
116913,by,0,0
116914,chi-square,0,0
116915,testing,0,0
116916,.,0,0
116917,Planned,0,0
116918,sample,0,1
116919,size,0,0
116920,was,0,0
116921,100,1,0
116922,patients,1,1
116923,per,1,0
116924,arm,1,1
116925,to,0,0
116926,provide,0,0
116927,80,0,1
116928,%,0,0
116929,power,0,0
116930,to,0,0
116931,detect,0,0
116932,a,0,0
116933,difference,0,0
116934,in,0,0
116935,incidence,0,0
116936,of,0,0
116937,grade,0,1
116938,2+,0,1
116939,SN,0,0
116940,toxicity,0,0
116941,from,0,1
116942,25,0,0
116943,%,0,0
116944,in,0,0
116945,the,0,0
116946,placebo,0,0
116947,group,0,0
116948,to,0,0
116949,10,0,0
116950,%,0,0
116951,in,0,0
116952,the,0,0
116953,vitamin,0,0
116954,E,0,0
116955,group,0,0
116956,.,0,1
116957,RESULTS,0,0
116958,Two-hundred,1,1
116959,seven,1,1
116960,patients,1,1
116961,were,1,1
116962,enrolled,1,1
116963,between,1,0
116964,December,1,1
116965,1,1,0
116966,",",1,0
116967,2006,1,1
116968,and,1,0
116969,December,1,1
116970,14,1,0
116971,",",1,0
116972,2007,1,1
116973,",",1,0
116974,producing,1,0
116975,189,1,1
116976,evaluable,1,1
116977,cases,1,1
116978,for,1,0
116979,analysis,1,0
116980,.,1,1
116981,Cytotoxic,0,0
116982,agents,0,0
116983,included,0,1
116984,taxanes,0,0
116985,(,0,1
116986,109,0,1
116987,),0,0
116988,",",0,0
116989,cisplatin,0,0
116990,(,0,0
116991,8,0,0
116992,),0,0
116993,",",0,0
116994,carboplatin,0,0
116995,(,0,0
116996,2,0,0
116997,),0,0
116998,",",0,0
116999,oxaliplatin,0,0
117000,(,0,0
117001,50,0,1
117002,),0,0
117003,",",0,0
117004,or,0,0
117005,combination,0,0
117006,(,0,0
117007,20,0,1
117008,),0,0
117009,.,0,0
117010,There,0,0
117011,was,0,0
117012,no,0,0
117013,difference,0,0
117014,in,0,0
117015,the,0,0
117016,incidence,0,0
117017,of,0,0
117018,grade,0,1
117019,2+,0,0
117020,SN,0,0
117021,between,0,0
117022,the,0,0
117023,two,0,0
117024,arms,0,0
117025,(,0,1
117026,34,0,1
117027,%,0,0
117028,-vitamin,0,0
117029,E,0,0
117030,",",0,0
117031,29,0,1
117032,%,0,0
117033,-placebo,0,0
117034,;,0,0
117035,P,0,0
117036,=,0,0
117037,0.43,0,0
117038,),0,0
117039,.,0,0
117040,There,0,0
117041,were,0,0
117042,no,0,0
117043,significant,0,0
117044,differences,0,0
117045,between,0,0
117046,treatment,0,0
117047,arms,0,0
117048,for,0,0
117049,time,0,0
117050,to,0,0
117051,onset,0,0
117052,of,0,0
117053,neuropathy,0,1
117054,(,0,1
117055,P,0,0
117056,=,0,0
117057,0.58,0,0
117058,),0,0
117059,",",0,0
117060,for,0,0
117061,chemotherapy,0,0
117062,dose,0,0
117063,reductions,0,0
117064,due,0,1
117065,to,0,1
117066,neuropathy,0,1
117067,(,0,0
117068,P,0,0
117069,=,0,0
117070,0.21,0,0
117071,),0,0
117072,",",0,0
117073,or,0,0
117074,for,0,0
117075,secondary,0,1
117076,endpoints,0,0
117077,derived,0,1
117078,from,0,1
117079,patient-reported,0,0
117080,neuropathy,0,1
117081,symptom,0,1
117082,assessments,0,0
117083,.,0,0
117084,The,0,0
117085,treatment,0,0
117086,was,0,0
117087,well,0,0
117088,tolerated,0,0
117089,overall,0,0
117090,.,0,1
117091,CONCLUSIONS,0,0
117092,Vitamin,0,0
117093,E,0,0
117094,did,0,0
117095,not,0,0
117096,appear,0,0
117097,to,0,0
117098,reduce,0,0
117099,the,0,0
117100,incidence,0,0
117101,of,0,0
117102,sensory,0,0
117103,neuropathy,0,1
117104,in,0,0
117105,the,0,0
117106,studied,0,0
117107,group,1,0
117108,of,1,0
117109,patients,1,1
117110,receiving,1,1
117111,neurotoxic,1,0
117112,chemotherapy,1,1
117113,.,1,1
117114,Ipilimumab,0,0
117115,efficacy,0,0
117116,and,0,0
117117,safety,0,0
117118,in,0,0
117119,patients,1,1
117120,with,1,1
117121,advanced,1,1
117122,melanoma,1,1
117123,:,1,1
117124,a,0,0
117125,retrospective,0,0
117126,analysis,0,0
117127,of,0,0
117128,HLA,0,1
117129,subtype,0,1
117130,from,0,1
117131,four,0,1
117132,trials,0,1
117133,.,0,1
117134,Ipilimumab,0,0
117135,is,0,0
117136,a,0,0
117137,fully,0,0
117138,human,0,0
117139,",",0,0
117140,monoclonal,0,0
117141,antibody,0,0
117142,that,0,0
117143,blocks,0,0
117144,cytotoxic,0,0
117145,T-lymphocyte,0,0
117146,antigen-4,0,0
117147,to,0,0
117148,potentiate,0,0
117149,an,0,0
117150,antitumor,0,0
117151,T-cell,0,1
117152,response,0,0
117153,.,0,0
117154,This,0,0
117155,agent,0,0
117156,improved,0,0
117157,overall,0,0
117158,survival,0,0
117159,in,0,0
117160,a,0,0
117161,phase,0,0
117162,III,0,0
117163,trial,0,0
117164,in,0,0
117165,previously,1,1
117166,treated,1,1
117167,patients,1,1
117168,with,1,1
117169,advanced,1,1
117170,melanoma,1,1
117171,.,1,0
117172,Because,0,0
117173,the,0,0
117174,mechanism,0,0
117175,of,0,0
117176,action,0,0
117177,for,0,0
117178,ipilimumab,0,0
117179,is,0,0
117180,thought,0,0
117181,to,0,0
117182,be,0,0
117183,HLA,0,1
117184,independent,0,0
117185,",",0,0
117186,most,0,0
117187,trials,0,0
117188,enrolled,1,1
117189,patients,1,1
117190,without,1,1
117191,regard,1,0
117192,to,1,0
117193,HLA,1,1
117194,subtype,1,1
117195,.,1,0
117196,However,0,0
117197,",",0,0
117198,enrollment,0,0
117199,in,0,0
117200,the,0,0
117201,phase,0,0
117202,III,0,0
117203,trial,0,0
117204,was,0,0
117205,restricted,0,0
117206,to,0,0
117207,class-I,1,1
117208,HLA-A*0201-positive,1,1
117209,patients,1,1
117210,because,0,0
117211,two,0,0
117212,of,0,0
117213,the,0,0
117214,three,0,0
117215,arms,0,0
117216,contained,0,0
117217,an,0,0
117218,HLA-A*0201-restricted,0,0
117219,gp100,0,0
117220,vaccine,0,0
117221,.,0,0
117222,HLA,0,0
117223,typing,0,0
117224,was,0,0
117225,also,0,0
117226,performed,0,0
117227,prospectively,0,0
117228,in,0,0
117229,several,0,0
117230,phase,0,1
117231,II,0,1
117232,trials,0,0
117233,and,0,0
117234,was,0,0
117235,available,0,0
117236,for,0,0
117237,93.5,1,0
117238,%,1,0
117239,of,1,0
117240,patients,1,1
117241,.,1,1
117242,In,0,0
117243,this,0,0
117244,retrospective,0,0
117245,analysis,0,0
117246,",",0,0
117247,pooled,0,0
117248,efficacy,0,0
117249,and,0,0
117250,safety,0,0
117251,data,0,0
117252,are,0,0
117253,presented,0,0
117254,according,0,0
117255,to,0,0
117256,HLA-A*0201,0,0
117257,status,0,0
117258,and,0,0
117259,dose,0,0
117260,from,0,1
117261,pretreated,1,1
117262,patients,1,1
117263,randomized,0,1
117264,to,0,0
117265,0.3,0,0
117266,",",0,0
117267,3,0,0
117268,",",0,0
117269,or,0,1
117270,10,0,0
117271,mg/kg,0,0
117272,ipilimumab,0,1
117273,in,0,0
117274,four,0,1
117275,phase,0,1
117276,II,0,1
117277,trials,0,0
117278,.,0,1
117279,Median,0,0
117280,overall,0,0
117281,survival,0,0
117282,(,0,0
117283,OS,0,0
117284,),0,0
117285,was,0,0
117286,similar,0,0
117287,for,0,0
117288,the,0,0
117289,187,0,1
117290,HLA-A*0201-positive,0,1
117291,[,0,0
117292,9.3,0,1
117293,months,0,0
117294,",",0,1
117295,95,0,0
117296,%,0,0
117297,CI,0,0
117298,(,0,0
117299,confidence,0,0
117300,interval,0,0
117301,),0,0
117302,7.4-11.5,0,0
117303,],0,1
117304,and,0,0
117305,266,0,1
117306,HLA-A*0201-negative,1,1
117307,patients,1,1
117308,[,0,1
117309,11.4,0,0
117310,months,0,0
117311,",",0,1
117312,95,0,0
117313,%,0,0
117314,CI,0,0
117315,9.3-15.1,0,0
117316,],0,1
117317,randomized,0,1
117318,to,0,0
117319,ipilimumab,0,0
117320,at,0,0
117321,all,0,0
117322,doses,0,0
117323,across,0,0
117324,the,0,0
117325,four,0,0
117326,phase,0,1
117327,II,0,1
117328,trials,0,0
117329,.,0,1
117330,These,0,0
117331,data,0,0
117332,are,0,0
117333,comparable,0,0
117334,to,0,0
117335,the,0,0
117336,OS,0,0
117337,for,0,0
117338,the,0,0
117339,137,1,1
117340,HLA-A*0201-positive,1,1
117341,patients,1,1
117342,randomized,0,1
117343,to,0,0
117344,ipilimumab,0,0
117345,in,0,0
117346,the,0,0
117347,phase,0,0
117348,III,0,0
117349,study,0,0
117350,[,0,0
117351,10.1,0,0
117352,months,0,0
117353,",",0,1
117354,95,0,0
117355,%,0,0
117356,CI,0,0
117357,8.0-13.8,0,0
117358,],0,1
117359,.,0,1
117360,Ipilimumab-induced,0,0
117361,adverse,0,0
117362,events,0,0
117363,and,0,1
117364,immune-related,0,1
117365,adverse,0,0
117366,events,0,0
117367,(,0,0
117368,skin,0,0
117369,",",0,0
117370,gastrointestinal,0,1
117371,",",0,0
117372,hepatic,0,0
117373,",",0,0
117374,other,0,0
117375,),0,0
117376,also,0,0
117377,occurred,0,0
117378,at,0,0
117379,similar,0,0
117380,frequencies,0,0
117381,among,0,1
117382,patients,0,1
117383,in,0,0
117384,the,0,0
117385,phase,0,0
117386,II,0,0
117387,and,0,0
117388,III,0,1
117389,trials,0,0
117390,",",0,0
117391,regardless,0,0
117392,of,0,0
117393,HLA-A*0201,0,0
117394,status,0,1
117395,.,0,0
117396,These,0,0
117397,findings,0,0
117398,support,0,0
117399,the,0,0
117400,hypothesis,0,0
117401,that,0,0
117402,ipilimumab-treated,1,1
117403,patients,1,1
117404,with,0,1
117405,advanced,0,1
117406,melanoma,0,1
117407,have,0,1
117408,similar,0,0
117409,outcomes,0,0
117410,regardless,0,1
117411,of,0,0
117412,their,0,0
117413,HLA-A*0201,0,0
117414,status,0,1
117415,.,0,1
117416,Complement,0,0
117417,activation,0,0
117418,on,0,0
117419,the,0,0
117420,surface,0,0
117421,of,0,0
117422,cell-derived,0,1
117423,microparticles,0,0
117424,during,0,0
117425,cardiac,1,1
117426,surgery,1,1
117427,with,1,1
117428,cardiopulmonary,1,1
117429,bypass,1,1
117430,-,0,0
117431,is,0,0
117432,retransfusion,0,0
117433,of,0,0
117434,pericardial,0,0
117435,blood,0,0
117436,harmful,0,0
117437,?,0,0
117438,OBJECTIVES,0,0
117439,To,0,0
117440,investigate,0,0
117441,whether,0,0
117442,cell-derived,0,1
117443,microparticles,0,0
117444,play,0,0
117445,a,0,0
117446,role,0,0
117447,in,0,0
117448,complement,0,0
117449,activation,0,0
117450,in,0,0
117451,pericardial,0,0
117452,blood,0,0
117453,of,0,0
117454,patients,1,1
117455,undergoing,1,1
117456,cardiac,1,1
117457,surgery,1,1
117458,with,1,1
117459,cardiopulmonary,1,1
117460,bypass,1,1
117461,(,1,0
117462,CPB,1,0
117463,),1,0
117464,and,0,0
117465,whether,0,0
117466,microparticles,0,0
117467,in,0,0
117468,pericardial,0,1
117469,blood,0,0
117470,contribute,0,0
117471,to,0,0
117472,systemic,0,0
117473,complement,0,0
117474,activation,0,0
117475,upon,0,0
117476,retransfusion,0,0
117477,.,0,1
117478,METHODS,0,0
117479,Pericardial,1,1
117480,blood,1,0
117481,of,1,0
117482,13,1,1
117483,patients,1,1
117484,was,0,0
117485,retransfused,0,0
117486,in,0,0
117487,9,0,0
117488,and,0,0
117489,discarded,0,0
117490,in,0,0
117491,4,0,0
117492,cases,0,1
117493,.,0,1
117494,Microparticles,0,0
117495,were,0,0
117496,isolated,0,1
117497,from,0,0
117498,systemic,0,0
117499,blood,0,0
117500,collected,0,0
117501,before,0,0
117502,anesthesia,0,1
117503,(,0,0
117504,T1,0,0
117505,),0,0
117506,and,0,0
117507,at,0,0
117508,the,0,0
117509,end,0,0
117510,of,0,0
117511,CPB,0,0
117512,(,0,1
117513,T2,0,1
117514,),0,0
117515,",",0,0
117516,and,0,0
117517,from,0,0
117518,pericardial,0,0
117519,blood,0,0
117520,.,0,0
117521,The,0,0
117522,microparticles,0,0
117523,were,0,0
117524,analyzed,0,0
117525,by,0,0
117526,flow,0,0
117527,cytometry,0,0
117528,for,0,0
117529,bound,0,0
117530,complement,0,0
117531,components,0,0
117532,C1q,0,1
117533,",",0,0
117534,C4,0,0
117535,and,0,0
117536,C3,0,1
117537,",",0,0
117538,and,0,0
117539,bound,0,0
117540,complement,0,0
117541,activator,0,0
117542,molecules,0,0
117543,C-reactive,0,0
117544,protein,0,0
117545,(,0,0
117546,CRP,0,0
117547,),0,0
117548,",",0,0
117549,serum,0,0
117550,amyloid,0,0
117551,P-component,0,0
117552,(,0,0
117553,SAP,0,1
117554,),0,0
117555,",",0,0
117556,immunoglobulin,0,0
117557,(,0,0
117558,Ig,0,1
117559,),0,0
117560,M,0,0
117561,and,0,0
117562,IgG,0,0
117563,.,0,1
117564,Fluid-phase,0,0
117565,complement,0,0
117566,activation,0,0
117567,products,0,0
117568,(,0,0
117569,C4b/c,0,0
117570,",",0,0
117571,C3b/c,0,0
117572,),0,0
117573,and,0,0
117574,activator,0,0
117575,molecules,0,0
117576,were,0,1
117577,determined,0,0
117578,by,0,0
117579,ELISA,0,1
117580,.,0,1
117581,RESULTS,0,0
117582,Compared,0,0
117583,with,0,1
117584,systemic,0,0
117585,T1,0,0
117586,blood,0,0
117587,",",0,0
117588,pericardial,0,0
117589,blood,0,0
117590,contained,0,0
117591,increased,0,0
117592,C4b/c,0,0
117593,and,0,0
117594,C3b/c,0,0
117595,",",0,0
117596,and,0,0
117597,increased,0,0
117598,levels,0,0
117599,of,0,0
117600,microparticles,0,0
117601,with,0,1
117602,bound,0,0
117603,complement,0,0
117604,components,0,0
117605,.,0,1
117606,In,0,0
117607,systemic,0,0
117608,T1,0,0
117609,samples,0,0
117610,",",0,0
117611,microparticle-bound,0,0
117612,CRP,0,0
117613,",",0,0
117614,whereas,0,0
117615,in,0,0
117616,pericardial,0,0
117617,blood,0,0
117618,",",0,0
117619,microparticle-bound,0,0
117620,SAP,0,1
117621,and,0,0
117622,IgM,0,0
117623,were,0,0
117624,associated,0,0
117625,with,0,1
117626,complement,0,0
117627,activation,0,0
117628,.,0,0
117629,At,0,0
117630,the,0,0
117631,end,0,0
117632,of,0,0
117633,CPB,0,0
117634,",",0,0
117635,increased,0,0
117636,C3b/c,0,0
117637,(,0,0
117638,but,0,0
117639,not,0,0
117640,C4b/c,0,0
117641,),0,0
117642,was,0,0
117643,present,0,0
117644,in,0,0
117645,systemic,0,0
117646,T2,0,1
117647,blood,0,0
117648,compared,0,0
117649,with,0,1
117650,T1,0,0
117651,",",0,0
117652,while,0,0
117653,concentrations,0,0
117654,of,0,1
117655,microparticles,0,0
117656,binding,0,0
117657,complement,0,0
117658,components,0,0
117659,and,0,0
117660,of,0,0
117661,those,0,0
117662,binding,0,0
117663,complement,0,0
117664,activator,0,1
117665,molecules,0,0
117666,were,0,1
117667,similar,0,0
117668,.,0,1
117669,Concentrations,0,0
117670,of,0,0
117671,fluid-phase,0,0
117672,complement,0,0
117673,activation,0,0
117674,products,0,0
117675,and,0,1
117676,microparticles,0,0
117677,were,0,1
117678,similar,0,0
117679,in,0,0
117680,patients,0,1
117681,whether,0,0
117682,or,0,1
117683,not,0,0
117684,retransfused,0,0
117685,with,0,1
117686,pericardial,0,0
117687,blood,0,0
117688,.,0,0
117689,CONCLUSIONS,0,0
117690,In,0,0
117691,pericardial,0,0
117692,blood,0,0
117693,of,0,0
117694,patients,1,1
117695,undergoing,1,1
117696,cardiac,1,1
117697,surgery,1,1
117698,with,1,1
117699,CPB,1,0
117700,",",0,0
117701,microparticles,0,0
117702,contribute,0,0
117703,to,0,0
117704,activation,0,0
117705,of,0,0
117706,the,0,0
117707,complement,0,0
117708,system,0,0
117709,via,0,0
117710,bound,0,0
117711,SAP,0,1
117712,and,0,0
117713,IgM,0,0
117714,.,0,0
117715,Retransfusion,0,0
117716,of,0,0
117717,pericardial,0,0
117718,blood,0,0
117719,",",0,0
117720,however,0,0
117721,",",0,0
117722,does,0,0
117723,not,0,0
117724,contribute,0,0
117725,to,0,0
117726,systemic,0,0
117727,complement,0,0
117728,activation,0,0
117729,.,0,1
117730,Theory,0,0
117731,of,0,0
117732,Mind,0,0
117733,training,0,0
117734,in,0,0
117735,children,1,1
117736,with,1,1
117737,autism,1,1
117738,:,1,1
117739,a,0,0
117740,randomized,0,0
117741,controlled,0,0
117742,trial,0,0
117743,.,0,1
117744,Many,0,0
117745,children,1,1
117746,with,1,1
117747,Autism,1,1
117748,Spectrum,1,1
117749,Disorders,1,1
117750,(,1,0
117751,ASD,1,1
117752,),1,0
117753,participate,0,1
117754,in,0,0
117755,social,0,0
117756,skills,0,0
117757,or,0,1
117758,Theory,0,0
117759,of,0,0
117760,Mind,0,0
117761,(,0,1
117762,ToM,0,0
117763,),0,1
117764,treatments,0,0
117765,.,0,0
117766,However,0,0
117767,",",0,0
117768,few,0,0
117769,studies,0,0
117770,have,0,0
117771,shown,0,0
117772,evidence,0,0
117773,for,0,0
117774,their,0,0
117775,effectiveness,0,0
117776,.,0,0
117777,The,0,0
117778,current,0,0
117779,study,0,0
117780,used,0,0
117781,a,0,0
117782,randomized,0,0
117783,controlled,0,0
117784,design,0,0
117785,to,0,0
117786,test,0,0
117787,the,0,0
117788,effectiveness,0,0
117789,of,0,0
117790,a,0,0
117791,16-week,0,0
117792,ToM,0,0
117793,treatment,0,0
117794,in,0,0
117795,8-13,1,1
117796,year,1,1
117797,old,1,1
117798,children,1,1
117799,with,1,1
117800,ASD,1,1
117801,and,1,1
117802,normal,1,1
117803,IQs,1,1
117804,(,1,1
117805,n,1,1
117806,=,1,0
117807,40,1,1
117808,),1,0
117809,.,1,1
117810,The,1,0
117811,results,0,0
117812,showed,0,0
117813,that,0,0
117814,",",0,0
117815,compared,0,0
117816,to,0,0
117817,controls,0,1
117818,",",0,0
117819,the,0,0
117820,treated,0,1
117821,children,0,1
117822,with,0,1
117823,ASD,0,1
117824,improved,0,0
117825,in,0,0
117826,their,0,0
117827,conceptual,0,0
117828,ToM,0,0
117829,skills,0,0
117830,",",0,0
117831,but,0,0
117832,their,0,0
117833,elementary,0,1
117834,understanding,0,0
117835,",",0,0
117836,self,0,0
117837,reported,0,0
117838,empathic,0,0
117839,skills,0,0
117840,or,0,1
117841,parent,0,1
117842,reported,0,0
117843,social,0,0
117844,behaviour,0,0
117845,did,0,0
117846,not,0,0
117847,improve,0,0
117848,.,0,0
117849,Despite,0,0
117850,the,0,0
117851,effects,0,0
117852,on,0,0
117853,conceptual,0,0
117854,understanding,0,0
117855,",",0,0
117856,the,0,0
117857,current,0,0
117858,study,0,0
117859,does,0,0
117860,not,0,0
117861,indicate,0,0
117862,strong,0,0
117863,evidence,0,0
117864,for,0,0
117865,the,0,0
117866,effectiveness,0,0
117867,of,0,0
117868,a,0,0
117869,ToM,0,0
117870,treatment,0,0
117871,on,0,0
117872,the,0,0
117873,daily,0,0
117874,life,0,0
117875,mindreading,0,1
117876,skills,0,0
117877,.,0,1
117878,Gene,0,0
117879,expression,0,0
117880,of,0,0
117881,endothelin-1,0,0
117882,and,0,0
117883,its,0,0
117884,receptors,0,0
117885,in,0,0
117886,the,0,0
117887,heart,1,1
117888,of,1,0
117889,broiler,1,1
117890,chickens,1,1
117891,with,1,1
117892,T,1,1
117893,(,1,1
117894,3,1,0
117895,),1,0
117896,-induced,1,0
117897,pulmonary,1,1
117898,hypertension,1,1
117899,.,1,0
117900,To,0,0
117901,investigate,0,0
117902,the,0,0
117903,effect,0,0
117904,of,0,0
117905,T,0,1
117906,(,0,1
117907,3,0,0
117908,),0,0
117909,-induced,0,0
117910,pulmonary,0,1
117911,hypertension,0,1
117912,on,0,0
117913,endothelin,0,0
117914,(,0,0
117915,ET,0,0
117916,),0,0
117917,production,0,0
117918,and,0,0
117919,genes,0,0
117920,expression,0,0
117921,of,0,0
117922,ET-1,0,0
117923,",",0,0
117924,ET,0,0
117925,(,0,0
117926,A,0,1
117927,),0,0
117928,and,0,0
117929,ET,0,0
117930,(,0,0
117931,B,0,1
117932,),0,1
117933,receptors,0,0
117934,(,0,1
117935,ET,0,0
117936,(,0,0
117937,A,0,1
117938,),0,0
117939,R,0,1
117940,and,0,0
117941,ET,0,0
117942,(,0,0
117943,B,0,1
117944,),0,1
117945,R,0,1
117946,),0,0
117947,during,0,0
117948,rearing,0,0
117949,",",0,0
117950,semiquantitative,0,0
117951,RT-PCR,0,0
117952,and,0,0
117953,enzyme,0,0
117954,immunometric,0,0
117955,assay,0,0
117956,were,0,0
117957,performed,0,0
117958,in,0,0
117959,the,0,0
117960,heart,0,1
117961,ventricles,0,0
117962,and,0,0
117963,serum,0,0
117964,",",0,0
117965,respectively,0,0
117966,.,0,0
117967,The,0,0
117968,ET-1,0,0
117969,and,0,0
117970,its,0,0
117971,receptor,0,0
117972,genes,0,0
117973,were,0,0
117974,expressed,0,0
117975,in,0,0
117976,the,0,0
117977,right,0,0
117978,and,0,0
117979,left,0,1
117980,ventricles,0,0
117981,of,0,0
117982,control,0,1
117983,and,0,0
117984,T,0,1
117985,(,0,0
117986,3,0,0
117987,),0,0
117988,-treated,0,0
117989,broilers,0,0
117990,at,0,0
117991,12,0,1
117992,",",0,0
117993,28,0,1
117994,and,0,0
117995,49,0,1
117996,days,0,0
117997,of,0,1
117998,age,0,1
117999,.,0,0
118000,There,0,0
118001,were,0,0
118002,significant,0,0
118003,(,0,1
118004,P,0,0
118005,<,0,0
118006,0.05,0,0
118007,),0,1
118008,reductions,0,0
118009,of,0,0
118010,the,0,0
118011,relative,0,0
118012,amounts,0,0
118013,of,0,0
118014,ET-1,0,0
118015,(,0,0
118016,in,0,0
118017,both,0,0
118018,ventricles,0,0
118019,),0,0
118020,and,0,0
118021,ET,0,0
118022,(,0,0
118023,A,0,1
118024,),0,0
118025,R,0,1
118026,(,0,0
118027,in,0,0
118028,the,0,0
118029,right,0,0
118030,ventricle,0,0
118031,),0,0
118032,mRNAs,0,0
118033,at,0,0
118034,28,0,1
118035,and,0,1
118036,49,0,1
118037,days,0,0
118038,of,0,0
118039,age,0,1
118040,",",0,0
118041,in,0,0
118042,T,0,1
118043,(,0,1
118044,3,0,0
118045,),0,0
118046,-treated,0,0
118047,broilers,0,0
118048,compared,0,0
118049,to,0,1
118050,controls,0,1
118051,.,0,1
118052,The,0,0
118053,relative,0,0
118054,amounts,0,0
118055,of,0,0
118056,ET,0,1
118057,(,0,1
118058,B,0,1
118059,),0,0
118060,R,0,1
118061,mRNA,0,0
118062,in,0,0
118063,the,0,0
118064,right,0,0
118065,and,0,0
118066,left,0,1
118067,ventricles,0,0
118068,did,0,0
118069,not,0,0
118070,significantly,0,0
118071,differ,0,0
118072,between,0,0
118073,control,0,0
118074,and,0,0
118075,T,0,1
118076,(,0,0
118077,3,0,0
118078,),0,0
118079,-treated,0,0
118080,broilers,0,0
118081,at,0,0
118082,any,0,0
118083,age,0,1
118084,.,0,0
118085,The,0,0
118086,serum,0,0
118087,level,0,0
118088,of,0,0
118089,ET,0,0
118090,was,0,0
118091,significantly,0,0
118092,(,0,0
118093,P,0,0
118094,<,0,0
118095,0.05,0,0
118096,),0,0
118097,increased,0,0
118098,in,0,0
118099,T,0,1
118100,(,0,1
118101,3,0,0
118102,),0,0
118103,-treated,0,0
118104,chickens,0,1
118105,at,0,1
118106,28,0,1
118107,and,0,1
118108,49,0,1
118109,days,0,0
118110,of,0,0
118111,age,0,1
118112,when,0,0
118113,compared,0,0
118114,with,0,0
118115,that,0,0
118116,of,0,0
118117,the,0,0
118118,control,0,0
118119,.,0,0
118120,It,0,0
118121,is,0,0
118122,concluded,0,0
118123,that,0,0
118124,ET-1,0,0
118125,",",0,0
118126,ET,0,0
118127,(,0,0
118128,A,0,1
118129,),0,0
118130,R,0,1
118131,and,0,0
118132,ET,0,0
118133,(,0,0
118134,B,0,1
118135,),0,1
118136,R,0,1
118137,genes,0,0
118138,are,0,0
118139,normally,0,1
118140,expressed,0,0
118141,in,0,0
118142,the,0,0
118143,heart,0,1
118144,ventricles,0,0
118145,of,0,1
118146,broilers,0,1
118147,.,0,0
118148,It,0,0
118149,is,0,0
118150,likely,0,0
118151,that,0,0
118152,increased,0,0
118153,serum,0,0
118154,level,0,0
118155,of,0,0
118156,ET,0,0
118157,and,0,0
118158,decreased,0,0
118159,ET-1/ET,0,0
118160,(,0,0
118161,A,0,1
118162,),0,1
118163,R,0,1
118164,genes,0,0
118165,expression,0,0
118166,in,0,0
118167,the,0,0
118168,ventricles,0,0
118169,are,0,0
118170,involved,0,0
118171,in,0,0
118172,the,0,0
118173,heart,0,1
118174,dysfunction,0,0
118175,of,0,0
118176,broiler,1,1
118177,chickens,1,1
118178,with,1,1
118179,developmental,1,1
118180,pulmonary,1,1
118181,hypertension,1,1
118182,.,1,1
118183,PDE5,0,1
118184,inhibition,0,0
118185,with,0,1
118186,sildenafil,0,0
118187,improves,0,0
118188,left,0,1
118189,ventricular,0,1
118190,diastolic,0,1
118191,function,0,0
118192,",",0,0
118193,cardiac,0,1
118194,geometry,0,0
118195,",",0,0
118196,and,0,0
118197,clinical,0,0
118198,status,0,1
118199,in,0,0
118200,patients,1,1
118201,with,1,1
118202,stable,1,1
118203,systolic,1,1
118204,heart,1,1
118205,failure,1,1
118206,:,1,1
118207,results,0,0
118208,of,0,0
118209,a,0,0
118210,1-year,0,0
118211,",",0,0
118212,prospective,0,0
118213,",",0,0
118214,randomized,0,0
118215,",",0,0
118216,placebo-controlled,0,0
118217,study,0,0
118218,.,0,0
118219,BACKGROUND,0,0
118220,In,0,0
118221,heart,0,1
118222,failure,0,1
118223,(,0,0
118224,HF,0,0
118225,),0,0
118226,",",0,0
118227,a,0,0
118228,defective,0,0
118229,nitric,0,0
118230,oxide,0,0
118231,signaling,0,0
118232,is,0,0
118233,involved,0,0
118234,in,0,0
118235,left,0,1
118236,ventricular,0,1
118237,(,0,0
118238,LV,0,1
118239,),0,0
118240,diastolic,0,1
118241,abnormalities,0,1
118242,and,0,0
118243,remodeling,0,0
118244,.,0,0
118245,PDE5,0,0
118246,inhibition,0,0
118247,",",0,0
118248,by,0,0
118249,blocking,0,0
118250,degradation,0,0
118251,of,0,0
118252,nitric,0,0
118253,oxide,0,0
118254,second-messenger,0,0
118255,cyclic,0,0
118256,guanosine,0,0
118257,monophosphate,0,0
118258,",",0,0
118259,might,0,0
118260,be,0,0
118261,beneficial,0,0
118262,.,0,0
118263,In,0,0
118264,a,0,0
118265,cohort,0,1
118266,of,0,0
118267,systolic,1,1
118268,HF,1,1
118269,patients,1,1
118270,",",0,0
118271,we,0,0
118272,tested,0,0
118273,the,0,0
118274,effects,0,0
118275,of,0,0
118276,PDE5,0,1
118277,inhibition,0,0
118278,(,0,0
118279,sildenafil,0,0
118280,),0,0
118281,on,0,0
118282,LV,0,1
118283,ejection,0,1
118284,fraction,0,0
118285,",",0,0
118286,diastolic,0,0
118287,function,0,0
118288,",",0,0
118289,cardiac,0,1
118290,geometry,0,0
118291,",",0,0
118292,and,0,0
118293,clinical,0,0
118294,status,0,1
118295,.,0,1
118296,METHODS,0,0
118297,AND,0,0
118298,RESULTS,0,0
118299,Forty-five,1,1
118300,HF,1,1
118301,patients,1,1
118302,(,1,1
118303,New,1,1
118304,York,1,1
118305,Heart,1,1
118306,Association,1,0
118307,class,1,1
118308,II-III,1,1
118309,),1,0
118310,were,0,0
118311,randomly,0,1
118312,assigned,0,0
118313,to,0,0
118314,placebo,0,0
118315,or,0,0
118316,sildenafil,0,0
118317,(,0,0
118318,50,0,1
118319,mg,0,0
118320,three,0,0
118321,times,0,0
118322,per,0,1
118323,day,0,0
118324,),0,0
118325,for,0,0
118326,1,0,0
118327,year,0,0
118328,",",0,0
118329,with,0,0
118330,assessment,0,0
118331,(,0,1
118332,6,0,0
118333,months,0,0
118334,and,0,1
118335,1,0,0
118336,year,0,0
118337,),0,0
118338,of,0,0
118339,LV,0,1
118340,ejection,0,1
118341,fraction,0,0
118342,",",0,0
118343,diastolic,0,0
118344,function,0,0
118345,",",0,0
118346,geometry,0,0
118347,",",0,0
118348,cardiopulmonary,0,1
118349,exercise,0,0
118350,performance,0,0
118351,",",0,0
118352,and,0,0
118353,quality,0,0
118354,of,0,0
118355,life,0,0
118356,.,0,0
118357,In,0,0
118358,the,0,0
118359,sildenafil,0,0
118360,group,0,0
118361,only,0,0
118362,",",0,0
118363,at,0,0
118364,6,0,0
118365,months,0,0
118366,and,0,1
118367,1,0,0
118368,year,0,0
118369,",",0,0
118370,LV,0,0
118371,ejection,0,1
118372,fraction,0,0
118373,",",0,0
118374,early,0,0
118375,diastolic,0,1
118376,tissue,0,0
118377,Doppler,0,1
118378,velocities,0,0
118379,(,0,1
118380,E,0,0
118381,',0,1
118382,),0,0
118383,at,0,0
118384,the,0,0
118385,mitral,0,1
118386,lateral,0,0
118387,(,0,1
118388,from,0,1
118389,4.62,0,0
118390,to,0,0
118391,5.20,0,0
118392,and,0,0
118393,5.19,0,0
118394,m/s,0,0
118395,),0,0
118396,and,0,0
118397,septal,0,1
118398,(,0,0
118399,from,0,1
118400,4.71,0,0
118401,to,0,0
118402,5.23,0,0
118403,and,0,0
118404,5.24,0,0
118405,m/s,0,0
118406,),0,0
118407,annuli,0,0
118408,significantly,0,0
118409,increased,0,0
118410,",",0,0
118411,whereas,0,0
118412,the,0,0
118413,ratio,0,0
118414,of,0,0
118415,early,0,0
118416,transmitral,0,1
118417,(,0,0
118418,E,0,0
118419,),0,0
118420,to,0,0
118421,E,0,0
118422,',0,1
118423,lateral,0,0
118424,decreased,0,0
118425,(,0,0
118426,from,0,0
118427,13.1,0,0
118428,to,0,0
118429,9.8,0,0
118430,to,0,0
118431,9.4,0,0
118432,),0,0
118433,(,0,0
118434,P,0,0
118435,<,0,0
118436,0.01,0,0
118437,),0,1
118438,.,0,1
118439,Changes,0,0
118440,were,0,0
118441,accompanied,0,0
118442,by,0,0
118443,a,0,0
118444,reverse,0,0
118445,remodeling,0,0
118446,of,0,0
118447,left,0,1
118448,atrial,0,1
118449,volume,0,0
118450,index,0,0
118451,(,0,0
118452,from,0,0
118453,32.0,0,0
118454,to,0,0
118455,29.0,0,0
118456,and,0,0
118457,29.1,0,1
118458,mL/m,0,0
118459,(,0,1
118460,2,0,1
118461,),0,1
118462,;,0,1
118463,P,0,0
118464,<,0,0
118465,0.01,0,0
118466,),0,0
118467,and,0,0
118468,LV,0,1
118469,mass,0,1
118470,index,0,0
118471,(,0,0
118472,from,0,0
118473,148.0,0,0
118474,to,0,0
118475,130.0,0,0
118476,and,0,0
118477,128.0,0,0
118478,g/m,0,0
118479,(,0,1
118480,2,0,1
118481,),0,1
118482,;,0,1
118483,P,0,0
118484,<,0,0
118485,0.01,0,0
118486,),0,0
118487,.,0,0
118488,Furthermore,0,0
118489,",",0,0
118490,sildenafil,0,0
118491,improved,0,0
118492,exercise,0,0
118493,performance,0,0
118494,(,0,0
118495,peak,0,0
118496,Vo,0,1
118497,(,0,1
118498,2,0,0
118499,),0,0
118500,),0,0
118501,",",0,0
118502,ventilation,0,0
118503,efficiency,0,0
118504,(,0,0
118505,ventilation,0,0
118506,to,0,0
118507,CO,0,0
118508,(,0,0
118509,2,0,0
118510,),0,0
118511,production,0,0
118512,slope,0,0
118513,),0,0
118514,",",0,0
118515,and,0,0
118516,quality,0,0
118517,of,0,0
118518,life,0,0
118519,(,0,0
118520,P,0,0
118521,<,0,0
118522,0.01,0,0
118523,),0,1
118524,.,0,1
118525,Minor,0,0
118526,adverse,0,0
118527,effects,0,0
118528,were,0,1
118529,noted,0,0
118530,:,0,1
118531,flushing,0,0
118532,in,0,0
118533,4,0,0
118534,and,0,0
118535,headache,0,0
118536,in,0,0
118537,2,0,0
118538,treated,0,1
118539,patients,0,1
118540,.,0,1
118541,CONCLUSIONS,0,0
118542,Findings,0,0
118543,confirm,0,0
118544,that,0,0
118545,in,0,0
118546,HF,0,0
118547,",",0,0
118548,sildenafil,0,0
118549,improves,0,0
118550,functional,0,0
118551,capacity,0,0
118552,and,0,0
118553,clinical,0,0
118554,status,0,0
118555,and,0,0
118556,provide,0,0
118557,the,0,0
118558,first,0,0
118559,human,0,0
118560,evidence,0,0
118561,that,0,0
118562,LV,0,1
118563,diastolic,0,1
118564,function,0,0
118565,and,0,0
118566,cardiac,0,1
118567,geometry,0,0
118568,are,0,0
118569,additional,0,0
118570,targets,0,0
118571,of,0,1
118572,benefits,0,0
118573,related,0,0
118574,to,0,0
118575,chronic,0,1
118576,PDE5,0,1
118577,inhibition,0,0
118578,.,0,1
118579,Pre-transplant,0,1
118580,pharmacokinetic,0,0
118581,profiling,0,0
118582,and,0,0
118583,tacrolimus,0,0
118584,requirements,0,1
118585,post-transplant,1,1
118586,.,1,1
118587,AIM,0,0
118588,To,0,0
118589,determine,0,0
118590,the,0,0
118591,proportion,0,0
118592,of,0,0
118593,patients,1,1
118594,achieving,1,0
118595,tacrolimus,1,0
118596,whole-blood,1,0
118597,concentrations,1,0
118598,of,1,0
118599,?10,1,0
118600,ng/mL,1,0
118601,within,1,0
118602,3,1,0
118603,days,1,0
118604,of,1,0
118605,kidney,1,1
118606,transplantation,1,1
118607,",",1,0
118608,after,1,0
118609,randomization,1,0
118610,either,1,0
118611,to,1,0
118612,standard,1,0
118613,dosing,1,0
118614,(,1,0
118615,control,1,0
118616,group,1,0
118617,),1,0
118618,or,1,0
118619,post-transplantation,1,0
118620,dosing,1,0
118621,guided,1,0
118622,by,1,0
118623,a,1,0
118624,2-hour,1,0
118625,(,1,0
118626,C,1,0
118627,(,1,1
118628,2,1,0
118629,),1,1
118630,),1,0
118631,level,1,0
118632,following,1,0
118633,a,1,0
118634,preoperative,1,0
118635,tacrolimus,1,0
118636,dose,1,0
118637,(,1,0
118638,T2,1,1
118639,group,1,1
118640,),1,0
118641,.,1,0
118642,METHODS,0,0
118643,The,0,0
118644,first,0,0
118645,postoperative,0,0
118646,tacrolimus,0,0
118647,dose,0,0
118648,was,0,0
118649,given,0,0
118650,either,0,0
118651,according,0,0
118652,to,0,0
118653,standard,0,0
118654,care,0,0
118655,(,0,0
118656,control,0,0
118657,group,0,0
118658,),0,0
118659,or,0,1
118660,0.15,0,0
118661,mg/kg,0,0
118662,b.d,0,1
118663,.,0,0
118664,if,0,0
118665,the,0,0
118666,pre-transplant,0,1
118667,C,0,0
118668,(,0,1
118669,2,0,0
118670,),0,0
118671,level,0,0
118672,was,0,0
118673,?20,0,1
118674,ng/mL,0,0
118675,",",0,0
118676,0.1,0,0
118677,mg/kg,0,0
118678,b.d,0,0
118679,.,0,0
118680,if,0,0
118681,the,0,0
118682,C,0,0
118683,(,0,0
118684,2,0,0
118685,),0,0
118686,level,0,0
118687,was,0,0
118688,21-59,0,1
118689,ng/mL,0,0
118690,or,0,1
118691,0.05,0,0
118692,mg/kg,0,0
118693,b.d,0,1
118694,.,0,0
118695,if,0,0
118696,the,0,0
118697,C,0,0
118698,(,0,0
118699,2,0,0
118700,),0,0
118701,level,0,0
118702,was,0,0
118703,?60,0,0
118704,ng/mL,0,0
118705,(,0,0
118706,T2,0,1
118707,group,0,1
118708,),0,0
118709,.,0,0
118710,Subsequent,0,0
118711,dosing,0,0
118712,in,0,0
118713,both,0,0
118714,groups,0,0
118715,was,0,0
118716,based,0,0
118717,upon,0,0
118718,tacrolimus,0,0
118719,trough,0,0
118720,level,0,0
118721,monitoring,1,0
118722,.,1,1
118723,Participants,1,1
118724,received,1,0
118725,concomitant,1,0
118726,mycophenolate,1,0
118727,mofetil,1,0
118728,and,1,0
118729,steroids,1,0
118730,.,1,1
118731,RESULTS,1,0
118732,Ninety,1,1
118733,patients,1,1
118734,were,1,0
118735,recruited,1,1
118736,",",1,0
118737,of,1,0
118738,which,1,0
118739,84,1,1
118740,were,1,0
118741,included,1,1
118742,in,1,0
118743,the,1,0
118744,analysis,1,0
118745,(,1,0
118746,control,1,0
118747,group,1,0
118748,n=43,1,1
118749,;,1,0
118750,T2,1,1
118751,group,1,0
118752,n=41,1,1
118753,),1,0
118754,.,0,0
118755,There,0,0
118756,was,0,0
118757,no,0,0
118758,difference,0,0
118759,in,0,0
118760,the,0,0
118761,proportion,0,0
118762,of,0,0
118763,subjects,0,1
118764,achieving,0,0
118765,tacrolimus,0,0
118766,trough,0,0
118767,levels,0,0
118768,?10,0,0
118769,ng/mL,0,0
118770,(,0,0
118771,82.9,0,0
118772,%,0,0
118773,Control,0,1
118774,vs,0,0
118775,93.0,0,0
118776,%,0,0
118777,T2,0,1
118778,;,0,0
118779,P=0.19,0,0
118780,),0,0
118781,or,0,1
118782,between,0,0
118783,10,0,1
118784,and,0,0
118785,15,0,1
118786,ng/mL,0,0
118787,(,0,0
118788,41.5,0,1
118789,%,0,0
118790,Control,0,1
118791,vs,0,0
118792,41.9,0,0
118793,%,0,0
118794,T2,0,1
118795,;,0,0
118796,P=0.97,0,0
118797,),0,0
118798,at,0,0
118799,day,0,0
118800,3,0,0
118801,post,0,0
118802,transplant,0,1
118803,.,0,0
118804,The,0,0
118805,T2,0,0
118806,group,0,0
118807,achieved,0,0
118808,tacrolimus,0,0
118809,trough,0,0
118810,levels,0,0
118811,of,0,0
118812,?10,0,0
118813,ng/mL,0,0
118814,significantly,0,0
118815,faster,0,0
118816,than,0,0
118817,the,0,0
118818,control,0,0
118819,group,0,0
118820,(,0,0
118821,100,0,0
118822,%,0,0
118823,achievement,0,0
118824,in,0,0
118825,14,0,1
118826,days,0,0
118827,(,0,1
118828,Control,0,1
118829,),0,0
118830,versus,0,0
118831,4,0,0
118832,days,0,0
118833,(,0,1
118834,T2,0,1
118835,),0,1
118836,;,0,0
118837,P=0.01,0,0
118838,),0,0
118839,.,0,0
118840,CONCLUSION,0,0
118841,Performing,0,0
118842,a,0,0
118843,pre-transplant,0,1
118844,tacrolimus,0,0
118845,C,0,0
118846,(,0,0
118847,2,0,0
118848,),0,0
118849,does,0,0
118850,not,0,0
118851,significantly,0,0
118852,increase,0,0
118853,the,0,0
118854,high,0,0
118855,proportion,0,0
118856,of,0,0
118857,subjects,0,1
118858,achieving,0,0
118859,10,0,1
118860,ng/mL,0,1
118861,tacrolimus,0,0
118862,concentrations,0,0
118863,by,0,0
118864,day,0,0
118865,3,0,0
118866,using,0,0
118867,routine,0,1
118868,protocols,0,0
118869,.,0,0
118870,However,0,0
118871,",",0,0
118872,compared,0,0
118873,with,0,1
118874,standard,0,0
118875,care,0,1
118876,",",0,0
118877,performing,0,0
118878,a,0,0
118879,pre-transplant,0,1
118880,tacrolimus,0,0
118881,C,0,0
118882,(,0,0
118883,2,0,0
118884,),0,0
118885,does,0,0
118886,lead,0,0
118887,to,0,0
118888,patients,0,1
118889,achieving,0,0
118890,a,0,0
118891,whole-blood,0,0
118892,concentration,0,0
118893,of,0,0
118894,?10,0,0
118895,ng/mL,0,1
118896,sooner,0,1
118897,.,0,1
118898,Pharmacogenetic,0,0
118899,interaction,0,0
118900,analysis,0,0
118901,for,0,0
118902,the,0,0
118903,efficacy,0,0
118904,of,0,0
118905,systemic,0,0
118906,treatment,0,0
118907,in,0,0
118908,metastatic,1,1
118909,colorectal,1,1
118910,cancer,1,1
118911,.,1,1
118912,BACKGROUND,0,0
118913,Pharmacogenetic,0,0
118914,markers,0,0
118915,related,0,0
118916,to,0,0
118917,drug,0,0
118918,metabolism,0,0
118919,and,0,0
118920,mechanisms,0,0
118921,of,0,0
118922,action,0,0
118923,could,0,0
118924,help,0,0
118925,to,0,0
118926,better,0,0
118927,select,0,0
118928,patients,1,1
118929,with,1,1
118930,metastatic,1,1
118931,colorectal,1,1
118932,cancer,1,1
118933,(,1,0
118934,mCRC,1,0
118935,),1,0
118936,for,0,0
118937,treatment,0,0
118938,.,0,1
118939,Genetic,0,0
118940,interaction,0,0
118941,analysis,0,0
118942,is,0,0
118943,used,0,0
118944,as,0,0
118945,a,0,0
118946,rational,0,0
118947,tool,0,0
118948,to,0,0
118949,study,0,0
118950,the,0,0
118951,contribution,0,0
118952,of,0,0
118953,polygenic,0,0
118954,variation,0,0
118955,in,0,0
118956,relation,0,0
118957,to,0,0
118958,drug,0,0
118959,response,0,0
118960,.,0,0
118961,PATIENTS,0,0
118962,AND,0,0
118963,METHODS,0,0
118964,A,0,0
118965,selection,0,0
118966,of,0,0
118967,17,1,1
118968,polymorphisms,1,1
118969,in,1,1
118970,genes,1,0
118971,encoding,1,0
118972,drug,1,0
118973,targets,1,0
118974,",",1,0
118975,pathway,1,0
118976,molecules,1,0
118977,and,1,0
118978,detoxification,1,1
118979,enzymes,1,0
118980,was,1,0
118981,analyzed,1,0
118982,in,1,0
118983,279,1,1
118984,previously,1,1
118985,untreated,1,1
118986,mCRC,1,0
118987,patients,1,1
118988,treated,1,1
118989,with,1,1
118990,capecitabine,1,0
118991,",",1,0
118992,oxaliplatin,1,0
118993,and,1,0
118994,bevacizumab,1,0
118995,(,1,0
118996,CAPOX-B,1,0
118997,),1,1
118998,.,1,0
118999,Multifactor,0,0
119000,dimensionality,0,0
119001,reduction,0,0
119002,analysis,0,0
119003,was,0,0
119004,used,0,0
119005,to,0,0
119006,identify,0,0
119007,a,0,0
119008,genetic,0,0
119009,interaction,0,0
119010,profile,0,0
119011,for,0,0
119012,progression-free,0,0
119013,survival,0,0
119014,(,0,0
119015,PFS,0,0
119016,),0,1
119017,.,0,1
119018,RESULTS,0,0
119019,Median,0,1
119020,PFS,0,0
119021,was,0,0
119022,10.9,0,0
119023,[,0,0
119024,95,0,0
119025,%,0,0
119026,confidence,0,0
119027,interval,0,0
119028,(,0,0
119029,CI,0,0
119030,),0,1
119031,9.4-12.4,0,0
119032,],0,1
119033,months,0,0
119034,.,0,1
119035,A,0,0
119036,genetic,0,0
119037,interaction,0,0
119038,profile,0,0
119039,consisting,0,0
119040,of,0,0
119041,the,0,0
119042,TYMS,0,0
119043,enhancer,0,0
119044,region,0,1
119045,and,0,0
119046,VEGF,0,1
119047,+405G,0,1
119048,>,0,1
119049,C,0,0
119050,polymorphisms,0,0
119051,was,0,0
119052,significantly,0,0
119053,associated,0,0
119054,with,0,1
119055,PFS,0,0
119056,.,0,1
119057,Median,0,0
119058,PFS,0,0
119059,was,0,0
119060,13.3,0,0
119061,(,0,0
119062,95,0,0
119063,%,0,0
119064,CI,0,0
119065,11.4-15.3,0,0
119066,),0,0
119067,and,0,0
119068,9.7,0,1
119069,(,0,0
119070,95,0,0
119071,%,0,0
119072,CI,0,0
119073,7.6-11.8,0,1
119074,),0,1
119075,months,0,0
119076,for,0,0
119077,the,0,0
119078,beneficial,0,0
119079,and,0,0
119080,unfavorable,0,0
119081,genetic,0,0
119082,profiles,0,0
119083,",",0,0
119084,respectively,0,0
119085,",",0,0
119086,corresponding,0,0
119087,to,0,0
119088,a,0,0
119089,hazards,0,0
119090,ratio,0,0
119091,for,0,0
119092,PFS,0,0
119093,of,0,0
119094,1.58,0,0
119095,(,0,1
119096,95,0,0
119097,%,0,0
119098,CI,0,0
119099,1.14-2.19,0,0
119100,),0,0
119101,.,0,0
119102,None,0,0
119103,of,0,0
119104,the,0,0
119105,studied,0,1
119106,polymorphisms,0,0
119107,were,0,1
119108,individually,0,0
119109,associated,0,0
119110,with,0,1
119111,PFS,0,0
119112,.,0,1
119113,CONCLUSIONS,0,0
119114,Our,0,0
119115,results,0,0
119116,support,0,0
119117,a,0,0
119118,genetic,0,0
119119,interaction,0,0
119120,between,0,0
119121,the,0,0
119122,TYMS,0,0
119123,enhancer,0,0
119124,region,0,1
119125,and,0,0
119126,VEGF,0,1
119127,+405G,0,1
119128,>,0,1
119129,C,0,0
119130,polymorphisms,0,0
119131,as,0,0
119132,a,0,0
119133,predictor,0,0
119134,of,0,0
119135,the,0,0
119136,efficacy,0,0
119137,of,0,0
119138,CAPOX-B,0,0
119139,in,0,0
119140,mCRC,1,0
119141,patients,1,1
119142,.,1,1
119143,[,0,0
119144,Management,0,0
119145,of,0,0
119146,the,0,0
119147,perineal,0,1
119148,wounds,0,1
119149,after,0,0
119150,abdominoperineal,0,1
119151,resection,0,1
119152,:,0,1
119153,simple,0,0
119154,drainage,0,0
119155,only,0,0
119156,or,0,0
119157,with,0,1
119158,continuous,0,0
119159,irrigation,0,0
119160,?,0,0
119161,],0,0
119162,.,0,0
119163,OBJECTIVE,0,0
119164,To,0,0
119165,compare,0,0
119166,the,0,0
119167,effects,0,0
119168,of,0,0
119169,presacral,0,1
119170,irrigation,0,0
119171,and,0,0
119172,simple,0,0
119173,drainage,0,0
119174,on,0,0
119175,the,0,0
119176,perineal,0,1
119177,wound,0,0
119178,healing,0,0
119179,in,0,0
119180,patients,1,1
119181,after,1,0
119182,abdominoperineal,1,1
119183,resection,1,1
119184,(,1,0
119185,APR,1,0
119186,),1,1
119187,.,1,0
119188,METHODS,0,0
119189,From,0,1
119190,October,0,1
119191,2004,0,1
119192,to,0,0
119193,August,0,1
119194,2009,0,1
119195,",",0,0
119196,patients,1,1
119197,with,1,1
119198,rectal,1,1
119199,cancer,1,1
119200,",",1,0
119201,ulcerative,1,1
119202,colitis,1,1
119203,or,1,1
119204,rectal,1,1
119205,gastrointestinal,1,1
119206,stromal,1,0
119207,tumor,1,1
119208,",",1,1
119209,who,1,1
119210,underwent,1,1
119211,APR,1,1
119212,or,1,1
119213,proctocolectomy,1,1
119214,",",0,0
119215,were,0,0
119216,randomized,0,0
119217,into,0,1
119218,two,0,1
119219,arms,0,0
119220,:,0,1
119221,simple,0,0
119222,drainage,0,0
119223,group,0,0
119224,(,0,0
119225,n,0,1
119226,=,0,0
119227,37,0,1
119228,),0,0
119229,and,0,0
119230,continuous,0,0
119231,irrigation,0,0
119232,(,0,0
119233,n,0,1
119234,=,0,0
119235,37,0,1
119236,),0,1
119237,.,0,1
119238,Patients,0,1
119239,randomized,0,0
119240,to,0,0
119241,arm,0,0
119242,B,0,0
119243,received,0,0
119244,simple,0,0
119245,drainage,0,0
119246,only,0,0
119247,to,0,0
119248,presacral,0,1
119249,space,0,0
119250,;,0,0
119251,while,0,0
119252,those,0,0
119253,patients,0,1
119254,in,0,0
119255,arm,0,1
119256,A,0,1
119257,received,0,0
119258,continuous,0,0
119259,irrigation,0,0
119260,in,0,0
119261,addition,0,0
119262,to,0,0
119263,simple,0,0
119264,drainage,0,1
119265,.,0,0
119266,Perineal,0,0
119267,wound,0,0
119268,healing,0,0
119269,was,0,0
119270,taken,0,0
119271,as,0,0
119272,endpoint,0,0
119273,of,0,0
119274,this,0,0
119275,study,0,0
119276,.,0,0
119277,Major,0,0
119278,complication,0,0
119279,was,0,0
119280,defined,0,0
119281,as,0,0
119282,wound,0,0
119283,dehiscence,0,0
119284,or,0,1
119285,wound,0,0
119286,infection,0,0
119287,that,0,0
119288,the,0,0
119289,perineal,0,0
119290,wound,0,0
119291,should,0,0
119292,be,0,0
119293,reopened,0,0
119294,for,0,0
119295,drainage,0,1
119296,.,0,1
119297,Minor,0,0
119298,complication,0,0
119299,was,0,0
119300,defined,0,0
119301,as,0,0
119302,delayed,0,0
119303,healing,0,0
119304,wound,0,0
119305,with,0,1
119306,seroma,0,0
119307,or,0,1
119308,hematoma,0,0
119309,.,0,0
119310,RESULTS,0,0
119311,A,0,0
119312,total,0,1
119313,of,0,0
119314,74,1,1
119315,patients,1,1
119316,were,1,1
119317,enrolled,1,1
119318,in,1,0
119319,present,1,0
119320,study,1,0
119321,",",0,0
119322,with,0,1
119323,37,0,1
119324,patients,0,1
119325,in,0,0
119326,each,0,0
119327,arm,0,0
119328,",",0,0
119329,and,0,0
119330,there,0,0
119331,were,0,0
119332,12,0,0
119333,cases,0,1
119334,and,0,1
119335,10,0,1
119336,cases,0,1
119337,who,0,1
119338,received,0,1
119339,preoperative,0,1
119340,radiation,0,0
119341,therapy,0,0
119342,",",0,0
119343,respectively,0,0
119344,.,0,0
119345,In,0,0
119346,the,0,0
119347,arm,0,0
119348,A,0,0
119349,",",0,0
119350,2,0,0
119351,patients,0,1
119352,developed,0,1
119353,major,0,1
119354,complications,0,0
119355,",",0,1
119356,3,0,0
119357,patients,0,1
119358,incurred,0,1
119359,with,0,1
119360,minor,0,0
119361,complications,0,0
119362,and,0,1
119363,32,0,1
119364,patients,0,1
119365,got,0,1
119366,primary,0,1
119367,healing,0,0
119368,of,0,0
119369,the,0,0
119370,perineal,0,1
119371,wounds,0,1
119372,.,0,1
119373,In,0,0
119374,arm,0,0
119375,B,0,1
119376,",",0,0
119377,8,0,0
119378,patients,0,1
119379,suffered,0,1
119380,major,0,1
119381,complications,0,0
119382,",",0,1
119383,3,0,0
119384,patients,0,1
119385,incurred,0,1
119386,with,0,1
119387,minor,0,0
119388,complications,0,0
119389,and,0,1
119390,26,0,1
119391,patients,0,1
119392,got,0,1
119393,primary,0,1
119394,healing,0,0
119395,of,0,0
119396,the,0,0
119397,perineal,0,0
119398,wounds,0,1
119399,.,0,0
119400,The,0,0
119401,incidence,0,0
119402,of,0,0
119403,major,0,0
119404,complication,0,0
119405,was,0,0
119406,significantly,0,0
119407,lower,0,0
119408,in,0,0
119409,arm,0,0
119410,A,0,1
119411,(,0,0
119412,5.4,0,0
119413,%,0,0
119414,vs.21.6,0,0
119415,%,0,0
119416,",",0,0
119417,P,0,0
119418,=,0,0
119419,0.042,0,0
119420,),0,1
119421,.,0,1
119422,Patients,0,1
119423,received,0,0
119424,preoperative,0,0
119425,radiation,0,0
119426,therapy,0,0
119427,had,0,0
119428,significantly,0,0
119429,higher,0,0
119430,rate,0,0
119431,of,0,0
119432,minor,0,0
119433,complications,0,0
119434,than,0,1
119435,patients,0,1
119436,underwent,0,1
119437,surgery,0,1
119438,only,0,0
119439,(,0,0
119440,18.2,0,0
119441,%,0,0
119442,vs.,0,0
119443,3.9,0,0
119444,%,0,0
119445,",",0,0
119446,P,0,0
119447,=,0,0
119448,0.039,0,0
119449,),0,1
119450,.,0,1
119451,CONCLUSIONS,0,0
119452,Simple,0,0
119453,drainage,0,1
119454,with,0,1
119455,continuous,0,0
119456,irrigation,0,0
119457,of,0,0
119458,the,0,0
119459,presacral,0,0
119460,space,0,0
119461,",",0,0
119462,in,0,0
119463,patients,0,1
119464,with,0,1
119465,abdominoperineal,0,1
119466,resection,0,1
119467,or,0,0
119468,proctocolectomy,0,0
119469,",",0,0
119470,could,0,0
119471,significantly,0,0
119472,lower,0,0
119473,the,0,0
119474,incidence,0,0
119475,of,0,0
119476,major,0,0
119477,complication,0,0
119478,and,0,0
119479,improve,0,0
119480,wound,0,0
119481,healing,0,0
119482,for,0,0
119483,perineal,0,1
119484,wound,0,0
119485,when,0,0
119486,compared,0,0
119487,with,0,0
119488,simple,0,0
119489,drainage,0,1
119490,only,0,0
119491,.,0,0
119492,Preoperative,0,0
119493,radiation,0,0
119494,therapy,0,0
119495,tends,0,0
119496,to,0,0
119497,increase,0,0
119498,the,0,0
119499,incidence,0,0
119500,of,0,0
119501,minor,0,0
119502,complications,0,0
119503,.,0,1
119504,Denosumab,0,0
119505,compared,0,0
119506,with,0,1
119507,zoledronic,0,0
119508,acid,0,0
119509,for,0,0
119510,the,0,0
119511,treatment,0,0
119512,of,0,0
119513,bone,0,0
119514,metastases,0,1
119515,in,0,0
119516,patients,1,1
119517,with,1,1
119518,advanced,1,1
119519,breast,1,1
119520,cancer,1,1
119521,:,1,1
119522,a,0,0
119523,randomized,0,0
119524,",",0,0
119525,double-blind,0,0
119526,study,0,0
119527,.,0,0
119528,PURPOSE,0,0
119529,This,0,0
119530,randomized,0,0
119531,study,0,0
119532,compared,0,0
119533,denosumab,0,0
119534,",",0,0
119535,a,0,0
119536,fully,0,0
119537,human,0,0
119538,monoclonal,0,0
119539,antibody,0,0
119540,against,0,0
119541,receptor,0,0
119542,activator,0,0
119543,of,0,0
119544,nuclear,0,0
119545,factor,0,0
119546,?,0,0
119547,B,0,0
119548,(,0,0
119549,RANK,0,1
119550,),0,0
119551,ligand,0,0
119552,",",0,0
119553,with,0,1
119554,zoledronic,0,0
119555,acid,0,0
119556,in,0,0
119557,delaying,0,0
119558,or,0,1
119559,preventing,0,0
119560,skeletal-related,0,0
119561,events,0,0
119562,(,0,1
119563,SREs,0,0
119564,),0,0
119565,in,1,0
119566,patients,1,1
119567,with,1,1
119568,breast,1,1
119569,cancer,1,1
119570,with,1,1
119571,bone,1,0
119572,metastases,1,1
119573,.,1,1
119574,PATIENTS,0,0
119575,AND,0,0
119576,METHODS,0,0
119577,Patients,0,1
119578,were,0,1
119579,randomly,0,1
119580,assigned,0,0
119581,to,0,0
119582,receive,0,0
119583,either,0,0
119584,subcutaneous,0,0
119585,denosumab,0,0
119586,120,0,1
119587,mg,0,0
119588,and,0,0
119589,intravenous,0,0
119590,placebo,1,0
119591,(,1,0
119592,n,1,1
119593,=,1,0
119594,"1,026",1,1
119595,),1,0
119596,or,0,1
119597,intravenous,0,0
119598,zoledronic,0,0
119599,acid,0,0
119600,4,0,0
119601,mg,0,0
119602,adjusted,0,0
119603,for,0,0
119604,creatinine,0,0
119605,clearance,0,0
119606,and,0,0
119607,subcutaneous,0,0
119608,placebo,1,0
119609,(,1,0
119610,n,1,1
119611,=,1,0
119612,"1,020",1,1
119613,),1,0
119614,every,0,0
119615,4,0,0
119616,weeks,0,0
119617,.,0,1
119618,All,0,1
119619,patients,0,1
119620,were,0,0
119621,strongly,0,0
119622,recommended,0,0
119623,to,0,0
119624,take,0,0
119625,daily,0,0
119626,calcium,0,0
119627,and,0,0
119628,vitamin,0,0
119629,D,0,0
119630,supplements,0,0
119631,.,0,1
119632,The,0,0
119633,primary,0,0
119634,end,0,0
119635,point,0,0
119636,was,0,0
119637,time,0,0
119638,to,0,0
119639,first,0,0
119640,on-study,0,0
119641,SRE,0,1
119642,(,0,0
119643,defined,0,0
119644,as,0,0
119645,pathologic,0,0
119646,fracture,0,1
119647,",",0,0
119648,radiation,0,0
119649,or,0,0
119650,surgery,0,1
119651,to,0,0
119652,bone,0,0
119653,",",0,0
119654,or,0,0
119655,spinal,0,1
119656,cord,0,1
119657,compression,0,0
119658,),0,0
119659,.,0,1
119660,RESULTS,0,0
119661,Denosumab,0,0
119662,was,0,0
119663,superior,0,0
119664,to,0,0
119665,zoledronic,0,0
119666,acid,0,0
119667,in,0,0
119668,delaying,0,0
119669,time,0,0
119670,to,0,0
119671,first,0,0
119672,on-study,0,0
119673,SRE,0,1
119674,(,0,0
119675,hazard,0,0
119676,ratio,0,0
119677,",",0,0
119678,0.82,0,0
119679,;,0,0
119680,95,0,0
119681,%,0,0
119682,CI,0,0
119683,",",0,0
119684,0.71,0,0
119685,to,0,0
119686,0.95,0,0
119687,;,0,1
119688,P,0,0
119689,=,0,0
119690,.01,0,0
119691,superiority,0,0
119692,),0,0
119693,and,0,0
119694,time,0,0
119695,to,0,0
119696,first,0,0
119697,and,0,0
119698,subsequent,0,0
119699,(,0,0
119700,multiple,0,0
119701,),0,0
119702,on-study,0,0
119703,SREs,0,0
119704,(,0,0
119705,rate,0,0
119706,ratio,0,0
119707,",",0,0
119708,0.77,0,0
119709,;,0,0
119710,95,0,0
119711,%,0,0
119712,CI,0,0
119713,",",0,0
119714,0.66,0,0
119715,to,0,0
119716,0.89,0,0
119717,;,0,1
119718,P,0,0
119719,=,0,0
119720,.001,0,0
119721,),0,0
119722,.,0,0
119723,Reduction,0,0
119724,in,0,0
119725,bone,0,0
119726,turnover,0,0
119727,markers,0,0
119728,was,0,0
119729,greater,0,0
119730,with,0,1
119731,denosumab,0,0
119732,.,0,1
119733,Overall,0,0
119734,survival,0,0
119735,",",0,0
119736,disease,0,1
119737,progression,0,0
119738,",",0,0
119739,and,0,0
119740,rates,0,0
119741,of,0,0
119742,adverse,0,0
119743,events,0,0
119744,(,0,1
119745,AEs,0,0
119746,),0,0
119747,and,0,0
119748,serious,0,0
119749,AEs,0,0
119750,were,0,0
119751,similar,0,0
119752,between,0,0
119753,groups,0,0
119754,.,0,1
119755,An,0,0
119756,excess,0,0
119757,of,0,0
119758,renal,0,1
119759,AEs,0,0
119760,and,0,1
119761,acute-phase,0,1
119762,reactions,0,0
119763,occurred,0,0
119764,with,0,1
119765,zoledronic,0,0
119766,acid,0,0
119767,;,0,0
119768,hypocalcemia,0,0
119769,occurred,0,0
119770,more,0,0
119771,frequently,0,0
119772,with,0,0
119773,denosumab,0,0
119774,.,0,0
119775,Osteonecrosis,0,0
119776,of,0,0
119777,the,0,0
119778,jaw,0,0
119779,occurred,0,0
119780,infrequently,0,0
119781,(,0,0
119782,2.0,0,0
119783,%,0,0
119784,",",0,0
119785,denosumab,0,0
119786,;,0,0
119787,1.4,0,0
119788,%,0,0
119789,",",0,0
119790,zoledronic,0,0
119791,acid,0,0
119792,;,0,1
119793,P,0,0
119794,=,0,0
119795,.39,0,0
119796,),0,1
119797,.,0,1
119798,CONCLUSION,0,0
119799,Denosumab,0,0
119800,was,0,0
119801,superior,0,0
119802,to,0,0
119803,zoledronic,0,0
119804,acid,0,0
119805,in,0,0
119806,delaying,0,0
119807,or,0,1
119808,preventing,0,0
119809,SREs,0,0
119810,in,1,0
119811,patients,1,1
119812,with,1,1
119813,breast,1,1
119814,cancer,1,1
119815,metastatic,1,1
119816,to,1,0
119817,bone,1,0
119818,and,0,0
119819,was,0,0
119820,generally,0,0
119821,well,0,0
119822,tolerated,0,0
119823,.,0,0
119824,With,0,0
119825,the,0,0
119826,convenience,0,1
119827,of,0,0
119828,a,0,0
119829,subcutaneous,0,0
119830,injection,0,0
119831,and,0,0
119832,no,0,0
119833,requirement,0,0
119834,for,0,0
119835,renal,0,1
119836,monitoring,0,0
119837,",",0,0
119838,denosumab,0,0
119839,represents,0,0
119840,a,0,0
119841,potential,0,0
119842,treatment,0,0
119843,option,0,0
119844,for,1,0
119845,patients,1,1
119846,with,1,1
119847,bone,1,1
119848,metastases,1,1
119849,.,1,1
119850,Endoscopic,0,1
119851,versus,0,0
119852,operative,0,0
119853,gastrostomy,1,1
119854,:,1,1
119855,final,0,0
119856,results,0,0
119857,of,0,0
119858,a,0,1
119859,prospective,0,0
119860,randomized,0,0
119861,trial,0,0
119862,.,0,0
119863,This,1,0
119864,study,1,0
119865,compared,1,0
119866,operative,1,0
119867,gastrostomy,1,1
119868,(,1,0
119869,OG,1,0
119870,),1,0
119871,(,1,0
119872,by,1,0
119873,surgeons,1,1
119874,),1,1
119875,with,1,1
119876,endoscopic,1,0
119877,gastrostomy,1,1
119878,(,1,0
119879,PEG,1,1
119880,),1,0
119881,(,1,0
119882,by,1,0
119883,physicians,1,1
119884,),1,1
119885,in,0,0
119886,a,0,0
119887,prospective,0,0
119888,randomized,0,0
119889,fashion,0,0
119890,to,0,0
119891,determine,0,0
119892,whether,0,0
119893,one,0,0
119894,technique,0,0
119895,was,0,0
119896,superior,0,0
119897,.,0,1
119898,PEG,0,0
119899,(,0,0
119900,Sachs-Vine,0,1
119901,),0,0
119902,and,0,0
119903,OG,0,0
119904,(,0,0
119905,Stamm,0,0
119906,),0,0
119907,were,0,0
119908,done,0,0
119909,using,0,0
119910,local,0,0
119911,anesthesia,0,1
119912,.,0,1
119913,Patients,1,1
119914,were,1,0
119915,assessed,1,0
119916,for,1,0
119917,complications,1,0
119918,",",1,0
119919,mortality,1,0
119920,",",1,0
119921,tube,1,0
119922,function,1,0
119923,",",1,0
119924,and,1,0
119925,cost,1,0
119926,.,1,1
119927,Groups,1,0
119928,were,1,0
119929,equally,1,0
119930,matched,1,1
119931,for,1,0
119932,indications,1,0
119933,and,1,1
119934,underlying,1,1
119935,disease,1,1
119936,.,1,1
119937,Fifty-seven,1,1
119938,had,1,0
119939,OG,1,0
119940,and,1,1
119941,64,1,1
119942,had,1,1
119943,attempted,1,0
119944,PEG,1,1
119945,.,1,1
119946,Complications,0,0
119947,occurred,0,0
119948,in,0,0
119949,26,0,1
119950,%,0,0
119951,of,0,0
119952,OG,0,0
119953,patients,0,1
119954,and,0,1
119955,9,0,0
119956,%,0,0
119957,died,0,1
119958,.,0,1
119959,Complications,0,0
119960,occurred,0,0
119961,in,0,0
119962,25,0,1
119963,%,0,0
119964,of,0,0
119965,PEG,0,1
119966,patients,0,1
119967,and,0,1
119968,12,0,1
119969,%,0,0
119970,died,0,1
119971,.,0,0
119972,Tube,0,0
119973,feeding,0,0
119974,was,0,0
119975,initiated,0,0
119976,in,0,0
119977,both,0,0
119978,groups,0,0
119979,within,0,0
119980,a,0,0
119981,mean,0,0
119982,of,0,0
119983,29,0,1
119984,(,0,1
119985,24,0,1
119986,to,0,0
119987,72,0,1
119988,),0,0
119989,hours,0,0
119990,of,0,0
119991,the,0,0
119992,gastrostomy,0,1
119993,placement,0,0
119994,.,0,1
119995,OG,0,0
119996,cost,0,0
119997,$,0,0
119998,1675,0,1
119999,and,0,0
120000,PEG,0,1
120001,$,0,0
120002,979,0,1
120003,to,0,0
120004,perform,0,1
120005,.,0,1
120006,Twenty-one,0,1
120007,PEG,0,1
120008,patients,0,1
120009,required,0,0
120010,endoscopic,0,0
120011,tube,0,0
120012,change,0,0
120013,which,0,0
120014,raised,0,0
120015,their,0,0
120016,total,0,1
120017,cost,0,0
120018,to,0,0
120019,$,0,0
120020,1574,0,0
120021,.,0,0
120022,We,0,0
120023,conclude,0,0
120024,there,0,0
120025,is,0,0
120026,no,0,0
120027,difference,0,0
120028,between,0,0
120029,OG,0,0
120030,(,0,0
120031,using,0,0
120032,local,0,0
120033,anesthesia,0,1
120034,),0,0
120035,and,0,0
120036,PEG,0,0
120037,with,0,1
120038,regard,0,0
120039,to,0,0
120040,morbidity,0,0
120041,",",0,0
120042,mortality,0,0
120043,",",0,0
120044,or,0,0
120045,tube,0,0
120046,function,0,0
120047,.,0,0
120048,The,0,0
120049,endoscopic,0,0
120050,technique,0,0
120051,does,0,0
120052,appear,0,0
120053,to,0,0
120054,have,0,0
120055,economic,0,0
120056,advantage,0,0
120057,.,0,1
120058,A,0,0
120059,placebo-controlled,0,0
120060,",",0,0
120061,randomized,0,1
120062,clinical,0,0
120063,trial,0,0
120064,using,0,0
120065,testosterone,0,0
120066,undecanoate,0,0
120067,with,0,1
120068,injectable,0,0
120069,norethisterone,0,0
120070,enanthate,0,0
120071,:,0,1
120072,effect,0,0
120073,on,0,0
120074,anthropometric,1,0
120075,",",1,0
120076,metabolic,1,0
120077,and,1,0
120078,biochemical,1,0
120079,parameters,1,0
120080,.,1,1
120081,Testosterone,0,0
120082,administered,0,0
120083,alone,0,0
120084,or,0,0
120085,in,0,0
120086,combination,0,0
120087,with,0,1
120088,progestogens,0,1
120089,in,0,0
120090,male,0,1
120091,contraception,0,1
120092,induces,0,0
120093,reversible,0,0
120094,oligo-azoospermia,0,1
120095,",",0,0
120096,but,0,0
120097,its,0,0
120098,effects,0,0
120099,on,0,0
120100,body,0,1
120101,composition,0,1
120102,and,0,0
120103,metabolism,0,0
120104,are,0,0
120105,less,0,0
120106,known,0,0
120107,.,0,0
120108,We,0,0
120109,analysed,1,0
120110,anthropometric,1,0
120111,and,1,1
120112,metabolic,1,1
120113,parameters,1,0
120114,in,1,1
120115,five,1,1
120116,groups,1,0
120117,of,1,1
120118,10,1,1
120119,males,1,1
120120,:,1,1
120121,four,1,1
120122,receiving,1,1
120123,testosterone,1,0
120124,undecanoate,1,0
120125,(,0,0
120126,TU,0,0
120127,:,0,1
120128,1000,0,0
120129,mg,0,0
120130,),0,0
120131,plus,0,0
120132,norethisterone,0,0
120133,enanthate,0,0
120134,(,0,1
120135,NETE,0,0
120136,:,0,1
120137,200,0,0
120138,mg,0,0
120139,),0,0
120140,at,0,0
120141,different,0,0
120142,intervals,0,0
120143,(,0,1
120144,every,0,0
120145,8,0,0
120146,weeks,0,0
120147,:,0,1
120148,NETE-8,0,0
120149,;,0,0
120150,every,0,0
120151,12,0,0
120152,weeks,0,0
120153,:,0,1
120154,NETE-12,0,0
120155,;,0,0
120156,every,0,0
120157,6,0,0
120158,weeks,0,0
120159,for,0,1
120160,12,0,1
120161,weeks,0,0
120162,and,0,0
120163,then,0,0
120164,every,0,0
120165,12,0,0
120166,weeks,0,0
120167,:,0,1
120168,NETE-6/12,0,0
120169,;,0,0
120170,every,0,0
120171,6,0,0
120172,weeks,0,0
120173,for,0,1
120174,12,0,1
120175,weeks,0,0
120176,and,0,0
120177,then,0,0
120178,TU,0,0
120179,plus,0,0
120180,placebo,0,0
120181,every,0,0
120182,12,0,1
120183,weeks,0,0
120184,:,0,1
120185,NETE-6/12/0,0,1
120186,),0,0
120187,and,0,0
120188,one,0,0
120189,placebo,0,0
120190,(,0,0
120191,NETE-0/0,0,0
120192,),0,0
120193,for,0,0
120194,a,0,0
120195,total,0,1
120196,of,0,0
120197,48,0,1
120198,weeks,0,0
120199,.,0,1
120200,Body,0,0
120201,mass,0,0
120202,index,0,0
120203,(,0,0
120204,BMI,0,1
120205,),0,0
120206,and,0,0
120207,waist,0,0
120208,circumference,0,0
120209,did,0,0
120210,not,0,0
120211,change,0,0
120212,in,0,0
120213,any,0,0
120214,groups,0,0
120215,except,0,0
120216,for,0,0
120217,the,0,0
120218,NETE-8,0,0
120219,in,0,0
120220,which,0,0
120221,BMI,0,0
120222,increased,0,0
120223,significantly,0,0
120224,(,0,0
120225,p,0,0
120226,=,0,0
120227,0.02,0,0
120228,),0,0
120229,at,0,0
120230,the,0,0
120231,end,0,0
120232,of,0,0
120233,the,0,0
120234,treatment,0,0
120235,period,0,0
120236,.,0,0
120237,Lean,0,0
120238,body,0,0
120239,mass,0,1
120240,(,0,0
120241,MAMC,0,0
120242,or,0,1
120243,AMA,0,0
120244,),0,0
120245,increased,0,0
120246,significantly,0,0
120247,in,0,0
120248,the,0,0
120249,highest,0,0
120250,hormonal,0,0
120251,dose,0,0
120252,groups,0,0
120253,(,0,0
120254,p,0,0
120255,=,0,0
120256,0.04,0,0
120257,",",0,0
120258,NETE-6/12,0,0
120259,;,0,0
120260,p,0,0
120261,=,0,0
120262,0.004,0,0
120263,",",0,0
120264,NETE-8,0,0
120265,),0,0
120266,.,0,0
120267,No,0,0
120268,differences,0,0
120269,were,0,0
120270,observed,0,0
120271,in,0,0
120272,glucose,0,0
120273,levels,0,0
120274,",",0,0
120275,insulin,0,0
120276,sensitivity,0,0
120277,index,0,0
120278,and,0,0
120279,lipid,0,0
120280,profile,0,0
120281,as,0,0
120282,well,0,0
120283,as,0,0
120284,in,0,0
120285,biochemical,0,0
120286,and,0,0
120287,cell,0,1
120288,count,0,0
120289,parameters,0,0
120290,in,0,0
120291,any,0,1
120292,groups,0,0
120293,.,0,0
120294,In,0,0
120295,conclusion,0,0
120296,",",0,0
120297,NETE,0,0
120298,and,0,0
120299,TU,0,0
120300,for,0,0
120301,48,0,1
120302,weeks,0,0
120303,were,0,1
120304,not,0,0
120305,accompanied,0,0
120306,by,0,0
120307,any,0,0
120308,metabolic,0,1
120309,changes,0,0
120310,and,0,0
120311,any,0,0
120312,adverse,0,0
120313,effects,0,0
120314,.,0,1
120315,The,0,0
120316,weight,0,0
120317,gain,0,0
120318,of,0,0
120319,the,0,0
120320,highest,0,0
120321,NETE,0,0
120322,plus,0,0
120323,TU,0,0
120324,dosage,0,0
120325,was,0,0
120326,mainly,0,0
120327,because,0,0
120328,of,0,0
120329,gain,0,0
120330,in,0,0
120331,muscle,0,0
120332,mass,0,1
120333,.,0,1
120334,Serum,0,1
120335,biochemical,0,0
120336,characteristics,0,0
120337,of,0,0
120338,Beluga,1,1
120339,",",1,0
120340,Huso,1,0
120341,huso,1,1
120342,(,1,0
120343,L.,1,1
120344,),1,0
120345,",",0,0
120346,in,0,0
120347,response,0,0
120348,to,0,0
120349,blood,0,0
120350,sampling,0,0
120351,after,0,0
120352,clove,0,0
120353,powder,0,0
120354,solution,0,0
120355,exposure,0,0
120356,.,0,0
120357,In,0,0
120358,order,0,0
120359,to,0,0
120360,investigate,0,0
120361,the,0,0
120362,effect,0,0
120363,of,0,0
120364,anesthesia,0,0
120365,on,0,0
120366,serum,0,0
120367,parameters,0,0
120368,",",0,0
120369,Beluga,1,1
120370,",",1,0
120371,Huso,1,0
120372,huso,1,1
120373,(,1,0
120374,L.,1,1
120375,),1,0
120376,were,0,0
120377,blood-sampled,0,0
120378,immediately,0,0
120379,without,0,1
120380,anesthesia,0,0
120381,(,0,0
120382,control,0,0
120383,),0,0
120384,or,0,0
120385,subjected,0,0
120386,to,0,0
120387,following,0,0
120388,anesthesia,0,1
120389,procedure,0,0
120390,:,0,1
120391,40,0,1
120392,",",0,0
120393,120,0,1
120394,",",0,0
120395,and,0,0
120396,240,0,0
120397,s,0,0
120398,exposure,0,0
120399,to,0,0
120400,"3,000",0,0
120401,",",0,0
120402,700,0,1
120403,",",0,0
120404,and,0,0
120405,500,0,0
120406,mg,0,0
120407,l??,0,0
120408,clove,0,0
120409,solution,0,0
120410,",",0,0
120411,respectively,0,0
120412,.,0,0
120413,Blood,0,0
120414,samples,0,0
120415,were,0,0
120416,collected,0,0
120417,after,0,0
120418,these,0,0
120419,periods,0,0
120420,",",0,0
120421,when,1,0
120422,fish,1,0
120423,were,1,0
120424,immobile,0,1
120425,and,0,0
120426,reached,0,0
120427,stage,0,1
120428,4,0,0
120429,anesthesia,0,1
120430,.,0,1
120431,Results,0,0
120432,showed,0,0
120433,that,0,0
120434,cortisol,0,0
120435,and,0,0
120436,glucose,0,0
120437,levels,0,0
120438,were,0,1
120439,significantly,0,0
120440,high,0,1
120441,in,0,0
120442,700,0,1
120443,and,0,0
120444,500,0,0
120445,but,0,0
120446,not,0,0
120447,"3,000",0,0
120448,mg,0,0
120449,l??,0,0
120450,group,0,1
120451,compared,0,0
120452,to,0,0
120453,control,0,0
120454,.,0,0
120455,Serum,0,0
120456,lactate,0,0
120457,levels,0,0
120458,were,0,0
120459,significantly,0,0
120460,high,0,1
120461,in,0,0
120462,500,0,0
120463,mg,0,0
120464,l??,0,0
120465,group,0,1
120466,compared,0,0
120467,to,0,0
120468,control,0,0
120469,group,0,0
120470,.,0,0
120471,Lactate,0,0
120472,levels,0,0
120473,were,0,0
120474,not,0,0
120475,significantly,0,0
120476,differed,0,0
120477,between,0,0
120478,control,0,0
120479,",",0,0
120480,"3,000",0,0
120481,",",0,0
120482,and,0,0
120483,700,0,1
120484,mg,0,0
120485,l??,0,0
120486,groups,0,0
120487,.,0,0
120488,There,0,0
120489,were,0,0
120490,no,0,0
120491,significant,0,0
120492,differences,0,0
120493,in,0,0
120494,serum,0,0
120495,levels,0,0
120496,of,0,0
120497,cholesterol,0,0
120498,",",0,0
120499,total,0,1
120500,protein,0,0
120501,",",0,0
120502,lactate,0,0
120503,dehydrogenase,0,0
120504,",",0,0
120505,aspartate,0,0
120506,aminotransferase,0,0
120507,",",0,0
120508,alanine,0,0
120509,aminotransferase,0,0
120510,",",0,0
120511,Na?,0,0
120512,",",0,0
120513,Cl?,0,0
120514,",",0,0
120515,K?,0,0
120516,",",0,0
120517,and,0,0
120518,Ca??,0,1
120519,.,0,1
120520,Results,0,0
120521,suggest,0,0
120522,that,0,0
120523,rapid,0,0
120524,anesthesia,0,1
120525,with,0,1
120526,higher,0,0
120527,dose,0,0
120528,is,0,0
120529,better,0,0
120530,than,0,0
120531,slow,0,0
120532,anesthesia,0,1
120533,with,0,1
120534,lower,0,0
120535,dose,0,0
120536,for,0,0
120537,blood,0,0
120538,sampling,0,0
120539,in,0,0
120540,Beluga,1,1
120541,.,1,1
120542,Relationship,0,0
120543,between,0,0
120544,baseline,0,0
120545,blood,0,0
120546,pressure,0,0
120547,parameters,0,0
120548,(,0,0
120549,including,0,0
120550,mean,0,0
120551,pressure,0,0
120552,",",0,0
120553,pulse,0,0
120554,pressure,0,0
120555,",",0,0
120556,and,0,0
120557,variability,0,0
120558,),0,0
120559,and,0,0
120560,early,0,0
120561,outcome,0,0
120562,after,0,0
120563,stroke,1,1
120564,:,1,1
120565,data,0,0
120566,from,0,0
120567,the,0,0
120568,Tinzaparin,1,0
120569,in,1,0
120570,Acute,1,1
120571,Ischaemic,1,1
120572,Stroke,1,1
120573,Trial,1,1
120574,(,1,0
120575,TAIST,1,1
120576,),1,1
120577,.,1,1
120578,BACKGROUND,0,0
120579,AND,0,0
120580,PURPOSE,0,0
120581,High,1,0
120582,blood,1,0
120583,pressure,1,0
120584,(,1,0
120585,BP,1,0
120586,),1,0
120587,in,1,0
120588,acute,1,1
120589,stroke,1,1
120590,is,0,0
120591,associated,0,0
120592,independently,0,0
120593,with,0,1
120594,a,0,0
120595,poor,0,0
120596,outcome,0,0
120597,.,0,1
120598,Recent,0,0
120599,evidence,0,0
120600,suggests,0,0
120601,that,0,0
120602,other,0,0
120603,hemodynamic,0,0
120604,parameters,0,0
120605,may,0,0
120606,also,0,0
120607,be,0,0
120608,associated,0,0
120609,with,0,1
120610,outcomes,0,0
120611,following,0,0
120612,stroke,0,1
120613,.,0,1
120614,METHODS,0,0
120615,The,0,0
120616,relationship,0,0
120617,between,0,0
120618,baseline,0,0
120619,BP,0,0
120620,",",0,0
120621,heart,0,1
120622,rate,0,0
120623,",",0,0
120624,and,0,0
120625,other,0,0
120626,hemodynamic,0,0
120627,parameters,0,0
120628,",",0,0
120629,and,0,0
120630,early,0,0
120631,outcomes,0,0
120632,were,0,0
120633,assessed,0,0
120634,using,1,0
120635,data,1,0
120636,from,1,1
120637,TAIST,1,1
120638,trial,1,1
120639,.,1,1
120640,RESULTS,0,0
120641,Death,0,0
120642,or,0,1
120643,neurological,0,0
120644,deterioration,0,0
120645,at,0,0
120646,day,0,0
120647,10,0,1
120648,was,0,0
120649,associated,0,0
120650,",",0,0
120651,both,0,0
120652,in,0,0
120653,unadjusted,0,0
120654,and,0,1
120655,adjusted,0,0
120656,analyses,0,0
120657,",",0,0
120658,with,0,1
120659,systolic,0,1
120660,BP,0,0
120661,(,0,0
120662,adjusted,0,0
120663,OR,0,0
120664,",",0,0
120665,1.02,0,0
120666,;,0,0
120667,95,0,0
120668,%,0,0
120669,CI,0,0
120670,",",0,0
120671,1.01-1.03,0,0
120672,),0,0
120673,",",0,0
120674,mean,0,0
120675,arterial,0,1
120676,pressure,0,0
120677,(,0,0
120678,OR,0,0
120679,",",0,1
120680,1.02,0,0
120681,;,0,0
120682,95,0,0
120683,%,0,0
120684,CI,0,0
120685,",",0,0
120686,1.01-1.04,0,0
120687,),0,0
120688,",",0,0
120689,pulse,0,0
120690,pressure,0,0
120691,(,0,0
120692,OR,0,0
120693,",",0,1
120694,1.02,0,0
120695,;,0,0
120696,95,0,0
120697,%,0,0
120698,CI,0,0
120699,",",0,0
120700,1.01-1.03,0,0
120701,),0,0
120702,",",0,0
120703,and,0,0
120704,BP,0,0
120705,variability,0,0
120706,(,0,0
120707,OR,0,0
120708,",",0,1
120709,1.03,0,0
120710,;,0,0
120711,95,0,0
120712,%,0,0
120713,CI,0,0
120714,",",0,0
120715,1.01-1.05,0,0
120716,),0,0
120717,.,0,1
120718,Similar,0,0
120719,relationships,0,0
120720,were,0,1
120721,noted,0,0
120722,for,0,0
120723,deterioration,0,0
120724,alone,0,0
120725,",",0,0
120726,and,0,0
120727,recurrent,0,1
120728,stroke,0,1
120729,.,0,1
120730,CONCLUSIONS,0,0
120731,Early,0,0
120732,death,0,0
120733,or,0,1
120734,neurologic,0,1
120735,deterioration,0,0
120736,",",0,0
120737,deterioration,0,0
120738,",",0,0
120739,and,0,0
120740,recurrent,0,1
120741,stroke,0,1
120742,are,0,0
120743,associated,0,0
120744,independently,0,0
120745,with,0,1
120746,high,1,1
120747,systolic,1,1
120748,BP,1,0
120749,",",1,0
120750,mean,1,0
120751,arterial,1,0
120752,pressure,1,0
120753,",",1,0
120754,pulse,1,0
120755,pressure,1,0
120756,",",1,0
120757,and,1,0
120758,BP,1,0
120759,variability,1,0
120760,.,1,0
120761,These,0,0
120762,measures,0,0
120763,offer,0,0
120764,potential,0,0
120765,therapeutic,0,0
120766,targets,0,0
120767,for,0,0
120768,improving,0,0
120769,early,0,0
120770,outcome,0,0
120771,after,0,0
120772,acute,1,1
120773,ischemic,1,1
120774,stroke,1,1
120775,.,1,1
120776,In,0,0
120777,vitro,0,0
120778,determination,0,0
120779,of,0,0
120780,the,0,0
120781,chromatic,0,0
120782,effect,0,0
120783,of,0,0
120784,a,0,0
120785,silver,0,0
120786,nanoparticles,0,0
120787,solution,0,0
120788,linked,0,0
120789,to,0,0
120790,the,0,0
120791,gantrez,0,0
120792,S-97,0,0
120793,copolymer,0,0
120794,on,0,0
120795,tooth,1,0
120796,enamel,1,0
120797,.,1,0
120798,Silver,0,0
120799,nanoparticles,0,0
120800,(,0,1
120801,NNPs,0,0
120802,),0,0
120803,",",0,0
120804,alone,0,0
120805,or,0,0
120806,in,0,0
120807,combination,0,0
120808,with,0,1
120809,the,0,0
120810,bioadhesive,0,0
120811,Gantrez,0,0
120812,S-97,0,0
120813,",",0,0
120814,have,0,0
120815,demonstrated,0,0
120816,their,0,0
120817,efficacy,0,0
120818,against,0,0
120819,Streptococcus,0,1
120820,mutans,0,0
120821,;,0,0
120822,however,0,0
120823,",",0,0
120824,it,0,0
120825,is,0,0
120826,not,0,0
120827,known,0,0
120828,if,0,0
120829,this,0,0
120830,combination,0,0
120831,changes,0,0
120832,the,0,0
120833,color,0,0
120834,of,0,0
120835,teeth,0,1
120836,.,0,0
120837,The,0,0
120838,aim,0,0
120839,of,0,0
120840,this,0,0
120841,work,0,0
120842,was,0,0
120843,to,0,0
120844,measure,0,0
120845,the,0,0
120846,color,0,0
120847,changes,0,0
120848,occurring,0,0
120849,after,0,0
120850,the,0,0
120851,use,0,0
120852,of,0,0
120853,a,0,0
120854,Gantrez-NNP,0,0
120855,combination,0,0
120856,on,0,0
120857,enamel,0,0
120858,tooth,0,1
120859,blocks,0,0
120860,.,0,1
120861,Two,1,1
120862,study,1,0
120863,groups,1,0
120864,were,1,0
120865,randomly,1,1
120866,formed,1,0
120867,:,1,1
120868,enamel,1,0
120869,blocks,1,0
120870,brushed,1,0
120871,with,1,1
120872,(,1,0
120873,a,1,0
120874,),1,0
120875,the,1,0
120876,Gantrez-NNP,1,0
120877,combination,1,0
120878,and,1,0
120879,(,1,0
120880,b,1,1
120881,),1,0
120882,conventional,1,0
120883,toothpaste,1,0
120884,",",1,0
120885,for,1,0
120886,1,1,0
120887,minute,1,0
120888,once,1,0
120889,daily,1,0
120890,for,1,0
120891,4,1,0
120892,weeks,1,0
120893,",",1,0
120894,then,1,0
120895,rinsed,1,0
120896,with,1,1
120897,distilled,1,0
120898,water,1,0
120899,and,1,0
120900,placed,1,0
120901,in,1,0
120902,thymol,1,0
120903,solution,1,0
120904,.,1,1
120905,Color,0,0
120906,changes,0,0
120907,in,0,0
120908,the,0,0
120909,enamel,0,0
120910,blocks,0,0
120911,were,0,0
120912,measured,0,0
120913,using,0,0
120914,a,0,0
120915,Minolta,0,0
120916,colorimeter,0,1
120917,CR300,0,0
120918,.,0,0
120919,Analysis,0,0
120920,of,0,0
120921,mixed,0,0
120922,models,0,0
120923,was,0,0
120924,performed,0,0
120925,with,0,1
120926,R,0,1
120927,2.10.1,0,0
120928,at,0,0
120929,a,0,0
120930,95,0,0
120931,%,0,0
120932,confidence,0,0
120933,level,0,0
120934,",",0,0
120935,using,0,0
120936,the,0,0
120937,nonlinear,0,0
120938,mixed,0,0
120939,effects,0,0
120940,(,0,1
120941,NLME,0,0
120942,),0,0
120943,package,0,0
120944,.,0,0
120945,The,0,0
120946,results,0,0
120947,showed,0,0
120948,that,0,0
120949,there,0,0
120950,were,0,0
120951,no,0,0
120952,color,0,0
120953,changes,0,0
120954,over,0,0
120955,time,0,0
120956,",",0,0
120957,only,0,0
120958,a,0,0
120959,high,0,0
120960,luminosity,0,0
120961,equal,0,0
120962,in,0,0
120963,both,0,0
120964,groups,0,0
120965,.,0,0
120966,Our,0,0
120967,study,0,0
120968,showed,0,0
120969,that,0,0
120970,the,0,0
120971,use,0,0
120972,of,0,0
120973,the,0,0
120974,Gantrez-NNP,0,0
120975,combination,0,0
120976,is,0,0
120977,safe,0,0
120978,with,0,0
120979,respect,0,0
120980,to,0,0
120981,dental,1,1
120982,esthetics,1,0
120983,in,0,0
120984,the,0,0
120985,control,0,0
120986,of,0,0
120987,S.,0,1
120988,mutans,0,0
120989,.,0,1
120990,Effect,0,0
120991,of,0,0
120992,weight,0,0
120993,loss,0,0
120994,on,0,0
120995,inflammation,0,0
120996,in,0,0
120997,patients,1,1
120998,with,1,1
120999,mild,1,1
121000,obstructive,1,1
121001,sleep,1,1
121002,apnea,1,1
121003,.,1,0
121004,BACKGROUND,0,0
121005,AND,0,0
121006,AIMS,0,0
121007,Inflammation,0,0
121008,may,0,0
121009,be,0,0
121010,one,0,0
121011,mediating,0,0
121012,mechanism,0,0
121013,for,0,0
121014,cardiovascular,1,1
121015,diseases,1,1
121016,in,1,0
121017,obstructive,1,1
121018,sleep,1,0
121019,apnea,1,1
121020,(,1,0
121021,OSA,1,1
121022,),1,0
121023,.,0,0
121024,However,0,0
121025,",",0,0
121026,little,0,0
121027,is,0,0
121028,known,0,0
121029,about,0,0
121030,subclinical,0,1
121031,inflammation,0,0
121032,or,0,0
121033,the,0,0
121034,effect,0,0
121035,of,0,0
121036,lifestyle,0,1
121037,intervention,0,0
121038,on,0,0
121039,inflammation,0,0
121040,in,0,0
121041,early,0,1
121042,stages,0,1
121043,of,0,1
121044,OSA,0,1
121045,.,0,0
121046,The,0,0
121047,aim,0,0
121048,of,0,0
121049,this,0,0
121050,substudy,0,0
121051,of,0,0
121052,an,0,0
121053,existing,0,0
121054,randomized,0,0
121055,controlled,0,0
121056,trial,0,0
121057,",",0,0
121058,with,0,0
121059,post,0,0
121060,hoc,0,0
121061,analyses,0,0
121062,",",0,0
121063,was,0,0
121064,to,0,0
121065,determine,0,0
121066,the,0,0
121067,impact,0,0
121068,of,0,0
121069,lifestyle,0,1
121070,changes,0,0
121071,aimed,0,0
121072,at,0,0
121073,weight,0,0
121074,reduction,0,0
121075,on,0,0
121076,inflammatory,0,0
121077,biomarkers,0,0
121078,in,0,0
121079,overweight,1,1
121080,patients,1,1
121081,with,1,1
121082,mild,1,1
121083,OSA,1,1
121084,.,1,1
121085,METHODS,0,0
121086,AND,0,0
121087,RESULTS,0,0
121088,Patients,1,1
121089,were,1,1
121090,randomized,1,1
121091,to,1,0
121092,supervised,1,0
121093,intensive,1,1
121094,lifestyle,1,1
121095,intervention,1,0
121096,group,1,0
121097,(,1,0
121098,N=28,1,1
121099,),1,0
121100,or,1,0
121101,to,1,0
121102,control,1,0
121103,group,1,0
121104,(,1,0
121105,N=31,1,0
121106,),1,0
121107,",",1,0
121108,which,1,0
121109,received,1,0
121110,routine,1,0
121111,lifestyle,1,1
121112,advices,1,0
121113,.,1,1
121114,Circulating,0,0
121115,concentrations,0,0
121116,of,0,0
121117,pro-,0,0
121118,and,0,1
121119,anti-inflammatory,0,0
121120,mediators,0,0
121121,were,0,1
121122,measured,0,0
121123,before,0,0
121124,and,0,0
121125,after,0,0
121126,the,0,0
121127,1-year,0,0
121128,intervention,0,0
121129,.,0,0
121130,The,0,0
121131,concentrations,0,0
121132,of,0,0
121133,two,0,1
121134,pro-inflammatory,0,0
121135,mediators,0,0
121136,",",0,1
121137,high-sensitivity,0,0
121138,C-reactive,0,0
121139,protein,0,0
121140,(,0,0
121141,hsCRP,0,0
121142,),0,0
121143,and,0,0
121144,interleukin,0,0
121145,(,0,0
121146,IL,0,1
121147,),0,0
121148,-6,0,0
121149,",",0,0
121150,decreased,0,0
121151,significantly,0,0
121152,in,0,0
121153,both,0,0
121154,groups,0,0
121155,.,0,0
121156,Although,0,0
121157,the,0,0
121158,changes,0,0
121159,in,0,0
121160,inflammatory,0,0
121161,biomarkers,0,0
121162,favored,0,0
121163,the,0,0
121164,supervised,0,0
121165,lifestyle,0,1
121166,intervention,0,0
121167,",",0,0
121168,the,0,0
121169,only,0,0
121170,significant,0,0
121171,reduction,0,0
121172,observed,0,0
121173,between,0,0
121174,the,0,0
121175,groups,0,0
121176,was,0,0
121177,for,0,0
121178,the,0,0
121179,anti-inflammatory,0,0
121180,IL-1,0,1
121181,receptor,0,0
121182,antagonist,0,0
121183,(,0,0
121184,IL-1RA,0,1
121185,),0,0
121186,.,0,0
121187,The,0,0
121188,change,0,0
121189,in,0,0
121190,hsCRP,0,0
121191,was,0,0
121192,associated,0,0
121193,with,0,1
121194,apnea-hypopnea,0,1
121195,index,0,0
121196,",",0,0
121197,and,0,0
121198,improving,0,0
121199,night-time,0,0
121200,oxygen,0,0
121201,saturation,0,0
121202,was,0,0
121203,related,0,0
121204,to,0,0
121205,tumor,0,0
121206,necrosis,0,0
121207,factor,0,0
121208,alpha,0,0
121209,.,0,0
121210,IL-1RA,0,0
121211,and,0,0
121212,IL-6,0,0
121213,were,0,0
121214,associated,0,0
121215,with,0,1
121216,insulin,0,0
121217,metabolism,0,0
121218,.,0,1
121219,CONCLUSION,0,0
121220,Weight,0,1
121221,loss,0,0
121222,resulted,0,0
121223,in,0,0
121224,reductions,0,0
121225,in,0,1
121226,concentrations,0,0
121227,of,0,0
121228,some,0,0
121229,pro-,0,0
121230,and,0,0
121231,anti-inflammatory,0,0
121232,mediators,0,0
121233,in,0,1
121234,overweight,1,1
121235,patients,1,1
121236,with,1,1
121237,mild,1,1
121238,OSA,1,1
121239,",",0,0
121240,overall,0,0
121241,favoring,0,0
121242,the,0,0
121243,supervised,0,0
121244,lifestyle,0,1
121245,intervention,0,0
121246,.,0,0
121247,These,0,0
121248,findings,0,0
121249,suggest,0,0
121250,that,0,0
121251,more,0,0
121252,intensive,0,0
121253,treatment,0,0
121254,of,0,0
121255,obesity,0,1
121256,in,0,0
121257,OSA,1,1
121258,patients,1,1
121259,might,0,0
121260,be,0,0
121261,well-justified,0,0
121262,.,0,1
121263,Treatment,0,0
121264,of,0,0
121265,acute,1,1
121266,otitis,1,1
121267,media,1,0
121268,in,1,0
121269,children,1,1
121270,under,1,1
121271,2,1,1
121272,years,1,1
121273,of,1,1
121274,age,1,1
121275,.,1,1
121276,BACKGROUND,0,0
121277,Recommendations,0,0
121278,vary,0,0
121279,regarding,0,0
121280,immediate,0,0
121281,antimicrobial,0,0
121282,treatment,0,0
121283,versus,0,0
121284,watchful,0,1
121285,waiting,0,1
121286,for,0,0
121287,children,1,1
121288,younger,1,1
121289,than,1,0
121290,2,1,0
121291,years,1,1
121292,of,1,0
121293,age,1,1
121294,with,1,1
121295,acute,1,1
121296,otitis,1,1
121297,media,1,0
121298,.,1,1
121299,METHODS,0,0
121300,We,0,0
121301,randomly,0,1
121302,assigned,0,0
121303,291,1,1
121304,children,1,1
121305,6,1,1
121306,to,1,1
121307,23,1,1
121308,months,1,0
121309,of,1,0
121310,age,1,1
121311,",",1,0
121312,with,1,1
121313,acute,1,1
121314,otitis,1,1
121315,media,1,0
121316,diagnosed,1,1
121317,with,1,1
121318,the,1,0
121319,use,1,0
121320,of,1,0
121321,stringent,1,1
121322,criteria,1,1
121323,",",0,0
121324,to,0,0
121325,receive,0,0
121326,amoxicillin-clavulanate,0,0
121327,or,0,0
121328,placebo,0,0
121329,for,0,0
121330,10,0,1
121331,days,0,0
121332,.,0,1
121333,We,0,0
121334,measured,0,0
121335,symptomatic,0,1
121336,response,0,0
121337,and,0,0
121338,rates,0,0
121339,of,0,0
121340,clinical,0,0
121341,failure,0,1
121342,.,0,0
121343,RESULTS,0,0
121344,Among,0,1
121345,the,0,1
121346,children,0,1
121347,who,0,1
121348,received,0,1
121349,amoxicillin-clavulanate,0,1
121350,",",0,0
121351,35,0,0
121352,%,0,0
121353,had,0,1
121354,initial,0,0
121355,resolution,0,0
121356,of,0,0
121357,symptoms,0,0
121358,by,0,0
121359,day,0,0
121360,2,0,0
121361,",",0,0
121362,61,0,1
121363,%,0,0
121364,by,0,0
121365,day,0,0
121366,4,0,0
121367,",",0,0
121368,and,0,0
121369,80,0,1
121370,%,0,0
121371,by,0,0
121372,day,0,0
121373,7,0,1
121374,;,0,0
121375,among,0,1
121376,children,0,1
121377,who,0,1
121378,received,0,1
121379,placebo,0,1
121380,",",0,0
121381,28,0,1
121382,%,0,0
121383,had,0,1
121384,initial,0,0
121385,resolution,0,0
121386,of,0,0
121387,symptoms,0,0
121388,by,0,0
121389,day,0,0
121390,2,0,0
121391,",",0,0
121392,54,0,1
121393,%,0,0
121394,by,0,0
121395,day,0,0
121396,4,0,0
121397,",",0,0
121398,and,0,0
121399,74,0,1
121400,%,0,0
121401,by,0,0
121402,day,0,0
121403,7,0,1
121404,(,0,0
121405,P=0.14,0,0
121406,for,0,0
121407,the,0,0
121408,overall,0,0
121409,comparison,0,0
121410,),0,0
121411,.,0,0
121412,For,0,0
121413,sustained,0,0
121414,resolution,0,0
121415,of,0,0
121416,symptoms,0,0
121417,",",0,0
121418,the,0,0
121419,corresponding,0,0
121420,values,0,0
121421,were,0,1
121422,20,0,1
121423,%,0,0
121424,",",0,0
121425,41,0,1
121426,%,0,0
121427,",",0,0
121428,and,0,0
121429,67,0,1
121430,%,0,0
121431,with,0,1
121432,amoxicillin-clavulanate,0,0
121433,",",0,0
121434,as,0,0
121435,compared,0,0
121436,with,0,1
121437,14,0,0
121438,%,0,0
121439,",",0,0
121440,36,0,0
121441,%,0,0
121442,",",0,0
121443,and,0,0
121444,53,0,1
121445,%,0,0
121446,with,0,1
121447,placebo,0,0
121448,(,0,0
121449,P=0.04,0,0
121450,for,0,0
121451,the,0,0
121452,overall,0,0
121453,comparison,0,0
121454,),0,0
121455,.,0,0
121456,Mean,0,0
121457,symptom,0,0
121458,scores,0,0
121459,over,0,0
121460,the,0,0
121461,first,0,0
121462,7,0,1
121463,days,0,0
121464,were,0,1
121465,lower,0,0
121466,for,0,0
121467,the,0,0
121468,children,0,1
121469,treated,0,1
121470,with,0,1
121471,amoxicillin-clavulanate,0,0
121472,than,0,0
121473,for,0,1
121474,those,0,1
121475,who,0,1
121476,received,0,1
121477,placebo,0,1
121478,(,0,0
121479,P=0.02,0,0
121480,),0,0
121481,.,0,0
121482,The,0,0
121483,rate,0,0
121484,of,0,0
121485,clinical,0,0
121486,failure,0,1
121487,--,0,1
121488,defined,0,0
121489,as,0,0
121490,the,0,0
121491,persistence,0,0
121492,of,0,0
121493,signs,0,0
121494,of,0,0
121495,acute,0,1
121496,infection,0,1
121497,on,0,0
121498,otoscopic,0,1
121499,examination,0,1
121500,--,0,1
121501,was,0,0
121502,also,0,0
121503,lower,0,0
121504,among,0,0
121505,the,0,0
121506,children,0,1
121507,treated,0,1
121508,with,0,1
121509,amoxicillin-clavulanate,0,0
121510,than,0,0
121511,among,0,1
121512,those,0,1
121513,who,0,1
121514,received,0,1
121515,placebo,0,1
121516,:,0,1
121517,4,0,0
121518,%,0,0
121519,versus,0,0
121520,23,0,1
121521,%,0,0
121522,at,0,0
121523,or,0,0
121524,before,0,0
121525,the,0,0
121526,visit,0,0
121527,on,0,0
121528,day,0,0
121529,4,0,0
121530,or,0,1
121531,5,0,0
121532,(,0,0
121533,P,0,0
121534,<,0,0
121535,0.001,0,0
121536,),0,0
121537,and,0,0
121538,16,0,1
121539,%,0,0
121540,versus,0,0
121541,51,0,1
121542,%,0,0
121543,at,0,0
121544,or,0,0
121545,before,0,0
121546,the,0,0
121547,visit,0,0
121548,on,0,0
121549,day,0,0
121550,10,0,1
121551,to,0,0
121552,12,0,0
121553,(,0,0
121554,P,0,0
121555,<,0,0
121556,0.001,0,0
121557,),0,1
121558,.,0,1
121559,Mastoiditis,0,0
121560,developed,0,0
121561,in,0,0
121562,one,0,1
121563,child,0,1
121564,who,0,1
121565,received,0,1
121566,placebo,0,1
121567,.,0,0
121568,Diarrhea,0,0
121569,and,0,0
121570,diaper-area,0,0
121571,dermatitis,0,1
121572,were,0,0
121573,more,0,0
121574,common,0,0
121575,among,0,1
121576,children,0,1
121577,who,0,1
121578,received,0,1
121579,amoxicillin-clavulanate,0,1
121580,.,0,0
121581,There,0,0
121582,were,0,0
121583,no,0,0
121584,significant,0,0
121585,changes,0,0
121586,in,0,0
121587,either,0,0
121588,group,0,0
121589,in,0,0
121590,the,0,0
121591,rates,0,0
121592,of,0,0
121593,nasopharyngeal,0,1
121594,colonization,0,0
121595,with,0,1
121596,nonsusceptible,0,1
121597,Streptococcus,0,1
121598,pneumoniae,0,1
121599,.,0,0
121600,CONCLUSIONS,0,0
121601,Among,0,1
121602,children,1,1
121603,6,1,1
121604,to,1,1
121605,23,1,1
121606,months,1,0
121607,of,1,0
121608,age,1,1
121609,with,1,1
121610,acute,1,1
121611,otitis,1,1
121612,media,1,0
121613,",",0,0
121614,treatment,0,0
121615,with,0,0
121616,amoxicillin-clavulanate,0,0
121617,for,0,0
121618,10,0,1
121619,days,0,0
121620,tended,0,0
121621,to,0,0
121622,reduce,0,0
121623,the,0,0
121624,time,0,0
121625,to,0,0
121626,resolution,0,0
121627,of,0,0
121628,symptoms,0,0
121629,and,0,0
121630,reduced,0,0
121631,the,0,0
121632,overall,0,0
121633,symptom,0,0
121634,burden,0,0
121635,and,0,0
121636,the,0,0
121637,rate,0,0
121638,of,0,0
121639,persistent,0,1
121640,signs,0,1
121641,of,0,0
121642,acute,0,1
121643,infection,0,1
121644,on,0,0
121645,otoscopic,0,1
121646,examination,0,1
121647,.,0,0
121648,(,0,0
121649,Funded,0,0
121650,by,0,0
121651,the,0,0
121652,National,0,0
121653,Institute,0,1
121654,of,0,0
121655,Allergy,0,1
121656,and,0,0
121657,Infectious,0,1
121658,Diseases,0,1
121659,;,0,0
121660,ClinicalTrials.gov,0,0
121661,number,0,0
121662,",",0,0
121663,NCT00377260,0,1
121664,.,0,1
121665,),0,0
121666,.,0,0
121667,The,0,0
121668,effect,0,0
121669,of,0,0
121670,an,0,0
121671,early,0,0
121672,education,0,0
121673,program,0,0
121674,on,0,0
121675,adult,1,1
121676,health,1,1
121677,:,1,1
121678,the,0,0
121679,Carolina,0,1
121680,Abecedarian,0,1
121681,Project,0,0
121682,randomized,0,0
121683,controlled,0,0
121684,trial,0,0
121685,.,0,0
121686,OBJECTIVES,0,0
121687,We,0,0
121688,explored,0,0
121689,whether,0,0
121690,a,0,0
121691,successful,0,0
121692,randomized,0,0
121693,controlled,0,0
121694,trial,0,0
121695,of,0,0
121696,early,0,0
121697,education,0,0
121698,",",0,0
121699,the,0,0
121700,Carolina,0,1
121701,Abecedarian,0,1
121702,Project,0,0
121703,(,0,0
121704,ABC,0,0
121705,),0,0
121706,",",0,0
121707,which,0,0
121708,enrolled,1,1
121709,infants,1,1
121710,from,1,1
121711,1972,1,1
121712,to,1,0
121713,1977,1,1
121714,at,1,0
121715,the,1,0
121716,Frank,1,1
121717,Porter,1,1
121718,Graham,1,1
121719,Child,1,1
121720,Development,1,0
121721,Institute,1,1
121722,in,1,0
121723,Chapel,1,1
121724,Hill,1,0
121725,",",1,0
121726,North,1,1
121727,Carolina,1,1
121728,",",0,0
121729,improved,0,0
121730,health,0,1
121731,outcomes,0,0
121732,and,0,0
121733,behaviors,0,0
121734,by,0,0
121735,21,0,1
121736,years,0,1
121737,of,0,1
121738,age,0,1
121739,.,0,1
121740,METHODS,0,0
121741,ABC,0,0
121742,randomized,1,1
121743,111,1,1
121744,infants,1,1
121745,to,1,0
121746,receive,1,0
121747,an,1,0
121748,intensive,1,0
121749,early,1,0
121750,education,1,0
121751,program,1,0
121752,or,1,1
121753,nutritional,1,0
121754,supplements,1,0
121755,and,1,1
121756,parental,1,0
121757,counseling,1,0
121758,alone,1,0
121759,;,1,0
121760,participants,1,1
121761,have,1,0
121762,been,1,0
121763,followed,1,0
121764,to,1,0
121765,the,1,0
121766,present,1,0
121767,day,1,0
121768,.,1,1
121769,We,0,0
121770,examined,0,0
121771,the,0,0
121772,effect,0,0
121773,of,0,0
121774,ABC,0,0
121775,on,0,0
121776,health,0,1
121777,outcomes,0,0
121778,and,0,0
121779,behavioral,0,1
121780,risk,0,1
121781,factors,0,0
121782,when,1,0
121783,participants,1,1
121784,were,1,0
121785,aged,1,1
121786,21,1,1
121787,years,1,1
121788,",",0,0
121789,and,0,0
121790,then,0,0
121791,explored,0,0
121792,the,0,0
121793,mediators,0,0
121794,of,0,0
121795,this,0,0
121796,relationship,0,0
121797,.,0,0
121798,RESULTS,0,0
121799,Relative,0,0
121800,to,0,0
121801,the,0,0
121802,control,0,0
121803,group,0,0
121804,",",0,0
121805,the,0,0
121806,ABC,0,0
121807,treatment,0,0
121808,group,0,0
121809,was,0,0
121810,previously,0,0
121811,found,0,0
121812,to,0,0
121813,have,0,0
121814,improved,0,0
121815,cognition,0,0
121816,and,0,0
121817,educational,0,0
121818,attainment,0,0
121819,.,0,1
121820,We,0,0
121821,found,0,0
121822,that,0,0
121823,the,0,0
121824,intervention,0,0
121825,also,0,0
121826,improved,0,0
121827,heath,0,1
121828,(,0,0
121829,P,0,0
121830,=,0,0
121831,.05,0,0
121832,),0,0
121833,and,0,0
121834,health,0,1
121835,behaviors,0,0
121836,(,0,1
121837,P,0,0
121838,=,0,0
121839,.03,0,0
121840,),0,0
121841,when,0,0
121842,participants,0,1
121843,were,0,0
121844,aged,0,1
121845,21,0,1
121846,years,0,1
121847,.,0,1
121848,These,0,0
121849,improvements,0,0
121850,in,0,0
121851,behaviors,0,0
121852,were,0,1
121853,not,0,0
121854,mediated,0,0
121855,by,0,0
121856,IQ,0,1
121857,",",0,0
121858,math,0,0
121859,and,0,0
121860,reading,0,0
121861,scores,0,0
121862,at,0,1
121863,15,0,1
121864,years,0,1
121865,of,0,0
121866,age,0,1
121867,",",0,0
121868,educational,0,0
121869,attainment,0,0
121870,",",0,0
121871,or,0,0
121872,health,0,0
121873,insurance,0,1
121874,.,0,1
121875,CONCLUSIONS,0,0
121876,Effective,0,0
121877,early,0,1
121878,education,0,0
121879,programs,0,0
121880,may,0,0
121881,improve,0,0
121882,health,0,0
121883,and,0,0
121884,reduce,0,0
121885,risky,0,0
121886,health,0,1
121887,behaviors,0,0
121888,in,0,0
121889,adulthood,0,1
121890,.,0,1
121891,Triple,0,0
121892,antiretroviral,0,1
121893,compared,0,0
121894,with,0,1
121895,zidovudine,0,0
121896,and,0,0
121897,single-dose,0,0
121898,nevirapine,0,0
121899,prophylaxis,0,1
121900,during,0,0
121901,pregnancy,0,1
121902,and,0,0
121903,breastfeeding,0,0
121904,for,0,0
121905,prevention,0,0
121906,of,0,0
121907,mother-to-child,0,0
121908,transmission,0,0
121909,of,0,0
121910,HIV-1,0,1
121911,(,0,1
121912,Kesho,0,0
121913,Bora,0,0
121914,study,0,1
121915,),0,0
121916,:,0,1
121917,a,0,0
121918,randomised,0,0
121919,controlled,0,0
121920,trial,0,0
121921,.,0,1
121922,BACKGROUND,0,0
121923,Breastfeeding,0,0
121924,is,0,0
121925,essential,0,0
121926,for,0,0
121927,child,0,1
121928,health,0,1
121929,and,0,0
121930,development,0,0
121931,in,0,0
121932,low-resource,0,1
121933,settings,0,0
121934,but,0,0
121935,carries,0,0
121936,a,0,0
121937,significant,0,0
121938,risk,0,0
121939,of,0,0
121940,transmission,0,0
121941,of,0,0
121942,HIV-1,0,1
121943,",",0,0
121944,especially,0,0
121945,in,0,0
121946,late,0,1
121947,stages,0,1
121948,of,0,0
121949,maternal,0,1
121950,disease,0,1
121951,.,0,1
121952,We,0,0
121953,aimed,0,0
121954,to,0,0
121955,assess,0,0
121956,the,0,0
121957,efficacy,0,0
121958,and,0,0
121959,safety,0,0
121960,of,0,0
121961,triple,0,0
121962,antiretroviral,0,1
121963,compared,0,0
121964,with,0,1
121965,zidovudine,0,0
121966,and,0,0
121967,single-dose,0,0
121968,nevirapine,0,0
121969,prophylaxis,0,0
121970,in,0,0
121971,pregnant,1,1
121972,women,1,1
121973,infected,1,1
121974,with,1,1
121975,HIV,1,1
121976,.,1,1
121977,METHODS,0,0
121978,Pregnant,1,1
121979,women,1,1
121980,with,1,1
121981,WHO,1,0
121982,stage,1,1
121983,1,1,0
121984,",",1,0
121985,2,1,0
121986,",",1,0
121987,or,1,1
121988,3,1,0
121989,HIV-1,1,1
121990,infection,1,1
121991,who,1,1
121992,had,1,1
121993,CD4,1,1
121994,cell,1,1
121995,counts,1,0
121996,of,1,0
121997,200-500,1,1
121998,cells,1,0
121999,per,1,1
122000,?L,1,0
122001,were,0,0
122002,enrolled,0,1
122003,at,0,0
122004,five,0,1
122005,study,0,1
122006,sites,0,0
122007,in,1,0
122008,Burkina,1,1
122009,Faso,1,0
122010,",",1,0
122011,Kenya,1,1
122012,",",1,0
122013,and,1,0
122014,South,1,1
122015,Africa,1,0
122016,to,1,0
122017,start,1,0
122018,study,1,0
122019,treatment,1,0
122020,at,1,0
122021,28-36,1,1
122022,weeks,1,0
122023,',1,1
122024,gestation,1,1
122025,.,1,1
122026,Women,0,1
122027,were,0,0
122028,randomly,0,1
122029,assigned,0,1
122030,(,0,0
122031,1:1,0,0
122032,),0,0
122033,by,0,0
122034,a,0,0
122035,computer,0,0
122036,generated,0,0
122037,random,0,1
122038,sequence,0,0
122039,to,0,0
122040,either,0,0
122041,triple,0,0
122042,antiretroviral,0,1
122043,prophylaxis,0,1
122044,(,0,0
122045,a,0,0
122046,combination,0,0
122047,of,0,0
122048,300,0,0
122049,mg,0,0
122050,zidovudine,0,1
122051,",",0,0
122052,150,0,0
122053,mg,0,0
122054,lamivudine,0,0
122055,",",0,0
122056,and,0,0
122057,400,0,0
122058,mg,0,0
122059,lopinavir,0,0
122060,plus,0,0
122061,100,0,0
122062,mg,0,0
122063,ritonavir,0,0
122064,twice,0,0
122065,daily,0,0
122066,until,0,0
122067,cessation,0,0
122068,of,0,0
122069,breastfeeding,0,0
122070,to,0,0
122071,a,0,0
122072,maximum,0,0
122073,of,0,0
122074,6?5,0,0
122075,months,0,0
122076,post,0,1
122077,partum,0,1
122078,),0,0
122079,or,0,0
122080,zidovudine,0,0
122081,and,0,0
122082,single-dose,0,0
122083,nevirapine,0,0
122084,(,0,0
122085,300,0,0
122086,mg,0,0
122087,zidovudine,0,0
122088,twice,0,0
122089,daily,0,0
122090,until,0,0
122091,delivery,0,0
122092,and,0,0
122093,a,0,0
122094,dose,0,0
122095,of,0,0
122096,600,0,1
122097,mg,0,0
122098,zidovudine,0,1
122099,plus,0,0
122100,200,0,0
122101,mg,0,0
122102,nevirapine,0,0
122103,at,0,0
122104,the,0,0
122105,onset,0,0
122106,of,0,0
122107,labour,0,0
122108,and,0,0
122109,",",0,0
122110,after,0,0
122111,a,0,0
122112,protocol,0,0
122113,amendment,0,0
122114,in,0,0
122115,December,0,1
122116,",",0,0
122117,2006,0,1
122118,",",0,0
122119,1,0,0
122120,week,0,0
122121,post-partum,0,1
122122,zidovudine,0,1
122123,300,0,0
122124,mg,0,0
122125,twice,0,0
122126,daily,0,0
122127,and,0,0
122128,lamivudine,0,0
122129,150,0,0
122130,mg,0,0
122131,twice,0,0
122132,daily,0,0
122133,),0,0
122134,.,0,0
122135,All,1,1
122136,infants,1,1
122137,received,1,0
122138,a,0,0
122139,0?6,0,0
122140,mL,0,0
122141,dose,0,0
122142,of,0,0
122143,nevirapine,0,0
122144,at,0,0
122145,birth,0,1
122146,and,0,0
122147,",",0,0
122148,from,0,0
122149,December,0,1
122150,",",0,0
122151,2006,0,1
122152,",",0,0
122153,4,0,0
122154,mg/kg,0,0
122155,twice,0,0
122156,daily,0,0
122157,of,0,0
122158,zidovudine,0,0
122159,for,0,0
122160,1,0,0
122161,week,0,0
122162,after,0,0
122163,birth,0,1
122164,.,0,1
122165,Patients,0,1
122166,and,0,0
122167,investigators,0,0
122168,were,0,0
122169,not,0,0
122170,masked,0,0
122171,to,0,0
122172,treatment,0,0
122173,.,0,0
122174,The,0,0
122175,primary,0,0
122176,endpoints,0,0
122177,were,0,1
122178,HIV-free,0,0
122179,infant,0,1
122180,survival,0,0
122181,at,0,0
122182,6,0,0
122183,weeks,0,0
122184,and,0,1
122185,12,0,1
122186,months,0,0
122187,;,0,1
122188,HIV-free,0,0
122189,survival,0,0
122190,at,0,0
122191,12,0,0
122192,months,0,0
122193,in,0,1
122194,infants,0,1
122195,who,0,1
122196,were,0,1
122197,ever,0,1
122198,breastfed,0,0
122199,;,0,0
122200,AIDS-free,0,0
122201,survival,0,0
122202,in,0,0
122203,mothers,0,1
122204,at,0,1
122205,18,0,1
122206,months,0,0
122207,;,0,1
122208,and,0,0
122209,serious,0,0
122210,adverse,0,0
122211,events,0,0
122212,in,0,1
122213,mothers,0,1
122214,and,0,1
122215,babies,0,1
122216,.,0,1
122217,Analysis,0,0
122218,was,0,0
122219,by,0,0
122220,intention,0,0
122221,to,0,0
122222,treat,0,0
122223,.,0,0
122224,This,0,0
122225,trial,0,0
122226,is,0,0
122227,registered,0,0
122228,with,0,0
122229,Current,0,1
122230,Controlled,0,1
122231,Trials,0,0
122232,",",0,0
122233,ISRCTN71468401,0,0
122234,.,0,0
122235,FINDINGS,1,0
122236,From,1,1
122237,June,1,1
122238,",",1,0
122239,2005,1,1
122240,",",1,0
122241,to,1,0
122242,August,1,1
122243,",",1,0
122244,2008,1,1
122245,",",1,0
122246,882,1,1
122247,women,1,1
122248,were,1,1
122249,enrolled,1,1
122250,",",1,0
122251,824,1,1
122252,of,0,1
122253,whom,0,1
122254,were,0,1
122255,randomised,0,1
122256,and,0,0
122257,gave,0,0
122258,birth,0,1
122259,to,0,0
122260,805,1,1
122261,singleton,1,1
122262,or,1,1
122263,first,1,0
122264,",",1,0
122265,liveborn,1,1
122266,infants,1,1
122267,.,1,1
122268,The,1,0
122269,cumulative,0,0
122270,rate,0,0
122271,of,0,0
122272,HIV,0,1
122273,transmission,0,0
122274,at,0,0
122275,6,0,0
122276,weeks,0,0
122277,was,0,0
122278,3?3,0,1
122279,%,0,0
122280,(,0,0
122281,95,0,0
122282,%,0,0
122283,CI,0,0
122284,1?9-5?6,0,0
122285,%,0,0
122286,),0,0
122287,in,0,0
122288,the,0,0
122289,triple,0,0
122290,antiretroviral,0,1
122291,group,0,0
122292,compared,0,0
122293,with,0,1
122294,5?0,0,0
122295,%,0,0
122296,(,0,0
122297,3?3-7?7,0,1
122298,%,0,0
122299,),0,0
122300,in,0,0
122301,the,0,0
122302,zidovudine,0,0
122303,and,0,0
122304,single-dose,0,0
122305,nevirapine,0,0
122306,group,0,0
122307,",",0,0
122308,and,0,0
122309,at,0,0
122310,12,0,1
122311,months,0,0
122312,was,0,0
122313,5?4,0,1
122314,%,0,0
122315,(,0,0
122316,3?6-8?1,0,0
122317,%,0,0
122318,),0,0
122319,in,0,0
122320,the,0,0
122321,triple,0,0
122322,antiretroviral,0,1
122323,group,0,0
122324,compared,0,0
122325,with,0,1
122326,9?5,0,0
122327,%,0,0
122328,(,0,0
122329,7?0-12?9,0,1
122330,%,0,0
122331,),0,0
122332,in,0,0
122333,the,0,0
122334,zidovudine,0,0
122335,and,0,0
122336,single-dose,0,0
122337,nevirapine,0,0
122338,group,0,0
122339,(,0,0
122340,p=0?029,0,0
122341,),0,0
122342,.,0,0
122343,The,0,0
122344,cumulative,0,0
122345,rate,0,0
122346,of,0,0
122347,HIV,0,1
122348,transmission,0,0
122349,or,0,0
122350,death,0,0
122351,at,0,0
122352,12,0,1
122353,months,0,0
122354,was,0,0
122355,10?2,0,1
122356,%,0,0
122357,(,0,0
122358,95,0,0
122359,%,0,0
122360,CI,0,0
122361,7?6-13?6,0,0
122362,%,0,0
122363,),0,0
122364,in,0,0
122365,the,0,0
122366,triple,0,0
122367,antiretroviral,0,1
122368,group,0,0
122369,compared,0,0
122370,with,0,1
122371,16?0,0,0
122372,%,0,0
122373,(,0,0
122374,12?7-20?0,0,0
122375,%,0,0
122376,),0,0
122377,in,0,0
122378,the,0,0
122379,zidovudine,0,0
122380,and,0,0
122381,single-dose,0,0
122382,nevirapine,0,0
122383,group,0,0
122384,(,0,0
122385,p=0?017,0,0
122386,),0,0
122387,.,0,0
122388,In,0,0
122389,infants,0,1
122390,whose,0,1
122391,mothers,0,1
122392,declared,0,0
122393,they,0,1
122394,intended,0,0
122395,to,0,0
122396,breastfeed,0,0
122397,",",0,0
122398,the,0,0
122399,cumulative,0,0
122400,rate,0,0
122401,of,0,0
122402,HIV,0,1
122403,transmission,0,0
122404,at,0,0
122405,12,0,1
122406,months,0,0
122407,was,0,0
122408,5?6,0,0
122409,%,0,0
122410,(,0,0
122411,95,0,0
122412,%,0,0
122413,CI,0,0
122414,3?4-8?9,0,0
122415,%,0,0
122416,),0,0
122417,in,0,0
122418,the,0,0
122419,triple,0,0
122420,antiretroviral,0,1
122421,group,0,0
122422,compared,0,0
122423,with,0,1
122424,10?7,0,0
122425,%,0,0
122426,(,0,0
122427,7?6-14?8,0,0
122428,%,0,0
122429,),0,0
122430,in,0,0
122431,the,0,0
122432,zidovudine,0,0
122433,and,0,0
122434,single-dose,0,0
122435,nevirapine,0,0
122436,group,0,0
122437,(,0,0
122438,p=0?02,0,0
122439,),0,0
122440,.,0,0
122441,AIDS-free,0,0
122442,survival,0,0
122443,in,0,0
122444,mothers,0,1
122445,at,0,1
122446,18,0,1
122447,months,0,0
122448,will,0,0
122449,be,0,0
122450,reported,0,0
122451,in,0,0
122452,a,0,0
122453,different,0,0
122454,publication,0,0
122455,.,0,0
122456,The,0,0
122457,incidence,0,0
122458,of,0,0
122459,laboratory,0,0
122460,and,0,0
122461,clinical,0,0
122462,serious,0,0
122463,adverse,0,0
122464,events,0,0
122465,in,0,0
122466,both,0,0
122467,mothers,0,1
122468,and,0,0
122469,their,0,1
122470,babies,0,1
122471,was,0,0
122472,similar,0,0
122473,between,0,0
122474,groups,0,0
122475,.,0,1
122476,INTERPRETATION,0,0
122477,Triple,0,0
122478,antiretroviral,0,1
122479,prophylaxis,0,0
122480,during,0,0
122481,pregnancy,0,1
122482,and,0,0
122483,breastfeeding,0,0
122484,is,0,0
122485,safe,0,0
122486,and,0,0
122487,reduces,0,0
122488,the,0,0
122489,risk,0,0
122490,of,0,0
122491,HIV,0,1
122492,transmission,0,0
122493,to,0,0
122494,infants,0,1
122495,.,0,1
122496,Revised,0,0
122497,WHO,0,0
122498,guidelines,0,1
122499,now,0,1
122500,recommend,0,0
122501,antiretroviral,0,0
122502,prophylaxis,0,0
122503,(,0,0
122504,either,0,0
122505,to,0,0
122506,the,0,0
122507,mother,0,0
122508,or,0,0
122509,to,0,0
122510,the,0,0
122511,baby,0,1
122512,),0,0
122513,during,0,0
122514,breastfeeding,0,0
122515,if,0,0
122516,the,0,0
122517,mother,0,0
122518,is,0,0
122519,not,0,0
122520,already,0,0
122521,receiving,0,0
122522,antiretroviral,0,1
122523,treatment,0,0
122524,for,0,0
122525,her,0,0
122526,own,0,1
122527,health,0,1
122528,.,0,1
122529,FUNDING,0,0
122530,Agence,0,0
122531,nationale,0,1
122532,de,0,0
122533,recherches,0,1
122534,sur,0,0
122535,le,0,0
122536,sida,0,0
122537,et,0,0
122538,les,0,0
122539,h?patites,0,0
122540,virales,0,0
122541,",",0,1
122542,Department,0,1
122543,for,0,0
122544,International,0,1
122545,Development,0,0
122546,",",0,0
122547,European,0,1
122548,and,0,0
122549,Developing,0,1
122550,Countries,0,1
122551,Clinical,0,0
122552,Trials,0,0
122553,Partnership,0,0
122554,",",0,0
122555,Thrasher,0,1
122556,Research,0,0
122557,Fund,0,1
122558,",",0,0
122559,Belgian,0,1
122560,Directorate,0,1
122561,General,0,1
122562,for,0,0
122563,International,0,1
122564,Cooperation,0,1
122565,",",0,0
122566,Centers,0,0
122567,for,0,1
122568,Disease,0,1
122569,Control,0,1
122570,and,0,0
122571,Prevention,0,0
122572,",",0,0
122573,Eunice,0,1
122574,Kennedy,0,1
122575,Shriver,0,1
122576,National,0,1
122577,Institute,0,1
122578,of,0,0
122579,Child,0,1
122580,Health,0,0
122581,and,0,0
122582,Human,0,1
122583,Development,0,0
122584,",",0,0
122585,and,0,0
122586,UNDP/UNFPA/World,0,0
122587,Bank/WHO,0,1
122588,Special,0,1
122589,Programme,0,0
122590,of,0,0
122591,Research,0,0
122592,",",0,0
122593,Development,0,0
122594,and,0,0
122595,Research,0,0
122596,Training,0,0
122597,in,0,0
122598,Human,0,1
122599,Reproduction,0,0
122600,.,0,1
122601,Dark-phase,0,1
122602,light,0,0
122603,contamination,0,0
122604,disrupts,0,0
122605,circadian,0,0
122606,rhythms,0,0
122607,in,0,0
122608,plasma,0,0
122609,measures,0,0
122610,of,0,0
122611,endocrine,1,1
122612,physiology,1,0
122613,and,1,0
122614,metabolism,1,0
122615,in,1,0
122616,rats,1,1
122617,.,1,1
122618,Dark-phase,0,0
122619,light,0,0
122620,contamination,0,0
122621,can,0,0
122622,significantly,0,0
122623,disrupt,0,0
122624,chronobiologic,0,0
122625,rhythms,0,0
122626,",",0,0
122627,thereby,0,0
122628,potentially,0,0
122629,altering,0,0
122630,the,0,0
122631,endocrine,0,1
122632,physiology,0,0
122633,and,0,0
122634,metabolism,0,0
122635,of,0,0
122636,experimental,1,0
122637,animals,1,1
122638,and,0,0
122639,influencing,0,0
122640,the,0,0
122641,outcome,0,0
122642,of,0,0
122643,scientific,0,1
122644,investigations,0,0
122645,.,0,1
122646,We,0,0
122647,sought,0,0
122648,to,0,0
122649,determine,0,0
122650,whether,0,0
122651,exposure,0,0
122652,to,0,0
122653,low-level,0,0
122654,light,0,0
122655,contamination,0,0
122656,during,0,0
122657,the,0,0
122658,dark,0,0
122659,phase,0,0
122660,influenced,0,0
122661,the,0,0
122662,normally,0,1
122663,entrained,0,0
122664,circadian,0,0
122665,rhythms,0,0
122666,of,0,0
122667,various,0,0
122668,substances,0,0
122669,in,0,1
122670,plasma,0,0
122671,.,0,1
122672,Male,1,0
122673,Sprague-Dawley,1,1
122674,rats,1,1
122675,(,1,1
122676,n,1,1
122677,=,1,0
122678,6,1,0
122679,per,1,0
122680,group,1,1
122681,),1,0
122682,were,0,0
122683,housed,0,1
122684,in,0,0
122685,photobiologic,0,0
122686,light-exposure,0,0
122687,chambers,0,0
122688,configured,0,0
122689,to,0,0
122690,create,0,0
122691,1,0,0
122692,),0,0
122693,a,0,0
122694,12:12-h,0,1
122695,light,0,0
122696,:,0,1
122697,dark,0,0
122698,cycle,0,0
122699,without,0,1
122700,dark-phase,0,0
122701,light,0,0
122702,contamination,0,0
122703,(,0,0
122704,control,0,1
122705,condition,0,1
122706,;,0,0
122707,123,0,1
122708,?W/cm,0,0
122709,(,0,1
122710,2,0,0
122711,),0,0
122712,",",0,0
122713,lights,0,0
122714,on,0,0
122715,at,0,1
122716,0600,0,0
122717,),0,0
122718,",",0,0
122719,2,0,0
122720,),0,0
122721,experimental,0,0
122722,exposure,0,0
122723,to,0,0
122724,a,0,0
122725,low,0,0
122726,level,0,0
122727,of,0,0
122728,light,0,0
122729,during,0,0
122730,the,0,0
122731,12-h,0,0
122732,dark,0,0
122733,phase,0,0
122734,(,0,0
122735,with,0,1
122736,0.02,0,0
122737,",",0,0
122738,0.05,0,0
122739,",",0,0
122740,0.06,0,0
122741,",",0,0
122742,or,0,1
122743,0.08,0,0
122744,?W/cm,0,0
122745,(,0,1
122746,2,0,1
122747,),0,0
122748,light,0,0
122749,at,0,0
122750,night,0,0
122751,),0,0
122752,",",0,0
122753,or,0,1
122754,3,0,0
122755,),0,0
122756,constant,0,0
122757,bright,0,0
122758,light,0,1
122759,(,0,0
122760,123,0,1
122761,?W/cm,0,0
122762,(,0,1
122763,2,0,0
122764,),0,1
122765,),0,1
122766,.,0,0
122767,Dietary,0,0
122768,and,0,0
122769,water,0,0
122770,intakes,0,0
122771,were,0,0
122772,recorded,0,0
122773,daily,0,0
122774,.,0,0
122775,After,0,0
122776,2,0,0
122777,wk,0,0
122778,",",0,0
122779,rats,0,1
122780,underwent,0,1
122781,6,0,0
122782,low-volume,0,1
122783,blood,0,0
122784,draws,0,0
122785,at,0,1
122786,4-h,0,1
122787,intervals,0,0
122788,(,0,0
122789,beginning,0,1
122790,at,0,0
122791,0400,0,1
122792,),0,0
122793,during,0,0
122794,both,0,0
122795,the,0,0
122796,light,0,0
122797,and,0,0
122798,dark,0,0
122799,phases,0,0
122800,.,0,1
122801,Circadian,0,0
122802,rhythms,0,0
122803,in,0,0
122804,dietary,0,0
122805,and,0,0
122806,water,0,0
122807,intake,0,0
122808,and,0,0
122809,levels,0,0
122810,of,0,0
122811,plasma,0,0
122812,total,0,1
122813,fatty,0,0
122814,acids,0,0
122815,and,0,1
122816,lipid,0,0
122817,fractions,0,0
122818,remained,0,0
122819,entrained,0,1
122820,during,0,0
122821,exposure,0,0
122822,to,0,0
122823,either,0,0
122824,control,0,0
122825,conditions,0,0
122826,or,0,1
122827,low-intensity,0,0
122828,light,0,0
122829,during,0,0
122830,the,0,0
122831,dark,0,0
122832,phase,0,0
122833,.,0,0
122834,However,0,0
122835,",",0,0
122836,these,0,0
122837,patterns,0,0
122838,were,0,0
122839,disrupted,0,0
122840,in,0,0
122841,rats,0,1
122842,exposed,0,0
122843,to,0,0
122844,constant,0,0
122845,bright,0,0
122846,light,0,0
122847,.,0,1
122848,Circadian,0,0
122849,patterns,0,0
122850,of,0,0
122851,plasma,0,0
122852,melatonin,0,0
122853,",",0,0
122854,glucose,0,0
122855,",",0,0
122856,lactic,0,0
122857,acid,0,0
122858,",",0,0
122859,and,0,0
122860,corticosterone,0,0
122861,were,0,0
122862,maintained,0,0
122863,in,0,0
122864,all,0,0
122865,rats,0,1
122866,except,0,0
122867,those,0,1
122868,exposed,0,0
122869,to,0,0
122870,constant,0,0
122871,bright,0,0
122872,light,0,0
122873,or,0,0
122874,the,0,0
122875,highest,0,0
122876,level,0,0
122877,of,0,0
122878,light,0,0
122879,during,0,0
122880,the,0,0
122881,dark,0,0
122882,phase,0,0
122883,.,0,0
122884,Therefore,0,0
122885,even,0,0
122886,minimal,0,0
122887,light,0,0
122888,contamination,0,0
122889,during,0,0
122890,the,0,0
122891,dark,0,0
122892,phase,0,0
122893,can,0,0
122894,disrupt,0,0
122895,normal,0,0
122896,circadian,0,0
122897,rhythms,0,0
122898,of,0,0
122899,endocrine,0,1
122900,metabolism,0,0
122901,and,0,0
122902,physiology,0,0
122903,and,0,0
122904,may,0,0
122905,alter,0,0
122906,the,0,0
122907,outcome,0,0
122908,of,0,0
122909,scientific,0,1
122910,investigations,0,0
122911,.,0,1
122912,Serotonergic,0,0
122913,control,0,0
122914,of,0,0
122915,TSH,0,0
122916,and,0,0
122917,PRL,0,0
122918,secretion,0,0
122919,in,0,0
122920,obese,1,1
122921,men,1,1
122922,.,1,1
122923,To,0,0
122924,evaluate,0,0
122925,whether,0,0
122926,the,0,0
122927,inhibitory,0,0
122928,control,0,0
122929,of,0,0
122930,TSH,0,0
122931,and,0,0
122932,the,0,0
122933,stimulatory,0,0
122934,control,0,0
122935,of,0,0
122936,prolactin,0,0
122937,(,0,0
122938,PRL,0,0
122939,),0,0
122940,secretion,0,0
122941,exerted,0,0
122942,by,0,0
122943,endogenous,0,0
122944,serotonin,0,0
122945,was,0,0
122946,altered,0,0
122947,in,0,0
122948,obesity,0,1
122949,",",0,0
122950,22,1,1
122951,obese,1,1
122952,men,1,1
122953,and,1,1
122954,10,1,1
122955,normal,1,1
122956,controls,1,1
122957,were,0,1
122958,tested,0,0
122959,with,0,1
122960,TRH,0,1
122961,(,0,1
122962,200,0,1
122963,micrograms,0,0
122964,IV,0,1
122965,bolus,0,0
122966,),0,0
122967,in,0,0
122968,the,0,0
122969,presence,0,0
122970,(,0,0
122971,experimental,0,0
122972,test,0,0
122973,),0,0
122974,and,0,0
122975,absence,0,0
122976,(,0,0
122977,control,0,0
122978,test,0,0
122979,),0,0
122980,of,0,0
122981,the,0,0
122982,serotonergic,0,0
122983,agonist,0,0
122984,fenfluramine,0,0
122985,(,0,0
122986,60,0,1
122987,mg,0,0
122988,PO,0,0
122989,90,0,0
122990,min,0,0
122991,before,0,0
122992,TRH,0,1
122993,),0,1
122994,.,0,0
122995,Control,0,0
122996,and,0,0
122997,experimental,0,0
122998,tests,0,0
122999,were,0,1
123000,also,0,0
123001,performed,0,0
123002,in,0,0
123003,seven,1,1
123004,male,1,1
123005,patients,1,1
123006,with,1,1
123007,subclinical,1,1
123008,hypothyroidism,1,1
123009,and,0,0
123010,were,0,0
123011,repeated,0,0
123012,in,0,0
123013,the,0,0
123014,same,0,0
123015,obese,1,1
123016,subjects,1,1
123017,after,1,1
123018,substantial,1,0
123019,weight,1,1
123020,loss,1,0
123021,.,1,1
123022,Basal,0,0
123023,TSH,0,0
123024,levels,0,0
123025,were,0,1
123026,similar,0,0
123027,in,0,0
123028,control,1,1
123029,and,1,0
123030,obese,1,1
123031,men,1,1
123032,.,1,1
123033,Normal,0,0
123034,TSH,0,0
123035,responses,0,0
123036,to,0,0
123037,TRH,0,1
123038,(,0,0
123039,peak,0,0
123040,less,0,0
123041,than,0,0
123042,or,0,0
123043,equal,0,0
123044,to,0,0
123045,14,0,1
123046,mU/L,0,0
123047,),0,1
123048,were,0,0
123049,observed,0,0
123050,in,0,0
123051,all,0,0
123052,normal,0,1
123053,controls,0,1
123054,(,0,1
123055,mean,0,1
123056,peak,0,0
123057,+/-,0,0
123058,SE,0,1
123059,9.8,0,0
123060,+/-,0,0
123061,0.6,0,0
123062,mU/L,0,0
123063,),0,0
123064,.,0,0
123065,In,0,0
123066,contrast,0,0
123067,",",0,0
123068,obese,1,1
123069,men,1,1
123070,were,0,1
123071,divided,0,1
123072,into,0,1
123073,two,0,1
123074,groups,0,1
123075,:,0,1
123076,nine,0,1
123077,in,0,1
123078,whom,0,1
123079,the,0,1
123080,TRH-induced,0,1
123081,TSH,0,0
123082,rise,0,0
123083,was,0,0
123084,higher,0,0
123085,than,0,0
123086,normal,0,1
123087,(,0,0
123088,group,0,1
123089,I,0,1
123090,:,0,1
123091,mean,0,0
123092,peak,0,0
123093,=,0,0
123094,16.5,0,0
123095,+/-,0,0
123096,0.5,0,0
123097,mU/L,0,0
123098,),0,0
123099,and,0,0
123100,13,0,1
123101,in,0,1
123102,whom,0,1
123103,it,0,1
123104,was,0,1
123105,normal,0,1
123106,(,0,0
123107,group,0,1
123108,II,0,1
123109,:,0,1
123110,mean,0,1
123111,peak,0,0
123112,=,0,0
123113,10.6,0,0
123114,+/-,0,0
123115,0.7,0,0
123116,mU/L,0,0
123117,),0,0
123118,.,0,0
123119,The,0,0
123120,hypothyroid,1,1
123121,men,1,1
123122,all,0,1
123123,had,0,0
123124,elevated,0,0
123125,basal,0,0
123126,and,0,0
123127,TRH-stimulated,0,0
123128,TSH,0,1
123129,levels,0,0
123130,.,0,1
123131,Basal,0,0
123132,PRL,0,0
123133,concentrations,0,0
123134,were,0,1
123135,similar,0,0
123136,in,0,0
123137,the,0,0
123138,normal,0,1
123139,controls,0,1
123140,and,0,1
123141,both,0,0
123142,groups,0,0
123143,of,0,0
123144,obese,1,1
123145,subjects,1,1
123146,.,1,1
123147,The,0,0
123148,PRL,0,0
123149,response,0,0
123150,to,0,0
123151,TRH,0,1
123152,was,0,0
123153,lower,0,0
123154,in,0,0
123155,both,0,0
123156,group,0,0
123157,I,0,0
123158,and,0,0
123159,group,0,0
123160,II,0,0
123161,obese,0,1
123162,men,0,1
123163,than,0,0
123164,in,0,1
123165,normal,0,1
123166,controls,0,1
123167,and,0,1
123168,was,0,0
123169,similar,0,0
123170,between,0,0
123171,group,0,0
123172,I,0,1
123173,and,0,0
123174,group,0,0
123175,II,0,1
123176,.,0,0
123177,(,0,0
123178,ABSTRACT,0,0
123179,TRUNCATED,0,1
123180,AT,0,1
123181,250,0,0
123182,WORDS,0,1
123183,),0,1
123184,Avatar,0,1
123185,assistant,0,1
123186,:,0,1
123187,improving,0,0
123188,social,0,0
123189,skills,0,0
123190,in,0,1
123191,students,1,1
123192,with,1,1
123193,an,1,0
123194,ASD,1,1
123195,through,0,0
123196,a,0,0
123197,computer-based,0,0
123198,intervention,0,0
123199,.,0,0
123200,This,0,0
123201,study,0,0
123202,assessed,0,0
123203,the,0,0
123204,efficacy,0,0
123205,of,0,0
123206,FaceSay,0,0
123207,",",0,0
123208,a,0,0
123209,computer-based,0,0
123210,social,0,0
123211,skills,0,0
123212,training,0,0
123213,program,0,1
123214,for,0,0
123215,children,1,1
123216,with,1,1
123217,Autism,1,1
123218,Spectrum,1,1
123219,Disorders,1,1
123220,(,1,0
123221,ASD,1,1
123222,),1,0
123223,.,1,0
123224,This,0,0
123225,randomized,0,0
123226,controlled,0,0
123227,study,1,0
123228,(,1,0
123229,N,1,1
123230,=,1,0
123231,49,1,1
123232,),1,0
123233,indicates,1,0
123234,that,0,0
123235,providing,1,0
123236,children,1,1
123237,with,1,1
123238,low-functioning,1,1
123239,autism,1,1
123240,(,1,0
123241,LFA,1,0
123242,),1,0
123243,and,1,0
123244,high,1,0
123245,functioning,1,0
123246,autism,1,1
123247,(,1,0
123248,HFA,1,1
123249,),1,0
123250,opportunities,1,0
123251,to,0,0
123252,practice,0,0
123253,attending,0,1
123254,to,0,0
123255,eye,0,0
123256,gaze,0,0
123257,",",0,0
123258,discriminating,0,0
123259,facial,0,0
123260,expressions,0,0
123261,and,0,0
123262,recognizing,0,0
123263,faces,0,0
123264,and,0,0
123265,emotions,0,0
123266,in,0,0
123267,FaceSay,0,0
123268,'s,0,1
123269,structured,0,0
123270,environment,0,0
123271,with,0,1
123272,interactive,0,0
123273,",",0,0
123274,realistic,0,0
123275,avatar,0,1
123276,assistants,0,0
123277,improved,0,0
123278,their,0,1
123279,social,0,1
123280,skills,0,0
123281,abilities,0,1
123282,.,0,1
123283,The,0,0
123284,children,0,1
123285,with,0,1
123286,LFA,0,1
123287,demonstrated,0,0
123288,improvements,0,0
123289,in,0,1
123290,two,0,0
123291,areas,0,0
123292,of,0,0
123293,the,0,0
123294,intervention,0,0
123295,:,0,1
123296,emotion,0,0
123297,recognition,0,0
123298,and,0,0
123299,social,0,0
123300,interactions,0,0
123301,.,0,1
123302,The,0,0
123303,children,0,1
123304,with,0,1
123305,HFA,0,1
123306,demonstrated,0,0
123307,improvements,0,0
123308,in,0,0
123309,all,0,1
123310,three,0,0
123311,areas,0,0
123312,:,0,1
123313,facial,0,1
123314,recognition,0,0
123315,",",0,0
123316,emotion,0,0
123317,recognition,0,0
123318,",",0,0
123319,and,0,0
123320,social,0,0
123321,interactions,0,0
123322,.,0,1
123323,These,0,0
123324,findings,0,0
123325,",",0,0
123326,particularly,0,0
123327,the,0,0
123328,measured,0,0
123329,improvements,0,0
123330,to,0,1
123331,social,0,1
123332,interactions,0,0
123333,in,0,0
123334,a,0,0
123335,natural,0,0
123336,environment,0,0
123337,",",0,0
123338,are,0,0
123339,encouraging,0,0
123340,.,0,1
123341,[,0,0
123342,Efficacy,0,0
123343,of,0,0
123344,naftopidil,0,0
123345,in,0,0
123346,patients,1,1
123347,with,1,1
123348,overactive,1,1
123349,bladder,1,1
123350,associated,1,0
123351,with,1,1
123352,benign,1,1
123353,prostatic,1,1
123354,hyperplasia,1,1
123355,:,1,1
123356,prospective,0,0
123357,randomized,0,0
123358,controlled,0,0
123359,study,0,0
123360,to,0,0
123361,compare,0,0
123362,differences,0,0
123363,in,0,0
123364,efficacy,0,0
123365,between,0,0
123366,morning,0,0
123367,and,0,0
123368,evening,0,0
123369,medication,0,0
123370,],0,1
123371,.,0,1
123372,A,0,0
123373,total,1,1
123374,of,1,0
123375,100,1,0
123376,patients,1,1
123377,with,1,1
123378,benign,1,1
123379,prostatic,1,1
123380,hyperplasia,1,1
123381,(,1,0
123382,BPH,1,0
123383,),1,0
123384,and,1,0
123385,overactive,1,1
123386,bladder,1,1
123387,(,1,0
123388,OAB,1,0
123389,),1,1
123390,symptoms,1,0
123391,(,1,1
123392,BPH/OAB,1,0
123393,),1,0
123394,",",1,0
123395,enrolled,1,1
123396,between,1,0
123397,June,1,1
123398,2006,1,1
123399,to,1,0
123400,March,1,1
123401,2008,1,1
123402,",",0,0
123403,were,0,0
123404,randomly,0,0
123405,divided,0,1
123406,into,0,0
123407,2,0,0
123408,groups,0,0
123409,of,0,0
123410,morning,0,0
123411,medication,0,0
123412,(,0,0
123413,M,0,0
123414,),0,0
123415,and,0,0
123416,evening,0,0
123417,medication,0,0
123418,(,0,0
123419,E,0,0
123420,),0,0
123421,groups,0,0
123422,",",0,0
123423,then,0,0
123424,50,0,0
123425,mg,0,0
123426,of,0,0
123427,naftopidil,0,0
123428,was,0,0
123429,given,0,0
123430,once,0,0
123431,a,0,0
123432,day,0,0
123433,after,0,0
123434,breakfast,0,0
123435,or,0,0
123436,supper,0,0
123437,for,0,0
123438,8,0,0
123439,weeks,0,0
123440,.,0,1
123441,Data,0,0
123442,were,0,0
123443,available,0,0
123444,for,0,0
123445,efficacy,0,0
123446,analysis,0,0
123447,on,0,0
123448,80,0,1
123449,patients,0,1
123450,(,0,1
123451,M,0,0
123452,group,0,1
123453,;,0,0
123454,43,0,1
123455,",",0,0
123456,E,0,0
123457,group,0,1
123458,;,0,0
123459,37,0,1
123460,),0,0
123461,.,0,0
123462,Naftopidil,0,0
123463,significantly,0,0
123464,improved,0,0
123465,the,0,0
123466,overall,0,0
123467,international,0,1
123468,prostatic,0,1
123469,symptom,0,1
123470,score,0,0
123471,;,0,0
123472,from,0,0
123473,19.2?7.9,0,0
123474,to,0,0
123475,11.7?5.8,0,0
123476,in,0,0
123477,the,0,0
123478,M,0,0
123479,group,0,0
123480,and,0,0
123481,from,0,0
123482,19.4?6.4,0,0
123483,to,0,0
123484,12.3?6.8,0,0
123485,in,0,0
123486,the,0,0
123487,E,0,0
123488,group,0,0
123489,(,0,0
123490,p,0,0
123491,<,0,0
123492,0.0001,0,0
123493,),0,0
123494,",",0,0
123495,QOL,0,0
123496,score,0,0
123497,from,0,1
123498,4.9?0.8,0,0
123499,to,0,0
123500,3.2?1.4,0,0
123501,in,0,0
123502,the,0,0
123503,M,0,0
123504,group,0,0
123505,and,0,0
123506,from,0,0
123507,5.0?0.8,0,0
123508,to,0,0
123509,3.6?1.3,0,0
123510,in,0,0
123511,the,0,0
123512,E,0,0
123513,group,0,0
123514,(,0,0
123515,p,0,0
123516,<,0,0
123517,0.0001,0,0
123518,),0,0
123519,",",0,0
123520,and,0,0
123521,OAB,0,0
123522,symptom,0,0
123523,score,0,0
123524,from,0,1
123525,7.8?2.6,0,0
123526,to,0,0
123527,5.0?2.5,0,0
123528,in,0,0
123529,the,0,0
123530,M,0,0
123531,group,0,0
123532,(,0,0
123533,p,0,0
123534,<,0,0
123535,0.0001,0,0
123536,),0,0
123537,and,0,0
123538,from,0,1
123539,8.6?2.9,0,0
123540,to,0,1
123541,5.8?,0,0
123542,3.3,0,0
123543,in,0,0
123544,the,0,0
123545,E,0,0
123546,group,0,0
123547,(,0,0
123548,p,0,0
123549,<,0,0
123550,0.0001,0,0
123551,),0,0
123552,.,0,0
123553,There,0,0
123554,was,0,0
123555,no,0,0
123556,significant,0,0
123557,difference,0,0
123558,in,0,0
123559,the,0,0
123560,incidence,0,0
123561,of,0,0
123562,adverse,0,0
123563,effects,0,0
123564,between,0,0
123565,the,0,0
123566,M,0,0
123567,group,0,0
123568,(,0,0
123569,6.1,0,0
123570,%,0,0
123571,),0,0
123572,and,0,0
123573,E,0,0
123574,group,0,0
123575,(,0,0
123576,2.2,0,0
123577,%,0,0
123578,),0,0
123579,.,0,0
123580,These,0,0
123581,results,0,0
123582,suggest,0,0
123583,that,0,0
123584,naftopidil,0,1
123585,improves,0,0
123586,storage,0,1
123587,symptoms,0,0
123588,as,0,0
123589,well,0,0
123590,as,0,0
123591,voiding,0,0
123592,symptoms,0,0
123593,regardless,0,1
123594,of,0,0
123595,timing,0,0
123596,of,0,0
123597,administration,0,0
123598,.,0,1
123599,Effectiveness,0,0
123600,of,0,0
123601,sensory,0,0
123602,integration,0,0
123603,interventions,0,0
123604,in,0,0
123605,children,1,1
123606,with,1,1
123607,autism,1,1
123608,spectrum,1,1
123609,disorders,1,1
123610,:,1,1
123611,a,0,0
123612,pilot,0,0
123613,study,0,0
123614,.,0,0
123615,The,0,0
123616,purpose,0,0
123617,of,0,0
123618,this,0,0
123619,pilot,0,0
123620,study,0,0
123621,was,0,0
123622,to,0,0
123623,establish,0,0
123624,a,0,0
123625,model,0,0
123626,for,0,0
123627,randomized,0,1
123628,controlled,0,0
123629,trial,0,0
123630,research,0,0
123631,",",0,0
123632,identify,0,0
123633,appropriate,0,0
123634,outcome,0,0
123635,measures,0,0
123636,",",0,0
123637,and,0,0
123638,address,0,0
123639,the,0,0
123640,effectiveness,0,0
123641,of,0,0
123642,sensory,0,0
123643,integration,0,0
123644,(,0,0
123645,SI,0,1
123646,),0,1
123647,interventions,0,0
123648,in,0,0
123649,children,1,1
123650,with,1,1
123651,autism,1,1
123652,spectrum,1,1
123653,disorders,1,1
123654,(,1,1
123655,ASD,1,1
123656,),1,1
123657,.,1,0
123658,Children,1,1
123659,ages,1,1
123660,6-12,1,0
123661,with,1,0
123662,ASD,1,1
123663,were,0,0
123664,randomly,0,1
123665,assigned,0,0
123666,to,0,0
123667,a,0,0
123668,fine,0,0
123669,motor,0,0
123670,or,0,1
123671,SI,0,0
123672,treatment,0,0
123673,group,0,0
123674,.,0,1
123675,Pretests,0,0
123676,and,0,0
123677,posttests,0,0
123678,measured,0,0
123679,social,0,0
123680,responsiveness,0,0
123681,",",0,0
123682,sensory,0,0
123683,processing,0,0
123684,",",0,0
123685,functional,0,0
123686,motor,0,0
123687,skills,0,0
123688,",",0,0
123689,and,0,0
123690,social-emotional,0,0
123691,factors,0,0
123692,.,0,1
123693,Results,0,0
123694,identified,0,1
123695,significant,0,0
123696,positive,0,1
123697,changes,0,0
123698,in,0,1
123699,Goal,0,1
123700,Attainment,0,1
123701,Scaling,0,1
123702,scores,0,0
123703,for,0,0
123704,both,0,0
123705,groups,0,0
123706,;,0,0
123707,more,0,0
123708,significant,0,0
123709,changes,0,0
123710,occurred,0,0
123711,in,0,0
123712,the,0,0
123713,SI,0,0
123714,group,0,0
123715,",",0,0
123716,and,0,0
123717,a,0,0
123718,significant,0,0
123719,decrease,0,0
123720,in,0,0
123721,autistic,0,1
123722,mannerisms,0,0
123723,occurred,0,0
123724,in,0,0
123725,the,0,0
123726,SI,0,0
123727,group,0,0
123728,.,0,0
123729,No,0,0
123730,other,0,0
123731,results,0,0
123732,were,0,1
123733,significant,0,0
123734,.,0,0
123735,The,0,0
123736,study,0,0
123737,discusses,0,0
123738,considerations,0,0
123739,for,0,0
123740,designing,0,0
123741,future,0,0
123742,outcome,0,0
123743,studies,0,0
123744,for,0,0
123745,children,1,1
123746,with,1,1
123747,ASD,1,1
123748,.,1,1
123749,Anastrozole,0,1
123750,single-dose,0,0
123751,protocol,0,0
123752,in,0,0
123753,women,1,1
123754,with,1,1
123755,oligo-,1,0
123756,or,1,1
123757,anovulatory,1,1
123758,infertility,1,1
123759,:,1,1
123760,results,0,0
123761,of,0,0
123762,a,0,0
123763,randomized,0,0
123764,phase,0,1
123765,II,0,1
123766,dose-response,0,0
123767,study,0,0
123768,.,0,0
123769,OBJECTIVE,0,0
123770,To,0,0
123771,compare,0,0
123772,the,0,0
123773,effects,0,0
123774,of,0,0
123775,anastrozole,0,0
123776,and,0,0
123777,clomiphene,0,0
123778,citrate,0,0
123779,(,0,0
123780,CC,0,0
123781,),0,0
123782,on,0,0
123783,follicular,1,1
123784,development,1,0
123785,and,1,0
123786,ovulation,1,0
123787,in,1,0
123788,infertile,1,1
123789,women,1,1
123790,with,1,1
123791,ovulatory,1,1
123792,dysfunction,1,1
123793,.,1,1
123794,DESIGN,0,0
123795,Phase,0,1
123796,II,0,1
123797,",",0,0
123798,prospective,0,0
123799,",",0,0
123800,randomized,0,0
123801,",",0,0
123802,assessor-blind,0,0
123803,",",0,0
123804,multicenter,0,0
123805,",",0,0
123806,dose-finding,0,0
123807,",",0,0
123808,noninferiority,0,0
123809,study,0,0
123810,.,0,1
123811,SETTING,0,1
123812,Outpatient,0,1
123813,.,0,1
123814,PATIENT,0,0
123815,(,0,0
123816,S,0,0
123817,),0,1
123818,Infertile,1,1
123819,women,1,1
123820,with,1,1
123821,ovulatory,1,1
123822,dysfunction,1,1
123823,",",1,0
123824,aged,1,1
123825,18-35,1,1
123826,years,1,1
123827,",",1,0
123828,and,1,0
123829,body,1,0
123830,mass,1,0
123831,index,1,0
123832,<,1,0
123833,35,1,0
123834,kg/m,1,1
123835,(,1,1
123836,2,1,0
123837,),1,1
123838,.,1,1
123839,INTERVENTION,0,0
123840,(,0,0
123841,S,0,0
123842,),0,0
123843,Single-dose,0,0
123844,anastrozole,0,0
123845,at,0,0
123846,5,0,0
123847,mg,0,0
123848,(,0,0
123849,n,0,1
123850,=,0,0
123851,39,0,1
123852,),0,0
123853,",",0,0
123854,10,0,0
123855,mg,0,0
123856,(,0,0
123857,n,0,1
123858,=,0,0
123859,39,0,1
123860,),0,0
123861,",",0,0
123862,20,0,0
123863,mg,0,0
123864,(,0,0
123865,n,0,1
123866,=,0,0
123867,39,0,1
123868,),0,0
123869,",",0,0
123870,or,0,1
123871,30,0,0
123872,mg,0,0
123873,(,0,0
123874,n,0,1
123875,=,0,0
123876,38,0,1
123877,),0,0
123878,or,0,1
123879,a,0,0
123880,5-day,0,0
123881,course,0,0
123882,of,0,0
123883,CC,0,1
123884,at,0,0
123885,50,0,1
123886,mg/d,0,0
123887,(,0,0
123888,n,0,1
123889,=,0,0
123890,39,0,1
123891,),0,0
123892,as,0,0
123893,starting,0,1
123894,doses,0,0
123895,.,0,1
123896,MAIN,0,0
123897,OUTCOME,0,0
123898,MEASURE,0,0
123899,(,0,0
123900,S,0,0
123901,),0,0
123902,The,0,0
123903,primary,0,0
123904,endpoint,0,0
123905,was,0,0
123906,the,0,0
123907,ovulation,0,0
123908,rate,0,0
123909,in,0,0
123910,the,0,0
123911,first,0,0
123912,treatment,0,0
123913,cycle,0,0
123914,(,0,0
123915,cycle,0,0
123916,1,0,0
123917,),0,0
123918,.,0,1
123919,Ovulation,0,0
123920,was,0,0
123921,defined,0,0
123922,as,0,0
123923,a,0,0
123924,midluteal,0,0
123925,phase,0,0
123926,serum,0,0
123927,P,0,0
123928,level,0,0
123929,?,0,0
123930,10,0,0
123931,ng/mL,0,0
123932,or,0,1
123933,clinical,0,0
123934,pregnancy,0,1
123935,.,0,1
123936,RESULT,0,0
123937,(,0,0
123938,S,0,0
123939,),0,0
123940,In,0,0
123941,cycle,0,0
123942,1,0,0
123943,the,0,0
123944,ovulation,0,0
123945,rates,0,0
123946,for,0,0
123947,a,0,0
123948,single,0,0
123949,dose,0,0
123950,of,0,0
123951,anastrozole,0,0
123952,at,0,0
123953,5,0,0
123954,",",0,0
123955,10,0,0
123956,",",0,0
123957,20,0,0
123958,",",0,0
123959,and,0,0
123960,30,0,1
123961,mg,0,0
123962,were,0,1
123963,46.2,0,0
123964,%,0,0
123965,",",0,0
123966,41.0,0,0
123967,%,0,0
123968,",",0,0
123969,23.1,0,0
123970,%,0,0
123971,",",0,0
123972,and,0,0
123973,28.9,0,0
123974,%,0,0
123975,",",0,0
123976,respectively,0,0
123977,",",0,0
123978,whereas,0,0
123979,that,0,0
123980,for,0,0
123981,CC,0,1
123982,at,0,0
123983,50,0,1
123984,mg/d,0,0
123985,was,0,0
123986,61.5,0,0
123987,%,0,0
123988,.,0,1
123989,Among,0,1
123990,women,0,1
123991,with,0,1
123992,fewer,0,0
123993,than,0,0
123994,six,0,1
123995,menses,0,0
123996,per,0,0
123997,year,0,0
123998,",",0,0
123999,the,0,0
124000,cumulative,0,0
124001,ovulation,0,0
124002,rates,0,0
124003,over,0,0
124004,three,0,1
124005,cycles,0,0
124006,were,0,1
124007,comparable,0,0
124008,in,0,0
124009,the,0,0
124010,anastrozole,0,0
124011,5,0,0
124012,mg,0,0
124013,(,0,0
124014,52.4,0,0
124015,%,0,0
124016,),0,0
124017,and,0,0
124018,CC,0,0
124019,50,0,1
124020,mg/d,0,0
124021,(,0,0
124022,42.3,0,0
124023,%,0,0
124024,),0,1
124025,groups,0,0
124026,.,0,1
124027,CONCLUSION,0,0
124028,(,0,0
124029,S,0,0
124030,),0,0
124031,In,0,0
124032,terms,0,0
124033,of,0,0
124034,ovulation,0,1
124035,rates,0,0
124036,in,0,0
124037,cycle,0,0
124038,1,0,0
124039,",",0,0
124040,single-dose,0,0
124041,anastrozole,0,0
124042,at,0,0
124043,5,0,0
124044,",",0,0
124045,10,0,0
124046,",",0,0
124047,20,0,0
124048,",",0,0
124049,and,0,0
124050,30,0,0
124051,mg,0,0
124052,was,0,0
124053,not,0,0
124054,as,0,0
124055,effective,0,0
124056,as,0,0
124057,CC,0,1
124058,at,0,0
124059,50,0,1
124060,mg/d,0,0
124061,for,0,0
124062,5,0,1
124063,days,0,0
124064,(,0,1
124065,noninferiority,0,0
124066,was,0,0
124067,not,0,0
124068,shown,0,0
124069,),0,0
124070,.,0,1
124071,Effects,0,0
124072,of,0,1
124073,weight,0,1
124074,loss,0,0
124075,and,0,0
124076,exercise,0,0
124077,on,0,0
124078,insulin,1,0
124079,resistance,1,0
124080,",",0,0
124081,and,0,0
124082,intramyocellular,0,0
124083,triacylglycerol,0,0
124084,",",0,0
124085,diacylglycerol,0,0
124086,and,0,0
124087,ceramide,0,0
124088,.,0,1
124089,AIMS/HYPOTHESIS,0,0
124090,Intramyocellular,0,0
124091,lipids,0,0
124092,",",0,0
124093,including,0,0
124094,diacylglycerol,0,0
124095,(,0,0
124096,DAG,0,0
124097,),0,0
124098,and,0,0
124099,ceramides,0,0
124100,",",0,0
124101,have,0,0
124102,been,0,0
124103,linked,0,0
124104,to,0,0
124105,insulin,0,0
124106,resistance,0,0
124107,.,0,0
124108,This,0,0
124109,randomised,0,0
124110,repeated-measures,0,0
124111,study,0,1
124112,examined,0,0
124113,the,0,0
124114,effects,0,0
124115,of,0,0
124116,diet-induced,0,1
124117,weight,0,1
124118,loss,0,0
124119,(,0,0
124120,DIWL,0,0
124121,),0,0
124122,and,0,0
124123,aerobic,0,0
124124,exercise,0,0
124125,(,0,0
124126,EX,0,0
124127,),0,0
124128,on,0,0
124129,insulin,0,0
124130,sensitivity,0,0
124131,and,0,0
124132,intramyocellular,0,0
124133,triacylglycerol,0,0
124134,(,0,0
124135,IMTG,0,0
124136,),0,0
124137,",",0,0
124138,DAG,0,0
124139,and,0,0
124140,ceramide,0,0
124141,.,0,1
124142,METHODS,0,0
124143,Sixteen,1,1
124144,overweight,1,1
124145,to,1,0
124146,obese,1,1
124147,adults,1,1
124148,(,1,1
124149,BMI,1,1
124150,30.6,1,0
124151,?,1,1
124152,0.8,1,0
124153,;,1,0
124154,67.2,1,1
124155,?,1,1
124156,4.0,1,0
124157,years,1,1
124158,of,1,0
124159,age,1,1
124160,),1,0
124161,with,1,1
124162,either,1,0
124163,impaired,1,1
124164,fasting,1,0
124165,glucose,1,0
124166,",",1,0
124167,or,1,0
124168,impaired,1,1
124169,glucose,1,0
124170,tolerance,1,0
124171,completed,1,1
124172,one,1,1
124173,of,1,0
124174,two,1,0
124175,lifestyle,1,1
124176,interventions,1,1
124177,:,1,1
124178,DIWL,1,0
124179,(,1,0
124180,n,1,1
124181,=,1,0
124182,8,1,0
124183,),1,0
124184,or,1,1
124185,EX,1,0
124186,(,1,0
124187,n,1,1
124188,=,1,0
124189,8,1,1
124190,),1,1
124191,.,0,1
124192,Insulin,0,0
124193,sensitivity,0,0
124194,was,0,0
124195,determined,0,0
124196,using,0,0
124197,hyperinsulinaemic-euglycaemic,0,0
124198,clamps,0,0
124199,.,0,1
124200,Intramyocellular,0,0
124201,lipids,0,0
124202,were,0,1
124203,measured,0,0
124204,in,0,0
124205,muscle,0,0
124206,biopsies,0,0
124207,using,0,0
124208,histochemistry,0,1
124209,and,0,0
124210,tandem,0,0
124211,mass,0,1
124212,spectrometry,0,1
124213,.,0,1
124214,RESULTS,0,0
124215,Insulin,0,0
124216,sensitivity,0,0
124217,was,0,0
124218,improved,0,0
124219,with,0,1
124220,DIWL,0,0
124221,(,0,1
124222,20.6,0,0
124223,?,0,1
124224,4.7,0,0
124225,%,0,0
124226,),0,0
124227,and,0,0
124228,EX,0,0
124229,(,0,1
124230,19.2,0,0
124231,?,0,1
124232,12.9,0,0
124233,%,0,0
124234,),0,1
124235,.,0,1
124236,Body,0,0
124237,weight,0,0
124238,and,0,0
124239,body,0,1
124240,fat,0,0
124241,were,0,0
124242,decreased,0,0
124243,by,0,0
124244,both,0,0
124245,interventions,0,0
124246,",",0,0
124247,with,0,1
124248,greater,0,0
124249,decreases,0,0
124250,in,0,0
124251,DIWL,0,0
124252,compared,0,0
124253,with,0,1
124254,EX,0,0
124255,.,0,1
124256,Muscle,0,0
124257,glycogen,0,0
124258,",",0,0
124259,IMTG,0,0
124260,content,0,0
124261,and,0,0
124262,oxidative,0,0
124263,capacity,0,0
124264,were,0,0
124265,all,0,0
124266,significantly,0,0
124267,(,0,0
124268,p,0,0
124269,<,0,0
124270,0.05,0,0
124271,),0,0
124272,decreased,0,0
124273,with,0,1
124274,DIWL,0,0
124275,and,0,0
124276,increased,0,0
124277,with,0,1
124278,EX,0,0
124279,.,0,0
124280,There,0,0
124281,were,0,0
124282,decreases,0,0
124283,in,0,0
124284,DAG,0,0
124285,with,0,1
124286,DIWL,0,0
124287,(,0,1
124288,-12.4,0,0
124289,?,0,1
124290,14.6,0,0
124291,%,0,0
124292,),0,0
124293,and,0,0
124294,EX,0,0
124295,(,0,0
124296,-40.9,0,0
124297,?,0,1
124298,12.0,0,0
124299,%,0,0
124300,),0,1
124301,.,0,1
124302,Ceramide,0,0
124303,decreased,0,0
124304,with,0,1
124305,EX,0,0
124306,(,0,1
124307,-33.7,0,0
124308,?,0,1
124309,11.2,0,0
124310,%,0,0
124311,),0,0
124312,",",0,0
124313,but,0,0
124314,not,0,0
124315,with,0,1
124316,DIWL,0,0
124317,.,0,1
124318,Dihydroceramide,0,0
124319,was,0,0
124320,decreased,0,0
124321,with,0,1
124322,both,0,0
124323,interventions,0,0
124324,.,0,1
124325,Sphingosine,0,0
124326,was,0,0
124327,decreased,0,0
124328,only,0,0
124329,with,0,1
124330,EX,0,0
124331,.,0,1
124332,Changes,0,0
124333,in,0,0
124334,total,0,1
124335,DAG,0,0
124336,",",0,0
124337,total,0,1
124338,ceramides,0,0
124339,and,0,1
124340,other,0,1
124341,sphingolipids,0,0
124342,did,0,0
124343,not,0,0
124344,correlate,0,0
124345,with,0,1
124346,changes,0,0
124347,in,0,0
124348,glucose,0,0
124349,disposal,0,1
124350,.,0,0
124351,Stearoyl-coenzyme,0,0
124352,A,0,0
124353,desaturase,0,0
124354,1,0,0
124355,(,0,0
124356,SCD1,0,0
124357,),0,0
124358,content,0,0
124359,was,0,0
124360,decreased,0,0
124361,with,0,1
124362,DIWL,0,0
124363,(,0,1
124364,-19.5,0,0
124365,?,0,1
124366,8.5,0,0
124367,%,0,0
124368,",",0,0
124369,p,0,0
124370,<,0,0
124371,0.05,0,0
124372,),0,0
124373,",",0,0
124374,but,0,0
124375,increased,0,0
124376,with,0,1
124377,EX,0,0
124378,(,0,1
124379,19.6,0,0
124380,?,0,1
124381,7.4,0,0
124382,%,0,0
124383,",",0,0
124384,p,0,0
124385,<,0,0
124386,0.05,0,0
124387,),0,1
124388,.,0,1
124389,Diacylglycerol,0,0
124390,acyltransferase,0,0
124391,1,0,0
124392,(,0,0
124393,DGAT1,0,1
124394,),0,0
124395,was,0,0
124396,unchanged,0,0
124397,with,0,1
124398,the,0,0
124399,interventions,0,0
124400,.,0,1
124401,CONCLUSIONS/INTERPRETATION,0,0
124402,Diet-induced,0,0
124403,weight,0,0
124404,loss,0,0
124405,and,0,0
124406,exercise,0,0
124407,training,0,0
124408,both,0,0
124409,improved,0,0
124410,insulin,0,0
124411,resistance,0,0
124412,and,0,0
124413,decreased,0,0
124414,DAG,0,0
124415,",",0,0
124416,while,0,0
124417,only,0,0
124418,exercise,0,0
124419,decreased,0,0
124420,ceramides,0,0
124421,",",0,0
124422,despite,0,0
124423,the,0,0
124424,interventions,0,0
124425,having,0,1
124426,different,0,0
124427,effects,0,0
124428,on,0,0
124429,IMTG,0,1
124430,.,0,1
124431,These,0,0
124432,alterations,0,0
124433,may,0,0
124434,be,0,0
124435,mediated,0,0
124436,through,0,0
124437,differential,0,0
124438,changes,0,0
124439,in,0,0
124440,skeletal,0,0
124441,muscle,0,0
124442,capacity,0,0
124443,for,0,0
124444,oxidation,0,0
124445,and,0,0
124446,triacylglycerol,0,0
124447,synthesis,0,0
124448,.,0,1
124449,TRIAL,0,0
124450,REGISTRATION,0,0
124451,ClinicalTrials.gov,0,1
124452,NCT00766298,0,1
124453,.,0,1
124454,[,0,0
124455,Effects,0,0
124456,of,0,0
124457,parecoxib,0,0
124458,on,0,0
124459,morphine,0,0
124460,dosage,0,0
124461,in,0,0
124462,postoperative,1,0
124463,patient-controlled,1,0
124464,analgesia,1,0
124465,following,0,0
124466,thoracoscope-assisted,0,0
124467,thoracotomy,0,1
124468,],0,1
124469,.,0,0
124470,OBJECTIVE,0,0
124471,To,0,0
124472,observe,0,0
124473,the,0,0
124474,effect,0,0
124475,of,0,0
124476,parecoxib,0,0
124477,on,0,0
124478,morphine,0,0
124479,dosage,0,0
124480,in,0,0
124481,patient-controlled,0,0
124482,analgesia,0,0
124483,(,0,0
124484,PCA,0,1
124485,),0,0
124486,following,0,0
124487,thoracoscope-assisted,0,1
124488,thoracotomy,1,1
124489,.,1,1
124490,METHODS,0,0
124491,A,1,0
124492,consecutive,1,1
124493,series,1,0
124494,of,1,0
124495,100,1,0
124496,patients,1,1
124497,undergoing,1,1
124498,thoracoscope-assisted,1,1
124499,thoracotomy,1,1
124500,were,0,0
124501,randomized,0,0
124502,into,0,1
124503,5,0,1
124504,groups,0,0
124505,and,0,1
124506,received,0,0
124507,PCA,0,1
124508,with,0,1
124509,morphine,0,0
124510,doses,0,0
124511,at,0,0
124512,0,0,0
124513,",",0,0
124514,5,0,0
124515,",",0,0
124516,10,0,0
124517,",",0,0
124518,15,0,0
124519,",",0,0
124520,and,0,0
124521,20,0,0
124522,mg,0,0
124523,given,0,0
124524,in,0,0
124525,200,0,0
124526,ml,0,0
124527,saline,0,0
124528,(,0,1
124529,groups,0,0
124530,P,0,0
124531,(,0,1
124532,1,0,0
124533,),0,0
124534,",",0,0
124535,P,0,0
124536,(,0,0
124537,2,0,0
124538,),0,0
124539,",",0,0
124540,P,0,0
124541,(,0,0
124542,3,0,0
124543,),0,0
124544,",",0,0
124545,P,0,0
124546,(,0,0
124547,4,0,0
124548,),0,0
124549,",",0,0
124550,and,0,0
124551,P,0,0
124552,(,0,0
124553,5,0,0
124554,),0,0
124555,",",0,0
124556,respectively,0,0
124557,),0,0
124558,.,0,0
124559,Parecoxib,0,0
124560,(,0,0
124561,40,0,1
124562,mg,0,0
124563,),0,0
124564,was,0,0
124565,given,0,0
124566,in,0,0
124567,all,0,0
124568,the,0,0
124569,patients,0,1
124570,immediately,0,0
124571,before,0,0
124572,the,0,0
124573,operation,0,0
124574,",",0,0
124575,and,0,0
124576,the,0,0
124577,mixture,0,0
124578,(,0,0
124579,4-5,0,0
124580,ml,0,0
124581,),0,0
124582,of,0,0
124583,lidocaine,0,0
124584,and,0,0
124585,ropivacaine,0,0
124586,was,0,0
124587,administered,0,0
124588,into,0,0
124589,the,0,0
124590,3,0,0
124591,intercostal,0,1
124592,spaces,0,1
124593,upper,0,1
124594,and,0,0
124595,lower,0,0
124596,to,0,0
124597,the,0,0
124598,incision,0,0
124599,before,0,0
124600,chest,0,0
124601,closure,0,1
124602,.,0,1
124603,PCA,0,0
124604,was,0,0
124605,administered,0,0
124606,for,0,0
124607,each,0,0
124608,patient,0,0
124609,.,0,0
124610,The,0,0
124611,visual,0,0
124612,analogue,0,0
124613,scale,0,0
124614,(,0,0
124615,VAS,0,1
124616,),0,0
124617,at,0,0
124618,rest,0,0
124619,and,0,0
124620,coughing,0,0
124621,and,0,0
124622,the,0,0
124623,respiratory,0,1
124624,functional,0,1
124625,parameters,0,0
124626,were,0,1
124627,recorded,0,0
124628,at,0,0
124629,1,0,0
124630,",",0,0
124631,2,0,0
124632,",",0,0
124633,4,0,0
124634,",",0,0
124635,8,0,0
124636,",",0,0
124637,12,0,0
124638,",",0,0
124639,24,0,0
124640,",",0,0
124641,36,0,1
124642,",",0,0
124643,and,0,0
124644,48,0,0
124645,h,0,0
124646,after,0,0
124647,the,0,0
124648,start,0,0
124649,of,0,0
124650,PCA,0,1
124651,",",0,0
124652,and,0,0
124653,the,0,0
124654,actual,0,0
124655,and,0,0
124656,effective,0,0
124657,button-pressing,0,0
124658,times,0,0
124659,(,0,0
124660,D,0,0
124661,(,0,1
124662,1,0,0
124663,),0,0
124664,/D,0,0
124665,(,0,0
124666,2,0,0
124667,),0,0
124668,),0,0
124669,in,0,0
124670,PCA,0,1
124671,were,0,0
124672,also,0,0
124673,recorded,0,0
124674,.,0,0
124675,RESULTS,0,0
124676,No,0,0
124677,patients,0,1
124678,showed,0,0
124679,signs,0,0
124680,of,0,0
124681,respiratory,0,1
124682,inhibition,0,0
124683,within,0,0
124684,24,0,0
124685,h,0,0
124686,after,0,0
124687,the,0,0
124688,operation,0,0
124689,",",0,0
124690,and,0,0
124691,the,0,0
124692,resting,0,0
124693,VAS,0,0
124694,was,0,0
124695,comparable,0,0
124696,between,0,0
124697,the,0,0
124698,groups,0,0
124699,within,0,0
124700,the,0,0
124701,initial,0,0
124702,6,0,0
124703,postoperative,0,1
124704,hours,0,0
124705,.,0,1
124706,At,0,0
124707,8,0,0
124708,to,0,0
124709,24,0,0
124710,h,0,0
124711,postoperatively,0,0
124712,",",0,0
124713,the,0,0
124714,VAS,0,0
124715,scores,0,0
124716,at,0,0
124717,rest,0,0
124718,and,0,0
124719,coughing,0,0
124720,were,0,0
124721,significantly,0,0
124722,higher,0,0
124723,in,0,0
124724,P,0,0
124725,(,0,1
124726,1,0,0
124727,),0,0
124728,group,0,0
124729,than,0,0
124730,in,0,0
124731,the,0,0
124732,other,0,0
124733,groups,0,0
124734,(,0,1
124735,P,0,0
124736,<,0,0
124737,0.05,0,0
124738,),0,0
124739,",",0,0
124740,and,0,0
124741,no,0,0
124742,significant,0,0
124743,differences,0,0
124744,were,0,1
124745,found,0,0
124746,between,0,0
124747,the,0,0
124748,groups,0,0
124749,at,0,0
124750,36,0,1
124751,to,0,0
124752,48,0,0
124753,h.,0,1
124754,D,0,0
124755,(,0,0
124756,1,0,0
124757,),0,0
124758,/D,0,0
124759,(,0,0
124760,2,0,0
124761,),0,0
124762,in,0,0
124763,groups,0,0
124764,P,0,0
124765,(,0,1
124766,1,0,0
124767,),0,0
124768,and,0,0
124769,P,0,0
124770,(,0,0
124771,2,0,0
124772,),0,0
124773,were,0,0
124774,significantly,0,0
124775,different,0,0
124776,from,0,0
124777,those,0,0
124778,in,0,0
124779,the,0,0
124780,other,0,0
124781,3,0,0
124782,groups,0,0
124783,at,0,1
124784,4-24,0,0
124785,h,0,0
124786,",",0,0
124787,but,0,0
124788,no,0,0
124789,such,0,0
124790,difference,0,0
124791,was,0,0
124792,found,0,0
124793,between,0,0
124794,groups,0,0
124795,P,0,0
124796,(,0,1
124797,3,0,0
124798,),0,0
124799,",",0,0
124800,P,0,0
124801,(,0,0
124802,4,0,0
124803,),0,0
124804,",",0,0
124805,and,0,0
124806,P,0,0
124807,(,0,0
124808,5,0,1
124809,),0,0
124810,.,0,0
124811,CONCLUSION,0,0
124812,The,0,0
124813,application,0,0
124814,of,0,0
124815,parecoxib,0,0
124816,may,0,0
124817,reduce,0,0
124818,the,0,0
124819,dosage,0,0
124820,of,0,0
124821,morphine,0,0
124822,in,0,0
124823,PCA,0,1
124824,following,0,0
124825,thoracoscope-assisted,0,1
124826,thoracotomy,0,1
124827,and,0,1
124828,results,0,0
124829,in,0,0
124830,good,0,0
124831,analgesic,0,0
124832,effect,0,0
124833,without,0,1
124834,affecting,0,0
124835,the,0,0
124836,patients,0,1
124837,respiratory,0,1
124838,function,0,0
124839,and,0,0
124840,sputum,0,0
124841,elimination,0,0
124842,.,0,1
124843,Vascular,0,1
124844,pedicle,0,0
124845,width,0,0
124846,in,0,0
124847,acute,1,1
124848,lung,1,1
124849,injury,1,1
124850,:,1,1
124851,correlation,0,0
124852,with,0,1
124853,intravascular,0,0
124854,pressures,0,0
124855,and,0,0
124856,ability,0,0
124857,to,0,0
124858,discriminate,0,0
124859,fluid,0,0
124860,status,0,0
124861,.,0,1
124862,INTRODUCTION,0,0
124863,Conservative,0,0
124864,fluid,0,0
124865,management,0,0
124866,in,0,0
124867,patients,1,1
124868,with,1,1
124869,acute,1,1
124870,lung,1,1
124871,injury,1,1
124872,(,1,0
124873,ALI,1,1
124874,),1,0
124875,increases,0,0
124876,time,0,0
124877,alive,0,1
124878,and,0,0
124879,free,0,0
124880,from,0,1
124881,mechanical,0,1
124882,ventilation,0,1
124883,.,0,1
124884,Vascular,0,0
124885,pedicle,0,0
124886,width,0,0
124887,(,0,0
124888,VPW,0,1
124889,),0,0
124890,is,0,0
124891,a,0,0
124892,non-invasive,0,0
124893,measurement,0,0
124894,of,0,0
124895,intravascular,0,0
124896,volume,0,0
124897,status,0,1
124898,.,0,0
124899,The,0,0
124900,VPW,0,0
124901,was,0,0
124902,studied,0,0
124903,in,0,0
124904,ALI,1,1
124905,patients,1,1
124906,to,0,0
124907,determine,0,0
124908,the,0,0
124909,correlation,0,0
124910,between,0,0
124911,VPW,0,1
124912,and,0,0
124913,intravascular,0,0
124914,pressure,0,0
124915,measurements,0,0
124916,and,0,0
124917,whether,0,0
124918,VPW,0,1
124919,could,0,0
124920,predict,0,0
124921,fluid,0,0
124922,status,0,0
124923,.,0,1
124924,METHODS,0,0
124925,This,0,0
124926,retrospective,0,0
124927,cohort,0,1
124928,study,0,0
124929,involved,0,0
124930,152,1,1
124931,patients,1,1
124932,with,1,1
124933,ALI,1,1
124934,enrolled,1,1
124935,in,1,0
124936,the,1,0
124937,Fluid,1,0
124938,and,1,0
124939,Catheter,1,0
124940,Treatment,1,0
124941,Trial,1,1
124942,(,1,0
124943,FACTT,1,0
124944,),1,0
124945,from,1,1
124946,five,1,1
124947,NHLBI,1,1
124948,ARDS,1,1
124949,(,1,0
124950,Acute,1,1
124951,Respiratory,1,1
124952,Distress,1,0
124953,Syndrome,1,1
124954,),1,1
124955,Network,1,0
124956,sites,1,0
124957,.,1,1
124958,VPW,0,1
124959,and,0,0
124960,central,0,0
124961,venous,0,0
124962,pressure,0,0
124963,(,0,0
124964,CVP,0,0
124965,),0,0
124966,or,0,1
124967,pulmonary,0,1
124968,artery,0,1
124969,occlusion,0,0
124970,pressure,0,0
124971,(,0,0
124972,PAOP,0,0
124973,),0,0
124974,from,0,0
124975,the,0,0
124976,first,0,0
124977,four,0,1
124978,study,0,1
124979,days,0,0
124980,were,0,1
124981,correlated,0,0
124982,.,0,0
124983,The,0,0
124984,relationships,0,0
124985,between,0,0
124986,VPW,0,1
124987,",",0,0
124988,positive,0,0
124989,end-expiratory,0,0
124990,pressure,0,0
124991,(,0,0
124992,PEEP,0,0
124993,),0,0
124994,",",0,0
124995,cumulative,0,0
124996,fluid,0,0
124997,balance,0,0
124998,",",0,0
124999,and,0,0
125000,PAOP,0,0
125001,were,0,0
125002,also,0,0
125003,evaluated,0,0
125004,.,0,0
125005,Receiver,0,0
125006,operator,0,0
125007,characteristic,0,0
125008,(,0,0
125009,ROC,0,1
125010,),0,1
125011,curves,0,0
125012,were,0,1
125013,used,0,0
125014,to,0,0
125015,determine,0,0
125016,the,0,0
125017,ability,0,0
125018,of,0,0
125019,VPW,0,1
125020,to,0,0
125021,detect,0,0
125022,PAOP,0,1
125023,<,0,0
125024,8,0,0
125025,mmHg,0,0
125026,and,0,0
125027,PAOP,0,1
125028,?,0,0
125029,18,0,0
125030,mm,0,0
125031,Hg,0,0
125032,.,0,0
125033,RESULTS,0,0
125034,A,0,0
125035,total,0,1
125036,of,0,0
125037,71,1,1
125038,and,1,1
125039,152,1,1
125040,patients,1,1
125041,provided,1,0
125042,118,0,1
125043,and,0,1
125044,276,0,1
125045,paired,0,0
125046,VPW/PAOP,0,0
125047,and,0,0
125048,VPW/CVP,0,0
125049,measurements,0,0
125050,",",0,0
125051,respectively,0,0
125052,.,0,0
125053,VPW,0,0
125054,correlated,0,0
125055,with,0,1
125056,PAOP,0,1
125057,(,0,0
125058,r,0,0
125059,=,0,0
125060,0.41,0,0
125061,;,0,0
125062,P,0,0
125063,<,0,0
125064,0.001,0,0
125065,),0,0
125066,and,0,0
125067,less,0,0
125068,well,0,0
125069,with,0,0
125070,CVP,0,0
125071,(,0,0
125072,r,0,0
125073,=,0,0
125074,0.21,0,0
125075,;,0,0
125076,P,0,0
125077,=,0,0
125078,0.001,0,0
125079,),0,0
125080,.,0,1
125081,In,0,0
125082,linear,0,0
125083,regression,0,0
125084,",",0,0
125085,VPW,0,1
125086,correlated,0,0
125087,with,0,1
125088,PAOP,0,1
125089,1.5-fold,0,0
125090,better,0,0
125091,than,0,0
125092,cumulative,0,0
125093,fluid,0,0
125094,balance,0,0
125095,and,0,0
125096,2.5-fold,0,0
125097,better,0,0
125098,than,0,0
125099,PEEP,0,0
125100,.,0,1
125101,VPW,0,0
125102,discriminated,0,0
125103,achievement,0,0
125104,of,0,0
125105,PAOP,0,1
125106,<,0,0
125107,8,0,0
125108,mm,0,0
125109,Hg,0,0
125110,(,0,0
125111,AUC,0,0
125112,=,0,1
125113,0.73,0,0
125114,;,0,1
125115,P,0,0
125116,=,0,0
125117,0.04,0,0
125118,),0,0
125119,with,0,1
125120,VPW,0,1
125121,?67,0,0
125122,mm,0,0
125123,demonstrating,0,0
125124,71,0,1
125125,%,0,0
125126,sensitivity,0,0
125127,(,0,0
125128,95,0,0
125129,%,0,0
125130,CI,0,0
125131,30,0,1
125132,to,0,0
125133,95,0,0
125134,%,0,0
125135,),0,0
125136,and,0,0
125137,68,0,1
125138,%,0,0
125139,specificity,0,0
125140,(,0,0
125141,95,0,0
125142,%,0,0
125143,CI,0,0
125144,59,0,1
125145,to,0,0
125146,75,0,1
125147,%,0,0
125148,),0,0
125149,.,0,0
125150,For,0,0
125151,discriminating,0,0
125152,a,0,0
125153,hydrostatic,0,0
125154,component,0,0
125155,of,0,0
125156,the,0,0
125157,edema,0,0
125158,(,0,0
125159,that,0,0
125160,is,0,0
125161,",",0,0
125162,PAOP,0,0
125163,?,0,0
125164,18,0,0
125165,mm,0,0
125166,Hg,0,0
125167,),0,0
125168,",",0,0
125169,VPW,0,1
125170,?,0,0
125171,72,0,0
125172,mm,0,0
125173,demonstrated,0,0
125174,61.4,0,0
125175,%,0,0
125176,sensitivity,0,0
125177,(,0,0
125178,95,0,0
125179,%,0,0
125180,CI,0,0
125181,47,0,1
125182,to,0,0
125183,74,0,1
125184,%,0,0
125185,),0,0
125186,and,0,0
125187,61,0,1
125188,%,0,0
125189,specificity,0,0
125190,(,0,0
125191,49,0,1
125192,to,0,0
125193,71,0,1
125194,%,0,0
125195,),0,0
125196,(,0,0
125197,area,0,0
125198,under,0,0
125199,the,0,0
125200,curve,0,0
125201,(,0,0
125202,AUC,0,0
125203,),0,1
125204,0.69,0,0
125205,;,0,1
125206,P,0,0
125207,=,0,0
125208,0.001,0,0
125209,),0,1
125210,.,0,1
125211,CONCLUSIONS,0,0
125212,VPW,0,0
125213,correlates,0,0
125214,with,0,0
125215,PAOP,0,0
125216,better,0,0
125217,than,0,0
125218,CVP,0,0
125219,in,1,0
125220,patients,1,1
125221,with,1,1
125222,ALI,1,1
125223,.,1,1
125224,Due,1,0
125225,to,0,0
125226,its,0,0
125227,only,0,0
125228,moderate,0,1
125229,sensitivity,0,0
125230,and,0,0
125231,specificity,0,0
125232,",",0,0
125233,the,0,0
125234,ability,0,0
125235,of,0,0
125236,VPW,0,1
125237,to,0,0
125238,discriminate,0,0
125239,fluid,0,0
125240,status,0,0
125241,in,1,0
125242,patients,1,1
125243,with,1,1
125244,acute,1,1
125245,lung,1,1
125246,injury,1,1
125247,is,0,0
125248,limited,0,0
125249,and,0,0
125250,should,0,0
125251,only,0,0
125252,be,0,0
125253,considered,0,0
125254,when,0,0
125255,intravascular,0,0
125256,pressures,0,0
125257,are,0,0
125258,unavailable,0,0
125259,.,0,1
125260,An,0,0
125261,interactive,1,0
125262,computer,1,0
125263,program,1,0
125264,can,0,0
125265,effectively,0,0
125266,educate,0,0
125267,potential,1,0
125268,users,1,1
125269,of,1,0
125270,cystic,1,1
125271,fibrosis,1,1
125272,carrier,1,0
125273,tests,1,0
125274,.,1,0
125275,The,0,0
125276,demand,0,0
125277,for,0,0
125278,cystic,0,1
125279,fibrosis,0,1
125280,(,0,0
125281,CF,0,0
125282,),0,0
125283,carrier,0,0
125284,testing,0,0
125285,is,0,0
125286,steadily,0,0
125287,growing,0,0
125288,",",0,0
125289,not,0,0
125290,only,0,0
125291,from,0,0
125292,individuals,1,1
125293,with,1,1
125294,raised,1,0
125295,a,1,0
125296,priori,1,0
125297,carrier,1,0
125298,risk,1,0
125299,",",0,0
125300,but,0,0
125301,also,0,0
125302,from,0,0
125303,the,0,0
125304,general,0,1
125305,population,0,1
125306,.,0,0
125307,This,0,0
125308,trend,0,0
125309,will,0,0
125310,likely,0,0
125311,exceed,0,0
125312,the,0,0
125313,availability,0,0
125314,of,0,0
125315,genetic,0,0
125316,counselors,0,0
125317,",",0,0
125318,making,0,0
125319,it,0,0
125320,impossible,0,0
125321,to,0,0
125322,provide,0,0
125323,standard,0,0
125324,face-to-face,0,0
125325,genetic,0,0
125326,counseling,0,0
125327,to,0,0
125328,all,0,0
125329,those,0,0
125330,asking,0,0
125331,for,0,0
125332,the,0,0
125333,test,0,0
125334,.,0,0
125335,In,0,0
125336,order,0,0
125337,to,0,0
125338,reduce,0,0
125339,the,0,0
125340,time,0,0
125341,needed,0,0
125342,to,0,0
125343,educate,0,0
125344,individuals,0,1
125345,on,0,0
125346,the,0,0
125347,basics,0,0
125348,of,0,0
125349,the,0,0
125350,disease,0,1
125351,",",0,0
125352,its,0,0
125353,genetic,0,0
125354,transmission,0,0
125355,",",0,0
125356,and,0,0
125357,carrier,0,0
125358,testing,0,0
125359,peculiarities,0,0
125360,",",0,0
125361,we,0,0
125362,developed,0,0
125363,an,0,0
125364,educational,0,0
125365,method,0,0
125366,based,0,0
125367,on,0,0
125368,an,0,0
125369,interactive,0,0
125370,computer,0,0
125371,program,0,0
125372,(,0,0
125373,IC,0,1
125374,),0,0
125375,.,0,0
125376,To,0,0
125377,assess,0,0
125378,the,0,0
125379,effectiveness,0,0
125380,of,0,0
125381,this,0,0
125382,program,0,0
125383,and,0,0
125384,to,0,0
125385,compare,0,0
125386,it,0,0
125387,to,0,0
125388,a,0,0
125389,classical,0,0
125390,genetic,0,0
125391,counseling,0,0
125392,session,0,0
125393,",",0,0
125394,we,0,0
125395,conducted,0,0
125396,a,0,0
125397,comparative,0,0
125398,trial,0,0
125399,.,0,0
125400,In,0,0
125401,a,0,0
125402,population,0,1
125403,setting,0,1
125404,of,0,0
125405,people,0,1
125406,undergoing,0,1
125407,assisted,0,1
125408,reproduction,0,1
125409,",",0,0
125410,44,1,1
125411,individuals,1,1
125412,were,0,1
125413,randomly,0,1
125414,assigned,0,0
125415,to,0,0
125416,either,0,0
125417,receiving,0,0
125418,standard,0,0
125419,one-on-one,0,1
125420,genetic,0,0
125421,counseling,0,0
125422,or,0,0
125423,education,0,0
125424,by,0,0
125425,the,0,0
125426,IC,0,0
125427,program,0,0
125428,.,0,0
125429,We,0,0
125430,measured,0,0
125431,pre-,0,0
125432,and,0,0
125433,post-intervention,0,0
125434,knowledge,0,0
125435,about,0,0
125436,CF,0,0
125437,genetic,0,0
125438,transmission,0,0
125439,and,0,0
125440,carrier,0,0
125441,testing,0,0
125442,.,0,0
125443,Starting,0,0
125444,from,0,0
125445,an,0,0
125446,equivalent,0,0
125447,baseline,0,0
125448,of,0,0
125449,correct,0,0
125450,answers,0,0
125451,to,0,0
125452,a,0,0
125453,specially,0,0
125454,designed,0,0
125455,multiple-choice,0,0
125456,questionnaire,0,0
125457,(,0,0
125458,47,0,1
125459,%,0,0
125460,in,0,0
125461,the,0,0
125462,counselor,0,0
125463,group,0,0
125464,and,0,0
125465,45,0,1
125466,%,0,0
125467,in,0,0
125468,the,0,0
125469,computer,0,0
125470,group,0,0
125471,),0,0
125472,both,0,0
125473,groups,0,0
125474,showed,0,0
125475,a,0,0
125476,highly,0,0
125477,significant,0,0
125478,and,0,0
125479,similar,0,0
125480,increase,0,0
125481,(,0,0
125482,reaching,0,0
125483,84,0,1
125484,%,0,0
125485,in,0,0
125486,the,0,0
125487,counselor,0,0
125488,group,0,0
125489,and,0,0
125490,85,0,0
125491,%,0,0
125492,in,0,0
125493,the,0,0
125494,computer,0,0
125495,group,0,0
125496,),0,0
125497,.,0,0
125498,The,0,0
125499,computer,0,0
125500,program,0,0
125501,under,0,0
125502,evaluation,0,0
125503,can,0,0
125504,successfully,0,0
125505,educate,0,0
125506,individuals,0,1
125507,considering,0,0
125508,genetic,0,0
125509,testing,0,0
125510,for,0,0
125511,CF,0,0
125512,.,0,1
125513,A,0,1
125514,randomized,0,1
125515,controlled,0,0
125516,trial,0,0
125517,of,0,0
125518,Hanen,0,0
125519,'s,0,1
125520,'More,0,0
125521,Than,0,1
125522,Words,0,0
125523,',0,1
125524,in,0,0
125525,toddlers,1,1
125526,with,1,1
125527,early,1,1
125528,autism,1,1
125529,symptoms,1,1
125530,.,1,1
125531,BACKGROUND,0,0
125532,This,0,0
125533,randomized,0,0
125534,controlled,0,0
125535,trial,0,0
125536,compared,0,0
125537,Hanen,0,0
125538,'s,0,1
125539,'More,0,0
125540,than,0,1
125541,Words,0,0
125542,',0,1
125543,(,0,1
125544,HMTW,0,0
125545,),0,0
125546,",",0,0
125547,a,0,0
125548,parent-implemented,0,0
125549,intervention,0,0
125550,",",0,0
125551,to,0,0
125552,a,0,0
125553,'business,0,1
125554,as,0,0
125555,usual,0,1
125556,',0,1
125557,control,0,1
125558,group,0,1
125559,.,0,0
125560,METHODS,0,0
125561,Sixty-two,1,1
125562,children,1,1
125563,(,1,1
125564,51,1,1
125565,boys,1,1
125566,and,1,1
125567,11,1,1
125568,girls,1,1
125569,;,1,1
125570,M,1,0
125571,age,1,1
125572,=,1,0
125573,20,1,1
125574,months,1,0
125575,;,1,1
125576,SD,1,1
125577,=,1,0
125578,2.6,1,1
125579,),1,1
125580,who,1,1
125581,met,1,1
125582,criteria,1,1
125583,for,1,0
125584,autism,1,1
125585,spectrum,1,1
125586,disorders,1,1
125587,(,1,1
125588,ASD,1,1
125589,),1,0
125590,and,1,0
125591,their,1,1
125592,parents,1,1
125593,participated,1,1
125594,in,1,0
125595,the,1,0
125596,study,1,0
125597,.,1,0
125598,The,0,0
125599,HMTW,0,0
125600,intervention,0,0
125601,was,0,0
125602,provided,0,0
125603,over,0,0
125604,3.5,0,1
125605,months,0,0
125606,.,0,0
125607,There,0,0
125608,were,0,0
125609,three,0,0
125610,measurement,0,0
125611,periods,0,0
125612,:,0,1
125613,prior,0,1
125614,to,0,0
125615,randomization,0,0
125616,(,0,0
125617,Time,0,0
125618,1,0,0
125619,),0,0
125620,and,0,0
125621,at,0,0
125622,5,0,0
125623,and,0,1
125624,9,0,1
125625,months,0,0
125626,post,0,1
125627,enrollment,0,1
125628,(,0,0
125629,Times,0,1
125630,2,0,0
125631,and,0,0
125632,3,0,0
125633,),0,0
125634,.,0,1
125635,Children,0,1
125636,'s,0,0
125637,communication,0,0
125638,and,0,1
125639,parental,0,0
125640,responsivity,0,0
125641,were,0,0
125642,measured,0,0
125643,at,0,0
125644,each,0,0
125645,time,0,0
125646,point,0,0
125647,.,0,0
125648,Children,0,1
125649,'s,0,1
125650,object,0,0
125651,interest,0,0
125652,",",0,0
125653,a,0,0
125654,putative,0,0
125655,moderator,0,0
125656,",",0,0
125657,was,0,0
125658,measured,0,0
125659,at,0,0
125660,Time,0,0
125661,1,0,0
125662,.,0,0
125663,RESULTS,0,0
125664,There,0,0
125665,were,0,0
125666,no,0,0
125667,main,0,0
125668,effects,0,0
125669,of,0,0
125670,the,0,0
125671,HMTW,0,0
125672,intervention,0,0
125673,on,0,0
125674,either,0,0
125675,parental,0,0
125676,responsivity,0,0
125677,or,0,1
125678,children,0,1
125679,'s,0,1
125680,communication,0,0
125681,.,0,0
125682,However,0,0
125683,",",0,0
125684,the,0,0
125685,effects,0,0
125686,on,0,0
125687,residualized,0,1
125688,gains,0,0
125689,in,0,0
125690,parental,0,0
125691,responsivity,0,0
125692,from,0,1
125693,Time,0,0
125694,1,0,0
125695,to,0,0
125696,both,0,0
125697,Times,0,0
125698,2,0,0
125699,and,0,0
125700,3,0,0
125701,yielded,0,0
125702,noteworthy,0,0
125703,effect,0,0
125704,sizes,0,0
125705,(,0,0
125706,Glass,0,0
125707,'s,0,1
125708,?,0,0
125709,=,0,0
125710,.71,0,0
125711,",",0,0
125712,.50,0,0
125713,respectively,0,0
125714,),0,0
125715,.,0,0
125716,In,0,0
125717,contrast,0,0
125718,",",0,0
125719,there,0,0
125720,were,0,0
125721,treatment,0,0
125722,effects,0,0
125723,on,0,0
125724,child,0,1
125725,communication,0,0
125726,gains,0,0
125727,to,0,0
125728,Time,0,0
125729,3,0,0
125730,that,0,0
125731,were,0,0
125732,moderated,0,0
125733,by,0,0
125734,children,0,1
125735,'s,0,1
125736,Time,0,0
125737,1,0,1
125738,object,0,0
125739,interest,0,0
125740,.,0,0
125741,Children,0,1
125742,with,0,1
125743,lower,0,0
125744,levels,0,0
125745,of,0,0
125746,Time,0,0
125747,1,0,0
125748,object,0,0
125749,interest,0,0
125750,exhibited,0,0
125751,facilitated,0,0
125752,growth,0,0
125753,in,0,0
125754,communication,0,0
125755,;,0,0
125756,children,0,1
125757,with,0,1
125758,higher,0,0
125759,levels,0,0
125760,of,0,0
125761,object,0,0
125762,interest,0,0
125763,exhibited,0,0
125764,growth,0,0
125765,attenuation,0,0
125766,.,0,0
125767,CONCLUSIONS,0,0
125768,The,0,0
125769,HMTW,0,0
125770,intervention,0,0
125771,showed,0,0
125772,differential,0,0
125773,effects,0,0
125774,on,0,0
125775,child,0,1
125776,communication,0,0
125777,depending,0,0
125778,on,0,0
125779,a,0,0
125780,baseline,0,0
125781,child,0,0
125782,factor,0,0
125783,.,0,1
125784,HMTW,0,0
125785,facilitated,0,0
125786,communication,0,0
125787,in,0,0
125788,children,0,1
125789,with,0,1
125790,lower,0,0
125791,levels,0,0
125792,of,0,0
125793,Time,0,0
125794,1,0,0
125795,object,0,0
125796,interest,0,0
125797,.,0,1
125798,Parents,1,0
125799,of,1,1
125800,children,1,1
125801,who,1,1
125802,evidence,1,0
125803,higher,1,0
125804,object,1,0
125805,interest,1,0
125806,may,0,0
125807,require,0,0
125808,greater,0,0
125809,support,0,0
125810,to,0,0
125811,implement,0,0
125812,the,0,0
125813,HMTW,0,0
125814,strategies,0,0
125815,",",0,0
125816,or,0,0
125817,may,0,0
125818,require,0,0
125819,different,0,0
125820,strategies,0,0
125821,than,0,0
125822,those,0,1
125823,provided,0,0
125824,by,0,0
125825,the,0,0
125826,HMTW,0,0
125827,curriculum,0,0
125828,.,0,1
125829,Evaluation,0,0
125830,of,0,0
125831,a,0,0
125832,preventive,0,0
125833,intervention,0,0
125834,for,0,0
125835,child,1,1
125836,anxiety,1,1
125837,in,0,0
125838,two,0,0
125839,randomized,0,1
125840,attention-control,0,1
125841,school,0,1
125842,trials,0,0
125843,.,0,1
125844,The,0,0
125845,present,0,0
125846,research,0,0
125847,examined,0,0
125848,the,0,0
125849,effectiveness,0,0
125850,of,0,0
125851,a,0,0
125852,cognitive-behavioral,0,0
125853,therapy,0,0
125854,(,0,0
125855,CBT,0,0
125856,),0,0
125857,based,0,0
125858,intervention,0,0
125859,program,0,0
125860,",",0,0
125861,FRIENDS,0,0
125862,",",0,0
125863,for,1,0
125864,children,1,1
125865,from,1,1
125866,grades,1,1
125867,4,1,0
125868,to,1,1
125869,6,1,0
125870,",",1,0
125871,using,1,0
125872,random,1,0
125873,assignment,1,0
125874,at,1,0
125875,the,1,0
125876,school-level,1,0
125877,and,0,0
125878,an,0,0
125879,attention-control,0,0
125880,design,0,0
125881,in,0,0
125882,two,0,0
125883,longitudinal,0,1
125884,studies,0,0
125885,.,0,1
125886,The,0,0
125887,first,0,0
125888,study,0,0
125889,targeted,0,0
125890,children,1,1
125891,with,1,1
125892,anxiety,1,1
125893,symptoms,1,0
125894,(,1,0
125895,N=191,1,1
125896,",",1,0
125897,mean,1,0
125898,age=10.1,1,1
125899,),1,0
125900,as,1,0
125901,screened,1,1
125902,with,1,1
125903,self,1,0
125904,",",1,0
125905,parent,1,0
125906,",",1,0
125907,and,1,0
125908,teacher-reports,1,0
125909,;,1,0
125910,the,1,0
125911,second,1,0
125912,study,1,0
125913,took,1,1
125914,a,1,0
125915,universal,1,0
125916,approach,1,0
125917,with,1,1
125918,full,1,1
125919,classrooms,1,1
125920,of,1,1
125921,children,1,1
125922,participating,1,1
125923,(,1,0
125924,N=253,1,1
125925,",",1,0
125926,mean,1,0
125927,age=9.8,1,1
125928,),1,0
125929,.,1,0
125930,The,0,0
125931,results,0,0
125932,showed,0,0
125933,no,0,0
125934,intervention,0,0
125935,effect,0,0
125936,in,0,0
125937,both,0,0
125938,studies,0,0
125939,",",0,0
125940,with,0,1
125941,children,0,1
125942,'s,0,1
125943,anxiety,0,1
125944,symptoms,0,0
125945,decreasing,0,0
125946,over,0,0
125947,time,0,0
125948,regardless,0,0
125949,of,0,0
125950,whether,0,0
125951,they,0,0
125952,were,0,0
125953,in,0,0
125954,the,0,0
125955,story-reading,0,0
125956,(,0,0
125957,attention,0,0
125958,control,0,0
125959,),0,0
125960,or,0,1
125961,FRIENDS,0,1
125962,condition,0,0
125963,.,0,0
125964,The,0,0
125965,findings,0,0
125966,also,0,0
125967,indicated,0,0
125968,that,0,0
125969,girls,0,1
125970,reported,0,0
125971,a,0,0
125972,higher,0,0
125973,level,0,0
125974,of,0,0
125975,anxiety,0,0
125976,than,0,0
125977,boys,0,1
125978,and,0,1
125979,children,0,1
125980,in,0,0
125981,higher,0,0
125982,grades,0,1
125983,reported,0,0
125984,lower,0,0
125985,anxiety,0,0
125986,relative,0,0
125987,to,0,0
125988,younger,0,1
125989,children,0,1
125990,in,0,0
125991,both,0,0
125992,studies,0,0
125993,.,0,0
125994,In,0,0
125995,addition,0,0
125996,",",0,0
125997,similar,0,0
125998,patterns,0,0
125999,were,0,1
126000,found,0,0
126001,using,0,0
126002,a,0,0
126003,subgroup,0,1
126004,of,1,0
126005,children,1,1
126006,with,1,1
126007,high-anxiety,1,0
126008,symptoms,1,0
126009,from,0,1
126010,both,0,0
126011,studies,0,0
126012,.,0,1
126013,[,0,0
126014,Results,0,0
126015,of,0,0
126016,three-year,0,1
126017,clinical,0,0
126018,study,0,0
126019,of,0,0
126020,prostamol,0,0
126021,uno,0,1
126022,efficacy,0,0
126023,and,0,0
126024,safety,0,0
126025,in,0,0
126026,patients,1,1
126027,with,1,1
126028,initial,1,1
126029,symptoms,1,1
126030,of,1,0
126031,prostatic,1,1
126032,adenoma,1,1
126033,and,1,0
126034,risk,1,0
126035,of,1,0
126036,its,1,0
126037,progression,1,0
126038,],1,0
126039,.,0,1
126040,Prostamol,0,0
126041,Uno,0,0
126042,(,0,0
126043,PU,0,0
126044,),0,0
126045,efficacy,0,0
126046,and,0,0
126047,safety,0,0
126048,were,0,0
126049,studied,0,0
126050,in,0,0
126051,a,0,0
126052,multicenter,1,0
126053,",",1,0
126054,open-population,1,0
126055,",",0,0
126056,randomized,0,0
126057,and,0,0
126058,comparative,0,0
126059,trial,0,0
126060,.,0,1
126061,PU,0,0
126062,was,0,0
126063,given,0,0
126064,in,0,0
126065,a,0,0
126066,single,0,0
126067,daily,0,0
126068,dose,0,0
126069,320,0,1
126070,mg,0,0
126071,for,0,0
126072,36,0,1
126073,months,0,0
126074,to,0,1
126075,50,1,1
126076,patients,1,1
126077,with,1,1
126078,initial,1,1
126079,symptoms,1,1
126080,of,1,0
126081,prostatic,1,1
126082,adenoma,1,1
126083,(,1,0
126084,PA,1,0
126085,),1,0
126086,in,1,0
126087,comparison,1,0
126088,with,1,1
126089,50,1,1
126090,matched,1,1
126091,controls,1,1
126092,.,1,1
126093,The,0,0
126094,trial,0,0
126095,evaluated,0,0
126096,PU,0,0
126097,action,0,0
126098,on,0,0
126099,the,0,0
126100,symptoms,0,0
126101,progression,0,0
126102,and,0,0
126103,quality,0,0
126104,of,0,0
126105,life,0,0
126106,with,0,1
126107,application,0,0
126108,of,0,0
126109,questionnaires,0,0
126110,IPSS,0,1
126111,and,0,1
126112,QoL,0,0
126113,(,0,0
126114,BS,0,1
126115,),0,0
126116,.,0,0
126117,It,0,0
126118,was,0,0
126119,found,0,0
126120,that,0,0
126121,PU,0,0
126122,treatment,0,0
126123,relieved,0,0
126124,PA,0,0
126125,symptoms,0,0
126126,by,0,0
126127,IPSS,0,1
126128,",",0,0
126129,while,0,0
126130,these,0,0
126131,symptoms,0,0
126132,progressed,0,0
126133,in,0,0
126134,the,0,0
126135,controls,0,1
126136,.,0,1
126137,QoL,0,0
126138,improved,0,0
126139,in,0,0
126140,the,0,0
126141,study,0,0
126142,group,0,0
126143,and,0,0
126144,deteriorated,0,0
126145,in,0,0
126146,the,0,0
126147,control,0,1
126148,one,0,0
126149,.,0,0
126150,Administration,0,0
126151,of,0,0
126152,PU,0,0
126153,significantly,0,0
126154,increased,0,0
126155,urinary,0,0
126156,flow,0,0
126157,rate,0,0
126158,though,0,0
126159,in,0,0
126160,the,0,0
126161,controls,0,1
126162,urinary,0,0
126163,flow,0,0
126164,rate,0,0
126165,decreased,0,0
126166,",",0,0
126167,size,0,0
126168,of,0,0
126169,the,0,0
126170,prostate,0,1
126171,diminished,0,0
126172,and,0,0
126173,increased,0,0
126174,",",0,0
126175,respectively,0,0
126176,.,0,0
126177,Changes,0,0
126178,in,0,0
126179,the,0,0
126180,PSA,0,0
126181,were,0,0
126182,not,0,0
126183,seen,0,0
126184,and,0,0
126185,were,0,0
126186,insignificant,0,0
126187,",",0,0
126188,respectively,0,0
126189,.,0,0
126190,The,0,0
126191,results,0,0
126192,of,0,0
126193,the,0,0
126194,study,0,0
126195,say,0,0
126196,that,0,0
126197,prostamol,0,0
126198,Uno,0,0
126199,in,0,0
126200,a,0,0
126201,dose,0,0
126202,320,0,1
126203,mg/day,0,0
126204,can,0,0
126205,prevent,0,0
126206,PA,0,0
126207,progression,0,0
126208,without,0,1
126209,side,0,0
126210,effects,0,0
126211,.,0,1
126212,The,0,0
126213,effect,0,0
126214,of,0,0
126215,pain-free,0,0
126216,treadmill,0,0
126217,training,0,0
126218,on,0,0
126219,fibrinogen,0,0
126220,",",0,0
126221,haematocrit,0,0
126222,",",0,0
126223,and,0,0
126224,lipid,0,0
126225,profile,0,0
126226,in,0,0
126227,patients,1,1
126228,with,1,1
126229,claudication,1,1
126230,.,1,0
126231,OBJECTIVE,0,0
126232,To,0,0
126233,assess,0,0
126234,the,0,0
126235,effect,0,0
126236,of,0,0
126237,pain-free,0,0
126238,treadmill,0,0
126239,training,0,0
126240,on,0,0
126241,changes,0,0
126242,of,0,0
126243,plasma,0,0
126244,fibrinogen,0,0
126245,",",0,0
126246,haematocrit,0,0
126247,",",0,0
126248,lipid,0,0
126249,profile,0,0
126250,",",0,0
126251,and,0,0
126252,walking,0,0
126253,ability,0,0
126254,in,0,0
126255,patients,1,1
126256,with,1,1
126257,claudication,1,1
126258,.,1,1
126259,DESIGN,0,0
126260,Randomized,0,0
126261,control,0,1
126262,trial,0,0
126263,.,0,0
126264,METHODS,0,0
126265,Sixty-eight,1,1
126266,patients,1,1
126267,with,1,1
126268,peripheral,1,1
126269,obstructive,1,1
126270,arterial,1,1
126271,disease,1,1
126272,and,1,0
126273,intermittent,1,0
126274,claudication,1,1
126275,(,1,0
126276,Fontaine,1,1
126277,stage,1,1
126278,II,1,1
126279,),1,0
126280,were,0,0
126281,randomly,0,1
126282,assigned,0,0
126283,into,0,0
126284,the,0,0
126285,treadmill,0,0
126286,training,0,0
126287,(,0,0
126288,repetitive,0,0
126289,intervals,0,0
126290,to,0,0
126291,onset,0,1
126292,of,0,0
126293,claudication,0,1
126294,pain,0,1
126295,",",0,0
126296,three,0,0
126297,times,0,0
126298,a,0,0
126299,week,0,0
126300,),0,0
126301,or,0,0
126302,a,0,0
126303,control,0,0
126304,group,0,0
126305,(,0,0
126306,no,0,0
126307,change,0,0
126308,in,0,0
126309,physical,0,0
126310,activity,0,0
126311,),0,0
126312,over,0,0
126313,3,0,1
126314,months,0,0
126315,.,0,1
126316,Both,0,0
126317,groups,0,0
126318,performed,0,0
126319,treadmill,0,0
126320,test,0,0
126321,to,0,0
126322,assess,0,0
126323,pain-free,0,0
126324,walking,0,0
126325,time,0,0
126326,(,0,0
126327,PFWT,0,1
126328,),0,0
126329,and,0,0
126330,maximal,0,0
126331,walking,0,0
126332,time,0,0
126333,(,0,0
126334,MWT,0,1
126335,),0,0
126336,and,0,0
126337,had,0,1
126338,blood,0,0
126339,analyses,0,0
126340,[,0,0
126341,for,0,0
126342,haematocrit,0,0
126343,",",0,0
126344,fibrinogen,0,0
126345,",",0,0
126346,triglycerides,0,0
126347,",",0,0
126348,and,0,0
126349,cholesterol,0,0
126350,:,0,1
126351,total,0,1
126352,",",0,0
126353,high-density,0,0
126354,lipoprotein,0,0
126355,(,0,0
126356,HDL,0,0
126357,),0,0
126358,and,0,0
126359,low-density,0,0
126360,lipoprotein,0,0
126361,(,0,0
126362,LDL,0,1
126363,),0,0
126364,],0,0
126365,done,0,0
126366,at,0,0
126367,baseline,0,0
126368,and,0,0
126369,after,0,0
126370,6,0,0
126371,and,0,1
126372,12,0,1
126373,weeks,0,0
126374,of,0,0
126375,the,0,0
126376,study,0,0
126377,.,0,0
126378,RESULTS,0,0
126379,Total,0,0
126380,and,0,0
126381,LDL,0,0
126382,cholesterol,0,0
126383,levels,0,0
126384,in,0,0
126385,the,0,0
126386,training,0,0
126387,group,0,0
126388,decreased,0,0
126389,(,0,0
126390,p,0,0
126391,<,0,0
126392,0.05,0,0
126393,),0,0
126394,by,0,0
126395,14.8,0,0
126396,%,0,0
126397,and,0,0
126398,"20,5",0,0
126399,%,0,0
126400,",",0,0
126401,respectively,0,0
126402,.,0,0
126403,Significant,0,0
126404,(,0,0
126405,p,0,0
126406,<,0,0
126407,0.05,0,0
126408,),0,0
126409,HDL,0,0
126410,cholesterol,0,0
126411,increased,0,0
126412,(,0,0
126413,14.6,0,0
126414,%,0,0
126415,),0,0
126416,and,0,0
126417,triglycerides,0,0
126418,decreased,0,0
126419,(,0,1
126420,19,0,1
126421,%,0,0
126422,),0,0
126423,in,0,0
126424,the,0,0
126425,training,0,0
126426,group,0,0
126427,but,0,0
126428,changes,0,0
126429,of,0,0
126430,all,0,0
126431,these,0,0
126432,lipids,0,0
126433,were,0,0
126434,insignificant,0,0
126435,in,0,0
126436,the,0,0
126437,control,0,0
126438,group,0,0
126439,over,0,0
126440,the,0,0
126441,3,0,0
126442,months,0,0
126443,.,0,1
126444,Haematocrit,0,0
126445,and,0,0
126446,fibrinogen,0,0
126447,changes,0,0
126448,were,0,1
126449,insignificant,0,0
126450,in,0,0
126451,both,0,0
126452,groups,0,0
126453,.,0,1
126454,PFWT,0,0
126455,was,0,0
126456,prolonged,0,0
126457,by,0,0
126458,109,0,1
126459,%,0,0
126460,and,0,0
126461,MWT,0,0
126462,increased,0,0
126463,by,0,0
126464,54,0,1
126465,%,0,0
126466,in,0,0
126467,the,0,0
126468,training,0,0
126469,group,0,0
126470,(,0,0
126471,p,0,0
126472,<,0,0
126473,0.01,0,0
126474,),0,0
126475,",",0,0
126476,but,0,0
126477,not,0,0
126478,in,0,0
126479,the,0,0
126480,control,0,0
126481,group,0,0
126482,.,0,0
126483,CONCLUSION,0,0
126484,The,0,0
126485,improvement,0,0
126486,in,0,0
126487,walking,0,0
126488,time,0,0
126489,over,0,0
126490,3,0,0
126491,months,0,0
126492,of,0,0
126493,pain-free,0,1
126494,treadmill,0,0
126495,training,0,0
126496,parallels,0,0
126497,with,0,1
126498,progressive,0,1
126499,normalization,0,0
126500,of,0,0
126501,lipid,0,0
126502,profiles,0,0
126503,in,0,1
126504,patients,1,1
126505,with,1,1
126506,claudication,1,1
126507,.,1,1
126508,Improving,0,0
126509,emotion,0,0
126510,regulation,0,0
126511,with,0,1
126512,CBT,0,0
126513,in,0,0
126514,young,1,1
126515,children,1,1
126516,with,1,1
126517,high,1,1
126518,functioning,1,0
126519,autism,1,1
126520,spectrum,1,1
126521,disorders,1,1
126522,:,1,1
126523,a,0,0
126524,pilot,0,0
126525,study,0,0
126526,.,0,0
126527,BACKGROUND,0,0
126528,AND,0,0
126529,AIMS,0,1
126530,This,0,0
126531,pilot,0,0
126532,study,0,0
126533,tested,0,0
126534,the,0,0
126535,efficacy,0,0
126536,of,0,0
126537,a,0,0
126538,developmentally,0,0
126539,modified,0,0
126540,CBT,0,0
126541,for,0,0
126542,young,1,1
126543,children,1,1
126544,with,1,1
126545,Autism,1,1
126546,Spectrum,1,1
126547,Disorders,1,1
126548,(,1,0
126549,ASD,1,1
126550,),1,0
126551,to,0,0
126552,teach,0,0
126553,emotion,0,0
126554,regulation,0,0
126555,strategies,0,0
126556,for,0,0
126557,reducing,0,0
126558,anger,0,0
126559,and,0,0
126560,anxiety,0,0
126561,",",0,0
126562,commonly,0,0
126563,noted,0,0
126564,problems,0,0
126565,in,0,0
126566,this,0,0
126567,population,0,1
126568,.,0,0
126569,METHOD,0,0
126570,Eleven,1,1
126571,5-7,1,1
126572,year-old,1,1
126573,children,1,1
126574,participated,1,1
126575,in,0,0
126576,a,0,0
126577,CBT-group,0,0
126578,while,0,0
126579,parents,0,1
126580,participated,0,1
126581,in,0,0
126582,psychoeducation,0,0
126583,.,0,1
126584,Children,0,1
126585,were,0,0
126586,randomly,0,1
126587,assigned,0,0
126588,to,0,0
126589,an,0,0
126590,experimental,0,0
126591,or,0,1
126592,delayed-treatment,0,0
126593,control,0,1
126594,group,0,0
126595,.,0,0
126596,RESULTS,0,0
126597,From,0,1
126598,pre-,0,0
126599,to,0,0
126600,post-treatment,0,0
126601,",",0,0
126602,all,0,0
126603,children,0,1
126604,had,0,0
126605,less,0,0
126606,parent,1,0
126607,reported,1,0
126608,negativity/lability,1,0
126609,",",0,0
126610,better,0,0
126611,parent,0,0
126612,reported,0,0
126613,emotion,0,0
126614,regulation,0,0
126615,",",0,0
126616,and,0,0
126617,shorter,0,0
126618,outbursts,0,0
126619,",",0,0
126620,and,0,0
126621,also,0,0
126622,generated,0,0
126623,more,0,0
126624,coping,0,0
126625,strategies,0,0
126626,in,0,0
126627,response,0,0
126628,to,0,1
126629,vignettes,0,0
126630,.,0,1
126631,Parents,0,0
126632,also,0,0
126633,reported,0,0
126634,increases,0,0
126635,in,0,0
126636,their,0,1
126637,own,0,1
126638,confidence,0,0
126639,and,0,0
126640,their,0,0
126641,child,0,0
126642,'s,0,1
126643,ability,0,0
126644,to,0,0
126645,deal,0,0
126646,with,0,1
126647,anger,0,0
126648,and,0,0
126649,anxiety,0,0
126650,.,0,0
126651,CONCLUSIONS,0,0
126652,This,0,0
126653,study,0,0
126654,suggests,0,0
126655,that,0,0
126656,young,1,1
126657,children,1,1
126658,with,1,1
126659,high,1,1
126660,functioning,1,0
126661,ASD,1,1
126662,may,0,0
126663,benefit,0,0
126664,from,0,0
126665,CBT,0,0
126666,to,0,0
126667,improve,0,0
126668,regulation,0,0
126669,of,0,0
126670,anger,0,0
126671,and,0,0
126672,anxiety,0,0
126673,",",0,0
126674,and,0,0
126675,parent,0,0
126676,training,0,0
126677,may,0,0
126678,improve,0,0
126679,parental,0,0
126680,self-efficacy,0,0
126681,.,0,1
126682,Future,0,0
126683,studies,0,0
126684,are,0,0
126685,needed,0,0
126686,to,0,0
126687,make,0,0
126688,conclusions,0,0
126689,about,0,0
126690,its,0,0
126691,efficacy,0,0
126692,.,0,1
126693,A,0,0
126694,randomized,0,0
126695,study,0,0
126696,on,0,0
126697,hormone-resistant,1,1
126698,prostatic,1,1
126699,cancer,1,1
126700,:,1,1
126701,estramustine,0,0
126702,phosphate,0,0
126703,versus,0,0
126704,low,0,0
126705,dose,0,0
126706,epirubicin,0,0
126707,with,0,1
126708,or,0,1
126709,without,0,1
126710,medroxyprogesterone,0,0
126711,acetate,0,0
126712,.,0,0
126713,A,0,0
126714,Norwegian,0,1
126715,multicenter,0,0
126716,study,0,0
126717,.,0,0
126718,A,0,0
126719,prospective,0,0
126720,randomized,0,0
126721,study,0,0
126722,has,0,0
126723,been,0,0
126724,carried,0,0
126725,out,0,0
126726,in,0,0
126727,order,0,0
126728,to,0,0
126729,compare,0,0
126730,three,0,0
126731,different,0,0
126732,treatment,0,0
126733,modalities,0,0
126734,for,0,0
126735,symptomatic,1,1
126736,metastatic,1,1
126737,hormone-resistant,1,1
126738,prostatic,1,1
126739,cancer,1,1
126740,.,1,0
126741,A,0,0
126742,total,1,1
126743,of,1,0
126744,79,1,1
126745,patients,1,1
126746,were,1,1
126747,included,1,1
126748,.,1,1
126749,One,0,1
126750,group,0,0
126751,was,0,0
126752,treated,0,1
126753,with,0,1
126754,estramustine,0,0
126755,phosphate,0,0
126756,",",0,0
126757,another,0,0
126758,with,0,0
126759,Epirubicin,0,1
126760,plus,0,0
126761,Medroxyprogesterone,0,0
126762,acetate,0,0
126763,(,0,0
126764,MPA,0,0
126765,),0,0
126766,",",0,0
126767,while,0,0
126768,the,0,0
126769,third,0,0
126770,arm,0,0
126771,consisted,0,1
126772,of,0,0
126773,Epirubicin,0,1
126774,plus,0,0
126775,placebo,0,0
126776,.,0,0
126777,Best,0,0
126778,palliation,0,1
126779,was,0,0
126780,obtained,0,0
126781,by,0,0
126782,the,0,0
126783,combination,0,0
126784,of,0,0
126785,Epirubicin,0,1
126786,and,0,1
126787,MPA,0,0
126788,.,0,0
126789,This,0,0
126790,combination,0,0
126791,also,0,0
126792,seemed,0,0
126793,to,0,0
126794,be,0,0
126795,associated,0,0
126796,with,0,0
126797,the,0,0
126798,longest,0,0
126799,response,0,0
126800,duration,0,0
126801,.,0,1
126802,The,0,0
126803,effects,0,0
126804,of,0,0
126805,aerobic,0,1
126806,exercise,0,0
126807,on,0,0
126808,academic,0,1
126809,engagement,0,0
126810,in,0,0
126811,young,1,1
126812,children,1,1
126813,with,1,1
126814,autism,1,1
126815,spectrum,1,1
126816,disorder,1,1
126817,.,1,0
126818,PURPOSE,0,0
126819,To,0,0
126820,determine,0,0
126821,whether,0,0
126822,participation,0,0
126823,in,0,0
126824,aerobic,0,0
126825,exercise,0,0
126826,before,0,0
126827,classroom,0,0
126828,activities,0,0
126829,improves,0,0
126830,academic,0,1
126831,engagement,0,0
126832,and,0,0
126833,reduces,0,0
126834,stereotypic,0,1
126835,behaviors,0,0
126836,in,0,0
126837,young,1,1
126838,children,1,1
126839,with,1,1
126840,autism,1,1
126841,spectrum,1,1
126842,disorder,1,1
126843,.,1,0
126844,METHODS,0,0
126845,This,0,0
126846,study,0,0
126847,employed,0,0
126848,a,0,0
126849,within-subjects,0,0
126850,crossover,0,0
126851,design,0,0
126852,",",0,0
126853,using,0,0
126854,a,0,0
126855,treatment,0,0
126856,condition,0,0
126857,(,0,0
126858,aerobic,0,0
126859,exercise,0,0
126860,),0,0
126861,and,0,0
126862,a,0,0
126863,control,0,0
126864,condition,0,0
126865,",",0,0
126866,across,0,0
126867,4,0,0
126868,classrooms,0,1
126869,.,0,1
126870,The,0,0
126871,treatment,0,0
126872,condition,0,0
126873,included,0,1
126874,15,0,1
126875,minutes,0,0
126876,of,0,0
126877,running/jogging,0,0
126878,followed,0,0
126879,by,0,0
126880,a,0,0
126881,classroom,0,0
126882,task,0,0
126883,.,0,0
126884,The,0,0
126885,control,0,0
126886,condition,0,0
126887,included,0,0
126888,a,0,0
126889,classroom,0,0
126890,task,0,0
126891,not,0,0
126892,preceded,0,0
126893,by,0,0
126894,exercise,0,0
126895,.,0,0
126896,The,0,0
126897,number,0,0
126898,of,0,0
126899,stereotypic,0,1
126900,behaviors,0,0
126901,",",0,0
126902,percentage,0,0
126903,of,0,0
126904,on-task,0,0
126905,behavior,0,0
126906,",",0,0
126907,and,0,0
126908,correct/incorrect,0,0
126909,responses,0,0
126910,were,0,1
126911,measured,0,0
126912,.,0,0
126913,The,0,0
126914,Wilcoxon,0,0
126915,signed,0,0
126916,rank,0,0
126917,test,0,0
126918,was,0,0
126919,used,0,0
126920,to,0,0
126921,compare,0,0
126922,differences,0,0
126923,between,0,0
126924,conditions,0,1
126925,.,0,1
126926,RESULTS,0,0
126927,Statistically,0,0
126928,significant,0,0
126929,improvements,0,0
126930,were,0,1
126931,found,0,0
126932,in,0,0
126933,correct,0,0
126934,responding,0,0
126935,following,0,0
126936,exercise,0,0
126937,(,0,0
126938,P,0,0
126939,<,0,0
126940,.05,0,0
126941,),0,0
126942,.,0,0
126943,No,0,0
126944,significant,0,0
126945,differences,0,0
126946,were,0,1
126947,found,0,0
126948,for,0,0
126949,on-task,0,0
126950,behavior,0,0
126951,or,0,1
126952,stereotypic,0,1
126953,behaviors,0,0
126954,.,0,1
126955,CONCLUSIONS,0,0
126956,Consistent,0,0
126957,with,0,1
126958,findings,0,0
126959,in,0,0
126960,older,0,1
126961,children,0,1
126962,",",0,0
126963,these,0,0
126964,results,0,0
126965,indicate,0,0
126966,that,0,0
126967,aerobic,0,0
126968,exercise,0,0
126969,prior,0,0
126970,to,0,0
126971,classroom,0,0
126972,activities,0,0
126973,may,0,0
126974,improve,0,0
126975,academic,0,0
126976,responding,0,0
126977,in,0,0
126978,young,1,1
126979,children,1,1
126980,with,1,1
126981,autism,1,1
126982,spectrum,1,1
126983,disorder,1,1
126984,.,1,1
126985,Comparison,0,0
126986,of,0,0
126987,the,0,0
126988,evolutional,0,0
126989,process,0,0
126990,of,0,0
126991,children,1,1
126992,with,1,1
126993,autism,1,1
126994,spectrum,1,1
126995,disorders,1,1
126996,in,0,0
126997,different,0,0
126998,language,0,0
126999,therapeutic,0,1
127000,interventions,0,0
127001,.,0,1
127002,PURPOSE,0,0
127003,To,0,0
127004,analyze,0,0
127005,and,0,0
127006,compare,0,0
127007,the,0,0
127008,extension,0,0
127009,and,0,0
127010,the,0,0
127011,speed,0,0
127012,of,0,0
127013,the,0,0
127014,evolutional,0,0
127015,process,0,0
127016,of,0,0
127017,children,1,1
127018,with,1,1
127019,Autism,1,1
127020,Spectrum,1,1
127021,Disorders,1,1
127022,in,0,0
127023,direct,0,0
127024,and,0,1
127025,indirect,0,0
127026,interventions,0,0
127027,as,0,0
127028,opposed,0,0
127029,to,0,0
127030,only,0,0
127031,indirect,0,0
127032,intervention,0,0
127033,.,0,0
127034,METHODS,0,0
127035,The,0,0
127036,design,0,0
127037,of,0,0
127038,this,0,0
127039,study,0,0
127040,is,0,0
127041,a,0,0
127042,clinical,0,0
127043,trial,0,0
127044,.,0,0
127045,The,0,0
127046,sample,0,0
127047,was,0,0
127048,composed,0,1
127049,of,0,0
127050,11,1,1
127051,children,1,1
127052,diagnosed,1,1
127053,with,1,1
127054,Autism,1,1
127055,(,1,0
127056,n=6,1,0
127057,),1,0
127058,and,1,0
127059,Asperger,1,1
127060,syndrome,1,1
127061,(,1,0
127062,n=5,1,0
127063,),1,0
127064,by,1,0
127065,a,1,0
127066,multidisciplinary,1,0
127067,team,1,0
127068,",",1,0
127069,that,1,0
127070,attended,1,1
127071,specialized,1,1
127072,speech-language,1,1
127073,pathology,1,1
127074,therapy,1,0
127075,at,1,0
127076,the,1,0
127077,institution,1,0
127078,were,1,0
127079,the,1,0
127080,study,1,0
127081,was,1,0
127082,carried,1,0
127083,out,1,0
127084,.,1,0
127085,These,0,0
127086,children,0,1
127087,were,0,0
127088,randomly,0,1
127089,divided,0,1
127090,into,0,0
127091,two,0,1
127092,groups,0,1
127093,:,0,1
127094,Therapy,0,1
127095,Group,0,1
127096,(,0,0
127097,TG,0,0
127098,),0,1
127099,-,0,0
127100,composed,0,1
127101,by,0,0
127102,six,0,1
127103,subjects,0,1
127104,receiving,0,1
127105,both,0,0
127106,direct,0,0
127107,and,0,0
127108,indirect,0,0
127109,intervention,0,0
127110,;,0,0
127111,and,0,0
127112,Orientation,0,0
127113,Group,0,1
127114,(,0,0
127115,OG,0,0
127116,),0,1
127117,-,0,0
127118,constituted,0,0
127119,by,0,0
127120,five,0,1
127121,subjects,0,1
127122,receiving,0,1
127123,exclusively,0,1
127124,indirect,0,0
127125,intervention,0,0
127126,.,0,1
127127,It,0,0
127128,was,0,0
127129,used,0,0
127130,the,0,0
127131,Autism,0,1
127132,Behavior,0,1
127133,Checklist,0,0
127134,(,0,0
127135,ABC,0,0
127136,),0,0
127137,to,0,0
127138,interview,0,0
127139,the,0,0
127140,mothers,0,0
127141,",",0,0
127142,and,0,0
127143,the,0,0
127144,Sample,0,0
127145,of,0,0
127146,Vocal,0,1
127147,Behavior,0,1
127148,(,0,0
127149,SVB,0,0
127150,),0,0
127151,",",0,0
127152,in,0,0
127153,three,0,1
127154,occasions,0,0
127155,:,0,1
127156,at,0,0
127157,the,0,0
127158,beginning,0,0
127159,of,0,0
127160,the,0,0
127161,intervention,0,0
127162,process,0,0
127163,(,0,0
127164,time,0,0
127165,0,0,0
127166,),0,0
127167,",",0,0
127168,six,0,1
127169,months,0,0
127170,later,0,1
127171,(,0,0
127172,time,0,0
127173,1,0,0
127174,),0,0
127175,and,0,1
127176,12,0,0
127177,months,0,0
127178,later,0,1
127179,(,0,0
127180,time,0,0
127181,2,0,1
127182,),0,0
127183,.,0,0
127184,RESULTS,0,0
127185,It,0,0
127186,was,0,0
127187,observed,0,0
127188,greater,0,0
127189,speed,0,0
127190,and,0,0
127191,extension,0,0
127192,in,0,0
127193,the,0,0
127194,evolutional,0,0
127195,process,0,0
127196,of,0,0
127197,the,0,0
127198,TG,0,0
127199,Group,0,0
127200,",",0,0
127201,both,0,0
127202,in,0,0
127203,the,0,0
127204,analysis,0,0
127205,of,0,0
127206,the,0,0
127207,Autism,0,1
127208,Behavior,0,1
127209,Checklist,0,0
127210,(,0,0
127211,total,0,1
127212,and,0,1
127213,partial,0,1
127214,scores,0,0
127215,),0,1
127216,and,0,0
127217,the,0,0
127218,Sample,0,0
127219,of,0,0
127220,Vocal,0,1
127221,Behavior,0,1
127222,",",0,0
127223,especially,0,0
127224,in,0,0
127225,the,0,0
127226,item,0,0
127227,Full,0,1
127228,Language,0,0
127229,.,0,0
127230,The,0,0
127231,performance,0,0
127232,of,0,0
127233,children,1,1
127234,with,1,1
127235,Asperger,1,1
127236,syndrome,1,1
127237,was,0,0
127238,considered,0,0
127239,more,0,0
127240,positive,0,0
127241,when,0,0
127242,compared,0,0
127243,to,0,0
127244,that,0,0
127245,of,0,0
127246,children,1,1
127247,with,1,1
127248,autism,1,1
127249,.,1,0
127250,There,0,0
127251,was,0,0
127252,greater,0,0
127253,evolution,0,0
127254,in,0,0
127255,younger,0,1
127256,children,0,1
127257,and,0,0
127258,with,0,1
127259,normal,0,1
127260,",",0,0
127261,mild,0,1
127262,",",0,0
127263,and,0,0
127264,moderate,0,1
127265,adaptive,0,0
127266,functioning,0,0
127267,.,0,0
127268,CONCLUSION,0,0
127269,The,0,0
127270,tendency,0,0
127271,towards,0,0
127272,better,0,0
127273,performance,0,0
127274,of,0,0
127275,the,0,0
127276,children,0,1
127277,attending,0,1
127278,direct,0,0
127279,and,0,0
127280,indirect,0,0
127281,intervention,0,0
127282,showed,0,0
127283,that,0,0
127284,this,0,0
127285,association,0,0
127286,is,0,0
127287,fundamental,0,0
127288,in,0,0
127289,the,0,0
127290,therapeutic,0,0
127291,process,0,0
127292,of,0,0
127293,children,1,1
127294,with,1,1
127295,Autism,1,1
127296,Spectrum,1,1
127297,Disorders,1,1
127298,.,1,1
127299,Impact,0,0
127300,of,0,0
127301,dronedarone,0,0
127302,on,0,0
127303,hospitalization,0,0
127304,burden,0,0
127305,in,0,0
127306,patients,1,1
127307,with,1,1
127308,atrial,1,1
127309,fibrillation,1,1
127310,:,1,1
127311,results,0,0
127312,from,0,1
127313,the,0,0
127314,ATHENA,0,0
127315,study,0,0
127316,.,0,1
127317,AIMS,0,0
127318,Cardiovascular,0,0
127319,(,0,0
127320,CV,0,1
127321,),0,0
127322,hospitalization,0,0
127323,is,0,0
127324,a,0,0
127325,predictor,0,0
127326,of,0,0
127327,CV,0,1
127328,mortality,0,0
127329,and,0,0
127330,has,0,0
127331,a,0,0
127332,negative,0,0
127333,impact,0,0
127334,on,0,0
127335,patients,0,1
127336,',0,1
127337,quality,0,0
127338,of,0,0
127339,life,0,0
127340,.,0,0
127341,The,0,0
127342,primary,0,0
127343,endpoint,0,0
127344,of,0,0
127345,A,0,0
127346,placebo-controlled,0,0
127347,",",0,0
127348,double-blind,0,0
127349,",",0,0
127350,parallel-arm,0,0
127351,Trial,0,0
127352,to,0,0
127353,assess,0,0
127354,the,0,0
127355,efficacy,0,0
127356,of,0,0
127357,dronedarone,0,1
127358,400,0,0
127359,mg,0,0
127360,bid,0,0
127361,for,0,0
127362,the,0,0
127363,prevention,0,0
127364,of,0,0
127365,cardiovascular,0,1
127366,Hospitalization,0,0
127367,or,0,1
127368,death,0,0
127369,from,0,0
127370,any,0,0
127371,cause,0,0
127372,in,0,0
127373,patiENTs,1,0
127374,with,1,1
127375,Atrial,1,1
127376,fibrillation/atrial,1,1
127377,flutter,1,1
127378,(,1,0
127379,ATHENA,1,0
127380,),1,0
127381,",",0,0
127382,a,0,0
127383,composite,0,0
127384,of,0,0
127385,first,0,0
127386,CV,0,1
127387,hospitalization,0,0
127388,or,0,0
127389,death,0,0
127390,from,0,0
127391,any,0,0
127392,cause,0,0
127393,",",0,0
127394,was,0,0
127395,significantly,0,0
127396,reduced,0,0
127397,by,0,0
127398,dronedarone,0,1
127399,.,0,0
127400,This,0,0
127401,post,0,0
127402,hoc,0,0
127403,analysis,0,0
127404,evaluated,0,0
127405,the,0,0
127406,secondary,0,0
127407,endpoint,0,0
127408,of,0,0
127409,CV,0,1
127410,hospitalization,0,1
127411,and,0,0
127412,the,0,0
127413,clinical,0,0
127414,benefit,0,0
127415,of,0,0
127416,dronedarone,0,0
127417,on,0,0
127418,the,0,0
127419,number,0,0
127420,and,0,0
127421,duration,0,0
127422,of,0,0
127423,CV,0,1
127424,hospitalizations,0,1
127425,in,0,0
127426,patients,1,1
127427,with,1,1
127428,atrial,1,1
127429,fibrillation,1,1
127430,(,1,0
127431,AF,1,1
127432,),1,1
127433,.,1,0
127434,METHODS,0,0
127435,AND,0,0
127436,RESULTS,0,0
127437,ATHENA,0,0
127438,was,0,0
127439,a,0,0
127440,double-blind,0,0
127441,",",0,0
127442,parallel,0,0
127443,group,0,0
127444,study,0,0
127445,in,0,0
127446,4628,1,1
127447,patients,1,1
127448,with,1,1
127449,a,1,0
127450,history,1,1
127451,of,1,0
127452,paroxysmal/persistent,1,1
127453,AF,1,0
127454,and,1,0
127455,additional,1,0
127456,risk,1,0
127457,factors,1,0
127458,",",0,0
127459,treated,0,1
127460,with,0,1
127461,placebo,0,0
127462,or,0,1
127463,dronedarone,0,1
127464,.,0,0
127465,Dronedarone,0,0
127466,treatment,0,0
127467,significantly,0,0
127468,reduced,0,0
127469,the,0,0
127470,risk,0,0
127471,of,0,0
127472,first,0,0
127473,CV,0,1
127474,hospitalization,0,1
127475,(,0,0
127476,P,0,0
127477,<,0,0
127478,0.0001,0,0
127479,vs.,0,0
127480,placebo,0,0
127481,),0,0
127482,",",0,0
127483,while,0,0
127484,the,0,0
127485,risk,0,0
127486,of,0,0
127487,first,0,0
127488,non-CV,0,1
127489,hospitalization,0,1
127490,was,0,0
127491,similar,0,0
127492,in,0,0
127493,both,0,0
127494,groups,0,0
127495,(,0,0
127496,P,0,0
127497,=,0,0
127498,0.77,0,0
127499,),0,0
127500,.,0,0
127501,About,0,0
127502,half,0,1
127503,of,0,0
127504,the,0,0
127505,CV,0,1
127506,hospitalizations,0,0
127507,were,0,1
127508,AF-related,0,0
127509,",",0,0
127510,with,0,1
127511,a,0,0
127512,median,0,0
127513,duration,0,0
127514,of,0,0
127515,hospital,0,1
127516,stay,0,0
127517,of,0,0
127518,four,0,1
127519,nights,0,1
127520,.,0,1
127521,The,0,0
127522,risk,0,0
127523,of,0,0
127524,any,0,0
127525,hospitalization,0,0
127526,for,0,0
127527,AF,0,0
127528,[,0,0
127529,hazard,0,0
127530,ratio,0,0
127531,(,0,0
127532,95,0,0
127533,%,0,0
127534,confidence,0,0
127535,interval,0,0
127536,),0,0
127537,0.626,0,0
127538,(,0,0
127539,0.546-0.719,0,0
127540,),0,0
127541,],0,0
127542,and,0,0
127543,duration,0,0
127544,of,0,0
127545,hospital,0,1
127546,stay,0,0
127547,were,0,0
127548,significantly,0,0
127549,reduced,0,0
127550,by,0,0
127551,dronedarone,0,0
127552,(,0,0
127553,P,0,0
127554,<,0,0
127555,0.0001,0,0
127556,vs.,0,0
127557,placebo,0,0
127558,),0,0
127559,.,0,0
127560,Dronedarone,0,0
127561,treatment,0,0
127562,reduced,0,0
127563,total,0,1
127564,hospitalizations,0,1
127565,for,0,1
127566,acute,0,1
127567,coronary,0,1
127568,syndrome,0,1
127569,(,0,0
127570,P,0,0
127571,=,0,0
127572,0.0105,0,0
127573,),0,0
127574,and,0,0
127575,the,0,0
127576,time,0,0
127577,between,0,0
127578,the,0,0
127579,first,0,0
127580,AF/atrial,0,0
127581,flutter,0,1
127582,recurrence,0,0
127583,and,0,0
127584,CV,0,0
127585,hospitalization/death,0,0
127586,(,0,0
127587,P,0,0
127588,=,0,0
127589,0.0048,0,0
127590,),0,1
127591,.,0,1
127592,Hospitalization,0,0
127593,burden,0,0
127594,was,0,0
127595,significantly,0,0
127596,reduced,0,0
127597,across,0,0
127598,all,0,0
127599,levels,0,0
127600,of,0,0
127601,care,0,1
127602,(,0,0
127603,P,0,0
127604,<,0,0
127605,0.05,0,0
127606,),0,1
127607,.,0,1
127608,Cumulative,0,0
127609,incidence,0,0
127610,data,0,0
127611,indicated,0,0
127612,that,0,0
127613,the,0,0
127614,effects,0,0
127615,of,0,0
127616,dronedarone,0,1
127617,persisted,0,0
127618,for,0,0
127619,at,0,0
127620,least,0,1
127621,24,0,1
127622,months,0,0
127623,.,0,1
127624,CONCLUSION,0,0
127625,Dronedarone,0,0
127626,reduced,0,0
127627,the,0,0
127628,risk,0,0
127629,for,0,0
127630,CV,0,1
127631,hospitalization,0,1
127632,and,0,0
127633,the,0,0
127634,total,0,1
127635,hospitalization,0,0
127636,burden,0,0
127637,in,0,0
127638,this,0,0
127639,patient,0,0
127640,group,0,0
127641,.,0,0
127642,The,0,0
127643,trial,0,0
127644,is,0,0
127645,registered,0,0
127646,under,0,0
127647,ClinicalTrials.gov,0,0
127648,#,0,1
127649,NCT,0,1
127650,00174785,0,0
127651,.,0,1
127652,Effect,0,0
127653,of,0,0
127654,a,0,0
127655,multi-faceted,0,0
127656,intervention,0,0
127657,on,0,0
127658,gingival,1,0
127659,health,1,1
127660,among,1,0
127661,adults,1,1
127662,with,1,1
127663,systemic,1,0
127664,sclerosis,1,1
127665,.,1,1
127666,OBJECTIVES,0,0
127667,To,0,0
127668,evaluate,0,0
127669,the,0,0
127670,effect,0,0
127671,of,0,0
127672,adaptive,0,0
127673,oral,0,0
127674,hygiene,0,1
127675,devices,0,0
127676,and,0,0
127677,orofacial,0,1
127678,exercise,0,0
127679,to,0,0
127680,improve,0,0
127681,gingival,0,0
127682,health,0,0
127683,among,1,0
127684,adults,1,1
127685,with,1,1
127686,systemic,1,0
127687,sclerosis,1,1
127688,(,1,0
127689,SSc,1,1
127690,),1,1
127691,.,1,1
127692,METHODS,0,0
127693,Forty-eight,1,1
127694,patients,1,1
127695,with,1,1
127696,SSc,1,1
127697,were,0,0
127698,assigned,0,0
127699,randomly,0,1
127700,to,0,0
127701,the,0,0
127702,multifaceted,0,0
127703,oral,0,0
127704,health,0,1
127705,intervention,0,0
127706,or,0,1
127707,usual,0,1
127708,dental,0,1
127709,care,0,1
127710,control,0,1
127711,group,0,0
127712,.,0,0
127713,Participants,0,1
127714,in,0,0
127715,the,0,0
127716,intervention,0,0
127717,group,0,0
127718,received,0,0
127719,a,0,0
127720,rechargeable,0,0
127721,",",0,0
127722,powered,0,0
127723,Oral-B?,0,1
127724,oscillating-rotating-pulsating,0,0
127725,toothbrush,0,0
127726,and,0,0
127727,a,0,0
127728,Reach?,0,0
127729,Access?,0,0
127730,Flosser,0,1
127731,that,0,0
127732,has,0,0
127733,a,0,0
127734,toothbrush-like,0,0
127735,handle,0,0
127736,.,0,0
127737,For,0,0
127738,those,0,0
127739,with,0,1
127740,an,0,0
127741,oral,0,0
127742,aperture,0,0
127743,of,0,0
127744,less,0,0
127745,than,0,0
127746,40,0,0
127747,mm,0,0
127748,",",0,0
127749,orofacial,0,1
127750,exercises,0,0
127751,were,0,1
127752,taught,0,1
127753,.,0,1
127754,Participants,0,1
127755,in,0,0
127756,the,0,0
127757,control,0,0
127758,group,0,0
127759,were,0,0
127760,each,0,0
127761,given,0,0
127762,a,0,0
127763,manual,0,0
127764,toothbrush,0,0
127765,and,0,0
127766,dental,0,1
127767,floss,0,0
127768,.,0,1
127769,Participants,0,1
127770,in,0,0
127771,both,0,0
127772,groups,0,0
127773,received,0,0
127774,instructions,0,0
127775,and,0,0
127776,demonstration,0,0
127777,on,0,0
127778,the,0,0
127779,use,0,0
127780,of,0,0
127781,the,0,0
127782,devices,0,0
127783,",",0,0
127784,and,0,0
127785,were,0,0
127786,requested,0,0
127787,to,0,0
127788,perform,0,0
127789,the,0,0
127790,respective,0,0
127791,intervention,0,0
127792,twice,0,0
127793,a,0,0
127794,day,0,0
127795,for,0,0
127796,6,0,0
127797,months,0,0
127798,.,0,1
127799,Evaluations,0,0
127800,were,0,0
127801,at,0,0
127802,baseline,0,0
127803,",",0,0
127804,3-,0,0
127805,",",0,0
127806,and,0,0
127807,6-months,0,0
127808,.,0,1
127809,The,0,0
127810,main,0,0
127811,outcome,0,0
127812,was,0,0
127813,gingival,0,0
127814,index,0,0
127815,(,0,0
127816,GI,0,0
127817,),0,0
127818,",",0,0
127819,an,0,0
127820,indicator,0,0
127821,of,0,0
127822,gingival,0,1
127823,inflammation,0,0
127824,.,0,1
127825,RESULTS,0,0
127826,Both,0,0
127827,groups,0,0
127828,showed,0,0
127829,significant,0,0
127830,reduction,0,0
127831,in,0,0
127832,GI,0,0
127833,scores,0,0
127834,at,0,1
127835,6,0,1
127836,months,0,0
127837,(,0,1
127838,ps,0,0
127839,<,0,0
127840,0.005,0,0
127841,),0,0
127842,.,0,0
127843,Reduction,0,0
127844,in,0,0
127845,GI,0,0
127846,scores,0,0
127847,of,0,0
127848,the,0,0
127849,intervention,0,0
127850,group,0,0
127851,at,0,0
127852,6,0,0
127853,months,0,0
127854,was,0,0
127855,20.8,0,0
127856,%,0,0
127857,which,0,0
127858,is,0,0
127859,considered,0,0
127860,to,0,0
127861,be,0,0
127862,clinically,0,0
127863,significant,0,0
127864,.,0,0
127865,Compared,0,0
127866,to,0,0
127867,the,0,0
127868,control,0,0
127869,group,0,0
127870,",",0,0
127871,the,0,0
127872,intervention,0,0
127873,group,0,0
127874,showed,0,0
127875,a,0,0
127876,significant,0,0
127877,and,0,0
127878,larger,0,0
127879,reduction,0,0
127880,in,0,0
127881,GI,0,0
127882,score,0,0
127883,by,0,0
127884,8,0,0
127885,%,0,0
127886,at,0,0
127887,6,0,0
127888,months,0,0
127889,(,0,1
127890,p=0.0007,0,0
127891,),0,0
127892,.,0,1
127893,CONCLUSIONS,0,0
127894,Results,0,0
127895,support,0,0
127896,the,0,0
127897,use,0,0
127898,of,0,0
127899,adaptive,0,0
127900,devices,0,0
127901,and,0,1
127902,orofacial,0,1
127903,exercise,0,0
127904,to,0,0
127905,improve,0,0
127906,gingival,0,0
127907,health,1,0
127908,in,1,0
127909,adults,1,1
127910,with,1,1
127911,SSc,1,0
127912,when,0,0
127913,compared,0,0
127914,to,0,0
127915,use,0,0
127916,of,0,0
127917,manual,0,0
127918,toothbrushing,0,0
127919,and,0,0
127920,finger-held,0,0
127921,flossing,0,0
127922,.,0,0
127923,Recommending,0,0
127924,and,0,0
127925,educating,1,0
127926,patients,1,1
127927,with,1,1
127928,SSc,1,1
127929,to,0,0
127930,use,0,0
127931,adaptive,0,0
127932,devices,0,0
127933,to,0,0
127934,clean,0,1
127935,the,0,0
127936,tooth,0,0
127937,surfaces,0,0
127938,looks,0,0
127939,promising,0,0
127940,for,0,0
127941,long-term,0,0
127942,oral,0,0
127943,health,0,1
127944,improvement,0,0
127945,.,0,1
127946,Effects,0,0
127947,of,0,0
127948,alcohol,0,1
127949,on,0,0
127950,the,0,0
127951,pharmacokinetics,0,0
127952,of,0,0
127953,morphine,0,0
127954,sulfate,0,0
127955,and,0,0
127956,naltrexone,0,0
127957,hydrochloride,0,0
127958,extended,0,0
127959,release,0,0
127960,capsules,0,0
127961,.,0,1
127962,Although,0,0
127963,contraindicated,0,0
127964,",",0,0
127965,coingestion,0,0
127966,of,0,0
127967,alcohol,0,1
127968,and,0,0
127969,opioids,0,0
127970,by,0,0
127971,patients,0,1
127972,or,0,1
127973,drug,0,0
127974,abusers,0,1
127975,is,0,0
127976,a,0,0
127977,major,0,0
127978,health,0,0
127979,concern,0,0
127980,because,0,0
127981,of,0,0
127982,dangerous,0,1
127983,additive,0,0
127984,and,0,0
127985,potentially,0,0
127986,life-threatening,0,0
127987,sedative,0,0
127988,and,0,1
127989,respiratory,0,1
127990,effects,0,0
127991,.,0,1
127992,In,0,0
127993,addition,0,0
127994,",",0,0
127995,alcohol,0,0
127996,has,0,0
127997,been,0,0
127998,shown,0,0
127999,to,0,0
128000,disrupt,0,0
128001,the,0,0
128002,extended-release,0,0
128003,characteristics,0,0
128004,of,0,1
128005,certain,0,0
128006,extended-release,0,0
128007,opioid,0,1
128008,formulations,0,0
128009,",",0,0
128010,releasing,0,0
128011,a,0,0
128012,hazardous,0,0
128013,amount,0,0
128014,of,0,0
128015,opioid,0,1
128016,over,0,0
128017,a,0,0
128018,short,0,0
128019,time,0,0
128020,period,0,0
128021,.,0,0
128022,Morphine,0,0
128023,sulfate,0,0
128024,and,0,0
128025,naltrexone,0,0
128026,hydrochloride,0,0
128027,extended,0,0
128028,release,0,0
128029,capsules,0,0
128030,(,0,1
128031,MS-sNT,0,0
128032,),0,0
128033,",",0,0
128034,which,0,0
128035,contain,0,0
128036,naltrexone,0,0
128037,sequestered,0,0
128038,in,0,0
128039,each,0,0
128040,pellet,0,0
128041,core,0,0
128042,",",0,0
128043,are,0,0
128044,indicated,0,0
128045,for,0,0
128046,management,0,0
128047,of,0,0
128048,chronic,0,1
128049,",",0,0
128050,moderate,0,1
128051,to,0,0
128052,severe,0,1
128053,pain,0,1
128054,.,0,0
128055,Sequestered,0,0
128056,naltrexone,0,0
128057,is,0,0
128058,designed,0,0
128059,for,0,0
128060,release,0,0
128061,upon,0,0
128062,product,0,0
128063,tampering,0,0
128064,(,0,0
128065,crushing,0,0
128066,),0,0
128067,to,0,0
128068,potentially,0,0
128069,mitigate,0,0
128070,morphine-induced,0,0
128071,subjective,0,0
128072,effects,0,0
128073,.,0,1
128074,This,0,0
128075,open-label,0,0
128076,",",0,0
128077,single-dose,0,0
128078,",",0,0
128079,4-way,0,0
128080,crossover,0,0
128081,",",0,0
128082,pharmacokinetic,0,0
128083,drug,0,0
128084,interaction,0,0
128085,study,0,0
128086,compared,0,0
128087,the,0,0
128088,relative,0,0
128089,bioavailability,0,0
128090,of,0,0
128091,morphine,0,0
128092,and,0,0
128093,naltrexone,0,0
128094,when,0,0
128095,MS-sNT,0,0
128096,is,0,0
128097,administered,0,0
128098,(,0,0
128099,under,0,0
128100,fasting,0,0
128101,conditions,0,0
128102,),0,1
128103,with,0,1
128104,increasing,0,0
128105,doses,0,0
128106,of,0,1
128107,alcohol,0,1
128108,.,0,1
128109,Thirty-two,1,1
128110,healthy,1,1
128111,",",1,0
128112,opioid-naive,1,1
128113,adults,1,1
128114,were,0,1
128115,randomized,0,1
128116,to,0,0
128117,MS-sNT,0,0
128118,administered,0,0
128119,with,0,1
128120,240,0,1
128121,mL,0,0
128122,of,0,1
128123,4,0,0
128124,%,0,0
128125,",",0,0
128126,20,0,0
128127,%,0,0
128128,",",0,0
128129,or,0,0
128130,40,0,0
128131,%,0,0
128132,alcohol,0,1
128133,or,0,1
128134,water,0,0
128135,.,0,0
128136,No,0,0
128137,drug,0,0
128138,interaction,0,0
128139,was,0,0
128140,found,0,0
128141,between,0,0
128142,morphine,0,0
128143,in,0,0
128144,MS-sNT,0,0
128145,and,0,0
128146,4,0,0
128147,%,0,0
128148,or,0,1
128149,20,0,0
128150,%,0,0
128151,alcohol,0,1
128152,.,0,0
128153,Administration,0,0
128154,with,0,1
128155,40,0,1
128156,%,0,0
128157,alcohol,0,1
128158,did,0,0
128159,not,0,0
128160,affect,0,0
128161,overall,0,0
128162,morphine,0,0
128163,exposure,0,0
128164,but,0,0
128165,was,0,0
128166,associated,0,0
128167,with,0,1
128168,a,0,0
128169,2-fold,0,0
128170,increase,0,0
128171,in,0,0
128172,C,0,0
128173,(,0,0
128174,max,0,0
128175,),0,0
128176,and,0,0
128177,reduction,0,0
128178,of,0,0
128179,t,0,0
128180,(,0,0
128181,max,0,0
128182,),0,0
128183,from,0,0
128184,9,0,0
128185,to,0,1
128186,4,0,0
128187,hours,0,0
128188,versus,0,0
128189,MS-sNT,0,0
128190,taken,0,0
128191,with,0,1
128192,water,0,0
128193,.,0,1
128194,Naltrexone,0,0
128195,sequestering,0,0
128196,was,0,0
128197,successful,0,0
128198,in,0,0
128199,all,0,0
128200,treatment,0,0
128201,arms,0,0
128202,and,0,0
128203,not,0,0
128204,affected,0,0
128205,by,0,0
128206,coadministration,0,0
128207,with,0,1
128208,alcohol,0,1
128209,over,0,0
128210,the,0,0
128211,dose,0,0
128212,range,0,0
128213,tested,0,0
128214,.,0,1
128215,Poor,0,1
128216,self-rated,0,0
128217,health,0,0
128218,is,0,0
128219,not,0,0
128220,associated,0,0
128221,with,0,0
128222,a,0,0
128223,high,0,1
128224,total,0,1
128225,allostatic,0,0
128226,load,0,0
128227,in,0,0
128228,type,1,1
128229,2,1,1
128230,diabetic,1,1
128231,patients,1,1
128232,--,1,1
128233,but,1,0
128234,high,0,0
128235,blood,0,0
128236,pressure,0,0
128237,is,0,0
128238,.,0,0
128239,OBJECTIVE,0,0
128240,Allostatic,0,0
128241,load,0,0
128242,has,0,0
128243,been,0,0
128244,linked,0,0
128245,to,0,0
128246,self-rated,0,0
128247,health,0,1
128248,(,0,0
128249,SRH,0,1
128250,),0,0
128251,",",0,0
128252,cardiovascular,0,0
128253,disease,0,1
128254,and,0,0
128255,mortality,0,0
128256,in,0,0
128257,non-diabetic,1,1
128258,individuals,1,1
128259,.,1,1
128260,The,0,0
128261,aim,0,0
128262,of,0,0
128263,this,0,0
128264,study,0,0
128265,was,0,0
128266,to,0,0
128267,construct,0,0
128268,an,0,0
128269,allostatic,0,0
128270,load,0,0
128271,score,0,0
128272,and,0,0
128273,to,0,0
128274,find,0,0
128275,any,0,0
128276,correlations,0,0
128277,with,0,1
128278,SRH,0,1
128279,.,0,1
128280,METHODS,0,0
128281,The,0,0
128282,subjects,1,1
128283,included,1,1
128284,in,1,0
128285,the,1,0
128286,study,1,0
128287,came,1,1
128288,from,1,0
128289,a,1,0
128290,randomized,1,0
128291,",",1,0
128292,controlled,1,0
128293,trial,1,0
128294,of,1,0
128295,type,1,1
128296,2,1,1
128297,diabetes,1,1
128298,.,1,1
128299,Blood,0,0
128300,samples,0,0
128301,were,0,0
128302,drawn,0,0
128303,",",0,0
128304,urine,0,0
128305,was,0,0
128306,collected,0,0
128307,for,0,0
128308,24h,0,0
128309,",",0,0
128310,and,0,0
128311,questionnaires,0,0
128312,",",0,0
128313,including,0,0
128314,SRH,0,1
128315,",",0,0
128316,were,0,0
128317,filled,0,0
128318,out,0,0
128319,on,0,0
128320,three,0,1
128321,occasions,0,0
128322,:,0,1
128323,at,0,1
128324,baseline,0,0
128325,;,0,0
128326,after,0,0
128327,the,0,0
128328,10-week,0,0
128329,intervention,0,0
128330,;,0,0
128331,and,0,0
128332,at,0,0
128333,a,0,0
128334,follow-up,0,0
128335,3,0,0
128336,months,0,0
128337,after,0,0
128338,the,0,0
128339,intervention,0,0
128340,.,0,0
128341,Allostatic,0,0
128342,load,0,0
128343,was,0,0
128344,estimated,0,0
128345,using,0,0
128346,a,0,0
128347,wide,0,1
128348,range,0,0
128349,of,0,0
128350,variables,0,0
128351,",",0,0
128352,including,0,0
128353,systolic,0,0
128354,and,0,0
128355,diastolic,0,1
128356,blood,0,0
128357,pressure,0,0
128358,",",0,0
128359,pulse,0,0
128360,pressure,0,0
128361,",",0,0
128362,cortisol,0,0
128363,",",0,0
128364,catecholamines,0,0
128365,",",0,0
128366,HbA,0,0
128367,(,0,0
128368,1c,0,0
128369,),0,0
128370,",",0,0
128371,insulin,0,0
128372,",",0,0
128373,plasma,0,0
128374,glucose,0,0
128375,and,0,0
128376,waist,0,0
128377,circumference,0,0
128378,.,0,1
128379,RESULTS,0,0
128380,There,0,0
128381,was,0,0
128382,no,0,0
128383,association,0,0
128384,between,0,0
128385,SRH,0,1
128386,and,0,0
128387,allostatic,0,0
128388,load,0,0
128389,.,0,0
128390,However,0,0
128391,",",0,0
128392,three,0,0
128393,other,0,0
128394,components,0,0
128395,were,0,1
128396,significantly,0,0
128397,correlated,0,0
128398,with,0,1
128399,allostatic,0,0
128400,load,0,0
128401,at,0,0
128402,the,0,0
128403,baseline,0,0
128404,investigation,0,0
128405,and,0,0
128406,the,0,0
128407,two,0,0
128408,follow-up,0,0
128409,investigations,0,0
128410,-,0,0
128411,namely,0,0
128412,",",0,0
128413,systolic,0,0
128414,blood,0,0
128415,pressure,0,0
128416,",",0,0
128417,diastolic,0,0
128418,blood,0,0
128419,pressure,0,0
128420,and,0,0
128421,HbA,0,0
128422,(,0,0
128423,1c,0,0
128424,),0,0
128425,.,0,0
128426,CONCLUSION,0,0
128427,The,0,0
128428,absence,0,0
128429,of,0,0
128430,an,0,0
128431,association,0,0
128432,between,0,0
128433,allostatic,0,0
128434,load,0,0
128435,and,0,0
128436,SRH,0,1
128437,in,0,0
128438,diabetic,1,1
128439,individuals,1,1
128440,contrasts,0,0
128441,with,0,1
128442,previous,0,1
128443,findings,0,0
128444,in,0,1
128445,non-diabetic,1,1
128446,women,1,1
128447,",",0,0
128448,and,0,0
128449,shows,0,0
128450,that,0,0
128451,it,0,0
128452,is,0,0
128453,hazardous,0,0
128454,to,0,0
128455,apply,0,0
128456,findings,0,0
128457,in,0,0
128458,one,0,1
128459,population,0,1
128460,to,0,0
128461,another,0,0
128462,",",0,0
128463,especially,0,0
128464,diabetic,1,1
128465,and,1,0
128466,non-diabetic,1,1
128467,populations,1,1
128468,.,1,1
128469,Effect,0,0
128470,of,0,0
128471,intensive,0,1
128472,insulin,0,0
128473,therapy,0,0
128474,on,0,0
128475,the,0,0
128476,somatotropic,0,0
128477,axis,0,0
128478,of,0,0
128479,critically,1,0
128480,ill,1,1
128481,children,1,1
128482,.,1,1
128483,CONTEXT,0,0
128484,Intensive,0,1
128485,insulin,0,0
128486,therapy,0,0
128487,(,0,0
128488,IIT,0,1
128489,),0,0
128490,improved,0,0
128491,outcome,0,0
128492,in,0,0
128493,the,0,0
128494,adult,0,1
128495,and,0,0
128496,pediatric,0,1
128497,intensive,0,1
128498,care,0,1
128499,unit,0,0
128500,(,0,0
128501,PICU,0,0
128502,),0,0
128503,compared,0,0
128504,with,0,1
128505,conventional,0,0
128506,insulin,0,0
128507,therapy,0,0
128508,(,0,0
128509,CIT,0,1
128510,),0,1
128511,.,0,1
128512,IIT,0,0
128513,did,0,0
128514,not,0,0
128515,increase,0,0
128516,the,0,0
128517,anabolic,0,0
128518,hormone,0,0
128519,IGF-I,0,0
128520,in,0,0
128521,critically,0,0
128522,ill,0,1
128523,adults,0,1
128524,",",0,0
128525,but,0,0
128526,feeding,0,0
128527,in,0,0
128528,critically,0,1
128529,ill,0,1
128530,children,0,1
128531,and,0,1
128532,pediatric,0,1
128533,hormonal,0,0
128534,responses,0,0
128535,may,0,0
128536,differ,0,0
128537,.,0,0
128538,Twenty-five,1,1
128539,percent,1,0
128540,of,1,0
128541,the,1,0
128542,children,1,1
128543,with,1,1
128544,IIT,1,1
128545,experienced,1,0
128546,hypoglycemia,1,0
128547,",",0,0
128548,which,0,0
128549,may,0,0
128550,have,0,0
128551,evoked,0,0
128552,counterregulatory,0,0
128553,responses,0,0
128554,.,0,1
128555,OBJECTIVE,0,0
128556,We,0,0
128557,hypothesized,0,0
128558,that,0,0
128559,IIT,0,0
128560,reactivates,0,0
128561,the,0,0
128562,somatotropic,0,0
128563,axis,0,0
128564,and,0,0
128565,anabolism,0,0
128566,in,0,0
128567,PICU,0,0
128568,patients,0,1
128569,.,0,1
128570,DESIGN,0,0
128571,This,0,0
128572,was,0,0
128573,a,0,0
128574,preplanned,0,0
128575,subanalysis,0,0
128576,of,0,0
128577,a,0,0
128578,randomized,0,0
128579,controlled,0,0
128580,trial,0,0
128581,on,0,0
128582,IIT,0,1
128583,.,0,1
128584,PATIENTS,0,0
128585,We,1,0
128586,studied,1,1
128587,369,1,1
128588,patients,1,1
128589,who,1,1
128590,stayed,1,1
128591,in,1,1
128592,PICU,1,0
128593,for,1,0
128594,at,1,0
128595,least,1,1
128596,3,1,0
128597,d,1,0
128598,(,1,0
128599,study,1,0
128600,1,1,0
128601,),1,0
128602,and,1,1
128603,126,1,1
128604,patients,1,1
128605,in,1,0
128606,a,1,0
128607,nested,1,1
128608,case-control,1,1
128609,study,1,0
128610,(,1,0
128611,study,1,0
128612,2,1,1
128613,),1,0
128614,.,1,1
128615,MAIN,0,0
128616,OUTCOME,0,0
128617,MEASURES,0,0
128618,Circulating,0,0
128619,insulin,0,0
128620,",",0,0
128621,C-peptide,0,0
128622,",",0,0
128623,GH,0,0
128624,",",0,0
128625,IGF-I,0,0
128626,",",0,0
128627,bioavailable,0,0
128628,IGF-I,0,0
128629,",",0,0
128630,IGF-binding,0,0
128631,protein,0,0
128632,(,0,0
128633,IGFBP,0,1
128634,),0,0
128635,-1,0,0
128636,",",0,0
128637,IGFBP-3,0,0
128638,",",0,0
128639,and,0,0
128640,acid-labile,0,0
128641,subunit,0,0
128642,were,0,0
128643,analyzed,0,0
128644,upon,0,0
128645,admission,0,1
128646,and,0,0
128647,d,0,1
128648,3,0,0
128649,.,0,0
128650,In,0,0
128651,the,0,0
128652,nested,0,1
128653,case-control,0,1
128654,study,0,0
128655,",",0,0
128656,the,0,0
128657,somatotropic,0,0
128658,axis,0,0
128659,",",0,0
128660,cortisol,0,0
128661,",",0,0
128662,and,0,0
128663,glucagon,0,0
128664,were,0,0
128665,analyzed,0,0
128666,before,0,0
128667,and,0,0
128668,after,0,0
128669,hypoglycemia,0,0
128670,.,0,0
128671,RESULTS,0,0
128672,On,0,0
128673,d,0,0
128674,3,0,0
128675,",",0,0
128676,C-peptide,0,0
128677,was,0,0
128678,more,0,0
128679,than,0,0
128680,10-fold,0,0
128681,lower,0,0
128682,(,0,0
128683,P,0,0
128684,<,0,0
128685,0.0001,0,0
128686,),0,0
128687,in,0,0
128688,the,0,0
128689,IIT,0,0
128690,group,0,0
128691,than,0,0
128692,in,0,0
128693,the,0,0
128694,CIT,0,1
128695,group,0,0
128696,.,0,1
128697,IIT,0,0
128698,increased,0,0
128699,circulating,0,0
128700,GH,0,0
128701,(,0,1
128702,P,0,0
128703,=,0,0
128704,0.04,0,0
128705,),0,0
128706,and,0,0
128707,lowered,0,0
128708,bioavailable,0,0
128709,IGF-I,0,1
128710,(,0,1
128711,P,0,0
128712,=,0,0
128713,0.002,0,0
128714,),0,1
128715,.,0,0
128716,IIT,0,0
128717,also,0,0
128718,decreased,0,0
128719,IGFBP-3,0,0
128720,(,0,0
128721,P,0,0
128722,=,0,0
128723,0.0005,0,0
128724,),0,0
128725,and,0,0
128726,acid-labile,0,0
128727,subunit,0,0
128728,(,0,0
128729,P,0,0
128730,=,0,0
128731,0.007,0,0
128732,),0,0
128733,",",0,0
128734,while,0,0
128735,increasing,0,0
128736,IGFBP-1,0,1
128737,(,0,1
128738,P,0,0
128739,=,0,0
128740,0.04,0,0
128741,),0,0
128742,and,0,0
128743,the,0,0
128744,urea/creatinine,0,0
128745,ratio,0,0
128746,",",0,0
128747,a,0,0
128748,marker,0,0
128749,of,0,0
128750,catabolism,0,0
128751,(,0,0
128752,P,0,0
128753,=,0,0
128754,0.03,0,0
128755,),0,0
128756,.,0,0
128757,In,0,0
128758,the,0,0
128759,nested,0,1
128760,case-control,0,1
128761,study,0,0
128762,",",0,0
128763,IGFBP-1,0,0
128764,was,0,0
128765,increased,0,0
128766,after,0,0
128767,hypoglycemia,0,0
128768,",",0,0
128769,whereas,0,0
128770,the,0,0
128771,somatotropic,0,0
128772,axis,0,0
128773,and,0,0
128774,the,0,0
128775,counterregulatory,0,0
128776,hormones,0,0
128777,cortisol,0,0
128778,and,0,0
128779,glucagon,0,0
128780,did,0,0
128781,not,0,0
128782,change,0,0
128783,.,0,0
128784,CONCLUSIONS,0,0
128785,Despite,0,0
128786,improved,0,0
128787,PICU,0,0
128788,outcome,0,0
128789,",",0,0
128790,IIT,0,0
128791,did,0,0
128792,not,0,0
128793,counteract,0,0
128794,the,0,0
128795,catabolic,0,0
128796,state,0,0
128797,of,0,0
128798,critical,0,0
128799,illness,0,1
128800,.,0,0
128801,Suppression,0,0
128802,of,0,0
128803,portal,0,0
128804,insulin,0,0
128805,may,0,0
128806,have,0,0
128807,resulted,0,0
128808,in,0,0
128809,lower,0,0
128810,bioavailable,0,0
128811,IGF-I,0,1
128812,.,0,1
128813,Exemestane,0,1
128814,for,0,0
128815,breast-cancer,1,1
128816,prevention,1,0
128817,in,1,0
128818,postmenopausal,1,1
128819,women,1,1
128820,.,1,1
128821,BACKGROUND,0,0
128822,Tamoxifen,0,0
128823,and,0,0
128824,raloxifene,0,0
128825,have,0,0
128826,limited,0,0
128827,patient,0,0
128828,acceptance,0,0
128829,for,0,0
128830,primary,0,1
128831,prevention,0,0
128832,of,0,0
128833,breast,0,1
128834,cancer,0,1
128835,.,0,1
128836,Aromatase,0,1
128837,inhibitors,0,0
128838,prevent,0,0
128839,more,0,0
128840,contralateral,0,0
128841,breast,0,1
128842,cancers,0,1
128843,and,0,0
128844,cause,0,0
128845,fewer,0,0
128846,side,0,0
128847,effects,0,0
128848,than,0,0
128849,tamoxifen,0,1
128850,in,0,0
128851,patients,1,1
128852,with,1,1
128853,early-stage,1,1
128854,breast,1,1
128855,cancer,1,1
128856,.,1,0
128857,METHODS,0,0
128858,In,0,0
128859,a,0,0
128860,randomized,0,0
128861,",",0,0
128862,placebo-controlled,0,0
128863,",",0,0
128864,double-blind,0,0
128865,trial,0,0
128866,of,0,0
128867,exemestane,0,0
128868,designed,0,0
128869,to,0,0
128870,detect,0,0
128871,a,0,0
128872,65,0,1
128873,%,0,0
128874,relative,0,0
128875,reduction,0,0
128876,in,0,0
128877,invasive,0,1
128878,breast,0,1
128879,cancer,0,1
128880,",",0,0
128881,eligible,1,1
128882,postmenopausal,1,1
128883,women,1,1
128884,35,1,1
128885,years,1,1
128886,of,1,0
128887,age,1,1
128888,or,1,1
128889,older,1,1
128890,had,1,0
128891,at,1,0
128892,least,1,1
128893,one,1,1
128894,of,1,0
128895,the,1,0
128896,following,1,0
128897,risk,1,1
128898,factors,1,0
128899,:,1,1
128900,60,1,1
128901,years,1,1
128902,of,1,0
128903,age,1,1
128904,or,1,1
128905,older,1,1
128906,;,1,0
128907,Gail,1,0
128908,5-year,1,0
128909,risk,1,0
128910,score,1,0
128911,greater,1,0
128912,than,1,0
128913,1.66,1,0
128914,%,1,0
128915,(,1,0
128916,chances,1,0
128917,in,1,0
128918,100,1,0
128919,of,1,0
128920,invasive,1,1
128921,breast,1,1
128922,cancer,1,1
128923,developing,1,0
128924,within,1,0
128925,5,1,1
128926,years,1,1
128927,),1,1
128928,;,1,1
128929,prior,1,1
128930,atypical,1,1
128931,ductal,1,1
128932,or,1,1
128933,lobular,1,1
128934,hyperplasia,1,1
128935,or,1,1
128936,lobular,1,1
128937,carcinoma,1,1
128938,in,1,0
128939,situ,1,0
128940,;,1,0
128941,or,1,1
128942,ductal,1,1
128943,carcinoma,1,1
128944,in,1,0
128945,situ,1,0
128946,with,1,1
128947,mastectomy,1,1
128948,.,1,1
128949,Toxic,0,0
128950,effects,0,0
128951,and,0,0
128952,health-related,0,0
128953,and,0,0
128954,menopause-specific,0,1
128955,qualities,0,0
128956,of,0,0
128957,life,0,0
128958,were,0,0
128959,measured,0,0
128960,.,0,0
128961,RESULTS,0,0
128962,A,0,0
128963,total,1,1
128964,of,1,0
128965,4560,1,1
128966,women,1,1
128967,for,1,1
128968,whom,1,1
128969,the,1,1
128970,median,1,1
128971,age,1,1
128972,was,1,0
128973,62.5,1,0
128974,years,1,1
128975,and,1,0
128976,the,1,0
128977,median,1,0
128978,Gail,1,0
128979,risk,1,0
128980,score,1,0
128981,was,1,0
128982,2.3,1,0
128983,%,1,0
128984,were,0,0
128985,randomly,0,1
128986,assigned,0,0
128987,to,0,0
128988,either,0,0
128989,exemestane,0,0
128990,or,0,0
128991,placebo,0,0
128992,.,0,0
128993,At,0,0
128994,a,0,0
128995,median,0,0
128996,follow-up,0,0
128997,of,0,0
128998,35,0,1
128999,months,0,0
129000,",",0,1
129001,11,0,0
129002,invasive,0,1
129003,breast,0,1
129004,cancers,0,1
129005,were,0,0
129006,detected,0,0
129007,in,0,0
129008,those,0,0
129009,given,0,0
129010,exemestane,0,0
129011,and,0,0
129012,in,0,0
129013,32,0,1
129014,of,0,0
129015,those,0,1
129016,given,0,0
129017,placebo,0,0
129018,",",0,0
129019,with,0,1
129020,a,0,0
129021,65,0,1
129022,%,0,0
129023,relative,0,0
129024,reduction,0,0
129025,in,0,0
129026,the,0,0
129027,annual,0,0
129028,incidence,0,0
129029,of,0,0
129030,invasive,0,1
129031,breast,0,1
129032,cancer,0,1
129033,(,0,0
129034,0.19,0,0
129035,%,0,0
129036,vs.,0,0
129037,0.55,0,0
129038,%,0,0
129039,;,0,0
129040,hazard,0,0
129041,ratio,0,0
129042,",",0,0
129043,0.35,0,0
129044,;,0,0
129045,95,0,0
129046,%,0,0
129047,confidence,0,0
129048,interval,0,0
129049,[,0,0
129050,CI,0,0
129051,],0,1
129052,",",0,0
129053,0.18,0,0
129054,to,0,0
129055,0.70,0,0
129056,;,0,1
129057,P=0.002,0,0
129058,),0,0
129059,.,0,0
129060,The,0,0
129061,annual,0,0
129062,incidence,0,0
129063,of,0,0
129064,invasive,0,1
129065,plus,0,0
129066,noninvasive,0,0
129067,(,0,0
129068,ductal,0,1
129069,carcinoma,0,1
129070,in,0,0
129071,situ,0,0
129072,),0,0
129073,breast,0,1
129074,cancers,0,1
129075,was,0,0
129076,0.35,0,0
129077,%,0,0
129078,on,0,0
129079,exemestane,0,0
129080,and,0,0
129081,0.77,0,0
129082,%,0,0
129083,on,0,0
129084,placebo,0,0
129085,(,0,0
129086,hazard,0,0
129087,ratio,0,0
129088,",",0,0
129089,0.47,0,0
129090,;,0,0
129091,95,0,0
129092,%,0,0
129093,CI,0,0
129094,",",0,0
129095,0.27,0,0
129096,to,0,0
129097,0.79,0,0
129098,;,0,1
129099,P=0.004,0,0
129100,),0,0
129101,.,0,1
129102,Adverse,0,0
129103,events,0,0
129104,occurred,0,0
129105,in,0,0
129106,88,0,0
129107,%,0,0
129108,of,0,0
129109,the,0,0
129110,exemestane,0,0
129111,group,0,0
129112,and,0,0
129113,85,0,0
129114,%,0,0
129115,of,0,0
129116,the,0,0
129117,placebo,0,0
129118,group,0,0
129119,(,0,0
129120,P=0.003,0,0
129121,),0,0
129122,",",0,0
129123,with,0,1
129124,no,0,0
129125,significant,0,0
129126,differences,0,0
129127,between,0,0
129128,the,0,0
129129,two,0,0
129130,groups,0,0
129131,in,0,1
129132,terms,0,0
129133,of,0,1
129134,skeletal,0,1
129135,fractures,0,1
129136,",",0,1
129137,cardiovascular,0,1
129138,events,0,0
129139,",",0,1
129140,other,0,0
129141,cancers,0,1
129142,",",0,0
129143,or,0,1
129144,treatment-related,0,0
129145,deaths,0,0
129146,.,0,1
129147,Minimal,0,0
129148,quality-of-life,0,0
129149,differences,0,0
129150,were,0,1
129151,observed,0,0
129152,.,0,1
129153,CONCLUSIONS,0,0
129154,Exemestane,0,0
129155,significantly,0,0
129156,reduced,0,0
129157,invasive,1,1
129158,breast,1,1
129159,cancers,1,1
129160,in,1,0
129161,postmenopausal,1,1
129162,women,1,1
129163,who,1,1
129164,were,1,1
129165,at,1,1
129166,moderately,1,0
129167,increased,1,0
129168,risk,1,0
129169,for,1,0
129170,breast,1,1
129171,cancer,1,1
129172,.,1,0
129173,During,0,0
129174,a,0,0
129175,median,0,0
129176,follow-up,0,0
129177,period,0,1
129178,of,0,0
129179,3,0,0
129180,years,0,1
129181,",",0,0
129182,exemestane,0,0
129183,was,0,0
129184,associated,0,0
129185,with,0,1
129186,no,0,0
129187,serious,0,0
129188,toxic,0,0
129189,effects,0,0
129190,and,0,0
129191,only,0,0
129192,minimal,0,0
129193,changes,0,0
129194,in,0,0
129195,health-related,0,0
129196,quality,0,0
129197,of,0,0
129198,life,0,0
129199,.,0,1
129200,(,0,0
129201,Funded,0,0
129202,by,0,0
129203,Pfizer,0,0
129204,and,0,1
129205,others,0,0
129206,;,0,1
129207,NCIC,0,0
129208,CTG,0,0
129209,MAP.3,0,0
129210,ClinicalTrials.gov,0,0
129211,number,0,0
129212,",",0,0
129213,NCT00083174,0,0
129214,.,0,1
129215,),0,0
129216,.,0,0
129217,Low-dose,0,0
129218,clonidine,0,0
129219,administration,0,0
129220,in,0,0
129221,the,0,0
129222,treatment,0,0
129223,of,0,0
129224,mild,1,1
129225,or,1,1
129226,moderate,1,1
129227,essential,1,1
129228,hypertension,1,1
129229,:,1,1
129230,results,0,0
129231,from,0,1
129232,a,0,1
129233,double-blind,0,0
129234,placebo-controlled,0,0
129235,study,0,1
129236,(,0,0
129237,Clobass,0,1
129238,),0,0
129239,.,0,0
129240,The,0,0
129241,Clobass,0,1
129242,Study,0,0
129243,Group,0,1
129244,.,0,1
129245,Five,1,0
129246,hundred,1,1
129247,and,1,1
129248,fifty-nine,1,1
129249,hypertensive,1,1
129250,outpatients,1,1
129251,with,1,1
129252,diastolic,1,1
129253,blood,1,0
129254,pressure,1,0
129255,between,1,0
129256,95,1,0
129257,and,1,0
129258,110,1,1
129259,mmHg,1,0
129260,participated,0,1
129261,in,0,0
129262,this,0,0
129263,double-blind,0,0
129264,",",0,0
129265,placebo-controlled,0,0
129266,",",0,0
129267,multicenter,0,0
129268,study,0,0
129269,.,0,1
129270,Eligible,0,0
129271,subjects,1,1
129272,were,0,1
129273,randomly,0,1
129274,allocated,0,0
129275,to,0,0
129276,receive,0,0
129277,either,0,0
129278,clonidine,0,0
129279,(,0,0
129280,75,0,1
129281,micrograms,0,0
129282,twice,0,0
129283,daily,0,0
129284,),0,0
129285,or,0,0
129286,a,0,0
129287,placebo,0,0
129288,.,0,0
129289,After,0,0
129290,4,0,0
129291,weeks,0,0
129292,",",0,1
129293,'responders,0,0
129294,',0,1
129295,to,0,0
129296,treatment,0,0
129297,(,0,0
129298,diastolic,0,0
129299,blood,0,0
129300,pressure,0,0
129301,reduced,0,0
129302,to,0,0
129303,less,0,0
129304,than,0,0
129305,or,0,0
129306,equal,0,0
129307,to,0,0
129308,90,0,1
129309,mmHg,0,0
129310,or,0,1
129311,by,0,0
129312,greater,0,0
129313,than,0,0
129314,or,0,0
129315,equal,0,0
129316,to,0,0
129317,10,0,1
129318,mmHg,0,0
129319,),0,1
129320,were,0,0
129321,kept,0,0
129322,on,0,0
129323,monotherapy,0,0
129324,and,0,0
129325,checked,0,0
129326,at,0,0
129327,4-weekly,0,0
129328,intervals,0,0
129329,for,0,0
129330,another,0,1
129331,3,0,0
129332,months,0,0
129333,.,0,1
129334,Non-responders,0,0
129335,were,0,0
129336,given,0,0
129337,15,0,1
129338,mg,0,0
129339,chlorthalidone,0,0
129340,and,0,0
129341,were,0,0
129342,also,0,0
129343,checked,0,0
129344,for,0,0
129345,a,0,0
129346,further,0,0
129347,3,0,0
129348,months,0,0
129349,.,0,1
129350,At,0,0
129351,the,0,0
129352,end,0,0
129353,of,0,0
129354,the,0,0
129355,first,0,0
129356,month,0,0
129357,",",0,0
129358,54.2,0,0
129359,%,0,0
129360,of,0,0
129361,the,0,0
129362,subjects,0,1
129363,were,0,1
129364,responders,0,0
129365,to,0,0
129366,clonidine,0,0
129367,and,0,0
129368,41.5,0,0
129369,%,0,0
129370,were,0,1
129371,responders,0,0
129372,to,0,0
129373,the,0,0
129374,placebo,0,0
129375,(,0,0
129376,P,0,0
129377,less,0,0
129378,than,0,0
129379,0.05,0,0
129380,for,0,0
129381,both,0,0
129382,groups,0,0
129383,),0,0
129384,.,0,1
129385,Of,0,0
129386,the,0,0
129387,remaining,0,0
129388,patients,0,1
129389,",",0,1
129390,69.0,0,0
129391,%,0,0
129392,became,0,0
129393,responders,0,0
129394,to,0,0
129395,clonidine,0,0
129396,plus,0,0
129397,chlorthalidone,0,0
129398,",",0,0
129399,whereas,0,0
129400,only,0,0
129401,34.7,0,0
129402,%,0,0
129403,were,0,1
129404,responders,0,0
129405,to,0,0
129406,placebo,0,0
129407,plus,0,0
129408,chlorthalidone,0,0
129409,(,0,0
129410,P,0,0
129411,less,0,0
129412,than,0,0
129413,0.01,0,0
129414,for,0,0
129415,both,0,0
129416,groups,0,0
129417,),0,1
129418,.,0,1
129419,Withdrawals,0,0
129420,from,0,0
129421,the,0,0
129422,study,0,0
129423,because,0,0
129424,of,0,0
129425,excessive,0,1
129426,diastolic,0,1
129427,blood,0,0
129428,pressure,0,0
129429,levels,0,0
129430,were,0,0
129431,about,0,0
129432,eight,0,0
129433,times,0,0
129434,less,0,0
129435,frequent,0,0
129436,among,0,0
129437,the,0,0
129438,subjects,0,1
129439,treated,0,1
129440,with,0,1
129441,clonidine,0,0
129442,",",0,0
129443,either,0,0
129444,alone,0,0
129445,or,0,0
129446,with,0,1
129447,chlorthalidone,0,0
129448,.,0,1
129449,Dry,0,0
129450,mouth,0,0
129451,was,0,0
129452,twice,0,0
129453,as,0,0
129454,frequent,0,0
129455,in,0,0
129456,the,0,0
129457,clonidine-treated,0,0
129458,patients,0,1
129459,",",0,0
129460,but,0,0
129461,there,0,0
129462,was,0,0
129463,no,0,0
129464,significant,0,0
129465,difference,0,0
129466,in,0,0
129467,the,0,0
129468,incidence,0,0
129469,of,0,0
129470,all,0,0
129471,side,0,0
129472,effects,0,0
129473,or,0,1
129474,the,0,0
129475,number,0,0
129476,of,0,0
129477,withdrawals,0,0
129478,from,0,1
129479,the,0,0
129480,study,0,0
129481,because,0,0
129482,of,0,0
129483,side,0,0
129484,effects,0,0
129485,between,0,0
129486,the,0,0
129487,two,0,0
129488,groups,0,0
129489,.,0,1
129490,We,0,0
129491,conclude,0,0
129492,that,0,0
129493,low-dose,0,0
129494,clonidine,0,0
129495,is,0,0
129496,effective,0,0
129497,in,0,0
129498,the,0,0
129499,treatment,0,0
129500,of,0,0
129501,mild,0,1
129502,or,0,1
129503,moderate,0,1
129504,hypertension,0,1
129505,.,0,1
129506,Clonidine-related,0,0
129507,side,0,0
129508,effects,0,0
129509,are,0,0
129510,still,0,0
129511,evident,0,0
129512,",",0,0
129513,but,0,0
129514,the,0,0
129515,overall,0,0
129516,tolerance,0,0
129517,profile,0,0
129518,for,0,0
129519,this,0,0
129520,reduced,0,0
129521,dosage,0,0
129522,of,0,0
129523,the,0,0
129524,drug,0,0
129525,appears,0,0
129526,to,0,0
129527,be,0,0
129528,favorable,0,0
129529,.,0,1
129530,[,1,0
129531,Diabetic,1,1
129532,retinopathy,1,1
129533,candesartan,0,0
129534,trial,0,0
129535,],0,1
129536,.,0,1
129537,Design,0,1
129538,and,0,0
129539,subject,0,0
129540,characteristics,0,0
129541,in,0,0
129542,the,0,0
129543,federally-funded,0,1
129544,citalopram,0,0
129545,trial,0,0
129546,in,0,0
129547,children,1,1
129548,with,1,1
129549,pervasive,1,1
129550,developmental,1,1
129551,disorders,1,1
129552,.,1,1
129553,The,0,0
129554,Studies,0,0
129555,to,0,1
129556,Advance,0,1
129557,Autism,0,1
129558,Research,0,0
129559,and,0,0
129560,Treatment,0,0
129561,Network,0,0
129562,conducted,0,0
129563,a,0,0
129564,randomized,0,0
129565,trial,0,0
129566,with,0,1
129567,citalopram,0,0
129568,in,0,0
129569,children,1,1
129570,with,1,1
129571,Pervasive,1,1
129572,developmental,1,1
129573,disorders,1,1
129574,(,1,1
129575,PDDs,1,1
129576,),1,0
129577,.,1,0
129578,We,0,0
129579,present,0,0
129580,the,0,0
129581,rationale,0,0
129582,",",0,0
129583,design,0,0
129584,and,0,0
129585,sample,0,1
129586,characteristics,0,0
129587,of,0,0
129588,the,0,0
129589,citalopram,0,0
129590,trial,0,0
129591,.,0,1
129592,Subjects,1,1
129593,(,1,0
129594,128,1,1
129595,boys,1,1
129596,",",1,1
129597,21,1,1
129598,girls,1,1
129599,),1,1
129600,had,1,1
129601,a,1,0
129602,mean,1,0
129603,age,1,1
129604,of,1,0
129605,9.3,1,0
129606,(,1,0
129607,?3.12,1,1
129608,),1,1
129609,years,1,1
129610,;,1,1
129611,132,1,1
129612,(,1,0
129613,88.6,1,0
129614,%,1,0
129615,),1,0
129616,were,1,0
129617,diagnosed,1,1
129618,with,1,1
129619,autistic,1,1
129620,disorder,1,1
129621,(,1,0
129622,4.7,1,0
129623,%,1,0
129624,with,1,1
129625,Asperger,1,1
129626,'s,1,1
129627,Disorder,1,1
129628,;,1,1
129629,6.7,1,0
129630,%,1,0
129631,with,1,1
129632,PDD-not,1,0
129633,otherwise,1,1
129634,specified,1,0
129635,),1,0
129636,.,1,0
129637,Less,1,0
129638,than,1,0
129639,half,1,1
129640,of,1,0
129641,the,1,0
129642,subjects,1,1
129643,were,1,0
129644,intellectually,1,1
129645,disabled,1,1
129646,;,1,0
129647,117,1,1
129648,(,1,0
129649,78.5,1,0
129650,%,1,0
129651,),1,0
129652,were,1,0
129653,rated,1,0
129654,Moderate,1,0
129655,or,1,0
129656,Marked,1,0
129657,on,1,0
129658,the,1,0
129659,Clinical,1,0
129660,Global,1,1
129661,Impression,1,0
129662,for,1,0
129663,Severity,1,0
129664,.,1,1
129665,Study,0,0
129666,measures,0,0
129667,were,0,1
129668,similar,0,0
129669,to,0,0
129670,previous,0,0
129671,Research,0,0
129672,Units,0,1
129673,on,0,0
129674,Pediatric,0,1
129675,Psychopharmacology,0,1
129676,trials,0,1
129677,.,0,1
129678,Subjects,1,1
129679,in,1,0
129680,this,1,0
129681,trial,1,0
129682,were,1,0
129683,slightly,1,0
129684,older,1,1
129685,and,1,0
129686,more,1,0
129687,likely,1,0
129688,to,1,0
129689,have,1,0
129690,complaints,1,1
129691,of,1,0
129692,repetitive,1,0
129693,behavior,1,0
129694,than,0,0
129695,participants,0,1
129696,in,0,1
129697,RUPP,0,1
129698,trials,0,1
129699,.,0,1
129700,Effects,0,0
129701,of,0,1
129702,dietary,0,0
129703,pyridoxine,0,0
129704,on,0,0
129705,haemato-immunological,0,0
129706,responses,0,0
129707,of,0,1
129708,Labeo,1,1
129709,rohita,1,1
129710,fingerlings,1,1
129711,reared,1,1
129712,at,1,0
129713,higher,1,0
129714,water,1,0
129715,temperature,1,0
129716,.,1,0
129717,A,0,0
129718,sixty-day,0,0
129719,feeding,0,0
129720,trial,0,0
129721,was,0,0
129722,carried,0,0
129723,out,0,0
129724,to,0,0
129725,elucidate,0,0
129726,the,0,0
129727,effect,0,0
129728,of,0,0
129729,dietary,0,0
129730,pyridoxine,0,0
129731,(,0,0
129732,PN,0,0
129733,),0,0
129734,on,0,0
129735,hemato-immunological,0,1
129736,parameters,0,0
129737,in,0,0
129738,Labeo,1,1
129739,rohita,1,1
129740,fingerlings,1,0
129741,exposed,1,0
129742,to,1,0
129743,an,1,0
129744,elevated,1,0
129745,temperature,1,0
129746,(,1,0
129747,ET,1,0
129748,),1,0
129749,of,1,0
129750,33,1,1
129751,?C,1,1
129752,.,1,1
129753,Two,1,0
129754,hundred,1,1
129755,and,1,0
129756,seventy,1,1
129757,fingerlings,1,1
129758,(,1,1
129759,6.71,1,0
129760,?,1,1
129761,0.32,1,0
129762,g,1,0
129763,),1,0
129764,were,1,0
129765,randomly,0,1
129766,distributed,0,0
129767,into,0,0
129768,six,0,1
129769,treatments,0,0
129770,in,0,1
129771,triplicates,0,0
129772,(,0,1
129773,15,0,1
129774,fish/tank,0,1
129775,),0,1
129776,.,0,1
129777,Five,0,0
129778,iso-nitrogenous,0,1
129779,(,0,1
129780,356.3,0,0
129781,?,0,1
129782,2.7,0,0
129783,g/kg,0,0
129784,crude,0,0
129785,protein,0,0
129786,),0,0
129787,purified,0,0
129788,diets,0,0
129789,were,0,0
129790,prepared,0,0
129791,with,0,1
129792,graded,0,1
129793,levels,0,0
129794,(,0,1
129795,0,0,0
129796,",",0,0
129797,10,0,0
129798,",",0,0
129799,50,0,1
129800,",",0,0
129801,100,0,0
129802,and,0,0
129803,200,0,1
129804,mg/kg,0,0
129805,diet,0,1
129806,),0,1
129807,of,0,0
129808,PN,0,0
129809,.,0,1
129810,Six,0,0
129811,treatment,0,0
129812,groups,0,0
129813,were,0,1
129814,P10T26,0,1
129815,(,0,0
129816,10,0,0
129817,mg,0,0
129818,PN,0,0
129819,+,0,0
129820,ambient,0,0
129821,temperature,0,0
129822,(,0,0
129823,26,0,1
129824,?C,0,1
129825,),0,0
129826,",",0,0
129827,P0T33,0,0
129828,(,0,0
129829,0,0,0
129830,mg,0,0
129831,PN,0,0
129832,+,0,0
129833,ET,0,0
129834,),0,0
129835,",",0,0
129836,P10T33,0,1
129837,(,0,0
129838,10,0,0
129839,mg,0,0
129840,PN,0,0
129841,+,0,0
129842,ET,0,0
129843,),0,0
129844,",",0,0
129845,P50T33,0,1
129846,(,0,0
129847,50,0,1
129848,mg,0,0
129849,PN,0,0
129850,+,0,0
129851,ET,0,0
129852,),0,0
129853,",",0,0
129854,P100T33,0,0
129855,(,0,0
129856,100,0,0
129857,mg,0,0
129858,PN,0,0
129859,+,0,0
129860,ET,0,0
129861,),0,0
129862,and,0,0
129863,P200T33,0,1
129864,(,0,0
129865,200,0,0
129866,mg,0,0
129867,PN,0,0
129868,+,0,0
129869,ET,0,1
129870,),0,0
129871,.,0,0
129872,The,0,0
129873,responses,1,0
129874,of,1,0
129875,L.,1,1
129876,rohita,1,1
129877,fingerlings,1,1
129878,to,1,1
129879,dietary,0,0
129880,PN,0,0
129881,were,0,0
129882,assessed,0,0
129883,in,0,0
129884,terms,0,0
129885,of,0,0
129886,growth,0,0
129887,and,0,0
129888,by,0,0
129889,analysing,0,0
129890,some,0,0
129891,hemato-immunological,0,1
129892,parameters,0,0
129893,.,0,0
129894,When,0,0
129895,PN,0,0
129896,supplementation,0,0
129897,increased,0,0
129898,from,0,0
129899,10,0,1
129900,to,0,1
129901,200,0,1
129902,mg/kg,0,0
129903,diet,0,1
129904,",",0,0
129905,a,0,0
129906,significant,0,0
129907,improvement,0,0
129908,in,0,0
129909,weight,0,0
129910,gain,0,0
129911,percentage,0,0
129912,was,0,0
129913,observed,0,0
129914,.,0,0
129915,Erythrocyte,0,0
129916,(,0,0
129917,RBC,0,0
129918,),0,0
129919,count,0,0
129920,",",0,0
129921,leucocyte,0,0
129922,(,0,0
129923,WBC,0,0
129924,),0,0
129925,count,0,0
129926,",",0,0
129927,haemoglobin,0,0
129928,content,0,0
129929,and,0,0
129930,respiratory,0,1
129931,burst,0,0
129932,activity,0,0
129933,were,0,0
129934,significantly,0,0
129935,(,0,0
129936,p,0,0
129937,<,0,0
129938,0.05,0,0
129939,),0,0
129940,higher,0,0
129941,in,0,0
129942,100,0,0
129943,mg,0,0
129944,PN/kg,0,0
129945,diet-fed,0,0
129946,group,0,0
129947,than,0,0
129948,their,0,0
129949,non-PN-fed,0,1
129950,counterpart,0,0
129951,.,0,0
129952,Also,0,0
129953,",",0,0
129954,serum,0,0
129955,albumin,0,0
129956,",",0,0
129957,globulin,0,0
129958,and,0,0
129959,lysozyme,0,0
129960,activity,0,0
129961,were,0,0
129962,found,0,0
129963,significantly,0,0
129964,(,0,0
129965,p,0,0
129966,<,0,0
129967,0.05,0,0
129968,),0,0
129969,higher,0,0
129970,in,0,0
129971,PN-fed,0,1
129972,groups,0,0
129973,.,0,1
129974,The,0,0
129975,overall,0,0
129976,results,0,0
129977,indicated,0,0
129978,that,0,0
129979,dietary,0,0
129980,PN,0,0
129981,supplementation,0,0
129982,at,0,0
129983,100,0,0
129984,mg/kg,0,0
129985,diet,0,0
129986,may,0,0
129987,reverse,0,0
129988,the,0,0
129989,negative,0,0
129990,effects,0,0
129991,caused,0,0
129992,by,0,0
129993,ET,0,0
129994,and,0,0
129995,may,0,0
129996,protect,0,0
129997,the,0,0
129998,haemato-immunological,0,0
129999,status,1,0
130000,of,1,0
130001,L.,1,1
130002,rohita,1,1
130003,fingerlings,1,1
130004,reared,1,1
130005,at,1,0
130006,higher,1,0
130007,water,1,0
130008,temperature,1,0
130009,.,1,1
130010,Pharmacodynamic,0,0
130011,effects,0,0
130012,on,0,0
130013,biochemical,0,0
130014,markers,0,0
130015,of,0,0
130016,bone,0,0
130017,turnover,0,0
130018,and,0,0
130019,pharmacokinetics,0,0
130020,of,0,0
130021,the,0,0
130022,cathepsin,0,0
130023,K,0,0
130024,inhibitor,0,0
130025,",",0,0
130026,ONO-5334,0,0
130027,",",0,0
130028,in,0,0
130029,an,0,0
130030,ascending,0,0
130031,multiple-dose,0,0
130032,",",0,0
130033,phase,0,0
130034,1,0,0
130035,study,0,1
130036,.,0,1
130037,Selective,0,0
130038,inhibitors,0,0
130039,of,0,0
130040,cathepsin,0,1
130041,K,0,0
130042,",",0,0
130043,which,0,0
130044,has,0,0
130045,a,0,0
130046,major,0,0
130047,role,0,0
130048,in,0,0
130049,the,0,0
130050,degradation,0,0
130051,of,0,0
130052,bone,0,0
130053,collagen,0,0
130054,",",0,0
130055,are,0,0
130056,potential,0,0
130057,new,0,0
130058,treatments,0,0
130059,for,0,0
130060,osteoporosis,0,1
130061,.,0,0
130062,The,0,0
130063,pharmacokinetics,0,0
130064,and,0,0
130065,the,0,0
130066,pharmacodynamic,0,0
130067,effects,0,0
130068,on,0,0
130069,biochemical,0,0
130070,markers,0,0
130071,of,0,0
130072,bone,0,0
130073,turnover,0,0
130074,of,0,0
130075,the,0,0
130076,new,0,0
130077,cathepsin,0,0
130078,K,0,0
130079,inhibitor,0,0
130080,",",0,0
130081,ONO-5334,0,0
130082,",",0,0
130083,were,0,0
130084,investigated,0,0
130085,in,0,0
130086,a,0,0
130087,multiple,0,0
130088,ascending,0,1
130089,dose,0,0
130090,",",0,0
130091,phase,0,0
130092,1,0,0
130093,study,0,0
130094,.,0,0
130095,A,1,0
130096,total,1,1
130097,of,1,0
130098,120,1,1
130099,healthy,1,1
130100,postmenopausal,1,1
130101,women,1,1
130102,were,1,0
130103,enrolled,1,1
130104,",",1,0
130105,and,1,0
130106,doses,1,0
130107,of,1,0
130108,10,1,1
130109,to,1,1
130110,600,1,1
130111,mg,1,0
130112,once,1,0
130113,daily,1,0
130114,and,1,0
130115,50,1,1
130116,and,1,0
130117,300,1,0
130118,mg,1,0
130119,twice,1,0
130120,daily,1,0
130121,were,1,0
130122,evaluated,1,0
130123,in,1,0
130124,15-,1,1
130125,and,1,1
130126,28-day,1,0
130127,multiple-dosing,1,0
130128,cohorts,1,1
130129,.,1,1
130130,Plasma,0,0
130131,ONO-5334,0,0
130132,concentration,0,0
130133,reached,0,0
130134,steady,0,0
130135,state,0,1
130136,within,0,1
130137,2,0,1
130138,days,0,0
130139,.,0,1
130140,Twenty-four,0,1
130141,hours,0,0
130142,after,0,0
130143,the,0,0
130144,last,0,0
130145,dose,0,0
130146,in,0,0
130147,the,0,0
130148,15-day,0,0
130149,multiple-dose,0,0
130150,cohort,0,1
130151,",",0,0
130152,100,0,0
130153,",",0,0
130154,300,0,0
130155,",",0,0
130156,and,0,0
130157,600,0,0
130158,mg,0,0
130159,once,0,0
130160,daily,0,0
130161,reduced,0,0
130162,urinary,0,0
130163,C-terminal,0,0
130164,telopeptide,0,0
130165,of,0,0
130166,type,0,1
130167,I,0,1
130168,collagen,0,0
130169,by,0,0
130170,a,0,0
130171,mean,0,0
130172,(,0,0
130173,?,0,0
130174,standard,0,0
130175,deviation,0,0
130176,),0,0
130177,44.9,0,0
130178,%,0,0
130179,?,0,0
130180,13.6,0,0
130181,%,0,0
130182,",",0,0
130183,84.5,0,0
130184,%,0,0
130185,?,0,0
130186,4.4,0,0
130187,%,0,0
130188,",",0,0
130189,and,0,0
130190,92.5,0,0
130191,%,0,0
130192,?,0,0
130193,1.3,0,0
130194,%,0,0
130195,",",0,0
130196,respectively,0,0
130197,.,0,0
130198,The,0,0
130199,28-day,0,0
130200,cohort,0,1
130201,showed,0,0
130202,similar,0,0
130203,effects,0,0
130204,.,0,0
130205,There,0,0
130206,were,0,0
130207,far,0,0
130208,smaller,0,0
130209,effects,0,0
130210,on,0,0
130211,bone-specific,0,0
130212,alkaline,0,0
130213,phosphatase,0,0
130214,(,0,0
130215,B-ALP,0,0
130216,),0,0
130217,",",0,0
130218,tartrate-resistant,0,0
130219,acid,0,0
130220,phosphatase,0,0
130221,5b,0,0
130222,(,0,0
130223,TRAP5b,0,0
130224,),0,0
130225,",",0,0
130226,or,0,0
130227,osteocalcin,0,0
130228,(,0,0
130229,OC,0,1
130230,),0,0
130231,(,0,0
130232,measured,0,0
130233,after,0,0
130234,28,0,1
130235,days,0,0
130236,),0,1
130237,.,0,1
130238,ONO-5334,0,0
130239,was,0,0
130240,well,0,0
130241,tolerated,0,0
130242,up,0,0
130243,to,0,0
130244,600,0,1
130245,mg/d,0,0
130246,and,0,0
130247,for,0,0
130248,up,0,0
130249,to,0,0
130250,28,0,1
130251,days,0,0
130252,of,0,0
130253,multiple,0,1
130254,dosing,0,0
130255,.,0,1
130256,Multiple,0,0
130257,dosing,0,0
130258,with,0,1
130259,ONO-5334,0,1
130260,100,0,0
130261,mg,0,0
130262,resulted,0,0
130263,in,0,0
130264,considerable,0,0
130265,suppression,0,0
130266,of,0,0
130267,bone,0,0
130268,resorption,0,0
130269,markers,0,0
130270,with,0,1
130271,no,0,0
130272,appreciable,0,0
130273,effects,0,0
130274,on,0,0
130275,bone,0,0
130276,formation,0,0
130277,markers,0,0
130278,(,0,0
130279,B-ALP,0,0
130280,",",0,0
130281,OC,0,1
130282,),0,0
130283,or,0,1
130284,osteoclast,0,0
130285,number,0,0
130286,(,0,0
130287,TRAP5b,0,0
130288,),0,1
130289,.,0,1
130290,Nepafenac,0,0
130291,for,0,0
130292,epiretinal,1,1
130293,membrane,1,0
130294,surgery,1,1
130295,.,1,1
130296,The,0,0
130297,IDvIP,0,0
130298,trial,0,0
130299,:,0,1
130300,a,0,0
130301,two-centre,0,0
130302,randomised,0,0
130303,double-blind,0,0
130304,controlled,0,0
130305,trial,0,0
130306,comparing,0,0
130307,intramuscular,0,0
130308,diamorphine,0,0
130309,and,0,0
130310,intramuscular,0,0
130311,pethidine,0,0
130312,for,0,0
130313,labour,1,1
130314,analgesia,1,0
130315,.,1,1
130316,BACKGROUND,0,0
130317,Intramuscular,0,0
130318,pethidine,0,0
130319,is,0,0
130320,routinely,0,0
130321,used,0,0
130322,throughout,0,0
130323,the,0,0
130324,UK,1,1
130325,for,0,0
130326,labour,0,1
130327,analgesia,0,0
130328,.,0,1
130329,Studies,0,0
130330,have,0,0
130331,suggested,0,0
130332,that,0,0
130333,pethidine,0,0
130334,provides,0,0
130335,little,0,0
130336,pain,0,0
130337,relief,0,0
130338,in,0,0
130339,labour,0,0
130340,and,0,0
130341,has,0,0
130342,a,0,0
130343,number,0,0
130344,of,0,0
130345,side,0,0
130346,effects,0,0
130347,affecting,0,0
130348,mother,1,1
130349,and,1,0
130350,neonate,1,1
130351,.,1,0
130352,It,0,0
130353,can,0,0
130354,cause,0,0
130355,nausea,0,0
130356,",",0,0
130357,vomiting,0,0
130358,and,0,0
130359,dysphoria,0,1
130360,in,0,0
130361,mothers,0,1
130362,and,0,0
130363,can,0,0
130364,cause,0,0
130365,reduced,0,0
130366,fetal,0,0
130367,heart,0,1
130368,rate,0,0
130369,variability,0,0
130370,and,0,0
130371,accelerations,0,0
130372,.,0,1
130373,Neonatal,0,1
130374,effects,0,0
130375,include,0,0
130376,respiratory,0,1
130377,depression,0,1
130378,and,0,0
130379,impaired,0,1
130380,feeding,0,0
130381,.,0,0
130382,There,0,0
130383,are,0,0
130384,few,0,0
130385,large,0,1
130386,studies,0,0
130387,comparing,0,0
130388,the,0,0
130389,relative,0,0
130390,side,0,0
130391,effects,0,0
130392,and,0,0
130393,efficacy,0,0
130394,of,0,0
130395,different,0,0
130396,opioids,0,0
130397,in,0,1
130398,labour,0,1
130399,.,0,0
130400,A,0,0
130401,small,0,0
130402,trial,0,0
130403,comparing,0,0
130404,intramuscular,0,0
130405,pethidine,0,0
130406,with,0,1
130407,diamorphine,0,0
130408,",",0,0
130409,showed,0,0
130410,diamorphine,0,0
130411,to,0,0
130412,have,0,0
130413,some,0,0
130414,benefits,0,0
130415,over,0,0
130416,pethidine,0,0
130417,when,0,0
130418,used,0,0
130419,for,0,0
130420,labour,0,0
130421,analgesia,0,0
130422,but,0,0
130423,the,0,0
130424,study,0,0
130425,did,0,0
130426,not,0,0
130427,investigate,0,0
130428,the,0,0
130429,adverse,0,0
130430,effects,0,0
130431,of,0,0
130432,either,0,1
130433,opioid,0,1
130434,.,0,0
130435,METHODS,0,0
130436,The,0,0
130437,Intramuscular,0,0
130438,Diamorphine,0,0
130439,versus,0,0
130440,Intramuscular,0,1
130441,Pethidine,0,0
130442,(,0,0
130443,IDvIP,0,0
130444,),0,0
130445,trial,0,0
130446,is,0,0
130447,a,0,0
130448,randomised,0,0
130449,double-blind,0,0
130450,two,0,0
130451,centre,0,1
130452,controlled,0,0
130453,trial,0,0
130454,comparing,0,0
130455,intramuscular,0,0
130456,diamorphine,0,0
130457,and,0,0
130458,pethidine,0,0
130459,regarding,0,0
130460,their,0,0
130461,analgesic,0,0
130462,efficacy,0,0
130463,in,0,0
130464,labour,1,0
130465,and,1,0
130466,their,1,0
130467,side,1,0
130468,effects,1,0
130469,in,1,0
130470,mother,1,1
130471,",",1,0
130472,fetus,1,0
130473,and,1,0
130474,neonate,1,1
130475,.,1,0
130476,Information,0,0
130477,about,0,0
130478,the,0,0
130479,trial,0,0
130480,will,0,0
130481,be,0,0
130482,provided,0,0
130483,to,0,0
130484,women,1,1
130485,in,1,0
130486,the,1,0
130487,antenatal,1,0
130488,period,1,0
130489,or,1,1
130490,in,1,0
130491,early,1,1
130492,labour,1,1
130493,.,1,0
130494,Consent,0,0
130495,and,0,0
130496,recruitment,0,0
130497,to,0,0
130498,the,0,0
130499,trial,0,0
130500,will,0,0
130501,be,0,0
130502,obtained,0,0
130503,when,0,0
130504,the,0,0
130505,mother,0,0
130506,requests,0,0
130507,opioid,0,0
130508,analgesia,0,0
130509,.,0,0
130510,The,0,0
130511,sample,0,0
130512,size,0,0
130513,requirement,0,0
130514,is,0,0
130515,406,1,0
130516,women,1,1
130517,with,1,1
130518,data,1,0
130519,on,1,0
130520,primary,1,1
130521,outcomes,1,0
130522,.,1,1
130523,The,0,0
130524,maternal,0,0
130525,primary,0,1
130526,outcomes,0,0
130527,are,0,0
130528,pain,0,0
130529,relief,0,0
130530,during,0,0
130531,the,0,0
130532,first,0,0
130533,3,0,0
130534,hours,0,0
130535,after,0,0
130536,trial,0,0
130537,analgesia,0,0
130538,and,0,0
130539,specifically,0,0
130540,pain,0,0
130541,relief,0,0
130542,after,0,0
130543,60,0,1
130544,minutes,0,0
130545,.,0,1
130546,The,0,0
130547,neonatal,0,1
130548,primary,0,1
130549,outcomes,0,0
130550,are,0,0
130551,need,0,0
130552,for,0,0
130553,resuscitation,0,1
130554,and,0,0
130555,Apgar,0,0
130556,Score,0,1
130557,<,0,0
130558,7,0,1
130559,at,0,0
130560,1,0,1
130561,minute,0,0
130562,.,0,0
130563,The,0,0
130564,secondary,0,0
130565,outcomes,0,0
130566,are,0,0
130567,an,0,0
130568,additional,0,0
130569,measure,0,0
130570,of,0,0
130571,pain,0,0
130572,relief,0,0
130573,",",0,0
130574,maternal,0,0
130575,sedation,0,0
130576,",",0,0
130577,nausea,0,0
130578,and,0,0
130579,vomiting,0,0
130580,",",0,0
130581,maternal,0,0
130582,oxygen,0,0
130583,saturation,0,0
130584,",",0,0
130585,satisfaction,0,0
130586,with,0,0
130587,analgesia,0,0
130588,",",0,0
130589,whether,0,0
130590,method,0,0
130591,of,0,0
130592,analgesia,0,0
130593,would,0,0
130594,be,0,0
130595,used,0,0
130596,again,0,0
130597,",",0,0
130598,use,0,0
130599,of,0,0
130600,Entonox,0,0
130601,",",0,0
130602,umbilical,0,0
130603,arterial,0,1
130604,and,0,0
130605,venous,0,0
130606,pH,0,0
130607,",",0,0
130608,fetal,0,1
130609,heart,0,1
130610,rate,0,0
130611,",",0,0
130612,meconium,0,0
130613,staining,0,0
130614,",",0,0
130615,time,0,0
130616,from,0,0
130617,delivery,0,0
130618,to,0,0
130619,first,0,0
130620,breath,0,0
130621,",",0,0
130622,Apgar,0,0
130623,scores,0,0
130624,at,0,0
130625,5,0,0
130626,mins,0,0
130627,",",0,0
130628,naloxone,0,0
130629,requirement,0,0
130630,",",0,0
130631,transfer,0,0
130632,to,0,0
130633,neonatal,0,1
130634,intensive,0,1
130635,care,0,1
130636,unit,0,0
130637,",",0,0
130638,neonatal,0,1
130639,haemoglobin,0,0
130640,oxygen,0,0
130641,saturation,0,0
130642,at,0,0
130643,30,0,1
130644,",",0,0
130645,60,0,1
130646,",",0,0
130647,90,0,0
130648,",",0,0
130649,and,0,0
130650,120,0,1
130651,mins,0,0
130652,after,0,0
130653,delivery,0,0
130654,",",0,0
130655,and,0,0
130656,neonatal,0,1
130657,sedation,0,0
130658,and,0,0
130659,feeding,0,0
130660,behaviour,0,0
130661,during,0,0
130662,first,0,0
130663,2,0,1
130664,hours,0,0
130665,.,0,1
130666,DISCUSSION,0,0
130667,If,0,0
130668,the,0,0
130669,trial,0,0
130670,demonstrates,0,0
130671,that,0,0
130672,diamorphine,0,0
130673,provides,0,0
130674,better,0,0
130675,analgesia,0,0
130676,with,0,0
130677,fewer,0,0
130678,side,0,0
130679,effects,0,0
130680,in,0,0
130681,mother,1,1
130682,and,1,0
130683,neonate,1,0
130684,this,0,0
130685,could,0,0
130686,lead,0,0
130687,to,0,0
130688,a,0,0
130689,change,0,0
130690,in,0,0
130691,national,0,1
130692,practice,0,0
130693,and,0,0
130694,result,0,0
130695,in,0,0
130696,diamorphine,0,0
130697,becoming,0,0
130698,the,0,0
130699,preferred,0,0
130700,intramuscular,0,0
130701,opioid,0,1
130702,for,0,0
130703,analgesia,0,0
130704,in,0,0
130705,labour,0,1
130706,.,0,1
130707,TRIAL,0,0
130708,REGISTRATION,0,0
130709,ISRCTN14898678Eudra,0,1
130710,No,0,0
130711,:,0,1
130712,2006-003250-18,0,0
130713,",",0,0
130714,REC,0,0
130715,Reference,0,0
130716,No,0,1
130717,:,0,1
130718,06/Q1702/95,0,0
130719,",",0,0
130720,MHRA,0,0
130721,Authorisation,0,0
130722,No,0,0
130723,:,0,1
130724,1443/0001/001-0001,0,0
130725,",",0,0
130726,NIHR,0,0
130727,UKCRN,0,0
130728,reference,0,0
130729,6895,0,1
130730,",",0,0
130731,RfPB,0,0
130732,grant,0,0
130733,PB-PG-0407-13170_IR5,0,1
130734,.,0,1
130735,A,0,0
130736,web-based,0,0
130737,approach,0,0
130738,to,0,0
130739,address,0,0
130740,cardiovascular,1,1
130741,risks,1,0
130742,in,1,1
130743,managers,1,1
130744,:,1,1
130745,results,0,0
130746,of,0,0
130747,a,0,0
130748,randomized,0,0
130749,trial,0,0
130750,.,0,0
130751,OBJECTIVES,0,0
130752,To,0,0
130753,examine,0,0
130754,whether,0,0
130755,a,0,0
130756,Web-based,0,0
130757,health,0,0
130758,and,0,0
130759,leadership,0,0
130760,development,0,0
130761,program,0,1
130762,--,0,0
130763,designed,0,0
130764,specifically,0,0
130765,for,0,0
130766,managers,1,1
130767,--,1,1
130768,was,1,0
130769,associated,0,0
130770,with,0,1
130771,changes,0,0
130772,in,0,0
130773,self-reported,0,0
130774,and,0,1
130775,biometric,0,0
130776,indicators,0,0
130777,of,0,0
130778,cardiovascular,0,1
130779,disease,0,1
130780,within,0,0
130781,the,0,0
130782,context,0,0
130783,of,0,0
130784,a,0,0
130785,randomized,0,0
130786,control,0,0
130787,trial,0,0
130788,.,0,0
130789,METHODS,0,0
130790,A,0,0
130791,total,0,1
130792,of,0,0
130793,145,1,1
130794,managers,1,1
130795,from,1,1
130796,8,1,1
130797,organizations,1,1
130798,participated,0,1
130799,in,0,0
130800,a,0,0
130801,6-month,0,0
130802,Internet-based,0,0
130803,program,0,0
130804,or,0,1
130805,a,0,0
130806,control,0,0
130807,condition,0,0
130808,.,0,1
130809,They,0,0
130810,completed,0,1
130811,pre-,0,0
130812,and,0,0
130813,posttest,0,0
130814,assessments,0,0
130815,that,0,0
130816,included,0,1
130817,both,0,0
130818,self-reported,0,0
130819,attitudes,0,0
130820,(,0,0
130821,on,0,0
130822,diet,0,0
130823,",",0,0
130824,exercise,0,0
130825,",",0,0
130826,and,0,0
130827,mental,0,1
130828,health,0,1
130829,),0,0
130830,and,0,0
130831,biometric,0,0
130832,measures,0,0
130833,(,0,0
130834,eg,0,0
130835,",",0,0
130836,body,0,0
130837,weight,0,0
130838,",",0,0
130839,waist,0,0
130840,circumference,0,0
130841,),0,0
130842,.,0,0
130843,RESULTS,0,0
130844,The,0,0
130845,intervention,0,0
130846,was,0,0
130847,associated,0,0
130848,with,0,1
130849,improvements,0,0
130850,in,0,1
130851,dietary,0,0
130852,attitudes,0,0
130853,",",0,0
130854,dietary,0,0
130855,self-efficacy,0,0
130856,",",0,0
130857,and,0,0
130858,exercise,0,0
130859,",",0,0
130860,and,0,0
130861,reductions,0,0
130862,in,0,0
130863,distress,0,1
130864,symptoms,0,1
130865,.,0,1
130866,Women,0,1
130867,in,0,0
130868,the,0,0
130869,program,0,0
130870,reduced,0,0
130871,their,0,0
130872,waist,0,0
130873,circumference,0,0
130874,significantly,0,0
130875,more,0,0
130876,than,0,0
130877,controls,0,0
130878,.,0,1
130879,CONCLUSIONS,0,0
130880,The,0,0
130881,program,0,0
130882,showed,0,0
130883,promise,0,0
130884,for,0,0
130885,reducing,0,0
130886,cardiovascular,0,1
130887,disease,0,1
130888,risk,0,1
130889,factors,0,0
130890,.,0,1
130891,Similar,0,0
130892,results,0,0
130893,across,0,0
130894,diverse,0,1
130895,organizations,0,1
130896,suggest,0,0
130897,the,0,0
130898,program,0,0
130899,may,0,0
130900,be,0,0
130901,useful,0,0
130902,across,0,0
130903,industry,0,1
130904,types,0,0
130905,.,0,1
130906,[,1,0
130907,Use,1,0
130908,of,1,0
130909,Tachocomb,1,0
130910,for,1,0
130911,prevention,1,0
130912,of,1,0
130913,postoperative,1,0
130914,lymphatic,1,1
130915,leaks,1,0
130916,in,1,0
130917,the,1,0
130918,abdomen,1,0
130919,],1,1
130920,.,0,1
130921,The,0,0
130922,effect,0,0
130923,of,0,0
130924,knee,0,1
130925,position,0,0
130926,on,0,0
130927,blood,0,0
130928,loss,0,0
130929,and,0,0
130930,range,0,0
130931,of,0,0
130932,motion,0,0
130933,following,0,0
130934,total,1,1
130935,knee,1,1
130936,arthroplasty,1,1
130937,.,1,0
130938,PURPOSE,0,0
130939,This,0,0
130940,study,0,0
130941,prospectively,0,0
130942,assessed,0,0
130943,the,0,0
130944,effects,0,0
130945,of,0,0
130946,knee,0,1
130947,position,0,1
130948,on,0,0
130949,blood,0,0
130950,loss,0,0
130951,and,0,0
130952,range,0,0
130953,of,0,0
130954,motion,0,0
130955,after,1,0
130956,primary,1,1
130957,total,1,1
130958,knee,1,1
130959,arthroplasty,1,1
130960,(,1,0
130961,TKA,1,0
130962,),1,1
130963,.,1,1
130964,METHODS,0,0
130965,One,1,1
130966,hundred,1,1
130967,and,1,0
130968,ten,1,1
130969,consecutive,1,1
130970,TKA,1,0
130971,patients,1,1
130972,were,0,0
130973,randomized,0,1
130974,into,0,0
130975,flexion,0,0
130976,group,0,0
130977,and,0,0
130978,extension,0,0
130979,group,0,0
130980,.,0,0
130981,Both,0,0
130982,groups,0,0
130983,had,0,0
130984,the,0,0
130985,leg,0,0
130986,elevated,0,0
130987,30?,0,1
130988,at,0,0
130989,the,0,0
130990,hip,0,1
130991,over,0,0
130992,an,0,0
130993,inactive,0,0
130994,CPM,0,0
130995,for,0,0
130996,72,0,1
130997,h,0,0
130998,postoperatively,0,0
130999,.,0,0
131000,The,0,0
131001,flexion,0,0
131002,group,0,0
131003,had,0,0
131004,the,0,0
131005,knee,0,1
131006,flexed,0,0
131007,to,0,0
131008,30?,0,1
131009,during,0,0
131010,this,0,0
131011,period,0,0
131012,.,0,0
131013,The,0,0
131014,extension,0,0
131015,group,0,0
131016,had,0,0
131017,the,0,0
131018,knee,0,1
131019,extended,0,0
131020,fully,0,0
131021,.,0,0
131022,Perioperative,0,0
131023,blood,0,0
131024,loss,0,0
131025,",",0,0
131026,hidden,0,0
131027,blood,0,0
131028,loss,0,0
131029,",",0,0
131030,knee,0,1
131031,swelling,0,0
131032,",",0,0
131033,ecchymosis,0,0
131034,",",0,0
131035,analgesia,0,0
131036,requirements,0,0
131037,",",0,0
131038,range,0,0
131039,of,0,0
131040,motion,0,0
131041,(,0,0
131042,ROM,0,1
131043,),0,0
131044,",",0,0
131045,fixed,0,0
131046,flexion,0,0
131047,deformity,0,1
131048,(,0,0
131049,FFD,0,0
131050,),0,0
131051,",",0,0
131052,straight-leg,0,0
131053,raising,0,0
131054,action,0,0
131055,",",0,0
131056,and,0,0
131057,postoperative,0,0
131058,complications,0,0
131059,within,0,1
131060,6,0,0
131061,weeks,0,0
131062,of,0,0
131063,surgery,0,1
131064,were,0,0
131065,measured,0,0
131066,for,0,0
131067,evaluation,0,0
131068,and,0,0
131069,comparison,0,0
131070,.,0,0
131071,RESULTS,0,0
131072,The,0,0
131073,postoperative,0,0
131074,hidden,0,0
131075,blood,0,0
131076,loss,0,0
131077,",",0,0
131078,knee,0,1
131079,swelling,0,0
131080,",",0,0
131081,and,0,0
131082,scope,0,0
131083,of,0,0
131084,ecchymosis,0,0
131085,were,0,0
131086,significantly,0,0
131087,lower,0,0
131088,in,0,0
131089,the,0,0
131090,flexion,0,0
131091,group,0,0
131092,than,0,0
131093,in,0,0
131094,the,0,0
131095,extension,0,0
131096,group,0,0
131097,",",0,0
131098,and,0,0
131099,ROM,0,0
131100,and,0,0
131101,straight-leg,0,0
131102,raising,0,0
131103,action,0,0
131104,were,0,0
131105,significantly,0,0
131106,higher,0,0
131107,during,0,0
131108,the,0,0
131109,early,0,0
131110,period,0,0
131111,after,0,0
131112,operation,0,0
131113,.,0,0
131114,No,0,0
131115,significant,0,0
131116,difference,0,0
131117,was,0,0
131118,observed,0,0
131119,in,0,0
131120,perioperative,0,0
131121,blood,0,0
131122,loss,0,0
131123,",",0,0
131124,the,0,0
131125,amount,0,0
131126,of,0,0
131127,morphine,0,0
131128,used,0,0
131129,",",0,0
131130,or,0,0
131131,FFD,0,0
131132,in,0,0
131133,the,0,0
131134,early,0,0
131135,postoperative,0,0
131136,period,0,0
131137,or,0,1
131138,in,0,0
131139,ROM,0,1
131140,and,0,0
131141,FFD,0,0
131142,at,0,0
131143,6,0,0
131144,weeks,0,0
131145,postoperatively,0,0
131146,.,0,0
131147,CONCLUSIONS,0,0
131148,The,0,0
131149,findings,0,0
131150,of,0,0
131151,this,0,0
131152,study,0,0
131153,indicate,0,0
131154,that,0,0
131155,flexion,0,0
131156,of,0,0
131157,the,0,0
131158,knee,0,1
131159,to,0,0
131160,30?,0,1
131161,with,0,1
131162,the,0,0
131163,leg,0,0
131164,elevated,0,0
131165,30?,0,1
131166,at,0,0
131167,the,0,0
131168,hip,0,1
131169,after,0,0
131170,total,0,1
131171,knee,0,1
131172,arthroplasty,0,1
131173,may,0,0
131174,mitigate,0,0
131175,knee,0,0
131176,swelling,0,0
131177,and,0,0
131178,provide,0,0
131179,other,0,0
131180,beneficial,0,0
131181,results,0,0
131182,during,0,0
131183,the,0,0
131184,early,0,0
131185,rehabilitation,0,0
131186,following,0,0
131187,TKA,0,0
131188,.,0,1
131189,LEVEL,0,0
131190,OF,0,0
131191,EVIDENCE,0,1
131192,Prospective,0,0
131193,comparative,0,0
131194,study,0,0
131195,",",0,0
131196,Level,0,0
131197,I,0,1
131198,.,0,1
131199,Predictors,0,0
131200,and,0,1
131201,moderators,0,0
131202,of,0,0
131203,parent,0,1
131204,training,0,0
131205,efficacy,0,0
131206,in,0,0
131207,a,0,0
131208,sample,1,1
131209,of,1,0
131210,children,1,1
131211,with,1,1
131212,autism,1,1
131213,spectrum,1,1
131214,disorders,1,1
131215,and,1,1
131216,serious,1,0
131217,behavioral,1,1
131218,problems,1,1
131219,.,1,1
131220,The,0,0
131221,Research,0,0
131222,Units,0,0
131223,on,0,0
131224,Pediatric,0,1
131225,Psychopharmacology,0,1
131226,--,0,1
131227,Autism,0,1
131228,Network,0,0
131229,reported,0,0
131230,additional,0,0
131231,benefit,0,0
131232,when,0,0
131233,adding,0,0
131234,parent,0,0
131235,training,0,0
131236,(,0,0
131237,PT,0,0
131238,),0,0
131239,to,0,0
131240,antipsychotic,0,0
131241,medication,0,0
131242,in,0,0
131243,children,1,1
131244,with,1,1
131245,autism,1,1
131246,spectrum,1,1
131247,disorders,1,1
131248,and,1,0
131249,serious,1,0
131250,behavior,1,0
131251,problems,1,1
131252,.,1,1
131253,The,0,0
131254,intent-to-treat,0,0
131255,analyses,0,0
131256,were,0,1
131257,rerun,0,0
131258,with,0,1
131259,putative,0,1
131260,predictors,0,0
131261,and,0,1
131262,moderators,0,0
131263,.,0,1
131264,The,0,0
131265,Home,0,0
131266,Situations,0,0
131267,Questionnaire,0,0
131268,(,0,0
131269,HSQ,0,1
131270,),0,0
131271,and,0,0
131272,the,0,0
131273,Hyperactivity/Noncompliance,0,0
131274,subscale,0,0
131275,of,0,0
131276,the,0,0
131277,Aberrant,0,1
131278,Behavior,0,1
131279,Checklist,0,0
131280,were,0,0
131281,used,0,0
131282,as,0,0
131283,outcome,0,0
131284,measures,0,0
131285,.,0,1
131286,Candidate,0,1
131287,predictors,0,0
131288,and,0,1
131289,moderators,0,0
131290,included,0,1
131291,21,0,1
131292,demographics,0,0
131293,and,0,1
131294,baseline,0,0
131295,measures,0,0
131296,of,0,0
131297,behavior,0,0
131298,.,0,0
131299,Higher,0,0
131300,baseline,0,0
131301,HSQ,0,1
131302,scores,0,0
131303,predicted,0,0
131304,greater,0,0
131305,improvement,0,0
131306,on,0,0
131307,the,0,0
131308,HSQ,0,0
131309,regardless,0,0
131310,of,0,0
131311,treatment,0,0
131312,assignment,0,0
131313,",",0,0
131314,but,0,0
131315,no,0,0
131316,other,0,0
131317,predictors,0,0
131318,of,0,0
131319,outcome,0,0
131320,were,0,0
131321,observed,0,0
131322,.,0,0
131323,None,0,0
131324,of,0,0
131325,the,0,0
131326,variables,0,0
131327,measured,0,0
131328,in,0,0
131329,this,0,0
131330,study,0,0
131331,moderated,0,0
131332,response,0,0
131333,to,0,0
131334,PT,0,0
131335,.,0,1
131336,Antipsychotic,0,0
131337,medication,0,0
131338,plus,0,0
131339,PT,0,0
131340,appears,0,0
131341,to,0,0
131342,be,0,0
131343,equally,0,0
131344,effective,0,0
131345,for,0,0
131346,children,1,1
131347,with,1,1
131348,a,1,0
131349,wide,1,1
131350,range,1,0
131351,of,1,0
131352,demographic,1,0
131353,and,1,1
131354,behavioral,1,1
131355,characteristics,1,0
131356,.,1,1
131357,[,0,0
131358,The,0,0
131359,Antonio,0,1
131360,Raichs,0,1
131361,memorial,0,1
131362,lecture,0,1
131363,.,0,1
131364,Future,0,0
131365,trends,0,0
131366,in,0,0
131367,marrow,1,1
131368,transplantation,1,1
131369,],1,1
131370,.,0,1
131371,Effects,0,0
131372,of,0,0
131373,a,0,1
131374,Chinese,0,1
131375,medical,0,0
131376,herbs,0,1
131377,complex,0,0
131378,on,0,0
131379,cellular,0,0
131380,immunity,0,0
131381,and,0,0
131382,toxicity-related,0,0
131383,conditions,0,0
131384,of,0,0
131385,breast,1,1
131386,cancer,1,1
131387,patients,1,1
131388,.,1,1
131389,Rose,0,0
131390,geranium,0,0
131391,(,0,0
131392,Pelargonium,0,0
131393,graveolens,0,0
131394,",",0,0
131395,Geraniaceae,0,1
131396,),0,0
131397,has,0,0
131398,anti-cancer,0,0
131399,and,0,0
131400,anti-inflammatory,0,0
131401,properties,0,0
131402,",",0,0
131403,and,0,0
131404,promotes,0,0
131405,wound,0,0
131406,healing,0,0
131407,.,0,0
131408,Similarly,0,0
131409,",",0,0
131410,Ganoderma,0,0
131411,tsugae,0,1
131412,(,0,0
131413,Ganodermataceae,0,0
131414,),0,0
131415,",",0,0
131416,Codonopsis,0,1
131417,pilosula,0,0
131418,(,0,0
131419,Campanulaceae,0,1
131420,),0,0
131421,and,0,0
131422,Angelica,0,0
131423,sinensis,0,1
131424,(,0,0
131425,Apiaceae,0,1
131426,),0,0
131427,are,0,0
131428,traditional,0,1
131429,Chinese,0,1
131430,herbs,0,1
131431,associated,0,0
131432,with,0,1
131433,immunomodulatory,0,0
131434,functions,0,0
131435,.,0,1
131436,In,0,0
131437,the,0,0
131438,present,0,0
131439,study,0,0
131440,",",0,0
131441,a,0,0
131442,randomised,0,0
131443,",",0,0
131444,double-blind,0,0
131445,",",0,0
131446,placebo-controlled,0,0
131447,study,0,0
131448,was,0,0
131449,conducted,0,0
131450,to,0,0
131451,examine,0,0
131452,whether,0,0
131453,the,0,0
131454,Chinese,0,1
131455,medicinal,0,1
131456,herb,0,0
131457,complex,0,0
131458,",",0,0
131459,RG-CMH,0,0
131460,",",0,0
131461,which,0,0
131462,represents,0,0
131463,a,0,0
131464,mixture,0,0
131465,of,0,0
131466,rose,0,0
131467,geranium,0,0
131468,and,0,0
131469,extracts,0,1
131470,of,0,0
131471,G.,0,0
131472,tsugae,0,1
131473,",",0,0
131474,C.,0,0
131475,pilosula,0,0
131476,and,0,0
131477,A.,0,0
131478,sinensis,0,0
131479,",",0,0
131480,can,0,0
131481,improve,0,0
131482,the,0,0
131483,immune,0,0
131484,cell,0,0
131485,count,0,0
131486,of,0,0
131487,cancer,1,1
131488,patients,1,1
131489,receiving,1,1
131490,chemotherapy,1,1
131491,and/or,1,0
131492,radiotherapy,1,1
131493,to,0,0
131494,prevent,0,0
131495,leucopenia,0,0
131496,and,0,0
131497,immune,0,0
131498,impairment,0,0
131499,that,0,0
131500,usually,0,0
131501,occurs,0,0
131502,during,0,0
131503,cancer,0,1
131504,therapy,0,0
131505,.,0,0
131506,A,0,0
131507,total,0,0
131508,of,0,0
131509,fifty-eight,1,1
131510,breast,1,1
131511,cancer,1,1
131512,patients,1,1
131513,who,1,1
131514,received,1,1
131515,chemotherapy,1,1
131516,or,1,1
131517,radiotherapy,1,1
131518,were,1,0
131519,enrolled,1,1
131520,.,1,0
131521,Immune,0,0
131522,cell,0,0
131523,levels,0,0
131524,in,0,0
131525,patient,0,1
131526,serum,0,0
131527,were,0,0
131528,determined,0,0
131529,before,0,0
131530,",",0,0
131531,and,0,0
131532,following,0,0
131533,",",0,0
131534,6,0,0
131535,weeks,0,0
131536,of,0,0
131537,cancer,0,1
131538,treatment,0,0
131539,for,0,0
131540,patients,0,1
131541,receiving,0,1
131542,either,0,0
131543,an,0,0
131544,RG-CMH,0,0
131545,or,0,0
131546,a,0,0
131547,placebo,0,0
131548,.,0,0
131549,Administration,0,0
131550,of,0,0
131551,RG-CMH,0,0
131552,was,0,0
131553,associated,0,0
131554,with,0,1
131555,a,0,0
131556,significant,0,0
131557,reduction,0,0
131558,in,0,0
131559,levels,0,0
131560,of,0,1
131561,leucocytes,0,1
131562,from,0,1
131563,31?5,0,0
131564,%,0,0
131565,for,0,0
131566,the,0,0
131567,placebo,0,0
131568,group,0,0
131569,to,0,0
131570,13?4,0,0
131571,%,0,0
131572,for,0,0
131573,the,0,0
131574,RG-CMH,0,0
131575,group,0,0
131576,.,0,0
131577,Similarly,0,0
131578,",",0,0
131579,levels,0,0
131580,of,0,0
131581,neutrophils,0,0
131582,significantly,0,0
131583,decreased,0,0
131584,from,0,0
131585,35?6,0,0
131586,%,0,0
131587,for,0,0
131588,the,0,0
131589,placebo,0,0
131590,group,0,0
131591,to,0,0
131592,11?0,0,0
131593,%,0,0
131594,for,0,0
131595,the,0,0
131596,RG-CMH,0,0
131597,group,0,0
131598,.,0,0
131599,RG-CMH,0,0
131600,intervention,0,0
131601,was,0,0
131602,also,0,0
131603,associated,0,0
131604,with,0,0
131605,a,0,0
131606,decrease,0,0
131607,in,0,0
131608,levels,0,0
131609,of,0,1
131610,T,0,1
131611,cells,0,0
131612,",",0,0
131613,helper,0,0
131614,T,0,1
131615,cells,0,0
131616,",",0,0
131617,cytotoxic,0,0
131618,T,0,1
131619,cells,0,0
131620,and,0,0
131621,natural,0,0
131622,killer,0,0
131623,cells,0,0
131624,compared,0,0
131625,with,0,1
131626,the,0,0
131627,placebo,0,0
131628,group,0,0
131629,.,0,0
131630,However,0,0
131631,",",0,0
131632,these,0,0
131633,differences,0,0
131634,between,0,0
131635,the,0,0
131636,two,0,0
131637,groups,0,0
131638,were,0,0
131639,not,0,0
131640,statistically,0,0
131641,significant,0,0
131642,.,0,0
131643,In,0,0
131644,conclusion,0,0
131645,",",0,0
131646,administration,0,0
131647,of,0,0
131648,RG-CMH,0,1
131649,to,0,1
131650,patients,0,1
131651,receiving,0,0
131652,chemotherapy/radiotherapy,0,0
131653,may,0,0
131654,have,0,0
131655,the,0,0
131656,capacity,0,0
131657,to,0,0
131658,delay,0,0
131659,",",0,0
131660,or,0,0
131661,ease,0,0
131662,",",0,0
131663,the,0,0
131664,reduction,0,0
131665,in,0,0
131666,levels,0,0
131667,of,0,1
131668,leucocytes,0,1
131669,and,0,1
131670,neutrophils,0,0
131671,that,0,0
131672,are,0,0
131673,experienced,0,0
131674,by,0,0
131675,patients,0,1
131676,during,0,0
131677,cancer,0,1
131678,treatment,0,0
131679,.,0,1
131680,[,0,0
131681,Sublingually,0,0
131682,administered,0,0
131683,captopril,0,0
131684,versus,0,0
131685,nifedipine,0,0
131686,in,0,0
131687,hypertension,1,1
131688,emergencies,1,1
131689,],1,1
131690,.,0,0
131691,Aim,0,0
131692,of,0,0
131693,the,0,0
131694,study,0,0
131695,was,0,0
131696,to,0,0
131697,assess,0,0
131698,the,0,0
131699,effectiveness,0,0
131700,and,0,0
131701,tolerability,0,0
131702,of,0,0
131703,sublingual,0,0
131704,captopril,0,0
131705,(,0,0
131706,SLC,0,0
131707,),0,0
131708,versus,0,0
131709,sublingual,0,0
131710,nifedipine,0,0
131711,(,0,0
131712,SLN,0,0
131713,),0,0
131714,in,0,0
131715,treating,0,1
131716,hypertensive,1,1
131717,emergencies,1,1
131718,.,1,1
131719,During,1,0
131720,hypertensive,1,1
131721,crises,1,1
131722,(,1,1
131723,systolic,1,1
131724,blood,1,0
131725,pressure,1,0
131726,exceeding,1,0
131727,200,1,0
131728,mmHg,1,0
131729,and,1,0
131730,diastolic,1,0
131731,blood,1,0
131732,pressure,1,0
131733,exceeding,1,0
131734,115,1,1
131735,mmHg,1,0
131736,),1,0
131737,forty,1,1
131738,hypertensive,1,1
131739,patients,1,1
131740,received,0,1
131741,either,0,1
131742,25,0,0
131743,mg,0,0
131744,of,0,0
131745,SLC,0,0
131746,or,0,1
131747,10,0,0
131748,mg,0,0
131749,of,0,0
131750,SLN,0,0
131751,in,0,0
131752,a,0,0
131753,randomized,0,0
131754,single,0,0
131755,blind,0,1
131756,fashion,0,0
131757,.,0,0
131758,Blood,0,0
131759,pressure,0,0
131760,and,0,0
131761,heart,0,1
131762,rate,0,0
131763,were,0,0
131764,then,0,0
131765,controlled,0,0
131766,after,0,0
131767,5,0,0
131768,",",0,0
131769,10,0,0
131770,",",0,0
131771,15,0,0
131772,",",0,0
131773,20,0,0
131774,",",0,0
131775,30,0,0
131776,",",0,0
131777,45,0,1
131778,",",0,0
131779,60,0,1
131780,",",0,0
131781,120,0,1
131782,min,0,0
131783,.,0,0
131784,and,0,0
131785,",",0,0
131786,in,0,0
131787,18,0,1
131788,cases,0,1
131789,",",0,0
131790,up,0,0
131791,to,0,0
131792,the,0,0
131793,8th,0,1
131794,hour,0,0
131795,from,0,0
131796,the,0,0
131797,administration,0,0
131798,.,0,0
131799,Our,0,0
131800,results,0,0
131801,showed,0,0
131802,:,0,1
131803,1,0,0
131804,),0,0
131805,a,0,0
131806,satisfactory,0,0
131807,control,0,0
131808,of,0,0
131809,the,0,0
131810,hypertensive,0,1
131811,crises,0,1
131812,in,0,1
131813,80,0,1
131814,%,0,0
131815,of,0,0
131816,patients,0,1
131817,treated,0,1
131818,with,0,1
131819,SLC,0,0
131820,with,0,1
131821,a,0,0
131822,significant,0,0
131823,blood,0,0
131824,pressure,0,0
131825,reduction,0,0
131826,after,0,0
131827,10,0,1
131828,min,0,0
131829,.,0,1
131830,(,0,0
131831,13/8,0,0
131832,mmHg,0,0
131833,",",0,0
131834,p,0,0
131835,less,0,0
131836,than,0,0
131837,0.02,0,0
131838,),0,0
131839,",",0,0
131840,while,0,0
131841,the,0,0
131842,maximum,0,0
131843,hypotensive,0,0
131844,effect,0,0
131845,was,0,0
131846,achieved,0,0
131847,after,0,0
131848,30,0,1
131849,min,0,0
131850,.,0,1
131851,(,0,0
131852,52/36,0,0
131853,mmHg,0,0
131854,",",0,0
131855,p,0,0
131856,less,0,0
131857,than,0,0
131858,0.001,0,0
131859,),0,1
131860,;,0,1
131861,SLN,0,0
131862,was,0,0
131863,able,0,0
131864,to,0,0
131865,reduce,0,0
131866,blood,0,0
131867,pressure,0,0
131868,in,0,0
131869,90,0,0
131870,%,0,0
131871,of,0,0
131872,all,0,0
131873,the,0,0
131874,cases,0,0
131875,",",0,0
131876,with,0,1
131877,a,0,0
131878,significant,0,0
131879,reduction,0,0
131880,after,0,0
131881,5,0,0
131882,min,0,0
131883,.,0,1
131884,(,0,0
131885,15/11,0,0
131886,mmHg,0,0
131887,",",0,0
131888,p,0,0
131889,less,0,0
131890,than,0,0
131891,0.02,0,0
131892,),0,1
131893,and,0,0
131894,hypotensive,0,0
131895,peak,0,0
131896,after,0,0
131897,20,0,1
131898,min,0,0
131899,(,0,0
131900,57/38,0,0
131901,mmHg,0,0
131902,",",0,0
131903,p,0,0
131904,greater,0,0
131905,than,0,0
131906,0.001,0,0
131907,),0,1
131908,;,0,1
131909,2,0,0
131910,),0,0
131911,no,0,0
131912,significant,0,0
131913,differences,0,0
131914,for,0,0
131915,hypotensive,0,0
131916,effectiveness,0,0
131917,between,0,0
131918,the,0,0
131919,two,0,0
131920,groups,0,0
131921,",",0,0
131922,but,0,0
131923,with,0,1
131924,SLC,0,0
131925,having,0,1
131926,a,0,0
131927,mildly,0,1
131928,delayed,0,0
131929,onset,0,0
131930,of,0,0
131931,action,0,0
131932,when,0,0
131933,compared,0,0
131934,to,0,0
131935,SLN,0,0
131936,;,0,1
131937,3,0,0
131938,),0,0
131939,antihypertensive,0,0
131940,effect,0,0
131941,lasting,0,0
131942,for,0,0
131943,about,0,0
131944,6,0,0
131945,hours,0,0
131946,in,0,1
131947,patients,0,1
131948,treated,0,1
131949,with,0,1
131950,SLC,0,0
131951,and,0,0
131952,blood,0,0
131953,pressure,0,0
131954,progressively,0,0
131955,raising,0,0
131956,after,0,0
131957,4,0,0
131958,hours,0,0
131959,in,0,1
131960,patients,0,1
131961,who,0,1
131962,received,0,1
131963,SLN,0,1
131964,;,0,1
131965,4,0,0
131966,),0,0
131967,a,0,0
131968,significant,0,0
131969,correlation,0,0
131970,between,0,0
131971,blood,0,0
131972,pressure,0,0
131973,reduction,0,0
131974,and,0,0
131975,blood,0,0
131976,pressure,0,0
131977,before,0,0
131978,drug,0,0
131979,administration,0,0
131980,in,0,0
131981,both,0,0
131982,groups,0,0
131983,;,0,0
131984,a,0,0
131985,significant,0,0
131986,correlation,0,0
131987,between,0,0
131988,pretreatment,0,0
131989,PRA,0,0
131990,and,0,0
131991,antihypertensive,0,0
131992,effect,0,0
131993,in,0,0
131994,the,0,0
131995,SLC,0,0
131996,group,0,0
131997,.,0,0
131998,We,0,0
131999,conclude,0,0
132000,that,0,0
132001,both,0,0
132002,drugs,0,0
132003,are,0,0
132004,effective,0,0
132005,and,0,0
132006,useful,0,0
132007,in,0,0
132008,treating,0,1
132009,hypertensive,1,1
132010,emergencies,1,1
132011,.,1,1
132012,Anyway,0,0
132013,we,0,0
132014,think,0,0
132015,that,0,0
132016,in,0,0
132017,severe,0,1
132018,forms,0,0
132019,SLN,0,0
132020,should,0,0
132021,be,0,0
132022,preferred,0,0
132023,for,0,0
132024,the,0,0
132025,shorter,0,0
132026,time,0,0
132027,preceding,0,0
132028,onset,0,0
132029,of,0,0
132030,action,0,0
132031,.,0,1
132032,Oral,0,0
132033,S-adenosylmethionine,0,0
132034,in,0,0
132035,the,0,0
132036,symptomatic,0,1
132037,treatment,0,0
132038,of,0,0
132039,intrahepatic,1,1
132040,cholestasis,1,1
132041,.,1,0
132042,A,0,0
132043,double-blind,0,0
132044,",",0,0
132045,placebo-controlled,0,0
132046,study,0,0
132047,.,0,1
132048,Parenteral,0,0
132049,S-adenosylmethionine,0,0
132050,proved,0,0
132051,to,0,0
132052,be,0,0
132053,effective,0,0
132054,in,0,0
132055,reversing,0,0
132056,intrahepatic,0,0
132057,cholestasis,0,1
132058,in,0,0
132059,pregnant,0,1
132060,women,0,1
132061,.,0,1
132062,Based,0,0
132063,on,0,0
132064,these,0,0
132065,findings,0,0
132066,",",0,0
132067,a,0,0
132068,prospective,0,0
132069,multicenter,1,0
132070,",",0,0
132071,double-blind,0,0
132072,",",0,0
132073,placebo-controlled,0,0
132074,trial,0,0
132075,was,0,0
132076,planned,0,0
132077,to,0,0
132078,assess,0,0
132079,whether,0,0
132080,oral,0,0
132081,S-adenosylmethionine,0,0
132082,is,0,0
132083,effective,0,0
132084,in,0,0
132085,cholestatic,1,1
132086,patients,1,1
132087,with,1,1
132088,chronic,1,1
132089,liver,1,1
132090,disease,1,1
132091,.,1,0
132092,Accordingly,0,0
132093,",",0,0
132094,220,1,0
132095,inpatients,1,1
132096,(,1,1
132097,26,1,1
132098,%,1,0
132099,chronic,1,1
132100,active,1,1
132101,hepatitis,1,1
132102,",",1,0
132103,68,1,1
132104,%,1,0
132105,cirrhosis,1,1
132106,",",1,0
132107,6,1,0
132108,%,1,0
132109,primary,1,1
132110,biliary,1,1
132111,cirrhosis,1,1
132112,),1,0
132113,with,1,1
132114,stable,1,1
132115,(,1,1
132116,1,1,0
132117,month,1,0
132118,or,1,1
132119,more,1,0
132120,),1,0
132121,at,1,0
132122,least,1,1
132123,twofold,1,0
132124,increases,1,0
132125,in,1,0
132126,serum,1,0
132127,total,1,1
132128,and,1,0
132129,conjugated,1,0
132130,bilirubin,1,0
132131,and,1,0
132132,alkaline,1,0
132133,phosphatase,1,0
132134,volunteered,1,1
132135,for,1,0
132136,the,1,0
132137,trial,1,0
132138,.,1,0
132139,Serum,0,0
132140,markers,0,0
132141,of,0,0
132142,cholestasis,0,1
132143,significantly,0,0
132144,(,0,0
132145,P,0,0
132146,less,0,0
132147,than,0,0
132148,0.01,0,0
132149,),0,0
132150,decreased,0,0
132151,after,0,0
132152,oral,0,0
132153,S-adenosylmethionine,0,0
132154,administration,0,0
132155,(,0,0
132156,1600,0,0
132157,mg/day,0,0
132158,),0,0
132159,",",0,0
132160,and,0,0
132161,their,0,0
132162,values,0,0
132163,were,0,0
132164,significantly,0,0
132165,(,0,0
132166,P,0,0
132167,less,0,0
132168,than,0,0
132169,0.01,0,0
132170,),0,0
132171,lower,0,0
132172,than,0,0
132173,the,0,0
132174,corresponding,0,0
132175,values,0,0
132176,in,0,0
132177,the,0,0
132178,placebo,0,0
132179,group,0,0
132180,.,0,0
132181,S-adenosylmethionine,0,0
132182,significantly,0,0
132183,(,0,0
132184,P,0,0
132185,less,0,0
132186,than,0,0
132187,0.01,0,0
132188,),0,1
132189,improved,0,0
132190,subjective,0,0
132191,symptoms,0,0
132192,such,0,0
132193,as,0,0
132194,pruritus,0,0
132195,",",0,0
132196,fatigue,0,0
132197,",",0,0
132198,and,0,0
132199,feeling,0,0
132200,of,0,0
132201,being,0,0
132202,unwell,0,1
132203,",",0,0
132204,whereas,0,0
132205,placebo,0,0
132206,was,0,0
132207,ineffective,0,0
132208,.,0,1
132209,Two,0,0
132210,patients,0,1
132211,in,0,0
132212,the,0,0
132213,S-adenosylmethionine,0,0
132214,group,0,0
132215,and,0,0
132216,9,0,0
132217,controls,0,1
132218,(,0,1
132219,P,0,0
132220,less,0,0
132221,than,0,0
132222,0.05,0,0
132223,),0,0
132224,withdrew,0,0
132225,from,0,0
132226,the,0,0
132227,trial,0,0
132228,for,0,0
132229,reduced,0,0
132230,compliance,0,0
132231,because,0,0
132232,of,0,0
132233,inefficacy,0,0
132234,of,0,0
132235,treatment,0,0
132236,.,0,1
132237,Oral,0,0
132238,S-adenosylmethionine,0,0
132239,was,0,0
132240,tolerated,0,0
132241,to,0,0
132242,the,0,0
132243,same,0,0
132244,extent,0,0
132245,as,0,0
132246,placebo,0,0
132247,.,0,0
132248,In,0,0
132249,conclusion,0,0
132250,",",0,0
132251,short-term,0,0
132252,administration,0,0
132253,of,0,0
132254,oral,0,0
132255,S-adenosylmethionine,0,0
132256,is,0,0
132257,more,0,0
132258,effective,0,0
132259,than,0,0
132260,placebo,0,0
132261,in,0,0
132262,improving,0,0
132263,clinical,0,0
132264,and,0,1
132265,laboratory,0,0
132266,measures,0,0
132267,of,0,0
132268,intrahepatic,0,1
132269,cholestasis,0,1
132270,and,0,0
132271,offers,0,0
132272,a,0,0
132273,new,0,0
132274,therapeutic,0,0
132275,modality,0,0
132276,for,0,0
132277,the,0,0
132278,symptomatic,0,1
132279,management,0,0
132280,of,0,0
132281,this,0,0
132282,syndrome,0,1
132283,.,0,0
132284,Effect,0,0
132285,of,0,0
132286,an,0,0
132287,induction,0,0
132288,period,0,0
132289,of,0,0
132290,pegylated,0,0
132291,interferon-?2a,0,0
132292,and,0,0
132293,ribavirin,0,1
132294,on,0,0
132295,early,0,0
132296,virological,0,0
132297,response,0,0
132298,in,1,0
132299,HIV-HCV-coinfected,1,1
132300,patients,1,1
132301,:,1,1
132302,results,0,0
132303,from,0,1
132304,the,0,0
132305,CORAL-2,0,0
132306,study,0,0
132307,.,0,0
132308,BACKGROUND,0,0
132309,It,0,0
132310,is,0,0
132311,uncertain,0,0
132312,whether,0,0
132313,a,0,0
132314,4-week,0,0
132315,induction,0,0
132316,period,0,0
132317,of,0,0
132318,pegylated,0,0
132319,interferon,0,0
132320,and,0,0
132321,ribavirin,0,0
132322,increases,0,0
132323,early,0,1
132324,virological,0,0
132325,response,0,0
132326,(,0,0
132327,EVR,0,0
132328,),0,0
132329,in,1,0
132330,HIV-HCV-coinfected,1,0
132331,patients,1,1
132332,.,1,1
132333,METHODS,1,0
132334,HIV,1,1
132335,and,1,0
132336,HCV,1,1
132337,genotype,1,0
132338,1-,1,0
132339,and,1,0
132340,4-coinfected,1,1
132341,subjects,1,1
132342,were,0,1
132343,randomized,0,1
132344,to,0,0
132345,receive,0,0
132346,pegylated,0,0
132347,interferon-?2a,0,0
132348,270,0,1
132349,?g/week,0,0
132350,plus,0,0
132351,ribavirin,0,1
132352,"1,600",0,0
132353,mg,0,0
132354,daily,0,0
132355,and,0,0
132356,epoetin-?,0,0
132357,for,0,0
132358,4,0,0
132359,weeks,0,0
132360,",",0,0
132361,followed,0,0
132362,by,0,0
132363,pegylated,0,0
132364,interferon-?2a,0,0
132365,at,0,0
132366,standard,0,0
132367,dosages,0,0
132368,plus,0,0
132369,weight-based,0,0
132370,ribavirin,0,1
132371,(,0,0
132372,WBR,0,0
132373,),0,0
132374,dosage,0,0
132375,for,0,0
132376,8,0,0
132377,weeks,0,0
132378,(,0,1
132379,induction,0,1
132380,arm,0,0
132381,[,0,0
132382,IA,0,1
132383,],0,1
132384,),0,0
132385,",",0,0
132386,or,0,0
132387,pegylated,0,0
132388,interferon-?2a,0,0
132389,plus,0,0
132390,WBR,0,0
132391,for,0,0
132392,12,0,1
132393,weeks,0,0
132394,(,0,1
132395,standard,0,0
132396,therapy,0,0
132397,arm,0,1
132398,[,0,0
132399,SA,0,1
132400,],0,1
132401,),0,1
132402,.,0,1
132403,HCV,0,0
132404,RNA,0,1
132405,was,0,0
132406,determined,0,0
132407,at,0,0
132408,weeks,0,0
132409,0,0,0
132410,",",0,0
132411,1,0,0
132412,",",0,0
132413,2,0,0
132414,",",0,0
132415,3,0,0
132416,",",0,0
132417,4,0,0
132418,",",0,0
132419,8,0,0
132420,and,0,0
132421,12,0,1
132422,.,0,1
132423,Ribavirin,0,0
132424,plasma,0,0
132425,trough,0,0
132426,concentrations,0,0
132427,were,0,1
132428,determined,0,0
132429,at,0,0
132430,weeks,0,0
132431,4,0,0
132432,(,0,1
132433,RBV-C,0,0
132434,(,0,1
132435,4,0,0
132436,),0,1
132437,),0,0
132438,and,0,0
132439,12,0,0
132440,(,0,0
132441,RBV-C,0,0
132442,(,0,1
132443,12,0,0
132444,),0,1
132445,),0,0
132446,.,0,0
132447,RESULTS,1,0
132448,A,1,0
132449,total,1,1
132450,of,1,0
132451,67,1,1
132452,patients,1,1
132453,were,1,1
132454,included,1,1
132455,;,1,0
132456,33,1,1
132457,in,1,0
132458,the,0,0
132459,SA,0,0
132460,and,0,0
132461,34,0,1
132462,in,0,0
132463,the,0,0
132464,IA,0,1
132465,.,0,0
132466,Overall,0,0
132467,",",0,0
132468,25,0,0
132469,%,0,0
132470,received,0,0
132471,nucleoside,0,0
132472,reverse,0,0
132473,transcriptase,0,0
132474,inhibitor,0,0
132475,(,0,0
132476,NRTI,0,1
132477,),0,0
132478,-sparing,0,0
132479,regimens,0,0
132480,.,0,1
132481,More,0,1
132482,patients,0,1
132483,achieved,0,0
132484,an,0,0
132485,HCV,0,0
132486,RNA,0,1
132487,decrease,0,0
132488,?1,0,1
132489,log,0,0
132490,(,0,0
132491,10,0,0
132492,),0,0
132493,at,0,0
132494,week,0,0
132495,4,0,0
132496,in,0,0
132497,the,0,0
132498,IA,0,1
132499,than,0,0
132500,in,0,0
132501,the,0,0
132502,SA,0,0
132503,(,0,0
132504,62,0,1
132505,%,0,0
132506,versus,0,0
132507,38,0,1
132508,%,0,0
132509,;,0,1
132510,P=0.017,0,0
132511,),0,0
132512,",",0,0
132513,but,0,0
132514,EVR,0,1
132515,rates,0,0
132516,were,0,1
132517,similar,0,0
132518,in,0,0
132519,the,0,0
132520,two,0,0
132521,groups,0,0
132522,(,0,1
132523,74,0,1
132524,%,0,0
132525,versus,0,0
132526,59,0,1
132527,%,0,0
132528,in,0,0
132529,the,0,0
132530,IA,0,1
132531,and,0,0
132532,SA,0,0
132533,",",0,0
132534,respectively,0,0
132535,;,0,0
132536,P=0.15,0,0
132537,),0,0
132538,.,0,1
132539,Independent,0,0
132540,predictors,0,0
132541,of,0,0
132542,faster,0,0
132543,HCV,0,1
132544,RNA,0,1
132545,decrease,0,0
132546,at,0,0
132547,12,0,1
132548,weeks,0,0
132549,were,0,1
132550,higher,0,0
132551,RBV-C,0,0
132552,(,0,0
132553,4,0,0
132554,),0,0
132555,and,0,0
132556,younger,0,1
132557,age,0,1
132558,.,0,0
132559,RBV-C,0,0
132560,(,0,0
132561,4,0,0
132562,),0,0
132563,were,0,0
132564,higher,0,0
132565,in,0,0
132566,patients,0,1
132567,allocated,0,1
132568,in,0,0
132569,the,0,0
132570,IA,0,1
132571,and,0,0
132572,in,0,0
132573,those,0,0
132574,receiving,0,0
132575,NRTIs,0,0
132576,(,0,1
132577,P=0.039,0,0
132578,),0,0
132579,.,0,0
132580,CONCLUSIONS,0,0
132581,A,0,0
132582,4-week,0,0
132583,induction,0,0
132584,with,0,1
132585,pegylated,0,0
132586,interferon-?2a,0,0
132587,plus,0,0
132588,ribavirin,0,1
132589,was,0,0
132590,associated,0,0
132591,with,0,1
132592,a,0,0
132593,greater,0,0
132594,decrease,0,0
132595,in,0,0
132596,HCV,0,1
132597,RNA,0,1
132598,at,0,0
132599,week,0,0
132600,4,0,0
132601,;,0,0
132602,however,0,0
132603,",",0,0
132604,this,0,0
132605,did,0,0
132606,not,0,0
132607,translate,0,0
132608,into,0,0
132609,higher,0,0
132610,EVR,0,1
132611,rates,0,0
132612,.,0,1
132613,Higher,0,0
132614,RBV,0,0
132615,doses,0,0
132616,and,0,0
132617,avoidance,0,0
132618,of,0,0
132619,NRTI-sparing,0,1
132620,antiretroviral,0,1
132621,regimens,0,0
132622,might,0,0
132623,improve,0,0
132624,HCV,0,0
132625,treatment,0,0
132626,efficacy,0,0
132627,.,0,1
132628,Functional,0,0
132629,outcome,0,0
132630,following,0,0
132631,intramedullary,0,0
132632,nailing,0,1
132633,of,0,0
132634,the,0,0
132635,femur,0,1
132636,:,0,1
132637,a,0,0
132638,prospective,0,0
132639,randomized,0,0
132640,comparison,0,0
132641,of,0,0
132642,piriformis,0,0
132643,fossa,0,1
132644,and,0,0
132645,greater,0,0
132646,trochanteric,0,1
132647,entry,0,1
132648,portals,0,0
132649,.,0,1
132650,BACKGROUND,0,0
132651,The,0,0
132652,purpose,0,0
132653,of,0,0
132654,the,0,0
132655,study,0,0
132656,was,0,0
132657,to,0,0
132658,prospectively,0,0
132659,compare,0,0
132660,the,0,0
132661,functional,0,0
132662,outcome,0,0
132663,of,0,0
132664,intramedullary,0,1
132665,nailing,0,1
132666,of,0,0
132667,the,0,0
132668,femur,0,0
132669,performed,0,0
132670,with,0,1
132671,use,0,0
132672,of,0,0
132673,a,0,0
132674,trochanteric,0,1
132675,and,0,0
132676,a,0,0
132677,piriformis,0,0
132678,fossa,0,1
132679,entry,0,0
132680,portal,0,0
132681,.,0,1
132682,METHODS,0,0
132683,One,1,1
132684,hundred,1,1
132685,and,1,1
132686,ten,1,1
132687,patients,1,1
132688,with,1,1
132689,a,1,0
132690,femoral,1,1
132691,shaft,1,1
132692,fracture,1,1
132693,were,1,0
132694,enrolled,1,1
132695,in,1,0
132696,a,1,0
132697,prospective,1,0
132698,",",1,0
132699,randomized,1,0
132700,study,1,0
132701,.,1,1
132702,Fifty-four,1,1
132703,patients,1,1
132704,were,0,1
132705,randomized,0,1
132706,to,0,0
132707,Group,0,1
132708,A,0,0
132709,(,0,0
132710,piriformis,0,0
132711,fossa,0,1
132712,portal,0,0
132713,),0,0
132714,and,0,0
132715,fifty-six,1,1
132716,to,0,0
132717,Group,0,1
132718,B,0,1
132719,(,0,0
132720,trochanteric,0,1
132721,portal,0,0
132722,),0,0
132723,.,0,1
132724,Outcome,0,0
132725,measures,0,0
132726,included,0,1
132727,the,0,0
132728,Western,0,1
132729,Ontario,0,1
132730,and,0,0
132731,McMaster,0,1
132732,Universities,0,1
132733,(,0,0
132734,WOMAC,0,0
132735,),0,1
132736,Osteoarthritis,0,1
132737,Index,0,0
132738,hip,0,1
132739,function,0,0
132740,score,0,0
132741,",",0,0
132742,pain,0,0
132743,",",0,0
132744,and,0,0
132745,blinded,0,0
132746,functional,0,0
132747,evaluation,0,0
132748,by,0,0
132749,a,0,0
132750,physical,0,0
132751,therapist,0,0
132752,.,0,1
132753,RESULTS,0,0
132754,Most,0,0
132755,measures,0,0
132756,of,0,0
132757,hip,0,1
132758,function,0,0
132759,did,0,0
132760,not,0,0
132761,differ,0,0
132762,between,0,0
132763,the,0,0
132764,two,0,0
132765,groups,0,0
132766,.,0,1
132767,The,0,0
132768,WOMAC,0,0
132769,score,0,0
132770,at,0,0
132771,three,0,0
132772,",",0,0
132773,six,0,0
132774,",",0,0
132775,and,0,0
132776,twelve,0,1
132777,months,0,0
132778,did,0,0
132779,not,0,0
132780,differ,0,0
132781,significantly,0,0
132782,between,0,0
132783,the,0,0
132784,piriformis,0,0
132785,fossa,0,1
132786,and,0,0
132787,trochanteric,0,1
132788,nailing,0,1
132789,groups,0,0
132790,.,0,1
132791,Functional,0,0
132792,tests,0,0
132793,included,0,1
132794,the,0,0
132795,chair,0,0
132796,stand,0,0
132797,test,0,0
132798,and,0,0
132799,the,0,0
132800,timed,0,0
132801,up,0,0
132802,and,0,0
132803,go,0,0
132804,test,0,0
132805,.,0,0
132806,Patients,0,1
132807,in,0,0
132808,Group,0,1
132809,B,0,1
132810,had,0,0
132811,significantly,0,0
132812,better,0,0
132813,scores,0,0
132814,on,0,0
132815,the,0,0
132816,chair,0,0
132817,stand,0,0
132818,test,0,0
132819,(,0,0
132820,13.3,0,0
132821,compared,0,0
132822,with,0,1
132823,11.1,0,0
132824,in,0,0
132825,Group,0,1
132826,A,0,0
132827,",",0,0
132828,p,0,0
132829,=,0,0
132830,0.04,0,0
132831,),0,0
132832,at,0,0
132833,six,0,1
132834,months,0,0
132835,postoperatively,0,0
132836,",",0,0
132837,but,0,0
132838,there,0,0
132839,was,0,0
132840,no,0,0
132841,difference,0,0
132842,at,0,0
132843,twelve,0,1
132844,months,0,0
132845,(,0,1
132846,14.0,0,0
132847,compared,0,0
132848,with,0,1
132849,13.6,0,0
132850,),0,1
132851,.,0,1
132852,The,0,0
132853,two,0,0
132854,groups,0,0
132855,did,0,0
132856,not,0,0
132857,differ,0,0
132858,significantly,0,0
132859,on,0,0
132860,the,0,0
132861,timed,0,0
132862,up,0,0
132863,and,0,0
132864,go,0,0
132865,test,0,0
132866,at,0,0
132867,either,0,0
132868,six,0,0
132869,or,0,0
132870,twelve,0,1
132871,months,0,0
132872,.,0,1
132873,The,0,0
132874,two,0,0
132875,groups,0,0
132876,also,0,0
132877,did,0,0
132878,not,0,0
132879,differ,0,0
132880,on,0,0
132881,the,0,0
132882,muscle,0,0
132883,strength,0,0
132884,testing,0,0
132885,.,0,1
132886,Intraoperative,0,0
132887,parameters,0,0
132888,differed,0,0
132889,significantly,0,0
132890,between,0,0
132891,the,0,0
132892,groups,0,0
132893,with,0,1
132894,respect,0,0
132895,to,0,0
132896,operative,0,0
132897,time,0,0
132898,",",0,0
132899,fluoroscopy,0,0
132900,time,0,0
132901,",",0,0
132902,and,0,0
132903,incision,0,0
132904,length,0,0
132905,",",0,0
132906,with,0,0
132907,the,0,0
132908,difference,0,0
132909,favoring,0,0
132910,Group,0,1
132911,B,0,1
132912,for,0,0
132913,each,0,0
132914,parameter,0,0
132915,.,0,0
132916,Analog,0,0
132917,pain,0,1
132918,scale,0,0
132919,values,0,0
132920,were,0,1
132921,similar,0,0
132922,in,0,0
132923,Group,0,1
132924,A,0,1
132925,(,0,1
132926,2.49,0,0
132927,),0,0
132928,and,0,0
132929,Group,0,1
132930,B,0,1
132931,(,0,1
132932,2.15,0,0
132933,),0,0
132934,at,0,0
132935,twelve,0,1
132936,months,0,0
132937,postoperatively,0,0
132938,.,0,1
132939,CONCLUSIONS,0,0
132940,Patients,0,1
132941,in,0,1
132942,our,0,1
132943,prospective,0,0
132944,randomized,0,1
132945,study,0,1
132946,who,0,1
132947,were,0,1
132948,treated,0,1
132949,with,0,1
132950,trochanteric,0,1
132951,nailing,0,1
132952,did,0,0
132953,not,0,0
132954,differ,0,0
132955,in,0,0
132956,hip,0,1
132957,function,0,0
132958,at,0,0
132959,one,0,0
132960,year,0,0
132961,postoperatively,0,0
132962,compared,0,0
132963,with,0,1
132964,patients,0,1
132965,treated,0,1
132966,with,0,1
132967,intramedullary,0,1
132968,nailing,0,1
132969,through,0,0
132970,the,0,0
132971,piriformis,0,0
132972,fossa,0,1
132973,.,0,0
132974,The,0,0
132975,values,0,0
132976,of,0,0
132977,several,0,0
132978,intraoperative,0,0
132979,parameters,0,0
132980,were,0,0
132981,significantly,0,0
132982,better,0,0
132983,in,0,0
132984,the,0,0
132985,trochanteric,0,1
132986,nailing,0,1
132987,group,0,0
132988,.,0,0
132989,Our,0,0
132990,data,0,0
132991,indicate,0,0
132992,that,0,0
132993,the,0,0
132994,functional,0,0
132995,hip,0,1
132996,outcome,0,0
132997,of,0,0
132998,femoral,0,1
132999,intramedullary,0,1
133000,nailing,0,1
133001,performed,0,0
133002,through,0,0
133003,the,0,0
133004,greater,0,0
133005,trochanter,0,0
133006,is,0,0
133007,equal,0,0
133008,to,0,0
133009,that,0,0
133010,of,0,0
133011,intramedullary,0,1
133012,nailing,0,1
133013,performed,0,0
133014,through,0,0
133015,the,0,0
133016,piriformis,0,0
133017,fossa,0,1
133018,.,0,1
133019,Social,0,0
133020,skills,0,0
133021,training,0,0
133022,for,0,0
133023,young,1,1
133024,adults,1,1
133025,with,1,1
133026,high-functioning,1,1
133027,autism,1,1
133028,spectrum,1,1
133029,disorders,1,1
133030,:,1,1
133031,a,0,0
133032,randomized,0,0
133033,controlled,0,0
133034,pilot,0,0
133035,study,0,0
133036,.,0,0
133037,Despite,0,0
133038,the,0,0
133039,psychosocial,0,1
133040,difficulties,0,0
133041,common,0,1
133042,among,0,1
133043,young,1,1
133044,adults,1,1
133045,with,1,1
133046,autism,1,1
133047,spectrum,1,1
133048,disorders,1,1
133049,(,1,1
133050,ASD,1,1
133051,),1,0
133052,",",0,0
133053,little,0,0
133054,to,0,0
133055,no,0,0
133056,evidence-based,0,0
133057,social,0,0
133058,skills,0,0
133059,interventions,0,0
133060,exist,0,0
133061,for,0,0
133062,this,0,0
133063,population,0,1
133064,.,0,0
133065,Using,0,0
133066,a,0,0
133067,randomized,0,0
133068,controlled,0,0
133069,trial,0,0
133070,(,0,0
133071,RCT,0,0
133072,),0,0
133073,design,0,0
133074,",",0,0
133075,the,0,0
133076,current,0,0
133077,study,0,0
133078,tested,0,0
133079,the,0,0
133080,effectiveness,0,0
133081,of,0,0
133082,an,0,0
133083,evidence-based,0,0
133084,",",0,0
133085,caregiver-assisted,0,0
133086,social,0,0
133087,skills,0,0
133088,intervention,0,0
133089,known,0,0
133090,as,0,0
133091,PEERS,0,0
133092,for,0,0
133093,Young,0,1
133094,Adults,0,1
133095,with,0,1
133096,high-functioning,1,1
133097,young,1,1
133098,adults,1,1
133099,with,1,1
133100,ASD,1,1
133101,(,1,0
133102,ages,1,1
133103,18-23,1,1
133104,),1,0
133105,using,0,0
133106,self-,0,0
133107,and,0,1
133108,caregiver-report,0,0
133109,measures,0,0
133110,.,0,1
133111,Results,0,0
133112,revealed,0,0
133113,that,0,0
133114,treated,0,1
133115,young,1,1
133116,adults,1,1
133117,reported,0,0
133118,significantly,0,0
133119,less,0,0
133120,loneliness,0,0
133121,and,0,0
133122,improved,0,0
133123,social,0,0
133124,skills,0,0
133125,knowledge,0,0
133126,",",0,0
133127,while,0,0
133128,caregivers,0,1
133129,reported,0,1
133130,significant,0,0
133131,improvements,0,0
133132,in,0,1
133133,young,1,1
133134,adults,1,1
133135,',1,1
133136,overall,0,0
133137,social,0,1
133138,skills,0,0
133139,",",0,0
133140,social,0,0
133141,responsiveness,0,0
133142,",",0,0
133143,empathy,0,0
133144,",",0,0
133145,and,0,0
133146,frequency,0,0
133147,of,0,0
133148,get-togethers,0,1
133149,.,0,1
133150,Results,0,0
133151,support,0,0
133152,the,0,0
133153,effectiveness,0,0
133154,of,0,0
133155,using,0,0
133156,this,0,0
133157,caregiver-assisted,0,0
133158,",",0,0
133159,manualized,0,0
133160,intervention,0,0
133161,for,0,0
133162,young,1,1
133163,adults,1,1
133164,with,1,1
133165,ASD,1,1
133166,.,1,1
133167,[,0,0
133168,The,0,0
133169,equipotency,0,0
133170,of,0,0
133171,ropivacaine,0,0
133172,",",0,0
133173,bupivacaine,0,0
133174,and,0,0
133175,etidocaine,0,0
133176,],0,0
133177,.,0,0
133178,Ropivacaine,0,0
133179,",",0,0
133180,congenerate,0,0
133181,to,0,0
133182,bupivacaine,0,0
133183,and,0,0
133184,mepivacaine,0,0
133185,has,0,0
133186,been,0,0
133187,widely,0,0
133188,studied,0,0
133189,in,0,0
133190,laboratory,0,0
133191,animals,0,0
133192,",",0,0
133193,but,0,0
133194,there,0,0
133195,have,0,0
133196,been,0,0
133197,few,0,0
133198,investigations,0,0
133199,of,0,0
133200,its,0,0
133201,efficacy,0,0
133202,in,0,0
133203,human,0,1
133204,epidural,0,0
133205,anesthesia,0,1
133206,and,0,0
133207,peripheral,0,0
133208,nerve,0,0
133209,blocks,0,0
133210,.,0,0
133211,The,0,0
133212,aim,0,0
133213,of,0,0
133214,this,0,0
133215,study,0,0
133216,was,0,0
133217,to,0,0
133218,compare,0,0
133219,the,0,0
133220,three,0,0
133221,long-acting,0,0
133222,local,0,0
133223,anesthetics,0,0
133224,(,0,1
133225,bupivacaine,0,0
133226,0.75,0,0
133227,%,0,0
133228,",",0,0
133229,ropivacaine,0,0
133230,1,0,0
133231,%,0,0
133232,and,0,0
133233,etidocaine,0,0
133234,1,0,0
133235,%,0,0
133236,),0,0
133237,and,0,0
133238,to,0,0
133239,try,0,0
133240,",",0,0
133241,with,0,0
133242,reference,0,0
133243,to,0,0
133244,previous,0,0
133245,studies,0,0
133246,",",0,0
133247,to,0,0
133248,make,0,0
133249,some,0,0
133250,statement,0,0
133251,about,0,0
133252,the,0,0
133253,equipotency,0,0
133254,of,0,0
133255,ropivacaine,0,0
133256,relative,0,0
133257,to,0,0
133258,bupivacaine,0,0
133259,and,0,0
133260,etidocaine,0,0
133261,.,0,1
133262,METHODS,0,0
133263,.,0,0
133264,In,0,0
133265,a,0,0
133266,double,0,0
133267,blind,0,0
133268,randomized,0,0
133269,study,0,0
133270,",",0,0
133271,epidural,0,0
133272,anesthesia,0,0
133273,was,0,0
133274,carried,0,0
133275,out,0,0
133276,with,0,1
133277,20,0,1
133278,ml,0,0
133279,bupivacaine,0,0
133280,0.75,0,0
133281,%,0,0
133282,(,0,0
133283,n,0,1
133284,=,0,0
133285,24,0,1
133286,),0,0
133287,and,0,0
133288,ropivacaine,0,0
133289,1,0,0
133290,%,0,0
133291,(,0,0
133292,n,0,1
133293,=,0,0
133294,21,0,1
133295,),0,0
133296,.,0,0
133297,Following,0,0
133298,this,0,0
133299,study,0,0
133300,epidural,0,0
133301,anesthesia,0,1
133302,was,0,0
133303,carried,0,0
133304,out,0,0
133305,with,0,1
133306,20,0,1
133307,ml,0,0
133308,etidocaine,0,0
133309,1,0,0
133310,%,0,0
133311,(,0,0
133312,n,0,1
133313,=,0,0
133314,20,0,1
133315,),0,0
133316,in,0,0
133317,an,0,0
133318,open,0,1
133319,study,0,0
133320,.,0,1
133321,Patients,1,1
133322,with,1,1
133323,ASA,1,1
133324,I,1,1
133325,or,1,1
133326,II,1,1
133327,were,1,0
133328,enrolled,1,1
133329,in,1,0
133330,the,1,0
133331,study,1,0
133332,.,1,0
133333,All,1,0
133334,patients,1,1
133335,were,1,0
133336,scheduled,1,1
133337,for,1,0
133338,varicose,1,0
133339,vein,1,1
133340,stripping,1,0
133341,.,1,0
133342,Male,1,0
133343,and,1,0
133344,female,1,1
133345,patients,1,1
133346,aged,1,1
133347,18-70,1,1
133348,years,1,1
133349,and,1,1
133350,weighing,1,1
133351,50-100,1,0
133352,kg,1,1
133353,were,1,1
133354,included,1,1
133355,in,1,0
133356,the,1,0
133357,study,1,0
133358,.,1,0
133359,Patients,0,1
133360,were,0,0
133361,all,0,0
133362,placed,0,0
133363,in,0,0
133364,a,0,0
133365,sitting,0,0
133366,position,0,0
133367,",",0,0
133368,after,0,0
133369,which,0,0
133370,the,0,0
133371,epidural,0,0
133372,space,0,0
133373,was,0,0
133374,identified,0,0
133375,by,0,0
133376,the,0,0
133377,loss,0,0
133378,of,0,0
133379,resistance,0,0
133380,technique,0,0
133381,and,0,0
133382,a,0,0
133383,midline,0,0
133384,approach,0,0
133385,",",0,0
133386,at,0,0
133387,the,0,0
133388,L-3/4,0,0
133389,interspace,0,0
133390,.,0,1
133391,Injections,0,0
133392,of,0,0
133393,3,0,0
133394,ml,0,0
133395,of,0,0
133396,the,0,0
133397,local,0,0
133398,anesthetic,0,0
133399,were,0,0
133400,given,0,0
133401,",",0,0
133402,followed,0,0
133403,by,0,0
133404,the,0,0
133405,remainder,0,0
133406,of,0,0
133407,the,0,0
133408,local,0,0
133409,anesthetic,0,0
133410,at,0,0
133411,10,0,1
133412,ml/min,0,0
133413,1,0,0
133414,min,0,0
133415,later,0,0
133416,.,0,0
133417,Following,0,0
133418,injection,0,0
133419,patients,0,1
133420,were,0,0
133421,immediately,0,0
133422,positioned,0,0
133423,supine,0,0
133424,.,0,1
133425,Analgesia,0,0
133426,was,0,0
133427,determined,0,0
133428,by,0,0
133429,the,0,0
133430,pin-prick,0,0
133431,method,0,0
133432,and,0,0
133433,motor,0,0
133434,blockade,0,0
133435,was,0,0
133436,assessed,0,0
133437,according,0,0
133438,to,0,0
133439,the,0,0
133440,Bromage,0,0
133441,scale,0,0
133442,.,0,0
133443,Heart,0,0
133444,rate,0,0
133445,and,0,0
133446,blood,0,0
133447,pressure,0,0
133448,were,0,0
133449,monitored,0,0
133450,until,0,0
133451,3,0,0
133452,h,0,0
133453,after,0,0
133454,injection,0,0
133455,.,0,1
133456,RESULTS,0,0
133457,.,0,0
133458,The,0,0
133459,latency,0,0
133460,of,0,0
133461,analgesia,0,0
133462,for,0,0
133463,the,0,0
133464,first,0,0
133465,blocked,0,0
133466,segment,0,0
133467,(,0,0
133468,T,0,1
133469,12,0,0
133470,for,0,0
133471,bupivacaine,0,0
133472,and,0,0
133473,ropivacaine,0,0
133474,and,0,0
133475,L-1,0,1
133476,for,0,0
133477,etidocaine,0,0
133478,),0,0
133479,was,0,0
133480,6.0,0,0
133481,min,0,0
133482,for,0,0
133483,bupivacaine,0,0
133484,0.75,0,0
133485,",",0,0
133486,5.5,0,0
133487,min,0,0
133488,for,0,0
133489,ropivacaine,0,0
133490,1,0,0
133491,%,0,0
133492,",",0,0
133493,and,0,0
133494,5.2,0,0
133495,min,0,0
133496,for,0,0
133497,etidocaine,0,0
133498,1,0,0
133499,%,0,0
133500,",",0,0
133501,and,0,0
133502,the,0,0
133503,highest,0,0
133504,thoracic,0,1
133505,dermatome,0,0
133506,(,0,1
133507,T,0,1
133508,5,0,0
133509,for,0,0
133510,bupivacaine,0,0
133511,",",0,0
133512,T,0,0
133513,4,0,0
133514,for,0,0
133515,ropivacaine,0,0
133516,and,0,0
133517,T,0,1
133518,7,0,0
133519,for,0,0
133520,etidocaine,0,0
133521,),0,0
133522,was,0,0
133523,reached,0,0
133524,after,0,0
133525,24,0,1
133526,+/-,0,0
133527,10,0,1
133528,",",0,0
133529,26,0,1
133530,+/-,0,0
133531,9,0,0
133532,",",0,0
133533,and,0,0
133534,30,0,1
133535,+/-,0,0
133536,18,0,1
133537,min,0,0
133538,for,0,0
133539,bupivacaine,0,0
133540,",",0,0
133541,ropivacaine,0,0
133542,",",0,0
133543,and,0,0
133544,etidocaine,0,0
133545,",",0,0
133546,respectively,0,0
133547,.,0,0
133548,The,0,0
133549,duration,0,0
133550,of,0,0
133551,sensory,0,0
133552,anesthesia,0,1
133553,at,0,0
133554,the,0,0
133555,T,0,1
133556,10,0,0
133557,dermatomal,0,0
133558,level,0,0
133559,was,0,0
133560,257,0,1
133561,+/-,0,0
133562,102,0,1
133563,",",0,0
133564,278,0,1
133565,+/-,0,0
133566,67,0,1
133567,",",0,0
133568,and,0,0
133569,191,0,1
133570,+/-,0,0
133571,86,0,1
133572,min,0,0
133573,for,0,0
133574,bupivacaine,0,0
133575,",",0,0
133576,ropivacaine,0,0
133577,",",0,0
133578,and,0,0
133579,etidocaine,0,0
133580,",",0,0
133581,respectively,0,0
133582,.,0,0
133583,The,0,0
133584,two-segment,0,0
133585,regression,0,0
133586,time,0,0
133587,was,0,0
133588,199,0,1
133589,+/-,0,0
133590,80,0,1
133591,min,0,0
133592,for,0,0
133593,bupivacaine,0,0
133594,",",0,0
133595,201,0,1
133596,+/-,0,0
133597,52,0,1
133598,min,0,0
133599,for,0,0
133600,ropivacaine,0,0
133601,",",0,0
133602,and,0,0
133603,174,0,1
133604,+/-,0,0
133605,81,0,1
133606,min,0,0
133607,for,0,0
133608,etidocaine,0,0
133609,.,0,0
133610,The,0,0
133611,total,0,0
133612,duration,0,0
133613,of,0,0
133614,sensory,0,0
133615,block,0,0
133616,was,0,0
133617,340,0,1
133618,+/-,0,0
133619,103,0,1
133620,min,0,0
133621,for,0,0
133622,bupivacaine,0,0
133623,",",0,0
133624,428,0,1
133625,+/-,0,0
133626,65,0,1
133627,min,0,0
133628,for,0,0
133629,ropivacaine,0,0
133630,and,0,0
133631,223,0,1
133632,+/-,0,0
133633,62,0,1
133634,min,0,0
133635,for,0,0
133636,etidocaine,0,0
133637,",",0,0
133638,respectively,0,0
133639,.,0,0
133640,In,0,0
133641,the,0,0
133642,ropivacaine,0,0
133643,and,0,0
133644,bupivacaine,0,0
133645,groups,0,0
133646,sensory,0,1
133647,anesthesia,0,1
133648,was,0,0
133649,considered,0,0
133650,adequate,0,0
133651,for,0,0
133652,surgery,0,1
133653,in,0,0
133654,all,0,0
133655,cases,0,1
133656,but,0,0
133657,one,0,1
133658,in,0,0
133659,each,0,1
133660,group,0,0
133661,;,0,0
133662,in,0,0
133663,the,0,0
133664,etidocaine,0,0
133665,group,0,0
133666,",",0,0
133667,however,0,0
133668,60,0,1
133669,%,0,0
133670,of,0,0
133671,the,0,0
133672,patients,0,1
133673,showed,0,0
133674,inadequate,0,1
133675,analgesia,0,0
133676,and,0,0
133677,all,0,0
133678,these,0,0
133679,patients,0,1
133680,(,0,0
133681,12/20,0,0
133682,),0,0
133683,required,0,0
133684,additional,0,0
133685,analgesics,0,0
133686,.,0,1
133687,Bupivacaine,0,0
133688,achieved,0,0
133689,an,0,0
133690,average,0,0
133691,of,0,0
133692,motor,0,0
133693,block,0,0
133694,2.1,0,0
133695,",",0,0
133696,ropivacaine,0,0
133697,2.3,0,0
133698,",",0,0
133699,and,0,0
133700,etidocaine,0,0
133701,2.4,0,0
133702,.,0,1
133703,CONCLUSION,0,0
133704,.,0,0
133705,The,0,0
133706,results,0,0
133707,of,0,0
133708,this,0,0
133709,study,0,0
133710,indicate,0,0
133711,that,0,0
133712,ropivacaine,0,0
133713,is,0,0
133714,an,0,0
133715,effective,0,0
133716,local,0,0
133717,anesthetic,0,0
133718,agent,0,0
133719,.,0,0
133720,Its,0,0
133721,potency,0,0
133722,is,0,0
133723,about,0,0
133724,equal,0,0
133725,to,0,0
133726,that,0,0
133727,of,0,0
133728,bupivacaine,0,0
133729,and,0,0
133730,much,0,0
133731,higher,0,0
133732,than,0,0
133733,that,0,0
133734,of,0,0
133735,etidocaine,0,0
133736,...,0,0
133737,Learning,0,0
133738,through,0,0
133739,interaction,0,0
133740,in,0,0
133741,children,1,1
133742,with,1,1
133743,autism,1,1
133744,:,1,1
133745,preliminary,0,0
133746,data,0,0
133747,from,0,1
133748,asocial-communication-based,0,1
133749,intervention,0,0
133750,.,0,0
133751,The,0,0
133752,study,0,0
133753,evaluates,0,0
133754,a,0,0
133755,social-communication-based,0,0
133756,approach,0,0
133757,to,0,0
133758,autism,0,1
133759,intervention,0,0
133760,aimed,0,0
133761,at,0,0
133762,improving,0,0
133763,the,0,0
133764,social,0,0
133765,interaction,0,0
133766,skills,0,0
133767,of,0,0
133768,children,1,1
133769,with,1,1
133770,autism,1,1
133771,spectrum,1,1
133772,disorder,1,1
133773,.,1,0
133774,We,0,0
133775,report,0,0
133776,preliminary,0,0
133777,results,0,0
133778,from,0,1
133779,an,0,0
133780,ongoing,0,0
133781,randomized,0,0
133782,controlled,0,0
133783,trial,0,0
133784,of,0,0
133785,51,1,1
133786,children,1,1
133787,aged,1,1
133788,2,1,1
133789,years,1,1
133790,0,1,0
133791,months,1,1
133792,to,1,1
133793,4,1,1
133794,years,1,1
133795,11,1,1
133796,months,1,1
133797,.,1,1
133798,Participants,0,1
133799,were,0,0
133800,assigned,0,1
133801,to,0,0
133802,either,0,0
133803,a,0,0
133804,target,0,0
133805,treatment,0,0
133806,or,0,0
133807,community,0,0
133808,treatment,0,0
133809,group,0,0
133810,.,0,0
133811,Families,0,0
133812,in,0,0
133813,the,0,0
133814,target,0,0
133815,treatment,0,0
133816,group,0,0
133817,were,0,0
133818,given,0,0
133819,2,0,0
133820,hours,0,0
133821,of,0,0
133822,therapy,0,0
133823,and,0,0
133824,coaching,0,0
133825,each,0,0
133826,week,0,0
133827,in,0,0
133828,an,0,0
133829,intervention,0,0
133830,emphasizing,0,0
133831,social-interaction,0,0
133832,and,0,0
133833,the,0,0
133834,parent-child,0,0
133835,relationship,0,0
133836,.,0,0
133837,Children,0,1
133838,in,0,0
133839,the,0,0
133840,community,0,0
133841,treatment,0,0
133842,group,0,0
133843,received,0,0
133844,a,0,0
133845,variety,0,0
133846,of,0,0
133847,services,0,1
133848,averaging,0,1
133849,3.9,0,0
133850,hours,0,0
133851,per,0,1
133852,week,0,0
133853,.,0,1
133854,After,0,0
133855,12,0,0
133856,months,0,0
133857,",",0,1
133858,outcomes,0,0
133859,were,0,0
133860,measured,0,0
133861,to,0,0
133862,determine,0,0
133863,changes,0,0
133864,in,0,0
133865,the,0,0
133866,groups,0,0
133867,in,0,0
133868,social,0,0
133869,interaction,0,0
133870,and,0,0
133871,communication,0,0
133872,.,0,0
133873,In,0,0
133874,addition,0,0
133875,",",0,0
133876,a,0,0
133877,regression,0,0
133878,analysis,0,0
133879,was,0,0
133880,conducted,0,0
133881,to,0,0
133882,determine,0,0
133883,whether,0,0
133884,changes,0,0
133885,in,0,0
133886,social,0,1
133887,interaction,0,0
133888,skills,0,0
133889,were,0,0
133890,associated,0,0
133891,with,0,1
133892,language,0,0
133893,development,0,0
133894,.,0,1
133895,Results,0,0
133896,suggest,0,0
133897,that,0,0
133898,children,0,1
133899,in,0,0
133900,the,0,0
133901,treatment,0,0
133902,group,0,0
133903,made,0,0
133904,significantly,0,0
133905,greater,0,0
133906,gains,0,0
133907,in,0,0
133908,social,0,1
133909,interaction,0,0
133910,skills,0,0
133911,in,0,0
133912,comparison,0,0
133913,to,0,0
133914,the,0,0
133915,community,0,0
133916,treatment,0,0
133917,group,0,0
133918,",",0,0
133919,but,0,0
133920,no,0,0
133921,between-group,0,0
133922,differences,0,0
133923,were,0,1
133924,found,0,0
133925,for,0,0
133926,standard,0,0
133927,language,0,1
133928,assessments,0,0
133929,.,0,1
133930,Initiation,0,0
133931,of,0,0
133932,joint,0,0
133933,attention,0,0
133934,",",0,0
133935,involvement,0,0
133936,",",0,0
133937,and,0,0
133938,severity,0,0
133939,of,0,0
133940,language,0,0
133941,delay,0,0
133942,were,0,0
133943,found,0,0
133944,to,0,0
133945,be,0,0
133946,significantly,0,0
133947,associated,0,0
133948,with,0,0
133949,improvement,0,0
133950,of,0,0
133951,language,0,0
133952,skills,0,0
133953,in,0,0
133954,children,1,1
133955,with,1,1
133956,autism,1,1
133957,.,1,0
133958,Finally,0,0
133959,caregiver,0,0
133960,skills,0,0
133961,targeted,0,0
133962,by,0,0
133963,the,0,0
133964,intervention,0,0
133965,were,0,0
133966,found,0,0
133967,to,0,0
133968,be,0,0
133969,significantly,0,0
133970,associated,0,0
133971,with,0,1
133972,changes,0,0
133973,in,0,1
133974,children,1,1
133975,'s,1,1
133976,interaction,0,1
133977,skills,0,0
133978,.,0,1
133979,A,0,0
133980,controlled,0,0
133981,crossover,0,0
133982,trial,0,0
133983,of,0,0
133984,fenfluramine,0,0
133985,in,0,0
133986,autism,1,1
133987,.,1,0
133988,We,0,0
133989,report,0,0
133990,a,0,0
133991,12,0,0
133992,month,0,0
133993,double-blind,0,0
133994,randomized,0,1
133995,crossover,0,0
133996,trial,0,0
133997,of,0,0
133998,fenfluramine,0,0
133999,in,0,0
134000,20,1,1
134001,children,1,1
134002,with,1,1
134003,the,1,0
134004,syndrome,1,1
134005,of,1,0
134006,autism,1,1
134007,.,1,1
134008,On,0,0
134009,active,0,0
134010,drug,0,0
134011,most,0,0
134012,of,0,0
134013,the,0,0
134014,children,1,1
134015,lost,0,0
134016,weight,0,0
134017,and,0,0
134018,blood,0,0
134019,serotonin,0,0
134020,levels,0,0
134021,fell,0,0
134022,by,0,0
134023,an,0,0
134024,average,0,0
134025,of,0,0
134026,60,0,1
134027,%,0,0
134028,.,0,0
134029,There,0,0
134030,was,0,0
134031,a,0,0
134032,fall,0,0
134033,in,0,0
134034,urinary,0,0
134035,dopamine,0,0
134036,(,0,0
134037,DA,0,0
134038,),0,0
134039,and,0,0
134040,noradrenaline,0,0
134041,(,0,0
134042,NA,0,1
134043,),0,1
134044,levels,0,0
134045,and,0,1
134046,increased,0,0
134047,excretion,0,0
134048,of,0,0
134049,homovanillic,0,0
134050,acid,0,0
134051,(,0,0
134052,HVA,0,0
134053,),0,0
134054,.,0,0
134055,Some,0,0
134056,of,0,0
134057,the,0,0
134058,children,1,1
134059,showed,0,0
134060,improvement,0,0
134061,in,0,0
134062,tests,0,0
134063,of,0,0
134064,cognitive,0,1
134065,and,0,0
134066,language,0,0
134067,function,0,0
134068,",",0,0
134069,although,0,0
134070,the,0,0
134071,results,0,0
134072,did,0,0
134073,not,0,0
134074,achieve,0,0
134075,overall,0,0
134076,statistical,0,0
134077,significance,0,0
134078,.,0,1
134079,Event-related,0,0
134080,brain,0,0
134081,potentials,0,0
134082,(,0,1
134083,ERPs,0,0
134084,),0,0
134085,were,0,0
134086,obtained,0,0
134087,in,0,0
134088,seven,0,1
134089,subjects,0,1
134090,on,0,0
134091,an,0,0
134092,auditory,0,0
134093,choice,0,0
134094,reaction,0,0
134095,time,0,0
134096,task,0,0
134097,.,0,1
134098,Side,0,0
134099,effects,0,0
134100,of,0,0
134101,the,0,0
134102,drug,0,0
134103,included,0,0
134104,irritability,0,0
134105,and,0,0
134106,lethargy,0,1
134107,.,0,0
134108,Fenfluramine,0,0
134109,may,0,0
134110,have,0,0
134111,a,0,0
134112,limited,0,0
134113,place,0,0
134114,in,0,0
134115,the,0,0
134116,management,0,0
134117,of,0,0
134118,some,0,0
134119,patients,1,1
134120,with,1,1
134121,autistic,1,1
134122,disorder,1,1
134123,.,1,1
134124,The,0,0
134125,effectiveness,0,0
134126,and,0,0
134127,cost,0,0
134128,of,0,0
134129,passive,0,0
134130,warming,0,0
134131,in,0,0
134132,adult,1,1
134133,ambulatory,1,1
134134,surgery,1,1
134135,patients,1,1
134136,.,1,0
134137,Hypothermia,0,0
134138,is,0,0
134139,a,0,0
134140,common,0,0
134141,problem,0,0
134142,for,0,0
134143,surgical,1,1
134144,patients,1,1
134145,and,0,0
134146,can,0,0
134147,result,0,0
134148,in,0,0
134149,many,0,0
134150,complications,0,0
134151,.,0,1
134152,Because,0,0
134153,few,0,0
134154,studies,0,0
134155,compare,0,0
134156,methods,0,1
134157,of,0,0
134158,passive,0,0
134159,warming,0,0
134160,",",0,0
134161,we,0,0
134162,used,0,0
134163,an,0,0
134164,unblinded,0,0
134165,",",0,0
134166,prospective,0,0
134167,",",0,0
134168,experimental,0,0
134169,",",0,0
134170,randomized,0,0
134171,design,0,0
134172,to,0,0
134173,compare,0,0
134174,the,0,0
134175,effectiveness,0,0
134176,of,0,0
134177,two,0,0
134178,passive,0,0
134179,methods,0,1
134180,of,0,0
134181,normothermia,0,1
134182,management,0,1
134183,in,0,0
134184,the,0,0
134185,postanesthesia,0,0
134186,care,0,0
134187,unit,0,0
134188,(,0,0
134189,PACU,0,1
134190,),0,0
134191,.,0,0
134192,We,0,0
134193,assigned,0,0
134194,a,0,0
134195,total,0,1
134196,of,0,0
134197,578,1,1
134198,adult,1,1
134199,ambulatory,1,1
134200,surgery,1,1
134201,patients,1,1
134202,to,0,0
134203,either,0,0
134204,a,0,0
134205,control,0,0
134206,group,0,0
134207,that,0,0
134208,was,0,0
134209,given,0,0
134210,two,0,0
134211,folded,0,0
134212,",",0,0
134213,warmed,0,0
134214,cotton,0,1
134215,blankets,0,0
134216,or,0,1
134217,a,0,0
134218,treatment,0,0
134219,group,0,0
134220,that,0,0
134221,was,0,0
134222,given,0,0
134223,a,0,0
134224,warmed,0,0
134225,",",0,0
134226,unfolded,0,0
134227,cotton,0,0
134228,sheet,0,0
134229,and,0,0
134230,cotton,0,0
134231,blanket,0,0
134232,.,0,0
134233,We,0,0
134234,recorded,0,0
134235,patients,0,1
134236,',0,1
134237,temperatures,0,0
134238,on,0,0
134239,their,0,0
134240,arrival,0,0
134241,in,0,0
134242,the,0,0
134243,PACU,0,0
134244,and,0,0
134245,at,0,0
134246,30,0,1
134247,minutes,0,0
134248,after,0,0
134249,arrival,0,0
134250,.,0,0
134251,The,0,0
134252,treatment,0,0
134253,group,0,0
134254,had,0,1
134255,temperatures,0,0
134256,that,0,0
134257,were,0,0
134258,significantly,0,0
134259,higher,0,0
134260,than,0,0
134261,those,0,0
134262,of,0,0
134263,the,0,0
134264,control,0,0
134265,group,0,0
134266,30,0,1
134267,minutes,0,0
134268,after,0,0
134269,arrival,0,0
134270,in,0,0
134271,the,0,0
134272,PACU,0,0
134273,",",0,0
134274,and,0,0
134275,the,0,0
134276,treatment,0,0
134277,group,0,0
134278,experienced,0,0
134279,a,0,0
134280,greater,0,0
134281,change,0,0
134282,in,0,0
134283,temperature,0,0
134284,from,0,1
134285,baseline,0,0
134286,measurements,0,0
134287,to,0,0
134288,those,0,0
134289,taken,0,0
134290,at,0,0
134291,30,0,1
134292,minutes,0,0
134293,.,0,1
134294,The,0,0
134295,treatment,0,0
134296,group,0,0
134297,also,0,0
134298,used,0,0
134299,fewer,0,0
134300,warmed,0,0
134301,blankets,0,0
134302,",",0,0
134303,resulting,0,0
134304,in,0,0
134305,cost,0,0
134306,savings,0,0
134307,for,0,0
134308,the,0,0
134309,PACU,0,0
134310,.,0,1
134311,Post,0,1
134312,hoc,0,0
134313,analysis,0,0
134314,of,0,0
134315,a,0,0
134316,single,0,0
134317,IV,0,0
134318,infusion,0,0
134319,of,0,0
134320,zoledronic,0,0
134321,acid,0,0
134322,versus,0,0
134323,daily,0,0
134324,oral,0,0
134325,risedronate,0,0
134326,on,0,0
134327,lumbar,0,1
134328,spine,0,0
134329,bone,0,0
134330,mineral,0,0
134331,density,0,0
134332,in,0,0
134333,different,0,0
134334,subgroups,1,0
134335,with,1,1
134336,glucocorticoid-induced,1,1
134337,osteoporosis,1,1
134338,.,1,0
134339,This,0,0
134340,study,0,0
134341,summarizes,0,0
134342,the,0,0
134343,treatment,0,0
134344,effect,0,0
134345,of,0,0
134346,zoledronic,0,0
134347,acid,0,0
134348,infusion,0,0
134349,on,0,0
134350,lumbar,0,1
134351,spine,0,0
134352,bone,0,0
134353,mineral,0,0
134354,density,0,0
134355,in,0,0
134356,different,1,0
134357,subgroups,1,0
134358,with,1,1
134359,glucocorticoid-induced,1,1
134360,osteoporosis,1,1
134361,.,1,1
134362,Zoledronic,0,0
134363,acid,0,0
134364,is,0,0
134365,significantly,0,0
134366,more,0,0
134367,effective,0,0
134368,than,0,0
134369,risedronate,0,0
134370,in,0,0
134371,increasing,0,0
134372,lumbar,0,1
134373,spine,0,0
134374,(,0,0
134375,LS,0,0
134376,),0,0
134377,bone,0,0
134378,mineral,0,0
134379,density,0,0
134380,(,0,0
134381,BMD,0,0
134382,),0,0
134383,in,0,0
134384,both,0,0
134385,prevention,0,0
134386,and,0,0
134387,treatment,0,0
134388,of,0,0
134389,glucocorticoid-induced,0,1
134390,osteoporosis,0,1
134391,.,0,0
134392,Introduction,0,0
134393,In,0,0
134394,patients,1,1
134395,on,1,0
134396,glucocorticoids,1,0
134397,",",0,0
134398,a,0,0
134399,single,0,0
134400,zoledronic,0,0
134401,acid,0,0
134402,infusion,0,0
134403,significantly,0,0
134404,increased,0,0
134405,BMD,0,0
134406,versus,0,0
134407,daily,0,0
134408,oral,0,0
134409,risedronate,0,0
134410,.,0,1
134411,We,0,0
134412,assessed,0,0
134413,treatment,0,0
134414,effect,0,0
134415,on,0,0
134416,LS,0,0
134417,BMD,0,1
134418,in,0,0
134419,different,1,0
134420,patient,1,1
134421,subgroups,1,0
134422,at,0,0
134423,month,0,0
134424,12,0,0
134425,that,0,0
134426,contributed,0,0
134427,to,0,0
134428,the,0,0
134429,risk,0,0
134430,of,0,0
134431,osteoporosis,0,1
134432,in,0,0
134433,addition,0,0
134434,to,0,1
134435,glucocorticoids,0,0
134436,.,0,1
134437,Methods,0,0
134438,Patients,1,1
134439,randomized,0,1
134440,to,0,1
134441,a,0,0
134442,single,0,0
134443,IV,0,0
134444,infusion,0,0
134445,of,0,0
134446,zoledronic,0,0
134447,acid,0,0
134448,5,0,0
134449,mg,0,0
134450,or,0,1
134451,risedronate,0,0
134452,(,0,0
134453,5,0,0
134454,mg/day,0,0
134455,),0,0
134456,and,0,0
134457,stratified,0,1
134458,based,0,0
134459,on,0,0
134460,glucocorticoids,0,0
134461,duration,0,0
134462,[,0,0
134463,treatment,0,0
134464,(,0,0
134465,>,0,1
134466,3,0,1
134467,months,0,0
134468,),0,1
134469,and,0,0
134470,prevention,0,0
134471,(,0,0
134472,?,0,0
134473,3,0,0
134474,months,0,0
134475,),0,1
134476,subpopulations,1,1
134477,],1,1
134478,were,1,0
134479,subgrouped,1,1
134480,by,1,0
134481,age,1,1
134482,;,1,1
134483,gender,1,1
134484,;,1,0
134485,menopausal,1,1
134486,status,1,0
134487,in,1,0
134488,women,1,1
134489,;,1,0
134490,dose,1,0
134491,and,1,0
134492,duration,1,0
134493,of,1,0
134494,prednisone,1,0
134495,during,1,0
134496,the,1,0
134497,trial,1,0
134498,;,1,0
134499,and,1,0
134500,baseline,1,0
134501,serum,1,0
134502,25-OH,1,1
134503,vitamin,1,0
134504,D,1,0
134505,",",1,0
134506,LS,1,0
134507,BMD,1,0
134508,T-score,1,0
134509,",",1,0
134510,creatinine,1,0
134511,clearance,1,0
134512,",",1,0
134513,and,1,0
134514,concomitant,1,0
134515,medication,1,0
134516,use,1,0
134517,.,1,0
134518,Results,0,0
134519,At,0,0
134520,month,0,0
134521,12,0,0
134522,",",0,0
134523,zoledronic,0,0
134524,acid,0,0
134525,significantly,0,0
134526,increased,0,0
134527,LS,0,0
134528,BMD,0,0
134529,versus,0,0
134530,risedronate,0,0
134531,in,0,0
134532,patients,0,1
134533,?,0,1
134534,74,0,1
134535,years,0,1
134536,(,0,1
134537,P,0,0
134538,<,0,0
134539,0.05,0,0
134540,),0,0
134541,in,0,0
134542,the,0,0
134543,treatment,0,0
134544,and,0,0
134545,65-74,0,1
134546,years,0,1
134547,(,0,1
134548,P,0,0
134549,=,0,0
134550,0.0008,0,0
134551,),0,0
134552,in,0,0
134553,the,0,0
134554,prevention,0,0
134555,subpopulation,0,1
134556,.,0,0
134557,At,0,0
134558,month,0,0
134559,12,0,0
134560,",",0,0
134561,zoledronic,0,0
134562,acid,0,0
134563,significantly,0,0
134564,increased,0,0
134565,LS,0,0
134566,BMD,0,0
134567,versus,0,0
134568,risedronate,0,0
134569,in,0,0
134570,both,0,0
134571,subpopulations,0,0
134572,irrespective,0,0
134573,of,0,0
134574,gender,0,0
134575,(,0,0
134576,all,0,0
134577,P,0,0
134578,<,0,0
134579,0.05,0,0
134580,),0,0
134581,",",0,0
134582,cumulative,0,0
134583,prednisone,0,0
134584,dose,0,0
134585,(,0,0
134586,all,0,0
134587,P,0,0
134588,<,0,0
134589,0.01,0,0
134590,),0,0
134591,",",0,0
134592,and,0,0
134593,postmenopausal,0,1
134594,status,0,0
134595,(,0,0
134596,all,0,0
134597,P,0,0
134598,<,0,0
134599,0.05,0,0
134600,),0,0
134601,.,0,1
134602,In,0,0
134603,premenopausal,0,1
134604,women,0,1
134605,",",0,0
134606,in,0,0
134607,both,0,0
134608,subpopulations,0,0
134609,",",0,0
134610,zoledronic,0,0
134611,acid,0,0
134612,significantly,0,0
134613,increased,0,0
134614,total,0,1
134615,hip,0,1
134616,BMD,0,0
134617,(,0,0
134618,all,0,0
134619,P,0,0
134620,<,0,0
134621,0.05,0,0
134622,),0,0
134623,versus,0,0
134624,risedronate,0,0
134625,at,0,0
134626,month,0,0
134627,12,0,0
134628,but,0,0
134629,not,0,0
134630,LS,0,0
134631,BMD,0,0
134632,.,0,1
134633,Osteoporotic,1,1
134634,patients,1,1
134635,in,1,0
134636,the,0,0
134637,prevention,0,0
134638,(,0,0
134639,P=0.0189,0,0
134640,),0,0
134641,and,0,0
134642,osteopenic,0,1
134643,patients,0,1
134644,in,0,0
134645,the,0,0
134646,treatment,0,0
134647,subpopulation,0,1
134648,(,0,0
134649,P=0.0305,0,0
134650,),0,0
134651,showed,0,0
134652,significant,0,0
134653,LS,0,0
134654,BMD,0,0
134655,increases,0,0
134656,with,0,1
134657,zoledronic,0,0
134658,acid,0,0
134659,versus,0,0
134660,risedronate,0,0
134661,at,0,0
134662,month,0,0
134663,12,0,1
134664,.,0,1
134665,Conclusions,0,0
134666,This,0,0
134667,post,0,0
134668,hoc,0,0
134669,analysis,0,0
134670,suggests,0,0
134671,that,0,0
134672,zoledronic,0,0
134673,acid,0,0
134674,is,0,0
134675,significantly,0,0
134676,more,0,0
134677,effective,0,0
134678,than,0,0
134679,risedronate,0,0
134680,in,0,0
134681,increasing,0,0
134682,LS,0,0
134683,BMD,0,0
134684,in,0,0
134685,prevention,0,0
134686,and,0,0
134687,treatment,0,0
134688,of,0,0
134689,glucocorticoid-induced,0,0
134690,osteoporosis,0,1
134691,across,0,0
134692,a,0,0
134693,wide,0,1
134694,range,0,0
134695,of,0,0
134696,patients,0,1
134697,.,0,1
134698,[,0,0
134699,Comparative,0,0
134700,effects,0,0
134701,of,0,0
134702,nebivolol,0,0
134703,and,0,0
134704,valsartan,0,0
134705,on,0,0
134706,atrial,0,1
134707,electromechanical,0,0
134708,coupling,0,0
134709,in,0,0
134710,newly,1,1
134711,diagnosed,1,1
134712,stage,1,1
134713,1,1,0
134714,hypertensive,1,1
134715,patients,1,1
134716,],1,1
134717,.,0,1
134718,OBJECTIVES,0,0
134719,Hypertension,0,0
134720,is,0,0
134721,an,0,0
134722,important,0,0
134723,cardiovascular,0,0
134724,risk,0,0
134725,factor,0,0
134726,for,0,0
134727,the,0,0
134728,development,0,0
134729,of,0,0
134730,atrial,0,1
134731,fibrillation,0,1
134732,(,0,0
134733,AF,0,1
134734,),0,1
134735,.,0,0
134736,Increased,0,0
134737,atrial,0,1
134738,electromechanical,0,0
134739,coupling,0,0
134740,time,0,0
134741,interval,0,0
134742,measured,0,0
134743,by,0,0
134744,tissue,0,0
134745,Doppler,0,0
134746,is,0,0
134747,accepted,0,0
134748,as,0,0
134749,an,0,0
134750,important,0,0
134751,factor,0,0
134752,for,0,0
134753,prediction,0,0
134754,of,0,0
134755,AF,0,0
134756,development,0,0
134757,in,0,0
134758,hypertensive,1,1
134759,patients,1,1
134760,.,1,1
134761,The,0,0
134762,aim,0,0
134763,of,0,0
134764,this,0,0
134765,study,0,0
134766,was,0,0
134767,to,0,0
134768,compare,0,0
134769,the,0,0
134770,effects,0,0
134771,of,0,0
134772,valsartan,0,0
134773,",",0,0
134774,an,0,0
134775,angiotensin,0,0
134776,receptor,0,0
134777,blocker,0,0
134778,",",0,0
134779,and,0,0
134780,nebivolol,0,0
134781,",",0,0
134782,a,0,0
134783,beta-blocker,0,0
134784,",",0,0
134785,on,0,0
134786,atrial,0,1
134787,electromechanical,0,0
134788,coupling,0,0
134789,in,0,0
134790,newly,1,1
134791,diagnosed,1,1
134792,stage,1,1
134793,1,1,0
134794,hypertensive,1,1
134795,patients,1,1
134796,.,1,1
134797,STUDY,0,0
134798,DESIGN,0,0
134799,The,0,0
134800,study,0,0
134801,included,0,0
134802,60,1,1
134803,newly,1,1
134804,diagnosed,1,1
134805,stage,1,1
134806,1,1,0
134807,hypertensive,1,1
134808,patients,1,1
134809,with,1,1
134810,no,1,0
134811,other,1,0
134812,systemic,1,0
134813,disease,1,1
134814,.,1,0
134815,The,0,0
134816,patients,0,1
134817,were,0,0
134818,randomized,0,1
134819,to,0,0
134820,receive,0,0
134821,nebivolol,1,0
134822,5,1,0
134823,mg,1,0
134824,(,0,1
134825,30,0,1
134826,patients,0,1
134827,;,0,1
134828,21,0,1
134829,women,0,1
134830,",",0,1
134831,9,0,1
134832,men,0,1
134833,;,0,1
134834,mean,0,1
134835,age,0,1
134836,48.4,0,1
134837,?,0,1
134838,11.4,0,0
134839,years,0,1
134840,),0,1
134841,and,1,0
134842,valsartan,1,0
134843,160,1,1
134844,mg,1,0
134845,(,0,1
134846,30,0,1
134847,patients,0,1
134848,;,0,1
134849,21,0,1
134850,women,0,1
134851,",",0,1
134852,9,0,1
134853,men,0,1
134854,;,0,1
134855,mean,0,1
134856,age,0,1
134857,49.8,0,1
134858,?,0,1
134859,11.3,0,0
134860,years,0,1
134861,),0,1
134862,.,0,1
134863,All,0,0
134864,the,0,0
134865,patients,0,1
134866,underwent,0,1
134867,tissue,0,0
134868,Doppler,0,0
134869,echocardiographic,0,1
134870,examination,0,0
134871,before,0,0
134872,and,0,0
134873,three,0,0
134874,months,0,0
134875,after,0,0
134876,treatment,0,0
134877,to,0,0
134878,compare,0,0
134879,the,0,0
134880,effects,0,0
134881,of,0,0
134882,the,0,0
134883,two,0,0
134884,drugs,0,0
134885,on,0,0
134886,atrial,0,1
134887,electromechanical,0,1
134888,coupling,0,1
134889,.,0,1
134890,RESULTS,0,0
134891,Baseline,0,0
134892,blood,0,0
134893,pressures,0,0
134894,",",0,0
134895,electrocardiographic,0,1
134896,and,0,0
134897,echocardiographic,0,1
134898,findings,0,0
134899,",",0,0
134900,and,0,0
134901,atrial,0,1
134902,electromechanical,0,0
134903,coupling,0,1
134904,were,0,0
134905,similar,0,0
134906,in,0,0
134907,both,0,0
134908,groups,0,0
134909,(,0,0
134910,p,0,0
134911,>,0,1
134912,0.05,0,0
134913,),0,0
134914,.,0,1
134915,Both,0,0
134916,drugs,0,0
134917,significantly,0,0
134918,reduced,0,0
134919,blood,0,0
134920,pressure,0,0
134921,after,0,0
134922,treatment,0,0
134923,",",0,0
134924,with,0,1
134925,similar,0,0
134926,efficacy,0,0
134927,(,0,0
134928,p,0,0
134929,>,0,1
134930,0.05,0,0
134931,),0,1
134932,.,0,1
134933,Atrial,0,0
134934,electromechanical,0,0
134935,coupling,0,1
134936,time,0,0
134937,intervals,0,0
134938,showed,0,0
134939,significant,0,0
134940,decreases,0,0
134941,in,0,0
134942,both,0,0
134943,groups,0,0
134944,.,0,1
134945,CONCLUSION,0,0
134946,Prolonged,0,0
134947,interatrial,0,1
134948,electromechanical,0,1
134949,time,0,0
134950,intervals,0,0
134951,in,0,0
134952,hypertensives,0,1
134953,are,0,0
134954,improved,0,0
134955,with,0,1
134956,antihypertensive,0,0
134957,treatment,0,0
134958,.,0,1
134959,A,0,0
134960,phase,0,0
134961,IIb,0,0
134962,dose-ranging,0,0
134963,study,0,0
134964,of,0,0
134965,the,0,0
134966,oral,0,0
134967,JAK,0,0
134968,inhibitor,0,0
134969,tofacitinib,0,0
134970,(,0,0
134971,"CP-690,550",0,1
134972,),0,0
134973,versus,0,0
134974,placebo,0,0
134975,in,0,0
134976,combination,0,0
134977,with,0,1
134978,background,0,0
134979,methotrexate,0,0
134980,in,0,0
134981,patients,1,1
134982,with,1,1
134983,active,1,1
134984,rheumatoid,1,1
134985,arthritis,1,1
134986,and,1,0
134987,an,1,0
134988,inadequate,1,0
134989,response,1,0
134990,to,1,0
134991,methotrexate,1,0
134992,alone,1,0
134993,.,1,0
134994,OBJECTIVE,0,0
134995,To,0,0
134996,compare,0,0
134997,the,0,0
134998,efficacy,0,0
134999,",",0,0
135000,safety,0,0
135001,",",0,0
135002,and,0,0
135003,tolerability,0,0
135004,of,0,0
135005,6,0,0
135006,dosages,0,0
135007,of,0,0
135008,oral,0,0
135009,tofacitinib,0,0
135010,(,0,0
135011,"CP-690,550",0,0
135012,),0,0
135013,with,0,1
135014,placebo,0,0
135015,for,0,0
135016,the,0,0
135017,treatment,0,0
135018,of,0,0
135019,active,1,1
135020,rheumatoid,1,1
135021,arthritis,1,1
135022,(,1,0
135023,RA,1,1
135024,),1,0
135025,in,1,0
135026,patients,1,1
135027,receiving,1,1
135028,a,1,0
135029,stable,1,1
135030,background,1,0
135031,regimen,1,0
135032,of,1,0
135033,methotrexate,1,0
135034,(,1,0
135035,MTX,1,1
135036,),1,1
135037,who,1,1
135038,have,1,1
135039,an,1,1
135040,inadequate,1,0
135041,response,1,0
135042,to,1,0
135043,MTX,1,0
135044,monotherapy,1,1
135045,.,1,0
135046,METHODS,0,0
135047,In,0,0
135048,this,0,0
135049,24-week,0,0
135050,",",0,0
135051,double-blind,0,0
135052,",",0,0
135053,phase,0,1
135054,IIb,0,0
135055,study,0,0
135056,",",0,0
135057,patients,1,1
135058,with,1,1
135059,active,1,1
135060,RA,1,1
135061,(,1,1
135062,n,1,1
135063,=,1,0
135064,507,1,1
135065,),1,0
135066,were,0,0
135067,randomized,0,0
135068,to,0,0
135069,receive,0,0
135070,placebo,0,0
135071,or,0,0
135072,tofacitinib,0,0
135073,(,0,0
135074,20,0,0
135075,mg/day,0,0
135076,",",0,0
135077,1,0,0
135078,mg,0,0
135079,twice,0,0
135080,daily,0,0
135081,",",0,0
135082,3,0,0
135083,mg,0,0
135084,twice,0,0
135085,daily,0,0
135086,",",0,0
135087,5,0,0
135088,mg,0,0
135089,twice,0,0
135090,daily,0,0
135091,",",0,0
135092,10,0,0
135093,mg,0,0
135094,twice,0,0
135095,daily,0,0
135096,",",0,0
135097,or,0,0
135098,15,0,0
135099,mg,0,0
135100,twice,0,0
135101,daily,0,0
135102,),0,0
135103,.,0,0
135104,All,0,1
135105,patients,0,1
135106,continued,0,0
135107,to,0,0
135108,receive,0,0
135109,a,0,0
135110,stable,0,0
135111,dosage,0,0
135112,of,0,0
135113,MTX,0,0
135114,.,0,1
135115,The,0,0
135116,primary,0,0
135117,end,0,0
135118,point,0,0
135119,was,0,0
135120,the,0,0
135121,American,0,1
135122,College,0,1
135123,of,0,0
135124,Rheumatology,0,1
135125,20,0,1
135126,%,0,0
135127,improvement,0,0
135128,criteria,0,1
135129,(,0,0
135130,ACR20,0,1
135131,),0,0
135132,response,0,0
135133,rate,0,0
135134,at,0,0
135135,week,0,0
135136,12,0,0
135137,.,0,0
135138,RESULTS,0,0
135139,At,0,0
135140,week,0,0
135141,12,0,0
135142,",",0,0
135143,ACR20,0,1
135144,response,0,0
135145,rates,0,0
135146,for,0,0
135147,patients,0,1
135148,receiving,0,1
135149,all,0,0
135150,tofacitinib,0,0
135151,dosages,0,0
135152,?3,0,0
135153,mg,0,0
135154,twice,0,0
135155,daily,0,0
135156,(,0,0
135157,52.9,0,0
135158,%,0,0
135159,for,0,0
135160,3,0,0
135161,mg,0,0
135162,twice,0,0
135163,daily,0,0
135164,",",0,0
135165,50.7,0,0
135166,%,0,0
135167,for,0,0
135168,5,0,0
135169,mg,0,0
135170,twice,0,0
135171,daily,0,0
135172,",",0,0
135173,58.1,0,0
135174,%,0,0
135175,for,0,0
135176,10,0,0
135177,mg,0,0
135178,twice,0,0
135179,daily,0,0
135180,",",0,0
135181,56.0,0,0
135182,%,0,0
135183,for,0,0
135184,15,0,1
135185,mg,0,0
135186,twice,0,0
135187,daily,0,0
135188,",",0,0
135189,and,0,0
135190,53.8,0,0
135191,%,0,0
135192,for,0,0
135193,20,0,1
135194,mg/day,0,1
135195,),0,0
135196,were,0,0
135197,significantly,0,0
135198,(,0,0
135199,P,0,0
135200,?,0,1
135201,0.05,0,0
135202,),0,0
135203,greater,0,0
135204,than,0,0
135205,those,0,0
135206,for,0,0
135207,placebo,0,0
135208,(,0,0
135209,33.3,0,0
135210,%,0,0
135211,),0,1
135212,.,0,1
135213,Improvements,0,0
135214,were,0,0
135215,sustained,0,0
135216,at,0,0
135217,week,0,0
135218,24,0,0
135219,for,0,0
135220,the,0,0
135221,ACR20,0,0
135222,",",0,0
135223,ACR50,0,0
135224,",",0,0
135225,and,0,0
135226,ACR70,0,1
135227,responses,0,0
135228,",",0,0
135229,scores,0,0
135230,for,0,0
135231,the,0,0
135232,Health,0,0
135233,Assessment,0,0
135234,Questionnaire,0,0
135235,disability,0,0
135236,index,0,0
135237,",",0,0
135238,the,0,0
135239,3-variable,0,0
135240,Disease,0,1
135241,Activity,0,0
135242,Score,0,1
135243,in,0,0
135244,28,0,1
135245,joints,0,1
135246,using,0,0
135247,the,0,0
135248,C-reactive,0,0
135249,protein,0,0
135250,level,0,0
135251,(,0,0
135252,DAS28-CRP,0,0
135253,),0,0
135254,",",0,0
135255,and,0,0
135256,a,0,0
135257,3-variable,0,0
135258,DAS28-CRP,0,0
135259,of,0,0
135260,<,0,0
135261,2.6,0,0
135262,.,0,0
135263,The,0,0
135264,most,0,0
135265,common,0,0
135266,treatment-emergent,0,0
135267,adverse,0,0
135268,events,0,0
135269,occurring,0,1
135270,in,0,1
135271,>,0,1
135272,10,0,1
135273,%,0,0
135274,of,0,0
135275,patients,0,1
135276,in,0,0
135277,any,0,0
135278,tofacitinib,0,0
135279,group,0,0
135280,were,0,0
135281,diarrhea,0,1
135282,",",0,0
135283,upper,0,0
135284,respiratory,0,1
135285,tract,0,0
135286,infection,0,0
135287,",",0,0
135288,and,0,0
135289,headache,0,0
135290,;,0,0
135291,21,0,1
135292,patients,0,1
135293,(,0,1
135294,4.1,0,0
135295,%,0,0
135296,),0,0
135297,experienced,0,0
135298,serious,0,0
135299,adverse,0,0
135300,events,0,0
135301,.,0,1
135302,Sporadic,0,1
135303,increases,0,0
135304,in,0,0
135305,transaminase,0,0
135306,levels,0,0
135307,",",0,0
135308,increases,0,0
135309,in,0,0
135310,cholesterol,0,0
135311,and,0,0
135312,serum,0,0
135313,creatinine,0,0
135314,levels,0,0
135315,",",0,0
135316,and,0,0
135317,decreases,0,0
135318,in,0,0
135319,neutrophil,0,0
135320,and,0,0
135321,hemoglobin,0,0
135322,levels,0,0
135323,were,0,1
135324,observed,0,0
135325,.,0,0
135326,CONCLUSION,1,0
135327,In,1,0
135328,patients,1,1
135329,with,1,1
135330,active,1,1
135331,RA,1,1
135332,in,1,1
135333,whom,1,1
135334,the,1,1
135335,response,1,0
135336,to,1,0
135337,MTX,1,0
135338,has,1,0
135339,been,1,0
135340,inadequate,1,0
135341,",",1,0
135342,the,1,0
135343,addition,0,0
135344,of,0,0
135345,tofacitinib,0,0
135346,at,0,0
135347,a,0,0
135348,dosage,0,0
135349,?3,0,0
135350,mg,0,0
135351,twice,0,0
135352,daily,0,0
135353,showed,0,0
135354,sustained,0,0
135355,efficacy,0,0
135356,and,0,0
135357,a,0,0
135358,manageable,0,0
135359,safety,0,0
135360,profile,0,0
135361,over,0,0
135362,24,0,1
135363,weeks,0,0
135364,.,0,1
135365,Effect,0,0
135366,of,0,0
135367,ischemic,0,1
135368,postconditioning,0,0
135369,in,0,0
135370,correction,0,0
135371,of,0,0
135372,tetralogy,0,1
135373,of,0,0
135374,Fallot,0,1
135375,.,0,1
135376,Inappropriate,0,0
135377,myocardial,0,1
135378,protection,0,0
135379,is,0,0
135380,considered,0,0
135381,one,0,0
135382,of,0,0
135383,the,0,0
135384,main,0,0
135385,causes,0,0
135386,of,0,0
135387,mortality,0,0
135388,and,0,0
135389,morbidity,0,0
135390,in,0,0
135391,the,0,0
135392,correction,0,0
135393,of,0,0
135394,tetralogy,1,1
135395,of,1,0
135396,Fallot,1,1
135397,(,1,1
135398,TOF,1,0
135399,),1,1
135400,.,1,1
135401,Results,0,0
135402,of,0,0
135403,previous,0,1
135404,reports,0,0
135405,about,0,0
135406,the,0,0
135407,effects,0,0
135408,of,0,0
135409,ischemic,0,1
135410,postconditioning,0,0
135411,on,0,0
135412,myocardial,0,1
135413,protection,0,0
135414,in,0,0
135415,animals,0,1
135416,and,0,1
135417,humans,0,0
135418,are,0,0
135419,very,0,0
135420,encouraging,0,0
135421,.,0,0
135422,This,0,0
135423,randomized,0,0
135424,and,0,0
135425,controlled,0,0
135426,trial,0,0
135427,aimed,0,0
135428,to,0,0
135429,assess,0,0
135430,the,0,0
135431,effect,0,0
135432,of,0,0
135433,ischemic,0,1
135434,postconditioning,0,0
135435,on,0,0
135436,protection,0,0
135437,against,0,0
135438,myocardial,0,1
135439,ischemia,0,1
135440,reperfusion,0,0
135441,injury,0,1
135442,in,0,0
135443,TOF,1,0
135444,patients,1,1
135445,receiving,1,1
135446,cardioplegia,1,0
135447,.,1,1
135448,From,1,1
135449,January,1,1
135450,2008,1,1
135451,to,1,0
135452,June,1,1
135453,2010,1,1
135454,",",1,0
135455,80,1,1
135456,consecutive,1,1
135457,children,1,1
135458,undergoing,1,1
135459,correction,1,1
135460,of,1,0
135461,TOF,1,0
135462,were,0,0
135463,enrolled,0,1
135464,and,0,0
135465,randomly,0,1
135466,assigned,0,0
135467,to,0,0
135468,either,0,0
135469,a,0,0
135470,postconditioning,0,0
135471,group,0,0
135472,(,0,0
135473,three,0,0
135474,cycles,0,0
135475,of,0,1
135476,30,0,1
135477,seconds,0,0
135478,of,0,0
135479,ischemia,0,1
135480,and,0,0
135481,30,0,1
135482,seconds,0,0
135483,of,0,0
135484,reperfusion,0,0
135485,using,0,0
135486,re-clamping,0,0
135487,and,0,0
135488,de-clamping,0,0
135489,starting,0,1
135490,30,0,1
135491,seconds,0,0
135492,after,0,0
135493,the,0,0
135494,initial,0,0
135495,de-clamping,0,0
135496,of,0,0
135497,the,0,0
135498,aorta,0,0
135499,",",0,0
135500,n,0,1
135501,=,0,0
135502,41,0,1
135503,),0,0
135504,or,0,0
135505,a,0,0
135506,control,0,0
135507,group,0,0
135508,(,0,0
135509,n,0,1
135510,=,0,0
135511,39,0,1
135512,),0,1
135513,.,0,1
135514,Cardiac,0,0
135515,troponin,0,0
135516,I,0,1
135517,(,0,0
135518,cTnI,0,0
135519,),0,0
135520,was,0,0
135521,assayed,0,0
135522,preoperatively,0,0
135523,",",0,0
135524,and,0,0
135525,then,0,0
135526,4,0,0
135527,hours,0,0
135528,",",0,1
135529,8,0,0
135530,hours,0,0
135531,",",0,1
135532,12,0,0
135533,hours,0,0
135534,",",0,1
135535,20,0,1
135536,hours,0,0
135537,",",0,0
135538,and,0,0
135539,48,0,0
135540,hours,0,0
135541,after,0,0
135542,persistent,0,1
135543,reperfusion,0,0
135544,.,0,0
135545,The,0,0
135546,pre-,0,0
135547,",",0,0
135548,intra-,0,0
135549,and,0,0
135550,postoperative,0,0
135551,relevant,0,0
135552,data,0,0
135553,of,0,0
135554,all,0,1
135555,selected,0,1
135556,patients,0,1
135557,were,0,1
135558,analyzed,0,0
135559,.,0,0
135560,As,0,0
135561,a,0,0
135562,result,0,0
135563,",",0,0
135564,ischemic,0,1
135565,postconditioning,0,0
135566,reduced,0,0
135567,postoperative,0,0
135568,peak,0,0
135569,release,0,0
135570,by,0,0
135571,45,0,1
135572,%,0,0
135573,for,0,0
135574,cTnI,0,0
135575,compared,0,0
135576,with,0,1
135577,the,0,0
135578,control,0,0
135579,group,0,0
135580,(,0,0
135581,0.43,0,0
135582,?,0,1
135583,0.18,0,0
135584,ng/mL,0,0
135585,versus,0,0
135586,0.78,0,0
135587,?,0,0
135588,0.15,0,0
135589,ng/mL,0,0
135590,",",0,0
135591,P,0,0
135592,<,0,0
135593,0.0001,0,0
135594,),0,1
135595,.,0,1
135596,Ischemic,0,1
135597,postconditioned,0,0
135598,patients,0,1
135599,had,0,1
135600,a,0,0
135601,lower,0,0
135602,peak,0,0
135603,inotropic,0,0
135604,score,0,0
135605,during,0,0
135606,the,0,0
135607,first,0,0
135608,postoperative,0,0
135609,24,0,1
135610,hours,0,0
135611,(,0,1
135612,5.6,0,0
135613,?,0,1
135614,2.2,0,0
135615,?g/kg/minute,0,0
135616,versus,0,0
135617,8.6,0,1
135618,?,0,0
135619,3.6,0,0
135620,?g/kg/minute,0,0
135621,",",0,0
135622,P,0,0
135623,<,0,0
135624,0.0001,0,0
135625,),0,0
135626,",",0,0
135627,extubation,0,0
135628,time,0,0
135629,(,0,1
135630,21.5,0,0
135631,?,0,1
135632,7.3,0,0
135633,hours,0,0
135634,versus,0,0
135635,30.2,0,1
135636,?,0,1
135637,12.4,0,0
135638,hours,0,0
135639,",",0,1
135640,P,0,0
135641,=,0,0
135642,0.0002,0,0
135643,),0,0
135644,and,0,0
135645,length,0,0
135646,of,0,0
135647,ICU,0,0
135648,stay,0,0
135649,(,0,0
135650,43.4,0,0
135651,?,0,1
135652,12.6,0,0
135653,hours,0,0
135654,versus,0,0
135655,56.3,0,1
135656,?,0,1
135657,17.8,0,0
135658,hours,0,0
135659,",",0,1
135660,P,0,0
135661,=,0,0
135662,0.0003,0,0
135663,),0,0
135664,",",0,0
135665,while,0,0
135666,they,0,0
135667,had,0,0
135668,a,0,0
135669,higher,0,0
135670,cardiac,0,1
135671,output,0,0
135672,on,0,0
135673,the,0,0
135674,first,0,0
135675,postoperative,0,0
135676,day,0,0
135677,(,0,1
135678,1.41,0,0
135679,?,0,1
135680,0.26,0,0
135681,L/minute,0,0
135682,versus,0,0
135683,1.28,0,0
135684,?,0,1
135685,0.25,0,0
135686,L/minute,0,0
135687,",",0,0
135688,P,0,0
135689,=,0,0
135690,0.0255,0,0
135691,),0,0
135692,as,0,0
135693,compared,0,0
135694,to,0,0
135695,the,0,0
135696,control,0,0
135697,group,0,0
135698,.,0,0
135699,In,0,0
135700,conclusion,0,0
135701,",",0,0
135702,ischemic,0,1
135703,postconditioning,0,0
135704,may,0,0
135705,to,0,0
135706,some,0,0
135707,extent,0,0
135708,provide,0,0
135709,myocardial,0,1
135710,protection,0,0
135711,in,1,0
135712,children,1,1
135713,undergoing,1,1
135714,correction,1,1
135715,of,1,0
135716,tetralogy,1,1
135717,of,1,0
135718,Fallot,1,1
135719,.,1,1
135720,Armodafinil,0,0
135721,and,0,0
135722,modafinil,0,1
135723,in,0,0
135724,patients,1,1
135725,with,1,1
135726,excessive,1,1
135727,sleepiness,1,0
135728,associated,1,0
135729,with,1,1
135730,shift,1,0
135731,work,1,0
135732,disorder,1,1
135733,:,1,1
135734,a,0,0
135735,pharmacokinetic/pharmacodynamic,0,0
135736,model,0,0
135737,for,0,0
135738,predicting,0,0
135739,and,0,0
135740,comparing,0,0
135741,their,0,0
135742,concentration-effect,0,0
135743,relationships,0,0
135744,.,0,1
135745,Armodafinil,0,0
135746,",",0,0
135747,the,0,0
135748,longer,0,0
135749,lasting,0,0
135750,R-isomer,0,0
135751,of,0,0
135752,racemic,0,0
135753,modafinil,0,0
135754,",",0,0
135755,improves,0,0
135756,wakefulness,0,0
135757,in,0,0
135758,patients,1,1
135759,with,1,1
135760,excessive,1,1
135761,sleepiness,1,0
135762,associated,1,0
135763,with,1,1
135764,shift,1,0
135765,work,1,0
135766,disorder,1,1
135767,(,1,0
135768,SWD,1,1
135769,),1,1
135770,.,1,1
135771,Pharmacokinetic,0,0
135772,studies,0,0
135773,suggest,0,0
135774,that,0,0
135775,armodafinil,0,0
135776,achieves,0,0
135777,higher,0,0
135778,plasma,0,0
135779,concentrations,0,0
135780,than,0,0
135781,modafinil,0,1
135782,late,0,1
135783,in,0,0
135784,a,0,0
135785,dose,0,0
135786,interval,0,0
135787,following,0,0
135788,equal,0,0
135789,oral,0,1
135790,doses,0,0
135791,.,0,1
135792,Pooled,0,0
135793,Multiple,0,0
135794,Sleep,0,0
135795,Latency,0,0
135796,Test,0,0
135797,(,0,0
135798,MSLT,0,0
135799,),0,0
135800,data,0,0
135801,from,0,1
135802,2,0,0
135803,randomized,1,1
135804,",",0,0
135805,double-blind,0,0
135806,",",0,0
135807,placebo-controlled,0,0
135808,trials,0,0
135809,in,0,1
135810,463,1,1
135811,patients,1,1
135812,with,1,1
135813,SWD,1,1
135814,",",1,0
135815,1,1,0
135816,with,1,1
135817,armodafinil,1,1
135818,150,1,0
135819,mg/d,1,0
135820,and,1,0
135821,1,1,0
135822,with,1,1
135823,modafinil,1,1
135824,200,1,0
135825,mg/d,1,0
135826,(,1,0
135827,both,1,0
135828,administered,1,0
135829,around,1,0
135830,2200,1,0
135831,h,1,0
135832,before,1,0
135833,night,1,0
135834,shifts,1,0
135835,),1,0
135836,",",0,0
135837,were,0,0
135838,used,0,0
135839,to,0,0
135840,build,0,0
135841,a,0,0
135842,pharmacokinetic/pharmacodynamic,0,0
135843,model,0,0
135844,.,0,0
135845,Predicted,0,0
135846,plasma,0,0
135847,drug,0,0
135848,concentrations,0,0
135849,were,0,0
135850,obtained,0,0
135851,by,0,0
135852,developing,0,0
135853,and,0,0
135854,applying,0,0
135855,a,0,0
135856,population,0,1
135857,pharmacokinetic,0,0
135858,model,0,0
135859,using,0,0
135860,nonlinear,0,0
135861,mixed-effects,0,0
135862,modeling,0,1
135863,.,0,1
135864,Armodafinil,0,0
135865,200,0,0
135866,mg,0,0
135867,produced,0,0
135868,a,0,0
135869,plasma,0,0
135870,concentration,0,0
135871,above,0,0
135872,the,0,0
135873,EC,0,0
135874,(,0,0
135875,50,0,1
135876,),0,1
135877,(,0,0
135878,4.6,0,0
135879,?g/mL,0,0
135880,),0,0
135881,for,0,0
135882,9,0,0
135883,hours,0,0
135884,",",0,1
135885,whereas,0,0
135886,modafinil,0,1
135887,200,0,0
135888,mg,0,0
135889,did,0,0
135890,not,0,0
135891,exceed,0,0
135892,the,0,0
135893,EC,0,0
135894,(,0,0
135895,50,0,1
135896,),0,0
135897,.,0,0
135898,Consequently,0,0
135899,",",0,0
135900,armodafinil,0,0
135901,produced,0,0
135902,greater,0,0
135903,increases,0,0
135904,in,0,0
135905,predicted,0,0
135906,placebo-subtracted,0,0
135907,MSLT,0,0
135908,times,0,0
135909,of,0,0
135910,0.5-1,0,0
135911,minute,0,0
135912,(,0,0
135913,up,0,0
135914,to,0,1
135915,10,0,1
135916,hours,0,0
135917,after,0,0
135918,dosing,0,0
135919,),0,0
135920,compared,0,0
135921,with,0,1
135922,modafinil,0,1
135923,.,0,0
135924,On,0,0
135925,a,0,0
135926,milligram-to-milligram,0,0
135927,basis,0,0
135928,",",0,0
135929,armodafinil,0,0
135930,200,0,0
135931,mg,0,0
135932,consistently,0,0
135933,increased,0,0
135934,wakefulness,0,0
135935,more,0,0
135936,than,0,0
135937,modafinil,0,0
135938,200,0,0
135939,mg,0,0
135940,",",0,0
135941,including,0,0
135942,times,0,0
135943,late,0,1
135944,in,0,0
135945,the,0,0
135946,8-hour,0,0
135947,shift,0,0
135948,.,0,1
135949,Single,0,0
135950,negative,0,0
135951,colposcopy,0,1
135952,:,0,1
135953,is,0,0
135954,it,0,0
135955,enough,0,0
135956,to,0,0
135957,rule,0,0
135958,out,0,0
135959,high-grade,0,1
135960,disease,0,1
135961,?,0,0
135962,It,0,0
135963,has,0,0
135964,been,0,0
135965,proposed,0,0
135966,that,0,0
135967,women,1,1
135968,who,1,1
135969,have,1,1
135970,a,1,1
135971,negative,1,0
135972,colposcopic,1,0
135973,examination,1,1
135974,or,1,1
135975,who,1,1
135976,have,1,1
135977,no,1,1
135978,cervical,1,1
135979,intraepithelial,1,1
135980,neoplasia,1,1
135981,(,1,0
135982,CIN,1,0
135983,),1,0
135984,on,1,0
135985,colposcopic,1,0
135986,biopsy,1,0
135987,can,0,0
135988,be,0,0
135989,safely,0,0
135990,returned,0,0
135991,to,0,0
135992,routine,0,0
135993,screening,0,0
135994,with,0,0
135995,the,0,0
135996,next,0,0
135997,visit,0,0
135998,being,0,0
135999,three,0,0
136000,or,0,1
136001,five,0,1
136002,years,0,1
136003,later,0,1
136004,.,0,1
136005,We,0,0
136006,present,0,0
136007,data,0,0
136008,regarding,0,0
136009,551,1,1
136010,women,1,1
136011,who,1,1
136012,had,1,1
136013,colposcopy,1,1
136014,in,1,0
136015,Wales,1,0
136016,for,1,0
136017,a,1,0
136018,low-grade,1,1
136019,cytological,1,0
136020,abnormality,1,1
136021,and,1,1
136022,who,1,1
136023,were,1,1
136024,followed,1,1
136025,through,1,0
136026,Cervical,1,1
136027,Screening,1,1
136028,Wales,1,0
136029,for,1,0
136030,subsequent,1,0
136031,CIN,1,1
136032,.,1,1
136033,Of,0,0
136034,436,0,1
136035,women,0,1
136036,declared,0,1
136037,CIN,0,1
136038,free,0,0
136039,initially,0,0
136040,",",0,0
136041,26,0,1
136042,(,0,0
136043,6.0,0,0
136044,%,0,0
136045,),0,0
136046,had,0,1
136047,high-grade,0,1
136048,CIN,0,0
136049,diagnosed,0,1
136050,on,0,0
136051,follow-up,0,0
136052,.,0,0
136053,We,0,0
136054,suggest,0,0
136055,that,0,0
136056,additional,0,0
136057,screening,0,1
136058,at,0,0
136059,an,0,0
136060,interval,0,0
136061,of,0,0
136062,less,0,0
136063,than,0,0
136064,three,0,0
136065,years,0,1
136066,should,0,0
136067,be,0,0
136068,offered,0,0
136069,to,0,0
136070,women,1,1
136071,with,1,1
136072,a,1,0
136073,negative,1,0
136074,colposcopy,1,1
136075,or,1,0
136076,a,1,0
136077,biopsy,1,0
136078,without,1,1
136079,CIN,1,1
136080,.,1,1
136081,Arthroscopic,0,1
136082,rotator,0,1
136083,cuff,0,0
136084,repair,0,0
136085,with,0,1
136086,and,0,0
136087,without,0,1
136088,acromioplasty,0,1
136089,in,0,0
136090,the,0,0
136091,treatment,0,0
136092,of,0,0
136093,full-thickness,1,0
136094,rotator,1,1
136095,cuff,1,1
136096,tears,1,1
136097,:,1,1
136098,a,0,0
136099,multicenter,0,0
136100,",",0,0
136101,randomized,0,0
136102,controlled,0,0
136103,trial,0,0
136104,.,0,0
136105,BACKGROUND,0,0
136106,The,0,0
136107,primary,0,0
136108,objective,0,0
136109,of,0,0
136110,this,0,0
136111,prospective,0,0
136112,randomized,0,0
136113,controlled,0,0
136114,trial,0,0
136115,was,0,0
136116,to,0,0
136117,compare,0,0
136118,functional,0,0
136119,and,0,0
136120,quality-of-life,0,0
136121,indices,0,0
136122,and,0,1
136123,rates,0,0
136124,of,0,0
136125,revision,0,1
136126,surgery,0,1
136127,in,0,0
136128,arthroscopic,1,0
136129,rotator,1,1
136130,cuff,1,0
136131,repair,1,0
136132,with,1,1
136133,and,1,0
136134,without,1,1
136135,acromioplasty,1,1
136136,.,1,1
136137,METHODS,0,0
136138,Eighty-six,1,1
136139,patients,1,1
136140,consented,0,1
136141,and,0,0
136142,were,0,0
136143,randomly,0,1
136144,assigned,0,0
136145,intraoperatively,0,0
136146,to,0,0
136147,one,0,0
136148,of,0,0
136149,two,0,0
136150,study,0,1
136151,groups,0,0
136152,",",0,0
136153,and,0,0
136154,sixty-eight,1,1
136155,of,1,0
136156,them,1,1
136157,completed,1,1
136158,the,1,0
136159,study,1,0
136160,.,1,0
136161,The,0,0
136162,primary,0,0
136163,outcome,0,0
136164,was,0,0
136165,the,0,0
136166,Western,0,1
136167,Ontario,0,1
136168,Rotator,0,1
136169,Cuff,0,1
136170,(,0,0
136171,WORC,0,0
136172,),0,0
136173,index,0,0
136174,.,0,0
136175,Secondary,0,0
136176,outcome,0,0
136177,measures,0,0
136178,included,0,1
136179,the,0,0
136180,American,0,1
136181,Shoulder,0,1
136182,and,0,0
136183,Elbow,0,1
136184,Surgeons,0,1
136185,(,0,0
136186,ASES,0,0
136187,),0,0
136188,shoulder,0,1
136189,assessment,0,0
136190,form,0,0
136191,and,0,0
136192,a,0,0
136193,count,0,0
136194,of,0,0
136195,revisions,0,0
136196,required,0,0
136197,in,0,0
136198,each,0,0
136199,group,0,0
136200,.,0,0
136201,Outcome,0,0
136202,measures,0,0
136203,were,0,0
136204,completed,0,1
136205,preoperatively,0,0
136206,and,0,0
136207,at,0,0
136208,three,0,0
136209,",",0,0
136210,six,0,0
136211,",",0,0
136212,twelve,0,1
136213,",",0,0
136214,eighteen,0,1
136215,",",0,0
136216,and,0,0
136217,twenty-four,0,1
136218,months,0,0
136219,after,0,0
136220,surgery,0,1
136221,.,0,1
136222,RESULTS,0,0
136223,WORC,0,0
136224,and,0,0
136225,ASES,0,0
136226,scores,0,0
136227,improved,0,0
136228,significantly,0,0
136229,in,0,0
136230,each,0,0
136231,group,0,0
136232,over,0,0
136233,time,0,0
136234,(,0,0
136235,p,0,0
136236,<,0,0
136237,0.001,0,0
136238,),0,0
136239,.,0,0
136240,There,0,0
136241,were,0,0
136242,no,0,0
136243,differences,0,0
136244,in,0,0
136245,WORC,0,1
136246,or,0,1
136247,ASES,0,0
136248,scores,0,0
136249,between,0,0
136250,the,0,0
136251,groups,0,0
136252,that,0,0
136253,had,0,1
136254,arthroscopic,0,1
136255,cuff,0,0
136256,repair,0,1
136257,with,0,1
136258,or,0,1
136259,without,0,1
136260,acromioplasty,0,1
136261,at,0,0
136262,any,0,0
136263,time,0,0
136264,point,0,0
136265,.,0,0
136266,There,0,0
136267,were,0,0
136268,no,0,0
136269,differences,0,0
136270,in,0,0
136271,scores,0,0
136272,on,0,0
136273,the,0,0
136274,basis,0,0
136275,of,0,0
136276,acromion,0,1
136277,type,0,1
136278,",",0,0
136279,nor,0,0
136280,were,0,0
136281,any,0,0
136282,interaction,0,0
136283,effects,0,0
136284,identified,0,0
136285,between,0,0
136286,group,0,0
136287,and,0,0
136288,acromion,0,1
136289,type,0,1
136290,.,0,1
136291,Four,1,0
136292,participants,1,1
136293,(,1,1
136294,9,1,0
136295,%,1,0
136296,),1,0
136297,in,1,0
136298,the,1,0
136299,group,1,0
136300,that,1,0
136301,had,1,0
136302,arthroscopic,1,1
136303,cuff,1,0
136304,repair,1,0
136305,alone,1,0
136306,",",1,0
136307,one,1,0
136308,with,1,1
136309,a,1,0
136310,Type-2,1,0
136311,and,1,0
136312,three,1,0
136313,with,1,1
136314,a,1,0
136315,Type-3,1,0
136316,acromion,1,0
136317,",",1,0
136318,required,1,0
136319,additional,1,0
136320,surgery,1,1
136321,by,0,0
136322,the,0,0
136323,twenty-four-month,0,1
136324,time,0,0
136325,point,0,0
136326,.,0,0
136327,The,0,0
136328,number,0,0
136329,of,0,1
136330,patients,0,1
136331,who,0,1
136332,required,0,1
136333,additional,0,1
136334,surgery,0,1
136335,was,0,0
136336,greater,0,0
136337,(,0,0
136338,p,0,0
136339,=,0,0
136340,0.05,0,0
136341,),0,0
136342,in,0,0
136343,the,0,0
136344,group,0,0
136345,that,0,0
136346,had,0,0
136347,arthroscopic,0,1
136348,cuff,0,0
136349,repair,0,0
136350,alone,0,0
136351,than,0,0
136352,in,0,0
136353,the,0,0
136354,group,0,0
136355,that,0,0
136356,had,0,0
136357,arthroscopic,0,1
136358,cuff,0,0
136359,repair,0,1
136360,and,0,0
136361,acromioplasty,0,1
136362,.,0,0
136363,CONCLUSIONS,0,0
136364,Our,0,0
136365,findings,0,0
136366,are,0,0
136367,consistent,0,0
136368,with,0,1
136369,previous,0,0
136370,research,0,1
136371,reports,0,0
136372,in,0,0
136373,which,0,0
136374,there,0,0
136375,was,0,0
136376,no,0,0
136377,difference,0,0
136378,in,0,0
136379,functional,0,0
136380,and,0,1
136381,quality-of-life,0,0
136382,indices,0,0
136383,for,0,1
136384,patients,1,1
136385,who,1,1
136386,had,1,1
136387,rotator,1,1
136388,cuff,1,0
136389,repair,1,0
136390,with,1,1
136391,or,1,1
136392,without,1,1
136393,acromioplasty,1,1
136394,.,1,0
136395,The,0,0
136396,higher,0,0
136397,reoperation,0,0
136398,rate,0,0
136399,was,0,0
136400,found,0,0
136401,in,0,0
136402,the,0,0
136403,group,1,0
136404,without,0,1
136405,acromioplasty,0,1
136406,.,0,0
136407,Further,0,0
136408,study,0,0
136409,that,0,0
136410,includes,0,0
136411,follow-up,0,0
136412,imaging,0,0
136413,and,0,0
136414,patient-reported,0,0
136415,outcomes,0,0
136416,over,0,0
136417,a,0,0
136418,greater,0,0
136419,follow-up,0,0
136420,period,0,0
136421,is,0,0
136422,needed,0,0
136423,.,0,0
136424,Effect,0,0
136425,of,0,0
136426,motivational,0,0
136427,music,0,1
136428,on,0,0
136429,lactate,0,0
136430,levels,0,0
136431,during,0,0
136432,recovery,0,0
136433,from,0,1
136434,intense,0,0
136435,exercise,0,0
136436,.,0,0
136437,The,0,0
136438,effects,0,0
136439,of,0,0
136440,music,0,1
136441,played,0,0
136442,during,0,0
136443,an,0,0
136444,exercise,0,0
136445,task,0,0
136446,on,0,0
136447,athletic,0,0
136448,performance,0,0
136449,have,0,0
136450,been,0,0
136451,previously,0,0
136452,studied,0,0
136453,.,0,0
136454,Yet,0,0
136455,",",0,0
136456,these,0,0
136457,results,0,0
136458,are,0,0
136459,not,0,0
136460,applicable,0,0
136461,for,0,0
136462,competitive,1,0
136463,athletes,1,1
136464,",",0,1
136465,who,0,1
136466,can,0,0
136467,use,0,0
136468,music,0,0
136469,only,0,0
136470,during,0,0
136471,warm-up,0,0
136472,or,0,0
136473,recovery,0,0
136474,from,0,0
136475,exercise,0,0
136476,.,0,0
136477,Therefore,0,0
136478,",",0,0
136479,the,0,0
136480,aim,0,0
136481,of,0,0
136482,this,0,0
136483,study,0,0
136484,was,0,0
136485,to,0,0
136486,determine,0,0
136487,the,0,0
136488,effect,0,0
136489,of,0,0
136490,motivational,0,0
136491,music,0,1
136492,(,0,0
136493,music,0,0
136494,that,0,0
136495,stimulates,0,0
136496,or,0,0
136497,inspires,0,0
136498,physical,0,0
136499,activity,0,0
136500,),0,0
136501,during,0,0
136502,recovery,0,0
136503,from,0,1
136504,intense,0,0
136505,exercise,0,0
136506,",",0,0
136507,on,0,0
136508,activity,0,0
136509,pattern,0,1
136510,",",0,0
136511,rate,0,0
136512,of,0,0
136513,perceived,0,0
136514,exertion,0,0
136515,(,0,0
136516,RPE,0,0
136517,),0,0
136518,",",0,0
136519,and,0,0
136520,blood,0,0
136521,lactate,0,0
136522,concentration,0,0
136523,.,0,0
136524,Twenty,1,1
136525,young,1,1
136526,",",1,0
136527,active,1,1
136528,men,1,1
136529,(,1,1
136530,mean,1,1
136531,age,1,1
136532,26.2,1,0
136533,?,1,1
136534,2.1,1,0
136535,years,1,1
136536,),1,1
136537,performed,0,0
136538,a,0,0
136539,6-minute,0,0
136540,run,0,0
136541,at,0,0
136542,peak,0,0
136543,oxygen,0,0
136544,consumption,0,0
136545,speed,0,0
136546,(,0,0
136547,predetermined,0,0
136548,from,0,0
136549,the,0,0
136550,VO,0,0
136551,(,0,0
136552,2,0,0
136553,),0,0
136554,max,0,0
136555,test,0,0
136556,),0,0
136557,.,0,0
136558,The,0,0
136559,mean,0,0
136560,heart,0,1
136561,rate,0,0
136562,(,0,0
136563,HR,0,0
136564,),0,0
136565,",",0,0
136566,RPE,0,0
136567,",",0,0
136568,number,0,0
136569,of,0,0
136570,steps,0,0
136571,(,0,0
136572,determined,0,0
136573,by,0,0
136574,step,0,0
136575,counter,0,0
136576,),0,0
136577,",",0,0
136578,and,0,0
136579,blood,0,0
136580,lactate,0,0
136581,concentrations,0,0
136582,were,0,0
136583,determined,0,0
136584,at,0,0
136585,3,0,0
136586,",",0,0
136587,6,0,0
136588,",",0,0
136589,9,0,0
136590,",",0,0
136591,12,0,0
136592,",",0,0
136593,and,0,0
136594,15,0,1
136595,minutes,0,0
136596,during,0,0
136597,the,0,0
136598,recovery,0,0
136599,from,0,0
136600,the,0,0
136601,exercise,0,0
136602,",",0,0
136603,with,0,0
136604,and,0,0
136605,without,0,1
136606,motivational,0,0
136607,music,0,1
136608,(,0,0
136609,2,0,0
136610,separate,0,0
136611,sessions,0,0
136612,",",0,0
136613,at,0,0
136614,random,0,1
136615,order,0,0
136616,),0,0
136617,.,0,0
136618,There,0,0
136619,was,0,0
136620,no,0,0
136621,difference,0,0
136622,in,0,0
136623,the,0,0
136624,mean,0,0
136625,HR,0,0
136626,during,0,0
136627,the,0,0
136628,recovery,0,0
136629,with,0,0
136630,and,0,0
136631,without,0,1
136632,music,0,1
136633,.,0,0
136634,Listening,0,0
136635,to,0,0
136636,motivational,0,0
136637,music,0,0
136638,during,0,0
136639,the,0,0
136640,recovery,0,0
136641,was,0,0
136642,associated,0,0
136643,with,0,1
136644,increased,0,0
136645,voluntary,0,1
136646,activity,0,0
136647,of,0,0
136648,the,0,0
136649,participants,0,1
136650,",",0,0
136651,determined,0,0
136652,by,0,0
136653,increased,0,0
136654,number,0,0
136655,of,0,0
136656,steps,0,0
136657,(,0,1
136658,499.4,0,0
136659,?,0,0
136660,220.1,0,0
136661,vs.,0,0
136662,413.2,0,0
136663,?,0,1
136664,150.6,0,0
136665,steps,0,0
136666,",",0,0
136667,with,0,1
136668,and,0,0
136669,without,0,1
136670,music,0,0
136671,",",0,0
136672,respectively,0,0
136673,;,0,0
136674,p,0,0
136675,?,0,0
136676,0.05,0,0
136677,),0,0
136678,.,0,0
136679,The,0,0
136680,increased,0,0
136681,number,0,0
136682,of,0,0
136683,steps,0,0
136684,during,0,0
136685,the,0,0
136686,recovery,0,0
136687,was,0,0
136688,accompanied,0,0
136689,by,0,0
136690,a,0,0
136691,significantly,0,0
136692,greater,0,0
136693,decrease,0,0
136694,in,0,0
136695,blood,0,0
136696,lactate,0,0
136697,concentration,0,0
136698,percentage,0,0
136699,(,0,0
136700,28.1,0,0
136701,?,0,0
136702,12.2,0,0
136703,vs.,0,0
136704,22.8,0,1
136705,?,0,1
136706,10.9,0,0
136707,%,0,0
136708,",",0,0
136709,with,0,0
136710,and,0,0
136711,without,0,1
136712,music,0,0
136713,",",0,0
136714,respectively,0,0
136715,",",0,0
136716,p,0,0
136717,?,0,0
136718,0.05,0,0
136719,),0,0
136720,.,0,0
136721,This,0,0
136722,was,0,0
136723,associated,0,0
136724,with,0,1
136725,a,0,0
136726,greater,0,0
136727,decrease,0,0
136728,in,0,0
136729,RPE,0,0
136730,(,0,1
136731,77.7,0,0
136732,?,0,0
136733,14.4,0,0
136734,vs.,0,0
136735,73.1,0,0
136736,?,0,1
136737,14.7,0,0
136738,%,0,0
136739,with,0,1
136740,and,0,0
136741,without,0,1
136742,music,0,0
136743,",",0,0
136744,respectively,0,0
136745,;,0,0
136746,p,0,0
136747,?,0,0
136748,0.05,0,0
136749,),0,0
136750,.,0,1
136751,Our,0,0
136752,results,0,0
136753,suggest,0,0
136754,that,0,0
136755,listening,0,0
136756,to,0,0
136757,motivational,0,0
136758,music,0,1
136759,during,0,0
136760,nonstructured,0,0
136761,recovery,0,0
136762,from,0,1
136763,intense,0,0
136764,exercise,0,0
136765,leads,0,0
136766,to,0,0
136767,increased,0,0
136768,activity,0,0
136769,",",0,0
136770,faster,0,0
136771,lactate,0,0
136772,clearance,0,0
136773,",",0,0
136774,and,0,0
136775,reduced,0,0
136776,RPE,0,0
136777,and,0,0
136778,therefore,0,0
136779,may,0,0
136780,be,0,0
136781,used,0,0
136782,by,0,0
136783,athletes,0,1
136784,in,0,0
136785,their,0,0
136786,effort,0,0
136787,to,0,0
136788,enhance,0,0
136789,recovery,0,0
136790,.,0,0
136791,A,0,0
136792,randomized,0,0
136793,",",0,0
136794,dose-escalation,0,1
136795,study,0,0
136796,of,0,0
136797,subconjunctival,0,0
136798,and,0,0
136799,intravitreal,0,0
136800,injections,0,0
136801,of,0,0
136802,sirolimus,0,0
136803,in,0,0
136804,patients,1,1
136805,with,1,1
136806,diabetic,1,1
136807,macular,1,1
136808,edema,1,1
136809,.,1,0
136810,OBJECTIVE,0,0
136811,To,0,0
136812,evaluate,0,0
136813,the,0,0
136814,safety,0,0
136815,and,0,0
136816,tolerability,0,0
136817,of,0,0
136818,a,0,0
136819,single,0,0
136820,subconjunctival,0,0
136821,(,0,0
136822,SCJ,0,0
136823,),0,0
136824,or,0,0
136825,intravitreal,0,0
136826,(,0,0
136827,IVT,0,0
136828,),0,0
136829,injection,0,0
136830,of,0,0
136831,an,0,0
136832,ophthalmic,0,0
136833,sirolimus,0,0
136834,formulation,0,0
136835,in,0,0
136836,eyes,0,1
136837,with,0,1
136838,diabetic,0,1
136839,macular,0,1
136840,edema,0,0
136841,(,0,0
136842,DME,0,1
136843,),0,1
136844,.,0,1
136845,DESIGN,0,0
136846,Randomized,0,0
136847,",",0,0
136848,open-label,0,0
136849,",",0,0
136850,dose-escalating,0,0
136851,phase,0,0
136852,I,0,1
136853,study,0,0
136854,.,0,0
136855,PARTICIPANTS,0,0
136856,Fifty,1,1
136857,eyes,1,1
136858,among,1,1
136859,50,1,1
136860,patients,1,1
136861,with,1,1
136862,DME,1,1
136863,",",1,0
136864,retinal,1,1
136865,thickness,1,0
136866,?,1,1
136867,300,1,0
136868,microns,1,0
136869,and,1,1
136870,best-corrected,1,0
136871,visual,1,0
136872,acuity,1,0
136873,(,1,0
136874,BCVA,1,0
136875,),1,1
136876,20/40,1,0
136877,to,1,1
136878,20/200,1,0
136879,.,1,0
136880,METHODS,0,0
136881,A,0,0
136882,single,0,0
136883,dose,0,0
136884,of,0,0
136885,sirolimus,0,0
136886,administered,0,0
136887,SCJ,0,0
136888,(,0,0
136889,220,0,1
136890,",",0,0
136891,440,0,1
136892,",",0,0
136893,880,0,1
136894,",",0,0
136895,1320,0,1
136896,",",0,0
136897,or,0,1
136898,1760,0,0
136899,?g,0,0
136900,),0,0
136901,or,0,1
136902,IVT,0,0
136903,(,0,0
136904,44,0,1
136905,",",0,0
136906,110,0,1
136907,",",0,0
136908,176,0,1
136909,",",0,0
136910,264,0,1
136911,",",0,0
136912,or,0,1
136913,352,0,1
136914,?g,0,0
136915,),0,1
136916,on,0,0
136917,day,0,1
136918,0,0,0
136919,;,0,0
136920,observation,0,0
136921,through,0,0
136922,day,0,0
136923,90,0,1
136924,.,0,1
136925,MAIN,0,0
136926,OUTCOME,0,0
136927,MEASURES,0,0
136928,Primary,0,1
136929,end,0,0
136930,points,0,0
136931,were,0,0
136932,the,0,0
136933,frequency,0,0
136934,and,0,0
136935,severity,0,0
136936,of,0,0
136937,ocular,0,1
136938,and,0,1
136939,systemic,0,0
136940,adverse,0,0
136941,events,0,0
136942,.,0,1
136943,Secondary,0,0
136944,end,0,0
136945,points,0,0
136946,were,0,1
136947,changes,0,0
136948,in,0,0
136949,BCVA,0,0
136950,and,0,0
136951,retinal,0,1
136952,thickness,0,0
136953,.,0,1
136954,RESULTS,0,0
136955,No,0,0
136956,dose-limiting,0,0
136957,toxicities,0,0
136958,were,0,1
136959,observed,0,0
136960,and,0,0
136961,ocular,0,1
136962,adverse,0,0
136963,events,0,0
136964,were,0,1
136965,mostly,0,1
136966,mild,0,1
136967,and,0,0
136968,transient,0,0
136969,.,0,0
136970,Conjunctival,0,0
136971,hyperemia,0,0
136972,",",0,0
136973,hemorrhage,0,0
136974,",",0,0
136975,and,0,0
136976,edema,0,0
136977,were,0,0
136978,common,0,0
136979,after,0,0
136980,the,0,0
136981,SCJ,0,0
136982,injection,0,0
136983,procedure,0,0
136984,and,0,0
136985,conjunctival,0,0
136986,hemorrhage,0,1
136987,was,0,0
136988,common,0,0
136989,after,0,0
136990,the,0,0
136991,IVT,0,0
136992,injection,0,0
136993,procedure,0,0
136994,.,0,1
136995,Three,0,0
136996,patients,0,1
136997,experienced,0,1
136998,ocular,0,1
136999,adverse,0,0
137000,events,0,0
137001,considered,0,0
137002,possibly,0,0
137003,related,0,0
137004,to,0,0
137005,study,0,0
137006,drug,0,0
137007,:,0,1
137008,Conjunctival,0,0
137009,edema,0,0
137010,and,0,0
137011,reduced,0,0
137012,visual,0,0
137013,acuity,0,0
137014,were,0,0
137015,reported,0,0
137016,in,0,0
137017,1,0,0
137018,SCJ,0,1
137019,patient,0,1
137020,each,0,0
137021,and,0,0
137022,iritis,0,1
137023,was,0,0
137024,reported,0,0
137025,in,0,0
137026,1,0,0
137027,IVT,0,0
137028,patient,0,1
137029,.,0,0
137030,No,0,0
137031,serious,0,0
137032,ocular,0,1
137033,adverse,0,0
137034,events,0,0
137035,were,0,1
137036,reported,0,0
137037,.,0,0
137038,No,0,0
137039,nonocular,0,0
137040,adverse,0,0
137041,events,0,0
137042,were,0,1
137043,considered,0,0
137044,related,0,0
137045,to,0,0
137046,study,0,0
137047,drug,0,0
137048,.,0,0
137049,Systemic,0,0
137050,exposure,0,0
137051,to,0,0
137052,sirolimus,0,0
137053,was,0,0
137054,low,0,0
137055,",",0,0
137056,with,0,1
137057,blood,0,0
137058,concentrations,0,0
137059,below,0,0
137060,levels,0,0
137061,necessary,0,0
137062,for,0,0
137063,systemic,0,0
137064,immunosuppression,0,0
137065,.,0,0
137066,For,0,0
137067,the,0,0
137068,SCJ,0,0
137069,group,0,0
137070,(,0,0
137071,n,0,1
137072,=,0,0
137073,25,0,1
137074,),0,0
137075,",",0,0
137076,a,0,0
137077,median,0,0
137078,increase,0,0
137079,in,0,0
137080,BCVA,0,0
137081,started,0,0
137082,at,0,0
137083,day,0,0
137084,7,0,1
137085,(,0,1
137086,5.0,0,0
137087,letters,0,0
137088,),0,1
137089,and,0,0
137090,was,0,0
137091,3.0,0,0
137092,",",0,0
137093,4.0,0,0
137094,",",0,0
137095,and,0,0
137096,4.0,0,0
137097,letters,0,0
137098,at,0,1
137099,days,0,0
137100,14,0,1
137101,",",0,0
137102,45,0,1
137103,and,0,0
137104,90,0,0
137105,",",0,0
137106,respectively,0,0
137107,.,0,0
137108,At,0,0
137109,day,0,0
137110,45,0,1
137111,",",0,0
137112,median,0,0
137113,decrease,0,0
137114,in,0,0
137115,retinal,0,1
137116,thickness,0,0
137117,was,0,0
137118,-23.7,0,0
137119,?m,0,1
137120,.,0,1
137121,For,0,0
137122,the,0,0
137123,IVT,0,0
137124,group,0,0
137125,(,0,0
137126,n,0,1
137127,=,0,0
137128,25,0,1
137129,),0,0
137130,",",0,0
137131,the,0,0
137132,median,0,0
137133,increase,0,0
137134,in,0,0
137135,BCVA,0,0
137136,was,0,0
137137,2.0,0,0
137138,letters,0,0
137139,at,0,1
137140,day,0,1
137141,7,0,1
137142,;,0,0
137143,at,0,1
137144,days,0,0
137145,14,0,1
137146,",",0,0
137147,45,0,1
137148,",",0,0
137149,and,0,0
137150,90,0,0
137151,",",0,0
137152,the,0,0
137153,median,0,0
137154,increase,0,0
137155,was,0,0
137156,maintained,0,0
137157,(,0,0
137158,4.0,0,0
137159,letters,0,0
137160,),0,1
137161,;,0,0
137162,the,0,0
137163,median,0,0
137164,decrease,0,0
137165,in,0,0
137166,retinal,0,1
137167,thickness,0,0
137168,was,0,0
137169,-52.0,0,0
137170,?m,0,1
137171,at,0,0
137172,day,0,0
137173,45,0,1
137174,.,0,0
137175,CONCLUSIONS,0,0
137176,Locally,0,0
137177,administered,0,0
137178,sirolimus,0,0
137179,was,0,0
137180,well-tolerated,0,0
137181,with,0,1
137182,minimal,0,0
137183,systemic,0,0
137184,exposure,0,0
137185,at,0,0
137186,all,0,0
137187,doses,0,0
137188,tested,0,0
137189,in,0,0
137190,this,0,0
137191,small,0,0
137192,phase,0,0
137193,I,0,1
137194,population,0,1
137195,.,0,0
137196,These,0,0
137197,findings,0,0
137198,support,0,0
137199,advancing,0,0
137200,the,0,0
137201,present,0,0
137202,sirolimus,0,0
137203,formulation,0,0
137204,into,0,0
137205,phase,0,1
137206,II,0,1
137207,studies,0,0
137208,.,0,1
137209,FINANCIAL,0,0
137210,DISCLOSURE,0,0
137211,(,0,0
137212,S,0,0
137213,),0,0
137214,Proprietary,0,0
137215,or,0,1
137216,commercial,0,0
137217,disclosure,0,0
137218,may,0,0
137219,be,0,0
137220,found,0,0
137221,after,0,0
137222,the,0,0
137223,references,0,0
137224,.,0,1
137225,Response,0,0
137226,prediction,0,0
137227,in,0,0
137228,metastasised,0,1
137229,colorectal,0,1
137230,cancer,0,1
137231,using,0,0
137232,intratumoural,0,0
137233,thymidylate,0,0
137234,synthase,0,0
137235,:,0,1
137236,results,0,0
137237,of,0,0
137238,a,0,0
137239,randomised,0,0
137240,multicentre,0,0
137241,trial,0,0
137242,.,0,1
137243,BACKGROUND,0,0
137244,Molecular,0,0
137245,markers,0,0
137246,to,0,0
137247,predict,0,0
137248,response,0,0
137249,to,0,0
137250,5-fluorouracil,0,0
137251,(,0,0
137252,FU,0,0
137253,),0,0
137254,-based,0,0
137255,treatment,0,0
137256,of,0,0
137257,recurrent,1,1
137258,or,1,1
137259,metastasised,1,1
137260,colorectal,1,1
137261,cancer,1,1
137262,(,1,0
137263,mCRC,1,0
137264,),1,0
137265,are,0,0
137266,not,0,0
137267,established,0,0
137268,.,0,0
137269,The,0,0
137270,aim,0,0
137271,of,0,0
137272,this,0,0
137273,trial,0,0
137274,was,0,0
137275,to,0,0
137276,determine,0,0
137277,the,0,0
137278,value,0,0
137279,of,0,0
137280,thymidylate,0,0
137281,synthase,0,0
137282,(,0,0
137283,TS,0,1
137284,),0,0
137285,",",0,0
137286,a,0,0
137287,key,0,0
137288,enzyme,0,0
137289,of,0,0
137290,DNA,0,0
137291,synthesis,0,0
137292,and,0,0
137293,target,0,0
137294,of,0,0
137295,5-FU,0,0
137296,",",0,0
137297,to,0,0
137298,predict,0,0
137299,response,0,0
137300,to,0,0
137301,chemotherapy,0,0
137302,of,0,0
137303,mCRC,0,0
137304,.,0,1
137305,METHODS,0,0
137306,Tumour,1,0
137307,tissue,1,0
137308,was,1,0
137309,obtained,1,0
137310,from,1,1
137311,168,1,1
137312,patients,1,1
137313,with,1,1
137314,mCRC,1,0
137315,for,1,0
137316,relative,1,0
137317,thymidylate,1,0
137318,synthase,1,0
137319,(,1,0
137320,TS,1,1
137321,),1,0
137322,mRNA,1,0
137323,quantitation,1,0
137324,.,1,1
137325,Patients,0,1
137326,were,0,0
137327,randomised,0,0
137328,to,0,0
137329,receive,0,0
137330,either,0,0
137331,5-FU/folinic,0,0
137332,acid,0,0
137333,(,0,0
137334,FA,0,0
137335,",",0,0
137336,FUFA,0,0
137337,),0,0
137338,alone,0,0
137339,or,0,0
137340,in,0,0
137341,combination,0,0
137342,with,0,1
137343,irinotecan,0,0
137344,5-fluorouracil/folinic,0,0
137345,acid,0,0
137346,and,0,0
137347,irinotecan,0,0
137348,(,0,0
137349,FOLFIRI,0,0
137350,),0,0
137351,stratified,0,1
137352,by,0,0
137353,TS,0,1
137354,(,0,0
137355,low,0,0
137356,versus,0,0
137357,high,0,1
137358,),0,0
137359,.,0,1
137360,Primary,0,0
137361,end-point,0,0
137362,was,0,0
137363,overall,0,0
137364,response,0,0
137365,to,0,0
137366,first-line,0,1
137367,treatment,0,0
137368,among,0,1
137369,TS,0,1
137370,high,0,1
137371,patients,0,1
137372,.,0,1
137373,All,0,1
137374,parties,0,0
137375,",",0,0
137376,except,0,0
137377,for,0,0
137378,the,0,0
137379,randomisation,0,0
137380,centre,0,1
137381,",",0,0
137382,were,0,0
137383,blinded,0,0
137384,for,0,0
137385,TS,0,1
137386,status,0,1
137387,.,0,1
137388,RESULTS,0,0
137389,Biopsies,0,1
137390,(,0,0
137391,n=168,0,1
137392,),0,0
137393,were,0,0
137394,taken,0,0
137395,without,0,1
137396,complications,0,0
137397,.,0,1
137398,TS,0,1
137399,levels,0,0
137400,were,0,1
137401,available,0,0
137402,for,0,0
137403,147,0,1
137404,patients,0,1
137405,(,0,1
137406,87.5,0,0
137407,%,0,0
137408,),0,0
137409,.,0,0
137410,Analysing,0,0
137411,response,0,0
137412,to,0,0
137413,FUFA,0,0
137414,and,0,0
137415,FOLFIRI,0,0
137416,in,0,0
137417,the,0,0
137418,per,0,0
137419,protocol,0,0
137420,set,0,0
137421,(,0,0
137422,n=119,0,1
137423,),0,0
137424,after,0,0
137425,un-blinding,0,0
137426,TS,0,1
137427,in,0,0
137428,the,0,0
137429,data,0,0
137430,base,0,0
137431,revealed,0,0
137432,a,0,0
137433,trend,0,0
137434,to,0,0
137435,better,0,0
137436,overall,0,0
137437,response,0,0
137438,to,0,0
137439,FOLFIRI,0,0
137440,(,0,0
137441,9/19,0,0
137442,",",0,0
137443,47,0,1
137444,%,0,0
137445,),0,0
137446,in,0,0
137447,TS,0,1
137448,high,0,1
137449,compared,0,0
137450,to,0,0
137451,FUFA,0,0
137452,(,0,0
137453,5/23,0,0
137454,",",0,0
137455,22,0,1
137456,%,0,0
137457,",",0,0
137458,p=0.077,0,0
137459,),0,0
137460,.,0,0
137461,In,0,0
137462,patients,0,1
137463,with,0,1
137464,biopsies,0,1
137465,taken,0,0
137466,from,0,1
137467,liver,0,1
137468,lesions,0,1
137469,(,0,1
137470,n=91,0,1
137471,),0,0
137472,overall,0,0
137473,response,0,0
137474,to,0,0
137475,FOLFIRI,0,0
137476,and,0,0
137477,FUFA,0,0
137478,in,0,0
137479,TS,0,1
137480,high,0,1
137481,was,0,0
137482,53,0,1
137483,%,0,0
137484,(,0,1
137485,9/17,0,0
137486,),0,1
137487,and,0,0
137488,18,0,1
137489,%,0,0
137490,(,0,1
137491,3/17,0,0
137492,),0,0
137493,",",0,0
137494,respectively,0,0
137495,(,0,0
137496,p=0.035,0,0
137497,),0,0
137498,.,0,0
137499,In,0,0
137500,patients,0,1
137501,with,0,1
137502,low,0,1
137503,TS,0,1
137504,",",0,0
137505,no,0,0
137506,remarkable,0,0
137507,difference,0,0
137508,in,0,0
137509,overall,0,0
137510,response,0,0
137511,to,0,0
137512,FOLFIRI,0,0
137513,and,0,0
137514,FUFA,0,0
137515,was,0,0
137516,observed,0,0
137517,.,0,0
137518,CONCLUSIONS,0,0
137519,Taking,0,0
137520,a,0,0
137521,pre-treatment,0,0
137522,biopsy,0,0
137523,is,0,0
137524,a,0,0
137525,safe,0,0
137526,and,0,0
137527,feasible,0,0
137528,procedure,0,0
137529,in,0,0
137530,mCRC,0,0
137531,.,0,0
137532,After,0,0
137533,validation,0,0
137534,of,0,0
137535,our,0,0
137536,data,0,0
137537,in,0,0
137538,a,0,0
137539,larger,0,0
137540,group,0,0
137541,TS,0,1
137542,determination,0,0
137543,may,0,0
137544,have,0,0
137545,the,0,0
137546,potential,0,0
137547,to,0,0
137548,better,0,0
137549,help,0,0
137550,direct,0,0
137551,systemic,0,0
137552,treatment,0,0
137553,in,0,0
137554,patients,1,1
137555,with,1,1
137556,primarily,1,1
137557,non-resectable,1,1
137558,mCRC,1,0
137559,.,1,1
137560,Significant,0,0
137561,differential,0,0
137562,effects,0,0
137563,of,0,1
137564,omega-3,0,0
137565,fatty,0,0
137566,acids,0,0
137567,and,0,0
137568,fenofibrate,0,0
137569,in,0,0
137570,patients,1,1
137571,with,1,1
137572,hypertriglyceridemia,1,1
137573,.,1,1
137574,BACKGROUND,0,0
137575,Omega-3,0,0
137576,fatty,0,0
137577,acids,0,0
137578,and,0,0
137579,fenofibrate,0,0
137580,are,0,0
137581,both,0,0
137582,used,0,0
137583,to,0,0
137584,treat,0,0
137585,patients,1,1
137586,with,1,1
137587,hypertriglyceridemia,1,1
137588,.,1,0
137589,However,0,0
137590,",",0,0
137591,a,0,0
137592,head-to-head,0,0
137593,comparison,0,0
137594,of,0,0
137595,the,0,0
137596,lipoprotein,0,0
137597,and,0,0
137598,metabolic,0,1
137599,effects,0,0
137600,of,0,0
137601,these,0,0
137602,two,0,0
137603,medicines,0,0
137604,has,0,0
137605,not,0,0
137606,been,0,0
137607,published,0,0
137608,.,0,0
137609,METHODS,0,0
137610,This,0,0
137611,was,0,0
137612,a,0,0
137613,randomized,0,0
137614,",",0,0
137615,single-blind,0,0
137616,",",0,0
137617,placebo-controlled,0,0
137618,",",0,0
137619,parallel,0,0
137620,study,0,0
137621,.,0,0
137622,Age,0,0
137623,",",0,0
137624,sex,0,0
137625,",",0,0
137626,and,0,0
137627,body,0,0
137628,mass,0,0
137629,index,0,0
137630,were,0,0
137631,matched,0,1
137632,among,0,1
137633,groups,0,0
137634,.,0,1
137635,All,0,1
137636,patients,0,1
137637,were,0,0
137638,recommended,0,0
137639,to,0,0
137640,maintain,0,0
137641,a,0,0
137642,low,0,0
137643,fat,0,0
137644,diet,0,1
137645,.,0,1
137646,Fifty,1,1
137647,patients,1,1
137648,in,1,0
137649,each,1,0
137650,group,1,0
137651,were,0,0
137652,given,0,0
137653,placebo,0,0
137654,",",0,0
137655,omega-3,0,0
137656,fatty,0,0
137657,acids,0,0
137658,2,0,1
137659,g,0,1
137660,(,0,0
137661,most,0,0
137662,commonly,0,0
137663,used,0,0
137664,dosage,0,0
137665,in,0,0
137666,Korean,0,1
137667,patients,0,1
137668,),0,0
137669,",",0,0
137670,or,0,0
137671,fenofibrate,0,0
137672,160,0,1
137673,mg,0,0
137674,",",0,0
137675,respectively,0,0
137676,daily,0,0
137677,for,0,0
137678,2,0,1
137679,months,0,0
137680,.,0,1
137681,RESULTS,0,0
137682,Omega-3,0,0
137683,fatty,0,0
137684,acids,0,0
137685,therapy,0,0
137686,decreased,0,0
137687,triglycerides,0,0
137688,by,0,0
137689,21,0,1
137690,%,0,0
137691,and,0,0
137692,triglycerides/HDL,0,0
137693,cholesterol,0,0
137694,and,0,0
137695,improved,0,0
137696,flow-mediated,0,0
137697,dilation,0,0
137698,(,0,0
137699,P,0,0
137700,<,0,0
137701,0.01,0,0
137702,),0,0
137703,",",0,0
137704,however,0,0
137705,",",0,0
137706,did,0,0
137707,not,0,0
137708,significantly,0,0
137709,change,0,0
137710,insulin,0,0
137711,",",0,0
137712,plasma,0,0
137713,adiponectin,0,0
137714,levels,0,0
137715,",",0,0
137716,and,0,0
137717,insulin,0,0
137718,sensitivity,0,0
137719,(,0,0
137720,determined,0,0
137721,by,0,0
137722,QUICKI,0,1
137723,),0,0
137724,relative,0,0
137725,to,0,0
137726,baseline,0,0
137727,measurements,0,0
137728,.,0,1
137729,Fenofibrate,0,0
137730,therapy,0,0
137731,decreased,0,0
137732,total,0,1
137733,cholesterol,0,0
137734,",",0,0
137735,triglycerides,0,0
137736,by,0,0
137737,29,0,1
137738,%,0,0
137739,",",0,0
137740,and,0,0
137741,triglycerides/HDL-cholesterol,0,0
137742,(,0,0
137743,all,0,0
137744,P,0,0
137745,<,0,0
137746,0.01,0,0
137747,),0,0
137748,and,0,0
137749,improved,0,0
137750,flow-mediated,0,0
137751,dilation,0,0
137752,when,0,0
137753,compared,0,0
137754,with,0,0
137755,baseline,0,0
137756,.,0,0
137757,When,0,0
137758,compared,0,0
137759,with,0,0
137760,placebo,0,0
137761,and,0,0
137762,omega-3,0,0
137763,fatty,0,0
137764,acids,0,0
137765,",",0,0
137766,fenofibrate,0,0
137767,therapy,0,0
137768,decreased,0,0
137769,non-HDL,0,0
137770,cholesterol,0,0
137771,(,0,0
137772,P,0,0
137773,<,0,0
137774,0.001,0,0
137775,),0,0
137776,and,0,0
137777,triglycerides/HDL,0,0
137778,cholesterol,0,0
137779,(,0,0
137780,P=0.016,0,0
137781,),0,0
137782,while,0,0
137783,increasing,0,0
137784,HDL,0,0
137785,cholesterol,0,0
137786,(,0,0
137787,P,0,0
137788,<,0,0
137789,0.001,0,0
137790,),0,0
137791,and,0,0
137792,apolipoprotein,0,0
137793,AI,0,1
137794,(,0,1
137795,P=0.001,0,0
137796,),0,0
137797,.,0,0
137798,Of,0,0
137799,note,0,0
137800,",",0,0
137801,when,0,0
137802,compared,0,0
137803,with,0,0
137804,omega-3,0,0
137805,fatty,0,0
137806,acids,0,0
137807,",",0,0
137808,fenofibrate,0,0
137809,therapy,0,0
137810,decreased,0,0
137811,fasting,0,0
137812,insulin,0,0
137813,(,0,0
137814,P=0.023,0,0
137815,),0,0
137816,and,0,0
137817,increased,0,0
137818,plasma,0,0
137819,adiponectin,0,0
137820,(,0,0
137821,P=0.002,0,0
137822,),0,0
137823,and,0,0
137824,insulin,0,0
137825,sensitivity,0,0
137826,(,0,0
137827,P=0.015,0,0
137828,),0,1
137829,.,0,1
137830,CONCLUSIONS,0,0
137831,Omega-3,0,0
137832,fatty,0,0
137833,acids,0,0
137834,and,0,1
137835,fenofibrate,0,0
137836,therapy,0,0
137837,promoted,0,0
137838,similar,0,0
137839,changes,0,0
137840,in,0,1
137841,triglycerides,0,0
137842,and,0,1
137843,endothelium-dependent,0,0
137844,dilation,0,0
137845,.,0,0
137846,However,0,0
137847,",",0,0
137848,fenofibrate,0,0
137849,therapy,0,0
137850,had,0,0
137851,substantially,0,0
137852,better,0,0
137853,effects,0,0
137854,on,0,0
137855,lipoprotein,0,0
137856,and,0,0
137857,metabolic,0,1
137858,profiles,0,0
137859,in,0,1
137860,patients,1,1
137861,with,1,1
137862,hypertriglyceridemia,1,1
137863,.,1,1
137864,Dopamine,0,0
137865,transporter,0,0
137866,gene,0,0
137867,moderates,0,0
137868,response,0,0
137869,to,0,0
137870,behavioral,1,0
137871,parent,1,0
137872,training,1,0
137873,in,1,0
137874,children,1,1
137875,with,1,1
137876,ADHD,1,1
137877,:,1,1
137878,a,0,0
137879,pilot,0,0
137880,study,0,0
137881,.,0,0
137882,There,0,0
137883,is,0,0
137884,great,0,0
137885,variability,0,0
137886,in,0,0
137887,the,0,0
137888,degree,0,0
137889,to,0,0
137890,which,0,0
137891,children,1,1
137892,with,1,1
137893,attention,1,0
137894,deficit/hyperactivity,1,1
137895,disorder,1,1
137896,(,1,0
137897,ADHD,1,0
137898,),1,0
137899,improve,0,0
137900,through,0,0
137901,behavioral,0,1
137902,treatments,0,0
137903,.,0,1
137904,This,0,0
137905,study,0,0
137906,investigates,0,0
137907,the,0,0
137908,influence,0,0
137909,of,0,0
137910,the,0,0
137911,dopamine,0,0
137912,transporter,0,0
137913,gene,0,0
137914,(,0,0
137915,SCL6A3/DAT1,0,0
137916,),0,0
137917,on,0,0
137918,outcome,0,0
137919,of,0,0
137920,behavioral,0,0
137921,parent,0,0
137922,training,0,0
137923,(,0,0
137924,BPT,0,1
137925,),0,1
137926,.,0,1
137927,Study,1,0
137928,subjects,1,1
137929,were,1,0
137930,a,1,0
137931,subsample,1,1
137932,(,1,0
137933,n,1,1
137934,=,1,0
137935,50,1,0
137936,",",1,1
137937,for,1,1
137938,whom,1,1
137939,DAT1,1,1
137940,genotypes,1,1
137941,were,1,1
137942,available,1,0
137943,),1,0
137944,of,1,0
137945,a,1,0
137946,randomized,1,0
137947,controlled,1,0
137948,BPT,1,0
137949,effectiveness,1,0
137950,study,1,0
137951,(,1,0
137952,N,1,1
137953,=,1,0
137954,94,1,1
137955,),1,0
137956,comparing,1,0
137957,BPT,1,1
137958,plus,1,0
137959,ongoing,1,0
137960,routine,1,0
137961,clinical,1,0
137962,care,1,1
137963,(,1,0
137964,RCC,1,0
137965,),1,0
137966,versus,1,0
137967,RCC,1,0
137968,alone,1,0
137969,in,1,0
137970,referred,1,1
137971,children,1,1
137972,(,1,1
137973,4-12,1,1
137974,years,1,1
137975,old,1,1
137976,),1,1
137977,with,1,1
137978,ADHD,1,0
137979,.,1,1
137980,Treatment,0,0
137981,outcome,0,0
137982,was,0,0
137983,based,0,0
137984,on,0,0
137985,parent-reported,0,0
137986,ADHD,0,1
137987,symptoms,0,0
137988,and,0,1
137989,behavioral,0,1
137990,problems,0,1
137991,.,0,1
137992,Presence,0,0
137993,of,0,0
137994,2,0,0
137995,versus,0,0
137996,no,0,0
137997,or,0,0
137998,1,0,0
137999,DAT1,0,1
138000,10-repeat,0,1
138001,allele,0,0
138002,served,0,0
138003,as,0,0
138004,moderator,0,0
138005,variable,0,1
138006,.,0,1
138007,Time,0,0
138008,?,0,0
138009,Treatment,0,0
138010,?,0,0
138011,Genotype,0,1
138012,effect,0,0
138013,was,0,0
138014,analyzed,0,0
138015,with,0,1
138016,repeated-measures,0,0
138017,analysis,0,0
138018,of,0,0
138019,variance,0,0
138020,",",0,0
138021,controlling,0,0
138022,for,0,0
138023,baseline,0,0
138024,medication,0,0
138025,status,0,1
138026,.,0,0
138027,Results,0,0
138028,indicate,0,0
138029,that,0,0
138030,DAT1,0,1
138031,moderated,0,0
138032,treatment,0,0
138033,response,0,0
138034,(,0,0
138035,p,0,0
138036,=,0,0
138037,.009,0,0
138038,),0,0
138039,.,0,0
138040,In,0,0
138041,children,0,1
138042,with,0,1
138043,no,0,0
138044,or,0,1
138045,1,0,0
138046,DAT1,0,1
138047,10-repeat,0,0
138048,allele,0,0
138049,",",0,0
138050,superior,0,0
138051,treatment,0,0
138052,effects,0,0
138053,of,0,0
138054,BPT,0,1
138055,+,0,0
138056,RCC,0,0
138057,compared,0,0
138058,with,0,1
138059,RCC,0,0
138060,alone,0,0
138061,were,0,0
138062,present,0,0
138063,(,0,1
138064,p,0,0
138065,=,0,0
138066,.005,0,0
138067,),0,0
138068,",",0,0
138069,which,0,0
138070,was,0,0
138071,not,0,0
138072,the,0,0
138073,case,0,0
138074,in,0,0
138075,children,0,1
138076,with,0,1
138077,2,0,1
138078,DAT1,0,1
138079,10-repeat,0,1
138080,alleles,0,0
138081,(,0,1
138082,p,0,0
138083,=,0,0
138084,.57,0,1
138085,),0,0
138086,.,0,0
138087,Our,0,0
138088,findings,0,0
138089,suggest,0,0
138090,that,0,0
138091,genetic,0,0
138092,differences,0,0
138093,in,0,0
138094,DAT1,0,1
138095,in,0,0
138096,children,0,1
138097,with,0,1
138098,ADHD,0,0
138099,influence,0,0
138100,their,0,0
138101,susceptibility,0,0
138102,to,0,0
138103,a,0,0
138104,behavioral,0,0
138105,intervention,0,0
138106,directed,0,0
138107,at,0,0
138108,shaping,0,0
138109,their,0,0
138110,environment,0,0
138111,through,0,0
138112,their,0,1
138113,parents,0,1
138114,.,0,0
138115,The,0,0
138116,role,0,0
138117,of,0,0
138118,the,0,0
138119,dopamine,0,0
138120,system,0,0
138121,in,0,0
138122,motivation,0,0
138123,and,0,0
138124,learning,0,0
138125,and,0,0
138126,in,0,0
138127,the,0,0
138128,aberrant,0,0
138129,sensitivity,0,0
138130,to,0,0
138131,reinforcement,0,0
138132,in,0,0
138133,children,0,1
138134,with,0,1
138135,ADHD,0,0
138136,may,0,0
138137,explain,0,0
138138,this,0,0
138139,moderating,0,0
138140,effect,0,0
138141,",",0,0
138142,given,0,0
138143,that,0,0
138144,the,0,0
138145,management,0,0
138146,of,0,0
138147,contingencies,0,0
138148,is,0,0
138149,typically,0,1
138150,addressed,0,0
138151,in,0,0
138152,BPT,0,1
138153,.,0,1
138154,Non-verbal,0,0
138155,communication,0,0
138156,of,0,0
138157,compassion,0,0
138158,:,0,1
138159,measuring,0,0
138160,psychophysiologic,0,0
138161,effects,0,0
138162,.,0,1
138163,BACKGROUND,0,0
138164,Calm,0,0
138165,",",0,0
138166,compassionate,0,0
138167,clinicians,0,0
138168,comfort,0,0
138169,others,0,0
138170,.,0,1
138171,To,0,0
138172,evaluate,0,0
138173,the,0,0
138174,direct,0,0
138175,psychophysiologic,0,0
138176,benefits,0,0
138177,of,0,0
138178,non-verbal,0,1
138179,communication,0,0
138180,of,0,0
138181,compassion,0,0
138182,(,0,0
138183,NVCC,0,0
138184,),0,0
138185,",",0,0
138186,it,0,0
138187,is,0,0
138188,important,0,0
138189,to,0,0
138190,minimize,0,0
138191,the,0,0
138192,effect,0,0
138193,of,0,0
138194,subjects,0,1
138195,',0,1
138196,expectation,0,0
138197,.,0,1
138198,This,0,0
138199,preliminary,0,0
138200,study,0,0
138201,was,0,0
138202,designed,0,0
138203,to,0,0
138204,a,0,0
138205,),0,0
138206,test,0,0
138207,the,0,0
138208,feasibility,0,0
138209,of,0,0
138210,two,0,0
138211,strategies,0,0
138212,for,0,0
138213,maintaining,0,0
138214,subject,0,0
138215,blinding,0,0
138216,to,0,0
138217,non-verbal,0,0
138218,communication,0,0
138219,of,0,0
138220,compassion,0,0
138221,(,0,0
138222,NVCC,0,0
138223,),0,0
138224,",",0,0
138225,and,0,0
138226,b,0,0
138227,),0,0
138228,determine,0,0
138229,whether,0,0
138230,blinded,0,0
138231,subjects,0,1
138232,would,0,0
138233,experience,0,1
138234,psychophysiologic,0,0
138235,effects,0,0
138236,from,0,1
138237,NVCC,0,1
138238,.,0,1
138239,METHODS,0,0
138240,Subjects,1,1
138241,were,1,1
138242,healthy,1,1
138243,volunteers,1,1
138244,who,1,1
138245,were,1,1
138246,told,1,1
138247,the,1,0
138248,study,1,0
138249,was,1,0
138250,evaluating,1,0
138251,the,1,0
138252,effect,1,0
138253,of,1,0
138254,time,1,0
138255,and,1,0
138256,touch,1,0
138257,on,1,0
138258,the,1,0
138259,autonomic,1,1
138260,nervous,1,0
138261,system,1,0
138262,.,1,0
138263,The,1,0
138264,practitioner,1,0
138265,had,1,0
138266,more,1,0
138267,than,1,0
138268,10,1,0
138269,years,1,1
138270,',1,1
138271,experience,1,0
138272,with,1,1
138273,loving-kindness,1,0
138274,meditation,1,0
138275,(,1,0
138276,LKM,1,0
138277,),1,0
138278,",",1,0
138279,a,1,0
138280,form,1,0
138281,of,1,0
138282,NVCC,1,0
138283,.,1,1
138284,Subjects,0,1
138285,completed,0,1
138286,10-point,0,0
138287,visual,0,0
138288,analog,0,0
138289,scales,0,0
138290,(,0,1
138291,VAS,0,1
138292,),0,0
138293,for,0,0
138294,stress,0,0
138295,",",0,0
138296,relaxation,0,0
138297,",",0,0
138298,and,0,0
138299,peacefulness,0,0
138300,before,0,0
138301,and,0,0
138302,after,0,0
138303,LKM,0,0
138304,.,0,1
138305,To,0,0
138306,assess,0,0
138307,physiologic,0,0
138308,effects,0,0
138309,",",0,1
138310,practitioners,0,1
138311,and,0,0
138312,subjects,0,1
138313,wore,0,1
138314,cardiorespiratory,0,1
138315,monitors,0,0
138316,to,0,0
138317,assess,0,0
138318,respiratory,0,1
138319,rate,0,0
138320,(,0,0
138321,RR,0,0
138322,),0,0
138323,",",0,0
138324,heart,0,1
138325,rate,0,0
138326,(,0,0
138327,HR,0,0
138328,),0,0
138329,and,0,0
138330,heart,0,1
138331,rate,0,0
138332,variability,0,0
138333,(,0,0
138334,HRV,0,0
138335,),0,0
138336,throughout,0,0
138337,the,0,0
138338,4,0,0
138339,10-minute,0,0
138340,study,0,1
138341,periods,0,0
138342,:,0,1
138343,Baseline,0,0
138344,(,0,0
138345,both,0,0
138346,practitioner,0,0
138347,and,0,0
138348,subjects,0,1
138349,read,0,0
138350,neutral,0,0
138351,material,0,1
138352,),0,1
138353,;,0,0
138354,non-tactile-LKM,0,0
138355,(,0,0
138356,subjects,0,1
138357,read,0,0
138358,while,0,0
138359,the,0,0
138360,practitioner,0,0
138361,practiced,0,0
138362,LKM,0,0
138363,while,0,0
138364,pretending,0,0
138365,to,0,0
138366,read,0,0
138367,),0,0
138368,;,0,0
138369,tactile-LKM,0,0
138370,(,0,1
138371,subjects,0,1
138372,rested,0,0
138373,while,0,0
138374,the,0,0
138375,practitioner,0,0
138376,practiced,0,0
138377,LKM,0,0
138378,while,0,0
138379,lightly,0,0
138380,touching,0,0
138381,the,0,0
138382,subject,0,0
138383,on,0,0
138384,arms,0,0
138385,",",0,0
138386,shoulders,0,1
138387,",",0,0
138388,hands,0,0
138389,",",0,0
138390,feet,0,0
138391,",",0,0
138392,and,0,0
138393,legs,0,0
138394,),0,1
138395,;,0,1
138396,Post-Intervention,0,1
138397,Rest,0,1
138398,(,0,1
138399,subjects,0,1
138400,rested,0,0
138401,;,0,0
138402,the,0,0
138403,practitioner,0,0
138404,read,0,0
138405,),0,0
138406,.,0,0
138407,To,0,0
138408,assess,0,0
138409,blinding,0,0
138410,",",0,0
138411,subjects,0,1
138412,were,0,0
138413,asked,0,0
138414,after,0,0
138415,the,0,1
138416,interventions,0,1
138417,what,0,0
138418,the,0,1
138419,practitioner,0,1
138420,was,0,0
138421,doing,0,0
138422,during,0,0
138423,each,0,0
138424,period,0,0
138425,(,0,0
138426,reading,0,0
138427,",",0,0
138428,touch,0,0
138429,",",0,0
138430,or,0,0
138431,something,0,0
138432,else,0,0
138433,),0,0
138434,.,0,1
138435,RESULTS,0,0
138436,Subjects,1,1
138437,',1,1
138438,mean,1,1
138439,age,1,1
138440,was,1,0
138441,43.6,1,1
138442,years,1,1
138443,;,1,1
138444,all,1,0
138445,were,1,0
138446,women,1,1
138447,.,1,1
138448,Blinding,0,0
138449,was,0,0
138450,maintained,0,0
138451,and,0,0
138452,the,0,0
138453,practitioner,0,0
138454,was,0,0
138455,able,0,0
138456,to,0,0
138457,maintain,0,0
138458,meditation,0,0
138459,for,0,0
138460,both,0,0
138461,tactile,0,0
138462,and,0,0
138463,non-tactile,0,0
138464,LKM,0,0
138465,interventions,0,0
138466,as,0,0
138467,reflected,0,0
138468,in,0,0
138469,significantly,0,0
138470,reduced,0,0
138471,RR,0,0
138472,.,0,0
138473,Despite,0,0
138474,blinding,0,0
138475,",",0,0
138476,subjects,0,1
138477,',0,1
138478,VAS,0,1
138479,scores,0,0
138480,improved,0,0
138481,from,0,1
138482,baseline,0,0
138483,to,0,0
138484,post-intervention,0,0
138485,for,0,0
138486,stress,0,0
138487,(,0,0
138488,5.5,0,0
138489,vs.,0,0
138490,2.2,0,0
138491,),0,0
138492,",",0,0
138493,relaxation,0,0
138494,(,0,0
138495,3.8,0,0
138496,vs.,0,0
138497,8.8,0,0
138498,),0,0
138499,and,0,0
138500,peacefulness,0,0
138501,(,0,0
138502,3.8,0,0
138503,vs.,0,0
138504,9.0,0,0
138505,",",0,0
138506,P,0,0
138507,<,0,0
138508,0.05,0,0
138509,for,0,0
138510,all,0,1
138511,comparisons,0,0
138512,),0,1
138513,.,0,1
138514,Subjects,0,1
138515,also,0,0
138516,had,0,1
138517,significant,0,0
138518,reductions,0,0
138519,in,0,0
138520,RR,0,0
138521,(,0,1
138522,P,0,0
138523,<,0,0
138524,0.0001,0,0
138525,),0,0
138526,and,0,0
138527,improved,0,0
138528,HRV,0,0
138529,(,0,0
138530,P,0,0
138531,<,0,0
138532,0.05,0,0
138533,),0,0
138534,with,0,1
138535,both,0,0
138536,tactile,0,0
138537,and,0,0
138538,non-tactile,0,0
138539,LKM,0,0
138540,.,0,1
138541,CONCLUSION,0,0
138542,It,0,0
138543,is,0,0
138544,possible,0,0
138545,to,0,0
138546,test,0,0
138547,the,0,0
138548,effects,0,0
138549,of,0,0
138550,LKM,0,1
138551,with,0,1
138552,tactile,0,0
138553,and,0,0
138554,non-tactile,0,0
138555,blinding,0,0
138556,strategies,0,0
138557,;,0,0
138558,even,0,0
138559,with,0,0
138560,blinding,0,0
138561,in,0,0
138562,this,0,0
138563,small,0,0
138564,preliminary,0,0
138565,study,0,0
138566,",",0,0
138567,subjects,0,1
138568,reported,0,0
138569,significant,0,0
138570,improvements,0,0
138571,in,0,0
138572,well-being,0,0
138573,which,0,0
138574,were,0,0
138575,reflected,0,0
138576,in,0,0
138577,objective,0,0
138578,physiologic,0,1
138579,measures,0,0
138580,of,0,0
138581,autonomic,0,1
138582,activity,0,0
138583,.,0,0
138584,Extending,0,0
138585,compassion,0,0
138586,is,0,0
138587,not,0,0
138588,only,0,0
138589,good,0,0
138590,care,0,1
138591,;,0,0
138592,it,0,0
138593,may,0,0
138594,also,0,0
138595,be,0,0
138596,good,0,0
138597,medicine,0,1
138598,.,0,1
138599,TRIAL,0,0
138600,REGISTRATION,0,0
138601,NUMBER,0,0
138602,US,0,0
138603,National,0,1
138604,ClinicalTrials.gov,0,0
138605,registration,0,0
138606,number,0,0
138607,",",0,0
138608,NCT01428674,0,0
138609,.,0,1
138610,Comparison,0,0
138611,of,0,0
138612,cefuroxime,0,0
138613,axetil,0,0
138614,",",0,0
138615,cefaclor,0,0
138616,",",0,0
138617,and,0,0
138618,amoxicillin-clavulanate,0,0
138619,potassium,0,0
138620,suspensions,0,0
138621,in,0,0
138622,acute,1,1
138623,otitis,1,1
138624,media,1,0
138625,in,1,0
138626,infants,1,1
138627,and,1,1
138628,children,1,1
138629,.,1,1
138630,In,0,0
138631,this,0,0
138632,randomized,0,0
138633,",",0,0
138634,blinded,0,0
138635,",",0,0
138636,multicenter,0,0
138637,comparison,0,0
138638,study,0,0
138639,",",0,0
138640,377,1,1
138641,infants,1,1
138642,and,1,1
138643,children,1,1
138644,with,1,1
138645,acute,1,1
138646,otitis,1,1
138647,media,1,0
138648,(,1,1
138649,AOM,1,1
138650,),1,0
138651,received,1,0
138652,a,1,0
138653,10-day,1,0
138654,course,1,0
138655,of,1,0
138656,an,1,0
138657,oral,1,0
138658,suspension,1,0
138659,of,0,0
138660,one,0,0
138661,of,0,0
138662,the,0,0
138663,following,0,0
138664,:,0,1
138665,cefuroxime,0,0
138666,axetil,0,0
138667,(,0,0
138668,CAE,0,1
138669,),0,0
138670,",",0,0
138671,30,0,1
138672,mg/kg/day,0,0
138673,;,0,0
138674,cefaclor,0,0
138675,(,0,0
138676,CEC,0,0
138677,),0,0
138678,",",0,0
138679,40,0,1
138680,mg/kg/day,0,0
138681,;,0,0
138682,or,0,1
138683,amoxicillin-clavulanate,0,0
138684,potassium,0,0
138685,(,0,0
138686,AMX-CL,0,0
138687,),0,0
138688,",",0,0
138689,40,0,1
138690,mg/kg/day,0,0
138691,.,0,1
138692,Clinical,0,0
138693,efficacy,0,0
138694,was,0,0
138695,determined,0,0
138696,by,0,0
138697,pneumatic,0,0
138698,otoscopy,0,1
138699,and,0,0
138700,tympanometric,0,1
138701,testing,0,0
138702,3,0,0
138703,to,0,0
138704,5,0,0
138705,",",0,0
138706,11,0,0
138707,to,0,0
138708,14,0,0
138709,",",0,0
138710,and,0,0
138711,22,0,1
138712,to,0,0
138713,26,0,1
138714,days,0,0
138715,after,0,0
138716,the,0,0
138717,initiation,0,0
138718,of,0,0
138719,therapy,0,0
138720,.,0,0
138721,There,0,0
138722,was,0,0
138723,a,0,0
138724,statistically,0,0
138725,significant,0,0
138726,difference,0,0
138727,among,0,0
138728,the,0,0
138729,three,0,0
138730,treatment,0,0
138731,groups,0,0
138732,with,0,1
138733,respect,0,0
138734,to,0,0
138735,clinical,0,0
138736,outcome,0,0
138737,;,0,0
138738,more,0,0
138739,patients,0,1
138740,in,0,0
138741,the,0,0
138742,CAE,0,0
138743,group,0,0
138744,(,0,0
138745,62,0,1
138746,%,0,0
138747,),0,0
138748,than,0,0
138749,in,0,0
138750,the,0,0
138751,CEC,0,0
138752,group,0,0
138753,(,0,0
138754,46,0,1
138755,%,0,0
138756,),0,0
138757,or,0,0
138758,the,0,0
138759,AMX-CL,0,0
138760,group,0,0
138761,(,0,0
138762,52,0,1
138763,%,0,0
138764,),0,0
138765,had,0,0
138766,complete,0,0
138767,resolution,0,0
138768,of,0,0
138769,signs,0,0
138770,and,0,1
138771,symptoms,0,1
138772,of,0,0
138773,AOM,0,1
138774,(,0,0
138775,including,0,0
138776,effusion,0,1
138777,),0,1
138778,.,0,0
138779,Paired,0,0
138780,comparisons,0,0
138781,revealed,0,0
138782,a,0,0
138783,significant,0,0
138784,difference,0,0
138785,in,0,0
138786,efficacy,0,0
138787,between,0,0
138788,CAE,0,1
138789,and,0,0
138790,CEC,0,0
138791,and,0,0
138792,a,0,0
138793,nearly,0,0
138794,significant,0,0
138795,difference,0,0
138796,between,0,0
138797,AMX-CL,0,0
138798,and,0,1
138799,CEC,0,0
138800,.,0,1
138801,Taste,0,0
138802,acceptability,0,0
138803,was,0,0
138804,highest,0,0
138805,for,0,0
138806,CEC,0,0
138807,and,0,0
138808,lowest,0,0
138809,for,0,0
138810,this,0,0
138811,formulation,0,0
138812,of,0,0
138813,CAE,0,1
138814,.,0,0
138815,Significantly,0,0
138816,more,0,0
138817,patients,0,1
138818,in,0,0
138819,the,0,0
138820,AMX-CL,0,0
138821,group,0,0
138822,than,0,0
138823,in,0,0
138824,the,0,0
138825,CAE,0,1
138826,or,0,1
138827,CEC,0,0
138828,group,0,0
138829,had,0,0
138830,a,0,0
138831,side,0,0
138832,effect,0,0
138833,",",0,0
138834,primarily,0,0
138835,diarrhea,0,0
138836,",",0,0
138837,vomiting,0,0
138838,",",0,0
138839,or,0,1
138840,diaper,0,0
138841,rash,0,0
138842,.,0,0
138843,We,0,0
138844,conclude,0,0
138845,that,0,0
138846,CAE,0,0
138847,suspension,0,0
138848,has,0,0
138849,greater,0,0
138850,clinical,0,0
138851,efficacy,0,0
138852,than,0,0
138853,CEC,0,0
138854,and,0,0
138855,fewer,0,0
138856,side,0,0
138857,effects,0,0
138858,than,0,0
138859,AMX-CL,0,1
138860,.,0,1
138861,Randomised,0,0
138862,clinical,0,0
138863,trial,0,0
138864,:,0,1
138865,efficacy,0,0
138866,of,0,0
138867,a,0,0
138868,new,0,0
138869,synbiotic,0,0
138870,formulation,0,0
138871,containing,0,0
138872,Lactobacillus,0,0
138873,paracasei,0,0
138874,B21060,0,0
138875,plus,0,0
138876,arabinogalactan,0,0
138877,and,0,0
138878,xilooligosaccharides,0,0
138879,in,0,0
138880,children,1,1
138881,with,1,1
138882,acute,1,1
138883,diarrhoea,1,1
138884,.,1,1
138885,BACKGROUND,0,0
138886,Acute,0,0
138887,diarrhoea,0,0
138888,is,0,0
138889,a,0,0
138890,frequent,0,0
138891,problem,0,0
138892,in,0,0
138893,children,1,1
138894,with,1,1
138895,heavy,1,1
138896,economic,1,0
138897,burden,1,0
138898,for,1,0
138899,families,1,1
138900,and,1,1
138901,society,1,1
138902,.,1,0
138903,AIM,0,0
138904,To,0,0
138905,test,0,0
138906,the,0,0
138907,efficacy,0,0
138908,of,0,0
138909,a,0,0
138910,new,0,0
138911,synbiotic,0,0
138912,formulation,0,0
138913,containing,0,0
138914,Lactobacillus,0,0
138915,paracasei,0,0
138916,B21060,0,0
138917,",",0,0
138918,arabinogalactan,0,0
138919,and,0,0
138920,xilooligosaccharides,0,0
138921,in,0,0
138922,children,1,1
138923,with,1,1
138924,acute,1,1
138925,diarrhoea,1,1
138926,.,1,1
138927,METHODS,0,0
138928,Double-blind,0,0
138929,",",0,0
138930,randomised,0,0
138931,",",0,0
138932,placebo-controlled,0,0
138933,trial,0,0
138934,",",0,0
138935,including,0,0
138936,children,1,1
138937,(,1,1
138938,age,1,1
138939,3-36,1,0
138940,m,1,1
138941,),1,0
138942,with,1,1
138943,acute,1,1
138944,diarrhoea,1,1
138945,who,0,1
138946,were,0,1
138947,allocated,0,1
138948,to,0,0
138949,placebo,0,0
138950,or,0,1
138951,synbiotic,0,0
138952,group,0,0
138953,.,0,1
138954,Major,0,0
138955,outcome,0,0
138956,was,0,0
138957,resolution,0,0
138958,rate,0,0
138959,of,0,0
138960,diarrhoea,0,0
138961,at,0,0
138962,72,0,1
138963,h.,0,1
138964,Total,0,1
138965,duration,0,0
138966,of,0,0
138967,diarrhoea,0,0
138968,",",0,0
138969,daily,0,0
138970,stool,0,0
138971,outputs,0,0
138972,",",0,0
138973,stool,0,0
138974,consistency,0,0
138975,",",0,0
138976,working,0,0
138977,days,0,0
138978,lost,0,1
138979,by,0,0
138980,parents,0,1
138981,",",0,1
138982,adjunctive,0,0
138983,medications,0,0
138984,",",0,0
138985,and,0,0
138986,hospitalisation,0,0
138987,were,0,0
138988,also,0,0
138989,assessed,0,0
138990,.,0,0
138991,RESULTS,0,0
138992,We,0,0
138993,enrolled,0,1
138994,55,1,1
138995,children,1,1
138996,in,1,0
138997,placebo,1,0
138998,group,1,0
138999,and,1,0
139000,52,1,1
139001,in,1,0
139002,synbiotic,1,0
139003,group,1,1
139004,.,1,1
139005,The,1,0
139006,two,1,0
139007,groups,1,0
139008,were,1,1
139009,similar,1,0
139010,for,1,0
139011,demographic,1,0
139012,and,1,1
139013,clinical,1,0
139014,characteristics,1,0
139015,.,1,1
139016,Resolution,0,0
139017,rate,0,0
139018,of,0,0
139019,diarrhoea,0,0
139020,at,0,0
139021,72,0,1
139022,h,0,0
139023,was,0,0
139024,significantly,0,0
139025,higher,0,0
139026,in,0,0
139027,synbiotic,0,0
139028,group,0,1
139029,(,0,0
139030,67,0,1
139031,%,0,0
139032,),0,0
139033,compared,0,0
139034,to,0,0
139035,placebo,0,0
139036,group,0,0
139037,(,0,0
139038,40,0,1
139039,%,0,0
139040,",",0,0
139041,P,0,0
139042,=,0,0
139043,0.005,0,0
139044,),0,1
139045,.,0,1
139046,Children,0,1
139047,in,0,0
139048,synbiotic,0,0
139049,group,0,0
139050,showed,0,0
139051,a,0,0
139052,significant,0,0
139053,reduction,0,0
139054,in,0,0
139055,the,0,0
139056,duration,0,0
139057,of,0,0
139058,diarrhoea,0,0
139059,(,0,0
139060,90.5,0,0
139061,h,0,0
139062,",",0,0
139063,78.1-102.9,0,0
139064,vs.,0,0
139065,109.8,0,0
139066,h,0,0
139067,",",0,0
139068,96.0-123.5,0,0
139069,",",0,0
139070,P,0,0
139071,=,0,0
139072,0.040,0,0
139073,),0,0
139074,",",0,0
139075,daily,0,0
139076,stool,0,0
139077,outputs,0,0
139078,(,0,0
139079,3.3,0,0
139080,",",0,0
139081,2.8-3.8,0,1
139082,vs.,0,0
139083,2.4,0,0
139084,",",0,0
139085,1.9-2.8,0,0
139086,",",0,0
139087,P,0,0
139088,=,0,0
139089,0.005,0,0
139090,),0,0
139091,and,0,0
139092,stool,0,0
139093,consistency,0,0
139094,(,0,0
139095,1.3,0,0
139096,",",0,0
139097,0.9-1.6,0,0
139098,vs.,0,0
139099,0.6,0,0
139100,",",0,0
139101,0.4-0.9,0,0
139102,",",0,0
139103,P,0,0
139104,=,0,0
139105,0.002,0,0
139106,),0,0
139107,compared,0,0
139108,to,0,0
139109,placebo,0,0
139110,group,0,0
139111,(,0,0
139112,data,0,0
139113,expressed,0,0
139114,as,0,0
139115,mean,0,0
139116,",",0,0
139117,95,0,0
139118,%,0,0
139119,CI,0,0
139120,),0,0
139121,.,0,0
139122,Rate,0,0
139123,of,0,0
139124,parents,0,1
139125,that,0,0
139126,missed,0,1
139127,at,0,0
139128,least,0,1
139129,one,0,1
139130,working,0,0
139131,day,0,0
139132,(,0,0
139133,41.8,0,0
139134,%,0,0
139135,vs.,0,0
139136,15.4,0,0
139137,%,0,0
139138,",",0,0
139139,P,0,0
139140,=,0,0
139141,0.003,0,0
139142,),0,0
139143,",",0,0
139144,rate,0,0
139145,of,0,0
139146,children,0,1
139147,that,0,0
139148,needed,0,0
139149,adjunctive,0,0
139150,medications,0,0
139151,(,0,1
139152,25.5,0,1
139153,%,0,0
139154,vs.,0,0
139155,5.8,0,0
139156,%,0,0
139157,",",0,0
139158,P,0,0
139159,=,0,0
139160,0.005,0,0
139161,),0,0
139162,or,0,1
139163,hospitalisation,0,0
139164,(,0,0
139165,10.9,0,0
139166,%,0,0
139167,vs.,0,0
139168,0,0,0
139169,%,0,0
139170,",",0,0
139171,P,0,0
139172,=,0,0
139173,0.014,0,0
139174,),0,0
139175,after,0,0
139176,the,0,0
139177,first,0,0
139178,72,0,0
139179,h,0,0
139180,of,0,0
139181,treatment,0,0
139182,",",0,0
139183,were,0,0
139184,reduced,0,0
139185,in,0,0
139186,synbiotic,0,0
139187,group,0,1
139188,.,0,1
139189,CONCLUSION,0,0
139190,The,0,0
139191,synbiotic,0,0
139192,formulation,0,0
139193,studied,0,0
139194,is,0,0
139195,effective,0,0
139196,in,0,0
139197,children,0,1
139198,with,0,1
139199,acute,0,1
139200,diarrhoea,0,1
139201,.,0,1
139202,Australian,0,1
139203,New,0,1
139204,Zealand,0,1
139205,Clinical,0,0
139206,Trials,0,0
139207,Registry,0,1
139208,(,0,0
139209,ACTRN12611000641998,0,1
139210,),0,1
139211,.,0,1
139212,Virtual,0,0
139213,reality,0,0
139214,for,0,0
139215,acute,0,1
139216,pain,0,0
139217,reduction,0,0
139218,in,0,0
139219,adolescents,1,1
139220,undergoing,1,1
139221,burn,1,1
139222,wound,1,1
139223,care,1,1
139224,:,1,1
139225,a,0,0
139226,prospective,0,0
139227,randomized,0,0
139228,controlled,0,0
139229,trial,0,0
139230,.,0,1
139231,BACKGROUND,0,0
139232,Effective,0,0
139233,pain,0,0
139234,management,0,0
139235,remains,0,0
139236,a,0,0
139237,challenge,0,0
139238,for,0,0
139239,adolescents,1,1
139240,during,1,0
139241,conscious,1,0
139242,burn,1,1
139243,wound,1,0
139244,care,1,1
139245,procedures,1,0
139246,.,1,1
139247,Virtual,0,0
139248,reality,0,0
139249,(,0,0
139250,VR,0,0
139251,),0,0
139252,shows,0,0
139253,promise,0,0
139254,as,0,0
139255,a,0,0
139256,non-pharmacological,0,0
139257,adjunct,0,0
139258,in,0,0
139259,reducing,0,0
139260,pain,0,1
139261,.,0,0
139262,AIMS,0,0
139263,This,0,0
139264,study,0,0
139265,assessed,0,0
139266,off-the-shelf,0,0
139267,VR,0,0
139268,for,0,0
139269,(,0,0
139270,1,0,0
139271,),0,0
139272,its,0,0
139273,effect,0,0
139274,on,0,0
139275,reducing,0,0
139276,acute,0,1
139277,pain,0,1
139278,intensity,0,0
139279,during,0,0
139280,adolescent,0,1
139281,burn,0,1
139282,wound,0,0
139283,care,0,0
139284,",",0,0
139285,and,0,0
139286,(,0,0
139287,2,0,0
139288,),0,0
139289,its,0,0
139290,clinical,0,0
139291,utility,0,0
139292,in,0,0
139293,a,0,0
139294,busy,0,1
139295,hospital,0,1
139296,setting,0,1
139297,.,0,1
139298,METHODS,0,0
139299,Forty-one,1,1
139300,adolescents,1,1
139301,(,1,1
139302,11-17,1,1
139303,years,1,1
139304,),1,1
139305,participated,0,1
139306,in,0,0
139307,this,0,0
139308,prospective,0,0
139309,randomized,0,0
139310,controlled,0,0
139311,trial,0,0
139312,.,0,0
139313,Acute,0,0
139314,pain,0,1
139315,outcomes,0,0
139316,including,0,0
139317,adolescent,0,1
139318,self-report,0,0
139319,",",0,0
139320,nursing,0,1
139321,staff,0,1
139322,behavioral,0,0
139323,observation,0,0
139324,",",0,0
139325,caregiver,0,0
139326,observation,0,0
139327,and,0,0
139328,physiological,0,0
139329,measures,0,0
139330,were,0,1
139331,collected,0,1
139332,.,0,0
139333,Length,0,0
139334,of,0,0
139335,procedure,0,0
139336,times,0,0
139337,and,0,1
139338,adolescent,0,1
139339,reactions,0,0
139340,were,0,1
139341,also,0,0
139342,recorded,0,0
139343,to,0,0
139344,inform,0,0
139345,clinical,0,0
139346,utility,0,0
139347,.,0,1
139348,RESULTS,0,0
139349,Nursing,0,0
139350,staff,0,1
139351,reported,0,0
139352,a,0,0
139353,statistically,0,0
139354,significant,0,0
139355,reduction,0,0
139356,in,0,0
139357,pain,0,1
139358,scores,0,0
139359,during,0,0
139360,dressing,0,0
139361,removal,0,0
139362,",",0,0
139363,and,0,0
139364,significantly,0,0
139365,less,0,0
139366,rescue,0,0
139367,doses,0,0
139368,of,0,1
139369,Entonox,0,0
139370,given,0,0
139371,to,0,0
139372,those,0,0
139373,receiving,0,0
139374,VR,0,0
139375,",",0,0
139376,compared,0,0
139377,to,0,0
139378,those,0,0
139379,receiving,0,0
139380,standard,0,0
139381,distraction,0,0
139382,.,0,0
139383,For,0,0
139384,all,0,0
139385,other,0,0
139386,pain,0,1
139387,outcomes,0,0
139388,and,0,0
139389,length,0,0
139390,of,0,0
139391,treatment,0,0
139392,",",0,0
139393,there,0,0
139394,was,0,0
139395,a,0,0
139396,trend,0,0
139397,for,0,0
139398,lower,0,0
139399,pain,0,1
139400,scores,0,0
139401,and,0,0
139402,treatment,0,0
139403,times,0,0
139404,for,0,0
139405,those,0,1
139406,receiving,0,0
139407,VR,0,0
139408,",",0,0
139409,but,0,0
139410,these,0,0
139411,differences,0,0
139412,were,0,0
139413,not,0,0
139414,statistically,0,0
139415,significant,0,0
139416,.,0,0
139417,CONCLUSION,0,0
139418,Despite,0,0
139419,only,0,0
139420,minimal,0,0
139421,pain,0,0
139422,reduction,0,0
139423,achieved,0,0
139424,using,0,0
139425,off-the-shelf,0,0
139426,VR,0,0
139427,",",0,0
139428,other,0,0
139429,results,0,0
139430,from,0,1
139431,this,0,0
139432,trial,0,0
139433,and,0,0
139434,previous,0,0
139435,research,0,0
139436,on,0,0
139437,younger,0,1
139438,children,0,1
139439,with,0,1
139440,burns,0,1
139441,suggest,0,0
139442,a,0,0
139443,customized,0,0
139444,",",0,0
139445,adolescent,0,1
139446,and,0,0
139447,hospital,0,1
139448,friendly,0,0
139449,device,0,0
139450,may,0,0
139451,be,0,0
139452,more,0,0
139453,effective,0,0
139454,in,0,0
139455,pain,0,1
139456,reduction,0,0
139457,.,0,1
139458,Combination,0,0
139459,peel,0,0
139460,with,0,1
139461,incorporated,0,0
139462,fractional,0,0
139463,prickle,0,0
139464,coral,0,0
139465,calcium,0,0
139466,for,0,0
139467,the,0,0
139468,treatment,0,0
139469,of,0,0
139470,keratosis,1,0
139471,pilaris,1,0
139472,:,1,1
139473,a,0,0
139474,pilot,0,0
139475,study,0,0
139476,.,0,1
139477,BACKGROUND,0,0
139478,Keratosis,1,1
139479,pilaris,1,0
139480,(,0,0
139481,KP,0,1
139482,),0,0
139483,is,0,0
139484,a,0,0
139485,common,0,0
139486,condition,0,0
139487,of,0,0
139488,follicular,0,1
139489,plugging,0,0
139490,with,0,1
139491,variable,0,1
139492,erythema,0,0
139493,.,0,0
139494,There,0,0
139495,is,0,0
139496,a,0,0
139497,lack,0,0
139498,of,0,0
139499,reliable,0,0
139500,response,0,0
139501,to,0,0
139502,the,0,0
139503,treatment,0,0
139504,of,0,0
139505,KP,0,1
139506,.,0,1
139507,OBJECTIVE,0,0
139508,We,0,0
139509,evaluated,0,0
139510,the,0,0
139511,effect,0,0
139512,and,0,0
139513,safety,0,0
139514,of,0,0
139515,combination,0,0
139516,peel,0,0
139517,with,0,1
139518,fractional,0,0
139519,prickle,0,0
139520,coral,0,1
139521,calcium,0,0
139522,(,0,0
139523,FCR?,0,1
139524,),0,0
139525,in,0,0
139526,the,0,0
139527,treatment,0,0
139528,of,0,0
139529,KP,0,1
139530,.,0,1
139531,MATERIALS,0,0
139532,AND,0,0
139533,METHODS,1,0
139534,Sixteen,1,1
139535,Korean,1,1
139536,patients,1,1
139537,were,1,1
139538,treated,1,1
139539,with,1,1
139540,FCR?,1,1
139541,on,1,0
139542,both,1,0
139543,upper,1,0
139544,arms,1,0
139545,for,1,1
139546,five,1,1
139547,sessions,1,0
139548,at,1,1
139549,2-week,1,1
139550,intervals,1,0
139551,.,1,1
139552,Clinical,1,0
139553,evaluations,0,0
139554,",",0,0
139555,mexameter,0,0
139556,measurements,0,0
139557,",",0,0
139558,and,0,0
139559,assessment,0,0
139560,of,0,0
139561,patients,0,1
139562,',0,1
139563,satisfaction,0,0
139564,and,0,1
139565,adverse,0,0
139566,events,0,0
139567,were,0,1
139568,performed,0,0
139569,at,0,0
139570,baseline,0,0
139571,and,0,0
139572,every,0,0
139573,visit,0,0
139574,.,0,0
139575,RESULTS,0,0
139576,After,0,0
139577,treatments,0,0
139578,",",0,0
139579,statistically,0,0
139580,significant,0,0
139581,improvements,0,0
139582,in,0,0
139583,the,0,0
139584,baseline,0,0
139585,KP,0,1
139586,were,0,0
139587,observed,0,0
139588,in,0,0
139589,erythema,0,0
139590,and,0,0
139591,melanin,0,0
139592,index,0,0
139593,of,0,0
139594,mexameter,0,0
139595,on,0,0
139596,treated,0,1
139597,upper,0,1
139598,arms,0,0
139599,.,0,1
139600,Both,0,0
139601,the,0,0
139602,physicians,0,0
139603,',0,1
139604,and,0,1
139605,patients,0,1
139606,',0,1
139607,assessments,0,0
139608,correlate,0,0
139609,with,0,1
139610,the,0,0
139611,results,0,0
139612,of,0,0
139613,mexameter,0,0
139614,scores,0,0
139615,.,0,1
139616,CONCLUSION,0,0
139617,Our,0,0
139618,results,0,0
139619,suggest,0,0
139620,FCR?,0,0
139621,should,0,0
139622,be,0,0
139623,considered,0,0
139624,as,0,0
139625,an,0,0
139626,effective,0,0
139627,and,0,0
139628,safe,0,0
139629,treatment,0,0
139630,option,0,0
139631,for,0,0
139632,the,0,0
139633,patients,1,1
139634,with,1,1
139635,KP,1,1
139636,.,1,1
139637,Theta,0,0
139638,burst,0,0
139639,stimulation,0,0
139640,in,0,0
139641,the,0,0
139642,rehabilitation,0,0
139643,of,0,0
139644,the,0,0
139645,upper,0,1
139646,limb,0,0
139647,:,0,1
139648,a,0,0
139649,semirandomized,0,0
139650,",",0,0
139651,placebo-controlled,0,0
139652,trial,0,0
139653,in,0,0
139654,chronic,1,1
139655,stroke,1,1
139656,patients,1,1
139657,.,1,1
139658,BACKGROUND,0,0
139659,Noninvasive,0,0
139660,cortical,0,0
139661,stimulation,0,0
139662,could,0,0
139663,represent,0,0
139664,an,0,0
139665,add-on,0,0
139666,treatment,0,0
139667,to,0,0
139668,enhance,0,0
139669,motor,0,0
139670,recovery,0,0
139671,after,0,0
139672,stroke,0,1
139673,.,0,0
139674,However,0,0
139675,",",0,0
139676,its,0,0
139677,clinical,0,0
139678,value,0,0
139679,",",0,0
139680,including,0,0
139681,anticipated,0,0
139682,size,0,0
139683,and,0,0
139684,duration,0,0
139685,of,0,0
139686,the,0,0
139687,treatment,0,0
139688,effects,0,0
139689,",",0,0
139690,remains,0,0
139691,largely,0,0
139692,unknown,0,0
139693,.,0,0
139694,OBJECTIVE,0,0
139695,The,0,0
139696,authors,0,0
139697,designed,0,0
139698,a,0,0
139699,small,0,0
139700,semi-randomized,0,0
139701,clinical,0,0
139702,trial,0,0
139703,to,0,0
139704,explore,0,0
139705,whether,0,0
139706,long-lasting,0,0
139707,clinically,0,1
139708,important,0,0
139709,gains,0,0
139710,can,0,0
139711,be,0,0
139712,achieved,0,0
139713,by,0,0
139714,adding,0,0
139715,theta,0,0
139716,burst,0,1
139717,stimulation,0,0
139718,(,0,0
139719,TBS,0,1
139720,),0,0
139721,",",0,0
139722,a,0,0
139723,form,0,0
139724,of,0,0
139725,repetitive,0,0
139726,transcranial,0,0
139727,magnetic,0,0
139728,stimulation,0,0
139729,(,0,0
139730,TMS,0,0
139731,),0,0
139732,",",0,0
139733,to,0,0
139734,a,0,0
139735,rehabilitation,0,0
139736,program,0,0
139737,for,0,0
139738,the,0,0
139739,hand,0,0
139740,.,0,0
139741,METHODS,0,0
139742,A,1,0
139743,total,1,1
139744,of,1,0
139745,41,1,1
139746,chronic,1,1
139747,stroke,1,1
139748,patients,1,1
139749,received,1,1
139750,excitatory,1,0
139751,TBS,1,1
139752,to,1,0
139753,the,1,0
139754,ipsilesional,1,0
139755,hemisphere,1,0
139756,or,1,0
139757,inhibitory,1,0
139758,TBS,1,1
139759,to,1,0
139760,the,1,0
139761,contralesional,1,0
139762,hemisphere,1,0
139763,in,1,0
139764,2,1,1
139765,centers,1,1
139766,;,1,1
139767,each,0,0
139768,active,0,0
139769,group,0,0
139770,was,0,0
139771,compared,0,0
139772,with,0,1
139773,a,0,0
139774,group,0,0
139775,receiving,0,0
139776,sham,0,0
139777,TBS,0,1
139778,.,0,1
139779,TBS,0,0
139780,was,0,0
139781,followed,0,0
139782,by,0,0
139783,physical,0,0
139784,therapy,0,0
139785,for,0,0
139786,10,0,1
139787,working,0,1
139788,days,0,0
139789,.,0,1
139790,Patients,0,1
139791,and,0,0
139792,therapists,0,0
139793,were,0,0
139794,blinded,0,0
139795,to,0,0
139796,the,0,0
139797,type,0,1
139798,of,0,0
139799,TBS,0,1
139800,.,0,1
139801,Primary,0,1
139802,outcome,0,0
139803,measures,0,0
139804,(,0,1
139805,9-hole,0,0
139806,Peg,0,0
139807,Test,0,1
139808,[,0,0
139809,9HPT,0,0
139810,],0,0
139811,",",0,0
139812,Jebsen,0,0
139813,Taylor,0,1
139814,Test,0,1
139815,[,0,0
139816,JTT,0,1
139817,],0,0
139818,",",0,0
139819,and,0,0
139820,grip,0,0
139821,and,0,0
139822,pinch-grip,0,0
139823,dynamometry,0,0
139824,),0,0
139825,were,0,0
139826,assessed,0,0
139827,4,0,0
139828,",",0,0
139829,30,0,0
139830,",",0,0
139831,and,0,0
139832,90,0,0
139833,days,0,0
139834,post,0,1
139835,treatment,0,0
139836,.,0,0
139837,The,0,0
139838,clinically,0,0
139839,important,0,0
139840,difference,0,0
139841,was,0,0
139842,defined,0,0
139843,as,0,0
139844,10,0,0
139845,%,0,0
139846,of,0,0
139847,the,0,0
139848,maximum,0,0
139849,score,0,0
139850,.,0,0
139851,RESULTS,0,0
139852,There,0,0
139853,were,0,0
139854,no,0,0
139855,differences,0,0
139856,between,0,0
139857,the,0,0
139858,active,0,0
139859,treatment,0,0
139860,and,0,0
139861,sham,0,0
139862,groups,0,0
139863,in,0,0
139864,any,0,0
139865,of,0,0
139866,the,0,0
139867,outcome,0,0
139868,measures,0,0
139869,.,0,1
139870,All,0,1
139871,patients,0,1
139872,achieved,0,0
139873,small,0,1
139874,sustainable,0,1
139875,improvements,0,0
139876,--,0,1
139877,9HPT,0,0
139878,",",0,0
139879,5,0,0
139880,%,0,0
139881,of,0,0
139882,maximum,0,0
139883,(,0,0
139884,confidence,0,0
139885,interval,0,0
139886,[,0,0
139887,CI,0,0
139888,],0,1
139889,=,0,0
139890,3,0,0
139891,%,0,0
139892,-7,0,0
139893,%,0,0
139894,),0,1
139895,;,0,0
139896,JTT,0,1
139897,",",0,0
139898,5.7,0,0
139899,%,0,0
139900,(,0,0
139901,CI,0,0
139902,=,0,0
139903,3,0,0
139904,%,0,0
139905,-8,0,0
139906,%,0,0
139907,),0,0
139908,;,0,0
139909,and,0,0
139910,grip,0,0
139911,strength,0,0
139912,",",0,0
139913,6,0,0
139914,%,0,0
139915,(,0,0
139916,CI,0,0
139917,=,0,0
139918,2,0,0
139919,%,0,0
139920,-10,0,0
139921,%,0,0
139922,),0,0
139923,--,0,0
139924,all,0,0
139925,below,0,0
139926,the,0,0
139927,defined,0,0
139928,clinically,0,0
139929,important,0,0
139930,level,0,0
139931,.,0,1
139932,CONCLUSIONS,0,0
139933,Cortical,0,0
139934,stimulation,0,0
139935,did,0,0
139936,not,0,0
139937,augment,0,0
139938,the,0,0
139939,gains,0,0
139940,from,0,0
139941,a,0,0
139942,late,0,0
139943,rehabilitation,0,0
139944,program,0,0
139945,.,0,0
139946,The,0,0
139947,effect,0,0
139948,size,0,0
139949,anticipated,0,0
139950,by,0,0
139951,the,0,0
139952,authors,0,0
139953,was,0,0
139954,overestimated,0,0
139955,.,0,0
139956,These,0,0
139957,results,0,0
139958,can,0,0
139959,improve,0,0
139960,the,0,0
139961,design,0,0
139962,of,0,0
139963,future,0,0
139964,work,0,0
139965,on,0,0
139966,therapeutic,0,0
139967,uses,0,0
139968,of,0,1
139969,TMS,0,1
139970,.,0,1
139971,Noradrenergic,0,0
139972,moderation,0,0
139973,of,0,0
139974,working,0,1
139975,memory,0,0
139976,impairments,0,0
139977,in,0,0
139978,adults,1,1
139979,with,1,1
139980,autism,1,1
139981,spectrum,1,1
139982,disorder,1,1
139983,.,1,0
139984,In,0,0
139985,addition,0,0
139986,to,0,0
139987,having,0,1
139988,difficulties,0,0
139989,with,0,1
139990,social,0,1
139991,communications,0,1
139992,",",0,0
139993,individuals,1,1
139994,with,1,1
139995,an,1,0
139996,autism,1,1
139997,spectrum,1,1
139998,disorder,1,1
139999,(,1,0
140000,ASD,1,1
140001,),1,0
140002,often,0,0
140003,also,0,0
140004,experience,0,0
140005,impairment,0,0
140006,in,0,0
140007,higher-order,0,0
140008,",",0,0
140009,executive,0,0
140010,skills,0,0
140011,.,0,1
140012,The,0,0
140013,present,0,0
140014,study,0,0
140015,examined,0,0
140016,the,0,0
140017,effects,0,0
140018,of,0,0
140019,pharmacological,0,0
140020,modulation,0,0
140021,of,0,0
140022,the,0,0
140023,norepinephrine,0,0
140024,system,0,0
140025,on,0,0
140026,the,0,0
140027,severity,0,0
140028,of,0,0
140029,such,0,0
140030,impairments,0,0
140031,.,0,1
140032,A,0,0
140033,sample,0,1
140034,of,0,0
140035,14,1,1
140036,high-functioning,1,1
140037,adults,1,1
140038,with,1,1
140039,ASD,1,1
140040,and,1,0
140041,a,1,0
140042,demographically-matched,1,1
140043,comparison,1,0
140044,group,1,0
140045,of,1,0
140046,13,1,1
140047,typically,1,1
140048,developing,1,0
140049,individuals,1,1
140050,participated,1,1
140051,.,1,1
140052,An,0,0
140053,AX,0,0
140054,continuous,0,0
140055,performance,0,0
140056,test,0,0
140057,(,0,0
140058,AX-CPT,0,0
140059,),0,0
140060,was,0,0
140061,used,0,0
140062,to,0,0
140063,evaluate,0,0
140064,working,0,0
140065,memory,0,0
140066,and,0,0
140067,inhibitory,0,0
140068,control,0,0
140069,.,0,0
140070,AX-CPT,0,0
140071,performance,0,0
140072,was,0,0
140073,assessed,0,0
140074,following,0,0
140075,administration,0,0
140076,of,0,0
140077,a,0,0
140078,single,0,0
140079,dose,0,0
140080,of,0,0
140081,propranolol,0,0
140082,(,0,0
140083,a,0,0
140084,beta,0,0
140085,adrenergic,0,0
140086,antagonist,0,0
140087,),0,0
140088,and,0,0
140089,following,0,0
140090,placebo,0,0
140091,(,0,0
140092,sugar,0,0
140093,pill,0,0
140094,),0,0
140095,administration,0,0
140096,.,0,1
140097,Individuals,1,0
140098,with,1,1
140099,ASD,1,1
140100,performed,0,0
140101,more,0,0
140102,poorly,0,0
140103,than,0,0
140104,non-ASD,0,1
140105,individuals,0,1
140106,in,0,0
140107,the,0,0
140108,working,0,0
140109,memory,0,0
140110,condition,0,0
140111,(,0,0
140112,BX,0,0
140113,trials,0,1
140114,),0,0
140115,.,0,0
140116,Importantly,0,0
140117,",",0,0
140118,administration,0,0
140119,of,0,0
140120,propranolol,0,0
140121,attenuated,0,0
140122,this,0,0
140123,impairment,0,0
140124,",",0,0
140125,with,0,1
140126,the,0,0
140127,ASD,0,1
140128,group,0,0
140129,performing,0,0
140130,significantly,0,0
140131,better,0,0
140132,in,0,0
140133,the,0,0
140134,propranolol,0,0
140135,condition,0,0
140136,than,0,0
140137,the,0,0
140138,placebo,0,0
140139,condition,0,0
140140,.,0,0
140141,Working,0,0
140142,memory,0,0
140143,performance,0,0
140144,of,0,0
140145,the,0,0
140146,non-ASD,0,0
140147,group,0,0
140148,was,0,0
140149,unaffected,0,0
140150,by,0,0
140151,propranolol/placebo,0,0
140152,administration,0,0
140153,.,0,0
140154,No,0,0
140155,group,0,0
140156,or,0,0
140157,medication,0,0
140158,effects,0,0
140159,were,0,0
140160,observed,0,0
140161,for,0,0
140162,the,0,0
140163,inhibition,0,0
140164,condition,0,0
140165,(,0,0
140166,AY,0,0
140167,trials,0,1
140168,),0,1
140169,.,0,1
140170,The,0,0
140171,present,0,0
140172,findings,0,0
140173,suggest,0,0
140174,that,0,0
140175,norepinephrine,0,0
140176,may,0,0
140177,play,0,0
140178,a,0,0
140179,role,0,0
140180,in,0,0
140181,some,0,0
140182,",",0,0
140183,but,0,0
140184,not,0,0
140185,necessarily,0,0
140186,all,0,0
140187,",",0,0
140188,cognitive,0,0
140189,impairments,0,0
140190,associated,0,0
140191,with,0,1
140192,ASD,0,1
140193,.,0,1
140194,Additional,0,0
140195,research,0,0
140196,is,0,0
140197,needed,0,0
140198,to,0,0
140199,fully,0,0
140200,understand,0,0
140201,whether,0,0
140202,this,0,0
140203,role,0,0
140204,is,0,0
140205,primarily,0,0
140206,causal,0,0
140207,or,0,0
140208,compensatory,0,0
140209,in,0,0
140210,nature,0,0
140211,.,0,1
140212,[,0,0
140213,Simvastatin,0,0
140214,versus,0,0
140215,gemfibrozil,0,0
140216,in,0,0
140217,the,0,0
140218,treatment,0,0
140219,of,0,0
140220,primary,1,1
140221,hypercholesterolemia,1,1
140222,in,1,0
140223,hypertensive,1,1
140224,patients,1,1
140225,treated,1,1
140226,with,1,1
140227,hydrochlorothiazide,1,0
140228,],1,1
140229,.,0,1
140230,Recent,0,0
140231,pharmacological,0,0
140232,studies,0,0
140233,confirmed,0,0
140234,the,0,0
140235,role,0,0
140236,of,0,0
140237,hypercholesterolemia,0,1
140238,in,0,0
140239,the,0,0
140240,pathogenesis,0,0
140241,of,0,0
140242,coronary,0,1
140243,atherosclerosis,0,1
140244,.,0,1
140245,A,0,0
140246,10,0,0
140247,%,0,0
140248,reduction,0,0
140249,in,0,0
140250,cholesterol,0,0
140251,levels,0,0
140252,can,0,0
140253,reduce,0,0
140254,the,0,0
140255,risk,0,0
140256,of,0,0
140257,coronary,0,1
140258,heart,0,1
140259,disease,0,1
140260,by,0,0
140261,15,0,1
140262,%,0,0
140263,.,0,0
140264,However,0,0
140265,many,0,0
140266,hypercholesterolemic,1,1
140267,patients,1,1
140268,often,0,0
140269,suffer,0,1
140270,from,0,0
140271,arterial,0,1
140272,hypertension,0,1
140273,and,0,0
140274,drugs,0,0
140275,such,0,0
140276,as,0,0
140277,thiazide,0,0
140278,diuretics,0,0
140279,cause,0,0
140280,an,0,0
140281,imbalance,0,0
140282,in,0,0
140283,lipid,0,0
140284,metabolism,0,0
140285,.,0,0
140286,The,0,0
140287,efficacy,0,0
140288,and,0,0
140289,the,0,0
140290,tolerability,0,0
140291,of,0,0
140292,simvastatin,0,0
140293,(,0,0
140294,a,0,0
140295,inhibitor,0,0
140296,of,0,0
140297,HGM-CoA,0,0
140298,reductase,0,0
140299,),0,0
140300,with,0,1
140301,that,0,0
140302,of,0,0
140303,gemfibrozil,0,0
140304,(,0,0
140305,a,0,0
140306,fibric,0,0
140307,acid,0,0
140308,derivative,0,0
140309,",",0,0
140310,which,0,0
140311,can,0,0
140312,reduce,0,0
140313,the,0,0
140314,VLDL,0,0
140315,level,0,0
140316,),0,0
140317,were,0,0
140318,compared,0,0
140319,in,0,0
140320,a,0,0
140321,placebo-controlled,0,0
140322,study,0,0
140323,in,0,0
140324,2,0,0
140325,groups,0,0
140326,of,0,1
140327,patients,1,1
140328,with,1,1
140329,primary,1,1
140330,hypercholesterolemia,1,1
140331,and,1,0
140332,mild-to-moderate,1,1
140333,essential,1,1
140334,hypertension,1,1
140335,treated,1,1
140336,with,1,1
140337,hydrochlorothiazide,1,0
140338,.,1,1
140339,After,1,0
140340,10,1,1
140341,weeks,1,0
140342,standard,1,1
140343,hypolipidemic,1,1
140344,diet,1,1
140345,and,1,0
140346,hydrochlorothiazide,1,0
140347,(,1,0
140348,25,1,0
140349,mg,1,0
140350,od,1,0
140351,),1,0
140352,therapy,1,0
140353,",",1,0
140354,30,1,1
140355,patients,1,1
140356,whose,1,1
140357,cholesterol,1,0
140358,levels,1,0
140359,were,1,0
140360,still,1,0
140361,greater,1,0
140362,than,1,0
140363,or,1,0
140364,equal,1,0
140365,to,1,0
140366,250,1,1
140367,mg/100,1,0
140368,ml,1,0
140369,and,1,0
140370,whose,1,1
140371,diastolic,1,0
140372,blood,1,0
140373,pressure,1,0
140374,was,1,0
140375,less,1,0
140376,than,1,0
140377,95,1,0
140378,mmHg,1,0
140379,were,0,1
140380,randomized,0,1
140381,to,0,0
140382,one,0,0
140383,of,0,0
140384,the,0,0
140385,following,0,0
140386,treatments,0,0
140387,:,0,1
140388,simvastatin,0,0
140389,",",0,0
140390,20,0,0
140391,mg,0,0
140392,od,0,0
140393,",",0,0
140394,gemfibrozil,0,0
140395,",",0,0
140396,600,0,0
140397,mg,0,0
140398,bid,0,0
140399,or,0,0
140400,placebo,0,0
140401,",",0,0
140402,while,0,0
140403,continuing,0,0
140404,dietetic,0,1
140405,and,0,0
140406,diuretic,0,0
140407,treatment,0,0
140408,.,0,1
140409,After,0,0
140410,24,0,0
140411,weeks,0,0
140412,treatment,0,0
140413,",",0,0
140414,simvastatin,0,0
140415,induced,0,0
140416,a,0,0
140417,37,0,1
140418,%,0,0
140419,reduction,0,0
140420,in,0,0
140421,cholesterol,0,0
140422,plasma,0,0
140423,levels,0,0
140424,",",0,0
140425,a,0,0
140426,9,0,0
140427,%,0,0
140428,increase,0,0
140429,of,0,0
140430,HDL,0,0
140431,and,0,0
140432,a,0,0
140433,16,0,1
140434,%,0,0
140435,reduction,0,0
140436,of,0,0
140437,LDL,0,1
140438,.,0,1
140439,APO-A1,0,0
140440,showed,0,0
140441,a,0,0
140442,4,0,0
140443,%,0,0
140444,increase,0,0
140445,",",0,0
140446,while,0,0
140447,APO-B,0,0
140448,showed,0,0
140449,a,0,0
140450,3,0,0
140451,%,0,0
140452,reduction,0,0
140453,.,0,1
140454,Gemfibrozil,0,0
140455,induced,0,0
140456,a,0,0
140457,20,0,0
140458,%,0,0
140459,reduction,0,0
140460,in,0,0
140461,plasma,0,0
140462,triglycerides,0,0
140463,and,0,0
140464,a,0,0
140465,13,0,0
140466,%,0,0
140467,decrease,0,0
140468,in,0,0
140469,plasma,0,0
140470,cholesterol,0,0
140471,",",0,0
140472,with,0,1
140473,a,0,0
140474,significant,0,0
140475,19,0,1
140476,%,0,0
140477,increase,0,0
140478,in,0,0
140479,HDL,0,0
140480,and,0,0
140481,a,0,0
140482,11,0,0
140483,%,0,0
140484,reduction,0,0
140485,in,0,0
140486,LDL,0,1
140487,.,0,1
140488,No,0,0
140489,significant,0,0
140490,variations,0,0
140491,in,0,0
140492,any,0,0
140493,of,0,0
140494,the,0,0
140495,lipid,0,0
140496,parameters,0,0
140497,monitored,0,1
140498,were,0,0
140499,observed,0,0
140500,in,0,0
140501,the,0,0
140502,placebo,0,0
140503,group,0,0
140504,.,0,0
140505,Treatment,0,0
140506,with,0,0
140507,simvastatin,0,0
140508,or,0,0
140509,gemfibrozil,0,0
140510,in,0,0
140511,hypertensive,0,1
140512,patients,0,1
140513,in,0,0
140514,hydrochlorothiazide,0,0
140515,monotherapy,0,0
140516,can,0,0
140517,reduce,0,0
140518,total,0,0
140519,cholesterol,0,0
140520,and,0,0
140521,LDL-cholesterol,0,0
140522,plasma,0,0
140523,levels,0,0
140524,",",0,0
140525,while,0,0
140526,significantly,0,0
140527,increasing,0,0
140528,HDL,0,0
140529,plasma,0,0
140530,levels,0,0
140531,compared,0,0
140532,to,0,0
140533,placebo,0,0
140534,.,0,0
140535,Simvastatin,0,0
140536,",",0,0
140537,however,0,0
140538,",",0,0
140539,resulted,0,0
140540,more,0,0
140541,efficient,0,0
140542,than,0,0
140543,gemfibrozil,0,0
140544,on,0,0
140545,total,0,1
140546,cholesterol,0,0
140547,or,0,1
140548,cholesterol,0,0
140549,fractions,0,0
140550,.,0,1
140551,Competitive,0,0
140552,memory,0,0
140553,training,0,0
140554,(,0,0
140555,COMET,0,0
140556,),0,0
140557,for,0,0
140558,treating,0,1
140559,low,1,1
140560,self-esteem,1,0
140561,in,1,1
140562,patients,1,1
140563,with,1,1
140564,depressive,1,1
140565,disorders,1,1
140566,:,1,1
140567,a,0,0
140568,randomized,0,0
140569,clinical,0,0
140570,trial,0,1
140571,.,0,1
140572,BACKGROUND,0,0
140573,Self-esteem,0,0
140574,is,0,0
140575,a,0,0
140576,major,0,0
140577,concern,0,0
140578,in,0,0
140579,mood,0,0
140580,disorders,0,1
140581,.,0,1
140582,Low,0,0
140583,self-esteem,0,0
140584,is,0,0
140585,a,0,0
140586,symptom,0,0
140587,of,0,0
140588,depressive,0,0
140589,disorders,0,1
140590,and,0,0
140591,is,0,0
140592,considered,0,0
140593,by,0,0
140594,some,0,0
140595,to,0,0
140596,be,0,0
140597,a,0,0
140598,predictor,0,0
140599,for,0,0
140600,relapse,0,0
140601,",",0,0
140602,whereas,0,0
140603,high,0,0
140604,self-esteem,0,0
140605,seems,0,0
140606,to,0,0
140607,buffer,0,0
140608,against,0,0
140609,depression,0,1
140610,.,0,0
140611,Recently,0,0
140612,",",0,0
140613,Competitive,0,0
140614,Memory,0,1
140615,Training,0,0
140616,(,0,0
140617,COMET,0,0
140618,),0,0
140619,has,0,0
140620,shown,0,0
140621,to,0,0
140622,be,0,0
140623,effective,0,0
140624,for,0,0
140625,the,0,0
140626,enhancement,0,0
140627,of,0,0
140628,self-esteem,0,0
140629,in,0,0
140630,several,0,0
140631,psychopathological,0,1
140632,conditions,0,1
140633,.,0,1
140634,The,0,0
140635,current,0,0
140636,study,0,0
140637,assesses,0,0
140638,whether,0,0
140639,COMET,0,0
140640,is,0,0
140641,also,0,0
140642,an,0,0
140643,effective,0,0
140644,intervention,0,0
140645,for,0,0
140646,patients,0,1
140647,with,0,1
140648,depressive,0,1
140649,disorders,0,1
140650,.,0,1
140651,METHODS,0,0
140652,Sixty-one,1,1
140653,patients,1,1
140654,with,1,1
140655,depressive,1,1
140656,disorders,1,1
140657,who,1,1
140658,were,1,1
140659,already,1,1
140660,in,1,0
140661,therapy,1,0
140662,in,1,0
140663,an,1,0
140664,outpatient,1,1
140665,mental,1,1
140666,health,1,1
140667,institution,1,1
140668,were,0,0
140669,randomly,0,1
140670,assigned,1,0
140671,to,0,0
140672,either,0,0
140673,eight,0,1
140674,group,0,0
140675,sessions,0,0
140676,of,0,0
140677,COMET,0,0
140678,in,0,0
140679,addition,0,0
140680,to,0,0
140681,their,0,0
140682,regular,0,0
140683,therapy,0,0
140684,(,0,0
140685,COMET,0,0
140686,+,0,0
140687,therapy,0,0
140688,as,0,0
140689,usual,0,1
140690,[,0,0
140691,TAU,0,0
140692,],0,1
140693,:,0,1
140694,the,0,0
140695,experimental,0,0
140696,group,0,0
140697,),0,0
140698,or,0,1
140699,to,0,0
140700,8,0,0
140701,weeks,0,0
140702,of,0,0
140703,ongoing,0,1
140704,regular,0,0
140705,therapy,0,0
140706,(,0,0
140707,TAU,0,0
140708,only,0,0
140709,:,0,1
140710,the,0,0
140711,control,0,0
140712,group,0,0
140713,),0,0
140714,.,0,0
140715,These,0,0
140716,latter,0,0
140717,(,0,0
140718,control,0,1
140719,),0,1
140720,patients,0,1
140721,received,0,1
140722,COMET,0,0
140723,after,0,0
140724,their,0,0
140725,TAU,0,0
140726,only,0,0
140727,period,0,0
140728,.,0,0
140729,All,0,0
140730,patients,0,1
140731,in,0,0
140732,both,0,0
140733,groups,0,0
140734,that,0,0
140735,completed,0,1
140736,COMET,0,0
140737,were,0,1
140738,contacted,0,0
140739,3,0,0
140740,and,0,0
140741,6,0,0
140742,months,0,0
140743,later,0,1
140744,to,0,0
140745,assess,0,0
140746,whether,0,0
140747,the,0,0
140748,effects,0,0
140749,of,0,0
140750,COMET,0,0
140751,had,0,1
140752,remained,0,0
140753,stable,0,1
140754,.,0,1
140755,RESULTS,0,0
140756,Compared,0,0
140757,to,0,0
140758,the,0,1
140759,patients,0,1
140760,who,0,1
140761,received,0,1
140762,TAU,0,0
140763,only,0,0
140764,",",0,0
140765,patients,0,1
140766,in,0,0
140767,the,0,0
140768,COMET,0,0
140769,+,0,0
140770,TAU,0,0
140771,condition,0,0
140772,showed,0,0
140773,significant,0,0
140774,improvement,0,0
140775,with,0,1
140776,large,0,1
140777,effect,0,0
140778,sizes,0,0
140779,on,0,0
140780,indices,0,0
140781,of,0,0
140782,self-esteem,0,0
140783,",",0,0
140784,depression,0,0
140785,",",0,0
140786,and,0,0
140787,depressive,0,0
140788,rumination,0,0
140789,.,0,0
140790,The,0,0
140791,therapeutic,0,0
140792,effects,0,0
140793,of,0,1
140794,COMET,0,1
140795,+,0,0
140796,TAU,0,0
140797,remained,0,0
140798,stable,0,1
140799,after,0,0
140800,3,0,0
140801,and,0,1
140802,6,0,0
140803,months,0,0
140804,on,0,0
140805,all,0,1
140806,outcome,0,0
140807,measures,0,0
140808,or,0,1
140809,improved,0,0
140810,even,0,0
140811,further,0,0
140812,.,0,0
140813,CONCLUSION,0,0
140814,COMET,0,0
140815,for,0,0
140816,low,0,0
140817,self-esteem,0,0
140818,seems,0,0
140819,to,0,0
140820,be,0,0
140821,an,0,0
140822,efficacious,0,0
140823,trans-diagnostic,0,0
140824,intervention,0,0
140825,that,0,0
140826,can,0,0
140827,relatively,0,0
140828,easily,0,0
140829,be,0,0
140830,added,0,0
140831,to,0,0
140832,the,0,0
140833,regular,0,0
140834,treatment,0,0
140835,of,0,0
140836,patients,0,1
140837,with,0,1
140838,depressive,0,1
140839,disorders,0,1
140840,.,0,1
140841,Kata,0,1
140842,techniques,0,0
140843,training,0,0
140844,consistently,0,0
140845,decreases,0,0
140846,stereotypy,0,0
140847,in,0,0
140848,children,1,1
140849,with,1,1
140850,autism,1,1
140851,spectrum,1,1
140852,disorder,1,1
140853,.,1,0
140854,The,0,0
140855,effects,0,0
140856,of,0,0
140857,14,0,1
140858,weeks,0,0
140859,of,0,1
140860,Kata,0,1
140861,techniques,0,0
140862,training,0,0
140863,on,0,0
140864,stereotypic,0,1
140865,behaviors,0,0
140866,of,0,1
140867,children,1,1
140868,with,1,1
140869,autism,1,1
140870,spectrum,1,1
140871,disorders,1,1
140872,(,1,1
140873,ASD,1,1
140874,),1,0
140875,were,0,0
140876,investigated,0,0
140877,.,0,0
140878,The,0,0
140879,study,0,0
140880,included,0,1
140881,30,1,1
140882,eligible,1,1
140883,(,1,1
140884,diagnosed,1,1
140885,ASD,1,1
140886,",",1,0
140887,school,1,1
140888,age,1,1
140889,),1,0
140890,children,1,1
140891,with,1,1
140892,ages,1,1
140893,ranging,1,1
140894,from,1,1
140895,5,1,1
140896,to,1,1
140897,16,1,1
140898,years,1,1
140899,whom,0,1
140900,they,0,1
140901,assigned,0,1
140902,to,0,0
140903,an,0,0
140904,exercise,0,0
140905,(,0,0
140906,n=15,0,1
140907,),0,0
140908,or,0,1
140909,a,0,0
140910,no-exercise,0,0
140911,control,0,0
140912,group,0,0
140913,(,0,0
140914,n=15,0,1
140915,),0,0
140916,.,0,0
140917,Participants,0,1
140918,of,0,0
140919,the,0,0
140920,exercise,0,0
140921,group,0,0
140922,received,0,0
140923,Kata,0,1
140924,techniques,0,0
140925,instruction,0,0
140926,four,0,1
140927,times,0,0
140928,per,0,0
140929,week,0,0
140930,for,0,0
140931,14,0,1
140932,weeks,0,0
140933,(,0,1
140934,56,0,1
140935,sessions,0,0
140936,),0,1
140937,.,0,1
140938,Stereotypy,0,0
140939,was,0,0
140940,assessed,0,0
140941,at,0,0
140942,baseline,0,0
140943,(,0,0
140944,pre-intervention,0,0
140945,),0,0
140946,",",0,0
140947,week,0,0
140948,14,0,0
140949,(,0,0
140950,post-intervention,0,0
140951,),0,0
140952,",",0,0
140953,and,0,0
140954,at,0,0
140955,one,0,0
140956,month,0,0
140957,follow,0,0
140958,up,0,0
140959,in,0,0
140960,both,0,0
140961,groups,0,0
140962,.,0,1
140963,Results,0,0
140964,showed,0,0
140965,that,0,0
140966,Kata,0,1
140967,techniques,0,0
140968,training,0,0
140969,significantly,0,0
140970,reduced,0,0
140971,stereotypy,0,0
140972,in,0,0
140973,the,0,0
140974,exercise,0,0
140975,group,0,0
140976,.,0,0
140977,Following,0,0
140978,participation,0,0
140979,in,0,0
140980,Kata,0,1
140981,techniques,0,0
140982,training,0,0
140983,",",0,0
140984,stereotypy,0,0
140985,decreased,0,0
140986,from,0,0
140987,baseline,0,0
140988,levels,0,0
140989,by,0,0
140990,a,0,0
140991,M,0,0
140992,of,0,0
140993,42.54,0,0
140994,%,0,0
140995,across,0,0
140996,participants,0,1
140997,.,0,1
140998,Interestingly,0,0
140999,",",0,0
141000,after,0,0
141001,30,0,1
141002,days,0,0
141003,of,0,0
141004,no,0,0
141005,practice,0,0
141006,",",0,0
141007,stereotypy,0,0
141008,in,0,0
141009,the,0,0
141010,exercise,0,0
141011,group,0,0
141012,remained,0,0
141013,significantly,0,0
141014,decreased,0,0
141015,compared,0,0
141016,to,0,0
141017,pre-intervention,0,0
141018,time,0,0
141019,.,0,0
141020,The,0,0
141021,participants,0,1
141022,of,0,0
141023,the,0,0
141024,control,0,0
141025,group,0,0
141026,did,0,0
141027,not,0,0
141028,show,0,0
141029,significant,0,0
141030,changes,0,0
141031,in,0,0
141032,the,0,0
141033,stereotypy,0,0
141034,.,0,0
141035,Teaching,0,0
141036,martial,0,1
141037,arts,0,1
141038,techniques,0,0
141039,to,0,1
141040,children,1,1
141041,with,1,1
141042,ASD,1,1
141043,for,0,0
141044,a,0,0
141045,long,0,0
141046,period,0,0
141047,of,0,0
141048,time,0,0
141049,consistently,0,0
141050,decreased,0,0
141051,their,0,0
141052,stereotypic,0,1
141053,behaviors,0,0
141054,.,0,1
141055,Placebo-controlled,0,0
141056,pilot,0,0
141057,trial,0,0
141058,of,0,0
141059,mecamylamine,0,0
141060,for,0,0
141061,treatment,0,0
141062,of,0,0
141063,autism,1,1
141064,spectrum,1,1
141065,disorders,1,1
141066,.,1,1
141067,OBJECTIVE,0,0
141068,To,0,0
141069,explore,0,0
141070,possible,0,0
141071,benefits,0,0
141072,of,0,0
141073,a,0,0
141074,nicotinic,0,0
141075,acetylcholine,0,0
141076,receptor,0,0
141077,(,0,0
141078,nAChR,0,0
141079,),0,0
141080,agent,0,0
141081,for,0,0
141082,autistic,0,1
141083,symptoms,0,0
141084,based,0,0
141085,on,0,0
141086,postmortem,0,0
141087,observation,0,0
141088,of,0,0
141089,nAChR,0,1
141090,abnormalities,0,1
141091,(,0,1
141092,deficient,0,1
141093,?4?2,0,0
141094,nAChRs,0,0
141095,",",0,0
141096,excess,0,0
141097,?7,0,0
141098,nAChRs,0,0
141099,),0,0
141100,in,0,0
141101,brains,1,1
141102,of,1,1
141103,patients,1,1
141104,with,1,1
141105,autism,1,1
141106,.,1,1
141107,METHOD,1,0
141108,Mecamylamine,0,0
141109,",",0,0
141110,because,0,0
141111,of,0,0
141112,its,0,0
141113,safety,0,0
141114,record,0,0
141115,in,0,0
141116,children,0,1
141117,with,0,1
141118,other,0,0
141119,disorders,0,1
141120,",",0,0
141121,was,0,0
141122,chosen,0,0
141123,for,0,0
141124,this,0,0
141125,first,0,0
141126,exploration,1,0
141127,.,1,1
141128,Twenty,1,1
141129,children,1,1
141130,with,1,1
141131,autism,1,1
141132,spectrum,1,1
141133,disorder,1,1
141134,age,1,1
141135,4-12,1,1
141136,years,1,1
141137,were,1,1
141138,randomly,0,1
141139,assigned,0,1
141140,for,0,0
141141,14,0,1
141142,weeks,0,0
141143,to,0,0
141144,placebo,0,0
141145,(,0,0
141146,n=8,0,0
141147,),0,0
141148,or,0,0
141149,mecamylamine,0,0
141150,(,0,0
141151,n=12,0,0
141152,),0,0
141153,in,0,0
141154,ascending,0,1
141155,fixed,0,1
141156,doses,0,0
141157,:,0,1
141158,0.5,0,0
141159,mg/day,0,0
141160,for,0,0
141161,6,0,0
141162,weeks,0,0
141163,",",0,1
141164,2.5,0,0
141165,mg,0,0
141166,for,0,0
141167,2,0,0
141168,weeks,0,0
141169,",",0,0
141170,then,0,0
141171,5,0,0
141172,mg/day,0,0
141173,for,0,0
141174,6,0,0
141175,weeks,0,0
141176,.,0,1
141177,Improvement,0,0
141178,was,0,0
141179,rated,0,0
141180,by,0,0
141181,a,0,0
141182,blinded,0,0
141183,independent,0,0
141184,evaluator,0,0
141185,.,0,0
141186,Because,0,0
141187,of,0,0
141188,small,0,1
141189,sample,0,1
141190,",",0,0
141191,data,0,0
141192,analysis,0,0
141193,was,0,0
141194,descriptive,0,1
141195,.,0,1
141196,RESULTS,1,0
141197,Eighteen,1,1
141198,participants,1,1
141199,(,1,1
141200,10,1,0
141201,mecamylamine,1,0
141202,",",1,0
141203,8,1,0
141204,placebo,1,0
141205,),1,0
141206,completed,1,1
141207,the,1,0
141208,study,1,0
141209,.,1,0
141210,All,1,0
141211,doses,0,0
141212,were,0,0
141213,well,0,0
141214,tolerated,0,0
141215,;,0,0
141216,the,0,0
141217,only,0,0
141218,side,0,0
141219,effect,0,0
141220,of,0,0
141221,note,0,0
141222,was,0,0
141223,constipation,0,1
141224,(,0,0
141225,50,0,1
141226,%,0,0
141227,compared,0,0
141228,with,0,1
141229,25,0,0
141230,%,0,0
141231,of,0,0
141232,placebo,0,0
141233,group,0,1
141234,),0,0
141235,.,0,1
141236,Three,0,1
141237,children,0,1
141238,had,0,1
141239,clinically,0,0
141240,nonsignificant,0,0
141241,electrocardiographic,0,0
141242,QT,0,0
141243,prolongation,0,0
141244,.,0,0
141245,Both,0,0
141246,groups,0,0
141247,showed,0,0
141248,modest,0,0
141249,to,0,0
141250,moderate,0,1
141251,improvement,0,0
141252,",",0,0
141253,but,0,0
141254,differences,0,0
141255,between,0,0
141256,groups,0,0
141257,were,0,1
141258,negligible,0,0
141259,.,0,0
141260,On,0,0
141261,the,0,0
141262,primary,0,0
141263,outcome,0,0
141264,measure,0,0
141265,",",0,0
141266,the,0,0
141267,Ohio,0,0
141268,Autism,0,1
141269,Clinical,0,0
141270,Impressions,0,0
141271,Scale,0,0
141272,",",0,0
141273,90,0,0
141274,%,0,0
141275,of,0,0
141276,the,0,0
141277,active,0,0
141278,treatment,0,0
141279,group,0,0
141280,showed,0,0
141281,improvement,0,0
141282,at,0,0
141283,some,0,0
141284,point,0,0
141285,(,0,0
141286,but,0,0
141287,only,0,0
141288,40,0,1
141289,%,0,0
141290,sustained,0,0
141291,it,0,0
141292,),0,0
141293,",",0,0
141294,compared,0,0
141295,with,0,1
141296,62,0,1
141297,%,0,0
141298,on,0,0
141299,placebo,0,0
141300,.,0,0
141301,Of,0,0
141302,the,0,0
141303,four,0,0
141304,in,0,0
141305,active,0,1
141306,treatment,0,0
141307,that,0,0
141308,sustained,0,0
141309,improvement,0,0
141310,",",0,0
141311,three,0,0
141312,had,0,0
141313,a,0,0
141314,maximum,0,0
141315,dose,0,0
141316,of,0,0
141317,0.13-0.15,0,0
141318,mg/kg/day,0,0
141319,",",0,0
141320,while,0,0
141321,those,0,1
141322,who,0,1
141323,regressed,0,1
141324,had,0,1
141325,doses,0,0
141326,?0.18,0,0
141327,mg/kg/day,0,0
141328,.,0,1
141329,Graphed,0,0
141330,means,0,0
141331,suggested,0,0
141332,better,0,0
141333,outcome,0,0
141334,with,0,0
141335,lower,0,0
141336,mg/kg,0,0
141337,and,0,0
141338,longer,0,0
141339,medication,0,0
141340,duration,0,0
141341,.,0,1
141342,Four,0,0
141343,parents,0,1
141344,spontaneously,0,1
141345,reported,0,0
141346,reduced,0,0
141347,hyperactivity,0,1
141348,and,0,0
141349,irritability,0,0
141350,and,0,0
141351,better,0,0
141352,verbalization,0,0
141353,and,0,0
141354,continued,0,0
141355,mecamylamine,0,0
141356,at,0,0
141357,their,0,0
141358,own,0,1
141359,expense,0,0
141360,.,0,1
141361,CONCLUSION,0,0
141362,Mecamylamine,0,0
141363,appeared,0,0
141364,to,0,0
141365,be,0,0
141366,safe,0,0
141367,",",0,0
141368,but,0,0
141369,not,0,0
141370,very,0,0
141371,effective,0,0
141372,in,0,0
141373,autism,0,1
141374,.,0,0
141375,The,0,0
141376,suggestion,0,0
141377,of,0,0
141378,better,0,0
141379,results,0,0
141380,at,0,0
141381,lower,0,0
141382,doses,0,0
141383,and,0,0
141384,longer,0,0
141385,exposure,0,0
141386,warrants,0,0
141387,consideration,0,0
141388,for,0,0
141389,future,0,0
141390,trials,0,1
141391,.,0,1
141392,The,0,0
141393,next,0,0
141394,step,0,0
141395,would,0,0
141396,be,0,0
141397,exploration,0,0
141398,of,0,0
141399,a,0,0
141400,more,0,0
141401,specific,0,0
141402,?4?2,0,0
141403,nAChR,0,0
141404,agonist,0,0
141405,",",0,0
141406,such,0,0
141407,as,0,0
141408,varenicline,0,0
141409,.,0,1
141410,[,0,0
141411,Effects,0,0
141412,of,0,0
141413,shuxuening,0,0
141414,injection,0,0
141415,on,0,0
141416,the,0,0
141417,levels,0,0
141418,of,0,0
141419,serum,0,0
141420,matrix,0,0
141421,metalloproteinase-9,0,0
141422,and,0,0
141423,tissue,0,0
141424,inhibitor,0,0
141425,of,0,0
141426,metalloproteinase-1,0,0
141427,in,0,0
141428,acute,1,1
141429,exacerbated,1,0
141430,chronic,1,1
141431,obstructive,1,1
141432,pulmonary,1,1
141433,disease,1,1
141434,patients,1,1
141435,],1,1
141436,.,0,0
141437,OBJECTIVE,0,0
141438,To,0,0
141439,observe,0,0
141440,the,0,0
141441,effects,0,0
141442,of,0,0
141443,Shuxuening,0,0
141444,Injection,0,0
141445,(,0,1
141446,SI,0,0
141447,),0,0
141448,on,0,0
141449,the,0,0
141450,levels,0,0
141451,of,0,0
141452,serum,0,0
141453,matrix,0,0
141454,metalloproteinase-9,0,0
141455,(,0,0
141456,MMP-9,0,0
141457,),0,0
141458,and,0,0
141459,tissue,0,0
141460,inhibitor,0,0
141461,of,0,0
141462,metalloproteinase,0,0
141463,(,0,0
141464,TIMP-1,0,0
141465,),0,0
141466,in,0,0
141467,acute,1,1
141468,exacerbated,1,0
141469,chronic,1,1
141470,obstructive,1,1
141471,pulmonary,1,1
141472,disease,1,1
141473,(,1,0
141474,COPD,1,1
141475,),1,1
141476,patients,1,1
141477,.,1,1
141478,METHODS,0,0
141479,Seventy-nine,1,1
141480,patients,1,1
141481,with,1,1
141482,acute,1,1
141483,exacerbated,1,0
141484,COPD,1,0
141485,were,0,0
141486,randomly,0,1
141487,assigned,0,0
141488,to,0,0
141489,the,0,0
141490,treatment,0,0
141491,group,0,0
141492,(,0,0
141493,39,0,1
141494,cases,0,1
141495,),0,1
141496,and,0,0
141497,the,0,0
141498,control,0,0
141499,group,0,0
141500,(,0,0
141501,40,0,1
141502,cases,0,1
141503,),0,1
141504,.,0,1
141505,Routine,0,0
141506,therapies,0,0
141507,for,0,1
141508,COPD,0,1
141509,were,0,0
141510,given,0,0
141511,to,0,0
141512,patients,0,1
141513,in,0,0
141514,the,0,0
141515,control,0,0
141516,group,0,0
141517,",",0,0
141518,while,0,0
141519,15,0,1
141520,mL,0,0
141521,SI,0,1
141522,was,0,0
141523,given,0,0
141524,to,0,0
141525,those,0,0
141526,in,0,0
141527,the,0,0
141528,treatment,0,0
141529,group,0,0
141530,by,0,0
141531,intravenous,0,0
141532,dripping,0,0
141533,",",0,0
141534,twice,0,0
141535,daily,0,0
141536,for,0,0
141537,total,0,1
141538,14,0,1
141539,days,0,0
141540,.,0,1
141541,The,0,0
141542,forced,0,0
141543,expiratory,0,0
141544,volume,0,0
141545,in,0,0
141546,one,0,0
141547,second,0,0
141548,(,0,0
141549,FEV1,0,0
141550,),0,0
141551,and,0,0
141552,forced,0,1
141553,vital,0,0
141554,capacity,0,0
141555,(,0,0
141556,FVC,0,0
141557,),0,0
141558,were,0,0
141559,detected,0,0
141560,by,0,0
141561,Spirometer,0,0
141562,.,0,1
141563,The,0,0
141564,FEV1/FVC,0,0
141565,(,0,0
141566,%,0,0
141567,),0,0
141568,and,0,0
141569,the,0,0
141570,FEV1,0,0
141571,%,0,0
141572,were,0,0
141573,calculated,0,0
141574,.,0,0
141575,The,0,0
141576,levels,0,0
141577,of,0,0
141578,serum,0,0
141579,MMP-9,0,0
141580,and,0,0
141581,TIMP-1,0,0
141582,were,0,0
141583,detected,0,0
141584,using,0,0
141585,ELISA,0,1
141586,before,0,0
141587,and,0,0
141588,after,0,0
141589,treatment,0,0
141590,",",0,0
141591,and,0,0
141592,compared,0,0
141593,with,0,1
141594,20,0,1
141595,healthy,0,1
141596,subjects,0,1
141597,as,0,0
141598,the,0,0
141599,control,0,0
141600,.,0,0
141601,RESULTS,0,0
141602,The,0,0
141603,FEV1,0,0
141604,",",0,0
141605,FVC,0,0
141606,",",0,0
141607,FEV1/FVC,0,0
141608,(,0,0
141609,%,0,0
141610,),0,0
141611,",",0,0
141612,and,0,0
141613,FEV1,0,0
141614,%,0,0
141615,were,0,0
141616,significantly,0,0
141617,improved,0,0
141618,after,0,0
141619,treatment,0,0
141620,in,0,0
141621,the,0,0
141622,treatment,0,0
141623,group,0,0
141624,when,0,0
141625,compared,0,0
141626,with,0,0
141627,before,0,0
141628,treatment,0,0
141629,and,0,0
141630,with,0,1
141631,the,0,0
141632,control,0,0
141633,group,0,0
141634,(,0,0
141635,P,0,0
141636,<,0,0
141637,0.05,0,0
141638,",",0,0
141639,P,0,0
141640,<,0,0
141641,0.01,0,0
141642,),0,0
141643,.,0,0
141644,When,0,0
141645,compared,0,0
141646,with,0,0
141647,before,0,0
141648,treatment,0,0
141649,and,0,0
141650,with,0,1
141651,the,0,0
141652,control,0,0
141653,group,0,0
141654,",",0,0
141655,the,0,0
141656,levels,0,0
141657,of,0,0
141658,serum,0,0
141659,MMP-9,0,0
141660,",",0,0
141661,TIMP-1,0,0
141662,",",0,0
141663,and,0,0
141664,the,0,0
141665,ratio,0,0
141666,of,0,0
141667,MMP-9/TIMP-1,0,0
141668,decreased,0,0
141669,more,0,0
141670,significantly,0,0
141671,in,0,0
141672,the,0,0
141673,treatment,0,0
141674,group,0,0
141675,after,0,0
141676,treatment,0,0
141677,(,0,0
141678,P,0,0
141679,<,0,0
141680,0.01,0,0
141681,),0,0
141682,.,0,0
141683,Correlation,0,0
141684,analyses,0,0
141685,showed,0,0
141686,that,0,0
141687,obvious,0,0
141688,negative,0,0
141689,correlation,0,0
141690,existed,0,0
141691,between,0,0
141692,the,0,0
141693,levels,0,0
141694,of,0,0
141695,serum,0,0
141696,MMP-9,0,0
141697,and,0,0
141698,TIMP-1,0,0
141699,and,0,0
141700,FEV1/FVC,0,0
141701,(,0,0
141702,%,0,0
141703,),0,0
141704,(,0,0
141705,r,0,0
141706,=,0,0
141707,-0.677,0,0
141708,",",0,0
141709,-0.629,0,0
141710,",",0,0
141711,P,0,0
141712,<,0,0
141713,0.01,0,0
141714,),0,1
141715,.,0,1
141716,Obvious,0,0
141717,negative,0,0
141718,correlation,0,0
141719,existed,0,0
141720,between,0,0
141721,the,0,0
141722,levels,0,0
141723,of,0,0
141724,serum,0,0
141725,MMP-9,0,0
141726,and,0,0
141727,TIMP-1,0,0
141728,and,0,0
141729,FEV1,0,0
141730,%,0,0
141731,(,0,0
141732,r,0,0
141733,=,0,0
141734,-0.562,0,0
141735,",",0,0
141736,-0.661,0,0
141737,",",0,0
141738,P,0,0
141739,<,0,0
141740,0.01,0,0
141741,),0,0
141742,.,0,0
141743,Furthermore,0,0
141744,",",0,0
141745,obvious,0,0
141746,negative,0,0
141747,correlation,0,0
141748,also,0,0
141749,existed,0,0
141750,between,0,0
141751,the,0,0
141752,ratio,0,0
141753,of,0,0
141754,MMP-9/,0,0
141755,TIMP-1,0,1
141756,and,0,0
141757,FEV1,0,0
141758,%,0,0
141759,",",0,0
141760,as,0,0
141761,well,0,0
141762,as,0,0
141763,FEV1/FVC,0,0
141764,(,0,0
141765,%,0,0
141766,),0,0
141767,(,0,0
141768,r,0,0
141769,=,0,0
141770,-0.732,0,0
141771,",",0,0
141772,-0.891,0,0
141773,",",0,0
141774,P,0,0
141775,<,0,0
141776,0.01,0,0
141777,),0,1
141778,.,0,1
141779,CONCLUSIONS,0,0
141780,SI,0,0
141781,could,0,0
141782,improve,0,0
141783,the,0,0
141784,pulmonary,0,0
141785,ventilation,0,0
141786,function,0,0
141787,of,0,0
141788,acute,1,1
141789,exacerbated,1,0
141790,COPD,1,1
141791,patients,1,1
141792,.,1,1
141793,One,0,1
141794,of,0,0
141795,its,0,0
141796,mechanisms,0,0
141797,might,0,0
141798,be,0,0
141799,correlated,0,0
141800,with,0,0
141801,lowering,0,0
141802,the,0,0
141803,serum,0,0
141804,levels,0,0
141805,of,0,0
141806,MMP-9,0,1
141807,and,0,0
141808,TIMP-1,0,0
141809,",",0,0
141810,and,0,0
141811,correcting,0,0
141812,the,0,0
141813,imbalance,0,0
141814,of,0,0
141815,MMP-9/TIMP-1,0,0
141816,.,0,1
141817,Effects,0,0
141818,of,0,1
141819,skin-to-skin,0,0
141820,contact,0,0
141821,on,0,0
141822,autonomic,0,1
141823,pain,0,1
141824,responses,0,0
141825,in,0,0
141826,preterm,1,1
141827,infants,1,1
141828,.,1,1
141829,UNLABELLED,0,0
141830,The,0,0
141831,purpose,0,0
141832,of,0,0
141833,this,0,0
141834,randomized,0,0
141835,crossover,0,0
141836,trial,0,0
141837,was,0,0
141838,to,0,0
141839,determine,0,0
141840,the,0,0
141841,effects,0,0
141842,on,0,0
141843,autonomic,0,1
141844,responses,0,0
141845,in,0,1
141846,preterm,1,1
141847,infants,1,1
141848,of,1,0
141849,longer,1,0
141850,Kangaroo,1,1
141851,Care,1,1
141852,(,1,1
141853,30,1,1
141854,minutes,1,0
141855,",",1,1
141856,KC30,1,0
141857,),1,0
141858,and,1,0
141859,shorter,1,0
141860,KC,1,1
141861,(,1,0
141862,15,1,1
141863,minutes,1,0
141864,",",1,1
141865,KC15,1,1
141866,),1,0
141867,before,1,0
141868,and,1,0
141869,throughout,1,0
141870,heel,1,1
141871,stick,1,0
141872,compared,1,0
141873,with,1,1
141874,incubator,1,0
141875,care,1,1
141876,(,1,0
141877,IC,1,1
141878,),1,1
141879,.,1,0
141880,Beat-to-beat,0,0
141881,heart,0,1
141882,rate,0,0
141883,(,0,0
141884,HR,0,0
141885,),0,0
141886,and,0,0
141887,spectral,0,0
141888,power,0,0
141889,analysis,0,0
141890,of,0,0
141891,heart,0,1
141892,rate,0,0
141893,variability,0,0
141894,",",0,0
141895,low,0,0
141896,frequency,0,0
141897,power,0,0
141898,(,0,0
141899,LF,0,0
141900,),0,0
141901,",",0,0
141902,high,0,0
141903,frequency,0,0
141904,power,0,0
141905,(,0,0
141906,HF,0,0
141907,),0,0
141908,",",0,0
141909,and,0,0
141910,LF/HF,0,1
141911,ratio,0,0
141912,were,0,0
141913,measured,0,0
141914,in,0,0
141915,26,1,1
141916,infants,1,1
141917,.,1,1
141918,HR,0,0
141919,changes,0,0
141920,from,0,1
141921,Baseline,0,0
141922,to,0,0
141923,Heel,0,0
141924,Stick,0,0
141925,were,0,0
141926,significantly,0,0
141927,less,0,0
141928,in,0,0
141929,KC30,0,0
141930,and,0,0
141931,KC15,0,0
141932,than,0,0
141933,in,0,0
141934,IC,0,0
141935,",",0,0
141936,and,0,0
141937,more,0,0
141938,infants,0,1
141939,had,0,1
141940,HR,0,0
141941,decrease,0,0
141942,in,0,0
141943,IC,0,0
141944,than,0,0
141945,in,0,0
141946,2,0,1
141947,KC,0,1
141948,conditions,0,0
141949,.,0,1
141950,In,0,0
141951,IC,0,0
141952,",",0,0
141953,LF,0,0
141954,and,0,0
141955,HF,0,0
141956,significantly,0,0
141957,increased,0,0
141958,from,0,0
141959,Baseline,0,0
141960,to,0,0
141961,Heel,0,0
141962,Stick,0,0
141963,and,0,0
141964,dropped,0,0
141965,from,0,0
141966,Heel,0,0
141967,Stick,0,0
141968,to,0,1
141969,Recovery,0,0
141970,;,0,0
141971,in,0,0
141972,2,0,0
141973,KC,0,1
141974,conditions,0,0
141975,",",0,0
141976,no,0,0
141977,changes,0,0
141978,across,0,0
141979,study,0,1
141980,phases,0,0
141981,were,0,1
141982,found,0,0
141983,.,0,0
141984,During,0,0
141985,Heel,0,0
141986,Stick,0,0
141987,",",0,0
141988,LF,0,0
141989,and,0,0
141990,HF,0,0
141991,were,0,0
141992,significantly,0,0
141993,higher,0,0
141994,in,0,0
141995,IC,0,0
141996,than,0,0
141997,in,0,0
141998,KC30,0,0
141999,.,0,1
142000,In,0,0
142001,all,0,0
142002,3,0,0
142003,conditions,0,0
142004,",",0,0
142005,LF/HF,0,1
142006,ratio,0,0
142007,decreased,0,0
142008,from,0,0
142009,Baseline,0,0
142010,to,0,0
142011,Heel,0,0
142012,Stick,0,0
142013,and,0,0
142014,increased,0,0
142015,to,0,0
142016,Recovery,0,0
142017,;,0,0
142018,no,0,0
142019,differences,0,0
142020,were,0,0
142021,found,0,0
142022,between,0,0
142023,IC,0,1
142024,and,0,1
142025,two,0,0
142026,KC,0,1
142027,conditions,0,1
142028,.,0,1
142029,Both,0,0
142030,longer,0,0
142031,and,0,0
142032,shorter,0,0
142033,KC,0,1
142034,before,0,0
142035,and,0,0
142036,throughout,0,0
142037,heel,0,0
142038,stick,0,0
142039,can,0,0
142040,stabilize,0,0
142041,HR,0,0
142042,response,0,0
142043,in,0,0
142044,preterm,0,1
142045,infants,0,1
142046,",",0,0
142047,and,0,0
142048,longer,0,0
142049,KC,0,1
142050,significantly,0,0
142051,affected,0,0
142052,infants,0,1
142053,',0,1
142054,sympathetic,0,0
142055,and,0,1
142056,parasympathetic,0,0
142057,responses,0,0
142058,during,0,0
142059,heel,0,1
142060,stick,0,0
142061,compared,0,0
142062,with,0,1
142063,incubator,0,1
142064,care,0,1
142065,.,0,0
142066,PERSPECTIVE,0,0
142067,This,0,0
142068,study,0,0
142069,showed,0,0
142070,that,0,0
142071,KC,0,1
142072,has,0,0
142073,a,0,0
142074,significant,0,0
142075,effect,0,0
142076,on,0,0
142077,reducing,0,0
142078,autonomic,0,1
142079,pain,0,1
142080,responses,0,0
142081,in,0,0
142082,preterm,1,1
142083,infants,1,1
142084,.,1,1
142085,The,0,0
142086,findings,0,0
142087,support,0,0
142088,that,0,0
142089,KC,0,1
142090,is,0,0
142091,a,0,0
142092,safe,0,0
142093,and,0,0
142094,effective,0,0
142095,pain,0,0
142096,intervention,0,0
142097,in,0,0
142098,the,0,0
142099,neonatal,0,1
142100,intensive,0,0
142101,care,0,1
142102,unit,0,1
142103,.,0,1
142104,Controlled-release,0,0
142105,melatonin,0,0
142106,",",0,0
142107,singly,0,0
142108,and,0,0
142109,combined,0,0
142110,with,0,1
142111,cognitive,0,0
142112,behavioural,0,0
142113,therapy,0,0
142114,",",0,0
142115,for,0,0
142116,persistent,1,1
142117,insomnia,1,1
142118,in,1,0
142119,children,1,1
142120,with,1,1
142121,autism,1,1
142122,spectrum,1,1
142123,disorders,1,1
142124,:,1,1
142125,a,0,0
142126,randomized,0,0
142127,placebo-controlled,0,0
142128,trial,0,0
142129,.,0,0
142130,Although,0,0
142131,melatonin,0,0
142132,and,0,0
142133,cognitive-behavioural,0,0
142134,therapy,0,0
142135,have,0,0
142136,shown,0,0
142137,efficacy,0,0
142138,in,0,0
142139,treating,0,0
142140,sleep,1,1
142141,disorders,1,1
142142,in,1,1
142143,children,1,1
142144,with,1,1
142145,autism,1,1
142146,spectrum,1,1
142147,disorders,1,1
142148,",",0,0
142149,little,0,0
142150,is,0,0
142151,known,0,0
142152,about,0,0
142153,their,0,0
142154,relative,0,0
142155,or,0,0
142156,combined,0,0
142157,efficacy,0,0
142158,.,0,1
142159,One,1,1
142160,hundred,1,1
142161,and,1,1
142162,sixty,1,1
142163,children,1,1
142164,with,1,1
142165,autism,1,1
142166,spectrum,1,1
142167,disorders,1,1
142168,",",1,0
142169,aged,1,1
142170,4-10,1,0
142171,years,1,1
142172,",",1,0
142173,suffering,1,1
142174,from,1,0
142175,sleep,1,1
142176,onset,1,1
142177,insomnia,1,1
142178,and,1,0
142179,impaired,1,1
142180,sleep,1,0
142181,maintenance,1,0
142182,",",0,0
142183,were,0,0
142184,assigned,0,0
142185,randomly,0,1
142186,to,0,0
142187,either,0,0
142188,(,0,0
142189,1,0,0
142190,),0,0
142191,combination,0,0
142192,of,0,0
142193,controlled-release,0,0
142194,melatonin,0,0
142195,and,0,0
142196,cognitive-behavioural,0,1
142197,therapy,0,0
142198,;,0,0
142199,(,0,0
142200,2,0,0
142201,),0,0
142202,controlled-release,0,0
142203,melatonin,0,0
142204,;,0,0
142205,(,0,0
142206,3,0,0
142207,),0,1
142208,four,0,1
142209,sessions,0,0
142210,of,0,0
142211,cognitive-behavioural,0,1
142212,therapy,0,0
142213,;,0,0
142214,or,0,1
142215,(,0,0
142216,4,0,0
142217,),0,0
142218,placebo,0,0
142219,drug,0,0
142220,treatment,0,0
142221,condition,0,0
142222,for,0,0
142223,12,0,0
142224,weeks,0,0
142225,in,0,0
142226,a,0,1
142227,1,0,0
142228,:,0,1
142229,1,0,1
142230,:,0,1
142231,1,0,1
142232,:,0,1
142233,1,0,0
142234,ratio,0,0
142235,.,0,1
142236,Children,0,1
142237,were,0,0
142238,studied,0,0
142239,at,0,0
142240,baseline,0,0
142241,and,0,0
142242,after,0,0
142243,12,0,0
142244,weeks,0,0
142245,of,0,1
142246,treatment,0,0
142247,.,0,1
142248,Treatment,0,0
142249,response,0,0
142250,was,0,0
142251,assessed,0,0
142252,with,0,1
142253,1-week,0,0
142254,actigraphic,0,0
142255,monitoring,0,0
142256,",",0,0
142257,sleep,0,0
142258,diary,0,0
142259,and,0,0
142260,sleep,0,0
142261,questionnaire,0,0
142262,.,0,1
142263,Main,0,0
142264,outcome,0,0
142265,measures,0,0
142266,",",0,0
142267,derived,0,0
142268,actigraphically,0,0
142269,",",0,0
142270,were,0,0
142271,sleep,0,0
142272,latency,0,0
142273,",",0,0
142274,total,0,1
142275,sleep,0,0
142276,time,0,0
142277,",",0,0
142278,wake,0,0
142279,after,0,0
142280,sleep,0,0
142281,onset,0,1
142282,and,0,0
142283,number,0,0
142284,of,0,0
142285,awakenings,0,0
142286,.,0,1
142287,The,0,0
142288,active,0,0
142289,treatment,0,0
142290,groups,0,0
142291,all,0,0
142292,resulted,0,0
142293,in,0,0
142294,improvements,0,0
142295,across,0,0
142296,all,0,1
142297,outcome,0,0
142298,measures,0,0
142299,",",0,0
142300,with,0,1
142301,moderate-to-large,0,0
142302,effect,0,0
142303,sizes,0,0
142304,from,0,0
142305,baseline,0,0
142306,to,0,0
142307,a,0,0
142308,12-week,0,0
142309,assessment,0,0
142310,.,0,1
142311,Melatonin,0,0
142312,treatment,0,0
142313,was,0,0
142314,mainly,0,0
142315,effective,0,0
142316,in,0,0
142317,reducing,0,0
142318,insomnia,0,1
142319,symptoms,0,0
142320,",",0,0
142321,while,0,0
142322,cognitive-behavioural,0,0
142323,therapy,0,0
142324,had,0,1
142325,a,0,0
142326,light,0,0
142327,positive,0,0
142328,impact,0,0
142329,mainly,0,0
142330,on,0,0
142331,sleep,0,0
142332,latency,0,0
142333,",",0,0
142334,suggesting,0,0
142335,that,0,0
142336,some,0,0
142337,behavioural,0,0
142338,aspects,0,0
142339,might,0,0
142340,play,0,0
142341,a,0,0
142342,role,0,0
142343,in,0,0
142344,determining,0,0
142345,initial,0,0
142346,insomnia,0,1
142347,.,0,0
142348,The,0,0
142349,combination,0,0
142350,treatment,0,0
142351,group,0,0
142352,showed,0,0
142353,a,0,0
142354,trend,0,0
142355,to,0,0
142356,outperform,0,0
142357,other,0,0
142358,active,0,1
142359,treatment,0,0
142360,groups,0,0
142361,",",0,0
142362,with,0,1
142363,fewer,0,0
142364,dropouts,0,0
142365,and,0,0
142366,a,0,0
142367,greater,0,0
142368,proportion,0,0
142369,of,0,0
142370,treatment,0,0
142371,responders,0,0
142372,achieving,0,0
142373,clinically,0,0
142374,significant,0,0
142375,changes,0,0
142376,(,0,1
142377,63.38,0,0
142378,%,0,0
142379,normative,0,1
142380,sleep,0,0
142381,efficiency,0,0
142382,criterion,0,0
142383,of,0,0
142384,>,0,1
142385,85,0,1
142386,%,0,0
142387,and,0,0
142388,84.62,0,0
142389,%,0,0
142390,",",0,0
142391,sleep,0,0
142392,onset,0,1
142393,latency,0,0
142394,<,0,0
142395,30,0,0
142396,min,0,0
142397,),0,0
142398,.,0,0
142399,This,0,0
142400,study,0,0
142401,demonstrates,0,0
142402,that,0,0
142403,adding,0,0
142404,behavioural,0,0
142405,intervention,0,0
142406,to,0,0
142407,melatonin,0,0
142408,treatment,0,0
142409,seems,0,0
142410,to,0,0
142411,result,0,0
142412,in,0,0
142413,a,0,0
142414,better,0,0
142415,treatment,0,0
142416,response,0,0
142417,",",0,0
142418,at,0,0
142419,least,0,0
142420,in,0,0
142421,the,0,0
142422,short,0,0
142423,term,0,1
142424,.,0,1
142425,Enhancing,0,0
142426,HIV,0,1
142427,medication,0,0
142428,adherence,0,0
142429,in,0,0
142430,India,0,1
142431,.,0,1
142432,BACKGROUND,0,0
142433,This,0,0
142434,pilot,0,0
142435,study,0,0
142436,evaluated,0,0
142437,an,0,0
142438,intervention,0,0
142439,designed,0,0
142440,to,0,0
142441,enhance,0,0
142442,adherence,0,0
142443,among,0,0
142444,those,0,0
142445,new,0,0
142446,to,0,0
142447,antiretroviral,0,1
142448,therapy,0,0
142449,.,0,1
142450,METHODS,1,0
142451,Participants,1,1
142452,(,1,0
142453,n,1,1
142454,=,1,0
142455,80,1,1
142456,),1,0
142457,were,1,0
142458,recruited,1,1
142459,from,1,0
142460,a,1,0
142461,hospital,1,0
142462,clinic,1,1
142463,in,1,0
142464,Chandigarh,1,1
142465,",",1,0
142466,India,1,1
142467,",",1,0
142468,and,1,0
142469,randomized,1,0
142470,to,1,0
142471,a,1,0
142472,3-month,1,0
142473,group,1,0
142474,intervention,1,0
142475,or,1,1
142476,individual,1,0
142477,enhanced,1,0
142478,standard,1,0
142479,of,1,0
142480,care,1,1
142481,followed,1,0
142482,by,1,0
142483,crossover,1,0
142484,of,1,0
142485,condition,1,0
142486,and,1,0
142487,assessed,1,0
142488,over,1,0
142489,6,1,1
142490,months,1,0
142491,.,1,1
142492,Adherence,0,0
142493,was,0,0
142494,measured,0,0
142495,by,0,0
142496,prescription,0,0
142497,refill,0,0
142498,",",0,0
142499,pill,0,0
142500,count,0,0
142501,",",0,0
142502,and,0,0
142503,self-report,0,0
142504,.,0,0
142505,RESULTS,0,0
142506,At,0,0
142507,baseline,0,0
142508,",",0,0
142509,56,0,1
142510,%,0,0
142511,of,0,0
142512,group,0,0
142513,condition,0,0
142514,(,0,0
142515,immediate,0,0
142516,intervention,0,0
142517,),0,0
142518,and,0,0
142519,54,0,1
142520,%,0,0
142521,of,0,0
142522,individual,0,0
142523,condition,0,0
142524,(,0,0
142525,delayed,0,0
142526,intervention,0,0
142527,),0,0
142528,participants,0,1
142529,were,0,1
142530,nonadherent,0,1
142531,by,0,0
142532,pill,0,0
142533,count,0,0
142534,and,0,0
142535,23,0,1
142536,%,0,0
142537,of,0,0
142538,group,0,0
142539,and,0,0
142540,26,0,1
142541,%,0,0
142542,of,0,0
142543,individual,0,0
142544,condition,0,1
142545,participants,0,1
142546,self-reported,0,0
142547,skipping,0,0
142548,medication,0,0
142549,at,0,0
142550,least,0,0
142551,once,0,0
142552,over,0,0
142553,the,0,0
142554,last,0,0
142555,3,0,0
142556,months,0,0
142557,.,0,1
142558,From,0,1
142559,the,0,0
142560,postintervention,0,0
142561,to,0,0
142562,long-term,0,0
142563,follow-up,0,0
142564,",",0,0
142565,adherence,0,0
142566,in,0,0
142567,the,0,0
142568,group,0,0
142569,condition,0,0
142570,(,0,0
142571,immediate,0,0
142572,intervention,0,0
142573,),0,0
142574,improved,0,0
142575,in,0,0
142576,comparison,0,0
142577,with,0,1
142578,adherence,0,0
142579,in,0,0
142580,the,0,0
142581,individual,0,0
142582,condition,0,0
142583,(,0,0
142584,delayed,0,0
142585,intervention,0,0
142586,;,0,0
142587,?,0,0
142588,(,0,0
142589,2,0,0
142590,),0,1
142591,=,0,0
142592,5.67,0,0
142593,",",0,0
142594,P,0,0
142595,=,0,0
142596,.02,0,0
142597,),0,0
142598,.,0,1
142599,CONCLUSIONS,0,0
142600,Results,0,0
142601,support,0,0
142602,the,0,0
142603,use,0,0
142604,of,0,0
142605,interventions,0,0
142606,early,0,1
142607,in,0,0
142608,treatment,0,0
142609,to,0,0
142610,provide,0,0
142611,information,0,0
142612,and,0,0
142613,social,0,0
142614,support,0,0
142615,to,0,0
142616,establish,0,0
142617,long-term,0,0
142618,healthy,0,1
142619,adherence,0,0
142620,behaviors,0,0
142621,.,0,1
142622,[,0,0
142623,Effect,0,0
142624,of,0,0
142625,probucol,0,0
142626,on,0,0
142627,serum,0,0
142628,malondialdehyde,0,0
142629,and,0,0
142630,superoxide,0,0
142631,dismutase,0,0
142632,in,0,0
142633,patients,1,1
142634,with,1,1
142635,primary,1,1
142636,hypertension,1,1
142637,],1,0
142638,.,0,0
142639,OBJECTIVE,0,0
142640,To,0,0
142641,observe,0,0
142642,the,0,0
142643,therapeutic,0,0
142644,effect,0,0
142645,of,0,0
142646,probucol,0,0
142647,on,0,0
142648,serum,0,0
142649,malondialdehyde,0,0
142650,(,0,0
142651,MDA,0,0
142652,),0,0
142653,and,0,0
142654,superoxide,0,0
142655,dismutase,0,0
142656,(,0,0
142657,SOD,0,0
142658,),0,0
142659,in,0,0
142660,patients,1,1
142661,with,1,1
142662,primary,1,1
142663,hypertension,1,1
142664,.,1,1
142665,METHODS,0,0
142666,A,0,0
142667,randomized,0,1
142668,study,0,0
142669,was,0,0
142670,performed,0,0
142671,on,0,0
142672,40,1,1
142673,patients,1,1
142674,with,1,1
142675,hypertension,1,1
142676,.,1,0
142677,The,0,0
142678,patients,0,1
142679,were,0,0
142680,randomly,0,1
142681,assigned,0,0
142682,to,0,0
142683,the,0,0
142684,control,0,0
142685,(,0,0
142686,levamlodipine,0,0
142687,besylate,0,0
142688,2.5,0,0
142689,mg/d,0,0
142690,plus,0,0
142691,benazepril,0,0
142692,10,0,0
142693,mg/d,0,0
142694,",",0,0
142695,n=20,0,1
142696,),0,0
142697,or,0,0
142698,probucol,0,0
142699,group,0,0
142700,(,0,0
142701,levamlodipine,0,0
142702,besylate,0,0
142703,2.5,0,0
142704,mg/d,0,0
142705,plus,0,0
142706,benazepril,0,0
142707,10,0,0
142708,mg/d,0,0
142709,plus,0,0
142710,probucol,0,0
142711,500,0,0
142712,mg/d,0,0
142713,",",0,0
142714,n=20,0,1
142715,),0,0
142716,.,0,0
142717,An,1,0
142718,additional,1,0
142719,twenty,1,1
142720,healthy,1,1
142721,people,1,1
142722,were,1,1
142723,enrolled,1,1
142724,in,1,0
142725,the,1,0
142726,study,1,0
142727,(,1,0
142728,normal,1,1
142729,group,1,1
142730,),1,0
142731,.,1,0
142732,All,0,1
142733,subjects,0,1
142734,were,0,0
142735,followed,0,0
142736,up,0,0
142737,for,0,0
142738,a,0,0
142739,period,0,0
142740,of,0,0
142741,four,0,1
142742,weeks,0,0
142743,.,0,1
142744,Lipids,0,0
142745,and,0,0
142746,hepatic/renal,0,1
142747,function,0,0
142748,were,0,0
142749,measured,0,0
142750,at,0,0
142751,baseline,0,0
142752,and,0,0
142753,after,0,0
142754,4,0,0
142755,weeks,0,0
142756,.,0,1
142757,The,0,0
142758,levels,0,0
142759,of,0,0
142760,serum,0,0
142761,MDA,0,0
142762,and,0,0
142763,SOD,0,0
142764,activity,0,0
142765,were,0,0
142766,assayed,0,0
142767,by,0,0
142768,chemical,0,0
142769,colorimetry,0,0
142770,",",0,0
142771,and,0,0
142772,other,0,0
142773,indices,0,0
142774,",",0,0
142775,including,0,0
142776,blood,0,0
142777,pressure,0,0
142778,",",0,0
142779,lipids,0,0
142780,and,0,0
142781,hepatic/renal,0,0
142782,function,0,0
142783,",",0,0
142784,were,0,0
142785,measured,0,0
142786,at,0,0
142787,baseline,0,0
142788,and,0,0
142789,after,0,0
142790,4,0,0
142791,weeks,0,0
142792,.,0,1
142793,RESULTS,0,0
142794,Compared,0,0
142795,to,0,0
142796,the,0,0
142797,normal,0,0
142798,group,0,0
142799,",",0,0
142800,the,0,0
142801,levels,0,0
142802,of,0,0
142803,MDA,0,0
142804,in,0,0
142805,all,0,0
142806,of,0,0
142807,the,0,0
142808,hypertension,1,1
142809,patient,1,0
142810,groups,0,0
142811,were,0,0
142812,higher,0,0
142813,",",0,0
142814,SOD,0,0
142815,was,0,0
142816,lower,0,0
142817,.,0,0
142818,The,0,0
142819,antihypertensive,0,0
142820,treatment,0,0
142821,decreased,0,0
142822,serum,0,0
142823,MDA,0,0
142824,levels,0,0
142825,but,0,0
142826,increased,0,0
142827,SOD,0,0
142828,content,0,0
142829,",",0,0
142830,and,0,0
142831,probucol,0,0
142832,treatment,0,0
142833,exaggerated,0,0
142834,these,0,0
142835,effects,0,0
142836,",",0,0
142837,with,0,1
142838,greater,0,0
142839,reduction,0,0
142840,of,0,0
142841,serum,0,0
142842,MDA,0,0
142843,levels,0,0
142844,and,0,0
142845,greater,0,0
142846,increase,0,0
142847,of,0,0
142848,SOD,0,0
142849,content,0,0
142850,.,0,0
142851,CONCLUSION,0,0
142852,The,0,0
142853,treatment,0,0
142854,with,0,0
142855,probucol,0,0
142856,can,0,0
142857,improve,0,0
142858,oxidative,0,0
142859,stress,0,0
142860,in,0,0
142861,hypertension,1,1
142862,patients,1,1
142863,",",0,0
142864,resulting,0,0
142865,in,0,0
142866,reduced,0,0
142867,serum,0,0
142868,MDA,0,0
142869,levels,0,0
142870,and,0,0
142871,improved,0,0
142872,SOD,0,0
142873,activity,0,0
142874,",",0,0
142875,thus,0,0
142876,contributing,0,0
142877,agreater,0,0
142878,antihypertensive,0,0
142879,effect,0,0
142880,.,0,1
142881,Effectiveness,0,0
142882,and,0,0
142883,durability,0,0
142884,of,0,0
142885,Interceptor?,0,0
142886,long-lasting,0,0
142887,insecticidal,0,0
142888,nets,1,0
142889,in,1,0
142890,a,1,0
142891,malaria,1,1
142892,endemic,1,1
142893,area,1,0
142894,of,1,0
142895,central,1,1
142896,India,1,1
142897,.,1,1
142898,BACKGROUND,0,0
142899,In,0,0
142900,the,0,0
142901,present,0,0
142902,study,0,0
142903,",",0,0
142904,Interceptor?,0,0
142905,",",0,0
142906,long-lasting,0,0
142907,polyester,0,0
142908,net,0,0
142909,",",0,0
142910,75,0,0
142911,denier,0,0
142912,and,0,0
142913,bursting,0,0
142914,strength,0,0
142915,of,0,0
142916,minimum,0,0
142917,250,0,0
142918,kPa,0,0
142919,coated,0,0
142920,with,0,1
142921,alpha-cypermethrin,0,0
142922,@,0,0
142923,200,0,1
142924,mg/m?,0,0
142925,was,0,0
142926,evaluated,0,0
142927,for,0,0
142928,its,0,0
142929,efficacy,0,0
142930,in,0,0
142931,reducing,0,0
142932,the,0,0
142933,mosquito,0,0
142934,density,0,0
142935,",",0,0
142936,blood,0,0
142937,feeding,0,0
142938,inhibition,0,0
142939,and,0,0
142940,malaria,1,1
142941,incidence,1,0
142942,in,1,0
142943,a,1,0
142944,tribal,1,1
142945,dominated,1,0
142946,malaria,1,1
142947,endemic,1,1
142948,area,1,0
142949,in,1,0
142950,Chhattisgarh,1,1
142951,state,1,0
142952,",",1,0
142953,central,1,0
142954,India,1,1
142955,.,1,1
142956,Its,1,0
142957,durability,0,0
142958,",",0,0
142959,washing,0,0
142960,practices,0,0
142961,and,0,1
142962,usage,0,0
142963,pattern,0,1
142964,by,0,0
142965,the,0,0
142966,community,1,0
142967,was,1,0
142968,also,0,0
142969,assessed,0,0
142970,up,0,0
142971,to,0,0
142972,a,0,0
142973,period,0,0
142974,of,0,0
142975,three,0,1
142976,years,0,1
142977,.,0,1
142978,METHODS,0,0
142979,The,0,0
142980,study,0,0
142981,was,0,0
142982,carried,0,0
142983,out,0,0
142984,in,0,0
142985,two,0,0
142986,phases,0,0
142987,.,0,1
142988,In,0,0
142989,the,0,0
142990,first,0,0
142991,phase,1,0
142992,(,1,1
142993,September,1,1
142994,2006,1,1
142995,to,1,0
142996,August,1,1
142997,2007,1,1
142998,),1,0
142999,",",1,0
143000,16,1,1
143001,malaria,1,1
143002,endemic,1,1
143003,villages,1,1
143004,in,1,0
143005,district,1,1
143006,Kanker,1,1
143007,were,1,0
143008,randomized,0,1
143009,into,0,1
143010,three,0,0
143011,groups,0,0
143012,",",0,0
143013,viz,0,0
143014,.,0,0
143015,Interceptor,0,0
143016,net,0,0
143017,(,0,1
143018,LN,0,1
143019,),0,0
143020,",",0,0
143021,untreated,0,1
143022,polyester,0,0
143023,net,0,0
143024,(,0,0
143025,100,0,0
143026,denier,0,0
143027,),0,0
143028,and,0,0
143029,without,0,1
143030,net,0,0
143031,.,0,1
143032,Malaria,0,0
143033,cases,0,1
143034,were,0,0
143035,detected,0,0
143036,by,0,0
143037,undertaking,0,0
143038,fortnightly,0,0
143039,surveillance,0,0
143040,by,0,0
143041,home,0,1
143042,visits,0,0
143043,and,0,0
143044,treated,0,1
143045,as,0,0
143046,per,0,0
143047,the,0,0
143048,national,0,1
143049,drug,0,0
143050,policy,0,0
143051,.,0,1
143052,Mosquito,0,1
143053,collections,0,0
143054,were,0,0
143055,made,0,0
143056,by,0,0
143057,hand,0,0
143058,catch,0,0
143059,and,0,0
143060,pyrethrum,0,0
143061,space,0,0
143062,spray,0,0
143063,methods,0,1
143064,from,0,1
143065,human,0,1
143066,dwellings,0,1
143067,once,0,0
143068,every,0,0
143069,month,0,0
143070,.,0,0
143071,Slide,0,0
143072,positivity,0,0
143073,rate,0,0
143074,(,0,0
143075,SPR,0,0
143076,),0,0
143077,and,0,0
143078,malaria,0,1
143079,incidence,0,0
143080,per,0,0
143081,1000,0,0
143082,population,0,1
143083,(,0,0
143084,PI,0,0
143085,),0,0
143086,were,0,0
143087,compared,0,0
143088,between,0,0
143089,the,0,0
143090,three,0,0
143091,study,0,0
143092,arms,0,0
143093,to,0,0
143094,assess,0,0
143095,the,0,0
143096,impact,0,0
143097,of,0,0
143098,use,0,0
143099,of,0,0
143100,Interceptor,0,1
143101,nets,0,0
143102,.,0,0
143103,Simultaneously,0,0
143104,",",0,0
143105,wash,0,0
143106,resistance,0,0
143107,studies,0,0
143108,were,0,0
143109,carried,0,0
143110,out,0,0
143111,in,0,0
143112,the,0,0
143113,laboratory,0,0
143114,by,0,0
143115,doing,0,0
143116,cone,0,0
143117,bioassays,0,0
143118,on,0,0
143119,Interceptor,0,1
143120,LNs,0,0
143121,washed,0,0
143122,up,0,0
143123,to,0,0
143124,20,0,1
143125,times,0,0
143126,.,0,1
143127,Activities,0,0
143128,undertaken,0,0
143129,in,0,0
143130,second,0,0
143131,Phase,0,1
143132,(,0,1
143133,April,0,0
143134,2008,0,1
143135,to,0,0
143136,October,0,1
143137,2009,0,1
143138,),0,0
143139,after,0,0
143140,an,0,0
143141,interval,0,0
143142,of,0,0
143143,about,0,0
143144,18,0,1
143145,months,0,0
143146,post-net,0,1
143147,distribution,0,1
143148,included,0,1
143149,questionnaire,0,0
143150,based,0,0
143151,surveys,0,0
143152,at,0,0
143153,every,0,0
143154,six,0,1
143155,months,0,0
143156,",",0,0
143157,i.e,0,0
143158,.,0,0
143159,18,0,0
143160,",",0,0
143161,24,0,0
143162,",",0,0
143163,30,0,1
143164,and,0,0
143165,36,0,1
143166,months,0,0
143167,to,0,0
143168,observe,0,0
143169,durability,0,0
143170,",",0,0
143171,usage,0,0
143172,pattern,0,1
143173,of,0,0
143174,LNs,0,0
143175,and,0,0
143176,washing,0,0
143177,practices,0,0
143178,by,0,0
143179,the,0,0
143180,community,1,0
143181,.,1,0
143182,After,1,0
143183,36,0,1
143184,months,0,0
143185,of,0,0
143186,field,0,0
143187,use,0,0
143188,",",0,0
143189,30,0,1
143190,nets,0,0
143191,were,0,1
143192,retrieved,0,1
143193,and,0,0
143194,sampled,0,1
143195,destructively,0,1
143196,for,0,0
143197,chemical,0,0
143198,analysis,0,0
143199,.,0,1
143200,RESULTS,0,0
143201,Interceptor,0,0
143202,nets,0,0
143203,were,0,1
143204,found,0,0
143205,effective,0,0
143206,in,0,0
143207,reducing,0,0
143208,the,0,0
143209,density,0,0
143210,",",0,0
143211,parity,0,1
143212,rate,0,0
143213,and,0,0
143214,blood,0,0
143215,feeding,0,0
143216,success,0,0
143217,rate,0,0
143218,of,0,0
143219,main,0,0
143220,malaria,0,1
143221,vector,0,1
143222,Anopheles,0,1
143223,culicifacies,0,1
143224,as,0,0
143225,compared,0,0
143226,to,0,0
143227,that,0,0
143228,in,0,0
143229,untreated,0,1
143230,net,0,0
143231,and,0,0
143232,no,0,0
143233,net,0,0
143234,villages,0,1
143235,.,0,1
143236,SPR,0,0
143237,in,0,0
143238,LN,0,1
143239,villages,0,1
143240,was,0,0
143241,3.7,0,0
143242,%,0,0
143243,as,0,0
143244,compared,0,0
143245,to,0,0
143246,6.5,0,0
143247,%,0,0
143248,in,0,0
143249,untreated,0,1
143250,and,0,0
143251,11,0,0
143252,%,0,0
143253,in,0,0
143254,no,0,0
143255,net,0,0
143256,villages,0,1
143257,.,0,1
143258,PI,0,0
143259,in,0,0
143260,LN,0,1
143261,villages,0,1
143262,was,0,0
143263,16.4,0,0
143264,in,0,0
143265,comparison,0,0
143266,to,0,0
143267,24.8,0,0
143268,and,0,0
143269,44.2,0,1
143270,in,0,0
143271,untreated,0,1
143272,polyester,0,0
143273,net,0,0
143274,and,0,0
143275,no,0,0
143276,net,0,0
143277,villages,0,1
143278,respectively,0,0
143279,.,0,1
143280,In,0,0
143281,surveys,0,0
143282,carried,0,0
143283,out,0,1
143284,after,0,0
143285,three,0,0
143286,years,0,1
143287,of,0,0
143288,initial,0,0
143289,distribution,0,1
143290,",",0,0
143291,78.7,0,0
143292,%,0,0
143293,(,0,1
143294,737/936,0,1
143295,),0,1
143296,nets,0,0
143297,were,0,0
143298,still,0,0
143299,in,0,0
143300,possession,0,0
143301,with,0,1
143302,the,0,0
143303,households,0,1
143304,",",0,0
143305,of,0,0
143306,which,0,0
143307,68,0,1
143308,%,0,0
143309,were,0,0
143310,used,0,0
143311,every,0,0
143312,night,0,0
143313,.,0,0
143314,An,0,0
143315,.,0,0
143316,culicifacies,0,0
143317,mortality,0,0
143318,was,0,0
143319,>,0,1
143320,80,0,1
143321,%,0,0
143322,in,0,0
143323,cone,0,0
143324,bioassays,0,0
143325,done,0,0
143326,on,0,0
143327,LNs,0,0
143328,washed,0,0
143329,up,0,0
143330,to,0,0
143331,20,0,0
143332,times,0,0
143333,in,0,1
143334,laboratory,0,0
143335,.,0,1
143336,Mean,0,0
143337,alpha-cypermethrin,0,0
143338,content,0,0
143339,was,0,0
143340,43.5,0,0
143341,?,0,1
143342,31.7,0,0
143343,mg/m?,0,0
143344,on,0,0
143345,Interceptor,0,0
143346,LNs,0,0
143347,withdrawn,0,0
143348,after,0,0
143349,three,0,0
143350,years,0,1
143351,of,0,0
143352,household,0,1
143353,use,0,0
143354,against,0,0
143355,the,0,0
143356,baseline,0,0
143357,specification,0,0
143358,of,0,0
143359,200,0,0
143360,mg/m?,0,0
143361,.,0,0
143362,A,0,0
143363,gradual,0,0
143364,increase,0,0
143365,in,0,0
143366,the,0,0
143367,proportion,0,0
143368,of,0,0
143369,holed,0,0
143370,nets,0,0
143371,was,0,0
143372,observed,0,0
143373,with,0,1
143374,the,0,0
143375,increased,0,0
143376,period,0,0
143377,of,0,0
143378,usage,0,0
143379,.,0,1
143380,CONCLUSION,0,0
143381,Interceptor,0,0
143382,nets,0,0
143383,were,0,0
143384,highly,0,0
143385,effective,0,0
143386,in,0,0
143387,reducing,0,0
143388,vector,0,0
143389,densities,0,0
143390,as,0,0
143391,well,0,0
143392,as,0,0
143393,malaria,0,1
143394,incidence,0,0
143395,in,0,0
143396,the,0,0
143397,study,1,0
143398,villages,1,1
143399,.,1,1
143400,Availability,1,0
143401,of,0,0
143402,78,0,1
143403,%,0,0
143404,nets,0,0
143405,with,0,1
143406,the,0,0
143407,households,0,1
143408,in,0,0
143409,usable,0,0
143410,condition,0,0
143411,clearly,0,0
143412,indicated,0,0
143413,durability,0,0
143414,of,0,0
143415,Interceptor,0,0
143416,LNs,0,0
143417,up,0,0
143418,to,0,0
143419,three,0,0
143420,years,0,1
143421,in,0,0
143422,the,0,0
143423,rural,0,1
143424,setting,1,1
143425,of,1,0
143426,India,1,1
143427,.,0,1
143428,The,0,0
143429,nets,0,0
143430,were,0,0
143431,found,0,0
143432,to,0,0
143433,contain,0,0
143434,an,0,0
143435,effective,0,0
143436,concentration,0,0
143437,of,0,0
143438,alpha-cypermethrin,0,0
143439,against,0,1
143440,malaria,0,1
143441,vector,0,1
143442,after,0,1
143443,three,0,0
143444,years,0,1
143445,of,0,0
143446,household,0,1
143447,use,0,0
143448,.,0,1
143449,Plerixafor,0,0
143450,plus,0,0
143451,granulocyte,0,0
143452,colony-stimulating,0,0
143453,factor,0,0
143454,versus,0,0
143455,placebo,0,0
143456,plus,0,0
143457,granulocyte,0,0
143458,colony-stimulating,0,0
143459,factor,0,0
143460,for,0,0
143461,mobilization,0,0
143462,of,0,0
143463,CD34,0,0
143464,(,0,1
143465,+,0,0
143466,),0,0
143467,hematopoietic,0,0
143468,stem,0,1
143469,cells,0,0
143470,in,0,0
143471,patients,1,1
143472,with,1,1
143473,multiple,1,1
143474,myeloma,1,1
143475,and,1,1
143476,low,1,1
143477,peripheral,1,1
143478,blood,1,0
143479,CD34,1,0
143480,(,1,0
143481,+,1,0
143482,),1,0
143483,cell,1,1
143484,count,1,0
143485,:,1,1
143486,results,0,0
143487,of,0,0
143488,a,0,0
143489,subset,0,1
143490,analysis,0,0
143491,of,0,0
143492,a,0,0
143493,randomized,0,0
143494,trial,0,0
143495,.,0,1
143496,Preapheresis,0,0
143497,peripheral,0,0
143498,blood,0,0
143499,(,0,0
143500,PB,0,0
143501,),0,0
143502,CD34,0,0
143503,(,0,0
143504,+,0,0
143505,),0,0
143506,cell,0,0
143507,count,0,0
143508,is,0,0
143509,a,0,0
143510,strong,0,0
143511,predictor,0,0
143512,of,0,0
143513,hematopoietic,0,0
143514,stem,0,1
143515,cell,0,1
143516,(,0,0
143517,HSC,0,0
143518,),0,0
143519,mobilization,0,0
143520,and,0,0
143521,is,0,0
143522,routinely,0,0
143523,used,0,0
143524,to,0,0
143525,optimize,0,0
143526,the,0,0
143527,timing,0,0
143528,",",0,0
143529,cost,0,0
143530,",",0,0
143531,and,0,0
143532,success,0,0
143533,of,0,0
143534,HSC,0,0
143535,collection,0,1
143536,in,0,0
143537,patients,1,1
143538,with,1,1
143539,multiple,1,1
143540,myeloma,1,1
143541,.,1,0
143542,However,0,0
143543,",",0,0
143544,a,0,0
143545,uniform,0,0
143546,PB,0,0
143547,CD34,0,0
143548,(,0,0
143549,+,0,0
143550,),0,0
143551,cell,0,0
143552,count,0,0
143553,that,0,0
143554,predicts,0,0
143555,mobilization,0,0
143556,failure,0,0
143557,has,0,0
143558,not,0,0
143559,been,0,0
143560,defined,0,0
143561,",",0,0
143562,resulting,0,0
143563,in,0,0
143564,the,0,0
143565,development,0,0
143566,of,0,0
143567,institute-specific,0,0
143568,algorithms,0,0
143569,for,0,0
143570,mobilization,0,0
143571,",",0,0
143572,particularly,0,0
143573,regarding,0,0
143574,the,0,0
143575,decision,0,0
143576,of,0,0
143577,when,0,0
143578,to,0,0
143579,use,0,0
143580,the,0,0
143581,novel,0,0
143582,stem,0,1
143583,cell,0,1
143584,mobilization,0,0
143585,agent,0,0
143586,plerixafor,0,0
143587,.,0,0
143588,In,0,0
143589,this,0,0
143590,post,0,0
143591,hoc,0,0
143592,analysis,0,0
143593,",",0,0
143594,we,0,0
143595,evaluated,0,0
143596,the,0,0
143597,mobilization,0,0
143598,efficacy,0,0
143599,of,0,0
143600,plerixafor,0,0
143601,plus,0,0
143602,granulocyte,0,0
143603,colony-stimulating,0,0
143604,factor,0,0
143605,(,0,0
143606,G-CSF,0,0
143607,),0,0
143608,versus,0,0
143609,placebo,0,0
143610,plus,0,0
143611,G-CSF,0,0
143612,in,0,0
143613,patients,1,1
143614,with,1,1
143615,multiple,1,0
143616,myeloma,1,1
143617,",",1,0
143618,stratified,1,1
143619,by,1,0
143620,preapheresis,1,0
143621,PB,1,0
143622,CD34,1,0
143623,(,1,0
143624,+,1,0
143625,),1,0
143626,cell,1,1
143627,count,1,0
143628,:,1,1
143629,<,1,0
143630,10,1,0
143631,",",1,0
143632,<,1,0
143633,15,1,0
143634,",",1,0
143635,<,1,0
143636,20,1,0
143637,",",1,0
143638,and,1,0
143639,?20,1,1
143640,cells/?L,1,0
143641,.,1,0
143642,Regardless,1,0
143643,of,0,0
143644,the,0,0
143645,PB,0,0
143646,CD34,0,0
143647,(,0,0
143648,+,0,0
143649,),0,0
143650,cell,0,0
143651,count,0,0
143652,",",0,0
143653,the,0,0
143654,total,0,0
143655,yield,0,0
143656,of,0,0
143657,CD34,0,0
143658,(,0,1
143659,+,0,0
143660,),0,1
143661,cells,0,0
143662,from,0,1
143663,apheresis,0,0
143664,was,0,0
143665,significantly,0,0
143666,higher,0,0
143667,in,0,0
143668,the,0,0
143669,plerixafor,0,0
143670,group,0,0
143671,than,0,0
143672,in,0,0
143673,the,0,0
143674,placebo,0,0
143675,group,0,0
143676,",",0,0
143677,and,0,0
143678,significantly,0,0
143679,more,0,0
143680,patients,0,1
143681,in,0,0
143682,the,0,0
143683,plerixafor,0,0
143684,group,0,0
143685,collected,0,0
143686,the,0,0
143687,minimum,0,0
143688,(,0,0
143689,?2,0,0
143690,?,0,0
143691,10,0,0
143692,(,0,0
143693,6,0,0
143694,),0,0
143695,cells/kg,0,0
143696,),0,0
143697,and,0,0
143698,optimum,0,0
143699,(,0,0
143700,?6,0,0
143701,?,0,0
143702,10,0,0
143703,(,0,0
143704,6,0,0
143705,),0,0
143706,cells/kg,0,0
143707,),0,0
143708,stem,0,1
143709,cell,0,1
143710,yields,0,0
143711,on,0,0
143712,each,0,0
143713,day,0,0
143714,of,0,0
143715,apheresis,0,0
143716,.,0,0
143717,As,0,0
143718,a,0,0
143719,corollary,0,0
143720,",",0,0
143721,the,0,0
143722,greater,0,0
143723,stem,0,1
143724,cell,0,0
143725,collection,0,0
143726,in,0,0
143727,plerixafor-treated,0,1
143728,patients,0,1
143729,resulted,0,0
143730,in,0,0
143731,the,0,0
143732,need,0,0
143733,for,0,0
143734,significantly,0,0
143735,fewer,0,0
143736,days,0,0
143737,of,0,0
143738,apheresis,0,0
143739,to,0,0
143740,reach,0,0
143741,minimum,0,0
143742,and,0,0
143743,optimum,0,0
143744,cell,0,1
143745,doses,0,0
143746,across,0,0
143747,all,0,0
143748,cell,0,0
143749,count,0,0
143750,groups,0,0
143751,.,0,1
143752,For,0,0
143753,all,0,0
143754,CD34,0,0
143755,(,0,0
143756,+,0,0
143757,),0,0
143758,cell,0,1
143759,count,0,0
143760,groups,0,0
143761,",",0,0
143762,the,0,0
143763,proportion,0,0
143764,of,0,0
143765,patients,0,1
143766,proceeding,0,1
143767,to,0,0
143768,transplantation,0,1
143769,and,0,0
143770,the,0,0
143771,median,0,0
143772,time,0,0
143773,to,0,0
143774,platelet,0,0
143775,and,0,0
143776,neutrophil,0,0
143777,engraftment,0,0
143778,were,0,0
143779,similar,0,0
143780,in,0,0
143781,the,0,0
143782,plerixafor,0,0
143783,and,0,0
143784,placebo,0,0
143785,groups,0,0
143786,.,0,1
143787,Our,0,0
143788,findings,0,0
143789,demonstrate,0,0
143790,that,0,0
143791,in,0,0
143792,patients,0,1
143793,with,0,1
143794,multiple,0,1
143795,myeloma,0,1
143796,who,0,1
143797,might,0,0
143798,be,0,0
143799,predicted,0,0
143800,to,0,0
143801,fail,0,0
143802,mobilization,0,0
143803,based,0,0
143804,on,0,0
143805,low,0,1
143806,PB,0,0
143807,CD34,0,0
143808,(,0,0
143809,+,0,0
143810,),0,0
143811,cell,0,0
143812,count,0,0
143813,",",0,0
143814,the,0,0
143815,addition,0,0
143816,of,0,0
143817,plerixafor,0,0
143818,to,0,0
143819,G-CSF,0,1
143820,allows,0,0
143821,for,0,0
143822,collection,0,0
143823,of,0,0
143824,the,0,0
143825,minimal,0,0
143826,and,0,0
143827,optimal,0,0
143828,cell,0,1
143829,doses,0,0
143830,in,0,0
143831,a,0,0
143832,greater,0,0
143833,proportion,0,0
143834,of,0,0
143835,patients,0,1
143836,compared,0,0
143837,with,0,1
143838,G-CSF,0,0
143839,alone,0,0
143840,.,0,0
143841,In,0,0
143842,addition,0,0
143843,",",0,0
143844,plerixafor,0,0
143845,plus,0,0
143846,G-CSF,0,0
143847,significantly,0,0
143848,improves,0,0
143849,the,0,0
143850,likelihood,0,0
143851,of,0,0
143852,optimal,0,0
143853,HSC,0,0
143854,collection,0,1
143855,in,0,0
143856,patients,0,1
143857,with,0,1
143858,higher,0,0
143859,preapheresis,0,0
143860,PB,0,0
143861,CD34,0,0
143862,(,0,0
143863,+,0,0
143864,),0,0
143865,cell,0,1
143866,counts,0,0
143867,(,0,0
143868,?20,0,1
143869,cells/?L,0,0
143870,),0,0
143871,compared,0,0
143872,with,0,1
143873,placebo,0,0
143874,plus,0,0
143875,G-CSF,0,0
143876,.,0,0
143877,Collectively,0,0
143878,",",0,0
143879,this,0,0
143880,analysis,0,0
143881,of,0,0
143882,predicted,0,0
143883,poor,0,1
143884,mobilizers,0,0
143885,validates,0,0
143886,the,0,0
143887,superiority,0,0
143888,of,0,0
143889,plerixafor,0,0
143890,plus,0,0
143891,G-CSF,0,0
143892,compared,0,0
143893,with,0,1
143894,G-CSF,0,0
143895,alone,0,0
143896,",",0,0
143897,which,0,0
143898,had,0,0
143899,been,0,0
143900,demonstrated,0,0
143901,previously,0,0
143902,in,0,0
143903,the,0,0
143904,overall,0,0
143905,patient,0,0
143906,population,0,1
143907,.,0,1
143908,The,0,0
143909,effects,0,0
143910,of,0,0
143911,orthotic,0,0
143912,heel,0,1
143913,lifts,0,0
143914,on,0,0
143915,Achilles,0,1
143916,tendon,0,1
143917,force,0,1
143918,and,0,0
143919,strain,0,0
143920,during,0,0
143921,running,0,0
143922,.,0,0
143923,This,0,0
143924,study,0,0
143925,assessed,0,0
143926,the,0,0
143927,effects,0,0
143928,of,0,0
143929,orthotic,0,0
143930,heel,0,1
143931,lifts,0,0
143932,on,0,0
143933,Achilles,0,1
143934,tendon,0,1
143935,(,0,0
143936,AT,0,1
143937,),0,0
143938,force,0,0
143939,and,0,0
143940,strain,0,0
143941,during,0,0
143942,running,0,0
143943,.,0,1
143944,Ten,1,1
143945,females,1,1
143946,ran,1,0
143947,barefoot,1,0
143948,over,1,0
143949,a,1,0
143950,force,1,0
143951,plate,1,0
143952,in,1,0
143953,three,1,1
143954,conditions,1,1
143955,:,1,1
143956,no,1,0
143957,heel,1,0
143958,lifts,1,0
143959,(,1,1
143960,NHL,1,1
143961,),1,0
143962,",",1,0
143963,with,1,1
143964,12,1,0
143965,mm,1,1
143966,heel,1,1
143967,lifts,1,0
143968,(,1,1
143969,12HL,1,1
143970,),1,0
143971,and,1,0
143972,with,1,1
143973,18,1,1
143974,mm,1,1
143975,heel,1,1
143976,lifts,1,0
143977,(,1,1
143978,18HL,1,1
143979,),1,1
143980,.,1,1
143981,Kinematics,0,0
143982,for,0,0
143983,the,0,0
143984,right,0,0
143985,lower,0,0
143986,limb,0,0
143987,were,0,0
143988,collected,0,0
143989,(,0,0
143990,200,0,0
143991,Hz,0,1
143992,),0,1
143993,.,0,0
143994,AT,0,0
143995,force,0,0
143996,was,0,0
143997,calculated,0,0
143998,from,0,1
143999,inverse,0,0
144000,dynamics,0,0
144001,.,0,1
144002,AT,0,0
144003,strain,0,0
144004,was,0,0
144005,determined,0,0
144006,from,0,1
144007,kinematics,0,0
144008,and,0,1
144009,ultrasound,0,0
144010,images,0,0
144011,of,0,0
144012,medial,0,0
144013,gastrocnemius,0,1
144014,(,0,0
144015,50,0,1
144016,Hz,0,1
144017,),0,1
144018,.,0,1
144019,Peak,0,0
144020,AT,0,0
144021,strain,0,0
144022,was,0,0
144023,less,0,0
144024,for,0,0
144025,18HL,0,1
144026,(,0,1
144027,5.5,0,1
144028,?,0,1
144029,4.4,0,0
144030,%,0,0
144031,),0,0
144032,than,0,0
144033,for,0,0
144034,NHL,0,1
144035,(,0,1
144036,7.4,0,0
144037,?,0,1
144038,4.2,0,0
144039,%,0,0
144040,),0,0
144041,(,0,0
144042,p,0,0
144043,=,0,0
144044,.029,0,0
144045,",",0,0
144046,effect,0,0
144047,size,0,0
144048,[,0,0
144049,ES,0,0
144050,],0,1
144051,=,0,0
144052,0.44,0,0
144053,),0,0
144054,but,0,0
144055,not,0,0
144056,for,0,0
144057,12HL,0,1
144058,(,0,1
144059,5.8,0,0
144060,?,0,1
144061,4.8,0,0
144062,%,0,0
144063,),0,0
144064,versus,0,0
144065,NHL,0,1
144066,(,0,0
144067,ES,0,0
144068,=,0,0
144069,0.35,0,0
144070,),0,1
144071,.,0,1
144072,Peak,0,0
144073,AT,0,0
144074,force,0,0
144075,was,0,0
144076,significantly,0,0
144077,(,0,0
144078,p,0,0
144079,=,0,0
144080,.024,0,0
144081,",",0,0
144082,ES,0,0
144083,=,0,0
144084,0.42,0,0
144085,),0,0
144086,less,0,0
144087,for,0,0
144088,18HL,0,1
144089,(,0,1
144090,2382,0,1
144091,?,0,1
144092,717,0,1
144093,N,0,1
144094,),0,0
144095,than,0,0
144096,for,0,0
144097,NHL,0,1
144098,(,0,1
144099,2710,0,1
144100,?,0,1
144101,830,0,0
144102,N,0,1
144103,),0,0
144104,but,0,0
144105,not,0,0
144106,for,0,0
144107,12HL,0,1
144108,(,0,1
144109,2538,0,1
144110,?,0,1
144111,823,0,1
144112,N,0,1
144113,",",0,0
144114,ES,0,0
144115,=,0,0
144116,0.21,0,0
144117,),0,0
144118,.,0,1
144119,The,0,0
144120,18HL,0,1
144121,reduced,0,0
144122,ankle,0,1
144123,dorsiflexion,0,0
144124,but,0,0
144125,not,0,0
144126,flexion-extension,0,0
144127,ankle,0,1
144128,moments,0,0
144129,and,0,0
144130,increased,0,0
144131,the,0,0
144132,AT,0,0
144133,moment,0,0
144134,arm,0,0
144135,compared,0,0
144136,with,0,1
144137,NHL,0,1
144138,.,0,1
144139,Thus,0,0
144140,",",0,0
144141,18HL,0,1
144142,reduced,0,0
144143,force,0,1
144144,and,0,0
144145,strain,0,0
144146,on,0,0
144147,the,0,0
144148,AT,0,0
144149,during,0,0
144150,running,0,0
144151,via,0,0
144152,a,0,0
144153,reduction,0,0
144154,in,0,0
144155,dorsiflexion,0,0
144156,",",0,0
144157,which,0,0
144158,lengthened,0,0
144159,the,0,0
144160,AT,0,0
144161,moment,0,0
144162,arm,0,0
144163,.,0,0
144164,Therefore,0,0
144165,",",0,0
144166,heel,0,0
144167,lifts,0,0
144168,could,0,0
144169,be,0,0
144170,used,0,0
144171,to,0,0
144172,reduce,0,0
144173,AT,0,0
144174,loading,0,0
144175,and,0,0
144176,strain,0,0
144177,during,0,0
144178,the,0,0
144179,rehabilitation,0,0
144180,of,0,0
144181,AT,0,1
144182,injuries,0,1
144183,.,0,1
144184,Dietary,0,0
144185,patterns,0,0
144186,differ,0,0
144187,between,0,0
144188,urban,1,1
144189,and,1,0
144190,rural,1,1
144191,older,1,1
144192,",",1,0
144193,long-term,1,0
144194,survivors,1,1
144195,of,1,0
144196,breast,1,1
144197,",",1,0
144198,prostate,1,1
144199,",",1,0
144200,and,1,0
144201,colorectal,1,1
144202,cancer,1,1
144203,and,0,0
144204,are,0,0
144205,associated,0,0
144206,with,0,1
144207,body,0,1
144208,mass,0,1
144209,index,0,0
144210,.,0,1
144211,BACKGROUND,0,0
144212,Older,1,0
144213,adult,1,1
144214,cancer,1,1
144215,survivors,1,1
144216,are,0,0
144217,at,0,0
144218,greater,0,0
144219,risk,0,0
144220,of,0,0
144221,cancer,0,1
144222,recurrence,0,0
144223,and,0,0
144224,other,0,0
144225,comorbidities,0,0
144226,that,0,0
144227,can,0,0
144228,be,0,0
144229,prevented,0,0
144230,through,0,0
144231,improved,0,0
144232,diet,0,1
144233,and,0,0
144234,weight,0,1
144235,management,0,1
144236,.,0,0
144237,The,0,0
144238,tertiary,0,1
144239,prevention,0,0
144240,needs,0,0
144241,of,0,0
144242,rural-dwelling,0,1
144243,survivors,0,1
144244,can,0,0
144245,be,0,0
144246,even,0,0
144247,greater,0,0
144248,",",0,0
144249,yet,0,0
144250,little,0,0
144251,is,0,0
144252,known,0,0
144253,about,0,0
144254,rural,0,1
144255,and,0,1
144256,urban,0,1
144257,differences,0,0
144258,in,0,1
144259,lifestyle,0,1
144260,factors,0,0
144261,among,0,1
144262,this,0,0
144263,high-risk,0,1
144264,population,0,1
144265,.,0,1
144266,OBJECTIVES,0,0
144267,To,0,0
144268,compare,0,0
144269,dietary,0,0
144270,patterns,0,0
144271,of,0,0
144272,urban,1,1
144273,and,1,0
144274,rural,1,1
144275,cancer,1,1
144276,survivors,1,1
144277,and,0,0
144278,to,0,0
144279,examine,0,0
144280,associations,0,0
144281,of,0,0
144282,dietary,0,0
144283,patterns,0,1
144284,with,0,1
144285,body,0,1
144286,mass,0,1
144287,index,0,0
144288,(,0,0
144289,BMI,0,1
144290,),0,0
144291,.,0,0
144292,DESIGN,0,0
144293,A,0,0
144294,secondary,0,0
144295,analysis,0,0
144296,was,0,0
144297,performed,0,0
144298,of,0,0
144299,baseline,0,0
144300,data,0,0
144301,from,0,1
144302,the,0,0
144303,Reach,0,0
144304,Out,0,0
144305,to,0,0
144306,Enhance,0,0
144307,Wellness,0,0
144308,(,0,0
144309,RENEW,0,0
144310,),0,0
144311,trial,0,0
144312,",",0,0
144313,a,0,0
144314,diet,0,0
144315,and,0,0
144316,exercise,0,0
144317,intervention,0,0
144318,among,0,0
144319,overweight,0,1
144320,",",0,0
144321,long-term,0,0
144322,(,0,0
144323,?5,0,1
144324,years,0,1
144325,),0,0
144326,",",0,0
144327,older,0,1
144328,survivors,0,1
144329,of,0,0
144330,colorectal,0,1
144331,",",0,0
144332,breast,0,1
144333,",",0,0
144334,and,0,0
144335,prostate,0,1
144336,cancer,1,1
144337,.,1,0
144338,Survivors,1,0
144339,in,1,0
144340,the,1,0
144341,present,1,0
144342,analysis,1,0
144343,(,1,0
144344,n=729,1,1
144345,),1,1
144346,underwent,1,1
144347,two,0,0
144348,45-,0,1
144349,to,0,0
144350,60-minute,0,0
144351,telephone,0,0
144352,surveys,0,0
144353,",",0,0
144354,which,0,0
144355,included,0,1
144356,two,0,0
144357,24-hour,0,1
144358,dietary,0,0
144359,recalls,0,0
144360,.,0,1
144361,Principal,0,0
144362,components,0,0
144363,analysis,0,0
144364,and,0,0
144365,multivariable,0,0
144366,general,0,1
144367,linear,0,0
144368,models,0,0
144369,were,0,1
144370,used,0,0
144371,to,0,0
144372,derive,0,0
144373,dietary,0,0
144374,patterns,0,0
144375,and,0,0
144376,to,0,0
144377,evaluate,0,0
144378,associations,0,0
144379,between,0,0
144380,dietary,0,0
144381,patterns,0,1
144382,and,0,0
144383,BMI,0,0
144384,",",0,0
144385,respectively,0,0
144386,.,0,0
144387,RESULTS,0,0
144388,Principal,0,0
144389,components,0,0
144390,analysis,0,0
144391,identified,0,1
144392,three,0,0
144393,primary,0,1
144394,dietary,0,0
144395,patterns,0,1
144396,among,0,1
144397,rural,0,1
144398,dwellers,0,1
144399,(,0,1
144400,high,0,1
144401,sweets,0,0
144402,and,0,1
144403,starches,0,0
144404,",",0,0
144405,high,0,1
144406,reduced-fat,0,0
144407,dairy,0,1
144408,",",0,0
144409,cereal,0,1
144410,",",0,0
144411,nuts,0,0
144412,",",0,0
144413,and,0,0
144414,fruits,0,0
144415,",",0,0
144416,and,0,0
144417,mixed,0,0
144418,),0,0
144419,and,0,0
144420,three,0,0
144421,among,0,1
144422,urban,0,1
144423,dwellers,0,1
144424,(,0,1
144425,high,0,1
144426,fruits,0,1
144427,and,0,1
144428,vegetables,0,0
144429,",",0,0
144430,high,0,1
144431,meat,0,0
144432,and,0,0
144433,refined,0,0
144434,grains,0,0
144435,",",0,0
144436,and,0,0
144437,high,0,1
144438,sugar-sweetened,0,1
144439,beverages,0,1
144440,),0,1
144441,.,0,1
144442,Among,1,1
144443,rural,1,1
144444,survivors,1,1
144445,",",1,0
144446,greater,0,0
144447,adherence,0,0
144448,to,0,0
144449,the,0,0
144450,high,0,0
144451,reduced-fat,0,0
144452,dairy,0,1
144453,",",0,0
144454,cereal,0,1
144455,",",0,0
144456,nuts,0,0
144457,",",0,0
144458,and,0,0
144459,fruits,0,0
144460,pattern,0,1
144461,was,0,0
144462,positively,0,0
144463,associated,0,0
144464,with,0,1
144465,lower,0,0
144466,BMI,0,1
144467,(,0,0
144468,P,0,0
144469,trend,0,0
144470,<,0,0
144471,0.05,0,0
144472,),0,0
144473,",",0,0
144474,whereas,0,0
144475,higher,0,0
144476,scores,0,0
144477,on,0,0
144478,the,0,0
144479,mixed,0,0
144480,pattern,0,1
144481,was,0,0
144482,associated,0,0
144483,with,0,1
144484,greater,0,0
144485,BMI,0,1
144486,(,0,0
144487,P,0,0
144488,trend,0,0
144489,<,0,0
144490,0.05,0,0
144491,),0,1
144492,.,0,1
144493,Greater,0,0
144494,adherence,0,0
144495,to,0,0
144496,the,0,0
144497,high,0,0
144498,fruits,0,0
144499,and,0,1
144500,vegetables,0,0
144501,pattern,0,1
144502,among,0,0
144503,urban,0,1
144504,survivors,0,1
144505,was,0,0
144506,inversely,0,0
144507,associated,0,0
144508,with,0,1
144509,BMI,0,1
144510,(,0,0
144511,P,0,0
144512,trend,0,0
144513,<,0,0
144514,0.05,0,0
144515,),0,1
144516,.,0,1
144517,CONCLUSIONS,0,0
144518,Urban,0,1
144519,and,0,0
144520,rural,0,1
144521,differences,0,0
144522,in,0,0
144523,dietary,0,0
144524,intake,0,0
144525,behavior,0,0
144526,should,0,0
144527,be,0,0
144528,considered,0,0
144529,in,0,0
144530,designing,0,0
144531,public,0,1
144532,health,0,1
144533,interventions,0,0
144534,among,0,0
144535,the,0,0
144536,increasing,0,0
144537,population,0,1
144538,of,0,0
144539,older,0,1
144540,cancer,0,1
144541,survivors,0,1
144542,.,0,1
144543,In,0,0
144544,addition,0,0
144545,",",0,0
144546,targeting,0,0
144547,overall,0,0
144548,dietary,0,0
144549,patterns,0,0
144550,might,0,0
144551,be,0,0
144552,one,0,0
144553,approach,0,0
144554,to,0,0
144555,help,0,0
144556,reduce,0,0
144557,the,0,0
144558,burden,0,0
144559,of,0,0
144560,obesity,0,1
144561,among,0,0
144562,this,0,0
144563,population,0,1
144564,.,0,0
144565,Phase,0,1
144566,II,0,1
144567,trial,0,0
144568,of,0,0
144569,nab-paclitaxel,0,0
144570,compared,0,0
144571,with,0,1
144572,docetaxel,0,0
144573,as,0,0
144574,first-line,0,1
144575,chemotherapy,0,1
144576,in,0,0
144577,patients,1,1
144578,with,1,1
144579,metastatic,1,1
144580,breast,1,1
144581,cancer,1,1
144582,:,1,1
144583,final,0,0
144584,analysis,0,0
144585,of,0,0
144586,overall,0,0
144587,survival,0,0
144588,.,0,0
144589,BACKGROUND,0,0
144590,A,0,0
144591,randomized,0,0
144592,phase,0,1
144593,II,0,1
144594,study,0,0
144595,in,0,0
144596,first-line,0,1
144597,MBC,0,1
144598,demonstrated,0,0
144599,superior,0,0
144600,efficacy,0,0
144601,and,0,0
144602,safety,0,0
144603,of,0,0
144604,weekly,0,0
144605,nab-paclitaxel,0,0
144606,compared,0,0
144607,with,0,1
144608,docetaxel,0,0
144609,.,0,1
144610,Final,0,0
144611,survival,0,0
144612,analyses,0,0
144613,and,0,0
144614,updated,0,0
144615,safety,0,0
144616,results,0,0
144617,are,0,0
144618,reported,0,0
144619,.,0,1
144620,PATIENTS,0,0
144621,AND,0,0
144622,METHODS,0,0
144623,Three,1,1
144624,hundred,1,1
144625,two,1,0
144626,patients,1,1
144627,with,1,1
144628,no,1,0
144629,previous,1,0
144630,chemotherapy,1,0
144631,for,1,0
144632,MBC,1,0
144633,were,0,0
144634,randomized,0,0
144635,to,0,0
144636,receive,0,0
144637,nab-paclitaxel,0,0
144638,300,0,0
144639,mg/m,0,0
144640,(,0,1
144641,2,0,0
144642,),0,0
144643,q3w,0,0
144644,",",0,0
144645,nab-paclitaxel,0,0
144646,100,0,0
144647,mg/m,0,0
144648,(,0,1
144649,2,0,0
144650,),0,1
144651,or,0,1
144652,150,0,0
144653,mg/m,0,0
144654,(,0,1
144655,2,0,0
144656,),0,0
144657,the,0,0
144658,first,0,0
144659,3,0,0
144660,of,0,1
144661,4,0,0
144662,weeks,0,0
144663,(,0,1
144664,qw,0,0
144665,3/4,0,0
144666,),0,0
144667,",",0,0
144668,or,0,0
144669,docetaxel,0,0
144670,100,0,0
144671,mg/m,0,0
144672,(,0,1
144673,2,0,0
144674,),0,1
144675,q3w,0,0
144676,.,0,0
144677,The,0,0
144678,trial,0,0
144679,was,0,0
144680,powered,0,0
144681,for,0,0
144682,analyses,0,0
144683,of,0,0
144684,antitumor,0,0
144685,activity,0,0
144686,and,0,0
144687,safety,0,0
144688,.,0,1
144689,RESULTS,0,0
144690,Treatment,0,0
144691,with,0,1
144692,nab-paclitaxel,0,0
144693,150,0,0
144694,mg/m,0,0
144695,(,0,1
144696,2,0,0
144697,),0,1
144698,qw,0,0
144699,3/4,0,0
144700,resulted,0,0
144701,in,0,0
144702,a,0,0
144703,median,0,0
144704,overall,0,0
144705,survival,0,0
144706,(,0,0
144707,OS,0,0
144708,),0,0
144709,of,0,0
144710,33.8,0,0
144711,months,0,0
144712,compared,0,0
144713,with,0,1
144714,22.2,0,0
144715,",",0,0
144716,27.7,0,0
144717,",",0,0
144718,and,0,0
144719,26.6,0,0
144720,months,0,0
144721,for,0,1
144722,nab-paclitaxel,0,0
144723,100,0,0
144724,mg/m,0,0
144725,(,0,1
144726,2,0,0
144727,),0,1
144728,qw,0,0
144729,3/4,0,0
144730,",",0,0
144731,nab-paclitaxel,0,0
144732,300,0,0
144733,mg/m,0,0
144734,(,0,1
144735,2,0,0
144736,),0,0
144737,q3w,0,0
144738,",",0,0
144739,and,0,0
144740,docetaxel,0,0
144741,",",0,0
144742,respectively,0,0
144743,(,0,0
144744,overall,0,0
144745,P,0,0
144746,=,0,0
144747,.047,0,0
144748,),0,1
144749,.,0,0
144750,Patients,0,1
144751,receiving,0,1
144752,150,0,0
144753,mg/m,0,0
144754,(,0,1
144755,2,0,0
144756,),0,0
144757,nab-paclitaxel,0,0
144758,had,0,1
144759,prolonged,0,0
144760,median,0,1
144761,OS,0,0
144762,compared,0,0
144763,with,0,1
144764,those,0,0
144765,in,0,0
144766,the,0,0
144767,100,0,0
144768,mg/m,0,0
144769,(,0,1
144770,2,0,0
144771,),0,0
144772,nab-paclitaxel,0,0
144773,arm,0,0
144774,(,0,0
144775,hazard,0,0
144776,ratio,0,0
144777,",",0,0
144778,0.575,0,0
144779,;,0,0
144780,P,0,0
144781,=,0,0
144782,.008,0,0
144783,),0,0
144784,.,0,0
144785,A,0,0
144786,trend,0,0
144787,toward,0,0
144788,a,0,0
144789,longer,0,0
144790,OS,0,0
144791,was,0,0
144792,noted,0,0
144793,in,0,0
144794,the,0,0
144795,150,0,0
144796,mg/m,0,0
144797,(,0,1
144798,2,0,0
144799,),0,0
144800,nab-paclitaxel,0,0
144801,arm,0,0
144802,versus,0,0
144803,docetaxel,0,0
144804,arm,0,0
144805,(,0,0
144806,hazard,0,0
144807,ratio,0,0
144808,",",0,0
144809,0.688,0,0
144810,),0,0
144811,.,0,1
144812,Grade,0,0
144813,3,0,0
144814,or,0,1
144815,4,0,0
144816,fatigue,0,0
144817,",",0,0
144818,neutropenia,0,0
144819,",",0,0
144820,and,0,0
144821,febrile,0,0
144822,neutropenia,0,0
144823,were,0,0
144824,less,0,0
144825,frequent,0,0
144826,in,0,0
144827,all,0,1
144828,nab-paclitaxel,0,0
144829,arms,0,0
144830,compared,0,0
144831,with,0,1
144832,docetaxel,0,0
144833,.,0,1
144834,CONCLUSIONS,0,0
144835,Consistent,0,0
144836,with,0,1
144837,previously,0,0
144838,published,0,0
144839,efficacy,0,0
144840,results,0,0
144841,",",0,0
144842,these,0,0
144843,data,0,0
144844,suggest,0,0
144845,that,0,0
144846,150,0,0
144847,mg/m,0,0
144848,(,0,1
144849,2,0,0
144850,),0,1
144851,qw,0,0
144852,3/4,0,0
144853,may,0,0
144854,represent,0,0
144855,the,0,0
144856,most,0,0
144857,clinically,0,0
144858,efficacious,0,0
144859,nab-paclitaxel,0,0
144860,dosing,0,0
144861,regimen,0,0
144862,for,0,1
144863,patients,1,1
144864,with,1,1
144865,no,1,0
144866,previous,1,0
144867,chemotherapy,1,0
144868,for,1,0
144869,MBC,1,1
144870,.,1,0
144871,A,0,0
144872,phase,0,0
144873,III,0,0
144874,trial,0,0
144875,confirming,0,0
144876,these,0,0
144877,results,0,0
144878,would,0,0
144879,be,0,0
144880,necessary,0,0
144881,and,0,0
144882,prudent,0,0
144883,before,0,0
144884,widespread,0,0
144885,adoption,0,0
144886,of,0,0
144887,the,0,0
144888,150,0,0
144889,mg/m,0,0
144890,(,0,1
144891,2,0,0
144892,),0,0
144893,dose,0,0
144894,in,0,0
144895,clinical,0,0
144896,practice,0,1
144897,.,0,1
144898,The,0,0
144899,impact,0,0
144900,of,0,0
144901,patient,0,0
144902,and,0,0
144903,physician,0,0
144904,computer,0,0
144905,mediated,0,0
144906,communication,0,0
144907,skill,0,0
144908,training,0,0
144909,on,0,0
144910,reported,0,0
144911,communication,0,0
144912,and,0,0
144913,patient,0,0
144914,satisfaction,0,0
144915,.,0,0
144916,OBJECTIVE,0,0
144917,The,0,0
144918,objective,0,0
144919,was,0,0
144920,to,0,0
144921,evaluate,0,0
144922,parallel,0,0
144923,patient,0,0
144924,and,0,0
144925,physician,0,0
144926,computer-mediated,0,0
144927,communication,0,0
144928,skill,0,0
144929,training,0,0
144930,on,0,0
144931,participants,0,1
144932,',0,1
144933,report,0,0
144934,of,0,0
144935,skill,0,0
144936,use,0,0
144937,and,0,0
144938,patient,0,0
144939,satisfaction,0,0
144940,.,0,1
144941,METHODS,0,0
144942,Separate,0,0
144943,patient,0,0
144944,and,0,0
144945,clinician,0,0
144946,web-tools,0,0
144947,comprised,0,1
144948,of,0,0
144949,over,0,0
144950,500,0,0
144951,",",0,0
144952,10-s,0,0
144953,video,0,0
144954,clips,0,0
144955,demonstrating,0,0
144956,patient-centered,0,0
144957,skills,0,0
144958,in,0,1
144959,various,0,0
144960,ways,0,0
144961,.,0,1
144962,Four,1,0
144963,clinician,1,0
144964,members,1,1
144965,of,1,0
144966,the,1,0
144967,American,1,1
144968,Academy,1,1
144969,of,1,0
144970,Family,1,1
144971,Physicians,1,1
144972,National,1,1
144973,Research,1,1
144974,Network,1,0
144975,participated,1,1
144976,by,1,0
144977,enrolling,1,1
144978,194,1,1
144979,patients,1,1
144980,into,1,1
144981,a,1,0
144982,randomized,1,0
144983,patient,1,0
144984,trial,1,0
144985,and,1,0
144986,29,1,1
144987,physicians,1,1
144988,into,1,1
144989,a,1,1
144990,non-randomized,1,0
144991,clinician,1,0
144992,trial,1,0
144993,of,1,0
144994,respective,1,1
144995,interventions,1,0
144996,.,1,1
144997,All,0,1
144998,participants,0,1
144999,completed,0,1
145000,baseline,0,0
145001,and,0,0
145002,follow-up,0,0
145003,self-report,0,0
145004,measures,0,0
145005,of,0,0
145006,visit,0,0
145007,communication,0,0
145008,and,0,0
145009,satisfaction,0,0
145010,.,0,1
145011,RESULTS,0,0
145012,Intervention,0,1
145013,patients,0,1
145014,reported,0,0
145015,using,0,0
145016,more,0,0
145017,skills,0,0
145018,than,0,0
145019,controls,0,1
145020,in,0,1
145021,five,0,1
145022,of,0,0
145023,six,0,1
145024,skill,0,0
145025,areas,0,0
145026,",",0,0
145027,including,0,0
145028,identification,0,0
145029,of,0,0
145030,problems/concerns,0,0
145031,",",0,0
145032,information,0,0
145033,exchange,0,0
145034,",",0,0
145035,treatment,0,0
145036,adherence,0,0
145037,",",0,0
145038,shared,0,0
145039,decision-making,0,0
145040,and,0,0
145041,interpersonal,0,0
145042,rapport,0,0
145043,(,0,0
145044,all,0,0
145045,p,0,0
145046,<,0,0
145047,.05,0,0
145048,),0,1
145049,;,0,0
145050,post,0,0
145051,intervention,0,0
145052,",",0,0
145053,physicians,0,1
145054,reported,0,0
145055,using,0,0
145056,more,0,0
145057,skills,0,0
145058,in,0,0
145059,the,0,0
145060,same,0,0
145061,5,0,0
145062,areas,0,0
145063,(,0,0
145064,all,0,0
145065,p,0,0
145066,<,0,0
145067,.01,0,0
145068,),0,1
145069,.,0,0
145070,Intervention,0,0
145071,group,0,0
145072,patients,0,1
145073,reported,0,0
145074,higher,0,0
145075,levels,0,0
145076,of,0,0
145077,satisfaction,0,0
145078,than,0,0
145079,controls,0,1
145080,in,0,1
145081,five,0,1
145082,of,0,1
145083,six,0,1
145084,domains,0,0
145085,(,0,0
145086,all,0,0
145087,p,0,0
145088,<,0,0
145089,.05,0,0
145090,),0,1
145091,.,0,1
145092,CONCLUSION,0,0
145093,Communication,0,0
145094,skill,0,0
145095,training,0,0
145096,delivered,0,0
145097,in,0,0
145098,a,0,0
145099,computer,0,0
145100,mediated,0,0
145101,format,0,0
145102,had,0,0
145103,a,0,0
145104,positive,0,0
145105,and,0,0
145106,parallel,0,0
145107,impact,0,0
145108,on,0,0
145109,both,0,0
145110,patient,0,0
145111,and,0,0
145112,clinician,0,0
145113,reported,0,0
145114,use,0,0
145115,of,0,0
145116,patient-centered,0,0
145117,communication,0,0
145118,and,0,0
145119,in,0,0
145120,patient,0,1
145121,satisfaction,0,0
145122,.,0,1
145123,PRACTICE,0,0
145124,IMPLICATIONS,0,0
145125,Computer-mediated,0,0
145126,interventions,0,0
145127,are,0,0
145128,cost,0,0
145129,and,0,0
145130,time,0,0
145131,effective,0,0
145132,thereby,0,0
145133,increasing,0,0
145134,patient,0,0
145135,and,0,0
145136,clinician,0,0
145137,willingness,0,0
145138,to,0,0
145139,undertake,0,0
145140,training,0,0
145141,.,0,0
145142,Selected,0,1
145143,polymorphisms,0,0
145144,of,0,0
145145,GSTP1,0,0
145146,and,0,1
145147,TERT,0,0
145148,were,0,0
145149,associated,0,0
145150,with,0,1
145151,glioma,1,1
145152,risk,1,0
145153,in,1,0
145154,Han,1,1
145155,Chinese,1,1
145156,.,1,1
145157,BACKGROUND,0,0
145158,Current,0,0
145159,evidence,0,0
145160,suggests,0,0
145161,that,0,0
145162,a,0,0
145163,majority,0,0
145164,of,0,0
145165,the,0,0
145166,inherited,0,1
145167,risks,0,0
145168,play,0,0
145169,a,0,0
145170,major,0,0
145171,role,0,0
145172,in,0,0
145173,glioma,1,1
145174,susceptibility,1,0
145175,",",0,0
145176,and,0,0
145177,glioma,0,1
145178,is,0,0
145179,due,0,0
145180,to,0,0
145181,the,0,0
145182,co-inheritance,0,0
145183,of,0,0
145184,multiple,0,0
145185,low-risk,0,1
145186,variants,0,1
145187,.,0,1
145188,These,0,0
145189,variants,0,0
145190,can,0,0
145191,be,0,0
145192,identified,0,0
145193,through,0,0
145194,association,0,0
145195,studies,0,0
145196,including,0,0
145197,such,0,0
145198,as,0,0
145199,genome-wide,0,1
145200,association,0,0
145201,studies,0,0
145202,(,0,1
145203,GWAS,0,1
145204,),0,0
145205,",",0,0
145206,which,0,0
145207,has,0,0
145208,led,0,0
145209,the,0,0
145210,glioma,0,1
145211,epidemiology,0,0
145212,researchers,0,0
145213,to,0,0
145214,focus,0,0
145215,on,0,0
145216,identifying,0,0
145217,potential,0,0
145218,disease-causing,0,1
145219,factors,0,0
145220,.,0,1
145221,METHODS,0,0
145222,We,0,0
145223,evaluated,0,0
145224,and,0,0
145225,validated,0,0
145226,10,1,0
145227,tag,1,0
145228,single,1,0
145229,nucleotide,1,0
145230,polymorphisms,1,0
145231,(,1,0
145232,tSNPs,1,0
145233,),1,0
145234,in,1,0
145235,seven,1,1
145236,genes,1,0
145237,associated,1,0
145238,with,1,1
145239,glioma,1,1
145240,susceptibility,1,0
145241,in,1,0
145242,a,1,0
145243,Han,1,0
145244,Chinese,1,1
145245,population,1,1
145246,",",1,0
145247,including,1,0
145248,301,1,1
145249,glioma,1,1
145250,cases,1,1
145251,and,1,1
145252,302,1,1
145253,controls,1,1
145254,",",1,0
145255,using,1,0
145256,a,1,0
145257,multiplexed,1,0
145258,single,1,0
145259,nucleotide,1,0
145260,polymorphism,1,0
145261,(,1,0
145262,SNP,1,0
145263,),1,0
145264,MassEXTEND,1,0
145265,assay,1,0
145266,.,1,0
145267,We,0,0
145268,ascertained,0,0
145269,the,0,0
145270,genotypic,0,0
145271,frequencies,0,0
145272,for,0,0
145273,each,0,0
145274,tSNP,0,0
145275,in,0,0
145276,control,0,1
145277,subjects,0,1
145278,were,0,1
145279,within,0,0
145280,Hardy-Weinberg,0,1
145281,equilibrium,0,0
145282,(,0,0
145283,HWE,0,1
145284,),0,0
145285,using,0,0
145286,an,0,0
145287,exact,0,0
145288,test,0,0
145289,",",0,0
145290,and,0,0
145291,then,0,0
145292,compared,0,0
145293,the,0,0
145294,genotype,0,0
145295,and,0,0
145296,allele,0,0
145297,frequencies,0,0
145298,of,0,0
145299,glioma,0,1
145300,patients,0,1
145301,and,0,0
145302,control,0,1
145303,subjects,0,1
145304,using,0,0
145305,the,0,0
145306,?2,0,0
145307,test,0,0
145308,.,0,0
145309,We,0,0
145310,then,0,0
145311,applied,0,0
145312,three,0,0
145313,genetic,0,1
145314,models,0,0
145315,(,0,1
145316,dominant,0,0
145317,",",0,0
145318,recessive,0,0
145319,",",0,0
145320,and,0,0
145321,additive,0,0
145322,),0,0
145323,using,0,0
145324,PLINK,0,0
145325,software,0,0
145326,to,0,0
145327,assess,0,0
145328,the,0,0
145329,association,0,0
145330,of,0,0
145331,each,0,0
145332,tSNP,0,0
145333,with,0,0
145334,glioma,0,1
145335,risk,0,0
145336,.,0,0
145337,RESULTS,0,0
145338,We,0,0
145339,identified,0,0
145340,two,0,0
145341,tSNPs,0,0
145342,to,0,0
145343,be,0,0
145344,associated,0,0
145345,with,0,0
145346,glioma,0,1
145347,susceptibility,0,0
145348,(,0,0
145349,rs1695,0,0
145350,",",0,0
145351,GSTP1,0,0
145352,",",0,0
145353,P,0,0
145354,=,0,0
145355,0.019,0,0
145356,;,0,0
145357,rs2853676,0,0
145358,",",0,0
145359,TERT,0,0
145360,",",0,0
145361,P,0,0
145362,=,0,0
145363,0.039,0,0
145364,),0,0
145365,",",0,0
145366,which,0,0
145367,we,0,0
145368,confirmed,0,0
145369,using,0,0
145370,dominant,0,0
145371,and,0,0
145372,additive,0,0
145373,model,0,0
145374,analyses,0,0
145375,.,0,0
145376,The,0,0
145377,genotype,0,0
145378,&,0,1
145379,ldquo,0,0
145380,;,0,0
145381,GA,0,0
145382,&,0,1
145383,rdquo,0,0
145384,;,0,0
145385,for,0,0
145386,rs1695,0,0
145387,was,0,0
145388,recognized,0,0
145389,to,0,0
145390,be,0,0
145391,a,0,0
145392,protective,0,0
145393,genotype,0,0
145394,for,0,0
145395,glioma,0,1
145396,(,0,0
145397,OR,0,0
145398,",",0,1
145399,0.67,0,0
145400,;,0,0
145401,95,0,0
145402,%,0,0
145403,CI,0,0
145404,",",0,0
145405,0.47-0.96,0,0
145406,;,0,0
145407,P,0,0
145408,=,0,0
145409,0.027,0,0
145410,),0,0
145411,",",0,0
145412,while,0,0
145413,the,0,0
145414,genotype,0,0
145415,&,0,1
145416,ldquo,0,0
145417,;,0,0
145418,AG,0,0
145419,&,0,1
145420,rdquo,0,0
145421,;,0,0
145422,for,0,0
145423,rs2853676,0,0
145424,was,0,0
145425,shown,0,0
145426,to,0,0
145427,be,0,0
145428,a,0,0
145429,risk,0,0
145430,genotype,0,0
145431,for,0,0
145432,glioma,0,1
145433,(,0,0
145434,OR,0,0
145435,",",0,1
145436,1.50,0,0
145437,;,0,0
145438,95,0,0
145439,%,0,0
145440,CI,0,0
145441,",",0,0
145442,1.05-2.15,0,0
145443,;,0,0
145444,P,0,0
145445,=,0,0
145446,0.025,0,0
145447,),0,1
145448,.,0,1
145449,CONCLUSION,0,0
145450,Our,0,0
145451,results,0,0
145452,",",0,0
145453,and,0,0
145454,those,0,0
145455,from,0,0
145456,previous,0,0
145457,studies,0,0
145458,",",0,0
145459,suggest,0,0
145460,potential,0,0
145461,genetic,0,0
145462,contributes,0,0
145463,for,0,0
145464,GSTP1,0,1
145465,and,0,0
145466,TERT,0,0
145467,in,0,0
145468,glioma,0,1
145469,development,0,0
145470,.,0,1
145471,A,0,0
145472,six-month,0,0
145473,crossover,0,0
145474,chemoprevention,0,1
145475,clinical,0,0
145476,trial,0,0
145477,of,0,0
145478,tea,0,0
145479,in,0,0
145480,smokers,1,1
145481,and,1,1
145482,non-smokers,1,1
145483,:,1,1
145484,methodological,0,0
145485,issues,0,0
145486,in,0,0
145487,a,0,0
145488,feasibility,0,0
145489,study,0,0
145490,.,0,1
145491,BACKGROUND,0,0
145492,Chemoprevention,0,0
145493,crossover,0,1
145494,trials,0,0
145495,of,0,0
145496,tea,0,0
145497,can,0,0
145498,be,0,0
145499,more,0,0
145500,efficient,0,0
145501,than,0,0
145502,parallel,0,0
145503,designs,0,0
145504,but,0,0
145505,the,0,0
145506,attrition,0,0
145507,and,0,0
145508,compliance,0,0
145509,rates,0,0
145510,with,0,1
145511,such,0,0
145512,trials,0,1
145513,are,0,0
145514,unknown,0,0
145515,.,0,1
145516,METHODS,0,0
145517,Attrition,0,0
145518,(,0,1
145519,dropouts,0,0
145520,),0,0
145521,and,0,0
145522,compliance,0,0
145523,with,0,1
145524,treatment,0,0
145525,were,0,0
145526,assessed,0,0
145527,in,0,0
145528,a,0,0
145529,25-week,0,0
145530,randomized,0,0
145531,",",0,0
145532,placebo,0,0
145533,controlled,0,0
145534,",",0,0
145535,crossover,0,0
145536,",",0,0
145537,feasibility,0,0
145538,clinical,0,0
145539,trial,0,0
145540,of,0,0
145541,four,0,1
145542,tea,0,0
145543,treatments,0,0
145544,to,0,0
145545,investigate,0,0
145546,the,0,0
145547,effect,0,0
145548,of,0,0
145549,tea,0,0
145550,on,0,0
145551,oral,0,0
145552,cancer,0,1
145553,biomarkers,0,0
145554,.,0,0
145555,Each,0,0
145556,treatment,0,0
145557,lasted,0,0
145558,4,0,0
145559,weeks,0,0
145560,with,0,1
145561,2,0,1
145562,weeks,0,0
145563,of,0,0
145564,washout,0,0
145565,in,0,0
145566,between,0,0
145567,.,0,1
145568,Participants,0,1
145569,were,0,1
145570,32,1,1
145571,smokers,1,1
145572,and,1,1
145573,33,1,1
145574,non-smokers,1,1
145575,without,1,1
145576,any,1,0
145577,evidence,1,0
145578,of,1,0
145579,premalignant,1,1
145580,oral,1,1
145581,lesions,1,1
145582,.,1,1
145583,The,1,0
145584,interventions,0,0
145585,consisted,0,1
145586,of,0,0
145587,packets,0,0
145588,of,0,0
145589,green,0,0
145590,tea,0,0
145591,",",0,0
145592,black,0,1
145593,tea,0,0
145594,",",0,0
145595,caffeinated,0,0
145596,water,0,0
145597,",",0,0
145598,or,0,0
145599,placebo,0,0
145600,.,0,1
145601,Participants,0,1
145602,were,0,0
145603,assigned,0,1
145604,to,0,0
145605,each,0,0
145606,treatment,0,0
145607,for,0,0
145608,four,0,1
145609,weeks,0,0
145610,",",0,0
145611,and,0,0
145612,were,0,0
145613,instructed,0,0
145614,to,0,0
145615,drink,0,0
145616,five,0,1
145617,packets,0,0
145618,per,0,0
145619,day,0,0
145620,while,0,0
145621,on,0,0
145622,the,0,0
145623,treatment,0,0
145624,.,0,0
145625,Dropout,0,0
145626,from,0,0
145627,the,0,0
145628,trial,0,0
145629,and,0,0
145630,compliance,0,0
145631,(,0,0
145632,consumption,0,0
145633,of,0,0
145634,?85,0,0
145635,%,0,0
145636,of,0,0
145637,the,0,0
145638,prescribed,0,0
145639,treatment,0,0
145640,packets,0,0
145641,),0,0
145642,are,0,0
145643,the,0,0
145644,main,0,0
145645,outcome,0,0
145646,measures,0,0
145647,reported,0,0
145648,.,0,1
145649,RESULTS,0,0
145650,There,0,0
145651,was,0,0
145652,a,0,0
145653,high,0,0
145654,rate,0,0
145655,of,0,0
145656,dropout,0,0
145657,(,0,0
145658,51,0,1
145659,%,0,0
145660,),0,0
145661,from,0,0
145662,the,0,0
145663,study,0,0
145664,",",0,0
145665,and,0,0
145666,the,0,0
145667,rates,0,0
145668,were,0,0
145669,significantly,0,0
145670,higher,0,0
145671,among,0,0
145672,smokers,0,1
145673,(,0,1
145674,64,0,1
145675,%,0,0
145676,),0,0
145677,than,0,0
145678,non-smokers,0,1
145679,(,0,1
145680,36,0,1
145681,%,0,0
145682,),0,0
145683,.,0,0
145684,Among,0,1
145685,participants,0,1
145686,who,0,1
145687,completed,0,1
145688,the,0,1
145689,study,0,0
145690,the,0,0
145691,rate,0,0
145692,of,0,0
145693,compliance,0,0
145694,was,0,0
145695,72,0,1
145696,%,0,0
145697,.,0,0
145698,The,0,0
145699,highest,0,0
145700,rates,0,0
145701,of,0,1
145702,dropouts,0,0
145703,occurred,0,0
145704,between,0,0
145705,the,0,0
145706,first,0,0
145707,and,0,0
145708,second,0,0
145709,treatment,0,0
145710,visits,0,0
145711,in,0,0
145712,both,0,0
145713,smokers,0,1
145714,(,0,0
145715,38,0,1
145716,%,0,0
145717,dropout,0,0
145718,),0,0
145719,and,0,0
145720,non-smokers,0,1
145721,(,0,1
145722,18,0,1
145723,%,0,0
145724,dropout,0,0
145725,),0,0
145726,.,0,0
145727,Throughout,0,0
145728,the,0,0
145729,study,0,0
145730,smokers,0,1
145731,were,0,0
145732,more,0,0
145733,likely,0,0
145734,to,0,0
145735,dropout,0,0
145736,than,0,0
145737,non-smokers,0,1
145738,.,0,1
145739,Black,0,0
145740,tea,0,0
145741,treatment,0,0
145742,was,0,0
145743,associated,0,0
145744,with,0,1
145745,the,0,0
145746,highest,0,0
145747,rates,0,0
145748,of,0,0
145749,dropout,0,0
145750,among,0,1
145751,smokers,0,1
145752,(,0,1
145753,37,0,1
145754,%,0,0
145755,),0,0
145756,",",0,0
145757,but,0,0
145758,was,0,0
145759,associated,0,0
145760,with,0,1
145761,the,0,0
145762,lowest,0,0
145763,rate,0,0
145764,of,0,0
145765,dropout,0,0
145766,among,0,1
145767,non-smokers,0,1
145768,(,0,1
145769,4,0,0
145770,%,0,0
145771,),0,1
145772,.,0,0
145773,CONCLUSIONS,0,0
145774,In,0,0
145775,a,0,0
145776,study,0,0
145777,conducted,0,0
145778,to,0,0
145779,test,0,0
145780,the,0,0
145781,feasibility,0,0
145782,of,0,0
145783,a,0,0
145784,four-treatment,0,0
145785,crossover,0,0
145786,tea,0,0
145787,trial,0,0
145788,",",0,0
145789,a,0,0
145790,high,0,0
145791,rate,0,0
145792,of,0,0
145793,dropout,0,0
145794,among,0,1
145795,smokers,0,1
145796,and,0,1
145797,non-smokers,0,1
145798,was,0,0
145799,observed,0,0
145800,.,0,0
145801,Multi-arm,0,0
145802,crossover,0,0
145803,tea,0,0
145804,trials,0,0
145805,might,0,0
145806,pose,0,0
145807,a,0,0
145808,higher,0,0
145809,burden,0,0
145810,on,0,0
145811,participants,0,1
145812,and,0,0
145813,research,0,0
145814,is,0,0
145815,needed,0,0
145816,to,0,0
145817,improve,0,0
145818,adherence,0,0
145819,and,0,0
145820,treatment,0,0
145821,compliance,0,0
145822,in,0,0
145823,such,0,0
145824,trials,0,1
145825,.,0,1
145826,TRIAL,0,0
145827,REGISTRATION,0,0
145828,NUMBER,0,1
145829,ISRCTN70410203,0,1
145830,.,0,1
145831,In,0,0
145832,vitro,0,0
145833,biocompatibility,0,0
145834,tests,0,0
145835,of,0,0
145836,glass,0,0
145837,ionomer,0,0
145838,cements,0,0
145839,impregnated,0,0
145840,with,0,1
145841,collagen,0,0
145842,or,0,1
145843,bioactive,0,0
145844,glass,0,0
145845,to,0,1
145846,fibroblasts,0,0
145847,.,0,1
145848,AIM,0,0
145849,AND,0,0
145850,DESIGN,0,0
145851,To,0,0
145852,evaluate,0,0
145853,the,0,0
145854,biocompatibility,0,0
145855,of,0,0
145856,glass,1,0
145857,ionomer,1,0
145858,cement,1,0
145859,(,0,0
145860,GIC,0,0
145861,),0,0
145862,impregnated,0,0
145863,with,0,1
145864,collagen,0,0
145865,or,0,1
145866,bioactive,0,0
145867,glass,0,0
145868,to,0,0
145869,BHK-21,0,0
145870,fibroblasts,0,0
145871,in,0,0
145872,vitro,0,0
145873,.,0,1
145874,Mineral,0,0
145875,Trioxide,0,0
145876,Aggregate,0,0
145877,was,0,0
145878,used,0,0
145879,as,0,0
145880,the,0,0
145881,standard,0,0
145882,for,0,0
145883,comparison,0,0
145884,.,0,1
145885,Human,1,1
145886,maxillary,1,1
145887,central,1,1
145888,incisors,1,1
145889,(,1,1
145890,n,1,1
145891,=,1,0
145892,70,1,1
145893,),1,0
145894,were,0,0
145895,instrumented,0,1
145896,with,0,1
145897,a,0,0
145898,rotary,0,0
145899,NiTi,0,0
145900,system,0,0
145901,and,0,0
145902,filled,0,1
145903,.,0,0
145904,Following,0,0
145905,resection,0,0
145906,of,0,0
145907,the,0,0
145908,apical,0,0
145909,3mm,0,0
145910,",",0,0
145911,root,1,0
145912,end,1,0
145913,cavities,1,1
145914,were,0,1
145915,prepared,0,0
145916,and,0,0
145917,restored,0,0
145918,with,0,1
145919,conventional,0,0
145920,GIC,0,0
145921,(,0,0
145922,group,0,0
145923,1,0,0
145924,),0,0
145925,or,0,1
145926,GIC,0,0
145927,with,0,1
145928,0.01,0,0
145929,%,0,0
145930,",",0,0
145931,0.1,0,0
145932,%,0,0
145933,or,0,1
145934,1,0,0
145935,%,0,0
145936,collagen,0,0
145937,(,0,0
145938,groups,0,0
145939,2,0,1
145940,",",0,0
145941,3,0,0
145942,",",0,0
145943,4,0,0
145944,respectively,0,0
145945,),0,0
145946,or,0,0
145947,",",0,0
145948,10,0,0
145949,%,0,0
145950,",",0,0
145951,30,0,0
145952,%,0,0
145953,or,0,1
145954,50,0,1
145955,%,0,0
145956,bioactive,0,0
145957,glass,0,0
145958,(,0,1
145959,groups,0,0
145960,5,0,1
145961,",",0,0
145962,6,0,0
145963,",",0,0
145964,7,0,0
145965,respectively,0,0
145966,),0,0
145967,",",0,0
145968,or,0,1
145969,Mineral,0,1
145970,Trioxide,0,0
145971,Aggregate,0,0
145972,(,0,0
145973,group,0,0
145974,8,0,0
145975,),0,0
145976,.,0,0
145977,The,0,0
145978,root,1,0
145979,slices,1,0
145980,were,0,0
145981,incubated,0,0
145982,in,0,0
145983,tissue,0,0
145984,culture,0,0
145985,plates,0,0
145986,with,0,0
145987,BHK-21,0,0
145988,fibroblast,0,0
145989,cell,0,1
145990,line,0,0
145991,.,0,0
145992,Phase,0,0
145993,contrast,0,0
145994,and,0,0
145995,scanning,0,0
145996,electron,0,0
145997,microscopes,0,0
145998,were,0,0
145999,used,0,0
146000,to,0,0
146001,score,0,0
146002,cell,0,0
146003,quantity,0,0
146004,",",0,0
146005,morphology,0,1
146006,and,0,0
146007,cell,0,1
146008,attachment,0,0
146009,.,0,0
146010,The,0,0
146011,data,0,0
146012,were,0,0
146013,statistically,0,0
146014,analyzed,0,0
146015,by,0,0
146016,one,0,1
146017,way,0,0
146018,ANOVA,0,0
146019,with,0,1
146020,Post,0,1
146021,Hoc,0,1
146022,Tukey,0,0
146023,HSD,0,1
146024,test,0,0
146025,(,0,0
146026,p,0,0
146027,=,0,0
146028,0.05,0,0
146029,),0,1
146030,.,0,1
146031,RESULTS,0,0
146032,AND,0,0
146033,CONCLUSIONS,0,0
146034,Group,0,1
146035,5,0,0
146036,showed,0,0
146037,the,0,0
146038,highest,0,0
146039,scores,0,0
146040,which,0,0
146041,was,0,0
146042,significantly,0,0
146043,higher,0,0
146044,than,0,0
146045,all,0,0
146046,other,0,0
146047,groups,0,0
146048,(,0,1
146049,p,0,0
146050,<,0,0
146051,0.05,0,0
146052,),0,0
146053,except,0,0
146054,group,0,0
146055,8,0,0
146056,",",0,0
146057,with,0,1
146058,which,0,0
146059,there,0,0
146060,was,0,0
146061,no,0,0
146062,significant,0,0
146063,difference,0,0
146064,(,0,0
146065,p,0,0
146066,>,0,1
146067,0.05,0,0
146068,),0,1
146069,.,0,1
146070,Glass,0,0
146071,ionomer,0,0
146072,cement,0,0
146073,with,0,1
146074,10,0,0
146075,%,0,0
146076,bioactive,0,0
146077,glass,0,0
146078,showed,0,0
146079,better,0,0
146080,adhesion,0,0
146081,and,0,0
146082,spreading,0,0
146083,of,0,0
146084,cells,0,0
146085,than,0,0
146086,glass,0,0
146087,ionomer,0,0
146088,cement,0,0
146089,with,0,1
146090,0.01,0,0
146091,%,0,0
146092,collagen,0,0
146093,.,0,0
146094,The,0,0
146095,biocompatibility,0,0
146096,of,0,0
146097,collagen,0,0
146098,and,0,0
146099,bioactive,0,0
146100,glass,0,0
146101,was,0,0
146102,concentration,0,0
146103,dependent,0,0
146104,.,0,0
146105,The,0,0
146106,addition,0,0
146107,of,0,0
146108,bioactive,0,0
146109,glass,0,0
146110,improved,0,0
146111,the,0,0
146112,biocompatibility,0,0
146113,of,0,0
146114,glass,0,0
146115,ionomer,0,0
146116,cement,0,0
146117,to,0,0
146118,fibroblasts,0,0
146119,better,0,0
146120,than,0,0
146121,addition,0,0
146122,of,0,0
146123,collagen,0,0
146124,.,0,1
146125,Errors,0,0
146126,during,0,0
146127,the,0,0
146128,preparation,0,0
146129,of,0,0
146130,drug,0,1
146131,infusions,0,0
146132,:,0,1
146133,a,0,0
146134,randomized,0,0
146135,controlled,0,0
146136,trial,0,0
146137,.,0,0
146138,BACKGROUND,0,0
146139,We,0,0
146140,investigated,0,0
146141,the,0,0
146142,extent,0,0
146143,and,0,0
146144,frequency,0,0
146145,of,0,0
146146,dose,0,0
146147,errors,0,0
146148,and,0,1
146149,treatment,0,0
146150,delays,0,0
146151,made,0,0
146152,as,0,0
146153,a,0,0
146154,consequence,0,0
146155,of,0,0
146156,preparing,0,0
146157,drug,0,0
146158,infusions,0,0
146159,at,0,0
146160,the,0,0
146161,bedside,0,0
146162,",",0,0
146163,rather,0,0
146164,than,0,0
146165,using,0,0
146166,pre-filled,0,1
146167,syringes,0,0
146168,.,0,1
146169,METHODS,0,0
146170,Forty-eight,1,1
146171,nurses,1,1
146172,with,1,1
146173,critical,1,0
146174,care,1,1
146175,experience,1,0
146176,volunteered,1,1
146177,to,1,0
146178,take,1,0
146179,part,1,0
146180,in,1,0
146181,this,1,0
146182,randomized,1,0
146183,",",1,0
146184,blinded,1,0
146185,",",1,0
146186,controlled,1,0
146187,study,1,0
146188,conducted,1,0
146189,in,1,0
146190,the,1,0
146191,simulation,1,0
146192,centre,1,1
146193,of,1,0
146194,an,1,0
146195,urban,1,1
146196,hospital,1,1
146197,.,1,1
146198,They,0,0
146199,assisted,0,0
146200,in,0,0
146201,the,0,0
146202,management,0,0
146203,of,0,0
146204,a,0,0
146205,simulated,1,0
146206,patient,1,0
146207,with,1,1
146208,septic,1,1
146209,shock,1,1
146210,.,1,1
146211,Vasopressor,0,0
146212,infusions,0,0
146213,were,0,0
146214,prepared,0,0
146215,either,0,0
146216,by,0,0
146217,diluting,0,0
146218,concentrated,0,0
146219,drugs,0,0
146220,from,0,1
146221,ampoules,0,0
146222,or,0,1
146223,were,0,0
146224,provided,0,0
146225,in,0,0
146226,syringes,0,0
146227,pre-filled,0,0
146228,beforehand,0,0
146229,by,0,0
146230,an,0,0
146231,intensive,0,0
146232,care,0,0
146233,unit,0,0
146234,resident,0,1
146235,.,0,0
146236,RESULTS,0,0
146237,The,0,0
146238,time,0,0
146239,taken,0,0
146240,for,0,0
146241,the,0,0
146242,infusion,0,0
146243,to,0,0
146244,be,0,0
146245,started,0,0
146246,and,0,0
146247,the,0,0
146248,final,0,0
146249,concentration,0,0
146250,of,0,0
146251,the,0,0
146252,drugs,0,0
146253,were,0,0
146254,measured,0,0
146255,.,0,0
146256,We,0,0
146257,also,0,0
146258,measured,0,0
146259,the,0,0
146260,concentration,0,0
146261,of,0,0
146262,infusions,0,0
146263,prepared,0,0
146264,by,0,0
146265,a,0,0
146266,pharmacist,0,0
146267,and,0,0
146268,a,0,0
146269,pharmaceutical,0,0
146270,company,0,0
146271,.,0,1
146272,Nurses,0,0
146273,took,0,1
146274,156,0,1
146275,s,0,0
146276,to,0,0
146277,start,0,1
146278,infusions,0,0
146279,when,0,0
146280,using,0,0
146281,pre-filled,0,0
146282,syringes,0,0
146283,compared,0,0
146284,with,0,1
146285,276,0,1
146286,s,0,0
146287,when,0,0
146288,preparing,0,0
146289,them,0,0
146290,de,0,0
146291,novo,0,0
146292,",",0,0
146293,a,0,0
146294,mean,0,0
146295,delay,0,0
146296,of,0,0
146297,106,0,1
146298,s,0,0
146299,[,0,0
146300,95,0,0
146301,%,0,0
146302,confidence,0,0
146303,interval,0,0
146304,(,0,0
146305,CI,0,0
146306,),0,1
146307,73-140,0,1
146308,s,0,0
146309,",",0,0
146310,P,0,0
146311,<,0,0
146312,0.0001,0,0
146313,],0,0
146314,.,0,1
146315,One,0,1
146316,infusion,0,0
146317,prepared,0,0
146318,from,0,1
146319,ampoules,0,0
146320,contained,0,0
146321,one-fifth,0,0
146322,of,0,0
146323,the,0,0
146324,expected,0,0
146325,concentration,0,0
146326,of,0,0
146327,epinephrine,0,0
146328,;,0,0
146329,another,0,0
146330,contained,0,0
146331,none,0,0
146332,at,0,0
146333,all,0,0
146334,.,0,0
146335,Medication,0,0
146336,errors,0,0
146337,were,0,1
146338,17.0,0,0
146339,times,0,0
146340,less,0,0
146341,likely,0,0
146342,when,0,0
146343,pre-filled,0,1
146344,syringes,0,0
146345,were,0,1
146346,used,0,0
146347,(,0,0
146348,95,0,0
146349,%,0,0
146350,CI,0,0
146351,5.2-55.5,0,0
146352,),0,0
146353,",",0,0
146354,and,0,0
146355,infusions,0,0
146356,prepared,0,0
146357,by,0,0
146358,pharmacy,0,0
146359,and,0,0
146360,industry,0,0
146361,were,0,0
146362,significantly,0,0
146363,more,0,0
146364,likely,0,0
146365,to,0,0
146366,contain,0,0
146367,the,0,0
146368,expected,0,0
146369,concentration,0,0
146370,(,0,0
146371,P,0,0
146372,<,0,0
146373,0.001,0,0
146374,for,0,0
146375,norepinephrine,0,0
146376,and,0,0
146377,P=0.001,0,0
146378,for,0,0
146379,epinephrine,0,0
146380,),0,0
146381,.,0,0
146382,CONCLUSIONS,0,0
146383,Providing,0,0
146384,drug,0,0
146385,infusions,0,0
146386,in,0,1
146387,syringes,0,0
146388,pre-filled,0,1
146389,by,0,0
146390,pharmacists,0,0
146391,or,0,1
146392,pharmaceutical,0,0
146393,companies,0,0
146394,would,0,0
146395,reduce,0,0
146396,medication,0,0
146397,errors,0,0
146398,and,0,0
146399,treatment,0,0
146400,delays,0,0
146401,",",0,0
146402,and,0,0
146403,improve,0,0
146404,patient,0,0
146405,safety,0,0
146406,.,0,0
146407,However,0,0
146408,",",0,0
146409,this,0,0
146410,approach,0,0
146411,would,0,0
146412,have,0,0
146413,substantial,0,0
146414,financial,0,0
146415,implications,0,0
146416,for,0,0
146417,healthcare,0,1
146418,providers,0,0
146419,",",0,0
146420,especially,0,0
146421,in,0,0
146422,less,0,0
146423,developed,0,1
146424,countries,0,1
146425,.,0,1
146426,Teaching,0,0
146427,emotion,0,0
146428,recognition,0,1
146429,skills,0,0
146430,to,0,1
146431,young,1,1
146432,children,1,1
146433,with,1,1
146434,autism,1,1
146435,:,1,1
146436,a,0,0
146437,randomised,0,0
146438,controlled,0,0
146439,trial,0,0
146440,of,0,0
146441,an,0,0
146442,emotion,0,0
146443,training,0,0
146444,programme,0,0
146445,.,0,1
146446,BACKGROUND,0,0
146447,Children,1,1
146448,with,1,1
146449,autism,1,1
146450,have,0,0
146451,difficulties,0,0
146452,in,0,0
146453,emotion,0,0
146454,recognition,0,0
146455,and,0,0
146456,a,0,0
146457,number,0,0
146458,of,0,0
146459,interventions,0,0
146460,have,0,1
146461,been,0,0
146462,designed,0,0
146463,to,0,0
146464,target,0,0
146465,these,0,0
146466,problems,0,0
146467,.,0,0
146468,However,0,0
146469,",",0,0
146470,few,0,0
146471,emotion,0,0
146472,training,0,0
146473,interventions,0,0
146474,have,0,0
146475,been,0,0
146476,trialled,0,0
146477,with,0,1
146478,young,1,1
146479,children,1,1
146480,with,1,1
146481,autism,1,1
146482,and,1,0
146483,co-morbid,1,1
146484,ID,1,1
146485,.,1,0
146486,This,0,0
146487,study,0,0
146488,aimed,0,0
146489,to,0,0
146490,evaluate,0,0
146491,the,0,0
146492,efficacy,0,0
146493,of,0,0
146494,an,0,0
146495,emotion,0,0
146496,training,0,0
146497,programme,0,0
146498,for,0,0
146499,a,0,0
146500,group,1,0
146501,of,1,0
146502,young,1,1
146503,children,1,1
146504,with,1,1
146505,autism,1,1
146506,with,1,1
146507,a,1,0
146508,range,1,0
146509,of,1,0
146510,intellectual,1,1
146511,ability,1,0
146512,.,1,1
146513,METHODS,0,0
146514,Participants,1,1
146515,were,1,1
146516,55,1,1
146517,children,1,1
146518,with,1,1
146519,autistic,1,1
146520,disorder,1,1
146521,",",1,0
146522,aged,1,1
146523,4-7,1,0
146524,years,1,1
146525,(,1,1
146526,FSIQ,1,1
146527,42-107,1,1
146528,),1,1
146529,.,1,1
146530,Children,0,1
146531,were,0,0
146532,randomly,0,1
146533,assigned,0,0
146534,to,0,0
146535,an,0,0
146536,intervention,0,0
146537,(,0,0
146538,n,0,1
146539,=,0,0
146540,28,0,1
146541,),0,0
146542,or,0,0
146543,control,0,0
146544,group,0,0
146545,(,0,0
146546,n,0,1
146547,=,0,0
146548,27,0,1
146549,),0,1
146550,.,0,1
146551,Participants,0,1
146552,in,0,0
146553,the,0,0
146554,intervention,0,0
146555,group,0,0
146556,watched,0,0
146557,a,0,0
146558,DVD,0,0
146559,designed,0,0
146560,to,0,0
146561,teach,0,0
146562,emotion,0,0
146563,recognition,0,0
146564,skills,0,0
146565,to,0,0
146566,children,0,1
146567,with,0,1
146568,autism,0,1
146569,(,0,1
146570,the,0,0
146571,Transporters,0,0
146572,),0,0
146573,",",0,0
146574,whereas,0,0
146575,the,0,0
146576,control,0,0
146577,group,0,0
146578,watched,0,0
146579,a,0,0
146580,DVD,0,0
146581,of,0,0
146582,Thomas,0,1
146583,the,0,0
146584,Tank,0,1
146585,Engine,0,0
146586,.,0,1
146587,Participants,0,1
146588,were,0,0
146589,assessed,0,0
146590,on,0,0
146591,their,0,0
146592,ability,0,0
146593,to,0,0
146594,complete,0,0
146595,basic,0,0
146596,emotion,0,0
146597,recognition,0,1
146598,tasks,0,0
146599,",",0,0
146600,mindreading,0,0
146601,and,0,0
146602,theory,0,0
146603,of,0,0
146604,mind,0,1
146605,(,0,0
146606,TOM,0,1
146607,),0,1
146608,tasks,0,0
146609,before,0,0
146610,and,0,0
146611,after,0,0
146612,the,0,0
146613,4-week,0,0
146614,intervention,0,0
146615,period,0,0
146616,",",0,0
146617,and,0,0
146618,at,0,0
146619,3-month,0,0
146620,follow-up,0,0
146621,.,0,1
146622,RESULTS,0,0
146623,Analyses,0,0
146624,controlled,0,0
146625,for,0,0
146626,the,0,0
146627,effect,0,0
146628,of,0,0
146629,chronological,0,0
146630,age,0,1
146631,",",0,0
146632,verbal,0,0
146633,intelligence,0,0
146634,",",0,0
146635,gender,0,0
146636,and,0,0
146637,DVD,0,0
146638,viewing,0,0
146639,time,0,0
146640,on,0,0
146641,outcomes,0,0
146642,.,0,1
146643,Children,0,1
146644,in,0,0
146645,the,0,0
146646,intervention,0,0
146647,group,0,0
146648,showed,0,0
146649,improved,0,0
146650,performance,0,0
146651,in,0,0
146652,the,0,0
146653,recognition,0,0
146654,of,0,0
146655,anger,0,0
146656,compared,0,0
146657,with,0,1
146658,the,0,0
146659,control,0,0
146660,group,0,0
146661,",",0,0
146662,with,0,1
146663,few,0,0
146664,improvements,0,0
146665,maintained,0,0
146666,at,0,0
146667,3-month,0,0
146668,follow-up,0,0
146669,.,0,0
146670,There,0,0
146671,was,0,0
146672,no,0,0
146673,generalisation,0,0
146674,of,0,0
146675,skills,0,0
146676,to,0,1
146677,TOM,0,1
146678,or,0,1
146679,social,0,1
146680,skills,0,0
146681,.,0,1
146682,CONCLUSIONS,0,0
146683,The,0,0
146684,Transporters,0,0
146685,programme,0,0
146686,showed,0,0
146687,limited,0,0
146688,efficacy,0,0
146689,in,0,0
146690,teaching,0,1
146691,basic,0,0
146692,emotion,0,0
146693,recognition,0,1
146694,skills,0,0
146695,to,0,1
146696,young,1,1
146697,children,1,1
146698,with,1,1
146699,autism,1,1
146700,with,0,1
146701,a,0,0
146702,lower,0,0
146703,range,0,0
146704,of,0,0
146705,cognitive,0,0
146706,ability,0,0
146707,.,0,1
146708,Improvements,0,0
146709,were,0,0
146710,limited,0,0
146711,to,0,0
146712,the,0,0
146713,recognition,0,0
146714,of,0,0
146715,expressions,0,0
146716,of,0,0
146717,anger,0,0
146718,",",0,0
146719,with,0,1
146720,poor,0,0
146721,maintenance,0,0
146722,of,0,0
146723,these,0,0
146724,skills,0,0
146725,at,0,0
146726,follow-up,0,0
146727,.,0,0
146728,These,0,0
146729,findings,0,0
146730,provide,0,0
146731,limited,0,0
146732,support,0,0
146733,for,0,0
146734,the,0,0
146735,efficacy,0,0
146736,of,0,0
146737,the,0,0
146738,Transporters,0,0
146739,programme,0,0
146740,for,0,0
146741,young,1,1
146742,children,1,1
146743,with,1,1
146744,autism,1,1
146745,of,0,0
146746,a,0,0
146747,lower,0,0
146748,cognitive,0,0
146749,range,0,1
146750,.,0,1
146751,Comparing,0,0
146752,the,0,0
146753,effectiveness,0,0
146754,of,0,0
146755,copper,0,0
146756,intrauterine,0,1
146757,devices,0,0
146758,available,0,0
146759,in,0,1
146760,Canada,1,1
146761,.,1,0
146762,Is,0,0
146763,FlexiT,0,0
146764,non-inferior,0,0
146765,to,0,0
146766,NovaT,0,0
146767,when,0,0
146768,inserted,0,0
146769,immediately,0,0
146770,after,0,0
146771,first-trimester,1,1
146772,abortion,1,1
146773,?,0,0
146774,Study,0,0
146775,protocol,0,0
146776,for,0,0
146777,a,0,0
146778,randomized,0,0
146779,controlled,0,0
146780,trial,0,0
146781,.,0,0
146782,BACKGROUND,0,0
146783,We,0,0
146784,describe,0,0
146785,the,0,0
146786,rationale,0,0
146787,and,0,0
146788,protocol,0,0
146789,for,0,0
146790,a,0,0
146791,randomized,0,0
146792,noninferiority,0,0
146793,controlled,0,0
146794,trial,0,0
146795,(,0,0
146796,RCT,0,0
146797,),0,0
146798,to,0,0
146799,determine,0,0
146800,if,0,0
146801,the,0,0
146802,Flexi-T380,0,0
146803,(,0,0
146804,+,0,0
146805,),0,0
146806,copper,0,0
146807,intrauterine,0,0
146808,contraceptive,0,1
146809,device,0,0
146810,(,0,0
146811,IUD,0,0
146812,),0,0
146813,is,0,0
146814,comparable,0,0
146815,in,0,0
146816,terms,0,0
146817,of,0,0
146818,effectiveness,0,0
146819,and,0,0
146820,expulsion,0,0
146821,rates,0,0
146822,to,0,0
146823,the,0,0
146824,most,0,0
146825,common,0,0
146826,Canadian,0,1
146827,IUD,0,0
146828,currently,0,1
146829,in,0,0
146830,use,0,0
146831,",",0,0
146832,NovaT-200,0,0
146833,",",0,0
146834,when,0,0
146835,placed,0,0
146836,immediately,0,0
146837,after,0,0
146838,a,0,0
146839,first-trimester,0,1
146840,abortion,0,1
146841,.,0,1
146842,METHODS/DESIGN,0,0
146843,Consenting,1,1
146844,women,1,1
146845,choosing,1,0
146846,to,1,0
146847,use,1,0
146848,an,1,0
146849,IUD,1,0
146850,after,1,0
146851,an,1,0
146852,abortion,1,1
146853,for,1,0
146854,a,1,0
146855,pregnancy,1,0
146856,of,1,0
146857,less,1,0
146858,than,1,0
146859,12,1,0
146860,weeks,1,0
146861,of,1,0
146862,gestation,1,1
146863,will,0,0
146864,be,0,0
146865,randomized,0,0
146866,to,0,0
146867,device-type,0,0
146868,groups,0,0
146869,to,0,0
146870,receive,0,1
146871,immediate,0,0
146872,post-abortion,0,0
146873,placement,0,0
146874,of,0,0
146875,either,0,0
146876,a,0,0
146877,Flexi-T380,0,0
146878,(,0,0
146879,+,0,0
146880,),0,0
146881,IUD,0,0
146882,",",0,0
146883,a,0,0
146884,device,0,0
146885,for,0,0
146886,which,0,0
146887,no,0,0
146888,current,0,0
146889,evidence,0,0
146890,on,0,0
146891,expulsion,0,0
146892,or,0,1
146893,effectiveness,0,0
146894,rates,0,0
146895,is,0,0
146896,available,0,0
146897,",",0,0
146898,or,0,0
146899,the,0,0
146900,Nova-T200,0,0
146901,IUD,0,0
146902,",",0,0
146903,the,0,0
146904,only,0,0
146905,other,0,0
146906,brand,0,0
146907,of,0,0
146908,copper,0,0
146909,IUD,0,1
146910,available,0,0
146911,in,0,0
146912,Canada,0,1
146913,at,0,0
146914,the,0,0
146915,time,0,0
146916,of,0,0
146917,study,0,0
146918,initiation,0,0
146919,.,0,0
146920,The,0,0
146921,primary,0,0
146922,outcome,0,0
146923,measure,0,0
146924,is,0,0
146925,IUD,0,0
146926,expulsion,0,0
146927,rate,0,0
146928,at,0,0
146929,1,0,0
146930,year,0,1
146931,.,0,1
146932,Secondary,0,0
146933,outcomes,0,0
146934,include,0,0
146935,:,0,1
146936,pregnancy,0,0
146937,rate,0,0
146938,",",0,0
146939,method,0,0
146940,continuation,0,0
146941,rate,0,0
146942,",",0,0
146943,complication,0,0
146944,rates,0,0
146945,(,0,0
146946,infection,0,0
146947,",",0,0
146948,perforation,0,0
146949,),0,0
146950,",",0,0
146951,and,0,0
146952,satisfaction,0,0
146953,with,0,1
146954,contraceptive,0,1
146955,method,0,0
146956,.,0,0
146957,A,0,0
146958,non-intervention,0,0
146959,group,0,0
146960,of,0,0
146961,consenting,0,1
146962,women,0,1
146963,choosing,0,0
146964,a,0,0
146965,range,0,0
146966,of,0,0
146967,other,0,0
146968,post-abortion,0,1
146969,contraception,0,1
146970,methods,0,1
146971,",",0,0
146972,including,0,0
146973,no,0,0
146974,contraception,0,0
146975,",",0,0
146976,will,0,0
146977,be,0,0
146978,included,0,0
146979,for,0,0
146980,comparison,0,0
146981,of,0,0
146982,secondary,0,1
146983,outcomes,0,0
146984,.,0,1
146985,Web-based,0,0
146986,contraception,0,1
146987,satisfaction,0,0
146988,questionnaires,0,0
146989,",",0,0
146990,clinical,0,0
146991,records,0,1
146992,",",0,0
146993,and,0,0
146994,government-linked,0,1
146995,health,0,1
146996,administrative,0,1
146997,databases,0,1
146998,will,0,0
146999,be,0,0
147000,used,0,0
147001,to,0,0
147002,assess,0,0
147003,primary,0,1
147004,and,0,0
147005,secondary,0,1
147006,outcomes,0,0
147007,.,0,1
147008,DISCUSSION,0,0
147009,The,0,0
147010,RCT,0,0
147011,design,0,0
147012,",",0,0
147013,combined,0,0
147014,with,0,1
147015,access,0,0
147016,to,0,0
147017,clinical,0,0
147018,records,0,1
147019,at,0,0
147020,all,0,1
147021,provincial,0,1
147022,abortion,0,1
147023,clinics,0,1
147024,",",0,0
147025,and,0,0
147026,to,0,0
147027,information,0,0
147028,in,0,0
147029,provincial,0,1
147030,single-payer,0,1
147031,linked,0,0
147032,administrative,0,1
147033,health,0,1
147034,databases,0,1
147035,",",0,0
147036,birth,0,1
147037,registry,0,1
147038,",",0,0
147039,and,0,0
147040,hospital,0,1
147041,records,0,0
147042,",",0,0
147043,offers,0,0
147044,a,0,0
147045,unique,0,0
147046,opportunity,0,0
147047,to,0,0
147048,determine,0,0
147049,if,0,0
147050,a,0,0
147051,novel,0,0
147052,IUD,0,0
147053,has,0,0
147054,a,0,0
147055,comparable,0,0
147056,expulsion,0,0
147057,rate,0,0
147058,to,0,0
147059,that,0,0
147060,of,0,0
147061,the,0,0
147062,current,0,0
147063,standard,0,0
147064,IUD,0,0
147065,in,0,0
147066,Canada,0,1
147067,",",0,0
147068,in,0,0
147069,addition,0,0
147070,to,0,0
147071,the,0,0
147072,first,0,0
147073,opportunity,0,0
147074,to,0,0
147075,determine,0,0
147076,pregnancy,0,0
147077,rate,0,0
147078,and,0,0
147079,method,0,0
147080,satisfaction,0,0
147081,at,0,0
147082,1,0,0
147083,year,0,0
147084,post-abortion,0,1
147085,for,0,0
147086,women,0,1
147087,choosing,0,0
147088,a,0,0
147089,range,0,0
147090,of,0,0
147091,post-abortion,0,1
147092,contraceptive,0,1
147093,options,0,0
147094,.,0,1
147095,We,0,0
147096,highlight,0,0
147097,considerations,0,0
147098,of,0,0
147099,design,0,0
147100,",",0,0
147101,implementation,0,0
147102,",",0,0
147103,and,0,0
147104,evaluation,0,0
147105,of,0,0
147106,the,0,0
147107,first,0,0
147108,trial,0,0
147109,to,0,0
147110,provide,0,0
147111,rigorous,0,0
147112,evidence,0,0
147113,for,0,0
147114,the,0,0
147115,effectiveness,0,0
147116,of,0,0
147117,current,0,0
147118,Canadian,0,1
147119,IUDs,0,0
147120,when,0,0
147121,inserted,0,0
147122,after,0,0
147123,first-trimester,0,1
147124,abortion,0,1
147125,.,0,1
147126,TRIAL,0,0
147127,REGISTRATION,0,0
147128,ClinicalTrials.gov,0,1
147129,Identifier,0,1
147130,NCT01174225,0,1
147131,.,0,1
147132,Links,0,1
147133,between,0,0
147134,multisensory,0,0
147135,processing,0,0
147136,and,0,0
147137,autism,0,1
147138,.,0,0
147139,Autism,1,1
147140,spectrum,1,1
147141,disorder,1,1
147142,is,0,0
147143,typically,0,0
147144,associated,0,0
147145,with,0,1
147146,social,0,0
147147,deficits,0,0
147148,and,0,0
147149,is,0,0
147150,often,0,0
147151,specifically,0,0
147152,linked,0,0
147153,to,0,0
147154,difficulty,0,0
147155,with,0,0
147156,processing,0,0
147157,faces,0,0
147158,and,0,0
147159,other,0,0
147160,socially,0,0
147161,relevant,0,0
147162,stimuli,0,0
147163,.,0,1
147164,Emerging,0,0
147165,research,0,0
147166,has,0,0
147167,suggested,0,0
147168,that,0,0
147169,children,1,1
147170,with,1,1
147171,autism,1,1
147172,might,0,0
147173,also,0,0
147174,have,0,0
147175,deficits,0,0
147176,in,0,0
147177,basic,0,1
147178,perceptual,0,1
147179,abilities,0,0
147180,including,0,0
147181,multisensory,0,0
147182,processing,0,0
147183,(,0,0
147184,e.g.,0,0
147185,",",0,0
147186,simultaneously,0,0
147187,processing,0,0
147188,visual,0,0
147189,and,0,1
147190,auditory,0,0
147191,inputs,0,0
147192,),0,1
147193,.,0,1
147194,The,0,0
147195,current,0,0
147196,study,0,0
147197,examined,0,0
147198,the,0,0
147199,relationship,0,0
147200,between,0,0
147201,multisensory,0,0
147202,temporal,0,0
147203,processing,0,0
147204,(,0,0
147205,assessed,0,0
147206,via,0,0
147207,a,0,0
147208,simultaneity,0,0
147209,judgment,0,0
147210,task,0,0
147211,wherein,0,0
147212,participants,0,1
147213,were,0,0
147214,to,0,0
147215,report,0,0
147216,whether,0,0
147217,a,0,0
147218,visual,0,0
147219,stimulus,0,0
147220,and,0,0
147221,an,0,0
147222,auditory,0,0
147223,stimulus,0,0
147224,occurred,0,0
147225,at,0,0
147226,the,0,0
147227,same,0,0
147228,time,0,0
147229,or,0,1
147230,at,0,0
147231,different,0,0
147232,times,0,0
147233,),0,1
147234,and,0,1
147235,self-reported,0,0
147236,symptoms,0,0
147237,of,0,0
147238,autism,0,1
147239,(,0,0
147240,assessed,0,0
147241,via,0,0
147242,the,0,0
147243,Autism,0,1
147244,Spectrum,0,1
147245,Quotient,0,0
147246,questionnaire,0,1
147247,),0,0
147248,.,0,0
147249,Data,0,0
147250,from,0,1
147251,over,1,0
147252,100,1,1
147253,healthy,1,1
147254,adults,1,1
147255,revealed,0,0
147256,a,0,0
147257,relationship,0,0
147258,between,0,0
147259,these,0,0
147260,two,0,0
147261,factors,0,0
147262,as,0,0
147263,multisensory,0,0
147264,timing,0,0
147265,perception,0,0
147266,correlated,0,0
147267,with,0,1
147268,symptoms,0,0
147269,of,0,0
147270,autism,0,1
147271,.,0,0
147272,Specifically,0,0
147273,",",0,0
147274,a,0,0
147275,stronger,0,0
147276,bias,0,0
147277,to,0,0
147278,perceive,0,0
147279,auditory,0,0
147280,stimuli,0,0
147281,occurring,0,1
147282,before,0,0
147283,visual,0,0
147284,stimuli,0,0
147285,as,0,0
147286,simultaneous,0,0
147287,was,0,0
147288,associated,0,0
147289,with,0,1
147290,greater,0,0
147291,levels,0,0
147292,of,0,0
147293,autistic,0,1
147294,symptoms,0,1
147295,.,0,1
147296,Additional,0,0
147297,data,0,0
147298,and,0,0
147299,analyses,0,0
147300,confirm,0,0
147301,that,0,0
147302,this,0,0
147303,relationship,0,0
147304,is,0,0
147305,specific,0,0
147306,to,0,0
147307,multisensory,0,0
147308,processing,0,0
147309,and,0,0
147310,symptoms,0,0
147311,of,0,0
147312,autism,0,1
147313,.,0,0
147314,These,0,0
147315,results,0,0
147316,provide,0,0
147317,insight,0,0
147318,into,0,0
147319,the,0,0
147320,nature,0,0
147321,of,0,0
147322,multisensory,0,0
147323,processing,0,0
147324,while,0,0
147325,also,0,0
147326,revealing,0,0
147327,a,0,0
147328,continuum,0,0
147329,over,0,0
147330,which,0,0
147331,perceptual,0,0
147332,abilities,0,0
147333,correlate,0,0
147334,with,0,1
147335,symptoms,0,0
147336,of,0,0
147337,autism,0,1
147338,and,0,0
147339,that,0,0
147340,this,0,0
147341,continuum,0,0
147342,is,0,0
147343,not,0,0
147344,just,0,0
147345,specific,0,0
147346,to,0,0
147347,clinical,0,0
147348,populations,0,0
147349,but,0,0
147350,is,0,0
147351,present,0,0
147352,within,0,0
147353,the,0,0
147354,general,1,1
147355,population,1,1
147356,.,1,1
147357,Psychological,0,1
147358,adjustment,0,0
147359,and,0,0
147360,levels,0,0
147361,of,0,0
147362,self,0,0
147363,esteem,0,0
147364,in,0,0
147365,children,1,1
147366,with,1,1
147367,visual-motor,1,0
147368,integration,1,0
147369,difficulties,1,0
147370,influences,0,0
147371,the,0,0
147372,results,0,0
147373,of,0,0
147374,a,0,0
147375,randomized,0,0
147376,intervention,0,0
147377,trial,0,0
147378,.,0,0
147379,This,0,0
147380,study,0,0
147381,evaluates,0,0
147382,how,0,0
147383,much,0,0
147384,the,0,0
147385,effects,0,0
147386,of,0,0
147387,intervention,0,0
147388,programs,0,1
147389,are,0,0
147390,influenced,0,0
147391,by,0,0
147392,pre-existing,1,1
147393,psychological,1,0
147394,adjustment,1,0
147395,and,1,0
147396,self-esteem,1,0
147397,levels,1,0
147398,in,1,0
147399,kindergarten,1,1
147400,and,1,0
147401,first,1,0
147402,grade,1,1
147403,children,1,1
147404,with,1,1
147405,poor,1,1
147406,visual-motor,1,0
147407,integration,1,0
147408,skills,1,0
147409,",",1,0
147410,from,1,1
147411,low,1,1
147412,socioeconomic,1,1
147413,backgrounds,1,1
147414,.,1,1
147415,One,1,1
147416,hundred,1,1
147417,and,1,0
147418,sixteen,1,1
147419,mainstream,1,1
147420,kindergarten,1,1
147421,and,1,0
147422,first-grade,1,1
147423,children,1,1
147424,",",1,0
147425,from,1,1
147426,low,1,1
147427,socioeconomic,1,1
147428,backgrounds,1,0
147429,",",1,0
147430,scoring,1,1
147431,below,1,0
147432,the,1,0
147433,25th,1,0
147434,percentile,1,0
147435,on,1,0
147436,a,1,0
147437,measure,1,0
147438,of,1,0
147439,visual-motor,1,0
147440,integration,1,0
147441,(,1,0
147442,VMI,1,0
147443,),1,0
147444,were,1,0
147445,recruited,1,1
147446,and,0,0
147447,randomly,0,1
147448,divided,0,1
147449,into,0,0
147450,two,0,0
147451,parallel,0,0
147452,intervention,0,1
147453,groups,0,0
147454,.,0,1
147455,One,0,1
147456,intervention,0,0
147457,group,0,0
147458,received,0,0
147459,directive,0,0
147460,visual-motor,0,0
147461,intervention,0,0
147462,(,0,0
147463,DVMI,0,0
147464,),0,0
147465,",",0,0
147466,while,0,0
147467,the,0,0
147468,second,0,0
147469,intervention,0,0
147470,group,0,0
147471,received,0,0
147472,a,0,0
147473,non-directive,0,0
147474,supportive,0,0
147475,intervention,0,0
147476,(,0,0
147477,NDSI,0,1
147478,),0,1
147479,.,0,1
147480,Tests,0,0
147481,were,0,0
147482,administered,0,0
147483,to,0,0
147484,evaluate,0,0
147485,visual-motor,0,0
147486,integration,0,0
147487,skills,0,0
147488,outcome,0,0
147489,.,0,0
147490,Children,0,1
147491,with,0,1
147492,higher,0,0
147493,baseline,0,0
147494,measures,0,0
147495,of,0,0
147496,psychological,0,0
147497,adjustment,0,0
147498,and,0,0
147499,self-esteem,0,0
147500,responded,0,0
147501,better,0,0
147502,in,0,0
147503,NDSI,0,0
147504,while,0,0
147505,children,0,1
147506,with,0,1
147507,lower,0,0
147508,baseline,0,0
147509,performance,0,0
147510,on,0,0
147511,psychological,0,0
147512,adjustment,0,0
147513,and,0,0
147514,self-esteem,0,0
147515,responded,0,0
147516,better,0,0
147517,in,0,0
147518,DVMI,0,0
147519,.,0,0
147520,This,0,0
147521,study,0,0
147522,suggests,0,0
147523,that,0,0
147524,children,0,1
147525,from,0,1
147526,low,0,1
147527,socioeconomic,0,1
147528,backgrounds,0,1
147529,with,0,1
147530,low,0,1
147531,VMI,0,0
147532,performance,0,0
147533,scores,0,0
147534,will,0,0
147535,benefit,0,0
147536,more,0,0
147537,from,0,0
147538,intervention,0,0
147539,programs,0,1
147540,if,0,0
147541,clinicians,0,0
147542,choose,0,1
147543,the,0,0
147544,type,0,1
147545,of,0,0
147546,intervention,0,0
147547,according,0,1
147548,to,0,0
147549,baseline,0,0
147550,psychological,0,0
147551,adjustment,0,0
147552,and,0,0
147553,self-esteem,0,0
147554,measures,0,0
147555,.,0,1
147556,Insular,0,1
147557,and,0,0
147558,anterior,0,1
147559,cingulate,0,0
147560,circuits,0,0
147561,in,0,0
147562,smokers,1,1
147563,with,1,1
147564,schizophrenia,1,1
147565,.,1,1
147566,Schizophrenia,1,1
147567,(,1,0
147568,SZ,1,0
147569,),1,0
147570,is,0,0
147571,associated,0,0
147572,with,0,1
147573,high,0,1
147574,rates,0,0
147575,of,0,0
147576,smoking,0,1
147577,.,0,0
147578,We,0,0
147579,previously,0,0
147580,found,0,0
147581,that,0,0
147582,resting,0,0
147583,state,0,1
147584,functional,0,0
147585,connectivity,0,0
147586,(,0,0
147587,rsFC,0,0
147588,),0,0
147589,between,0,0
147590,the,0,0
147591,dorsal,0,0
147592,anterior,0,1
147593,cingulate,0,0
147594,(,0,0
147595,dACC,0,0
147596,),0,0
147597,and,0,0
147598,striatum,0,0
147599,is,0,0
147600,independently,0,0
147601,associated,0,0
147602,with,0,1
147603,nicotine,0,0
147604,addiction,0,1
147605,and,0,0
147606,psychiatric,0,1
147607,illness,0,1
147608,.,0,0
147609,Since,0,0
147610,the,0,0
147611,insula,0,0
147612,is,0,0
147613,implicated,0,0
147614,in,0,0
147615,nicotine,0,0
147616,dependence,0,0
147617,",",0,0
147618,we,0,0
147619,hypothesized,0,0
147620,that,0,0
147621,SZ,0,0
147622,smokers,0,1
147623,will,0,0
147624,have,0,0
147625,greater,0,0
147626,dysfunction,0,0
147627,in,0,0
147628,smoking-related,0,1
147629,insular,0,1
147630,and,0,0
147631,dACC,0,0
147632,circuits,0,0
147633,than,0,0
147634,normal,1,1
147635,control,1,1
147636,smokers,1,1
147637,(,1,1
147638,NC,1,1
147639,),1,0
147640,independent,0,0
147641,of,0,0
147642,smoking,0,0
147643,severity,0,0
147644,",",0,0
147645,consistent,0,0
147646,with,0,1
147647,an,0,0
147648,inherent,0,0
147649,disease-related,0,0
147650,weakening,0,0
147651,of,0,0
147652,smoking-related,0,1
147653,circuits,0,0
147654,.,0,1
147655,Nicotine,0,0
147656,challenge,0,0
147657,was,0,0
147658,used,0,0
147659,to,0,0
147660,demonstrate,0,0
147661,that,0,0
147662,decreased,0,0
147663,rsFC,0,0
147664,in,0,0
147665,identified,0,0
147666,circuits,0,0
147667,reflects,0,0
147668,addiction,0,1
147669,trait,0,0
147670,and,0,0
147671,is,0,0
147672,not,0,0
147673,affected,0,0
147674,by,0,0
147675,pharmacological,0,0
147676,state,0,1
147677,.,0,1
147678,Twenty-four,1,1
147679,NC,1,0
147680,smokers,1,1
147681,and,1,1
147682,20,1,1
147683,smokers,1,1
147684,with,1,1
147685,SZ,1,1
147686,matched,1,1
147687,on,1,0
147688,nicotine,1,0
147689,addiction,1,1
147690,severity,1,0
147691,participated,0,1
147692,in,0,0
147693,a,0,0
147694,resting,0,0
147695,state,0,0
147696,fMRI,0,0
147697,study,0,0
147698,and,0,0
147699,were,0,0
147700,scanned,0,1
147701,during,0,0
147702,two,0,0
147703,separate,0,0
147704,sessions,0,0
147705,while,0,0
147706,receiving,0,1
147707,a,0,0
147708,placebo,0,0
147709,or,0,0
147710,nicotine,0,0
147711,patch,0,0
147712,",",0,0
147713,in,0,0
147714,a,0,0
147715,randomized,0,0
147716,",",0,0
147717,cross-over,0,0
147718,design,0,0
147719,.,0,0
147720,Using,0,0
147721,individualized,0,0
147722,",",0,0
147723,anatomically,0,1
147724,defined,0,0
147725,anterior,0,1
147726,and,0,0
147727,posterior,0,0
147728,insula,0,0
147729,and,0,0
147730,dACC,0,0
147731,as,0,0
147732,regions,0,0
147733,of,0,0
147734,interest,0,0
147735,(,0,0
147736,ROI,0,0
147737,),0,0
147738,",",0,0
147739,whole,0,0
147740,brain,0,0
147741,rsFC,0,0
147742,was,0,0
147743,performed,0,0
147744,using,0,0
147745,each,0,0
147746,ROI,0,0
147747,as,0,0
147748,a,0,0
147749,seed,0,0
147750,.,0,0
147751,Significant,0,0
147752,negative,0,0
147753,correlations,0,0
147754,between,0,0
147755,smoking,0,1
147756,severity,0,0
147757,and,0,0
147758,rsFC,0,0
147759,between,0,0
147760,insula,0,0
147761,",",0,0
147762,dACC,0,0
147763,and,0,0
147764,striatum,0,0
147765,were,0,0
147766,found,0,0
147767,for,0,0
147768,both,0,0
147769,groups,0,0
147770,.,0,0
147771,Furthermore,0,0
147772,",",0,0
147773,smokers,1,1
147774,with,1,1
147775,SZ,1,1
147776,demonstrated,0,0
147777,additive,0,0
147778,reductions,0,0
147779,in,0,0
147780,circuit,0,0
147781,strength,0,0
147782,between,0,0
147783,the,0,0
147784,dACC,0,0
147785,and,0,0
147786,insula,0,0
147787,compared,0,0
147788,to,0,0
147789,NC,1,1
147790,smokers,1,1
147791,independent,0,0
147792,of,0,0
147793,smoking,0,1
147794,severity,0,0
147795,.,0,1
147796,Nicotine,0,0
147797,challenge,0,0
147798,did,0,0
147799,not,0,0
147800,significantly,0,0
147801,alter,0,0
147802,rsFC,0,0
147803,in,0,0
147804,insula-dACC-striatal,0,1
147805,circuits,0,0
147806,.,0,1
147807,Reduced,0,0
147808,rsFC,0,0
147809,strength,0,0
147810,between,0,0
147811,the,0,0
147812,insula,0,0
147813,",",0,0
147814,dACC,0,0
147815,and,0,0
147816,striatum,0,0
147817,is,0,0
147818,associated,0,0
147819,with,0,0
147820,nicotine,0,0
147821,addiction,0,1
147822,severity,0,0
147823,in,0,0
147824,both,0,0
147825,non-psychiatrically,0,1
147826,ill,0,1
147827,and,0,0
147828,in,0,0
147829,SZ,0,1
147830,smokers,0,1
147831,.,0,1
147832,Decreased,0,0
147833,insula-dACC,0,0
147834,rsFC,0,0
147835,may,0,0
147836,index,0,0
147837,overlapping,0,0
147838,circuitry,0,0
147839,associated,0,0
147840,with,0,1
147841,smoking,0,1
147842,and,0,0
147843,SZ,0,1
147844,.,0,1
147845,Multiple,0,1
147846,courses,0,0
147847,of,0,0
147848,rituximab,0,1
147849,produce,0,0
147850,sustained,0,0
147851,clinical,0,0
147852,and,0,0
147853,radiographic,0,1
147854,efficacy,0,0
147855,and,0,0
147856,safety,0,0
147857,in,0,0
147858,patients,1,1
147859,with,1,1
147860,rheumatoid,1,1
147861,arthritis,1,1
147862,and,1,0
147863,an,1,0
147864,inadequate,1,0
147865,response,1,0
147866,to,1,0
147867,1,1,0
147868,or,1,1
147869,more,1,0
147870,tumor,1,0
147871,necrosis,1,0
147872,factor,1,0
147873,inhibitors,1,0
147874,:,1,1
147875,5-year,0,1
147876,data,0,0
147877,from,0,1
147878,the,0,0
147879,REFLEX,0,0
147880,study,0,0
147881,.,0,0
147882,OBJECTIVE,0,0
147883,This,0,0
147884,5-year,0,0
147885,observational,0,1
147886,posthoc,0,0
147887,analysis,0,0
147888,of,0,0
147889,the,0,0
147890,REFLEX,0,0
147891,study,0,0
147892,and,0,0
147893,its,0,0
147894,open-label,0,0
147895,extension,0,0
147896,assessed,0,0
147897,clinical,0,0
147898,efficacy,0,0
147899,",",0,0
147900,radiographic,0,0
147901,response,0,0
147902,",",0,0
147903,and,0,0
147904,safety,0,0
147905,of,0,0
147906,rituximab,0,1
147907,(,0,0
147908,RTX,0,0
147909,),0,0
147910,in,0,0
147911,patients,1,1
147912,with,1,1
147913,rheumatoid,1,1
147914,arthritis,1,1
147915,(,1,0
147916,RA,1,1
147917,),1,1
147918,who,1,1
147919,had,1,1
147920,an,1,1
147921,inadequate,1,1
147922,response,1,0
147923,to,1,0
147924,tumor,1,0
147925,necrosis,1,0
147926,factor,1,0
147927,(,1,0
147928,TNF,1,1
147929,),1,1
147930,inhibitors,1,0
147931,.,1,1
147932,METHODS,0,0
147933,Patients,1,1
147934,in,1,1
147935,REFLEX,1,1
147936,were,0,0
147937,originally,0,1
147938,randomized,0,0
147939,to,0,0
147940,placebo,0,0
147941,(,0,0
147942,PBO,0,0
147943,),0,0
147944,+,0,0
147945,methotrexate,0,0
147946,(,0,0
147947,MTX,0,0
147948,;,0,1
147949,PBO-randomized,0,0
147950,),0,0
147951,or,0,1
147952,RTX,0,1
147953,+,0,0
147954,MTX,0,0
147955,(,0,0
147956,RTX-randomized,0,0
147957,),0,1
147958,.,0,1
147959,PBO-randomized,1,0
147960,patients,1,1
147961,were,0,1
147962,rescued,0,0
147963,with,0,1
147964,RTX,0,0
147965,as,0,0
147966,appropriate,0,0
147967,.,0,1
147968,Patients,0,1
147969,responding,0,0
147970,to,0,0
147971,initial,0,0
147972,RTX,0,0
147973,treatment,0,0
147974,could,0,0
147975,receive,0,0
147976,further,0,0
147977,RTX,0,1
147978,courses,0,0
147979,.,0,1
147980,For,0,0
147981,clinical,0,0
147982,efficacy,0,0
147983,and,0,0
147984,safety,0,0
147985,analyses,0,0
147986,",",0,0
147987,PBO-randomized,0,0
147988,patients,0,1
147989,were,0,1
147990,re-baselined,0,0
147991,prior,0,1
147992,to,0,0
147993,first,0,0
147994,RTX,0,0
147995,treatment,0,0
147996,and,0,0
147997,the,0,0
147998,data,0,0
147999,were,0,0
148000,pooled,0,0
148001,with,0,1
148002,RTX-randomized,0,0
148003,patient,0,1
148004,data,0,0
148005,.,0,1
148006,Efficacy,0,0
148007,outcomes,0,0
148008,24,0,0
148009,weeks,0,0
148010,after,0,0
148011,each,0,0
148012,course,0,0
148013,were,0,0
148014,calculated,0,0
148015,relative,0,0
148016,to,0,0
148017,first,0,0
148018,RTX,0,0
148019,pretreatment,0,0
148020,baseline,0,0
148021,.,0,1
148022,Radiographic,0,0
148023,outcomes,0,0
148024,were,0,1
148025,assessed,0,0
148026,relative,0,0
148027,to,0,0
148028,randomization,0,0
148029,baseline,0,0
148030,for,0,0
148031,both,0,0
148032,PBO-randomized,0,0
148033,and,0,0
148034,RTX-randomized,0,0
148035,groups,0,0
148036,.,0,0
148037,RESULTS,0,0
148038,A,0,0
148039,total,0,1
148040,of,0,0
148041,480,1,1
148042,patients,1,1
148043,received,1,1
148044,?,1,1
148045,1,1,0
148046,RTX,1,0
148047,course,1,0
148048,.,1,0
148049,At,0,0
148050,24,0,0
148051,weeks,0,0
148052,",",0,1
148053,American,0,1
148054,College,0,1
148055,of,0,0
148056,Rheumatology,0,1
148057,20/50/70,0,0
148058,responses,0,0
148059,were,0,1
148060,62.0,0,0
148061,%,0,0
148062,",",0,0
148063,30.8,0,0
148064,%,0,0
148065,",",0,0
148066,and,0,0
148067,13.0,0,0
148068,%,0,0
148069,",",0,0
148070,respectively,0,0
148071,at,0,0
148072,course,0,0
148073,1,0,0
148074,(,0,0
148075,n,0,1
148076,=,0,0
148077,400,0,0
148078,),0,0
148079,and,0,0
148080,70.3,0,0
148081,%,0,0
148082,",",0,0
148083,41.8,0,0
148084,%,0,0
148085,",",0,0
148086,and,0,0
148087,22.0,0,0
148088,%,0,0
148089,at,0,0
148090,course,0,0
148091,5,0,0
148092,(,0,0
148093,n,0,1
148094,=,0,0
148095,91,0,1
148096,),0,1
148097,.,0,1
148098,European,0,1
148099,League,0,1
148100,Against,0,0
148101,Rheumatism,0,1
148102,good/moderate,0,1
148103,responses,0,0
148104,were,0,1
148105,77.2,0,0
148106,%,0,0
148107,and,0,0
148108,84.4,0,0
148109,%,0,0
148110,at,0,1
148111,courses,0,0
148112,1,0,1
148113,(,0,1
148114,n,0,1
148115,=,0,0
148116,390,0,1
148117,),0,0
148118,and,0,0
148119,5,0,0
148120,(,0,0
148121,n,0,1
148122,=,0,0
148123,90,0,1
148124,),0,1
148125,.,0,1
148126,Rates,0,0
148127,of,0,0
148128,adverse,0,0
148129,events,0,0
148130,(,0,1
148131,AE,0,0
148132,),0,0
148133,",",0,0
148134,serious,0,0
148135,AE,0,0
148136,",",0,0
148137,and,0,0
148138,infections,0,0
148139,generally,0,0
148140,remained,0,0
148141,stable,0,1
148142,.,0,1
148143,Rate,0,0
148144,of,0,0
148145,progressive,0,1
148146,joint,0,1
148147,damage,0,0
148148,(,0,1
148149,PJD,0,0
148150,;,0,0
148151,change,0,0
148152,in,0,0
148153,mean,0,1
148154,Total,0,1
148155,Sharp,0,0
148156,Score,0,1
148157,),0,0
148158,decreased,0,0
148159,over,0,0
148160,time,0,0
148161,in,0,0
148162,both,0,0
148163,PBO-randomized,0,0
148164,(,0,0
148165,n,0,1
148166,=,0,0
148167,79,0,1
148168,),0,0
148169,and,0,0
148170,RTX-randomized,0,0
148171,(,0,0
148172,n,0,1
148173,=,0,0
148174,105,0,1
148175,),0,1
148176,groups,0,0
148177,.,0,1
148178,Mean,0,0
148179,change,0,0
148180,from,0,0
148181,baseline,0,0
148182,in,0,0
148183,PJD,0,0
148184,over,0,0
148185,5,0,1
148186,years,0,1
148187,was,0,0
148188,greater,0,0
148189,in,0,0
148190,PBO-randomized,0,0
148191,versus,0,0
148192,RTX-randomized,0,0
148193,patients,0,1
148194,(,0,1
148195,5.51,0,0
148196,vs,0,0
148197,3.21,0,0
148198,),0,0
148199,.,0,1
148200,CONCLUSION,0,0
148201,RTX,0,0
148202,re-treatment,0,0
148203,over,0,0
148204,5,0,0
148205,years,0,1
148206,is,0,0
148207,associated,0,0
148208,with,0,0
148209,maintained,0,0
148210,or,0,1
148211,improved,0,0
148212,efficacy,0,0
148213,",",0,0
148214,continued,0,0
148215,inhibition,0,0
148216,of,0,0
148217,PJD,0,0
148218,",",0,0
148219,and,0,0
148220,a,0,0
148221,safety,0,0
148222,profile,0,0
148223,consistent,0,0
148224,with,0,1
148225,that,0,0
148226,previously,0,0
148227,reported,0,0
148228,.,0,0
148229,A,0,0
148230,delay,0,0
148231,in,0,0
148232,initiating,0,0
148233,RTX,0,0
148234,treatment,0,0
148235,may,0,0
148236,result,0,0
148237,in,0,0
148238,increased,0,0
148239,PJD,0,0
148240,.,0,1
148241,Dalteparin,0,0
148242,low,0,1
148243,molecular,0,0
148244,weight,0,0
148245,heparin,0,0
148246,(,0,0
148247,LMWH,0,0
148248,),0,0
148249,in,0,0
148250,ovarian,1,1
148251,cancer,1,1
148252,:,1,1
148253,a,0,0
148254,phase,0,0
148255,II,0,0
148256,randomized,0,1
148257,study,0,0
148258,.,0,1
148259,OBJECTIVE,0,0
148260,Low,0,1
148261,molecular,0,0
148262,weight,0,0
148263,heparin,0,0
148264,reduces,0,0
148265,the,0,0
148266,risk,0,0
148267,of,0,0
148268,venous,0,0
148269,thromboembolism,0,1
148270,(,0,0
148271,VTE,0,0
148272,),0,0
148273,and,0,0
148274,may,0,0
148275,have,0,0
148276,antineoplastic,0,0
148277,effects,0,0
148278,by,0,0
148279,interfering,0,0
148280,with,0,1
148281,angiogenesis,0,0
148282,and,0,0
148283,with,0,1
148284,tumor,0,0
148285,growth,0,0
148286,and,0,0
148287,metastasis,0,1
148288,.,0,0
148289,A,0,0
148290,multicentre,0,0
148291,phase,0,1
148292,II,0,1
148293,randomized,0,1
148294,trial,0,0
148295,was,0,0
148296,done,0,0
148297,to,0,0
148298,evaluate,0,0
148299,the,0,0
148300,antineoplastic,0,0
148301,potential,0,0
148302,of,0,0
148303,dalteparin,0,0
148304,in,0,0
148305,ovarian,0,1
148306,cancer,0,1
148307,(,0,0
148308,OC,0,1
148309,),0,1
148310,.,0,0
148311,MATERIALS,0,0
148312,AND,0,0
148313,METHODS,0,0
148314,Women,1,1
148315,with,1,1
148316,newly-diagnosed,1,1
148317,epithelial,1,1
148318,OC,1,1
148319,were,0,0
148320,randomized,0,0
148321,to,0,0
148322,receive,0,0
148323,standard,0,0
148324,chemotherapy,0,0
148325,(,0,0
148326,CT,0,0
148327,),0,0
148328,and,0,0
148329,one,0,1
148330,of,0,0
148331,3,0,0
148332,doses,0,0
148333,of,0,0
148334,dalteparin,0,1
148335,(,0,1
148336,50,0,1
148337,IU/kg,0,0
148338,",",0,0
148339,100,0,0
148340,IU/kg,0,0
148341,",",0,0
148342,or,0,1
148343,150,0,0
148344,IU/kg,0,0
148345,),0,0
148346,subcutaneously,0,0
148347,once,0,0
148348,daily,0,0
148349,during,0,0
148350,the,0,0
148351,first,0,0
148352,3,0,0
148353,of,0,1
148354,6,0,0
148355,cycles,0,0
148356,of,0,1
148357,3-weekly,0,0
148358,CT,0,1
148359,.,0,1
148360,Blood,0,0
148361,was,0,0
148362,drawn,0,0
148363,on,0,0
148364,day,0,0
148365,1,0,0
148366,of,0,0
148367,each,0,0
148368,cycle,0,0
148369,for,0,0
148370,CA125,0,1
148371,and,0,0
148372,",",0,0
148373,in,0,0
148374,a,0,0
148375,substudy,0,0
148376,of,0,0
148377,randomized,0,1
148378,patients,0,1
148379,",",0,0
148380,for,0,0
148381,markers,0,0
148382,of,0,0
148383,coagulation,0,0
148384,activation,0,0
148385,and,0,0
148386,angiogenesis,0,0
148387,.,0,0
148388,The,0,0
148389,primary,0,0
148390,outcome,0,0
148391,was,0,0
148392,tumor,0,0
148393,response,0,0
148394,defined,0,0
148395,by,0,0
148396,?,0,0
148397,50,0,0
148398,%,0,0
148399,reduction,0,0
148400,in,0,0
148401,serum,0,0
148402,CA125,0,1
148403,from,0,0
148404,baseline,0,0
148405,sustained,0,0
148406,for,0,0
148407,at,0,0
148408,least,0,1
148409,28,0,1
148410,days,0,0
148411,.,0,1
148412,Patients,0,1
148413,were,0,0
148414,followed,0,0
148415,until,0,0
148416,the,0,0
148417,end,0,0
148418,of,0,0
148419,CT,0,1
148420,.,0,0
148421,RESULTS,0,0
148422,The,0,0
148423,study,0,0
148424,was,0,0
148425,terminated,0,0
148426,early,0,0
148427,due,0,0
148428,to,0,0
148429,poor,0,1
148430,recruitment,1,0
148431,.,1,1
148432,Seventy-seven,1,1
148433,women,1,1
148434,were,1,1
148435,evaluable,1,1
148436,for,1,0
148437,the,1,0
148438,primary,1,1
148439,outcome,1,0
148440,.,1,1
148441,A,0,0
148442,50,0,0
148443,%,0,0
148444,drop,0,0
148445,in,0,0
148446,CA125,0,1
148447,at,0,0
148448,the,0,0
148449,end,0,0
148450,of,0,0
148451,cycle,0,0
148452,3,0,0
148453,was,0,0
148454,seen,0,0
148455,in,0,0
148456,85,0,0
148457,%,0,0
148458,of,0,0
148459,the,0,0
148460,50,0,1
148461,IU/kg,0,0
148462,group,0,0
148463,",",0,0
148464,92,0,0
148465,%,0,0
148466,of,0,0
148467,the,0,0
148468,100,0,0
148469,IU/kg,0,0
148470,group,0,0
148471,",",0,0
148472,and,0,0
148473,85,0,0
148474,%,0,0
148475,of,0,0
148476,the,0,0
148477,150,0,0
148478,IU/kg,0,0
148479,group,0,1
148480,.,0,0
148481,There,0,0
148482,were,0,0
148483,no,0,0
148484,symptomatic,0,1
148485,VTE,0,0
148486,or,0,1
148487,major,0,0
148488,bleeding,0,1
148489,events,0,0
148490,while,0,0
148491,on,0,0
148492,dalteparin,0,1
148493,.,0,1
148494,Two,0,0
148495,patients,0,1
148496,experienced,0,1
148497,VTE,0,1
148498,several,0,0
148499,days,0,0
148500,after,0,0
148501,discontinuing,0,0
148502,study,0,1
148503,drug,0,0
148504,.,0,1
148505,Women,0,1
148506,on,0,0
148507,dalteparin,0,0
148508,had,0,1
148509,lower,0,0
148510,levels,0,0
148511,of,0,0
148512,D-dimer,0,0
148513,and,0,0
148514,thrombin-antithrombin,0,0
148515,",",0,0
148516,and,0,0
148517,higher,0,0
148518,levels,0,0
148519,of,0,0
148520,tissue,0,0
148521,factor,0,0
148522,pathway,0,0
148523,inhibitor,0,0
148524,",",0,0
148525,relative,0,0
148526,to,0,0
148527,baseline,0,0
148528,.,0,1
148529,CONCLUSION,0,0
148530,Dalteparin,0,0
148531,is,0,0
148532,safe,0,0
148533,and,0,0
148534,well,0,0
148535,tolerated,0,0
148536,in,0,0
148537,women,1,1
148538,receiving,1,1
148539,CT,1,1
148540,for,1,0
148541,newly-diagnosed,1,1
148542,epithelial,1,1
148543,OC,1,1
148544,.,1,1
148545,A,0,0
148546,dose-response,0,0
148547,effect,0,0
148548,was,0,0
148549,not,0,0
148550,identified,0,0
148551,.,0,0
148552,The,0,0
148553,lack,0,0
148554,of,0,0
148555,control,0,0
148556,group,0,0
148557,precluded,0,0
148558,any,0,0
148559,inference,0,0
148560,on,0,0
148561,the,0,0
148562,antineoplastic,0,0
148563,effect,0,0
148564,of,0,0
148565,dalteparin,0,0
148566,.,0,1
148567,Effects,0,0
148568,of,0,1
148569,psychosocial,0,1
148570,program,0,0
148571,for,0,0
148572,preparing,0,0
148573,long-term,1,0
148574,hospitalized,1,1
148575,patients,1,1
148576,with,1,1
148577,schizophrenia,1,1
148578,for,1,0
148579,discharge,1,0
148580,from,1,1
148581,hospital,1,1
148582,:,1,1
148583,randomized,0,0
148584,controlled,0,0
148585,trial,0,0
148586,.,0,0
148587,AIM,0,0
148588,The,0,0
148589,aims,0,0
148590,of,0,0
148591,the,0,0
148592,present,0,0
148593,study,0,0
148594,were,0,0
148595,to,0,0
148596,revise,0,1
148597,the,0,0
148598,Community,1,0
148599,Re-entry,1,0
148600,Program-Japanese,1,1
148601,version,0,0
148602,and,0,0
148603,to,0,0
148604,review,0,0
148605,the,0,0
148606,effectiveness,0,0
148607,of,0,0
148608,the,0,0
148609,revised,0,0
148610,Program,0,0
148611,",",0,0
148612,named,0,0
148613,the,0,0
148614,Discharge,0,0
148615,Preparation,0,1
148616,Program,0,0
148617,.,0,1
148618,METHODS,0,0
148619,This,0,0
148620,study,0,0
148621,was,0,0
148622,a,0,0
148623,randomized,0,0
148624,controlled,0,0
148625,trial,0,0
148626,.,0,0
148627,The,0,0
148628,Discharge,1,0
148629,Preparation,1,0
148630,Program,1,0
148631,(,1,0
148632,DPP,1,0
148633,),1,0
148634,was,0,0
148635,the,0,0
148636,intervention,1,0
148637,condition,1,0
148638,(,1,0
148639,n,1,1
148640,=,1,0
148641,26,1,1
148642,),1,0
148643,",",0,0
148644,and,0,0
148645,the,0,0
148646,usual,0,0
148647,rehabilitation,0,0
148648,program,0,0
148649,was,0,0
148650,the,0,0
148651,control,1,0
148652,condition,1,0
148653,(,1,0
148654,n,1,1
148655,=,1,0
148656,23,1,1
148657,),1,1
148658,.,1,1
148659,Outcome,0,0
148660,indicators,0,0
148661,included,0,1
148662,factors,0,0
148663,that,0,0
148664,make,0,0
148665,patient,0,0
148666,discharge,0,0
148667,difficult,0,0
148668,(,0,0
148669,which,0,0
148670,nurses,0,1
148671,evaluated,0,0
148672,),0,0
148673,",",0,0
148674,psychiatric,0,0
148675,symptom,0,0
148676,",",0,0
148677,knowledge,0,0
148678,about,0,0
148679,the,0,0
148680,illness,0,1
148681,or,0,0
148682,medication,0,0
148683,",",0,0
148684,and,0,0
148685,the,0,0
148686,number,1,0
148687,of,1,1
148688,patients,1,1
148689,who,1,1
148690,were,1,1
148691,discharged,1,1
148692,within,1,0
148693,6,1,0
148694,months,1,0
148695,after,1,0
148696,the,1,0
148697,end,1,0
148698,of,1,0
148699,a,1,0
148700,program,1,0
148701,.,1,0
148702,RESULTS,0,0
148703,Significant,0,0
148704,improvements,0,0
148705,were,0,1
148706,found,0,0
148707,in,0,0
148708,the,0,0
148709,score,0,0
148710,of,0,0
148711,the,0,0
148712,'Issues,0,1
148713,on,0,0
148714,treatment,0,0
148715,compliance,0,0
148716,',0,0
148717,factor,0,0
148718,and,0,0
148719,the,0,0
148720,score,0,0
148721,of,0,0
148722,the,0,0
148723,'Autistic,0,1
148724,life,0,0
148725,',0,0
148726,factor,0,0
148727,",",0,0
148728,which,0,0
148729,are,0,0
148730,subscales,0,0
148731,of,0,0
148732,the,0,0
148733,Discharge,0,0
148734,Difficulty,0,0
148735,Scale,0,0
148736,",",0,0
148737,for,0,0
148738,the,0,0
148739,DPP,0,0
148740,group,0,0
148741,",",0,0
148742,on,0,0
148743,two-way,0,0
148744,ANOVA,0,0
148745,(,0,1
148746,'Issues,0,1
148747,on,0,0
148748,treatment,0,0
148749,compliance,0,0
148750,',0,1
148751,:,0,1
148752,F,0,0
148753,=,0,0
148754,3.818,0,0
148755,",",0,0
148756,P,0,0
148757,<,0,0
148758,0.10,0,0
148759,;,0,0
148760,'Autistic,0,1
148761,life,0,0
148762,',0,1
148763,:,0,1
148764,F,0,1
148765,=,0,0
148766,4.155,0,0
148767,",",0,0
148768,P,0,0
148769,<,0,0
148770,0.05,0,0
148771,),0,0
148772,These,0,1
148773,factors,0,0
148774,affected,0,0
148775,discharge,0,0
148776,outcome,0,0
148777,.,0,0
148778,Thus,0,0
148779,",",0,0
148780,the,0,0
148781,program,0,0
148782,may,0,0
148783,be,0,0
148784,capable,0,0
148785,of,0,0
148786,promoting,0,0
148787,discharge,0,0
148788,of,0,0
148789,long-term,1,0
148790,hospitalized,1,1
148791,psychiatric,1,1
148792,patients,1,1
148793,.,1,1
148794,With,0,0
148795,regard,0,0
148796,to,0,0
148797,the,0,0
148798,number,0,0
148799,of,0,0
148800,patients,0,1
148801,discharged,0,1
148802,in,0,1
148803,6,0,0
148804,months,0,0
148805,after,0,0
148806,the,0,0
148807,end,0,0
148808,of,0,0
148809,a,0,0
148810,program,0,0
148811,",",0,0
148812,there,0,0
148813,was,0,0
148814,no,0,0
148815,significant,0,0
148816,difference,0,0
148817,between,0,0
148818,both,0,0
148819,groups,0,0
148820,.,0,1
148821,CONCLUSION,0,0
148822,The,0,0
148823,present,0,0
148824,result,0,0
148825,is,0,0
148826,in,0,0
148827,agreement,0,0
148828,with,0,1
148829,past,0,0
148830,studies,0,0
148831,",",0,0
148832,and,0,0
148833,the,0,0
148834,DPP,0,0
148835,is,0,0
148836,useful,0,0
148837,in,0,0
148838,discharge,0,0
148839,support,0,0
148840,for,0,0
148841,patients,1,1
148842,with,1,1
148843,schizophrenia,1,1
148844,in,1,0
148845,Japan,1,1
148846,.,1,1
148847,The,0,0
148848,effects,0,0
148849,of,0,0
148850,a,0,1
148851,six-week,0,0
148852,supervised,0,0
148853,multimodal,0,0
148854,exercise,0,0
148855,intervention,0,0
148856,during,0,0
148857,chemotherapy,0,0
148858,on,0,0
148859,cancer-related,1,0
148860,fatigue,1,0
148861,.,1,1
148862,PURPOSE,0,0
148863,Cancer,0,0
148864,related,0,0
148865,fatigue,0,0
148866,(,0,0
148867,CRF,0,0
148868,),0,0
148869,is,0,0
148870,a,0,0
148871,common,0,0
148872,problem,0,0
148873,for,0,0
148874,cancer,1,1
148875,patients,1,1
148876,across,1,0
148877,diagnoses,1,1
148878,during,1,0
148879,chemotherapy,1,0
148880,and,0,0
148881,is,0,0
148882,associated,0,0
148883,with,0,0
148884,physical,0,0
148885,inactivity,0,0
148886,",",0,0
148887,lower,0,0
148888,functional,0,0
148889,level,0,0
148890,and,0,0
148891,lack,0,0
148892,of,0,0
148893,energy,0,0
148894,.,0,1
148895,Few,0,0
148896,RCT,0,0
148897,exercise,0,0
148898,intervention,0,0
148899,studies,0,0
148900,have,0,0
148901,included,0,1
148902,cancer,1,1
148903,patients,1,1
148904,undergoing,1,1
148905,chemotherapy,1,1
148906,.,1,0
148907,The,0,0
148908,objective,0,0
148909,of,0,0
148910,this,0,0
148911,study,0,0
148912,is,0,0
148913,to,0,0
148914,evaluate,0,0
148915,whether,0,0
148916,a,0,0
148917,six-week,0,0
148918,supervised,0,0
148919,multimodal,0,0
148920,exercise,0,0
148921,intervention,0,0
148922,",",0,0
148923,adjunct,0,0
148924,to,0,0
148925,chemotherapy,0,0
148926,and,0,0
148927,standard,0,0
148928,care,0,0
148929,",",0,0
148930,can,0,0
148931,reduce,0,0
148932,the,0,0
148933,patient,0,0
148934,'s,0,1
148935,CRF,0,0
148936,level,0,0
148937,.,0,1
148938,METHODS,0,0
148939,Data,0,0
148940,is,0,0
148941,based,0,0
148942,on,0,0
148943,analyses,0,0
148944,of,0,0
148945,a,0,1
148946,prospective,0,0
148947,randomised,0,0
148948,controlled,0,0
148949,trial,0,0
148950,'The,0,1
148951,Body,0,1
148952,&,0,1
148953,Cancer,0,1
148954,Trial,0,1
148955,',0,1
148956,.,0,1
148957,213,1,1
148958,cancer,1,1
148959,patients,1,1
148960,with,1,1
148961,different,1,1
148962,diagnoses,1,1
148963,were,0,1
148964,randomised,0,0
148965,into,1,0
148966,an,0,0
148967,intervention,0,0
148968,group,0,0
148969,or,0,1
148970,wait-list,0,0
148971,control,0,1
148972,group,0,0
148973,.,0,0
148974,The,0,0
148975,primary,0,0
148976,outcome,0,0
148977,",",0,0
148978,Fatigue,0,0
148979,score,0,0
148980,(,0,0
148981,CRF,0,0
148982,),0,0
148983,",",0,0
148984,was,0,0
148985,evaluated,0,0
148986,by,0,0
148987,the,0,0
148988,Functional,0,0
148989,Assessment,0,0
148990,of,0,0
148991,Cancer,0,1
148992,Therapy-Anaemia,0,1
148993,Questionnaire,0,0
148994,(,0,0
148995,FACT-An-,0,0
148996,),0,0
148997,(,0,0
148998,FACT-G,0,0
148999,score,0,0
149000,&,0,1
149001,FACT-An,0,0
149002,Anemia,0,1
149003,subscale,0,0
149004,),0,0
149005,.,0,1
149006,INTERVENTION,0,0
149007,Supervised,0,0
149008,exercise,0,0
149009,",",0,0
149010,comprising,0,1
149011,high-intensity,0,0
149012,cardiovascular,0,1
149013,and,0,0
149014,heavy,0,0
149015,resistance,0,0
149016,training,0,0
149017,",",0,0
149018,relaxation-,0,0
149019,and,0,0
149020,body,0,1
149021,awareness,0,0
149022,training,0,0
149023,and,0,0
149024,massage,0,0
149025,",",0,0
149026,9,0,0
149027,h,0,0
149028,weekly,0,0
149029,for,0,1
149030,6,0,1
149031,weeks,0,0
149032,.,0,1
149033,RESULTS,0,0
149034,CRF,0,0
149035,was,0,0
149036,significantly,0,0
149037,reduced,0,0
149038,in,0,0
149039,the,0,0
149040,intervention,0,0
149041,group,0,0
149042,",",0,0
149043,corresponding,0,0
149044,to,0,0
149045,a,0,0
149046,Fatigue,0,0
149047,score,0,0
149048,reduction,0,0
149049,of,0,0
149050,3.04,0,0
149051,(,0,0
149052,effect,0,0
149053,size,0,0
149054,of,0,0
149055,0.44,0,0
149056,",",0,0
149057,95,0,0
149058,%,0,0
149059,CI,0,0
149060,0.17-0.72,0,0
149061,),0,0
149062,(,0,0
149063,P,0,0
149064,=,0,0
149065,.002,0,0
149066,),0,0
149067,",",0,0
149068,the,0,0
149069,FACT-An,0,0
149070,score,0,0
149071,by,0,0
149072,5.40,0,0
149073,(,0,1
149074,P,0,0
149075,=,0,0
149076,.015,0,0
149077,),0,0
149078,",",0,0
149079,the,0,0
149080,FACT-An,0,0
149081,Toi,0,0
149082,score,0,0
149083,by,0,0
149084,5.22,0,0
149085,(,0,1
149086,P,0,0
149087,=,0,0
149088,.009,0,0
149089,),0,0
149090,and,0,0
149091,the,0,0
149092,Anaemia-ANS,0,0
149093,by,0,0
149094,3.76,0,0
149095,(,0,1
149096,P,0,0
149097,=,0,0
149098,.002,0,0
149099,),0,0
149100,.,0,0
149101,There,0,0
149102,was,0,0
149103,no,0,0
149104,statistically,0,0
149105,significant,0,0
149106,effect,0,0
149107,on,0,0
149108,the,0,0
149109,General,0,0
149110,Quality,0,0
149111,of,0,0
149112,Life,0,0
149113,score,0,0
149114,(,0,0
149115,FACT-G,0,0
149116,),0,0
149117,or,0,0
149118,on,0,0
149119,any,0,0
149120,of,0,0
149121,the,0,0
149122,individual,0,0
149123,wellbeing,0,0
149124,scores,0,0
149125,;,0,1
149126,Physical,0,1
149127,(,0,0
149128,P,0,0
149129,=,0,0
149130,.13,0,0
149131,),0,0
149132,",",0,0
149133,Emotional,0,0
149134,(,0,0
149135,P,0,0
149136,=,0,0
149137,.87,0,0
149138,),0,0
149139,",",0,0
149140,Social,0,0
149141,(,0,0
149142,P,0,0
149143,=,0,0
149144,.83,0,0
149145,),0,0
149146,and,0,0
149147,Functional,0,0
149148,(,0,0
149149,P,0,0
149150,=,0,0
149151,.26,0,0
149152,),0,1
149153,.,0,0
149154,CONCLUSION,0,0
149155,In,0,0
149156,summary,0,0
149157,",",0,0
149158,this,0,0
149159,six-week,0,0
149160,supervised,0,0
149161,multimodal,0,0
149162,exercise,0,0
149163,intervention,0,0
149164,can,0,0
149165,lead,0,0
149166,to,0,0
149167,significant,0,0
149168,reduction,0,0
149169,in,0,0
149170,self-reported,0,0
149171,CRF,1,0
149172,in,1,0
149173,cancer,1,1
149174,patients,1,1
149175,undergoing,1,1
149176,chemotherapy,1,1
149177,.,1,1
149178,Role,0,0
149179,of,0,0
149180,posterior,0,0
149181,tibial,0,1
149182,nerve,0,0
149183,stimulation,0,0
149184,in,0,0
149185,the,0,0
149186,treatment,0,0
149187,of,0,0
149188,refractory,0,1
149189,monosymptomatic,0,1
149190,nocturnal,0,1
149191,enuresis,0,1
149192,:,0,1
149193,a,0,0
149194,pilot,0,0
149195,study,0,0
149196,.,0,0
149197,PURPOSE,0,0
149198,We,0,0
149199,evaluated,0,0
149200,the,0,0
149201,early,0,0
149202,clinical,0,0
149203,and,0,1
149204,urodynamic,0,1
149205,results,0,0
149206,of,0,1
149207,posterior,0,1
149208,tibial,0,1
149209,nerve,0,0
149210,stimulation,0,0
149211,in,0,0
149212,patients,1,1
149213,with,1,1
149214,refractory,1,1
149215,monosymptomatic,1,1
149216,nocturnal,1,1
149217,enuresis,1,1
149218,.,1,1
149219,MATERIALS,0,0
149220,AND,0,0
149221,METHODS,0,0
149222,We,0,0
149223,randomly,0,1
149224,assigned,0,0
149225,28,1,1
149226,patients,1,1
149227,with,1,1
149228,refractory,1,1
149229,monosymptomatic,1,1
149230,nocturnal,1,1
149231,enuresis,1,1
149232,to,1,0
149233,2,1,0
149234,equal,1,1
149235,groups,1,0
149236,.,1,1
149237,Group,0,1
149238,1,0,0
149239,received,0,0
149240,a,0,0
149241,weekly,0,0
149242,session,0,0
149243,of,0,0
149244,posterior,0,0
149245,tibial,0,1
149246,nerve,0,0
149247,stimulation,0,0
149248,for,0,0
149249,12,0,0
149250,weeks,0,0
149251,and,0,1
149252,group,0,1
149253,2,0,0
149254,was,0,0
149255,the,0,0
149256,placebo,0,0
149257,group,0,0
149258,.,0,0
149259,Evaluation,0,0
149260,was,0,0
149261,performed,0,0
149262,in,0,0
149263,each,0,0
149264,group,0,0
149265,at,0,0
149266,baseline,0,0
149267,and,0,0
149268,after,0,0
149269,posterior,0,0
149270,tibial,0,1
149271,nerve,0,0
149272,stimulation,0,0
149273,to,0,0
149274,compare,0,0
149275,clinical,0,0
149276,and,0,0
149277,urodynamic,0,1
149278,findings,0,0
149279,.,0,1
149280,Another,0,1
149281,clinical,0,0
149282,assessment,0,0
149283,was,0,0
149284,done,0,0
149285,3,0,0
149286,months,0,0
149287,after,0,0
149288,the,0,0
149289,first,0,0
149290,followup,0,0
149291,.,0,0
149292,RESULTS,0,0
149293,The,0,0
149294,2,0,0
149295,groups,0,0
149296,were,0,1
149297,comparable,0,0
149298,in,0,0
149299,baseline,0,0
149300,clinical,0,0
149301,and,0,1
149302,urodynamic,0,1
149303,data,0,0
149304,.,0,1
149305,Overall,0,0
149306,",",0,0
149307,13,1,1
149308,patients,1,1
149309,(,1,1
149310,46.4,1,1
149311,%,1,0
149312,),1,0
149313,had,1,0
149314,detrusor,1,1
149315,overactivity,1,1
149316,and,1,0
149317,14,1,0
149318,(,1,0
149319,50,1,1
149320,%,1,0
149321,),1,0
149322,had,1,0
149323,decreased,1,0
149324,bladder,1,1
149325,capacity,1,0
149326,.,1,0
149327,After,0,0
149328,treatment,0,0
149329,11,0,1
149330,group,0,1
149331,1,0,0
149332,patients,0,1
149333,(,0,1
149334,78.6,0,1
149335,%,0,0
149336,),0,0
149337,had,0,0
149338,a,0,0
149339,partial,0,0
149340,or,0,1
149341,full,0,0
149342,response,0,0
149343,to,0,0
149344,posterior,0,0
149345,tibial,0,0
149346,nerve,0,0
149347,stimulation,0,0
149348,but,0,0
149349,only,0,0
149350,2,0,0
149351,(,0,0
149352,14.3,0,0
149353,%,0,0
149354,),0,0
149355,in,0,0
149356,group,0,1
149357,2,0,0
149358,had,0,1
149359,a,0,0
149360,partial,0,0
149361,response,0,0
149362,(,0,0
149363,p,0,0
149364,=,0,0
149365,0.002,0,0
149366,),0,0
149367,.,0,0
149368,Also,0,0
149369,",",0,0
149370,the,0,0
149371,average,0,0
149372,number,0,0
149373,of,0,0
149374,wet,0,0
149375,nights,0,1
149376,in,0,1
149377,group,0,1
149378,1,0,0
149379,was,0,0
149380,significantly,0,0
149381,lower,0,0
149382,than,0,0
149383,at,0,0
149384,baseline,0,0
149385,(,0,0
149386,p,0,0
149387,=,0,0
149388,0.002,0,0
149389,),0,0
149390,.,0,0
149391,All,0,0
149392,urodynamic,0,0
149393,parameters,0,0
149394,significantly,0,0
149395,improved,0,0
149396,in,0,0
149397,group,0,1
149398,1,0,0
149399,.,0,0
149400,In,0,0
149401,contrast,0,0
149402,",",0,0
149403,the,0,0
149404,number,0,0
149405,of,0,0
149406,wet,0,0
149407,nights,0,1
149408,and,0,1
149409,urodynamic,0,1
149410,parameters,0,0
149411,did,0,0
149412,not,0,0
149413,change,0,0
149414,significantly,0,0
149415,in,0,0
149416,group,0,0
149417,2,0,0
149418,.,0,0
149419,At,0,0
149420,3-month,0,0
149421,followup,0,0
149422,the,0,0
149423,number,0,0
149424,of,0,0
149425,patients,0,1
149426,with,0,1
149427,a,0,0
149428,partial,0,0
149429,or,0,1
149430,full,0,0
149431,response,0,0
149432,in,0,0
149433,group,0,1
149434,1,0,0
149435,had,0,0
149436,decreased,0,0
149437,from,0,1
149438,11,0,0
149439,(,0,1
149440,78.6,0,1
149441,%,0,0
149442,),0,0
149443,to,0,0
149444,6,0,0
149445,(,0,0
149446,42.9,0,0
149447,%,0,0
149448,),0,0
149449,.,0,0
149450,No,0,0
149451,change,0,0
149452,was,0,0
149453,evident,0,0
149454,in,0,0
149455,group,0,1
149456,2,0,0
149457,.,0,1
149458,CONCLUSIONS,0,0
149459,Posterior,0,0
149460,tibial,0,0
149461,nerve,0,0
149462,stimulation,0,0
149463,can,0,0
149464,be,0,0
149465,a,0,0
149466,viable,0,0
149467,treatment,0,0
149468,option,0,0
149469,in,0,0
149470,some,0,0
149471,patients,1,1
149472,with,1,1
149473,refractory,1,1
149474,monosymptomatic,1,1
149475,nocturnal,1,1
149476,enuresis,1,1
149477,.,1,0
149478,However,0,0
149479,",",0,0
149480,deterioration,0,0
149481,in,0,0
149482,some,0,0
149483,responders,0,0
149484,with,0,1
149485,time,0,0
149486,suggests,0,0
149487,the,0,0
149488,need,0,0
149489,for,0,0
149490,maintenance,0,0
149491,protocols,0,0
149492,.,0,1
149493,Effects,0,0
149494,of,0,0
149495,strontium,0,0
149496,on,0,0
149497,the,0,0
149498,quality,0,0
149499,of,0,0
149500,bone,0,0
149501,apatite,0,1
149502,crystals,0,0
149503,:,0,1
149504,a,0,0
149505,paired,0,0
149506,biopsy,0,0
149507,study,0,0
149508,in,0,0
149509,postmenopausal,1,1
149510,osteoporotic,1,1
149511,women,1,1
149512,.,1,1
149513,UNLABELLED,0,0
149514,In,0,0
149515,paired,1,0
149516,biopsies,1,1
149517,of,1,1
149518,osteoporotic,1,1
149519,women,1,1
149520,treated,1,1
149521,with,1,1
149522,either,1,0
149523,strontium,1,0
149524,ranelate,1,0
149525,or,1,0
149526,a,1,0
149527,placebo,1,0
149528,for,1,0
149529,36,1,1
149530,months,1,0
149531,",",0,1
149532,characteristics,0,0
149533,of,0,0
149534,bone,0,1
149535,apatite,0,1
149536,crystals,0,0
149537,were,0,1
149538,not,0,0
149539,influenced,0,0
149540,by,0,0
149541,the,0,0
149542,presence,0,0
149543,of,0,0
149544,strontium,0,0
149545,.,0,0
149546,The,0,0
149547,mean,0,0
149548,rate,0,0
149549,of,0,0
149550,substitutions,0,0
149551,of,0,0
149552,calcium,0,0
149553,by,0,0
149554,strontium,0,0
149555,ions,0,0
149556,was,0,0
149557,4.5,0,0
149558,%,0,0
149559,.,0,1
149560,INTRODUCTION,0,0
149561,The,0,0
149562,potential,0,0
149563,effect,0,0
149564,of,0,0
149565,strontium,0,0
149566,(,0,0
149567,Sr,0,1
149568,),0,0
149569,on,0,0
149570,bone,0,0
149571,apatite,0,1
149572,crystals,0,0
149573,was,0,0
149574,investigated,0,0
149575,in,0,0
149576,paired,1,0
149577,biopsies,1,1
149578,of,1,1
149579,osteoporotic,1,1
149580,women,1,1
149581,treated,1,1
149582,with,1,1
149583,either,1,0
149584,strontium,1,0
149585,ranelate,1,0
149586,(,1,0
149587,SrRan,1,1
149588,),1,0
149589,or,1,0
149590,a,1,0
149591,placebo,1,0
149592,for,1,0
149593,36,1,1
149594,months,1,0
149595,.,1,1
149596,METHODS,0,0
149597,In,0,0
149598,ten,1,1
149599,paired,1,0
149600,biopsies,1,0
149601,",",0,0
149602,crystallinity,0,0
149603,",",0,0
149604,apparent,0,0
149605,length,0,0
149606,and,0,0
149607,width/thickness,0,0
149608,of,0,0
149609,crystals,0,0
149610,",",0,0
149611,interplanar,0,0
149612,distances,0,0
149613,",",0,0
149614,and,0,0
149615,lattice,0,0
149616,parameters,0,0
149617,of,0,0
149618,unit,0,1
149619,cells,0,0
149620,were,0,0
149621,assessed,0,0
149622,by,0,0
149623,X-ray,0,0
149624,diffraction,0,0
149625,and,0,0
149626,selected,0,1
149627,area,0,0
149628,electron,0,0
149629,diffraction,0,0
149630,.,0,0
149631,RESULTS,0,0
149632,All,0,0
149633,these,0,0
149634,parameters,0,0
149635,",",0,0
149636,reflecting,0,0
149637,crystal,0,0
149638,and,0,0
149639,unit,0,0
149640,cell,0,1
149641,characteristics,0,0
149642,",",0,0
149643,were,0,0
149644,not,0,0
149645,influenced,0,0
149646,by,0,0
149647,the,0,0
149648,presence,0,0
149649,of,0,0
149650,Sr,0,1
149651,and,0,0
149652,were,0,0
149653,similar,0,0
149654,in,0,0
149655,SrRan,0,1
149656,and,0,0
149657,placebo,0,0
149658,groups,0,0
149659,after,0,1
149660,36,0,1
149661,months,0,0
149662,of,0,1
149663,treatment,0,0
149664,.,0,0
149665,The,0,0
149666,mean,0,0
149667,rate,0,0
149668,of,0,0
149669,substitutions,0,0
149670,of,0,0
149671,calcium,0,0
149672,by,0,0
149673,Sr,0,1
149674,ions,0,0
149675,was,0,0
149676,4.5,0,0
149677,%,0,0
149678,.,0,1
149679,CONCLUSION,0,0
149680,Overall,0,0
149681,",",0,0
149682,the,0,0
149683,quality,0,0
149684,of,0,0
149685,bone,0,0
149686,apatite,0,1
149687,crystals,0,0
149688,was,0,0
149689,maintained,0,0
149690,after,0,0
149691,36,0,1
149692,months,0,0
149693,of,0,0
149694,treatment,0,0
149695,with,0,1
149696,SrRan,0,1
149697,.,0,1
149698,Assessing,0,0
149699,the,0,0
149700,effect,0,0
149701,of,0,0
149702,CT,0,0
149703,slice,0,0
149704,interval,0,0
149705,on,0,0
149706,unidimensional,0,0
149707,",",0,0
149708,bidimensional,0,0
149709,and,0,0
149710,volumetric,0,0
149711,measurements,0,0
149712,of,0,1
149713,solid,0,1
149714,tumours,0,1
149715,.,0,1
149716,OBJECTIVES,0,0
149717,To,0,0
149718,study,0,0
149719,the,0,0
149720,magnitude,0,0
149721,of,0,0
149722,differences,0,0
149723,in,0,1
149724,tumour,0,1
149725,unidimensional,0,0
149726,(,0,1
149727,1D,0,0
149728,),0,0
149729,",",0,0
149730,bidimensional,0,0
149731,(,0,0
149732,2D,0,1
149733,),0,0
149734,and,0,0
149735,volumetric,0,0
149736,(,0,0
149737,VOL,0,0
149738,),0,1
149739,measurements,0,0
149740,determined,0,0
149741,from,0,1
149742,computed,0,0
149743,tomography,0,0
149744,(,0,0
149745,CT,0,0
149746,),0,0
149747,images,0,0
149748,reconstructed,0,0
149749,at,0,0
149750,5,0,0
149751,",",0,0
149752,2.5,0,0
149753,and,0,0
149754,1.25,0,0
149755,mm,0,0
149756,slice,0,0
149757,intervals,0,0
149758,.,0,1
149759,MATERIALS,0,0
149760,AND,0,0
149761,METHODS,0,0
149762,A,0,0
149763,total,0,1
149764,of,0,0
149765,118,1,1
149766,lesions,1,1
149767,in,1,0
149768,lung,1,1
149769,",",1,0
149770,liver,1,1
149771,and,1,0
149772,lymph,1,1
149773,nodes,1,0
149774,were,1,0
149775,selected,1,1
149776,from,1,1
149777,30,1,1
149778,patients,1,1
149779,enrolled,1,1
149780,in,1,0
149781,early,1,0
149782,phase,1,1
149783,clinical,1,0
149784,trials,1,0
149785,.,1,1
149786,Each,0,0
149787,CT,0,0
149788,scan,0,0
149789,was,0,0
149790,reconstructed,0,0
149791,at,0,0
149792,5,0,0
149793,",",0,0
149794,2.5,0,0
149795,and,0,0
149796,1.25,0,0
149797,mm,0,0
149798,slice,0,0
149799,intervals,0,0
149800,during,0,0
149801,the,0,0
149802,image,0,0
149803,acquisition,0,0
149804,.,0,1
149805,Lesions,0,0
149806,were,0,0
149807,semi-automatically,0,0
149808,segmented,0,0
149809,on,0,0
149810,each,0,0
149811,interval,0,0
149812,image,0,0
149813,series,0,0
149814,and,0,0
149815,supervised,0,0
149816,by,0,0
149817,a,0,0
149818,radiologist,0,0
149819,.,0,0
149820,1D,0,0
149821,",",0,0
149822,2D,0,1
149823,and,0,0
149824,VOL,0,0
149825,were,0,0
149826,computed,0,0
149827,based,0,0
149828,on,0,0
149829,the,0,0
149830,final,0,0
149831,segmentation,0,1
149832,results,0,0
149833,.,0,1
149834,Average,0,0
149835,measurement,0,0
149836,differences,0,0
149837,across,0,0
149838,different,0,0
149839,slice,0,0
149840,intervals,0,0
149841,were,0,0
149842,obtained,0,0
149843,using,0,0
149844,linear,0,0
149845,mixed-effects,0,0
149846,analysis,0,0
149847,of,0,0
149848,variance,0,0
149849,models,0,0
149850,.,0,1
149851,RESULTS,0,0
149852,Lesion,0,0
149853,diameters,0,0
149854,ranged,0,0
149855,from,0,1
149856,6.1,0,0
149857,to,0,0
149858,80.1,0,0
149859,mm,0,0
149860,(,0,1
149861,median,0,0
149862,18.4,0,0
149863,mm,0,1
149864,),0,0
149865,.,0,0
149866,The,0,0
149867,largest,0,0
149868,difference,0,0
149869,was,0,0
149870,seen,0,0
149871,between,0,0
149872,1.25,0,0
149873,and,0,0
149874,5,0,0
149875,mm,0,0
149876,(,0,0
149877,mean,0,0
149878,difference,0,0
149879,of,0,0
149880,7.6,0,0
149881,%,0,0
149882,for,0,0
149883,1D,0,0
149884,[,0,0
149885,P,0,0
149886,<,0,0
149887,0.0001,0,0
149888,],0,1
149889,",",0,0
149890,13.1,0,0
149891,%,0,0
149892,for,0,0
149893,2D,0,1
149894,[,0,0
149895,P,0,0
149896,<,0,0
149897,0.0001,0,0
149898,],0,0
149899,",",0,0
149900,-5.7,0,0
149901,%,0,0
149902,for,0,0
149903,VOL,0,0
149904,[,0,0
149905,P,0,0
149906,=,0,0
149907,0.0001,0,0
149908,],0,1
149909,),0,0
149910,.,0,1
149911,Mean,0,0
149912,differences,0,0
149913,between,0,0
149914,1.25,0,0
149915,and,0,1
149916,2.5,0,0
149917,mm,0,0
149918,were,0,0
149919,all,0,0
149920,within,0,0
149921,?3.5,0,0
149922,%,0,0
149923,(,0,0
149924,within,0,0
149925,?6,0,0
149926,%,0,0
149927,confidence,0,0
149928,interval,0,0
149929,),0,0
149930,.,0,0
149931,For,0,0
149932,VOL,0,0
149933,",",0,0
149934,there,0,0
149935,was,0,0
149936,a,0,0
149937,larger,0,0
149938,average,0,0
149939,difference,0,0
149940,between,0,0
149941,measurements,0,0
149942,on,0,0
149943,different,0,0
149944,slice,0,0
149945,intervals,0,0
149946,for,0,0
149947,the,0,0
149948,smaller,0,0
149949,lesions,0,0
149950,(,0,0
149951,<,0,0
149952,10,0,0
149953,mm,0,0
149954,),0,0
149955,compared,0,0
149956,with,0,1
149957,the,0,0
149958,larger,0,0
149959,lesions,0,0
149960,.,0,1
149961,CONCLUSIONS,0,0
149962,Different,0,0
149963,slice,0,0
149964,intervals,0,0
149965,may,0,0
149966,give,0,0
149967,different,0,0
149968,1D,0,0
149969,",",0,0
149970,2D,0,1
149971,and,0,0
149972,VOL,0,0
149973,measurements,0,0
149974,.,0,1
149975,In,0,0
149976,clinical,0,0
149977,practice,0,0
149978,",",0,0
149979,it,0,0
149980,would,0,0
149981,be,0,0
149982,prudent,0,0
149983,to,0,0
149984,use,0,0
149985,the,0,0
149986,same,0,0
149987,slice,0,0
149988,interval,0,0
149989,for,0,0
149990,consecutive,0,1
149991,measurements,0,0
149992,.,0,1
149993,Linguistic,0,1
149994,alignment,0,0
149995,in,0,0
149996,adults,1,1
149997,with,1,1
149998,and,1,0
149999,without,1,1
150000,Asperger,1,1
150001,'s,1,1
150002,syndrome,1,1
150003,.,1,1
150004,Individuals,1,0
150005,with,1,1
150006,Asperger,1,1
150007,'s,1,1
150008,syndrome,1,1
150009,(,1,1
150010,AS,1,0
150011,),1,0
150012,often,0,0
150013,have,0,0
150014,difficulties,0,0
150015,with,0,1
150016,social,0,1
150017,interactions,0,0
150018,and,0,1
150019,conversations,0,0
150020,.,0,1
150021,We,0,0
150022,investigated,0,0
150023,if,0,0
150024,these,0,0
150025,difficulties,0,0
150026,could,0,0
150027,be,0,0
150028,attributable,0,0
150029,to,0,0
150030,a,0,0
150031,deficit,0,0
150032,in,0,0
150033,the,0,0
150034,ability,0,0
150035,to,0,0
150036,linguistically,0,0
150037,converge,0,0
150038,with,0,0
150039,an,0,0
150040,interlocutor,0,0
150041,",",0,0
150042,which,0,0
150043,is,0,0
150044,posited,0,0
150045,to,0,0
150046,be,0,0
150047,important,0,0
150048,for,0,0
150049,successful,0,0
150050,communication,0,0
150051,.,0,0
150052,To,0,0
150053,that,0,0
150054,end,0,0
150055,",",0,0
150056,participants,0,1
150057,completed,0,1
150058,two,0,0
150059,cooperative,0,1
150060,tasks,0,0
150061,with,0,1
150062,a,0,0
150063,confederate,0,1
150064,",",0,0
150065,which,0,0
150066,allowed,0,0
150067,us,0,1
150068,to,0,0
150069,measure,0,0
150070,linguistic,0,0
150071,alignment,0,0
150072,with,0,1
150073,the,0,0
150074,confederate,0,1
150075,in,0,0
150076,terms,0,0
150077,of,0,0
150078,lexical,0,0
150079,choice,0,0
150080,",",0,0
150081,syntactic,0,0
150082,structure,0,0
150083,and,0,0
150084,spatial,0,0
150085,frame,0,0
150086,of,0,0
150087,reference,0,0
150088,.,0,0
150089,There,0,0
150090,was,0,0
150091,no,0,0
150092,difference,0,0
150093,in,0,0
150094,the,0,0
150095,performance,0,0
150096,of,0,0
150097,individuals,1,1
150098,with,1,1
150099,AS,1,1
150100,and,0,0
150101,matched,0,1
150102,controls,0,1
150103,and,0,0
150104,both,0,0
150105,groups,0,0
150106,showed,0,0
150107,significant,0,0
150108,alignment,0,0
150109,with,0,1
150110,the,0,0
150111,confederate,0,1
150112,at,0,0
150113,all,0,0
150114,three,0,0
150115,levels,0,0
150116,.,0,1
150117,We,0,0
150118,conclude,0,0
150119,that,0,0
150120,linguistic,0,0
150121,alignment,0,0
150122,is,0,0
150123,intact,0,0
150124,in,0,0
150125,adults,1,1
150126,with,1,1
150127,AS,1,1
150128,engaged,1,1
150129,in,1,0
150130,structured,1,0
150131,",",1,0
150132,goal-directed,1,0
150133,social,1,1
150134,interactions,1,0
150135,.,1,1
150136,Effects,0,0
150137,of,0,0
150138,a,0,0
150139,standardized,0,0
150140,pamphlet,0,0
150141,on,0,0
150142,insomnia,1,1
150143,in,1,0
150144,children,1,1
150145,with,1,1
150146,autism,1,1
150147,spectrum,1,1
150148,disorders,1,1
150149,.,1,1
150150,OBJECTIVE,0,0
150151,Sleep,0,0
150152,difficulties,0,0
150153,are,0,0
150154,common,0,0
150155,reasons,0,0
150156,why,1,0
150157,parents,1,1
150158,seek,1,0
150159,medical,1,0
150160,intervention,1,0
150161,in,1,0
150162,children,1,1
150163,with,1,1
150164,autism,1,1
150165,spectrum,1,1
150166,disorders,1,1
150167,(,1,1
150168,ASDs,1,1
150169,),1,0
150170,.,1,0
150171,We,0,0
150172,determined,0,0
150173,whether,0,0
150174,a,0,0
150175,pamphlet,0,0
150176,alone,0,0
150177,could,0,0
150178,be,0,0
150179,used,0,0
150180,by,0,0
150181,parents,0,1
150182,to,0,0
150183,help,0,0
150184,their,0,0
150185,child,0,0
150186,'s,0,1
150187,insomnia,0,1
150188,.,0,1
150189,METHODS,0,0
150190,Thirty-six,1,1
150191,children,1,1
150192,with,1,1
150193,ASD,1,1
150194,",",1,0
150195,ages,1,1
150196,2,1,0
150197,to,1,0
150198,10,1,1
150199,years,1,1
150200,",",1,0
150201,were,1,0
150202,enrolled,1,1
150203,.,1,0
150204,All,1,0
150205,had,1,0
150206,prolonged,1,0
150207,sleep,1,0
150208,latency,1,0
150209,confirmed,1,0
150210,by,1,0
150211,actigraphy,1,0
150212,showing,1,0
150213,a,1,0
150214,mean,1,0
150215,sleep,1,0
150216,latency,1,0
150217,of,1,0
150218,30,1,1
150219,minutes,1,0
150220,or,1,1
150221,more,1,0
150222,.,1,1
150223,Parents,1,0
150224,were,1,0
150225,randomly,1,1
150226,assigned,1,0
150227,to,1,0
150228,receive,1,0
150229,the,1,0
150230,sleep,1,0
150231,education,1,0
150232,pamphlet,1,0
150233,or,1,0
150234,no,1,0
150235,intervention,1,0
150236,.,1,0
150237,Children,0,1
150238,wore,0,0
150239,an,0,0
150240,actigraphy,0,0
150241,device,0,0
150242,to,0,0
150243,record,0,0
150244,baseline,0,0
150245,sleep,0,0
150246,parameters,0,0
150247,",",0,0
150248,with,0,1
150249,the,0,0
150250,primary,0,0
150251,outcome,0,0
150252,variable,0,0
150253,being,0,0
150254,change,0,0
150255,in,0,0
150256,sleep,0,1
150257,latency,0,0
150258,.,0,1
150259,Actigraphy,0,0
150260,data,0,0
150261,were,0,0
150262,collected,0,0
150263,a,0,0
150264,second,0,0
150265,time,0,0
150266,2,0,0
150267,weeks,0,0
150268,after,0,0
150269,the,0,0
150270,parent,0,0
150271,received,0,0
150272,the,0,0
150273,randomization,0,0
150274,assignment,0,0
150275,and,0,0
150276,analyzed,0,0
150277,by,0,0
150278,using,0,0
150279,Student,0,0
150280,'s,0,1
150281,t,0,0
150282,test,0,0
150283,.,0,1
150284,Parents,0,0
150285,were,0,0
150286,also,0,0
150287,asked,0,0
150288,a,0,0
150289,series,0,0
150290,of,0,0
150291,questions,0,0
150292,to,0,0
150293,gather,0,1
150294,information,0,0
150295,about,0,0
150296,the,0,0
150297,pamphlet,0,0
150298,and,0,0
150299,its,0,0
150300,usefulness,0,0
150301,.,0,0
150302,RESULTS,0,0
150303,Although,0,0
150304,participants,0,1
150305,randomized,0,1
150306,to,0,0
150307,the,0,0
150308,2,0,0
150309,arms,0,0
150310,did,0,0
150311,not,0,0
150312,differ,0,0
150313,statistically,0,0
150314,in,0,0
150315,age,0,1
150316,",",0,0
150317,gender,0,0
150318,",",0,0
150319,socioeconomic,0,0
150320,status,0,0
150321,",",0,0
150322,total,0,1
150323,Children,0,1
150324,'s,0,1
150325,Sleep,0,0
150326,Habits,0,1
150327,Questionnaire,0,0
150328,score,0,0
150329,",",0,0
150330,or,0,0
150331,actigraphy,0,0
150332,parameters,0,0
150333,",",0,0
150334,some,0,0
150335,differences,0,0
150336,may,0,0
150337,be,0,0
150338,large,0,0
150339,enough,0,0
150340,to,0,0
150341,affect,0,0
150342,results,0,0
150343,.,0,1
150344,Mean,0,0
150345,change,0,0
150346,in,0,0
150347,sleep-onset,0,0
150348,latency,0,0
150349,did,0,0
150350,not,0,0
150351,differ,0,0
150352,between,0,0
150353,the,0,0
150354,randomized,0,0
150355,groups,0,0
150356,(,0,0
150357,pamphlet,0,0
150358,versus,0,0
150359,no,0,0
150360,pamphlet,0,0
150361,),0,0
150362,.,0,1
150363,Parents,0,0
150364,commented,0,0
150365,that,0,0
150366,the,0,0
150367,pamphlet,0,0
150368,contained,0,0
150369,good,0,0
150370,information,0,0
150371,",",0,0
150372,but,0,0
150373,indicated,0,0
150374,that,0,0
150375,it,0,0
150376,would,0,0
150377,have,0,0
150378,been,0,0
150379,more,0,0
150380,useful,0,0
150381,to,0,0
150382,be,0,0
150383,given,0,0
150384,specific,0,0
150385,examples,0,0
150386,of,0,0
150387,how,0,0
150388,to,0,0
150389,take,0,0
150390,the,0,0
150391,information,0,0
150392,and,0,0
150393,put,0,0
150394,it,0,0
150395,into,0,0
150396,practice,0,0
150397,.,0,0
150398,CONCLUSIONS,0,0
150399,A,0,0
150400,sleep,0,0
150401,education,0,0
150402,pamphlet,0,0
150403,did,0,0
150404,not,0,0
150405,appear,0,0
150406,to,0,0
150407,improve,0,0
150408,sleep,1,0
150409,latency,1,0
150410,in,1,0
150411,children,1,1
150412,with,1,1
150413,ASDs,1,1
150414,.,1,1
150415,Clinical,0,0
150416,trial,0,1
150417,:,0,1
150418,marine,0,1
150419,lipid,0,0
150420,suppositories,0,0
150421,as,0,1
150422,laxatives,0,0
150423,.,0,1
150424,UNLABELLED,0,0
150425,Cod-liver,0,0
150426,oil,0,0
150427,and,0,0
150428,other,0,0
150429,marine,0,1
150430,products,0,0
150431,containing,0,0
150432,polyunsaturated,0,0
150433,fatty,0,0
150434,acids,0,0
150435,have,0,0
150436,anti-inflammatory,0,0
150437,",",0,0
150438,anti-bacterial,0,0
150439,and,0,0
150440,anti-viral,0,0
150441,effects,0,0
150442,and,0,0
150443,may,0,0
150444,be,0,0
150445,useful,0,0
150446,in,0,0
150447,the,0,0
150448,treatment,0,0
150449,of,0,0
150450,various,0,0
150451,inflammatory,0,0
150452,and,0,0
150453,infectious,0,1
150454,diseases,0,1
150455,.,0,1
150456,We,0,0
150457,developed,0,0
150458,suppositories,0,0
150459,and,0,0
150460,ointment,0,0
150461,with,0,1
150462,30,0,1
150463,%,0,0
150464,free,0,1
150465,fatty,0,0
150466,acid,0,0
150467,(,0,0
150468,FFA,0,0
150469,),0,0
150470,extract,0,0
150471,from,0,1
150472,omega-3,0,0
150473,fish,0,1
150474,oil,0,0
150475,.,0,0
150476,Our,0,0
150477,purpose,0,0
150478,was,0,0
150479,to,0,0
150480,evaluate,0,0
150481,the,0,0
150482,safety,0,0
150483,of,0,0
150484,marine,0,1
150485,lipid,0,0
150486,suppositories,0,0
150487,and,0,0
150488,ointment,0,0
150489,in,0,0
150490,healthy,1,1
150491,volunteers,1,1
150492,and,0,0
150493,to,0,0
150494,explore,0,0
150495,the,0,0
150496,laxative,0,0
150497,effect,0,0
150498,of,0,0
150499,the,0,0
150500,suppositories,0,0
150501,.,0,1
150502,Thirty,1,1
150503,healthy,1,1
150504,volunteers,1,1
150505,were,0,0
150506,randomized,0,0
150507,either,0,0
150508,to,0,0
150509,a,0,0
150510,study,0,0
150511,group,0,0
150512,administrating,0,0
150513,30,0,1
150514,%,0,0
150515,FFA,0,0
150516,suppositories,0,0
150517,and,0,1
150518,applying,0,0
150519,30,0,1
150520,%,0,0
150521,FFA,0,0
150522,ointment,0,0
150523,to,0,0
150524,the,0,0
150525,perianal,0,0
150526,region,0,1
150527,twice,0,0
150528,per,0,0
150529,day,0,0
150530,for,0,0
150531,two,0,0
150532,weeks,0,0
150533,",",0,0
150534,or,0,1
150535,to,0,0
150536,a,0,0
150537,control,0,0
150538,group,0,0
150539,using,0,0
150540,placebo,0,0
150541,suppositories,0,0
150542,and,0,0
150543,ointment,0,0
150544,in,0,0
150545,a,0,0
150546,double,0,0
150547,blinded,0,0
150548,manner,0,0
150549,.,0,1
150550,RESULTS,0,0
150551,No,0,0
150552,serious,0,0
150553,toxic,0,0
150554,effects,0,0
150555,or,0,1
150556,irritation,0,1
150557,were,0,0
150558,observed,0,0
150559,.,0,0
150560,In,0,0
150561,the,0,0
150562,study,0,0
150563,group,0,0
150564,93,0,1
150565,%,0,0
150566,felt,0,0
150567,the,0,0
150568,urge,0,0
150569,to,0,0
150570,defecate,0,0
150571,after,0,0
150572,administration,0,0
150573,of,0,0
150574,the,0,0
150575,suppositories,0,0
150576,as,0,0
150577,compared,0,0
150578,to,0,0
150579,37,0,1
150580,%,0,0
150581,in,0,0
150582,the,0,0
150583,control,0,0
150584,group,0,0
150585,(,0,0
150586,P,0,0
150587,=,0,0
150588,0.001,0,0
150589,),0,0
150590,.,0,0
150591,Subsequently,0,0
150592,90,0,0
150593,%,0,0
150594,in,0,0
150595,the,0,0
150596,study,0,0
150597,group,0,0
150598,defecated,0,0
150599,",",0,0
150600,compared,0,0
150601,to,0,0
150602,33,0,1
150603,%,0,0
150604,in,0,0
150605,the,0,0
150606,control,0,0
150607,group,0,0
150608,(,0,0
150609,P,0,0
150610,=,0,0
150611,0.001,0,0
150612,),0,0
150613,.,0,0
150614,CONCLUSION,0,0
150615,The,0,0
150616,marine,0,0
150617,lipid,0,0
150618,suppositories,0,0
150619,and,0,1
150620,ointment,0,0
150621,were,0,0
150622,well,0,0
150623,tolerated,0,0
150624,with,0,0
150625,no,0,0
150626,significant,0,0
150627,toxic,0,0
150628,side,0,0
150629,effects,0,0
150630,observed,0,0
150631,during,0,0
150632,the,0,0
150633,study,0,0
150634,period,0,0
150635,.,0,0
150636,The,0,0
150637,suppositories,0,0
150638,have,0,0
150639,a,0,0
150640,distinct,0,0
150641,laxative,0,0
150642,effect,0,0
150643,and,0,0
150644,we,0,0
150645,aim,0,0
150646,to,0,0
150647,explore,0,0
150648,this,0,0
150649,effect,0,0
150650,in,0,0
150651,further,0,0
150652,clinical,0,1
150653,trials,0,1
150654,.,0,1
150655,Prognostic,0,1
150656,interaction,0,0
150657,between,0,0
150658,expression,0,0
150659,of,0,0
150660,p53,0,0
150661,and,0,0
150662,estrogen,0,0
150663,receptor,0,0
150664,in,0,0
150665,patients,1,1
150666,with,1,1
150667,node-negative,1,1
150668,breast,1,1
150669,cancer,1,1
150670,:,1,1
150671,results,0,0
150672,from,0,1
150673,IBCSG,0,1
150674,Trials,0,1
150675,VIII,0,1
150676,and,0,0
150677,IX,0,0
150678,.,0,1
150679,INTRODUCTION,0,0
150680,The,0,0
150681,prognostic,0,0
150682,significance,0,0
150683,of,0,0
150684,p53,0,0
150685,protein,0,0
150686,expression,0,0
150687,in,0,0
150688,early,0,0
150689,breast,0,1
150690,cancer,0,1
150691,remains,0,0
150692,uncertain,0,0
150693,",",0,0
150694,with,0,1
150695,some,0,0
150696,but,0,0
150697,not,0,0
150698,all,0,0
150699,studies,0,0
150700,finding,0,0
150701,an,0,0
150702,association,0,0
150703,with,0,1
150704,poorer,0,0
150705,outcomes,0,0
150706,.,0,1
150707,Estrogen,0,0
150708,receptor,0,0
150709,(,0,0
150710,ER,0,1
150711,),0,0
150712,expression,0,0
150713,is,0,0
150714,both,0,0
150715,a,0,0
150716,positive,0,0
150717,prognostic,0,0
150718,marker,0,0
150719,and,0,0
150720,predictive,0,0
150721,of,0,0
150722,response,0,0
150723,to,0,0
150724,endocrine,0,1
150725,therapies,0,0
150726,.,0,0
150727,The,0,0
150728,relationship,0,0
150729,between,0,0
150730,these,0,0
150731,biomarkers,0,0
150732,is,0,0
150733,unknown,0,0
150734,.,0,0
150735,METHODS,0,0
150736,We,0,0
150737,constructed,0,0
150738,tissue,0,0
150739,microarrays,0,1
150740,(,0,1
150741,TMAs,0,1
150742,),0,0
150743,from,0,1
150744,available,0,0
150745,pathological,0,0
150746,material,0,1
150747,from,0,1
150748,1113,1,1
150749,patients,1,1
150750,participating,1,1
150751,in,0,0
150752,two,0,0
150753,randomized,0,1
150754,clinical,0,0
150755,trials,0,0
150756,comparing,0,0
150757,endocrine,0,1
150758,therapy,0,0
150759,alone,0,0
150760,versus,0,0
150761,chemo-endocrine,0,0
150762,therapy,0,0
150763,in,0,0
150764,node-negative,1,1
150765,breast,1,1
150766,cancer,1,1
150767,.,1,0
150768,Expression,0,0
150769,of,0,0
150770,p53,0,0
150771,defined,0,0
150772,as,0,0
150773,>,0,1
150774,10,0,1
150775,%,0,0
150776,positive,0,0
150777,nuclei,0,0
150778,was,0,0
150779,analyzed,0,0
150780,together,0,0
150781,with,0,1
150782,prior,0,1
150783,immunohistochemical,0,0
150784,assays,0,0
150785,of,0,1
150786,ER,0,1
150787,performed,0,0
150788,at,0,0
150789,central,0,1
150790,pathological,0,0
150791,review,0,0
150792,of,0,0
150793,whole,0,0
150794,tumor,0,1
150795,sections,0,1
150796,.,0,1
150797,RESULTS,0,0
150798,ER,0,0
150799,was,0,0
150800,present,0,0
150801,(,0,1
150802,i.e,0,0
150803,.,0,1
150804,>,0,0
150805,1,0,0
150806,%,0,0
150807,positive,0,0
150808,tumor,0,0
150809,cell,0,1
150810,nuclei,0,0
150811,),0,0
150812,in,0,0
150813,80.1,0,0
150814,%,0,0
150815,(,0,1
150816,880/1092,0,1
150817,),0,0
150818,.,0,0
150819,p53,0,0
150820,expression,0,0
150821,was,0,0
150822,significantly,0,0
150823,more,0,0
150824,frequent,0,0
150825,when,0,0
150826,ER,0,1
150827,was,0,0
150828,absent,0,0
150829,",",0,0
150830,125/212,0,0
150831,(,0,0
150832,59,0,1
150833,%,0,0
150834,),0,0
150835,than,0,0
150836,when,0,0
150837,ER,0,1
150838,was,0,0
150839,present,0,0
150840,",",0,0
150841,171/880,0,1
150842,(,0,0
150843,19,0,1
150844,%,0,0
150845,),0,0
150846,",",0,0
150847,p,0,0
150848,<,0,0
150849,0.0001,0,0
150850,.,0,0
150851,A,0,0
150852,significant,0,0
150853,qualitative,0,0
150854,interaction,0,0
150855,was,0,0
150856,observed,0,0
150857,such,0,0
150858,that,0,0
150859,p53,0,0
150860,expression,0,0
150861,was,0,0
150862,associated,0,0
150863,with,0,1
150864,better,0,0
150865,disease-free,0,0
150866,survival,0,0
150867,(,0,0
150868,DFS,0,1
150869,),0,0
150870,and,0,0
150871,overall,0,0
150872,survival,0,0
150873,(,0,0
150874,OS,0,0
150875,),0,0
150876,among,0,0
150877,patients,0,1
150878,whose,0,1
150879,tumors,0,1
150880,did,0,0
150881,not,0,0
150882,express,0,0
150883,ER,0,0
150884,",",0,0
150885,but,0,0
150886,worse,0,0
150887,DFS,0,1
150888,and,0,0
150889,OS,0,0
150890,among,0,1
150891,patients,0,1
150892,whose,0,1
150893,tumors,0,1
150894,expressed,0,0
150895,ER,0,1
150896,.,0,0
150897,The,0,0
150898,interaction,0,0
150899,remained,0,0
150900,significant,0,0
150901,after,0,0
150902,allowance,0,0
150903,for,0,0
150904,pathologic,0,1
150905,variables,0,0
150906,",",0,0
150907,and,0,0
150908,treatment,0,0
150909,.,0,1
150910,Similar,0,0
150911,effects,0,0
150912,were,0,1
150913,seen,0,0
150914,when,0,0
150915,luminal,0,1
150916,and,0,0
150917,non-luminal,0,1
150918,intrinsic,0,1
150919,subtypes,0,1
150920,were,0,1
150921,compared,0,0
150922,.,0,1
150923,CONCLUSIONS,0,0
150924,Interpretation,0,0
150925,of,0,0
150926,the,0,0
150927,prognostic,0,0
150928,significance,0,0
150929,of,0,0
150930,p53,0,0
150931,expression,0,0
150932,requires,0,0
150933,knowledge,0,0
150934,of,0,0
150935,concurrent,0,0
150936,expression,0,0
150937,of,0,0
150938,ER,0,1
150939,.,0,0
150940,The,0,0
150941,reason,0,0
150942,for,0,0
150943,the,0,0
150944,interaction,0,0
150945,between,0,0
150946,p53,0,0
150947,and,0,0
150948,ER,0,0
150949,is,0,0
150950,unknown,0,0
150951,but,0,0
150952,may,0,0
150953,reflect,0,0
150954,qualitatively,0,0
150955,different,0,0
150956,p53,0,0
150957,mutations,0,1
150958,underlying,0,0
150959,the,0,0
150960,p53,0,0
150961,expression,0,0
150962,in,0,0
150963,tumors,0,1
150964,with,0,1
150965,or,0,1
150966,without,0,1
150967,ER,0,1
150968,expression,0,0
150969,.,0,1
150970,TRIAL,0,0
150971,REGISTRATION,0,0
150972,Current,0,1
150973,Controlled,0,1
150974,Trials,0,0
150975,ACTRN12607000037404,0,1
150976,(,0,0
150977,Trial,0,1
150978,VIII,0,1
150979,),0,0
150980,and,0,0
150981,ACTRN12607000029493,0,1
150982,(,0,0
150983,Trial,0,1
150984,IX,0,1
150985,),0,1
150986,.,0,1
150987,Emotional,0,0
150988,reactivity,0,1
150989,to,0,0
150990,social,0,0
150991,rejection,0,1
150992,and,0,0
150993,negative,0,0
150994,evaluation,0,0
150995,among,0,0
150996,persons,1,1
150997,with,1,1
150998,borderline,1,1
150999,personality,1,1
151000,features,1,1
151001,.,1,1
151002,The,0,0
151003,present,0,0
151004,study,0,0
151005,examined,0,0
151006,the,0,0
151007,emotional,0,0
151008,reactivity,0,0
151009,of,0,0
151010,persons,1,1
151011,with,1,1
151012,heightened,1,0
151013,borderline,1,1
151014,personality,1,1
151015,(,1,0
151016,BP,1,0
151017,),1,0
151018,features,1,0
151019,to,0,0
151020,social,0,0
151021,rejection,0,1
151022,and,0,0
151023,negative,0,0
151024,evaluation,0,0
151025,in,0,0
151026,the,0,0
151027,laboratory,0,0
151028,.,0,0
151029,Individuals,1,0
151030,with,1,1
151031,high,1,1
151032,levels,1,0
151033,of,1,1
151034,BP,1,1
151035,features,1,1
151036,(,1,1
151037,n,1,1
151038,=,1,0
151039,30,1,1
151040,),1,0
151041,and,1,0
151042,controls,1,1
151043,with,1,1
151044,low,1,1
151045,levels,1,0
151046,of,1,1
151047,BP,1,1
151048,features,1,1
151049,(,1,1
151050,n,1,1
151051,=,1,0
151052,44,1,1
151053,),1,0
151054,were,0,0
151055,randomly,0,1
151056,assigned,0,0
151057,to,0,0
151058,a,0,0
151059,condition,0,0
151060,involving,0,0
151061,negative,0,0
151062,evaluation,0,0
151063,based,0,0
151064,on,0,0
151065,writing,0,0
151066,(,0,0
151067,negative,0,0
151068,evaluation/academic,0,1
151069,),0,0
151070,",",0,0
151071,or,0,0
151072,a,0,0
151073,condition,0,0
151074,involving,0,0
151075,negative,0,0
151076,evaluation,0,0
151077,based,0,0
151078,on,0,0
151079,personal,0,1
151080,characteristics,0,0
151081,as,0,0
151082,well,0,0
151083,as,0,0
151084,social,0,0
151085,rejection,0,1
151086,(,0,0
151087,negative,0,0
151088,evaluation/social,0,0
151089,rejection,0,1
151090,),0,0
151091,.,0,0
151092,Hypothesis,0,0
151093,1,0,0
151094,was,0,0
151095,that,0,0
151096,high-BP,1,1
151097,individuals,1,1
151098,",",0,0
151099,but,0,0
151100,not,0,0
151101,low-BP,1,0
151102,controls,1,0
151103,",",0,0
151104,would,0,0
151105,show,0,0
151106,greater,0,0
151107,emotional,0,0
151108,reactivity,0,0
151109,to,0,0
151110,the,0,0
151111,negative,0,0
151112,evaluation/social,0,0
151113,rejection,0,1
151114,stressor,0,0
151115,",",0,0
151116,compared,0,0
151117,with,0,1
151118,the,0,0
151119,negative,0,0
151120,evaluation/academic,0,1
151121,(,0,0
151122,writing,0,0
151123,),0,0
151124,stressor,0,0
151125,.,0,1
151126,Hypothesis,0,0
151127,2,0,0
151128,was,0,0
151129,that,0,0
151130,high-BP,1,0
151131,individuals,1,1
151132,would,0,0
151133,specifically,0,0
151134,show,0,0
151135,greater,0,0
151136,reactivity,0,0
151137,of,0,0
151138,shame-,0,0
151139,and,0,1
151140,anger-related,0,0
151141,emotions,0,0
151142,to,0,0
151143,the,0,0
151144,negative,0,0
151145,evaluation/social,0,0
151146,rejection,0,1
151147,stressor,0,0
151148,compared,0,0
151149,with,0,1
151150,the,0,0
151151,negative,0,0
151152,evaluation/academic,0,1
151153,stressor,0,0
151154,.,0,1
151155,Findings,0,0
151156,indicated,0,0
151157,that,0,0
151158,high-BP,1,1
151159,individuals,1,1
151160,showed,0,0
151161,heightened,0,0
151162,emotional,0,0
151163,reactivity,0,0
151164,to,0,0
151165,the,0,0
151166,social,0,0
151167,rejection,0,0
151168,stressor,0,0
151169,but,0,0
151170,not,0,0
151171,to,0,0
151172,the,0,0
151173,negative,0,0
151174,evaluation,0,0
151175,stressor,0,0
151176,",",0,0
151177,but,0,0
151178,the,0,0
151179,opposite,0,0
151180,pattern,0,1
151181,occurred,0,0
151182,for,0,0
151183,controls,0,1
151184,.,0,1
151185,In,0,0
151186,addition,0,0
151187,",",0,0
151188,there,0,0
151189,was,0,0
151190,evidence,0,0
151191,for,0,0
151192,heightened,0,0
151193,reactivity,0,0
151194,of,0,0
151195,irritability,0,0
151196,",",0,0
151197,distress,0,0
151198,",",0,0
151199,and,0,0
151200,shame,0,0
151201,for,0,0
151202,the,0,0
151203,high-BP,0,0
151204,group,0,0
151205,",",0,0
151206,specifically,0,0
151207,in,0,0
151208,the,0,0
151209,social,0,0
151210,rejection,0,1
151211,condition,0,0
151212,.,0,1
151213,Does,0,0
151214,single,0,0
151215,use,0,0
151216,of,0,0
151217,an,0,0
151218,autologous,0,0
151219,transfusion,0,0
151220,system,0,0
151221,in,0,0
151222,TKA,1,0
151223,reduce,0,0
151224,the,0,0
151225,need,0,0
151226,for,0,0
151227,allogenic,0,1
151228,blood,0,0
151229,?,0,0
151230,:,0,0
151231,a,0,0
151232,prospective,0,0
151233,randomized,0,0
151234,trial,0,0
151235,.,0,1
151236,BACKGROUND,0,0
151237,Mechanical,0,0
151238,autotransfusion,0,0
151239,systems,0,0
151240,for,0,0
151241,washed,0,0
151242,shed,0,0
151243,blood,0,0
151244,(,0,0
151245,WSB,0,1
151246,),0,0
151247,were,0,0
151248,introduced,0,0
151249,to,0,0
151250,reduce,0,0
151251,the,0,0
151252,need,0,0
151253,for,0,0
151254,postoperative,0,0
151255,allogenic,0,1
151256,blood,0,0
151257,transfusions,0,0
151258,(,0,1
151259,ABTs,0,0
151260,),0,0
151261,.,0,0
151262,Although,0,0
151263,some,0,0
151264,authors,0,0
151265,have,0,0
151266,postulated,0,0
151267,decreased,0,0
151268,requirements,0,0
151269,for,0,0
151270,ABT,0,0
151271,by,0,0
151272,using,0,0
151273,autologous,0,1
151274,retransfusion,0,1
151275,devices,0,0
151276,",",0,0
151277,other,0,0
151278,trials,0,0
151279,",",0,0
151280,mostly,0,0
151281,evaluating,0,0
151282,retransfusion,0,0
151283,devices,0,0
151284,for,0,0
151285,unwashed,0,0
151286,shed,0,0
151287,blood,0,0
151288,(,0,0
151289,USB,0,0
151290,),0,0
151291,",",0,0
151292,verified,0,0
151293,a,0,0
151294,small,0,0
151295,or,0,0
151296,no,0,0
151297,benefit,0,0
151298,in,0,0
151299,reducing,0,0
151300,the,0,0
151301,need,0,0
151302,for,0,0
151303,postoperative,0,0
151304,ABT,0,0
151305,.,0,0
151306,Because,0,0
151307,of,0,0
151308,these,0,0
151309,contradictory,0,0
151310,findings,0,0
151311,it,0,0
151312,is,0,0
151313,still,0,0
151314,unclear,0,0
151315,whether,0,0
151316,autologous,0,1
151317,retransfusion,0,1
151318,systems,0,0
151319,for,0,0
151320,WSB,0,0
151321,can,0,0
151322,reduce,0,0
151323,transfusion,0,0
151324,requirements,0,0
151325,.,0,1
151326,QUESTIONS/PURPOSES,0,0
151327,We,0,0
151328,therefore,0,0
151329,asked,0,0
151330,whether,0,0
151331,one,0,1
151332,such,0,0
151333,autologous,0,1
151334,transfusion,0,0
151335,system,0,0
151336,for,0,0
151337,WSB,0,0
151338,can,0,0
151339,reduce,0,0
151340,the,0,0
151341,requirements,0,0
151342,for,0,0
151343,postoperative,0,1
151344,ABT,0,0
151345,.,0,1
151346,METHODS,0,0
151347,In,0,0
151348,a,0,0
151349,prospective,0,0
151350,",",0,0
151351,randomized,0,0
151352,",",0,0
151353,controlled,0,0
151354,study,0,0
151355,",",0,0
151356,we,1,0
151357,enrolled,1,1
151358,151,1,1
151359,patients,1,1
151360,undergoing,1,1
151361,TKA,1,1
151362,.,1,1
151363,In,0,0
151364,Group,1,1
151365,A,1,1
151366,(,1,1
151367,n=76,1,1
151368,patients,1,1
151369,),1,0
151370,",",0,0
151371,the,0,0
151372,autotransfusion,0,0
151373,system,0,0
151374,was,0,0
151375,used,0,0
151376,for,0,0
151377,a,0,0
151378,total,0,1
151379,of,0,0
151380,6,0,0
151381,hours,0,0
151382,(,0,0
151383,intraoperatively,0,0
151384,and,0,0
151385,postoperatively,0,0
151386,),0,0
151387,and,0,0
151388,the,0,0
151389,WSB,0,0
151390,was,0,0
151391,retransfused,0,0
151392,after,0,0
151393,processing,0,0
151394,.,0,1
151395,In,0,0
151396,Control,1,1
151397,Group,1,1
151398,B,1,1
151399,(,1,1
151400,n=75,1,1
151401,patients,1,1
151402,),1,0
151403,",",0,0
151404,a,0,0
151405,regular,0,0
151406,drain,0,0
151407,without,0,1
151408,suction,0,0
151409,was,0,0
151410,used,0,0
151411,.,0,0
151412,We,0,0
151413,used,0,0
151414,signs,0,0
151415,of,0,0
151416,anemia,0,1
151417,and/or,0,0
151418,a,0,0
151419,hemoglobin,0,0
151420,value,0,0
151421,less,0,0
151422,than,0,0
151423,8,0,0
151424,g/dL,0,0
151425,as,0,0
151426,indications,0,0
151427,for,0,0
151428,transfusion,0,0
151429,.,0,1
151430,If,0,0
151431,necessary,0,0
151432,",",0,0
151433,we,0,0
151434,administered,0,0
151435,one,0,1
151436,or,0,1
151437,two,0,0
151438,units,0,0
151439,of,0,0
151440,allogenic,0,1
151441,blood,0,0
151442,.,0,1
151443,RESULTS,0,0
151444,Twenty-three,0,1
151445,patients,0,1
151446,(,0,1
151447,33,0,1
151448,%,0,0
151449,),0,0
151450,in,0,0
151451,Group,0,1
151452,A,0,1
151453,",",0,1
151454,who,0,1
151455,received,0,1
151456,an,0,1
151457,average,0,0
151458,of,0,0
151459,283,0,1
151460,mL,0,0
151461,(,0,0
151462,range,0,0
151463,",",0,0
151464,160-406,0,0
151465,mL,0,0
151466,),0,0
151467,of,0,0
151468,salvaged,0,0
151469,blood,0,0
151470,",",0,0
151471,needed,0,0
151472,a,0,0
151473,mean,0,0
151474,of,0,0
151475,2.1,0,0
151476,units,0,0
151477,of,0,0
151478,allogenic,0,1
151479,blood,0,0
151480,",",0,0
151481,compared,0,0
151482,with,0,1
151483,23,0,1
151484,patients,0,1
151485,(,0,1
151486,33,0,1
151487,%,0,0
151488,),0,0
151489,in,0,0
151490,Control,0,1
151491,Group,0,1
151492,B,0,1
151493,who,0,1
151494,needed,0,1
151495,a,0,1
151496,mean,0,0
151497,of,0,0
151498,2.1,0,0
151499,units,0,0
151500,of,0,0
151501,allogenic,0,1
151502,blood,0,0
151503,.,0,1
151504,CONCLUSIONS,0,0
151505,We,0,0
151506,found,0,0
151507,the,0,0
151508,use,0,0
151509,of,0,0
151510,an,0,0
151511,autotransfusion,0,0
151512,system,0,0
151513,did,0,0
151514,not,0,0
151515,reduce,0,0
151516,the,0,0
151517,rate,0,0
151518,of,0,0
151519,postoperative,0,0
151520,ABTs,0,0
151521,.,0,1
151522,LEVEL,0,0
151523,OF,0,0
151524,EVIDENCE,0,1
151525,Level,0,0
151526,II,0,1
151527,",",0,0
151528,therapeutic,0,0
151529,study,0,0
151530,.,0,0
151531,See,0,0
151532,the,0,0
151533,Guidelines,0,0
151534,for,0,0
151535,Authors,0,0
151536,for,0,0
151537,a,0,0
151538,complete,0,0
151539,description,0,0
151540,of,0,0
151541,levels,0,0
151542,of,0,0
151543,evidence,0,0
151544,.,0,1
151545,A,0,0
151546,randomised,0,0
151547,controlled,0,0
151548,trial,0,0
151549,of,0,0
151550,bumetanide,0,0
151551,in,0,0
151552,the,0,0
151553,treatment,0,0
151554,of,0,0
151555,autism,1,1
151556,in,1,0
151557,children,1,1
151558,.,1,1
151559,Gamma,0,0
151560,aminobutyric,0,0
151561,acid,0,0
151562,(,0,0
151563,GABA,0,0
151564,),0,0
151565,-mediated,0,0
151566,synapses,0,0
151567,and,0,0
151568,the,0,0
151569,oscillations,0,0
151570,they,0,0
151571,orchestrate,0,0
151572,are,0,0
151573,altered,0,0
151574,in,0,0
151575,autism,0,1
151576,.,0,1
151577,GABA-acting,0,0
151578,benzodiazepines,0,0
151579,exert,0,0
151580,in,0,0
151581,some,0,0
151582,patients,0,1
151583,with,0,1
151584,autism,0,1
151585,paradoxical,0,0
151586,effects,0,0
151587,",",0,0
151588,raising,0,0
151589,the,0,0
151590,possibility,0,0
151591,that,0,0
151592,like,0,0
151593,in,0,0
151594,epilepsies,0,1
151595,",",0,0
151596,GABA,0,0
151597,excites,0,0
151598,neurons,0,0
151599,because,0,0
151600,of,0,0
151601,elevated,0,1
151602,intracellular,0,0
151603,concentrations,0,0
151604,of,0,0
151605,chloride,0,0
151606,.,0,0
151607,Following,0,0
151608,a,0,0
151609,successful,0,0
151610,pilot,0,0
151611,study,0,0
151612,",",0,0
151613,(,0,0
151614,1,0,0
151615,),0,0
151616,we,0,0
151617,have,0,0
151618,now,0,0
151619,performed,0,0
151620,a,0,0
151621,double-blind,0,0
151622,clinical,0,0
151623,trial,0,0
151624,using,0,0
151625,the,0,0
151626,diuretic,0,0
151627,",",0,0
151628,chloride-importer,0,0
151629,antagonist,0,0
151630,bumetanide,0,0
151631,that,0,0
151632,reduces,0,0
151633,intracellular,0,0
151634,chloride,0,0
151635,reinforcing,0,0
151636,GABAergic,0,1
151637,inhibition,0,0
151638,.,0,1
151639,Sixty,1,1
151640,children,1,1
151641,with,1,1
151642,autism,1,1
151643,or,1,1
151644,Asperger,1,1
151645,syndrome,1,1
151646,(,1,0
151647,3-11,1,1
151648,years,1,1
151649,old,1,1
151650,),1,0
151651,received,0,0
151652,for,0,0
151653,3,0,0
151654,months,0,0
151655,placebo,0,0
151656,or,0,1
151657,bumetanide,0,0
151658,(,0,0
151659,1,0,0
151660,mg,0,0
151661,daily,0,0
151662,),0,0
151663,",",0,0
151664,followed,0,0
151665,by,0,0
151666,1-month,0,0
151667,wash,0,0
151668,out,0,0
151669,.,0,0
151670,Determination,0,0
151671,of,0,0
151672,the,0,0
151673,severity,0,0
151674,of,0,0
151675,autism,0,1
151676,was,0,0
151677,made,0,0
151678,with,0,1
151679,video,0,0
151680,films,0,0
151681,at,0,1
151682,day,0,0
151683,0,0,0
151684,(,0,0
151685,D0,0,0
151686,),0,0
151687,and,0,0
151688,D90,0,0
151689,by,0,0
151690,blind,0,0
151691,",",0,0
151692,independent,0,0
151693,evaluators,0,0
151694,.,0,1
151695,Bumetanide,0,0
151696,reduced,0,0
151697,significantly,0,0
151698,the,0,0
151699,Childhood,0,1
151700,Autism,0,1
151701,Rating,0,0
151702,Scale,0,0
151703,(,0,0
151704,CARS,0,0
151705,),0,0
151706,(,0,1
151707,D90-D0,0,0
151708,;,0,1
151709,P,0,0
151710,<,0,0
151711,0.004,0,0
151712,treated,0,1
151713,vs,0,0
151714,placebo,0,0
151715,),0,0
151716,",",0,0
151717,Clinical,0,0
151718,Global,0,1
151719,Impressions,0,0
151720,(,0,0
151721,P,0,0
151722,<,0,0
151723,0.017,0,0
151724,treated,0,0
151725,vs,0,0
151726,placebo,0,0
151727,),0,0
151728,and,0,0
151729,Autism,0,1
151730,Diagnostic,0,1
151731,Observation,0,0
151732,Schedule,0,0
151733,values,0,0
151734,when,0,0
151735,the,0,0
151736,most,0,0
151737,severe,0,1
151738,cases,0,1
151739,(,0,1
151740,CARS,0,1
151741,values,0,0
151742,above,0,1
151743,the,0,0
151744,mean,0,0
151745,?,0,0
151746,s.d,0,0
151747,.,0,0
151748,;,0,0
151749,n=9,0,1
151750,),0,0
151751,were,0,0
151752,removed,0,0
151753,(,0,0
151754,Wilcoxon,0,0
151755,test,0,0
151756,:,0,1
151757,P-value=0.031,0,0
151758,;,0,0
151759,Student,0,0
151760,'s,0,1
151761,t-test,0,0
151762,:,0,1
151763,P-value=0.017,0,0
151764,),0,0
151765,.,0,1
151766,Side,0,0
151767,effects,0,0
151768,were,0,1
151769,restricted,0,1
151770,to,0,0
151771,an,0,0
151772,occasional,0,0
151773,mild,0,1
151774,hypokalaemia,0,0
151775,(,0,0
151776,3.0-3.5,0,1
151777,mM,0,0
151778,l,0,0
151779,(,0,0
151780,-1,0,0
151781,),0,0
151782,K,0,0
151783,(,0,0
151784,+,0,0
151785,),0,0
151786,),0,0
151787,that,0,0
151788,was,0,0
151789,treated,0,1
151790,with,0,1
151791,supplemental,0,1
151792,potassium,0,0
151793,.,0,0
151794,In,0,0
151795,a,0,0
151796,companion,0,0
151797,study,0,0
151798,",",0,0
151799,chronic,0,1
151800,bumetanide,0,0
151801,treatment,0,0
151802,significantly,0,0
151803,improved,0,0
151804,accuracy,0,0
151805,in,0,0
151806,facial,0,1
151807,emotional,0,0
151808,labelling,0,0
151809,",",0,0
151810,and,0,0
151811,increased,0,0
151812,brain,0,0
151813,activation,0,0
151814,in,0,0
151815,areas,0,0
151816,involved,0,0
151817,in,0,0
151818,social,0,0
151819,and,0,0
151820,emotional,0,0
151821,perception,0,0
151822,(,0,0
151823,Hadjikhani,0,1
151824,et,0,0
151825,al.,0,0
151826,",",0,0
151827,submitted,0,0
151828,),0,0
151829,.,0,0
151830,Therefore,0,0
151831,",",0,0
151832,bumetanide,0,0
151833,is,0,0
151834,a,0,0
151835,promising,0,0
151836,novel,0,0
151837,therapeutic,0,0
151838,agent,0,0
151839,to,0,0
151840,treat,0,0
151841,autism,0,1
151842,.,0,0
151843,Larger,0,0
151844,trials,0,0
151845,are,0,0
151846,warranted,0,0
151847,to,0,0
151848,better,0,0
151849,determine,0,0
151850,the,0,0
151851,population,0,0
151852,best,0,0
151853,suited,0,0
151854,for,0,0
151855,this,0,0
151856,treatment,0,0
151857,.,0,0
151858,Simvastatin,0,0
151859,reduces,0,0
151860,sympathetic,0,0
151861,outflow,0,0
151862,and,0,0
151863,augments,0,0
151864,endothelium-independent,0,0
151865,dilation,0,1
151866,in,0,0
151867,non-hyperlipidaemic,1,1
151868,primary,1,1
151869,hypertension,1,1
151870,.,1,1
151871,OBJECTIVES,0,0
151872,Previous,0,1
151873,reports,0,0
151874,",",0,0
151875,involving,0,1
151876,hypercholesterolaemic,1,1
151877,hypertensive,1,1
151878,subjects,1,1
151879,",",0,0
151880,that,0,0
151881,statins,0,0
151882,reduce,0,0
151883,muscle,0,0
151884,sympathetic,0,0
151885,nerve,0,0
151886,activity,0,0
151887,(,0,0
151888,MSNA,0,1
151889,),0,0
151890,did,0,0
151891,not,0,0
151892,investigate,0,0
151893,potential,0,0
151894,neural,0,0
151895,sites,0,0
151896,of,0,0
151897,such,0,0
151898,sympathoinhibition,0,0
151899,or,0,0
151900,determine,0,0
151901,its,0,0
151902,consequences,0,0
151903,for,0,0
151904,endothelial,0,0
151905,function,0,0
151906,or,0,1
151907,insulin,0,0
151908,resistance,0,0
151909,.,0,0
151910,This,0,0
151911,study,0,0
151912,of,0,0
151913,hypertensive,1,1
151914,subjects,1,1
151915,with,1,1
151916,lower,1,0
151917,plasma,1,0
151918,cholesterol,1,0
151919,tested,0,0
151920,the,0,0
151921,hypotheses,0,0
151922,that,0,0
151923,lipophilic,0,0
151924,simvastatin,0,0
151925,would,0,0
151926,attenuate,0,0
151927,resting,0,0
151928,sympathoexcitation,0,0
151929,and,0,0
151930,augment,0,0
151931,baroreflex,0,0
151932,modulation,0,0
151933,of,0,0
151934,MSNA,0,1
151935,and,0,0
151936,heart,0,1
151937,rate,0,0
151938,(,0,0
151939,HR,0,0
151940,),0,0
151941,",",0,0
151942,flow-mediated,0,0
151943,vasodilation,0,0
151944,and,0,0
151945,insulin,0,0
151946,sensitivity,0,0
151947,.,0,1
151948,DESIGN,0,0
151949,Prospective,0,0
151950,",",0,0
151951,randomised,0,0
151952,",",0,0
151953,double-blind,0,0
151954,",",0,0
151955,placebo-controlled,0,0
151956,crossover,0,0
151957,study,0,1
151958,.,0,1
151959,SETTING,0,1
151960,Academic,0,1
151961,hospital-based,0,1
151962,study,0,1
151963,.,0,1
151964,PATIENTS,0,0
151965,Fourteen,1,1
151966,non-hyperlipidaemic,1,1
151967,primary,1,1
151968,hypertensive,1,1
151969,subjects,1,1
151970,(,1,1
151971,10,1,1
151972,men,1,1
151973,;,1,1
151974,overall,1,0
151975,mean?SD,1,0
151976,age,1,1
151977,58?12,1,0
151978,years,1,1
151979,),1,1
151980,.,1,1
151981,INTERVENTIONS,0,0
151982,Four,0,1
151983,weeks,0,0
151984,of,0,0
151985,simvastatin,0,0
151986,(,0,0
151987,80,0,1
151988,mg/day,0,0
151989,),0,0
151990,or,0,1
151991,placebo,0,0
151992,.,0,1
151993,MAIN,0,0
151994,OUTCOME,0,0
151995,MEASURES,0,0
151996,Resting,0,0
151997,blood,0,0
151998,pressure,0,0
151999,(,0,0
152000,BP,0,0
152001,),0,0
152002,",",0,0
152003,HR,0,0
152004,",",0,0
152005,MSNA,0,0
152006,",",0,0
152007,spontaneous,0,0
152008,arterial,0,1
152009,baroreflex,0,0
152010,MSNA,0,1
152011,and,0,0
152012,HR,0,0
152013,modulation,0,0
152014,",",0,0
152015,endothelium-dependent,0,0
152016,and,0,0
152017,endothelium-independent,0,0
152018,vasodilation,0,0
152019,",",0,0
152020,and,0,0
152021,the,0,0
152022,homoeostatic,0,0
152023,model,0,0
152024,assessment,0,0
152025,of,0,0
152026,insulin,0,0
152027,resistance,0,0
152028,(,0,0
152029,HOMA-IR,0,0
152030,),0,1
152031,.,0,1
152032,RESULTS,0,0
152033,Simvastatin,0,0
152034,lowered,0,0
152035,MSNA,0,1
152036,burst,0,0
152037,frequency,0,0
152038,(,0,0
152039,from,0,0
152040,32?12,0,1
152041,to,0,0
152042,25?9,0,0
152043,bursts/min,0,0
152044,),0,0
152045,and,0,0
152046,MSNA,0,1
152047,burst,0,0
152048,incidence,0,0
152049,(,0,0
152050,from,0,0
152051,55?23,0,1
152052,%,0,0
152053,to,0,0
152054,43?17,0,1
152055,%,0,0
152056,;,0,0
152057,all,0,0
152058,p,0,0
152059,<,0,0
152060,0.01,0,0
152061,),0,0
152062,without,0,1
152063,affecting,0,0
152064,BP,0,0
152065,",",0,0
152066,HR,0,0
152067,",",0,0
152068,baroreflex,0,0
152069,modulation,0,0
152070,of,0,0
152071,either,0,0
152072,MSNA,0,0
152073,or,0,0
152074,HR,0,0
152075,",",0,0
152076,or,0,0
152077,HR,0,0
152078,variability,0,0
152079,(,0,0
152080,all,0,0
152081,p,0,0
152082,>,0,0
152083,0.05,0,0
152084,),0,0
152085,.,0,1
152086,Plasma,0,0
152087,glucose,0,0
152088,",",0,0
152089,insulin,0,0
152090,",",0,0
152091,HOMA-IR,0,0
152092,and,0,0
152093,endothelium-dependent,0,0
152094,vasodilation,0,0
152095,(,0,0
152096,all,0,0
152097,p,0,0
152098,>,0,0
152099,0.05,0,0
152100,),0,0
152101,were,0,0
152102,unchanged,0,0
152103,",",0,0
152104,whereas,0,0
152105,endothelium-independent,0,0
152106,vasodilation,0,0
152107,increased,0,0
152108,(,0,0
152109,7.1?3.8,0,0
152110,%,0,0
152111,to,0,0
152112,9.7?3.9,0,0
152113,%,0,0
152114,",",0,0
152115,n=13,0,0
152116,;,0,0
152117,p,0,0
152118,<,0,0
152119,0.01,0,0
152120,),0,0
152121,.,0,0
152122,The,0,0
152123,fall,0,0
152124,in,0,0
152125,MSNA,0,1
152126,was,0,0
152127,unrelated,0,1
152128,to,0,0
152129,the,0,0
152130,decrease,0,0
152131,in,0,0
152132,low-density,0,0
152133,lipoprotein,0,0
152134,cholesterol,0,0
152135,(,0,0
152136,r=0.41,0,0
152137,",",0,0
152138,p=0.14,0,0
152139,),0,0
152140,.,0,0
152141,CONCLUSIONS,0,0
152142,These,0,0
152143,findings,0,0
152144,are,0,0
152145,consistent,0,0
152146,with,0,1
152147,the,0,0
152148,concept,0,0
152149,that,0,0
152150,",",0,0
152151,in,0,0
152152,non-hyperlipidaemic,1,1
152153,subjects,1,1
152154,with,1,1
152155,primary,1,1
152156,hypertension,1,1
152157,",",1,0
152158,simvastatin,1,0
152159,causes,0,0
152160,a,0,0
152161,cholesterol-independent,0,0
152162,reduction,0,0
152163,in,0,0
152164,an,0,0
152165,elevated,0,0
152166,central,0,0
152167,set-point,0,0
152168,for,0,0
152169,MSNA,0,0
152170,",",0,0
152171,without,0,1
152172,affecting,0,0
152173,arterial,0,1
152174,baroreflex,0,0
152175,modulation,0,0
152176,of,0,0
152177,either,0,0
152178,MSNA,0,0
152179,or,0,1
152180,HR,0,0
152181,.,0,0
152182,There,0,0
152183,may,0,0
152184,be,0,0
152185,less,0,0
152186,neurogenic,0,1
152187,constraint,0,0
152188,on,0,0
152189,endothelium-independent,0,0
152190,vasodilation,0,0
152191,as,0,0
152192,a,0,0
152193,consequence,0,0
152194,.,0,0
152195,A,0,0
152196,phase,0,0
152197,III,0,0
152198,study,0,0
152199,of,0,0
152200,laparoscopy-assisted,0,0
152201,versus,0,0
152202,open,0,1
152203,distal,0,1
152204,gastrectomy,0,1
152205,with,0,1
152206,nodal,0,1
152207,dissection,0,1
152208,for,0,0
152209,clinical,0,0
152210,stage,0,1
152211,IA/IB,0,1
152212,gastric,0,1
152213,Cancer,0,1
152214,(,0,1
152215,JCOG0912,0,0
152216,),0,0
152217,.,0,0
152218,A,0,0
152219,Phase,0,0
152220,III,0,1
152221,study,0,0
152222,was,0,0
152223,started,0,0
152224,in,0,0
152225,Japan,1,0
152226,to,0,0
152227,evaluate,0,0
152228,the,0,0
152229,non-inferiority,0,0
152230,of,0,0
152231,overall,0,0
152232,survival,0,0
152233,of,0,0
152234,laparoscopy-assisted,0,0
152235,distal,0,1
152236,gastrectomy,0,1
152237,with,0,1
152238,open,1,1
152239,distal,1,1
152240,gastrectomy,1,1
152241,in,1,0
152242,patients,1,1
152243,with,1,1
152244,clinical,1,0
152245,IA,1,1
152246,(,1,1
152247,T1N0,1,1
152248,),1,0
152249,or,1,1
152250,IB,1,1
152251,[,1,0
152252,T1N1,1,1
152253,or,1,1
152254,T2,1,1
152255,(,1,0
152256,MP,1,0
152257,),1,1
152258,N0,1,0
152259,],1,1
152260,gastric,1,1
152261,cancer,1,1
152262,.,1,0
152263,This,0,0
152264,study,0,0
152265,followed,0,0
152266,the,0,0
152267,previous,0,0
152268,Phase,0,1
152269,II,0,1
152270,study,0,0
152271,to,0,0
152272,confirm,0,0
152273,the,0,0
152274,safety,0,0
152275,of,0,0
152276,laparoscopy-assisted,0,0
152277,distal,0,1
152278,gastrectomy,0,1
152279,(,0,0
152280,JCOG0703,0,0
152281,),0,0
152282,and,0,0
152283,began,0,1
152284,in,0,0
152285,March,0,1
152286,2010,0,1
152287,.,0,0
152288,A,0,0
152289,total,0,1
152290,of,1,0
152291,920,1,1
152292,patients,1,1
152293,will,1,0
152294,be,1,0
152295,accrued,1,0
152296,from,1,0
152297,33,1,1
152298,institutions,1,1
152299,within,1,1
152300,5,1,1
152301,years,1,1
152302,.,1,1
152303,The,0,0
152304,primary,0,0
152305,endpoint,0,0
152306,is,0,0
152307,overall,0,0
152308,survival,0,0
152309,.,0,0
152310,The,0,0
152311,secondary,0,0
152312,endpoints,0,0
152313,are,0,0
152314,relapse-free,0,0
152315,survival,0,0
152316,",",0,0
152317,proportion,0,0
152318,of,0,0
152319,laparoscopy-assisted,0,0
152320,distal,0,1
152321,gastrectomy,0,1
152322,completion,0,0
152323,",",0,0
152324,proportion,0,0
152325,of,0,0
152326,conversion,0,0
152327,to,0,0
152328,open,0,1
152329,surgery,0,1
152330,",",0,0
152331,adverse,0,0
152332,events,0,0
152333,",",0,1
152334,short-term,0,0
152335,clinical,0,0
152336,outcomes,0,0
152337,",",0,0
152338,postoperative,0,0
152339,quality,0,0
152340,of,0,0
152341,life,0,0
152342,.,0,0
152343,Only,0,0
152344,a,0,0
152345,credentialed,1,0
152346,surgeon,1,0
152347,can,0,0
152348,be,0,0
152349,responsible,0,0
152350,for,0,0
152351,both,0,0
152352,open,0,1
152353,distal,0,0
152354,gastrectomy,0,1
152355,and,0,0
152356,laparoscopy-assisted,0,0
152357,distal,0,1
152358,gastrectomy,0,1
152359,.,0,1
152360,Translating,0,0
152361,the,0,0
152362,Dietary,0,0
152363,Approaches,0,0
152364,to,0,0
152365,Stop,0,0
152366,Hypertension,0,1
152367,(,0,0
152368,DASH,0,0
152369,),0,0
152370,diet,0,0
152371,for,0,0
152372,use,0,0
152373,in,0,0
152374,underresourced,1,0
152375,",",1,0
152376,urban,1,1
152377,African,1,1
152378,American,1,1
152379,communities,1,1
152380,",",1,1
152381,2010,1,1
152382,.,1,1
152383,INTRODUCTION,0,0
152384,Randomized,0,0
152385,trials,0,0
152386,have,0,0
152387,demonstrated,0,0
152388,the,0,0
152389,effectiveness,0,0
152390,of,0,0
152391,the,0,0
152392,Dietary,0,0
152393,Approaches,0,0
152394,to,0,0
152395,Stop,0,0
152396,Hypertension,0,1
152397,(,0,0
152398,DASH,0,0
152399,),0,0
152400,program,0,0
152401,for,0,0
152402,lowering,0,0
152403,blood,0,0
152404,pressure,0,0
152405,;,0,0
152406,however,0,0
152407,",",0,0
152408,program,0,0
152409,participation,0,0
152410,has,0,0
152411,been,0,0
152412,limited,0,0
152413,in,0,0
152414,some,0,0
152415,populations,0,1
152416,.,0,0
152417,The,0,0
152418,objective,0,0
152419,of,0,0
152420,this,0,0
152421,pilot,0,0
152422,study,0,0
152423,was,0,0
152424,to,0,0
152425,test,0,0
152426,the,0,0
152427,feasibility,0,0
152428,of,0,0
152429,using,0,0
152430,a,0,0
152431,culturally,0,0
152432,modified,0,0
152433,version,0,0
152434,of,0,0
152435,DASH,0,0
152436,among,0,1
152437,African,1,1
152438,Americans,1,1
152439,in,1,1
152440,an,1,1
152441,underresourced,1,0
152442,community,1,1
152443,.,1,1
152444,METHODS,0,0
152445,This,0,0
152446,randomized,0,0
152447,controlled,0,0
152448,pilot,0,0
152449,study,0,0
152450,recruited,0,1
152451,African,1,1
152452,Americans,1,1
152453,in,1,1
152454,2,1,1
152455,North,1,1
152456,Carolina,1,1
152457,neighborhoods,1,1
152458,who,1,1
152459,had,1,1
152460,high,1,1
152461,blood,1,0
152462,pressure,1,0
152463,and,1,0
152464,used,1,0
152465,fewer,1,0
152466,than,1,0
152467,3,1,0
152468,antihypertension,1,0
152469,medications,1,0
152470,.,1,1
152471,We,0,0
152472,offered,0,0
152473,2,0,0
152474,individual,0,0
152475,and,0,1
152476,9,0,0
152477,group,0,1
152478,DASH,0,0
152479,sessions,0,0
152480,to,0,0
152481,intervention,0,0
152482,participants,0,1
152483,and,0,1
152484,1,0,0
152485,individual,0,0
152486,session,0,0
152487,and,0,0
152488,printed,0,0
152489,DASH,0,0
152490,educational,0,1
152491,materials,0,1
152492,to,0,0
152493,control,0,1
152494,participants,0,1
152495,.,0,1
152496,We,0,0
152497,collected,0,0
152498,data,0,0
152499,at,0,0
152500,baseline,0,0
152501,(,0,1
152502,March,0,1
152503,2010,0,1
152504,),0,0
152505,and,0,1
152506,12,0,0
152507,weeks,0,0
152508,(,0,1
152509,June,0,1
152510,2010,0,1
152511,),0,1
152512,.,0,1
152513,RESULTS,0,0
152514,Of,1,1
152515,152,1,1
152516,potential,1,0
152517,participants,1,1
152518,",",1,1
152519,25,1,0
152520,were,1,0
152521,randomly,1,1
152522,assigned,1,0
152523,to,1,0
152524,either,1,0
152525,the,1,0
152526,intervention,1,0
152527,(,1,0
152528,n,1,1
152529,=,1,0
152530,14,1,1
152531,),1,0
152532,or,1,0
152533,the,1,0
152534,control,1,0
152535,(,1,0
152536,n,1,1
152537,=,1,0
152538,11,1,1
152539,),1,1
152540,group,1,1
152541,;,1,1
152542,22,1,1
152543,were,1,0
152544,women,1,1
152545,",",1,0
152546,and,1,0
152547,21,1,1
152548,were,1,0
152549,educated,1,1
152550,beyond,1,0
152551,high,1,1
152552,school,1,1
152553,.,1,0
152554,At,1,0
152555,baseline,1,0
152556,",",1,0
152557,mean,1,0
152558,blood,1,0
152559,pressure,1,0
152560,was,1,0
152561,130/78,1,1
152562,mm,1,1
152563,Hg,1,1
152564,;,1,1
152565,19,1,1
152566,participants,1,1
152567,used,1,0
152568,antihypertension,1,0
152569,medications,1,0
152570,",",1,0
152571,and,1,0
152572,mean,1,0
152573,body,1,0
152574,mass,1,0
152575,index,1,0
152576,was,1,0
152577,35.9,1,0
152578,kg/m,1,1
152579,(,1,1
152580,2,1,0
152581,),1,0
152582,.,1,1
152583,Intervention,0,0
152584,participants,0,1
152585,attended,0,1
152586,7,0,1
152587,of,0,0
152588,9,0,0
152589,group,0,1
152590,sessions,0,0
152591,on,0,0
152592,average,0,1
152593,.,0,1
152594,After,0,0
152595,12,0,0
152596,weeks,0,0
152597,",",0,0
152598,we,0,0
152599,observed,0,0
152600,significant,0,0
152601,increases,0,0
152602,in,0,0
152603,fruit,0,1
152604,and,0,0
152605,vegetable,0,0
152606,consumption,0,0
152607,and,0,0
152608,increases,0,0
152609,in,0,0
152610,participants,0,1
152611,',0,1
152612,confidence,0,0
152613,in,0,0
152614,their,0,0
152615,ability,0,0
152616,to,0,0
152617,reduce,0,0
152618,salt,0,0
152619,and,0,0
152620,fat,0,0
152621,consumption,0,0
152622,and,0,0
152623,eat,0,0
152624,healthier,0,1
152625,snacks,0,0
152626,in,0,0
152627,intervention,0,0
152628,compared,0,0
152629,with,0,1
152630,control,0,1
152631,participants,0,1
152632,.,0,1
152633,We,0,0
152634,found,0,0
152635,no,0,0
152636,significant,0,0
152637,decreases,0,0
152638,in,0,0
152639,blood,0,0
152640,pressure,0,0
152641,.,0,1
152642,CONCLUSION,0,0
152643,Implementation,0,0
152644,of,0,0
152645,a,0,0
152646,culturally,0,0
152647,modified,0,0
152648,",",0,0
152649,community-based,0,1
152650,DASH,0,0
152651,intervention,0,0
152652,was,0,0
152653,feasible,0,0
152654,in,0,0
152655,our,0,0
152656,small,1,1
152657,sample,1,1
152658,of,1,1
152659,African,1,1
152660,Americans,1,1
152661,",",1,1
152662,which,1,0
152663,included,1,1
152664,people,1,1
152665,being,1,0
152666,treated,1,1
152667,for,1,0
152668,high,1,0
152669,blood,1,0
152670,pressure,1,0
152671,.,1,1
152672,Future,0,0
152673,studies,0,0
152674,should,0,0
152675,evaluate,0,0
152676,the,0,0
152677,long-term,0,0
152678,effect,0,0
152679,of,0,0
152680,this,0,0
152681,program,0,0
152682,in,0,0
152683,a,0,0
152684,larger,0,0
152685,sample,0,1
152686,.,0,0
152687,Influence,0,0
152688,of,0,0
152689,lime,0,0
152690,juice,0,0
152691,on,0,0
152692,the,0,0
152693,severity,0,0
152694,of,0,0
152695,sickle,1,1
152696,cell,1,1
152697,anemia,1,1
152698,.,1,0
152699,BACKGROUND,0,0
152700,AND,0,0
152701,OBJECTIVES,0,0
152702,The,0,0
152703,pain,0,0
152704,in,0,0
152705,sickle,0,1
152706,cell,0,1
152707,anemia,0,1
152708,(,0,0
152709,SCA,0,0
152710,),0,0
152711,is,0,0
152712,often,0,0
152713,triggered,0,0
152714,by,0,0
152715,dehydration,0,0
152716,",",0,0
152717,acidosis,0,0
152718,",",0,0
152719,and,0,0
152720,fever,0,0
152721,that,0,0
152722,are,0,0
152723,usually,0,0
152724,due,0,0
152725,to,0,0
152726,malaria,0,1
152727,.,0,0
152728,Intake,0,0
152729,of,0,0
152730,lime,0,0
152731,juice,0,0
152732,was,0,0
152733,recently,0,1
152734,demonstrated,0,0
152735,to,0,0
152736,facilitate,0,0
152737,clearance,0,0
152738,of,0,0
152739,the,0,0
152740,malaria,0,1
152741,parasite,0,0
152742,.,0,0
152743,It,0,0
152744,was,0,0
152745,therefore,0,0
152746,sought,0,0
152747,to,0,0
152748,determine,0,0
152749,whether,0,0
152750,regular,0,0
152751,intake,0,0
152752,of,0,0
152753,lime,0,0
152754,juice,0,0
152755,will,0,0
152756,ameliorate,0,0
152757,crisis,0,0
152758,",",0,0
152759,especially,0,0
152760,recurrent,0,1
152761,bone,0,0
152762,pain,0,1
152763,.,0,0
152764,DESIGN,0,0
152765,In,0,0
152766,this,0,0
152767,preliminary,0,0
152768,",",0,0
152769,open-labeled,0,0
152770,",",0,0
152771,randomized,0,0
152772,study,0,0
152773,",",0,0
152774,the,0,0
152775,effects,0,0
152776,of,0,0
152777,lime,0,0
152778,juice,0,0
152779,on,0,0
152780,the,0,0
152781,clinical,0,0
152782,and,0,0
152783,some,0,0
152784,laboratory,0,0
152785,characteristics,0,0
152786,of,0,1
152787,children,1,1
152788,with,1,1
152789,SCA,1,0
152790,were,0,1
152791,tested,0,0
152792,.,0,0
152793,RESULTS,0,0
152794,Among,0,1
152795,the,0,0
152796,113,1,1
152797,children,1,1
152798,with,1,1
152799,SCA,1,0
152800,studied,1,1
152801,in,1,0
152802,two,1,0
152803,hospitals,1,1
152804,",",1,0
152805,the,1,0
152806,58,1,1
152807,receiving,1,0
152808,lime,1,0
152809,treatment,1,0
152810,had,1,0
152811,lower,1,0
152812,rates,1,0
152813,of,1,0
152814,significant,1,0
152815,painful,1,0
152816,episodes,1,0
152817,than,1,0
152818,the,1,0
152819,55,1,1
152820,without,1,0
152821,lime,1,0
152822,(,1,0
152823,37,1,1
152824,versus,1,0
152825,83,1,1
152826,crises,1,1
152827,in,1,1
152828,6,1,0
152829,months,1,0
152830,",",1,0
152831,and,1,0
152832,0.64?0.11,1,0
152833,versus,1,0
152834,1.51?0.34,1,0
152835,average,1,0
152836,rates,1,0
152837,per,1,0
152838,child,1,1
152839,",",1,0
152840,p,1,0
152841,<,1,0
152842,0.001,1,0
152843,),1,0
152844,.,1,0
152845,Also,0,0
152846,",",0,0
152847,fewer,0,0
152848,subjects,0,1
152849,than,0,0
152850,the,0,0
152851,controls,0,1
152852,had,0,1
152853,significant,0,0
152854,painful,0,0
152855,episodes,0,1
152856,(,0,1
152857,50.0,0,0
152858,%,0,0
152859,versus,0,0
152860,92.7,0,0
152861,%,0,0
152862,),0,1
152863,;,0,0
152864,febrile,0,1
152865,illness,0,1
152866,(,0,0
152867,46.6,0,1
152868,%,0,0
152869,versus,0,0
152870,87.3,0,0
152871,%,0,0
152872,),0,0
152873,and,0,0
152874,admission,0,0
152875,rate,0,0
152876,(,0,0
152877,3.4,0,0
152878,%,0,0
152879,versus,0,0
152880,34.5,0,0
152881,%,0,0
152882,),0,0
152883,(,0,0
152884,p,0,0
152885,<,0,0
152886,0.001,0,0
152887,),0,0
152888,.,0,0
152889,The,0,0
152890,mean,0,0
152891,hematocrit,0,0
152892,of,0,0
152893,the,0,0
152894,subjects,0,1
152895,(,0,0
152896,26.23?2.03,0,0
152897,%,0,0
152898,),0,0
152899,at,0,0
152900,the,0,0
152901,end,0,0
152902,of,0,0
152903,the,0,0
152904,study,0,0
152905,was,0,0
152906,also,0,0
152907,higher,0,0
152908,",",0,0
152909,p,0,0
152910,<,0,0
152911,0.001,0,0
152912,.,0,0
152913,However,0,0
152914,",",0,0
152915,transfusion,0,0
152916,rate,0,0
152917,",",0,0
152918,presence,0,0
152919,of,0,0
152920,hepatomegaly,0,1
152921,",",0,0
152922,splenomegaly,0,1
152923,",",0,0
152924,and,0,0
152925,jaundice,0,1
152926,was,0,0
152927,similar,0,0
152928,.,0,0
152929,Treatment,0,0
152930,with,0,1
152931,lime,0,0
152932,did,0,0
152933,not,0,0
152934,cause,0,0
152935,any,0,0
152936,significant,0,0
152937,side-effect,0,0
152938,.,0,1
152939,CONCLUSIONS,0,0
152940,Regular,0,0
152941,intake,0,0
152942,of,0,0
152943,lime,0,0
152944,juice,0,0
152945,may,0,0
152946,be,0,0
152947,of,0,0
152948,great,0,0
152949,therapeutic,0,0
152950,and,0,0
152951,nutritional,0,0
152952,relevance,0,0
152953,in,0,0
152954,children,1,1
152955,with,1,1
152956,SCA,1,1
152957,.,1,1
152958,Drug-drug,0,0
152959,interaction,0,0
152960,study,0,0
152961,of,0,0
152962,ACT-178882,0,0
152963,",",0,0
152964,a,0,0
152965,new,0,0
152966,renin,0,0
152967,inhibitor,0,0
152968,",",0,0
152969,and,0,0
152970,diltiazem,0,0
152971,in,0,0
152972,healthy,1,1
152973,subjects,1,1
152974,.,1,1
152975,BACKGROUND,0,0
152976,AND,0,0
152977,OBJECTIVE,0,0
152978,The,0,0
152979,cytochrome,0,0
152980,P450,0,0
152981,(,0,0
152982,CYP,0,0
152983,),0,0
152984,enzyme,0,0
152985,",",0,0
152986,CYP3A4,0,0
152987,",",0,0
152988,metabolizes,0,0
152989,ACT-178882,0,0
152990,",",0,0
152991,a,0,0
152992,new,0,0
152993,direct,0,0
152994,renin,0,0
152995,inhibitor,0,0
152996,.,0,0
152997,This,0,0
152998,study,0,0
152999,investigated,0,0
153000,the,0,0
153001,effect,0,0
153002,of,0,0
153003,diltiazem,0,0
153004,",",0,0
153005,a,0,0
153006,moderate,0,1
153007,inhibitor,0,0
153008,of,0,0
153009,CYP3A4,0,0
153010,",",0,0
153011,on,0,0
153012,the,0,0
153013,single-dose,0,0
153014,pharmacokinetics,0,0
153015,of,0,0
153016,ACT-178882,0,0
153017,in,0,0
153018,healthy,1,1
153019,subjects,1,1
153020,.,1,1
153021,METHODS,0,0
153022,In,0,0
153023,this,0,0
153024,open-label,0,0
153025,",",0,0
153026,two-way,0,0
153027,crossover,0,0
153028,",",0,0
153029,drug-drug,0,0
153030,interaction,0,0
153031,study,0,0
153032,",",0,0
153033,healthy,1,1
153034,young,1,1
153035,male,1,1
153036,subjects,1,1
153037,received,0,1
153038,treatments,0,0
153039,A,0,1
153040,and,0,0
153041,B,0,0
153042,in,0,0
153043,a,0,0
153044,randomized,0,0
153045,fashion,0,0
153046,.,0,0
153047,Treatment,0,0
153048,A,0,0
153049,consisted,0,1
153050,of,0,0
153051,a,0,0
153052,single,0,0
153053,dose,0,0
153054,of,0,0
153055,100,0,0
153056,mg,0,0
153057,ACT-178882,0,0
153058,and,0,0
153059,treatment,0,0
153060,B,0,0
153061,of,0,0
153062,diltiazem,0,0
153063,300,0,0
153064,mg,0,0
153065,once,0,0
153066,a,0,0
153067,day,0,0
153068,for,0,0
153069,13,0,1
153070,days,0,0
153071,and,0,0
153072,a,0,0
153073,single,0,0
153074,dose,0,0
153075,of,0,0
153076,100,0,0
153077,mg,0,0
153078,ACT-178882,0,0
153079,on,0,0
153080,day,0,0
153081,4,0,0
153082,.,0,1
153083,Serial,0,0
153084,blood,0,0
153085,samples,0,0
153086,for,0,0
153087,the,0,0
153088,measurement,0,0
153089,of,0,0
153090,ACT-178882,0,0
153091,were,0,0
153092,drawn,0,0
153093,pre-dose,0,0
153094,and,0,0
153095,up,0,0
153096,to,0,0
153097,120,0,1
153098,h,0,0
153099,post-dose,0,0
153100,during,0,0
153101,treatment,0,0
153102,A,0,1
153103,and,0,0
153104,pre-dose,0,0
153105,ACT-178882,0,0
153106,and,0,0
153107,up,0,0
153108,to,0,0
153109,240,0,1
153110,h,0,0
153111,post-dose,0,0
153112,during,0,0
153113,treatment,0,0
153114,B.,0,0
153115,Trough,0,0
153116,blood,0,0
153117,samples,0,0
153118,for,0,0
153119,the,0,0
153120,measurement,0,0
153121,of,0,0
153122,diltiazem,0,0
153123,were,0,0
153124,taken,0,0
153125,on,0,0
153126,days,0,0
153127,1-5,0,0
153128,of,0,0
153129,dosing,0,0
153130,during,0,0
153131,treatment,0,0
153132,B,0,1
153133,.,0,1
153134,Safety,0,0
153135,was,0,0
153136,assessed,0,0
153137,by,0,0
153138,recording,0,0
153139,of,0,0
153140,vital,0,1
153141,signs,0,0
153142,and,0,0
153143,electrocardiogram,0,0
153144,",",0,0
153145,clinical,0,0
153146,laboratory,0,0
153147,tests,0,0
153148,and,0,0
153149,adverse,0,0
153150,event,0,0
153151,reporting,0,0
153152,.,0,0
153153,RESULTS,1,0
153154,Fourteen,1,1
153155,subjects,1,1
153156,were,1,1
153157,enrolled,1,1
153158,and,1,0
153159,completed,1,1
153160,the,1,0
153161,study,1,0
153162,.,0,0
153163,In,0,0
153164,the,0,0
153165,absence,0,0
153166,of,0,0
153167,diltiazem,0,0
153168,",",0,0
153169,the,0,0
153170,mean,0,0
153171,(,0,0
153172,95,0,0
153173,%,0,0
153174,confidence,0,0
153175,interval,0,0
153176,[,0,0
153177,CI,0,0
153178,],0,1
153179,),0,0
153180,maximum,0,0
153181,concentration,0,0
153182,(,0,0
153183,Cmax,0,0
153184,),0,0
153185,and,0,0
153186,area,0,0
153187,under,0,0
153188,the,0,0
153189,curve,0,0
153190,from,0,0
153191,time,0,0
153192,zero,0,0
153193,to,0,0
153194,infinity,0,0
153195,(,0,0
153196,AUC?,0,0
153197,),0,0
153198,were,0,0
153199,26.8,0,0
153200,(,0,0
153201,20.1-35.8,0,0
153202,),0,0
153203,ng/mL,0,0
153204,and,0,0
153205,454,0,1
153206,(,0,0
153207,351-587,0,1
153208,),0,0
153209,ng?h/mL,0,0
153210,",",0,0
153211,respectively,0,0
153212,.,0,0
153213,In,0,0
153214,the,0,0
153215,presence,0,0
153216,of,0,0
153217,diltiazem,0,0
153218,these,0,0
153219,values,0,0
153220,were,0,1
153221,43.5,0,0
153222,(,0,1
153223,36.8-51.4,0,0
153224,),0,0
153225,ng/mL,0,0
153226,and,0,0
153227,918,0,1
153228,(,0,0
153229,781-1078,0,1
153230,),0,0
153231,ng?h/mL,0,0
153232,",",0,0
153233,respectively,0,0
153234,.,0,0
153235,The,0,0
153236,median,0,0
153237,time,0,0
153238,to,0,0
153239,Cmax,0,0
153240,(,0,0
153241,tmax,0,0
153242,),0,0
153243,for,0,0
153244,ACT-178882,0,0
153245,was,0,0
153246,prolonged,0,0
153247,from,0,1
153248,3.5,0,1
153249,to,0,0
153250,5.0,0,0
153251,h,0,0
153252,by,0,0
153253,diltiazem,0,0
153254,whereas,0,0
153255,its,0,0
153256,apparent,0,1
153257,terminal,0,0
153258,half-life,0,0
153259,(,0,0
153260,t?,0,0
153261,),0,0
153262,was,0,0
153263,unaffected,0,0
153264,by,0,0
153265,diltiazem,0,0
153266,",",0,0
153267,22.9,0,0
153268,and,0,0
153269,24.2,0,0
153270,h,0,0
153271,for,0,0
153272,treatments,0,0
153273,A,0,1
153274,and,0,0
153275,B,0,0
153276,",",0,0
153277,respectively,0,0
153278,.,0,0
153279,Using,0,0
153280,treatment,0,0
153281,A,0,0
153282,as,0,0
153283,reference,0,0
153284,",",0,0
153285,the,0,0
153286,geometric,0,0
153287,mean,0,0
153288,ratio,0,0
153289,(,0,0
153290,90,0,0
153291,%,0,0
153292,CI,0,0
153293,),0,0
153294,was,0,0
153295,1.62,0,0
153296,(,0,1
153297,1.36-1.94,0,0
153298,),0,0
153299,for,0,0
153300,Cmax,0,0
153301,and,0,0
153302,2.02,0,0
153303,(,0,0
153304,1.75-2.34,0,0
153305,),0,0
153306,for,0,0
153307,AUC?,0,0
153308,",",0,0
153309,indicating,0,0
153310,a,0,0
153311,significant,0,0
153312,interaction,0,0
153313,between,0,0
153314,ACT-178882,0,0
153315,and,0,0
153316,diltiazem,0,0
153317,.,0,0
153318,One,0,1
153319,(,0,0
153320,7.1,0,0
153321,%,0,0
153322,),0,0
153323,and,0,0
153324,3,0,0
153325,(,0,0
153326,21.3,0,0
153327,%,0,0
153328,),0,0
153329,of,0,0
153330,14,0,1
153331,subjects,0,1
153332,reported,0,0
153333,an,0,0
153334,adverse,0,0
153335,event,0,0
153336,during,0,0
153337,treatment,0,0
153338,A,0,1
153339,and,0,0
153340,B,0,0
153341,",",0,0
153342,respectively,0,0
153343,",",0,0
153344,with,0,0
153345,headache,0,0
153346,being,0,0
153347,the,0,0
153348,most,0,0
153349,frequently,0,0
153350,reported,0,0
153351,",",0,0
153352,with,0,1
153353,three,0,0
153354,events,0,0
153355,.,0,0
153356,There,0,0
153357,were,0,0
153358,no,0,0
153359,clinically,0,0
153360,relevant,0,0
153361,effects,0,0
153362,of,0,1
153363,treatments,0,0
153364,on,0,0
153365,vital,0,1
153366,signs,0,0
153367,",",0,0
153368,electrocardiogram,0,0
153369,or,0,0
153370,clinical,0,0
153371,laboratory,0,0
153372,variables,0,0
153373,.,0,1
153374,CONCLUSION,0,0
153375,Concomitant,0,0
153376,administration,0,0
153377,of,0,0
153378,diltiazem,0,0
153379,doubled,0,0
153380,the,0,0
153381,exposure,0,0
153382,to,0,0
153383,ACT-178882,0,0
153384,without,0,1
153385,affecting,0,0
153386,t?,0,0
153387,.,0,0
153388,The,0,0
153389,clinical,0,0
153390,significance,0,0
153391,of,0,0
153392,this,0,0
153393,increase,0,0
153394,is,0,0
153395,at,0,0
153396,present,0,0
153397,unknown,0,0
153398,and,0,0
153399,will,0,0
153400,need,0,0
153401,to,0,0
153402,be,0,0
153403,investigated,0,0
153404,in,0,0
153405,future,0,0
153406,clinical,0,1
153407,studies,0,0
153408,.,0,1
153409,Treatment,0,0
153410,with,0,0
153411,ACT-178882,0,0
153412,alone,0,0
153413,or,0,0
153414,in,0,0
153415,combination,0,0
153416,with,0,1
153417,diltiazem,0,0
153418,was,0,0
153419,safe,0,0
153420,and,0,0
153421,well,0,0
153422,tolerated,0,0
153423,.,0,0
153424,Wheelchair,0,0
153425,skills,0,0
153426,training,0,0
153427,to,0,0
153428,improve,0,0
153429,confidence,0,0
153430,with,0,0
153431,using,0,0
153432,a,0,0
153433,manual,0,0
153434,wheelchair,0,0
153435,among,0,0
153436,older,1,1
153437,adults,1,1
153438,:,1,1
153439,a,0,0
153440,pilot,0,0
153441,study,0,0
153442,.,0,0
153443,OBJECTIVE,0,0
153444,To,0,0
153445,examine,0,0
153446,the,0,0
153447,effects,0,0
153448,of,0,0
153449,wheelchair,0,1
153450,skills,0,0
153451,training,0,0
153452,on,0,0
153453,confidence,0,0
153454,in,0,0
153455,older,1,1
153456,adults,1,1
153457,who,1,1
153458,are,1,1
153459,inexperienced,1,1
153460,wheelchair,1,1
153461,users,1,1
153462,.,1,1
153463,DESIGN,0,0
153464,Parallel,0,0
153465,group,0,0
153466,",",0,0
153467,single-blind,0,0
153468,randomized,0,0
153469,controlled,0,0
153470,trial,0,1
153471,.,0,1
153472,SETTING,0,1
153473,Research,0,0
153474,laboratory,0,0
153475,in,0,0
153476,a,0,0
153477,rehabilitation,0,0
153478,hospital,0,1
153479,.,0,1
153480,PARTICIPANTS,0,0
153481,Participants,1,1
153482,(,1,1
153483,N=20,1,1
153484,),1,1
153485,who,1,1
153486,were,1,1
153487,community-living,1,1
153488,older,1,1
153489,adults,1,1
153490,at,1,0
153491,least,1,1
153492,65,1,1
153493,years,1,1
153494,old,1,1
153495,(,1,1
153496,mean,1,0
153497,age,1,1
153498,",",1,0
153499,70y,1,1
153500,),1,0
153501,",",1,0
153502,50,1,1
153503,%,1,0
153504,women,1,1
153505,",",1,1
153506,and,1,1
153507,who,1,1
153508,had,1,1
153509,no,1,1
153510,experience,1,0
153511,of,1,0
153512,using,1,0
153513,a,1,0
153514,wheelchair,1,0
153515,were,0,0
153516,randomly,0,1
153517,allocated,0,0
153518,to,0,0
153519,an,0,0
153520,intervention,0,0
153521,(,0,0
153522,n=10,0,1
153523,),0,0
153524,or,0,1
153525,control,0,0
153526,(,0,0
153527,n=10,0,1
153528,),0,1
153529,group,0,0
153530,.,0,0
153531,INTERVENTIONS,0,0
153532,The,0,0
153533,intervention,0,0
153534,group,0,0
153535,received,0,0
153536,two,0,0
153537,1-hour,0,0
153538,training,0,0
153539,sessions,0,0
153540,that,0,0
153541,followed,0,0
153542,the,0,0
153543,Wheelchair,0,0
153544,Skills,0,0
153545,Training,0,0
153546,Program,0,0
153547,(,0,0
153548,WSTP,0,0
153549,),0,0
153550,protocol,0,0
153551,.,0,0
153552,The,0,0
153553,control,0,0
153554,group,0,0
153555,received,0,0
153556,a,0,0
153557,single,0,0
153558,socialization,0,0
153559,contact,0,0
153560,.,0,1
153561,MAIN,0,0
153562,OUTCOME,0,0
153563,MEASURE,0,0
153564,The,0,0
153565,Wheelchair,0,0
153566,Use,0,0
153567,Confidence,0,0
153568,Scale-Manual,0,0
153569,(,0,0
153570,WheelCon-M,0,0
153571,),0,0
153572,was,0,0
153573,used,0,0
153574,to,0,0
153575,evaluate,0,0
153576,confidence,0,0
153577,with,0,0
153578,using,0,0
153579,a,0,0
153580,manual,0,0
153581,wheelchair,0,0
153582,.,0,0
153583,The,0,0
153584,WheelCon-M,0,0
153585,is,0,0
153586,a,0,0
153587,self-report,0,0
153588,questionnaire,0,0
153589,that,0,0
153590,comprises,0,1
153591,65,0,1
153592,items,0,0
153593,in,0,1
153594,6,0,1
153595,conceptual,0,1
153596,areas,0,1
153597,.,0,1
153598,RESULTS,0,0
153599,A,0,0
153600,1-way,0,0
153601,between-groups,0,0
153602,analysis,0,0
153603,of,0,0
153604,covariance,0,0
153605,revealed,0,0
153606,a,0,0
153607,significant,0,0
153608,difference,0,0
153609,in,0,0
153610,postintervention,0,0
153611,WheelCon-M,0,0
153612,scores,0,0
153613,between,0,0
153614,the,0,0
153615,intervention,0,0
153616,and,0,0
153617,control,0,0
153618,groups,0,0
153619,(,0,0
153620,"F1,17=10.9",0,0
153621,",",0,0
153622,P=.004,0,0
153623,),0,0
153624,after,0,0
153625,controlling,0,0
153626,for,0,0
153627,baseline,0,0
153628,WheelCon-M,0,0
153629,scores,0,0
153630,.,0,1
153631,A,0,0
153632,large,0,0
153633,effect,0,0
153634,size,0,0
153635,was,0,0
153636,also,0,0
153637,observed,0,0
153638,(,0,0
153639,partial,0,1
153640,?,0,1
153641,(,0,0
153642,2,0,0
153643,),0,0
153644,=.39,0,0
153645,),0,0
153646,.,0,1
153647,Secondary,0,0
153648,analyses,0,0
153649,revealed,0,0
153650,that,0,0
153651,the,0,0
153652,WSTP,0,0
153653,had,0,0
153654,greater,0,0
153655,effects,0,0
153656,on,0,0
153657,confidence,0,0
153658,in,0,0
153659,areas,0,0
153660,related,0,0
153661,to,0,0
153662,maneuvering,0,0
153663,around,0,0
153664,the,0,0
153665,physical,0,0
153666,environment,0,0
153667,",",0,0
153668,knowledge,0,0
153669,and,0,0
153670,problem,0,0
153671,solving,0,0
153672,",",0,0
153673,advocacy,0,0
153674,",",0,0
153675,and,0,0
153676,managing,0,0
153677,emotions,0,0
153678,than,0,0
153679,in,0,1
153680,areas,0,0
153681,related,0,0
153682,to,0,0
153683,performing,0,0
153684,activities,0,0
153685,and,0,0
153686,behaving,0,0
153687,in,0,0
153688,social,0,1
153689,situations,0,0
153690,.,0,1
153691,CONCLUSION,0,0
153692,Two,0,1
153693,1-hour,0,0
153694,WSTP,0,0
153695,sessions,0,0
153696,improve,0,0
153697,confidence,0,0
153698,with,0,1
153699,using,0,0
153700,a,0,0
153701,manual,0,0
153702,wheelchair,0,0
153703,among,1,0
153704,older,1,1
153705,adults,1,1
153706,who,1,1
153707,are,1,1
153708,inexperienced,1,1
153709,wheelchair,1,1
153710,users,1,1
153711,.,1,1
153712,Disparities,0,1
153713,in,0,1
153714,transition,0,1
153715,planning,0,0
153716,for,0,0
153717,youth,1,1
153718,with,1,1
153719,autism,1,1
153720,spectrum,1,1
153721,disorder,1,1
153722,.,1,1
153723,OBJECTIVE,0,0
153724,Little,0,0
153725,is,0,0
153726,known,0,0
153727,about,0,0
153728,accessibility,0,0
153729,to,0,0
153730,health,0,0
153731,care,0,0
153732,transition,0,0
153733,(,0,0
153734,HCT,0,0
153735,),0,1
153736,services,0,1
153737,for,0,0
153738,youth,1,1
153739,with,1,1
153740,autism,1,1
153741,spectrum,1,1
153742,disorder,1,1
153743,(,1,0
153744,ASD,1,1
153745,),1,0
153746,.,1,0
153747,This,0,0
153748,study,0,0
153749,expands,0,0
153750,our,0,0
153751,understanding,0,0
153752,by,0,0
153753,examining,0,0
153754,the,0,0
153755,receipt,0,0
153756,of,0,0
153757,HCT,0,0
153758,services,0,1
153759,in,0,0
153760,youth,1,1
153761,with,1,1
153762,ASD,1,1
153763,compared,1,0
153764,with,1,1
153765,youth,1,1
153766,with,1,1
153767,other,1,0
153768,special,1,1
153769,health,1,1
153770,care,1,1
153771,needs,1,0
153772,(,1,1
153773,OSHCN,1,1
153774,),1,1
153775,.,1,0
153776,METHODS,0,0
153777,We,1,0
153778,used,1,0
153779,the,1,0
153780,2005-2006,1,1
153781,National,1,1
153782,Survey,1,0
153783,of,1,0
153784,Children,1,1
153785,with,1,1
153786,Special,1,1
153787,Health,1,0
153788,Care,1,1
153789,Needs,1,1
153790,to,1,0
153791,examine,1,0
153792,receipt,1,0
153793,of,1,0
153794,HCT,1,0
153795,services,1,1
153796,for,1,0
153797,youth,1,1
153798,(,1,0
153799,aged,1,1
153800,12-17,1,1
153801,years,1,1
153802,),1,1
153803,with,1,1
153804,ASD,1,1
153805,and,1,0
153806,youth,1,1
153807,with,1,1
153808,OSHCN,1,1
153809,.,1,1
153810,Logistic,0,0
153811,regression,0,0
153812,analyses,0,0
153813,explored,0,0
153814,whether,0,0
153815,individual,0,0
153816,",",0,0
153817,family,0,0
153818,",",0,0
153819,or,0,0
153820,health,0,0
153821,system,0,0
153822,factors,0,0
153823,were,0,0
153824,associated,0,0
153825,with,0,1
153826,receipt,0,0
153827,of,0,0
153828,HCT,0,0
153829,services,0,1
153830,for,0,0
153831,youth,0,1
153832,with,0,1
153833,ASD,0,1
153834,.,0,1
153835,RESULTS,0,0
153836,Whereas,0,0
153837,half,0,1
153838,of,0,0
153839,youth,0,1
153840,with,0,1
153841,OSHCN,0,1
153842,received,0,1
153843,HCT,0,0
153844,services,0,1
153845,",",0,0
153846,less,0,0
153847,than,0,0
153848,a,0,0
153849,quarter,0,1
153850,of,0,0
153851,youth,0,1
153852,with,0,1
153853,ASD,0,1
153854,did,0,0
153855,.,0,0
153856,Only,0,0
153857,14,0,0
153858,%,0,0
153859,of,0,0
153860,youth,0,1
153861,with,0,1
153862,ASD,0,1
153863,had,0,1
153864,a,0,0
153865,discussion,0,0
153866,with,0,1
153867,their,0,0
153868,pediatrician,0,0
153869,about,0,0
153870,transitioning,0,1
153871,to,0,0
153872,an,0,0
153873,adult,0,1
153874,provider,0,0
153875,",",0,0
153876,less,0,0
153877,than,0,0
153878,a,0,0
153879,quarter,0,1
153880,had,0,0
153881,a,0,0
153882,discussion,0,0
153883,about,0,0
153884,health,0,0
153885,insurance,0,1
153886,retention,0,0
153887,",",0,0
153888,and,0,0
153889,just,0,0
153890,under,0,0
153891,half,0,1
153892,discussed,0,0
153893,adult,0,1
153894,health,0,1
153895,care,0,1
153896,needs,0,0
153897,or,0,1
153898,were,0,0
153899,encouraged,0,0
153900,to,0,0
153901,take,0,0
153902,on,0,0
153903,appropriate,0,0
153904,responsibility,0,1
153905,.,0,1
153906,Logistic,0,0
153907,regression,0,0
153908,analyses,0,0
153909,indicated,0,0
153910,that,0,0
153911,having,0,1
153912,a,0,0
153913,developmental,0,0
153914,disability,0,0
153915,or,0,1
153916,multiple,0,0
153917,health,0,1
153918,conditions,0,0
153919,in,0,0
153920,addition,0,0
153921,to,0,0
153922,ASD,0,1
153923,and,0,0
153924,quality,0,0
153925,of,0,0
153926,health,0,1
153927,care,0,1
153928,were,0,0
153929,strong,0,0
153930,predictors,0,0
153931,of,0,0
153932,HCT,0,0
153933,",",0,0
153934,whereas,0,0
153935,demographic,0,0
153936,and,0,0
153937,family,0,1
153938,variables,0,0
153939,accounted,0,0
153940,for,0,0
153941,little,0,0
153942,variance,0,0
153943,.,0,1
153944,CONCLUSIONS,0,0
153945,Youth,1,1
153946,with,1,1
153947,ASD,1,1
153948,experience,0,0
153949,disparities,0,0
153950,in,0,0
153951,access,0,0
153952,to,0,0
153953,HCT,0,1
153954,services,0,1
153955,.,0,1
153956,Youth,1,0
153957,with,1,1
153958,comorbid,1,1
153959,conditions,1,0
153960,are,0,0
153961,at,0,0
153962,greatest,0,0
153963,risk,0,0
153964,for,0,0
153965,poor,0,0
153966,access,0,0
153967,to,0,0
153968,HCT,0,0
153969,services,0,1
153970,and,0,0
153971,increased,0,0
153972,quality,0,0
153973,of,0,0
153974,care,0,0
153975,has,0,0
153976,a,0,0
153977,positive,0,0
153978,effect,0,0
153979,.,0,0
153980,Research,0,0
153981,is,0,0
153982,needed,0,0
153983,to,0,0
153984,understand,0,0
153985,barriers,0,0
153986,to,0,0
153987,care,0,1
153988,and,0,0
153989,develop,0,0
153990,policy,0,0
153991,and,0,0
153992,practice,0,0
153993,guidelines,0,0
153994,tailored,0,0
153995,for,0,0
153996,youth,1,1
153997,with,1,1
153998,ASD,1,1
153999,.,1,1
154000,Association,0,0
154001,between,0,0
154002,weight,0,0
154003,loss,0,0
154004,and,0,0
154005,improvement,0,0
154006,of,0,0
154007,ventricular,0,0
154008,systolic,0,1
154009,function,0,0
154010,in,0,0
154011,advanced,1,1
154012,heart,1,1
154013,failure,1,1
154014,.,1,0
154015,In,0,0
154016,heart,0,1
154017,failure,0,1
154018,(,0,0
154019,HF,0,0
154020,),0,0
154021,",",0,0
154022,longitudinal,0,1
154023,changes,0,0
154024,in,0,0
154025,ventricular,0,1
154026,ejection,0,1
154027,fraction,0,0
154028,are,0,0
154029,poorly,0,0
154030,studied,0,0
154031,.,0,0
154032,The,0,0
154033,authors,0,0
154034,',0,1
154035,objective,0,0
154036,was,0,0
154037,to,0,0
154038,document,0,0
154039,the,0,0
154040,dynamic,0,0
154041,changes,0,0
154042,in,0,0
154043,systolic,0,1
154044,function,0,0
154045,of,0,0
154046,both,0,0
154047,ventricles,0,0
154048,during,0,0
154049,acute,0,1
154050,HF,0,1
154051,and,0,0
154052,after,0,0
154053,a,0,0
154054,3-month,0,0
154055,follow-up,0,0
154056,period,0,0
154057,",",0,0
154058,and,0,0
154059,to,0,0
154060,identify,0,0
154061,factors,0,0
154062,associated,0,0
154063,with,0,1
154064,ventricular,0,0
154065,improvement,0,0
154066,.,0,0
154067,A,0,0
154068,limited,0,0
154069,access,0,0
154070,dataset,0,0
154071,from,0,0
154072,the,0,0
154073,Evaluation,0,0
154074,Study,0,0
154075,of,0,0
154076,Congestive,0,1
154077,Heart,1,1
154078,Failure,1,1
154079,and,0,0
154080,Pulmonary,0,1
154081,Artery,0,1
154082,Catheterization,0,1
154083,Effectiveness,0,0
154084,(,0,0
154085,ESCAPE,0,0
154086,),0,0
154087,trial,0,0
154088,provided,0,0
154089,by,0,0
154090,The,0,0
154091,National,0,0
154092,Heart,0,0
154093,",",0,0
154094,Lung,0,0
154095,",",0,0
154096,and,0,0
154097,Blood,0,0
154098,Institute,0,1
154099,was,0,0
154100,analyzed,0,0
154101,.,0,0
154102,In,1,0
154103,patients,1,1
154104,admitted,1,1
154105,to,1,0
154106,the,1,0
154107,hospital,1,0
154108,with,1,1
154109,acute,1,1
154110,HF,1,0
154111,",",1,0
154112,both,1,0
154113,ventricles,1,0
154114,were,1,0
154115,evaluated,1,0
154116,by,1,0
154117,echocardiography,1,0
154118,on,1,0
154119,admission,1,0
154120,",",1,0
154121,at,1,0
154122,discharge,1,0
154123,",",1,0
154124,and,1,0
154125,at,1,0
154126,3,1,0
154127,months,1,0
154128,.,1,1
154129,From,0,1
154130,baseline,0,0
154131,to,0,0
154132,3,0,0
154133,months,0,0
154134,",",0,0
154135,left,0,1
154136,ventricular,0,0
154137,ejection,0,1
154138,fraction,0,0
154139,(,0,0
154140,LVEF,0,1
154141,),0,0
154142,increased,0,0
154143,in,0,0
154144,43.4,0,0
154145,%,0,0
154146,of,0,0
154147,patients,0,1
154148,",",0,0
154149,decreased,0,0
154150,in,0,0
154151,23.9,0,0
154152,%,0,0
154153,",",0,0
154154,and,0,0
154155,remained,0,0
154156,unchanged,0,0
154157,in,0,0
154158,32.7,0,0
154159,%,0,0
154160,.,0,0
154161,Similarly,0,0
154162,",",0,0
154163,right,0,0
154164,ventricular,0,0
154165,systolic,0,1
154166,function,0,0
154167,improved,0,0
154168,in,0,0
154169,40.9,0,0
154170,%,0,0
154171,",",0,0
154172,deteriorated,0,0
154173,in,0,0
154174,25.0,0,0
154175,%,0,0
154176,",",0,0
154177,and,0,0
154178,remained,0,0
154179,stable,0,1
154180,in,0,0
154181,34.1,0,0
154182,%,0,0
154183,.,0,1
154184,Weight,0,0
154185,loss,0,0
154186,during,0,0
154187,index,0,0
154188,admission,0,1
154189,and,0,0
154190,cardiac,0,1
154191,index/cardiac,0,0
154192,output,0,0
154193,increase,0,0
154194,were,0,0
154195,the,0,0
154196,only,0,0
154197,factors,0,0
154198,associated,0,0
154199,with,0,1
154200,LVEF,0,1
154201,improvement,0,0
154202,from,0,0
154203,baseline,0,0
154204,to,0,0
154205,month,0,0
154206,3,0,0
154207,.,0,0
154208,There,0,0
154209,was,0,0
154210,no,0,0
154211,difference,0,0
154212,between,0,0
154213,ischemic,0,1
154214,and,0,0
154215,nonischemic,0,1
154216,etiology,0,0
154217,.,0,0
154218,In,0,0
154219,acute,0,1
154220,HF,0,1
154221,",",0,0
154222,ischemic,0,1
154223,or,0,0
154224,nonischemic,0,1
154225,",",0,0
154226,systolic,0,0
154227,function,0,0
154228,of,0,0
154229,the,0,0
154230,ventricles,0,0
154231,improved,0,0
154232,during,0,0
154233,3,0,0
154234,months,0,0
154235,in,0,0
154236,about,0,0
154237,40,0,1
154238,%,0,0
154239,of,0,0
154240,patients,0,1
154241,and,0,1
154242,remained,0,0
154243,unchanged,0,0
154244,or,0,1
154245,deteriorated,0,0
154246,in,0,0
154247,the,0,0
154248,rest,0,0
154249,.,0,0
154250,Weight,0,0
154251,loss,0,0
154252,and,0,0
154253,increase,0,0
154254,in,0,0
154255,cardiac,0,1
154256,index/output,0,0
154257,during,0,0
154258,hospitalization,0,0
154259,was,0,0
154260,associated,0,0
154261,with,0,1
154262,improvement,0,0
154263,in,0,0
154264,LVEF,0,1
154265,.,0,1
154266,Modulation,0,0
154267,of,0,0
154268,the,0,0
154269,intestinal,0,0
154270,environment,0,0
154271,",",0,0
154272,innate,0,0
154273,immune,0,0
154274,response,0,0
154275,",",0,0
154276,and,0,0
154277,barrier,0,0
154278,function,0,0
154279,by,0,0
154280,dietary,0,0
154281,threonine,0,0
154282,and,0,0
154283,purified,0,0
154284,fiber,0,0
154285,during,0,0
154286,a,0,0
154287,coccidiosis,0,0
154288,challenge,0,0
154289,in,0,0
154290,broiler,1,1
154291,chicks,1,1
154292,.,1,0
154293,Coccidiosis,0,0
154294,is,0,0
154295,a,0,0
154296,major,0,0
154297,contributor,0,0
154298,to,0,0
154299,economic,0,0
154300,losses,0,0
154301,in,0,0
154302,the,0,0
154303,poultry,1,0
154304,industry,0,0
154305,due,0,0
154306,to,0,0
154307,its,0,0
154308,detrimental,0,0
154309,effects,0,0
154310,on,0,0
154311,growth,0,0
154312,performance,0,0
154313,and,0,0
154314,nutrient,0,0
154315,utilization,0,0
154316,.,0,1
154317,We,0,0
154318,hypothesized,0,0
154319,that,0,0
154320,the,0,0
154321,combined,0,0
154322,effects,0,0
154323,of,0,1
154324,supplemental,0,1
154325,dietary,0,0
154326,Thr,0,1
154327,and,0,0
154328,purified,0,0
154329,fiber,0,0
154330,may,0,0
154331,modulate,0,0
154332,the,0,0
154333,intestinal,0,0
154334,environment,0,0
154335,and,0,0
154336,positively,0,0
154337,affect,0,0
154338,intestinal,0,0
154339,immune,0,0
154340,responses,0,0
154341,and,0,0
154342,barrier,0,0
154343,function,0,0
154344,in,0,0
154345,broiler,1,1
154346,chicks,1,1
154347,infected,1,1
154348,with,1,1
154349,Eimeria,1,1
154350,maxima,1,0
154351,.,1,0
154352,A,0,0
154353,Thr-deficient,0,0
154354,basal,0,0
154355,diet,0,1
154356,(,0,0
154357,3.1,0,0
154358,g,0,1
154359,of,0,0
154360,Thr/kg,0,1
154361,of,0,0
154362,diet,0,1
154363,),0,0
154364,was,0,0
154365,supplemented,0,0
154366,with,0,1
154367,70,0,1
154368,g/kg,0,1
154369,of,0,0
154370,silica,0,0
154371,sand,0,1
154372,(,0,0
154373,control,0,0
154374,),0,0
154375,or,0,1
154376,high-methoxy,0,0
154377,pectin,0,0
154378,and,0,0
154379,1,0,0
154380,of,0,0
154381,2,0,1
154382,concentrations,0,0
154383,of,0,0
154384,Thr,0,1
154385,(,0,1
154386,1.8,0,0
154387,or,0,1
154388,5.3,0,0
154389,g/kg,0,1
154390,of,0,0
154391,diet,0,1
154392,;,0,1
154393,4,0,0
154394,diets,0,0
154395,total,0,1
154396,),0,0
154397,",",0,0
154398,and,0,0
154399,fed,0,0
154400,to,0,0
154401,chicks,1,1
154402,from,1,1
154403,hatch,1,0
154404,to,1,0
154405,d,1,0
154406,16,1,1
154407,posthatch,1,0
154408,.,1,0
154409,On,0,0
154410,d,0,0
154411,10,0,0
154412,posthatch,0,0
154413,",",0,0
154414,chicks,0,1
154415,received,0,0
154416,0.5,0,0
154417,mL,0,0
154418,of,0,0
154419,distilled,0,0
154420,water,0,0
154421,or,0,1
154422,an,0,0
154423,acute,0,1
154424,dose,0,0
154425,of,0,0
154426,Eimeria,0,1
154427,maxima,0,0
154428,(,0,1
154429,1.5,0,0
154430,?,0,1
154431,10,0,0
154432,(,0,0
154433,3,0,0
154434,),0,0
154435,sporulated,0,0
154436,oocytes,0,0
154437,),0,1
154438,with,0,1
154439,6,0,0
154440,replicate,0,0
154441,pens,0,1
154442,of,0,1
154443,6,0,0
154444,chicks,0,1
154445,per,0,0
154446,each,0,1
154447,of,0,0
154448,8,0,0
154449,treatment,0,0
154450,combinations,0,0
154451,(,0,1
154452,4,0,0
154453,diets,0,0
154454,and,0,1
154455,2,0,1
154456,inoculation,0,0
154457,states,0,1
154458,),0,1
154459,.,0,1
154460,Body,0,0
154461,weight,0,0
154462,gain,0,0
154463,",",0,0
154464,feed,0,0
154465,intake,0,0
154466,",",0,0
154467,and,0,0
154468,G,0,0
154469,:,0,1
154470,F,0,0
154471,increased,0,0
154472,(,0,0
154473,P,0,0
154474,<,0,0
154475,0.01,0,0
154476,),0,0
154477,with,0,1
154478,addition,0,0
154479,of,0,0
154480,5.3,0,0
154481,g,0,1
154482,of,0,0
154483,Thr/kg,0,1
154484,of,0,0
154485,diet,0,1
154486,.,0,1
154487,Eimeria,0,0
154488,maxima,0,0
154489,schizonts,0,0
154490,were,0,1
154491,present,0,0
154492,only,0,0
154493,in,0,0
154494,intestinal,0,0
154495,tissue,0,0
154496,sampled,0,1
154497,from,0,0
154498,infected,0,1
154499,birds,0,1
154500,(,0,1
154501,P,0,0
154502,<,0,0
154503,0.01,0,0
154504,),0,1
154505,.,0,1
154506,Weights,0,0
154507,of,0,0
154508,cecal,0,1
154509,digesta,0,0
154510,were,0,0
154511,highest,0,0
154512,(,0,0
154513,P,0,0
154514,<,0,0
154515,0.01,0,0
154516,),0,0
154517,in,0,0
154518,pectin-fed,0,0
154519,birds,0,1
154520,",",0,0
154521,and,0,0
154522,ceca,0,0
154523,with,0,1
154524,the,0,0
154525,heaviest,0,1
154526,weights,0,0
154527,also,0,0
154528,had,0,0
154529,the,0,0
154530,highest,0,0
154531,concentrations,0,0
154532,of,0,0
154533,total,0,1
154534,short-chain,0,0
154535,fatty,0,0
154536,acids,0,0
154537,.,0,1
154538,Expression,0,0
154539,of,0,0
154540,interleukin-12,0,0
154541,in,0,0
154542,ileal,0,1
154543,mucosa,0,1
154544,was,0,0
154545,highest,0,0
154546,(,0,0
154547,P,0,0
154548,<,0,0
154549,0.01,0,0
154550,),0,0
154551,in,0,0
154552,infected,0,1
154553,birds,0,1
154554,receiving,0,1
154555,the,0,0
154556,control,0,0
154557,diet,0,0
154558,with,0,1
154559,5.3,0,0
154560,g,0,1
154561,of,0,0
154562,supplemental,0,1
154563,Thr/kg,0,1
154564,.,0,1
154565,In,0,0
154566,cecal,0,0
154567,tonsils,0,1
154568,",",0,0
154569,interferon-?,0,0
154570,expression,0,0
154571,was,0,0
154572,highest,0,0
154573,in,0,0
154574,infected,0,1
154575,birds,0,1
154576,receiving,0,1
154577,the,0,0
154578,control,0,0
154579,diet,0,0
154580,(,0,0
154581,fiber,0,0
154582,?,0,0
154583,infection,0,0
154584,",",0,0
154585,P,0,0
154586,<,0,0
154587,0.05,0,0
154588,),0,1
154589,;,0,0
154590,interferon-?,0,0
154591,expression,0,0
154592,was,0,0
154593,lowest,0,0
154594,in,0,0
154595,infected,0,1
154596,birds,0,1
154597,fed,0,1
154598,the,0,0
154599,high,0,0
154600,Thr,0,1
154601,diet,0,1
154602,(,0,0
154603,Thr,0,1
154604,?,0,0
154605,infection,0,0
154606,",",0,0
154607,P,0,0
154608,<,0,0
154609,0.05,0,0
154610,),0,0
154611,.,0,0
154612,There,0,0
154613,were,0,0
154614,no,0,0
154615,differences,0,0
154616,due,0,0
154617,to,0,0
154618,infection,0,0
154619,or,0,1
154620,Thr,0,1
154621,supplementation,0,0
154622,for,0,0
154623,cytokine,0,0
154624,expression,0,0
154625,in,0,0
154626,birds,0,1
154627,fed,0,1
154628,pectin-containing,0,0
154629,treatments,0,0
154630,.,0,1
154631,Overall,0,0
154632,",",0,0
154633,we,0,0
154634,conclude,0,0
154635,that,0,0
154636,although,0,0
154637,pectin,0,0
154638,has,0,0
154639,some,0,0
154640,protective,0,0
154641,function,0,0
154642,against,0,0
154643,coccidiosis,0,0
154644,",",0,0
154645,Thr,0,1
154646,supplementation,0,0
154647,had,0,0
154648,the,0,0
154649,greatest,0,0
154650,effect,0,0
154651,on,0,0
154652,intestinal,0,1
154653,immune,0,0
154654,response,0,0
154655,and,0,0
154656,maintenance,0,0
154657,of,0,0
154658,near,0,0
154659,normal,0,1
154660,growth,1,0
154661,in,1,0
154662,young,1,1
154663,broiler,1,1
154664,chicks,1,1
154665,infected,1,1
154666,with,1,1
154667,E.,1,1
154668,maxima,1,0
154669,.,1,1
154670,A,0,1
154671,randomized,0,1
154672,controlled,0,0
154673,trial,0,0
154674,of,0,0
154675,COMPASS,0,0
154676,web-based,0,0
154677,and,0,0
154678,face-to-face,0,0
154679,teacher,0,0
154680,coaching,0,0
154681,in,0,0
154682,autism,1,1
154683,.,1,0
154684,OBJECTIVE,0,0
154685,Most,0,0
154686,children,1,1
154687,with,1,1
154688,autism,1,1
154689,rely,0,0
154690,on,0,0
154691,schools,0,1
154692,as,0,0
154693,their,0,1
154694,primary,0,1
154695,source,0,0
154696,of,0,0
154697,intervention,0,0
154698,",",0,0
154699,yet,0,0
154700,research,0,0
154701,has,0,0
154702,suggested,0,0
154703,that,0,0
154704,teachers,0,1
154705,rarely,0,0
154706,use,0,0
154707,evidence-based,0,0
154708,practices,0,1
154709,.,0,1
154710,To,0,0
154711,address,0,0
154712,the,0,0
154713,need,0,0
154714,for,0,0
154715,improved,0,0
154716,educational,0,1
154717,outcomes,0,0
154718,",",0,0
154719,a,0,0
154720,previously,0,0
154721,tested,0,0
154722,consultation,0,0
154723,intervention,0,0
154724,called,0,0
154725,the,0,0
154726,Collaborative,0,0
154727,Model,0,0
154728,for,0,0
154729,Promoting,0,0
154730,Competence,0,1
154731,and,0,0
154732,Success,0,1
154733,(,0,1
154734,COMPASS,0,1
154735,;,0,0
154736,Ruble,0,1
154737,",",0,0
154738,Dalrymple,0,0
154739,",",0,0
154740,&,0,0
154741,McGrew,0,0
154742,",",0,0
154743,2010,0,1
154744,;,0,0
154745,Ruble,0,1
154746,",",0,0
154747,Dalrymple,0,0
154748,",",0,0
154749,&,0,0
154750,McGrew,0,0
154751,",",0,0
154752,2012,0,1
154753,),0,0
154754,was,0,0
154755,evaluated,0,0
154756,in,0,0
154757,a,0,0
154758,2nd,0,0
154759,randomized,0,0
154760,controlled,0,0
154761,trial,0,0
154762,",",0,0
154763,with,0,0
154764,the,0,0
154765,addition,1,0
154766,of,1,0
154767,a,1,0
154768,web-based,1,0
154769,group,1,0
154770,.,1,1
154771,METHOD,0,0
154772,Forty-nine,1,1
154773,teacher-child,1,1
154774,dyads,1,1
154775,were,0,1
154776,randomized,0,1
154777,into,0,0
154778,1,0,0
154779,of,0,1
154780,3,0,1
154781,groups,0,0
154782,:,0,1
154783,(,0,1
154784,1,0,0
154785,),0,0
154786,a,0,0
154787,placebo,0,0
154788,control,0,0
154789,(,0,0
154790,PBO,0,0
154791,),0,0
154792,group,0,0
154793,",",0,0
154794,(,0,0
154795,2,0,0
154796,),0,0
154797,COMPASS,0,0
154798,followed,0,0
154799,by,0,0
154800,face-to-face,0,0
154801,(,0,0
154802,FF,0,1
154803,),0,0
154804,coaching,0,0
154805,sessions,0,0
154806,",",0,0
154807,and,0,0
154808,(,0,0
154809,3,0,0
154810,),0,0
154811,COMPASS,0,0
154812,followed,0,0
154813,by,0,0
154814,web-based,0,0
154815,(,0,1
154816,WEB,0,0
154817,),0,0
154818,coaching,0,0
154819,sessions,0,0
154820,.,0,1
154821,Three,0,1
154822,individualized,0,0
154823,goals,0,0
154824,(,0,1
154825,social,0,0
154826,",",0,0
154827,communication,0,0
154828,",",0,0
154829,and,0,0
154830,independence,0,0
154831,skills,0,0
154832,),0,1
154833,were,0,0
154834,selected,0,1
154835,for,0,0
154836,intervention,0,0
154837,for,0,0
154838,each,0,0
154839,child,1,0
154840,.,1,0
154841,The,0,0
154842,primary,0,0
154843,outcome,0,0
154844,of,0,0
154845,independent,0,0
154846,ratings,0,0
154847,of,0,0
154848,child,0,1
154849,goal,0,0
154850,attainment,0,0
154851,and,0,0
154852,several,0,0
154853,process,0,0
154854,measures,0,0
154855,(,0,0
154856,e.g.,0,0
154857,",",0,0
154858,consultant,0,1
154859,and,0,0
154860,teacher,0,0
154861,fidelity,0,0
154862,),0,0
154863,were,0,0
154864,evaluated,0,0
154865,.,0,0
154866,RESULTS,0,0
154867,Using,0,0
154868,an,0,0
154869,intent-to-treat,0,0
154870,approach,0,0
154871,",",0,0
154872,findings,0,0
154873,replicated,0,0
154874,earlier,0,0
154875,results,0,0
154876,with,0,0
154877,a,0,0
154878,very,0,0
154879,large,0,1
154880,effect,0,0
154881,size,0,0
154882,(,0,0
154883,d,0,1
154884,=,0,0
154885,1.41,0,0
154886,),0,0
154887,for,0,0
154888,the,0,0
154889,FF,0,1
154890,group,0,0
154891,and,0,0
154892,a,0,0
154893,large,0,1
154894,effect,0,0
154895,size,0,0
154896,(,0,0
154897,d,0,1
154898,=,0,0
154899,1.12,0,0
154900,),0,0
154901,for,0,0
154902,the,0,0
154903,WEB,0,0
154904,group,0,0
154905,relative,0,0
154906,to,0,0
154907,the,0,0
154908,PBO,0,0
154909,group,0,0
154910,.,0,0
154911,There,0,0
154912,were,0,0
154913,no,0,0
154914,differences,0,0
154915,in,0,0
154916,overall,0,0
154917,change,0,0
154918,across,0,0
154919,goal,0,0
154920,domains,0,0
154921,between,0,0
154922,the,0,0
154923,FF,0,1
154924,and,0,0
154925,WEB,0,0
154926,groups,0,0
154927,",",0,0
154928,suggesting,0,0
154929,the,0,0
154930,efficacy,0,0
154931,of,0,0
154932,videoconferencing,0,0
154933,technology,0,0
154934,.,0,1
154935,CONCLUSIONS,0,0
154936,COMPASS,0,0
154937,is,0,0
154938,effective,0,0
154939,and,0,0
154940,results,0,0
154941,in,0,0
154942,improved,0,0
154943,educational,0,1
154944,outcomes,0,0
154945,for,0,1
154946,young,1,1
154947,children,1,1
154948,with,1,1
154949,autism,1,1
154950,.,1,1
154951,Videoconferencing,0,0
154952,technology,0,0
154953,",",0,0
154954,as,0,0
154955,a,0,0
154956,scalable,0,0
154957,tool,0,0
154958,",",0,0
154959,has,0,0
154960,promise,0,0
154961,for,0,0
154962,facilitating,0,0
154963,access,0,0
154964,to,0,0
154965,autism,0,1
154966,specialists,0,0
154967,and,0,0
154968,bridging,0,0
154969,the,0,0
154970,research-to-practice,0,0
154971,gap,0,0
154972,.,0,1
154973,Association,0,0
154974,between,0,0
154975,frequency,0,0
154976,of,0,0
154977,ready-to-eat,0,0
154978,cereal,0,1
154979,consumption,0,0
154980,",",0,0
154981,nutrient,0,0
154982,intakes,0,0
154983,",",0,0
154984,and,0,0
154985,body,0,0
154986,mass,0,0
154987,index,0,0
154988,in,0,0
154989,fourth-,1,1
154990,to,1,1
154991,sixth-grade,1,1
154992,low-income,1,1
154993,minority,1,1
154994,children,1,1
154995,.,1,1
154996,BACKGROUND,0,0
154997,The,0,0
154998,consumption,0,0
154999,of,0,0
155000,non-ready-to-eat,0,0
155001,cereal,0,1
155002,and,0,0
155003,ready-to-eat,0,0
155004,cereal,0,1
155005,(,0,0
155006,RTEC,0,0
155007,),0,1
155008,breakfasts,0,0
155009,have,0,0
155010,been,0,0
155011,associated,0,0
155012,with,0,1
155013,increased,0,0
155014,nutrient,0,1
155015,intakes,0,0
155016,and,0,0
155017,lower,0,0
155018,body,0,0
155019,mass,0,0
155020,index,0,0
155021,(,0,0
155022,BMI,0,1
155023,),0,0
155024,.,0,0
155025,These,0,0
155026,relationships,0,0
155027,have,0,0
155028,not,0,0
155029,been,0,0
155030,examined,0,0
155031,in,0,0
155032,low-income,1,1
155033,minority,1,1
155034,children,1,1
155035,.,1,1
155036,OBJECTIVES,0,0
155037,To,0,0
155038,evaluate,0,0
155039,",",0,0
155040,in,0,0
155041,low-income,1,1
155042,minority,1,1
155043,children,1,1
155044,",",0,0
155045,whether,0,0
155046,there,0,0
155047,is,0,0
155048,a,0,0
155049,relationship,0,0
155050,among,0,0
155051,the,0,0
155052,frequency,0,0
155053,of,0,0
155054,RTEC,0,0
155055,consumption,0,0
155056,and,0,0
155057,nutrient,0,0
155058,intakes,0,0
155059,measured,0,0
155060,at,0,0
155061,baseline,0,0
155062,",",0,0
155063,and,0,0
155064,whether,0,0
155065,there,0,0
155066,is,0,0
155067,a,0,0
155068,relationship,0,0
155069,between,0,0
155070,the,0,0
155071,frequency,0,0
155072,of,0,0
155073,RTEC,0,0
155074,and,0,0
155075,BMI,0,0
155076,controlling,0,0
155077,for,0,0
155078,age,0,1
155079,",",0,0
155080,sex,0,0
155081,",",0,0
155082,ethnicity,0,0
155083,",",0,0
155084,and,0,0
155085,energy,0,0
155086,intake,0,0
155087,.,0,0
155088,DESIGN,0,0
155089,A,0,0
155090,longitudinal,0,0
155091,study,0,0
155092,design,0,0
155093,where,0,0
155094,a,0,0
155095,cohort,0,0
155096,was,0,0
155097,followed,0,0
155098,for,0,0
155099,3,0,0
155100,years,0,1
155101,.,0,1
155102,SUBJECTS/SETTING,0,0
155103,Participants,1,1
155104,were,1,1
155105,625,1,1
155106,fourth-,1,1
155107,through,1,0
155108,sixth-grade,1,1
155109,",",1,0
155110,low-income,1,1
155111,children,1,1
155112,living,1,1
155113,in,1,0
155114,San,1,0
155115,Antonio,1,1
155116,",",1,0
155117,Texas,1,1
155118,",",1,0
155119,and,1,0
155120,enrolled,1,1
155121,in,1,0
155122,the,1,0
155123,control,1,0
155124,arm,1,0
155125,of,1,0
155126,the,1,0
155127,Bienestar,1,1
155128,Diabetes,1,1
155129,Prevention,1,1
155130,Program,1,0
155131,'s,1,1
155132,cluster,1,0
155133,randomized,1,1
155134,trial,1,0
155135,.,1,1
155136,Three,0,0
155137,multiple-pass,0,0
155138,24-hour,0,1
155139,dietary,0,0
155140,recalls,0,0
155141,were,0,1
155142,collected,0,0
155143,at,0,0
155144,the,0,0
155145,beginning,0,0
155146,of,0,0
155147,their,0,0
155148,fourth-grade,0,1
155149,year,0,0
155150,and,0,0
155151,at,0,0
155152,the,0,0
155153,end,0,0
155154,of,0,0
155155,their,0,0
155156,fifth-,0,1
155157,and,0,0
155158,sixth-grade,0,1
155159,years,0,1
155160,.,0,1
155161,Children,1,1
155162,'s,1,0
155163,age,1,1
155164,",",1,0
155165,sex,1,0
155166,",",1,0
155167,ethnicity,1,0
155168,",",0,0
155169,and,0,0
155170,height,0,0
155171,and,0,0
155172,weight,0,0
155173,(,0,0
155174,used,0,0
155175,to,0,0
155176,calculate,0,0
155177,BMI,0,1
155178,),0,0
155179,were,0,0
155180,collected,0,0
155181,between,0,0
155182,August,0,1
155183,2001,0,1
155184,and,0,0
155185,May,0,1
155186,2004,0,1
155187,.,0,1
155188,STATISTICAL,0,0
155189,ANALYSES,0,0
155190,PERFORMED,0,0
155191,Descriptive,0,1
155192,and,0,0
155193,inferential,0,0
155194,statistical,0,0
155195,analyses,0,0
155196,were,0,1
155197,performed,0,0
155198,.,0,0
155199,The,0,0
155200,frequency,0,0
155201,of,0,0
155202,breakfast,0,0
155203,consumption,0,0
155204,was,0,0
155205,examined,0,0
155206,using,0,0
155207,a,0,0
155208,6?4,0,0
155209,cross-tabulation,0,0
155210,table,0,0
155211,with,0,1
155212,?,0,0
155213,(,0,0
155214,2,0,0
155215,),0,0
155216,test,0,0
155217,to,0,0
155218,establish,0,0
155219,categorical,0,0
155220,differences,0,0
155221,.,0,1
155222,The,0,0
155223,degree,0,0
155224,of,0,0
155225,association,0,0
155226,between,0,0
155227,BMI,0,1
155228,percentile,0,0
155229,and,0,0
155230,frequency,0,0
155231,of,0,0
155232,RTEC,0,0
155233,consumption,0,0
155234,adjusted,0,0
155235,for,0,0
155236,age,0,1
155237,",",0,0
155238,sex,0,0
155239,",",0,0
155240,ethnicity,0,0
155241,",",0,0
155242,and,0,0
155243,nutrition-related,0,0
155244,parameters,0,0
155245,were,0,1
155246,calculated,0,0
155247,using,0,0
155248,a,0,0
155249,partial,0,0
155250,correlation,0,0
155251,multivariate,0,0
155252,linear,0,0
155253,model,0,0
155254,analysis,0,0
155255,.,0,0
155256,RESULTS,0,0
155257,There,0,0
155258,was,0,0
155259,a,0,0
155260,significant,0,0
155261,positive,0,0
155262,relationship,0,0
155263,between,0,0
155264,the,0,0
155265,frequency,0,0
155266,of,0,0
155267,RTEC,0,0
155268,consumption,0,0
155269,and,0,0
155270,nutrient,0,0
155271,intakes,0,0
155272,measured,0,0
155273,at,0,0
155274,baseline,0,0
155275,.,0,0
155276,There,0,0
155277,was,0,0
155278,also,0,0
155279,a,0,0
155280,significant,0,0
155281,inverse,0,0
155282,relationship,0,0
155283,between,0,0
155284,frequency,0,0
155285,of,0,0
155286,RTEC,0,0
155287,consumption,0,0
155288,and,0,0
155289,BMI,0,0
155290,percentile,0,0
155291,over,0,0
155292,the,0,0
155293,cumulative,0,0
155294,3-year,0,0
155295,period,0,0
155296,controlling,0,0
155297,for,0,0
155298,age,0,1
155299,",",0,0
155300,sex,0,0
155301,",",0,0
155302,ethnicity,0,0
155303,",",0,0
155304,and,0,0
155305,energy,0,0
155306,intake,0,0
155307,.,0,1
155308,CONCLUSIONS,1,0
155309,Children,1,1
155310,who,1,1
155311,frequently,0,1
155312,consumed,0,1
155313,RTEC,0,0
155314,had,0,1
155315,greater,0,0
155316,intakes,0,0
155317,of,0,0
155318,essential,0,1
155319,nutrients,0,0
155320,at,0,0
155321,baseline,0,0
155322,and,0,0
155323,significantly,0,0
155324,lower,0,0
155325,BMI,0,0
155326,over,0,0
155327,a,0,0
155328,3-year,0,0
155329,period,0,0
155330,.,0,1
155331,Effects,0,0
155332,of,0,1
155333,low,0,1
155334,and,0,0
155335,high,0,1
155336,protein,0,0
155337,:,0,1
155338,carbohydrate,0,0
155339,ratios,0,0
155340,in,0,0
155341,the,0,0
155342,diet,0,0
155343,of,0,0
155344,pregnant,1,1
155345,gilts,1,1
155346,on,0,0
155347,maternal,0,1
155348,cortisol,0,0
155349,concentrations,0,0
155350,and,0,0
155351,the,0,0
155352,adrenocortical,0,1
155353,and,0,0
155354,sympathoadrenal,0,0
155355,reactivity,0,0
155356,in,1,0
155357,their,1,0
155358,offspring,1,1
155359,.,1,0
155360,Inadequate,0,0
155361,maternal,0,0
155362,nutrition,0,0
155363,during,0,0
155364,gestation,0,1
155365,may,0,0
155366,cause,0,0
155367,an,0,0
155368,adverse,0,0
155369,environment,0,0
155370,for,0,0
155371,the,0,0
155372,fetus,0,0
155373,leading,0,0
155374,to,0,0
155375,alterations,0,0
155376,of,0,0
155377,the,0,0
155378,hypothalamic-pituitary-adrenal,0,0
155379,(,0,0
155380,HPA,0,1
155381,),0,0
155382,and,0,0
155383,sympatho-adrenomedullary,0,0
155384,(,0,0
155385,SAM,0,0
155386,),0,0
155387,systems,0,0
155388,later,0,0
155389,in,0,0
155390,life,0,0
155391,.,0,0
155392,In,0,0
155393,the,0,0
155394,present,0,0
155395,study,0,0
155396,",",0,0
155397,we,0,0
155398,investigated,0,0
155399,the,0,0
155400,effects,0,0
155401,of,0,0
155402,diets,0,0
155403,with,0,1
155404,low,0,1
155405,and,0,0
155406,high,0,1
155407,protein,0,0
155408,:,0,1
155409,carbohydrate,0,0
155410,ratios,0,0
155411,on,0,0
155412,cortisol,0,0
155413,concentrations,0,0
155414,of,0,1
155415,pregnant,1,1
155416,gilts,1,1
155417,as,0,0
155418,well,0,0
155419,as,0,0
155420,the,0,0
155421,long-term,0,0
155422,effects,0,0
155423,on,0,0
155424,the,0,0
155425,function,0,0
155426,of,0,0
155427,the,0,0
155428,HPA,0,0
155429,and,0,0
155430,SAM,0,0
155431,axes,0,0
155432,in,1,0
155433,their,1,1
155434,offspring,1,0
155435,.,1,0
155436,Throughout,0,0
155437,gestation,0,1
155438,",",0,0
155439,33,1,1
155440,German,1,1
155441,Landrace,1,1
155442,gilts,1,1
155443,were,0,1
155444,fed,0,0
155445,high,0,1
155446,(,0,0
155447,HP,0,0
155448,",",0,0
155449,30,0,0
155450,%,0,0
155451,),0,0
155452,",",0,0
155453,low,0,0
155454,(,0,0
155455,LP,0,0
155456,",",0,0
155457,6.5,0,0
155458,%,0,0
155459,),0,0
155460,",",0,0
155461,or,0,0
155462,adequate,0,0
155463,(,0,0
155464,AP,0,0
155465,",",0,0
155466,12.1,0,0
155467,%,0,0
155468,),0,0
155469,protein,0,0
155470,diets,0,0
155471,",",0,0
155472,which,0,0
155473,were,0,0
155474,made,0,0
155475,isocaloric,0,0
155476,by,0,0
155477,adjusting,0,0
155478,the,0,0
155479,carbohydrate,0,0
155480,content,0,0
155481,.,0,0
155482,The,0,0
155483,salivary,0,1
155484,cortisol,0,0
155485,concentrations,0,0
155486,of,1,0
155487,the,1,0
155488,sows,1,1
155489,were,0,0
155490,measured,0,0
155491,in,0,0
155492,the,0,0
155493,course,0,0
155494,of,0,0
155495,the,0,0
155496,gestation,0,1
155497,period,0,0
155498,.,0,0
155499,The,1,0
155500,offspring,1,0
155501,were,1,0
155502,cross-fostered,1,1
155503,",",0,0
155504,and,0,0
155505,the,0,0
155506,plasma,0,0
155507,cortisol,0,0
155508,and,0,0
155509,catecholamine,0,0
155510,concentrations,0,0
155511,of,0,0
155512,the,0,0
155513,offspring,1,0
155514,were,0,0
155515,determined,0,0
155516,on,0,0
155517,postnatal,0,0
155518,d,0,1
155519,(,0,0
155520,PND,0,0
155521,),0,1
155522,1,0,0
155523,and,0,0
155524,27,0,1
155525,and,0,0
155526,under,0,0
155527,specific,0,0
155528,challenging,0,1
155529,conditions,0,1
155530,:,0,1
155531,after,0,0
155532,weaning,0,0
155533,(,0,1
155534,PND,0,0
155535,29,0,1
155536,),0,0
155537,and,0,0
155538,after,0,0
155539,ACTH,0,1
155540,and,0,0
155541,insulin,0,0
155542,challenges,0,0
155543,(,0,1
155544,PND,0,0
155545,68,0,1
155546,and,0,0
155547,70,0,1
155548,",",0,0
155549,respectively,0,0
155550,),0,0
155551,.,0,0
155552,Glucocorticoid,0,0
155553,receptor,0,0
155554,(,0,0
155555,GR,0,0
155556,),0,0
155557,binding,0,0
155558,and,0,0
155559,neurotransmitter,0,0
155560,concentrations,0,0
155561,were,0,1
155562,measured,0,0
155563,in,0,0
155564,stress-related,0,0
155565,brain,0,0
155566,regions,0,0
155567,",",0,0
155568,and,0,0
155569,histological,0,0
155570,analyses,0,0
155571,of,0,0
155572,the,0,0
155573,adrenal,0,1
155574,were,0,0
155575,performed,0,0
155576,.,0,1
155577,Maternal,0,0
155578,salivary,0,1
155579,cortisol,0,0
155580,concentrations,0,0
155581,increased,0,0
155582,throughout,0,0
155583,gestation,0,1
155584,(,0,0
155585,P,0,0
155586,<,0,0
155587,0.001,0,0
155588,),0,0
155589,and,0,0
155590,the,0,0
155591,LP,0,0
155592,gilts,0,1
155593,had,0,1
155594,greater,0,0
155595,salivary,0,1
155596,cortisol,0,0
155597,compared,0,0
155598,with,0,1
155599,the,0,0
155600,AP,0,0
155601,and,0,0
155602,HP,0,0
155603,gilts,0,1
155604,(,0,1
155605,P,0,0
155606,<,0,0
155607,0.05,0,0
155608,),0,0
155609,.,0,1
155610,No,0,0
155611,differences,0,0
155612,between,0,0
155613,diets,0,0
155614,were,0,1
155615,found,0,0
155616,for,0,0
155617,cortisol,0,0
155618,",",0,0
155619,corticosteroid-binding,0,0
155620,globulin,0,0
155621,",",0,0
155622,and,0,0
155623,catecholamine,0,0
155624,concentrations,0,0
155625,in,0,0
155626,plasma,0,0
155627,and,0,0
155628,for,0,0
155629,GR,0,0
155630,binding,0,0
155631,in,0,0
155632,hippocampus,0,0
155633,and,0,0
155634,hypothalamus,0,0
155635,in,0,0
155636,piglets,1,1
155637,at,0,1
155638,PND,0,1
155639,1,0,1
155640,and,0,1
155641,27,0,1
155642,.,0,0
155643,However,0,0
155644,",",0,0
155645,the,0,0
155646,cortisol,0,0
155647,response,0,0
155648,to,0,0
155649,weaning,0,0
155650,was,0,0
155651,increased,0,0
155652,in,0,0
155653,LP,0,1
155654,piglets,0,1
155655,(,0,1
155656,P,0,0
155657,<,0,0
155658,0.05,0,0
155659,),0,0
155660,",",0,0
155661,and,0,0
155662,in,0,0
155663,HP,0,0
155664,offspring,0,0
155665,the,0,0
155666,basal,0,0
155667,plasma,0,0
155668,noradrenaline,0,0
155669,concentrations,0,0
155670,were,0,1
155671,increased,0,0
155672,(,0,0
155673,P,0,0
155674,<,0,0
155675,0.05,0,0
155676,),0,0
155677,.,0,0
155678,The,0,0
155679,cortisol,0,0
155680,response,0,0
155681,to,0,0
155682,the,0,0
155683,ACTH,0,0
155684,and,0,0
155685,the,0,0
155686,insulin,0,0
155687,challenge,0,0
155688,did,0,0
155689,not,0,0
155690,differ,0,0
155691,between,0,0
155692,diets,0,0
155693,.,0,1
155694,On,0,0
155695,PND,0,0
155696,81,0,1
155697,",",0,0
155698,an,0,0
155699,increased,0,0
155700,adrenal,0,1
155701,medulla,0,0
155702,area,0,0
155703,was,0,0
155704,observed,0,0
155705,in,0,0
155706,LP,0,0
155707,offspring,0,0
155708,compared,0,0
155709,with,0,1
155710,the,0,0
155711,AP,0,0
155712,offspring,0,0
155713,(,0,0
155714,P,0,0
155715,<,0,0
155716,0.05,0,0
155717,),0,0
155718,.,0,1
155719,Our,0,0
155720,results,0,0
155721,show,0,0
155722,that,0,0
155723,maternal,0,1
155724,diets,0,0
155725,with,0,1
155726,aberrant,0,1
155727,protein,0,0
155728,:,0,1
155729,carbohydrate,0,0
155730,ratios,0,0
155731,during,0,0
155732,gestation,0,1
155733,have,0,0
155734,moderate,0,1
155735,long-term,0,0
155736,effects,0,0
155737,on,0,0
155738,the,0,0
155739,function,0,0
155740,of,0,0
155741,the,0,0
155742,HPA,0,0
155743,and,0,0
155744,SAM,0,0
155745,system,0,0
155746,in,0,0
155747,the,0,0
155748,offspring,0,0
155749,",",0,0
155750,which,0,0
155751,indicates,0,0
155752,that,0,0
155753,pigs,1,0
155754,show,0,0
155755,a,0,0
155756,considerable,0,0
155757,plasticity,0,0
155758,to,0,0
155759,cope,0,0
155760,with,0,1
155761,maternal,0,0
155762,malnutrition,0,1
155763,.,0,1
155764,Prevalence,0,1
155765,and,0,0
155766,treatment,0,0
155767,outcome,0,0
155768,of,0,0
155769,cervicitis,1,1
155770,of,1,0
155771,unknown,1,0
155772,etiology,1,1
155773,.,1,1
155774,BACKGROUND,0,0
155775,Mucopurulent,0,1
155776,cervicitis,0,1
155777,(,0,0
155778,MPC,0,0
155779,),0,0
155780,is,0,0
155781,a,0,0
155782,clinical,0,0
155783,syndrome,0,1
155784,characterized,0,0
155785,by,0,0
155786,mucopurulent,0,1
155787,discharge,0,0
155788,from,0,0
155789,the,0,0
155790,cervix,0,1
155791,and,0,0
155792,other,0,0
155793,signs,0,0
155794,of,0,0
155795,inflammation,0,0
155796,.,0,0
155797,This,0,0
155798,was,0,0
155799,a,0,0
155800,phase,0,0
155801,III,0,0
155802,",",0,0
155803,multicenter,0,0
155804,study,0,0
155805,designed,0,0
155806,to,0,0
155807,evaluate,0,0
155808,the,0,0
155809,effectiveness,0,0
155810,of,0,0
155811,placebo,0,0
155812,versus,0,0
155813,empiric,0,0
155814,antibiotic,0,0
155815,treatment,0,0
155816,for,0,0
155817,clinical,0,0
155818,cure,0,0
155819,of,0,0
155820,MPC,0,0
155821,of,0,0
155822,unknown,0,0
155823,etiology,0,1
155824,at,0,0
155825,2-month,0,0
155826,follow-up,0,0
155827,.,0,0
155828,Unfortunately,0,0
155829,",",0,0
155830,enrollment,0,1
155831,was,0,0
155832,terminated,0,0
155833,because,0,0
155834,of,0,0
155835,low,0,1
155836,accrual,0,1
155837,of,0,1
155838,women,1,1
155839,with,1,1
155840,cervicitis,1,1
155841,of,1,0
155842,unknown,1,0
155843,etiology,1,0
155844,",",0,0
155845,but,0,0
155846,important,0,0
155847,prevalence,0,1
155848,and,0,0
155849,outcome,0,0
155850,data,0,0
155851,were,0,1
155852,obtained,0,0
155853,.,0,1
155854,METHODS,0,0
155855,Five,1,0
155856,hundred,1,1
155857,seventy-seven,1,1
155858,women,1,1
155859,were,1,1
155860,screened,1,1
155861,for,1,0
155862,MPC,1,1
155863,.,1,1
155864,Women,1,1
155865,with,1,1
155866,MPC,1,0
155867,were,0,0
155868,randomized,0,0
155869,to,0,0
155870,the,0,0
155871,treatment,0,0
155872,or,0,0
155873,placebo,0,0
155874,arm,0,0
155875,of,0,0
155876,the,0,0
155877,study,0,0
155878,",",0,0
155879,and,0,0
155880,the,0,0
155881,2,0,0
155882,arms,0,0
155883,were,0,1
155884,evaluated,0,0
155885,based,0,0
155886,on,0,0
155887,the,0,0
155888,etiology,0,0
155889,",",0,0
155890,clinical,0,0
155891,cure,0,0
155892,rates,0,0
155893,",",0,0
155894,adverse,0,0
155895,events,0,0
155896,(,0,1
155897,AEs,0,0
155898,),0,0
155899,",",0,0
155900,and,0,0
155901,rates,0,0
155902,of,0,0
155903,pelvic,0,1
155904,inflammatory,0,0
155905,disease,0,1
155906,.,0,1
155907,RESULTS,0,0
155908,One,1,1
155909,hundred,1,1
155910,thirty-one,1,1
155911,(,1,0
155912,23,1,1
155913,%,1,0
155914,[,1,0
155915,131/577,1,0
155916,],1,1
155917,),1,0
155918,screened,1,1
155919,women,1,1
155920,were,0,1
155921,found,0,0
155922,to,0,0
155923,have,0,0
155924,MPC,0,0
155925,.,0,0
155926,Eighty-seven,1,1
155927,were,1,0
155928,enrolled,1,1
155929,and,0,0
155930,randomized,0,0
155931,.,0,0
155932,After,0,0
155933,excluding,0,0
155934,women,0,1
155935,with,0,1
155936,sexually,0,1
155937,transmitted,0,0
155938,infections,0,0
155939,and,0,1
155940,other,0,0
155941,exclusions,0,0
155942,",",0,0
155943,61,0,1
155944,%,0,0
155945,(,0,1
155946,53/87,0,1
155947,),0,0
155948,had,0,0
155949,cervicitis,0,1
155950,of,0,0
155951,unknown,0,0
155952,etiology,0,1
155953,.,0,0
155954,The,0,0
155955,overall,0,0
155956,clinical,0,0
155957,failure,0,1
155958,rate,0,0
155959,was,0,0
155960,30,0,0
155961,%,0,0
155962,(,0,1
155963,10/33,0,0
155964,),0,0
155965,",",0,0
155966,and,0,0
155967,the,0,0
155968,clinical,0,0
155969,cure,0,0
155970,rate,0,0
155971,was,0,0
155972,only,0,0
155973,24,0,0
155974,%,0,0
155975,(,0,1
155976,8/33,0,0
155977,),0,1
155978,.,0,1
155979,Rates,0,0
155980,were,0,0
155981,not,0,0
155982,significantly,0,0
155983,different,0,0
155984,between,0,0
155985,the,0,0
155986,arms,0,0
155987,.,0,0
155988,There,0,0
155989,were,0,0
155990,24,0,0
155991,gastrointestinal,0,1
155992,AEs,0,0
155993,in,0,0
155994,the,0,0
155995,treatment,0,0
155996,arm,0,0
155997,compared,0,0
155998,with,0,1
155999,1,0,0
156000,AE,0,0
156001,in,0,0
156002,the,0,0
156003,placebo,0,0
156004,arm,0,0
156005,.,0,0
156006,CONCLUSIONS,0,0
156007,More,0,1
156008,than,0,0
156009,half,0,1
156010,of,0,0
156011,the,0,0
156012,cases,0,1
156013,of,0,0
156014,MPC,0,1
156015,were,0,0
156016,of,0,0
156017,unknown,0,0
156018,etiology,0,1
156019,.,0,1
156020,Clinical,0,0
156021,cure,0,0
156022,rates,0,0
156023,for,0,0
156024,the,0,0
156025,placebo,0,0
156026,and,0,0
156027,treatment,0,0
156028,arms,0,0
156029,were,0,0
156030,extremely,0,0
156031,low,0,0
156032,",",0,0
156033,with,0,1
156034,most,0,0
156035,women,0,1
156036,concluding,0,0
156037,the,0,0
156038,study,0,0
156039,with,0,0
156040,a,0,0
156041,partial,0,0
156042,response,0,0
156043,.,0,1
156044,Gastrointestinal,0,0
156045,AEs,0,0
156046,were,0,0
156047,higher,0,0
156048,in,0,0
156049,the,0,0
156050,treatment,0,0
156051,arm,0,0
156052,.,0,1
156053,Is,0,0
156054,the,0,0
156055,effect,0,0
156056,of,0,0
156057,mobile,0,1
156058,phone,0,0
156059,radiofrequency,0,0
156060,waves,0,1
156061,on,0,0
156062,human,0,1
156063,skin,0,1
156064,perfusion,0,0
156065,non-thermal,0,0
156066,?,0,0
156067,OBJECTIVE,0,0
156068,To,0,0
156069,establish,0,0
156070,whether,0,0
156071,SkBF,0,0
156072,can,0,0
156073,be,0,0
156074,modified,0,0
156075,by,0,0
156076,exposure,0,0
156077,to,0,0
156078,the,0,0
156079,radiofrequency,0,0
156080,waves,0,0
156081,emitted,0,0
156082,by,0,0
156083,a,0,0
156084,mobile,0,0
156085,phone,0,0
156086,when,0,0
156087,the,0,0
156088,latter,0,0
156089,is,0,0
156090,held,0,0
156091,against,0,0
156092,the,0,0
156093,jaw,0,0
156094,and,0,0
156095,ear,0,1
156096,.,0,1
156097,METHODS,0,0
156098,Variations,0,1
156099,in,0,0
156100,SkBF,0,0
156101,and,0,0
156102,Tsk,0,0
156103,in,0,0
156104,adult,1,1
156105,volunteers,1,1
156106,were,0,0
156107,simultaneously,0,0
156108,recorded,0,0
156109,with,0,0
156110,a,0,0
156111,thermostatic,0,0
156112,laser,0,0
156113,Doppler,0,0
156114,system,0,0
156115,during,0,0
156116,a,0,0
156117,20-minute,0,0
156118,radiofrequency,0,0
156119,exposure,0,0
156120,session,0,0
156121,and,0,0
156122,a,0,0
156123,20-minute,0,0
156124,sham,0,0
156125,session,0,0
156126,.,0,0
156127,The,0,0
156128,skin,0,0
156129,microvessels,0,0
156130,',0,1
156131,vasodilatory,0,0
156132,reserve,0,1
156133,was,0,0
156134,assessed,0,0
156135,with,0,1
156136,a,0,0
156137,heat,0,0
156138,challenge,0,0
156139,at,0,0
156140,the,0,0
156141,end,0,0
156142,of,0,0
156143,the,0,0
156144,protocol,0,0
156145,.,0,0
156146,RESULTS,0,0
156147,During,0,0
156148,the,0,0
156149,radiofrequency,0,0
156150,exposure,0,0
156151,session,0,0
156152,",",0,0
156153,SkBF,0,0
156154,increased,0,0
156155,(,0,0
156156,vs.,0,0
156157,baseline,0,0
156158,),0,0
156159,more,0,0
156160,than,0,0
156161,during,0,0
156162,the,0,0
156163,sham,0,0
156164,exposure,0,0
156165,session,0,0
156166,.,0,0
156167,The,0,0
156168,sessions,0,0
156169,did,0,0
156170,not,0,0
156171,differ,0,0
156172,significant,0,0
156173,in,0,0
156174,terms,0,0
156175,of,0,0
156176,the,0,0
156177,Tsk,0,0
156178,time-course,0,0
156179,response,0,0
156180,.,0,0
156181,The,0,0
156182,skin,0,0
156183,microvessels,0,0
156184,',0,1
156185,vasodilatory,0,0
156186,ability,0,0
156187,was,0,0
156188,found,0,0
156189,to,0,0
156190,be,0,0
156191,greater,0,0
156192,during,0,0
156193,radiofrequency,0,0
156194,exposure,0,0
156195,than,0,0
156196,during,0,0
156197,sham,0,0
156198,exposure,0,0
156199,.,0,1
156200,CONCLUSIONS,0,0
156201,Our,0,0
156202,results,0,0
156203,reveal,0,0
156204,the,0,0
156205,existence,0,0
156206,of,0,0
156207,a,0,0
156208,specific,0,0
156209,vasodilatory,0,0
156210,effect,0,0
156211,of,0,0
156212,mobile,0,1
156213,phone,0,0
156214,radiofrequency,0,0
156215,emission,0,1
156216,on,0,0
156217,skin,0,0
156218,perfusion,0,0
156219,.,0,1
156220,The,0,0
156221,role,0,0
156222,of,0,0
156223,treatment,0,0
156224,fidelity,0,0
156225,on,0,0
156226,outcomes,0,0
156227,during,0,0
156228,a,0,0
156229,randomized,0,0
156230,field,0,0
156231,trial,0,0
156232,of,0,0
156233,an,0,0
156234,autism,1,1
156235,intervention,0,0
156236,.,0,0
156237,This,0,0
156238,randomized,0,0
156239,field,0,0
156240,trial,0,0
156241,comparing,0,0
156242,Strategies,0,0
156243,for,0,0
156244,Teaching,0,0
156245,based,0,0
156246,on,0,0
156247,Autism,0,1
156248,Research,0,1
156249,and,0,0
156250,Structured,0,0
156251,Teaching,0,0
156252,enrolled,0,1
156253,educators,0,0
156254,in,0,1
156255,33,1,1
156256,kindergarten-through-second-grade,1,1
156257,autism,1,1
156258,support,1,0
156259,classrooms,1,1
156260,and,1,1
156261,119,1,1
156262,students,1,1
156263,",",1,0
156264,aged,1,1
156265,5-8,1,1
156266,years,1,1
156267,in,1,0
156268,the,1,0
156269,School,1,0
156270,District,1,1
156271,of,1,0
156272,Philadelphia,1,1
156273,.,1,1
156274,Students,1,0
156275,were,0,0
156276,assessed,0,0
156277,at,0,0
156278,the,0,0
156279,beginning,0,0
156280,and,0,0
156281,end,0,0
156282,of,0,0
156283,the,0,0
156284,academic,0,1
156285,year,0,0
156286,using,0,0
156287,the,0,0
156288,Differential,0,1
156289,Ability,0,0
156290,Scales,0,0
156291,.,0,1
156292,Program,0,0
156293,fidelity,0,0
156294,was,0,0
156295,measured,0,0
156296,through,0,0
156297,video,0,0
156298,coding,0,0
156299,and,0,0
156300,use,0,0
156301,of,0,0
156302,a,0,0
156303,checklist,0,0
156304,.,0,0
156305,Outcomes,0,0
156306,were,0,0
156307,assessed,0,0
156308,using,0,0
156309,linear,0,0
156310,regression,0,0
156311,with,0,1
156312,random,0,1
156313,effects,0,0
156314,for,0,0
156315,classroom,0,1
156316,and,0,0
156317,student,1,0
156318,.,1,0
156319,Average,0,0
156320,fidelity,0,0
156321,was,0,0
156322,57,0,1
156323,%,0,0
156324,in,0,0
156325,Strategies,0,0
156326,for,0,0
156327,Teaching,0,0
156328,based,0,0
156329,on,0,0
156330,Autism,0,1
156331,Research,0,1
156332,classrooms,0,1
156333,and,0,1
156334,48,0,0
156335,%,0,0
156336,in,0,0
156337,Structured,0,0
156338,Teaching,0,1
156339,classrooms,0,1
156340,.,0,0
156341,There,0,0
156342,was,0,0
156343,a,0,0
156344,9.2-point,0,0
156345,(,0,0
156346,standard,0,0
156347,deviation,0,1
156348,=,0,0
156349,9.6,0,0
156350,),0,0
156351,increase,0,0
156352,in,0,0
156353,Differential,0,1
156354,Ability,0,0
156355,Scales,0,0
156356,score,0,0
156357,over,0,0
156358,the,0,0
156359,8-month,0,0
156360,study,0,0
156361,period,0,0
156362,",",0,0
156363,but,0,0
156364,no,0,0
156365,main,0,0
156366,effect,0,0
156367,of,0,0
156368,program,0,0
156369,.,0,0
156370,There,0,0
156371,was,0,0
156372,a,0,0
156373,significant,0,0
156374,interaction,0,0
156375,between,0,0
156376,fidelity,0,0
156377,and,0,0
156378,group,0,0
156379,.,0,0
156380,In,0,0
156381,classrooms,0,1
156382,with,0,1
156383,either,0,1
156384,low,0,0
156385,or,0,1
156386,high,0,1
156387,program,0,0
156388,fidelity,0,0
156389,",",0,0
156390,students,1,1
156391,in,1,0
156392,Strategies,1,0
156393,for,1,0
156394,Teaching,1,0
156395,based,1,0
156396,on,1,0
156397,Autism,1,1
156398,Research,1,0
156399,experienced,0,0
156400,a,0,0
156401,greater,0,0
156402,gain,0,0
156403,in,0,0
156404,Differential,0,1
156405,Ability,0,0
156406,Scales,0,0
156407,score,0,0
156408,than,0,0
156409,students,1,1
156410,in,1,1
156411,Structured,1,0
156412,Teaching,1,0
156413,(,0,0
156414,11.2,0,0
156415,vs.,0,0
156416,5.5,0,0
156417,points,0,0
156418,and,0,1
156419,11.3,0,0
156420,vs.,0,0
156421,8.9,0,0
156422,points,0,0
156423,",",0,0
156424,respectively,0,0
156425,),0,0
156426,.,0,0
156427,In,0,0
156428,classrooms,0,1
156429,with,0,1
156430,moderate,0,1
156431,fidelity,0,0
156432,",",0,0
156433,students,1,1
156434,in,1,0
156435,Structured,1,1
156436,Teaching,1,0
156437,experienced,0,0
156438,a,0,0
156439,greater,0,0
156440,gain,0,0
156441,than,0,0
156442,students,1,1
156443,in,1,0
156444,Strategies,1,0
156445,for,1,0
156446,Teaching,1,0
156447,based,1,0
156448,on,1,0
156449,Autism,1,1
156450,Research,1,1
156451,(,0,0
156452,10.1,0,0
156453,vs.,0,0
156454,4.4,0,0
156455,points,0,0
156456,),0,1
156457,.,0,1
156458,The,0,0
156459,results,0,0
156460,suggest,0,0
156461,significant,0,0
156462,variability,0,0
156463,in,0,0
156464,implementation,0,0
156465,of,0,0
156466,evidence-based,0,0
156467,practices,0,1
156468,",",0,0
156469,even,0,0
156470,with,0,1
156471,supports,0,0
156472,",",0,0
156473,and,0,0
156474,also,0,0
156475,suggest,0,0
156476,the,0,0
156477,need,0,0
156478,to,0,0
156479,address,0,0
156480,challenging,0,0
156481,issues,0,0
156482,related,0,0
156483,to,0,0
156484,implementation,0,0
156485,measurement,0,0
156486,in,0,0
156487,community,0,1
156488,settings,0,1
156489,.,0,1
156490,Evaluation,0,0
156491,of,0,0
156492,the,0,0
156493,effect,0,0
156494,of,0,0
156495,low,0,0
156496,level,0,0
156497,laser,0,0
156498,on,0,0
156499,prevention,0,0
156500,of,0,0
156501,chemotherapy-induced,1,1
156502,mucositis,1,0
156503,.,1,0
156504,Radiotherapy,0,0
156505,in,0,0
156506,the,0,0
156507,head,0,1
156508,and,0,0
156509,neck,0,1
156510,region,0,1
156511,and,0,0
156512,chemotherapy,0,0
156513,might,0,0
156514,give,0,0
156515,rise,0,0
156516,to,0,0
156517,oral,0,0
156518,mucositis,0,0
156519,which,0,0
156520,is,0,0
156521,a,0,0
156522,severe,0,1
156523,and,0,0
156524,painful,0,0
156525,inflammation,0,0
156526,.,0,0
156527,There,0,0
156528,is,0,0
156529,no,0,0
156530,known,0,0
156531,definite,0,1
156532,cure,0,0
156533,for,0,0
156534,mucositis,0,0
156535,.,0,0
156536,A,0,0
156537,number,0,0
156538,of,0,0
156539,studies,0,0
156540,have,0,0
156541,attempted,0,0
156542,to,0,0
156543,evaluate,0,0
156544,the,0,0
156545,effect,0,0
156546,of,0,0
156547,low-power,0,0
156548,laser,0,0
156549,on,0,0
156550,radiotherapy-,0,1
156551,and,0,0
156552,chemotherapy-induced,0,1
156553,mucositis,0,0
156554,.,0,0
156555,The,0,0
156556,present,0,0
156557,study,0,0
156558,was,0,0
156559,undertaken,0,0
156560,to,0,0
156561,evaluate,0,0
156562,the,0,0
156563,effect,0,0
156564,of,0,0
156565,low-power,0,0
156566,laser,0,0
156567,on,0,0
156568,the,0,0
156569,prevention,0,0
156570,of,0,0
156571,mucositis,0,0
156572,",",0,0
156573,xerostomia,0,0
156574,and,0,0
156575,pain,0,0
156576,as,0,0
156577,a,0,0
156578,result,0,0
156579,of,0,0
156580,chemotherapy,0,0
156581,.,0,0
156582,The,0,0
156583,subjects,0,1
156584,in,0,0
156585,this,0,0
156586,double-blind,0,0
156587,randomized,0,0
156588,controlled,0,0
156589,study,0,0
156590,were,0,0
156591,24,1,0
156592,adult,1,1
156593,patients,1,1
156594,who,1,1
156595,underwent,1,1
156596,chemotherapy,1,1
156597,during,1,0
156598,2009-2010,1,1
156599,.,1,1
156600,The,0,0
156601,results,0,0
156602,showed,0,0
156603,that,0,0
156604,low-power,0,0
156605,laser,0,0
156606,was,0,0
156607,able,0,0
156608,to,0,0
156609,decrease,0,0
156610,the,0,0
156611,effect,0,0
156612,of,0,0
156613,chemotherapy,0,0
156614,on,0,0
156615,oral,0,0
156616,mucositis,0,0
156617,",",0,0
156618,xerostomia,0,0
156619,and,0,0
156620,pain,0,0
156621,in,0,0
156622,a,0,0
156623,variety,0,0
156624,of,0,0
156625,malignancies,0,1
156626,(,0,1
156627,P,0,0
156628,&,0,1
156629,lt,0,1
156630,;,0,0
156631,0.05,0,0
156632,),0,0
156633,.,0,0
156634,It,0,0
156635,can,0,0
156636,be,0,0
156637,concluded,0,0
156638,that,0,0
156639,low-power,0,0
156640,laser,0,0
156641,might,0,0
156642,decrease,0,0
156643,the,0,0
156644,intensity,0,0
156645,of,0,0
156646,mucositis,0,0
156647,.,0,1
156648,Double-blind,0,0
156649,",",0,0
156650,placebo-controlled,0,0
156651,",",0,0
156652,dose-ranging,0,0
156653,study,0,0
156654,of,0,0
156655,new,0,0
156656,recombinant,0,0
156657,hypoallergenic,0,0
156658,Bet,0,1
156659,v,0,0
156660,1,0,0
156661,in,0,0
156662,an,0,0
156663,environmental,0,0
156664,exposure,0,0
156665,chamber,0,1
156666,.,0,1
156667,BACKGROUND,0,0
156668,Recombinant,0,0
156669,allergens,0,0
156670,offer,0,0
156671,a,0,0
156672,tool,0,0
156673,for,0,0
156674,improving,0,0
156675,specific,0,0
156676,immunotherapy,0,1
156677,(,0,0
156678,SIT,0,1
156679,),0,0
156680,.,0,0
156681,OBJECTIVE,0,0
156682,To,0,0
156683,find,0,0
156684,the,0,0
156685,optimal,0,0
156686,dose,0,0
156687,of,0,0
156688,a,0,0
156689,new,0,0
156690,hypoallergenic,0,0
156691,folding,0,0
156692,variant,0,1
156693,of,0,0
156694,recombinant,0,0
156695,Bet,0,1
156696,v,0,0
156697,1,0,0
156698,(,0,0
156699,rBet,0,0
156700,v,0,0
156701,1-FV,0,1
156702,),0,1
156703,as,0,0
156704,SIT,0,1
156705,for,0,0
156706,patients,1,1
156707,with,1,1
156708,birch,1,1
156709,pollen,1,0
156710,allergy,1,1
156711,.,1,0
156712,METHODS,0,0
156713,Before,0,0
156714,SIT,0,1
156715,",",0,0
156716,thirty-seven,1,1
156717,adult,1,1
156718,patients,1,1
156719,were,1,0
156720,exposed,1,0
156721,for,1,0
156722,eight,1,1
156723,hours,1,0
156724,in,1,0
156725,an,1,0
156726,environmental,1,0
156727,exposure,1,0
156728,chamber,1,0
156729,(,1,0
156730,EEC,1,0
156731,),1,0
156732,to,1,0
156733,birch,1,1
156734,pollen,1,0
156735,at,1,0
156736,an,1,0
156737,average,1,0
156738,concentration,1,0
156739,of,1,0
156740,3500,1,1
156741,?,1,1
156742,500,1,0
156743,grains/m,1,0
156744,(,1,1
156745,3,1,0
156746,),1,0
156747,",",0,0
156748,then,0,0
156749,randomized,0,0
156750,to,0,0
156751,four,0,0
156752,maintenance,0,0
156753,dose,0,0
156754,groups,0,0
156755,of,0,0
156756,rBet,0,1
156757,v,0,0
156758,1-FV,0,1
156759,and,0,0
156760,one,0,1
156761,placebo,0,0
156762,group,0,1
156763,:,0,1
156764,20,0,0
156765,?g,0,0
156766,(,0,0
156767,n,0,1
156768,=,0,0
156769,7,0,1
156770,),0,0
156771,",",0,0
156772,80,0,1
156773,?g,0,0
156774,(,0,0
156775,n,0,1
156776,=,0,0
156777,8,0,0
156778,),0,0
156779,",",0,0
156780,160,0,1
156781,?g,0,0
156782,(,0,0
156783,n,0,1
156784,=,0,0
156785,7,0,1
156786,),0,0
156787,",",0,0
156788,320,0,1
156789,?g,0,0
156790,(,0,0
156791,n,0,1
156792,=,0,0
156793,8,0,0
156794,),0,0
156795,",",0,0
156796,and,0,0
156797,placebo,0,0
156798,(,0,0
156799,n,0,1
156800,=,0,0
156801,7,0,1
156802,),0,1
156803,.,0,1
156804,Patients,0,1
156805,were,0,0
156806,treated,0,1
156807,for,0,0
156808,10,0,1
156809,weeks,0,0
156810,with,0,1
156811,weekly,0,0
156812,injections,0,0
156813,and,0,0
156814,then,0,0
156815,re-exposed,0,0
156816,in,0,0
156817,the,0,0
156818,EEC,0,0
156819,.,0,0
156820,The,0,0
156821,optimal,0,0
156822,dose,0,0
156823,for,0,0
156824,SIT,0,1
156825,was,0,0
156826,assessed,0,0
156827,using,0,0
156828,efficacy,0,0
156829,results,0,0
156830,from,0,1
156831,the,0,0
156832,EEC,0,0
156833,",",0,0
156834,IgG,0,0
156835,responses,0,0
156836,",",0,0
156837,and,0,0
156838,tolerability,0,0
156839,.,0,0
156840,RESULTS,1,0
156841,Thirty-six,1,1
156842,patients,1,1
156843,were,1,1
156844,evaluable,0,1
156845,for,0,0
156846,efficacy,0,0
156847,assessment,0,0
156848,.,0,0
156849,The,0,0
156850,total,0,0
156851,symptom,0,0
156852,score,0,0
156853,significantly,0,0
156854,decreased,0,0
156855,in,0,0
156856,all,0,0
156857,active,0,1
156858,groups,0,0
156859,compared,0,0
156860,with,0,1
156861,placebo,0,0
156862,(,0,0
156863,-18.8,0,0
156864,%,0,0
156865,for,0,0
156866,placebo,0,0
156867,patients,0,1
156868,;,0,1
156869,-71.9,0,0
156870,%,0,0
156871,",",0,0
156872,P,0,0
156873,=,0,0
156874,0.0022,0,0
156875,for,0,0
156876,20,0,1
156877,?g,0,0
156878,;,0,1
156879,-75.6,0,0
156880,%,0,0
156881,",",0,0
156882,P,0,0
156883,=,0,0
156884,0.0007,0,0
156885,for,0,0
156886,80,0,1
156887,?g,0,0
156888,;,0,1
156889,-81.8,0,0
156890,%,0,0
156891,",",0,0
156892,P,0,0
156893,=,0,0
156894,0.0009,0,0
156895,for,0,0
156896,160,0,1
156897,?g,0,0
156898,;,0,1
156899,-78.3,0,0
156900,%,0,0
156901,",",0,0
156902,P,0,0
156903,=,0,0
156904,0.0003,0,0
156905,for,0,0
156906,320,0,1
156907,?g,0,0
156908,),0,1
156909,.,0,1
156910,IgG1,0,0
156911,increased,0,0
156912,significantly,0,0
156913,in,0,0
156914,all,0,0
156915,active,0,1
156916,groups,0,0
156917,compared,0,0
156918,to,0,0
156919,placebo,0,0
156920,.,0,0
156921,All,0,0
156922,four,0,0
156923,active,0,1
156924,doses,0,0
156925,were,0,1
156926,well,0,0
156927,tolerated,0,0
156928,",",0,0
156929,no,0,0
156930,serious,0,0
156931,adverse,0,0
156932,event,0,0
156933,occurred,0,0
156934,;,0,0
156935,two,0,0
156936,Grade,0,0
156937,II,0,1
156938,reactions,0,0
156939,",",0,0
156940,according,0,1
156941,to,0,0
156942,EAACI,0,0
156943,classification,0,0
156944,",",0,0
156945,were,0,0
156946,observed,0,0
156947,",",0,0
156948,one,0,0
156949,in,0,0
156950,each,0,0
156951,of,0,0
156952,the,0,0
156953,160-,0,1
156954,and,0,0
156955,320-?g,0,1
156956,groups,0,0
156957,.,0,1
156958,CONCLUSIONS,0,0
156959,Considering,0,0
156960,efficacy,0,0
156961,",",0,0
156962,immunological,0,0
156963,response,0,0
156964,",",0,0
156965,and,0,0
156966,tolerability,0,0
156967,",",0,0
156968,a,0,0
156969,maintenance,0,0
156970,dose,0,0
156971,of,0,0
156972,80,0,1
156973,?g,0,0
156974,of,0,0
156975,rBet,0,0
156976,v,0,0
156977,1-FV,0,0
156978,appears,0,0
156979,to,0,0
156980,be,0,0
156981,the,0,0
156982,ideal,0,0
156983,dose,0,0
156984,for,0,0
156985,allergen,0,0
156986,immunotherapy,1,0
156987,in,1,0
156988,birch,1,1
156989,pollen,1,1
156990,allergic,1,1
156991,patients,1,1
156992,.,1,1
156993,Study,0,0
156994,design,0,0
156995,and,0,0
156996,rationale,0,0
156997,of,0,0
156998,a,0,0
156999,dose-ranging,0,0
157000,trial,0,0
157001,of,0,0
157002,LX4211,0,0
157003,",",0,0
157004,a,0,0
157005,dual,0,0
157006,inhibitor,0,0
157007,of,0,0
157008,SGLT1,0,1
157009,and,0,0
157010,SGLT2,0,0
157011,",",0,0
157012,in,0,0
157013,type,1,1
157014,2,1,1
157015,diabetes,1,1
157016,inadequately,1,1
157017,controlled,1,0
157018,on,1,0
157019,metformin,1,0
157020,monotherapy,1,1
157021,.,1,1
157022,Sodium-glucose,0,0
157023,cotransporters,0,0
157024,1,0,1
157025,(,0,1
157026,SGLT1,0,1
157027,),0,0
157028,and,0,0
157029,2,0,0
157030,(,0,0
157031,SGLT2,0,0
157032,),0,0
157033,are,0,0
157034,the,0,0
157035,major,0,0
157036,cellular,0,0
157037,transporters,0,0
157038,responsible,0,0
157039,for,0,0
157040,gastrointestinal,0,1
157041,(,0,1
157042,GI,0,0
157043,),0,0
157044,glucose,0,0
157045,absorption,0,0
157046,and,0,0
157047,renal,0,1
157048,glucose,0,0
157049,reabsorption,0,0
157050,",",0,0
157051,respectively,0,0
157052,.,0,0
157053,LX4211,0,0
157054,",",0,0
157055,a,0,0
157056,dual,0,0
157057,inhibitor,0,0
157058,of,0,0
157059,SGLT1,0,1
157060,and,0,0
157061,SGLT2,0,0
157062,",",0,0
157063,reduces,0,0
157064,glucose,0,0
157065,absorption,0,0
157066,from,0,0
157067,the,0,0
157068,GI,0,0
157069,tract,0,1
157070,and,0,0
157071,enhances,0,0
157072,urinary,0,1
157073,glucose,0,0
157074,excretion,0,0
157075,.,0,0
157076,Although,0,0
157077,several,0,0
157078,SGLT2-selective,0,0
157079,inhibitors,0,0
157080,have,0,1
157081,been,0,0
157082,tested,0,0
157083,in,0,0
157084,large,0,1
157085,phase,0,1
157086,2,0,0
157087,studies,0,0
157088,",",0,0
157089,dual,0,1
157090,inhibition,0,0
157091,of,0,0
157092,SGLT1,0,1
157093,and,0,0
157094,SGLT2,0,0
157095,is,0,0
157096,novel,0,0
157097,at,0,0
157098,this,0,0
157099,stage,0,1
157100,of,0,0
157101,drug,0,0
157102,development,0,0
157103,",",0,0
157104,and,0,0
157105,it,0,0
157106,has,0,0
157107,implications,0,0
157108,for,0,0
157109,clinical-trial,0,1
157110,design,0,0
157111,.,0,0
157112,In,0,0
157113,this,0,0
157114,article,0,0
157115,",",0,0
157116,we,0,0
157117,describe,0,0
157118,the,0,0
157119,design,0,0
157120,and,0,0
157121,rationale,0,0
157122,of,0,0
157123,a,0,0
157124,phase,0,0
157125,2,0,0
157126,",",0,0
157127,multicenter,0,0
157128,",",0,0
157129,randomized,0,0
157130,",",0,0
157131,double-blind,0,0
157132,",",0,0
157133,placebo-controlled,0,0
157134,",",0,0
157135,parallel,0,0
157136,group,0,0
157137,study,0,0
157138,to,0,0
157139,evaluate,0,0
157140,the,0,0
157141,safety,0,0
157142,and,0,0
157143,efficacy,0,0
157144,of,0,0
157145,LX4211,0,0
157146,in,0,0
157147,subjects,1,1
157148,with,1,1
157149,type,1,1
157150,2,1,1
157151,diabetes,1,1
157152,mellitus,1,1
157153,who,1,1
157154,have,1,1
157155,inadequate,1,1
157156,glycemic,1,0
157157,control,1,1
157158,on,1,0
157159,metformin,1,0
157160,monotherapy,1,0
157161,.,1,0
157162,The,0,0
157163,primary,0,0
157164,endpoint,0,0
157165,is,0,0
157166,the,0,0
157167,change,0,0
157168,in,0,0
157169,glycated,0,1
157170,hemoglobin,0,0
157171,A1c,0,1
157172,from,0,0
157173,baseline,0,0
157174,to,0,0
157175,week,0,0
157176,12,0,0
157177,.,0,1
157178,Secondary,0,0
157179,endpoints,0,0
157180,include,0,0
157181,the,0,0
157182,proportion,0,0
157183,of,0,0
157184,subjects,0,1
157185,achieving,0,0
157186,a,0,0
157187,glycated,0,0
157188,hemoglobin,0,0
157189,A1c,0,0
157190,value,0,0
157191,of,0,0
157192,<,0,0
157193,7,0,0
157194,%,0,0
157195,",",0,0
157196,change,0,0
157197,from,0,0
157198,baseline,0,0
157199,in,0,0
157200,fasting,0,0
157201,plasma,0,0
157202,glucose,0,0
157203,and,0,0
157204,postprandial,0,0
157205,glucose,0,0
157206,(,0,0
157207,as,0,0
157208,part,0,0
157209,of,0,0
157210,an,0,0
157211,oral,0,0
157212,glucose,0,0
157213,tolerance,0,0
157214,test,0,0
157215,),0,0
157216,",",0,0
157217,body,0,0
157218,weight,0,0
157219,",",0,0
157220,and,0,0
157221,blood,0,0
157222,pressure,0,0
157223,.,0,0
157224,Safety,0,0
157225,is,0,0
157226,evaluated,0,0
157227,with,0,0
157228,particular,0,0
157229,focus,0,0
157230,on,0,0
157231,hypoglycemia,0,0
157232,",",0,0
157233,GI,0,0
157234,symptoms,0,0
157235,",",0,0
157236,and,0,0
157237,incidence,0,0
157238,of,0,0
157239,genitourinary,0,1
157240,tract,0,1
157241,infections,0,1
157242,.,0,1
157243,[,0,0
157244,The,0,0
157245,effects,0,0
157246,of,0,0
157247,early,0,1
157248,enteral,0,1
157249,nutrition,0,0
157250,with,0,1
157251,addition,0,0
157252,of,0,0
157253,probiotics,0,0
157254,on,0,0
157255,the,0,0
157256,prognosis,0,0
157257,of,0,0
157258,patients,1,1
157259,suffering,1,1
157260,from,1,1
157261,severe,1,1
157262,acute,1,1
157263,pancreatitis,1,1
157264,],1,1
157265,.,0,1
157266,OBJECTIVE,0,0
157267,To,0,0
157268,investigate,0,0
157269,the,0,0
157270,curative,0,0
157271,effect,0,0
157272,of,0,0
157273,early,0,1
157274,enteral,0,1
157275,nutrition,0,0
157276,(,0,0
157277,EN,0,0
157278,),0,0
157279,supplemented,0,0
157280,with,0,1
157281,probiotics,0,0
157282,(,0,1
157283,bifidobacterium,0,0
157284,),0,0
157285,in,0,0
157286,patients,1,1
157287,with,1,1
157288,severe,1,1
157289,acute,1,1
157290,pancreatitis,1,1
157291,(,1,0
157292,ASP,1,1
157293,),1,1
157294,.,1,1
157295,METHODS,0,0
157296,Seventy,1,1
157297,SAP,1,1
157298,cases,1,1
157299,admitted,1,1
157300,from,1,1
157301,January,1,1
157302,2005,1,1
157303,to,1,0
157304,October,1,1
157305,2012,1,1
157306,were,1,0
157307,randomly,1,1
157308,assigned,1,0
157309,into,0,0
157310,parenteral,1,0
157311,nutrition,1,0
157312,(,1,0
157313,PN,1,0
157314,),1,0
157315,group,1,0
157316,(,1,0
157317,n=22,1,1
157318,),1,0
157319,",",1,0
157320,EN,1,0
157321,group,1,0
157322,(,1,0
157323,n=25,1,1
157324,),1,0
157325,and,1,0
157326,bifidobacterium,1,0
157327,added,1,0
157328,EN,1,0
157329,(,1,0
157330,P+EN,1,1
157331,),1,0
157332,group,1,0
157333,(,1,0
157334,n=23,1,1
157335,),1,0
157336,.,1,0
157337,In,0,0
157338,P+EN,0,1
157339,group,0,0
157340,",",0,0
157341,patients,0,1
157342,were,0,0
157343,given,0,0
157344,their,0,0
157345,nutrition,0,0
157346,the,0,0
157347,same,0,0
157348,as,0,0
157349,that,0,0
157350,of,0,0
157351,EN,0,0
157352,",",0,0
157353,and,0,0
157354,also,0,0
157355,probiotics,0,0
157356,(,0,0
157357,bifidobacterium,0,0
157358,",",0,0
157359,4,0,0
157360,capsules,0,0
157361,every,0,0
157362,12,0,0
157363,hours,0,0
157364,",",0,0
157365,given,0,0
157366,through,0,0
157367,nasal,0,0
157368,gastric,0,1
157369,tube,0,0
157370,",",0,0
157371,each,0,0
157372,capsule,0,0
157373,weighing,0,1
157374,210,0,1
157375,mg,0,0
157376,),0,0
157377,.,0,0
157378,The,0,0
157379,routine,0,0
157380,treatment,0,0
157381,including,0,0
157382,anti-infection,0,0
157383,and,0,0
157384,anti-acid,0,0
157385,agents,0,0
157386,",",0,0
157387,and,0,0
157388,that,0,0
157389,of,0,0
157390,inhibition,0,0
157391,of,0,0
157392,pancreatic,0,1
157393,secretion,0,0
157394,were,0,0
157395,given,0,0
157396,",",0,0
157397,except,0,0
157398,for,0,0
157399,the,0,0
157400,different,0,0
157401,nutritional,0,0
157402,interventions,0,0
157403,in,0,0
157404,all,0,1
157405,groups,0,0
157406,.,0,0
157407,The,0,0
157408,blood,0,0
157409,samples,0,0
157410,were,0,0
157411,collected,0,0
157412,for,0,0
157413,e,0,0
157414,same,0,0
157415,measurements,0,0
157416,of,0,0
157417,interleukin-8,0,0
157418,(,0,1
157419,IL-8,0,0
157420,),0,0
157421,and,0,0
157422,tumor,0,0
157423,necrosis,0,0
157424,factor,0,0
157425,(,0,0
157426,TNF-?,0,0
157427,),0,0
157428,by,0,0
157429,enzyme,0,0
157430,linked,0,0
157431,immunosorbent,0,0
157432,assay,0,0
157433,(,0,0
157434,ELISA,0,1
157435,),0,0
157436,",",0,0
157437,and,0,0
157438,for,0,0
157439,the,0,0
157440,C-reactive,0,0
157441,protein,0,0
157442,(,0,0
157443,CRP,0,0
157444,),0,0
157445,",",0,0
157446,lactic,0,0
157447,acid,0,0
157448,dehydrogenase,0,0
157449,(,0,0
157450,LDH,0,0
157451,),0,0
157452,",",0,0
157453,white,0,1
157454,blood,0,0
157455,cell,0,1
157456,(,0,0
157457,WBC,0,0
157458,),0,0
157459,count,0,0
157460,",",0,0
157461,amylase,0,0
157462,and,0,0
157463,lipase,0,0
157464,by,0,0
157465,biochemistry,0,0
157466,assay,0,0
157467,1,0,0
157468,day,0,0
157469,before,0,0
157470,intervention,0,0
157471,of,0,0
157472,nutrition,0,0
157473,",",0,0
157474,and,0,0
157475,7,0,0
157476,days,0,0
157477,and,0,1
157478,14,0,1
157479,days,0,0
157480,after,0,0
157481,intervention,0,0
157482,.,0,1
157483,Changes,0,0
157484,in,0,0
157485,organ,0,1
157486,function,0,0
157487,and,0,0
157488,outcome,0,0
157489,were,0,0
157490,also,0,0
157491,recorded,0,0
157492,at,0,0
157493,the,0,0
157494,same,0,0
157495,time,0,0
157496,points,0,0
157497,.,0,0
157498,RESULTS,0,0
157499,The,0,0
157500,plasma,0,0
157501,levels,0,0
157502,of,0,0
157503,IL-8,0,0
157504,",",0,0
157505,TNF-?,0,0
157506,",",0,0
157507,CRP,0,0
157508,",",0,0
157509,LDH,0,0
157510,",",0,0
157511,WBC,0,0
157512,count,0,0
157513,",",0,0
157514,amylase,0,0
157515,and,0,0
157516,lipase,0,0
157517,were,0,0
157518,significantly,0,0
157519,reduced,0,0
157520,after,0,0
157521,nutritional,0,0
157522,intervention,0,0
157523,compared,0,0
157524,with,0,1
157525,their,0,0
157526,levels,0,0
157527,on,0,0
157528,day,0,0
157529,1,0,0
157530,before,0,0
157531,intervention,0,0
157532,in,0,0
157533,all,0,0
157534,three,0,0
157535,groups,0,0
157536,.,0,1
157537,The,0,0
157538,plasma,0,0
157539,IL-8,0,0
157540,",",0,0
157541,TNF-?,0,0
157542,",",0,0
157543,CRP,0,0
157544,",",0,0
157545,lipase,0,0
157546,",",0,0
157547,LDH,0,0
157548,at,0,0
157549,14,0,1
157550,days,0,0
157551,after,0,0
157552,intervention,0,0
157553,of,0,0
157554,nutrition,0,0
157555,in,0,0
157556,P+EN,0,1
157557,group,0,0
157558,were,0,0
157559,significantly,0,0
157560,lower,0,0
157561,than,0,0
157562,those,0,0
157563,in,0,0
157564,PN,0,0
157565,group,0,1
157566,and,0,0
157567,EN,0,0
157568,group,0,0
157569,(,0,1
157570,IL-8,0,0
157571,:,0,1
157572,21.00,0,0
157573,?,0,0
157574,7.07,0,0
157575,?g/L,0,0
157576,vs.,0,0
157577,48.00,0,0
157578,?,0,0
157579,10.32,0,0
157580,?g/L,0,0
157581,",",0,0
157582,32.00,0,0
157583,?,0,0
157584,9.30,0,0
157585,?g/L,0,0
157586,;,0,1
157587,TNF-?,0,1
157588,:,0,1
157589,44.3,0,1
157590,?,0,1
157591,10.9,0,0
157592,ng/L,0,1
157593,vs.,0,0
157594,132.1,0,0
157595,?,0,0
157596,34.1,0,0
157597,ng/L,0,0
157598,",",0,0
157599,67.8,0,0
157600,?,0,0
157601,22.3,0,0
157602,ng/L,0,1
157603,;,0,1
157604,CRP,0,1
157605,:,0,1
157606,35.0,0,0
157607,?,0,0
157608,12.4,0,0
157609,mg/L,0,0
157610,vs.,0,0
157611,103.2,0,0
157612,?,0,0
157613,49.2,0,0
157614,mg/L,0,0
157615,",",0,0
157616,63.0,0,0
157617,?,0,0
157618,29.2,0,0
157619,mg/L,0,0
157620,;,0,1
157621,lipase,0,0
157622,:,0,1
157623,269,0,1
157624,?,0,1
157625,79,0,0
157626,U/L,0,1
157627,vs.,0,0
157628,670,0,1
157629,?,0,1
157630,145,0,1
157631,U/L,0,0
157632,",",0,1
157633,310,0,1
157634,?,0,0
157635,78,0,1
157636,U/L,0,1
157637,;,0,1
157638,LDH,0,0
157639,:,0,1
157640,21.8,0,1
157641,?,0,1
157642,10.3,0,0
157643,U/L,0,1
157644,vs.,0,0
157645,78.1,0,0
157646,?,0,1
157647,37.4,0,0
157648,U/L,0,0
157649,",",0,1
157650,37.9,0,0
157651,?,0,0
157652,25.1,0,0
157653,U/L,0,0
157654,",",0,0
157655,P,0,0
157656,<,0,0
157657,0.05,0,0
157658,or,0,0
157659,P,0,0
157660,<,0,0
157661,0.01,0,0
157662,),0,0
157663,.,0,0
157664,The,0,0
157665,WBC,0,0
157666,count,0,0
157667,in,0,0
157668,P+EN,0,1
157669,group,0,0
157670,was,0,0
157671,significantly,0,0
157672,lower,0,0
157673,than,0,0
157674,that,0,0
157675,in,0,0
157676,PN,0,0
157677,group,0,1
157678,(,0,0
157679,5.9,0,0
157680,?,0,1
157681,3.0,0,0
157682,?,0,0
157683,10?/L,0,0
157684,",",0,0
157685,6.3,0,0
157686,?,0,1
157687,3.2,0,0
157688,?,0,0
157689,10?/L,0,0
157690,vs.,0,0
157691,9.6,0,0
157692,?,0,1
157693,3.0,0,0
157694,?10?/L,0,0
157695,",",0,0
157696,both,0,0
157697,P,0,0
157698,<,0,0
157699,0.05,0,0
157700,),0,0
157701,",",0,0
157702,but,0,0
157703,there,0,0
157704,was,0,0
157705,no,0,0
157706,significant,0,0
157707,difference,0,0
157708,in,0,0
157709,amylase,0,0
157710,between,0,0
157711,P+EN,0,1
157712,group,0,1
157713,and,0,0
157714,PN,0,0
157715,group,0,0
157716,(,0,0
157717,211,0,1
157718,?,0,1
157719,49,0,0
157720,U/L,0,0
157721,",",0,1
157722,236,0,1
157723,?,0,0
157724,52,0,1
157725,U/L,0,1
157726,vs.,0,0
157727,298,0,1
157728,?,0,1
157729,71,0,0
157730,U/L,0,0
157731,",",0,0
157732,P,0,0
157733,>,0,1
157734,0.05,0,0
157735,),0,0
157736,.,0,0
157737,The,0,0
157738,gastrointestinal,0,0
157739,dysfunction,0,0
157740,score,0,0
157741,in,0,0
157742,P+EN,0,1
157743,",",0,0
157744,EN,0,0
157745,",",0,0
157746,PN,0,0
157747,groups,0,0
157748,14,0,1
157749,days,0,0
157750,after,0,0
157751,nutritional,0,0
157752,intervention,0,0
157753,was,0,0
157754,0.28,0,0
157755,?,0,0
157756,0.05,0,0
157757,",",0,0
157758,0.43,0,0
157759,?,0,0
157760,0.09,0,0
157761,",",0,0
157762,0.71,0,0
157763,?,0,0
157764,0.11,0,0
157765,",",0,0
157766,respectively,0,0
157767,",",0,0
157768,with,0,0
157769,statistically,0,0
157770,significant,0,0
157771,differences,0,0
157772,(,0,1
157773,all,0,1
157774,P,0,0
157775,<,0,0
157776,0.01,0,0
157777,),0,1
157778,.,0,0
157779,Compared,0,0
157780,with,0,1
157781,PN,0,0
157782,and,0,1
157783,EN,0,0
157784,groups,0,0
157785,",",0,0
157786,the,0,0
157787,incidence,0,0
157788,of,0,0
157789,upper,0,1
157790,gastrointestinal,0,1
157791,bleeding,0,1
157792,(,0,0
157793,1,0,0
157794,vs.,0,0
157795,9,0,0
157796,",",0,0
157797,2,0,0
157798,),0,0
157799,",",0,0
157800,infection,0,0
157801,and,0,0
157802,abscess,0,1
157803,(,0,0
157804,2,0,0
157805,vs.,0,0
157806,12,0,0
157807,",",0,0
157808,5,0,0
157809,),0,0
157810,was,0,0
157811,lower,0,0
157812,(,0,0
157813,all,0,0
157814,P,0,0
157815,<,0,0
157816,0.01,0,0
157817,),0,0
157818,",",0,0
157819,and,0,0
157820,hospital,0,1
157821,day,0,0
157822,was,0,0
157823,significantly,0,0
157824,shortened,0,0
157825,in,0,0
157826,P+EN,0,1
157827,group,0,1
157828,(,0,0
157829,10.4,0,0
157830,?,0,1
157831,3.9,0,0
157832,days,0,0
157833,vs.,0,0
157834,25.8,0,1
157835,?,0,1
157836,6.4,0,0
157837,days,0,0
157838,",",0,1
157839,13.4,0,0
157840,?,0,1
157841,5.2,0,0
157842,days,0,0
157843,",",0,0
157844,both,0,0
157845,P,0,0
157846,<,0,0
157847,0.01,0,0
157848,),0,0
157849,.,0,0
157850,There,0,0
157851,was,0,0
157852,no,0,0
157853,significant,0,0
157854,statistical,0,0
157855,difference,0,0
157856,in,0,0
157857,mortality,0,0
157858,rate,0,0
157859,among,0,0
157860,three,0,1
157861,groups,0,0
157862,.,0,1
157863,CONCLUSION,0,0
157864,Our,0,0
157865,results,0,0
157866,indicated,0,0
157867,that,0,0
157868,early,0,1
157869,EN,0,0
157870,with,0,1
157871,addition,0,0
157872,of,0,0
157873,probiotics,0,0
157874,(,0,1
157875,bifidobacterium,0,0
157876,),0,0
157877,resulted,0,0
157878,in,0,0
157879,significant,0,0
157880,lowering,0,0
157881,of,0,0
157882,the,0,0
157883,level,0,0
157884,of,0,0
157885,pro-inflammatory,0,0
157886,cytokines,0,0
157887,",",0,0
157888,earlier,0,0
157889,restoration,0,0
157890,of,0,0
157891,gastrointestinal,0,1
157892,function,0,0
157893,",",0,0
157894,decrease,0,0
157895,of,0,0
157896,complications,0,0
157897,such,0,0
157898,as,0,0
157899,infection,0,0
157900,",",0,0
157901,and,0,0
157902,shortening,0,0
157903,of,0,0
157904,hospital,0,1
157905,day,0,0
157906,in,0,0
157907,patients,0,1
157908,with,0,1
157909,SAP,0,1
157910,.,0,1
157911,Environmental,0,0
157912,enrichment,0,0
157913,as,0,0
157914,an,0,0
157915,effective,0,0
157916,treatment,0,0
157917,for,0,0
157918,autism,0,1
157919,:,0,1
157920,a,0,0
157921,randomized,0,0
157922,controlled,0,0
157923,trial,0,0
157924,.,0,0
157925,Enriched,0,0
157926,sensorimotor,0,0
157927,environments,0,0
157928,enable,0,0
157929,rodents,0,1
157930,to,0,0
157931,compensate,0,0
157932,for,0,0
157933,a,0,0
157934,wide,0,1
157935,range,0,0
157936,of,0,0
157937,neurological,0,1
157938,challenges,0,0
157939,",",0,0
157940,including,0,0
157941,those,0,0
157942,induced,0,0
157943,in,0,0
157944,animal,0,1
157945,models,0,0
157946,of,0,0
157947,autism,0,1
157948,.,0,0
157949,Given,0,0
157950,the,0,0
157951,sensorimotor,0,0
157952,deficits,0,0
157953,in,0,0
157954,most,0,0
157955,children,1,1
157956,with,1,1
157957,autism,1,1
157958,",",0,0
157959,we,0,0
157960,attempted,0,0
157961,to,0,0
157962,translate,0,0
157963,that,0,0
157964,approach,0,0
157965,to,0,0
157966,their,0,0
157967,treatment,0,0
157968,.,0,0
157969,In,0,0
157970,a,0,0
157971,randomized,0,0
157972,controlled,0,0
157973,trial,0,0
157974,",",0,0
157975,3-12,1,1
157976,year-old,1,1
157977,children,1,1
157978,with,1,1
157979,autism,1,1
157980,were,0,0
157981,assigned,0,0
157982,to,0,0
157983,either,0,0
157984,a,0,0
157985,sensorimotor,0,0
157986,enrichment,0,0
157987,group,0,0
157988,",",0,0
157989,which,0,0
157990,received,0,0
157991,daily,0,0
157992,olfactory/tactile,0,0
157993,stimulation,0,0
157994,along,0,0
157995,with,0,1
157996,exercises,0,0
157997,that,0,0
157998,stimulated,0,0
157999,other,0,0
158000,paired,0,0
158001,sensory,0,1
158002,modalities,0,0
158003,",",0,0
158004,or,0,1
158005,to,0,0
158006,a,0,0
158007,control,0,0
158008,group,0,0
158009,.,0,0
158010,We,0,0
158011,administered,0,0
158012,tests,0,0
158013,of,0,0
158014,cognitive,0,1
158015,performance,0,0
158016,and,0,0
158017,autism,0,1
158018,severity,0,0
158019,to,0,0
158020,both,0,0
158021,groups,0,0
158022,at,0,0
158023,the,0,0
158024,initiation,0,0
158025,of,0,0
158026,the,0,0
158027,study,0,0
158028,and,0,0
158029,after,0,0
158030,6,0,0
158031,months,0,0
158032,.,0,1
158033,Severity,0,0
158034,of,0,0
158035,autism,0,1
158036,",",0,0
158037,as,0,0
158038,assessed,0,0
158039,with,0,1
158040,the,0,0
158041,Childhood,0,1
158042,Autism,0,1
158043,Rating,0,0
158044,Scale,0,0
158045,",",0,0
158046,improved,0,0
158047,significantly,0,0
158048,in,0,0
158049,the,0,0
158050,enriched,0,0
158051,group,0,0
158052,compared,0,0
158053,to,0,0
158054,controls,0,1
158055,.,0,0
158056,Indeed,0,0
158057,",",0,0
158058,42,0,1
158059,%,0,0
158060,of,0,0
158061,the,0,0
158062,enriched,0,0
158063,group,0,0
158064,and,0,0
158065,only,0,0
158066,7,0,0
158067,%,0,0
158068,of,0,0
158069,the,0,0
158070,control,0,0
158071,group,0,1
158072,had,0,1
158073,what,0,0
158074,we,0,1
158075,considered,0,1
158076,to,0,0
158077,be,0,0
158078,a,0,0
158079,clinically,0,0
158080,significant,0,0
158081,improvement,0,0
158082,of,0,0
158083,5,0,0
158084,points,0,0
158085,on,0,0
158086,that,0,0
158087,scale,0,0
158088,.,0,0
158089,Sensorimotor,0,0
158090,enrichment,0,0
158091,also,0,0
158092,produced,0,0
158093,a,0,0
158094,clear,0,0
158095,improvement,0,0
158096,in,0,0
158097,cognition,0,0
158098,",",0,0
158099,as,0,0
158100,determined,0,0
158101,by,0,0
158102,their,0,0
158103,Leiter-R,0,0
158104,Visualization,0,0
158105,and,0,1
158106,Reasoning,0,1
158107,scores,0,0
158108,.,0,1
158109,At,0,0
158110,6,0,0
158111,months,0,0
158112,",",0,0
158113,the,0,0
158114,change,0,0
158115,in,0,0
158116,average,0,0
158117,scores,0,0
158118,for,0,0
158119,the,0,0
158120,enriched,0,0
158121,group,0,0
158122,was,0,0
158123,11.3,0,0
158124,points,0,0
158125,higher,0,0
158126,than,0,0
158127,that,0,0
158128,for,0,0
158129,the,0,0
158130,control,0,0
158131,group,0,0
158132,.,0,0
158133,Finally,0,0
158134,",",0,0
158135,69,0,0
158136,%,0,0
158137,of,0,0
158138,parents,0,1
158139,in,0,0
158140,the,0,0
158141,enriched,0,0
158142,group,0,0
158143,and,0,0
158144,31,0,1
158145,%,0,0
158146,of,0,0
158147,parents,0,1
158148,in,0,0
158149,the,0,0
158150,control,0,0
158151,group,0,0
158152,reported,0,0
158153,improvement,0,0
158154,in,0,0
158155,their,0,0
158156,child,0,1
158157,over,0,0
158158,the,0,0
158159,6-month,0,0
158160,study,0,0
158161,.,0,1
158162,Environmental,0,0
158163,enrichment,0,0
158164,therefore,0,0
158165,appears,0,0
158166,to,0,0
158167,be,0,0
158168,effective,0,0
158169,in,0,0
158170,ameliorating,0,0
158171,some,0,0
158172,of,0,0
158173,the,0,0
158174,symptoms,0,0
158175,of,0,0
158176,autism,0,1
158177,in,0,0
158178,children,0,1
158179,.,0,1
158180,Methylphenidate,0,0
158181,and/or,0,0
158182,a,0,0
158183,nursing,0,0
158184,telephone,0,0
158185,intervention,0,0
158186,for,0,0
158187,fatigue,0,0
158188,in,0,0
158189,patients,1,1
158190,with,1,1
158191,advanced,1,1
158192,cancer,1,1
158193,:,1,1
158194,a,0,0
158195,randomized,0,0
158196,",",0,0
158197,placebo-controlled,0,0
158198,",",0,0
158199,phase,0,1
158200,II,0,1
158201,trial,0,0
158202,.,0,0
158203,PURPOSE,0,0
158204,Cancer-related-fatigue,0,0
158205,(,0,0
158206,CRF,0,0
158207,),0,0
158208,is,0,0
158209,common,0,0
158210,in,0,0
158211,advanced,1,1
158212,cancer,1,1
158213,.,1,0
158214,The,0,0
158215,primary,0,0
158216,objective,0,0
158217,of,0,0
158218,the,0,0
158219,study,0,0
158220,was,0,0
158221,to,0,0
158222,compare,0,0
158223,the,0,0
158224,effects,0,0
158225,of,0,0
158226,methylphenidate,0,1
158227,(,0,0
158228,MP,0,0
158229,),0,0
158230,with,0,1
158231,those,0,0
158232,of,0,0
158233,placebo,0,0
158234,(,0,0
158235,PL,0,0
158236,),0,0
158237,on,0,0
158238,CRF,0,0
158239,as,0,0
158240,measured,0,0
158241,using,0,0
158242,the,0,0
158243,Functional,0,0
158244,Assessment,0,0
158245,of,0,0
158246,Chronic,0,1
158247,Illness,0,0
158248,Therapy-Fatigue,0,1
158249,(,0,0
158250,FACIT-F,0,0
158251,),0,0
158252,fatigue,0,0
158253,subscale,0,0
158254,.,0,0
158255,The,0,0
158256,effect,0,0
158257,of,0,0
158258,a,0,0
158259,combined,0,0
158260,intervention,0,0
158261,including,0,0
158262,MP,0,0
158263,plus,0,0
158264,a,0,0
158265,nursing,0,0
158266,telephone,0,0
158267,intervention,0,0
158268,(,0,0
158269,NTI,0,1
158270,),0,0
158271,was,0,0
158272,also,0,0
158273,assessed,0,0
158274,.,0,0
158275,PATIENTS,0,0
158276,AND,0,0
158277,METHODS,0,0
158278,Patients,1,1
158279,with,1,1
158280,advanced,1,1
158281,cancer,1,1
158282,with,1,1
158283,a,1,0
158284,fatigue,1,0
158285,score,1,0
158286,of,1,0
158287,?,1,0
158288,4,1,0
158289,out,1,0
158290,of,1,0
158291,10,1,1
158292,on,1,0
158293,the,1,0
158294,Edmonton,1,1
158295,Symptom,1,1
158296,Assessment,1,0
158297,Scale,1,0
158298,(,1,0
158299,ESAS,1,1
158300,),1,0
158301,were,1,0
158302,randomly,0,1
158303,assigned,0,1
158304,to,0,0
158305,one,0,0
158306,of,0,0
158307,the,0,0
158308,following,0,0
158309,four,0,1
158310,groups,0,1
158311,:,0,1
158312,MP+NTI,0,0
158313,",",0,0
158314,PL+NTI,0,0
158315,",",0,0
158316,MP,0,0
158317,+,0,0
158318,control,0,0
158319,telephone,0,0
158320,intervention,0,0
158321,(,0,0
158322,CTI,0,0
158323,),0,0
158324,",",0,0
158325,and,0,0
158326,PL+CTI,0,1
158327,.,0,1
158328,Methylphenidate,0,0
158329,dose,0,0
158330,was,0,0
158331,5,0,0
158332,mg,0,0
158333,every,0,0
158334,2,0,0
158335,hours,0,0
158336,as,0,0
158337,needed,0,0
158338,up,0,0
158339,to,0,0
158340,20,0,1
158341,mg,0,0
158342,per,0,1
158343,day,0,0
158344,.,0,0
158345,The,0,0
158346,primary,0,0
158347,end,0,0
158348,point,0,0
158349,was,0,0
158350,the,0,0
158351,median,0,0
158352,difference,0,0
158353,in,0,0
158354,FACIT-F,0,0
158355,fatigue,0,0
158356,at,0,0
158357,day,0,0
158358,15,0,1
158359,.,0,1
158360,Secondary,0,1
158361,outcomes,0,0
158362,included,0,1
158363,anxiety,0,0
158364,",",0,0
158365,depression,0,0
158366,",",0,0
158367,and,0,0
158368,sleep,0,0
158369,.,0,0
158370,RESULTS,1,0
158371,One,1,1
158372,hundred,1,1
158373,forty-one,1,1
158374,patients,1,1
158375,were,1,1
158376,evaluable,1,1
158377,.,1,1
158378,Median,0,0
158379,FACIT-F,0,0
158380,fatigue,0,1
158381,scores,0,0
158382,improved,0,0
158383,from,0,1
158384,baseline,0,0
158385,to,0,0
158386,day,0,0
158387,15,0,0
158388,in,0,0
158389,all,0,1
158390,groups,0,0
158391,:,0,1
158392,MP+NTI,0,0
158393,(,0,0
158394,median,0,0
158395,score,0,0
158396,",",0,0
158397,4.5,0,0
158398,;,0,0
158399,P,0,0
158400,=,0,0
158401,.005,0,0
158402,),0,0
158403,",",0,0
158404,PL+NTI,0,0
158405,(,0,0
158406,median,0,0
158407,score,0,0
158408,",",0,0
158409,8.0,0,0
158410,;,0,0
158411,P,0,0
158412,<,0,0
158413,.001,0,0
158414,),0,0
158415,",",0,0
158416,MP+CTI,0,0
158417,(,0,0
158418,median,0,0
158419,score,0,0
158420,",",0,0
158421,7.0,0,1
158422,;,0,0
158423,P,0,0
158424,=,0,0
158425,.004,0,0
158426,),0,0
158427,",",0,0
158428,and,0,0
158429,PL+CTI,0,1
158430,(,0,0
158431,median,0,0
158432,score,0,0
158433,",",0,0
158434,5.0,0,0
158435,;,0,0
158436,P,0,0
158437,=,0,0
158438,.03,0,0
158439,),0,0
158440,.,0,0
158441,However,0,0
158442,",",0,0
158443,there,0,0
158444,were,0,0
158445,no,0,0
158446,significant,0,0
158447,differences,0,0
158448,in,0,0
158449,the,0,0
158450,median,0,0
158451,improvement,0,0
158452,in,0,0
158453,FACIT-F,0,0
158454,fatigue,0,0
158455,between,0,0
158456,the,0,0
158457,MP,0,0
158458,and,0,0
158459,PL,0,0
158460,groups,0,0
158461,(,0,1
158462,5.5,0,1
158463,v,0,0
158464,6.0,0,0
158465,",",0,0
158466,respectively,0,0
158467,;,0,0
158468,P,0,0
158469,=,0,0
158470,.69,0,0
158471,),0,0
158472,and,0,0
158473,among,0,0
158474,all,0,0
158475,four,0,1
158476,groups,0,0
158477,(,0,1
158478,P,0,0
158479,=,0,0
158480,.16,0,0
158481,),0,1
158482,.,0,0
158483,Fatigue,0,0
158484,(,0,0
158485,P,0,0
158486,<,0,0
158487,.001,0,0
158488,),0,0
158489,",",0,0
158490,nausea,0,0
158491,(,0,0
158492,P,0,0
158493,=,0,0
158494,.01,0,0
158495,),0,0
158496,",",0,0
158497,depression,0,1
158498,(,0,0
158499,P,0,0
158500,=,0,0
158501,.02,0,0
158502,),0,0
158503,",",0,0
158504,anxiety,0,0
158505,(,0,0
158506,P,0,0
158507,=,0,0
158508,.01,0,0
158509,),0,0
158510,",",0,0
158511,drowsiness,0,0
158512,(,0,0
158513,P,0,0
158514,<,0,0
158515,.001,0,0
158516,),0,0
158517,",",0,0
158518,appetite,0,0
158519,(,0,0
158520,P,0,0
158521,=,0,0
158522,.009,0,0
158523,),0,0
158524,",",0,0
158525,sleep,0,0
158526,(,0,0
158527,P,0,0
158528,<,0,0
158529,.001,0,0
158530,),0,0
158531,",",0,0
158532,and,0,0
158533,feeling,0,0
158534,of,0,0
158535,well-being,0,0
158536,(,0,0
158537,P,0,0
158538,<,0,0
158539,.001,0,0
158540,),0,0
158541,",",0,0
158542,as,0,0
158543,measured,0,0
158544,by,0,0
158545,the,0,0
158546,ESAS,0,0
158547,",",0,0
158548,significantly,0,0
158549,improved,0,0
158550,in,0,1
158551,patients,0,1
158552,who,0,1
158553,received,0,1
158554,NTI,0,1
158555,.,0,1
158556,Grade,0,0
158557,?,0,0
158558,3,0,0
158559,adverse,0,0
158560,events,0,0
158561,did,0,0
158562,not,0,0
158563,differ,0,0
158564,between,0,0
158565,MP,0,0
158566,and,0,0
158567,PL,0,0
158568,(,0,0
158569,40,0,1
158570,of,0,0
158571,93,0,1
158572,patients,0,1
158573,v,0,0
158574,29,0,1
158575,of,0,1
158576,97,0,1
158577,patients,0,1
158578,",",0,0
158579,respectively,0,0
158580,;,0,0
158581,P,0,0
158582,=,0,0
158583,.06,0,0
158584,),0,1
158585,.,0,1
158586,CONCLUSION,0,0
158587,MP,0,0
158588,and,0,0
158589,NTI,0,0
158590,alone,0,0
158591,or,0,0
158592,combined,0,0
158593,were,0,0
158594,not,0,0
158595,superior,0,0
158596,to,0,0
158597,placebo,0,0
158598,in,0,0
158599,improving,0,0
158600,CRF,0,0
158601,.,0,1
158602,The,0,0
158603,effectiveness,0,0
158604,of,0,0
158605,educational,0,1
158606,interventions,0,0
158607,to,0,0
158608,enhance,0,0
158609,the,0,0
158610,adoption,0,0
158611,of,0,0
158612,fee-based,0,1
158613,arsenic,0,0
158614,testing,0,0
158615,in,1,0
158616,Bangladesh,1,1
158617,:,1,1
158618,a,0,0
158619,cluster,0,0
158620,randomized,0,0
158621,controlled,0,0
158622,trial,0,0
158623,.,0,0
158624,Arsenic,0,0
158625,(,0,0
158626,As,0,0
158627,),0,0
158628,testing,0,0
158629,could,0,0
158630,help,0,0
158631,22,0,1
158632,million,0,0
158633,people,0,1
158634,",",0,0
158635,using,0,0
158636,drinking,0,0
158637,water,0,0
158638,sources,0,0
158639,that,0,0
158640,exceed,0,0
158641,the,0,0
158642,Bangladesh,0,0
158643,As,0,0
158644,standard,0,0
158645,",",0,0
158646,to,0,0
158647,identify,0,0
158648,safe,0,0
158649,sources,0,0
158650,.,0,1
158651,A,0,0
158652,cluster,0,0
158653,randomized,0,0
158654,controlled,0,0
158655,trial,0,0
158656,was,0,0
158657,conducted,0,0
158658,to,0,0
158659,evaluate,0,0
158660,the,0,0
158661,effectiveness,0,0
158662,of,0,0
158663,household,0,1
158664,education,0,0
158665,and,0,0
158666,local,0,0
158667,media,0,0
158668,in,0,0
158669,the,0,0
158670,increasing,0,0
158671,demand,0,0
158672,for,0,0
158673,fee-based,0,1
158674,As,0,0
158675,testing,0,0
158676,.,0,0
158677,Randomly,1,1
158678,selected,1,1
158679,households,1,1
158680,(,1,1
158681,N,1,1
158682,=,1,0
158683,452,1,1
158684,),1,0
158685,were,0,0
158686,divided,0,1
158687,into,0,1
158688,three,0,1
158689,interventions,0,0
158690,implemented,0,0
158691,by,0,0
158692,community,0,1
158693,workers,0,1
158694,:,0,1
158695,1,0,1
158696,),0,0
158697,fee-based,0,1
158698,As,0,0
158699,testing,0,0
158700,with,0,1
158701,household,0,1
158702,education,0,0
158703,(,0,0
158704,HE,0,0
158705,),0,1
158706,;,0,0
158707,2,0,0
158708,),0,0
158709,fee-based,0,1
158710,As,0,0
158711,testing,0,0
158712,with,0,1
158713,household,0,1
158714,education,0,0
158715,and,0,0
158716,a,0,0
158717,local,0,0
158718,media,0,0
158719,campaign,0,1
158720,(,0,1
158721,HELM,0,0
158722,),0,1
158723,;,0,0
158724,and,0,0
158725,3,0,0
158726,),0,0
158727,fee-based,0,1
158728,As,0,0
158729,testing,0,0
158730,alone,0,0
158731,(,0,0
158732,Control,0,1
158733,),0,0
158734,.,0,0
158735,The,0,0
158736,fee,0,0
158737,for,0,0
158738,the,0,0
158739,As,0,0
158740,test,0,0
158741,was,0,0
158742,US,0,0
158743,$,0,0
158744,0.28,0,0
158745,",",0,0
158746,higher,0,0
158747,than,0,0
158748,the,0,0
158749,cost,0,0
158750,of,0,0
158751,the,0,0
158752,test,0,0
158753,(,0,0
158754,US,0,0
158755,$,0,0
158756,0.16,0,0
158757,),0,0
158758,.,0,1
158759,Of,0,0
158760,households,0,1
158761,with,0,1
158762,untested,0,1
158763,wells,0,0
158764,",",0,0
158765,93,0,1
158766,%,0,0
158767,in,0,0
158768,both,0,0
158769,intervention,0,0
158770,groups,0,0
158771,HE,0,0
158772,and,0,1
158773,HELM,0,0
158774,purchased,0,0
158775,an,0,0
158776,As,0,0
158777,test,0,0
158778,",",0,0
158779,whereas,0,0
158780,only,0,0
158781,53,0,1
158782,%,0,0
158783,in,0,0
158784,the,0,0
158785,control,0,0
158786,group,0,0
158787,.,0,0
158788,In,0,0
158789,conclusion,0,0
158790,",",0,0
158791,fee-based,0,1
158792,As,0,0
158793,testing,0,0
158794,with,0,1
158795,household,0,1
158796,education,0,0
158797,is,0,0
158798,effective,0,0
158799,in,0,0
158800,the,0,0
158801,increasing,0,0
158802,demand,0,0
158803,for,0,0
158804,As,0,0
158805,testing,0,0
158806,in,1,0
158807,rural,1,1
158808,Bangladesh,1,1
158809,.,1,1
158810,Prospective,0,0
158811,",",0,0
158812,blinded,0,0
158813,exploratory,0,0
158814,evaluation,0,0
158815,of,0,0
158816,the,0,0
158817,PlayWisely,0,0
158818,program,0,0
158819,in,0,0
158820,children,1,1
158821,with,1,1
158822,autism,1,1
158823,spectrum,1,1
158824,disorder,1,1
158825,.,1,0
158826,The,0,0
158827,purpose,0,0
158828,of,0,0
158829,the,0,0
158830,study,0,0
158831,was,0,0
158832,to,0,0
158833,explore,0,0
158834,a,0,0
158835,low-cost,0,0
158836,intervention,0,0
158837,that,0,0
158838,targets,0,0
158839,an,0,0
158840,increasingly,0,0
158841,common,0,0
158842,developmental,0,1
158843,disorder,0,1
158844,.,0,0
158845,The,0,0
158846,study,0,0
158847,was,0,0
158848,a,0,0
158849,blinded,0,0
158850,",",0,0
158851,exploratory,0,0
158852,evaluation,0,0
158853,of,0,0
158854,the,0,0
158855,PlayWisely,0,0
158856,program,0,0
158857,on,0,0
158858,autism,0,1
158859,symptoms,0,0
158860,and,0,0
158861,essential,0,1
158862,learning,0,0
158863,foundation,0,0
158864,skills,0,0
158865,(,0,0
158866,attention,0,0
158867,",",0,0
158868,recognition,0,0
158869,",",0,0
158870,and,0,0
158871,memory,0,0
158872,skills,0,0
158873,),0,1
158874,in,0,0
158875,children,1,1
158876,with,1,1
158877,a,1,0
158878,diagnosis,1,1
158879,of,1,0
158880,autism,1,1
158881,",",1,0
158882,autism,1,1
158883,spectrum,1,1
158884,disorder,1,1
158885,(,1,0
158886,ASD,1,1
158887,),1,0
158888,",",1,0
158889,pervasive,1,1
158890,developmental,1,1
158891,disorder,1,1
158892,-,1,0
158893,not,1,0
158894,otherwise,1,0
158895,specified,1,0
158896,(,1,0
158897,PDD-NOS,1,0
158898,),1,0
158899,",",1,0
158900,and,1,0
158901,Asperger,1,1
158902,syndrome,1,1
158903,(,1,0
158904,AS,1,1
158905,),1,1
158906,.,1,1
158907,Eighteen,1,1
158908,children,1,1
158909,",",1,0
158910,1,1,0
158911,to,1,0
158912,10,1,1
158913,years,1,1
158914,of,1,0
158915,age,1,1
158916,",",0,0
158917,were,0,0
158918,evaluated,0,0
158919,using,0,0
158920,the,0,0
158921,Childhood,0,1
158922,Autism,0,1
158923,Rating,0,0
158924,Scale,0,0
158925,",",0,0
158926,Second,0,0
158927,Edition,0,0
158928,(,0,0
158929,CARS2,0,1
158930,),0,1
158931,;,0,0
158932,the,0,0
158933,PlayWisely,0,0
158934,Interactive,0,0
158935,Test,0,0
158936,of,0,0
158937,Attention,0,0
158938,",",0,0
158939,Recognition,0,0
158940,",",0,0
158941,and,0,0
158942,Memory,0,1
158943,Skills,0,0
158944,;,0,1
158945,Autism,0,1
158946,Treatment,0,0
158947,Evaluation,0,0
158948,Checklist,0,0
158949,(,0,0
158950,ATEC,0,0
158951,),0,0
158952,",",0,0
158953,and,0,0
158954,the,0,0
158955,Modified,0,0
158956,Checklist,0,0
158957,for,0,0
158958,Autism,0,1
158959,in,0,0
158960,Toddlers,0,1
158961,(,0,1
158962,M-CHAT,0,0
158963,),0,0
158964,.,0,0
158965,There,0,0
158966,were,0,0
158967,significant,0,0
158968,treatment,0,0
158969,effects,0,0
158970,for,0,0
158971,the,0,0
158972,PlayWisely,0,0
158973,measure,0,0
158974,on,0,0
158975,the,0,0
158976,Yellow,0,0
158977,Sets,0,1
158978,that,0,0
158979,examine,0,0
158980,recognition,0,0
158981,;,0,0
158982,Purple,0,0
158983,Sets,0,0
158984,that,0,0
158985,examine,0,0
158986,brain,0,0
158987,region,0,1
158988,agility,0,0
158989,and,0,0
158990,early,0,0
158991,memory,0,1
158992,skills,0,0
158993,;,0,1
158994,Blue,0,0
158995,Sets,0,1
158996,that,0,0
158997,examine,0,0
158998,phonemic,0,0
158999,awareness,0,0
159000,and,0,0
159001,recognition,0,1
159002,;,0,0
159003,and,0,0
159004,for,0,0
159005,the,0,0
159006,Total,0,0
159007,Sets,0,0
159008,",",0,0
159009,with,0,1
159010,a,0,0
159011,similar,0,0
159012,trend,0,0
159013,toward,0,0
159014,improvement,0,0
159015,in,0,0
159016,the,0,0
159017,Green,0,0
159018,Sets,0,0
159019,that,0,0
159020,examine,0,0
159021,perception,0,0
159022,and,0,0
159023,Red,0,0
159024,Sets,0,1
159025,that,0,0
159026,examine,0,0
159027,attention,0,0
159028,.,0,0
159029,No,0,0
159030,other,0,0
159031,measures,0,0
159032,reached,0,0
159033,statistical,0,0
159034,significance,0,0
159035,.,0,0
159036,The,0,0
159037,results,0,0
159038,suggest,0,0
159039,that,0,0
159040,PlayWisely,0,0
159041,can,0,0
159042,improve,0,0
159043,recognition,0,0
159044,",",0,0
159045,brain,0,0
159046,region,0,1
159047,agility,0,0
159048,",",0,0
159049,phonemic,0,0
159050,awareness,0,0
159051,",",0,0
159052,letter,0,0
159053,recognition,0,0
159054,",",0,0
159055,and,0,0
159056,early,0,0
159057,memory,0,0
159058,skills,0,0
159059,in,0,1
159060,ASD,0,1
159061,.,0,1
159062,It,0,0
159063,was,0,0
159064,observed,0,0
159065,by,0,0
159066,the,0,0
159067,parents,0,1
159068,",",0,0
159069,coaches,0,0
159070,",",0,0
159071,and,0,0
159072,study,0,0
159073,investigators,0,0
159074,that,0,0
159075,the,0,1
159076,children,0,1
159077,who,0,1
159078,were,0,1
159079,less,0,1
159080,than,0,0
159081,3,0,0
159082,years,0,1
159083,of,0,0
159084,age,0,1
159085,showed,0,0
159086,improvements,0,0
159087,in,0,0
159088,autism,0,1
159089,symptoms,0,0
159090,;,0,0
159091,however,0,0
159092,",",0,0
159093,the,0,0
159094,group,0,0
159095,was,0,0
159096,too,0,0
159097,small,0,0
159098,to,0,0
159099,reach,0,0
159100,statistical,0,0
159101,significance,0,0
159102,.,0,1
159103,Future,0,0
159104,studies,0,0
159105,are,0,0
159106,needed,0,0
159107,to,0,0
159108,see,0,0
159109,if,0,0
159110,this,0,0
159111,intervention,0,0
159112,can,0,0
159113,mitigate,0,0
159114,autism,0,1
159115,symptoms,0,0
159116,in,0,0
159117,very,0,1
159118,young,0,1
159119,children,0,1
159120,with,0,1
159121,ASD,0,1
159122,.,0,1
159123,Targeting,0,0
159124,alpha-7,0,0
159125,nicotinic,0,0
159126,neurotransmission,0,0
159127,in,0,0
159128,schizophrenia,1,1
159129,:,1,1
159130,a,0,0
159131,novel,0,0
159132,agonist,0,0
159133,strategy,0,0
159134,.,0,0
159135,Alpha7,0,0
159136,nicotinic,0,0
159137,acetylcholine,0,0
159138,receptor,0,0
159139,(,0,0
159140,?7,0,0
159141,nAChR,0,1
159142,),0,0
159143,agonists,0,0
159144,may,0,0
159145,be,0,0
159146,valuable,0,0
159147,treatments,0,0
159148,for,0,1
159149,negative,0,1
159150,symptoms,0,1
159151,and,0,1
159152,cognitive,0,0
159153,impairment,0,0
159154,in,1,0
159155,schizophrenia,1,1
159156,.,1,0
159157,Unfortunately,0,0
159158,",",0,0
159159,chronic,0,1
159160,exposure,0,0
159161,to,0,0
159162,an,0,0
159163,agonist,0,0
159164,may,0,0
159165,reduce,0,0
159166,the,0,0
159167,receptor,0,0
159168,'s,0,1
159169,sensitivity,0,0
159170,.,0,0
159171,Therefore,0,0
159172,",",0,0
159173,we,0,0
159174,combined,0,0
159175,CDP-choline,0,0
159176,",",0,0
159177,a,0,0
159178,dietary,0,0
159179,source,0,0
159180,of,0,0
159181,the,0,0
159182,direct,0,0
159183,agonist,0,0
159184,choline,0,0
159185,",",0,0
159186,with,0,0
159187,galantamine,0,0
159188,",",0,0
159189,a,0,0
159190,positive,0,0
159191,allosteric,0,0
159192,modulator,0,1
159193,(,0,0
159194,PAM,0,0
159195,),0,0
159196,of,0,0
159197,nicotinic,0,0
159198,acetylcholine,0,0
159199,receptors,0,0
159200,",",0,0
159201,to,0,0
159202,improve,0,0
159203,the,0,0
159204,efficiency,0,0
159205,of,0,0
159206,transducing,0,0
159207,the,0,0
159208,choline,0,0
159209,signal,0,0
159210,and,0,0
159211,",",0,0
159212,possibly,0,0
159213,",",0,0
159214,preserve,0,0
159215,the,0,0
159216,receptor,0,0
159217,in,0,0
159218,a,0,0
159219,sensitive,0,0
159220,state,0,0
159221,.,0,1
159222,We,0,0
159223,conducted,0,0
159224,a,0,0
159225,single-site,0,0
159226,",",0,0
159227,double-blind,0,0
159228,randomized,0,1
159229,clinical,0,0
159230,trial,0,0
159231,comparing,0,0
159232,galantamine/CDP-choline,0,0
159233,to,0,0
159234,placebos,0,0
159235,in,1,0
159236,schizophrenia,1,1
159237,patients,1,1
159238,with,1,1
159239,negative,1,1
159240,symptoms,1,1
159241,who,1,1
159242,were,1,1
159243,receiving,1,1
159244,second,1,0
159245,generation,1,0
159246,antipsychotics,1,1
159247,.,1,1
159248,Forty-three,1,1
159249,subjects,1,1
159250,received,0,1
159251,galantamine,0,0
159252,and,0,0
159253,CDP-choline,0,0
159254,or,0,1
159255,matching,0,0
159256,placebos,0,0
159257,for,0,1
159258,16weeks,0,1
159259,.,0,1
159260,The,0,0
159261,primary,0,0
159262,outcome,0,0
159263,measure,0,0
159264,was,0,0
159265,the,0,0
159266,5-item,0,0
159267,Marder,0,0
159268,negative-symptoms,0,0
159269,factor,0,0
159270,of,0,0
159271,the,0,0
159272,Positive,0,1
159273,and,0,0
159274,Negative,0,1
159275,Syndrome,0,1
159276,Scale,0,0
159277,(,0,0
159278,PANSS,0,1
159279,),0,0
159280,.,0,0
159281,Cognition,0,0
159282,and,0,0
159283,functioning,0,0
159284,were,0,0
159285,also,0,0
159286,assessed,0,0
159287,.,0,0
159288,Trial,0,0
159289,completion,0,0
159290,was,0,0
159291,high,0,1
159292,;,0,1
159293,79,0,1
159294,%,0,0
159295,.,0,0
159296,There,0,0
159297,was,0,0
159298,no,0,0
159299,significant,0,0
159300,treatment,0,0
159301,effect,0,0
159302,on,0,0
159303,negative,0,0
159304,symptoms,0,0
159305,",",0,1
159306,other,0,0
159307,PANSS,0,0
159308,symptom,0,1
159309,factors,0,0
159310,",",0,0
159311,or,0,1
159312,the,0,0
159313,MATRICS,0,0
159314,Cognitive,0,0
159315,Consensus,0,1
159316,Battery,0,1
159317,.,0,0
159318,There,0,0
159319,were,0,0
159320,significant,0,0
159321,treatment,0,0
159322,effects,0,0
159323,in,0,0
159324,overall,0,0
159325,functioning,0,0
159326,and,0,0
159327,a,0,0
159328,test,0,0
159329,of,0,0
159330,free,0,0
159331,verbal,0,0
159332,recall,0,0
159333,.,0,1
159334,Three,0,0
159335,subjects,0,1
159336,discontinued,0,0
159337,treatment,0,0
159338,in,0,0
159339,the,0,0
159340,active,0,0
159341,treatment,0,0
159342,group,0,0
159343,for,0,0
159344,gastro-intestinal,0,1
159345,adverse,0,0
159346,events,0,0
159347,(,0,1
159348,AE,0,0
159349,),0,0
159350,.,0,0
159351,The,0,0
159352,most,0,0
159353,common,0,0
159354,AE,0,0
159355,for,0,0
159356,galantamine/CDP-choline,0,0
159357,was,0,0
159358,abdominal,0,1
159359,pain,0,1
159360,;,0,0
159361,for,0,0
159362,placebo,0,0
159363,it,0,0
159364,was,0,0
159365,headache,0,0
159366,and,0,0
159367,sweating,0,0
159368,.,0,0
159369,Although,0,0
159370,there,0,0
159371,was,0,0
159372,no,0,0
159373,significant,0,0
159374,treatment,0,0
159375,effect,0,0
159376,on,0,0
159377,negative,0,0
159378,symptoms,0,0
159379,",",0,0
159380,the,0,0
159381,direction,0,0
159382,of,0,0
159383,effect,0,0
159384,mirrored,0,0
159385,the,0,0
159386,effects,0,0
159387,on,0,0
159388,a,0,0
159389,cognitive,0,0
159390,measure,0,0
159391,and,0,0
159392,overall,0,0
159393,functioning,0,0
159394,.,0,1
159395,Further,0,0
159396,study,0,0
159397,of,0,0
159398,?7,0,0
159399,nAChR,0,0
159400,agonist/PAMs,0,0
159401,is,0,0
159402,warranted,0,0
159403,in,0,0
159404,larger,0,0
159405,studies,0,0
159406,that,0,0
159407,will,0,0
159408,have,0,0
159409,greater,0,0
159410,power,0,0
159411,.,0,0
159412,Beliefs,0,0
159413,underlying,0,0
159414,the,0,0
159415,intention,0,0
159416,to,0,0
159417,donate,0,0
159418,again,0,0
159419,among,0,0
159420,first-time,1,1
159421,blood,1,1
159422,donors,1,1
159423,who,1,1
159424,experience,1,1
159425,a,1,1
159426,mild,1,1
159427,adverse,1,0
159428,event,1,0
159429,.,1,0
159430,Using,0,0
159431,the,0,0
159432,belief,0,0
159433,basis,0,0
159434,of,0,0
159435,the,0,0
159436,theory,0,0
159437,of,0,0
159438,planned,0,0
159439,behavior,0,0
159440,(,0,0
159441,TPB,0,0
159442,),0,0
159443,",",0,0
159444,the,0,0
159445,current,0,0
159446,study,0,0
159447,explored,0,0
159448,the,0,0
159449,rate,0,0
159450,of,0,0
159451,mild,0,1
159452,reactions,0,0
159453,reported,0,0
159454,by,0,0
159455,donors,0,1
159456,in,0,0
159457,relation,0,0
159458,to,0,0
159459,their,0,0
159460,first,0,0
159461,donation,0,1
159462,and,0,0
159463,the,0,0
159464,intention,0,0
159465,and,0,0
159466,beliefs,0,0
159467,of,0,0
159468,those,0,0
159469,donors,0,1
159470,with,0,1
159471,regard,0,0
159472,to,0,0
159473,returning,0,0
159474,to,0,0
159475,donate,0,1
159476,again,0,0
159477,.,0,0
159478,A,0,0
159479,high,0,0
159480,proportion,0,0
159481,of,0,0
159482,first-time,0,1
159483,donors,0,1
159484,indicated,0,0
159485,that,0,0
159486,they,0,1
159487,had,0,1
159488,experienced,0,0
159489,a,0,0
159490,reaction,0,0
159491,to,0,0
159492,blood,0,0
159493,donation,0,1
159494,.,0,0
159495,Further,0,0
159496,",",0,1
159497,donors,0,1
159498,who,0,1
159499,reacted,0,0
159500,were,0,1
159501,less,0,0
159502,likely,0,0
159503,to,0,0
159504,intend,0,0
159505,to,0,0
159506,return,0,0
159507,to,0,0
159508,donate,0,0
159509,.,0,0
159510,Regression,0,0
159511,analyses,0,0
159512,suggested,0,0
159513,that,0,0
159514,targeting,0,0
159515,different,0,0
159516,beliefs,0,0
159517,for,0,0
159518,those,0,1
159519,donors,0,1
159520,who,0,1
159521,had,0,1
159522,and,0,1
159523,had,0,0
159524,not,0,0
159525,reacted,0,0
159526,would,0,0
159527,yield,0,0
159528,most,0,0
159529,benefit,0,0
159530,in,0,0
159531,bolstering,0,0
159532,donors,0,1
159533,',0,1
159534,intentions,0,0
159535,to,0,1
159536,remain,0,0
159537,donating,0,0
159538,.,0,0
159539,The,0,0
159540,findings,0,0
159541,provide,0,0
159542,insight,0,0
159543,into,0,0
159544,those,0,1
159545,messages,0,0
159546,that,0,0
159547,could,0,0
159548,be,0,0
159549,communicated,0,0
159550,via,0,0
159551,the,0,0
159552,mass,0,1
159553,media,0,0
159554,or,0,1
159555,in,0,0
159556,targeted,0,0
159557,communications,0,1
159558,to,0,0
159559,retain,0,0
159560,first-time,1,1
159561,donors,1,1
159562,who,0,1
159563,have,0,1
159564,experienced,0,1
159565,a,0,0
159566,mild,0,1
159567,vasovagal,0,0
159568,reaction,0,1
159569,.,0,1
159570,Serum,0,1
159571,selenium,0,0
159572,concentration,0,0
159573,and,0,0
159574,antioxidant,0,0
159575,activity,0,0
159576,in,0,0
159577,cervical,1,1
159578,cancer,1,1
159579,patients,1,1
159580,before,1,0
159581,and,1,0
159582,after,1,0
159583,treatment,1,0
159584,.,1,1
159585,AIM,0,0
159586,In,0,0
159587,the,0,0
159588,present,0,0
159589,study,0,0
159590,",",0,0
159591,the,0,0
159592,effect,0,0
159593,of,0,0
159594,chemo,0,0
159595,and,0,0
159596,radio,0,0
159597,therapies,0,0
159598,on,0,0
159599,serum,0,0
159600,trace,0,0
159601,elements,0,0
159602,content,0,0
159603,and,0,0
159604,antioxidant,0,0
159605,activity,0,0
159606,in,0,0
159607,blood,0,0
159608,serum,0,0
159609,of,0,0
159610,cervical,1,1
159611,cancer,1,1
159612,patients,1,1
159613,was,0,0
159614,evaluated,0,0
159615,.,0,0
159616,METHODS,0,0
159617,Among,0,1
159618,104,1,1
159619,cervical,1,1
159620,cancer,1,1
159621,patients,1,1
159622,selected,1,1
159623,for,1,0
159624,the,1,0
159625,present,1,0
159626,study,1,0
159627,",",1,0
159628,54,1,1
159629,and,1,0
159630,50,1,1
159631,patients,1,1
159632,were,1,1
159633,treated,1,1
159634,with,1,1
159635,chemo-,1,0
159636,and,1,0
159637,radiotherapy,1,1
159638,respectively,1,0
159639,.,1,0
159640,Plasma,0,0
159641,Se,0,0
159642,",",0,0
159643,Zn,0,0
159644,",",0,0
159645,Cu,0,0
159646,and,0,0
159647,some,0,0
159648,enzymatic,0,0
159649,antioxidants,0,0
159650,activities,0,0
159651,were,0,1
159652,estimated,0,0
159653,in,0,0
159654,serum,0,0
159655,before,0,0
159656,and,0,0
159657,after,0,0
159658,the,0,0
159659,treatment,0,0
159660,.,0,0
159661,RESULTS,0,0
159662,The,0,0
159663,decreased,0,0
159664,levels,0,0
159665,of,0,0
159666,serum,0,0
159667,trace,0,0
159668,elements,0,0
159669,",",0,0
159670,glutathione,0,0
159671,peroxidase,0,0
159672,activity,0,0
159673,and,0,0
159674,total,0,1
159675,antioxidant,0,0
159676,capacity,0,0
159677,",",0,0
159678,and,0,0
159679,increased,0,0
159680,malondialdehyde,0,0
159681,",",0,0
159682,glutathion,0,0
159683,reductase,0,0
159684,was,0,0
159685,observed,0,0
159686,in,0,0
159687,cervical,1,1
159688,cancer,1,1
159689,patients,1,1
159690,when,0,0
159691,compared,0,0
159692,to,0,0
159693,healthy,0,1
159694,controls,0,1
159695,.,0,1
159696,The,0,0
159697,increased,0,0
159698,concentration,0,0
159699,of,0,0
159700,serum,0,0
159701,Se,0,0
159702,",",0,0
159703,Zn,0,0
159704,was,0,0
159705,observed,0,0
159706,in,0,0
159707,patients,1,1
159708,treated,1,1
159709,with,1,1
159710,chemotherapy,1,0
159711,.,1,0
159712,Simultaneously,0,0
159713,there,0,0
159714,was,0,0
159715,a,0,0
159716,significant,0,0
159717,(,0,0
159718,P,0,0
159719,<,0,0
159720,0.001,0,0
159721,),0,0
159722,increase,0,0
159723,in,0,0
159724,glutathione,0,0
159725,peroxidase,0,0
159726,and,0,0
159727,total,0,1
159728,antioxidant,0,0
159729,capacity,0,0
159730,",",0,0
159731,and,0,0
159732,significant,0,0
159733,decrease,0,0
159734,(,0,0
159735,P,0,0
159736,<,0,0
159737,0.05,0,0
159738,),0,0
159739,in,0,0
159740,malondialdehyde,0,0
159741,and,0,0
159742,glutathion,0,0
159743,reductase,0,0
159744,levels,0,0
159745,in,0,0
159746,the,0,0
159747,serum,0,0
159748,of,0,0
159749,patients,0,1
159750,treated,0,1
159751,with,0,1
159752,chemotherapy,0,0
159753,compared,0,0
159754,to,0,0
159755,the,0,0
159756,patients,0,1
159757,treated,0,1
159758,with,0,1
159759,radiotherapy,0,1
159760,.,0,0
159761,CONCLUSION,0,0
159762,The,0,0
159763,results,0,0
159764,demonstrated,0,0
159765,that,0,0
159766,chemotherapy,0,0
159767,but,0,0
159768,not,0,0
159769,radiotherapy,0,1
159770,results,0,0
159771,in,0,0
159772,significant,0,0
159773,increase,0,0
159774,in,0,0
159775,the,0,0
159776,trace,0,0
159777,elements,0,1
159778,levels,0,0
159779,and,0,1
159780,antioxidant,0,0
159781,activities,0,0
159782,in,0,0
159783,blood,0,0
159784,serum,0,0
159785,of,0,0
159786,cervical,1,1
159787,cancer,1,1
159788,patients,1,1
159789,.,1,1
159790,Bayesian,0,1
159791,adaptive,0,0
159792,trials,0,1
159793,offer,0,0
159794,advantages,0,0
159795,in,0,0
159796,comparative,0,0
159797,effectiveness,0,0
159798,trials,0,1
159799,:,0,1
159800,an,0,0
159801,example,0,0
159802,in,0,0
159803,status,1,1
159804,epilepticus,1,1
159805,.,1,0
159806,OBJECTIVE,0,0
159807,We,0,0
159808,present,0,0
159809,a,0,0
159810,novel,0,0
159811,Bayesian,0,0
159812,adaptive,0,0
159813,comparative,0,0
159814,effectiveness,0,0
159815,trial,0,0
159816,comparing,0,0
159817,three,0,0
159818,treatments,0,0
159819,for,0,0
159820,status,0,1
159821,epilepticus,0,1
159822,that,0,0
159823,uses,0,0
159824,adaptive,0,0
159825,randomization,0,0
159826,with,0,1
159827,potential,0,0
159828,early,0,1
159829,stopping,0,0
159830,.,0,1
159831,STUDY,0,0
159832,DESIGN,0,0
159833,AND,0,0
159834,SETTING,0,1
159835,The,0,0
159836,trial,0,0
159837,will,0,0
159838,enroll,0,1
159839,720,1,1
159840,unique,1,0
159841,patients,1,1
159842,in,1,0
159843,emergency,1,1
159844,departments,1,1
159845,and,1,0
159846,uses,1,0
159847,a,1,0
159848,Bayesian,1,0
159849,adaptive,1,0
159850,design,1,1
159851,.,1,0
159852,RESULTS,0,0
159853,The,0,0
159854,trial,0,0
159855,design,0,0
159856,is,0,0
159857,compared,0,0
159858,to,0,0
159859,a,0,0
159860,trial,0,0
159861,without,0,0
159862,adaptive,0,0
159863,randomization,0,0
159864,and,0,0
159865,produces,0,0
159866,an,0,0
159867,efficient,0,0
159868,trial,0,0
159869,in,0,0
159870,which,0,0
159871,a,0,0
159872,higher,0,0
159873,proportion,0,0
159874,of,0,0
159875,patients,0,1
159876,are,0,0
159877,likely,0,0
159878,to,0,0
159879,be,0,0
159880,randomized,0,0
159881,to,0,0
159882,the,0,0
159883,most,0,0
159884,effective,0,0
159885,treatment,0,0
159886,arm,0,0
159887,while,0,0
159888,generally,0,0
159889,using,0,0
159890,fewer,0,0
159891,total,0,1
159892,patients,0,1
159893,and,0,0
159894,offers,0,0
159895,higher,0,0
159896,power,0,0
159897,than,0,0
159898,an,0,0
159899,analogous,0,0
159900,trial,0,0
159901,with,0,1
159902,fixed,0,0
159903,randomization,0,0
159904,when,0,0
159905,identifying,0,0
159906,a,0,0
159907,superior,0,0
159908,treatment,0,0
159909,.,0,0
159910,CONCLUSION,0,0
159911,When,0,0
159912,one,0,0
159913,treatment,0,0
159914,is,0,0
159915,superior,0,0
159916,to,0,0
159917,the,0,0
159918,other,0,0
159919,two,0,0
159920,",",0,0
159921,the,0,0
159922,trial,0,0
159923,design,0,0
159924,provides,0,0
159925,better,0,0
159926,patient,0,0
159927,care,0,0
159928,",",0,0
159929,higher,0,0
159930,power,0,0
159931,",",0,0
159932,and,0,0
159933,a,0,0
159934,lower,0,0
159935,expected,0,0
159936,sample,0,1
159937,size,0,0
159938,.,0,1
159939,Singing,0,0
159940,can,0,0
159941,facilitate,0,0
159942,foreign,1,1
159943,language,1,0
159944,learning,1,0
159945,.,1,0
159946,This,0,0
159947,study,0,0
159948,presents,0,0
159949,the,0,0
159950,first,0,0
159951,experimental,0,0
159952,evidence,0,0
159953,that,0,0
159954,singing,0,0
159955,can,0,0
159956,facilitate,0,0
159957,short-term,0,0
159958,paired-associate,0,0
159959,phrase,0,0
159960,learning,0,0
159961,in,0,0
159962,an,0,0
159963,unfamiliar,1,1
159964,language,1,0
159965,(,1,0
159966,Hungarian,1,1
159967,),1,1
159968,.,1,1
159969,Sixty,1,1
159970,adult,1,1
159971,participants,1,1
159972,were,0,0
159973,randomly,0,1
159974,assigned,0,1
159975,to,0,0
159976,one,0,1
159977,of,0,0
159978,three,0,0
159979,listen-and-repeat,0,1
159980,learning,0,0
159981,conditions,0,1
159982,:,0,1
159983,speaking,0,1
159984,",",0,0
159985,rhythmic,0,0
159986,speaking,0,0
159987,",",0,0
159988,or,0,0
159989,singing,0,0
159990,.,0,0
159991,Participants,0,1
159992,in,0,0
159993,the,0,0
159994,singing,0,0
159995,condition,0,0
159996,showed,0,0
159997,superior,0,0
159998,overall,0,0
159999,performance,0,0
160000,on,0,0
160001,a,0,0
160002,collection,0,0
160003,of,0,0
160004,Hungarian,0,1
160005,language,0,0
160006,tests,0,0
160007,after,0,0
160008,a,0,0
160009,15-min,0,0
160010,learning,0,0
160011,period,0,0
160012,",",0,0
160013,as,0,0
160014,compared,0,0
160015,with,0,1
160016,participants,0,1
160017,in,0,0
160018,the,0,0
160019,speaking,0,0
160020,and,0,0
160021,rhythmic,0,0
160022,speaking,0,1
160023,conditions,0,0
160024,.,0,1
160025,This,0,0
160026,superior,0,0
160027,performance,0,0
160028,was,0,0
160029,statistically,0,0
160030,significant,0,0
160031,(,0,0
160032,p,0,0
160033,<,0,0
160034,.05,0,0
160035,),0,0
160036,for,0,0
160037,the,0,0
160038,two,0,0
160039,tests,0,0
160040,that,0,0
160041,required,0,0
160042,participants,0,1
160043,to,0,0
160044,recall,0,0
160045,and,0,0
160046,produce,0,0
160047,spoken,0,0
160048,Hungarian,0,1
160049,phrases,0,0
160050,.,0,1
160051,The,0,0
160052,differences,0,0
160053,in,0,0
160054,performance,0,0
160055,were,0,0
160056,not,0,0
160057,explained,0,0
160058,by,0,0
160059,potentially,0,0
160060,influencing,0,0
160061,factors,0,0
160062,such,0,0
160063,as,0,0
160064,age,1,1
160065,",",1,0
160066,gender,1,0
160067,",",1,0
160068,mood,1,0
160069,",",1,0
160070,phonological,1,0
160071,working,1,0
160072,memory,1,0
160073,ability,1,0
160074,",",1,0
160075,or,1,0
160076,musical,1,1
160077,ability,1,0
160078,and,1,0
160079,training,1,0
160080,.,1,0
160081,These,0,0
160082,results,0,0
160083,suggest,0,0
160084,that,0,0
160085,a,0,0
160086,listen-and-sing,0,1
160087,learning,0,0
160088,method,0,0
160089,can,0,0
160090,facilitate,0,0
160091,verbatim,0,0
160092,memory,0,0
160093,for,0,0
160094,spoken,0,0
160095,foreign,0,1
160096,language,0,1
160097,phrases,0,0
160098,.,0,1
160099,[,0,0
160100,Therapeutic,0,0
160101,efficacy,0,0
160102,of,0,0
160103,compound,0,0
160104,Xuanju,0,1
160105,capsule,0,0
160106,on,0,0
160107,type,1,1
160108,III,1,1
160109,prostatitis,1,1
160110,],1,1
160111,.,0,1
160112,OBJECTIVE,0,0
160113,To,0,0
160114,evaluate,0,0
160115,the,0,0
160116,therapeutic,0,0
160117,effect,0,0
160118,of,0,0
160119,Compound,0,0
160120,Xuanju,0,1
160121,Capsule,0,0
160122,on,0,0
160123,type,0,1
160124,III,0,1
160125,prostatitis,0,1
160126,.,0,1
160127,METHODS,0,0
160128,A,0,0
160129,total,0,1
160130,of,0,0
160131,242,1,1
160132,patients,1,1
160133,with,1,1
160134,type,1,1
160135,III,1,1
160136,prostatitis,1,1
160137,diagnosed,1,1
160138,by,1,0
160139,the,1,0
160140,NIH,1,0
160141,criteria,1,1
160142,were,0,0
160143,randomly,0,1
160144,divided,0,0
160145,into,0,0
160146,an,0,0
160147,experimental,0,0
160148,and,0,0
160149,a,0,0
160150,control,0,0
160151,group,0,0
160152,of,0,0
160153,equal,0,0
160154,number,0,0
160155,",",0,0
160156,the,0,0
160157,former,0,0
160158,treated,0,1
160159,with,0,1
160160,Compound,0,0
160161,Xuanju,0,1
160162,Capsule,0,0
160163,+,0,0
160164,Tamsulosin,0,0
160165,Hydrochloride,0,0
160166,",",0,0
160167,and,0,0
160168,the,0,0
160169,latter,0,0
160170,with,0,1
160171,Quinolinone,0,0
160172,antibiotics,0,0
160173,+,0,0
160174,Tamsulosin,0,0
160175,and,0,0
160176,Hydrochloride,0,0
160177,",",0,0
160178,both,0,0
160179,for,0,0
160180,6,0,0
160181,months,0,0
160182,.,0,1
160183,After,0,0
160184,treatment,0,0
160185,",",0,0
160186,we,0,0
160187,assessed,0,0
160188,the,0,0
160189,therapeutic,0,0
160190,effects,0,0
160191,based,0,0
160192,on,0,0
160193,the,0,0
160194,NIH-CPSI,0,0
160195,scores,0,0
160196,and,0,0
160197,the,0,0
160198,improvement,0,0
160199,of,0,0
160200,relevant,0,0
160201,complications,0,0
160202,.,0,1
160203,RESULTS,0,0
160204,All,1,1
160205,the,1,0
160206,242,1,1
160207,patients,1,1
160208,completed,1,1
160209,the,1,0
160210,treatment,1,0
160211,.,1,0
160212,The,0,0
160213,total,0,0
160214,effectiveness,0,0
160215,rate,0,0
160216,was,0,0
160217,77.69,0,0
160218,%,0,0
160219,(,0,1
160220,94/121,0,0
160221,),0,0
160222,in,0,0
160223,the,0,0
160224,experimental,0,0
160225,group,0,0
160226,",",0,0
160227,71.56,0,0
160228,%,0,0
160229,(,0,1
160230,78/109,0,0
160231,),0,0
160232,in,0,0
160233,those,0,1
160234,with,0,1
160235,complications,0,0
160236,.,0,1
160237,In,0,0
160238,comparison,0,0
160239,",",0,0
160240,it,0,0
160241,was,0,0
160242,only,0,0
160243,47.10,0,0
160244,%,0,0
160245,(,0,1
160246,57/121,0,0
160247,),0,0
160248,in,0,0
160249,the,0,0
160250,control,0,0
160251,group,0,0
160252,",",0,0
160253,31.78,0,0
160254,%,0,0
160255,(,0,1
160256,34/107,0,1
160257,),0,0
160258,in,0,0
160259,those,0,1
160260,with,0,1
160261,complications,0,0
160262,.,0,1
160263,Both,0,0
160264,the,0,0
160265,NIH-CPSI,0,0
160266,scores,0,0
160267,and,0,0
160268,the,0,0
160269,improvement,0,0
160270,of,0,0
160271,complications,0,0
160272,were,0,0
160273,significantly,0,0
160274,higher,0,0
160275,in,0,0
160276,the,0,0
160277,experimental,0,0
160278,than,0,0
160279,in,0,0
160280,the,0,0
160281,control,0,0
160282,group,0,0
160283,(,0,0
160284,P,0,0
160285,<,0,0
160286,0.05,0,0
160287,),0,1
160288,.,0,1
160289,CONCLUSION,0,0
160290,Compound,0,0
160291,Xuanju,0,1
160292,Capsule,0,0
160293,has,0,0
160294,a,0,0
160295,good,0,0
160296,therapeutic,0,0
160297,effect,0,0
160298,on,0,0
160299,type,0,1
160300,III,0,1
160301,prostatitis,0,1
160302,.,0,1
160303,A,0,1
160304,randomized,0,1
160305,double,0,0
160306,blind,0,1
160307,placebo,0,0
160308,controlled,0,0
160309,clinical,0,0
160310,trial,0,0
160311,of,0,0
160312,N-Acetylcysteine,0,0
160313,added,0,0
160314,to,0,0
160315,risperidone,0,0
160316,for,0,0
160317,treating,0,0
160318,autistic,1,1
160319,disorders,1,1
160320,.,1,1
160321,BACKGROUND,0,0
160322,This,0,0
160323,study,0,0
160324,examined,0,0
160325,the,0,0
160326,efficacy,0,0
160327,and,0,0
160328,safety,0,0
160329,of,0,0
160330,N-acetylcysteine,0,0
160331,(,0,1
160332,NAC,0,0
160333,),0,0
160334,augmentation,0,0
160335,for,0,0
160336,treating,0,0
160337,irritability,0,0
160338,in,0,0
160339,children,1,1
160340,and,1,1
160341,adolescents,1,1
160342,with,1,1
160343,autism,1,1
160344,spectrum,1,1
160345,disorders,1,1
160346,(,1,1
160347,ASD,1,1
160348,),1,1
160349,.,1,1
160350,METHOD,0,0
160351,Forty,1,1
160352,children,1,1
160353,and,1,1
160354,adolescents,1,1
160355,met,1,1
160356,diagnostic,1,0
160357,criteria,1,1
160358,for,1,0
160359,ASD,1,1
160360,according,1,1
160361,to,1,0
160362,DSM-IV,1,1
160363,.,1,0
160364,They,0,0
160365,were,0,0
160366,randomly,0,1
160367,allocated,0,1
160368,into,0,0
160369,one,0,0
160370,of,0,0
160371,the,0,0
160372,two,0,0
160373,groups,0,0
160374,of,0,0
160375,NAC,0,1
160376,(,0,1
160377,1200,0,1
160378,mg/day,0,0
160379,),0,0
160380,+risperidone,0,0
160381,or,0,1
160382,placebo+risperidone,0,0
160383,.,0,0
160384,NAC,0,0
160385,and,0,0
160386,placebo,0,0
160387,were,0,0
160388,administered,0,0
160389,in,0,0
160390,the,0,0
160391,form,0,0
160392,of,0,0
160393,effervescent,0,0
160394,and,0,0
160395,in,0,0
160396,two,0,0
160397,divided,0,1
160398,doses,0,0
160399,for,0,1
160400,8,0,1
160401,weeks,0,0
160402,.,0,1
160403,Irritability,0,0
160404,subscale,0,0
160405,score,0,0
160406,of,0,0
160407,Aberrant,0,1
160408,Behavior,0,1
160409,Checklist,0,0
160410,(,0,0
160411,ABC,0,0
160412,),0,0
160413,was,0,0
160414,considered,0,0
160415,as,0,0
160416,the,0,0
160417,main,0,0
160418,outcome,0,0
160419,measure,0,0
160420,.,0,1
160421,Adverse,0,0
160422,effects,0,0
160423,were,0,1
160424,also,0,0
160425,checked,0,0
160426,.,0,0
160427,RESULTS,0,0
160428,The,0,0
160429,mean,0,0
160430,score,0,0
160431,of,0,0
160432,irritability,0,0
160433,in,0,0
160434,the,0,0
160435,NAC+risperidone,0,0
160436,and,0,0
160437,placebo+risperidone,0,0
160438,groups,0,0
160439,at,0,0
160440,baseline,0,0
160441,was,0,0
160442,13.2,0,0
160443,(,0,1
160444,5.3,0,0
160445,),0,1
160446,and,0,0
160447,16.7,0,1
160448,(,0,0
160449,7.8,0,0
160450,),0,0
160451,",",0,0
160452,respectively,0,0
160453,.,0,0
160454,The,0,0
160455,scores,0,0
160456,after,0,0
160457,8,0,1
160458,weeks,0,0
160459,were,0,1
160460,9.7,0,1
160461,(,0,1
160462,4.1,0,0
160463,),0,1
160464,and,0,0
160465,15.1,0,0
160466,(,0,0
160467,7.8,0,0
160468,),0,0
160469,",",0,0
160470,respectively,0,0
160471,.,0,0
160472,Repeated,0,0
160473,measures,0,0
160474,of,0,0
160475,ANOVA,0,0
160476,showed,0,0
160477,that,0,0
160478,there,0,0
160479,was,0,0
160480,a,0,0
160481,significant,0,0
160482,difference,0,0
160483,between,0,0
160484,the,0,0
160485,two,0,0
160486,groups,0,0
160487,after,0,1
160488,8,0,1
160489,weeks,0,0
160490,.,0,1
160491,The,0,0
160492,most,0,0
160493,common,0,0
160494,adverse,0,0
160495,effects,0,0
160496,in,0,0
160497,the,0,0
160498,NAC+risperidone,0,0
160499,group,0,0
160500,were,0,0
160501,constipation,0,1
160502,(,0,0
160503,16.1,0,0
160504,%,0,0
160505,),0,0
160506,",",0,0
160507,increased,0,0
160508,appetite,0,0
160509,(,0,0
160510,16.1,0,0
160511,%,0,0
160512,),0,0
160513,",",0,0
160514,fatigue,0,0
160515,(,0,0
160516,12.9,0,0
160517,%,0,0
160518,),0,0
160519,",",0,0
160520,nervousness,0,0
160521,(,0,0
160522,12.9,0,0
160523,%,0,0
160524,),0,0
160525,",",0,0
160526,and,0,0
160527,daytime,0,0
160528,drowsiness,0,0
160529,(,0,0
160530,12.9,0,0
160531,%,0,0
160532,),0,0
160533,.,0,0
160534,There,0,0
160535,was,0,0
160536,no,0,0
160537,fatal,0,1
160538,adverse,0,0
160539,effect,0,0
160540,.,0,1
160541,CONCLUSIONS,0,0
160542,Risperidone,0,0
160543,plus,0,0
160544,NAC,0,0
160545,more,0,0
160546,than,0,0
160547,risperidone,0,0
160548,plus,0,0
160549,placebo,0,0
160550,decreased,0,0
160551,irritability,0,0
160552,in,0,0
160553,children,1,1
160554,and,1,1
160555,adolescents,1,1
160556,with,1,1
160557,ASD,1,1
160558,.,1,0
160559,Meanwhile,0,0
160560,",",0,0
160561,it,0,0
160562,did,0,0
160563,not,0,0
160564,change,0,0
160565,the,0,0
160566,core,0,0
160567,symptoms,0,0
160568,of,0,0
160569,autism,0,1
160570,.,0,1
160571,Adverse,0,0
160572,effects,0,0
160573,were,0,1
160574,not,0,0
160575,common,0,0
160576,and,0,0
160577,NAC,0,0
160578,was,0,0
160579,generally,0,0
160580,tolerated,0,0
160581,well,0,0
160582,.,0,0
160583,TRIAL,0,0
160584,REGISTRATION,0,0
160585,This,0,0
160586,trial,0,0
160587,was,0,0
160588,registered,0,0
160589,at,0,0
160590,http,0,0
160591,:,0,1
160592,//www.irct.ir,0,0
160593,.,0,0
160594,The,0,0
160595,registration,0,0
160596,number,0,0
160597,of,0,0
160598,this,0,0
160599,trial,0,0
160600,was,0,0
160601,IRCT201106103930N6,0,1
160602,.,0,1
160603,EULAR,1,0
160604,Sjogren,1,1
160605,'s,1,1
160606,Syndrome,1,1
160607,Disease,1,1
160608,Activity,1,0
160609,Index,1,0
160610,(,1,0
160611,ESSDAI,1,0
160612,),1,0
160613,is,1,0
160614,sensitive,1,0
160615,to,1,0
160616,show,1,0
160617,efficacy,1,0
160618,of,1,0
160619,rituximab,1,1
160620,treatment,1,0
160621,in,1,0
160622,a,1,0
160623,randomised,1,0
160624,controlled,1,0
160625,trial,1,1
160626,.,1,1
160627,Use,0,0
160628,of,0,0
160629,EORTC,0,0
160630,target,0,0
160631,definition,0,0
160632,guidelines,0,0
160633,for,0,0
160634,dose-intensified,0,0
160635,salvage,0,0
160636,radiation,0,0
160637,therapy,0,0
160638,for,0,0
160639,recurrent,0,1
160640,prostate,0,1
160641,cancer,0,1
160642,:,0,1
160643,results,0,0
160644,of,0,0
160645,the,0,0
160646,quality,0,0
160647,assurance,0,0
160648,program,0,0
160649,of,0,0
160650,the,0,0
160651,randomized,0,0
160652,trial,0,0
160653,SAKK,0,1
160654,09/10,0,1
160655,.,0,1
160656,PURPOSE,0,0
160657,Different,0,0
160658,international,0,1
160659,target,0,0
160660,volume,0,0
160661,delineation,0,0
160662,guidelines,0,0
160663,exist,0,0
160664,and,0,0
160665,different,0,0
160666,treatment,0,0
160667,techniques,0,0
160668,are,0,0
160669,available,0,0
160670,for,0,0
160671,salvage,0,0
160672,radiation,0,0
160673,therapy,0,0
160674,(,0,0
160675,RT,0,1
160676,),0,0
160677,for,0,0
160678,recurrent,0,1
160679,prostate,0,1
160680,cancer,0,1
160681,",",0,0
160682,but,0,0
160683,less,0,0
160684,is,0,0
160685,known,0,0
160686,regarding,0,0
160687,their,0,0
160688,respective,0,0
160689,applicability,0,0
160690,in,0,0
160691,clinical,0,0
160692,practice,0,1
160693,.,0,1
160694,METHODS,0,0
160695,AND,0,0
160696,MATERIALS,0,0
160697,A,0,1
160698,randomized,0,1
160699,phase,0,1
160700,III,0,1
160701,trial,0,0
160702,testing,0,0
160703,64,1,1
160704,Gy,1,1
160705,vs,1,0
160706,70,1,1
160707,Gy,1,1
160708,salvage,1,0
160709,RT,1,1
160710,was,0,0
160711,accompanied,0,0
160712,by,0,0
160713,an,0,0
160714,intense,0,0
160715,quality,0,0
160716,assurance,0,0
160717,program,0,0
160718,including,0,0
160719,a,0,0
160720,site-specific,0,0
160721,and,0,0
160722,study-specific,0,0
160723,questionnaire,0,0
160724,and,0,0
160725,a,0,0
160726,dummy,0,0
160727,run,0,0
160728,(,0,0
160729,DR,0,0
160730,),0,0
160731,.,0,0
160732,Target,0,0
160733,volume,0,0
160734,delineation,0,0
160735,was,0,0
160736,performed,0,0
160737,according,0,0
160738,to,0,0
160739,the,0,0
160740,European,0,1
160741,Organisation,0,0
160742,for,0,0
160743,the,0,0
160744,Research,0,0
160745,and,0,0
160746,Treatment,0,0
160747,of,0,0
160748,Cancer,0,1
160749,guidelines,0,0
160750,",",0,0
160751,and,0,0
160752,a,0,0
160753,DR-based,0,0
160754,treatment,0,0
160755,plan,0,0
160756,was,0,0
160757,established,0,0
160758,for,0,0
160759,70,0,1
160760,Gy,0,1
160761,.,0,1
160762,Major,0,0
160763,and,0,0
160764,minor,0,0
160765,protocol,0,0
160766,deviations,0,0
160767,were,0,0
160768,noted,0,0
160769,",",0,0
160770,interobserver,0,0
160771,agreement,0,0
160772,of,0,0
160773,delineated,0,0
160774,target,0,0
160775,contours,0,0
160776,was,0,0
160777,assessed,0,0
160778,",",0,0
160779,and,0,0
160780,dose-volume,0,0
160781,histogram,0,0
160782,(,0,0
160783,DVH,0,1
160784,),0,1
160785,parameters,0,0
160786,of,0,0
160787,different,0,0
160788,treatment,0,0
160789,techniques,0,0
160790,were,0,1
160791,compared,0,0
160792,.,0,1
160793,RESULTS,0,0
160794,Thirty,1,1
160795,European,1,1
160796,centers,1,1
160797,participated,1,1
160798,",",1,0
160799,43,1,1
160800,%,1,0
160801,of,1,0
160802,which,1,0
160803,were,1,0
160804,using,1,0
160805,3-dimensional,1,0
160806,conformal,1,1
160807,RT,1,1
160808,(,1,1
160809,3D-CRT,1,1
160810,),1,0
160811,",",1,0
160812,with,1,1
160813,the,1,0
160814,remaining,1,0
160815,centers,1,1
160816,using,1,0
160817,intensity,1,0
160818,modulated,1,0
160819,RT,1,1
160820,(,1,0
160821,IMRT,1,0
160822,),1,0
160823,or,1,1
160824,volumetric,1,0
160825,modulated,1,0
160826,arc,1,0
160827,technique,1,0
160828,(,1,0
160829,VMAT,1,0
160830,),1,0
160831,.,1,0
160832,The,0,0
160833,first,0,0
160834,submitted,0,0
160835,version,0,0
160836,of,0,0
160837,the,0,0
160838,DR,0,0
160839,contained,0,0
160840,major,0,1
160841,deviations,0,0
160842,in,0,1
160843,21,0,1
160844,of,0,0
160845,30,0,1
160846,(,0,1
160847,70,0,1
160848,%,0,0
160849,),0,0
160850,centers,0,1
160851,",",0,0
160852,mostly,0,0
160853,caused,0,0
160854,by,0,0
160855,inappropriately,0,0
160856,defined,0,0
160857,or,0,0
160858,lack,0,0
160859,of,0,0
160860,prostate,0,1
160861,bed,0,0
160862,(,0,0
160863,PB,0,0
160864,),0,0
160865,.,0,0
160866,All,0,0
160867,but,0,0
160868,5,1,0
160869,centers,1,1
160870,completed,1,1
160871,the,1,0
160872,DR,1,0
160873,successfully,1,0
160874,with,0,1
160875,their,0,0
160876,second,0,0
160877,submitted,0,0
160878,version,0,0
160879,.,0,0
160880,The,0,0
160881,interobserver,0,0
160882,agreement,0,0
160883,of,0,0
160884,the,0,0
160885,PB,0,0
160886,was,0,0
160887,moderate,0,1
160888,and,0,0
160889,was,0,0
160890,improved,0,0
160891,by,0,0
160892,the,0,0
160893,DR,0,0
160894,review,0,0
160895,",",0,0
160896,as,0,0
160897,indicated,0,0
160898,by,0,0
160899,an,0,0
160900,increased,0,0
160901,?,0,0
160902,value,0,0
160903,(,0,0
160904,0.59,0,0
160905,vs,0,0
160906,0.55,0,0
160907,),0,0
160908,",",0,0
160909,mean,0,0
160910,sensitivity,0,0
160911,(,0,0
160912,0.64,0,0
160913,vs,0,0
160914,0.58,0,0
160915,),0,0
160916,",",0,0
160917,volume,0,0
160918,of,0,0
160919,total,0,1
160920,agreement,0,0
160921,(,0,0
160922,3.9,0,0
160923,vs,0,0
160924,3.3,0,0
160925,cm,0,1
160926,(,0,1
160927,3,0,0
160928,),0,0
160929,),0,0
160930,",",0,0
160931,and,0,0
160932,decrease,0,0
160933,in,0,0
160934,the,0,0
160935,union,0,1
160936,volume,0,0
160937,(,0,0
160938,79.3,0,0
160939,vs,0,0
160940,84.2,0,0
160941,cm,0,1
160942,(,0,1
160943,3,0,0
160944,),0,1
160945,),0,0
160946,.,0,0
160947,Rectal,0,1
160948,and,0,0
160949,bladder,0,1
160950,wall,0,1
160951,DVH,0,0
160952,parameters,0,0
160953,of,0,0
160954,IMRT,0,1
160955,and,0,0
160956,VMAT,0,0
160957,vs,0,0
160958,3D-CRT,0,1
160959,plans,0,0
160960,were,0,0
160961,not,0,0
160962,significantly,0,0
160963,different,0,0
160964,.,0,0
160965,CONCLUSIONS,0,0
160966,The,0,0
160967,interobserver,0,0
160968,agreement,0,0
160969,of,0,0
160970,PB,0,0
160971,delineation,0,0
160972,was,0,0
160973,moderate,0,1
160974,but,0,0
160975,was,0,0
160976,improved,0,0
160977,by,0,0
160978,the,0,0
160979,DR.,0,1
160980,Major,0,0
160981,deviations,0,0
160982,could,0,0
160983,be,0,0
160984,identified,0,0
160985,for,0,0
160986,the,0,0
160987,majority,0,0
160988,of,0,0
160989,centers,0,1
160990,.,0,1
160991,The,0,0
160992,DR,0,0
160993,has,0,0
160994,improved,0,0
160995,the,0,0
160996,acquaintance,0,0
160997,of,0,0
160998,the,0,0
160999,participating,0,1
161000,centers,0,1
161001,with,0,1
161002,the,0,0
161003,trial,0,0
161004,protocol,0,0
161005,.,0,1
161006,Aftermath,0,0
161007,of,0,0
161008,a,0,0
161009,clinical,0,0
161010,trial,0,0
161011,:,0,1
161012,evaluating,0,0
161013,the,0,0
161014,sustainability,0,0
161015,of,0,0
161016,a,0,0
161017,medical,0,0
161018,device,0,0
161019,intervention,0,0
161020,in,1,0
161021,Ghana,1,1
161022,.,1,1
161023,A,0,0
161024,randomized,0,0
161025,controlled,0,0
161026,trial,0,0
161027,recently,0,0
161028,demonstrated,0,0
161029,that,0,0
161030,continuous,0,0
161031,positive,0,0
161032,airway,0,1
161033,pressure,0,0
161034,(,1,0
161035,CPAP,1,1
161036,),1,0
161037,effectively,1,0
161038,decreases,1,0
161039,respiratory,1,0
161040,rate,1,0
161041,in,1,0
161042,children,1,1
161043,presenting,1,1
161044,to,1,0
161045,Ghanaian,1,1
161046,district,1,1
161047,hospitals,1,1
161048,with,1,1
161049,respiratory,1,1
161050,distress,1,1
161051,.,1,0
161052,A,0,0
161053,follow-up,0,0
161054,study,0,1
161055,16,0,1
161056,months,0,0
161057,later,0,1
161058,evaluated,0,0
161059,the,0,0
161060,extent,0,0
161061,to,0,0
161062,which,0,0
161063,the,0,0
161064,skills,0,0
161065,and,0,0
161066,equipment,0,1
161067,necessary,0,0
161068,for,0,0
161069,CPAP,0,1
161070,use,0,0
161071,have,0,0
161072,been,0,0
161073,maintained,0,0
161074,.,0,0
161075,Seven,0,0
161076,of,0,0
161077,eight,0,1
161078,CPAP,0,1
161079,machines,0,1
161080,were,0,1
161081,functional,0,0
161082,",",0,0
161083,but,0,0
161084,five,0,1
161085,of,0,0
161086,eight,0,1
161087,oxygen,0,0
161088,concentrators,0,0
161089,and,0,0
161090,three,0,1
161091,of,0,0
161092,four,0,1
161093,electric,0,0
161094,generators,0,0
161095,were,0,1
161096,non-functional,0,1
161097,.,0,1
161098,Nurses,1,0
161099,trained,1,1
161100,by,1,0
161101,US,1,0
161102,study,1,1
161103,personnel,1,1
161104,(,1,0
161105,first-generation,1,1
161106,),1,0
161107,and,1,0
161108,nurses,1,1
161109,trained,1,1
161110,by,1,0
161111,Ghanaian,1,1
161112,nurses,1,1
161113,after,1,0
161114,the,1,0
161115,study,1,0
161116,(,1,0
161117,second-generation,1,1
161118,),1,0
161119,were,1,0
161120,evaluated,1,0
161121,on,1,0
161122,CPAP,1,1
161123,knowledge,1,0
161124,and,1,0
161125,skills,1,0
161126,.,1,1
161127,Twenty-eight,1,1
161128,nurses,1,1
161129,participated,1,1
161130,in,1,0
161131,the,1,0
161132,study,1,0
161133,",",1,0
161134,9,1,0
161135,first-generation,1,0
161136,and,1,0
161137,19,1,1
161138,second-generation,1,1
161139,.,1,1
161140,First-generation,0,0
161141,trainees,0,0
161142,scored,0,0
161143,significantly,0,0
161144,higher,0,0
161145,than,0,0
161146,second-generation,0,1
161147,trainees,0,0
161148,on,0,0
161149,both,0,0
161150,skills,0,0
161151,and,0,0
161152,knowledge,0,0
161153,assessments,0,0
161154,(,0,1
161155,p,0,0
161156,=,0,0
161157,0.003,0,0
161158,),0,1
161159,.,0,1
161160,Appropriate,0,0
161161,technical,0,0
161162,support,0,0
161163,and,0,0
161164,training,0,0
161165,must,0,0
161166,be,0,0
161167,ensured,0,0
161168,to,0,0
161169,address,0,0
161170,equipment,0,1
161171,maintenance,0,0
161172,.,0,0
161173,Protocolization,0,0
161174,of,0,0
161175,the,0,0
161176,training,0,0
161177,program,0,0
161178,",",0,0
161179,in,0,0
161180,conjunction,0,0
161181,with,0,1
161182,skills,0,0
161183,and,0,0
161184,knowledge,0,0
161185,assessment,0,0
161186,",",0,0
161187,may,0,0
161188,improve,0,0
161189,acquisition,0,0
161190,and,0,0
161191,retention,0,0
161192,among,0,0
161193,second-,0,1
161194,and,0,1
161195,future-generation,0,0
161196,trainees,0,1
161197,.,0,1
161198,Outcomes,0,0
161199,and,0,0
161200,biochemical,0,0
161201,parameters,0,0
161202,following,0,0
161203,cardiac,1,1
161204,surgery,1,1
161205,:,1,1
161206,effects,0,0
161207,of,0,0
161208,transfusion,0,0
161209,of,0,0
161210,residual,0,0
161211,blood,0,0
161212,using,0,0
161213,centrifugation,0,0
161214,and,0,0
161215,multiple-pass,0,0
161216,hemoconcentration,0,0
161217,.,0,0
161218,OBJECTIVES,0,0
161219,To,0,0
161220,determine,0,0
161221,whether,0,0
161222,or,0,0
161223,not,0,0
161224,there,0,0
161225,was,0,0
161226,a,0,0
161227,significant,0,0
161228,difference,0,0
161229,between,0,0
161230,the,0,0
161231,methods,0,1
161232,of,0,0
161233,centrifugation,0,0
161234,(,0,0
161235,CF,0,0
161236,),0,0
161237,and,0,0
161238,multiple-pass,0,0
161239,hemoconcentration,0,0
161240,(,0,0
161241,MPH,0,0
161242,),0,0
161243,of,0,0
161244,the,0,0
161245,residual,0,0
161246,cardiopulmonary-bypass,0,1
161247,volume,0,0
161248,in,0,0
161249,relation,0,0
161250,to,0,0
161251,biochemical,0,0
161252,measurements,0,0
161253,and,0,1
161254,patient,0,1
161255,outcomes,0,0
161256,.,0,1
161257,DESIGN,0,0
161258,Prospective,0,0
161259,",",0,0
161260,randomized,0,0
161261,",",0,0
161262,and,0,0
161263,controlled,0,0
161264,.,0,0
161265,SETTING,0,0
161266,Conducted,0,0
161267,at,0,0
161268,a,1,0
161269,western,1,1
161270,Canadian,1,1
161271,tertiary,1,1
161272,care,1,1
161273,hospital,1,1
161274,.,1,1
161275,PARTICIPANTS,0,0
161276,Consisted,1,1
161277,of,1,0
161278,61,1,1
161279,consecutive,1,1
161280,male,1,1
161281,and,1,0
161282,female,1,1
161283,patients,1,1
161284,from,1,1
161285,ages,1,1
161286,40,1,1
161287,to,1,1
161288,80,1,1
161289,who,1,1
161290,were,1,1
161291,scheduled,1,1
161292,for,1,0
161293,cardiac,1,1
161294,surgery,1,1
161295,with,1,1
161296,cardiopulmonary,1,1
161297,bypass,1,1
161298,.,1,1
161299,INTERVENTIONS,0,0
161300,Either,0,0
161301,the,0,0
161302,centrifugation,0,0
161303,or,0,0
161304,multiple-pass,0,0
161305,hemoconcentration,0,0
161306,method,0,0
161307,was,0,0
161308,used,0,0
161309,to,0,0
161310,process,0,0
161311,the,0,0
161312,residual,0,0
161313,blood,0,0
161314,from,0,0
161315,the,0,0
161316,cardiopulmonary,0,1
161317,bypass,0,1
161318,circuit,0,0
161319,.,0,0
161320,RESULTS,0,0
161321,The,0,0
161322,12-hour,0,0
161323,postoperative,0,0
161324,levels,0,0
161325,of,0,0
161326,serum,0,0
161327,hemoglobin,0,0
161328,were,0,0
161329,not,0,0
161330,significantly,0,0
161331,different,0,0
161332,in,0,0
161333,the,0,0
161334,centrifugation,0,0
161335,group,0,0
161336,as,0,0
161337,compared,0,0
161338,to,0,0
161339,the,0,0
161340,multiple-pass,0,0
161341,hemoconcentration,0,0
161342,group,0,0
161343,.,0,0
161344,However,0,0
161345,",",0,0
161346,the,0,0
161347,serum,0,0
161348,levels,0,0
161349,of,0,0
161350,total,0,1
161351,protein,0,0
161352,and,0,0
161353,albumin,0,0
161354,were,0,0
161355,significantly,0,0
161356,higher,0,0
161357,in,0,0
161358,the,0,0
161359,multiple-pass,0,0
161360,hemoconcentration,0,0
161361,group,0,0
161362,as,0,0
161363,compared,0,0
161364,to,0,0
161365,the,0,0
161366,centrifugation,0,0
161367,group,0,0
161368,.,0,0
161369,Additionally,0,0
161370,",",0,0
161371,after,0,0
161372,12-hours,0,0
161373,postoperatively,0,0
161374,",",0,0
161375,the,0,0
161376,serum,0,0
161377,fibrinogen,0,0
161378,and,0,0
161379,platelet,0,1
161380,counts,0,0
161381,were,0,0
161382,significantly,0,0
161383,higher,0,0
161384,in,0,0
161385,the,0,0
161386,multiple-pass,0,0
161387,hemoconcentration,0,0
161388,group,0,0
161389,as,0,0
161390,compared,0,0
161391,to,0,0
161392,those,0,0
161393,of,0,0
161394,the,0,0
161395,centrifugation,0,0
161396,group,0,0
161397,.,0,0
161398,The,0,0
161399,allogeneic,0,0
161400,product,0,0
161401,transfusion,0,0
161402,index,0,0
161403,and,0,0
161404,the,0,0
161405,chest-tube,0,0
161406,blood,0,0
161407,drainage,0,1
161408,indices,0,0
161409,were,0,0
161410,lower,0,0
161411,in,0,0
161412,the,0,0
161413,multiple-pass,0,0
161414,hemoconcentration,0,0
161415,group,0,0
161416,as,0,0
161417,compared,0,0
161418,to,0,0
161419,the,0,0
161420,centrifugation,0,0
161421,group,0,0
161422,.,0,0
161423,CONCLUSION,0,0
161424,Although,0,0
161425,the,0,0
161426,CF,0,0
161427,method,0,0
161428,provided,0,0
161429,a,0,0
161430,product,0,0
161431,in,0,0
161432,a,0,0
161433,shorter,0,0
161434,turnaround,0,0
161435,time,0,0
161436,",",0,0
161437,with,0,1
161438,consistent,0,0
161439,clearance,0,0
161440,of,0,0
161441,heparin,0,0
161442,",",0,0
161443,the,0,0
161444,MPH,0,0
161445,method,0,0
161446,trended,0,0
161447,towards,0,0
161448,enhanced,0,0
161449,biochemical,0,0
161450,and,0,0
161451,clinical,0,0
161452,patient,0,0
161453,outcomes,0,0
161454,over,0,0
161455,the,0,0
161456,12-hour,0,0
161457,postoperative,0,0
161458,period,0,1
161459,.,0,1
161460,A,0,0
161461,comparison,0,0
161462,of,0,0
161463,Villalta-Prandoni,0,0
161464,scale,0,0
161465,and,0,0
161466,venous,0,0
161467,clinical,0,0
161468,severity,0,0
161469,score,0,0
161470,in,0,0
161471,the,0,0
161472,assessment,0,0
161473,of,0,0
161474,post,1,0
161475,thrombotic,1,1
161476,syndrome,1,1
161477,.,1,1
161478,BACKGROUND,0,0
161479,Post-thrombotic,0,1
161480,syndrome,0,1
161481,(,0,0
161482,PTS,0,0
161483,),0,0
161484,is,0,0
161485,the,0,0
161486,most,0,0
161487,important,0,0
161488,late,0,1
161489,complication,0,0
161490,of,0,0
161491,acute,1,1
161492,deep,1,1
161493,venous,1,1
161494,thrombosis,1,1
161495,(,1,0
161496,DVT,1,0
161497,),1,0
161498,",",0,0
161499,with,0,1
161500,as,0,0
161501,many,0,0
161502,as,0,0
161503,two-thirds,0,1
161504,of,0,1
161505,patients,0,1
161506,developing,0,1
161507,symptoms,0,0
161508,of,0,0
161509,pain,0,1
161510,",",0,0
161511,edema,0,0
161512,",",0,0
161513,hyperpigmentation,0,0
161514,",",0,0
161515,or,0,0
161516,ulceration,0,1
161517,.,0,0
161518,Although,0,0
161519,several,0,0
161520,instruments,0,1
161521,are,0,0
161522,available,0,0
161523,for,0,0
161524,evaluation,0,0
161525,of,0,0
161526,the,0,0
161527,severity,0,0
161528,of,0,0
161529,PTS,0,0
161530,",",0,0
161531,including,0,0
161532,the,0,0
161533,Villalta-Prandoni,0,0
161534,scale,0,0
161535,(,0,0
161536,VPS,0,0
161537,),0,0
161538,and,0,0
161539,Venous,0,1
161540,Clinical,0,0
161541,Severity,0,0
161542,Score,0,1
161543,(,0,0
161544,VCSS,0,0
161545,),0,0
161546,",",0,0
161547,no,0,0
161548,studies,0,0
161549,have,0,0
161550,yet,0,0
161551,compared,0,0
161552,the,0,0
161553,2,0,0
161554,instruments,0,0
161555,.,0,1
161556,The,0,0
161557,purpose,0,0
161558,of,0,0
161559,this,0,0
161560,study,0,0
161561,is,0,0
161562,to,0,0
161563,compare,0,0
161564,the,0,0
161565,2,0,0
161566,instruments,0,0
161567,as,0,0
161568,part,0,1
161569,of,0,0
161570,a,0,0
161571,larger,0,0
161572,randomized,0,0
161573,controlled,0,0
161574,study,0,0
161575,that,0,0
161576,assessed,0,0
161577,the,0,0
161578,impact,0,0
161579,of,0,0
161580,graduated,0,1
161581,compressive,0,1
161582,stockings,0,0
161583,in,0,0
161584,the,0,0
161585,prevention,0,0
161586,of,0,0
161587,PTS,0,0
161588,.,0,1
161589,METHODS,0,0
161590,Sixty-nine,1,1
161591,consecutive,1,1
161592,patients,1,1
161593,with,1,1
161594,acute,1,1
161595,DVT,1,0
161596,documented,1,0
161597,by,1,0
161598,duplex,1,0
161599,ultrasonography,1,0
161600,were,0,0
161601,randomized,0,0
161602,to,0,0
161603,treatment,0,0
161604,with,0,1
161605,30-40,0,1
161606,mm,0,1
161607,Hg,0,0
161608,graduated,0,1
161609,compressive,0,0
161610,stockings,0,0
161611,(,0,1
161612,GCS,0,1
161613,),0,0
161614,or,0,1
161615,no,0,0
161616,stockings,0,0
161617,.,0,1
161618,Patients,1,1
161619,were,1,0
161620,followed,1,0
161621,clinically,1,0
161622,at,1,0
161623,months,1,0
161624,1,1,1
161625,",",1,0
161626,3,1,0
161627,",",1,0
161628,6,1,0
161629,",",1,0
161630,12,1,0
161631,",",1,0
161632,18,1,1
161633,",",1,0
161634,and,1,0
161635,24,1,0
161636,after,1,0
161637,the,1,0
161638,diagnosis,1,1
161639,of,1,0
161640,DVT,1,0
161641,.,1,1
161642,PTS,0,0
161643,as,0,0
161644,defined,0,0
161645,by,0,0
161646,the,0,0
161647,VPS,0,0
161648,and,0,0
161649,VCSS,0,0
161650,were,0,0
161651,assessed,0,0
161652,at,0,0
161653,these,0,0
161654,follow-up,0,0
161655,visits,0,0
161656,.,0,1
161657,Based,0,0
161658,upon,0,0
161659,the,0,0
161660,VPS,0,0
161661,",",0,0
161662,PTS,0,0
161663,was,0,0
161664,scored,0,0
161665,as,0,0
161666,absent,0,0
161667,(,0,0
161668,score,0,0
161669,<,0,0
161670,3,0,0
161671,or,0,0
161672,3,0,0
161673,without,0,1
161674,objective,0,0
161675,criteria,0,1
161676,),0,0
161677,",",0,0
161678,mild,0,1
161679,to,0,0
161680,moderate,0,1
161681,(,0,0
161682,score,0,0
161683,?3,0,0
161684,with,0,1
161685,1,0,0
161686,objective,0,0
161687,criteria,0,1
161688,),0,0
161689,",",0,0
161690,or,0,0
161691,severe,0,1
161692,(,0,0
161693,score,0,0
161694,?4,0,0
161695,),0,0
161696,.,0,0
161697,For,0,0
161698,the,0,0
161699,VCSS,0,0
161700,",",0,0
161701,PTS,0,0
161702,was,0,0
161703,considered,0,0
161704,to,0,0
161705,be,0,0
161706,absent,0,0
161707,(,0,0
161708,score,0,0
161709,?3,0,0
161710,),0,0
161711,",",0,0
161712,mild,0,1
161713,to,0,0
161714,moderate,0,1
161715,(,0,0
161716,score,0,0
161717,4-7,0,0
161718,),0,0
161719,",",0,0
161720,or,0,0
161721,severe,0,1
161722,(,0,0
161723,score,0,0
161724,?8,0,0
161725,),0,0
161726,.,0,0
161727,The,0,0
161728,2,0,0
161729,instruments,0,0
161730,were,0,1
161731,compared,0,0
161732,for,0,0
161733,mild,0,1
161734,to,0,0
161735,moderate,0,1
161736,and,0,0
161737,severe,0,1
161738,disease,0,1
161739,using,0,0
161740,the,0,0
161741,Pearson,0,0
161742,chi-squared,0,0
161743,test,0,0
161744,and,0,0
161745,gamma,0,0
161746,statistic,0,0
161747,.,0,0
161748,RESULTS,0,0
161749,Good,0,1
161750,correlation,0,0
161751,was,0,0
161752,detected,0,0
161753,in,0,0
161754,the,0,0
161755,ability,0,0
161756,of,0,0
161757,VPS,0,0
161758,and,0,1
161759,VCSS,0,0
161760,instruments,0,0
161761,to,0,0
161762,detect,0,0
161763,mild,0,1
161764,to,0,0
161765,moderate,0,1
161766,disease,0,1
161767,(,0,0
161768,gamma,0,0
161769,statistic,0,0
161770,=,0,0
161771,0.71-0.98,0,0
161772,;,0,0
161773,P,0,0
161774,<,0,0
161775,0.05,0,0
161776,),0,0
161777,.,0,1
161778,For,0,0
161779,severe,0,1
161780,disease,0,1
161781,",",0,0
161782,a,0,0
161783,statistically,0,0
161784,significant,0,0
161785,correlation,0,0
161786,was,0,0
161787,not,0,0
161788,found,0,0
161789,in,0,0
161790,the,0,0
161791,ability,0,0
161792,of,0,0
161793,the,0,0
161794,2,0,0
161795,instruments,0,0
161796,to,0,0
161797,detect,0,0
161798,disease,0,1
161799,(,0,0
161800,gamma,0,0
161801,statistic,0,0
161802,=,0,0
161803,0.5-0.98,0,0
161804,;,0,0
161805,P,0,0
161806,>,0,1
161807,0.05,0,0
161808,),0,0
161809,",",0,0
161810,especially,0,0
161811,at,0,0
161812,12,0,0
161813,and,0,1
161814,24,0,1
161815,months,0,0
161816,.,0,1
161817,CONCLUSION,0,0
161818,Both,0,0
161819,VPS,0,0
161820,and,0,0
161821,the,0,0
161822,VCSS,0,0
161823,scoring,0,1
161824,systems,0,0
161825,are,0,0
161826,important,0,0
161827,tools,0,0
161828,in,0,0
161829,the,0,0
161830,identification,0,0
161831,and,0,0
161832,follow-up,0,0
161833,of,0,0
161834,PTS,0,0
161835,.,0,0
161836,There,0,0
161837,exists,0,0
161838,agreement,0,0
161839,between,0,0
161840,the,0,0
161841,2,0,0
161842,instruments,0,0
161843,for,0,0
161844,detecting,0,0
161845,mild,0,1
161846,to,0,0
161847,moderate,0,1
161848,disease,0,1
161849,.,0,0
161850,For,0,0
161851,severe,0,1
161852,disease,0,1
161853,however,0,0
161854,",",0,0
161855,VCSS,0,0
161856,may,0,0
161857,possibly,0,0
161858,be,0,0
161859,a,0,0
161860,more,0,0
161861,sensitive,0,0
161862,instrument,0,0
161863,.,0,1
161864,Intravesical,0,0
161865,seeding,0,0
161866,of,0,0
161867,upper,0,1
161868,urinary,0,1
161869,tract,0,1
161870,urothelial,0,1
161871,carcinoma,0,1
161872,cells,0,0
161873,during,0,0
161874,nephroureterectomy,1,1
161875,:,1,1
161876,an,0,0
161877,exploratory,0,0
161878,analysis,0,0
161879,from,0,0
161880,the,0,0
161881,THPMG,0,0
161882,trial,0,0
161883,.,0,0
161884,OBJECTIVE,0,0
161885,The,0,0
161886,Pirarubicin,0,0
161887,Monotherapy,0,0
161888,Study,0,0
161889,Group,0,1
161890,trial,0,0
161891,was,0,0
161892,a,0,0
161893,randomized,0,0
161894,Phase,0,1
161895,II,0,1
161896,study,0,0
161897,that,0,0
161898,evaluated,0,0
161899,the,0,0
161900,efficacy,0,0
161901,of,0,0
161902,intravesical,0,0
161903,instillation,0,0
161904,of,0,0
161905,pirarubicin,0,0
161906,in,0,0
161907,the,0,0
161908,prevention,0,0
161909,of,0,0
161910,bladder,0,1
161911,recurrence,0,0
161912,after,0,0
161913,nephroureterectomy,1,1
161914,for,1,0
161915,upper,1,1
161916,urinary,1,1
161917,tract,1,1
161918,urothelial,1,1
161919,carcinoma,1,1
161920,.,1,0
161921,This,0,0
161922,study,0,0
161923,conducted,0,0
161924,further,0,0
161925,analysis,0,0
161926,of,0,0
161927,the,0,0
161928,Pirarubicin,0,0
161929,Monotherapy,0,0
161930,Study,0,0
161931,Group,0,1
161932,cohort,0,1
161933,",",0,0
161934,focusing,0,0
161935,on,0,0
161936,intravesical,0,0
161937,seeding,0,0
161938,of,0,0
161939,cancer,0,1
161940,cells,0,0
161941,.,0,1
161942,METHODS,0,0
161943,Using,0,0
161944,the,0,0
161945,data,1,0
161946,from,1,0
161947,the,1,0
161948,Pirarubicin,1,0
161949,Monotherapy,1,0
161950,Study,1,0
161951,Group,1,1
161952,trial,1,0
161953,",",0,0
161954,bladder,0,1
161955,recurrence-free,0,0
161956,survival,0,0
161957,rates,0,0
161958,and,0,1
161959,factors,0,0
161960,associated,0,0
161961,with,0,1
161962,bladder,0,1
161963,recurrence,0,0
161964,in,0,0
161965,the,0,0
161966,control,0,0
161967,group,0,0
161968,were,0,0
161969,analyzed,0,0
161970,.,0,0
161971,RESULTS,0,0
161972,Of,0,1
161973,36,1,1
161974,patients,1,1
161975,in,1,0
161976,the,1,0
161977,control,1,0
161978,group,1,0
161979,",",1,0
161980,14,1,0
161981,with,1,1
161982,positive,1,1
161983,urine,1,0
161984,cytology,1,0
161985,had,0,0
161986,more,0,0
161987,frequent,0,0
161988,recurrence,0,0
161989,when,0,0
161990,compared,0,0
161991,with,0,0
161992,the,0,0
161993,22,1,1
161994,patients,1,1
161995,with,1,1
161996,negative,1,0
161997,cytology,1,1
161998,(,1,0
161999,P,1,0
162000,=,1,0
162001,0.004,1,0
162002,),1,1
162003,.,1,0
162004,Based,0,0
162005,on,0,0
162006,the,0,0
162007,multivariate,0,0
162008,analysis,0,0
162009,in,0,0
162010,the,0,0
162011,control,0,0
162012,group,0,0
162013,",",0,0
162014,voided,0,0
162015,urine,0,0
162016,cytology,0,1
162017,was,0,0
162018,an,0,0
162019,independent,0,0
162020,predictive,0,0
162021,factor,0,0
162022,of,0,0
162023,bladder,0,1
162024,recurrence,0,0
162025,(,0,0
162026,hazard,0,0
162027,ratio,0,0
162028,",",0,0
162029,5.54,0,0
162030,;,0,0
162031,95,0,0
162032,%,0,0
162033,confidence,0,0
162034,interval,0,0
162035,1.12-27.5,0,0
162036,;,0,1
162037,P,0,0
162038,=,0,0
162039,0.036,0,0
162040,),0,0
162041,.,0,1
162042,Of,0,0
162043,72,1,1
162044,patients,1,1
162045,in,1,0
162046,the,1,0
162047,Pirarubicin,1,0
162048,Monotherapy,1,0
162049,Study,1,0
162050,Group,1,1
162051,trial,1,0
162052,",",0,0
162053,31,0,1
162054,had,0,1
162055,positive,0,0
162056,urine,0,0
162057,cytology,0,1
162058,.,0,0
162059,Among,1,1
162060,the,1,0
162061,31,1,1
162062,patients,1,1
162063,",",1,1
162064,17,1,1
162065,patients,1,1
162066,who,1,1
162067,received,1,1
162068,pirarubicin,1,0
162069,instillation,1,0
162070,had,0,1
162071,fewer,0,0
162072,recurrences,0,0
162073,when,0,0
162074,compared,0,0
162075,with,0,0
162076,14,1,1
162077,patients,1,1
162078,who,1,1
162079,received,1,1
162080,control,1,1
162081,treatment,1,0
162082,(,0,0
162083,P,0,0
162084,=,0,0
162085,0.0001,0,0
162086,),0,0
162087,.,0,0
162088,On,0,0
162089,multivariate,0,0
162090,analysis,0,0
162091,",",0,0
162092,pirarubicin,0,0
162093,instillation,0,0
162094,was,0,0
162095,an,0,0
162096,independent,0,0
162097,predictor,0,0
162098,of,0,0
162099,better,0,0
162100,recurrence-free,0,0
162101,survival,0,0
162102,rates,0,0
162103,in,0,0
162104,the,0,0
162105,patients,0,1
162106,with,0,1
162107,positive,0,1
162108,urine,0,0
162109,cytology,0,1
162110,(,0,0
162111,hazard,0,0
162112,ratio,0,0
162113,",",0,0
162114,0.02,0,0
162115,;,0,0
162116,95,0,0
162117,%,0,0
162118,confidence,0,0
162119,interval,0,0
162120,",",0,0
162121,0.00-0.53,0,0
162122,;,0,0
162123,P,0,0
162124,=,0,0
162125,0.018,0,0
162126,),0,0
162127,.,0,1
162128,Of,0,0
162129,21,0,1
162130,patients,0,1
162131,with,0,1
162132,bladder,0,1
162133,recurrence,0,0
162134,",",0,0
162135,17,0,1
162136,had,0,1
162137,recurrent,0,1
162138,tumor,0,0
162139,around,0,0
162140,cystotomy,0,0
162141,or,0,1
162142,in,0,0
162143,the,0,0
162144,bladder,0,1
162145,neck,0,1
162146,compromised,0,0
162147,by,0,0
162148,the,0,0
162149,urethral,0,1
162150,catheter,0,0
162151,",",0,0
162152,supporting,0,0
162153,the,0,0
162154,notion,0,0
162155,that,0,0
162156,tumor,0,1
162157,cells,0,0
162158,seeded,0,0
162159,in,0,0
162160,the,0,0
162161,injured,0,1
162162,urothelium,0,0
162163,.,0,1
162164,CONCLUSIONS,0,0
162165,Intravesical,0,0
162166,instillation,0,0
162167,of,0,0
162168,pirarubicin,0,0
162169,immediately,0,0
162170,after,0,0
162171,nephroureterectomy,0,1
162172,significantly,0,0
162173,reduced,0,0
162174,the,0,0
162175,bladder,0,1
162176,recurrence,0,0
162177,rate,0,0
162178,in,0,0
162179,patients,0,1
162180,with,0,1
162181,positive,0,1
162182,voided,0,0
162183,urine,0,0
162184,cytology,0,1
162185,.,0,0
162186,The,0,0
162187,results,0,0
162188,suggest,0,0
162189,that,0,0
162190,intravesical,0,0
162191,seeding,0,0
162192,of,0,0
162193,upper,0,1
162194,urinary,0,1
162195,tract,0,1
162196,urothelial,0,0
162197,carcinoma,0,1
162198,occurs,0,0
162199,during,0,0
162200,nephroureterectomy,0,1
162201,.,0,1
162202,A,0,0
162203,randomized,0,0
162204,",",0,0
162205,double-blind,0,0
162206,comparison,0,0
162207,of,0,0
162208,atomoxetine,0,1
162209,and,0,0
162210,placebo,0,0
162211,on,0,0
162212,response,0,0
162213,inhibition,0,0
162214,and,0,0
162215,interference,0,0
162216,control,0,0
162217,in,0,0
162218,children,1,1
162219,and,1,1
162220,adolescents,1,1
162221,with,1,1
162222,autism,1,1
162223,spectrum,1,1
162224,disorder,1,1
162225,and,1,0
162226,comorbid,1,1
162227,attention-deficit/hyperactivity,1,1
162228,disorder,1,1
162229,symptoms,1,1
162230,.,1,1
162231,Oxytocin,0,0
162232,promotes,0,0
162233,facial,0,0
162234,emotion,0,0
162235,recognition,0,0
162236,and,0,0
162237,amygdala,0,0
162238,reactivity,0,0
162239,in,0,0
162240,adults,1,1
162241,with,1,1
162242,asperger,1,1
162243,syndrome,1,1
162244,.,1,0
162245,The,0,0
162246,neuropeptide,0,0
162247,oxytocin,0,0
162248,has,0,0
162249,recently,0,0
162250,been,0,0
162251,shown,0,0
162252,to,0,0
162253,enhance,0,0
162254,eye,0,0
162255,gaze,0,0
162256,and,0,0
162257,emotion,0,0
162258,recognition,0,0
162259,in,0,0
162260,healthy,1,1
162261,men,1,1
162262,.,1,0
162263,Here,0,0
162264,",",0,0
162265,we,0,0
162266,report,0,0
162267,a,0,0
162268,randomized,0,0
162269,double-blind,0,0
162270,",",0,0
162271,placebo-controlled,0,0
162272,trial,0,0
162273,that,0,0
162274,examined,0,0
162275,the,0,0
162276,neural,0,0
162277,and,0,0
162278,behavioral,0,1
162279,effects,0,0
162280,of,0,0
162281,a,0,0
162282,single,0,0
162283,dose,0,0
162284,of,0,0
162285,intranasal,0,0
162286,oxytocin,0,0
162287,on,0,0
162288,emotion,0,0
162289,recognition,0,1
162290,in,0,0
162291,individuals,1,1
162292,with,1,1
162293,Asperger,1,1
162294,syndrome,1,1
162295,(,1,0
162296,AS,1,0
162297,),1,0
162298,",",0,0
162299,a,0,0
162300,clinical,0,0
162301,condition,0,0
162302,characterized,0,0
162303,by,0,0
162304,impaired,0,1
162305,eye,0,0
162306,gaze,0,0
162307,and,0,0
162308,facial,0,0
162309,emotion,0,0
162310,recognition,0,1
162311,.,0,0
162312,Using,0,0
162313,functional,0,0
162314,magnetic,0,0
162315,resonance,0,0
162316,imaging,0,0
162317,",",0,0
162318,we,0,0
162319,examined,0,0
162320,whether,0,0
162321,oxytocin,0,0
162322,would,0,0
162323,enhance,0,0
162324,emotion,0,0
162325,recognition,0,0
162326,from,0,1
162327,facial,0,1
162328,sections,0,1
162329,of,0,0
162330,the,0,0
162331,eye,0,0
162332,vs,0,0
162333,the,0,0
162334,mouth,0,0
162335,region,0,1
162336,and,0,0
162337,modulate,0,0
162338,regional,0,0
162339,activity,0,0
162340,in,0,0
162341,brain,0,0
162342,areas,0,0
162343,associated,0,0
162344,with,0,1
162345,face,0,0
162346,perception,0,0
162347,in,0,0
162348,both,0,0
162349,adults,1,1
162350,with,1,1
162351,AS,1,1
162352,",",0,0
162353,and,0,0
162354,a,0,0
162355,neurotypical,0,1
162356,control,0,0
162357,group,0,0
162358,.,0,0
162359,Intranasal,0,0
162360,administration,0,0
162361,of,0,0
162362,the,0,0
162363,neuropeptide,0,0
162364,oxytocin,0,0
162365,improved,0,0
162366,performance,0,0
162367,in,0,0
162368,a,0,0
162369,facial,0,0
162370,emotion,0,0
162371,recognition,0,0
162372,task,0,0
162373,in,0,0
162374,individuals,1,1
162375,with,1,1
162376,AS,1,1
162377,.,1,1
162378,This,0,0
162379,was,0,0
162380,linked,0,0
162381,to,0,0
162382,increased,0,0
162383,left,0,1
162384,amygdala,0,0
162385,reactivity,0,0
162386,in,0,0
162387,response,0,0
162388,to,0,0
162389,facial,0,1
162390,stimuli,0,0
162391,and,0,1
162392,increased,0,0
162393,activity,0,0
162394,in,0,0
162395,the,0,0
162396,neural,0,0
162397,network,0,0
162398,involved,0,0
162399,in,0,0
162400,social,0,0
162401,cognition,0,0
162402,.,0,1
162403,Our,0,0
162404,data,0,0
162405,suggest,0,0
162406,that,0,0
162407,the,0,0
162408,amygdala,0,0
162409,",",0,0
162410,together,0,0
162411,with,0,0
162412,functionally,0,0
162413,associated,0,0
162414,cortical,0,0
162415,areas,0,0
162416,mediate,0,0
162417,the,0,0
162418,positive,0,0
162419,effect,0,0
162420,of,0,0
162421,oxytocin,0,0
162422,on,0,0
162423,social,0,0
162424,cognitive,0,0
162425,functioning,0,0
162426,in,0,0
162427,AS,0,1
162428,.,0,1
162429,A,0,0
162430,shortened,0,0
162431,versus,0,0
162432,standard,0,0
162433,matched,0,1
162434,postpartum,0,1
162435,magnesium,0,0
162436,sulphate,0,0
162437,regimen,0,0
162438,in,0,0
162439,the,0,0
162440,treatment,0,0
162441,of,0,0
162442,eclampsia,1,1
162443,:,1,1
162444,a,0,0
162445,randomised,0,0
162446,controlled,0,0
162447,trial,0,0
162448,.,0,0
162449,Magnesium,0,0
162450,sulphate,0,0
162451,is,0,0
162452,currently,0,0
162453,the,0,0
162454,most,0,0
162455,ideal,0,0
162456,drug,0,0
162457,for,0,0
162458,the,0,0
162459,treatment,0,0
162460,of,0,0
162461,eclampsia,0,1
162462,but,0,0
162463,its,0,0
162464,use,0,0
162465,in,0,0
162466,Nigeria,0,1
162467,is,0,0
162468,still,0,0
162469,limited,0,0
162470,due,0,0
162471,its,0,0
162472,cost,0,0
162473,and,0,0
162474,clinicians,0,0
162475,inexperience,0,0
162476,with,0,1
162477,the,0,0
162478,drug,0,0
162479,.,0,0
162480,The,0,0
162481,purpose,0,0
162482,of,0,0
162483,this,0,0
162484,study,0,0
162485,was,0,0
162486,to,0,0
162487,determine,0,0
162488,whether,0,0
162489,a,0,0
162490,shortened,0,0
162491,postpartum,0,1
162492,course,0,0
162493,of,0,0
162494,magnesium,0,0
162495,sulphate,0,0
162496,is,0,0
162497,as,0,0
162498,effective,0,0
162499,as,0,0
162500,the,0,0
162501,standard,0,0
162502,Pritchard,0,1
162503,regimen,0,0
162504,in,0,0
162505,controlling,0,0
162506,fits,0,0
162507,in,0,0
162508,eclampsia,0,1
162509,Between,1,1
162510,January,1,1
162511,and,1,0
162512,June,1,1
162513,2011,1,1
162514,",",1,0
162515,98,1,1
162516,eclamptic,1,1
162517,mothers,1,1
162518,presenting,1,1
162519,at,1,0
162520,the,1,0
162521,labour,1,0
162522,ward,1,1
162523,of,1,0
162524,the,1,0
162525,University,1,1
162526,of,1,0
162527,Maiduguri,1,1
162528,Teaching,1,0
162529,Hospital,1,1
162530,were,0,0
162531,randomised,0,0
162532,to,0,0
162533,receive,0,0
162534,either,0,0
162535,the,0,0
162536,standard,0,0
162537,Pritchard,0,1
162538,regimen,0,0
162539,of,0,0
162540,magnesium,0,0
162541,sulphate,0,0
162542,or,0,0
162543,a,0,0
162544,shortened,0,0
162545,postpartum,0,1
162546,course,0,0
162547,in,0,0
162548,which,0,0
162549,only,0,0
162550,two,0,0
162551,doses,0,0
162552,of,0,0
162553,intramuscular,0,0
162554,magnesium,0,0
162555,sulphate,0,0
162556,is,0,0
162557,given,0,0
162558,four,0,0
162559,hours,0,0
162560,apart,0,1
162561,.,0,0
162562,The,0,0
162563,maternal,0,0
162564,and,0,0
162565,fetal,0,1
162566,outcomes,0,0
162567,were,0,1
162568,compared,0,0
162569,.,0,0
162570,The,0,0
162571,primary,0,0
162572,outcome,0,0
162573,measure,0,0
162574,was,0,0
162575,recurrence,0,0
162576,of,0,0
162577,fits,0,0
162578,.,0,1
162579,The,0,0
162580,recurrence,0,0
162581,of,0,0
162582,fits,0,0
162583,and,0,1
162584,other,0,0
162585,maternal,0,1
162586,complications,0,0
162587,were,0,1
162588,similar,0,0
162589,in,0,0
162590,the,0,0
162591,two,0,0
162592,groups,0,0
162593,.,0,1
162594,The,0,0
162595,total,0,0
162596,dosage,0,0
162597,of,0,0
162598,magnesium,0,0
162599,sulphate,0,0
162600,in,0,0
162601,the,0,0
162602,shortened,0,0
162603,group,0,0
162604,was,0,0
162605,reduced,0,0
162606,by,0,0
162607,40,0,1
162608,%,0,0
162609,in,0,0
162610,66,0,1
162611,%,0,0
162612,of,0,0
162613,patients,0,1
162614,.,0,1
162615,The,0,0
162616,shortened,0,0
162617,postpartum,0,1
162618,course,0,0
162619,of,0,0
162620,magnesium,0,0
162621,sulphate,0,0
162622,is,0,0
162623,as,0,0
162624,effective,0,0
162625,as,0,0
162626,the,0,0
162627,standard,0,0
162628,Pritchard,0,1
162629,regimen,0,0
162630,in,0,0
162631,the,0,0
162632,management,0,0
162633,of,0,0
162634,eclampsia,0,1
162635,.,0,1
162636,Japan,0,0
162637,useful,0,0
162638,medication,0,0
162639,program,0,0
162640,for,0,0
162641,schizophrenia,0,1
162642,(,0,0
162643,JUMPs,0,0
162644,),0,0
162645,-long-term,0,0
162646,study,0,0
162647,on,0,0
162648,discontinuation,0,0
162649,rate,0,0
162650,",",0,0
162651,resolution,0,0
162652,and,0,0
162653,remission,0,0
162654,",",0,0
162655,and,0,0
162656,improvement,0,0
162657,in,0,0
162658,social,0,0
162659,functioning,0,0
162660,rate,0,0
162661,associated,0,0
162662,with,0,1
162663,atypical,0,1
162664,antipsychotic,0,1
162665,medications,0,0
162666,in,0,1
162667,patients,1,1
162668,with,1,1
162669,schizophrenia,1,1
162670,.,1,0
162671,BACKGROUND,0,0
162672,It,0,0
162673,is,0,0
162674,desirable,0,0
162675,to,0,0
162676,establish,0,0
162677,evidence,0,0
162678,for,0,0
162679,the,0,0
162680,selection,0,0
162681,of,0,0
162682,antipsychotics,0,0
162683,from,0,1
162684,the,0,0
162685,viewpoint,0,0
162686,of,0,0
162687,recovery,0,0
162688,of,0,0
162689,social,0,0
162690,activity,0,0
162691,in,0,0
162692,individual,1,0
162693,patient,1,1
162694,with,1,1
162695,schizophrenia,1,1
162696,receiving,1,1
162697,medication,1,0
162698,.,1,0
162699,From,0,0
162700,this,0,0
162701,perspective,0,0
162702,",",0,0
162703,awareness,0,0
162704,of,0,0
162705,the,0,0
162706,importance,0,0
162707,of,0,0
162708,studies,0,0
162709,about,0,0
162710,drug,0,0
162711,effectiveness,0,0
162712,on,0,0
162713,treatment,0,0
162714,discontinuation,0,0
162715,rate,0,0
162716,",",0,0
162717,remission,0,0
162718,rate,0,0
162719,",",0,0
162720,and,0,0
162721,improvement,0,0
162722,in,0,0
162723,QOL,0,0
162724,has,0,0
162725,grown,0,0
162726,recently,0,0
162727,.,0,0
162728,In,0,0
162729,Western,0,1
162730,countries,0,1
162731,",",0,1
162732,numerous,0,0
162733,reports,0,0
162734,are,0,0
162735,available,0,0
162736,in,0,0
162737,effectiveness,0,0
162738,studies,0,0
162739,",",0,0
162740,which,0,0
162741,are,0,0
162742,related,0,0
162743,to,0,0
162744,olanzapine,0,0
162745,and,0,0
162746,risperidone,0,0
162747,primarily,0,0
162748,",",0,0
162749,whereas,0,0
162750,evidence,0,0
162751,for,0,0
162752,other,0,0
162753,second-generation,0,1
162754,antipsychotics,0,0
162755,(,0,1
162756,SGAs,0,0
162757,),0,0
162758,is,0,0
162759,poor,0,0
162760,.,0,0
162761,In,0,0
162762,Japan,0,0
162763,",",0,0
162764,no,0,0
162765,effectiveness,0,0
162766,study,0,0
162767,has,0,0
162768,been,0,0
162769,reported,0,0
162770,:,0,0
162771,thus,0,0
162772,",",0,0
162773,it,0,0
162774,is,0,0
162775,desirable,0,0
162776,to,0,0
162777,collect,0,1
162778,data,0,0
162779,that,0,0
162780,will,0,0
162781,serve,0,0
162782,as,0,0
162783,evidence,0,0
162784,for,0,0
162785,selection,0,0
162786,of,0,0
162787,the,0,0
162788,3,0,0
162789,SGAs,0,0
162790,approved,0,1
162791,after,0,0
162792,olanzapine,0,0
162793,.,0,1
162794,METHODS,0,0
162795,The,0,0
162796,present,0,0
162797,study,0,0
162798,was,0,0
162799,a,0,0
162800,long-term,0,0
162801,effectiveness,0,0
162802,study,0,0
162803,under,0,0
162804,healthcare,1,0
162805,setting,1,1
162806,in,1,0
162807,Japan,1,1
162808,.,1,1
162809,It,0,0
162810,was,0,0
162811,designed,0,0
162812,as,0,0
162813,an,0,0
162814,open-label,0,0
162815,",",0,0
162816,multicenter,0,0
162817,",",0,0
162818,randomized,0,0
162819,",",0,0
162820,comparative,0,0
162821,study,0,0
162822,involving,0,1
162823,104-week,0,1
162824,oral,0,0
162825,treatment,0,0
162826,with,0,1
162827,1,0,0
162828,of,0,0
162829,the,0,0
162830,3,0,0
162831,drugs,0,0
162832,(,0,0
162833,aripiprazole,0,0
162834,",",0,0
162835,blonanserin,0,0
162836,",",0,0
162837,and,0,0
162838,paliperidone,0,0
162839,),0,0
162840,in,0,0
162841,patients,1,1
162842,with,1,1
162843,schizophrenia,1,1
162844,aged,1,1
162845,20,1,1
162846,years,1,1
162847,or,1,1
162848,over,1,1
162849,who,1,1
162850,required,1,1
162851,antipsychotic,1,1
162852,medication,1,0
162853,or,1,0
162854,switching,1,0
162855,of,1,0
162856,the,1,0
162857,current,1,0
162858,medication,1,0
162859,to,1,0
162860,others,1,0
162861,for,1,0
162862,reasons,1,0
162863,such,1,0
162864,as,1,0
162865,lack,1,0
162866,of,1,0
162867,efficacy,1,0
162868,and,1,0
162869,intolerability,1,0
162870,.,1,0
162871,The,0,0
162872,primary,0,0
162873,endpoint,0,0
162874,is,0,0
162875,treatment,0,0
162876,discontinuation,0,0
162877,rate,0,0
162878,for,0,0
162879,any,0,0
162880,causes,0,0
162881,.,0,0
162882,The,0,0
162883,secondary,0,0
162884,endpoints,0,0
162885,include,0,0
162886,remission,0,0
162887,rate,0,0
162888,",",0,0
162889,improvement,0,0
162890,of,0,0
162891,social,0,0
162892,activity,0,0
162893,",",0,0
162894,alleviation,0,0
162895,",",0,0
162896,aggravation,0,0
162897,or,0,0
162898,recurrence,0,0
162899,of,0,0
162900,psychiatric,0,1
162901,symptoms,0,0
162902,",",0,0
162903,and,0,0
162904,safety,0,0
162905,.,0,0
162906,The,1,0
162907,target,1,0
162908,number,1,0
162909,of,1,0
162910,subjects,1,1
162911,was,1,0
162912,set,1,0
162913,at,1,0
162914,300,1,0
162915,.,1,1
162916,DISCUSSION,0,0
162917,Because,0,0
162918,this,0,0
162919,study,0,0
162920,is,0,0
162921,expected,0,0
162922,to,0,0
162923,yield,0,0
162924,evidence,0,0
162925,regarding,0,0
162926,the,0,0
162927,selection,0,0
162928,of,0,0
162929,antipsychotics,0,0
162930,for,0,0
162931,facilitating,0,0
162932,the,0,0
162933,recovery,0,0
162934,of,0,0
162935,social,0,0
162936,activity,0,0
162937,in,0,0
162938,patients,1,1
162939,with,1,1
162940,schizophrenia,1,1
162941,",",0,0
162942,it,0,0
162943,is,0,0
162944,considered,0,0
162945,highly,1,0
162946,valuable,1,0
162947,to,1,0
162948,perform,1,0
162949,this,1,0
162950,effectiveness,1,0
162951,study,1,0
162952,under,1,0
162953,ordinary,1,0
162954,healthcare,1,0
162955,setting,1,1
162956,in,1,0
162957,Japan,1,1
162958,.,1,1
162959,TRIAL,0,0
162960,REGISTRATION,0,0
162961,UMIN,0,0
162962,Clinical,0,0
162963,Trials,0,1
162964,Registry,0,1
162965,000007942,0,1
162966,.,0,1
162967,See,0,0
162968,what,0,0
162969,I,0,1
162970,see,0,1
162971,",",0,0
162972,do,0,0
162973,as,0,0
162974,I,0,1
162975,do,0,0
162976,:,0,0
162977,promoting,0,0
162978,joint,0,0
162979,attention,0,0
162980,and,0,0
162981,imitation,0,0
162982,in,0,0
162983,preschoolers,1,1
162984,with,1,1
162985,autism,1,1
162986,spectrum,1,1
162987,disorder,1,1
162988,.,1,0
162989,Since,0,0
162990,imitation,0,0
162991,and,0,0
162992,joint,0,0
162993,attention,0,0
162994,are,0,0
162995,both,0,0
162996,important,0,0
162997,abilities,0,0
162998,for,0,1
162999,young,0,1
163000,children,0,1
163001,and,0,1
163002,since,0,0
163003,children,1,1
163004,with,1,1
163005,autism,1,1
163006,spectrum,1,1
163007,disorder,1,1
163008,show,0,0
163009,a,0,0
163010,range,0,0
163011,of,0,0
163012,problems,0,1
163013,in,0,0
163014,these,0,0
163015,domains,0,0
163016,",",0,0
163017,imitation,0,0
163018,and,0,0
163019,joint,0,0
163020,attention,0,0
163021,are,0,0
163022,important,0,0
163023,targets,0,0
163024,for,0,0
163025,intervention,0,0
163026,.,0,0
163027,In,0,0
163028,this,0,0
163029,study,0,0
163030,",",0,0
163031,we,0,0
163032,examined,0,0
163033,the,0,0
163034,possibility,0,0
163035,of,0,0
163036,promoting,0,0
163037,imitation,0,0
163038,and,0,0
163039,joint,0,0
163040,attention,0,0
163041,by,0,0
163042,means,0,0
163043,of,0,0
163044,a,0,0
163045,training,0,0
163046,programme,0,0
163047,specifically,0,0
163048,designed,0,0
163049,for,0,0
163050,low-intensity,0,0
163051,",",0,0
163052,non-residential,0,1
163053,treatment,0,0
163054,.,0,1
163055,Two,1,0
163056,matched,1,1
163057,groups,1,0
163058,of,1,1
163059,18,1,1
163060,children,1,1
163061,each,1,0
163062,participated,1,1
163063,in,1,0
163064,the,1,0
163065,study,1,0
163066,.,1,0
163067,The,0,0
163068,experimental,0,0
163069,group,0,0
163070,",",0,0
163071,receiving,0,0
163072,the,0,0
163073,training,0,0
163074,programme,0,0
163075,",",0,0
163076,improved,0,0
163077,significantly,0,0
163078,more,0,0
163079,on,0,0
163080,joint,0,0
163081,attention,0,0
163082,than,0,0
163083,the,0,0
163084,group,0,0
163085,receiving,0,0
163086,only,0,0
163087,treatment,0,0
163088,as,0,0
163089,usual,0,1
163090,.,0,0
163091,Only,0,0
163092,the,0,0
163093,experimental,0,0
163094,group,0,0
163095,obtained,0,0
163096,a,0,0
163097,significantly,0,0
163098,higher,0,0
163099,imitation,0,0
163100,score,0,0
163101,during,0,0
163102,the,0,0
163103,post-test,0,0
163104,compared,0,0
163105,to,0,0
163106,the,0,0
163107,pre-test,0,0
163108,.,0,0
163109,This,0,0
163110,study,0,0
163111,shows,0,0
163112,that,0,0
163113,it,0,0
163114,is,0,0
163115,possible,0,0
163116,to,0,0
163117,promote,0,0
163118,joint,0,0
163119,attention,0,0
163120,with,0,1
163121,a,0,0
163122,low-intensity,0,0
163123,treatment,0,0
163124,programme,0,0
163125,.,0,0
163126,The,0,0
163127,results,0,0
163128,concerning,0,0
163129,imitation,0,0
163130,are,0,0
163131,more,0,0
163132,modest,0,0
163133,.,0,0
163134,Future,0,0
163135,replications,0,0
163136,should,0,0
163137,involve,0,0
163138,measures,0,0
163139,of,0,0
163140,stability,0,0
163141,and,0,0
163142,generalization,0,0
163143,.,0,1
163144,Effect,0,0
163145,of,0,0
163146,clinical,0,0
163147,context,0,0
163148,on,0,0
163149,simulator-based,0,0
163150,assessment,0,0
163151,of,0,0
163152,blood,1,0
163153,pressure,1,0
163154,taking,1,1
163155,-,0,0
163156,a,0,0
163157,pilot,0,0
163158,randomized,0,0
163159,study,0,0
163160,.,0,1
163161,BACKGROUND,0,0
163162,Blood,0,0
163163,pressure,0,0
163164,measurement,0,0
163165,is,0,0
163166,an,0,0
163167,essential,0,0
163168,clinical,0,0
163169,skill,0,0
163170,that,0,0
163171,can,0,0
163172,readily,0,0
163173,be,0,0
163174,assessed,0,0
163175,in,0,0
163176,objective,0,0
163177,structured,0,0
163178,clinical,0,0
163179,examination,0,1
163180,(,0,0
163181,OSCE,0,0
163182,),0,0
163183,.,0,0
163184,While,0,0
163185,the,0,0
163186,use,0,0
163187,of,0,0
163188,simulators,0,0
163189,can,0,0
163190,enhance,0,0
163191,test,0,0
163192,validity,0,0
163193,and,0,0
163194,reliability,0,0
163195,",",0,0
163196,the,0,0
163197,given,0,0
163198,clinical,0,0
163199,context,0,0
163200,may,0,0
163201,also,0,0
163202,affect,0,0
163203,student,0,0
163204,performance,0,0
163205,.,0,0
163206,AIMS,0,0
163207,To,0,0
163208,investigate,0,0
163209,the,0,0
163210,impact,0,0
163211,of,0,0
163212,variations,0,0
163213,in,0,0
163214,clinical,0,0
163215,context,0,0
163216,on,0,0
163217,blood,0,0
163218,pressure,0,0
163219,measurement,0,0
163220,in,0,0
163221,a,0,0
163222,simulator-based,0,0
163223,OSCE,0,0
163224,.,0,1
163225,METHOD,0,0
163226,We,0,0
163227,randomized,1,1
163228,162,1,1
163229,first-year,1,1
163230,medical,1,1
163231,students,1,1
163232,into,1,1
163233,four,1,1
163234,groups,1,0
163235,that,1,0
163236,received,1,1
163237,different,1,0
163238,lead-in,1,0
163239,statements,1,0
163240,before,1,0
163241,measuring,1,0
163242,blood,1,0
163243,pressure,1,0
163244,on,1,0
163245,a,1,0
163246,manikin,1,0
163247,simulator,1,0
163248,.,1,0
163249,These,0,0
163250,statements,0,0
163251,described,0,0
163252,hypothetical,0,0
163253,patients,0,1
163254,with,0,1
163255,different,0,0
163256,likelihoods,0,0
163257,of,0,0
163258,having,0,1
163259,systemic,0,0
163260,hypertension,0,1
163261,.,0,0
163262,RESULTS,0,0
163263,The,0,0
163264,lead-in,0,0
163265,that,0,0
163266,described,0,0
163267,the,0,0
163268,highest,0,0
163269,likelihood,0,0
163270,of,0,0
163271,hypertension,0,1
163272,was,0,0
163273,associated,0,0
163274,with,0,1
163275,significantly,0,0
163276,higher,0,0
163277,reported,0,0
163278,readings,0,0
163279,and,0,0
163280,lower,0,0
163281,accuracy,0,0
163282,.,0,0
163283,The,0,0
163284,lead-in,0,0
163285,that,0,0
163286,suggested,0,0
163287,normality,0,0
163288,yielded,0,0
163289,the,0,0
163290,best,0,0
163291,performance,0,0
163292,.,0,1
163293,CONCLUSION,0,0
163294,Student,1,0
163295,performance,0,0
163296,in,0,0
163297,simulator-based,0,0
163298,OSCE,0,0
163299,may,0,0
163300,be,0,0
163301,affected,0,0
163302,by,0,0
163303,the,0,0
163304,clinical,0,0
163305,context,0,0
163306,provided,0,0
163307,.,0,0
163308,However,0,0
163309,",",0,0
163310,we,0,0
163311,argue,0,0
163312,that,0,0
163313,construct,0,0
163314,validity,0,0
163315,should,0,0
163316,be,0,0
163317,viewed,0,0
163318,in,0,0
163319,light,0,0
163320,of,0,0
163321,the,0,0
163322,application,0,0
163323,of,0,0
163324,a,0,0
163325,test,0,0
163326,",",0,0
163327,in,0,0
163328,that,0,0
163329,patients,0,1
163330,may,0,0
163331,also,0,0
163332,present,0,0
163333,with,0,1
163334,different,0,0
163335,cues,0,0
163336,and,0,1
163337,likelihoods,0,0
163338,of,0,0
163339,having,0,1
163340,hypertension,0,1
163341,.,0,1
163342,Variations,0,0
163343,in,0,0
163344,construct,0,0
163345,design,0,0
163346,should,0,0
163347,be,0,0
163348,further,0,0
163349,explored,0,0
163350,to,0,0
163351,enhance,0,0
163352,the,0,0
163353,training,0,0
163354,and,0,0
163355,assessment,0,0
163356,of,0,0
163357,clinical,0,0
163358,competence,0,0
163359,that,0,0
163360,reflects,0,0
163361,the,0,0
163362,unpredictability,0,0
163363,encountered,0,0
163364,in,0,0
163365,daily,0,0
163366,clinical,0,0
163367,practice,0,1
163368,.,0,1
163369,Combining,0,0
163370,afferent,0,0
163371,stimulation,0,0
163372,and,0,0
163373,mirror,0,0
163374,therapy,0,0
163375,for,0,0
163376,rehabilitating,0,1
163377,motor,0,0
163378,function,0,0
163379,",",0,0
163380,motor,0,0
163381,control,0,0
163382,",",0,0
163383,ambulation,0,0
163384,",",0,0
163385,and,0,0
163386,daily,0,0
163387,functions,0,0
163388,after,0,0
163389,stroke,0,1
163390,.,0,1
163391,BACKGROUND,0,0
163392,Mirror,0,0
163393,therapy,0,0
163394,(,0,0
163395,MT,0,0
163396,),0,0
163397,and,0,0
163398,mesh,0,0
163399,glove,0,0
163400,(,0,0
163401,MG,0,0
163402,),0,0
163403,afferent,0,0
163404,stimulation,0,0
163405,may,0,0
163406,be,0,0
163407,effective,0,0
163408,in,0,0
163409,reducing,0,0
163410,motor,0,0
163411,impairment,0,0
163412,after,0,0
163413,stroke,0,1
163414,.,0,0
163415,A,0,0
163416,hybrid,0,0
163417,intervention,0,0
163418,of,0,0
163419,MT,0,0
163420,combined,0,0
163421,with,0,1
163422,MG,0,0
163423,(,0,1
163424,MT,0,0
163425,+,0,0
163426,MG,0,0
163427,),0,0
163428,may,0,0
163429,broaden,0,0
163430,aspects,0,0
163431,of,0,0
163432,treatment,0,1
163433,benefits,0,0
163434,.,0,1
163435,OBJECTIVE,0,0
163436,To,0,0
163437,demonstrate,0,0
163438,the,0,0
163439,comparative,0,0
163440,effects,0,0
163441,of,0,1
163442,MG,0,0
163443,+,0,0
163444,MT,0,0
163445,",",0,0
163446,MT,0,0
163447,",",0,0
163448,and,0,0
163449,a,0,0
163450,control,0,0
163451,treatment,0,0
163452,(,0,0
163453,CT,0,0
163454,),0,0
163455,on,0,0
163456,the,0,0
163457,outcomes,0,0
163458,of,0,0
163459,motor,0,0
163460,impairments,0,0
163461,",",0,0
163462,manual,0,0
163463,dexterity,0,0
163464,",",0,0
163465,ambulation,0,0
163466,function,0,0
163467,",",0,0
163468,motor,0,0
163469,control,0,0
163470,",",0,0
163471,and,0,0
163472,daily,0,0
163473,function,0,0
163474,.,0,1
163475,METHODS,0,0
163476,Forty-three,1,1
163477,chronic,1,1
163478,stroke,1,1
163479,patients,1,1
163480,with,1,1
163481,mild,1,1
163482,to,1,0
163483,moderate,1,1
163484,upper,1,0
163485,extremity,1,1
163486,impairment,1,0
163487,were,0,0
163488,randomly,0,1
163489,assigned,0,0
163490,to,0,0
163491,receive,0,0
163492,MT,0,0
163493,+,0,0
163494,MG,0,0
163495,",",0,0
163496,MT,0,0
163497,",",0,0
163498,or,0,0
163499,CT,0,0
163500,for,0,0
163501,1.5,0,0
163502,hours/day,0,0
163503,",",0,0
163504,5,0,0
163505,days/week,0,0
163506,for,0,0
163507,4,0,0
163508,weeks,0,0
163509,.,0,1
163510,Outcome,0,0
163511,measures,0,0
163512,were,0,1
163513,the,0,0
163514,Fugl-Meyer,0,0
163515,Assessment,0,0
163516,(,0,0
163517,FMA,0,0
163518,),0,0
163519,and,0,0
163520,muscle,0,0
163521,tone,0,0
163522,measured,0,0
163523,by,0,0
163524,Myoton-3,0,0
163525,for,0,0
163526,motor,0,0
163527,impairment,0,0
163528,and,0,0
163529,the,0,0
163530,Box,0,0
163531,and,0,0
163532,Block,0,1
163533,Test,0,0
163534,(,0,0
163535,BBT,0,0
163536,),0,0
163537,and,0,0
163538,10-Meter,0,1
163539,Walk,0,0
163540,Test,0,1
163541,(,0,1
163542,10,0,1
163543,MWT,0,1
163544,),0,0
163545,for,0,0
163546,motor,0,0
163547,function,0,0
163548,.,0,1
163549,Secondary,0,0
163550,outcomes,0,0
163551,included,0,1
163552,kinematic,0,0
163553,parameters,0,0
163554,for,0,0
163555,motor,0,0
163556,control,0,0
163557,and,0,0
163558,the,0,0
163559,Motor,0,0
163560,Activity,0,0
163561,Log,0,1
163562,and,0,0
163563,ABILHAND,0,1
163564,Questionnaire,0,0
163565,for,0,0
163566,daily,0,0
163567,function,0,0
163568,.,0,1
163569,RESULTS,0,0
163570,FMA,0,0
163571,total,0,1
163572,scores,0,0
163573,were,0,0
163574,significantly,0,0
163575,higher,0,0
163576,and,0,0
163577,synergistic,0,0
163578,shoulder,0,1
163579,abduction,0,1
163580,during,0,0
163581,reach,0,0
163582,was,0,0
163583,less,0,0
163584,in,0,0
163585,the,0,0
163586,MT,0,0
163587,+,0,0
163588,MG,0,0
163589,and,0,0
163590,MT,0,0
163591,groups,0,0
163592,compared,0,0
163593,with,0,1
163594,the,0,0
163595,CT,0,0
163596,group,0,0
163597,.,0,0
163598,Performance,0,0
163599,on,0,0
163600,the,0,0
163601,BBT,0,0
163602,and,0,0
163603,the,0,0
163604,10,0,0
163605,MWT,0,0
163606,(,0,0
163607,velocity,0,0
163608,and,0,0
163609,stride,0,0
163610,length,0,0
163611,in,0,0
163612,self-paced,0,0
163613,task,0,0
163614,and,0,0
163615,velocity,0,0
163616,in,0,0
163617,as-quickly-as-possible,0,0
163618,task,0,0
163619,),0,0
163620,were,0,0
163621,improved,0,0
163622,after,0,0
163623,MT,0,0
163624,+,0,0
163625,MG,0,0
163626,compared,0,0
163627,with,0,1
163628,MT,0,0
163629,.,0,1
163630,CONCLUSIONS,0,0
163631,MT,0,0
163632,+,0,0
163633,MG,0,0
163634,improved,0,0
163635,manual,0,0
163636,dexterity,0,0
163637,and,0,0
163638,ambulation,0,0
163639,.,0,1
163640,MT,0,0
163641,+,0,0
163642,MG,0,0
163643,and,0,0
163644,MT,0,0
163645,reduced,0,0
163646,motor,0,0
163647,impairment,0,0
163648,and,0,0
163649,synergistic,0,0
163650,shoulder,0,1
163651,abduction,0,1
163652,more,0,0
163653,than,0,0
163654,CT.,0,0
163655,Future,0,0
163656,studies,0,0
163657,may,0,0
163658,integrate,0,0
163659,functional,0,0
163660,task,0,0
163661,practice,0,0
163662,into,0,0
163663,treatments,0,0
163664,to,0,0
163665,enhance,0,0
163666,functional,0,0
163667,outcomes,0,0
163668,in,0,1
163669,patients,0,1
163670,with,0,1
163671,various,0,0
163672,levels,0,0
163673,of,0,0
163674,motor,0,0
163675,severity,0,0
163676,.,0,0
163677,The,0,0
163678,long-term,0,0
163679,effects,0,0
163680,of,0,1
163681,MG,0,0
163682,+,0,0
163683,MT,0,0
163684,remain,0,0
163685,to,0,0
163686,be,0,0
163687,evaluated,0,0
163688,.,0,0
163689,The,0,0
163690,cardiovascular,0,0
163691,effects,0,0
163692,of,0,0
163693,sevoflurane,0,0
163694,and,0,0
163695,isoflurane,0,0
163696,after,0,0
163697,premedication,0,0
163698,of,0,0
163699,healthy,1,1
163700,dogs,1,1
163701,undergoing,1,1
163702,elective,1,1
163703,surgery,1,1
163704,.,1,1
163705,Sevoflurane,0,0
163706,and,0,0
163707,isoflurane,0,0
163708,are,0,0
163709,commonly,0,0
163710,used,0,0
163711,in,0,0
163712,veterinary,0,1
163713,anesthesia,0,1
163714,.,0,0
163715,The,0,0
163716,objective,0,0
163717,of,0,0
163718,this,0,0
163719,prospective,0,0
163720,",",0,0
163721,randomized,0,0
163722,",",0,0
163723,open-label,0,0
163724,clinical,0,0
163725,study,0,0
163726,was,0,0
163727,to,0,0
163728,compare,0,0
163729,the,0,0
163730,cardiovascular,0,0
163731,effects,0,0
163732,of,0,0
163733,sevoflurane,0,0
163734,and,0,0
163735,isoflurane,0,0
163736,via,0,0
163737,direct,0,0
163738,arterial,0,1
163739,blood,0,0
163740,pressure,0,0
163741,measurements,0,0
163742,and,0,0
163743,the,0,0
163744,lithium,0,0
163745,dilution,0,0
163746,cardiac,0,1
163747,output,0,0
163748,(,0,0
163749,LDCO,0,1
163750,),0,0
163751,on,0,0
163752,premedicated,1,1
163753,healthy,1,1
163754,dogs,1,1
163755,undergoing,1,1
163756,elective,1,1
163757,tibial,1,1
163758,plateau,1,0
163759,leveling,1,0
163760,osteotomy,1,1
163761,(,1,0
163762,TPLO,1,1
163763,),1,1
163764,.,1,1
163765,Nineteen,1,1
163766,client-owned,1,1
163767,dogs,1,1
163768,were,0,1
163769,included,0,1
163770,.,0,0
163771,All,0,0
163772,dogs,0,1
163773,were,0,0
163774,premedicated,0,1
163775,with,0,1
163776,hydromorphone,0,0
163777,(,0,0
163778,0.05,0,0
163779,mg/kg,0,0
163780,IV,0,0
163781,and,0,0
163782,glycopyrrolate,0,0
163783,0.01,0,0
163784,mg/kg,0,0
163785,subcutaneously,0,0
163786,),0,1
163787,.,0,0
163788,Ten,1,1
163789,dogs,1,1
163790,were,1,1
163791,anesthetized,1,1
163792,with,1,1
163793,sevoflurane,1,0
163794,and,1,0
163795,nine,1,1
163796,dogs,1,1
163797,were,1,1
163798,anesthetized,1,1
163799,with,1,1
163800,isoflurane,1,0
163801,.,1,1
163802,Eighteen,0,1
163803,dogs,0,1
163804,were,0,1
163805,instrumented,0,1
163806,with,0,1
163807,a,0,0
163808,dorsal,0,0
163809,pedal,0,0
163810,arterial,0,1
163811,catheter,0,0
163812,",",0,0
163813,and,0,0
163814,one,0,0
163815,dog,0,1
163816,had,0,1
163817,a,0,0
163818,femoral,0,1
163819,arterial,0,1
163820,catheter,0,0
163821,.,0,0
163822,All,0,0
163823,dogs,0,1
163824,had,0,1
163825,continuous,0,0
163826,",",0,0
163827,direct,0,0
163828,systolic,0,1
163829,(,0,0
163830,SAP,0,1
163831,),0,0
163832,",",0,0
163833,diastolic,0,1
163834,(,0,0
163835,DAP,0,0
163836,),0,0
163837,",",0,0
163838,and,0,0
163839,mean,0,0
163840,arterial,0,1
163841,(,0,0
163842,MAP,0,0
163843,),0,0
163844,blood,0,0
163845,pressure,0,0
163846,readings,0,0
163847,as,0,0
163848,well,0,0
163849,as,0,0
163850,heart,0,1
163851,rate,0,0
163852,(,0,0
163853,HR,0,0
163854,),0,0
163855,",",0,0
163856,cardiac,0,1
163857,output,0,0
163858,(,0,0
163859,CO,0,0
163860,),0,0
163861,",",0,0
163862,cardiac,0,1
163863,index,0,0
163864,(,0,0
163865,CI,0,0
163866,),0,0
163867,",",0,0
163868,systemic,0,0
163869,vascular,0,0
163870,resistance,0,0
163871,(,0,0
163872,SVR,0,0
163873,),0,0
163874,",",0,0
163875,systemic,0,0
163876,vascular,0,0
163877,resistance,0,0
163878,index,0,0
163879,(,0,0
163880,SVRI,0,0
163881,),0,0
163882,",",0,0
163883,stroke,0,1
163884,volume,0,0
163885,variation,0,0
163886,(,0,0
163887,SVV,0,1
163888,),0,0
163889,",",0,0
163890,and,0,0
163891,pulse,0,0
163892,pressure,0,0
163893,variation,0,0
163894,(,0,0
163895,PPV,0,1
163896,),0,0
163897,recorded,0,0
163898,q,0,0
163899,5,0,0
163900,min,0,0
163901,during,0,0
163902,the,0,0
163903,surgical,0,0
163904,procedure,0,0
163905,.,0,0
163906,There,0,0
163907,was,0,0
163908,no,0,0
163909,significant,0,0
163910,statistical,0,0
163911,difference,0,0
163912,in,0,0
163913,all,0,0
163914,parameters,0,0
163915,between,0,0
163916,the,0,0
163917,sevoflurane,0,0
163918,and,0,0
163919,isoflurane,0,0
163920,treatment,0,0
163921,groups,0,0
163922,.,0,0
163923,Both,0,0
163924,sevoflurane,0,0
163925,and,0,0
163926,isoflurane,0,0
163927,inhalant,0,1
163928,anesthetics,0,0
163929,appear,0,0
163930,to,0,0
163931,have,0,0
163932,similar,0,0
163933,hemodynamic,0,0
163934,effects,0,0
163935,when,0,0
163936,used,0,0
163937,as,0,0
163938,part,0,0
163939,of,0,0
163940,a,0,0
163941,multimodal,0,0
163942,anesthetic,0,0
163943,protocol,0,0
163944,in,0,0
163945,premedicated,1,1
163946,healthy,1,1
163947,dogs,1,1
163948,undergoing,1,1
163949,an,1,0
163950,elective,1,1
163951,surgical,1,0
163952,procedure,1,0
163953,.,1,1
163954,Stimulus,0,0
163955,over-selectivity,0,0
163956,in,0,0
163957,temporal,1,0
163958,brain,1,1
163959,injury,1,1
163960,:,1,1
163961,mindfulness,0,0
163962,as,0,0
163963,a,0,0
163964,potential,0,0
163965,intervention,0,0
163966,.,0,0
163967,OBJECTIVE,0,0
163968,The,0,0
163969,current,0,0
163970,study,0,0
163971,aimed,0,0
163972,to,0,0
163973,investigate,0,0
163974,the,0,0
163975,impact,0,0
163976,of,0,0
163977,brief,0,0
163978,mindfulness,0,0
163979,training,0,0
163980,on,0,0
163981,the,0,0
163982,performance,0,0
163983,of,0,0
163984,a,0,0
163985,sample,0,1
163986,of,0,0
163987,patients,1,1
163988,with,1,1
163989,TBI,1,1
163990,in,1,0
163991,an,1,0
163992,over-selectivity,1,0
163993,task,1,0
163994,.,1,0
163995,PARTICIPANTS,0,0
163996,Twenty-four,1,1
163997,patients,1,1
163998,who,1,1
163999,had,1,1
164000,suffered,1,1
164001,TBI,1,1
164002,and,1,0
164003,reported,1,0
164004,problems,1,1
164005,with,1,1
164006,focused,1,0
164007,or,1,1
164008,sustained,1,0
164009,attention,1,0
164010,.,1,1
164011,METHOD,0,0
164012,The,0,0
164013,study,0,0
164014,was,0,0
164015,a,0,0
164016,between-subjects,0,0
164017,design,0,0
164018,(,0,0
164019,mindfulness,0,0
164020,intervention,0,0
164021,vs,0,0
164022,control,0,1
164023,),0,0
164024,with,0,1
164025,difference,0,0
164026,between,0,0
164027,number,0,0
164028,of,0,0
164029,most,0,0
164030,and,0,0
164031,least,0,1
164032,chosen,0,0
164033,stimulus,0,0
164034,selections,0,0
164035,on,0,0
164036,an,0,0
164037,over-selectivity,0,0
164038,task,0,0
164039,as,0,0
164040,the,0,0
164041,dependent,0,0
164042,measure,0,0
164043,.,0,0
164044,RESULTS,0,0
164045,The,0,0
164046,results,0,0
164047,of,0,0
164048,this,0,0
164049,study,0,0
164050,indicated,0,0
164051,that,0,0
164052,stimulus,0,0
164053,over-selectivity,0,0
164054,was,0,0
164055,present,0,0
164056,in,0,0
164057,a,0,0
164058,group,0,0
164059,of,0,0
164060,patients,0,1
164061,with,0,1
164062,TBI,0,1
164063,.,0,0
164064,However,0,0
164065,",",0,0
164066,the,0,0
164067,level,0,0
164068,of,0,0
164069,emergent,0,1
164070,over-selectivity,0,0
164071,was,0,0
164072,significantly,0,0
164073,reduced,0,0
164074,by,0,0
164075,a,0,0
164076,mindfulness,0,0
164077,induction,0,0
164078,when,0,0
164079,compared,0,0
164080,to,0,0
164081,a,0,0
164082,no-,0,0
164083,intervention,0,0
164084,control,0,1
164085,group,0,0
164086,.,0,0
164087,CONCLUSIONS,0,0
164088,The,0,0
164089,findings,0,0
164090,are,0,0
164091,discussed,0,0
164092,in,0,0
164093,terms,0,0
164094,of,0,0
164095,the,0,0
164096,efficacy,0,0
164097,of,0,0
164098,mindfulness,0,0
164099,training,0,0
164100,in,0,0
164101,reducing,0,0
164102,TBI-related,0,1
164103,cognitive,0,1
164104,deficits,0,0
164105,.,0,1
164106,TGF-beta,0,0
164107,receptor,0,0
164108,type-2,0,1
164109,expression,0,0
164110,in,0,0
164111,cancer-associated,0,1
164112,fibroblasts,0,0
164113,regulates,0,0
164114,breast,0,1
164115,cancer,0,1
164116,cell,0,1
164117,growth,0,0
164118,and,0,0
164119,survival,0,0
164120,and,0,0
164121,is,0,0
164122,a,0,0
164123,prognostic,0,0
164124,marker,0,0
164125,in,0,0
164126,pre-menopausal,0,1
164127,breast,0,1
164128,cancer,0,1
164129,.,0,0
164130,Transforming,0,0
164131,growth,0,0
164132,factor-beta,0,0
164133,(,0,0
164134,TGF-?,0,0
164135,),0,0
164136,is,0,0
164137,a,0,0
164138,pleiotropic,0,0
164139,cytokine,0,0
164140,with,0,1
164141,the,0,0
164142,capability,0,0
164143,to,0,0
164144,act,0,0
164145,as,0,0
164146,tumour,0,0
164147,suppressor,0,0
164148,or,0,1
164149,tumour,0,0
164150,promoter,0,0
164151,depending,0,0
164152,on,0,0
164153,the,0,0
164154,cellular,0,0
164155,context,0,0
164156,.,0,1
164157,TGF-beta,0,0
164158,receptor,0,0
164159,type-2,0,1
164160,(,0,0
164161,TGFBR2,0,0
164162,),0,0
164163,is,0,0
164164,the,0,0
164165,ligand-binding,0,0
164166,receptor,0,0
164167,for,0,0
164168,all,0,0
164169,members,0,1
164170,of,0,0
164171,the,0,0
164172,TGF-?,0,0
164173,family,0,1
164174,.,0,1
164175,Data,0,0
164176,from,1,0
164177,mouse,1,1
164178,model,1,0
164179,experiments,1,0
164180,demonstrated,1,0
164181,that,0,0
164182,loss,0,0
164183,of,0,0
164184,Tgfbr2,0,0
164185,expression,0,0
164186,in,0,0
164187,mammary,0,1
164188,fibroblasts,0,1
164189,was,0,0
164190,linked,0,0
164191,to,0,0
164192,tumour,0,0
164193,initiation,0,0
164194,and,0,0
164195,metastasis,0,1
164196,.,0,0
164197,Using,1,0
164198,a,1,0
164199,randomised,1,0
164200,tamoxifen,1,0
164201,trial,1,0
164202,cohort,1,1
164203,including,1,0
164204,in,1,0
164205,total,1,1
164206,564,1,1
164207,invasive,1,1
164208,breast,1,1
164209,carcinomas,1,1
164210,",",1,0
164211,we,0,0
164212,examined,0,0
164213,TGFBR2,0,0
164214,expression,0,0
164215,(,0,0
164216,n=252,0,1
164217,),0,0
164218,and,0,0
164219,phosphorylation,0,0
164220,level,0,0
164221,of,0,0
164222,downstream,0,0
164223,target,0,0
164224,SMAD2,0,1
164225,(,0,0
164226,pSMAD2,0,0
164227,),0,0
164228,(,0,0
164229,n=319,0,1
164230,),0,0
164231,in,0,0
164232,cancer-associated,0,1
164233,fibroblasts,0,1
164234,(,0,1
164235,CAFs,0,1
164236,),0,0
164237,and,0,0
164238,assessed,0,0
164239,links,0,0
164240,to,0,1
164241,clinicopathological,0,1
164242,markers,0,0
164243,",",0,0
164244,prognostic,0,0
164245,and,0,0
164246,treatment-predictive,0,0
164247,values,0,0
164248,.,0,1
164249,The,0,0
164250,study,0,0
164251,revealed,0,0
164252,that,0,0
164253,CAF-specific,0,0
164254,TGFBR2,0,0
164255,expression,0,0
164256,correlated,0,0
164257,with,0,1
164258,improved,0,0
164259,recurrence-free,0,1
164260,survival,0,0
164261,.,0,1
164262,Multivariate,0,0
164263,analysis,0,0
164264,confirmed,0,0
164265,CAF-TGFBR2,0,0
164266,to,0,0
164267,be,0,0
164268,an,0,0
164269,independent,0,0
164270,prognostic,0,0
164271,marker,0,0
164272,(,0,0
164273,multivariate,0,0
164274,Cox,0,0
164275,regression,0,0
164276,",",0,0
164277,hazard,0,0
164278,ratio,0,0
164279,:,0,1
164280,0.534,0,0
164281,",",0,0
164282,95,0,0
164283,%,0,0
164284,(,0,0
164285,CI,0,0
164286,),0,1
164287,:,0,1
164288,0.360-0.793,0,0
164289,",",0,0
164290,P=0.002,0,0
164291,),0,0
164292,.,0,0
164293,CAF-specific,0,0
164294,pSMAD2,0,0
164295,levels,0,0
164296,",",0,0
164297,however,0,0
164298,",",0,0
164299,did,0,0
164300,not,0,0
164301,associate,0,0
164302,with,0,1
164303,survival,0,0
164304,outcome,0,0
164305,.,0,0
164306,Experimentally,0,0
164307,",",0,0
164308,TGF-?,0,0
164309,signalling,0,0
164310,in,0,0
164311,fibroblasts,0,0
164312,was,0,0
164313,modulated,0,0
164314,using,0,0
164315,a,0,0
164316,TGF-?,0,0
164317,ligand,0,0
164318,and,0,0
164319,inhibitor,0,0
164320,or,0,0
164321,through,0,0
164322,lentiviral,0,0
164323,short,0,0
164324,hairpin,0,0
164325,RNA-mediated,0,0
164326,TGFBR2-specific,0,0
164327,knockdown,0,0
164328,.,0,0
164329,To,0,0
164330,determine,0,0
164331,the,0,0
164332,role,0,0
164333,of,0,0
164334,fibroblastic,0,1
164335,TGF-?,0,0
164336,pathway,0,0
164337,on,0,0
164338,breast,0,1
164339,cancer,0,1
164340,cells,0,0
164341,",",0,0
164342,we,0,0
164343,used,0,0
164344,cell,0,0
164345,contact-dependent,0,0
164346,cell,0,0
164347,growth,0,0
164348,and,0,0
164349,clonogenicity,0,0
164350,assays,0,0
164351,",",0,0
164352,which,0,0
164353,showed,0,0
164354,that,0,0
164355,knockdown,0,0
164356,of,0,0
164357,TGFBR2,0,0
164358,in,0,0
164359,CAFs,0,0
164360,resulted,0,0
164361,in,0,0
164362,increased,0,0
164363,cell,0,0
164364,growth,0,0
164365,",",0,0
164366,proliferation,0,0
164367,and,0,0
164368,clonogenic,0,0
164369,survival,0,0
164370,.,0,0
164371,Further,1,0
164372,",",1,0
164373,in,1,0
164374,a,1,0
164375,mouse,1,0
164376,model,1,0
164377,transfected,1,0
164378,CAFs,0,0
164379,were,0,0
164380,co-injected,0,0
164381,with,0,1
164382,MCF7,0,0
164383,and,0,0
164384,tumour,0,0
164385,weight,0,0
164386,and,0,0
164387,proportion,0,0
164388,was,0,0
164389,monitored,0,0
164390,.,0,0
164391,We,0,0
164392,found,0,0
164393,that,0,0
164394,mouse,1,1
164395,xenograft,1,0
164396,tumours,0,1
164397,comprising,0,1
164398,TGFBR2,0,1
164399,knockdown,0,0
164400,fibroblasts,0,0
164401,were,0,0
164402,slightly,0,0
164403,bigger,0,0
164404,and,0,0
164405,displayed,0,0
164406,increased,0,0
164407,tumour,0,0
164408,cell,0,1
164409,capacity,0,0
164410,.,0,0
164411,Overall,0,0
164412,",",0,0
164413,our,0,0
164414,data,0,0
164415,demonstrate,0,0
164416,that,0,0
164417,fibroblast-related,0,0
164418,biomarkers,0,0
164419,possess,0,0
164420,clinically,0,0
164421,relevant,0,0
164422,information,0,0
164423,and,0,0
164424,that,0,0
164425,fibroblasts,0,0
164426,confer,0,0
164427,effects,0,0
164428,on,0,0
164429,breast,0,1
164430,cancer,0,1
164431,cell,0,0
164432,growth,0,0
164433,and,0,0
164434,survival,0,0
164435,.,0,0
164436,Regulation,0,0
164437,of,0,0
164438,tumour-stromal,0,0
164439,cross-talk,0,0
164440,through,0,0
164441,fibroblastic,0,1
164442,TGF-?,0,0
164443,pathway,0,0
164444,may,0,0
164445,depend,0,0
164446,on,0,0
164447,fibroblast,0,0
164448,phenotype,0,1
164449,",",0,0
164450,emphasising,0,0
164451,the,0,0
164452,importance,0,0
164453,to,0,0
164454,characterise,0,0
164455,tumour,0,1
164456,microenvironment,0,1
164457,subtypes,0,1
164458,.,0,1
164459,Humour-related,0,1
164460,interventions,0,0
164461,for,0,0
164462,people,1,1
164463,with,1,1
164464,mental,1,1
164465,illness,1,1
164466,:,1,1
164467,a,0,0
164468,randomized,0,0
164469,controlled,0,0
164470,pilot,0,0
164471,study,0,0
164472,.,0,0
164473,This,0,0
164474,study,0,0
164475,explored,0,0
164476,the,0,0
164477,feasibility,0,0
164478,and,0,0
164479,effects,0,0
164480,of,0,0
164481,humour-related,0,1
164482,interventions,0,0
164483,for,0,0
164484,mentally,1,1
164485,ill,1,1
164486,adults,1,1
164487,.,1,1
164488,Twelve,1,1
164489,",",1,0
164490,randomly,1,0
164491,assigned,1,0
164492,",",1,0
164493,participated,1,1
164494,in,0,0
164495,each,0,0
164496,of,0,0
164497,3,0,0
164498,arms,0,0
164499,--,0,1
164500,stand,0,0
164501,up,0,0
164502,comedy,0,0
164503,training,0,0
164504,(,0,0
164505,the,0,0
164506,experimental,0,0
164507,arm,0,0
164508,),0,0
164509,",",0,0
164510,discussing,0,0
164511,comedy,0,0
164512,videos,0,0
164513,(,0,0
164514,the,0,0
164515,active,0,0
164516,control,0,0
164517,arm,0,0
164518,),0,0
164519,",",0,0
164520,and,0,0
164521,no,0,0
164522,humour-related,0,0
164523,intervention,0,0
164524,(,0,0
164525,the,0,0
164526,passive,0,0
164527,control,0,0
164528,arm,0,0
164529,),0,0
164530,.,0,0
164531,Quantitative,0,0
164532,and,0,0
164533,qualitative,0,0
164534,data,0,0
164535,were,0,1
164536,collected,0,0
164537,at,0,0
164538,baseline,0,0
164539,",",0,0
164540,end,0,0
164541,of,0,0
164542,interventions,0,0
164543,(,0,1
164544,3,0,1
164545,months,0,0
164546,),0,1
164547,and,0,0
164548,follow,0,0
164549,up,0,0
164550,(,0,0
164551,after,0,0
164552,another,0,1
164553,3,0,0
164554,months,0,0
164555,),0,1
164556,.,0,1
164557,Scale,0,0
164558,comparisons,0,0
164559,were,0,1
164560,largely,0,0
164561,negative,0,0
164562,",",0,0
164563,although,0,0
164564,self-esteem,0,0
164565,marginally,0,0
164566,increased,0,0
164567,in,0,0
164568,the,0,0
164569,experimental,0,0
164570,arm,0,0
164571,.,0,0
164572,Interview,0,0
164573,responses,0,0
164574,indicated,0,0
164575,benefits,0,0
164576,for,0,0
164577,the,0,0
164578,interventions,0,0
164579,",",0,0
164580,including,0,0
164581,improved,0,0
164582,self-esteem,0,0
164583,in,0,0
164584,the,0,0
164585,experimental,0,0
164586,arm,0,0
164587,.,0,0
164588,These,0,0
164589,results,0,0
164590,",",0,0
164591,though,0,0
164592,mixed,0,0
164593,",",0,0
164594,justify,0,0
164595,further,0,0
164596,study,0,0
164597,.,0,1
164598,Evaluating,0,0
164599,the,0,0
164600,acceptability,0,0
164601,and,0,0
164602,efficacy,0,0
164603,of,0,0
164604,a,0,0
164605,psycho-educational,0,0
164606,intervention,0,0
164607,for,0,0
164608,coping,0,0
164609,and,0,0
164610,symptom,0,0
164611,management,0,1
164612,by,0,0
164613,children,1,1
164614,with,1,1
164615,cancer,1,1
164616,:,1,1
164617,a,0,0
164618,randomized,0,0
164619,controlled,0,0
164620,study,0,0
164621,.,0,0
164622,AIMS,0,0
164623,To,0,0
164624,evaluate,0,0
164625,the,0,0
164626,acceptability,0,0
164627,and,0,0
164628,efficacy,0,0
164629,of,0,0
164630,a,0,0
164631,psycho-educational,0,0
164632,intervention,0,0
164633,designed,0,0
164634,to,0,0
164635,improve,0,0
164636,effective,0,0
164637,coping,0,0
164638,and,0,0
164639,reduce,0,0
164640,symptom,0,0
164641,severity,0,0
164642,in,0,0
164643,children,1,1
164644,with,1,1
164645,cancer,1,1
164646,.,1,1
164647,BACKGROUND,0,0
164648,Cancer,0,0
164649,treatments,0,0
164650,increase,0,0
164651,survival,0,0
164652,rates,0,0
164653,and,0,0
164654,also,0,0
164655,cause,0,0
164656,physical,0,0
164657,and,0,0
164658,psychological,0,0
164659,effects,0,0
164660,on,0,0
164661,children,1,1
164662,with,1,1
164663,cancer,1,1
164664,.,1,0
164665,A,0,0
164666,psycho-educational,0,0
164667,intervention,0,0
164668,is,0,0
164669,used,0,0
164670,to,0,0
164671,assist,0,0
164672,children,1,1
164673,and,1,0
164674,adolescents,1,1
164675,with,1,1
164676,these,1,0
164677,effects,1,0
164678,and,0,0
164679,its,0,0
164680,efficacy,0,0
164681,has,0,0
164682,been,0,0
164683,described,0,0
164684,in,0,0
164685,several,0,0
164686,studies,0,0
164687,.,0,1
164688,DESIGN,0,0
164689,A,0,0
164690,randomized,0,0
164691,controlled,0,0
164692,trial,0,0
164693,.,0,1
164694,METHODS,0,0
164695,Participants,1,1
164696,being,1,1
164697,treated,1,1
164698,were,1,0
164699,recruited,1,1
164700,and,1,0
164701,randomly,1,1
164702,assigned,1,0
164703,to,1,0
164704,two,1,0
164705,groups,1,0
164706,from,1,1
164707,September,1,1
164708,2011-February,1,1
164709,2013,1,1
164710,in,1,0
164711,Taiwan,1,1
164712,.,1,0
164713,The,0,0
164714,intervention,0,0
164715,group,0,0
164716,received,0,0
164717,a,0,0
164718,psycho-educational,0,0
164719,intervention,0,0
164720,in,0,0
164721,addition,0,0
164722,to,0,0
164723,standard,0,0
164724,care,0,0
164725,",",0,0
164726,while,0,0
164727,the,0,0
164728,control,0,0
164729,group,0,0
164730,received,0,0
164731,only,0,0
164732,standard,0,0
164733,care,0,1
164734,.,0,0
164735,Each,0,0
164736,participant,0,0
164737,was,0,0
164738,assessed,0,0
164739,using,0,0
164740,a,0,0
164741,paediatric,0,1
164742,cancer,0,1
164743,coping,0,0
164744,scale,0,0
164745,and,0,0
164746,perceived,0,0
164747,symptom,0,0
164748,severity,0,0
164749,was,0,0
164750,evaluated,0,0
164751,at,0,0
164752,three,0,0
164753,time,0,0
164754,points,0,0
164755,(,0,0
164756,baseline,0,0
164757,",",0,0
164758,1,0,0
164759,month,0,0
164760,and,0,1
164761,3,0,0
164762,months,0,0
164763,),0,1
164764,.,0,1
164765,A,0,0
164766,repeated-measures,0,0
164767,analysis,0,0
164768,of,0,0
164769,variance,0,0
164770,was,0,0
164771,used,0,0
164772,to,0,0
164773,estimate,0,0
164774,the,0,0
164775,effects,0,0
164776,of,0,0
164777,intervention,0,0
164778,.,0,1
164779,Qualitative,0,0
164780,findings,0,0
164781,were,0,1
164782,analysed,0,0
164783,using,0,0
164784,content,0,0
164785,analysis,0,0
164786,.,0,1
164787,RESULTS,0,0
164788,No,0,0
164789,significant,0,0
164790,difference,0,0
164791,in,0,0
164792,coping,0,0
164793,scores,0,0
164794,was,0,0
164795,found,0,0
164796,between,0,0
164797,groups,0,0
164798,",",0,0
164799,but,0,0
164800,the,0,0
164801,experimental,0,0
164802,group,0,0
164803,reported,0,0
164804,significantly,0,0
164805,lower,0,0
164806,scores,0,0
164807,in,0,0
164808,gastrointestinal,0,1
164809,problems,0,1
164810,and,0,1
164811,pain,0,1
164812,.,0,0
164813,Most,0,0
164814,symptoms,0,0
164815,decreased,0,0
164816,significantly,0,0
164817,over,0,0
164818,time,0,0
164819,in,0,0
164820,both,0,0
164821,groups,0,0
164822,",",0,0
164823,except,0,0
164824,for,0,0
164825,gastrointestinal,0,1
164826,problems,0,1
164827,.,0,1
164828,The,0,0
164829,scores,0,0
164830,in,0,0
164831,pain,0,1
164832,",",0,0
164833,bone,0,0
164834,marrow,0,1
164835,suppression,0,0
164836,and,0,0
164837,body,0,1
164838,image,0,0
164839,showed,0,0
164840,significant,0,0
164841,interaction,0,0
164842,effects,0,0
164843,between,0,0
164844,groups,0,0
164845,on,0,0
164846,changes,0,0
164847,over,0,0
164848,time,0,0
164849,.,0,1
164850,Qualitative,0,0
164851,results,0,0
164852,reported,0,0
164853,that,0,0
164854,participants,0,1
164855,evaluated,0,0
164856,the,0,0
164857,intervention,0,0
164858,positively,0,0
164859,",",0,0
164860,especially,0,0
164861,about,0,0
164862,receipt,0,0
164863,of,0,0
164864,psychological,0,0
164865,support,0,0
164866,and,0,0
164867,learnt,0,0
164868,coping,0,0
164869,skills,0,0
164870,.,0,1
164871,CONCLUSIONS,0,0
164872,The,0,0
164873,psycho-educational,0,0
164874,intervention,0,0
164875,administered,0,0
164876,was,0,0
164877,acceptable,0,0
164878,for,0,0
164879,children,1,1
164880,with,1,1
164881,cancer,1,1
164882,and,0,0
164883,was,0,0
164884,found,0,0
164885,to,0,0
164886,reduce,0,0
164887,gastrointestinal,0,1
164888,problems,0,1
164889,and,0,1
164890,pain,0,1
164891,.,0,1
164892,Population,0,1
164893,pharmacokinetic/pharmacodynamic,0,0
164894,analysis,0,0
164895,of,0,0
164896,the,0,0
164897,DPP-4,0,0
164898,inhibitor,0,0
164899,linagliptin,0,0
164900,in,0,0
164901,Japanese,1,1
164902,patients,1,1
164903,with,1,1
164904,type,1,1
164905,2,1,1
164906,diabetes,1,1
164907,mellitus,1,1
164908,.,1,1
164909,OBJECTIVES,0,0
164910,Linagliptin,0,0
164911,is,0,0
164912,a,0,0
164913,novel,0,0
164914,",",0,0
164915,highly,0,0
164916,selective,0,0
164917,and,0,0
164918,long,0,1
164919,acting,0,0
164920,DPP-4,0,0
164921,inhibitor,0,0
164922,for,0,0
164923,the,0,0
164924,treatment,0,0
164925,of,0,0
164926,type,0,1
164927,2,0,1
164928,diabetes,0,1
164929,mellitus,0,1
164930,(,0,1
164931,T2DM,0,0
164932,),0,1
164933,.,0,0
164934,Linagliptin,0,0
164935,exhibits,0,0
164936,non-linear,0,0
164937,pharmacokinetics,0,0
164938,(,0,1
164939,PK,0,1
164940,),0,0
164941,due,0,0
164942,to,0,0
164943,saturable,0,0
164944,binding,0,0
164945,to,0,0
164946,plasma,0,0
164947,and,0,0
164948,tissue,0,0
164949,DPP-4,0,0
164950,.,0,0
164951,The,0,0
164952,aim,0,0
164953,of,0,0
164954,this,0,0
164955,study,0,0
164956,was,0,0
164957,to,0,0
164958,characterize,0,0
164959,the,0,0
164960,PK,0,0
164961,and,0,0
164962,PK/DPP-4,0,0
164963,inhibition,0,0
164964,relationship,0,0
164965,of,0,0
164966,linagliptin,0,0
164967,in,0,0
164968,Japanese,1,1
164969,patients,1,1
164970,with,1,1
164971,T2DM,1,0
164972,using,0,0
164973,a,0,0
164974,population,0,1
164975,PK/DPP-4,0,0
164976,model,0,0
164977,and,0,0
164978,to,0,0
164979,support,0,0
164980,the,0,0
164981,rationale,0,0
164982,for,0,0
164983,the,0,0
164984,therapeutic,0,0
164985,dose,0,0
164986,in,0,0
164987,Japanese,0,1
164988,patients,0,1
164989,by,0,0
164990,simulation,0,0
164991,.,0,1
164992,METHODS,0,0
164993,Linagliptin,0,0
164994,plasma,0,0
164995,concentration,0,0
164996,and,0,0
164997,DPP-4,0,0
164998,inhibition,0,0
164999,measurements,0,0
165000,from,0,1
165001,a,0,0
165002,placebo-controlled,0,0
165003,",",0,0
165004,parallel,0,0
165005,group,0,0
165006,multiple,0,0
165007,(,0,0
165008,28,0,1
165009,days,0,0
165010,),0,1
165011,dose,0,0
165012,trial,0,0
165013,that,0,0
165014,included,0,1
165015,36,1,1
165016,T2DM,1,0
165017,patients,1,1
165018,(,1,1
165019,18,1,1
165020,patients,1,1
165021,each,1,1
165022,in,1,0
165023,2.5,1,0
165024,mg,1,0
165025,and,1,1
165026,10,1,1
165027,mg,1,0
165028,dose,1,0
165029,group,1,1
165030,),1,0
165031,were,0,0
165032,used,0,0
165033,for,0,0
165034,analysis,0,0
165035,.,0,1
165036,Modeling,0,0
165037,was,0,0
165038,performed,0,0
165039,using,0,0
165040,FOCE,0,0
165041,INTERACTION,0,0
165042,estimation,0,0
165043,method,0,0
165044,implemented,0,0
165045,in,0,0
165046,NONMEM,0,1
165047,V.,0,0
165048,The,0,0
165049,linagliptin,0,0
165050,plasma,0,0
165051,concentration-,0,0
165052,and,0,0
165053,DPP-4,0,0
165054,inhibition-,0,0
165055,time,0,0
165056,profiles,0,0
165057,were,0,0
165058,simulated,0,0
165059,for,0,0
165060,Japanese,0,1
165061,patients,0,1
165062,receiving,0,1
165063,5,0,1
165064,mg,0,0
165065,linagliptin,0,0
165066,once,0,0
165067,daily,0,0
165068,by,0,0
165069,the,0,0
165070,model,0,0
165071,established,0,0
165072,.,0,1
165073,RESULTS,0,0
165074,Nonlinear,0,0
165075,PK,0,1
165076,of,0,0
165077,linagliptin,0,0
165078,in,0,0
165079,T2DM,0,0
165080,patients,0,1
165081,were,0,0
165082,well,0,0
165083,described,0,0
165084,by,0,0
165085,a,0,0
165086,2-compartment,0,0
165087,model,0,0
165088,assuming,0,0
165089,concentration-dependent,0,0
165090,binding,0,0
165091,to,0,0
165092,DPP-4,0,0
165093,in,0,0
165094,the,0,0
165095,central,0,0
165096,and,0,0
165097,peripheral,0,1
165098,compartment,0,0
165099,.,0,1
165100,Plasma,0,0
165101,DPP-4,0,0
165102,inhibition,0,0
165103,was,0,0
165104,integrated,0,0
165105,in,0,0
165106,the,0,0
165107,model,0,0
165108,by,0,0
165109,relating,0,0
165110,the,0,0
165111,model-predicted,0,0
165112,DPP-4,0,0
165113,occupancy,0,0
165114,with,0,1
165115,linagliptin,0,0
165116,linearly,0,0
165117,to,0,0
165118,DPP-4,0,0
165119,inhibition,0,0
165120,.,0,0
165121,The,0,0
165122,simulation,0,0
165123,predicted,0,0
165124,that,0,0
165125,for,0,0
165126,the,0,0
165127,5,0,0
165128,mg,0,0
165129,dose,0,0
165130,group,0,0
165131,the,0,0
165132,trough,0,0
165133,DPP-4,0,0
165134,inhibition,0,0
165135,at,0,0
165136,steady-state,0,0
165137,was,0,0
165138,84.2,0,0
165139,%,0,0
165140,",",0,0
165141,which,0,0
165142,is,0,0
165143,higher,0,0
165144,than,0,0
165145,the,0,0
165146,target,0,0
165147,inhibition,0,0
165148,(,0,0
165149,?80,0,0
165150,%,0,0
165151,),0,0
165152,for,0,0
165153,an,0,0
165154,effective,0,0
165155,dose,0,0
165156,of,0,0
165157,DPP-4,0,0
165158,inhibitor,0,0
165159,.,0,0
165160,In,0,0
165161,2.5,0,0
165162,mg,0,0
165163,dose,0,0
165164,group,0,0
165165,",",0,0
165166,steady-state,0,0
165167,DPP-4,0,0
165168,inhibition,0,0
165169,of,0,0
165170,>,0,1
165171,80,0,1
165172,%,0,0
165173,was,0,0
165174,not,0,0
165175,maintained,0,0
165176,over,0,0
165177,24,0,1
165178,hours,0,0
165179,(,0,1
165180,observed,0,0
165181,and,0,0
165182,simulated,0,0
165183,),0,0
165184,.,0,0
165185,CONCLUSIONS,0,0
165186,The,0,0
165187,nonlinear,0,0
165188,PK,0,1
165189,of,0,0
165190,linagliptin,0,0
165191,and,0,0
165192,its,0,0
165193,plasma,0,0
165194,DPP-4,0,0
165195,inhibition,0,0
165196,in,0,0
165197,patients,0,1
165198,were,0,1
165199,well,0,0
165200,characterized,0,0
165201,by,0,0
165202,a,0,0
165203,target-mediated,0,0
165204,drug,0,0
165205,disposition,0,0
165206,model,0,0
165207,relating,0,0
165208,DPP-4,0,0
165209,occupancy,0,0
165210,with,0,1
165211,linagliptin,0,0
165212,to,0,0
165213,DPP-4,0,0
165214,inhibition,0,0
165215,.,0,1
165216,Simulations,0,0
165217,of,0,0
165218,plasma,0,0
165219,DPP-4,0,0
165220,inhibition,0,0
165221,suggest,0,0
165222,that,0,0
165223,5,0,1
165224,mg,0,0
165225,linagliptin,0,0
165226,once,0,0
165227,daily,0,0
165228,is,0,0
165229,an,0,0
165230,appropriate,0,0
165231,therapeutic,0,0
165232,dose,0,0
165233,for,0,0
165234,Japanese,0,1
165235,patients,0,1
165236,with,0,1
165237,T2DM,0,1
165238,.,0,1
165239,Changes,0,0
165240,in,0,0
165241,body,0,1
165242,weight,0,0
165243,and,0,0
165244,blood,0,0
165245,pressure,0,0
165246,:,0,1
165247,paradoxical,0,0
165248,outcome,0,0
165249,events,0,0
165250,in,0,0
165251,overweight,1,1
165252,and,1,0
165253,obese,1,1
165254,subjects,1,1
165255,with,1,1
165256,cardiovascular,1,1
165257,disease,1,1
165258,.,1,0
165259,BACKGROUND/OBJECTIVES,0,0
165260,The,0,0
165261,Sibutramine,0,0
165262,Cardiovascular,0,1
165263,OUTcomes,0,0
165264,(,0,0
165265,SCOUT,0,1
165266,),0,0
165267,trial,0,0
165268,showed,0,0
165269,a,0,0
165270,significantly,0,0
165271,increased,0,0
165272,relative,0,0
165273,risk,0,0
165274,of,0,0
165275,nonfatal,0,0
165276,cardiovascular,0,1
165277,events,0,0
165278,",",0,0
165279,but,0,0
165280,not,0,0
165281,mortality,0,0
165282,",",0,0
165283,in,0,0
165284,overweight,1,1
165285,and,1,1
165286,obese,1,1
165287,subjects,1,1
165288,receiving,1,1
165289,long-term,1,0
165290,sibutramine,1,0
165291,treatment,1,0
165292,with,1,1
165293,diet,1,0
165294,and,1,0
165295,exercise,1,0
165296,.,1,0
165297,We,0,0
165298,examined,0,0
165299,the,0,0
165300,relationship,0,0
165301,between,0,0
165302,early,0,1
165303,changes,0,0
165304,(,0,1
165305,both,0,0
165306,increases,0,0
165307,and,0,0
165308,decreases,0,0
165309,),0,0
165310,in,0,0
165311,body,0,1
165312,weight,0,0
165313,and,0,0
165314,blood,0,0
165315,pressure,0,0
165316,",",0,0
165317,and,0,0
165318,the,0,0
165319,impact,0,0
165320,of,0,0
165321,these,0,0
165322,changes,0,0
165323,on,0,0
165324,subsequent,0,0
165325,cardiovascular,0,1
165326,outcome,0,0
165327,events,0,0
165328,.,0,0
165329,SUBJECTS/METHODS,0,0
165330,A,1,0
165331,total,1,1
165332,of,1,0
165333,9804,1,1
165334,male,1,1
165335,and,1,0
165336,female,1,1
165337,subjects,1,1
165338,",",1,0
165339,aged,1,1
165340,55,1,1
165341,years,1,1
165342,or,1,1
165343,older,1,1
165344,",",1,0
165345,with,1,0
165346,a,1,0
165347,body,1,0
165348,mass,1,0
165349,index,1,0
165350,of,1,0
165351,27-45,1,1
165352,kg,1,1
165353,m,1,1
165354,(,1,0
165355,-2,1,0
165356,),1,0
165357,were,1,0
165358,included,1,1
165359,in,1,0
165360,this,1,0
165361,current,1,0
165362,subanalysis,1,0
165363,of,1,0
165364,the,0,0
165365,SCOUT,0,1
165366,trial,0,0
165367,.,0,1
165368,Subjects,0,1
165369,were,0,0
165370,required,1,0
165371,to,1,0
165372,have,1,0
165373,a,1,0
165374,history,1,0
165375,of,1,0
165376,cardiovascular,1,1
165377,disease,1,1
165378,and/or,1,1
165379,type,1,1
165380,2,1,1
165381,diabetes,1,1
165382,mellitus,1,1
165383,with,1,1
165384,at,1,0
165385,least,1,1
165386,one,1,1
165387,cardiovascular,1,1
165388,risk,1,0
165389,factor,1,0
165390,(,1,0
165391,hypertension,1,1
165392,",",1,0
165393,dyslipidemia,1,1
165394,",",1,0
165395,current,1,0
165396,smoking,1,0
165397,or,1,1
165398,diabetic,1,1
165399,nephropathy,1,1
165400,),1,0
165401,to,1,0
165402,assess,0,0
165403,cardiovascular,0,1
165404,outcomes,0,0
165405,.,0,1
165406,Post,0,1
165407,hoc,0,0
165408,subgroup,0,1
165409,analyses,0,0
165410,of,0,0
165411,weight,0,1
165412,change,0,0
165413,(,0,0
165414,categories,0,1
165415,),0,0
165416,and,0,0
165417,blood,0,0
165418,pressure,0,0
165419,were,0,0
165420,performed,0,0
165421,overall,0,0
165422,and,0,0
165423,by,0,0
165424,treatment,0,0
165425,group,0,0
165426,(,0,0
165427,6-week,0,0
165428,sibutramine,0,0
165429,followed,0,0
165430,by,0,0
165431,randomized,0,0
165432,placebo,0,0
165433,or,0,1
165434,continued,0,0
165435,sibutramine,0,0
165436,),0,0
165437,.,0,0
165438,The,0,0
165439,primary,0,0
165440,outcome,0,0
165441,event,0,0
165442,(,0,0
165443,POE,0,1
165444,),0,0
165445,was,0,0
165446,a,0,0
165447,composite,0,0
165448,of,0,0
165449,nonfatal,0,0
165450,myocardial,0,1
165451,infarction,0,1
165452,",",0,0
165453,nonfatal,0,0
165454,stroke,0,1
165455,",",0,0
165456,resuscitated,0,1
165457,cardiac,0,1
165458,arrest,0,1
165459,or,0,1
165460,cardiovascular,0,1
165461,death,0,0
165462,.,0,1
165463,Time-to-event,0,0
165464,analyses,0,0
165465,of,0,0
165466,the,0,0
165467,POE,0,0
165468,were,0,0
165469,performed,0,0
165470,using,0,0
165471,Cox,0,0
165472,regression,0,0
165473,models,0,0
165474,with,0,1
165475,factors,0,0
165476,for,0,0
165477,treatment,0,0
165478,",",0,0
165479,subgroups,0,0
165480,and,0,1
165481,interactions,0,0
165482,.,0,1
165483,RESULTS,0,0
165484,During,0,0
165485,the,0,0
165486,initial,0,0
165487,6-week,0,0
165488,sibutramine,0,0
165489,treatment,0,0
165490,period,0,0
165491,",",0,0
165492,systolic,0,0
165493,blood,0,0
165494,pressure,0,0
165495,decreased,0,0
165496,progressively,0,0
165497,with,0,1
165498,increasing,0,0
165499,weight,0,0
165500,loss,0,0
165501,in,0,0
165502,hypertensive,0,1
165503,subjects,0,1
165504,(,0,1
165505,-8.1?10.5,0,0
165506,mm,0,0
165507,Hg,0,0
165508,with,0,1
165509,<,0,0
165510,5,0,0
165511,kg,0,0
165512,weight,0,0
165513,loss,0,0
165514,to,0,0
165515,-10.8?11.0,0,0
165516,mm,0,0
165517,Hg,0,0
165518,with,0,1
165519,?5,0,1
165520,kg,0,1
165521,weight,0,0
165522,loss,0,0
165523,),0,0
165524,.,0,0
165525,The,0,0
165526,highest,0,0
165527,POE,0,0
165528,incidence,0,0
165529,occurred,0,0
165530,mainly,0,0
165531,in,0,0
165532,groups,0,0
165533,with,0,1
165534,increases,0,0
165535,in,0,0
165536,both,0,0
165537,weight,0,0
165538,and,0,0
165539,blood,0,0
165540,pressure,0,0
165541,.,0,0
165542,However,0,0
165543,",",0,0
165544,with,0,0
165545,long-term,0,0
165546,sibutramine,0,0
165547,treatment,0,0
165548,",",0,0
165549,a,0,0
165550,markedly,0,0
165551,lower,0,0
165552,blood,0,0
165553,pressure,0,0
165554,tended,0,0
165555,to,0,0
165556,increase,0,0
165557,POEs,0,0
165558,.,0,0
165559,CONCLUSION,0,0
165560,Modest,0,0
165561,weight,0,0
165562,loss,0,0
165563,and,0,0
165564,modest,0,0
165565,lower,0,0
165566,blood,0,0
165567,pressure,0,0
165568,each,0,0
165569,reduced,0,0
165570,the,0,0
165571,incidence,0,0
165572,of,0,0
165573,cardiovascular,0,1
165574,events,0,0
165575,",",0,0
165576,as,0,0
165577,expected,0,0
165578,.,0,0
165579,However,0,0
165580,",",0,0
165581,the,0,0
165582,combination,0,0
165583,of,0,0
165584,early,0,1
165585,marked,0,0
165586,weight,0,0
165587,loss,0,0
165588,and,0,0
165589,rapid,0,0
165590,blood,0,0
165591,pressure,0,0
165592,reduction,0,0
165593,seems,0,0
165594,to,0,0
165595,be,0,0
165596,harmful,0,0
165597,in,0,0
165598,this,1,0
165599,obese,1,1
165600,elderly,1,1
165601,cardiovascular,1,1
165602,diseased,1,1
165603,population,1,1
165604,.,0,1
165605,A,0,0
165606,randomized,0,0
165607,controlled,0,0
165608,trial,0,0
165609,of,0,0
165610,the,0,0
165611,Korean,0,1
165612,version,0,0
165613,of,0,0
165614,the,0,0
165615,PEERS,0,0
165616,(,0,0
165617,?,0,0
165618,),0,0
165619,parent-assisted,0,0
165620,social,0,1
165621,skills,0,0
165622,training,0,0
165623,program,0,1
165624,for,1,0
165625,teens,1,1
165626,with,1,1
165627,ASD,1,1
165628,.,1,1
165629,Impaired,0,1
165630,social,0,0
165631,functioning,0,0
165632,is,0,0
165633,a,0,0
165634,hallmark,0,0
165635,feature,0,0
165636,of,0,0
165637,autism,0,1
165638,spectrum,0,1
165639,disorder,0,1
165640,(,0,0
165641,ASD,0,1
165642,),0,0
165643,",",0,0
165644,often,0,0
165645,requiring,0,0
165646,treatment,0,0
165647,throughout,0,0
165648,the,0,0
165649,life,0,0
165650,span,0,1
165651,.,0,1
165652,PEERS,0,0
165653,(,0,0
165654,?,0,1
165655,),0,0
165656,(,0,0
165657,Program,0,0
165658,for,0,0
165659,the,0,0
165660,Education,0,1
165661,and,0,0
165662,Enrichment,0,0
165663,of,0,0
165664,Relational,0,0
165665,Skills,0,0
165666,),0,0
165667,is,0,0
165668,a,0,0
165669,parent-assisted,1,0
165670,social,1,0
165671,skills,1,0
165672,training,1,0
165673,for,1,0
165674,teens,1,1
165675,with,1,1
165676,ASD,1,1
165677,.,1,1
165678,Although,0,0
165679,PEERS,0,0
165680,(,0,1
165681,?,0,0
165682,),0,0
165683,has,0,0
165684,an,0,0
165685,established,0,0
165686,evidence,0,0
165687,base,0,0
165688,in,0,0
165689,improving,0,0
165690,the,0,0
165691,social,0,0
165692,skills,0,0
165693,of,0,1
165694,adolescents,0,1
165695,and,0,1
165696,young,0,1
165697,adults,0,1
165698,with,0,1
165699,ASD,0,1
165700,in,0,0
165701,North,0,1
165702,America,0,0
165703,",",0,0
165704,the,0,0
165705,efficacy,0,0
165706,of,0,0
165707,this,0,0
165708,treatment,0,0
165709,has,0,0
165710,yet,0,0
165711,to,0,0
165712,be,0,0
165713,established,0,0
165714,in,0,0
165715,cross-cultural,0,0
165716,validation,0,1
165717,trials,0,0
165718,.,0,0
165719,The,0,0
165720,objective,0,0
165721,of,0,0
165722,this,0,0
165723,study,0,0
165724,is,0,0
165725,to,0,0
165726,examine,0,0
165727,the,0,0
165728,feasibility,0,0
165729,and,0,0
165730,treatment,0,0
165731,efficacy,0,0
165732,of,0,0
165733,a,0,0
165734,Korean,0,1
165735,version,0,0
165736,of,0,0
165737,PEERS,0,0
165738,(,0,1
165739,?,0,0
165740,),0,0
165741,for,0,0
165742,enhancing,0,0
165743,social,0,0
165744,skills,0,0
165745,through,0,0
165746,a,0,0
165747,randomized,0,0
165748,controlled,0,0
165749,trial,0,0
165750,(,0,0
165751,RCT,0,0
165752,),0,0
165753,.The,0,0
165754,English,0,0
165755,version,0,0
165756,of,0,0
165757,the,0,0
165758,PEERS,0,0
165759,(,0,0
165760,?,0,0
165761,),0,0
165762,Treatment,0,0
165763,Manual,0,1
165764,(,0,0
165765,Laugeson,0,0
165766,&,0,1
165767,Frankel,0,1
165768,",",0,0
165769,2010,0,1
165770,),0,0
165771,was,0,0
165772,translated,0,0
165773,into,0,0
165774,Korean,1,1
165775,and,1,0
165776,reviewed,1,1
165777,by,1,0
165778,21,1,1
165779,child,1,1
165780,mental,1,1
165781,health,1,1
165782,professionals,1,1
165783,.,1,1
165784,Items,1,0
165785,identified,0,0
165786,as,0,0
165787,culturally,0,1
165788,sensitive,0,0
165789,were,0,0
165790,surveyed,1,1
165791,by,1,0
165792,447,1,1
165793,middle,1,1
165794,school,1,1
165795,students,1,1
165796,",",1,0
165797,and,1,0
165798,material,0,0
165799,was,0,0
165800,modified,0,0
165801,accordingly,1,0
165802,.,1,1
165803,Participants,1,1
165804,included,1,1
165805,47,1,1
165806,teens,1,1
165807,between,1,0
165808,12,1,1
165809,and,1,1
165810,18,1,1
165811,years,1,1
165812,of,1,0
165813,age,1,1
165814,with,1,1
165815,a,1,0
165816,diagnosis,1,1
165817,of,1,0
165818,ASD,1,1
165819,and,1,0
165820,a,1,0
165821,verbal,1,0
165822,intelligence,1,0
165823,quotient,1,0
165824,(,1,0
165825,IQ,1,1
165826,),1,1
165827,?,1,1
165828,65,1,1
165829,.,0,0
165830,Eligible,0,0
165831,teens,0,1
165832,were,0,1
165833,randomly,0,1
165834,assigned,0,0
165835,to,0,0
165836,a,0,0
165837,treatment,0,0
165838,group,0,0
165839,(,0,0
165840,TG,0,0
165841,),0,0
165842,or,0,0
165843,delayed,0,0
165844,treatment,0,0
165845,control,0,0
165846,group,0,0
165847,(,0,0
165848,CG,0,1
165849,),0,1
165850,.,0,0
165851,Primary,0,0
165852,outcome,0,0
165853,measures,0,0
165854,included,0,1
165855,questionnaires,0,0
165856,and,0,1
165857,direct,0,0
165858,observations,0,0
165859,quantifying,0,0
165860,social,0,0
165861,ability,0,0
165862,and,0,0
165863,problems,0,1
165864,directly,0,0
165865,related,0,0
165866,to,0,0
165867,ASD,0,1
165868,.,0,1
165869,Secondary,0,0
165870,outcome,0,0
165871,measures,0,0
165872,included,0,1
165873,scales,0,0
165874,for,0,0
165875,depressive,0,0
165876,symptoms,0,0
165877,",",0,0
165878,anxiety,0,0
165879,",",0,0
165880,and,0,0
165881,other,0,0
165882,behavioral,0,1
165883,problems,0,1
165884,.,0,1
165885,Rating,0,0
165886,scales,0,0
165887,for,0,0
165888,parental,0,1
165889,depressive,0,0
165890,symptoms,0,0
165891,and,0,0
165892,anxiety,0,1
165893,were,0,0
165894,examined,0,0
165895,to,0,0
165896,detect,0,0
165897,changes,0,0
165898,in,0,0
165899,parental,0,1
165900,psychosocial,0,1
165901,functioning,0,0
165902,throughout,0,0
165903,the,0,0
165904,PEERS,0,0
165905,(,0,0
165906,?,0,0
165907,),0,0
165908,treatment,0,0
165909,.,0,1
165910,Independent,0,0
165911,samples,0,0
165912,t-tests,0,0
165913,revealed,0,0
165914,no,0,0
165915,significant,0,0
165916,differences,0,0
165917,at,0,0
165918,baseline,0,0
165919,across,0,0
165920,the,0,0
165921,TG,0,0
165922,and,0,0
165923,CG,0,1
165924,conditions,0,0
165925,with,0,1
165926,regard,0,0
165927,to,0,0
165928,age,0,1
165929,(,0,0
165930,14.04,0,0
165931,?,0,1
165932,1.64,0,0
165933,and,0,0
165934,13.54,0,0
165935,?,0,1
165936,1.50,0,0
165937,years,0,1
165938,),0,1
165939,",",0,0
165940,IQ,0,1
165941,(,0,0
165942,99.39,0,0
165943,?,0,1
165944,18.09,0,0
165945,&,0,1
165946,100.67,0,0
165947,?,0,1
165948,16.97,0,0
165949,),0,0
165950,",",0,0
165951,parental,0,0
165952,education,0,0
165953,",",0,0
165954,socioeconomic,0,0
165955,status,0,0
165956,",",0,0
165957,or,0,1
165958,ASD,0,1
165959,symptoms,0,0
165960,(,0,1
165961,p,0,0
165962,<,0,0
165963,0.05,0,0
165964,),0,0
165965,",",0,0
165966,respectively,0,0
165967,.,0,0
165968,Results,0,0
165969,for,0,0
165970,treatment,0,0
165971,outcome,0,0
165972,suggest,0,0
165973,that,0,0
165974,the,0,0
165975,TG,0,0
165976,showed,0,0
165977,significant,0,0
165978,improvement,0,0
165979,in,0,0
165980,communication,0,0
165981,and,0,0
165982,social,0,0
165983,interaction,0,0
165984,domain,0,0
165985,scores,0,0
165986,on,0,0
165987,the,0,0
165988,Autism,0,1
165989,Diagnostic,0,1
165990,Observation,0,0
165991,Schedule,0,0
165992,",",0,0
165993,interpersonal,0,0
165994,relationship,0,0
165995,and,0,0
165996,play/leisure,0,0
165997,time,0,0
165998,on,0,0
165999,the,0,0
166000,subdomain,0,1
166001,scores,0,0
166002,of,0,0
166003,the,0,0
166004,Korean,0,1
166005,version,0,0
166006,of,0,0
166007,the,0,0
166008,Vineland,0,1
166009,Adaptive,0,0
166010,Behavior,0,1
166011,Scale,0,0
166012,(,0,0
166013,p,0,0
166014,'s,0,1
166015,<,0,0
166016,0.01,0,0
166017,),0,0
166018,",",0,0
166019,social,0,0
166020,skills,0,0
166021,knowledge,0,0
166022,total,0,1
166023,scores,0,0
166024,on,0,0
166025,the,0,0
166026,Test,0,0
166027,of,0,0
166028,Adolescent,0,1
166029,Social,0,1
166030,Skills,0,0
166031,Knowledge-Revised,0,0
166032,(,0,0
166033,p,0,0
166034,<,0,0
166035,0.01,0,0
166036,),0,0
166037,",",0,0
166038,and,0,0
166039,decreased,0,0
166040,depressive,0,0
166041,symptoms,0,0
166042,on,0,0
166043,the,0,0
166044,Child,0,1
166045,Depression,0,0
166046,Inventory,0,1
166047,following,0,0
166048,treatment,0,0
166049,(,0,0
166050,p,0,0
166051,<,0,0
166052,0.05,0,0
166053,),0,1
166054,.,0,1
166055,Analyses,0,0
166056,of,0,0
166057,parental,0,0
166058,outcome,0,0
166059,reveal,0,0
166060,a,0,0
166061,significant,0,0
166062,decrease,0,0
166063,in,0,0
166064,maternal,0,0
166065,state,0,1
166066,anxiety,0,0
166067,in,0,0
166068,the,0,0
166069,TG,0,0
166070,after,0,0
166071,controlling,0,0
166072,for,0,0
166073,potential,0,0
166074,confounding,0,0
166075,variables,0,0
166076,(,0,1
166077,p,0,0
166078,<,0,0
166079,0.05,0,0
166080,),0,0
166081,.,0,1
166082,Despite,0,0
166083,cultural,0,0
166084,and,0,1
166085,linguistic,0,1
166086,differences,0,0
166087,",",0,0
166088,the,0,0
166089,PEERS,0,0
166090,(,0,0
166091,?,0,0
166092,),0,0
166093,social,0,0
166094,skills,0,0
166095,intervention,0,0
166096,appears,0,0
166097,to,0,0
166098,be,0,0
166099,efficacious,1,0
166100,for,1,0
166101,teens,1,1
166102,with,1,1
166103,ASD,1,1
166104,in,1,0
166105,Korea,1,1
166106,with,0,1
166107,modest,0,0
166108,cultural,0,0
166109,adjustment,0,0
166110,.,0,0
166111,In,0,0
166112,an,0,0
166113,RCT,0,0
166114,",",0,0
166115,participants,0,1
166116,receiving,0,1
166117,the,0,0
166118,PEERS,0,0
166119,(,0,0
166120,?,0,0
166121,),0,0
166122,treatment,0,0
166123,showed,0,0
166124,significant,0,0
166125,improvement,0,0
166126,in,0,0
166127,social,0,0
166128,skills,0,0
166129,knowledge,0,0
166130,",",0,0
166131,interpersonal,0,0
166132,skills,0,0
166133,",",0,0
166134,and,0,0
166135,play/leisure,0,0
166136,skills,0,0
166137,",",0,0
166138,as,0,0
166139,well,0,0
166140,as,0,0
166141,a,0,0
166142,decrease,0,0
166143,in,0,0
166144,depressive,0,0
166145,symptoms,0,1
166146,and,0,1
166147,ASD,0,1
166148,symptoms,0,0
166149,.,0,1
166150,This,0,0
166151,study,0,0
166152,represents,0,0
166153,one,0,0
166154,of,0,0
166155,only,0,0
166156,a,0,0
166157,few,0,0
166158,cross-cultural,0,0
166159,validation,0,0
166160,trials,0,0
166161,of,0,0
166162,an,0,0
166163,established,0,0
166164,evidence-based,0,0
166165,treatment,0,0
166166,for,0,0
166167,adolescents,1,1
166168,with,1,1
166169,ASD,1,1
166170,.,1,1
166171,Phosphorylated,0,0
166172,p-70S6K,0,1
166173,predicts,0,0
166174,tamoxifen,0,1
166175,resistance,0,0
166176,in,0,0
166177,postmenopausal,1,1
166178,breast,1,1
166179,cancer,1,1
166180,patients,1,1
166181,randomized,0,1
166182,between,0,0
166183,adjuvant,0,0
166184,tamoxifen,0,0
166185,versus,0,0
166186,no,0,0
166187,systemic,0,0
166188,treatment,0,0
166189,.,0,1
166190,INTRODUCTION,0,0
166191,Activation,0,0
166192,of,0,0
166193,the,0,0
166194,phosphatidylinositol-3-kinase,0,0
166195,(,0,0
166196,PI3K,0,0
166197,),0,0
166198,and/or,0,0
166199,mitogen-activated,0,0
166200,protein,0,0
166201,kinase,0,0
166202,(,0,0
166203,MAPK,0,0
166204,),0,0
166205,pathways,0,0
166206,results,0,0
166207,in,0,0
166208,anti-estrogen,0,0
166209,resistance,0,0
166210,in,0,0
166211,vitro,0,0
166212,",",0,0
166213,but,0,0
166214,a,0,0
166215,biomarker,0,0
166216,with,0,1
166217,clinical,0,0
166218,validity,0,0
166219,to,0,0
166220,predict,0,0
166221,intrinsic,0,0
166222,resistance,0,0
166223,has,0,0
166224,not,0,0
166225,been,0,0
166226,identified,0,0
166227,.,0,0
166228,In,0,0
166229,metastatic,1,1
166230,breast,1,1
166231,cancer,1,1
166232,patients,1,1
166233,with,1,1
166234,previous,1,0
166235,exposure,1,0
166236,to,1,0
166237,endocrine,1,1
166238,therapy,1,0
166239,",",0,0
166240,the,0,0
166241,addition,0,0
166242,of,0,0
166243,a,0,0
166244,mammalian,0,0
166245,target,0,0
166246,of,0,0
166247,rapamycine,0,0
166248,(,0,0
166249,mTOR,0,0
166250,),0,0
166251,inhibitor,0,0
166252,has,0,0
166253,been,0,0
166254,shown,0,0
166255,to,0,0
166256,be,0,0
166257,beneficial,0,0
166258,.,0,0
166259,Whether,0,0
166260,or,0,0
166261,not,0,0
166262,patients,0,1
166263,on,0,0
166264,adjuvant,0,0
166265,endocrine,0,1
166266,treatment,0,0
166267,might,0,0
166268,benefit,0,0
166269,from,0,0
166270,these,0,0
166271,drugs,0,0
166272,is,0,0
166273,currently,0,1
166274,unclear,0,0
166275,.,0,0
166276,A,0,0
166277,biomarker,0,0
166278,that,0,0
166279,predicts,0,0
166280,intrinsic,0,0
166281,resistance,0,0
166282,could,0,0
166283,potentially,0,0
166284,be,0,0
166285,used,0,0
166286,as,0,0
166287,companion,0,0
166288,diagnostic,0,0
166289,in,0,0
166290,this,0,0
166291,setting,0,1
166292,.,0,0
166293,We,0,0
166294,tested,0,0
166295,the,0,0
166296,clinical,0,0
166297,validity,0,0
166298,of,0,0
166299,different,0,0
166300,downstream-activated,0,0
166301,proteins,0,0
166302,in,0,0
166303,the,0,0
166304,PI3K,0,0
166305,and/or,0,0
166306,MAPK,0,0
166307,pathways,0,0
166308,to,0,0
166309,predict,0,0
166310,intrinsic,0,0
166311,tamoxifen,0,0
166312,resistance,0,0
166313,in,0,0
166314,postmenopausal,0,1
166315,primary,0,1
166316,breast,0,1
166317,cancer,0,1
166318,patients,0,1
166319,.,0,1
166320,METHODS,0,0
166321,We,0,0
166322,recollected,0,0
166323,primary,1,0
166324,tumor,1,0
166325,tissue,1,0
166326,from,1,1
166327,patients,1,1
166328,who,1,1
166329,participated,1,1
166330,in,1,1
166331,a,1,0
166332,randomized,1,0
166333,trial,1,0
166334,of,1,0
166335,adjuvant,1,0
166336,tamoxifen,1,1
166337,(,1,1
166338,1-3,1,1
166339,years,1,1
166340,),1,1
166341,versus,1,0
166342,observation,1,0
166343,.,1,0
166344,After,0,0
166345,constructing,0,0
166346,a,0,0
166347,tissue,0,0
166348,micro-array,0,0
166349,",",0,0
166350,cores,0,0
166351,from,0,1
166352,563,0,1
166353,estrogen,0,1
166354,receptor,0,1
166355,?,0,0
166356,positive,0,0
166357,were,0,0
166358,immunostained,0,0
166359,for,0,0
166360,p-AKT,0,1
166361,(,0,0
166362,Thr308,0,0
166363,),0,0
166364,",",0,0
166365,p-AKT,0,1
166366,(,0,0
166367,Ser473,0,0
166368,),0,0
166369,",",0,0
166370,p-mTOR,0,0
166371,",",0,0
166372,p-p706SK,0,0
166373,and,0,0
166374,p-ERK1/2,0,0
166375,.,0,1
166376,Cox,0,0
166377,proportional,0,0
166378,hazard,0,0
166379,models,0,0
166380,for,0,0
166381,recurrence,0,0
166382,free,0,0
166383,interval,0,0
166384,were,0,0
166385,used,0,0
166386,to,0,0
166387,assess,0,0
166388,hazard,0,0
166389,ratios,0,0
166390,and,0,1
166391,interactions,0,0
166392,between,0,0
166393,these,0,0
166394,markers,0,0
166395,and,0,0
166396,tamoxifen,0,1
166397,treatment,0,0
166398,efficacy,0,0
166399,.,0,1
166400,RESULTS,0,0
166401,Interactions,0,0
166402,were,0,1
166403,identified,0,1
166404,between,0,0
166405,tamoxifen,0,0
166406,and,0,0
166407,p-AKT,0,1
166408,(,0,0
166409,Thr308,0,0
166410,),0,0
166411,",",0,0
166412,p-mTOR,0,0
166413,",",0,0
166414,p-p70S6K,0,0
166415,and,0,0
166416,p-ERK1/2,0,0
166417,.,0,0
166418,Applying,0,0
166419,a,0,0
166420,conservative,0,0
166421,level,0,0
166422,of,0,0
166423,significance,0,0
166424,",",0,0
166425,p-p70S6K,0,0
166426,remained,0,0
166427,significantly,0,0
166428,associated,0,0
166429,with,0,1
166430,tamoxifen,0,0
166431,resistance,0,0
166432,.,0,1
166433,Patients,0,1
166434,with,0,1
166435,p-p70S6K,0,0
166436,negative,0,1
166437,tumors,0,1
166438,derived,0,1
166439,significant,0,0
166440,benefit,0,0
166441,from,0,0
166442,tamoxifen,0,0
166443,(,0,1
166444,HR,0,0
166445,0.24,0,0
166446,",",0,0
166447,P,0,0
166448,<,0,0
166449,0.0001,0,0
166450,),0,0
166451,",",0,0
166452,while,0,0
166453,patients,0,1
166454,whose,0,1
166455,tumor,0,1
166456,did,0,0
166457,express,0,0
166458,p-p70S6K,0,0
166459,did,0,0
166460,not,0,0
166461,(,0,0
166462,HR,0,0
166463,=,0,0
166464,1.02,0,0
166465,",",0,0
166466,P,0,0
166467,=0.95,0,0
166468,),0,0
166469,",",0,0
166470,P,0,0
166471,for,0,0
166472,interaction,0,0
166473,0.004,0,0
166474,.,0,0
166475,In,0,0
166476,systemically,0,0
166477,untreated,0,1
166478,breast,0,1
166479,cancer,0,1
166480,patients,0,1
166481,",",0,0
166482,p-p70S6K,0,0
166483,was,0,0
166484,associated,0,0
166485,with,0,1
166486,a,0,0
166487,decreased,0,0
166488,risk,0,0
166489,for,0,0
166490,recurrence,0,0
166491,.,0,1
166492,CONCLUSIONS,1,0
166493,Patients,1,1
166494,whose,1,1
166495,tumor,1,1
166496,expresses,1,0
166497,p-p70S6K,1,0
166498,",",1,0
166499,as,1,0
166500,a,1,0
166501,marker,1,0
166502,of,1,0
166503,downstream,1,0
166504,PI3K,1,0
166505,and/or,1,0
166506,MAPK,1,0
166507,pathway,1,0
166508,activation,1,0
166509,",",1,0
166510,have,1,0
166511,a,1,0
166512,favorable,0,0
166513,prognosis,0,0
166514,",",0,0
166515,but,0,0
166516,do,0,0
166517,not,0,0
166518,benefit,0,0
166519,from,0,0
166520,adjuvant,0,0
166521,tamoxifen,0,1
166522,.,0,0
166523,A,0,0
166524,potential,0,0
166525,benefit,0,0
166526,from,0,1
166527,inhibitors,0,0
166528,of,0,0
166529,the,0,0
166530,PI3K/Akt/mTOR,0,0
166531,pathway,0,0
166532,in,0,0
166533,these,0,0
166534,patients,0,1
166535,needs,0,0
166536,to,0,0
166537,be,0,0
166538,further,0,0
166539,explored,0,0
166540,.,0,0
166541,Addictive,0,1
166542,internet,1,0
166543,use,1,0
166544,among,0,0
166545,Korean,1,1
166546,adolescents,1,1
166547,:,1,1
166548,a,0,0
166549,national,0,1
166550,survey,0,1
166551,.,0,0
166552,BACKGROUND,0,0
166553,A,0,0
166554,psychological,0,0
166555,disorder,0,1
166556,called,0,0
166557,'Internet,0,0
166558,addiction,0,1
166559,',0,0
166560,has,0,0
166561,newly,0,1
166562,emerged,0,0
166563,along,0,0
166564,with,0,1
166565,a,0,0
166566,dramatic,0,0
166567,increase,0,0
166568,of,0,0
166569,worldwide,0,0
166570,Internet,0,1
166571,use,0,0
166572,.,0,0
166573,However,0,0
166574,",",0,0
166575,few,0,0
166576,studies,0,0
166577,have,0,0
166578,used,0,0
166579,population-level,0,0
166580,samples,0,0
166581,nor,0,0
166582,taken,0,0
166583,into,0,0
166584,account,0,0
166585,contextual,0,0
166586,factors,0,0
166587,on,0,0
166588,Internet,0,1
166589,addiction,0,1
166590,.,0,0
166591,METHODS,0,0
166592,AND,0,0
166593,FINDINGS,0,0
166594,We,0,0
166595,identified,0,1
166596,"57,857",1,0
166597,middle,1,1
166598,and,1,0
166599,high,1,1
166600,school,1,1
166601,students,1,1
166602,(,1,1
166603,13-18,1,1
166604,year,1,1
166605,olds,1,1
166606,),1,0
166607,from,1,1
166608,a,1,0
166609,Korean,1,1
166610,nationally,1,1
166611,representative,1,1
166612,survey,1,0
166613,",",1,0
166614,which,1,0
166615,was,1,0
166616,surveyed,1,1
166617,in,1,0
166618,2009,1,1
166619,.,1,1
166620,To,0,0
166621,identify,0,0
166622,associated,0,0
166623,factors,0,0
166624,with,0,1
166625,addictive,0,1
166626,Internet,0,1
166627,use,0,0
166628,",",0,0
166629,two-level,0,0
166630,multilevel,0,0
166631,regression,0,0
166632,models,0,0
166633,were,0,0
166634,fitted,0,0
166635,with,0,1
166636,individual-level,0,0
166637,responses,0,0
166638,(,0,1
166639,1st,0,1
166640,level,0,0
166641,),0,0
166642,nested,0,1
166643,within,0,0
166644,schools,0,1
166645,(,0,1
166646,2nd,0,1
166647,level,0,0
166648,),0,0
166649,to,0,0
166650,estimate,0,0
166651,associations,0,0
166652,of,0,0
166653,individual,0,0
166654,and,0,0
166655,school,0,1
166656,characteristics,0,0
166657,simultaneously,0,0
166658,.,0,1
166659,Gender,0,0
166660,differences,0,0
166661,of,0,0
166662,addictive,0,1
166663,Internet,0,1
166664,use,0,0
166665,were,0,0
166666,estimated,0,0
166667,with,0,1
166668,the,0,0
166669,regression,0,0
166670,model,0,0
166671,stratified,0,1
166672,by,0,0
166673,gender,0,1
166674,.,0,1
166675,Significant,0,0
166676,associations,0,0
166677,were,0,1
166678,found,0,0
166679,between,0,0
166680,addictive,0,1
166681,Internet,0,1
166682,use,0,0
166683,and,0,0
166684,school,0,1
166685,grade,0,0
166686,",",0,0
166687,parental,0,0
166688,education,0,0
166689,",",0,0
166690,alcohol,0,0
166691,use,0,0
166692,",",0,0
166693,tobacco,0,1
166694,use,0,0
166695,",",0,0
166696,and,0,0
166697,substance,0,0
166698,use,0,0
166699,.,0,1
166700,Female,1,1
166701,students,1,1
166702,in,1,1
166703,girls,1,1
166704,',1,1
166705,schools,1,1
166706,were,0,0
166707,more,0,0
166708,likely,0,0
166709,to,0,0
166710,use,0,0
166711,Internet,0,0
166712,addictively,0,0
166713,than,0,0
166714,those,0,0
166715,in,0,0
166716,coeducational,0,1
166717,schools,0,1
166718,.,0,1
166719,Our,0,0
166720,results,0,0
166721,also,0,0
166722,revealed,0,0
166723,significant,0,0
166724,gender,0,1
166725,differences,0,0
166726,of,0,0
166727,addictive,0,1
166728,Internet,0,1
166729,use,0,0
166730,in,0,0
166731,its,0,0
166732,associated,0,0
166733,individual-,0,0
166734,and,0,0
166735,school-level,0,0
166736,factors,0,0
166737,.,0,1
166738,CONCLUSIONS,0,0
166739,Our,0,0
166740,results,0,0
166741,suggest,0,0
166742,that,0,0
166743,multilevel,0,0
166744,risk,0,0
166745,factors,0,0
166746,along,0,0
166747,with,0,1
166748,gender,0,1
166749,differences,0,0
166750,should,0,0
166751,be,0,0
166752,considered,0,0
166753,to,0,0
166754,protect,0,0
166755,adolescents,1,1
166756,from,0,1
166757,addictive,0,1
166758,Internet,0,1
166759,use,0,0
166760,.,0,1
166761,Comparison,0,0
166762,of,0,0
166763,the,0,0
166764,cardiorespiratory,0,0
166765,effects,0,0
166766,of,0,0
166767,a,0,0
166768,combination,0,0
166769,of,0,0
166770,ketamine,0,0
166771,and,0,0
166772,propofol,0,0
166773,",",0,0
166774,propofol,0,0
166775,alone,0,0
166776,",",0,0
166777,or,0,0
166778,a,0,0
166779,combination,0,0
166780,of,0,0
166781,ketamine,0,0
166782,and,0,0
166783,diazepam,0,0
166784,before,0,0
166785,and,0,0
166786,after,0,0
166787,induction,0,0
166788,of,0,0
166789,anesthesia,1,1
166790,in,1,0
166791,dogs,1,1
166792,sedated,1,1
166793,with,1,1
166794,acepromazine,1,0
166795,and,1,0
166796,oxymorphone,1,0
166797,.,1,0
166798,OBJECTIVE,0,0
166799,To,0,0
166800,evaluate,0,0
166801,the,0,0
166802,cardiorespiratory,0,0
166803,effects,0,0
166804,of,0,0
166805,IV,0,1
166806,administration,0,0
166807,of,0,0
166808,propofol,0,0
166809,(,0,0
166810,4,0,0
166811,mg/kg,0,0
166812,),0,0
166813,",",0,0
166814,ketamine,0,0
166815,hydrochloride,0,0
166816,and,0,0
166817,propofol,0,0
166818,(,0,0
166819,2,0,0
166820,mg/kg,0,0
166821,each,0,0
166822,;,0,0
166823,K-P,0,0
166824,),0,0
166825,",",0,0
166826,or,0,0
166827,ketamine,0,0
166828,hydrochloride,0,0
166829,(,0,0
166830,5,0,0
166831,mg/kg,0,0
166832,),0,0
166833,and,0,0
166834,diazepam,0,0
166835,(,0,0
166836,0.2,0,0
166837,mg/kg,0,0
166838,;,0,1
166839,K-D,0,1
166840,),0,0
166841,before,0,0
166842,and,0,0
166843,after,0,0
166844,induction,0,0
166845,of,0,0
166846,anesthesia,0,1
166847,(,0,0
166848,IoA,0,0
166849,),0,0
166850,in,0,0
166851,dogs,1,1
166852,sedated,1,1
166853,with,1,1
166854,acepromazine,1,0
166855,maleate,1,0
166856,and,1,0
166857,oxymorphone,1,0
166858,hydrochloride,1,0
166859,.,1,0
166860,ANIMALS,1,0
166861,10,1,0
166862,healthy,1,1
166863,adult,1,1
166864,Beagles,1,1
166865,.,1,1
166866,PROCEDURES,0,0
166867,Each,0,0
166868,dog,0,0
166869,was,0,0
166870,randomly,0,1
166871,allocated,0,0
166872,to,0,0
166873,receive,0,0
166874,2,0,0
166875,of,0,0
166876,3,0,1
166877,treatments,0,0
166878,(,0,1
166879,1-week,0,0
166880,interval,0,0
166881,),0,0
166882,.,0,0
166883,For,0,0
166884,instrumentation,0,0
166885,prior,0,0
166886,to,0,0
166887,each,0,0
166888,treatment,0,0
166889,",",0,0
166890,each,0,0
166891,dog,0,0
166892,was,0,0
166893,anesthetized,0,1
166894,with,0,1
166895,isoflurane,0,0
166896,.,0,1
166897,After,0,0
166898,full,0,0
166899,recovery,0,0
166900,",",0,0
166901,acepromazine,0,0
166902,(,0,0
166903,0.02,0,0
166904,mg/kg,0,0
166905,),0,0
166906,and,0,0
166907,oxymorphone,0,0
166908,(,0,0
166909,0.05,0,0
166910,mg/kg,0,0
166911,),0,0
166912,were,0,0
166913,administered,0,0
166914,IV,0,1
166915,.,0,1
166916,Fifteen,0,1
166917,minutes,0,0
166918,later,0,0
166919,(,0,0
166920,before,0,0
166921,IoA,0,0
166922,),0,0
166923,",",0,0
166924,each,0,0
166925,dog,0,0
166926,received,0,0
166927,treatment,0,0
166928,IV,0,0
166929,with,0,1
166930,propofol,0,0
166931,",",0,0
166932,K-P,0,0
166933,",",0,0
166934,or,0,1
166935,K-D.,0,1
166936,Cardiorespiratory,0,0
166937,and,0,0
166938,arterial,0,1
166939,blood,0,0
166940,gas,0,1
166941,variables,0,0
166942,were,0,0
166943,assessed,0,0
166944,before,0,0
166945,",",0,0
166946,immediately,0,0
166947,after,0,0
166948,",",0,0
166949,and,0,0
166950,5,0,0
166951,minutes,0,0
166952,after,0,1
166953,IoA,0,1
166954,.,0,1
166955,RESULTS,0,0
166956,Compared,0,0
166957,with,0,1
166958,findings,0,0
166959,before,0,0
166960,IoA,0,1
166961,",",0,0
166962,dogs,0,1
166963,receiving,0,1
166964,the,0,0
166965,K-P,0,0
166966,or,0,1
166967,K-D,0,1
166968,treatment,0,0
166969,had,0,0
166970,increased,0,0
166971,cardiac,0,1
166972,output,0,0
166973,",",0,0
166974,oxygen,0,0
166975,delivery,0,0
166976,",",0,0
166977,and,0,0
166978,heart,0,1
166979,rate,0,0
166980,5,0,0
166981,minutes,0,0
166982,after,0,1
166983,IoA,0,1
166984,;,0,1
166985,K-P,0,0
166986,administration,0,0
166987,did,0,0
166988,not,0,0
166989,change,0,0
166990,mean,0,0
166991,arterial,0,1
166992,blood,0,0
166993,pressure,0,0
166994,or,0,0
166995,stroke,0,1
166996,volume,0,0
166997,and,0,0
166998,decreased,0,0
166999,systemic,0,0
167000,vascular,0,0
167001,resistance,0,0
167002,.,0,1
167003,Propofol,0,0
167004,decreased,0,0
167005,mean,0,1
167006,arterial,0,1
167007,blood,0,0
167008,pressure,0,0
167009,and,0,0
167010,systemic,0,0
167011,vascular,0,0
167012,resistance,0,0
167013,immediately,0,0
167014,after,0,0
167015,IoA,0,0
167016,but,0,0
167017,did,0,0
167018,not,0,0
167019,change,0,0
167020,heart,0,1
167021,rate,0,0
167022,",",0,0
167023,cardiac,0,1
167024,output,0,0
167025,",",0,0
167026,or,0,0
167027,oxygen,0,0
167028,delivery,0,0
167029,.,0,0
167030,All,0,0
167031,treatments,0,0
167032,caused,0,0
167033,some,0,0
167034,degree,0,0
167035,of,0,0
167036,apnea,0,1
167037,",",0,0
167038,hypoventilation,0,1
167039,",",0,0
167040,and,0,0
167041,hypoxemia,0,1
167042,(,0,0
167043,Pao2,0,0
167044,<,0,0
167045,80,0,0
167046,mm,0,0
167047,Hg,0,0
167048,),0,0
167049,.,0,1
167050,CONCLUSIONS,0,0
167051,AND,0,0
167052,CLINICAL,0,1
167053,RELEVANCE,0,1
167054,In,0,0
167055,dogs,0,1
167056,",",0,0
167057,K-P,0,0
167058,treatment,0,0
167059,maintained,0,0
167060,mean,0,1
167061,arterial,0,1
167062,blood,0,0
167063,pressure,0,0
167064,better,0,0
167065,than,0,0
167066,propofol,0,0
167067,alone,0,0
167068,and,0,0
167069,increased,0,0
167070,heart,0,1
167071,rate,0,0
167072,",",0,0
167073,cardiac,0,1
167074,output,0,0
167075,",",0,0
167076,or,0,0
167077,oxygen,0,0
167078,delivery,0,0
167079,",",0,0
167080,as,0,0
167081,did,0,0
167082,the,0,0
167083,K-D,0,1
167084,treatment,0,0
167085,.,0,1
167086,Supplemental,0,0
167087,100,0,0
167088,%,0,0
167089,oxygen,0,0
167090,should,0,0
167091,be,0,0
167092,provided,0,0
167093,during,0,0
167094,IoA,0,0
167095,with,0,1
167096,all,0,1
167097,3,0,0
167098,treatments,0,0
167099,.,0,1
167100,Are,0,0
167101,'leaky,0,0
167102,gut,0,0
167103,',0,0
167104,and,0,0
167105,behavior,0,0
167106,associated,0,0
167107,with,0,1
167108,gluten,0,0
167109,and,0,0
167110,dairy,0,1
167111,containing,0,0
167112,diet,0,0
167113,in,0,0
167114,children,1,1
167115,with,1,1
167116,autism,1,1
167117,spectrum,1,1
167118,disorders,1,1
167119,?,0,1
167120,OBJECTIVES,0,0
167121,Studies,0,0
167122,have,0,1
167123,suggested,0,0
167124,a,0,0
167125,link,0,0
167126,between,0,0
167127,diet,0,0
167128,and,0,0
167129,behavior,0,0
167130,in,0,0
167131,children,1,1
167132,with,1,1
167133,autism,1,1
167134,spectrum,1,1
167135,disorders,1,1
167136,(,1,1
167137,ASDs,1,1
167138,),1,1
167139,.,1,1
167140,Parental,0,0
167141,reports,0,0
167142,of,0,1
167143,behavioral,0,1
167144,changes,0,0
167145,upon,0,0
167146,exposure,0,0
167147,to,0,0
167148,gluten,0,0
167149,and/or,0,0
167150,casein,0,0
167151,are,0,0
167152,common,0,0
167153,in,0,0
167154,clinical,0,0
167155,practice,0,0
167156,.,0,0
167157,An,0,0
167158,association,0,0
167159,between,0,0
167160,diet,0,0
167161,type,0,1
167162,",",0,0
167163,intestinal,0,0
167164,permeability,0,0
167165,(,0,0
167166,IP,0,0
167167,),0,0
167168,(,0,0
167169,'leaky,0,0
167170,gut,0,0
167171,',0,1
167172,),0,0
167173,",",0,0
167174,and,0,0
167175,behavior,0,0
167176,has,0,0
167177,been,0,0
167178,long,0,0
167179,proposed,0,0
167180,but,0,0
167181,not,0,0
167182,substantiated,0,0
167183,.,0,0
167184,We,0,0
167185,explored,0,0
167186,this,0,0
167187,possible,0,0
167188,association,0,0
167189,in,0,0
167190,this,0,0
167191,trial,0,0
167192,.,0,0
167193,METHODS,0,0
167194,This,0,0
167195,randomized,0,0
167196,double-blind,0,0
167197,",",0,0
167198,placebo-controlled,0,0
167199,study,0,0
167200,explored,0,0
167201,the,0,0
167202,effects,0,0
167203,of,0,0
167204,gluten,0,0
167205,and,0,0
167206,milk,0,1
167207,on,0,0
167208,IP,0,0
167209,and,0,0
167210,behavior,0,0
167211,in,0,0
167212,children,1,1
167213,with,1,1
167214,ASDs,1,1
167215,over,0,0
167216,a,0,0
167217,period,0,0
167218,of,0,0
167219,4,0,0
167220,weeks,0,0
167221,.,0,1
167222,IP,0,0
167223,assessed,0,0
167224,by,0,0
167225,lactulose,0,0
167226,:,0,1
167227,mannitol,0,0
167228,(,0,0
167229,L/M,0,0
167230,),0,0
167231,sugar,0,0
167232,permeability,0,0
167233,test,0,0
167234,and,0,0
167235,behavior,0,0
167236,assessed,0,0
167237,by,0,0
167238,the,0,0
167239,Aberrant,0,1
167240,Behavior,0,1
167241,Checklist,0,0
167242,and,0,0
167243,Conners,0,1
167244,Parent,0,1
167245,Rating,0,0
167246,were,0,0
167247,measured,0,0
167248,.,0,1
167249,Gastrointestinal,0,0
167250,symptoms,0,0
167251,in,0,0
167252,both,0,0
167253,groups,0,0
167254,were,0,0
167255,also,0,0
167256,monitored,0,0
167257,.,0,0
167258,RESULTS,0,0
167259,Neither,0,0
167260,the,0,0
167261,L/M,0,0
167262,ratio,0,0
167263,nor,0,0
167264,behavioral,0,1
167265,scores,0,0
167266,were,0,1
167267,different,0,0
167268,between,0,0
167269,groups,0,0
167270,exposed,0,0
167271,to,0,0
167272,gluten/dairy,0,0
167273,or,0,0
167274,placebo,0,0
167275,.,0,0
167276,The,0,0
167277,changes,0,0
167278,observed,0,0
167279,were,0,0
167280,noted,0,0
167281,to,0,0
167282,be,0,0
167283,small,0,0
167284,and,0,0
167285,not,0,0
167286,clinically,0,0
167287,significant,0,0
167288,.,0,0
167289,DISCUSSION,0,0
167290,Our,0,0
167291,study,0,0
167292,although,0,0
167293,underpowered,0,0
167294,to,0,0
167295,show,0,0
167296,small,0,0
167297,differences,0,0
167298,does,0,0
167299,not,0,0
167300,support,0,0
167301,an,0,0
167302,association,0,0
167303,between,0,0
167304,dietary,0,0
167305,gluten/milk,0,0
167306,",",0,0
167307,IP,0,0
167308,",",0,0
167309,and,0,0
167310,behavioral,0,0
167311,changes,0,0
167312,in,0,1
167313,subjects,1,1
167314,with,1,1
167315,ASD,1,1
167316,.,1,1
167317,Safety,0,0
167318,and,0,0
167319,efficacy,0,0
167320,of,0,0
167321,a,0,0
167322,low,0,0
167323,molecular,0,0
167324,weight,0,0
167325,heparin,0,0
167326,(,0,0
167327,Logiparin,0,0
167328,),0,0
167329,versus,0,0
167330,dextran,0,0
167331,as,0,0
167332,prophylaxis,0,0
167333,against,0,0
167334,thrombosis,0,0
167335,after,0,0
167336,total,1,1
167337,hip,1,1
167338,replacement,1,1
167339,.,1,0
167340,In,0,0
167341,order,0,0
167342,to,0,0
167343,study,0,0
167344,the,0,0
167345,plasma,0,0
167346,levels,0,0
167347,of,0,0
167348,factor,0,0
167349,XaI,0,1
167350,and,0,0
167351,IIaI,0,1
167352,activity,0,0
167353,an,0,0
167354,enzymatically,0,0
167355,depolymerized,0,0
167356,low,0,0
167357,molecular,0,0
167358,weight,0,0
167359,heparin,0,0
167360,(,0,0
167361,LMW-heparin,0,0
167362,;,0,1
167363,Logiparin,0,0
167364,),0,0
167365,was,0,0
167366,given,0,0
167367,s.c.,0,0
167368,in,0,0
167369,a,0,0
167370,dose,0,0
167371,of,0,0
167372,35,0,1
167373,XaI,0,1
167374,mu/kg,0,0
167375,b.w,0,0
167376,.,0,0
167377,once,0,0
167378,daily,0,0
167379,for,0,0
167380,7,0,1
167381,days,0,0
167382,to,0,1
167383,10,1,1
167384,patients,1,1
167385,undergoing,1,1
167386,total,1,1
167387,hip,1,1
167388,replacement,1,1
167389,(,1,0
167390,THR,1,0
167391,),1,0
167392,in,0,0
167393,a,0,0
167394,pilot,0,0
167395,study,0,0
167396,.,0,0
167397,The,0,0
167398,XaI,0,0
167399,activity,0,0
167400,was,0,0
167401,less,0,0
167402,than,0,0
167403,or,0,0
167404,equal,0,0
167405,to,0,0
167406,0.24,0,0
167407,XaI,0,1
167408,units/ml,0,0
167409,and,0,0
167410,the,0,0
167411,IIaI,0,0
167412,activity,0,0
167413,less,0,0
167414,than,0,0
167415,or,0,0
167416,equal,0,0
167417,to,0,0
167418,0.043,0,0
167419,IIaI,0,1
167420,mu/ml,0,0
167421,.,0,0
167422,No,0,0
167423,accumulation,0,0
167424,of,0,0
167425,the,0,0
167426,activities,0,0
167427,were,0,0
167428,seen,0,0
167429,.,0,0
167430,No,0,0
167431,phlebographically,0,0
167432,verified,0,0
167433,thrombi,0,0
167434,or,0,0
167435,any,0,0
167436,bleeding,0,1
167437,complications,0,0
167438,were,0,1
167439,registered,0,1
167440,.,0,0
167441,From,0,0
167442,this,0,0
167443,study,0,0
167444,it,0,0
167445,was,0,0
167446,concluded,0,0
167447,that,0,0
167448,the,0,0
167449,given,0,0
167450,dose,0,0
167451,of,0,0
167452,Logiparin,0,0
167453,was,0,0
167454,safe,0,0
167455,with,0,1
167456,regard,0,0
167457,to,0,0
167458,bleeding,0,1
167459,complications,0,0
167460,.,0,1
167461,Based,0,0
167462,on,0,0
167463,these,0,0
167464,data,0,0
167465,",",0,0
167466,an,0,0
167467,open,0,0
167468,",",0,0
167469,randomized,0,0
167470,controlled,0,0
167471,trial,0,0
167472,was,0,0
167473,started,0,0
167474,.,0,0
167475,In,0,0
167476,this,0,0
167477,main,0,0
167478,study,0,0
167479,the,0,0
167480,thromboprophylactic,0,0
167481,effect,0,0
167482,of,0,0
167483,the,0,0
167484,LMW-heparin,0,0
167485,(,0,0
167486,Logiparin,0,0
167487,),0,0
167488,in,0,0
167489,a,0,0
167490,dose,0,0
167491,of,0,0
167492,35,0,1
167493,XaI,0,1
167494,mu/kg,0,0
167495,b.w,0,0
167496,.,0,0
167497,once,0,0
167498,daily,0,0
167499,was,0,0
167500,compared,0,0
167501,with,0,1
167502,that,0,0
167503,of,0,0
167504,dextran,0,0
167505,70,0,1
167506,in,0,0
167507,patients,1,1
167508,undergoing,1,1
167509,THR,1,0
167510,.,1,1
167511,100,1,0
167512,patients,1,1
167513,were,1,1
167514,randomized,1,1
167515,.,1,0
167516,The,0,0
167517,over-all,0,0
167518,thrombosis,0,0
167519,rate,0,0
167520,was,0,0
167521,28,0,1
167522,%,0,0
167523,in,0,0
167524,patients,0,1
167525,treated,0,1
167526,with,0,1
167527,LMW-heparin,0,0
167528,and,0,0
167529,39,0,1
167530,%,0,0
167531,in,0,0
167532,those,0,0
167533,given,0,0
167534,dextran,0,0
167535,",",0,0
167536,a,0,0
167537,non-significant,0,0
167538,difference,0,0
167539,.,0,0
167540,No,0,0
167541,bleeding,0,0
167542,complications,0,0
167543,",",0,1
167544,deaths,0,0
167545,or,0,1
167546,pulmonary,0,1
167547,embolism,0,1
167548,were,0,0
167549,recorded,0,0
167550,in,0,0
167551,either,0,0
167552,group,0,0
167553,.,0,0
167554,Peroperative,0,0
167555,blood,0,0
167556,loss,0,0
167557,and,0,0
167558,transfusion,0,0
167559,requirements,0,0
167560,were,0,1
167561,similar,0,0
167562,in,0,0
167563,the,0,0
167564,two,0,0
167565,groups,0,0
167566,.,0,1
167567,In,0,0
167568,conclusion,0,0
167569,",",0,0
167570,the,0,0
167571,investigated,0,0
167572,LMW-heparin,0,0
167573,(,0,1
167574,Logiparin,0,0
167575,),0,0
167576,is,0,0
167577,safe,0,0
167578,and,0,0
167579,effective,0,0
167580,in,0,0
167581,preventing,0,0
167582,postoperative,0,0
167583,thromboembolism,0,1
167584,in,0,0
167585,patients,1,1
167586,undergoing,1,1
167587,total,1,1
167588,hip,1,1
167589,replacement,1,1
167590,",",0,0
167591,but,0,0
167592,the,0,0
167593,dosage,0,0
167594,can,0,0
167595,probably,0,0
167596,be,0,0
167597,optimized,0,0
167598,.,0,0
167599,Short-term,0,0
167600,speech-language,0,1
167601,intervention,0,0
167602,for,0,0
167603,children,1,1
167604,with,1,1
167605,disorders,1,1
167606,of,1,0
167607,the,1,0
167608,autism,1,1
167609,spectrum,1,1
167610,.,1,0
167611,PURPOSE,0,0
167612,To,0,0
167613,assess,0,0
167614,any,0,0
167615,changes,0,0
167616,in,0,0
167617,the,0,0
167618,Functional,0,0
167619,Communicative,0,0
167620,Profile,0,1
167621,(,0,0
167622,FCP,0,0
167623,),0,0
167624,and,0,0
167625,in,0,0
167626,the,0,0
167627,Social,0,0
167628,Cognitive,0,0
167629,Performance,0,0
167630,(,0,0
167631,SCP,0,1
167632,),0,0
167633,of,0,0
167634,children,1,1
167635,with,1,1
167636,Autism,1,1
167637,Spectrum,1,1
167638,Disorders,1,1
167639,",",0,0
167640,based,0,0
167641,on,0,0
167642,two,0,0
167643,short,0,0
167644,periods,0,0
167645,of,0,0
167646,intervention,0,0
167647,.,0,1
167648,METHODS,0,0
167649,The,0,0
167650,study,0,0
167651,was,0,0
167652,conducted,0,0
167653,with,0,1
167654,21,1,1
167655,children,1,1
167656,with,1,1
167657,Autism,1,1
167658,Spectrum,1,1
167659,Disorder,1,1
167660,diagnoses,1,1
167661,",",0,0
167662,randomly,0,1
167663,allocated,0,0
167664,into,0,0
167665,two,0,0
167666,groups,0,1
167667,",",0,1
167668,who,0,1
167669,received,0,1
167670,the,0,1
167671,same,0,0
167672,short-term,0,0
167673,intervention,0,0
167674,types,0,0
167675,(,0,1
167676,6,0,0
167677,weeks,0,0
167678,with,0,1
167679,the,0,0
167680,mother,0,0
167681,and,0,0
167682,6,0,0
167683,weeks,0,0
167684,with,0,1
167685,the,0,0
167686,support,0,0
167687,of,0,0
167688,an,0,0
167689,educational,0,0
167690,software,0,0
167691,program,0,1
167692,),0,0
167693,.,0,0
167694,The,0,0
167695,intervention,0,0
167696,process,0,0
167697,was,0,0
167698,conducted,0,0
167699,by,0,0
167700,speech-language,0,1
167701,pathologists,0,1
167702,who,0,1
167703,were,0,1
167704,part,0,1
167705,of,0,0
167706,a,0,0
167707,graduate,0,1
167708,program,0,0
167709,in,0,0
167710,this,0,0
167711,area,0,0
167712,.,0,0
167713,RESULTS,0,0
167714,Samples,0,1
167715,of,0,0
167716,15-minute,0,0
167717,interaction,0,0
167718,sessions,0,0
167719,between,0,0
167720,the,0,0
167721,child,0,0
167722,and,0,0
167723,speech-language,0,1
167724,pathologist,0,1
167725,were,0,0
167726,used,0,0
167727,to,0,0
167728,assess,0,0
167729,the,0,0
167730,changes,0,0
167731,in,0,0
167732,the,0,0
167733,FCP,0,0
167734,and,0,0
167735,the,0,0
167736,SCP,0,0
167737,.,0,0
167738,The,0,0
167739,statistic,0,0
167740,analysis,0,0
167741,pointed,0,0
167742,out,0,0
167743,differences,0,0
167744,only,0,0
167745,in,0,0
167746,Group,0,1
167747,1,0,0
167748,for,0,0
167749,the,0,0
167750,variables,0,0
167751,percentage,0,0
167752,of,0,0
167753,communicative,0,0
167754,space,0,0
167755,used,0,0
167756,and,0,0
167757,use,0,0
167758,of,0,0
167759,the,0,0
167760,mediating,0,0
167761,object,0,0
167762,.,0,0
167763,CONCLUSION,0,0
167764,With,0,0
167765,the,0,0
167766,intervention,0,0
167767,sessions,0,0
167768,structured,0,0
167769,over,0,0
167770,12,0,0
167771,weeks,0,0
167772,",",0,0
167773,it,0,0
167774,was,0,0
167775,possible,0,0
167776,to,0,0
167777,observe,0,0
167778,a,0,0
167779,few,0,0
167780,changes,0,0
167781,in,0,0
167782,the,0,0
167783,children,0,1
167784,'s,0,1
167785,FCP,0,0
167786,and,0,1
167787,in,0,0
167788,the,0,0
167789,SCP,0,0
167790,.,0,0
167791,Therefore,0,0
167792,",",0,0
167793,we,0,0
167794,point,0,0
167795,out,0,0
167796,the,0,0
167797,need,0,0
167798,for,0,0
167799,new,0,0
167800,research,0,1
167801,studies,0,0
167802,of,0,0
167803,longer,0,0
167804,duration,0,0
167805,.,0,0
167806,Brief,0,0
167807,acceptance-based,0,0
167808,intervention,0,0
167809,for,0,0
167810,increasing,0,0
167811,intake,0,0
167812,attendance,0,0
167813,at,1,0
167814,a,1,0
167815,community,1,0
167816,mental,1,1
167817,health,1,1
167818,center,1,1
167819,.,1,0
167820,Intake,0,0
167821,no-show,0,0
167822,rates,0,0
167823,for,0,0
167824,psychotherapy,0,1
167825,vary,0,0
167826,from,0,0
167827,20,0,1
167828,%,0,0
167829,to,0,0
167830,57,0,1
167831,%,0,0
167832,(,0,0
167833,Swenson,0,1
167834,&,0,1
167835,Pekarik,0,1
167836,",",0,0
167837,1988,0,1
167838,),0,0
167839,",",0,0
167840,and,0,0
167841,experiential,0,0
167842,avoidance,0,0
167843,may,0,0
167844,be,0,0
167845,related,0,0
167846,to,0,0
167847,failure,0,1
167848,to,0,0
167849,attend,0,1
167850,intake,0,0
167851,sessions,0,0
167852,.,0,1
167853,This,0,0
167854,pilot,0,0
167855,study,0,0
167856,attempted,0,0
167857,to,0,0
167858,increase,0,0
167859,intake,0,0
167860,attendance,0,0
167861,at,1,0
167862,a,1,0
167863,community,1,0
167864,mental,1,1
167865,health,1,0
167866,center,1,1
167867,by,0,0
167868,employing,0,0
167869,a,0,0
167870,brief,0,0
167871,experiential,0,0
167872,acceptance-based,0,0
167873,intervention,0,0
167874,.,0,1
167875,Those,1,1
167876,who,1,1
167877,scheduled,1,1
167878,intakes,1,1
167879,were,0,0
167880,randomly,0,1
167881,assigned,0,1
167882,to,0,0
167883,1,0,0
167884,of,0,0
167885,2,0,1
167886,groups,0,0
167887,:,0,1
167888,orientation,0,0
167889,letter,0,0
167890,or,0,1
167891,acceptance-enhanced,0,0
167892,orientation,0,0
167893,letter,0,0
167894,;,0,0
167895,rates,0,0
167896,from,0,1
167897,these,0,0
167898,conditions,0,0
167899,were,0,0
167900,compared,0,0
167901,with,0,1
167902,a,0,0
167903,retrospective,0,1
167904,comparison,0,0
167905,control,0,1
167906,group,0,0
167907,.,0,1
167908,Participants,0,1
167909,were,0,0
167910,randomized,0,1
167911,by,0,0
167912,way,0,0
167913,of,0,0
167914,an,0,0
167915,online,0,0
167916,random,0,0
167917,number,0,0
167918,generator,0,0
167919,.,0,1
167920,Persons,0,1
167921,assigned,0,0
167922,to,0,0
167923,the,0,0
167924,orientation,0,0
167925,group,0,0
167926,did,0,0
167927,not,0,0
167928,have,0,0
167929,a,0,0
167930,higher,0,0
167931,show,0,0
167932,rate,0,0
167933,than,0,0
167934,persons,0,1
167935,within,0,0
167936,the,0,0
167937,control,0,0
167938,group,0,0
167939,(,0,0
167940,?48,0,0
167941,%,0,0
167942,compared,0,0
167943,with,0,1
167944,?52,0,0
167945,%,0,0
167946,),0,0
167947,.,0,1
167948,Persons,0,1
167949,assigned,0,0
167950,to,0,0
167951,the,0,0
167952,acceptance,0,0
167953,group,0,0
167954,did,0,0
167955,have,0,0
167956,higher,0,0
167957,show,0,0
167958,rates,0,0
167959,than,0,0
167960,persons,0,1
167961,in,0,0
167962,the,0,0
167963,other,0,0
167964,two,0,0
167965,groups,0,0
167966,(,0,1
167967,?67,0,0
167968,%,0,0
167969,compared,0,0
167970,with,0,1
167971,?48,0,0
167972,%,0,0
167973,and,0,0
167974,?52,0,0
167975,%,0,0
167976,",",0,0
167977,respectively,0,0
167978,),0,0
167979,",",0,0
167980,however,0,0
167981,this,0,0
167982,difference,0,0
167983,was,0,0
167984,nonsignificant,0,0
167985,.,0,0
167986,Results,0,0
167987,suggest,0,0
167988,that,0,0
167989,brief,0,0
167990,acceptance-based,0,0
167991,interventions,0,0
167992,should,0,0
167993,be,0,0
167994,further,0,0
167995,studied,0,0
167996,for,0,0
167997,their,0,0
167998,potential,0,0
167999,value,0,0
168000,in,0,0
168001,maximizing,0,0
168002,client,0,0
168003,attendance,0,0
168004,.,0,1
168005,Prophylactic,0,0
168006,training,0,0
168007,for,0,0
168008,the,0,0
168009,prevention,0,0
168010,of,0,0
168011,radiotherapy-induced,0,0
168012,trismus,0,0
168013,-,0,0
168014,a,0,0
168015,randomised,0,0
168016,study,0,0
168017,.,0,1
168018,BACKGROUND,0,0
168019,Radiotherapy-induced,0,0
168020,trismus,0,0
168021,(,0,0
168022,RTIT,0,0
168023,),0,0
168024,is,0,0
168025,a,0,0
168026,debilitating,0,0
168027,condition,0,0
168028,without,0,1
168029,any,0,0
168030,proven,0,0
168031,effective,0,0
168032,treatment,0,0
168033,.,0,0
168034,This,0,0
168035,study,0,0
168036,investigates,0,0
168037,the,0,0
168038,effectiveness,0,0
168039,of,0,0
168040,prophylactic,0,0
168041,training,0,0
168042,to,0,0
168043,prevent,0,0
168044,RTIT,0,0
168045,during,0,0
168046,and,0,0
168047,up,0,0
168048,to,0,0
168049,12,0,0
168050,months,0,0
168051,after,0,0
168052,completed,1,1
168053,RT,1,1
168054,in,1,0
168055,patients,1,1
168056,with,1,1
168057,head,1,1
168058,and,1,0
168059,neck,1,1
168060,cancer,1,1
168061,(,1,0
168062,HNC,1,0
168063,),1,0
168064,",",0,0
168065,also,0,0
168066,investigating,0,0
168067,the,0,0
168068,incidence,0,0
168069,of,0,0
168070,RTIT,0,1
168071,.,0,1
168072,METHODS,0,0
168073,Sixty-six,1,1
168074,consecutive,1,1
168075,patients,1,1
168076,from,1,1
168077,two,1,1
168078,RT,1,1
168079,clinics,1,1
168080,in,1,0
168081,Sweden,1,1
168082,were,0,0
168083,randomised,0,0
168084,into,0,0
168085,one,0,1
168086,of,0,1
168087,two,0,1
168088,groups,0,0
168089,:,0,1
168090,training,0,0
168091,with,0,1
168092,TheraBite,0,1
168093,(,0,1
168094,?,0,1
168095,),0,0
168096,Jaw,0,0
168097,Motion,0,1
168098,Rehabilitation,0,1
168099,System,0,1
168100,(,0,0
168101,?,0,0
168102,),0,0
168103,or,0,0
168104,a,0,0
168105,control,0,0
168106,group,0,0
168107,.,0,0
168108,Maximum,0,0
168109,interincisal,0,0
168110,openings,0,1
168111,(,0,1
168112,MIO,0,1
168113,),0,0
168114,were,0,0
168115,recorded,0,0
168116,at,0,0
168117,baseline,0,0
168118,and,0,0
168119,once,0,0
168120,a,0,0
168121,week,0,0
168122,during,0,0
168123,treatment,0,0
168124,",",0,0
168125,three,0,0
168126,",",0,0
168127,six,0,1
168128,and,0,0
168129,12,0,1
168130,months,0,0
168131,after,0,0
168132,completed,0,1
168133,RT,0,1
168134,.,0,1
168135,Training,0,0
168136,frequency,0,0
168137,was,0,0
168138,recorded,0,0
168139,by,0,0
168140,patients,0,1
168141,in,0,0
168142,a,0,0
168143,log,0,0
168144,book,0,0
168145,.,0,0
168146,RESULTS,0,0
168147,There,0,0
168148,were,0,0
168149,no,0,0
168150,significant,0,0
168151,differences,0,0
168152,in,0,0
168153,MIO,0,1
168154,between,0,0
168155,the,0,0
168156,intervention,0,0
168157,and,0,0
168158,control,0,0
168159,groups,0,0
168160,at,0,0
168161,any,0,0
168162,of,0,0
168163,the,0,0
168164,measurement,0,0
168165,points,0,0
168166,.,0,1
168167,Patients,0,1
168168,in,0,0
168169,both,0,0
168170,groups,0,0
168171,maintained,0,0
168172,their,0,1
168173,normal,0,1
168174,variation,0,0
168175,in,0,0
168176,MIO,0,1
168177,at,0,1
168178,12,0,0
168179,months,0,0
168180,after,0,0
168181,completed,0,1
168182,RT,0,1
168183,.,0,1
168184,A,0,0
168185,small,0,0
168186,group,0,0
168187,of,0,0
168188,patients,0,1
168189,in,0,0
168190,the,0,0
168191,control,0,0
168192,group,0,0
168193,had,0,0
168194,a,0,0
168195,17,0,1
168196,%,0,0
168197,mean,0,0
168198,decrease,0,0
168199,in,0,0
168200,MIO,0,1
168201,by,0,0
168202,week,0,0
168203,6,0,0
168204,compared,0,0
168205,to,0,0
168206,baseline,0,0
168207,and,0,0
168208,improved,0,0
168209,their,0,0
168210,MIO,0,0
168211,by,0,0
168212,using,0,0
168213,the,0,0
168214,training,0,0
168215,programme,0,0
168216,.,0,0
168217,There,0,0
168218,was,0,0
168219,a,0,0
168220,significant,0,0
168221,mean,0,0
168222,difference,0,0
168223,in,0,0
168224,MIO,0,1
168225,from,0,1
168226,baseline,0,0
168227,to,0,0
168228,week,0,0
168229,6,0,0
168230,(,0,0
168231,3,0,0
168232,mm,0,0
168233,",",0,0
168234,p,0,0
168235,=,0,0
168236,0.018,0,0
168237,),0,0
168238,",",0,0
168239,and,0,0
168240,month,0,0
168241,6,0,0
168242,(,0,0
168243,2.7,0,0
168244,mm,0,0
168245,",",0,0
168246,p,0,0
168247,=,0,0
168248,0.040,0,0
168249,),0,0
168250,",",0,0
168251,for,0,0
168252,patients,0,1
168253,receiving,0,1
168254,3D,0,1
168255,conformal,0,1
168256,radiotherapy,0,1
168257,.,0,0
168258,There,0,0
168259,was,0,0
168260,a,0,0
168261,significant,0,0
168262,difference,0,0
168263,in,0,0
168264,MIO,0,1
168265,between,0,0
168266,patients,0,1
168267,treated,0,1
168268,with,0,1
168269,RT,0,1
168270,and,0,0
168271,concurrent,0,0
168272,chemotherapy,0,0
168273,compared,0,0
168274,to,0,0
168275,patients,0,1
168276,with,0,1
168277,RT,0,1
168278,only,0,0
168279,at,0,0
168280,12,0,0
168281,months,0,0
168282,(,0,1
168283,p,0,0
168284,=,0,0
168285,0.033,0,0
168286,),0,1
168287,.,0,1
168288,CONCLUSIONS,1,0
168289,Patients,1,1
168290,with,1,1
168291,HNC,1,1
168292,undergoing,1,1
168293,high,1,1
168294,dose,1,0
168295,RT,1,1
168296,do,0,0
168297,not,0,0
168298,need,0,0
168299,to,0,0
168300,be,0,0
168301,burdened,0,0
168302,with,0,0
168303,an,0,0
168304,intense,0,0
168305,prophylactic,0,0
168306,training,0,0
168307,programme,0,0
168308,during,0,0
168309,RT,0,1
168310,and,0,0
168311,up,0,0
168312,to,0,0
168313,12,0,0
168314,months,0,0
168315,after,0,0
168316,completed,0,1
168317,RT,0,1
168318,.,0,1
168319,MIO,0,0
168320,measurements,0,0
168321,during,0,0
168322,RT,0,1
168323,and,0,0
168324,up,0,0
168325,to,0,0
168326,12,0,0
168327,months,0,0
168328,after,0,0
168329,completed,0,1
168330,RT,0,1
168331,are,0,0
168332,recommended,0,0
168333,to,0,0
168334,identify,0,0
168335,a,0,0
168336,small,0,0
168337,risk,0,1
168338,group,0,1
168339,who,0,1
168340,are,0,0
168341,an,0,1
168342,exception,0,0
168343,and,0,0
168344,may,0,0
168345,need,0,0
168346,a,0,0
168347,training,0,0
168348,programme,0,0
168349,.,0,1
168350,Omitting,0,0
168351,radiotherapy,0,1
168352,in,0,0
168353,early,0,0
168354,positron,1,1
168355,emission,1,1
168356,tomography-negative,1,1
168357,stage,1,1
168358,I/II,1,0
168359,Hodgkin,1,1
168360,lymphoma,1,1
168361,is,0,0
168362,associated,0,0
168363,with,0,0
168364,an,0,0
168365,increased,0,0
168366,risk,0,0
168367,of,0,0
168368,early,0,1
168369,relapse,0,1
168370,:,0,1
168371,Clinical,0,0
168372,results,0,0
168373,of,0,0
168374,the,0,0
168375,preplanned,0,0
168376,interim,0,0
168377,analysis,0,0
168378,of,0,0
168379,the,0,0
168380,randomized,0,1
168381,EORTC/LYSA/FIL,0,0
168382,H10,0,0
168383,trial,0,0
168384,.,0,1
168385,PURPOSE,0,0
168386,Combined-modality,0,0
168387,treatment,0,0
168388,is,0,0
168389,standard,0,0
168390,treatment,0,0
168391,for,0,0
168392,patients,1,1
168393,with,1,1
168394,clinical,1,0
168395,stage,1,1
168396,I/II,1,0
168397,Hodgkin,1,1
168398,lymphoma,1,1
168399,(,1,0
168400,HL,1,1
168401,),1,0
168402,.,1,0
168403,We,0,0
168404,hypothesized,0,0
168405,that,0,0
168406,an,0,0
168407,early,0,0
168408,positron,0,0
168409,emission,0,1
168410,tomography,0,0
168411,(,0,0
168412,PET,0,0
168413,),0,0
168414,scan,0,0
168415,could,0,0
168416,be,0,0
168417,used,0,0
168418,to,0,0
168419,adapt,0,0
168420,treatment,0,0
168421,.,0,0
168422,Therefore,0,0
168423,",",0,0
168424,we,0,0
168425,started,0,0
168426,the,0,0
168427,randomized,0,0
168428,EORTC/LYSA/FIL,0,0
168429,Intergroup,0,0
168430,H10,0,0
168431,trial,0,0
168432,evaluating,0,0
168433,whether,0,0
168434,involved-node,0,1
168435,radiotherapy,0,1
168436,(,0,0
168437,IN-RT,0,0
168438,),0,0
168439,could,0,0
168440,be,0,0
168441,omitted,0,0
168442,without,0,0
168443,compromising,0,0
168444,progression-free,0,0
168445,survival,0,0
168446,in,0,0
168447,patients,1,1
168448,attaining,1,1
168449,a,1,0
168450,negative,1,0
168451,early,1,0
168452,PET,1,0
168453,scan,1,0
168454,after,1,0
168455,two,1,0
168456,cycles,1,0
168457,of,1,0
168458,ABVD,1,1
168459,(,0,0
168460,doxorubicin,0,0
168461,",",0,0
168462,bleomycin,0,0
168463,",",0,0
168464,vinblastine,0,0
168465,",",0,0
168466,and,0,0
168467,dacarbazine,0,0
168468,),0,0
168469,as,0,0
168470,compared,0,0
168471,with,0,1
168472,standard,0,0
168473,combined-modality,0,0
168474,treatment,0,0
168475,.,0,0
168476,PATIENTS,0,0
168477,AND,0,0
168478,METHODS,0,0
168479,Patients,1,1
168480,age,1,1
168481,15,1,1
168482,to,1,0
168483,70,1,1
168484,years,1,1
168485,with,1,1
168486,untreated,1,1
168487,clinical,1,0
168488,stage,1,1
168489,I/II,1,1
168490,HL,1,1
168491,were,1,1
168492,eligible,1,1
168493,.,1,0
168494,Here,0,0
168495,we,0,0
168496,report,0,0
168497,the,0,0
168498,clinical,0,0
168499,outcome,0,0
168500,of,0,0
168501,the,0,0
168502,preplanned,0,0
168503,interim,0,0
168504,futility,0,0
168505,analysis,0,0
168506,scheduled,0,1
168507,to,0,0
168508,occur,0,0
168509,after,0,0
168510,documentation,0,0
168511,of,0,0
168512,34,0,1
168513,events,0,0
168514,in,0,0
168515,the,0,0
168516,early,0,0
168517,PET-negative,0,1
168518,group,0,0
168519,.,0,0
168520,Because,0,0
168521,testing,0,0
168522,for,0,0
168523,futility,0,0
168524,in,0,0
168525,this,0,0
168526,noninferiority,0,0
168527,trial,0,0
168528,corresponds,0,0
168529,to,0,0
168530,testing,0,0
168531,the,0,0
168532,hypothesis,0,0
168533,of,0,0
168534,no,0,0
168535,difference,0,0
168536,",",0,0
168537,a,0,0
168538,one-sided,0,0
168539,superiority,0,0
168540,test,0,0
168541,was,0,0
168542,conducted,0,0
168543,.,0,0
168544,RESULTS,0,0
168545,The,1,0
168546,analysis,1,0
168547,included,1,1
168548,"1,137",1,1
168549,patients,1,1
168550,.,1,1
168551,In,0,0
168552,the,0,0
168553,favorable,1,0
168554,subgroup,1,1
168555,",",0,0
168556,85.8,0,0
168557,%,0,0
168558,had,0,1
168559,a,0,0
168560,negative,0,0
168561,early,0,0
168562,PET,0,0
168563,scan,0,0
168564,(,0,0
168565,standard,0,0
168566,arm,0,0
168567,",",0,0
168568,one,0,0
168569,event,0,0
168570,v,0,0
168571,experimental,0,0
168572,arm,0,0
168573,",",0,0
168574,nine,0,1
168575,events,0,0
168576,),0,1
168577,.,0,1
168578,In,0,0
168579,the,0,0
168580,unfavorable,1,0
168581,subgroup,1,1
168582,",",0,0
168583,74.8,0,0
168584,%,0,0
168585,had,0,1
168586,a,0,0
168587,negative,0,0
168588,early,0,0
168589,PET,0,0
168590,scan,0,0
168591,(,0,0
168592,standard,0,0
168593,arm,0,0
168594,",",0,0
168595,seven,0,1
168596,events,0,0
168597,v,0,0
168598,experimental,0,0
168599,arm,0,0
168600,",",0,0
168601,16,0,1
168602,events,0,0
168603,),0,1
168604,.,0,1
168605,The,0,0
168606,independent,0,0
168607,data,0,0
168608,monitoring,0,0
168609,committee,0,0
168610,concluded,0,0
168611,it,0,0
168612,was,0,0
168613,unlikely,0,0
168614,that,0,0
168615,we,0,0
168616,would,0,0
168617,show,0,0
168618,noninferiority,0,0
168619,in,0,0
168620,the,0,0
168621,final,0,0
168622,results,0,0
168623,for,0,0
168624,the,0,0
168625,experimental,0,0
168626,arm,0,0
168627,and,0,0
168628,advised,0,0
168629,stopping,0,0
168630,random,0,1
168631,assignment,0,0
168632,for,0,0
168633,early,0,1
168634,PET-negative,0,1
168635,patients,0,1
168636,.,0,1
168637,CONCLUSION,0,0
168638,On,0,0
168639,the,0,0
168640,basis,0,0
168641,of,0,0
168642,this,0,0
168643,analysis,0,0
168644,",",0,0
168645,combined-modality,0,0
168646,treatment,0,0
168647,resulted,0,0
168648,in,0,0
168649,fewer,0,0
168650,early,0,1
168651,progressions,0,0
168652,in,0,0
168653,clinical,0,0
168654,stage,0,1
168655,I/II,0,0
168656,HL,0,1
168657,",",0,0
168658,although,0,0
168659,early,0,0
168660,outcome,0,0
168661,was,0,0
168662,excellent,0,0
168663,in,0,0
168664,both,0,0
168665,arms,0,0
168666,.,0,0
168667,The,0,0
168668,final,0,0
168669,analysis,0,0
168670,will,0,0
168671,reveal,0,0
168672,whether,0,0
168673,this,0,0
168674,finding,0,0
168675,is,0,0
168676,maintained,0,0
168677,over,0,0
168678,time,0,0
168679,.,0,1
168680,Aerobic,0,1
168681,versus,0,0
168682,resistance,0,0
168683,training,0,0
168684,effects,0,0
168685,on,0,0
168686,health-related,1,0
168687,quality,1,0
168688,of,1,0
168689,life,1,0
168690,",",1,0
168691,body,1,0
168692,composition,1,0
168693,",",1,0
168694,and,1,0
168695,function,1,0
168696,of,1,0
168697,older,1,1
168698,adults,1,1
168699,.,1,0
168700,This,0,0
168701,study,0,0
168702,aimed,0,0
168703,to,0,0
168704,investigate,0,0
168705,the,0,0
168706,effects,0,0
168707,of,0,0
168708,training,0,0
168709,on,0,0
168710,health-related,0,0
168711,quality,0,0
168712,of,0,0
168713,life,0,0
168714,(,0,0
168715,HRQoL,0,0
168716,),0,0
168717,",",0,0
168718,body,0,0
168719,composition,0,0
168720,",",0,0
168721,and,0,0
168722,function,1,0
168723,in,1,0
168724,older,1,1
168725,adults,1,1
168726,.,1,1
168727,Fifty,1,1
168728,participants,1,1
168729,were,1,1
168730,randomized,1,1
168731,into,0,0
168732,aerobic,0,0
168733,training,0,0
168734,(,0,1
168735,AT,0,1
168736,--,0,1
168737,70,0,1
168738,%,0,0
168739,-80,0,0
168740,%,0,0
168741,HR,0,0
168742,reserve,0,1
168743,),0,0
168744,",",0,0
168745,resistance,0,0
168746,training,0,0
168747,(,0,0
168748,RT,0,1
168749,--,0,1
168750,80,0,1
168751,%,0,0
168752,1RM,0,0
168753,),0,0
168754,",",0,0
168755,or,0,1
168756,controls,0,1
168757,.,0,1
168758,They,0,0
168759,had,0,0
168760,HRQoL,0,0
168761,",",0,0
168762,body,0,0
168763,composition,0,0
168764,",",0,0
168765,and,0,0
168766,function,0,0
168767,assessed,0,0
168768,before,0,0
168769,and,0,0
168770,after,0,0
168771,8,0,0
168772,months,0,0
168773,.,0,1
168774,Training,0,0
168775,groups,0,0
168776,reduced,0,0
168777,body,0,1
168778,fat,0,0
168779,",",0,0
168780,increased,0,0
168781,performance,0,0
168782,in,0,0
168783,the,0,0
168784,stair,0,0
168785,ascent,0,0
168786,",",0,0
168787,8-ft,0,0
168788,up-and-go,0,0
168789,and,0,1
168790,sit-to-stand,0,1
168791,five-times,0,0
168792,tests,0,0
168793,",",0,0
168794,and,0,0
168795,improved,0,0
168796,their,0,0
168797,physical,0,0
168798,component,0,0
168799,score,0,0
168800,(,0,0
168801,PCS,0,0
168802,;,0,0
168803,p,0,0
168804,?,0,0
168805,.03,0,0
168806,),0,0
168807,.,0,1
168808,AT,0,0
168809,increased,0,0
168810,performance,0,0
168811,in,0,0
168812,the,0,0
168813,6MWT,0,0
168814,test,0,0
168815,",",0,0
168816,and,0,0
168817,improved,0,0
168818,general,0,1
168819,and,0,0
168820,mental,0,1
168821,health,0,1
168822,(,0,0
168823,MH,0,1
168824,),0,0
168825,domains,0,0
168826,when,0,0
168827,compared,0,0
168828,to,0,0
168829,controls,0,1
168830,(,0,1
168831,p,0,0
168832,<,0,0
168833,.01,0,0
168834,),0,0
168835,.,0,0
168836,Finally,0,0
168837,",",0,0
168838,changes,0,0
168839,in,0,0
168840,stair,0,0
168841,ascent,0,0
168842,were,0,0
168843,associated,0,0
168844,with,0,1
168845,changes,0,0
168846,in,0,0
168847,bodily,0,0
168848,pain,0,0
168849,",",0,0
168850,MH,0,1
168851,",",0,0
168852,and,0,0
168853,mental,0,1
168854,component,0,0
168855,score,0,0
168856,(,0,0
168857,p,0,0
168858,?,0,0
168859,.04,0,0
168860,),0,0
168861,",",0,0
168862,while,0,0
168863,changes,0,0
168864,in,0,0
168865,handgrip,0,0
168866,strength,0,0
168867,were,0,0
168868,associated,0,0
168869,with,0,1
168870,changes,0,0
168871,in,0,0
168872,physical,0,0
168873,role,0,0
168874,and,0,0
168875,MH,0,1
168876,(,0,0
168877,p,0,0
168878,=,0,0
168879,.03,0,0
168880,),0,1
168881,.,0,0
168882,AT,0,0
168883,and,0,0
168884,RT,0,1
168885,were,0,1
168886,effective,0,0
168887,interventions,0,0
168888,for,0,0
168889,decreasing,0,0
168890,body,0,1
168891,fat,0,0
168892,and,0,0
168893,improving,0,0
168894,functionality,0,0
168895,and,0,0
168896,the,0,0
168897,PCS,1,0
168898,in,1,0
168899,older,1,1
168900,adults,1,1
168901,.,1,1
168902,Factors,0,1
168903,associated,0,0
168904,with,0,1
168905,low,0,0
168906,consumption,0,0
168907,of,0,0
168908,fruits,0,1
168909,and,0,1
168910,vegetables,0,0
168911,by,0,0
168912,preschoolers,1,1
168913,of,1,1
168914,low,1,1
168915,socio-economic,1,1
168916,level,1,0
168917,.,1,0
168918,OBJECTIVE,0,0
168919,To,0,0
168920,evaluate,0,0
168921,factors,0,0
168922,associated,0,0
168923,with,0,1
168924,low,0,0
168925,consumption,0,0
168926,of,0,0
168927,fruits,0,1
168928,and,0,1
168929,vegetables,0,0
168930,among,0,1
168931,preschoolers,1,1
168932,from,1,1
168933,families,1,1
168934,treated,1,1
168935,at,1,0
168936,basic,1,0
168937,health,1,1
168938,centers,1,1
168939,in,1,0
168940,Porto,1,1
168941,Alegre,1,1
168942,",",1,0
168943,RS,1,0
168944,",",1,0
168945,Brazil,1,1
168946,.,1,0
168947,METHODS,0,0
168948,This,0,0
168949,was,0,0
168950,a,0,0
168951,cohort,0,1
168952,study,0,0
168953,nested,0,1
168954,in,0,0
168955,a,0,0
168956,randomized,0,0
168957,field,0,0
168958,trial,0,0
168959,.,0,0
168960,Data,0,0
168961,collection,0,0
168962,was,0,0
168963,performed,0,0
168964,through,0,0
168965,structured,0,0
168966,questionnaires,0,0
168967,to,0,0
168968,obtain,0,0
168969,demographic,0,0
168970,and,0,0
168971,dietary,0,0
168972,data,0,0
168973,",",0,0
168974,combined,0,0
168975,with,0,1
168976,two,0,0
168977,24-hour,0,1
168978,recalls,0,0
168979,in,1,0
168980,the,1,0
168981,age,1,1
168982,groups,1,0
168983,12-16,1,1
168984,months,1,0
168985,and,1,0
168986,again,1,0
168987,at,1,0
168988,2-3,1,0
168989,years,1,1
168990,of,1,1
168991,age,1,1
168992,.,1,1
168993,Data,0,0
168994,on,0,0
168995,the,0,0
168996,consumption,0,0
168997,of,0,0
168998,one,0,1
168999,daily,0,0
169000,serving,0,1
169001,of,0,0
169002,fruits,0,1
169003,(,0,1
169004,80,0,1
169005,g,0,1
169006,),0,0
169007,and,0,0
169008,vegetables,0,0
169009,(,0,1
169010,60,0,1
169011,g,0,1
169012,),0,0
169013,were,0,0
169014,evaluated,0,0
169015,",",0,0
169016,as,0,0
169017,well,0,0
169018,as,0,0
169019,consumption,0,0
169020,of,0,0
169021,non-recommended,0,1
169022,foods,0,0
169023,such,0,0
169024,as,0,0
169025,candy,0,0
169026,",",0,0
169027,chocolate,0,0
169028,",",0,0
169029,and,0,0
169030,soft,0,1
169031,drinks,0,0
169032,.,0,1
169033,Statistical,0,0
169034,analyses,0,0
169035,were,0,1
169036,performed,0,0
169037,using,0,0
169038,Poisson,0,0
169039,regression,0,0
169040,with,0,1
169041,robust,0,0
169042,estimation,0,0
169043,.,0,0
169044,RESULTS,0,0
169045,A,1,0
169046,total,1,1
169047,of,1,0
169048,388,1,1
169049,children,1,1
169050,aged,1,1
169051,2-3,1,1
169052,years,1,1
169053,were,1,1
169054,evaluated,1,0
169055,;,1,0
169056,of,0,0
169057,these,0,0
169058,",",0,0
169059,58,0,1
169060,%,0,0
169061,and,0,0
169062,87.4,0,0
169063,%,0,0
169064,did,0,0
169065,not,0,0
169066,consume,0,1
169067,one,0,0
169068,daily,0,0
169069,serving,0,1
169070,of,0,0
169071,fruits,0,1
169072,and,0,1
169073,vegetables,0,0
169074,",",0,0
169075,respectively,0,0
169076,.,0,0
169077,The,0,0
169078,following,0,0
169079,factors,0,0
169080,were,0,1
169081,negatively,0,0
169082,associated,0,0
169083,with,0,0
169084,fruit,0,1
169085,consumption,0,0
169086,:,0,1
169087,family,0,0
169088,income,0,0
169089,higher,0,0
169090,than,0,0
169091,four,0,0
169092,minimum,0,1
169093,wages,0,0
169094,",",0,0
169095,(,0,0
169096,p=0.024,0,0
169097,),0,0
169098,",",0,0
169099,lower,0,0
169100,paternal,0,1
169101,educational,0,0
169102,level,0,0
169103,(,0,0
169104,p=0.03,0,0
169105,),0,0
169106,",",0,0
169107,and,0,0
169108,lower,0,0
169109,fruit,0,0
169110,consumption,0,0
169111,at,0,0
169112,12-16,0,1
169113,months,0,0
169114,(,0,1
169115,p=0.002,0,0
169116,),0,0
169117,.,0,0
169118,Factors,0,0
169119,negatively,0,0
169120,associated,0,0
169121,with,0,0
169122,the,0,0
169123,consumption,0,0
169124,of,0,0
169125,vegetables,0,0
169126,were,0,1
169127,low,0,1
169128,paternal,0,1
169129,educational,0,1
169130,level,0,0
169131,(,0,0
169132,p=0.033,0,0
169133,),0,0
169134,and,0,0
169135,consumption,0,0
169136,of,0,0
169137,high-sugar,0,0
169138,content,0,0
169139,beverages,0,0
169140,at,0,1
169141,12-16,0,1
169142,months,0,0
169143,(,0,1
169144,p=0.014,0,0
169145,),0,0
169146,.,0,0
169147,CONCLUSION,0,0
169148,This,0,0
169149,study,0,0
169150,demonstrated,0,0
169151,a,0,0
169152,high,0,0
169153,prevalence,0,1
169154,of,0,1
169155,children,0,1
169156,who,0,1
169157,consumed,0,1
169158,less,0,1
169159,than,0,0
169160,one,0,0
169161,daily,0,0
169162,serving,0,1
169163,of,0,0
169164,fruit,0,1
169165,and,0,1
169166,vegetables,0,0
169167,;,0,1
169168,early,0,1
169169,feeding,0,0
169170,practices,0,1
169171,",",0,0
169172,parental,0,0
169173,education,0,0
169174,",",0,0
169175,and,0,0
169176,family,0,1
169177,income,0,0
169178,were,0,0
169179,associated,0,0
169180,with,0,1
169181,this,0,0
169182,process,0,0
169183,.,0,0
169184,Multicenter,0,1
169185,randomized,0,1
169186,phase,0,1
169187,2,0,0
169188,clinical,0,0
169189,trial,0,0
169190,of,0,0
169191,a,0,0
169192,recombinant,0,0
169193,human,0,0
169194,endostatin,0,0
169195,adenovirus,0,0
169196,in,0,0
169197,patients,1,1
169198,with,1,1
169199,advanced,1,1
169200,head,1,1
169201,and,1,0
169202,neck,1,1
169203,carcinoma,1,1
169204,.,1,0
169205,A,0,0
169206,randomized,0,0
169207,",",0,0
169208,open-label,0,0
169209,",",0,0
169210,phase,0,1
169211,2,0,0
169212,",",0,0
169213,multicenter,0,0
169214,clinical,0,0
169215,trial,0,0
169216,was,0,0
169217,conducted,0,0
169218,to,0,0
169219,evaluate,0,0
169220,the,0,0
169221,efficacy,0,0
169222,and,0,0
169223,safety,0,0
169224,of,0,0
169225,the,0,0
169226,addition,0,0
169227,of,0,0
169228,a,0,0
169229,recombinant,0,0
169230,human,0,0
169231,endostatin,0,0
169232,adenovirus,0,0
169233,(,0,0
169234,E10A,0,0
169235,),0,0
169236,to,0,0
169237,cisplatin,0,0
169238,and,0,0
169239,paclitaxel,0,0
169240,in,0,0
169241,patients,1,1
169242,with,1,1
169243,advanced,1,1
169244,head,1,1
169245,and,1,0
169246,neck,1,1
169247,squamous,1,1
169248,cell,1,1
169249,carcinoma,1,1
169250,or,1,1
169251,nasopharyngeal,1,1
169252,carcinoma,1,1
169253,.,1,1
169254,Patients,1,1
169255,with,1,1
169256,locally,1,1
169257,advanced,1,1
169258,or,1,0
169259,metastatic,1,1
169260,head,1,1
169261,and,1,0
169262,neck,1,1
169263,squamous,1,1
169264,cell,1,1
169265,carcinoma,1,1
169266,or,1,1
169267,nasopharyngeal,1,1
169268,carcinoma,1,1
169269,not,1,0
169270,suitable,1,0
169271,for,1,0
169272,operation,1,0
169273,or,1,1
169274,radiotherapy,1,1
169275,were,0,0
169276,randomly,0,1
169277,assigned,0,0
169278,to,0,0
169279,receive,0,0
169280,E10A,0,0
169281,plus,0,0
169282,chemotherapy,0,0
169283,every,0,0
169284,3,0,0
169285,weeks,0,0
169286,for,0,0
169287,a,0,0
169288,maximum,0,0
169289,of,0,0
169290,six,0,1
169291,cycles,0,0
169292,or,0,1
169293,to,0,0
169294,receive,0,0
169295,chemotherapy,0,0
169296,only,0,0
169297,.,0,1
169298,One,1,0
169299,hundred,1,1
169300,and,1,1
169301,thirty-six,1,1
169302,eligible,1,1
169303,patients,1,1
169304,were,1,1
169305,randomly,1,1
169306,assigned,1,0
169307,.,1,0
169308,The,0,0
169309,addition,0,0
169310,of,0,0
169311,E10A,0,0
169312,did,0,0
169313,not,0,0
169314,significantly,0,0
169315,improve,0,0
169316,the,0,0
169317,objective,0,0
169318,response,0,0
169319,rate,0,0
169320,(,0,0
169321,29.9,0,0
169322,versus,0,0
169323,39.7,0,0
169324,%,0,0
169325,",",0,0
169326,P,0,0
169327,=,0,0
169328,0.154,0,0
169329,),0,0
169330,.,0,0
169331,However,0,0
169332,",",0,0
169333,patients,0,1
169334,who,0,1
169335,received,0,1
169336,endostatin,0,0
169337,had,0,0
169338,longer,0,0
169339,progression-free,0,0
169340,survival,0,0
169341,(,0,0
169342,7.03,0,0
169343,versus,0,0
169344,3.60,0,0
169345,months,0,0
169346,",",0,1
169347,P,0,0
169348,=,0,0
169349,0.006,0,0
169350,;,0,0
169351,hazard,0,0
169352,ratio,0,0
169353,:,0,1
169354,0.55,0,0
169355,),0,0
169356,.,0,0
169357,The,0,0
169358,combination,0,0
169359,of,0,0
169360,E10A,0,0
169361,with,0,1
169362,chemotherapy,0,0
169363,benefited,0,0
169364,prior,0,1
169365,chemotherapy-treated,0,1
169366,patients,0,1
169367,and,0,1
169368,those,0,1
169369,who,0,1
169370,received,0,1
169371,three,0,1
169372,to,0,0
169373,four,0,1
169374,treatment,0,0
169375,cycles,0,0
169376,(,0,1
169377,6.50,0,0
169378,versus,0,0
169379,3.43,0,0
169380,months,0,0
169381,",",0,1
169382,P,0,0
169383,=,0,0
169384,0.003,0,0
169385,;,0,0
169386,8.27,0,1
169387,versus,0,0
169388,4.27,0,0
169389,months,0,0
169390,",",0,1
169391,P,0,0
169392,=,0,0
169393,0.018,0,0
169394,;,0,0
169395,respectively,0,0
169396,),0,0
169397,.,0,0
169398,The,0,0
169399,overall,0,0
169400,disease,0,1
169401,control,0,0
169402,rate,0,0
169403,significantly,0,0
169404,increased,0,0
169405,from,0,0
169406,80.6,0,0
169407,%,0,0
169408,in,0,0
169409,the,0,0
169410,control,0,0
169411,group,0,0
169412,to,0,0
169413,92.6,0,0
169414,%,0,0
169415,in,0,0
169416,the,0,0
169417,test,0,0
169418,group,0,0
169419,(,0,0
169420,P,0,0
169421,=,0,0
169422,0.034,0,0
169423,),0,0
169424,.,0,0
169425,Except,0,0
169426,for,0,0
169427,fever,0,0
169428,",",0,0
169429,no,0,0
169430,adverse,0,0
169431,events,0,0
169432,were,0,1
169433,associated,0,0
169434,with,0,1
169435,the,0,0
169436,E10A,0,0
169437,treatment,0,0
169438,.,0,0
169439,In,0,0
169440,summary,0,0
169441,",",0,0
169442,E10A,0,0
169443,plus,0,0
169444,chemotherapy,0,0
169445,is,0,0
169446,a,0,0
169447,safe,0,0
169448,and,0,0
169449,effective,0,0
169450,therapeutic,0,0
169451,approach,0,0
169452,in,0,0
169453,patients,1,1
169454,with,1,1
169455,advanced,1,1
169456,head,1,1
169457,and,1,0
169458,neck,1,1
169459,squamous,1,1
169460,cell,1,1
169461,carcinoma,1,1
169462,or,1,1
169463,nasopharyngeal,1,1
169464,carcinoma,1,1
169465,.,1,1
169466,Cobedding,0,1
169467,of,0,0
169468,twin,1,1
169469,premature,1,1
169470,infants,1,1
169471,:,1,1
169472,calming,0,1
169473,effects,0,0
169474,on,0,0
169475,pain,0,1
169476,responses,0,0
169477,.,0,1
169478,BACKGROUND,0,0
169479,The,0,0
169480,purpose,0,0
169481,of,0,0
169482,this,0,0
169483,trial,0,0
169484,was,0,0
169485,to,0,0
169486,determine,0,0
169487,whether,0,0
169488,cobedding,0,0
169489,of,0,0
169490,preterm,1,1
169491,twins,1,0
169492,has,0,0
169493,analgesic,0,0
169494,effects,0,0
169495,during,0,0
169496,heel,0,1
169497,lancing,0,0
169498,or,0,0
169499,not,0,0
169500,.,0,0
169501,METHODS,0,0
169502,One,1,1
169503,hundred,1,1
169504,premature,1,1
169505,twins,1,1
169506,(,1,1
169507,50,1,1
169508,sets,1,0
169509,),1,1
169510,born,1,1
169511,between,1,0
169512,26,1,1
169513,weeks,1,0
169514,',1,1
169515,and,1,1
169516,34,1,1
169517,weeks,1,0
169518,',1,1
169519,gestation,1,1
169520,undergoing,1,1
169521,heel,1,0
169522,blood,1,0
169523,sampling,1,0
169524,were,0,0
169525,randomly,0,1
169526,assigned,0,1
169527,into,0,0
169528,two,0,1
169529,groups,0,0
169530,:,0,1
169531,the,0,0
169532,cobedding,0,0
169533,group,0,0
169534,(,0,0
169535,receiving,0,0
169536,care,0,1
169537,in,0,0
169538,the,0,0
169539,same,0,0
169540,incubator,0,0
169541,),0,0
169542,and,0,0
169543,the,0,0
169544,standard,0,0
169545,care,0,0
169546,group,0,0
169547,(,0,0
169548,receiving,0,0
169549,care,0,1
169550,in,0,0
169551,separate,0,0
169552,incubators,0,1
169553,),0,1
169554,.,0,1
169555,Pain,0,0
169556,was,0,0
169557,assessed,0,0
169558,using,0,0
169559,the,0,0
169560,premature,0,1
169561,infant,0,0
169562,pain,0,0
169563,profile,0,0
169564,score,0,0
169565,.,0,0
169566,Duration,0,0
169567,of,0,0
169568,crying,0,0
169569,was,0,0
169570,measured,0,0
169571,after,0,0
169572,heel,0,0
169573,blood,0,0
169574,sampling,0,0
169575,",",0,0
169576,and,0,0
169577,salivary,0,1
169578,cortisol,0,0
169579,was,0,0
169580,measured,0,0
169581,prior,0,0
169582,to,0,0
169583,and,0,0
169584,after,0,0
169585,heel,0,0
169586,blood,0,0
169587,sampling,0,0
169588,.,0,1
169589,RESULTS,0,0
169590,Infants,0,1
169591,in,0,0
169592,the,0,0
169593,standard,0,0
169594,care,0,0
169595,group,0,0
169596,cried,0,0
169597,for,0,0
169598,a,0,0
169599,longer,0,0
169600,time,0,0
169601,during,0,0
169602,heel,0,0
169603,lancing,0,0
169604,than,0,0
169605,those,0,0
169606,in,0,0
169607,the,0,0
169608,cobedding,0,0
169609,group,0,0
169610,(,0,0
169611,42.6,0,0
169612,?,0,1
169613,19.8,0,0
169614,seconds,0,0
169615,vs.,0,0
169616,36.4,0,0
169617,?,0,1
169618,21.7,0,0
169619,seconds,0,0
169620,",",0,0
169621,p,0,0
169622,=,0,0
169623,0.03,0,0
169624,),0,0
169625,.,0,0
169626,The,0,0
169627,mean,0,0
169628,premature,0,1
169629,infant,0,1
169630,pain,0,0
169631,profile,0,0
169632,score,0,0
169633,after,0,0
169634,heel,0,1
169635,lancing,0,0
169636,was,0,0
169637,significantly,0,0
169638,higher,0,0
169639,in,0,0
169640,the,0,0
169641,standard,0,0
169642,care,0,0
169643,group,0,0
169644,(,0,0
169645,9.8,0,0
169646,?,0,0
169647,2.6,0,0
169648,vs.,0,0
169649,8.06,0,1
169650,?,0,1
169651,2.8,0,0
169652,",",0,0
169653,p,0,0
169654,=,0,0
169655,0.002,0,0
169656,),0,0
169657,.,0,0
169658,The,0,0
169659,mean,0,0
169660,salivary,0,1
169661,cortisol,0,0
169662,after,0,0
169663,heel,0,1
169664,lancing,0,0
169665,was,0,0
169666,also,0,0
169667,significantly,0,0
169668,higher,0,0
169669,in,0,0
169670,the,0,0
169671,standard,0,0
169672,care,0,0
169673,group,0,0
169674,(,0,0
169675,24.3,0,1
169676,?,0,1
169677,7.4,0,0
169678,nmol/L,0,0
169679,vs.,0,0
169680,20.8,0,0
169681,?,0,0
169682,7.4,0,0
169683,nmol/L,0,0
169684,",",0,0
169685,p,0,0
169686,=,0,0
169687,0.02,0,0
169688,),0,0
169689,.,0,0
169690,No,0,0
169691,significant,0,0
169692,adverse,0,0
169693,effects,0,0
169694,were,0,1
169695,seen,0,0
169696,with,0,1
169697,cobedding,0,0
169698,.,0,1
169699,CONCLUSION,0,0
169700,Cobedding,0,0
169701,is,0,0
169702,a,0,0
169703,comforting,0,0
169704,measure,1,0
169705,for,1,0
169706,twin,1,1
169707,premature,1,1
169708,infants,1,1
169709,during,1,0
169710,heel,0,1
169711,lancing,0,0
169712,",",0,0
169713,which,0,0
169714,can,0,0
169715,be,0,0
169716,performed,0,0
169717,without,0,0
169718,any,0,0
169719,significant,0,0
169720,adverse,0,0
169721,effects,0,0
169722,.,0,1
169723,Hemodialysis,1,1
169724,catheter,1,0
169725,design,1,0
169726,and,1,0
169727,catheter,1,0
169728,performance,1,0
169729,:,1,1
169730,a,0,0
169731,randomized,0,0
169732,controlled,0,0
169733,trial,0,0
169734,.,0,0
169735,BACKGROUND,0,0
169736,A,0,0
169737,complication,0,0
169738,of,0,0
169739,long-term,0,0
169740,use,0,0
169741,of,0,0
169742,tunneled,0,1
169743,cuffed,0,1
169744,catheters,0,0
169745,for,0,0
169746,hemodialysis,0,1
169747,is,0,0
169748,the,0,0
169749,high,0,0
169750,rate,0,0
169751,of,0,0
169752,infection,0,0
169753,and,0,0
169754,thrombus-related,0,0
169755,dysfunction,0,1
169756,.,0,1
169757,Specific,0,0
169758,mechanical,0,0
169759,features,0,1
169760,of,0,0
169761,tunneled,0,1
169762,cuffed,0,0
169763,catheters,0,0
169764,may,0,0
169765,improve,0,0
169766,hemodynamic,0,0
169767,performance,0,0
169768,and,0,0
169769,decrease,0,0
169770,thrombosis,0,0
169771,and,0,0
169772,infection,0,1
169773,rates,0,0
169774,.,0,0
169775,However,0,0
169776,",",0,0
169777,there,0,0
169778,currently,0,0
169779,is,0,0
169780,no,0,0
169781,proven,0,0
169782,advantage,0,0
169783,of,0,0
169784,one,0,0
169785,design,0,0
169786,over,0,0
169787,another,0,0
169788,.,0,0
169789,STUDY,0,0
169790,DESIGN,0,0
169791,Single-center,0,1
169792,randomized,0,1
169793,clinical,0,0
169794,trial,0,1
169795,.,0,1
169796,SETTING,0,1
169797,&,0,1
169798,PARTICIPANTS,0,0
169799,302,1,1
169800,hemodialysis,1,1
169801,patients,1,1
169802,who,1,1
169803,required,1,1
169804,a,1,1
169805,tunneled,1,0
169806,cuffed,1,0
169807,catheter,1,0
169808,as,1,0
169809,temporary,1,0
169810,or,1,1
169811,definite,1,1
169812,vascular,1,0
169813,access,1,0
169814,.,1,1
169815,INTERVENTION,0,0
169816,Palindrome,0,0
169817,Symmetric,0,1
169818,Tip,0,0
169819,Dialysis,0,1
169820,Catheter,0,0
169821,or,0,1
169822,HemoStar,0,1
169823,Long-Term,0,1
169824,Hemodialysis,0,1
169825,Catheter,0,0
169826,.,0,1
169827,OUTCOMES,0,0
169828,&,0,1
169829,MEASUREMENTS,0,0
169830,The,0,0
169831,primary,0,0
169832,end,0,0
169833,point,0,0
169834,was,0,0
169835,primary,0,1
169836,assisted,0,1
169837,patency,0,0
169838,.,0,1
169839,Secondary,0,0
169840,end,0,0
169841,points,0,0
169842,were,0,0
169843,incidence,0,0
169844,of,0,0
169845,catheter-related,0,0
169846,bloodstream,0,1
169847,infections,0,1
169848,(,0,1
169849,CRBSIs,0,1
169850,),0,0
169851,",",0,0
169852,thrombosis,0,0
169853,",",0,0
169854,and,0,0
169855,2,0,0
169856,indicators,0,0
169857,of,0,0
169858,rheologic,0,0
169859,function,0,0
169860,:,0,1
169861,mean,0,1
169862,effective,0,0
169863,blood,0,0
169864,flow,0,0
169865,rate,0,0
169866,and,0,0
169867,urokinase,0,0
169868,use,0,0
169869,.,0,1
169870,RESULTS,0,0
169871,Mean,0,1
169872,primary,0,1
169873,assisted,0,0
169874,patency,0,0
169875,was,0,0
169876,135.9,0,0
169877,days,0,0
169878,for,0,0
169879,Palindrome,0,1
169880,and,0,1
169881,136.5,0,0
169882,days,0,0
169883,for,0,0
169884,HemoStar,0,1
169885,(,0,1
169886,P=0.8,0,0
169887,),0,1
169888,.,0,1
169889,Definite,0,0
169890,CRBSI,0,0
169891,occurred,0,0
169892,in,0,0
169893,0.24,0,0
169894,and,0,1
169895,"0.10/1,000",0,0
169896,catheter-days,0,0
169897,for,0,0
169898,Palindrome,0,1
169899,and,0,0
169900,HemoStar,0,0
169901,",",0,0
169902,respectively,0,0
169903,(,0,0
169904,P=0.3,0,0
169905,),0,1
169906,.,0,1
169907,Removal,0,0
169908,rates,0,0
169909,for,0,0
169910,thrombosis,0,0
169911,that,0,0
169912,could,0,0
169913,not,0,0
169914,be,0,0
169915,resolved,0,0
169916,with,0,1
169917,thrombolysis,0,0
169918,were,0,1
169919,0.53,0,0
169920,and,0,1
169921,"0.43/1,000",0,1
169922,catheter-days,0,0
169923,for,0,0
169924,Palindrome,0,1
169925,and,0,0
169926,HemoStar,0,0
169927,",",0,0
169928,respectively,0,0
169929,(,0,0
169930,P=0.7,0,0
169931,),0,1
169932,.,0,0
169933,Urokinase,0,0
169934,use,0,0
169935,was,0,0
169936,lower,0,0
169937,for,0,0
169938,Palindrome,0,0
169939,than,0,0
169940,for,0,0
169941,HemoStar,0,0
169942,",",0,0
169943,as,0,0
169944,evidenced,0,0
169945,by,0,0
169946,a,0,0
169947,lower,0,0
169948,number,0,0
169949,of,0,0
169950,urokinase,0,0
169951,"infusions/1,000",0,0
169952,catheter-days,0,0
169953,(,0,1
169954,17,0,1
169955,and,0,1
169956,35,0,1
169957,;,0,1
169958,P,0,0
169959,<,0,0
169960,0.001,0,0
169961,),0,0
169962,and,0,0
169963,higher,0,0
169964,number,0,0
169965,of,0,0
169966,catheters,0,0
169967,that,0,0
169968,never,0,1
169969,required,0,0
169970,thrombolysis,0,0
169971,(,0,0
169972,58,0,1
169973,%,0,0
169974,and,0,0
169975,45,0,1
169976,%,0,0
169977,;,0,1
169978,P=0.03,0,0
169979,),0,0
169980,.,0,1
169981,Mean,0,0
169982,effective,0,0
169983,blood,0,0
169984,flow,0,0
169985,rate,0,0
169986,was,0,0
169987,higher,0,0
169988,for,0,0
169989,Palindrome,0,0
169990,than,0,0
169991,for,0,0
169992,HemoStar,0,1
169993,(,0,1
169994,333,0,1
169995,and,0,1
169996,304mL/min,0,1
169997,;,0,1
169998,P,0,0
169999,<,0,0
170000,0.001,0,0
170001,),0,1
170002,.,0,1
170003,LIMITATIONS,0,0
170004,Single-center,0,1
170005,nonblinded,0,1
170006,trial,0,0
170007,.,0,1
170008,CONCLUSIONS,0,0
170009,Primary,0,1
170010,assisted,0,0
170011,patency,0,0
170012,and,0,0
170013,incidence,0,0
170014,of,0,0
170015,infection,0,0
170016,and,0,0
170017,thrombosis,0,0
170018,were,0,0
170019,similar,0,0
170020,for,0,0
170021,both,0,0
170022,catheter,0,0
170023,types,0,0
170024,.,0,1
170025,The,0,0
170026,Palindrome,0,0
170027,catheter,0,0
170028,required,0,0
170029,less,0,0
170030,thrombolysis,0,0
170031,and,0,0
170032,achieved,0,0
170033,higher,0,0
170034,blood,0,0
170035,flow,0,0
170036,rates,0,0
170037,than,0,0
170038,the,0,0
170039,HemoStar,0,0
170040,catheter,0,0
170041,.,0,0
170042,These,0,0
170043,findings,0,0
170044,suggest,0,0
170045,that,0,0
170046,mechanical,0,0
170047,catheter,0,0
170048,design,0,0
170049,may,0,0
170050,improve,0,0
170051,catheter,0,0
170052,rheology,0,0
170053,",",0,0
170054,but,0,0
170055,does,0,0
170056,not,0,0
170057,affect,0,0
170058,risks,0,0
170059,for,0,0
170060,thrombosis,0,1
170061,and,0,0
170062,infection,0,0
170063,and,0,0
170064,hence,0,0
170065,catheter,0,0
170066,survival,0,0
170067,.,0,1
170068,Assessment,0,0
170069,of,0,0
170070,acute,0,1
170071,bronchodilator,0,0
170072,effects,0,0
170073,from,0,1
170074,specific,0,0
170075,airway,0,1
170076,resistance,0,0
170077,changes,0,0
170078,in,0,0
170079,stable,1,1
170080,COPD,1,1
170081,patients,1,1
170082,.,1,1
170083,BACKGROUND,0,0
170084,In,1,0
170085,COPD,1,1
170086,patients,1,1
170087,",",0,0
170088,reversibility,0,0
170089,is,0,0
170090,currently,0,0
170091,evaluated,0,0
170092,from,0,0
170093,the,0,0
170094,changes,0,0
170095,of,0,0
170096,forced,0,1
170097,expiratory,0,0
170098,volume,0,0
170099,at,0,0
170100,1s,0,0
170101,(,0,0
170102,?FEV1,0,1
170103,),0,0
170104,and,0,0
170105,forced,0,1
170106,vital,0,0
170107,capacity,0,0
170108,(,0,0
170109,?FVC,0,0
170110,),0,0
170111,.,0,0
170112,By,0,0
170113,lowering,0,0
170114,peripheral,0,0
170115,airway,0,1
170116,smooth,0,1
170117,muscle,0,0
170118,tone,0,0
170119,",",0,0
170120,bronchodilators,0,0
170121,should,0,0
170122,decrease,0,0
170123,dynamic,0,0
170124,hyperinflation,0,0
170125,",",0,0
170126,gas,0,0
170127,trapping,0,0
170128,",",0,0
170129,and,0,0
170130,possibly,0,0
170131,dyspnea,0,0
170132,at,0,0
170133,rest,0,0
170134,.,0,0
170135,Hence,0,0
170136,",",0,0
170137,we,0,0
170138,hypothesize,0,0
170139,that,0,0
170140,specific,0,0
170141,airway,0,1
170142,resistance,0,0
170143,changes,0,0
170144,(,0,0
170145,?sRAW,0,0
170146,),0,0
170147,should,0,0
170148,better,0,0
170149,characterize,0,0
170150,the,0,0
170151,acute,0,1
170152,response,0,0
170153,to,0,1
170154,bronchodilators,0,0
170155,.,0,1
170156,METHODS,0,0
170157,On,0,0
170158,two,0,0
170159,days,1,0
170160,",",1,1
170161,60,1,1
170162,COPD,1,1
170163,patients,1,1
170164,underwent,1,1
170165,dyspnea,0,0
170166,evaluation,0,0
170167,(,0,0
170168,VAS,0,1
170169,score,0,0
170170,),0,0
170171,and,0,0
170172,pulmonary,0,1
170173,function,0,0
170174,testing,0,0
170175,at,0,0
170176,baseline,0,0
170177,and,0,0
170178,one,0,0
170179,hour,0,0
170180,after,0,0
170181,placebo,0,0
170182,or,0,1
170183,300?g,0,0
170184,indacaterol,0,0
170185,administration,0,0
170186,.,0,1
170187,RESULTS,0,0
170188,Spirographic,0,1
170189,and,0,0
170190,?sRAW-based,0,1
170191,criteria,0,1
170192,identified,0,1
170193,as,0,0
170194,responders,0,0
170195,24,0,1
170196,and,0,1
170197,45,0,1
170198,patients,0,1
170199,",",0,0
170200,respectively,0,0
170201,.,0,0
170202,?sRAW,0,0
170203,correlated,0,0
170204,with,0,1
170205,changes,0,0
170206,of,0,0
170207,intrathoracic,0,1
170208,gas,0,1
170209,volume,0,0
170210,(,0,0
170211,?ITGV,0,1
170212,),0,0
170213,(,0,0
170214,r=0.61,0,0
170215,;,0,0
170216,p,0,0
170217,<,0,0
170218,0.001,0,0
170219,),0,0
170220,",",0,0
170221,residual,0,0
170222,volume,0,0
170223,(,0,0
170224,?RV,0,0
170225,),0,0
170226,(,0,0
170227,r=0.60,0,0
170228,;,0,0
170229,p,0,0
170230,<,0,0
170231,0.001,0,0
170232,),0,0
170233,",",0,0
170234,?FVC,0,0
170235,(,0,0
170236,r=0.44,0,0
170237,;,0,0
170238,p=0.001,0,0
170239,),0,0
170240,",",0,0
170241,and,0,0
170242,?VAS,0,1
170243,(,0,0
170244,r=0.73,0,0
170245,;,0,0
170246,p,0,0
170247,<,0,0
170248,0.001,0,0
170249,),0,0
170250,",",0,0
170251,while,0,0
170252,?FEV1,0,0
170253,correlated,0,0
170254,only,0,0
170255,with,0,1
170256,?FVC,0,0
170257,(,0,1
170258,r=0.34,0,0
170259,;,0,0
170260,p=0.008,0,0
170261,),0,0
170262,.,0,1
170263,Significant,0,0
170264,differences,0,0
170265,in,0,1
170266,terms,0,0
170267,of,0,0
170268,?ITGV,0,1
170269,(,0,0
170270,p=0.002,0,0
170271,),0,0
170272,",",0,0
170273,?RV,0,0
170274,(,0,0
170275,p=0.023,0,0
170276,),0,0
170277,",",0,0
170278,and,0,0
170279,?VAS,0,1
170280,(,0,0
170281,p,0,0
170282,<,0,0
170283,0.001,0,0
170284,),0,0
170285,occurred,0,0
170286,only,0,0
170287,if,0,0
170288,patients,0,1
170289,were,0,1
170290,stratified,0,1
170291,according,0,1
170292,to,0,0
170293,?sRAW,0,0
170294,.,0,0
170295,CONCLUSIONS,0,0
170296,In,0,0
170297,assessing,0,0
170298,the,0,0
170299,acute,0,1
170300,functional,0,0
170301,effect,0,0
170302,of,0,0
170303,bronchodilators,0,0
170304,",",0,0
170305,?sRAW-based,0,0
170306,criterion,0,0
170307,is,0,0
170308,preferable,0,0
170309,to,0,0
170310,FEV1-FVC-based,0,0
170311,criteria,0,1
170312,",",0,0
170313,being,0,0
170314,more,0,0
170315,closely,0,0
170316,related,0,0
170317,to,0,0
170318,bronchodilator-induced,0,0
170319,improvements,0,0
170320,of,0,0
170321,lung,0,1
170322,mechanics,0,1
170323,and,0,0
170324,dyspnea,0,0
170325,at,0,0
170326,rest,0,0
170327,.,0,1
170328,Association,0,0
170329,study,0,0
170330,of,0,0
170331,the,0,0
170332,let-7,0,0
170333,miRNA-complementary,0,0
170334,site,0,0
170335,variant,0,1
170336,in,0,0
170337,the,0,0
170338,3,0,0
170339,',0,1
170340,untranslated,0,0
170341,region,0,1
170342,of,0,0
170343,the,0,0
170344,KRAS,0,0
170345,gene,0,0
170346,in,0,0
170347,stage,1,1
170348,III,1,1
170349,colon,1,1
170350,cancer,1,1
170351,(,1,0
170352,NCCTG,1,0
170353,N0147,1,1
170354,Clinical,1,0
170355,Trial,1,1
170356,),1,0
170357,.,1,0
170358,PURPOSE,0,0
170359,A,0,0
170360,let-7,0,0
170361,microRNA-complementary,0,0
170362,site,0,0
170363,(,0,0
170364,LCS6,0,0
170365,),0,0
170366,polymorphism,0,0
170367,in,0,0
170368,the,0,0
170369,3,0,0
170370,',0,1
170371,untranslated,0,0
170372,region,0,1
170373,of,0,0
170374,the,0,0
170375,KRAS,0,0
170376,gene,0,0
170377,has,0,0
170378,been,0,0
170379,shown,0,0
170380,to,0,0
170381,disrupt,0,0
170382,let-7,0,0
170383,binding,0,0
170384,and,0,0
170385,upregulate,0,0
170386,KRAS,0,1
170387,expression,0,0
170388,.,0,0
170389,We,0,0
170390,evaluated,0,0
170391,the,0,0
170392,LCS6,0,0
170393,genotype,0,0
170394,and,0,0
170395,its,0,0
170396,association,0,0
170397,with,0,1
170398,KRAS,0,1
170399,mutation,0,1
170400,status,0,0
170401,",",0,0
170402,clinicopathologic,0,1
170403,features,0,0
170404,",",0,0
170405,and,0,0
170406,disease-free,0,0
170407,survival,0,0
170408,(,0,0
170409,DFS,0,1
170410,),0,0
170411,in,0,0
170412,patients,1,1
170413,with,1,1
170414,stage,1,1
170415,III,1,1
170416,colon,1,1
170417,cancer,1,1
170418,who,1,1
170419,enrolled,1,1
170420,in,1,1
170421,a,1,0
170422,phase,1,1
170423,III,1,1
170424,clinical,1,0
170425,trial,1,0
170426,(,1,0
170427,NCCTG,1,0
170428,N0147,1,1
170429,),1,1
170430,.,1,1
170431,EXPERIMENTAL,0,0
170432,DESIGN,0,0
170433,The,0,0
170434,LCS6,0,0
170435,genotype,0,0
170436,was,0,0
170437,assayed,0,0
170438,by,0,0
170439,real-time,0,0
170440,PCR,0,0
170441,in,0,0
170442,DNA,0,0
170443,extracted,0,1
170444,from,0,0
170445,whole,0,0
170446,blood,0,0
170447,(,0,0
170448,n,0,1
170449,=,0,0
170450,"2,834",0,1
170451,),0,0
170452,and,0,0
170453,compared,0,0
170454,with,0,1
170455,paired,0,0
170456,tumor,0,1
170457,tissue,0,0
170458,(,0,0
170459,n,0,1
170460,=,0,0
170461,977,0,1
170462,),0,1
170463,.,0,1
170464,?,0,0
170465,(,0,0
170466,2,0,0
170467,),0,0
170468,and,0,0
170469,two-sample,0,0
170470,t,0,0
170471,tests,0,0
170472,were,0,0
170473,used,0,0
170474,to,0,0
170475,compare,0,0
170476,baseline,0,0
170477,factors,0,0
170478,and,0,1
170479,KRAS,0,1
170480,mutation,0,1
170481,status,0,0
170482,between,1,0
170483,patients,1,1
170484,defined,1,1
170485,by,1,0
170486,LCS6,1,0
170487,variant,1,1
170488,status,1,0
170489,.,1,1
170490,Log-rank,0,0
170491,tests,0,0
170492,and,0,0
170493,multivariate,0,0
170494,Cox,0,0
170495,models,0,0
170496,assessed,0,0
170497,associations,0,0
170498,between,0,0
170499,LCS6,0,0
170500,status,0,1
170501,and,0,0
170502,DFS,0,1
170503,",",0,0
170504,respectively,0,0
170505,.,0,0
170506,RESULTS,0,0
170507,We,0,0
170508,identified,0,0
170509,432,0,1
170510,(,0,0
170511,15.2,0,0
170512,%,0,0
170513,),0,0
170514,blood,0,0
170515,samples,0,0
170516,and,0,0
170517,143,0,1
170518,(,0,0
170519,14.6,0,1
170520,%,0,0
170521,),0,0
170522,tumor,0,1
170523,samples,0,0
170524,heterozygous,0,1
170525,or,0,1
170526,homozygous,0,0
170527,for,0,0
170528,the,0,0
170529,LCS6,0,0
170530,G-allele,0,0
170531,",",0,0
170532,and,0,0
170533,"2,402",0,1
170534,of,0,0
170535,"2,834",0,1
170536,(,0,1
170537,84.8,0,0
170538,%,0,0
170539,),0,0
170540,blood,0,0
170541,samples,0,0
170542,and,0,0
170543,834,0,1
170544,of,0,0
170545,977,0,1
170546,(,0,1
170547,85.4,0,0
170548,%,0,0
170549,),0,0
170550,tumor,0,1
170551,samples,0,0
170552,homozygous,0,1
170553,for,0,0
170554,the,0,0
170555,LCS6,0,0
170556,T-allele,0,0
170557,.,0,1
170558,Genotype,0,1
170559,results,0,0
170560,were,0,0
170561,highly,0,0
170562,concordant,0,0
170563,(,0,0
170564,99.8,0,0
170565,%,0,0
170566,),0,0
170567,in,0,0
170568,cases,0,1
170569,with,0,1
170570,paired,0,0
170571,blood,0,0
170572,and,0,0
170573,tumor,0,0
170574,tissue,0,0
170575,(,0,0
170576,n,0,1
170577,=,0,0
170578,977,0,1
170579,),0,1
170580,.,0,1
170581,G-allele,0,0
170582,carriers,0,0
170583,were,0,0
170584,significantly,0,0
170585,more,0,0
170586,frequent,0,0
170587,in,1,0
170588,Caucasians,1,1
170589,versus,1,1
170590,other,1,1
170591,races,1,0
170592,(,0,1
170593,?,0,1
170594,(,0,0
170595,2,0,0
170596,),0,0
170597,test,0,0
170598,",",0,0
170599,P,0,0
170600,<,0,0
170601,0.0001,0,0
170602,),0,0
170603,.,0,0
170604,The,0,0
170605,LCS6,0,0
170606,genotype,0,0
170607,was,0,0
170608,not,0,0
170609,associated,0,0
170610,with,0,1
170611,KRAS,0,1
170612,mutation,0,1
170613,status,0,0
170614,",",0,0
170615,clinicopathologic,0,1
170616,features,0,0
170617,(,0,0
170618,all,0,1
170619,P,0,0
170620,>,0,1
170621,0.2,0,0
170622,),0,0
170623,",",0,0
170624,or,0,0
170625,DFS,0,1
170626,(,0,0
170627,log-rank,0,0
170628,P,0,0
170629,=,0,1
170630,0.49,0,0
170631,;,0,0
170632,HR,0,0
170633,",",0,0
170634,0.929,0,0
170635,;,0,0
170636,95,0,0
170637,%,0,0
170638,confidence,0,0
170639,interval,0,0
170640,",",0,0
170641,0.76-1.14,0,0
170642,),0,0
170643,",",0,0
170644,even,0,0
170645,after,0,0
170646,combining,0,0
170647,LCS6,0,0
170648,genotype,0,0
170649,with,0,1
170650,KRAS,0,1
170651,mutation,0,1
170652,status,0,1
170653,.,0,0
170654,CONCLUSIONS,0,0
170655,In,0,0
170656,the,0,0
170657,largest,0,0
170658,association,0,0
170659,study,0,0
170660,investigating,0,0
170661,the,0,0
170662,LCS6,0,0
170663,polymorphism,0,0
170664,in,0,0
170665,colon,0,1
170666,cancers,0,1
170667,",",0,0
170668,the,0,0
170669,germline,0,1
170670,LCS6,0,0
170671,genotype,0,0
170672,was,0,0
170673,not,0,0
170674,associated,0,0
170675,with,0,1
170676,KRAS,0,1
170677,mutation,0,1
170678,status,0,0
170679,or,0,0
170680,with,0,1
170681,clinical,0,0
170682,outcome,0,0
170683,in,0,0
170684,patients,1,1
170685,with,1,1
170686,stage,1,1
170687,III,1,1
170688,tumors,1,1
170689,.,1,1
170690,Evidence-based,0,1
170691,narratives,0,0
170692,to,0,0
170693,improve,0,0
170694,recall,0,0
170695,of,0,0
170696,opioid,0,1
170697,prescribing,0,1
170698,guidelines,0,0
170699,:,0,1
170700,a,0,0
170701,randomized,0,0
170702,experiment,0,0
170703,.,0,1
170704,OBJECTIVES,0,0
170705,Physicians,0,1
170706,adopt,0,1
170707,evidence-based,0,0
170708,guidelines,0,0
170709,with,0,1
170710,variable,0,1
170711,consistency,0,0
170712,.,0,1
170713,Narratives,0,0
170714,",",0,0
170715,or,0,1
170716,stories,0,0
170717,",",0,0
170718,offer,0,0
170719,a,0,0
170720,novel,0,0
170721,dissemination,0,0
170722,strategy,0,0
170723,for,0,0
170724,clinical,0,0
170725,recommendations,0,0
170726,.,0,1
170727,The,0,0
170728,study,0,0
170729,objective,0,0
170730,was,0,0
170731,to,0,0
170732,compare,0,0
170733,whether,0,0
170734,evidence-based,0,0
170735,narrative,0,0
170736,versus,0,0
170737,traditional,0,1
170738,summary,0,0
170739,improved,0,0
170740,recall,0,0
170741,of,0,0
170742,opioid,0,1
170743,prescribing,0,1
170744,guidelines,0,0
170745,from,0,1
170746,the,0,0
170747,American,0,1
170748,College,0,1
170749,of,0,0
170750,Emergency,0,1
170751,Physicians,0,1
170752,(,0,0
170753,ACEP,0,1
170754,),0,1
170755,.,0,0
170756,METHODS,0,0
170757,This,0,0
170758,was,0,0
170759,a,0,0
170760,prospective,0,0
170761,",",0,0
170762,randomized,0,0
170763,controlled,0,0
170764,experiment,0,0
170765,to,0,0
170766,compare,0,0
170767,whether,0,0
170768,narrative,0,0
170769,versus,0,0
170770,summary,0,0
170771,promoted,0,0
170772,short-term,0,0
170773,recall,0,0
170774,of,0,0
170775,six,0,1
170776,themes,0,0
170777,contained,0,0
170778,in,0,0
170779,the,0,0
170780,ACEP,0,1
170781,opioid,0,1
170782,guideline,0,0
170783,.,0,0
170784,The,0,0
170785,experiment,0,0
170786,was,0,0
170787,modeled,0,0
170788,after,0,0
170789,the,0,0
170790,free-recall,0,0
170791,test,0,0
170792,",",0,0
170793,an,0,0
170794,established,0,0
170795,technique,0,0
170796,in,0,0
170797,studies,0,0
170798,of,0,0
170799,memory,0,0
170800,.,0,0
170801,At,0,0
170802,a,0,0
170803,regional,0,0
170804,conference,0,0
170805,",",0,0
170806,emergency,1,1
170807,physicians,1,1
170808,(,1,1
170809,EPs,1,1
170810,),1,0
170811,were,0,0
170812,randomized,0,0
170813,to,0,0
170814,read,0,0
170815,either,0,0
170816,a,0,0
170817,summary,0,0
170818,of,0,0
170819,the,0,0
170820,guideline,0,0
170821,(,0,0
170822,control,0,0
170823,),0,0
170824,or,0,0
170825,a,0,0
170826,narrative,0,0
170827,(,0,0
170828,intervention,0,0
170829,),0,0
170830,.,0,0
170831,The,0,0
170832,fictional,0,0
170833,narrative,0,0
170834,was,0,0
170835,constructed,0,0
170836,to,0,0
170837,match,0,0
170838,the,0,0
170839,summary,0,0
170840,in,0,0
170841,content,0,0
170842,and,0,0
170843,length,0,0
170844,.,0,0
170845,One,0,0
170846,hour,0,0
170847,after,0,0
170848,reading,0,0
170849,the,0,0
170850,text,0,0
170851,",",0,0
170852,participants,0,1
170853,listed,0,1
170854,all,0,0
170855,content,0,0
170856,that,0,0
170857,they,0,0
170858,could,0,0
170859,recall,0,0
170860,.,0,0
170861,Two,0,0
170862,reviewers,0,0
170863,independently,0,1
170864,scored,0,0
170865,the,0,0
170866,responses,0,0
170867,to,0,0
170868,assess,0,0
170869,recall,0,0
170870,of,0,0
170871,the,0,0
170872,six,0,1
170873,themes,0,0
170874,.,0,1
170875,The,0,0
170876,primary,0,0
170877,outcome,0,0
170878,was,0,0
170879,the,0,0
170880,total,0,1
170881,number,0,0
170882,of,0,0
170883,themes,0,0
170884,recalled,0,0
170885,per,0,0
170886,participant,0,0
170887,.,0,1
170888,Secondary,0,0
170889,outcomes,0,0
170890,included,0,1
170891,the,0,0
170892,proportion,0,0
170893,of,0,0
170894,responses,0,0
170895,in,0,0
170896,each,0,0
170897,study,0,0
170898,arm,0,0
170899,that,0,0
170900,recalled,0,0
170901,individual,0,0
170902,themes,0,0
170903,and,0,0
170904,the,0,0
170905,proportion,0,0
170906,of,0,0
170907,responses,0,0
170908,in,0,0
170909,each,0,0
170910,arm,0,0
170911,that,0,0
170912,contained,0,0
170913,falsely,0,0
170914,recalled,0,0
170915,or,0,0
170916,extraneous,0,0
170917,information,0,0
170918,.,0,1
170919,RESULTS,0,0
170920,Ninety-five,1,1
170921,physicians,1,1
170922,were,1,1
170923,randomized,1,1
170924,.,1,1
170925,Eighty-two,1,1
170926,physicians,1,1
170927,completed,1,1
170928,the,1,0
170929,experiment,1,0
170930,",",1,0
170931,for,1,0
170932,a,1,0
170933,response,1,0
170934,rate,1,0
170935,of,1,0
170936,86,1,1
170937,%,1,0
170938,.,1,0
170939,The,0,0
170940,mean,0,0
170941,of,0,0
170942,the,0,0
170943,total,0,1
170944,number,0,0
170945,of,0,0
170946,themes,0,0
170947,recalled,0,0
170948,per,0,0
170949,participant,0,0
170950,was,0,0
170951,3.1,0,0
170952,in,0,0
170953,the,0,0
170954,narrative,0,0
170955,arm,0,0
170956,versus,0,0
170957,2.0,0,0
170958,in,0,0
170959,the,0,0
170960,summary,0,0
170961,arm,0,0
170962,(,0,0
170963,difference,0,0
170964,=,0,0
170965,1.1,0,0
170966,",",0,0
170967,95,0,0
170968,%,0,0
170969,confidence,0,0
170970,interval,0,0
170971,[,0,0
170972,CI,0,0
170973,],0,1
170974,=,0,0
170975,0.6,0,0
170976,to,0,0
170977,1.7,0,0
170978,),0,0
170979,.,0,1
170980,For,0,0
170981,three,0,0
170982,themes,0,0
170983,",",0,0
170984,the,0,0
170985,proportion,0,0
170986,of,0,0
170987,responses,0,0
170988,that,0,0
170989,recalled,0,0
170990,the,0,0
170991,theme,0,0
170992,was,0,0
170993,significantly,0,0
170994,greater,0,0
170995,in,0,0
170996,the,0,0
170997,narrative,0,0
170998,arm,0,0
170999,compared,0,0
171000,to,0,0
171001,the,0,0
171002,summary,0,0
171003,arm,0,0
171004,",",0,0
171005,with,0,1
171006,the,0,0
171007,differences,0,0
171008,ranging,0,1
171009,from,0,1
171010,20,0,1
171011,%,0,0
171012,to,0,0
171013,51,0,1
171014,%,0,0
171015,.,0,1
171016,For,0,0
171017,one,0,0
171018,theme,0,0
171019,",",0,0
171020,recall,0,0
171021,was,0,0
171022,significantly,0,0
171023,greater,0,0
171024,in,0,0
171025,the,0,0
171026,summary,0,0
171027,arm,0,0
171028,.,0,1
171029,For,0,0
171030,two,0,0
171031,themes,0,0
171032,",",0,0
171033,there,0,0
171034,was,0,0
171035,no,0,0
171036,statistically,0,0
171037,significant,0,0
171038,difference,0,0
171039,in,0,0
171040,recall,0,0
171041,between,0,0
171042,the,0,0
171043,arms,0,0
171044,.,0,0
171045,In,0,0
171046,the,0,0
171047,summary,0,0
171048,arm,0,0
171049,",",0,0
171050,54,0,1
171051,%,0,0
171052,of,0,0
171053,responses,0,0
171054,were,0,1
171055,found,0,0
171056,to,0,0
171057,contain,0,0
171058,falsely,0,0
171059,recalled,0,0
171060,or,0,0
171061,extraneous,0,0
171062,information,0,0
171063,versus,0,0
171064,21,0,1
171065,%,0,0
171066,of,0,0
171067,responses,0,0
171068,in,0,0
171069,the,0,0
171070,narrative,0,0
171071,arm,0,0
171072,(,0,0
171073,difference,0,0
171074,=,0,0
171075,33,0,0
171076,%,0,0
171077,",",0,0
171078,95,0,0
171079,%,0,0
171080,CI,0,0
171081,=,0,0
171082,14,0,0
171083,%,0,0
171084,to,0,0
171085,53,0,1
171086,%,0,0
171087,),0,1
171088,.,0,1
171089,CONCLUSIONS,0,0
171090,Physicians,1,1
171091,exposed,0,1
171092,to,0,1
171093,a,0,0
171094,narrative,0,0
171095,about,0,0
171096,opioid,0,1
171097,guidelines,0,0
171098,were,0,0
171099,more,0,0
171100,likely,0,0
171101,to,0,0
171102,recall,0,0
171103,guideline,0,0
171104,content,0,0
171105,at,0,0
171106,1,0,0
171107,hour,0,0
171108,than,0,0
171109,those,0,0
171110,exposed,0,0
171111,to,0,0
171112,a,0,0
171113,summary,0,0
171114,of,0,0
171115,the,0,0
171116,guidelines,0,0
171117,.,0,1
171118,Future,0,0
171119,studies,0,0
171120,should,0,0
171121,examine,0,0
171122,whether,0,0
171123,the,0,0
171124,incorporation,0,0
171125,of,0,0
171126,narratives,0,0
171127,in,0,0
171128,dissemination,0,0
171129,campaigns,0,0
171130,improves,0,0
171131,guideline,0,0
171132,adoption,0,0
171133,and,0,0
171134,changes,0,0
171135,clinical,0,0
171136,practice,0,0
171137,Sociopsychological,0,1
171138,tailoring,0,0
171139,to,0,0
171140,address,0,0
171141,colorectal,0,1
171142,cancer,0,1
171143,screening,0,1
171144,disparities,0,0
171145,:,0,1
171146,a,0,0
171147,randomized,0,0
171148,controlled,0,0
171149,trial,0,0
171150,.,0,1
171151,PURPOSE,0,0
171152,Interventions,0,0
171153,tailored,0,0
171154,to,0,0
171155,sociopsychological,0,1
171156,factors,0,0
171157,associated,0,0
171158,with,0,1
171159,health,0,1
171160,behaviors,0,0
171161,have,0,0
171162,promise,0,0
171163,for,0,0
171164,reducing,0,0
171165,colorectal,0,1
171166,cancer,0,1
171167,screening,0,1
171168,disparities,0,0
171169,",",0,0
171170,but,0,0
171171,limited,0,0
171172,research,0,0
171173,has,0,0
171174,assessed,0,0
171175,their,0,0
171176,impact,0,0
171177,in,0,0
171178,multiethnic,0,1
171179,populations,0,1
171180,.,0,1
171181,We,0,0
171182,examined,0,0
171183,whether,0,0
171184,an,0,0
171185,interactive,0,0
171186,multimedia,0,0
171187,computer,0,0
171188,program,0,0
171189,(,0,0
171190,IMCP,0,1
171191,),0,0
171192,tailored,0,0
171193,to,0,0
171194,expanded,0,0
171195,health,0,0
171196,belief,0,0
171197,model,0,0
171198,sociopsychological,0,1
171199,factors,0,0
171200,could,0,0
171201,promote,0,0
171202,colorectal,0,1
171203,cancer,0,1
171204,screening,0,1
171205,in,0,0
171206,a,0,0
171207,multiethnic,1,1
171208,sample,1,1
171209,.,1,1
171210,METHODS,0,0
171211,We,0,0
171212,undertook,0,0
171213,a,0,0
171214,randomized,0,0
171215,controlled,0,0
171216,trial,0,0
171217,",",0,0
171218,comparing,0,0
171219,an,0,0
171220,IMCP,0,1
171221,tailored,0,0
171222,to,0,0
171223,colorectal,0,1
171224,cancer,0,1
171225,screening,0,0
171226,self-efficacy,0,0
171227,",",0,0
171228,knowledge,0,0
171229,",",0,0
171230,barriers,0,0
171231,",",0,0
171232,readiness,0,0
171233,",",0,0
171234,test,0,0
171235,preference,0,0
171236,",",0,0
171237,and,0,0
171238,experiences,0,0
171239,with,0,1
171240,a,0,1
171241,nontailored,0,0
171242,informational,0,0
171243,program,0,0
171244,",",0,0
171245,both,0,0
171246,delivered,0,0
171247,before,0,0
171248,office,0,1
171249,visits,0,0
171250,.,0,1
171251,The,0,0
171252,primary,0,0
171253,outcome,0,0
171254,was,0,0
171255,record-documented,0,0
171256,colorectal,0,1
171257,cancer,0,1
171258,screening,0,1
171259,during,0,0
171260,a,0,0
171261,12-month,0,0
171262,follow-up,0,0
171263,period,0,1
171264,.,0,1
171265,Secondary,0,0
171266,outcomes,0,0
171267,included,0,1
171268,postvisit,0,0
171269,sociopsychological,0,1
171270,factor,0,0
171271,status,0,0
171272,and,0,0
171273,discussion,0,0
171274,",",0,0
171275,as,0,0
171276,well,0,0
171277,as,0,0
171278,clinician,0,0
171279,recommendation,0,0
171280,of,0,0
171281,screening,0,1
171282,during,0,0
171283,office,0,1
171284,visits,0,0
171285,.,0,1
171286,We,0,0
171287,enrolled,1,1
171288,"1,164",1,1
171289,patients,1,1
171290,stratified,1,1
171291,by,1,0
171292,ethnicity,1,1
171293,and,1,0
171294,language,1,0
171295,(,1,0
171296,49.3,1,0
171297,%,1,0
171298,non-Hispanic,1,1
171299,",",1,0
171300,27.2,1,0
171301,%,1,0
171302,Hispanic/English,1,1
171303,",",1,0
171304,23.4,1,0
171305,%,1,0
171306,Hispanic/Spanish,1,1
171307,),1,0
171308,from,1,1
171309,26,1,1
171310,offices,1,1
171311,around,1,1
171312,5,1,1
171313,centers,1,1
171314,(,1,1
171315,Sacramento,1,1
171316,",",1,0
171317,California,1,1
171318,;,1,0
171319,Rochester,1,1
171320,and,1,0
171321,the,1,0
171322,Bronx,1,0
171323,",",1,0
171324,New,1,1
171325,York,1,1
171326,;,1,0
171327,Denver,1,1
171328,",",1,0
171329,Colorado,1,1
171330,;,1,0
171331,and,1,0
171332,San,1,0
171333,Antonio,1,1
171334,",",1,0
171335,Texas,1,1
171336,),1,0
171337,.,1,1
171338,RESULTS,0,0
171339,Adjusting,0,0
171340,for,0,0
171341,ethnicity/language,0,1
171342,",",0,0
171343,study,0,0
171344,center,0,1
171345,",",0,0
171346,and,0,0
171347,the,0,0
171348,previsit,0,0
171349,value,0,0
171350,of,0,0
171351,the,0,0
171352,dependent,0,0
171353,variable,0,0
171354,",",0,0
171355,compared,0,0
171356,with,0,1
171357,control,0,0
171358,patients,0,1
171359,",",0,0
171360,the,0,0
171361,IMCP,0,0
171362,led,0,0
171363,to,0,0
171364,significantly,0,0
171365,greater,0,0
171366,colorectal,0,1
171367,cancer,0,1
171368,screening,0,0
171369,knowledge,0,0
171370,",",0,0
171371,self-efficacy,0,0
171372,",",0,0
171373,readiness,0,0
171374,",",0,0
171375,test,0,0
171376,preference,0,0
171377,specificity,0,0
171378,",",0,0
171379,discussion,0,0
171380,",",0,0
171381,and,0,0
171382,recommendation,0,0
171383,.,0,0
171384,During,0,0
171385,the,0,0
171386,followup,0,0
171387,period,0,0
171388,",",0,0
171389,132,0,1
171390,(,0,0
171391,23,0,1
171392,%,0,0
171393,),0,0
171394,IMCP,0,1
171395,and,0,0
171396,123,0,1
171397,(,0,0
171398,22,0,1
171399,%,0,0
171400,),0,0
171401,control,0,1
171402,patients,0,1
171403,received,0,0
171404,screening,0,1
171405,(,0,0
171406,adjusted,0,0
171407,difference,0,0
171408,=,0,0
171409,0.5,0,0
171410,percentage,0,0
171411,points,0,0
171412,",",0,0
171413,95,0,0
171414,%,0,0
171415,CI,0,0
171416,-4.3,0,0
171417,to,0,0
171418,5.3,0,0
171419,),0,0
171420,.,0,1
171421,IMCP,0,1
171422,effects,0,0
171423,did,0,0
171424,not,0,0
171425,differ,0,0
171426,significantly,0,0
171427,by,0,0
171428,ethnicity/language,0,1
171429,.,0,1
171430,CONCLUSIONS,0,0
171431,Sociopsychological,0,1
171432,factor,0,0
171433,tailoring,0,0
171434,was,0,0
171435,no,0,0
171436,more,0,0
171437,effective,0,0
171438,than,0,0
171439,nontailored,0,1
171440,information,0,0
171441,in,0,0
171442,encouraging,0,0
171443,colorectal,0,1
171444,cancer,0,1
171445,screening,0,1
171446,in,0,0
171447,a,0,0
171448,multiethnic,1,1
171449,sample,1,1
171450,",",0,0
171451,despite,0,0
171452,enhancing,0,0
171453,sociopsychological,0,1
171454,factors,0,0
171455,and,0,1
171456,visit,0,0
171457,behaviors,0,0
171458,associated,0,0
171459,with,0,1
171460,screening,0,1
171461,.,0,0
171462,The,0,0
171463,utility,0,0
171464,of,0,0
171465,sociopsychological,0,1
171466,tailoring,0,0
171467,in,0,0
171468,addressing,0,0
171469,screening,0,1
171470,disparities,0,0
171471,remains,0,1
171472,uncertain,0,0
171473,.,0,0
171474,Communication,0,0
171475,interventions,0,0
171476,for,0,0
171477,minimally,1,1
171478,verbal,1,0
171479,children,1,1
171480,with,1,1
171481,autism,1,1
171482,:,1,1
171483,a,0,0
171484,sequential,0,0
171485,multiple,0,0
171486,assignment,0,0
171487,randomized,0,1
171488,trial,0,0
171489,.,0,0
171490,OBJECTIVE,0,0
171491,This,0,0
171492,study,0,0
171493,tested,0,0
171494,the,0,0
171495,effect,0,0
171496,of,0,0
171497,beginning,0,0
171498,treatment,0,0
171499,with,0,1
171500,a,0,0
171501,speech-generating,0,0
171502,device,0,0
171503,(,0,0
171504,SGD,0,0
171505,),0,0
171506,in,0,0
171507,the,0,0
171508,context,0,0
171509,of,0,0
171510,a,0,0
171511,blended,0,0
171512,",",0,0
171513,adaptive,0,0
171514,treatment,0,0
171515,design,0,0
171516,for,0,0
171517,improving,0,0
171518,spontaneous,0,0
171519,",",0,0
171520,communicative,0,0
171521,utterances,0,0
171522,in,0,0
171523,school-aged,1,1
171524,",",1,0
171525,minimally,1,1
171526,verbal,1,0
171527,children,1,1
171528,with,1,1
171529,autism,1,1
171530,.,1,1
171531,METHOD,0,0
171532,A,1,0
171533,total,1,1
171534,of,1,0
171535,61,1,1
171536,minimally,1,1
171537,verbal,1,0
171538,children,1,1
171539,with,1,1
171540,autism,1,1
171541,",",1,0
171542,aged,1,1
171543,5,1,0
171544,to,1,1
171545,8,1,0
171546,years,1,1
171547,",",0,0
171548,were,0,0
171549,randomized,0,0
171550,to,0,0
171551,a,0,0
171552,blended,0,0
171553,developmental/behavioral,0,1
171554,intervention,0,0
171555,(,0,0
171556,JASP+EMT,0,0
171557,),0,0
171558,with,0,1
171559,or,0,1
171560,without,0,1
171561,the,0,0
171562,augmentation,0,0
171563,of,0,0
171564,a,0,0
171565,SGD,0,0
171566,for,0,0
171567,6,0,0
171568,months,0,0
171569,with,0,1
171570,a,0,0
171571,3-month,0,0
171572,follow-up,0,0
171573,.,0,0
171574,The,0,0
171575,intervention,0,0
171576,consisted,0,1
171577,of,0,0
171578,2,0,1
171579,stages,0,1
171580,.,0,1
171581,In,0,0
171582,stage,0,1
171583,1,0,0
171584,",",0,0
171585,all,0,0
171586,children,0,1
171587,received,0,1
171588,2,0,1
171589,sessions,0,0
171590,per,0,0
171591,week,0,0
171592,for,0,0
171593,3,0,0
171594,months,0,0
171595,.,0,1
171596,Stage,0,1
171597,2,0,0
171598,intervention,0,0
171599,was,0,0
171600,adapted,0,0
171601,(,0,0
171602,by,0,0
171603,increased,0,0
171604,sessions,0,0
171605,or,0,1
171606,adding,0,0
171607,the,0,0
171608,SGD,0,0
171609,),0,0
171610,based,0,0
171611,on,0,0
171612,the,0,0
171613,child,0,0
171614,'s,0,1
171615,early,0,0
171616,response,0,0
171617,.,0,0
171618,The,0,0
171619,primary,0,0
171620,outcome,0,0
171621,was,0,0
171622,the,0,0
171623,total,0,1
171624,number,0,0
171625,of,0,0
171626,spontaneous,0,1
171627,communicative,0,1
171628,utterances,0,1
171629,;,0,1
171630,secondary,0,1
171631,measures,0,0
171632,were,0,1
171633,the,0,0
171634,total,0,1
171635,number,0,0
171636,of,0,0
171637,novel,0,0
171638,words,0,0
171639,and,0,1
171640,total,0,1
171641,comments,0,0
171642,from,0,1
171643,a,0,0
171644,natural,0,0
171645,language,0,0
171646,sample,0,1
171647,.,0,1
171648,RESULTS,0,0
171649,Primary,0,1
171650,aim,0,0
171651,results,0,0
171652,found,0,0
171653,improvements,0,0
171654,in,0,1
171655,spontaneous,0,1
171656,communicative,0,1
171657,utterances,0,1
171658,",",0,1
171659,novel,0,0
171660,words,0,0
171661,",",0,0
171662,and,0,0
171663,comments,0,0
171664,that,0,0
171665,all,0,0
171666,favored,0,0
171667,the,0,0
171668,blended,0,0
171669,behavioral,0,0
171670,intervention,0,0
171671,that,0,0
171672,began,0,1
171673,by,0,0
171674,including,0,0
171675,an,0,0
171676,SGD,0,0
171677,(,0,0
171678,JASP+EMT+SGD,0,0
171679,),0,0
171680,as,0,0
171681,opposed,0,0
171682,to,0,0
171683,spoken,0,0
171684,words,0,0
171685,alone,0,0
171686,(,0,0
171687,JASP+EMT,0,0
171688,),0,1
171689,.,0,0
171690,Secondary,0,0
171691,aim,0,0
171692,results,0,0
171693,suggest,0,0
171694,that,0,0
171695,the,0,0
171696,adaptive,0,0
171697,intervention,0,0
171698,beginning,0,0
171699,with,0,1
171700,JASP+EMT+SGD,0,0
171701,and,0,0
171702,intensifying,0,0
171703,JASP+EMT+SGD,0,0
171704,for,0,1
171705,children,0,1
171706,who,0,1
171707,were,0,1
171708,slow,0,1
171709,responders,0,0
171710,led,0,0
171711,to,0,0
171712,better,0,0
171713,posttreatment,0,0
171714,outcomes,0,0
171715,.,0,1
171716,CONCLUSION,0,0
171717,Minimally,1,1
171718,verbal,1,0
171719,school-aged,1,1
171720,children,1,1
171721,can,0,0
171722,make,0,0
171723,significant,0,0
171724,and,0,0
171725,rapid,0,0
171726,gains,0,0
171727,in,0,1
171728,spoken,0,0
171729,spontaneous,0,0
171730,language,0,0
171731,with,0,1
171732,a,0,0
171733,novel,0,0
171734,",",0,0
171735,blended,0,0
171736,intervention,0,0
171737,that,0,0
171738,focuses,0,0
171739,on,0,0
171740,joint,0,0
171741,engagement,0,0
171742,and,0,0
171743,play,0,0
171744,skills,0,0
171745,and,0,0
171746,incorporates,0,0
171747,an,0,0
171748,SGD,0,0
171749,.,0,1
171750,Future,0,0
171751,studies,0,0
171752,should,0,0
171753,further,0,0
171754,explore,0,0
171755,the,0,0
171756,tailoring,0,0
171757,design,0,0
171758,used,0,0
171759,in,0,0
171760,this,0,0
171761,study,0,0
171762,to,0,0
171763,better,0,0
171764,understand,0,0
171765,children,0,1
171766,'s,0,1
171767,response,0,0
171768,to,0,1
171769,treatment,0,0
171770,.,0,0
171771,Clinical,0,0
171772,trial,0,0
171773,registration,0,0
171774,information-Developmental,0,0
171775,and,0,0
171776,Augmented,0,0
171777,Intervention,0,1
171778,for,0,0
171779,Facilitating,0,0
171780,Expressive,0,1
171781,Language,0,0
171782,(,0,0
171783,CCNIA,0,1
171784,),0,1
171785,;,0,0
171786,http,0,0
171787,:,0,1
171788,//clinicaltrials.gov/,0,0
171789,;,0,0
171790,NCT01013545,0,0
171791,.,0,1
171792,Causes,0,1
171793,of,0,0
171794,variation,0,0
171795,in,0,0
171796,BCG,0,0
171797,vaccine,0,0
171798,efficacy,0,0
171799,:,0,1
171800,examining,0,0
171801,evidence,0,0
171802,from,0,0
171803,the,0,0
171804,BCG,0,0
171805,REVAC,0,0
171806,cluster,0,0
171807,randomized,0,0
171808,trial,0,0
171809,to,0,0
171810,explore,0,0
171811,the,0,0
171812,masking,0,0
171813,and,0,0
171814,the,0,0
171815,blocking,0,0
171816,hypotheses,0,0
171817,.,0,1
171818,BCG,0,0
171819,protection,0,0
171820,varies,0,0
171821,and,0,0
171822,in,0,0
171823,some,0,0
171824,places,0,0
171825,(,0,0
171826,nearest,0,0
171827,the,0,0
171828,equator,0,0
171829,),0,0
171830,is,0,0
171831,low,0,0
171832,or,0,0
171833,absent,0,0
171834,.,0,0
171835,Understanding,0,0
171836,this,0,0
171837,variation,0,0
171838,can,0,0
171839,inform,0,0
171840,the,0,0
171841,efforts,0,0
171842,to,0,0
171843,develop,0,1
171844,new,0,0
171845,vaccines,0,0
171846,against,0,1
171847,tuberculosis,0,1
171848,.,0,1
171849,Two,0,0
171850,main,0,0
171851,hypotheses,0,0
171852,are,0,0
171853,used,0,0
171854,to,0,0
171855,explain,0,0
171856,this,0,0
171857,variation,0,0
171858,:,0,1
171859,under,0,0
171860,masking,0,0
171861,",",0,0
171862,new,0,0
171863,vaccines,0,0
171864,are,0,0
171865,unlikely,0,0
171866,to,0,0
171867,increase,0,0
171868,protection,0,0
171869,;,0,0
171870,under,0,0
171871,blocking,0,0
171872,new,0,1
171873,vaccines,0,0
171874,have,0,0
171875,a,0,0
171876,greater,0,0
171877,potential,0,0
171878,to,0,0
171879,be,0,0
171880,effective,0,0
171881,when,0,0
171882,BCG,0,0
171883,is,0,0
171884,not,0,0
171885,.,0,0
171886,We,0,0
171887,conducted,0,0
171888,a,0,0
171889,cluster,0,0
171890,randomized,0,0
171891,trial,0,0
171892,to,0,0
171893,explored,0,0
171894,the,0,0
171895,masking,0,0
171896,and,0,0
171897,blocking,0,0
171898,hypotheses,0,0
171899,by,0,0
171900,studying,0,0
171901,BCG,0,0
171902,vaccine,0,0
171903,efficacy,0,0
171904,of,0,0
171905,neonatal,0,1
171906,vaccination,0,1
171907,and,0,0
171908,when,0,0
171909,administered,0,0
171910,for,0,0
171911,the,0,0
171912,first,0,0
171913,or,0,0
171914,a,0,0
171915,second,0,0
171916,(,0,0
171917,revaccination,0,1
171918,),0,0
171919,time,0,0
171920,at,0,0
171921,school,1,1
171922,age,1,1
171923,in,1,0
171924,two,1,0
171925,sites,1,0
171926,(,1,1
171927,Manaus,1,1
171928,close,1,0
171929,and,1,0
171930,Salvador,1,1
171931,further,1,0
171932,south,1,1
171933,from,1,0
171934,the,1,0
171935,equator,1,1
171936,),1,0
171937,.,1,0
171938,Seven,1,0
171939,hundred,1,1
171940,and,1,0
171941,sixty,1,1
171942,three,1,0
171943,state,1,1
171944,schools,1,1
171945,were,1,0
171946,matched,1,1
171947,on,1,0
171948,socio,1,1
171949,economic,1,0
171950,characteristics,1,0
171951,of,1,0
171952,the,1,0
171953,neighborhood,1,0
171954,and,1,0
171955,"239,934",1,1
171956,children,1,1
171957,were,1,1
171958,randomized,1,1
171959,to,0,0
171960,vaccine,0,0
171961,(,0,0
171962,BCG,0,0
171963,vaccination,0,1
171964,at,0,0
171965,school,0,1
171966,age,0,1
171967,),0,0
171968,or,0,0
171969,control,0,0
171970,group,0,0
171971,.,0,0
171972,Protection,0,0
171973,by,0,0
171974,first,0,0
171975,BCG,0,1
171976,vaccination,0,1
171977,at,0,0
171978,school,0,1
171979,age,0,1
171980,was,0,0
171981,high,0,0
171982,in,0,0
171983,Salvador,1,1
171984,(,0,1
171985,34,0,1
171986,%,0,0
171987,",",0,0
171988,95,0,0
171989,%,0,0
171990,CI,0,0
171991,7-53,0,0
171992,%,0,0
171993,",",0,0
171994,p=0.017,0,0
171995,),0,0
171996,but,0,0
171997,low,0,0
171998,in,0,0
171999,Manaus,1,1
172000,(,0,1
172001,8,0,0
172002,%,0,0
172003,",",0,0
172004,95,0,0
172005,%,0,0
172006,CI,0,0
172007,t0,0,0
172008,39-40,0,0
172009,%,0,0
172010,",",0,0
172011,p=0.686,0,0
172012,),0,0
172013,.,0,0
172014,For,0,0
172015,revaccination,0,0
172016,at,0,0
172017,school,0,1
172018,age,0,1
172019,",",0,0
172020,protection,0,0
172021,was,0,0
172022,modest,0,0
172023,in,0,0
172024,Salvador,0,1
172025,(,0,1
172026,19,0,1
172027,%,0,0
172028,",",0,0
172029,95,0,0
172030,%,0,0
172031,CI,0,0
172032,3-33,0,0
172033,%,0,0
172034,",",0,0
172035,p=0.022,0,0
172036,),0,0
172037,and,0,0
172038,absent,0,0
172039,in,0,0
172040,Manaus,0,1
172041,(,0,1
172042,1,0,0
172043,%,0,0
172044,",",0,0
172045,95,0,0
172046,%,0,0
172047,CI,0,0
172048,to,0,0
172049,27-23,0,1
172050,%,0,0
172051,",",0,0
172052,p=0.932,0,0
172053,),0,0
172054,.,0,0
172055,Vaccine,0,0
172056,efficacy,0,0
172057,for,0,0
172058,neonatal,0,1
172059,vaccination,0,1
172060,was,0,0
172061,similar,0,0
172062,in,0,0
172063,Salvador,0,1
172064,(,0,1
172065,40,0,1
172066,%,0,0
172067,",",0,0
172068,95,0,0
172069,%,0,0
172070,CI,0,0
172071,22-54,0,1
172072,%,0,0
172073,",",0,0
172074,p,0,0
172075,<,0,0
172076,0.001,0,0
172077,),0,0
172078,and,0,0
172079,Manaus,0,1
172080,(,0,0
172081,36,0,1
172082,%,0,0
172083,",",0,0
172084,95,0,0
172085,%,0,0
172086,CI,0,0
172087,11-53,0,0
172088,%,0,0
172089,",",0,0
172090,p=0.008,0,0
172091,),0,0
172092,.,0,0
172093,Variation,0,0
172094,in,0,0
172095,BCG,0,1
172096,efficacy,0,0
172097,was,0,0
172098,marked,0,0
172099,when,0,0
172100,vaccine,0,0
172101,was,0,0
172102,given,0,0
172103,at,0,0
172104,school,0,1
172105,age,0,1
172106,but,0,0
172107,absent,0,0
172108,at,0,0
172109,birth,0,1
172110,",",0,0
172111,which,0,0
172112,points,0,0
172113,towards,0,0
172114,blocking,0,0
172115,as,0,0
172116,the,0,0
172117,dominant,0,0
172118,mechanism,0,0
172119,.,0,1
172120,New,0,0
172121,tuberculosis,0,1
172122,vaccines,0,0
172123,that,0,0
172124,overcome,0,0
172125,or,0,0
172126,by,0,0
172127,pass,0,0
172128,this,0,0
172129,blocking,0,0
172130,effect,0,0
172131,could,0,0
172132,confer,0,0
172133,protection,0,0
172134,in,0,0
172135,situations,0,0
172136,where,0,0
172137,BCG,0,0
172138,is,0,0
172139,not,0,0
172140,protective,0,0
172141,.,0,1
172142,Changes,0,0
172143,in,0,0
172144,motor,0,0
172145,cortex,0,0
172146,excitability,0,0
172147,associated,0,0
172148,with,0,1
172149,temporal,0,0
172150,repetitive,0,0
172151,transcranial,0,0
172152,magnetic,0,0
172153,stimulation,0,0
172154,in,0,0
172155,tinnitus,1,1
172156,:,1,1
172157,hints,0,0
172158,for,0,0
172159,cross-modal,0,0
172160,plasticity,0,0
172161,?,0,0
172162,BACKGROUND,0,0
172163,Motor,0,0
172164,cortex,0,0
172165,excitability,0,0
172166,was,0,0
172167,found,0,0
172168,to,0,0
172169,be,0,0
172170,changed,0,0
172171,after,0,0
172172,repetitive,0,0
172173,transcranial,0,0
172174,magnetic,0,0
172175,stimulation,0,0
172176,(,0,0
172177,rTMS,0,0
172178,),0,0
172179,of,0,0
172180,the,0,0
172181,temporal,0,0
172182,cortex,0,0
172183,highlighting,0,0
172184,the,0,0
172185,occurrence,0,0
172186,of,0,0
172187,cross-modal,0,0
172188,plasticity,0,0
172189,in,0,0
172190,non-invasive,0,0
172191,brain,0,0
172192,stimulation,0,0
172193,.,0,0
172194,Here,0,0
172195,",",0,0
172196,we,0,0
172197,investigated,0,0
172198,the,0,0
172199,effects,0,0
172200,of,0,0
172201,temporal,0,0
172202,low-frequency,0,0
172203,rTMS,0,0
172204,on,0,0
172205,motor,0,0
172206,cortex,0,0
172207,plasticity,0,0
172208,in,0,0
172209,a,0,0
172210,large,0,1
172211,sample,0,1
172212,of,0,0
172213,tinnitus,1,1
172214,patients,1,1
172215,.,1,1
172216,In,0,0
172217,116,1,1
172218,patients,1,1
172219,with,1,1
172220,chronic,1,1
172221,tinnitus,1,1
172222,different,0,0
172223,parameters,0,0
172224,of,0,0
172225,cortical,0,0
172226,excitability,0,0
172227,were,0,0
172228,assessed,0,0
172229,before,0,0
172230,and,0,0
172231,after,0,0
172232,ten,0,1
172233,rTMS,0,0
172234,treatment,0,1
172235,sessions,0,0
172236,.,0,1
172237,Patients,0,1
172238,received,0,0
172239,one,0,1
172240,of,0,0
172241,three,0,1
172242,different,0,0
172243,protocols,0,0
172244,all,0,1
172245,including,0,0
172246,1,0,0
172247,Hz,0,0
172248,rTMS,0,0
172249,over,0,0
172250,the,0,0
172251,left,0,1
172252,temporal,0,0
172253,cortex,0,0
172254,.,0,1
172255,Treatment,0,0
172256,response,0,0
172257,was,0,0
172258,defined,0,0
172259,as,0,0
172260,improvement,0,0
172261,by,0,0
172262,at,0,0
172263,least,0,1
172264,five,0,1
172265,points,0,0
172266,in,0,0
172267,the,0,0
172268,tinnitus,0,0
172269,questionnaire,0,0
172270,(,0,0
172271,TQ,0,1
172272,),0,1
172273,.,0,1
172274,Variables,0,0
172275,of,0,0
172276,interest,0,0
172277,were,0,0
172278,resting,0,0
172279,motor,0,0
172280,threshold,0,0
172281,(,0,0
172282,RMT,0,0
172283,),0,0
172284,",",0,0
172285,short-interval,0,0
172286,intra-cortical,0,0
172287,inhibition,0,0
172288,(,0,0
172289,SICI,0,0
172290,),0,0
172291,",",0,0
172292,intracortical,0,0
172293,facilitation,0,0
172294,(,0,0
172295,ICF,0,0
172296,),0,0
172297,",",0,0
172298,and,0,0
172299,cortical,0,0
172300,silent,0,0
172301,period,0,0
172302,(,0,0
172303,CSP,0,0
172304,),0,1
172305,.,0,0
172306,RESULTS,0,0
172307,After,0,0
172308,rTMS,0,0
172309,treatment,0,0
172310,RMT,0,0
172311,was,0,0
172312,decreased,0,0
172313,by,0,0
172314,about,0,0
172315,1,0,0
172316,%,0,0
172317,of,0,0
172318,stimulator,0,0
172319,output,0,0
172320,near-significantly,0,0
172321,in,0,0
172322,the,0,0
172323,whole,0,0
172324,group,0,0
172325,of,0,0
172326,patients,0,1
172327,.,0,1
172328,SICI,0,0
172329,was,0,0
172330,associated,0,0
172331,with,0,1
172332,significant,0,0
172333,changes,0,0
172334,with,0,1
172335,respect,0,0
172336,to,0,0
172337,treatment,0,0
172338,response,0,0
172339,.,0,0
172340,The,0,0
172341,group,0,0
172342,of,0,0
172343,treatment,0,0
172344,responders,0,0
172345,showed,0,0
172346,a,0,0
172347,decrease,0,0
172348,of,0,0
172349,SICI,0,0
172350,over,0,0
172351,the,0,0
172352,course,0,0
172353,of,0,0
172354,treatment,0,0
172355,",",0,0
172356,the,0,0
172357,group,0,0
172358,of,0,0
172359,non-responders,0,0
172360,the,0,0
172361,reverse,0,0
172362,pattern,0,1
172363,.,0,1
172364,CONCLUSIONS,0,0
172365,Minor,0,0
172366,RMT,0,0
172367,changes,0,0
172368,during,0,0
172369,rTMS,0,0
172370,treatment,0,0
172371,do,0,0
172372,not,0,0
172373,necessarily,0,0
172374,suggest,0,0
172375,the,0,0
172376,need,0,0
172377,for,0,0
172378,systematic,0,0
172379,re-examination,0,1
172380,of,0,0
172381,the,0,0
172382,RMT,0,0
172383,for,0,0
172384,safety,0,0
172385,and,0,0
172386,efficacy,0,0
172387,issues,0,0
172388,.,0,1
172389,Treatment,0,0
172390,response,0,0
172391,to,0,0
172392,rTMS,0,0
172393,was,0,0
172394,shown,0,0
172395,to,0,0
172396,be,0,0
172397,related,0,0
172398,to,0,0
172399,changes,0,0
172400,in,0,0
172401,SICI,0,0
172402,that,0,0
172403,might,0,0
172404,reflect,0,0
172405,modulation,0,0
172406,of,0,0
172407,GABAergic,0,0
172408,mechanisms,0,0
172409,directly,0,0
172410,or,0,0
172411,indirectly,0,0
172412,related,0,0
172413,to,0,0
172414,rTMS,0,0
172415,treatment,0,0
172416,effects,0,0
172417,.,0,1
172418,Intramedullary,0,1
172419,repair,0,1
172420,device,0,0
172421,against,0,0
172422,volar,0,0
172423,plating,0,0
172424,in,0,0
172425,the,0,0
172426,reconstruction,0,0
172427,of,0,0
172428,extra-articular,0,1
172429,and,0,1
172430,simple,0,0
172431,articular,0,1
172432,distal,0,1
172433,radius,0,1
172434,fractures,0,1
172435,;,0,0
172436,a,0,0
172437,randomized,0,0
172438,pilot,0,0
172439,study,0,0
172440,.,0,0
172441,PURPOSE,0,0
172442,This,0,0
172443,prospective,0,0
172444,randomized,0,0
172445,pilot,0,0
172446,study,0,0
172447,reports,0,0
172448,our,0,0
172449,institutional,0,0
172450,experience,0,0
172451,and,0,0
172452,early,0,1
172453,results,0,0
172454,using,0,1
172455,Sonoma,0,1
172456,Wrx,0,0
172457,(,0,0
172458,Sonoma,0,1
172459,Orthopedic,0,1
172460,Products,0,0
172461,",",0,1
172462,Santa,0,1
172463,Rosa,0,1
172464,",",0,0
172465,CA,0,0
172466,),0,0
172467,in,0,0
172468,the,0,0
172469,treatment,0,0
172470,of,0,0
172471,extra-articular,0,1
172472,and,0,1
172473,simple,0,0
172474,intra-articular,0,0
172475,distal,0,1
172476,radius,0,1
172477,fractures,0,1
172478,.,0,1
172479,MATERIAL,0,0
172480,AND,0,0
172481,METHODS,0,0
172482,A,1,0
172483,total,1,1
172484,of,1,0
172485,64,1,1
172486,patients,1,1
172487,",",1,0
172488,were,1,0
172489,enrolled,1,1
172490,in,1,0
172491,the,1,0
172492,study,1,0
172493,.,1,0
172494,They,1,0
172495,were,1,0
172496,considered,1,0
172497,eligible,1,1
172498,if,1,0
172499,they,1,1
172500,had,1,1
172501,;,1,0
172502,unstable,1,1
172503,extra-articular,1,1
172504,distal,1,1
172505,radius,1,1
172506,fractures,1,1
172507,and,1,1
172508,simple,1,0
172509,intra-articular,1,0
172510,distal,1,1
172511,radius,1,1
172512,fractures,1,1
172513,suitable,1,0
172514,for,1,0
172515,closed,1,1
172516,reduction,1,0
172517,(,1,0
172518,AO,1,0
172519,types,1,1
172520,;,1,1
172521,A2.2,1,0
172522,",",1,0
172523,A2.3,1,0
172524,",",1,0
172525,A3.1,1,0
172526,C2.1,1,0
172527,",",1,0
172528,C2.2,1,0
172529,),1,0
172530,.,1,1
172531,Patients,1,1
172532,in,1,0
172533,group,1,1
172534,I,0,1
172535,received,0,0
172536,intramedullary,0,0
172537,fixation,0,0
172538,using,0,0
172539,the,0,0
172540,Sonoma,0,1
172541,Wrx,0,0
172542,device,0,0
172543,and,0,0
172544,patients,0,1
172545,in,0,0
172546,group,0,1
172547,II,0,1
172548,received,0,0
172549,standard,0,0
172550,volar,0,0
172551,locking,0,0
172552,plate,0,0
172553,fixation,0,0
172554,.,0,1
172555,Radiographic,0,0
172556,criteria,0,1
172557,of,0,0
172558,acceptable,0,0
172559,healing,0,0
172560,were,0,0
172561,used,0,0
172562,for,0,0
172563,evaluation,0,0
172564,.,0,1
172565,RESULTS,0,0
172566,Two,0,1
172567,groups,0,0
172568,were,0,1
172569,similar,0,0
172570,in,0,0
172571,terms,0,0
172572,of,0,0
172573,baseline,0,0
172574,characteristics,0,0
172575,.,0,1
172576,Mean,0,0
172577,time,0,0
172578,of,0,0
172579,operation,0,0
172580,was,0,0
172581,significantly,0,0
172582,shorter,0,0
172583,in,0,0
172584,Group,1,1
172585,1,1,0
172586,vs.,0,0
172587,in,0,0
172588,group,1,0
172589,2,1,0
172590,(,0,1
172591,36.81,0,0
172592,?,0,0
172593,7.11,0,0
172594,vs.,0,0
172595,48.97,0,0
172596,?,0,1
172597,5.9,0,0
172598,minutes,0,0
172599,",",0,0
172600,p,0,0
172601,=,0,0
172602,0.001,0,0
172603,),0,0
172604,.,0,0
172605,Time,0,0
172606,to,0,0
172607,healing,0,0
172608,of,0,0
172609,the,0,0
172610,fracture,0,1
172611,was,0,0
172612,not,0,0
172613,different,0,0
172614,between,0,0
172615,two,0,0
172616,groups,0,0
172617,(,0,1
172618,5.45,0,0
172619,?,0,0
172620,1.09,0,0
172621,vs.,0,0
172622,5.70,0,0
172623,?,0,1
172624,1.04,0,0
172625,weeks,0,0
172626,for,0,1
172627,Group,0,1
172628,1,0,1
172629,vs.,0,0
172630,2,0,0
172631,",",0,0
172632,respectively,0,0
172633,p,0,0
172634,=,0,0
172635,0.36,0,0
172636,),0,1
172637,.,0,1
172638,Overall,0,0
172639,complications,0,0
172640,occurred,0,0
172641,in,0,1
172642,9,0,0
172643,patients,1,1
172644,in,1,1
172645,group,1,1
172646,1,1,0
172647,and,1,0
172648,in,0,0
172649,15,0,1
172650,patients,0,1
172651,in,1,1
172652,group,1,1
172653,2,1,0
172654,(,1,0
172655,p,0,0
172656,=,0,0
172657,0.17,0,0
172658,),0,0
172659,.,0,1
172660,Follow-up,0,0
172661,was,0,0
172662,completed,0,1
172663,in,0,0
172664,all,0,0
172665,patients,1,1
172666,with,1,1
172667,a,0,0
172668,median,0,0
172669,time,0,0
172670,of,0,0
172671,12,0,0
172672,months,0,0
172673,and,0,1
172674,13,0,1
172675,months,0,0
172676,in,1,1
172677,group,1,1
172678,1,1,0
172679,and,1,0
172680,2,1,0
172681,",",1,0
172682,respectively,0,0
172683,.,0,0
172684,On,0,0
172685,radiographic,0,0
172686,evaluation,0,0
172687,radial,0,0
172688,inclination,0,0
172689,",",0,0
172690,radial,0,0
172691,height,0,0
172692,and,0,0
172693,volar,0,0
172694,tilt,0,0
172695,were,0,0
172696,not,0,0
172697,significantly,0,0
172698,different,0,0
172699,between,0,0
172700,group,0,1
172701,1,0,0
172702,and,0,0
172703,2,0,0
172704,",",0,0
172705,respectively,0,0
172706,.,0,0
172707,There,0,0
172708,were,0,0
172709,no,0,0
172710,significant,0,0
172711,differences,0,0
172712,between,0,0
172713,two,0,0
172714,groups,0,0
172715,in,0,0
172716,regard,0,0
172717,to,0,0
172718,wrist,0,1
172719,rotational,0,0
172720,degrees,0,0
172721,measured,0,0
172722,in,0,0
172723,last,0,0
172724,follow-up,0,0
172725,visit,0,0
172726,.,0,1
172727,CONCLUSION,0,0
172728,Sonoma,0,1
172729,Wrx,0,0
172730,Device,0,0
172731,is,0,0
172732,reliable,0,0
172733,and,0,0
172734,effective,0,0
172735,in,0,0
172736,terms,0,0
172737,of,0,0
172738,achieving,0,0
172739,satisfactory,0,0
172740,outcomes,0,0
172741,in,0,0
172742,treatment,0,0
172743,of,0,0
172744,distal,0,1
172745,radius,0,1
172746,fractures,0,1
172747,.,0,0
172748,It,0,0
172749,may,0,0
172750,be,0,0
172751,reasonable,0,0
172752,to,0,0
172753,use,0,0
172754,this,0,0
172755,device,0,0
172756,to,0,0
172757,prevent,0,0
172758,complications,0,0
172759,that,0,0
172760,are,0,0
172761,related,0,0
172762,to,0,0
172763,extensive,0,0
172764,soft,0,1
172765,tissue,0,0
172766,dissection,0,1
172767,.,0,1
172768,The,0,0
172769,effects,0,0
172770,of,0,0
172771,prism,0,1
172772,adaptation,0,0
172773,on,0,0
172774,egocentric,0,0
172775,metric,0,0
172776,distance,0,0
172777,estimation,0,0
172778,.,0,0
172779,OBJECTIVE,0,0
172780,The,0,0
172781,present,0,0
172782,experiment,0,0
172783,evaluated,0,0
172784,whether,0,0
172785,training,0,0
172786,involving,0,1
172787,throwing,0,0
172788,transferred,0,0
172789,to,0,0
172790,metric,0,0
172791,distance,0,0
172792,estimation,0,0
172793,(,0,0
172794,i.e.,0,0
172795,",",0,0
172796,describing,0,0
172797,in,0,0
172798,feet,0,0
172799,and,0,0
172800,inches,0,0
172801,the,0,0
172802,distance,0,0
172803,between,0,0
172804,oneself,0,0
172805,and,0,0
172806,targets,0,0
172807,),0,1
172808,.,0,1
172809,BACKGROUND,0,0
172810,In,0,0
172811,prior,0,0
172812,work,0,0
172813,",",0,0
172814,we,0,0
172815,found,0,0
172816,that,0,0
172817,metric,0,0
172818,estimation,0,0
172819,training,0,0
172820,negatively,0,0
172821,transferred,0,0
172822,to,0,0
172823,throwing,0,0
172824,.,0,0
172825,We,0,0
172826,explained,0,0
172827,our,0,0
172828,results,0,0
172829,in,0,0
172830,terms,0,0
172831,of,0,0
172832,cognitive,0,1
172833,intrusion,0,0
172834,.,0,0
172835,The,0,0
172836,present,0,0
172837,study,0,0
172838,tested,0,0
172839,that,0,0
172840,possibility,0,0
172841,by,0,0
172842,swapping,0,0
172843,our,0,0
172844,training,0,0
172845,and,0,0
172846,transfer,0,1
172847,tasks,0,0
172848,.,0,1
172849,METHOD,0,0
172850,During,0,0
172851,pretesting,0,0
172852,",",0,0
172853,participants,1,1
172854,verbally,1,0
172855,estimated,1,0
172856,the,1,0
172857,metric,1,0
172858,distances,1,0
172859,between,1,0
172860,themselves,1,0
172861,and,1,0
172862,targets,1,0
172863,",",1,0
172864,or,1,1
172865,they,1,0
172866,threw,1,0
172867,a,1,0
172868,beanbag,1,0
172869,to,1,0
172870,targets,1,0
172871,.,1,1
172872,During,0,0
172873,training,0,0
172874,",",0,0
172875,participants,0,1
172876,donned,0,1
172877,goggles,0,0
172878,that,0,0
172879,distorted,0,0
172880,their,0,0
172881,vision,0,0
172882,.,0,0
172883,While,0,0
172884,wearing,0,0
172885,the,0,0
172886,goggles,0,0
172887,",",0,0
172888,they,0,0
172889,threw,0,0
172890,a,0,0
172891,beanbag,0,0
172892,to,0,0
172893,targets,0,0
172894,.,0,1
172895,Half,0,0
172896,received,0,0
172897,feedback,0,0
172898,.,0,0
172899,During,0,0
172900,posttesting,0,0
172901,",",0,0
172902,participants,0,1
172903,removed,0,0
172904,the,0,0
172905,distorting,0,0
172906,goggles,0,0
172907,and,0,0
172908,completed,0,1
172909,the,0,0
172910,same,0,0
172911,task,0,0
172912,that,0,0
172913,they,0,0
172914,performed,0,0
172915,during,0,0
172916,pretesting,0,0
172917,.,0,0
172918,RESULTS,0,0
172919,The,0,0
172920,results,0,0
172921,indicated,0,0
172922,that,0,0
172923,the,0,0
172924,distorting,0,0
172925,goggles,0,0
172926,degraded,0,0
172927,throwing,0,0
172928,at,0,0
172929,the,0,0
172930,beginning,0,0
172931,of,0,0
172932,training,0,0
172933,",",0,0
172934,visual,0,0
172935,feedback,0,0
172936,improved,0,0
172937,throwing,0,0
172938,during,0,0
172939,training,0,0
172940,",",0,0
172941,the,0,0
172942,effects,0,0
172943,of,0,0
172944,training,0,0
172945,with,0,1
172946,feedback,0,0
172947,persisted,0,0
172948,into,0,0
172949,the,0,0
172950,throwing,0,0
172951,posttest,0,0
172952,",",0,0
172953,and,0,0
172954,the,0,0
172955,effects,0,0
172956,of,0,0
172957,training,0,0
172958,with,0,1
172959,feedback,0,0
172960,did,0,0
172961,not,0,0
172962,transfer,0,0
172963,to,0,0
172964,the,0,0
172965,verbal,0,0
172966,metric,0,0
172967,estimation,0,0
172968,posttest,0,0
172969,.,0,0
172970,CONCLUSION,0,0
172971,Training,0,0
172972,involving,0,1
172973,throwing,0,0
172974,was,0,0
172975,effective,0,0
172976,",",0,0
172977,but,0,0
172978,did,0,0
172979,not,0,0
172980,transfer,0,0
172981,to,0,0
172982,verbal,0,0
172983,metric,0,0
172984,distance,0,0
172985,estimation,0,0
172986,.,0,0
172987,This,0,0
172988,supports,0,0
172989,our,0,0
172990,argument,0,0
172991,that,0,0
172992,the,0,0
172993,negative,0,0
172994,transfer,0,0
172995,observed,0,0
172996,in,0,0
172997,our,0,0
172998,previous,0,0
172999,study,0,0
173000,stemmed,0,0
173001,from,0,0
173002,cognitive,0,1
173003,intrusion,0,0
173004,.,0,0
173005,APPLICATION,0,0
173006,The,0,0
173007,present,0,0
173008,experiment,0,0
173009,suggests,0,0
173010,that,0,0
173011,the,0,0
173012,creation,0,0
173013,of,0,0
173014,distance,0,0
173015,estimation,0,0
173016,training,0,0
173017,should,0,0
173018,begin,0,0
173019,with,0,0
173020,a,0,0
173021,careful,0,0
173022,analysis,0,0
173023,of,0,0
173024,the,0,0
173025,transfer,0,0
173026,task,0,0
173027,",",0,0
173028,and,0,0
173029,that,0,0
173030,distance,0,0
173031,estimation,0,0
173032,training,0,0
173033,programs,0,0
173034,should,0,0
173035,explicitly,0,0
173036,teach,0,0
173037,trainees,1,0
173038,that,1,0
173039,their,1,0
173040,training,1,0
173041,will,0,0
173042,not,0,0
173043,generalize,0,0
173044,to,0,0
173045,all,0,0
173046,distance,0,0
173047,estimation,0,0
173048,tasks,0,0
173049,.,0,1
173050,Self-management,0,0
173051,improvement,0,0
173052,program,0,0
173053,combined,0,0
173054,with,0,1
173055,community,0,0
173056,involvement,0,0
173057,in,0,0
173058,Thai,1,1
173059,hypertensive,1,1
173060,population,1,1
173061,:,1,1
173062,an,0,0
173063,action,0,0
173064,research,0,0
173065,.,0,0
173066,OBJECTIVE,0,0
173067,To,0,0
173068,investigate,0,0
173069,the,0,0
173070,effectiveness,0,0
173071,of,0,0
173072,a,0,0
173073,program,0,0
173074,that,0,0
173075,utilizes,0,0
173076,community,0,0
173077,involvement,0,0
173078,to,0,0
173079,improve,0,0
173080,the,0,0
173081,self-management,0,0
173082,strategies,0,0
173083,among,0,1
173084,people,1,1
173085,living,1,1
173086,with,1,1
173087,hypertension,1,1
173088,.,1,1
173089,MATERIAL,0,0
173090,AND,0,0
173091,METHOD,0,0
173092,Forty-four,1,1
173093,subjects,1,1
173094,",",1,0
173095,aged,1,1
173096,35,1,0
173097,to,1,0
173098,59-year-old,1,1
173099,",",1,0
173100,with,1,1
173101,hypertension,1,1
173102,in,1,0
173103,Nakhon,1,1
173104,Pathom,1,1
173105,Province,1,1
173106,",",1,0
173107,Thailand,1,1
173108,",",0,0
173109,were,0,0
173110,randomly,0,1
173111,allocated,0,0
173112,to,0,0
173113,either,0,0
173114,an,0,0
173115,experimental,0,0
173116,group,0,0
173117,(,0,0
173118,n,0,1
173119,=,0,0
173120,22,0,1
173121,),0,0
173122,or,0,0
173123,a,0,0
173124,control,0,0
173125,group,0,0
173126,(,0,0
173127,n,0,1
173128,=,0,0
173129,20,0,1
173130,),0,0
173131,.,0,0
173132,The,0,0
173133,experimental,0,0
173134,group,0,0
173135,attended,0,1
173136,a,0,0
173137,program,0,0
173138,to,0,0
173139,improve,0,0
173140,self-management,0,0
173141,methods,0,1
173142,based,0,0
173143,on,0,0
173144,social,0,0
173145,cognitive,0,0
173146,theory,0,1
173147,(,0,0
173148,SCT,0,1
173149,),0,0
173150,.,0,0
173151,The,0,0
173152,program,0,0
173153,lasted,0,0
173154,12,0,0
173155,weeks,0,0
173156,",",0,0
173157,consisted,0,1
173158,of,0,0
173159,1,0,1
173160,1/2,0,1
173161,hours,0,0
173162,meeting,0,1
173163,once,0,0
173164,a,0,0
173165,week,0,0
173166,",",0,0
173167,including,0,0
173168,group,0,0
173169,meetings,0,0
173170,and,0,0
173171,home,0,1
173172,visit,0,0
173173,monitoring,0,0
173174,.,0,1
173175,Mann-Whitney,0,0
173176,U,0,0
173177,test,0,0
173178,and,0,0
173179,Friedman,0,0
173180,test,0,0
173181,were,0,0
173182,employed,0,0
173183,to,0,0
173184,analyze,0,0
173185,the,0,0
173186,program,0,0
173187,'s,0,1
173188,effectiveness,0,0
173189,.,0,1
173190,RESULTS,0,0
173191,After,0,0
173192,the,0,0
173193,program,0,0
173194,",",0,0
173195,the,0,0
173196,mean,0,0
173197,rank,0,0
173198,of,0,0
173199,the,0,0
173200,perceived,0,0
173201,self-efficacy,0,0
173202,for,0,0
173203,the,0,0
173204,self-management,0,0
173205,strategies,0,0
173206,was,0,0
173207,statistically,0,0
173208,different,0,0
173209,between,0,0
173210,the,0,0
173211,two,0,0
173212,groups,0,0
173213,(,0,1
173214,p,0,0
173215,=,0,0
173216,0.023,0,0
173217,),0,0
173218,.,0,0
173219,In,0,0
173220,the,0,0
173221,experimental,0,0
173222,group,0,0
173223,",",0,0
173224,after,0,0
173225,the,0,0
173226,twelve,0,1
173227,week,0,0
173228,",",0,0
173229,the,0,0
173230,mean,0,0
173231,rank,0,0
173232,of,0,0
173233,perceived,0,0
173234,self-efficacy,0,0
173235,and,0,0
173236,outcome,0,0
173237,expectancy,0,0
173238,increased,0,0
173239,and,0,0
173240,diastolic,0,1
173241,blood,0,0
173242,pressure,0,0
173243,decreased,0,0
173244,after,0,0
173245,the,0,0
173246,eight,0,1
173247,week,0,0
173248,.,0,0
173249,CONCLUSION,0,0
173250,The,0,0
173251,program,0,0
173252,applied,0,0
173253,social,0,0
173254,cognitive,0,0
173255,theory,0,1
173256,(,0,0
173257,SCT,0,1
173258,),0,0
173259,to,0,0
173260,promote,0,0
173261,self-management,0,0
173262,techniques,0,0
173263,",",0,0
173264,increased,0,0
173265,the,0,0
173266,health,0,0
173267,promoting,0,0
173268,behavior,0,0
173269,among,0,1
173270,hypertensive,0,1
173271,people,0,1
173272,.,0,1
173273,Standardized,0,0
173274,treatment,0,0
173275,of,0,0
173276,Chinese,0,1
173277,medicine,0,1
173278,decoction,0,0
173279,for,0,0
173280,cancer,1,1
173281,pain,1,1
173282,patients,1,1
173283,with,1,1
173284,opioid-induced,1,1
173285,constipation,1,1
173286,:,1,1
173287,a,0,0
173288,multi-center,0,0
173289,prospective,0,0
173290,randomized,0,1
173291,controlled,0,0
173292,study,0,0
173293,.,0,0
173294,OBJECTIVE,0,0
173295,To,0,0
173296,observe,0,0
173297,the,0,0
173298,efficacy,0,0
173299,and,0,0
173300,the,0,0
173301,influence,0,0
173302,on,0,0
173303,quality,0,0
173304,of,0,0
173305,life,0,0
173306,(,0,0
173307,QOL,0,0
173308,),0,0
173309,of,0,0
173310,syndrome,0,1
173311,differentiation,0,0
173312,treatment,0,0
173313,with,0,1
173314,Chinese,0,1
173315,medicine,0,1
173316,(,0,0
173317,CM,0,0
173318,),0,0
173319,for,0,0
173320,opioid-induced,1,1
173321,constipation,1,1
173322,as,0,0
173323,well,0,0
173324,as,0,0
173325,the,0,0
173326,safety,0,0
173327,and,0,0
173328,influence,0,0
173329,on,0,0
173330,analgesic,0,0
173331,effect,0,0
173332,of,0,0
173333,opioids,0,0
173334,.,0,1
173335,METHODS,0,0
173336,Totally,1,0
173337,406,1,1
173338,cases,1,0
173339,enrolled,1,1
173340,from,1,1
173341,53,1,1
173342,collaborating,1,1
173343,medical,1,1
173344,centers,1,1
173345,were,0,1
173346,randomly,0,1
173347,assigned,0,0
173348,to,0,0
173349,a,0,0
173350,CM,0,0
173351,group,0,0
173352,and,0,0
173353,a,0,0
173354,control,0,0
173355,group,0,0
173356,.,0,0
173357,The,0,0
173358,CM,0,0
173359,group,0,0
173360,were,0,0
173361,treated,0,1
173362,with,0,1
173363,CM,0,0
173364,decoction,0,0
173365,based,0,0
173366,on,0,0
173367,syndrome,0,1
173368,differentiation,0,0
173369,",",0,0
173370,and,0,0
173371,the,0,0
173372,control,0,0
173373,group,0,0
173374,were,0,0
173375,treated,0,1
173376,with,0,1
173377,Phenolphthalein,0,0
173378,Tablet,0,0
173379,.,0,1
173380,Both,0,0
173381,groups,0,0
173382,were,0,0
173383,treated,0,1
173384,for,0,0
173385,14,0,1
173386,days,0,0
173387,.,0,1
173388,Cleveland,0,1
173389,constipation,0,1
173390,score,0,0
173391,(,0,0
173392,CCS,0,0
173393,),0,0
173394,",",0,0
173395,numerical,0,0
173396,rating,0,0
173397,scale,0,0
173398,(,0,0
173399,NRS,0,0
173400,),0,0
173401,of,0,0
173402,pain,0,1
173403,and,0,0
173404,Chinese,0,1
173405,version,0,0
173406,of,0,0
173407,European,0,1
173408,Organisation,0,1
173409,for,0,0
173410,Research,0,0
173411,and,0,0
173412,Treatment,0,0
173413,of,0,0
173414,Cancer,0,1
173415,",",0,0
173416,Quality,0,0
173417,of,0,0
173418,Life,0,0
173419,Questionnaire-C30,0,0
173420,V3.0,0,0
173421,(,0,0
173422,EORTC,0,0
173423,QLQ-C30,0,1
173424,V3.0,0,0
173425,),0,0
173426,were,0,0
173427,used,0,0
173428,to,0,0
173429,evaluate,0,0
173430,the,0,0
173431,efficacy,0,0
173432,",",0,0
173433,pain,0,0
173434,controlled,0,0
173435,and,0,0
173436,QOL,0,0
173437,status,0,0
173438,.,0,0
173439,RESULTS,0,0
173440,The,0,0
173441,comparisons,0,0
173442,of,0,0
173443,CCS,0,1
173444,score,0,0
173445,reduction,0,0
173446,and,0,0
173447,QOL,0,0
173448,between,0,0
173449,the,0,0
173450,two,0,0
173451,groups,0,0
173452,after,0,0
173453,treatment,0,0
173454,suggested,0,0
173455,that,0,0
173456,the,0,0
173457,improvements,0,0
173458,of,0,0
173459,constipation,0,1
173460,and,0,0
173461,QOL,0,0
173462,in,0,0
173463,the,0,0
173464,CM,0,0
173465,group,0,0
173466,were,0,0
173467,better,0,0
173468,than,0,0
173469,that,0,0
173470,in,0,0
173471,the,0,0
173472,control,0,0
173473,group,0,0
173474,(,0,0
173475,P,0,0
173476,<,0,0
173477,0.05,0,0
173478,),0,0
173479,.,0,0
173480,The,0,0
173481,total,0,0
173482,efficiency,0,0
173483,of,0,0
173484,the,0,0
173485,CM,0,0
173486,group,0,0
173487,was,0,0
173488,better,0,0
173489,than,0,0
173490,the,0,0
173491,control,0,0
173492,group,0,0
173493,(,0,0
173494,93.5,0,0
173495,%,0,0
173496,vs.,0,0
173497,86.4,0,0
173498,%,0,0
173499,",",0,0
173500,P,0,0
173501,<,0,0
173502,0.05,0,0
173503,),0,0
173504,.,0,0
173505,There,0,0
173506,was,0,0
173507,no,0,0
173508,significant,0,0
173509,difference,0,0
173510,in,0,0
173511,NRS,0,0
173512,scores,0,0
173513,between,0,0
173514,before,0,0
173515,and,0,0
173516,after,0,0
173517,treatment,0,0
173518,in,0,0
173519,both,0,0
173520,groups,0,0
173521,.,0,0
173522,There,0,0
173523,was,0,0
173524,no,0,0
173525,serious,0,0
173526,drug-related,0,0
173527,adverse,0,0
173528,event,0,0
173529,during,0,0
173530,the,0,0
173531,course,0,0
173532,of,0,0
173533,study,0,0
173534,.,0,1
173535,CONCLUSION,0,0
173536,CM,0,0
173537,decoction,0,0
173538,could,0,0
173539,effectively,0,0
173540,treat,0,0
173541,opioid-induced,1,0
173542,constipation,1,1
173543,and,0,0
173544,improve,0,0
173545,patients,0,1
173546,',0,1
173547,QOL,0,0
173548,at,0,1
173549,the,0,0
173550,same,0,0
173551,time,0,0
173552,.,0,0
173553,It,0,0
173554,is,0,0
173555,safe,0,0
173556,and,0,0
173557,does,0,0
173558,n't,0,0
173559,affect,0,0
173560,the,0,0
173561,analgesic,0,0
173562,effect,0,0
173563,of,0,0
173564,opioids,0,0
173565,when,0,0
173566,treating,0,0
173567,constipation,0,0
173568,.,0,1
173569,A,0,0
173570,randomized,0,0
173571,controlled,0,0
173572,study,0,0
173573,of,0,0
173574,a,0,0
173575,social,0,0
173576,skills,0,0
173577,training,0,0
173578,for,0,0
173579,preadolescent,1,1
173580,children,1,1
173581,with,1,1
173582,autism,1,1
173583,spectrum,1,1
173584,disorders,1,1
173585,:,1,1
173586,generalization,0,1
173587,of,0,0
173588,skills,0,0
173589,by,0,0
173590,training,0,0
173591,parents,0,1
173592,and,0,1
173593,teachers,0,1
173594,?,0,1
173595,BACKGROUND,0,0
173596,Social,0,0
173597,skills,0,0
173598,training,0,0
173599,(,0,1
173600,SST,0,0
173601,),0,0
173602,is,0,0
173603,a,0,0
173604,common,0,0
173605,intervention,0,0
173606,for,0,0
173607,children,1,1
173608,with,1,1
173609,autism,1,1
173610,spectrum,1,1
173611,disorders,1,1
173612,(,1,1
173613,ASDs,1,1
173614,),1,0
173615,to,0,0
173616,improve,0,0
173617,their,0,0
173618,social,0,0
173619,and,0,0
173620,communication,0,0
173621,skills,0,0
173622,.,0,1
173623,Despite,0,0
173624,the,0,0
173625,fact,0,0
173626,that,0,0
173627,SSTs,0,0
173628,are,0,0
173629,often,0,0
173630,applied,0,0
173631,in,0,0
173632,clinical,0,0
173633,practice,0,0
173634,",",0,0
173635,the,0,0
173636,evidence,0,0
173637,for,0,0
173638,the,0,0
173639,effectiveness,0,0
173640,of,0,0
173641,these,0,0
173642,trainings,0,0
173643,for,0,0
173644,children,1,1
173645,with,1,1
173646,ASD,1,1
173647,is,0,0
173648,inconclusive,0,0
173649,.,0,0
173650,Moreover,0,0
173651,",",0,0
173652,long,0,0
173653,term,0,0
173654,outcome,0,0
173655,and,0,0
173656,generalization,0,0
173657,of,0,0
173658,learned,0,0
173659,skills,0,0
173660,are,0,0
173661,little,0,0
173662,evaluated,0,0
173663,.,0,0
173664,Additionally,0,0
173665,",",0,0
173666,there,0,0
173667,is,0,0
173668,no,0,0
173669,research,0,0
173670,on,0,0
173671,the,0,0
173672,influence,0,0
173673,of,0,0
173674,involvement,0,0
173675,of,0,0
173676,parents,0,1
173677,and,0,1
173678,teachers,0,1
173679,on,0,0
173680,effectiveness,0,0
173681,of,0,0
173682,SST,0,0
173683,and,0,0
173684,on,0,0
173685,the,0,0
173686,generalization,0,0
173687,of,0,0
173688,learned,0,0
173689,social,0,0
173690,skills,0,0
173691,to,0,1
173692,daily,0,0
173693,life,0,0
173694,.,0,0
173695,We,0,0
173696,expect,0,0
173697,parent,0,0
173698,and,0,0
173699,teacher,0,0
173700,involvement,0,0
173701,in,0,0
173702,SST,0,0
173703,to,0,0
173704,enhance,0,0
173705,treatment,0,0
173706,efficacy,0,0
173707,and,0,0
173708,to,0,0
173709,facilitate,0,0
173710,generalization,0,0
173711,of,0,0
173712,learned,0,0
173713,skills,0,0
173714,to,0,1
173715,daily,0,0
173716,life,0,0
173717,.,0,0
173718,METHOD/DESIGN,0,0
173719,In,0,0
173720,a,0,0
173721,randomized,0,0
173722,controlled,0,0
173723,trial,0,0
173724,(,0,0
173725,RCT,0,0
173726,),0,0
173727,with,0,1
173728,three,0,0
173729,conditions,0,0
173730,",",0,1
173731,120,1,1
173732,participants,1,1
173733,with,1,1
173734,ASD,1,1
173735,at,1,0
173736,the,1,0
173737,end,1,0
173738,of,1,0
173739,primary,1,1
173740,school,1,1
173741,(,1,1
173742,10-12,1,1
173743,years,1,1
173744,of,1,0
173745,calendar,1,1
173746,age,1,1
173747,),1,0
173748,have,1,0
173749,been,1,0
173750,randomized,1,0
173751,to,1,0
173752,SST,1,0
173753,",",1,0
173754,SST-PTI,1,0
173755,(,1,0
173756,SST,1,0
173757,with,1,1
173758,Parent,1,1
173759,&,1,1
173760,Teacher,1,1
173761,Involvement,1,1
173762,),1,0
173763,",",1,0
173764,or,1,1
173765,care-as-usual,1,0
173766,.,1,0
173767,The,0,0
173768,SST,0,0
173769,consists,0,0
173770,of,0,0
173771,18,0,1
173772,group,0,1
173773,sessions,0,0
173774,of,0,1
173775,1.5,0,0
173776,hours,0,0
173777,for,0,0
173778,the,0,0
173779,children,0,1
173780,.,0,0
173781,In,0,0
173782,the,0,0
173783,SST-PTI,0,0
173784,condition,0,0
173785,",",0,0
173786,parents,0,1
173787,additionally,0,0
173788,participate,0,1
173789,in,0,0
173790,8,0,0
173791,parent,0,1
173792,sessions,0,0
173793,and,0,1
173794,parents,0,1
173795,and,0,1
173796,teachers,0,1
173797,are,0,0
173798,actively,0,0
173799,involved,0,0
173800,in,0,0
173801,homework,0,0
173802,assignments,0,0
173803,.,0,0
173804,Assessment,0,0
173805,takes,0,0
173806,place,0,0
173807,at,0,0
173808,three,0,1
173809,moments,0,0
173810,:,0,1
173811,before,0,0
173812,and,0,0
173813,immediately,0,0
173814,after,0,0
173815,the,0,0
173816,intervention,0,0
173817,period,0,0
173818,and,0,0
173819,at,0,0
173820,6,0,0
173821,months,0,0
173822,follow-up,0,0
173823,.,0,1
173824,Primary,0,0
173825,outcome,0,0
173826,is,0,0
173827,socialization,0,0
173828,",",0,0
173829,as,0,0
173830,an,0,0
173831,aspect,0,0
173832,of,0,0
173833,adaptive,0,0
173834,functioning,0,1
173835,.,0,1
173836,Secondary,0,0
173837,outcomes,0,0
173838,focus,0,1
173839,on,0,0
173840,specific,0,0
173841,social,0,1
173842,skills,0,0
173843,children,0,1
173844,learn,0,0
173845,during,0,0
173846,SST,0,0
173847,and,0,0
173848,on,0,0
173849,more,0,0
173850,general,0,1
173851,social,0,0
173852,skills,0,0
173853,pertaining,0,0
173854,to,0,0
173855,home,0,0
173856,and,0,0
173857,community,0,1
173858,settings,0,0
173859,from,0,1
173860,a,0,0
173861,multi-informant,0,0
173862,perspective,0,0
173863,.,0,0
173864,Additionally,0,0
173865,",",0,0
173866,possible,0,0
173867,predictors,0,0
173868,of,0,0
173869,treatment,0,0
173870,outcome,0,0
173871,will,0,0
173872,be,0,0
173873,assessed,0,0
173874,.,0,0
173875,DISCUSSION,0,0
173876,The,0,0
173877,current,0,0
173878,study,0,0
173879,is,0,0
173880,an,0,0
173881,RCT,0,0
173882,study,0,0
173883,evaluating,0,0
173884,SST,0,0
173885,in,0,0
173886,a,0,0
173887,large,0,1
173888,sample,0,1
173889,of,0,0
173890,Dutch,1,1
173891,children,1,1
173892,with,1,1
173893,ASD,1,1
173894,in,1,0
173895,a,1,0
173896,specific,1,0
173897,age,1,1
173898,range,1,1
173899,(,1,0
173900,10-12,1,1
173901,years,1,1
173902,),1,1
173903,.,1,1
173904,Strengths,0,0
173905,of,0,0
173906,the,0,0
173907,study,0,0
173908,are,0,0
173909,the,0,0
173910,use,0,0
173911,of,0,0
173912,one,0,0
173913,manualized,0,0
173914,protocol,0,0
173915,",",0,0
173916,application,0,0
173917,of,0,0
173918,standardized,0,0
173919,and,0,0
173920,internationally,0,1
173921,used,0,0
173922,rating,0,0
173923,instruments,0,0
173924,",",0,0
173925,use,0,0
173926,of,0,0
173927,multiple,0,0
173928,raters,0,0
173929,",",0,0
173930,investigation,0,0
173931,of,0,0
173932,generalization,0,0
173933,of,0,0
173934,learned,0,0
173935,skills,0,0
173936,to,0,1
173937,daily,0,0
173938,life,0,0
173939,",",0,0
173940,and,0,0
173941,the,0,0
173942,evaluation,0,0
173943,of,0,0
173944,efficacy,0,0
173945,in,0,0
173946,the,0,0
173947,longer,0,0
173948,term,0,0
173949,by,0,0
173950,follow-up,0,0
173951,measures,0,0
173952,at,0,1
173953,6,0,0
173954,months,0,0
173955,after,0,0
173956,the,0,0
173957,end,0,0
173958,of,0,0
173959,training,0,0
173960,.,0,1
173961,TRIAL,0,0
173962,REGISTRATION,0,0
173963,NTR2405,0,0
173964,.,0,1
173965,Comparison,0,0
173966,of,0,0
173967,postoperative,0,0
173968,short-term,0,0
173969,complications,0,0
173970,after,0,1
173971,laparoscopic,1,1
173972,transabdominal,1,1
173973,preperitoneal,1,1
173974,(,1,0
173975,TAPP,1,0
173976,),1,0
173977,versus,1,0
173978,Lichtenstein,1,1
173979,tension,1,0
173980,free,1,0
173981,inguinal,1,1
173982,hernia,1,1
173983,repair,1,1
173984,:,1,1
173985,a,0,0
173986,randomized,0,0
173987,trial,0,0
173988,study,0,1
173989,.,0,0
173990,AIM,0,0
173991,The,0,0
173992,aim,0,0
173993,of,0,0
173994,this,0,0
173995,randomized,0,0
173996,trial,0,0
173997,was,0,0
173998,to,0,0
173999,compare,0,0
174000,short-term,0,0
174001,postoperative,0,0
174002,complications,1,0
174003,of,1,1
174004,laparoscopic,1,1
174005,transabdominal,1,1
174006,preperitoneal,1,1
174007,(,1,0
174008,TAPP,1,0
174009,),1,0
174010,and,1,0
174011,Lichtenstein,1,1
174012,tension,1,0
174013,free,1,0
174014,hernia,1,1
174015,repair,1,1
174016,.,1,1
174017,METHODS,0,0
174018,A,1,0
174019,total,1,1
174020,of,1,0
174021,120,1,1
174022,patients,1,1
174023,who,1,1
174024,went,1,1
174025,inguinal,1,1
174026,hernia,1,1
174027,repair,1,1
174028,at,1,0
174029,Shahid,1,1
174030,Sadoughi,1,1
174031,university,1,1
174032,training,1,0
174033,hospital,1,1
174034,from,1,1
174035,April,1,0
174036,2011,1,1
174037,to,1,0
174038,August,1,1
174039,2013,1,1
174040,were,0,0
174041,randomized,0,1
174042,into,0,1
174043,two,0,0
174044,TAPP,0,1
174045,(,0,1
174046,N.=60,0,1
174047,),0,0
174048,and,0,0
174049,Lichtenstein,0,1
174050,(,0,0
174051,N.=60,0,1
174052,),0,0
174053,repair,0,1
174054,group,0,1
174055,.,0,1
174056,Follow-up,0,0
174057,occurred,0,0
174058,within,0,1
174059,6,0,1
174060,weeks,0,0
174061,.,0,1
174062,The,0,0
174063,postoperative,0,0
174064,assessments,0,0
174065,included,0,1
174066,pain,0,1
174067,score,0,0
174068,(,0,0
174069,VAS,0,1
174070,),0,0
174071,",",0,0
174072,hematoma/seroma,0,0
174073,",",0,0
174074,urinary,0,0
174075,retention,0,0
174076,",",0,0
174077,wound,0,0
174078,infection,0,0
174079,incidence,0,0
174080,",",0,0
174081,and,0,0
174082,duration,0,0
174083,of,0,0
174084,hospital,0,1
174085,stay,0,0
174086,.,0,1
174087,RESULTS,0,0
174088,Pain,0,0
174089,was,0,0
174090,the,0,0
174091,most,0,0
174092,common,0,0
174093,symptoms,0,0
174094,in,0,0
174095,both,0,0
174096,groups,0,0
174097,.,0,0
174098,The,0,0
174099,TAPP,0,0
174100,group,0,0
174101,patients,0,1
174102,significantly,0,0
174103,had,0,0
174104,experienced,0,0
174105,less,0,0
174106,postoperative,0,0
174107,pain,0,0
174108,than,0,0
174109,the,0,0
174110,Lichtenstein,0,0
174111,group,0,0
174112,in,0,0
174113,all,0,0
174114,moments,0,0
174115,(,0,0
174116,P,0,0
174117,<,0,0
174118,0.05,0,0
174119,),0,1
174120,.,0,1
174121,TAPP,0,0
174122,group,0,0
174123,had,0,0
174124,lower,0,0
174125,incidence,0,0
174126,of,0,0
174127,hematoma,0,0
174128,(,0,0
174129,TAPP,0,0
174130,",",0,0
174131,6.6,0,0
174132,%,0,0
174133,vs.,0,0
174134,Lichtenstein,0,1
174135,13.3,0,1
174136,%,0,0
174137,;,0,1
174138,P=0.67,0,0
174139,),0,0
174140,",",0,0
174141,seroma,0,0
174142,(,0,0
174143,TAPP,0,0
174144,10,0,0
174145,%,0,0
174146,vs.,0,0
174147,Lichtenstein,0,1
174148,13.3,0,1
174149,%,0,0
174150,;,0,1
174151,P=1.00,0,0
174152,),0,0
174153,",",0,0
174154,and,0,0
174155,infection,0,0
174156,(,0,0
174157,TAPP,0,0
174158,0,0,0
174159,vs.,0,0
174160,Lichtenstein,0,1
174161,1.6,0,0
174162,%,0,0
174163,;,0,1
174164,P=0.67,0,0
174165,),0,0
174166,.,0,0
174167,However,0,0
174168,",",0,0
174169,no,0,0
174170,differences,0,0
174171,between,0,0
174172,the,0,0
174173,2,0,0
174174,groups,0,0
174175,were,0,1
174176,found,0,0
174177,in,0,0
174178,terms,0,0
174179,of,0,1
174180,postoperative,0,1
174181,complications,0,0
174182,.,0,1
174183,In,0,0
174184,TAPP,0,0
174185,group,0,0
174186,mean,0,0
174187,of,0,0
174188,hospital,0,1
174189,stay,0,0
174190,significantly,0,0
174191,was,0,0
174192,less,0,0
174193,than,0,0
174194,Lichtenstein,0,0
174195,group,0,1
174196,(,0,0
174197,TAPP,0,0
174198,",",0,0
174199,8.13?2.19,0,0
174200,vs.,0,0
174201,Lichtenstein,0,1
174202,",",0,0
174203,13.15?1.5,0,0
174204,days,0,0
174205,;,0,1
174206,P,0,0
174207,<,0,0
174208,0.001,0,0
174209,),0,0
174210,.,0,0
174211,CONCLUSION,0,0
174212,The,0,0
174213,laparoscopic,0,0
174214,TAPP,0,0
174215,repair,0,0
174216,is,0,0
174217,safer,0,0
174218,and,0,0
174219,less,0,0
174220,complicated,0,0
174221,approach,0,0
174222,to,0,0
174223,inguinal,0,1
174224,hernia,0,1
174225,repair,0,1
174226,.,0,0
174227,The,0,0
174228,two,0,0
174229,main,0,0
174230,short-term,0,0
174231,advantages,0,0
174232,of,0,0
174233,the,0,0
174234,laparoscopic,0,1
174235,TAPP,0,0
174236,repair,0,1
174237,with,0,1
174238,the,0,0
174239,tension,0,0
174240,free,0,0
174241,Lichtenstein,0,1
174242,repair,0,0
174243,were,0,0
174244,less,0,0
174245,postoperative,0,0
174246,pain,0,0
174247,and,0,0
174248,earlier,0,0
174249,return,0,0
174250,to,0,0
174251,the,0,0
174252,normal,0,1
174253,life,0,0
174254,activities,0,0
174255,.,0,0
174256,No,0,0
174257,difference,0,0
174258,was,0,0
174259,seen,0,0
174260,in,0,0
174261,overall,0,0
174262,complications,0,0
174263,.,0,1
174264,Safety,0,0
174265,and,0,0
174266,preliminary,0,0
174267,immunogenicity,0,0
174268,of,0,0
174269,Cuban,0,1
174270,pneumococcal,0,1
174271,conjugate,0,0
174272,vaccine,0,0
174273,candidate,0,0
174274,in,0,0
174275,healthy,1,1
174276,children,1,1
174277,:,1,1
174278,a,0,0
174279,randomized,0,0
174280,phase,0,0
174281,I,0,1
174282,clinical,0,0
174283,trial,0,0
174284,.,0,0
174285,A,0,0
174286,new,0,0
174287,heptavalent,0,0
174288,conjugate,0,0
174289,vaccine,0,0
174290,(,0,0
174291,PCV7-TT,0,0
174292,),0,0
174293,is,0,0
174294,under,0,0
174295,development,0,0
174296,in,0,0
174297,Cuba,0,1
174298,.,0,0
174299,PCV7-TT,0,0
174300,contains,0,0
174301,2,0,0
174302,?g,0,0
174303,of,0,0
174304,serotypes,0,0
174305,1,0,1
174306,",",0,0
174307,5,0,0
174308,",",0,0
174309,14,0,0
174310,",",0,0
174311,18C,0,0
174312,",",0,0
174313,19F,0,0
174314,",",0,0
174315,23F,0,1
174316,and,0,0
174317,4,0,0
174318,?g,0,0
174319,of,0,0
174320,6B,0,1
174321,",",0,0
174322,each,0,0
174323,one,0,0
174324,conjugated,0,0
174325,to,0,0
174326,tetanus,0,1
174327,toxoid,0,0
174328,(,0,0
174329,TT,0,0
174330,),0,0
174331,.,0,0
174332,This,0,0
174333,vaccine,0,0
174334,was,0,0
174335,designed,0,0
174336,with,0,1
174337,the,0,0
174338,serotypes,0,0
174339,that,0,0
174340,cause,0,0
174341,most,0,0
174342,invasive,0,1
174343,pneumococcal,0,1
174344,diseases,0,1
174345,(,0,1
174346,IPD,0,0
174347,),0,0
174348,worldwide,0,0
174349,.,0,0
174350,In,0,0
174351,the,0,0
174352,present,0,0
174353,study,0,0
174354,",",0,0
174355,we,0,0
174356,investigated,0,0
174357,the,0,0
174358,safety,0,0
174359,and,0,0
174360,explored,0,0
174361,the,0,0
174362,immunogenicity,0,0
174363,of,0,0
174364,PCV7-TT,0,1
174365,during,0,0
174366,a,0,0
174367,controlled,0,0
174368,",",0,0
174369,randomized,0,0
174370,and,0,0
174371,double,0,0
174372,blind,0,1
174373,clinical,0,0
174374,trial,0,0
174375,phase,0,0
174376,I,0,1
174377,in,0,0
174378,4-5-year-old,1,1
174379,children,1,1
174380,.,1,1
174381,PCV7-TT,0,0
174382,was,0,0
174383,well,0,0
174384,tolerated,0,0
174385,and,0,0
174386,as,0,0
174387,safe,0,0
174388,as,0,0
174389,Synflorix,0,1
174390,used,0,0
174391,as,0,0
174392,control,0,1
174393,vaccine,0,0
174394,.,0,0
174395,Following,0,0
174396,a,0,0
174397,single-dose,0,0
174398,vaccination,0,0
174399,",",0,0
174400,all,0,0
174401,individual,0,0
174402,serotypes,0,0
174403,included,0,1
174404,in,0,0
174405,PCV7-TT,0,0
174406,induced,0,0
174407,statistically,0,0
174408,significant,0,0
174409,increase,0,0
174410,of,0,0
174411,IgG,0,0
174412,GMC,0,0
174413,and,0,0
174414,OPA,0,1
174415,GMT,0,0
174416,.,0,0
174417,These,0,0
174418,are,0,0
174419,the,0,0
174420,first,0,0
174421,clinical,0,0
174422,results,0,0
174423,of,0,0
174424,PCV7-TT,0,1
174425,in,0,0
174426,children,0,1
174427,and,0,0
174428,they,0,1
174429,pave,0,0
174430,the,0,0
174431,way,0,0
174432,toward,0,0
174433,next,0,0
174434,clinical,0,0
174435,trials,0,1
174436,in,0,1
174437,children,0,1
174438,and,0,1
174439,infants,0,1
174440,.,0,1
174441,This,0,0
174442,clinical,0,0
174443,trial,0,0
174444,was,0,0
174445,published,0,0
174446,in,0,0
174447,the,0,0
174448,Cuban,0,1
174449,Public,0,1
174450,Register,0,1
174451,of,0,0
174452,Clinical,0,0
174453,Trials,0,0
174454,with,0,1
174455,code,0,0
174456,RPCEC00000173,0,1
174457,.,0,1
174458,Assessing,0,0
174459,the,0,0
174460,benefit,0,0
174461,of,0,0
174462,a,0,0
174463,personalized,0,0
174464,EHR-generated,0,0
174465,informed,0,0
174466,consent,0,1
174467,in,1,0
174468,a,1,0
174469,dental,1,1
174470,school,1,1
174471,setting,1,1
174472,.,1,0
174473,Informed,0,0
174474,consents,0,0
174475,are,0,0
174476,routinely,0,0
174477,used,0,0
174478,as,0,0
174479,an,0,0
174480,important,0,0
174481,source,0,0
174482,of,0,0
174483,information,0,0
174484,to,0,0
174485,help,0,0
174486,patients,1,1
174487,make,0,0
174488,appropriate,0,0
174489,clinical,0,0
174490,decisions,0,0
174491,.,0,0
174492,However,0,0
174493,",",0,0
174494,current,0,0
174495,standard,0,0
174496,consent,0,1
174497,forms,0,0
174498,may,0,0
174499,not,0,0
174500,accomplish,0,0
174501,their,0,0
174502,intended,0,0
174503,purpose,0,0
174504,due,0,0
174505,to,0,0
174506,the,0,0
174507,variety,0,0
174508,of,0,0
174509,patient,0,0
174510,literacy,0,0
174511,and,0,0
174512,experiences,0,0
174513,and,0,0
174514,",",0,0
174515,in,0,0
174516,the,0,0
174517,dental,0,1
174518,school,0,1
174519,setting,0,1
174520,",",0,0
174521,the,0,0
174522,developing,0,0
174523,competence,0,0
174524,of,0,0
174525,students,0,1
174526,.,0,1
174527,The,0,0
174528,purpose,0,0
174529,of,0,0
174530,this,0,0
174531,pilot,0,0
174532,study,0,0
174533,was,0,0
174534,to,0,0
174535,test,0,0
174536,the,0,0
174537,efficacy,0,0
174538,of,0,0
174539,a,0,0
174540,personalized,0,0
174541,informed,0,0
174542,consent,0,0
174543,generated,0,0
174544,through,0,0
174545,an,0,0
174546,electronic,0,0
174547,health,0,0
174548,record,0,0
174549,(,0,0
174550,EHR,0,0
174551,),0,0
174552,at,0,0
174553,one,0,1
174554,dental,0,1
174555,school,0,1
174556,and,0,0
174557,its,0,0
174558,role,0,0
174559,in,0,0
174560,patient,0,0
174561,decision,0,0
174562,making,0,0
174563,.,0,0
174564,In,0,0
174565,the,0,0
174566,study,0,0
174567,",",0,0
174568,a,0,0
174569,set,0,0
174570,of,0,0
174571,informed,0,0
174572,consents,0,0
174573,",",0,0
174574,or,0,1
174575,SmartConsents,0,0
174576,",",0,0
174577,were,0,0
174578,developed,0,0
174579,for,0,0
174580,specific,0,0
174581,diagnoses,0,1
174582,and,0,1
174583,procedures,0,0
174584,",",0,0
174585,enhanced,0,0
174586,with,0,1
174587,graphics,0,0
174588,",",0,0
174589,and,0,0
174590,delivered,0,0
174591,through,0,0
174592,the,0,0
174593,school,0,1
174594,'s,0,1
174595,EHR,0,0
174596,.,0,1
174597,Fifty,1,1
174598,patients,1,1
174599,were,1,0
174600,recruited,1,1
174601,in,1,0
174602,the,1,0
174603,school,1,1
174604,'s,1,1
174605,Urgent,1,1
174606,Care,1,1
174607,Clinic,1,0
174608,and,0,0
174609,divided,0,0
174610,evenly,0,0
174611,into,0,0
174612,two,0,0
174613,groups,0,1
174614,:,0,1
174615,one,0,1
174616,(,0,0
174617,control,0,1
174618,),0,0
174619,receiving,0,0
174620,the,0,0
174621,standard,0,0
174622,consent,0,0
174623,",",0,0
174624,with,0,1
174625,the,0,0
174626,second,0,0
174627,receiving,0,0
174628,a,0,0
174629,SmartConsent,0,0
174630,.,0,0
174631,Following,0,0
174632,treatment,0,0
174633,",",0,0
174634,patients,0,1
174635,were,0,0
174636,assessed,0,0
174637,based,0,0
174638,on,0,0
174639,demographics,0,0
174640,",",0,0
174641,decisional,0,0
174642,conflict,0,0
174643,",",0,0
174644,satisfaction,0,0
174645,",",0,0
174646,health,0,0
174647,literacy,0,0
174648,",",0,0
174649,and,0,0
174650,knowledge,0,0
174651,.,0,0
174652,Overall,0,0
174653,",",0,0
174654,there,0,0
174655,were,0,0
174656,no,0,0
174657,significant,0,0
174658,differences,0,0
174659,in,0,1
174660,main,0,0
174661,effects,0,0
174662,between,0,0
174663,SmartConsent,0,1
174664,and,0,0
174665,standard,0,0
174666,informed,0,0
174667,consents,0,0
174668,for,0,0
174669,decisional,0,0
174670,conflict,0,0
174671,and,0,0
174672,satisfaction,0,0
174673,",",0,0
174674,although,0,0
174675,significant,0,0
174676,differences,0,0
174677,were,0,1
174678,identified,0,1
174679,during,0,0
174680,secondary,0,0
174681,analysis,0,0
174682,of,0,0
174683,satisfaction,0,0
174684,",",0,0
174685,gender,0,0
174686,",",0,0
174687,and,0,0
174688,ethnicity,0,1
174689,.,0,0
174690,The,0,0
174691,study,0,0
174692,also,0,0
174693,demonstrated,0,0
174694,the,0,0
174695,potential,0,0
174696,for,0,0
174697,consents,0,0
174698,to,0,0
174699,aid,0,0
174700,the,0,0
174701,student,0,0
174702,provider,0,0
174703,in,0,0
174704,better,0,0
174705,communicating,0,0
174706,with,0,1
174707,patients,1,1
174708,.,1,1
174709,The,0,0
174710,effects,0,0
174711,of,0,0
174712,a,0,0
174713,course,0,0
174714,of,0,0
174715,intranasal,0,0
174716,oxytocin,0,0
174717,on,0,0
174718,social,0,0
174719,behaviors,0,0
174720,in,0,0
174721,youth,1,1
174722,diagnosed,1,1
174723,with,1,1
174724,autism,1,1
174725,spectrum,1,1
174726,disorders,1,1
174727,:,1,1
174728,a,0,0
174729,randomized,0,0
174730,controlled,0,0
174731,trial,0,0
174732,.,0,0
174733,BACKGROUND,0,0
174734,There,0,0
174735,is,0,0
174736,increasing,0,0
174737,interest,0,0
174738,in,0,0
174739,oxytocin,0,0
174740,as,0,0
174741,a,0,0
174742,therapeutic,0,0
174743,to,0,0
174744,treat,0,1
174745,social,0,0
174746,deficits,0,0
174747,in,0,0
174748,autism,1,1
174749,spectrum,1,1
174750,disorders,1,1
174751,(,1,1
174752,ASD,1,1
174753,),1,0
174754,.,1,0
174755,The,0,0
174756,aim,0,0
174757,of,0,0
174758,this,0,0
174759,study,0,0
174760,was,0,0
174761,to,0,0
174762,investigate,0,0
174763,the,0,0
174764,efficacy,0,0
174765,of,0,0
174766,a,0,0
174767,course,0,0
174768,of,0,0
174769,oxytocin,0,0
174770,nasal,0,0
174771,spray,0,0
174772,to,0,0
174773,improve,0,0
174774,social,0,0
174775,behavior,0,0
174776,in,0,0
174777,youth,1,1
174778,with,1,1
174779,ASD,1,1
174780,.,1,1
174781,METHODS,0,0
174782,In,0,0
174783,a,0,0
174784,double-blind,0,0
174785,",",0,0
174786,placebo-controlled,0,0
174787,trial,0,0
174788,across,0,0
174789,two,1,0
174790,Australian,1,1
174791,university,1,1
174792,sites,1,0
174793,between,1,0
174794,February,1,1
174795,2009,1,1
174796,and,1,0
174797,January,1,1
174798,2012,1,1
174799,",",1,0
174800,50,1,1
174801,male,1,1
174802,participants,1,1
174803,aged,1,1
174804,between,1,0
174805,12,1,0
174806,and,1,1
174807,18,1,1
174808,years,1,1
174809,",",1,0
174810,with,1,1
174811,Autistic,1,1
174812,or,1,1
174813,Asperger,1,1
174814,'s,1,1
174815,Disorder,1,1
174816,",",0,0
174817,were,0,0
174818,randomized,0,0
174819,to,0,0
174820,receive,0,0
174821,either,0,0
174822,oxytocin,0,0
174823,(,0,0
174824,n,0,1
174825,=,0,0
174826,26,0,1
174827,),0,0
174828,or,0,1
174829,placebo,0,0
174830,(,0,0
174831,n,0,1
174832,=,0,0
174833,24,0,1
174834,),0,0
174835,nasal,0,1
174836,sprays,0,0
174837,(,0,1
174838,either,0,1
174839,18,0,1
174840,or,0,1
174841,24,0,1
174842,International,0,1
174843,Units,0,1
174844,),0,0
174845,",",0,0
174846,administered,0,0
174847,twice-daily,0,0
174848,for,0,0
174849,8,0,0
174850,weeks,0,0
174851,.,0,1
174852,Participants,0,1
174853,were,0,0
174854,assessed,0,0
174855,at,0,0
174856,baseline,0,0
174857,",",0,0
174858,after,0,0
174859,4-,0,0
174860,and,0,0
174861,8-weeks,0,0
174862,of,0,0
174863,treatment,0,0
174864,",",0,0
174865,and,0,0
174866,at,0,0
174867,3-month,0,0
174868,follow-up,0,0
174869,.,0,1
174870,Primary,0,1
174871,outcomes,0,0
174872,were,0,1
174873,change,0,0
174874,in,0,0
174875,total,0,1
174876,scores,0,0
174877,on,0,0
174878,the,0,0
174879,caregiver-completed,0,0
174880,Social,0,0
174881,Responsiveness,0,1
174882,Scale,0,0
174883,and,0,0
174884,clinician-ratings,0,0
174885,on,0,0
174886,the,0,0
174887,Clinical,0,0
174888,Global,0,1
174889,Impressions-Improvement,0,0
174890,scale,0,0
174891,.,0,1
174892,Secondary,0,0
174893,assessments,0,0
174894,included,0,1
174895,caregiver,0,0
174896,reports,0,0
174897,of,0,0
174898,repetitive,0,0
174899,and,0,1
174900,other,0,0
174901,developmental,0,1
174902,behaviors,0,0
174903,and,0,1
174904,social,0,0
174905,cognition,0,0
174906,.,0,1
174907,CLINICAL,0,0
174908,TRIAL,0,0
174909,REGISTRATION,0,0
174910,Australian,0,1
174911,New,0,1
174912,Zealand,0,1
174913,Clinical,0,0
174914,Trials,0,1
174915,Registry,0,1
174916,www.anzctr.org.au,0,0
174917,ACTRN12609000513213,0,1
174918,.,0,1
174919,RESULTS,0,0
174920,Participants,0,1
174921,who,0,1
174922,received,0,1
174923,oxytocin,0,1
174924,showed,0,0
174925,no,0,0
174926,benefit,0,0
174927,following,0,0
174928,treatment,0,0
174929,on,0,0
174930,primary,0,1
174931,or,0,1
174932,secondary,0,1
174933,outcomes,0,0
174934,.,0,0
174935,However,0,0
174936,",",0,0
174937,caregivers,0,1
174938,who,0,1
174939,believed,0,1
174940,their,0,1
174941,children,0,1
174942,received,0,0
174943,oxytocin,0,0
174944,reported,0,0
174945,greater,0,0
174946,improvements,0,0
174947,compared,0,0
174948,to,0,1
174949,caregivers,0,1
174950,who,0,1
174951,believed,0,1
174952,their,0,1
174953,child,0,1
174954,received,0,0
174955,placebo,0,0
174956,.,0,1
174957,Nasal,0,0
174958,sprays,0,0
174959,were,0,0
174960,well,0,0
174961,tolerated,0,0
174962,and,0,0
174963,there,0,0
174964,was,0,0
174965,no,0,0
174966,evidence,0,0
174967,of,0,0
174968,increased,0,0
174969,side,0,0
174970,effects,0,0
174971,resulting,0,0
174972,from,0,1
174973,oxytocin,0,0
174974,administration,0,0
174975,.,0,0
174976,CONCLUSIONS,0,0
174977,This,0,0
174978,is,0,0
174979,the,0,0
174980,first,0,0
174981,evaluation,0,0
174982,of,0,0
174983,the,0,0
174984,efficacy,0,0
174985,for,0,0
174986,a,0,0
174987,course,0,0
174988,of,0,0
174989,oxytocin,0,0
174990,treatment,0,0
174991,for,0,0
174992,youth,0,1
174993,with,0,1
174994,ASD,0,1
174995,.,0,1
174996,Although,0,0
174997,results,0,0
174998,did,0,0
174999,not,0,0
175000,suggest,0,0
175001,clinical,0,0
175002,efficacy,0,0
175003,",",0,0
175004,further,0,0
175005,research,0,0
175006,is,0,0
175007,needed,0,0
175008,to,0,0
175009,explore,0,0
175010,alternative,0,0
175011,delivery,0,0
175012,methods,0,1
175013,",",0,0
175014,earlier,0,0
175015,age,0,1
175016,of,0,0
175017,intervention,0,0
175018,",",0,0
175019,and,0,0
175020,the,0,0
175021,influence,0,0
175022,of,0,0
175023,caregiver,0,0
175024,expectation,0,0
175025,on,0,0
175026,treatment,0,0
175027,response,0,0
175028,.,0,1
175029,Safety,0,0
175030,",",0,0
175031,pharmacokinetics,0,0
175032,",",0,0
175033,pharmacogenomics,0,0
175034,and,0,0
175035,QT,0,0
175036,concentration-effect,0,0
175037,modelling,0,0
175038,of,0,0
175039,the,0,0
175040,SirT1,0,0
175041,inhibitor,0,0
175042,selisistat,0,1
175043,in,0,0
175044,healthy,1,1
175045,volunteers,1,1
175046,.,1,1
175047,AIM,0,0
175048,Selisistat,0,0
175049,(,0,0
175050,SEN0014196,0,0
175051,),0,0
175052,",",0,0
175053,a,0,0
175054,first-in-class,0,0
175055,SirT1,0,0
175056,inhibitor,0,0
175057,",",0,0
175058,is,0,0
175059,being,0,0
175060,developed,0,0
175061,as,0,0
175062,a,0,0
175063,disease-modifying,0,0
175064,therapy,0,0
175065,for,0,0
175066,Huntington,1,1
175067,'s,1,1
175068,disease,1,1
175069,.,1,1
175070,This,0,0
175071,first-in-human,0,0
175072,study,0,0
175073,investigated,0,0
175074,the,0,0
175075,safety,0,0
175076,",",0,0
175077,pharmacokinetics,0,0
175078,and,0,0
175079,pharmacogenomics,0,0
175080,of,0,0
175081,single,0,0
175082,and,0,1
175083,multiple,0,0
175084,doses,0,0
175085,of,0,0
175086,selisistat,0,1
175087,in,0,0
175088,healthy,1,1
175089,male,1,1
175090,and,1,0
175091,female,1,1
175092,subjects,1,1
175093,.,1,1
175094,METHOD,0,0
175095,In,0,0
175096,this,0,0
175097,double-blind,0,0
175098,",",0,0
175099,randomized,0,0
175100,",",0,0
175101,placebo-controlled,0,0
175102,study,0,0
175103,",",0,0
175104,seven,1,1
175105,cohorts,1,1
175106,of,1,1
175107,eight,1,1
175108,subjects,1,1
175109,received,0,1
175110,a,0,0
175111,single,0,0
175112,dose,0,0
175113,of,0,0
175114,selisistat,0,1
175115,at,0,0
175116,dose,0,0
175117,levels,0,0
175118,of,0,0
175119,5,0,1
175120,",",0,0
175121,25,0,0
175122,",",0,0
175123,75,0,1
175124,",",0,0
175125,150,0,0
175126,",",0,0
175127,300,0,0
175128,and,0,0
175129,600,0,1
175130,mg,0,0
175131,and,0,1
175132,four,1,1
175133,cohorts,1,1
175134,of,1,1
175135,eight,1,1
175136,subjects,1,1
175137,were,0,1
175138,administered,0,0
175139,100,0,0
175140,",",0,0
175141,200,0,0
175142,and,0,0
175143,300,0,0
175144,mg,0,0
175145,once,0,0
175146,daily,0,0
175147,for,0,0
175148,7,0,1
175149,days,0,0
175150,.,0,1
175151,Blood,0,0
175152,sampling,0,0
175153,and,0,0
175154,safety,0,0
175155,assessments,0,0
175156,were,0,0
175157,conducted,0,0
175158,throughout,0,0
175159,the,0,0
175160,study,0,0
175161,.,0,0
175162,RESULTS,0,0
175163,Selisistat,0,0
175164,was,0,0
175165,rapidly,0,0
175166,absorbed,0,0
175167,and,0,0
175168,systemic,0,0
175169,exposure,0,0
175170,increased,0,0
175171,in,0,0
175172,proportion,0,0
175173,to,0,0
175174,dose,0,0
175175,in,0,0
175176,the,0,0
175177,5-300,0,0
175178,mg,0,0
175179,range,0,1
175180,.,0,0
175181,Steady-state,0,0
175182,plasma,0,0
175183,concentrations,0,0
175184,were,0,1
175185,achieved,0,0
175186,within,0,0
175187,4,0,0
175188,days,0,0
175189,of,0,0
175190,repeated,0,0
175191,dosing,0,0
175192,.,0,0
175193,The,0,0
175194,incidence,0,0
175195,of,0,0
175196,drug,0,0
175197,related,0,0
175198,adverse,0,0
175199,events,0,0
175200,showed,0,0
175201,no,0,0
175202,correlation,0,0
175203,with,0,1
175204,dose,0,0
175205,level,0,0
175206,or,0,0
175207,number,0,0
175208,of,0,0
175209,doses,0,0
175210,received,0,1
175211,and,0,0
175212,was,0,0
175213,comparable,0,0
175214,with,0,1
175215,the,0,0
175216,placebo,0,0
175217,group,0,0
175218,.,0,0
175219,No,0,0
175220,serious,0,0
175221,adverse,0,0
175222,events,0,0
175223,were,0,1
175224,reported,0,0
175225,and,0,0
175226,no,0,0
175227,subjects,0,1
175228,were,0,0
175229,withdrawn,0,0
175230,due,0,0
175231,to,0,0
175232,adverse,0,0
175233,events,0,0
175234,.,0,0
175235,There,0,0
175236,were,0,0
175237,no,0,0
175238,trends,0,0
175239,in,0,0
175240,clinical,0,0
175241,laboratory,0,0
175242,parameters,0,0
175243,or,0,1
175244,vital,0,1
175245,signs,0,0
175246,.,0,1
175247,No,0,0
175248,trends,0,0
175249,in,0,0
175250,heart,0,1
175251,rate,0,0
175252,or,0,1
175253,ECG,0,1
175254,parameters,0,0
175255,",",0,0
175256,including,0,0
175257,the,0,0
175258,QTc,0,0
175259,interval,0,0
175260,and,0,0
175261,T-wave,0,0
175262,morphology,0,1
175263,",",0,0
175264,were,0,0
175265,observed,0,0
175266,.,0,0
175267,There,0,0
175268,were,0,0
175269,no,0,0
175270,findings,0,0
175271,in,0,0
175272,physical,0,0
175273,or,0,1
175274,neurological,0,1
175275,examinations,0,0
175276,or,0,1
175277,postural,0,0
175278,control,0,1
175279,.,0,1
175280,Transcriptional,0,0
175281,alteration,0,0
175282,was,0,0
175283,observed,0,0
175284,in,0,0
175285,peripheral,0,1
175286,blood,0,0
175287,.,0,1
175288,CONCLUSION,0,0
175289,Selisistat,0,0
175290,was,0,0
175291,safe,0,0
175292,and,0,0
175293,well,0,0
175294,tolerated,0,0
175295,by,0,0
175296,healthy,1,1
175297,male,1,1
175298,and,1,0
175299,female,1,1
175300,subjects,1,1
175301,after,0,0
175302,single,0,0
175303,doses,0,0
175304,up,0,0
175305,to,0,0
175306,600,0,1
175307,mg,0,0
175308,and,0,0
175309,multiple,0,0
175310,doses,0,0
175311,up,0,0
175312,to,0,0
175313,300,0,0
175314,mg,0,0
175315,day,0,0
175316,(,0,0
175317,-1,0,0
175318,),0,0
175319,.,0,1
175320,Efficacy,0,0
175321,of,0,0
175322,rhubarb,0,0
175323,combined,0,0
175324,with,0,1
175325,early,0,1
175326,enteral,0,1
175327,nutrition,0,0
175328,for,0,0
175329,the,0,0
175330,treatment,0,0
175331,of,0,0
175332,severe,0,1
175333,acute,0,1
175334,pancreatitis,0,1
175335,:,0,1
175336,a,0,0
175337,randomized,0,0
175338,controlled,0,0
175339,trial,0,0
175340,.,0,0
175341,OBJECTIVE,0,0
175342,To,0,0
175343,investigate,0,0
175344,the,0,0
175345,effect,0,0
175346,of,0,0
175347,rhubarb,0,0
175348,combined,0,0
175349,with,0,1
175350,early,0,1
175351,enteral,0,1
175352,nutrition,0,0
175353,(,0,0
175354,EEN,0,0
175355,),0,0
175356,on,0,0
175357,the,0,0
175358,gastrointestinal,0,1
175359,function,0,0
175360,",",0,0
175361,disease,0,1
175362,severity,0,0
175363,and,0,0
175364,systemic,0,0
175365,inflammation,0,0
175366,in,0,0
175367,patients,1,1
175368,with,1,1
175369,severe,1,1
175370,acute,1,1
175371,pancreatitis,1,1
175372,(,1,0
175373,SAP,1,1
175374,),1,0
175375,.,1,0
175376,METHODS,0,0
175377,A,0,0
175378,total,0,1
175379,of,0,0
175380,126,1,1
175381,patients,1,1
175382,with,1,1
175383,SAP,1,1
175384,were,0,0
175385,randomly,0,1
175386,assigned,0,1
175387,into,0,0
175388,three,0,1
175389,groups,0,1
175390,:,0,1
175391,parenteral,0,0
175392,nutrition,0,0
175393,group,0,0
175394,",",0,0
175395,treated,0,1
175396,with,0,1
175397,standard,0,0
175398,solution,0,0
175399,first,0,0
175400,and,0,0
175401,EN,0,0
175402,14,0,1
175403,days,0,0
175404,later,0,1
175405,;,0,0
175406,EEN,0,0
175407,group,0,0
175408,",",0,0
175409,treated,0,1
175410,with,0,1
175411,EN,0,0
175412,suspension,0,0
175413,;,0,0
175414,or,0,1
175415,EEN,0,0
175416,combined,0,0
175417,with,0,1
175418,rhubarb,0,0
175419,group,0,0
175420,",",0,0
175421,treated,0,0
175422,with,0,1
175423,rhubarb,0,0
175424,and,0,0
175425,then,0,0
175426,EN,0,0
175427,2,0,0
175428,h,0,0
175429,later,0,0
175430,.,0,0
175431,The,0,0
175432,gastrointestinal,0,0
175433,function,0,0
175434,",",0,0
175435,APACHE,0,0
175436,II,0,1
175437,scores,0,0
175438,",",0,0
175439,the,0,0
175440,levels,0,0
175441,of,0,0
175442,plasma,0,0
175443,IL-6,0,0
175444,",",0,0
175445,IL-11,0,0
175446,",",0,0
175447,C-reactive,0,0
175448,proteins,0,0
175449,(,0,1
175450,CRP,0,1
175451,),0,0
175452,and,0,0
175453,the,0,0
175454,liver,0,0
175455,and,0,0
175456,kidney,0,1
175457,functional,0,1
175458,measures,0,0
175459,were,0,1
175460,longitudinally,0,1
175461,analyzed,0,0
175462,.,0,1
175463,RESULTS,0,0
175464,Patients,0,1
175465,in,0,1
175466,the,0,1
175467,EEN/rhubarb,0,0
175468,group,0,0
175469,had,0,0
175470,the,0,0
175471,shortest,0,0
175472,period,0,0
175473,of,0,0
175474,abdominal,0,1
175475,pain,0,1
175476,and,0,0
175477,the,0,0
175478,fastest,0,0
175479,recovery,0,0
175480,from,0,0
175481,abnormal,0,0
175482,bowel,0,1
175483,movement,0,0
175484,and,0,0
175485,high,0,0
175486,fever,0,0
175487,as,0,0
175488,well,0,0
175489,as,0,0
175490,significantly,0,0
175491,shorter,0,0
175492,periods,0,0
175493,of,0,0
175494,intensive-care,0,1
175495,unit,0,0
175496,and,0,0
175497,hospital,0,1
175498,stays,0,0
175499,.,0,0
175500,The,0,0
175501,combination,0,0
175502,of,0,0
175503,EEN,0,0
175504,and,0,0
175505,rhubarb,0,0
175506,significantly,0,0
175507,reduced,0,0
175508,the,0,0
175509,values,0,0
175510,of,0,0
175511,APACHE,0,0
175512,II,0,1
175513,scores,0,0
175514,.,0,1
175515,Combination,0,0
175516,therapies,0,0
175517,significantly,0,0
175518,reduced,0,0
175519,abnormally,0,0
175520,higher,0,0
175521,white,0,1
175522,blood,0,0
175523,cell,0,1
175524,(,0,0
175525,WBC,0,0
175526,),0,1
175527,counts,0,0
175528,and,0,1
175529,levels,0,0
175530,of,0,0
175531,plasma,0,0
175532,CRP,0,1
175533,and,0,0
175534,IL-6,0,0
175535,",",0,0
175536,but,0,0
175537,increased,0,0
175538,the,0,0
175539,levels,0,0
175540,of,0,0
175541,plasma,0,0
175542,IL-11,0,1
175543,.,0,1
175544,Finally,0,0
175545,",",0,0
175546,combination,0,0
175547,therapies,0,0
175548,improved,0,0
175549,the,0,0
175550,SAP-related,0,0
175551,damages,0,0
175552,of,0,0
175553,liver,0,1
175554,and,0,0
175555,kidney,0,1
175556,function,0,0
175557,by,0,0
175558,reducing,0,0
175559,abnormally,0,0
175560,higher,0,0
175561,levels,0,0
175562,of,0,0
175563,plasma,0,0
175564,alanine,0,0
175565,aminotransferase,0,0
175566,",",0,0
175567,aspartate,0,0
175568,aminotransferase,0,0
175569,",",0,0
175570,and,0,0
175571,creatinine,0,0
175572,(,0,0
175573,Cr,0,0
175574,),0,1
175575,.,0,1
175576,CONCLUSION,0,0
175577,Combination,0,0
175578,of,0,0
175579,EEN,0,0
175580,and,0,0
175581,rhubarb,0,0
175582,significantly,0,0
175583,improved,0,0
175584,the,0,0
175585,gastrointestinal,0,0
175586,function,0,0
175587,",",0,0
175588,inhibited,0,0
175589,systemic,0,0
175590,inflammation,0,0
175591,and,0,0
175592,disease,0,1
175593,severity,0,0
175594,and,0,0
175595,mitigated,0,0
175596,the,0,0
175597,disease-related,0,0
175598,damages,0,0
175599,of,0,0
175600,liver,0,1
175601,and,0,0
175602,kidney,0,1
175603,function,0,0
175604,in,0,0
175605,SAP,1,1
175606,patients,1,1
175607,.,1,1
175608,Acute,0,1
175609,effects,0,0
175610,of,0,0
175611,static,0,0
175612,active,0,1
175613,or,0,1
175614,dynamic,0,0
175615,active,0,1
175616,stretching,0,0
175617,on,0,0
175618,eccentric-exercise-induced,1,0
175619,hamstring,1,1
175620,muscle,1,0
175621,damage,1,0
175622,.,1,0
175623,OBJECTIVES,0,0
175624,To,0,0
175625,examine,0,0
175626,whether,0,0
175627,an,0,0
175628,acute,0,1
175629,bout,0,0
175630,of,0,0
175631,active,0,1
175632,or,0,1
175633,dynamic,0,0
175634,hamstring-stretching,0,0
175635,exercises,0,0
175636,would,0,0
175637,reduce,0,0
175638,the,0,0
175639,amount,0,0
175640,of,0,0
175641,muscle,0,0
175642,damage,0,0
175643,observed,0,0
175644,after,0,0
175645,a,0,0
175646,strenuous,0,0
175647,eccentric,0,0
175648,task,0,0
175649,and,0,0
175650,to,0,0
175651,determine,0,0
175652,whether,0,0
175653,the,0,0
175654,stretching,0,0
175655,protocols,0,0
175656,elicit,0,0
175657,similar,0,0
175658,responses,0,0
175659,.,0,1
175660,DESIGN,0,0
175661,A,0,0
175662,randomized,0,0
175663,controlled,0,0
175664,clinical,0,0
175665,trial,0,1
175666,.,0,1
175667,METHODS,0,0
175668,Thirty-six,1,1
175669,young,1,1
175670,male,1,1
175671,students,1,1
175672,performed,1,0
175673,5,1,0
175674,min,1,0
175675,of,1,0
175676,jogging,1,0
175677,as,1,0
175678,a,1,0
175679,warm-up,1,0
175680,and,1,0
175681,were,1,0
175682,allocated,1,1
175683,to,1,0
175684,1,1,0
175685,of,1,0
175686,3,1,1
175687,groups,1,1
175688,:,1,1
175689,3,1,0
175690,min,1,0
175691,of,1,0
175692,static,1,0
175693,active,1,1
175694,stretching,1,0
175695,(,1,0
175696,SAS,1,0
175697,),1,0
175698,",",1,0
175699,3,1,0
175700,min,1,0
175701,of,1,0
175702,dynamic,1,0
175703,active,1,1
175704,stretching,1,0
175705,(,1,0
175706,DAS,1,0
175707,),1,0
175708,",",1,0
175709,or,1,0
175710,control,1,0
175711,(,1,0
175712,CON,1,0
175713,),1,0
175714,.,1,0
175715,All,0,1
175716,subjects,1,1
175717,performed,1,0
175718,eccentric,1,0
175719,exercise,1,0
175720,immediately,1,0
175721,after,1,0
175722,stretching,1,0
175723,.,1,1
175724,Heart,0,0
175725,rate,0,0
175726,",",0,0
175727,core,0,0
175728,temperature,0,0
175729,",",0,0
175730,maximal,0,0
175731,voluntary,0,1
175732,isometric,0,1
175733,contraction,0,0
175734,",",0,0
175735,passive,0,0
175736,hip,0,1
175737,flexion,0,0
175738,",",0,0
175739,passive,0,0
175740,hamstring,0,0
175741,stiffness,0,0
175742,(,0,0
175743,PHS,0,0
175744,),0,0
175745,",",0,0
175746,plasma,0,0
175747,creatine,0,0
175748,kinase,0,0
175749,activity,0,0
175750,",",0,0
175751,and,0,0
175752,myoglobin,0,0
175753,were,0,0
175754,recorded,0,0
175755,at,0,0
175756,prestretching,0,0
175757,",",0,0
175758,at,0,0
175759,poststretching,0,0
175760,",",0,0
175761,and,0,0
175762,every,0,0
175763,day,0,0
175764,after,0,0
175765,the,0,0
175766,eccentric,0,0
175767,exercises,0,0
175768,for,0,1
175769,5,0,1
175770,d.,0,1
175771,RESULTS,0,0
175772,After,0,0
175773,stretching,0,0
175774,",",0,0
175775,the,0,0
175776,change,0,0
175777,in,0,0
175778,hip,0,1
175779,flexion,0,0
175780,was,0,0
175781,significantly,0,0
175782,higher,0,0
175783,in,0,0
175784,the,0,0
175785,SAS,0,0
175786,(,0,0
175787,5?,0,0
175788,),0,0
175789,and,0,0
175790,DAS,0,0
175791,(,0,0
175792,10.8?,0,0
175793,),0,1
175794,groups,0,0
175795,than,0,0
175796,in,0,0
175797,the,0,0
175798,CON,0,0
175799,(,0,0
175800,-4.1?,0,0
175801,),0,0
175802,group,0,0
175803,.,0,0
175804,The,0,0
175805,change,0,0
175806,in,0,0
175807,PHS,0,0
175808,was,0,0
175809,significantly,0,0
175810,higher,0,0
175811,in,0,0
175812,the,0,0
175813,DAS,0,0
175814,(,0,0
175815,5.6,0,0
175816,%,0,0
175817,),0,0
175818,group,0,0
175819,than,0,0
175820,in,0,0
175821,the,0,0
175822,CON,0,0
175823,(,0,0
175824,-5.7,0,0
175825,%,0,0
175826,),0,0
175827,and,0,0
175828,SAS,0,0
175829,(,0,0
175830,-6.7,0,0
175831,%,0,0
175832,),0,1
175833,groups,0,0
175834,.,0,1
175835,Furthermore,0,0
175836,",",0,0
175837,changes,0,0
175838,in,0,0
175839,muscle-damage,0,1
175840,markers,0,0
175841,were,0,0
175842,smaller,0,0
175843,in,0,0
175844,the,0,0
175845,SAS,0,0
175846,group,0,0
175847,than,0,0
175848,in,0,0
175849,the,0,0
175850,DAS,0,0
175851,and,0,0
175852,CON,0,0
175853,groups,0,0
175854,.,0,1
175855,CONCLUSIONS,0,0
175856,Prior,0,1
175857,active,0,0
175858,stretching,0,0
175859,could,0,0
175860,be,0,0
175861,useful,0,0
175862,for,0,0
175863,attenuating,0,0
175864,the,0,0
175865,symptoms,0,0
175866,of,0,0
175867,muscle,0,0
175868,damage,0,0
175869,after,0,0
175870,eccentric,0,0
175871,exercise,0,0
175872,.,0,0
175873,SAS,0,0
175874,is,0,0
175875,recommended,0,0
175876,over,0,0
175877,DAS,0,0
175878,as,0,0
175879,a,0,0
175880,stretching,0,0
175881,protocol,0,0
175882,in,0,0
175883,terms,0,0
175884,of,0,0
175885,strength,0,0
175886,",",0,0
175887,hamstring,0,0
175888,range,0,0
175889,of,0,0
175890,motion,0,0
175891,",",0,0
175892,and,0,0
175893,damage,0,0
175894,markers,0,0
175895,.,0,1
175896,A,0,0
175897,neuropsychological,0,0
175898,rehabilitation,0,0
175899,program,0,0
175900,for,0,0
175901,patients,1,1
175902,with,1,1
175903,Multiple,1,1
175904,Sclerosis,1,1
175905,based,1,0
175906,on,1,0
175907,the,1,0
175908,model,1,0
175909,of,1,0
175910,the,1,0
175911,ICF,1,0
175912,.,1,0
175913,BACKGROUND,0,0
175914,Forty,0,1
175915,to,0,0
175916,sixty,0,1
175917,percent,0,0
175918,of,0,0
175919,MS,0,1
175920,patients,0,1
175921,suffer,0,1
175922,from,0,1
175923,cognitive,0,1
175924,impairments,0,1
175925,.,0,1
175926,Cognitive,0,0
175927,deficits,0,0
175928,are,0,0
175929,a,0,0
175930,great,0,0
175931,burden,0,0
175932,for,0,0
175933,patients,0,1
175934,affected,0,0
175935,.,0,1
175936,In,0,0
175937,particular,0,0
175938,they,0,0
175939,may,0,0
175940,lead,0,0
175941,to,0,0
175942,a,0,0
175943,reduced,0,0
175944,quality,0,0
175945,of,0,0
175946,life,0,0
175947,",",0,0
175948,loss,0,0
175949,of,0,0
175950,work,0,0
175951,and,0,0
175952,problems,0,1
175953,with,0,1
175954,the,0,0
175955,social,0,0
175956,environment,0,0
175957,.,0,0
175958,OBJECTIVE,0,0
175959,The,0,0
175960,aim,0,0
175961,of,0,0
175962,this,0,0
175963,study,0,0
175964,was,0,0
175965,to,0,0
175966,evaluate,0,0
175967,a,0,0
175968,specific,0,0
175969,neuropsychological,0,1
175970,rehabilitation,0,1
175971,program,0,0
175972,for,0,0
175973,MS,1,1
175974,patients,1,1
175975,according,1,1
175976,to,1,0
175977,the,1,0
175978,ICF,1,0
175979,to,0,0
175980,be,0,0
175981,able,0,0
175982,to,0,0
175983,meet,0,0
175984,more,0,0
175985,properly,0,0
175986,individual,0,0
175987,requirements,0,0
175988,on,0,0
175989,the,0,0
175990,therapy,0,0
175991,level,0,0
175992,of,0,0
175993,function,0,0
175994,as,0,0
175995,well,0,0
175996,as,0,0
175997,of,0,0
175998,activities,0,0
175999,and,0,1
176000,participation,0,0
176001,.,0,1
176002,METHODS,0,0
176003,Forty,1,1
176004,patients,1,1
176005,with,1,1
176006,MS,1,1
176007,were,1,0
176008,randomised,1,0
176009,in,1,0
176010,an,1,0
176011,intervention,1,0
176012,(,1,0
176013,IG,1,1
176014,),1,1
176015,-,1,0
176016,and,1,0
176017,a,1,0
176018,control,1,0
176019,group,1,0
176020,(,1,0
176021,CG,1,1
176022,),1,0
176023,.,1,0
176024,The,0,0
176025,outcome,0,0
176026,measure,0,0
176027,of,0,0
176028,the,0,0
176029,IG,0,1
176030,",",0,0
176031,who,0,1
176032,started,0,1
176033,an,0,1
176034,intensive,0,0
176035,computer,0,0
176036,based,0,0
176037,home,0,0
176038,training,0,0
176039,of,0,0
176040,attention,0,0
176041,and,0,0
176042,attended,0,1
176043,psychological,0,0
176044,counselling,0,0
176045,was,0,0
176046,compared,0,0
176047,to,0,0
176048,the,0,0
176049,untrained,0,1
176050,CG,0,1
176051,.,0,1
176052,RESULTS,0,0
176053,In,0,0
176054,specific,0,0
176055,domains,0,0
176056,of,0,0
176057,attention,0,0
176058,(,0,0
176059,simple,0,0
176060,and,0,0
176061,cued,0,0
176062,alertness,0,0
176063,and,0,0
176064,divided,0,1
176065,attention,0,0
176066,),0,0
176067,significant,0,0
176068,group,0,1
176069,differences,0,0
176070,between,0,0
176071,CG,0,1
176072,and,0,0
176073,IG,0,0
176074,could,0,0
176075,be,0,0
176076,found,0,0
176077,.,0,0
176078,The,0,0
176079,IG,0,0
176080,reported,0,0
176081,an,0,0
176082,improvement,0,0
176083,of,0,0
176084,mental,0,1
176085,fatigue,0,0
176086,and,0,0
176087,retardation,0,1
176088,.,0,0
176089,CONCLUSION,0,0
176090,These,0,0
176091,findings,0,0
176092,support,0,0
176093,the,0,0
176094,idea,0,0
176095,that,0,0
176096,a,0,0
176097,neuropsychological,0,0
176098,rehabilitation,0,0
176099,program,0,0
176100,",",0,0
176101,which,0,0
176102,based,0,0
176103,on,0,0
176104,the,0,0
176105,model,0,0
176106,of,0,0
176107,ICF,0,0
176108,",",0,0
176109,could,0,0
176110,improve,0,0
176111,cognitive,0,0
176112,impairment,0,0
176113,and,0,0
176114,could,0,0
176115,also,0,0
176116,have,0,0
176117,a,0,0
176118,positive,0,0
176119,influence,0,0
176120,of,0,0
176121,activities,0,0
176122,and,0,1
176123,participation,0,0
176124,.,0,1
176125,Randomized,0,0
176126,controlled,0,0
176127,trial,0,0
176128,of,0,0
176129,parental,0,0
176130,responsiveness,0,0
176131,intervention,0,0
176132,for,0,0
176133,toddlers,1,1
176134,at,1,1
176135,high,1,1
176136,risk,1,0
176137,for,1,0
176138,autism,1,1
176139,.,1,0
176140,This,0,0
176141,study,0,0
176142,tested,0,0
176143,the,0,0
176144,effects,0,0
176145,of,0,0
176146,a,0,0
176147,parent-mediated,1,0
176148,intervention,0,0
176149,on,0,0
176150,parental,0,0
176151,responsiveness,0,0
176152,with,0,1
176153,their,0,0
176154,toddlers,1,1
176155,at,1,0
176156,high,1,1
176157,risk,1,0
176158,for,1,0
176159,an,1,0
176160,autism,1,1
176161,spectrum,1,1
176162,disorder,1,1
176163,(,1,0
176164,ASD,1,1
176165,),1,1
176166,.,1,1
176167,Participants,1,1
176168,included,1,1
176169,caregivers,1,1
176170,and,1,1
176171,their,1,1
176172,66,1,1
176173,toddlers,1,1
176174,at,1,1
176175,high,1,1
176176,risk,1,1
176177,for,1,0
176178,ASD,1,1
176179,.,1,1
176180,Caregivers,1,0
176181,were,0,0
176182,randomized,0,1
176183,to,0,0
176184,12,0,0
176185,sessions,0,0
176186,of,0,0
176187,an,0,0
176188,individualized,0,0
176189,parent,0,0
176190,education,0,0
176191,intervention,0,0
176192,aimed,0,0
176193,at,0,0
176194,improving,0,0
176195,parental,0,0
176196,responsiveness,0,0
176197,or,0,1
176198,to,0,0
176199,a,0,0
176200,monitoring,0,0
176201,control,0,0
176202,group,0,0
176203,involving,0,1
176204,4,0,0
176205,sessions,0,0
176206,of,0,0
176207,behavioral,0,1
176208,support,0,0
176209,.,0,1
176210,Parental,0,0
176211,responsiveness,0,0
176212,and,0,0
176213,child,0,1
176214,outcomes,0,0
176215,were,0,0
176216,measured,0,0
176217,at,0,0
176218,three,0,0
176219,time,0,0
176220,points,0,0
176221,:,0,1
176222,at,0,0
176223,beginning,0,0
176224,and,0,0
176225,end,0,0
176226,of,0,0
176227,the,0,0
176228,3-month,0,0
176229,treatment,0,0
176230,and,0,0
176231,at,0,0
176232,12-months,0,0
176233,post-study,0,0
176234,entry,0,1
176235,.,0,1
176236,Parental,0,0
176237,responsiveness,0,0
176238,improved,0,0
176239,significantly,0,0
176240,in,0,0
176241,the,0,0
176242,treatment,0,0
176243,group,0,0
176244,but,0,0
176245,not,0,0
176246,the,0,0
176247,control,0,0
176248,group,0,0
176249,.,0,0
176250,However,0,0
176251,",",0,0
176252,parental,0,0
176253,responsiveness,0,0
176254,was,0,0
176255,not,0,0
176256,fully,0,0
176257,maintained,0,0
176258,at,0,0
176259,follow,0,0
176260,up,0,0
176261,.,0,0
176262,There,0,0
176263,were,0,0
176264,no,0,0
176265,treatment,0,0
176266,effects,0,0
176267,on,0,0
176268,child,0,1
176269,outcomes,0,0
176270,of,0,0
176271,joint,0,1
176272,attention,0,0
176273,or,0,1
176274,language,0,0
176275,.,0,0
176276,Children,0,1
176277,in,0,0
176278,both,0,0
176279,groups,0,0
176280,made,0,0
176281,significant,0,0
176282,developmental,0,1
176283,gains,0,0
176284,in,0,0
176285,cognition,0,0
176286,and,0,0
176287,language,0,0
176288,skills,0,0
176289,over,0,0
176290,one,0,1
176291,year,0,1
176292,.,0,1
176293,These,0,0
176294,results,0,0
176295,support,0,0
176296,parental,0,0
176297,responsiveness,0,0
176298,as,0,0
176299,an,0,0
176300,important,0,0
176301,intervention,0,0
176302,target,0,0
176303,given,0,0
176304,its,0,0
176305,general,0,1
176306,association,0,0
176307,with,0,1
176308,child,0,1
176309,outcomes,0,0
176310,in,0,0
176311,the,0,0
176312,extant,0,0
176313,literature,0,0
176314,;,0,0
176315,however,0,0
176316,",",0,0
176317,additional,0,0
176318,supports,0,0
176319,are,0,0
176320,likely,0,0
176321,needed,0,0
176322,to,0,0
176323,fully,0,0
176324,maintain,0,0
176325,the,0,0
176326,treatment,0,0
176327,effect,0,0
176328,and,0,0
176329,to,0,0
176330,affect,0,0
176331,child,0,1
176332,outcomes,0,0
176333,.,0,1
176334,Dental,1,1
176335,prophylaxis,1,0
176336,decreases,1,0
176337,the,1,0
176338,risk,1,0
176339,of,1,0
176340,esophageal,1,1
176341,cancer,1,1
176342,in,1,1
176343,males,1,1
176344,;,1,1
176345,a,1,0
176346,nationwide,1,1
176347,population-based,1,1
176348,study,1,1
176349,in,1,0
176350,Taiwan,1,1
176351,.,1,1
176352,BACKGROUND,0,0
176353,Periodontal,0,0
176354,disease,0,1
176355,(,0,0
176356,PD,0,0
176357,),0,0
176358,is,0,0
176359,one,0,0
176360,of,0,0
176361,the,0,0
176362,most,0,0
176363,common,0,0
176364,chronic,0,1
176365,inflammatory,0,0
176366,diseases,0,1
176367,.,0,1
176368,Esophageal,1,1
176369,cancer,1,1
176370,(,1,0
176371,EC,1,0
176372,),1,0
176373,is,1,0
176374,also,1,0
176375,a,1,0
176376,common,1,0
176377,cause,1,0
176378,of,1,0
176379,death,1,0
176380,due,1,0
176381,to,1,0
176382,cancer,1,1
176383,among,1,1
176384,males,1,1
176385,.,1,1
176386,Systemic,0,1
176387,inflammatory,0,0
176388,processes,0,0
176389,have,0,0
176390,been,0,0
176391,shown,0,0
176392,to,0,0
176393,increase,0,0
176394,the,0,0
176395,risk,0,0
176396,of,0,0
176397,cancer,0,1
176398,.,0,1
176399,We,0,0
176400,conducted,0,0
176401,a,0,0
176402,retrospective,0,0
176403,cohort,0,1
176404,study,0,0
176405,to,0,0
176406,investigate,0,0
176407,the,0,0
176408,association,0,0
176409,between,0,0
176410,PD,0,1
176411,and,0,1
176412,EC,0,0
176413,.,0,1
176414,METHODS,0,0
176415,A,0,0
176416,total,0,1
176417,of,0,0
176418,"718,409",1,1
176419,subjects,1,1
176420,were,1,1
176421,recruited,1,1
176422,from,1,0
176423,the,1,0
176424,Taiwan,1,1
176425,National,1,1
176426,Health,1,0
176427,Insurance,1,1
176428,Research,1,1
176429,Database,1,1
176430,(,1,0
176431,NHIRD,1,0
176432,),1,0
176433,and,0,0
176434,followed,0,0
176435,from,0,1
176436,January,0,1
176437,1,0,0
176438,",",0,0
176439,2000,0,1
176440,to,0,0
176441,December,0,1
176442,31,0,1
176443,",",0,0
176444,2010,0,1
176445,.,0,0
176446,Of,0,0
176447,these,0,0
176448,",",0,0
176449,"519,831",1,1
176450,subjects,1,1
176451,were,1,1
176452,diagnosed,1,1
176453,with,1,1
176454,PD,1,1
176455,and,0,0
176456,were,0,0
176457,grouped,0,1
176458,according,0,0
176459,to,0,0
176460,the,0,0
176461,most,0,0
176462,advanced,0,1
176463,treatment,0,0
176464,they,0,1
176465,received,0,0
176466,:,0,1
176467,dental,0,1
176468,prophylaxis,0,0
176469,",",0,0
176470,intensive,0,0
176471,treatment,0,0
176472,",",0,0
176473,or,0,0
176474,no,0,0
176475,treatment,0,0
176476,.,0,0
176477,The,0,0
176478,IRs,0,0
176479,of,0,0
176480,EC,0,0
176481,were,0,0
176482,compared,0,0
176483,among,0,1
176484,groups,0,0
176485,.,0,1
176486,RESULTS,0,0
176487,A,0,0
176488,total,0,1
176489,of,0,0
176490,682,1,1
176491,patients,1,1
176492,developed,1,1
176493,EC,1,0
176494,",",0,0
176495,resulting,0,0
176496,in,0,0
176497,an,0,0
176498,overall,0,0
176499,IR,0,1
176500,of,0,0
176501,0.11,0,0
176502,case-number,0,1
176503,per,0,1
176504,1000,0,0
176505,person-years,0,0
176506,(,1,1
176507,?/y,1,1
176508,),1,0
176509,.,1,0
176510,The,1,0
176511,dental,1,0
176512,prophylaxis,1,0
176513,group,1,0
176514,had,1,0
176515,a,0,0
176516,significantly,0,0
176517,lower,0,0
176518,IR,0,0
176519,of,0,0
176520,EC,0,0
176521,(,0,1
176522,0.06?/y,0,0
176523,),0,0
176524,than,0,0
176525,other,0,0
176526,groups,0,0
176527,(,0,1
176528,p,0,0
176529,<,0,0
176530,0.001,0,0
176531,),0,1
176532,.,0,1
176533,Multivariable,0,0
176534,Cox,0,0
176535,regression,0,0
176536,analysis,0,0
176537,further,0,0
176538,revealed,0,0
176539,that,0,0
176540,male,1,1
176541,subjects,1,1
176542,[,1,0
176543,hazard,1,0
176544,ratio,0,0
176545,(,0,0
176546,HR,0,0
176547,),0,0
176548,=,0,0
176549,10.04,0,0
176550,",",0,0
176551,95,0,0
176552,%,0,0
176553,confidence,0,0
176554,interval,0,0
176555,(,0,0
176556,CI,0,0
176557,),0,0
176558,=,0,0
176559,7.58-13.30,0,0
176560,],0,0
176561,",",0,0
176562,as,0,0
176563,well,0,0
176564,as,0,0
176565,a,0,0
176566,history,0,1
176567,of,0,0
176568,esophageal,0,1
176569,ulcers,0,1
176570,(,0,1
176571,HR,0,0
176572,=,0,0
176573,7.10,0,0
176574,",",0,0
176575,95,0,0
176576,%,0,0
176577,CI,0,0
176578,=,0,0
176579,5.03-10.01,0,0
176580,),0,0
176581,",",0,0
176582,alcohol,0,0
176583,abuse,0,0
176584,(,0,0
176585,HR,0,0
176586,=,0,0
176587,5.46,0,0
176588,",",0,0
176589,95,0,0
176590,%,0,0
176591,CI,0,0
176592,=,0,0
176593,2.26-13.18,0,0
176594,),0,0
176595,",",0,0
176596,or,0,0
176597,esophageal,0,1
176598,reflux,0,1
176599,(,0,0
176600,HR,0,0
176601,=,0,0
176602,1.86,0,0
176603,",",0,0
176604,95,0,0
176605,%,0,0
176606,CI,0,0
176607,=,0,0
176608,1.02-3.52,0,0
176609,),0,0
176610,",",0,0
176611,were,0,0
176612,factors,0,0
176613,associated,0,0
176614,with,0,1
176615,a,0,0
176616,higher,0,0
176617,risk,0,0
176618,of,0,0
176619,EC,0,0
176620,.,0,1
176621,And,1,0
176622,the,1,0
176623,dental,1,1
176624,prophylaxis,1,0
176625,group,1,0
176626,showed,0,0
176627,a,0,0
176628,significantly,0,0
176629,lower,0,0
176630,risk,0,0
176631,for,0,0
176632,EC,0,0
176633,(,0,1
176634,HR,0,0
176635,=,0,0
176636,0.53,0,0
176637,",",0,0
176638,95,0,0
176639,%,0,0
176640,CI,0,0
176641,=,0,0
176642,0.44-0.65,0,0
176643,),0,0
176644,.,0,0
176645,Further,0,0
176646,subgroup,0,1
176647,analysis,1,0
176648,showed,1,0
176649,that,1,0
176650,the,1,0
176651,dental,1,1
176652,prophylaxis,1,0
176653,group,1,0
176654,among,1,0
176655,males,1,1
176656,had,1,1
176657,a,1,0
176658,significant,1,0
176659,lower,1,0
176660,risk,1,0
176661,(,1,0
176662,HR,1,0
176663,=,0,0
176664,0.54,0,0
176665,",",0,0
176666,95,0,0
176667,%,0,0
176668,CI,0,0
176669,=,0,0
176670,0.44-0.66,0,0
176671,),0,0
176672,for,0,0
176673,EC,0,0
176674,",",0,0
176675,while,0,0
176676,that,0,0
176677,of,0,0
176678,the,0,0
176679,females,0,1
176680,did,0,0
176681,not,0,0
176682,has,0,0
176683,statistically,0,0
176684,significant,0,0
176685,difference,0,0
176686,.,0,0
176687,CONCLUSION,0,0
176688,For,0,0
176689,this,0,0
176690,cohort,0,0
176691,",",0,0
176692,subjects,0,1
176693,received,0,0
176694,dental,0,1
176695,prophylaxis,0,0
176696,reduced,0,0
176697,the,0,0
176698,risk,0,0
176699,of,0,0
176700,EC,0,0
176701,compared,0,0
176702,to,0,0
176703,all,0,0
176704,PD,0,0
176705,and,0,0
176706,no,0,0
176707,PD,0,0
176708,groups,0,0
176709,among,0,1
176710,males,0,1
176711,.,0,1
176712,Inhibition,0,0
176713,of,0,0
176714,PCSK9,0,1
176715,with,0,1
176716,evolocumab,0,1
176717,in,0,0
176718,homozygous,1,1
176719,familial,1,1
176720,hypercholesterolaemia,1,1
176721,(,0,0
176722,TESLA,0,0
176723,Part,0,1
176724,B,0,1
176725,),0,1
176726,:,0,1
176727,a,0,0
176728,randomised,0,0
176729,",",0,0
176730,double-blind,0,0
176731,",",0,0
176732,placebo-controlled,0,0
176733,trial,0,0
176734,.,0,1
176735,BACKGROUND,0,0
176736,Homozygous,1,1
176737,familial,1,1
176738,hypercholesterolaemia,1,1
176739,is,0,0
176740,a,0,0
176741,rare,0,0
176742,",",0,0
176743,serious,0,0
176744,disorder,0,1
176745,caused,0,0
176746,by,0,0
176747,very,0,0
176748,low,0,0
176749,or,0,1
176750,absent,0,1
176751,plasma,0,0
176752,clearance,0,0
176753,of,0,0
176754,LDL,0,0
176755,",",0,0
176756,substantially,0,0
176757,raised,0,0
176758,LDL,0,0
176759,cholesterol,0,0
176760,",",0,0
176761,and,0,0
176762,accelerated,0,0
176763,development,0,0
176764,of,0,0
176765,cardiovascular,0,1
176766,disease,0,1
176767,.,0,1
176768,Conventional,0,0
176769,lipid-lowering,0,1
176770,treatments,0,0
176771,are,0,0
176772,modestly,0,0
176773,effective,0,0
176774,.,0,0
176775,Evolocumab,0,0
176776,",",0,0
176777,a,0,0
176778,monoclonal,0,0
176779,antibody,0,0
176780,to,0,0
176781,proprotein,0,0
176782,convertase,0,0
176783,subtilisin/kexin,0,0
176784,type,0,1
176785,9,0,0
176786,(,0,0
176787,PCSK9,0,1
176788,),0,0
176789,",",0,0
176790,reduced,0,0
176791,LDL,0,0
176792,cholesterol,0,0
176793,by,0,0
176794,16,0,1
176795,%,0,0
176796,in,0,0
176797,a,0,0
176798,pilot,0,0
176799,study,0,0
176800,.,0,0
176801,We,0,0
176802,now,0,0
176803,report,0,0
176804,results,0,0
176805,with,0,1
176806,evolocumab,0,1
176807,in,0,0
176808,a,0,0
176809,randomised,0,0
176810,",",0,0
176811,double-blind,0,0
176812,",",0,0
176813,placebo-controlled,0,0
176814,phase,0,1
176815,3,0,0
176816,trial,0,0
176817,.,0,1
176818,METHODS,0,0
176819,This,0,0
176820,randomised,0,0
176821,",",0,0
176822,double-blind,0,0
176823,",",0,0
176824,placebo-controlled,0,0
176825,phase,0,1
176826,3,0,0
176827,trial,0,0
176828,was,0,0
176829,undertaken,0,0
176830,at,0,0
176831,17,0,1
176832,sites,0,0
176833,in,0,1
176834,ten,1,1
176835,countries,1,1
176836,in,1,1
176837,North,1,1
176838,America,1,0
176839,",",1,0
176840,Europe,1,0
176841,",",1,0
176842,the,1,0
176843,Middle,1,1
176844,East,1,0
176845,",",1,0
176846,and,1,0
176847,South,1,1
176848,Africa,1,1
176849,.,1,1
176850,50,1,0
176851,eligible,1,1
176852,patients,1,1
176853,(,1,1
176854,aged,1,1
176855,?12,1,1
176856,years,1,1
176857,),1,1
176858,with,1,1
176859,homozygous,1,1
176860,familial,1,1
176861,hypercholesterolaemia,1,1
176862,",",1,0
176863,on,1,0
176864,stable,1,1
176865,lipid-regulating,1,0
176866,therapy,1,0
176867,for,1,0
176868,at,1,0
176869,least,1,1
176870,4,1,0
176871,weeks,1,0
176872,",",1,0
176873,and,1,0
176874,not,1,0
176875,receiving,1,0
176876,lipoprotein,1,0
176877,apheresis,1,0
176878,",",1,0
176879,were,1,0
176880,randomly,1,0
176881,allocated,1,0
176882,by,1,0
176883,a,1,0
176884,computer-generated,1,0
176885,randomisation,1,0
176886,sequence,1,0
176887,in,1,0
176888,a,1,0
176889,2:1,1,1
176890,ratio,1,0
176891,to,1,0
176892,receive,1,0
176893,subcutaneous,1,1
176894,evolocumab,1,1
176895,420,1,1
176896,mg,1,0
176897,or,1,1
176898,placebo,1,0
176899,every,1,0
176900,4,1,0
176901,weeks,1,0
176902,for,1,1
176903,12,1,1
176904,weeks,1,0
176905,.,1,1
176906,Randomisation,0,0
176907,was,0,0
176908,stratified,0,1
176909,by,0,0
176910,LDL,0,0
176911,cholesterol,0,0
176912,at,0,0
176913,screening,0,1
176914,(,0,1
176915,<,0,0
176916,11,0,0
176917,mmol/L,0,0
176918,or,0,0
176919,?11,0,1
176920,mmol/L,0,0
176921,),0,0
176922,and,0,0
176923,implemented,0,0
176924,by,0,0
176925,a,0,0
176926,computerised,0,0
176927,interactive,0,0
176928,voice-response,0,0
176929,system,1,0
176930,.,1,0
176931,Patients,1,1
176932,",",1,0
176933,study,1,0
176934,personnel,1,1
176935,",",1,0
176936,and,1,0
176937,the,1,0
176938,funder,1,0
176939,were,1,0
176940,masked,1,0
176941,to,1,0
176942,treatment,1,0
176943,and,1,0
176944,to,1,0
176945,the,1,0
176946,efficacy,1,0
176947,results,1,0
176948,by,1,0
176949,the,1,0
176950,central,1,0
176951,laboratory,1,0
176952,not,1,0
176953,returning,1,0
176954,LDL,1,0
176955,cholesterol,1,0
176956,or,1,0
176957,any,1,0
176958,lipid,1,0
176959,results,1,0
176960,to,1,0
176961,the,1,0
176962,clinical,1,0
176963,sites,1,0
176964,after,1,0
176965,the,1,0
176966,baseline,1,0
176967,visit,1,0
176968,.,1,0
176969,The,1,0
176970,primary,0,0
176971,endpoint,0,0
176972,was,0,0
176973,percentage,0,0
176974,change,0,0
176975,in,0,0
176976,ultracentrifugation,0,0
176977,LDL,0,0
176978,cholesterol,0,0
176979,from,0,0
176980,baseline,0,0
176981,at,0,0
176982,week,0,0
176983,12,0,0
176984,compared,0,0
176985,with,0,1
176986,placebo,0,0
176987,",",0,0
176988,analysed,0,0
176989,by,0,0
176990,intention-to-treat,0,0
176991,.,0,0
176992,This,0,0
176993,trial,0,0
176994,is,0,0
176995,registered,0,0
176996,with,0,0
176997,ClinicalTrials.gov,0,0
176998,",",0,0
176999,number,0,0
177000,NCT01588496,0,0
177001,.,0,0
177002,FINDINGS,0,0
177003,Of,0,0
177004,the,0,0
177005,50,1,1
177006,eligible,1,1
177007,patients,1,1
177008,randomly,1,1
177009,assigned,1,1
177010,to,1,0
177011,the,1,0
177012,two,1,0
177013,treatment,1,0
177014,groups,1,0
177015,",",1,0
177016,49,1,1
177017,actually,1,0
177018,received,1,0
177019,the,1,0
177020,study,1,0
177021,drug,1,0
177022,and,1,0
177023,completed,1,1
177024,the,1,0
177025,study,1,0
177026,(,1,0
177027,16,1,1
177028,in,1,0
177029,the,1,0
177030,placebo,1,0
177031,group,1,0
177032,and,1,0
177033,33,1,1
177034,in,1,0
177035,the,1,0
177036,evolocumab,1,1
177037,group,1,0
177038,),1,0
177039,.,1,0
177040,Compared,1,0
177041,with,0,0
177042,placebo,0,0
177043,",",0,0
177044,evolocumab,0,0
177045,significantly,0,0
177046,reduced,0,0
177047,ultracentrifugation,0,0
177048,LDL,0,0
177049,cholesterol,0,0
177050,at,0,0
177051,12,0,0
177052,weeks,0,0
177053,by,0,0
177054,30?9,0,0
177055,%,0,0
177056,(,0,0
177057,95,0,0
177058,%,0,0
177059,CI,0,0
177060,-43?9,0,0
177061,%,0,0
177062,to,0,0
177063,-18?0,0,0
177064,%,0,0
177065,;,0,0
177066,p,0,0
177067,<,0,0
177068,0?0001,0,0
177069,),0,0
177070,.,0,1
177071,Treatment-emergent,0,0
177072,adverse,0,0
177073,events,0,0
177074,occurred,0,0
177075,in,0,0
177076,ten,0,1
177077,(,0,0
177078,63,0,1
177079,%,0,0
177080,),0,0
177081,of,0,0
177082,16,0,1
177083,patients,0,1
177084,in,0,0
177085,the,0,0
177086,placebo,0,0
177087,group,0,0
177088,and,0,0
177089,12,0,0
177090,(,0,0
177091,36,0,1
177092,%,0,0
177093,),0,0
177094,of,0,0
177095,33,0,1
177096,in,0,0
177097,the,0,0
177098,evolocumab,0,1
177099,group,0,0
177100,.,0,0
177101,No,0,0
177102,serious,0,0
177103,clinical,0,0
177104,or,0,1
177105,laboratory,0,0
177106,adverse,0,0
177107,events,0,0
177108,occurred,0,0
177109,",",0,0
177110,and,0,0
177111,no,0,0
177112,anti-evolocumab,0,0
177113,antibody,0,0
177114,development,0,0
177115,was,0,0
177116,detected,0,0
177117,during,0,0
177118,the,0,0
177119,study,0,0
177120,.,0,0
177121,INTERPRETATION,1,0
177122,In,1,0
177123,patients,1,1
177124,with,1,1
177125,homozygous,1,1
177126,familial,1,1
177127,hypercholesterolaemia,1,1
177128,receiving,1,1
177129,stable,0,1
177130,background,0,0
177131,lipid-lowering,0,1
177132,treatment,0,0
177133,and,0,0
177134,not,0,0
177135,on,0,0
177136,apheresis,0,0
177137,",",0,0
177138,evolocumab,0,1
177139,420,0,0
177140,mg,0,0
177141,administered,0,0
177142,every,0,0
177143,4,0,0
177144,weeks,0,0
177145,was,0,0
177146,well,0,0
177147,tolerated,0,0
177148,and,0,0
177149,significantly,0,0
177150,reduced,0,0
177151,LDL,0,0
177152,cholesterol,0,0
177153,compared,0,0
177154,with,0,1
177155,placebo,0,0
177156,.,0,1
177157,FUNDING,0,0
177158,Amgen,0,0
177159,Inc,0,0
177160,.,0,1
177161,Comparing,0,0
177162,antipsychotic,0,0
177163,treatments,0,0
177164,for,0,1
177165,schizophrenia,1,1
177166,:,1,1
177167,a,0,0
177168,health,0,0
177169,state,0,0
177170,approach,0,0
177171,.,0,0
177172,The,0,0
177173,overall,0,0
177174,impact,0,0
177175,of,0,0
177176,first,0,0
177177,and,0,0
177178,second,0,0
177179,generation,0,0
177180,antipsychotics,0,0
177181,on,0,0
177182,quality,0,0
177183,of,0,0
177184,life,0,0
177185,and,0,0
177186,symptoms,0,0
177187,of,0,0
177188,people,1,1
177189,with,1,1
177190,schizophrenia,1,1
177191,remains,0,0
177192,controversial,0,0
177193,.,0,0
177194,We,0,0
177195,applied,0,0
177196,health,0,0
177197,state,0,0
177198,modeling,0,0
177199,to,0,0
177200,data,0,0
177201,from,0,1
177202,the,0,0
177203,Clinical,0,0
177204,Antipsychotic,0,1
177205,Trials,0,0
177206,of,0,0
177207,Intervention,0,1
177208,Effectiveness,0,0
177209,(,0,0
177210,CATIE,0,1
177211,),0,0
177212,Schizophrenia,0,1
177213,study,0,0
177214,",",0,0
177215,a,0,0
177216,randomized,0,0
177217,trial,0,0
177218,of,0,0
177219,antipsychotic,0,0
177220,medications,0,0
177221,",",0,0
177222,and,0,0
177223,evaluated,0,0
177224,the,0,0
177225,likelihood,0,0
177226,of,0,0
177227,patients,0,1
177228,moving,0,0
177229,to,0,0
177230,more,0,0
177231,favorable,0,0
177232,health,0,0
177233,states,0,1
177234,over,0,0
177235,time,0,0
177236,.,0,1
177237,We,0,0
177238,applied,0,0
177239,K-means,0,0
177240,clustering,0,0
177241,to,0,0
177242,the,0,0
177243,data,0,0
177244,to,0,0
177245,create,0,0
177246,discrete,0,0
177247,groupings,0,0
177248,of,0,1
177249,patients,0,1
177250,with,0,1
177251,symptom,0,1
177252,and,0,0
177253,side,0,0
177254,effect,0,0
177255,characteristics,0,0
177256,that,0,0
177257,were,0,0
177258,then,0,0
177259,validated,0,0
177260,using,0,0
177261,quality,0,0
177262,of,0,0
177263,life,0,0
177264,measures,0,0
177265,.,0,1
177266,We,0,0
177267,compared,0,0
177268,cluster,0,0
177269,distributions,0,0
177270,across,0,0
177271,medications,0,0
177272,at,0,0
177273,baseline,0,0
177274,and,0,0
177275,6,0,0
177276,months,0,0
177277,after,0,0
177278,randomization,0,1
177279,.,0,1
177280,"1,049",1,1
177281,patients,1,1
177282,were,1,1
177283,included,1,1
177284,in,1,0
177285,the,1,0
177286,initial,1,0
177287,cluster,1,0
177288,analysis,1,0
177289,.,1,0
177290,Five,0,0
177291,health,0,1
177292,states,0,1
177293,were,0,1
177294,identified,0,1
177295,:,0,1
177296,(,0,0
177297,1,0,0
177298,),0,0
177299,low,0,1
177300,symptoms,0,0
177301,and,0,0
177302,low,0,1
177303,side,0,0
177304,effects,0,0
177305,(,0,1
177306,LS,0,0
177307,+,0,0
177308,LSE,0,1
177309,),0,0
177310,(,0,0
177311,2,0,0
177312,),0,0
177313,low,0,1
177314,symptoms,0,0
177315,and,0,0
177316,obesity,0,1
177317,(,0,0
177318,LS,0,0
177319,+,0,0
177320,Ob,0,0
177321,),0,0
177322,(,0,0
177323,3,0,0
177324,),0,0
177325,high,0,1
177326,symptoms,0,0
177327,and,0,0
177328,low,0,1
177329,side,0,0
177330,effects,0,0
177331,(,0,1
177332,HS,0,1
177333,+,0,0
177334,LSE,0,1
177335,),0,0
177336,(,0,0
177337,4,0,0
177338,),0,0
177339,high,0,1
177340,symptoms,0,0
177341,with,0,1
177342,depression,0,1
177343,and,0,0
177344,akathisia,0,0
177345,(,0,0
177346,HS,0,1
177347,+,0,0
177348,Dp,0,1
177349,+,0,0
177350,Ak,0,0
177351,),0,0
177352,and,0,0
177353,(,0,0
177354,5,0,0
177355,),0,0
177356,moderate,0,1
177357,symptoms,0,0
177358,and,0,0
177359,high,0,1
177360,side,0,0
177361,effects,0,0
177362,(,0,1
177363,MS,0,1
177364,+,0,0
177365,HSE,0,1
177366,),0,0
177367,.,0,1
177368,Six-month,0,0
177369,outcomes,0,0
177370,among,0,1
177371,patients,0,1
177372,randomly,0,1
177373,assigned,0,1
177374,to,0,0
177375,perphenazine,0,0
177376,",",0,0
177377,olanzapine,0,0
177378,",",0,0
177379,risperidone,0,0
177380,and,0,0
177381,quetiapine,0,0
177382,were,0,0
177383,compared,0,0
177384,.,0,0
177385,At,0,0
177386,baseline,0,0
177387,",",0,0
177388,almost,0,0
177389,20,0,0
177390,%,0,0
177391,of,0,0
177392,patients,0,1
177393,were,0,1
177394,in,0,0
177395,the,0,0
177396,worst,0,0
177397,health,0,0
177398,state,0,0
177399,(,0,0
177400,HS,0,1
177401,+,0,0
177402,Dp,0,1
177403,+,0,0
177404,Ak,0,0
177405,),0,0
177406,",",0,0
177407,with,0,1
177408,greater,0,0
177409,decreases,0,0
177410,at,0,0
177411,6,0,0
177412,months,0,0
177413,in,0,0
177414,this,0,0
177415,health,0,0
177416,state,0,0
177417,for,0,0
177418,perphenazine,0,0
177419,(,0,0
177420,9.2,0,0
177421,%,0,0
177422,decrease,0,0
177423,),0,0
177424,and,0,0
177425,olanzapine,0,0
177426,(,0,0
177427,11.1,0,0
177428,%,0,0
177429,),0,1
177430,groups,0,0
177431,compared,0,0
177432,to,0,0
177433,risperidone,0,0
177434,(,0,0
177435,4.7,0,0
177436,%,0,0
177437,),0,0
177438,and,0,0
177439,quetiapine,0,1
177440,(,0,0
177441,6.7,0,0
177442,%,0,0
177443,),0,0
177444,.,0,0
177445,This,0,0
177446,study,0,0
177447,demonstrated,0,0
177448,that,0,0
177449,health,0,1
177450,state,0,0
177451,analysis,0,0
177452,can,0,0
177453,provide,0,0
177454,insight,0,0
177455,into,0,0
177456,the,0,0
177457,overall,0,0
177458,clinical,0,0
177459,state,0,1
177460,of,0,0
177461,patients,0,1
177462,beyond,0,0
177463,the,0,0
177464,mere,0,0
177465,comparison,0,0
177466,of,0,0
177467,average,0,0
177468,scores,0,0
177469,and,0,0
177470,largely,0,0
177471,confirmed,0,0
177472,original,0,1
177473,CATIE,0,1
177474,findings,0,0
177475,.,0,1
177476,Nicardipine,0,0
177477,is,0,0
177478,superior,0,0
177479,to,0,0
177480,esmolol,0,0
177481,for,0,0
177482,the,0,0
177483,management,0,0
177484,of,0,0
177485,postcraniotomy,1,1
177486,emergence,1,0
177487,hypertension,1,1
177488,:,1,1
177489,a,0,0
177490,randomized,0,0
177491,open-label,0,0
177492,study,0,1
177493,.,0,1
177494,BACKGROUND,0,0
177495,Emergence,0,0
177496,hypertension,1,1
177497,after,1,0
177498,craniotomy,1,0
177499,is,0,0
177500,a,0,0
177501,well-documented,0,0
177502,phenomenon,0,0
177503,for,0,0
177504,which,0,0
177505,natural,0,0
177506,history,0,0
177507,is,0,0
177508,poorly,0,0
177509,understood,0,0
177510,.,0,0
177511,Most,0,0
177512,clinicians,0,0
177513,attribute,0,0
177514,this,0,0
177515,phenomenon,0,0
177516,to,0,0
177517,an,0,0
177518,acute,0,1
177519,and,0,0
177520,transient,0,0
177521,increase,0,0
177522,in,0,0
177523,catecholamine,0,0
177524,release,0,0
177525,",",0,0
177526,but,0,0
177527,other,0,0
177528,mechanisms,0,0
177529,such,0,0
177530,as,0,0
177531,neurogenic,0,1
177532,hypertension,0,1
177533,or,0,0
177534,activation,0,0
177535,of,0,0
177536,the,0,0
177537,renin-angiotensin-aldosterone,0,0
177538,system,0,0
177539,have,0,0
177540,also,0,0
177541,been,0,0
177542,proposed,0,0
177543,.,0,0
177544,In,0,0
177545,this,0,0
177546,open-label,0,0
177547,study,0,0
177548,",",0,0
177549,we,0,0
177550,compared,0,0
177551,the,0,0
177552,monotherapeutic,0,0
177553,antihypertensive,0,0
177554,efficacy,0,0
177555,of,0,0
177556,the,0,0
177557,2,0,0
177558,most,0,0
177559,titratable,0,0
177560,drugs,0,0
177561,used,0,0
177562,to,0,0
177563,treat,0,0
177564,postcraniotomy,0,1
177565,emergence,0,0
177566,hypertension,0,1
177567,:,0,1
177568,nicardipine,0,0
177569,and,0,0
177570,esmolol,0,0
177571,.,0,0
177572,We,0,0
177573,also,0,0
177574,investigated,0,0
177575,the,0,0
177576,effect,0,0
177577,of,0,0
177578,preoperative,0,0
177579,hypertension,0,1
177580,on,0,0
177581,postcraniotomy,0,1
177582,hypertension,0,1
177583,and,0,0
177584,the,0,0
177585,natural,0,0
177586,history,0,1
177587,of,0,0
177588,postcraniotomy,0,1
177589,hypertension,0,1
177590,in,0,0
177591,the,0,0
177592,early,0,0
177593,postoperative,0,0
177594,period,0,1
177595,.,0,1
177596,METHODS,0,0
177597,Fifty-two,1,1
177598,subjects,1,1
177599,were,0,1
177600,prospectively,0,1
177601,randomized,0,0
177602,to,0,0
177603,receive,0,0
177604,either,0,0
177605,nicardipine,0,0
177606,or,0,0
177607,esmolol,0,0
177608,as,0,0
177609,the,0,0
177610,sole,0,0
177611,drug,0,0
177612,for,0,0
177613,treatment,0,0
177614,of,0,0
177615,emergence,0,0
177616,hypertension,0,1
177617,at,0,0
177618,the,0,0
177619,conclusion,0,0
177620,of,0,0
177621,brain,1,0
177622,tumor,1,0
177623,resection,1,1
177624,(,1,0
177625,40,1,1
177626,subjects,1,1
177627,finally,1,0
177628,analyzed,1,0
177629,),1,0
177630,.,1,0
177631,After,0,0
177632,a,0,0
177633,uniform,0,0
177634,anesthetic,0,0
177635,",",0,0
177636,standardized,0,0
177637,protocols,0,0
177638,of,0,0
177639,these,0,0
177640,antihypertensive,0,0
177641,medications,0,0
177642,were,0,1
177643,administered,0,0
177644,for,0,0
177645,the,0,0
177646,treatment,0,0
177647,of,0,0
177648,systolic,0,1
177649,blood,0,0
177650,pressure,0,0
177651,(,0,0
177652,SBP,0,1
177653,),0,0
177654,>,0,1
177655,130,0,1
177656,",",0,0
177657,with,0,1
177658,the,0,0
177659,goal,0,0
177660,of,0,0
177661,maintaining,0,0
177662,SBP,0,1
177663,<,0,0
177664,140,0,1
177665,throughout,0,0
177666,the,0,0
177667,first,0,0
177668,postoperative,0,0
177669,day,0,0
177670,.,0,0
177671,In,0,0
177672,the,0,0
177673,event,0,0
177674,of,0,0
177675,study,0,0
177676,medication,0,0
177677,failure,0,1
177678,",",0,0
177679,a,0,0
177680,rescue,0,0
177681,antihypertensive,0,0
177682,(,0,0
177683,labetalol,0,0
177684,or,0,1
177685,hydralazine,0,0
177686,),0,0
177687,was,0,0
177688,used,0,0
177689,.,0,0
177690,The,0,0
177691,O'Brien-Fleming,0,0
177692,Spending,0,0
177693,Function,0,0
177694,was,0,0
177695,used,0,0
177696,to,0,0
177697,calculate,0,0
177698,the,0,0
177699,appropriate,0,0
177700,?,0,0
177701,value,0,0
177702,for,0,0
177703,each,0,0
177704,interim,0,0
177705,analysis,0,0
177706,of,0,0
177707,the,0,0
177708,primary,0,1
177709,outcome,0,0
177710,;,0,0
177711,univariate,0,0
177712,analysis,0,0
177713,was,0,0
177714,performed,0,0
177715,otherwise,0,0
177716,",",0,0
177717,with,0,0
177718,a,0,0
177719,2-sided,0,0
177720,P,0,0
177721,<,0,0
177722,0.05,0,0
177723,considered,0,0
177724,statistically,0,0
177725,significant,0,0
177726,.,0,0
177727,RESULTS,0,0
177728,The,0,0
177729,incidence,0,0
177730,of,0,0
177731,nicardipine,0,0
177732,failure,0,1
177733,(,0,0
177734,5,0,0
177735,%,0,0
177736,",",0,0
177737,95,0,0
177738,%,0,0
177739,confidence,0,0
177740,interval,0,0
177741,[,0,0
177742,CI,0,0
177743,],0,1
177744,0.1,0,0
177745,%,0,0
177746,-24.9,0,0
177747,%,0,0
177748,),0,0
177749,was,0,0
177750,significantly,0,0
177751,less,0,0
177752,than,0,0
177753,that,0,0
177754,of,0,0
177755,esmolol,0,0
177756,(,0,0
177757,55,0,1
177758,%,0,0
177759,",",0,0
177760,95,0,0
177761,%,0,0
177762,CI,0,0
177763,31.5,0,0
177764,%,0,0
177765,-76.9,0,0
177766,%,0,0
177767,),0,0
177768,as,0,0
177769,a,0,0
177770,sole,0,0
177771,drug,0,0
177772,in,0,0
177773,controlling,0,0
177774,SBP,0,0
177775,after,0,0
177776,brain,0,0
177777,tumor,0,0
177778,resection,0,1
177779,(,0,0
177780,difference,0,0
177781,99,0,1
177782,%,0,0
177783,CI,0,0
177784,13.8,0,0
177785,%,0,0
177786,-75.7,0,0
177787,%,0,0
177788,",",0,0
177789,P,0,0
177790,=,0,0
177791,0.0012,0,0
177792,),0,0
177793,.,0,0
177794,The,0,0
177795,presence,0,0
177796,of,0,0
177797,preoperative,0,0
177798,hypertension,0,1
177799,or,0,0
177800,the,0,0
177801,approach,0,0
177802,to,0,0
177803,surgery,0,1
177804,(,0,0
177805,open,0,1
177806,craniotomy,0,0
177807,versus,0,0
177808,endonasal,0,0
177809,transsphenoidal,0,1
177810,),0,0
177811,had,0,0
177812,no,0,0
177813,significant,0,0
177814,effect,0,0
177815,on,0,0
177816,the,0,0
177817,incidence,0,0
177818,of,0,0
177819,failure,0,1
177820,of,0,0
177821,the,0,0
177822,antihypertensive,0,0
177823,regimen,0,0
177824,used,0,0
177825,.,0,1
177826,We,0,0
177827,did,0,0
177828,not,0,0
177829,observe,0,0
177830,a,0,0
177831,difference,0,0
177832,in,0,0
177833,the,0,0
177834,need,0,0
177835,for,0,0
177836,opioid,0,1
177837,therapy,0,0
177838,for,0,0
177839,postcraniotomy,0,1
177840,pain,0,1
177841,between,0,0
177842,drug,0,0
177843,groups,0,0
177844,(,0,1
177845,99,0,1
177846,%,0,0
177847,CI,0,0
177848,difference,0,0
177849,-39.2,0,0
177850,%,0,0
177851,-30.2,0,0
177852,%,0,0
177853,),0,0
177854,.,0,0
177855,Failure,0,0
177856,of,0,0
177857,the,0,0
177858,study,0,0
177859,drug,0,0
177860,predicted,0,0
177861,the,0,0
177862,need,0,0
177863,for,0,0
177864,rescue,0,0
177865,drug,0,0
177866,therapy,0,0
177867,in,0,0
177868,the,0,0
177869,initial,0,0
177870,12,0,0
177871,hours,0,0
177872,after,0,0
177873,discharge,0,0
177874,from,0,0
177875,the,0,0
177876,recovery,0,0
177877,room,0,0
177878,(,0,0
177879,difference,0,0
177880,success,0,0
177881,versus,0,0
177882,failure,0,1
177883,=,0,0
177884,-41.7,0,0
177885,%,0,0
177886,",",0,0
177887,99,0,0
177888,%,0,0
177889,CI,0,0
177890,difference,0,0
177891,-72.3,0,0
177892,%,0,0
177893,to,0,0
177894,-1.8,0,0
177895,%,0,0
177896,",",0,0
177897,P,0,0
177898,=,0,0
177899,0.0336,0,0
177900,),0,0
177901,but,0,0
177902,not,0,0
177903,during,0,0
177904,the,0,0
177905,period,0,0
177906,12,0,0
177907,to,0,0
177908,24,0,1
177909,hours,0,0
177910,after,0,0
177911,discharge,0,0
177912,from,0,0
177913,the,0,0
177914,recovery,0,0
177915,room,0,0
177916,(,0,0
177917,difference,0,0
177918,success,0,0
177919,versus,0,0
177920,failure,0,1
177921,=,0,0
177922,-27.4,0,0
177923,%,0,0
177924,",",0,0
177925,99,0,0
177926,%,0,0
177927,CI,0,0
177928,difference,0,0
177929,-63.8,0,0
177930,%,0,0
177931,-9.2,0,0
177932,%,0,0
177933,",",0,0
177934,P,0,0
177935,=,0,0
177936,0.143,0,0
177937,),0,0
177938,.,0,0
177939,However,0,0
177940,",",0,0
177941,in,0,0
177942,those,1,0
177943,patients,1,1
177944,carrying,1,0
177945,a,1,0
177946,preoperative,1,0
177947,diagnosis,1,1
177948,of,1,0
177949,hypertension,1,1
177950,",",1,0
177951,the,0,0
177952,need,0,0
177953,for,0,0
177954,rescue,0,0
177955,medication,0,0
177956,was,0,0
177957,only,0,0
177958,different,0,0
177959,during,0,0
177960,the,0,0
177961,period,0,0
177962,12,0,0
177963,to,0,0
177964,24,0,1
177965,hours,0,0
177966,after,0,0
177967,discharge,0,0
177968,from,0,0
177969,the,0,0
177970,recovery,0,0
177971,room,0,0
177972,(,0,0
177973,difference,0,0
177974,normotensive,0,1
177975,versus,0,0
177976,hypertensive,0,1
177977,=,0,0
177978,-35.4,0,0
177979,%,0,0
177980,",",0,0
177981,99,0,0
177982,%,0,0
177983,CI,0,0
177984,difference,0,0
177985,-66.9,0,0
177986,%,0,0
177987,to,0,0
177988,-0.3,0,0
177989,%,0,0
177990,",",0,0
177991,P,0,0
177992,=,0,0
177993,0.0254,0,0
177994,),0,1
177995,.,0,1
177996,CONCLUSIONS,0,0
177997,Nicardipine,0,0
177998,is,0,0
177999,superior,0,0
178000,to,0,0
178001,esmolol,0,0
178002,for,0,0
178003,the,0,0
178004,treatment,0,0
178005,of,0,0
178006,postcraniotomy,0,1
178007,emergence,0,0
178008,hypertension,0,1
178009,.,0,0
178010,This,0,0
178011,type,0,0
178012,of,0,0
178013,hypertension,0,1
178014,is,0,0
178015,thought,0,0
178016,to,0,0
178017,be,0,0
178018,a,0,0
178019,transient,0,0
178020,phenomenon,0,0
178021,not,0,0
178022,solely,0,0
178023,related,0,0
178024,to,0,0
178025,sympathetic,0,0
178026,activation,0,0
178027,and,0,0
178028,catecholamine,0,0
178029,surge,0,0
178030,but,0,0
178031,also,0,0
178032,possibly,0,0
178033,encompassing,0,0
178034,other,0,0
178035,physiologic,0,1
178036,factors,0,0
178037,.,0,1
178038,For,0,0
178039,treating,0,0
178040,postcraniotomy,0,1
178041,emergence,0,0
178042,hypertension,0,1
178043,",",0,0
178044,nicardipine,0,0
178045,is,0,0
178046,a,0,0
178047,relatively,0,0
178048,effective,0,0
178049,sole,0,0
178050,drug,0,0
178051,",",0,0
178052,whereas,0,0
178053,if,0,0
178054,esmolol,0,0
178055,is,0,0
178056,used,0,0
178057,",",0,0
178058,rescue,0,0
178059,antihypertensive,0,0
178060,medications,0,0
178061,should,0,0
178062,be,0,0
178063,readily,0,0
178064,available,0,0
178065,.,0,1
178066,Effects,0,0
178067,of,0,1
178068,aerobic,0,1
178069,exercise,0,0
178070,on,0,0
178071,cognition,0,0
178072,and,0,0
178073,hippocampal,0,0
178074,volume,0,0
178075,in,0,0
178076,Alzheimer,1,1
178077,'s,1,1
178078,disease,1,1
178079,:,1,1
178080,study,0,0
178081,protocol,0,0
178082,of,0,0
178083,a,0,0
178084,randomized,0,0
178085,controlled,0,0
178086,trial,0,0
178087,(,0,0
178088,The,0,0
178089,FIT-AD,0,1
178090,trial,0,0
178091,),0,0
178092,.,0,1
178093,BACKGROUND,0,0
178094,Alzheimer,1,1
178095,'s,1,1
178096,disease,1,1
178097,",",0,0
178098,a,0,0
178099,global,0,0
178100,public,0,1
178101,health,0,1
178102,issue,0,0
178103,",",0,0
178104,accounts,0,0
178105,for,0,0
178106,60,0,1
178107,to,0,0
178108,80,0,1
178109,%,0,0
178110,of,0,0
178111,all,0,1
178112,dementias,0,1
178113,.,0,1
178114,Alzheimer,0,1
178115,'s,0,0
178116,disease,0,1
178117,primarily,0,1
178118,causes,0,0
178119,cognitive,0,0
178120,impairment,0,0
178121,and,0,0
178122,drugs,0,0
178123,have,0,0
178124,only,0,0
178125,modest,0,0
178126,short-term,0,0
178127,effects,0,0
178128,",",0,0
178129,highlighting,0,0
178130,a,0,0
178131,pressing,0,0
178132,need,0,0
178133,to,0,0
178134,develop,0,0
178135,effective,0,0
178136,interventions,0,0
178137,.,0,1
178138,Aerobic,0,0
178139,exercise,0,0
178140,holds,0,0
178141,promise,0,0
178142,for,0,0
178143,treating,0,0
178144,cognitive,0,0
178145,impairment,0,1
178146,in,0,0
178147,Alzheimer,1,1
178148,'s,1,1
178149,disease,1,1
178150,through,0,0
178151,biologically,0,0
178152,sound,0,1
178153,mechanisms,0,0
178154,.,0,0
178155,Nonetheless,0,0
178156,",",0,0
178157,aerobic,0,0
178158,exercise,0,0
178159,studies,0,0
178160,in,0,0
178161,Alzheimer,0,1
178162,'s,0,1
178163,disease,0,1
178164,are,0,0
178165,limited,0,0
178166,with,0,1
178167,mixed,0,1
178168,findings,0,0
178169,.,0,1
178170,METHODS/DESIGN,0,0
178171,This,0,0
178172,pilot,0,0
178173,randomized,0,0
178174,controlled,0,0
178175,trial,0,0
178176,will,0,0
178177,investigate,0,0
178178,the,0,0
178179,effects,0,0
178180,of,0,0
178181,a,0,0
178182,6-month,0,0
178183,",",0,0
178184,individualized,0,0
178185,",",0,0
178186,moderate-intensity,0,0
178187,cycling,0,0
178188,intervention,0,0
178189,(,0,0
178190,20,0,1
178191,to,0,1
178192,50,0,1
178193,minutes,0,0
178194,per,0,0
178195,session,0,0
178196,",",0,0
178197,3,0,0
178198,times,0,0
178199,a,0,0
178200,week,0,0
178201,),0,0
178202,on,0,0
178203,cognition,0,0
178204,and,0,0
178205,hippocampal,0,0
178206,volume,0,0
178207,in,0,0
178208,community-dwelling,1,1
178209,older,1,1
178210,adults,1,1
178211,with,1,1
178212,mild-to-moderate,1,1
178213,Alzheimer,1,1
178214,'s,1,1
178215,disease,1,1
178216,.,1,1
178217,The,0,0
178218,specific,0,0
178219,aims,0,0
178220,are,0,0
178221,to,0,0
178222,:,0,1
178223,1,0,0
178224,),0,0
178225,determine,0,0
178226,the,0,0
178227,immediate,0,0
178228,effect,0,0
178229,of,0,0
178230,the,0,0
178231,cycling,0,0
178232,intervention,0,0
178233,on,0,0
178234,cognition,0,0
178235,in,0,0
178236,Alzheimer,0,1
178237,'s,0,1
178238,disease,0,1
178239,;,0,1
178240,2,0,0
178241,),0,0
178242,examine,0,0
178243,if,0,0
178244,the,0,0
178245,cycling,0,0
178246,intervention,0,0
178247,slows,0,0
178248,cognitive,0,0
178249,decline,0,0
178250,in,0,0
178251,Alzheimer,0,1
178252,'s,0,1
178253,disease,0,1
178254,from,0,1
178255,baseline,0,0
178256,to,0,0
178257,12,0,1
178258,months,0,0
178259,;,0,1
178260,and,0,1
178261,3,0,0
178262,),0,0
178263,assess,0,0
178264,the,0,0
178265,effect,0,0
178266,of,0,0
178267,aerobic,0,0
178268,exercise,0,0
178269,on,0,0
178270,hippocampal,0,0
178271,volume,0,0
178272,over,0,0
178273,12,0,1
178274,months,0,0
178275,.,0,1
178276,Ninety,1,1
178277,subjects,1,1
178278,will,1,0
178279,be,1,0
178280,randomized,1,0
178281,on,0,0
178282,a,0,0
178283,2:1,0,1
178284,allocation,0,0
178285,ratio,0,0
178286,to,0,0
178287,cycling,0,0
178288,or,0,0
178289,attention,0,0
178290,control,0,0
178291,(,0,0
178292,low-intensity,0,0
178293,stretching,0,0
178294,),0,0
178295,and,0,0
178296,followed,0,0
178297,for,0,0
178298,another,0,0
178299,6,0,0
178300,months,0,0
178301,.,0,1
178302,Allocations,0,0
178303,will,0,0
178304,be,0,0
178305,concealed,0,0
178306,to,0,0
178307,all,0,0
178308,investigators,0,0
178309,and,0,0
178310,outcome,0,0
178311,assessors,0,0
178312,will,0,0
178313,be,0,0
178314,blinded,0,0
178315,to,0,0
178316,group,0,0
178317,assignments,0,0
178318,and,0,1
178319,previous,0,1
178320,data,0,0
178321,.,0,0
178322,Cognition,0,0
178323,will,0,0
178324,be,0,0
178325,measured,0,0
178326,by,0,0
178327,the,0,0
178328,Alzheimer,0,1
178329,'s,0,1
178330,disease,0,1
178331,Assessment,0,0
178332,Scale-Cognition,0,0
178333,at,0,0
178334,baseline,0,0
178335,before,0,0
178336,randomization,0,0
178337,and,0,0
178338,at,0,0
178339,3,0,0
178340,",",0,0
178341,6,0,0
178342,",",0,0
178343,9,0,0
178344,",",0,0
178345,and,0,0
178346,12,0,0
178347,months,0,0
178348,.,0,1
178349,Hippocampal,0,0
178350,volume,0,0
178351,will,0,0
178352,be,0,0
178353,measured,0,0
178354,by,0,0
178355,magnetic,0,0
178356,resonance,0,0
178357,imaging,0,0
178358,at,0,0
178359,baseline,0,0
178360,and,0,0
178361,6,0,0
178362,and,0,0
178363,12,0,1
178364,months,0,0
178365,.,0,1
178366,The,0,0
178367,sample,1,0
178368,size,1,0
178369,of,1,0
178370,90,1,0
178371,will,0,0
178372,give,0,0
178373,80,0,0
178374,%,0,0
178375,power,0,0
178376,to,0,0
178377,detect,0,0
178378,a,0,0
178379,2.5-point,0,0
178380,difference,0,0
178381,in,0,0
178382,within-group,0,0
178383,changes,0,0
178384,in,0,0
178385,the,0,0
178386,Alzheimer,0,1
178387,'s,0,1
178388,disease,0,1
178389,Assessment,0,0
178390,Scale-Cognition,0,0
178391,at,0,0
178392,6,0,0
178393,months,0,0
178394,for,0,0
178395,the,0,0
178396,cycling,0,0
178397,group,0,0
178398,.,0,1
178399,DISCUSSION,0,0
178400,Findings,0,0
178401,from,0,1
178402,this,0,0
178403,study,0,0
178404,will,0,0
178405,address,0,0
178406,the,0,0
178407,critical,0,0
178408,gap,0,0
178409,of,0,0
178410,exercise,0,0
178411,efficacy,0,0
178412,in,0,0
178413,Alzheimer,0,1
178414,'s,0,1
178415,disease,0,1
178416,and,0,0
178417,use,0,0
178418,of,0,0
178419,magnetic,0,0
178420,resonance,0,0
178421,imaging,0,0
178422,as,0,0
178423,an,0,0
178424,outcome,0,0
178425,measure,0,0
178426,in,0,0
178427,clinical,0,0
178428,trials,0,1
178429,.,0,1
178430,This,0,0
178431,study,0,0
178432,will,0,0
178433,provide,0,0
178434,a,0,0
178435,potential,0,0
178436,treatment,0,0
178437,that,0,0
178438,may,0,0
178439,increase,0,0
178440,physical,0,0
178441,function,0,0
178442,and,0,0
178443,quality,0,0
178444,of,0,0
178445,life,0,0
178446,and,0,0
178447,curb,0,0
178448,the,0,0
178449,prohibitive,0,0
178450,costs,0,0
178451,for,0,0
178452,the,0,0
178453,growing,0,0
178454,dementia,0,1
178455,population,0,1
178456,.,0,1
178457,TRIAL,0,0
178458,REGISTRATION,0,0
178459,Primary,0,1
178460,registration,0,1
178461,:,0,1
178462,(,0,0
178463,NCT01954550,0,0
178464,;,0,0
178465,date,0,0
178466,of,0,0
178467,registration,0,1
178468,:,0,1
178469,20,0,1
178470,September,0,1
178471,2013,0,1
178472,),0,1
178473,.,0,1
178474,Secondary,0,0
178475,registration,0,0
178476,:,0,1
178477,(,0,0
178478,NCT01954550,0,0
178479,;,0,0
178480,date,0,0
178481,of,0,0
178482,registration,0,1
178483,:,0,1
178484,1,0,0
178485,October,0,1
178486,2013,0,1
178487,),0,1
178488,.,0,1
178489,Intense,1,1
178490,androgen-deprivation,1,0
178491,therapy,1,0
178492,with,1,1
178493,abiraterone,1,0
178494,acetate,1,0
178495,plus,1,0
178496,leuprolide,1,0
178497,acetate,1,0
178498,in,1,0
178499,patients,1,1
178500,with,1,1
178501,localized,1,1
178502,high-risk,1,1
178503,prostate,1,1
178504,cancer,1,1
178505,:,1,1
178506,results,1,0
178507,of,1,0
178508,a,1,0
178509,randomized,1,0
178510,phase,1,1
178511,II,1,1
178512,neoadjuvant,1,0
178513,study,1,0
178514,.,1,1
178515,PURPOSE,0,0
178516,Cure,0,1
178517,rates,0,0
178518,for,0,0
178519,localized,0,1
178520,high-risk,0,1
178521,prostate,0,1
178522,cancers,0,1
178523,(,0,1
178524,PCa,0,0
178525,),0,0
178526,and,0,0
178527,some,0,0
178528,intermediate-risk,0,1
178529,PCa,0,0
178530,are,0,0
178531,frequently,0,0
178532,suboptimal,0,0
178533,with,0,1
178534,local,0,0
178535,therapy,0,0
178536,.,0,0
178537,Outcomes,0,0
178538,are,0,0
178539,improved,0,0
178540,by,0,0
178541,concomitant,0,0
178542,androgen-deprivation,0,0
178543,therapy,0,0
178544,(,0,0
178545,ADT,0,0
178546,),0,0
178547,with,0,1
178548,radiation,0,0
178549,therapy,0,0
178550,",",0,0
178551,but,0,0
178552,not,0,0
178553,by,0,0
178554,concomitant,0,0
178555,ADT,0,1
178556,with,0,1
178557,surgery,0,1
178558,.,0,1
178559,Luteinizing,0,0
178560,hormone-releasing,0,0
178561,hormone,0,1
178562,agonist,0,0
178563,(,0,0
178564,LHRHa,0,0
178565,;,0,0
178566,leuprolide,0,0
178567,acetate,0,0
178568,),0,0
178569,does,0,0
178570,not,0,0
178571,reduce,0,0
178572,serum,0,0
178573,androgens,0,0
178574,as,0,0
178575,effectively,0,0
178576,as,0,0
178577,abiraterone,0,0
178578,acetate,0,0
178579,(,0,0
178580,AA,0,0
178581,),0,0
178582,",",0,0
178583,a,0,0
178584,prodrug,0,0
178585,of,0,0
178586,abiraterone,0,0
178587,",",0,0
178588,a,0,0
178589,CYP17,0,0
178590,inhibitor,0,0
178591,that,0,0
178592,lowers,0,0
178593,serum,0,0
178594,testosterone,0,0
178595,(,0,0
178596,<,0,0
178597,1,0,0
178598,ng/dL,0,0
178599,),0,0
178600,and,0,0
178601,improves,0,0
178602,survival,0,0
178603,in,0,0
178604,metastatic,0,1
178605,PCa,0,0
178606,.,0,0
178607,The,0,0
178608,possibility,0,0
178609,that,0,0
178610,greater,0,0
178611,androgen,0,0
178612,suppression,0,0
178613,in,0,0
178614,patients,0,1
178615,with,0,1
178616,localized,0,1
178617,high-risk,0,1
178618,PCa,0,0
178619,will,0,0
178620,result,0,0
178621,in,0,0
178622,improved,0,0
178623,clinical,0,0
178624,outcomes,0,0
178625,makes,0,0
178626,paramount,0,0
178627,the,0,0
178628,reassessment,0,0
178629,of,0,0
178630,neoadjuvant,0,0
178631,ADT,0,0
178632,with,0,0
178633,more,0,0
178634,robust,0,0
178635,androgen,0,0
178636,suppression,0,0
178637,.,0,0
178638,PATIENTS,1,0
178639,AND,1,0
178640,METHODS,1,0
178641,A,1,1
178642,neoadjuvant,1,0
178643,randomized,1,1
178644,phase,1,1
178645,II,1,0
178646,trial,1,0
178647,of,1,0
178648,LHRHa,1,0
178649,with,1,1
178650,AA,1,0
178651,was,1,0
178652,conducted,1,0
178653,in,1,0
178654,patients,1,1
178655,with,1,1
178656,localized,1,1
178657,high-risk,1,1
178658,PCa,1,0
178659,(,1,1
178660,N,1,1
178661,=,1,0
178662,58,1,1
178663,),1,0
178664,.,1,0
178665,For,1,0
178666,the,1,0
178667,first,1,0
178668,12,1,0
178669,weeks,1,0
178670,",",1,1
178671,patients,1,1
178672,were,1,0
178673,randomly,1,1
178674,assigned,1,0
178675,to,1,0
178676,LHRHa,1,0
178677,versus,1,0
178678,LHRHa,1,0
178679,plus,1,0
178680,AA,1,0
178681,.,1,0
178682,After,1,0
178683,a,1,0
178684,research,1,0
178685,prostate,1,1
178686,biopsy,1,0
178687,",",1,0
178688,all,1,0
178689,patients,1,1
178690,received,1,0
178691,12,1,1
178692,additional,1,0
178693,weeks,1,0
178694,of,1,0
178695,LHRHa,1,0
178696,plus,1,0
178697,AA,1,0
178698,followed,1,0
178699,by,1,0
178700,prostatectomy,1,1
178701,.,1,0
178702,RESULTS,0,0
178703,The,0,0
178704,levels,0,0
178705,of,0,0
178706,intraprostatic,0,0
178707,androgens,0,1
178708,from,0,1
178709,12-week,0,0
178710,prostate,0,1
178711,biopsies,0,0
178712,",",0,0
178713,including,0,0
178714,the,0,0
178715,primary,0,0
178716,end,0,0
178717,point,0,0
178718,(,0,0
178719,dihydrotestosterone/testosterone,0,0
178720,),0,0
178721,",",0,0
178722,were,0,0
178723,significantly,0,0
178724,lower,0,0
178725,(,0,0
178726,dehydroepiandrosterone,0,0
178727,",",0,0
178728,?,0,0
178729,(,0,0
178730,4,0,0
178731,),0,0
178732,"-androstene-3,17-dione",0,1
178733,",",0,0
178734,dihydrotestosterone,0,0
178735,",",0,0
178736,all,0,0
178737,P,0,0
178738,<,0,0
178739,.001,0,0
178740,;,0,0
178741,testosterone,0,0
178742,",",0,0
178743,P,0,0
178744,<,0,0
178745,.05,0,0
178746,),0,0
178747,with,0,1
178748,LHRHa,0,0
178749,plus,0,0
178750,AA,0,0
178751,compared,0,0
178752,with,0,1
178753,LHRHa,0,0
178754,alone,0,0
178755,.,0,0
178756,Prostatectomy,0,0
178757,pathologic,0,0
178758,staging,0,0
178759,demonstrated,0,0
178760,a,0,0
178761,low,0,0
178762,incidence,0,0
178763,of,0,0
178764,complete,0,1
178765,responses,0,0
178766,and,0,1
178767,minimal,0,0
178768,residual,0,0
178769,disease,0,1
178770,",",0,0
178771,with,0,1
178772,residual,0,0
178773,T3-,0,1
178774,or,0,1
178775,lymph,0,1
178776,node-positive,0,1
178777,disease,0,1
178778,in,0,0
178779,the,0,0
178780,majority,0,0
178781,.,0,0
178782,CONCLUSION,0,0
178783,LHRHa,0,0
178784,plus,0,0
178785,AA,0,0
178786,treatment,0,0
178787,suppresses,0,0
178788,tissue,0,0
178789,androgens,0,0
178790,more,0,0
178791,effectively,0,0
178792,than,0,0
178793,LHRHa,0,0
178794,alone,0,0
178795,.,0,0
178796,Intensive,0,0
178797,intratumoral,0,0
178798,androgen,0,0
178799,suppression,0,0
178800,with,0,1
178801,LHRHa,0,0
178802,plus,0,0
178803,AA,0,0
178804,before,0,0
178805,prostatectomy,0,1
178806,for,0,0
178807,localized,0,1
178808,high-risk,0,1
178809,PCa,0,0
178810,may,0,0
178811,reduce,0,0
178812,tumor,0,0
178813,burden,0,0
178814,.,0,1
178815,Administration,0,0
178816,of,0,0
178817,subcutaneous,0,0
178818,buffered,0,0
178819,lidocaine,0,0
178820,prior,0,0
178821,to,0,0
178822,breast,1,1
178823,lymphoscintigraphy,1,0
178824,reduces,0,0
178825,pain,0,1
178826,without,0,1
178827,decreasing,0,0
178828,lymph,0,1
178829,node,0,1
178830,visualization,0,0
178831,.,0,0
178832,UNLABELLED,0,0
178833,Breast,0,1
178834,lymphoscintigraphy,0,0
178835,using,0,0
178836,(,0,0
178837,99m,0,0
178838,),0,1
178839,Tc-sulfur,0,0
178840,colloid,0,0
178841,(,0,0
178842,(,0,0
178843,99m,0,0
178844,),0,0
178845,Tc-SC,0,1
178846,),0,0
178847,is,0,0
178848,well,0,0
178849,established,0,0
178850,in,0,0
178851,clinical,0,0
178852,practice,0,0
178853,for,0,0
178854,staging,0,0
178855,patients,1,1
178856,with,1,1
178857,breast,1,1
178858,carcinoma,1,1
178859,.,1,0
178860,Nearly,0,0
178861,all,0,0
178862,patients,0,1
178863,report,0,0
178864,having,0,0
178865,pain,0,0
178866,during,0,0
178867,the,0,0
178868,procedure,0,0
178869,.,0,0
178870,However,0,0
178871,",",0,0
178872,techniques,0,0
178873,used,0,0
178874,to,0,0
178875,minimize,0,0
178876,pain,0,0
178877,during,0,0
178878,breast,1,1
178879,lymphoscintigraphy,1,0
178880,are,0,0
178881,highly,0,0
178882,variable,0,0
178883,across,0,0
178884,institutions,0,1
178885,.,0,1
178886,Our,0,0
178887,study,0,0
178888,was,0,0
178889,to,0,0
178890,determine,0,0
178891,whether,0,0
178892,anesthetizing,0,1
178893,the,0,0
178894,skin,0,0
178895,with,0,1
178896,sodium,0,0
178897,bicarbonatehether-buffered,0,0
178898,lidocaine,0,0
178899,before,0,0
178900,performing,0,0
178901,breast,0,1
178902,lymphoscintigraphy,0,0
178903,reduced,0,0
178904,the,0,0
178905,pain,0,0
178906,experienced,0,0
178907,by,0,0
178908,the,0,0
178909,patients,0,1
178910,.,0,0
178911,The,0,0
178912,second,0,0
178913,objective,0,0
178914,of,0,0
178915,this,0,0
178916,study,0,0
178917,was,0,0
178918,to,0,0
178919,evaluate,0,0
178920,whether,0,0
178921,anesthetizing,0,1
178922,the,0,0
178923,skin,0,0
178924,with,0,1
178925,buffered,0,0
178926,lidocaine,0,0
178927,changed,0,0
178928,visualization,0,0
178929,of,0,0
178930,lymph,0,1
178931,nodes,0,1
178932,.,0,1
178933,METHODS,0,0
178934,This,0,0
178935,prospective,0,0
178936,",",0,0
178937,patient-masked,0,0
178938,and,0,0
178939,randomized,0,1
178940,study,0,0
178941,involved,0,0
178942,performing,0,0
178943,breast,1,1
178944,lymphoscintigraphy,1,0
178945,in,0,0
178946,a,0,0
178947,control,1,0
178948,group,1,0
178949,and,1,0
178950,experimental,1,0
178951,group,1,0
178952,of,1,0
178953,female,1,1
178954,breast,1,1
178955,cancer,1,1
178956,patients,1,1
178957,.,1,0
178958,The,0,0
178959,control,0,0
178960,group,0,0
178961,did,0,0
178962,not,0,0
178963,receive,0,0
178964,skin,0,0
178965,anesthetic,0,0
178966,before,0,0
178967,(,0,1
178968,99m,0,0
178969,),0,1
178970,Tc-SC,0,1
178971,injections,0,0
178972,",",0,0
178973,whereas,0,0
178974,the,0,0
178975,experimental,0,0
178976,group,0,0
178977,first,0,0
178978,underwent,0,1
178979,skin,0,0
178980,anesthesia,0,0
178981,with,0,1
178982,an,0,0
178983,injection,0,0
178984,of,0,0
178985,2,0,0
178986,%,0,0
178987,sodium,0,0
178988,bicarbonate-buffered,0,0
178989,lidocaine,0,0
178990,.,0,0
178991,All,0,0
178992,patients,0,1
178993,were,0,0
178994,asked,0,0
178995,to,0,0
178996,rate,0,0
178997,their,0,0
178998,pain,0,1
178999,levels,0,0
179000,",",0,0
179001,using,0,0
179002,the,0,0
179003,National,0,0
179004,Institutes,0,1
179005,of,0,1
179006,Health,0,1
179007,pain,0,1
179008,scale,0,0
179009,",",0,0
179010,before,0,0
179011,the,0,0
179012,procedure,0,0
179013,and,0,0
179014,immediately,0,0
179015,after,0,0
179016,the,0,0
179017,injections,0,0
179018,.,0,0
179019,The,0,0
179020,change,0,0
179021,in,0,0
179022,pain,0,0
179023,from,0,1
179024,baseline,0,0
179025,was,0,0
179026,compared,0,0
179027,between,0,0
179028,the,0,0
179029,2,0,0
179030,groups,0,0
179031,.,0,1
179032,After,0,0
179033,the,0,0
179034,injections,0,0
179035,",",0,0
179036,scintigraphic,0,0
179037,imaging,0,0
179038,of,0,0
179039,the,0,0
179040,axilla,0,1
179041,was,0,0
179042,performed,0,0
179043,",",0,0
179044,and,0,0
179045,the,0,0
179046,number,0,0
179047,of,0,0
179048,axillary,0,1
179049,lymph,0,1
179050,nodes,0,1
179051,visualized,0,0
179052,was,0,0
179053,recorded,0,0
179054,.,0,1
179055,RESULTS,0,0
179056,No,0,0
179057,significant,0,0
179058,difference,0,0
179059,was,0,0
179060,found,0,0
179061,in,0,0
179062,preprocedural,0,0
179063,baseline,0,0
179064,pain,0,1
179065,from,0,0
179066,the,0,0
179067,control,0,0
179068,group,0,0
179069,",",0,0
179070,compared,0,0
179071,with,0,1
179072,the,0,0
179073,experimental,0,0
179074,group,0,0
179075,.,0,0
179076,There,0,0
179077,was,0,0
179078,a,0,0
179079,statistically,0,0
179080,significant,0,0
179081,difference,0,0
179082,in,0,0
179083,the,0,0
179084,increase,0,0
179085,in,0,0
179086,pain,0,0
179087,experienced,0,0
179088,during,0,0
179089,the,0,0
179090,procedure,0,0
179091,between,0,0
179092,the,0,0
179093,control,0,0
179094,group,0,0
179095,and,0,0
179096,the,0,0
179097,experimental,0,0
179098,group,0,0
179099,(,0,0
179100,P,0,0
179101,=,0,0
179102,0.009,0,0
179103,),0,0
179104,.,0,0
179105,There,0,0
179106,was,0,0
179107,no,0,0
179108,significant,0,0
179109,difference,0,0
179110,in,0,0
179111,the,0,0
179112,detection,0,0
179113,of,0,0
179114,lymph,0,1
179115,nodes,0,0
179116,between,0,0
179117,the,0,0
179118,control,0,0
179119,and,0,0
179120,experimental,0,0
179121,groups,0,0
179122,(,0,1
179123,P,0,0
179124,=,0,0
179125,0.56,0,0
179126,),0,0
179127,.,0,0
179128,CONCLUSION,0,0
179129,The,0,0
179130,results,0,0
179131,from,0,0
179132,our,0,0
179133,study,0,0
179134,indicate,0,0
179135,that,0,0
179136,injecting,0,1
179137,subcutaneous,0,0
179138,buffered,0,0
179139,lidocaine,0,0
179140,before,0,0
179141,intradermal,0,0
179142,injection,0,0
179143,of,0,0
179144,(,0,0
179145,99m,0,0
179146,),0,0
179147,Tc-SC,0,1
179148,for,0,0
179149,breast,0,1
179150,lymphoscintigraphy,0,0
179151,significantly,0,0
179152,decreases,0,0
179153,patient,0,0
179154,pain,0,0
179155,without,0,1
179156,interfering,0,0
179157,with,0,1
179158,lymph,0,1
179159,node,0,1
179160,visualization,0,0
179161,.,0,1
179162,Parent-implemented,0,0
179163,social,0,0
179164,intervention,0,0
179165,for,0,0
179166,toddlers,1,1
179167,with,1,1
179168,autism,1,1
179169,:,1,1
179170,an,0,0
179171,RCT,0,0
179172,.,0,0
179173,OBJECTIVES,0,0
179174,To,0,0
179175,compare,0,0
179176,the,0,0
179177,effects,0,0
179178,of,0,0
179179,two,0,1
179180,9-month,0,1
179181,parent-implemented,0,0
179182,interventions,0,0
179183,within,0,1
179184,the,0,0
179185,Early,0,1
179186,Social,0,0
179187,Interaction,0,0
179188,(,0,0
179189,ESI,0,0
179190,),0,0
179191,Project,0,0
179192,.,0,0
179193,Both,0,0
179194,individual-ESI,0,0
179195,",",0,0
179196,offered,0,0
179197,2,0,0
179198,or,0,1
179199,3,0,0
179200,times,0,0
179201,per,0,0
179202,week,0,0
179203,at,0,0
179204,home,0,0
179205,or,0,1
179206,in,0,0
179207,the,0,0
179208,community,0,0
179209,",",0,0
179210,and,0,0
179211,group-ESI,0,0
179212,",",0,0
179213,offered,0,0
179214,once,0,0
179215,per,0,0
179216,week,0,0
179217,in,0,0
179218,a,0,0
179219,clinic,0,1
179220,",",0,0
179221,taught,0,0
179222,parents,0,0
179223,how,0,0
179224,to,0,0
179225,embed,0,0
179226,strategies,0,0
179227,to,0,0
179228,support,0,0
179229,social,0,0
179230,communication,0,0
179231,throughout,0,0
179232,everyday,0,0
179233,activities,0,0
179234,.,0,1
179235,METHODS,0,0
179236,Participants,0,1
179237,in,0,1
179238,the,0,0
179239,randomized,0,0
179240,controlled,0,0
179241,trial,0,0
179242,included,0,1
179243,82,1,1
179244,children,1,1
179245,diagnosed,1,1
179246,with,1,1
179247,autism,1,1
179248,spectrum,1,1
179249,disorder,1,1
179250,at,1,0
179251,16,1,1
179252,to,1,1
179253,20,1,1
179254,months,1,0
179255,.,1,1
179256,Children,0,1
179257,were,0,0
179258,matched,0,1
179259,on,0,0
179260,pretreatment,0,0
179261,nonverbal,0,1
179262,developmental,0,1
179263,level,0,0
179264,and,0,0
179265,pairs,0,0
179266,were,0,0
179267,randomly,0,1
179268,assigned,0,0
179269,to,0,0
179270,treatment,0,0
179271,condition,0,0
179272,.,0,0
179273,Child,0,0
179274,outcomes,0,0
179275,included,0,0
179276,measures,0,0
179277,of,0,0
179278,social,0,0
179279,communication,0,0
179280,",",0,0
179281,autism,0,1
179282,symptoms,0,0
179283,",",0,0
179284,adaptive,0,0
179285,behavior,0,0
179286,",",0,0
179287,and,0,0
179288,developmental,0,1
179289,level,0,0
179290,.,0,1
179291,Child,0,0
179292,outcomes,0,0
179293,are,0,0
179294,reported,0,0
179295,from,0,0
179296,baseline,0,0
179297,to,0,0
179298,the,0,0
179299,end,0,0
179300,of,0,0
179301,the,0,0
179302,9-month,0,0
179303,interventions,0,0
179304,.,0,1
179305,RESULTS,0,0
179306,Children,0,1
179307,in,0,0
179308,individual-ESI,0,0
179309,showed,0,0
179310,differential,0,0
179311,change,0,0
179312,on,0,0
179313,a,0,0
179314,standardized,0,0
179315,examiner-administered,0,0
179316,observational,0,1
179317,measure,0,0
179318,of,0,0
179319,social,0,0
179320,communication,0,0
179321,",",0,0
179322,as,0,0
179323,they,0,0
179324,improved,0,0
179325,at,0,0
179326,a,0,0
179327,faster,0,0
179328,rate,0,0
179329,than,0,0
179330,children,0,1
179331,in,0,1
179332,group-ESI,0,1
179333,.,0,0
179334,Individual-ESI,0,0
179335,also,0,0
179336,showed,0,0
179337,differential,0,0
179338,efficacy,0,0
179339,on,0,0
179340,a,0,0
179341,parent,0,0
179342,report,0,0
179343,measure,0,0
179344,of,0,0
179345,communication,0,0
179346,",",0,0
179347,daily,0,0
179348,living,0,1
179349,",",0,0
179350,and,0,0
179351,social,0,0
179352,skills,0,0
179353,",",0,0
179354,as,0,0
179355,they,0,0
179356,showed,0,0
179357,improvement,0,0
179358,or,0,0
179359,stability,0,0
179360,",",0,0
179361,whereas,0,0
179362,group-ESI,0,0
179363,led,0,0
179364,to,0,0
179365,worsening,0,0
179366,or,0,0
179367,no,0,0
179368,significant,0,0
179369,change,0,0
179370,on,0,0
179371,these,0,0
179372,skills,0,0
179373,.,0,0
179374,Finally,0,0
179375,",",0,0
179376,individual-ESI,0,0
179377,showed,0,0
179378,differential,0,0
179379,change,0,0
179380,on,0,0
179381,examiner-administered,0,0
179382,measures,0,0
179383,of,0,0
179384,receptive,0,1
179385,language,0,0
179386,skills,0,0
179387,",",0,0
179388,as,0,0
179389,children,0,1
179390,in,0,0
179391,individual-ESI,0,0
179392,improved,0,0
179393,significantly,0,0
179394,",",0,0
179395,whereas,0,0
179396,group-ESI,0,0
179397,showed,0,0
179398,no,0,0
179399,change,0,0
179400,.,0,0
179401,CONCLUSIONS,0,0
179402,These,0,0
179403,findings,0,0
179404,support,0,0
179405,the,0,0
179406,efficacy,0,0
179407,of,0,0
179408,individual-ESI,0,0
179409,compared,0,0
179410,with,0,1
179411,group-ESI,0,0
179412,on,0,0
179413,child,0,1
179414,outcomes,0,0
179415,",",0,0
179416,suggesting,0,0
179417,the,0,0
179418,importance,0,0
179419,of,0,0
179420,individualized,0,0
179421,parent,0,0
179422,coaching,0,0
179423,in,0,0
179424,natural,0,0
179425,environments,0,0
179426,.,0,1
179427,The,0,0
179428,efficacy,0,0
179429,of,0,0
179430,a,0,0
179431,parent-implemented,0,0
179432,intervention,0,0
179433,using,0,0
179434,little,0,0
179435,professional,0,1
179436,time,0,0
179437,has,0,0
179438,potential,0,0
179439,for,0,0
179440,community,0,0
179441,viability,0,0
179442,",",0,0
179443,which,0,0
179444,is,0,0
179445,particularly,0,0
179446,important,0,0
179447,in,0,0
179448,light,0,0
179449,of,0,0
179450,the,0,0
179451,lack,0,0
179452,of,0,0
179453,main,0,0
179454,effects,0,0
179455,on,0,0
179456,child,0,1
179457,outcomes,0,0
179458,of,0,0
179459,most,0,0
179460,other,0,0
179461,parent-implemented,0,0
179462,interventions,0,1
179463,.,0,1
179464,Does,0,0
179465,cognition,0,0
179466,predict,0,0
179467,treatment,0,0
179468,response,0,0
179469,and,0,0
179470,remission,0,0
179471,in,0,0
179472,psychotherapy,0,0
179473,for,0,0
179474,late-life,1,1
179475,depression,1,1
179476,?,0,0
179477,OBJECTIVES,0,0
179478,To,0,0
179479,identify,0,0
179480,cognitive,0,0
179481,predictors,0,0
179482,of,0,0
179483,geriatric,1,1
179484,depression,1,1
179485,treatment,0,0
179486,outcome,0,0
179487,.,0,0
179488,METHOD,0,0
179489,Older,1,0
179490,participants,1,1
179491,completed,1,1
179492,baseline,1,0
179493,measures,1,0
179494,of,1,0
179495,memory,1,0
179496,and,1,0
179497,executive,1,0
179498,function,1,0
179499,",",1,0
179500,health,1,0
179501,",",1,0
179502,and,1,0
179503,baseline,1,0
179504,and,1,0
179505,post-treatment,1,0
179506,Hamilton,1,1
179507,Depression,1,0
179508,Scales,1,0
179509,(,1,0
179510,HAM-D,1,1
179511,),1,0
179512,in,1,0
179513,a,1,0
179514,12-week,1,0
179515,trial,1,0
179516,comparing,1,0
179517,psychotherapies,1,0
179518,(,1,1
179519,problem-solving,1,0
179520,vs.,1,0
179521,supportive,1,0
179522,;,1,0
179523,N,1,1
179524,=,1,0
179525,46,1,1
179526,),1,0
179527,.,1,1
179528,We,0,0
179529,examined,0,0
179530,cognitive,0,0
179531,predictors,0,0
179532,to,0,0
179533,identify,0,0
179534,treatment,0,0
179535,responders,0,0
179536,(,0,0
179537,i.e.,0,0
179538,",",0,0
179539,HAM-D,0,1
179540,scores,0,0
179541,reduced,0,0
179542,by,0,0
179543,?50,0,1
179544,%,0,0
179545,),0,0
179546,and,0,0
179547,remitters,0,0
179548,(,0,0
179549,i.e.,0,0
179550,",",0,0
179551,post-treatment,0,0
179552,HAM-D,0,0
179553,score,0,0
179554,?10,0,0
179555,),0,0
179556,.,0,1
179557,RESULTS,0,0
179558,Empirically,0,0
179559,derived,0,0
179560,decision,0,0
179561,trees,0,1
179562,identified,0,0
179563,poorer,0,0
179564,performance,0,0
179565,on,0,0
179566,switching,0,0
179567,(,0,0
179568,i.e.,0,0
179569,",",0,0
179570,Trails,0,0
179571,B,0,0
179572,),0,0
179573,",",0,0
179574,with,0,1
179575,a,0,0
179576,cut-score,0,0
179577,of,0,0
179578,?82,0,0
179579,predicting,0,0
179580,psychotherapy,0,1
179581,responders,0,0
179582,.,0,1
179583,No,0,0
179584,other,0,0
179585,cognitive,0,0
179586,or,0,1
179587,health,0,1
179588,variables,0,0
179589,predicted,0,0
179590,psychotherapy,0,1
179591,outcomes,0,0
179592,in,0,0
179593,the,0,0
179594,decision,0,0
179595,trees,0,1
179596,.,0,1
179597,CONCLUSIONS,0,0
179598,Psychotherapies,0,0
179599,that,0,0
179600,support,0,0
179601,or,0,0
179602,improve,0,0
179603,the,0,0
179604,executive,0,0
179605,skill,0,0
179606,of,0,0
179607,switching,0,0
179608,may,0,0
179609,augment,0,0
179610,treatment,0,0
179611,response,0,0
179612,for,1,0
179613,older,1,1
179614,patients,1,1
179615,exhibiting,1,0
179616,executive,1,0
179617,dysfunction,1,1
179618,in,1,0
179619,depression,1,1
179620,.,1,1
179621,If,1,0
179622,replicated,1,0
179623,",",0,0
179624,Trails,0,0
179625,B,0,0
179626,has,0,0
179627,potential,0,0
179628,as,0,0
179629,a,0,0
179630,brief,0,0
179631,cognitive,0,0
179632,tool,0,0
179633,for,0,0
179634,clinical,0,0
179635,decision-making,1,0
179636,in,1,0
179637,geriatric,1,1
179638,depression,1,1
179639,.,1,1
179640,Treatment,0,0
179641,of,0,0
179642,Wilms,1,0
179643,',1,1
179644,tumor,1,1
179645,.,1,1
179646,Results,0,0
179647,of,0,0
179648,the,0,0
179649,Third,0,1
179650,National,1,1
179651,Wilms,1,1
179652,',1,1
179653,Tumor,1,1
179654,Study,0,1
179655,.,0,0
179656,The,0,0
179657,Third,0,0
179658,National,1,1
179659,Wilms,1,1
179660,',1,1
179661,Tumor,1,1
179662,Study,0,1
179663,sought,0,0
179664,to,0,0
179665,reduce,0,0
179666,treatment,0,0
179667,for,0,0
179668,low-risk,1,1
179669,patients,1,1
179670,and,0,0
179671,find,0,0
179672,better,0,0
179673,chemotherapy,0,0
179674,for,0,0
179675,those,1,0
179676,at,1,0
179677,high,1,0
179678,risk,1,0
179679,for,1,0
179680,relapse,1,0
179681,.,1,1
179682,Eligible,1,0
179683,patients,1,1
179684,(,1,1
179685,1439,1,1
179686,),1,0
179687,were,0,0
179688,randomized,0,0
179689,according,0,0
179690,to,0,0
179691,stage,1,1
179692,(,1,0
179693,I-IV,1,0
179694,),1,0
179695,and,1,0
179696,histology,1,0
179697,(,1,0
179698,favorable,1,0
179699,[,1,0
179700,FH,1,1
179701,],1,1
179702,or,1,1
179703,unfavorable,1,0
179704,[,1,0
179705,UH,1,0
179706,],1,1
179707,),1,0
179708,",",1,0
179709,and,1,0
179710,contributed,1,0
179711,data,1,0
179712,to,1,0
179713,survival,1,0
179714,and,1,0
179715,relapse-free,1,0
179716,survival,1,0
179717,(,1,0
179718,RFS,1,0
179719,),1,0
179720,analyses,1,0
179721,.,1,0
179722,Four-year,1,0
179723,(,1,0
179724,postnephrectomy,1,1
179725,),1,0
179726,survival,1,0
179727,percentages,1,0
179728,and,0,0
179729,randomized,0,1
179730,treatment,0,0
179731,regimens,0,0
179732,for,0,0
179733,low-risk,0,1
179734,patients,0,1
179735,were,0,1
179736,96.5,0,0
179737,%,0,0
179738,for,0,0
179739,607,0,1
179740,Stage,0,1
179741,I/FH,0,1
179742,patients,0,1
179743,who,0,1
179744,received,0,1
179745,dactinomycin,0,1
179746,(,0,0
179747,Actinomycin,0,0
179748,D,0,0
179749,[,0,0
179750,AMD,0,0
179751,],0,0
179752,",",0,0
179753,Merck,0,1
179754,Sharp,0,0
179755,&,0,1
179756,Dohme,0,0
179757,",",0,0
179758,West,0,0
179759,Point,0,0
179760,",",0,0
179761,PA,0,0
179762,),0,0
179763,and,0,0
179764,vincristine,0,0
179765,(,0,0
179766,VCR,0,0
179767,),0,0
179768,for,0,0
179769,10,0,1
179770,weeks,0,0
179771,versus,0,0
179772,6,0,1
179773,months,0,0
179774,;,0,1
179775,92.2,0,0
179776,%,0,0
179777,for,0,0
179778,278,0,1
179779,Stage,0,1
179780,II/FH,0,1
179781,patients,0,1
179782,;,0,1
179783,and,0,0
179784,86.9,0,0
179785,%,0,0
179786,for,0,0
179787,275,0,1
179788,Stage,0,1
179789,III/FH,0,1
179790,patients,0,1
179791,who,0,1
179792,received,0,1
179793,AMD,0,1
179794,+,0,0
179795,VCR,0,0
179796,+/-,0,0
179797,Adriamycin,0,1
179798,(,0,0
179799,ADR,0,0
179800,",",0,1
179801,Adria,0,0
179802,Laboratories,0,1
179803,",",0,1
179804,Columbus,0,1
179805,",",0,0
179806,OH,0,0
179807,),0,0
179808,for,0,0
179809,15,0,1
179810,months,0,0
179811,.,0,1
179812,Stage,0,1
179813,II/FH,0,0
179814,patients,0,1
179815,also,0,0
179816,had,0,1
179817,either,0,0
179818,zero,0,0
179819,or,0,1
179820,2000,0,1
179821,cGy,0,0
179822,irradiation,0,0
179823,(,0,0
179824,RT,0,1
179825,),0,0
179826,postoperatively,0,0
179827,and,0,0
179828,Stage,0,1
179829,III/FH,0,1
179830,patients,0,1
179831,either,0,1
179832,1000,0,0
179833,or,0,1
179834,2000,0,1
179835,cGy,0,0
179836,.,0,1
179837,Four-year,0,0
179838,survival,0,0
179839,was,0,0
179840,73.0,0,0
179841,%,0,0
179842,for,0,0
179843,279,0,1
179844,high-risk,1,1
179845,patients,1,1
179846,(,0,1
179847,any,0,0
179848,Stage,0,1
179849,IV,0,0
179850,",",0,0
179851,all,0,0
179852,UH,0,0
179853,),0,1
179854,who,0,1
179855,received,0,1
179856,postoperative,0,1
179857,radiation,0,0
179858,therapy,0,0
179859,(,0,0
179860,RT,0,1
179861,),0,0
179862,and,0,0
179863,AMD,0,0
179864,+,0,0
179865,VCR,0,0
179866,+,0,0
179867,ADR,0,1
179868,+/-,0,0
179869,cyclophosphamide,0,0
179870,(,0,0
179871,CPM,0,0
179872,),0,1
179873,.,0,0
179874,Statistical,0,0
179875,analysis,0,0
179876,of,0,0
179877,survival,0,0
179878,and,0,0
179879,RFS,0,0
179880,experience,0,0
179881,shows,0,0
179882,that,0,0
179883,the,0,0
179884,less,0,0
179885,intensive,0,0
179886,therapy,0,0
179887,does,0,0
179888,not,0,0
179889,worsen,0,0
179890,results,0,0
179891,for,0,0
179892,low-risk,0,1
179893,patients,0,1
179894,and,0,0
179895,CPM,0,0
179896,does,0,0
179897,not,0,0
179898,benefit,0,0
179899,those,0,0
179900,at,0,0
179901,high,0,0
179902,risk,0,1
179903,.,0,1
179904,A,0,0
179905,step-by-step,0,0
179906,introduction,0,0
179907,to,0,0
179908,vegetables,0,0
179909,at,0,0
179910,the,0,0
179911,beginning,0,0
179912,of,0,0
179913,complementary,0,0
179914,feeding,0,0
179915,.,0,0
179916,The,0,0
179917,effects,0,0
179918,of,0,0
179919,early,0,1
179920,and,0,0
179921,repeated,0,0
179922,exposure,0,0
179923,.,0,1
179924,Breastfeeding,1,0
179925,(,1,0
179926,BF,1,0
179927,),1,0
179928,is,0,0
179929,associated,0,0
179930,with,0,0
179931,willingness,0,0
179932,to,0,0
179933,accept,0,0
179934,vegetables,0,0
179935,.,0,0
179936,This,0,0
179937,may,0,0
179938,be,0,0
179939,due,0,0
179940,to,0,0
179941,the,0,0
179942,variety,0,0
179943,of,0,0
179944,flavours,0,0
179945,delivered,0,0
179946,via,0,0
179947,breast,0,1
179948,milk,0,1
179949,.,0,0
179950,Some,0,0
179951,mothers,1,1
179952,add,0,0
179953,vegetables,0,0
179954,to,0,0
179955,milk,0,1
179956,during,0,0
179957,complementary,0,0
179958,feeding,0,0
179959,(,0,0
179960,CF,0,0
179961,),0,0
179962,to,0,0
179963,enhance,0,0
179964,acceptance,0,0
179965,.,0,0
179966,The,0,0
179967,present,0,0
179968,study,0,0
179969,tested,0,0
179970,a,0,0
179971,step-by-step,0,0
179972,exposure,0,0
179973,to,0,0
179974,vegetables,0,0
179975,in,0,0
179976,milk,0,1
179977,then,0,0
179978,rice,0,0
179979,during,0,0
179980,CF,0,0
179981,",",0,0
179982,on,0,0
179983,intake,0,0
179984,and,0,0
179985,liking,0,0
179986,of,0,0
179987,vegetables,0,0
179988,.,0,1
179989,Just,0,0
179990,before,0,0
179991,CF,0,0
179992,",",0,0
179993,enrolled,1,1
179994,mothers,1,1
179995,were,1,1
179996,randomised,1,0
179997,to,1,0
179998,an,1,0
179999,intervention,1,0
180000,(,1,0
180001,IG,1,0
180002,",",1,0
180003,n,1,1
180004,=,1,0
180005,18,1,1
180006,;,1,1
180007,6,1,0
180008,BF,1,0
180009,),1,0
180010,or,1,0
180011,control,1,0
180012,group,1,0
180013,(,1,0
180014,CG,1,0
180015,",",1,0
180016,n,1,1
180017,=,1,0
180018,18,1,1
180019,;,1,1
180020,6,1,0
180021,BF,1,0
180022,),1,1
180023,.,1,1
180024,IG,1,0
180025,infants,1,1
180026,received,0,1
180027,12,0,1
180028,daily,0,0
180029,exposures,0,0
180030,to,0,1
180031,vegetable,0,0
180032,puree,0,0
180033,added,0,0
180034,to,0,0
180035,milk,0,1
180036,(,0,0
180037,days,0,0
180038,1-12,0,0
180039,),0,0
180040,",",0,0
180041,then,0,0
180042,12,0,0
180043,?,0,0
180044,2,0,0
180045,daily,0,0
180046,exposures,0,0
180047,to,0,1
180048,vegetable,0,0
180049,puree,0,0
180050,added,0,0
180051,to,0,0
180052,rice,0,0
180053,at,0,0
180054,home,0,0
180055,(,0,0
180056,days,0,0
180057,13-24,0,1
180058,),0,0
180059,.,0,0
180060,Plain,0,0
180061,milk,0,0
180062,and,0,0
180063,rice,0,0
180064,were,0,0
180065,given,0,0
180066,to,0,0
180067,CG,0,1
180068,.,0,0
180069,Then,0,0
180070,both,0,0
180071,received,0,0
180072,11,0,0
180073,daily,0,0
180074,exposures,0,0
180075,to,0,1
180076,vegetable,0,0
180077,puree,0,0
180078,.,0,1
180079,Intake,0,0
180080,was,0,0
180081,weighed,0,0
180082,and,0,0
180083,liking,0,0
180084,rated,0,0
180085,on,0,0
180086,days,0,0
180087,25-26,0,1
180088,and,0,1
180089,33-35,0,1
180090,after,0,0
180091,the,0,0
180092,start,0,0
180093,of,0,0
180094,CF,0,0
180095,in,0,0
180096,the,0,0
180097,laboratory,0,0
180098,",",0,0
180099,supplemented,0,0
180100,by,0,0
180101,the,0,0
180102,same,0,0
180103,data,0,0
180104,recorded,0,0
180105,at,0,0
180106,home,0,1
180107,.,0,1
180108,Vegetables,0,0
180109,were,0,0
180110,rotated,0,0
180111,daily,0,0
180112,(,0,0
180113,carrots,0,0
180114,",",0,1
180115,green,0,0
180116,beans,0,0
180117,",",0,0
180118,spinach,0,0
180119,",",0,0
180120,broccoli,0,0
180121,),0,0
180122,.,0,0
180123,Intake,0,0
180124,",",0,0
180125,liking,0,0
180126,and,0,0
180127,pace,0,0
180128,of,0,0
180129,eating,0,0
180130,were,0,0
180131,greater,0,0
180132,for,0,0
180133,IG,0,0
180134,than,0,0
180135,CG,0,1
180136,infants,0,1
180137,.,0,1
180138,Intake,0,0
180139,and,0,0
180140,liking,0,0
180141,of,0,0
180142,carrots,0,0
180143,were,0,1
180144,greater,0,0
180145,than,0,0
180146,green,0,0
180147,beans,0,1
180148,.,0,0
180149,However,0,0
180150,",",0,0
180151,at,0,0
180152,6m,0,0
180153,then,0,0
180154,18m,0,1
180155,follow,0,0
180156,up,0,0
180157,",",0,0
180158,vegetable,0,0
180159,(,0,0
180160,carrot,0,0
180161,>,0,1
180162,green,0,0
180163,beans,0,1
180164,),0,0
180165,but,0,0
180166,not,0,0
180167,group,0,0
180168,differences,0,0
180169,were,0,1
180170,observed,1,0
180171,.,1,1
180172,Mothers,1,0
180173,reported,1,0
180174,appreciation,0,0
180175,of,0,0
180176,the,0,0
180177,structure,0,0
180178,and,0,0
180179,guidance,0,0
180180,of,0,0
180181,this,0,0
180182,systematic,0,0
180183,approach,0,0
180184,.,0,1
180185,Early,0,0
180186,exposure,0,0
180187,to,0,0
180188,vegetables,0,0
180189,in,0,0
180190,a,0,0
180191,step-by-step,0,0
180192,method,0,0
180193,could,0,0
180194,be,0,0
180195,included,0,0
180196,in,0,0
180197,CF,0,0
180198,guidelines,0,0
180199,and,0,0
180200,longer,0,0
180201,term,0,1
180202,benefits,0,0
180203,assessed,0,0
180204,by,0,0
180205,extending,0,0
180206,the,0,0
180207,exposure,0,0
180208,period,0,0
180209,.,0,1
180210,Reducing,0,0
180211,iodine,0,0
180212,load,0,0
180213,in,0,0
180214,hepatic,0,0
180215,CT,0,1
180216,for,0,0
180217,patients,1,1
180218,with,1,1
180219,chronic,1,1
180220,liver,1,1
180221,disease,1,1
180222,with,0,1
180223,a,0,0
180224,combination,0,0
180225,of,0,0
180226,low-tube-voltage,0,0
180227,and,0,0
180228,adaptive,0,0
180229,statistical,0,0
180230,iterative,0,0
180231,reconstruction,0,1
180232,.,0,1
180233,PURPOSE,0,0
180234,To,0,0
180235,prospectively,0,0
180236,assess,0,0
180237,the,0,0
180238,effect,0,0
180239,of,0,0
180240,reduced,0,0
180241,iodine,0,0
180242,load,0,0
180243,to,0,0
180244,contrast,0,0
180245,enhancement,0,0
180246,",",0,0
180247,image,0,0
180248,quality,0,0
180249,",",0,0
180250,and,0,0
180251,detectability,0,0
180252,of,0,0
180253,hepatocellular,0,1
180254,carcinomas,0,1
180255,(,0,0
180256,HCCs,0,0
180257,),0,0
180258,in,0,0
180259,hepatic,0,0
180260,CT,0,1
180261,with,0,1
180262,a,0,0
180263,combination,0,0
180264,of,0,0
180265,80,0,1
180266,kVp,0,1
180267,tube,0,0
180268,voltage,0,0
180269,setting,0,1
180270,and,0,0
180271,adaptive,0,0
180272,statistical,0,0
180273,iterative,0,0
180274,reconstruction,0,1
180275,(,0,0
180276,ASIR,0,0
180277,),0,0
180278,technique,0,0
180279,in,0,0
180280,patients,1,1
180281,with,1,1
180282,chronic,1,1
180283,liver,1,1
180284,disease,1,1
180285,.,1,0
180286,MATERIALS,0,0
180287,AND,0,0
180288,METHODS,0,0
180289,This,0,0
180290,HIPAA-compliant,0,1
180291,study,0,0
180292,was,0,0
180293,approved,0,0
180294,by,0,0
180295,our,0,0
180296,institutional,0,0
180297,review,0,0
180298,board,0,0
180299,and,0,0
180300,written,0,0
180301,informed,0,0
180302,consent,0,1
180303,was,0,0
180304,obtained,0,0
180305,in,0,0
180306,all,0,1
180307,patients,0,1
180308,.,0,0
180309,During,0,0
180310,a,0,0
180311,recent,0,0
180312,9-month,0,0
180313,period,0,0
180314,",",0,0
180315,170,1,1
180316,consecutive,1,1
180317,patients,1,1
180318,(,1,1
180319,114,1,1
180320,men,1,1
180321,and,1,1
180322,56,1,1
180323,women,1,1
180324,;,1,1
180325,age,1,1
180326,range,1,0
180327,",",1,0
180328,40-85,1,1
180329,years,1,1
180330,;,1,0
180331,mean,1,1
180332,",",1,0
180333,67.7,1,0
180334,years,1,1
180335,),1,1
180336,with,1,1
180337,suspected,1,1
180338,chronic,1,1
180339,liver,1,1
180340,diseases,1,1
180341,were,0,0
180342,randomized,0,1
180343,into,0,1
180344,three,0,0
180345,CT,0,1
180346,groups,0,0
180347,according,0,1
180348,to,0,0
180349,the,0,0
180350,following,0,0
180351,iodine-load,0,0
180352,and,0,0
180353,tube-voltage,0,0
180354,protocols,0,0
180355,:,0,1
180356,600,0,1
180357,milligram,0,0
180358,per,0,0
180359,kilogram,0,0
180360,body,0,1
180361,weight,0,0
180362,(,0,0
180363,mg/kg,0,0
180364,),0,0
180365,iodine,0,0
180366,load,0,0
180367,and,0,0
180368,120,0,1
180369,peak,0,0
180370,kilovolt,0,0
180371,(,0,0
180372,kVp,0,1
180373,),0,0
180374,tube,0,0
180375,voltage,0,0
180376,setting,0,1
180377,(,0,0
180378,600-120,0,0
180379,group,0,0
180380,),0,0
180381,",",0,0
180382,500,0,0
180383,mg/kg,0,0
180384,and,0,0
180385,80,0,1
180386,kVp,0,1
180387,(,0,0
180388,500-80,0,1
180389,group,0,0
180390,),0,0
180391,",",0,0
180392,and,0,0
180393,400mg/kg,0,0
180394,and,0,0
180395,80,0,1
180396,kVp,0,1
180397,(,0,0
180398,400-80,0,0
180399,group,0,1
180400,),0,0
180401,.,0,0
180402,Analysis,0,0
180403,of,0,0
180404,variance,0,0
180405,was,0,0
180406,conducted,0,0
180407,to,0,0
180408,evaluate,0,0
180409,differences,0,0
180410,in,0,0
180411,CT,0,1
180412,number,0,0
180413,",",0,0
180414,background,0,0
180415,noise,0,0
180416,",",0,0
180417,signal-to-noise,0,0
180418,ratio,0,0
180419,(,0,0
180420,SNR,0,0
180421,),0,0
180422,",",0,0
180423,effective,0,0
180424,dose,0,0
180425,",",0,0
180426,HCC-to-liver,0,0
180427,contrast-to-noise,0,0
180428,ratio,0,0
180429,(,0,0
180430,CNR,0,0
180431,),0,0
180432,",",0,0
180433,and,0,0
180434,figure,0,0
180435,of,0,0
180436,merit,0,0
180437,(,0,0
180438,FOM,0,0
180439,),0,1
180440,.,0,0
180441,Sensitivity,0,0
180442,",",0,0
180443,specificity,0,0
180444,",",0,0
180445,and,0,0
180446,area,0,0
180447,under,0,0
180448,the,0,0
180449,receiver-operating-characteristic,0,0
180450,curve,0,0
180451,(,0,0
180452,AUC,0,0
180453,),0,0
180454,were,0,0
180455,compared,0,0
180456,to,0,0
180457,assess,0,0
180458,the,0,0
180459,detectability,0,0
180460,of,0,0
180461,HCCs,0,0
180462,.,0,1
180463,RESULTS,0,0
180464,Vascular,0,0
180465,and,0,0
180466,hepatic,0,0
180467,enhancement,0,0
180468,in,0,0
180469,the,0,0
180470,400-80,0,0
180471,and,0,0
180472,500-80,0,1
180473,groups,0,0
180474,was,0,0
180475,comparable,0,0
180476,to,0,0
180477,or,0,0
180478,greater,0,0
180479,than,0,0
180480,that,0,0
180481,in,0,0
180482,the,0,0
180483,600-120,0,0
180484,group,0,0
180485,(,0,0
180486,P,0,0
180487,<,0,0
180488,.05,0,0
180489,),0,0
180490,.,0,0
180491,Subjective,0,0
180492,image,0,0
180493,quality,0,0
180494,was,0,0
180495,comparable,0,0
180496,among,0,0
180497,the,0,0
180498,three,0,0
180499,groups,0,0
180500,.,0,1
180501,Sensitivity,0,0
180502,",",0,0
180503,specificity,0,0
180504,",",0,0
180505,and,0,0
180506,AUC,0,0
180507,for,0,0
180508,detecting,0,0
180509,HCCs,0,0
180510,were,0,1
180511,comparable,0,0
180512,among,0,0
180513,the,0,0
180514,groups,0,0
180515,.,0,0
180516,The,0,0
180517,effective,0,0
180518,dose,0,0
180519,was,0,0
180520,kept,0,0
180521,low,0,0
180522,(,0,0
180523,3.3-4.1,0,0
180524,mSv,0,0
180525,),0,0
180526,in,0,0
180527,all,0,1
180528,three,0,0
180529,groups,0,0
180530,.,0,1
180531,CONCLUSION,0,0
180532,Iodine,0,0
180533,load,0,0
180534,can,0,0
180535,be,0,0
180536,reduced,0,0
180537,by,0,0
180538,33,0,1
180539,%,0,0
180540,in,0,0
180541,CT,0,0
180542,of,0,0
180543,the,0,0
180544,liver,0,1
180545,with,0,0
180546,a,0,0
180547,combination,0,0
180548,of,0,0
180549,80,0,1
180550,kVp,0,1
180551,tube,0,0
180552,voltage,0,0
180553,setting,0,1
180554,and,0,0
180555,ASIR,0,0
180556,technique,0,0
180557,",",0,0
180558,without,0,0
180559,compromising,0,0
180560,the,0,0
180561,contrast,0,0
180562,enhancement,0,0
180563,",",0,0
180564,image,0,0
180565,quality,0,0
180566,",",0,0
180567,and,0,0
180568,detection,0,0
180569,of,0,0
180570,HCCs,0,0
180571,.,0,1
180572,Exercise,0,0
180573,echocardiography,0,0
180574,demonstrates,0,0
180575,biventricular,0,0
180576,systolic,0,0
180577,dysfunction,0,1
180578,and,0,0
180579,reveals,0,0
180580,decreased,0,0
180581,left,0,1
180582,ventricular,0,0
180583,contractile,0,1
180584,reserve,0,1
180585,in,0,0
180586,children,1,1
180587,after,1,0
180588,tetralogy,1,1
180589,of,1,0
180590,Fallot,1,1
180591,repair,1,1
180592,.,1,1
180593,BACKGROUND,0,0
180594,Long-term,0,0
180595,biventricular,0,1
180596,systolic,0,0
180597,performance,0,0
180598,is,0,0
180599,a,0,0
180600,key,0,0
180601,determinant,0,0
180602,of,0,0
180603,clinical,0,0
180604,outcomes,0,0
180605,late,0,1
180606,after,0,0
180607,tetralogy,0,1
180608,of,0,0
180609,Fallot,0,1
180610,(,0,1
180611,TOF,0,0
180612,),0,0
180613,repair,0,1
180614,.,0,0
180615,A,0,0
180616,need,0,0
180617,exists,0,0
180618,for,0,0
180619,early,0,0
180620,indices,0,0
180621,of,0,0
180622,both,0,0
180623,left,0,1
180624,ventricular,0,0
180625,(,0,0
180626,LV,0,1
180627,),0,0
180628,and,0,0
180629,right,0,0
180630,ventricular,0,0
180631,(,0,0
180632,RV,0,0
180633,),0,0
180634,compromise,0,0
180635,in,0,0
180636,this,0,0
180637,population,0,1
180638,.,0,0
180639,METHODS,0,0
180640,Twenty-nine,1,1
180641,children,1,1
180642,(,1,0
180643,age,1,1
180644,range,1,0
180645,",",1,0
180646,5-18,1,1
180647,years,1,1
180648,),1,1
180649,with,1,1
180650,repaired,1,0
180651,TOF,1,0
180652,and,1,0
180653,44,1,1
180654,healthy,1,1
180655,controls,1,1
180656,were,0,1
180657,prospectively,0,1
180658,evaluated,0,0
180659,.,0,0
180660,M-mode,0,0
180661,and,0,0
180662,tissue,0,0
180663,Doppler,0,1
180664,data,0,0
180665,were,0,0
180666,obtained,0,0
180667,for,0,0
180668,each,0,0
180669,ventricle,0,0
180670,and,0,0
180671,the,0,0
180672,RV,0,0
180673,outflow,0,0
180674,tract,0,1
180675,at,0,0
180676,rest,0,0
180677,and,0,0
180678,during,0,0
180679,semisupine,0,0
180680,bicycle,0,1
180681,exercise,0,0
180682,.,0,0
180683,By,0,0
180684,making,0,0
180685,measurements,0,0
180686,of,0,0
180687,myocardial,0,1
180688,acceleration,0,0
180689,during,0,0
180690,isovolumic,0,0
180691,contraction,0,1
180692,during,0,0
180693,exercise,0,0
180694,",",0,0
180695,at,0,0
180696,increasing,0,0
180697,heart,0,1
180698,rates,0,0
180699,",",0,0
180700,LV,0,1
180701,force-frequency,0,0
180702,curves,0,0
180703,were,0,1
180704,constructed,0,0
180705,.,0,1
180706,Patients,0,1
180707,also,0,0
180708,underwent,0,1
180709,cardiac,0,1
180710,magnetic,0,0
180711,resonance,0,0
180712,imaging,0,0
180713,",",0,0
180714,cardiopulmonary,0,1
180715,exercise,0,0
180716,testing,0,0
180717,",",0,0
180718,and,0,0
180719,measurement,0,0
180720,of,0,0
180721,serum,0,0
180722,neurohormonal,0,1
180723,markers,0,0
180724,.,0,1
180725,RESULTS,0,0
180726,Children,1,1
180727,with,1,1
180728,repaired,1,1
180729,TOF,1,0
180730,had,0,1
180731,dilated,0,1
180732,right,0,1
180733,ventricles,0,1
180734,(,0,1
180735,RV,0,1
180736,end-diastolic,0,1
180737,volume,0,0
180738,index,0,0
180739,=,0,0
180740,153,0,1
180741,?,0,1
180742,37.3,0,0
180743,mL/m,0,0
180744,(,0,1
180745,2,0,0
180746,),0,1
180747,),0,0
180748,but,0,0
180749,normal,0,1
180750,ejection,0,1
180751,fractions,0,0
180752,as,0,0
180753,measured,0,0
180754,on,0,0
180755,magnetic,0,0
180756,resonance,0,0
180757,imaging,0,0
180758,(,0,0
180759,LV,0,0
180760,ejection,0,1
180761,fraction,0,0
180762,=,0,0
180763,59.3,0,1
180764,?,0,1
180765,6.2,0,0
180766,%,0,0
180767,",",0,0
180768,RV,0,0
180769,ejection,0,1
180770,fraction,0,0
180771,=,0,0
180772,50.2,0,1
180773,?,0,1
180774,8.5,0,0
180775,%,0,0
180776,),0,0
180777,and,0,0
180778,normal,0,1
180779,serum,0,0
180780,neurohormonal,0,1
180781,markers,0,0
180782,.,0,1
180783,Detailed,0,0
180784,resting,0,0
180785,echocardiography,0,0
180786,detected,0,0
180787,abnormal,0,0
180788,ventricular,0,0
180789,function,0,0
180790,",",0,0
180791,worst,0,0
180792,in,0,0
180793,the,0,0
180794,right,0,0
180795,ventricle,0,0
180796,and,0,0
180797,RV,0,0
180798,outflow,0,0
180799,tract,0,1
180800,.,0,1
180801,Exercise,0,0
180802,exacerbated,0,0
180803,these,0,0
180804,findings,0,0
180805,and,0,0
180806,provoked,0,0
180807,significant,0,0
180808,decline,0,0
180809,in,0,0
180810,LV,0,1
180811,indices,0,0
180812,.,0,1
180813,The,0,0
180814,LV,0,0
180815,force-frequency,0,0
180816,curves,0,0
180817,of,0,1
180818,patients,0,1
180819,were,0,0
180820,attenuated,0,0
180821,",",0,0
180822,with,0,1
180823,an,0,0
180824,early,0,0
180825,plateau,0,0
180826,and,0,0
180827,inadequate,0,1
180828,increase,0,0
180829,of,0,0
180830,isovolumic,0,0
180831,contraction,0,1
180832,.,0,1
180833,Correlations,0,0
180834,were,0,0
180835,seen,0,0
180836,between,0,0
180837,peak,0,0
180838,exercise,0,0
180839,LV,0,1
180840,isovolumic,0,0
180841,contraction,0,0
180842,and,0,0
180843,percentage,0,0
180844,predicted,0,0
180845,peak,0,0
180846,oxygen,0,0
180847,uptake,0,0
180848,(,0,0
180849,r,0,0
180850,=,0,0
180851,0.51,0,0
180852,",",0,0
180853,P,0,0
180854,=,0,0
180855,.02,0,0
180856,),0,0
180857,",",0,0
180858,LV,0,0
180859,and,0,0
180860,RV,0,0
180861,ejection,0,1
180862,fractions,0,0
180863,(,0,0
180864,r,0,0
180865,=,0,0
180866,0.41,0,0
180867,",",0,0
180868,P,0,0
180869,=,0,0
180870,.03,0,0
180871,),0,0
180872,",",0,0
180873,and,0,0
180874,RV,0,0
180875,and,0,0
180876,LV,0,1
180877,long-axis,0,0
180878,fractional,0,0
180879,shortening,0,0
180880,(,0,0
180881,r,0,0
180882,=,0,0
180883,0.44,0,0
180884,",",0,0
180885,P,0,0
180886,=,0,0
180887,.02,0,0
180888,),0,0
180889,.,0,0
180890,CONCLUSIONS,0,0
180891,The,0,0
180892,postsurgical,0,0
180893,pathophysiology,0,0
180894,of,0,0
180895,TOF,0,0
180896,begins,0,0
180897,early,0,0
180898,after,0,0
180899,repair,0,1
180900,.,0,0
180901,At,0,0
180902,a,0,0
180903,time,0,0
180904,when,0,0
180905,clinically,0,0
180906,well,0,0
180907,and,0,0
180908,while,0,0
180909,routine,0,0
180910,indices,0,0
180911,of,0,0
180912,heart,0,1
180913,function,0,0
180914,remain,0,0
180915,normal,1,0
180916,",",1,0
180917,children,1,1
180918,with,1,1
180919,repaired,1,1
180920,TOF,1,0
180921,exhibit,1,0
180922,RV,1,0
180923,dilatation,1,1
180924,and,1,0
180925,subtle,1,0
180926,",",1,0
180927,interlinked,1,0
180928,biventricular,0,1
180929,abnormalities,0,1
180930,on,0,0
180931,resting,0,0
180932,echocardiography,0,0
180933,.,0,0
180934,Exercise,0,0
180935,echocardiography,0,0
180936,provides,0,0
180937,additional,0,0
180938,information,0,0
180939,and,0,0
180940,reveals,0,0
180941,abnormal,0,0
180942,LV,0,1
180943,excitation-contractile,0,0
180944,coupling,0,0
180945,that,0,0
180946,may,0,0
180947,be,0,0
180948,linked,0,0
180949,to,0,0
180950,impaired,0,1
180951,exercise,0,0
180952,capacity,0,0
180953,.,0,1
180954,Effect,0,0
180955,of,0,0
180956,L-type,0,1
180957,calcium,0,0
180958,channel,0,0
180959,blocker,0,0
180960,(,0,0
180961,amlodipine,0,0
180962,),0,0
180963,on,0,0
180964,myocardial,0,1
180965,iron,0,0
180966,deposition,0,0
180967,in,0,0
180968,patients,1,1
180969,with,1,1
180970,thalassaemia,1,1
180971,with,1,1
180972,moderate-to-severe,1,1
180973,myocardial,1,1
180974,iron,1,0
180975,deposition,1,1
180976,:,1,1
180977,protocol,0,0
180978,for,0,0
180979,a,0,0
180980,randomised,0,0
180981,",",0,0
180982,controlled,0,0
180983,trial,0,0
180984,.,0,1
180985,INTRODUCTION,0,0
180986,Sideroblastic,0,1
180987,cardiomyopathy,0,1
180988,secondary,0,0
180989,to,0,0
180990,repeated,0,0
180991,blood,0,0
180992,transfusions,0,0
180993,is,0,0
180994,a,0,0
180995,feared,0,0
180996,complication,0,0
180997,in,0,0
180998,thalassaemia,0,1
180999,.,0,1
181000,Control,0,0
181001,of,0,0
181002,myocardial,0,1
181003,iron,0,0
181004,is,0,0
181005,thus,0,0
181006,becoming,0,0
181007,the,0,0
181008,cornerstone,0,0
181009,of,0,0
181010,thalassaemia,0,1
181011,management,0,1
181012,.,0,1
181013,Recent,0,0
181014,evidence,0,0
181015,suggests,0,0
181016,a,0,0
181017,role,0,0
181018,for,0,0
181019,L-type,0,1
181020,Ca,0,1
181021,(,0,1
181022,2+,0,1
181023,),0,1
181024,channels,0,0
181025,in,0,0
181026,mediating,0,0
181027,iron,0,0
181028,uptake,0,0
181029,by,0,0
181030,the,0,0
181031,heart,0,1
181032,.,0,0
181033,Blocking,0,0
181034,the,0,0
181035,cellular,0,0
181036,iron,0,0
181037,uptake,0,0
181038,through,0,0
181039,these,0,0
181040,channels,0,0
181041,may,0,0
181042,add,0,0
181043,to,0,0
181044,the,0,0
181045,benefit,0,0
181046,of,0,0
181047,therapy,0,0
181048,to,0,0
181049,standard,0,0
181050,chelation,0,0
181051,in,0,0
181052,reducing,0,0
181053,myocardial,0,1
181054,iron,0,0
181055,.,0,0
181056,We,0,0
181057,aim,0,0
181058,to,0,0
181059,determine,0,0
181060,the,0,0
181061,efficacy,0,0
181062,of,0,0
181063,amlodipine,0,0
181064,(,0,0
181065,a,0,0
181066,calcium,0,0
181067,channel,0,0
181068,blocker,0,0
181069,),0,0
181070,as,0,0
181071,an,0,0
181072,adjunct,0,0
181073,to,0,0
181074,standard,0,0
181075,aggressive,0,1
181076,chelation,0,0
181077,in,0,0
181078,retarding,0,0
181079,myocardial,0,1
181080,iron,0,0
181081,deposition,0,0
181082,in,0,0
181083,thalassaemics,0,1
181084,with,0,1
181085,or,0,1
181086,without,0,1
181087,cardiomyopathy,0,1
181088,.,0,1
181089,OUTCOMES,0,0
181090,The,0,0
181091,primary,0,0
181092,outcome,0,0
181093,is,0,0
181094,to,0,0
181095,compare,0,0
181096,the,0,0
181097,efficacy,0,0
181098,of,0,0
181099,amlodipine+chelation,0,0
181100,(,0,0
181101,intervention,0,0
181102,),0,0
181103,versus,0,0
181104,standard,0,0
181105,chelation,0,0
181106,(,0,0
181107,control,0,0
181108,),0,0
181109,in,0,0
181110,retarding,0,0
181111,myocardial,0,1
181112,iron,0,0
181113,deposition,0,1
181114,.,0,1
181115,Secondary,0,0
181116,outcomes,0,0
181117,include,0,0
181118,the,0,0
181119,effect,0,0
181120,of,0,0
181121,amlodipine,0,0
181122,therapy,0,0
181123,on,0,0
181124,systolic,0,1
181125,and,0,0
181126,diastolic,0,1
181127,function,0,0
181128,",",0,0
181129,strain,0,0
181130,and,0,0
181131,strain,0,0
181132,rate,0,0
181133,and,0,0
181134,liver,0,1
181135,iron,0,0
181136,content,0,0
181137,.,0,0
181138,METHODS,0,0
181139,AND,0,0
181140,ANALYSIS,0,0
181141,This,0,0
181142,is,0,0
181143,a,0,0
181144,single-centre,0,0
181145,",",0,0
181146,parallel-group,0,0
181147,",",0,0
181148,prospective,0,0
181149,randomised,0,0
181150,control,0,1
181151,trial,0,0
181152,.,0,1
181153,Twenty,1,1
181154,patients,1,1
181155,will,0,0
181156,be,0,0
181157,randomised,0,0
181158,in,0,0
181159,a,0,0
181160,1:1,0,0
181161,allocation,0,0
181162,ratio,0,0
181163,into,0,0
181164,the,0,0
181165,intervention,0,0
181166,and,0,0
181167,control,0,1
181168,arms,0,0
181169,.,0,1
181170,In,0,0
181171,addition,0,0
181172,to,0,0
181173,conventional,0,0
181174,echocardiography,0,0
181175,",",0,0
181176,MRI,0,0
181177,T2*,0,0
181178,values,0,0
181179,for,0,0
181180,assessment,0,0
181181,of,0,0
181182,cardiac,0,1
181183,and,0,0
181184,liver,0,1
181185,iron,0,0
181186,load,0,0
181187,will,0,0
181188,be,0,0
181189,obtained,0,0
181190,at,0,0
181191,baseline,0,0
181192,and,0,0
181193,at,0,0
181194,6,0,0
181195,and,0,1
181196,12,0,1
181197,months,0,0
181198,.,0,1
181199,Cardiac,0,0
181200,T2*,0,0
181201,will,0,0
181202,be,0,0
181203,reported,0,0
181204,as,0,0
181205,the,0,0
181206,geometric,0,0
181207,mean,0,0
181208,and,0,0
181209,per,0,0
181210,cent,0,0
181211,coefficient,0,0
181212,of,0,0
181213,variation,0,0
181214,",",0,0
181215,and,0,0
181216,an,0,0
181217,increase,0,0
181218,in,0,0
181219,cardiac,0,1
181220,T2*,0,0
181221,values,0,0
181222,from,0,0
181223,baseline,0,0
181224,will,0,0
181225,be,0,0
181226,used,0,0
181227,as,0,0
181228,an,0,0
181229,end,0,0
181230,point,0,0
181231,to,0,0
181232,compare,0,0
181233,the,0,0
181234,efficacy,0,0
181235,of,0,0
181236,therapy,0,0
181237,.,0,0
181238,A,0,0
181239,p,0,0
181240,Value,0,0
181241,of,0,0
181242,<,0,0
181243,0.05,0,0
181244,will,0,0
181245,be,0,0
181246,considered,0,0
181247,significant,0,0
181248,.,0,1
181249,STUDY,0,0
181250,SETTING,0,1
181251,Department,1,1
181252,of,1,0
181253,Pediatric,1,1
181254,and,1,0
181255,Child,1,1
181256,Health,1,0
181257,",",1,0
181258,Aga,1,0
181259,Khan,1,1
181260,University,1,1
181261,Hospital,1,1
181262,",",1,0
181263,Karachi,1,1
181264,",",1,0
181265,Pakistan,1,1
181266,.,1,0
181267,ETHICS,0,0
181268,AND,0,0
181269,DISSEMINATION,0,0
181270,This,0,0
181271,study,0,0
181272,has,0,0
181273,been,0,0
181274,approved,0,0
181275,by,0,0
181276,the,0,0
181277,Ethics,0,1
181278,Review,0,0
181279,Committee,0,1
181280,and,0,0
181281,Clinical,0,0
181282,Trials,0,0
181283,Unit,0,0
181284,at,0,0
181285,The,1,0
181286,Aga,1,0
181287,Khan,1,1
181288,University,1,1
181289,with,0,1
181290,respect,0,0
181291,to,0,0
181292,scientific,0,0
181293,content,0,0
181294,and,0,0
181295,compliance,0,0
181296,with,0,1
181297,applicable,0,0
181298,research,0,0
181299,and,0,0
181300,human,0,1
181301,subjects,0,1
181302,regulations,0,1
181303,.,0,1
181304,Findings,0,0
181305,will,0,0
181306,be,0,0
181307,reported,0,0
181308,through,0,0
181309,scientific,0,0
181310,publications,0,0
181311,and,0,1
181312,research,0,1
181313,conferences,0,0
181314,and,0,0
181315,project,0,0
181316,summary,0,0
181317,papers,0,1
181318,for,0,1
181319,participants,0,1
181320,.,0,1
181321,TRIAL,0,0
181322,REGISTRATION,0,0
181323,NUMBER,0,1
181324,ClinicalTrials.Gov,0,0
181325,.,0,1
181326,Registration,0,0
181327,no,0,0
181328,:,0,1
181329,NCT02065492,0,0
181330,.,0,1
181331,Rationale,0,1
181332,and,0,0
181333,design,0,0
181334,of,0,0
181335,the,0,0
181336,Clinical,0,0
181337,Evaluation,0,0
181338,of,0,0
181339,Magnetic,0,0
181340,Resonance,0,0
181341,Imaging,0,1
181342,in,0,0
181343,Coronary,0,1
181344,heart,0,1
181345,disease,0,1
181346,2,0,0
181347,trial,0,0
181348,(,0,1
181349,CE-MARC,0,0
181350,2,0,1
181351,),0,1
181352,:,0,1
181353,a,0,0
181354,prospective,0,0
181355,",",0,0
181356,multicenter,0,0
181357,",",0,0
181358,randomized,0,0
181359,trial,0,0
181360,of,0,0
181361,diagnostic,0,0
181362,strategies,0,0
181363,in,0,1
181364,suspected,1,1
181365,coronary,1,1
181366,heart,1,1
181367,disease,1,1
181368,.,1,0
181369,BACKGROUND,0,0
181370,A,0,0
181371,number,0,0
181372,of,0,0
181373,investigative,0,0
181374,strategies,0,0
181375,exist,0,0
181376,for,0,0
181377,the,0,0
181378,diagnosis,0,1
181379,of,0,0
181380,coronary,0,1
181381,heart,0,1
181382,disease,0,1
181383,(,0,0
181384,CHD,0,1
181385,),0,0
181386,.,0,0
181387,Despite,0,0
181388,the,0,0
181389,widespread,0,0
181390,availability,0,0
181391,of,0,0
181392,noninvasive,0,0
181393,imaging,0,0
181394,",",0,0
181395,invasive,0,0
181396,angiography,0,0
181397,is,0,0
181398,commonly,0,0
181399,used,0,0
181400,early,0,0
181401,in,0,0
181402,the,0,0
181403,diagnostic,0,0
181404,pathway,0,0
181405,.,0,0
181406,Consequently,0,0
181407,",",0,0
181408,approximately,0,0
181409,60,0,1
181410,%,0,0
181411,of,0,0
181412,angiograms,0,0
181413,reveal,0,0
181414,no,0,0
181415,evidence,0,0
181416,of,0,0
181417,obstructive,0,1
181418,coronary,0,1
181419,disease,0,1
181420,.,0,0
181421,Reducing,0,0
181422,unnecessary,0,0
181423,angiography,0,0
181424,has,0,0
181425,potential,0,0
181426,financial,0,0
181427,savings,0,0
181428,and,0,1
181429,avoids,0,0
181430,exposing,0,0
181431,the,0,0
181432,patient,0,0
181433,to,0,0
181434,unnecessary,0,0
181435,risk,0,0
181436,.,0,0
181437,There,0,0
181438,are,0,0
181439,no,0,0
181440,large-scale,0,0
181441,comparative,0,0
181442,effectiveness,0,0
181443,trials,0,0
181444,of,0,0
181445,the,0,0
181446,different,0,0
181447,diagnostic,0,0
181448,strategies,0,0
181449,recommended,0,1
181450,in,0,0
181451,international,0,1
181452,guidelines,0,0
181453,and,0,0
181454,none,0,0
181455,that,0,0
181456,have,0,0
181457,evaluated,0,0
181458,the,0,0
181459,safety,0,0
181460,and,0,0
181461,efficacy,0,0
181462,of,0,0
181463,cardiovascular,0,1
181464,magnetic,0,0
181465,resonance,0,0
181466,.,0,1
181467,TRIAL,0,0
181468,DESIGN,0,0
181469,CE-MARC,0,0
181470,2,0,0
181471,is,0,0
181472,a,0,0
181473,prospective,0,0
181474,",",0,0
181475,multicenter,0,0
181476,",",0,0
181477,3-arm,0,0
181478,parallel,0,0
181479,group,0,0
181480,",",0,0
181481,randomized,0,0
181482,controlled,0,0
181483,trial,0,0
181484,of,0,0
181485,patients,1,1
181486,with,1,1
181487,suspected,1,1
181488,CHD,1,1
181489,(,1,0
181490,pretest,1,0
181491,likelihood,1,0
181492,10,1,0
181493,%,1,0
181494,-90,1,0
181495,%,1,0
181496,),1,0
181497,requiring,1,1
181498,further,1,0
181499,investigation,1,0
181500,.,1,0
181501,A,1,0
181502,total,1,1
181503,of,1,0
181504,"1,200",1,0
181505,patients,1,1
181506,will,1,0
181507,be,1,0
181508,randomized,1,0
181509,on,0,0
181510,a,0,0
181511,2:2:1,0,0
181512,basis,0,0
181513,to,0,0
181514,receive,0,0
181515,3.0-T,0,0
181516,cardiovascular,0,1
181517,magnetic,0,0
181518,resonance-guided,0,0
181519,care,0,1
181520,",",0,0
181521,single-photon,0,0
181522,emission,0,1
181523,computed,0,0
181524,tomography-guided,0,0
181525,care,0,1
181526,(,0,0
181527,according,0,0
181528,to,0,0
181529,American,0,1
181530,College,0,1
181531,of,0,0
181532,Cardiology/American,0,1
181533,Heart,0,1
181534,Association,0,0
181535,appropriate-use,0,1
181536,criteria,0,1
181537,),0,0
181538,",",0,0
181539,or,0,1
181540,National,0,0
181541,Institute,0,1
181542,for,0,0
181543,Health,0,0
181544,and,0,0
181545,Care,0,1
181546,Excellence,0,0
181547,guidelines-based,0,0
181548,management,0,1
181549,.,0,0
181550,The,0,0
181551,primary,0,0
181552,(,0,0
181553,efficacy,0,0
181554,),0,0
181555,end,0,0
181556,point,0,0
181557,is,0,0
181558,the,0,0
181559,occurrence,0,0
181560,of,0,0
181561,unnecessary,0,0
181562,angiography,0,0
181563,as,0,0
181564,defined,0,0
181565,by,0,0
181566,a,0,0
181567,normal,0,1
181568,(,0,0
181569,>,0,1
181570,0.8,0,1
181571,),0,1
181572,invasive,0,1
181573,fractional,0,0
181574,flow,0,0
181575,reserve,0,1
181576,.,0,0
181577,Safety,0,0
181578,of,0,0
181579,each,0,0
181580,strategy,0,0
181581,will,0,0
181582,be,0,0
181583,assessed,0,0
181584,by,0,0
181585,3-year,0,0
181586,major,0,1
181587,adverse,0,0
181588,cardiovascular,0,1
181589,event,0,0
181590,rates,0,0
181591,.,0,1
181592,Cost-effectiveness,0,0
181593,and,0,0
181594,health-related,0,0
181595,quality-of-life,0,0
181596,measures,0,0
181597,will,0,0
181598,be,0,0
181599,performed,0,0
181600,.,0,0
181601,CONCLUSIONS,0,0
181602,The,0,0
181603,CE-MARC,0,0
181604,2,0,0
181605,trial,0,0
181606,will,0,0
181607,provide,0,0
181608,comparative,0,0
181609,efficacy,0,0
181610,and,0,0
181611,safety,0,0
181612,evidence,0,0
181613,for,0,0
181614,3,0,0
181615,different,0,0
181616,strategies,0,0
181617,of,0,0
181618,investigating,0,0
181619,patients,1,1
181620,with,1,1
181621,suspected,1,1
181622,CHD,1,1
181623,",",0,0
181624,with,0,0
181625,the,0,0
181626,intension,0,0
181627,of,0,0
181628,reducing,0,0
181629,unnecessary,0,0
181630,invasive,0,1
181631,angiography,0,1
181632,rates,0,0
181633,.,0,1
181634,Evaluation,0,0
181635,of,0,0
181636,these,0,0
181637,management,0,0
181638,strategies,0,0
181639,has,0,0
181640,the,0,0
181641,potential,0,0
181642,to,0,0
181643,improve,0,0
181644,patient,0,0
181645,care,0,0
181646,",",0,0
181647,health-related,0,0
181648,quality,0,0
181649,of,0,0
181650,life,0,0
181651,",",0,0
181652,and,0,0
181653,the,0,0
181654,cost-effectiveness,0,0
181655,of,0,0
181656,CHD,0,1
181657,investigation,0,0
181658,.,0,1
181659,Comparison,0,0
181660,on,0,0
181661,therapeutic,0,0
181662,effect,0,0
181663,of,0,0
181664,plasma,0,0
181665,exchange,0,0
181666,and,0,0
181667,intravenous,0,0
181668,immunoglobulin,0,1
181669,for,0,0
181670,Guillian-Barre,1,1
181671,syndrome,1,1
181672,.,1,0
181673,OBJECTIVES,0,0
181674,To,0,0
181675,observe,0,0
181676,and,0,0
181677,compare,0,0
181678,the,0,0
181679,clinical,0,0
181680,curative,0,1
181681,effect,0,0
181682,of,0,0
181683,the,0,0
181684,plasma,1,0
181685,exchange,1,0
181686,(,1,0
181687,PE,1,1
181688,),1,0
181689,and,1,0
181690,intravenous,1,0
181691,immunoglobulin,1,1
181692,(,1,0
181693,IVIg,1,0
181694,),1,0
181695,for,1,0
181696,Guillian-Barre,1,1
181697,Syndrome,1,1
181698,(,1,0
181699,GBS,1,0
181700,),1,1
181701,.,1,1
181702,METHODS,0,0
181703,Overall,0,0
181704,",",0,0
181705,64,1,1
181706,adult,1,1
181707,patients,1,1
181708,with,1,1
181709,GBS,1,0
181710,for,1,0
181711,PE,1,1
181712,and,1,0
181713,IVIg,1,0
181714,treatment,1,0
181715,",",1,0
181716,respectively,1,0
181717,",",1,0
181718,and,1,0
181719,nerve,1,0
181720,function,1,0
181721,were,0,0
181722,observed,0,0
181723,pre-treatment,0,0
181724,and,0,0
181725,at,0,0
181726,1,0,0
181727,week/2,0,0
181728,weeks,0,0
181729,after,0,0
181730,completion,0,0
181731,of,0,0
181732,treatment,0,0
181733,;,0,0
181734,the,0,0
181735,blood,0,0
181736,immunoglobulin,0,0
181737,",",0,0
181738,complement,0,0
181739,",",0,0
181740,fibrinogen,0,0
181741,(,0,0
181742,Fib,0,0
181743,),0,0
181744,and,0,0
181745,monocyte,0,0
181746,percentage,0,0
181747,(,0,0
181748,MON,0,1
181749,%,0,0
181750,),0,0
181751,were,0,0
181752,detected,0,0
181753,simultaneously,0,0
181754,.,0,0
181755,RESULTS,0,0
181756,After,0,0
181757,PE,0,1
181758,treatment,0,0
181759,",",0,0
181760,nerve,0,0
181761,function,0,0
181762,defect,0,1
181763,appeared,0,0
181764,to,0,0
181765,improve,0,0
181766,better,0,0
181767,than,0,0
181768,the,0,0
181769,IVIg,0,0
181770,group,0,0
181771,and,0,0
181772,clinical,0,0
181773,effect,0,0
181774,was,0,0
181775,better,0,0
181776,than,0,0
181777,the,0,0
181778,IVIg,0,0
181779,group,0,0
181780,.,0,1
181781,Treatment,0,0
181782,effective,0,0
181783,rates,0,0
181784,of,0,0
181785,the,0,0
181786,two,0,0
181787,groups,0,0
181788,after,0,1
181789,2,0,1
181790,weeks,0,0
181791,",",0,0
181792,respectively,0,0
181793,",",0,0
181794,are,0,0
181795,96,0,0
181796,and,0,0
181797,79,0,1
181798,%,0,0
181799,.,0,1
181800,PE,0,1
181801,and,0,0
181802,IVIg,0,0
181803,can,0,0
181804,significantly,0,0
181805,reduce,0,0
181806,the,1,0
181807,GBS,1,0
181808,patients,1,1
181809,',1,1
181810,blood,1,0
181811,immunoglobulin,0,1
181812,IgG,0,0
181813,",",0,0
181814,IgA,0,0
181815,",",0,0
181816,IgM,0,0
181817,",",0,0
181818,C3,0,1
181819,and,0,0
181820,C4,0,0
181821,",",0,0
181822,but,0,0
181823,these,0,0
181824,were,0,0
181825,significantly,0,0
181826,lower,0,0
181827,in,0,0
181828,the,0,0
181829,PE,0,1
181830,group,0,0
181831,than,0,0
181832,in,0,0
181833,the,0,0
181834,IVIg,0,0
181835,group,0,0
181836,.,0,0
181837,Fib,0,0
181838,and,0,0
181839,MON,0,1
181840,%,0,0
181841,were,0,0
181842,significantly,0,0
181843,lower,0,0
181844,in,0,0
181845,the,0,0
181846,PE,0,1
181847,group,0,0
181848,than,0,0
181849,in,0,0
181850,the,0,0
181851,IVIg,0,0
181852,group,0,0
181853,.,0,1
181854,CONCLUSION,0,0
181855,Both,0,0
181856,PE,0,1
181857,and,0,0
181858,IVIg,0,0
181859,have,0,0
181860,a,0,0
181861,high,0,0
181862,response,0,0
181863,as,0,0
181864,therapy,0,0
181865,and,0,0
181866,are,0,0
181867,reasonable,0,0
181868,therapeutic,0,0
181869,options,0,0
181870,for,0,1
181871,GBS,0,0
181872,.,0,0
181873,However,0,0
181874,",",0,0
181875,PE,0,1
181876,treatment,0,0
181877,has,0,0
181878,a,0,0
181879,more,0,0
181880,significantly,0,0
181881,curative,0,0
181882,effect,0,0
181883,",",0,0
181884,as,0,0
181885,it,0,0
181886,can,0,0
181887,effectively,0,0
181888,improve,0,0
181889,symptoms,0,0
181890,and,0,0
181891,be,0,0
181892,helpful,0,0
181893,in,0,0
181894,the,0,0
181895,early,0,0
181896,rehabilitation,1,0
181897,of,1,0
181898,patients,1,1
181899,.,1,1
181900,Effect,0,0
181901,of,0,0
181902,low,0,1
181903,versus,0,0
181904,high,0,1
181905,dialysate,0,0
181906,sodium,0,0
181907,concentration,0,0
181908,on,0,0
181909,blood,0,0
181910,pressure,0,0
181911,and,0,0
181912,endothelial-derived,0,0
181913,vasoregulators,0,0
181914,during,0,0
181915,hemodialysis,0,1
181916,:,0,1
181917,a,0,0
181918,randomized,0,0
181919,crossover,0,0
181920,study,0,0
181921,.,0,1
181922,BACKGROUND,0,0
181923,Intradialytic,0,0
181924,hypertension,0,1
181925,affects,0,0
181926,?15,0,0
181927,%,0,0
181928,of,0,0
181929,hemodialysis,0,1
181930,patients,0,1
181931,and,0,0
181932,is,0,0
181933,associated,0,0
181934,with,0,0
181935,increased,0,0
181936,morbidity,0,0
181937,and,0,0
181938,mortality,0,0
181939,.,0,0
181940,While,0,0
181941,intradialytic,0,0
181942,hypertension,0,1
181943,is,0,0
181944,associated,0,0
181945,with,0,0
181946,increases,0,0
181947,in,0,1
181948,endothelin,0,0
181949,1,0,0
181950,relative,0,0
181951,to,0,0
181952,nitric,0,0
181953,oxide,0,0
181954,(,0,0
181955,NO,0,0
181956,),0,0
181957,",",0,0
181958,the,0,0
181959,cause,0,0
181960,of,0,0
181961,these,0,0
181962,imbalances,0,0
181963,is,0,0
181964,unknown,0,0
181965,.,0,0
181966,In,0,0
181967,vitro,0,0
181968,evidence,0,0
181969,suggests,0,0
181970,that,0,0
181971,altering,0,0
181972,plasma,0,0
181973,sodium,0,0
181974,levels,0,0
181975,could,0,0
181976,affect,0,0
181977,endothelial-derived,0,0
181978,vasoregulators,0,0
181979,and,0,0
181980,blood,0,0
181981,pressure,0,0
181982,(,0,0
181983,BP,0,0
181984,),0,0
181985,.,0,0
181986,Thus,0,0
181987,",",0,0
181988,we,0,0
181989,hypothesized,0,0
181990,that,0,0
181991,compared,0,0
181992,to,0,0
181993,high,0,0
181994,dialysate,0,0
181995,sodium,0,0
181996,",",0,0
181997,low,0,0
181998,dialysate,0,0
181999,sodium,0,0
182000,concentration,0,0
182001,would,0,0
182002,lower,0,0
182003,endothelin,0,0
182004,1,0,0
182005,levels,0,0
182006,",",0,0
182007,increase,0,0
182008,NO,0,0
182009,release,0,0
182010,",",0,0
182011,and,0,0
182012,reduce,0,0
182013,BP,0,0
182014,.,0,0
182015,STUDY,0,0
182016,DESIGN,0,0
182017,3-week,0,0
182018,",",0,0
182019,2-arm,0,0
182020,",",0,0
182021,randomized,0,0
182022,",",0,0
182023,crossover,0,0
182024,study,0,0
182025,.,0,0
182026,SETTING,0,1
182027,&,0,1
182028,PARTICIPANTS,1,0
182029,16,1,1
182030,patients,1,1
182031,with,1,1
182032,intradialytic,1,0
182033,hypertension,1,1
182034,.,1,1
182035,INTERVENTION,1,0
182036,Low,0,1
182037,(,0,0
182038,5,0,0
182039,mEq/L,0,0
182040,below,0,0
182041,serum,0,0
182042,sodium,0,0
182043,),0,0
182044,versus,0,0
182045,high,0,1
182046,(,0,1
182047,5,0,1
182048,mEq/L,0,0
182049,above,0,0
182050,serum,0,0
182051,sodium,0,0
182052,),0,0
182053,dialysate,0,0
182054,sodium,0,0
182055,concentration,0,0
182056,.,0,1
182057,OUTCOMES,0,0
182058,Endothelin,0,0
182059,1,0,0
182060,",",0,0
182061,nitrite,0,0
182062,(,0,0
182063,NO2,0,0
182064,(,0,1
182065,-,0,0
182066,),0,0
182067,),0,0
182068,",",0,0
182069,and,0,0
182070,BP,0,0
182071,.,0,1
182072,MEASUREMENTS,0,0
182073,Mixed,0,1
182074,linear,0,0
182075,regression,0,0
182076,was,0,0
182077,used,0,0
182078,to,0,0
182079,compare,0,0
182080,the,0,0
182081,effect,0,0
182082,of,0,0
182083,dialysate,0,0
182084,sodium,0,0
182085,(,0,0
182086,low,0,0
182087,vs,0,0
182088,high,0,1
182089,),0,0
182090,and,0,0
182091,randomization,0,0
182092,arm,0,0
182093,(,0,0
182094,low-then-high,0,0
182095,vs,0,0
182096,high-then-low,0,1
182097,),0,1
182098,on,0,0
182099,intradialytic,0,0
182100,changes,0,0
182101,in,0,1
182102,endothelin,0,0
182103,1,0,0
182104,",",0,0
182105,NO2,0,0
182106,(,0,0
182107,-,0,0
182108,),0,0
182109,",",0,0
182110,and,0,0
182111,BP,0,0
182112,values,0,0
182113,.,0,0
182114,RESULTS,0,0
182115,The,0,0
182116,average,0,0
182117,systolic,0,1
182118,BP,0,0
182119,throughout,0,0
182120,all,0,0
182121,hemodialysis,0,1
182122,treatments,0,0
182123,in,0,0
182124,a,0,0
182125,given,0,0
182126,week,0,0
182127,was,0,0
182128,lower,0,0
182129,with,0,1
182130,low,0,0
182131,dialysate,0,0
182132,sodium,0,0
182133,concentrations,0,0
182134,compared,0,0
182135,with,0,1
182136,treatments,0,0
182137,with,0,1
182138,high,0,1
182139,dialysate,0,0
182140,sodium,0,0
182141,concentrations,0,0
182142,(,0,0
182143,parameter,0,0
182144,estimate,0,0
182145,",",0,0
182146,-9.9,0,0
182147,[,0,0
182148,95,0,0
182149,%,0,0
182150,CI,0,0
182151,",",0,0
182152,-13.3,0,0
182153,to,0,0
182154,-6.4,0,0
182155,],0,1
182156,mm,0,1
182157,Hg,0,0
182158,;,0,1
182159,P,0,0
182160,<,0,0
182161,0.001,0,0
182162,),0,0
182163,.,0,0
182164,The,0,0
182165,average,0,0
182166,change,0,0
182167,in,0,0
182168,systolic,0,1
182169,BP,0,0
182170,during,0,0
182171,hemodialysis,0,1
182172,also,0,0
182173,was,0,0
182174,significantly,0,0
182175,lower,0,0
182176,with,0,1
182177,low,0,1
182178,vs,0,0
182179,high,0,1
182180,dialysate,0,0
182181,sodium,0,0
182182,concentrations,0,0
182183,(,0,0
182184,parameter,0,0
182185,estimate,0,0
182186,",",0,0
182187,-6.1,0,0
182188,[,0,0
182189,95,0,0
182190,%,0,0
182191,CI,0,0
182192,",",0,0
182193,-9.0,0,0
182194,to,0,0
182195,-3.2,0,0
182196,],0,1
182197,mm,0,1
182198,Hg,0,0
182199,;,0,1
182200,P,0,0
182201,<,0,0
182202,0.001,0,0
182203,),0,0
182204,.,0,0
182205,There,0,0
182206,were,0,0
182207,no,0,0
182208,significant,0,0
182209,differences,0,0
182210,in,0,1
182211,intradialytic,0,0
182212,levels,0,0
182213,of,0,1
182214,endothelin,0,0
182215,1,0,0
182216,or,0,1
182217,NO2,0,1
182218,(,0,0
182219,-,0,0
182220,),0,0
182221,with,0,1
182222,low,0,1
182223,vs,0,0
182224,high,0,1
182225,dialysate,0,0
182226,sodium,0,0
182227,concentrations,0,0
182228,.,0,1
182229,LIMITATIONS,0,0
182230,Carryover,0,0
182231,effects,0,0
182232,limited,0,0
182233,the,0,0
182234,power,0,0
182235,to,0,0
182236,detect,0,0
182237,significant,0,0
182238,changes,0,0
182239,in,0,1
182240,endothelial-derived,0,0
182241,vasoregulators,0,0
182242,",",0,0
182243,and,0,0
182244,future,0,0
182245,studies,0,0
182246,will,0,0
182247,require,0,1
182248,parallel,0,0
182249,trial,0,1
182250,designs,0,0
182251,.,0,1
182252,CONCLUSIONS,0,0
182253,Low,0,1
182254,dialysate,0,0
182255,sodium,0,0
182256,concentrations,0,0
182257,significantly,0,0
182258,decreased,0,0
182259,systolic,0,0
182260,BP,0,0
182261,and,0,0
182262,ameliorated,0,0
182263,intradialytic,0,0
182264,hypertension,0,1
182265,.,0,1
182266,Longer,0,0
182267,studies,0,0
182268,are,0,0
182269,needed,0,0
182270,to,0,0
182271,determine,0,0
182272,the,0,0
182273,long-term,0,0
182274,effects,0,0
182275,of,0,0
182276,low,0,1
182277,dialysate,0,0
182278,sodium,0,0
182279,concentrations,0,0
182280,on,0,0
182281,BP,0,1
182282,and,0,1
182283,clinical,0,0
182284,outcomes,0,0
182285,.,0,1
182286,Cariprazine,0,0
182287,in,0,0
182288,the,0,0
182289,treatment,0,0
182290,of,0,0
182291,acute,0,1
182292,mania,0,1
182293,in,0,0
182294,bipolar,0,1
182295,I,0,1
182296,disorder,0,1
182297,:,0,0
182298,a,0,0
182299,double-blind,0,0
182300,",",0,0
182301,placebo-controlled,0,0
182302,",",0,0
182303,phase,0,1
182304,III,0,1
182305,trial,0,0
182306,.,0,0
182307,BACKGROUND,0,0
182308,This,0,0
182309,Phase,0,0
182310,III,0,0
182311,",",0,0
182312,randomized,0,0
182313,",",0,0
182314,double-blind,0,0
182315,",",0,0
182316,placebo-controlled,0,0
182317,study,0,0
182318,investigated,0,0
182319,the,0,0
182320,efficacy,0,0
182321,and,0,0
182322,tolerability,0,0
182323,of,0,0
182324,flexibly-dosed,0,0
182325,cariprazine,0,0
182326,in,0,0
182327,patients,1,1
182328,with,1,1
182329,acute,1,1
182330,manic,1,1
182331,or,1,1
182332,mixed,1,0
182333,episodes,1,0
182334,associated,1,0
182335,with,1,1
182336,bipolar,1,1
182337,I,1,1
182338,disorder,1,1
182339,.,1,1
182340,METHODS,0,0
182341,Patients,0,1
182342,were,0,1
182343,randomized,0,1
182344,to,0,0
182345,3,0,0
182346,weeks,0,0
182347,of,0,0
182348,double-blind,0,0
182349,treatment,1,0
182350,with,1,1
182351,cariprazine,1,0
182352,3-12mg/day,1,0
182353,(,1,1
182354,n=158,1,1
182355,),1,0
182356,or,1,1
182357,placebo,1,0
182358,(,1,0
182359,n=154,1,1
182360,),1,0
182361,.,1,0
182362,The,0,0
182363,primary,0,0
182364,efficacy,0,0
182365,parameter,0,0
182366,was,0,0
182367,change,0,0
182368,from,0,0
182369,baseline,0,0
182370,to,0,0
182371,Week,0,0
182372,3,0,0
182373,in,0,0
182374,Young,0,1
182375,Mania,0,1
182376,Rating,0,0
182377,Scale,0,0
182378,(,0,0
182379,YMRS,0,0
182380,),0,0
182381,total,0,1
182382,score,0,0
182383,.,0,0
182384,The,0,0
182385,secondary,0,0
182386,efficacy,0,0
182387,parameter,0,0
182388,was,0,0
182389,change,0,0
182390,from,0,0
182391,baseline,0,0
182392,to,0,0
182393,Week,0,0
182394,3,0,0
182395,in,0,0
182396,Clinical,0,0
182397,Global,0,1
182398,Impressions-Severity,0,0
182399,(,0,0
182400,CGI-S,0,0
182401,),0,0
182402,score,0,0
182403,.,0,1
182404,RESULTS,0,0
182405,Mean,0,1
182406,change,0,0
182407,from,0,0
182408,baseline,0,0
182409,to,0,0
182410,Week,0,0
182411,3,0,0
182412,in,0,0
182413,YMRS,0,0
182414,total,0,1
182415,score,0,0
182416,was,0,0
182417,significantly,0,0
182418,greater,0,0
182419,for,0,0
182420,patients,0,1
182421,receiving,0,1
182422,cariprazine,0,0
182423,3-12mg/day,0,0
182424,versus,0,0
182425,placebo,0,0
182426,(,0,0
182427,P=0.0004,0,0
182428,),0,1
182429,.,0,1
182430,Significant,0,0
182431,differences,0,0
182432,between,0,0
182433,groups,0,0
182434,in,0,1
182435,YMRS,0,0
182436,total,0,1
182437,score,0,0
182438,mean,0,1
182439,change,0,0
182440,were,0,0
182441,observed,0,0
182442,by,0,0
182443,Day,0,1
182444,4,0,0
182445,(,0,0
182446,first,0,0
182447,postbaseline,0,0
182448,assessment,0,0
182449,),0,0
182450,and,0,0
182451,maintained,0,0
182452,throughout,0,0
182453,double-blind,0,0
182454,treatment,0,0
182455,(,0,0
182456,all,0,0
182457,assessments,0,0
182458,",",0,0
182459,P,0,0
182460,<,0,0
182461,0.01,0,0
182462,),0,1
182463,.,0,0
182464,Cariprazine,0,0
182465,also,0,0
182466,demonstrated,0,0
182467,statistically,0,0
182468,significant,0,0
182469,superiority,0,0
182470,over,0,0
182471,placebo,0,0
182472,on,0,0
182473,YMRS,0,0
182474,response,0,0
182475,(,0,0
182476,?50,0,1
182477,%,0,0
182478,improvement,0,0
182479,:,0,1
182480,cariprazine,0,0
182481,",",0,0
182482,58.9,0,0
182483,%,0,0
182484,;,0,0
182485,placebo,0,0
182486,",",0,0
182487,44.1,0,0
182488,%,0,0
182489,;,0,1
182490,P=0.0097,0,0
182491,),0,0
182492,and,0,0
182493,remission,0,0
182494,(,0,0
182495,YMRS,0,0
182496,total,0,1
182497,score?12,0,0
182498,:,0,1
182499,cariprazine,0,0
182500,",",0,0
182501,51.9,0,1
182502,%,0,0
182503,;,0,0
182504,placebo,0,0
182505,",",0,0
182506,34.9,0,0
182507,%,0,0
182508,;,0,1
182509,P=0.0025,0,0
182510,),0,0
182511,and,0,0
182512,mean,0,0
182513,change,0,0
182514,in,0,0
182515,CGI-S,0,0
182516,(,0,1
182517,P=0.0027,0,0
182518,),0,0
182519,score,0,0
182520,and,0,0
182521,Positive,0,1
182522,and,0,0
182523,Negative,0,1
182524,Syndrome,0,1
182525,Scale,0,0
182526,(,0,0
182527,PANSS,0,0
182528,),0,0
182529,(,0,0
182530,P=0.0035,0,0
182531,),0,0
182532,total,0,1
182533,score,0,0
182534,.,0,0
182535,The,0,0
182536,most,0,0
182537,common,0,0
182538,cariprazine-related,0,0
182539,(,0,1
182540,?10,0,0
182541,%,0,0
182542,and,0,0
182543,twice,0,0
182544,placebo,0,0
182545,),0,0
182546,treatment,0,0
182547,emergent,0,1
182548,adverse,0,0
182549,events,0,0
182550,(,0,1
182551,TEAEs,0,1
182552,),0,0
182553,were,0,0
182554,akathisia,0,0
182555,",",0,0
182556,extrapyramidal,0,0
182557,disorder,0,1
182558,",",0,0
182559,tremor,0,0
182560,",",0,0
182561,dyspepsia,0,1
182562,",",0,0
182563,and,0,0
182564,vomiting,0,0
182565,.,0,0
182566,Mean,0,0
182567,change,0,0
182568,from,0,0
182569,baseline,0,0
182570,in,0,0
182571,metabolic,0,1
182572,parameters,0,0
182573,were,0,1
182574,generally,0,0
182575,small,0,0
182576,and,0,0
182577,similar,0,0
182578,between,0,0
182579,groups,0,0
182580,.,0,1
182581,LIMITATIONS,0,0
182582,Lack,0,0
182583,of,0,0
182584,active,0,1
182585,comparator,0,0
182586,arm,0,1
182587,;,0,0
182588,short,0,0
182589,duration,0,0
182590,of,0,0
182591,study,0,0
182592,.,0,1
182593,CONCLUSION,0,0
182594,In,0,0
182595,this,0,0
182596,study,0,0
182597,",",0,0
182598,cariprazine,0,0
182599,3-12mg/day,0,0
182600,was,0,0
182601,effective,0,0
182602,and,0,0
182603,generally,0,0
182604,well,0,0
182605,tolerated,0,0
182606,in,0,0
182607,the,0,0
182608,treatment,0,0
182609,of,0,0
182610,manic,0,1
182611,and,0,0
182612,mixed,0,0
182613,episodes,0,0
182614,associated,0,0
182615,with,0,1
182616,bipolar,0,1
182617,I,0,1
182618,disorder,0,1
182619,.,0,0
182620,Concentrated,0,0
182621,parenteral,0,1
182622,nutrition,0,1
182623,solutions,0,0
182624,and,0,1
182625,central,1,1
182626,venous,1,1
182627,catheter,1,0
182628,complications,1,0
182629,in,1,0
182630,preterm,1,1
182631,infants,1,1
182632,.,1,1
182633,UNLABELLED,0,0
182634,Standardised,0,0
182635,",",0,0
182636,concentrated,0,0
182637,neonatal,0,1
182638,parenteral,0,0
182639,nutrition,0,0
182640,(,0,0
182641,PN,0,0
182642,),0,0
182643,regimens,0,0
182644,can,0,0
182645,overcome,0,0
182646,early,0,0
182647,nutritional,0,0
182648,deficits,0,0
182649,in,0,0
182650,very,1,1
182651,preterm,1,1
182652,infants,1,1
182653,.,1,1
182654,A,0,0
182655,PN,0,0
182656,regimen,0,0
182657,with,0,1
182658,increased,0,0
182659,macronutrient,0,0
182660,content,0,0
182661,(,0,0
182662,standardised,0,0
182663,",",0,0
182664,concentrated,0,0
182665,",",0,0
182666,added,0,0
182667,macronutrients,0,0
182668,parenteral,0,1
182669,(,0,1
182670,SCAMP,0,0
182671,),0,0
182672,),0,0
182673,has,0,0
182674,been,0,0
182675,shown,0,0
182676,to,0,0
182677,improve,0,0
182678,early,0,0
182679,head,0,1
182680,growth,0,0
182681,in,0,0
182682,a,0,0
182683,randomised,0,0
182684,controlled,0,0
182685,trial,0,0
182686,.,0,1
182687,Line,0,0
182688,complications,0,0
182689,including,0,1
182690,late,0,1
182691,onset,0,1
182692,sepsis,0,1
182693,were,0,0
182694,secondary,0,0
182695,outcomes,0,0
182696,of,0,0
182697,this,0,0
182698,study,0,0
182699,.,0,0
182700,Infants,0,1
182701,were,0,0
182702,started,0,0
182703,on,0,0
182704,standardised,0,0
182705,",",0,0
182706,concentrated,0,0
182707,PN,0,0
182708,at,0,0
182709,birth,0,1
182710,and,0,0
182711,randomised,0,0
182712,at,0,0
182713,2-5,0,0
182714,days,0,0
182715,to,0,0
182716,either,0,0
182717,switch,0,0
182718,to,0,0
182719,SCAMP,0,0
182720,or,0,0
182721,remain,0,0
182722,on,0,0
182723,control,0,0
182724,PN,0,0
182725,.,0,1
182726,Central,0,0
182727,venous,0,0
182728,catheter,0,0
182729,(,0,0
182730,CVC,0,0
182731,),0,0
182732,",",0,0
182733,blood,0,0
182734,culture,0,0
182735,(,0,0
182736,BC,0,0
182737,),0,0
182738,and,0,0
182739,inflammatory,0,0
182740,marker,0,0
182741,data,0,0
182742,were,0,0
182743,collected,0,0
182744,for,0,0
182745,the,0,0
182746,28-day,0,0
182747,intervention,0,0
182748,period,0,1
182749,.,0,1
182750,150,1,0
182751,infants,1,1
182752,were,1,1
182753,randomised,1,0
182754,with,1,1
182755,mean,1,0
182756,(,1,0
182757,SD,1,0
182758,),1,0
182759,birth,1,1
182760,weight,1,0
182761,(,1,0
182762,g,1,0
182763,),1,0
182764,of,1,0
182765,900,1,1
182766,(,1,1
182767,158,1,1
182768,),1,1
182769,versus,1,0
182770,884,1,1
182771,(,1,0
182772,183,1,1
182773,),1,0
182774,in,1,0
182775,SCAMP,1,0
182776,(,1,0
182777,n=74,1,1
182778,),1,0
182779,and,1,0
182780,control,1,0
182781,(,1,0
182782,n=76,1,1
182783,),1,1
182784,groups,1,0
182785,",",0,0
182786,respectively,0,0
182787,.,0,0
182788,There,0,0
182789,were,0,0
182790,no,0,0
182791,differences,0,0
182792,in,0,0
182793,CVC,0,0
182794,use/type,0,1
182795,or,0,0
182796,duration,0,0
182797,or,0,0
182798,in,0,0
182799,positive/negative,0,0
182800,BC,0,0
182801,with/without,0,1
182802,associated,0,0
182803,C,0,0
182804,reactive,0,0
182805,protein,0,0
182806,rise,0,0
182807,in,0,0
182808,SCAMP,0,0
182809,versus,0,0
182810,control,0,1
182811,groups,0,0
182812,.,0,1
182813,Increasing,0,0
182814,the,0,0
182815,macronutrient,0,0
182816,content,0,0
182817,of,0,0
182818,a,0,0
182819,standardised,0,0
182820,",",0,0
182821,concentrated,0,0
182822,neonatal,0,1
182823,PN,0,0
182824,regimen,0,0
182825,does,0,0
182826,not,0,0
182827,increase,0,0
182828,CVC,0,0
182829,complication,0,0
182830,rates,0,0
182831,.,0,1
182832,TRIAL,0,0
182833,REGISTRATION,0,0
182834,NUMBER,0,1
182835,ISRCTN,0,0
182836,76597892,0,0
182837,.,0,1
182838,Effects,0,0
182839,of,0,1
182840,stellate,0,0
182841,ganglionic,0,0
182842,block,0,0
182843,on,0,0
182844,hemodynamic,0,0
182845,changes,0,0
182846,and,0,1
182847,intrapulmonary,0,1
182848,shunt,0,0
182849,in,0,0
182850,perioperative,1,0
182851,patients,1,1
182852,with,1,1
182853,esophageal,1,1
182854,cancer,1,1
182855,.,1,0
182856,OBJECTIVE,0,0
182857,The,0,0
182858,aim,0,0
182859,of,0,0
182860,this,0,0
182861,study,0,0
182862,was,0,0
182863,to,0,0
182864,observe,0,0
182865,the,0,0
182866,effects,0,0
182867,of,0,0
182868,stellate,0,0
182869,ganglion,0,0
182870,block,0,0
182871,(,0,0
182872,SGB,0,0
182873,),0,0
182874,on,0,0
182875,hemodynamic,0,0
182876,changes,0,0
182877,and,0,1
182878,intrapulmonary,0,1
182879,shunt,0,0
182880,during,0,0
182881,one-lung,0,0
182882,ventilation,0,1
182883,(,0,0
182884,OLV,0,1
182885,),0,1
182886,.,0,0
182887,PATIENTS,0,0
182888,AND,0,0
182889,METHODS,1,0
182890,Thirty,1,1
182891,ASA,1,1
182892,class,1,1
182893,I-II,1,1
182894,patients,1,1
182895,undergoing,1,1
182896,elective,1,1
182897,esophageal,1,1
182898,surgery,1,1
182899,were,0,0
182900,randomly,0,1
182901,divided,0,1
182902,into,0,0
182903,two,0,1
182904,groups,0,1
182905,:,0,1
182906,general,0,1
182907,anesthesia,0,0
182908,group,0,0
182909,(,0,0
182910,group,0,0
182911,N,0,1
182912,",",0,0
182913,n=15,0,1
182914,),0,0
182915,and,0,0
182916,general,0,1
182917,anesthesia,0,1
182918,combined,0,0
182919,SGB,0,0
182920,group,0,0
182921,(,0,0
182922,group,0,0
182923,S,0,0
182924,",",0,0
182925,n=15,0,1
182926,),0,0
182927,",",0,0
182928,patients,0,1
182929,in,0,0
182930,group,0,1
182931,S,0,0
182932,were,0,0
182933,received,0,0
182934,left,0,1
182935,SGB,0,0
182936,before,0,0
182937,induction,0,1
182938,.,0,1
182939,Radial,0,0
182940,artery,0,1
182941,was,0,0
182942,cannulated,0,0
182943,for,0,0
182944,arterial,0,1
182945,blood,0,0
182946,pressure,0,0
182947,(,0,0
182948,ABP,0,0
182949,),0,0
182950,monitoring,0,0
182951,and,0,0
182952,blood,0,0
182953,sampling,0,0
182954,and,0,0
182955,Swan-Ganz,0,1
182956,catheter,0,0
182957,was,0,0
182958,position,0,0
182959,in,0,0
182960,the,0,0
182961,pulmonary,0,1
182962,artery,0,1
182963,via,0,0
182964,right,0,1
182965,internal,0,1
182966,jugular,0,1
182967,vein,0,1
182968,under,0,0
182969,local,0,0
182970,anesthesia,0,1
182971,.,0,0
182972,ECG,0,0
182973,",",0,0
182974,MAP,0,0
182975,",",0,0
182976,HR,0,0
182977,",",0,0
182978,CVP,0,0
182979,",",0,0
182980,continuous,0,0
182981,cardiac,0,1
182982,output,0,0
182983,(,0,0
182984,CCO,0,0
182985,),0,0
182986,index,0,0
182987,and,0,0
182988,BIS,0,0
182989,were,0,0
182990,continuously,0,0
182991,monitored,0,0
182992,during,0,0
182993,anesthesia,0,1
182994,.,0,1
182995,General,0,0
182996,anesthesia,0,0
182997,was,0,0
182998,induced,0,0
182999,with,0,1
183000,propofol,0,0
183001,1.5-2.0,0,0
183002,mg/kg,0,0
183003,",",0,0
183004,sufentanil,0,0
183005,0.4,0,0
183006,?g/kg,0,0
183007,",",0,0
183008,and,0,0
183009,Rocuronium,0,0
183010,0.6-0.9,0,0
183011,mg/kg,0,0
183012,.,0,1
183013,Endobronchial,0,0
183014,occluder,0,0
183015,was,0,0
183016,placed,0,0
183017,blindly,0,0
183018,after,0,0
183019,tracheal,0,1
183020,indubation,0,1
183021,and,0,0
183022,the,0,0
183023,correct,0,0
183024,position,0,0
183025,was,0,0
183026,verified,0,0
183027,by,0,0
183028,auscultation,0,0
183029,and,0,0
183030,fiberoptic,0,0
183031,bronchoscopy,0,1
183032,.,0,0
183033,The,0,0
183034,patients,0,1
183035,were,0,0
183036,mechanically,0,1
183037,ventilated,0,1
183038,.,0,0
183039,The,0,0
183040,ventilation,0,0
183041,conditions,0,0
183042,were,0,1
183043,Fio2=100,0,0
183044,%,0,0
183045,",",0,0
183046,VT,0,0
183047,=,0,0
183048,8-10,0,1
183049,ml/kg,0,0
183050,",",0,0
183051,I,0,1
183052,:,0,0
183053,E,0,0
183054,=,0,0
183055,1:2,0,0
183056,and,0,0
183057,respiratory,0,1
183058,rate,0,0
183059,was,0,0
183060,adjusted,0,0
183061,to,0,0
183062,maintained,0,0
183063,PETCO2,0,0
183064,at,0,0
183065,35-45,0,1
183066,mmHg,0,0
183067,during,0,0
183068,both,0,0
183069,two-lung,0,0
183070,ventilation,0,0
183071,(,0,0
183072,TLV,0,0
183073,),0,0
183074,and,0,0
183075,OLV,0,1
183076,.,0,1
183077,Anesthesia,0,0
183078,was,0,0
183079,maintained,0,0
183080,with,0,1
183081,continuous,0,0
183082,infusion,0,0
183083,of,0,0
183084,propofol,0,0
183085,4-10,0,0
183086,mg/kg?h,0,0
183087,",",0,0
183088,sufentanil,0,0
183089,0.2,0,0
183090,?g/kg?h,0,0
183091,",",0,0
183092,vecuronium,0,0
183093,o.1,0,0
183094,mg/kg?h,0,0
183095,",",0,0
183096,BIS,0,0
183097,was,0,0
183098,maintained,0,0
183099,at,0,0
183100,45-55,0,1
183101,.,0,1
183102,Blood,0,0
183103,samples,0,0
183104,were,0,0
183105,taken,0,0
183106,from,0,0
183107,radial,0,0
183108,artery,0,1
183109,and,0,0
183110,S-G,0,0
183111,catheter,0,0
183112,for,0,0
183113,blood,0,0
183114,gas,0,1
183115,analysis,0,0
183116,at,0,0
183117,following,0,0
183118,intervals,0,0
183119,:,0,1
183120,during,0,0
183121,spontaneous,0,0
183122,breathing,0,0
183123,when,0,0
183124,the,0,0
183125,patient,0,0
183126,was,0,0
183127,awake,0,0
183128,(,0,0
183129,T0,0,0
183130,),0,0
183131,",",0,0
183132,1,0,0
183133,min,0,0
183134,after,0,0
183135,tracheal,0,1
183136,indubation,0,1
183137,(,0,0
183138,T1,0,0
183139,),0,0
183140,",",0,0
183141,1,0,0
183142,min,0,0
183143,after,0,0
183144,patient,0,0
183145,was,0,0
183146,placed,0,0
183147,in,0,0
183148,lateral,0,0
183149,position,0,1
183150,(,0,0
183151,T2,0,1
183152,),0,0
183153,and,0,0
183154,15,0,0
183155,min,0,0
183156,after,0,0
183157,it,0,0
183158,(,0,0
183159,T3,0,1
183160,),0,0
183161,",",0,0
183162,1,0,0
183163,min,0,0
183164,after,0,0
183165,ribs,0,0
183166,was,0,0
183167,braced,0,0
183168,(,0,0
183169,T4,0,1
183170,),0,0
183171,",",0,0
183172,30,0,0
183173,",",0,0
183174,60,0,1
183175,",",0,0
183176,120,0,1
183177,min,0,0
183178,during,0,0
183179,the,0,0
183180,course,0,0
183181,of,0,0
183182,OLV,0,1
183183,(,0,0
183184,T5,0,0
183185,",",0,0
183186,T6,0,1
183187,",",0,0
183188,T7,0,0
183189,),0,0
183190,",",0,0
183191,the,0,0
183192,two,0,0
183193,lungs,0,0
183194,were,0,1
183195,ventilated,0,1
183196,again,0,0
183197,for,0,0
183198,30,0,0
183199,min,0,0
183200,(,0,0
183201,T8,0,0
183202,),0,0
183203,and,0,0
183204,Qs/Qt,0,0
183205,was,0,0
183206,calculated,0,0
183207,.,0,1
183208,RESULTS,0,0
183209,SVRI,0,0
183210,",",0,0
183211,MAP,0,0
183212,",",0,0
183213,HR,0,0
183214,in,0,0
183215,group,0,1
183216,N,0,1
183217,increased,0,0
183218,significantly,0,0
183219,at,0,0
183220,T1,0,0
183221,",",0,0
183222,T2,0,0
183223,",",0,0
183224,T4,0,0
183225,compared,0,0
183226,with,0,1
183227,group,0,0
183228,S,0,0
183229,(,0,0
183230,p,0,0
183231,<,0,0
183232,0.05,0,0
183233,),0,1
183234,.,0,1
183235,Qs/Qt,0,0
183236,was,0,0
183237,significantly,0,0
183238,increased,0,0
183239,after,0,0
183240,patient,0,0
183241,was,0,0
183242,placed,0,0
183243,in,0,0
183244,lateral,0,0
183245,position,0,1
183246,and,0,0
183247,increased,0,0
183248,further,0,0
183249,during,0,0
183250,OLV,0,0
183251,;,0,0
183252,the,0,0
183253,calculated,0,0
183254,Qs/Qt,0,1
183255,values,0,0
183256,were,0,0
183257,highest,0,0
183258,at,0,0
183259,T5?,0,1
183260,PaO2,0,0
183261,was,0,0
183262,significantly,0,0
183263,lower,0,0
183264,after,0,0
183265,OLV,0,1
183266,was,0,0
183267,started,0,0
183268,and,0,0
183269,reached,0,0
183270,the,0,0
183271,lowest,0,0
183272,level,0,0
183273,at,0,0
183274,T6,0,1
183275,then,0,0
183276,was,0,0
183277,gradually,0,0
183278,increasing,0,0
183279,.,0,0
183280,There,0,0
183281,was,0,0
183282,no,0,0
183283,significant,0,0
183284,difference,0,0
183285,in,0,0
183286,Qs/Qt,0,0
183287,and,0,0
183288,PaO2,0,0
183289,at,0,0
183290,all,0,0
183291,time,0,0
183292,points,0,0
183293,between,0,0
183294,two,0,1
183295,groups,0,0
183296,.,0,1
183297,CONCLUSIONS,0,0
183298,SGB,0,0
183299,before,0,0
183300,induction,0,0
183301,effectively,0,0
183302,suppress,0,0
183303,the,0,0
183304,stress,0,0
183305,response,0,0
183306,work,0,0
183307,as,0,0
183308,stable,0,1
183309,blood,0,0
183310,dynamics,0,0
183311,and,0,0
183312,does,0,0
183313,not,0,0
183314,affect,0,0
183315,Qs/Qt,0,0
183316,and,0,0
183317,arterial,0,1
183318,oxygenation,0,0
183319,during,0,0
183320,OLV,0,1
183321,",",0,0
183322,SGB,0,0
183323,is,0,0
183324,a,0,0
183325,safe,0,0
183326,technique,0,0
183327,of,0,0
183328,anesthesia,0,1
183329,for,0,0
183330,general,0,1
183331,thoracic,0,1
183332,surgery,0,1
183333,.,0,1
183334,Continual,0,0
183335,feeding,0,0
183336,of,0,0
183337,two,0,0
183338,types,0,0
183339,of,0,0
183340,microalgal,0,0
183341,biomass,0,1
183342,affected,0,0
183343,protein,0,0
183344,digestion,0,1
183345,and,0,0
183346,metabolism,0,0
183347,in,0,0
183348,laying,1,0
183349,hens,1,1
183350,.,1,1
183351,A,0,0
183352,14-wk,0,0
183353,study,0,0
183354,was,0,0
183355,conducted,0,0
183356,to,0,0
183357,determine,0,0
183358,the,0,0
183359,nutritional,0,0
183360,efficacy,0,0
183361,and,0,0
183362,ssmetabolic,0,1
183363,impact,0,0
183364,of,0,0
183365,2,0,0
183366,types,0,0
183367,of,0,0
183368,microalgal,0,0
183369,biomass,0,1
183370,as,0,0
183371,alternative,0,0
183372,protein,0,0
183373,sources,0,0
183374,in,0,0
183375,laying,1,1
183376,hen,1,1
183377,diets,0,0
183378,.,0,1
183379,Shaver,1,0
183380,hens,1,0
183381,(,1,0
183382,total,1,1
183383,=,1,0
183384,150,1,0
183385,and,1,0
183386,26,1,1
183387,wk,1,1
183388,old,1,1
183389,),1,1
183390,were,0,0
183391,fed,0,0
183392,1,0,0
183393,of,0,0
183394,5,0,1
183395,diets,0,0
183396,:,0,1
183397,a,0,0
183398,control,0,0
183399,or,0,0
183400,a,0,0
183401,defatted,0,0
183402,green,0,0
183403,microalgal,0,0
183404,biomass,0,0
183405,(,0,0
183406,DG,0,0
183407,;,0,0
183408,Desmodesmus,0,0
183409,spp,0,0
183410,.,0,0
183411,),0,0
183412,at,0,0
183413,25,0,1
183414,%,0,0
183415,and,0,0
183416,a,0,0
183417,full-fatted,0,0
183418,diatom,0,0
183419,biomass,0,0
183420,(,0,0
183421,FD,0,0
183422,;,0,0
183423,Staurosira,0,0
183424,spp,0,0
183425,.,0,0
183426,),0,0
183427,at,0,0
183428,11.7,0,0
183429,%,0,0
183430,inclusion,0,1
183431,with,0,1
183432,or,0,0
183433,without,0,1
183434,protease,0,0
183435,.,0,0
183436,This,0,0
183437,experiment,0,0
183438,consisted,0,1
183439,of,0,0
183440,5,0,1
183441,replicates,0,1
183442,per,0,0
183443,treatment,0,0
183444,and,0,0
183445,each,0,0
183446,replicate,0,0
183447,contained,0,0
183448,6,0,0
183449,hens,0,1
183450,individually,0,0
183451,reared,0,1
183452,in,0,0
183453,cages,0,0
183454,(,0,1
183455,1,0,0
183456,hen,0,1
183457,for,0,0
183458,biochemical,0,0
183459,data/replicate,0,1
183460,),0,0
183461,.,0,0
183462,Despite,0,0
183463,decreased,0,0
183464,ADFI,0,0
183465,(,0,1
183466,P,0,0
183467,=,0,0
183468,0.03,0,0
183469,),0,0
183470,",",0,0
183471,hens,0,1
183472,fed,0,0
183473,DG,0,0
183474,or,0,1
183475,FD,0,0
183476,had,0,1
183477,final,0,0
183478,BW,0,0
183479,",",0,0
183480,overall,0,0
183481,hen-day,0,0
183482,egg,0,0
183483,production,0,0
183484,",",0,0
183485,and,0,0
183486,egg,0,0
183487,quality,0,0
183488,similar,0,0
183489,to,0,0
183490,the,0,0
183491,controls,0,1
183492,.,0,1
183493,Feeding,0,0
183494,DG,0,0
183495,or,0,1
183496,FD,0,0
183497,did,0,0
183498,not,0,0
183499,alter,0,0
183500,plasma,0,0
183501,concentrations,0,0
183502,of,0,0
183503,insulin,0,0
183504,",",0,0
183505,glutamine,0,0
183506,",",0,0
183507,and,0,0
183508,uric,0,0
183509,acid,0,0
183510,or,0,1
183511,alkaline,0,0
183512,phosphatase,0,0
183513,activity,0,0
183514,at,0,0
183515,wk,0,1
183516,8,0,0
183517,or,0,1
183518,14,0,1
183519,but,0,0
183520,decreased,0,0
183521,plasma,0,0
183522,3-methyhistine,0,0
183523,concentrations,0,0
183524,(,0,1
183525,P,0,0
183526,=,0,0
183527,0.03,0,0
183528,),0,0
183529,and,0,0
183530,tartrate-resistant,0,0
183531,acid,0,0
183532,phosphatase,0,0
183533,(,0,0
183534,TRAP,0,0
183535,),0,1
183536,activities,0,0
183537,(,0,1
183538,P,0,0
183539,<,0,0
183540,0.001,0,0
183541,),0,0
183542,at,0,0
183543,wk,0,1
183544,14,0,0
183545,and,0,0
183546,improved,0,0
183547,(,0,0
183548,P,0,0
183549,=,0,0
183550,0.002,0,0
183551,),0,0
183552,ileal,0,1
183553,total,0,1
183554,AA,0,0
183555,digestibility,0,0
183556,.,0,0
183557,Although,0,0
183558,DG,0,0
183559,or,0,1
183560,FD,0,0
183561,exhibited,0,0
183562,moderate,0,1
183563,effects,0,0
183564,on,0,0
183565,intestinal,0,1
183566,brush,0,0
183567,border,0,1
183568,protease,0,0
183569,activities,0,0
183570,and,0,0
183571,mRNA,0,0
183572,levels,0,0
183573,of,0,0
183574,duodenal,0,1
183575,transporters,0,0
183576,Pept1,0,1
183577,",",0,0
183578,Lat1,0,0
183579,",",0,0
183580,and,0,0
183581,Cat1,0,0
183582,",",0,0
183583,both,0,0
183584,substantially,0,0
183585,enhanced,0,0
183586,(,0,0
183587,P,0,0
183588,<,0,0
183589,0.05,0,0
183590,),0,0
183591,phosphorylation,0,0
183592,of,0,0
183593,hepatic,0,0
183594,protein,0,0
183595,synthesis,0,0
183596,key,0,0
183597,regulator,0,0
183598,S6,0,0
183599,ribosomal,0,0
183600,protein,0,0
183601,(,0,0
183602,S6,0,0
183603,),0,0
183604,and,0,0
183605,the,0,0
183606,ratio,0,0
183607,of,0,0
183608,phospho-S6,0,0
183609,to,0,0
183610,S6,0,0
183611,in,0,0
183612,the,0,0
183613,liver,0,1
183614,of,0,0
183615,hens,0,0
183616,.,0,1
183617,However,0,0
183618,",",0,0
183619,DG,0,0
183620,and,0,0
183621,FD,0,0
183622,manifested,0,0
183623,with,0,1
183624,different,0,0
183625,impacts,0,0
183626,on,0,0
183627,weights,0,0
183628,of,0,0
183629,egg,0,0
183630,and,0,0
183631,egg,0,0
183632,albumen,0,0
183633,",",0,0
183634,proteolytic,0,0
183635,activity,0,0
183636,of,0,0
183637,jejunal,0,0
183638,digesta,0,0
183639,",",0,0
183640,plasma,0,0
183641,TRAP,0,0
183642,activity,0,0
183643,",",0,0
183644,ileal,0,1
183645,total,0,1
183646,AA,0,0
183647,digestibility,0,0
183648,",",0,0
183649,and,0,0
183650,several,0,0
183651,intestinal,0,1
183652,genes,0,0
183653,and,0,1
183654,hepatic,0,1
183655,proteins,0,0
183656,.,0,1
183657,Supplemental,0,0
183658,protease,0,0
183659,in,0,0
183660,the,0,0
183661,DG,0,0
183662,and,0,0
183663,FD,0,0
183664,diets,0,0
183665,produced,0,0
183666,mixed,0,0
183667,effects,0,0
183668,on,0,0
183669,a,0,0
183670,number,0,0
183671,of,0,0
183672,measures,0,0
183673,.,0,1
183674,In,0,0
183675,conclusion,0,0
183676,",",0,0
183677,our,0,0
183678,findings,0,0
183679,revealed,0,0
183680,the,0,0
183681,feasibility,0,0
183682,of,0,0
183683,including,0,0
183684,greater,0,0
183685,levels,0,0
183686,of,0,0
183687,microalgal,0,0
183688,biomass,0,0
183689,as,0,0
183690,a,0,0
183691,source,0,0
183692,of,0,0
183693,feed,0,0
183694,protein,0,0
183695,for,0,0
183696,laying,1,0
183697,hens,1,1
183698,and,0,0
183699,a,0,0
183700,novel,0,0
183701,potential,0,0
183702,of,0,0
183703,the,0,0
183704,biomass,0,0
183705,in,0,0
183706,improving,0,0
183707,dietary,0,0
183708,protein,0,0
183709,digestion,0,1
183710,and,0,0
183711,body,0,0
183712,protein,0,0
183713,metabolism,0,0
183714,than,0,0
183715,previously,0,1
183716,perceived,0,0
183717,.,0,0
183718,N-acetylcysteine,0,0
183719,as,0,0
183720,an,0,0
183721,adjunctive,0,0
183722,therapy,0,0
183723,to,0,0
183724,risperidone,0,0
183725,for,0,0
183726,treatment,0,0
183727,of,0,0
183728,irritability,0,0
183729,in,1,0
183730,autism,1,1
183731,:,1,1
183732,a,0,0
183733,randomized,0,0
183734,",",0,0
183735,double-blind,0,0
183736,",",0,0
183737,placebo-controlled,0,0
183738,clinical,0,0
183739,trial,0,0
183740,of,0,0
183741,efficacy,0,0
183742,and,0,0
183743,safety,0,0
183744,.,0,0
183745,OBJECTIVES,0,0
183746,According,0,0
183747,to,0,0
183748,the,0,0
183749,proposed,0,0
183750,interference,0,0
183751,of,0,0
183752,N-acetylcysteine,0,0
183753,(,0,1
183754,NAC,0,0
183755,),0,0
183756,with,0,1
183757,pathophysiologic,0,0
183758,processes,0,0
183759,of,0,1
183760,autistic,0,1
183761,disorders,0,1
183762,(,0,1
183763,ADs,0,1
183764,),0,0
183765,",",0,0
183766,we,0,0
183767,aimed,0,0
183768,to,0,0
183769,assess,0,0
183770,the,0,0
183771,effectiveness,0,0
183772,and,0,0
183773,safety,0,0
183774,of,0,0
183775,NAC,0,0
183776,as,0,0
183777,an,0,0
183778,adjunct,0,0
183779,to,0,0
183780,risperidone,0,0
183781,in,0,0
183782,the,0,0
183783,treatment,0,0
183784,of,0,0
183785,ADs,0,1
183786,in,0,0
183787,a,0,0
183788,randomized,0,0
183789,",",0,0
183790,double-blind,0,0
183791,",",0,0
183792,clinical,0,0
183793,trial,0,0
183794,.,0,1
183795,METHODS,0,0
183796,The,0,0
183797,participants,1,1
183798,were,1,0
183799,referred,1,1
183800,outpatients,1,1
183801,between,1,0
183802,4,1,0
183803,and,1,1
183804,12,1,1
183805,years,1,1
183806,of,1,0
183807,age,1,1
183808,with,1,1
183809,the,1,0
183810,diagnosis,1,1
183811,of,1,0
183812,ADs,1,1
183813,and,1,0
183814,a,1,0
183815,score,1,0
183816,of,1,0
183817,more,1,0
183818,than,1,0
183819,12,1,0
183820,on,1,0
183821,Aberrant,1,1
183822,Behavior,1,1
183823,Checklist-Community,1,0
183824,(,1,0
183825,ABC-C,1,1
183826,),1,0
183827,Irritability,1,0
183828,subscale,1,0
183829,score,1,0
183830,.,1,0
183831,The,0,0
183832,participants,0,1
183833,were,0,0
183834,randomized,0,1
183835,into,0,1
183836,2,0,1
183837,groups,0,1
183838,.,0,1
183839,One,0,1
183840,group,0,0
183841,received,0,0
183842,risperidone,0,0
183843,plus,0,0
183844,NAC,0,0
183845,",",0,0
183846,and,0,0
183847,the,0,0
183848,other,0,0
183849,group,0,0
183850,received,0,0
183851,risperidone,0,0
183852,plus,0,0
183853,placebo,0,0
183854,.,0,0
183855,The,0,0
183856,dose,0,0
183857,of,0,0
183858,risperidone,0,0
183859,was,0,0
183860,titrated,0,0
183861,between,0,0
183862,1,0,0
183863,and,0,0
183864,2.0,0,0
183865,mg/d,0,0
183866,",",0,0
183867,and,0,0
183868,the,0,0
183869,dose,0,0
183870,of,0,0
183871,NAC,0,0
183872,was,0,0
183873,600,0,1
183874,to,0,0
183875,900,0,1
183876,mg/d,0,0
183877,.,0,0
183878,The,0,0
183879,main,0,0
183880,outcome,0,0
183881,was,0,0
183882,mean,0,0
183883,decrease,0,0
183884,in,0,0
183885,the,0,0
183886,ABC-C,0,0
183887,irritability,0,0
183888,subscale,0,0
183889,score,0,0
183890,from,0,0
183891,baseline,0,0
183892,at,0,0
183893,5,0,0
183894,and,0,1
183895,10,0,1
183896,weeks,0,0
183897,.,0,1
183898,Changes,0,0
183899,in,0,0
183900,other,0,1
183901,subscales,0,0
183902,were,0,1
183903,considered,0,0
183904,as,0,0
183905,secondary,0,1
183906,outcome,0,0
183907,measures,0,0
183908,.,0,1
183909,RESULTS,0,0
183910,Forty,1,1
183911,patients,1,1
183912,completed,1,1
183913,the,1,0
183914,10-week,1,0
183915,trial,1,0
183916,.,1,1
183917,Baseline,0,0
183918,characteristics,0,0
183919,including,0,0
183920,age,0,1
183921,",",0,0
183922,sex,0,0
183923,and,0,0
183924,body,0,0
183925,weight,0,0
183926,",",0,0
183927,as,0,0
183928,well,0,0
183929,as,0,0
183930,baseline,0,0
183931,scores,0,0
183932,in,0,1
183933,5,0,1
183934,subscales,0,0
183935,did,0,0
183936,not,0,0
183937,demonstrate,0,0
183938,statistically,0,0
183939,significant,0,0
183940,difference,0,0
183941,between,0,0
183942,the,0,0
183943,2,0,0
183944,groups,0,0
183945,.,0,1
183946,Repeated-measures,0,0
183947,analysis,0,0
183948,showed,0,0
183949,significant,0,0
183950,effect,0,0
183951,for,0,0
183952,time,0,0
183953,?,0,0
183954,treatment,0,0
183955,interaction,0,0
183956,in,0,0
183957,irritability,0,0
183958,(,0,0
183959,P,0,0
183960,=,0,0
183961,0.01,0,0
183962,),0,0
183963,and,0,0
183964,hyperactivity/noncompliance,0,0
183965,(,0,0
183966,P,0,0
183967,=,0,0
183968,0.02,0,0
183969,),0,1
183970,subscales,0,0
183971,.,0,1
183972,By,0,0
183973,week,0,0
183974,10,0,0
183975,",",0,0
183976,the,0,0
183977,NAC,0,0
183978,group,0,0
183979,showed,0,0
183980,significantly,0,0
183981,more,0,0
183982,reduction,0,0
183983,in,0,0
183984,irritability,0,0
183985,(,0,0
183986,P,0,0
183987,=,0,0
183988,0.02,0,0
183989,),0,0
183990,and,0,0
183991,hyperactivity/noncompliance,0,0
183992,(,0,0
183993,P,0,0
183994,=,0,0
183995,0.01,0,0
183996,),0,1
183997,subscales,0,0
183998,scores,0,0
183999,.,0,1
184000,CONCLUSIONS,0,0
184001,N-acetylcysteine,0,0
184002,can,0,0
184003,be,0,0
184004,considered,0,0
184005,as,0,0
184006,an,0,0
184007,adjuvant,0,0
184008,therapy,0,0
184009,for,0,0
184010,ADs,0,1
184011,with,0,1
184012,beneficial,0,0
184013,therapeutic,0,1
184014,outcomes,0,0
184015,.,0,1
184016,Pharmacokinetic,0,0
184017,study,0,0
184018,between,0,0
184019,a,0,0
184020,bilayer,0,0
184021,matrix,0,0
184022,fentalyl,0,0
184023,patch,0,0
184024,and,0,0
184025,a,0,0
184026,monolayer,0,0
184027,matrix,0,0
184028,fentanyl,0,0
184029,patch,0,0
184030,:,0,1
184031,single,0,0
184032,dose,0,0
184033,administration,0,0
184034,in,0,0
184035,healthy,1,1
184036,volunteers,1,1
184037,.,1,1
184038,AIMS,0,0
184039,Transdermal,0,0
184040,fentanyl,0,0
184041,is,0,0
184042,a,0,0
184043,well,0,0
184044,established,0,0
184045,treatment,0,0
184046,for,0,0
184047,cancer,0,1
184048,pain,0,1
184049,.,0,0
184050,The,0,0
184051,aim,0,0
184052,of,0,0
184053,the,0,0
184054,present,0,0
184055,study,0,0
184056,is,0,0
184057,to,0,0
184058,assess,0,0
184059,the,0,0
184060,relative,0,0
184061,bioavailability,0,0
184062,of,0,0
184063,fentanyl,0,0
184064,from,0,1
184065,two,0,0
184066,different,0,0
184067,transdermal,0,0
184068,systems,0,0
184069,by,0,0
184070,evaluating,0,0
184071,plasma,0,0
184072,drug,0,0
184073,concentrations,0,0
184074,after,0,0
184075,single,0,0
184076,administration,0,0
184077,of,0,0
184078,Fentalgon?,0,0
184079,(,0,0
184080,test,0,0
184081,),0,0
184082,",",0,0
184083,a,0,0
184084,novel,0,0
184085,bilayer,0,0
184086,matrix,0,0
184087,type,0,1
184088,patch,0,0
184089,",",0,0
184090,and,0,0
184091,Durogesic,0,0
184092,SMAT,0,0
184093,(,0,0
184094,reference,0,0
184095,),0,0
184096,",",0,0
184097,a,0,0
184098,monolayer,0,0
184099,matrix,0,0
184100,type,0,1
184101,patch,0,0
184102,.,0,0
184103,In,0,0
184104,the,0,0
184105,Fentalgon,0,0
184106,patch,0,0
184107,the,0,0
184108,upper,0,0
184109,6,0,0
184110,%,0,0
184111,fentanyl,0,0
184112,reservoir,0,0
184113,layer,0,0
184114,maintains,0,0
184115,a,0,0
184116,stable,0,0
184117,concentration,0,0
184118,gradient,0,0
184119,between,0,0
184120,the,0,0
184121,lower,0,0
184122,4,0,0
184123,%,0,0
184124,donor,0,0
184125,layer,0,0
184126,and,0,0
184127,the,0,0
184128,skin,0,0
184129,.,0,0
184130,The,0,0
184131,system,0,0
184132,provides,0,0
184133,a,0,0
184134,constant,0,0
184135,drug,0,0
184136,delivery,0,0
184137,over,0,0
184138,72,0,1
184139,h.,0,1
184140,METHODS,0,0
184141,This,0,0
184142,was,0,0
184143,an,0,0
184144,open,0,1
184145,label,0,0
184146,",",0,0
184147,single,0,0
184148,centre,0,1
184149,",",0,0
184150,randomized,0,0
184151,",",0,0
184152,single,0,0
184153,dose,0,0
184154,",",0,0
184155,two,0,0
184156,period,0,0
184157,crossover,0,1
184158,clinical,0,0
184159,trial,0,0
184160,",",0,0
184161,that,0,0
184162,included,1,1
184163,36,1,1
184164,healthy,1,1
184165,male,1,1
184166,volunteers,1,1
184167,.,1,1
184168,The,0,0
184169,patches,0,0
184170,were,0,0
184171,applied,0,0
184172,to,0,0
184173,non-irritated,0,0
184174,and,0,0
184175,non-irradiated,0,0
184176,skin,0,0
184177,on,0,0
184178,the,0,0
184179,intraclavicular,0,0
184180,pectoral,0,0
184181,area,0,0
184182,.,0,1
184183,Blood,0,0
184184,samples,0,0
184185,were,0,0
184186,collected,0,0
184187,at,0,0
184188,different,0,0
184189,time,0,0
184190,points,0,0
184191,(,0,0
184192,from,0,1
184193,baseline,0,0
184194,to,0,0
184195,120,0,1
184196,h,0,0
184197,post-removal,0,0
184198,of,0,0
184199,the,0,0
184200,devices,0,0
184201,),0,0
184202,and,0,1
184203,fentanyl,0,0
184204,concentrations,0,0
184205,were,0,1
184206,determined,0,0
184207,using,0,0
184208,a,0,0
184209,validated,0,0
184210,LC/MS/MS,0,0
184211,method,0,0
184212,.,0,1
184213,Bioequivalence,0,0
184214,was,0,0
184215,to,0,0
184216,be,0,0
184217,claimed,0,0
184218,if,0,0
184219,the,0,0
184220,90,0,0
184221,%,0,0
184222,confidence,0,0
184223,interval,0,0
184224,of,0,0
184225,AUC,0,0
184226,(,0,0
184227,0,0,0
184228,",",0,0
184229,t,0,0
184230,),0,0
184231,and,0,0
184232,C,0,0
184233,(,0,0
184234,max,0,0
184235,),0,0
184236,ratios,0,0
184237,(,0,1
184238,test,0,0
184239,:,0,1
184240,reference,0,0
184241,),0,0
184242,were,0,0
184243,within,0,0
184244,the,0,0
184245,acceptance,0,0
184246,range,0,0
184247,of,0,0
184248,80-125,0,0
184249,%,0,0
184250,and,0,0
184251,75-133,0,1
184252,%,0,0
184253,",",0,0
184254,respectively,0,0
184255,.,0,0
184256,RESULTS,0,0
184257,The,0,0
184258,90,0,0
184259,%,0,0
184260,confidence,0,0
184261,intervals,0,0
184262,of,0,0
184263,the,0,0
184264,AUC,0,0
184265,(,0,0
184266,0,0,0
184267,",",0,0
184268,t,0,0
184269,),0,0
184270,ratio,0,0
184271,(,0,0
184272,116.3,0,0
184273,%,0,0
184274,[,0,0
184275,109.6,0,0
184276,",",0,0
184277,123.4,0,0
184278,%,0,0
184279,],0,1
184280,),0,0
184281,and,0,0
184282,C,0,0
184283,(,0,0
184284,max,0,0
184285,),0,0
184286,ratio,0,0
184287,(,0,0
184288,114.4,0,0
184289,%,0,0
184290,[,0,0
184291,105.8,0,0
184292,",",0,0
184293,123.8,0,0
184294,%,0,0
184295,],0,0
184296,were,0,0
184297,well,0,0
184298,included,0,0
184299,in,0,0
184300,the,0,0
184301,acceptance,0,0
184302,range,0,0
184303,and,0,0
184304,the,0,0
184305,C,0,0
184306,(,0,0
184307,max,0,0
184308,),0,0
184309,ratio,0,0
184310,also,0,0
184311,met,0,1
184312,the,0,0
184313,narrower,0,0
184314,bounds,0,0
184315,of,0,0
184316,80-125,0,0
184317,%,0,0
184318,.,0,0
184319,There,0,0
184320,was,0,0
184321,no,0,0
184322,relevant,0,0
184323,difference,0,0
184324,in,0,0
184325,overall,0,0
184326,safety,0,0
184327,profiles,0,0
184328,of,0,0
184329,the,0,0
184330,two,0,0
184331,preparations,0,0
184332,investigated,0,0
184333,",",0,0
184334,which,0,0
184335,were,0,0
184336,adequately,0,0
184337,tolerated,0,0
184338,",",0,0
184339,as,0,0
184340,expected,0,0
184341,for,0,0
184342,opioid-na?ve,0,1
184343,subjects,0,1
184344,.,0,1
184345,CONCLUSIONS,0,0
184346,The,0,0
184347,new,0,0
184348,bilayer,0,0
184349,matrix,0,0
184350,type,0,1
184351,patch,0,0
184352,",",0,0
184353,Fentalgon?,0,0
184354,",",0,0
184355,is,0,0
184356,bioequivalent,0,0
184357,to,0,0
184358,the,0,0
184359,monolayer,0,0
184360,matrix,0,0
184361,type,0,1
184362,Durogesic,0,0
184363,SMAT,0,0
184364,fentanyl,0,0
184365,patch,0,0
184366,with,0,1
184367,respect,0,0
184368,to,0,0
184369,the,0,0
184370,rate,0,0
184371,and,0,0
184372,extent,0,0
184373,of,0,0
184374,exposure,0,0
184375,of,0,0
184376,fentanyl,0,0
184377,(,0,0
184378,Eudra/CT,0,0
184379,no,0,0
184380,.,0,0
184381,2005-000046-36,0,0
184382,),0,0
184383,.,0,1
184384,Randomized,0,0
184385,trial,0,0
184386,of,0,0
184387,interferon-,0,0
184388,and,0,0
184389,ribavirin-free,0,0
184390,ombitasvir/paritaprevir/ritonavir,0,0
184391,in,0,0
184392,treatment-experienced,1,1
184393,hepatitis,1,1
184394,C,1,0
184395,virus-infected,1,1
184396,patients,1,1
184397,.,1,1
184398,UNLABELLED,0,0
184399,Approximately,0,0
184400,2,0,0
184401,million,0,1
184402,Japanese,1,1
184403,individuals,1,1
184404,are,0,0
184405,infected,0,1
184406,with,0,1
184407,hepatitis,0,1
184408,C,0,0
184409,virus,0,1
184410,and,0,0
184411,are,0,0
184412,at,0,0
184413,risk,0,0
184414,for,0,0
184415,cirrhosis,0,1
184416,",",0,0
184417,end-stage,0,1
184418,liver,0,1
184419,disease,0,1
184420,",",0,0
184421,and,0,0
184422,hepatocellular,0,1
184423,carcinoma,0,1
184424,.,0,1
184425,Patients,0,1
184426,in,0,1
184427,whom,0,1
184428,interferon,0,1
184429,(,0,1
184430,IFN,0,1
184431,),0,0
184432,/ribavirin,0,0
184433,(,0,0
184434,RBV,0,0
184435,),0,0
184436,therapy,0,0
184437,has,0,0
184438,failed,0,0
184439,remain,0,0
184440,at,0,0
184441,risk,0,0
184442,as,0,0
184443,effective,0,0
184444,therapeutic,0,1
184445,options,0,0
184446,are,0,0
184447,limited,0,0
184448,.,0,0
184449,This,0,0
184450,phase,0,0
184451,2,0,0
184452,",",0,0
184453,randomized,0,0
184454,",",0,0
184455,open-label,0,0
184456,study,0,0
184457,evaluated,0,0
184458,an,0,0
184459,IFN-,0,0
184460,and,0,0
184461,RBV-free,0,0
184462,regimen,0,0
184463,of,0,0
184464,once-daily,0,0
184465,ombitasvir,0,1
184466,(,0,0
184467,ABT-267,0,0
184468,),0,0
184469,",",0,0
184470,an,0,0
184471,NS5A,0,0
184472,inhibitor,0,0
184473,",",0,0
184474,plus,0,0
184475,paritaprevir,0,0
184476,(,0,0
184477,ABT-450,0,0
184478,),0,0
184479,",",0,0
184480,an,0,0
184481,NS3/4A,0,0
184482,protease,0,0
184483,inhibitor,0,0
184484,dosed,0,0
184485,with,0,1
184486,ritonavir,0,0
184487,(,0,0
184488,paritaprevir/ritonavir,0,0
184489,),0,0
184490,",",0,0
184491,in,0,0
184492,pegylated,1,0
184493,IFN/RBV,1,1
184494,treatment-experienced,1,1
184495,Japanese,1,1
184496,patients,1,1
184497,with,1,1
184498,hepatitis,1,1
184499,C,1,0
184500,virus,1,1
184501,subtype,1,1
184502,1b,1,1
184503,or,1,1
184504,genotype,1,0
184505,2,1,0
184506,infection,1,0
184507,.,1,1
184508,Patients,1,1
184509,without,1,1
184510,cirrhosis,1,1
184511,(,1,0
184512,aged,1,1
184513,18-75,1,1
184514,years,1,1
184515,),1,1
184516,with,1,1
184517,subtype,1,1
184518,1b,1,1
184519,infection,1,0
184520,received,0,1
184521,ombitasvir,0,1
184522,25,0,1
184523,mg,0,0
184524,plus,0,0
184525,paritaprevir/ritonavir,0,1
184526,100/100,0,0
184527,mg,0,0
184528,or,0,1
184529,150/100,0,0
184530,mg,0,0
184531,for,0,0
184532,12,0,0
184533,or,0,1
184534,24,0,1
184535,weeks,0,0
184536,;,0,1
184537,patients,1,1
184538,with,1,1
184539,genotype,1,0
184540,2,1,0
184541,infection,1,1
184542,received,0,1
184543,ombitasvir,0,1
184544,25,0,1
184545,mg,0,0
184546,plus,0,0
184547,paritaprevir/ritonavir,0,1
184548,100/100,0,0
184549,mg,0,0
184550,or,0,1
184551,150/100,0,0
184552,mg,0,0
184553,for,0,0
184554,12,0,1
184555,weeks,0,0
184556,.,0,1
184557,Sustained,0,0
184558,virologic,0,0
184559,response,0,0
184560,(,0,0
184561,SVR,0,0
184562,),0,0
184563,at,0,0
184564,posttreatment,0,0
184565,week,0,0
184566,24,0,0
184567,(,0,0
184568,SVR24,0,1
184569,),0,0
184570,was,0,0
184571,the,0,0
184572,primary,0,0
184573,endpoint,0,0
184574,.,0,1
184575,Adverse,0,0
184576,events,0,0
184577,were,0,1
184578,collected,0,0
184579,throughout,0,0
184580,the,0,0
184581,study,0,0
184582,.,0,0
184583,One,1,1
184584,hundred,1,1
184585,ten,1,1
184586,patients,1,1
184587,received,0,1
184588,?1,0,1
184589,dose,0,0
184590,of,0,0
184591,study,0,0
184592,medication,0,0
184593,.,0,0
184594,In,0,0
184595,the,0,0
184596,subtype,0,1
184597,1b,0,0
184598,cohort,0,1
184599,",",0,0
184600,SVR24,0,1
184601,rates,0,0
184602,were,0,1
184603,high,0,1
184604,(,0,0
184605,88.9,0,0
184606,%,0,0
184607,-100,0,0
184608,%,0,0
184609,),0,0
184610,regardless,0,0
184611,of,0,0
184612,paritaprevir,0,0
184613,dose,0,0
184614,or,0,0
184615,treatment,0,0
184616,duration,0,0
184617,.,0,0
184618,In,0,0
184619,the,0,0
184620,genotype,0,0
184621,2,0,0
184622,cohort,0,1
184623,",",0,0
184624,SVR24,0,1
184625,rates,0,0
184626,were,0,1
184627,57.9,0,1
184628,%,0,0
184629,and,0,0
184630,72.2,0,0
184631,%,0,0
184632,with,0,1
184633,100,0,0
184634,mg,0,0
184635,and,0,1
184636,150,0,0
184637,mg,0,0
184638,of,0,0
184639,paritaprevir,0,0
184640,",",0,0
184641,respectively,0,0
184642,.,0,0
184643,The,0,0
184644,SVR24,0,0
184645,rate,0,0
184646,was,0,0
184647,higher,0,0
184648,in,0,0
184649,patients,0,1
184650,with,0,1
184651,subtype,0,1
184652,2a,0,0
184653,(,0,1
184654,90,0,0
184655,%,0,0
184656,),0,0
184657,than,0,0
184658,2b,0,1
184659,(,0,1
184660,27,0,1
184661,%,0,0
184662,),0,0
184663,.,0,0
184664,Concordance,0,0
184665,between,0,0
184666,SVR12,0,0
184667,and,0,1
184668,SVR24,0,1
184669,was,0,0
184670,100,0,0
184671,%,0,0
184672,.,0,0
184673,The,0,0
184674,most,0,0
184675,common,0,0
184676,adverse,0,0
184677,events,0,0
184678,overall,0,0
184679,were,0,1
184680,nasopharyngitis,0,1
184681,(,0,0
184682,29,0,1
184683,%,0,0
184684,),0,0
184685,and,0,0
184686,headache,0,0
184687,(,0,0
184688,14,0,0
184689,%,0,0
184690,),0,0
184691,.,0,0
184692,CONCLUSION,0,0
184693,In,0,0
184694,this,1,0
184695,difficult-to-treat,1,1
184696,population,1,1
184697,of,1,0
184698,patients,1,1
184699,in,1,1
184700,whom,1,1
184701,prior,1,1
184702,pegylated,1,1
184703,IFN/RBV,1,0
184704,had,1,0
184705,failed,1,0
184706,",",1,0
184707,ombitasvir/paritaprevir/ritonavir,0,0
184708,demonstrated,0,0
184709,potent,0,0
184710,antiviral,0,0
184711,activity,0,0
184712,with,0,1
184713,a,0,0
184714,favorable,0,0
184715,safety,0,0
184716,profile,0,0
184717,among,1,0
184718,Japanese,1,1
184719,patients,1,1
184720,with,1,1
184721,hepatitis,1,1
184722,C,1,0
184723,virus,1,1
184724,genotype,1,0
184725,1b,1,1
184726,or,1,1
184727,2a,1,0
184728,infection,1,1
184729,.,1,1
184730,Final,0,1
184731,Report,0,1
184732,of,0,0
184733,the,0,0
184734,Intergroup,0,0
184735,Randomized,0,0
184736,Study,0,0
184737,of,0,0
184738,Combined,0,0
184739,Androgen-Deprivation,0,1
184740,Therapy,0,1
184741,Plus,0,1
184742,Radiotherapy,0,1
184743,Versus,0,1
184744,Androgen-Deprivation,0,0
184745,Therapy,0,1
184746,Alone,0,0
184747,in,0,0
184748,Locally,0,1
184749,Advanced,0,1
184750,Prostate,0,1
184751,Cancer,0,1
184752,.,0,1
184753,PURPOSE,0,0
184754,We,0,0
184755,have,0,0
184756,previously,0,0
184757,reported,0,0
184758,that,0,0
184759,radiotherapy,0,1
184760,(,0,0
184761,RT,0,1
184762,),0,0
184763,added,0,0
184764,to,0,0
184765,androgen-deprivation,0,0
184766,therapy,0,0
184767,(,0,0
184768,ADT,0,0
184769,),0,0
184770,improves,0,0
184771,survival,0,0
184772,in,0,0
184773,men,1,1
184774,with,1,1
184775,locally,1,1
184776,advanced,1,1
184777,prostate,1,1
184778,cancer,1,1
184779,.,1,0
184780,Here,0,0
184781,",",0,0
184782,we,0,0
184783,report,0,0
184784,the,0,0
184785,prespecified,0,0
184786,final,0,0
184787,analysis,0,0
184788,of,0,0
184789,this,0,0
184790,randomized,0,0
184791,trial,0,0
184792,.,0,1
184793,PATIENTS,0,0
184794,AND,0,0
184795,METHODS,0,0
184796,NCIC,1,0
184797,Clinical,1,0
184798,Trials,1,1
184799,Group,1,1
184800,PR.3/Medical,1,1
184801,Research,1,1
184802,Council,1,1
184803,PR07/Intergroup,1,1
184804,T94-0110,1,0
184805,was,0,0
184806,a,0,0
184807,randomized,0,0
184808,controlled,0,0
184809,trial,0,0
184810,of,0,0
184811,patients,1,1
184812,with,1,1
184813,locally,1,1
184814,advanced,1,1
184815,prostate,1,1
184816,cancer,1,1
184817,.,1,0
184818,Patients,1,1
184819,with,1,1
184820,T3-4,1,1
184821,",",1,0
184822,N0/Nx,1,0
184823,",",1,0
184824,M0,1,0
184825,prostate,1,1
184826,cancer,1,1
184827,or,1,1
184828,T1-2,1,0
184829,disease,1,1
184830,with,1,1
184831,either,1,0
184832,prostate-specific,1,0
184833,antigen,1,0
184834,(,1,0
184835,PSA,1,0
184836,),1,0
184837,of,1,0
184838,more,1,0
184839,than,1,0
184840,40,1,1
184841,?g/L,1,0
184842,or,1,1
184843,PSA,1,1
184844,of,1,0
184845,20,1,1
184846,to,1,1
184847,40,1,1
184848,?g/L,1,0
184849,plus,1,0
184850,Gleason,1,1
184851,score,1,0
184852,of,1,0
184853,8,1,0
184854,to,1,1
184855,10,1,0
184856,were,1,0
184857,randomly,0,1
184858,assigned,0,0
184859,to,0,0
184860,lifelong,0,1
184861,ADT,0,0
184862,alone,0,0
184863,or,0,0
184864,to,0,0
184865,ADT+RT,0,1
184866,.,0,0
184867,The,0,0
184868,RT,0,0
184869,dose,0,0
184870,was,0,0
184871,64,0,1
184872,to,0,1
184873,69,0,1
184874,Gy,0,1
184875,in,0,0
184876,35,0,1
184877,to,0,1
184878,39,0,1
184879,fractions,0,0
184880,to,0,0
184881,the,0,0
184882,prostate,0,1
184883,and,0,0
184884,pelvis,0,0
184885,or,0,0
184886,prostate,0,1
184887,alone,0,0
184888,.,0,0
184889,Overall,0,0
184890,survival,0,0
184891,was,0,0
184892,compared,0,0
184893,using,0,0
184894,a,0,0
184895,log-rank,0,0
184896,test,0,0
184897,stratified,0,1
184898,for,0,0
184899,prespecified,0,1
184900,variables,0,0
184901,.,0,1
184902,RESULTS,1,0
184903,One,1,1
184904,thousand,1,1
184905,two,1,0
184906,hundred,1,1
184907,five,1,1
184908,patients,1,1
184909,were,1,1
184910,randomly,0,1
184911,assigned,0,1
184912,between,0,0
184913,1995,0,1
184914,and,0,0
184915,2005,0,1
184916,",",0,0
184917,602,0,1
184918,to,0,0
184919,ADT,0,0
184920,alone,0,0
184921,and,0,0
184922,603,0,1
184923,to,0,0
184924,ADT+RT,0,1
184925,.,0,0
184926,At,0,0
184927,a,0,0
184928,median,0,0
184929,follow-up,0,0
184930,time,0,0
184931,of,0,0
184932,8,0,0
184933,years,0,1
184934,",",0,1
184935,465,0,1
184936,patients,0,1
184937,had,0,1
184938,died,0,1
184939,",",0,0
184940,including,0,0
184941,199,0,1
184942,patients,0,1
184943,from,0,1
184944,prostate,0,1
184945,cancer,0,1
184946,.,0,1
184947,Overall,0,0
184948,survival,0,0
184949,was,0,0
184950,significantly,0,0
184951,improved,0,0
184952,in,0,0
184953,the,0,0
184954,patients,0,1
184955,allocated,0,1
184956,to,0,0
184957,ADT+RT,0,1
184958,(,0,0
184959,hazard,0,0
184960,ratio,0,0
184961,[,0,0
184962,HR,0,0
184963,],0,1
184964,",",0,0
184965,0.70,0,0
184966,;,0,0
184967,95,0,0
184968,%,0,0
184969,CI,0,0
184970,",",0,0
184971,0.57,0,0
184972,to,0,0
184973,0.85,0,0
184974,;,0,1
184975,P,0,0
184976,<,0,0
184977,.001,0,0
184978,),0,1
184979,.,0,1
184980,Deaths,0,0
184981,from,0,0
184982,prostate,0,1
184983,cancer,0,1
184984,were,0,0
184985,significantly,0,0
184986,reduced,0,0
184987,by,0,0
184988,the,0,0
184989,addition,0,0
184990,of,0,0
184991,RT,0,1
184992,to,0,0
184993,ADT,0,0
184994,(,0,0
184995,HR,0,0
184996,",",0,1
184997,0.46,0,0
184998,;,0,0
184999,95,0,0
185000,%,0,0
185001,CI,0,0
185002,",",0,0
185003,0.34,0,0
185004,to,0,0
185005,0.61,0,0
185006,;,0,1
185007,P,0,0
185008,<,0,0
185009,.001,0,0
185010,),0,1
185011,.,0,1
185012,Patients,0,1
185013,on,0,0
185014,ADT+RT,0,1
185015,reported,0,0
185016,a,0,0
185017,higher,0,0
185018,frequency,0,0
185019,of,0,0
185020,adverse,0,0
185021,events,0,0
185022,related,0,0
185023,to,0,0
185024,bowel,0,0
185025,toxicity,0,0
185026,",",0,0
185027,but,0,0
185028,only,0,0
185029,two,0,0
185030,of,0,0
185031,589,0,1
185032,patients,0,1
185033,had,0,1
185034,grade,0,1
185035,3,0,0
185036,or,0,1
185037,greater,0,0
185038,diarrhea,0,1
185039,at,0,0
185040,24,0,0
185041,months,0,0
185042,after,0,1
185043,RT,0,1
185044,.,0,1
185045,CONCLUSION,0,0
185046,This,0,0
185047,analysis,0,0
185048,demonstrates,0,0
185049,that,0,0
185050,the,0,0
185051,previously,0,0
185052,reported,0,0
185053,benefit,0,0
185054,in,0,0
185055,survival,0,0
185056,is,0,0
185057,maintained,0,0
185058,at,0,0
185059,a,0,0
185060,median,0,0
185061,follow-up,0,0
185062,of,0,0
185063,8,0,0
185064,years,0,1
185065,and,0,0
185066,firmly,0,0
185067,establishes,0,0
185068,the,0,0
185069,role,0,0
185070,of,0,0
185071,RT,0,1
185072,in,0,0
185073,the,0,0
185074,treatment,0,0
185075,of,0,0
185076,men,1,1
185077,with,1,1
185078,locally,1,1
185079,advanced,1,1
185080,prostate,1,1
185081,cancer,1,1
185082,.,1,1
185083,Mask,0,0
185084,ventilation,0,0
185085,with,0,1
185086,two,0,0
185087,different,0,0
185088,face,0,1
185089,masks,0,0
185090,in,0,0
185091,the,0,0
185092,delivery,0,0
185093,room,0,0
185094,for,0,0
185095,preterm,1,1
185096,infants,1,1
185097,:,1,1
185098,a,0,0
185099,randomized,0,0
185100,controlled,0,0
185101,trial,0,0
185102,.,0,0
185103,BACKGROUND,0,0
185104,If,0,0
185105,an,0,0
185106,infant,1,0
185107,fails,1,0
185108,to,1,0
185109,initiate,1,0
185110,spontaneous,1,0
185111,breathing,1,0
185112,after,1,0
185113,birth,1,1
185114,",",0,0
185115,international,0,1
185116,guidelines,0,0
185117,recommend,0,0
185118,a,0,0
185119,positive,0,0
185120,pressure,0,0
185121,ventilation,0,0
185122,(,0,0
185123,PPV,0,1
185124,),0,0
185125,.,0,0
185126,However,0,0
185127,",",0,0
185128,PPV,0,0
185129,by,0,0
185130,face,0,0
185131,mask,0,0
185132,is,0,0
185133,frequently,0,0
185134,inadequate,0,0
185135,because,0,0
185136,of,0,0
185137,leak,0,0
185138,between,0,0
185139,the,0,0
185140,face,0,0
185141,and,0,0
185142,mask,0,0
185143,.,0,0
185144,Despite,0,0
185145,a,0,0
185146,variety,0,0
185147,of,0,0
185148,available,0,0
185149,face,0,1
185150,masks,0,0
185151,",",0,0
185152,none,0,0
185153,have,0,0
185154,been,0,0
185155,prospectively,0,0
185156,compared,0,0
185157,in,0,0
185158,a,0,0
185159,randomized,0,0
185160,fashion,0,0
185161,.,0,1
185162,We,0,0
185163,aimed,0,0
185164,to,0,0
185165,evaluate,0,0
185166,and,0,0
185167,compare,0,0
185168,leak,0,0
185169,between,0,0
185170,two,0,0
185171,commercially,0,0
185172,available,0,0
185173,round,0,0
185174,face,0,1
185175,masks,0,0
185176,(,0,0
185177,Fisher,0,1
185178,&,0,1
185179,Paykel,0,1
185180,(,0,0
185181,F,0,1
185182,&,0,1
185183,P,0,0
185184,),0,0
185185,and,0,0
185186,Laerdal,0,1
185187,),0,0
185188,in,0,0
185189,preterm,1,1
185190,infants,1,1
185191,<,1,0
185192,33,1,1
185193,weeks,1,0
185194,gestational,1,1
185195,age,1,1
185196,in,1,0
185197,the,1,0
185198,delivery,1,0
185199,room,1,0
185200,.,1,1
185201,METHODS,0,0
185202,Infants,1,1
185203,born,1,1
185204,at,1,1
185205,the,1,0
185206,Royal,1,1
185207,Alexandra,1,1
185208,Hospital,1,1
185209,from,1,1
185210,April,1,0
185211,to,1,1
185212,September,1,1
185213,2013,1,1
185214,at,1,0
185215,<,1,0
185216,33,1,1
185217,weeks,1,0
185218,gestational,1,1
185219,age,1,1
185220,who,1,1
185221,received,1,1
185222,mask,1,1
185223,PPV,1,1
185224,in,1,0
185225,the,1,0
185226,delivery,1,0
185227,room,1,0
185228,routinely,0,0
185229,had,0,0
185230,a,0,0
185231,flow,0,0
185232,sensor,0,0
185233,placed,0,0
185234,between,0,0
185235,the,0,0
185236,mask,0,0
185237,and,0,0
185238,T-piece,0,1
185239,resuscitator,0,0
185240,.,0,1
185241,Infants,0,1
185242,were,0,0
185243,randomly,0,1
185244,assigned,0,0
185245,to,0,0
185246,receive,0,0
185247,PPV,0,0
185248,with,0,1
185249,either,0,0
185250,a,0,0
185251,F,0,0
185252,&,0,1
185253,P,0,0
185254,or,0,1
185255,Laerdal,0,1
185256,face,0,0
185257,mask,0,0
185258,.,0,0
185259,All,0,0
185260,resuscitators,0,0
185261,were,0,0
185262,trained,0,1
185263,in,0,0
185264,the,0,0
185265,use,0,0
185266,of,0,0
185267,both,0,0
185268,face,0,1
185269,masks,0,0
185270,.,0,1
185271,We,0,0
185272,compared,0,0
185273,mask,0,0
185274,leak,0,0
185275,",",0,0
185276,airway,0,1
185277,pressures,0,0
185278,",",0,0
185279,tidal,0,1
185280,volume,0,0
185281,and,0,0
185282,ventilation,0,0
185283,rate,0,0
185284,between,0,0
185285,the,0,0
185286,two,0,0
185287,groups,0,0
185288,.,0,1
185289,RESULTS,0,0
185290,Fifty-six,1,1
185291,preterm,1,1
185292,infants,1,1
185293,(,1,0
185294,n=28,1,1
185295,in,1,0
185296,each,1,0
185297,group,1,0
185298,),1,0
185299,were,1,0
185300,enrolled,1,1
185301,;,1,0
185302,mean?s.d,1,0
185303,.,1,0
185304,gestational,1,1
185305,age,1,1
185306,28?3,1,1
185307,weeks,1,0
185308,;,1,1
185309,birth,1,1
185310,weight,1,0
185311,1210?448,1,0
185312,g,1,1
185313,;,1,0
185314,and,1,0
185315,30,1,1
185316,(,1,0
185317,52,1,1
185318,%,1,0
185319,),1,0
185320,were,1,0
185321,male,1,1
185322,.,1,1
185323,Apgar,1,0
185324,scores,0,0
185325,at,0,1
185326,1,0,1
185327,and,0,1
185328,5,0,1
185329,min,0,0
185330,were,0,1
185331,5?3,0,0
185332,and,0,0
185333,7?2,0,0
185334,",",0,0
185335,respectively,0,0
185336,.,0,0
185337,Infants,0,1
185338,randomized,0,0
185339,to,0,0
185340,the,0,0
185341,F,0,0
185342,&,0,1
185343,P,0,0
185344,face,0,0
185345,mask,0,0
185346,and,0,0
185347,Laerdal,0,1
185348,face,0,0
185349,mask,0,0
185350,had,0,0
185351,similar,0,0
185352,mask,0,0
185353,leak,0,0
185354,(,0,0
185355,30,0,0
185356,(,0,0
185357,25-38,0,1
185358,),0,1
185359,versus,0,0
185360,35,0,1
185361,(,0,0
185362,24-46,0,1
185363,),0,0
185364,%,0,0
185365,",",0,0
185366,median,0,0
185367,(,0,0
185368,interquartile,0,0
185369,range,0,1
185370,),0,0
185371,",",0,0
185372,respectively,0,0
185373,",",0,0
185374,P=0.40,0,0
185375,),0,0
185376,and,0,0
185377,tidal,0,1
185378,volume,0,0
185379,(,0,0
185380,7.1,0,0
185381,(,0,0
185382,4.9-8.9,0,0
185383,),0,1
185384,versus,0,0
185385,6.6,0,0
185386,(,0,0
185387,5.2-8.9,0,0
185388,),0,0
185389,ml,0,0
185390,kg,0,0
185391,(,0,0
185392,-1,0,0
185393,),0,0
185394,",",0,0
185395,P=0.69,0,0
185396,),0,0
185397,during,0,0
185398,PPV,0,1
185399,.,0,0
185400,There,0,0
185401,were,0,0
185402,no,0,0
185403,significant,0,0
185404,differences,0,0
185405,in,0,0
185406,ventilation,0,0
185407,rate,0,0
185408,",",0,0
185409,inflation,0,0
185410,time,0,0
185411,or,0,1
185412,airway,0,1
185413,pressures,0,0
185414,between,0,0
185415,groups,0,1
185416,.,0,1
185417,CONCLUSION,0,0
185418,The,0,0
185419,use,0,0
185420,of,0,0
185421,either,0,0
185422,face,0,0
185423,mask,0,0
185424,during,0,0
185425,PPV,0,1
185426,in,0,0
185427,the,0,0
185428,delivery,0,0
185429,room,0,0
185430,yields,0,0
185431,similar,0,0
185432,mask,0,0
185433,leak,0,0
185434,in,0,0
185435,preterm,1,1
185436,infants,1,1
185437,<,1,0
185438,33,1,1
185439,weeks,1,0
185440,gestational,1,1
185441,age,1,1
185442,.,1,1
185443,Enhancing,0,0
185444,the,0,0
185445,experience,1,0
185446,of,1,0
185447,carers,1,1
185448,in,1,0
185449,the,1,0
185450,chemotherapy,1,0
185451,outpatient,1,1
185452,setting,1,1
185453,:,1,1
185454,an,0,0
185455,exploratory,0,0
185456,randomised,0,0
185457,controlled,0,0
185458,trial,0,0
185459,to,0,0
185460,test,0,0
185461,impact,0,0
185462,",",0,0
185463,acceptability,0,0
185464,and,0,0
185465,feasibility,0,0
185466,of,0,0
185467,a,0,0
185468,complex,0,0
185469,intervention,0,0
185470,co-designed,0,0
185471,by,0,0
185472,carers,1,1
185473,and,1,1
185474,staff,1,1
185475,.,1,0
185476,PURPOSE,0,0
185477,Supporting,0,0
185478,someone,0,1
185479,through,0,0
185480,chemotherapy,0,0
185481,can,0,0
185482,be,0,0
185483,emotionally,0,0
185484,and,0,0
185485,physically,0,0
185486,demanding,0,0
185487,.,0,0
185488,However,0,0
185489,",",0,0
185490,research,0,0
185491,has,0,0
185492,yet,0,0
185493,to,0,0
185494,establish,0,0
185495,the,0,0
185496,type,0,0
185497,of,0,0
185498,support,0,0
185499,carers,0,1
185500,require,0,0
185501,or,0,0
185502,the,0,0
185503,best,0,0
185504,way,0,0
185505,to,0,0
185506,provide,0,0
185507,this,0,0
185508,.,0,0
185509,This,0,0
185510,study,0,0
185511,tested,0,0
185512,the,0,0
185513,feasibility,0,0
185514,and,0,0
185515,acceptability,0,0
185516,of,0,0
185517,a,0,0
185518,complex,0,0
185519,intervention,0,0
185520,for,0,0
185521,carers,1,1
185522,that,1,0
185523,was,1,0
185524,co-designed,1,0
185525,by,1,0
185526,staff,1,1
185527,and,1,0
185528,carers,1,1
185529,of,1,0
185530,patients,1,1
185531,starting,1,1
185532,chemotherapy,1,1
185533,.,1,1
185534,METHODS,0,0
185535,Forty-seven,1,1
185536,carers,1,1
185537,were,1,0
185538,recruited,1,1
185539,",",1,0
185540,randomised,1,0
185541,between,1,0
185542,the,1,0
185543,intervention,1,0
185544,(,1,0
185545,n,1,1
185546,=,1,0
185547,24,1,1
185548,),1,0
185549,and,1,0
185550,control,1,0
185551,(,1,0
185552,n,1,1
185553,=,1,0
185554,23,1,1
185555,),1,1
185556,groups,1,0
185557,.,1,1
185558,A,0,0
185559,questionnaire,1,0
185560,was,0,0
185561,completed,0,1
185562,pre-,0,0
185563,and,0,0
185564,post-intervention,0,0
185565,measuring,0,0
185566,knowledge,0,0
185567,of,0,0
185568,chemotherapy,0,0
185569,and,0,0
185570,its,0,0
185571,side,0,0
185572,effects,0,0
185573,",",0,0
185574,experience,0,0
185575,of,0,0
185576,care,0,0
185577,",",0,0
185578,satisfaction,0,0
185579,with,0,1
185580,outpatient,0,1
185581,services,0,1
185582,",",0,0
185583,coping,0,0
185584,and,0,0
185585,emotional,0,0
185586,wellbeing,0,0
185587,.,0,0
185588,The,0,0
185589,intervention,1,0
185590,process,1,0
185591,was,0,0
185592,evaluated,0,0
185593,by,0,0
185594,carers,0,1
185595,and,0,1
185596,healthcare,0,1
185597,professionals,0,0
185598,(,0,1
185599,HCPs,0,0
185600,),0,0
185601,in,0,0
185602,focus,1,1
185603,groups,1,0
185604,.,1,1
185605,RESULTS,0,0
185606,Recruitment,0,0
185607,to,0,0
185608,the,0,0
185609,study,0,0
185610,was,0,0
185611,unproblematic,0,0
185612,and,0,0
185613,attrition,0,1
185614,from,0,0
185615,it,0,0
185616,was,0,0
185617,low,0,0
185618,",",0,0
185619,suggesting,0,0
185620,the,0,0
185621,intervention,0,0
185622,and,0,0
185623,study,0,1
185624,processes,0,0
185625,were,0,1
185626,acceptable,0,0
185627,to,0,0
185628,patients,0,1
185629,and,0,1
185630,carers,0,1
185631,.,0,1
185632,Carers,0,0
185633,in,0,0
185634,receipt,0,0
185635,of,0,0
185636,the,0,0
185637,'Take,0,0
185638,Care,0,0
185639,',0,1
185640,intervention,0,0
185641,reported,0,0
185642,statistically,0,0
185643,significantly,0,0
185644,better,0,0
185645,understanding,0,0
185646,of,0,0
185647,symptoms,0,0
185648,and,0,1
185649,side,0,0
185650,effects,0,0
185651,and,0,0
185652,their,0,0
185653,information,0,0
185654,needs,0,0
185655,being,0,0
185656,more,0,0
185657,frequently,0,0
185658,met,0,0
185659,than,0,0
185660,carers,0,1
185661,in,0,0
185662,the,0,0
185663,control,0,0
185664,.,0,0
185665,Confidence,0,0
185666,in,0,0
185667,coping,0,0
185668,improved,0,0
185669,between,0,0
185670,baseline,0,0
185671,and,0,0
185672,follow-up,0,0
185673,for,0,0
185674,the,0,0
185675,intervention,0,0
185676,group,0,0
185677,and,0,0
185678,declined,0,0
185679,for,0,0
185680,the,0,0
185681,control,0,0
185682,although,0,0
185683,differences,0,0
185684,were,0,1
185685,insufficient,0,0
185686,to,0,0
185687,achieve,0,0
185688,statistical,0,0
185689,significance,0,0
185690,.,0,0
185691,There,0,0
185692,was,0,0
185693,no,0,0
185694,significant,0,0
185695,difference,0,0
185696,between,0,0
185697,the,0,0
185698,two,0,0
185699,groups,0,0
185700,',0,1
185701,emotional,0,0
185702,wellbeing,0,0
185703,.,0,1
185704,HCP,0,0
185705,and,0,0
185706,carer,0,0
185707,focus,0,1
185708,groups,0,0
185709,confirmed,0,0
185710,the,0,0
185711,feasibility,0,0
185712,and,0,0
185713,acceptability,0,0
185714,of,0,0
185715,the,0,0
185716,intervention,0,0
185717,.,0,0
185718,CONCLUSIONS,0,0
185719,The,0,0
185720,'Take,0,0
185721,Care,0,0
185722,',0,1
185723,intervention,0,0
185724,proved,0,0
185725,acceptable,0,0
185726,to,0,0
185727,carers,1,1
185728,and,1,0
185729,HCPs,1,0
185730,and,0,0
185731,demonstrates,0,0
185732,considerable,0,0
185733,promise,0,0
185734,and,0,0
185735,utility,0,0
185736,in,0,0
185737,practice,0,0
185738,.,0,1
185739,Study,0,0
185740,findings,0,0
185741,support,0,0
185742,the,0,0
185743,conduct,0,0
185744,of,0,0
185745,a,0,0
185746,fully,0,0
185747,powered,0,0
185748,RCT,0,0
185749,to,0,0
185750,determine,0,0
185751,the,0,0
185752,intervention,0,0
185753,'s,0,0
185754,effectiveness,0,0
185755,and,0,1
185756,cost-effectiveness,0,0
185757,.,0,1
185758,A,0,0
185759,possible,0,0
185760,link,0,0
185761,between,0,0
185762,early,0,1
185763,probiotic,0,0
185764,intervention,0,0
185765,and,0,0
185766,the,0,0
185767,risk,0,0
185768,of,0,0
185769,neuropsychiatric,1,1
185770,disorders,1,1
185771,later,1,1
185772,in,1,0
185773,childhood,1,1
185774,:,1,1
185775,a,0,0
185776,randomized,0,0
185777,trial,0,0
185778,.,0,1
185779,BACKGROUND,0,0
185780,Recent,0,1
185781,experimental,0,0
185782,evidence,0,0
185783,suggests,0,0
185784,that,0,0
185785,gut,0,0
185786,microbiota,0,0
185787,may,0,0
185788,alter,0,0
185789,function,0,0
185790,within,0,0
185791,the,0,0
185792,nervous,0,0
185793,system,0,0
185794,providing,0,0
185795,new,0,0
185796,insight,0,0
185797,on,0,0
185798,the,0,0
185799,mechanism,0,0
185800,of,0,0
185801,neuropsychiatric,0,1
185802,disorders,0,1
185803,.,0,1
185804,METHODS,0,0
185805,Seventy-five,1,1
185806,infants,1,1
185807,who,1,1
185808,were,1,1
185809,randomized,1,1
185810,to,1,0
185811,receive,1,0
185812,Lactobacillus,1,0
185813,rhamnosus,1,0
185814,GG,1,0
185815,(,1,0
185816,ATCC,1,0
185817,53103,1,0
185818,),1,0
185819,or,1,0
185820,placebo,1,0
185821,during,1,0
185822,the,1,0
185823,first,1,0
185824,6,1,0
185825,mo,1,1
185826,of,1,0
185827,life,1,0
185828,were,1,0
185829,followed-up,1,1
185830,for,1,0
185831,13,1,1
185832,y,1,1
185833,.,1,1
185834,Gut,0,0
185835,microbiota,0,0
185836,was,0,0
185837,assessed,0,0
185838,at,0,0
185839,the,0,0
185840,age,0,1
185841,of,0,0
185842,3,0,0
185843,wk,0,1
185844,",",0,0
185845,3,0,0
185846,",",0,0
185847,6,0,0
185848,",",0,0
185849,12,0,0
185850,",",0,0
185851,18,0,1
185852,",",0,0
185853,24,0,0
185854,mo,0,0
185855,",",0,0
185856,and,0,0
185857,13,0,1
185858,y,0,1
185859,using,0,0
185860,fluorescein,0,0
185861,in,0,0
185862,situ,0,0
185863,hybridization,0,0
185864,(,0,0
185865,FISH,0,0
185866,),0,0
185867,and,0,0
185868,qPCR,0,1
185869,",",0,0
185870,and,0,0
185871,indirectly,0,0
185872,by,0,0
185873,determining,0,0
185874,the,0,0
185875,blood,0,0
185876,group,0,0
185877,secretor,0,0
185878,type,0,1
185879,at,0,0
185880,the,0,0
185881,age,0,1
185882,of,0,0
185883,13,0,1
185884,y,0,1
185885,.,0,1
185886,The,0,0
185887,diagnoses,0,1
185888,of,0,0
185889,attention,0,0
185890,deficit,0,0
185891,hyperactivity,0,1
185892,disorder,0,1
185893,(,0,0
185894,ADHD,0,0
185895,),0,0
185896,and,0,0
185897,Asperger,0,1
185898,syndrome,0,1
185899,(,0,0
185900,AS,0,1
185901,),0,0
185902,by,0,0
185903,a,0,0
185904,child,0,0
185905,neurologist,0,1
185906,or,0,1
185907,psychiatrist,0,0
185908,were,0,0
185909,based,0,0
185910,on,0,0
185911,ICD-10,0,0
185912,diagnostic,0,1
185913,criteria,0,1
185914,.,0,1
185915,RESULTS,0,0
185916,At,0,0
185917,the,0,0
185918,age,0,1
185919,of,0,0
185920,13,0,1
185921,y,0,1
185922,",",0,0
185923,ADHD,0,0
185924,or,0,1
185925,AS,0,1
185926,was,0,0
185927,diagnosed,0,1
185928,in,0,0
185929,6/35,0,1
185930,(,0,1
185931,17.1,0,0
185932,%,0,0
185933,),0,0
185934,children,0,1
185935,in,0,0
185936,the,0,0
185937,placebo,0,0
185938,and,0,0
185939,none,0,0
185940,in,0,0
185941,the,0,0
185942,probiotic,0,0
185943,group,0,0
185944,(,0,0
185945,P,0,0
185946,=,0,0
185947,0.008,0,0
185948,),0,0
185949,.,0,0
185950,The,0,0
185951,mean,0,0
185952,(,0,0
185953,SD,0,0
185954,),0,1
185955,numbers,0,0
185956,of,0,1
185957,Bifidobacterium,0,0
185958,species,0,0
185959,bacteria,0,0
185960,in,0,0
185961,feces,0,0
185962,during,0,0
185963,the,0,0
185964,first,0,0
185965,6,0,0
185966,mo,0,1
185967,of,0,0
185968,life,0,0
185969,was,0,0
185970,lower,0,0
185971,in,0,0
185972,affected,0,0
185973,children,0,1
185974,8.26,0,0
185975,(,0,1
185976,1.24,0,0
185977,),0,0
185978,log,0,0
185979,cells/g,0,0
185980,than,0,0
185981,in,0,0
185982,healthy,0,1
185983,children,0,1
185984,9.12,0,0
185985,(,0,1
185986,0.64,0,0
185987,),0,0
185988,log,0,0
185989,cells/g,0,0
185990,;,0,0
185991,P,0,0
185992,=,0,0
185993,0.03,0,0
185994,.,0,1
185995,CONCLUSION,0,0
185996,Probiotic,0,0
185997,supplementation,0,0
185998,early,0,0
185999,in,0,0
186000,life,0,0
186001,may,0,0
186002,reduce,0,0
186003,the,0,0
186004,risk,0,0
186005,of,0,0
186006,neuropsychiatric,0,1
186007,disorder,0,1
186008,development,1,0
186009,later,1,0
186010,in,1,0
186011,childhood,1,1
186012,possible,1,0
186013,by,0,0
186014,mechanisms,0,0
186015,not,0,0
186016,limited,0,0
186017,to,0,0
186018,gut,0,0
186019,microbiota,0,0
186020,composition,0,1
186021,.,0,1
186022,Initial,0,0
186023,abstinence,0,0
186024,status,0,0
186025,and,0,0
186026,contingency,0,0
186027,management,0,0
186028,treatment,0,0
186029,outcomes,0,0
186030,:,0,1
186031,does,0,0
186032,race,0,0
186033,matter,0,0
186034,?,0,0
186035,OBJECTIVE,0,0
186036,Limited,0,0
186037,research,0,0
186038,has,0,0
186039,evaluated,0,0
186040,African,1,1
186041,American,1,1
186042,substance,1,1
186043,users,1,1
186044,',1,1
186045,response,0,0
186046,to,0,1
186047,evidence-based,0,0
186048,treatments,0,0
186049,.,0,1
186050,This,0,0
186051,study,0,0
186052,examined,0,0
186053,the,0,0
186054,efficacy,0,0
186055,of,0,0
186056,contingency,0,0
186057,management,0,0
186058,(,0,0
186059,CM,0,0
186060,),0,0
186061,in,0,0
186062,African,1,1
186063,American,1,1
186064,and,1,0
186065,White,1,0
186066,cocaine,1,1
186067,users,1,1
186068,.,1,0
186069,METHOD,0,0
186070,A,0,0
186071,secondary,0,0
186072,analysis,0,0
186073,evaluated,0,0
186074,effects,0,0
186075,of,0,0
186076,race,0,0
186077,",",0,0
186078,treatment,0,0
186079,condition,0,0
186080,",",0,0
186081,and,0,0
186082,baseline,0,0
186083,cocaine,0,0
186084,urine,0,0
186085,sample,0,1
186086,results,0,0
186087,on,0,0
186088,treatment,0,0
186089,outcomes,0,0
186090,of,0,0
186091,African,1,1
186092,American,1,1
186093,(,1,1
186094,n,1,1
186095,=,1,0
186096,444,1,1
186097,),1,0
186098,and,1,0
186099,White,1,0
186100,(,1,0
186101,n,1,1
186102,=,1,0
186103,403,1,1
186104,),1,0
186105,cocaine,1,1
186106,abusers,1,1
186107,participating,1,1
186108,in,1,0
186109,one,1,1
186110,of,1,0
186111,six,1,1
186112,randomized,1,1
186113,clinical,1,0
186114,trials,1,1
186115,comparing,1,0
186116,CM,1,1
186117,to,1,0
186118,standard,1,0
186119,care,1,1
186120,.,1,0
186121,RESULTS,0,0
186122,African,1,1
186123,American,1,1
186124,and,1,1
186125,White,1,1
186126,patients,1,1
186127,who,1,1
186128,initiated,1,1
186129,treatment,1,1
186130,with,1,1
186131,a,1,0
186132,cocaine-negative,1,1
186133,urine,1,0
186134,sample,1,1
186135,remained,0,0
186136,in,0,0
186137,treatment,0,0
186138,for,0,0
186139,similar,0,0
186140,durations,0,0
186141,and,0,0
186142,submitted,0,0
186143,a,0,0
186144,comparable,0,0
186145,proportion,0,0
186146,of,0,0
186147,negative,0,0
186148,samples,0,0
186149,during,0,0
186150,treatment,0,0
186151,regardless,0,0
186152,of,0,0
186153,treatment,0,0
186154,type,0,1
186155,;,0,0
186156,CM,0,0
186157,was,0,0
186158,efficacious,0,0
186159,in,0,0
186160,both,0,0
186161,races,0,0
186162,in,0,0
186163,terms,0,0
186164,of,0,0
186165,engendering,0,0
186166,longer,0,0
186167,durations,0,0
186168,of,0,0
186169,abstinence,0,1
186170,in,0,1
186171,patients,0,1
186172,who,0,1
186173,began,0,1
186174,treatment,0,1
186175,abstinent,0,1
186176,.,0,1
186177,Whites,1,1
186178,who,1,1
186179,began,1,1
186180,treatment,1,1
186181,with,1,1
186182,a,1,0
186183,cocaine,1,0
186184,positive,1,0
186185,sample,1,1
186186,remained,0,0
186187,in,0,0
186188,treatment,0,0
186189,longer,0,0
186190,and,0,0
186191,submitted,0,0
186192,a,0,0
186193,higher,0,0
186194,proportion,0,0
186195,of,0,0
186196,negative,0,0
186197,samples,0,0
186198,when,0,0
186199,assigned,0,1
186200,to,0,0
186201,CM,0,0
186202,than,0,0
186203,standard,0,0
186204,care,0,1
186205,.,0,1
186206,African,1,1
186207,Americans,1,1
186208,who,1,1
186209,initiated,1,1
186210,treatment,1,1
186211,with,1,1
186212,a,1,0
186213,cocaine,1,0
186214,positive,1,0
186215,sample,1,1
186216,",",0,0
186217,however,0,0
186218,",",0,0
186219,did,0,0
186220,not,0,0
186221,remain,0,0
186222,in,0,0
186223,treatment,0,0
186224,longer,0,0
186225,with,0,1
186226,CM,0,0
186227,compared,0,0
186228,with,0,1
186229,standard,0,0
186230,care,0,1
186231,",",0,0
186232,and,0,0
186233,gains,0,0
186234,in,0,0
186235,terms,0,0
186236,of,0,0
186237,drug,0,0
186238,use,0,0
186239,outcomes,0,0
186240,were,0,0
186241,muted,0,0
186242,in,0,0
186243,nature,0,0
186244,relative,0,0
186245,to,0,0
186246,Whites,0,1
186247,.,0,0
186248,This,0,0
186249,interaction,0,0
186250,effect,0,0
186251,persisted,0,0
186252,through,0,0
186253,the,0,0
186254,9-month,0,0
186255,follow-up,0,0
186256,period,0,1
186257,.,0,1
186258,CONCLUSIONS,0,0
186259,CM,0,0
186260,is,0,0
186261,not,0,0
186262,equally,0,0
186263,effective,0,0
186264,in,0,0
186265,reducing,0,0
186266,drug,0,0
186267,use,0,0
186268,among,0,0
186269,all,0,0
186270,subgroups,0,0
186271,",",0,0
186272,specifically,0,0
186273,African,1,1
186274,American,1,1
186275,patients,1,1
186276,who,1,1
186277,are,1,1
186278,using,1,1
186279,cocaine,1,0
186280,upon,1,0
186281,treatment,1,0
186282,entry,1,1
186283,.,1,0
186284,Future,0,0
186285,research,0,0
186286,on,0,0
186287,improving,0,0
186288,treatment,0,0
186289,outcomes,0,0
186290,in,0,0
186291,this,0,0
186292,population,0,1
186293,is,0,0
186294,needed,0,0
186295,.,0,0
186296,The,0,0
186297,Effects,0,0
186298,of,0,0
186299,Naltrexone,0,1
186300,on,0,0
186301,Subjective,0,0
186302,Response,0,0
186303,to,0,0
186304,Methamphetamine,0,1
186305,in,0,0
186306,a,0,0
186307,Clinical,1,0
186308,Sample,1,1
186309,:,1,1
186310,a,0,0
186311,Double-Blind,0,0
186312,",",0,0
186313,Placebo-Controlled,0,0
186314,Laboratory,0,1
186315,Study,0,0
186316,.,0,1
186317,Methamphetamine,1,0
186318,(,1,0
186319,MA,1,0
186320,),1,0
186321,use,1,0
186322,disorder,1,1
186323,is,0,0
186324,a,0,0
186325,serious,0,0
186326,psychiatric,0,1
186327,condition,0,0
186328,for,0,0
186329,which,0,0
186330,there,0,0
186331,are,0,0
186332,no,0,0
186333,FDA-approved,0,0
186334,medications,0,0
186335,.,0,1
186336,Naltrexone,0,0
186337,(,0,0
186338,NTX,0,0
186339,),0,0
186340,is,0,0
186341,an,0,0
186342,opioid,0,0
186343,receptor,0,0
186344,antagonist,0,0
186345,with,0,1
186346,demonstrated,0,0
186347,efficacy,0,0
186348,",",0,0
186349,albeit,0,0
186350,moderate,0,1
186351,",",0,0
186352,for,0,0
186353,the,0,0
186354,treatment,0,0
186355,of,0,0
186356,alcoholism,0,1
186357,and,0,0
186358,opioid,0,1
186359,dependence,0,0
186360,.,0,1
186361,Preclinical,0,0
186362,and,0,0
186363,clinical,0,0
186364,studies,0,0
186365,suggest,0,0
186366,that,0,0
186367,NTX,0,0
186368,may,0,0
186369,be,0,0
186370,useful,0,0
186371,for,0,0
186372,the,0,0
186373,treatment,0,0
186374,of,0,0
186375,MA,0,0
186376,use,0,0
186377,disorder,0,1
186378,.,0,0
186379,To,0,0
186380,inform,0,0
186381,treatment,0,0
186382,development,0,0
186383,",",0,0
186384,we,0,0
186385,conducted,0,0
186386,a,0,0
186387,double-blind,0,0
186388,",",0,0
186389,randomized,0,0
186390,",",0,0
186391,crossover,0,0
186392,",",0,0
186393,placebo-controlled,0,0
186394,human,0,1
186395,laboratory,0,0
186396,study,0,0
186397,of,0,0
186398,NTX,0,1
186399,.,0,1
186400,Non-treatment-seeking,1,0
186401,individuals,1,1
186402,meeting,1,1
186403,DSM-IV,1,1
186404,criteria,1,1
186405,for,1,0
186406,MA,1,0
186407,abuse,1,1
186408,or,1,0
186409,dependence,1,0
186410,(,1,0
186411,n=30,1,1
186412,),1,0
186413,completed,1,1
186414,two,1,0
186415,separate,1,0
186416,5-day,1,0
186417,inpatient,1,1
186418,stays,1,0
186419,.,1,1
186420,During,0,0
186421,each,0,0
186422,admission,0,0
186423,",",0,0
186424,participants,0,1
186425,completed,0,1
186426,testing,0,0
186427,sessions,0,0
186428,comprised,0,1
186429,of,0,0
186430,MA,0,0
186431,cue-reactivity,0,0
186432,and,0,0
186433,intravenous,0,0
186434,MA,0,0
186435,administration,0,0
186436,(,0,0
186437,30,0,0
186438,mg,0,0
186439,),0,0
186440,after,0,0
186441,receiving,0,1
186442,oral,0,0
186443,NTX,0,1
186444,(,0,1
186445,50,0,1
186446,mg,0,0
186447,),0,0
186448,or,0,0
186449,placebo,0,0
186450,for,0,0
186451,4,0,0
186452,days,0,0
186453,.,0,1
186454,This,0,0
186455,study,0,0
186456,tested,0,0
186457,the,0,0
186458,hypotheses,0,0
186459,that,0,0
186460,NTX,0,0
186461,would,0,0
186462,(,0,0
186463,a,0,0
186464,),0,0
186465,attenuate,0,0
186466,cue-induced,0,0
186467,MA,0,0
186468,craving,0,0
186469,",",0,0
186470,and,0,0
186471,(,0,0
186472,b,0,0
186473,),0,0
186474,reduce,0,0
186475,subjective,0,0
186476,responses,0,0
186477,to,0,1
186478,MA,0,0
186479,administration,0,0
186480,.,0,0
186481,Results,0,0
186482,largely,0,0
186483,supported,0,0
186484,the,0,0
186485,study,0,0
186486,hypotheses,0,0
186487,such,0,0
186488,that,0,0
186489,(,0,0
186490,a,0,0
186491,),0,0
186492,NTX,0,0
186493,significantly,0,0
186494,blunted,0,0
186495,cue-induced,0,0
186496,craving,0,0
186497,for,0,0
186498,MA,0,0
186499,and,0,0
186500,(,0,0
186501,b,0,1
186502,),0,0
186503,attenuated,0,0
186504,several,0,0
186505,of,0,0
186506,the,0,0
186507,hedonic,0,0
186508,subjective,0,0
186509,effects,0,0
186510,of,0,0
186511,MA,0,0
186512,",",0,0
186513,including,0,0
186514,craving,0,0
186515,",",0,0
186516,during,0,0
186517,controlled,0,0
186518,MA,0,0
186519,administration,0,0
186520,and,0,0
186521,as,0,0
186522,compared,0,0
186523,with,0,1
186524,placebo,0,0
186525,.,0,1
186526,NTX,0,0
186527,decreased,0,0
186528,overall,0,0
186529,subjective,0,0
186530,ratings,0,0
186531,of,0,0
186532,'crave,0,0
186533,drug,0,0
186534,",",0,0
186535,',0,0
186536,'stimulated,0,0
186537,",",0,0
186538,',0,0
186539,and,0,0
186540,'would,0,0
186541,like,0,0
186542,drug,0,0
186543,access,0,0
186544,",",0,0
186545,',0,0
186546,decreased,0,0
186547,the,0,0
186548,the,0,0
186549,post-MA,0,0
186550,administration,0,0
186551,timecourse,0,0
186552,of,0,0
186553,'anxious,0,1
186554,',0,1
186555,and,0,0
186556,increased,0,0
186557,ratings,0,0
186558,of,0,0
186559,'bad,0,1
186560,drug,0,0
186561,effects,0,0
186562,",",0,0
186563,',0,1
186564,as,0,0
186565,compared,0,0
186566,with,0,1
186567,placebo,0,0
186568,.,0,0
186569,These,0,0
186570,findings,0,0
186571,support,0,0
186572,a,0,0
186573,potential,0,0
186574,mechanism,0,0
186575,of,0,0
186576,action,0,0
186577,by,0,0
186578,showing,0,0
186579,that,0,0
186580,NTX,0,1
186581,reduced,0,0
186582,cue-induced,0,0
186583,craving,0,0
186584,and,0,0
186585,subjective,0,0
186586,responses,0,0
186587,to,0,1
186588,MA,0,0
186589,.,0,0
186590,This,0,0
186591,is,0,0
186592,consistent,0,0
186593,with,0,1
186594,positive,0,0
186595,treatment,0,0
186596,studies,0,0
186597,of,0,0
186598,NTX,0,1
186599,for,0,0
186600,amphetamine,0,0
186601,dependence,0,0
186602,",",0,0
186603,as,0,0
186604,well,0,0
186605,as,0,0
186606,ongoing,0,0
186607,clinical,0,0
186608,trials,0,1
186609,for,0,1
186610,MA,0,0
186611,.,0,1
186612,Femoral,0,1
186613,neck,0,1
186614,osteotomy,0,0
186615,guide,0,0
186616,for,0,0
186617,total,1,1
186618,hip,1,1
186619,arthroplasty,1,1
186620,.,1,1
186621,BACKGROUND,0,0
186622,Total,0,0
186623,hip,0,1
186624,arthroplasty,0,1
186625,(,0,0
186626,THA,0,0
186627,),0,0
186628,is,0,0
186629,a,0,0
186630,common,0,0
186631,last-resort,0,0
186632,treatment,0,0
186633,for,0,0
186634,hip,0,1
186635,disease,0,1
186636,",",0,0
186637,but,0,0
186638,postoperative,1,0
186639,patients,1,1
186640,often,0,0
186641,complain,0,1
186642,of,0,0
186643,discrepancies,0,0
186644,in,0,0
186645,leg,0,1
186646,length,0,0
186647,.,0,0
186648,This,0,0
186649,study,0,0
186650,introduces,0,0
186651,a,0,0
186652,device,0,0
186653,designed,0,0
186654,to,0,0
186655,increase,0,0
186656,the,0,0
186657,precision,0,0
186658,of,0,0
186659,the,0,0
186660,femoral,0,1
186661,neck,0,1
186662,osteotomy,0,1
186663,and,0,0
186664,reduce,0,0
186665,the,0,0
186666,incidence,0,0
186667,of,0,0
186668,leg,0,0
186669,length,0,0
186670,discrepancy,0,0
186671,.,0,0
186672,METHODS,0,0
186673,Forty-eight,1,1
186674,patients,1,1
186675,undergoing,1,1
186676,THA,1,0
186677,were,0,0
186678,divided,0,1
186679,into,0,1
186680,two,0,0
186681,groups,0,0
186682,",",0,0
186683,with,0,1
186684,and,0,0
186685,without,0,1
186686,the,0,0
186687,use,0,0
186688,of,0,0
186689,the,0,0
186690,femoral,0,1
186691,osteotomy,0,1
186692,guide,0,0
186693,.,0,0
186694,All,0,0
186695,operations,0,0
186696,were,0,0
186697,performed,0,0
186698,through,0,0
186699,a,0,0
186700,posterolateral,0,1
186701,approach,0,0
186702,.,0,1
186703,Differences,0,0
186704,in,0,0
186705,leg,0,0
186706,length,0,0
186707,were,0,0
186708,recorded,0,0
186709,before,0,0
186710,and,0,0
186711,after,0,0
186712,the,0,0
186713,operation,0,0
186714,.,0,0
186715,Measurements,0,0
186716,were,0,0
186717,also,0,0
186718,made,0,0
186719,to,0,0
186720,compare,0,0
186721,the,0,0
186722,preoperative,0,0
186723,plan,0,0
186724,with,0,1
186725,the,0,0
186726,actual,0,0
186727,amount,0,0
186728,of,0,0
186729,bone,0,0
186730,removed,0,0
186731,.,0,0
186732,RESULTS,0,0
186733,The,0,0
186734,mean,0,0
186735,average,0,0
186736,difference,0,0
186737,in,0,0
186738,femoral,0,1
186739,neck,0,1
186740,resection,0,1
186741,height,0,0
186742,was,0,0
186743,0.84,0,0
186744,mm,0,0
186745,when,0,0
186746,using,0,0
186747,the,0,0
186748,osteotomy,0,0
186749,guide,0,0
186750,and,0,0
186751,1.69,0,0
186752,mm,0,0
186753,without,0,1
186754,the,0,0
186755,guide,0,0
186756,.,0,0
186757,Discrepancies,0,0
186758,in,0,0
186759,postoperative,0,0
186760,leg,0,0
186761,length,0,0
186762,were,0,0
186763,5.45,0,0
186764,mm,0,0
186765,and,0,1
186766,13.37,0,0
186767,mm,0,0
186768,in,0,0
186769,the,0,0
186770,groups,0,0
186771,with,0,1
186772,and,0,0
186773,without,0,1
186774,the,0,0
186775,guide,0,0
186776,",",0,0
186777,respectively,0,0
186778,.,0,0
186779,CONCLUSION,0,0
186780,The,0,0
186781,femoral,0,0
186782,neck,0,1
186783,osteotomy,0,0
186784,guide,0,0
186785,is,0,0
186786,an,0,0
186787,effectively,0,0
186788,auxiliary,0,0
186789,tool,0,0
186790,for,0,0
186791,increasing,0,0
186792,the,0,0
186793,accuracy,0,0
186794,of,0,0
186795,bone,0,0
186796,resection,1,1
186797,in,1,0
186798,arthroplasty,1,1
186799,using,1,0
186800,the,1,0
186801,posterolateral,1,1
186802,approach,1,0
186803,.,1,1
186804,TRIAL,1,0
186805,REGISTRATION,0,0
186806,ChiCTR-OOC-15005904,0,0
186807,;,0,1
186808,date,0,0
186809,:,0,1
186810,2015-01-30,0,1
186811,.,0,1
186812,Effect,0,0
186813,of,0,0
186814,enzalutamide,0,1
186815,on,0,0
186816,health-related,0,0
186817,quality,0,0
186818,of,0,0
186819,life,0,0
186820,",",0,0
186821,pain,0,0
186822,",",0,0
186823,and,0,0
186824,skeletal-related,0,0
186825,events,0,0
186826,in,0,0
186827,asymptomatic,1,1
186828,and,1,0
186829,minimally,1,1
186830,symptomatic,1,1
186831,",",1,0
186832,chemotherapy-naive,1,1
186833,patients,1,1
186834,with,1,1
186835,metastatic,1,1
186836,castration-resistant,1,1
186837,prostate,1,1
186838,cancer,1,1
186839,(,1,0
186840,PREVAIL,1,0
186841,),1,1
186842,:,1,1
186843,results,0,0
186844,from,0,1
186845,a,0,0
186846,randomised,0,0
186847,",",0,0
186848,phase,0,0
186849,3,0,0
186850,trial,0,0
186851,.,0,1
186852,BACKGROUND,0,0
186853,Enzalutamide,0,0
186854,significantly,0,0
186855,increased,0,0
186856,overall,0,0
186857,survival,0,0
186858,and,0,0
186859,radiographic,0,1
186860,progression-free,0,0
186861,survival,0,0
186862,compared,0,0
186863,with,0,1
186864,placebo,0,0
186865,in,0,0
186866,the,0,0
186867,PREVAIL,0,0
186868,trial,0,0
186869,of,0,0
186870,asymptomatic,1,1
186871,and,1,0
186872,minimally,1,1
186873,symptomatic,1,1
186874,",",1,0
186875,chemotherapy-naive,1,1
186876,patients,1,1
186877,with,1,1
186878,metastatic,1,1
186879,castration-resistant,1,1
186880,prostate,1,1
186881,cancer,1,1
186882,.,1,0
186883,We,0,0
186884,report,0,0
186885,the,0,0
186886,effect,0,0
186887,of,0,0
186888,enzalutamide,0,1
186889,on,0,0
186890,health-related,0,0
186891,quality,0,0
186892,of,0,0
186893,life,0,0
186894,(,0,0
186895,HRQoL,0,0
186896,),0,0
186897,",",0,0
186898,pain,0,0
186899,",",0,0
186900,and,0,0
186901,skeletal-related,0,0
186902,events,0,0
186903,observed,0,0
186904,during,0,0
186905,this,0,0
186906,trial,0,0
186907,.,0,0
186908,METHODS,0,0
186909,In,0,0
186910,this,0,0
186911,phase,0,0
186912,3,0,0
186913,",",0,0
186914,double-blind,0,0
186915,trial,0,0
186916,",",0,0
186917,patients,1,1
186918,were,1,0
186919,randomly,1,1
186920,assigned,1,1
186921,(,1,0
186922,1:1,1,0
186923,),1,0
186924,to,1,0
186925,receive,1,0
186926,enzalutamide,1,1
186927,160,1,1
186928,mg/day,1,0
186929,(,1,0
186930,n=872,1,1
186931,),1,0
186932,or,1,1
186933,placebo,1,0
186934,(,1,0
186935,n=845,1,1
186936,),1,0
186937,orally,1,0
186938,.,1,0
186939,HRQoL,0,0
186940,was,0,0
186941,assessed,0,0
186942,at,0,0
186943,baseline,0,0
186944,and,0,0
186945,during,0,0
186946,treatment,0,0
186947,using,0,0
186948,the,0,0
186949,Functional,0,0
186950,Assessment,0,0
186951,of,0,0
186952,Cancer,0,1
186953,Therapy-Prostate,0,1
186954,(,0,0
186955,FACT-P,0,0
186956,),0,0
186957,and,0,0
186958,EQ-5D,0,0
186959,questionnaires,0,0
186960,.,0,1
186961,Pain,0,0
186962,status,0,0
186963,was,0,0
186964,assessed,0,0
186965,at,0,0
186966,screening,0,0
186967,",",0,0
186968,baseline,0,0
186969,",",0,0
186970,week,0,0
186971,13,0,0
186972,",",0,0
186973,and,0,0
186974,week,0,0
186975,25,0,0
186976,with,0,1
186977,the,0,0
186978,Brief,0,0
186979,Pain,0,1
186980,Inventory,0,1
186981,Short,0,1
186982,Form,0,1
186983,(,0,0
186984,BPI-SF,0,1
186985,),0,0
186986,.,0,0
186987,The,0,0
186988,primary,0,0
186989,analysis,0,0
186990,of,0,0
186991,HRQoL,0,0
186992,data,0,0
186993,used,0,0
186994,a,0,0
186995,mixed-effects,0,0
186996,model,0,0
186997,to,0,0
186998,test,0,0
186999,the,0,0
187000,difference,0,0
187001,between,0,0
187002,least,0,1
187003,square,0,0
187004,means,0,0
187005,change,0,0
187006,from,0,0
187007,baseline,0,0
187008,at,0,0
187009,week,0,0
187010,61,0,1
187011,.,0,1
187012,We,0,0
187013,assessed,0,0
187014,change,0,0
187015,from,0,0
187016,baseline,0,0
187017,",",0,0
187018,percentage,0,0
187019,improvement,0,0
187020,",",0,0
187021,and,0,0
187022,time,0,0
187023,to,0,0
187024,deterioration,0,0
187025,in,0,0
187026,HRQoL,0,0
187027,and,0,0
187028,pain,0,0
187029,",",0,0
187030,the,0,0
187031,proportion,0,0
187032,of,0,0
187033,patients,0,1
187034,with,0,1
187035,a,0,0
187036,skeletal-related,0,0
187037,event,0,0
187038,",",0,0
187039,and,0,0
187040,time,0,0
187041,to,0,0
187042,first,0,0
187043,skeletal-related,0,0
187044,event,0,0
187045,.,0,1
187046,Analysis,0,0
187047,was,0,0
187048,done,0,0
187049,on,0,0
187050,the,0,0
187051,intention-to-treat,0,0
187052,population,0,1
187053,.,0,0
187054,This,0,0
187055,study,0,0
187056,is,0,0
187057,registered,0,0
187058,with,0,0
187059,ClinicalTrials.gov,0,0
187060,",",0,0
187061,number,0,0
187062,NCT01212991,0,1
187063,.,0,1
187064,FINDINGS,0,0
187065,Median,0,1
187066,treatment,0,0
187067,duration,0,0
187068,was,0,0
187069,16?6,0,1
187070,months,0,0
187071,(,0,1
187072,IQR,0,1
187073,10?1-21?1,0,1
187074,),0,0
187075,in,0,0
187076,the,0,0
187077,enzalutamide,0,0
187078,group,0,0
187079,and,0,0
187080,4?6,0,0
187081,months,0,0
187082,(,0,1
187083,2?8-9?7,0,1
187084,),0,0
187085,in,0,0
187086,the,0,0
187087,placebo,0,0
187088,group,0,0
187089,.,0,0
187090,The,0,0
187091,mixed-effects,0,0
187092,model,0,0
187093,analyses,0,0
187094,showed,0,0
187095,significant,0,0
187096,treatment,0,0
187097,differences,0,0
187098,in,0,0
187099,change,0,0
187100,from,0,0
187101,baseline,0,0
187102,to,0,0
187103,week,0,0
187104,61,0,1
187105,with,0,1
187106,enzalutamide,0,1
187107,compared,0,0
187108,with,0,1
187109,placebo,0,0
187110,for,0,0
187111,most,0,0
187112,FACT-P,0,0
187113,endpoints,0,0
187114,and,0,1
187115,EQ-5D,0,0
187116,visual,0,0
187117,analogue,0,0
187118,scale,0,0
187119,.,0,0
187120,Median,0,0
187121,time,0,0
187122,to,0,0
187123,deterioration,0,0
187124,in,0,0
187125,FACT-P,0,0
187126,total,0,1
187127,score,0,0
187128,was,0,0
187129,11?3,0,1
187130,months,0,0
187131,(,0,1
187132,95,0,0
187133,%,0,0
187134,CI,0,0
187135,11?1-13?9,0,1
187136,),0,0
187137,in,0,0
187138,the,0,0
187139,enzalutamide,0,0
187140,group,0,0
187141,and,0,0
187142,5?6,0,0
187143,months,0,0
187144,(,0,1
187145,5?5-5?6,0,1
187146,),0,0
187147,in,0,0
187148,the,0,0
187149,placebo,0,0
187150,groups,0,0
187151,(,0,0
187152,hazard,0,0
187153,ratio,0,0
187154,[,0,0
187155,HR,0,0
187156,],0,1
187157,0?62,0,0
187158,[,0,0
187159,95,0,0
187160,%,0,0
187161,CI,0,0
187162,0?54-0?72,0,0
187163,],0,1
187164,;,0,0
187165,p,0,0
187166,<,0,0
187167,0?0001,0,0
187168,),0,0
187169,.,0,0
187170,A,0,0
187171,significantly,0,0
187172,greater,0,0
187173,proportion,0,0
187174,of,0,0
187175,patients,0,1
187176,in,0,0
187177,the,0,0
187178,enzalutamide,0,0
187179,group,0,0
187180,than,0,0
187181,in,0,0
187182,the,0,0
187183,placebo,0,0
187184,group,0,0
187185,reported,0,0
187186,clinically,0,0
187187,meaningful,0,0
187188,improvements,0,0
187189,in,0,1
187190,FACT-P,0,0
187191,total,0,1
187192,score,0,0
187193,(,0,0
187194,327,0,1
187195,[,0,0
187196,40,0,1
187197,%,0,0
187198,],0,1
187199,of,0,0
187200,826,0,1
187201,vs,0,0
187202,181,0,1
187203,[,0,0
187204,23,0,1
187205,%,0,0
187206,],0,1
187207,of,0,0
187208,790,0,1
187209,),0,0
187210,",",0,0
187211,in,0,0
187212,EQ-5D,0,0
187213,utility,0,0
187214,index,0,0
187215,(,0,0
187216,224,0,1
187217,[,0,0
187218,28,0,1
187219,%,0,0
187220,],0,1
187221,of,0,0
187222,812,0,1
187223,vs,0,0
187224,99,0,1
187225,[,0,0
187226,16,0,1
187227,%,0,0
187228,],0,1
187229,of,0,0
187230,623,0,1
187231,),0,0
187232,",",0,0
187233,and,0,0
187234,visual,0,0
187235,analogue,0,0
187236,scale,0,0
187237,(,0,0
187238,218,0,1
187239,[,0,0
187240,27,0,1
187241,%,0,0
187242,],0,1
187243,of,0,0
187244,803,0,1
187245,vs,0,0
187246,106,0,1
187247,of,0,0
187248,[,0,0
187249,18,0,1
187250,%,0,0
187251,],0,1
187252,603,0,1
187253,;,0,0
187254,all,0,0
187255,p,0,0
187256,<,0,0
187257,0?0001,0,0
187258,),0,0
187259,.,0,1
187260,Median,0,0
187261,time,0,0
187262,to,0,0
187263,progression,0,0
187264,in,0,0
187265,BPI-SF,0,1
187266,pain,0,1
187267,at,0,0
187268,its,0,0
187269,worst,0,0
187270,was,0,0
187271,5?7,0,1
187272,months,0,0
187273,(,0,1
187274,95,0,0
187275,%,0,0
187276,CI,0,0
187277,5?6-5?7,0,1
187278,),0,0
187279,in,0,0
187280,the,0,0
187281,enzalutamide,0,0
187282,group,0,0
187283,and,0,0
187284,5?6,0,0
187285,months,0,0
187286,(,0,1
187287,5?4-5?6,0,1
187288,),0,0
187289,in,0,0
187290,the,0,0
187291,placebo,0,0
187292,group,0,0
187293,(,0,0
187294,HR,0,0
187295,0?62,0,0
187296,[,0,0
187297,95,0,0
187298,%,0,0
187299,CI,0,0
187300,0?53-0?74,0,0
187301,],0,1
187302,;,0,0
187303,p,0,0
187304,<,0,0
187305,0?0001,0,0
187306,),0,0
187307,.,0,0
187308,Progression,0,0
187309,of,0,0
187310,pain,0,0
187311,at,0,0
187312,its,0,0
187313,worst,0,0
187314,was,0,0
187315,less,0,0
187316,common,0,0
187317,in,0,0
187318,the,0,0
187319,enzalutamide,0,0
187320,group,0,0
187321,than,0,0
187322,in,0,0
187323,the,0,0
187324,placebo,0,0
187325,group,0,0
187326,at,0,0
187327,week,0,0
187328,13,0,1
187329,(,0,0
187330,220,0,1
187331,[,0,0
187332,29,0,1
187333,%,0,0
187334,],0,1
187335,of,0,0
187336,769,0,1
187337,vs,0,0
187338,257,0,1
187339,[,0,0
187340,42,0,1
187341,%,0,0
187342,],0,1
187343,of,0,0
187344,610,0,1
187345,;,0,0
187346,p,0,0
187347,<,0,0
187348,0?0001,0,0
187349,),0,0
187350,",",0,0
187351,but,0,0
187352,not,0,0
187353,at,0,0
187354,week,0,0
187355,25,0,1
187356,(,0,0
187357,225,0,1
187358,[,0,0
187359,32,0,1
187360,%,0,0
187361,],0,1
187362,of,0,0
187363,705,0,1
187364,vs,0,0
187365,135,0,1
187366,[,0,0
187367,38,0,1
187368,%,0,0
187369,],0,1
187370,of,0,0
187371,360,0,1
187372,;,0,1
187373,p=0?068,0,0
187374,),0,0
187375,.,0,0
187376,278,0,1
187377,(,0,0
187378,32,0,1
187379,%,0,0
187380,),0,0
187381,of,0,0
187382,872,0,1
187383,patients,0,1
187384,in,0,0
187385,the,0,0
187386,enzalutamide,0,0
187387,group,0,0
187388,and,0,0
187389,309,0,1
187390,(,0,0
187391,37,0,1
187392,%,0,0
187393,),0,0
187394,of,0,0
187395,845,0,1
187396,patients,0,1
187397,in,0,0
187398,the,0,0
187399,placebo,0,0
187400,group,0,0
187401,had,0,0
187402,experienced,0,0
187403,a,0,0
187404,skeletal-related,0,0
187405,event,0,0
187406,by,0,0
187407,data,0,0
187408,cutoff,0,0
187409,.,0,1
187410,Median,0,0
187411,time,0,0
187412,to,0,0
187413,first,0,0
187414,skeletal-related,0,0
187415,events,0,0
187416,in,0,0
187417,the,0,0
187418,enzalutamide,0,0
187419,group,0,0
187420,was,0,0
187421,31?1,0,1
187422,months,0,0
187423,(,0,1
187424,95,0,0
187425,%,0,0
187426,CI,0,0
187427,29?5-not,0,0
187428,reached,0,0
187429,),0,0
187430,and,0,0
187431,31?3,0,1
187432,months,0,0
187433,(,0,1
187434,95,0,0
187435,%,0,0
187436,CI,0,0
187437,23?9-not,0,0
187438,reached,0,0
187439,),0,0
187440,in,0,0
187441,the,0,0
187442,placebo,0,0
187443,group,0,0
187444,(,0,0
187445,HR,0,0
187446,0?72,0,0
187447,[,0,0
187448,95,0,0
187449,%,0,0
187450,CI,0,0
187451,0?61-0?84,0,0
187452,],0,1
187453,;,0,0
187454,p,0,0
187455,<,0,0
187456,0?0001,0,0
187457,),0,0
187458,.,0,1
187459,INTERPRETATION,0,0
187460,In,0,0
187461,addition,0,0
187462,to,0,0
187463,improving,0,0
187464,overall,0,0
187465,survival,0,0
187466,relative,0,0
187467,to,0,0
187468,placebo,0,0
187469,",",0,0
187470,enzalutamide,0,0
187471,significantly,0,0
187472,improves,0,0
187473,patient-related,0,0
187474,outcomes,0,0
187475,and,0,1
187476,delays,0,0
187477,occurrence,0,0
187478,of,0,0
187479,first,0,0
187480,skeletal-related,0,0
187481,event,1,0
187482,in,1,0
187483,chemotherapy-naive,1,1
187484,men,1,1
187485,with,1,1
187486,metastatic,1,1
187487,castration-resistant,1,1
187488,prostate,1,1
187489,cancer,1,1
187490,.,0,1
187491,FUNDING,0,0
187492,Astellas,0,0
187493,Pharma,0,0
187494,and,0,0
187495,Medivation,0,0
187496,.,0,1
187497,Icosapent,0,0
187498,Ethyl,0,0
187499,(,0,0
187500,Eicosapentaenoic,0,0
187501,Acid,0,0
187502,Ethyl,0,0
187503,Ester,0,1
187504,),0,1
187505,:,0,1
187506,Effects,0,0
187507,Upon,0,1
187508,High-Sensitivity,0,0
187509,C-Reactive,0,1
187510,Protein,0,0
187511,and,0,0
187512,Lipid,0,0
187513,Parameters,0,0
187514,in,0,0
187515,Patients,1,1
187516,With,1,1
187517,Metabolic,1,1
187518,Syndrome,1,1
187519,.,1,1
187520,BACKGROUND,0,0
187521,The,0,0
187522,aim,0,0
187523,of,0,0
187524,this,0,0
187525,analysis,0,0
187526,was,0,0
187527,to,0,0
187528,examine,0,0
187529,the,0,0
187530,effects,0,0
187531,of,0,0
187532,icosapent,0,0
187533,ethyl,0,0
187534,(,0,0
187535,eicosapentaenoic,0,0
187536,acid,0,0
187537,ethyl,0,0
187538,ester,0,0
187539,",",0,0
187540,IPE,0,0
187541,),0,0
187542,on,0,0
187543,high-sensitivity,0,0
187544,C-reactive,0,0
187545,protein,0,0
187546,(,0,0
187547,hsCRP,0,0
187548,),0,0
187549,and,0,0
187550,lipid,0,0
187551,parameters,0,0
187552,in,0,1
187553,patients,1,1
187554,with,1,1
187555,metabolic,1,1
187556,syndrome,1,1
187557,",",1,0
187558,with,1,0
187559,and,1,0
187560,without,1,1
187561,stable,1,1
187562,statin,1,1
187563,therapy,1,0
187564,.,1,0
187565,METHODS,0,0
187566,This,0,0
187567,post,0,0
187568,hoc,0,0
187569,exploratory,0,0
187570,analysis,0,0
187571,evaluated,0,0
187572,patients,1,1
187573,with,1,1
187574,metabolic,1,1
187575,syndrome,1,1
187576,treated,1,1
187577,with,1,1
187578,IPE,1,0
187579,4,1,0
187580,grams/day,1,0
187581,",",1,0
187582,IPE,1,0
187583,2,1,0
187584,grams/day,1,0
187585,",",1,0
187586,or,1,0
187587,placebo,1,0
187588,in,1,0
187589,phase,1,1
187590,3,1,0
187591,",",1,0
187592,randomized,1,0
187593,",",1,0
187594,placebo-controlled,1,0
187595,studies,1,0
187596,entitled,1,1
187597,:,1,1
187598,MARINE,1,0
187599,[,1,0
187600,triglyceride,1,0
187601,(,1,0
187602,TG,1,0
187603,),1,1
187604,levels,1,0
187605,?500,1,0
187606,and,1,1
187607,?2000,1,0
187608,mg/dL,1,0
187609,],1,0
187610,and,1,0
187611,ANCHOR,1,0
187612,[,1,0
187613,TG,1,0
187614,levels,1,0
187615,?200,1,0
187616,and,1,1
187617,<,1,0
187618,500,1,0
187619,mg/dL,1,0
187620,",",1,0
187621,despite,1,0
187622,low-density,1,0
187623,lipoprotein,1,0
187624,cholesterol,1,0
187625,(,1,0
187626,LDL-C,1,1
187627,),1,0
187628,control,1,0
187629,with,1,1
187630,stable,1,1
187631,statin,1,1
187632,therapy,1,0
187633,],1,1
187634,.,1,1
187635,RESULTS,0,0
187636,Compared,0,0
187637,with,0,1
187638,placebo,0,0
187639,in,0,0
187640,patients,1,1
187641,with,1,1
187642,metabolic,1,1
187643,syndrome,1,1
187644,in,1,0
187645,MARINE,1,0
187646,(,1,0
187647,n=204,1,1
187648,),1,0
187649,and,1,0
187650,ANCHOR,1,0
187651,(,1,0
187652,n=645,1,1
187653,),1,0
187654,",",1,0
187655,at,0,0
187656,the,0,0
187657,approved,0,0
187658,dose,0,0
187659,of,0,0
187660,4,0,0
187661,grams/day,0,0
187662,",",0,0
187663,IPE,0,0
187664,significantly,0,0
187665,lowered,0,0
187666,hsCRP,0,0
187667,levels,0,0
187668,40.0,0,0
187669,%,0,0
187670,(,0,0
187671,P=0.0007,0,0
187672,),0,0
187673,in,0,0
187674,MARINE,0,0
187675,and,0,0
187676,23.0,0,0
187677,%,0,0
187678,(,0,0
187679,P=0.0003,0,0
187680,),0,0
187681,in,0,0
187682,ANCHOR,0,0
187683,.,0,0
187684,Compared,0,0
187685,with,0,0
187686,placebo,0,0
187687,in,0,0
187688,MARINE,0,0
187689,",",0,0
187690,which,0,0
187691,included,0,1
187692,patients,0,1
187693,with,0,1
187694,and,0,0
187695,without,0,1
187696,statin,0,0
187697,therapy,0,0
187698,",",0,0
187699,IPE,0,0
187700,4,0,0
187701,grams/day,0,0
187702,significantly,0,0
187703,reduced,0,0
187704,hsCRP,0,0
187705,levels,0,0
187706,78.0,0,0
187707,%,0,0
187708,in,0,0
187709,statin-treated,0,1
187710,patients,0,1
187711,(,0,1
187712,P=0.0035,0,0
187713,",",0,0
187714,n=16,0,1
187715,),0,0
187716,.,0,0
187717,Compared,0,0
187718,with,0,0
187719,placebo,0,0
187720,in,0,0
187721,MARINE,0,0
187722,",",0,0
187723,IPE,0,0
187724,4,0,0
187725,grams/day,0,0
187726,significantly,0,0
187727,reduced,0,0
187728,TG,0,0
187729,levels,0,0
187730,(,0,1
187731,35.0,0,1
187732,%,0,0
187733,;,0,1
187734,P,0,0
187735,<,0,0
187736,0.0001,0,0
187737,),0,0
187738,",",0,0
187739,non-high-density,0,0
187740,lipoprotein,0,0
187741,cholesterol,0,0
187742,(,0,0
187743,non-HDL-C,0,0
187744,;,0,1
187745,19.9,0,0
187746,%,0,0
187747,;,0,1
187748,P,0,0
187749,<,0,0
187750,0.0001,0,0
187751,),0,0
187752,",",0,0
187753,and,0,0
187754,apolipoprotein,0,0
187755,B,0,0
187756,levels,0,0
187757,(,0,1
187758,ApoB,0,1
187759,),0,0
187760,(,0,0
187761,9.1,0,0
187762,%,0,0
187763,;,0,1
187764,P=0.0015,0,0
187765,),0,0
187766,without,0,1
187767,raising,0,0
187768,LDL-C,0,1
187769,levels,0,0
187770,.,0,1
187771,Compared,0,0
187772,with,0,0
187773,placebo,0,0
187774,in,0,0
187775,ANCHOR,0,0
187776,",",0,0
187777,IPE,0,0
187778,4,0,0
187779,grams/day,0,0
187780,significantly,0,0
187781,reduced,0,0
187782,TG,0,0
187783,(,0,0
187784,21.7,0,0
187785,%,0,0
187786,;,0,1
187787,P,0,0
187788,<,0,0
187789,0.0001,0,0
187790,),0,0
187791,",",0,0
187792,non-HDL-C,0,0
187793,(,0,0
187794,13.5,0,0
187795,%,0,0
187796,;,0,1
187797,P,0,0
187798,<,0,0
187799,0.0001,0,0
187800,),0,0
187801,",",0,0
187802,ApoB,0,1
187803,(,0,0
187804,8.8,0,0
187805,%,0,0
187806,;,0,1
187807,P,0,0
187808,<,0,0
187809,0.0001,0,0
187810,),0,0
187811,",",0,0
187812,LDL-C,0,1
187813,(,0,0
187814,5.2,0,0
187815,%,0,0
187816,;,0,1
187817,P=0.0236,0,0
187818,),0,0
187819,",",0,0
187820,and,0,0
187821,HDL-C,0,0
187822,levels,0,0
187823,(,0,1
187824,4.0,0,1
187825,%,0,0
187826,;,0,1
187827,P=0.0053,0,0
187828,),0,0
187829,.,0,1
187830,CONCLUSIONS,0,0
187831,Compared,0,0
187832,with,0,1
187833,placebo,0,0
187834,",",0,0
187835,IPE,0,0
187836,4,0,0
187837,grams/day,0,0
187838,significantly,0,0
187839,lowered,0,0
187840,hsCRP,0,0
187841,levels,0,0
187842,and,0,0
187843,improved,0,0
187844,lipids,0,0
187845,without,0,1
187846,raising,0,0
187847,LDL-C,0,1
187848,levels,0,0
187849,in,0,1
187850,patients,1,1
187851,with,1,1
187852,metabolic,1,1
187853,syndrome,1,1
187854,and,1,0
187855,high,1,0
187856,(,1,0
187857,?200,1,0
187858,and,1,1
187859,<,1,0
187860,500,1,0
187861,mg/dL,1,0
187862,),1,0
187863,or,1,0
187864,very,1,0
187865,high,1,0
187866,(,1,0
187867,?500,1,0
187868,and,1,0
187869,?2000,1,0
187870,mg/dL,1,0
187871,),1,0
187872,TG,1,0
187873,levels,1,0
187874,",",1,0
187875,with,1,1
187876,or,1,0
187877,without,1,1
187878,stable,1,1
187879,statin,1,1
187880,therapy,1,0
187881,.,1,1
187882,Sensory,0,0
187883,Adapted,0,1
187884,Dental,0,1
187885,Environments,0,0
187886,to,0,0
187887,Enhance,0,0
187888,Oral,0,0
187889,Care,0,0
187890,for,0,0
187891,Children,1,1
187892,with,1,1
187893,Autism,1,1
187894,Spectrum,1,1
187895,Disorders,1,1
187896,:,1,1
187897,A,0,1
187898,Randomized,0,0
187899,Controlled,0,0
187900,Pilot,0,1
187901,Study,0,0
187902,.,0,0
187903,This,0,0
187904,pilot,0,0
187905,and,0,0
187906,feasibility,0,0
187907,study,0,0
187908,examined,0,0
187909,the,0,0
187910,impact,0,0
187911,of,0,0
187912,a,0,0
187913,sensory,0,0
187914,adapted,0,0
187915,dental,0,1
187916,environment,0,0
187917,(,0,0
187918,SADE,0,0
187919,),0,0
187920,to,0,0
187921,reduce,0,0
187922,distress,0,0
187923,",",0,0
187924,sensory,0,0
187925,discomfort,0,0
187926,",",0,0
187927,and,0,0
187928,perception,0,0
187929,of,0,0
187930,pain,0,1
187931,during,0,0
187932,oral,0,0
187933,prophylaxis,0,1
187934,for,0,0
187935,children,1,1
187936,with,1,1
187937,autism,1,1
187938,spectrum,1,1
187939,disorder,1,1
187940,(,1,0
187941,ASD,1,1
187942,),1,1
187943,.,1,1
187944,Participants,1,1
187945,were,1,1
187946,44,1,1
187947,children,1,1
187948,ages,1,1
187949,6-12,1,0
187950,(,1,0
187951,n,1,1
187952,=,1,0
187953,22,1,1
187954,typical,1,1
187955,",",1,0
187956,n,1,1
187957,=,1,0
187958,22,1,1
187959,ASD,1,1
187960,),1,0
187961,.,1,0
187962,In,0,0
187963,an,0,0
187964,experimental,0,0
187965,crossover,0,0
187966,design,0,0
187967,",",0,0
187968,each,0,0
187969,participant,0,0
187970,underwent,0,1
187971,two,0,0
187972,professional,0,1
187973,dental,0,1
187974,cleanings,0,1
187975,",",0,0
187976,one,0,1
187977,in,0,0
187978,a,0,0
187979,regular,0,0
187980,dental,0,1
187981,environment,0,0
187982,(,0,0
187983,RDE,0,0
187984,),0,0
187985,and,0,0
187986,one,0,0
187987,in,0,0
187988,a,0,0
187989,SADE,0,0
187990,",",0,0
187991,administered,0,0
187992,in,0,0
187993,a,0,0
187994,randomized,0,0
187995,and,0,0
187996,counterbalanced,0,0
187997,order,0,0
187998,3-4,0,1
187999,months,0,0
188000,apart,0,1
188001,.,0,1
188002,Outcomes,0,0
188003,included,0,1
188004,measures,0,0
188005,of,0,0
188006,physiological,0,0
188007,anxiety,0,0
188008,",",0,0
188009,behavioral,0,0
188010,distress,0,0
188011,",",0,0
188012,pain,0,0
188013,intensity,0,0
188014,",",0,0
188015,and,0,0
188016,sensory,0,0
188017,discomfort,0,0
188018,.,0,0
188019,Both,1,0
188020,groups,1,0
188021,exhibited,0,0
188022,decreased,0,0
188023,physiological,0,0
188024,anxiety,0,1
188025,and,0,0
188026,reported,0,0
188027,lower,0,0
188028,pain,0,1
188029,and,0,0
188030,sensory,0,0
188031,discomfort,0,0
188032,in,0,0
188033,the,0,0
188034,SADE,0,0
188035,condition,0,0
188036,compared,0,0
188037,to,0,0
188038,RDE,0,0
188039,",",0,0
188040,indicating,0,0
188041,a,0,0
188042,beneficial,0,0
188043,effect,0,0
188044,of,0,0
188045,the,0,0
188046,SADE,0,0
188047,.,0,1
188048,Three-year,0,1
188049,efficacy,0,0
188050,and,0,0
188051,safety,0,0
188052,of,0,0
188053,a,0,0
188054,new,0,0
188055,52-mg,0,0
188056,levonorgestrel-releasing,0,0
188057,intrauterine,0,1
188058,system,0,0
188059,.,0,0
188060,OBJECTIVE,0,0
188061,To,0,0
188062,assess,0,0
188063,3-year,0,0
188064,data,0,0
188065,on,0,0
188066,the,0,0
188067,efficacy,0,0
188068,and,0,0
188069,safety,0,0
188070,of,0,0
188071,a,0,0
188072,new,0,0
188073,52-mg,0,0
188074,levonorgestrel,1,1
188075,intrauterine,1,0
188076,contraceptive,1,1
188077,(,1,0
188078,LNG20,1,1
188079,),1,0
188080,designed,0,0
188081,for,0,0
188082,up,0,0
188083,to,0,1
188084,7,0,1
188085,years,0,1
188086,use,0,0
188087,.,0,1
188088,STUDY,0,0
188089,DESIGN,0,0
188090,Nulliparous,1,1
188091,and,1,0
188092,parous,1,1
188093,women,1,1
188094,aged,1,1
188095,16-45,1,1
188096,years,1,1
188097,at,1,0
188098,enrollment,1,1
188099,with,1,1
188100,regular,1,0
188101,menstrual,1,1
188102,cycles,1,0
188103,and,1,0
188104,requesting,1,1
188105,contraception,1,1
188106,were,1,0
188107,enrolled,1,1
188108,in,1,0
188109,an,1,0
188110,open-label,1,0
188111,",",0,0
188112,partially,0,0
188113,randomized,0,0
188114,trial,0,0
188115,to,0,0
188116,evaluate,0,0
188117,LNG20,0,0
188118,.,0,0
188119,The,0,0
188120,primary,0,0
188121,outcome,0,0
188122,was,0,0
188123,pregnancy,0,0
188124,rate,0,0
188125,for,0,0
188126,women,0,1
188127,aged,0,1
188128,16-35,0,1
188129,years,0,1
188130,calculated,0,0
188131,as,0,0
188132,the,0,0
188133,Pearl,0,1
188134,Index,0,0
188135,.,0,1
188136,Women,1,1
188137,aged,1,1
188138,36-45,1,1
188139,years,1,1
188140,received,1,1
188141,LNG20,1,1
188142,for,1,0
188143,safety,1,0
188144,evaluation,1,0
188145,only,1,0
188146,.,1,0
188147,All,0,0
188148,participants,0,1
188149,had,0,0
188150,in-person,0,0
188151,or,0,1
188152,phone,0,0
188153,follow-up,0,0
188154,approximately,0,0
188155,every,0,0
188156,3,0,0
188157,months,0,0
188158,during,0,0
188159,the,0,0
188160,study,0,0
188161,.,0,0
188162,RESULTS,0,0
188163,A,0,0
188164,total,1,1
188165,of,1,0
188166,1600,1,1
188167,women,1,1
188168,aged,1,1
188169,16-35,1,1
188170,years,1,1
188171,and,1,1
188172,151,1,1
188173,women,1,1
188174,aged,1,1
188175,36-45,1,1
188176,years,1,1
188177,agreed,1,1
188178,to,1,0
188179,LNG20,1,0
188180,placement,1,0
188181,",",1,0
188182,including,1,0
188183,1011,1,1
188184,(,1,1
188185,57.7,1,1
188186,%,1,0
188187,),1,0
188188,nulliparous,1,1
188189,and,1,0
188190,438,1,1
188191,(,1,0
188192,25.1,1,0
188193,%,1,0
188194,),1,1
188195,obese,1,1
188196,women,1,1
188197,.,1,1
188198,Successful,1,0
188199,placement,1,0
188200,occurred,1,0
188201,in,1,0
188202,1714,1,1
188203,(,1,1
188204,97.9,1,0
188205,%,1,0
188206,),1,1
188207,women,1,1
188208,.,1,1
188209,Six,1,1
188210,pregnancies,1,0
188211,occurred,1,0
188212,",",1,0
188213,four,1,0
188214,of,1,0
188215,which,1,0
188216,were,1,1
188217,ectopic,1,0
188218,.,1,1
188219,The,0,0
188220,Pearl,0,0
188221,Index,0,0
188222,for,0,0
188223,LNG20,0,1
188224,was,0,0
188225,0.15,0,0
188226,(,0,0
188227,95,0,0
188228,%,0,0
188229,CI,0,0
188230,0.02-0.55,0,0
188231,),0,0
188232,through,0,0
188233,Year,0,1
188234,1,0,0
188235,",",0,0
188236,0.26,0,0
188237,(,0,0
188238,95,0,0
188239,%,0,0
188240,CI,0,0
188241,0.10-0.57,0,0
188242,),0,0
188243,through,0,0
188244,Year,0,1
188245,2,0,0
188246,",",0,0
188247,and,0,0
188248,0.22,0,0
188249,(,0,0
188250,95,0,0
188251,%,0,0
188252,CI,0,0
188253,0.08-0.49,0,0
188254,),0,0
188255,through,0,0
188256,Year,0,1
188257,3,0,0
188258,.,0,0
188259,The,0,0
188260,cumulative,0,0
188261,life-table,0,0
188262,pregnancy,0,1
188263,rate,0,0
188264,was,0,0
188265,0.55,0,0
188266,(,0,0
188267,95,0,0
188268,%,0,0
188269,CI,0,0
188270,0.24-1.23,0,0
188271,),0,0
188272,through,0,0
188273,3,0,1
188274,years,0,1
188275,.,0,1
188276,Expulsion,0,0
188277,was,0,0
188278,reported,0,0
188279,in,0,0
188280,62,0,1
188281,(,0,1
188282,3.5,0,1
188283,%,0,0
188284,),0,0
188285,participants,0,1
188286,",",0,0
188287,most,0,0
188288,(,0,0
188289,50,0,1
188290,[,0,0
188291,80.6,0,0
188292,%,0,0
188293,],0,0
188294,),0,0
188295,during,0,0
188296,the,0,0
188297,first,0,0
188298,year,0,0
188299,of,0,0
188300,use,0,0
188301,.,0,1
188302,Of,0,1
188303,women,1,1
188304,who,1,1
188305,discontinued,1,1
188306,LNG20,1,1
188307,and,1,0
188308,desired,1,0
188309,pregnancy,1,0
188310,",",0,0
188311,86.8,0,0
188312,%,0,0
188313,conceived,0,0
188314,spontaneously,0,0
188315,within,0,0
188316,12,0,0
188317,months,0,0
188318,.,0,1
188319,Pelvic,0,0
188320,infection,0,0
188321,was,0,0
188322,diagnosed,0,1
188323,in,0,0
188324,10,1,1
188325,(,1,1
188326,0.6,1,0
188327,%,1,0
188328,),1,1
188329,women,1,1
188330,.,1,1
188331,Only,0,0
188332,26,1,1
188333,(,1,0
188334,1.5,1,0
188335,%,1,0
188336,),1,1
188337,LNG20,1,1
188338,users,0,1
188339,discontinued,0,0
188340,due,0,0
188341,to,0,0
188342,bleeding,0,1
188343,complaints,0,1
188344,.,0,1
188345,CONCLUSION,0,0
188346,The,0,0
188347,LNG20,0,0
188348,intrauterine,0,0
188349,system,0,0
188350,is,0,0
188351,highly,0,0
188352,effective,0,0
188353,and,0,0
188354,safe,0,0
188355,over,0,0
188356,3,0,0
188357,years,0,1
188358,of,0,0
188359,use,0,0
188360,in,0,0
188361,nulliparous,1,1
188362,and,1,1
188363,parous,1,1
188364,women,1,1
188365,.,1,1
188366,IMPLICATIONS,0,0
188367,STATEMENT,0,0
188368,A,0,1
188369,new,0,0
188370,52-mg,0,0
188371,levonorgestrel-releasing,0,0
188372,intrauterine,0,0
188373,system,0,0
188374,is,0,0
188375,effective,0,0
188376,and,0,0
188377,safe,0,0
188378,for,0,0
188379,nulliparous,0,1
188380,and,0,1
188381,parous,0,1
188382,women,0,1
188383,for,0,0
188384,at,0,1
188385,least,0,1
188386,3,0,1
188387,years,0,1
188388,.,0,1
188389,The,0,0
188390,Beyond,0,0
188391,Ageing,0,1
188392,Project,0,1
188393,Phase,0,1
188394,2,0,1
188395,--,0,1
188396,a,0,0
188397,double-blind,0,0
188398,",",0,0
188399,selective,0,0
188400,prevention,0,0
188401,",",0,0
188402,randomised,0,0
188403,",",0,0
188404,placebo-controlled,0,0
188405,trial,0,0
188406,of,0,0
188407,omega-3,0,0
188408,fatty,0,0
188409,acids,0,0
188410,and,0,0
188411,sertraline,0,0
188412,in,0,0
188413,an,1,0
188414,older,1,1
188415,age,1,1
188416,cohort,1,1
188417,at,1,0
188418,risk,1,0
188419,for,1,0
188420,depression,1,1
188421,:,1,1
188422,study,0,0
188423,protocol,0,0
188424,for,0,0
188425,a,0,0
188426,randomized,0,0
188427,controlled,0,0
188428,trial,0,0
188429,.,0,0
188430,BACKGROUND,0,0
188431,Late-life,1,0
188432,depression,1,1
188433,is,0,0
188434,associated,0,0
188435,with,0,1
188436,high,1,1
188437,rates,1,0
188438,of,1,0
188439,morbidity,1,0
188440,",",1,0
188441,premature,1,1
188442,mortality,1,0
188443,",",1,0
188444,disability,1,0
188445,",",1,0
188446,functional,1,0
188447,decline,1,0
188448,",",1,0
188449,caregiver,1,0
188450,burden,1,0
188451,and,1,0
188452,increased,1,0
188453,health,1,1
188454,care,1,1
188455,costs,1,0
188456,.,1,1
188457,While,0,0
188458,clinical,0,0
188459,and,0,0
188460,public,0,1
188461,health,0,1
188462,approaches,0,0
188463,are,0,0
188464,focused,0,0
188465,on,0,0
188466,prevention,0,0
188467,or,0,1
188468,early,0,0
188469,intervention,0,0
188470,strategies,0,0
188471,",",0,0
188472,the,0,0
188473,ideal,0,0
188474,method,0,0
188475,of,0,0
188476,intervention,0,0
188477,remains,0,0
188478,unclear,0,0
188479,.,0,0
188480,No,0,0
188481,study,0,0
188482,has,0,0
188483,set,0,0
188484,out,0,0
188485,to,0,0
188486,evaluate,0,0
188487,the,0,0
188488,role,0,0
188489,of,0,0
188490,neurobiological,0,0
188491,agents,0,0
188492,in,0,0
188493,preventing,0,0
188494,depressive,0,0
188495,symptoms,0,0
188496,in,0,0
188497,older,0,1
188498,populations,0,1
188499,at,0,0
188500,risk,0,0
188501,of,0,0
188502,depression,0,1
188503,.,0,0
188504,METHODS/DESIGN,0,0
188505,Subjects,1,1
188506,with,1,0
188507,previously,1,0
188508,reported,1,0
188509,sub-threshold,1,0
188510,depressive,1,0
188511,symptoms,1,0
188512,",",1,0
188513,aged,1,1
188514,60,1,1
188515,to,1,1
188516,74,1,1
188517,years,1,1
188518,",",0,0
188519,will,0,0
188520,be,0,0
188521,screened,0,1
188522,to,0,0
188523,participate,0,1
188524,in,0,0
188525,a,0,0
188526,single-centre,0,1
188527,",",0,0
188528,double-blind,0,0
188529,",",0,0
188530,randomised,0,0
188531,controlled,0,0
188532,trial,0,0
188533,with,0,1
188534,three,0,0
188535,parallel,0,0
188536,groups,0,0
188537,involving,0,1
188538,omega-3,0,0
188539,fatty,0,0
188540,acid,0,0
188541,supplementation,0,0
188542,or,0,1
188543,sertraline,0,0
188544,hydrochloride,0,0
188545,",",0,0
188546,compared,0,0
188547,with,0,1
188548,matching,0,0
188549,placebo,0,0
188550,.,0,0
188551,Subjects,1,0
188552,will,1,0
188553,be,1,0
188554,excluded,1,0
188555,if,1,0
188556,they,1,0
188557,have,1,0
188558,current,1,0
188559,depression,1,1
188560,or,1,1
188561,suicide,1,1
188562,ideation,1,0
188563,;,1,0
188564,are,1,0
188565,taking,1,0
188566,antidepressants,1,0
188567,or,1,1
188568,any,1,0
188569,supplement,1,0
188570,containing,1,0
188571,omega-3,1,0
188572,fatty,1,0
188573,acid,1,0
188574,;,1,0
188575,or,1,0
188576,have,1,0
188577,a,1,0
188578,prior,1,0
188579,history,1,1
188580,of,1,0
188581,stroke,1,1
188582,or,1,1
188583,other,1,0
188584,serious,1,0
188585,cerebrovascular,1,1
188586,or,1,1
188587,cardiovascular,1,0
188588,disease,1,1
188589,",",1,0
188590,neurological,1,0
188591,disease,1,1
188592,",",1,0
188593,significant,1,0
188594,psychiatric,1,1
188595,disease,1,1
188596,(,1,0
188597,other,1,0
188598,than,1,0
188599,depression,1,1
188600,),1,0
188601,or,1,1
188602,neurodegenerative,1,1
188603,disease,1,1
188604,.,1,0
188605,The,0,0
188606,trial,0,0
188607,will,0,0
188608,consist,0,0
188609,of,0,0
188610,a,0,0
188611,12,0,0
188612,month,0,0
188613,treatment,0,0
188614,phase,0,0
188615,with,0,1
188616,follow-up,0,0
188617,at,0,0
188618,three,0,0
188619,months,0,0
188620,and,0,1
188621,12,0,1
188622,months,0,0
188623,to,0,0
188624,assess,0,0
188625,outcome,0,0
188626,events,0,0
188627,.,0,1
188628,At,0,0
188629,three,0,0
188630,months,0,0
188631,",",0,0
188632,subjects,0,1
188633,will,0,0
188634,undergo,0,1
188635,structural,0,0
188636,neuroimaging,0,0
188637,to,0,0
188638,assess,0,0
188639,whether,0,0
188640,treatment,0,0
188641,effects,0,0
188642,on,0,0
188643,depressive,0,1
188644,symptoms,0,0
188645,correlate,0,0
188646,with,0,1
188647,brain,0,1
188648,changes,0,0
188649,.,0,0
188650,Additionally,0,0
188651,",",0,0
188652,proton,0,0
188653,spectroscopy,0,0
188654,techniques,0,0
188655,will,0,0
188656,be,0,0
188657,used,0,0
188658,to,0,0
188659,capture,0,0
188660,brain-imaging,0,0
188661,markers,0,0
188662,of,0,0
188663,the,0,0
188664,biological,0,0
188665,effects,0,0
188666,of,0,0
188667,the,0,0
188668,interventions,0,0
188669,.,0,0
188670,The,0,0
188671,trial,0,0
188672,will,0,0
188673,be,0,0
188674,conducted,0,0
188675,in,0,0
188676,urban,1,1
188677,New,1,1
188678,South,1,1
188679,Wales,1,0
188680,",",1,0
188681,Australia,1,1
188682,",",0,0
188683,and,0,0
188684,will,0,0
188685,recruit,0,0
188686,a,0,0
188687,community-based,1,1
188688,sample,1,1
188689,of,1,0
188690,450,1,1
188691,adults,1,1
188692,.,1,1
188693,Using,0,0
188694,intention-to-treat,0,0
188695,methods,0,1
188696,",",0,0
188697,the,0,0
188698,primary,0,0
188699,endpoint,0,0
188700,is,0,0
188701,an,0,0
188702,absence,0,0
188703,of,0,0
188704,clinically,0,0
188705,relevant,0,0
188706,depression,0,1
188707,scores,0,0
188708,at,0,1
188709,12,0,1
188710,months,0,0
188711,between,0,0
188712,the,0,0
188713,omega-3,0,0
188714,fatty,0,0
188715,acid,0,0
188716,and,0,0
188717,sertraline,0,0
188718,interventions,0,0
188719,and,0,0
188720,the,0,0
188721,placebo,0,0
188722,condition,0,0
188723,.,0,0
188724,DISCUSSION,0,0
188725,The,0,0
188726,current,0,0
188727,health,0,0
188728,",",0,0
188729,social,0,0
188730,and,0,0
188731,economic,0,0
188732,costs,0,0
188733,of,0,0
188734,late-life,0,1
188735,depression,0,1
188736,make,0,0
188737,prevention,0,0
188738,imperative,0,0
188739,from,0,0
188740,a,0,0
188741,public,0,1
188742,health,0,1
188743,perspective,0,0
188744,.,0,0
188745,This,0,0
188746,innovative,0,0
188747,trial,0,0
188748,aims,0,0
188749,to,0,0
188750,address,0,0
188751,the,0,0
188752,long-neglected,0,0
188753,area,0,0
188754,of,0,0
188755,prevention,0,0
188756,of,0,0
188757,depression,0,1
188758,in,0,0
188759,older,0,1
188760,adults,0,1
188761,.,0,0
188762,The,0,0
188763,interventions,0,0
188764,are,0,0
188765,targeted,0,0
188766,to,0,0
188767,the,0,0
188768,pathophysiology,0,0
188769,of,0,0
188770,disease,0,1
188771,",",0,0
188772,and,0,0
188773,regardless,0,0
188774,of,0,0
188775,the,0,0
188776,effect,0,0
188777,size,0,0
188778,of,0,0
188779,treatment,0,0
188780,",",0,0
188781,the,0,0
188782,outcomes,0,0
188783,will,0,0
188784,offer,0,0
188785,major,0,0
188786,scientific,0,0
188787,advances,0,0
188788,regarding,0,0
188789,the,0,0
188790,neurobiological,0,0
188791,action,0,0
188792,of,0,0
188793,these,0,0
188794,agents,0,0
188795,.,0,0
188796,The,0,0
188797,main,0,0
188798,results,0,0
188799,are,0,0
188800,expected,0,0
188801,to,0,0
188802,be,0,0
188803,available,0,0
188804,in,0,0
188805,2017,0,1
188806,.,0,1
188807,TRIAL,0,0
188808,REGISTRATION,0,0
188809,Australian,0,1
188810,and,0,0
188811,New,0,1
188812,Zealand,0,1
188813,Clinical,0,0
188814,Trials,0,1
188815,Registry,0,1
188816,ACTRN12610000032055,0,1
188817,(,0,1
188818,12,0,1
188819,January,0,1
188820,2010,0,1
188821,),0,1
188822,.,0,1
188823,Assessment,0,0
188824,from,0,1
188825,Functional,0,1
188826,Perspectives,0,1
188827,:,0,1
188828,Using,0,1
188829,Sensorimotor,0,0
188830,Control,0,1
188831,in,0,0
188832,the,0,0
188833,Hand,0,0
188834,as,0,0
188835,an,0,0
188836,Outcome,0,0
188837,Indicator,0,1
188838,in,0,0
188839,the,0,0
188840,Surgical,0,1
188841,Treatment,0,0
188842,of,0,0
188843,Carpal,1,1
188844,Tunnel,1,1
188845,Syndrome,1,1
188846,.,1,0
188847,To,0,0
188848,investigate,0,0
188849,whether,0,0
188850,sensorimotor,0,0
188851,control,0,0
188852,of,0,0
188853,the,0,0
188854,hand,0,0
188855,could,0,0
188856,be,0,0
188857,an,0,0
188858,outcome,0,0
188859,indicator,0,0
188860,after,0,0
188861,carpal,0,1
188862,tunnel,0,1
188863,release,0,0
188864,(,0,0
188865,CTR,0,0
188866,),0,0
188867,",",0,0
188868,this,0,0
188869,work,0,0
188870,examined,0,0
188871,changes,0,0
188872,in,0,0
188873,the,0,0
188874,results,0,0
188875,of,0,0
188876,patients,0,1
188877,',0,1
188878,manual,0,0
188879,tactile,0,0
188880,test,0,0
188881,(,0,0
188882,MTT,0,0
188883,),0,0
188884,",",0,0
188885,pinch-holding-up,0,0
188886,activity,0,0
188887,(,0,0
188888,PHUA,0,1
188889,),0,0
188890,",",0,0
188891,two-point,0,0
188892,discrimination,0,0
188893,(,0,0
188894,2PD,0,0
188895,),0,0
188896,and,0,0
188897,Semmes-Weinstein,0,0
188898,monofilament,0,0
188899,(,0,0
188900,SWM,0,0
188901,),0,1
188902,tests,0,0
188903,.,0,1
188904,Participants,0,1
188905,included,0,1
188906,30,1,1
188907,predominantly,1,1
188908,sensory,1,0
188909,neuropathy,1,1
188910,CTS,1,0
188911,patients,1,1
188912,",",1,0
188913,as,1,0
188914,confirmed,1,0
188915,by,1,0
188916,a,1,0
188917,nerve,1,0
188918,conduction,1,0
188919,study,1,0
188920,.,1,0
188921,The,0,0
188922,MTT,0,0
188923,",",0,0
188924,precision,0,0
188925,pinch,0,0
188926,performance,0,0
188927,in,0,0
188928,PHUA,0,1
188929,and,0,0
188930,traditional,0,0
188931,sensibility,0,0
188932,(,0,0
188933,2PD,0,0
188934,and,0,0
188935,SWM,0,0
188936,),0,1
188937,tests,0,0
188938,were,0,1
188939,used,0,0
188940,to,0,0
188941,examine,0,0
188942,different,0,0
188943,aspects,0,0
188944,of,0,0
188945,sensory,0,0
188946,status,0,1
188947,at,0,0
188948,the,0,0
188949,time-points,0,0
188950,of,0,0
188951,two,0,0
188952,weeks,0,0
188953,before,0,0
188954,operation,0,1
188955,and,0,0
188956,one,0,0
188957,month,0,0
188958,post-operation,0,0
188959,",",0,0
188960,with,0,1
188961,a,0,0
188962,single-blind,0,0
188963,design,0,0
188964,.,0,0
188965,The,0,0
188966,results,0,0
188967,showed,0,0
188968,significant,0,0
188969,improvements,0,0
188970,in,0,0
188971,the,0,0
188972,sensory,0,0
188973,function,0,0
188974,as,0,0
188975,detected,0,0
188976,by,0,0
188977,the,0,0
188978,2PD,0,0
188979,and,0,0
188980,SWM,0,0
188981,tests,0,0
188982,(,0,1
188983,p,0,0
188984,<,0,0
188985,0.001,0,0
188986,),0,0
188987,and,0,0
188988,sensorimotor,0,0
188989,function,0,0
188990,as,0,0
188991,detected,0,0
188992,by,0,0
188993,the,0,0
188994,MTT,0,0
188995,(,0,0
188996,p,0,0
188997,<,0,0
188998,0.001,0,0
188999,),0,0
189000,and,0,0
189001,PHUA,0,1
189002,test,0,0
189003,(,0,0
189004,p,0,0
189005,<,0,0
189006,0.05,0,0
189007,),0,0
189008,for,0,0
189009,patients,0,1
189010,receiving,0,1
189011,CTR,0,1
189012,.,0,0
189013,The,0,0
189014,responsiveness,0,0
189015,of,0,0
189016,the,0,0
189017,SWM,0,0
189018,",",0,0
189019,MTT,0,0
189020,and,0,0
189021,PHUA,0,1
189022,tests,0,0
189023,(,0,0
189024,effect,0,0
189025,size,0,0
189026,>,0,1
189027,0.5,0,0
189028,",",0,0
189029,p,0,0
189030,<,0,0
189031,0.01,0,0
189032,),0,0
189033,are,0,0
189034,better,0,0
189035,than,0,0
189036,that,0,0
189037,of,0,0
189038,two-point,0,0
189039,discrimination,0,0
189040,test,0,0
189041,(,0,0
189042,effect,0,0
189043,size,0,0
189044,<,0,0
189045,0.5,0,0
189046,",",0,0
189047,p,0,0
189048,<,0,0
189049,0.001,0,0
189050,),0,0
189051,.,0,0
189052,However,0,0
189053,",",0,0
189054,pinch,0,0
189055,strength,0,0
189056,saw,0,0
189057,a,0,0
189058,decline,0,0
189059,compared,0,0
189060,to,0,0
189061,baseline,0,0
189062,with,0,1
189063,a,0,0
189064,moderate,0,1
189065,effect,0,0
189066,sizes,0,0
189067,(,0,0
189068,effect,0,0
189069,size,0,0
189070,=,0,0
189071,0.7,0,0
189072,",",0,0
189073,p,0,0
189074,<,0,0
189075,0.001,0,0
189076,),0,0
189077,.,0,0
189078,This,0,0
189079,cohort,0,0
189080,study,0,0
189081,found,0,0
189082,that,0,0
189083,the,0,0
189084,MTT,0,0
189085,and,0,0
189086,PHUA,0,1
189087,test,0,0
189088,can,0,0
189089,both,0,0
189090,meet,0,0
189091,all,0,0
189092,the,0,0
189093,statistical,0,0
189094,criteria,0,1
189095,with,0,1
189096,regard,0,0
189097,to,0,0
189098,assessing,0,0
189099,treatment,0,0
189100,outcomes,0,0
189101,for,0,0
189102,patients,1,1
189103,with,1,1
189104,CTS,1,0
189105,.,1,1
189106,In,0,0
189107,addition,0,0
189108,",",0,0
189109,the,0,0
189110,results,0,0
189111,of,0,0
189112,this,0,0
189113,work,0,0
189114,provide,0,0
189115,clinicians,0,0
189116,with,0,0
189117,the,0,0
189118,information,0,0
189119,that,0,0
189120,the,0,0
189121,sensorimotor,0,0
189122,functions,0,0
189123,of,0,0
189124,the,0,0
189125,hands,0,0
189126,",",0,0
189127,as,0,0
189128,assessed,0,0
189129,by,0,0
189130,MTT,0,0
189131,and,0,0
189132,PHUA,0,1
189133,",",0,0
189134,are,0,0
189135,responsive,0,0
189136,to,0,0
189137,clinical,0,0
189138,changes,0,0
189139,due,0,1
189140,to,0,1
189141,CTR,0,1
189142,.,0,1
189143,Self-management,0,0
189144,education,0,0
189145,for,0,0
189146,adults,1,1
189147,with,1,1
189148,poorly,1,1
189149,controlled,1,0
189150,epilepsy,1,1
189151,(,1,0
189152,SMILE,1,0
189153,(,1,0
189154,UK,1,1
189155,),1,1
189156,),1,1
189157,:,1,1
189158,statistical,0,0
189159,",",0,0
189160,economic,0,0
189161,and,0,0
189162,qualitative,0,0
189163,analysis,0,0
189164,plan,0,0
189165,for,0,0
189166,a,0,0
189167,randomised,0,0
189168,controlled,0,0
189169,trial,0,0
189170,.,0,0
189171,BACKGROUND,0,0
189172,There,0,0
189173,is,0,0
189174,a,0,0
189175,need,0,0
189176,to,0,0
189177,test,0,0
189178,the,0,0
189179,effectiveness,0,0
189180,of,0,0
189181,new,0,0
189182,educational,0,1
189183,interventions,0,0
189184,for,0,0
189185,people,0,1
189186,with,0,1
189187,poorly,0,1
189188,controlled,0,0
189189,epilepsy,0,1
189190,.,0,0
189191,The,0,0
189192,SMILE,1,0
189193,(,1,0
189194,self-management,1,0
189195,education,1,0
189196,for,1,0
189197,adults,1,1
189198,with,1,1
189199,poorly,1,1
189200,controlled,1,0
189201,epilepsy,1,1
189202,),1,0
189203,trial,1,0
189204,evaluates,0,0
189205,a,0,0
189206,complex,0,0
189207,service,0,1
189208,intervention,0,0
189209,that,0,0
189210,involves,0,0
189211,a,0,0
189212,2-day,0,0
189213,self-management,0,0
189214,course,0,0
189215,with,0,1
189216,the,0,0
189217,aim,0,0
189218,of,0,0
189219,improving,0,0
189220,quality,0,0
189221,of,0,0
189222,life,0,0
189223,and,0,0
189224,clinical,0,0
189225,outcomes,0,0
189226,.,0,1
189227,This,0,0
189228,article,0,0
189229,describes,0,0
189230,the,0,0
189231,statistical,0,0
189232,",",0,0
189233,economic,0,0
189234,",",0,0
189235,and,0,0
189236,qualitative,0,0
189237,analysis,0,0
189238,plan,0,0
189239,for,0,0
189240,the,0,0
189241,trial,0,0
189242,.,0,0
189243,METHODS,0,0
189244,AND,0,0
189245,DESIGN,0,0
189246,SMILE,1,0
189247,is,1,0
189248,a,1,0
189249,pragmatic,1,0
189250,",",1,0
189251,parallel,1,0
189252,design,1,0
189253,",",1,0
189254,two-arm,1,0
189255,",",1,0
189256,multi-centre,1,0
189257,randomised,1,0
189258,controlled,1,0
189259,superiority,1,0
189260,trial,1,0
189261,of,1,0
189262,a,1,0
189263,group-based,1,0
189264,interactive,1,0
189265,course,1,0
189266,compared,1,0
189267,with,1,1
189268,treatment,1,0
189269,as,1,0
189270,usual,1,1
189271,for,1,1
189272,people,1,1
189273,who,1,1
189274,have,1,1
189275,experienced,1,1
189276,two,1,0
189277,or,1,1
189278,more,1,0
189279,seizures,1,1
189280,in,1,0
189281,the,1,0
189282,past,1,0
189283,12,1,1
189284,months,1,0
189285,.,1,1
189286,RESULTS,0,0
189287,A,0,0
189288,summary,0,0
189289,of,0,0
189290,the,0,0
189291,objectives,0,0
189292,and,0,0
189293,design,0,0
189294,of,0,0
189295,the,0,0
189296,trial,0,0
189297,are,0,0
189298,reported,0,0
189299,as,0,0
189300,well,0,0
189301,as,0,0
189302,the,0,0
189303,manner,0,0
189304,in,0,0
189305,which,0,0
189306,the,0,0
189307,data,0,0
189308,will,0,0
189309,be,0,0
189310,summarised,0,0
189311,and,0,0
189312,inferentially,0,0
189313,analysed,0,0
189314,.,0,0
189315,This,0,0
189316,includes,0,0
189317,the,0,0
189318,type,0,0
189319,of,0,0
189320,modelling,0,0
189321,that,0,0
189322,will,0,0
189323,be,0,0
189324,employed,0,0
189325,for,0,0
189326,each,0,0
189327,of,0,0
189328,the,0,0
189329,primary,0,0
189330,and,0,0
189331,secondary,0,1
189332,outcomes,0,0
189333,and,0,1
189334,the,0,0
189335,methods,0,1
189336,by,0,0
189337,which,0,0
189338,the,0,0
189339,assumptions,0,0
189340,of,0,0
189341,these,0,0
189342,models,0,0
189343,will,0,0
189344,be,0,0
189345,checked,0,0
189346,.,0,0
189347,Strategies,0,0
189348,are,0,0
189349,described,0,0
189350,for,0,0
189351,handling,0,0
189352,clustering,0,0
189353,of,0,0
189354,outcome,0,0
189355,data,0,0
189356,",",0,0
189357,missing,0,0
189358,observations,0,0
189359,",",0,0
189360,and,0,0
189361,treatment,0,0
189362,non-compliance,0,0
189363,.,0,0
189364,CONCLUSION,0,0
189365,This,0,0
189366,update,0,0
189367,to,0,0
189368,the,0,0
189369,previously,0,0
189370,published,0,0
189371,trial,0,0
189372,protocol,0,0
189373,provides,0,0
189374,a,0,0
189375,description,0,0
189376,of,0,0
189377,the,0,0
189378,trial,0,0
189379,analysis,0,0
189380,which,0,0
189381,is,0,0
189382,transparent,0,0
189383,and,0,0
189384,specified,0,0
189385,before,0,0
189386,any,0,0
189387,outcome,0,0
189388,data,0,0
189389,are,0,0
189390,available,0,0
189391,.,0,0
189392,It,0,0
189393,also,0,0
189394,provides,0,0
189395,guidance,0,0
189396,to,0,0
189397,those,0,0
189398,planning,0,0
189399,the,0,0
189400,analysis,0,0
189401,of,0,0
189402,similar,0,0
189403,trials,0,1
189404,.,0,1
189405,TRIAL,0,0
189406,REGISTRATION,0,0
189407,Current,0,1
189408,Controlled,0,1
189409,Trials,0,1
189410,ISRCTN57937389,0,0
189411,;,0,0
189412,date,0,0
189413,assigned,0,1
189414,:,0,1
189415,27,0,1
189416,March,0,1
189417,2013,0,1
189418,.,0,1
189419,A,0,0
189420,Randomized,0,0
189421,",",0,0
189422,Placebo-Controlled,0,0
189423,Trial,0,1
189424,Evaluating,0,0
189425,Safety,0,0
189426,and,0,0
189427,Immunogenicity,0,0
189428,of,0,0
189429,the,0,0
189430,Killed,0,1
189431,",",0,0
189432,Bivalent,0,0
189433,",",0,0
189434,Whole-Cell,0,0
189435,Oral,0,0
189436,Cholera,0,1
189437,Vaccine,0,0
189438,in,1,0
189439,Ethiopia,1,1
189440,.,1,1
189441,Killed,0,0
189442,whole-cell,0,0
189443,oral,0,0
189444,cholera,0,0
189445,vaccine,0,0
189446,(,0,0
189447,OCV,0,0
189448,),0,0
189449,has,0,0
189450,been,0,0
189451,a,0,0
189452,key,0,0
189453,component,0,0
189454,of,0,0
189455,a,0,0
189456,comprehensive,0,0
189457,package,0,0
189458,including,0,0
189459,water,0,0
189460,and,0,0
189461,sanitation,0,0
189462,measures,0,0
189463,for,0,0
189464,recent,0,1
189465,cholera,0,1
189466,epidemics,0,0
189467,.,0,0
189468,The,0,0
189469,vaccine,0,0
189470,",",0,0
189471,given,0,0
189472,in,0,0
189473,a,0,0
189474,two-dose,0,0
189475,regimen,0,0
189476,",",0,0
189477,has,0,0
189478,been,0,0
189479,evaluated,0,0
189480,in,0,0
189481,a,1,0
189482,large,1,1
189483,number,1,0
189484,of,1,0
189485,human,1,1
189486,volunteers,1,1
189487,in,1,0
189488,India,1,1
189489,",",1,0
189490,Vietnam,1,1
189491,",",1,0
189492,and,1,0
189493,Bangladesh,1,0
189494,",",0,0
189495,where,0,0
189496,it,0,0
189497,has,0,0
189498,demonstrated,0,0
189499,safety,0,0
189500,",",0,0
189501,immunogenicity,0,0
189502,",",0,0
189503,and,0,0
189504,clinical,0,0
189505,efficacy,0,0
189506,.,0,1
189507,We,0,0
189508,conducted,0,0
189509,a,0,0
189510,double-blind,0,0
189511,randomized,0,1
189512,placebo-controlled,0,0
189513,trial,0,0
189514,in,1,0
189515,Ethiopia,1,1
189516,",",0,0
189517,where,0,0
189518,we,0,0
189519,evaluated,1,0
189520,the,1,0
189521,safety,1,0
189522,and,1,0
189523,immunogenicity,1,0
189524,of,1,0
189525,the,1,0
189526,vaccine,1,0
189527,in,1,0
189528,216,1,1
189529,healthy,1,1
189530,adults,1,1
189531,and,1,1
189532,children,1,1
189533,.,1,1
189534,OCV,0,0
189535,was,0,0
189536,found,0,0
189537,to,0,0
189538,be,0,0
189539,safe,0,0
189540,and,0,0
189541,elicited,0,0
189542,a,0,0
189543,robust,0,0
189544,immunological,0,0
189545,response,0,0
189546,against,0,0
189547,Vibrio,0,1
189548,cholerae,0,0
189549,O1,0,0
189550,",",0,0
189551,with,0,1
189552,81,0,1
189553,%,0,0
189554,adults,0,1
189555,and,0,0
189556,77,0,1
189557,%,0,0
189558,children,0,1
189559,demonstrating,0,0
189560,seroconversion,0,1
189561,14,0,1
189562,days,0,0
189563,after,0,0
189564,the,0,0
189565,second,0,0
189566,dose,0,0
189567,of,0,0
189568,vaccine,0,0
189569,.,0,0
189570,This,0,0
189571,is,0,0
189572,the,0,0
189573,first,0,0
189574,study,0,0
189575,to,0,0
189576,evaluate,0,0
189577,safety,0,0
189578,and,0,0
189579,immunogenicity,0,0
189580,of,0,0
189581,the,0,0
189582,vaccine,0,0
189583,in,0,0
189584,a,0,0
189585,population,1,1
189586,outside,1,0
189587,Asia,1,0
189588,using,0,0
189589,a,0,0
189590,placebo-controlled,0,0
189591,",",0,0
189592,double-blind,0,0
189593,",",0,0
189594,randomized,0,0
189595,study,0,0
189596,design,0,1
189597,.,0,1
189598,A,0,0
189599,Randomized,0,0
189600,Controlled,0,0
189601,Trial,0,0
189602,to,0,0
189603,Improve,0,0
189604,Social,0,0
189605,Skills,0,0
189606,in,0,0
189607,Young,1,1
189608,Adults,1,1
189609,with,1,1
189610,Autism,1,1
189611,Spectrum,1,1
189612,Disorder,1,1
189613,:,1,1
189614,The,0,0
189615,UCLA,0,0
189616,PEERS,0,0
189617,(,0,0
189618,?,0,0
189619,),0,0
189620,Program,0,0
189621,.,0,0
189622,Research,0,0
189623,suggests,0,0
189624,that,0,0
189625,impaired,0,1
189626,social,0,1
189627,skills,0,0
189628,are,0,0
189629,often,0,0
189630,the,0,0
189631,most,0,0
189632,significant,0,0
189633,challenge,0,0
189634,for,0,0
189635,those,0,0
189636,with,0,1
189637,autism,0,1
189638,spectrum,0,1
189639,disorder,0,1
189640,(,0,0
189641,ASD,0,1
189642,),0,0
189643,",",0,0
189644,yet,0,0
189645,few,0,0
189646,evidence-based,0,0
189647,social,0,1
189648,skills,0,0
189649,interventions,0,0
189650,exist,0,0
189651,for,1,0
189652,adults,1,1
189653,on,1,0
189654,the,1,0
189655,spectrum,1,1
189656,.,1,0
189657,This,0,0
189658,replication,0,0
189659,trial,0,0
189660,tested,0,0
189661,the,0,0
189662,effectiveness,0,0
189663,of,0,0
189664,PEERS,0,0
189665,",",0,0
189666,a,0,0
189667,caregiver-assisted,0,0
189668,social,0,0
189669,skills,0,0
189670,program,0,1
189671,for,1,0
189672,high-functioning,1,1
189673,young,1,1
189674,adults,1,1
189675,with,1,1
189676,ASD,1,1
189677,.,1,1
189678,Using,0,0
189679,a,0,0
189680,randomized,1,0
189681,controlled,1,0
189682,design,1,0
189683,",",1,0
189684,22,1,1
189685,young,1,1
189686,adults,1,1
189687,18-24,1,1
189688,years,1,1
189689,of,1,0
189690,age,1,1
189691,were,1,0
189692,randomly,1,1
189693,assigned,1,0
189694,to,0,0
189695,a,0,0
189696,treatment,0,0
189697,(,0,0
189698,n,0,1
189699,=,0,0
189700,12,0,1
189701,),0,0
189702,or,0,1
189703,delayed,0,0
189704,treatment,0,0
189705,control,0,0
189706,(,0,0
189707,n,0,1
189708,=,0,0
189709,10,0,1
189710,),0,0
189711,group,0,1
189712,.,0,1
189713,Results,0,0
189714,revealed,0,0
189715,that,0,0
189716,the,0,0
189717,treatment,0,0
189718,group,0,0
189719,improved,0,0
189720,significantly,0,0
189721,in,0,0
189722,overall,0,0
189723,social,0,1
189724,skills,0,0
189725,",",0,0
189726,frequency,0,0
189727,of,0,0
189728,social,0,0
189729,engagement,0,0
189730,",",0,0
189731,and,0,0
189732,social,0,0
189733,skills,0,0
189734,knowledge,0,0
189735,",",0,0
189736,and,0,0
189737,significantly,0,0
189738,reduced,0,0
189739,ASD,0,1
189740,symptoms,0,0
189741,related,0,0
189742,to,0,0
189743,social,0,0
189744,responsiveness,0,0
189745,following,0,0
189746,PEERS,0,0
189747,.,0,1
189748,Most,0,0
189749,treatment,0,0
189750,gains,0,0
189751,were,0,0
189752,maintained,0,0
189753,at,0,0
189754,a,0,0
189755,16-week,0,0
189756,follow-up,0,0
189757,assessment,0,0
189758,with,0,1
189759,new,0,1
189760,improvements,0,0
189761,observed,0,0
189762,.,0,1
189763,Disclosure,0,0
189764,of,0,0
189765,HSV-2,0,0
189766,serological,0,1
189767,test,0,0
189768,results,0,0
189769,in,0,0
189770,the,0,0
189771,context,0,0
189772,of,0,0
189773,an,0,0
189774,adolescent,1,1
189775,HIV,1,1
189776,prevention,1,0
189777,trial,1,0
189778,in,1,0
189779,Kenya,1,1
189780,.,1,1
189781,OBJECTIVES,0,0
189782,Herpes,0,0
189783,simplex,0,1
189784,virus,0,1
189785,type,0,1
189786,2,0,0
189787,(,0,0
189788,HSV-2,0,1
189789,),0,1
189790,biomarkers,0,0
189791,are,0,0
189792,often,0,0
189793,used,0,0
189794,in,0,0
189795,adolescent,1,1
189796,sub-Saharan,1,1
189797,HIV,1,1
189798,prevention,1,1
189799,studies,0,0
189800,",",0,0
189801,but,0,0
189802,evaluations,0,0
189803,of,0,0
189804,test,0,0
189805,performance,0,0
189806,and,0,0
189807,disclosure,0,0
189808,outcomes,0,0
189809,are,0,0
189810,rare,0,0
189811,in,0,0
189812,the,0,0
189813,published,0,0
189814,literature,0,0
189815,.,0,0
189816,Therefore,0,0
189817,",",0,0
189818,we,0,0
189819,investigated,0,0
189820,the,0,0
189821,proportion,0,0
189822,of,0,0
189823,ELISA-positive,0,1
189824,and,0,1
189825,indeterminate,0,1
189826,samples,0,0
189827,confirmed,0,1
189828,by,0,0
189829,western,0,1
189830,blot,0,0
189831,(,0,0
189832,WB,0,0
189833,),0,0
189834,",",0,0
189835,the,0,0
189836,psychosocial,0,0
189837,response,0,0
189838,to,0,0
189839,disclosure,0,0
189840,and,0,0
189841,whether,0,0
189842,reports,0,0
189843,of,0,0
189844,sexual,0,1
189845,behaviour,0,0
189846,and,0,0
189847,HSV-2,0,0
189848,symptoms,0,0
189849,are,0,0
189850,consistent,0,0
189851,with,0,1
189852,WB,0,1
189853,confirmatory,0,1
189854,results,0,0
189855,among,0,1
189856,adolescent,1,1
189857,orphans,1,1
189858,in,1,1
189859,Kenya,1,1
189860,.,1,1
189861,METHODS,0,0
189862,In,0,0
189863,2011,0,1
189864,",",0,0
189865,837,1,1
189866,Kenyan,1,0
189867,orphan,1,1
189868,youth,1,1
189869,in,1,0
189870,grades,1,1
189871,7,1,1
189872,and,1,1
189873,8,1,0
189874,enrolled,1,1
189875,in,1,0
189876,an,1,0
189877,HIV,1,1
189878,prevention,1,0
189879,clinical,1,0
189880,trial,1,0
189881,with,1,1
189882,HSV-2,1,0
189883,biomarker,1,0
189884,outcomes,1,0
189885,.,1,1
189886,We,0,0
189887,used,0,0
189888,a,0,0
189889,modified,0,0
189890,algorithm,0,0
189891,for,0,0
189892,the,0,0
189893,Kalon,0,0
189894,HSV-2,0,0
189895,ELISA,0,1
189896,to,0,0
189897,improve,0,0
189898,specificity,0,0
189899,;,0,0
189900,positive,0,0
189901,and,0,0
189902,indeterminate,0,1
189903,results,0,0
189904,were,0,1
189905,WB,0,1
189906,tested,0,0
189907,.,0,0
189908,We,0,0
189909,developed,0,0
189910,culturally,0,0
189911,sensitive,0,0
189912,protocols,0,0
189913,for,0,0
189914,disclosing,0,0
189915,positive,0,0
189916,results,0,0
189917,",",0,0
189918,and,0,0
189919,documented,0,0
189920,psychosocial,0,1
189921,responses,0,0
189922,",",0,0
189923,reports,0,0
189924,of,0,0
189925,sexual,0,1
189926,contact,0,0
189927,and,0,0
189928,HSV-2,0,1
189929,symptoms,0,0
189930,.,0,1
189931,RESULTS,0,0
189932,28,1,1
189933,adolescents,1,1
189934,(,1,1
189935,3.3,1,0
189936,%,1,0
189937,),1,0
189938,were,0,0
189939,identified,0,0
189940,as,0,0
189941,HSV-2,0,0
189942,seropositive,0,1
189943,",",0,0
189944,six,0,0
189945,as,0,0
189946,indeterminate,0,1
189947,.,0,0
189948,Of,0,0
189949,these,0,0
189950,",",0,0
189951,22,1,1
189952,positive,1,0
189953,and,1,0
189954,all,1,1
189955,indeterminates,1,0
189956,were,1,1
189957,WB,1,1
189958,tested,1,0
189959,;,1,0
189960,20,1,1
189961,and,1,0
189962,5,1,0
189963,",",1,0
189964,respectively,1,0
189965,",",0,0
189966,were,0,0
189967,confirmed,0,0
189968,positive,0,0
189969,.,0,0
189970,Most,0,0
189971,youth,0,1
189972,reported,0,0
189973,moderate,0,1
189974,brief,0,0
189975,stress,0,0
189976,after,0,0
189977,disclosure,0,0
189978,;,0,0
189979,22,0,1
189980,%,0,0
189981,reported,0,0
189982,longer,0,0
189983,and,0,0
189984,more,0,0
189985,severe,0,1
189986,distress,0,0
189987,.,0,1
189988,Boys,0,0
189989,were,0,0
189990,more,0,0
189991,likely,0,0
189992,to,0,0
189993,be,0,0
189994,in,0,0
189995,the,0,0
189996,latter,0,0
189997,category,0,0
189998,.,0,1
189999,Self-reported,0,0
190000,virginity,0,1
190001,was,0,0
190002,highly,0,0
190003,inconsistent,0,0
190004,with,0,1
190005,WB-confirmed,0,1
190006,positives,0,0
190007,.,0,1
190008,CONCLUSIONS,0,0
190009,The,0,0
190010,higher,0,0
190011,than,0,0
190012,manufacturer,0,0
190013,'s,0,1
190014,cut-off,0,0
190015,for,0,0
190016,Kalon,0,0
190017,ELISA,0,1
190018,modestly,0,0
190019,reduced,0,0
190020,the,0,0
190021,rate,0,0
190022,of,0,0
190023,false-positive,0,0
190024,test,0,0
190025,results,0,0
190026,",",0,0
190027,but,0,0
190028,also,0,0
190029,increased,0,0
190030,false,0,0
190031,negatives,0,0
190032,.,0,1
190033,Investigators,0,0
190034,should,0,0
190035,consider,0,0
190036,the,0,0
190037,risk,0,0
190038,:,0,1
190039,benefit,0,0
190040,ratio,0,0
190041,in,0,0
190042,deciding,0,0
190043,whether,0,0
190044,or,0,1
190045,not,0,0
190046,to,0,0
190047,disclose,0,0
190048,HSV-2,0,0
190049,results,0,0
190050,to,0,1
190051,adolescent,1,1
190052,participants,1,1
190053,under,0,0
190054,specific,0,0
190055,field,0,0
190056,conditions,0,0
190057,.,0,1
190058,TRIAL,0,0
190059,REGISTRATION,0,0
190060,NUMBER,0,1
190061,NCT01501864,0,1
190062,.,0,1
190063,Optimal,0,0
190064,vaccination,0,1
190065,program,0,0
190066,for,0,0
190067,healthy,1,1
190068,adults,1,1
190069,in,1,1
190070,China,1,1
190071,.,1,0
190072,There,0,0
190073,is,0,0
190074,still,0,0
190075,no,0,0
190076,suitable,0,0
190077,routine,0,0
190078,hepatitis,0,1
190079,B,0,0
190080,immunization,0,0
190081,strategy,0,0
190082,for,0,0
190083,adults,1,1
190084,in,1,1
190085,China,1,1
190086,.,1,1
190087,To,0,0
190088,establish,0,0
190089,an,0,0
190090,optimal,0,0
190091,vaccination,0,0
190092,schedule,0,0
190093,for,0,0
190094,healthy,1,1
190095,adults,1,1
190096,",",0,0
190097,we,0,0
190098,investigated,0,0
190099,various,0,0
190100,schedules,0,0
190101,in,0,1
190102,healthy,1,1
190103,adults,1,1
190104,.,1,1
190105,In,0,0
190106,this,0,0
190107,randomized,0,1
190108,5143,1,1
190109,healthy,1,1
190110,adults,1,1
190111,received,1,1
190112,10,1,1
190113,?g,1,0
190114,hepatitis,1,1
190115,B,1,0
190116,vaccine,1,0
190117,at,1,0
190118,0,1,0
190119,",",1,0
190120,1,1,0
190121,and,1,0
190122,3,1,0
190123,months,1,0
190124,(,1,1
190125,group,1,1
190126,A,1,0
190127,),1,0
190128,",",1,0
190129,0,1,0
190130,",",1,0
190131,1,1,0
190132,and,1,0
190133,6,1,0
190134,months,1,0
190135,(,1,1
190136,group,1,1
190137,B,1,1
190138,),1,0
190139,",",1,0
190140,or,1,0
190141,0,1,0
190142,",",1,0
190143,1,1,0
190144,and,1,0
190145,12,1,1
190146,months,1,0
190147,(,1,1
190148,group,1,1
190149,C,1,0
190150,),1,0
190151,.,1,0
190152,Blood,0,0
190153,samples,0,0
190154,were,0,0
190155,collected,0,1
190156,after,0,0
190157,1,0,0
190158,month,0,0
190159,and,0,1
190160,12,0,0
190161,months,0,0
190162,after,0,0
190163,the,0,0
190164,third,0,0
190165,dose,0,0
190166,.,0,0
190167,The,0,0
190168,geometric,0,0
190169,mean,0,0
190170,titer,0,0
190171,(,0,0
190172,GMT,0,0
190173,),0,0
190174,",",0,0
190175,seroconversion,0,0
190176,rate,0,0
190177,(,0,0
190178,levels,0,0
190179,of,0,0
190180,anti-HBs,0,1
190181,?,0,0
190182,10,0,0
190183,mIU/mL,0,0
190184,),0,0
190185,and,0,0
190186,high,0,0
190187,response,0,0
190188,rate,0,0
190189,(,0,0
190190,levels,0,0
190191,of,0,0
190192,anti-HBs,0,1
190193,?,0,0
190194,100,0,0
190195,mIU/mL,0,0
190196,),0,0
190197,were,0,0
190198,assayed,0,0
190199,.,0,0
190200,In,0,0
190201,our,0,0
190202,study,0,0
190203,",",1,0
190204,2438,1,1
190205,healthy,1,1
190206,adults,1,1
190207,finished,1,0
190208,the,1,0
190209,full,1,0
190210,vaccination,1,0
190211,program,1,0
190212,and,1,0
190213,follow-up,1,0
190214,.,1,0
190215,The,1,0
190216,seroconversion/sero-protective,0,0
190217,rate,0,0
190218,of,0,0
190219,groups,0,0
190220,A-C,0,1
190221,at,0,1
190222,one,0,1
190223,and,0,0
190224,12,0,0
190225,month,0,0
190226,after,0,0
190227,administration,0,0
190228,of,0,0
190229,the,0,0
190230,third,0,0
190231,vaccine,0,0
190232,dose,0,0
190233,was,0,0
190234,100,0,0
190235,%,0,0
190236,",",0,0
190237,99.9,0,0
190238,%,0,0
190239,and,0,0
190240,97.9,0,0
190241,%,0,0
190242,verse,0,0
190243,64.9,0,0
190244,%,0,0
190245,",",0,0
190246,75.7,0,0
190247,%,0,0
190248,and,0,0
190249,79.0,0,0
190250,%,0,0
190251,",",0,0
190252,respectively,0,0
190253,.,0,0
190254,GMT,0,0
190255,for,0,0
190256,anti-HBs,0,0
190257,tested,0,0
190258,in,0,0
190259,group,0,0
190260,A,0,1
190261,to,0,0
190262,C,0,0
190263,within,0,0
190264,1,0,0
190265,or,0,1
190266,12,0,0
190267,month,0,0
190268,after,0,0
190269,the,0,0
190270,third,0,0
190271,vaccination,0,1
190272,was,0,0
190273,213.16,0,0
190274,",",0,0
190275,432.58,0,0
190276,and,0,0
190277,451.47,0,0
190278,mIU/ml,0,1
190279,verse,0,0
190280,22.07,0,0
190281,",",0,0
190282,46.70,0,0
190283,and,0,0
190284,56.18,0,1
190285,mIU/ml,0,0
190286,",",0,0
190287,respectively,0,0
190288,.,0,0
190289,There,0,0
190290,were,0,0
190291,significant,0,0
190292,differences,0,0
190293,of,0,0
190294,seroconversion/sero-protective,0,0
190295,rate,0,0
190296,and,0,0
190297,GMT,0,0
190298,among,0,0
190299,the,0,0
190300,3,0,0
190301,groups,0,0
190302,(,0,1
190303,p,0,0
190304,<,0,0
190305,0.01,0,0
190306,),0,1
190307,.,0,0
190308,Given,0,0
190309,the,0,0
190310,high,0,0
190311,anti-HBs,0,0
190312,seroconversion,0,1
190313,rate,0,0
190314,and,0,0
190315,GMT,0,0
190316,in,0,0
190317,all,0,1
190318,3,0,0
190319,groups,0,0
190320,",",0,0
190321,a,0,0
190322,flexible,0,0
190323,schedule,0,0
190324,for,0,0
190325,Hepatitis,0,1
190326,B,0,0
190327,vaccine,0,0
190328,should,0,0
190329,be,0,0
190330,recommended,0,0
190331,to,0,0
190332,adults,0,1
190333,",",0,0
190334,but,0,0
190335,0-1-12,0,0
190336,schedule,0,0
190337,is,0,0
190338,a,0,0
190339,better,0,0
190340,choice,0,0
190341,.,0,0
190342,A,0,0
190343,pilot,0,0
190344,double-blind,0,0
190345,placebo-controlled,0,0
190346,trial,0,0
190347,of,0,0
190348,pioglitazone,0,0
190349,as,0,0
190350,adjunctive,0,0
190351,treatment,0,0
190352,to,0,0
190353,risperidone,0,0
190354,:,0,1
190355,Effects,0,0
190356,on,0,0
190357,aberrant,0,0
190358,behavior,0,0
190359,in,0,0
190360,children,1,1
190361,with,1,1
190362,autism,1,1
190363,.,1,0
190364,To,0,0
190365,assess,0,0
190366,the,0,0
190367,safety,0,0
190368,and,0,0
190369,efficacy,0,0
190370,of,0,0
190371,pioglitazone,0,0
190372,added,0,0
190373,to,0,0
190374,risperidone,0,0
190375,in,0,0
190376,the,0,0
190377,treatment,0,0
190378,of,0,0
190379,irritability,0,0
190380,in,0,0
190381,autistic,1,1
190382,disorder,1,1
190383,(,1,0
190384,AD,1,0
190385,),1,0
190386,",",0,0
190387,we,0,0
190388,conducted,0,0
190389,this,0,0
190390,study,0,0
190391,.,0,0
190392,In,0,0
190393,a,0,0
190394,10-week,0,0
190395,",",0,0
190396,randomized,0,0
190397,",",0,0
190398,double-blind,0,0
190399,",",0,0
190400,parallel-group,0,0
190401,",",0,0
190402,placebo-controlled,0,0
190403,clinical,0,0
190404,trial,0,0
190405,",",0,0
190406,44,1,1
190407,outpatients,1,1
190408,of,1,0
190409,both,1,0
190410,genders,1,0
190411,aged,1,1
190412,4-12,1,1
190413,years,1,1
190414,with,1,1
190415,a,1,0
190416,diagnosis,1,1
190417,of,1,0
190418,AD,1,0
190419,and,1,0
190420,a,1,0
190421,score,1,0
190422,of,1,0
190423,?12,1,0
190424,on,1,0
190425,the,1,0
190426,Aberrant,1,1
190427,Behavior,1,1
190428,Checklist-Community,1,0
190429,(,1,0
190430,ABC-C,1,0
190431,),1,0
190432,irritability,1,0
190433,subscale,1,0
190434,were,1,0
190435,included,1,1
190436,.,1,0
190437,Mean,0,0
190438,change,0,0
190439,of,0,0
190440,ABC-C,0,0
190441,irritability,0,0
190442,subscale,0,0
190443,score,0,0
190444,as,0,0
190445,primary,0,0
190446,outcome,0,0
190447,",",0,0
190448,change,0,0
190449,in,0,0
190450,other,0,0
190451,ABC-C,0,1
190452,subscale,0,0
190453,scores,0,0
190454,and,0,0
190455,partial,0,1
190456,and,0,0
190457,complete,0,1
190458,responses,0,0
190459,were,0,1
190460,compared,0,0
190461,between,0,0
190462,two,0,0
190463,groups,1,1
190464,.,1,1
190465,Twenty,1,1
190466,patients,1,1
190467,completed,1,1
190468,the,0,0
190469,trial,0,0
190470,in,0,0
190471,each,0,0
190472,group,0,0
190473,.,0,0
190474,Level,0,0
190475,of,0,0
190476,reduction,0,0
190477,and,0,0
190478,effect,0,0
190479,of,0,0
190480,time?treatment,0,0
190481,interaction,0,0
190482,in,0,0
190483,the,0,0
190484,treatment,0,0
190485,group,0,0
190486,were,0,0
190487,significant,0,0
190488,for,0,0
190489,irritability,0,0
190490,(,0,0
190491,P=0.03,0,0
190492,),0,0
190493,",",0,0
190494,lethargy/social,0,0
190495,withdrawal,0,0
190496,(,0,0
190497,P=0.04,0,0
190498,),0,0
190499,and,0,0
190500,hyperactivity/non-compliance,0,0
190501,(,0,0
190502,P=0.03,0,0
190503,),0,0
190504,but,0,0
190505,not,0,0
190506,for,0,0
190507,stereotypic,0,1
190508,behavior,0,0
190509,and,0,0
190510,inappropriate,0,0
190511,speech,0,0
190512,subscales,0,0
190513,compared,0,0
190514,with,0,1
190515,the,0,0
190516,placebo,0,0
190517,group,0,0
190518,.,0,0
190519,Vomiting,0,0
190520,and,0,0
190521,headache,0,0
190522,were,0,0
190523,the,0,0
190524,most,0,0
190525,frequent,0,0
190526,reported,0,0
190527,side-effects,0,0
190528,.,0,1
190529,Results,0,0
190530,of,0,0
190531,this,0,0
190532,preliminary,0,0
190533,study,0,0
190534,indicate,0,0
190535,positive,0,0
190536,effects,0,0
190537,of,0,0
190538,pioglitazone,0,0
190539,compared,0,0
190540,with,0,1
190541,placebo,0,0
190542,in,0,0
190543,improving,0,0
190544,the,0,0
190545,behavioral,0,0
190546,symptoms,0,0
190547,of,0,1
190548,AD,0,1
190549,.,0,1
190550,The,0,0
190551,VA,0,0
190552,augmentation,0,0
190553,and,0,0
190554,switching,0,0
190555,treatments,0,0
190556,for,0,0
190557,improving,0,0
190558,depression,0,1
190559,outcomes,0,0
190560,(,0,1
190561,VAST-D,0,1
190562,),0,1
190563,study,0,1
190564,:,0,1
190565,Rationale,0,0
190566,and,0,0
190567,design,0,1
190568,considerations,0,0
190569,.,0,1
190570,Because,0,0
190571,two-thirds,0,1
190572,of,0,1
190573,patients,1,1
190574,with,1,1
190575,Major,1,1
190576,Depressive,1,0
190577,Disorder,1,1
190578,do,0,0
190579,not,0,0
190580,achieve,0,0
190581,remission,0,0
190582,with,0,1
190583,their,0,0
190584,first,0,0
190585,antidepressant,0,0
190586,",",0,0
190587,we,0,0
190588,designed,0,0
190589,a,0,0
190590,trial,0,0
190591,of,0,0
190592,three,0,0
190593,next-step,0,0
190594,strategies,0,0
190595,:,0,1
190596,switching,0,0
190597,to,0,0
190598,another,0,0
190599,antidepressant,0,0
190600,(,0,0
190601,bupropion-SR,0,0
190602,),0,0
190603,or,0,1
190604,augmenting,0,0
190605,the,0,0
190606,current,0,0
190607,antidepressant,0,0
190608,with,0,1
190609,either,0,0
190610,another,0,0
190611,antidepressant,0,0
190612,(,0,0
190613,bupropion-SR,0,0
190614,),0,0
190615,or,0,1
190616,with,0,1
190617,an,0,0
190618,atypical,0,1
190619,antipsychotic,0,0
190620,(,0,0
190621,aripiprazole,0,0
190622,),0,0
190623,.,0,0
190624,The,0,0
190625,study,0,0
190626,will,0,0
190627,compare,0,0
190628,12-week,0,0
190629,remission,0,0
190630,rates,0,0
190631,and,0,0
190632,",",0,0
190633,among,0,1
190634,those,0,1
190635,who,0,1
190636,have,0,1
190637,at,0,1
190638,least,0,0
190639,a,0,0
190640,partial,0,0
190641,response,0,0
190642,",",0,0
190643,relapse,0,0
190644,rates,0,0
190645,for,0,0
190646,up,0,0
190647,to,0,1
190648,6,0,0
190649,months,0,0
190650,of,0,0
190651,additional,0,0
190652,treatment,0,0
190653,.,0,0
190654,We,0,0
190655,review,0,0
190656,seven,0,1
190657,key,0,0
190658,efficacy/effectiveness,0,0
190659,design,0,1
190660,decisions,0,0
190661,in,0,0
190662,this,0,0
190663,mixed,0,0
190664,efficacy-effectiveness,0,0
190665,trial,0,1
190666,.,0,1
190667,U.S.,0,0
190668,Food,0,1
190669,and,0,0
190670,Drug,0,0
190671,Administration,0,0
190672,Approval,0,1
190673,Summary,0,1
190674,:,0,1
190675,Ramucirumab,0,0
190676,for,0,0
190677,the,0,0
190678,Treatment,0,0
190679,of,0,0
190680,Metastatic,1,1
190681,Non-Small,1,1
190682,Cell,1,1
190683,Lung,1,0
190684,Cancer,1,1
190685,Following,1,1
190686,Disease,1,1
190687,Progression,1,1
190688,On,1,0
190689,or,1,1
190690,After,1,0
190691,Platinum-Based,1,1
190692,Chemotherapy,1,1
190693,.,1,0
190694,UNLABELLED,0,0
190695,On,0,0
190696,December,0,1
190697,12,0,0
190698,",",0,0
190699,2014,0,1
190700,",",0,0
190701,the,0,0
190702,U.S.,0,0
190703,Food,0,1
190704,and,0,0
190705,Drug,0,0
190706,Administration,0,0
190707,(,0,0
190708,FDA,0,1
190709,),0,0
190710,approved,0,0
190711,ramucirumab,0,0
190712,for,0,0
190713,use,0,0
190714,in,0,0
190715,combination,0,0
190716,with,0,1
190717,docetaxel,0,0
190718,for,0,0
190719,the,0,0
190720,treatment,0,0
190721,of,0,0
190722,patients,1,1
190723,with,1,1
190724,metastatic,1,1
190725,non-small,1,1
190726,cell,1,1
190727,lung,1,1
190728,cancer,1,1
190729,(,1,0
190730,NSCLC,1,0
190731,),1,0
190732,with,1,1
190733,disease,1,1
190734,progression,1,0
190735,on,1,0
190736,or,1,1
190737,after,1,0
190738,platinum-based,1,0
190739,chemotherapy,1,1
190740,.,1,1
190741,Patients,1,1
190742,with,1,1
190743,epidermal,1,1
190744,growth,1,0
190745,factor,1,0
190746,receptor,1,0
190747,or,1,1
190748,anaplastic,1,1
190749,lymphoma,1,1
190750,kinase,1,0
190751,genomic,1,0
190752,tumor,1,0
190753,aberrations,1,0
190754,should,0,0
190755,have,0,0
190756,disease,0,0
190757,progression,0,0
190758,on,0,0
190759,FDA-approved,0,0
190760,therapy,0,0
190761,for,0,0
190762,these,0,0
190763,aberrations,0,0
190764,prior,0,0
190765,to,0,0
190766,receiving,0,1
190767,ramucirumab,0,0
190768,.,0,0
190769,This,0,0
190770,approval,0,0
190771,was,0,0
190772,based,0,0
190773,on,0,0
190774,an,0,0
190775,improvement,0,0
190776,in,0,0
190777,overall,0,0
190778,survival,0,0
190779,(,0,0
190780,OS,0,0
190781,),0,0
190782,with,0,1
190783,an,0,0
190784,acceptable,0,0
190785,toxicity,0,0
190786,profile,0,0
190787,in,0,0
190788,a,0,0
190789,randomized,0,0
190790,",",0,0
190791,multicenter,0,0
190792,",",0,0
190793,double-blinded,0,0
190794,",",0,0
190795,placebo-controlled,0,0
190796,trial,0,0
190797,of,0,0
190798,"1,253",1,1
190799,patients,1,1
190800,with,1,1
190801,metastatic,1,1
190802,NSCLC,1,0
190803,previously,1,1
190804,treated,1,0
190805,with,1,0
190806,a,1,0
190807,platinum-based,1,0
190808,combination,1,0
190809,therapy,1,0
190810,.,1,1
190811,Patients,0,1
190812,were,0,0
190813,randomized,0,1
190814,1:1,0,0
190815,to,0,0
190816,receive,0,0
190817,either,0,0
190818,ramucirumab,0,0
190819,in,0,0
190820,combination,0,0
190821,with,0,1
190822,docetaxel,0,0
190823,or,0,0
190824,placebo,0,0
190825,in,0,0
190826,combination,0,0
190827,with,0,1
190828,docetaxel,0,0
190829,.,0,0
190830,The,0,0
190831,primary,0,0
190832,endpoint,0,0
190833,was,0,0
190834,OS,0,0
190835,.,0,1
190836,Patients,0,1
190837,who,0,1
190838,received,0,1
190839,ramucirumab,0,1
190840,in,0,0
190841,combination,0,0
190842,with,0,1
190843,docetaxel,0,0
190844,had,0,1
190845,improved,0,0
190846,OS,0,0
190847,(,0,0
190848,hazard,0,0
190849,ratio,0,0
190850,[,0,0
190851,HR,0,0
190852,],0,1
190853,:,0,1
190854,0.86,0,0
190855,;,0,0
190856,95,0,0
190857,%,0,0
190858,confidence,0,0
190859,interval,0,0
190860,[,0,0
190861,CI,0,0
190862,],0,1
190863,:,0,1
190864,0.75,0,0
190865,",",0,0
190866,0.98,0,0
190867,),0,0
190868,.,0,1
190869,Median,0,0
190870,OS,0,0
190871,was,0,0
190872,10.5,0,0
190873,months,0,0
190874,on,0,0
190875,the,0,0
190876,ramucirumab,0,0
190877,plus,0,0
190878,docetaxel,0,0
190879,arm,0,0
190880,versus,0,0
190881,9.1,0,0
190882,months,0,0
190883,on,0,0
190884,the,0,0
190885,placebo,0,0
190886,plus,0,0
190887,docetaxel,0,0
190888,arm,0,0
190889,.,0,0
190890,The,0,0
190891,most,0,0
190892,frequent,0,0
190893,(,0,0
190894,?,0,0
190895,30,0,0
190896,%,0,0
190897,),0,1
190898,adverse,0,0
190899,reactions,0,0
190900,in,0,1
190901,ramucirumab-treated,0,1
190902,patients,0,1
190903,were,0,1
190904,fatigue,0,0
190905,",",0,0
190906,neutropenia,0,0
190907,",",0,0
190908,and,0,0
190909,diarrhea,0,1
190910,.,0,0
190911,The,0,0
190912,most,0,0
190913,frequent,0,0
190914,(,0,0
190915,?,0,0
190916,5,0,0
190917,%,0,0
190918,),0,0
190919,grade,0,1
190920,3,0,0
190921,and,0,1
190922,4,0,0
190923,adverse,0,0
190924,reactions,0,0
190925,in,0,0
190926,the,0,0
190927,ramucirumab,0,0
190928,arm,0,0
190929,were,0,0
190930,fatigue,0,0
190931,",",0,0
190932,neutropenia,0,0
190933,",",0,0
190934,febrile,0,0
190935,neutropenia,0,0
190936,",",0,0
190937,leukopenia,0,0
190938,",",0,0
190939,and,0,0
190940,hypertension,0,1
190941,.,0,1
190942,IMPLICATIONS,0,0
190943,FOR,0,0
190944,PRACTICE,0,0
190945,This,0,0
190946,report,0,0
190947,presents,0,0
190948,key,0,0
190949,information,0,0
190950,on,0,0
190951,the,0,0
190952,U.S.,0,0
190953,Food,0,1
190954,and,0,0
190955,Drug,0,0
190956,Administration,0,0
190957,approval,0,0
190958,of,0,0
190959,ramucirumab,0,0
190960,",",0,0
190961,a,0,0
190962,monoclonal,0,0
190963,antibody,0,0
190964,targeting,0,0
190965,vascular,0,0
190966,endothelial,0,0
190967,growth,0,0
190968,factor,0,0
190969,receptor-2,0,0
190970,",",0,0
190971,given,0,0
190972,in,0,0
190973,combination,0,0
190974,with,0,1
190975,docetaxel,0,0
190976,for,0,0
190977,the,0,0
190978,treatment,1,0
190979,of,1,0
190980,patients,1,1
190981,with,1,1
190982,metastatic,1,1
190983,non-small,1,1
190984,cell,1,1
190985,lung,1,1
190986,cancer,1,1
190987,whose,1,1
190988,disease,1,1
190989,has,1,0
190990,progressed,1,0
190991,on,1,0
190992,or,1,1
190993,after,1,0
190994,platinum-based,1,0
190995,chemotherapy,1,1
190996,.,1,0
190997,This,1,0
190998,report,0,0
190999,specifically,0,0
191000,addresses,0,0
191001,the,0,0
191002,issues,0,0
191003,of,0,0
191004,safety,1,0
191005,in,1,0
191006,patients,1,1
191007,with,1,1
191008,squamous,1,1
191009,cell,1,1
191010,tumors,1,1
191011,",",1,0
191012,effect,1,0
191013,of,0,0
191014,treatment,1,0
191015,in,1,0
191016,elderly,1,1
191017,patients,1,1
191018,",",1,0
191019,and,1,0
191020,uncertainties,0,0
191021,regarding,0,0
191022,effects,1,0
191023,in,1,1
191024,patients,1,1
191025,with,1,1
191026,tumors,1,1
191027,harboring,1,1
191028,epidermal,1,1
191029,growth,1,0
191030,factor,1,0
191031,receptor,1,0
191032,or,1,1
191033,anaplastic,1,1
191034,lymphoma,1,1
191035,kinase,1,0
191036,genomic,1,0
191037,tumor,1,1
191038,aberrations,1,0
191039,.,1,1
191040,The,0,0
191041,ileal,0,0
191042,bile,0,0
191043,acid,0,0
191044,transporter,0,0
191045,inhibitor,0,0
191046,A4250,0,0
191047,decreases,0,0
191048,serum,0,0
191049,bile,0,0
191050,acids,0,0
191051,by,0,0
191052,interrupting,0,0
191053,the,0,0
191054,enterohepatic,0,0
191055,circulation,0,0
191056,.,0,1
191057,BACKGROUND,0,0
191058,Reabsorption,0,0
191059,of,0,0
191060,bile,0,1
191061,acids,0,0
191062,from,0,1
191063,the,0,0
191064,intestine,0,0
191065,by,0,0
191066,ileal,0,1
191067,bile,0,0
191068,acid,0,0
191069,transporter,0,0
191070,is,0,0
191071,pivotal,0,0
191072,for,0,0
191073,the,0,0
191074,enterohepatic,0,0
191075,circulation,0,0
191076,of,0,0
191077,BAs,0,0
191078,and,0,0
191079,sterol,0,0
191080,homoeostasis,0,1
191081,.,0,1
191082,AIM,0,0
191083,To,0,0
191084,assess,0,0
191085,tolerability,0,0
191086,and,0,0
191087,study,0,0
191088,",",0,0
191089,bile,0,0
191090,acid,0,0
191091,metabolism,0,0
191092,in,0,0
191093,a,0,0
191094,phase,0,0
191095,1,0,0
191096,trial,0,0
191097,with,0,1
191098,the,0,0
191099,selective,0,0
191100,ileal,0,1
191101,bile,0,0
191102,acid,0,0
191103,transporter,0,0
191104,inhibitor,0,0
191105,A4250,0,0
191106,.,0,1
191107,METHODS,0,0
191108,A,0,0
191109,randomised,0,0
191110,double-blind,0,0
191111,",",0,0
191112,single-ascending,0,0
191113,dose,0,0
191114,(,0,0
191115,SAD,0,0
191116,),0,0
191117,and,0,0
191118,multiple-ascending-dose,0,0
191119,study,0,0
191120,consisting,0,1
191121,of,0,0
191122,five,1,1
191123,cohorts,1,1
191124,comprising,1,1
191125,40,1,1
191126,individuals,1,1
191127,with,1,1
191128,a,1,0
191129,single,1,0
191130,administration,1,0
191131,of,1,0
191132,A4250,1,0
191133,(,0,0
191134,0.1,0,0
191135,",",0,0
191136,0.3,0,0
191137,",",0,0
191138,1,0,0
191139,",",0,0
191140,3,0,0
191141,",",0,0
191142,or,0,1
191143,10,0,0
191144,mg,0,0
191145,),0,0
191146,or,0,0
191147,placebo,0,0
191148,and,1,0
191149,three,1,0
191150,cohorts,1,1
191151,comprising,1,1
191152,24,1,1
191153,individuals,1,1
191154,with,1,1
191155,a,1,0
191156,1-week,1,0
191157,administration,1,0
191158,of,1,0
191159,A4250,1,0
191160,(,0,1
191161,1,0,0
191162,or,0,1
191163,3,0,0
191164,mg,0,0
191165,once,0,0
191166,daily,0,0
191167,or,0,0
191168,1.5,0,0
191169,mg,0,0
191170,twice,0,0
191171,daily,0,0
191172,),0,0
191173,or,0,0
191174,placebo,0,0
191175,.,0,0
191176,For,0,0
191177,the,0,0
191178,multiple-ascending-dose,0,0
191179,study,0,0
191180,",",0,0
191181,bile,0,0
191182,acids,0,0
191183,were,0,1
191184,measured,0,0
191185,by,0,0
191186,HPLC-MS,0,1
191187,in,0,0
191188,plasma,0,0
191189,and,0,0
191190,faeces,0,0
191191,",",0,0
191192,and,0,0
191193,fibroblast,0,0
191194,growth,0,0
191195,factor,0,0
191196,19,0,1
191197,(,0,0
191198,FGF19,0,1
191199,),0,0
191200,and,0,0
191201,7?-hydroxy-4-cholesten-3-one,0,0
191202,(,0,0
191203,C4,0,1
191204,),0,0
191205,were,0,0
191206,measured,0,0
191207,in,0,0
191208,plasma,0,0
191209,.,0,1
191210,RESULTS,0,0
191211,No,0,0
191212,serious,0,0
191213,adverse,0,0
191214,events,0,0
191215,occurred,0,0
191216,and,0,0
191217,all,0,0
191218,participants,0,1
191219,finished,0,0
191220,the,0,0
191221,trial,0,0
191222,per,0,0
191223,protocol,0,0
191224,.,0,0
191225,At,0,0
191226,the,0,0
191227,end,0,0
191228,of,0,0
191229,the,0,0
191230,multiple-ascending-dose,0,0
191231,study,0,0
191232,",",0,0
191233,plasma,0,0
191234,total,0,1
191235,bile,0,1
191236,acids,0,0
191237,and,0,1
191238,FGF19,0,0
191239,decreased,0,0
191240,by,0,0
191241,47,0,1
191242,%,0,0
191243,and,0,0
191244,76,0,1
191245,%,0,0
191246,",",0,0
191247,respectively,0,0
191248,",",0,0
191249,at,0,0
191250,3,0,0
191251,mg/day,0,0
191252,(,0,0
191253,P,0,0
191254,<,0,0
191255,0.01,0,0
191256,),0,0
191257,",",0,0
191258,and,0,0
191259,by,0,0
191260,15,0,1
191261,%,0,0
191262,and,0,0
191263,16,0,1
191264,%,0,0
191265,",",0,0
191266,respectively,0,0
191267,",",0,0
191268,at,0,0
191269,1.5,0,0
191270,mg,0,0
191271,twice,0,0
191272,daily,0,0
191273,(,0,0
191274,P,0,0
191275,<,0,0
191276,0.05,0,0
191277,),0,1
191278,.,0,1
191279,Plasma,0,0
191280,C4,0,0
191281,and,0,0
191282,faecal,0,0
191283,bile,0,1
191284,acids,0,0
191285,increased,0,0
191286,at,0,0
191287,all,0,0
191288,dose,0,0
191289,regimens,0,0
191290,",",0,0
191291,by,0,0
191292,555,0,1
191293,%,0,0
191294,",",0,0
191295,664,0,1
191296,%,0,0
191297,",",0,0
191298,292,0,1
191299,%,0,0
191300,and,0,0
191301,338,0,1
191302,%,0,0
191303,",",0,0
191304,421,0,1
191305,%,0,0
191306,",",0,0
191307,420,0,0
191308,%,0,0
191309,",",0,0
191310,respectively,0,0
191311,(,0,0
191312,P,0,0
191313,<,0,0
191314,0.01-0.05,0,0
191315,),0,0
191316,.,0,0
191317,The,0,0
191318,primary,0,0
191319,bile,0,0
191320,acids,0,0
191321,cholic,0,0
191322,and,0,1
191323,chenodeoxycholic,0,0
191324,acids,0,0
191325,constituted,0,1
191326,the,0,0
191327,majority,0,0
191328,of,0,0
191329,faecal,0,0
191330,bile,0,1
191331,acids,0,0
191332,in,0,0
191333,the,0,0
191334,A4250-treated,0,1
191335,groups,0,0
191336,.,0,1
191337,CONCLUSIONS,0,0
191338,A4250,0,0
191339,is,0,0
191340,well,0,0
191341,tolerated,0,0
191342,.,0,0
191343,By,0,0
191344,blocking,0,0
191345,ileal,0,1
191346,bile,0,0
191347,acid,0,0
191348,transporter,0,0
191349,in,0,0
191350,the,0,0
191351,terminal,0,0
191352,ileum,0,0
191353,",",0,0
191354,it,0,0
191355,highly,0,0
191356,efficiently,0,0
191357,interrupts,0,0
191358,the,0,0
191359,enterohepatic,0,0
191360,circulation,0,0
191361,of,0,0
191362,BAs,0,0
191363,",",0,0
191364,and,0,0
191365,should,0,0
191366,be,0,0
191367,of,0,0
191368,benefit,0,0
191369,to,1,0
191370,patients,1,1
191371,with,1,1
191372,cholestatic,1,1
191373,liver,1,1
191374,diseases,1,1
191375,.,1,1
191376,Clinical,1,0
191377,Trial,0,0
191378,registration,0,1
191379,EudraCT,0,0
191380,2013-001175-21,0,1
191381,.,0,1
191382,Effectiveness,0,0
191383,of,0,0
191384,Neuromuscular,0,1
191385,Electrical,0,0
191386,Stimulation,0,0
191387,on,0,0
191388,Patients,1,1
191389,With,1,1
191390,Dysphagia,1,1
191391,With,1,1
191392,Medullary,1,1
191393,Infarction,1,1
191394,.,1,1
191395,OBJECTIVE,0,0
191396,To,0,0
191397,evaluate,0,0
191398,and,0,0
191399,compare,0,0
191400,the,0,0
191401,effects,0,0
191402,of,0,0
191403,neuromuscular,0,1
191404,electrical,0,0
191405,stimulation,0,0
191406,(,0,0
191407,NMES,0,0
191408,),0,0
191409,acting,0,0
191410,on,0,0
191411,the,0,0
191412,sensory,0,0
191413,input,0,0
191414,or,0,1
191415,motor,0,0
191416,muscle,0,0
191417,in,0,0
191418,treating,0,0
191419,patients,1,1
191420,with,1,1
191421,dysphagia,1,1
191422,with,1,1
191423,medullary,1,1
191424,infarction,1,1
191425,.,1,1
191426,DESIGN,0,0
191427,Prospective,0,0
191428,randomized,0,0
191429,controlled,0,0
191430,study,0,0
191431,.,0,1
191432,SETTING,0,1
191433,Department,0,1
191434,of,0,0
191435,physical,0,0
191436,medicine,0,1
191437,and,0,0
191438,rehabilitation,0,0
191439,.,0,1
191440,PARTICIPANTS,0,0
191441,Patients,1,1
191442,with,1,1
191443,dysphagia,1,1
191444,with,1,1
191445,medullary,1,1
191446,infarction,1,1
191447,(,1,0
191448,N=82,1,0
191449,),1,1
191450,.,1,1
191451,INTERVENTIONS,0,0
191452,Participants,0,1
191453,were,0,1
191454,randomized,0,1
191455,over,0,0
191456,3,0,0
191457,intervention,0,1
191458,groups,0,0
191459,:,0,1
191460,traditional,0,1
191461,swallowing,0,0
191462,therapy,0,0
191463,",",0,0
191464,sensory,0,0
191465,approach,0,0
191466,combined,0,0
191467,with,0,1
191468,traditional,0,1
191469,swallowing,0,0
191470,therapy,0,0
191471,",",0,0
191472,and,0,0
191473,motor,0,0
191474,approach,0,0
191475,combined,0,0
191476,with,0,1
191477,traditional,0,1
191478,swallowing,0,1
191479,therapy,0,0
191480,.,0,1
191481,Electrical,0,0
191482,stimulation,0,0
191483,sessions,0,0
191484,were,0,1
191485,for,0,0
191486,20,0,1
191487,minutes,0,0
191488,",",0,0
191489,twice,0,0
191490,a,0,0
191491,day,0,0
191492,",",0,0
191493,for,0,0
191494,5d/wk,0,0
191495,",",0,0
191496,over,0,0
191497,a,0,0
191498,4-week,0,0
191499,period,0,0
191500,.,0,1
191501,MAIN,0,0
191502,OUTCOME,0,0
191503,MEASURES,0,0
191504,Swallowing,0,1
191505,function,0,0
191506,was,0,0
191507,evaluated,0,0
191508,by,0,0
191509,the,0,0
191510,water,0,0
191511,swallow,0,0
191512,test,0,0
191513,and,0,0
191514,Standardized,0,0
191515,Swallowing,0,1
191516,Assessment,0,0
191517,",",0,0
191518,oral,0,0
191519,intake,0,0
191520,was,0,0
191521,evaluated,0,0
191522,by,0,0
191523,the,0,0
191524,Functional,0,0
191525,Oral,0,0
191526,Intake,0,0
191527,Scale,0,0
191528,",",0,0
191529,quality,0,0
191530,of,0,0
191531,life,0,0
191532,was,0,0
191533,evaluated,0,0
191534,by,0,0
191535,the,0,0
191536,Swallowing-Related,0,0
191537,Quality,0,0
191538,of,0,0
191539,Life,0,0
191540,(,0,1
191541,SWAL-QOL,0,0
191542,),0,0
191543,Scale,0,0
191544,",",0,0
191545,and,0,0
191546,cognition,0,0
191547,was,0,0
191548,evaluated,0,0
191549,by,0,0
191550,the,0,0
191551,Mini-Mental,0,1
191552,State,0,0
191553,Examination,0,1
191554,(,0,0
191555,MMSE,0,0
191556,),0,0
191557,.,0,0
191558,RESULTS,0,0
191559,There,0,0
191560,were,0,0
191561,no,0,0
191562,statistically,0,0
191563,significant,0,0
191564,differences,0,0
191565,between,0,0
191566,the,0,0
191567,groups,0,0
191568,in,0,0
191569,age,0,1
191570,",",0,0
191571,sex,0,0
191572,",",0,0
191573,duration,0,0
191574,",",0,0
191575,MMSE,0,0
191576,score,0,0
191577,",",0,0
191578,or,0,0
191579,severity,0,0
191580,of,0,0
191581,the,0,0
191582,swallowing,0,0
191583,disorder,0,1
191584,(,0,0
191585,P,0,0
191586,>,0,1
191587,.05,0,0
191588,),0,0
191589,.,0,0
191590,All,0,1
191591,groups,0,0
191592,showed,0,0
191593,improved,0,0
191594,swallowing,0,0
191595,function,0,0
191596,(,0,0
191597,P?.01,0,1
191598,),0,1
191599,;,0,0
191600,the,0,0
191601,sensory,0,0
191602,approach,0,0
191603,combined,0,0
191604,with,0,1
191605,traditional,0,1
191606,swallowing,0,0
191607,therapy,0,0
191608,group,0,0
191609,showed,0,0
191610,significantly,0,0
191611,greater,0,0
191612,improvement,0,0
191613,than,0,0
191614,the,0,0
191615,other,0,0
191616,2,0,0
191617,groups,0,0
191618,",",0,0
191619,and,0,0
191620,the,0,0
191621,motor,0,0
191622,approach,0,0
191623,combined,0,0
191624,with,0,1
191625,traditional,0,1
191626,swallowing,0,0
191627,therapy,0,0
191628,group,0,0
191629,showed,0,0
191630,greater,0,0
191631,improvement,0,0
191632,than,0,0
191633,the,0,0
191634,traditional,0,0
191635,swallowing,0,0
191636,therapy,0,0
191637,group,0,0
191638,(,0,0
191639,P,0,0
191640,<,0,0
191641,.05,0,0
191642,),0,0
191643,.,0,1
191644,SWAL-QOL,0,0
191645,Scale,0,0
191646,scores,0,0
191647,increased,0,0
191648,more,0,0
191649,significantly,0,0
191650,in,0,0
191651,the,0,0
191652,sensory,0,0
191653,approach,0,0
191654,combined,0,0
191655,with,0,1
191656,traditional,0,1
191657,swallowing,0,0
191658,therapy,0,0
191659,and,0,0
191660,motor,0,0
191661,approach,0,0
191662,combined,0,0
191663,with,0,1
191664,traditional,0,1
191665,swallowing,0,1
191666,therapy,0,0
191667,groups,0,0
191668,than,0,0
191669,in,0,0
191670,the,0,0
191671,traditional,0,0
191672,swallowing,0,0
191673,therapy,0,0
191674,group,0,0
191675,",",0,0
191676,and,0,0
191677,the,0,0
191678,sensory,0,0
191679,approach,0,0
191680,combined,0,0
191681,with,0,1
191682,traditional,0,1
191683,swallowing,0,0
191684,therapy,0,0
191685,and,0,0
191686,motor,0,0
191687,approach,0,0
191688,combined,0,0
191689,with,0,1
191690,traditional,0,1
191691,swallowing,0,1
191692,therapy,0,0
191693,groups,0,0
191694,showed,0,0
191695,statistically,0,0
191696,significant,0,0
191697,differences,0,0
191698,(,0,1
191699,P=.04,0,1
191700,),0,1
191701,.,0,1
191702,CONCLUSIONS,0,0
191703,NMES,0,0
191704,that,0,0
191705,targets,0,0
191706,either,0,0
191707,sensory,0,0
191708,input,0,0
191709,or,0,1
191710,motor,0,0
191711,muscle,0,0
191712,coupled,0,0
191713,with,0,1
191714,traditional,0,0
191715,therapy,0,0
191716,is,0,0
191717,conducive,0,0
191718,to,0,0
191719,recovery,0,0
191720,from,0,0
191721,dysphagia,0,1
191722,and,0,0
191723,improves,0,0
191724,quality,0,0
191725,of,0,0
191726,life,0,0
191727,for,1,0
191728,patients,1,1
191729,with,1,1
191730,dysphagia,1,1
191731,with,1,1
191732,medullary,1,1
191733,infarction,1,1
191734,.,1,0
191735,A,0,0
191736,sensory,0,0
191737,approach,0,0
191738,appears,0,0
191739,to,0,0
191740,be,0,0
191741,better,0,0
191742,than,0,0
191743,a,0,0
191744,motor,0,0
191745,approach,0,0
191746,.,0,1
191747,Influence,0,0
191748,of,0,0
191749,ibopamine,0,0
191750,on,0,0
191751,heart,0,1
191752,rate,0,0
191753,and,0,0
191754,arrhythmic,0,0
191755,pattern,0,1
191756,in,0,0
191757,patients,1,1
191758,with,1,1
191759,congestive,1,1
191760,heart,1,1
191761,failure,1,1
191762,.,1,0
191763,A,0,0
191764,double-blind,0,0
191765,multicentre,0,0
191766,study,0,1
191767,.,0,0
191768,Ibopamine,0,0
191769,is,0,0
191770,a,0,0
191771,dopaminergic,0,0
191772,and,0,0
191773,adrenergic,0,0
191774,receptor,0,0
191775,agonist,0,0
191776,",",0,0
191777,which,0,0
191778,is,0,0
191779,active,0,0
191780,in,0,0
191781,the,0,0
191782,treatment,0,0
191783,of,0,0
191784,congestive,0,1
191785,heart,0,1
191786,failure,0,1
191787,.,0,0
191788,Since,0,0
191789,the,0,0
191790,long-term,0,0
191791,prognosis,0,0
191792,for,0,0
191793,patients,1,1
191794,with,1,1
191795,congestive,1,1
191796,heart,1,1
191797,failure,1,1
191798,remains,0,0
191799,very,0,0
191800,poor,0,0
191801,and,0,0
191802,the,0,0
191803,incidence,0,0
191804,of,0,0
191805,arrhythmic,0,0
191806,death,0,0
191807,is,0,0
191808,high,0,0
191809,",",0,0
191810,every,0,0
191811,new,0,0
191812,drug,0,0
191813,to,0,0
191814,be,0,0
191815,employed,0,0
191816,against,0,0
191817,this,0,0
191818,disease,0,1
191819,should,0,0
191820,be,0,0
191821,thoroughly,0,0
191822,tested,0,0
191823,in,0,0
191824,order,0,0
191825,to,0,0
191826,rule,0,0
191827,out,0,0
191828,any,0,0
191829,possible,0,0
191830,arrhythmogenic,0,1
191831,action,0,0
191832,.,0,0
191833,This,0,0
191834,multicentre,0,0
191835,study,0,0
191836,was,0,0
191837,designed,0,0
191838,to,0,0
191839,evaluate,0,0
191840,the,0,0
191841,effect,0,0
191842,of,0,0
191843,ibopamine,0,0
191844,versus,0,0
191845,placebo,0,0
191846,in,0,0
191847,double-blind,0,0
191848,conditions,0,0
191849,on,0,0
191850,heart,0,1
191851,rate,0,0
191852,",",0,0
191853,rhythm,0,1
191854,and,0,0
191855,electrical,0,0
191856,safety,0,0
191857,.,0,1
191858,Ibopamine,0,0
191859,was,0,0
191860,employed,0,0
191861,at,0,0
191862,a,0,0
191863,dose,0,0
191864,of,0,0
191865,100,0,0
191866,mg,0,0
191867,t.i.d,0,0
191868,.,0,0
191869,in,0,0
191870,97,1,1
191871,patients,1,1
191872,(,1,1
191873,aged,1,1
191874,31-83,1,1
191875,years,1,1
191876,),1,1
191877,belonging,1,1
191878,to,1,0
191879,NYHA,1,1
191880,class,1,1
191881,II,1,1
191882,and,1,0
191883,III,1,1
191884,with,1,1
191885,congestive,1,1
191886,heart,1,1
191887,failure,1,1
191888,of,1,0
191889,different,1,0
191890,aetiology,1,0
191891,",",1,0
191892,but,1,0
191893,without,1,0
191894,any,1,0
191895,complex,1,0
191896,ventricular,1,0
191897,arrhythmias,1,1
191898,in,1,0
191899,basal,1,0
191900,conditions,1,0
191901,(,1,1
191902,couplets,1,0
191903,with,1,1
191904,R'-R,1,1
191905,less,1,0
191906,than,1,0
191907,or,1,0
191908,equal,1,0
191909,to,1,0
191910,400,1,0
191911,msec,1,0
191912,",",1,0
191913,ventricular,1,0
191914,tachycardia,1,1
191915,",",1,0
191916,R,1,1
191917,on,1,0
191918,T,1,1
191919,phenomena,1,0
191920,),1,0
191921,.,1,0
191922,Using,0,0
191923,a,0,0
191924,random,0,0
191925,cross-over,0,0
191926,design,0,0
191927,the,0,0
191928,patients,0,1
191929,were,0,0
191930,submitted,0,1
191931,to,0,0
191932,48,0,0
191933,hr,0,0
191934,.,0,1
191935,Holter,0,0
191936,recordings,0,0
191937,in,0,0
191938,basal,0,1
191939,conditions,0,0
191940,and,0,0
191941,following,0,0
191942,7,0,1
191943,days,0,0
191944,of,0,0
191945,ibopamine,0,0
191946,and,0,0
191947,placebo,0,0
191948,treatment,0,0
191949,.,0,0
191950,No,0,0
191951,influence,0,0
191952,on,0,0
191953,heart,0,1
191954,rhythm,0,1
191955,was,0,0
191956,noted,0,0
191957,.,0,0
191958,No,0,0
191959,significant,0,0
191960,variations,0,0
191961,in,0,0
191962,maximum,0,0
191963,heart,0,1
191964,rate,0,0
191965,(,0,0
191966,ibopamine,0,0
191967,117.7,0,0
191968,+/-,0,1
191969,20.9,0,1
191970,;,0,1
191971,placebo,0,0
191972,118.1,0,1
191973,+/-,0,0
191974,20.7,0,0
191975,),0,0
191976,",",0,0
191977,medium,0,0
191978,heart,0,1
191979,rate,0,0
191980,(,0,0
191981,ibopamine,0,0
191982,71.8,0,0
191983,+/-,0,1
191984,10.2,0,0
191985,;,0,1
191986,placebo,0,0
191987,72.6,0,0
191988,+/-,0,0
191989,10.1,0,0
191990,),0,0
191991,or,0,1
191992,minimum,0,0
191993,heart,0,1
191994,rate,0,0
191995,(,0,0
191996,ibopamine,0,0
191997,55.3,0,1
191998,+/-,0,1
191999,11.7,0,0
192000,;,0,1
192001,placebo,0,0
192002,54.6,0,1
192003,+/-,0,0
192004,10.6,0,0
192005,),0,1
192006,were,0,0
192007,observed,0,0
192008,.,0,0
192009,The,0,0
192010,mean,0,0
192011,number/hr,0,0
192012,.,0,0
192013,of,0,0
192014,ectopic,0,1
192015,supraventricular,0,1
192016,beats,0,1
192017,was,0,0
192018,26.1,0,1
192019,+/-,0,0
192020,61.9,0,1
192021,after,0,0
192022,ibopamine,0,0
192023,and,0,0
192024,21.7,0,0
192025,+/-,0,0
192026,35.8,0,1
192027,after,0,0
192028,placebo,0,0
192029,(,0,0
192030,p,0,0
192031,=,0,0
192032,ns,0,0
192033,),0,0
192034,.,0,0
192035,The,0,0
192036,complexity,0,0
192037,of,0,0
192038,ectopic,0,1
192039,supraventricular,0,1
192040,beats,0,0
192041,did,0,0
192042,not,0,0
192043,change,0,0
192044,.,0,0
192045,The,0,0
192046,mean,0,0
192047,number/hr,0,0
192048,.,0,0
192049,of,0,0
192050,ectopic,0,1
192051,ventricular,0,1
192052,beats,0,1
192053,was,0,0
192054,31.1,0,1
192055,+/-,0,0
192056,52.5,0,1
192057,after,0,0
192058,ibopamine,0,0
192059,and,0,0
192060,30.4,0,0
192061,+/-,0,0
192062,57.8,0,1
192063,after,0,0
192064,placebo,0,0
192065,(,0,0
192066,p,0,0
192067,=,0,0
192068,ns,0,0
192069,),0,0
192070,.,0,0
192071,Neither,0,0
192072,the,0,0
192073,distribution,0,0
192074,of,0,0
192075,the,0,0
192076,patients,0,1
192077,among,0,0
192078,Lown,0,1
192079,classification,0,1
192080,nor,0,0
192081,the,0,0
192082,Final,0,0
192083,Score,0,0
192084,of,0,0
192085,the,0,0
192086,Italian,0,1
192087,Lown,0,1
192088,Classification,0,0
192089,(,0,1
192090,26.1,0,0
192091,+/-,0,0
192092,18.0,0,0
192093,and,0,1
192094,26.6,0,0
192095,+/-,0,0
192096,17.9,0,0
192097,in,0,0
192098,the,0,0
192099,1st,0,0
192100,and,0,0
192101,2nd,0,0
192102,day,0,0
192103,of,0,0
192104,monitoring,0,0
192105,after,0,0
192106,ibopamine,0,0
192107,and,0,0
192108,25.7,0,1
192109,+/-,0,0
192110,18.6,0,0
192111,and,0,1
192112,25.7,0,1
192113,+/-,0,0
192114,18.8,0,0
192115,after,0,0
192116,placebo,0,0
192117,;,0,0
192118,p,0,0
192119,=,0,0
192120,ns,0,0
192121,),0,0
192122,showed,0,0
192123,any,0,0
192124,difference,0,0
192125,between,0,0
192126,active,0,1
192127,treatment,0,0
192128,and,0,0
192129,placebo,0,0
192130,.,0,1
192131,Similar,0,0
192132,results,0,0
192133,were,0,1
192134,achieved,0,0
192135,when,0,0
192136,the,0,0
192137,patients,0,1
192138,were,0,0
192139,sub-divided,0,1
192140,into,0,1
192141,subgroups,0,0
192142,according,0,1
192143,to,0,0
192144,sequences,0,0
192145,of,0,0
192146,treatment,0,0
192147,(,0,0
192148,basal,0,0
192149,--,0,1
192150,--,0,1
192151,ibopamine,0,0
192152,--,0,1
192153,--,0,0
192154,placebo,0,0
192155,and,0,0
192156,basal,0,0
192157,--,0,1
192158,--,0,1
192159,placebo,0,0
192160,--,0,1
192161,--,0,1
192162,ibopamine,0,0
192163,),0,0
192164,",",0,0
192165,NYHA,0,1
192166,class,0,1
192167,II,0,1
192168,or,0,1
192169,III,0,0
192170,",",0,0
192171,aetiology,0,0
192172,of,0,0
192173,congestive,0,1
192174,heart,0,1
192175,failure,0,1
192176,(,0,0
192177,dilatative,0,1
192178,cardiomyopathy,0,1
192179,",",0,0
192180,ischemic,0,1
192181,cardiomyopathy,0,1
192182,and,0,0
192183,other,0,0
192184,aetiologies,0,1
192185,),0,1
192186,",",0,0
192187,associated,0,0
192188,treatment,0,0
192189,with,0,1
192190,digitalis,0,0
192191,or,0,1
192192,diuretics,0,0
192193,and,0,0
192194,the,0,0
192195,number,0,0
192196,and,0,0
192197,complexity,0,0
192198,of,0,0
192199,base,0,0
192200,ectopic,0,1
192201,ventricular,0,1
192202,beats,0,1
192203,.,0,1
192204,None,0,0
192205,of,0,0
192206,the,0,0
192207,patients,0,1
192208,experienced,0,0
192209,sustained,0,0
192210,ventricular,0,1
192211,tachycardia,0,1
192212,.,0,1
192213,(,0,0
192214,ABSTRACT,0,0
192215,TRUNCATED,0,1
192216,AT,0,1
192217,400,0,0
192218,WORDS,0,1
192219,),0,1
192220,Efficacy,0,0
192221,of,0,0
192222,colchicine,0,0
192223,versus,0,0
192224,placebo,0,0
192225,for,0,0
192226,the,0,0
192227,treatment,0,0
192228,of,0,0
192229,pericardial,1,0
192230,effusion,1,1
192231,after,1,0
192232,open-heart,1,1
192233,surgery,1,1
192234,:,1,1
192235,A,0,0
192236,randomized,0,0
192237,",",0,0
192238,placebo-controlled,0,0
192239,trial,0,0
192240,.,0,1
192241,BACKGROUND,0,0
192242,Pericardial,1,1
192243,effusion,1,0
192244,(,1,0
192245,PE,1,1
192246,),1,0
192247,",",0,0
192248,a,0,0
192249,common,0,0
192250,complication,0,0
192251,after,0,0
192252,open-heart,0,1
192253,surgery,0,1
192254,",",0,0
192255,accounts,0,0
192256,for,0,0
192257,50,0,1
192258,%,0,0
192259,to,0,0
192260,85,0,0
192261,%,0,0
192262,of,0,0
192263,patients,0,1
192264,.,0,1
192265,Although,0,0
192266,reversible,0,0
192267,in,0,0
192268,most,0,0
192269,of,0,0
192270,the,0,0
192271,cases,0,0
192272,",",0,0
192273,it,0,0
192274,could,0,0
192275,be,0,0
192276,life,0,0
192277,threatening,0,0
192278,in,0,0
192279,the,0,0
192280,occurrence,0,0
192281,of,0,0
192282,tamponade,0,0
192283,in,0,0
192284,large,0,1
192285,effusions,0,1
192286,.,0,1
192287,We,0,0
192288,aimed,0,0
192289,to,0,0
192290,determine,0,0
192291,the,0,0
192292,therapeutic,0,0
192293,efficacy,0,0
192294,of,0,0
192295,colchicine,0,0
192296,on,0,0
192297,PE,1,1
192298,after,1,0
192299,open-heart,1,1
192300,surgery,1,1
192301,.,1,1
192302,METHODS,0,0
192303,The,0,0
192304,study,0,0
192305,is,0,0
192306,a,0,0
192307,prospective,0,0
192308,",",0,0
192309,randomized,0,0
192310,",",0,0
192311,triple-blind,0,0
192312,",",0,0
192313,placebo-controlled,0,0
192314,single-center,1,1
192315,trial,1,0
192316,at,1,0
192317,Tehran,1,1
192318,Heart,1,1
192319,Center,1,1
192320,.,1,1
192321,A,1,0
192322,total,1,1
192323,of,1,0
192324,149,1,1
192325,patients,1,1
192326,with,1,1
192327,mild,1,1
192328,or,1,1
192329,moderate,1,1
192330,PE,1,1
192331,in,1,0
192332,transthoracic,1,1
192333,echocardiography,1,0
192334,were,0,0
192335,randomly,0,1
192336,assigned,0,0
192337,to,0,0
192338,receive,0,0
192339,1,0,0
192340,mg/d,0,0
192341,colchicine,0,0
192342,(,0,1
192343,n,0,1
192344,=,0,0
192345,74,0,1
192346,),0,0
192347,or,0,1
192348,1,0,0
192349,tablet,0,0
192350,of,0,0
192351,placebo,0,0
192352,(,0,0
192353,n,0,1
192354,=,0,0
192355,75,0,1
192356,),0,0
192357,for,0,0
192358,2,0,1
192359,weeks,0,0
192360,and,0,0
192361,then,0,0
192362,underwent,0,1
192363,follow-up,0,0
192364,echocardiography,0,1
192365,.,0,1
192366,RESULTS,0,0
192367,Baseline,0,0
192368,and,0,0
192369,clinical,0,0
192370,characteristics,0,0
192371,were,0,0
192372,not,0,0
192373,significantly,0,0
192374,different,0,0
192375,between,0,0
192376,the,0,0
192377,2,0,0
192378,study,0,0
192379,groups,0,0
192380,except,0,0
192381,for,0,0
192382,age,0,1
192383,(,0,0
192384,P,0,0
192385,=,0,0
192386,.02,0,0
192387,),0,0
192388,and,0,0
192389,graft,0,0
192390,numbers,0,0
192391,(,0,1
192392,P,0,0
192393,=,0,0
192394,.005,0,0
192395,),0,0
192396,.,0,0
192397,There,0,0
192398,was,0,0
192399,no,0,0
192400,significant,0,0
192401,difference,0,0
192402,in,0,0
192403,pretreatment,0,0
192404,and,0,0
192405,posttreatment,0,0
192406,PE,0,1
192407,sizes,0,0
192408,between,0,0
192409,the,0,0
192410,2,0,0
192411,study,0,0
192412,groups,0,0
192413,(,0,1
192414,P,0,0
192415,=,0,0
192416,.440,0,0
192417,and,0,0
192418,.844,0,0
192419,",",0,0
192420,respectively,0,0
192421,),0,0
192422,.,0,0
192423,Median,0,0
192424,(,0,0
192425,25th-75th,0,0
192426,percentiles,0,0
192427,),0,1
192428,of,0,0
192429,effusion,0,1
192430,changes,0,0
192431,was,0,0
192432,5,0,0
192433,mm,0,0
192434,(,0,0
192435,1-7.6,0,0
192436,mm,0,0
192437,),0,0
192438,in,0,0
192439,the,0,0
192440,colchicine,0,0
192441,group,0,0
192442,and,0,0
192443,5,0,0
192444,mm,0,0
192445,(,0,0
192446,1-6.6,0,0
192447,mm,0,0
192448,),0,0
192449,in,0,0
192450,the,0,0
192451,placebo,0,0
192452,group,0,0
192453,(,0,0
192454,P,0,0
192455,=,0,0
192456,.932,0,0
192457,),0,1
192458,.,0,1
192459,Intervention,0,0
192460,had,0,0
192461,no,0,0
192462,significant,0,0
192463,impact,0,0
192464,on,0,0
192465,pretreatment,0,0
192466,and,0,0
192467,posttreatment,0,0
192468,effusion,0,1
192469,values,0,0
192470,and,0,0
192471,changes,0,0
192472,in,0,0
192473,isolated,0,1
192474,coronary,1,1
192475,artery,1,1
192476,bypass,1,1
192477,graft,1,0
192478,surgery,1,1
192479,patients,1,1
192480,(,0,1
192481,P,0,0
192482,=,0,0
192483,.607,0,0
192484,",",0,0
192485,.539,0,0
192486,",",0,0
192487,and,0,0
192488,.628,0,0
192489,",",0,0
192490,respectively,0,0
192491,),0,0
192492,.,0,0
192493,After,0,0
192494,adjustment,0,0
192495,for,0,0
192496,possible,0,0
192497,confounders,0,0
192498,",",0,0
192499,there,0,0
192500,was,0,0
192501,still,0,0
192502,no,0,0
192503,significant,0,0
192504,difference,0,0
192505,in,0,0
192506,postoperative,0,0
192507,PE,0,1
192508,between,0,0
192509,the,0,0
192510,2,0,0
192511,study,0,0
192512,groups,0,0
192513,(,0,1
192514,t,0,0
192515,=,0,0
192516,-0.285,0,0
192517,",",0,0
192518,P,0,0
192519,=,0,0
192520,.776,0,0
192521,),0,1
192522,.,0,0
192523,CONCLUSION,0,0
192524,We,0,0
192525,concluded,0,0
192526,that,0,0
192527,prescription,0,0
192528,of,0,0
192529,colchicine,0,0
192530,does,0,0
192531,not,0,0
192532,seem,0,0
192533,to,0,0
192534,be,0,0
192535,effective,0,0
192536,in,0,0
192537,treatment,0,0
192538,of,0,0
192539,asymptomatic,0,1
192540,postoperative,0,0
192541,PE,1,1
192542,.,1,0
192543,This,0,0
192544,could,0,0
192545,be,0,0
192546,justified,0,0
192547,in,0,0
192548,case,0,0
192549,that,0,0
192550,the,0,0
192551,etiology,0,0
192552,of,0,0
192553,most,0,0
192554,of,0,0
192555,the,0,0
192556,PEs,1,0
192557,might,0,0
192558,be,0,0
192559,contribution,0,0
192560,of,0,0
192561,noninflammatory,0,1
192562,factors,0,0
192563,which,0,0
192564,are,0,0
192565,better,0,0
192566,to,0,0
192567,be,0,0
192568,dealt,0,0
192569,with,0,1
192570,observational,0,1
192571,approaches,0,0
192572,.,0,1
192573,Pembrolizumab,0,0
192574,versus,0,0
192575,docetaxel,0,0
192576,for,0,0
192577,previously,1,0
192578,treated,1,1
192579,",",1,0
192580,PD-L1-positive,1,0
192581,",",1,0
192582,advanced,1,1
192583,non-small-cell,1,1
192584,lung,1,1
192585,cancer,1,1
192586,(,0,0
192587,KEYNOTE-010,0,0
192588,),0,1
192589,:,0,1
192590,a,0,0
192591,randomised,0,0
192592,controlled,0,0
192593,trial,0,0
192594,.,0,0
192595,BACKGROUND,0,0
192596,Despite,0,0
192597,recent,0,1
192598,advances,0,0
192599,in,0,0
192600,the,0,0
192601,treatment,0,0
192602,of,0,0
192603,advanced,1,1
192604,non-small-cell,1,1
192605,lung,1,1
192606,cancer,1,1
192607,",",0,0
192608,there,0,0
192609,remains,0,0
192610,a,0,0
192611,need,0,0
192612,for,0,0
192613,effective,0,0
192614,treatments,0,0
192615,for,0,0
192616,progressive,0,1
192617,disease,0,1
192618,.,0,1
192619,We,0,0
192620,assessed,0,0
192621,the,0,0
192622,efficacy,0,0
192623,of,0,0
192624,pembrolizumab,0,1
192625,for,0,0
192626,patients,0,1
192627,with,0,1
192628,previously,1,1
192629,treated,1,1
192630,",",1,0
192631,PD-L1-positive,1,0
192632,",",1,0
192633,advanced,1,1
192634,non-small-cell,1,1
192635,lung,1,1
192636,cancer,1,1
192637,.,1,0
192638,METHODS,0,0
192639,We,0,0
192640,did,0,0
192641,this,0,0
192642,randomised,0,0
192643,",",0,0
192644,open-label,0,0
192645,",",0,0
192646,phase,0,1
192647,2/3,0,0
192648,study,0,0
192649,at,0,0
192650,202,1,1
192651,academic,1,1
192652,medical,1,1
192653,centres,1,1
192654,in,1,1
192655,24,1,1
192656,countries,1,1
192657,.,1,1
192658,Patients,1,1
192659,with,1,1
192660,previously,1,1
192661,treated,1,1
192662,non-small-cell,1,1
192663,lung,1,1
192664,cancer,1,1
192665,with,1,1
192666,PD-L1,1,1
192667,expression,1,0
192668,on,1,0
192669,at,1,0
192670,least,1,1
192671,1,1,0
192672,%,1,0
192673,of,1,0
192674,tumour,1,1
192675,cells,1,0
192676,were,0,1
192677,randomly,0,1
192678,assigned,0,1
192679,(,0,0
192680,1:1:1,0,0
192681,),0,0
192682,in,0,0
192683,blocks,0,0
192684,of,0,0
192685,six,0,1
192686,per,0,0
192687,stratum,0,0
192688,with,0,1
192689,an,0,0
192690,interactive,0,0
192691,voice-response,0,0
192692,system,0,0
192693,to,0,0
192694,receive,0,0
192695,pembrolizumab,0,1
192696,2,0,0
192697,mg/kg,0,0
192698,",",0,0
192699,pembrolizumab,0,0
192700,10,0,0
192701,mg/kg,0,0
192702,",",0,0
192703,or,0,0
192704,docetaxel,0,0
192705,75,0,0
192706,mg/m,0,0
192707,(,0,1
192708,2,0,0
192709,),0,0
192710,every,0,0
192711,3,0,0
192712,weeks,0,0
192713,.,0,1
192714,The,0,0
192715,primary,0,0
192716,endpoints,0,0
192717,were,0,1
192718,overall,0,0
192719,survival,0,0
192720,and,0,0
192721,progression-free,0,0
192722,survival,0,0
192723,both,0,0
192724,in,0,0
192725,the,0,0
192726,total,0,1
192727,population,0,1
192728,and,0,0
192729,in,0,0
192730,patients,0,1
192731,with,0,1
192732,PD-L1,0,1
192733,expression,0,0
192734,on,0,0
192735,at,0,0
192736,least,0,1
192737,50,0,1
192738,%,0,0
192739,of,0,0
192740,tumour,0,1
192741,cells,0,0
192742,.,0,1
192743,We,0,0
192744,used,0,0
192745,a,0,0
192746,threshold,0,0
192747,for,0,0
192748,significance,0,0
192749,of,0,0
192750,p,0,0
192751,<,0,0
192752,0.00825,0,0
192753,(,0,0
192754,one-sided,0,0
192755,),0,0
192756,for,0,0
192757,the,0,0
192758,analysis,0,0
192759,of,0,0
192760,overall,0,0
192761,survival,0,0
192762,and,0,0
192763,a,0,0
192764,threshold,0,0
192765,of,0,0
192766,p,0,0
192767,<,0,0
192768,0.001,0,0
192769,for,0,0
192770,progression-free,0,0
192771,survival,0,0
192772,.,0,0
192773,This,0,0
192774,trial,0,0
192775,is,0,0
192776,registered,0,0
192777,at,0,0
192778,ClinicalTrials.gov,0,0
192779,",",0,0
192780,number,0,0
192781,NCT01905657,0,0
192782,.,0,1
192783,FINDINGS,0,0
192784,Between,1,0
192785,Aug,1,0
192786,28,1,1
192787,",",1,0
192788,2013,1,1
192789,",",1,0
192790,and,1,0
192791,Feb,1,0
192792,27,1,1
192793,",",1,0
192794,2015,1,1
192795,",",1,0
192796,we,1,0
192797,enrolled,1,1
192798,1034,1,1
192799,patients,1,1
192800,:,1,1
192801,345,0,1
192802,allocated,0,1
192803,to,0,0
192804,pembrolizumab,0,1
192805,2,0,0
192806,mg/kg,0,0
192807,",",0,0
192808,346,0,1
192809,allocated,0,0
192810,to,0,0
192811,pembrolizumab,0,1
192812,10,0,0
192813,mg/kg,0,0
192814,",",0,0
192815,and,0,0
192816,343,0,1
192817,allocated,0,1
192818,to,0,0
192819,docetaxel,0,0
192820,.,0,0
192821,By,0,0
192822,Sept,0,0
192823,30,0,1
192824,",",0,0
192825,2015,0,1
192826,",",0,0
192827,521,0,1
192828,patients,0,1
192829,had,0,1
192830,died,0,1
192831,.,0,0
192832,In,0,0
192833,the,0,0
192834,total,0,1
192835,population,0,1
192836,",",0,0
192837,median,0,0
192838,overall,0,0
192839,survival,0,0
192840,was,0,0
192841,10.4,0,0
192842,months,0,0
192843,with,0,1
192844,pembrolizumab,0,1
192845,2,0,0
192846,mg/kg,0,0
192847,",",0,0
192848,12.7,0,0
192849,months,0,0
192850,with,0,1
192851,pembrolizumab,0,1
192852,10,0,0
192853,mg/kg,0,0
192854,",",0,0
192855,and,0,0
192856,8.5,0,0
192857,months,0,0
192858,with,0,1
192859,docetaxel,0,0
192860,.,0,1
192861,Overall,0,0
192862,survival,0,0
192863,was,0,0
192864,significantly,0,0
192865,longer,0,0
192866,for,0,0
192867,pembrolizumab,0,0
192868,2,0,0
192869,mg/kg,0,0
192870,versus,0,0
192871,docetaxel,0,0
192872,(,0,0
192873,hazard,0,0
192874,ratio,0,0
192875,[,0,0
192876,HR,0,0
192877,],0,1
192878,0.71,0,0
192879,",",0,0
192880,95,0,0
192881,%,0,0
192882,CI,0,0
192883,0.58-0.88,0,0
192884,;,0,0
192885,p=0.0008,0,0
192886,),0,0
192887,and,0,0
192888,for,0,0
192889,pembrolizumab,0,1
192890,10,0,1
192891,mg/kg,0,0
192892,versus,0,0
192893,docetaxel,0,0
192894,(,0,0
192895,0.61,0,0
192896,",",0,1
192897,0.49-0.75,0,0
192898,;,0,0
192899,p,0,0
192900,<,0,0
192901,0.0001,0,0
192902,),0,0
192903,.,0,1
192904,Median,0,0
192905,progression-free,0,0
192906,survival,0,0
192907,was,0,0
192908,3.9,0,0
192909,months,0,0
192910,with,0,1
192911,pembrolizumab,0,1
192912,2,0,0
192913,mg/kg,0,0
192914,",",0,0
192915,4.0,0,0
192916,months,0,0
192917,with,0,1
192918,pembrolizumab,0,1
192919,10,0,0
192920,mg/kg,0,0
192921,",",0,0
192922,and,0,0
192923,4.0,0,0
192924,months,0,0
192925,with,0,1
192926,docetaxel,0,0
192927,",",0,0
192928,with,0,1
192929,no,0,0
192930,significant,0,0
192931,difference,0,0
192932,for,0,0
192933,pembrolizumab,0,1
192934,2,0,0
192935,mg/kg,0,0
192936,versus,0,0
192937,docetaxel,0,0
192938,(,0,0
192939,0.88,0,0
192940,",",0,1
192941,0.74-1.05,0,0
192942,;,0,0
192943,p=0.07,0,0
192944,),0,0
192945,or,0,0
192946,for,0,0
192947,pembrolizumab,0,1
192948,10,0,1
192949,mg/kg,0,0
192950,versus,0,0
192951,docetaxel,0,0
192952,(,0,0
192953,HR,0,0
192954,0.79,0,0
192955,",",0,0
192956,95,0,0
192957,%,0,0
192958,CI,0,0
192959,0.66-0.94,0,0
192960,;,0,0
192961,p=0.004,0,0
192962,),0,0
192963,.,0,0
192964,Among,0,1
192965,patients,0,1
192966,with,0,1
192967,at,0,1
192968,least,0,1
192969,50,0,1
192970,%,0,0
192971,of,0,0
192972,tumour,0,1
192973,cells,0,0
192974,expressing,0,0
192975,PD-L1,0,1
192976,",",0,0
192977,overall,0,0
192978,survival,0,0
192979,was,0,0
192980,significantly,0,0
192981,longer,0,0
192982,with,0,0
192983,pembrolizumab,0,0
192984,2,0,0
192985,mg/kg,0,0
192986,than,0,0
192987,with,0,1
192988,docetaxel,0,0
192989,(,0,1
192990,median,0,1
192991,14.9,0,0
192992,months,0,0
192993,vs,0,0
192994,8.2,0,0
192995,months,0,0
192996,;,0,1
192997,HR,0,0
192998,0.54,0,0
192999,",",0,0
193000,95,0,0
193001,%,0,0
193002,CI,0,0
193003,0.38-0.77,0,0
193004,;,0,0
193005,p=0.0002,0,0
193006,),0,0
193007,and,0,0
193008,with,0,1
193009,pembrolizumab,0,1
193010,10,0,1
193011,mg/kg,0,0
193012,than,0,0
193013,with,0,1
193014,docetaxel,0,0
193015,(,0,1
193016,17.3,0,0
193017,months,0,0
193018,vs,0,0
193019,8.2,0,0
193020,months,0,0
193021,;,0,1
193022,0.50,0,0
193023,",",0,0
193024,0.36-0.70,0,0
193025,;,0,0
193026,p,0,0
193027,<,0,0
193028,0.0001,0,0
193029,),0,0
193030,.,0,0
193031,Likewise,0,0
193032,",",0,0
193033,for,0,0
193034,this,0,0
193035,patient,0,0
193036,population,0,1
193037,",",0,0
193038,progression-free,0,0
193039,survival,0,0
193040,was,0,0
193041,significantly,0,0
193042,longer,0,0
193043,with,0,0
193044,pembrolizumab,0,0
193045,2,0,0
193046,mg/kg,0,0
193047,than,0,0
193048,with,0,1
193049,docetaxel,0,0
193050,(,0,1
193051,median,0,1
193052,5.0,0,0
193053,months,0,0
193054,vs,0,0
193055,4.1,0,0
193056,months,0,0
193057,;,0,1
193058,HR,0,0
193059,0.59,0,0
193060,",",0,0
193061,95,0,0
193062,%,0,0
193063,CI,0,0
193064,0.44-0.78,0,0
193065,;,0,0
193066,p=0.0001,0,0
193067,),0,0
193068,and,0,0
193069,with,0,1
193070,pembrolizumab,0,1
193071,10,0,1
193072,mg/kg,0,0
193073,than,0,0
193074,with,0,1
193075,docetaxel,0,0
193076,(,0,1
193077,5.2,0,0
193078,months,0,0
193079,vs,0,0
193080,4.1,0,0
193081,months,0,0
193082,;,0,1
193083,0.59,0,0
193084,",",0,0
193085,0.45-0.78,0,0
193086,;,0,0
193087,p,0,0
193088,<,0,0
193089,0.0001,0,0
193090,),0,0
193091,.,0,1
193092,Grade,0,0
193093,3-5,0,0
193094,treatment-related,0,0
193095,adverse,0,0
193096,events,0,0
193097,were,0,1
193098,less,0,0
193099,common,0,0
193100,with,0,1
193101,pembrolizumab,0,1
193102,than,0,0
193103,with,0,1
193104,docetaxel,0,0
193105,(,0,0
193106,43,0,1
193107,[,0,0
193108,13,0,1
193109,%,0,0
193110,],0,1
193111,of,0,0
193112,339,0,1
193113,patients,0,1
193114,given,0,0
193115,2,0,1
193116,mg/kg,0,0
193117,",",0,1
193118,55,0,1
193119,[,0,0
193120,16,0,1
193121,%,0,0
193122,],0,1
193123,of,0,0
193124,343,0,1
193125,given,0,0
193126,10,0,0
193127,mg/kg,0,0
193128,",",0,0
193129,and,0,0
193130,109,0,1
193131,[,0,0
193132,35,0,1
193133,%,0,0
193134,],0,1
193135,of,0,0
193136,309,0,1
193137,given,0,0
193138,docetaxel,0,0
193139,),0,0
193140,.,0,1
193141,INTERPRETATION,0,0
193142,Pembrolizumab,0,1
193143,prolongs,0,0
193144,overall,0,0
193145,survival,0,0
193146,and,0,0
193147,has,0,0
193148,a,0,0
193149,favourable,0,0
193150,benefit-to-risk,0,0
193151,profile,0,0
193152,in,0,0
193153,patients,1,1
193154,with,1,1
193155,previously,1,1
193156,treated,1,1
193157,",",1,0
193158,PD-L1-positive,1,0
193159,",",1,0
193160,advanced,1,1
193161,non-small-cell,1,1
193162,lung,1,1
193163,cancer,1,1
193164,.,1,0
193165,These,0,0
193166,data,0,0
193167,establish,0,0
193168,pembrolizumab,0,1
193169,as,0,0
193170,a,0,0
193171,new,0,0
193172,treatment,0,0
193173,option,0,0
193174,for,0,0
193175,this,0,0
193176,population,0,1
193177,and,0,0
193178,validate,0,0
193179,the,0,0
193180,use,0,0
193181,of,0,0
193182,PD-L1,0,1
193183,selection,0,0
193184,.,0,1
193185,FUNDING,0,0
193186,Merck,0,1
193187,&,0,1
193188,Co,0,1
193189,.,0,1
193190,[,1,0
193191,EMLA,1,0
193192,cream,1,0
193193,(,1,0
193194,lidocaine/prilocaine,1,0
193195,),1,0
193196,versus,1,0
193197,infiltration,1,0
193198,analgesia,1,0
193199,with,1,1
193200,carbocaine,1,0
193201,(,1,0
193202,mepivacaine,1,0
193203,),1,0
193204,in,1,0
193205,vasectomy,1,1
193206,],1,0
193207,.,0,0
193208,The,0,0
193209,analgesic,0,0
193210,efficacy,0,0
193211,of,0,0
193212,EMLA,0,0
193213,cream,0,0
193214,was,0,0
193215,compared,0,0
193216,with,0,1
193217,infiltration,0,0
193218,with,0,1
193219,1,0,0
193220,%,0,0
193221,carbocaine,0,0
193222,in,0,0
193223,13,1,1
193224,bilateral,1,1
193225,vasectomies,1,1
193226,.,1,1
193227,Twelve,0,1
193228,patients,0,1
193229,preferred,0,0
193230,infiltration,0,0
193231,analgesia,0,0
193232,.,0,0
193233,EMLA,0,0
193234,analgesia,0,0
193235,was,0,0
193236,only,0,0
193237,effective,0,0
193238,in,0,0
193239,the,0,0
193240,skin,0,0
193241,",",0,0
193242,and,0,0
193243,had,0,0
193244,to,0,0
193245,be,0,0
193246,supplemented,0,0
193247,as,0,0
193248,the,0,0
193249,incision,0,0
193250,reached,0,0
193251,subcutaneous,0,0
193252,tissue,0,0
193253,.,0,1
193254,[,0,0
193255,Are,0,0
193256,there,0,0
193257,indications,0,0
193258,for,0,0
193259,adjuvant,0,0
193260,chemotherapy,0,1
193261,after,0,0
193262,excision,1,1
193263,of,1,0
193264,colorectal,1,1
193265,cancer,1,1
193266,?,0,0
193267,],0,0
193268,.,0,0
193269,[,1,0
193270,Cannulation,1,1
193271,of,1,0
193272,the,1,0
193273,internal,1,0
193274,jugular,1,1
193275,vein,1,1
193276,using,1,0
193277,2,1,0
193278,ultrasonic,1,1
193279,technics,1,0
193280,.,1,1
193281,A,0,0
193282,comparative,0,0
193283,controlled,0,0
193284,study,0,0
193285,],0,0
193286,.,0,0
193287,The,0,0
193288,internal,0,0
193289,jugular,0,1
193290,vein,0,1
193291,(,0,0
193292,IJV,0,0
193293,),0,0
193294,is,0,0
193295,a,0,0
193296,common,0,0
193297,access,0,0
193298,route,0,0
193299,to,0,0
193300,the,0,0
193301,central,0,0
193302,venous,0,0
193303,system,0,0
193304,.,0,1
193305,Anatomical,0,0
193306,landmarks,0,0
193307,(,0,0
193308,group,0,0
193309,I,0,1
193310,),0,0
193311,are,0,0
193312,normally,0,0
193313,used,0,0
193314,for,0,0
193315,localization,0,0
193316,of,0,0
193317,the,0,0
193318,IJV,0,0
193319,.,0,0
193320,We,0,0
193321,have,0,0
193322,compared,0,0
193323,this,0,0
193324,method,0,0
193325,with,0,1
193326,two,0,0
193327,other,0,1
193328,methods,0,1
193329,based,0,0
193330,on,0,0
193331,ultrasonic,0,1
193332,waves,0,1
193333,to,0,0
193334,identify,0,0
193335,the,0,0
193336,IJV,0,0
193337,and,0,0
193338,the,0,0
193339,carotid,0,0
193340,artery,0,1
193341,(,0,0
193342,CA,0,1
193343,),0,0
193344,(,0,0
193345,even,0,0
193346,in,0,0
193347,atypical,0,1
193348,positions,0,0
193349,),0,1
193350,.,0,1
193351,We,0,0
193352,employed,0,0
193353,an,0,0
193354,ultrasound,0,0
193355,Doppler,0,0
193356,device,0,0
193357,in,0,0
193358,group,0,0
193359,II,0,1
193360,and,0,0
193361,a,0,0
193362,real-time,0,0
193363,ultrasonograph,0,0
193364,in,0,0
193365,group,0,1
193366,III,0,1
193367,.,0,1
193368,Central,0,0
193369,venous,0,1
193370,catheters,0,1
193371,were,0,1
193372,placed,0,1
193373,into,0,0
193374,the,0,0
193375,right,0,0
193376,IJV,0,0
193377,by,0,0
193378,the,0,0
193379,Seldinger,0,1
193380,technique,0,0
193381,.,0,0
193382,The,0,0
193383,IJV,0,0
193384,could,0,0
193385,be,0,0
193386,located,0,0
193387,in,0,0
193388,all,0,0
193389,patients,0,1
193390,with,0,1
193391,both,0,0
193392,ultrasound,0,0
193393,methods,0,1
193394,",",0,0
193395,but,0,0
193396,the,0,0
193397,course,0,0
193398,of,0,0
193399,the,0,0
193400,IJV,0,0
193401,could,0,0
193402,only,0,0
193403,be,0,0
193404,identified,0,0
193405,by,0,0
193406,ultrasonography,0,0
193407,.,0,0
193408,For,0,0
193409,this,0,0
193410,reason,0,0
193411,",",0,0
193412,the,0,0
193413,direction,0,0
193414,of,0,0
193415,the,0,0
193416,IJV,0,0
193417,was,0,0
193418,classified,0,1
193419,as,0,0
193420,typical,0,1
193421,in,0,0
193422,80,0,1
193423,%,0,0
193424,of,0,0
193425,group,0,0
193426,I,0,1
193427,",",0,0
193428,in,0,0
193429,85,0,0
193430,%,0,0
193431,of,0,0
193432,group,0,0
193433,II,0,1
193434,",",0,0
193435,but,0,0
193436,in,0,0
193437,only,0,0
193438,45,0,1
193439,%,0,0
193440,of,0,0
193441,group,0,1
193442,III,0,1
193443,.,0,1
193444,No,0,0
193445,intergroup,0,0
193446,differences,0,0
193447,were,0,0
193448,found,0,0
193449,with,0,1
193450,respect,0,0
193451,to,0,0
193452,the,0,0
193453,number,0,0
193454,of,0,0
193455,punctures,0,0
193456,(,0,1
193457,mean,0,1
193458,value,0,0
193459,1.6,0,0
193460,+/-,0,0
193461,0.83,0,0
193462,),0,0
193463,and,0,0
193464,the,0,0
193465,incidence,0,0
193466,of,0,0
193467,complications,0,0
193468,.,0,1
193469,The,0,0
193470,time,0,0
193471,required,0,0
193472,to,0,0
193473,locate,0,0
193474,the,0,0
193475,site,0,0
193476,and,0,0
193477,direction,0,0
193478,of,0,0
193479,puncture,0,0
193480,increased,0,0
193481,with,0,1
193482,technical,0,0
193483,sophistication,0,0
193484,.,0,0
193485,There,0,0
193486,was,0,0
193487,",",0,0
193488,however,0,0
193489,",",0,0
193490,no,0,0
193491,difference,0,0
193492,in,0,0
193493,the,0,0
193494,total,0,1
193495,time,0,0
193496,for,0,0
193497,catheter,0,0
193498,placement,0,0
193499,",",0,0
193500,because,0,0
193501,puncture,0,0
193502,was,0,0
193503,performed,0,0
193504,faster,0,0
193505,when,0,0
193506,aided,0,0
193507,by,0,0
193508,sonography,0,0
193509,.,0,1
193510,In,0,0
193511,four,0,0
193512,patients,0,1
193513,in,0,1
193514,groups,0,0
193515,I,0,1
193516,and,0,0
193517,II,0,0
193518,",",0,1
193519,in,0,1
193520,whom,0,1
193521,attempts,0,1
193522,to,0,1
193523,puncture,0,0
193524,the,0,0
193525,IJV,0,0
193526,had,0,0
193527,not,0,0
193528,been,0,0
193529,successful,0,0
193530,",",0,0
193531,this,0,0
193532,could,0,0
193533,subsequently,0,0
193534,be,0,0
193535,achieved,0,0
193536,with,0,1
193537,ultrasonographic,0,0
193538,aid,0,0
193539,.,0,1
193540,One,0,0
193541,patient,0,0
193542,(,0,0
193543,group,0,0
193544,I,0,1
193545,),0,0
193546,displayed,0,0
193547,a,0,0
193548,hematoma,0,0
193549,following,0,0
193550,inadvertent,0,0
193551,puncture,0,0
193552,of,0,0
193553,the,0,0
193554,CA,0,0
193555,.,0,0
193556,In,0,0
193557,one,0,0
193558,patient,0,1
193559,in,0,0
193560,group,0,0
193561,II,0,1
193562,the,0,0
193563,IJV,0,0
193564,and,0,0
193565,CA,0,0
193566,could,0,0
193567,not,0,0
193568,be,0,0
193569,distinguished,0,0
193570,as,0,0
193571,one,0,0
193572,was,0,0
193573,overlying,0,0
193574,the,0,0
193575,other,0,0
193576,.,0,0
193577,The,0,0
193578,echocamera,0,1
193579,provided,0,0
193580,improved,0,0
193581,localization,0,0
193582,of,0,0
193583,the,0,0
193584,IJV,0,0
193585,and,0,0
193586,the,0,0
193587,CA,0,0
193588,in,0,0
193589,comparison,0,0
193590,with,0,1
193591,the,0,0
193592,Doppler,0,0
193593,ultrasound,0,0
193594,.,0,0
193595,(,0,0
193596,ABSTRACT,0,0
193597,TRUNCATED,0,1
193598,AT,0,1
193599,250,0,0
193600,WORDS,0,1
193601,),0,1
193602,Internet-based,0,1
193603,Mindfulness,0,0
193604,Meditation,0,0
193605,for,0,0
193606,Cognition,0,0
193607,and,0,0
193608,Mood,0,1
193609,in,0,0
193610,Older,1,1
193611,Adults,1,1
193612,:,1,1
193613,A,0,0
193614,Pilot,0,1
193615,Study,0,0
193616,.,0,1
193617,CONTEXT,0,0
193618,Older,1,0
193619,adults,1,1
193620,are,0,0
193621,at,0,0
193622,risk,0,0
193623,for,0,0
193624,greater,0,0
193625,chronic,0,1
193626,stress,0,0
193627,and,0,0
193628,cognitive,0,0
193629,decline,0,0
193630,.,0,0
193631,Training,0,0
193632,in,0,0
193633,mindfulness,0,0
193634,meditation,0,0
193635,(,0,0
193636,MM,0,0
193637,),0,0
193638,may,0,0
193639,help,0,0
193640,reduce,0,0
193641,stress,0,0
193642,and,0,0
193643,",",0,0
193644,thus,0,0
193645,",",0,0
193646,cognitive,0,0
193647,decline,0,0
193648,in,0,0
193649,older,0,1
193650,adults,0,1
193651,",",0,0
193652,but,0,0
193653,little,0,0
193654,research,0,0
193655,has,0,0
193656,explored,0,0
193657,that,0,0
193658,hypothesis,0,0
193659,.,0,0
193660,OBJECTIVE,0,0
193661,The,0,0
193662,current,0,0
193663,study,0,0
193664,'s,0,1
193665,primary,0,1
193666,aim,0,0
193667,was,0,0
193668,to,0,0
193669,evaluate,0,0
193670,the,0,0
193671,feasibility,0,0
193672,and,0,0
193673,acceptability,0,0
193674,for,0,0
193675,use,0,0
193676,by,0,0
193677,older,1,1
193678,adults,1,1
193679,of,0,0
193680,the,0,0
193681,Internet,0,1
193682,Mindfulness,0,0
193683,Meditation,0,0
193684,Intervention,0,1
193685,(,0,0
193686,IMMI,0,1
193687,),0,0
193688,",",0,0
193689,a,0,0
193690,program,0,0
193691,that,0,0
193692,had,0,0
193693,been,0,0
193694,developed,0,0
193695,by,0,0
193696,the,0,0
193697,research,0,0
193698,team,0,0
193699,",",0,0
193700,as,0,0
193701,well,0,0
193702,as,0,0
193703,of,0,0
193704,an,0,0
193705,Internet-based,0,0
193706,health-and-wellness,0,0
193707,education,0,0
193708,program,0,0
193709,",",0,0
193710,the,0,0
193711,control,0,0
193712,.,0,0
193713,The,0,0
193714,secondary,0,0
193715,aim,0,0
193716,was,0,0
193717,to,0,0
193718,collect,0,0
193719,preliminary,0,0
193720,pre-,0,0
193721,and,0,0
193722,postintervention,0,0
193723,data,0,0
193724,on,0,0
193725,mood,0,0
193726,and,0,0
193727,cognitive,0,0
193728,function,0,0
193729,.,0,0
193730,DESIGN,0,0
193731,The,0,0
193732,study,0,0
193733,was,0,0
193734,a,0,0
193735,randomized,0,0
193736,",",0,0
193737,controlled,0,0
193738,trial,0,0
193739,(,0,0
193740,RCT,0,0
193741,),0,0
193742,",",0,0
193743,a,0,0
193744,pilot,0,0
193745,study,0,0
193746,",",0,0
193747,with,0,1
193748,participants,1,1
193749,randomized,0,1
193750,either,0,0
193751,to,0,0
193752,the,0,0
193753,meditation,0,0
193754,group,0,0
193755,or,0,0
193756,the,0,0
193757,education,0,0
193758,group,0,0
193759,.,0,0
193760,SETTING,0,1
193761,Participants,0,1
193762,obtained,0,0
193763,access,0,0
193764,to,0,0
193765,the,0,0
193766,programs,0,0
193767,from,0,1
193768,their,0,1
193769,homes,0,1
193770,",",0,0
193771,and,0,0
193772,the,0,0
193773,baseline,0,0
193774,and,0,0
193775,endpoint,0,0
193776,assessments,0,0
193777,occurred,0,0
193778,in,0,0
193779,their,0,0
193780,homes,0,1
193781,as,0,0
193782,well,0,0
193783,.,0,0
193784,PARTICIPANTS,0,0
193785,Older,1,1
193786,adults,1,1
193787,aged,1,1
193788,65-90,1,1
193789,y,1,1
193790,were,1,0
193791,recruited,1,1
193792,from,1,0
193793,the,1,0
193794,Portland,1,1
193795,",",1,0
193796,OR,1,0
193797,",",1,0
193798,metropolitan,1,1
193799,area,1,0
193800,.,1,1
193801,Twenty-one,1,1
193802,people,1,1
193803,enrolled,1,1
193804,in,1,0
193805,the,1,0
193806,study,1,0
193807,.,1,1
193808,INTERVENTION,0,0
193809,Participants,0,1
193810,in,0,1
193811,both,0,1
193812,groups,0,0
193813,took,0,1
193814,part,0,1
193815,in,0,0
193816,a,0,0
193817,1-h,0,0
193818,online,0,0
193819,session,0,0
193820,each,0,0
193821,week,0,0
193822,for,0,0
193823,6,0,0
193824,wk,0,0
193825,",",0,0
193826,with,0,1
193827,30,0,1
193828,min,0,0
193829,of,0,0
193830,daily,0,0
193831,home,0,1
193832,practice,0,0
193833,.,0,1
193834,OUTCOME,0,0
193835,MEASURES,0,0
193836,Feasibility,0,0
193837,and,0,0
193838,acceptability,0,0
193839,were,0,0
193840,assessed,0,0
193841,through,0,0
193842,measures,0,0
193843,of,0,0
193844,adherence,0,0
193845,to,0,0
193846,the,0,0
193847,protocol,0,0
193848,and,0,0
193849,a,0,0
193850,client,0,0
193851,satisfaction,0,0
193852,questionnaire,0,0
193853,.,0,0
193854,Mood,0,0
193855,and,0,0
193856,cognitive,0,1
193857,outcomes,0,0
193858,were,0,1
193859,also,0,0
193860,evaluated,0,0
193861,before,0,0
193862,and,0,0
193863,after,0,0
193864,the,0,0
193865,interventions,0,0
193866,.,0,1
193867,RESULTS,0,0
193868,Sixteen,1,1
193869,participants,1,1
193870,completed,0,1
193871,the,0,0
193872,study,0,0
193873,",",0,0
193874,8,0,0
193875,in,0,0
193876,each,0,0
193877,group,1,0
193878,",",0,0
193879,and,0,0
193880,5,1,0
193881,dropped,0,0
193882,out,0,0
193883,",",0,0
193884,for,0,0
193885,a,0,0
193886,76,0,1
193887,%,0,0
193888,completion,0,0
193889,rate,0,0
193890,.,0,1
193891,Participants,1,1
193892,',1,1
193893,mean,0,1
193894,age,0,1
193895,was,0,0
193896,76.2,0,0
193897,y,0,1
193898,;,0,1
193899,88,0,0
193900,%,0,0
193901,were,0,0
193902,Caucasian,0,1
193903,",",0,0
193904,and,0,0
193905,50,0,1
193906,%,0,0
193907,were,0,1
193908,female,0,1
193909,.,0,1
193910,Acceptability,0,0
193911,was,0,0
193912,high,0,0
193913,for,0,0
193914,the,0,0
193915,interventions,0,0
193916,",",0,0
193917,based,0,0
193918,on,0,0
193919,above-average,0,0
193920,scores,0,0
193921,on,0,0
193922,the,0,0
193923,client,0,0
193924,satisfaction,0,0
193925,questionnaire,0,0
193926,.,0,0
193927,The,0,0
193928,IMMI,0,1
193929,participants,0,1
193930,completed,0,1
193931,(,0,1
193932,1,0,1
193933,),0,1
193934,4.25,0,0
193935,?,0,1
193936,2.4,0,0
193937,sessions,0,0
193938,",",0,0
193939,with,0,1
193940,a,0,0
193941,range,0,0
193942,of,0,0
193943,0-6,0,0
193944,;,0,0
193945,(,0,0
193946,2,0,0
193947,),0,1
193948,604,0,1
193949,?,0,1
193950,506,0,0
193951,home-practice,0,0
193952,minutes,0,0
193953,",",0,0
193954,with,0,1
193955,a,0,0
193956,range,0,0
193957,0-1432,0,0
193958,;,0,0
193959,and,0,0
193960,(,0,0
193961,3,0,0
193962,),0,1
193963,21.3,0,0
193964,?,0,1
193965,15.5,0,0
193966,d,0,0
193967,of,0,0
193968,practice,0,0
193969,",",0,0
193970,with,0,0
193971,a,0,0
193972,range,0,0
193973,of,0,0
193974,0-46,0,0
193975,.,0,0
193976,The,0,0
193977,education,0,0
193978,group,0,0
193979,completed,0,1
193980,(,0,0
193981,1,0,1
193982,),0,1
193983,4.75,0,0
193984,?,0,1
193985,1.8,0,0
193986,sessions,0,0
193987,",",0,0
193988,with,0,1
193989,a,0,0
193990,range,0,0
193991,of,0,0
193992,2-6,0,1
193993,;,0,1
193994,(,0,0
193995,2,0,0
193996,),0,1
193997,873,0,1
193998,?,0,1
193999,395,0,1
194000,home-practice,0,0
194001,minutes,0,0
194002,",",0,0
194003,with,0,1
194004,a,0,0
194005,range,0,0
194006,of,0,0
194007,327-1524,0,1
194008,;,0,0
194009,and,0,0
194010,(,0,0
194011,3,0,0
194012,),0,1
194013,25.6,0,0
194014,d,0,0
194015,of,0,0
194016,practice,0,0
194017,",",0,0
194018,with,0,0
194019,a,0,0
194020,range,0,0
194021,of,0,0
194022,11-35,0,1
194023,.,0,0
194024,The,0,0
194025,intervention,0,0
194026,and,0,0
194027,control,0,1
194028,formats,0,0
194029,were,0,0
194030,both,0,0
194031,feasible,0,0
194032,",",0,0
194033,and,0,0
194034,the,0,0
194035,control,0,0
194036,group,0,0
194037,was,0,0
194038,appropriate,0,0
194039,.,0,1
194040,As,0,0
194041,expected,0,0
194042,due,0,0
194043,to,0,0
194044,the,0,0
194045,pilot,0,0
194046,nature,0,0
194047,of,0,0
194048,the,0,0
194049,study,0,0
194050,",",0,0
194051,no,0,0
194052,differences,0,0
194053,existed,0,0
194054,between,0,0
194055,groups,0,0
194056,for,0,0
194057,the,0,0
194058,mood,0,0
194059,or,0,1
194060,cognitive,0,1
194061,outcomes,0,0
194062,.,0,1
194063,CONCLUSIONS,0,0
194064,Administering,0,0
194065,interventions,0,0
194066,via,0,0
194067,the,0,0
194068,Internet,0,1
194069,to,0,0
194070,older,0,1
194071,adults,0,1
194072,is,0,0
194073,feasible,0,0
194074,.,0,0
194075,The,0,0
194076,2,0,0
194077,interventions,0,0
194078,were,0,1
194079,acceptable,0,0
194080,to,0,0
194081,participants,0,1
194082,and,0,0
194083,equal,0,0
194084,with,0,1
194085,regard,0,0
194086,to,0,0
194087,perceived,0,0
194088,credibility,0,0
194089,and,0,0
194090,acceptability,0,0
194091,.,0,1
194092,Future,0,0
194093,RCTs,0,0
194094,are,0,0
194095,planned,0,0
194096,to,0,0
194097,evaluate,0,0
194098,the,0,0
194099,clinical,0,0
194100,efficacy,0,0
194101,of,0,0
194102,the,0,0
194103,2,0,0
194104,interventions,0,0
194105,.,0,1
194106,[,0,0
194107,Dose-reduced,0,0
194108,antihypertensive,0,0
194109,agents,0,0
194110,--,0,1
194111,use,0,0
194112,in,0,0
194113,complex,0,1
194114,nonmedicamentous,0,1
194115,therapy,0,0
194116,of,0,0
194117,hypertension,0,1
194118,],0,1
194119,.,0,0
194120,In,0,0
194121,order,0,0
194122,to,0,0
194123,estimate,0,0
194124,the,0,0
194125,influence,0,0
194126,of,0,0
194127,a,0,0
194128,non-medicamentous,0,0
194129,therapy,0,0
194130,(,0,0
194131,CNT,0,0
194132,),0,0
194133,on,0,0
194134,the,0,0
194135,consumption,0,0
194136,of,0,0
194137,medicaments,0,0
194138,and,0,1
194139,coronary,0,1
194140,risk,0,0
194141,in,0,0
194142,high,0,0
194143,blood,0,0
194144,pressure,0,0
194145,73,1,1
194146,hypertensives,1,1
194147,of,1,0
194148,a,1,0
194149,medicamentously,1,0
194150,stabilized,1,0
194151,CNT-group,1,0
194152,were,0,0
194153,examined,0,0
194154,in,0,0
194155,comparison,0,0
194156,to,0,0
194157,a,0,0
194158,group,1,0
194159,of,1,0
194160,the,1,0
194161,same,1,0
194162,size,1,0
194163,of,1,0
194164,patients,1,1
194165,with,1,1
194166,hypertension,1,1
194167,who,1,1
194168,were,1,1
194169,managed,1,1
194170,exclusively,1,0
194171,medicamentously,1,0
194172,for,0,0
194173,behaviour,0,0
194174,of,0,0
194175,blood,0,0
194176,pressure,0,0
194177,",",0,0
194178,need,0,0
194179,of,0,0
194180,antihypertensive,0,0
194181,drugs,0,0
194182,and,0,1
194183,changes,0,0
194184,of,0,0
194185,hypertension-associated,0,1
194186,risk,0,1
194187,factors,0,0
194188,.,0,1
194189,After,0,0
194190,an,0,0
194191,exactly,0,0
194192,controlled,0,0
194193,6-month,0,0
194194,treatment,0,0
194195,hypertensives,1,1
194196,with,0,1
194197,additionally,0,0
194198,recommended,0,0
194199,far-reaching,0,0
194200,CNT,0,0
194201,showed,0,0
194202,an,0,0
194203,economization,0,0
194204,of,0,0
194205,medicaments,0,0
194206,by,0,0
194207,scarcely,0,1
194208,the,0,0
194209,half,0,0
194210,in,0,0
194211,comparison,0,0
194212,to,0,0
194213,the,0,0
194214,reference,0,0
194215,group,0,0
194216,.,0,0
194217,By,0,0
194218,means,0,0
194219,of,0,0
194220,suitable,0,0
194221,control,0,0
194222,methods,0,1
194223,a,0,0
194224,causal,0,0
194225,non-medicamentously,0,0
194226,conditioned,0,0
194227,decrease,0,0
194228,of,0,0
194229,blood,0,0
194230,pressure,0,0
194231,could,0,0
194232,be,0,0
194233,excluded,0,0
194234,.,0,0
194235,A,0,0
194236,different,0,0
194237,need,0,0
194238,of,0,0
194239,antihypertensive,0,0
194240,drugs,0,0
194241,was,0,0
194242,simulated,0,0
194243,by,0,0
194244,the,0,0
194245,exacter,0,0
194246,intake,0,0
194247,of,0,0
194248,medicaments,0,0
194249,in,0,0
194250,the,0,0
194251,index-patients,0,1
194252,.,0,0
194253,Notwithstanding,0,0
194254,the,0,0
194255,metabolic,0,1
194256,effects,0,0
194257,of,0,0
194258,the,0,0
194259,additional,0,0
194260,therapy,0,0
194261,have,0,0
194262,induced,0,0
194263,a,0,0
194264,positive,0,0
194265,change,0,0
194266,of,0,0
194267,atherogenic,0,1
194268,lipids,0,0
194269,.,0,1
194270,The,0,0
194271,examinations,0,0
194272,indicate,0,0
194273,in,0,0
194274,general,0,1
194275,the,0,0
194276,difficulty,0,0
194277,of,0,0
194278,the,0,0
194279,judgement,0,0
194280,of,0,0
194281,efficacy,0,0
194282,of,0,0
194283,non-medicamentous,0,1
194284,therapeutic,0,1
194285,measures,0,0
194286,in,0,0
194287,connection,0,0
194288,with,0,1
194289,a,0,0
194290,rational,0,0
194291,dose-reduced,0,0
194292,long-term,0,0
194293,therapy,0,0
194294,with,0,1
194295,antihypertensive,0,1
194296,drugs,0,0
194297,.,0,1
194298,An,0,0
194299,evaluation,0,0
194300,of,0,0
194301,sealing,0,0
194302,ability,0,0
194303,of,0,0
194304,calcium,0,0
194305,hydroxide,0,0
194306,sealers,0,0
194307,.,0,1
194308,Solid,0,0
194309,core,0,0
194310,filling,0,0
194311,material,0,1
194312,such,0,0
194313,as,0,0
194314,gutta-percha,0,0
194315,has,0,0
194316,been,0,0
194317,used,0,0
194318,to,0,0
194319,fill,0,0
194320,the,0,0
194321,root,0,0
194322,canal,0,0
194323,in,0,0
194324,conjunction,0,0
194325,with,0,1
194326,a,0,0
194327,sealer,0,0
194328,to,0,0
194329,prevent,0,0
194330,apical,0,0
194331,leakage,0,0
194332,.,0,0
194333,The,0,0
194334,purpose,0,0
194335,of,0,0
194336,this,0,0
194337,study,0,0
194338,was,0,0
194339,to,0,0
194340,compare,0,0
194341,apical,0,0
194342,seal,0,0
194343,of,0,0
194344,five,0,1
194345,different,0,0
194346,root,0,1
194347,canal,0,1
194348,sealers,0,0
194349,.,0,1
194350,Sixty,1,1
194351,roots,1,0
194352,of,1,0
194353,maxillary,1,1
194354,central,1,1
194355,incisors,1,1
194356,were,0,1
194357,cleansed,0,0
194358,and,0,0
194359,shaped,0,0
194360,and,0,0
194361,randomly,0,1
194362,assigned,0,0
194363,to,0,0
194364,one,0,1
194365,of,0,0
194366,six,0,1
194367,groups,0,0
194368,of,0,1
194369,ten,0,1
194370,roots,0,1
194371,each,0,1
194372,.,0,0
194373,The,0,0
194374,root,0,0
194375,canals,0,0
194376,were,0,0
194377,obturated,0,0
194378,with,0,1
194379,gutta-percha,0,0
194380,and,0,0
194381,one,0,1
194382,of,0,0
194383,the,0,0
194384,sealers,0,0
194385,by,0,0
194386,the,0,0
194387,lateral-vertical,0,0
194388,condensation,0,0
194389,technique,0,0
194390,.,0,0
194391,Groups,0,0
194392,I,0,0
194393,",",0,0
194394,II,0,0
194395,",",0,0
194396,III,0,0
194397,",",0,0
194398,IV,0,0
194399,",",0,0
194400,and,0,0
194401,V,0,0
194402,consisted,0,1
194403,of,0,0
194404,roots,0,0
194405,in,0,0
194406,which,0,0
194407,the,0,0
194408,canal,0,0
194409,was,0,0
194410,filled,0,0
194411,with,0,1
194412,gutta-percha,0,0
194413,along,0,0
194414,with,0,1
194415,either,0,0
194416,Roth,0,0
194417,'s,0,0
194418,sealer,0,0
194419,",",0,0
194420,AH26,0,0
194421,",",0,0
194422,Sealapex,0,0
194423,",",0,0
194424,CRCS,0,0
194425,",",0,0
194426,or,0,0
194427,Nogenol,0,0
194428,sealer,0,0
194429,",",0,0
194430,respectively,0,0
194431,.,0,0
194432,Group,0,0
194433,VI,0,0
194434,was,0,0
194435,filled,0,1
194436,with,0,1
194437,gutta-percha,0,0
194438,and,0,0
194439,without,0,1
194440,sealer,0,0
194441,to,0,0
194442,serve,0,0
194443,as,0,0
194444,a,0,0
194445,control,0,0
194446,.,0,0
194447,The,0,0
194448,access,0,0
194449,opening,0,0
194450,was,0,0
194451,filled,0,0
194452,with,0,1
194453,amalgam,0,0
194454,.,0,0
194455,Each,1,0
194456,tooth,1,0
194457,was,0,0
194458,then,0,0
194459,placed,0,0
194460,in,0,0
194461,a,0,0
194462,capped,0,0
194463,vial,0,0
194464,containing,0,0
194465,2,0,0
194466,X,0,1
194467,2,0,1
194468,inch,0,0
194469,gauze,0,0
194470,pads,0,0
194471,saturated,0,0
194472,with,0,1
194473,distilled,0,0
194474,water,0,0
194475,",",0,0
194476,and,0,0
194477,the,0,0
194478,sealer,0,0
194479,was,0,0
194480,allowed,0,0
194481,to,0,0
194482,set,0,0
194483,at,0,0
194484,37,0,1
194485,degrees,0,0
194486,C,0,0
194487,in,0,0
194488,the,0,0
194489,humidor,0,0
194490,for,0,0
194491,48,0,1
194492,hours,0,0
194493,.,0,1
194494,The,0,0
194495,roots,0,0
194496,",",0,0
194497,except,0,0
194498,for,0,0
194499,the,0,0
194500,apical,0,0
194501,2,0,0
194502,mm,0,0
194503,",",0,0
194504,were,0,0
194505,coated,0,0
194506,with,0,1
194507,two,0,0
194508,layers,0,0
194509,of,0,0
194510,nail,0,1
194511,polish,0,1
194512,.,0,0
194513,The,0,0
194514,roots,0,0
194515,were,0,0
194516,stained,0,0
194517,with,0,1
194518,india,0,1
194519,ink,0,0
194520,",",0,0
194521,decalcified,0,1
194522,",",0,0
194523,dehydrated,0,0
194524,",",0,0
194525,and,0,0
194526,then,0,0
194527,placed,0,0
194528,in,0,0
194529,methylsalicylate,0,0
194530,to,0,0
194531,make,0,0
194532,them,0,1
194533,transparent,0,0
194534,.,0,0
194535,The,0,0
194536,leakage,0,0
194537,was,0,0
194538,measured,0,0
194539,with,0,1
194540,a,0,0
194541,filar,0,0
194542,micrometer,0,0
194543,eyepiece,0,0
194544,under,0,0
194545,a,0,0
194546,dissecting,0,0
194547,microscope,0,0
194548,.,0,0
194549,The,0,0
194550,mean,0,0
194551,apical,0,0
194552,leakage,0,0
194553,of,0,0
194554,six,0,1
194555,groups,0,0
194556,was,0,0
194557,as,0,0
194558,follows,0,0
194559,:,0,0
194560,I,0,0
194561,=,0,0
194562,0.45,0,0
194563,mm,0,0
194564,",",0,0
194565,II,0,0
194566,=,0,0
194567,0.277,0,0
194568,mm,0,0
194569,",",0,0
194570,III,0,0
194571,=,0,0
194572,0.343,0,0
194573,mm,0,0
194574,",",0,0
194575,IV,0,0
194576,=,0,0
194577,0.263,0,0
194578,mm,0,0
194579,",",0,0
194580,V,0,0
194581,=,0,0
194582,0.336,0,0
194583,mm,0,0
194584,",",0,0
194585,and,0,0
194586,VI,0,0
194587,=,0,0
194588,2.310,0,0
194589,mm,0,0
194590,.,0,1
194591,Results,0,0
194592,showed,0,0
194593,no,0,0
194594,significant,0,0
194595,difference,0,0
194596,in,0,0
194597,the,0,0
194598,apical,0,0
194599,seal,0,0
194600,produced,0,0
194601,by,0,0
194602,gutta-percha,0,0
194603,and,0,0
194604,the,0,0
194605,tested,0,0
194606,root,0,0
194607,canal,0,1
194608,sealers,0,0
194609,.,0,1
194610,(,0,0
194611,ABSTRACT,0,0
194612,TRUNCATED,0,1
194613,AT,0,1
194614,250,0,0
194615,WORDS,0,1
194616,),0,1
194617,Intranasal,0,1
194618,recombinant,0,0
194619,alfa-2b,0,0
194620,interferon,0,0
194621,treatment,0,0
194622,of,0,0
194623,naturally,1,0
194624,occurring,1,0
194625,common,1,0
194626,colds,1,1
194627,.,1,1
194628,In,0,0
194629,a,0,0
194630,double-blind,0,0
194631,",",0,0
194632,placebo-controlled,0,0
194633,study,0,0
194634,",",0,0
194635,patients,1,1
194636,with,1,1
194637,naturally,1,1
194638,occurring,1,0
194639,common,1,0
194640,colds,1,1
194641,of,1,0
194642,less,1,0
194643,than,1,0
194644,or,1,0
194645,equal,1,0
194646,to,1,0
194647,48,1,1
194648,h,1,0
194649,duration,1,0
194650,were,0,0
194651,randomly,0,1
194652,assigned,0,0
194653,to,0,0
194654,receive,0,0
194655,nasal,0,0
194656,sprays,0,0
194657,of,0,1
194658,recombinant,0,0
194659,alfa-2b,0,0
194660,interferon,0,0
194661,at,0,0
194662,10,0,1
194663,or,0,1
194664,20,0,1
194665,MU/day,0,0
194666,or,0,1
194667,placebo,0,1
194668,four,0,1
194669,times,0,0
194670,per,0,0
194671,day,0,0
194672,for,0,0
194673,5,0,1
194674,days,0,0
194675,.,0,1
194676,The,0,0
194677,10-MU,1,0
194678,(,1,0
194679,n,1,1
194680,=,1,0
194681,74,1,1
194682,),1,0
194683,",",1,0
194684,20-MU,1,0
194685,(,1,0
194686,n,1,1
194687,=,1,0
194688,74,1,1
194689,),1,0
194690,",",1,0
194691,and,1,0
194692,placebo,1,0
194693,(,1,0
194694,n,1,1
194695,=,1,0
194696,72,1,1
194697,),1,1
194698,groups,1,0
194699,had,0,1
194700,comparable,0,0
194701,frequencies,0,0
194702,of,0,0
194703,documented,0,1
194704,rhinovirus,0,1
194705,colds,0,1
194706,(,0,1
194707,50,0,1
194708,to,0,0
194709,65,0,1
194710,%,0,0
194711,),0,0
194712,and,0,0
194713,mean,0,1
194714,durations,0,0
194715,of,0,0
194716,pretreatment,0,0
194717,symptoms,0,0
194718,(,0,1
194719,26,0,1
194720,to,0,0
194721,27,0,1
194722,h,0,0
194723,),0,0
194724,.,0,0
194725,The,0,0
194726,median,0,0
194727,duration,0,0
194728,of,0,0
194729,colds,0,0
194730,tended,0,0
194731,to,0,0
194732,be,0,0
194733,longer,0,0
194734,in,0,0
194735,the,0,0
194736,20-MU,0,0
194737,group,0,0
194738,(,0,1
194739,10,0,1
194740,days,0,0
194741,),0,1
194742,than,0,0
194743,the,0,0
194744,10-MU,0,0
194745,group,0,0
194746,(,0,1
194747,8,0,0
194748,days,0,0
194749,),0,1
194750,or,0,1
194751,placebo,0,0
194752,group,0,0
194753,(,0,0
194754,8,0,0
194755,days,0,0
194756,),0,1
194757,(,0,1
194758,P,0,0
194759,=,0,0
194760,0.06,0,0
194761,),0,0
194762,.,0,0
194763,In,0,0
194764,those,0,0
194765,with,0,1
194766,proven,0,0
194767,rhinovirus,0,1
194768,colds,0,0
194769,treated,0,1
194770,within,0,1
194771,24,0,0
194772,h,0,0
194773,",",0,0
194774,the,0,0
194775,median,0,0
194776,duration,0,0
194777,was,0,0
194778,significantly,0,0
194779,longer,0,0
194780,in,0,0
194781,the,0,0
194782,20-MU,0,0
194783,group,0,0
194784,(,0,1
194785,9,0,0
194786,days,0,0
194787,),0,1
194788,than,0,0
194789,in,0,0
194790,the,0,0
194791,placebo,0,0
194792,group,0,0
194793,(,0,0
194794,6,0,0
194795,days,0,0
194796,),0,1
194797,.,0,1
194798,No,0,0
194799,differences,0,0
194800,favoring,0,0
194801,interferon,0,0
194802,treatment,0,0
194803,were,0,0
194804,found,0,0
194805,in,0,0
194806,respiratory,0,1
194807,symptom,0,1
194808,scores,0,0
194809,or,0,1
194810,resolution,0,0
194811,of,0,0
194812,specific,0,0
194813,symptoms,0,1
194814,.,0,1
194815,On,0,0
194816,days,0,0
194817,5,0,1
194818,and,0,1
194819,7,0,0
194820,",",0,0
194821,nasal,0,0
194822,washings,0,0
194823,from,0,1
194824,compliant,0,1
194825,subjects,0,1
194826,with,0,1
194827,proven,0,1
194828,rhinovirus,0,1
194829,colds,0,1
194830,yielded,0,0
194831,rhinoviruses,0,0
194832,more,0,0
194833,often,0,0
194834,in,0,0
194835,placebo,0,0
194836,(,0,0
194837,47,0,1
194838,and,0,0
194839,48,0,0
194840,%,0,0
194841,",",0,0
194842,respectively,0,0
194843,),0,0
194844,than,0,0
194845,in,0,0
194846,interferon,0,0
194847,(,0,0
194848,15,0,1
194849,and,0,0
194850,16,0,1
194851,%,0,0
194852,",",0,0
194853,respectively,0,0
194854,),0,0
194855,recipients,0,1
194856,(,0,1
194857,P,0,0
194858,less,0,0
194859,than,0,0
194860,0.02,0,0
194861,),0,0
194862,",",0,0
194863,but,0,0
194864,no,0,0
194865,differences,0,0
194866,in,0,0
194867,new,0,1
194868,respiratory,0,1
194869,illness,0,1
194870,occurrence,0,0
194871,were,0,0
194872,observed,0,0
194873,in,0,0
194874,household,0,1
194875,contacts,0,1
194876,.,0,1
194877,Interferon,0,0
194878,recipients,0,1
194879,had,0,1
194880,significantly,0,0
194881,higher,0,0
194882,frequencies,0,0
194883,of,0,0
194884,blood,0,0
194885,in,0,0
194886,nasal,0,0
194887,mucus,0,0
194888,(,0,0
194889,16,0,1
194890,to,0,0
194891,18,0,1
194892,%,0,0
194893,),0,0
194894,than,0,0
194895,did,0,0
194896,placebo,0,0
194897,recipients,0,1
194898,(,0,0
194899,4,0,0
194900,%,0,0
194901,),0,0
194902,during,0,0
194903,treatment,0,0
194904,.,0,1
194905,Antibiotics,0,0
194906,for,0,0
194907,presumed,0,1
194908,secondary,0,1
194909,infections,0,1
194910,were,0,0
194911,given,0,0
194912,more,0,0
194913,often,0,0
194914,in,0,0
194915,the,0,0
194916,20-MU,0,0
194917,group,0,0
194918,(,0,0
194919,11,0,0
194920,%,0,0
194921,),0,0
194922,than,0,0
194923,in,0,0
194924,the,0,0
194925,placebo,0,0
194926,group,0,0
194927,(,0,0
194928,0,0,0
194929,%,0,0
194930,),0,0
194931,(,0,0
194932,P,0,0
194933,less,0,0
194934,than,0,0
194935,0.01,0,0
194936,),0,1
194937,.,0,1
194938,Nasal,0,0
194939,sprays,0,0
194940,of,0,0
194941,recombinant,0,0
194942,alfa-2b,0,0
194943,interferon,0,0
194944,were,0,0
194945,not,0,0
194946,an,0,0
194947,effective,0,0
194948,treatment,0,0
194949,for,0,0
194950,natural,0,0
194951,colds,0,1
194952,and,0,1
194953,were,0,0
194954,associated,0,0
194955,with,0,1
194956,toxicity,0,0
194957,.,0,1
194958,Primary,1,1
194959,hypothyroidism,1,1
194960,associated,0,0
194961,with,0,1
194962,interferon,1,0
194963,therapy,1,0
194964,of,1,0
194965,breast,1,1
194966,cancer,1,1
194967,.,1,1
194968,Comparison,0,0
194969,of,0,0
194970,endotracheal,0,1
194971,and,0,0
194972,peripheral,0,0
194973,intravenous,0,0
194974,adrenaline,0,0
194975,in,0,0
194976,cardiac,1,1
194977,arrest,1,1
194978,.,1,0
194979,Is,0,0
194980,the,0,0
194981,endotracheal,0,0
194982,route,0,0
194983,reliable,0,0
194984,?,0,0
194985,Twelve,1,1
194986,patients,1,1
194987,presenting,1,1
194988,to,1,0
194989,an,1,0
194990,accident,1,0
194991,and,1,0
194992,emergency,1,1
194993,department,1,1
194994,in,1,0
194995,asystolic,1,1
194996,cardiac,1,1
194997,arrest,1,1
194998,were,1,0
194999,randomly,1,1
195000,allocated,1,0
195001,to,1,0
195002,treatment,1,0
195003,with,1,1
195004,endotracheal,1,1
195005,adrenaline,1,0
195006,(,1,1
195007,five,1,1
195008,patients,1,1
195009,),1,1
195010,or,1,1
195011,peripheral,1,1
195012,intravenous,1,0
195013,adrenaline,1,0
195014,(,1,1
195015,seven,1,1
195016,patients,1,1
195017,),1,1
195018,.,1,1
195019,Femoral-artery,0,0
195020,blood,0,0
195021,samples,0,0
195022,were,0,0
195023,taken,0,0
195024,for,0,0
195025,assay,0,0
195026,of,0,0
195027,adrenaline,0,0
195028,and,0,0
195029,noradrenaline,0,0
195030,.,0,0
195031,After,0,0
195032,intravenous,0,0
195033,adrenaline,0,0
195034,there,0,0
195035,was,0,0
195036,a,0,0
195037,good,0,0
195038,clinical,0,0
195039,and,0,0
195040,biochemical,0,0
195041,response,0,0
195042,",",0,0
195043,but,0,0
195044,after,0,0
195045,endotracheal,0,1
195046,adrenaline,0,0
195047,there,0,0
195048,was,0,0
195049,no,0,0
195050,change,0,0
195051,in,0,0
195052,serum,0,0
195053,adrenaline,0,0
195054,and,0,0
195055,no,0,0
195056,measurable,0,0
195057,clinical,0,0
195058,response,0,0
195059,.,0,0
195060,The,0,0
195061,endotracheal,0,0
195062,route,0,0
195063,of,0,0
195064,adrenaline,0,0
195065,administration,0,0
195066,is,0,0
195067,not,0,0
195068,reliable,0,0
195069,in,0,0
195070,out-of-hospital,0,1
195071,cardiac,0,1
195072,arrest,0,1
195073,.,0,1
195074,Methotrexate/nitrous-oxide,0,0
195075,toxic,0,0
195076,interaction,0,0
195077,in,0,0
195078,perioperative,1,0
195079,chemotherapy,1,1
195080,for,1,0
195081,early,1,0
195082,breast,1,1
195083,cancer,1,1
195084,.,1,1
195085,Comparative,0,0
195086,efficacy,0,0
195087,of,0,0
195088,oral,0,0
195089,erythromycin,0,0
195090,versus,0,0
195091,oral,0,0
195092,tetracycline,0,0
195093,in,0,0
195094,the,0,0
195095,treatment,0,0
195096,of,0,0
195097,acne,0,1
195098,vulgaris,0,1
195099,.,0,0
195100,A,0,0
195101,double-blind,0,0
195102,study,0,0
195103,.,0,0
195104,The,0,0
195105,efficacy,0,0
195106,of,0,0
195107,erythromycin,0,0
195108,base,0,0
195109,(,0,0
195110,E-Mycin,0,0
195111,tablets,0,0
195112,",",0,0
195113,333,0,1
195114,mg,0,0
195115,),0,0
195116,and,0,0
195117,the,0,0
195118,efficacy,0,0
195119,of,0,0
195120,tetracycline,0,0
195121,hydrochloride,0,0
195122,(,0,0
195123,Panmycin,0,0
195124,tablets,0,0
195125,),0,1
195126,were,0,0
195127,compared,0,0
195128,in,0,0
195129,this,0,0
195130,double-blind,0,0
195131,",",0,0
195132,randomized,0,0
195133,study,0,0
195134,.,0,1
195135,Two,1,0
195136,hundred,1,1
195137,patients,1,1
195138,with,1,1
195139,moderate,1,1
195140,to,1,0
195141,moderately,1,1
195142,severe,1,1
195143,acne,1,1
195144,vulgaris,1,1
195145,were,0,1
195146,randomly,0,1
195147,assigned,0,0
195148,to,0,0
195149,the,0,0
195150,study,0,0
195151,.,0,0
195152,One,0,1
195153,hundred,0,1
195154,patients,0,1
195155,received,0,1
195156,1,0,0
195157,gm,0,0
195158,of,0,0
195159,erythromycin,0,0
195160,base,0,0
195161,by,0,0
195162,mouth,0,0
195163,per,0,0
195164,day,0,0
195165,for,0,0
195166,4,0,0
195167,weeks,0,0
195168,",",0,0
195169,followed,0,0
195170,by,0,0
195171,333,0,1
195172,mg/day,0,0
195173,for,0,0
195174,8,0,0
195175,weeks,0,0
195176,",",0,0
195177,plus,0,0
195178,placebo,0,0
195179,for,0,0
195180,tetracycline,0,0
195181,.,0,0
195182,The,0,0
195183,second,0,0
195184,group,0,0
195185,of,0,0
195186,patients,0,1
195187,received,0,1
195188,1,0,0
195189,gm,0,0
195190,of,0,0
195191,tetracycline,0,0
195192,by,0,0
195193,mouth,0,0
195194,per,0,0
195195,day,0,0
195196,for,0,0
195197,4,0,0
195198,weeks,0,0
195199,",",0,0
195200,followed,0,0
195201,by,0,0
195202,500,0,0
195203,mg/day,0,0
195204,for,0,0
195205,8,0,0
195206,weeks,0,0
195207,",",0,0
195208,plus,0,0
195209,placebo,0,0
195210,for,0,0
195211,erythromycin,0,0
195212,.,0,0
195213,Both,0,0
195214,drugs,0,0
195215,reduced,0,0
195216,acne,0,1
195217,severity,0,0
195218,to,0,0
195219,the,0,0
195220,same,0,0
195221,extent,0,0
195222,.,0,0
195223,Pustules,0,0
195224,",",0,0
195225,papules,0,0
195226,",",0,0
195227,and,0,0
195228,open,0,1
195229,comedo,0,1
195230,counts,0,0
195231,decreased,0,0
195232,significantly,0,0
195233,over,0,0
195234,the,0,0
195235,12-week,0,0
195236,period,0,0
195237,.,0,1
195238,Seventy-seven,0,1
195239,percent,0,0
195240,of,0,0
195241,the,0,0
195242,erythromycin-treated,0,0
195243,patients,0,1
195244,and,0,1
195245,89,0,1
195246,%,0,0
195247,of,0,0
195248,the,0,0
195249,tetracycline-treated,0,0
195250,patients,0,1
195251,stated,0,1
195252,that,0,0
195253,their,0,0
195254,acne,0,1
195255,was,0,0
195256,markedly,0,0
195257,improved,0,0
195258,or,0,0
195259,improved,0,0
195260,by,0,0
195261,week,0,0
195262,12,0,0
195263,.,0,0
195264,Most,0,0
195265,of,0,0
195266,the,0,0
195267,side,0,0
195268,effects,0,0
195269,in,0,1
195270,patients,0,1
195271,treated,0,1
195272,with,0,1
195273,erythromycin,0,0
195274,were,0,1
195275,gastrointestinal,0,1
195276,symptoms,0,0
195277,.,0,1
195278,Among,0,1
195279,the,0,0
195280,side,0,0
195281,effects,0,0
195282,in,0,1
195283,patients,0,1
195284,treated,0,1
195285,with,0,1
195286,tetracycline,0,0
195287,were,0,0
195288,Candida,0,1
195289,vaginitis,0,1
195290,in,0,0
195291,one,0,0
195292,patient,0,1
195293,and,0,0
195294,pseudotumor,0,0
195295,cerebri,0,0
195296,in,0,0
195297,one,0,1
195298,patient,0,1
195299,.,0,1
195300,Comparison,0,0
195301,of,0,0
195302,ketanserin,0,0
195303,and,0,0
195304,pindolol,0,0
195305,in,0,0
195306,hypertension,1,1
195307,.,1,0
195308,The,0,0
195309,antihypertensive,0,0
195310,effects,0,0
195311,of,0,0
195312,ketanserin,0,0
195313,(,0,0
195314,40,0,0
195315,mg,0,0
195316,twice,0,0
195317,daily,0,0
195318,),0,0
195319,and,0,0
195320,pindolol,0,0
195321,(,0,0
195322,5,0,0
195323,mg,0,0
195324,twice,0,0
195325,daily,0,0
195326,),0,0
195327,as,0,0
195328,monotherapy,0,0
195329,were,0,0
195330,compared,0,0
195331,in,0,0
195332,a,0,0
195333,crossover,0,0
195334,",",0,0
195335,double-blind,0,0
195336,trial,0,0
195337,in,0,0
195338,17,1,1
195339,patients,1,1
195340,with,1,1
195341,essential,1,1
195342,hypertension,1,1
195343,.,1,0
195344,Both,0,0
195345,ketanserin,0,0
195346,and,0,0
195347,pindolol,0,0
195348,decreased,0,0
195349,supine,0,0
195350,systolic,0,1
195351,and,0,0
195352,diastolic,0,0
195353,blood,0,0
195354,pressure,0,0
195355,significantly,0,0
195356,(,0,0
195357,P,0,0
195358,less,0,0
195359,than,0,0
195360,0.01,0,0
195361,for,0,0
195362,systolic,0,1
195363,and,0,0
195364,P,0,0
195365,less,0,0
195366,than,0,0
195367,0.001,0,0
195368,for,0,0
195369,diastolic,0,1
195370,),0,0
195371,when,0,0
195372,evaluated,0,0
195373,at,0,0
195374,the,0,0
195375,end,0,0
195376,of,0,0
195377,the,0,0
195378,2-month,0,0
195379,treatment,0,0
195380,periods,0,0
195381,.,0,0
195382,There,0,0
195383,was,0,0
195384,no,0,0
195385,significant,0,0
195386,difference,0,0
195387,between,0,0
195388,the,0,0
195389,two,0,0
195390,drugs,0,0
195391,.,0,1
195392,No,0,0
195393,significant,0,0
195394,changes,0,0
195395,in,0,0
195396,heart,0,1
195397,rate,0,0
195398,were,0,0
195399,observed,0,0
195400,on,0,0
195401,either,0,0
195402,drug,0,0
195403,.,0,0
195404,Both,0,0
195405,drugs,0,0
195406,were,0,0
195407,well,0,0
195408,tolerated,0,0
195409,.,0,0
195410,Placebo-controlled,0,0
195411,study,0,1
195412,of,0,0
195413,oral,0,0
195414,enoximone,0,0
195415,in,0,0
195416,congestive,0,1
195417,heart,0,1
195418,failure,0,1
195419,with,0,1
195420,initial,0,0
195421,and,0,1
195422,final,0,0
195423,intravenous,0,0
195424,hemodynamic,0,0
195425,evaluation,0,0
195426,.,0,1
195427,Seventeen,1,0
195428,patients,1,1
195429,with,1,1
195430,stable,1,1
195431,congestive,1,1
195432,heart,1,1
195433,failure,1,1
195434,(,1,0
195435,class,1,1
195436,II,1,1
195437,and,1,0
195438,III,1,1
195439,New,1,1
195440,York,1,1
195441,Heart,1,1
195442,Association,1,0
195443,),1,0
195444,received,0,0
195445,intravenous,0,0
195446,and,0,0
195447,oral,0,0
195448,enoximone,0,0
195449,in,0,0
195450,a,0,0
195451,2-part,0,1
195452,study,0,0
195453,.,0,1
195454,Hemodynamic,0,0
195455,data,0,0
195456,were,0,0
195457,first,0,0
195458,obtained,0,0
195459,after,0,0
195460,intravenous,0,0
195461,administration,0,0
195462,of,0,0
195463,0.75,0,0
195464,mg/kg,0,0
195465,of,0,0
195466,enoximone,0,0
195467,;,0,1
195468,data,0,0
195469,were,0,0
195470,again,0,0
195471,obtained,0,0
195472,after,0,0
195473,12,0,0
195474,weeks,0,0
195475,of,0,0
195476,therapy,0,0
195477,with,0,1
195478,either,0,0
195479,oral,0,0
195480,enoximone,0,0
195481,(,0,0
195482,150,0,0
195483,mg,0,0
195484,3,0,0
195485,times,0,0
195486,daily,0,0
195487,),0,0
195488,or,0,0
195489,placebo,0,0
195490,.,0,0
195491,The,0,0
195492,efficacy,0,0
195493,and,0,0
195494,safety,0,0
195495,of,0,0
195496,oral,0,0
195497,enoximone,0,0
195498,were,0,0
195499,also,0,0
195500,studied,0,0
195501,in,0,0
195502,a,0,0
195503,12-week,0,0
195504,",",0,0
195505,double-blind,0,0
195506,randomized,0,1
195507,format,0,0
195508,.,0,0
195509,In,0,0
195510,the,0,0
195511,intravenous,0,0
195512,study,0,0
195513,",",0,0
195514,enoximone,0,0
195515,was,0,0
195516,delivered,0,0
195517,over,0,0
195518,5,0,1
195519,minutes,0,0
195520,and,0,1
195521,hemodynamic,0,0
195522,data,0,0
195523,were,0,1
195524,measured,0,0
195525,for,0,0
195526,up,0,0
195527,to,0,0
195528,12,0,0
195529,hours,0,0
195530,after,0,1
195531,.,0,1
195532,Cardiac,0,0
195533,index,0,0
195534,increased,0,0
195535,2.76,0,0
195536,+/-,0,0
195537,0.63,0,0
195538,to,0,1
195539,3.42,0,0
195540,+/-,0,0
195541,0.72,0,0
195542,liters/min/m2,0,0
195543,),0,0
195544,",",0,0
195545,pulmonary,0,1
195546,wedge,0,0
195547,pressure,0,0
195548,decreased,0,0
195549,(,0,0
195550,19.5,0,0
195551,+/-,0,0
195552,8.8,0,0
195553,to,0,1
195554,14.6,0,1
195555,+/-,0,0
195556,8.0,0,1
195557,mm,0,1
195558,Hg,0,0
195559,),0,0
195560,as,0,0
195561,did,0,0
195562,mean,0,1
195563,arterial,0,1
195564,blood,0,0
195565,pressure,0,0
195566,(,0,0
195567,101,0,1
195568,+/-,0,0
195569,14.8,0,0
195570,to,0,1
195571,85,0,1
195572,+/-,0,0
195573,13.7,0,0
195574,mm,0,1
195575,Hg,0,0
195576,),0,0
195577,and,0,0
195578,systemic,0,0
195579,vascular,0,0
195580,resistance,0,0
195581,(,0,0
195582,"1,880",0,1
195583,+/-,0,0
195584,573,0,1
195585,to,0,1
195586,"1,254",0,1
195587,+/-,0,0
195588,383,0,1
195589,dynes,0,0
195590,s,0,0
195591,cm-5,0,1
195592,),0,0
195593,.,0,0
195594,Heart,0,0
195595,rate,0,0
195596,increased,0,0
195597,slightly,0,0
195598,(,0,0
195599,82,0,1
195600,+/-,0,0
195601,17,0,1
195602,to,0,1
195603,86,0,1
195604,+/-,0,0
195605,14,0,1
195606,beats/min,0,0
195607,),0,0
195608,.,0,0
195609,All,0,0
195610,these,0,0
195611,changes,0,0
195612,were,0,1
195613,maximal,0,0
195614,1,0,0
195615,to,0,1
195616,2,0,0
195617,hours,0,0
195618,after,0,0
195619,infusion,0,0
195620,and,0,0
195621,lasted,0,0
195622,8,0,0
195623,hours,0,0
195624,at,0,1
195625,least,0,1
195626,.,0,1
195627,Patients,0,1
195628,were,0,0
195629,then,0,0
195630,randomized,0,0
195631,double-blind,0,0
195632,to,0,0
195633,oral,0,0
195634,treatment,0,0
195635,.,0,0
195636,Baseline,0,0
195637,values,0,0
195638,showed,0,0
195639,that,0,0
195640,the,0,0
195641,7,0,1
195642,patients,0,1
195643,who,0,1
195644,received,0,1
195645,placebo,0,0
195646,had,0,0
195647,more,0,0
195648,severe,0,1
195649,CHF,0,0
195650,.,0,1
195651,Therefore,0,0
195652,",",0,0
195653,comparison,0,0
195654,might,0,0
195655,be,0,0
195656,biased,0,0
195657,.,0,0
195658,Patient,0,0
195659,overall,0,0
195660,assessment,0,0
195661,showed,0,0
195662,a,0,0
195663,continuous,0,0
195664,benefit,0,0
195665,in,0,0
195666,both,0,0
195667,groups,0,0
195668,.,0,1
195669,Ejection,0,0
195670,fraction,0,0
195671,improved,0,0
195672,from,0,1
195673,30.1,0,0
195674,+/-,0,0
195675,6.8,0,0
195676,%,0,0
195677,to,0,0
195678,33.9,0,0
195679,+/-,0,0
195680,9.9,0,0
195681,%,0,0
195682,in,0,0
195683,the,0,0
195684,enoximone,0,0
195685,group,0,0
195686,while,0,0
195687,it,0,0
195688,remained,0,0
195689,unchanged,0,0
195690,with,0,1
195691,placebo,0,0
195692,(,0,0
195693,23.4,0,0
195694,+/-,0,0
195695,6.5,0,0
195696,%,0,0
195697,to,0,0
195698,23.4,0,0
195699,+/-,0,0
195700,1.5,0,0
195701,%,0,0
195702,),0,0
195703,.,0,0
195704,(,0,0
195705,ABSTRACT,0,0
195706,TRUNCATED,0,1
195707,AT,0,1
195708,250,0,0
195709,WORDS,0,1
195710,),0,1
195711,Comparison,0,0
195712,of,0,0
195713,four,0,1
195714,continuously,0,0
195715,administered,0,0
195716,progestogen,0,0
195717,plus,0,0
195718,oestradiol,0,0
195719,combinations,0,0
195720,for,0,1
195721,climacteric,0,1
195722,complaints,0,1
195723,.,0,1
195724,Sixty,1,1
195725,women,1,1
195726,with,1,1
195727,climacteric,1,1
195728,complaints,1,1
195729,who,1,1
195730,had,1,1
195731,not,1,1
195732,menstruated,1,1
195733,for,1,0
195734,at,1,0
195735,least,1,1
195736,1,1,0
195737,year,1,0
195738,were,0,0
195739,randomly,0,1
195740,allocated,0,0
195741,to,0,0
195742,receive,0,0
195743,one,0,1
195744,of,0,0
195745,four,0,1
195746,hormonal,0,1
195747,replacement,0,1
195748,regimens,0,0
195749,.,0,1
195750,All,0,1
195751,four,0,0
195752,formulations,0,0
195753,were,0,1
195754,administered,0,0
195755,daily,0,0
195756,and,0,0
195757,continuously,0,0
195758,and,0,0
195759,each,0,0
195760,contained,0,0
195761,2,0,0
195762,mg,0,0
195763,of,0,0
195764,micronized,0,0
195765,oestradiol-17,0,0
195766,beta,0,0
195767,in,0,0
195768,combination,0,0
195769,with,0,1
195770,either,0,0
195771,norethisterone,0,0
195772,acetate,0,0
195773,1,0,0
195774,mg,0,0
195775,(,0,0
195776,group,0,0
195777,A,0,1
195778,),0,0
195779,or,0,1
195780,0.5,0,0
195781,mg,0,0
195782,(,0,0
195783,group,0,0
195784,B,0,1
195785,),0,0
195786,or,0,0
195787,megestrol,0,0
195788,acetate,0,0
195789,5,0,0
195790,mg,0,0
195791,(,0,0
195792,group,0,0
195793,C,0,0
195794,),0,0
195795,or,0,1
195796,2.5,0,0
195797,mg,0,0
195798,(,0,0
195799,group,0,0
195800,D,0,0
195801,),0,0
195802,.,0,0
195803,The,0,0
195804,clinical,0,0
195805,efficacy,0,0
195806,was,0,0
195807,the,0,0
195808,same,0,0
195809,although,0,0
195810,the,0,0
195811,alleviation,0,0
195812,of,0,0
195813,vasomotor,0,1
195814,symptoms,0,0
195815,was,0,0
195816,somewhat,0,0
195817,slower,0,0
195818,in,0,0
195819,those,0,0
195820,women,0,1
195821,receiving,0,1
195822,preparation,0,0
195823,A,0,1
195824,.,0,0
195825,The,0,0
195826,endometrium,0,0
195827,was,0,0
195828,atrophied,0,1
195829,in,0,0
195830,nearly,0,0
195831,all,0,0
195832,biopsies,0,0
195833,.,0,1
195834,Irregular,0,0
195835,uterine,0,1
195836,bleeding,0,1
195837,was,0,0
195838,almost,0,0
195839,entirely,0,0
195840,confined,0,0
195841,to,0,0
195842,the,0,0
195843,earlier,0,0
195844,phase,0,0
195845,of,0,0
195846,the,0,0
195847,study,0,0
195848,and,0,0
195849,was,0,0
195850,substantially,0,0
195851,less,0,0
195852,with,0,0
195853,the,0,0
195854,formulation,0,0
195855,containing,0,0
195856,1,0,0
195857,mg,0,0
195858,norethisterone,0,0
195859,acetate,0,0
195860,.,0,0
195861,It,0,0
195862,is,0,0
195863,concluded,0,0
195864,that,0,0
195865,a,0,0
195866,continuous,0,0
195867,oestradiol-progestogen,0,0
195868,combination,0,0
195869,can,0,0
195870,be,0,0
195871,used,0,0
195872,for,0,0
195873,long-term,0,0
195874,treatment,0,0
195875,of,0,0
195876,climacteric,1,1
195877,complaints,1,1
195878,in,1,1
195879,postmenopausal,1,1
195880,women,1,1
195881,and,0,0
195882,that,0,0
195883,after,0,0
195884,4,0,0
195885,months,0,0
195886,the,0,0
195887,clinical,0,0
195888,efficacy,0,0
195889,is,0,0
195890,the,0,0
195891,same,0,0
195892,irrespective,0,0
195893,of,0,0
195894,the,0,0
195895,type,0,1
195896,and,0,0
195897,dose,0,0
195898,of,0,0
195899,progestogen,0,0
195900,administered,0,0
195901,.,0,1
195902,Plasma,0,1
195903,"3,4-dihydroxyphenylethyleneglycol",0,0
195904,and,0,0
195905,3-methoxy-4-hydroxyphenylethyleneglycol,0,0
195906,as,0,0
195907,indicators,0,0
195908,of,0,1
195909,central,0,1
195910,noradrenergic,0,0
195911,activity,0,0
195912,.,0,0
195913,A,0,0
195914,comparative,0,0
195915,study,0,0
195916,on,0,0
195917,control,1,1
195918,subjects,1,1
195919,and,1,1
195920,depressed,1,1
195921,patients,1,1
195922,.,1,1
195923,Animal,0,0
195924,studies,0,0
195925,have,0,0
195926,suggested,0,0
195927,interspecies,0,0
195928,differences,0,0
195929,in,0,0
195930,brain,0,0
195931,norepinephrine,0,0
195932,(,0,0
195933,NE,0,0
195934,),0,0
195935,metabolism,0,0
195936,",",0,0
195937,especially,0,0
195938,with,0,0
195939,regard,0,0
195940,to,0,0
195941,the,0,0
195942,relative,0,0
195943,proportions,0,0
195944,of,0,0
195945,"3,4-dihydroxyphenylethyleneglycol",0,0
195946,(,0,1
195947,DOPEG,0,0
195948,),0,0
195949,compared,0,0
195950,to,0,0
195951,3-methoxy-4-hydroxyphenylethyleneglycol,0,0
195952,(,0,0
195953,MOPEG,0,1
195954,),0,0
195955,.,0,0
195956,In,0,0
195957,order,0,0
195958,to,0,0
195959,question,0,0
195960,the,0,0
195961,value,0,0
195962,of,0,0
195963,both,0,0
195964,glycol,0,0
195965,metabolites,0,0
195966,as,0,0
195967,peripheral,0,1
195968,indices,0,0
195969,of,0,1
195970,central,0,1
195971,noradrenergic,0,0
195972,activity,0,0
195973,",",0,0
195974,a,0,0
195975,comparative,0,0
195976,study,0,0
195977,of,0,0
195978,plasma,0,0
195979,DOPEG,0,0
195980,and,0,0
195981,MOPEG,0,0
195982,(,0,0
195983,measured,0,0
195984,by,0,0
195985,HPLC,0,1
195986,),0,0
195987,related,0,0
195988,to,0,0
195989,depression,0,1
195990,",",0,0
195991,sex,0,0
195992,",",0,0
195993,age,0,1
195994,and,0,0
195995,diagnostic,0,0
195996,categories,0,1
195997,(,0,1
195998,DSM-III,0,1
195999,),0,0
196000,was,0,0
196001,carried,0,0
196002,out,0,0
196003,on,0,0
196004,depressed,1,1
196005,and,1,1
196006,control,1,1
196007,subjects,1,1
196008,.,1,1
196009,In,0,0
196010,addition,0,0
196011,",",0,0
196012,two,1,0
196013,groups,1,0
196014,of,1,1
196015,8,1,1
196016,patients,1,1
196017,were,0,1
196018,randomly,0,1
196019,submitted,0,0
196020,to,0,0
196021,a,0,0
196022,desipramine,0,0
196023,150,0,0
196024,mg/day,0,0
196025,",",0,0
196026,or,0,0
196027,a,0,0
196028,metapramine,0,0
196029,450,0,1
196030,mg/day,0,0
196031,antidepressant,0,0
196032,treatment,0,0
196033,influencing,0,0
196034,the,0,0
196035,formation,0,0
196036,of,0,0
196037,DOPEG,0,0
196038,and,0,0
196039,MOPEG,0,0
196040,in,0,0
196041,a,0,0
196042,different,0,0
196043,way,0,0
196044,.,0,0
196045,The,0,0
196046,study,0,0
196047,did,0,0
196048,not,0,0
196049,demonstrate,0,0
196050,any,0,0
196051,difference,0,0
196052,between,0,0
196053,DOPEG,0,0
196054,and,0,0
196055,MOPEG,0,0
196056,for,0,0
196057,most,0,0
196058,of,0,0
196059,the,0,0
196060,experimental,0,0
196061,factors,0,0
196062,.,0,1
196063,We,0,0
196064,found,0,0
196065,also,0,0
196066,a,0,0
196067,significant,0,0
196068,positive,0,0
196069,correlation,0,0
196070,between,0,0
196071,plasma,0,0
196072,levels,0,0
196073,of,0,0
196074,DOPEG,0,0
196075,and,0,1
196076,MOPEG,0,0
196077,.,0,1
196078,Our,0,0
196079,results,0,0
196080,support,0,0
196081,the,0,0
196082,idea,0,0
196083,that,0,0
196084,each,0,0
196085,of,0,0
196086,these,0,0
196087,two,0,0
196088,biological,0,0
196089,indices,0,0
196090,can,0,0
196091,be,0,0
196092,used,0,0
196093,in,0,0
196094,the,0,0
196095,assessment,0,0
196096,of,0,0
196097,central,0,0
196098,noradrenergic,0,0
196099,activity,0,0
196100,.,0,1
196101,Chemotherapy,0,1
196102,of,0,0
196103,advanced,1,1
196104,gastric,1,1
196105,carcinoma,1,1
196106,(,1,0
196107,stage,1,1
196108,IV,1,1
196109,),1,1
196110,:,1,1
196111,a,0,0
196112,randomized,0,0
196113,study,0,0
196114,of,0,0
196115,FAM,0,0
196116,versus,0,0
196117,5-FU,0,0
196118,plus,0,0
196119,BCNU,0,1
196120,.,0,1
196121,Forty-six,1,1
196122,patients,1,1
196123,with,1,1
196124,advanced,1,1
196125,gastric,1,1
196126,carcinoma,1,1
196127,(,1,0
196128,Stage,1,1
196129,IV,1,1
196130,),1,0
196131,were,1,0
196132,evaluated,1,0
196133,in,0,0
196134,a,0,0
196135,prospective,0,0
196136,randomized,0,0
196137,comparison,0,0
196138,of,0,0
196139,two,0,0
196140,chemotherapy,0,1
196141,regimens,0,0
196142,(,0,0
196143,FAM,0,0
196144,versus,0,0
196145,5-FU,0,0
196146,plus,0,0
196147,BCNU,0,1
196148,),0,0
196149,to,0,0
196150,identify,0,0
196151,therapeutic,0,0
196152,activity,0,0
196153,.,0,1
196154,Treatment,0,0
196155,groups,0,0
196156,were,0,0
196157,well,0,0
196158,balanced,0,0
196159,with,0,0
196160,respect,0,0
196161,to,0,0
196162,known,0,0
196163,prognostic,0,0
196164,factors,0,0
196165,.,0,1
196166,Thirty-three,1,1
196167,patients,1,1
196168,had,1,1
196169,measurable,1,0
196170,disease,1,1
196171,and,1,0
196172,thirteen,1,1
196173,had,1,0
196174,only,1,0
196175,microscopic,1,0
196176,residual,1,0
196177,disease,1,1
196178,in,1,0
196179,the,1,0
196180,resection,1,1
196181,margins,1,0
196182,.,1,1
196183,The,0,0
196184,overall,0,0
196185,median,0,0
196186,survival,0,0
196187,of,0,0
196188,the,0,0
196189,entire,0,0
196190,group,0,0
196191,was,0,0
196192,13.2,0,1
196193,months,0,0
196194,.,0,1
196195,Two,0,1
196196,(,0,0
196197,6,0,0
196198,%,0,0
196199,),0,0
196200,patients,0,1
196201,with,0,1
196202,measurable,0,0
196203,disease,0,1
196204,reached,0,0
196205,complete,0,0
196206,response,0,0
196207,(,0,0
196208,CR,0,0
196209,),0,0
196210,",",0,0
196211,1,0,0
196212,(,0,0
196213,3,0,0
196214,%,0,0
196215,),0,0
196216,partial,0,0
196217,response,0,0
196218,(,0,0
196219,PR,0,0
196220,),0,0
196221,",",0,0
196222,12,0,0
196223,(,0,0
196224,36,0,1
196225,%,0,0
196226,),0,0
196227,had,0,0
196228,stable,0,1
196229,disease,0,1
196230,(,0,0
196231,SD,0,0
196232,),0,0
196233,and,0,0
196234,18,0,1
196235,(,0,0
196236,56,0,1
196237,%,0,0
196238,),0,0
196239,had,0,0
196240,progressive,0,0
196241,disease,0,1
196242,(,0,0
196243,PD,0,1
196244,),0,0
196245,.,0,0
196246,The,0,0
196247,responders,0,0
196248,had,0,0
196249,not,0,0
196250,reached,0,0
196251,the,0,0
196252,median,0,0
196253,survival,0,0
196254,yet,0,0
196255,",",0,0
196256,the,0,0
196257,patients,0,1
196258,with,0,1
196259,SD,0,0
196260,had,0,1
196261,a,0,0
196262,median,0,0
196263,survival,0,0
196264,of,0,0
196265,14.7,0,0
196266,months,0,0
196267,and,0,0
196268,the,0,0
196269,PD,0,1
196270,9.5,0,0
196271,months,0,0
196272,.,0,1
196273,In,0,0
196274,the,0,0
196275,FAM,0,0
196276,arm,0,0
196277,there,0,0
196278,were,0,0
196279,3,0,0
196280,(,0,0
196281,18,0,1
196282,%,0,0
196283,),0,1
196284,responders,0,0
196285,(,0,1
196286,2,0,1
196287,CR,0,0
196288,and,0,1
196289,1,0,0
196290,PR,0,0
196291,),0,0
196292,",",0,0
196293,7,0,0
196294,(,0,0
196295,41,0,1
196296,%,0,0
196297,),0,0
196298,SD,0,0
196299,and,0,0
196300,7,0,1
196301,(,0,0
196302,41,0,1
196303,%,0,0
196304,),0,0
196305,PD,0,0
196306,",",0,0
196307,versus,0,0
196308,O,0,0
196309,responders,0,0
196310,",",0,0
196311,5,0,0
196312,(,0,0
196313,31,0,1
196314,%,0,0
196315,),0,0
196316,SD,0,0
196317,and,0,0
196318,11,0,0
196319,(,0,0
196320,69,0,1
196321,%,0,0
196322,),0,0
196323,PD,0,0
196324,in,0,0
196325,the,0,0
196326,5-FU,0,0
196327,plus,0,0
196328,BCNU,0,1
196329,arm,0,0
196330,.,0,0
196331,In,0,0
196332,the,0,0
196333,FAM,0,0
196334,arm,0,0
196335,the,0,0
196336,median,0,0
196337,survival,0,0
196338,was,0,0
196339,15.7,0,0
196340,months,0,0
196341,versus,0,0
196342,9.9,0,1
196343,months,0,0
196344,in,0,0
196345,the,0,0
196346,other,0,0
196347,therapeutic,0,0
196348,arm,0,1
196349,.,0,0
196350,The,0,0
196351,statistical,0,0
196352,analysis,0,0
196353,indicated,0,0
196354,that,0,0
196355,survival,0,0
196356,associated,0,0
196357,with,0,1
196358,FAM,0,0
196359,regimen,0,0
196360,was,0,0
196361,superior,0,0
196362,to,0,0
196363,that,0,0
196364,reached,0,0
196365,with,0,0
196366,the,0,0
196367,5-FU,0,0
196368,plus,0,0
196369,BCNU,0,1
196370,regimen,0,0
196371,.,0,1
196372,Thirteen,1,1
196373,patients,1,1
196374,with,0,1
196375,unmeasurable,0,0
196376,disease,0,1
196377,had,0,1
196378,a,0,0
196379,median,0,0
196380,survival,0,0
196381,of,0,0
196382,15.9,0,1
196383,months,0,0
196384,.,0,1
196385,Postoperative,0,0
196386,pain,0,1
196387,control,0,0
196388,for,0,0
196389,outpatient,1,1
196390,oral,1,0
196391,surgery,1,1
196392,.,1,1
196393,16,1,1
196394,healthy,1,1
196395,patients,1,1
196396,requiring,1,1
196397,removal,1,0
196398,of,1,0
196399,bilateral,1,1
196400,symmetrically-impacted,1,1
196401,mandibular,1,1
196402,third,1,1
196403,molars,1,1
196404,participated,0,1
196405,in,0,0
196406,a,0,0
196407,double-blind,0,0
196408,randomised,0,0
196409,crossover,0,0
196410,trial,0,0
196411,to,0,0
196412,test,0,0
196413,the,0,0
196414,effectiveness,0,0
196415,of,0,0
196416,postoperative,0,0
196417,pain,0,1
196418,control,0,0
196419,using,0,0
196420,a,0,0
196421,long-acting,0,0
196422,anti-inflammatory,0,0
196423,agent,0,0
196424,(,0,0
196425,diflunisal,0,0
196426,),0,0
196427,in,0,0
196428,combination,0,0
196429,with,0,1
196430,a,0,0
196431,long-acting,0,0
196432,local,0,0
196433,anaesthetic,0,0
196434,agent,0,0
196435,(,0,0
196436,bupivacaine,0,0
196437,),0,0
196438,.,0,1
196439,Results,0,0
196440,were,0,0
196441,compared,0,0
196442,to,0,0
196443,the,0,0
196444,more,0,0
196445,traditional,0,0
196446,method,0,0
196447,of,0,0
196448,using,0,0
196449,an,0,0
196450,oral,0,0
196451,analgesic,0,0
196452,with,0,1
196453,shorter,0,0
196454,duration,0,0
196455,of,0,0
196456,action,0,0
196457,(,0,0
196458,paracetamol,0,0
196459,with,0,1
196460,codeine,0,0
196461,),0,0
196462,with,0,1
196463,lignocaine,0,0
196464,as,0,0
196465,the,0,0
196466,local,0,0
196467,anaesthetic,0,0
196468,.,0,0
196469,Using,0,0
196470,a,0,0
196471,visual,0,0
196472,analogue,0,0
196473,pain,0,0
196474,scale,0,0
196475,",",0,0
196476,patients,0,1
196477,reported,0,0
196478,that,0,0
196479,significantly,0,0
196480,reduced,0,0
196481,pain,0,0
196482,was,0,0
196483,experienced,0,0
196484,over,0,0
196485,the,0,0
196486,first,0,0
196487,4,0,0
196488,days,0,0
196489,postoperatively,0,0
196490,with,0,1
196491,the,0,0
196492,diflunisal/bupivacaine,0,0
196493,treatment,0,0
196494,and,0,0
196495,patient,0,0
196496,preference,0,0
196497,for,0,0
196498,this,0,0
196499,treatment,0,0
196500,was,0,0
196501,highly,0,0
196502,significant,0,0
196503,.,0,0
196504,This,0,0
196505,report,0,0
196506,represents,0,0
196507,the,0,0
196508,first,0,0
196509,such,0,0
196510,study,0,0
196511,of,0,0
196512,diflunisal,0,0
196513,used,0,0
196514,for,0,0
196515,an,0,0
196516,extended,0,0
196517,course,0,0
196518,in,0,0
196519,oral,0,0
196520,surgery,0,1
196521,with,0,1
196522,pain,0,0
196523,assessment,0,0
196524,over,0,0
196525,the,0,0
196526,same,0,0
196527,period,0,0
196528,.,0,0
196529,No,0,0
196530,significant,0,0
196531,side-effects,0,0
196532,or,0,1
196533,adverse,0,0
196534,reactions,0,0
196535,were,0,1
196536,encountered,0,0
196537,.,0,1
196538,[,1,0
196539,Complaints,1,1
196540,in,1,1
196541,the,1,1
196542,postoperative,1,0
196543,phase,1,0
196544,related,1,0
196545,to,1,0
196546,anesthetics,1,0
196547,],1,1
196548,.,0,1
196549,In,0,0
196550,two,0,0
196551,prospective,0,0
196552,",",0,0
196553,randomized,0,1
196554,studies,0,0
196555,the,0,0
196556,frequency,0,0
196557,of,0,0
196558,headache,1,0
196559,",",1,0
196560,nausea,1,0
196561,",",1,0
196562,vomiting,1,0
196563,",",1,0
196564,and,1,0
196565,analgesic,1,0
196566,requirement,1,0
196567,during,1,0
196568,the,1,0
196569,first,1,0
196570,postoperative,1,0
196571,24,1,1
196572,h,1,0
196573,was,0,0
196574,observed,0,0
196575,in,0,0
196576,order,0,0
196577,to,0,0
196578,study,0,0
196579,differences,0,0
196580,between,0,0
196581,the,0,0
196582,sexes,0,1
196583,and,0,0
196584,the,0,0
196585,inhalation,0,0
196586,anesthetics,0,0
196587,halothane,0,0
196588,",",0,0
196589,enflurane,0,0
196590,",",0,0
196591,isoflurane,0,0
196592,",",0,0
196593,or,0,0
196594,balanced,0,0
196595,anesthesia,0,0
196596,with,0,1
196597,enflurane/alfentanil,0,0
196598,.,0,0
196599,Nausea,0,0
196600,and,0,0
196601,vomiting,0,0
196602,were,0,0
196603,more,0,0
196604,frequent,0,0
196605,after,0,0
196606,enflurane,0,0
196607,than,0,0
196608,after,0,0
196609,halothane,0,0
196610,or,0,1
196611,isoflurane,0,0
196612,.,0,0
196613,There,0,0
196614,was,0,0
196615,no,0,0
196616,significant,0,0
196617,difference,0,0
196618,between,0,0
196619,anesthetics,0,0
196620,and,0,0
196621,frequency,0,0
196622,of,0,0
196623,headache,0,0
196624,",",0,0
196625,but,0,0
196626,there,0,0
196627,were,0,0
196628,significant,0,0
196629,differences,0,0
196630,in,0,0
196631,postoperative,0,0
196632,analgesic,0,0
196633,requirements,0,0
196634,which,0,0
196635,were,0,0
196636,highest,0,0
196637,after,0,0
196638,halothane,0,0
196639,and,0,0
196640,lowest,0,0
196641,after,0,0
196642,isoflurane,0,0
196643,.,0,1
196644,Postoperative,0,0
196645,complaints,0,0
196646,were,0,0
196647,always,0,0
196648,significantly,0,0
196649,greater,0,0
196650,among,0,0
196651,women,1,1
196652,than,0,0
196653,among,0,1
196654,men,1,1
196655,.,1,1
196656,The,0,0
196657,second,0,0
196658,study,0,0
196659,indicated,0,0
196660,that,0,0
196661,balanced,0,0
196662,anesthesia,0,0
196663,did,0,0
196664,not,0,0
196665,reduce,0,0
196666,the,0,0
196667,analgesic,0,0
196668,requirement,0,0
196669,compared,0,0
196670,to,0,0
196671,enflurane,0,0
196672,without,0,0
196673,alfentanil,0,0
196674,",",0,0
196675,but,0,0
196676,lead,0,0
196677,to,0,0
196678,a,0,0
196679,higher,0,0
196680,incidence,0,0
196681,of,0,0
196682,vomiting,0,0
196683,.,0,0
196684,After,0,0
196685,premedication,0,0
196686,with,0,1
196687,flunitrazepam,0,0
196688,and,0,0
196689,atropine,0,0
196690,and,0,0
196691,combined,0,0
196692,with,0,1
196693,70,0,1
196694,%,0,0
196695,N2O/30,0,1
196696,%,0,0
196697,O2,0,0
196698,",",0,0
196699,isoflurane,0,0
196700,was,0,0
196701,the,0,0
196702,most,0,0
196703,favorable,0,0
196704,anesthetic,0,0
196705,agent,0,0
196706,with,0,1
196707,regard,0,0
196708,to,0,0
196709,the,0,0
196710,parameters,0,0
196711,studied,0,1
196712,.,0,1
196713,Balanced,0,0
196714,anesthesia,0,0
196715,with,0,1
196716,enflurane/alfentanil,0,0
196717,did,0,0
196718,not,0,0
196719,show,0,0
196720,any,0,0
196721,advantages,0,0
196722,for,0,0
196723,patients,1,1
196724,in,1,0
196725,the,1,0
196726,postoperative,1,0
196727,phase,1,0
196728,under,0,0
196729,the,0,0
196730,given,0,0
196731,conditions,0,0
196732,.,0,1
196733,[,0,0
196734,Trial,0,1
196735,of,0,0
196736,a,0,0
196737,calcium,0,0
196738,antagonist,0,0
196739,in,0,0
196740,dysmenorrhea,1,1
196741,],1,1
196742,.,0,1
196743,Psoriasis,1,1
196744,of,1,0
196745,the,1,0
196746,scalp,1,0
196747,treated,0,1
196748,with,0,1
196749,Grenz,0,1
196750,rays,0,0
196751,or,0,1
196752,topical,0,0
196753,corticosteroid,0,0
196754,combined,0,0
196755,with,0,1
196756,Grenz,0,1
196757,rays,0,0
196758,.,0,1
196759,A,0,0
196760,comparative,0,0
196761,randomized,0,0
196762,trial,0,0
196763,.,0,0
196764,To,0,0
196765,investigate,0,0
196766,the,0,0
196767,effect,0,0
196768,of,0,0
196769,Grenz,0,0
196770,ray,0,0
196771,therapy,0,0
196772,alone,0,0
196773,compared,0,0
196774,with,0,1
196775,Grenz,0,1
196776,rays,0,0
196777,combined,0,0
196778,with,0,1
196779,a,0,0
196780,topical,0,0
196781,corticosteroid,0,0
196782,(,0,0
196783,betamethasone,0,0
196784,dipropionate,0,0
196785,),0,0
196786,in,0,0
196787,psoriasis,0,1
196788,of,0,0
196789,the,0,0
196790,scalp,0,0
196791,",",0,0
196792,40,1,1
196793,patients,1,1
196794,were,0,1
196795,randomized,0,1
196796,into,0,1
196797,two,0,0
196798,groups,0,1
196799,.,0,1
196800,One,0,1
196801,group,0,0
196802,received,0,1
196803,4,0,0
196804,Gy,1,1
196805,of,1,0
196806,Grenz,1,1
196807,rays,1,0
196808,administered,0,0
196809,on,0,0
196810,six,0,1
196811,occasions,0,0
196812,at,0,1
196813,intervals,0,0
196814,of,0,1
196815,1,0,0
196816,week,0,0
196817,and,0,0
196818,the,0,0
196819,other,0,0
196820,group,0,0
196821,was,0,0
196822,given,0,0
196823,the,0,0
196824,same,0,0
196825,Grenz,0,0
196826,ray,0,0
196827,treatment,0,0
196828,plus,0,0
196829,topical,0,0
196830,corticosteroid,0,0
196831,.,0,0
196832,The,0,0
196833,patients,0,1
196834,were,0,0
196835,assessed,0,0
196836,before,0,0
196837,and,0,0
196838,after,0,0
196839,Grenz,0,0
196840,ray,0,0
196841,therapy,0,0
196842,and,0,0
196843,were,0,0
196844,followed-up,0,1
196845,for,0,1
196846,6,0,1
196847,months,0,0
196848,.,0,1
196849,Of,0,0
196850,the,0,0
196851,37,1,1
196852,patients,1,1
196853,who,1,1
196854,completed,1,1
196855,the,1,1
196856,trial,1,0
196857,16,0,1
196858,out,0,0
196859,of,0,0
196860,19,0,1
196861,(,0,1
196862,84,0,1
196863,%,0,0
196864,),0,0
196865,of,0,0
196866,the,0,0
196867,patients,0,1
196868,in,0,0
196869,the,0,0
196870,Grenz,0,0
196871,ray,0,0
196872,group,0,0
196873,",",0,0
196874,and,0,0
196875,13,0,0
196876,out,0,0
196877,of,0,0
196878,18,0,1
196879,(,0,1
196880,72,0,1
196881,%,0,0
196882,),0,0
196883,of,0,0
196884,the,0,0
196885,patients,0,1
196886,in,0,0
196887,the,0,0
196888,combination,0,0
196889,group,0,0
196890,healed,0,0
196891,.,0,0
196892,The,0,0
196893,remission,0,0
196894,time,0,0
196895,did,0,0
196896,not,0,0
196897,differ,0,0
196898,significantly,0,0
196899,between,0,0
196900,the,0,0
196901,two,0,0
196902,groups,0,0
196903,.,0,1
196904,Of,0,0
196905,the,0,0
196906,patients,1,1
196907,who,1,1
196908,healed,1,1
196909,",",0,1
196910,5,0,0
196911,of,0,0
196912,16,0,1
196913,patients,0,1
196914,in,0,0
196915,the,0,0
196916,Grenz,0,0
196917,ray,0,0
196918,only,0,0
196919,group,0,0
196920,and,0,0
196921,4,0,0
196922,of,0,0
196923,13,0,1
196924,patients,0,1
196925,in,0,0
196926,the,0,0
196927,combination,0,0
196928,group,0,0
196929,remained,0,0
196930,healed,0,0
196931,at,0,0
196932,6,0,0
196933,months,0,0
196934,.,0,1
196935,We,0,0
196936,conclude,0,0
196937,that,0,0
196938,Grenz,0,0
196939,ray,0,0
196940,therapy,0,0
196941,is,0,0
196942,a,0,0
196943,useful,0,0
196944,treatment,0,0
196945,modality,0,0
196946,for,0,0
196947,scalp,0,0
196948,psoriasis,0,1
196949,",",0,0
196950,but,0,0
196951,that,0,0
196952,the,0,0
196953,addition,0,0
196954,of,0,0
196955,a,0,0
196956,topical,0,0
196957,corticosteroid,0,0
196958,has,0,0
196959,only,0,0
196960,a,0,0
196961,minor,0,0
196962,effect,0,0
196963,.,0,1
196964,The,0,0
196965,influence,0,0
196966,of,0,0
196967,adult,1,1
196968,intervention,0,0
196969,on,0,0
196970,infants,1,1
196971,',1,1
196972,level,0,0
196973,of,0,0
196974,attention,0,0
196975,.,0,0
196976,The,0,0
196977,effects,0,0
196978,of,0,0
196979,adult,0,1
196980,intervention,0,0
196981,on,0,0
196982,infants,0,1
196983,',0,1
196984,level,0,0
196985,of,0,0
196986,attention,0,0
196987,to,0,0
196988,objects,0,0
196989,were,0,0
196990,studied,0,1
196991,with,0,1
196992,10-month-old,1,1
196993,infants,1,1
196994,.,1,1
196995,After,0,0
196996,a,0,0
196997,baseline,0,0
196998,measure,0,0
196999,of,0,0
197000,spontaneous,0,0
197001,attention,0,0
197002,was,0,0
197003,obtained,0,0
197004,",",0,0
197005,infants,1,1
197006,were,0,0
197007,randomly,0,1
197008,assigned,0,1
197009,to,0,0
197010,1,0,0
197011,of,0,0
197012,4,0,0
197013,conditions,0,0
197014,(,0,1
197015,low,0,0
197016,",",0,0
197017,medium,0,0
197018,",",0,0
197019,high,0,0
197020,intervention,0,0
197021,",",0,0
197022,or,0,0
197023,no-intervention,0,0
197024,control,0,1
197025,),0,0
197026,.,0,0
197027,Level,0,0
197028,of,0,0
197029,intervention,0,0
197030,was,0,0
197031,controlled,0,0
197032,by,0,0
197033,systematically,0,0
197034,varying,0,0
197035,the,0,0
197036,manner,0,0
197037,and,0,0
197038,frequency,0,0
197039,with,0,1
197040,which,0,0
197041,objects,0,0
197042,were,0,0
197043,presented,0,0
197044,",",0,0
197045,the,0,0
197046,extent,0,0
197047,to,0,0
197048,which,0,0
197049,the,0,0
197050,experimenter,0,0
197051,talked,0,0
197052,to,0,0
197053,the,0,0
197054,infant,0,0
197055,",",0,0
197056,and,0,0
197057,physical,0,0
197058,proximity,0,0
197059,.,0,1
197060,Infant,0,0
197061,attention,0,0
197062,was,0,0
197063,defined,0,0
197064,as,0,0
197065,duration,0,0
197066,of,0,0
197067,time,0,0
197068,spent,0,0
197069,examining,0,0
197070,objects,0,0
197071,.,0,1
197072,The,0,0
197073,overall,0,0
197074,duration,0,0
197075,of,0,0
197076,infant,0,1
197077,attention,0,0
197078,increased,0,0
197079,during,0,0
197080,medium,0,0
197081,intervention,0,0
197082,when,0,0
197083,compared,0,0
197084,to,0,0
197085,the,0,0
197086,control,0,0
197087,group,0,0
197088,.,0,0
197089,Baseline,0,0
197090,attention,0,0
197091,was,0,0
197092,then,0,0
197093,used,0,0
197094,to,0,0
197095,separate,0,0
197096,low,0,0
197097,and,0,0
197098,high,0,1
197099,attenders,0,1
197100,.,0,1
197101,Low,0,1
197102,attending,0,1
197103,infants,0,1
197104,attended,0,1
197105,more,0,0
197106,in,0,0
197107,medium,0,0
197108,and,0,0
197109,high,0,0
197110,intervention,0,0
197111,than,0,0
197112,in,0,0
197113,the,0,0
197114,low,0,0
197115,condition,0,0
197116,",",0,0
197117,while,0,0
197118,high,0,1
197119,attending,0,1
197120,infants,0,1
197121,were,0,1
197122,unaffected,0,0
197123,by,0,0
197124,intervention,0,0
197125,.,0,0
197126,The,0,0
197127,results,0,0
197128,show,0,0
197129,that,0,0
197130,level,0,0
197131,of,0,0
197132,intervention,0,0
197133,interacts,0,0
197134,with,0,1
197135,the,0,0
197136,child,0,0
197137,'s,0,1
197138,spontaneous,0,0
197139,tendency,0,0
197140,to,0,0
197141,focus,0,0
197142,attention,0,0
197143,on,0,0
197144,objects,0,0
197145,.,0,1
197146,Ventilatory,0,0
197147,function,0,0
197148,during,0,0
197149,urography,0,1
197150,:,0,1
197151,a,0,0
197152,comparison,0,0
197153,of,0,0
197154,iopamidol,0,0
197155,and,0,0
197156,sodium,0,0
197157,iothalamate,0,0
197158,.,0,0
197159,The,0,0
197160,effects,0,0
197161,on,0,0
197162,respiratory,0,1
197163,function,0,0
197164,during,0,0
197165,intravenous,0,0
197166,urography,0,1
197167,of,0,0
197168,the,0,0
197169,ionic,0,0
197170,contrast,0,0
197171,medium,0,0
197172,sodium,0,0
197173,iothalamate,0,0
197174,and,0,0
197175,the,0,0
197176,non-ionic,0,0
197177,contrast,0,0
197178,medium,0,0
197179,iopamidol,0,0
197180,were,0,0
197181,compared,0,0
197182,.,0,1
197183,Forced,0,0
197184,expiratory,0,0
197185,volume,0,0
197186,in,0,0
197187,1,0,0
197188,s,0,0
197189,(,0,0
197190,FEV1,0,0
197191,),0,0
197192,and,0,0
197193,forced,0,1
197194,vital,0,0
197195,capacity,0,0
197196,(,0,0
197197,FVC,0,0
197198,),0,0
197199,were,0,0
197200,recorded,0,0
197201,in,0,0
197202,37,1,1
197203,non-atopic,1,1
197204,patients,1,1
197205,referred,1,1
197206,for,1,0
197207,intravenous,1,0
197208,urography,1,1
197209,.,1,1
197210,Nineteen,1,1
197211,patients,1,1
197212,received,0,1
197213,iopamidol,0,0
197214,and,0,1
197215,18,1,1
197216,patients,1,1
197217,received,0,1
197218,sodium,0,0
197219,iothalamate,0,0
197220,.,0,0
197221,Both,0,0
197222,the,0,0
197223,sodium,0,0
197224,iothalamate,0,0
197225,and,0,0
197226,the,0,0
197227,iopamidol,0,0
197228,groups,0,0
197229,showed,0,0
197230,a,0,0
197231,significant,0,0
197232,fall,0,0
197233,in,0,0
197234,FEV1,0,0
197235,and,0,0
197236,FVC,0,0
197237,(,0,0
197238,P,0,0
197239,less,0,0
197240,than,0,0
197241,0.001,0,0
197242,),0,1
197243,.,0,1
197244,The,0,0
197245,reductions,0,0
197246,in,0,0
197247,FEV1,0,1
197248,and,0,1
197249,FVC,0,0
197250,were,0,0
197251,comparable,0,0
197252,and,0,0
197253,were,0,0
197254,not,0,0
197255,symptomatic,0,1
197256,.,0,0
197257,The,0,0
197258,differences,0,0
197259,in,0,0
197260,the,0,0
197261,percentage,0,0
197262,changes,0,0
197263,of,0,0
197264,the,0,0
197265,FEV1,0,0
197266,and,0,0
197267,FVC,0,0
197268,in,0,0
197269,the,0,0
197270,iopamidol,0,0
197271,and,0,0
197272,the,0,0
197273,sodium,0,0
197274,iothalamate,0,0
197275,groups,0,0
197276,were,0,0
197277,not,0,0
197278,statistically,0,0
197279,significant,0,0
197280,(,0,0
197281,P,0,0
197282,greater,0,0
197283,than,0,0
197284,0.5,0,0
197285,and,0,0
197286,P,0,0
197287,greater,0,0
197288,than,0,0
197289,0.1,0,0
197290,respectively,0,0
197291,),0,0
197292,.,0,0
197293,No,0,0
197294,significant,0,0
197295,change,0,0
197296,in,0,0
197297,the,0,0
197298,ratio,0,0
197299,of,0,0
197300,the,0,0
197301,FEV1,0,0
197302,and,0,0
197303,the,0,0
197304,FVC,0,0
197305,was,0,0
197306,demonstrated,0,0
197307,in,0,0
197308,either,0,0
197309,the,0,0
197310,iopamidol,0,0
197311,or,0,0
197312,the,0,0
197313,sodium,0,0
197314,iothalamate,0,0
197315,groups,0,0
197316,.,0,1
197317,Both,0,0
197318,the,0,0
197319,ionic,0,0
197320,and,0,0
197321,the,0,0
197322,non-ionic,0,0
197323,contrast,0,0
197324,media,0,0
197325,produced,0,0
197326,a,0,0
197327,measurable,0,0
197328,but,0,0
197329,asymptomatic,0,1
197330,and,0,0
197331,biologically,0,0
197332,insignificant,0,0
197333,fall,0,0
197334,in,0,0
197335,static,0,0
197336,ventilatory,0,0
197337,function,0,0
197338,.,0,0
197339,Bronchospasm,0,0
197340,does,0,0
197341,not,0,0
197342,appear,0,0
197343,to,0,0
197344,be,0,0
197345,an,0,0
197346,important,0,0
197347,contrast-induced,0,0
197348,effect,0,0
197349,in,0,0
197350,non-atopic,0,1
197351,individuals,0,1
197352,.,0,1
197353,Iopamidol,0,0
197354,offers,0,0
197355,no,0,0
197356,advantage,0,0
197357,over,0,0
197358,sodium,0,0
197359,iothalamate,0,0
197360,with,0,1
197361,respect,0,0
197362,to,0,0
197363,ventilatory,0,0
197364,effects,0,0
197365,in,0,1
197366,non-atopic,1,1
197367,patients,1,1
197368,undergoing,1,1
197369,intravenous,1,0
197370,urography,1,1
197371,.,1,1
197372,Educational,0,1
197373,intervention,0,0
197374,for,0,0
197375,altering,0,0
197376,water-sanitation,0,0
197377,behavior,0,0
197378,to,0,0
197379,reduce,0,0
197380,childhood,1,1
197381,diarrhea,1,1
197382,in,1,0
197383,urban,1,1
197384,Bangladesh,1,1
197385,:,1,1
197386,impact,0,0
197387,on,0,0
197388,nutritional,0,0
197389,status,0,1
197390,.,0,1
197391,We,0,0
197392,evaluated,0,0
197393,whether,0,0
197394,an,0,0
197395,educational,0,0
197396,intervention,0,0
197397,that,0,0
197398,was,0,0
197399,effective,0,0
197400,in,0,0
197401,reducing,0,0
197402,childhood,1,1
197403,diarrhea,1,1
197404,also,0,0
197405,improved,0,0
197406,childhood,0,1
197407,nutritional,0,0
197408,status,0,1
197409,.,0,1
197410,Fifty-one,1,1
197411,communities,1,1
197412,of,1,1
197413,38,1,1
197414,families,1,1
197415,each,1,1
197416,were,0,0
197417,randomized,0,0
197418,to,0,0
197419,receive,0,0
197420,the,0,0
197421,intervention,0,0
197422,or,0,0
197423,no,0,0
197424,intervention,0,0
197425,.,0,0
197426,During,0,0
197427,1,0,0
197428,y,0,1
197429,of,0,0
197430,follow-up,0,0
197431,the,0,0
197432,rate,0,0
197433,of,0,0
197434,diarrhea,0,1
197435,(,0,0
197436,per,0,0
197437,100,0,0
197438,wk,0,1
197439,),0,0
197440,in,0,0
197441,children,1,1
197442,less,1,0
197443,than,1,0
197444,6,1,0
197445,y,1,1
197446,in,0,0
197447,the,0,0
197448,intervention,0,0
197449,group,0,0
197450,was,0,0
197451,5.89,0,0
197452,episodes,0,0
197453,whereas,0,0
197454,that,0,0
197455,in,0,0
197456,the,0,0
197457,nonintervention,0,0
197458,group,0,0
197459,was,0,0
197460,7.55,0,0
197461,episodes,0,0
197462,(,0,1
197463,protective,0,0
197464,efficacy,0,0
197465,22,0,1
197466,%,0,0
197467,;,0,0
197468,p,0,0
197469,less,0,0
197470,than,0,0
197471,0.0001,0,0
197472,),0,0
197473,.,0,0
197474,During,0,0
197475,the,0,0
197476,same,0,0
197477,follow-up,0,0
197478,period,0,1
197479,children,0,1
197480,in,0,0
197481,both,0,0
197482,groups,0,0
197483,exhibited,0,0
197484,comparable,0,0
197485,patterns,0,1
197486,of,0,0
197487,weight,0,1
197488,gain,0,0
197489,;,0,0
197490,1,0,0
197491,y,0,1
197492,after,0,0
197493,the,0,0
197494,intervention,0,0
197495,the,0,0
197496,mean,0,0
197497,weight,0,0
197498,for,0,0
197499,age,0,1
197500,of,0,0
197501,children,0,1
197502,in,0,0
197503,both,0,0
197504,groups,0,0
197505,was,0,0
197506,76,0,1
197507,%,0,0
197508,of,0,0
197509,the,0,0
197510,NCHS,0,0
197511,standard,0,0
197512,.,0,0
197513,No,0,0
197514,significant,0,0
197515,differences,0,0
197516,were,0,1
197517,observed,0,0
197518,in,0,0
197519,the,0,0
197520,proportion,0,0
197521,of,0,0
197522,each,0,0
197523,group,0,0
197524,that,0,0
197525,experienced,0,0
197526,a,0,0
197527,major,0,0
197528,deterioration,0,0
197529,or,0,0
197530,improvement,0,0
197531,of,0,0
197532,nutritional,0,0
197533,status,0,1
197534,.,0,0
197535,We,0,0
197536,conclude,0,0
197537,that,0,0
197538,an,0,0
197539,intervention,0,0
197540,that,0,0
197541,reduces,0,0
197542,rates,0,0
197543,of,0,0
197544,childhood,1,1
197545,diarrhea,1,1
197546,may,0,0
197547,not,0,0
197548,necessarily,0,0
197549,also,0,0
197550,improve,0,0
197551,nutritional,0,0
197552,status,0,1
197553,.,0,1
197554,Dysthymia,0,1
197555,:,0,1
197556,a,0,0
197557,randomized,0,0
197558,study,0,0
197559,of,0,0
197560,cognitive,0,0
197561,marital,0,0
197562,therapy,0,0
197563,and,0,1
197564,antidepressants,0,0
197565,.,0,1
197566,Preliminary,0,0
197567,data,0,0
197568,from,0,0
197569,a,0,0
197570,randomized,0,0
197571,study,0,0
197572,of,0,0
197573,the,0,0
197574,effectiveness,0,0
197575,of,0,0
197576,combined,0,0
197577,marital,0,0
197578,therapy,0,0
197579,and,0,0
197580,antidepressant,0,0
197581,medication,0,0
197582,in,0,0
197583,the,0,0
197584,treatment,1,0
197585,of,1,0
197586,dysthymic,1,1
197587,married,1,1
197588,women,1,1
197589,is,0,0
197590,presented,0,0
197591,.,0,0
197592,The,0,0
197593,study,0,0
197594,compares,0,0
197595,doxepin,0,0
197596,with,0,0
197597,placebo,0,0
197598,",",0,0
197599,and,0,0
197600,a,0,0
197601,marital,0,0
197602,therapy,0,0
197603,designed,0,0
197604,to,0,0
197605,enhance,0,0
197606,intimacy,0,0
197607,through,0,0
197608,facilitating,0,0
197609,self-disclosure,0,0
197610,between,0,0
197611,spouses,0,1
197612,with,0,0
197613,a,0,0
197614,more,0,0
197615,supportive,0,0
197616,and,0,0
197617,educational,0,1
197618,therapeutic,0,0
197619,approach,0,0
197620,.,0,0
197621,After,0,0
197622,ten,0,1
197623,weeks,0,0
197624,of,0,0
197625,combined,0,0
197626,treatment,0,0
197627,",",0,0
197628,the,0,0
197629,dysthymic,1,1
197630,women,1,1
197631,show,0,0
197632,statistically,0,0
197633,significant,0,0
197634,improvement,0,0
197635,on,0,0
197636,all,0,0
197637,the,0,0
197638,depression,0,0
197639,measures,0,0
197640,as,0,0
197641,well,0,0
197642,as,0,0
197643,on,0,0
197644,the,0,0
197645,intimacy,0,0
197646,scale,0,0
197647,.,0,0
197648,A,0,0
197649,trend,0,0
197650,is,0,0
197651,developing,0,0
197652,for,0,0
197653,greater,0,0
197654,reduction,0,0
197655,of,0,0
197656,depressive,0,0
197657,symptomatology,0,0
197658,in,0,0
197659,the,0,0
197660,group,0,0
197661,treated,0,0
197662,with,0,1
197663,self-disclosure,0,0
197664,.,0,0
197665,The,0,0
197666,evidence,0,0
197667,appears,0,0
197668,to,0,0
197669,suggest,0,0
197670,the,0,0
197671,possibility,0,0
197672,that,0,0
197673,the,0,0
197674,presence,0,0
197675,of,0,0
197676,a,0,0
197677,patient,0,0
197678,'s,0,0
197679,husband,0,0
197680,as,0,0
197681,a,0,0
197682,supportive,0,0
197683,figure,0,0
197684,may,0,0
197685,of,0,0
197686,itself,0,0
197687,be,0,0
197688,a,0,0
197689,potent,0,0
197690,therapeutic,0,0
197691,manoeuvre,0,0
197692,in,0,0
197693,the,0,0
197694,treatment,0,0
197695,of,0,0
197696,dysthymic,0,1
197697,women,0,1
197698,.,0,1
197699,Pulsatile,0,0
197700,insulin,0,0
197701,delivery,0,0
197702,is,0,0
197703,more,0,0
197704,efficient,0,0
197705,than,0,0
197706,continuous,0,0
197707,infusion,0,0
197708,in,0,0
197709,modulating,0,0
197710,islet,0,1
197711,cell,0,0
197712,function,0,0
197713,in,0,0
197714,normal,1,1
197715,subjects,1,1
197716,and,1,1
197717,patients,1,1
197718,with,1,1
197719,type,1,1
197720,1,1,1
197721,diabetes,1,1
197722,.,1,1
197723,The,0,0
197724,respective,0,0
197725,modulating,0,0
197726,effects,0,0
197727,of,0,0
197728,continuous,0,0
197729,and,0,0
197730,intermittent,0,1
197731,insulin,0,0
197732,delivery,0,0
197733,on,0,0
197734,pancreatic,0,1
197735,islet,0,1
197736,cell,0,1
197737,function,0,0
197738,were,0,0
197739,studied,0,1
197740,in,0,0
197741,seven,1,1
197742,normal,1,1
197743,men,1,1
197744,and,1,1
197745,nine,1,1
197746,insulin-dependent,1,1
197747,(,1,1
197748,type,1,1
197749,1,1,1
197750,),1,1
197751,diabetic,1,1
197752,patients,1,1
197753,.,1,1
197754,In,0,0
197755,the,0,0
197756,normal,1,1
197757,men,1,1
197758,",",0,0
197759,saline,0,0
197760,or,0,0
197761,continuous,0,0
197762,(,0,0
197763,0.8,0,0
197764,mU,0,0
197765,kg-1,0,0
197766,min-1,0,0
197767,),0,0
197768,or,0,0
197769,pulsatile,0,0
197770,(,0,0
197771,5.2,0,0
197772,mU,0,0
197773,kg-1,0,0
197774,min-1,0,0
197775,",",0,0
197776,with,0,1
197777,a,0,0
197778,switching,0,0
197779,on/off,0,0
197780,length,0,0
197781,of,0,0
197782,2/11,0,0
197783,min,0,0
197784,),0,0
197785,human,0,1
197786,insulin,0,0
197787,were,0,0
197788,delivered,0,0
197789,on,0,0
197790,different,0,0
197791,days,0,0
197792,and,0,1
197793,in,0,0
197794,random,0,1
197795,order,0,0
197796,.,0,0
197797,Despite,0,0
197798,hyperinsulinemia,0,0
197799,",",0,0
197800,blood,0,0
197801,glucose,0,0
197802,was,0,0
197803,kept,0,0
197804,close,0,0
197805,to,0,0
197806,its,0,0
197807,basal,0,0
197808,value,0,0
197809,by,0,0
197810,the,0,0
197811,glucose,0,0
197812,clamp,0,0
197813,technique,0,0
197814,.,0,0
197815,The,0,0
197816,diabetic,1,1
197817,patients,1,1
197818,also,0,0
197819,were,0,0
197820,infused,0,0
197821,in,0,0
197822,random,0,1
197823,order,0,0
197824,and,0,0
197825,on,0,0
197826,different,0,0
197827,days,0,0
197828,with,0,1
197829,either,0,0
197830,saline,0,0
197831,or,0,0
197832,a,0,0
197833,smaller,0,0
197834,amount,0,0
197835,of,0,0
197836,insulin,0,0
197837,delivered,0,0
197838,continuously,0,0
197839,(,0,0
197840,0.15,0,0
197841,mU,0,0
197842,kg-1,0,0
197843,min-1,0,0
197844,),0,0
197845,or,0,0
197846,in,0,0
197847,a,0,0
197848,pulsatile,0,0
197849,manner,0,0
197850,(,0,0
197851,0.97,0,0
197852,mU,0,0
197853,kg-1,0,0
197854,min-1,0,0
197855,for,0,0
197856,2,0,0
197857,min,0,0
197858,",",0,0
197859,followed,0,0
197860,by,0,0
197861,11,0,1
197862,min,0,0
197863,during,0,0
197864,which,0,0
197865,no,0,0
197866,insulin,0,0
197867,was,0,0
197868,infused,0,0
197869,),0,0
197870,.,0,0
197871,In,0,0
197872,all,0,0
197873,experiments,0,0
197874,",",0,0
197875,5,0,0
197876,g,0,0
197877,arginine,0,0
197878,were,0,0
197879,given,0,0
197880,iv,0,0
197881,as,0,0
197882,a,0,0
197883,bolus,0,0
197884,dose,0,0
197885,30,0,1
197886,min,0,0
197887,before,0,0
197888,the,0,0
197889,end,0,0
197890,of,0,0
197891,the,0,0
197892,study,0,0
197893,",",0,0
197894,and,0,0
197895,plasma,0,0
197896,C-peptide,0,0
197897,and,0,0
197898,glucagon,0,0
197899,levels,0,0
197900,were,0,0
197901,determined,0,0
197902,to,0,0
197903,assess,0,0
197904,islet,0,1
197905,cell,0,0
197906,function,0,0
197907,.,0,0
197908,In,0,0
197909,the,0,0
197910,normal,1,1
197911,men,1,1
197912,",",0,0
197913,insulin,0,0
197914,administration,0,0
197915,resulted,0,0
197916,in,0,0
197917,a,0,0
197918,significant,0,0
197919,decline,0,0
197920,of,0,0
197921,basal,0,0
197922,plasma,0,0
197923,glucagon,0,0
197924,and,0,0
197925,C-peptide,0,0
197926,levels,0,0
197927,and,0,0
197928,in,0,0
197929,a,0,0
197930,clear-cut,0,0
197931,decrease,0,0
197932,in,0,0
197933,the,0,0
197934,arginine-induced,0,0
197935,glucagon,0,0
197936,response,0,0
197937,.,0,0
197938,These,0,0
197939,effects,0,0
197940,of,0,0
197941,insulin,0,0
197942,were,0,0
197943,significantly,0,0
197944,more,0,0
197945,marked,0,0
197946,when,0,0
197947,insulin,0,0
197948,was,0,0
197949,delivered,0,0
197950,in,0,0
197951,a,0,0
197952,pulsatile,0,0
197953,rather,0,0
197954,than,0,0
197955,a,0,0
197956,continuous,0,0
197957,manner,0,0
197958,.,0,0
197959,In,0,0
197960,the,0,0
197961,insulin-dependent,1,1
197962,diabetic,1,1
197963,patients,1,1
197964,",",0,0
197965,the,0,0
197966,lower,0,0
197967,dose,0,0
197968,of,0,0
197969,insulin,0,0
197970,infused,0,0
197971,continuously,0,0
197972,did,0,0
197973,not,0,0
197974,alter,0,0
197975,the,0,0
197976,basal,0,0
197977,or,0,0
197978,arginine-stimulated,0,0
197979,glucagon,0,0
197980,response,0,0
197981,.,0,0
197982,In,0,0
197983,contrast,0,0
197984,",",0,0
197985,when,0,0
197986,the,0,0
197987,same,0,0
197988,amount,0,0
197989,of,0,0
197990,insulin,0,0
197991,was,0,0
197992,delivered,0,0
197993,intermittently,0,0
197994,",",0,0
197995,arginine-induced,0,0
197996,glucagon,0,0
197997,release,0,0
197998,was,0,0
197999,greatly,0,0
198000,reduced,0,0
198001,.,0,0
198002,Thus,0,0
198003,",",0,0
198004,these,0,0
198005,data,0,0
198006,support,0,0
198007,the,0,0
198008,concept,0,0
198009,that,0,0
198010,insulin,0,0
198011,per,0,0
198012,se,0,0
198013,is,0,0
198014,a,0,0
198015,potent,0,0
198016,physiological,0,0
198017,modulator,0,0
198018,of,0,0
198019,islet,0,1
198020,A-,0,0
198021,and,0,0
198022,B-cell,0,0
198023,function,0,0
198024,.,0,0
198025,Furthermore,0,0
198026,",",0,0
198027,they,0,0
198028,suggest,0,0
198029,that,0,0
198030,these,0,0
198031,effects,0,0
198032,of,0,0
198033,insulin,0,0
198034,are,0,0
198035,reinforced,0,0
198036,when,0,0
198037,the,0,0
198038,hormone,0,0
198039,is,0,0
198040,administered,0,0
198041,in,0,0
198042,an,0,0
198043,intermittent,0,0
198044,manner,0,0
198045,in,0,0
198046,an,0,0
198047,attempt,0,0
198048,to,0,0
198049,reproduce,0,0
198050,the,0,0
198051,pulsatile,0,0
198052,physiological,0,0
198053,release,0,0
198054,of,0,0
198055,insulin,0,0
198056,.,0,1
198057,Transcutaneous,0,0
198058,electrical,0,0
198059,nerve,0,0
198060,stimulation,0,0
198061,after,0,0
198062,thoracotomy,0,1
198063,.,0,1
198064,Pain,0,0
198065,relief,0,0
198066,and,0,0
198067,peak,0,0
198068,expiratory,0,0
198069,flow,0,0
198070,rate,0,0
198071,--,0,0
198072,a,0,0
198073,trial,0,0
198074,of,0,0
198075,transcutaneous,0,0
198076,electrical,0,0
198077,nerve,0,0
198078,stimulation,0,0
198079,.,0,1
198080,Forty,1,1
198081,patients,1,1
198082,scheduled,1,1
198083,to,1,0
198084,undergo,1,1
198085,thoracotomy,1,0
198086,were,0,0
198087,randomly,0,1
198088,allocated,0,0
198089,to,0,0
198090,receive,0,0
198091,either,0,0
198092,transcutaneous,0,0
198093,electrical,0,0
198094,nerve,0,0
198095,stimulation,0,0
198096,with,0,1
198097,intramuscular,0,0
198098,papaveretum,0,1
198099,(,0,1
198100,20,0,1
198101,patients,0,1
198102,),0,1
198103,or,0,1
198104,intramuscular,0,0
198105,papaveretum,0,0
198106,alone,0,0
198107,(,0,0
198108,20,0,1
198109,patients,0,1
198110,),0,1
198111,for,0,0
198112,postoperative,0,0
198113,pain,0,1
198114,relief,0,0
198115,.,0,0
198116,Total,0,0
198117,intramuscular,0,0
198118,analgesic,0,0
198119,requirements,0,0
198120,in,0,0
198121,the,0,0
198122,first,0,0
198123,24,0,0
198124,hours,0,0
198125,",",0,0
198126,time,0,0
198127,to,0,0
198128,satisfactory,0,0
198129,transfer,0,0
198130,to,0,0
198131,oral,0,0
198132,analgesia,0,0
198133,",",0,0
198134,antiemetic,0,0
198135,requirements,0,0
198136,and,0,0
198137,length,0,0
198138,of,0,0
198139,stay,0,0
198140,in,0,0
198141,hospital,0,1
198142,postoperatively,0,0
198143,were,0,0
198144,noted,0,0
198145,.,0,1
198146,Peak,0,0
198147,expiratory,0,0
198148,flow,0,0
198149,rate,0,0
198150,was,0,0
198151,compared,0,0
198152,pre-,0,0
198153,and,0,0
198154,postoperatively,0,0
198155,in,0,0
198156,the,0,0
198157,two,0,0
198158,groups,0,0
198159,.,0,1
198160,Use,0,0
198161,of,0,0
198162,nerve,0,0
198163,stimulation,0,0
198164,did,0,0
198165,not,0,0
198166,significantly,0,0
198167,alter,0,0
198168,the,0,0
198169,requirements,0,0
198170,for,0,0
198171,analgesia,0,0
198172,although,0,0
198173,there,0,0
198174,was,0,0
198175,a,0,0
198176,reduction,0,0
198177,in,0,0
198178,postoperative,0,0
198179,nausea,0,0
198180,and,0,0
198181,vomiting,0,0
198182,in,0,0
198183,the,0,0
198184,nerve,0,0
198185,stimulation,0,0
198186,group,0,0
198187,.,0,0
198188,There,0,0
198189,was,0,0
198190,no,0,0
198191,difference,0,0
198192,between,0,0
198193,the,0,0
198194,two,0,0
198195,groups,0,0
198196,with,0,1
198197,respect,0,0
198198,to,0,0
198199,changes,0,0
198200,in,0,0
198201,peak,0,0
198202,expiratory,0,0
198203,flow,0,0
198204,rate,0,0
198205,.,0,1
198206,Alpha,0,0
198207,interferon,0,0
198208,clinical,0,0
198209,trial,0,0
198210,for,0,0
198211,multiple,1,0
198212,sclerosis,1,1
198213,:,1,1
198214,design,0,1
198215,considerations,0,0
198216,.,0,0
198217,The,0,0
198218,design,0,0
198219,and,0,0
198220,course,0,0
198221,of,0,0
198222,a,0,0
198223,placebo-controlled,0,0
198224,alpha-2,0,0
198225,interferon,0,0
198226,trial,0,0
198227,in,0,0
198228,MS,1,1
198229,patients,1,1
198230,are,0,0
198231,described,0,0
198232,.,0,0
198233,No,0,0
198234,beneficial,0,0
198235,effect,0,0
198236,of,0,0
198237,the,0,0
198238,interferon,0,0
198239,on,0,0
198240,the,0,0
198241,course,0,0
198242,of,0,0
198243,MS,0,0
198244,could,0,0
198245,be,0,0
198246,shown,0,0
198247,.,0,0
198248,Physicians,1,1
198249,',1,1
198250,management,1,1
198251,of,1,1
198252,hypertension,1,1
198253,:,1,1
198254,a,0,0
198255,randomized,0,0
198256,controlled,0,0
198257,CME,0,0
198258,trial,0,1
198259,.,0,1
198260,Predictors,0,0
198261,of,0,0
198262,blood,0,0
198263,pressure,0,0
198264,change,0,0
198265,in,0,0
198266,a,0,0
198267,series,0,0
198268,of,0,0
198269,controlled,0,0
198270,dietary,0,0
198271,intervention,0,1
198272,studies,0,0
198273,.,0,1
198274,Three,0,0
198275,controlled,0,0
198276,dietary,0,0
198277,intervention,0,0
198278,studies,0,0
198279,were,0,0
198280,carried,0,0
198281,out,0,0
198282,in,0,0
198283,1981-1983,1,1
198284,in,1,0
198285,North,1,1
198286,Karelia,1,1
198287,",",1,0
198288,Finland,1,1
198289,",",0,0
198290,to,0,0
198291,asses,0,0
198292,the,0,0
198293,impact,0,0
198294,of,0,0
198295,dietary,0,0
198296,fat,0,0
198297,intake,0,0
198298,modification,0,0
198299,on,0,0
198300,blood,0,0
198301,pressure,0,0
198302,(,0,0
198303,BP,0,0
198304,),0,0
198305,.,0,0
198306,All,0,0
198307,these,0,0
198308,studies,0,0
198309,involved,0,0
198310,middle-aged,1,1
198311,men,1,1
198312,and,1,1
198313,women,1,1
198314,in,1,0
198315,rural,1,1
198316,or,1,1
198317,semirural,1,1
198318,areas,1,0
198319,and,1,0
198320,comprised,1,1
198321,a,1,0
198322,baseline,1,0
198323,period,1,0
198324,",",1,0
198325,a,1,0
198326,six,1,0
198327,week,1,0
198328,(,1,0
198329,or,1,1
198330,12,1,0
198331,weeks,1,0
198332,in,1,0
198333,the,1,0
198334,third,1,0
198335,study,1,0
198336,),1,0
198337,intervention,1,0
198338,period,1,0
198339,and,1,0
198340,a,1,0
198341,four,1,0
198342,to,1,0
198343,six,1,1
198344,week,1,0
198345,return,1,0
198346,to,1,0
198347,baseline,1,0
198348,.,1,0
198349,During,0,0
198350,the,0,0
198351,intervention,0,0
198352,period,0,0
198353,the,0,0
198354,total,0,1
198355,fat,0,0
198356,intake,0,0
198357,was,0,0
198358,reduced,0,0
198359,from,0,1
198360,39,0,1
198361,%,0,0
198362,to,0,0
198363,24,0,0
198364,%,0,0
198365,of,0,0
198366,energy,0,0
198367,and,0,0
198368,the,0,0
198369,polyunsaturated/saturated,0,0
198370,(,0,0
198371,P/S,0,0
198372,),0,0
198373,ratio,0,0
198374,increased,0,0
198375,from,0,0
198376,0.2,0,0
198377,to,0,0
198378,0.4-1.2,0,0
198379,.,0,0
198380,In,0,0
198381,all,0,0
198382,groups,0,0
198383,energy,0,0
198384,intake,0,0
198385,was,0,0
198386,kept,0,0
198387,constant,0,0
198388,.,0,0
198389,For,0,0
198390,the,0,0
198391,present,0,0
198392,report,0,0
198393,data,0,0
198394,from,0,1
198395,the,0,0
198396,three,0,0
198397,studies,0,0
198398,were,0,1
198399,pooled,0,0
198400,for,0,0
198401,a,0,0
198402,series,0,0
198403,of,0,0
198404,stepwise,0,0
198405,regression,0,0
198406,analyses,0,0
198407,to,0,0
198408,predict,0,0
198409,changes,0,0
198410,in,0,0
198411,BP,0,1
198412,with,0,1
198413,different,0,0
198414,dietary,0,0
198415,changes,0,0
198416,.,0,1
198417,For,0,0
198418,both,0,0
198419,systolic,0,0
198420,(,0,0
198421,SBP,0,1
198422,),0,0
198423,and,0,0
198424,diastolic,0,1
198425,(,0,0
198426,DBP,0,1
198427,),0,0
198428,blood,0,0
198429,pressure,0,0
198430,",",0,0
198431,change,0,0
198432,in,0,0
198433,polyunsaturated,0,0
198434,fatty,0,0
198435,acid,0,0
198436,intake,0,0
198437,was,0,0
198438,the,0,0
198439,strongest,0,0
198440,dietary,0,0
198441,predictor,0,0
198442,of,0,0
198443,BP,0,0
198444,change,0,0
198445,.,0,1
198446,Changes,0,0
198447,in,0,0
198448,body,0,1
198449,weight,0,0
198450,",",0,0
198451,total,0,1
198452,fat,0,0
198453,intake,0,0
198454,",",0,0
198455,urinary,0,0
198456,sodium,0,0
198457,and,0,0
198458,potassium,0,0
198459,did,0,0
198460,not,0,0
198461,have,0,0
198462,significant,0,0
198463,predictive,0,0
198464,power,0,0
198465,in,0,0
198466,any,0,0
198467,of,0,0
198468,the,0,0
198469,analyses,0,0
198470,.,0,0
198471,The,0,0
198472,findings,0,0
198473,support,0,0
198474,the,0,0
198475,hypothesis,0,0
198476,that,0,0
198477,modification,0,0
198478,of,0,0
198479,dietary,0,0
198480,fat,0,0
198481,intake,0,0
198482,is,0,0
198483,a,0,0
198484,significant,0,0
198485,predictor,0,0
198486,of,0,0
198487,change,0,0
198488,in,0,0
198489,BP,0,0
198490,.,0,1
198491,Postoperative,0,0
198492,radiotherapy,0,1
198493,in,0,0
198494,breast,1,1
198495,cancer,1,1
198496,--,1,1
198497,long-term,1,0
198498,results,0,0
198499,from,0,1
198500,the,0,0
198501,Oslo,1,1
198502,study,1,0
198503,.,1,0
198504,The,0,0
198505,long-term,0,0
198506,results,0,0
198507,of,0,0
198508,a,0,1
198509,randomized,0,0
198510,clinical,0,0
198511,trial,0,0
198512,evaluating,0,0
198513,the,1,0
198514,effect,1,0
198515,of,1,0
198516,postoperative,1,0
198517,radiotherapy,1,1
198518,as,1,0
198519,an,1,0
198520,adjuvant,1,0
198521,to,1,0
198522,radical,1,0
198523,mastectomy,1,1
198524,are,1,0
198525,presented,1,0
198526,.,1,0
198527,There,0,0
198528,were,0,0
198529,1115,1,1
198530,patients,1,1
198531,including,1,1
198532,27,1,1
198533,protocol,1,1
198534,deviants,1,0
198535,.,1,1
198536,The,0,0
198537,follow-up,0,0
198538,time,0,0
198539,is,0,0
198540,11-20,0,1
198541,years,0,1
198542,.,0,1
198543,In,0,0
198544,the,0,0
198545,first,0,0
198546,part,0,0
198547,a,0,0
198548,conventional,0,0
198549,roentgen,0,1
198550,unit,0,0
198551,was,0,0
198552,used,0,0
198553,",",0,0
198554,and,0,0
198555,in,0,0
198556,the,0,0
198557,second,0,0
198558,part,0,0
198559,a,0,0
198560,60Co,0,0
198561,unit,0,0
198562,",",0,0
198563,with,0,0
198564,considerably,0,0
198565,increased,0,0
198566,dosage,0,0
198567,and,0,0
198568,altered,0,0
198569,treatment,0,0
198570,plan,0,0
198571,.,0,0
198572,Both,0,0
198573,types,0,0
198574,of,0,0
198575,radiation,0,1
198576,techniques,0,0
198577,lowered,0,0
198578,the,0,0
198579,incidence,0,0
198580,of,0,0
198581,loco-regional,0,1
198582,recurrences,0,0
198583,significantly,0,0
198584,",",0,0
198585,but,0,0
198586,had,0,0
198587,no,0,0
198588,significant,0,0
198589,influence,0,0
198590,on,0,0
198591,the,0,0
198592,overall,0,0
198593,survival,0,0
198594,.,0,0
198595,The,0,0
198596,relapse-free,0,0
198597,survival,0,0
198598,was,0,0
198599,significantly,0,0
198600,improved,0,0
198601,by,0,0
198602,60Co,0,0
198603,radiation,0,1
198604,in,0,0
198605,Stage,0,1
198606,II,0,1
198607,patients,0,1
198608,",",0,0
198609,but,0,0
198610,was,0,0
198611,unaffected,0,0
198612,by,0,0
198613,radiation,0,0
198614,in,0,0
198615,the,0,0
198616,other,0,0
198617,subgroups,0,0
198618,.,0,1
198619,Regarding,0,0
198620,survival,0,0
198621,",",0,0
198622,Stage,0,1
198623,II,0,1
198624,patients,0,1
198625,with,0,1
198626,medially,0,0
198627,located,0,1
198628,tumors,0,1
198629,seemed,0,0
198630,to,0,0
198631,benefit,0,0
198632,more,0,0
198633,from,0,0
198634,60Co,0,0
198635,radiation,0,0
198636,than,0,0
198637,those,0,0
198638,with,0,1
198639,lateral,0,1
198640,tumors,0,1
198641,.,0,1
198642,A,0,0
198643,significant,0,0
198644,increase,0,0
198645,in,0,0
198646,the,0,0
198647,number,0,0
198648,of,0,0
198649,deaths,0,0
198650,caused,0,0
198651,by,0,0
198652,myocardial,0,1
198653,infarction,0,1
198654,was,0,0
198655,observed,0,0
198656,in,0,0
198657,Stage,0,1
198658,I,0,1
198659,patients,0,1
198660,having,0,1
198661,60Co,0,0
198662,radiation,0,0
198663,",",0,0
198664,indicating,0,0
198665,that,0,0
198666,the,0,0
198667,radiation,0,0
198668,dose,0,0
198669,to,0,0
198670,the,0,0
198671,heart,0,0
198672,is,0,0
198673,of,0,0
198674,significance,0,0
198675,.,0,1
198676,A,0,0
198677,randomized,0,0
198678,comparison,0,0
198679,of,0,0
198680,tamoxifen,0,0
198681,with,0,1
198682,surgical,0,0
198683,oophorectomy,0,1
198684,in,0,0
198685,premenopausal,1,1
198686,patients,1,1
198687,with,1,1
198688,advanced,1,1
198689,breast,1,1
198690,cancer,1,1
198691,.,1,0
198692,We,0,0
198693,randomized,0,0
198694,122,1,1
198695,premenopausal,1,1
198696,women,1,1
198697,to,0,0
198698,receive,0,0
198699,tamoxifen,0,0
198700,or,0,0
198701,to,0,0
198702,undergo,0,1
198703,a,0,0
198704,surgical,0,0
198705,oophorectomy,0,1
198706,.,0,1
198707,Of,0,0
198708,54,1,1
198709,evaluable,1,1
198710,women,1,1
198711,treated,1,1
198712,with,1,1
198713,tamoxifen,1,0
198714,",",1,0
198715,24,1,0
198716,%,1,0
198717,had,1,1
198718,an,1,0
198719,objective,1,0
198720,response,1,0
198721,",",1,0
198722,as,1,0
198723,compared,1,0
198724,with,1,1
198725,21,1,1
198726,%,1,0
198727,of,1,0
198728,53,1,1
198729,women,1,1
198730,having,1,1
198731,an,1,0
198732,oophorectomy,1,0
198733,.,0,0
198734,The,0,0
198735,median,0,0
198736,duration,0,0
198737,of,0,0
198738,response,0,0
198739,for,0,0
198740,tamoxifen,0,0
198741,(,0,1
198742,20,0,1
198743,months,0,0
198744,),0,1
198745,was,0,0
198746,longer,0,0
198747,than,0,0
198748,that,0,0
198749,for,0,0
198750,surgical,0,0
198751,oophorectomy,0,1
198752,(,0,1
198753,7,0,1
198754,months,0,0
198755,),0,0
198756,",",0,0
198757,but,0,0
198758,this,0,0
198759,did,0,0
198760,not,0,0
198761,achieve,0,0
198762,statistical,0,0
198763,significance,0,0
198764,(,0,0
198765,P,0,0
198766,=,0,0
198767,.056,0,0
198768,),0,0
198769,.,0,1
198770,Overall,0,0
198771,median,0,0
198772,survival,0,0
198773,was,0,0
198774,15,0,1
198775,months,0,0
198776,for,0,1
198777,58,1,1
198778,patients,1,1
198779,receiving,0,1
198780,tamoxifen,0,1
198781,and,0,1
198782,25,0,1
198783,months,0,0
198784,for,0,1
198785,53,0,1
198786,patients,0,1
198787,undergoing,0,1
198788,oophorectomy,0,1
198789,(,0,1
198790,P,0,0
198791,=,0,0
198792,.18,0,0
198793,),0,0
198794,.,0,0
198795,Toxicity,0,0
198796,was,0,0
198797,greater,0,0
198798,in,0,0
198799,those,0,0
198800,undergoing,0,1
198801,oophorectomy,0,0
198802,",",0,0
198803,though,0,0
198804,both,0,0
198805,treatments,0,0
198806,were,0,0
198807,well,0,0
198808,tolerated,0,0
198809,.,0,0
198810,In,0,0
198811,those,0,0
198812,premenopausal,1,1
198813,women,1,1
198814,for,0,1
198815,whom,0,1
198816,hormonal,0,1
198817,therapy,0,1
198818,is,0,0
198819,indicated,0,0
198820,",",0,0
198821,tamoxifen,0,0
198822,is,0,0
198823,a,0,0
198824,suitable,0,0
198825,alternative,0,0
198826,to,0,0
198827,surgical,0,0
198828,oophorectomy,0,1
198829,.,0,1
198830,Monotherapy,0,0
198831,of,0,0
198832,mild,1,1
198833,hypertension,1,1
198834,with,0,1
198835,nifedipine,0,0
198836,.,0,0
198837,The,0,0
198838,effectiveness,0,0
198839,of,0,0
198840,nifedipine,0,0
198841,as,0,0
198842,first-line,0,1
198843,monotherapy,0,1
198844,for,0,0
198845,mild,1,1
198846,diastolic,1,1
198847,hypertension,1,1
198848,(,1,0
198849,range,1,1
198850,:,1,1
198851,95,1,0
198852,to,1,0
198853,105,1,1
198854,mm,1,0
198855,Hg,1,1
198856,),1,1
198857,was,0,0
198858,tested,0,0
198859,in,0,0
198860,this,0,0
198861,placebo-controlled,0,0
198862,",",0,0
198863,double-blind,0,0
198864,",",0,0
198865,randomized,0,1
198866,trial,0,0
198867,.,0,1
198868,Fifty-six,1,1
198869,patients,1,1
198870,were,1,1
198871,enrolled,1,1
198872,and,0,0
198873,",",0,0
198874,after,0,0
198875,titration,0,0
198876,of,0,0
198877,the,0,0
198878,placebo,0,0
198879,or,0,0
198880,active,0,0
198881,drug,0,0
198882,",",0,0
198883,they,0,0
198884,were,0,0
198885,followed,0,0
198886,for,0,0
198887,12,0,1
198888,weeks,0,0
198889,.,0,1
198890,Significant,0,0
198891,declines,0,0
198892,in,0,0
198893,the,0,0
198894,sitting,0,0
198895,systolic,0,0
198896,and,0,1
198897,diastolic,0,1
198898,pressures,0,0
198899,of,0,1
198900,-19,0,0
198901,+/-,0,0
198902,4,0,0
198903,mm,0,0
198904,Hg,0,0
198905,(,0,0
198906,standard,0,0
198907,error,0,0
198908,),0,0
198909,and,0,0
198910,-13,0,0
198911,+/-,0,0
198912,2,0,0
198913,mm,0,0
198914,Hg,0,0
198915,",",0,0
198916,respectively,0,0
198917,",",0,0
198918,were,0,0
198919,observed,0,0
198920,during,0,0
198921,this,0,0
198922,follow-up,0,0
198923,period,0,0
198924,.,0,0
198925,Overall,0,0
198926,",",0,0
198927,75,0,0
198928,percent,0,0
198929,of,0,0
198930,patients,0,1
198931,receiving,0,1
198932,active,0,1
198933,drug,0,0
198934,had,0,1
198935,diastolic,0,0
198936,pressures,0,0
198937,less,0,0
198938,than,0,0
198939,or,0,0
198940,equal,0,0
198941,to,0,0
198942,90,0,1
198943,mm,0,0
198944,Hg,0,0
198945,at,0,0
198946,the,0,0
198947,last,0,0
198948,treatment,0,0
198949,visit,0,0
198950,.,0,0
198951,Heart,0,0
198952,rate,0,0
198953,was,0,0
198954,not,0,0
198955,significantly,0,0
198956,changed,0,0
198957,in,0,0
198958,the,0,0
198959,sitting,0,0
198960,position,0,0
198961,during,0,0
198962,the,0,0
198963,treatment,0,0
198964,period,0,0
198965,",",0,0
198966,and,0,0
198967,the,0,0
198968,majority,0,0
198969,of,0,0
198970,patients,0,1
198971,(,0,1
198972,75,0,1
198973,percent,0,1
198974,),0,0
198975,showed,0,0
198976,a,0,0
198977,response,0,0
198978,to,0,0
198979,nifedipine,0,0
198980,doses,0,0
198981,of,0,1
198982,10,0,1
198983,or,0,1
198984,20,0,1
198985,mg,0,0
198986,orally,0,1
198987,three,0,0
198988,times,0,0
198989,daily,0,0
198990,in,0,0
198991,the,0,0
198992,capsule,0,0
198993,form,0,0
198994,.,0,0
198995,The,0,0
198996,levels,0,0
198997,of,0,0
198998,the,0,0
198999,systolic,0,0
199000,and,0,0
199001,diastolic,0,1
199002,pressures,0,0
199003,at,0,1
199004,entry,0,0
199005,were,0,0
199006,not,0,0
199007,predictive,0,0
199008,of,0,0
199009,the,0,0
199010,dose,0,0
199011,of,0,0
199012,nifedipine,0,0
199013,required,0,0
199014,for,0,0
199015,effective,0,0
199016,blood,0,0
199017,pressure,0,0
199018,control,0,1
199019,.,0,1
199020,Untoward,0,0
199021,effects,0,0
199022,of,0,0
199023,fenfluramine,0,1
199024,in,0,0
199025,autistic,1,1
199026,children,1,1
199027,.,1,1
199028,Several,0,0
199029,recent,0,0
199030,studies,0,0
199031,have,0,0
199032,described,0,0
199033,the,0,0
199034,benefits,0,0
199035,of,0,0
199036,fenfluramine,0,0
199037,for,0,0
199038,the,0,0
199039,symptomatic,0,1
199040,treatment,0,0
199041,of,0,0
199042,infantile,1,1
199043,autism,1,1
199044,.,1,0
199045,No,0,0
199046,large,0,1
199047,surveys,0,0
199048,of,0,1
199049,side,0,0
199050,effects,0,0
199051,of,0,0
199052,this,0,0
199053,drug,0,0
199054,have,0,0
199055,been,0,0
199056,reported,0,0
199057,in,0,0
199058,autistic,1,1
199059,children,1,1
199060,.,1,1
199061,To,0,0
199062,evaluate,0,0
199063,the,0,0
199064,untoward,0,0
199065,effects,0,0
199066,of,0,0
199067,fenfluramine,0,1
199068,in,0,0
199069,children,1,1
199070,with,1,1
199071,autism,1,1
199072,",",1,0
199073,12,1,0
199074,subjects,1,1
199075,were,0,1
199076,systematically,0,0
199077,studied,0,1
199078,.,0,0
199079,Medication,0,0
199080,was,0,0
199081,administered,0,0
199082,in,0,0
199083,a,0,0
199084,double-blind,0,0
199085,",",0,0
199086,placebo-controlled,0,0
199087,cross-over,0,0
199088,study,0,1
199089,.,0,1
199090,Parents,0,0
199091,were,0,0
199092,trained,0,1
199093,in,0,0
199094,monitoring,0,0
199095,untoward,0,0
199096,effects,0,0
199097,.,0,1
199098,These,0,0
199099,observations,0,0
199100,were,0,0
199101,compiled,0,1
199102,in,0,0
199103,detailed,0,0
199104,daily,0,0
199105,notes,0,0
199106,.,0,1
199107,In,1,0
199108,addition,1,0
199109,",",1,0
199110,four,1,1
199111,cases,1,1
199112,describing,1,0
199113,unusual,1,1
199114,effects,1,0
199115,found,1,0
199116,in,1,0
199117,a,1,0
199118,sample,1,1
199119,of,1,0
199120,170,1,1
199121,patients,1,1
199122,treated,1,1
199123,with,1,1
199124,fenfluramine,1,0
199125,are,1,0
199126,also,1,0
199127,reported,1,0
199128,.,1,0
199129,In,0,0
199130,the,0,0
199131,initial,0,0
199132,2,0,0
199133,weeks,0,0
199134,of,0,0
199135,active,0,1
199136,drug,0,0
199137,listlessness,0,0
199138,",",0,0
199139,food,0,0
199140,refusal,0,0
199141,",",0,0
199142,and,0,0
199143,stomach,0,0
199144,upset,0,0
199145,were,0,0
199146,frequently,0,0
199147,seen,0,0
199148,.,0,0
199149,A,0,0
199150,different,0,0
199151,pattern,0,1
199152,of,0,0
199153,untoward,0,0
199154,effects,0,0
199155,was,0,0
199156,seen,0,0
199157,in,0,0
199158,the,0,0
199159,final,0,0
199160,14,0,0
199161,weeks,0,0
199162,of,0,1
199163,treatment,0,0
199164,.,0,0
199165,Irritability,0,0
199166,",",0,0
199167,agitation,0,0
199168,",",0,0
199169,and,0,0
199170,crying,0,0
199171,along,0,0
199172,with,0,1
199173,continued,0,0
199174,food,0,0
199175,refusal,0,0
199176,were,0,0
199177,noted,0,0
199178,.,0,0
199179,The,0,0
199180,subjects,0,1
199181,lost,0,0
199182,2.1,0,0
199183,%,0,0
199184,of,0,0
199185,body,0,0
199186,weight,0,0
199187,during,0,0
199188,active,0,1
199189,drug,0,0
199190,phase,0,0
199191,",",0,0
199192,but,0,0
199193,there,0,0
199194,was,0,0
199195,a,0,0
199196,rebound,0,0
199197,weight,0,0
199198,gain,0,0
199199,during,0,0
199200,the,0,0
199201,subsequent,0,0
199202,placebo,0,0
199203,phase,0,1
199204,.,0,0
199205,A,0,0
199206,thorough,0,0
199207,understanding,0,0
199208,of,0,0
199209,fenfluramine,0,0
199210,'s,0,1
199211,side,0,0
199212,effects,0,0
199213,and,0,1
199214,adverse,0,0
199215,reactions,0,0
199216,is,0,0
199217,necessary,0,0
199218,so,0,0
199219,as,0,0
199220,to,0,0
199221,differentiate,0,0
199222,them,0,0
199223,from,0,0
199224,the,0,0
199225,multiple,0,0
199226,symptoms,0,0
199227,inherent,0,0
199228,in,0,0
199229,the,0,0
199230,syndrome,0,1
199231,of,0,0
199232,autism,1,1
199233,.,1,1
199234,Sucralfate,0,0
199235,overcomes,0,0
199236,adverse,0,0
199237,effect,0,0
199238,of,0,0
199239,cigarette,0,1
199240,smoking,0,1
199241,on,0,0
199242,duodenal,1,1
199243,ulcer,1,1
199244,healing,0,0
199245,and,0,0
199246,prolongs,0,0
199247,subsequent,0,0
199248,remission,0,1
199249,.,0,0
199250,A,0,0
199251,unicenter,0,0
199252,",",0,0
199253,single-blind,0,0
199254,",",0,0
199255,randomized,0,0
199256,study,0,0
199257,was,0,0
199258,conducted,0,0
199259,on,0,0
199260,283,1,1
199261,patients,1,1
199262,with,1,1
199263,active,1,1
199264,duodenal,1,1
199265,ulcer,1,1
199266,to,1,0
199267,compare,1,0
199268,possible,1,0
199269,factors,1,0
199270,that,1,0
199271,may,1,0
199272,affect,1,0
199273,healing,1,0
199274,and,1,0
199275,relapse,1,0
199276,in,1,0
199277,patients,1,1
199278,treated,1,1
199279,with,1,1
199280,a,1,0
199281,potent,1,0
199282,antisecretory,1,0
199283,agent,1,0
199284,",",1,0
199285,cimetidine,1,0
199286,",",1,0
199287,or,1,0
199288,a,1,0
199289,site-protective,1,0
199290,and,1,0
199291,cytoprotective,1,0
199292,agent,1,0
199293,",",1,0
199294,sucralfate,1,0
199295,.,1,0
199296,The,0,0
199297,endoscopic,0,0
199298,healing,0,0
199299,rates,0,0
199300,at,0,1
199301,4,0,1
199302,wk,0,1
199303,were,0,1
199304,76,0,1
199305,%,0,0
199306,and,0,0
199307,79,0,1
199308,%,0,0
199309,",",0,0
199310,respectively,0,0
199311,",",0,0
199312,and,0,0
199313,cross-over,0,0
199314,treatment,0,0
199315,of,0,0
199316,the,0,0
199317,failures,0,0
199318,for,0,0
199319,a,0,1
199320,further,0,0
199321,4,0,0
199322,wk,0,0
199323,resulted,0,0
199324,in,0,0
199325,68,0,1
199326,%,0,0
199327,healing,0,0
199328,with,0,1
199329,cimetidine,0,0
199330,and,0,0
199331,69,0,1
199332,%,0,0
199333,healing,0,0
199334,with,0,1
199335,sucralfate,0,0
199336,",",0,0
199337,both,0,0
199338,differences,0,0
199339,being,0,0
199340,not,0,0
199341,statistically,0,0
199342,different,0,0
199343,.,0,0
199344,Unlike,0,0
199345,cimetidine,0,0
199346,",",0,0
199347,healing,0,0
199348,by,0,0
199349,sucralfate,0,0
199350,was,0,0
199351,unaffected,0,0
199352,by,0,0
199353,cigarette,0,0
199354,smoking,0,0
199355,",",0,0
199356,reluctance,0,0
199357,to,0,0
199358,give,0,0
199359,up,0,0
199360,smoking,0,0
199361,",",0,0
199362,habitual,0,0
199363,use,0,0
199364,of,0,0
199365,alcohol,0,1
199366,",",0,0
199367,high,0,0
199368,maximal,0,0
199369,acid,0,0
199370,output,0,0
199371,",",0,0
199372,and,0,0
199373,large,0,1
199374,ulcer,0,1
199375,diameter,0,0
199376,.,0,0
199377,In,0,0
199378,particular,0,0
199379,",",0,0
199380,the,0,0
199381,healing,0,0
199382,rate,0,0
199383,of,0,0
199384,smokers,0,1
199385,treated,0,1
199386,with,0,1
199387,sucralfate,0,0
199388,(,0,0
199389,82,0,1
199390,%,0,0
199391,),0,0
199392,was,0,0
199393,significantly,0,0
199394,greater,0,0
199395,than,0,0
199396,that,0,0
199397,of,0,0
199398,smokers,0,1
199399,treated,0,1
199400,with,0,1
199401,cimetidine,0,0
199402,(,0,0
199403,63,0,1
199404,%,0,0
199405,),0,1
199406,.,0,0
199407,Duodenal,0,1
199408,bulb,0,0
199409,deformity,0,1
199410,significantly,0,0
199411,affected,0,0
199412,healing,0,0
199413,in,0,0
199414,both,1,0
199415,groups,1,0
199416,",",0,0
199417,and,0,0
199418,was,0,0
199419,the,0,0
199420,only,0,0
199421,offsetting,0,0
199422,factor,0,0
199423,identifiable,0,0
199424,for,0,0
199425,sucralfate,0,0
199426,out,0,0
199427,of,0,0
199428,46,0,1
199429,factors,0,0
199430,examined,0,0
199431,.,0,1
199432,Of,0,0
199433,the,0,0
199434,patients,1,1
199435,with,1,1
199436,healed,1,1
199437,ulcers,1,1
199438,",",1,1
199439,238,1,1
199440,participated,1,1
199441,in,0,0
199442,a,0,0
199443,24-mo,0,0
199444,follow-up,0,0
199445,study,0,0
199446,consisting,0,1
199447,of,0,0
199448,interviews,0,1
199449,at,0,1
199450,2-mo,0,1
199451,intervals,0,0
199452,and,0,0
199453,endoscopy,0,1
199454,at,0,0
199455,4-mo,0,1
199456,intervals,0,0
199457,or,0,0
199458,whenever,0,0
199459,symptoms,0,0
199460,recurred,0,0
199461,.,0,1
199462,The,0,0
199463,cumulative,0,0
199464,relapse,0,0
199465,rate,0,0
199466,was,0,0
199467,significantly,0,0
199468,(,0,0
199469,p,0,0
199470,less,0,0
199471,than,0,0
199472,0.007,0,0
199473,),0,0
199474,greater,0,0
199475,in,0,0
199476,patients,1,1
199477,healed,0,1
199478,with,0,1
199479,cimetidine,0,0
199480,than,0,0
199481,with,0,1
199482,sucralfate,0,0
199483,",",0,0
199484,50,0,0
199485,%,0,0
199486,relapse,0,0
199487,occurring,0,0
199488,at,0,0
199489,6,0,0
199490,and,0,0
199491,12,0,0
199492,mo,0,0
199493,",",0,0
199494,respectively,0,0
199495,.,0,0
199496,In,0,0
199497,both,0,0
199498,",",0,0
199499,the,0,0
199500,cumulative,0,0
199501,relapse,0,0
199502,rate,0,0
199503,was,0,0
199504,significantly,0,0
199505,greater,0,0
199506,in,0,0
199507,cigarette,0,1
199508,smokers,0,1
199509,than,0,0
199510,in,0,0
199511,nonsmokers,0,1
199512,",",0,0
199513,but,0,0
199514,smokers,0,1
199515,and,0,1
199516,nonsmokers,0,1
199517,treated,0,1
199518,with,0,1
199519,cimetidine,0,0
199520,relapsed,0,1
199521,(,0,0
199522,50,0,0
199523,%,0,0
199524,at,0,0
199525,4,0,0
199526,and,0,0
199527,8,0,0
199528,mo,0,0
199529,",",0,0
199530,respectively,0,0
199531,),0,0
199532,faster,0,0
199533,than,0,0
199534,the,0,0
199535,corresponding,0,0
199536,smokers,0,1
199537,and,0,1
199538,nonsmokers,0,1
199539,treated,0,1
199540,with,0,1
199541,sucralfate,0,0
199542,(,0,0
199543,50,0,0
199544,%,0,0
199545,at,0,0
199546,8,0,0
199547,and,0,0
199548,18,0,1
199549,mo,0,0
199550,",",0,0
199551,respectively,0,0
199552,),0,0
199553,.,0,0
199554,Furthermore,0,0
199555,",",0,0
199556,in,0,0
199557,cimetidine-,0,0
199558,but,0,0
199559,not,0,0
199560,sucralfate-healed,0,0
199561,patients,0,1
199562,",",0,0
199563,early,0,0
199564,ulcer,0,1
199565,relapse,0,0
199566,(,0,0
199567,within,0,0
199568,6,0,0
199569,mo,0,1
199570,),0,0
199571,was,0,0
199572,associated,0,0
199573,with,0,1
199574,short,0,0
199575,duration,0,0
199576,of,0,0
199577,illness,0,1
199578,",",0,0
199579,short,0,0
199580,remission,0,0
199581,period,0,0
199582,",",0,0
199583,long,0,0
199584,symptomatic,0,1
199585,spell,0,0
199586,",",0,0
199587,and,0,0
199588,reluctance,0,0
199589,to,0,0
199590,give,0,0
199591,up,0,0
199592,smoking,0,0
199593,.,0,0
199594,We,0,0
199595,conclude,0,0
199596,that,0,0
199597,smoking,0,0
199598,adversely,0,0
199599,affects,0,0
199600,duodenal,0,0
199601,ulcer,0,1
199602,healing,0,0
199603,by,0,0
199604,cimetidine,0,0
199605,and,0,0
199606,hastens,0,0
199607,subsequent,0,0
199608,relapse,0,0
199609,",",0,0
199610,and,0,0
199611,that,0,0
199612,sucralfate,0,0
199613,overcomes,0,0
199614,the,0,0
199615,adverse,0,0
199616,effect,0,0
199617,of,0,0
199618,smoking,0,0
199619,on,0,0
199620,healing,0,0
199621,as,0,0
199622,encountered,0,0
199623,with,0,1
199624,cimetidine,0,0
199625,",",0,0
199626,and,0,0
199627,results,0,0
199628,in,0,0
199629,a,0,0
199630,subsequent,0,0
199631,remission,0,0
199632,period,0,0
199633,double,0,0
199634,that,0,0
199635,of,0,0
199636,cimetidine,0,0
199637,.,0,1
199638,Circadian,0,0
199639,changes,0,0
199640,in,0,0
199641,the,0,0
199642,pharmacokinetics,0,0
199643,of,0,0
199644,oral,1,0
199645,ketoprofen,1,0
199646,.,1,1
199647,Several,0,0
199648,investigations,0,0
199649,which,0,0
199650,have,0,0
199651,taken,0,0
199652,treatment,0,0
199653,time,0,0
199654,into,0,0
199655,account,0,0
199656,have,0,0
199657,shown,0,0
199658,that,0,0
199659,the,0,0
199660,pharmacokinetic,0,0
199661,parameters,0,0
199662,",",0,0
199663,the,0,0
199664,therapeutic,0,0
199665,efficacy,0,0
199666,and,0,0
199667,even,0,0
199668,the,0,0
199669,toxicity,0,0
199670,of,0,0
199671,a,0,0
199672,large,0,1
199673,number,0,0
199674,of,0,0
199675,products,0,0
199676,may,0,0
199677,vary,0,0
199678,according,0,0
199679,to,0,0
199680,the,0,0
199681,administration,0,0
199682,schedule,0,0
199683,.,0,0
199684,The,0,0
199685,present,0,0
199686,study,0,0
199687,was,0,0
199688,carried,0,0
199689,out,0,0
199690,in,0,0
199691,order,0,0
199692,to,0,0
199693,evaluate,0,0
199694,any,0,0
199695,circadian,0,0
199696,changes,0,0
199697,in,0,1
199698,pharmacokinetic,0,0
199699,parameters,0,0
199700,of,0,0
199701,ketoprofen,0,0
199702,",",0,0
199703,a,0,0
199704,new,0,0
199705,non-steroidal,0,0
199706,anti-inflammatory,0,0
199707,drug,0,0
199708,(,0,0
199709,NSAID,0,1
199710,),0,0
199711,.,0,0
199712,This,0,0
199713,randomised,0,0
199714,crossover,0,0
199715,study,0,0
199716,consisted,0,1
199717,of,0,0
199718,a,0,0
199719,single,0,0
199720,oral,0,0
199721,dose,0,0
199722,of,0,0
199723,ketoprofen,0,0
199724,100mg,0,0
199725,administered,0,0
199726,to,0,0
199727,8,1,0
199728,healthy,1,1
199729,male,1,1
199730,volunteers,1,1
199731,",",1,0
199732,mean,1,1
199733,age,1,1
199734,27.2,1,1
199735,years,1,1
199736,",",0,0
199737,at,0,0
199738,07.00,0,0
199739,hours,0,0
199740,",",0,1
199741,13.00,0,0
199742,hours,0,0
199743,",",0,1
199744,19.00,0,0
199745,hours,0,0
199746,or,0,1
199747,01.00,0,0
199748,hours,0,0
199749,in,0,1
199750,4,0,0
199751,study,0,1
199752,periods,0,0
199753,during,0,0
199754,the,0,0
199755,first,0,0
199756,3,0,0
199757,months,0,0
199758,of,0,0
199759,the,0,0
199760,year,0,0
199761,.,0,0
199762,The,0,0
199763,order,0,0
199764,of,0,0
199765,administration,0,0
199766,was,0,0
199767,randomised,0,0
199768,",",0,0
199769,with,0,0
199770,each,0,0
199771,subject,0,0
199772,acting,0,0
199773,as,0,0
199774,his,0,0
199775,own,0,1
199776,control,0,0
199777,.,0,0
199778,A,0,0
199779,total,0,1
199780,of,0,0
199781,14,1,0
199782,blood,1,0
199783,and,1,0
199784,4,1,0
199785,urine,1,1
199786,samples,1,0
199787,were,0,1
199788,taken,0,0
199789,over,0,0
199790,a,0,0
199791,12-hour,0,0
199792,period,0,0
199793,.,0,0
199794,The,0,0
199795,peak,0,0
199796,plasma,0,0
199797,concentration,0,0
199798,was,0,0
199799,twice,0,0
199800,as,0,0
199801,high,0,0
199802,after,0,0
199803,drug,0,0
199804,administration,0,0
199805,at,0,0
199806,07.00,0,0
199807,hours,0,0
199808,(,0,1
199809,13.4,0,0
199810,+/-,0,0
199811,1,0,0
199812,mg/L,0,0
199813,),0,0
199814,than,0,0
199815,after,0,0
199816,other,0,0
199817,administration,0,0
199818,times,0,0
199819,(,0,1
199820,13.00,0,0
199821,hours,0,0
199822,:,0,1
199823,6.9,0,0
199824,+/-,0,0
199825,1,0,1
199826,;,0,1
199827,19.00,0,0
199828,hours,0,0
199829,:,0,1
199830,7.2,0,1
199831,+/-,0,0
199832,0.7,0,1
199833,;,0,1
199834,01.00,0,0
199835,hours,0,0
199836,:,0,1
199837,6.3,0,0
199838,+/-,0,0
199839,0.5,0,0
199840,mg/L,0,0
199841,),0,0
199842,[,0,0
199843,p,0,0
199844,less,0,0
199845,than,0,0
199846,0.001,0,0
199847,],0,1
199848,.,0,0
199849,The,0,0
199850,time,0,0
199851,to,0,0
199852,reach,0,0
199853,peak,0,0
199854,concentration,0,0
199855,was,0,0
199856,much,0,0
199857,longer,0,0
199858,after,0,0
199859,drug,0,0
199860,administration,0,0
199861,at,0,0
199862,01.00,0,0
199863,hours,0,0
199864,(,0,1
199865,135,0,1
199866,+/-,0,0
199867,16.7,0,1
199868,min,0,0
199869,),0,0
199870,than,0,0
199871,at,0,0
199872,07.00,0,0
199873,(,0,1
199874,73.1,0,0
199875,+/-,0,0
199876,14.1,0,0
199877,min,0,0
199878,),0,0
199879,",",0,0
199880,13.00,0,0
199881,(,0,0
199882,75,0,1
199883,+/-,0,0
199884,16.5,0,0
199885,min,0,0
199886,),0,0
199887,or,0,1
199888,19.00,0,0
199889,hours,0,0
199890,(,0,1
199891,82.5,0,1
199892,+/-,0,0
199893,12.7,0,0
199894,min,0,0
199895,),0,0
199896,[,0,0
199897,p,0,0
199898,less,0,0
199899,than,0,0
199900,0.05,0,0
199901,],0,1
199902,.,0,0
199903,The,0,0
199904,lag,0,0
199905,time,0,0
199906,was,0,0
199907,significantly,0,0
199908,longer,0,0
199909,at,0,0
199910,01.00,0,0
199911,hours,0,0
199912,than,0,0
199913,at,0,1
199914,13.00,0,0
199915,hours,0,0
199916,(,0,1
199917,p,0,0
199918,less,0,0
199919,than,0,0
199920,0.01,0,0
199921,),0,1
199922,.,0,0
199923,The,0,0
199924,absorption,0,0
199925,rate,0,0
199926,constant,0,0
199927,after,0,0
199928,treatment,0,0
199929,at,0,0
199930,01.00,0,0
199931,hours,0,0
199932,was,0,0
199933,less,0,0
199934,than,0,0
199935,at,0,0
199936,the,0,0
199937,other,0,0
199938,times,0,0
199939,of,0,0
199940,administration,0,0
199941,(,0,0
199942,p,0,0
199943,less,0,0
199944,than,0,0
199945,0.05,0,0
199946,),0,1
199947,.,0,0
199948,The,0,0
199949,bodyweight-corrected,0,0
199950,area,0,0
199951,under,0,0
199952,the,0,0
199953,curve,0,0
199954,(,0,0
199955,AUC0-12,0,0
199956,),0,0
199957,was,0,0
199958,greater,0,0
199959,after,0,0
199960,07.00,0,0
199961,hours,0,0
199962,than,0,0
199963,after,0,0
199964,13.00,0,0
199965,(,0,0
199966,p,0,0
199967,less,0,0
199968,than,0,0
199969,0.01,0,0
199970,),0,1
199971,or,0,1
199972,19.00,0,0
199973,hours,0,0
199974,(,0,1
199975,p,0,0
199976,less,0,0
199977,than,0,0
199978,0.05,0,0
199979,),0,0
199980,and,0,0
199981,greater,0,0
199982,after,0,0
199983,01.00,0,0
199984,hours,0,0
199985,than,0,0
199986,after,0,1
199987,13.00,0,0
199988,hours,0,0
199989,(,0,1
199990,p,0,0
199991,less,0,0
199992,than,0,0
199993,0.05,0,0
199994,),0,1
199995,.,0,0
199996,The,0,0
199997,elimination,0,0
199998,half-life,0,0
199999,was,0,0
200000,significantly,0,0
200001,longer,0,0
200002,after,0,0
200003,administration,0,0
200004,at,0,0
200005,01.00,0,0
200006,hours,0,0
200007,than,0,0
200008,after,0,1
200009,19.00,0,0
200010,hours,0,0
200011,(,0,1
200012,p,0,0
200013,less,0,0
200014,than,0,0
200015,0.05,0,0
200016,),0,0
200017,",",0,0
200018,while,0,0
200019,the,0,0
200020,total,0,1
200021,clearance,0,0
200022,was,0,0
200023,lowest,0,0
200024,at,0,0
200025,07.00,0,0
200026,hours,0,0
200027,.,0,1
200028,Cosinor,0,0
200029,analysis,0,0
200030,demonstrated,0,0
200031,statistically,0,0
200032,significant,0,0
200033,circadian,0,0
200034,rhythms,0,0
200035,for,0,0
200036,all,0,0
200037,pharmacokinetic,0,0
200038,parameters,0,0
200039,described,0,1
200040,above,0,0
200041,.,0,0
200042,The,0,0
200043,amount,0,0
200044,of,0,0
200045,ketoprofen,0,0
200046,eliminated,0,0
200047,in,0,0
200048,the,0,0
200049,urine,0,0
200050,was,0,0
200051,delayed,0,0
200052,",",0,0
200053,and,0,0
200054,was,0,0
200055,significantly,0,0
200056,greater,0,0
200057,after,0,0
200058,the,0,0
200059,administration,0,0
200060,at,0,0
200061,01.00,0,0
200062,hours,0,0
200063,than,0,1
200064,07.00,0,0
200065,hours,0,0
200066,or,0,1
200067,19.00,0,0
200068,hours,0,0
200069,(,0,1
200070,p,0,0
200071,less,0,0
200072,than,0,0
200073,0.01,0,0
200074,),0,1
200075,.,0,0
200076,The,0,0
200077,relationship,0,0
200078,between,0,0
200079,absorption,0,0
200080,",",0,0
200081,diffusion,0,0
200082,and/or,0,0
200083,elimination,0,0
200084,mechanisms,0,0
200085,of,0,0
200086,the,0,0
200087,drug,0,0
200088,are,0,0
200089,discussed,0,0
200090,.,0,1
200091,[,0,0
200092,Intra-arterial,0,0
200093,chemotherapy,0,1
200094,in,0,0
200095,advanced,0,1
200096,ovarian,0,1
200097,cancers,0,1
200098,.,0,1
200099,2,0,0
200100,.,0,0
200101,Therapeutic,0,0
200102,results,0,0
200103,in,0,0
200104,relation,0,0
200105,to,0,0
200106,prognostic,0,0
200107,factors,0,0
200108,],0,1
200109,.,0,1
200110,85,1,0
200111,patients,1,1
200112,with,1,1
200113,advanced,1,1
200114,ovarian,1,1
200115,carcinomas,1,1
200116,were,0,0
200117,treated,0,0
200118,either,0,0
200119,intra-arterially,0,0
200120,with,0,0
200121,MTX,0,0
200122,and,0,0
200123,5-FU,0,0
200124,",",0,0
200125,later,0,0
200126,systemically,0,0
200127,with,0,0
200128,the,0,0
200129,CMFV-combination,0,0
200130,(,0,0
200131,therapy,0,0
200132,arm,0,0
200133,A,0,0
200134,),0,0
200135,or,0,0
200136,only,0,0
200137,systemically,0,0
200138,(,0,0
200139,therapy,0,0
200140,arm,0,0
200141,B,0,0
200142,),0,0
200143,after,0,0
200144,randomization,0,0
200145,.,0,0
200146,The,0,0
200147,achieved,0,0
200148,rates,0,0
200149,of,0,0
200150,remission,0,1
200151,and,0,0
200152,survival,0,0
200153,time,0,0
200154,showed,0,0
200155,an,0,0
200156,obvious,0,0
200157,dependence,0,0
200158,on,0,0
200159,the,0,0
200160,histological,0,0
200161,type,0,1
200162,of,0,0
200163,tumor,0,0
200164,and,0,0
200165,on,0,0
200166,the,0,0
200167,degree,0,0
200168,of,0,0
200169,differentiation,0,0
200170,.,0,0
200171,Whereas,0,0
200172,the,0,0
200173,results,0,0
200174,of,0,0
200175,the,0,0
200176,treatment,0,0
200177,were,0,0
200178,nearly,0,0
200179,identical,0,0
200180,in,0,0
200181,both,0,0
200182,groups,0,0
200183,of,0,0
200184,treatment,0,0
200185,with,0,1
200186,badly,0,0
200187,differentiated,0,0
200188,carcinomas,0,1
200189,",",0,0
200190,a,0,0
200191,significant,0,0
200192,improvement,0,0
200193,could,0,0
200194,be,0,0
200195,achieved,0,0
200196,by,0,0
200197,the,0,0
200198,initial,0,0
200199,local,0,0
200200,treatment,0,0
200201,of,0,0
200202,well,0,0
200203,and,0,0
200204,moderately,0,0
200205,differentiated,0,1
200206,malignancies,0,1
200207,.,0,1
200208,More,0,1
200209,than,0,0
200210,one,0,0
200211,third,0,1
200212,of,0,0
200213,the,0,0
200214,cases,1,1
200215,of,1,0
200216,advanced,1,1
200217,tumors,1,1
200218,were,0,1
200219,operable,0,1
200220,by,0,0
200221,local,0,0
200222,chemotherapy,0,1
200223,.,0,0
200224,Thus,0,0
200225,the,0,0
200226,survival,0,0
200227,time,0,0
200228,could,0,0
200229,be,0,0
200230,extended,0,0
200231,.,0,0
200232,The,0,0
200233,intra-arterial,0,0
200234,chemotherapy,0,0
200235,represents,0,0
200236,an,0,0
200237,expensive,0,0
200238,",",0,0
200239,but,0,0
200240,effective,0,0
200241,method,0,0
200242,of,0,0
200243,treatment,0,0
200244,of,0,0
200245,advanced,0,1
200246,ovarian,0,1
200247,carcinomas,0,1
200248,.,0,1
200249,Deleterious,0,1
200250,effects,0,0
200251,of,0,0
200252,low-dose,0,0
200253,oestrogen,0,0
200254,therapy,0,0
200255,on,0,0
200256,coronary,0,1
200257,status,0,1
200258,in,0,0
200259,patients,1,1
200260,with,1,1
200261,prostatic,1,1
200262,cancer,1,1
200263,.,1,0
200264,The,0,0
200265,effects,0,0
200266,of,0,0
200267,oestrogen,0,0
200268,therapy,0,0
200269,and,0,0
200270,of,0,0
200271,orchidectomy,0,1
200272,on,0,0
200273,coronary,0,1
200274,status,0,0
200275,",",0,0
200276,as,0,0
200277,reflected,0,0
200278,by,0,0
200279,exercise,0,0
200280,ECG-testing,0,0
200281,before,0,0
200282,and,0,0
200283,after,0,0
200284,one,0,0
200285,year,0,0
200286,of,0,0
200287,treatment,0,0
200288,",",0,0
200289,were,0,0
200290,assessed,0,0
200291,in,0,0
200292,a,0,0
200293,randomized,0,0
200294,study,0,0
200295,of,0,0
200296,patients,1,1
200297,(,1,1
200298,N,1,1
200299,=,1,0
200300,100,1,0
200301,),1,0
200302,with,1,1
200303,prostatic,1,1
200304,cancer,1,1
200305,.,1,1
200306,Oestrogen,0,0
200307,was,0,0
200308,given,0,0
200309,as,0,0
200310,polyestradiol,0,0
200311,phosphate,0,0
200312,80,0,1
200313,mg,0,0
200314,i.m,0,0
200315,.,0,0
200316,per,0,0
200317,month,0,0
200318,in,0,0
200319,combination,0,0
200320,with,0,1
200321,150,0,0
200322,micrograms,0,0
200323,ethinylestradiol,0,1
200324,p.o,0,1
200325,.,0,0
200326,per,0,0
200327,day,0,0
200328,.,0,0
200329,There,0,0
200330,were,0,0
200331,no,0,0
200332,significant,0,0
200333,inter-group,0,0
200334,differences,0,0
200335,in,0,0
200336,conventional,0,1
200337,risk,0,1
200338,factors,0,0
200339,or,0,1
200340,in,0,0
200341,pre-treatment,0,0
200342,exercise,0,0
200343,test,0,0
200344,results,0,0
200345,.,0,1
200346,Twelve,0,1
200347,months,0,0
200348,after,0,0
200349,the,0,0
200350,start,0,0
200351,of,0,0
200352,therapy,0,0
200353,the,0,0
200354,oestrogen,0,0
200355,group,0,0
200356,showed,0,0
200357,a,0,0
200358,significantly,0,0
200359,greater,0,0
200360,depression,0,0
200361,of,0,0
200362,the,0,0
200363,ST-segment,0,0
200364,during,0,0
200365,maximal,0,0
200366,exercise,0,0
200367,in,0,0
200368,leads,0,0
200369,CH2,0,1
200370,(,0,1
200371,P,0,0
200372,less,0,0
200373,than,0,0
200374,0.0005,0,0
200375,),0,1
200376,and,0,0
200377,CH5,0,0
200378,(,0,0
200379,P,0,0
200380,less,0,0
200381,than,0,0
200382,0.01,0,0
200383,),0,0
200384,compared,0,0
200385,with,0,1
200386,the,0,0
200387,pre-treatment,0,0
200388,depression,0,1
200389,.,0,0
200390,Twenty-five,0,1
200391,per,0,0
200392,cent,0,0
200393,(,0,0
200394,N,0,1
200395,=,0,0
200396,13,0,1
200397,),0,0
200398,of,0,0
200399,the,0,0
200400,patients,0,1
200401,in,0,0
200402,the,0,0
200403,oestrogen,0,0
200404,group,0,0
200405,suffered,0,1
200406,cardiovascular,0,1
200407,complications,0,0
200408,during,0,0
200409,the,0,0
200410,year,0,0
200411,of,0,0
200412,therapy,0,0
200413,",",0,0
200414,whereas,0,0
200415,no,0,0
200416,such,0,0
200417,complications,0,0
200418,were,0,1
200419,observed,0,0
200420,in,0,0
200421,the,0,0
200422,orchidectomy,0,1
200423,group,0,0
200424,.,0,0
200425,However,0,0
200426,",",0,0
200427,even,0,0
200428,the,0,0
200429,patients,0,1
200430,in,0,0
200431,the,0,0
200432,oestrogen,0,1
200433,group,0,1
200434,who,0,1
200435,had,0,1
200436,not,0,1
200437,suffered,0,1
200438,cardiovascular,0,1
200439,complications,0,0
200440,had,0,1
200441,significantly,0,0
200442,greater,0,0
200443,depressions,0,0
200444,of,0,0
200445,the,0,0
200446,ST-segment,0,0
200447,during,0,0
200448,exercise,0,0
200449,both,0,0
200450,in,0,0
200451,lead,0,0
200452,CH2,0,0
200453,(,0,0
200454,P,0,0
200455,less,0,0
200456,than,0,0
200457,0.0005,0,0
200458,),0,0
200459,and,0,0
200460,in,0,0
200461,CH5,0,0
200462,(,0,0
200463,P,0,0
200464,less,0,0
200465,than,0,0
200466,0.05,0,0
200467,),0,1
200468,.,0,0
200469,There,0,0
200470,was,0,0
200471,no,0,0
200472,significant,0,0
200473,change,0,0
200474,in,0,0
200475,the,0,0
200476,ST-segment,0,0
200477,level,0,0
200478,in,0,0
200479,the,0,0
200480,orchidectomy,0,1
200481,group,0,0
200482,twelve,0,1
200483,months,0,0
200484,after,0,0
200485,surgery,0,1
200486,.,0,1
200487,In,0,0
200488,summary,0,0
200489,",",0,0
200490,we,0,0
200491,found,0,0
200492,evidence,0,0
200493,of,0,0
200494,an,0,0
200495,induction,0,0
200496,of,0,0
200497,myocardial,0,1
200498,ischaemia,0,0
200499,during,0,0
200500,treatment,0,0
200501,with,0,1
200502,exogenous,0,0
200503,oestrogens,0,0
200504,at,0,1
200505,low,0,1
200506,dosage,0,0
200507,in,0,0
200508,patients,1,1
200509,with,1,1
200510,prostatic,1,1
200511,cancer,1,1
200512,.,1,0
200513,This,0,0
200514,deleterious,0,0
200515,effect,0,0
200516,of,0,0
200517,oestrogen,0,0
200518,on,0,0
200519,the,0,0
200520,coronary,0,1
200521,status,0,0
200522,argues,0,0
200523,against,0,0
200524,oestrogen,0,0
200525,therapy,0,0
200526,",",0,0
200527,since,0,0
200528,oestrogen,0,0
200529,has,0,0
200530,not,0,0
200531,been,0,0
200532,shown,0,0
200533,to,0,0
200534,be,0,0
200535,more,0,0
200536,beneficial,0,0
200537,than,0,0
200538,orchidectomy,0,1
200539,against,0,0
200540,prostatic,0,1
200541,carcinoma,0,1
200542,.,0,1
200543,[,0,0
200544,Randomized,0,0
200545,cooperative,0,1
200546,studies,0,0
200547,of,0,0
200548,the,0,0
200549,surgical,0,0
200550,treatment,0,0
200551,of,0,0
200552,cancer,1,1
200553,of,1,0
200554,the,1,0
200555,thyroid,1,1
200556,gland,1,1
200557,],1,1
200558,.,0,1
200559,Zinc,0,0
200560,supplementation,0,0
200561,in,0,0
200562,alcoholic,1,1
200563,cirrhosis,1,1
200564,.,1,0
200565,A,0,0
200566,double-blind,0,0
200567,clinical,0,0
200568,trial,0,1
200569,.,0,0
200570,A,0,0
200571,double-blind,0,0
200572,clinical,0,0
200573,trial,0,0
200574,with,0,1
200575,zinc,0,0
200576,sulfate,0,0
200577,",",0,0
200578,0.2,0,0
200579,g,0,1
200580,three,0,0
200581,times,0,0
200582,daily,0,0
200583,",",0,0
200584,and,0,0
200585,a,0,0
200586,placebo,0,0
200587,was,0,0
200588,performed,0,0
200589,in,0,0
200590,30,1,1
200591,patients,1,1
200592,with,1,1
200593,biopsy-proven,1,1
200594,alcoholic,1,1
200595,liver,1,1
200596,cirrhosis,1,1
200597,.,1,0
200598,The,0,0
200599,disease,0,0
200600,was,0,0
200601,in,0,0
200602,a,0,0
200603,stable,0,1
200604,phase,0,0
200605,",",0,0
200606,and,0,0
200607,none,0,0
200608,of,0,0
200609,the,0,0
200610,patients,0,1
200611,showed,0,0
200612,evidence,0,0
200613,of,0,0
200614,a,0,0
200615,decompensated,0,1
200616,liver,0,1
200617,function,0,0
200618,.,0,0
200619,Parameters,0,0
200620,of,0,0
200621,liver,0,1
200622,function,0,0
200623,",",0,0
200624,taste,0,0
200625,acuity,0,0
200626,",",0,0
200627,dark,0,0
200628,adaptation,0,0
200629,and,0,0
200630,of,0,0
200631,zinc,0,0
200632,and,0,0
200633,vitamin,0,0
200634,A,0,0
200635,metabolism,0,0
200636,were,0,0
200637,followed,0,0
200638,for,0,0
200639,six,0,1
200640,weeks,0,0
200641,.,0,1
200642,In,0,0
200643,the,0,0
200644,zinc-treated,0,0
200645,group,0,0
200646,of,0,0
200647,16,0,1
200648,patients,0,1
200649,",",0,0
200650,serum,0,0
200651,zinc,0,0
200652,rose,0,0
200653,from,0,0
200654,a,0,0
200655,normal,0,1
200656,mean,0,0
200657,value,0,0
200658,of,0,0
200659,13.3,0,0
200660,to,0,1
200661,17.4,0,0
200662,mumol/l,0,0
200663,",",0,0
200664,whereas,0,0
200665,the,0,0
200666,mean,0,0
200667,serum,0,0
200668,vitamin,0,0
200669,A,0,0
200670,level,0,0
200671,remained,0,0
200672,practically,0,0
200673,unaltered,0,0
200674,within,0,0
200675,the,0,0
200676,normal,0,0
200677,range,0,0
200678,",",0,0
200679,1.89,0,0
200680,at,0,0
200681,the,0,0
200682,entry,0,0
200683,and,0,0
200684,1.83,0,0
200685,mumol/l,0,0
200686,at,0,0
200687,the,0,0
200688,end,0,0
200689,of,0,0
200690,the,0,0
200691,study,0,0
200692,.,0,0
200693,Plasma,0,0
200694,prothrombin,0,0
200695,and,0,0
200696,serum,0,0
200697,alkaline,0,0
200698,phosphatase,0,0
200699,levels,0,0
200700,of,0,0
200701,the,0,0
200702,zinc,0,0
200703,group,0,0
200704,increased,0,0
200705,and,0,0
200706,serum,0,0
200707,bilirubin,0,0
200708,and,0,0
200709,serum,0,0
200710,carotene,0,0
200711,decreased,0,0
200712,significantly,0,0
200713,.,0,0
200714,The,0,0
200715,dark,0,0
200716,adaptation,0,0
200717,did,0,0
200718,not,0,0
200719,change,0,0
200720,",",0,0
200721,but,0,0
200722,the,0,0
200723,taste,0,0
200724,function,0,0
200725,was,0,0
200726,significantly,0,0
200727,improved,0,0
200728,during,0,0
200729,zinc,0,0
200730,treatment,0,0
200731,.,0,0
200732,The,0,0
200733,results,0,0
200734,indicate,0,0
200735,that,0,0
200736,zinc,0,0
200737,supplementation,0,0
200738,causes,0,0
200739,alleviation,0,0
200740,of,0,0
200741,certain,0,0
200742,abnormalities,0,1
200743,of,0,0
200744,cirrhotics,1,1
200745,",",0,0
200746,which,0,0
200747,deserves,0,0
200748,further,0,0
200749,attention,0,0
200750,.,0,1
200751,Parietal,0,0
200752,cell,0,0
200753,density,0,0
200754,in,0,0
200755,duodenal,1,1
200756,ulcer,1,1
200757,patients,1,1
200758,after,1,0
200759,short-term,1,0
200760,treatment,1,0
200761,with,1,1
200762,cimetidine,1,0
200763,and,1,1
200764,antacids,1,0
200765,.,1,1
200766,In,0,0
200767,a,0,0
200768,prospective,0,0
200769,study,0,0
200770,",",0,0
200771,20,1,0
200772,patients,1,1
200773,with,1,1
200774,endoscopically,1,1
200775,proven,1,1
200776,duodenal,1,1
200777,ulcers,1,1
200778,were,0,1
200779,randomised,0,0
200780,to,0,0
200781,be,0,0
200782,treated,0,1
200783,with,0,1
200784,cimetidine,0,0
200785,1,0,0
200786,g,0,1
200787,daily,0,0
200788,or,0,1
200789,with,0,1
200790,antacids,0,0
200791,350,0,1
200792,mmol,0,0
200793,daily,0,0
200794,.,0,0
200795,The,0,0
200796,duration,0,0
200797,of,0,0
200798,treatment,0,0
200799,was,0,0
200800,30,0,1
200801,days,0,0
200802,",",0,0
200803,but,0,0
200804,this,0,0
200805,was,0,0
200806,extended,0,0
200807,to,0,0
200808,three,0,0
200809,months,0,0
200810,in,0,1
200811,3,0,1
200812,patients,0,1
200813,in,0,0
200814,the,0,0
200815,cimetidine,0,0
200816,group,0,0
200817,and,0,0
200818,4,0,0
200819,patients,0,1
200820,in,0,0
200821,the,0,0
200822,antacid,0,0
200823,group,0,0
200824,.,0,0
200825,A,0,0
200826,morphological,0,0
200827,study,0,0
200828,of,0,0
200829,biopsies,0,0
200830,taken,0,0
200831,via,0,0
200832,a,0,0
200833,gastroscope,0,0
200834,from,0,0
200835,the,0,0
200836,corpus,0,0
200837,mucosa,0,1
200838,showed,0,0
200839,no,0,0
200840,change,0,0
200841,in,0,0
200842,mucosal,0,0
200843,height,0,0
200844,",",0,0
200845,parietal,0,0
200846,cell,0,0
200847,density,0,0
200848,per,0,0
200849,unit,0,0
200850,volume,0,0
200851,or,0,1
200852,changes,0,0
200853,in,0,0
200854,cellular,0,0
200855,infiltration,0,0
200856,after,0,0
200857,30,0,1
200858,and,0,1
200859,90,0,1
200860,days,0,0
200861,treatment,0,0
200862,in,0,0
200863,the,0,0
200864,two,0,0
200865,groups,0,0
200866,.,0,1
200867,Neither,0,0
200868,H-2,0,0
200869,receptor,0,1
200870,blockers,0,0
200871,nor,0,0
200872,antacids,0,0
200873,alter,0,0
200874,mucosal,0,0
200875,height,0,0
200876,or,0,1
200877,parietal,0,0
200878,cell,0,1
200879,density,0,0
200880,.,0,1
200881,Treatment,0,0
200882,was,0,0
200883,not,0,0
200884,found,0,0
200885,to,0,0
200886,induce,0,0
200887,gastritic,0,1
200888,changes,0,0
200889,in,0,0
200890,the,0,0
200891,mucosa,0,1
200892,.,0,0
200893,Butorphanol,0,0
200894,and,0,0
200895,meperidine,0,0
200896,compared,0,0
200897,in,0,0
200898,patients,1,1
200899,with,1,1
200900,acute,1,1
200901,ureteral,1,1
200902,colic,1,1
200903,.,1,1
200904,Pain,0,0
200905,relief,0,0
200906,was,0,0
200907,evaluated,0,0
200908,in,0,0
200909,81,1,1
200910,patients,1,1
200911,with,1,1
200912,acute,1,1
200913,ureteral,1,1
200914,colic,1,1
200915,and,1,0
200916,the,1,0
200917,confirmed,1,0
200918,presence,1,0
200919,of,1,0
200920,a,1,0
200921,calculus,1,1
200922,.,1,0
200923,A,0,0
200924,randomized,1,0
200925,double-blind,1,0
200926,comparison,1,0
200927,of,1,0
200928,intramuscular,1,0
200929,2,1,1
200930,and,1,0
200931,4,1,0
200932,mg.,1,0
200933,butorphanol,1,0
200934,and,1,0
200935,80,1,1
200936,mg.,1,0
200937,meperidine,1,0
200938,was,1,0
200939,used,1,0
200940,.,1,0
200941,Pain,0,0
200942,intensity,0,0
200943,and,0,0
200944,pain,0,0
200945,relief,0,0
200946,were,0,0
200947,evaluated,0,0
200948,at,0,0
200949,half,0,1
200950,hour,0,0
200951,and,0,0
200952,hourly,0,0
200953,intervals,0,0
200954,for,0,1
200955,4,0,1
200956,hours,0,0
200957,.,0,1
200958,A,0,0
200959,2,0,0
200960,mg.,0,0
200961,dose,0,0
200962,of,0,0
200963,butorphanol,0,0
200964,was,0,0
200965,found,0,0
200966,to,0,0
200967,be,0,0
200968,analgesically,0,1
200969,equivalent,0,0
200970,to,0,0
200971,80,0,1
200972,mg.,0,0
200973,meperidine,0,0
200974,",",0,0
200975,while,0,0
200976,a,0,0
200977,4,0,0
200978,mg.,0,0
200979,dose,0,0
200980,of,0,0
200981,butorphanol,0,0
200982,was,0,0
200983,found,0,0
200984,to,0,0
200985,be,0,0
200986,more,0,0
200987,effective,0,0
200988,than,0,0
200989,80,0,1
200990,mg.,0,0
200991,meperidine,0,0
200992,and,0,0
200993,2,0,0
200994,mg.,0,0
200995,butorphanol,0,0
200996,.,0,0
200997,Each,0,0
200998,patient,0,0
200999,received,0,0
201000,up,0,0
201001,to,0,0
201002,2,0,0
201003,doses,0,0
201004,of,0,0
201005,analgesic,0,0
201006,medication,0,0
201007,when,0,0
201008,necessary,0,0
201009,.,0,0
201010,There,0,0
201011,was,0,0
201012,no,0,0
201013,significant,0,0
201014,difference,0,0
201015,in,0,0
201016,the,0,0
201017,incidence,0,0
201018,of,0,0
201019,side,0,0
201020,effects,0,0
201021,among,0,1
201022,treatments,0,0
201023,.,0,1
201024,One,0,1
201025,patient,0,0
201026,had,0,1
201027,visual,0,0
201028,hallucinations,0,0
201029,after,0,0
201030,a,0,1
201031,2,0,0
201032,mg.,0,0
201033,dose,0,0
201034,of,0,0
201035,butorphanol,0,0
201036,",",0,0
201037,possibly,0,0
201038,owing,0,0
201039,to,0,0
201040,its,0,0
201041,antagonistic,0,0
201042,activity,0,0
201043,to,0,0
201044,significant,0,0
201045,narcotic,0,1
201046,experience,0,0
201047,given,0,0
201048,previously,0,0
201049,at,0,0
201050,another,0,0
201051,hospital,0,1
201052,.,0,0
201053,There,0,0
201054,was,0,0
201055,no,0,0
201056,other,0,0
201057,evidence,0,0
201058,of,0,0
201059,toxicity,0,0
201060,with,0,1
201061,butorphanol,0,0
201062,.,0,1
201063,It,0,0
201064,was,0,0
201065,found,0,0
201066,to,0,0
201067,be,0,0
201068,a,0,0
201069,safe,0,0
201070,",",0,0
201071,effective,0,0
201072,and,0,0
201073,wall,0,1
201074,tolerated,0,0
201075,drug,0,0
201076,for,0,0
201077,the,0,0
201078,treatment,0,0
201079,of,0,0
201080,ureteral,0,1
201081,colic,0,1
201082,and,0,0
201083,is,0,0
201084,recommended,0,0
201085,in,0,0
201086,place,0,0
201087,of,0,0
201088,narcotics,0,1
201089,.,0,1
201090,Comparison,0,0
201091,of,0,0
201092,maintenance,0,0
201093,treatment,0,0
201094,regimens,0,0
201095,for,0,0
201096,first,0,0
201097,central,1,1
201098,nervous,1,0
201099,system,1,0
201100,relapse,1,0
201101,in,1,0
201102,children,1,1
201103,with,1,1
201104,acute,1,1
201105,lymphocytic,1,1
201106,leukemia,1,1
201107,.,1,0
201108,A,0,0
201109,Pediatric,0,1
201110,Oncology,0,1
201111,Group,0,1
201112,study,0,1
201113,.,0,1
201114,Eighty-seven,1,1
201115,children,1,1
201116,with,1,1
201117,central,1,1
201118,nervous,1,0
201119,system,1,0
201120,(,1,0
201121,CNS,1,0
201122,),1,0
201123,leukemia,1,1
201124,were,0,0
201125,randomized,0,0
201126,to,0,0
201127,receive,0,0
201128,either,0,0
201129,induction,0,0
201130,intrathecal,0,0
201131,chemotherapy,0,1
201132,(,0,0
201133,ITC,0,0
201134,),0,0
201135,and,0,0
201136,cranial,0,0
201137,irradiation,0,0
201138,(,0,0
201139,CRT,0,1
201140,),0,0
201141,plus,0,0
201142,maintenance,0,0
201143,ITC,0,0
201144,",",0,0
201145,or,0,0
201146,induction,0,0
201147,ITC,0,0
201148,and,0,0
201149,craniospinal,0,0
201150,irradiation,0,0
201151,(,0,0
201152,CSpRT,0,0
201153,),0,0
201154,with,0,1
201155,no,0,0
201156,maintenance,0,0
201157,ITC,0,0
201158,.,0,1
201159,ITC,0,0
201160,consisted,0,1
201161,of,0,0
201162,six,0,1
201163,weekly,0,0
201164,injections,0,0
201165,of,0,0
201166,methotrexate,0,0
201167,",",0,0
201168,hydrocortisone,0,0
201169,",",0,0
201170,and,0,0
201171,arabinosylcytosine,0,0
201172,.,0,0
201173,Also,0,0
201174,",",0,0
201175,intensification,0,0
201176,of,0,0
201177,systemic,0,0
201178,induction,0,1
201179,and,0,0
201180,maintenance,0,0
201181,chemotherapy,0,0
201182,was,0,0
201183,given,0,0
201184,.,0,1
201185,CRT,0,0
201186,+,0,0
201187,ITC,0,0
201188,was,0,0
201189,given,0,0
201190,as,0,0
201191,CRT,0,1
201192,",",0,0
201193,2400,0,0
201194,rad,0,0
201195,in,0,0
201196,12,0,1
201197,fractions,0,0
201198,followed,0,0
201199,by,0,0
201200,ITC,0,0
201201,maintenance,0,0
201202,bimonthly,0,0
201203,for,0,0
201204,2,0,1
201205,years,0,1
201206,.,0,1
201207,Craniospinal,0,0
201208,irradiation,0,0
201209,consisted,0,1
201210,of,0,0
201211,CRT,0,1
201212,+,0,0
201213,1400,0,1
201214,rad,0,0
201215,in,0,0
201216,ten,0,1
201217,fractions,0,0
201218,to,0,0
201219,the,0,0
201220,spine,0,0
201221,.,0,0
201222,Randomization,0,0
201223,was,0,0
201224,stratified,0,1
201225,according,0,0
201226,to,0,0
201227,whether,0,0
201228,CNS,0,0
201229,leukemia,0,1
201230,occurred,0,0
201231,at,0,0
201232,initial,0,0
201233,diagnosis,0,1
201234,of,0,0
201235,acute,0,1
201236,lymphocytic,0,1
201237,leukemia,0,1
201238,(,0,0
201239,ALL,0,0
201240,),0,0
201241,(,0,0
201242,Stratum,0,0
201243,I,0,1
201244,",",0,0
201245,15,0,1
201246,patients,0,1
201247,),0,0
201248,",",0,0
201249,during,0,0
201250,first,0,0
201251,bone,0,0
201252,marrow,0,1
201253,(,0,0
201254,BM,0,1
201255,),0,0
201256,remission,0,0
201257,(,0,0
201258,Stratum,0,0
201259,II,0,1
201260,",",0,0
201261,49,0,1
201262,patients,0,1
201263,),0,1
201264,",",0,0
201265,simultaneous,0,0
201266,with,0,1
201267,first,0,0
201268,BM,0,1
201269,relapse,0,0
201270,(,0,0
201271,Stratum,0,0
201272,III,0,1
201273,",",0,0
201274,12,0,0
201275,patients,0,1
201276,),0,0
201277,",",0,0
201278,or,0,0
201279,during,0,0
201280,second,0,0
201281,BM,0,1
201282,remission,0,0
201283,(,0,0
201284,Stratum,0,0
201285,IV,0,0
201286,",",0,0
201287,11,0,0
201288,patients,0,1
201289,),0,1
201290,.,0,1
201291,The,0,0
201292,median,0,0
201293,follow-up,0,0
201294,for,0,1
201295,patients,0,1
201296,who,0,1
201297,remain,0,1
201298,at,0,1
201299,risk,0,0
201300,is,0,0
201301,15,0,0
201302,+,0,0
201303,months,0,0
201304,.,0,1
201305,Eight,0,0
201306,children,0,1
201307,(,0,1
201308,seven,0,1
201309,on,0,0
201310,CRT,0,1
201311,+,0,0
201312,ITC,0,0
201313,",",0,0
201314,one,0,0
201315,on,0,0
201316,CSpRT,0,1
201317,),0,0
201318,developed,0,0
201319,presumed,0,1
201320,therapy,0,0
201321,related,0,0
201322,encephalopathy,0,0
201323,.,0,0
201324,In,0,0
201325,Stratum,0,0
201326,II,0,1
201327,",",0,0
201328,16,0,1
201329,of,0,0
201330,29,0,1
201331,(,0,1
201332,55,0,1
201333,%,0,0
201334,),0,1
201335,patients,0,1
201336,receiving,0,1
201337,CRT,0,1
201338,+,0,0
201339,ITC,0,0
201340,experienced,0,0
201341,adverse,0,0
201342,events,0,0
201343,:,0,1
201344,3,0,0
201345,deaths,0,0
201346,during,0,0
201347,continuous,0,0
201348,complete,0,1
201349,remission,0,1
201350,(,0,0
201351,CCR,0,1
201352,),0,0
201353,and,0,0
201354,13,0,1
201355,relapses,0,0
201356,(,0,1
201357,2,0,0
201358,CNS,0,0
201359,",",0,0
201360,1,0,0
201361,CNS,0,0
201362,+,0,0
201363,BM,0,1
201364,",",0,0
201365,1,0,0
201366,BM,0,0
201367,+,0,0
201368,testes,0,1
201369,",",0,0
201370,and,0,0
201371,2,0,0
201372,testes,0,1
201373,),0,1
201374,as,0,0
201375,compared,0,0
201376,with,0,1
201377,only,0,0
201378,5,0,0
201379,relapses,0,0
201380,in,0,1
201381,20,0,1
201382,(,0,1
201383,25,0,1
201384,%,0,0
201385,),0,0
201386,patients,0,1
201387,on,0,0
201388,CSpRT,0,1
201389,(,0,1
201390,1,0,0
201391,CNS,0,0
201392,",",0,0
201393,1,0,0
201394,CNS,0,0
201395,+,0,0
201396,BM,0,1
201397,",",0,0
201398,1,0,0
201399,BM,0,0
201400,",",0,0
201401,and,0,0
201402,2,0,0
201403,testes,0,1
201404,),0,1
201405,.,0,1
201406,The,0,0
201407,children,0,1
201408,on,0,0
201409,both,0,0
201410,regimens,0,0
201411,were,0,0
201412,comparable,0,0
201413,for,0,0
201414,sex,0,0
201415,",",0,0
201416,race,0,0
201417,",",0,0
201418,age,0,1
201419,at,0,0
201420,initial,0,0
201421,ALL,0,0
201422,diagnosis,0,1
201423,",",0,0
201424,time,0,0
201425,from,0,0
201426,ALL,0,0
201427,diagnosis,0,1
201428,to,0,0
201429,first,0,0
201430,episode,0,1
201431,of,0,0
201432,CNS,0,0
201433,leukemia,0,1
201434,",",0,0
201435,systemic,0,0
201436,therapy,0,0
201437,both,0,0
201438,before,0,0
201439,and,0,0
201440,after,0,0
201441,CNS,0,0
201442,relapse,0,0
201443,",",0,0
201444,and,0,0
201445,number,0,0
201446,of,0,0
201447,blasts,0,1
201448,in,0,0
201449,the,0,0
201450,spinal,0,1
201451,fluid,0,0
201452,at,0,0
201453,diagnosis,0,1
201454,of,0,0
201455,CNS,0,0
201456,leukemia,0,1
201457,.,0,0
201458,The,0,0
201459,conclusion,0,0
201460,is,0,0
201461,that,0,0
201462,children,0,1
201463,with,0,1
201464,isolated,0,1
201465,CNS,0,0
201466,leukemia,0,1
201467,can,0,0
201468,achieve,0,0
201469,prolonged,0,0
201470,survival,0,0
201471,with,0,1
201472,aggressive,0,1
201473,therapy,0,0
201474,",",0,0
201475,and,0,0
201476,that,0,0
201477,CSpRT,0,0
201478,is,0,0
201479,possibly,0,0
201480,less,0,0
201481,toxic,0,0
201482,and,0,0
201483,more,0,0
201484,likely,0,0
201485,than,0,0
201486,is,0,0
201487,CRT,0,1
201488,+,0,0
201489,ITC,0,0
201490,to,0,0
201491,prevent,0,0
201492,subsequent,0,0
201493,BM,0,1
201494,and,0,0
201495,testicular,0,1
201496,relapse,0,0
201497,(,0,0
201498,P,0,0
201499,less,0,0
201500,than,0,0
201501,0.02,0,0
201502,),0,0
201503,",",0,0
201504,but,0,0
201505,not,0,0
201506,subsequent,0,0
201507,CNS,0,0
201508,relapse,0,0
201509,(,0,0
201510,P,0,0
201511,=,0,0
201512,0.7,0,0
201513,),0,0
201514,.,0,0
201515,A,0,0
201516,possible,0,0
201517,systemic,0,0
201518,therapy,0,0
201519,effect,0,0
201520,of,0,0
201521,spinal,0,1
201522,irradiation,0,0
201523,is,0,0
201524,postulated,0,0
201525,to,0,0
201526,explain,0,0
201527,the,0,0
201528,superiority,0,0
201529,of,0,0
201530,CSpRT,0,1
201531,.,0,1
201532,A,0,0
201533,randomized,0,0
201534,comparative,0,0
201535,trial,0,0
201536,of,0,0
201537,combined,0,0
201538,versus,0,0
201539,alternating,0,0
201540,therapy,0,0
201541,with,0,1
201542,cytostatic,0,0
201543,drugs,0,0
201544,and,0,1
201545,high-dose,0,0
201546,medroxyprogesteron,0,0
201547,acetate,0,0
201548,in,0,0
201549,advanced,1,1
201550,breast,1,1
201551,cancer,1,1
201552,.,1,0
201553,A,0,0
201554,prospective,0,0
201555,multicenter,0,0
201556,trial,0,0
201557,was,0,0
201558,conducted,0,0
201559,in,0,0
201560,155,1,1
201561,consecutive,1,1
201562,patients,1,1
201563,with,1,1
201564,Stage,1,1
201565,IV,1,0
201566,breast,1,1
201567,cancer,1,1
201568,randomly,1,1
201569,allocated,1,0
201570,to,1,0
201571,receive,1,0
201572,either,1,0
201573,(,1,0
201574,1,1,0
201575,),1,0
201576,vincristin,1,0
201577,(,1,0
201578,V,1,0
201579,),1,1
201580,1.2,1,0
201581,mg/m2,1,0
201582,(,1,0
201583,maximum,1,0
201584,dose,1,0
201585,",",1,0
201586,2,1,0
201587,mg,1,0
201588,),1,0
201589,",",1,0
201590,Adriamycin,1,0
201591,(,1,0
201592,A,1,1
201593,),1,0
201594,(,1,0
201595,doxorubicin,1,0
201596,),1,0
201597,40,1,1
201598,mg/m2,1,0
201599,",",1,0
201600,and,1,0
201601,cyclophosphamide,1,0
201602,(,1,0
201603,C,1,0
201604,),1,1
201605,500,1,0
201606,mg/m2,1,0
201607,",",1,0
201608,all,1,0
201609,intravenously,1,0
201610,on,1,0
201611,day,1,0
201612,1,1,0
201613,",",1,0
201614,every,1,0
201615,4,1,0
201616,weeks,1,0
201617,",",1,0
201618,in,1,0
201619,combination,1,0
201620,with,1,1
201621,medroxyprogesteron,1,0
201622,acetate,1,0
201623,(,1,0
201624,MPA,1,0
201625,),1,1
201626,600,1,0
201627,mg,1,0
201628,orally,1,0
201629,on,1,0
201630,days,1,0
201631,1,1,1
201632,through,1,0
201633,14,1,1
201634,",",1,0
201635,500,1,0
201636,mg,1,0
201637,intramuscularly,1,1
201638,on,1,0
201639,days,1,0
201640,1,1,1
201641,through,1,0
201642,28,1,1
201643,",",1,0
201644,and,1,0
201645,twice,1,0
201646,weekly,1,0
201647,afterwards,1,0
201648,(,1,0
201649,combined,1,0
201650,chemoendocrine,1,1
201651,approach,1,0
201652,),1,0
201653,or,1,1
201654,(,1,0
201655,2,1,0
201656,),1,0
201657,the,1,0
201658,same,1,0
201659,combination,1,0
201660,chemotherapy,1,1
201661,(,1,0
201662,VAC,1,1
201663,),1,0
201664,for,1,0
201665,three,1,0
201666,cycles,1,0
201667,alternating,1,0
201668,with,1,1
201669,MPA,1,0
201670,in,1,0
201671,the,1,0
201672,above-mentioned,1,0
201673,dosage,1,0
201674,during,1,0
201675,8,1,0
201676,weeks,1,0
201677,(,1,1
201678,alternating,1,0
201679,chemoendocrine,1,1
201680,approach,1,1
201681,),1,0
201682,.,0,0
201683,Results,0,0
201684,show,0,0
201685,an,0,0
201686,overall,0,0
201687,response,0,0
201688,rate,0,0
201689,of,0,0
201690,73,0,1
201691,%,0,0
201692,with,0,1
201693,26,0,1
201694,%,0,0
201695,complete,0,1
201696,responses,0,0
201697,in,0,0
201698,the,0,0
201699,combined,0,0
201700,treatment,0,0
201701,arm,0,0
201702,",",0,0
201703,whereas,0,0
201704,in,0,0
201705,the,0,0
201706,alternating,0,0
201707,arm,0,0
201708,",",0,0
201709,an,0,0
201710,overall,0,0
201711,response,0,0
201712,rate,0,0
201713,of,0,0
201714,76,0,1
201715,%,0,0
201716,with,0,1
201717,20,0,1
201718,%,0,0
201719,complete,0,1
201720,responses,0,0
201721,was,0,0
201722,observed,0,0
201723,.,0,0
201724,In,0,0
201725,patients,1,1
201726,with,1,1
201727,more,1,0
201728,than,1,0
201729,one,1,0
201730,metastatic,1,1
201731,site,1,0
201732,",",0,0
201733,response,0,0
201734,rate,0,0
201735,was,0,0
201736,higher,0,0
201737,in,0,0
201738,the,0,0
201739,combination,0,0
201740,treatment,0,0
201741,",",0,0
201742,and,0,0
201743,only,0,0
201744,in,0,0
201745,this,0,0
201746,arm,0,0
201747,were,0,0
201748,complete,0,1
201749,responses,0,0
201750,observed,0,0
201751,in,0,0
201752,these,0,0
201753,patients,0,1
201754,.,0,0
201755,Although,0,0
201756,the,0,0
201757,median,0,0
201758,duration,0,0
201759,of,0,0
201760,response,0,0
201761,was,0,0
201762,long,0,0
201763,in,0,0
201764,both,0,0
201765,treatment,0,0
201766,arms,0,0
201767,(,0,0
201768,combination,0,0
201769,",",0,0
201770,19,0,1
201771,months,0,0
201772,versus,0,0
201773,alternating,0,0
201774,",",0,0
201775,21,0,1
201776,months,0,0
201777,),0,0
201778,",",0,0
201779,the,0,0
201780,median,0,0
201781,overall,0,0
201782,survival,0,0
201783,in,0,0
201784,both,0,0
201785,groups,0,0
201786,was,0,0
201787,not,0,0
201788,definitely,0,0
201789,prolonged,0,0
201790,(,0,0
201791,22,0,1
201792,versus,0,0
201793,24,0,1
201794,months,0,0
201795,",",0,0
201796,respectively,0,0
201797,),0,0
201798,.,0,0
201799,However,0,0
201800,",",0,0
201801,results,0,0
201802,in,0,0
201803,subsets,0,1
201804,of,0,1
201805,patients,0,1
201806,suggest,0,0
201807,that,0,0
201808,the,0,0
201809,alternating,0,0
201810,chemoendocrine,0,0
201811,approach,0,0
201812,may,0,0
201813,be,0,0
201814,better,0,0
201815,for,0,0
201816,estrogen,1,0
201817,receptor,1,0
201818,(,1,0
201819,ER,1,1
201820,),1,1
201821,-negative,1,1
201822,patients,1,1
201823,",",0,0
201824,for,0,0
201825,patients,1,1
201826,younger,1,1
201827,than,1,0
201828,51,1,1
201829,years,1,1
201830,of,1,0
201831,age,1,1
201832,",",0,0
201833,and,0,0
201834,for,0,0
201835,patients,1,1
201836,with,1,1
201837,a,1,0
201838,disease-free,1,0
201839,interval,1,0
201840,of,1,0
201841,1,1,0
201842,year,1,0
201843,or,1,1
201844,less,1,0
201845,.,1,0
201846,Patients,1,1
201847,with,1,1
201848,these,1,0
201849,parameters,1,0
201850,probably,1,0
201851,belong,1,0
201852,to,1,0
201853,the,1,0
201854,same,1,0
201855,population,1,1
201856,.,1,0
201857,It,0,0
201858,is,0,0
201859,concluded,0,0
201860,that,0,0
201861,combination,0,0
201862,of,0,0
201863,chemotherapy,0,0
201864,and,0,0
201865,high-dose,0,0
201866,MPA,0,0
201867,may,0,0
201868,be,0,0
201869,indicated,0,0
201870,in,0,0
201871,ER-positive,0,1
201872,patients,0,1
201873,when,0,0
201874,a,0,0
201875,clinical,0,0
201876,response,0,0
201877,is,0,0
201878,urgently,0,0
201879,needed,0,0
201880,.,0,0
201881,In,0,0
201882,ER-negative,0,1
201883,patients,0,1
201884,",",0,0
201885,the,0,0
201886,alternating,0,0
201887,use,0,0
201888,of,0,0
201889,both,0,0
201890,treatment,0,0
201891,modalities,0,0
201892,deserves,0,0
201893,further,0,0
201894,investigation,0,0
201895,.,0,1
201896,Rapid,0,0
201897,tightening,0,0
201898,of,0,0
201899,blood,0,0
201900,glucose,0,0
201901,control,0,0
201902,leads,0,0
201903,to,0,0
201904,transient,0,0
201905,deterioration,0,0
201906,of,0,0
201907,retinopathy,0,1
201908,in,0,0
201909,insulin,1,0
201910,dependent,1,0
201911,diabetes,1,1
201912,mellitus,1,1
201913,:,1,1
201914,the,0,0
201915,Oslo,1,1
201916,study,1,0
201917,.,1,0
201918,In,0,0
201919,a,0,0
201920,study,0,0
201921,of,0,0
201922,retinopathy,1,1
201923,during,1,0
201924,one,1,0
201925,year,1,1
201926,of,1,0
201927,tight,1,0
201928,blood,1,0
201929,glucose,1,0
201930,control,1,0
201931,45,1,1
201932,type,1,1
201933,I,1,1
201934,(,1,0
201935,insulin,1,0
201936,dependent,1,1
201937,),1,0
201938,diabetics,1,1
201939,without,1,1
201940,proliferative,1,1
201941,retinopathy,1,1
201942,were,0,0
201943,randomised,0,0
201944,to,0,0
201945,receive,0,0
201946,either,0,0
201947,continuous,0,0
201948,subcutaneous,0,0
201949,insulin,0,0
201950,infusion,0,0
201951,",",0,0
201952,multiple,0,0
201953,insulin,0,0
201954,injections,0,0
201955,",",0,0
201956,or,0,1
201957,conventional,0,0
201958,insulin,0,0
201959,treatment,0,0
201960,(,0,0
201961,controls,0,1
201962,),0,1
201963,.,0,1
201964,Near,0,0
201965,normoglycaemia,0,0
201966,was,0,0
201967,achieved,0,0
201968,with,0,1
201969,continuous,0,0
201970,infusion,0,0
201971,and,0,0
201972,multiple,0,0
201973,injections,0,0
201974,but,0,0
201975,not,0,0
201976,with,0,1
201977,conventional,0,0
201978,treatment,0,0
201979,.,0,1
201980,Blind,0,0
201981,evaluation,0,0
201982,of,0,0
201983,fluorescein,0,0
201984,angiograms,0,0
201985,performed,0,0
201986,three,0,1
201987,monthly,0,0
201988,showed,0,0
201989,progression,0,0
201990,of,0,0
201991,retinopathy,0,1
201992,in,0,0
201993,the,0,0
201994,control,0,0
201995,group,0,0
201996,",",0,0
201997,transient,0,0
201998,deterioration,0,0
201999,in,0,0
202000,the,0,0
202001,continuous,0,0
202002,infusion,0,0
202003,group,0,0
202004,",",0,0
202005,and,0,0
202006,no,0,0
202007,change,0,0
202008,in,0,0
202009,the,0,0
202010,multiple,0,0
202011,injection,0,0
202012,group,0,0
202013,.,0,0
202014,Half,0,0
202015,the,0,0
202016,patients,0,1
202017,receiving,0,1
202018,continuous,0,0
202019,infusion,0,0
202020,and,0,0
202021,multiple,0,0
202022,injections,0,0
202023,developed,0,1
202024,retinal,0,1
202025,cotton,0,1
202026,wool,0,0
202027,spots,0,0
202028,after,0,0
202029,three,0,1
202030,to,0,1
202031,six,0,1
202032,months,0,0
202033,.,0,1
202034,These,0,0
202035,changes,0,0
202036,regressed,0,0
202037,in,0,0
202038,all,0,0
202039,but,0,0
202040,four,0,0
202041,patients,0,1
202042,after,0,1
202043,12,0,1
202044,months,0,0
202045,.,0,1
202046,Control,0,1
202047,patients,0,1
202048,did,0,0
202049,not,0,0
202050,develop,0,0
202051,cotton,0,0
202052,wool,0,0
202053,spots,0,0
202054,.,0,1
202055,Patients,0,1
202056,who,0,1
202057,developed,0,1
202058,cotton,0,1
202059,wool,0,0
202060,spots,0,0
202061,are,0,0
202062,characterised,0,0
202063,by,0,0
202064,a,0,0
202065,larger,0,0
202066,decrement,0,0
202067,in,0,0
202068,glycosylated,0,0
202069,haemoglobin,0,1
202070,and,0,0
202071,blood,0,0
202072,glucose,0,0
202073,values,0,0
202074,",",0,0
202075,more,0,0
202076,frequent,0,0
202077,episodes,0,0
202078,of,0,0
202079,hypoglycaemia,0,0
202080,",",0,0
202081,a,0,0
202082,longer,0,0
202083,duration,0,0
202084,of,0,0
202085,diabetes,0,1
202086,",",0,0
202087,and,0,0
202088,more,0,0
202089,severe,0,1
202090,retinopathy,0,0
202091,at,0,0
202092,onset,0,1
202093,.,0,0
202094,A,0,0
202095,large,0,1
202096,and,0,0
202097,rapid,0,0
202098,fall,0,0
202099,in,0,0
202100,blood,0,0
202101,glucose,0,0
202102,concentration,0,0
202103,may,0,0
202104,promote,0,0
202105,transient,0,0
202106,deterioration,0,0
202107,of,0,0
202108,diabetic,0,1
202109,retinopathy,0,1
202110,.,0,1
202111,Zinc,0,0
202112,and,0,0
202113,copper,0,0
202114,balances,0,0
202115,in,0,0
202116,preterm,1,1
202117,infants,1,1
202118,.,1,1
202119,Preterm,1,1
202120,infants,1,1
202121,are,0,0
202122,at,0,0
202123,risk,0,0
202124,for,0,0
202125,copper,0,0
202126,and,0,0
202127,zinc,0,0
202128,depletion,0,0
202129,if,0,0
202130,sufficient,0,0
202131,quantities,0,0
202132,of,0,0
202133,these,0,0
202134,nutrients,0,0
202135,are,0,0
202136,not,0,0
202137,provided,0,0
202138,in,0,0
202139,a,0,0
202140,bioavailable,0,0
202141,form,0,0
202142,in,0,0
202143,postnatal,0,0
202144,life,0,0
202145,.,0,0
202146,The,0,0
202147,purpose,0,0
202148,of,0,0
202149,this,0,0
202150,study,0,0
202151,was,0,0
202152,to,0,0
202153,determine,0,0
202154,whether,0,0
202155,the,0,0
202156,use,0,0
202157,of,0,0
202158,a,0,0
202159,whey-predominant,0,1
202160,",",0,0
202161,50,0,1
202162,%,0,0
202163,medium,0,0
202164,chain,0,0
202165,triglyceride,0,0
202166,formula,0,0
202167,with,0,1
202168,relatively,0,0
202169,high,0,1
202170,concentrations,0,0
202171,of,0,0
202172,zinc,0,0
202173,and,0,0
202174,copper,0,0
202175,would,0,0
202176,promote,0,0
202177,the,0,0
202178,achievement,0,0
202179,of,0,0
202180,the,0,0
202181,in,0,0
202182,utero,0,1
202183,accretion,0,0
202184,rate,0,0
202185,for,0,0
202186,zinc,0,0
202187,and,0,0
202188,copper,0,0
202189,in,0,0
202190,the,0,0
202191,preterm,1,1
202192,infant,1,1
202193,.,1,1
202194,Two,1,0
202195,groups,1,0
202196,of,1,1
202197,five,1,1
202198,preterm,1,1
202199,infants,1,1
202200,were,0,1
202201,fed,0,0
202202,a,0,0
202203,diet,0,0
202204,containing,0,0
202205,12.5,0,0
202206,mg/L,0,0
202207,of,0,0
202208,zinc,0,0
202209,and,0,0
202210,either,0,0
202211,0.9,0,0
202212,mg/L,0,0
202213,or,0,1
202214,2.1,0,0
202215,mg/L,0,0
202216,of,0,0
202217,copper,0,0
202218,.,0,1
202219,Seventy-two-hour,0,0
202220,metabolic,0,1
202221,balance,0,0
202222,studies,0,0
202223,were,0,0
202224,performed,0,0
202225,at,0,0
202226,an,0,0
202227,average,0,0
202228,postconceptual,0,0
202229,age,0,1
202230,of,0,0
202231,34,0,1
202232,weeks,0,0
202233,and,0,0
202234,an,0,0
202235,average,0,0
202236,weight,0,0
202237,of,0,0
202238,"1,549",0,1
202239,g.,0,0
202240,All,0,1
202241,infants,0,1
202242,were,0,0
202243,in,0,0
202244,positive,0,0
202245,zinc,0,0
202246,balance,0,0
202247,and,0,0
202248,nine,0,1
202249,of,0,0
202250,ten,0,1
202251,achieved,0,0
202252,the,0,0
202253,in,0,0
202254,utero,0,1
202255,accretion,0,0
202256,rate,0,0
202257,for,0,0
202258,zinc,0,0
202259,for,0,0
202260,a,0,0
202261,34-week,0,0
202262,gestation,0,1
202263,fetus,0,0
202264,(,0,0
202265,greater,0,0
202266,than,0,0
202267,or,0,0
202268,equal,0,0
202269,to,0,0
202270,0.432,0,0
202271,mg/d,0,0
202272,),0,1
202273,.,0,1
202274,Three,0,0
202275,infants,0,1
202276,receiving,0,1
202277,the,0,0
202278,high,0,0
202279,copper,0,0
202280,formula,0,0
202281,and,0,0
202282,two,0,0
202283,receiving,0,0
202284,the,0,0
202285,lower,0,0
202286,copper,0,0
202287,formula,0,0
202288,were,0,0
202289,in,0,0
202290,positive,0,0
202291,copper,0,0
202292,balance,0,0
202293,.,0,1
202294,Two,0,0
202295,infants,0,1
202296,from,0,1
202297,each,0,0
202298,group,0,0
202299,achieved,0,0
202300,the,0,0
202301,in,0,0
202302,utero,0,1
202303,accretion,0,0
202304,rate,0,0
202305,for,0,0
202306,copper,0,0
202307,for,0,0
202308,a,0,0
202309,34-week,0,0
202310,gestation,0,1
202311,fetus,0,1
202312,(,0,0
202313,0.088,0,0
202314,mg/d,0,0
202315,),0,0
202316,.,0,0
202317,A,0,0
202318,formula,0,0
202319,that,0,0
202320,provides,0,0
202321,12.5,0,0
202322,mg/L,0,0
202323,of,0,0
202324,zinc,0,0
202325,permits,0,0
202326,positive,0,0
202327,zinc,0,0
202328,balance,0,0
202329,and,0,0
202330,zinc,0,0
202331,retention,0,0
202332,similar,0,0
202333,to,0,0
202334,in,0,0
202335,utero,0,1
202336,rates,0,0
202337,.,0,1
202338,A,0,0
202339,formula,0,0
202340,that,0,0
202341,provides,0,0
202342,as,0,0
202343,much,0,0
202344,as,0,0
202345,2.1,0,0
202346,mg/L,0,0
202347,of,0,0
202348,copper,0,0
202349,",",0,0
202350,however,0,0
202351,",",0,0
202352,may,0,0
202353,not,0,0
202354,always,0,0
202355,permit,0,0
202356,positive,0,0
202357,copper,0,0
202358,balance,0,0
202359,.,0,1
202360,Effect,0,0
202361,of,0,0
202362,increasing,0,0
202363,doses,0,0
202364,of,0,0
202365,labetalol,0,0
202366,on,0,0
202367,blood,0,0
202368,pressure,0,0
202369,",",0,0
202370,plasma,0,0
202371,renin,0,0
202372,activity,0,0
202373,and,0,0
202374,aldosterone,0,0
202375,in,0,0
202376,hypertensive,1,1
202377,patients,1,1
202378,.,1,1
202379,1,0,0
202380,.,0,0
202381,Four,0,0
202382,different,0,0
202383,doses,0,0
202384,of,0,0
202385,labetalol,0,0
202386,(,0,0
202387,150,0,0
202388,",",0,0
202389,300,0,0
202390,",",0,0
202391,600,0,1
202392,and,0,0
202393,900,0,1
202394,mg/day,0,0
202395,),0,0
202396,were,0,0
202397,given,0,0
202398,for,0,0
202399,1,0,0
202400,week,0,0
202401,to,0,0
202402,each,0,0
202403,of,0,0
202404,four,1,1
202405,groups,1,0
202406,of,1,1
202407,patients,1,1
202408,with,1,1
202409,essential,1,1
202410,hypertension,1,1
202411,(,1,1
202412,six,1,1
202413,patients,1,1
202414,for,1,0
202415,each,1,0
202416,group,1,0
202417,),1,0
202418,.,1,1
202419,2,0,0
202420,.,0,0
202421,Labetalol,0,0
202422,decreased,0,0
202423,mean,0,0
202424,blood,0,0
202425,pressure,0,0
202426,and,0,0
202427,heart,0,1
202428,rate,0,0
202429,to,0,0
202430,the,0,0
202431,same,0,0
202432,extent,0,0
202433,on,0,0
202434,the,0,0
202435,first,0,0
202436,and,0,0
202437,the,0,0
202438,seventh,0,0
202439,days,0,0
202440,of,0,0
202441,treatment,0,0
202442,.,0,0
202443,Only,0,0
202444,standing,0,0
202445,blood,0,0
202446,pressure,0,0
202447,showed,0,0
202448,a,0,0
202449,dose-dependent,0,0
202450,inhibition,0,0
202451,both,0,0
202452,in,0,0
202453,the,0,0
202454,supine,0,0
202455,and,0,0
202456,upright,0,0
202457,position,0,1
202458,.,0,1
202459,3,0,0
202460,.,0,0
202461,Labetalol,0,0
202462,exerted,0,0
202463,a,0,0
202464,net,0,0
202465,inhibitory,0,0
202466,effect,0,0
202467,on,0,0
202468,plasma,0,0
202469,renin,0,0
202470,activity,0,0
202471,",",0,0
202472,which,0,0
202473,was,0,0
202474,related,0,0
202475,to,0,0
202476,basal,0,0
202477,renin,0,0
202478,values,0,0
202479,and,0,0
202480,was,0,0
202481,already,0,0
202482,maximal,0,0
202483,at,0,0
202484,the,0,0
202485,lowest,0,0
202486,doses,0,0
202487,.,0,0
202488,This,0,0
202489,effect,0,0
202490,was,0,0
202491,well,0,0
202492,maintained,0,0
202493,in,0,0
202494,the,0,0
202495,supine,0,0
202496,position,0,0
202497,.,0,0
202498,This,0,0
202499,effect,0,0
202500,was,0,0
202501,well,0,0
202502,maintained,0,0
202503,in,0,0
202504,the,0,0
202505,supine,0,0
202506,position,0,0
202507,",",0,0
202508,although,0,0
202509,during,0,0
202510,standing,0,0
202511,it,0,0
202512,tended,0,0
202513,to,0,0
202514,be,0,0
202515,less,0,0
202516,evident,0,0
202517,with,0,0
202518,increasing,0,0
202519,doses,0,0
202520,.,0,1
202521,4,0,0
202522,.,0,0
202523,Urinary,0,0
202524,aldosterone,0,0
202525,was,0,0
202526,decreased,0,0
202527,in,0,0
202528,a,0,0
202529,dose-dependent,0,0
202530,fashion,0,0
202531,and,0,0
202532,its,0,0
202533,changes,0,0
202534,were,0,0
202535,largely,0,0
202536,independent,0,0
202537,fashion,0,0
202538,and,0,0
202539,its,0,0
202540,changes,0,0
202541,were,0,0
202542,largely,0,0
202543,independent,0,0
202544,of,0,0
202545,plasma,0,0
202546,renin,0,0
202547,activity,0,0
202548,.,0,1
202549,5,0,0
202550,.,0,0
202551,Neither,0,0
202552,basal,0,0
202553,values,0,0
202554,nor,0,0
202555,changes,0,0
202556,of,0,0
202557,renin,0,0
202558,and,0,0
202559,aldosterone,0,0
202560,were,0,0
202561,related,0,0
202562,to,0,0
202563,the,0,0
202564,hypotensive,0,0
202565,effect,0,0
202566,of,0,0
202567,labetalol,0,0
202568,.,0,1
202569,6,0,0
202570,.,0,0
202571,During,0,0
202572,labetalol,0,0
202573,treatment,0,0
202574,urinary,0,0
202575,sodium,0,0
202576,excretion,0,0
202577,fell,0,0
202578,for,0,0
202579,2-3,0,1
202580,days,0,0
202581,and,0,0
202582,then,0,0
202583,returned,0,0
202584,to,0,0
202585,basal,0,0
202586,values,0,0
202587,.,0,0
202588,The,0,0
202589,retentive,0,0
202590,effect,0,0
202591,of,0,0
202592,labetalol,0,0
202593,on,0,0
202594,sodium,0,0
202595,was,0,0
202596,directly,0,0
202597,related,0,0
202598,to,0,0
202599,the,0,0
202600,decrease,0,0
202601,of,0,0
202602,blood,0,0
202603,pressure,0,0
202604,",",0,0
202605,and,0,0
202606,the,0,0
202607,successive,0,0
202608,sodium,0,0
202609,escape,0,0
202610,might,0,0
202611,be,0,0
202612,explained,0,0
202613,either,0,0
202614,by,0,0
202615,the,0,0
202616,observed,0,0
202617,increase,0,0
202618,of,0,0
202619,plasma,0,0
202620,volume,0,0
202621,(,0,0
202622,indirectly,0,0
202623,measured,0,0
202624,by,0,0
202625,packed,0,0
202626,cell,0,1
202627,volume,0,0
202628,),0,0
202629,or,0,0
202630,by,0,0
202631,aldosterone,0,0
202632,inhibition,0,0
202633,.,0,1
202634,Differential,0,1
202635,inhibition,0,0
202636,of,0,0
202637,bronchoconstriction,0,0
202638,by,0,0
202639,the,0,0
202640,calcium,0,0
202641,channel,0,0
202642,blockers,0,0
202643,",",0,0
202644,verapamil,0,0
202645,and,0,0
202646,nifedipine,0,0
202647,.,0,1
202648,Recent,0,0
202649,studies,0,0
202650,have,0,0
202651,demonstrated,0,0
202652,that,0,0
202653,the,0,0
202654,calcium,0,0
202655,channel,0,0
202656,blocking,0,0
202657,agents,0,0
202658,can,0,0
202659,inhibit,0,0
202660,experimentally,0,0
202661,induced,0,0
202662,bronchoconstriction,0,0
202663,in,0,0
202664,asthmatics,1,1
202665,",",0,0
202666,but,0,0
202667,their,0,0
202668,protective,0,0
202669,action,0,0
202670,has,0,0
202671,been,0,0
202672,variable,0,0
202673,.,0,0
202674,To,0,0
202675,clarify,0,0
202676,the,0,0
202677,influence,0,0
202678,of,0,0
202679,stimulus,0,0
202680,intensity,0,0
202681,and,0,0
202682,choice,0,0
202683,of,0,0
202684,calcium,0,0
202685,blocker,0,0
202686,on,0,0
202687,these,0,0
202688,reported,0,0
202689,differences,0,0
202690,in,0,0
202691,outcome,0,0
202692,",",0,0
202693,we,0,0
202694,performed,0,0
202695,noncumulative,0,0
202696,thermal,0,1
202697,stimulus-response,0,0
202698,curves,0,0
202699,using,0,0
202700,isocapnic,0,1
202701,hyperventilation,0,0
202702,of,0,0
202703,cold,0,0
202704,air,0,1
202705,in,0,0
202706,8,1,0
202707,asthmatics,1,1
202708,.,1,1
202709,Subjects,1,1
202710,received,0,0
202711,pretreatment,0,0
202712,with,0,1
202713,orally,0,0
202714,administered,0,0
202715,nifedipine,0,0
202716,(,0,0
202717,20,0,0
202718,mg,0,0
202719,),0,0
202720,",",0,0
202721,intravenously,0,0
202722,administered,0,0
202723,verapamil,0,0
202724,(,0,0
202725,10,0,0
202726,mg,0,0
202727,bolus,0,0
202728,followed,0,0
202729,by,0,0
202730,a,0,0
202731,continuous,0,0
202732,infusion,0,0
202733,),0,0
202734,",",0,0
202735,or,0,1
202736,appropriate,0,0
202737,placebos,0,0
202738,in,0,0
202739,a,0,0
202740,randomized,0,0
202741,",",0,0
202742,double-blind,0,0
202743,fashion,0,0
202744,.,0,1
202745,Verapamil,0,0
202746,afforded,0,0
202747,no,0,0
202748,consistent,0,0
202749,protection,0,0
202750,against,0,0
202751,the,0,0
202752,thermal,0,0
202753,challenges,0,0
202754,",",0,1
202755,whereas,0,0
202756,nifedipine,0,0
202757,significantly,0,0
202758,blunted,0,0
202759,the,0,0
202760,bronchoconstrictor,0,0
202761,response,0,0
202762,to,0,0
202763,stimuli,0,0
202764,of,0,0
202765,low,0,1
202766,(,0,0
202767,p,0,0
202768,less,0,0
202769,than,0,0
202770,0.02,0,0
202771,),0,1
202772,and,0,0
202773,middle,0,1
202774,(,0,0
202775,p,0,0
202776,less,0,0
202777,than,0,0
202778,0.03,0,0
202779,),0,1
202780,intensity,0,0
202781,.,0,0
202782,At,0,0
202783,the,0,0
202784,highest,0,0
202785,thermal,0,0
202786,burden,0,0
202787,",",0,0
202788,the,0,0
202789,effect,0,0
202790,of,0,0
202791,nifedipine,0,0
202792,was,0,0
202793,inconsistent,0,0
202794,and,0,0
202795,not,0,0
202796,significantly,0,0
202797,different,0,0
202798,from,0,0
202799,that,0,0
202800,of,0,0
202801,placebo,0,0
202802,.,0,0
202803,These,0,0
202804,results,0,0
202805,indicate,0,0
202806,that,0,0
202807,the,0,0
202808,protection,0,0
202809,from,0,0
202810,bronchoconstriction,0,0
202811,afforded,0,0
202812,by,0,0
202813,the,0,0
202814,calcium,0,0
202815,channel,0,0
202816,blockers,0,0
202817,depends,0,0
202818,on,0,0
202819,the,0,0
202820,choice,0,0
202821,of,0,0
202822,agent,0,0
202823,and,0,0
202824,the,0,0
202825,intensity,0,0
202826,of,0,0
202827,the,0,0
202828,bronchoconstricting,0,0
202829,stimulus,0,0
202830,",",0,0
202831,and,0,0
202832,they,0,0
202833,raise,0,0
202834,the,0,0
202835,possibility,0,0
202836,that,0,0
202837,the,0,0
202838,contribution,0,0
202839,of,0,0
202840,transmembrane,0,0
202841,calcium,0,0
202842,ion,0,0
202843,influx,0,0
202844,to,0,0
202845,the,0,0
202846,pathogenesis,0,0
202847,of,0,0
202848,bronchoconstriction,0,0
202849,may,0,0
202850,vary,0,0
202851,according,0,0
202852,to,0,0
202853,stimulus,0,0
202854,intensity,0,0
202855,.,0,1
202856,Chronic,1,1
202857,lateral,1,1
202858,humeral,1,1
202859,epicondylitis,1,1
202860,--,1,1
202861,a,1,0
202862,double-blind,0,0
202863,controlled,0,0
202864,assessment,0,0
202865,of,0,0
202866,pulsed,0,0
202867,electromagnetic,0,0
202868,field,0,0
202869,therapy,0,0
202870,.,0,0
202871,Pulsed,0,0
202872,electromagnetic,0,0
202873,fields,0,0
202874,(,0,1
202875,PEMF,0,0
202876,),0,0
202877,have,0,0
202878,been,0,0
202879,shown,0,0
202880,to,0,0
202881,be,0,0
202882,beneficial,0,0
202883,in,0,0
202884,the,0,0
202885,treatment,0,0
202886,of,0,0
202887,rotator,0,1
202888,cuff,0,0
202889,tendinitis,0,1
202890,.,0,0
202891,As,0,0
202892,lateral,1,0
202893,humeral,1,1
202894,epicondylitis,1,1
202895,(,1,0
202896,tennis,1,0
202897,elbow,1,1
202898,),1,0
202899,is,0,0
202900,a,0,0
202901,similar,0,0
202902,chronic,0,1
202903,tendon,0,0
202904,lesion,0,0
202905,",",0,0
202906,30,1,0
202907,patients,1,1
202908,with,1,1
202909,both,1,0
202910,clinical,1,0
202911,and,1,0
202912,thermographic,1,0
202913,evidence,1,0
202914,of,1,0
202915,tennis,1,0
202916,elbow,1,1
202917,were,0,0
202918,randomly,0,1
202919,allocated,0,0
202920,to,0,0
202921,receive,0,0
202922,either,0,0
202923,active,0,0
202924,or,0,1
202925,inactive,0,1
202926,PEMF,0,0
202927,therapy,0,0
202928,.,0,0
202929,Treatment,0,0
202930,was,0,0
202931,continued,0,0
202932,for,0,0
202933,a,0,0
202934,minimum,0,0
202935,period,0,0
202936,of,0,0
202937,eight,0,1
202938,weeks,0,0
202939,.,0,1
202940,At,0,0
202941,this,0,0
202942,time,0,0
202943,there,0,0
202944,was,0,0
202945,no,0,0
202946,statistical,0,0
202947,difference,0,0
202948,between,0,0
202949,the,0,0
202950,two,0,0
202951,groups,0,0
202952,.,0,1
202953,Fluorouracil,0,0
202954,as,0,0
202955,an,0,0
202956,adjuvant,0,0
202957,to,0,0
202958,surgery,0,1
202959,in,0,0
202960,carcinoma,1,1
202961,of,1,0
202962,the,1,0
202963,colon,1,1
202964,.,1,0
202965,PRL-8-53,0,1
202966,:,0,1
202967,enhanced,0,0
202968,learning,0,0
202969,and,0,0
202970,subsequent,0,0
202971,retention,0,0
202972,in,0,0
202973,humans,1,0
202974,as,0,0
202975,a,0,0
202976,result,0,0
202977,of,0,0
202978,low,0,1
202979,oral,0,0
202980,doses,0,0
202981,of,0,0
202982,new,0,0
202983,psychotropic,0,1
202984,agent,0,0
202985,.,0,0
202986,The,0,0
202987,effect,0,0
202988,of,0,0
202989,3-,0,0
202990,(,0,1
202991,2-benzylmethylaminoethyl,0,0
202992,),0,0
202993,benzoic,0,0
202994,acid,0,0
202995,methyl,0,0
202996,ester,0,0
202997,hydrochloride,0,0
202998,(,0,0
202999,PRL-8-53,0,1
203000,),0,0
203001,on,0,0
203002,learning,0,0
203003,and,0,0
203004,on,0,0
203005,retention,0,0
203006,of,0,0
203007,verbal,0,0
203008,information,0,0
203009,in,0,0
203010,human,1,1
203011,subjects,1,1
203012,was,0,0
203013,investigated,0,0
203014,.,0,0
203015,Using,0,0
203016,the,0,0
203017,serial,0,0
203018,anticipation,0,0
203019,method,0,0
203020,under,0,0
203021,double-blind,0,0
203022,conditions,0,1
203023,it,0,0
203024,was,0,0
203025,found,0,0
203026,that,0,0
203027,PRL-8-53,0,1
203028,causes,0,0
203029,slight,0,0
203030,improvement,0,0
203031,of,0,0
203032,acquisition,0,0
203033,.,0,0
203034,Retinetion,0,0
203035,of,0,0
203036,verbal,0,0
203037,information,0,0
203038,was,0,0
203039,found,0,0
203040,improved,0,0
203041,to,0,0
203042,a,0,0
203043,statistically,0,0
203044,significant,0,0
203045,degree,0,0
203046,(,0,0
203047,most,0,0
203048,P,0,0
203049,values,0,0
203050,better,0,0
203051,than,0,0
203052,0.01,0,0
203053,",",0,0
203054,some,0,0
203055,better,0,0
203056,than,0,0
203057,0.001,0,0
203058,),0,1
203059,.,0,0
203060,No,0,0
203061,significant,0,0
203062,changes,0,0
203063,were,0,1
203064,found,0,0
203065,for,0,0
203066,either,0,0
203067,visual,0,0
203068,reaction,0,0
203069,time,0,0
203070,or,0,0
203071,motor,0,0
203072,control,0,0
203073,after,0,0
203074,drug,0,0
203075,when,0,0
203076,compared,0,0
203077,with,0,0
203078,placebo,0,0
203079,values,0,0
203080,.,0,1
203081,Joint,0,0
203082,study,0,0
203083,of,0,0
203084,extracranial,0,0
203085,arterial,0,1
203086,occlusion,0,1
203087,.,0,1
203088,VI,0,0
203089,.,0,0
203090,Racial,0,1
203091,differences,0,0
203092,in,0,1
203093,hospitalized,1,1
203094,patients,1,1
203095,with,1,1
203096,ischemic,1,1
203097,stroke,1,1
203098,.,1,1
203099,Sequential,0,0
203100,radiotherapy,0,1
203101,and,0,0
203102,chemotherapy,0,0
203103,in,0,0
203104,the,0,0
203105,treatment,0,0
203106,of,0,0
203107,Hodgkin,1,1
203108,'s,1,1
203109,disease,1,1
203110,.,1,1
203111,A,0,0
203112,progress,0,0
203113,report,0,0
203114,.,0,1
203115,A,0,0
203116,tube,1,0
203117,spacer,1,0
203118,to,0,0
203119,improve,0,0
203120,inhalation,0,0
203121,of,0,0
203122,drugs,0,0
203123,from,0,1
203124,pressurised,0,1
203125,aerosols,0,1
203126,.,0,1
203127,Triamcinolone,0,0
203128,acetonide,0,0
203129,in,0,0
203130,the,0,0
203131,treatment,0,0
203132,of,0,0
203133,bursitis,1,1
203134,and,1,0
203135,other,1,0
203136,foot,1,1
203137,disorders,1,1
203138,.,1,1
203139,Alcoholism,1,1
203140,",",1,0
203141,avoidance,1,0
203142,learning,1,0
203143,and,1,0
203144,emotional,1,0
203145,responsiveness,1,0
203146,.,1,1
203147,A,0,0
203148,comparative,0,0
203149,trial,0,0
203150,of,0,0
203151,fixed,0,0
203152,ratio,0,0
203153,beta-adrenoceptor,0,0
203154,blocker,0,0
203155,and,0,0
203156,diuretic,0,0
203157,combination,0,0
203158,products,0,0
203159,in,0,0
203160,moderate,1,1
203161,hypertension,1,1
203162,.,1,1
203163,Two,0,0
203164,fixed,0,0
203165,ratio,0,0
203166,combination,0,0
203167,tablets,0,0
203168,",",0,0
203169,10,0,0
203170,mg,0,0
203171,pindolol,0,0
203172,combined,0,0
203173,with,0,1
203174,5,0,1
203175,mg,0,0
203176,clopamide,0,0
203177,and,0,0
203178,100,0,0
203179,mg,0,0
203180,metoprolol,0,0
203181,combined,0,0
203182,with,0,1
203183,12.5,0,0
203184,mg,0,0
203185,hydrochlorothiazide,0,0
203186,",",0,0
203187,were,0,0
203188,compared,0,0
203189,at,0,0
203190,two,0,0
203191,dose,0,0
203192,levels,0,0
203193,in,0,0
203194,a,0,0
203195,double-blind,0,0
203196,crossover,0,0
203197,trial,0,0
203198,in,0,0
203199,10,1,0
203200,previously,1,1
203201,untreated,1,1
203202,hypertensive,1,1
203203,patients,1,1
203204,.,1,1
203205,No,0,0
203206,significant,0,0
203207,difference,0,0
203208,was,0,0
203209,observed,0,0
203210,between,0,0
203211,resting,0,0
203212,blood,0,0
203213,pressure,0,0
203214,on,0,0
203215,the,0,0
203216,two,0,0
203217,combinations,0,0
203218,at,0,0
203219,either,0,1
203220,dose,0,0
203221,level,0,0
203222,.,0,1
203223,Exercise,0,0
203224,systolic,0,0
203225,pressure,0,0
203226,was,0,0
203227,lower,0,0
203228,after,0,0
203229,the,0,0
203230,pindolol/clopamide,0,0
203231,combination,0,0
203232,at,0,0
203233,low,0,0
203234,dose,0,0
203235,(,0,0
203236,p,0,0
203237,less,0,0
203238,than,0,0
203239,0.05,0,0
203240,),0,1
203241,.,0,0
203242,The,0,0
203243,incidence,0,0
203244,of,0,0
203245,side-effects,0,0
203246,in,0,0
203247,this,0,0
203248,trial,0,0
203249,was,0,0
203250,high,0,0
203251,but,0,0
203252,proper,0,0
203253,comparison,0,0
203254,of,0,0
203255,the,0,0
203256,two,0,0
203257,products,0,0
203258,could,0,0
203259,not,0,0
203260,be,0,0
203261,made,0,0
203262,because,0,0
203263,of,0,0
203264,the,0,0
203265,small,0,0
203266,number,0,0
203267,of,0,0
203268,patients,0,1
203269,.,0,0
203270,It,0,0
203271,is,0,0
203272,suggested,0,0
203273,that,0,0
203274,combination,0,0
203275,products,0,0
203276,should,0,0
203277,be,0,0
203278,used,0,0
203279,only,0,0
203280,after,0,0
203281,patients,0,1
203282,have,0,0
203283,failed,0,0
203284,to,0,0
203285,respond,0,0
203286,adequately,0,0
203287,to,0,0
203288,a,0,0
203289,single,0,0
203290,agent,0,0
203291,.,0,1
203292,Schizophrenia,0,1
203293,.,0,0
203294,A,0,0
203295,follow-up,0,0
203296,study,0,0
203297,of,0,0
203298,the,0,0
203299,results,0,0
203300,of,0,0
203301,five,0,1
203302,forms,0,0
203303,of,0,1
203304,treatment,0,1
203305,.,0,1
203306,Two,1,0
203307,hundred,1,1
203308,twenty-eight,1,1
203309,first-admission,1,1
203310,schizophrenic,1,1
203311,patients,1,1
203312,were,0,1
203313,randomly,0,1
203314,assigned,0,0
203315,to,0,0
203316,the,0,0
203317,following,0,0
203318,five,0,1
203319,treatments,0,0
203320,:,0,1
203321,psychotherapy,0,0
203322,alone,0,0
203323,",",0,0
203324,drug,0,0
203325,alone,0,0
203326,",",0,0
203327,psychotherapy,0,0
203328,plus,0,0
203329,drug,0,0
203330,",",0,0
203331,electroconvulsive,0,0
203332,therapy,0,0
203333,(,0,0
203334,ECT,0,0
203335,",",0,0
203336,and,0,0
203337,milieu,0,0
203338,.,0,0
203339,A,0,0
203340,there-,0,0
203341,to,0,0
203342,five-year,0,0
203343,follow-up,0,0
203344,examined,0,0
203345,their,0,0
203346,course,0,0
203347,after,0,0
203348,release,0,0
203349,from,0,0
203350,the,0,0
203351,hospital,0,1
203352,.,0,0
203353,The,0,0
203354,drug,0,0
203355,alone,0,0
203356,and,0,0
203357,ECT,0,0
203358,groups,0,0
203359,tended,0,0
203360,to,0,0
203361,have,0,0
203362,the,0,0
203363,best,0,0
203364,outcome,0,0
203365,and,0,0
203366,the,0,0
203367,psychotherapy,0,0
203368,alone,0,0
203369,group,0,0
203370,the,0,0
203371,worst,0,0
203372,.,0,0
203373,The,0,0
203374,positive,0,0
203375,effect,0,0
203376,from,0,1
203377,prior,0,0
203378,drug,0,0
203379,treatment,0,0
203380,began,0,1
203381,to,0,0
203382,dissipate,0,0
203383,after,0,0
203384,three,0,0
203385,years,0,1
203386,postadmission,0,0
203387,.,0,1
203388,For,0,0
203389,the,0,0
203390,in-hospital,0,0
203391,treatment,0,0
203392,successes,0,0
203393,",",0,0
203394,the,0,0
203395,advantage,0,0
203396,from,0,0
203397,drug,0,0
203398,treatment,0,0
203399,and,0,0
203400,the,0,0
203401,disadvantage,0,0
203402,from,0,0
203403,psychotherapy,0,0
203404,were,0,0
203405,less,0,0
203406,apparent,0,0
203407,.,0,0
203408,Overall,0,0
203409,",",0,0
203410,the,0,0
203411,follow-up,0,0
203412,outcome,0,0
203413,is,0,0
203414,far,0,0
203415,from,0,0
203416,reassuring,0,0
203417,",",0,1
203418,whatever,0,0
203419,the,0,1
203420,type,0,1
203421,of,0,0
203422,treatment,0,0
203423,.,0,0
203424,Even,0,0
203425,though,0,0
203426,a,0,0
203427,few,0,0
203428,patients,0,1
203429,may,0,0
203430,do,0,0
203431,well,0,0
203432,",",0,0
203433,much,0,0
203434,remains,0,0
203435,to,0,0
203436,be,0,0
203437,done,0,0
203438,in,0,0
203439,and,0,0
203440,out,0,0
203441,of,0,0
203442,the,0,0
203443,hospital,0,1
203444,.,0,0
203445,A,0,0
203446,double-blind,0,0
203447,comparison,0,0
203448,of,0,0
203449,bromperidol,0,0
203450,and,0,0
203451,haloperidol,0,0
203452,in,0,0
203453,newly,1,1
203454,admitted,1,1
203455,schizophrenic,1,1
203456,patients,1,1
203457,.,1,1
203458,Acute,0,1
203459,intervention,0,0
203460,studies,0,0
203461,in,0,0
203462,patients,1,1
203463,with,1,1
203464,myocardial,1,1
203465,infarction,1,1
203466,using,0,0
203467,atenolol,0,0
203468,",",0,0
203469,propranolol,0,0
203470,",",0,0
203471,oxprenolol,0,0
203472,and,0,0
203473,disopyramide,0,0
203474,phosphate,0,0
203475,.,0,0
203476,The,0,0
203477,value,0,0
203478,of,0,0
203479,beta-blockade,0,0
203480,and,0,0
203481,of,0,0
203482,disopyramide,0,0
203483,phosphate,0,0
203484,in,0,0
203485,the,0,0
203486,immediate,0,0
203487,treatment,0,0
203488,of,0,0
203489,patients,1,1
203490,with,1,1
203491,suspected,1,1
203492,acute,1,1
203493,myocardial,1,1
203494,infarction,1,1
203495,was,0,0
203496,assessed,0,0
203497,in,0,0
203498,two,0,0
203499,placebo,0,0
203500,controlled,0,1
203501,trials,0,0
203502,.,0,1
203503,In,1,0
203504,the,1,0
203505,first,1,0
203506,study,1,1
203507,388,1,1
203508,patients,1,1
203509,with,1,1
203510,suspected,1,1
203511,acute,1,1
203512,myocardial,1,1
203513,infarction,1,1
203514,were,0,0
203515,randomly,0,1
203516,allocated,0,0
203517,to,0,0
203518,treatment,0,0
203519,with,0,1
203520,propranolol,0,0
203521,",",0,0
203522,atenolol,0,0
203523,",",0,0
203524,or,0,0
203525,placebo,0,0
203526,",",0,0
203527,and,0,0
203528,when,0,0
203529,analysed,0,0
203530,on,0,0
203531,an,0,0
203532,initial,0,0
203533,intention,0,0
203534,to,0,0
203535,treat,0,0
203536,basis,0,0
203537,there,0,0
203538,was,0,0
203539,no,0,0
203540,significant,0,0
203541,difference,0,0
203542,between,0,0
203543,the,0,0
203544,three,0,0
203545,groups,0,0
203546,in,0,0
203547,respect,0,0
203548,of,0,0
203549,the,0,0
203550,mortality,0,0
203551,at,0,0
203552,one,0,1
203553,year,0,1
203554,.,0,0
203555,In,0,0
203556,addition,0,0
203557,",",0,0
203558,there,0,0
203559,was,0,0
203560,no,0,0
203561,evidence,0,0
203562,to,0,0
203563,suggest,0,0
203564,that,0,0
203565,either,0,0
203566,atenolol,0,0
203567,",",0,0
203568,or,0,0
203569,propranolol,0,0
203570,reduced,0,0
203571,the,0,0
203572,incidence,0,0
203573,of,0,0
203574,'serious,0,0
203575,',0,1
203576,ventricular,0,1
203577,arrhythmias,0,1
203578,in,0,0
203579,the,0,0
203580,coronary,0,1
203581,care,0,1
203582,unit,0,0
203583,.,0,0
203584,In,0,0
203585,the,0,0
203586,second,0,0
203587,study,0,1
203588,473,1,1
203589,patients,1,1
203590,with,1,1
203591,suspected,1,1
203592,acute,1,1
203593,myocardial,1,1
203594,infarction,1,1
203595,were,0,0
203596,randomly,0,1
203597,allocated,0,0
203598,to,0,0
203599,treatment,0,0
203600,with,0,1
203601,oxprenolol,0,0
203602,",",0,0
203603,disopyramide,0,0
203604,phosphate,0,0
203605,",",0,0
203606,or,0,0
203607,placebo,0,0
203608,.,0,0
203609,Again,0,0
203610,no,0,0
203611,significant,0,0
203612,differences,0,0
203613,were,0,1
203614,seen,0,0
203615,with,0,1
203616,respect,0,0
203617,to,0,0
203618,the,0,0
203619,mortality,0,0
203620,at,0,0
203621,six,0,1
203622,weeks,0,0
203623,.,0,0
203624,There,0,0
203625,was,0,0
203626,",",0,0
203627,however,0,0
203628,",",0,0
203629,a,0,0
203630,significantly,0,0
203631,increased,0,0
203632,incidence,0,0
203633,of,0,0
203634,heart,0,1
203635,failure,0,1
203636,in,0,0
203637,the,0,0
203638,group,0,0
203639,which,0,0
203640,received,0,0
203641,disopyramide,0,0
203642,phosphate,0,0
203643,.,0,1
203644,Patients,1,1
203645,who,0,1
203646,received,0,1
203647,this,0,0
203648,drug,0,0
203649,also,0,0
203650,showed,0,0
203651,a,0,0
203652,reduced,0,0
203653,number,0,0
203654,of,0,0
203655,dysrhythmic,0,1
203656,episodes,0,1
203657,on,0,0
203658,24-hour,0,1
203659,ECG,0,1
203660,recordings,0,0
203661,",",0,0
203662,but,0,0
203663,this,0,0
203664,trend,0,0
203665,did,0,0
203666,not,0,0
203667,achieve,0,0
203668,statistical,0,0
203669,significance,0,0
203670,.,0,0
203671,These,0,0
203672,results,0,0
203673,suggest,0,0
203674,that,0,0
203675,none,0,0
203676,of,0,0
203677,the,0,0
203678,three,0,0
203679,beta-blockers,0,0
203680,tested,0,0
203681,nor,0,0
203682,disopyramide,0,0
203683,phosphate,0,0
203684,is,0,0
203685,likely,0,0
203686,to,0,0
203687,reduce,0,0
203688,the,0,0
203689,mortality,0,0
203690,from,0,0
203691,acute,0,1
203692,myocardial,0,1
203693,infarction,0,1
203694,when,0,0
203695,given,0,0
203696,prophylactically,0,0
203697,",",0,0
203698,although,0,0
203699,disopyramide,0,0
203700,phosphate,0,0
203701,does,0,0
203702,reduce,0,0
203703,the,0,0
203704,incidence,0,0
203705,of,0,0
203706,'serious,0,0
203707,',0,1
203708,ventriicular,0,1
203709,arrhythmias,0,1
203710,.,0,1
203711,The,0,0
203712,influence,0,0
203713,of,0,0
203714,beta-adrenoceptor,0,0
203715,blockade,0,0
203716,on,0,0
203717,left,1,1
203718,ventricular,1,1
203719,function,1,0
203720,.,1,1
203721,1,0,0
203722,This,0,0
203723,study,0,0
203724,was,0,0
203725,designed,0,0
203726,to,0,0
203727,compare,0,0
203728,in,0,0
203729,a,0,0
203730,randomized,0,0
203731,cross-over,0,0
203732,trial,0,0
203733,pindolol,0,0
203734,",",0,0
203735,a,0,0
203736,beta-adrenoceptor,0,0
203737,blocking,0,0
203738,agent,0,0
203739,with,0,1
203740,intrinsic,0,0
203741,sympathomimetic,0,0
203742,activity,0,0
203743,and,0,0
203744,metoprolol,0,0
203745,",",0,0
203746,a,0,0
203747,cardioselective,0,0
203748,beta-adrenoceptor,0,0
203749,blocker,0,0
203750,lacking,0,0
203751,sympathomimetic,0,0
203752,activity,0,0
203753,in,0,0
203754,hypertensives,1,1
203755,with,1,1
203756,incipient,1,1
203757,heart,1,1
203758,failure,1,1
203759,.,1,0
203760,Cardiac,0,0
203761,function,0,0
203762,was,0,0
203763,investigated,0,0
203764,by,0,0
203765,M-Mode,0,1
203766,and,0,1
203767,2D-echo-cardiography,0,1
203768,.,0,1
203769,2,0,0
203770,Both,0,0
203771,pindolol,0,0
203772,and,0,0
203773,metoprolol,0,0
203774,in,0,0
203775,equipotent,0,0
203776,doses,0,0
203777,lowered,0,0
203778,blood,0,0
203779,pressure,0,0
203780,to,0,0
203781,the,0,0
203782,same,0,0
203783,extent,0,0
203784,.,0,1
203785,3,0,0
203786,There,0,0
203787,was,0,0
203788,no,0,0
203789,difference,0,0
203790,in,0,0
203791,overall,0,0
203792,left,1,1
203793,ventricular,1,0
203794,function,1,0
203795,in,0,0
203796,ventricular,0,0
203797,geometry,0,0
203798,or,0,1
203799,in,0,0
203800,wall,0,1
203801,dynamics,0,0
203802,after,0,0
203803,either,0,1
203804,drug,0,0
203805,.,0,0
203806,4,0,0
203807,In,0,0
203808,comparison,0,0
203809,to,0,0
203810,metoprolol,0,0
203811,",",0,0
203812,pindolol,0,0
203813,produced,0,0
203814,less,0,0
203815,reduction,0,0
203816,in,0,0
203817,resting,0,0
203818,heart,0,1
203819,rate,0,0
203820,",",0,0
203821,cardiac,0,1
203822,index,0,0
203823,and,0,0
203824,ejection,0,1
203825,velocity,0,0
203826,reflecting,0,0
203827,the,0,0
203828,intrinsic,0,0
203829,sympathomimetic,0,0
203830,activity,0,0
203831,of,0,0
203832,the,0,0
203833,drug,0,0
203834,.,0,0
203835,Ceftriaxone,0,0
203836,versus,0,0
203837,ampicillin,0,0
203838,and,0,0
203839,chloramphenicol,0,0
203840,for,0,0
203841,treatment,0,0
203842,of,0,0
203843,bacterial,1,0
203844,meningitis,1,1
203845,in,1,0
203846,children,1,1
203847,.,1,1
203848,78,1,1
203849,patients,1,1
203850,with,1,1
203851,bacterial,1,0
203852,meningitis,1,1
203853,were,1,0
203854,evaluated,1,0
203855,in,0,0
203856,a,0,0
203857,prospective,0,0
203858,",",0,0
203859,randomised,0,0
203860,study,0,0
203861,comparing,0,0
203862,twice-daily,0,0
203863,ceftriaxone,0,0
203864,as,0,0
203865,single-drug,0,0
203866,therapy,0,0
203867,with,0,1
203868,ampicillin,0,0
203869,and,0,0
203870,chloramphenicol,0,0
203871,given,0,0
203872,every,0,0
203873,6,0,0
203874,h.,0,0
203875,The,0,0
203876,groups,0,0
203877,were,0,0
203878,comparable,0,0
203879,in,0,0
203880,age,0,1
203881,",",0,0
203882,sex,0,0
203883,",",0,0
203884,days,0,0
203885,of,0,0
203886,illness,0,1
203887,before,0,0
203888,admission,0,0
203889,",",0,0
203890,and,0,0
203891,bacterial,0,0
203892,colony,0,0
203893,counts,0,0
203894,in,0,0
203895,cerebrospinal,0,1
203896,fluid,0,0
203897,(,0,0
203898,CSF,0,1
203899,),0,0
203900,.,0,0
203901,The,0,0
203902,pathogens,0,0
203903,were,0,1
203904,Haemophilus,0,1
203905,influenzae,0,1
203906,type,0,1
203907,b,0,1
203908,(,0,0
203909,54,0,1
203910,cases,0,1
203911,),0,0
203912,",",0,0
203913,streptococci,0,1
203914,(,0,0
203915,9,0,0
203916,cases,0,1
203917,),0,0
203918,",",0,0
203919,meningococci,0,1
203920,(,0,0
203921,9,0,0
203922,cases,0,1
203923,),0,0
203924,",",0,0
203925,and,0,0
203926,unknown,0,0
203927,(,0,1
203928,6,0,0
203929,cases,0,1
203930,),0,1
203931,.,0,1
203932,In,0,0
203933,40,0,1
203934,CSF,0,1
203935,specimens,0,1
203936,obtained,0,0
203937,4-12,0,0
203938,h,0,0
203939,after,0,0
203940,initiation,0,0
203941,of,0,0
203942,therapy,0,0
203943,",",0,0
203944,cultures,0,0
203945,were,0,0
203946,negative,0,1
203947,in,0,0
203948,57,0,1
203949,%,0,0
203950,of,0,0
203951,the,0,0
203952,ceftriaxone,0,0
203953,patients,0,1
203954,and,0,0
203955,in,0,0
203956,42,0,1
203957,%,0,0
203958,of,0,0
203959,the,0,0
203960,others,0,0
203961,.,0,0
203962,The,0,0
203963,mean,0,0
203964,falls,0,0
203965,in,0,0
203966,the,0,0
203967,CSF,0,1
203968,bacterial,0,0
203969,colony,0,0
203970,counts,0,0
203971,were,0,1
203972,4.7,0,0
203973,and,0,1
203974,5.0,0,0
203975,log10,0,0
203976,colony-forming,0,0
203977,units/ml,0,0
203978,",",0,0
203979,respectively,0,0
203980,.,0,0
203981,Mean,0,0
203982,bactericidal,0,0
203983,activity,0,0
203984,in,0,0
203985,CSF,0,1
203986,was,0,0
203987,significantly,0,0
203988,greater,0,0
203989,in,0,0
203990,the,0,0
203991,ceftriaxone,0,0
203992,than,0,0
203993,in,0,0
203994,the,0,0
203995,conventional,0,0
203996,treatment,0,0
203997,group,0,0
203998,at,0,0
203999,the,0,0
204000,beginning,0,0
204001,and,0,0
204002,end,0,0
204003,of,0,0
204004,therapy,0,0
204005,.,0,0
204006,There,0,0
204007,were,0,0
204008,no,0,0
204009,significant,0,0
204010,differences,0,0
204011,in,0,1
204012,clinical,0,0
204013,responses,0,0
204014,or,0,1
204015,in,0,0
204016,frequency,0,0
204017,of,0,0
204018,complications,0,0
204019,",",0,0
204020,except,0,0
204021,for,0,0
204022,mild,0,1
204023,diarrhoea,0,0
204024,",",0,0
204025,which,0,0
204026,occurred,0,0
204027,in,0,0
204028,16,0,1
204029,ceftriaxone,0,0
204030,patients,0,1
204031,and,0,0
204032,in,0,0
204033,8,0,0
204034,in,0,0
204035,the,0,0
204036,other,0,0
204037,group,0,0
204038,(,0,0
204039,p,0,0
204040,less,0,0
204041,than,0,0
204042,0.05,0,0
204043,),0,1
204044,.,0,1
204045,[,0,0
204046,The,0,0
204047,somatostatin,0,0
204048,infusion,0,0
204049,test,0,0
204050,for,0,0
204051,the,0,0
204052,evaluation,0,0
204053,of,0,0
204054,glucose,0,0
204055,utilization,0,0
204056,in,0,0
204057,bezafibrate,0,0
204058,medication,0,0
204059,],0,0
204060,.,0,0
204061,The,0,0
204062,utilisation,0,0
204063,of,0,0
204064,blood,0,0
204065,glucose,0,0
204066,may,0,0
204067,be,0,0
204068,used,0,0
204069,for,0,0
204070,definition,0,0
204071,of,0,0
204072,insulin,0,0
204073,resistance,0,0
204074,in,0,0
204075,type,1,1
204076,II,1,0
204077,diabetes,1,1
204078,mellitus,1,1
204079,.,1,0
204080,To,0,0
204081,evaluate,0,0
204082,this,0,0
204083,possibility,0,0
204084,we,0,0
204085,adapted,0,0
204086,an,0,0
204087,infusion,0,0
204088,test,0,0
204089,of,0,0
204090,somatostatin,1,0
204091,in,1,0
204092,10,1,1
204093,normal,1,1
204094,persons,1,1
204095,(,1,1
204096,age,1,1
204097,26,1,1
204098,+/-,1,0
204099,3,1,0
204100,years,1,1
204101,",",1,0
204102,relative,1,0
204103,body,1,1
204104,weight,1,1
204105,26,1,1
204106,+/-,1,0
204107,10,1,1
204108,%,1,0
204109,according,1,1
204110,to,1,0
204111,Broca,1,1
204112,),1,0
204113,in,0,0
204114,a,0,0
204115,randomized,0,0
204116,cross-over,0,0
204117,therapy,0,0
204118,with,0,1
204119,bezafibrate,0,0
204120,(,0,0
204121,3,0,0
204122,X,0,1
204123,200,0,0
204124,mg/die,0,0
204125,),0,0
204126,.,0,0
204127,As,0,0
204128,the,0,0
204129,coefficient,0,0
204130,of,0,0
204131,variation,0,0
204132,(,0,0
204133,VC,0,0
204134,),0,0
204135,of,0,0
204136,measured,0,0
204137,blood,0,0
204138,glucose,0,0
204139,continuously,0,0
204140,increased,0,0
204141,the,0,0
204142,best,0,0
204143,time,0,0
204144,of,0,0
204145,a,0,0
204146,steady,0,0
204147,state,0,0
204148,was,0,0
204149,between,0,0
204150,90,0,1
204151,and,0,0
204152,130,0,1
204153,min,0,0
204154,after,0,0
204155,beginning,0,0
204156,the,0,0
204157,infusion,0,0
204158,(,0,0
204159,mean,0,1
204160,VC,0,0
204161,8.9,0,0
204162,%,0,0
204163,),0,0
204164,.,0,0
204165,While,0,0
204166,insulin,0,0
204167,remained,0,0
204168,nearly,0,0
204169,constant,0,0
204170,(,0,0
204171,41,0,1
204172,(,0,1
204173,45,0,1
204174,;,0,1
204175,38,0,1
204176,),0,0
204177,microU/ml,0,0
204178,),0,0
204179,blood,0,0
204180,glucose,0,0
204181,dropped,0,0
204182,by,0,0
204183,about,0,0
204184,14,0,0
204185,%,0,0
204186,and,0,0
204187,reached,0,0
204188,a,0,0
204189,steady,0,0
204190,state,0,0
204191,of,0,0
204192,89,0,1
204193,(,0,1
204194,134,0,1
204195,;,0,1
204196,45,0,1
204197,),0,0
204198,mg/dl,0,0
204199,.,0,0
204200,During,0,0
204201,the,0,0
204202,therapy,0,0
204203,of,0,0
204204,bezafibrate,0,0
204205,blood,0,0
204206,glucose,0,0
204207,was,0,0
204208,significantly,0,0
204209,decreased,0,0
204210,by,0,0
204211,36,0,1
204212,%,0,0
204213,130,0,1
204214,min,0,0
204215,after,0,0
204216,beginning,0,0
204217,the,0,0
204218,infusion,0,0
204219,.,0,0
204220,Although,0,0
204221,the,0,0
204222,effect,0,0
204223,was,0,0
204224,not,0,0
204225,significant,0,0
204226,during,0,0
204227,the,0,0
204228,whole,0,0
204229,time,0,0
204230,of,0,0
204231,the,0,0
204232,steady,0,0
204233,state,0,0
204234,it,0,0
204235,became,0,0
204236,evident,0,0
204237,by,0,0
204238,a,0,0
204239,negative,0,0
204240,correlation,0,0
204241,with,0,1
204242,lactate,0,0
204243,(,0,0
204244,r,0,0
204245,=,0,0
204246,-0.687,0,0
204247,),0,0
204248,and,0,0
204249,pyruvate,0,0
204250,(,0,0
204251,r,0,0
204252,=,0,0
204253,-0.843,0,0
204254,),0,0
204255,.,0,0
204256,A,0,0
204257,correlation,0,0
204258,with,0,0
204259,a,0,0
204260,concomitant,0,0
204261,decrease,0,0
204262,of,0,0
204263,triglyceride,0,0
204264,and,0,0
204265,cholesterol,0,0
204266,also,0,0
204267,induced,0,0
204268,by,0,0
204269,bezafibrate,0,0
204270,could,0,0
204271,not,0,0
204272,be,0,0
204273,proven,0,0
204274,.,0,0
204275,The,0,0
204276,results,0,0
204277,show,0,0
204278,that,0,0
204279,the,0,0
204280,infusion,0,0
204281,test,0,0
204282,of,0,0
204283,somatostatin,0,0
204284,is,0,0
204285,fitted,0,0
204286,to,0,0
204287,measure,0,0
204288,a,0,0
204289,steady,0,0
204290,state,0,0
204291,of,0,0
204292,blood,0,0
204293,glucose,0,0
204294,and,0,0
204295,insulin,0,0
204296,and,0,0
204297,that,0,0
204298,it,0,0
204299,is,0,0
204300,possible,0,0
204301,by,0,0
204302,this,0,0
204303,technique,0,0
204304,to,0,0
204305,quantify,0,0
204306,a,0,0
204307,changed,0,0
204308,utilisation,0,0
204309,of,0,0
204310,blood,0,0
204311,glucose,0,0
204312,induced,0,0
204313,by,0,0
204314,specific,0,0
204315,therapy,0,0
204316,.,0,1
204317,[,0,0
204318,Local,0,0
204319,application,0,0
204320,of,0,0
204321,anti-cancer,0,0
204322,drugs,0,0
204323,for,0,0
204324,the,0,0
204325,treatment,0,0
204326,of,0,0
204327,malignant,1,1
204328,pleural,1,1
204329,and,1,0
204330,pericardial,1,0
204331,effusion,1,1
204332,],1,1
204333,.,0,1
204334,Pleural,0,0
204335,effusion,0,0
204336,is,0,0
204337,a,0,0
204338,common,0,0
204339,complication,0,0
204340,in,0,0
204341,patients,1,1
204342,with,1,1
204343,malignant,1,1
204344,neoplasm,1,1
204345,.,1,0
204346,A,0,0
204347,randomized,0,0
204348,controlled,0,0
204349,study,0,0
204350,of,0,0
204351,intrapleural,0,0
204352,instillation,0,0
204353,of,0,0
204354,Adriamycin,0,0
204355,(,1,0
204356,control,1,0
204357,group,1,0
204358,",",1,0
204359,30,1,1
204360,patients,1,1
204361,),1,1
204362,and,0,1
204363,Adriamycin,0,1
204364,Nocardia,0,1
204365,rubra,0,0
204366,cell,0,0
204367,wall,0,0
204368,skeleton,0,1
204369,(,1,0
204370,N-CWS,1,0
204371,group,1,0
204372,",",1,0
204373,26,1,1
204374,patients,1,1
204375,),1,1
204376,with,0,1
204377,tube,0,0
204378,thoracostomy,0,1
204379,was,0,0
204380,performed,0,0
204381,in,1,0
204382,55,1,1
204383,patients,1,1
204384,with,1,1
204385,malignant,1,1
204386,pleural,1,1
204387,effusion,1,1
204388,due,1,0
204389,to,1,0
204390,primary,1,1
204391,lung,1,1
204392,cancer,1,1
204393,.,1,0
204394,The,0,0
204395,response,0,0
204396,rates,0,0
204397,for,0,0
204398,control,0,1
204399,of,0,0
204400,pleural,0,1
204401,effusion,0,1
204402,were,0,0
204403,73.4,0,0
204404,%,0,0
204405,in,0,0
204406,the,0,0
204407,N-CWS,0,0
204408,group,0,0
204409,and,0,0
204410,46.1,0,0
204411,%,0,0
204412,in,0,0
204413,the,0,0
204414,N-CWS,0,0
204415,group,0,0
204416,.,0,0
204417,These,0,0
204418,results,0,0
204419,suggest,0,0
204420,that,0,0
204421,intrapleural,0,0
204422,instillation,0,0
204423,using,0,0
204424,a,0,0
204425,combination,0,0
204426,of,0,0
204427,anti-cancer,0,0
204428,agent,0,0
204429,and,0,0
204430,immunopotentiator,0,0
204431,is,0,0
204432,an,0,0
204433,effective,0,0
204434,treatment,0,0
204435,for,0,0
204436,malignant,0,1
204437,pleurisy,0,1
204438,.,0,1
204439,Cardiac,0,0
204440,tamponade,0,0
204441,secondary,0,0
204442,to,0,0
204443,cancer,0,1
204444,is,0,0
204445,a,0,0
204446,life-threatening,0,0
204447,complication,0,0
204448,requiring,0,1
204449,immediate,0,0
204450,treatment,0,0
204451,.,0,1
204452,Twenty-four,1,1
204453,patients,1,1
204454,with,1,1
204455,malignant,1,1
204456,pericardial,1,1
204457,effusion,1,1
204458,were,0,0
204459,treated,0,1
204460,by,0,0
204461,intrapericardial,0,0
204462,instillation,0,0
204463,of,0,0
204464,anti-cancer,0,0
204465,drugs,0,0
204466,",",0,0
204467,such,0,0
204468,as,0,0
204469,Carbazilquinone,0,0
204470,",",0,0
204471,Mitomycin-C,0,0
204472,or,0,0
204473,ACNU,0,0
204474,",",0,0
204475,with,0,1
204476,pericardial,0,0
204477,drainage,0,1
204478,.,0,0
204479,The,0,0
204480,range,0,0
204481,of,0,0
204482,survival,0,0
204483,time,0,0
204484,from,0,0
204485,the,0,0
204486,instillation,0,0
204487,of,0,0
204488,anti-cancer,0,0
204489,drug,0,0
204490,was,0,0
204491,3-365,0,1
204492,days,0,0
204493,(,0,1
204494,average,0,1
204495,days,0,0
204496,),0,1
204497,.,0,0
204498,In,0,0
204499,only,0,0
204500,4,0,0
204501,patients,0,1
204502,",",0,0
204503,reaccumulation,0,0
204504,of,0,0
204505,pericardial,0,0
204506,effusion,0,1
204507,was,0,0
204508,recognized,0,0
204509,.,0,0
204510,There,0,0
204511,were,0,0
204512,no,0,0
204513,serious,0,0
204514,complications,0,0
204515,with,0,1
204516,this,0,0
204517,procedure,0,0
204518,.,0,0
204519,It,0,0
204520,was,0,0
204521,considered,0,0
204522,that,0,0
204523,local,0,0
204524,instillation,0,0
204525,of,0,0
204526,anti-cancer,0,0
204527,agents,0,0
204528,with,0,1
204529,pericardial,0,1
204530,drainage,0,1
204531,was,0,0
204532,a,0,0
204533,useful,0,0
204534,therapeutic,0,0
204535,modality,0,0
204536,for,0,0
204537,malignant,0,1
204538,pericarditis,0,1
204539,.,0,1
204540,Caries,0,1
204541,preventive,0,1
204542,effects,0,0
204543,of,0,1
204544,toothpastes,0,1
204545,containing,0,0
204546,monofluorophosphate,0,0
204547,and,0,0
204548,trimetaphosphate,0,0
204549,:,0,1
204550,a,0,0
204551,3-year,0,0
204552,clinical,0,0
204553,trial,0,1
204554,.,0,0
204555,The,0,0
204556,caries-preventive,0,0
204557,effects,0,0
204558,of,0,1
204559,two,0,1
204560,toothpastes,0,1
204561,were,0,1
204562,tested,0,0
204563,in,0,0
204564,a,0,0
204565,3-year,0,0
204566,clinical,0,0
204567,trial,0,1
204568,involving,0,1
204569,1319,1,1
204570,children,1,1
204571,aged,1,1
204572,11-13,1,1
204573,years,1,1
204574,.,1,1
204575,The,0,0
204576,test,0,0
204577,toothpastes,0,0
204578,were,0,1
204579,:,0,1
204580,1,0,0
204581,),0,0
204582,a,0,0
204583,low,0,0
204584,abrasion,0,0
204585,paste,0,0
204586,containing,0,0
204587,0.8,0,0
204588,%,0,0
204589,sodium,0,0
204590,monofluorophosphate,0,0
204591,(,0,0
204592,MFP,0,1
204593,),0,0
204594,",",0,0
204595,and,0,0
204596,2,0,0
204597,),0,0
204598,a,0,0
204599,paste,0,0
204600,containing,0,0
204601,3,0,0
204602,%,0,0
204603,sodium,0,0
204604,trimetaphosphate,0,0
204605,(,0,0
204606,TMP,0,1
204607,),0,0
204608,.,0,0
204609,The,0,0
204610,control,0,0
204611,toothpaste,0,0
204612,was,0,0
204613,a,0,0
204614,conventional,0,0
204615,",",0,0
204616,moderately,0,0
204617,abrasive,0,0
204618,paste,0,0
204619,containing,0,0
204620,0.8,0,0
204621,%,0,0
204622,sodium,0,0
204623,monofluorophosphate,0,0
204624,.,0,0
204625,The,0,0
204626,children,1,1
204627,were,0,0
204628,examined,0,0
204629,clinically,0,0
204630,and,0,0
204631,radiologically,0,1
204632,each,0,0
204633,year,0,0
204634,.,0,0
204635,Toothpaste,0,0
204636,was,0,0
204637,supplied,0,0
204638,to,0,0
204639,the,0,0
204640,children,0,1
204641,'s,0,1
204642,homes,0,1
204643,",",0,1
204644,and,0,0
204645,its,0,0
204646,use,0,0
204647,was,0,0
204648,unsupervised,0,0
204649,.,0,1
204650,Caries,0,0
204651,increments,0,0
204652,after,0,1
204653,3,0,1
204654,years,0,1
204655,",",0,0
204656,in,0,0
204657,terms,0,0
204658,of,0,1
204659,DMF,0,1
204660,teeth,0,1
204661,and,0,1
204662,DMF,0,1
204663,surfaces,0,0
204664,",",0,0
204665,showed,0,0
204666,no,0,0
204667,significant,0,0
204668,differences,0,0
204669,between,0,0
204670,the,1,0
204671,MFP,1,1
204672,test,1,0
204673,group,1,0
204674,(,1,0
204675,444,1,1
204676,children,1,1
204677,),1,1
204678,and,1,0
204679,the,1,0
204680,MFP,1,1
204681,control,1,0
204682,group,1,0
204683,(,1,0
204684,450,1,1
204685,children,1,1
204686,),1,1
204687,.,0,0
204688,However,0,0
204689,",",0,0
204690,the,0,0
204691,TMP,1,0
204692,test,1,0
204693,group,1,0
204694,(,1,0
204695,425,1,1
204696,children,1,1
204697,),1,0
204698,had,0,1
204699,significantly,0,0
204700,higher,0,0
204701,caries,0,1
204702,increments,0,0
204703,than,0,0
204704,the,0,0
204705,MFP,0,1
204706,control,0,0
204707,group,0,0
204708,.,0,0
204709,All,0,0
204710,three,1,0
204711,groups,1,0
204712,of,1,1
204713,children,1,1
204714,showed,0,0
204715,some,0,0
204716,improvement,0,0
204717,in,0,0
204718,oral,0,0
204719,hygiene,0,0
204720,and,0,0
204721,in,0,0
204722,gingival,0,0
204723,health,0,1
204724,",",0,0
204725,but,0,0
204726,there,0,0
204727,were,0,0
204728,no,0,0
204729,significant,0,0
204730,differences,0,0
204731,between,0,0
204732,the,0,0
204733,groups,0,0
204734,.,0,1
204735,The,0,0
204736,role,0,0
204737,of,0,0
204738,the,0,0
204739,MA-sensitive,0,0
204740,leukocyte,0,0
204741,chemotaxis,0,0
204742,in,0,0
204743,rheumatoid,1,1
204744,arthritis,1,1
204745,.,1,0
204746,A,0,0
204747,randomized,0,0
204748,double-blind,0,0
204749,clinical,0,0
204750,trial,0,0
204751,of,0,0
204752,griseofulvin,0,0
204753,treatment,0,0
204754,.,0,0
204755,Polymorphonuclear,0,0
204756,leukocyte,0,0
204757,(,0,0
204758,PMN,0,0
204759,),0,0
204760,chemotaxis,0,0
204761,is,0,0
204762,thought,0,0
204763,to,0,0
204764,play,0,0
204765,an,0,0
204766,essential,0,0
204767,role,0,0
204768,in,0,0
204769,the,0,0
204770,pathogenesis,0,0
204771,of,0,0
204772,rheumatoid,0,1
204773,arthritis,0,1
204774,.,0,1
204775,PMN,0,0
204776,chemotaxis,0,0
204777,is,0,0
204778,in,0,0
204779,part,0,0
204780,sensitive,0,0
204781,to,0,0
204782,microtubule,0,0
204783,antagonists,0,0
204784,(,0,0
204785,MAs,0,0
204786,),0,0
204787,",",0,0
204788,e.g,0,0
204789,.,0,0
204790,colchicine,0,0
204791,.,0,0
204792,The,0,0
204793,antimycotic,0,0
204794,antibiotic,0,0
204795,griseofulvin,0,0
204796,inhibits,0,0
204797,the,0,0
204798,MA-sensitive,0,0
204799,PMN,0,0
204800,chemotaxis,0,0
204801,in,0,0
204802,vitro,0,0
204803,in,0,0
204804,concentrations,0,0
204805,far,0,0
204806,below,0,0
204807,those,0,0
204808,obtained,0,0
204809,in,0,0
204810,serum,0,0
204811,during,0,0
204812,antimycotic,0,0
204813,therapy,0,0
204814,.,0,0
204815,The,0,0
204816,role,0,0
204817,of,0,0
204818,the,0,0
204819,MA-sensitive,0,0
204820,chemotaxis,0,0
204821,in,0,0
204822,rheumatoid,0,1
204823,arthritis,0,1
204824,could,0,0
204825,thus,0,0
204826,be,0,0
204827,elucidated,0,0
204828,by,0,0
204829,a,0,0
204830,clinical,0,0
204831,trial,0,0
204832,of,0,0
204833,griseofulvin,0,0
204834,treatment,0,0
204835,.,0,0
204836,Griseofulvin,0,0
204837,(,1,0
204838,n,1,1
204839,=,1,0
204840,20,1,1
204841,),1,0
204842,was,0,0
204843,tested,0,0
204844,in,0,0
204845,a,0,0
204846,randomized,0,0
204847,double-blind,0,0
204848,study,0,0
204849,versus,0,0
204850,placebo,0,0
204851,(,1,0
204852,m,1,1
204853,=,1,0
204854,19,1,1
204855,),1,0
204856,during,0,0
204857,one,0,1
204858,year,0,1
204859,in,0,0
204860,patients,1,1
204861,with,1,1
204862,rheumatoid,1,1
204863,arthritis,1,1
204864,of,1,0
204865,mild-moderate,1,1
204866,activity,1,0
204867,.,1,0
204868,No,0,0
204869,beneficial,0,0
204870,effect,0,0
204871,of,0,0
204872,griseofulvin,0,0
204873,treatment,0,0
204874,was,0,0
204875,noted,0,0
204876,on,0,0
204877,clinical,0,0
204878,symptoms,0,1
204879,or,0,1
204880,laboratory,0,0
204881,parameters,0,0
204882,of,0,0
204883,rheumatoid,0,1
204884,arthritis,0,1
204885,.,0,0
204886,Moreover,0,0
204887,",",0,0
204888,the,0,0
204889,placebo-treated,0,0
204890,patients,0,1
204891,showed,0,0
204892,more,0,0
204893,improvement,0,0
204894,than,0,0
204895,the,0,0
204896,griseofulvin-treated,0,1
204897,patients,0,1
204898,.,0,0
204899,It,0,0
204900,is,0,0
204901,therefore,0,0
204902,suggested,0,0
204903,that,0,0
204904,the,0,0
204905,MA-sensitive,0,0
204906,chemotaxis,0,0
204907,plays,0,0
204908,a,0,0
204909,reparative,0,0
204910,role,0,0
204911,in,0,0
204912,the,0,0
204913,inflammatory,0,0
204914,lesions,0,0
204915,of,0,0
204916,rheumatoid,0,1
204917,arthritis,0,1
204918,.,0,1
204919,Effect,0,0
204920,of,0,0
204921,cicloxilic,0,0
204922,acid,0,0
204923,on,0,0
204924,bile,0,0
204925,lipid,0,0
204926,composition,0,1
204927,in,0,0
204928,patients,1,1
204929,with,1,1
204930,gallstones,1,1
204931,:,1,1
204932,a,0,0
204933,multicenter,0,0
204934,trial,0,0
204935,.,0,0
204936,24,1,0
204937,gallstone,1,1
204938,patients,1,1
204939,were,0,0
204940,treated,0,1
204941,with,0,1
204942,cicloxilic,0,0
204943,acid,0,0
204944,",",0,0
204945,an,0,0
204946,agent,0,0
204947,endowed,0,0
204948,with,0,1
204949,choleretic,0,0
204950,activity,0,0
204951,",",0,0
204952,at,0,0
204953,the,0,0
204954,dose,0,0
204955,of,0,0
204956,240,0,1
204957,mg/day,0,0
204958,for,0,0
204959,1,0,0
204960,month,0,0
204961,.,0,1
204962,24,1,0
204963,comparable,1,0
204964,patients,1,1
204965,on,1,0
204966,placebo,1,0
204967,treatment,1,0
204968,acted,0,0
204969,as,0,0
204970,controls,0,1
204971,.,0,1
204972,Bile,0,0
204973,lipid,0,0
204974,composition,0,1
204975,was,0,0
204976,determined,0,0
204977,and,0,0
204978,the,0,0
204979,saturation,0,0
204980,index,0,0
204981,calculated,0,0
204982,before,0,0
204983,and,0,0
204984,after,0,0
204985,treatment,0,0
204986,",",0,0
204987,on,0,0
204988,samples,0,0
204989,collected,0,1
204990,by,0,0
204991,duodenal,0,1
204992,siphonage,0,1
204993,after,0,0
204994,caerulein,0,0
204995,stimulation,0,0
204996,",",0,0
204997,in,0,0
204998,both,0,0
204999,groups,0,0
205000,.,0,0
205001,In,0,0
205002,the,0,0
205003,cicloxilic,0,0
205004,group,0,0
205005,there,0,0
205006,was,0,0
205007,little,0,0
205008,or,0,1
205009,no,0,0
205010,change,0,0
205011,in,0,0
205012,bile,0,0
205013,salts,0,0
205014,and,0,0
205015,phospholipids,0,0
205016,",",0,0
205017,whereas,0,0
205018,biliary,0,1
205019,cholesterol,0,0
205020,concentration,0,0
205021,was,0,0
205022,significantly,0,0
205023,reduced,0,0
205024,(,0,0
205025,p,0,0
205026,less,0,0
205027,than,0,0
205028,0.05,0,0
205029,),0,0
205030,and,0,0
205031,consequently,0,0
205032,the,0,0
205033,lithogenic,0,0
205034,index,0,0
205035,lowered,0,0
205036,(,0,0
205037,from,0,1
205038,1.5,0,0
205039,to,0,0
205040,1.2,0,0
205041,",",0,0
205042,p,0,0
205043,less,0,0
205044,than,0,0
205045,0.01,0,0
205046,),0,1
205047,.,0,1
205048,Cicloxilic,0,0
205049,acid,0,0
205050,can,0,0
205051,have,0,0
205052,a,0,0
205053,place,0,0
205054,in,0,0
205055,gallstone,0,1
205056,disease,0,1
205057,therapy,0,0
205058,in,0,0
205059,association,0,0
205060,with,0,1
205061,the,0,0
205062,litholytic,0,0
205063,bile,0,0
205064,acids,0,0
205065,or,0,1
205066,in,0,0
205067,the,0,0
205068,prevention,0,0
205069,of,0,0
205070,gallstone,0,1
205071,formation,0,0
205072,in,0,0
205073,high-risk,0,1
205074,populations,0,1
205075,.,0,1
205076,A,0,0
205077,controlled,0,0
205078,study,0,0
205079,of,0,0
205080,the,0,0
205081,effect,0,0
205082,of,0,0
205083,indomethacin,0,0
205084,in,0,0
205085,uremic,1,1
205086,pericarditis,1,1
205087,.,1,0
205088,To,0,0
205089,determine,0,0
205090,the,0,0
205091,impact,0,0
205092,of,0,0
205093,indomethacin,0,0
205094,on,0,0
205095,the,0,0
205096,course,0,0
205097,of,0,0
205098,uremic,0,1
205099,pericarditis,0,1
205100,we,0,0
205101,performed,0,0
205102,a,0,0
205103,prospective,0,0
205104,",",0,0
205105,double,0,0
205106,blind,0,0
205107,study,0,0
205108,in,0,0
205109,which,0,0
205110,24,1,1
205111,patients,1,1
205112,with,1,1
205113,endstage,1,1
205114,chronic,1,1
205115,renal,1,1
205116,failure,1,1
205117,and,1,0
205118,pericarditis,1,1
205119,randomly,1,1
205120,received,1,0
205121,indomethacin,1,0
205122,",",1,0
205123,25,1,1
205124,mg,1,0
205125,four,1,1
205126,times,1,0
205127,daily,1,0
205128,",",1,0
205129,(,1,0
205130,11,1,0
205131,patients,1,1
205132,),1,1
205133,or,1,1
205134,a,1,0
205135,placebo,1,0
205136,(,1,0
205137,13,1,1
205138,patients,1,1
205139,),1,1
205140,for,0,0
205141,a,0,0
205142,3-week,0,0
205143,period,0,0
205144,.,0,0
205145,All,0,0
205146,patients,1,1
205147,received,1,0
205148,peritoneal,1,1
205149,or,1,1
205150,hemodialysis,1,1
205151,treatment,1,0
205152,concurrently,1,0
205153,with,0,0
205154,the,0,0
205155,study,0,0
205156,drug,0,0
205157,.,0,0
205158,In,0,0
205159,contrast,0,0
205160,to,0,0
205161,the,0,0
205162,placebo,0,0
205163,",",0,0
205164,indomethacin,0,0
205165,produced,0,0
205166,an,0,0
205167,immediate,0,0
205168,and,0,0
205169,sustained,0,0
205170,reduction,0,0
205171,of,0,0
205172,fever,0,0
205173,in,0,0
205174,all,0,0
205175,but,0,0
205176,one,0,0
205177,patient,0,0
205178,.,0,0
205179,On,0,0
205180,the,0,0
205181,other,0,0
205182,hand,0,0
205183,",",0,0
205184,indomethacin,0,0
205185,had,0,0
205186,no,0,0
205187,effect,0,0
205188,on,0,0
205189,the,0,0
205190,duration,0,0
205191,of,0,0
205192,chest,0,0
205193,pain,0,1
205194,(,0,0
205195,mean,0,1
205196,days,0,0
205197,+/-,0,1
205198,SE,0,1
205199,:,0,1
205200,placebo,0,0
205201,1.4,0,0
205202,+/-,0,0
205203,0.6,0,0
205204,",",0,0
205205,indomethacin,0,0
205206,5.5,0,1
205207,+/-,0,0
205208,3.3,0,0
205209,),0,0
205210,",",0,0
205211,duration,0,0
205212,of,0,0
205213,pericardial,0,0
205214,friction,0,0
205215,rub,0,0
205216,(,0,0
205217,placebo,0,0
205218,10.3,0,0
205219,+/-,0,0
205220,1.7,0,0
205221,",",0,0
205222,indomethacin,0,0
205223,16.0,0,0
205224,+/-,0,0
205225,3.8,0,0
205226,),0,0
205227,",",0,0
205228,or,0,0
205229,on,0,0
205230,the,0,0
205231,amount,0,0
205232,of,0,0
205233,pericardial,0,0
205234,effusion,0,1
205235,.,0,0
205236,Further,0,0
205237,",",0,0
205238,indomethacin,0,0
205239,did,0,0
205240,not,0,0
205241,diminish,0,0
205242,the,0,0
205243,need,0,0
205244,for,0,0
205245,invasive,0,1
205246,surgical,0,1
205247,procedures,0,0
205248,for,0,0
205249,relief,0,0
205250,of,0,0
205251,tamponade,0,0
205252,(,0,0
205253,three,0,0
205254,of,0,0
205255,13,0,1
205256,placebo,0,0
205257,patients,0,1
205258,",",0,0
205259,two,0,0
205260,of,0,0
205261,11,0,1
205262,indomethacin,0,0
205263,patients,0,1
205264,),0,1
205265,or,0,1
205266,result,0,0
205267,in,0,0
205268,decreased,0,0
205269,mortality,0,0
205270,rate,0,0
205271,.,0,0
205272,Death,0,0
205273,(,0,0
205274,not,0,0
205275,due,0,0
205276,to,0,0
205277,pericarditis,0,1
205278,),0,0
205279,occurred,0,0
205280,in,0,0
205281,two,0,0
205282,patients,0,1
205283,treated,0,1
205284,with,0,1
205285,indomethacin,0,0
205286,and,0,0
205287,one,0,1
205288,patient,0,1
205289,who,0,1
205290,received,0,1
205291,the,0,1
205292,placebo,0,0
205293,.,0,0
205294,In,0,0
205295,our,0,0
205296,patients,0,1
205297,pericarditis,0,1
205298,encompassed,0,0
205299,a,0,0
205300,wide,0,1
205301,spectrum,0,1
205302,ranging,0,0
205303,from,0,0
205304,a,0,0
205305,mild,0,1
205306,illness,0,1
205307,of,0,0
205308,several,0,0
205309,days,0,0
205310,duration,0,0
205311,to,0,0
205312,a,0,0
205313,painful,0,0
205314,and,0,0
205315,debilitating,0,0
205316,disease,0,1
205317,lasting,0,0
205318,weeks,0,0
205319,and,0,1
205320,requiring,0,1
205321,surgical,0,0
205322,intervention,0,0
205323,.,0,0
205324,Although,0,0
205325,the,0,0
205326,size,0,0
205327,of,0,0
205328,our,0,0
205329,population,0,1
205330,prohibits,0,0
205331,definitive,0,0
205332,conclusions,0,0
205333,",",0,0
205334,it,0,0
205335,would,0,0
205336,appear,0,0
205337,that,0,0
205338,",",0,0
205339,except,0,0
205340,for,0,0
205341,fever,0,0
205342,",",0,0
205343,the,0,0
205344,manifestations,0,0
205345,and,0,0
205346,natural,0,0
205347,history,0,1
205348,of,0,0
205349,this,0,0
205350,illness,0,1
205351,are,0,0
205352,unaffected,0,0
205353,by,0,0
205354,indomethacin,0,0
205355,.,0,1
205356,Fentanyl,0,0
205357,supplementation,0,0
205358,to,0,0
205359,inhalation,1,0
205360,anaesthesia,1,1
205361,.,1,0
205362,In,0,0
205363,eight,1,1
205364,out,1,1
205365,of,1,0
205366,15,1,1
205367,healthy,1,1
205368,patients,1,1
205369,undergoing,1,1
205370,body,1,1
205371,surface,1,0
205372,surgery,1,1
205373,",",0,0
205374,the,0,0
205375,effect,0,0
205376,of,0,0
205377,a,0,0
205378,fentanyl,0,0
205379,infusion,0,0
205380,on,0,0
205381,a,0,0
205382,conventional,0,0
205383,thiopentone,0,0
205384,",",0,0
205385,nitrous,0,0
205386,oxide,0,0
205387,",",0,0
205388,oxygen,0,0
205389,and,0,0
205390,halothane,0,0
205391,anaesthetic,0,0
205392,was,0,0
205393,studied,0,0
205394,.,0,0
205395,The,0,0
205396,fentanyl,0,0
205397,infusion,0,0
205398,(,0,0
205399,2,0,0
205400,micrograms/kg/hour,0,0
205401,),0,0
205402,reduced,0,0
205403,the,0,0
205404,induction,0,0
205405,dose,0,0
205406,of,0,0
205407,thiopentone,0,0
205408,and,0,0
205409,caused,0,0
205410,marked,0,0
205411,respiratory,0,1
205412,depression,0,1
205413,with,0,1
205414,a,0,0
205415,reduction,0,0
205416,in,0,0
205417,the,0,0
205418,patients,0,1
205419,',0,1
205420,response,0,0
205421,to,0,1
205422,surgery,0,1
205423,.,0,0
205424,The,0,0
205425,mean,0,0
205426,arterial,0,1
205427,pressures,0,0
205428,and,0,1
205429,pulse,0,0
205430,rates,0,0
205431,were,0,0
205432,not,0,0
205433,significantly,0,0
205434,different,0,0
205435,in,0,0
205436,each,0,0
205437,group,0,0
205438,throughout,0,0
205439,the,0,0
205440,course,0,0
205441,of,0,0
205442,the,0,0
205443,operation,0,0
205444,.,0,0
205445,The,0,0
205446,fentanyl,0,0
205447,made,0,0
205448,no,0,0
205449,difference,0,0
205450,to,0,0
205451,the,0,0
205452,patients,0,1
205453,',0,1
205454,postoperative,0,0
205455,analgesic,0,0
205456,requirements,0,1
205457,or,0,1
205458,to,0,0
205459,their,0,0
205460,recovery,0,0
205461,in,0,0
205462,the,0,0
205463,first,0,0
205464,24,0,1
205465,hours,0,0
205466,.,0,1
205467,The,0,0
205468,treatment,0,0
205469,of,0,0
205470,acne,1,1
205471,vulgaris,1,1
205472,in,0,0
205473,general,1,1
205474,practice,1,0
205475,.,1,0
205476,A,0,0
205477,double-blind,0,0
205478,assessment,0,0
205479,of,0,0
205480,co-trimoxazole,0,1
205481,and,0,0
205482,tetracycline,0,0
205483,.,0,1
205484,[,0,0
205485,Maintaining,0,0
205486,sinus,0,1
205487,rhythm,0,1
205488,with,0,1
205489,quinidine,0,0
205490,and,0,0
205491,amiodarone,0,0
205492,after,1,0
205493,electric,1,0
205494,cardioversion,1,1
205495,],1,1
205496,.,0,1
205497,Bovine,1,1
205498,carotid,1,1
205499,artery,1,1
205500,heterografts,1,0
205501,versus,1,0
205502,polytetrafluoroethylene,1,0
205503,grafts,1,1
205504,.,1,1
205505,A,0,0
205506,prospective,0,0
205507,",",0,0
205508,randomized,0,0
205509,study,0,0
205510,.,0,0
205511,A,0,0
205512,prospective,0,0
205513,",",0,0
205514,randomized,0,0
205515,comparison,0,0
205516,of,0,0
205517,BCAH,0,0
205518,and,0,0
205519,PTFE,0,0
205520,vascular,0,0
205521,access,0,0
205522,grafts,0,0
205523,resulted,0,0
205524,in,0,0
205525,no,0,0
205526,statistically,0,0
205527,significant,0,0
205528,difference,0,0
205529,when,0,0
205530,analyzed,0,0
205531,for,0,0
205532,survival,0,0
205533,rates,0,0
205534,of,0,0
205535,complications,0,0
205536,",",0,0
205537,types,0,0
205538,of,0,0
205539,complications,0,0
205540,",",0,0
205541,reasons,0,0
205542,for,0,0
205543,failure,0,1
205544,",",0,0
205545,and,0,0
205546,clot,0,0
205547,salvageability,0,0
205548,.,0,0
205549,The,0,0
205550,results,0,0
205551,in,0,0
205552,diabetic,1,1
205553,patients,1,1
205554,were,0,1
205555,similar,0,0
205556,to,0,0
205557,those,0,0
205558,in,0,0
205559,nondiabetic,1,1
205560,patients,1,1
205561,.,1,1
205562,The,0,0
205563,majority,0,0
205564,of,0,0
205565,retrospective,0,1
205566,studies,0,0
205567,and,0,1
205568,subjective,0,0
205569,experiences,0,0
205570,favor,0,0
205571,PTFE,0,0
205572,grafts,0,1
205573,over,0,0
205574,BCAHs,0,1
205575,.,0,0
205576,The,0,0
205577,explanation,0,0
205578,may,0,0
205579,be,0,0
205580,part,0,0
205581,that,0,0
205582,BCAH,0,0
205583,preceded,0,0
205584,PTFE,0,0
205585,grafts,0,1
205586,into,0,1
205587,clinical,0,0
205588,use,0,0
205589,",",0,0
205590,and,0,0
205591,inexperience,0,0
205592,in,0,0
205593,the,0,0
205594,operating,0,0
205595,room,0,0
205596,and,0,0
205597,in,0,0
205598,the,0,0
205599,dialysis,0,1
205600,unit,0,0
205601,had,0,0
205602,an,0,0
205603,effect,0,0
205604,on,0,0
205605,BCAH,0,0
205606,results,0,0
205607,.,0,1
205608,A,0,0
205609,review,0,0
205610,of,0,0
205611,impressions,0,0
205612,of,0,0
205613,the,0,0
205614,graft,0,0
205615,materials,0,0
205616,indicated,0,0
205617,a,0,0
205618,decided,0,0
205619,preference,0,0
205620,for,0,0
205621,PTFE,0,1
205622,grafts,0,1
205623,.,0,1
205624,High-dose,0,0
205625,weekly,0,0
205626,fractionation,0,0
205627,radiotherapy,0,1
205628,in,0,0
205629,advanced,1,1
205630,cancer,1,1
205631,of,1,0
205632,the,1,0
205633,uterine,1,1
205634,cervix,1,1
205635,.,1,0
205636,A,0,0
205637,trial,0,0
205638,comparing,0,0
205639,two,1,0
205640,different,1,0
205641,radiotherapy,1,1
205642,techniques,1,0
205643,and,0,0
205644,schedules,0,0
205645,in,0,0
205646,the,0,0
205647,treatment,0,0
205648,of,0,0
205649,83,1,1
205650,patients,1,1
205651,with,1,1
205652,advanced,1,1
205653,cancer,1,1
205654,of,1,0
205655,the,1,0
205656,uterine,1,1
205657,cervix,1,1
205658,(,1,0
205659,stage,1,1
205660,IIIB,1,0
205661,),1,0
205662,employing,1,0
205663,external,1,0
205664,irradiation,1,0
205665,alone,1,0
205666,is,0,0
205667,described,0,0
205668,.,0,0
205669,The,0,0
205670,one,0,0
205671,technique,0,0
205672,",",0,0
205673,used,0,0
205674,routinely,0,0
205675,in,0,0
205676,this,0,0
205677,department,0,1
205678,",",0,0
205679,employed,0,0
205680,a,0,0
205681,conventional,0,0
205682,daily,0,0
205683,fractionation,0,0
205684,schedule,0,0
205685,while,0,0
205686,the,0,0
205687,other,0,0
205688,used,0,0
205689,a,0,0
205690,high-dose,0,0
205691,weekly,0,0
205692,fractionation,0,1
205693,regimen,0,0
205694,.,0,1
205695,The,0,0
205696,techniques,0,0
205697,are,0,0
205698,described,0,0
205699,.,0,0
205700,The,0,0
205701,aim,0,0
205702,of,0,0
205703,the,0,0
205704,trial,0,0
205705,was,0,0
205706,to,0,0
205707,compare,0,0
205708,the,0,0
205709,efficacy,0,0
205710,and,0,0
205711,morbidity,0,0
205712,of,0,0
205713,these,0,0
205714,two,0,0
205715,methods,0,1
205716,of,0,1
205717,treatment,0,0
205718,.,0,1
205719,Dose,0,0
205720,distribution,0,0
205721,curves,0,0
205722,in,0,0
205723,cross-section,0,1
205724,and,0,0
205725,midsagittal,0,0
205726,planes,0,0
205727,are,0,0
205728,shown,0,0
205729,and,0,0
205730,calculations,0,0
205731,or,0,1
205732,equivalent,0,0
205733,doses,0,0
205734,at,0,1
205735,various,0,0
205736,selected,0,1
205737,points,0,0
205738,using,0,0
205739,Ellis,0,1
205740,'s,0,1
205741,nominal,0,0
205742,single-dose,0,0
205743,formula,0,0
205744,are,0,0
205745,tabulated,0,0
205746,.,0,0
205747,The,0,0
205748,2-year,0,0
205749,survival,0,0
205750,figures,0,0
205751,were,0,1
205752,33,0,1
205753,%,0,0
205754,for,0,0
205755,the,0,0
205756,daily,0,0
205757,fractionation,0,0
205758,technique,0,0
205759,and,0,0
205760,22,0,1
205761,%,0,0
205762,for,0,0
205763,the,0,0
205764,weekly,0,0
205765,regimen,0,0
205766,.,0,1
205767,Serious,0,0
205768,late,0,1
205769,complication,0,0
205770,rates,0,0
205771,were,0,1
205772,6,0,0
205773,%,0,0
205774,for,0,0
205775,the,0,0
205776,daily,0,0
205777,regimen,0,0
205778,and,0,1
205779,22,0,1
205780,%,0,0
205781,for,0,0
205782,the,0,0
205783,weekly,0,0
205784,schedule,0,0
205785,.,0,0
205786,These,0,0
205787,differences,0,0
205788,are,0,0
205789,not,0,0
205790,statistically,0,0
205791,significant,0,0
205792,.,0,0
205793,Late,0,0
205794,complication,0,0
205795,rates,0,0
205796,in,0,0
205797,the,0,0
205798,weekly,0,0
205799,fractionation,0,0
205800,regimen,0,0
205801,appeared,0,0
205802,to,0,0
205803,be,0,0
205804,lower,0,0
205805,than,0,0
205806,figures,0,0
205807,quoted,0,0
205808,by,0,0
205809,other,0,0
205810,authors,0,0
205811,.,0,1
205812,Local,0,0
205813,control,0,0
205814,within,0,0
205815,the,0,0
205816,irradiated,0,0
205817,volume,0,0
205818,was,0,0
205819,better,0,0
205820,in,0,0
205821,the,0,0
205822,group,0,0
205823,treated,0,0
205824,by,0,0
205825,the,0,0
205826,daily,0,0
205827,fractionation,0,0
205828,method,0,0
205829,.,0,1
205830,Comparative,0,0
205831,efficacy,0,0
205832,and,0,0
205833,safety,0,0
205834,of,0,0
205835,lofexidine,0,0
205836,and,0,0
205837,clonidine,0,0
205838,given,0,0
205839,alone,0,0
205840,or,0,0
205841,concomitantly,0,0
205842,with,0,0
205843,hydrochlorothiazide,0,0
205844,in,0,0
205845,hypertensive,1,1
205846,outpatients,1,1
205847,.,1,1
205848,Platelet,1,1
205849,inhibitory,1,0
205850,drugs,1,0
205851,:,1,1
205852,an,0,0
205853,in,0,0
205854,vivo,0,0
205855,method,0,0
205856,of,0,0
205857,evaluation,0,0
205858,in,0,0
205859,patients,0,1
205860,.,0,1
205861,The,0,0
205862,measurement,0,0
205863,of,0,0
205864,platelet,1,0
205865,deposition,1,0
205866,in,1,0
205867,human,1,0
205868,thrombi,1,1
205869,is,0,0
205870,essential,0,0
205871,for,0,0
205872,the,0,0
205873,evaluation,0,0
205874,of,0,0
205875,platelet-inhibitory,0,0
205876,drugs,0,0
205877,and,0,1
205878,prosthetic,0,1
205879,materials,0,1
205880,for,0,0
205881,use,0,0
205882,in,0,0
205883,patients,0,1
205884,.,0,1
205885,The,0,0
205886,rate,0,0
205887,of,0,0
205888,111Indium-labelled,0,0
205889,platelet,0,0
205890,accumulation,0,0
205891,on,0,0
205892,Dacron,1,0
205893,arterial,1,1
205894,grafts,1,1
205895,was,0,0
205896,measured,0,0
205897,in,0,0
205898,27,1,1
205899,patients,1,1
205900,randomised,0,1
205901,to,0,0
205902,take,0,0
205903,either,0,0
205904,aspirin,0,0
205905,and,0,0
205906,dipyridamole,0,0
205907,(,0,0
205908,ASA,0,1
205909,+,0,0
205910,DPM,0,0
205911,),0,0
205912,or,0,1
205913,placebo,0,0
205914,.,0,1
205915,Autologous,0,0
205916,platelets,0,0
205917,were,0,1
205918,labelled,0,0
205919,and,0,0
205920,re-injected,0,1
205921,seven,0,1
205922,days,0,0
205923,following,0,0
205924,surgery,0,1
205925,and,0,0
205926,the,0,0
205927,graft,0,0
205928,thrombogenicity,0,0
205929,index,0,0
205930,calculated,0,0
205931,as,0,0
205932,the,0,0
205933,daily,0,0
205934,rise,0,0
205935,in,0,0
205936,the,0,0
205937,ratio,0,0
205938,of,0,0
205939,emissions,0,0
205940,from,0,1
205941,the,0,0
205942,graft,0,0
205943,over,0,0
205944,a,0,0
205945,reference,0,0
205946,site,0,0
205947,.,0,0
205948,The,0,0
205949,mean,0,0
205950,(,0,0
205951,+/-,0,0
205952,SD,0,1
205953,),0,0
205954,thrombogenicity,0,0
205955,index,0,0
205956,in,0,0
205957,12,0,1
205958,patients,0,1
205959,undergoing,0,1
205960,femoro-popliteal,0,1
205961,bypass,0,1
205962,was,0,0
205963,0.25,0,0
205964,+/-,0,0
205965,0.09,0,0
205966,on,0,0
205967,placebo,0,0
205968,and,0,0
205969,0.16,0,0
205970,+/-,0,0
205971,0.07,0,0
205972,on,0,0
205973,ASA,0,1
205974,+,0,0
205975,DPM,0,0
205976,started,0,0
205977,pre-operatively,0,0
205978,(,0,0
205979,p,0,0
205980,less,0,0
205981,than,0,0
205982,0.05,0,0
205983,),0,1
205984,.,0,1
205985,Post-operative,0,0
205986,ASA,0,1
205987,+,0,0
205988,DPM,0,0
205989,therapy,0,0
205990,started,0,0
205991,two,0,0
205992,days,0,0
205993,following,0,0
205994,platelet,0,0
205995,labelling,0,0
205996,in,0,0
205997,15,0,1
205998,patients,0,1
205999,with,0,1
206000,aorto-femoral,0,1
206001,grafts,0,0
206002,also,0,0
206003,significantly,0,0
206004,reduce,0,0
206005,thrombogenicity,0,0
206006,to,0,0
206007,0.12,0,0
206008,+/-,0,0
206009,0.05,0,0
206010,compared,0,0
206011,with,0,1
206012,0.25,0,0
206013,+/-,0,0
206014,0.08,0,0
206015,on,0,0
206016,placebo,0,0
206017,(,0,0
206018,p,0,0
206019,less,0,0
206020,than,0,0
206021,0.01,0,0
206022,),0,0
206023,.,0,0
206024,In,0,0
206025,the,0,0
206026,latter,0,0
206027,patients,0,1
206028,the,0,0
206029,ratio,0,0
206030,of,0,0
206031,emissions,0,0
206032,from,0,1
206033,the,0,0
206034,graft,0,0
206035,over,0,0
206036,reference,0,0
206037,fell,0,0
206038,significantly,0,0
206039,on,0,0
206040,starting,0,0
206041,ASA,0,1
206042,+,0,0
206043,DPM,0,0
206044,",",0,0
206045,suggesting,0,0
206046,a,0,0
206047,net,0,0
206048,loss,0,0
206049,of,0,0
206050,platelets,0,0
206051,from,0,1
206052,the,0,0
206053,graft,0,0
206054,.,0,0
206055,These,0,0
206056,results,0,0
206057,indicate,0,0
206058,that,0,0
206059,the,0,0
206060,rate,0,0
206061,of,0,0
206062,in,0,0
206063,vivo,0,0
206064,platelet,0,0
206065,accumulation,0,0
206066,on,0,0
206067,Dacron,0,0
206068,grafts,0,0
206069,can,0,0
206070,be,0,0
206071,quantitated,0,0
206072,and,0,0
206073,that,0,0
206074,ASA,0,1
206075,+,0,0
206076,DPM,0,0
206077,reduced,0,0
206078,this,0,0
206079,rate,0,0
206080,in,0,0
206081,man,0,1
206082,.,0,1
206083,Two,0,1
206084,blind,0,1
206085,randomized,0,1
206086,cross-over,0,0
206087,trials,0,0
206088,in,0,0
206089,the,0,0
206090,treatment,1,0
206091,of,1,0
206092,primary,1,1
206093,open,1,1
206094,angle,1,0
206095,glaucoma,1,1
206096,.,1,0
206097,We,0,0
206098,present,0,0
206099,the,0,0
206100,results,0,0
206101,of,0,0
206102,two,0,1
206103,blind,0,1
206104,randomized,0,1
206105,trials,0,1
206106,comparing,0,0
206107,both,0,0
206108,guanethidine,0,0
206109,3,0,0
206110,per,0,0
206111,cent,0,0
206112,and,0,0
206113,adrenaline,0,0
206114,0.5,0,0
206115,per,0,0
206116,cent,0,0
206117,(,0,1
206118,Ganda,0,1
206119,3.0/0.5,0,0
206120,),0,0
206121,and,0,0
206122,guanethidine,0,0
206123,1,0,0
206124,per,0,0
206125,cent,0,0
206126,and,0,0
206127,adrenaline,0,0
206128,0.2,0,0
206129,per,0,0
206130,cent,0,0
206131,(,0,1
206132,Ganda,0,1
206133,1.0/0.2,0,0
206134,),0,0
206135,in,0,0
206136,single,0,0
206137,drop,0,0
206138,form,0,0
206139,with,0,1
206140,Timolol,0,0
206141,(,0,1
206142,Timoptol,0,0
206143,),0,0
206144,0.25,0,0
206145,per,0,0
206146,cent,0,1
206147,.,0,1
206148,Results,0,0
206149,of,0,0
206150,48-hour,0,0
206151,phasing,0,0
206152,at,0,0
206153,the,0,0
206154,end,0,0
206155,of,0,0
206156,one,0,0
206157,month,0,0
206158,'s,0,1
206159,treatment,0,0
206160,demonstrated,0,0
206161,a,0,0
206162,significantly,0,0
206163,greater,0,0
206164,fall,0,0
206165,in,0,0
206166,intraocular,0,0
206167,pressure,0,0
206168,with,0,1
206169,Ganda,0,1
206170,3.0/0.5,0,0
206171,(,0,0
206172,9.8,0,0
206173,mm,0,0
206174,Hg,0,0
206175,),0,0
206176,than,0,0
206177,with,0,1
206178,Timolol,0,0
206179,0.25,0,0
206180,per,0,0
206181,cent,0,1
206182,(,0,0
206183,7.67,0,0
206184,mm,0,0
206185,Hg,0,0
206186,),0,0
206187,P,0,0
206188,less,0,0
206189,than,0,0
206190,0.001,0,0
206191,.,0,0
206192,There,0,0
206193,was,0,0
206194,no,0,0
206195,significant,0,0
206196,difference,0,0
206197,in,0,0
206198,the,0,0
206199,fall,0,0
206200,in,0,0
206201,intraocular,0,0
206202,pressure,0,0
206203,between,0,0
206204,Ganda,0,1
206205,1.0/0.2,0,0
206206,(,0,0
206207,8.87,0,0
206208,mm,0,0
206209,Hg,0,0
206210,),0,0
206211,and,0,0
206212,Timolol,0,0
206213,0.25,0,0
206214,per,0,0
206215,cent,0,1
206216,(,0,0
206217,8.24,0,0
206218,mm,0,0
206219,Hg,0,0
206220,),0,0
206221,.,0,1
206222,Treatment,0,0
206223,of,0,0
206224,stable,1,1
206225,angina,1,1
206226,of,1,0
206227,effort,1,0
206228,with,0,1
206229,verapamil,0,0
206230,:,0,1
206231,a,0,0
206232,double-blind,0,0
206233,",",0,0
206234,placebo-controlled,0,0
206235,randomized,0,0
206236,crossover,0,1
206237,study,0,0
206238,.,0,0
206239,The,0,0
206240,effects,0,0
206241,of,0,0
206242,verapamil,0,0
206243,were,0,0
206244,assessed,0,0
206245,in,0,0
206246,26,1,1
206247,patients,1,1
206248,with,1,1
206249,stable,1,1
206250,exertional,1,1
206251,angina,1,1
206252,pectoris,1,1
206253,in,0,0
206254,a,0,0
206255,double-blind,0,0
206256,",",0,0
206257,placebo-controlled,0,0
206258,",",0,0
206259,randomized,0,0
206260,crossover,0,0
206261,protocol,0,0
206262,using,0,0
206263,serial,0,0
206264,treadmill,0,1
206265,tests,0,0
206266,.,0,1
206267,Verapamil,0,1
206268,",",0,0
206269,480,0,0
206270,mg/day,0,0
206271,",",0,0
206272,reduced,0,0
206273,anginal,0,0
206274,frequency,0,0
206275,from,0,1
206276,5.6,0,0
206277,+/-,0,0
206278,7.3,0,0
206279,to,0,1
206280,2.2,0,0
206281,+/-,0,0
206282,3.9,0,0
206283,attacks,0,1
206284,per,0,0
206285,week,0,0
206286,(,0,0
206287,p,0,0
206288,less,0,0
206289,than,0,0
206290,0.001,0,0
206291,),0,1
206292,and,0,0
206293,nitroglycerin,0,0
206294,consumption,0,0
206295,from,0,1
206296,3.4,0,1
206297,+/-,0,0
206298,4.9,0,0
206299,to,0,1
206300,1.2,0,0
206301,+/-,0,0
206302,2.5,0,0
206303,tablets,0,0
206304,per,0,0
206305,week,0,0
206306,(,0,0
206307,p,0,0
206308,less,0,0
206309,than,0,0
206310,0.05,0,0
206311,),0,0
206312,compared,0,0
206313,with,0,1
206314,placebo,0,0
206315,.,0,1
206316,Treadmill,0,0
206317,time,0,0
206318,increased,0,0
206319,from,0,1
206320,6.4,0,0
206321,+/-,0,0
206322,2.1,0,0
206323,minutes,0,0
206324,during,0,0
206325,the,0,0
206326,placebo,0,0
206327,phase,0,0
206328,to,0,0
206329,7.5,0,0
206330,+/-,0,0
206331,1.8,0,0
206332,minutes,0,0
206333,during,0,0
206334,the,0,0
206335,verapamil,0,0
206336,phase,0,0
206337,(,0,0
206338,p,0,0
206339,less,0,0
206340,than,0,0
206341,0.001,0,0
206342,),0,1
206343,.,0,1
206344,Verapamil,0,0
206345,'s,0,1
206346,beneficial,0,0
206347,effect,0,0
206348,appeared,0,0
206349,to,0,0
206350,be,0,0
206351,related,0,0
206352,",",0,0
206353,in,0,0
206354,part,0,0
206355,",",0,0
206356,to,0,0
206357,a,0,0
206358,10,0,0
206359,%,0,0
206360,reduction,0,0
206361,of,0,0
206362,the,0,0
206363,rate-pressure,0,0
206364,product,0,0
206365,at,0,0
206366,rest,0,0
206367,(,0,0
206368,p,0,0
206369,less,0,0
206370,than,0,0
206371,0.05,0,0
206372,),0,0
206373,and,0,0
206374,a,0,0
206375,12,0,0
206376,%,0,0
206377,reduction,0,0
206378,during,0,0
206379,submaximal,0,0
206380,exercise,0,0
206381,(,0,0
206382,p,0,0
206383,less,0,0
206384,than,0,0
206385,0.001,0,0
206386,),0,1
206387,.,0,0
206388,Verapamil,0,0
206389,also,0,0
206390,caused,0,0
206391,less,0,0
206392,marked,0,0
206393,ST-segment,0,0
206394,depressions,0,1
206395,at,0,0
206396,peak,0,0
206397,exercise,0,0
206398,(,0,0
206399,p,0,0
206400,less,0,0
206401,than,0,0
206402,0.05,0,0
206403,),0,0
206404,at,0,0
206405,a,0,0
206406,similar,0,0
206407,rate-pressure,0,0
206408,product,0,0
206409,",",0,0
206410,suggesting,0,0
206411,a,0,0
206412,favorable,0,0
206413,redistribution,0,0
206414,of,0,0
206415,coronary,0,1
206416,blood,0,0
206417,flow,0,0
206418,to,0,0
206419,the,0,0
206420,ischemic,0,1
206421,zone,0,1
206422,.,0,1
206423,Side,0,0
206424,effects,0,0
206425,from,0,1
206426,verapamil,0,0
206427,were,0,0
206428,minimal,0,0
206429,",",0,0
206430,consisting,0,0
206431,mainly,0,0
206432,of,0,0
206433,constipation,0,1
206434,(,0,1
206435,six,0,1
206436,patients,0,1
206437,),0,1
206438,.,0,0
206439,Verapamil,0,0
206440,appears,0,0
206441,to,0,0
206442,be,0,0
206443,a,0,0
206444,safe,0,0
206445,and,0,0
206446,effective,0,0
206447,drug,0,0
206448,for,0,0
206449,treating,0,0
206450,angina,1,1
206451,of,0,0
206452,effort,0,0
206453,.,0,1
206454,Postoperative,0,0
206455,dreaming,0,1
206456,.,0,0
206457,A,0,0
206458,comparison,0,0
206459,of,0,0
206460,the,0,0
206461,incidence,0,0
206462,following,0,0
206463,pentazocine,0,0
206464,and,0,0
206465,morphine,0,0
206466,premedication,0,0
206467,.,0,0
206468,The,0,0
206469,incidence,0,0
206470,of,0,0
206471,postoperative,0,0
206472,dreaming,0,0
206473,following,0,0
206474,the,0,0
206475,use,0,0
206476,of,0,0
206477,morphine,0,0
206478,and,0,0
206479,pentazocine,0,0
206480,as,0,0
206481,premedicants,0,0
206482,in,0,0
206483,an,0,0
206484,otherwise,0,1
206485,standard,0,0
206486,anaesthetic,0,0
206487,sequence,0,0
206488,is,0,0
206489,compared,0,0
206490,in,0,0
206491,healthy,1,1
206492,volunteers,1,1
206493,.,1,1
206494,No,0,0
206495,statistically,0,0
206496,significant,0,0
206497,difference,0,0
206498,was,0,0
206499,demonstrated,0,0
206500,between,0,0
206501,the,0,0
206502,two,0,0
206503,drugs,0,0
206504,.,0,1
206505,The,0,0
206506,causes,0,0
206507,of,0,0
206508,psychotomimetic,0,1
206509,problems,0,1
206510,in,0,0
206511,the,0,0
206512,postoperative,0,0
206513,period,0,0
206514,and,0,0
206515,the,0,0
206516,difficulty,0,0
206517,of,0,0
206518,precise,0,0
206519,definition,0,0
206520,of,0,0
206521,hallucinations,0,0
206522,are,0,0
206523,discussed,0,0
206524,.,0,1
206525,Changes,0,0
206526,in,0,0
206527,the,0,0
206528,fatty,0,0
206529,acid,0,0
206530,composition,0,1
206531,of,0,0
206532,the,0,0
206533,plasma,0,0
206534,lipid,0,0
206535,esters,0,0
206536,during,0,0
206537,lipid-lowering,0,1
206538,treatment,0,0
206539,with,0,1
206540,diet,0,0
206541,",",0,0
206542,clofibrate,0,0
206543,and,0,0
206544,niceritrol,0,0
206545,.,0,0
206546,Reduction,0,0
206547,of,0,0
206548,the,0,0
206549,proportion,0,0
206550,of,0,0
206551,linoleate,0,0
206552,by,0,0
206553,clofibrate,0,0
206554,but,0,0
206555,not,0,0
206556,by,0,0
206557,niceritrol,0,0
206558,.,0,0
206559,The,0,0
206560,fatty,0,0
206561,acid,0,0
206562,composition,0,1
206563,of,0,0
206564,the,0,0
206565,plasma,0,0
206566,lipid,0,0
206567,esters,0,0
206568,has,0,0
206569,been,0,0
206570,studied,0,0
206571,during,0,0
206572,lipid-lowering,0,1
206573,treatment,0,0
206574,of,0,0
206575,95,1,0
206576,patients,1,1
206577,with,1,1
206578,atherosclerotic,1,1
206579,disease,1,1
206580,.,1,0
206581,During,0,0
206582,the,0,0
206583,first,0,0
206584,two,0,0
206585,months,0,0
206586,of,0,0
206587,the,0,0
206588,trial,0,0
206589,only,0,0
206590,a,0,0
206591,diet,0,0
206592,was,0,0
206593,prescribed,0,0
206594,.,0,0
206595,During,0,0
206596,the,0,0
206597,ensuing,0,0
206598,two,0,0
206599,months,0,0
206600,either,0,0
206601,clofibrate,0,0
206602,or,0,0
206603,niceritrol,0,0
206604,",",0,0
206605,a,0,0
206606,nicotinic,0,0
206607,acid,0,0
206608,ester,0,0
206609,",",0,0
206610,was,0,0
206611,added,0,0
206612,in,0,0
206613,a,0,0
206614,randomized,0,0
206615,order,0,0
206616,.,0,0
206617,During,0,0
206618,the,0,0
206619,last,0,0
206620,two,0,0
206621,months,0,0
206622,the,0,0
206623,second,0,0
206624,drug,0,0
206625,was,0,0
206626,added,0,0
206627,.,0,0
206628,The,0,0
206629,combined,0,0
206630,treatment,0,0
206631,with,0,1
206632,diet,0,0
206633,",",0,0
206634,clofibrate,0,0
206635,and,0,0
206636,niceritrol,0,0
206637,caused,0,0
206638,highly,0,0
206639,significant,0,0
206640,serum,0,0
206641,lipid,0,0
206642,reductions,0,0
206643,.,0,1
206644,The,0,0
206645,fatty,0,0
206646,acid,0,0
206647,composition,0,1
206648,in,0,0
206649,the,0,0
206650,plasma,0,0
206651,lipid,0,0
206652,esters,0,0
206653,was,0,0
206654,determined,0,0
206655,in,0,0
206656,samples,0,0
206657,from,0,1
206658,each,0,0
206659,trial,0,0
206660,period,0,0
206661,to,0,0
206662,measure,0,0
206663,the,0,0
206664,degree,0,0
206665,of,0,0
206666,dietary,0,0
206667,adherence,0,0
206668,.,0,0
206669,During,0,0
206670,dietary,0,0
206671,treatment,0,0
206672,the,0,0
206673,relative,0,0
206674,content,0,0
206675,of,0,0
206676,saturated,0,0
206677,and,0,0
206678,monounsaturated,0,0
206679,fatty,0,0
206680,acids,0,0
206681,secreased,0,0
206682,and,0,0
206683,the,0,0
206684,polyunsaturated,0,0
206685,fatty,0,0
206686,acids,0,0
206687,increased,0,0
206688,with,0,1
206689,an,0,0
206690,increasing,0,0
206691,ratio,0,0
206692,between,0,0
206693,pulyunsaturated,0,0
206694,and,0,0
206695,saturated,0,0
206696,fatty,0,0
206697,acids,0,0
206698,(,0,1
206699,P/S,0,0
206700,ratio,0,0
206701,),0,0
206702,in,0,0
206703,the,0,0
206704,cholesterol,0,0
206705,esters,0,0
206706,and,0,1
206707,triglycerides,0,0
206708,.,0,1
206709,Only,0,0
206710,minor,0,0
206711,changes,0,0
206712,were,0,1
206713,seen,0,0
206714,in,0,0
206715,the,0,0
206716,phospholipids,0,0
206717,.,0,0
206718,The,0,0
206719,changes,0,0
206720,caused,0,0
206721,by,0,0
206722,the,0,0
206723,diet,0,0
206724,were,0,0
206725,partly,0,0
206726,reversed,0,0
206727,by,0,0
206728,clofibrate,0,0
206729,while,0,0
206730,niceritrol,0,0
206731,did,0,0
206732,not,0,0
206733,cause,0,0
206734,any,0,0
206735,major,0,0
206736,changes,0,0
206737,of,0,0
206738,the,0,0
206739,fatty,0,0
206740,acid,0,0
206741,composition,0,1
206742,.,0,1
206743,Clofibrate,0,0
206744,treatment,0,0
206745,coincided,0,0
206746,with,0,1
206747,increasing,0,0
206748,amounts,0,0
206749,of,0,1
206750,monounsaturated,0,0
206751,fatty,0,0
206752,acids,0,0
206753,",",0,0
206754,especially,0,0
206755,oleate,0,0
206756,(,0,0
206757,18,0,1
206758,:,0,1
206759,1,0,0
206760,),0,0
206761,",",0,0
206762,in,0,0
206763,the,0,0
206764,cholesterol,0,0
206765,esters,0,0
206766,",",0,0
206767,triglycerides,0,0
206768,and,0,0
206769,phospholipids,0,0
206770,while,0,0
206771,there,0,0
206772,were,0,1
206773,significant,0,0
206774,reductions,0,0
206775,of,0,0
206776,the,0,0
206777,content,0,0
206778,of,0,0
206779,linoleic,0,0
206780,(,0,1
206781,18,0,1
206782,:,0,1
206783,2,0,0
206784,),0,0
206785,acid,0,0
206786,in,0,0
206787,both,0,0
206788,the,0,0
206789,cholesterol,0,0
206790,esters,0,0
206791,and,0,1
206792,triglycerides,0,0
206793,.,0,1
206794,The,0,0
206795,18,0,1
206796,:,0,1
206797,2/18,0,0
206798,:,0,1
206799,1,0,0
206800,ratio,0,0
206801,decreased,0,0
206802,significantly,0,0
206803,in,0,0
206804,all,0,0
206805,the,0,0
206806,lipid,0,0
206807,esters,0,0
206808,analyzed,0,0
206809,.,0,0
206810,However,0,0
206811,",",0,0
206812,the,0,0
206813,P/S,0,0
206814,ratio,0,0
206815,was,0,0
206816,not,0,0
206817,significantly,0,0
206818,affected,0,0
206819,",",0,0
206820,partly,0,0
206821,because,0,0
206822,the,0,0
206823,relative,0,0
206824,content,0,0
206825,of,0,0
206826,saturated,0,0
206827,fatty,0,0
206828,acids,0,0
206829,also,0,0
206830,tended,0,0
206831,to,0,0
206832,decrease,0,0
206833,during,0,0
206834,clofibrate,0,0
206835,treatment,0,0
206836,.,0,0
206837,It,0,0
206838,is,0,0
206839,concluded,0,0
206840,that,0,0
206841,addition,0,0
206842,of,0,0
206843,clofibrate,0,0
206844,treatment,0,0
206845,to,0,1
206846,patients,1,1
206847,who,1,1
206848,are,1,1
206849,on,1,0
206850,a,1,0
206851,diet,1,0
206852,enriched,1,0
206853,with,1,1
206854,polyunsaturated,1,0
206855,fats,1,0
206856,is,0,0
206857,associated,0,0
206858,with,0,0
206859,a,0,0
206860,change,0,0
206861,from,0,0
206862,polyunsaturated,0,0
206863,to,0,0
206864,monounsaturated,0,0
206865,fatty,0,0
206866,acids,0,0
206867,in,0,0
206868,the,0,0
206869,plasma,0,0
206870,lipid,0,0
206871,esters,0,0
206872,but,0,0
206873,does,0,0
206874,not,0,0
206875,significantly,0,0
206876,effect,0,0
206877,the,0,0
206878,ratio,0,0
206879,between,0,0
206880,polyunsaturated,0,0
206881,and,0,0
206882,saturated,0,0
206883,fatty,0,0
206884,acids,0,0
206885,.,0,1
206886,The,0,0
206887,fatty,0,0
206888,acid,0,0
206889,changes,0,0
206890,caused,0,0
206891,by,0,0
206892,clofibrate,0,0
206893,treatment,0,0
206894,and,0,0
206895,counteracted,0,0
206896,by,0,0
206897,an,0,0
206898,increased,0,0
206899,amount,0,0
206900,of,0,0
206901,polyunsaturated,0,0
206902,fat,0,0
206903,in,0,0
206904,the,0,0
206905,diet,0,1
206906,.,0,1
206907,A,0,0
206908,controlled,0,0
206909,trial,0,0
206910,with,0,1
206911,diclofensine,0,0
206912,",",0,0
206913,a,0,0
206914,new,0,0
206915,psychoactive,0,0
206916,drug,0,0
206917,",",0,0
206918,in,0,0
206919,the,0,0
206920,treatment,0,0
206921,of,0,0
206922,depression,0,1
206923,.,0,0
206924,Diclofensine,0,0
206925,inhibits,0,0
206926,the,0,0
206927,uptake,0,0
206928,of,0,0
206929,serotonin,0,0
206930,",",0,0
206931,noradrenaline,0,0
206932,and,0,0
206933,dopamine,0,0
206934,.,0,0
206935,In,0,0
206936,a,0,0
206937,controlled,0,0
206938,study,0,0
206939,",",0,0
206940,out-patients,1,1
206941,suffering,1,1
206942,from,1,1
206943,moderate,1,1
206944,to,1,0
206945,severe,1,1
206946,depression,1,1
206947,were,0,0
206948,treated,0,1
206949,with,0,1
206950,the,0,0
206951,objective,0,0
206952,of,0,0
206953,assessing,0,0
206954,the,0,0
206955,new,0,0
206956,drug,0,0
206957,'s,0,1
206958,therapeutically,0,0
206959,effective,0,0
206960,dose,0,0
206961,range,0,1
206962,.,0,1
206963,Maprotiline,0,0
206964,was,0,0
206965,used,0,0
206966,as,0,0
206967,a,0,0
206968,reference,0,0
206969,drug,0,0
206970,:,0,1
206971,fourteen,1,1
206972,patients,1,1
206973,were,1,1
206974,assigned,1,1
206975,to,1,0
206976,receive,1,0
206977,diclofensine,1,0
206978,and,1,0
206979,thirteen,1,1
206980,to,1,0
206981,receive,1,0
206982,maprotiline,1,0
206983,in,1,0
206984,a,1,0
206985,double-blind,1,0
206986,design,1,0
206987,.,1,0
206988,Depending,0,0
206989,on,0,0
206990,tolerance,0,0
206991,and,0,0
206992,efficacy,0,0
206993,",",0,0
206994,they,0,0
206995,were,0,0
206996,treated,0,1
206997,for,0,0
206998,periods,0,0
206999,ranging,0,1
207000,from,0,1
207001,5,0,1
207002,to,0,1
207003,150,0,0
207004,days,0,0
207005,.,0,1
207006,Doses,0,0
207007,were,0,0
207008,titrated,0,0
207009,to,0,0
207010,the,0,0
207011,optimum,0,0
207012,.,0,0
207013,Findings,0,0
207014,suggest,0,0
207015,that,0,0
207016,a,0,0
207017,50,0,1
207018,mg,0,0
207019,daily,0,0
207020,dose,0,0
207021,of,0,0
207022,diclofensine,0,0
207023,would,0,0
207024,be,0,0
207025,sufficient,0,0
207026,for,0,0
207027,the,0,0
207028,majority,0,0
207029,of,0,0
207030,the,0,0
207031,patients,0,1
207032,.,0,0
207033,The,0,0
207034,dosage,0,0
207035,can,0,0
207036,be,0,0
207037,safely,0,0
207038,increased,0,0
207039,up,0,0
207040,to,0,0
207041,150,0,0
207042,mg,0,0
207043,daily,0,0
207044,but,0,0
207045,this,0,0
207046,offers,0,0
207047,few,0,0
207048,therapeutic,0,0
207049,advantages,0,0
207050,.,0,1
207051,While,0,0
207052,the,0,0
207053,efficacy,0,0
207054,index,0,0
207055,of,0,0
207056,the,0,0
207057,two,0,0
207058,drugs,0,0
207059,was,0,0
207060,similar,0,0
207061,(,0,0
207062,approximately,0,1
207063,60,0,1
207064,%,0,0
207065,),0,0
207066,",",0,0
207067,they,0,0
207068,differed,0,0
207069,greatly,0,0
207070,in,0,0
207071,their,0,0
207072,profile,0,0
207073,of,0,0
207074,side-effects,0,0
207075,.,0,1
207076,No,0,0
207077,signs,0,0
207078,of,0,0
207079,abrupt,0,0
207080,dissipation,0,0
207081,of,0,0
207082,the,0,0
207083,achieved,0,0
207084,clinical,0,0
207085,effects,0,0
207086,were,0,1
207087,observed,0,0
207088,during,0,0
207089,continued,0,0
207090,treatment,0,0
207091,",",0,0
207092,and,0,0
207093,no,0,0
207094,withdrawal,0,0
207095,reactions,0,0
207096,were,0,0
207097,observed,0,0
207098,when,0,0
207099,the,0,0
207100,treatment,0,0
207101,was,0,0
207102,stopped,0,0
207103,.,0,0
207104,The,0,0
207105,new,0,0
207106,drug,0,0
207107,may,0,0
207108,be,0,0
207109,more,0,0
207110,effective,0,0
207111,in,0,0
207112,treating,0,0
207113,patients,1,1
207114,in,1,1
207115,whom,1,1
207116,a,1,1
207117,psycho-energizing,1,1
207118,and,1,0
207119,mood,1,0
207120,alleviating,1,0
207121,effect,1,0
207122,is,1,0
207123,desired,1,0
207124,.,1,0
207125,Multimodal,0,0
207126,therapy,0,0
207127,for,0,0
207128,the,0,0
207129,management,0,0
207130,of,0,0
207131,primary,1,1
207132,",",1,0
207133,nonmetastatic,1,1
207134,Ewing,1,1
207135,'s,1,1
207136,sarcoma,1,1
207137,of,1,1
207138,bone,1,0
207139,:,1,1
207140,an,0,0
207141,Intergroup,0,0
207142,Study,0,0
207143,.,0,1
207144,A,0,0
207145,randomized,0,0
207146,study,0,1
207147,of,0,0
207148,264,1,1
207149,children,1,1
207150,and,1,1
207151,adults,1,1
207152,with,1,1
207153,previously,1,1
207154,untreated,1,1
207155,localized,1,1
207156,Ewing,1,1
207157,'s,1,1
207158,sarcoma,1,1
207159,of,1,0
207160,bone,1,0
207161,was,0,0
207162,undertaken,0,0
207163,between,1,0
207164,1973,1,1
207165,and,1,0
207166,1978,1,1
207167,by,1,0
207168,83,1,1
207169,institutions,1,1
207170,of,1,1
207171,three,1,1
207172,national,1,1
207173,study,1,1
207174,groups,1,0
207175,:,1,1
207176,Children,1,1
207177,'s,1,1
207178,Cancer,1,1
207179,Study,1,1
207180,Group,1,1
207181,",",1,0
207182,Southwest,1,1
207183,Oncology,1,1
207184,Group,1,1
207185,",",1,0
207186,and,1,0
207187,Cancer,1,1
207188,and,1,0
207189,Leukemia,1,1
207190,Group,1,1
207191,B,1,1
207192,.,1,0
207193,The,0,0
207194,Intergroup,0,0
207195,Study,0,0
207196,was,0,0
207197,designed,0,0
207198,to,0,0
207199,determine,0,0
207200,if,0,0
207201,the,0,0
207202,addition,0,0
207203,of,0,0
207204,adriamycin,0,0
207205,(,0,0
207206,ADR,0,0
207207,),0,0
207208,or,0,1
207209,bilateral,0,1
207210,pulmonary,0,1
207211,radiotherapy,0,1
207212,(,0,0
207213,RT,0,1
207214,),0,0
207215,to,0,0
207216,vincristine,0,0
207217,",",0,0
207218,dactinomycin,0,0
207219,",",0,0
207220,and,0,0
207221,cyclophosphamide,0,0
207222,(,0,0
207223,VAC,0,1
207224,therapy,0,0
207225,),0,0
207226,would,0,0
207227,improve,0,0
207228,survival,0,0
207229,and,0,0
207230,reduce,0,0
207231,local,0,0
207232,recurrences,0,0
207233,and,0,1
207234,metastases,0,1
207235,.,0,1
207236,All,0,1
207237,patients,0,1
207238,received,0,0
207239,RT,0,1
207240,to,0,0
207241,the,0,0
207242,primary,0,0
207243,lesion,0,0
207244,",",0,0
207245,and,0,0
207246,the,0,0
207247,survival,0,0
207248,rate,0,0
207249,after,0,0
207250,3,0,0
207251,years,0,1
207252,was,0,0
207253,65,0,1
207254,%,0,0
207255,.,0,0
207256,The,0,0
207257,most,0,0
207258,effective,0,0
207259,treatment,0,0
207260,regimen,0,0
207261,was,0,0
207262,VAC,0,1
207263,plus,0,0
207264,ADR,0,1
207265,;,0,0
207266,74,0,1
207267,%,0,0
207268,of,0,0
207269,the,0,0
207270,patients,0,1
207271,were,0,0
207272,free,0,1
207273,of,0,0
207274,disease,0,1
207275,at,0,0
207276,2,0,1
207277,years,0,1
207278,.,0,1
207279,The,0,0
207280,lengths,0,0
207281,of,0,0
207282,disease-free,0,0
207283,status,0,1
207284,and,0,0
207285,survival,0,0
207286,of,0,0
207287,patients,0,1
207288,treated,0,1
207289,with,0,1
207290,VAC,0,1
207291,plus,0,0
207292,ADR,0,0
207293,or,0,1
207294,VAC,0,1
207295,plus,0,0
207296,RT,0,0
207297,did,0,0
207298,not,0,0
207299,differ,0,0
207300,.,0,0
207301,However,0,0
207302,",",0,0
207303,both,0,0
207304,regimens,0,0
207305,were,0,0
207306,significantly,0,0
207307,superior,0,0
207308,to,0,0
207309,treatment,0,0
207310,with,0,1
207311,VAC,0,1
207312,alone,0,0
207313,.,0,0
207314,The,0,0
207315,addition,0,0
207316,of,0,0
207317,ADR,0,0
207318,or,0,1
207319,bilateral,0,1
207320,pulmonary,0,1
207321,RT,0,1
207322,to,0,0
207323,VAC,0,1
207324,was,0,0
207325,highly,0,0
207326,advantageous,0,0
207327,to,0,0
207328,patients,0,1
207329,with,0,1
207330,nonpelvic,0,1
207331,primaries,0,1
207332,.,0,1
207333,Bone,0,0
207334,and,0,0
207335,lung,0,1
207336,were,0,0
207337,the,0,0
207338,major,0,0
207339,sites,0,0
207340,of,0,0
207341,distant,0,1
207342,relapse,0,0
207343,",",0,0
207344,but,0,0
207345,the,0,0
207346,addition,0,0
207347,of,0,0
207348,bilateral,0,1
207349,pulmonary,0,1
207350,RT,0,1
207351,showed,0,0
207352,no,0,0
207353,advantage,0,0
207354,over,0,0
207355,that,0,0
207356,of,0,0
207357,ADR,0,0
207358,in,0,0
207359,reducing,0,0
207360,the,0,0
207361,occurrence,0,0
207362,of,0,0
207363,lung,0,1
207364,metastases,0,1
207365,.,0,1
207366,These,0,0
207367,recent,0,0
207368,results,0,0
207369,should,0,0
207370,eliminate,0,0
207371,some,0,0
207372,of,0,0
207373,the,0,0
207374,pessimism,0,0
207375,that,0,0
207376,has,0,0
207377,accompanied,0,0
207378,a,0,0
207379,diagnosis,0,1
207380,of,0,0
207381,Ewing,0,1
207382,'s,0,1
207383,sarcoma,0,1
207384,",",0,0
207385,although,0,0
207386,distant,0,1
207387,metastases,0,1
207388,continued,0,0
207389,to,0,0
207390,be,0,0
207391,a,0,0
207392,major,0,0
207393,reason,0,0
207394,for,0,0
207395,failure,0,1
207396,in,0,0
207397,the,0,0
207398,control,0,0
207399,of,0,0
207400,this,0,0
207401,tumor,0,0
207402,.,0,0
207403,Survival,0,0
207404,of,0,0
207405,these,0,0
207406,patients,0,1
207407,can,0,0
207408,be,0,0
207409,improved,0,0
207410,through,0,0
207411,well-controlled,0,1
207412,clinical,0,0
207413,trials,0,0
207414,designed,0,0
207415,to,0,0
207416,determine,0,0
207417,optimal,0,0
207418,adjuvant,0,0
207419,chemotherapy,0,1
207420,and,0,0
207421,treatment,0,0
207422,of,0,0
207423,the,0,0
207424,primary,0,1
207425,lesion,0,0
207426,.,0,1
207427,Non-Hodgkin,0,1
207428,'s,0,1
207429,malignant,0,1
207430,lymphomas,0,1
207431,:,0,1
207432,treatment,0,0
207433,of,0,0
207434,localized,0,1
207435,relapses,0,0
207436,with,0,1
207437,chemo,0,1
207438,+,0,0
207439,radio,0,0
207440,+,0,0
207441,BCG-therapy,0,1
207442,.,0,1
207443,16,1,1
207444,patients,1,1
207445,with,1,1
207446,relapsing,1,1
207447,non-Hodgkin,1,1
207448,'s,1,1
207449,malignant,1,1
207450,lymphomas,1,1
207451,considered,1,0
207452,as,1,0
207453,clinical,1,0
207454,stage,1,1
207455,I,1,1
207456,or,1,1
207457,II,1,1
207458,were,0,0
207459,treated,0,1
207460,by,0,0
207461,an,0,0
207462,association,0,0
207463,of,0,0
207464,chemo,0,1
207465,+,0,0
207466,radiotherapy,0,1
207467,and,0,0
207468,thereafter,0,0
207469,by,0,0
207470,maintenance,0,0
207471,BCG,0,1
207472,therapy,0,0
207473,.,0,0
207474,5,1,0
207475,of,1,0
207476,them,1,1
207477,were,1,0
207478,included,1,0
207479,in,1,0
207480,a,1,0
207481,randomized,1,0
207482,trial,1,0
207483,and,0,0
207484,have,0,0
207485,a,0,0
207486,significantly,0,0
207487,different,0,0
207488,disease-free,0,0
207489,survival,0,0
207490,from,0,1
207491,patients,0,1
207492,receiving,0,1
207493,the,0,0
207494,same,0,0
207495,treatment,0,0
207496,but,0,0
207497,without,0,1
207498,BCG,0,1
207499,.,0,1
207500,11,1,0
207501,were,1,0
207502,systematically,1,0
207503,treated,1,1
207504,by,1,0
207505,BCG,1,0
207506,and,0,0
207507,they,0,0
207508,also,0,0
207509,have,0,0
207510,a,0,0
207511,fairly,0,0
207512,good,0,0
207513,disease-free,0,0
207514,survival,0,0
207515,.,0,0
207516,Such,0,0
207517,a,0,0
207518,treatment,0,0
207519,appears,0,0
207520,to,0,0
207521,be,0,0
207522,of,0,0
207523,value,0,0
207524,in,0,0
207525,treating,0,0
207526,these,0,0
207527,patients,0,1
207528,and,0,0
207529,even,0,0
207530,probably,0,0
207531,of,0,0
207532,curing,0,0
207533,some,0,0
207534,of,0,0
207535,them,0,1
207536,.,0,1
207537,[,0,0
207538,Dose-effect,0,0
207539,relationship,0,0
207540,of,0,0
207541,isosorbide,0,0
207542,dinitrate,0,0
207543,in,0,0
207544,the,0,0
207545,treatment,0,0
207546,of,0,0
207547,angina,0,1
207548,pectoris,0,1
207549,(,0,0
207550,author,0,0
207551,'s,0,1
207552,transl,0,1
207553,),0,1
207554,],0,0
207555,.,0,1
207556,Fifteen,1,0
207557,males,1,1
207558,with,1,1
207559,angiographic,1,0
207560,evidence,1,0
207561,of,1,0
207562,coronary,1,1
207563,heart,1,1
207564,disease,1,1
207565,and,1,0
207566,stable,1,1
207567,",",1,0
207568,exercise-induced,1,0
207569,angina,1,1
207570,pectoris,1,1
207571,were,0,0
207572,given,0,0
207573,placebo,0,0
207574,or,0,1
207575,isosorbide,0,0
207576,dinitrate,0,0
207577,(,0,0
207578,ISDN,0,0
207579,),0,0
207580,in,0,0
207581,a,0,0
207582,dialy,0,0
207583,dose,0,0
207584,of,0,0
207585,30,0,1
207586,mg,0,0
207587,",",0,1
207588,120,0,1
207589,mg,0,0
207590,",",0,0
207591,240,0,0
207592,mg,0,0
207593,and,0,0
207594,480,0,0
207595,mg,0,0
207596,in,0,0
207597,a,0,0
207598,randomized,0,0
207599,single-blind,0,0
207600,trial,0,1
207601,.,0,0
207602,The,0,0
207603,daily,0,0
207604,doses,0,0
207605,were,0,1
207606,given,0,0
207607,as,0,0
207608,a,0,0
207609,single,0,0
207610,oral,0,0
207611,dose,0,0
207612,of,0,0
207613,5,0,0
207614,mg,0,0
207615,",",0,1
207616,20,0,0
207617,mg,0,0
207618,",",0,0
207619,40,0,0
207620,mg,0,0
207621,and,0,0
207622,80,0,1
207623,mg,0,0
207624,tablets,0,0
207625,.,0,1
207626,Each,0,0
207627,dose,0,0
207628,and,0,0
207629,placebo,0,0
207630,was,0,0
207631,given,0,0
207632,for,0,0
207633,seven,0,1
207634,days,0,0
207635,.,0,1
207636,On,0,0
207637,the,0,0
207638,seventh,0,0
207639,day,0,0
207640,an,0,0
207641,exercise,0,0
207642,ECG,0,0
207643,of,0,0
207644,standardized,0,0
207645,level,0,0
207646,and,0,0
207647,duration,0,0
207648,of,0,0
207649,exercise,0,0
207650,was,0,0
207651,recorded,0,0
207652,.,0,0
207653,The,0,0
207654,ischaemia,0,0
207655,response,0,0
207656,in,0,0
207657,the,0,0
207658,ECG,0,0
207659,revealed,0,0
207660,a,0,0
207661,dose-dependent,0,0
207662,reduction,0,0
207663,by,0,0
207664,28,0,1
207665,%,0,0
207666,(,0,0
207667,5,0,0
207668,mg,0,0
207669,ISDN,0,0
207670,),0,0
207671,",",0,0
207672,43,0,1
207673,%,0,0
207674,(,0,0
207675,20,0,0
207676,mg,0,0
207677,),0,0
207678,",",0,0
207679,60,0,1
207680,%,0,0
207681,(,0,0
207682,40,0,1
207683,mg,0,0
207684,),0,0
207685,and,0,0
207686,73,0,1
207687,%,0,0
207688,(,0,0
207689,80,0,1
207690,mg,0,0
207691,),0,0
207692,.,0,0
207693,The,0,0
207694,number,0,0
207695,of,0,0
207696,anginal,0,1
207697,attacks,0,1
207698,similarly,0,0
207699,fell,0,0
207700,parallel,0,0
207701,to,0,0
207702,dose,0,0
207703,.,0,0
207704,Plasma,0,0
207705,level,0,0
207706,of,0,0
207707,ISDN,0,0
207708,and,0,0
207709,the,0,0
207710,mononitrates,0,0
207711,",",0,0
207712,measured,0,0
207713,one,0,0
207714,and,0,1
207715,four,0,1
207716,hours,0,0
207717,after,0,0
207718,drug,0,0
207719,intake,0,0
207720,",",0,0
207721,rose,0,0
207722,almost,0,0
207723,linearly,0,0
207724,in,0,0
207725,relation,0,0
207726,to,0,0
207727,dose,0,0
207728,.,0,1
207729,Oral,0,0
207730,ISDN,0,0
207731,thus,0,0
207732,has,0,0
207733,a,0,0
207734,dose-dependent,0,0
207735,effect,0,0
207736,on,0,0
207737,the,0,0
207738,frequency,0,0
207739,of,0,0
207740,angina,0,1
207741,and,0,0
207742,ischaemia,0,0
207743,parameters,0,0
207744,during,0,0
207745,ergometric,0,0
207746,exercise,0,0
207747,.,0,0
207748,The,0,0
207749,protracted,0,0
207750,anti-anginal,0,0
207751,effect,0,0
207752,of,0,0
207753,ISDN,0,0
207754,is,0,0
207755,largely,0,0
207756,due,0,0
207757,to,0,0
207758,its,0,0
207759,metabolites,0,0
207760,.,0,1
207761,At,0,0
207762,high,0,1
207763,doses,0,0
207764,there,0,0
207765,is,0,0
207766,presumably,0,0
207767,an,0,0
207768,added,0,0
207769,effect,0,0
207770,of,0,0
207771,the,0,0
207772,high,0,0
207773,blood,0,0
207774,level,0,0
207775,of,0,0
207776,the,0,0
207777,basic,0,0
207778,substance.U,0,1
207779,Antibiotic,0,0
207780,therapy,0,0
207781,of,0,0
207782,acute,0,1
207783,exacerbations,0,1
207784,of,0,0
207785,chronic,0,1
207786,bronchitis,0,1
207787,.,0,0
207788,A,0,0
207789,controlled,0,0
207790,study,0,0
207791,using,0,0
207792,tetracycline,0,0
207793,.,0,1
207794,We,0,0
207795,conducted,0,0
207796,a,0,0
207797,double-blind,0,0
207798,",",0,0
207799,randomized,0,0
207800,",",0,0
207801,placebo-controlled,0,0
207802,trial,0,0
207803,in,0,0
207804,40,1,1
207805,patients,1,1
207806,to,1,0
207807,evaluate,1,0
207808,the,1,0
207809,need,1,0
207810,for,1,0
207811,antibiotics,1,0
207812,in,1,1
207813,acute,1,1
207814,exacerbations,1,1
207815,of,1,0
207816,chronic,1,1
207817,bronchitis,1,1
207818,.,1,0
207819,All,1,0
207820,patients,1,1
207821,were,1,0
207822,sufficiently,1,0
207823,ill,1,1
207824,to,1,0
207825,require,1,0
207826,hospitalization,1,0
207827,although,1,0
207828,none,1,0
207829,needed,1,0
207830,ventilatory,1,0
207831,support,1,0
207832,;,1,0
207833,the,1,0
207834,presence,1,0
207835,of,1,0
207836,pneumonia,1,0
207837,was,1,0
207838,excluded,1,0
207839,.,1,1
207840,Treatment,0,0
207841,consisted,0,1
207842,of,0,0
207843,bronchodilators,0,0
207844,",",0,0
207845,corticosteroids,0,0
207846,",",0,0
207847,and,0,0
207848,either,0,0
207849,tetracycline,0,0
207850,",",0,0
207851,500,0,0
207852,mg,0,0
207853,",",0,0
207854,or,0,0
207855,placebo,0,0
207856,by,0,0
207857,mouth,0,0
207858,every,0,0
207859,6,0,0
207860,hours,0,0
207861,for,0,1
207862,1,0,1
207863,week,0,0
207864,.,0,1
207865,Arterial,0,0
207866,blood,0,0
207867,gases,0,0
207868,",",0,0
207869,spirometric,0,0
207870,tests,0,0
207871,",",0,0
207872,bacteriologic,0,0
207873,evaluation,0,0
207874,of,0,0
207875,sputum,0,0
207876,",",0,0
207877,and,0,0
207878,patient,0,0
207879,and,0,0
207880,physician,0,0
207881,evaluation,0,0
207882,of,0,0
207883,the,0,0
207884,severity,0,0
207885,of,0,0
207886,illness,0,1
207887,were,0,0
207888,assessed,0,0
207889,at,0,0
207890,the,0,0
207891,beginning,0,0
207892,and,0,0
207893,end,0,0
207894,of,0,0
207895,the,0,0
207896,study,0,0
207897,.,0,0
207898,All,0,0
207899,patients,0,1
207900,improved,0,0
207901,both,0,0
207902,symptomatically,0,0
207903,and,0,0
207904,by,0,0
207905,objective,0,0
207906,measures,0,0
207907,of,0,0
207908,lung,0,1
207909,function,0,0
207910,.,0,0
207911,At,0,0
207912,the,0,0
207913,end,0,0
207914,of,0,0
207915,the,0,0
207916,study,0,0
207917,period,0,0
207918,there,0,0
207919,were,0,0
207920,no,0,0
207921,differences,0,0
207922,between,0,0
207923,those,0,1
207924,patients,0,1
207925,receiving,0,1
207926,tetracycline,0,0
207927,and,0,0
207928,those,0,0
207929,receiving,0,0
207930,placebo,0,0
207931,.,0,0
207932,We,0,0
207933,conclude,0,0
207934,that,0,0
207935,antibiotic,0,0
207936,therapy,0,0
207937,is,0,0
207938,not,0,0
207939,needed,0,0
207940,in,0,0
207941,moderately,1,1
207942,ill,1,1
207943,patients,1,1
207944,with,1,1
207945,exacerbations,1,1
207946,of,1,0
207947,chronic,1,1
207948,bronchitis,1,1
207949,.,1,1
207950,Prostaglandin,1,0
207951,E1,1,1
207952,as,1,0
207953,a,1,0
207954,hypotensive,1,0
207955,drug,1,0
207956,during,1,0
207957,general,1,1
207958,anaesthesia,1,1
207959,.,1,1
207960,Hypotension,0,0
207961,induced,0,0
207962,by,0,0
207963,prostaglandin,0,0
207964,E1,0,1
207965,(,0,0
207966,PGE1,0,0
207967,),0,0
207968,infusion,0,0
207969,(,0,0
207970,100-150,0,0
207971,ng/kg/minute,0,0
207972,),0,0
207973,during,0,0
207974,halothane,0,0
207975,anaesthesia,0,1
207976,to,0,0
207977,reduce,0,0
207978,operative,0,0
207979,blood,0,0
207980,loss,0,0
207981,during,1,0
207982,mastectomy,1,1
207983,was,0,0
207984,investigated,0,0
207985,.,0,1
207986,PGE1,0,0
207987,decreased,0,0
207988,systolic,0,1
207989,arterial,0,1
207990,pressure,0,0
207991,approximately,0,1
207992,34,0,1
207993,%,0,0
207994,from,0,1
207995,pre-administration,0,0
207996,values,0,0
207997,.,0,0
207998,The,0,0
207999,duration,0,0
208000,of,0,0
208001,induced,1,0
208002,hypotension,1,0
208003,was,0,0
208004,about,0,0
208005,75,0,1
208006,minutes,0,0
208007,.,0,0
208008,When,0,0
208009,the,0,0
208010,infusion,0,0
208011,was,0,0
208012,stopped,0,0
208013,",",0,0
208014,blood,0,0
208015,pressure,0,0
208016,returned,0,0
208017,to,0,0
208018,within,0,0
208019,15,0,0
208020,%,0,0
208021,of,0,0
208022,the,0,0
208023,control,0,0
208024,with,0,1
208025,15,0,1
208026,minutes,0,0
208027,.,0,1
208028,Heart,0,0
208029,rate,0,0
208030,did,0,0
208031,not,0,0
208032,change,0,0
208033,significantly,0,0
208034,during,0,0
208035,PGE1,0,0
208036,infusion,0,0
208037,;,0,0
208038,the,0,0
208039,pre-ejection,0,0
208040,period,0,0
208041,and,0,0
208042,left,0,1
208043,ventricular,0,0
208044,ejection,0,1
208045,period,0,0
208046,were,0,0
208047,shortened,0,0
208048,.,0,0
208049,Renal,0,0
208050,function,0,0
208051,during,0,0
208052,the,0,0
208053,hypotensive,0,0
208054,period,0,0
208055,was,0,0
208056,well,0,0
208057,maintained,0,0
208058,.,0,0
208059,Blood,0,0
208060,loss,0,0
208061,during,0,0
208062,surgery,0,1
208063,was,0,0
208064,significantly,0,0
208065,decreased,0,0
208066,.,0,0
208067,These,0,0
208068,findings,0,0
208069,suggest,0,0
208070,that,0,0
208071,PGE1,0,0
208072,can,0,0
208073,be,0,0
208074,used,0,0
208075,safely,0,0
208076,to,0,0
208077,control,0,0
208078,arterial,0,0
208079,pressure,0,0
208080,during,0,0
208081,surgery,0,1
208082,.,0,1
208083,An,0,0
208084,evaluation,0,0
208085,method,0,0
208086,providing,0,0
208087,confidence,0,0
208088,intervals,0,0
208089,applied,0,0
208090,to,0,0
208091,radioimmunoassay,1,0
208092,.,1,0
208093,A,0,0
208094,method,0,0
208095,for,0,0
208096,evaluation,0,0
208097,of,0,0
208098,radioimmunoassay,1,0
208099,results,0,0
208100,is,0,0
208101,described,0,0
208102,.,0,0
208103,The,0,0
208104,order,0,0
208105,of,0,0
208106,the,0,0
208107,single,0,0
208108,tubes,0,0
208109,in,0,0
208110,each,0,0
208111,assay,0,0
208112,run,0,0
208113,is,0,0
208114,randomized,0,0
208115,.,0,0
208116,A,0,0
208117,polynomial,0,0
208118,is,0,0
208119,fitted,0,0
208120,to,0,0
208121,untransformed,0,0
208122,data,0,0
208123,(,0,1
208124,y,0,1
208125,=,0,0
208126,counts,0,0
208127,per,0,1
208128,minute,0,0
208129,;,0,0
208130,x,0,0
208131,=,0,0
208132,concentration,0,0
208133,of,0,0
208134,curve.A,0,0
208135,confidence,0,0
208136,interval,0,0
208137,is,0,0
208138,calculated,0,0
208139,for,0,0
208140,each,0,0
208141,sample,0,1
208142,",",0,0
208143,taking,0,0
208144,into,0,0
208145,account,0,0
208146,the,0,0
208147,variance,0,0
208148,of,0,0
208149,the,0,0
208150,standard,0,0
208151,curve,0,0
208152,and,0,0
208153,that,0,0
208154,of,0,0
208155,the,0,0
208156,actual,0,0
208157,duplicate,0,0
208158,assay,0,0
208159,jointly,0,0
208160,.,0,0
208161,The,0,0
208162,effects,0,0
208163,of,0,0
208164,prophylactic,0,0
208165,management,0,1
208166,and,0,0
208167,therapeutics,0,0
208168,on,0,0
208169,hypertensive,1,1
208170,disease,1,1
208171,in,1,0
208172,pregnancy,1,1
208173,:,1,1
208174,preliminary,0,0
208175,studies,0,0
208176,.,0,1
208177,A,0,0
208178,controlled,0,0
208179,prospective,0,0
208180,evaluation,0,0
208181,of,0,0
208182,pregnancy,0,0
208183,complicated,0,1
208184,by,0,0
208185,chronic,0,1
208186,hypertension,0,1
208187,is,0,0
208188,proposed,0,0
208189,and,0,0
208190,preliminary,0,0
208191,data,0,0
208192,on,0,0
208193,population,0,1
208194,selection,0,0
208195,and,0,0
208196,pregnancy,0,0
208197,outcome,0,0
208198,are,0,0
208199,presented,0,0
208200,.,0,1
208201,Sixty-three,1,1
208202,women,1,1
208203,with,1,1
208204,evidence,1,0
208205,of,1,0
208206,underlying,1,0
208207,hypertensive,1,1
208208,disease,1,1
208209,were,1,0
208210,followed,1,0
208211,prospectively,0,1
208212,throughout,0,0
208213,pregnancy,0,1
208214,.,0,1
208215,Twenty-three,0,1
208216,patients,0,1
208217,were,0,1
208218,followed,0,0
208219,in,0,0
208220,a,0,0
208221,protocol,0,0
208222,of,0,0
208223,intensified,0,0
208224,prenatal,0,1
208225,care,0,1
208226,and,0,0
208227,randomized,0,0
208228,assignment,0,0
208229,of,0,0
208230,antihypertensive,0,1
208231,agents,0,1
208232,:,0,1
208233,placebo,0,0
208234,",",0,0
208235,hydralazine,0,0
208236,",",0,0
208237,or,0,0
208238,methyldopa,0,0
208239,.,0,1
208240,Forty,1,0
208241,patients,1,1
208242,were,1,1
208243,followed,1,0
208244,in,1,0
208245,the,1,0
208246,high-risk,1,1
208247,pregnancy,1,1
208248,clinics,1,1
208249,at,1,1
208250,Duke,1,1
208251,University,1,1
208252,.,1,0
208253,The,0,0
208254,incidence,0,0
208255,of,0,0
208256,preeclampsia,0,1
208257,in,0,0
208258,the,0,0
208259,randomized,0,1
208260,prophylactic,0,0
208261,antihypertensive,0,0
208262,group,0,0
208263,was,0,0
208264,statistically,0,0
208265,lower,0,0
208266,than,0,0
208267,that,0,0
208268,in,0,0
208269,the,0,0
208270,nonrandomized,0,0
208271,group,0,0
208272,(,0,0
208273,8.7,0,0
208274,versus,0,0
208275,32.5,0,0
208276,%,0,0
208277,;,0,0
208278,P,0,0
208279,less,0,0
208280,than,0,0
208281,.01,0,0
208282,),0,0
208283,.,0,0
208284,There,0,0
208285,were,0,0
208286,no,0,0
208287,other,0,0
208288,statistically,0,0
208289,significant,0,0
208290,differences,0,0
208291,between,0,0
208292,the,0,0
208293,groups,0,0
208294,.,0,1
208295,The,0,0
208296,63,1,1
208297,hypertensive,1,1
208298,women,1,1
208299,had,0,1
208300,a,0,0
208301,high,0,0
208302,incidence,0,0
208303,of,0,0
208304,diabetes,0,1
208305,mellitus,0,1
208306,diagnosed,0,1
208307,during,0,0
208308,pregnancy,0,1
208309,(,0,0
208310,49.2,0,1
208311,%,0,0
208312,),0,0
208313,as,0,0
208314,compared,0,0
208315,to,0,0
208316,the,0,0
208317,authors,0,0
208318,',0,1
208319,general,0,1
208320,obstetric,0,1
208321,population,0,1
208322,(,0,0
208323,8.1,0,0
208324,%,0,0
208325,),0,1
208326,.,0,1
208327,Changing,0,1
208328,sodium,0,0
208329,intake,0,0
208330,in,0,0
208331,children,1,1
208332,.,1,1
208333,The,0,0
208334,Minneapolis,0,0
208335,Children,0,1
208336,'s,0,1
208337,Blood,0,0
208338,Pressure,0,0
208339,Study,0,0
208340,.,0,0
208341,To,0,0
208342,assess,0,0
208343,the,0,0
208344,effects,0,0
208345,of,0,0
208346,modifying,0,0
208347,dietary,0,0
208348,sodium,0,0
208349,intake,0,0
208350,",",0,0
208351,80,1,1
208352,school,1,1
208353,children,1,1
208354,with,1,1
208355,blood,1,0
208356,pressures,1,0
208357,above,1,0
208358,the,1,0
208359,95th,1,0
208360,percentile,1,0
208361,for,1,0
208362,age,1,1
208363,and,1,0
208364,sex,1,0
208365,but,1,0
208366,below,1,0
208367,130/90,1,1
208368,mm,1,0
208369,Hg,1,0
208370,at,1,0
208371,school,1,1
208372,screening,1,1
208373,were,0,0
208374,randomized,0,0
208375,to,0,0
208376,a,0,0
208377,family,0,0
208378,intervention,0,0
208379,program,0,0
208380,or,0,0
208381,a,0,0
208382,control,0,0
208383,group,0,0
208384,.,0,1
208385,Twenty,1,1
208386,children,1,1
208387,aged,1,1
208388,6,1,0
208389,to,1,1
208390,9,1,1
208391,years,1,1
208392,and,1,1
208393,their,1,1
208394,families,1,1
208395,began,0,1
208396,a,0,0
208397,program,0,0
208398,to,0,0
208399,modify,0,0
208400,the,0,0
208401,family,0,0
208402,diet,0,0
208403,toward,0,0
208404,a,0,0
208405,goal,0,0
208406,of,0,0
208407,70,0,1
208408,mEq,0,0
208409,sodium,0,0
208410,per,0,0
208411,person,0,1
208412,per,0,0
208413,day,0,0
208414,.,0,1
208415,Adherence,0,0
208416,was,0,0
208417,assessed,0,0
208418,by,0,0
208419,3-day,0,0
208420,food,0,1
208421,records,0,1
208422,and,0,1
208423,urine,0,0
208424,collections,0,0
208425,in,0,1
208426,children,0,1
208427,and,0,1
208428,adults,0,1
208429,.,0,0
208430,The,0,0
208431,sodium,0,0
208432,intakes,0,0
208433,and,0,0
208434,blood,0,0
208435,pressures,0,0
208436,of,0,0
208437,the,0,0
208438,intervention,0,0
208439,and,0,0
208440,control,0,0
208441,group,0,0
208442,were,0,0
208443,compared,0,0
208444,1,0,0
208445,year,0,0
208446,after,0,0
208447,randomization,0,0
208448,.,0,1
208449,Sodium,0,0
208450,intake,0,0
208451,was,0,0
208452,significantly,0,0
208453,lower,0,0
208454,in,0,0
208455,the,0,0
208456,intervention,0,0
208457,group,0,0
208458,only,0,0
208459,in,0,0
208460,the,0,0
208461,active,0,1
208462,participants,0,1
208463,as,0,0
208464,compared,0,0
208465,to,0,0
208466,dropouts,0,0
208467,and,0,1
208468,controls,0,1
208469,(,0,1
208470,87,0,1
208471,vs,0,0
208472,130,0,1
208473,and,0,0
208474,133,0,1
208475,mmoles/24,0,0
208476,hr,0,0
208477,),0,1
208478,.,0,0
208479,There,0,0
208480,were,0,0
208481,no,0,0
208482,significant,0,0
208483,differences,0,0
208484,between,0,0
208485,the,0,0
208486,groups,0,0
208487,in,0,0
208488,height,0,0
208489,",",0,0
208490,weight,0,0
208491,",",0,0
208492,or,0,0
208493,blood,0,0
208494,pressure,0,0
208495,.,0,1
208496,Scaling,0,0
208497,clinical,0,0
208498,judgments,0,0
208499,of,0,0
208500,symptom,0,1
208501,pathology,0,1
208502,by,0,0
208503,means,0,0
208504,of,0,0
208505,the,0,0
208506,psychophysiological,0,0
208507,method,0,0
208508,of,0,0
208509,magnitude,0,0
208510,estimation,0,0
208511,.,0,0
208512,Summing,0,0
208513,scores,0,0
208514,across,0,0
208515,heterogeneous,0,1
208516,symptom,0,1
208517,items,0,0
208518,without,0,1
208519,consideration,0,0
208520,of,0,0
208521,their,0,0
208522,differing,0,0
208523,psychopathological,0,1
208524,significance,0,0
208525,has,0,0
208526,been,0,0
208527,criticized,0,0
208528,as,0,0
208529,producing,0,0
208530,an,0,0
208531,inadequate,0,1
208532,picture,0,0
208533,of,0,0
208534,an,0,0
208535,individual,0,0
208536,'s,0,1
208537,clinical,0,0
208538,status,0,1
208539,.,0,0
208540,The,0,0
208541,purpose,0,0
208542,of,0,0
208543,this,0,0
208544,study,0,0
208545,was,0,0
208546,to,0,0
208547,derive,0,0
208548,symptom,0,1
208549,item,0,0
208550,weights,0,0
208551,representing,0,1
208552,clinically,0,0
208553,judged,0,0
208554,seriousness,0,0
208555,of,0,0
208556,each,0,0
208557,symptom,0,0
208558,through,0,0
208559,the,0,0
208560,application,0,0
208561,of,0,0
208562,Steven,0,0
208563,'s,0,1
208564,psychophysical,0,0
208565,method,0,0
208566,of,0,0
208567,magnitude,0,0
208568,estimation,0,0
208569,.,0,0
208570,A,0,0
208571,nationwide,0,1
208572,sample,0,1
208573,of,0,0
208574,129,1,1
208575,clinicians,1,0
208576,rated,0,1
208577,the,0,0
208578,pathological,0,0
208579,significance,0,0
208580,of,0,0
208581,221,0,1
208582,symptom,0,1
208583,items,0,0
208584,in,0,0
208585,a,0,0
208586,design,0,0
208587,such,0,0
208588,that,0,0
208589,every,0,0
208590,rater,0,0
208591,rated,0,0
208592,121,0,1
208593,items,0,0
208594,",",0,0
208595,21,0,1
208596,of,0,0
208597,which,0,0
208598,were,0,0
208599,rated,0,0
208600,by,0,0
208601,all,0,0
208602,raters,0,0
208603,and,0,0
208604,100,0,0
208605,of,0,0
208606,which,0,0
208607,were,0,0
208608,rated,0,0
208609,only,0,0
208610,by,0,0
208611,the,0,0
208612,A,0,0
208613,or,0,1
208614,B,0,0
208615,subgroup,0,1
208616,to,0,0
208617,which,0,0
208618,each,0,0
208619,rater,0,0
208620,was,0,0
208621,randomly,0,1
208622,assigned,0,0
208623,.,0,0
208624,Each,0,0
208625,item,0,0
208626,was,0,0
208627,rated,0,0
208628,as,0,0
208629,to,0,0
208630,the,0,0
208631,seriousness,0,0
208632,of,0,0
208633,the,0,0
208634,pathology,0,0
208635,it,0,0
208636,would,0,0
208637,represent,0,0
208638,if,0,0
208639,manifested,0,0
208640,by,0,0
208641,either,0,0
208642,a,0,0
208643,boy,0,1
208644,child,0,0
208645,",",0,0
208646,girl,0,1
208647,child,0,0
208648,",",0,0
208649,boy,0,1
208650,adolescent,0,1
208651,",",0,0
208652,or,0,0
208653,girl,0,1
208654,adolescent,0,1
208655,",",0,0
208656,with,0,0
208657,one-fourth,0,0
208658,of,0,0
208659,the,0,0
208660,raters,0,0
208661,assigned,0,1
208662,to,0,0
208663,each,0,0
208664,condition,0,0
208665,.,0,0
208666,The,0,0
208667,results,0,0
208668,of,0,0
208669,211,0,1
208670,two-way,0,1
208671,analyses,0,0
208672,of,0,0
208673,variance,0,0
208674,revealed,0,0
208675,that,0,0
208676,age,0,1
208677,and,0,0
208678,age,0,1
208679,and,0,0
208680,sex,0,0
208681,in,0,0
208682,interaction,0,0
208683,",",0,0
208684,but,0,0
208685,not,0,0
208686,sex,0,0
208687,alone,0,0
208688,",",0,0
208689,significantly,0,0
208690,influenced,0,0
208691,the,0,0
208692,clinical,0,0
208693,ratings,0,0
208694,.,0,1
208695,The,0,0
208696,resulting,0,0
208697,magnitude,0,0
208698,estimation,0,0
208699,ratings,0,0
208700,of,0,0
208701,symptom,0,1
208702,pathology,0,1
208703,ranged,0,0
208704,from,0,0
208705,1.0,0,0
208706,to,0,1
208707,9.9,0,1
208708,.,0,1
208709,They,0,0
208710,were,0,0
208711,demonstrated,0,0
208712,to,0,0
208713,have,0,0
208714,satisfactoy,0,0
208715,reliability,0,0
208716,and,0,0
208717,convergent,0,0
208718,validity,0,0
208719,and,0,0
208720,to,0,0
208721,have,0,0
208722,the,0,0
208723,psychophysical,0,0
208724,characteristics,0,0
208725,of,0,0
208726,a,0,0
208727,prothetic,0,0
208728,continuum,0,1
208729,.,0,1
208730,Corticosteroids,0,1
208731,plus,0,0
208732,pulse,0,0
208733,cyclophosphamide,0,0
208734,and,0,0
208735,plasma,0,0
208736,exchanges,0,0
208737,versus,0,0
208738,corticosteroids,0,0
208739,plus,0,0
208740,pulse,0,0
208741,cyclophosphamide,0,0
208742,alone,0,0
208743,in,0,0
208744,the,0,0
208745,treatment,0,0
208746,of,0,0
208747,polyarteritis,1,1
208748,nodosa,1,1
208749,and,1,0
208750,Churg-Strauss,1,1
208751,syndrome,1,1
208752,patients,1,1
208753,with,1,1
208754,factors,1,0
208755,predicting,1,0
208756,poor,1,1
208757,prognosis,1,1
208758,.,1,0
208759,A,0,0
208760,prospective,0,0
208761,",",0,0
208762,randomized,0,0
208763,trial,0,0
208764,in,0,0
208765,sixty-two,1,1
208766,patients,1,1
208767,.,1,1
208768,OBJECTIVE,0,0
208769,To,0,0
208770,define,0,0
208771,the,0,0
208772,most,0,0
208773,effective,0,0
208774,treatment,0,0
208775,for,0,0
208776,severe,1,1
208777,polyarteritis,1,1
208778,nodosa,1,1
208779,(,1,0
208780,PAN,1,1
208781,),1,0
208782,and,1,0
208783,Churg-Strauss,1,0
208784,syndrome,1,1
208785,(,1,0
208786,CSS,1,1
208787,),1,0
208788,and,0,0
208789,to,0,0
208790,investigate,0,0
208791,the,0,0
208792,indication,0,0
208793,for,0,0
208794,plasma,0,0
208795,exchange,0,0
208796,treatment,0,0
208797,.,0,0
208798,METHODS,0,0
208799,We,0,0
208800,conducted,0,0
208801,a,0,0
208802,prospective,0,0
208803,",",0,0
208804,randomized,0,0
208805,",",0,0
208806,multicenter,0,0
208807,trial,0,0
208808,in,0,0
208809,which,0,0
208810,62,1,1
208811,patients,1,1
208812,were,1,1
208813,randomly,1,1
208814,assigned,1,0
208815,to,1,0
208816,receive,1,0
208817,either,1,0
208818,prednisone,1,0
208819,plus,1,0
208820,cyclophosphamide,1,0
208821,(,1,0
208822,intravenous,1,0
208823,bolus,1,0
208824,),1,0
208825,(,1,0
208826,group,1,1
208827,A,1,1
208828,;,1,0
208829,n,1,1
208830,=,1,0
208831,28,1,1
208832,),1,0
208833,or,1,1
208834,prednisone,1,0
208835,plus,1,0
208836,cyclophosphamide,1,0
208837,(,1,0
208838,intravenous,1,0
208839,bolus,1,0
208840,),1,0
208841,plus,1,0
208842,plasma,1,0
208843,exchanges,1,0
208844,(,1,1
208845,group,1,1
208846,B,1,1
208847,;,1,0
208848,n,1,1
208849,=,1,0
208850,34,1,1
208851,),1,0
208852,as,1,0
208853,first-line,1,1
208854,treatment,1,0
208855,for,1,0
208856,severe,1,1
208857,PAN,1,1
208858,or,1,1
208859,CSS,1,1
208860,.,1,1
208861,Factors,0,0
208862,predicting,0,0
208863,poor,0,1
208864,prognosis,0,1
208865,were,0,1
208866,renal,0,1
208867,symptoms,0,0
208868,",",0,0
208869,gastrointestinal,0,1
208870,tract,0,0
208871,involvement,0,0
208872,",",0,0
208873,cardiomyopathy,0,1
208874,",",0,0
208875,central,0,0
208876,nervous,0,0
208877,system,0,0
208878,involvement,0,0
208879,",",0,0
208880,weight,0,0
208881,loss,0,0
208882,>,0,1
208883,10,0,0
208884,%,0,0
208885,of,0,0
208886,body,0,0
208887,weight,0,0
208888,",",0,0
208889,and,0,0
208890,age,0,1
208891,>,0,1
208892,50,0,1
208893,years,0,1
208894,old,0,1
208895,.,0,1
208896,Patients,0,1
208897,with,0,1
208898,hepatitis,0,1
208899,B,0,1
208900,virus-related,0,1
208901,PAN,0,1
208902,were,0,0
208903,not,0,0
208904,included,0,0
208905,in,0,0
208906,this,0,0
208907,study,0,0
208908,.,0,0
208909,The,0,0
208910,end,0,0
208911,point,0,0
208912,of,0,0
208913,the,0,0
208914,study,0,0
208915,was,0,0
208916,control,0,0
208917,of,0,0
208918,the,0,0
208919,disease,0,1
208920,(,0,0
208921,recovery,0,0
208922,or,0,1
208923,remission,0,0
208924,),0,0
208925,or,0,1
208926,death,0,0
208927,.,0,1
208928,RESULTS,0,0
208929,Clinical,0,0
208930,symptoms,0,0
208931,and,0,1
208932,laboratory,0,1
208933,findings,0,0
208934,did,0,0
208935,not,0,0
208936,differ,0,0
208937,significantly,0,0
208938,in,0,0
208939,the,0,0
208940,2,0,0
208941,groups,0,0
208942,.,0,1
208943,Initial,0,0
208944,control,0,0
208945,of,0,0
208946,the,0,0
208947,disease,0,1
208948,was,0,0
208949,similar,0,0
208950,in,0,0
208951,both,0,0
208952,groups,0,0
208953,.,0,0
208954,Relapse,0,0
208955,after,0,0
208956,initial,0,0
208957,control,0,1
208958,of,0,0
208959,the,0,0
208960,disease,0,1
208961,was,0,0
208962,observed,0,0
208963,in,0,0
208964,7,0,1
208965,patients,0,1
208966,(,0,1
208967,4,0,0
208968,in,0,0
208969,group,0,1
208970,A,0,1
208971,and,0,0
208972,3,0,0
208973,in,0,0
208974,group,0,1
208975,B,0,1
208976,),0,0
208977,.,0,0
208978,The,0,0
208979,mean,0,0
208980,+/-,0,0
208981,SD,0,0
208982,followup,0,1
208983,period,0,0
208984,was,0,0
208985,31.1,0,0
208986,+/-,0,0
208987,20,0,1
208988,months,0,0
208989,for,0,0
208990,group,0,1
208991,A,0,1
208992,and,0,0
208993,35.9,0,0
208994,+/-,0,0
208995,16.8,0,0
208996,months,0,0
208997,for,0,0
208998,group,0,1
208999,B,0,1
209000,.,0,1
209001,At,0,0
209002,5,0,0
209003,years,0,1
209004,of,0,0
209005,followup,0,1
209006,",",0,0
209007,38,0,1
209008,patients,0,1
209009,(,0,1
209010,61.3,0,0
209011,%,0,0
209012,),0,0
209013,were,0,0
209014,cured,0,0
209015,(,0,0
209016,16,0,1
209017,in,0,0
209018,group,0,1
209019,A,0,1
209020,and,0,0
209021,22,0,1
209022,in,0,0
209023,group,0,1
209024,B,0,1
209025,),0,0
209026,",",0,0
209027,and,0,0
209028,5,0,0
209029,(,0,0
209030,8.1,0,0
209031,%,0,0
209032,),0,0
209033,were,0,0
209034,in,0,0
209035,remission,0,0
209036,without,0,1
209037,treatment,0,0
209038,but,0,0
209039,had,0,0
209040,not,0,0
209041,yet,0,0
209042,completed,0,1
209043,the,0,0
209044,cure-defining,0,0
209045,period,0,0
209046,of,0,0
209047,18,0,1
209048,months,0,0
209049,(,0,1
209050,3,0,0
209051,in,0,0
209052,group,0,1
209053,A,0,1
209054,and,0,0
209055,2,0,0
209056,in,0,0
209057,group,0,1
209058,B,0,1
209059,),0,0
209060,.,0,0
209061,Eight,0,0
209062,(,0,0
209063,12.9,0,0
209064,%,0,0
209065,),0,0
209066,(,0,0
209067,2,0,0
209068,in,0,0
209069,group,0,1
209070,A,0,1
209071,and,0,0
209072,2,0,0
209073,in,0,0
209074,group,0,1
209075,B,0,1
209076,),0,0
209077,were,0,0
209078,considered,0,0
209079,to,0,0
209080,be,0,0
209081,in,0,0
209082,clinical,0,0
209083,remission,0,1
209084,and,0,0
209085,required,0,0
209086,a,0,0
209087,maintenance,0,0
209088,regimen,0,0
209089,of,0,0
209090,low-dose,0,0
209091,corticosteroids,0,0
209092,.,0,1
209093,Eleven,0,1
209094,patients,0,1
209095,died,0,1
209096,during,0,0
209097,the,0,0
209098,study,0,0
209099,period,0,0
209100,(,0,0
209101,7,0,0
209102,in,0,0
209103,group,0,0
209104,A,0,0
209105,[,0,0
209106,25,0,0
209107,%,0,0
209108,],0,0
209109,",",0,0
209110,4,0,0
209111,in,0,0
209112,group,0,0
209113,B,0,0
209114,[,0,0
209115,11.8,0,0
209116,%,0,0
209117,],0,1
209118,),0,0
209119,.,0,0
209120,Uncontrolled,0,0
209121,vasculitis,0,1
209122,was,0,0
209123,responsible,0,0
209124,for,0,0
209125,4,0,0
209126,deaths,0,0
209127,(,0,1
209128,2,0,0
209129,in,0,0
209130,each,0,0
209131,group,0,0
209132,),0,0
209133,",",0,0
209134,and,0,0
209135,treatment,0,0
209136,side,0,0
209137,effects,0,0
209138,caused,0,0
209139,the,0,0
209140,death,0,0
209141,of,0,0
209142,1,0,0
209143,patient,0,1
209144,in,0,0
209145,group,0,1
209146,A,0,1
209147,.,0,0
209148,There,0,0
209149,was,0,0
209150,no,0,0
209151,significant,0,0
209152,difference,0,0
209153,between,0,0
209154,the,0,0
209155,5-year,0,0
209156,cumulative,0,0
209157,survival,0,0
209158,rates,0,0
209159,of,0,0
209160,the,0,0
209161,2,0,0
209162,groups,0,0
209163,(,0,1
209164,75,0,1
209165,%,0,0
209166,and,0,0
209167,88,0,0
209168,%,0,0
209169,",",0,0
209170,respectively,0,0
209171,),0,0
209172,.,0,0
209173,CONCLUSION,0,0
209174,Based,0,0
209175,on,0,0
209176,our,0,0
209177,data,0,0
209178,",",0,0
209179,combined,0,0
209180,treatment,0,0
209181,with,0,1
209182,prednisone,0,0
209183,",",0,0
209184,cyclophosphamide,0,0
209185,",",0,0
209186,and,0,0
209187,plasma,0,0
209188,exchanges,0,0
209189,is,0,0
209190,not,0,0
209191,superior,0,0
209192,to,0,0
209193,treatment,0,0
209194,with,0,1
209195,prednisone,0,0
209196,and,0,0
209197,cyclophosphamide,0,0
209198,alone,0,0
209199,",",0,0
209200,and,0,0
209201,plasma,0,0
209202,exchanges,0,0
209203,should,0,0
209204,not,0,0
209205,be,0,0
209206,systematically,0,0
209207,proposed,0,0
209208,for,0,0
209209,initial,0,0
209210,treatment,0,0
209211,of,0,0
209212,severe,0,1
209213,PAN,0,1
209214,or,0,1
209215,CSS,0,1
209216,.,0,1
209217,The,0,0
209218,effect,0,0
209219,of,0,0
209220,iron,0,0
209221,in,0,0
209222,formula,0,0
209223,milk,0,1
209224,after,0,0
209225,6,0,0
209226,months,0,0
209227,of,0,1
209228,age,0,1
209229,.,0,1
209230,Ninety,1,1
209231,two,1,0
209232,normal,1,1
209233,birthweight,1,1
209234,infants,1,1
209235,aged,1,1
209236,6,1,1
209237,months,1,0
209238,entered,0,1
209239,a,0,0
209240,double,0,0
209241,blind,0,0
209242,controlled,0,0
209243,trial,0,0
209244,which,0,0
209245,compared,0,0
209246,a,0,0
209247,follow,0,0
209248,on,0,0
209249,formula,0,0
209250,milk,0,1
209251,with,0,1
209252,no,0,0
209253,added,0,0
209254,iron,0,0
209255,against,0,0
209256,the,0,0
209257,same,0,0
209258,formula,0,0
209259,milk,0,1
209260,containing,0,0
209261,1.2,0,0
209262,mg,0,0
209263,of,0,0
209264,iron,0,0
209265,per,0,0
209266,100,0,0
209267,ml,0,0
209268,.,0,0
209269,There,0,0
209270,was,0,0
209271,no,0,0
209272,significant,0,0
209273,difference,0,0
209274,in,0,0
209275,the,0,0
209276,social,0,0
209277,class,0,1
209278,or,0,1
209279,demographic,0,0
209280,characteristics,0,0
209281,of,0,0
209282,the,0,0
209283,two,0,0
209284,treatment,0,0
209285,groups,0,0
209286,or,0,1
209287,in,0,0
209288,the,0,0
209289,proportion,0,0
209290,of,0,0
209291,each,0,0
209292,group,0,0
209293,completing,0,0
209294,the,0,0
209295,trial,0,0
209296,.,0,0
209297,There,0,0
209298,was,0,0
209299,no,0,0
209300,difference,0,0
209301,between,0,0
209302,the,0,0
209303,two,0,0
209304,groups,0,0
209305,in,0,0
209306,the,0,0
209307,quantity,0,0
209308,of,0,0
209309,milk,0,0
209310,taken,0,0
209311,but,0,0
209312,the,0,0
209313,amounts,0,0
209314,taken,0,0
209315,lessened,0,0
209316,between,0,0
209317,6,0,0
209318,and,0,1
209319,18,0,1
209320,months,0,0
209321,of,0,1
209322,age,0,1
209323,.,0,0
209324,There,0,0
209325,was,0,0
209326,no,0,0
209327,difference,0,0
209328,between,0,0
209329,the,0,0
209330,two,0,0
209331,groups,0,0
209332,with,0,1
209333,respect,0,0
209334,to,0,0
209335,mean,0,0
209336,haemoglobin,0,0
209337,and,0,0
209338,median,0,0
209339,serum,0,0
209340,ferritin,0,0
209341,at,0,0
209342,6,0,0
209343,",",0,0
209344,9,0,0
209345,",",0,0
209346,12,0,0
209347,",",0,0
209348,15,0,0
209349,",",0,0
209350,and,0,0
209351,18,0,1
209352,months,0,0
209353,of,0,1
209354,age,0,1
209355,.,0,0
209356,Very,0,0
209357,few,0,0
209358,infants,0,1
209359,developed,0,0
209360,iron,0,0
209361,deficiency,0,1
209362,anaemia,0,1
209363,in,0,0
209364,either,0,0
209365,group,0,0
209366,but,0,0
209367,there,0,0
209368,was,0,0
209369,a,0,0
209370,tendency,0,0
209371,for,0,0
209372,serum,0,0
209373,ferritin,0,0
209374,levels,0,0
209375,to,0,0
209376,fall,0,1
209377,between,0,0
209378,6,0,0
209379,and,0,1
209380,18,0,1
209381,months,0,0
209382,of,0,0
209383,age,0,1
209384,in,0,0
209385,both,0,0
209386,groups,0,0
209387,.,0,0
209388,The,0,0
209389,results,0,0
209390,suggest,0,0
209391,that,0,0
209392,iron,0,0
209393,added,0,0
209394,to,0,0
209395,follow,0,0
209396,on,0,0
209397,milk,0,0
209398,was,0,0
209399,not,0,0
209400,an,0,0
209401,important,0,0
209402,source,0,0
209403,of,0,0
209404,dietary,0,0
209405,iron,0,0
209406,in,0,0
209407,the,0,0
209408,infants,0,1
209409,studied,0,1
209410,.,0,1
209411,Double-blind,0,0
209412,comparison,0,0
209413,of,0,0
209414,the,0,0
209415,efficacy,0,0
209416,and,0,0
209417,safety,0,0
209418,of,0,0
209419,trandolapril,0,0
209420,2,0,0
209421,mg,0,0
209422,and,0,0
209423,hydrochlorothiazide,0,0
209424,25,0,1
209425,mg,0,0
209426,in,0,1
209427,patients,1,1
209428,with,1,1
209429,mild-to-moderate,1,1
209430,essential,1,1
209431,hypertension,1,1
209432,.,1,1
209433,Investigator,0,0
209434,Study,0,0
209435,Group,0,1
209436,.,0,0
209437,This,0,0
209438,multicenter,0,0
209439,international,0,0
209440,trial,0,0
209441,recruited,0,1
209442,205,1,1
209443,patients,1,1
209444,from,1,1
209445,16,1,1
209446,investigators,1,0
209447,.,1,1
209448,After,0,0
209449,a,0,0
209450,4-week,0,0
209451,",",0,0
209452,single-blind,0,0
209453,placebo,0,0
209454,run-in,0,0
209455,",",0,0
209456,patients,0,1
209457,were,0,0
209458,randomized,0,1
209459,to,0,0
209460,receive,0,0
209461,16,0,1
209462,weeks,0,0
209463,of,0,1
209464,trandolapril,0,1
209465,2,0,0
209466,mg/day,0,0
209467,(,0,1
209468,68,0,1
209469,patients,0,1
209470,),0,0
209471,",",0,0
209472,hydrochlorothiazide,0,0
209473,(,0,0
209474,HCTZ,0,0
209475,),0,1
209476,25,0,0
209477,mg/day,0,0
209478,(,0,1
209479,68,0,1
209480,patients,0,1
209481,),0,0
209482,",",0,0
209483,or,0,0
209484,the,0,0
209485,combination,0,0
209486,(,0,0
209487,69,0,1
209488,patients,0,1
209489,),0,1
209490,.,0,1
209491,Morning,0,0
209492,predosing,0,0
209493,supine,0,0
209494,diastolic,0,1
209495,blood,0,0
209496,pressure,0,0
209497,(,0,0
209498,DBP,0,1
209499,),0,0
209500,was,0,0
209501,the,0,0
209502,primary,0,0
209503,efficacy,0,0
209504,measurement,0,0
209505,.,0,0
209506,Intention-to-treat,0,0
209507,analysis,0,0
209508,showed,0,0
209509,significant,0,0
209510,decreases,0,0
209511,in,0,0
209512,all,0,1
209513,three,0,0
209514,groups,0,0
209515,in,0,1
209516,mean,0,1
209517,(,0,1
209518,+/-,0,0
209519,SEM,0,0
209520,),0,0
209521,supine,0,0
209522,DBP,0,1
209523,throughout,0,0
209524,the,0,0
209525,study,0,0
209526,",",0,0
209527,with,0,1
209528,no,0,0
209529,significant,0,0
209530,differences,0,0
209531,at,0,1
209532,week,0,0
209533,16,0,1
209534,between,0,0
209535,trandolapril,0,0
209536,(,0,0
209537,-10.6,0,0
209538,+/-,0,0
209539,1.3,0,0
209540,mm,0,1
209541,Hg,0,0
209542,),0,0
209543,and,0,0
209544,HCTZ,0,0
209545,(,0,0
209546,-10.9,0,0
209547,+/-,0,0
209548,1.3,0,0
209549,mm,0,1
209550,Hg,0,0
209551,),0,0
209552,.,0,0
209553,The,0,0
209554,combination,0,0
209555,gave,0,0
209556,a,0,0
209557,significantly,0,0
209558,greater,0,0
209559,reduction,0,0
209560,than,0,0
209561,either,0,0
209562,drug,0,0
209563,alone,0,0
209564,(,0,0
209565,-15.1,0,0
209566,+/-,0,0
209567,1.13,0,0
209568,mm,0,1
209569,Hg,0,0
209570,),0,0
209571,.,0,0
209572,Blood,0,0
209573,pressure,0,0
209574,was,0,0
209575,normalized,0,0
209576,in,0,0
209577,the,0,0
209578,combination,0,0
209579,group,0,0
209580,in,0,0
209581,67,0,1
209582,%,0,0
209583,of,0,0
209584,patients,0,1
209585,",",0,0
209586,a,0,0
209587,significantly,0,0
209588,higher,0,0
209589,proportion,0,0
209590,than,0,0
209591,either,0,0
209592,trandolapril,0,0
209593,(,0,0
209594,63,0,1
209595,%,0,0
209596,),0,0
209597,or,0,1
209598,HCTZ,0,0
209599,(,0,0
209600,60,0,1
209601,%,0,0
209602,;,0,0
209603,p,0,0
209604,=,0,0
209605,0.04,0,0
209606,),0,0
209607,.,0,0
209608,Each,0,0
209609,treatment,0,0
209610,was,0,0
209611,well,0,0
209612,tolerated,0,0
209613,.,0,0
209614,The,0,0
209615,incidence,0,0
209616,of,0,0
209617,adverse,0,0
209618,events,0,0
209619,was,0,0
209620,similar,0,0
209621,in,0,0
209622,all,0,1
209623,three,0,0
209624,groups,0,0
209625,.,0,1
209626,Trandolapril,0,0
209627,2,0,0
209628,mg,0,0
209629,once,0,0
209630,daily,0,0
209631,is,0,0
209632,an,0,0
209633,effective,0,0
209634,antihypertensive,0,0
209635,agent,0,0
209636,",",0,0
209637,comparable,0,0
209638,to,0,0
209639,HCTZ,0,0
209640,.,0,0
209641,Furthermore,0,0
209642,",",0,0
209643,the,0,0
209644,combination,0,0
209645,of,0,0
209646,the,0,0
209647,two,0,0
209648,drugs,0,0
209649,was,0,0
209650,shown,0,0
209651,to,0,0
209652,enhance,0,0
209653,the,0,0
209654,antihypertensive,0,0
209655,effect,0,0
209656,of,0,0
209657,the,0,0
209658,two,0,0
209659,compounds,0,0
209660,alone,0,0
209661,.,0,1
209662,Multicyclic,0,0
209663,",",0,0
209664,dose-intensive,0,0
209665,chemotherapy,0,0
209666,supported,0,0
209667,by,0,0
209668,sequential,0,0
209669,reinfusion,0,0
209670,of,0,0
209671,hematopoietic,0,1
209672,progenitors,0,1
209673,in,0,0
209674,whole,0,0
209675,blood,0,0
209676,.,0,0
209677,PURPOSE,0,0
209678,To,0,0
209679,support,0,0
209680,multicyclic,0,0
209681,",",0,0
209682,dose-intensive,0,0
209683,chemotherapy,0,0
209684,",",0,0
209685,we,0,0
209686,assessed,0,0
209687,the,0,0
209688,effects,0,0
209689,of,0,0
209690,reinfusing,0,0
209691,hematopoietic,0,1
209692,progenitors,0,1
209693,collected,0,1
209694,at,0,0
209695,each,0,0
209696,cycle,0,0
209697,in,0,0
209698,leukapheresis,0,0
209699,product,0,0
209700,or,0,1
209701,whole,0,0
209702,blood,0,0
209703,.,0,1
209704,PATIENTS,0,0
209705,AND,0,0
209706,METHODS,0,0
209707,Twenty-five,1,1
209708,patients,1,1
209709,with,1,1
209710,small-cell,1,1
209711,lung,1,1
209712,cancer,1,1
209713,(,1,0
209714,SCLC,1,0
209715,),1,0
209716,were,0,0
209717,treated,0,1
209718,with,0,1
209719,six,0,1
209720,cycles,0,0
209721,of,0,0
209722,ifosfamide,0,0
209723,",",0,0
209724,carboplatin,0,0
209725,",",0,0
209726,and,0,0
209727,etoposide,0,0
209728,(,0,0
209729,ICE,0,0
209730,),0,0
209731,with,0,1
209732,granulocyte,0,0
209733,colony-stimulating,0,0
209734,factor,0,0
209735,(,0,0
209736,G-CSF,0,1
209737,),0,1
209738,300,0,0
209739,micrograms/d,0,0
209740,subcutaneously,0,0
209741,(,0,0
209742,SC,0,0
209743,),0,0
209744,on,0,0
209745,days,0,0
209746,4,0,0
209747,to,0,1
209748,15,0,1
209749,.,0,1
209750,Hematopoietic,0,0
209751,progenitors,0,0
209752,collected,0,1
209753,during,0,0
209754,each,0,0
209755,cycle,0,0
209756,were,0,0
209757,reinfused,0,0
209758,on,0,0
209759,day,0,0
209760,3,0,0
209761,of,0,0
209762,the,0,0
209763,next,0,0
209764,cycle,0,0
209765,.,0,1
209766,Cohort,0,1
209767,1,0,0
209768,(,0,0
209769,n,0,1
209770,=,0,0
209771,6,0,0
209772,),0,0
209773,was,0,0
209774,treated,0,1
209775,every,0,0
209776,3,0,0
209777,weeks,0,0
209778,",",0,0
209779,with,0,1
209780,leukapheresis,0,0
209781,after,0,0
209782,2,0,0
209783,weeks,0,0
209784,and,0,0
209785,cryopreservation,0,0
209786,of,0,0
209787,the,0,0
209788,leukapheresis,0,0
209789,product,0,0
209790,.,0,1
209791,Chemotherapy,0,0
209792,was,0,0
209793,given,0,0
209794,if,0,0
209795,the,0,0
209796,WBC,0,0
209797,count,0,0
209798,was,0,0
209799,>,0,1
209800,or,0,1
209801,=,0,0
209802,3,0,0
209803,x,0,1
209804,10,0,1
209805,(,0,1
209806,9,0,0
209807,),0,0
209808,/L,0,0
209809,and,0,0
209810,platelet,0,0
209811,count,0,0
209812,>,0,1
209813,or,0,1
209814,=,0,0
209815,100,0,0
209816,x,0,0
209817,10,0,1
209818,(,0,0
209819,9,0,0
209820,),0,1
209821,/L,0,0
209822,.,0,1
209823,Cohort,0,1
209824,2,0,0
209825,(,0,0
209826,n,0,1
209827,=,0,0
209828,7,0,1
209829,),0,0
209830,was,0,0
209831,treated,0,1
209832,every,0,0
209833,2,0,0
209834,weeks,0,0
209835,",",0,0
209836,with,0,1
209837,leukapheresis,0,0
209838,on,0,0
209839,day,0,0
209840,1,0,0
209841,of,0,0
209842,the,0,0
209843,next,0,0
209844,cycle,0,0
209845,and,0,0
209846,storage,0,0
209847,of,0,0
209848,the,0,0
209849,leukapheresis,0,0
209850,product,0,0
209851,at,0,0
209852,4,0,0
209853,degrees,0,0
209854,C.,0,0
209855,Cohort,0,1
209856,3,0,0
209857,(,0,0
209858,n,0,1
209859,=,0,0
209860,12,0,1
209861,),0,0
209862,was,0,0
209863,treated,0,1
209864,every,0,0
209865,2,0,0
209866,weeks,0,0
209867,",",0,0
209868,with,0,1
209869,500,0,0
209870,to,0,1
209871,750,0,1
209872,mL,0,0
209873,of,0,0
209874,blood,0,0
209875,drawn,0,0
209876,by,0,0
209877,venesection,0,1
209878,on,0,0
209879,day,0,0
209880,1,0,0
209881,of,0,0
209882,the,0,0
209883,next,0,0
209884,cycle,0,0
209885,and,0,0
209886,stored,0,0
209887,at,0,0
209888,4,0,0
209889,degrees,0,0
209890,C.,0,0
209891,In,0,1
209892,cohorts,0,1
209893,2,0,1
209894,and,0,1
209895,3,0,0
209896,",",0,0
209897,chemotherapy,0,0
209898,was,0,0
209899,given,0,0
209900,if,0,0
209901,the,0,0
209902,WBC,0,0
209903,count,0,0
209904,was,0,0
209905,>,0,1
209906,or,0,1
209907,=,0,0
209908,3,0,0
209909,x,0,1
209910,10,0,1
209911,(,0,1
209912,9,0,0
209913,),0,0
209914,/L,0,0
209915,and,0,0
209916,platelet,0,0
209917,count,0,0
209918,>,0,1
209919,or,0,1
209920,=,0,0
209921,30,0,1
209922,x,0,0
209923,10,0,1
209924,(,0,0
209925,9,0,0
209926,),0,1
209927,/L,0,0
209928,.,0,0
209929,Blood,0,0
209930,and,0,0
209931,leukapheresis,0,0
209932,products,0,0
209933,were,0,0
209934,assayed,0,0
209935,for,0,0
209936,hematopoietic,0,1
209937,progenitors,0,1
209938,.,0,1
209939,RESULTS,0,0
209940,ICE,0,0
209941,chemotherapy,0,1
209942,with,0,1
209943,G-CSF,0,0
209944,was,0,0
209945,effective,0,0
209946,in,0,0
209947,mobilizing,0,0
209948,blood,0,0
209949,progenitors,0,1
209950,(,0,0
209951,median,0,0
209952,",",0,0
209953,120-fold,0,0
209954,),0,0
209955,.,0,1
209956,Long-term,0,0
209957,cultures,0,0
209958,showed,0,0
209959,no,0,0
209960,evidence,0,0
209961,of,0,0
209962,stem-cell,0,1
209963,depletion,0,0
209964,.,0,0
209965,The,0,0
209966,cytotoxic,0,0
209967,dose-intensity,0,0
209968,of,0,0
209969,standard,0,0
209970,every-4-weeks,0,0
209971,ICE,0,0
209972,is,0,0
209973,100,0,0
209974,%,0,0
209975,.,0,0
209976,In,0,0
209977,the,0,0
209978,first,0,0
209979,three,0,0
209980,cycles,0,0
209981,",",0,0
209982,it,0,0
209983,was,0,0
209984,134,0,1
209985,%,0,0
209986,(,0,0
209987,median,0,0
209988,),0,0
209989,in,0,0
209990,cohort,0,1
209991,1,0,0
209992,and,0,0
209993,200,0,0
209994,%,0,0
209995,in,0,1
209996,cohorts,0,1
209997,2,0,1
209998,and,0,1
209999,3,0,0
210000,(,0,0
210001,P,0,0
210002,<,0,0
210003,.0001,0,0
210004,),0,0
210005,.,0,0
210006,Toxicity,0,0
210007,and,0,0
210008,supportive,0,0
210009,care,0,1
210010,requirements,0,0
210011,were,0,0
210012,not,0,0
210013,increased,0,0
210014,.,0,0
210015,CONCLUSION,0,0
210016,The,0,0
210017,dose-intensity,0,0
210018,of,0,0
210019,ICE,0,0
210020,chemotherapy,0,0
210021,can,0,0
210022,be,0,0
210023,doubled,0,0
210024,by,0,0
210025,reinfusing,0,0
210026,hematopoietic,0,1
210027,progenitors,0,1
210028,collected,0,1
210029,by,0,0
210030,leukapheresis,0,0
210031,or,0,1
210032,venesection,0,1
210033,and,0,0
210034,stored,0,0
210035,at,0,0
210036,4,0,0
210037,degrees,0,0
210038,C,0,1
210039,.,0,1
210040,Pharmacokinetics,0,1
210041,and,0,1
210042,pharmacodynamics,0,0
210043,of,0,0
210044,the,0,0
210045,monoamine,0,1
210046,oxidase,0,0
210047,B,0,0
210048,inhibitor,0,0
210049,mofegiline,0,0
210050,assessed,0,0
210051,during,0,0
210052,a,0,0
210053,phase,0,0
210054,I,0,1
210055,dose,0,0
210056,tolerance,0,0
210057,trial,0,0
210058,.,0,0
210059,The,0,0
210060,safety,0,0
210061,",",0,0
210062,pharmacokinetics,0,0
210063,",",0,0
210064,and,0,0
210065,pharmacodynamics,0,0
210066,of,0,0
210067,single,0,0
210068,oral,0,0
210069,doses,0,0
210070,of,0,0
210071,up,0,0
210072,to,0,1
210073,48,0,1
210074,mg,0,0
210075,and,0,1
210076,daily,0,0
210077,(,0,0
210078,for,0,0
210079,28,0,1
210080,days,0,0
210081,),0,1
210082,doses,0,0
210083,of,0,0
210084,up,0,1
210085,24,0,1
210086,mg,0,0
210087,mofegiline,0,0
210088,were,0,0
210089,investigated,0,0
210090,in,0,0
210091,healthy,1,1
210092,male,1,1
210093,volunteers,1,1
210094,.,1,1
210095,Plasma,0,0
210096,pharmacokinetics,0,0
210097,indicated,0,0
210098,rapid,0,0
210099,absorption,0,0
210100,and,0,0
210101,elimination,0,0
210102,:,0,1
210103,time,0,0
210104,to,0,0
210105,reach,0,0
210106,maximum,0,0
210107,concentration,0,0
210108,occurred,0,0
210109,at,0,0
210110,about,0,0
210111,1,0,1
210112,hour,0,0
210113,;,0,1
210114,half-life,0,0
210115,ranged,0,0
210116,from,0,1
210117,1,0,0
210118,to,0,1
210119,3,0,1
210120,hours,0,0
210121,.,0,1
210122,Maximal,0,0
210123,plasma,0,0
210124,concentration,0,0
210125,and,0,0
210126,area,0,0
210127,under,0,0
210128,the,0,0
210129,plasma,0,0
210130,concentration-time,0,0
210131,curve,0,0
210132,increased,0,0
210133,and,0,0
210134,oral,0,0
210135,clearance,0,0
210136,decreased,0,0
210137,disproportionately,0,0
210138,with,0,1
210139,dose,0,0
210140,.,0,1
210141,Mofegiline,0,0
210142,rapidly,0,0
210143,and,0,0
210144,markedly,0,0
210145,inhibited,0,0
210146,platelet,0,0
210147,monoamine,0,1
210148,oxidase,0,0
210149,B,0,0
210150,(,0,0
210151,MAOB,0,0
210152,),0,0
210153,activity,0,0
210154,",",0,0
210155,which,0,0
210156,returned,0,0
210157,to,0,0
210158,baseline,0,0
210159,within,0,0
210160,14,0,1
210161,days,0,0
210162,.,0,1
210163,Urinary,0,0
210164,excretion,0,0
210165,of,0,0
210166,phenylethylamine,0,0
210167,increased,0,0
210168,proportionately,0,0
210169,with,0,1
210170,doses,0,0
210171,up,0,0
210172,to,0,0
210173,24,0,0
210174,mg.,0,0
210175,No,0,0
210176,changes,0,0
210177,in,0,0
210178,urinary,0,1
210179,elimination,0,0
210180,of,0,0
210181,catecholamines,0,0
210182,",",0,0
210183,blood,0,0
210184,pressure,0,0
210185,",",0,0
210186,heart,0,1
210187,rate,0,0
210188,",",0,0
210189,or,0,1
210190,ECG,0,0
210191,were,0,0
210192,observed,0,0
210193,.,0,0
210194,A,0,0
210195,classic,0,0
210196,maximum,0,0
210197,tolerated,0,0
210198,dose,0,0
210199,was,0,0
210200,not,0,0
210201,achieved,0,0
210202,in,0,0
210203,these,0,0
210204,studies,0,0
210205,.,0,0
210206,However,0,0
210207,",",0,0
210208,the,0,0
210209,48,0,0
210210,mg,0,0
210211,single,0,0
210212,dose,0,0
210213,and,0,0
210214,the,0,0
210215,24,0,0
210216,mg,0,0
210217,multiple,0,0
210218,daily,0,0
210219,dose,0,0
210220,far,0,0
210221,exceeded,0,0
210222,the,0,0
210223,dose,0,0
210224,(,0,0
210225,1,0,0
210226,mg,0,0
210227,),0,0
210228,that,0,0
210229,was,0,0
210230,associated,0,0
210231,with,0,1
210232,>,0,1
210233,90,0,1
210234,%,0,0
210235,platelet,0,1
210236,MAOB,0,0
210237,inhibition,0,0
210238,.,0,1
210239,Effect,0,0
210240,of,0,0
210241,perception,0,0
210242,of,0,0
210243,mechanical,0,0
210244,loading,0,0
210245,on,0,0
210246,human,0,1
210247,respiratory,0,1
210248,pattern,0,1
210249,regulation,0,0
210250,.,0,0
210251,We,0,0
210252,applied,0,0
210253,external,0,0
210254,flow,0,0
210255,resistive,0,0
210256,(,0,0
210257,R,0,1
210258,),0,0
210259,and,0,0
210260,elastic,0,0
210261,(,0,0
210262,E,0,0
210263,),0,1
210264,mechanical,0,1
210265,loads,0,0
210266,over,0,0
210267,the,0,0
210268,entire,0,0
210269,respiratory,0,1
210270,cycle,0,0
210271,to,0,0
210272,five,1,1
210273,normal,1,1
210274,subjects,1,1
210275,by,0,0
210276,using,0,0
210277,a,0,0
210278,pseudorandom,0,0
210279,loading,0,0
210280,protocol,0,0
210281,.,0,1
210282,Loads,0,0
210283,ranged,0,0
210284,in,0,0
210285,magnitude,0,0
210286,from,0,1
210287,imperceptible,0,0
210288,(,0,1
210289,R0/E0,0,0
210290,),0,0
210291,through,0,0
210292,just,0,1
210293,perceptible,0,0
210294,(,0,0
210295,R1/E1,0,0
210296,),0,0
210297,to,0,0
210298,large,0,1
210299,(,0,0
210300,R2/E2,0,1
210301,),0,0
210302,and,0,0
210303,resulted,0,0
210304,in,0,0
210305,respiratory,0,1
210306,pattern,0,1
210307,responses,0,0
210308,that,0,0
210309,were,0,1
210310,due,0,0
210311,to,0,0
210312,reflex,0,0
210313,responses,0,0
210314,alone,0,0
210315,(,0,0
210316,R0/E0,0,0
210317,),0,0
210318,or,0,0
210319,to,0,0
210320,a,0,0
210321,combination,0,0
210322,of,0,0
210323,reflex,0,0
210324,responses,0,0
210325,and,0,1
210326,behavioral,0,1
210327,reactions,0,0
210328,to,0,0
210329,the,0,0
210330,perception,0,0
210331,of,0,0
210332,impeded,0,0
210333,breathing,0,0
210334,(,0,0
210335,R1/E1,0,0
210336,and,0,0
210337,R2/E2,0,1
210338,),0,0
210339,.,0,0
210340,Pattern,0,0
210341,regulation,0,0
210342,dynamics,0,0
210343,were,0,0
210344,estimated,0,0
210345,from,0,0
210346,the,0,0
210347,computed,0,0
210348,impulse,0,0
210349,responses,0,0
210350,of,0,0
210351,tidal,0,1
210352,volume,0,0
210353,and,0,0
210354,inspiratory,0,0
210355,and,0,0
210356,expiratory,0,1
210357,durations,0,0
210358,.,0,1
210359,We,0,0
210360,anticipated,0,0
210361,that,0,0
210362,emergence,0,0
210363,of,0,0
210364,behavioral,0,0
210365,contributions,0,0
210366,would,0,0
210367,be,0,0
210368,marked,0,0
210369,by,0,0
210370,increased,0,0
210371,variability,0,0
210372,in,0,0
210373,response,0,0
210374,strategies,0,0
210375,and,0,0
210376,by,0,0
210377,increased,0,0
210378,nonlinearity,0,0
210379,in,0,0
210380,the,0,0
210381,observed,0,0
210382,responses,0,0
210383,.,0,1
210384,Regarding,0,0
210385,the,0,0
210386,immediate,0,0
210387,pattern,0,1
210388,response,0,0
210389,to,0,0
210390,loading,0,0
210391,",",0,0
210392,there,0,0
210393,was,0,0
210394,a,0,0
210395,tendency,0,0
210396,for,0,0
210397,increased,0,0
210398,qualitative,0,0
210399,variation,0,0
210400,across,0,0
210401,subjects,0,1
210402,as,0,0
210403,the,0,0
210404,load,0,0
210405,size,0,0
210406,increased,0,0
210407,",",0,0
210408,but,0,0
210409,the,0,0
210410,within-subject,0,0
210411,variability,0,0
210412,(,0,0
210413,coefficient,0,0
210414,of,0,0
210415,variation,0,0
210416,),0,0
210417,was,0,0
210418,unaffected,0,0
210419,.,0,1
210420,We,0,0
210421,found,0,0
210422,no,0,0
210423,evidence,0,0
210424,for,0,0
210425,increased,0,0
210426,nonlinearity,0,0
210427,as,0,0
210428,loads,0,0
210429,became,0,1
210430,perceptible,0,0
210431,.,0,0
210432,The,0,0
210433,emergence,0,0
210434,of,0,0
210435,behavioral,0,0
210436,control,0,1
210437,in,0,0
210438,some,0,0
210439,instances,0,0
210440,seemed,0,0
210441,to,0,0
210442,be,0,0
210443,marked,0,0
210444,by,0,0
210445,reduction,0,0
210446,of,0,0
210447,complexity,0,0
210448,of,0,0
210449,the,0,0
210450,impulse,0,0
210451,response,0,0
210452,to,0,0
210453,one,0,0
210454,dominated,0,0
210455,by,0,0
210456,the,0,0
210457,zeroth-order,0,0
210458,lag,0,0
210459,",",0,0
210460,leading,0,0
210461,to,0,0
210462,dynamically,0,0
210463,simpler,0,0
210464,responses,0,0
210465,compared,0,0
210466,to,0,0
210467,control,0,1
210468,.,0,1
210469,Lisinopril,0,0
210470,administration,0,0
210471,improves,0,0
210472,insulin,0,0
210473,action,0,0
210474,in,0,0
210475,aged,1,1
210476,patients,1,1
210477,with,1,1
210478,hypertension,1,1
210479,.,1,1
210480,Thirty,1,1
210481,elderly,1,1
210482,",",1,0
210483,mildly,1,1
210484,hypertensive,1,1
210485,patients,1,1
210486,were,0,1
210487,enrolled,0,1
210488,for,0,0
210489,a,0,0
210490,single-blind,0,0
210491,",",0,0
210492,randomised,0,0
210493,cross-over,0,0
210494,placebo,0,0
210495,controlled,0,0
210496,trial,0,0
210497,in,0,0
210498,which,0,0
210499,placebo,0,0
210500,and,0,0
210501,lisinopril,0,0
210502,(,0,0
210503,20,0,0
210504,mg/day,0,0
210505,before,0,0
210506,breakfast,0,0
210507,),0,0
210508,were,0,0
210509,given,0,0
210510,for,0,0
210511,4,0,0
210512,and,0,1
210513,8,0,0
210514,weeks,0,0
210515,",",0,0
210516,respectively,0,0
210517,.,0,0
210518,A,0,0
210519,wash-out,0,0
210520,period,0,0
210521,of,0,0
210522,3,0,0
210523,weeks,0,0
210524,between,0,0
210525,placebo,0,0
210526,and,0,0
210527,lisinopril,0,0
210528,was,0,0
210529,observed,0,0
210530,.,0,0
210531,In,0,0
210532,each,0,0
210533,patient,0,0
210534,a,0,0
210535,euglycaemic,0,0
210536,glucose,0,0
210537,clamp,0,0
210538,with,0,1
210539,simultaneous,0,0
210540,indirect,0,0
210541,calorimetry,0,0
210542,allowed,0,0
210543,us,0,1
210544,to,0,0
210545,determine,0,0
210546,whole,0,0
210547,body,0,1
210548,glucose,0,0
210549,disposal,0,1
210550,and,0,0
210551,substrate,0,0
210552,oxidation,0,0
210553,.,0,1
210554,Changes,0,0
210555,in,0,0
210556,morning,0,0
210557,SBP,0,1
210558,and,0,0
210559,DBP,0,1
210560,were,0,0
210561,also,0,0
210562,determined,0,0
210563,.,0,0
210564,Lisinopril,0,0
210565,vs.,0,0
210566,placebo,0,0
210567,significantly,0,0
210568,improved,0,0
210569,whole,0,0
210570,body,0,1
210571,glucose,0,0
210572,disposal,0,1
210573,(,0,0
210574,40.4,0,0
210575,+/-,0,0
210576,0.4,0,0
210577,vs.,0,0
210578,30.3,0,1
210579,+/-,0,0
210580,0.4,0,0
210581,mumol/kg,0,0
210582,LBM,0,1
210583,x,0,1
210584,min,0,0
210585,;,0,0
210586,P,0,0
210587,<,0,0
210588,0.01,0,0
210589,),0,0
210590,",",0,0
210591,non-oxidative,0,0
210592,glucose,0,0
210593,metabolism,0,0
210594,(,0,0
210595,18.1,0,0
210596,+/-,0,0
210597,0.7,0,0
210598,vs.,0,0
210599,10.9,0,0
210600,+/-,0,0
210601,0.6,0,0
210602,mumol/kg,0,0
210603,LBM,0,1
210604,x,0,1
210605,min,0,0
210606,;,0,0
210607,P,0,0
210608,<,0,0
210609,0.01,0,0
210610,),0,0
210611,and,0,0
210612,fasting,0,0
210613,plasma,0,0
210614,potassium,0,0
210615,levels,0,0
210616,(,0,1
210617,4.8,0,0
210618,+/-,0,0
210619,3,0,0
210620,vs.,0,0
210621,4.4,0,0
210622,+/-,0,0
210623,0.4,0,0
210624,mmol/l,0,0
210625,;,0,1
210626,P,0,0
210627,<,0,0
210628,0.05,0,0
210629,),0,1
210630,.,0,1
210631,SBP,0,0
210632,(,0,0
210633,175,0,1
210634,+/-,0,0
210635,3.3,0,1
210636,vs.,0,0
210637,160,0,1
210638,+/-,0,0
210639,3.0,0,0
210640,mm,0,1
210641,Hg,0,0
210642,;,0,0
210643,P,0,0
210644,<,0,0
210645,0.001,0,0
210646,),0,0
210647,and,0,0
210648,DBP,0,1
210649,(,0,0
210650,106,0,1
210651,+/-,0,0
210652,2.3,0,0
210653,vs.,0,0
210654,95,0,0
210655,+/-,0,0
210656,2.0,0,0
210657,mm,0,1
210658,Hg,0,0
210659,;,0,0
210660,P,0,0
210661,<,0,0
210662,0.001,0,0
210663,),0,0
210664,were,0,0
210665,significantly,0,0
210666,reduced,0,0
210667,by,0,0
210668,lisinopril,0,0
210669,administration,0,0
210670,.,0,1
210671,After,0,0
210672,ACE,0,0
210673,inhibition,0,0
210674,",",0,0
210675,fasting,0,0
210676,plasma,0,0
210677,potassium,0,0
210678,levels,0,0
210679,correlated,0,0
210680,with,0,1
210681,the,0,0
210682,decline,0,0
210683,in,0,0
210684,mean,0,1
210685,arterial,0,1
210686,BP,0,0
210687,(,0,0
210688,r,0,0
210689,=,0,0
210690,-0.71,0,0
210691,;,0,1
210692,P,0,0
210693,<,0,0
210694,0.006,0,0
210695,),0,0
210696,.,0,0
210697,In,0,0
210698,conclusion,0,0
210699,",",0,0
210700,lisinopril,0,0
210701,administration,0,0
210702,reduces,0,0
210703,arterial,0,0
210704,BP,0,0
210705,and,0,0
210706,improves,0,0
210707,insulin,0,0
210708,sensitivity,0,0
210709,in,0,0
210710,elderly,1,1
210711,hypertensive,1,1
210712,patients,1,1
210713,.,1,1
210714,Reducing,0,0
210715,the,0,0
210716,risk,0,0
210717,of,0,0
210718,coronary,0,1
210719,events,0,0
210720,:,0,1
210721,evidence,0,0
210722,from,0,0
210723,the,0,0
210724,Scandinavian,0,1
210725,Simvastatin,0,0
210726,Survival,0,0
210727,Study,0,0
210728,(,0,1
210729,4S,0,0
210730,),0,0
210731,.,0,0
210732,The,0,0
210733,Scandinavian,0,1
210734,Simvastatin,0,0
210735,Survival,0,0
210736,Study,0,0
210737,(,0,1
210738,4S,0,0
210739,),0,0
210740,was,0,0
210741,designed,0,0
210742,to,0,0
210743,evaluate,0,0
210744,the,0,0
210745,effects,0,0
210746,of,0,0
210747,cholesterol,0,0
210748,reduction,0,0
210749,with,0,1
210750,simvastatin,0,0
210751,on,0,0
210752,mortality,0,0
210753,and,0,0
210754,morbidity,0,0
210755,in,0,0
210756,patients,1,1
210757,with,1,1
210758,coronary,1,1
210759,artery,1,1
210760,disease,1,1
210761,(,1,0
210762,CAD,1,0
210763,),1,0
210764,.,1,0
210765,A,0,0
210766,total,1,1
210767,of,1,0
210768,"4,444",1,1
210769,patients,1,1
210770,with,1,1
210771,angina,1,1
210772,pectoris,1,1
210773,or,1,1
210774,previous,1,0
210775,myocardial,1,1
210776,infarction,1,1
210777,and,1,0
210778,serum,1,0
210779,cholesterol,1,0
210780,levels,1,0
210781,of,1,0
210782,213-310,1,1
210783,mg/dl,1,0
210784,(,1,0
210785,5.5-8.0,1,0
210786,mmol/liter,1,0
210787,),1,0
210788,while,1,0
210789,treated,1,1
210790,with,1,1
210791,a,1,0
210792,lipid-lowering,1,1
210793,diet,1,0
210794,were,0,0
210795,randomly,0,1
210796,assigned,0,0
210797,to,0,0
210798,double-blind,0,0
210799,treatment,0,0
210800,with,0,0
210801,simvastatin,0,0
210802,or,0,1
210803,placebo,0,0
210804,.,0,0
210805,Over,0,0
210806,the,0,0
210807,5.4,0,0
210808,years,0,1
210809,of,0,0
210810,median,0,1
210811,follow-up,0,0
210812,",",0,0
210813,simvastatin,0,0
210814,produced,0,0
210815,changes,0,0
210816,in,0,0
210817,total,0,1
210818,cholesterol,0,0
210819,",",0,0
210820,low,0,0
210821,density,0,0
210822,lipoprotein,0,0
210823,(,0,0
210824,LDL,0,0
210825,),0,0
210826,cholesterol,0,0
210827,",",0,0
210828,and,0,0
210829,high,0,0
210830,density,0,0
210831,lipoprotein,0,0
210832,(,0,0
210833,HDL,0,0
210834,),0,0
210835,cholesterol,0,0
210836,of,0,0
210837,-25,0,0
210838,%,0,0
210839,",",0,0
210840,-35,0,0
210841,%,0,0
210842,",",0,0
210843,and,0,0
210844,+8,0,0
210845,%,0,0
210846,",",0,0
210847,respectively,0,0
210848,",",0,0
210849,with,0,1
210850,minimal,0,0
210851,adverse,0,0
210852,effects,0,0
210853,.,0,1
210854,A,0,0
210855,total,0,1
210856,of,0,0
210857,256,1,1
210858,patients,1,1
210859,(,0,1
210860,12,0,0
210861,%,0,0
210862,),0,0
210863,in,0,0
210864,the,0,0
210865,placebo,0,0
210866,group,0,0
210867,died,0,1
210868,compared,0,0
210869,with,0,1
210870,182,0,1
210871,(,0,1
210872,8,0,0
210873,%,0,0
210874,),0,0
210875,in,0,0
210876,the,0,0
210877,simvastatin,0,0
210878,group,0,0
210879,",",0,0
210880,a,0,0
210881,risk,0,0
210882,reduction,0,0
210883,of,0,0
210884,30,0,1
210885,%,0,0
210886,(,0,0
210887,p,0,0
210888,=,0,0
210889,0.0003,0,0
210890,),0,0
210891,attributable,0,0
210892,to,0,0
210893,a,0,0
210894,42,0,1
210895,%,0,0
210896,reduction,0,0
210897,in,0,0
210898,the,0,0
210899,risk,0,0
210900,of,0,0
210901,coronary,0,1
210902,death,0,0
210903,.,0,1
210904,Noncardiovascular,0,0
210905,causes,0,0
210906,accounted,0,0
210907,for,0,0
210908,49,0,1
210909,and,0,1
210910,46,0,1
210911,deaths,0,0
210912,in,0,0
210913,the,0,0
210914,placebo,0,0
210915,and,0,0
210916,simvastatin,0,0
210917,groups,0,0
210918,",",0,0
210919,respectively,0,0
210920,.,0,0
210921,Major,0,0
210922,coronary,0,1
210923,events,0,0
210924,were,0,1
210925,experienced,0,0
210926,by,0,0
210927,622,0,1
210928,patients,0,1
210929,(,0,1
210930,28,0,1
210931,%,0,0
210932,),0,0
210933,in,0,0
210934,the,0,0
210935,placebo,0,0
210936,group,0,0
210937,and,0,0
210938,431,0,1
210939,patients,0,1
210940,(,0,1
210941,19,0,1
210942,%,0,0
210943,),0,0
210944,in,0,0
210945,the,0,0
210946,simvastatin,0,0
210947,group,0,0
210948,",",0,0
210949,corresponding,0,0
210950,to,0,0
210951,a,0,0
210952,risk,0,0
210953,reduction,0,0
210954,of,0,0
210955,34,0,1
210956,%,0,0
210957,(,0,0
210958,p,0,0
210959,<,0,0
210960,0.00001,0,0
210961,),0,0
210962,.,0,0
210963,This,0,0
210964,risk,0,0
210965,was,0,0
210966,also,0,0
210967,significantly,0,0
210968,reduced,0,0
210969,in,0,0
210970,subgroups,0,0
210971,consisting,0,1
210972,of,0,0
210973,women,1,1
210974,and,1,1
210975,patients,1,1
210976,of,1,0
210977,both,1,0
210978,sexes,1,1
210979,aged,0,1
210980,>,0,1
210981,or,0,1
210982,=,0,0
210983,60,0,1
210984,years,0,1
210985,.,0,1
210986,Other,0,0
210987,benefits,0,0
210988,of,0,0
210989,treatment,0,0
210990,included,0,1
210991,a,0,0
210992,37,0,1
210993,%,0,0
210994,reduction,0,0
210995,(,0,0
210996,p,0,0
210997,<,0,0
210998,0.00001,0,0
210999,),0,0
211000,in,0,0
211001,the,0,0
211002,risk,0,0
211003,of,0,0
211004,undergoing,0,1
211005,myocardial,0,1
211006,revascularization,0,1
211007,procedures,0,1
211008,.,0,1
211009,Simvastatin,0,0
211010,was,0,0
211011,beneficial,0,0
211012,regardless,0,0
211013,of,0,0
211014,whether,0,0
211015,patients,0,1
211016,had,0,1
211017,a,0,0
211018,history,0,1
211019,of,0,0
211020,myocardial,0,1
211021,infarction,0,1
211022,or,0,1
211023,whether,0,0
211024,they,0,1
211025,were,0,1
211026,smokers,0,1
211027,or,0,1
211028,had,0,1
211029,hypertension,0,1
211030,.,0,0
211031,(,0,0
211032,ABSTRACT,0,0
211033,TRUNCATED,0,1
211034,AT,0,1
211035,250,0,0
211036,WORDS,0,1
211037,),0,1
211038,Why,0,0
211039,are,0,0
211040,there,0,0
211041,sometimes,0,0
211042,concreteness,0,0
211043,effects,0,0
211044,in,0,0
211045,memory,1,0
211046,for,0,0
211047,prose,0,0
211048,?,0,1
211049,Four,1,0
211050,experiments,1,0
211051,explored,0,0
211052,on-line,0,0
211053,encoding,0,0
211054,strategies,0,0
211055,and,0,0
211056,memory,1,0
211057,for,1,0
211058,high,1,0
211059,imagery,1,0
211060,and,1,0
211061,low,1,0
211062,imagery,1,0
211063,texts,1,0
211064,.,1,0
211065,Results,0,0
211066,consistently,0,0
211067,indicated,0,0
211068,that,0,0
211069,concreteness,0,0
211070,effects,0,0
211071,in,0,0
211072,memory,0,0
211073,for,0,0
211074,text,0,0
211075,depend,0,0
211076,on,0,0
211077,how,0,0
211078,materials,0,1
211079,are,0,0
211080,presented,0,0
211081,in,0,0
211082,several,0,0
211083,different,0,1
211084,respects,0,0
211085,.,0,1
211086,Most,0,0
211087,importantly,0,0
211088,",",0,0
211089,the,0,0
211090,experiments,0,0
211091,clarified,0,0
211092,apparently,0,1
211093,contradictory,0,0
211094,results,0,0
211095,of,0,1
211096,previous,0,1
211097,studies,0,0
211098,by,0,0
211099,indicating,0,0
211100,that,0,0
211101,concreteness,0,0
211102,effects,0,0
211103,generally,0,0
211104,do,0,0
211105,not,0,0
211106,occur,0,0
211107,in,0,0
211108,memory,0,0
211109,for,0,0
211110,prose,0,0
211111,when,0,0
211112,imageability,0,0
211113,is,0,0
211114,manipulated,0,0
211115,between-subjects,1,0
211116,",",0,0
211117,and,0,0
211118,that,0,0
211119,their,0,0
211120,occurrence,0,0
211121,when,0,0
211122,imageability,0,0
211123,is,0,0
211124,manipulated,0,0
211125,within-subjects,0,0
211126,depends,0,0
211127,on,0,0
211128,the,0,0
211129,order,0,0
211130,occurrence,0,0
211131,when,0,0
211132,imageability,0,0
211133,is,0,0
211134,manipulated,0,0
211135,within-subjects,0,0
211136,depends,0,0
211137,on,0,0
211138,the,0,0
211139,order,0,0
211140,of,0,0
211141,presentation,0,0
211142,.,0,0
211143,In,0,0
211144,addition,0,0
211145,",",0,0
211146,moving,0,0
211147,window,0,0
211148,analyses,0,0
211149,of,0,0
211150,text,0,0
211151,processing,0,0
211152,strategies,0,0
211153,indicated,0,0
211154,that,0,0
211155,differential,0,0
211156,strategies,0,0
211157,observed,0,0
211158,in,0,0
211159,previous,0,0
211160,studies,0,0
211161,when,0,0
211162,subjects,1,1
211163,listened,0,0
211164,to,0,0
211165,high,0,1
211166,vs,0,0
211167,low,0,0
211168,imagery,0,0
211169,text,0,0
211170,do,0,0
211171,not,0,0
211172,generalize,0,0
211173,to,0,0
211174,reading,0,0
211175,of,0,0
211176,the,0,0
211177,same,0,0
211178,materials,0,1
211179,.,0,1
211180,Potential,0,0
211181,explanations,0,0
211182,for,0,0
211183,the,0,0
211184,pattern,0,1
211185,of,0,0
211186,results,0,0
211187,are,0,0
211188,evaluated,0,0
211189,",",0,0
211190,and,0,0
211191,implications,0,0
211192,for,0,0
211193,theories,0,0
211194,of,0,0
211195,mental,0,1
211196,imagery,0,0
211197,and,0,0
211198,memory,0,0
211199,are,0,0
211200,considered,0,0
211201,.,0,1
211202,Quantifying,0,0
211203,the,0,0
211204,extent,0,0
211205,of,0,0
211206,osteonecrosis,1,1
211207,of,1,0
211208,the,1,0
211209,femoral,1,1
211210,head,1,1
211211,.,1,0
211212,A,0,0
211213,new,0,0
211214,method,0,0
211215,using,0,0
211216,MRI,0,0
211217,.,0,1
211218,In,0,0
211219,a,0,0
211220,randomised,0,0
211221,trial,0,0
211222,comparing,0,0
211223,core,0,0
211224,decompression,0,0
211225,with,0,1
211226,conservative,0,1
211227,treatment,0,0
211228,we,0,0
211229,tested,0,0
211230,the,0,0
211231,hypothesis,0,0
211232,that,0,0
211233,the,0,0
211234,extent,0,0
211235,of,0,0
211236,necrosis,0,0
211237,at,0,0
211238,the,0,0
211239,initial,0,0
211240,MRI,0,0
211241,predicts,0,0
211242,the,0,0
211243,subsequent,0,0
211244,risk,0,0
211245,of,0,0
211246,collapse,0,0
211247,of,0,0
211248,the,0,0
211249,femoral,0,1
211250,head,0,1
211251,.,0,0
211252,After,0,0
211253,the,0,0
211254,initial,0,0
211255,clinical,0,0
211256,evaluation,0,0
211257,",",0,0
211258,including,0,0
211259,plain,0,0
211260,radiography,0,1
211261,and,0,0
211262,MRI,0,0
211263,",",0,0
211264,37,1,1
211265,hips,1,1
211266,with,1,1
211267,early-stage,1,1
211268,osteonecrosis,1,1
211269,(,1,0
211270,ON,1,0
211271,),1,0
211272,in,1,0
211273,33,1,1
211274,patients,1,1
211275,were,1,1
211276,randomly,1,1
211277,assigned,1,0
211278,to,0,0
211279,a,0,0
211280,core-decompression,0,0
211281,group,0,0
211282,or,0,0
211283,a,0,0
211284,conservatively-treated,0,0
211285,group,0,0
211286,.,0,0
211287,All,0,0
211288,were,0,0
211289,followed,0,0
211290,regularly,0,0
211291,by,0,0
211292,clinical,0,0
211293,evaluation,0,0
211294,",",0,0
211295,plain,0,0
211296,radiography,0,0
211297,and,0,0
211298,MRI,0,0
211299,at,0,0
211300,intervals,0,0
211301,of,0,1
211302,three,0,1
211303,months,0,0
211304,.,0,1
211305,The,0,0
211306,extent,0,0
211307,of,0,0
211308,ON,0,0
211309,was,0,0
211310,estimated,0,0
211311,on,0,0
211312,the,0,0
211313,basis,0,0
211314,of,0,0
211315,abnormal,0,0
211316,signal,0,0
211317,intensity,0,0
211318,in,0,0
211319,the,0,0
211320,weight-bearing,0,0
211321,portion,0,0
211322,of,0,0
211323,the,0,0
211324,femoral,0,1
211325,head,0,1
211326,as,0,0
211327,determined,0,0
211328,from,0,0
211329,a,0,0
211330,combination,0,0
211331,of,0,0
211332,coronal,0,0
211333,and,0,1
211334,sagittal,0,1
211335,MRIs,0,1
211336,.,0,0
211337,The,0,0
211338,arc,0,0
211339,of,0,0
211340,the,0,0
211341,necrotic,0,0
211342,portion,0,0
211343,in,0,0
211344,the,0,0
211345,mid-coronal,0,0
211346,image,0,0
211347,(,0,0
211348,A,0,0
211349,),0,0
211350,and,0,0
211351,that,0,0
211352,in,0,0
211353,the,0,0
211354,mid-sagittal,0,0
211355,image,0,0
211356,(,0,0
211357,B,0,1
211358,),0,0
211359,were,0,0
211360,used,0,0
211361,to,0,0
211362,quantify,0,0
211363,the,0,0
211364,extent,0,0
211365,of,0,0
211366,necrosis,0,0
211367,by,0,0
211368,the,0,0
211369,formula,0,0
211370,:,0,1
211371,(,0,0
211372,A/180,0,0
211373,),0,0
211374,x,0,0
211375,(,0,0
211376,B/180,0,0
211377,),0,0
211378,x,0,0
211379,100,0,0
211380,.,0,0
211381,There,0,0
211382,was,0,0
211383,a,0,0
211384,strong,0,0
211385,correlation,0,0
211386,between,0,0
211387,this,0,0
211388,index,0,0
211389,and,0,0
211390,the,0,0
211391,risk,0,0
211392,of,0,0
211393,collapse,0,0
211394,before,0,0
211395,and,0,0
211396,after,0,0
211397,adjustment,0,0
211398,for,0,0
211399,age,0,1
211400,",",0,0
211401,gender,0,0
211402,",",0,0
211403,stage,0,1
211404,and,0,0
211405,treatment,0,0
211406,group,0,0
211407,.,0,0
211408,We,0,0
211409,conclude,0,0
211410,that,0,0
211411,the,0,0
211412,extent,0,0
211413,of,0,0
211414,the,0,0
211415,necrotic,0,0
211416,portion,0,0
211417,ascertain,0,0
211418,by,0,0
211419,this,0,0
211420,method,0,0
211421,is,0,0
211422,a,0,0
211423,major,0,0
211424,predictor,0,0
211425,of,0,0
211426,future,0,0
211427,collapse,0,1
211428,.,0,0
211429,We,0,0
211430,propose,0,0
211431,a,0,0
211432,systematic,0,0
211433,method,0,0
211434,of,0,0
211435,determining,0,0
211436,the,0,0
211437,index,0,0
211438,of,0,0
211439,the,0,0
211440,necrotic,0,0
211441,portion,0,0
211442,which,0,0
211443,may,0,0
211444,be,0,0
211445,clinically,0,0
211446,useful,0,0
211447,in,0,0
211448,the,0,0
211449,management,0,0
211450,of,0,0
211451,early-stage,1,1
211452,ON,1,0
211453,of,1,0
211454,the,1,0
211455,femoral,1,1
211456,head,1,1
211457,.,1,1
211458,The,0,0
211459,efficacy,0,0
211460,of,0,0
211461,a,0,0
211462,herbal-based,0,0
211463,toothpaste,0,0
211464,on,0,0
211465,the,0,0
211466,control,0,0
211467,of,0,0
211468,plaque,1,0
211469,and,1,0
211470,gingivitis,1,1
211471,.,1,0
211472,A,0,0
211473,double-blind,0,0
211474,controlled,0,0
211475,clinical,0,0
211476,trial,0,0
211477,with,0,1
211478,parallel,0,0
211479,groups,0,0
211480,was,0,0
211481,designed,0,0
211482,to,0,0
211483,investigate,0,0
211484,the,0,0
211485,effectiveness,0,0
211486,of,0,0
211487,a,0,0
211488,herbal-based,0,0
211489,toothpaste,0,0
211490,in,0,0
211491,the,0,0
211492,control,0,0
211493,of,0,0
211494,plaque,0,0
211495,and,0,0
211496,gingivitis,0,1
211497,as,0,0
211498,compared,0,0
211499,with,0,1
211500,a,0,0
211501,conventional,0,0
211502,dentifrice,0,0
211503,.,0,1
211504,70,1,1
211505,subjects,1,1
211506,with,1,1
211507,gingivitis,1,1
211508,completed,0,1
211509,the,0,0
211510,6-week,0,0
211511,study,0,0
211512,.,0,0
211513,All,1,0
211514,participants,1,1
211515,had,1,0
211516,at,1,0
211517,least,1,1
211518,20,1,1
211519,natural,1,0
211520,teeth,1,1
211521,with,1,1
211522,no,1,0
211523,probing,1,0
211524,depths,1,0
211525,greater,1,0
211526,than,1,0
211527,3,1,0
211528,mm,1,0
211529,and,1,0
211530,a,1,0
211531,plaque,1,0
211532,index,1,0
211533,of,1,0
211534,2,1,0
211535,or,1,1
211536,more,1,0
211537,at,1,0
211538,baseline,1,0
211539,.,1,0
211540,At,0,0
211541,baseline,0,0
211542,",",0,0
211543,both,0,0
211544,groups,0,0
211545,were,0,0
211546,balanced,0,0
211547,for,0,0
211548,the,0,0
211549,parameters,0,0
211550,measured,0,0
211551,:,0,1
211552,plaque,0,0
211553,index,0,0
211554,",",0,0
211555,plaque,0,0
211556,vitality,0,0
211557,",",0,0
211558,gingival,0,0
211559,index,0,0
211560,",",0,0
211561,bleeding,0,0
211562,on,0,0
211563,probing,0,0
211564,and,0,0
211565,gingival,0,1
211566,crevicular,0,0
211567,fluid,0,0
211568,flow,0,0
211569,.,0,0
211570,At,0,0
211571,the,0,0
211572,end,0,0
211573,of,0,0
211574,the,0,0
211575,trial,0,0
211576,",",0,0
211577,there,0,0
211578,were,0,0
211579,reductions,0,0
211580,within,0,0
211581,both,0,0
211582,groups,0,0
211583,",",0,0
211584,however,0,0
211585,",",0,0
211586,there,0,0
211587,were,0,0
211588,no,0,0
211589,significant,0,0
211590,differences,0,0
211591,between,0,0
211592,the,0,0
211593,groups,0,0
211594,.,0,1
211595,It,0,0
211596,was,0,0
211597,concluded,0,0
211598,that,0,0
211599,the,0,0
211600,herbal,0,0
211601,based,0,0
211602,toothpaste,0,0
211603,was,0,0
211604,as,0,0
211605,effective,0,0
211606,as,0,0
211607,the,0,0
211608,conventionally,0,0
211609,formulated,0,0
211610,dentifrice,0,0
211611,in,0,0
211612,the,0,0
211613,control,0,0
211614,of,0,0
211615,plaque,0,0
211616,and,0,0
211617,gingivitis,0,1
211618,.,0,1
211619,Brief,0,1
211620,report,0,0
211621,:,0,1
211622,a,0,0
211623,pilot,0,0
211624,study,0,0
211625,of,0,0
211626,auditory,0,0
211627,integration,0,0
211628,training,0,0
211629,in,0,0
211630,autism,1,1
211631,.,1,1
211632,Prospective,0,0
211633,trial,0,0
211634,of,0,0
211635,intraoperative,0,0
211636,mitomycin,0,0
211637,C,0,0
211638,in,0,0
211639,the,0,0
211640,treatment,0,0
211641,of,0,0
211642,primary,1,1
211643,pterygium,1,1
211644,.,1,0
211645,AIMS,0,0
211646,A,0,0
211647,prospective,0,0
211648,",",0,0
211649,randomised,0,0
211650,",",0,0
211651,double,0,0
211652,blind,0,0
211653,",",0,0
211654,placebo,0,0
211655,controlled,0,0
211656,study,0,0
211657,of,0,0
211658,intraoperative,0,0
211659,mitomycin,0,0
211660,C,0,0
211661,as,0,0
211662,adjunctive,0,0
211663,treatment,0,0
211664,of,0,0
211665,primary,1,1
211666,pterygium,1,1
211667,was,0,0
211668,conducted,0,0
211669,.,0,1
211670,METHODS,0,0
211671,A,1,0
211672,total,1,1
211673,of,1,0
211674,66,1,1
211675,eyes,1,1
211676,of,1,1
211677,54,1,1
211678,patients,1,1
211679,with,1,1
211680,primary,1,1
211681,pterygium,1,1
211682,were,0,0
211683,treated,0,1
211684,with,0,1
211685,excision,0,0
211686,",",0,0
211687,with,0,0
211688,or,0,0
211689,without,0,1
211690,a,0,0
211691,single,0,0
211692,intraoperative,0,0
211693,application,0,0
211694,of,0,0
211695,mitomycin,0,0
211696,C,0,0
211697,(,0,0
211698,0.1,0,0
211699,mg/ml,0,0
211700,for,0,0
211701,5,0,1
211702,minutes,0,0
211703,),0,1
211704,to,0,0
211705,evaluate,0,0
211706,the,0,0
211707,efficacy,0,0
211708,and,0,0
211709,toxicity,0,0
211710,of,0,0
211711,this,0,0
211712,adjunctive,0,0
211713,treatment,0,0
211714,.,0,0
211715,The,0,0
211716,mean,0,0
211717,follow,0,0
211718,up,0,0
211719,was,0,0
211720,14.1,0,0
211721,months,0,0
211722,(,0,0
211723,range,0,1
211724,12-23,0,0
211725,months,0,0
211726,),0,1
211727,.,0,1
211728,RESULTS,0,0
211729,Of,0,0
211730,the,0,0
211731,36,0,1
211732,eyes,0,1
211733,that,0,0
211734,underwent,0,1
211735,simple,0,0
211736,excision,0,1
211737,",",0,0
211738,14,0,0
211739,(,0,0
211740,38.8,0,0
211741,%,0,0
211742,),0,0
211743,exhibited,0,0
211744,recurrences,0,0
211745,whereas,0,0
211746,only,0,0
211747,one,0,1
211748,of,0,0
211749,30,0,1
211750,eyes,0,1
211751,(,0,1
211752,3.33,0,0
211753,%,0,0
211754,),0,0
211755,treated,0,1
211756,with,0,1
211757,excision,0,1
211758,and,0,0
211759,intraoperative,0,0
211760,application,0,0
211761,of,0,0
211762,mitomycin,0,0
211763,C,0,0
211764,had,0,0
211765,recurrence,0,0
211766,(,0,0
211767,p,0,0
211768,=,0,0
211769,0.0006,0,0
211770,),0,0
211771,.,0,1
211772,Neither,0,0
211773,serious,0,0
211774,ocular,0,1
211775,complications,0,0
211776,nor,0,1
211777,systemic,0,0
211778,toxicity,0,0
211779,were,0,0
211780,noted,0,0
211781,in,0,0
211782,the,0,0
211783,mitomycin,0,0
211784,C,0,0
211785,treated,0,1
211786,group,0,0
211787,.,0,1
211788,CONCLUSION,0,0
211789,Intraoperative,0,0
211790,mitomycin,0,0
211791,C,0,0
211792,appears,0,0
211793,to,0,0
211794,be,0,0
211795,an,0,0
211796,effective,0,0
211797,and,0,0
211798,safe,0,0
211799,adjunctive,0,0
211800,treatment,0,0
211801,of,0,0
211802,primary,1,1
211803,pterygium,1,1
211804,.,1,1
211805,Paracervical,0,0
211806,anesthesia,0,1
211807,for,0,0
211808,outpatient,0,1
211809,hysteroscopy,0,1
211810,.,0,1
211811,One,1,1
211812,hundred,1,1
211813,seventy-seven,1,1
211814,women,1,1
211815,aged,1,1
211816,41,1,1
211817,+/-,1,0
211818,8,1,0
211819,(,1,1
211820,mean,1,1
211821,+/-,1,0
211822,SD,1,1
211823,),1,0
211824,years,1,1
211825,",",1,0
211826,referred,1,1
211827,for,1,0
211828,evaluation,1,0
211829,of,1,0
211830,excessive,1,1
211831,uterine,1,1
211832,bleeding,1,1
211833,",",1,0
211834,were,1,0
211835,enrolled,1,1
211836,in,0,0
211837,an,0,0
211838,open-label,0,0
211839,randomized,0,0
211840,trial,0,0
211841,to,0,0
211842,evaluate,0,0
211843,the,0,0
211844,efficacy,0,0
211845,of,0,0
211846,local,0,0
211847,anesthesia,0,1
211848,before,0,0
211849,hysteroscopy,1,1
211850,in,1,0
211851,an,1,0
211852,outpatient,1,1
211853,population,1,1
211854,.,1,0
211855,The,0,0
211856,patients,0,1
211857,underwent,0,1
211858,hysteroscopy,0,1
211859,and,0,0
211860,endometrial,0,1
211861,biopsy,0,1
211862,with,0,1
211863,paracervical,0,0
211864,block,0,0
211865,by,0,0
211866,10,0,1
211867,mL,0,0
211868,of,0,1
211869,1,0,0
211870,%,0,0
211871,mepivacaine,0,0
211872,hydrochloride,0,0
211873,solution,0,0
211874,(,0,0
211875,n,0,1
211876,=,0,0
211877,87,0,1
211878,),0,0
211879,or,0,1
211880,no,0,0
211881,local,0,0
211882,anesthesia,0,0
211883,(,0,0
211884,n,0,1
211885,=,0,0
211886,90,0,1
211887,),0,0
211888,and,0,0
211889,assessed,0,0
211890,lower,0,0
211891,abdominal,0,1
211892,and,0,0
211893,pelvic,0,1
211894,pain,0,1
211895,according,0,1
211896,to,0,0
211897,a,0,0
211898,10-point,0,0
211899,linear,0,0
211900,analog,0,0
211901,scale,0,0
211902,.,0,0
211903,The,0,0
211904,mean,0,0
211905,+/-,0,0
211906,SD,0,0
211907,pain,0,1
211908,score,0,0
211909,was,0,0
211910,4.5,0,0
211911,+/-,0,0
211912,2.0,0,0
211913,at,0,0
211914,hysteroscopy,0,1
211915,and,0,0
211916,5.2,0,0
211917,+/-,0,0
211918,2.1,0,0
211919,at,0,0
211920,endometrial,0,1
211921,biopsy,0,1
211922,in,0,0
211923,the,0,0
211924,87,0,1
211925,subjects,0,1
211926,given,0,0
211927,a,0,0
211928,paracervical,0,0
211929,block,0,0
211930,versus,0,0
211931,4.9,0,0
211932,+/-,0,0
211933,2.2,0,0
211934,and,0,1
211935,5.7,0,0
211936,+/-,0,0
211937,2.4,0,0
211938,in,0,0
211939,the,0,0
211940,90,0,0
211941,women,0,1
211942,not,0,0
211943,given,0,0
211944,local,0,0
211945,anesthesia,0,0
211946,",",0,0
211947,without,0,0
211948,statistically,0,0
211949,significant,0,0
211950,differences,0,0
211951,.,0,1
211952,Paracervical,0,0
211953,anesthesia,0,0
211954,for,0,0
211955,routine,0,0
211956,outpatient,0,1
211957,hysteroscopy,0,1
211958,in,0,0
211959,premenopausal,1,1
211960,women,1,1
211961,may,0,0
211962,be,0,0
211963,superfluous,0,0
211964,.,0,1
211965,Failure,0,0
211966,of,0,0
211967,naltrexone,0,0
211968,hydrochloride,0,0
211969,to,0,0
211970,reduce,0,0
211971,self-injurious,1,1
211972,and,1,0
211973,autistic,1,1
211974,behavior,1,0
211975,in,1,0
211976,mentally,1,1
211977,retarded,1,1
211978,adults,1,1
211979,.,1,1
211980,Double-blind,0,0
211981,placebo-controlled,0,0
211982,studies,0,0
211983,.,0,1
211984,BACKGROUND,0,0
211985,It,0,0
211986,is,0,0
211987,hypothesized,0,0
211988,that,0,0
211989,self-injurious,0,1
211990,behavior,0,0
211991,(,0,0
211992,SIB,0,0
211993,),0,0
211994,and,0,0
211995,symptoms,0,0
211996,of,0,0
211997,autism,0,1
211998,may,0,0
211999,be,0,0
212000,due,0,0
212001,to,0,0
212002,overactivity,0,1
212003,in,0,0
212004,some,0,0
212005,opioid,0,1
212006,systems,0,0
212007,in,0,0
212008,the,0,0
212009,brain,0,0
212010,.,0,0
212011,We,0,0
212012,examined,0,0
212013,the,0,0
212014,efficacy,0,0
212015,and,0,0
212016,safety,0,0
212017,of,0,0
212018,naltrexone,0,0
212019,hydrochloride,0,0
212020,",",0,0
212021,an,0,0
212022,opioid,0,0
212023,antagonist,0,0
212024,",",0,0
212025,in,0,0
212026,the,0,0
212027,treatment,0,0
212028,of,0,0
212029,SIB,1,0
212030,and,1,0
212031,autism,1,1
212032,in,1,0
212033,mentally,1,1
212034,retarded,1,1
212035,adults,1,1
212036,.,1,1
212037,METHOD,0,0
212038,Thirty-three,1,1
212039,mentally,1,1
212040,retarded,1,1
212041,adults,1,1
212042,with,1,1
212043,autism,1,1
212044,and/or,1,0
212045,SIB,1,0
212046,participated,1,1
212047,in,1,0
212048,double-blind,1,0
212049,",",1,0
212050,placebo-controlled,1,0
212051,crossover,1,1
212052,studies,1,0
212053,.,1,1
212054,Active,0,0
212055,treatment,0,0
212056,was,0,0
212057,first,0,0
212058,a,0,0
212059,single,0,0
212060,100-mg,0,0
212061,dose,0,0
212062,of,0,0
212063,naltrexone,0,0
212064,hydrochloride,0,0
212065,.,0,0
212066,Subsequently,0,0
212067,",",0,0
212068,19,0,1
212069,subjects,0,1
212070,were,0,1
212071,treated,0,1
212072,with,0,1
212073,50,0,1
212074,mg/d,0,0
212075,and,0,1
212076,14,0,1
212077,with,0,1
212078,150,0,0
212079,mg/d,0,0
212080,of,0,0
212081,naltrexone,0,0
212082,hydrochloride,0,0
212083,for,0,0
212084,4,0,0
212085,weeks,0,0
212086,.,0,1
212087,The,0,0
212088,outcome,0,0
212089,was,0,0
212090,assessed,0,0
212091,by,0,0
212092,means,0,0
212093,of,0,1
212094,direct,0,1
212095,observations,0,0
212096,(,0,1
212097,n,0,1
212098,=,0,0
212099,11,0,1
212100,),0,0
212101,and,0,0
212102,on,0,0
212103,the,0,0
212104,basis,0,0
212105,of,0,0
212106,scores,0,0
212107,on,0,0
212108,a,0,0
212109,list,0,0
212110,of,0,0
212111,target,0,0
212112,behaviors,0,0
212113,",",0,0
212114,the,0,0
212115,Aberrant,0,0
212116,Behavior,0,1
212117,Checklist,0,0
212118,",",0,0
212119,and,0,0
212120,the,0,0
212121,Clinical,0,0
212122,Global,0,1
212123,Impression,0,1
212124,Scale,0,0
212125,.,0,1
212126,RESULTS,0,0
212127,Thirty-two,0,1
212128,subjects,0,1
212129,(,0,1
212130,seven,0,1
212131,with,0,1
212132,autism,0,1
212133,",",0,0
212134,16,0,1
212135,with,0,1
212136,autism,0,1
212137,and,0,0
212138,SIB,0,0
212139,",",0,0
212140,and,0,0
212141,nine,0,1
212142,with,0,1
212143,SIB,0,1
212144,),0,0
212145,completed,0,1
212146,the,0,0
212147,trial,0,0
212148,.,0,0
212149,Naltrexone,0,0
212150,treatment,0,0
212151,failed,0,0
212152,to,0,0
212153,have,0,0
212154,therapeutic,0,0
212155,effects,0,0
212156,on,0,0
212157,SIB,0,1
212158,and,0,0
212159,autism,0,1
212160,.,0,0
212161,On,0,0
212162,the,0,0
212163,contrary,0,0
212164,",",0,0
212165,naltrexone,0,0
212166,increased,0,0
212167,the,0,0
212168,incidence,0,0
212169,of,0,0
212170,stereotypic,0,1
212171,behavior,0,0
212172,on,0,0
212173,the,0,0
212174,Aberrant,0,1
212175,Behavior,0,1
212176,Checklist,0,0
212177,",",0,0
212178,and,0,0
212179,the,0,0
212180,care,0,0
212181,staff,0,0
212182,evaluated,0,0
212183,the,0,0
212184,effect,0,0
212185,of,0,0
212186,the,0,0
212187,50-mg/d,0,0
212188,treatment,0,0
212189,as,0,0
212190,being,0,0
212191,significantly,0,0
212192,worse,0,0
212193,than,0,0
212194,that,0,0
212195,of,0,0
212196,the,0,0
212197,placebo,0,0
212198,treatment,0,0
212199,as,0,0
212200,measured,0,0
212201,by,0,0
212202,the,0,0
212203,Clinical,0,0
212204,Global,0,1
212205,Impression,0,1
212206,Scale,0,0
212207,.,0,1
212208,CONCLUSION,0,0
212209,Our,0,0
212210,findings,0,0
212211,suggest,0,0
212212,that,0,0
212213,naltrexone,0,0
212214,has,0,0
212215,no,0,0
212216,clinical,0,0
212217,value,0,0
212218,for,0,0
212219,a,0,0
212220,broad,0,0
212221,group,0,0
212222,of,0,0
212223,mentally,0,1
212224,retarded,0,1
212225,subjects,0,1
212226,with,0,1
212227,SIB,0,1
212228,and/or,0,1
212229,autism,0,1
212230,.,0,1
212231,[,0,0
212232,Late,0,0
212233,cardiac,0,1
212234,toxicity,0,0
212235,in,0,0
212236,Hodgkin,0,1
212237,'s,0,1
212238,disease,0,1
212239,.,0,1
212240,A,0,0
212241,study,0,0
212242,with,0,1
212243,pulsed,0,0
212244,Doppler,0,1
212245,echocardiography,0,1
212246,],0,1
212247,.,0,1
212248,49,1,1
212249,patients,1,1
212250,(,1,1
212251,22,1,1
212252,women,1,1
212253,",",1,1
212254,27,1,1
212255,men,1,1
212256,",",1,0
212257,mean,1,1
212258,age,1,1
212259,43.7,1,0
212260,[,1,0
212261,21-65,1,1
212262,],1,1
212263,years,1,1
212264,),1,1
212265,with,1,1
212266,Hodgkin,1,1
212267,'s,1,1
212268,disease,1,1
212269,were,0,0
212270,examined,0,0
212271,by,0,0
212272,Doppler,0,0
212273,echocardiography,0,0
212274,a,0,0
212275,median,1,0
212276,of,1,0
212277,5.37,1,0
212278,(,1,1
212279,2-10,1,1
212280,),1,1
212281,years,1,1
212282,after,1,0
212283,the,1,0
212284,end,1,0
212285,of,1,0
212286,chemotherapy,1,0
212287,(,1,0
212288,given,1,0
212289,according,1,0
212290,to,1,0
212291,the,1,0
212292,COPP/ABVD,1,0
212293,scheme,1,0
212294,",",1,0
212295,with,1,0
212296,or,1,0
212297,without,1,1
212298,mediastinal,1,1
212299,irradiation,1,0
212300,),1,0
212301,for,0,0
212302,possible,0,0
212303,chronic,0,1
212304,changes,0,0
212305,in,0,0
212306,myocardium,0,1
212307,",",0,0
212308,pericardium,0,0
212309,or,0,1
212310,cardiac,0,1
212311,valves,0,1
212312,",",0,0
212313,as,0,0
212314,well,0,0
212315,as,0,0
212316,for,0,0
212317,any,0,0
212318,haemodynamic,0,0
212319,sequelae,0,0
212320,.,0,1
212321,Maximal,0,0
212322,and,0,0
212323,integrated,0,0
212324,early,0,0
212325,(,0,0
212326,E,0,0
212327,",",0,0
212328,Ei,0,0
212329,),0,0
212330,and,0,0
212331,late,0,1
212332,(,0,0
212333,A,0,0
212334,",",0,0
212335,Ai,0,0
212336,),0,0
212337,diastolic,0,1
212338,flow,0,0
212339,velocities,0,0
212340,and,0,0
212341,their,0,0
212342,ratio,0,0
212343,(,0,0
212344,E/A,0,0
212345,",",0,0
212346,Ei/Ai,0,0
212347,),0,0
212348,were,0,0
212349,measured,0,0
212350,by,0,0
212351,pulsed,0,0
212352,Doppler,0,0
212353,over,0,0
212354,the,0,0
212355,mitral,0,1
212356,and,0,0
212357,tricuspid,0,1
212358,valves,0,1
212359,.,0,1
212360,Although,0,0
212361,on,0,0
212362,two-dimensional,0,0
212363,echo,0,1
212364,21,0,1
212365,patients,0,1
212366,(,0,1
212367,42.9,0,0
212368,%,0,0
212369,),0,0
212370,were,0,0
212371,found,0,0
212372,to,0,0
212373,have,0,0
212374,valvar,0,1
212375,thickening,0,0
212376,",",0,0
212377,19,0,1
212378,(,0,0
212379,38.8,0,0
212380,%,0,0
212381,),0,0
212382,pericardial,0,0
212383,thickening,0,0
212384,and,0,0
212385,9,0,0
212386,(,0,0
212387,18.4,0,0
212388,%,0,0
212389,),0,0
212390,a,0,0
212391,reduced,0,0
212392,fibre,0,0
212393,shortening,0,0
212394,fraction,0,0
212395,",",0,0
212396,the,0,0
212397,Doppler,0,0
212398,indices,0,0
212399,were,0,0
212400,statistically,0,0
212401,not,0,0
212402,significantly,0,0
212403,different,0,0
212404,from,0,0
212405,those,0,1
212406,in,0,0
212407,25,0,1
212408,controls,0,1
212409,with,0,1
212410,normal,0,1
212411,hearts,0,1
212412,.,0,1
212413,These,0,0
212414,echocardiographic,0,0
212415,data,0,0
212416,of,0,0
212417,functional,0,1
212418,and,0,1
212419,morphological,0,0
212420,parameters,0,0
212421,indicate,0,0
212422,that,0,0
212423,there,0,0
212424,was,0,0
212425,no,0,0
212426,effect,0,0
212427,on,0,0
212428,various,0,0
212429,measurements,0,0
212430,of,0,0
212431,diastolic,0,1
212432,function,0,0
212433,after,0,0
212434,chemotherapy,0,0
212435,with,0,1
212436,or,0,1
212437,without,0,1
212438,mediastinal,0,1
212439,radiation,0,1
212440,.,0,0
212441,In,0,0
212442,successfully,1,0
212443,treated,1,1
212444,patients,1,1
212445,with,1,1
212446,Hodgkin,1,1
212447,'s,1,1
212448,disease,1,1
212449,the,0,0
212450,described,0,0
212451,changes,0,0
212452,are,0,0
212453,of,0,0
212454,minor,0,0
212455,significance,0,0
212456,.,0,1
212457,The,0,0
212458,effect,0,0
212459,of,0,0
212460,metformin,0,0
212461,and,0,0
212462,insulin,0,0
212463,on,0,0
212464,sympathetic,0,0
212465,nerve,0,0
212466,activity,0,0
212467,",",0,0
212468,norepinephrine,0,0
212469,spillover,0,0
212470,and,0,0
212471,blood,0,0
212472,pressure,0,0
212473,in,0,0
212474,obese,1,1
212475,",",1,0
212476,insulin,1,0
212477,resistant,1,0
212478,",",1,0
212479,normoglycemic,1,1
212480,",",1,0
212481,hypertensive,1,1
212482,men,1,1
212483,.,1,1
212484,To,0,0
212485,evaluate,0,0
212486,the,0,0
212487,effect,0,0
212488,of,0,0
212489,metformin,0,0
212490,on,0,0
212491,insulin,0,0
212492,sensitivity,0,0
212493,and,0,0
212494,to,0,0
212495,further,0,0
212496,examine,0,0
212497,the,0,0
212498,relationship,0,0
212499,between,0,0
212500,insulin,0,0
212501,resistance,0,0
212502,",",0,0
212503,sympathetic,0,0
212504,nerve,0,0
212505,activity,0,0
212506,and,0,0
212507,blood,0,0
212508,pressure,0,0
212509,",",0,0
212510,6,1,0
212511,obese,1,1
212512,insulin,1,0
212513,resistant,1,1
212514,",",1,0
212515,normoglycemic,1,1
212516,hypertensive,1,1
212517,men,1,1
212518,were,1,1
212519,investigated,1,0
212520,(,1,0
212521,age,1,1
212522,49,1,1
212523,+/-,1,0
212524,2,1,1
212525,years,1,1
212526,",",1,1
212527,BMI,1,1
212528,27.6,1,0
212529,+/-,1,0
212530,1.2,1,0
212531,",",1,0
212532,mean,1,1
212533,+/-,1,0
212534,SEM,1,1
212535,),1,1
212536,.,1,0
212537,The,0,0
212538,study,0,0
212539,had,0,0
212540,a,0,0
212541,placebo,0,0
212542,controlled,0,0
212543,",",0,0
212544,double,0,0
212545,blind,0,0
212546,",",0,0
212547,cross,0,0
212548,over,0,0
212549,design,0,0
212550,with,0,1
212551,6,0,0
212552,weeks,0,0
212553,',0,1
212554,metformin,0,0
212555,treatment,0,0
212556,(,0,0
212557,850,0,1
212558,mg,0,0
212559,b.i.d,0,0
212560,),0,0
212561,vs,0,0
212562,placebo,0,0
212563,.,0,0
212564,Blood,0,0
212565,pressure,0,0
212566,was,0,0
212567,measured,0,0
212568,weekly,0,0
212569,.,0,0
212570,At,0,0
212571,the,0,0
212572,end,0,0
212573,of,0,0
212574,each,0,0
212575,treatment,0,0
212576,period,0,0
212577,",",0,0
212578,glucose,0,0
212579,infusion,0,0
212580,rate,0,0
212581,(,0,0
212582,GIR,0,1
212583,),0,0
212584,",",0,0
212585,muscle,0,0
212586,sympathetic,0,0
212587,nerve,0,0
212588,activity,0,0
212589,(,0,0
212590,MSA,0,1
212591,),0,0
212592,and,0,0
212593,renal,0,1
212594,and,0,0
212595,total,0,1
212596,body,0,1
212597,norepinephrine,0,0
212598,(,0,0
212599,NE,0,0
212600,),0,1
212601,kinetics,0,0
212602,(,0,0
212603,radioisotope,0,0
212604,dilution,0,0
212605,),0,0
212606,were,0,0
212607,examined,0,0
212608,during,0,0
212609,euglycemic,0,1
212610,hyperinsulinemic,0,1
212611,clamp,0,0
212612,.,0,0
212613,Fasting,0,0
212614,insulin,0,0
212615,was,0,0
212616,13,0,1
212617,+/-,0,0
212618,3,0,0
212619,and,0,1
212620,10,0,1
212621,+/-,0,0
212622,2,0,0
212623,mU/l,0,0
212624,and,0,0
212625,fasting,0,0
212626,glucose,0,0
212627,5.3,0,0
212628,+/-,0,0
212629,0.2,0,0
212630,and,0,1
212631,5.1,0,0
212632,+/-,0,0
212633,0.1,0,0
212634,mmol/l,0,0
212635,after,0,0
212636,placebo,0,0
212637,and,0,0
212638,metformin,0,0
212639,treatment,0,0
212640,",",0,0
212641,respectively,0,0
212642,(,0,0
212643,ns,0,0
212644,),0,1
212645,.,0,0
212646,GIR,0,0
212647,during,0,0
212648,the,0,0
212649,last,0,0
212650,hour,0,0
212651,of,0,0
212652,the,0,0
212653,insulin,0,0
212654,clamp,0,0
212655,was,0,0
212656,3.7,0,0
212657,+/-,0,0
212658,0.6,0,1
212659,vs,0,0
212660,3.6,0,1
212661,+/-,0,0
212662,0.6,0,0
212663,mg/kg,0,0
212664,x,0,0
212665,min,0,0
212666,(,0,0
212667,ns,0,0
212668,),0,0
212669,.,0,1
212670,Resting,0,0
212671,MSA,0,1
212672,",",0,0
212673,total,0,1
212674,body,0,1
212675,and,0,0
212676,right,0,0
212677,renal,0,1
212678,NE,0,0
212679,spillover,0,0
212680,did,0,0
212681,not,0,0
212682,differ,0,0
212683,significantly,0,0
212684,after,0,0
212685,placebo,0,0
212686,and,0,0
212687,metformin,0,0
212688,treatment,0,0
212689,.,0,0
212690,Systolic,0,1
212691,and,0,0
212692,diastolic,0,1
212693,blood,0,0
212694,pressures,0,0
212695,were,0,1
212696,151,0,1
212697,+/-,0,0
212698,10/95,0,1
212699,+/-,0,0
212700,5,0,0
212701,mmHg,0,0
212702,after,0,0
212703,placebo,0,0
212704,and,0,0
212705,146,0,1
212706,+/-,0,0
212707,5/94,0,1
212708,+/-,0,0
212709,5,0,0
212710,mmHg,0,0
212711,after,0,0
212712,metformin,0,0
212713,treatment,0,0
212714,(,0,0
212715,ns,0,0
212716,),0,1
212717,.,0,1
212718,Thus,0,0
212719,metformin,0,0
212720,treatment,0,0
212721,did,0,0
212722,not,0,0
212723,have,0,0
212724,any,0,0
212725,significant,0,0
212726,effect,0,0
212727,on,0,0
212728,insulin,0,0
212729,sensitivity,0,0
212730,",",0,0
212731,blood,0,0
212732,pressure,0,0
212733,or,0,1
212734,sympathetic,0,0
212735,activity,0,0
212736,in,0,0
212737,this,0,0
212738,small,0,0
212739,group,0,0
212740,of,0,0
212741,patients,0,1
212742,.,0,1
212743,Renal,0,0
212744,plasma,0,0
212745,flow,0,0
212746,and,0,0
212747,MSA,0,1
212748,increased,0,0
212749,significantly,0,0
212750,during,0,0
212751,the,0,0
212752,insulin,0,0
212753,clamp,0,0
212754,",",0,0
212755,whereas,0,0
212756,renal,0,1
212757,NE,0,0
212758,and,0,0
212759,total,0,1
212760,body,0,1
212761,NE,0,0
212762,spillover,0,0
212763,remained,0,0
212764,unchanged,0,0
212765,",",0,0
212766,suggesting,0,0
212767,nonuniform,0,0
212768,regional,0,1
212769,sympathetic,0,0
212770,nerve,0,0
212771,responses,0,0
212772,to,0,0
212773,acute,0,1
212774,hyperinsulinemia,0,1
212775,.,0,0
212776,Prophylactic,0,0
212777,cranial,0,0
212778,irradiation,0,0
212779,for,0,0
212780,patients,0,1
212781,with,0,1
212782,small-cell,1,1
212783,lung,1,1
212784,cancer,1,1
212785,in,1,0
212786,complete,1,1
212787,remission,1,1
212788,.,1,1
212789,BACKGROUND,0,0
212790,Prophylactic,0,0
212791,cranial,0,0
212792,irradiation,0,0
212793,in,0,0
212794,patients,1,1
212795,with,1,1
212796,small-cell,1,1
212797,lung,1,1
212798,cancer,1,1
212799,decreases,0,0
212800,the,0,0
212801,overall,0,0
212802,rate,0,0
212803,of,0,0
212804,brain,0,0
212805,metastases,0,1
212806,without,0,1
212807,an,0,0
212808,effect,0,0
212809,on,0,0
212810,overall,0,0
212811,survival,0,0
212812,.,0,0
212813,It,0,0
212814,has,0,0
212815,been,0,0
212816,suggested,0,0
212817,that,0,0
212818,this,0,0
212819,treatment,0,0
212820,may,0,0
212821,increase,0,0
212822,neuropsychological,0,0
212823,syndromes,0,0
212824,and,0,1
212825,brain,0,1
212826,abnormalities,0,0
212827,indicated,0,0
212828,by,0,0
212829,computed,0,0
212830,tomography,0,0
212831,scans,0,0
212832,.,0,0
212833,However,0,0
212834,",",0,0
212835,other,0,0
212836,retrospective,0,1
212837,data,0,0
212838,suggested,0,0
212839,a,0,0
212840,beneficial,0,0
212841,effect,0,0
212842,on,0,0
212843,overall,0,0
212844,survival,0,0
212845,for,0,0
212846,patients,1,1
212847,in,1,0
212848,complete,1,1
212849,remission,1,1
212850,.,1,0
212851,PURPOSE,0,0
212852,Our,0,0
212853,purpose,0,0
212854,was,0,0
212855,to,0,0
212856,evaluate,0,0
212857,the,0,0
212858,effects,0,0
212859,of,0,0
212860,prophylactic,0,0
212861,cranial,0,0
212862,irradiation,0,0
212863,on,0,0
212864,brain,0,0
212865,metastasis,0,1
212866,",",0,0
212867,overall,0,0
212868,survival,0,0
212869,",",0,0
212870,and,0,0
212871,late-occurring,0,0
212872,toxic,0,0
212873,effects,0,0
212874,in,0,0
212875,patients,1,1
212876,with,1,1
212877,small-cell,1,1
212878,lung,1,1
212879,cancer,1,1
212880,in,1,0
212881,complete,1,1
212882,remission,1,1
212883,.,1,1
212884,METHODS,0,0
212885,We,0,0
212886,conducted,0,0
212887,a,0,0
212888,prospective,0,0
212889,study,0,0
212890,of,0,0
212891,300,1,1
212892,patients,1,1
212893,who,1,1
212894,had,1,1
212895,small-cell,1,1
212896,lung,1,1
212897,cancer,1,1
212898,that,1,0
212899,was,1,0
212900,in,1,0
212901,complete,1,1
212902,remission,1,1
212903,.,1,0
212904,The,0,0
212905,patients,0,1
212906,were,0,0
212907,randomly,0,1
212908,assigned,0,0
212909,to,0,0
212910,receive,0,0
212911,either,0,0
212912,prophylactic,0,0
212913,cranial,0,0
212914,irradiation,0,0
212915,delivering,0,0
212916,24,0,0
212917,Gy,0,1
212918,in,0,1
212919,eight,0,1
212920,fractions,0,1
212921,during,0,1
212922,12,0,1
212923,days,0,0
212924,(,0,1
212925,treatment,0,0
212926,group,0,0
212927,),0,0
212928,or,0,0
212929,no,0,0
212930,prophylactic,0,0
212931,cranial,0,0
212932,irradiation,0,0
212933,(,0,0
212934,control,0,0
212935,group,0,1
212936,),0,0
212937,.,0,0
212938,A,0,0
212939,neuropsychological,0,0
212940,examination,0,0
212941,and,0,0
212942,a,0,0
212943,computed,0,0
212944,tomography,0,0
212945,scan,0,0
212946,of,0,0
212947,the,0,0
212948,brain,0,0
212949,were,0,0
212950,performed,0,0
212951,at,0,0
212952,the,0,0
212953,time,0,0
212954,of,0,0
212955,random,0,1
212956,assignment,0,0
212957,and,0,0
212958,repeatedly,0,0
212959,assessed,0,0
212960,at,0,0
212961,6,0,0
212962,",",0,0
212963,18,0,1
212964,",",0,0
212965,30,0,0
212966,",",0,0
212967,and,0,0
212968,48,0,1
212969,months,0,0
212970,.,0,1
212971,Patterns,0,0
212972,of,0,0
212973,failure,0,1
212974,were,0,0
212975,analyzed,0,0
212976,according,0,1
212977,to,0,0
212978,total,0,1
212979,event,0,0
212980,rates,0,0
212981,and,0,0
212982,also,0,0
212983,according,0,0
212984,to,0,0
212985,an,0,0
212986,isolated,0,0
212987,first,0,0
212988,site,0,0
212989,of,0,0
212990,relapse,0,0
212991,",",0,0
212992,using,0,0
212993,a,0,0
212994,competing-risk,0,0
212995,approach,0,0
212996,.,0,1
212997,RESULTS,0,0
212998,Two,1,1
212999,hundred,1,1
213000,ninety-four,1,1
213001,patients,1,1
213002,who,1,1
213003,did,1,1
213004,not,1,1
213005,have,1,0
213006,brain,1,0
213007,metastases,1,1
213008,at,0,0
213009,the,0,0
213010,time,0,0
213011,of,0,0
213012,random,0,1
213013,assignment,0,0
213014,were,0,0
213015,analyzed,0,0
213016,.,0,0
213017,The,0,0
213018,2-year,0,0
213019,cumulative,0,0
213020,rate,0,0
213021,of,0,0
213022,brain,0,0
213023,metastasis,0,1
213024,as,0,0
213025,an,0,0
213026,isolated,0,0
213027,first,0,0
213028,site,0,0
213029,of,0,0
213030,relapse,0,0
213031,was,0,0
213032,45,0,1
213033,%,0,0
213034,in,0,0
213035,the,0,0
213036,control,0,0
213037,group,0,0
213038,and,0,0
213039,19,0,1
213040,%,0,0
213041,in,0,0
213042,the,0,0
213043,treatment,0,0
213044,group,0,0
213045,(,0,0
213046,P,0,0
213047,<,0,0
213048,10,0,0
213049,(,0,0
213050,-6,0,0
213051,),0,1
213052,),0,0
213053,.,0,0
213054,The,0,0
213055,total,0,1
213056,2-year,0,0
213057,rate,0,0
213058,of,0,0
213059,brain,0,0
213060,metastasis,0,1
213061,was,0,0
213062,67,0,1
213063,%,0,0
213064,and,0,0
213065,40,0,1
213066,%,0,0
213067,",",0,0
213068,respectively,0,0
213069,(,0,0
213070,relative,0,0
213071,risk,0,1
213072,=,0,0
213073,0.35,0,0
213074,;,0,0
213075,P,0,0
213076,<,0,0
213077,10,0,0
213078,(,0,0
213079,-13,0,0
213080,),0,1
213081,),0,0
213082,.,0,0
213083,The,0,0
213084,2-year,0,0
213085,overall,0,0
213086,survival,0,0
213087,rate,0,0
213088,was,0,0
213089,21.5,0,0
213090,%,0,0
213091,in,0,0
213092,the,0,0
213093,control,0,0
213094,group,0,0
213095,and,0,0
213096,29,0,1
213097,%,0,0
213098,in,0,0
213099,the,0,0
213100,treatment,0,0
213101,group,0,0
213102,(,0,0
213103,relative,0,0
213104,risk,0,1
213105,=,0,0
213106,0.83,0,0
213107,;,0,1
213108,P,0,0
213109,=,0,0
213110,.14,0,0
213111,),0,0
213112,.,0,0
213113,There,0,0
213114,were,0,0
213115,no,0,0
213116,significant,0,0
213117,differences,0,0
213118,between,0,0
213119,the,0,0
213120,two,0,0
213121,groups,0,0
213122,in,0,1
213123,terms,0,0
213124,of,0,0
213125,neuropsychological,0,1
213126,function,0,0
213127,or,0,1
213128,abnormalities,0,0
213129,indicated,0,0
213130,by,0,0
213131,computed,0,0
213132,tomography,0,0
213133,brain,0,1
213134,scans,0,0
213135,.,0,1
213136,CONCLUSIONS,0,0
213137,Prophylactic,0,0
213138,cranial,0,0
213139,irradiation,0,0
213140,given,0,0
213141,to,0,0
213142,patients,1,1
213143,with,1,1
213144,small-cell,1,1
213145,lung,1,1
213146,cancer,1,1
213147,in,1,0
213148,complete,1,0
213149,remission,1,0
213150,decreases,0,0
213151,the,0,0
213152,risk,0,0
213153,of,0,0
213154,brain,0,0
213155,metastasis,0,1
213156,threefold,0,0
213157,without,0,1
213158,a,0,0
213159,significant,0,0
213160,increase,0,0
213161,in,0,0
213162,complications,0,0
213163,.,0,1
213164,A,0,0
213165,possible,0,0
213166,beneficial,0,0
213167,effect,0,0
213168,on,0,0
213169,overall,0,0
213170,survival,0,0
213171,should,0,0
213172,be,0,0
213173,tested,0,0
213174,with,0,0
213175,a,0,0
213176,higher,0,0
213177,statistical,0,0
213178,power,0,0
213179,.,0,0
213180,IMPLICATIONS,0,0
213181,The,0,0
213182,results,0,0
213183,of,0,0
213184,the,0,0
213185,trial,0,0
213186,favor,0,0
213187,",",0,0
213188,at,0,0
213189,present,0,0
213190,",",0,0
213191,the,0,0
213192,indication,0,0
213193,of,0,0
213194,prophylactic,0,0
213195,cranial,0,0
213196,irradiation,0,0
213197,for,0,1
213198,patients,1,1
213199,who,1,1
213200,are,1,1
213201,in,1,1
213202,complete,1,1
213203,remission,1,1
213204,.,1,1
213205,A,0,0
213206,longer,0,0
213207,follow-up,0,0
213208,and,0,0
213209,confirmatory,0,0
213210,trials,0,0
213211,are,0,0
213212,needed,0,0
213213,to,0,0
213214,fully,0,0
213215,assess,0,0
213216,late-occurring,0,0
213217,toxic,0,1
213218,effects,0,0
213219,.,0,1
213220,The,0,0
213221,possible,0,0
213222,effect,0,0
213223,on,0,0
213224,overall,0,0
213225,survival,0,0
213226,needs,0,0
213227,to,0,0
213228,be,0,0
213229,evaluated,0,0
213230,with,0,0
213231,a,0,0
213232,larger,0,0
213233,number,0,0
213234,of,0,0
213235,patients,1,1
213236,in,1,0
213237,complete,1,1
213238,remission,1,0
213239,",",0,0
213240,and,0,0
213241,a,0,0
213242,meta-analysis,0,0
213243,of,0,0
213244,similar,0,0
213245,trials,0,0
213246,is,0,0
213247,recommended,0,0
213248,.,0,0
213249,The,0,0
213250,antiemetic,0,0
213251,efficacy,0,0
213252,of,0,0
213253,prophylactic,0,0
213254,granisetron,0,0
213255,in,0,0
213256,gynecologic,1,1
213257,surgery,1,1
213258,.,1,1
213259,Postoperative,0,0
213260,nausea,0,0
213261,and,0,0
213262,vomiting,0,0
213263,are,0,0
213264,common,0,0
213265,after,0,0
213266,recovery,1,0
213267,from,1,1
213268,anesthesia,1,1
213269,.,1,1
213270,We,0,0
213271,examined,0,0
213272,the,0,0
213273,prophylactic,0,0
213274,effect,0,0
213275,of,0,0
213276,granisetron,0,0
213277,on,0,0
213278,postoperative,0,0
213279,nausea,0,0
213280,and,0,0
213281,vomiting,0,0
213282,in,0,0
213283,120,1,1
213284,female,1,1
213285,patients,1,1
213286,(,1,1
213287,ASA,1,1
213288,physical,1,0
213289,status,1,1
213290,I,1,1
213291,),1,0
213292,undergoing,1,1
213293,gynecologic,1,1
213294,surgery,1,1
213295,.,1,1
213296,They,0,0
213297,were,0,0
213298,randomly,0,1
213299,allocated,0,1
213300,to,0,0
213301,one,0,1
213302,of,0,0
213303,three,0,1
213304,groups,0,0
213305,(,0,1
213306,n,0,1
213307,=,0,0
213308,40,0,0
213309,for,0,0
213310,each,0,1
213311,),0,0
213312,:,0,1
213313,saline,0,0
213314,(,0,0
213315,as,0,0
213316,a,0,0
213317,control,0,0
213318,),0,0
213319,",",0,0
213320,granisetron,0,0
213321,20,0,0
213322,micrograms/kg,0,0
213323,",",0,0
213324,and,0,0
213325,granisetron,0,0
213326,40,0,1
213327,micrograms/kg,0,0
213328,.,0,1
213329,Saline,0,0
213330,or,0,0
213331,granisetron,0,0
213332,was,0,0
213333,given,0,0
213334,intravenously,0,0
213335,(,0,0
213336,IV,0,0
213337,),0,0
213338,over,0,0
213339,5,0,1
213340,min,0,0
213341,approximately,0,1
213342,30,0,1
213343,min,0,0
213344,before,0,0
213345,the,0,0
213346,end,0,0
213347,of,0,0
213348,anesthesia,0,1
213349,.,0,0
213350,Nausea,0,0
213351,",",0,0
213352,vomiting,0,0
213353,",",0,0
213354,and,0,0
213355,safety,0,0
213356,assessments,0,0
213357,were,0,0
213358,performed,0,0
213359,during,0,0
213360,the,0,0
213361,24-h,0,0
213362,recovery,0,0
213363,period,0,0
213364,.,0,0
213365,For,0,0
213366,the,0,0
213367,24-h,0,0
213368,period,0,0
213369,after,0,0
213370,surgery,0,1
213371,",",0,0
213372,the,0,0
213373,number,0,0
213374,of,0,0
213375,emesis-free,0,0
213376,patients,0,1
213377,was,0,0
213378,significantly,0,0
213379,larger,0,0
213380,in,0,0
213381,the,0,0
213382,granisetron,0,0
213383,groups,0,0
213384,than,0,0
213385,in,0,0
213386,the,0,0
213387,control,0,0
213388,group,0,0
213389,(,0,0
213390,83,0,0
213391,%,0,0
213392,",",0,0
213393,78,0,1
213394,%,0,0
213395,",",0,0
213396,and,0,0
213397,20,0,0
213398,%,0,0
213399,of,0,0
213400,patients,0,1
213401,receiving,0,1
213402,granisetron,0,0
213403,20,0,1
213404,micrograms/kg,0,0
213405,and,0,0
213406,40,0,1
213407,micrograms/kg,0,0
213408,",",0,0
213409,and,0,0
213410,saline,0,0
213411,",",0,0
213412,respectively,0,0
213413,),0,0
213414,.,0,0
213415,Granisetron,0,0
213416,at,0,0
213417,both,0,0
213418,doses,0,0
213419,also,0,0
213420,was,0,0
213421,superior,0,0
213422,to,0,0
213423,the,0,0
213424,control,0,0
213425,for,0,0
213426,the,0,0
213427,prevention,0,0
213428,of,0,0
213429,nausea,0,0
213430,over,0,0
213431,the,0,0
213432,24-h,0,0
213433,study,0,0
213434,period,0,0
213435,(,0,0
213436,nausea,0,0
213437,visual,0,0
213438,analog,0,0
213439,scales,0,0
213440,at,0,0
213441,24-h,0,1
213442,postsurgery,0,1
213443,:,0,1
213444,49,0,1
213445,mm,0,0
213446,",",0,0
213447,17,0,0
213448,mm,0,0
213449,",",0,0
213450,and,0,0
213451,18,0,1
213452,mm,0,0
213453,in,0,0
213454,the,0,0
213455,control,0,0
213456,",",0,0
213457,granisetron,0,0
213458,20,0,0
213459,micrograms/kg,0,0
213460,",",0,0
213461,and,0,0
213462,granisetron,0,0
213463,40,0,1
213464,micrograms/kg,0,0
213465,groups,0,0
213466,",",0,0
213467,respectively,0,0
213468,),0,0
213469,.,0,0
213470,Fewer,0,0
213471,patients,0,1
213472,received,0,0
213473,rescue,0,0
213474,antiemetics,0,0
213475,in,0,0
213476,the,0,0
213477,granisetron,0,0
213478,groups,0,0
213479,than,0,0
213480,in,0,0
213481,the,0,0
213482,control,0,0
213483,group,0,0
213484,(,0,0
213485,10,0,0
213486,%,0,0
213487,",",0,0
213488,10,0,0
213489,%,0,0
213490,",",0,0
213491,and,0,0
213492,43,0,1
213493,%,0,0
213494,of,0,0
213495,patients,0,1
213496,in,0,1
213497,granisetron,0,0
213498,20,0,1
213499,micrograms/kg,0,0
213500,and,0,0
213501,40,0,1
213502,micrograms/kg,0,0
213503,",",0,0
213504,and,0,0
213505,the,0,0
213506,control,0,0
213507,groups,0,0
213508,",",0,0
213509,respectively,0,0
213510,),0,0
213511,.,0,0
213512,The,0,0
213513,adverse,0,0
213514,events,0,0
213515,in,0,0
213516,the,0,0
213517,granisetron,0,0
213518,groups,0,0
213519,were,0,1
213520,similar,0,0
213521,to,0,0
213522,those,0,0
213523,in,0,0
213524,the,0,0
213525,control,0,0
213526,group,0,0
213527,.,0,0
213528,The,0,0
213529,administration,0,0
213530,of,0,0
213531,granisetron,0,0
213532,had,0,1
213533,no,0,0
213534,significant,0,0
213535,effect,0,0
213536,on,0,0
213537,vital,0,0
213538,signs,0,1
213539,or,0,1
213540,clinical,0,0
213541,laboratory,0,0
213542,test,0,0
213543,profiles,0,0
213544,.,0,1
213545,Granisetron,0,0
213546,given,0,0
213547,at,0,0
213548,20,0,1
213549,or,0,1
213550,40,0,1
213551,micrograms/kg,0,0
213552,i.v,0,0
213553,.,0,0
213554,during,0,0
213555,anesthesia,0,0
213556,appears,0,0
213557,to,0,0
213558,be,0,0
213559,a,0,0
213560,simple,0,0
213561,",",0,0
213562,effective,0,0
213563,",",0,0
213564,and,0,0
213565,safe,0,0
213566,method,0,0
213567,for,0,0
213568,preventing,0,0
213569,postoperative,0,0
213570,nausea,0,0
213571,and,0,0
213572,vomiting,0,0
213573,.,0,1
213574,[,0,0
213575,Effects,0,0
213576,of,0,0
213577,betamethasone,0,0
213578,on,0,0
213579,neuromuscular,0,1
213580,blockade,0,0
213581,induced,0,0
213582,by,0,0
213583,vecuronium,0,0
213584,in,0,0
213585,continuous,0,0
213586,infusion,0,0
213587,],0,0
213588,.,0,0
213589,The,0,0
213590,aim,0,0
213591,of,0,0
213592,the,0,0
213593,study,0,0
213594,was,0,0
213595,to,0,0
213596,determine,0,0
213597,a,0,0
213598,possible,0,0
213599,interaction,0,0
213600,between,0,0
213601,a,0,0
213602,corticosteroid,0,0
213603,(,0,0
213604,betamethasone,0,0
213605,),0,0
213606,and,0,0
213607,vecuronium,0,0
213608,",",0,0
213609,a,0,0
213610,nondepolarizing,0,0
213611,muscle,0,0
213612,relaxant,0,0
213613,.,0,0
213614,The,0,0
213615,authors,0,0
213616,studied,0,1
213617,20,1,1
213618,patients,1,1
213619,",",1,1
213620,ASA,1,1
213621,I-II,1,0
213622,",",1,0
213623,aged,1,1
213624,20-54,1,1
213625,",",1,0
213626,both,1,0
213627,sexes,1,1
213628,",",1,0
213629,scheduled,1,1
213630,for,1,0
213631,abdominal,1,1
213632,surgery,1,1
213633,.,1,1
213634,Mechanomyographic,0,0
213635,and,0,0
213636,clinical,0,0
213637,evaluation,0,0
213638,by,0,0
213639,single,0,0
213640,twitch,0,0
213641,and,0,0
213642,TOF,0,0
213643,stimulation,0,0
213644,of,0,0
213645,the,0,0
213646,ulnar,0,0
213647,nerve,0,0
213648,at,0,0
213649,the,0,0
213650,wrist,0,0
213651,and,0,0
213652,measurement,0,0
213653,of,0,0
213654,the,0,0
213655,concomitant,0,0
213656,abductor,0,0
213657,pollicis,0,1
213658,muscle,0,0
213659,was,0,0
213660,applied,0,0
213661,.,0,0
213662,The,0,0
213663,onset,0,0
213664,time,0,0
213665,of,0,0
213666,vecuronium,0,0
213667,after,0,0
213668,a,0,0
213669,single,0,0
213670,bolus,0,0
213671,dose,0,0
213672,of,0,0
213673,0.08,0,0
213674,mg/kg,0,0
213675,",",0,0
213676,duration,0,0
213677,of,0,0
213678,action,0,0
213679,to,0,0
213680,10,0,0
213681,%,0,0
213682,single,0,0
213683,twitch,0,0
213684,recovery,0,0
213685,",",0,0
213686,duration,0,0
213687,of,0,0
213688,continuous,0,0
213689,infusion,0,0
213690,of,0,0
213691,0.4-0.5,0,0
213692,micrograms/kg/min,0,0
213693,of,0,0
213694,vecuronium,0,0
213695,started,0,0
213696,at,0,0
213697,10,0,0
213698,%,0,0
213699,single,0,0
213700,twitch,0,0
213701,recovery,0,0
213702,",",0,0
213703,and,0,0
213704,the,0,0
213705,effects,0,0
213706,of,0,0
213707,0.1,0,1
213708,mg/kg,0,0
213709,betamethasone,0,0
213710,administration,0,0
213711,10,0,0
213712,min,0,0
213713,after,0,0
213714,continuous,0,0
213715,infusion,0,0
213716,were,0,0
213717,evaluated,0,0
213718,.,0,0
213719,The,0,0
213720,recovery,0,0
213721,rate,0,0
213722,of,0,0
213723,vecuronium,0,0
213724,after,0,0
213725,stopping,0,0
213726,infusion,0,0
213727,at,0,0
213728,10,0,0
213729,%,0,0
213730,recovery,0,0
213731,was,0,0
213732,also,0,0
213733,evaluated,0,0
213734,.,0,0
213735,Corticosteroids,0,0
213736,may,0,0
213737,interact,0,0
213738,with,0,0
213739,non-depolarizing,0,0
213740,muscle,0,0
213741,relaxants,0,0
213742,both,0,0
213743,in,0,0
213744,prejunctional,0,0
213745,and,0,0
213746,postjunctional,0,0
213747,acetylcholine,0,0
213748,receptors,0,0
213749,by,0,0
213750,several,0,0
213751,mechanisms,0,0
213752,of,0,0
213753,action,0,0
213754,.,0,1
213755,Physiological,0,0
213756,pacing,0,0
213757,improves,0,0
213758,symptoms,0,1
213759,and,0,1
213760,increases,0,0
213761,exercise,0,0
213762,capacity,0,0
213763,in,0,0
213764,the,0,0
213765,elderly,1,1
213766,patient,1,0
213767,.,1,1
213768,We,0,0
213769,evaluated,0,0
213770,the,0,0
213771,benefits,0,0
213772,of,0,0
213773,physiological,0,0
213774,pacing,0,0
213775,in,0,0
213776,the,0,0
213777,elderly,1,1
213778,by,1,0
213779,recruiting,1,1
213780,13,1,1
213781,subjects,1,1
213782,>,1,1
213783,75,1,1
213784,years,1,1
213785,of,1,0
213786,age,1,1
213787,",",1,0
213788,already,1,0
213789,fitted,1,0
213790,with,1,0
213791,a,1,0
213792,physiological,1,0
213793,pacing,1,0
213794,system,1,0
213795,.,1,0
213796,All,1,0
213797,had,1,0
213798,been,1,0
213799,paced,1,1
213800,for,1,0
213801,complete,1,0
213802,or,1,1
213803,Mobitz,1,1
213804,II,1,1
213805,heart,1,1
213806,block,1,0
213807,.,1,0
213808,Double,0,0
213809,blind,0,0
213810,cross,0,1
213811,over,0,0
213812,study,0,0
213813,was,0,0
213814,performed,0,0
213815,comparing,0,0
213816,exercise,0,0
213817,capacity,0,0
213818,",",0,0
213819,measuring,0,0
213820,distance,0,0
213821,walked,0,0
213822,on,0,0
213823,a,0,0
213824,6-min,0,0
213825,walking,0,0
213826,test,0,0
213827,and,0,0
213828,time,0,0
213829,taken,0,0
213830,to,0,0
213831,climb,0,0
213832,two,0,0
213833,flights,0,0
213834,of,0,1
213835,stairs,0,0
213836,;,0,1
213837,and,0,0
213838,symptoms,0,0
213839,",",0,0
213840,evaluated,0,0
213841,by,0,0
213842,an,0,0
213843,activity,0,0
213844,of,0,0
213845,daily,0,0
213846,living,0,1
213847,questionnaire,0,0
213848,",",0,0
213849,in,0,0
213850,atrioventricular,0,1
213851,synchronous,0,1
213852,and,0,0
213853,ventricular,0,0
213854,pacing,0,0
213855,.,0,1
213856,Mean,0,0
213857,distance,0,0
213858,walked,0,0
213859,was,0,0
213860,significantly,0,0
213861,higher,0,0
213862,in,0,0
213863,atrioventricular,0,1
213864,synchronous,0,1
213865,than,0,0
213866,in,0,0
213867,ventricular,0,0
213868,pacing,0,0
213869,(,0,0
213870,360,0,1
213871,+/-,0,0
213872,65,0,1
213873,m,0,1
213874,vs.,0,0
213875,327,0,1
213876,+/-,0,0
213877,69,0,1
213878,m,0,1
213879,;,0,1
213880,P,0,0
213881,<,0,0
213882,0.01,0,0
213883,),0,0
213884,.,0,0
213885,No,0,0
213886,significant,0,0
213887,difference,0,0
213888,was,0,0
213889,found,0,0
213890,in,0,0
213891,the,0,0
213892,ability,0,0
213893,to,0,0
213894,climb,0,0
213895,stairs,0,0
213896,but,0,0
213897,there,0,0
213898,was,0,0
213899,a,0,0
213900,marked,0,0
213901,improvement,0,0
213902,in,0,0
213903,the,0,0
213904,symptomatic,0,1
213905,questionnaire,0,0
213906,score,0,0
213907,",",0,0
213908,19,0,1
213909,+/-,0,0
213910,5,0,1
213911,in,0,0
213912,physiological,0,0
213913,pacing,0,0
213914,increasing,0,0
213915,to,0,0
213916,28,0,1
213917,+/-,0,0
213918,10,0,1
213919,with,0,1
213920,ventricular,0,1
213921,.,0,1
213922,Physiological,0,0
213923,pacing,0,0
213924,in,0,0
213925,the,0,0
213926,elderly,0,1
213927,produces,0,0
213928,an,0,0
213929,increase,0,0
213930,in,0,0
213931,exercise,0,0
213932,tolerance,0,0
213933,and,0,0
213934,improves,0,0
213935,symptoms,0,0
213936,;,0,0
213937,therefore,0,0
213938,",",0,0
213939,age,0,1
213940,alone,0,0
213941,should,0,0
213942,not,0,0
213943,be,0,0
213944,a,0,0
213945,contraindication,0,0
213946,to,0,0
213947,a,0,0
213948,physiological,0,0
213949,system,0,0
213950,.,0,1
213951,[,0,0
213952,Carbohydrate,0,1
213953,substitutes,0,0
213954,:,0,1
213955,comparative,0,0
213956,study,0,0
213957,of,0,0
213958,intestinal,1,0
213959,absorption,1,0
213960,of,1,0
213961,fructose,1,0
213962,",",0,0
213963,sorbitol,0,0
213964,and,0,0
213965,xylitol,0,0
213966,],0,1
213967,.,0,1
213968,BACKGROUND,0,0
213969,The,0,0
213970,carbohydrate,0,0
213971,substitutes,0,0
213972,fructose,0,0
213973,",",0,0
213974,sorbitol,0,0
213975,and,0,0
213976,xylitol,0,0
213977,are,0,0
213978,gaining,0,0
213979,more,0,0
213980,and,0,0
213981,more,0,0
213982,importance,0,0
213983,in,0,0
213984,the,0,0
213985,production,0,0
213986,of,0,0
213987,dietary,0,0
213988,food,0,0
213989,.,0,0
213990,But,0,0
213991,they,0,0
213992,can,0,0
213993,provoke,0,0
213994,gastrointestinal,0,1
213995,side-effects,0,0
213996,.,0,1
213997,In,0,0
213998,a,0,0
213999,randomized,0,0
214000,double,0,0
214001,blind,0,1
214002,study,0,0
214003,the,0,0
214004,rate,0,0
214005,of,0,0
214006,malabsorption,0,0
214007,of,0,0
214008,these,0,0
214009,sugars,0,0
214010,was,0,0
214011,compared,0,0
214012,and,0,0
214013,the,0,0
214014,concomitant,0,0
214015,symptoms,0,0
214016,were,0,1
214017,recorded,0,0
214018,.,0,1
214019,SUBJECTS,0,0
214020,AND,0,0
214021,METHODS,0,0
214022,25,1,1
214023,healthy,1,1
214024,controls,1,1
214025,received,0,1
214026,25,0,1
214027,g,0,0
214028,of,0,0
214029,each,0,0
214030,sugar,0,0
214031,within,0,0
214032,3,0,0
214033,consecutive,0,1
214034,days,0,0
214035,.,0,1
214036,The,0,0
214037,intestinal,0,0
214038,absorption,0,0
214039,was,0,0
214040,determined,0,0
214041,by,0,0
214042,H2-exhalation,0,0
214043,tests,0,0
214044,and,0,0
214045,the,0,0
214046,clinical,0,0
214047,symptoms,0,0
214048,were,0,1
214049,recorded,0,0
214050,.,0,0
214051,RESULTS,0,0
214052,The,0,0
214053,rate,0,0
214054,of,0,0
214055,malabsorption,0,1
214056,was,0,0
214057,84,0,1
214058,%,0,0
214059,for,0,0
214060,sorbitol,0,0
214061,",",0,0
214062,36,0,1
214063,%,0,0
214064,for,0,0
214065,fructose,0,1
214066,and,0,0
214067,12,0,0
214068,%,0,0
214069,for,0,0
214070,xylitol,0,0
214071,(,0,0
214072,p,0,0
214073,<,0,0
214074,0.01,0,0
214075,for,0,0
214076,sorbitol,0,0
214077,versus,0,0
214078,fructose,0,0
214079,and,0,0
214080,xylitol,0,0
214081,),0,0
214082,.,0,0
214083,57,0,0
214084,%,0,0
214085,of,0,0
214086,the,0,0
214087,participants,0,1
214088,with,0,1
214089,pathological,0,1
214090,H2-test,0,0
214091,after,0,0
214092,sorbitol,0,0
214093,and,0,0
214094,56,0,1
214095,%,0,0
214096,after,0,0
214097,fructose,0,1
214098,reported,0,0
214099,symptoms,0,0
214100,",",0,0
214101,while,0,0
214102,all,0,0
214103,of,0,0
214104,the,0,0
214105,3,0,0
214106,malabsorbers,0,1
214107,of,0,0
214108,xylitol,0,0
214109,were,0,1
214110,symptomatic,0,1
214111,.,0,1
214112,CONCLUSIONS,0,0
214113,There,0,0
214114,is,0,0
214115,an,0,0
214116,advantage,0,0
214117,to,0,0
214118,administering,0,0
214119,xylitol,0,0
214120,and,0,0
214121,fructose,0,0
214122,with,0,1
214123,regard,0,0
214124,to,0,0
214125,the,0,0
214126,intestinal,0,0
214127,absorption,0,0
214128,and,0,0
214129,concomitant,0,0
214130,symptoms,0,0
214131,as,0,0
214132,compared,0,0
214133,with,0,1
214134,sorbitol,0,0
214135,.,0,1
214136,H2-exhalation,0,0
214137,tests,0,0
214138,appear,0,0
214139,to,0,0
214140,be,0,0
214141,a,0,0
214142,reliable,0,0
214143,diagnostic,0,0
214144,tool,0,0
214145,to,0,0
214146,detect,0,0
214147,carbohydrate,0,0
214148,malabsorption,0,0
214149,and,0,0
214150,should,0,0
214151,find,0,0
214152,broader,0,0
214153,application,0,0
214154,in,0,0
214155,patients,0,1
214156,suffering,0,1
214157,from,0,1
214158,non-specific,0,0
214159,abdominal,0,1
214160,complaints,0,1
214161,.,0,1
214162,Epidemiology,0,1
214163,of,0,0
214164,stroke,1,1
214165,.,1,0
214166,Importance,0,0
214167,of,0,0
214168,preventive,0,1
214169,pharmacological,0,0
214170,strategies,0,0
214171,in,0,1
214172,elderly,1,1
214173,patients,1,1
214174,and,0,1
214175,associated,0,0
214176,costs,0,0
214177,.,0,1
214178,Stroke,0,0
214179,is,0,0
214180,a,0,0
214181,major,0,0
214182,cause,0,0
214183,of,0,0
214184,death,0,0
214185,and,0,0
214186,disability,0,0
214187,in,0,0
214188,developed,0,1
214189,countries,0,1
214190,.,0,1
214191,The,0,0
214192,incidence,0,0
214193,of,0,0
214194,stroke,0,1
214195,increases,0,0
214196,exponentially,0,0
214197,with,0,1
214198,age,0,1
214199,",",0,0
214200,yet,0,0
214201,",",0,0
214202,traditionally,0,0
214203,",",0,0
214204,many,0,0
214205,medical,0,1
214206,practitioners,0,1
214207,have,0,0
214208,been,0,0
214209,reluctant,0,0
214210,to,0,0
214211,treat,0,0
214212,hypertension,1,1
214213,in,1,0
214214,older,1,1
214215,patients,1,1
214216,.,1,1
214217,Since,1,0
214218,1991,1,1
214219,",",1,0
214220,the,1,0
214221,results,1,0
214222,of,1,0
214223,3,1,1
214224,major,1,1
214225,trials,1,1
214226,--,1,1
214227,the,1,0
214228,British,1,1
214229,Medical,1,1
214230,Research,1,1
214231,Council,1,0
214232,(,1,0
214233,MRC,1,0
214234,),1,0
214235,trial,1,0
214236,of,1,0
214237,treatment,1,0
214238,in,1,0
214239,older,1,1
214240,adults,1,1
214241,",",1,0
214242,the,1,0
214243,Swedish,1,1
214244,Trial,1,0
214245,in,1,1
214246,Old,1,1
214247,Patients,1,1
214248,with,1,1
214249,Hypertension,1,1
214250,(,1,1
214251,STOP-Hypertension,1,1
214252,),1,0
214253,and,1,0
214254,the,1,0
214255,Systolic,1,1
214256,Hypertension,1,1
214257,in,1,0
214258,the,1,0
214259,Elderly,1,1
214260,Program,1,0
214261,(,1,1
214262,SHEP,1,1
214263,),1,1
214264,--,1,0
214265,have,1,0
214266,conclusively,1,0
214267,established,1,0
214268,the,1,0
214269,benefits,1,0
214270,of,1,0
214271,treating,1,1
214272,older,1,1
214273,patients,1,1
214274,(,1,0
214275,>,1,1
214276,60,1,1
214277,years,1,1
214278,),1,1
214279,with,1,1
214280,both,1,0
214281,diastolic,1,0
214282,and,1,0
214283,isolated,1,1
214284,systolic,1,1
214285,hypertension,1,1
214286,.,1,1
214287,International,0,0
214288,guidelines,0,0
214289,for,0,0
214290,the,0,0
214291,management,0,0
214292,of,0,0
214293,hypertension,0,1
214294,--,0,1
214295,including,0,0
214296,the,0,0
214297,Fifth,0,0
214298,Report,0,0
214299,of,0,0
214300,the,0,0
214301,Joint,0,0
214302,National,0,1
214303,Committee,0,1
214304,",",0,0
214305,the,0,0
214306,1993,0,1
214307,report,0,0
214308,of,0,0
214309,the,0,0
214310,World,0,1
214311,Health,0,0
214312,Organization,0,1
214313,and,0,0
214314,the,0,0
214315,International,0,0
214316,Society,0,1
214317,of,0,0
214318,Hypertension,0,1
214319,and,0,0
214320,the,0,0
214321,second,0,0
214322,report,0,0
214323,of,0,0
214324,the,0,0
214325,British,0,1
214326,Hypertension,0,1
214327,Society,0,1
214328,Working,0,1
214329,Party,0,1
214330,--,0,1
214331,have,0,0
214332,all,0,0
214333,been,0,0
214334,modified,0,0
214335,to,0,0
214336,reflect,0,0
214337,the,0,0
214338,emerging,0,0
214339,evidence,0,0
214340,concerning,0,0
214341,the,0,0
214342,benefits,0,0
214343,of,0,0
214344,treating,0,1
214345,older,0,1
214346,patients,0,1
214347,.,0,1
214348,Cost-effectiveness,0,0
214349,data,0,0
214350,are,0,0
214351,similarly,0,0
214352,in,0,0
214353,accord,0,0
214354,with,0,1
214355,giving,0,0
214356,high,0,1
214357,priority,0,0
214358,to,0,0
214359,the,0,0
214360,treatment,1,0
214361,of,1,0
214362,older,1,1
214363,individuals,1,1
214364,with,1,1
214365,hypertension,1,1
214366,.,1,1
214367,Naltrexone,0,1
214368,plasma,0,0
214369,levels,0,0
214370,",",0,0
214371,clinical,0,0
214372,response,0,0
214373,and,0,0
214374,effect,0,0
214375,on,0,0
214376,weight,0,0
214377,in,0,0
214378,autistic,1,1
214379,children,1,1
214380,.,1,1
214381,This,0,0
214382,research,0,0
214383,measured,0,0
214384,naltrexone,0,0
214385,levels,0,0
214386,in,0,0
214387,plasma,0,0
214388,",",0,0
214389,to,0,0
214390,assess,0,0
214391,the,0,0
214392,relationship,0,0
214393,between,0,0
214394,behavioral,0,0
214395,response,0,0
214396,to,0,0
214397,naltrexone,0,0
214398,and,0,0
214399,plasma,0,0
214400,levels,0,0
214401,",",0,0
214402,and,0,0
214403,the,0,0
214404,effects,0,0
214405,of,0,0
214406,naltrexone,0,0
214407,on,0,0
214408,weight,0,0
214409,in,0,0
214410,hospitalized,1,1
214411,autistic,1,1
214412,children,1,1
214413,(,1,1
214414,n,1,1
214415,=,1,0
214416,41,1,1
214417,),1,0
214418,.,1,0
214419,A,0,0
214420,double-blind,0,0
214421,",",0,0
214422,placebo-controlled,0,0
214423,",",0,0
214424,parallel,0,0
214425,groups,0,0
214426,design,0,1
214427,with,0,1
214428,fixed,0,0
214429,dose,0,0
214430,was,0,0
214431,used,0,0
214432,",",0,0
214433,with,0,1
214434,random,0,1
214435,assignment,0,0
214436,to,0,0
214437,naltrexone,0,0
214438,or,0,1
214439,placebo,0,0
214440,.,0,0
214441,Drug,0,0
214442,plasma,0,0
214443,levels,0,0
214444,were,0,0
214445,analyzed,0,0
214446,by,0,0
214447,gas,0,1
214448,chromatography/mass,0,1
214449,spectrometry,0,0
214450,",",0,0
214451,and,0,0
214452,weights,0,0
214453,were,0,0
214454,obtained,0,0
214455,weekly,0,0
214456,.,0,0
214457,Naltrexone,0,0
214458,levels,0,0
214459,measured,0,0
214460,in,0,1
214461,17,1,1
214462,children,1,1
214463,ranged,0,0
214464,from,0,1
214465,0.12,0,0
214466,to,0,1
214467,5.60,0,0
214468,ng/mL,0,0
214469,(,0,1
214470,mean,0,1
214471,=,0,0
214472,0.71,0,0
214473,",",0,0
214474,standard,0,0
214475,error,0,0
214476,of,0,0
214477,the,0,0
214478,mean,0,1
214479,=,0,0
214480,0.32,0,0
214481,),0,0
214482,.,0,0
214483,There,0,0
214484,was,0,0
214485,no,0,0
214486,relationship,0,0
214487,between,0,0
214488,plasma,0,0
214489,levels,0,0
214490,and,0,0
214491,age,0,1
214492,",",0,0
214493,level,0,0
214494,of,0,0
214495,intellectual,0,1
214496,functioning,0,0
214497,",",0,0
214498,scores,0,0
214499,on,0,0
214500,the,0,0
214501,14,1,0
214502,selected,1,1
214503,Children,1,1
214504,'s,1,1
214505,Psychiatric,0,1
214506,Rating,0,0
214507,Scale,0,0
214508,(,0,0
214509,CPRS,0,0
214510,),0,0
214511,items,0,0
214512,",",0,0
214513,Clinical,0,0
214514,Global,0,1
214515,Impressions,0,0
214516,",",0,0
214517,Global,0,1
214518,Clinical,0,0
214519,Consensus,0,0
214520,",",0,0
214521,and,0,0
214522,the,0,0
214523,CPRS,0,0
214524,hyperactivity,0,1
214525,factor,0,0
214526,.,0,0
214527,There,0,0
214528,was,0,0
214529,a,0,0
214530,trend,0,0
214531,(,0,0
214532,p,0,0
214533,=,0,0
214534,.06,0,0
214535,),0,0
214536,for,0,0
214537,children,0,1
214538,receiving,0,1
214539,naltrexone,0,0
214540,in,0,0
214541,the,0,0
214542,highest,0,0
214543,weight,0,0
214544,percentile,0,0
214545,(,0,0
214546,>,0,0
214547,or,0,1
214548,=,0,0
214549,90th,0,0
214550,),0,0
214551,to,0,0
214552,lose,0,0
214553,weight,0,0
214554,(,0,0
214555,mean,0,1
214556,=,0,0
214557,-0.42,0,0
214558,kg,0,1
214559,),0,0
214560,but,0,0
214561,this,0,0
214562,was,0,0
214563,not,0,0
214564,the,0,0
214565,case,0,0
214566,for,0,0
214567,those,0,0
214568,in,0,0
214569,the,0,0
214570,lower,0,0
214571,weight,0,0
214572,percentiles,0,0
214573,(,0,1
214574,mean,0,1
214575,=,0,0
214576,+0.03,0,0
214577,kg,0,1
214578,),0,0
214579,.,0,1
214580,Necessary,0,0
214581,but,0,0
214582,not,0,0
214583,sufficient,0,0
214584,:,0,1
214585,the,0,0
214586,effect,0,0
214587,of,0,0
214588,screening,0,1
214589,and,0,0
214590,feedback,0,0
214591,on,0,0
214592,outcomes,0,0
214593,of,0,0
214594,primary,1,1
214595,care,1,1
214596,patients,1,1
214597,with,1,1
214598,untreated,1,1
214599,anxiety,1,1
214600,.,1,0
214601,OBJECTIVE,0,0
214602,To,0,0
214603,consider,0,0
214604,the,0,0
214605,impact,0,0
214606,on,0,0
214607,primary,0,1
214608,care,0,1
214609,patient,0,1
214610,outcomes,0,0
214611,of,0,0
214612,using,0,0
214613,both,0,0
214614,a,0,0
214615,screener,0,0
214616,to,0,0
214617,determine,0,0
214618,elevated,0,0
214619,anxiety,0,0
214620,levels,0,0
214621,among,0,1
214622,patients,1,1
214623,with,1,1
214624,previously,1,1
214625,undetected,1,1
214626,anxiety,1,0
214627,and,0,0
214628,a,0,0
214629,physician,0,0
214630,intervention,0,0
214631,to,0,0
214632,inform,0,0
214633,physicians,0,1
214634,of,0,0
214635,their,0,1
214636,patients,0,1
214637,',0,1
214638,conditions,0,1
214639,.,0,1
214640,DESIGN,0,0
214641,Participating,1,1
214642,physicians,1,1
214643,were,1,1
214644,randomized,1,1
214645,to,1,0
214646,either,1,0
214647,the,1,0
214648,demonstration,1,0
214649,or,1,0
214650,the,1,0
214651,control,1,0
214652,arm,1,0
214653,",",1,0
214654,and,1,0
214655,patients,1,1
214656,were,1,0
214657,assigned,1,1
214658,to,1,0
214659,a,1,0
214660,study,1,0
214661,arm,1,0
214662,based,1,0
214663,on,1,0
214664,the,1,0
214665,randomization,1,0
214666,of,1,0
214667,their,1,1
214668,physicians,1,1
214669,.,1,1
214670,The,0,0
214671,patients,0,1
214672,were,0,0
214673,followed,0,0
214674,for,0,0
214675,change,0,0
214676,in,0,0
214677,outcome,0,0
214678,measures,0,0
214679,during,0,0
214680,the,0,0
214681,five-month,0,0
214682,study,0,0
214683,period,0,0
214684,.,0,0
214685,SETTING,0,0
214686,A,0,0
214687,mixed-model,0,0
214688,health,0,0
214689,maintenance,0,0
214690,organization,0,0
214691,serving,0,1
214692,approximately,0,1
214693,"110,000",0,0
214694,enrollees,0,1
214695,in,0,1
214696,central,0,1
214697,Colorado,0,1
214698,.,0,1
214699,PATIENTS/PARTICIPANTS,0,0
214700,573,1,1
214701,patients,1,1
214702,who,1,1
214703,had,1,1
214704,unrecognized,1,1
214705,and,1,0
214706,untreated,1,1
214707,anxiety,1,0
214708,identified,1,0
214709,from,1,0
214710,the,1,0
214711,approximately,1,0
214712,"8,000",1,1
214713,patients,1,1
214714,who,1,1
214715,completed,1,1
214716,the,1,1
214717,waiting,1,0
214718,room,1,0
214719,screening,1,1
214720,questionnaire,1,0
214721,.,1,0
214722,INTERVENTIONS,0,0
214723,A,0,0
214724,physician,0,0
214725,intervention,0,0
214726,served,0,0
214727,the,0,0
214728,dual,0,1
214729,function,0,0
214730,of,0,0
214731,1,0,0
214732,),0,0
214733,providing,0,0
214734,an,0,0
214735,educational,0,0
214736,demonstration,0,0
214737,of,0,0
214738,anxiety,0,0
214739,in,0,0
214740,the,0,0
214741,primary,0,0
214742,care,0,0
214743,setting,0,1
214744,and,0,0
214745,2,0,0
214746,),0,0
214747,providing,0,0
214748,a,0,0
214749,reporting,0,0
214750,system,0,0
214751,for,0,0
214752,summarizing,0,0
214753,the,0,0
214754,anxiety,0,0
214755,symptom,0,0
214756,levels,0,0
214757,and,0,0
214758,functioning,0,0
214759,status,0,0
214760,of,0,0
214761,the,0,0
214762,patients,0,1
214763,enrolled,0,1
214764,in,0,0
214765,the,0,0
214766,study,0,0
214767,.,0,0
214768,MEASUREMENTS,0,0
214769,AND,0,0
214770,MAIN,0,0
214771,RESULTS,0,0
214772,Patient,0,0
214773,outcomes,0,0
214774,were,0,0
214775,measured,0,0
214776,as,0,0
214777,changes,0,0
214778,in,0,0
214779,global,0,0
214780,anxiety,0,1
214781,scores,0,0
214782,",",0,0
214783,functioning,0,0
214784,and,0,0
214785,well-being,0,0
214786,",",0,0
214787,and,0,0
214788,patients,0,1
214789,',0,1
214790,reports,0,0
214791,of,0,1
214792,global,0,0
214793,improvements,0,0
214794,.,0,1
214795,CONCLUSIONS,0,0
214796,The,0,0
214797,findings,0,0
214798,indicate,0,0
214799,that,0,0
214800,this,0,0
214801,method,0,0
214802,of,0,0
214803,reporting,0,0
214804,symptoms,0,0
214805,and,0,0
214806,functioning,0,0
214807,status,0,0
214808,to,0,0
214809,primary,0,1
214810,care,0,1
214811,physicians,0,0
214812,did,0,0
214813,not,0,0
214814,significantly,0,0
214815,change,0,0
214816,patient,0,0
214817,outcomes,0,0
214818,.,0,1
214819,Improvement,0,0
214820,in,0,0
214821,outcomes,0,0
214822,appeared,0,0
214823,to,0,0
214824,be,0,0
214825,more,0,0
214826,closely,0,0
214827,associated,0,0
214828,with,0,0
214829,the,0,0
214830,patient,0,0
214831,'s,0,0
214832,severity,0,0
214833,of,0,0
214834,psychological,0,0
214835,distress,0,1
214836,.,0,1
214837,The,0,0
214838,effect,0,0
214839,of,0,0
214840,eradication,0,0
214841,of,0,0
214842,Helicobacter,0,1
214843,pylori,0,0
214844,upon,0,0
214845,the,0,0
214846,duodenal,0,1
214847,ulcer,0,1
214848,recurrence,0,0
214849,--,0,1
214850,a,0,0
214851,24,0,0
214852,month,0,0
214853,follow-up,0,0
214854,study,0,1
214855,.,0,1
214856,OBJECTIVES,0,0
214857,To,0,0
214858,evaluate,0,0
214859,the,0,0
214860,effect,0,0
214861,of,0,0
214862,eradication,0,0
214863,of,0,0
214864,Helicobacter,0,1
214865,pylori,0,1
214866,(,0,0
214867,H.pylori,0,1
214868,),0,0
214869,in,0,0
214870,the,0,0
214871,patients,1,1
214872,with,1,1
214873,duodenal,1,1
214874,ulcer,1,1
214875,(,1,0
214876,Du,1,0
214877,),1,0
214878,upon,1,0
214879,the,0,0
214880,DU,0,1
214881,recurrence,0,0
214882,.,0,0
214883,METHODS,0,0
214884,This,0,0
214885,study,0,0
214886,was,0,0
214887,performed,0,0
214888,for,0,0
214889,190,1,1
214890,patients,1,1
214891,with,1,1
214892,DU,1,1
214893,.,1,1
214894,Four,0,0
214895,different,0,0
214896,methods-microscopy,0,0
214897,of,0,0
214898,Gram,0,1
214899,stained,0,0
214900,mucosal,0,0
214901,smear,0,0
214902,",",0,0
214903,specific,0,0
214904,culture,0,0
214905,",",0,0
214906,biopsy,0,0
214907,urease,0,0
214908,test,0,0
214909,",",0,0
214910,histology,0,0
214911,of,0,0
214912,H,0,1
214913,&,0,1
214914,E,0,0
214915,staining-were,0,0
214916,taken,0,0
214917,for,0,0
214918,identifying,0,0
214919,colonization,0,0
214920,of,0,0
214921,H.,0,1
214922,pylori,0,0
214923,before,0,0
214924,treatment,0,0
214925,",",0,0
214926,and,0,0
214927,for,0,0
214928,finding,0,0
214929,the,0,0
214930,eradication,0,0
214931,of,0,0
214932,H.,0,1
214933,pylori,0,1
214934,4,0,0
214935,weeks,0,0
214936,after,0,0
214937,completion,0,0
214938,of,0,0
214939,therapy,0,0
214940,in,0,0
214941,each,0,0
214942,treatment,0,0
214943,group,0,0
214944,(,0,0
214945,cometidine,0,0
214946,",",0,0
214947,omeprazole,0,0
214948,",",0,0
214949,colloidal,0,0
214950,bismuth,0,0
214951,subcitrate,0,0
214952,(,0,0
214953,CBS,0,0
214954,),0,0
214955,",",0,0
214956,CBS,0,0
214957,and,0,0
214958,metronidazole,0,0
214959,double,0,0
214960,therapy,0,0
214961,",",0,0
214962,CBS,0,0
214963,",",0,0
214964,metronidazole,0,0
214965,and,0,0
214966,amoxicillin,0,0
214967,triple,0,0
214968,therapy,0,0
214969,),0,0
214970,.,0,0
214971,To,0,0
214972,detect,0,0
214973,DU,0,1
214974,recurrence,0,0
214975,",",0,0
214976,the,0,0
214977,gastroscopy,0,0
214978,was,0,0
214979,performed,0,0
214980,at,0,0
214981,6,0,0
214982,",",0,0
214983,12,0,0
214984,",",0,0
214985,18,0,1
214986,",",0,0
214987,and,0,0
214988,24,0,0
214989,months,0,0
214990,after,0,0
214991,therapy,0,0
214992,.,0,0
214993,RESULTS,0,0
214994,The,0,0
214995,eradication,0,0
214996,rate,0,0
214997,of,0,0
214998,the,0,0
214999,cimetidine,0,0
215000,group,0,0
215001,the,0,0
215002,omeprazole,0,0
215003,group,0,0
215004,",",0,0
215005,and,0,0
215006,the,0,0
215007,CBS,0,0
215008,group,0,0
215009,were,0,0
215010,0,0,0
215011,%,0,0
215012,",",0,0
215013,7.7,0,0
215014,%,0,0
215015,",",0,0
215016,0,0,0
215017,%,0,0
215018,",",0,0
215019,respectively,0,0
215020,",",0,0
215021,and,0,0
215022,that,0,0
215023,of,0,0
215024,the,0,0
215025,double,0,0
215026,therapy,0,0
215027,group,0,0
215028,and,0,0
215029,the,0,0
215030,triple,0,0
215031,therapy,0,0
215032,group,0,0
215033,were,0,0
215034,44.4,0,0
215035,%,0,0
215036,and,0,0
215037,89.3,0,0
215038,%,0,0
215039,",",0,0
215040,respectively,0,0
215041,.,0,0
215042,Seventy,1,1
215043,three,1,1
215044,patients,1,1
215045,who,0,1
215046,were,0,1
215047,followed,0,1
215048,up,0,0
215049,for,0,0
215050,2,0,1
215051,years,0,1
215052,were,0,1
215053,categorized,0,1
215054,into,0,1
215055,two,1,0
215056,groups,1,0
215057,according,0,1
215058,to,0,0
215059,the,0,0
215060,eradication,0,0
215061,of,0,0
215062,H.,0,1
215063,pylori,0,1
215064,.,0,0
215065,The,0,0
215066,recurrence,0,0
215067,rate,0,0
215068,was,0,0
215069,3.2,0,0
215070,%,0,0
215071,both,0,0
215072,in,0,0
215073,1,0,0
215074,year,0,1
215075,and,0,1
215076,2,0,0
215077,years,0,1
215078,later,0,1
215079,in,0,0
215080,the,0,0
215081,former,0,0
215082,group-one,0,0
215083,consisting,0,1
215084,of,0,0
215085,31,1,1
215086,patients,1,1
215087,with,0,1
215088,H.,0,1
215089,pylori,0,0
215090,eradicated,0,0
215091,",",0,0
215092,while,0,0
215093,the,0,0
215094,recurrence,0,0
215095,rate,0,0
215096,was,0,0
215097,57.1,0,0
215098,%,0,0
215099,in,0,0
215100,1,0,0
215101,year,0,1
215102,and,0,0
215103,78.6,0,0
215104,%,0,0
215105,in,0,0
215106,2,0,0
215107,years,0,1
215108,later,0,0
215109,",",0,0
215110,in,0,0
215111,the,0,0
215112,latter,0,0
215113,group-the,0,0
215114,other,0,0
215115,of,0,1
215116,42,1,1
215117,patients,1,1
215118,with,1,1
215119,H.,1,1
215120,pylori,1,0
215121,not,0,0
215122,eradicated,0,0
215123,.,0,0
215124,CONCLUSION,0,0
215125,The,0,0
215126,eradication,0,0
215127,of,0,0
215128,H.,0,1
215129,pylori,0,1
215130,in,0,0
215131,patients,1,1
215132,with,1,1
215133,DU,1,1
215134,reduces,0,0
215135,the,0,0
215136,recurrence,0,0
215137,of,0,0
215138,DU,0,1
215139,.,0,1
215140,Vitamin,0,0
215141,C,0,0
215142,and,0,0
215143,acute,0,1
215144,illness,0,1
215145,in,0,0
215146,Navajo,1,1
215147,school,1,1
215148,children,1,1
215149,.,1,1
215150,To,0,0
215151,evaluate,0,0
215152,earlier,0,0
215153,observations,0,0
215154,",",0,0
215155,including,0,0
215156,our,0,0
215157,own,0,1
215158,",",0,0
215159,showing,0,0
215160,usefulness,0,0
215161,of,0,0
215162,vitamin,0,0
215163,C,0,0
215164,for,0,0
215165,managing,0,0
215166,the,0,0
215167,common,0,0
215168,cold,0,0
215169,",",0,0
215170,we,0,0
215171,performed,0,0
215172,a,0,0
215173,double-blind,0,0
215174,trial,0,0
215175,of,0,0
215176,vitamin,0,0
215177,C,0,0
215178,versus,0,0
215179,placebo,0,0
215180,in,0,0
215181,868,1,1
215182,children,1,1
215183,.,1,0
215184,There,0,0
215185,was,0,0
215186,no,0,0
215187,difference,0,0
215188,in,0,0
215189,number,0,0
215190,becoming,0,0
215191,ill,0,1
215192,(,0,1
215193,133,0,1
215194,versus,0,0
215195,129,0,1
215196,),0,0
215197,",",0,0
215198,number,0,0
215199,of,0,0
215200,episodes,0,0
215201,(,0,1
215202,166,0,1
215203,versus,0,0
215204,159,0,1
215205,),0,1
215206,or,0,1
215207,mean,0,1
215208,illness,0,1
215209,duration,0,0
215210,(,0,0
215211,5.5,0,0
215212,versus,0,0
215213,5.8,0,0
215214,days,0,0
215215,),0,1
215216,between,0,0
215217,the,0,0
215218,groups,0,0
215219,.,0,1
215220,Children,1,1
215221,receiving,1,0
215222,vitamin,1,0
215223,C,1,0
215224,had,0,0
215225,fewer,0,0
215226,throat,0,1
215227,cultures,0,0
215228,yielding,0,0
215229,beta-hemolytic,0,1
215230,streptococcus,0,1
215231,(,0,0
215232,six,0,1
215233,versus,0,0
215234,13,0,1
215235,",",0,0
215236,P,0,0
215237,less,0,0
215238,than,0,0
215239,0.10,0,0
215240,),0,0
215241,",",0,0
215242,but,0,0
215243,no,0,0
215244,difference,0,0
215245,in,0,0
215246,overall,0,0
215247,complicated,0,1
215248,illness,0,1
215249,rate,0,0
215250,(,0,0
215251,24,0,0
215252,versus,0,0
215253,25,0,1
215254,),0,1
215255,.,0,1
215256,Plasma,0,0
215257,ascorbic,0,0
215258,acid,0,0
215259,levels,0,0
215260,were,0,0
215261,higher,0,0
215262,in,0,0
215263,the,0,0
215264,vitamin,1,0
215265,group,1,0
215266,24,0,0
215267,to,0,0
215268,26,0,1
215269,hours,0,0
215270,after,0,0
215271,supplementation,0,0
215272,(,0,0
215273,1.28,0,0
215274,versus,0,0
215275,1.04,0,0
215276,mg,0,0
215277,per,0,0
215278,100,0,0
215279,ml,0,0
215280,",",0,0
215281,P,0,0
215282,less,0,0
215283,than,0,0
215284,0.01,0,0
215285,),0,1
215286,.,0,1
215287,Children,1,1
215288,with,1,1
215289,high,1,1
215290,plasma,1,0
215291,ascorbic,1,0
215292,acid,1,0
215293,concentrations,0,0
215294,had,0,0
215295,longer,0,0
215296,mean,0,0
215297,illness,0,0
215298,(,0,0
215299,6.8,0,0
215300,versus,0,0
215301,4.0,0,0
215302,days,0,0
215303,",",0,0
215304,P,0,0
215305,less,0,0
215306,than,0,0
215307,0.05,0,0
215308,),0,0
215309,than,0,0
215310,those,0,0
215311,with,0,1
215312,low,0,1
215313,levels,0,0
215314,.,0,1
215315,Vitamin,0,0
215316,C,0,0
215317,does,0,0
215318,not,0,0
215319,seem,0,0
215320,to,0,0
215321,be,0,0
215322,an,0,0
215323,effective,0,0
215324,prophylactic,0,0
215325,or,0,1
215326,therapeutic,0,0
215327,agent,0,0
215328,for,0,0
215329,upper,0,0
215330,respiratory,0,1
215331,illness,0,1
215332,.,0,1
215333,Changes,0,0
215334,in,0,1
215335,beta-carotene,0,0
215336,levels,0,0
215337,by,0,0
215338,long-term,0,0
215339,administration,0,0
215340,of,0,0
215341,natural,0,0
215342,beta-carotene,0,0
215343,derived,0,0
215344,from,0,1
215345,Dunaliella,0,0
215346,bardawil,0,0
215347,in,0,0
215348,humans,1,1
215349,.,1,1
215350,Long-term,0,0
215351,administration,0,0
215352,of,0,0
215353,a,0,0
215354,beta-carotene,0,0
215355,preparation,0,0
215356,derived,0,0
215357,from,0,0
215358,Dunaliella,0,0
215359,bardawil,0,0
215360,",",0,0
215361,a,0,0
215362,beta-carotene-rich,0,0
215363,algae,0,0
215364,",",0,0
215365,was,0,0
215366,studied,0,0
215367,in,0,0
215368,healthy,1,1
215369,young,1,1
215370,male,1,1
215371,volunteers,1,1
215372,.,1,1
215373,The,0,0
215374,daily,0,0
215375,administration,0,0
215376,of,0,0
215377,60,0,1
215378,mg,0,0
215379,of,0,0
215380,the,0,0
215381,beta-carotene,0,0
215382,preparation,0,0
215383,(,0,0
215384,30,0,0
215385,mg,0,0
215386,of,0,0
215387,all-trans,0,0
215388,beta-carotene,0,0
215389,and,0,0
215390,30,0,0
215391,mg,0,0
215392,of,0,0
215393,9-cis,0,0
215394,beta-carotene,0,0
215395,),0,0
215396,was,0,0
215397,performed,0,0
215398,and,0,0
215399,beta-carotene,0,0
215400,concentrations,0,0
215401,were,0,1
215402,determined,0,0
215403,in,0,0
215404,the,0,0
215405,plasma,0,0
215406,",",0,0
215407,red,0,1
215408,blood,0,0
215409,cells,0,0
215410,(,0,1
215411,RBC,0,0
215412,),0,0
215413,",",0,0
215414,platelets,0,0
215415,(,0,0
215416,PLT,0,1
215417,),0,0
215418,",",0,0
215419,and,0,0
215420,mononuclear,0,0
215421,cells,0,0
215422,(,0,1
215423,MN,0,1
215424,),0,0
215425,.,0,0
215426,The,0,0
215427,all-trans,0,0
215428,beta-carotene,0,0
215429,level,0,0
215430,increased,0,0
215431,four-,0,0
215432,",",0,0
215433,two-,0,0
215434,",",0,0
215435,and,0,0
215436,threefold,0,0
215437,the,0,0
215438,baseline,0,0
215439,in,0,0
215440,plasma,0,0
215441,",",0,0
215442,PLT,0,0
215443,",",0,0
215444,and,0,0
215445,MN,0,0
215446,",",0,0
215447,respectively,0,0
215448,.,0,0
215449,Basal,0,0
215450,levels,0,0
215451,of,0,0
215452,9-cis,0,0
215453,beta-carotene,0,0
215454,in,0,0
215455,plasma,0,0
215456,",",0,0
215457,PLT,0,0
215458,",",0,0
215459,and,0,0
215460,MN,0,0
215461,were,0,0
215462,low,0,0
215463,and,0,0
215464,found,0,0
215465,as,0,0
215466,one-tenth,0,0
215467,",",0,0
215468,one-fifth,0,0
215469,",",0,0
215470,and,0,0
215471,one-fifth,0,0
215472,of,0,0
215473,all-trans,0,0
215474,beta-carotene,0,0
215475,",",0,0
215476,which,0,0
215477,increased,0,0
215478,three-,0,0
215479,",",0,0
215480,two-,0,0
215481,",",0,0
215482,and,0,0
215483,1.5-fold,0,0
215484,the,0,0
215485,baseline,0,0
215486,",",0,0
215487,respectively,0,0
215488,.,0,0
215489,Plasma,0,0
215490,and,0,0
215491,RBC,0,0
215492,alpha-tocopherol,0,0
215493,levels,0,0
215494,were,0,0
215495,not,0,0
215496,changed,0,0
215497,by,0,0
215498,the,0,0
215499,intake,0,0
215500,of,0,0
215501,beta-carotene,0,0
215502,.,0,0
215503,No,0,0
215504,side,0,0
215505,effects,0,0
215506,or,0,1
215507,toxicities,0,0
215508,were,0,0
215509,documented,0,0
215510,in,0,0
215511,any,0,0
215512,of,0,0
215513,the,0,0
215514,subjects,0,1
215515,during,0,0
215516,the,0,0
215517,administration,0,0
215518,period,0,0
215519,.,0,0
215520,In,0,0
215521,conclusion,0,0
215522,",",0,0
215523,the,0,0
215524,bioavailability,0,0
215525,of,0,0
215526,beta-carotene,0,0
215527,derived,0,0
215528,from,0,1
215529,Dunaliella,0,1
215530,bardawil,0,0
215531,was,0,0
215532,preferential,0,0
215533,for,0,0
215534,all-trans,0,0
215535,beta-carotene,0,0
215536,",",0,0
215537,although,0,0
215538,a,0,0
215539,small,0,0
215540,amount,0,0
215541,of,0,0
215542,the,0,0
215543,9-cis,0,0
215544,form,0,0
215545,was,0,0
215546,detected,0,0
215547,in,0,0
215548,the,0,0
215549,plasma,0,0
215550,and,0,0
215551,blood,0,0
215552,cells,0,0
215553,.,0,1
215554,Angiotensin,0,0
215555,converting,0,0
215556,enzyme,0,0
215557,inhibition,0,0
215558,does,0,0
215559,not,0,0
215560,affect,0,0
215561,the,0,0
215562,response,0,0
215563,to,0,0
215564,exogenous,0,0
215565,angiotensin,0,0
215566,II,0,1
215567,in,0,0
215568,the,0,0
215569,human,1,1
215570,forearm,1,0
215571,.,1,0
215572,Suppression,0,0
215573,of,0,0
215574,endogenous,0,0
215575,levels,0,0
215576,of,0,0
215577,angiotensin,0,0
215578,II,0,1
215579,by,0,0
215580,angiotensin,0,0
215581,converting,0,0
215582,enzyme,0,0
215583,inhibition,0,0
215584,",",0,0
215585,may,0,0
215586,result,0,0
215587,in,0,0
215588,up-regulation,0,0
215589,of,0,0
215590,vascular,0,0
215591,AT1,0,1
215592,receptors,0,0
215593,.,0,1
215594,We,0,0
215595,have,0,0
215596,evaluated,0,0
215597,the,0,0
215598,effects,0,0
215599,of,0,0
215600,orally,0,1
215601,administered,0,0
215602,enalapril,0,0
215603,on,0,0
215604,angiotensin,0,0
215605,II,0,1
215606,induced,0,0
215607,vasoconstriction,0,0
215608,in,0,0
215609,the,0,0
215610,human,1,1
215611,forearm,1,0
215612,.,1,0
215613,Subjects,1,0
215614,received,0,0
215615,in,0,0
215616,random,0,1
215617,order,0,0
215618,",",0,0
215619,enalapril,0,0
215620,(,0,0
215621,20,0,0
215622,mg,0,0
215623,),0,0
215624,or,0,0
215625,matched,0,1
215626,placebo,0,0
215627,daily,0,0
215628,for,0,1
215629,2,0,1
215630,weeks,0,0
215631,.,0,1
215632,Forearm,0,0
215633,blood,0,0
215634,flow,0,0
215635,response,0,0
215636,to,0,0
215637,increasing,0,0
215638,doses,0,0
215639,of,0,0
215640,angiotensin,0,0
215641,II,0,1
215642,was,0,0
215643,measured,0,0
215644,using,0,0
215645,venous,0,0
215646,occlusion,0,1
215647,plethysmography,0,0
215648,at,0,0
215649,the,0,0
215650,beginning,0,0
215651,of,0,0
215652,the,0,0
215653,study,0,0
215654,and,0,0
215655,at,0,0
215656,the,0,0
215657,end,0,0
215658,of,0,0
215659,each,0,0
215660,2,0,0
215661,week,0,0
215662,treatment,0,0
215663,period,0,0
215664,.,0,0
215665,Treatment,0,0
215666,with,0,0
215667,enalapril,0,0
215668,significantly,0,0
215669,reduced,0,0
215670,plasma,0,0
215671,angiotensin,0,0
215672,II,0,1
215673,levels,0,0
215674,and,0,0
215675,supine,0,0
215676,blood,0,0
215677,pressure,0,0
215678,compared,0,0
215679,with,0,1
215680,placebo,0,0
215681,.,0,0
215682,The,0,0
215683,percentage,0,0
215684,reductions,0,0
215685,in,0,0
215686,forearm,0,1
215687,blood,0,0
215688,flow,0,0
215689,in,0,0
215690,the,0,0
215691,infused,0,0
215692,arm,0,0
215693,",",0,0
215694,in,0,0
215695,response,0,0
215696,to,0,0
215697,the,0,0
215698,maximum,0,0
215699,dose,0,0
215700,of,0,0
215701,angiotensin,0,0
215702,II,0,1
215703,(,0,0
215704,"50,000",0,0
215705,fmol,0,0
215706,min-1,0,0
215707,),0,0
215708,were,0,0
215709,48.1,0,1
215710,+/-,0,0
215711,3.6,0,0
215712,%,0,0
215713,at,0,0
215714,baseline,0,0
215715,",",0,0
215716,57.5,0,0
215717,+/-,0,0
215718,3.6,0,0
215719,%,0,0
215720,on,0,0
215721,placebo,0,0
215722,and,0,0
215723,54.5,0,0
215724,+/-,0,0
215725,4.2,0,0
215726,%,0,0
215727,on,0,0
215728,enalapril,0,0
215729,.,0,0
215730,The,0,0
215731,differences,0,0
215732,were,0,0
215733,not,0,0
215734,significantly,0,0
215735,different,0,0
215736,.,0,0
215737,This,0,0
215738,demonstrates,0,0
215739,that,0,0
215740,suppression,0,0
215741,of,0,0
215742,plasma,0,0
215743,angiotensin,0,0
215744,II,0,1
215745,for,0,0
215746,a,0,0
215747,14,0,0
215748,day,0,0
215749,period,0,0
215750,does,0,0
215751,not,0,0
215752,enhance,0,0
215753,the,0,0
215754,response,0,0
215755,to,0,0
215756,exogenous,0,0
215757,intra-arterial,0,0
215758,angiotensin,0,0
215759,II,0,1
215760,in,0,0
215761,the,0,0
215762,human,1,0
215763,forearm,1,0
215764,of,1,0
215765,healthy,1,1
215766,salt,1,0
215767,replete,1,1
215768,subjects,1,1
215769,.,1,1
215770,[,0,0
215771,Effect,0,0
215772,of,0,0
215773,acupuncture,0,0
215774,on,0,0
215775,T-lymphocyte,0,0
215776,and,0,0
215777,its,0,0
215778,subsets,0,0
215779,from,0,1
215780,the,0,0
215781,peripheral,0,0
215782,blood,0,0
215783,of,0,0
215784,patients,1,1
215785,with,1,1
215786,malignant,1,1
215787,neoplasm,1,1
215788,],1,0
215789,.,0,0
215790,Effect,0,0
215791,of,0,0
215792,acupuncture,0,0
215793,on,0,0
215794,the,0,0
215795,T-lymphocyte,0,0
215796,and,0,0
215797,its,0,0
215798,subsets,0,0
215799,from,0,1
215800,the,0,0
215801,peripheral,0,0
215802,blood,0,0
215803,of,0,0
215804,patients,1,1
215805,with,1,1
215806,malignant,1,1
215807,neoplasm,1,1
215808,has,0,0
215809,been,0,0
215810,researched,0,0
215811,in,0,0
215812,this,0,0
215813,study,0,0
215814,.,0,0
215815,51,1,1
215816,patients,1,1
215817,were,0,1
215818,divided,0,1
215819,into,0,1
215820,two,0,1
215821,groups,0,1
215822,:,0,1
215823,one,0,1
215824,in,0,0
215825,acupuncture,0,0
215826,treatment,0,0
215827,and,0,0
215828,the,0,0
215829,other,0,0
215830,without,0,0
215831,any,0,0
215832,treatment,0,0
215833,.,0,0
215834,48,1,0
215835,healthy,1,1
215836,adults,1,1
215837,were,1,1
215838,also,1,0
215839,studied,1,0
215840,as,1,0
215841,normal,1,1
215842,control,1,1
215843,group,1,0
215844,.,1,0
215845,The,0,0
215846,results,0,0
215847,showed,0,0
215848,that,0,0
215849,the,0,0
215850,percentages,0,0
215851,of,0,0
215852,OKT3+,0,0
215853,",",0,0
215854,OKT4+,0,0
215855,",",0,0
215856,OKT8+,0,0
215857,cells,0,0
215858,in,0,0
215859,the,0,0
215860,peripheral,0,0
215861,blood,0,0
215862,of,0,0
215863,the,0,0
215864,51,0,1
215865,patients,0,1
215866,were,0,1
215867,lower,0,0
215868,than,0,0
215869,those,0,0
215870,of,0,0
215871,the,0,0
215872,normal,0,1
215873,adults,0,1
215874,respectively,0,0
215875,.,0,0
215876,After,0,0
215877,the,0,0
215878,acupuncture,0,0
215879,treatment,0,0
215880,",",0,0
215881,the,0,0
215882,percentages,0,0
215883,of,0,0
215884,OKT3+,0,0
215885,",",0,0
215886,OKT4+,0,0
215887,",",0,0
215888,OKT8+,0,0
215889,cells,0,0
215890,were,0,0
215891,obviously,0,0
215892,higher,0,0
215893,than,0,0
215894,those,0,0
215895,before,0,0
215896,acupuncture,0,0
215897,;,0,0
215898,the,0,0
215899,control,0,0
215900,group,0,0
215901,of,0,0
215902,patients,0,1
215903,showed,0,0
215904,no,0,0
215905,significant,0,0
215906,variation,0,0
215907,.,0,0
215908,This,0,0
215909,result,0,0
215910,revealed,0,0
215911,that,0,0
215912,acupuncture,0,0
215913,seemed,0,0
215914,to,0,0
215915,have,0,0
215916,more,0,0
215917,affect,0,0
215918,on,0,0
215919,OKT4+,0,1
215920,cells,0,0
215921,than,0,0
215922,on,0,0
215923,OKT8+,0,0
215924,cells,0,0
215925,.,0,1
215926,From,0,1
215927,our,0,0
215928,study,0,0
215929,we,0,0
215930,believe,0,0
215931,that,0,0
215932,acupuncture,0,0
215933,can,0,0
215934,be,0,0
215935,used,0,0
215936,as,0,0
215937,one,0,0
215938,of,0,0
215939,the,0,0
215940,many,0,0
215941,treatments,0,0
215942,for,0,0
215943,patients,1,1
215944,with,1,1
215945,cancer,1,1
215946,.,1,1
215947,[,0,0
215948,Report,0,1
215949,of,0,0
215950,a,0,0
215951,controlled,0,0
215952,clinical,0,0
215953,trial,0,0
215954,of,0,0
215955,a,0,0
215956,new,0,0
215957,synthetic,0,0
215958,drug,0,0
215959,",",0,0
215960,parsalmide,0,0
215961,",",0,0
215962,in,0,0
215963,rheumatic,1,1
215964,arthropathies,1,1
215965,(,1,0
215966,inflammatory,1,0
215967,and,1,0
215968,degenerative,1,1
215969,),1,0
215970,],1,0
215971,.,0,0
215972,The,0,0
215973,anti-inflammatory,0,0
215974,",",0,0
215975,analgesic,0,0
215976,and,0,0
215977,tranquillizing,0,1
215978,activity,0,0
215979,of,0,0
215980,a,0,0
215981,synthetic,0,0
215982,compound,0,0
215983,called,0,0
215984,parsalmide,0,0
215985,was,0,0
215986,investigated,0,0
215987,in,0,0
215988,patients,1,1
215989,suffering,1,1
215990,from,1,1
215991,inflammatory,1,0
215992,and,1,0
215993,degenerative,1,1
215994,rheumatic,1,1
215995,arthropathies,1,1
215996,.,1,1
215997,The,0,0
215998,study,0,0
215999,was,0,0
216000,carried,0,0
216001,out,0,0
216002,in,0,0
216003,30,1,1
216004,subjects,1,1
216005,using,1,0
216006,the,1,0
216007,controlled,1,0
216008,experiment,1,0
216009,technique,1,0
216010,according,1,0
216011,to,1,0
216012,the,1,0
216013,between,1,0
216014,patient,1,0
216015,pattern,1,1
216016,",",1,0
216017,attributing,1,0
216018,parsalmide,1,0
216019,and,1,0
216020,indomethacin,1,0
216021,at,1,0
216022,random,1,1
216023,to,1,0
216024,two,1,0
216025,groups,1,0
216026,.,1,1
216027,Both,0,0
216028,preparations,0,0
216029,were,0,0
216030,found,0,0
216031,to,0,0
216032,possess,0,0
216033,good,0,0
216034,anti-inflammatory,0,0
216035,and,0,0
216036,analgesic,0,0
216037,action,0,0
216038,",",0,0
216039,comparable,0,0
216040,clinically,0,0
216041,and,0,0
216042,statistically,0,0
216043,.,0,0
216044,Tolerance,0,0
216045,was,0,0
216046,very,0,0
216047,good,0,0
216048,",",0,0
216049,particularly,0,0
216050,at,0,0
216051,gastroenteric,0,1
216052,level,0,0
216053,(,0,0
216054,no,0,0
216055,side,0,0
216056,and/or,0,0
216057,undesired,0,0
216058,effects,0,0
216059,were,0,1
216060,observed,0,0
216061,),0,0
216062,and,0,0
216063,at,0,0
216064,the,0,0
216065,level,0,0
216066,of,0,0
216067,haemopoietic,0,0
216068,",",0,0
216069,renal,0,1
216070,and,0,0
216071,hepatic,0,0
216072,function,0,0
216073,.,0,1
216074,Aerosolized,0,0
216075,pentamidine,0,0
216076,as,0,0
216077,primary,0,1
216078,prophylaxis,0,1
216079,for,0,0
216080,Pneumocystis,0,1
216081,carinii,0,1
216082,pneumonia,0,1
216083,:,0,1
216084,efficacy,0,0
216085,",",0,0
216086,mortality,0,0
216087,and,0,0
216088,morbidity,0,0
216089,.,0,1
216090,OBJECTIVE,0,0
216091,Primary,0,1
216092,prophylaxis,0,0
216093,against,0,0
216094,Pneumocystis,0,1
216095,carinii,0,1
216096,pneumonia,0,0
216097,(,0,0
216098,PCP,0,0
216099,),0,0
216100,for,0,0
216101,patients,1,1
216102,with,1,1
216103,HIV,1,1
216104,infection,1,0
216105,has,0,0
216106,been,0,0
216107,recommended,0,0
216108,by,0,0
216109,the,0,0
216110,Centers,0,0
216111,for,0,1
216112,Disease,0,1
216113,Control,0,1
216114,and,0,0
216115,Prevention,0,1
216116,.,0,0
216117,We,0,0
216118,evaluated,0,0
216119,alternatives,0,0
216120,to,0,0
216121,routine,0,1
216122,primary,0,1
216123,PCP,0,0
216124,prophylaxis,0,1
216125,with,0,1
216126,aerosolized,0,0
216127,pentamidine,0,0
216128,.,0,1
216129,METHODS,0,0
216130,A,1,0
216131,total,1,1
216132,of,1,0
216133,121,1,1
216134,HIV-infected,1,1
216135,patients,1,1
216136,with,1,1
216137,CD4+,1,0
216138,cell,1,1
216139,counts,1,0
216140,<,1,0
216141,or,1,0
216142,=,1,0
216143,200,1,0
216144,x,1,0
216145,10,1,1
216146,(,1,1
216147,6,1,0
216148,),1,0
216149,/l,1,0
216150,or,1,0
216151,an,1,0
216152,AIDS,1,1
216153,diagnosis,1,1
216154,were,0,0
216155,enrolled,0,1
216156,in,0,0
216157,a,0,0
216158,controlled,0,0
216159,study,0,0
216160,of,0,0
216161,aerosolized,0,0
216162,pentamidine,0,0
216163,as,0,0
216164,primary,0,1
216165,PCP,0,0
216166,prophylaxis,0,1
216167,.,0,1
216168,Patients,0,1
216169,were,0,0
216170,randomly,0,1
216171,assigned,0,0
216172,to,0,0
216173,treatment,0,0
216174,(,0,0
216175,n,0,1
216176,=,0,0
216177,61,0,1
216178,),0,0
216179,with,0,1
216180,aerosolized,0,0
216181,pentamidine,0,0
216182,once,0,0
216183,every,0,0
216184,month,0,0
216185,or,0,0
216186,to,0,0
216187,no,0,0
216188,treatment,0,0
216189,(,0,0
216190,n,0,1
216191,=,0,0
216192,60,0,1
216193,),0,1
216194,.,0,1
216195,Patients,0,1
216196,were,0,0
216197,evaluated,0,0
216198,for,0,0
216199,PCP,0,0
216200,",",0,0
216201,mortality,0,0
216202,",",0,0
216203,morbidity,0,0
216204,and,0,0
216205,progression,0,0
216206,of,0,0
216207,HIV,0,1
216208,disease,0,1
216209,.,0,1
216210,Morbidity,0,0
216211,was,0,0
216212,estimated,0,0
216213,from,0,0
216214,the,0,0
216215,number,0,0
216216,of,0,0
216217,days,0,0
216218,patients,0,1
216219,were,0,1
216220,unable,0,0
216221,to,0,0
216222,work,0,0
216223,due,0,0
216224,to,0,0
216225,illness,0,1
216226,",",0,0
216227,number,0,0
216228,of,0,0
216229,days,0,0
216230,hospitalized,0,1
216231,and,0,1
216232,AIDS,0,1
216233,events,0,0
216234,.,0,1
216235,RESULTS,0,0
216236,Baseline,0,0
216237,characteristics,0,0
216238,were,0,1
216239,similar,0,0
216240,in,0,0
216241,the,0,0
216242,treatment,0,0
216243,and,0,0
216244,control,0,0
216245,groups,0,0
216246,and,0,1
216247,mean,0,1
216248,CD4+,0,1
216249,cell,0,1
216250,counts,0,0
216251,were,0,1
216252,116,0,1
216253,and,0,1
216254,107,0,1
216255,x,0,0
216256,10,0,1
216257,(,0,1
216258,6,0,0
216259,),0,0
216260,/l,0,0
216261,",",0,0
216262,respectively,0,0
216263,.,0,0
216264,Eight,0,0
216265,incidents,0,0
216266,of,0,0
216267,PCP,0,1
216268,and,0,1
216269,19,0,1
216270,deaths,0,0
216271,were,0,1
216272,observed,0,0
216273,in,0,0
216274,the,0,0
216275,treatment,0,0
216276,group,0,0
216277,during,0,0
216278,a,0,0
216279,median,0,0
216280,follow-up,0,0
216281,of,0,0
216282,16.4,0,0
216283,months,0,0
216284,(,0,0
216285,range,0,0
216286,",",0,0
216287,2.3-32.4,0,0
216288,months,0,0
216289,),0,1
216290,.,0,1
216291,Nineteen,0,1
216292,incidents,0,0
216293,of,0,0
216294,PCP,0,1
216295,and,0,1
216296,13,0,1
216297,deaths,0,0
216298,",",0,0
216299,of,0,0
216300,which,0,0
216301,one,0,1
216302,was,0,0
216303,related,0,0
216304,to,0,0
216305,an,0,0
216306,acute,0,1
216307,episode,0,1
216308,of,0,0
216309,PCP,0,0
216310,",",0,0
216311,were,0,0
216312,noted,0,0
216313,in,0,0
216314,the,0,0
216315,control,0,0
216316,group,0,0
216317,.,0,0
216318,Median,0,0
216319,follow-up,0,0
216320,of,0,0
216321,controls,0,1
216322,was,0,0
216323,18.5,0,0
216324,months,0,0
216325,(,0,0
216326,range,0,0
216327,",",0,0
216328,3.1-32.9,0,0
216329,months,0,0
216330,),0,1
216331,.,0,1
216332,Patients,0,1
216333,in,0,0
216334,the,0,0
216335,treatment,0,0
216336,group,0,0
216337,were,0,0
216338,unable,0,0
216339,to,0,0
216340,work,0,0
216341,19,0,1
216342,%,0,0
216343,of,0,0
216344,the,0,0
216345,observation,0,0
216346,time,0,0
216347,and,0,0
216348,were,0,0
216349,hospitalized,0,1
216350,for,0,0
216351,4.3,0,0
216352,%,0,0
216353,of,0,0
216354,that,0,0
216355,time,0,0
216356,.,0,0
216357,Corresponding,0,0
216358,figures,0,0
216359,were,0,1
216360,20,0,1
216361,and,0,0
216362,3.0,0,0
216363,%,0,0
216364,",",0,0
216365,respectively,0,0
216366,",",0,0
216367,in,0,0
216368,the,0,0
216369,control,0,0
216370,group,0,0
216371,.,0,1
216372,CONCLUSIONS,0,0
216373,Aerosolized,0,0
216374,pentamidine,0,0
216375,had,0,1
216376,significant,0,0
216377,prophylactic,0,0
216378,efficacy,0,0
216379,",",0,0
216380,but,0,0
216381,we,0,0
216382,could,0,0
216383,not,0,0
216384,detect,0,0
216385,any,0,0
216386,major,0,0
216387,effect,0,0
216388,on,0,0
216389,mortality,0,0
216390,and,0,0
216391,morbidity,0,0
216392,.,0,0
216393,The,0,0
216394,overall,0,0
216395,mortality,0,0
216396,and,0,0
216397,morbidity,0,0
216398,were,0,0
216399,not,0,0
216400,markedly,0,0
216401,influenced,0,0
216402,by,0,0
216403,PCP,0,0
216404,.,0,1
216405,Clinical,0,0
216406,check-ups,0,0
216407,and,0,0
216408,treatment,0,0
216409,of,0,0
216410,acute,0,1
216411,PCP,0,0
216412,could,0,0
216413,be,0,0
216414,a,0,0
216415,justifiable,0,0
216416,alternative,0,0
216417,to,0,0
216418,drug,0,0
216419,prophylaxis,0,0
216420,with,0,1
216421,aerosolized,0,0
216422,pentamidine,0,0
216423,in,0,0
216424,selected,0,1
216425,patients,1,1
216426,.,1,1
216427,Use,0,0
216428,and,0,0
216429,limitations,0,0
216430,of,0,0
216431,Holter,0,1
216432,electrocardiography,0,0
216433,in,0,0
216434,assessing,0,0
216435,drug,1,0
216436,therapy,1,0
216437,of,1,0
216438,myocardial,1,1
216439,ischemia,1,1
216440,during,1,0
216441,the,1,0
216442,peri-PTCA,1,0
216443,period,1,0
216444,.,1,0
216445,Incidence,0,0
216446,and,0,0
216447,pattern,0,1
216448,of,0,0
216449,myocardial,0,1
216450,ischemia,0,1
216451,during,0,0
216452,the,0,0
216453,peri-PTCA,1,0
216454,(,1,0
216455,percutaneous,1,1
216456,transluminal,1,1
216457,coronary,1,1
216458,angioplasty,1,1
216459,),1,0
216460,period,0,0
216461,and,0,0
216462,the,0,0
216463,possible,0,0
216464,role,0,0
216465,of,0,0
216466,continuous,0,0
216467,intravenous,0,0
216468,isosorbide,0,0
216469,dinitrate,0,0
216470,in,0,0
216471,its,0,0
216472,prevention,0,0
216473,were,0,0
216474,examined,0,0
216475,prospectively,0,1
216476,in,0,0
216477,30,1,1
216478,patients,1,1
216479,.,1,1
216480,Holter,0,1
216481,electrocardiographic,0,0
216482,monitoring,0,0
216483,was,0,0
216484,performed,0,0
216485,for,0,0
216486,21,0,1
216487,+/-,0,0
216488,3,0,0
216489,h,0,0
216490,before,0,0
216491,PTCA,0,0
216492,and,0,0
216493,continued,0,0
216494,during,0,0
216495,and,0,0
216496,for,0,0
216497,41,0,1
216498,+/-,0,0
216499,8,0,0
216500,h,0,0
216501,after,0,0
216502,the,0,0
216503,procedure,0,0
216504,.,0,0
216505,Before,0,0
216506,PTCA,0,0
216507,",",0,0
216508,19,0,1
216509,ischemic,0,1
216510,episodes,0,1
216511,were,0,1
216512,present,0,0
216513,in,0,0
216514,10,0,1
216515,(,0,1
216516,33,0,1
216517,%,0,0
216518,),0,0
216519,of,0,0
216520,30,1,1
216521,patients,1,1
216522,.,1,1
216523,PTCA,0,0
216524,produced,0,0
216525,an,0,0
216526,abrupt,0,0
216527,decrease,0,0
216528,in,0,0
216529,number,0,0
216530,(,0,0
216531,p,0,0
216532,=,0,0
216533,0.015,0,0
216534,),0,0
216535,and,0,0
216536,duration,0,0
216537,(,0,0
216538,p,0,0
216539,=,0,0
216540,0.03,0,0
216541,),0,0
216542,of,0,0
216543,spontaneous,0,1
216544,ischemic,0,1
216545,episodes,0,1
216546,.,0,1
216547,The,0,0
216548,rarity,0,0
216549,of,0,0
216550,recurrent,0,1
216551,myocardial,0,1
216552,ischemic,0,1
216553,events,0,0
216554,by,0,0
216555,Holter,0,1
216556,monitoring,0,0
216557,after,0,0
216558,PTCA,0,0
216559,negated,0,0
216560,any,0,0
216561,attempt,0,0
216562,at,0,0
216563,assessing,0,0
216564,the,0,0
216565,efficacy,0,0
216566,of,0,0
216567,intravenous,0,0
216568,isosorbide,0,0
216569,dinitrate,0,0
216570,in,0,0
216571,their,0,0
216572,prevention,0,0
216573,.,0,0
216574,Holter,0,0
216575,monitoring,0,0
216576,could,0,0
216577,not,0,0
216578,be,0,0
216579,used,0,0
216580,as,0,0
216581,an,0,0
216582,early,0,0
216583,predictor,0,0
216584,of,0,0
216585,late,0,1
216586,coronary,0,1
216587,restenosis,0,0
216588,.,0,1
216589,A,0,0
216590,cost-benefit,0,0
216591,comparison,0,0
216592,of,0,0
216593,intensive,0,1
216594,diabetes,0,1
216595,management,0,1
216596,with,0,1
216597,implantable,0,1
216598,pumps,0,0
216599,versus,0,0
216600,multiple,0,1
216601,subcutaneous,0,1
216602,injections,0,0
216603,in,0,1
216604,patients,1,1
216605,with,1,1
216606,type,1,1
216607,I,1,1
216608,diabetes,1,1
216609,.,1,0
216610,OBJECTIVE,0,0
216611,To,0,0
216612,investigate,0,0
216613,if,0,0
216614,intraperitoneal,0,0
216615,(,0,1
216616,IP,0,0
216617,),0,0
216618,insulin,0,0
216619,infusion,0,0
216620,via,0,0
216621,programmable,0,1
216622,implantable,0,1
216623,pumps,0,0
216624,is,0,0
216625,a,0,0
216626,potential,0,0
216627,alternative,0,0
216628,to,0,0
216629,subcutaneous,0,0
216630,(,0,0
216631,SC,0,1
216632,),0,0
216633,insulin,0,0
216634,via,0,0
216635,multiple,0,1
216636,injections,0,0
216637,.,0,1
216638,RESEARCH,0,1
216639,DESIGN,0,0
216640,AND,0,0
216641,METHODS,0,0
216642,We,0,0
216643,compared,0,0
216644,the,0,0
216645,cost-benefits,0,0
216646,of,0,0
216647,the,0,0
216648,two,0,0
216649,methods,0,1
216650,using,0,0
216651,a,0,0
216652,randomized,0,0
216653,",",0,0
216654,prospective,0,0
216655,",",0,0
216656,6-month,0,0
216657,",",0,0
216658,crossover,0,0
216659,design,0,0
216660,in,0,0
216661,10,1,0
216662,adult,1,1
216663,type,1,1
216664,I,1,1
216665,diabetic,1,1
216666,patients,1,1
216667,.,1,1
216668,RESULTS,0,0
216669,When,0,0
216670,judged,0,0
216671,on,0,0
216672,the,0,0
216673,last,0,0
216674,month,0,0
216675,of,0,0
216676,IP,0,0
216677,versus,0,0
216678,SC,0,1
216679,periods,0,0
216680,in,0,0
216681,the,0,0
216682,nine,0,1
216683,patients,0,1
216684,who,0,1
216685,completed,0,1
216686,the,0,1
216687,study,0,0
216688,",",0,0
216689,metabolic,0,0
216690,data,0,0
216691,showed,0,0
216692,better,0,0
216693,glycemic,0,0
216694,control,0,0
216695,(,0,1
216696,HbA1c,0,0
216697,:,0,1
216698,7.2,0,0
216699,+/-,0,0
216700,0.2,0,0
216701,IP,0,0
216702,vs.,0,0
216703,8.5,0,0
216704,+/-,0,0
216705,0.7,0,0
216706,%,0,0
216707,SC,0,0
216708,",",0,0
216709,mean,0,1
216710,+/-,0,0
216711,SE,0,0
216712,",",0,0
216713,P,0,0
216714,=,0,0
216715,0.02,0,0
216716,),0,0
216717,",",0,0
216718,reduced,0,0
216719,glycemic,0,0
216720,fluctuations,0,0
216721,(,0,1
216722,SD,0,0
216723,of,0,0
216724,capillary,0,0
216725,glucose,0,1
216726,values,0,0
216727,:,0,1
216728,3.4,0,1
216729,+/-,0,0
216730,0.2,0,0
216731,IP,0,0
216732,vs.,0,0
216733,4.6,0,0
216734,+/-,0,0
216735,0.2,0,0
216736,mM,0,0
216737,SC,0,0
216738,",",0,0
216739,P,0,0
216740,<,0,0
216741,0.01,0,0
216742,),0,0
216743,",",0,0
216744,and,0,0
216745,fewer,0,0
216746,mild,0,1
216747,hypoglycemic,0,1
216748,events,0,0
216749,(,0,1
216750,5.7,0,1
216751,+/-,0,0
216752,2.0,0,0
216753,IP,0,0
216754,vs.,0,0
216755,10.0,0,0
216756,+/-,0,0
216757,3.1,0,0
216758,events/month,0,0
216759,SC,0,1
216760,",",0,0
216761,P,0,0
216762,=,0,0
216763,0.02,0,0
216764,),0,0
216765,.,0,0
216766,Quality,0,0
216767,of,0,0
216768,life,0,0
216769,",",0,0
216770,judged,0,0
216771,by,0,0
216772,Diabetes,0,1
216773,Control,0,1
216774,and,0,0
216775,Complications,0,0
216776,Trial,0,1
216777,questionnaires,0,0
216778,",",0,0
216779,was,0,0
216780,unaffected,0,0
216781,by,0,0
216782,pump,0,0
216783,therapy,0,0
216784,.,0,1
216785,Direct,0,0
216786,costs,0,0
216787,",",0,0
216788,including,0,0
216789,pump,0,0
216790,acquisition,0,0
216791,",",0,0
216792,implantation,0,0
216793,",",0,0
216794,and,0,0
216795,follow-up,0,0
216796,",",0,0
216797,were,0,0
216798,2.6-fold,0,0
216799,higher,0,0
216800,with,0,1
216801,IP,0,0
216802,than,0,0
216803,with,0,1
216804,SC,0,1
216805,delivery,0,0
216806,.,0,0
216807,CONCLUSIONS,0,0
216808,The,0,0
216809,implantable,0,0
216810,pump,0,0
216811,is,0,0
216812,more,0,0
216813,effective,0,0
216814,in,0,0
216815,the,0,0
216816,short,0,0
216817,term,0,0
216818,",",0,0
216819,equally,0,0
216820,accepted,0,0
216821,",",0,0
216822,but,0,0
216823,more,0,0
216824,costly,0,0
216825,than,0,0
216826,multiple,0,1
216827,injections,0,0
216828,and,0,0
216829,should,0,0
216830,be,0,0
216831,limited,0,0
216832,to,0,0
216833,patients,0,1
216834,with,0,1
216835,unsatisfactory,0,0
216836,glycemic,0,0
216837,control,0,1
216838,despite,0,0
216839,intensive,0,1
216840,diabetes,0,1
216841,management,0,1
216842,with,0,1
216843,SC,0,1
216844,insulin,0,0
216845,.,0,0
216846,In,0,0
216847,addition,0,0
216848,",",0,0
216849,longer-term,0,0
216850,",",0,0
216851,larger-scale,0,0
216852,",",0,0
216853,and,0,0
216854,comparative,0,0
216855,evaluation,0,0
216856,is,0,0
216857,required,0,0
216858,.,0,0
216859,Correlation,0,0
216860,between,0,0
216861,in,0,0
216862,vivo,0,0
216863,humoral,0,0
216864,and,0,0
216865,in,0,0
216866,vitro,0,0
216867,cellular,0,0
216868,immune,0,0
216869,responses,0,0
216870,following,0,0
216871,immunization,0,1
216872,with,0,1
216873,hepatitis,0,1
216874,B,0,1
216875,surface,0,0
216876,antigen,0,0
216877,(,0,0
216878,HBsAg,0,1
216879,),0,1
216880,vaccines,0,0
216881,.,0,1
216882,To,0,0
216883,study,0,0
216884,the,0,0
216885,regulation,0,0
216886,of,0,0
216887,the,0,0
216888,human,1,0
216889,immune,1,0
216890,response,1,0
216891,to,1,0
216892,hepatitis,1,1
216893,B,1,0
216894,surface,1,0
216895,antigen,1,0
216896,(,0,0
216897,HBsAg,0,1
216898,),0,0
216899,we,0,0
216900,have,0,0
216901,carefully,0,0
216902,monitored,0,0
216903,the,0,0
216904,in,0,0
216905,vivo,0,0
216906,humoral,0,0
216907,and,0,0
216908,in,0,0
216909,vitro,0,0
216910,cellular,0,0
216911,immune,0,0
216912,responses,0,0
216913,to,0,0
216914,HBsAg,0,1
216915,in,0,0
216916,50,1,1
216917,subjects,1,1
216918,receiving,1,1
216919,four,1,1
216920,doses,1,0
216921,of,1,0
216922,hepatitis,1,1
216923,B,1,1
216924,vaccine,1,0
216925,according,1,0
216926,to,1,0
216927,a,1,0
216928,0,1,0
216929,",",1,0
216930,1,1,0
216931,",",1,0
216932,2,1,0
216933,",",1,0
216934,12,1,0
216935,month,1,0
216936,vaccination,1,1
216937,scheme,1,0
216938,.,1,1
216939,Twenty-three,1,1
216940,subjects,1,1
216941,were,1,1
216942,given,1,0
216943,a,1,0
216944,plasma-derived,1,0
216945,vaccine,1,0
216946,(,1,0
216947,Hevac,1,0
216948,B,1,1
216949,),1,0
216950,and,1,0
216951,27,1,1
216952,received,1,0
216953,a,1,0
216954,recombinant,1,0
216955,HBsAg,1,1
216956,vaccine,1,0
216957,(,1,1
216958,yeast-derived,1,0
216959,;,1,1
216960,Engerix-B,1,1
216961,),1,0
216962,.,1,0
216963,The,0,0
216964,humoral,0,0
216965,and,0,0
216966,cellular,0,0
216967,immune,0,0
216968,responses,0,0
216969,were,0,0
216970,measured,0,0
216971,before,0,0
216972,vaccination,0,0
216973,(,0,0
216974,day,0,0
216975,0,0,0
216976,),0,1
216977,;,0,1
216978,6,0,0
216979,days,0,0
216980,after,0,0
216981,the,0,0
216982,second,0,0
216983,dose,0,0
216984,(,0,0
216985,day,0,0
216986,36,0,1
216987,),0,1
216988,;,0,1
216989,6,0,0
216990,days,0,0
216991,(,0,1
216992,day,0,0
216993,66,0,1
216994,),0,0
216995,",",0,0
216996,2,0,0
216997,months,0,0
216998,(,0,1
216999,day,0,0
217000,120,0,1
217001,),0,0
217002,and,0,1
217003,10,0,1
217004,months,0,0
217005,(,0,1
217006,day,0,0
217007,365,0,1
217008,),0,0
217009,after,0,0
217010,the,0,0
217011,third,0,0
217012,dose,0,0
217013,and,0,0
217014,1,0,0
217015,month,0,0
217016,after,0,0
217017,the,0,0
217018,fourth,0,0
217019,dose,0,0
217020,(,0,0
217021,day,0,0
217022,395,0,1
217023,),0,0
217024,.,0,0
217025,Based,0,0
217026,on,0,0
217027,the,0,0
217028,kinetics,0,0
217029,of,0,0
217030,the,0,0
217031,humoral,0,0
217032,immune,0,0
217033,responses,0,0
217034,",",0,0
217035,the,0,0
217036,vaccinees,0,0
217037,could,0,0
217038,be,0,0
217039,classified,0,0
217040,into,0,0
217041,fast,0,0
217042,",",0,0
217043,intermediate,0,0
217044,and,0,0
217045,slow/non-responders,0,1
217046,.,0,1
217047,Based,0,0
217048,on,0,0
217049,the,0,0
217050,magnitude,0,0
217051,of,0,0
217052,the,0,0
217053,immune,0,0
217054,response,0,0
217055,(,0,0
217056,anti-HBs,0,0
217057,titre,0,1
217058,),0,0
217059,on,0,0
217060,day,0,0
217061,395,0,1
217062,",",0,0
217063,the,0,0
217064,vaccinees,0,0
217065,could,0,0
217066,be,0,0
217067,divided,0,0
217068,into,0,0
217069,high,0,0
217070,(,0,0
217071,>,0,1
217072,or,0,1
217073,=,0,0
217074,2000,0,1
217075,U,0,0
217076,l-1,0,0
217077,),0,0
217078,and,0,0
217079,low,0,1
217080,(,0,0
217081,<,0,0
217082,or,0,1
217083,=,0,0
217084,2000,0,1
217085,U,0,0
217086,l-1,0,0
217087,),0,1
217088,responders,0,0
217089,.,0,1
217090,A,0,0
217091,close,0,0
217092,correlation,0,0
217093,between,0,0
217094,the,0,0
217095,kinetics,0,0
217096,and,0,0
217097,the,0,0
217098,magnitude,0,0
217099,of,0,0
217100,the,0,0
217101,humoral,0,0
217102,immune,0,0
217103,response,0,0
217104,was,0,0
217105,observed,0,0
217106,.,0,0
217107,The,0,0
217108,in,0,0
217109,vivo,0,0
217110,anti-HBs,0,1
217111,response,0,0
217112,was,0,0
217113,measured,0,0
217114,using,0,0
217115,commercially,0,0
217116,available,0,0
217117,immunoradiometric,0,0
217118,assays,0,0
217119,.,0,1
217120,The,0,0
217121,in,0,0
217122,vitro,0,0
217123,cellular,0,0
217124,immune,0,0
217125,response,0,0
217126,was,0,0
217127,measured,0,0
217128,using,0,0
217129,an,0,0
217130,HBsAg-specific,0,0
217131,lymphoproliferation,0,1
217132,assay,0,0
217133,.,0,0
217134,Because,0,0
217135,of,0,0
217136,interassay,0,0
217137,variability,0,0
217138,the,0,0
217139,results,0,0
217140,were,0,0
217141,considered,0,0
217142,as,0,0
217143,dichotomous,0,0
217144,variables,0,0
217145,(,0,0
217146,proliferation,0,0
217147,versus,0,0
217148,non-proliferation,0,1
217149,),0,0
217150,for,0,0
217151,further,0,0
217152,data,0,0
217153,analysis,0,0
217154,.,0,0
217155,A,0,0
217156,statistically,0,0
217157,significant,0,0
217158,correlation,0,0
217159,was,0,0
217160,observed,0,0
217161,between,0,0
217162,the,0,0
217163,kinetics,0,0
217164,and,0,0
217165,magnitude,0,0
217166,of,0,0
217167,the,0,0
217168,humoral,0,0
217169,immune,0,0
217170,response,0,0
217171,on,0,0
217172,the,0,0
217173,one,0,0
217174,hand,0,0
217175,and,0,0
217176,the,0,0
217177,in,0,0
217178,vitro,0,0
217179,anti-HBs,0,0
217180,response,0,0
217181,on,0,0
217182,the,0,0
217183,other,0,0
217184,hand,0,0
217185,.,0,1
217186,(,0,0
217187,ABSTRACT,0,0
217188,TRUNCATED,0,1
217189,AT,0,1
217190,250,0,0
217191,WORDS,0,1
217192,),0,1
217193,Endurance,0,1
217194,physical,0,0
217195,activity,0,0
217196,",",0,0
217197,diet,0,0
217198,and,0,0
217199,fibrinolysis,0,0
217200,.,0,0
217201,The,0,0
217202,impact,0,0
217203,of,0,0
217204,long-term,0,0
217205,",",0,0
217206,heavy,0,0
217207,exercise,0,0
217208,on,0,0
217209,recently,0,1
217210,established,0,0
217211,cardiovascular/thromboembolic,0,0
217212,risk,0,0
217213,factors,0,0
217214,of,0,0
217215,the,0,0
217216,fibrinolytic,0,0
217217,system,0,0
217218,",",0,0
217219,tissue,0,0
217220,plasminogen,0,0
217221,activator,0,0
217222,(,0,0
217223,tPA,0,1
217224,),0,0
217225,and,0,0
217226,plasminogen,0,0
217227,activator,0,0
217228,inhibitor,0,0
217229,(,0,0
217230,PAI-1,0,0
217231,),0,0
217232,in,0,0
217233,relation,0,0
217234,to,0,0
217235,food,0,0
217236,composition,0,0
217237,was,0,0
217238,studied,0,1
217239,.,0,1
217240,Twenty,1,1
217241,healthy,1,1
217242,men,1,1
217243,",",1,0
217244,aged,1,1
217245,18-55,1,1
217246,years,1,1
217247,participated,0,1
217248,in,0,0
217249,a,0,0
217250,14-day,0,0
217251,skiing,0,0
217252,tour,0,0
217253,through,0,0
217254,the,0,0
217255,Swedish,0,1
217256,mountains,0,1
217257,",",0,0
217258,carrying,0,0
217259,a,0,0
217260,pack,0,0
217261,load,0,0
217262,of,0,0
217263,30,0,1
217264,kg,0,0
217265,",",0,0
217266,and,0,0
217267,spending,0,0
217268,each,0,0
217269,night,0,0
217270,in,0,0
217271,self-dug,0,0
217272,igloos,0,1
217273,(,0,0
217274,ambient,0,0
217275,temp,0,0
217276,-10,0,0
217277,degrees,0,0
217278,to,0,0
217279,-25,0,0
217280,degrees,0,0
217281,C,0,0
217282,),0,0
217283,",",0,0
217284,and,0,0
217285,were,0,0
217286,randomized,0,0
217287,to,0,0
217288,2,0,0
217289,food,0,0
217290,regimens,0,0
217291,having,0,1
217292,30,0,1
217293,or,0,1
217294,40,0,1
217295,energy,0,0
217296,percent,0,0
217297,of,0,0
217298,fat,0,0
217299,.,0,1
217300,Individual,0,0
217301,records,0,1
217302,were,0,1
217303,kept,0,0
217304,of,0,0
217305,all,0,0
217306,consumed,0,1
217307,food,0,0
217308,.,0,0
217309,Citrated,0,0
217310,plasma,0,0
217311,was,0,0
217312,obtained,0,0
217313,before,0,0
217314,and,0,0
217315,after,0,0
217316,1,0,0
217317,and,0,1
217318,2,0,0
217319,weeks,0,0
217320,of,0,1
217321,exercise,0,0
217322,:,0,1
217323,tPA,0,1
217324,release,0,0
217325,was,0,0
217326,assessed,0,0
217327,by,0,0
217328,a,0,0
217329,10,0,0
217330,min,0,0
217331,venous,0,0
217332,occlusion,0,1
217333,(,0,0
217334,VO,0,0
217335,),0,0
217336,test,0,0
217337,.,0,0
217338,At,0,0
217339,baseline,0,0
217340,",",0,0
217341,daily,0,0
217342,dietary,0,0
217343,fiber,0,0
217344,intake,0,0
217345,correlated,0,0
217346,negatively,0,0
217347,with,0,1
217348,PAI-1,0,0
217349,activity,0,0
217350,.,0,0
217351,Already,0,0
217352,after,0,0
217353,the,0,0
217354,first,0,0
217355,week,0,0
217356,of,0,0
217357,the,0,0
217358,skiing,0,0
217359,tour,0,0
217360,there,0,0
217361,were,0,0
217362,significant,0,0
217363,drops,0,0
217364,in,0,1
217365,PAI-1,0,1
217366,activities,0,0
217367,",",0,0
217368,cholesterol,0,0
217369,and,0,0
217370,triglycerides,0,0
217371,.,0,1
217372,The,0,0
217373,tPA,0,1
217374,mass,0,1
217375,concentrations,0,0
217376,also,0,0
217377,dropped,0,0
217378,",",0,0
217379,both,0,0
217380,before,0,0
217381,and,0,0
217382,after,0,0
217383,VO,0,0
217384,",",0,0
217385,but,0,0
217386,tPA,0,1
217387,activities,0,0
217388,were,0,1
217389,unchanged,0,0
217390,",",0,0
217391,as,0,0
217392,were,0,0
217393,von,0,1
217394,Willebrand,0,1
217395,factor,0,0
217396,(,0,0
217397,vWF,0,0
217398,),0,1
217399,levels,0,0
217400,.,0,1
217401,These,0,0
217402,changes,0,0
217403,were,0,0
217404,related,0,0
217405,mainly,0,0
217406,to,0,0
217407,the,0,0
217408,expenditure,0,0
217409,of,0,0
217410,energy,0,0
217411,",",0,0
217412,calculated,0,0
217413,from,0,0
217414,the,0,0
217415,food,0,0
217416,consumption,0,0
217417,",",0,0
217418,and,0,0
217419,appeared,0,0
217420,to,0,0
217421,be,0,0
217422,mediated,0,0
217423,through,0,0
217424,changed,0,0
217425,insulin,0,0
217426,sensitivity,0,0
217427,and,0,0
217428,decreased,0,0
217429,body,0,1
217430,fat,0,0
217431,mass,0,1
217432,.,0,0
217433,The,0,0
217434,energy,0,0
217435,percent,0,0
217436,of,0,0
217437,fat,0,0
217438,in,0,0
217439,the,0,0
217440,food,0,0
217441,had,0,0
217442,no,0,0
217443,differential,0,0
217444,impact,0,0
217445,.,0,0
217446,The,0,0
217447,effects,0,0
217448,receded,0,0
217449,a,0,1
217450,few,0,0
217451,weeks,0,0
217452,after,0,0
217453,cessation,0,1
217454,of,0,0
217455,the,0,0
217456,endurance,0,0
217457,exercise,0,0
217458,.,0,0
217459,Thus,0,0
217460,",",0,0
217461,endurance,0,0
217462,physical,0,0
217463,activity,0,0
217464,improves,0,0
217465,the,0,0
217466,fibrinolytic,0,0
217467,risk,0,0
217468,factor,0,0
217469,profile,0,0
217470,by,0,0
217471,reducing,0,0
217472,PAI-1,0,0
217473,while,0,0
217474,leaving,0,0
217475,tPA,0,1
217476,activity,0,0
217477,unaffected,0,0
217478,",",0,0
217479,independently,0,0
217480,of,0,0
217481,food,0,0
217482,composition,0,1
217483,.,0,0
217484,A,0,0
217485,low,0,0
217486,dietary,0,0
217487,fiber,0,0
217488,intake,0,0
217489,appears,0,0
217490,to,0,0
217491,be,0,0
217492,associated,0,0
217493,with,0,0
217494,higher,0,0
217495,PAI-1,0,0
217496,activities,0,0
217497,at,0,0
217498,baseline,0,0
217499,.,0,1
217500,Relationship,0,0
217501,between,0,0
217502,subjective,0,0
217503,effects,0,0
217504,and,0,1
217505,drug,1,1
217506,preferences,1,0
217507,:,1,1
217508,ethanol,0,0
217509,and,0,0
217510,diazepam,0,0
217511,.,0,0
217512,The,0,0
217513,relationship,0,0
217514,between,0,0
217515,subjective,0,0
217516,effects,0,0
217517,and,0,1
217518,drug,0,0
217519,preferences,0,0
217520,in,0,0
217521,normal,1,1
217522,volunteers,1,1
217523,was,0,0
217524,explored,0,0
217525,in,0,0
217526,a,0,0
217527,meta-analysis,0,0
217528,of,0,0
217529,several,0,0
217530,previously,0,1
217531,published,0,1
217532,studies,0,0
217533,.,0,1
217534,Subjective,0,0
217535,effects,0,0
217536,of,0,0
217537,",",0,0
217538,and,0,0
217539,preference,0,0
217540,for,0,0
217541,",",0,0
217542,ethanol,0,0
217543,and,0,0
217544,diazepam,0,0
217545,vs.,0,0
217546,placebo,0,0
217547,were,0,0
217548,measured,0,0
217549,using,0,0
217550,a,0,0
217551,choice,0,0
217552,procedure,0,0
217553,.,0,1
217554,Subjects,0,1
217555,were,0,0
217556,grouped,0,1
217557,according,0,0
217558,to,0,0
217559,their,0,0
217560,drug,0,0
217561,choices,0,0
217562,:,0,1
217563,'non-choosers,1,0
217564,',1,1
217565,never,1,1
217566,chose,1,1
217567,drug,1,0
217568,",",1,0
217569,whereas,1,0
217570,'choosers,1,0
217571,',1,1
217572,always,1,0
217573,chose,1,1
217574,drug,1,0
217575,.,1,1
217576,The,0,0
217577,two,0,0
217578,groups,0,0
217579,were,0,1
217580,compared,0,0
217581,on,0,0
217582,their,0,0
217583,subjective,0,0
217584,responses,0,0
217585,to,0,0
217586,drug,0,0
217587,and,0,0
217588,on,0,0
217589,demographic,0,0
217590,variables,0,0
217591,.,0,1
217592,Ethanol,0,0
217593,decreased,0,0
217594,Arousal,0,0
217595,",",0,0
217596,Elation,0,0
217597,",",0,0
217598,Positive,0,1
217599,Mood,0,1
217600,and,0,0
217601,Vigor,0,0
217602,",",0,0
217603,and,0,0
217604,increased,0,0
217605,Anxiety,0,0
217606,",",0,0
217607,Depression,0,0
217608,and,0,0
217609,Fatigue,0,0
217610,in,0,0
217611,the,0,0
217612,non-choosers,0,0
217613,",",0,0
217614,whereas,0,0
217615,it,0,0
217616,increased,0,0
217617,Arousal,0,1
217618,and,0,0
217619,Vigor,0,0
217620,in,0,0
217621,the,0,0
217622,choosers,0,0
217623,.,0,1
217624,Ethanol,0,1
217625,choosers,0,0
217626,were,0,0
217627,also,0,0
217628,more,0,0
217629,likely,0,0
217630,to,0,0
217631,be,0,0
217632,males,1,1
217633,and/or,1,1
217634,full-time,1,1
217635,students,1,1
217636,than,0,1
217637,non-choosers,0,1
217638,.,0,1
217639,Diazepam,0,0
217640,produced,0,0
217641,sedative-like,0,0
217642,effects,0,0
217643,in,0,0
217644,both,0,0
217645,choosers,0,0
217646,and,0,0
217647,non-choosers,0,0
217648,",",0,0
217649,but,0,0
217650,markedly,0,0
217651,decreased,0,0
217652,Anxiety,0,0
217653,and,0,0
217654,increased,0,0
217655,Friendliness,0,0
217656,in,0,0
217657,choosers,0,0
217658,only,0,0
217659,.,0,1
217660,Diazepam,0,0
217661,choice,0,0
217662,was,0,0
217663,also,0,0
217664,associated,0,0
217665,with,0,0
217666,more,0,0
217667,frequent,0,0
217668,recreational,0,0
217669,use,0,0
217670,of,0,0
217671,marijuana,0,0
217672,and,0,1
217673,stimulants,0,1
217674,.,0,0
217675,Thus,0,0
217676,",",0,0
217677,both,0,0
217678,demographic,0,0
217679,variables,0,0
217680,and,0,1
217681,subjective,0,0
217682,drug,0,0
217683,effects,0,0
217684,were,0,0
217685,related,0,0
217686,to,0,0
217687,drug,0,0
217688,preference,0,0
217689,.,0,1
217690,Surrogate,1,0
217691,and,1,0
217692,auxiliary,1,0
217693,endpoints,1,0
217694,in,1,1
217695,clinical,1,0
217696,trials,1,0
217697,",",1,0
217698,with,1,1
217699,potential,1,0
217700,applications,1,0
217701,in,1,0
217702,cancer,1,1
217703,and,1,0
217704,AIDS,1,1
217705,research,1,0
217706,.,1,1
217707,Surrogate,0,0
217708,endpoints,0,0
217709,have,0,0
217710,been,0,0
217711,defined,0,0
217712,by,0,0
217713,Prentice,0,1
217714,as,0,0
217715,response,0,0
217716,variables,0,0
217717,that,0,0
217718,can,0,0
217719,substitute,0,0
217720,for,0,0
217721,a,0,0
217722,'true,0,0
217723,',0,0
217724,endpoint,0,0
217725,for,0,0
217726,the,0,0
217727,purpose,0,0
217728,of,0,0
217729,comparing,0,0
217730,specific,0,0
217731,interventions,0,1
217732,or,0,1
217733,treatments,0,0
217734,in,0,0
217735,a,0,0
217736,clinical,0,0
217737,trial,0,0
217738,.,0,0
217739,The,0,0
217740,applicability,0,0
217741,of,0,0
217742,this,0,0
217743,definition,0,0
217744,",",0,0
217745,and,0,0
217746,of,0,0
217747,related,0,0
217748,surrogate,0,0
217749,endpoint,0,0
217750,criteria,0,1
217751,",",0,0
217752,is,0,0
217753,discussed,0,0
217754,",",0,0
217755,with,0,0
217756,emphasis,1,0
217757,on,1,0
217758,cancer,1,1
217759,and,1,0
217760,AIDS,1,1
217761,research,1,1
217762,settings,1,0
217763,.,1,1
217764,Auxiliary,0,1
217765,endpoints,0,0
217766,are,0,0
217767,defined,0,0
217768,as,0,0
217769,response,0,0
217770,variables,0,0
217771,",",0,0
217772,or,0,1
217773,covariates,0,0
217774,",",0,0
217775,that,0,0
217776,can,0,0
217777,strengthen,0,0
217778,true,0,0
217779,endpoint,0,0
217780,analyses,0,0
217781,.,0,0
217782,Specifically,0,0
217783,",",0,0
217784,such,0,0
217785,response,0,0
217786,variables,0,0
217787,provide,0,0
217788,some,0,0
217789,additional,0,0
217790,information,0,0
217791,on,0,0
217792,true,0,0
217793,endpoint,0,0
217794,occurrence,0,0
217795,times,0,0
217796,for,0,0
217797,study,0,1
217798,subjects,0,1
217799,having,0,1
217800,censored,0,1
217801,values,0,0
217802,for,0,0
217803,such,0,0
217804,times,0,0
217805,.,0,1
217806,Auxiliary,0,0
217807,variables,0,0
217808,will,0,0
217809,very,0,0
217810,frequently,0,0
217811,be,0,0
217812,available,0,0
217813,",",0,0
217814,and,0,0
217815,they,0,0
217816,may,0,0
217817,be,0,0
217818,able,0,0
217819,to,0,0
217820,be,0,0
217821,used,0,0
217822,without,0,0
217823,making,0,0
217824,additional,0,0
217825,strong,0,1
217826,assumptions,0,0
217827,.,0,1
217828,Approaches,0,0
217829,to,0,0
217830,the,0,0
217831,use,0,0
217832,of,0,0
217833,auxiliary,0,0
217834,variables,0,0
217835,using,0,1
217836,ideas,0,0
217837,based,0,0
217838,on,0,0
217839,augmented,0,0
217840,score,0,0
217841,and,0,0
217842,augmented,0,0
217843,likelihood,0,0
217844,methods,0,1
217845,are,0,0
217846,described,0,0
217847,.,0,1
217848,Evolution,0,0
217849,of,0,0
217850,coronary,0,1
217851,stenoses,0,1
217852,is,0,0
217853,related,0,0
217854,to,0,0
217855,baseline,0,0
217856,severity,0,0
217857,--,0,0
217858,a,0,0
217859,prospective,0,0
217860,quantitative,0,0
217861,angiographic,0,0
217862,analysis,0,0
217863,in,0,0
217864,patients,1,1
217865,with,1,1
217866,moderate,1,1
217867,coronary,1,1
217868,disease,1,1
217869,.,1,1
217870,INTACT,0,0
217871,Investigators,0,1
217872,.,0,1
217873,International,0,1
217874,Nifedipine,0,0
217875,Trial,0,1
217876,on,0,0
217877,Antiatherosclerotic,0,1
217878,Therapy,0,1
217879,.,0,0
217880,A,0,0
217881,correlation,0,0
217882,of,0,0
217883,the,0,0
217884,angiographic,0,0
217885,evolution,0,0
217886,of,0,0
217887,coronary,0,1
217888,stenoses,0,1
217889,(,0,0
217890,stenosis,0,1
217891,diameter,0,0
217892,>,0,0
217893,or,0,0
217894,=,0,0
217895,20,0,0
217896,%,0,0
217897,),0,0
217898,with,0,1
217899,morphological,0,0
217900,stenosis,0,1
217901,parameters,0,0
217902,at,0,0
217903,baseline,0,0
217904,could,0,0
217905,help,0,0
217906,to,0,0
217907,identify,0,0
217908,the,0,0
217909,risk,0,0
217910,of,0,0
217911,progressive,0,1
217912,stenoses,0,1
217913,.,0,0
217914,Therefore,0,0
217915,",",0,0
217916,the,0,0
217917,data,0,0
217918,of,0,0
217919,the,0,0
217920,prospective,0,0
217921,INTACT,0,0
217922,study,0,1
217923,(,0,0
217924,International,0,1
217925,Nifedipine,0,0
217926,Trial,0,1
217927,on,0,0
217928,Antiatherosclerotic,0,1
217929,Therapy,0,1
217930,),0,0
217931,were,0,0
217932,reviewed,0,1
217933,.,0,1
217934,In,0,0
217935,348,1,1
217936,patients,1,1
217937,with,1,1
217938,moderate,1,1
217939,coronary,1,1
217940,artery,1,1
217941,disease,1,1
217942,",",1,0
217943,standardized,1,0
217944,coronary,1,1
217945,angiograms,1,0
217946,were,1,1
217947,taken,1,0
217948,3,1,0
217949,years,1,1
217950,apart,1,1
217951,and,0,0
217952,were,0,0
217953,quantitatively,0,0
217954,analysed,0,0
217955,.,0,0
217956,Changes,0,0
217957,in,0,0
217958,the,0,0
217959,minimal,0,0
217960,diameter,0,0
217961,of,0,0
217962,the,0,0
217963,1063,0,1
217964,preexisting,0,1
217965,coronary,0,1
217966,stenoses,0,1
217967,compared,0,0
217968,between,0,0
217969,both,0,0
217970,angiograms,0,0
217971,were,0,0
217972,set,0,0
217973,in,0,0
217974,relation,0,0
217975,to,0,0
217976,a,0,0
217977,number,0,0
217978,of,0,0
217979,conventional,0,0
217980,stenosis,0,1
217981,parameters,0,0
217982,at,0,0
217983,baseline,0,0
217984,.,0,1
217985,Regression,0,0
217986,analysis,0,0
217987,demonstrated,0,0
217988,a,0,0
217989,significant,0,0
217990,correlation,0,0
217991,of,0,0
217992,the,0,0
217993,changes,0,0
217994,in,0,0
217995,minimal,0,0
217996,diameter,0,0
217997,with,0,1
217998,baseline,0,0
217999,%,0,0
218000,diameter,0,0
218001,stenosis,0,1
218002,(,0,0
218003,r,0,0
218004,=,0,0
218005,0.30,0,0
218006,;,0,0
218007,P,0,0
218008,<,0,0
218009,0.001,0,0
218010,),0,0
218011,",",0,0
218012,minimal,0,0
218013,diameter,0,0
218014,(,0,0
218015,r,0,0
218016,=,0,1
218017,-0.28,0,0
218018,;,0,1
218019,P,0,0
218020,<,0,0
218021,0.001,0,0
218022,),0,0
218023,and,0,0
218024,reference,0,0
218025,diameter,0,0
218026,of,0,0
218027,stenoses,0,1
218028,(,0,1
218029,r,0,0
218030,=,0,0
218031,-0.14,0,0
218032,;,0,1
218033,P,0,0
218034,<,0,0
218035,0.001,0,0
218036,),0,0
218037,.,0,1
218038,The,0,0
218039,changes,0,0
218040,were,0,0
218041,not,0,0
218042,correlated,0,0
218043,with,0,0
218044,stenosis,0,1
218045,length,0,0
218046,and,0,0
218047,plaque,0,0
218048,area,0,0
218049,.,0,0
218050,The,0,0
218051,baseline,0,0
218052,parameters,0,0
218053,of,0,0
218054,22,0,1
218055,preexisting,0,1
218056,stenoses,0,1
218057,progressing,0,1
218058,to,0,1
218059,occlusions,0,1
218060,differed,0,0
218061,from,0,0
218062,those,0,0
218063,remaining,0,0
218064,patent,0,0
218065,only,0,0
218066,with,0,0
218067,regard,0,0
218068,to,0,0
218069,the,0,0
218070,%,0,0
218071,diameter,0,0
218072,stenosis,0,1
218073,(,0,0
218074,43,0,1
218075,+/-,0,0
218076,9,0,0
218077,%,0,0
218078,vs,0,0
218079,39,0,1
218080,+/-,0,0
218081,11,0,1
218082,%,0,0
218083,;,0,1
218084,P,0,0
218085,<,0,0
218086,0.05,0,0
218087,),0,1
218088,.,0,1
218089,Additional,0,0
218090,progression,0,0
218091,of,0,0
218092,coronary,0,1
218093,disease,0,1
218094,became,0,0
218095,manifest,0,0
218096,through,0,0
218097,development,0,0
218098,of,0,0
218099,228,0,1
218100,stenoses,0,1
218101,and,0,1
218102,19,0,1
218103,occlusions,0,1
218104,at,0,1
218105,arterial,0,1
218106,sites,0,0
218107,free,0,1
218108,from,0,1
218109,definitive,0,0
218110,stenoses,0,1
218111,in,0,0
218112,the,0,0
218113,baseline,0,0
218114,angiograms,0,0
218115,.,0,0
218116,Thus,0,0
218117,",",0,0
218118,progression,0,0
218119,of,0,0
218120,atherosclerosis,0,1
218121,predominantly,0,1
218122,occurred,0,0
218123,in,0,0
218124,mild,0,1
218125,preexisting,0,1
218126,coronary,0,1
218127,stenoses,0,1
218128,and,0,0
218129,developed,0,0
218130,at,0,0
218131,previously,0,0
218132,angiographically,0,1
218133,normal,0,1
218134,sites,0,0
218135,.,0,1
218136,Since,0,0
218137,the,0,0
218138,conventional,0,0
218139,angiographic,0,0
218140,parameters,0,0
218141,analysed,0,0
218142,in,0,0
218143,this,0,0
218144,study,0,0
218145,failed,0,0
218146,to,0,0
218147,identify,0,0
218148,individual,0,0
218149,arterial,0,1
218150,sites,0,0
218151,with,0,1
218152,an,0,0
218153,increased,0,0
218154,risk,0,0
218155,for,0,0
218156,progression,0,0
218157,",",0,0
218158,definition,0,0
218159,of,0,0
218160,new,0,0
218161,angiographic,0,1
218162,parameters,0,0
218163,or,0,1
218164,application,0,0
218165,of,0,0
218166,new,0,0
218167,techniques,0,0
218168,seem,0,0
218169,mandatory,0,0
218170,to,0,0
218171,this,0,0
218172,end,0,0
218173,.,0,0
218174,Intestinal,0,1
218175,absorption,0,0
218176,of,0,0
218177,dietary,0,0
218178,fat,0,0
218179,in,0,0
218180,patients,1,1
218181,with,1,1
218182,multiple,1,1
218183,sclerosis,1,1
218184,.,1,1
218185,Fat,0,0
218186,absorption,0,0
218187,was,0,0
218188,studied,0,1
218189,in,0,0
218190,24,1,0
218191,patients,1,1
218192,with,1,1
218193,clinically,1,1
218194,definite,1,1
218195,multiple,1,0
218196,sclerosis,1,1
218197,and,1,0
218198,in,1,0
218199,36,1,1
218200,healthy,1,1
218201,control,1,1
218202,subjects,1,1
218203,.,1,1
218204,Beta-carotene,0,0
218205,and,0,0
218206,vitamin,0,0
218207,A,0,0
218208,in,0,0
218209,their,0,0
218210,plasma,0,0
218211,were,0,0
218212,also,0,0
218213,measured,0,0
218214,.,0,0
218215,This,0,0
218216,double-blind,0,0
218217,and,0,0
218218,randomized,0,1
218219,study,0,0
218220,showed,0,0
218221,no,0,0
218222,differences,0,0
218223,between,0,0
218224,these,0,0
218225,two,0,0
218226,populations,0,1
218227,with,0,1
218228,regard,0,0
218229,to,0,0
218230,the,0,0
218231,three,0,0
218232,parameters,0,0
218233,.,0,1
218234,We,0,0
218235,did,0,0
218236,not,0,0
218237,find,0,0
218238,evidence,0,0
218239,for,0,0
218240,fat,0,0
218241,malabsorption,0,1
218242,in,0,0
218243,multiple,0,0
218244,sclerosis,0,1
218245,.,0,1
218246,Modest,0,0
218247,antihypertensive,0,0
218248,effect,0,0
218249,of,0,0
218250,epanolol,0,0
218251,",",0,0
218252,a,0,0
218253,beta,0,0
218254,1-selective,0,0
218255,receptor,0,0
218256,blocker,0,0
218257,with,0,1
218258,beta,0,0
218259,1,0,0
218260,agonist,0,1
218261,activity,0,0
218262,:,0,1
218263,an,0,0
218264,acute,0,1
218265,and,0,0
218266,long-term,0,0
218267,hemodynamic,0,0
218268,study,0,0
218269,at,0,0
218270,rest,0,0
218271,and,0,0
218272,during,0,0
218273,exercise,0,0
218274,and,0,0
218275,double,0,0
218276,crossover,0,0
218277,comparison,0,0
218278,with,0,1
218279,atenolol,0,0
218280,on,0,0
218281,ambulatory,0,0
218282,blood,0,0
218283,pressure,0,0
218284,.,0,0
218285,Beta-blockers,0,0
218286,with,0,1
218287,less,0,0
218288,cardiodepressive,0,0
218289,effect,0,0
218290,than,0,0
218291,traditional,0,1
218292,nonselective,0,0
218293,beta,0,0
218294,(,0,0
218295,1+2,0,0
218296,),0,0
218297,-blocking,0,0
218298,agents,0,0
218299,could,0,0
218300,be,0,0
218301,useful,0,0
218302,in,0,0
218303,the,0,0
218304,treatment,0,0
218305,of,0,0
218306,hypertension,0,1
218307,",",0,0
218308,provided,0,0
218309,the,0,0
218310,reduction,0,0
218311,in,0,0
218312,blood,0,0
218313,pressure,0,0
218314,was,0,0
218315,satisfactory,0,0
218316,.,0,1
218317,Epanolol,0,0
218318,",",0,0
218319,a,0,0
218320,selective,0,0
218321,beta,0,0
218322,1-receptor,0,0
218323,blocker,0,0
218324,with,0,1
218325,intrinsic,0,0
218326,sympathomimetic,0,0
218327,activity,0,0
218328,",",0,0
218329,induced,0,0
218330,a,0,0
218331,fall,0,0
218332,in,0,0
218333,intraarterial,0,0
218334,pressure,0,0
218335,of,0,0
218336,8,0,0
218337,%,0,0
218338,at,0,0
218339,rest,0,0
218340,sitting,0,0
218341,and,0,0
218342,11,0,0
218343,%,0,0
218344,during,0,0
218345,100,0,0
218346,W,0,0
218347,bicycle,0,0
218348,exercise,0,0
218349,after,0,0
218350,the,0,0
218351,first,0,0
218352,dose,0,0
218353,of,0,0
218354,200,0,0
218355,mg,0,0
218356,in,0,1
218357,12,1,1
218358,patients,1,1
218359,with,1,1
218360,essential,1,1
218361,hypertension,1,1
218362,.,1,1
218363,Heart,0,0
218364,rate,0,0
218365,",",0,0
218366,stroke,0,1
218367,index,0,0
218368,",",0,0
218369,and,0,0
218370,cardiac,0,1
218371,index,0,0
218372,initially,0,0
218373,fell,0,0
218374,by,0,0
218375,14,0,0
218376,%,0,0
218377,",",0,0
218378,11,0,0
218379,%,0,0
218380,",",0,0
218381,and,0,0
218382,23,0,0
218383,%,0,0
218384,",",0,0
218385,respectively,0,0
218386,.,0,0
218387,The,0,0
218388,total,0,1
218389,peripheral,0,0
218390,resistance,0,0
218391,index,0,0
218392,increased,0,0
218393,by,0,0
218394,21,0,1
218395,%,0,0
218396,after,0,0
218397,2,0,0
218398,hours,0,0
218399,",",0,0
218400,and,0,0
218401,then,0,0
218402,reverted,0,0
218403,towards,0,0
218404,the,0,0
218405,pretreatment,0,0
218406,level,0,0
218407,.,0,0
218408,After,0,0
218409,10,0,0
218410,months,0,0
218411,of,0,0
218412,epanolol,0,1
218413,treatment,0,0
218414,(,0,1
218415,mean,0,1
218416,300,0,0
218417,mg/day,0,0
218418,),0,0
218419,",",0,0
218420,the,0,0
218421,reduction,0,0
218422,in,0,0
218423,arterial,0,1
218424,pressure,0,0
218425,was,0,0
218426,5,0,0
218427,%,0,0
218428,at,0,0
218429,rest,0,0
218430,and,0,0
218431,10,0,0
218432,%,0,0
218433,during,0,0
218434,exercise,0,0
218435,.,0,1
218436,Cardiac,0,0
218437,index,0,0
218438,and,0,0
218439,heart,0,1
218440,rate,0,0
218441,were,0,0
218442,still,0,0
218443,reduced,0,0
218444,14-21,0,1
218445,%,0,0
218446,",",0,0
218447,while,0,0
218448,total,0,1
218449,peripheral,0,1
218450,resistance,0,0
218451,was,0,0
218452,unchanged,0,0
218453,or,0,1
218454,slightly,0,0
218455,increased,0,0
218456,(,0,0
218457,2-10,0,0
218458,%,0,0
218459,),0,0
218460,.,0,0
218461,Twenty-four,0,1
218462,hour,0,0
218463,ambulatory,0,0
218464,blood,0,0
218465,pressure,0,0
218466,was,0,0
218467,higher,0,0
218468,on,0,0
218469,epanolol,0,1
218470,(,0,0
218471,300,0,0
218472,mg/day,0,0
218473,),0,0
218474,than,0,0
218475,on,0,0
218476,atenolol,0,0
218477,(,0,0
218478,150,0,0
218479,mg/day,0,0
218480,),0,0
218481,treatment,0,0
218482,(,0,0
218483,137/97,0,0
218484,vs.,0,0
218485,128/91,0,0
218486,mmHg,0,0
218487,),0,0
218488,.,0,0
218489,Thus,0,0
218490,",",0,0
218491,the,0,0
218492,achieved,0,0
218493,blood,0,0
218494,pressure,0,0
218495,reduction,0,0
218496,induced,0,0
218497,by,0,0
218498,epanolol,0,1
218499,was,0,0
218500,moderate,0,1
218501,",",0,0
218502,while,0,0
218503,other,0,0
218504,characteristics,0,0
218505,of,0,0
218506,beta-receptor,0,0
218507,blockade,0,0
218508,",",0,0
218509,in,0,0
218510,particular,0,0
218511,",",0,0
218512,the,0,0
218513,reduction,0,0
218514,of,0,0
218515,heart,0,1
218516,rate,0,0
218517,and,0,0
218518,cardiac,0,1
218519,output,0,0
218520,",",0,0
218521,were,0,0
218522,maintained,0,0
218523,.,0,0
218524,This,0,0
218525,suggests,0,0
218526,that,0,0
218527,the,0,0
218528,compound,0,0
218529,may,0,0
218530,be,0,0
218531,useful,0,0
218532,for,0,0
218533,other,0,0
218534,cardiovascular,1,1
218535,disorders,1,1
218536,",",0,0
218537,e.g.,0,0
218538,",",0,0
218539,angina,1,1
218540,pectoris,1,1
218541,in,1,0
218542,patients,1,1
218543,without,1,1
218544,hypertension,1,1
218545,or,1,1
218546,cardiac,1,1
218547,arrhythmia,1,1
218548,.,1,1
218549,Pain,0,0
218550,relief,0,0
218551,can,0,0
218552,reduce,0,0
218553,hypoxemia,0,0
218554,in,0,0
218555,distressed,1,1
218556,neonates,1,1
218557,during,0,0
218558,routine,0,1
218559,treatment,0,1
218560,procedures,0,0
218561,.,0,1
218562,OBJECTIVE,0,0
218563,To,0,0
218564,determine,0,0
218565,whether,0,0
218566,the,0,0
218567,use,0,0
218568,of,0,0
218569,opioids,0,0
218570,could,0,0
218571,reduce,0,0
218572,the,0,0
218573,hypoxemia,0,0
218574,and,0,0
218575,hemodynamic,0,0
218576,instability,0,1
218577,associated,0,0
218578,with,0,1
218579,routine,0,0
218580,intensive,0,1
218581,care,0,1
218582,procedures,0,0
218583,in,0,0
218584,neonates,1,1
218585,with,1,1
218586,respiratory,1,1
218587,distress,1,1
218588,.,1,1
218589,DESIGN,0,0
218590,Randomized,0,0
218591,and,0,0
218592,placebo-controlled,0,0
218593,study,0,1
218594,.,0,1
218595,METHODS,0,0
218596,Physiological,0,0
218597,",",0,0
218598,plasma,0,0
218599,beta-endorphin,0,0
218600,",",0,0
218601,cortisol,0,0
218602,",",0,0
218603,and,0,0
218604,glucose,0,0
218605,responses,0,0
218606,to,0,0
218607,routine,0,0
218608,treatment,0,0
218609,procedures,0,0
218610,were,0,0
218611,studied,0,1
218612,in,0,0
218613,84,1,1
218614,mechanically,1,1
218615,ventilated,1,1
218616,distressed,1,1
218617,neonates,1,1
218618,randomized,0,1
218619,into,0,1
218620,groups,0,0
218621,receiving,0,1
218622,1,0,0
218623,mg/kg,0,0
218624,meperidine,0,0
218625,or,0,1
218626,0.9,0,0
218627,%,0,0
218628,saline,0,0
218629,15,0,1
218630,minutes,0,0
218631,before,0,0
218632,tracheal,0,1
218633,suction,0,0
218634,or,0,1
218635,routine,0,0
218636,nursing,0,1
218637,care,0,1
218638,.,0,0
218639,RESULTS,0,0
218640,The,0,0
218641,duration,0,0
218642,of,0,0
218643,hypoxemia,0,1
218644,(,0,0
218645,transcutaneous,0,0
218646,partial,0,1
218647,pressure,0,0
218648,of,0,0
218649,O2,0,1
218650,<,0,0
218651,6.6,0,0
218652,kPa,0,0
218653,(,0,1
218654,<,0,0
218655,50,0,1
218656,mm,0,1
218657,Hg,0,0
218658,),0,0
218659,and/or,0,0
218660,arterial,0,0
218661,blood,0,0
218662,oxygen,0,0
218663,saturation,0,0
218664,<,0,0
218665,80,0,1
218666,%,0,0
218667,),0,0
218668,during,0,0
218669,treatment,0,0
218670,procedures,0,0
218671,was,0,0
218672,significantly,0,0
218673,longer,0,0
218674,in,0,0
218675,the,0,0
218676,saline,0,0
218677,group,0,0
218678,(,0,0
218679,mean,0,1
218680,82,0,1
218681,vs,0,0
218682,36,0,1
218683,seconds,0,0
218684,",",0,1
218685,P,0,0
218686,=,0,0
218687,.001,0,0
218688,),0,0
218689,and,0,0
218690,distress,0,0
218691,quantified,0,0
218692,by,0,0
218693,a,0,0
218694,novel,0,0
218695,behavioral,0,0
218696,scoring,0,1
218697,method,0,0
218698,was,0,0
218699,much,0,0
218700,higher,0,0
218701,.,0,0
218702,Changes,0,0
218703,in,0,0
218704,arterial,0,1
218705,blood,0,0
218706,pressure,0,0
218707,",",0,0
218708,heart,0,1
218709,rate,0,0
218710,",",0,0
218711,or,0,0
218712,plasma,0,0
218713,beta-endorphin,0,0
218714,",",0,0
218715,cortisol,0,0
218716,",",0,0
218717,and,0,0
218718,glucose,0,0
218719,concentration,0,0
218720,did,0,0
218721,not,0,0
218722,show,0,0
218723,any,0,0
218724,statistically,0,0
218725,significant,0,0
218726,differences,0,0
218727,between,0,0
218728,the,0,0
218729,groups,0,0
218730,.,0,1
218731,CONCLUSION,0,0
218732,Newborns,1,1
218733,with,1,1
218734,respiratory,1,1
218735,difficulties,1,0
218736,often,0,0
218737,suffer,0,1
218738,from,0,0
218739,hypoxemia,0,1
218740,during,0,0
218741,essential,0,1
218742,treatment,0,1
218743,procedures,0,0
218744,.,0,0
218745,The,0,0
218746,use,0,0
218747,of,0,0
218748,opioid,0,0
218749,analgesia,0,0
218750,may,0,0
218751,reduce,0,0
218752,the,0,0
218753,duration,0,0
218754,of,0,0
218755,hypoxemia,0,1
218756,and,0,0
218757,the,0,0
218758,associated,0,0
218759,distress,0,0
218760,and,0,0
218761,",",0,0
218762,therefore,0,0
218763,",",0,0
218764,may,0,0
218765,improve,0,0
218766,the,0,0
218767,long-term,0,0
218768,results,0,0
218769,of,0,1
218770,neonatal,0,1
218771,intensive,0,1
218772,care,0,1
218773,.,0,1
218774,Peripheral,0,0
218775,intravenous,0,0
218776,line,0,0
218777,survival,0,0
218778,and,0,0
218779,phlebitis,0,0
218780,prevention,0,0
218781,in,0,0
218782,patients,1,1
218783,receiving,1,1
218784,intravenous,1,1
218785,antibiotics,1,0
218786,:,1,1
218787,heparin/hydrocortisone,0,0
218788,versus,0,0
218789,in-line,0,1
218790,filters,0,0
218791,.,0,1
218792,OBJECTIVE,0,0
218793,To,0,0
218794,compare,0,0
218795,the,0,0
218796,use,0,0
218797,of,0,0
218798,in-line,0,0
218799,filtration,0,0
218800,with,0,1
218801,the,0,0
218802,addition,0,0
218803,of,0,0
218804,heparin/hydrocortisone,0,0
218805,(,0,0
218806,hep/hc,0,0
218807,),0,0
218808,to,0,0
218809,the,0,0
218810,infusate,0,0
218811,for,0,0
218812,both,0,0
218813,phlebitis,0,0
218814,prevention,0,0
218815,and,0,0
218816,intravenous,0,0
218817,(,0,0
218818,i.v,0,0
218819,.,0,1
218820,),0,0
218821,line,0,0
218822,survival,0,0
218823,in,0,0
218824,peripheral,0,1
218825,i.v,0,0
218826,.,0,1
218827,catheters,0,0
218828,.,0,0
218829,This,0,0
218830,study,0,0
218831,was,0,0
218832,specific,1,0
218833,for,1,0
218834,a,1,0
218835,patient,1,0
218836,group,1,0
218837,receiving,1,1
218838,prolonged,1,0
218839,courses,1,0
218840,of,1,0
218841,i.v,1,0
218842,.,1,1
218843,antibiotics,1,0
218844,.,1,0
218845,Analysis,0,0
218846,of,0,0
218847,the,0,0
218848,two,0,0
218849,endpoints,0,0
218850,for,0,1
218851,conventional,0,1
218852,short,0,0
218853,i.v,0,0
218854,.,0,1
218855,catheters,0,0
218856,(,0,0
218857,short,0,1
218858,lines,0,0
218859,),0,0
218860,versus,0,0
218861,long,0,0
218862,(,0,0
218863,30,0,0
218864,cm,0,1
218865,),0,0
218866,i.v,0,0
218867,.,0,1
218868,catheters,0,0
218869,(,0,0
218870,long,0,1
218871,lines,0,0
218872,),0,0
218873,was,0,0
218874,also,0,0
218875,performed,0,0
218876,.,0,1
218877,METHODS,0,0
218878,Patients,1,1
218879,with,1,1
218880,cystic,1,1
218881,fibrosis,1,1
218882,receiving,1,1
218883,intermittent,1,1
218884,i.v,1,0
218885,.,1,1
218886,antibiotics,1,0
218887,were,0,0
218888,randomly,0,1
218889,allocated,0,0
218890,to,0,0
218891,receive,0,0
218892,their,0,0
218893,drugs,0,0
218894,either,0,0
218895,through,0,0
218896,an,0,0
218897,in-line,0,0
218898,filter,0,0
218899,using,0,0
218900,a,0,0
218901,drug-free,0,1
218902,infusate,0,0
218903,or,0,1
218904,with,0,1
218905,no,0,0
218906,filter,0,0
218907,and,0,0
218908,an,0,0
218909,infusate,0,0
218910,containing,0,0
218911,heparin,0,0
218912,500,0,0
218913,units,0,0
218914,and,0,1
218915,hydrocortisone,0,0
218916,10,0,0
218917,mg/L,0,0
218918,.,0,1
218919,Infusion,0,0
218920,sites,0,0
218921,were,0,0
218922,assessed,0,0
218923,daily,0,0
218924,.,0,0
218925,RESULTS,0,0
218926,Both,0,0
218927,the,0,0
218928,hep/hc,0,0
218929,and,0,0
218930,filter,0,0
218931,groups,0,0
218932,were,0,1
218933,similar,0,0
218934,in,0,0
218935,terms,0,0
218936,of,0,0
218937,phlebitis,0,0
218938,incidence,0,0
218939,and,0,0
218940,i.v,0,0
218941,.,0,0
218942,line,0,0
218943,survival,0,0
218944,when,0,0
218945,analyzed,0,0
218946,separately,0,0
218947,for,0,0
218948,both,0,0
218949,short,0,0
218950,and,0,0
218951,long,0,1
218952,lines,0,0
218953,.,0,1
218954,Long,0,1
218955,lines,0,0
218956,displayed,0,0
218957,markedly,0,0
218958,prolonged,0,0
218959,survival,0,0
218960,times,0,0
218961,and,0,0
218962,reduced,0,0
218963,phlebitis,0,0
218964,compared,0,0
218965,with,0,1
218966,short,0,1
218967,lines,0,0
218968,.,0,1
218969,CONCLUSIONS,0,0
218970,The,0,0
218971,effectiveness,0,0
218972,of,0,0
218973,i.v,0,0
218974,.,0,1
218975,filters,0,0
218976,in,0,0
218977,excluding,0,1
218978,the,0,0
218979,large,0,1
218980,particle,0,0
218981,load,0,0
218982,introduced,0,0
218983,by,0,0
218984,i.v,0,0
218985,.,0,1
218986,antibiotics,0,0
218987,and,0,0
218988,hence,0,0
218989,in,0,0
218990,reducing,0,0
218991,the,0,0
218992,subsequent,0,0
218993,phlebitis,0,0
218994,makes,0,0
218995,them,0,0
218996,a,0,0
218997,useful,0,0
218998,alternative,0,0
218999,to,0,0
219000,the,0,0
219001,use,0,0
219002,of,0,0
219003,hep/hc,0,0
219004,.,0,0
219005,The,0,0
219006,use,0,0
219007,of,0,0
219008,filters,0,0
219009,in,0,0
219010,this,0,0
219011,patient,0,0
219012,group,0,0
219013,may,0,0
219014,offer,0,0
219015,advantages,0,0
219016,in,0,0
219017,terms,0,0
219018,of,0,0
219019,ease,0,0
219020,of,0,0
219021,use,0,0
219022,and,0,0
219023,a,0,0
219024,possible,0,0
219025,decrease,0,0
219026,in,0,0
219027,hep/hc-related,0,0
219028,problems,0,1
219029,.,0,1
219030,Long,0,1
219031,lines,0,0
219032,offer,0,0
219033,practical,0,0
219034,advantages,0,0
219035,over,0,0
219036,short,0,1
219037,lines,0,0
219038,for,0,1
219039,patients,1,1
219040,requiring,1,1
219041,longer,1,0
219042,term,1,1
219043,i.v,1,0
219044,.,1,0
219045,access,1,0
219046,.,1,0
219047,[,0,0
219048,No,0,0
219049,better,0,0
219050,vigilance,0,0
219051,after,0,0
219052,general,0,1
219053,anesthesia,0,1
219054,with,0,1
219055,propofol,0,0
219056,in,0,0
219057,colonic,0,1
219058,surgery,0,1
219059,.,0,0
219060,A,0,0
219061,comparison,0,0
219062,of,0,0
219063,three,0,0
219064,procedures,0,1
219065,for,0,0
219066,general,0,1
219067,anesthesia,0,1
219068,(,0,0
219069,propofol,0,0
219070,",",0,0
219071,halothane,0,0
219072,and,0,0
219073,midazolam/fentanyl,0,0
219074,),0,0
219075,in,0,0
219076,combination,0,0
219077,with,0,1
219078,catheter,0,0
219079,epidural,0,0
219080,anesthesia,0,1
219081,],0,1
219082,.,0,0
219083,Early,0,0
219084,mental,0,1
219085,and,0,0
219086,psychomotor,0,0
219087,recovery,0,0
219088,was,0,0
219089,studied,1,1
219090,in,1,0
219091,67,1,1
219092,patients,1,1
219093,undergoing,1,1
219094,colorectal,1,1
219095,surgery,1,1
219096,under,1,0
219097,continuous,1,0
219098,epidural,1,0
219099,anaesthesia,1,1
219100,and,1,0
219101,light,1,0
219102,general,1,1
219103,anaesthesia,1,1
219104,using,1,0
219105,propofol,1,0
219106,",",1,0
219107,halothane,1,0
219108,",",1,0
219109,and,1,0
219110,midazolam/fentanyl,1,0
219111,.,1,0
219112,The,0,0
219113,study,0,0
219114,was,0,0
219115,approved,0,0
219116,by,0,0
219117,the,0,0
219118,local,0,0
219119,ethics,0,1
219120,committee,0,0
219121,.,0,1
219122,All,0,0
219123,patients,0,1
219124,received,0,0
219125,epidural,0,0
219126,anaesthesia,0,1
219127,with,0,1
219128,0.25,0,0
219129,%,0,0
219130,bupivacaine,0,0
219131,and,0,0
219132,were,0,0
219133,then,0,0
219134,randomly,0,1
219135,allocated,0,0
219136,to,0,0
219137,one,0,1
219138,of,0,0
219139,three,0,1
219140,groups,0,0
219141,.,0,1
219142,In,0,0
219143,group,0,0
219144,I,0,1
219145,(,0,0
219146,halothane,0,0
219147,),0,0
219148,",",0,0
219149,light,0,0
219150,general,0,1
219151,anaesthesia,0,1
219152,was,0,0
219153,induced,0,0
219154,with,0,1
219155,thiopental,0,0
219156,3-5,0,1
219157,mg/kg,0,0
219158,and,0,0
219159,maintained,0,0
219160,with,0,1
219161,halothane,0,0
219162,.,0,0
219163,The,0,0
219164,propofol,0,0
219165,group,0,0
219166,(,0,0
219167,II,0,1
219168,),0,0
219169,received,0,0
219170,2,0,0
219171,mg/kg,0,0
219172,for,0,0
219173,induction,0,0
219174,and,0,0
219175,a,0,0
219176,mean,0,0
219177,continuous,0,0
219178,infusion,0,0
219179,of,0,0
219180,1.7,0,0
219181,mg/kg.h,0,0
219182,.,0,0
219183,In,0,0
219184,group,0,0
219185,III,0,1
219186,(,0,0
219187,Mi/Fe,0,0
219188,),0,0
219189,",",0,0
219190,midazolam,0,0
219191,and,0,0
219192,fentanyl,0,0
219193,were,0,0
219194,used,0,0
219195,for,0,0
219196,induction,0,0
219197,and,0,0
219198,maintenance,0,0
219199,.,0,0
219200,All,0,0
219201,patients,0,1
219202,were,0,0
219203,intubated,0,1
219204,",",0,0
219205,received,0,0
219206,non-depolarising,0,0
219207,muscle,0,0
219208,relaxants,0,0
219209,",",0,0
219210,and,0,0
219211,were,0,0
219212,manually,0,0
219213,ventilated,0,1
219214,with,0,1
219215,nitrous,0,0
219216,oxide-oxygen,0,0
219217,(,0,0
219218,2:1.2,0,0
219219,),0,0
219220,.,0,1
219221,For,0,0
219222,postoperative,0,0
219223,analgesia,0,0
219224,",",0,0
219225,0.05,0,0
219226,mg/kg,0,0
219227,morphine,0,0
219228,was,0,0
219229,administrated,0,0
219230,epidurally,0,0
219231,30,0,0
219232,min,0,0
219233,before,0,0
219234,the,0,0
219235,end,0,0
219236,of,0,0
219237,the,0,0
219238,operation,0,0
219239,;,0,0
219240,30,0,0
219241,",",0,0
219242,60,0,1
219243,",",0,0
219244,90,0,0
219245,",",0,0
219246,and,0,0
219247,120,0,1
219248,min,0,0
219249,after,0,0
219250,arriving,0,0
219251,in,0,0
219252,the,0,0
219253,recovery,0,0
219254,room,0,0
219255,",",0,0
219256,vigilance,0,0
219257,was,0,0
219258,assessed,0,0
219259,using,0,0
219260,a,0,0
219261,modified,0,0
219262,Steward,0,0
219263,score,0,0
219264,",",0,0
219265,the,0,0
219266,Trieger,0,0
219267,test,0,0
219268,",",0,0
219269,the,0,0
219270,ability,0,0
219271,to,0,0
219272,recall,0,0
219273,a,0,0
219274,column,0,0
219275,of,0,0
219276,numbers,0,0
219277,(,0,1
219278,KAI,0,0
219279,test,0,0
219280,),0,0
219281,",",0,0
219282,and,0,0
219283,symbol,0,0
219284,counting,0,0
219285,(,0,0
219286,CI,0,0
219287,test,0,0
219288,),0,0
219289,.,0,0
219290,Heart,0,0
219291,rate,0,0
219292,",",0,0
219293,blood,0,0
219294,pressure,0,0
219295,",",0,0
219296,arterial,0,0
219297,oxygen,0,0
219298,saturation,0,0
219299,",",0,0
219300,and,0,0
219301,blood,0,0
219302,gases,0,0
219303,were,0,1
219304,recorded,0,0
219305,.,0,1
219306,RESULTS,0,0
219307,.,0,0
219308,The,0,0
219309,three,0,0
219310,groups,0,0
219311,were,0,1
219312,comparable,0,0
219313,with,0,1
219314,regard,0,0
219315,to,0,0
219316,age,0,1
219317,",",0,0
219318,sex,0,0
219319,",",0,0
219320,ASA,0,0
219321,classification,0,0
219322,",",0,0
219323,and,0,0
219324,duration,0,0
219325,of,0,0
219326,anaesthesia,0,1
219327,and,0,0
219328,operation,0,0
219329,(,0,0
219330,Table,0,0
219331,3,0,1
219332,),0,1
219333,.,0,0
219334,There,0,0
219335,was,0,0
219336,no,0,0
219337,difference,0,0
219338,between,0,0
219339,the,0,0
219340,groups,0,0
219341,in,0,0
219342,performance,0,0
219343,of,0,0
219344,the,0,0
219345,recovery,0,0
219346,tests,0,0
219347,(,0,1
219348,Figs,0,1
219349,.,0,1
219350,2-5,0,0
219351,),0,0
219352,",",0,0
219353,blood,0,0
219354,pressure,0,0
219355,",",0,0
219356,heart,0,1
219357,rate,0,0
219358,",",0,0
219359,arterial,0,0
219360,blood,0,0
219361,gas,0,1
219362,analysis,0,0
219363,(,0,0
219364,Fig,0,1
219365,.,0,1
219366,6,0,0
219367,),0,0
219368,",",0,0
219369,or,0,0
219370,oxygen,0,0
219371,saturation,0,0
219372,.,0,0
219373,Comparing,0,0
219374,pre-,0,0
219375,and,0,1
219376,postoperative,0,0
219377,values,0,0
219378,",",0,0
219379,we,0,0
219380,found,0,0
219381,severe,0,1
219382,psychomotor,0,0
219383,and,0,0
219384,mental,0,1
219385,impairment,0,0
219386,in,0,0
219387,all,0,1
219388,groups,0,0
219389,.,0,1
219390,pCO2,0,0
219391,was,0,0
219392,slightly,0,0
219393,elevated,0,0
219394,in,0,0
219395,all,0,0
219396,groups,0,0
219397,",",0,0
219398,but,0,0
219399,only,0,0
219400,3,0,0
219401,patients,0,1
219402,in,0,0
219403,the,0,0
219404,propofol,0,0
219405,group,0,0
219406,and,0,0
219407,6,0,0
219408,in,0,0
219409,the,0,0
219410,midazolam/fentanyl,0,0
219411,group,0,0
219412,developed,0,0
219413,hypercapnia,0,1
219414,above,0,0
219415,50,0,1
219416,mm,0,1
219417,Hg,0,0
219418,.,0,1
219419,Patients,0,1
219420,receiving,0,0
219421,propofol,0,0
219422,or,0,1
219423,midazolam/fentanyl,0,0
219424,had,0,0
219425,significantly,0,0
219426,less,0,0
219427,postoperative,0,0
219428,nausea,0,0
219429,and,0,0
219430,vomiting,0,0
219431,than,0,0
219432,those,0,0
219433,receiving,0,0
219434,halothane,0,0
219435,(,0,1
219436,Table,0,0
219437,5,0,1
219438,),0,1
219439,.,0,1
219440,CONCLUSION,0,0
219441,.,0,0
219442,It,0,0
219443,is,0,0
219444,concluded,0,0
219445,that,0,0
219446,propofol,0,0
219447,offers,0,0
219448,no,0,0
219449,advantage,0,0
219450,over,0,0
219451,halothane,0,0
219452,or,0,1
219453,midazolam/fentanyl,0,0
219454,where,0,0
219455,early,0,0
219456,postoperative,0,0
219457,recovery,0,0
219458,is,0,0
219459,concerned,0,0
219460,.,0,0
219461,Intraoperatively,0,0
219462,",",0,0
219463,all,0,0
219464,three,0,0
219465,techniques,0,0
219466,provided,0,0
219467,good,0,0
219468,anaesthesia,0,1
219469,.,0,1
219470,Propofol,0,0
219471,and,0,0
219472,midazolam/fentanyl,0,0
219473,caused,0,0
219474,less,0,0
219475,postoperative,0,0
219476,nausea,0,0
219477,and,0,0
219478,vomiting,0,0
219479,than,0,0
219480,halothane,0,0
219481,anaesthesia,0,1
219482,.,0,1
219483,Evaluation,0,0
219484,of,0,0
219485,postural,0,0
219486,stability,0,0
219487,by,0,0
219488,computerised,0,0
219489,posturography,0,0
219490,following,0,0
219491,outpatient,1,1
219492,paediatric,1,1
219493,anaesthesia,1,1
219494,.,1,0
219495,Comparison,0,0
219496,of,0,0
219497,propofol/alfentanil/N2O,0,0
219498,anaesthesia,0,1
219499,with,0,1
219500,thiopentone/halothane/N2O,0,1
219501,anaesthesia,0,1
219502,.,0,1
219503,Simple,0,0
219504,clinical,0,0
219505,tests,0,0
219506,",",0,0
219507,like,0,0
219508,Romberg,0,1
219509,'s,0,1
219510,test,0,0
219511,or,0,1
219512,a,0,0
219513,walking,0,0
219514,test,0,0
219515,",",0,0
219516,have,0,0
219517,proved,0,0
219518,to,0,0
219519,be,0,0
219520,inadequate,0,1
219521,guidelines,0,0
219522,for,0,0
219523,safe,0,0
219524,discharge,0,0
219525,after,0,0
219526,outpatient,0,1
219527,anaesthesia,0,1
219528,.,0,0
219529,A,0,0
219530,randomised,0,0
219531,study,0,0
219532,was,0,0
219533,therefore,0,0
219534,planned,0,0
219535,to,0,0
219536,compare,0,0
219537,postural,0,0
219538,stability,0,0
219539,measured,0,0
219540,by,0,0
219541,computerised,0,0
219542,posturography,0,0
219543,in,0,0
219544,31,1,1
219545,oral,1,0
219546,midazolam-atropine,1,1
219547,premedicated,1,1
219548,children,1,1
219549,aged,1,1
219550,6.9,1,0
219551,(,1,0
219552,s.e,1,1
219553,.,1,1
219554,0.4,1,0
219555,),1,1
219556,years,1,1
219557,who,1,1
219558,had,1,1
219559,been,1,1
219560,anaesthetised,1,1
219561,with,1,1
219562,either,1,0
219563,propofol/alfentanil/N2O,1,0
219564,or,1,0
219565,thiopentone/halothane/N2O,1,0
219566,.,1,0
219567,The,0,0
219568,sway,0,0
219569,velocity,0,0
219570,of,0,0
219571,the,0,0
219572,children,0,1
219573,was,0,0
219574,measured,0,0
219575,before,0,0
219576,premedication,0,0
219577,and,0,0
219578,1,0,0
219579,",",0,0
219580,2,0,0
219581,and,0,0
219582,3,0,0
219583,h,0,0
219584,after,0,0
219585,the,0,0
219586,end,0,0
219587,of,0,0
219588,anaesthesia,0,1
219589,.,0,1
219590,Results,0,0
219591,show,0,0
219592,that,0,0
219593,sway,0,0
219594,velocity,0,0
219595,had,0,0
219596,returned,0,0
219597,to,0,0
219598,baseline,0,0
219599,values,0,0
219600,3,0,0
219601,h,0,0
219602,after,0,0
219603,the,0,0
219604,end,0,0
219605,of,0,0
219606,anaesthesia,0,1
219607,in,0,0
219608,all,0,1
219609,children,0,1
219610,who,0,1
219611,had,0,1
219612,received,0,1
219613,propofol/alfentanil/N2O,0,0
219614,and,0,0
219615,in,0,0
219616,12,0,0
219617,of,0,0
219618,the,0,0
219619,15,0,1
219620,children,0,1
219621,who,0,1
219622,had,0,1
219623,received,0,1
219624,thiopentone/halothane/N2O,0,0
219625,.,0,0
219626,The,0,0
219627,quantified,0,0
219628,version,0,0
219629,of,0,0
219630,the,0,0
219631,Romberg,0,1
219632,test,0,0
219633,performed,0,0
219634,with,0,1
219635,eyes,0,1
219636,open,0,1
219637,or,0,0
219638,closed,0,0
219639,was,0,0
219640,not,0,0
219641,impaired,0,1
219642,after,0,0
219643,anaesthesia,0,1
219644,",",0,0
219645,compared,0,0
219646,with,0,0
219647,the,0,0
219648,control,0,0
219649,values,0,0
219650,",",0,0
219651,indicating,0,0
219652,that,0,0
219653,in,0,1
219654,children,0,1
219655,poor,0,1
219656,equilibrium,0,0
219657,is,0,0
219658,not,0,0
219659,compensated,0,0
219660,by,0,0
219661,vision,0,0
219662,.,0,0
219663,The,0,0
219664,clinical,0,0
219665,recovery,0,0
219666,with,0,1
219667,respect,0,0
219668,to,0,0
219669,the,0,0
219670,times,0,0
219671,to,0,0
219672,eye,0,0
219673,opening,0,0
219674,",",0,0
219675,to,0,0
219676,responding,0,0
219677,to,0,0
219678,command,0,0
219679,or,0,0
219680,to,0,0
219681,being,0,0
219682,fully,0,0
219683,awake,0,0
219684,did,0,0
219685,not,0,0
219686,differ,0,0
219687,between,0,0
219688,the,0,0
219689,two,0,0
219690,anaesthesia,0,1
219691,methods,0,1
219692,.,0,1
219693,On,0,0
219694,the,0,0
219695,basis,0,0
219696,of,0,0
219697,recovery,0,0
219698,assessed,0,0
219699,by,0,0
219700,postural,0,0
219701,stability,0,0
219702,",",0,0
219703,propofol/alfentanil/N2O,0,0
219704,anaesthesia,0,0
219705,was,0,0
219706,not,0,0
219707,preferable,0,0
219708,to,0,0
219709,thiopentone/halothane/N2O,0,0
219710,anaesthesia,0,1
219711,after,0,0
219712,minor,0,0
219713,paediatric,0,1
219714,otolaryngological,0,1
219715,surgery,0,1
219716,.,0,1
219717,Cefprozil,0,0
219718,versus,0,0
219719,penicillin,0,0
219720,V,0,0
219721,in,0,0
219722,treatment,0,0
219723,of,0,0
219724,streptococcal,1,1
219725,tonsillopharyngitis,1,1
219726,.,1,0
219727,In,0,0
219728,a,0,0
219729,randomized,0,0
219730,multicenter,0,0
219731,study,0,0
219732,",",0,0
219733,the,0,0
219734,efficacy,0,0
219735,and,0,0
219736,safety,0,0
219737,of,0,0
219738,cefprozil,0,0
219739,were,0,0
219740,compared,0,0
219741,with,0,1
219742,those,0,0
219743,of,0,0
219744,penicillin,0,0
219745,in,0,0
219746,the,0,0
219747,treatment,0,0
219748,of,0,0
219749,group,1,0
219750,A,1,1
219751,streptococcal,1,1
219752,tonsillopharyngitis,1,1
219753,in,1,0
219754,children,1,1
219755,.,1,1
219756,Of,1,0
219757,the,1,0
219758,409,1,1
219759,patients,1,1
219760,enrolled,1,1
219761,",",1,0
219762,323,1,1
219763,were,1,0
219764,evaluable,1,1
219765,for,1,0
219766,their,1,0
219767,clinical,1,0
219768,and,1,0
219769,bacteriological,1,0
219770,responses,1,0
219771,;,1,1
219772,of,0,0
219773,these,0,0
219774,323,1,1
219775,children,1,1
219776,",",0,1
219777,172,0,1
219778,received,0,0
219779,cefprozil,0,0
219780,and,0,0
219781,151,0,1
219782,received,0,0
219783,penicillin,0,0
219784,V.,0,0
219785,The,0,0
219786,clinical,0,0
219787,responses,0,0
219788,in,0,1
219789,patients,0,1
219790,treated,0,1
219791,with,0,1
219792,cefprozil,0,0
219793,were,0,0
219794,significantly,0,0
219795,better,0,0
219796,than,0,0
219797,those,0,0
219798,in,0,1
219799,patients,0,1
219800,who,0,1
219801,received,0,1
219802,penicillin,0,1
219803,(,0,0
219804,95.3,0,0
219805,versus,0,0
219806,88.1,0,0
219807,%,0,0
219808,;,0,1
219809,P,0,0
219810,=,0,0
219811,0.023,0,0
219812,),0,0
219813,.,0,0
219814,Eradication,0,0
219815,of,0,0
219816,the,0,0
219817,original,0,0
219818,serotype,0,0
219819,of,0,0
219820,group,0,0
219821,A,0,1
219822,streptococci,0,1
219823,was,0,0
219824,achieved,0,0
219825,in,0,0
219826,91.3,0,0
219827,%,0,0
219828,of,0,0
219829,patients,0,1
219830,treated,0,1
219831,with,0,1
219832,cefprozil,0,0
219833,and,0,0
219834,87.4,0,0
219835,%,0,0
219836,of,0,0
219837,patients,0,1
219838,treated,0,1
219839,with,0,1
219840,penicillin,0,0
219841,",",0,0
219842,the,0,0
219843,difference,0,0
219844,not,0,0
219845,being,0,0
219846,statistically,0,0
219847,significant,0,0
219848,(,0,0
219849,P,0,0
219850,=,0,0
219851,0.125,0,0
219852,),0,0
219853,.,0,0
219854,However,0,0
219855,",",0,0
219856,there,0,0
219857,were,0,0
219858,significantly,0,0
219859,more,0,0
219860,symptomatic,0,0
219861,patients,0,1
219862,among,0,1
219863,the,0,0
219864,bacteriological,0,0
219865,failures,0,0
219866,in,0,0
219867,the,0,0
219868,penicillin,0,0
219869,group,0,0
219870,(,0,0
219871,68.4,0,0
219872,%,0,0
219873,),0,0
219874,than,0,0
219875,in,0,0
219876,the,0,0
219877,cefprozil,0,0
219878,group,0,0
219879,(,0,0
219880,26.7,0,0
219881,%,0,0
219882,),0,0
219883,.,0,1
219884,beta-Lactamase-producing,0,0
219885,Staphylococcus,0,0
219886,aureus,0,0
219887,was,0,0
219888,more,0,0
219889,frequently,0,0
219890,isolated,0,0
219891,from,0,0
219892,the,0,0
219893,throat,0,1
219894,flora,0,0
219895,during,0,0
219896,penicillin,0,0
219897,therapy,0,0
219898,than,0,0
219899,during,0,0
219900,cefprozil,0,0
219901,treatment,0,0
219902,.,0,0
219903,No,0,0
219904,difference,0,0
219905,in,0,0
219906,the,0,0
219907,incidence,0,0
219908,of,0,0
219909,adverse,0,0
219910,events,0,0
219911,probably,0,0
219912,related,0,0
219913,or,0,0
219914,of,0,0
219915,unknown,0,0
219916,relationship,0,0
219917,to,0,0
219918,the,0,0
219919,study,0,0
219920,drugs,0,0
219921,was,0,0
219922,observed,0,0
219923,in,0,0
219924,the,0,0
219925,two,0,0
219926,treatment,0,0
219927,groups,0,0
219928,(,0,1
219929,5.2,0,0
219930,%,0,0
219931,of,0,0
219932,those,0,0
219933,treated,0,0
219934,with,0,0
219935,cefprozil,0,0
219936,and,0,0
219937,6.0,0,0
219938,%,0,0
219939,of,0,0
219940,those,0,0
219941,treated,0,0
219942,with,0,1
219943,penicillin,0,1
219944,),0,0
219945,.,0,0
219946,Cefprozil,0,0
219947,can,0,0
219948,be,0,0
219949,considered,0,0
219950,a,0,0
219951,safe,0,0
219952,and,0,0
219953,reliable,0,0
219954,drug,0,0
219955,for,0,0
219956,the,0,0
219957,treatment,0,0
219958,of,0,0
219959,streptococcal,1,1
219960,pharyngitis,1,1
219961,in,1,0
219962,children,1,1
219963,.,1,1
219964,Increased,0,0
219965,blood,0,0
219966,pressure,0,0
219967,and,0,0
219968,neural,0,0
219969,tone,0,0
219970,in,0,0
219971,the,0,0
219972,silent,0,0
219973,ischemia,0,1
219974,of,0,0
219975,hypertension,0,1
219976,:,0,1
219977,disparate,0,0
219978,effects,0,0
219979,of,0,0
219980,immediate,0,0
219981,release,0,0
219982,nifedipine,0,0
219983,.,0,0
219984,OBJECTIVES,0,0
219985,The,0,0
219986,aims,0,0
219987,of,0,0
219988,this,0,0
219989,study,0,0
219990,were,0,0
219991,1,0,0
219992,),0,0
219993,to,0,0
219994,evaluate,0,0
219995,the,0,0
219996,role,0,0
219997,of,0,0
219998,blood,0,0
219999,pressure,0,0
220000,and,0,0
220001,associated,0,0
220002,neural,0,0
220003,tonicity,0,0
220004,in,0,0
220005,ambient,0,0
220006,ischemia,0,1
220007,of,0,0
220008,a,0,0
220009,group,0,0
220010,of,0,0
220011,hypertensive,1,1
220012,patients,1,1
220013,with,1,1
220014,stable,1,1
220015,angina,1,1
220016,",",0,0
220017,and,0,0
220018,2,0,0
220019,),0,0
220020,to,0,0
220021,determine,0,0
220022,the,0,0
220023,efficacy,0,0
220024,of,0,0
220025,immediate,0,0
220026,release,0,0
220027,nifedipine,0,0
220028,therapy,0,0
220029,in,0,0
220030,controlling,0,0
220031,the,0,0
220032,total,0,1
220033,ischemic,0,1
220034,burden,0,0
220035,in,0,0
220036,both,0,0
220037,office-measured,0,0
220038,and,0,0
220039,ambulatory,0,1
220040,blood,0,0
220041,pressure,0,0
220042,.,0,1
220043,BACKGROUND,0,0
220044,Low,0,1
220045,heart,0,1
220046,rate,0,0
220047,ischemia,0,0
220048,",",0,0
220049,as,0,0
220050,detected,0,0
220051,by,0,0
220052,Holter,0,1
220053,ambulatory,0,1
220054,electrocardiographic,0,0
220055,monitoring,0,0
220056,",",0,0
220057,suggests,0,0
220058,that,0,0
220059,reduced,0,0
220060,coronary,0,1
220061,flow,0,0
220062,is,0,0
220063,the,0,0
220064,major,0,0
220065,factor,0,0
220066,leading,0,0
220067,to,0,0
220068,ischemia,0,1
220069,.,0,0
220070,We,0,0
220071,previously,0,0
220072,found,0,0
220073,that,0,0
220074,91,0,1
220075,%,0,0
220076,of,0,0
220077,the,0,0
220078,ischemic,0,1
220079,episodes,0,0
220080,in,0,0
220081,our,0,0
220082,hypertensive,1,1
220083,patients,1,1
220084,with,1,1
220085,stable,1,1
220086,angina,1,1
220087,were,0,1
220088,silent,0,1
220089,.,0,1
220090,METHODS,0,0
220091,We,0,0
220092,measured,0,0
220093,plasma,0,0
220094,norepinephrine,0,0
220095,content,0,0
220096,during,0,0
220097,ischemic,0,1
220098,events,0,0
220099,from,0,1
220100,blood,0,0
220101,obtained,0,0
220102,from,0,0
220103,automatic,0,0
220104,pump,0,0
220105,withdrawal,0,0
220106,with,0,1
220107,the,0,0
220108,assistance,0,0
220109,of,0,0
220110,a,0,0
220111,real-time,0,0
220112,ST,0,1
220113,segment,0,0
220114,depression,0,1
220115,monitor,0,0
220116,.,0,0
220117,We,0,0
220118,then,0,0
220119,related,0,0
220120,the,0,0
220121,norepinephrine,0,0
220122,content,0,0
220123,to,0,0
220124,ischemic,0,1
220125,episodes,0,0
220126,assessed,0,0
220127,by,0,0
220128,48-h,0,0
220129,Holter,0,1
220130,recording,0,0
220131,",",0,0
220132,blood,0,0
220133,pressure,0,0
220134,reading,0,0
220135,by,0,0
220136,ambulatory,0,0
220137,blood,0,0
220138,pressure,0,0
220139,monitoring,0,0
220140,and,0,0
220141,patients,0,1
220142,',0,1
220143,diaries,0,1
220144,.,0,1
220145,Measurements,0,0
220146,were,0,0
220147,taken,0,0
220148,during,0,0
220149,the,0,0
220150,placebo,0,0
220151,period,0,0
220152,and,0,0
220153,immediate-release,0,0
220154,nifedipine,0,0
220155,therapy,0,0
220156,in,0,0
220157,30,1,1
220158,hypertensive,1,1
220159,patients,1,1
220160,(,1,1
220161,20,1,1
220162,with,1,1
220163,and,1,0
220164,10,1,1
220165,without,1,1
220166,stable,1,1
220167,angina,1,1
220168,),1,0
220169,.,1,0
220170,RESULTS,0,0
220171,More,0,1
220172,than,0,0
220173,half,0,1
220174,of,0,0
220175,the,0,0
220176,patients,0,1
220177,had,0,1
220178,ischemic,0,1
220179,episodes,0,1
220180,;,0,1
220181,95,0,0
220182,%,0,0
220183,of,0,0
220184,these,0,0
220185,were,0,0
220186,silent,0,0
220187,.,0,0
220188,Ischemic,0,1
220189,episodes,0,0
220190,peaked,0,0
220191,in,0,0
220192,the,0,0
220193,early,0,0
220194,morning,0,0
220195,",",0,0
220196,and,0,0
220197,55,0,1
220198,%,0,0
220199,occurred,0,0
220200,during,0,0
220201,routine,0,1
220202,sedentary,0,1
220203,activities,0,0
220204,.,0,0
220205,There,0,0
220206,was,0,0
220207,a,0,0
220208,10,0,0
220209,%,0,0
220210,to,0,0
220211,15,0,0
220212,%,0,0
220213,increase,0,0
220214,in,0,0
220215,heart,0,1
220216,rate,0,0
220217,at,0,0
220218,the,0,0
220219,onset,0,0
220220,of,0,0
220221,ischemia,0,1
220222,associated,0,0
220223,with,0,1
220224,a,0,0
220225,30,0,0
220226,%,0,0
220227,higher,0,0
220228,plasma,0,0
220229,norepinephrine,0,0
220230,level,0,0
220231,.,0,1
220232,Seventy-five,0,1
220233,percent,0,0
220234,of,0,0
220235,patients,0,1
220236,had,0,1
220237,increased,0,0
220238,norepinephrine,0,0
220239,after,0,0
220240,nifedipine,0,0
220241,therapy,0,0
220242,.,0,1
220243,Nifedipine,0,0
220244,therapy,0,0
220245,controlled,0,0
220246,measured,0,0
220247,blood,0,0
220248,pressure,0,0
220249,but,0,0
220250,not,0,0
220251,24-h,0,0
220252,ambulatory,0,0
220253,blood,0,0
220254,pressure,0,0
220255,.,0,1
220256,Ischemic,0,1
220257,episodes,0,0
220258,were,0,0
220259,reduced,0,0
220260,only,0,0
220261,in,0,0
220262,patients,0,1
220263,whose,0,1
220264,ambulatory,0,1
220265,blood,0,0
220266,pressure,0,0
220267,was,0,0
220268,controlled,0,0
220269,.,0,0
220270,CONCLUSIONS,0,0
220271,The,0,0
220272,results,0,0
220273,suggest,0,0
220274,that,0,0
220275,increased,0,0
220276,neural,0,0
220277,tone,0,0
220278,at,0,0
220279,the,0,0
220280,time,0,0
220281,of,0,0
220282,the,0,0
220283,ischemic,0,1
220284,event,0,0
220285,may,0,0
220286,play,0,0
220287,a,0,0
220288,role,0,0
220289,in,0,0
220290,reducing,0,0
220291,coronary,0,1
220292,perfusion,0,0
220293,leading,0,0
220294,to,0,0
220295,silent,0,0
220296,ischemia,0,1
220297,.,0,1
220298,Nifedipine,0,0
220299,therapy,0,0
220300,(,0,0
220301,immediate,0,0
220302,release,0,0
220303,),0,0
220304,was,0,0
220305,effective,0,0
220306,in,0,0
220307,control,0,0
220308,of,0,0
220309,ischemia,0,0
220310,only,0,0
220311,when,0,0
220312,both,0,0
220313,ambulatory,0,0
220314,and,0,0
220315,office-measured,0,0
220316,blood,0,0
220317,pressure,0,0
220318,were,0,0
220319,controlled,0,0
220320,.,0,1
220321,Comparison,0,0
220322,of,0,0
220323,outcome,0,0
220324,of,0,0
220325,labetalol,1,0
220326,or,1,1
220327,hydralazine,1,0
220328,therapy,1,0
220329,during,1,0
220330,hypertension,1,1
220331,in,1,0
220332,pregnancy,1,0
220333,in,1,0
220334,very,1,0
220335,low,1,0
220336,birth,1,1
220337,weight,1,1
220338,infants,1,1
220339,.,1,1
220340,Ninety-seven,1,1
220341,women,1,1
220342,with,1,1
220343,moderate,1,1
220344,to,1,0
220345,severe,1,1
220346,preeclampsia,1,1
220347,(,1,0
220348,PE,1,1
220349,),1,0
220350,were,0,0
220351,allocated,0,1
220352,at,0,0
220353,random,0,1
220354,to,0,0
220355,labetalol,0,0
220356,or,0,0
220357,hydralazine,0,0
220358,treatment,0,0
220359,.,0,0
220360,Of,0,0
220361,these,0,0
220362,",",0,0
220363,22,1,1
220364,women,1,1
220365,with,1,1
220366,severe,1,1
220367,PE,1,1
220368,gave,1,0
220369,birth,1,1
220370,to,1,0
220371,neonates,1,1
220372,with,1,1
220373,VLBW,1,1
220374,(,1,0
220375,very,1,0
220376,low,1,0
220377,birth,1,1
220378,weight,1,0
220379,<,1,0
220380,or,1,1
220381,=,1,0
220382,1500,1,1
220383,g,1,1
220384,),1,1
220385,.,1,0
220386,Seven,1,0
220387,were,1,0
220388,allocated,1,0
220389,to,1,0
220390,labetalol,1,0
220391,treatment,1,0
220392,(,1,0
220393,Group,1,1
220394,A,1,1
220395,),1,0
220396,",",1,0
220397,eight,1,1
220398,to,1,0
220399,hydralazine,1,0
220400,treatment,1,0
220401,(,1,0
220402,Group,1,1
220403,B,1,1
220404,),1,0
220405,and,0,0
220406,seven,1,1
220407,women,1,1
220408,received,1,1
220409,both,1,0
220410,drugs,1,0
220411,due,1,0
220412,to,1,1
220413,poor,1,1
220414,blood,1,0
220415,pressure,1,0
220416,control,1,0
220417,with,1,1
220418,a,1,0
220419,single,1,0
220420,drug,1,0
220421,therapy,1,0
220422,(,0,0
220423,Group,0,1
220424,C,0,0
220425,),0,0
220426,.,0,0
220427,No,0,0
220428,difference,0,0
220429,in,0,0
220430,cesarean,0,1
220431,section,0,1
220432,rate,0,0
220433,or,0,0
220434,in,0,0
220435,the,0,0
220436,indication,0,0
220437,for,0,0
220438,operative,0,0
220439,delivery,0,0
220440,could,0,0
220441,be,0,0
220442,seen,0,0
220443,.,0,0
220444,Gestational,1,0
220445,age,1,1
220446,was,1,0
220447,29.9,1,0
220448,weeks,1,0
220449,(,1,1
220450,25.4-32.5,1,0
220451,),1,0
220452,in,0,0
220453,Group,0,1
220454,A,0,1
220455,",",0,0
220456,28.6,1,0
220457,weeks,1,0
220458,(,1,1
220459,26.6-33.4,1,1
220460,),1,0
220461,in,0,0
220462,Group,0,1
220463,B,0,1
220464,and,0,1
220465,27.3,1,0
220466,weeks,1,0
220467,(,1,1
220468,26.7-31.1,1,0
220469,),1,0
220470,in,0,0
220471,Group,0,1
220472,C,0,0
220473,(,0,0
220474,median,0,0
220475,and,0,0
220476,range,0,1
220477,),0,0
220478,.,0,1
220479,Birth,0,0
220480,weight,0,0
220481,did,0,0
220482,not,0,0
220483,differ,0,0
220484,between,0,0
220485,groups,0,0
220486,and,0,1
220487,13,1,1
220488,of,1,0
220489,the,1,0
220490,22,1,1
220491,infants,1,1
220492,weighed,1,1
220493,below,1,0
220494,1000,1,0
220495,g.,1,0
220496,There,0,0
220497,was,0,0
220498,a,0,0
220499,tendency,0,0
220500,to,0,0
220501,lower,0,0
220502,Apgar,0,0
220503,scores,0,0
220504,at,0,1
220505,five,0,1
220506,minutes,0,0
220507,in,0,0
220508,the,0,0
220509,hydralazine,0,0
220510,group,0,0
220511,.,0,0
220512,Time,0,0
220513,spent,0,0
220514,in,0,0
220515,the,0,0
220516,neonatal,0,1
220517,intensive,0,0
220518,care,0,1
220519,unit,0,0
220520,did,0,0
220521,not,0,0
220522,differ,0,0
220523,between,0,0
220524,groups,0,0
220525,.,0,1
220526,Five,0,0
220527,of,0,0
220528,the,0,0
220529,11,0,0
220530,neonates,1,1
220531,with,0,1
220532,gestational,0,1
220533,age,0,1
220534,(,0,0
220535,GA,0,1
220536,),0,0
220537,<,0,0
220538,or,0,1
220539,=,0,0
220540,28,0,1
220541,weeks,0,0
220542,and,0,1
220543,three,0,0
220544,of,0,0
220545,the,0,0
220546,seven,0,1
220547,neonates,1,1
220548,in,0,1
220549,GA,0,1
220550,29-30,0,1
220551,weeks,0,0
220552,died,0,1
220553,.,0,1
220554,Neither,0,0
220555,the,0,0
220556,number,0,0
220557,of,0,0
220558,infants,1,1
220559,requiring,0,1
220560,intermittent,0,1
220561,positive,0,0
220562,pressure,0,0
220563,ventilation,0,0
220564,or,0,0
220565,duration,0,0
220566,of,0,0
220567,O2-,0,1
220568,treatment,0,0
220569,",",0,0
220570,nor,0,0
220571,number,0,0
220572,of,0,0
220573,infants,0,1
220574,with,0,1
220575,respiratory,0,1
220576,distress,0,1
220577,syndrome,0,1
220578,differed,0,0
220579,between,0,0
220580,groups,0,0
220581,.,0,1
220582,We,0,0
220583,did,0,0
220584,not,0,0
220585,find,0,0
220586,any,0,0
220587,difference,0,0
220588,in,0,0
220589,the,0,0
220590,outcome,0,0
220591,of,0,0
220592,the,0,0
220593,VLBW,1,1
220594,infants,1,1
220595,when,1,0
220596,the,1,0
220597,hypertensive,1,1
220598,mother,1,0
220599,had,1,0
220600,been,1,0
220601,treated,1,1
220602,with,1,1
220603,either,1,0
220604,hydralazine,1,0
220605,or,1,0
220606,labetalol,1,0
220607,.,1,1
220608,Deficiency,0,0
220609,of,0,0
220610,serum,0,0
220611,ionized,0,0
220612,magnesium,0,0
220613,in,0,0
220614,patients,1,1
220615,receiving,1,1
220616,hemodialysis,1,1
220617,or,1,1
220618,peritoneal,1,1
220619,dialysis,1,1
220620,.,1,1
220621,Serum,0,0
220622,total,0,1
220623,magnesium,0,0
220624,(,0,0
220625,TMg,0,0
220626,),0,1
220627,measurements,0,0
220628,in,0,0
220629,dialysis,1,1
220630,patients,1,1
220631,are,0,0
220632,variable,0,0
220633,",",0,0
220634,with,0,1
220635,some,0,0
220636,groups,0,0
220637,reporting,0,0
220638,hypermagnesemia,0,1
220639,and,0,0
220640,some,0,0
220641,hypomagnesemia,0,0
220642,.,0,0
220643,It,0,0
220644,had,0,0
220645,not,0,0
220646,been,0,0
220647,possible,0,0
220648,to,0,0
220649,measure,0,0
220650,the,0,0
220651,biologically,0,0
220652,active,0,0
220653,fraction,0,0
220654,",",0,0
220655,ionized,0,0
220656,magnesium,0,0
220657,(,0,0
220658,IMg2+,0,0
220659,),0,0
220660,.,0,0
220661,The,0,0
220662,authors,0,0
220663,utilized,0,0
220664,an,0,0
220665,ion-selective,0,0
220666,electrode,0,0
220667,to,0,0
220668,measure,0,0
220669,IMg,0,0
220670,in,0,0
220671,26,1,1
220672,hemodialysis,1,1
220673,patients,1,1
220674,and,1,1
220675,10,1,1
220676,peritoneal,1,1
220677,dialysis,1,1
220678,(,1,0
220679,CAPD,1,0
220680,),1,1
220681,patients,1,1
220682,and,1,0
220683,compared,1,0
220684,the,1,0
220685,results,1,0
220686,with,1,1
220687,those,1,1
220688,from,1,0
220689,66,1,1
220690,age,1,1
220691,matched,1,1
220692,control,1,1
220693,subjects,1,1
220694,.,1,1
220695,Dialysate,0,0
220696,magnesium,0,0
220697,was,0,0
220698,0.375,0,0
220699,mM/L,0,0
220700,for,0,0
220701,the,0,0
220702,hemodialysis,0,1
220703,and,0,0
220704,0.25,0,0
220705,mM/L,0,0
220706,for,0,0
220707,the,0,0
220708,CAPD,0,0
220709,patients,0,1
220710,.,0,0
220711,When,0,0
220712,compared,0,0
220713,with,0,0
220714,control,0,0
220715,subjects,0,1
220716,",",0,0
220717,both,0,0
220718,hemodialysis,0,0
220719,and,0,0
220720,CAPD,0,0
220721,patients,0,1
220722,had,0,1
220723,significantly,0,0
220724,lower,0,0
220725,IMg2+,0,0
220726,(,0,0
220727,0.55,0,0
220728,+/-,0,0
220729,0.02,0,0
220730,and,0,1
220731,0.50,0,0
220732,+/-,0,0
220733,0.02,0,0
220734,vs.,0,0
220735,0.60,0,0
220736,+/-,0,0
220737,0.004,0,0
220738,mM/L,0,1
220739,;,0,0
220740,p,0,0
220741,<,0,0
220742,0.05,0,0
220743,),0,0
220744,and,0,0
220745,greater,0,0
220746,or,0,1
220747,normal,0,1
220748,TMg,0,0
220749,values,0,0
220750,(,0,1
220751,0.99,0,0
220752,+/-,0,0
220753,0.04,0,0
220754,",",0,0
220755,different,0,0
220756,at,0,0
220757,the,0,0
220758,p,0,0
220759,<,0,0
220760,0.001,0,0
220761,level,0,0
220762,",",0,0
220763,and,0,0
220764,0.85,0,0
220765,+/-,0,0
220766,0.04,0,0
220767,vs.,0,0
220768,0.84,0,0
220769,+/-,0,0
220770,0.008,0,0
220771,),0,1
220772,.,0,0
220773,Ionized,0,0
220774,calcium,0,0
220775,(,0,0
220776,ICa2+,0,1
220777,),0,1
220778,values,0,0
220779,were,0,1
220780,similar,0,0
220781,for,0,0
220782,all,0,1
220783,three,1,0
220784,groups,1,0
220785,(,0,1
220786,1.15,0,0
220787,+/-,0,0
220788,0.02,0,0
220789,and,0,1
220790,1.21,0,0
220791,+/-,0,0
220792,0.04,0,0
220793,vs.,0,0
220794,1.17,0,0
220795,+/-,0,0
220796,0.01,0,0
220797,),0,0
220798,",",0,0
220799,resulting,0,0
220800,in,0,0
220801,increased,0,0
220802,mean,0,1
220803,ICa2+/IMg2+,0,0
220804,ratios,0,0
220805,(,0,1
220806,2.14,0,0
220807,+/-,0,0
220808,0.07,0,0
220809,and,0,1
220810,2.42,0,0
220811,+/-,0,0
220812,0.06,0,0
220813,vs.,0,0
220814,1.95,0,0
220815,+/-,0,0
220816,0.02,0,0
220817,for,0,0
220818,the,0,0
220819,control,0,0
220820,subjects,0,1
220821,;,0,0
220822,p,0,0
220823,<,0,0
220824,0.05,0,0
220825,),0,0
220826,.,0,0
220827,The,0,0
220828,percent,0,0
220829,of,0,0
220830,total,0,1
220831,magnesium,0,0
220832,that,0,0
220833,was,0,0
220834,ionized,0,0
220835,(,0,0
220836,%,0,0
220837,IMg2+,0,0
220838,),0,0
220839,was,0,0
220840,low,0,0
220841,in,0,0
220842,both,0,0
220843,the,0,0
220844,hemodialysis,0,0
220845,and,0,0
220846,CAPD,0,0
220847,patients,0,1
220848,(,0,1
220849,55.6,0,0
220850,+/-,0,0
220851,0.93,0,0
220852,and,0,1
220853,59.2,0,1
220854,+/-,0,0
220855,1.05,0,0
220856,),0,0
220857,compared,0,0
220858,with,0,1
220859,that,0,0
220860,of,0,0
220861,control,0,0
220862,subjects,0,1
220863,(,0,1
220864,72,0,1
220865,+/-,0,0
220866,0.61,0,0
220867,;,0,0
220868,p,0,0
220869,<,0,0
220870,0.05,0,0
220871,),0,0
220872,.,0,1
220873,IMg2+,0,0
220874,values,0,0
220875,correlated,0,0
220876,with,0,1
220877,TMg,0,0
220878,values,0,0
220879,in,0,0
220880,both,0,0
220881,hemodialysis,0,1
220882,(,0,0
220883,r,0,0
220884,=,0,0
220885,0.93,0,0
220886,;,0,0
220887,p,0,0
220888,<,0,0
220889,0.0001,0,0
220890,),0,0
220891,and,0,0
220892,CAPD,0,0
220893,(,0,0
220894,r,0,0
220895,=,0,0
220896,0.92,0,0
220897,;,0,0
220898,p,0,0
220899,<,0,0
220900,0.0001,0,0
220901,),0,0
220902,patients,0,1
220903,did,0,0
220904,not,0,0
220905,correlate,0,0
220906,with,0,0
220907,age,0,1
220908,",",0,0
220909,time,0,0
220910,on,0,0
220911,dialysis,0,0
220912,",",0,0
220913,weight,0,0
220914,",",0,0
220915,fasting,0,0
220916,cholesterol,0,0
220917,or,0,0
220918,triglyceride,0,0
220919,",",0,0
220920,albumin,0,0
220921,",",0,0
220922,blood,0,0
220923,urea,0,0
220924,nitrogen,0,0
220925,(,0,0
220926,BUN,0,0
220927,),0,0
220928,",",0,0
220929,creatinine,0,0
220930,",",0,0
220931,hematocrit,0,0
220932,",",0,0
220933,phosphate,0,0
220934,",",0,0
220935,or,0,1
220936,PTH,0,0
220937,values,0,0
220938,.,0,1
220939,(,0,0
220940,ABSTRACT,0,0
220941,TRUNCATED,0,1
220942,AT,0,1
220943,250,0,0
220944,WORDS,0,1
220945,),0,1
220946,Ovulation,0,0
220947,and,0,0
220948,follicular,0,1
220949,development,0,0
220950,associated,0,0
220951,with,0,1
220952,three,0,0
220953,low-dose,0,0
220954,oral,0,1
220955,contraceptives,0,1
220956,:,0,1
220957,a,0,0
220958,randomized,0,0
220959,controlled,0,0
220960,trial,0,0
220961,.,0,0
220962,OBJECTIVE,0,0
220963,To,0,0
220964,address,0,0
220965,the,0,0
220966,hypothesis,0,0
220967,that,0,0
220968,multiphasic,0,1
220969,oral,0,0
220970,contraceptives,0,1
220971,(,0,1
220972,OCs,0,0
220973,),0,0
220974,increase,0,0
220975,rather,0,0
220976,than,0,0
220977,decrease,0,0
220978,the,0,0
220979,risk,0,0
220980,of,0,0
220981,functional,0,1
220982,ovarian,0,1
220983,cysts,0,1
220984,.,0,1
220985,METHODS,0,0
220986,In,0,0
220987,this,0,0
220988,single-center,0,1
220989,",",0,0
220990,randomized,0,0
220991,controlled,0,0
220992,study,0,0
220993,",",0,0
220994,women,1,1
220995,were,0,0
220996,assigned,0,1
220997,to,0,0
220998,a,0,0
220999,multiphasic,0,0
221000,pill,0,0
221001,",",0,0
221002,a,0,0
221003,lower-dose,0,0
221004,monophasic,0,0
221005,pill,0,0
221006,",",0,0
221007,a,0,0
221008,higher-dose,0,0
221009,monophasic,0,0
221010,pill,0,0
221011,",",0,0
221012,or,0,0
221013,nonsteroidal,0,0
221014,contraception,0,1
221015,.,0,1
221016,Forty,1,1
221017,volunteers,1,1
221018,were,1,1
221019,randomized,1,1
221020,(,1,0
221021,ten,1,1
221022,each,1,0
221023,),1,0
221024,to,1,0
221025,three,1,0
221026,different,1,0
221027,pill,1,0
221028,regimens,1,0
221029,or,1,0
221030,to,1,0
221031,nonsteroidal,1,0
221032,contraception,1,1
221033,.,1,0
221034,During,0,0
221035,6,0,0
221036,months,0,0
221037,of,0,0
221038,treatment,0,0
221039,",",0,0
221040,follicular,0,1
221041,development,0,0
221042,was,0,0
221043,measured,0,0
221044,by,0,0
221045,vaginal,0,1
221046,ultrasonography,0,0
221047,and,0,0
221048,ovulation,0,0
221049,was,0,0
221050,indicated,0,0
221051,by,0,0
221052,serum,0,0
221053,progesterone,0,1
221054,levels,0,0
221055,.,0,0
221056,RESULTS,0,0
221057,The,0,0
221058,relative,0,0
221059,risk,0,0
221060,(,0,0
221061,RR,0,0
221062,),0,0
221063,of,0,0
221064,developing,0,0
221065,a,0,0
221066,follicular,0,1
221067,structure,0,0
221068,greater,0,0
221069,than,0,0
221070,30,0,0
221071,mm,0,0
221072,in,0,0
221073,diameter,0,0
221074,during,0,0
221075,a,0,0
221076,cycle,0,0
221077,with,0,0
221078,the,0,0
221079,higher-dose,0,0
221080,monophasic,0,0
221081,pill,0,0
221082,was,0,0
221083,0.5,0,0
221084,(,0,0
221085,95,0,0
221086,%,0,0
221087,confidence,0,0
221088,interval,0,0
221089,[,0,0
221090,CI,0,0
221091,],0,1
221092,0.1-1.9,0,0
221093,;,0,0
221094,P,0,0
221095,=,0,0
221096,.49,0,0
221097,),0,0
221098,compared,0,0
221099,with,0,1
221100,the,0,0
221101,multiphasic,0,0
221102,pill,0,0
221103,.,0,0
221104,The,0,0
221105,risk,0,0
221106,with,0,0
221107,the,0,0
221108,lower-dose,0,0
221109,monophasic,0,0
221110,pill,0,0
221111,was,0,0
221112,comparable,0,0
221113,to,0,0
221114,that,0,0
221115,with,0,0
221116,the,0,0
221117,multiphasic,0,0
221118,pill,0,0
221119,(,0,0
221120,RR,0,0
221121,1.3,0,0
221122,",",0,0
221123,95,0,0
221124,%,0,0
221125,CI,0,0
221126,0.5-3.6,0,0
221127,;,0,1
221128,P,0,0
221129,=,0,0
221130,.56,0,0
221131,),0,0
221132,.,0,0
221133,With,0,0
221134,the,0,0
221135,multiphasic,0,0
221136,pill,0,0
221137,",",0,0
221138,the,0,0
221139,maximum,0,0
221140,ovulation,0,0
221141,rate,0,0
221142,over,0,0
221143,60,0,1
221144,cycles,0,0
221145,was,0,0
221146,1.7,0,0
221147,per,0,1
221148,100,0,1
221149,cycles,0,0
221150,(,0,1
221151,95,0,0
221152,%,0,0
221153,CI,0,0
221154,0.0-8.9,0,0
221155,),0,0
221156,.,0,0
221157,CONCLUSION,0,0
221158,This,0,0
221159,multiphasic,0,0
221160,pill,0,0
221161,more,0,0
221162,closely,0,0
221163,resembled,0,0
221164,the,0,0
221165,lower-dose,0,0
221166,monophasic,0,0
221167,pill,0,0
221168,than,0,0
221169,the,0,0
221170,higher-dose,0,0
221171,monophasic,0,0
221172,pill,0,0
221173,in,0,0
221174,its,0,0
221175,suppression,0,0
221176,of,0,0
221177,follicular,0,1
221178,development,0,0
221179,.,0,1
221180,A,0,0
221181,multicenter,0,0
221182,study,0,0
221183,on,0,0
221184,the,0,0
221185,use,0,0
221186,of,0,0
221187,pulsed,0,0
221188,low-intensity,0,0
221189,direct,0,0
221190,current,0,0
221191,for,0,0
221192,healing,0,0
221193,chronic,1,1
221194,stage,1,1
221195,II,1,1
221196,and,1,0
221197,stage,1,1
221198,III,1,1
221199,decubitus,1,0
221200,ulcers,1,1
221201,.,1,1
221202,BACKGROUND,0,0
221203,AND,0,0
221204,DESIGN,0,0
221205,Pulsed,0,0
221206,low-intensity,0,0
221207,direct,0,0
221208,current,0,0
221209,(,0,1
221210,300,0,0
221211,to,0,0
221212,600,0,1
221213,microA,0,0
221214,),0,0
221215,has,0,0
221216,been,0,0
221217,used,0,0
221218,in,0,0
221219,a,0,0
221220,double-blind,0,0
221221,placebo,0,0
221222,multicenter,0,0
221223,study,0,0
221224,in,0,0
221225,the,0,0
221226,treatment,0,0
221227,of,0,0
221228,stage,1,1
221229,II,1,1
221230,and,1,0
221231,stage,1,1
221232,III,1,1
221233,chronic,1,1
221234,decubitus,1,1
221235,ulcers,1,1
221236,.,1,1
221237,RESULTS,0,0
221238,Seventy-four,1,1
221239,ulcers,1,1
221240,were,1,1
221241,treated,1,1
221242,in,1,0
221243,four,1,1
221244,centers,1,1
221245,.,1,1
221246,Forty-three,1,1
221247,patients,1,1
221248,were,1,1
221249,selected,1,1
221250,for,1,0
221251,the,1,0
221252,experimental,1,0
221253,group,1,0
221254,",",1,0
221255,and,1,0
221256,31,1,1
221257,control,1,1
221258,subjects,1,1
221259,used,1,0
221260,the,1,0
221261,sham,1,0
221262,instrument,1,0
221263,(,1,0
221264,placebo,1,0
221265,group,1,1
221266,),1,0
221267,.,1,0
221268,In,0,0
221269,the,0,0
221270,treated,0,0
221271,group,0,0
221272,",",0,0
221273,25,0,1
221274,ulcers,0,1
221275,(,0,1
221276,58,0,1
221277,%,0,0
221278,),0,0
221279,healed,0,0
221280,in,0,0
221281,8,0,0
221282,weeks,0,0
221283,",",0,1
221284,whereas,0,0
221285,in,0,0
221286,the,0,0
221287,placebo,0,0
221288,group,0,0
221289,",",0,0
221290,only,0,0
221291,one,0,0
221292,ulcer,0,1
221293,(,0,0
221294,3,0,0
221295,%,0,0
221296,),0,0
221297,healed,0,0
221298,and,0,0
221299,most,0,0
221300,ulcers,0,1
221301,increased,0,0
221302,in,0,0
221303,size,0,0
221304,.,0,1
221305,Statistical,0,0
221306,analysis,0,0
221307,",",0,0
221308,based,0,0
221309,on,0,0
221310,surface,0,0
221311,area,0,0
221312,and,0,0
221313,ulcer,0,1
221314,depth,0,0
221315,before,0,0
221316,and,0,0
221317,after,0,0
221318,treatment,0,0
221319,",",0,0
221320,showed,0,0
221321,that,0,0
221322,low-intensity,0,0
221323,direct,0,0
221324,current,0,0
221325,had,0,1
221326,a,0,0
221327,significant,0,0
221328,influence,0,0
221329,on,0,0
221330,the,0,0
221331,healing,0,0
221332,rates,0,0
221333,for,0,0
221334,these,0,0
221335,ulcers,0,1
221336,(,0,0
221337,P,0,0
221338,<,0,0
221339,.0001,0,0
221340,),0,1
221341,.,0,1
221342,Experiments,0,0
221343,with,0,1
221344,guinea,0,1
221345,pigs,0,1
221346,(,0,1
221347,n,0,1
221348,=,0,0
221349,10,0,1
221350,),0,0
221351,showed,0,0
221352,that,0,0
221353,pulsed,0,0
221354,low-intensity,0,0
221355,direct,0,0
221356,current,0,0
221357,caused,0,0
221358,a,0,0
221359,rapid,0,0
221360,calcium,0,0
221361,flux,0,0
221362,in,0,0
221363,the,0,0
221364,epidermis,0,0
221365,.,0,0
221366,CONCLUSIONS,0,0
221367,Pulsed,0,0
221368,low-intensity,0,0
221369,direct,0,0
221370,current,0,0
221371,represents,0,0
221372,a,0,0
221373,useful,0,0
221374,approach,0,0
221375,for,0,0
221376,the,0,0
221377,treatment,0,0
221378,of,0,0
221379,stage,0,1
221380,II,0,1
221381,and,0,0
221382,stage,0,1
221383,III,0,1
221384,chronic,0,1
221385,decubitus,0,0
221386,ulcers,0,1
221387,by,0,0
221388,increasing,0,0
221389,the,0,0
221390,healing,0,0
221391,rate,0,0
221392,.,0,0
221393,The,0,0
221394,growth,0,0
221395,of,0,0
221396,fibroblasts,0,0
221397,and,0,0
221398,keratinocytes,0,0
221399,may,0,0
221400,be,0,0
221401,enhanced,0,0
221402,by,0,0
221403,pulsed,0,0
221404,low-intensity,0,0
221405,direct,0,0
221406,current,0,0
221407,due,0,1
221408,to,0,0
221409,changes,0,0
221410,in,0,0
221411,calcium,0,0
221412,homeostasis,0,0
221413,.,0,1
221414,Video,0,0
221415,rating,0,0
221416,analysis,0,0
221417,of,0,0
221418,effect,0,0
221419,of,0,0
221420,maprotiline,0,0
221421,in,0,0
221422,patients,1,1
221423,with,1,1
221424,dementia,1,1
221425,and,1,0
221426,depression,1,1
221427,.,1,0
221428,In,0,0
221429,patients,1,1
221430,with,1,1
221431,dementia,1,1
221432,and,1,0
221433,mild,1,1
221434,depression,1,1
221435,(,1,1
221436,DSM-III-R,1,0
221437,290.21,1,0
221438,),1,0
221439,",",0,0
221440,the,0,0
221441,effect,0,0
221442,of,0,0
221443,low,0,1
221444,doses,0,0
221445,of,0,0
221446,the,0,0
221447,antidepressant,0,0
221448,maprotiline,0,0
221449,(,0,0
221450,up,0,0
221451,to,0,0
221452,75,0,1
221453,mg/d,0,0
221454,),0,0
221455,was,0,0
221456,examined,0,0
221457,.,0,0
221458,The,0,0
221459,main,0,0
221460,parameter,0,0
221461,was,0,0
221462,a,0,0
221463,video,0,0
221464,rating,0,0
221465,of,0,0
221466,global,0,0
221467,impression,0,0
221468,.,0,0
221469,The,0,0
221470,Mini-Mental,0,0
221471,State,0,0
221472,Examination,0,1
221473,(,0,0
221474,MMS,0,1
221475,),0,0
221476,and,0,0
221477,the,0,0
221478,Geriatric,0,1
221479,Depression,0,0
221480,Scale,0,0
221481,(,0,0
221482,GDS,0,0
221483,),0,0
221484,were,0,0
221485,applied,0,0
221486,to,0,0
221487,evaluate,0,0
221488,the,0,0
221489,effect,0,0
221490,of,0,0
221491,maprotiline,0,0
221492,on,0,0
221493,cognitive,0,0
221494,and,0,1
221495,depressive,0,1
221496,symptoms,0,0
221497,.,0,1
221498,The,0,0
221499,double-blind,0,0
221500,",",0,0
221501,placebo-controlled,0,0
221502,trial,0,0
221503,was,0,0
221504,of,0,0
221505,eight,0,1
221506,weeks,0,0
221507,',0,1
221508,duration,0,0
221509,and,0,1
221510,included,0,1
221511,127,1,1
221512,patients,1,1
221513,",",0,0
221514,randomized,0,1
221515,in,0,0
221516,two,0,0
221517,groups,0,0
221518,.,0,1
221519,The,0,0
221520,antidepressant,0,0
221521,effect,0,0
221522,of,0,0
221523,maprotiline,0,0
221524,was,0,0
221525,reflected,0,0
221526,in,0,0
221527,the,0,0
221528,GDS,0,0
221529,.,0,0
221530,There,0,0
221531,was,0,0
221532,",",0,0
221533,however,0,0
221534,",",0,0
221535,no,0,0
221536,indication,0,0
221537,of,0,0
221538,an,0,0
221539,effect,0,0
221540,of,0,0
221541,maprotiline,0,0
221542,on,0,0
221543,cognitive,0,0
221544,performance,0,0
221545,.,0,0
221546,The,0,0
221547,global,0,0
221548,impression,0,0
221549,",",0,0
221550,evaluated,0,0
221551,by,0,0
221552,video,0,0
221553,rating,0,0
221554,",",0,0
221555,gave,0,0
221556,no,0,0
221557,indication,0,0
221558,as,0,0
221559,to,0,0
221560,a,0,0
221561,beneficial,0,0
221562,effect,0,0
221563,of,0,0
221564,the,0,0
221565,treatment,0,0
221566,.,0,0
221567,-,0,0
221568,The,0,0
221569,video,0,0
221570,analysis,0,0
221571,showed,0,0
221572,a,0,0
221573,significant,0,0
221574,interrater,0,0
221575,reliability,0,0
221576,.,0,0
221577,The,0,0
221578,discrepancy,0,0
221579,between,0,0
221580,the,0,0
221581,results,0,0
221582,of,0,0
221583,the,0,0
221584,video,0,0
221585,rating,0,0
221586,and,0,0
221587,the,0,0
221588,GDS,0,0
221589,is,0,0
221590,discussed,0,0
221591,.,0,0
221592,-,0,0
221593,The,0,0
221594,results,0,0
221595,confirm,0,0
221596,similar,0,0
221597,findings,0,0
221598,of,0,1
221599,other,0,1
221600,authors,0,0
221601,;,0,0
221602,i.e.,0,0
221603,",",0,0
221604,that,0,0
221605,a,0,0
221606,sedating,0,0
221607,antidepressant,0,0
221608,with,0,1
221609,some,0,0
221610,anticholinergic,0,0
221611,effects,0,0
221612,can,0,0
221613,not,0,0
221614,be,0,0
221615,expected,0,0
221616,to,0,0
221617,improve,0,0
221618,cognitive,0,0
221619,functions,0,0
221620,despite,0,0
221621,its,0,0
221622,antidepressant,0,0
221623,effect,0,0
221624,.,0,0
221625,The,0,0
221626,main,0,0
221627,interest,0,0
221628,of,0,0
221629,this,0,0
221630,study,0,0
221631,",",0,0
221632,however,0,0
221633,",",0,0
221634,lies,0,0
221635,in,0,0
221636,its,0,0
221637,methodology,0,0
221638,(,0,0
221639,video,0,0
221640,analysis,0,0
221641,),0,1
221642,.,0,1
221643,Radiation-induced,0,0
221644,brachial,0,1
221645,plexopathy,0,1
221646,:,0,1
221647,neurological,0,0
221648,follow-up,0,0
221649,in,0,0
221650,161,1,1
221651,recurrence-free,1,0
221652,breast,1,1
221653,cancer,1,1
221654,patients,1,1
221655,.,1,0
221656,PURPOSE,0,0
221657,The,0,0
221658,purpose,0,0
221659,was,0,0
221660,to,0,0
221661,assess,0,0
221662,the,0,0
221663,incidence,0,0
221664,and,0,0
221665,clinical,0,0
221666,manifestations,0,0
221667,of,0,1
221668,radiation-induced,0,0
221669,brachial,0,1
221670,plexopathy,0,1
221671,in,0,0
221672,breast,1,1
221673,cancer,1,1
221674,patients,1,1
221675,",",1,0
221676,treated,1,1
221677,according,1,0
221678,to,1,0
221679,the,1,0
221680,Danish,1,1
221681,Breast,1,1
221682,Cancer,1,1
221683,Cooperative,1,1
221684,Group,1,1
221685,protocols,1,0
221686,.,1,0
221687,METHODS,0,0
221688,AND,0,0
221689,MATERIALS,0,0
221690,One,1,1
221691,hundred,1,1
221692,and,1,0
221693,sixty-one,1,1
221694,recurrence-free,1,0
221695,breast,1,1
221696,cancer,1,1
221697,patients,1,1
221698,were,1,0
221699,examined,1,0
221700,for,1,0
221701,radiation-induced,1,0
221702,brachial,1,1
221703,plexopathy,1,1
221704,after,1,0
221705,a,1,0
221706,median,1,0
221707,follow-up,1,0
221708,period,1,1
221709,of,1,0
221710,50,1,1
221711,months,1,0
221712,(,1,1
221713,13-99,1,1
221714,months,1,0
221715,),1,1
221716,.,1,1
221717,After,0,0
221718,total,0,1
221719,mastectomy,0,1
221720,and,0,0
221721,axillary,0,1
221722,node,0,0
221723,sampling,0,0
221724,",",0,0
221725,high-risk,1,1
221726,patients,1,1
221727,were,0,1
221728,randomized,0,1
221729,to,0,0
221730,adjuvant,0,0
221731,therapy,0,0
221732,.,0,0
221733,One,0,1
221734,hundred,0,1
221735,twenty-eight,0,1
221736,patients,0,1
221737,were,0,1
221738,treated,0,1
221739,with,0,1
221740,postoperative,0,0
221741,radiotherapy,0,1
221742,with,0,1
221743,50,0,1
221744,Gy,0,1
221745,in,0,0
221746,25,0,1
221747,daily,0,0
221748,fractions,0,1
221749,over,0,0
221750,5,0,1
221751,weeks,0,0
221752,.,0,1
221753,In,0,0
221754,addition,0,0
221755,",",0,0
221756,82,0,1
221757,of,0,0
221758,these,0,0
221759,patients,0,1
221760,received,0,0
221761,cytotoxic,0,0
221762,therapy,0,0
221763,(,0,0
221764,cyclophosphamide,0,0
221765,",",0,0
221766,methotrexate,0,0
221767,",",0,0
221768,and,0,0
221769,5-fluorouracil,0,0
221770,),0,0
221771,and,0,0
221772,46,0,1
221773,received,0,0
221774,tamoxifen,0,1
221775,.,0,1
221776,RESULTS,0,0
221777,Five,0,0
221778,percent,0,1
221779,and,0,0
221780,9,0,0
221781,%,0,0
221782,of,0,0
221783,the,0,0
221784,patients,0,1
221785,receiving,0,1
221786,radiotherapy,0,1
221787,had,0,1
221788,disabling,0,1
221789,and,0,0
221790,mild,0,1
221791,radiation-induced,0,0
221792,brachial,0,0
221793,plexopathy,0,1
221794,",",0,0
221795,respectively,0,0
221796,.,0,0
221797,Radiation-induced,0,0
221798,brachial,0,0
221799,plexopathy,0,0
221800,was,0,0
221801,more,0,0
221802,frequent,0,0
221803,in,0,0
221804,patients,0,1
221805,receiving,0,1
221806,cytotoxic,0,0
221807,therapy,0,0
221808,(,0,0
221809,p,0,0
221810,=,0,0
221811,0.04,0,0
221812,),0,0
221813,and,0,0
221814,in,0,0
221815,younger,0,1
221816,patients,0,1
221817,(,0,0
221818,p,0,0
221819,=,0,0
221820,0.04,0,0
221821,),0,0
221822,.,0,0
221823,The,0,0
221824,clinical,0,0
221825,manifestations,0,0
221826,were,0,1
221827,paraesthesia,0,1
221828,(,0,0
221829,100,0,0
221830,%,0,0
221831,),0,0
221832,",",0,0
221833,hypaesthesia,0,0
221834,(,0,0
221835,74,0,1
221836,%,0,0
221837,),0,0
221838,",",0,0
221839,weakness,0,0
221840,(,0,0
221841,58,0,1
221842,%,0,0
221843,),0,0
221844,",",0,0
221845,decreased,0,0
221846,muscle,0,0
221847,stretch,0,0
221848,reflexes,0,0
221849,(,0,1
221850,47,0,1
221851,%,0,0
221852,),0,0
221853,",",0,0
221854,and,0,0
221855,pain,0,0
221856,(,0,0
221857,47,0,1
221858,%,0,0
221859,),0,0
221860,.,0,0
221861,CONCLUSION,0,0
221862,The,0,0
221863,brachial,0,0
221864,plexus,0,0
221865,is,0,0
221866,more,0,0
221867,vulnerable,0,0
221868,to,0,0
221869,large,0,1
221870,fraction,0,1
221871,size,0,0
221872,.,0,0
221873,Fractions,0,0
221874,of,0,0
221875,2,0,1
221876,Gy,0,1
221877,or,0,1
221878,less,0,0
221879,are,0,0
221880,advisable,0,0
221881,.,0,1
221882,Cytotoxic,0,0
221883,therapy,0,0
221884,adds,0,0
221885,to,0,0
221886,the,0,0
221887,damaging,0,0
221888,effect,0,0
221889,of,0,0
221890,radiotherapy,0,1
221891,.,0,1
221892,Peripheral,0,0
221893,nerves,0,0
221894,in,0,0
221895,younger,1,1
221896,patients,1,1
221897,seems,0,0
221898,more,0,0
221899,vulnerable,0,0
221900,.,0,0
221901,Radiation-induced,0,0
221902,brachial,0,0
221903,plexopathy,0,1
221904,occurs,0,0
221905,mainly,0,0
221906,as,0,0
221907,diffuse,0,0
221908,damage,0,0
221909,to,0,0
221910,the,0,0
221911,brachial,0,0
221912,plexus,0,1
221913,.,0,1
221914,Subcutaneous,0,1
221915,low-molecular-weight,0,0
221916,heparin,0,0
221917,compared,0,0
221918,with,0,1
221919,continuous,0,0
221920,intravenous,0,0
221921,unfractionated,0,0
221922,heparin,0,0
221923,in,0,0
221924,the,0,0
221925,treatment,0,0
221926,of,0,0
221927,proximal,1,1
221928,deep,1,0
221929,vein,1,1
221930,thrombosis,1,1
221931,.,1,0
221932,BACKGROUND,0,0
221933,A,0,0
221934,low-molecular-weight,0,0
221935,heparin,0,0
221936,",",0,0
221937,enoxaparin,0,0
221938,sodium,0,0
221939,",",0,0
221940,has,0,0
221941,been,0,0
221942,shown,0,0
221943,to,0,0
221944,be,0,0
221945,effective,0,0
221946,and,0,0
221947,safe,0,0
221948,in,0,0
221949,preventing,0,0
221950,deep,1,0
221951,vein,1,1
221952,thrombosis,1,0
221953,both,1,0
221954,in,1,0
221955,general,1,1
221956,surgery,1,1
221957,and,1,0
221958,in,1,0
221959,high-risk,1,1
221960,orthopedic,1,1
221961,surgery,1,1
221962,.,1,1
221963,We,0,0
221964,conducted,0,0
221965,a,0,0
221966,controlled,0,0
221967,",",0,0
221968,randomized,0,0
221969,trial,0,0
221970,with,0,1
221971,enoxaparin,0,0
221972,in,0,0
221973,the,0,0
221974,treatment,0,0
221975,of,0,0
221976,established,0,0
221977,deep,0,0
221978,vein,0,1
221979,thrombosis,0,1
221980,.,0,0
221981,METHODS,0,0
221982,In,0,0
221983,a,0,0
221984,multicenter,0,0
221985,trial,0,0
221986,",",0,0
221987,we,0,0
221988,compared,0,0
221989,fixed-dose,0,0
221990,subcutaneous,0,0
221991,enoxaparin,0,0
221992,",",0,0
221993,given,0,0
221994,twice,0,0
221995,daily,0,0
221996,",",0,0
221997,with,0,1
221998,adjusted-dose,0,0
221999,intravenous,0,0
222000,unfractionated,0,0
222001,heparin,0,0
222002,(,0,0
222003,UFH,0,0
222004,),0,0
222005,given,0,0
222006,by,0,0
222007,continuous,0,0
222008,intravenous,0,0
222009,infusion,0,0
222010,for,0,0
222011,the,0,0
222012,initial,0,0
222013,10,0,0
222014,days,0,0
222015,of,0,0
222016,treatment,0,0
222017,of,0,0
222018,patients,1,1
222019,with,1,1
222020,proximal,1,1
222021,vein,1,1
222022,thrombosis,1,1
222023,.,1,0
222024,The,0,0
222025,primary,0,0
222026,efficacy,0,0
222027,outcome,0,0
222028,was,0,0
222029,the,0,0
222030,change,0,0
222031,of,0,0
222032,the,0,0
222033,size,0,0
222034,of,0,0
222035,the,0,0
222036,thrombus,0,0
222037,assessed,0,0
222038,by,0,0
222039,repeated,0,0
222040,venograms,0,0
222041,between,0,0
222042,day,0,0
222043,0,0,0
222044,and,0,0
222045,day,0,0
222046,10,0,0
222047,.,0,0
222048,The,0,0
222049,primary,0,0
222050,analysis,0,0
222051,of,0,0
222052,safety,0,0
222053,was,0,0
222054,based,0,0
222055,on,0,0
222056,the,0,0
222057,incidence,0,0
222058,of,0,0
222059,major,0,0
222060,bleeding,0,1
222061,during,0,0
222062,10,0,1
222063,days,0,0
222064,of,0,1
222065,treatment,0,0
222066,.,0,0
222067,RESULTS,0,0
222068,There,1,0
222069,were,1,0
222070,67,1,0
222071,patients,1,1
222072,in,1,0
222073,each,1,1
222074,group,1,0
222075,.,1,0
222076,Venographic,0,0
222077,assessment,0,0
222078,of,0,0
222079,clot,0,0
222080,size,0,0
222081,evolution,0,0
222082,between,0,0
222083,day,0,0
222084,0,0,0
222085,and,0,0
222086,day,0,0
222087,10,0,0
222088,showed,0,0
222089,a,0,0
222090,statistically,0,0
222091,significant,0,0
222092,superiority,0,0
222093,(,0,0
222094,P,0,0
222095,<,0,0
222096,.002,0,0
222097,),0,0
222098,of,0,0
222099,enoxaparin,0,0
222100,over,0,0
222101,the,0,0
222102,reference,0,0
222103,treatment,0,0
222104,with,0,1
222105,UFH,0,0
222106,.,0,0
222107,Moreover,0,0
222108,",",0,0
222109,the,0,0
222110,incidence,0,0
222111,of,0,0
222112,overall,0,0
222113,recurrent,0,1
222114,thromboembolic,0,1
222115,events,0,0
222116,during,0,1
222117,10,0,1
222118,days,0,0
222119,of,0,0
222120,treatment,0,0
222121,was,0,0
222122,significantly,0,0
222123,higher,0,0
222124,(,0,0
222125,P,0,0
222126,<,0,0
222127,.002,0,0
222128,),0,0
222129,in,0,0
222130,the,0,0
222131,UFH,0,0
222132,group,0,0
222133,(,0,0
222134,seven,0,1
222135,of,0,0
222136,67,0,1
222137,),0,0
222138,than,0,0
222139,in,0,0
222140,the,0,0
222141,enoxaparin,0,0
222142,group,0,0
222143,(,0,0
222144,one,0,1
222145,of,0,0
222146,67,0,1
222147,),0,1
222148,.,0,0
222149,There,0,0
222150,were,0,0
222151,no,0,0
222152,serious,0,0
222153,bleeding,0,1
222154,complications,0,0
222155,in,0,0
222156,either,0,1
222157,group,0,0
222158,.,0,0
222159,CONCLUSIONS,0,0
222160,Enoxaparin,0,0
222161,is,0,0
222162,at,0,0
222163,least,0,0
222164,as,0,0
222165,effective,0,0
222166,and,0,0
222167,safe,0,0
222168,as,0,0
222169,UFH,0,0
222170,under,0,0
222171,the,0,0
222172,conditions,0,0
222173,of,0,0
222174,this,0,0
222175,study,0,0
222176,.,0,0
222177,Moreover,0,0
222178,",",0,0
222179,it,0,0
222180,is,0,0
222181,more,0,0
222182,comfortable,0,0
222183,for,0,0
222184,patients,0,1
222185,and,0,0
222186,less,0,0
222187,time-consuming,0,0
222188,for,0,0
222189,nurses,0,1
222190,and,0,1
222191,laboratories,0,1
222192,.,0,0
222193,Thus,0,0
222194,",",0,0
222195,our,0,0
222196,study,0,0
222197,confirmed,0,0
222198,",",0,0
222199,with,0,1
222200,the,0,0
222201,use,0,0
222202,of,0,0
222203,enoxaparin,0,0
222204,",",0,0
222205,other,0,0
222206,observations,0,0
222207,that,0,0
222208,low-molecular-weight,0,0
222209,heparin,0,0
222210,provides,0,0
222211,a,0,0
222212,real,0,0
222213,therapeutic,0,0
222214,advance,0,0
222215,in,0,0
222216,the,0,0
222217,treatment,0,0
222218,of,0,0
222219,deep,1,0
222220,vein,1,1
222221,thrombosis,1,1
222222,.,1,1
222223,The,0,0
222224,relative,0,0
222225,contributions,0,0
222226,of,0,0
222227,medication,0,0
222228,adherence,0,0
222229,and,0,0
222230,AA,0,0
222231,meeting,0,0
222232,attendance,0,0
222233,to,0,0
222234,abstinent,0,1
222235,outcome,0,0
222236,for,0,0
222237,chronic,1,1
222238,alcoholics,1,1
222239,.,1,1
222240,Our,0,0
222241,preliminary,0,0
222242,studies,0,0
222243,of,0,0
222244,the,0,0
222245,efficacy,0,0
222246,of,0,0
222247,lithium,0,0
222248,carbonate,0,0
222249,therapy,0,0
222250,for,0,0
222251,alcoholism,0,1
222252,under,0,0
222253,double-blind,0,0
222254,",",0,0
222255,placebo-controlled,0,0
222256,conditions,0,0
222257,demonstrated,0,0
222258,that,0,1
222259,alcoholics,1,1
222260,who,1,1
222261,took,1,1
222262,their,1,1
222263,assigned,1,1
222264,medication,1,0
222265,(,1,0
222266,lithium,1,0
222267,or,1,1
222268,placebo,1,0
222269,),1,0
222270,for,1,0
222271,the,1,0
222272,first,1,0
222273,6,1,0
222274,months,1,0
222275,after,1,0
222276,discharge,1,0
222277,from,1,0
222278,an,1,0
222279,inpatient,1,1
222280,rehabilitation,1,0
222281,program,1,0
222282,were,0,0
222283,more,0,0
222284,likely,0,0
222285,to,0,0
222286,abstain,0,1
222287,from,0,0
222288,any,0,0
222289,alcohol,0,0
222290,use,0,0
222291,for,0,0
222292,18,0,1
222293,months,0,0
222294,following,0,0
222295,discharge,0,0
222296,than,0,0
222297,were,0,1
222298,alcoholics,1,1
222299,who,1,1
222300,took,1,1
222301,their,1,1
222302,medication,1,0
222303,erratically,1,0
222304,or,1,0
222305,not,1,0
222306,at,1,0
222307,all,1,0
222308,.,1,0
222309,Attendance,1,0
222310,at,1,0
222311,Alcoholics,1,1
222312,Anonymous,1,1
222313,(,1,0
222314,AA,1,0
222315,),1,1
222316,meetings,1,0
222317,was,0,0
222318,also,0,0
222319,associated,0,0
222320,with,0,0
222321,medication,0,0
222322,adherence,0,0
222323,.,0,0
222324,We,0,0
222325,applied,0,0
222326,a,0,0
222327,structural,0,0
222328,equation,0,0
222329,model,0,0
222330,to,0,0
222331,data,0,0
222332,on,0,0
222333,the,0,0
222334,relationships,0,0
222335,between,0,0
222336,medication,0,0
222337,adherence,0,0
222338,",",0,0
222339,AA,0,0
222340,meeting,0,0
222341,attendance,0,0
222342,and,0,0
222343,abstinent,0,1
222344,outcome,0,0
222345,to,0,0
222346,clarify,0,0
222347,whether,0,0
222348,medication,0,0
222349,adherence,0,0
222350,or,0,1
222351,AA,0,0
222352,meeting,0,0
222353,attendance,0,0
222354,better,0,0
222355,explains,0,0
222356,the,0,0
222357,positive-outcome,0,0
222358,adherence,0,0
222359,effect,0,0
222360,we,0,0
222361,observed,0,0
222362,.,0,0
222363,Both,0,0
222364,medication,0,0
222365,adherence,0,0
222366,and,0,0
222367,AA,0,0
222368,meeting,0,1
222369,attendance,0,0
222370,evidenced,0,0
222371,direct,0,0
222372,and,0,1
222373,independent,0,0
222374,influences,0,0
222375,on,0,0
222376,abstinent,0,1
222377,outcome,0,0
222378,:,0,1
222379,medication,0,0
222380,adherence,0,0
222381,showed,0,0
222382,a,0,0
222383,small,0,0
222384,direct,0,0
222385,influence,0,0
222386,",",0,0
222387,and,0,0
222388,AA,0,0
222389,meeting,0,1
222390,attendance,0,0
222391,showed,0,0
222392,a,0,0
222393,much,0,0
222394,larger,0,0
222395,",",0,0
222396,independent,0,0
222397,influence,0,0
222398,.,0,1
222399,Pharmacokinetic,0,0
222400,study,0,0
222401,of,0,0
222402,RU,0,1
222403,486,0,1
222404,and,0,0
222405,its,0,0
222406,metabolites,0,0
222407,after,0,0
222408,oral,0,0
222409,administration,0,0
222410,of,0,0
222411,single,0,0
222412,doses,0,0
222413,to,0,0
222414,pregnant,1,1
222415,and,1,0
222416,non-pregnant,1,1
222417,women,1,1
222418,.,1,1
222419,RU,0,1
222420,486,0,1
222421,and,0,0
222422,three,0,0
222423,of,0,0
222424,its,0,0
222425,metabolites,0,0
222426,(,0,1
222427,RU,0,1
222428,42633-monodemethyl,0,0
222429,",",0,0
222430,RU,0,1
222431,42848-didemethyl,0,0
222432,",",0,0
222433,and,0,0
222434,RU,0,1
222435,42698-hydroxymetabolite,0,0
222436,),0,0
222437,were,0,0
222438,determined,0,0
222439,by,0,0
222440,HPLC,0,0
222441,in,0,0
222442,plasma,0,0
222443,from,0,1
222444,nine,1,1
222445,non-pregnant,1,1
222446,and,1,1
222447,36,1,1
222448,pregnant,1,1
222449,women,1,1
222450,.,1,1
222451,Each,0,0
222452,non-pregnant,0,1
222453,subject,0,0
222454,took,0,1
222455,an,0,0
222456,oral,0,0
222457,dose,0,0
222458,of,0,0
222459,RU,0,1
222460,486,0,1
222461,(,0,0
222462,25,0,1
222463,",",0,0
222464,100,0,0
222465,",",0,0
222466,400,0,0
222467,and,0,0
222468,600,0,1
222469,mg,0,0
222470,consecutively,0,1
222471,),0,0
222472,once,0,0
222473,per,0,0
222474,menstrual,0,0
222475,cycle,0,0
222476,.,0,1
222477,Six,0,0
222478,of,0,0
222479,the,0,0
222480,nine,0,1
222481,women,0,1
222482,also,0,0
222483,received,0,0
222484,a,0,0
222485,dose,0,0
222486,of,0,0
222487,200,0,0
222488,mg,0,0
222489,.,0,1
222490,The,0,0
222491,36,1,1
222492,pregnant,1,1
222493,women,1,1
222494,were,0,1
222495,randomized,0,1
222496,into,0,1
222497,four,0,1
222498,groups,0,0
222499,which,0,0
222500,were,0,0
222501,given,0,0
222502,a,0,0
222503,single,0,0
222504,dose,0,0
222505,of,0,0
222506,25,0,1
222507,",",0,0
222508,100,0,0
222509,",",0,0
222510,400,0,0
222511,or,0,1
222512,600,0,1
222513,mg,0,0
222514,RU,0,1
222515,486,0,1
222516,.,0,1
222517,Blood,0,0
222518,samples,0,0
222519,were,0,0
222520,taken,0,0
222521,up,0,0
222522,to,0,0
222523,120,0,0
222524,h,0,0
222525,after,0,0
222526,dosing,0,0
222527,.,0,1
222528,Peak,0,0
222529,concentrations,0,0
222530,of,0,1
222531,RU,0,1
222532,486,0,1
222533,occurred,0,0
222534,on,0,0
222535,most,0,0
222536,occasions,0,0
222537,within,0,1
222538,2,0,1
222539,h.,0,1
222540,Plasma,0,1
222541,concentrations,0,0
222542,at,0,1
222543,1,0,0
222544,h,0,0
222545,and,0,0
222546,at,0,0
222547,24,0,0
222548,h,0,0
222549,increased,0,0
222550,in,0,0
222551,proportion,0,0
222552,to,0,0
222553,log,0,0
222554,dose,0,0
222555,.,0,0
222556,There,0,0
222557,was,0,0
222558,a,0,0
222559,wide,0,1
222560,variability,0,0
222561,(,0,0
222562,up,0,0
222563,to,0,0
222564,ten-fold,0,0
222565,),0,0
222566,in,0,0
222567,the,0,0
222568,pharmacokinetic,0,0
222569,parameters,0,0
222570,within,0,0
222571,each,0,0
222572,dose,0,0
222573,group,0,0
222574,.,0,1
222575,Plasma,0,0
222576,concentrations,0,0
222577,of,0,1
222578,RU,0,1
222579,42633,0,1
222580,were,0,0
222581,similar,0,0
222582,to,0,0
222583,those,0,0
222584,of,0,0
222585,RU,0,1
222586,486,0,1
222587,but,0,0
222588,concentrations,0,0
222589,of,0,1
222590,RU,0,1
222591,42848,0,1
222592,and,0,0
222593,RU,0,1
222594,42698,0,0
222595,were,0,0
222596,much,0,0
222597,lower,0,0
222598,.,0,0
222599,As,0,0
222600,with,0,1
222601,RU,0,1
222602,486,0,1
222603,",",0,0
222604,the,0,0
222605,plasma,0,0
222606,concentrations,0,0
222607,of,0,0
222608,the,0,0
222609,metabolites,0,0
222610,were,0,0
222611,maintained,0,0
222612,at,0,0
222613,high,0,1
222614,levels,0,0
222615,for,0,0
222616,up,0,0
222617,to,0,0
222618,48-72,0,0
222619,h,0,0
222620,after,0,0
222621,dosing,0,0
222622,.,0,0
222623,The,0,0
222624,findings,0,0
222625,were,0,0
222626,consistent,0,0
222627,with,0,1
222628,a,0,0
222629,rapid,0,0
222630,metabolism,0,0
222631,of,0,0
222632,RU,0,1
222633,486,0,1
222634,to,0,0
222635,RU,0,1
222636,42633,0,1
222637,;,0,0
222638,removal,0,0
222639,of,0,0
222640,the,0,0
222641,second,0,0
222642,methyl,0,0
222643,group,0,0
222644,leading,0,0
222645,to,0,0
222646,RU,0,1
222647,42698,0,0
222648,occurred,0,0
222649,much,0,0
222650,more,0,0
222651,slowly,0,0
222652,and,0,0
222653,to,0,0
222654,a,0,0
222655,much,0,0
222656,less,0,0
222657,extent,0,0
222658,than,0,0
222659,removal,0,0
222660,of,0,0
222661,the,0,0
222662,first,0,0
222663,.,0,0
222664,There,0,0
222665,appeared,0,0
222666,to,0,0
222667,be,0,0
222668,no,0,0
222669,significant,0,0
222670,differences,0,0
222671,between,0,0
222672,the,0,0
222673,non-pregnant,1,1
222674,and,1,0
222675,pregnant,1,1
222676,women,1,1
222677,in,0,0
222678,either,0,0
222679,the,0,0
222680,plasma,0,0
222681,concentrations,0,0
222682,or,0,1
222683,pharmacokinetic,0,0
222684,parameters,0,0
222685,of,0,1
222686,RU,0,1
222687,486,0,1
222688,and,0,0
222689,its,0,0
222690,metabolites,0,0
222691,.,0,1
222692,Diode,0,0
222693,laser,0,0
222694,photocoagulation,0,0
222695,for,0,0
222696,threshold,1,0
222697,retinopathy,1,1
222698,of,1,0
222699,prematurity,1,1
222700,.,1,0
222701,A,0,0
222702,randomized,0,0
222703,study,0,0
222704,.,0,0
222705,BACKGROUND,0,0
222706,Although,0,0
222707,peripheral,0,0
222708,cryotherapy,0,0
222709,decreases,0,0
222710,the,0,0
222711,incidence,0,0
222712,of,0,0
222713,unfavorable,0,0
222714,anatomic,0,0
222715,outcomes,0,0
222716,in,0,0
222717,threshold,0,0
222718,retinopathy,1,1
222719,of,1,0
222720,prematurity,1,1
222721,(,1,0
222722,ROP,1,0
222723,),1,0
222724,",",0,0
222725,apnea,0,1
222726,",",0,0
222727,bradycardia,0,0
222728,",",0,0
222729,and,0,0
222730,lid,0,0
222731,edema,0,0
222732,can,0,0
222733,occur,0,0
222734,.,0,0
222735,Argon,0,0
222736,laser,0,0
222737,indirect,0,0
222738,ophthalmoscope,0,0
222739,photocoagulation,0,0
222740,has,0,0
222741,been,0,0
222742,used,0,0
222743,as,0,0
222744,an,0,0
222745,alternative,0,0
222746,to,0,0
222747,cryotherapy,0,0
222748,",",0,0
222749,with,0,0
222750,fewer,0,0
222751,adverse,0,0
222752,effects,0,0
222753,.,0,1
222754,Retinal,0,0
222755,lesions,0,0
222756,placed,0,1
222757,with,0,1
222758,diode,0,0
222759,lasers,0,1
222760,are,0,0
222761,deeper,0,0
222762,than,0,0
222763,similar,0,0
222764,argon,0,1
222765,laser,0,0
222766,lesions,0,0
222767,",",0,0
222768,and,0,0
222769,it,0,0
222770,is,0,0
222771,not,0,0
222772,known,0,0
222773,whether,0,0
222774,this,0,0
222775,difference,0,0
222776,could,0,0
222777,influence,0,0
222778,the,0,0
222779,response,0,0
222780,to,0,0
222781,ablative,0,1
222782,therapy,0,0
222783,.,0,1
222784,METHODS,0,0
222785,Patients,1,1
222786,were,0,1
222787,enrolled,0,1
222788,under,0,0
222789,a,0,0
222790,prospective,0,0
222791,",",0,0
222792,randomized,0,0
222793,protocol,0,0
222794,.,0,0
222795,One,0,0
222796,eye,0,0
222797,of,0,0
222798,each,0,0
222799,patient,0,0
222800,with,0,1
222801,symmetric,0,1
222802,",",0,0
222803,threshold,0,0
222804,ROP,0,0
222805,was,0,0
222806,treated,0,1
222807,with,0,1
222808,an,0,0
222809,814/815,0,0
222810,nm,0,0
222811,diode,0,0
222812,laser,0,0
222813,",",0,0
222814,while,0,0
222815,the,0,0
222816,other,0,0
222817,eye,0,0
222818,was,0,0
222819,treated,0,1
222820,with,0,1
222821,cryotherapy,0,0
222822,.,0,1
222823,Patients,0,1
222824,with,0,1
222825,asymmetric,0,1
222826,diseases,0,1
222827,also,0,0
222828,were,0,0
222829,randomized,0,0
222830,for,0,0
222831,treatment,0,0
222832,in,0,0
222833,the,0,0
222834,threshold,0,0
222835,eye,0,0
222836,.,0,0
222837,RESULTS,0,0
222838,Nineteen,1,1
222839,infants,1,1
222840,(,1,1
222841,33,1,1
222842,eyes,1,1
222843,),1,1
222844,were,1,0
222845,treated,1,1
222846,",",1,0
222847,ranging,1,0
222848,from,1,0
222849,485,1,1
222850,to,1,1
222851,863,1,1
222852,g,1,1
222853,birth,1,1
222854,weight,1,1
222855,(,1,0
222856,23,1,1
222857,to,1,1
222858,27,1,1
222859,weeks,1,0
222860,gestational,1,1
222861,age,1,1
222862,),1,1
222863,;,1,0
222864,18,1,1
222865,patients,1,1
222866,(,1,1
222867,32,1,1
222868,eyes,1,1
222869,),1,1
222870,were,0,0
222871,followed,0,0
222872,for,0,0
222873,3,0,0
222874,months,0,0
222875,or,0,1
222876,longer,0,0
222877,.,0,1
222878,Four,1,0
222879,patients,1,1
222880,(,1,1
222881,8,1,1
222882,eyes,1,1
222883,),1,1
222884,had,1,1
222885,bilateral,1,1
222886,zone,1,1
222887,1,1,1
222888,disease,1,1
222889,.,1,1
222890,Postconceptional,1,0
222891,age,1,1
222892,was,1,0
222893,36,1,1
222894,to,1,1
222895,45,1,1
222896,weeks,1,0
222897,at,1,0
222898,the,1,0
222899,time,1,0
222900,of,1,0
222901,treatment,1,0
222902,.,1,0
222903,The,0,0
222904,diode,0,0
222905,laser,0,0
222906,treatment,0,0
222907,was,0,0
222908,better,0,0
222909,tolerated,0,0
222910,than,0,0
222911,cryotherapy,0,0
222912,",",0,0
222913,and,0,0
222914,the,0,0
222915,treatment,0,0
222916,apparatus,0,0
222917,was,0,0
222918,more,0,0
222919,easily,0,0
222920,transported,0,0
222921,.,0,0
222922,Apneic,0,1
222923,episodes,0,0
222924,requiring,0,0
222925,intubation,0,0
222926,resulted,0,0
222927,from,0,0
222928,two,0,0
222929,cryotherapy,0,0
222930,sessions,0,0
222931,but,0,0
222932,no,0,0
222933,diode,0,0
222934,laser,0,0
222935,sessions,0,0
222936,.,0,1
222937,Five,0,0
222938,cryotherapy-treated,0,0
222939,eyes,0,1
222940,required,0,0
222941,retreatment,0,0
222942,because,0,0
222943,of,0,0
222944,persistent,0,1
222945,disease,0,1
222946,with,0,1
222947,adjacent,0,0
222948,skip,0,1
222949,areas,0,0
222950,.,0,1
222951,In,0,0
222952,the,0,0
222953,group,0,0
222954,followed,0,0
222955,for,0,0
222956,3,0,0
222957,to,0,1
222958,15,0,1
222959,months,0,0
222960,",",0,1
222961,1,0,0
222962,cryotherapy-treated,0,0
222963,eye,0,0
222964,and,0,0
222965,1,0,0
222966,diode,0,0
222967,laser-treated,0,0
222968,eye,0,0
222969,progressed,0,0
222970,to,0,0
222971,stage,0,1
222972,5,0,0
222973,retinal,0,1
222974,detachment,0,1
222975,.,0,1
222976,CONCLUSION,0,0
222977,Compared,0,0
222978,with,0,1
222979,cryotherapy,0,0
222980,",",0,0
222981,the,0,0
222982,diode,0,0
222983,laser,0,0
222984,was,0,0
222985,more,0,0
222986,convenient,0,0
222987,",",0,0
222988,technically,0,0
222989,easier,0,0
222990,to,0,0
222991,administer,0,0
222992,",",0,0
222993,and,0,0
222994,better,0,0
222995,tolerated,0,0
222996,by,0,0
222997,the,0,0
222998,patient,0,0
222999,.,0,0
223000,Although,0,0
223001,the,0,0
223002,number,0,0
223003,of,0,0
223004,patients,0,1
223005,was,0,0
223006,too,0,0
223007,small,0,0
223008,for,0,0
223009,meaningful,0,0
223010,statistical,0,0
223011,analysis,0,0
223012,of,0,0
223013,outcome,0,0
223014,",",0,0
223015,diode,0,0
223016,laser,0,0
223017,peripheral,0,0
223018,retinal,0,0
223019,ablation,0,1
223020,appeared,0,0
223021,to,0,0
223022,be,0,0
223023,as,0,0
223024,effective,0,0
223025,as,0,0
223026,cryotherapy,0,0
223027,for,0,0
223028,the,0,0
223029,treatment,0,0
223030,of,0,0
223031,threshold,0,0
223032,ROP,0,1
223033,.,0,1
223034,Antinuclear,1,1
223035,antibodies,1,0
223036,with,0,1
223037,enalapril,0,0
223038,.,0,1
223039,Metabolic,0,0
223040,responses,0,0
223041,to,0,0
223042,oral,0,0
223043,surgery,0,1
223044,under,0,0
223045,local,0,0
223046,anesthesia,0,1
223047,and,0,0
223048,sedation,0,0
223049,with,0,1
223050,intravenous,0,1
223051,midazolam,0,1
223052,:,0,1
223053,the,0,0
223054,effects,0,0
223055,of,0,0
223056,two,0,1
223057,different,0,0
223058,local,0,1
223059,anesthetics,0,0
223060,.,0,1
223061,The,0,0
223062,effects,0,0
223063,of,0,0
223064,epinephrine-free,0,0
223065,and,0,1
223066,epinephrine-containing,0,0
223067,local,0,0
223068,anesthetic,0,0
223069,solutions,0,0
223070,on,0,0
223071,plasma,0,0
223072,potassium,0,0
223073,and,0,0
223074,blood,0,0
223075,glucose,0,0
223076,concentrations,0,0
223077,were,0,1
223078,investigated,0,0
223079,in,0,0
223080,20,1,1
223081,patients,1,1
223082,undergoing,1,1
223083,oral,1,0
223084,surgery,1,1
223085,with,1,1
223086,intravenous,1,0
223087,midazolam,1,0
223088,sedation,1,1
223089,.,1,1
223090,Ten,0,1
223091,patients,0,1
223092,were,0,1
223093,randomly,0,1
223094,assigned,0,0
223095,to,0,0
223096,receive,0,0
223097,4.4,0,0
223098,mL,0,0
223099,of,0,0
223100,2,0,0
223101,%,0,0
223102,lidocaine,0,0
223103,with,0,1
223104,"1:80,000",0,0
223105,epinephrine,0,0
223106,as,0,0
223107,a,0,0
223108,local,0,0
223109,anesthetic,0,0
223110,and,0,0
223111,10,0,0
223112,were,0,0
223113,given,0,0
223114,4.4,0,0
223115,mL,0,0
223116,of,0,0
223117,3,0,0
223118,%,0,0
223119,prilocaine,0,0
223120,with,0,1
223121,0.03,0,0
223122,IU/mL,0,0
223123,felypressin,0,0
223124,.,0,0
223125,There,0,0
223126,were,0,0
223127,significant,0,0
223128,changes,0,0
223129,from,0,1
223130,baseline,0,0
223131,potassium,0,0
223132,and,0,0
223133,glucose,0,0
223134,concentrations,0,0
223135,both,0,0
223136,within,0,0
223137,and,0,0
223138,between,0,0
223139,treatments,0,0
223140,in,0,0
223141,the,0,0
223142,early,0,0
223143,postinjection,0,0
223144,period,0,0
223145,.,0,0
223146,The,0,0
223147,epinephrine-containing,0,0
223148,local,0,0
223149,anesthetic,0,0
223150,significantly,0,0
223151,reduced,0,0
223152,the,0,0
223153,plasma,0,0
223154,potassium,0,0
223155,concentration,0,0
223156,10,0,0
223157,min,0,0
223158,after,0,0
223159,injection,0,0
223160,",",0,0
223161,by,0,0
223162,0.16,0,0
223163,+/-,0,0
223164,0.20,0,0
223165,mmol/L,0,0
223166,(,0,0
223167,mean,0,1
223168,+/-,0,0
223169,SD,0,0
223170,),0,0
223171,",",0,0
223172,and,0,0
223173,increased,0,0
223174,the,0,0
223175,blood,0,0
223176,glucose,0,0
223177,concentration,0,0
223178,at,0,0
223179,10,0,0
223180,",",0,0
223181,20,0,0
223182,",",0,0
223183,and,0,0
223184,30,0,0
223185,min,0,0
223186,(,0,0
223187,by,0,0
223188,0.46,0,0
223189,+/-,0,0
223190,0.37,0,0
223191,",",0,0
223192,0.63,0,0
223193,+/-,0,0
223194,0.45,0,0
223195,",",0,0
223196,and,0,0
223197,0.56,0,0
223198,+/-,0,0
223199,0.28,0,0
223200,mmol/L,0,0
223201,",",0,0
223202,respectively,0,0
223203,),0,0
223204,.,0,0
223205,Conversely,0,0
223206,",",0,0
223207,plasma,0,0
223208,potassium,0,0
223209,increased,0,0
223210,and,0,0
223211,blood,0,0
223212,glucose,0,0
223213,decreased,0,0
223214,10,0,0
223215,",",0,0
223216,20,0,0
223217,",",0,0
223218,and,0,0
223219,30,0,0
223220,min,0,0
223221,following,0,0
223222,the,0,0
223223,administration,0,0
223224,of,0,0
223225,the,0,0
223226,epinephrine-free,0,0
223227,solution,0,0
223228,.,0,1
223229,At,0,0
223230,30,0,0
223231,min,0,0
223232,potassium,0,0
223233,was,0,0
223234,increased,0,0
223235,by,0,0
223236,0.24,0,0
223237,+/-,0,0
223238,0.16,0,0
223239,mmol/L,0,0
223240,",",0,0
223241,and,0,0
223242,glucose,0,0
223243,was,0,0
223244,decreased,0,0
223245,by,0,0
223246,0.23,0,0
223247,+/-,0,0
223248,0.16,0,0
223249,mmol/L,0,0
223250,.,0,0
223251,It,0,0
223252,is,0,0
223253,concluded,0,0
223254,that,0,0
223255,epinephrine-free,0,0
223256,and,0,1
223257,epinephrine-containing,0,0
223258,local,0,0
223259,anesthetics,0,0
223260,differ,0,0
223261,in,0,0
223262,their,0,0
223263,metabolic,0,1
223264,effects,0,0
223265,during,0,0
223266,oral,0,0
223267,surgery,0,1
223268,with,0,1
223269,midazolam,0,0
223270,sedation,0,1
223271,.,0,1
223272,Effect,0,0
223273,of,0,0
223274,dietary,0,0
223275,supplementation,0,0
223276,with,0,1
223277,n-3,0,0
223278,fatty,0,0
223279,acids,0,0
223280,on,0,0
223281,coronary,1,1
223282,artery,1,1
223283,bypass,1,1
223284,graft,1,0
223285,patency,1,0
223286,.,1,0
223287,Epidemiologic,0,0
223288,and,0,0
223289,experimental,0,0
223290,data,0,0
223291,suggest,0,0
223292,that,0,0
223293,a,0,0
223294,high,0,0
223295,dietary,0,0
223296,intake,0,0
223297,of,0,0
223298,long-chain,0,0
223299,polyunsaturated,0,0
223300,n-3,0,0
223301,fatty,0,0
223302,acids,0,0
223303,may,0,0
223304,reduce,0,0
223305,the,0,0
223306,risk,0,0
223307,of,0,0
223308,atherothrombotic,0,1
223309,disease,0,1
223310,.,0,0
223311,In,0,0
223312,a,0,0
223313,randomized,0,0
223314,",",0,0
223315,controlled,0,0
223316,study,0,0
223317,",",0,0
223318,610,1,1
223319,patients,1,1
223320,undergoing,1,1
223321,coronary,1,1
223322,artery,1,1
223323,bypass,1,1
223324,grafting,1,1
223325,were,0,0
223326,assigned,0,0
223327,either,0,0
223328,to,0,0
223329,a,0,0
223330,fish,0,0
223331,oil,0,0
223332,group,0,0
223333,",",0,0
223334,receiving,0,0
223335,4,0,0
223336,g/day,0,0
223337,of,0,0
223338,fish,0,0
223339,oil,0,0
223340,concentrate,0,0
223341,",",0,0
223342,or,0,0
223343,to,0,0
223344,a,0,0
223345,control,0,0
223346,group,0,0
223347,.,0,0
223348,All,1,0
223349,patients,1,1
223350,received,1,0
223351,antithrombotic,1,0
223352,treatment,1,0
223353,",",1,0
223354,either,1,0
223355,aspirin,1,0
223356,or,1,1
223357,warfarin,1,0
223358,.,1,0
223359,Their,0,1
223360,diet,0,0
223361,and,0,0
223362,serum,0,0
223363,phospholipid,0,0
223364,fatty,0,0
223365,acid,0,0
223366,profiles,0,0
223367,were,0,1
223368,monitored,0,1
223369,.,0,0
223370,The,0,0
223371,primary,0,0
223372,end,0,0
223373,point,0,0
223374,was,0,0
223375,1-year,0,0
223376,graft,0,0
223377,patency,0,0
223378,",",0,0
223379,which,0,0
223380,was,0,0
223381,assessed,0,0
223382,by,0,0
223383,angiography,0,0
223384,in,0,0
223385,95,0,0
223386,%,0,0
223387,of,0,0
223388,patients,0,1
223389,.,0,1
223390,Vein,0,0
223391,graft,0,0
223392,occlusion,0,1
223393,rates,0,0
223394,per,0,1
223395,distal,0,1
223396,anastomoses,0,0
223397,were,0,1
223398,27,0,1
223399,%,0,0
223400,in,0,0
223401,the,0,0
223402,fish,0,0
223403,oil,0,0
223404,group,0,0
223405,and,0,0
223406,33,0,1
223407,%,0,0
223408,in,0,0
223409,the,0,0
223410,control,0,0
223411,group,0,0
223412,(,0,0
223413,odds,0,0
223414,ratio,0,0
223415,0.77,0,0
223416,",",0,0
223417,95,0,0
223418,%,0,0
223419,confidence,0,0
223420,interval,0,0
223421,",",0,0
223422,0.60,0,0
223423,to,0,0
223424,0.99,0,0
223425,",",0,0
223426,p,0,0
223427,=,0,0
223428,0.034,0,0
223429,),0,0
223430,.,0,0
223431,In,0,0
223432,the,0,0
223433,fish,0,0
223434,oil,0,0
223435,group,0,0
223436,",",0,0
223437,43,0,1
223438,%,0,0
223439,of,0,0
223440,the,0,0
223441,patients,0,1
223442,had,0,0
223443,>,0,1
223444,or,0,1
223445,=,0,0
223446,1,0,0
223447,occluded,0,0
223448,vein,0,1
223449,graft,0,0
223450,(,0,0
223451,s,0,0
223452,),0,0
223453,compared,0,0
223454,with,0,1
223455,51,0,1
223456,%,0,0
223457,in,0,0
223458,the,0,0
223459,control,0,0
223460,group,0,0
223461,(,0,0
223462,odds,0,0
223463,ratio,0,0
223464,0.72,0,0
223465,",",0,0
223466,95,0,0
223467,%,0,0
223468,confidence,0,0
223469,interval,0,0
223470,",",0,0
223471,0.51,0,0
223472,to,0,0
223473,1.01,0,0
223474,",",0,0
223475,p,0,0
223476,=,0,0
223477,0.05,0,0
223478,),0,0
223479,.,0,0
223480,Moreover,0,0
223481,",",0,0
223482,in,0,0
223483,the,0,0
223484,entire,0,0
223485,patient,0,0
223486,group,0,0
223487,",",0,0
223488,there,0,0
223489,was,0,0
223490,a,0,0
223491,significant,0,0
223492,trend,0,0
223493,to,0,0
223494,fewer,0,0
223495,patients,0,1
223496,with,0,1
223497,vein,0,1
223498,graft,0,1
223499,occlusions,0,1
223500,with,0,1
223501,increasing,0,0
223502,relative,0,0
223503,change,0,0
223504,in,0,0
223505,serum,0,0
223506,phospholipid,0,0
223507,n-3,0,0
223508,fatty,0,0
223509,acids,0,0
223510,during,0,0
223511,the,0,0
223512,study,0,0
223513,period,0,0
223514,(,0,0
223515,p,0,0
223516,for,0,0
223517,linear,0,0
223518,trend,0,0
223519,=,0,0
223520,0.0037,0,0
223521,),0,0
223522,.,0,0
223523,Thus,0,0
223524,",",0,0
223525,in,0,0
223526,patients,1,1
223527,undergoing,1,1
223528,coronary,1,1
223529,artery,1,1
223530,bypass,1,1
223531,grafting,1,0
223532,",",0,0
223533,dietary,0,0
223534,supplementation,0,0
223535,with,0,1
223536,n-3,0,0
223537,fatty,0,0
223538,acids,0,0
223539,reduced,0,0
223540,the,0,0
223541,incidence,0,0
223542,of,0,0
223543,vein,0,0
223544,graft,0,0
223545,occlusion,0,0
223546,",",0,0
223547,and,0,0
223548,an,0,0
223549,inverse,0,0
223550,relation,0,0
223551,between,0,0
223552,relative,0,0
223553,change,0,0
223554,in,0,0
223555,serum,0,0
223556,phospholipid,0,0
223557,n-3,0,0
223558,fatty,0,0
223559,acids,0,0
223560,and,0,0
223561,vein,0,1
223562,graft,0,0
223563,occlusions,0,1
223564,was,0,0
223565,observed,0,0
223566,.,0,1
223567,Direct,0,0
223568,analysis,0,0
223569,of,0,0
223570,resistance,0,0
223571,in,0,0
223572,the,0,0
223573,cutaneous,0,1
223574,microflora,0,0
223575,during,0,0
223576,treatment,0,0
223577,of,0,0
223578,acne,1,1
223579,vulgaris,1,1
223580,with,0,1
223581,topical,0,0
223582,1,0,0
223583,%,0,0
223584,nadifloxacin,0,0
223585,and,0,0
223586,2,0,0
223587,%,0,0
223588,erythromycin,0,0
223589,.,0,1
223590,Effects,0,0
223591,of,0,0
223592,interaction,0,0
223593,of,0,0
223594,RRR-alpha-tocopheryl,0,0
223595,acetate,0,0
223596,and,0,0
223597,fish,0,0
223598,oil,0,0
223599,on,0,0
223600,low-density-lipoprotein,0,0
223601,oxidation,0,0
223602,in,0,0
223603,postmenopausal,1,1
223604,women,1,1
223605,with,1,1
223606,and,1,0
223607,without,1,1
223608,hormone-replacement,1,0
223609,therapy,1,0
223610,.,1,1
223611,We,0,0
223612,evaluated,0,0
223613,the,0,0
223614,effects,0,0
223615,of,0,0
223616,RRR-alpha-tocpheryl,0,0
223617,acetate,0,0
223618,(,0,0
223619,alpha-tocopheryl,0,0
223620,acetate,0,0
223621,),0,0
223622,and,0,0
223623,hormone-replacement,0,0
223624,therapy,0,0
223625,(,0,0
223626,HRT,0,0
223627,),0,0
223628,on,0,0
223629,the,0,0
223630,oxidative,0,0
223631,susceptibility,0,0
223632,of,0,0
223633,low-density,0,0
223634,lipoprotein,0,0
223635,(,0,0
223636,LDL,0,0
223637,),0,0
223638,in,0,0
223639,postmenopausal,1,1
223640,women,1,1
223641,consuming,1,0
223642,a,1,0
223643,fish,1,0
223644,oil,1,0
223645,supplement,1,0
223646,.,1,0
223647,The,0,0
223648,independent,0,0
223649,effect,0,0
223650,of,0,0
223651,fish,0,0
223652,oil,0,0
223653,was,0,0
223654,also,0,0
223655,assessed,0,0
223656,.,0,0
223657,Forty-eight,1,1
223658,women,1,1
223659,",",1,0
223660,equally,1,0
223661,divided,1,0
223662,between,1,0
223663,women,1,1
223664,using,1,0
223665,and,1,0
223666,not,1,0
223667,using,1,0
223668,HRT,1,0
223669,",",0,0
223670,participated,0,1
223671,in,0,0
223672,a,0,0
223673,double-blind,0,0
223674,crossover,0,0
223675,trial,0,0
223676,.,0,0
223677,Each,0,0
223678,of,0,0
223679,the,0,0
223680,four,0,1
223681,periods,0,0
223682,lasted,0,0
223683,5,0,0
223684,wk,0,1
223685,and,0,0
223686,was,0,0
223687,followed,0,0
223688,by,0,0
223689,a,0,0
223690,4-wk,0,0
223691,washout,0,0
223692,interval,0,0
223693,.,0,0
223694,During,0,0
223695,each,0,0
223696,period,0,0
223697,all,0,0
223698,subjects,0,1
223699,were,0,0
223700,given,0,0
223701,a,0,0
223702,15-g,0,0
223703,supplement,0,0
223704,of,0,0
223705,fish,0,0
223706,oil,0,0
223707,and,0,0
223708,either,0,0
223709,0,0,0
223710,(,0,0
223711,placebo,0,0
223712,),0,0
223713,",",0,0
223714,100,0,0
223715,",",0,0
223716,200,0,0
223717,",",0,0
223718,or,0,1
223719,400,0,0
223720,mg,0,0
223721,alpha-tocopheryl,0,0
223722,acetate,0,0
223723,daily,0,0
223724,.,0,1
223725,LDL,0,0
223726,resistance,0,0
223727,to,0,0
223728,oxidative,0,0
223729,modification,0,0
223730,was,0,0
223731,assessed,0,0
223732,by,0,0
223733,calculating,0,0
223734,lag,0,0
223735,time,0,0
223736,",",0,0
223737,propagation,0,0
223738,rate,0,0
223739,",",0,0
223740,and,0,0
223741,maximum,0,0
223742,production,0,0
223743,of,0,0
223744,conjugated,0,0
223745,dienes,0,0
223746,.,0,1
223747,Supplementation,0,0
223748,with,0,1
223749,fish,0,0
223750,oil,0,0
223751,and,0,0
223752,placebo,0,0
223753,shortened,0,0
223754,lag,0,0
223755,time,0,0
223756,and,0,0
223757,slowed,0,0
223758,propagation,0,0
223759,rate,0,0
223760,in,0,0
223761,women,0,1
223762,both,0,0
223763,using,0,0
223764,and,0,0
223765,not,0,0
223766,using,0,0
223767,HRT,0,0
223768,.,0,1
223769,After,0,0
223770,subjects,0,1
223771,consumed,0,1
223772,fish,0,0
223773,oil,0,0
223774,",",0,0
223775,supplementation,0,0
223776,with,0,1
223777,alpha-tocopheryl,0,0
223778,acetate,0,0
223779,increased,0,0
223780,plasma,0,0
223781,and,0,0
223782,LDL,0,0
223783,alpha-tocopherol,0,0
223784,contents,0,0
223785,significantly,0,0
223786,and,0,0
223787,lengthened,0,0
223788,lag,0,0
223789,time,0,0
223790,(,0,0
223791,at,0,0
223792,even,0,0
223793,the,0,0
223794,lowest,0,0
223795,concentration,0,0
223796,),0,0
223797,but,0,0
223798,had,0,0
223799,no,0,0
223800,significant,0,0
223801,effect,0,0
223802,on,0,0
223803,propagation,0,0
223804,rate,0,0
223805,or,0,1
223806,maximum,0,0
223807,production,0,0
223808,compared,0,0
223809,with,0,1
223810,values,0,0
223811,measured,0,0
223812,after,0,0
223813,consumption,0,0
223814,of,0,0
223815,fish,0,0
223816,oil,0,0
223817,alone,0,0
223818,.,0,0
223819,Women,0,0
223820,not,0,0
223821,using,0,0
223822,HRT,0,0
223823,had,0,1
223824,faster,0,0
223825,propagation,0,0
223826,rates,0,0
223827,and,0,0
223828,higher,0,0
223829,maximum,0,0
223830,production,0,0
223831,than,0,0
223832,women,0,1
223833,using,0,1
223834,HRT,0,1
223835,;,0,0
223836,after,0,0
223837,supplementation,0,0
223838,with,0,1
223839,fish,0,0
223840,oil,0,0
223841,and,0,0
223842,alpha-tocopheryl,0,0
223843,acetate,0,0
223844,these,0,0
223845,differences,0,0
223846,prevailed,0,0
223847,.,0,1
223848,Supplements,0,0
223849,as,0,0
223850,low,0,1
223851,as,0,0
223852,100,0,1
223853,mg,0,0
223854,alpha-tocopheryl,0,0
223855,acetate/d,0,0
223856,increase,0,0
223857,the,0,0
223858,resistance,0,0
223859,of,0,0
223860,LDL,0,0
223861,to,0,0
223862,oxidation,0,0
223863,when,0,0
223864,fish,0,0
223865,oil,0,0
223866,supplements,0,0
223867,are,0,0
223868,used,0,0
223869,.,0,0
223870,HRT,0,0
223871,and,0,0
223872,fish,0,0
223873,oil,0,0
223874,supplements,0,0
223875,may,0,0
223876,independently,0,0
223877,affect,0,0
223878,LDL,0,0
223879,oxidative,0,0
223880,susceptibility,0,0
223881,.,0,1
223882,Placebo-controlled,0,1
223883,acute,0,1
223884,dosage,0,0
223885,naltrexone,0,0
223886,study,0,0
223887,in,0,0
223888,young,1,1
223889,autistic,1,1
223890,children,1,1
223891,.,1,1
223892,In,0,0
223893,a,0,0
223894,double-blind,0,0
223895,",",0,0
223896,placebo-controlled,0,0
223897,crossover,0,0
223898,trial,0,1
223899,23,1,1
223900,autistic,1,1
223901,children,1,1
223902,were,0,1
223903,treated,0,1
223904,with,0,1
223905,a,0,0
223906,single,0,0
223907,40-mg,0,0
223908,dose,0,0
223909,of,0,0
223910,the,0,0
223911,opiate,0,1
223912,antagonist,0,0
223913,naltrexone,0,0
223914,.,0,1
223915,Drug,0,0
223916,effects,0,0
223917,were,0,1
223918,monitored,0,0
223919,by,0,0
223920,detailed,0,0
223921,playroom,0,0
223922,observations,0,0
223923,",",0,0
223924,actometers,0,0
223925,",",0,0
223926,and,0,0
223927,parents,0,1
223928,',0,1
223929,checklist,0,0
223930,ratings,0,0
223931,(,0,1
223932,Aberrant,0,1
223933,Behavior,0,1
223934,Checklist,0,0
223935,",",0,0
223936,social,0,0
223937,items,0,0
223938,and,0,1
223939,target,0,0
223940,behaviors,0,0
223941,),0,1
223942,.,0,1
223943,Naltrexone,0,0
223944,treatment,0,0
223945,failed,0,0
223946,to,0,0
223947,produce,0,0
223948,significant,0,0
223949,changes,0,0
223950,in,0,0
223951,social,0,0
223952,behavior,0,0
223953,",",0,0
223954,but,0,0
223955,it,0,0
223956,did,0,0
223957,reduce,0,0
223958,irritability,0,0
223959,and,0,0
223960,target,0,0
223961,scores,0,0
223962,on,0,0
223963,behavior,0,1
223964,checklists,0,0
223965,.,0,1
223966,The,0,0
223967,playroom,0,0
223968,data,0,0
223969,indicated,0,0
223970,that,0,0
223971,naltrexone,0,0
223972,significantly,0,0
223973,affected,0,0
223974,indices,0,0
223975,of,0,0
223976,activity,0,0
223977,and,0,0
223978,attention,0,0
223979,.,0,1
223980,Lung,0,0
223981,function,0,0
223982,measurement,0,0
223983,in,0,0
223984,general,0,1
223985,practice,0,1
223986,:,0,1
223987,a,0,0
223988,comparison,0,0
223989,of,0,0
223990,the,0,0
223991,Escort,0,0
223992,spirometer,0,0
223993,with,0,1
223994,the,0,0
223995,Micromed,0,0
223996,turbine,0,0
223997,spirometer,0,0
223998,and,0,0
223999,the,0,0
224000,mini-Wright,0,0
224001,peak,0,0
224002,flow,0,0
224003,meter,0,0
224004,.,0,0
224005,It,0,0
224006,is,0,0
224007,important,0,0
224008,that,0,0
224009,new,0,1
224010,types,0,0
224011,of,0,0
224012,spirometer,0,0
224013,for,0,0
224014,widespread,0,0
224015,clinical,0,0
224016,use,0,0
224017,are,0,0
224018,pragmatically,0,0
224019,evaluated,0,0
224020,in,0,0
224021,primary,0,1
224022,care,0,1
224023,.,0,0
224024,This,0,0
224025,study,0,0
224026,compared,0,0
224027,measurements,0,0
224028,taken,0,0
224029,by,0,0
224030,a,0,0
224031,new,0,0
224032,portable,0,0
224033,Fleisch,0,1
224034,pneumotachograph,0,0
224035,spirometer,0,0
224036,(,0,0
224037,known,0,0
224038,as,0,0
224039,the,0,0
224040,Escort,0,0
224041,),0,0
224042,with,0,1
224043,those,0,0
224044,of,0,0
224045,the,0,0
224046,commonly,0,0
224047,used,0,0
224048,mini-Wright,0,0
224049,peak,0,0
224050,flow,0,0
224051,meter,0,0
224052,and,0,0
224053,the,0,0
224054,Micromed,0,0
224055,Pocket,0,0
224056,turbine,0,1
224057,spirometer,0,0
224058,.,0,0
224059,A,0,0
224060,pragmatic,0,0
224061,study,0,0
224062,was,0,0
224063,conducted,0,0
224064,in,0,0
224065,two,0,0
224066,phases,0,0
224067,during,1,1
224068,routine,1,1
224069,surgeries,1,1
224070,at,0,1
224071,Aldermoor,0,1
224072,Health,0,0
224073,Centre,0,0
224074,",",0,0
224075,Southampton,0,1
224076,.,0,0
224077,Phase,0,0
224078,I,0,0
224079,compared,0,0
224080,the,0,0
224081,new,0,0
224082,spirometer,0,0
224083,with,0,1
224084,the,0,0
224085,mini-Wright,0,0
224086,peak,0,0
224087,flow,0,0
224088,meter,0,0
224089,and,0,0
224090,Phase,0,1
224091,2,0,0
224092,compared,0,0
224093,the,0,0
224094,new,0,0
224095,spirometer,0,0
224096,and,0,0
224097,the,0,0
224098,turbine,0,0
224099,spirometer,0,0
224100,.,0,1
224101,One,1,1
224102,hundred,1,1
224103,patients,1,1
224104,aged,1,1
224105,5-88,1,1
224106,years,1,1
224107,(,1,1
224108,56,1,1
224109,patients,1,1
224110,with,1,1
224111,a,1,0
224112,history,1,1
224113,of,1,0
224114,chronic,1,1
224115,respiratory,1,1
224116,complaints,1,1
224117,and,1,1
224118,44,1,1
224119,patients,1,1
224120,without,1,1
224121,),1,1
224122,entered,1,1
224123,Phase,1,1
224124,1,1,0
224125,",",1,0
224126,and,1,0
224127,100,1,0
224128,patients,1,1
224129,aged,1,1
224130,6-82,1,1
224131,years,1,1
224132,(,1,1
224133,62,1,1
224134,patients,1,1
224135,with,1,1
224136,a,1,0
224137,history,1,1
224138,of,1,0
224139,chronic,1,1
224140,respiratory,1,1
224141,complaints,1,1
224142,and,1,1
224143,38,1,1
224144,patients,1,1
224145,without,1,1
224146,),1,1
224147,entered,1,1
224148,Phase,1,1
224149,2,1,0
224150,.,1,0
224151,Each,0,0
224152,patient,0,0
224153,contributed,0,0
224154,only,0,0
224155,once,0,0
224156,to,0,0
224157,each,0,0
224158,phase,0,0
224159,",",0,0
224160,but,0,0
224161,some,0,0
224162,entered,0,0
224163,both,0,0
224164,phases,0,0
224165,on,0,0
224166,separate,0,1
224167,occasions,0,0
224168,.,0,1
224169,Ninety-five,0,1
224170,percent,0,0
224171,limits,0,0
224172,of,0,0
224173,agreement,0,0
224174,(,0,0
224175,mean,0,1
224176,+/-,0,0
224177,SD,0,1
224178,),0,0
224179,were,0,0
224180,wide,0,1
224181,for,0,0
224182,all,0,1
224183,comparisons,0,0
224184,.,0,1
224185,Graphical,0,0
224186,plots,0,0
224187,revealed,0,0
224188,trends,0,0
224189,towards,0,0
224190,higher,0,0
224191,Escort,0,0
224192,values,0,0
224193,as,0,0
224194,mean,0,1
224195,values,0,0
224196,rose,0,0
224197,compared,0,0
224198,with,0,1
224199,both,0,0
224200,mini-Wright,0,0
224201,and,0,0
224202,turbine,0,1
224203,readings,0,0
224204,for,0,1
224205,peak,0,0
224206,expiratory,0,0
224207,flow,0,0
224208,rate,0,0
224209,and,0,0
224210,forced,0,1
224211,expiratory,0,0
224212,volume,0,0
224213,in,0,0
224214,one,0,1
224215,second,0,1
224216,.,0,1
224217,Possible,0,0
224218,over-reading,0,0
224219,of,0,0
224220,peak,0,0
224221,expiratory,0,0
224222,flow,0,0
224223,rate,0,0
224224,with,0,1
224225,the,0,0
224226,mini-Wright,0,0
224227,meter,0,0
224228,at,0,0
224229,low,0,1
224230,mean,0,1
224231,values,0,0
224232,was,0,0
224233,also,0,0
224234,seen,0,0
224235,.,0,0
224236,Readings,0,0
224237,taken,0,0
224238,with,0,1
224239,these,0,0
224240,different,0,0
224241,types,0,0
224242,of,0,0
224243,meter,0,0
224244,can,0,0
224245,not,0,0
224246,be,0,0
224247,interchanged,0,0
224248,with,0,0
224249,confidence,0,0
224250,in,0,0
224251,clinical,0,0
224252,practice,0,0
224253,.,0,0
224254,The,0,0
224255,clinical,0,0
224256,significance,0,0
224257,of,0,0
224258,the,0,0
224259,theoretically,0,0
224260,more,0,0
224261,accurate,0,0
224262,measures,0,0
224263,of,0,0
224264,lung,0,1
224265,function,0,0
224266,produced,0,0
224267,with,0,1
224268,the,0,0
224269,new,0,0
224270,meter,0,0
224271,",",0,0
224272,and,0,0
224273,indeed,0,0
224274,of,0,0
224275,spirometry,0,0
224276,itself,0,0
224277,",",0,0
224278,needs,0,0
224279,further,0,0
224280,investigation,0,0
224281,.,0,1
224282,Chronopharmacology,0,0
224283,of,0,0
224284,enalapril,0,0
224285,in,0,0
224286,hypertensive,1,1
224287,patients,1,1
224288,.,1,1
224289,The,0,0
224290,pharmacokinetics,0,0
224291,and,0,0
224292,pharmacodynamics,0,0
224293,of,0,0
224294,enalapril,0,0
224295,",",0,0
224296,an,0,0
224297,angiotensin,0,0
224298,converting,0,0
224299,enzyme,0,0
224300,inhibitor,0,0
224301,",",0,0
224302,are,0,0
224303,reported,0,0
224304,to,0,0
224305,vary,0,0
224306,with,0,1
224307,the,0,0
224308,time,0,0
224309,of,0,0
224310,administration,0,0
224311,.,0,0
224312,The,0,0
224313,present,0,0
224314,study,0,0
224315,was,0,0
224316,undertaken,0,0
224317,to,0,0
224318,examine,0,0
224319,whether,0,0
224320,the,0,0
224321,effect,0,0
224322,of,0,0
224323,enalapril,0,0
224324,on,0,0
224325,plasma,0,0
224326,bradykinin,0,0
224327,(,0,0
224328,BK,0,1
224329,),0,0
224330,",",0,0
224331,substance,0,0
224332,P,0,0
224333,and,0,0
224334,prostaglandin,0,0
224335,E2,0,0
224336,(,0,0
224337,PGE2,0,0
224338,),0,0
224339,",",0,0
224340,which,0,0
224341,are,0,0
224342,likely,0,0
224343,to,0,0
224344,be,0,0
224345,involved,0,0
224346,in,0,0
224347,the,0,0
224348,mechanism,0,0
224349,of,0,0
224350,enalapril-induced,0,0
224351,cough,0,1
224352,",",0,0
224353,might,0,0
224354,also,0,0
224355,be,0,0
224356,affected,0,0
224357,by,0,0
224358,its,0,0
224359,time,0,0
224360,of,0,0
224361,administration,0,0
224362,.,0,1
224363,Enalapril,0,0
224364,5,0,0
224365,mg,0,0
224366,or,0,1
224367,placebo,0,0
224368,was,0,0
224369,given,0,0
224370,orally,0,0
224371,at,0,0
224372,10:00,0,0
224373,h,0,0
224374,(,0,0
224375,day,0,0
224376,trial,0,0
224377,),0,0
224378,or,0,1
224379,22:00,0,0
224380,h,0,0
224381,(,0,0
224382,night,0,0
224383,trial,0,0
224384,),0,0
224385,to,0,0
224386,12,1,0
224387,patients,1,1
224388,with,1,1
224389,essential,1,1
224390,hypertension,1,1
224391,.,1,1
224392,Serum,0,0
224393,concentrations,0,0
224394,of,0,0
224395,total,0,1
224396,drug,0,0
224397,(,0,0
224398,enalapril,0,0
224399,+,0,0
224400,enalaprilat,0,0
224401,",",0,0
224402,its,0,0
224403,active,0,1
224404,metabolite,0,0
224405,),0,0
224406,during,0,0
224407,the,0,0
224408,day,0,0
224409,and,0,0
224410,night,0,0
224411,trials,0,0
224412,did,0,0
224413,not,0,0
224414,differ,0,0
224415,significantly,0,0
224416,at,0,0
224417,any,0,0
224418,time,0,0
224419,.,0,0
224420,However,0,0
224421,",",0,0
224422,serum,0,0
224423,enalaprilat,0,0
224424,tended,0,0
224425,to,0,0
224426,be,0,0
224427,higher,0,0
224428,and,0,0
224429,its,0,0
224430,maximum,0,0
224431,concentration,0,0
224432,greater,0,0
224433,in,0,0
224434,the,0,0
224435,day,0,0
224436,trial,0,0
224437,than,0,0
224438,in,0,0
224439,the,0,0
224440,night,0,0
224441,trial,0,0
224442,.,0,0
224443,Blood,0,0
224444,pressure,0,0
224445,24,0,0
224446,h,0,0
224447,after,0,0
224448,administration,0,0
224449,of,0,0
224450,enalapril,0,0
224451,was,0,0
224452,reduced,0,0
224453,at,0,0
224454,22:00,0,0
224455,h,0,0
224456,",",0,0
224457,but,0,0
224458,not,0,0
224459,at,0,0
224460,10:00,0,0
224461,h.,0,1
224462,Plasma,0,1
224463,BK,0,1
224464,tended,0,0
224465,to,0,0
224466,increase,0,0
224467,following,0,0
224468,enalapril,0,0
224469,administration,0,0
224470,at,0,0
224471,10:00,0,0
224472,h,0,0
224473,",",0,0
224474,but,0,0
224475,not,0,0
224476,at,0,0
224477,22:00,0,0
224478,h.,0,1
224479,Remarkable,0,1
224480,increases,0,0
224481,in,0,0
224482,plasma,0,0
224483,BK,0,1
224484,were,0,0
224485,observed,0,0
224486,in,0,0
224487,two,0,0
224488,patients,0,1
224489,in,0,0
224490,the,0,0
224491,day,0,0
224492,trial,0,0
224493,and,0,0
224494,one,0,0
224495,of,0,0
224496,them,0,1
224497,also,0,0
224498,complained,0,0
224499,of,0,0
224500,cough,0,1
224501,.,0,0
224502,However,0,0
224503,",",0,0
224504,no,0,0
224505,such,0,0
224506,increase,0,0
224507,in,0,0
224508,plasma,0,0
224509,BK,0,1
224510,or,0,1
224511,subsequent,0,0
224512,adverse,0,0
224513,effect,0,0
224514,were,0,0
224515,recorded,0,0
224516,in,0,0
224517,the,0,0
224518,night,0,0
224519,trial,0,0
224520,.,0,0
224521,Plasma,0,0
224522,substance,0,0
224523,P,0,0
224524,and,0,0
224525,PGE2,0,0
224526,did,0,0
224527,not,0,0
224528,change,0,0
224529,significantly,0,0
224530,following,0,0
224531,enalapril,0,0
224532,administration,0,0
224533,either,0,0
224534,in,0,0
224535,the,0,0
224536,day,0,0
224537,or,0,0
224538,night,0,0
224539,trial,0,0
224540,.,0,0
224541,The,0,0
224542,results,0,0
224543,suggest,0,0
224544,that,0,0
224545,the,0,0
224546,response,0,0
224547,of,0,0
224548,BK,0,1
224549,to,0,0
224550,enalapril,0,0
224551,is,0,0
224552,affected,0,0
224553,by,0,0
224554,the,0,0
224555,time,0,0
224556,of,0,0
224557,administration,0,0
224558,.,0,1
224559,In,0,0
224560,patients,0,1
224561,who,0,1
224562,complain,0,1
224563,of,0,1
224564,cough,0,1
224565,during,0,0
224566,treatment,0,0
224567,with,0,1
224568,enalapril,0,0
224569,during,0,0
224570,the,0,0
224571,daytime,0,0
224572,",",0,0
224573,this,0,0
224574,adverse,0,0
224575,effect,0,0
224576,might,0,0
224577,be,0,0
224578,diminished,0,0
224579,or,0,0
224580,eliminated,0,0
224581,by,0,0
224582,a,0,0
224583,switch,0,0
224584,to,0,0
224585,night-time,0,0
224586,administration,0,0
224587,.,0,1
224588,Five-year,0,1
224589,follow-up,0,0
224590,of,0,0
224591,the,0,0
224592,Fluorouracil,0,0
224593,Filtering,0,0
224594,Surgery,0,1
224595,Study,0,0
224596,.,0,0
224597,The,0,0
224598,Fluorouracil,0,0
224599,Filtering,0,0
224600,Surgery,0,1
224601,Study,0,1
224602,Group,0,1
224603,.,0,1
224604,PURPOSE,0,0
224605,To,0,0
224606,determine,0,0
224607,the,0,0
224608,efficacy,0,0
224609,and,0,0
224610,safety,0,0
224611,of,0,0
224612,subconjunctival,0,0
224613,5-,0,0
224614,fluorouracil,0,0
224615,injections,0,0
224616,after,0,0
224617,trabeculectomy,0,1
224618,in,0,0
224619,patients,1,1
224620,with,1,1
224621,poor,1,1
224622,prognoses,1,0
224623,",",1,0
224624,to,1,0
224625,determine,1,0
224626,risk,1,0
224627,factors,1,0
224628,for,1,0
224629,surgical,1,1
224630,failure,1,1
224631,and,1,0
224632,to,1,0
224633,examine,1,0
224634,the,1,0
224635,relationship,1,0
224636,of,1,0
224637,intraocular,1,0
224638,pressure,1,0
224639,and,1,0
224640,visual,1,0
224641,function,1,0
224642,.,1,0
224643,METHODS,0,0
224644,In,0,0
224645,this,0,0
224646,multicenter,0,0
224647,clinical,0,0
224648,trial,0,0
224649,",",0,0
224650,213,1,1
224651,patients,1,1
224652,with,1,1
224653,previous,1,0
224654,cataract,1,1
224655,surgery,1,1
224656,or,1,1
224657,previous,1,0
224658,failed,1,0
224659,filtering,1,0
224660,surgery,1,1
224661,were,0,0
224662,randomly,0,1
224663,assigned,0,0
224664,to,0,0
224665,receive,0,0
224666,either,0,0
224667,trabeculectomy,0,0
224668,alone,0,0
224669,or,0,0
224670,trabeculectomy,0,0
224671,with,0,1
224672,postoperative,0,0
224673,subconjunctival,0,0
224674,5-fluorouracil,0,1
224675,injections,0,0
224676,.,0,1
224677,Measurements,0,0
224678,of,0,0
224679,intraocular,0,0
224680,pressure,0,0
224681,",",0,0
224682,visual,0,0
224683,acuity,0,0
224684,",",0,0
224685,and,0,0
224686,visual,0,0
224687,fields,0,0
224688,were,0,1
224689,performed,0,0
224690,throughout,0,0
224691,the,0,0
224692,five,0,1
224693,years,0,1
224694,",",0,0
224695,with,0,1
224696,the,0,0
224697,clinician,0,0
224698,masked,0,0
224699,to,0,0
224700,the,0,0
224701,treatment,0,0
224702,group,0,0
224703,.,0,0
224704,Failure,0,0
224705,was,0,0
224706,defined,0,0
224707,as,0,0
224708,a,0,0
224709,reoperation,0,0
224710,to,0,0
224711,control,0,0
224712,intraocular,0,0
224713,pressure,0,0
224714,or,0,1
224715,an,0,0
224716,intraocular,0,0
224717,pressure,0,0
224718,greater,0,0
224719,than,0,0
224720,21,0,1
224721,mm,0,0
224722,Hg,0,0
224723,at,0,0
224724,or,0,1
224725,after,0,0
224726,the,0,0
224727,first-year,0,1
224728,examination,0,0
224729,.,0,1
224730,RESULTS,0,0
224731,Fifty-four,0,1
224732,(,0,1
224733,51,0,1
224734,%,0,0
224735,),0,0
224736,of,0,0
224737,the,0,0
224738,105,0,1
224739,eyes,0,1
224740,in,0,0
224741,the,0,0
224742,5-fluorouracil,0,0
224743,group,0,0
224744,and,0,0
224745,80,0,1
224746,(,0,0
224747,74,0,1
224748,%,0,0
224749,),0,0
224750,of,0,0
224751,the,0,0
224752,108,0,1
224753,eyes,0,1
224754,in,0,0
224755,the,0,0
224756,standard,0,0
224757,filtering,0,0
224758,surgery,0,1
224759,group,0,0
224760,were,0,0
224761,classified,0,1
224762,as,0,0
224763,failures,0,0
224764,(,0,1
224765,P,0,0
224766,<,0,0
224767,.001,0,0
224768,",",0,0
224769,Mantel-Cox,0,0
224770,survival,0,0
224771,analysis,0,0
224772,),0,0
224773,.,0,0
224774,Risk,0,1
224775,factors,0,0
224776,for,0,0
224777,failure,0,1
224778,include,0,0
224779,high,0,0
224780,intraocular,0,0
224781,pressure,0,0
224782,",",0,0
224783,a,0,0
224784,short,0,0
224785,time,0,0
224786,interval,0,0
224787,after,0,0
224788,the,0,0
224789,last,0,0
224790,procedure,0,0
224791,involving,0,1
224792,a,0,0
224793,conjunctival,0,0
224794,incision,0,0
224795,",",0,0
224796,the,0,0
224797,number,0,0
224798,of,0,0
224799,procedures,0,0
224800,with,0,1
224801,conjunctival,0,1
224802,incisions,0,0
224803,",",0,0
224804,and,0,0
224805,Hispanic,0,1
224806,ethnicity,0,1
224807,.,0,1
224808,Patients,0,1
224809,in,0,0
224810,both,0,0
224811,treatment,0,0
224812,groups,0,0
224813,with,0,1
224814,controlled,0,1
224815,intraocular,0,1
224816,pressures,0,0
224817,were,0,0
224818,more,0,0
224819,likely,0,0
224820,to,0,0
224821,maintain,0,0
224822,visual,0,0
224823,acuity,0,0
224824,.,0,1
224825,Patients,0,1
224826,in,0,0
224827,the,0,0
224828,5-fluorouracil,0,0
224829,group,0,0
224830,had,0,0
224831,a,0,0
224832,higher,0,0
224833,risk,0,0
224834,of,0,0
224835,late-onset,0,1
224836,bleb,0,1
224837,leaks,0,0
224838,(,0,1
224839,9,0,1
224840,%,0,0
224841,nine,0,1
224842,of,0,0
224843,105,0,1
224844,),0,0
224845,than,0,0
224846,those,0,0
224847,in,0,0
224848,the,0,0
224849,standard,0,0
224850,filtering,0,0
224851,surgery,0,1
224852,group,0,0
224853,(,0,0
224854,2,0,0
224855,%,0,0
224856,two,0,0
224857,of,0,0
224858,108,0,1
224859,),0,1
224860,(,0,0
224861,P,0,0
224862,=,0,0
224863,.032,0,0
224864,",",0,0
224865,Fisher,0,0
224866,'s,0,1
224867,exact,0,0
224868,test,0,0
224869,),0,0
224870,.,0,0
224871,CONCLUSIONS,0,0
224872,We,0,0
224873,recommend,0,0
224874,the,0,0
224875,use,0,0
224876,of,0,0
224877,subconjunctival,0,0
224878,5-fluorouracil,0,0
224879,after,0,0
224880,trabeculectomy,0,1
224881,in,0,0
224882,eyes,1,1
224883,after,1,0
224884,previous,1,0
224885,cataract,1,1
224886,surgery,1,1
224887,or,1,1
224888,unsuccessful,1,0
224889,filtering,1,0
224890,surgery,1,1
224891,",",0,0
224892,but,0,0
224893,caution,0,0
224894,against,0,0
224895,its,0,0
224896,routine,0,0
224897,use,0,0
224898,in,0,0
224899,patients,0,1
224900,with,0,1
224901,good,0,1
224902,prognoses,0,1
224903,.,0,1
224904,Efficacy,0,0
224905,of,0,0
224906,outpatient,0,1
224907,induction,0,1
224908,with,0,1
224909,low-dose,0,0
224910,intravaginal,0,0
224911,prostaglandin,0,0
224912,E2,0,1
224913,:,0,1
224914,a,0,0
224915,randomized,0,0
224916,",",0,0
224917,double-blind,0,0
224918,",",0,0
224919,placebo-controlled,0,0
224920,trial,0,0
224921,.,0,0
224922,OBJECTIVE,0,0
224923,Our,0,0
224924,purpose,0,0
224925,was,0,0
224926,to,0,0
224927,determine,0,0
224928,whether,0,0
224929,a,0,0
224930,protocol,0,0
224931,for,0,0
224932,outpatient,1,1
224933,induction,0,0
224934,is,0,0
224935,safe,0,0
224936,and,0,0
224937,effective,0,0
224938,for,0,0
224939,initiating,0,0
224940,labor,0,1
224941,.,0,1
224942,STUDY,0,0
224943,DESIGN,0,0
224944,A,0,0
224945,randomized,0,0
224946,",",0,0
224947,double-blind,0,0
224948,",",0,0
224949,placebo-controlled,0,0
224950,trial,0,0
224951,was,0,0
224952,performed,0,0
224953,with,0,1
224954,100,1,0
224955,low-risk,1,1
224956,patients,1,1
224957,having,1,1
224958,well-dated,1,1
224959,pregnancies,1,1
224960,.,1,1
224961,Women,1,1
224962,with,1,1
224963,a,1,0
224964,Bishop,1,0
224965,score,1,0
224966,<,1,0
224967,or,1,0
224968,=,1,0
224969,6,1,0
224970,at,1,0
224971,38,1,1
224972,to,1,1
224973,40,1,1
224974,weeks,1,0
224975,',1,1
224976,gestation,1,1
224977,were,0,0
224978,administered,0,0
224979,either,0,0
224980,2,0,0
224981,mg,0,0
224982,of,0,0
224983,intravaginal,0,0
224984,prostaglandin,0,0
224985,E2,0,1
224986,gel,0,0
224987,or,0,0
224988,placebo,0,0
224989,for,0,0
224990,5,0,1
224991,consecutive,0,1
224992,days,0,0
224993,as,0,0
224994,outpatients,0,1
224995,while,0,0
224996,undergoing,0,1
224997,fetal,0,1
224998,monitoring,0,0
224999,.,0,0
225000,RESULTS,0,0
225001,The,0,0
225002,median,0,0
225003,interval,0,0
225004,from,0,0
225005,randomization,0,0
225006,to,0,0
225007,delivery,0,0
225008,was,0,0
225009,4,0,0
225010,days,0,0
225011,in,0,0
225012,the,0,0
225013,prostaglandin,0,0
225014,E2,0,0
225015,group,0,0
225016,(,0,0
225017,range,0,0
225018,0,0,0
225019,to,0,0
225020,28,0,1
225021,days,0,0
225022,),0,1
225023,versus,0,0
225024,10,0,0
225025,days,0,0
225026,in,0,0
225027,the,0,0
225028,placebo,0,0
225029,group,0,0
225030,(,0,0
225031,range,0,0
225032,0,0,0
225033,to,0,0
225034,26,0,1
225035,days,0,0
225036,",",0,0
225037,p,0,0
225038,=,0,0
225039,0.002,0,0
225040,),0,0
225041,.,0,1
225042,Twenty-seven,0,1
225043,of,0,0
225044,50,1,1
225045,patients,1,1
225046,(,0,1
225047,54,0,1
225048,%,0,0
225049,),0,0
225050,in,0,0
225051,the,0,0
225052,prostaglandin,0,0
225053,E2,0,0
225054,group,0,0
225055,were,0,0
225056,admitted,0,1
225057,for,0,0
225058,labor,0,1
225059,during,0,0
225060,the,0,0
225061,dosing,0,0
225062,interval,0,0
225063,compared,0,0
225064,with,0,1
225065,10,0,1
225066,placebo-treated,0,0
225067,patients,0,1
225068,(,0,1
225069,20,0,1
225070,%,0,0
225071,",",0,0
225072,p,0,0
225073,=,0,0
225074,0.001,0,0
225075,),0,0
225076,.,0,0
225077,The,0,0
225078,mean,0,0
225079,gestational,0,1
225080,age,0,1
225081,at,0,0
225082,delivery,0,0
225083,was,0,0
225084,significantly,0,0
225085,reduced,0,0
225086,in,0,0
225087,the,0,0
225088,treatment,0,0
225089,group,0,0
225090,(,0,0
225091,39.9,0,0
225092,+/-,0,0
225093,1.0,0,0
225094,weeks,0,0
225095,vs,0,0
225096,40.5,0,1
225097,+/-,0,0
225098,0.99,0,0
225099,weeks,0,0
225100,",",0,0
225101,p,0,0
225102,=,0,0
225103,0.003,0,0
225104,),0,0
225105,as,0,0
225106,was,0,0
225107,the,0,0
225108,incidence,0,0
225109,of,0,0
225110,postdates,0,0
225111,pregnancy,0,1
225112,(,0,1
225113,40,0,1
225114,%,0,0
225115,vs,0,0
225116,66,0,1
225117,%,0,0
225118,",",0,0
225119,p,0,0
225120,=,0,0
225121,0.016,0,0
225122,),0,0
225123,.,0,1
225124,Hyperstimulation,0,0
225125,was,0,0
225126,observed,0,0
225127,in,0,0
225128,one,0,1
225129,prostaglandin,0,0
225130,E2-treated,0,0
225131,patient,0,0
225132,",",0,0
225133,but,0,0
225134,no,0,0
225135,intervention,0,0
225136,was,0,0
225137,required,0,0
225138,.,0,1
225139,CONCLUSIONS,0,0
225140,Outpatient,0,1
225141,low-dose,0,0
225142,prostaglandin,0,0
225143,E2,0,1
225144,gel,0,0
225145,administration,0,0
225146,is,0,0
225147,effective,0,0
225148,for,0,0
225149,initiating,0,0
225150,labor,0,1
225151,in,0,0
225152,patients,1,1
225153,with,1,1
225154,an,1,0
225155,unfavorable,1,0
225156,cervix,1,0
225157,and,0,0
225158,appears,0,0
225159,safe,0,0
225160,if,0,0
225161,performed,0,0
225162,with,0,1
225163,adequate,0,0
225164,monitoring,0,0
225165,.,0,1
225166,Iobitridol,0,0
225167,300,0,0
225168,compared,0,0
225169,to,0,0
225170,iopromide,0,0
225171,300,0,0
225172,--,0,0
225173,a,0,0
225174,double-blind,0,0
225175,randomized,0,0
225176,phase-III,0,0
225177,study,0,0
225178,of,0,0
225179,clinical,0,0
225180,tolerance,0,0
225181,in,0,0
225182,total,1,1
225183,body,1,1
225184,CT.,1,0
225185,UNLABELLED,0,0
225186,PURPOSE,0,0
225187,",",0,0
225188,MATERIAL,0,0
225189,AND,0,0
225190,METHODS,0,0
225191,:,0,1
225192,The,0,0
225193,clinical,0,0
225194,safety,0,0
225195,of,0,0
225196,iobitriodol,0,0
225197,300,0,0
225198,mg,0,0
225199,I/ml,0,0
225200,and,0,0
225201,iopromide,0,0
225202,300,0,0
225203,mg,0,0
225204,I/ml,0,0
225205,were,0,0
225206,compared,0,0
225207,in,0,0
225208,a,0,0
225209,randomized,0,0
225210,double,0,0
225211,blind,0,1
225212,phase-III,0,0
225213,study,0,0
225214,conducted,0,0
225215,on,0,0
225216,60,1,1
225217,patients,1,1
225218,undergoing,1,1
225219,abdominal,1,1
225220,CT,1,1
225221,for,1,0
225222,a,1,0
225223,variety,1,0
225224,of,1,0
225225,indications,1,0
225226,.,1,1
225227,Each,0,0
225228,examination,0,0
225229,was,0,0
225230,rated,0,0
225231,as,0,0
225232,diagnostic,0,0
225233,or,0,1
225234,nondiagnostic,0,1
225235,and,0,0
225236,the,0,0
225237,image,0,0
225238,quality,0,0
225239,was,0,0
225240,noted,0,0
225241,.,0,0
225242,Nature,0,0
225243,",",0,0
225244,onset,0,0
225245,",",0,0
225246,intensity,0,0
225247,as,0,0
225248,well,0,0
225249,as,0,0
225250,outcome,0,0
225251,of,0,0
225252,each,0,0
225253,adverse,0,0
225254,reaction,0,0
225255,were,0,0
225256,recorded,0,0
225257,.,0,0
225258,RESULTS,0,0
225259,There,0,0
225260,was,0,0
225261,no,0,0
225262,significant,0,0
225263,difference,0,0
225264,in,0,0
225265,imaging,0,0
225266,quality,0,0
225267,and,0,0
225268,side,0,0
225269,effects,0,0
225270,between,0,0
225271,the,0,0
225272,contrast,0,0
225273,media,0,0
225274,.,0,1
225275,In,0,0
225276,this,0,0
225277,study,0,0
225278,",",0,0
225279,both,0,0
225280,iobitridol,0,0
225281,and,0,0
225282,iopromide,0,0
225283,provided,0,0
225284,excellent,0,0
225285,image,0,0
225286,quality,0,0
225287,and,0,0
225288,a,0,0
225289,low,0,0
225290,rate,0,0
225291,of,0,0
225292,side,0,0
225293,effects,0,0
225294,.,0,1
225295,CONCLUSION,0,0
225296,Iobitridol,0,0
225297,is,0,0
225298,a,0,0
225299,safe,0,0
225300,and,0,0
225301,effective,0,0
225302,nonionic,0,0
225303,contrast,0,0
225304,agent,0,0
225305,for,0,0
225306,contrast-enhanced,0,1
225307,body,0,1
225308,CT,0,1
225309,.,0,1
225310,Pentoxifylline,0,0
225311,therapy,0,0
225312,in,0,0
225313,HIV,1,1
225314,seropositive,1,1
225315,subjects,1,1
225316,with,1,1
225317,elevated,1,1
225318,TNF,1,1
225319,.,1,1
225320,Tumor,0,0
225321,necrosis,0,0
225322,factor-alpha,0,0
225323,(,0,1
225324,TNF-alpha,0,0
225325,),0,0
225326,is,0,0
225327,thought,0,0
225328,to,0,0
225329,induce,0,0
225330,cachexia,0,1
225331,in,0,0
225332,subjects,0,1
225333,infected,0,1
225334,with,0,1
225335,human,0,1
225336,immunodeficiency,0,1
225337,virus,0,1
225338,(,0,0
225339,HIV,0,1
225340,),0,0
225341,",",0,0
225342,and,0,0
225343,it,0,0
225344,has,0,0
225345,been,0,0
225346,suggested,0,0
225347,that,0,0
225348,HIV-seropositive,1,1
225349,patients,1,1
225350,would,0,0
225351,benefit,0,0
225352,from,0,0
225353,treatment,0,0
225354,with,0,1
225355,pentoxifylline,0,0
225356,",",0,0
225357,a,0,0
225358,known,0,0
225359,suppressor,0,0
225360,of,0,0
225361,TNF-alpha,0,0
225362,production,0,0
225363,.,0,0
225364,The,0,0
225365,purpose,0,0
225366,of,0,0
225367,the,0,0
225368,present,0,0
225369,study,0,0
225370,was,0,0
225371,to,0,0
225372,examine,0,0
225373,how,0,0
225374,pentoxifylline,0,0
225375,at,0,0
225376,a,0,0
225377,dose,0,0
225378,of,0,0
225379,800,0,0
225380,mg,0,0
225381,thrice,0,0
225382,daily,0,0
225383,would,0,0
225384,influence,0,0
225385,the,0,0
225386,cellular,0,0
225387,immune,0,0
225388,system,0,0
225389,in,0,0
225390,HIV-seropositive,0,1
225391,persons,1,1
225392,with,1,1
225393,elevated,1,1
225394,TNF-alpha,1,1
225395,.,1,1
225396,Six,1,0
225397,HIV-seropositive,1,1
225398,subjects,1,1
225399,with,1,1
225400,elevated,1,1
225401,amounts,1,0
225402,of,1,0
225403,TNF-alpha,1,0
225404,in,1,0
225405,plasma,1,0
225406,at,1,0
225407,least,1,1
225408,at,1,0
225409,two,1,0
225410,occasions,1,0
225411,were,0,1
225412,included,0,1
225413,in,0,0
225414,an,0,0
225415,open,0,1
225416,",",0,0
225417,controlled,0,0
225418,",",0,0
225419,randomized,0,0
225420,",",0,0
225421,cross-over,0,0
225422,study,0,0
225423,consisting,0,1
225424,of,0,0
225425,a,0,0
225426,6,0,0
225427,week,0,0
225428,treatment,0,0
225429,period,0,0
225430,and,0,0
225431,a,0,0
225432,6,0,0
225433,week,0,0
225434,control,0,1
225435,period,0,0
225436,.,0,0
225437,Blood,0,0
225438,samples,0,0
225439,were,0,0
225440,collected,0,0
225441,before,0,0
225442,and,0,0
225443,at,0,0
225444,the,0,0
225445,end,0,0
225446,of,0,0
225447,each,0,0
225448,period,0,0
225449,.,0,0
225450,Pentoxifylline,0,0
225451,treatment,0,0
225452,did,0,0
225453,not,0,0
225454,influence,0,0
225455,the,0,0
225456,concentration,0,0
225457,of,0,0
225458,plasma-TNF-alpha,0,0
225459,",",0,0
225460,subpopulations,0,0
225461,of,0,0
225462,blood,0,0
225463,mononuclear,0,0
225464,cells,0,0
225465,",",0,0
225466,the,0,0
225467,proliferative,0,0
225468,responses,0,0
225469,nor,0,0
225470,the,0,0
225471,natural,0,0
225472,killer,0,0
225473,(,0,0
225474,NK,0,0
225475,),0,0
225476,",",0,0
225477,and,0,0
225478,lymphokine,0,0
225479,activated,0,0
225480,killer,0,0
225481,(,0,0
225482,LAK,0,0
225483,),0,0
225484,cell,0,1
225485,activities,0,0
225486,.,0,0
225487,Furthermore,0,0
225488,",",0,0
225489,pentoxifylline,0,0
225490,treatment,0,0
225491,did,0,0
225492,not,0,0
225493,influence,0,0
225494,the,0,0
225495,weight,0,0
225496,",",0,0
225497,temperature,0,0
225498,",",0,0
225499,well,0,0
225500,being,0,0
225501,",",0,0
225502,or,0,0
225503,tiredness,0,0
225504,of,0,0
225505,the,0,0
225506,subjects,0,1
225507,.,0,0
225508,However,0,0
225509,",",0,0
225510,the,0,0
225511,patients,0,1
225512,frequently,0,0
225513,reported,0,0
225514,gastrointestinal,0,1
225515,side,0,0
225516,effects,0,0
225517,.,0,1
225518,In,0,0
225519,vitro,0,0
225520,",",0,0
225521,however,0,0
225522,",",0,0
225523,pentoxifylline,0,0
225524,at,0,0
225525,suprapharmacological,0,0
225526,concentrations,0,0
225527,inhibited,0,0
225528,the,0,0
225529,blood,0,0
225530,mononuclear,0,0
225531,cell,0,0
225532,(,0,0
225533,BMNC,0,0
225534,),0,0
225535,proliferative,0,1
225536,responses,0,0
225537,",",0,0
225538,NK,0,0
225539,",",0,0
225540,and,0,0
225541,LAK,0,0
225542,cell,0,1
225543,activities,0,0
225544,.,0,1
225545,[,0,0
225546,Effectiveness,0,0
225547,of,0,0
225548,adjuvant,0,0
225549,hormone,0,0
225550,therapy,0,0
225551,in,0,0
225552,breast,0,1
225553,cancer,0,1
225554,],0,1
225555,.,0,1
225556,A,0,0
225557,third,0,0
225558,series,0,0
225559,of,0,0
225560,randomized,0,1
225561,tests,0,0
225562,was,0,0
225563,undertaken,0,0
225564,to,0,0
225565,evaluate,0,0
225566,the,0,0
225567,efficacy,0,0
225568,of,0,0
225569,postoperative,0,0
225570,adjuvant,0,0
225571,hormone,0,0
225572,therapy,0,0
225573,(,0,0
225574,tamoxifen,0,0
225575,",",0,0
225576,diethylstilbestrol,0,0
225577,",",0,0
225578,orimethen,0,0
225579,amino,0,0
225580,glutethymide,0,0
225581,),0,0
225582,in,0,0
225583,breast,1,1
225584,cancer,1,1
225585,patients,1,1
225586,.,1,1
225587,Tamoxifen,0,0
225588,was,0,0
225589,studied,0,1
225590,in,0,0
225591,176,1,1
225592,patients,1,1
225593,with,1,1
225594,T1-2N0M0,1,1
225595,tumors,1,1
225596,.,1,1
225597,Five-year,0,0
225598,recurrence-free,0,0
225599,survival,0,0
225600,was,0,0
225601,registered,0,1
225602,in,0,0
225603,85.2,0,0
225604,%,0,0
225605,of,0,0
225606,menopausal,0,1
225607,patients,0,1
225608,treated,0,1
225609,with,0,1
225610,tamoxifen,0,1
225611,versus,0,0
225612,71.1,0,0
225613,%,0,0
225614,in,0,0
225615,control,0,0
225616,(,0,0
225617,P,0,0
225618,<,0,0
225619,0.05,0,0
225620,),0,1
225621,.,0,1
225622,Five-year,0,0
225623,recurrence-free,0,0
225624,survival,0,0
225625,in,0,0
225626,menopausal,0,1
225627,females,0,1
225628,with,0,1
225629,breast,0,1
225630,tumors,0,1
225631,",",0,0
225632,stage,0,1
225633,IIb,0,0
225634,",",0,0
225635,was,0,0
225636,71.1,0,0
225637,%,0,0
225638,among,0,0
225639,those,0,0
225640,treated,0,0
225641,with,0,0
225642,diethylstilbestrol,0,1
225643,and,0,0
225644,as,0,0
225645,low,0,0
225646,as,0,0
225647,57.4,0,0
225648,%,0,0
225649,in,0,0
225650,the,0,0
225651,tamoxifen,0,0
225652,group,0,0
225653,(,0,0
225654,P,0,0
225655,<,0,0
225656,0.05,0,0
225657,),0,1
225658,.,0,1
225659,Untoward,0,0
225660,side-effect,0,0
225661,incidence,0,0
225662,was,0,0
225663,much,0,0
225664,higher,0,0
225665,in,0,0
225666,the,0,0
225667,diethylstilbestrol,0,1
225668,group,0,0
225669,(,0,0
225670,30.4,0,0
225671,%,0,0
225672,),0,0
225673,as,0,0
225674,compared,0,0
225675,with,0,1
225676,tamoxifen,0,0
225677,(,0,0
225678,3.5,0,0
225679,%,0,0
225680,),0,0
225681,.,0,0
225682,No,0,0
225683,significant,0,0
225684,difference,0,0
225685,was,0,0
225686,found,0,0
225687,for,0,0
225688,the,0,0
225689,relationship,0,0
225690,between,0,0
225691,orimethen,0,0
225692,and,0,0
225693,tamoxifen,0,0
225694,treatment,0,0
225695,with,0,1
225696,respect,0,0
225697,to,0,0
225698,5-year,0,0
225699,survival,0,0
225700,and,0,0
225701,recurrence-free,0,0
225702,survival,0,0
225703,.,0,1
225704,Comparison,0,0
225705,of,0,0
225706,regimens,0,0
225707,of,0,0
225708,amphotericin,0,0
225709,B,0,0
225710,deoxycholate,0,0
225711,in,0,0
225712,kala-azar,1,1
225713,.,1,0
225714,A,0,0
225715,total,0,1
225716,of,0,0
225717,288,1,1
225718,parasitologically,1,1
225719,proved,1,0
225720,patients,1,1
225721,of,1,1
225722,kala-azar,1,1
225723,were,0,1
225724,randomly,0,1
225725,allocated,0,1
225726,to,0,0
225727,three,0,0
225728,treatment,0,0
225729,groups,0,0
225730,.,0,1
225731,Patients,0,1
225732,in,0,0
225733,groups,0,0
225734,A,0,1
225735,",",0,0
225736,B,0,0
225737,and,0,0
225738,C,0,0
225739,received,0,0
225740,amphotericin,0,0
225741,B,0,1
225742,(,0,1
225743,AMB,0,0
225744,),0,0
225745,in,0,0
225746,a,0,0
225747,dose,0,0
225748,of,0,0
225749,1,0,0
225750,mg/kg,0,0
225751,body,0,1
225752,weight,0,0
225753,(,0,0
225754,bw,0,0
225755,),0,0
225756,/day,0,0
225757,",",0,0
225758,0.75,0,0
225759,mg/kg,0,0
225760,bw/day,0,0
225761,and,0,0
225762,0.5,0,0
225763,mg/kg,0,0
225764,bw/day,0,0
225765,for,0,0
225766,20,0,1
225767,days,0,0
225768,respectively,0,0
225769,.,0,1
225770,Apparent,0,0
225771,cure,0,0
225772,(,0,0
225773,afebrile,0,0
225774,at,0,0
225775,the,0,0
225776,end,0,0
225777,of,0,0
225778,therapy,0,0
225779,),0,0
225780,occurred,0,0
225781,in,0,0
225782,all,0,0
225783,patients,0,1
225784,and,0,0
225785,parasitological,0,0
225786,cure,0,0
225787,in,0,0
225788,96,0,1
225789,(,0,1
225790,100,0,0
225791,%,0,0
225792,),0,0
225793,",",0,0
225794,92,0,1
225795,(,0,0
225796,96,0,1
225797,%,0,0
225798,),0,0
225799,and,0,0
225800,84,0,1
225801,(,0,0
225802,88,0,1
225803,%,0,0
225804,),0,0
225805,patients,0,1
225806,respectively,0,0
225807,in,0,0
225808,groups,0,0
225809,A,0,1
225810,",",0,0
225811,B,0,0
225812,and,0,0
225813,C.,0,0
225814,Ultimate,0,0
225815,cure,0,0
225816,(,0,0
225817,no,0,0
225818,relapse,0,0
225819,in,0,0
225820,six,0,1
225821,months,0,0
225822,of,0,0
225823,follow,0,0
225824,up,0,0
225825,),0,0
225826,occurred,0,0
225827,in,0,0
225828,95,0,0
225829,(,0,1
225830,99,0,1
225831,%,0,0
225832,),0,0
225833,",",0,0
225834,87,0,1
225835,(,0,0
225836,91,0,1
225837,%,0,0
225838,),0,0
225839,and,0,0
225840,79,0,1
225841,(,0,0
225842,82,0,1
225843,%,0,0
225844,),0,0
225845,patients,0,1
225846,in,0,1
225847,groups,0,0
225848,A,0,1
225849,",",0,0
225850,B,0,0
225851,and,0,0
225852,C,0,0
225853,respectively,0,0
225854,.,0,0
225855,The,0,0
225856,difference,0,0
225857,between,0,0
225858,the,0,0
225859,ultimate,0,0
225860,cure,0,0
225861,in,0,0
225862,the,0,0
225863,three,0,0
225864,groups,0,0
225865,was,0,0
225866,significant,0,0
225867,(,0,1
225868,P,0,0
225869,<,0,0
225870,0.05,0,0
225871,),0,0
225872,.,0,0
225873,The,0,0
225874,incidence,0,0
225875,of,0,0
225876,adverse,0,0
225877,events,0,0
225878,(,0,0
225879,rise,0,0
225880,in,0,0
225881,serum,0,0
225882,creatinine,0,0
225883,and,0,0
225884,fall,0,0
225885,in,0,0
225886,serum,0,0
225887,potassium,0,0
225888,",",0,0
225889,loss,0,0
225890,of,0,0
225891,appetite,0,0
225892,and,0,0
225893,shivering,0,0
225894,",",0,0
225895,rigor,0,0
225896,and,0,0
225897,fever,0,0
225898,during,0,0
225899,infusion,0,0
225900,indicative,0,0
225901,of,0,0
225902,renal,0,1
225903,",",0,0
225904,GIT,0,1
225905,and,0,0
225906,infusion,0,0
225907,related,0,0
225908,toxicities,0,0
225909,respectively,0,0
225910,),0,0
225911,was,0,0
225912,similar,0,0
225913,in,0,0
225914,the,0,0
225915,three,0,0
225916,groups,0,0
225917,.,0,1
225918,This,0,0
225919,study,0,0
225920,showed,0,0
225921,that,0,0
225922,amphotericin,0,0
225923,B,0,0
225924,should,0,0
225925,be,0,0
225926,given,0,0
225927,at,0,0
225928,a,0,0
225929,dosage,0,0
225930,of,0,0
225931,1,0,0
225932,mg/kg,0,0
225933,bw/day,0,0
225934,for,0,0
225935,20,0,1
225936,days,0,0
225937,for,0,1
225938,Indian,1,1
225939,kala-azar,1,1
225940,patients,1,1
225941,to,0,0
225942,minimise,0,0
225943,relapses,0,0
225944,and,0,0
225945,prevent,0,0
225946,development,0,0
225947,of,0,0
225948,drug,0,0
225949,unresponsiveness,0,1
225950,.,0,1
225951,Randomized,0,0
225952,trial,0,0
225953,comparing,0,0
225954,induction,0,0
225955,chemotherapy,0,0
225956,versus,0,0
225957,induction,0,0
225958,chemotherapy,0,0
225959,followed,0,0
225960,by,0,0
225961,maintenance,0,0
225962,chemotherapy,0,1
225963,in,0,0
225964,small-cell,1,1
225965,lung,1,1
225966,cancer,1,1
225967,.,1,1
225968,European,0,1
225969,Lung,0,0
225970,Cancer,0,1
225971,Working,0,1
225972,Party,0,1
225973,.,0,1
225974,PURPOSE,0,0
225975,AND,0,0
225976,METHODS,0,0
225977,The,0,0
225978,European,0,1
225979,Lung,0,0
225980,Cancer,0,1
225981,Working,0,1
225982,Party,0,1
225983,(,0,0
225984,ELCWP,0,1
225985,),0,0
225986,performed,0,0
225987,a,0,0
225988,randomized,0,0
225989,trial,0,0
225990,with,0,1
225991,the,0,0
225992,primary,0,0
225993,end,0,0
225994,point,0,0
225995,to,0,0
225996,determine,0,0
225997,if,0,0
225998,maintenance,0,0
225999,chemotherapy,0,1
226000,with,0,1
226001,12,0,0
226002,courses,0,0
226003,of,0,0
226004,etoposide,0,0
226005,(,0,0
226006,120,0,1
226007,mg/m2,0,0
226008,on,0,0
226009,days,0,0
226010,1,0,1
226011,and,0,1
226012,3,0,0
226013,),0,0
226014,and,0,0
226015,vindesine,0,0
226016,(,0,0
226017,3,0,0
226018,mg/m2,0,0
226019,on,0,0
226020,day,0,0
226021,3,0,0
226022,),0,0
226023,could,0,0
226024,improve,0,0
226025,progression-free,0,0
226026,survival,0,0
226027,in,0,0
226028,small-cell,1,1
226029,lung,1,1
226030,cancer,1,1
226031,(,1,0
226032,SCLC,1,0
226033,),1,1
226034,patients,1,1
226035,who,1,1
226036,responded,1,1
226037,to,1,1
226038,six,1,1
226039,courses,1,0
226040,of,1,0
226041,induction,1,1
226042,chemotherapy,1,0
226043,with,1,1
226044,ifosfamide,1,0
226045,",",1,0
226046,etoposide,1,0
226047,",",1,0
226048,and,1,0
226049,an,1,0
226050,anthracycline,1,0
226051,(,1,0
226052,doxorubicin,1,0
226053,or,1,1
226054,epirubicin,1,0
226055,),1,0
226056,.,1,0
226057,RESULTS,0,0
226058,Among,1,1
226059,235,1,1
226060,eligible,1,1
226061,patients,1,1
226062,initially,1,1
226063,registered,1,1
226064,",",1,0
226065,91,1,1
226066,were,1,0
226067,randomized,1,0
226068,to,1,0
226069,receive,1,0
226070,maintenance,1,0
226071,therapy,1,0
226072,",",1,0
226073,including,1,0
226074,seven,1,1
226075,patients,1,1
226076,who,1,1
226077,were,1,1
226078,no,1,0
226079,longer,1,0
226080,responding,1,0
226081,.,1,0
226082,Among,0,1
226083,84,0,1
226084,randomized,0,1
226085,responders,0,0
226086,",",0,0
226087,progression-free,0,0
226088,survival,0,0
226089,was,0,0
226090,significantly,0,0
226091,improved,0,0
226092,(,0,0
226093,P,0,0
226094,=,0,0
226095,.003,0,0
226096,),0,0
226097,by,0,0
226098,maintenance,0,0
226099,therapy,0,0
226100,",",0,0
226101,with,0,1
226102,median,0,0
226103,durations,0,0
226104,(,0,0
226105,maintenance,0,0
226106,v,0,0
226107,follow-up,0,0
226108,),0,1
226109,of,0,0
226110,25,0,1
226111,versus,0,0
226112,12,0,1
226113,weeks,0,0
226114,after,0,0
226115,the,0,0
226116,second,0,0
226117,randomization,0,0
226118,",",0,0
226119,but,0,0
226120,survival,0,0
226121,was,0,0
226122,not,0,0
226123,significantly,0,0
226124,increased,0,0
226125,(,0,0
226126,P,0,0
226127,=,0,0
226128,.10,0,0
226129,),0,0
226130,",",0,0
226131,with,0,1
226132,median,0,0
226133,durations,0,0
226134,of,0,1
226135,48,0,1
226136,and,0,1
226137,38,0,1
226138,weeks,0,0
226139,.,0,1
226140,However,0,0
226141,",",0,0
226142,in,0,0
226143,a,0,0
226144,multi-variate,0,0
226145,analysis,0,0
226146,that,0,0
226147,took,0,0
226148,into,0,0
226149,account,0,0
226150,disease,0,1
226151,extent,0,0
226152,",",0,0
226153,maintenance,0,0
226154,therapy,0,0
226155,",",0,0
226156,Karnofsky,0,1
226157,performance,0,0
226158,status,0,0
226159,(,0,0
226160,PS,0,1
226161,),0,0
226162,",",0,0
226163,and,0,0
226164,absolute,0,0
226165,dose-intensity,0,0
226166,(,0,0
226167,ADI,0,0
226168,),0,0
226169,of,0,0
226170,anthracycline,0,1
226171,given,0,0
226172,during,0,0
226173,induction,0,0
226174,",",0,0
226175,limited,0,0
226176,disease,0,1
226177,(,0,0
226178,LD,0,0
226179,),0,0
226180,and,0,0
226181,maintenance,0,0
226182,were,0,0
226183,found,0,0
226184,to,0,0
226185,be,0,0
226186,independent,0,0
226187,positive,0,0
226188,predictors,0,0
226189,of,0,0
226190,survival,0,0
226191,.,0,1
226192,CONCLUSION,0,0
226193,We,0,0
226194,conclude,0,0
226195,that,0,0
226196,maintenance,0,0
226197,chemotherapy,0,0
226198,in,0,0
226199,responding,0,0
226200,patients,0,1
226201,is,0,0
226202,beneficial,0,0
226203,in,0,0
226204,SCLC,0,1
226205,.,0,1
226206,[,0,0
226207,Clinical,0,0
226208,early,0,0
226209,phase,0,1
226210,II,0,1
226211,study,0,0
226212,of,0,0
226213,bicalutamide,0,1
226214,(,0,0
226215,Casodex,0,0
226216,),0,0
226217,in,0,0
226218,patients,1,1
226219,with,1,1
226220,prostatic,1,1
226221,cancer,1,1
226222,],1,0
226223,.,0,0
226224,To,0,0
226225,investigate,0,0
226226,the,0,0
226227,efficacy,0,0
226228,and,0,0
226229,safety,0,0
226230,of,0,0
226231,bicalutamide,0,1
226232,(,0,0
226233,Casodex,0,0
226234,),0,0
226235,with,0,1
226236,its,0,0
226237,clinically,0,0
226238,recommended,0,0
226239,dose,0,0
226240,",",0,0
226241,the,0,0
226242,randomized,0,0
226243,early,0,0
226244,phase,0,1
226245,II,0,1
226246,study,0,0
226247,was,0,0
226248,performed,0,0
226249,in,0,0
226250,124,1,1
226251,patients,1,1
226252,with,1,1
226253,prostatic,1,1
226254,cancer,1,1
226255,(,1,0
226256,stage,1,1
226257,C,1,0
226258,",",1,0
226259,D,1,0
226260,),1,0
226261,.,1,0
226262,The,0,0
226263,patients,0,1
226264,were,0,0
226265,given,0,0
226266,50,0,1
226267,",",0,0
226268,80,0,1
226269,or,0,1
226270,100,0,0
226271,mg,0,0
226272,of,0,0
226273,bicalutamide,0,0
226274,orally,0,0
226275,once,0,0
226276,a,0,0
226277,day,0,0
226278,in,0,0
226279,fixed,0,0
226280,doses,0,0
226281,for,0,1
226282,12,0,1
226283,weeks,0,1
226284,;,0,1
226285,122,0,1
226286,patients,0,1
226287,were,0,1
226288,eligible,0,1
226289,for,0,0
226290,evaluation,0,0
226291,.,0,0
226292,The,0,0
226293,overall,0,0
226294,response,0,0
226295,rate,0,0
226296,was,0,0
226297,50.0,0,0
226298,%,0,0
226299,(,0,1
226300,20/40,0,0
226301,),0,0
226302,",",0,0
226303,61.0,0,0
226304,%,0,0
226305,(,0,1
226306,25/41,0,0
226307,),0,1
226308,and,0,0
226309,53.7,0,1
226310,%,0,0
226311,(,0,1
226312,22/41,0,0
226313,),0,0
226314,in,0,0
226315,the,0,0
226316,50,0,0
226317,mg,0,0
226318,",",0,0
226319,80,0,1
226320,mg,0,0
226321,and,0,0
226322,100,0,0
226323,mg,0,0
226324,groups,0,0
226325,",",0,0
226326,respectively,0,0
226327,.,0,0
226328,The,0,0
226329,response,0,0
226330,rate,0,0
226331,in,0,0
226332,prostate,0,1
226333,lesion,0,0
226334,",",0,0
226335,bone,0,0
226336,and,0,0
226337,lymph,0,1
226338,node,0,1
226339,metastases,0,1
226340,was,0,0
226341,slightly,0,0
226342,higher,0,0
226343,in,0,0
226344,the,0,0
226345,80,0,1
226346,mg,0,0
226347,group,0,0
226348,than,0,0
226349,in,0,0
226350,the,0,0
226351,50,0,0
226352,mg,0,0
226353,and,0,0
226354,100,0,0
226355,mg,0,0
226356,groups,0,0
226357,.,0,0
226358,The,0,0
226359,proportion,0,0
226360,of,0,0
226361,patients,0,1
226362,showing,0,0
226363,a,0,0
226364,response,0,0
226365,with,0,0
226366,regard,0,0
226367,to,0,0
226368,serum,0,0
226369,PSA,0,0
226370,(,0,0
226371,CR,0,0
226372,and,0,0
226373,PR,0,0
226374,),0,0
226375,was,0,0
226376,84.2,0,0
226377,",",0,0
226378,92.7,0,0
226379,and,0,0
226380,97.6,0,0
226381,%,0,0
226382,in,0,0
226383,the,0,0
226384,50,0,0
226385,",",0,0
226386,80,0,1
226387,and,0,0
226388,100,0,0
226389,mg,0,0
226390,groups,0,0
226391,",",0,0
226392,respectively,0,0
226393,.,0,0
226394,The,0,0
226395,incidence,0,0
226396,of,0,0
226397,adverse,0,0
226398,reactions,0,0
226399,was,0,0
226400,65.0,0,1
226401,",",0,0
226402,61.0,0,0
226403,and,0,0
226404,61.0,0,0
226405,%,0,0
226406,in,0,0
226407,the,0,0
226408,50,0,0
226409,",",0,0
226410,80,0,1
226411,and,0,0
226412,100,0,0
226413,mg,0,0
226414,groups,0,0
226415,",",0,0
226416,respectively,0,0
226417,",",0,0
226418,and,0,0
226419,there,0,0
226420,was,0,0
226421,no,0,0
226422,significant,0,0
226423,difference,0,0
226424,in,0,0
226425,overall,0,0
226426,safety,0,0
226427,rating,0,0
226428,in,0,0
226429,the,0,0
226430,three,0,0
226431,groups,0,0
226432,.,0,1
226433,Frequent,0,0
226434,adverse,0,0
226435,reactions,0,0
226436,were,0,1
226437,gynecomastia,0,1
226438,and,0,0
226439,breast,0,1
226440,pain,0,0
226441,.,0,0
226442,Only,0,0
226443,one,0,0
226444,patient,0,0
226445,in,0,0
226446,the,0,0
226447,80,0,1
226448,mg,0,0
226449,group,0,0
226450,was,0,0
226451,withdrawn,0,0
226452,due,0,0
226453,to,0,0
226454,shortness,0,0
226455,of,0,0
226456,breath,0,0
226457,.,0,1
226458,Serum,0,0
226459,concentrations,0,0
226460,of,0,0
226461,LH,0,1
226462,",",0,0
226463,testosterone,0,0
226464,and,0,0
226465,estradiol,0,0
226466,increased,0,0
226467,significantly,0,0
226468,after,0,0
226469,treatment,0,0
226470,.,0,1
226471,Bicalutamide,0,0
226472,was,0,0
226473,concluded,0,0
226474,to,0,0
226475,be,0,0
226476,effective,0,0
226477,and,0,0
226478,well,0,0
226479,tolerated,0,0
226480,in,0,0
226481,patients,1,1
226482,with,1,1
226483,prostatic,1,1
226484,cancer,1,1
226485,",",0,0
226486,and,0,0
226487,its,0,0
226488,recommended,0,0
226489,dose,0,0
226490,was,0,0
226491,80,0,1
226492,mg,0,0
226493,once,0,0
226494,daily,0,0
226495,.,0,0
226496,Accuracy,0,0
226497,of,0,0
226498,pelvic,1,1
226499,radiotherapy,1,1
226500,:,1,1
226501,prospective,0,0
226502,analysis,0,0
226503,of,0,0
226504,90,1,1
226505,patients,1,1
226506,in,0,0
226507,a,0,0
226508,randomised,0,0
226509,trial,0,0
226510,of,0,0
226511,blocked,0,0
226512,versus,0,0
226513,standard,0,0
226514,radiotherapy,0,1
226515,.,0,0
226516,The,0,0
226517,aim,0,0
226518,of,0,0
226519,this,0,0
226520,study,0,0
226521,was,0,0
226522,to,0,0
226523,assess,0,0
226524,the,0,0
226525,accuracy,0,0
226526,of,0,0
226527,pelvic,0,1
226528,radiotherapy,0,1
226529,during,0,0
226530,a,0,0
226531,trial,0,0
226532,of,0,0
226533,blocked,0,0
226534,radiotherapy,0,1
226535,at,0,0
226536,the,0,0
226537,Royal,0,1
226538,Marsden,0,1
226539,Hospital,0,1
226540,",",0,0
226541,UK,1,1
226542,.,1,0
226543,Prospective,0,0
226544,evaluation,0,0
226545,was,0,0
226546,performed,0,0
226547,on,0,0
226548,90,1,1
226549,patients,1,1
226550,receiving,1,1
226551,CT,1,1
226552,planned,1,1
226553,pelvic,1,1
226554,radiotherapy,1,1
226555,using,1,0
226556,weekly,1,0
226557,anterior-posterior,1,0
226558,and,1,1
226559,lateral,1,1
226560,portal,1,0
226561,films,1,1
226562,.,1,1
226563,Field,0,0
226564,placement,0,0
226565,errors,0,0
226566,(,0,1
226567,FPEs,0,1
226568,),0,0
226569,were,0,0
226570,calculated,0,0
226571,by,0,0
226572,comparing,0,0
226573,field,0,0
226574,centres,0,1
226575,of,0,0
226576,each,0,0
226577,film,0,0
226578,with,0,0
226579,a,0,0
226580,designated,0,0
226581,point,0,0
226582,of,0,0
226583,interest,0,0
226584,.,0,1
226585,Data,0,0
226586,was,0,0
226587,evaluated,0,0
226588,to,0,0
226589,calculate,0,0
226590,the,0,0
226591,overall,0,0
226592,treatment,0,0
226593,simulator,0,0
226594,differences,0,0
226595,",",0,0
226596,the,0,0
226597,number,0,0
226598,of,0,0
226599,error,0,0
226600,free,0,1
226601,treatments,0,0
226602,",",0,0
226603,and,0,0
226604,mean,0,0
226605,treatment-simulator,0,0
226606,position,0,0
226607,and,0,0
226608,to,0,0
226609,evaluate,0,0
226610,the,0,0
226611,role,0,0
226612,of,0,0
226613,systematic,0,0
226614,versus,0,0
226615,random,0,1
226616,errors,0,0
226617,.,0,1
226618,Age,0,0
226619,",",0,0
226620,weight,0,0
226621,",",0,0
226622,disease,0,1
226623,site,0,0
226624,",",0,0
226625,position,0,0
226626,of,0,0
226627,treatment,0,0
226628,",",0,0
226629,fractionation,0,0
226630,",",0,0
226631,blocked,0,0
226632,versus,0,0
226633,conventional,0,1
226634,techniques,0,0
226635,were,0,1
226636,assessed,0,0
226637,for,0,0
226638,their,0,0
226639,effect,0,0
226640,on,0,0
226641,treatment,0,0
226642,accuracy,0,0
226643,.,0,0
226644,The,0,0
226645,mean,0,0
226646,absolute,0,0
226647,error,0,0
226648,between,0,0
226649,treatment,0,0
226650,and,0,0
226651,simulator,0,0
226652,films,0,0
226653,was,0,0
226654,anterior,0,1
226655,right-left,0,0
226656,(,0,0
226657,ARL,0,0
226658,),0,1
226659,0.25,0,0
226660,cm,0,1
226661,",",0,0
226662,anterior,0,1
226663,superior-inferior,0,0
226664,(,0,1
226665,ASI,0,0
226666,),0,1
226667,0.32,0,0
226668,cm,0,1
226669,",",0,0
226670,lateral,0,0
226671,anterior-posterior,0,0
226672,(,0,1
226673,LAP,0,1
226674,),0,1
226675,0.42,0,0
226676,cm,0,1
226677,",",0,0
226678,and,0,0
226679,lateral,0,0
226680,superior-inferior,0,0
226681,(,0,1
226682,LSI,0,1
226683,),0,1
226684,0.28,0,0
226685,cm,0,1
226686,.,0,1
226687,On,0,0
226688,average,0,0
226689,the,0,0
226690,field,0,0
226691,centre,0,1
226692,was,0,0
226693,displaced,0,1
226694,by,0,0
226695,0.66,0,0
226696,cm,0,1
226697,(,0,0
226698,standard,0,0
226699,deviation,0,0
226700,",",0,0
226701,S.D,0,0
226702,.,0,0
226703,=,0,0
226704,0.34,0,0
226705,),0,0
226706,from,0,0
226707,that,0,0
226708,intended,0,0
226709,.,0,0
226710,On,0,0
226711,each,0,0
226712,treatment,0,0
226713,day,0,0
226714,29,0,1
226715,%,0,0
226716,of,0,0
226717,anterior,0,1
226718,films,0,1
226719,and,0,1
226720,45,0,1
226721,%,0,0
226722,of,0,0
226723,lateral,0,1
226724,films,0,0
226725,had,0,1
226726,at,0,0
226727,least,0,1
226728,one,0,1
226729,0.5,0,0
226730,cm,0,1
226731,error,0,0
226732,.,0,1
226733,Overall,0,0
226734,59,0,1
226735,%,0,0
226736,of,0,0
226737,treatments,0,0
226738,had,0,1
226739,at,0,0
226740,least,0,1
226741,one,0,1
226742,0.5,0,0
226743,cm,0,1
226744,error,0,0
226745,and,0,0
226746,9,0,0
226747,%,0,0
226748,a,0,0
226749,1.0,0,0
226750,cm,0,1
226751,error,0,0
226752,.,0,0
226753,The,0,0
226754,field,0,0
226755,centre,0,1
226756,was,0,0
226757,more,0,0
226758,than,0,0
226759,0.5,0,0
226760,cm,0,1
226761,from,0,0
226762,the,0,0
226763,position,0,0
226764,intended,0,0
226765,in,0,0
226766,66,0,1
226767,%,0,0
226768,of,0,0
226769,treatments,0,0
226770,and,0,1
226771,over,0,0
226772,1,0,0
226773,cm,0,1
226774,for,0,1
226775,14,0,1
226776,%,0,0
226777,of,0,0
226778,treatments,0,0
226779,.,0,1
226780,Analysis,0,0
226781,of,0,0
226782,variance,0,0
226783,showed,0,0
226784,that,0,0
226785,both,0,0
226786,random,0,0
226787,and,0,0
226788,systematic,0,0
226789,errors,0,0
226790,occurred,0,0
226791,in,0,0
226792,all,0,1
226793,directions,0,0
226794,.,0,0
226795,Though,0,0
226796,random,0,1
226797,errors,0,0
226798,were,0,1
226799,of,0,0
226800,similar,0,0
226801,magnitude,0,0
226802,in,0,0
226803,all,0,0
226804,direction,0,0
226805,(,0,0
226806,variance,0,0
226807,sigma,0,0
226808,2,0,0
226809,=,0,0
226810,0.06-0.09,0,0
226811,cm2,0,0
226812,),0,1
226813,;,0,0
226814,systematic,0,0
226815,errors,0,0
226816,showed,0,0
226817,a,0,0
226818,4-fold,0,0
226819,variation,0,0
226820,being,0,0
226821,greatest,0,0
226822,in,0,0
226823,the,0,0
226824,LAP,0,0
226825,direction,0,0
226826,(,0,0
226827,sigma,0,0
226828,2,0,1
226829,=,0,0
226830,0.19,0,0
226831,cm2,0,0
226832,),0,0
226833,and,0,0
226834,least,0,0
226835,the,0,0
226836,ARL,0,0
226837,direction,0,0
226838,(,0,0
226839,sigma,0,0
226840,2,0,1
226841,=,0,0
226842,0.048,0,0
226843,cm2,0,0
226844,),0,0
226845,.,0,0
226846,No,0,0
226847,factor,0,0
226848,consistently,0,0
226849,predicted,0,0
226850,for,0,0
226851,worse,0,0
226852,outcome,0,0
226853,in,0,0
226854,all,0,1
226855,directions,0,0
226856,.,0,1
226857,Hypofractionated,0,0
226858,treatments,0,0
226859,were,0,1
226860,less,0,0
226861,accurate,0,0
226862,in,0,0
226863,the,0,0
226864,LSI,0,0
226865,direction,0,0
226866,(,0,0
226867,P,0,0
226868,>,0,1
226869,0.05,0,0
226870,),0,1
226871,.,0,1
226872,Systematic,0,0
226873,errors,0,0
226874,were,0,1
226875,associated,0,0
226876,in,0,0
226877,the,0,0
226878,ARL,0,0
226879,direction,0,0
226880,with,0,1
226881,hypofractionation,0,1
226882,(,0,0
226883,P,0,0
226884,<,0,0
226885,0.01,0,0
226886,),0,0
226887,and,0,0
226888,",",0,0
226889,in,0,0
226890,the,0,0
226891,LSI,0,0
226892,direction,0,0
226893,with,0,1
226894,weight,0,0
226895,(,0,0
226896,P,0,0
226897,<,0,0
226898,0.03,0,0
226899,),0,0
226900,and,0,0
226901,age,0,1
226902,(,0,0
226903,P,0,0
226904,<,0,0
226905,0.05,0,0
226906,),0,0
226907,.,0,0
226908,We,0,0
226909,conclude,0,0
226910,that,0,0
226911,significant,0,0
226912,random,0,1
226913,and,0,0
226914,systematic,0,0
226915,errors,0,0
226916,can,0,0
226917,occur,0,0
226918,during,0,0
226919,pelvic,0,1
226920,radiotherapy,0,1
226921,especially,0,0
226922,in,0,0
226923,the,0,0
226924,LAP,0,0
226925,direction,0,0
226926,.,0,0
226927,These,0,0
226928,results,0,0
226929,suggest,0,0
226930,that,0,0
226931,in,0,0
226932,the,0,0
226933,absence,0,0
226934,of,0,0
226935,a,0,0
226936,customised,0,0
226937,immobilisation,0,0
226938,device,0,0
226939,",",0,0
226940,to,0,0
226941,cover,0,0
226942,95,0,0
226943,%,0,0
226944,of,0,0
226945,errors,0,0
226946,",",0,0
226947,margins,0,0
226948,of,0,0
226949,0.6,0,0
226950,cm,0,1
226951,for,0,0
226952,RL,0,0
226953,and,0,1
226954,SI,0,1
226955,directions,0,0
226956,and,0,1
226957,0.9,0,0
226958,cm,0,1
226959,for,0,0
226960,AP,0,0
226961,direction,0,0
226962,should,0,0
226963,be,0,0
226964,allowed,0,0
226965,between,0,0
226966,the,0,0
226967,planning,0,0
226968,and,0,0
226969,clinical,0,0
226970,target,0,0
226971,volumes,0,0
226972,.,0,0
226973,However,0,0
226974,",",0,0
226975,ideally,0,0
226976,",",0,0
226977,each,0,0
226978,centre,0,0
226979,should,0,0
226980,determine,0,0
226981,their,0,0
226982,own,0,1
226983,margin,0,0
226984,requirements,0,0
226985,according,0,1
226986,to,0,0
226987,local,0,0
226988,clinical,0,0
226989,practice,0,1
226990,.,0,1
226991,Risperidone,0,0
226992,in,0,0
226993,the,0,0
226994,treatment,0,0
226995,of,0,0
226996,negative,0,0
226997,symptoms,0,0
226998,of,0,1
226999,schizophrenia,1,1
227000,:,1,1
227001,a,0,0
227002,meta-analysis,0,0
227003,.,0,0
227004,Risperidone,0,0
227005,has,0,0
227006,antiserotonergic,0,0
227007,and,0,0
227008,antidopaminergic,0,1
227009,properties,0,0
227010,that,0,0
227011,may,0,0
227012,make,0,0
227013,it,0,0
227014,more,0,0
227015,effective,0,0
227016,than,0,0
227017,conventional,0,1
227018,antipsychotic,0,1
227019,agents,0,0
227020,in,0,0
227021,the,0,0
227022,treatment,0,0
227023,of,0,0
227024,the,0,0
227025,negative,0,0
227026,symptoms,0,0
227027,of,0,0
227028,schizophrenia,1,1
227029,.,1,1
227030,Clinical,0,0
227031,trials,0,0
227032,in,0,1
227033,chronic,1,1
227034,schizophrenic,1,1
227035,patients,1,1
227036,have,0,1
227037,shown,0,0
227038,trends,0,0
227039,in,0,0
227040,favor,0,0
227041,of,0,0
227042,risperidone,0,0
227043,in,0,0
227044,the,0,0
227045,control,0,0
227046,of,0,0
227047,negative,0,1
227048,symptoms,0,0
227049,compared,0,0
227050,with,0,1
227051,haloperidol,0,0
227052,",",0,0
227053,perphenazine,0,0
227054,or,0,0
227055,zuclopenthixol,0,0
227056,",",0,0
227057,but,0,0
227058,the,0,0
227059,differences,0,0
227060,were,0,0
227061,not,0,0
227062,consistently,0,0
227063,statistically,0,0
227064,significant,0,0
227065,.,0,0
227066,A,0,0
227067,meta-analysis,0,0
227068,of,0,0
227069,the,0,0
227070,pooled,0,0
227071,results,0,0
227072,from,0,1
227073,six,1,1
227074,double-blind,1,1
227075,trials,1,0
227076,showed,0,0
227077,that,0,0
227078,risperidone,0,0
227079,at,0,0
227080,doses,0,0
227081,ranging,0,1
227082,from,0,1
227083,4,0,0
227084,to,0,0
227085,8,0,0
227086,mg/day,0,0
227087,had,0,0
227088,a,0,0
227089,significantly,0,0
227090,(,0,0
227091,p,0,0
227092,<,0,0
227093,0.004,0,0
227094,),0,0
227095,higher,0,0
227096,negative,0,0
227097,symptom,0,0
227098,response,0,0
227099,rate,0,0
227100,",",0,0
227101,defined,0,0
227102,as,0,0
227103,the,0,0
227104,percentage,0,0
227105,of,0,0
227106,patients,0,1
227107,with,0,1
227108,a,0,1
227109,20,0,0
227110,%,0,0
227111,or,0,1
227112,more,0,0
227113,reduction,0,0
227114,in,0,0
227115,scores,0,0
227116,on,0,0
227117,the,0,0
227118,negative,0,0
227119,subscale,0,0
227120,of,0,0
227121,the,0,0
227122,Positive,0,1
227123,and,0,0
227124,Negative,0,1
227125,Syndrome,0,1
227126,Scale,0,0
227127,",",0,0
227128,than,0,0
227129,patients,0,1
227130,receiving,0,1
227131,active,0,1
227132,controls,0,1
227133,.,0,1
227134,The,0,0
227135,combined,1,0
227136,patient,1,0
227137,population,1,1
227138,treated,0,1
227139,with,0,1
227140,4-8,0,1
227141,mg/day,0,0
227142,of,0,0
227143,risperidone,0,0
227144,was,0,0
227145,1.43,0,0
227146,times,0,0
227147,more,0,0
227148,likely,0,0
227149,to,0,0
227150,have,0,0
227151,had,0,0
227152,a,0,0
227153,clinical,0,0
227154,response,0,0
227155,on,0,0
227156,the,0,0
227157,negative,0,0
227158,symptom,0,0
227159,subscale,0,0
227160,than,0,0
227161,the,0,0
227162,combined,0,0
227163,population,0,1
227164,treated,0,1
227165,with,0,1
227166,haloperidol,0,0
227167,",",0,0
227168,perphenazine,0,0
227169,or,0,0
227170,zuclopenthixol,0,0
227171,.,0,1
227172,Prediction,0,0
227173,of,0,0
227174,the,0,0
227175,infarct-related,0,0
227176,artery,0,1
227177,in,0,0
227178,acute,0,1
227179,myocardial,0,1
227180,infarction,0,1
227181,by,0,0
227182,a,0,0
227183,scoring,0,0
227184,system,0,0
227185,using,0,0
227186,summary,0,0
227187,ST-segment,0,1
227188,and,0,1
227189,T-wave,0,1
227190,changes,0,0
227191,.,0,1
227192,We,0,0
227193,developed,0,0
227194,a,0,0
227195,scoring,0,0
227196,system,0,0
227197,to,0,0
227198,predict,0,0
227199,the,0,0
227200,artery,0,0
227201,responsible,0,0
227202,for,0,0
227203,an,0,0
227204,acute,0,1
227205,myocardial,0,1
227206,infarction,0,1
227207,(,0,0
227208,AMI,0,1
227209,),0,0
227210,using,0,0
227211,ST-segment,0,0
227212,and,0,1
227213,T-wave,0,1
227214,changes,0,0
227215,on,0,0
227216,the,0,0
227217,initial,0,0
227218,electrocardiogram,0,0
227219,(,0,0
227220,ECG,0,1
227221,),0,0
227222,using,0,0
227223,data,0,0
227224,from,0,1
227225,228,1,1
227226,patients,1,1
227227,(,1,1
227228,development,1,0
227229,set,1,0
227230,),1,0
227231,with,1,1
227232,symptoms,1,0
227233,compatible,1,1
227234,with,1,1
227235,AMI,1,1
227236,and,1,0
227237,tested,1,0
227238,in,1,0
227239,a,1,0
227240,similar,1,0
227241,group,1,0
227242,of,1,0
227243,223,1,1
227244,patients,1,1
227245,(,1,1
227246,test,1,0
227247,set,1,0
227248,),1,0
227249,from,1,0
227250,the,1,0
227251,Thrombolysis,1,1
227252,and,1,0
227253,Angioplasty,1,1
227254,in,1,0
227255,Myocardial,1,1
227256,Infarction,1,1
227257,(,1,0
227258,TAMI-5,1,0
227259,),1,1
227260,Trial,1,0
227261,.,1,1
227262,Using,0,0
227263,stepwise,0,0
227264,logistic,0,0
227265,regression,0,0
227266,we,0,0
227267,were,0,0
227268,able,0,0
227269,to,0,0
227270,accurately,0,0
227271,predict,0,0
227272,the,0,0
227273,left,0,0
227274,anterior,0,1
227275,descending,0,1
227276,(,0,0
227277,LAD,0,0
227278,),0,0
227279,",",0,0
227280,right,0,0
227281,",",0,0
227282,or,0,0
227283,left,0,1
227284,circumflex,0,1
227285,(,0,0
227286,LC,0,0
227287,),0,0
227288,coronary,0,1
227289,artery,0,1
227290,as,0,0
227291,the,0,0
227292,infarct-related,0,0
227293,artery,0,1
227294,using,0,0
227295,2,0,1
227296,variables,0,0
227297,:,0,1
227298,(,0,1
227299,1,0,0
227300,),0,0
227301,the,0,0
227302,summation,0,0
227303,of,0,0
227304,the,0,0
227305,ST-segment,0,0
227306,elevation,0,0
227307,in,0,0
227308,leads,0,0
227309,V1,0,0
227310,to,0,0
227311,V4,0,1
227312,;,0,0
227313,and,0,0
227314,(,0,0
227315,2,0,0
227316,),0,0
227317,the,0,0
227318,summation,0,0
227319,of,0,0
227320,the,0,0
227321,T-wave,0,0
227322,negativity,0,0
227323,in,0,0
227324,leads,0,0
227325,I,0,1
227326,",",0,0
227327,aVL,0,0
227328,",",0,0
227329,and,0,0
227330,V5,0,0
227331,.,0,0
227332,In,0,0
227333,the,0,0
227334,development,0,0
227335,set,0,0
227336,",",0,0
227337,these,0,0
227338,2,0,0
227339,variables,0,0
227340,demonstrated,0,0
227341,respective,0,1
227342,sensitivity,0,0
227343,and,0,0
227344,specificity,0,0
227345,of,0,0
227346,98,0,1
227347,%,0,0
227348,and,0,0
227349,90,0,0
227350,%,0,0
227351,for,0,0
227352,LAD,0,0
227353,lesions,0,1
227354,",",0,0
227355,82,0,1
227356,%,0,0
227357,and,0,0
227358,85,0,0
227359,%,0,0
227360,for,0,0
227361,right,0,1
227362,narrowings,0,0
227363,",",0,0
227364,and,0,0
227365,82,0,1
227366,%,0,0
227367,and,0,0
227368,84,0,1
227369,%,0,0
227370,for,0,0
227371,LC,0,0
227372,narrowings,0,1
227373,.,0,1
227374,In,0,0
227375,the,0,0
227376,test,0,0
227377,set,0,0
227378,",",0,0
227379,the,0,0
227380,sensitivity,0,0
227381,and,0,0
227382,specificity,0,0
227383,were,0,0
227384,97,0,1
227385,%,0,0
227386,and,0,0
227387,95,0,0
227388,%,0,0
227389,for,0,0
227390,LAD,0,0
227391,lesions,0,1
227392,",",0,0
227393,85,0,1
227394,%,0,0
227395,and,0,0
227396,86,0,1
227397,%,0,0
227398,for,0,0
227399,right,0,1
227400,lesions,0,0
227401,",",0,0
227402,and,0,0
227403,73,0,0
227404,%,0,0
227405,and,0,0
227406,60,0,1
227407,%,0,0
227408,for,0,0
227409,LC,0,0
227410,coronary,0,1
227411,artery,0,1
227412,lesions,0,1
227413,.,0,1
227414,Information,0,0
227415,easily,0,0
227416,obtained,0,0
227417,on,0,0
227418,the,0,0
227419,ECG,0,0
227420,can,0,0
227421,accurately,0,0
227422,predict,0,0
227423,the,0,0
227424,likelihood,0,0
227425,of,0,0
227426,the,0,0
227427,LAD,0,0
227428,",",0,0
227429,right,0,0
227430,",",0,0
227431,or,0,0
227432,LC,0,0
227433,artery,0,1
227434,as,0,0
227435,the,0,0
227436,infarct-related,0,1
227437,artery,0,1
227438,.,0,0
227439,This,0,0
227440,may,0,0
227441,be,0,0
227442,useful,0,0
227443,in,0,0
227444,the,0,0
227445,decision,0,0
227446,to,0,0
227447,administer,0,0
227448,thrombolytic,0,1
227449,treatment,0,0
227450,.,0,1
227451,Comparison,0,0
227452,of,0,0
227453,analgesic,0,0
227454,effect,0,0
227455,of,0,0
227456,locally,0,0
227457,and,0,0
227458,systemically,0,0
227459,administered,0,0
227460,ketorolac,0,0
227461,in,0,0
227462,mastectomy,1,1
227463,patients,1,1
227464,.,1,1
227465,BACKGROUND,0,0
227466,Ketorolac,0,0
227467,is,0,0
227468,a,0,0
227469,parenteral,0,0
227470,nonsteroidal,0,0
227471,antiinflammatory,0,0
227472,drug,0,0
227473,(,0,0
227474,NSAID,0,1
227475,),0,1
227476,.,0,1
227477,Two,0,0
227478,features,0,0
227479,have,0,0
227480,limited,0,0
227481,its,0,0
227482,clinical,0,0
227483,utility,0,0
227484,:,0,1
227485,tendency,0,0
227486,to,0,0
227487,elicit,0,0
227488,kidney,0,1
227489,failure,0,1
227490,and,0,0
227491,inability,0,0
227492,to,0,0
227493,produce,0,0
227494,complete,0,0
227495,analgesia,0,0
227496,.,0,0
227497,Because,0,0
227498,most,0,0
227499,NSAIDs,0,0
227500,are,0,0
227501,weak,0,0
227502,acids,0,0
227503,(,0,1
227504,pKa,0,0
227505,3-5,0,1
227506,),0,0
227507,and,0,0
227508,become,0,0
227509,concentrated,0,0
227510,in,0,0
227511,acidic,0,0
227512,tissues,0,0
227513,",",0,0
227514,such,0,0
227515,as,0,0
227516,injured,0,1
227517,and,0,1
227518,inflamed,0,1
227519,tissues,0,0
227520,",",0,0
227521,we,0,0
227522,hypothesized,0,0
227523,that,0,0
227524,local,0,0
227525,administration,0,0
227526,may,0,0
227527,enhance,0,0
227528,its,0,0
227529,analgesic,0,0
227530,efficacy,0,0
227531,while,0,0
227532,lowering,0,0
227533,the,0,0
227534,potential,0,0
227535,for,0,0
227536,systemic,0,0
227537,complications,0,0
227538,.,0,1
227539,METHODS,0,0
227540,We,0,0
227541,conducted,0,0
227542,a,0,0
227543,randomized,0,0
227544,",",0,0
227545,placebo-controlled,0,0
227546,study,0,0
227547,of,0,0
227548,60,1,1
227549,group,1,1
227550,I-II,1,1
227551,(,1,0
227552,American,1,1
227553,Society,1,1
227554,of,1,0
227555,Anesthesiology,1,1
227556,criteria,1,1
227557,),1,1
227558,mastectomy,1,1
227559,patients,1,1
227560,",",1,0
227561,20,1,1
227562,in,1,0
227563,each,1,0
227564,group,1,0
227565,.,1,0
227566,Near,0,0
227567,the,0,0
227568,end,0,0
227569,of,0,0
227570,surgery,0,1
227571,and,0,0
227572,every,0,0
227573,6,0,0
227574,h,0,0
227575,postoperatively,0,0
227576,",",0,0
227577,20,0,0
227578,ml,0,0
227579,of,0,0
227580,the,0,0
227581,study,0,0
227582,solution,0,0
227583,containing,0,0
227584,normal,0,1
227585,saline,0,0
227586,with,0,1
227587,or,0,1
227588,without,0,1
227589,30,0,0
227590,mg,0,0
227591,of,0,0
227592,ketorolac,0,0
227593,were,0,0
227594,administered,0,0
227595,simultaneously,0,0
227596,either,0,0
227597,via,0,0
227598,a,0,0
227599,Jackson-Pratt,0,0
227600,drain,0,0
227601,or,0,0
227602,intravenously,0,0
227603,in,0,0
227604,a,0,0
227605,double-blind,0,0
227606,fashion,0,0
227607,.,0,0
227608,The,0,0
227609,quality,0,0
227610,of,0,0
227611,pain,0,0
227612,control,0,0
227613,",",0,0
227614,the,0,0
227615,amount,0,0
227616,and,0,0
227617,character,0,0
227618,of,0,0
227619,the,0,0
227620,drain,0,0
227621,fluid,0,0
227622,",",0,0
227623,incidence,0,0
227624,of,0,0
227625,nausea,0,0
227626,and,0,0
227627,vomiting,0,0
227628,",",0,0
227629,length,0,0
227630,of,0,0
227631,stay,0,0
227632,in,0,0
227633,the,0,0
227634,postoperative,0,0
227635,care,0,0
227636,unit,0,0
227637,",",0,0
227638,and,0,0
227639,amount,0,0
227640,of,0,0
227641,morphine,0,0
227642,used,0,0
227643,for,0,0
227644,treatment,0,0
227645,of,0,0
227646,break-through,0,0
227647,pain,0,1
227648,were,0,0
227649,recorded,0,0
227650,.,0,1
227651,RESULTS,0,0
227652,Intraoperative,0,0
227653,administration,0,0
227654,of,0,0
227655,ketorolac,0,0
227656,resulted,0,0
227657,in,0,0
227658,better,0,0
227659,quality,0,0
227660,of,0,0
227661,pain,0,0
227662,control,0,0
227663,in,0,0
227664,the,0,0
227665,immediate,0,0
227666,postoperative,0,0
227667,period,0,0
227668,regardless,0,0
227669,of,0,0
227670,route,0,0
227671,of,0,0
227672,administration,0,0
227673,.,0,0
227674,The,0,0
227675,incidence,0,0
227676,of,0,0
227677,nausea,0,0
227678,was,0,0
227679,significantly,0,0
227680,higher,0,0
227681,in,0,0
227682,the,0,0
227683,placebo,0,0
227684,group,0,0
227685,",",0,0
227686,and,0,0
227687,drain,0,0
227688,output,0,0
227689,in,0,0
227690,the,0,0
227691,ketorolac,0,0
227692,groups,0,0
227693,did,0,0
227694,not,0,0
227695,exceed,0,0
227696,the,0,0
227697,output,0,0
227698,in,0,0
227699,the,0,0
227700,placebo,0,0
227701,group,0,0
227702,.,0,1
227703,CONCLUSION,0,0
227704,Analgesic,0,0
227705,of,0,0
227706,the,0,0
227707,locally,0,0
227708,administered,0,0
227709,ketorolac,0,0
227710,is,0,0
227711,equally,0,0
227712,effective,0,0
227713,to,0,0
227714,the,0,0
227715,efficacy,0,0
227716,of,0,0
227717,ketorolac,0,0
227718,administered,0,0
227719,intravenously,0,1
227720,.,0,0
227721,The,0,0
227722,effect,0,0
227723,of,0,0
227724,tunnelling,0,0
227725,on,0,0
227726,epidural,0,0
227727,catheter,0,0
227728,migration,0,0
227729,.,0,0
227730,A,0,0
227731,prospective,0,0
227732,",",0,0
227733,randomised,0,0
227734,study,0,0
227735,of,0,0
227736,82,1,1
227737,patients,1,1
227738,having,1,1
227739,postoperative,1,0
227740,epidural,1,0
227741,analgesia,1,0
227742,was,0,0
227743,performed,0,0
227744,to,0,0
227745,determine,0,0
227746,whether,0,0
227747,the,0,0
227748,tunnelling,0,0
227749,of,0,0
227750,an,0,0
227751,epidural,1,0
227752,catheter,1,0
227753,influences,0,0
227754,its,0,0
227755,migration,0,0
227756,.,0,0
227757,Tunnelling,0,0
227758,of,0,0
227759,the,0,0
227760,catheter,0,0
227761,subcutaneously,0,0
227762,for,0,0
227763,a,0,0
227764,distance,0,0
227765,of,0,0
227766,5,0,0
227767,cm,0,1
227768,reduced,0,0
227769,the,0,0
227770,incidence,0,0
227771,of,0,0
227772,inward,0,0
227773,migration,0,0
227774,of,0,0
227775,1,0,0
227776,cm,0,1
227777,or,0,1
227778,more,0,0
227779,(,0,0
227780,p,0,0
227781,<,0,0
227782,0.01,0,0
227783,),0,0
227784,compared,0,0
227785,to,0,0
227786,a,0,0
227787,standard,0,0
227788,method,0,0
227789,of,0,0
227790,fixation,0,0
227791,with,0,1
227792,a,0,0
227793,transparent,0,0
227794,adhesive,0,0
227795,dressing,0,0
227796,.,0,0
227797,This,0,0
227798,effect,0,0
227799,was,0,0
227800,more,0,0
227801,marked,0,0
227802,if,0,0
227803,the,0,0
227804,epidural,0,0
227805,catheter,0,0
227806,was,0,0
227807,sited,0,0
227808,in,0,0
227809,the,0,0
227810,thoracic,0,1
227811,rather,0,0
227812,than,0,0
227813,the,0,0
227814,lumbar,0,1
227815,area,0,0
227816,.,0,1
227817,Sixty,0,1
227818,two,0,0
227819,percent,0,1
227820,(,0,0
227821,n,0,1
227822,=,0,0
227823,26,0,1
227824,),0,0
227825,of,0,0
227826,tunnelled,0,1
227827,catheters,0,1
227828,remained,0,0
227829,within,0,1
227830,0.5,0,0
227831,cm,0,1
227832,of,0,0
227833,their,0,1
227834,original,0,1
227835,position,0,0
227836,compared,0,0
227837,to,0,0
227838,38,0,1
227839,%,0,0
227840,(,0,0
227841,n,0,1
227842,=,0,0
227843,16,0,1
227844,),0,0
227845,of,0,0
227846,non-tunnelled,0,1
227847,catheters,0,0
227848,",",0,0
227849,although,0,0
227850,this,0,0
227851,difference,0,0
227852,was,0,0
227853,not,0,0
227854,statistically,0,0
227855,significant,0,0
227856,.,0,0
227857,Outward,0,0
227858,catheter,0,0
227859,migration,0,0
227860,was,0,0
227861,not,0,0
227862,reduced,0,0
227863,by,0,0
227864,subcutaneous,0,0
227865,tunnelling,0,0
227866,.,0,1
227867,MRI,0,0
227868,signal,0,0
227869,hyperintensities,0,1
227870,in,0,0
227871,geriatric,1,1
227872,depression,1,1
227873,.,1,0
227874,OBJECTIVE,0,0
227875,The,0,0
227876,authors,0,0
227877,rated,0,0
227878,periventricular,0,1
227879,and,0,0
227880,subcortical,0,0
227881,signal,0,0
227882,hyperintensities,0,1
227883,on,0,0
227884,magnetic,0,0
227885,resonance,0,0
227886,imaging,0,0
227887,(,0,0
227888,MRI,0,0
227889,),0,0
227890,scans,0,0
227891,in,0,0
227892,elderly,1,1
227893,patients,1,1
227894,with,1,1
227895,depression,1,1
227896,and,1,0
227897,in,1,0
227898,normal,1,1
227899,subjects,1,1
227900,with,0,1
227901,similar,0,0
227902,demographic,0,1
227903,features,0,1
227904,to,0,0
227905,examine,0,0
227906,whether,0,0
227907,such,0,0
227908,changes,0,0
227909,discriminate,0,0
227910,patients,0,1
227911,with,0,1
227912,depression,0,1
227913,from,0,1
227914,normal,0,1
227915,subjects,0,1
227916,and,0,0
227917,whether,0,0
227918,they,0,0
227919,are,0,0
227920,associated,0,0
227921,with,0,1
227922,any,0,0
227923,clinical,0,0
227924,variables,0,0
227925,.,0,1
227926,METHOD,0,0
227927,Two,1,1
227928,established,1,0
227929,hyperintensity,1,0
227930,rating,1,0
227931,systems,1,0
227932,were,0,0
227933,used,0,0
227934,to,0,0
227935,compare,0,0
227936,the,0,0
227937,MRI,1,0
227938,brain,1,0
227939,scans,1,0
227940,of,1,0
227941,48,1,1
227942,elderly,1,1
227943,patients,1,1
227944,with,1,1
227945,depression,1,1
227946,diagnosed,1,1
227947,according,1,0
227948,to,1,0
227949,DSM-III-R,1,0
227950,with,1,1
227951,the,1,0
227952,scans,1,0
227953,of,1,0
227954,39,1,1
227955,normal,1,1
227956,elderly,1,1
227957,subjects,1,1
227958,.,1,1
227959,RESULTS,0,0
227960,Elderly,1,1
227961,depressed,1,1
227962,patients,1,1
227963,manifested,0,0
227964,significantly,0,0
227965,more,0,0
227966,severe,0,1
227967,hyperintensity,0,0
227968,ratings,0,0
227969,in,0,0
227970,the,0,0
227971,subcortical,0,0
227972,gray,0,1
227973,matter,0,0
227974,than,0,0
227975,age-matched,0,1
227976,comparison,0,0
227977,subjects,0,1
227978,.,0,1
227979,Significant,0,0
227980,differences,0,0
227981,were,0,1
227982,not,0,0
227983,identified,0,0
227984,between,0,0
227985,patients,0,1
227986,with,0,1
227987,similar,0,0
227988,current,0,0
227989,ages,0,1
227990,and,0,1
227991,cerebrovascular,0,1
227992,disease,0,1
227993,risk,0,1
227994,who,0,1
227995,had,0,1
227996,early-onset,0,1
227997,or,0,1
227998,late-onset,0,1
227999,depression,0,1
228000,.,0,1
228001,CONCLUSIONS,0,0
228002,These,0,0
228003,findings,0,0
228004,support,0,0
228005,those,0,0
228006,of,0,0
228007,neuroimaging,0,0
228008,studies,0,0
228009,implicating,0,0
228010,the,0,0
228011,basal,0,0
228012,ganglia,0,0
228013,in,0,0
228014,depression,0,1
228015,and,0,0
228016,geriatric,0,1
228017,depression,0,1
228018,.,0,0
228019,The,0,0
228020,data,0,0
228021,suggest,0,0
228022,that,0,0
228023,the,0,0
228024,relationship,0,0
228025,observed,0,0
228026,in,0,0
228027,some,0,0
228028,reports,0,0
228029,between,0,0
228030,late-onset,0,1
228031,depression,0,1
228032,and,0,0
228033,MRI,0,0
228034,hyperintensities,0,0
228035,is,0,0
228036,most,0,0
228037,likely,0,0
228038,a,0,0
228039,function,0,0
228040,of,0,0
228041,cerebrovascular,0,1
228042,disease,0,1
228043,risk,0,0
228044,and,0,0
228045,age,0,1
228046,.,0,1
228047,Serum,0,1
228048,bactericidal,0,0
228049,activities,0,0
228050,and,0,1
228051,comparative,0,0
228052,pharmacokinetics,0,0
228053,of,0,0
228054,meropenem,0,0
228055,and,0,0
228056,imipenem-cilastatin,0,0
228057,.,0,0
228058,The,0,0
228059,pharmacokinetics,0,0
228060,and,0,0
228061,serum,0,0
228062,bactericidal,0,0
228063,activities,0,0
228064,(,0,1
228065,SBAs,0,0
228066,),0,0
228067,of,0,0
228068,imipenem,0,0
228069,and,0,0
228070,meropenem,0,0
228071,were,0,0
228072,investigated,0,0
228073,in,0,0
228074,a,0,0
228075,randomized,0,0
228076,crossover,0,0
228077,study,0,0
228078,.,0,0
228079,Twelve,1,1
228080,healthy,1,1
228081,male,1,1
228082,volunteers,1,1
228083,received,0,0
228084,a,0,0
228085,constant,0,0
228086,30-min,0,0
228087,infusion,0,0
228088,of,0,0
228089,either,0,0
228090,1,0,0
228091,g,0,0
228092,of,0,0
228093,imipenem,0,0
228094,plus,0,0
228095,1,0,0
228096,g,0,0
228097,of,0,0
228098,cilastatin,0,0
228099,or,0,1
228100,1,0,0
228101,g,0,0
228102,of,0,0
228103,meropenem,0,0
228104,.,0,0
228105,The,0,0
228106,concentrations,0,0
228107,of,0,0
228108,the,0,0
228109,drugs,0,0
228110,in,0,0
228111,serum,0,0
228112,and,0,0
228113,urine,0,0
228114,were,0,0
228115,determined,0,0
228116,by,0,0
228117,bioassay,0,0
228118,and,0,0
228119,high-pressure,0,0
228120,liquid,0,0
228121,chromatography,0,0
228122,.,0,1
228123,Pharmacokinetic,0,0
228124,parameters,0,0
228125,were,0,1
228126,based,0,0
228127,on,0,0
228128,an,0,0
228129,open,0,1
228130,two-compartment,0,0
228131,model,0,0
228132,and,0,0
228133,a,0,0
228134,noncompartmental,0,0
228135,technique,0,0
228136,.,0,0
228137,At,0,0
228138,the,0,0
228139,end,0,0
228140,of,0,0
228141,infusion,0,0
228142,",",0,0
228143,the,0,0
228144,mean,0,0
228145,concentrations,0,0
228146,of,0,0
228147,imipenem,0,0
228148,and,0,0
228149,meropenem,0,0
228150,measured,0,0
228151,in,0,0
228152,serum,0,0
228153,were,0,1
228154,61.2,0,0
228155,+/-,0,0
228156,9.8,0,0
228157,and,0,1
228158,51.6,0,1
228159,+/-,0,0
228160,6.5,0,0
228161,mg/liter,0,0
228162,",",0,0
228163,respectively,0,0
228164,;,0,0
228165,urinary,0,0
228166,recoveries,0,0
228167,were,0,1
228168,48.6,0,1
228169,%,0,0
228170,+/-,0,0
228171,8.2,0,0
228172,%,0,0
228173,and,0,0
228174,60.0,0,0
228175,%,0,0
228176,+/-,0,0
228177,6.5,0,0
228178,%,0,0
228179,of,0,0
228180,the,0,0
228181,dose,0,0
228182,in,0,0
228183,12,0,0
228184,h,0,0
228185,",",0,0
228186,respectively,0,0
228187,;,0,0
228188,and,0,0
228189,the,0,0
228190,areas,0,0
228191,under,0,0
228192,the,0,0
228193,concentration-time,0,0
228194,curve,0,0
228195,from,0,1
228196,time,0,0
228197,zero,0,0
228198,to,0,0
228199,infinity,0,0
228200,were,0,0
228201,96.1,0,0
228202,+/-,0,0
228203,14.4,0,0
228204,and,0,1
228205,70.5,0,0
228206,+/-,0,0
228207,10.3,0,0
228208,mg.h/liter,0,0
228209,",",0,0
228210,respectively,0,0
228211,(,0,0
228212,P,0,0
228213,<,0,0
228214,or,0,1
228215,=,0,0
228216,0.02,0,0
228217,),0,0
228218,.,0,1
228219,Imipenem,0,0
228220,had,0,0
228221,a,0,0
228222,mean,0,0
228223,half-life,0,0
228224,of,0,0
228225,66.7,0,0
228226,+/-,0,0
228227,10.4,0,0
228228,min,0,0
228229,;,0,0
228230,that,0,0
228231,of,0,0
228232,meropenem,0,0
228233,was,0,0
228234,64.4,0,0
228235,+/-,0,0
228236,6.9,0,0
228237,min,0,0
228238,.,0,1
228239,The,0,0
228240,volumes,0,0
228241,of,0,0
228242,distribution,0,1
228243,at,0,0
228244,steady,0,0
228245,state,0,1
228246,of,0,0
228247,imipenem,0,0
228248,and,0,0
228249,meropenem,0,0
228250,were,0,0
228251,15.3,0,1
228252,+/-,0,0
228253,3.3,0,1
228254,and,0,1
228255,18.6,0,0
228256,+/-,0,0
228257,3.0,0,0
228258,liters/70,0,0
228259,kg,0,0
228260,",",0,0
228261,respectively,0,0
228262,",",0,0
228263,and,0,0
228264,the,0,0
228265,mean,0,0
228266,renal,0,1
228267,clearances,0,0
228268,per,0,1
228269,1.73,0,1
228270,m2,0,1
228271,were,0,1
228272,85.6,0,0
228273,+/-,0,0
228274,17.6,0,0
228275,and,0,1
228276,144.6,0,0
228277,+/-,0,0
228278,26.0,0,0
228279,ml/min,0,0
228280,",",0,0
228281,respectively,0,0
228282,.,0,0
228283,Both,1,0
228284,antibiotics,1,0
228285,were,1,0
228286,well,1,0
228287,tolerated,1,0
228288,in,1,0
228289,this,1,0
228290,single-dose,1,0
228291,administration,1,0
228292,study,1,0
228293,.,1,0
228294,The,0,0
228295,SBAs,0,0
228296,were,0,0
228297,measured,0,0
228298,by,0,0
228299,the,0,0
228300,microdilution,0,0
228301,method,0,0
228302,of,0,0
228303,Reller,0,0
228304,and,0,0
228305,Stratton,0,0
228306,(,0,0
228307,L.,0,1
228308,B.,0,0
228309,Reller,0,0
228310,and,0,0
228311,C.,0,0
228312,W.,0,1
228313,Stratton,0,0
228314,",",0,0
228315,J.,0,0
228316,Infect,0,1
228317,.,0,1
228318,Dis,0,0
228319,.,0,0
228320,136:196-204,0,0
228321,",",0,0
228322,1977,0,1
228323,),0,0
228324,against,0,0
228325,40,0,1
228326,clinically,0,1
228327,isolated,0,1
228328,strains,0,0
228329,.,0,1
228330,Mean,0,1
228331,reciprocal,0,0
228332,bactericidal,0,0
228333,titers,0,0
228334,were,0,1
228335,measured,0,0
228336,1,0,0
228337,and,0,0
228338,6,0,0
228339,h,0,0
228340,after,0,0
228341,administration,0,0
228342,.,0,1
228343,After,0,0
228344,1,0,0
228345,and,0,0
228346,6,0,0
228347,h,0,0
228348,the,0,0
228349,median,0,0
228350,SBAs,0,0
228351,for,0,0
228352,imipenem,0,0
228353,and,0,0
228354,meropenem,0,0
228355,",",0,0
228356,were,0,0
228357,409,0,1
228358,and,0,0
228359,34.9,0,0
228360,and,0,0
228361,97.9,0,1
228362,and,0,0
228363,5.8,0,0
228364,",",0,0
228365,respectively,0,0
228366,",",0,0
228367,against,0,0
228368,Staphylococcus,0,0
228369,aureus,0,1
228370,",",0,0
228371,19.9,0,0
228372,and,0,0
228373,4.4,0,0
228374,and,0,0
228375,19.4,0,0
228376,and,0,0
228377,4.8,0,0
228378,",",0,0
228379,respectively,0,0
228380,",",0,0
228381,against,0,0
228382,Pseudomonas,0,1
228383,aeruginosa,0,0
228384,",",0,0
228385,34.3,0,0
228386,and,0,0
228387,2.2,0,0
228388,and,0,0
228389,232,0,1
228390,and,0,0
228391,15.5,0,0
228392,",",0,0
228393,respectively,0,0
228394,",",0,0
228395,against,0,0
228396,Enterobacter,0,0
228397,cloacae,0,0
228398,",",0,0
228399,and,0,0
228400,13.4,0,0
228401,and,0,0
228402,2.25,0,0
228403,and,0,0
228404,90.7,0,0
228405,and,0,0
228406,7.9,0,0
228407,",",0,0
228408,respectively,0,0
228409,",",0,0
228410,against,0,0
228411,Proteus,0,1
228412,mirabilis,0,1
228413,.,0,0
228414,Both,1,0
228415,drugs,1,0
228416,had,1,0
228417,rather,1,0
228418,short,1,0
228419,biological,1,0
228420,elimination,1,0
228421,half-lives,1,0
228422,and,1,0
228423,a,1,0
228424,predominantly,1,1
228425,renal,1,1
228426,route,1,0
228427,of,1,0
228428,elimination,1,0
228429,.,1,0
228430,Both,0,0
228431,carbapenems,0,0
228432,revealed,0,0
228433,high,0,1
228434,SBAs,0,0
228435,against,0,0
228436,clinically,0,0
228437,important,0,0
228438,pathogens,0,0
228439,at,0,1
228440,1,0,1
228441,h,0,0
228442,;,0,0
228443,meropenem,0,0
228444,had,0,0
228445,a,0,0
228446,higher,0,0
228447,SBA,0,1
228448,against,0,0
228449,E.,0,0
228450,cloacae,0,0
228451,and,0,0
228452,P.,0,1
228453,mirabilis,0,1
228454,",",0,0
228455,and,0,0
228456,the,0,0
228457,SBA,0,0
228458,of,0,0
228459,imipenem,0,0
228460,against,0,0
228461,S.,0,1
228462,aureus,0,1
228463,was,0,0
228464,greater,0,0
228465,than,0,0
228466,the,0,0
228467,SBA,0,1
228468,of,0,0
228469,meropenem,0,0
228470,.,0,1
228471,The,0,0
228472,use,0,0
228473,of,0,0
228474,a,0,0
228475,water,0,0
228476,extract,0,0
228477,from,0,0
228478,the,0,0
228479,bark,0,1
228480,of,0,0
228481,Choerospondias,0,0
228482,axillaris,0,0
228483,in,0,0
228484,the,0,0
228485,treatment,1,0
228486,of,1,0
228487,second,1,0
228488,degree,1,1
228489,burns,1,1
228490,.,1,1
228491,Burns,1,0
228492,are,1,0
228493,common,1,0
228494,in,1,0
228495,Vietnam,1,1
228496,",",0,0
228497,and,0,0
228498,because,0,0
228499,of,0,0
228500,economic,0,0
228501,constraints,0,0
228502,and,0,1
228503,limited,0,0
228504,resources,0,0
228505,for,0,0
228506,the,0,0
228507,import,0,0
228508,of,0,0
228509,appropriate,0,0
228510,treatments,0,0
228511,",",0,0
228512,the,0,0
228513,health,0,0
228514,authorities,0,0
228515,are,0,0
228516,obliged,0,0
228517,to,0,0
228518,rely,0,0
228519,on,0,0
228520,traditional,0,1
228521,herbal,0,1
228522,remedies,0,0
228523,.,0,0
228524,It,0,0
228525,is,0,0
228526,therefore,0,0
228527,essential,0,0
228528,to,0,0
228529,evaluate,0,0
228530,current,0,0
228531,drugs,0,0
228532,",",0,0
228533,one,0,1
228534,of,0,0
228535,which,0,0
228536,is,0,0
228537,the,0,0
228538,water,0,0
228539,extract,0,0
228540,of,0,0
228541,the,0,0
228542,bark,0,0
228543,of,0,0
228544,the,0,0
228545,tree,0,1
228546,Choerospondias,0,0
228547,axillaris,0,0
228548,.,0,0
228549,It,0,0
228550,has,0,0
228551,been,0,0
228552,used,0,0
228553,for,0,0
228554,many,0,0
228555,years,0,1
228556,in,0,0
228557,the,0,0
228558,Vietnam-Sweden,1,1
228559,hospital,1,1
228560,at,1,0
228561,Uong,1,1
228562,Bi,1,0
228563,in,1,0
228564,northern,1,1
228565,Vietnam,1,1
228566,.,1,1
228567,We,0,0
228568,assessed,0,0
228569,the,0,0
228570,efficacy,0,0
228571,of,0,0
228572,the,0,0
228573,remedy,0,0
228574,in,0,0
228575,an,0,0
228576,open,0,1
228577,",",0,0
228578,randomised,0,0
228579,controlled,0,0
228580,clinical,0,0
228581,trial,0,0
228582,",",0,0
228583,in,0,0
228584,which,0,0
228585,20,1,1
228586,patients,1,1
228587,with,1,1
228588,second,1,1
228589,degree,1,1
228590,burns,1,1
228591,were,1,0
228592,treated,1,1
228593,with,1,1
228594,the,1,0
228595,extract,1,0
228596,of,1,0
228597,the,1,0
228598,Choerospondias,1,0
228599,axillaris,1,0
228600,and,1,0
228601,19,1,1
228602,with,1,1
228603,saline,1,0
228604,gauze,1,0
228605,.,1,0
228606,The,0,0
228607,mean,0,0
228608,healing,0,0
228609,time,0,0
228610,was,0,0
228611,significantly,0,0
228612,shorter,0,0
228613,for,0,0
228614,patients,0,1
228615,treated,0,1
228616,with,0,1
228617,Choerospondias,0,0
228618,axillaris,0,1
228619,(,0,0
228620,11,0,1
228621,days,0,0
228622,),0,1
228623,compared,0,0
228624,with,0,1
228625,patients,0,1
228626,treated,0,1
228627,with,0,1
228628,saline,0,0
228629,gauze,0,0
228630,(,0,1
228631,17,0,1
228632,days,0,0
228633,),0,1
228634,(,0,1
228635,p,0,0
228636,<,0,0
228637,0.01,0,0
228638,),0,0
228639,",",0,0
228640,and,0,0
228641,the,0,0
228642,number,0,0
228643,of,0,0
228644,wound,0,1
228645,infections,0,1
228646,was,0,0
228647,significantly,0,0
228648,lower,0,0
228649,in,0,0
228650,the,0,0
228651,Choerospondias,0,0
228652,axillaris,0,0
228653,group,0,0
228654,(,0,0
228655,7/20,0,0
228656,compared,0,0
228657,with,0,1
228658,16/19,0,0
228659,",",0,0
228660,p,0,0
228661,=,0,0
228662,0.003,0,0
228663,),0,0
228664,.,0,0
228665,The,0,0
228666,bark,0,0
228667,extract,0,0
228668,was,0,0
228669,easy,0,0
228670,to,0,0
228671,apply,0,0
228672,and,0,0
228673,additional,0,0
228674,wound,0,0
228675,care,0,1
228676,was,0,0
228677,not,0,0
228678,usually,0,0
228679,necessary,0,0
228680,",",0,0
228681,while,0,0
228682,the,0,0
228683,treatment,0,0
228684,with,0,1
228685,saline,0,0
228686,gauze,0,0
228687,was,0,0
228688,laborious,0,0
228689,for,0,0
228690,both,0,0
228691,patients,0,1
228692,and,0,0
228693,staff,0,1
228694,and,0,0
228695,was,0,0
228696,much,0,0
228697,more,0,0
228698,expensive,0,0
228699,.,0,0
228700,The,0,0
228701,extract,0,0
228702,from,0,0
228703,Choerospondias,0,0
228704,axillaris,0,0
228705,is,0,0
228706,a,0,0
228707,convenient,0,0
228708,treatment,0,0
228709,for,0,0
228710,second,1,0
228711,degree,1,1
228712,burns,1,1
228713,in,0,0
228714,both,1,0
228715,children,1,1
228716,and,1,1
228717,adults,1,1
228718,.,1,1
228719,Inhibition,0,0
228720,of,0,0
228721,epidural,0,0
228722,morphine-induced,0,0
228723,pruritus,0,0
228724,by,0,0
228725,intravenous,0,0
228726,droperidol,0,0
228727,.,0,0
228728,The,0,0
228729,effect,0,0
228730,of,0,0
228731,increasing,0,0
228732,the,0,0
228733,doses,0,0
228734,of,0,0
228735,morphine,0,0
228736,and,0,0
228737,of,0,0
228738,droperidol,0,0
228739,.,0,1
228740,BACKGROUND,0,0
228741,AND,0,0
228742,OBJECTIVES,0,0
228743,Because,0,0
228744,the,0,0
228745,mechanism,0,0
228746,of,0,0
228747,inhibition,0,0
228748,of,0,0
228749,epidural,0,0
228750,morphine-induced,0,0
228751,pruritus,0,0
228752,by,0,0
228753,droperidol,0,0
228754,is,0,0
228755,not,0,0
228756,clear,0,0
228757,",",0,0
228758,this,0,0
228759,study,0,0
228760,was,0,0
228761,undertaken,0,0
228762,to,0,0
228763,determine,0,0
228764,the,0,0
228765,effects,0,0
228766,of,0,0
228767,larger,0,0
228768,doses,0,0
228769,of,0,0
228770,droperidol,0,0
228771,or,0,0
228772,morphine,0,0
228773,",",0,0
228774,or,0,0
228775,both,0,0
228776,.,0,0
228777,METHODS,0,0
228778,A,0,0
228779,double-blind,0,0
228780,study,0,0
228781,was,0,0
228782,performed,0,0
228783,in,0,0
228784,210,1,1
228785,ASA,1,1
228786,I,1,1
228787,or,1,1
228788,II,1,1
228789,patients,1,1
228790,undergoing,1,1
228791,cesarean,1,1
228792,delivery,1,1
228793,",",1,1
228794,who,1,1
228795,were,1,1
228796,randomly,1,1
228797,assigned,1,1
228798,to,1,0
228799,six,1,1
228800,groups,1,0
228801,.,1,1
228802,All,0,1
228803,patients,0,1
228804,received,0,0
228805,epidural,0,0
228806,anesthesia,0,1
228807,with,0,1
228808,0.5,0,0
228809,%,0,0
228810,bupivacaine,0,0
228811,containing,0,0
228812,"1:200,000",0,0
228813,epinephrine,0,0
228814,",",0,0
228815,to,0,0
228816,which,0,0
228817,2,0,0
228818,mg,0,0
228819,(,0,1
228820,groups,0,0
228821,1,0,0
228822,",",0,0
228823,2,0,0
228824,",",0,0
228825,and,0,0
228826,3,0,0
228827,),0,0
228828,or,0,1
228829,4,0,0
228830,mg,0,0
228831,(,0,1
228832,groups,0,0
228833,4,0,0
228834,",",0,0
228835,5,0,0
228836,",",0,0
228837,and,0,0
228838,6,0,0
228839,),0,0
228840,morphine,0,0
228841,sulfate,0,0
228842,was,0,0
228843,added,0,0
228844,.,0,0
228845,Just,0,0
228846,after,0,0
228847,delivery,0,0
228848,",",0,0
228849,2.5,0,0
228850,mg,0,0
228851,droperidol,0,0
228852,was,0,0
228853,given,0,0
228854,intravenously,0,1
228855,to,0,0
228856,groups,0,0
228857,2,0,1
228858,and,0,1
228859,5,0,0
228860,",",0,0
228861,and,0,0
228862,5,0,0
228863,mg,0,0
228864,was,0,0
228865,given,0,0
228866,to,0,0
228867,groups,0,0
228868,3,0,0
228869,and,0,1
228870,6,0,0
228871,.,0,0
228872,During,0,0
228873,the,0,0
228874,postoperative,0,0
228875,period,0,0
228876,",",0,0
228877,the,0,0
228878,patients,0,1
228879,were,0,0
228880,assessed,0,0
228881,for,0,0
228882,the,0,0
228883,occurrence,0,0
228884,and,0,0
228885,severity,0,0
228886,of,0,0
228887,pruritus,0,0
228888,(,0,0
228889,classified,0,0
228890,as,0,0
228891,absent,0,0
228892,",",0,0
228893,mild,0,1
228894,",",0,0
228895,moderate,0,1
228896,",",0,0
228897,or,0,0
228898,severe,0,1
228899,),0,0
228900,or,0,0
228901,other,0,0
228902,untoward,0,0
228903,symptoms,0,1
228904,.,0,1
228905,The,0,0
228906,groups,0,0
228907,were,0,0
228908,compared,0,0
228909,for,0,0
228910,the,0,0
228911,incidence,0,0
228912,of,0,0
228913,pruritus,0,0
228914,by,0,0
228915,the,0,0
228916,Mann-Whitney,0,0
228917,nonparametric,0,0
228918,test,0,0
228919,.,0,0
228920,RESULTS,0,0
228921,The,0,0
228922,incidence,0,0
228923,of,0,0
228924,pruritus,0,0
228925,was,0,0
228926,significantly,0,0
228927,reduced,0,0
228928,only,0,0
228929,when,0,0
228930,the,0,0
228931,control,0,0
228932,group,0,0
228933,.,0,0
228934,(,0,0
228935,no,0,0
228936,droperidol,0,0
228937,),0,0
228938,was,0,0
228939,compared,0,0
228940,with,0,1
228941,the,0,0
228942,group,0,0
228943,that,0,0
228944,received,0,0
228945,2.5,0,0
228946,mg,0,0
228947,droperidol,0,0
228948,",",0,0
228949,both,0,0
228950,when,0,0
228951,2,0,0
228952,mg,0,0
228953,and,0,0
228954,when,0,0
228955,4,0,0
228956,mg,0,0
228957,morphine,0,0
228958,was,0,0
228959,used,0,0
228960,.,0,0
228961,A,0,0
228962,5-mg,0,0
228963,dose,0,0
228964,of,0,0
228965,droperidol,0,0
228966,had,0,1
228967,no,0,0
228968,inhibitory,0,0
228969,effect,0,0
228970,.,0,0
228971,There,0,0
228972,was,0,0
228973,no,0,0
228974,difference,0,0
228975,in,0,0
228976,the,0,0
228977,incidence,0,0
228978,of,0,0
228979,pruritus,0,0
228980,between,0,0
228981,use,0,0
228982,of,0,0
228983,2,0,0
228984,mg,0,0
228985,and,0,1
228986,4,0,0
228987,mg,0,0
228988,morphine,0,0
228989,.,0,0
228990,Other,0,0
228991,untoward,0,0
228992,effects,0,0
228993,of,0,0
228994,morphine,0,0
228995,either,0,0
228996,could,0,0
228997,not,0,0
228998,be,0,0
228999,observed,0,0
229000,or,0,0
229001,occurred,0,0
229002,with,0,1
229003,an,0,0
229004,incidence,0,0
229005,unaffected,0,0
229006,by,0,0
229007,either,0,0
229008,dose,0,0
229009,of,0,0
229010,droperidol,0,0
229011,.,0,1
229012,CONCLUSION,0,0
229013,Pruritus,0,1
229014,caused,0,0
229015,by,0,0
229016,epidural,0,0
229017,use,0,0
229018,of,0,0
229019,2,0,0
229020,or,0,1
229021,4,0,0
229022,mg,0,0
229023,of,0,0
229024,morphine,0,0
229025,is,0,0
229026,inhibited,0,0
229027,by,0,0
229028,the,0,0
229029,intravenous,0,0
229030,use,0,0
229031,of,0,0
229032,2.5,0,0
229033,mg,0,0
229034,droperidol,0,0
229035,but,0,0
229036,not,0,0
229037,by,0,0
229038,a,0,0
229039,larger,0,0
229040,dose,0,0
229041,.,0,0
229042,A,0,0
229043,component,0,0
229044,analysis,0,0
229045,of,0,0
229046,cognitive-behavioral,0,0
229047,treatment,0,0
229048,for,0,0
229049,depression,1,1
229050,.,1,0
229051,The,0,0
229052,purpose,0,0
229053,of,0,0
229054,this,0,0
229055,study,0,0
229056,was,0,0
229057,to,0,0
229058,provide,0,0
229059,an,0,0
229060,experimental,0,0
229061,test,0,0
229062,of,0,0
229063,the,0,0
229064,theory,0,0
229065,of,0,0
229066,change,0,0
229067,put,0,0
229068,forth,0,0
229069,by,0,0
229070,A.,0,0
229071,T.,0,1
229072,Beck,0,1
229073,",",0,0
229074,A.,0,0
229075,J,0,0
229076,.,0,0
229077,Rush,0,0
229078,",",0,0
229079,B.,0,0
229080,F.,0,1
229081,Shaw,0,0
229082,",",0,0
229083,and,0,0
229084,G.,0,0
229085,Emery,0,1
229086,(,0,1
229087,1979,0,1
229088,),0,0
229089,to,0,0
229090,explain,0,0
229091,the,0,0
229092,efficacy,0,0
229093,of,0,0
229094,cognitive-behavioral,0,0
229095,therapy,0,0
229096,(,0,0
229097,CT,0,0
229098,),0,0
229099,for,0,0
229100,depression,0,1
229101,.,0,0
229102,The,0,0
229103,comparison,0,0
229104,involved,0,0
229105,randomly,0,1
229106,assigning,0,0
229107,150,1,0
229108,outpatients,1,1
229109,with,1,1
229110,major,1,1
229111,depression,1,1
229112,to,1,0
229113,a,1,0
229114,treatment,1,0
229115,focused,1,0
229116,exclusively,1,0
229117,on,1,0
229118,the,1,0
229119,behavioral,1,0
229120,activation,1,0
229121,(,1,0
229122,BA,1,0
229123,),1,0
229124,component,1,0
229125,of,1,0
229126,CT,1,0
229127,",",0,0
229128,a,0,0
229129,treatment,0,0
229130,that,0,0
229131,included,0,0
229132,both,0,0
229133,BA,0,0
229134,and,0,0
229135,the,0,0
229136,teaching,0,0
229137,of,0,0
229138,skills,0,0
229139,to,0,0
229140,modify,0,0
229141,automatic,0,0
229142,thoughts,0,0
229143,(,0,1
229144,AT,0,1
229145,),0,0
229146,",",0,0
229147,but,0,0
229148,excluding,0,0
229149,the,0,0
229150,components,0,0
229151,of,0,0
229152,CT,0,1
229153,focused,0,0
229154,on,0,0
229155,core,0,0
229156,schema,0,0
229157,",",0,0
229158,or,0,0
229159,the,0,0
229160,full,0,0
229161,CT,0,0
229162,treatment,0,0
229163,.,0,1
229164,Four,0,0
229165,experienced,0,0
229166,cognitive,0,1
229167,therapists,0,0
229168,conducted,0,1
229169,all,0,1
229170,treatments,0,0
229171,.,0,0
229172,Despite,0,0
229173,excellent,0,0
229174,adherence,0,0
229175,to,0,0
229176,treatment,0,0
229177,protocols,0,0
229178,by,0,0
229179,the,0,0
229180,therapists,0,0
229181,",",0,0
229182,a,0,0
229183,clear,0,0
229184,bias,0,0
229185,favoring,0,0
229186,CT,0,0
229187,",",0,0
229188,and,0,0
229189,the,0,0
229190,competent,0,0
229191,performance,0,0
229192,of,0,0
229193,CT,0,0
229194,",",0,0
229195,there,0,0
229196,was,0,0
229197,no,0,0
229198,evidence,0,0
229199,that,0,0
229200,the,0,0
229201,complete,0,0
229202,treatment,0,0
229203,produced,0,0
229204,better,0,0
229205,outcomes,0,0
229206,",",0,0
229207,at,0,0
229208,either,0,0
229209,the,0,0
229210,termination,0,0
229211,of,0,0
229212,acute,0,1
229213,treatment,0,0
229214,or,0,1
229215,the,0,0
229216,6-month,0,0
229217,follow-up,0,0
229218,",",0,0
229219,than,0,0
229220,either,0,0
229221,component,0,0
229222,treatment,0,0
229223,.,0,0
229224,Furthermore,0,0
229225,",",0,0
229226,both,0,0
229227,BA,0,0
229228,and,0,0
229229,AT,0,1
229230,treatments,0,0
229231,were,0,0
229232,just,0,1
229233,as,0,0
229234,effective,0,0
229235,as,0,0
229236,CT,0,1
229237,at,0,0
229238,altering,0,0
229239,negative,0,0
229240,thinking,0,0
229241,as,0,0
229242,well,0,0
229243,as,0,0
229244,dysfunctional,0,0
229245,attributional,0,1
229246,styles,0,1
229247,.,0,0
229248,Finally,0,0
229249,",",0,0
229250,attributional,0,0
229251,style,0,0
229252,was,0,0
229253,highly,0,0
229254,predictive,0,0
229255,of,0,0
229256,both,0,0
229257,short-,0,0
229258,and,0,0
229259,long-term,0,0
229260,outcomes,0,0
229261,in,0,0
229262,the,0,0
229263,BA,0,0
229264,condition,0,0
229265,",",0,0
229266,but,0,0
229267,not,0,0
229268,in,0,0
229269,the,0,0
229270,CT,0,0
229271,condition,0,0
229272,.,0,1
229273,Relationship,0,0
229274,of,0,0
229275,the,0,0
229276,dose,0,0
229277,of,0,0
229278,intravenous,0,0
229279,gammaglobulin,0,0
229280,to,0,0
229281,the,0,0
229282,prevention,0,0
229283,of,0,0
229284,infections,0,1
229285,in,0,1
229286,adults,1,1
229287,with,1,1
229288,common,1,1
229289,variable,1,1
229290,immunodeficiency,1,1
229291,.,1,0
229292,The,0,0
229293,objective,0,0
229294,was,0,0
229295,to,0,0
229296,assess,0,0
229297,clinical,0,0
229298,efficacy,0,0
229299,of,0,0
229300,3,0,0
229301,dosages,0,0
229302,of,0,1
229303,intravenous,0,1
229304,gammaglobulins,0,0
229305,to,0,0
229306,prevent,0,0
229307,infectious,0,1
229308,episodes,0,0
229309,in,0,0
229310,adult,0,1
229311,common,0,0
229312,variable,0,1
229313,immunodeficiency,0,1
229314,.,0,1
229315,We,0,0
229316,designed,0,0
229317,a,0,0
229318,randomized,0,0
229319,",",0,0
229320,double,0,0
229321,blind,0,0
229322,",",0,0
229323,dose-assessing,0,0
229324,study,0,0
229325,.,0,0
229326,The,1,0
229327,setting,1,0
229328,was,1,0
229329,at,1,0
229330,University,1,1
229331,Hospital,1,1
229332,",",1,0
229333,Out-patient,1,1
229334,Clinic,1,0
229335,.,1,1
229336,Our,0,0
229337,patients,1,1
229338,were,1,1
229339,twenty-one,1,1
229340,adult,1,1
229341,patients,1,1
229342,with,1,1
229343,common,1,1
229344,variable,1,1
229345,immunodeficiency,1,1
229346,.,1,0
229347,The,0,0
229348,measurements,0,0
229349,were,0,0
229350,comparative,0,0
229351,study,0,0
229352,of,0,0
229353,the,0,0
229354,number,0,0
229355,and,0,0
229356,severity,0,0
229357,of,0,0
229358,infections,0,1
229359,using,0,1
229360,3,0,1
229361,various,0,0
229362,dosages,0,0
229363,of,0,1
229364,intravenous,0,1
229365,gammaglobulins,0,0
229366,",",0,0
229367,each,0,0
229368,given,0,0
229369,monthly,0,0
229370,for,0,0
229371,M,0,0
229372,least,0,1
229373,6,0,0
229374,months,0,0
229375,.,0,1
229376,Results,0,0
229377,indicated,0,0
229378,four,0,1
229379,hundred,0,1
229380,and,0,1
229381,eighty-four,0,1
229382,infectious,0,1
229383,episodes,0,0
229384,occurred,0,0
229385,while,0,0
229386,giving,0,0
229387,305,0,1
229388,infusions,0,0
229389,of,0,1
229390,IVIG,0,0
229391,200,0,1
229392,mg/kg,0,0
229393,;,0,1
229394,205,0,1
229395,infectious,0,1
229396,episodes,0,0
229397,while,0,0
229398,giving,0,0
229399,170,0,1
229400,infusions,0,0
229401,of,0,1
229402,400,0,1
229403,mg/kg,0,0
229404,and,0,1
229405,436,0,1
229406,infectious,0,1
229407,episodes,0,0
229408,while,0,0
229409,giving,0,0
229410,247,0,1
229411,infusions,0,0
229412,of,0,1
229413,600,0,1
229414,mg/kg,0,0
229415,.,0,0
229416,The,0,0
229417,morbidity,0,0
229418,scores,0,0
229419,(,0,0
229420,infection/infusion,0,0
229421,),0,0
229422,were,0,0
229423,1.59,0,0
229424,",",0,0
229425,1.21,0,0
229426,and,0,0
229427,1.77,0,0
229428,respectively,0,0
229429,(,0,0
229430,p,0,0
229431,-,0,0
229432,N/S,0,0
229433,),0,0
229434,.,0,0
229435,There,0,0
229436,was,0,0
229437,no,0,0
229438,significant,0,0
229439,difference,0,0
229440,in,0,0
229441,the,0,0
229442,severity,0,0
229443,of,0,0
229444,infections,0,0
229445,on,0,0
229446,the,0,0
229447,above,0,0
229448,3,0,0
229449,dosages,0,0
229450,",",0,0
229451,and,0,0
229452,no,0,0
229453,difference,0,0
229454,in,0,0
229455,the,0,0
229456,duration,0,0
229457,of,0,0
229458,infection-free,0,0
229459,intervals,0,0
229460,.,0,1
229461,The,0,0
229462,conclusions,0,0
229463,resulted,0,0
229464,in,0,0
229465,no,0,0
229466,significant,0,0
229467,differences,0,0
229468,in,0,0
229469,morbidity,0,0
229470,in,0,0
229471,adult,0,1
229472,patients,0,1
229473,with,0,1
229474,common,0,1
229475,variable,0,1
229476,immunodeficiency,0,1
229477,treated,0,1
229478,in,0,0
229479,cross-over,0,0
229480,pattern,0,1
229481,with,0,1
229482,IVIG,0,0
229483,200,0,0
229484,mg/kg,0,0
229485,",",0,0
229486,400,0,0
229487,mg/kg,0,0
229488,and,0,0
229489,600,0,1
229490,mg/kg,0,0
229491,.,0,0
229492,Thus,0,0
229493,",",0,0
229494,high,0,0
229495,dosages,0,0
229496,of,0,0
229497,IVIG,0,0
229498,are,0,0
229499,not,0,0
229500,conferring,0,0
229501,better,0,0
229502,protection,0,0
229503,against,0,0
229504,infections,0,1
229505,in,0,1
229506,such,0,0
229507,patients,0,1
229508,.,0,1
229509,The,0,0
229510,tension-free,0,0
229511,hernioplasty,0,0
229512,in,0,0
229513,a,0,0
229514,randomized,0,0
229515,trial,0,0
229516,.,0,0
229517,BACKGROUND,0,0
229518,The,0,0
229519,tension-free,0,0
229520,hernioplasty,0,1
229521,as,0,0
229522,introduced,0,0
229523,by,0,0
229524,Lichtenstein,0,0
229525,has,0,0
229526,gained,0,0
229527,increasing,0,0
229528,acceptance,0,0
229529,during,0,0
229530,the,0,0
229531,last,0,0
229532,decade,0,0
229533,although,0,0
229534,the,0,0
229535,technique,0,0
229536,has,0,0
229537,not,0,0
229538,been,0,0
229539,evaluated,0,0
229540,in,0,0
229541,a,0,0
229542,randomized,0,0
229543,trial,0,0
229544,.,0,1
229545,METHODS,0,0
229546,This,0,0
229547,randomized,0,0
229548,study,0,0
229549,compares,0,0
229550,the,0,0
229551,2-year,0,0
229552,follow-up,0,0
229553,results,0,0
229554,after,0,1
229555,102,1,1
229556,tension-free,1,0
229557,hernioplasties,1,1
229558,with,1,1
229559,implantation,1,1
229560,of,1,0
229561,a,1,0
229562,prolene,1,0
229563,mesh,1,0
229564,in,1,0
229565,all,1,0
229566,groin,1,0
229567,hernias,1,1
229568,to,1,0
229569,53,1,1
229570,Cooper,1,1
229571,ligament,1,1
229572,repairs,1,1
229573,in,1,0
229574,direct,1,0
229575,hernias,1,1
229576,and,1,0
229577,53,1,1
229578,abdominal,1,1
229579,ring,1,0
229580,repairs,1,1
229581,in,1,0
229582,indirect,1,0
229583,hernias,1,1
229584,.,1,0
229585,RESULTS,0,0
229586,After,0,0
229587,tension-free,0,0
229588,repairs,0,1
229589,five,0,1
229590,hernias,0,1
229591,recurred,0,0
229592,(,0,1
229593,5,0,0
229594,%,0,0
229595,),0,0
229596,",",0,0
229597,and,0,0
229598,after,0,0
229599,either,0,0
229600,Cooper,0,1
229601,ligament,0,0
229602,or,0,1
229603,abdominal,0,1
229604,ring,0,0
229605,repair,0,1
229606,",",0,0
229607,16,0,1
229608,recurrences,0,0
229609,were,0,1
229610,found,0,0
229611,(,0,0
229612,15,0,1
229613,%,0,0
229614,),0,0
229615,(,0,0
229616,P,0,0
229617,=,0,0
229618,0.025,0,0
229619,),0,0
229620,.,0,1
229621,No,0,0
229622,indirect,0,0
229623,hernias,0,1
229624,recurred,0,0
229625,after,0,0
229626,a,0,0
229627,tension-free,0,0
229628,repair,0,1
229629,;,0,1
229630,2,0,0
229631,recurred,0,0
229632,after,0,0
229633,abdominal,0,1
229634,ring,0,0
229635,repair,0,1
229636,(,0,0
229637,4,0,0
229638,%,0,0
229639,;,0,1
229640,NS,0,0
229641,),0,0
229642,.,0,0
229643,The,0,0
229644,recurrence,0,0
229645,rate,0,0
229646,after,0,0
229647,tension-free,0,0
229648,repairs,0,1
229649,for,0,1
229650,primary,0,1
229651,direct,0,0
229652,inguinal,0,1
229653,hernias,0,1
229654,was,0,0
229655,7,0,0
229656,%,0,0
229657,as,0,0
229658,compared,0,0
229659,with,0,1
229660,30,0,0
229661,%,0,0
229662,after,0,0
229663,Cooper,0,1
229664,ligament,0,1
229665,repair,0,1
229666,(,0,0
229667,P,0,0
229668,=,0,0
229669,0.0081,0,0
229670,),0,0
229671,.,0,0
229672,No,0,0
229673,difference,0,0
229674,in,0,0
229675,complication,0,0
229676,rate,0,0
229677,between,0,0
229678,the,0,0
229679,tested,0,0
229680,methods,0,1
229681,was,0,0
229682,found,0,0
229683,.,0,1
229684,CONCLUSION,0,0
229685,Recurrence,0,0
229686,rate,0,0
229687,is,0,0
229688,reduced,0,0
229689,to,0,0
229690,one-third,0,1
229691,after,0,0
229692,tension-free,1,0
229693,herniotomies,1,1
229694,as,0,0
229695,compared,0,0
229696,with,0,1
229697,the,0,0
229698,conventionel,0,0
229699,herniotomies,0,1
229700,without,0,1
229701,increase,0,0
229702,in,0,0
229703,complication,0,0
229704,rate,0,0
229705,.,0,1
229706,Injection,0,0
229707,pain,0,1
229708,with,0,1
229709,propofol,0,0
229710,.,0,0
229711,Reduction,0,0
229712,with,0,0
229713,aspiration,0,0
229714,of,0,0
229715,blood,0,0
229716,.,0,0
229717,A,0,0
229718,randomised,0,0
229719,",",0,0
229720,controlled,0,0
229721,",",0,0
229722,single-blind,0,0
229723,study,0,0
229724,was,0,0
229725,performed,0,0
229726,on,0,0
229727,100,1,0
229728,patients,1,1
229729,to,0,0
229730,investigate,0,0
229731,a,0,0
229732,new,0,0
229733,method,0,0
229734,of,0,0
229735,reducing,0,0
229736,pain,0,1
229737,on,0,0
229738,propofol,0,0
229739,injection,0,0
229740,.,0,0
229741,Aspiration,0,0
229742,of,0,0
229743,2,0,0
229744,ml,0,0
229745,of,0,0
229746,the,0,0
229747,patient,0,0
229748,'s,0,0
229749,blood,0,0
229750,into,0,1
229751,a,0,0
229752,syringe,0,0
229753,of,0,0
229754,propofol,0,0
229755,immediately,0,0
229756,before,0,0
229757,injection,0,0
229758,was,0,0
229759,compared,0,0
229760,with,0,1
229761,the,0,0
229762,addition,0,0
229763,of,0,0
229764,lignocaine,0,0
229765,20,0,1
229766,mg,0,0
229767,or,0,1
229768,normal,0,1
229769,saline,0,0
229770,2,0,0
229771,ml,0,0
229772,to,0,0
229773,the,0,0
229774,propofol,0,0
229775,before,0,0
229776,injection,0,0
229777,.,0,0
229778,The,0,0
229779,addition,0,0
229780,of,0,0
229781,blood,0,0
229782,was,0,0
229783,significantly,0,0
229784,more,0,0
229785,effective,0,0
229786,in,0,0
229787,reducing,0,0
229788,pain,0,1
229789,on,0,0
229790,injection,0,0
229791,than,0,0
229792,the,0,0
229793,addition,0,0
229794,of,0,0
229795,saline,0,0
229796,(,0,0
229797,p,0,0
229798,<,0,0
229799,0.001,0,0
229800,),0,0
229801,",",0,0
229802,but,0,0
229803,was,0,0
229804,not,0,0
229805,significantly,0,0
229806,more,0,0
229807,effective,0,0
229808,than,0,0
229809,the,0,0
229810,addition,0,0
229811,of,0,0
229812,lignocaine,0,0
229813,.,0,1
229814,Effects,0,0
229815,of,0,1
229816,perioperative,0,0
229817,indomethacin,0,0
229818,on,0,0
229819,intracranial,0,1
229820,pressure,0,0
229821,",",0,0
229822,cerebral,0,1
229823,blood,0,0
229824,flow,0,0
229825,",",0,0
229826,and,0,0
229827,cerebral,0,1
229828,metabolism,0,0
229829,in,1,0
229830,patients,1,1
229831,subjected,1,0
229832,to,1,0
229833,craniotomy,1,0
229834,for,1,0
229835,cerebral,1,1
229836,tumors,1,1
229837,.,1,1
229838,This,0,0
229839,study,0,0
229840,was,0,0
229841,carried,0,0
229842,out,0,0
229843,to,0,0
229844,evaluate,0,0
229845,the,0,0
229846,effects,0,0
229847,of,0,0
229848,perioperative,0,0
229849,indomethacin,0,0
229850,on,0,0
229851,intracranial,0,1
229852,pressure,0,0
229853,(,0,0
229854,ICP,0,0
229855,),0,0
229856,",",0,0
229857,cerebral,0,1
229858,blood,0,0
229859,flow,0,0
229860,(,0,0
229861,CBF,0,0
229862,),0,0
229863,",",0,0
229864,and,0,0
229865,cerebral,0,1
229866,metabolism,0,0
229867,.,0,1
229868,Twenty,1,1
229869,patients,1,1
229870,subjected,1,0
229871,to,1,0
229872,craniotomy,1,0
229873,for,1,0
229874,supratentorial,1,1
229875,cerebral,1,1
229876,tumors,1,1
229877,were,0,1
229878,anesthetized,0,1
229879,with,0,1
229880,thiopental,0,0
229881,",",0,0
229882,fentanyl,0,0
229883,",",0,0
229884,nitrous,0,0
229885,oxide,0,0
229886,",",0,0
229887,and,0,0
229888,isoflurane,0,0
229889,.,0,0
229890,A,0,0
229891,PaCO2,0,0
229892,level,0,0
229893,averaging,0,0
229894,4.8,0,0
229895,kPa,0,1
229896,(,0,0
229897,median,0,1
229898,),0,0
229899,was,0,0
229900,achieved,0,0
229901,.,0,0
229902,The,0,0
229903,patients,0,1
229904,were,0,0
229905,randomized,1,1
229906,to,0,0
229907,intravenous,0,0
229908,indomethacin,0,0
229909,50,0,1
229910,mg,0,0
229911,or,0,1
229912,placebo,0,0
229913,administrated,0,0
229914,after,0,0
229915,exposure,0,0
229916,of,0,0
229917,the,0,0
229918,dura,0,0
229919,.,0,0
229920,ICP,0,0
229921,was,0,0
229922,measured,0,0
229923,continuously,0,0
229924,subdurally,0,0
229925,with,0,0
229926,a,0,0
229927,22-gauge,0,0
229928,canula,0,0
229929,connected,0,0
229930,to,0,0
229931,a,0,0
229932,transducer,0,0
229933,.,0,0
229934,CBF,0,0
229935,and,0,0
229936,the,0,0
229937,arteriovenous,0,0
229938,difference,0,0
229939,of,0,0
229940,oxygen,0,0
229941,(,0,0
229942,AVDO2,0,0
229943,),0,0
229944,were,0,0
229945,measured,0,0
229946,twice,0,0
229947,",",0,0
229948,before,0,0
229949,and,0,0
229950,after,0,0
229951,indomethacin/placebo,0,0
229952,administration,0,0
229953,.,0,0
229954,A,0,0
229955,significant,0,0
229956,decrease,0,0
229957,in,0,0
229958,ICP,0,0
229959,from,0,1
229960,6.5,0,0
229961,to,0,1
229962,1.5,0,0
229963,mm,0,0
229964,Hg,0,1
229965,(,0,1
229966,median,0,1
229967,),0,0
229968,was,0,0
229969,found,0,0
229970,after,0,0
229971,indomethacin,0,0
229972,administration,0,0
229973,.,0,0
229974,This,0,0
229975,decrease,0,0
229976,was,0,0
229977,caused,0,0
229978,by,0,0
229979,a,0,0
229980,significant,0,0
229981,decrease,0,0
229982,in,0,0
229983,CBF,0,0
229984,associated,0,0
229985,with,0,1
229986,a,0,0
229987,significant,0,0
229988,increase,0,0
229989,in,0,0
229990,AVDO2,0,0
229991,.,0,1
229992,Indomethacin,0,0
229993,did,0,0
229994,not,0,0
229995,affect,0,0
229996,the,0,0
229997,cerebral,0,1
229998,metabolic,0,0
229999,rate,0,0
230000,of,0,0
230001,oxygen,0,0
230002,",",0,0
230003,the,0,0
230004,arteriovenous,0,0
230005,difference,0,0
230006,of,0,0
230007,lactate,0,0
230008,",",0,0
230009,or,0,0
230010,the,0,0
230011,lactate/oxygen,0,0
230012,index,0,0
230013,",",0,0
230014,suggesting,0,0
230015,that,0,0
230016,indomethacin,0,0
230017,did,0,0
230018,not,0,0
230019,provoke,0,0
230020,global,0,0
230021,cerebral,0,1
230022,ischemia,0,1
230023,.,0,0
230024,In,0,0
230025,the,0,0
230026,indomethacin,0,0
230027,group,0,0
230028,",",0,0
230029,dura,0,0
230030,was,0,0
230031,sufficiently,0,0
230032,relaxed,0,0
230033,in,0,0
230034,eight,0,1
230035,of,0,1
230036,nine,0,1
230037,patients,0,1
230038,and,0,1
230039,dura,0,1
230040,was,0,0
230041,opened,0,0
230042,without,0,1
230043,the,0,0
230044,occurrence,0,0
230045,of,0,0
230046,cerebral,0,1
230047,swelling,0,0
230048,.,0,1
230049,In,0,0
230050,one,0,0
230051,patient,0,0
230052,",",0,0
230053,mannitol,0,0
230054,treatment,0,0
230055,was,0,0
230056,necessary,0,0
230057,to,0,0
230058,prevent,0,0
230059,dural,0,0
230060,tightness,0,0
230061,.,0,0
230062,In,0,0
230063,the,0,0
230064,placebo,0,0
230065,group,0,0
230066,",",0,0
230067,mannitol,0,0
230068,supplemented,0,0
230069,with,0,1
230070,hypocapnia,0,0
230071,was,0,0
230072,applied,0,0
230073,in,0,0
230074,five,1,1
230075,patients,1,1
230076,.,1,1
230077,These,0,0
230078,findings,0,0
230079,suggest,0,0
230080,that,0,0
230081,perioperative,0,0
230082,treatment,0,0
230083,with,0,1
230084,indomethacin,0,0
230085,is,0,0
230086,an,0,0
230087,excellent,0,0
230088,treatment,0,0
230089,of,0,0
230090,intracranial,0,1
230091,hypertension,0,1
230092,during,0,0
230093,normocapnic,0,1
230094,isoflurane,0,0
230095,anesthesia,0,0
230096,for,0,0
230097,craniotomy,0,0
230098,.,0,1
230099,Final,0,1
230100,report,0,0
230101,of,0,0
230102,a,0,0
230103,randomized,0,0
230104,controlled,0,0
230105,study,0,0
230106,with,0,1
230107,streptococcal,0,1
230108,preparation,0,0
230109,OK-432,0,1
230110,as,0,0
230111,a,0,0
230112,supplementary,0,0
230113,immunopotentiator,0,0
230114,for,0,0
230115,laryngeal,1,1
230116,cancer,1,1
230117,.,1,1
230118,We,0,0
230119,conducted,0,0
230120,a,0,0
230121,randomized,0,0
230122,controlled,0,0
230123,study,0,0
230124,of,0,0
230125,streptococcal,0,1
230126,preparation,0,0
230127,OK-432,0,1
230128,on,0,0
230129,120,1,1
230130,newly,1,1
230131,identified,1,0
230132,cases,1,0
230133,of,1,0
230134,laryngeal,1,1
230135,squamous,1,1
230136,cell,1,1
230137,carcinoma,1,1
230138,who,1,1
230139,were,1,1
230140,registered,1,1
230141,at,1,0
230142,10,1,1
230143,participating,1,1
230144,institutions,1,1
230145,between,1,0
230146,November,1,1
230147,1984,1,1
230148,and,1,0
230149,October,1,1
230150,1989,1,1
230151,.,1,1
230152,The,0,0
230153,patients,0,1
230154,were,0,0
230155,divided,0,1
230156,into,0,1
230157,two,0,1
230158,groups,0,0
230159,:,0,1
230160,those,0,1
230161,in,0,0
230162,early,0,0
230163,stages,0,1
230164,(,0,0
230165,stage,0,1
230166,I,0,1
230167,or,0,1
230168,II,0,1
230169,),0,0
230170,and,0,0
230171,those,0,0
230172,in,0,0
230173,advanced,0,1
230174,stages,0,1
230175,(,0,1
230176,stage,0,1
230177,III,0,1
230178,or,0,1
230179,IV,0,1
230180,),0,0
230181,;,0,0
230182,these,0,0
230183,groups,0,0
230184,were,0,0
230185,further,0,0
230186,subdivided,0,1
230187,into,0,0
230188,an,0,0
230189,immunotherapy,0,0
230190,group,0,0
230191,(,0,0
230192,receiving,0,1
230193,OK-432,0,1
230194,),0,0
230195,and,0,0
230196,a,0,0
230197,control,0,0
230198,group,0,1
230199,(,0,1
230200,who,0,1
230201,did,0,1
230202,not,0,1
230203,receive,0,0
230204,OK-432,0,1
230205,),0,0
230206,.,0,0
230207,The,0,0
230208,usefulness,0,0
230209,of,0,0
230210,OK-432,0,1
230211,was,0,0
230212,studied,0,0
230213,using,0,0
230214,the,0,0
230215,sealed,0,0
230216,envelope,0,0
230217,method,0,0
230218,.,0,0
230219,The,0,0
230220,basic,0,0
230221,therapy,0,0
230222,for,0,0
230223,all,0,0
230224,cases,0,0
230225,was,0,0
230226,radiotherapy,0,1
230227,and,0,0
230228,",",0,0
230229,when,0,0
230230,required,0,0
230231,",",0,0
230232,surgery,0,1
230233,.,0,0
230234,As,0,0
230235,adjuvant,0,0
230236,therapy,0,0
230237,",",0,0
230238,5Fu,0,1
230239,or,0,1
230240,derivatives,0,0
230241,were,0,0
230242,administered,0,0
230243,to,0,0
230244,all,0,0
230245,cases,0,0
230246,from,0,0
230247,the,0,0
230248,beginning,0,0
230249,of,0,0
230250,the,0,0
230251,treatment,0,0
230252,period,0,0
230253,to,0,0
230254,one,0,0
230255,year,0,0
230256,after,0,0
230257,the,0,0
230258,basic,0,0
230259,therapy,0,0
230260,",",0,0
230261,with,0,0
230262,the,0,0
230263,exception,0,0
230264,of,0,0
230265,cases,0,1
230266,in,0,1
230267,whom,0,1
230268,side,0,0
230269,effects,0,0
230270,were,0,0
230271,serious,0,0
230272,enough,0,0
230273,to,0,0
230274,contraindicate,0,0
230275,use,0,0
230276,of,0,0
230277,the,0,0
230278,drug,0,0
230279,.,0,0
230280,The,0,0
230281,target,0,0
230282,administration,0,0
230283,period,0,0
230284,was,0,0
230285,5,0,1
230286,years,0,1
230287,.,0,1
230288,Of,1,0
230289,the,1,0
230290,initial,1,0
230291,120,1,1
230292,cases,1,1
230293,",",1,1
230294,11,1,1
230295,cases,1,1
230296,were,1,1
230297,disqualified,1,1
230298,(,1,0
230299,3,1,0
230300,cases,1,1
230301,of,1,0
230302,double,1,0
230303,cancer,1,1
230304,and,1,0
230305,8,1,0
230306,of,1,0
230307,incomplete,1,1
230308,primary,1,1
230309,therapy,1,0
230310,),1,0
230311,and,1,0
230312,the,1,0
230313,remaining,1,0
230314,109,1,1
230315,were,1,0
230316,used,1,0
230317,for,1,0
230318,evaluation,1,0
230319,.,1,0
230320,The,0,0
230321,5-year,0,0
230322,survival,0,0
230323,rate,0,0
230324,and,0,0
230325,the,0,0
230326,5-year,0,0
230327,recurrence-free,0,0
230328,rate,0,0
230329,were,0,0
230330,76,0,1
230331,%,0,0
230332,and,0,0
230333,84,0,1
230334,%,0,0
230335,",",0,0
230336,respectively,0,0
230337,",",0,0
230338,in,0,0
230339,the,0,0
230340,immunized,0,1
230341,groups,0,0
230342,(,0,0
230343,both,0,0
230344,the,0,0
230345,early,0,0
230346,and,0,0
230347,advanced,0,1
230348,groups,0,0
230349,),0,0
230350,",",0,0
230351,whereas,0,0
230352,the,0,0
230353,same,0,0
230354,rates,0,0
230355,for,0,0
230356,the,0,0
230357,control,0,0
230358,groups,0,0
230359,were,0,1
230360,78,0,1
230361,%,0,0
230362,and,0,0
230363,75,0,1
230364,%,0,0
230365,.,0,0
230366,There,0,0
230367,was,0,0
230368,a,0,0
230369,tendency,0,0
230370,for,0,0
230371,the,0,0
230372,immunized,0,1
230373,groups,0,0
230374,to,0,0
230375,enjoy,0,0
230376,a,0,0
230377,slightly,0,0
230378,longer,0,0
230379,recurrence-free,0,0
230380,period,0,0
230381,.,0,0
230382,Over,0,0
230383,a,0,0
230384,24-month,0,0
230385,observation,0,0
230386,period,0,0
230387,the,0,0
230388,immunized,0,1
230389,group,0,0
230390,always,0,0
230391,had,0,0
230392,higher,0,0
230393,levels,0,0
230394,of,0,0
230395,peripheral,0,1
230396,leukocytes,0,0
230397,and,0,1
230398,peripheral,0,1
230399,lymphocytes,0,0
230400,;,0,1
230401,this,0,0
230402,difference,0,0
230403,was,0,0
230404,significant,0,0
230405,for,0,0
230406,the,0,0
230407,first,0,0
230408,21,0,1
230409,months,0,0
230410,.,0,1
230411,Inhibition,0,0
230412,of,0,0
230413,bone,0,0
230414,marrow,0,1
230415,function,0,0
230416,is,0,0
230417,sometimes,0,0
230418,observed,0,0
230419,with,0,1
230420,radiotherapy,0,1
230421,.,0,0
230422,It,0,0
230423,is,0,0
230424,hoped,0,0
230425,that,0,0
230426,",",0,0
230427,if,0,0
230428,this,0,0
230429,inhibition,0,0
230430,can,0,0
230431,be,0,0
230432,mitigated,0,0
230433,",",0,0
230434,it,0,0
230435,will,0,0
230436,be,0,0
230437,possible,0,0
230438,to,0,0
230439,assist,0,0
230440,the,0,0
230441,compromised,0,0
230442,immune,0,0
230443,system,0,0
230444,and,0,0
230445,maintain,0,0
230446,a,0,0
230447,certain,0,0
230448,level,0,0
230449,of,0,0
230450,immune,0,0
230451,performance,0,0
230452,which,0,0
230453,will,0,0
230454,prevent,0,0
230455,recurrence,0,0
230456,and,0,0
230457,improve,0,0
230458,survival,0,0
230459,rate,0,0
230460,.,0,0
230461,In,0,0
230462,the,0,0
230463,present,0,0
230464,study,0,0
230465,we,0,0
230466,observed,0,0
230467,a,0,0
230468,tendency,0,0
230469,of,0,0
230470,the,0,0
230471,lower,0,0
230472,recurrence,0,0
230473,rate,0,0
230474,in,0,0
230475,the,0,0
230476,immunized,0,1
230477,group,0,0
230478,",",0,0
230479,and,0,0
230480,we,0,0
230481,hypothesize,0,0
230482,that,0,0
230483,OK-432,0,0
230484,is,0,0
230485,effective,0,0
230486,in,0,0
230487,extending,0,0
230488,the,0,0
230489,recurrence-free,0,0
230490,period,0,0
230491,.,0,1
230492,Effects,0,0
230493,of,0,1
230494,tryptophan,0,0
230495,depletion,0,0
230496,in,0,0
230497,drug-free,1,1
230498,adults,1,1
230499,with,1,1
230500,autistic,1,1
230501,disorder,1,1
230502,.,1,0
230503,BACKGROUND,0,0
230504,The,0,0
230505,primary,0,0
230506,objective,0,0
230507,of,0,0
230508,this,0,0
230509,study,0,0
230510,was,0,0
230511,to,0,0
230512,investigate,0,0
230513,the,0,0
230514,behavioral,0,0
230515,and,0,0
230516,biochemical,0,0
230517,responses,0,0
230518,to,0,0
230519,acute,0,1
230520,tryptophan,0,0
230521,depletion,0,0
230522,in,0,0
230523,drug-free,1,1
230524,adult,1,1
230525,patients,1,1
230526,with,1,1
230527,autistic,1,1
230528,disorder,1,1
230529,.,1,1
230530,METHODS,0,0
230531,Twenty,1,1
230532,drug-free,1,1
230533,adults,1,1
230534,with,1,1
230535,autistic,1,1
230536,disorder,1,1
230537,(,1,1
230538,16,1,1
230539,men,1,1
230540,and,1,1
230541,4,1,0
230542,women,1,1
230543,),1,1
230544,(,1,1
230545,mean,1,1
230546,[,1,0
230547,+/-,1,0
230548,SD,1,0
230549,],1,0
230550,age,1,1
230551,",",1,0
230552,30.5,1,0
230553,+/-,1,0
230554,8.5,1,0
230555,years,1,1
230556,),1,1
230557,underwent,0,1
230558,short-term,0,0
230559,tryptophan,0,0
230560,depletion,0,0
230561,in,0,0
230562,a,0,0
230563,double-blind,0,0
230564,",",0,0
230565,placebo-controlled,0,0
230566,",",0,0
230567,randomized,0,0
230568,crossover,0,0
230569,design,0,1
230570,.,0,1
230571,Patients,0,1
230572,received,0,0
230573,a,0,0
230574,24-hour,0,0
230575,",",0,0
230576,low-tryptophan,0,0
230577,diet,0,0
230578,followed,0,0
230579,the,0,0
230580,next,0,0
230581,morning,0,0
230582,by,0,0
230583,an,0,0
230584,amino,0,0
230585,acid,0,0
230586,drink,0,0
230587,.,0,1
230588,Behavioral,0,0
230589,ratings,0,0
230590,were,0,1
230591,obtained,0,0
230592,on,0,0
230593,the,0,0
230594,morning,0,0
230595,of,0,0
230596,the,0,0
230597,amino,0,0
230598,acid,0,0
230599,drink,0,0
230600,(,0,0
230601,baseline,0,0
230602,),0,0
230603,and,0,0
230604,180,0,1
230605,",",0,0
230606,300,0,0
230607,",",0,0
230608,and,0,0
230609,420,0,1
230610,minutes,0,0
230611,after,0,0
230612,the,0,0
230613,drink,0,0
230614,.,0,0
230615,Plasma,0,0
230616,free,0,0
230617,and,0,0
230618,total,0,1
230619,tryptophan,0,0
230620,levels,0,0
230621,were,0,0
230622,obtained,0,0
230623,at,0,0
230624,baseline,0,0
230625,and,0,0
230626,5,0,0
230627,hours,0,0
230628,after,0,0
230629,the,0,0
230630,drink,0,0
230631,.,0,0
230632,The,0,0
230633,active,0,0
230634,and,0,0
230635,sham,0,0
230636,testing,0,0
230637,sessions,0,0
230638,were,0,0
230639,separated,0,1
230640,by,0,0
230641,7,0,1
230642,days,0,0
230643,.,0,1
230644,RESULTS,0,0
230645,Eleven,1,1
230646,(,1,0
230647,65,1,1
230648,%,1,0
230649,),1,0
230650,of,1,0
230651,the,1,0
230652,17,1,1
230653,patients,1,1
230654,who,1,1
230655,completed,1,1
230656,both,1,1
230657,test,1,0
230658,days,1,0
230659,showed,0,0
230660,a,0,0
230661,significant,0,0
230662,global,0,0
230663,worsening,0,0
230664,of,0,0
230665,behavioral,0,0
230666,symptoms,0,1
230667,with,0,1
230668,short-term,0,0
230669,tryptophan,0,0
230670,depletion,0,0
230671,",",0,0
230672,but,0,0
230673,none,0,0
230674,of,0,0
230675,the,0,0
230676,17,0,1
230677,patients,0,1
230678,showed,0,0
230679,any,0,0
230680,significant,0,0
230681,change,0,0
230682,in,0,0
230683,clinical,0,0
230684,status,0,1
230685,from,0,0
230686,baseline,0,0
230687,after,0,0
230688,sham,0,0
230689,depletion,0,0
230690,(,0,0
230691,P,0,0
230692,=,0,0
230693,.001,0,0
230694,),0,1
230695,.,0,0
230696,Tryptophan,0,0
230697,depletion,0,0
230698,led,0,0
230699,to,0,0
230700,a,0,0
230701,significant,0,0
230702,increase,0,0
230703,in,0,0
230704,behaviors,0,0
230705,such,0,0
230706,as,0,0
230707,whirling,0,0
230708,",",0,0
230709,flapping,0,0
230710,",",0,0
230711,pacing,0,0
230712,",",0,0
230713,banging,0,0
230714,and,0,0
230715,hitting,0,0
230716,self,0,0
230717,",",0,0
230718,rocking,0,0
230719,",",0,0
230720,and,0,0
230721,toe,0,0
230722,walking,0,0
230723,(,0,0
230724,P,0,0
230725,<,0,0
230726,.05,0,0
230727,),0,0
230728,.,0,0
230729,In,0,0
230730,addition,0,0
230731,",",0,0
230732,patients,0,1
230733,were,0,0
230734,significantly,0,0
230735,less,0,0
230736,calm,0,0
230737,and,0,0
230738,happy,0,0
230739,and,0,0
230740,more,0,0
230741,anxious,0,0
230742,.,0,0
230743,No,0,0
230744,significant,0,0
230745,change,0,0
230746,was,0,0
230747,observed,0,0
230748,in,0,0
230749,social,0,0
230750,relatedness,0,0
230751,or,0,1
230752,repetitive,0,0
230753,thoughts,0,0
230754,and,0,1
230755,behavior,0,0
230756,.,0,0
230757,Plasma,0,0
230758,total,0,1
230759,and,0,0
230760,free,0,1
230761,tryptophan,0,0
230762,levels,0,0
230763,were,0,1
230764,reduced,0,0
230765,86,0,1
230766,%,0,0
230767,and,0,0
230768,69,0,1
230769,%,0,0
230770,",",0,0
230771,respectively,0,0
230772,",",0,0
230773,5,0,0
230774,hours,0,0
230775,after,0,0
230776,the,0,0
230777,tryptophan-deficient,0,0
230778,amino,0,0
230779,acid,0,0
230780,drink,0,0
230781,.,0,1
230782,Patients,0,1
230783,who,0,1
230784,had,0,1
230785,a,0,1
230786,significant,0,0
230787,global,0,0
230788,exacerbation,0,1
230789,of,0,0
230790,symptoms,0,0
230791,had,0,1
230792,significantly,0,0
230793,higher,0,0
230794,baseline,0,0
230795,plasma,0,0
230796,total,0,1
230797,tryptophan,0,0
230798,levels,0,0
230799,(,0,1
230800,P,0,0
230801,<,0,0
230802,.001,0,0
230803,),0,0
230804,and,0,0
230805,Autism,0,1
230806,Behavior,0,1
230807,Checklist,0,0
230808,scores,0,0
230809,(,0,1
230810,P,0,0
230811,=,0,0
230812,.005,0,0
230813,),0,0
230814,than,0,0
230815,did,0,1
230816,patients,0,1
230817,who,0,1
230818,showed,0,1
230819,no,0,1
230820,significant,0,0
230821,change,0,0
230822,in,0,0
230823,symptoms,0,0
230824,after,0,0
230825,tryptophan,0,1
230826,depletion,0,0
230827,.,0,0
230828,CONCLUSIONS,0,0
230829,The,0,0
230830,results,0,0
230831,of,0,0
230832,this,0,0
230833,study,0,0
230834,are,0,0
230835,consistent,0,0
230836,with,0,1
230837,previous,0,0
230838,research,0,0
230839,that,0,0
230840,has,0,0
230841,implicated,0,0
230842,a,0,0
230843,dysregulation,0,0
230844,in,0,0
230845,serotonin,0,0
230846,function,0,0
230847,in,0,0
230848,some,0,0
230849,patients,1,1
230850,with,1,1
230851,autism,1,1
230852,.,1,0
230853,These,0,0
230854,data,0,0
230855,suggest,0,0
230856,that,0,0
230857,the,0,0
230858,short-term,0,0
230859,reduction,0,0
230860,of,0,0
230861,serotonin,0,0
230862,precursor,0,0
230863,availability,0,0
230864,may,0,0
230865,exacerbate,0,0
230866,some,0,0
230867,symptoms,0,0
230868,characteristic,0,0
230869,of,0,0
230870,autism,0,1
230871,in,0,0
230872,some,0,0
230873,patients,0,1
230874,.,0,1
230875,Continued,0,0
230876,investigation,0,0
230877,into,0,0
230878,the,0,0
230879,role,0,0
230880,of,0,0
230881,serotonin,0,0
230882,in,0,0
230883,the,0,0
230884,pathogenesis,0,0
230885,and,0,0
230886,treatment,0,0
230887,of,0,0
230888,autistic,1,1
230889,disorder,1,1
230890,is,0,0
230891,warranted,0,0
230892,.,0,0
230893,Age,0,0
230894,and,0,0
230895,autonomic,0,1
230896,effects,0,0
230897,on,0,0
230898,interrelationships,0,0
230899,between,0,0
230900,lung,0,1
230901,volume,0,0
230902,and,0,0
230903,heart,0,1
230904,rate,0,0
230905,.,0,0
230906,To,0,0
230907,determine,0,0
230908,effects,0,0
230909,of,0,0
230910,aging,0,1
230911,and,0,0
230912,autonomic,0,1
230913,input,0,0
230914,on,0,0
230915,interrelationships,0,0
230916,between,0,0
230917,respiratory,0,1
230918,and,0,0
230919,heart,0,1
230920,rate,0,0
230921,variability,0,0
230922,",",0,0
230923,we,0,0
230924,collected,0,0
230925,5,0,0
230926,min,0,0
230927,of,0,0
230928,lung,0,1
230929,volume,0,0
230930,of,0,0
230931,R-R,0,0
230932,interval,0,0
230933,data,0,0
230934,from,0,1
230935,7,1,1
230936,young,1,1
230937,[,1,0
230938,27,1,1
230939,+/-,1,0
230940,3,1,0
230941,(,1,1
230942,SD,1,0
230943,),1,0
230944,yr,1,1
230945,],1,0
230946,and,1,0
230947,10,1,0
230948,older,1,1
230949,(,1,1
230950,69,1,1
230951,+/-,1,0
230952,6,1,0
230953,yr,1,1
230954,),1,0
230955,healthy,1,1
230956,supine,1,0
230957,humans,1,0
230958,before,1,0
230959,and,1,0
230960,after,1,0
230961,double,1,0
230962,pharmacological,1,0
230963,autonomic,1,1
230964,blockade,1,0
230965,with,1,1
230966,propranolol,1,0
230967,(,1,0
230968,0.2,1,0
230969,mg/kg,1,0
230970,iv,1,0
230971,),1,0
230972,and,1,0
230973,atropine,1,0
230974,(,1,0
230975,0.04,1,0
230976,mg/kg,1,0
230977,iv,1,0
230978,),1,0
230979,.,1,0
230980,Estimates,0,0
230981,of,0,0
230982,respiratory,0,1
230983,and,0,0
230984,heart,0,1
230985,rate,0,0
230986,power,0,0
230987,spectra,0,0
230988,and,0,0
230989,linear,0,0
230990,transfer,0,0
230991,functions,0,0
230992,between,0,0
230993,the,0,0
230994,two,0,0
230995,groups,0,0
230996,were,0,1
230997,generated,0,0
230998,by,0,0
230999,Fourier,0,0
231000,analysis,0,0
231001,.,0,0
231002,Age,0,0
231003,",",0,0
231004,double,0,0
231005,blockade,0,0
231006,effects,0,0
231007,",",0,0
231008,the,0,0
231009,age-drug,0,1
231010,interactions,0,0
231011,were,0,1
231012,determined,0,0
231013,by,0,0
231014,analysis,0,0
231015,of,0,0
231016,variance,0,0
231017,for,0,0
231018,repeated,0,0
231019,measures,0,0
231020,.,0,1
231021,Basal,0,0
231022,R-R,0,0
231023,intervals,0,0
231024,were,0,1
231025,unaffected,0,0
231026,by,0,0
231027,age,0,1
231028,.,0,1
231029,Double,0,0
231030,blockade,0,0
231031,decreased,0,0
231032,R-R,0,0
231033,intervals,0,0
231034,and,0,0
231035,variability,0,0
231036,in,0,0
231037,both,0,0
231038,age,0,1
231039,groups,0,0
231040,(,0,1
231041,P,0,0
231042,<,0,0
231043,0.0001,0,0
231044,),0,0
231045,",",0,0
231046,but,0,0
231047,R-R,0,0
231048,intervals,0,0
231049,decreased,0,0
231050,less,0,0
231051,in,0,0
231052,older,0,1
231053,than,0,0
231054,in,0,0
231055,young,0,1
231056,subjects,0,1
231057,(,0,1
231058,P,0,0
231059,<,0,0
231060,0.0001,0,0
231061,),0,0
231062,.,0,0
231063,In,0,0
231064,contrast,0,0
231065,",",0,0
231066,basal,0,0
231067,respiratory,0,1
231068,intervals,0,0
231069,and,0,0
231070,standard,0,1
231071,deviation,0,0
231072,were,0,0
231073,greater,0,0
231074,in,0,0
231075,older,0,1
231076,subjects,0,1
231077,(,0,0
231078,P,0,0
231079,=,0,0
231080,0.05,0,0
231081,),0,0
231082,and,0,0
231083,were,0,0
231084,unaffected,0,0
231085,by,0,0
231086,double,0,0
231087,blockade,0,0
231088,in,0,0
231089,young,1,1
231090,and,1,0
231091,older,1,1
231092,subjects,1,1
231093,.,1,1
231094,Lung,0,0
231095,volume-to-heart,0,0
231096,rate,0,0
231097,spectral,0,0
231098,coherence,0,0
231099,was,0,0
231100,highest,0,0
231101,at,0,0
231102,frequencies,0,0
231103,associated,0,0
231104,with,0,1
231105,respiration,0,0
231106,and,0,0
231107,greater,0,0
231108,in,0,0
231109,young,0,1
231110,than,0,0
231111,in,0,0
231112,older,0,1
231113,subjects,0,1
231114,(,0,0
231115,P,0,0
231116,<,0,0
231117,0.07,0,0
231118,),0,1
231119,.,0,1
231120,Double,0,0
231121,blockade,0,0
231122,decreased,0,0
231123,lung,0,1
231124,volume-to-heart,0,0
231125,rate,0,0
231126,variability,0,0
231127,transfer,0,0
231128,function,0,0
231129,magnitude,0,0
231130,(,0,0
231131,P,0,0
231132,<,0,0
231133,0.007,0,0
231134,),0,0
231135,and,0,0
231136,increased,0,0
231137,phase,0,1
231138,angle,0,0
231139,(,0,0
231140,P,0,0
231141,<,0,0
231142,0.02,0,0
231143,),0,0
231144,without,0,1
231145,age,0,1
231146,effects,0,0
231147,or,0,1
231148,age-drug,0,1
231149,interactions,0,0
231150,.,0,1
231151,In,0,0
231152,conclusion,0,0
231153,",",0,0
231154,heart,0,1
231155,rate,0,0
231156,",",0,0
231157,respiration,0,0
231158,",",0,0
231159,and,0,0
231160,respiration-heart,0,1
231161,rate,0,0
231162,interrelations,0,0
231163,are,0,0
231164,altered,0,0
231165,by,0,0
231166,aging,0,1
231167,",",0,0
231168,and,0,0
231169,double,0,0
231170,autonomic,0,1
231171,pharmacological,0,0
231172,blockade,0,0
231173,does,0,0
231174,not,0,0
231175,eliminate,0,0
231176,all,0,0
231177,age-related,0,0
231178,differences,0,0
231179,.,0,1
231180,Durability,0,0
231181,of,0,0
231182,central,0,1
231183,venous,0,1
231184,catheters,0,1
231185,.,0,1
231186,A,0,0
231187,randomized,0,0
231188,trial,0,0
231189,in,0,0
231190,children,1,1
231191,with,1,1
231192,malignant,1,1
231193,diseases,1,1
231194,.,1,1
231195,In,0,0
231196,a,0,0
231197,prospective,0,0
231198,randomized,0,0
231199,study,0,0
231200,the,0,0
231201,durability,0,0
231202,of,0,0
231203,tunnelled,0,1
231204,and,0,1
231205,non-tunnelled,0,1
231206,central,0,1
231207,venous,0,1
231208,catheters,0,1
231209,was,0,0
231210,investigated,0,0
231211,in,0,0
231212,children,1,1
231213,with,1,1
231214,malignant,1,1
231215,diseases,1,1
231216,.,1,1
231217,Twenty,1,1
231218,children,1,1
231219,were,1,1
231220,included,1,1
231221,in,1,0
231222,the,1,0
231223,study,1,0
231224,but,1,0
231225,four,1,1
231226,(,1,0
231227,two,1,0
231228,in,1,0
231229,each,1,0
231230,group,1,0
231231,),1,0
231232,had,1,0
231233,to,1,0
231234,be,1,0
231235,excluded,1,1
231236,;,1,0
231237,three,1,0
231238,because,1,0
231239,the,1,0
231240,entry,1,0
231241,criteria,1,1
231242,turned,1,0
231243,out,1,0
231244,not,1,0
231245,to,1,0
231246,be,1,0
231247,fulfilled,1,1
231248,and,1,0
231249,one,1,0
231250,because,1,0
231251,of,1,0
231252,lack,1,0
231253,of,1,0
231254,data,1,0
231255,.,1,1
231256,The,0,0
231257,median,0,0
231258,duration,0,0
231259,of,0,0
231260,the,0,0
231261,tunnelled,0,1
231262,catheters,0,0
231263,was,0,0
231264,224,0,1
231265,days,0,0
231266,with,0,1
231267,a,0,0
231268,range,0,0
231269,of,0,0
231270,25-846,0,1
231271,days,0,0
231272,which,0,0
231273,was,0,0
231274,significantly,0,0
231275,longer,0,0
231276,than,0,0
231277,that,0,0
231278,of,0,0
231279,conventional,0,0
231280,catheters,0,1
231281,(,0,1
231282,39.5,0,1
231283,days,0,0
231284,",",0,0
231285,range,0,1
231286,9-228,0,1
231287,days,0,0
231288,),0,1
231289,.,0,1
231290,In,0,0
231291,addition,0,0
231292,six,0,1
231293,of,0,0
231294,eight,0,1
231295,conventional,0,1
231296,catheters,0,1
231297,were,0,1
231298,accidentally,0,1
231299,removed,0,0
231300,whereas,0,0
231301,all,0,0
231302,catheters,0,0
231303,in,0,0
231304,the,0,0
231305,tunnelled,0,1
231306,group,0,0
231307,had,0,0
231308,to,0,0
231309,be,0,0
231310,removed,0,0
231311,via,0,0
231312,a,0,0
231313,small,0,0
231314,incision,0,0
231315,.,0,1
231316,Three,0,0
231317,cases,0,0
231318,of,0,0
231319,catheter,0,0
231320,related,0,0
231321,sepsis,0,1
231322,",",0,0
231323,two,0,0
231324,in,0,0
231325,the,0,0
231326,tunnelled,0,0
231327,group,0,0
231328,and,0,0
231329,one,0,0
231330,in,0,0
231331,the,0,0
231332,conventional,0,0
231333,group,0,0
231334,",",0,0
231335,were,0,0
231336,registered,0,0
231337,.,0,0
231338,The,0,0
231339,corresponding,0,0
231340,number,0,0
231341,of,0,0
231342,infections,0,0
231343,per,0,1
231344,catheter,0,1
231345,days,0,0
231346,were,0,1
231347,1,0,1
231348,in,0,0
231349,1189,0,1
231350,days,0,0
231351,and,0,1
231352,1,0,1
231353,in,0,0
231354,522,0,1
231355,days,0,0
231356,",",0,0
231357,respectively,0,0
231358,.,0,0
231359,In,0,0
231360,conclusion,0,0
231361,cuffed,0,0
231362,",",0,0
231363,tunnelled,0,1
231364,central,0,1
231365,venous,0,1
231366,catheters,0,0
231367,are,0,0
231368,less,0,0
231369,prone,0,0
231370,to,0,0
231371,displacement,0,0
231372,than,0,0
231373,traditional,0,1
231374,percutaneous,0,1
231375,central,0,1
231376,venous,0,1
231377,catheters,0,0
231378,when,0,0
231379,used,0,0
231380,in,0,0
231381,children,1,1
231382,with,1,1
231383,malignant,1,1
231384,diseases,1,1
231385,.,1,1
231386,Modulation,0,0
231387,of,0,0
231388,oxidant,0,0
231389,stress,0,0
231390,in,0,0
231391,vivo,0,0
231392,in,0,0
231393,chronic,1,1
231394,cigarette,1,1
231395,smokers,1,1
231396,.,1,1
231397,BACKGROUND,0,0
231398,Free,0,0
231399,radical-induced,0,0
231400,oxidative,0,0
231401,damage,0,0
231402,is,0,0
231403,thought,0,0
231404,to,0,0
231405,be,0,0
231406,involved,0,0
231407,in,0,0
231408,the,0,0
231409,pathogenesis,0,0
231410,of,0,0
231411,diseases,0,1
231412,associated,0,0
231413,with,0,1
231414,cigarette,0,1
231415,smoking,0,1
231416,.,0,0
231417,We,0,0
231418,examined,0,0
231419,the,0,0
231420,production,0,0
231421,of,0,0
231422,8-epi-prostaglandin,0,0
231423,(,0,1
231424,PG,0,0
231425,),0,0
231426,F2,0,0
231427,alpha,0,0
231428,",",0,0
231429,a,0,0
231430,stable,0,0
231431,product,0,0
231432,of,0,0
231433,lipid,0,0
231434,peroxidation,0,0
231435,in,0,0
231436,vivo,0,0
231437,",",0,0
231438,and,0,0
231439,its,0,0
231440,modulation,0,0
231441,by,0,0
231442,aspirin,0,0
231443,and,0,0
231444,antioxidant,0,0
231445,vitamins,0,0
231446,in,0,0
231447,chronic,1,1
231448,cigarette,1,1
231449,smokers,1,1
231450,.,1,1
231451,METHODS,0,0
231452,AND,0,0
231453,RESULTS,0,0
231454,We,0,0
231455,performed,0,0
231456,the,0,0
231457,following,0,0
231458,studies,0,0
231459,:,0,1
231460,(,0,1
231461,1,0,0
231462,),0,0
231463,a,1,0
231464,cross-sectional,1,0
231465,comparison,1,0
231466,of,1,0
231467,smokers,1,1
231468,and,1,1
231469,control,1,1
231470,subjects,1,1
231471,",",0,0
231472,(,0,0
231473,2,0,0
231474,),0,0
231475,an,0,0
231476,examination,0,0
231477,of,0,0
231478,the,0,0
231479,dose-response,0,0
231480,relationship,0,0
231481,",",0,0
231482,(,0,0
231483,3,0,0
231484,),0,0
231485,an,0,0
231486,exploration,0,0
231487,of,0,0
231488,the,0,0
231489,effect,0,0
231490,of,0,0
231491,smoking,0,0
231492,cessation,0,1
231493,(,0,1
231494,3,0,0
231495,weeks,0,0
231496,),0,1
231497,and,0,0
231498,nicotine,0,0
231499,patch,0,0
231500,supplementation,0,0
231501,",",0,0
231502,(,0,0
231503,4,0,0
231504,),0,0
231505,the,0,0
231506,effect,0,0
231507,of,0,0
231508,aspirin,0,0
231509,consumption,0,0
231510,",",0,0
231511,and,0,0
231512,(,0,0
231513,5,0,0
231514,),0,0
231515,the,0,0
231516,effects,0,0
231517,of,0,0
231518,5,0,1
231519,days,0,0
231520,',0,1
231521,dosing,0,0
231522,with,0,1
231523,vitamin,0,0
231524,E,0,0
231525,(,0,0
231526,100,0,0
231527,and,0,1
231528,800,0,0
231529,U,0,0
231530,),0,0
231531,",",0,0
231532,vitamin,0,0
231533,C,0,0
231534,(,0,0
231535,2,0,0
231536,g,0,1
231537,),0,0
231538,",",0,0
231539,and,0,0
231540,their,0,0
231541,combination,0,0
231542,.,0,0
231543,8-epi-PGF2,0,0
231544,alpha,0,0
231545,excretion,0,0
231546,(,0,0
231547,in,0,0
231548,pmol/mmol,0,0
231549,",",0,0
231550,mean,0,0
231551,+/-,0,0
231552,SEM,0,1
231553,),0,0
231554,was,0,0
231555,176.5+/-30.6,0,0
231556,in,0,0
231557,heavy,1,1
231558,smokers,1,1
231559,",",0,0
231560,92.7+/-4.8,0,0
231561,(,0,0
231562,P,0,0
231563,<,0,0
231564,.05,0,0
231565,),0,0
231566,in,0,0
231567,moderate,1,1
231568,smokers,1,1
231569,",",0,0
231570,and,0,0
231571,54.1+/-2.7,0,0
231572,(,0,0
231573,P,0,0
231574,<,0,0
231575,.005,0,0
231576,),0,0
231577,in,0,0
231578,nonsmokers,1,1
231579,.,1,1
231580,Urinary,0,0
231581,levels,0,0
231582,fell,0,0
231583,from,0,1
231584,145.5+/-24.9,0,0
231585,to,0,0
231586,114.6+/-27.1,0,0
231587,(,0,0
231588,week,0,0
231589,2,0,0
231590,",",0,0
231591,P,0,0
231592,<,0,0
231593,.05,0,0
231594,),0,0
231595,and,0,0
231596,112.6+/-24.9,0,0
231597,(,0,0
231598,week,0,0
231599,3,0,0
231600,",",0,0
231601,P,0,0
231602,<,0,0
231603,.05,0,0
231604,),0,0
231605,on,0,0
231606,cessation,0,0
231607,of,0,0
231608,smoking,0,1
231609,.,0,1
231610,Aspirin,0,0
231611,treatment,0,0
231612,failed,0,0
231613,to,0,0
231614,suppress,0,0
231615,urinary,0,0
231616,levels,0,0
231617,of,0,0
231618,8-epi-PGF2,0,0
231619,alpha,0,0
231620,despite,0,0
231621,a,0,0
231622,significant,0,0
231623,reduction,0,0
231624,in,0,0
231625,urinary,0,0
231626,11-dehydro-TxB2,0,0
231627,production,0,0
231628,and,0,0
231629,suppression,0,0
231630,of,0,0
231631,8-epi-PGF2,0,0
231632,alpha,0,0
231633,and,0,0
231634,TxB2,0,0
231635,in,0,0
231636,serum,0,0
231637,.,0,1
231638,Vitamin,0,0
231639,C,0,0
231640,(,0,0
231641,pre,0,0
231642,",",0,0
231643,194.6+/-40.9,0,0
231644,;,0,0
231645,post,0,0
231646,",",0,0
231647,137.2+/-34.1,0,0
231648,;,0,0
231649,P,0,0
231650,<,0,0
231651,.05,0,0
231652,),0,0
231653,and,0,0
231654,a,0,0
231655,combination,0,0
231656,of,0,0
231657,vitamin,0,0
231658,C,0,0
231659,and,0,0
231660,E,0,0
231661,(,0,0
231662,pre,0,0
231663,",",0,0
231664,171.0+/-39.8,0,0
231665,;,0,0
231666,post,0,0
231667,",",0,0
231668,133.5+/-29.6,0,0
231669,P,0,0
231670,<,0,0
231671,.05,0,0
231672,),0,0
231673,suppressed,0,0
231674,urinary,0,0
231675,8-epi-PGF2,0,0
231676,alpha,0,0
231677,",",0,0
231678,whereas,0,0
231679,vitamin,0,0
231680,E,0,0
231681,alone,0,0
231682,had,0,0
231683,no,0,0
231684,effect,0,0
231685,.,0,0
231686,CONCLUSIONS,0,0
231687,Urinary,0,0
231688,8-epi-PGF2,0,0
231689,alpha,0,0
231690,may,0,0
231691,represent,0,0
231692,a,0,0
231693,noninvasive,0,0
231694,",",0,0
231695,quantitative,0,0
231696,index,0,0
231697,of,0,0
231698,oxidant,0,0
231699,stress,0,0
231700,in,0,0
231701,vivo,0,0
231702,.,0,1
231703,Elevated,0,0
231704,levels,0,0
231705,of,0,0
231706,8-epi-PGF2,0,0
231707,alpha,0,0
231708,in,0,0
231709,smokers,1,1
231710,may,0,0
231711,be,0,0
231712,modulated,0,0
231713,by,0,0
231714,quitting,0,1
231715,cigarettes,0,1
231716,and,0,0
231717,switching,0,0
231718,to,0,0
231719,nicotine,0,0
231720,patches,0,0
231721,or,0,1
231722,by,0,0
231723,antioxidant,0,0
231724,vitamin,0,0
231725,therapy,0,0
231726,.,0,1
231727,Trunk,0,1
231728,exercise,0,0
231729,combined,0,0
231730,with,0,1
231731,spinal,0,1
231732,manipulative,0,0
231733,or,0,1
231734,NSAID,0,0
231735,therapy,0,0
231736,for,0,0
231737,chronic,1,1
231738,low,1,0
231739,back,1,1
231740,pain,1,1
231741,:,1,1
231742,a,0,0
231743,randomized,0,0
231744,",",0,0
231745,observer-blinded,0,0
231746,clinical,0,0
231747,trial,0,1
231748,.,0,0
231749,OBJECTIVES,0,0
231750,To,0,0
231751,study,0,0
231752,the,0,0
231753,relative,0,0
231754,efficacy,0,0
231755,of,0,0
231756,three,0,0
231757,different,0,0
231758,treatment,0,0
231759,for,0,0
231760,chronic,1,1
231761,low,1,0
231762,back,1,1
231763,pain,1,0
231764,(,1,0
231765,CLBP,1,0
231766,),1,1
231767,.,1,1
231768,Two,0,0
231769,preplanned,0,0
231770,comparisons,0,0
231771,were,0,1
231772,made,0,0
231773,:,0,1
231774,(,0,0
231775,a,0,0
231776,),0,0
231777,Spinal,0,1
231778,manipulative,0,0
231779,therapy,0,0
231780,(,0,0
231781,SMT,0,0
231782,),0,0
231783,combined,0,0
231784,with,0,1
231785,trunk,0,0
231786,strengthening,0,0
231787,exercises,0,0
231788,(,0,1
231789,TSE,0,1
231790,),0,0
231791,vs.,0,0
231792,SMT,0,0
231793,combined,0,0
231794,with,0,1
231795,trunk,0,0
231796,stretching,0,0
231797,exercises,0,0
231798,",",0,0
231799,and,0,0
231800,(,0,0
231801,b,0,1
231802,),0,0
231803,SMT,0,0
231804,combined,0,0
231805,with,0,1
231806,TSE,0,1
231807,vs.,0,0
231808,nonsteroidal,0,0
231809,anti-inflammatory,0,0
231810,drug,0,0
231811,(,0,0
231812,NSAID,0,0
231813,),0,0
231814,therapy,0,0
231815,combined,0,0
231816,with,0,1
231817,TSE,0,1
231818,.,0,1
231819,STUDY,0,0
231820,DESIGN,0,0
231821,Interdisciplinary,0,0
231822,",",0,0
231823,prospective,0,0
231824,",",0,0
231825,observer-blinded,0,0
231826,",",0,0
231827,randomized,0,1
231828,clinical,0,0
231829,trial,0,0
231830,with,0,1
231831,a,0,0
231832,1-yr,0,0
231833,follow-up,0,0
231834,period,0,0
231835,.,0,0
231836,The,0,0
231837,trial,0,0
231838,evaluated,0,0
231839,therapies,0,0
231840,in,0,0
231841,combination,0,0
231842,only,0,0
231843,and,0,0
231844,was,0,0
231845,not,0,0
231846,designed,0,0
231847,to,0,0
231848,test,0,0
231849,the,0,0
231850,individual,0,0
231851,treatment,0,0
231852,components,0,0
231853,.,0,1
231854,SETTING,0,1
231855,Primary,1,1
231856,contact,1,0
231857,",",1,0
231858,college,1,1
231859,out-patient,1,0
231860,clinic,1,1
231861,.,1,0
231862,PATIENTS,0,0
231863,In,0,0
231864,total,0,1
231865,",",0,1
231866,174,1,1
231867,patients,1,1
231868,aged,1,1
231869,20-60,1,1
231870,yr,1,1
231871,were,0,1
231872,admitted,0,1
231873,to,0,0
231874,the,0,0
231875,study,0,0
231876,.,0,0
231877,MAIN,0,0
231878,OUTCOME,0,0
231879,MEASURES,0,0
231880,Patient-rated,0,0
231881,low,0,0
231882,back,0,1
231883,pain,0,0
231884,",",0,0
231885,disability,0,0
231886,",",0,0
231887,and,0,0
231888,functional,0,0
231889,health,0,0
231890,status,0,1
231891,at,0,0
231892,5,0,0
231893,and,0,0
231894,11,0,1
231895,wk,0,1
231896,.,0,1
231897,INTERVENTIONS,0,0
231898,Five,0,0
231899,weeks,0,0
231900,of,0,0
231901,SMT,0,0
231902,or,0,1
231903,NSAID,0,0
231904,therapy,0,0
231905,in,0,0
231906,combination,0,0
231907,with,0,1
231908,supervised,0,0
231909,trunk,0,0
231910,exercise,0,0
231911,",",0,0
231912,followed,0,0
231913,by,0,0
231914,and,0,0
231915,additional,0,0
231916,6,0,0
231917,wk,0,1
231918,of,0,0
231919,supervised,0,0
231920,exercise,0,0
231921,alone,0,0
231922,.,0,0
231923,RESULTS,0,0
231924,Individual,0,0
231925,group,0,1
231926,comparisons,0,0
231927,after,0,0
231928,5,0,1
231929,and,0,0
231930,11,0,0
231931,wk,0,0
231932,of,0,0
231933,intervention,0,0
231934,on,0,0
231935,all,0,0
231936,three,0,0
231937,main,0,0
231938,outcome,0,0
231939,measures,0,0
231940,did,0,0
231941,not,0,0
231942,reveal,0,0
231943,any,0,0
231944,clear,0,0
231945,clinically,0,0
231946,important,0,0
231947,or,0,0
231948,statistically,0,0
231949,significant,0,0
231950,differences,0,0
231951,.,0,0
231952,There,0,0
231953,seemed,0,0
231954,to,0,0
231955,be,0,0
231956,a,0,0
231957,sustained,0,0
231958,reduction,0,0
231959,in,0,0
231960,medication,0,0
231961,use,0,0
231962,at,0,0
231963,the,0,0
231964,1-yr,0,0
231965,follow-up,0,0
231966,.,0,0
231967,in,0,0
231968,the,0,0
231969,SMT/TSE,0,0
231970,group,0,0
231971,.,0,0
231972,Continuance,0,0
231973,of,0,0
231974,exercise,0,0
231975,during,0,0
231976,the,0,0
231977,follow-up,0,0
231978,year,0,0
231979,",",0,0
231980,regardless,0,0
231981,of,0,0
231982,type,0,1
231983,",",0,0
231984,was,0,0
231985,associated,0,0
231986,with,0,1
231987,a,0,0
231988,better,0,0
231989,outcome,0,0
231990,.,0,0
231991,CONCLUSION,0,0
231992,Each,0,0
231993,of,0,0
231994,the,0,0
231995,three,0,0
231996,therapeutic,0,0
231997,regimens,0,0
231998,was,0,0
231999,associated,0,0
232000,with,0,1
232001,similar,0,0
232002,and,0,0
232003,clinically,0,0
232004,important,0,0
232005,improvement,0,0
232006,over,0,0
232007,time,0,0
232008,that,0,0
232009,was,0,0
232010,considered,0,0
232011,superior,0,0
232012,to,0,0
232013,the,0,0
232014,expected,0,0
232015,natural,0,0
232016,history,0,1
232017,of,0,0
232018,long-standing,0,1
232019,CLBP,0,0
232020,.,0,1
232021,For,0,0
232022,the,0,0
232023,management,0,0
232024,of,0,0
232025,CLBP,0,0
232026,",",0,0
232027,trunk,0,0
232028,exercise,0,0
232029,in,0,0
232030,combination,0,0
232031,with,0,1
232032,SMT,0,0
232033,or,0,1
232034,NSAID,0,0
232035,therapy,0,0
232036,seemed,0,0
232037,to,0,0
232038,be,0,0
232039,beneficial,0,0
232040,and,0,0
232041,worthwhile,0,0
232042,.,0,0
232043,The,0,0
232044,magnitude,0,0
232045,of,0,0
232046,nonspecific,0,0
232047,therapeutic,0,0
232048,(,0,0
232049,placebo,0,0
232050,),0,0
232051,effects,0,0
232052,",",0,0
232053,cost-effectiveness,0,0
232054,and,0,0
232055,relative,0,0
232056,risks,0,0
232057,of,0,0
232058,side,0,0
232059,effects,0,0
232060,associated,0,0
232061,with,0,1
232062,these,0,0
232063,types,0,0
232064,of,0,0
232065,therapy,0,0
232066,need,0,0
232067,to,0,0
232068,be,0,0
232069,addressed,0,0
232070,in,0,0
232071,future,0,0
232072,studies,0,0
232073,.,0,1
232074,Colonoscopic,0,1
232075,miss,0,1
232076,rates,0,0
232077,of,0,0
232078,adenomas,1,1
232079,determined,0,0
232080,by,0,0
232081,back-to-back,0,0
232082,colonoscopies,0,1
232083,.,0,1
232084,BACKGROUND,0,0
232085,&,0,1
232086,AIMS,0,1
232087,The,0,0
232088,miss,0,0
232089,rate,0,0
232090,of,0,0
232091,colonoscopy,0,1
232092,for,0,0
232093,neoplasms,0,1
232094,is,0,0
232095,poorly,0,0
232096,understood,0,0
232097,.,0,0
232098,The,0,0
232099,aim,0,0
232100,of,0,0
232101,this,0,0
232102,study,0,0
232103,was,0,0
232104,to,0,0
232105,determine,0,0
232106,the,0,0
232107,miss,0,0
232108,rate,0,0
232109,of,0,0
232110,colonoscopy,0,1
232111,by,0,0
232112,same,0,0
232113,day,0,0
232114,back-to-back,0,0
232115,colonoscopy,0,1
232116,.,0,1
232117,METHODS,0,0
232118,Two,0,1
232119,consecutive,0,1
232120,same,0,0
232121,day,0,0
232122,colonoscopies,0,1
232123,were,0,0
232124,performed,0,0
232125,in,0,0
232126,183,1,1
232127,patients,1,1
232128,.,1,1
232129,The,0,0
232130,patients,0,1
232131,were,0,0
232132,randomized,0,1
232133,to,0,0
232134,undergo,0,1
232135,the,0,0
232136,second,0,0
232137,colonoscopy,0,0
232138,by,0,0
232139,the,0,0
232140,same,0,0
232141,or,0,0
232142,a,0,0
232143,different,0,0
232144,endoscopist,0,0
232145,and,0,0
232146,in,0,0
232147,the,0,0
232148,same,0,0
232149,or,0,1
232150,different,0,0
232151,position,0,1
232152,.,0,0
232153,RESULTS,0,0
232154,The,0,0
232155,overall,0,0
232156,miss,0,0
232157,rate,0,0
232158,for,0,0
232159,adenomas,0,1
232160,was,0,0
232161,24,0,0
232162,%,0,0
232163,",",0,0
232164,27,0,1
232165,%,0,0
232166,for,0,0
232167,adenomas,0,1
232168,<,0,0
232169,or,0,1
232170,=,0,0
232171,5,0,0
232172,mm,0,0
232173,",",0,0
232174,13,0,0
232175,%,0,0
232176,for,0,0
232177,adenomas,0,1
232178,6-9,0,1
232179,mm,0,0
232180,",",0,0
232181,and,0,0
232182,6,0,0
232183,%,0,0
232184,for,0,0
232185,adenomas,0,1
232186,>,0,1
232187,or,0,1
232188,=,0,0
232189,1,0,0
232190,cm,0,1
232191,.,0,1
232192,Patients,1,1
232193,with,1,1
232194,two,1,0
232195,or,1,1
232196,more,1,0
232197,adenomas,1,1
232198,at,0,0
232199,the,0,0
232200,first,0,0
232201,examination,0,0
232202,were,0,0
232203,more,0,0
232204,likely,0,0
232205,than,0,0
232206,patients,1,1
232207,with,1,1
232208,no,1,0
232209,or,1,1
232210,one,1,0
232211,adenoma,1,1
232212,detected,0,0
232213,at,0,0
232214,the,0,0
232215,first,0,0
232216,examination,0,0
232217,to,0,0
232218,have,0,0
232219,one,0,0
232220,or,0,1
232221,more,0,0
232222,adenomas,0,1
232223,at,0,0
232224,the,0,0
232225,second,0,0
232226,examination,0,0
232227,(,0,0
232228,odds,0,0
232229,ratio,0,0
232230,",",0,1
232231,3.3,0,0
232232,;,0,0
232233,95,0,0
232234,%,0,0
232235,confidence,0,0
232236,interval,0,0
232237,",",0,0
232238,1.69-6.46,0,0
232239,),0,0
232240,.,0,1
232241,Right,0,0
232242,colon,0,1
232243,adenomas,0,1
232244,were,0,0
232245,missed,0,0
232246,more,0,0
232247,often,0,0
232248,(,0,0
232249,27,0,1
232250,%,0,0
232251,),0,0
232252,than,0,0
232253,left,0,1
232254,colon,0,1
232255,adenomas,0,1
232256,(,0,0
232257,21,0,1
232258,%,0,0
232259,),0,0
232260,",",0,0
232261,but,0,0
232262,the,0,0
232263,difference,0,0
232264,was,0,0
232265,not,0,0
232266,significant,0,0
232267,.,0,0
232268,There,0,0
232269,was,0,0
232270,evidence,0,0
232271,of,0,0
232272,variation,0,0
232273,in,0,0
232274,sensitivity,0,0
232275,between,0,0
232276,endoscopists,0,0
232277,",",0,0
232278,but,0,0
232279,significant,0,0
232280,miss,0,1
232281,rates,0,0
232282,for,0,1
232283,small,0,1
232284,adenomas,0,1
232285,were,0,1
232286,found,0,0
232287,among,0,0
232288,essentially,0,0
232289,all,0,0
232290,endoscopists,0,0
232291,.,0,1
232292,CONCLUSIONS,0,0
232293,Using,0,0
232294,current,0,0
232295,colonoscopic,0,0
232296,technology,0,0
232297,",",0,0
232298,there,0,0
232299,are,0,0
232300,significant,0,0
232301,miss,0,1
232302,rates,0,0
232303,for,0,0
232304,adenomas,0,1
232305,<,0,0
232306,1,0,0
232307,cm,0,1
232308,even,0,0
232309,with,0,1
232310,meticulous,0,0
232311,colonoscopy,0,1
232312,.,0,1
232313,Miss,0,0
232314,rates,0,0
232315,are,0,0
232316,low,0,0
232317,for,0,0
232318,adenomas,0,1
232319,>,0,1
232320,or,0,1
232321,=,0,0
232322,1,0,0
232323,cm,0,1
232324,.,0,1
232325,The,0,0
232326,results,0,0
232327,suggest,0,0
232328,the,0,0
232329,need,0,0
232330,for,0,0
232331,improvements,0,0
232332,in,0,0
232333,colonoscopic,0,1
232334,technology,0,0
232335,.,0,1
232336,Effects,0,0
232337,of,0,0
232338,omeprazole,0,0
232339,and,0,0
232340,amoxycillin,0,0
232341,on,0,0
232342,the,0,0
232343,human,0,1
232344,oral,0,0
232345,and,0,1
232346,gastrointestinal,0,1
232347,microflora,0,0
232348,in,0,1
232349,patients,1,1
232350,with,1,1
232351,Helicobacter,1,1
232352,pylori,1,1
232353,infection,1,1
232354,.,1,1
232355,Fourteen,1,1
232356,patients,1,1
232357,with,1,1
232358,Helicobacter,1,1
232359,pylori,1,1
232360,infection,1,0
232361,were,0,0
232362,treated,0,1
232363,with,0,1
232364,omeprazole,0,0
232365,capsules,0,0
232366,20,0,1
232367,mg,0,0
232368,and,0,1
232369,amoxycillin,0,0
232370,capsules,0,0
232371,1000,0,0
232372,mg,0,0
232373,twice,0,0
232374,daily,0,0
232375,for,0,0
232376,14,0,0
232377,days,0,0
232378,and,0,1
232379,14,0,1
232380,patients,0,1
232381,with,0,1
232382,omeprazole,0,1
232383,capsules,0,0
232384,20,0,1
232385,mg,0,0
232386,and,0,0
232387,placebo,0,0
232388,twice,0,0
232389,daily,0,0
232390,for,0,0
232391,14,0,1
232392,days,0,0
232393,.,0,1
232394,Samples,0,0
232395,from,0,0
232396,saliva,0,0
232397,",",0,0
232398,dental,0,1
232399,plaque,0,0
232400,and,0,0
232401,faeces,0,0
232402,and,0,0
232403,biopsies,0,1
232404,from,0,1
232405,antrum,0,1
232406,and,0,0
232407,corpus,0,0
232408,were,0,0
232409,analysed,0,0
232410,in,0,0
232411,order,0,0
232412,to,0,0
232413,determine,0,0
232414,the,0,0
232415,ecological,0,0
232416,changes,0,0
232417,in,0,0
232418,the,0,0
232419,normal,0,1
232420,microflora,0,0
232421,.,0,1
232422,Several,0,0
232423,microorganisms,0,0
232424,were,0,1
232425,affected,0,0
232426,by,0,0
232427,both,0,0
232428,treatment,0,0
232429,regimens,0,0
232430,.,0,1
232431,Two,0,1
232432,patients,0,1
232433,were,0,1
232434,colonised,0,0
232435,with,0,1
232436,enterobacteria,0,0
232437,in,0,0
232438,the,0,0
232439,oral,0,0
232440,cavity,0,0
232441,and,0,0
232442,stomach,0,0
232443,during,0,0
232444,the,0,0
232445,omeprazole,0,0
232446,plus,0,0
232447,amoxycillin,0,0
232448,treatment,0,0
232449,.,0,0
232450,A,0,0
232451,general,0,0
232452,increase,0,0
232453,in,0,0
232454,the,0,0
232455,number,0,0
232456,of,0,0
232457,microorganisms,0,0
232458,from,0,1
232459,gastric,0,1
232460,mucosa,0,1
232461,was,0,0
232462,observed,0,0
232463,in,0,0
232464,both,0,0
232465,treatment,0,0
232466,groups,0,0
232467,.,0,0
232468,A,0,0
232469,selection,0,0
232470,of,0,0
232471,resistant,0,1
232472,enterobacteria,0,1
232473,and,0,0
232474,an,0,0
232475,increase,0,0
232476,in,0,0
232477,beta-lactamase,0,0
232478,production,0,0
232479,was,0,0
232480,observed,0,0
232481,in,0,0
232482,the,0,0
232483,faecal,0,0
232484,samples,0,0
232485,during,0,0
232486,the,0,0
232487,omeprazole,0,0
232488,plus,0,0
232489,amoxycillin,0,0
232490,treatment,0,0
232491,.,0,0
232492,Eradication,0,0
232493,of,0,0
232494,H.,0,1
232495,pylori,0,0
232496,in,0,0
232497,the,0,0
232498,omeprazole-amoxycillin,0,0
232499,group,0,0
232500,was,0,0
232501,50,0,1
232502,%,0,0
232503,and,0,0
232504,in,0,0
232505,the,0,0
232506,omeprazole,0,0
232507,placebo,0,0
232508,group,0,0
232509,0,0,0
232510,%,0,0
232511,four,0,1
232512,weeks,0,0
232513,after,0,0
232514,treatment,0,0
232515,.,0,0
232516,No,0,0
232517,viable,0,0
232518,H.,0,1
232519,pylori,0,1
232520,were,0,0
232521,cultivated,0,0
232522,in,0,0
232523,the,0,0
232524,saliva,0,0
232525,",",0,0
232526,dental,0,1
232527,plaque,0,0
232528,or,0,1
232529,faecal,0,1
232530,samples,0,0
232531,.,0,1
232532,Treatment,0,0
232533,with,0,1
232534,omeprazole,0,0
232535,20,0,1
232536,mg,0,0
232537,and,0,0
232538,amoxycillin,0,0
232539,1000,0,0
232540,mg,0,0
232541,twice,0,0
232542,daily,0,0
232543,for,0,0
232544,14,0,1
232545,days,0,0
232546,altered,0,1
232547,the,0,0
232548,normal,0,0
232549,microflora,0,0
232550,in,0,0
232551,the,0,0
232552,oral,0,0
232553,",",0,0
232554,gastric,0,1
232555,and,0,0
232556,intestinal,0,1
232557,tract,0,1
232558,and,0,0
232559,antibiotic,0,0
232560,resistant,0,1
232561,microorganisms,0,0
232562,increased,0,0
232563,in,0,0
232564,numbers,0,0
232565,in,0,0
232566,the,0,0
232567,intestinal,0,0
232568,microflora,0,0
232569,.,0,1
232570,Opioid-immune,0,1
232571,interactions,0,0
232572,in,0,1
232573,autism,1,1
232574,:,1,1
232575,behavioural,0,0
232576,and,0,0
232577,immunological,0,0
232578,assessment,0,0
232579,during,0,0
232580,a,0,0
232581,double-blind,0,0
232582,treatment,0,0
232583,with,0,1
232584,naltrexone,0,0
232585,.,0,0
232586,The,0,0
232587,emerging,0,0
232588,concept,0,0
232589,of,0,0
232590,opioid,0,1
232591,peptides,0,0
232592,as,0,0
232593,a,0,0
232594,new,0,0
232595,class,0,1
232596,of,0,0
232597,chemical,0,1
232598,messengers,0,0
232599,of,0,0
232600,the,0,0
232601,neuroimmune,0,0
232602,axis,0,0
232603,and,0,0
232604,the,0,0
232605,presence,0,0
232606,of,0,0
232607,a,0,0
232608,number,0,0
232609,of,0,0
232610,immunological,0,0
232611,abnormalities,0,1
232612,in,0,0
232613,infantile,0,1
232614,autism,0,1
232615,prompted,0,0
232616,us,0,1
232617,to,0,0
232618,correlate,0,0
232619,biological,0,0
232620,(,0,0
232621,hormonal,0,1
232622,and,0,0
232623,immunological,0,0
232624,),0,1
232625,determinations,0,0
232626,and,0,1
232627,behavioural,0,1
232628,performances,0,0
232629,during,0,0
232630,treatment,0,0
232631,with,0,1
232632,the,0,0
232633,potent,0,0
232634,opiate,0,1
232635,antagonist,0,0
232636,",",0,0
232637,naltrexone,0,0
232638,(,0,0
232639,NAL,0,0
232640,),0,1
232641,.,0,1
232642,Twelve,1,1
232643,autistic,1,1
232644,patients,1,1
232645,ranging,1,1
232646,from,1,1
232647,7,1,1
232648,to,1,1
232649,15,1,1
232650,years,1,1
232651,",",1,0
232652,diagnosed,1,1
232653,according,1,0
232654,to,1,0
232655,DSM-III-R,1,0
232656,",",0,0
232657,entered,0,0
232658,a,0,0
232659,double-blind,0,0
232660,crossover,0,0
232661,study,0,0
232662,with,0,1
232663,NAL,0,0
232664,at,0,0
232665,the,0,0
232666,doses,0,0
232667,of,0,0
232668,0.5,0,0
232669,",",0,0
232670,1.0,0,0
232671,and,0,0
232672,1.5,0,0
232673,mg/kg,0,0
232674,every,0,0
232675,48,0,0
232676,hours,0,0
232677,.,0,1
232678,The,0,0
232679,behavioural,0,0
232680,evaluation,0,0
232681,was,0,0
232682,conducted,0,0
232683,using,0,0
232684,the,0,0
232685,specific,0,0
232686,BSE,0,0
232687,and,0,0
232688,CARS,0,0
232689,rating,0,0
232690,scales,0,0
232691,NAL,0,1
232692,treatment,0,0
232693,produced,0,0
232694,a,0,0
232695,significant,0,0
232696,reduction,0,0
232697,of,0,0
232698,the,0,0
232699,autistic,0,1
232700,symptomatology,0,0
232701,in,0,0
232702,seven,0,1
232703,(,0,1
232704,responders,0,0
232705,),0,0
232706,out,0,1
232707,of,0,0
232708,12,0,1
232709,children,1,1
232710,.,1,1
232711,The,0,0
232712,behavioural,0,0
232713,improvement,0,0
232714,was,0,0
232715,accompanied,0,0
232716,by,0,0
232717,alterations,0,0
232718,in,0,0
232719,the,0,0
232720,distribution,0,0
232721,of,0,0
232722,the,0,0
232723,major,0,0
232724,lymphocyte,0,0
232725,subsets,0,0
232726,",",0,0
232727,with,0,1
232728,a,0,0
232729,significant,0,0
232730,increase,0,0
232731,of,0,0
232732,the,0,0
232733,T-helper-inducers,0,0
232734,(,0,0
232735,CD4+CD8-,0,0
232736,),0,0
232737,and,0,0
232738,a,0,0
232739,significant,0,0
232740,reduction,0,0
232741,of,0,0
232742,the,0,0
232743,T-cytotoxic-suppressor,0,0
232744,(,0,0
232745,CD4-CD8+,0,1
232746,),0,0
232747,resulting,0,0
232748,in,0,0
232749,a,0,0
232750,normalization,0,0
232751,of,0,0
232752,the,0,0
232753,CD4/CD8,0,0
232754,ratio,0,0
232755,.,0,1
232756,Changes,0,0
232757,in,0,0
232758,natural,0,0
232759,killer,0,0
232760,cells,0,0
232761,and,0,0
232762,activity,0,0
232763,were,0,0
232764,inversely,0,0
232765,related,0,0
232766,to,0,0
232767,plasma,0,0
232768,beta-endorphin,0,0
232769,levels,0,0
232770,.,0,0
232771,It,0,0
232772,is,0,0
232773,suggested,0,0
232774,that,0,0
232775,the,0,0
232776,mechanisms,0,0
232777,underlying,0,0
232778,opioid-immune,0,1
232779,interactions,0,0
232780,are,0,0
232781,altered,0,0
232782,in,0,0
232783,this,0,0
232784,population,1,1
232785,of,1,0
232786,autistic,1,1
232787,children,1,1
232788,and,0,0
232789,that,0,0
232790,an,0,0
232791,immunological,0,0
232792,screening,0,0
232793,may,0,0
232794,have,0,0
232795,prognostic,0,0
232796,value,0,0
232797,for,0,0
232798,the,0,0
232799,pharmacological,0,0
232800,therapy,0,0
232801,with,0,1
232802,opiate,0,1
232803,antagonists,0,0
232804,.,0,1
232805,Effects,0,0
232806,of,0,1
232807,preoperative,1,0
232808,intentional,1,0
232809,hemodilution,1,0
232810,on,0,0
232811,the,0,0
232812,extravasation,0,0
232813,rate,0,0
232814,of,0,0
232815,albumin,0,0
232816,and,0,0
232817,fluid,0,0
232818,.,0,0
232819,OBJECTIVE,0,0
232820,To,0,0
232821,evaluate,0,0
232822,the,0,0
232823,effects,0,0
232824,of,0,0
232825,preoperative,0,0
232826,intentional,0,0
232827,hemodilution,0,0
232828,with,0,1
232829,4,0,0
232830,%,0,0
232831,albumin,0,0
232832,solution,0,0
232833,on,0,0
232834,the,0,0
232835,extravasation,0,0
232836,rate,0,0
232837,of,0,0
232838,intravascular,0,0
232839,albumin,0,0
232840,and,0,0
232841,fluid,0,0
232842,in,0,0
232843,surgical,1,1
232844,patients,1,1
232845,.,1,1
232846,DESIGN,0,0
232847,A,0,0
232848,prospective,0,0
232849,",",0,0
232850,randomized,0,0
232851,",",0,0
232852,clinical,0,0
232853,study,0,0
232854,.,0,1
232855,SETTING,0,1
232856,University,1,1
232857,teaching,1,1
232858,hospital,1,1
232859,.,1,1
232860,PATIENTS,0,0
232861,Two,1,1
232862,groups,1,0
232863,(,1,1
232864,control,1,1
232865,group,1,0
232866,[,1,0
232867,group,1,0
232868,1,1,0
232869,],1,0
232870,and,1,0
232871,hemodiluted,1,1
232872,group,1,0
232873,[,1,0
232874,group,1,0
232875,2,1,0
232876,],1,0
232877,),1,0
232878,of,1,0
232879,13,1,1
232880,healthy,1,1
232881,patients,1,1
232882,were,0,1
232883,studied,0,1
232884,during,0,0
232885,a,0,0
232886,long-term,0,0
232887,(,0,0
232888,>,0,1
232889,4,0,0
232890,hrs,0,0
232891,),0,0
232892,surgical,0,0
232893,procedure,0,0
232894,.,0,1
232895,INTERVENTIONS,0,0
232896,Autologous,0,0
232897,technetium-99m,0,0
232898,(,0,0
232899,99mTc,0,0
232900,),0,0
232901,-labeled,0,0
232902,red,0,1
232903,blood,0,0
232904,cells,0,0
232905,and,0,0
232906,indium-oxine,0,0
232907,(,0,0
232908,(,0,0
232909,111,0,1
232910,),0,0
232911,In,0,0
232912,),0,0
232913,-labeled,0,0
232914,human,0,1
232915,serum,0,0
232916,albumin,0,0
232917,were,0,0
232918,injected,0,0
232919,intravenously,0,0
232920,during,0,0
232921,anesthesia,0,0
232922,at,0,0
232923,T,0,1
232924,=,0,0
232925,0,0,0
232926,min,0,0
232927,in,0,0
232928,the,0,0
232929,two,0,0
232930,groups,0,0
232931,for,0,0
232932,the,0,0
232933,determination,0,0
232934,of,0,0
232935,total,0,1
232936,blood,0,0
232937,volume,0,0
232938,and,0,0
232939,albumin,0,0
232940,diffusion,0,0
232941,space,0,0
232942,",",0,0
232943,respectively,0,0
232944,.,0,0
232945,In,0,0
232946,addition,0,0
232947,",",0,0
232948,body,0,1
232949,tetrapolar,0,0
232950,electrical,0,0
232951,impedance,0,0
232952,was,0,0
232953,used,0,0
232954,to,0,0
232955,assess,0,0
232956,extracellular,0,0
232957,fluid,0,0
232958,volume,0,0
232959,.,0,0
232960,In,0,0
232961,the,0,0
232962,hemodiluted,1,0
232963,group,1,0
232964,(,1,0
232965,group,1,0
232966,2,1,0
232967,),1,0
232968,",",0,0
232969,15,0,0
232970,mL/kg,0,0
232971,of,0,0
232972,blood,0,0
232973,was,0,0
232974,withdrawn,0,0
232975,over,0,0
232976,30,0,1
232977,mins,0,0
232978,(,0,0
232979,T,0,1
232980,=,0,0
232981,20,0,0
232982,mins,0,0
232983,to,0,1
232984,T,0,1
232985,=,0,0
232986,50,0,1
232987,mins,0,0
232988,),0,0
232989,and,0,0
232990,simultaneously,0,0
232991,replaced,0,0
232992,by,0,0
232993,an,0,0
232994,equal,0,0
232995,volume,0,0
232996,of,0,0
232997,4,0,0
232998,%,0,0
232999,albumin,0,0
233000,solution,0,0
233001,(,0,0
233002,0.6,0,0
233003,g/kg,0,1
233004,),0,1
233005,.,0,0
233006,MEASUREMENTS,0,0
233007,AND,0,0
233008,MAIN,0,0
233009,RESULTS,0,0
233010,The,0,0
233011,albumin,0,0
233012,diffusion,0,0
233013,space,0,0
233014,",",0,0
233015,the,0,0
233016,colloid,0,0
233017,oncotic,0,0
233018,pressure,0,0
233019,",",0,0
233020,the,0,0
233021,plasma,0,0
233022,albumin,0,0
233023,concentration,0,0
233024,and,0,0
233025,the,0,0
233026,electrical,0,0
233027,impedance,0,0
233028,were,0,0
233029,measured,0,0
233030,before,0,0
233031,(,0,0
233032,T,0,1
233033,=,0,0
233034,10,0,0
233035,mins,0,0
233036,),0,1
233037,and,0,0
233038,after,0,0
233039,(,0,0
233040,T,0,1
233041,=,0,0
233042,60,0,1
233043,",",0,0
233044,120,0,1
233045,",",0,0
233046,and,0,0
233047,240,0,1
233048,mins,0,0
233049,),0,1
233050,hemodilution,0,0
233051,.,0,0
233052,Urine,0,0
233053,was,0,0
233054,collected,0,0
233055,from,0,1
233056,T,0,1
233057,=,0,1
233058,10,0,1
233059,mins,0,0
233060,to,0,1
233061,T,0,1
233062,=,0,0
233063,240,0,1
233064,mins,0,0
233065,.,0,1
233066,The,0,0
233067,total,0,0
233068,blood,0,0
233069,volume,0,0
233070,was,0,0
233071,calculated,0,0
233072,at,0,0
233073,T,0,1
233074,=,0,1
233075,10,0,1
233076,mins,0,0
233077,.,0,1
233078,No,0,0
233079,differences,0,0
233080,in,0,0
233081,the,0,0
233082,initial,0,0
233083,values,0,0
233084,were,0,1
233085,found,0,0
233086,between,0,0
233087,the,0,0
233088,two,0,0
233089,groups,0,0
233090,.,0,1
233091,In,0,0
233092,group,0,0
233093,2,0,0
233094,",",0,0
233095,hemodilution,0,0
233096,(,0,0
233097,hematocrit,0,0
233098,30,0,1
233099,+/-,0,0
233100,3,0,0
233101,%,0,0
233102,),0,0
233103,resulted,0,0
233104,in,0,0
233105,a,0,0
233106,steeper,0,0
233107,increase,0,0
233108,in,0,0
233109,the,0,0
233110,albumin,0,0
233111,diffusion,0,0
233112,space,0,0
233113,(,0,0
233114,p,0,0
233115,<,0,0
233116,.05,0,0
233117,),0,0
233118,and,0,0
233119,a,0,0
233120,progressive,0,0
233121,decrease,0,0
233122,in,0,0
233123,the,0,0
233124,body,0,1
233125,electrical,0,0
233126,impedance,0,0
233127,(,0,0
233128,p,0,0
233129,<,0,0
233130,.05,0,0
233131,),0,0
233132,.,0,0
233133,The,0,0
233134,extravasation,0,0
233135,rate,0,0
233136,of,0,0
233137,albumin,0,0
233138,was,0,0
233139,0.052,0,0
233140,+/-,0,0
233141,0.007,0,0
233142,mL/kg/min,0,0
233143,in,0,0
233144,group,0,0
233145,2,0,0
233146,vs.,0,0
233147,0.038,0,0
233148,+/-,0,0
233149,0.020,0,0
233150,mL/kg/min,0,0
233151,in,0,0
233152,group,0,0
233153,1,0,0
233154,(,0,0
233155,p,0,0
233156,<,0,0
233157,.05,0,0
233158,),0,0
233159,.,0,0
233160,The,0,0
233161,value,0,0
233162,of,0,0
233163,calculated,0,0
233164,plasma,0,0
233165,volume,0,0
233166,at,0,0
233167,T,0,1
233168,=,0,0
233169,0,0,0
233170,min,0,0
233171,did,0,0
233172,not,0,0
233173,shown,0,0
233174,any,0,0
233175,difference,0,0
233176,between,0,0
233177,the,0,0
233178,two,0,0
233179,groups,0,0
233180,.,0,1
233181,This,0,0
233182,value,0,0
233183,was,0,0
233184,then,0,0
233185,lower,0,0
233186,than,0,0
233187,expected,0,0
233188,in,0,0
233189,group,0,0
233190,2,0,0
233191,",",0,0
233192,corresponding,0,0
233193,to,0,0
233194,a,0,0
233195,loss,0,0
233196,of,0,0
233197,plasma,0,0
233198,volume,0,0
233199,of,0,0
233200,>,0,1
233201,3,0,0
233202,mL/kg,0,1
233203,.,0,1
233204,Urine,0,0
233205,output,0,0
233206,was,0,0
233207,significantly,0,0
233208,lower,0,0
233209,in,0,0
233210,group,0,0
233211,2,0,0
233212,than,0,0
233213,in,0,0
233214,group,1,1
233215,1,1,0
233216,(,1,0
233217,0.7,1,0
233218,+/-,1,0
233219,0.4,1,0
233220,vs.,1,0
233221,1.4,1,0
233222,+/-,1,0
233223,1.0,1,0
233224,mL/min,1,0
233225,",",1,0
233226,respectively,1,0
233227,;,1,0
233228,p,1,0
233229,<,1,0
233230,.05,1,0
233231,),1,0
233232,.,1,0
233233,A,0,0
233234,comparable,0,0
233235,decrease,0,0
233236,in,0,0
233237,colloid,0,0
233238,oncotic,0,0
233239,pressure,0,0
233240,and,0,0
233241,in,0,0
233242,plasma,0,0
233243,albumin,0,0
233244,concentration,0,0
233245,was,0,0
233246,observed,0,0
233247,in,0,0
233248,both,0,0
233249,groups,0,0
233250,.,0,1
233251,CONCLUSIONS,0,0
233252,These,0,0
233253,results,0,0
233254,suggest,0,0
233255,that,0,0
233256,preoperative,0,0
233257,hemodilution,0,0
233258,using,0,0
233259,4,0,0
233260,%,0,0
233261,albumin,0,0
233262,on,0,0
233263,a,0,0
233264,1:1,0,0
233265,volume,0,0
233266,basis,0,0
233267,for,0,0
233268,blood,0,0
233269,substitution,0,0
233270,during,0,0
233271,a,0,0
233272,prolonged,0,0
233273,surgical,0,0
233274,procedure,0,0
233275,with,0,1
233276,reduced,0,0
233277,blood,0,0
233278,losses,0,0
233279,enhances,0,0
233280,the,0,0
233281,extravasation,0,0
233282,rate,0,0
233283,of,0,0
233284,albumin,0,0
233285,and,0,0
233286,fluid,0,0
233287,to,0,0
233288,the,0,0
233289,interstitial,0,0
233290,tissues,0,0
233291,",",0,0
233292,impeding,0,0
233293,the,0,0
233294,maintenance,0,0
233295,of,0,0
233296,isovolemia,0,0
233297,.,0,0
233298,These,0,0
233299,findings,0,0
233300,support,0,0
233301,the,0,0
233302,use,0,0
233303,of,0,0
233304,a,0,0
233305,volume,0,0
233306,of,0,0
233307,infused,0,0
233308,colloid,0,0
233309,solution,0,0
233310,higher,0,0
233311,than,0,0
233312,that,0,0
233313,of,0,0
233314,withdrawn,0,0
233315,blood,0,0
233316,during,0,0
233317,preoperative,1,0
233318,hemodilution,1,1
233319,.,1,1
233320,Pharmacokinetic,0,0
233321,properties,0,0
233322,of,0,0
233323,YM17E,0,1
233324,",",0,0
233325,an,0,0
233326,inhibitor,0,0
233327,of,0,0
233328,acyl,0,0
233329,coenzyme,0,0
233330,A,0,0
233331,:,0,0
233332,cholesterol,0,0
233333,acyl,0,0
233334,transferase,0,0
233335,",",0,0
233336,and,0,0
233337,serum,0,0
233338,cholesterol,0,0
233339,levels,0,0
233340,in,0,0
233341,healthy,1,1
233342,volunteers,1,1
233343,.,1,1
233344,We,0,0
233345,conducted,0,0
233346,a,0,0
233347,single,0,0
233348,and,0,0
233349,repeat,0,0
233350,oral,0,0
233351,dose,0,0
233352,study,0,0
233353,of,0,0
233354,YM17E,0,1
233355,",",0,0
233356,a,0,0
233357,novel,0,0
233358,inhibitor,0,0
233359,of,0,0
233360,acyl,0,0
233361,coenzyme,0,0
233362,A,0,0
233363,(,0,0
233364,CoA,0,0
233365,),0,1
233366,:,0,1
233367,cholesterol,0,0
233368,acyltransferase,0,0
233369,",",0,0
233370,in,0,0
233371,healthy,1,1
233372,male,1,1
233373,volunteers,1,1
233374,to,0,0
233375,evaluate,0,0
233376,the,0,0
233377,pharmacokinetic,0,0
233378,profile,0,0
233379,",",0,0
233380,tolerability,0,0
233381,and,0,0
233382,effect,0,0
233383,of,0,0
233384,the,0,0
233385,drug,0,0
233386,on,0,0
233387,serum,0,0
233388,cholesterol,0,0
233389,.,0,0
233390,In,0,0
233391,the,0,0
233392,single,0,0
233393,administration,0,0
233394,study,0,0
233395,",",0,0
233396,YM17E,0,1
233397,was,0,0
233398,administered,0,0
233399,after,0,0
233400,a,0,0
233401,meal,0,0
233402,to,0,0
233403,two,1,0
233404,groups,1,0
233405,of,1,1
233406,subjects,1,1
233407,(,1,0
233408,each,1,0
233409,containing,1,0
233410,six,1,1
233411,subjects,1,1
233412,taking,1,1
233413,the,1,0
233414,drug,1,0
233415,and,1,0
233416,three,1,0
233417,taking,1,0
233418,placebo,1,0
233419,),1,0
233420,receiving,1,0
233421,3,1,0
233422,",",1,0
233423,60,1,1
233424,and,1,0
233425,300,1,0
233426,mg,1,0
233427,or,1,1
233428,15,1,0
233429,",",1,0
233430,60,1,1
233431,and,1,0
233432,450,1,1
233433,mg,1,0
233434,YM17E,1,1
233435,",",1,0
233436,respectively,1,0
233437,.,1,0
233438,Plasma,0,0
233439,concentrations,0,0
233440,of,0,0
233441,unchanged,0,0
233442,drug,0,0
233443,following,0,0
233444,single,0,0
233445,oral,0,0
233446,administration,0,0
233447,at,0,0
233448,3-300,0,0
233449,mg,0,0
233450,after,0,0
233451,a,0,0
233452,meal,0,0
233453,increased,0,0
233454,with,0,1
233455,increasing,0,0
233456,dose,0,0
233457,.,0,0
233458,In,0,0
233459,contrast,0,0
233460,",",0,0
233461,plasma,0,0
233462,concentrations,0,0
233463,after,0,0
233464,administration,0,0
233465,of,0,0
233466,450,0,1
233467,mg,0,0
233468,were,0,0
233469,almost,0,0
233470,the,0,0
233471,same,0,0
233472,as,0,0
233473,after,0,0
233474,300,0,0
233475,mg,0,0
233476,.,0,1
233477,Unchanged,0,0
233478,YM17E,0,0
233479,was,0,0
233480,not,0,0
233481,detected,0,0
233482,in,0,0
233483,urine,0,0
233484,after,0,0
233485,single,0,0
233486,administration,0,0
233487,",",0,0
233488,suggesting,0,0
233489,that,0,0
233490,it,0,0
233491,was,0,0
233492,excreted,0,0
233493,via,0,0
233494,the,0,0
233495,bile,0,0
233496,or,0,0
233497,urine,0,0
233498,after,0,0
233499,metabolism,0,0
233500,.,0,1
233501,Five,0,0
233502,active,0,1
233503,metabolites,0,0
233504,(,0,1
233505,M1,0,0
233506,",",0,0
233507,M2-a,0,0
233508,",",0,0
233509,M2-b,0,0
233510,",",0,0
233511,M3,0,1
233512,and,0,0
233513,M4,0,1
233514,),0,0
233515,were,0,0
233516,observed,0,0
233517,in,0,0
233518,plasma,0,0
233519,at,0,0
233520,concentrations,0,0
233521,comparable,0,0
233522,to,0,0
233523,those,0,0
233524,of,0,0
233525,unchanged,0,0
233526,YM17E,0,1
233527,.,0,1
233528,Their,0,1
233529,plasma,0,0
233530,concentrations,0,0
233531,increased,0,0
233532,in,0,0
233533,a,0,0
233534,slightly,0,0
233535,greater,0,0
233536,than,0,0
233537,dose-dependent,0,0
233538,manner,0,0
233539,from,0,1
233540,3,0,0
233541,to,0,0
233542,300,0,0
233543,mg,0,0
233544,.,0,0
233545,The,0,0
233546,effect,0,0
233547,of,0,0
233548,food,0,0
233549,was,0,0
233550,studied,0,0
233551,in,0,0
233552,an,0,0
233553,open,0,1
233554,crossover,0,0
233555,design,0,0
233556,with,0,1
233557,a,0,0
233558,1-week,0,0
233559,washout,0,0
233560,period,0,0
233561,.,0,0
233562,Twelve,0,0
233563,subjects,0,1
233564,received,0,0
233565,150,0,0
233566,mg,0,0
233567,YM17E,0,1
233568,in,0,0
233569,both,0,0
233570,the,0,0
233571,fasted,0,0
233572,and,0,0
233573,post-prandial,0,0
233574,states,0,1
233575,.,0,1
233576,The,0,0
233577,AUC,0,0
233578,and,0,0
233579,Cmax,0,0
233580,after,0,0
233581,fasting,0,0
233582,were,0,0
233583,closely,0,0
233584,similar,0,0
233585,to,0,0
233586,those,0,0
233587,after,0,0
233588,a,0,0
233589,meal,0,0
233590,",",0,0
233591,showing,0,0
233592,that,0,0
233593,bioavailability,0,0
233594,was,0,0
233595,not,0,0
233596,affected,0,0
233597,by,0,0
233598,food,0,0
233599,intake,0,0
233600,.,0,0
233601,In,0,0
233602,the,0,0
233603,repeated,0,0
233604,oral,0,0
233605,dose,0,0
233606,study,0,0
233607,",",0,0
233608,the,0,0
233609,subjects,0,1
233610,received,0,0
233611,test,0,0
233612,drug,0,0
233613,at,0,0
233614,150,0,0
233615,mg,0,0
233616,or,0,1
233617,300,0,0
233618,mg,0,0
233619,(,0,0
233620,n,0,1
233621,=,0,0
233622,6,0,0
233623,each,0,0
233624,),0,0
233625,or,0,0
233626,placebo,0,0
233627,(,0,0
233628,n,0,1
233629,=,0,0
233630,3,0,0
233631,),0,0
233632,twice,0,0
233633,a,0,0
233634,day,0,0
233635,(,0,0
233636,after,0,0
233637,breakfast,0,0
233638,and,0,0
233639,after,0,0
233640,dinner,0,1
233641,),0,0
233642,for,0,0
233643,7,0,1
233644,days,0,0
233645,.,0,1
233646,On,0,0
233647,days,0,0
233648,1,0,1
233649,and,0,1
233650,7,0,0
233651,",",0,0
233652,the,0,0
233653,subjects,0,1
233654,received,0,0
233655,YM17E,0,1
233656,once,0,0
233657,a,0,0
233658,day,0,0
233659,(,0,0
233660,after,0,0
233661,breakfast,0,0
233662,),0,0
233663,for,0,0
233664,evaluation,0,0
233665,of,0,0
233666,pharmacokinetic,0,0
233667,properties,0,0
233668,.,0,1
233669,After,0,0
233670,repeated,0,0
233671,oral,0,0
233672,administration,0,0
233673,of,0,0
233674,150,0,0
233675,mg,0,0
233676,b.d.,0,0
233677,",",0,0
233678,plasma,0,0
233679,concentrations,0,0
233680,reached,0,0
233681,steady,0,0
233682,state,0,0
233683,by,0,0
233684,day,0,0
233685,5,0,0
233686,(,0,0
233687,mean,0,1
233688,Cmin,0,0
233689,48.6,0,1
233690,ng.ml-1,0,0
233691,),0,0
233692,.,0,0
233693,After,0,0
233694,repeated,0,0
233695,administration,0,0
233696,of,0,0
233697,300,0,0
233698,mg,0,0
233699,b.d.,0,0
233700,",",0,0
233701,plasma,0,0
233702,concentrations,0,0
233703,prior,0,1
233704,to,0,0
233705,each,0,0
233706,daily,0,0
233707,morning,0,0
233708,dose,0,0
233709,increased,0,0
233710,up,0,0
233711,to,0,0
233712,the,0,0
233713,5th,0,0
233714,day,0,0
233715,(,0,0
233716,mean,0,1
233717,Cmin,0,0
233718,166.6,0,0
233719,ng.ml-1,0,0
233720,),0,0
233721,and,0,0
233722,then,0,0
233723,tended,0,0
233724,to,0,0
233725,decrease,0,0
233726,until,0,0
233727,the,0,0
233728,7th,0,0
233729,day,0,0
233730,.,0,0
233731,No,0,0
233732,significant,0,0
233733,signs,0,0
233734,",",0,1
233735,symptoms,0,0
233736,or,0,1
233737,changes,0,0
233738,in,0,0
233739,serum,0,0
233740,cholesterol,0,0
233741,levels,0,0
233742,were,0,0
233743,observed,0,0
233744,during,0,0
233745,the,0,0
233746,single,0,0
233747,and,0,0
233748,repeated,0,0
233749,oral,0,0
233750,dose,0,0
233751,studies,0,0
233752,at,0,0
233753,150,0,0
233754,mg,0,0
233755,b.d,0,0
233756,.,0,0
233757,Although,0,0
233758,statistical,0,0
233759,analysis,0,0
233760,was,0,0
233761,not,0,0
233762,conducted,0,0
233763,because,0,0
233764,of,0,0
233765,the,0,0
233766,small,1,0
233767,number,1,0
233768,of,1,0
233769,subjects,1,1
233770,",",0,0
233771,all,0,0
233772,subjects,0,1
233773,receiving,0,1
233774,repeated,0,0
233775,oral,0,0
233776,administration,0,0
233777,of,0,0
233778,300,0,0
233779,mg,0,0
233780,twice,0,0
233781,daily,0,0
233782,showed,0,0
233783,a,0,0
233784,25,0,0
233785,%,0,0
233786,decrease,0,0
233787,in,0,0
233788,serum,0,0
233789,cholesterol,0,0
233790,level,0,0
233791,on,0,0
233792,day,0,0
233793,7,0,0
233794,",",0,0
233795,but,0,0
233796,also,0,0
233797,the,0,0
233798,simultaneous,0,0
233799,occurrence,0,0
233800,of,0,0
233801,diarrhoea,0,1
233802,.,0,1
233803,Outcome,1,0
233804,assessment,1,0
233805,for,1,0
233806,clinical,1,0
233807,trials,1,1
233808,:,1,1
233809,how,0,0
233810,many,0,0
233811,adjudicators,1,0
233812,do,0,0
233813,we,0,0
233814,need,0,0
233815,?,0,0
233816,Canadian,0,1
233817,Lung,0,0
233818,Oncology,0,1
233819,Group,0,1
233820,.,0,1
233821,Considerable,0,0
233822,effort,0,0
233823,is,0,0
233824,often,0,0
233825,expended,0,0
233826,to,0,0
233827,adjudicate,0,0
233828,outcomes,0,0
233829,in,0,0
233830,clinical,0,0
233831,trials,0,0
233832,",",0,0
233833,but,0,0
233834,little,0,0
233835,has,0,0
233836,been,0,0
233837,written,0,0
233838,on,0,0
233839,the,0,0
233840,administration,0,0
233841,of,0,0
233842,the,0,0
233843,adjudication,0,0
233844,process,0,0
233845,and,0,0
233846,its,0,0
233847,possible,0,0
233848,impact,0,0
233849,on,0,0
233850,study,0,1
233851,results,0,0
233852,.,0,1
233853,As,0,0
233854,a,0,0
233855,case,0,0
233856,study,0,0
233857,",",0,0
233858,we,0,0
233859,describe,0,0
233860,the,0,0
233861,function,0,0
233862,and,0,0
233863,performance,0,0
233864,of,0,0
233865,an,0,0
233866,adjudication,1,0
233867,committee,1,0
233868,in,1,0
233869,a,1,0
233870,large,1,1
233871,randomized,1,0
233872,trial,1,1
233873,of,0,0
233874,two,0,0
233875,diagnostic,0,1
233876,approaches,0,0
233877,to,0,0
233878,potentially,1,0
233879,operable,1,1
233880,lung,1,1
233881,cancer,1,1
233882,.,1,0
233883,Up,1,0
233884,to,1,0
233885,five,1,1
233886,independent,1,0
233887,adjudicators,1,0
233888,independently,0,1
233889,determined,0,0
233890,two,0,0
233891,primary,0,1
233892,outcomes,0,0
233893,:,0,1
233894,tumor,0,0
233895,status,0,0
233896,at,0,0
233897,death,0,0
233898,or,0,1
233899,at,0,0
233900,final,0,0
233901,follow-up,0,0
233902,and,0,0
233903,the,0,0
233904,cause,0,0
233905,of,0,0
233906,death,0,0
233907,.,0,1
233908,Patients,1,1
233909,for,0,0
233910,whom,0,1
233911,there,0,1
233912,was,0,0
233913,any,0,0
233914,disagreement,0,0
233915,were,0,0
233916,discussed,0,0
233917,in,0,0
233918,committee,0,0
233919,until,0,0
233920,a,0,0
233921,consensus,0,0
233922,was,0,0
233923,achieved,0,0
233924,.,0,0
233925,We,0,0
233926,describe,0,0
233927,the,0,0
233928,pattern,0,0
233929,of,0,0
233930,agreement,0,0
233931,among,0,0
233932,the,0,0
233933,adjudicators,0,0
233934,and,0,0
233935,with,0,1
233936,the,0,0
233937,final,0,0
233938,consensus,0,0
233939,result,0,0
233940,.,0,0
233941,Additionally,0,0
233942,",",0,0
233943,we,0,0
233944,model,0,0
233945,the,0,0
233946,adjudication,0,0
233947,process,0,0
233948,and,0,0
233949,predict,0,0
233950,the,0,0
233951,results,0,0
233952,if,0,0
233953,a,0,0
233954,smaller,0,0
233955,committee,0,0
233956,had,0,0
233957,been,0,0
233958,used,0,0
233959,.,0,0
233960,We,0,0
233961,found,0,0
233962,that,0,0
233963,reducing,0,0
233964,the,0,0
233965,number,0,0
233966,of,0,0
233967,adjudicators,0,0
233968,from,0,1
233969,five,0,1
233970,to,0,0
233971,two,0,0
233972,or,0,0
233973,three,0,0
233974,would,0,0
233975,probably,0,0
233976,have,0,0
233977,changed,0,0
233978,the,0,0
233979,consensus,0,0
233980,outcome,0,0
233981,in,0,0
233982,less,0,0
233983,than,0,0
233984,10,0,0
233985,%,0,0
233986,of,0,0
233987,cases,0,1
233988,.,0,1
233989,Correspondingly,0,0
233990,",",0,0
233991,the,0,0
233992,effect,0,0
233993,on,0,0
233994,the,0,0
233995,final,0,0
233996,study,0,0
233997,results,0,0
233998,(,0,0
233999,comparing,0,0
234000,primary,0,1
234001,outcomes,0,0
234002,in,0,0
234003,both,0,0
234004,randomized,0,1
234005,arms,0,0
234006,),0,0
234007,would,0,0
234008,have,0,0
234009,been,0,0
234010,altered,0,0
234011,very,0,0
234012,little,0,0
234013,.,0,0
234014,Even,0,0
234015,using,0,0
234016,a,0,0
234017,single,0,0
234018,adjudicator,0,0
234019,would,0,0
234020,not,0,0
234021,have,0,0
234022,affected,0,0
234023,the,0,0
234024,results,0,0
234025,substantially,0,0
234026,.,0,1
234027,About,0,0
234028,90,0,0
234029,minutes,0,0
234030,of,0,0
234031,person-time,0,0
234032,per,0,0
234033,patient,1,1
234034,was,0,0
234035,required,0,0
234036,for,0,0
234037,activities,0,0
234038,directly,0,0
234039,related,0,0
234040,to,0,0
234041,the,0,0
234042,adjudication,0,0
234043,process,0,0
234044,",",0,0
234045,or,0,0
234046,approximately,0,0
234047,6,0,0
234048,months,0,0
234049,of,0,0
234050,full,0,1
234051,time,0,0
234052,work,0,0
234053,for,0,0
234054,the,0,0
234055,entire,0,0
234056,study,0,0
234057,.,0,0
234058,This,0,0
234059,level,0,0
234060,of,0,0
234061,effort,0,0
234062,could,0,0
234063,be,0,0
234064,substantially,0,0
234065,reduced,0,0
234066,by,0,0
234067,using,0,0
234068,fewer,0,0
234069,adjudicators,0,0
234070,with,0,1
234071,little,0,0
234072,impact,0,0
234073,on,0,0
234074,the,0,0
234075,results,0,0
234076,.,0,0
234077,Thus,0,0
234078,",",0,0
234079,we,0,0
234080,suggest,0,0
234081,that,0,0
234082,when,0,0
234083,high,0,1
234084,observer,0,0
234085,agreement,0,0
234086,is,0,0
234087,demonstrated,0,0
234088,or,0,0
234089,anticipated,0,0
234090,",",0,0
234091,adjudication,0,0
234092,committees,0,0
234093,should,0,0
234094,consist,0,0
234095,of,0,0
234096,no,0,0
234097,more,0,0
234098,than,0,0
234099,three,0,0
234100,members,0,1
234101,.,0,1
234102,Further,0,0
234103,work,0,0
234104,is,0,0
234105,needed,0,0
234106,to,0,0
234107,evaluate,0,0
234108,if,0,0
234109,smaller,0,0
234110,committees,0,0
234111,are,0,0
234112,adequate,0,0
234113,to,0,0
234114,detect,0,0
234115,small,0,0
234116,but,0,0
234117,important,0,0
234118,treatment,0,0
234119,effects,0,0
234120,or,0,1
234121,if,0,0
234122,they,0,0
234123,compromise,0,0
234124,validity,0,0
234125,when,0,0
234126,the,0,0
234127,level,0,0
234128,of,0,0
234129,adjudicator,0,0
234130,agreement,0,0
234131,is,0,0
234132,lower,0,0
234133,.,0,0
234134,Comparison,0,0
234135,of,0,0
234136,cuffed,0,0
234137,and,0,0
234138,uncuffed,0,1
234139,endotracheal,0,1
234140,tubes,0,0
234141,in,0,0
234142,young,1,1
234143,children,1,1
234144,during,1,0
234145,general,1,1
234146,anesthesia,1,1
234147,.,1,1
234148,BACKGROUND,0,0
234149,Uncuffed,0,1
234150,endotracheal,0,1
234151,tubes,0,0
234152,are,0,0
234153,routinely,0,0
234154,used,0,0
234155,in,0,0
234156,young,1,1
234157,children,1,1
234158,.,1,1
234159,This,0,0
234160,study,0,0
234161,tests,0,0
234162,a,0,0
234163,formula,0,0
234164,for,0,0
234165,selecting,0,0
234166,appropriately,0,1
234167,sized,0,1
234168,cuffed,0,0
234169,endotracheal,0,1
234170,tubes,0,0
234171,and,0,0
234172,compares,0,0
234173,the,0,0
234174,use,0,0
234175,of,0,0
234176,cuffed,0,0
234177,versus,0,0
234178,uncuffed,0,1
234179,endotracheal,0,1
234180,tubes,0,0
234181,for,0,0
234182,patients,1,1
234183,whose,0,1
234184,lungs,0,0
234185,are,0,0
234186,mechanically,0,0
234187,ventilated,0,1
234188,during,0,0
234189,anesthesia,0,1
234190,.,0,1
234191,METHODS,0,0
234192,Full-term,1,1
234193,newborns,1,1
234194,and,1,1
234195,children,1,1
234196,(,1,1
234197,n,1,1
234198,=,1,0
234199,488,1,1
234200,),1,0
234201,through,1,0
234202,8,1,0
234203,yr,1,1
234204,of,1,1
234205,age,1,1
234206,who,1,1
234207,required,1,1
234208,general,1,1
234209,anesthesia,1,1
234210,and,1,0
234211,tracheal,1,1
234212,intubation,1,0
234213,were,0,0
234214,assigned,0,0
234215,randomly,0,1
234216,to,0,0
234217,receive,0,0
234218,either,0,0
234219,a,0,0
234220,cuffed,0,0
234221,tube,0,0
234222,sized,0,1
234223,by,0,0
234224,a,0,0
234225,new,0,0
234226,formula,0,0
234227,[,0,0
234228,size,0,0
234229,(,0,0
234230,mm,0,0
234231,internal,0,1
234232,diameter,0,0
234233,),0,0
234234,=,0,0
234235,(,0,0
234236,age/4,0,1
234237,),0,0
234238,+,0,0
234239,3,0,0
234240,],0,0
234241,",",0,0
234242,or,0,0
234243,an,0,0
234244,uncuffed,0,0
234245,tube,0,0
234246,sized,0,1
234247,by,0,0
234248,the,0,0
234249,modified,0,0
234250,Cole,0,1
234251,'s,0,1
234252,formula,0,0
234253,[,0,0
234254,size,0,0
234255,(,0,0
234256,mm,0,0
234257,internal,0,1
234258,diameter,0,0
234259,),0,0
234260,=,0,0
234261,(,0,0
234262,age/4,0,1
234263,),0,0
234264,+,0,0
234265,4,0,0
234266,],0,0
234267,.,0,0
234268,The,0,0
234269,number,0,0
234270,of,0,0
234271,intubations,0,1
234272,required,0,0
234273,to,0,0
234274,achieve,0,0
234275,an,0,0
234276,appropriately,0,0
234277,sized,0,0
234278,tube,0,0
234279,",",0,0
234280,the,0,0
234281,need,0,0
234282,to,0,0
234283,use,0,0
234284,more,0,0
234285,than,0,0
234286,21.min-1,0,0
234287,fresh,0,1
234288,gas,0,1
234289,flow,0,0
234290,",",0,0
234291,the,0,0
234292,concentration,0,0
234293,of,0,0
234294,nitrous,0,0
234295,oxide,0,0
234296,in,0,0
234297,the,0,0
234298,operating,0,0
234299,room,0,0
234300,",",0,0
234301,and,0,0
234302,the,0,0
234303,incidence,0,0
234304,of,0,0
234305,croup,0,1
234306,were,0,0
234307,compared,0,0
234308,.,0,1
234309,RESULTS,0,0
234310,Cuffed,0,0
234311,tubes,0,0
234312,selected,0,1
234313,by,0,0
234314,our,0,0
234315,formula,0,0
234316,were,0,0
234317,appropriate,0,0
234318,for,0,0
234319,99,0,1
234320,%,0,0
234321,of,0,0
234322,patients,0,1
234323,.,0,1
234324,Uncuffed,0,1
234325,tubes,0,0
234326,selected,0,1
234327,by,0,0
234328,Cole,0,1
234329,'s,0,1
234330,formula,0,0
234331,were,0,1
234332,appropriate,0,0
234333,for,0,0
234334,77,0,1
234335,%,0,0
234336,of,0,0
234337,patients,0,1
234338,(,0,1
234339,P,0,0
234340,<,0,0
234341,0.001,0,0
234342,),0,0
234343,.,0,1
234344,The,0,0
234345,lungs,0,0
234346,of,0,0
234347,patients,0,1
234348,with,0,1
234349,cuffed,0,1
234350,tubes,0,0
234351,were,0,1
234352,adequately,0,0
234353,ventilated,0,1
234354,with,0,1
234355,2,0,0
234356,1.min-1,0,0
234357,fresh,0,1
234358,gas,0,1
234359,flow,0,0
234360,",",0,0
234361,whereas,0,0
234362,11,0,0
234363,%,0,0
234364,of,0,0
234365,those,0,0
234366,with,0,1
234367,uncuffed,0,1
234368,tubes,0,0
234369,needed,0,0
234370,greater,0,0
234371,fresh,0,0
234372,gas,0,1
234373,flow,0,0
234374,(,0,0
234375,P,0,0
234376,<,0,0
234377,0.001,0,0
234378,),0,1
234379,.,0,1
234380,Ambient,0,0
234381,nitrous,0,0
234382,oxide,0,0
234383,concentration,0,0
234384,exceeded,0,0
234385,25,0,1
234386,parts,0,0
234387,per,0,1
234388,million,0,1
234389,in,0,0
234390,37,0,1
234391,%,0,0
234392,of,0,0
234393,cases,0,1
234394,with,0,1
234395,uncuffed,0,1
234396,tubes,0,0
234397,and,0,1
234398,in,0,0
234399,0,0,0
234400,%,0,0
234401,of,0,0
234402,cases,0,1
234403,with,0,1
234404,cuffed,0,1
234405,tubes,0,0
234406,(,0,1
234407,P,0,0
234408,<,0,0
234409,0.001,0,0
234410,),0,1
234411,.,0,1
234412,Three,0,0
234413,patients,0,1
234414,in,0,0
234415,each,0,0
234416,group,0,0
234417,were,0,0
234418,treated,0,1
234419,for,0,0
234420,croup,0,1
234421,symptoms,0,0
234422,(,0,1
234423,1.2,0,0
234424,%,0,0
234425,cuffed,0,1
234426,;,0,0
234427,1.3,0,0
234428,%,0,0
234429,uncuffed,0,1
234430,),0,0
234431,.,0,0
234432,CONCLUSIONS,0,0
234433,Our,0,0
234434,formula,0,0
234435,for,0,0
234436,cuffed,0,0
234437,tube,0,0
234438,selection,0,0
234439,is,0,0
234440,appropriate,0,0
234441,for,0,0
234442,young,1,1
234443,children,1,1
234444,.,1,1
234445,Advantages,0,0
234446,of,0,0
234447,cuffed,0,1
234448,endotracheal,0,1
234449,tubes,0,0
234450,include,0,0
234451,avoidance,0,0
234452,of,0,0
234453,repeated,0,0
234454,laryngoscopy,0,0
234455,",",0,0
234456,use,0,0
234457,of,0,0
234458,low,0,1
234459,fresh,0,1
234460,gas,0,1
234461,flow,0,0
234462,",",0,0
234463,and,0,0
234464,reduction,0,0
234465,of,0,0
234466,the,0,0
234467,concentration,0,0
234468,of,0,0
234469,anesthetics,0,0
234470,detectable,0,0
234471,in,0,0
234472,the,0,0
234473,operating,0,0
234474,room,0,0
234475,.,0,0
234476,We,0,0
234477,conclude,0,0
234478,that,0,0
234479,cuffed,0,0
234480,endotracheal,0,1
234481,tubes,0,0
234482,may,0,0
234483,be,0,0
234484,used,0,0
234485,routinely,0,0
234486,during,0,0
234487,controlled,0,0
234488,ventilation,0,0
234489,in,0,0
234490,full-term,1,1
234491,newborns,1,1
234492,and,1,1
234493,children,1,1
234494,during,1,0
234495,anesthesia,1,1
234496,.,1,1
234497,Randomised,0,0
234498,trial,0,0
234499,of,0,0
234500,effect,0,0
234501,of,0,0
234502,amiodarone,0,0
234503,on,0,0
234504,mortality,0,0
234505,in,0,0
234506,patients,1,1
234507,with,1,1
234508,left-ventricular,1,1
234509,dysfunction,1,1
234510,after,1,0
234511,recent,1,0
234512,myocardial,1,1
234513,infarction,1,1
234514,:,1,1
234515,EMIAT,1,0
234516,.,1,1
234517,European,0,1
234518,Myocardial,0,1
234519,Infarct,0,1
234520,Amiodarone,0,1
234521,Trial,0,1
234522,Investigators,0,1
234523,.,0,1
234524,BACKGROUND,0,0
234525,Ventricular,0,1
234526,arrhythmias,0,1
234527,are,0,0
234528,a,0,0
234529,major,0,0
234530,cause,0,0
234531,of,0,0
234532,death,0,0
234533,after,0,0
234534,myocardial,0,1
234535,infarction,0,1
234536,",",0,0
234537,especially,0,0
234538,in,0,0
234539,patients,1,1
234540,with,1,1
234541,poor,1,1
234542,left-ventricular,1,1
234543,function,1,0
234544,.,1,1
234545,Previous,0,0
234546,attempts,0,0
234547,to,0,0
234548,identify,0,0
234549,and,0,0
234550,suppress,0,0
234551,arrhythmias,0,1
234552,with,0,1
234553,various,0,0
234554,antiarrhythmic,0,1
234555,drugs,0,0
234556,failed,0,0
234557,to,0,0
234558,reduce,0,0
234559,or,0,0
234560,actually,0,0
234561,increase,0,0
234562,mortality,0,0
234563,.,0,0
234564,Amiodarone,0,0
234565,is,0,0
234566,a,0,0
234567,powerful,0,0
234568,antiarrhythmic,0,0
234569,drug,0,0
234570,with,0,1
234571,several,0,0
234572,potentially,0,0
234573,beneficial,0,0
234574,actions,0,0
234575,",",0,0
234576,and,0,0
234577,has,0,0
234578,shown,0,0
234579,benefit,0,0
234580,in,0,0
234581,several,0,0
234582,small-scale,0,1
234583,studies,0,0
234584,.,0,1
234585,We,0,0
234586,postulated,0,0
234587,that,0,0
234588,this,0,0
234589,drug,0,0
234590,might,0,0
234591,reduce,0,0
234592,mortality,0,0
234593,in,0,0
234594,patients,1,1
234595,at,1,1
234596,high,1,1
234597,risk,1,0
234598,of,1,0
234599,death,1,0
234600,after,0,0
234601,myocardial,0,1
234602,infarction,0,1
234603,because,0,0
234604,of,0,0
234605,impaired,0,1
234606,ventricular,0,0
234607,function,0,0
234608,",",0,0
234609,irrespective,0,0
234610,of,0,0
234611,whether,0,0
234612,they,0,1
234613,had,0,1
234614,ventricular,0,1
234615,arrhythmias,0,1
234616,.,0,1
234617,METHODS,0,0
234618,The,0,0
234619,European,0,1
234620,Myocardial,0,1
234621,Infarct,0,1
234622,Amiodarone,0,1
234623,Trial,0,1
234624,(,0,0
234625,EMIAT,0,0
234626,),0,0
234627,was,0,0
234628,a,0,0
234629,randomised,0,0
234630,double-blind,0,0
234631,placebo-controlled,0,0
234632,trial,0,0
234633,to,0,0
234634,assess,0,0
234635,whether,0,0
234636,amiodarone,0,0
234637,reduced,0,0
234638,all-cause,0,0
234639,mortality,0,0
234640,(,0,0
234641,primary,0,1
234642,endpoint,0,0
234643,),0,0
234644,and,0,0
234645,cardiac,0,1
234646,mortality,0,0
234647,and,0,0
234648,arrhythmic,0,0
234649,death,0,0
234650,(,0,0
234651,secondary,0,1
234652,endpoints,0,0
234653,),0,1
234654,in,0,0
234655,survivors,0,1
234656,of,0,0
234657,myocardial,0,1
234658,infarction,0,1
234659,with,0,1
234660,a,0,0
234661,left-ventricular,0,1
234662,ejection,0,1
234663,fraction,0,0
234664,(,0,0
234665,LVEF,0,1
234666,),0,0
234667,of,0,0
234668,40,0,1
234669,%,0,0
234670,or,0,1
234671,less,0,0
234672,.,0,0
234673,Intention-to-treat,0,0
234674,and,0,0
234675,on-treatment,0,0
234676,analyses,0,0
234677,were,0,1
234678,done,0,0
234679,.,0,1
234680,FINDINGS,0,0
234681,EMIAT,1,0
234682,enrolled,1,1
234683,1486,1,1
234684,patients,1,1
234685,(,1,1
234686,743,1,1
234687,in,1,0
234688,the,1,0
234689,amiodarone,1,0
234690,group,1,0
234691,",",1,0
234692,743,1,1
234693,in,1,0
234694,the,1,0
234695,placebo,1,0
234696,group,1,0
234697,),1,0
234698,.,1,0
234699,Median,0,0
234700,follow-up,0,0
234701,was,0,0
234702,21,0,1
234703,months,0,0
234704,.,0,1
234705,All-cause,0,0
234706,mortality,0,0
234707,(,1,0
234708,103,1,1
234709,deaths,1,0
234710,in,1,0
234711,the,1,0
234712,amiodarone,1,0
234713,group,1,0
234714,",",1,0
234715,102,1,1
234716,in,1,0
234717,the,1,0
234718,placebo,1,0
234719,group,1,0
234720,),1,0
234721,and,1,0
234722,cardiac,1,1
234723,mortality,1,0
234724,did,0,0
234725,not,0,0
234726,differ,0,0
234727,between,0,0
234728,the,0,0
234729,two,0,0
234730,groups,0,0
234731,.,0,1
234732,However,0,0
234733,",",0,0
234734,in,0,0
234735,the,0,0
234736,amiodarone,0,0
234737,group,0,0
234738,",",0,0
234739,there,0,0
234740,was,0,0
234741,a,0,0
234742,35,0,0
234743,%,0,0
234744,risk,0,0
234745,reduction,0,0
234746,(,0,0
234747,95,0,0
234748,%,0,0
234749,CI,0,0
234750,0-58,0,0
234751,",",0,0
234752,p,0,0
234753,=,0,0
234754,0.05,0,0
234755,),0,0
234756,in,0,0
234757,arrhythmic,0,1
234758,deaths,0,0
234759,.,0,1
234760,INTERPRETATION,0,0
234761,Our,0,0
234762,findings,0,0
234763,do,0,0
234764,not,0,0
234765,support,0,0
234766,the,0,0
234767,systematic,0,0
234768,prophylactic,0,0
234769,use,0,0
234770,of,0,0
234771,amiodarone,0,0
234772,in,0,0
234773,all,0,0
234774,patients,0,1
234775,with,0,1
234776,depressed,0,1
234777,left-ventricular,0,1
234778,function,0,0
234779,after,0,0
234780,myocardial,0,1
234781,infarction,0,1
234782,.,0,0
234783,However,0,0
234784,",",0,0
234785,the,0,0
234786,lack,0,0
234787,of,0,0
234788,proarrhythmia,0,0
234789,and,0,0
234790,the,0,0
234791,reduction,0,0
234792,in,0,0
234793,arrhythmic,0,0
234794,death,0,0
234795,support,0,0
234796,the,0,0
234797,use,0,0
234798,of,0,0
234799,amiodarone,0,0
234800,in,0,0
234801,patients,0,1
234802,for,0,1
234803,whom,0,1
234804,antiarrhythmic,0,1
234805,therapy,0,1
234806,is,0,0
234807,indicated,0,0
234808,.,0,0
234809,[,0,0
234810,Restorative,0,1
234811,proctectomy,0,1
234812,",",0,0
234813,reconstruction,0,0
234814,of,0,0
234815,continuity,0,0
234816,with,0,1
234817,or,0,0
234818,without,0,1
234819,colon,0,1
234820,J,0,0
234821,pouch,0,1
234822,],0,1
234823,.,0,1
234824,Of,0,0
234825,63,1,1
234826,patients,1,1
234827,undergoing,1,1
234828,deep,1,1
234829,anterior,1,1
234830,resection,1,1
234831,of,1,0
234832,the,1,0
234833,rectum,1,1
234834,",",1,0
234835,39,1,1
234836,patients,1,1
234837,received,1,1
234838,a,1,0
234839,straight,1,0
234840,colo-anal,1,1
234841,anastomosis,1,0
234842,(,0,0
234843,CAA,0,0
234844,),0,0
234845,",",0,0
234846,24,0,0
234847,additionally,0,0
234848,had,0,0
234849,a,0,0
234850,colon-j-pouch,0,0
234851,(,0,0
234852,CPA,0,0
234853,),0,0
234854,constructed,0,0
234855,.,0,1
234856,Local,0,0
234857,septic,0,1
234858,complications,0,0
234859,occurred,0,0
234860,in,0,0
234861,12.5,0,0
234862,%,0,0
234863,of,0,0
234864,patients,0,1
234865,after,0,0
234866,pouch-anal,0,1
234867,anastomosis,0,0
234868,compared,0,0
234869,to,0,0
234870,20.5,0,0
234871,%,0,0
234872,after,0,0
234873,colo-anal,0,1
234874,anastomosis,0,1
234875,:,0,1
234876,stool,0,0
234877,frequency,0,0
234878,",",0,0
234879,after,0,0
234880,pouch-anal,0,1
234881,anastomosis,0,1
234882,was,0,0
234883,3.3,0,0
234884,per,0,0
234885,24,0,1
234886,h,0,0
234887,compared,0,0
234888,to,0,0
234889,5.2,0,0
234890,per,0,0
234891,24,0,0
234892,h,0,0
234893,after,0,0
234894,straight,0,0
234895,anastomosis,0,0
234896,within,0,0
234897,the,0,0
234898,first,0,0
234899,year,0,0
234900,after,0,0
234901,ileostomy,0,0
234902,closure,0,1
234903,(,0,0
234904,p,0,0
234905,=,0,0
234906,0.053,0,0
234907,),0,1
234908,;,0,0
234909,continence,0,0
234910,was,0,0
234911,slightly,0,0
234912,better,0,0
234913,in,0,0
234914,the,0,0
234915,pouch,0,1
234916,group,0,0
234917,(,0,0
234918,n.s,0,0
234919,.,0,1
234920,),0,0
234921,;,0,0
234922,and,0,0
234923,anal,0,1
234924,manometry,0,0
234925,showed,0,0
234926,a,0,0
234927,significant,0,0
234928,postoperative,0,0
234929,decrease,0,0
234930,only,0,0
234931,in,0,0
234932,resting,0,0
234933,pressure,0,0
234934,after,0,0
234935,straight,0,0
234936,colo-anal,0,1
234937,anastomosis,0,0
234938,(,0,0
234939,p,0,0
234940,<,0,0
234941,0.001,0,0
234942,),0,1
234943,.,0,1
234944,Pouch,0,0
234945,construction,0,0
234946,should,0,0
234947,be,0,0
234948,considered,0,0
234949,after,0,0
234950,deep,0,0
234951,rectal,0,1
234952,resection,0,1
234953,",",0,0
234954,as,0,0
234955,it,0,0
234956,seems,0,0
234957,to,0,0
234958,improve,0,0
234959,functional,0,0
234960,outcome,0,0
234961,and,0,0
234962,has,0,0
234963,fewer,0,0
234964,local,0,0
234965,septic,0,1
234966,complications,0,0
234967,than,0,0
234968,straight,0,0
234969,anastomosis,0,1
234970,.,0,1
234971,[,0,0
234972,Laparoscopic,0,1
234973,or,0,1
234974,conventional,0,0
234975,inguinal,1,1
234976,hernia,1,1
234977,repair,1,1
234978,with,0,1
234979,or,0,1
234980,without,0,1
234981,implant,0,0
234982,.,0,1
234983,A,0,0
234984,prospective,0,0
234985,randomized,0,0
234986,study,0,1
234987,],0,1
234988,.,0,1
234989,Treatment,0,0
234990,with,0,1
234991,buspirone,0,0
234992,in,0,0
234993,a,0,0
234994,patient,1,0
234995,with,1,1
234996,autism,1,1
234997,.,1,0
234998,This,0,0
234999,study,0,0
235000,evaluates,0,0
235001,the,0,0
235002,safety,0,0
235003,and,0,0
235004,efficacy,0,0
235005,of,0,0
235006,buspirone,0,0
235007,hydrochloride,0,0
235008,for,0,0
235009,the,0,0
235010,treatment,0,0
235011,of,0,0
235012,a,0,0
235013,patient,1,0
235014,with,1,0
235015,autism,1,1
235016,and,1,0
235017,hyperactivity,1,1
235018,disorder,1,1
235019,and,0,0
235020,determines,0,0
235021,the,0,0
235022,effect,0,0
235023,of,0,0
235024,buspirone,0,0
235025,on,0,0
235026,the,0,0
235027,number,0,0
235028,of,0,0
235029,performance,0,0
235030,tasks,0,0
235031,completed,0,1
235032,by,0,0
235033,the,0,0
235034,patient,0,0
235035,at,0,0
235036,school,0,1
235037,.,0,0
235038,A,0,0
235039,3-week,0,0
235040,",",0,0
235041,double-blind,0,0
235042,",",0,0
235043,placebo-controlled,0,0
235044,crossover,0,0
235045,study,0,0
235046,was,0,0
235047,performed,0,0
235048,in,1,0
235049,a,1,0
235050,private,1,1
235051,physician,1,0
235052,",",1,0
235053,office-based,1,1
235054,practice,1,0
235055,.,1,0
235056,A,1,0
235057,child,1,0
235058,with,1,0
235059,autism,1,1
235060,",",1,0
235061,which,1,0
235062,was,1,0
235063,diagnosed,1,1
235064,by,1,0
235065,Diagnostic,1,1
235066,and,1,0
235067,Statistical,1,0
235068,Manual,1,1
235069,of,1,0
235070,Mental,1,1
235071,Disorders,1,1
235072,",",1,0
235073,Third,1,0
235074,Edition,1,0
235075,",",1,0
235076,Revised,1,0
235077,",",1,0
235078,criteria,1,1
235079,",",1,0
235080,was,1,0
235081,studied,1,0
235082,.,1,0
235083,The,0,0
235084,child,0,0
235085,received,0,0
235086,placebo,0,0
235087,for,0,0
235088,3,0,0
235089,weeks,0,0
235090,and,0,0
235091,buspirone,0,0
235092,for,0,0
235093,3,0,1
235094,weeks,0,0
235095,;,0,0
235096,there,0,0
235097,was,0,0
235098,a,0,0
235099,1-week,0,0
235100,interval,0,0
235101,between,0,0
235102,the,0,0
235103,2,0,0
235104,treatments,0,0
235105,.,0,1
235106,The,0,0
235107,outcome,0,0
235108,was,0,0
235109,measured,0,0
235110,by,0,0
235111,using,0,0
235112,Conners,0,1
235113,abbreviated,0,0
235114,parent,0,0
235115,and,0,0
235116,teacher,0,1
235117,questionnaires,0,0
235118,and,0,0
235119,by,0,0
235120,determining,0,0
235121,the,0,0
235122,number,0,0
235123,of,0,0
235124,daily,0,0
235125,performance,0,0
235126,tasks,0,0
235127,completed,0,1
235128,by,0,0
235129,the,0,0
235130,child,0,0
235131,at,0,0
235132,school,0,1
235133,.,0,1
235134,Statistical,0,0
235135,analysis,0,0
235136,was,0,0
235137,performed,0,0
235138,by,0,0
235139,linear,0,0
235140,models,0,0
235141,and,0,1
235142,standard,0,1
235143,F,0,1
235144,tests,0,0
235145,.,0,1
235146,Buspirone,0,0
235147,was,0,0
235148,found,0,0
235149,to,0,0
235150,be,0,0
235151,safe,0,0
235152,and,0,0
235153,efficacious,0,0
235154,",",0,0
235155,without,0,1
235156,side,0,0
235157,effects,0,0
235158,",",0,0
235159,for,0,0
235160,decreasing,0,0
235161,hyperactivity,0,1
235162,and,0,0
235163,increasing,0,0
235164,completed,0,1
235165,performance,0,0
235166,tasks,0,0
235167,.,0,1
235168,The,0,0
235169,beneficial,0,0
235170,effects,0,0
235171,of,0,0
235172,buspirone,0,0
235173,in,0,0
235174,helping,0,0
235175,this,0,0
235176,patient,0,0
235177,with,0,0
235178,autism,1,1
235179,in,0,0
235180,his,0,0
235181,natural,0,0
235182,daily,0,0
235183,settings,0,0
235184,suggest,0,0
235185,that,0,0
235186,buspirone,0,0
235187,may,0,0
235188,be,0,0
235189,an,0,0
235190,alternative,0,0
235191,to,0,0
235192,neuroleptic,0,1
235193,agents,0,0
235194,in,0,0
235195,the,0,0
235196,medical,0,0
235197,therapy,0,0
235198,of,0,0
235199,autism,0,1
235200,;,0,0
235201,further,0,0
235202,study,0,0
235203,in,0,0
235204,other,0,0
235205,patients,0,1
235206,is,0,0
235207,needed,0,0
235208,.,0,0
235209,Brief,0,1
235210,report,0,0
235211,:,0,1
235212,autistic,1,1
235213,children,1,1
235214,'s,1,1
235215,attentiveness,0,0
235216,and,0,0
235217,responsivity,0,0
235218,improve,0,0
235219,after,0,0
235220,touch,0,0
235221,therapy,0,0
235222,.,0,1
235223,[,0,0
235224,Antazoline/tetryzoline,0,1
235225,eyedrops,0,0
235226,in,0,0
235227,comparison,0,0
235228,with,0,1
235229,levocabastine,0,0
235230,eyedrops,0,0
235231,in,0,1
235232,acute,1,1
235233,allergic,1,1
235234,conjunctivitis,1,1
235235,],1,1
235236,.,0,1
235237,BACKGROUND,0,0
235238,Allergic,1,1
235239,conjunctivitis,1,0
235240,is,0,0
235241,one,0,0
235242,of,0,0
235243,the,0,0
235244,most,0,0
235245,frequent,0,0
235246,allergic,0,1
235247,diseases,0,1
235248,of,0,0
235249,the,0,0
235250,anterior,0,1
235251,eye,0,0
235252,segment,0,0
235253,.,0,0
235254,METHODS,0,0
235255,This,0,0
235256,multicentre,0,0
235257,",",0,0
235258,clinical,0,0
235259,trial,0,0
235260,was,0,0
235261,an,0,0
235262,investigation,0,0
235263,to,0,0
235264,compare,0,0
235265,the,0,0
235266,antiallergic,0,0
235267,efficacy,0,0
235268,",",0,0
235269,local,0,0
235270,tolerance,0,0
235271,and,0,0
235272,safety,0,0
235273,of,0,0
235274,Antazolin/Tetryzolin,0,0
235275,eye,0,0
235276,drops,0,0
235277,and,0,0
235278,Levocabastine,0,0
235279,eye,0,0
235280,drops,0,0
235281,.,0,1
235282,69,1,1
235283,patients,1,1
235284,were,0,1
235285,treated,0,1
235286,over,0,0
235287,a,0,0
235288,2,0,0
235289,weeks,0,0
235290,course,0,0
235291,of,0,0
235292,therapy,0,0
235293,.,0,0
235294,The,0,0
235295,subjective,0,0
235296,and,0,0
235297,objective,0,0
235298,ocular,0,1
235299,symptoms,0,0
235300,were,0,0
235301,documented,0,0
235302,over,0,0
235303,the,0,0
235304,treatment,0,0
235305,period,0,0
235306,.,0,1
235307,RESULTS,0,0
235308,Both,0,0
235309,eye,0,0
235310,drops,0,0
235311,reduced,0,0
235312,subjective,0,0
235313,and,0,0
235314,objective,0,0
235315,ocular,0,1
235316,symptoms,0,1
235317,effective,0,0
235318,.,0,1
235319,The,0,0
235320,difference,0,0
235321,between,0,0
235322,the,0,0
235323,treatments,0,0
235324,(,0,0
235325,p,0,0
235326,=,0,0
235327,0.0395,0,0
235328,),0,0
235329,was,0,0
235330,the,0,0
235331,faster,0,0
235332,onset,0,0
235333,of,0,0
235334,action,0,0
235335,of,0,0
235336,Antazolin/Tetryzolin,0,0
235337,30,0,1
235338,minutes,0,0
235339,after,0,0
235340,administration,0,0
235341,of,0,0
235342,the,0,0
235343,first,0,0
235344,drop,0,0
235345,of,0,0
235346,trial,0,0
235347,medication,0,0
235348,.,0,0
235349,CONCLUSION,0,0
235350,A,0,0
235351,fast,0,0
235352,and,0,0
235353,effective,0,0
235354,onset,0,1
235355,of,0,0
235356,action,0,0
235357,is,0,0
235358,of,0,0
235359,high,0,0
235360,clinical,0,0
235361,relevance,0,0
235362,.,0,0
235363,Therefore,0,0
235364,the,0,0
235365,benefits,0,0
235366,of,0,0
235367,using,0,0
235368,Antazolin/Tetryzolin,0,0
235369,eye,0,0
235370,drops,0,0
235371,was,0,0
235372,clearly,0,0
235373,outweigh,0,0
235374,.,0,1
235375,Cranberry,0,1
235376,concentrate,0,0
235377,:,0,1
235378,UTI,1,1
235379,prophylaxis,0,1
235380,.,0,1
235381,Postoperative,0,0
235382,analgesia,0,0
235383,with,0,1
235384,preoperative,0,0
235385,oral,0,0
235386,ibuprofen,0,0
235387,or,0,0
235388,acetaminophen,0,0
235389,in,0,0
235390,children,1,1
235391,undergoing,1,1
235392,myringotomy,1,1
235393,.,1,1
235394,Previous,0,0
235395,studies,0,0
235396,have,0,0
235397,shown,0,0
235398,over,0,0
235399,70,1,1
235400,%,1,0
235401,of,1,0
235402,children,1,1
235403,require,0,1
235404,analgesics,0,0
235405,following,0,0
235406,bilateral,1,1
235407,myringotomy,1,1
235408,and,1,0
235409,tube,1,0
235410,placement,1,0
235411,(,1,0
235412,BM,1,1
235413,&,1,1
235414,T,1,1
235415,),1,0
235416,.,1,0
235417,This,0,0
235418,double-blind,0,0
235419,",",0,0
235420,placebo-controlled,0,0
235421,study,0,0
235422,compared,0,0
235423,the,0,0
235424,postoperative,0,0
235425,analgesic,0,0
235426,effects,0,0
235427,of,0,0
235428,preoperatively,0,0
235429,administered,0,0
235430,oral,0,0
235431,acetaminophen,0,0
235432,or,0,1
235433,ibuprofen,0,0
235434,.,0,1
235435,Forty,1,1
235436,three,1,0
235437,ASA,1,1
235438,I,1,1
235439,or,1,1
235440,II,1,1
235441,children,1,1
235442,age,1,1
235443,six,1,1
235444,months,1,0
235445,or,1,1
235446,older,1,1
235447,scheduled,1,1
235448,for,1,0
235449,elective,1,1
235450,BM,1,1
235451,&,1,1
235452,T,1,1
235453,were,0,0
235454,randomized,0,0
235455,to,0,0
235456,receive,0,0
235457,acetaminophen,0,0
235458,(,0,0
235459,paracetamol,0,0
235460,),0,0
235461,15,0,0
235462,mg.kg-1,0,0
235463,",",0,0
235464,ibuprofen,0,0
235465,10,0,0
235466,mg.kg-1,0,0
235467,",",0,0
235468,or,0,0
235469,placebo,0,0
235470,.,0,0
235471,Postoperative,0,0
235472,pain,0,0
235473,was,0,0
235474,assessed,0,0
235475,using,0,0
235476,the,0,0
235477,Children,0,1
235478,'s,0,1
235479,Hospital,0,1
235480,of,0,1
235481,Eastern,0,1
235482,Ontario,0,1
235483,Pain,0,1
235484,Scale,0,0
235485,(,0,0
235486,CHEOPS,0,0
235487,),0,0
235488,upon,0,0
235489,arrival,0,0
235490,to,0,0
235491,the,0,0
235492,PACU,0,0
235493,and,0,0
235494,at,0,0
235495,5,0,0
235496,",",0,0
235497,10,0,0
235498,",",0,0
235499,15,0,0
235500,",",0,0
235501,30,0,0
235502,",",0,0
235503,45,0,1
235504,",",0,0
235505,and,0,0
235506,60,0,1
235507,min,0,0
235508,.,0,1
235509,CHEOP,0,0
235510,scores,0,0
235511,did,0,0
235512,not,0,0
235513,differ,0,0
235514,between,0,0
235515,the,0,0
235516,groups,0,0
235517,at,0,0
235518,any,0,0
235519,time,0,0
235520,.,0,0
235521,There,0,0
235522,was,0,0
235523,no,0,0
235524,difference,0,0
235525,in,0,0
235526,the,0,0
235527,number,0,0
235528,of,0,0
235529,children,1,1
235530,receiving,1,1
235531,rescue,1,0
235532,analgesia,1,0
235533,.,1,0
235534,This,0,0
235535,study,0,0
235536,showed,0,0
235537,no,0,0
235538,benefit,0,0
235539,of,0,0
235540,preoperatively,0,0
235541,administered,0,0
235542,oral,0,0
235543,ibuprofen,0,0
235544,10,0,0
235545,mg.kg-1,0,0
235546,or,0,1
235547,acetaminophen,0,0
235548,15,0,0
235549,mg.kg-1,0,0
235550,over,0,0
235551,placebo,0,0
235552,for,0,0
235553,the,0,0
235554,relief,0,0
235555,of,0,0
235556,postoperative,0,0
235557,pain,0,1
235558,in,0,0
235559,children,1,1
235560,undergoing,1,1
235561,BM,1,1
235562,&,1,1
235563,T,1,1
235564,.,1,1
235565,Intravenous,0,1
235566,magnesium,0,0
235567,sulfate,0,0
235568,in,0,0
235569,acute,1,1
235570,severe,1,1
235571,asthma,1,1
235572,not,1,0
235573,responding,1,0
235574,to,1,0
235575,conventional,1,1
235576,therapy,1,0
235577,.,1,0
235578,OBJECTIVE,0,0
235579,To,0,0
235580,evaluate,0,0
235581,the,0,0
235582,effectiveness,0,0
235583,of,0,0
235584,early,0,0
235585,administration,0,0
235586,of,0,0
235587,intravenous,0,0
235588,Magnesium,0,1
235589,sulfate,0,0
235590,(,0,0
235591,i.v,0,0
235592,.,0,1
235593,MgSO4,0,0
235594,),0,0
235595,in,0,0
235596,children,1,1
235597,with,1,1
235598,acute,1,1
235599,severe,1,1
235600,asthma,1,1
235601,not,1,0
235602,responding,1,0
235603,to,1,0
235604,conventional,1,1
235605,therapy,1,0
235606,.,1,1
235607,DESIGN,0,0
235608,Randomized,0,0
235609,double-blind,0,0
235610,",",0,0
235611,placebo-controlled,0,0
235612,trial,0,0
235613,.,0,1
235614,SETTING,0,1
235615,Pediatric,1,1
235616,emergency,1,1
235617,service,1,1
235618,of,1,0
235619,a,1,0
235620,large,1,1
235621,teaching,1,1
235622,hospital,1,1
235623,.,1,0
235624,SUBJECTS,0,0
235625,47,1,1
235626,children,1,1
235627,aged,1,1
235628,between,1,0
235629,1-12,1,0
235630,years,1,1
235631,with,1,1
235632,acute,1,1
235633,severe,1,1
235634,asthma,1,1
235635,showing,1,0
235636,inadequate,1,1
235637,or,1,1
235638,poor,1,1
235639,response,1,0
235640,to,1,0
235641,3,1,0
235642,doses,1,0
235643,of,1,0
235644,nebulized,1,1
235645,salbutamol,1,0
235646,given,1,0
235647,at,1,0
235648,an,1,0
235649,interval,1,0
235650,of,1,0
235651,20,1,1
235652,min,1,0
235653,each,1,0
235654,.,1,0
235655,INTERVENTION,0,0
235656,The,0,0
235657,MgSO4,0,0
235658,group,0,0
235659,received,0,0
235660,0.2,0,0
235661,ml/kg,0,0
235662,of,0,0
235663,50,0,1
235664,%,0,0
235665,MgSO4,0,0
235666,as,0,0
235667,intravenous,0,0
235668,(,0,1
235669,i.v,0,0
235670,.,0,1
235671,),0,0
235672,infusion,0,0
235673,over,0,0
235674,35,0,1
235675,minutes,0,0
235676,and,0,0
235677,the,0,0
235678,placebo,0,0
235679,group,0,0
235680,received,0,0
235681,normal,0,1
235682,saline,0,0
235683,infusion,0,0
235684,in,0,0
235685,the,0,0
235686,same,0,0
235687,dose,0,0
235688,and,0,0
235689,at,0,0
235690,the,0,0
235691,same,0,0
235692,rate,0,0
235693,.,0,1
235694,MgSO4,0,0
235695,solution,0,0
235696,and,0,0
235697,normal,0,1
235698,saline,0,0
235699,were,0,0
235700,coded,0,1
235701,and,0,0
235702,dispensed,0,0
235703,in,0,0
235704,identical,0,1
235705,containers,0,0
235706,.,0,1
235707,Decoding,0,0
235708,was,0,0
235709,done,0,0
235710,at,0,0
235711,the,0,0
235712,completion,0,0
235713,of,0,0
235714,the,0,0
235715,study,0,0
235716,.,0,0
235717,All,0,0
235718,the,0,0
235719,patients,0,1
235720,received,0,0
235721,oxygen,0,0
235722,",",0,0
235723,nebulized,0,0
235724,salbutamol,0,0
235725,",",0,0
235726,i.v,0,0
235727,.,0,0
235728,aminophylline,0,0
235729,and,0,0
235730,corticosteroids,0,0
235731,.,0,1
235732,RESULTS,0,0
235733,MgSO4,0,0
235734,group,0,0
235735,showed,0,0
235736,early,0,0
235737,and,0,0
235738,significant,0,0
235739,improvement,0,0
235740,as,0,0
235741,compared,0,0
235742,to,0,0
235743,placebo,0,0
235744,group,0,0
235745,in,0,0
235746,PEFR,0,0
235747,and,0,0
235748,SaO2,0,0
235749,at,0,0
235750,30,0,1
235751,min,0,0
235752,and,0,0
235753,1,0,0
235754,",",0,0
235755,2,0,0
235756,",",0,0
235757,3,0,0
235758,and,0,0
235759,7,0,1
235760,hours,0,0
235761,after,0,0
235762,stopping,0,0
235763,the,0,0
235764,infusion,0,0
235765,(,0,0
235766,p,0,0
235767,ranging,0,0
235768,from,0,1
235769,<,0,0
235770,0.05,0,0
235771,to,0,0
235772,<,0,0
235773,0.01,0,0
235774,),0,0
235775,.,0,0
235776,The,0,0
235777,clinical,0,0
235778,asthma,0,1
235779,score,0,0
235780,also,0,0
235781,showed,0,0
235782,significant,0,0
235783,improvement,0,0
235784,in,0,0
235785,the,0,0
235786,MgSO4,0,0
235787,group,0,0
235788,1,0,0
235789,",",0,0
235790,2,0,0
235791,",",0,0
235792,3,0,0
235793,and,0,0
235794,11,0,1
235795,hours,0,0
235796,after,0,0
235797,stopping,0,0
235798,the,0,0
235799,infusion,0,0
235800,(,0,0
235801,p,0,0
235802,<,0,0
235803,0.01,0,0
235804,),0,1
235805,.,0,1
235806,CONCLUSION,0,0
235807,Addition,0,0
235808,of,0,0
235809,MgSO4,0,0
235810,to,0,0
235811,conventional,0,0
235812,therapy,0,0
235813,helps,0,0
235814,in,0,0
235815,achieving,0,0
235816,earlier,0,0
235817,improvement,0,0
235818,in,0,0
235819,clinical,0,0
235820,signs,0,1
235821,and,0,1
235822,symptoms,0,0
235823,of,0,0
235824,asthma,0,1
235825,and,0,0
235826,PEFR,0,0
235827,in,0,0
235828,patients,1,1
235829,not,1,0
235830,responding,1,0
235831,to,1,0
235832,conventional,1,0
235833,therapy,1,0
235834,alone,1,0
235835,.,1,0
235836,Maximal,1,0
235837,bioavailability,1,0
235838,of,1,0
235839,digoxin,1,0
235840,from,1,1
235841,tablets,1,0
235842,and,1,1
235843,oral,1,0
235844,solution,1,0
235845,in,1,0
235846,steady,1,0
235847,state,1,1
235848,.,1,0
235849,Comparison,0,0
235850,has,0,0
235851,been,0,0
235852,made,0,0
235853,between,0,0
235854,the,0,0
235855,absorption,0,0
235856,of,0,0
235857,digoxin,0,0
235858,from,0,1
235859,Lanoxin,0,0
235860,tablets,0,0
235861,and,0,0
235862,the,0,0
235863,absorption,0,0
235864,of,0,0
235865,international,0,1
235866,chemical,0,1
235867,reference,0,0
235868,substance,0,0
235869,digoxin,0,0
235870,from,0,0
235871,an,0,0
235872,oral,0,0
235873,solution,0,0
235874,.,0,1
235875,Plasma,0,0
235876,levels,0,0
235877,",",0,0
235878,areas,0,0
235879,under,0,0
235880,24-hour,0,1
235881,plasma,0,0
235882,concentration,0,0
235883,curves,0,0
235884,and,0,0
235885,urinary,0,1
235886,excretion,0,0
235887,were,0,0
235888,similar,0,0
235889,by,0,0
235890,both,0,0
235891,formulations,0,0
235892,in,0,0
235893,steady,0,0
235894,state,0,1
235895,.,0,1
235896,78,0,0
235897,%,0,0
235898,of,0,0
235899,the,0,0
235900,digoxin,0,0
235901,administered,0,0
235902,was,0,0
235903,absorbed,0,0
235904,from,0,0
235905,the,0,0
235906,tablets,0,0
235907,and,0,0
235908,76,0,1
235909,%,0,0
235910,from,0,0
235911,the,0,0
235912,solution,0,0
235913,.,0,0
235914,Rapid,0,0
235915,dissolution,0,0
235916,in,0,0
235917,the,0,0
235918,intestinal,0,1
235919,fluids,0,0
235920,accounts,0,0
235921,for,0,0
235922,the,0,0
235923,high,0,0
235924,digoxin,0,0
235925,bioavailability,0,0
235926,of,0,0
235927,the,0,0
235928,tablets,0,0
235929,.,0,1
235930,The,0,0
235931,influence,0,0
235932,of,0,0
235933,preoperative,0,0
235934,antibiotics,0,0
235935,on,0,0
235936,success,0,0
235937,of,0,0
235938,endosseous,1,1
235939,implants,1,1
235940,up,1,0
235941,to,1,0
235942,and,1,0
235943,including,1,0
235944,stage,1,1
235945,II,1,1
235946,surgery,1,1
235947,:,1,1
235948,a,1,0
235949,study,1,0
235950,of,1,0
235951,"2,641",1,1
235952,implants,1,1
235953,.,1,1
235954,According,0,0
235955,to,0,0
235956,the,0,0
235957,American,0,1
235958,College,0,1
235959,of,0,0
235960,Surgeons,0,1
235961,",",0,0
235962,complex,0,0
235963,oral,0,0
235964,surgical,0,1
235965,procedures,0,0
235966,",",0,0
235967,including,0,0
235968,the,0,0
235969,transoral,0,1
235970,placement,0,0
235971,of,0,0
235972,endosseous,1,1
235973,implants,1,0
235974,",",0,0
235975,are,0,0
235976,of,0,0
235977,the,0,0
235978,type,0,0
235979,that,0,0
235980,may,0,0
235981,require,0,0
235982,prophylactic,0,0
235983,antibiotics,0,0
235984,.,0,0
235985,However,0,0
235986,",",0,0
235987,the,0,0
235988,routine,0,0
235989,use,0,0
235990,of,0,0
235991,prophylactic,0,0
235992,antibiotics,0,0
235993,in,0,0
235994,the,0,0
235995,field,0,0
235996,of,0,0
235997,dental,0,1
235998,implantology,0,0
235999,continues,0,0
236000,to,0,0
236001,be,0,0
236002,controversial,0,0
236003,",",0,0
236004,and,0,0
236005,their,0,0
236006,utilization,0,0
236007,varies,0,0
236008,widely,0,0
236009,.,0,0
236010,No,0,0
236011,data,0,0
236012,from,0,0
236013,a,0,0
236014,randomized,0,1
236015,prospective,0,0
236016,clinical,0,0
236017,study,0,0
236018,of,0,0
236019,the,0,0
236020,prophylactic,0,0
236021,use,0,0
236022,of,0,0
236023,antibiotics,0,0
236024,in,0,0
236025,implant,0,1
236026,surgery,0,1
236027,have,0,0
236028,been,0,0
236029,previously,0,0
236030,published,0,0
236031,.,0,0
236032,As,0,0
236033,part,0,0
236034,of,0,0
236035,the,0,0
236036,comprehensive,0,0
236037,Dental,0,1
236038,Implant,0,1
236039,Clinical,0,0
236040,Research,0,1
236041,Group,0,1
236042,clinical,0,0
236043,implant,0,0
236044,study,0,0
236045,",",0,0
236046,the,0,0
236047,preoperative,0,0
236048,or,0,0
236049,postoperative,0,0
236050,use,0,0
236051,of,0,0
236052,antibiotics,0,0
236053,",",0,0
236054,the,0,0
236055,type,0,0
236056,used,0,0
236057,",",0,0
236058,and,0,0
236059,the,0,0
236060,duration,0,0
236061,of,0,0
236062,coverage,0,0
236063,was,0,0
236064,left,0,1
236065,to,0,0
236066,the,0,0
236067,discretion,0,0
236068,of,0,0
236069,the,0,0
236070,surgeon,0,1
236071,.,0,0
236072,These,0,0
236073,data,0,0
236074,were,0,0
236075,recorded,0,0
236076,and,0,0
236077,correlated,0,0
236078,with,0,1
236079,failure,0,1
236080,of,0,0
236081,osseointegration,0,0
236082,during,0,0
236083,healing,0,0
236084,(,0,0
236085,stage,0,1
236086,I,0,1
236087,),0,0
236088,and,0,0
236089,at,0,0
236090,stage,0,1
236091,II,0,1
236092,surgery,0,1
236093,(,0,0
236094,uncovering,0,0
236095,),0,0
236096,.,0,1
236097,The,0,0
236098,results,0,0
236099,showed,0,0
236100,that,0,0
236101,significantly,0,0
236102,fewer,0,0
236103,failures,0,0
236104,occurred,0,0
236105,when,0,0
236106,preoperative,0,0
236107,antibiotics,0,0
236108,were,0,1
236109,used,0,0
236110,.,0,1
236111,The,0,0
236112,effect,0,0
236113,of,0,0
236114,valaciclovir,0,0
236115,on,0,0
236116,cytomegalovirus,0,1
236117,viremia,0,0
236118,and,0,0
236119,viruria,0,1
236120,detected,0,0
236121,by,0,0
236122,polymerase,0,0
236123,chain,0,0
236124,reaction,0,0
236125,in,0,0
236126,patients,1,1
236127,with,1,1
236128,advanced,1,1
236129,human,1,1
236130,immunodeficiency,1,1
236131,virus,1,1
236132,disease,1,1
236133,.,1,0
236134,AIDS,0,1
236135,Clinical,0,0
236136,Trials,0,1
236137,Group,0,1
236138,Protocol,0,1
236139,204/Glaxo,0,1
236140,Wellcome,0,1
236141,123-014,0,1
236142,International,0,1
236143,CMV,0,1
236144,Prophylaxis,0,1
236145,Study,0,1
236146,Group,0,1
236147,.,0,1
236148,Samples,0,0
236149,of,0,0
236150,blood,0,0
236151,and,0,0
236152,urine,0,0
236153,were,0,0
236154,collected,0,0
236155,at,0,0
236156,baseline,0,0
236157,",",0,0
236158,week,0,0
236159,4,0,0
236160,",",0,0
236161,and,0,0
236162,week,0,0
236163,8,0,0
236164,and,0,0
236165,then,0,0
236166,every,0,0
236167,8,0,0
236168,weeks,0,0
236169,from,0,1
236170,310,1,1
236171,patients,1,1
236172,entering,1,1
236173,a,1,0
236174,controlled,1,0
236175,trial,1,0
236176,of,1,0
236177,prophylaxis,1,0
236178,with,1,1
236179,valaciclovir,1,0
236180,versus,1,0
236181,acyclovir,1,0
236182,.,1,1
236183,Samples,0,0
236184,were,0,0
236185,tested,0,0
236186,under,0,0
236187,code,0,0
236188,by,0,0
236189,polymerase,0,0
236190,chain,0,0
236191,reaction,0,0
236192,(,0,0
236193,PCR,0,0
236194,),0,0
236195,in,0,0
236196,one,0,1
236197,laboratory,0,0
236198,.,0,0
236199,The,0,0
236200,median,0,0
236201,number,0,0
236202,of,0,0
236203,samples,0,0
236204,collected,0,1
236205,from,0,0
236206,each,0,0
236207,patient,0,0
236208,was,0,0
236209,5,0,0
236210,for,0,0
236211,blood,0,0
236212,(,0,0
236213,range,0,0
236214,",",0,0
236215,0-15,0,0
236216,),0,0
236217,and,0,0
236218,5,0,0
236219,for,0,0
236220,urine,0,0
236221,(,0,0
236222,range,0,0
236223,",",0,0
236224,0-15,0,0
236225,),0,0
236226,.,0,0
236227,Both,0,0
236228,baseline,0,0
236229,PCR,0,0
236230,viremia,0,0
236231,and,0,0
236232,PCR,0,0
236233,viruria,0,1
236234,were,0,0
236235,significantly,0,0
236236,associated,0,0
236237,with,0,1
236238,future,0,0
236239,cytomegalovirus,0,1
236240,(,0,0
236241,CMV,0,0
236242,),0,0
236243,disease,0,1
236244,(,0,0
236245,P,0,0
236246,=,0,0
236247,.002,0,0
236248,and,0,0
236249,P,0,0
236250,=,0,0
236251,.02,0,0
236252,",",0,0
236253,respectively,0,0
236254,),0,0
236255,.,0,0
236256,The,0,0
236257,greatest,0,0
236258,effect,0,0
236259,of,0,0
236260,valaciclovir,0,0
236261,on,0,0
236262,CMV,0,0
236263,disease,0,1
236264,was,0,0
236265,seen,0,0
236266,in,0,1
236267,patients,0,1
236268,who,0,1
236269,were,0,1
236270,PCR-positive,0,1
236271,in,0,0
236272,blood,0,0
236273,at,0,0
236274,baseline,0,0
236275,(,0,0
236276,P,0,0
236277,=,0,0
236278,.002,0,0
236279,),0,0
236280,",",0,0
236281,although,0,0
236282,a,0,0
236283,significant,0,0
236284,effect,0,0
236285,was,0,0
236286,also,0,0
236287,seen,0,0
236288,in,0,0
236289,those,0,1
236290,who,0,1
236291,were,0,1
236292,PCR-negative,0,1
236293,in,0,0
236294,urine,0,0
236295,(,0,0
236296,P,0,0
236297,=,0,0
236298,.02,0,0
236299,),0,0
236300,.,0,0
236301,Thus,0,0
236302,",",0,0
236303,PCR,0,0
236304,viremia,0,0
236305,provides,0,0
236306,prognostic,0,0
236307,information,0,0
236308,about,0,0
236309,CMV,0,0
236310,disease,0,1
236311,in,0,0
236312,AIDS,0,1
236313,patients,0,1
236314,",",0,0
236315,and,0,0
236316,valaciclovir,0,0
236317,showed,0,0
236318,activity,0,0
236319,as,0,0
236320,both,0,0
236321,a,0,0
236322,preemptive,0,0
236323,and,0,0
236324,prophylactic,0,0
236325,agent,0,0
236326,.,0,1
236327,Safety,0,0
236328,and,0,0
236329,immunogenicity,0,0
236330,of,0,0
236331,a,0,0
236332,combined,0,0
236333,pentavalent,0,0
236334,diphtheria,0,0
236335,",",0,0
236336,tetanus,0,0
236337,",",0,0
236338,acellular,0,0
236339,pertussis,0,0
236340,",",0,0
236341,inactivated,0,0
236342,poliovirus,0,0
236343,and,0,0
236344,Haemophilus,0,1
236345,influenzae,0,1
236346,type,0,1
236347,b-tetanus,0,0
236348,conjugate,0,0
236349,vaccine,0,0
236350,in,0,0
236351,infants,1,1
236352,",",0,0
236353,compared,0,0
236354,with,0,1
236355,a,0,0
236356,whole,0,0
236357,cell,0,0
236358,pertussis,0,0
236359,pentavalent,0,0
236360,vaccine,0,0
236361,.,0,0
236362,BACKGROUND,0,0
236363,We,0,0
236364,compared,0,0
236365,the,0,0
236366,safety,0,0
236367,and,0,0
236368,immunogenicity,0,0
236369,of,0,0
236370,two,0,0
236371,combined,0,0
236372,diphtheria-tetanus-pertussis-inactivated,0,1
236373,poliovirus,0,1
236374,vaccines,0,0
236375,containing,0,0
236376,either,0,0
236377,acellular,0,0
236378,(,0,0
236379,Pa,0,0
236380,",",0,0
236381,SmithKline,0,0
236382,Beecham,0,1
236383,Biologicals,0,1
236384,),0,0
236385,or,0,1
236386,whole,0,0
236387,cell,0,1
236388,(,0,0
236389,Pw,0,1
236390,",",0,0
236391,Pasteur,0,1
236392,Merieux,0,0
236393,Connaught,0,1
236394,),0,0
236395,pertussis,0,0
236396,components,0,0
236397,",",0,0
236398,mixed,0,0
236399,with,0,1
236400,a,0,0
236401,Haemophilus,0,1
236402,influenzae,0,0
236403,type,0,1
236404,b,0,0
236405,polysaccharide,0,0
236406,polyribosylribitol,0,0
236407,phosphate-tetanus,0,0
236408,conjugate,0,0
236409,vaccine,0,0
236410,in,0,0
236411,an,0,0
236412,open,0,1
236413,",",0,0
236414,randomized,0,0
236415,study,0,0
236416,in,0,0
236417,healthy,1,1
236418,infants,1,1
236419,.,1,1
236420,DESIGN,0,0
236421,The,0,0
236422,combined,0,0
236423,vaccines,0,0
236424,were,0,1
236425,given,0,0
236426,at,0,0
236427,2,0,0
236428,",",0,0
236429,4,0,0
236430,",",0,0
236431,6,0,0
236432,and,0,0
236433,12,0,1
236434,months,0,0
236435,of,0,0
236436,age,0,1
236437,",",0,0
236438,and,0,0
236439,serum,0,0
236440,samples,0,0
236441,were,0,0
236442,obtained,0,0
236443,at,0,0
236444,ages,0,1
236445,2,0,1
236446,",",0,0
236447,6,0,0
236448,",",0,0
236449,7,0,0
236450,",",0,0
236451,12,0,0
236452,and,0,0
236453,13,0,1
236454,months,0,0
236455,.,0,1
236456,Adverse,0,0
236457,events,0,0
236458,were,0,1
236459,obtained,0,0
236460,by,0,0
236461,diary,0,0
236462,cards,0,1
236463,.,0,1
236464,RESULTS,0,0
236465,The,1,0
236466,Pa,1,0
236467,group,1,0
236468,(,1,0
236469,n,1,1
236470,=,1,0
236471,101,1,1
236472,),1,0
236473,had,1,0
236474,a,1,0
236475,clearly,1,0
236476,lower,1,0
236477,incidence,1,0
236478,of,1,0
236479,both,1,0
236480,local,1,0
236481,and,1,0
236482,systemic,1,0
236483,adverse,1,0
236484,events,1,0
236485,than,1,0
236486,the,1,0
236487,Pw,1,1
236488,group,1,0
236489,(,1,0
236490,n,1,1
236491,=,1,0
236492,100,1,1
236493,),1,1
236494,.,1,1
236495,Immunogenicity,0,0
236496,was,0,0
236497,comparable,0,0
236498,for,0,0
236499,the,0,0
236500,diphtheria,0,0
236501,and,0,0
236502,tetanus,0,1
236503,components,0,0
236504,",",0,0
236505,but,0,0
236506,significantly,0,0
236507,superior,0,0
236508,for,0,0
236509,pertussis,0,0
236510,toxin,0,0
236511,",",0,0
236512,filamentous,0,0
236513,hemagglutinin,0,0
236514,",",0,0
236515,pertactin,0,0
236516,and,0,0
236517,polioviruses,0,1
236518,1,0,0
236519,",",0,0
236520,2,0,0
236521,and,0,0
236522,3,0,0
236523,in,0,0
236524,the,0,0
236525,Pa,0,0
236526,group,0,0
236527,.,0,0
236528,Both,0,0
236529,groups,0,0
236530,had,0,1
236531,an,0,0
236532,appropriate,0,0
236533,response,0,0
236534,with,0,1
236535,regard,0,0
236536,to,0,0
236537,H.,0,1
236538,influenzae,0,1
236539,type,0,1
236540,b,0,0
236541,polysaccharide,0,0
236542,polyribosylribitol,0,0
236543,phosphate,0,0
236544,",",0,0
236545,but,0,0
236546,the,0,0
236547,dynamics,0,0
236548,of,0,0
236549,the,0,0
236550,response,0,0
236551,were,0,0
236552,significantly,0,0
236553,different,0,0
236554,:,0,1
236555,geometric,0,0
236556,mean,0,1
236557,concentrations,0,0
236558,(,0,1
236559,micrograms,0,0
236560,per,0,0
236561,ml,0,0
236562,),0,0
236563,after,0,0
236564,the,0,0
236565,second,0,0
236566,",",0,0
236567,third,0,1
236568,and,0,0
236569,booster,0,0
236570,doses,0,0
236571,were,0,1
236572,1.27,0,0
236573,",",0,0
236574,5.06,0,0
236575,and,0,0
236576,23.12,0,0
236577,in,0,0
236578,the,0,0
236579,Pa,0,0
236580,group,0,0
236581,and,0,0
236582,2.72,0,0
236583,",",0,0
236584,6.66,0,0
236585,and,0,0
236586,13.59,0,0
236587,in,0,0
236588,the,0,0
236589,Pw,0,1
236590,group,0,0
236591,",",0,0
236592,respectively,0,0
236593,(,0,0
236594,P,0,0
236595,=,0,0
236596,0.0002,0,0
236597,after,0,0
236598,second,0,1
236599,dose,0,0
236600,;,0,1
236601,P,0,0
236602,=,0,0
236603,0.0005,0,0
236604,after,0,0
236605,booster,0,0
236606,),0,0
236607,.,0,0
236608,CONCLUSION,0,0
236609,The,0,0
236610,presently,0,0
236611,studied,0,0
236612,diphtheria,0,0
236613,",",0,0
236614,tetanus,0,0
236615,",",0,0
236616,acellular,0,0
236617,pertussis-H.,0,1
236618,influenzae,0,1
236619,b,0,0
236620,vaccine,0,0
236621,conjugated,0,0
236622,to,0,0
236623,tetanus,0,1
236624,toxoid,0,0
236625,combination,0,0
236626,was,0,0
236627,at,0,0
236628,least,0,0
236629,as,0,0
236630,immunogenic,0,0
236631,as,0,0
236632,the,0,0
236633,diphtheria,0,0
236634,",",0,0
236635,tetanus,0,0
236636,",",0,0
236637,whole,0,0
236638,cell,0,1
236639,pertussis-H.,0,1
236640,influenzae,0,1
236641,b,0,0
236642,vaccine,0,0
236643,conjugated,0,0
236644,to,0,0
236645,tetanus,0,1
236646,toxoid,0,0
236647,combination,0,0
236648,",",0,0
236649,with,0,0
236650,a,0,0
236651,significantly,0,0
236652,better,0,0
236653,safety,0,0
236654,profile,0,0
236655,.,0,0
236656,This,0,0
236657,is,0,0
236658,of,0,0
236659,obvious,0,0
236660,importance,0,0
236661,in,0,0
236662,countries,0,0
236663,where,0,1
236664,inactivated,0,0
236665,poliovirus,0,0
236666,vaccine,0,0
236667,is,0,0
236668,part,0,0
236669,of,0,0
236670,the,0,0
236671,routine,0,0
236672,infant,0,1
236673,immunization,0,1
236674,programs,0,1
236675,.,0,1
236676,A,0,0
236677,carbohydrate,0,0
236678,meal,0,0
236679,attenuates,0,0
236680,the,0,0
236681,forearm,0,0
236682,vasoconstrictor,0,0
236683,response,0,0
236684,to,0,0
236685,lower,0,0
236686,body,0,1
236687,subatmospheric,0,0
236688,pressure,0,0
236689,in,0,0
236690,healthy,1,1
236691,young,1,1
236692,adults,1,1
236693,.,1,1
236694,The,0,0
236695,cardiovascular,0,0
236696,(,0,0
236697,CV,0,0
236698,),0,0
236699,responses,0,0
236700,to,0,0
236701,meal,0,0
236702,ingestion,0,0
236703,and,0,0
236704,orthostasis,0,0
236705,are,0,0
236706,well,0,0
236707,established,0,0
236708,.,0,0
236709,The,0,0
236710,effect,0,0
236711,of,0,0
236712,meal,0,0
236713,ingestion,0,0
236714,and,0,0
236715,meal,0,0
236716,composition,0,1
236717,on,0,0
236718,the,0,0
236719,CV,0,1
236720,responses,0,0
236721,to,0,1
236722,orthostasis,0,0
236723,are,0,0
236724,unknown,0,0
236725,.,0,0
236726,The,0,0
236727,effect,0,0
236728,of,0,0
236729,high,0,0
236730,carbohydrate,0,0
236731,(,0,0
236732,HC,0,0
236733,),0,0
236734,and,0,0
236735,high,0,0
236736,fat,0,0
236737,(,0,0
236738,HF,0,0
236739,),0,0
236740,meal,0,0
236741,ingestion,0,0
236742,on,0,0
236743,the,0,0
236744,CV,0,1
236745,responses,0,0
236746,to,0,0
236747,simulated,0,0
236748,orthostatic,0,0
236749,stress,0,0
236750,(,0,0
236751,using,0,0
236752,graded,0,0
236753,lower,0,0
236754,body,0,1
236755,subatmospheric,0,0
236756,pressure,0,0
236757,(,0,0
236758,LBSP,0,0
236759,),0,1
236760,),0,0
236761,was,0,0
236762,assessed,0,0
236763,in,0,0
236764,nine,1,1
236765,healthy,1,1
236766,young,1,1
236767,volunteers,1,1
236768,.,1,1
236769,Cardiac,0,0
236770,output,0,0
236771,(,0,0
236772,CO,0,0
236773,),0,0
236774,",",0,0
236775,forearm,0,0
236776,blood,0,0
236777,flow,0,0
236778,(,0,0
236779,FABF,0,0
236780,),0,0
236781,heart,0,1
236782,rate,0,0
236783,(,0,0
236784,HR,0,0
236785,),0,0
236786,and,0,0
236787,blood,0,0
236788,pressure,0,0
236789,(,0,0
236790,BP,0,0
236791,),0,0
236792,were,0,0
236793,measured,0,0
236794,before,0,0
236795,and,0,0
236796,during,0,0
236797,LBSP,0,0
236798,while,0,0
236799,fasted,0,0
236800,and,0,0
236801,after,0,0
236802,eating,0,0
236803,HC,0,0
236804,and,0,1
236805,HF,0,1
236806,meals,0,0
236807,.,0,1
236808,Ingestion,0,0
236809,of,0,0
236810,both,0,0
236811,meals,0,0
236812,led,0,0
236813,to,0,0
236814,an,0,0
236815,increase,0,0
236816,in,0,0
236817,CO,0,0
236818,and,0,1
236819,HR,0,0
236820,.,0,0
236821,Both,0,0
236822,meals,0,0
236823,resulted,0,0
236824,in,0,0
236825,a,0,0
236826,fall,0,0
236827,in,0,0
236828,total,0,1
236829,peripheral,0,1
236830,resistance,0,0
236831,but,0,0
236832,only,0,0
236833,HC,0,0
236834,led,0,0
236835,to,0,0
236836,a,0,0
236837,significant,0,0
236838,fall,0,0
236839,in,0,0
236840,BP,0,0
236841,(,0,1
236842,p,0,0
236843,<,0,0
236844,0.05,0,0
236845,),0,1
236846,.,0,1
236847,HF,0,0
236848,had,0,0
236849,no,0,0
236850,effect,0,0
236851,on,0,0
236852,the,0,0
236853,CV,0,1
236854,responses,0,0
236855,to,0,0
236856,LBSP,0,0
236857,",",0,0
236858,whereas,0,0
236859,HC,0,0
236860,resulted,0,0
236861,in,0,0
236862,attenuated,0,0
236863,FABF,0,0
236864,and,0,0
236865,forearm,0,0
236866,vascular,0,0
236867,resistance,0,0
236868,responses,0,0
236869,(,0,1
236870,p,0,0
236871,<,0,0
236872,0.05,0,0
236873,),0,0
236874,.,0,0
236875,Thus,0,0
236876,",",0,0
236877,ingestion,0,0
236878,of,0,0
236879,an,0,0
236880,HC,0,0
236881,meal,0,0
236882,significantly,0,0
236883,attenuates,0,0
236884,the,0,0
236885,forearm,0,0
236886,vascular,0,0
236887,response,0,0
236888,to,0,0
236889,orthostatic,0,0
236890,stress,0,0
236891,and,0,0
236892,the,0,0
236893,hypotensive,0,0
236894,effect,0,0
236895,of,0,0
236896,orthostasis,0,0
236897,is,0,0
236898,additive,0,0
236899,to,0,0
236900,that,0,0
236901,occurring,0,0
236902,after,0,0
236903,an,0,0
236904,HC,0,0
236905,meal,0,0
236906,.,0,1
236907,Electrical,0,0
236908,sources,0,0
236909,of,0,1
236910,P300,0,0
236911,event-related,0,0
236912,brain,0,1
236913,potentials,0,0
236914,revealed,0,0
236915,by,0,0
236916,low,0,1
236917,resolution,0,0
236918,electromagnetic,0,0
236919,tomography,0,0
236920,.,0,1
236921,2,0,0
236922,.,0,0
236923,Effects,0,0
236924,of,0,0
236925,nootropic,0,0
236926,therapy,0,0
236927,in,0,0
236928,age-associated,1,0
236929,memory,1,0
236930,impairment,1,0
236931,.,1,0
236932,In,0,0
236933,a,0,0
236934,double-blind,0,0
236935,",",0,0
236936,placebo-controlled,0,0
236937,study,0,0
236938,the,0,0
236939,effects,0,0
236940,of,0,0
236941,Actovegin,0,1
236942,on,0,0
236943,frontal,0,0
236944,and,0,1
236945,parietal,0,1
236946,electrical,0,0
236947,P300,0,1
236948,sources,0,0
236949,revealed,0,0
236950,by,0,0
236951,low,0,1
236952,resolution,0,0
236953,electromagnetic,0,0
236954,tomography,0,0
236955,(,0,0
236956,LORETA,0,1
236957,),0,0
236958,were,0,0
236959,studied,0,1
236960,in,0,0
236961,age-associated,1,0
236962,memory,1,0
236963,impairment,1,0
236964,(,1,0
236965,AAMI,1,1
236966,),1,1
236967,patients,1,1
236968,.,1,1
236969,Actovegin,0,0
236970,is,0,0
236971,a,0,0
236972,protein-free,0,0
236973,metabolically,0,1
236974,active,0,1
236975,hemoderivative,0,0
236976,improving,0,0
236977,oxygen,0,0
236978,and,0,0
236979,glucose,0,0
236980,utilization,0,0
236981,.,0,0
236982,Each,0,0
236983,patient,0,0
236984,had,0,0
236985,",",0,0
236986,in,0,0
236987,randomized,0,0
236988,order,0,0
236989,",",0,0
236990,a,0,0
236991,treatment,0,0
236992,of,0,0
236993,2,0,0
236994,weeks,0,0
236995,with,0,1
236996,250,0,1
236997,ml,0,0
236998,20,0,1
236999,%,0,0
237000,Actovegin,0,0
237001,and,0,0
237002,250,0,0
237003,ml,0,0
237004,placebo,0,0
237005,daily,0,0
237006,.,0,1
237007,Auditory,0,0
237008,ERPs,0,0
237009,were,0,0
237010,recorded,0,0
237011,before,0,0
237012,and,0,0
237013,5,0,0
237014,h,0,0
237015,after,0,0
237016,drug,0,0
237017,administration,0,0
237018,on,0,0
237019,day,0,0
237020,1,0,0
237021,(,0,0
237022,acute,0,1
237023,effect,0,0
237024,),0,0
237025,and,0,0
237026,on,0,0
237027,day,0,0
237028,15,0,1
237029,(,0,0
237030,subacute,0,1
237031,and,0,0
237032,superimposed,0,0
237033,effect,0,0
237034,),0,0
237035,.,0,0
237036,Compared,0,0
237037,to,0,0
237038,age-,0,1
237039,and,0,0
237040,sex-matched,0,1
237041,normal,0,1
237042,controls,0,1
237043,",",0,1
237044,AAMI,1,1
237045,patients,1,1
237046,showed,0,0
237047,a,0,0
237048,trend,0,0
237049,towards,0,0
237050,P300,0,0
237051,latency,0,0
237052,prolongation,0,0
237053,and,0,0
237054,a,0,0
237055,significantly,0,0
237056,reduced,0,0
237057,P300,0,0
237058,global,0,0
237059,field,0,0
237060,power,0,0
237061,(,0,0
237062,GFP,0,0
237063,),0,1
237064,.,0,1
237065,Maximal,0,0
237066,LORETA,0,0
237067,source,0,0
237068,strength,0,0
237069,did,0,0
237070,not,0,0
237071,differ,0,0
237072,from,0,0
237073,controls,0,1
237074,.,0,1
237075,After,0,0
237076,Actovegin,0,0
237077,parietal,0,1
237078,P300,0,0
237079,scalp,0,1
237080,amplitudes,0,0
237081,increased,0,0
237082,",",0,0
237083,while,0,0
237084,frontal,0,0
237085,and,0,1
237086,temporal,0,0
237087,amplitudes,0,0
237088,decreased,0,0
237089,as,0,0
237090,compared,0,0
237091,to,0,0
237092,placebo,0,0
237093,.,0,0
237094,This,0,0
237095,increase,0,0
237096,in,0,0
237097,hilliness,0,0
237098,",",0,0
237099,measured,0,0
237100,by,0,0
237101,the,0,0
237102,GFP,0,0
237103,",",0,0
237104,was,0,0
237105,significant,0,0
237106,.,0,0
237107,Moreover,0,0
237108,",",0,0
237109,the,0,0
237110,parietal,0,0
237111,P300,0,0
237112,source,0,1
237113,strength,0,0
237114,increased,0,0
237115,after,0,0
237116,acute,0,1
237117,",",0,0
237118,subacute,0,1
237119,and,0,0
237120,superimposed,0,0
237121,infusion,0,0
237122,of,0,0
237123,Actovegin,0,0
237124,as,0,0
237125,compared,0,0
237126,to,0,0
237127,placebo,0,0
237128,.,0,0
237129,This,0,0
237130,may,0,0
237131,reflect,0,0
237132,improved,0,0
237133,availability,0,0
237134,of,0,0
237135,cognitive,0,0
237136,processing,0,0
237137,resources,0,0
237138,in,0,0
237139,the,0,0
237140,parietal,0,0
237141,cortex,0,0
237142,",",0,0
237143,an,0,0
237144,area,0,0
237145,that,0,0
237146,on,0,0
237147,the,0,0
237148,one,0,0
237149,hand,0,0
237150,plays,0,0
237151,an,0,0
237152,important,0,0
237153,role,0,0
237154,in,0,0
237155,fundamental,0,0
237156,aspects,0,0
237157,of,0,0
237158,attention,0,0
237159,and,0,0
237160,on,0,0
237161,the,0,0
237162,other,0,0
237163,hand,0,0
237164,has,0,0
237165,been,0,0
237166,found,0,0
237167,to,0,0
237168,be,0,0
237169,functionally,0,0
237170,impaired,0,0
237171,in,0,0
237172,dementia,0,1
237173,.,0,1
237174,Randomised,0,0
237175,community-based,0,1
237176,trial,0,0
237177,of,0,0
237178,annual,0,1
237179,single-dose,0,0
237180,diethylcarbamazine,0,0
237181,with,0,1
237182,or,0,0
237183,without,0,1
237184,ivermectin,0,0
237185,against,0,0
237186,Wuchereria,1,1
237187,bancrofti,1,1
237188,infection,1,1
237189,in,1,0
237190,human,1,1
237191,beings,1,1
237192,and,1,1
237193,mosquitoes,1,1
237194,.,1,1
237195,BACKGROUND,0,0
237196,WHO,0,0
237197,has,0,0
237198,targeted,0,0
237199,lymphatic,0,0
237200,filariasis,0,1
237201,for,0,0
237202,elimination,0,0
237203,.,0,1
237204,Studies,0,0
237205,of,0,0
237206,vector-parasite,0,1
237207,relations,0,0
237208,of,0,0
237209,Wuchereria,0,1
237210,bancrofti,0,1
237211,suggest,0,0
237212,that,0,0
237213,a,0,0
237214,reduction,0,0
237215,in,0,0
237216,the,0,0
237217,microfilarial,0,0
237218,reservoir,0,0
237219,by,0,0
237220,mass,0,0
237221,chemotherapy,0,0
237222,may,0,0
237223,interrupt,0,0
237224,transmission,0,0
237225,and,0,0
237226,thereby,0,0
237227,eliminate,0,0
237228,infection,0,0
237229,.,0,0
237230,However,0,0
237231,",",0,0
237232,no,0,0
237233,field,0,0
237234,data,0,0
237235,exist,0,0
237236,on,0,0
237237,the,0,0
237238,impact,0,0
237239,of,0,0
237240,chemotherapy,0,0
237241,alone,0,0
237242,on,0,0
237243,vector,0,0
237244,efficiency,0,0
237245,and,0,0
237246,transmission,0,0
237247,intensity,0,0
237248,of,0,0
237249,W,0,0
237250,bancrofti,0,1
237251,.,0,0
237252,We,0,0
237253,compared,0,0
237254,the,0,0
237255,impact,0,0
237256,of,0,0
237257,an,0,0
237258,annual,0,0
237259,community-wide,0,0
237260,single-dose,0,0
237261,treatment,0,0
237262,with,0,1
237263,diethylcarbamazine,0,0
237264,alone,0,0
237265,or,0,1
237266,with,0,1
237267,ivermectin,0,0
237268,on,0,0
237269,rate,0,0
237270,and,0,0
237271,intensity,0,0
237272,of,0,0
237273,microfilaraemia,0,0
237274,",",0,0
237275,and,0,0
237276,transmission,0,0
237277,intensity,0,0
237278,in,0,0
237279,an,0,0
237280,area,0,0
237281,of,0,0
237282,Papua,0,1
237283,New,0,1
237284,Guinea,0,1
237285,endemic,0,1
237286,for,0,0
237287,intense,0,0
237288,W,0,0
237289,bancrofti,0,1
237290,transmission,0,0
237291,.,0,0
237292,METHODS,0,0
237293,We,0,0
237294,carried,0,0
237295,out,0,0
237296,clinical,0,0
237297,and,0,0
237298,parasitological,0,0
237299,surveys,0,1
237300,in,0,1
237301,14,1,1
237302,communities,1,1
237303,in,1,1
237304,matched,1,1
237305,pairs,1,1
237306,.,1,1
237307,People,1,1
237308,aged,1,1
237309,5,1,1
237310,years,1,1
237311,or,1,1
237312,older,1,1
237313,in,1,0
237314,seven,1,1
237315,communities,1,1
237316,received,1,0
237317,randomly,1,1
237318,assigned,1,1
237319,diethylcarbamazine,1,0
237320,6,1,0
237321,mg/kg,1,0
237322,and,1,0
237323,people,1,1
237324,in,1,0
237325,the,1,0
237326,other,1,0
237327,seven,1,1
237328,communities,1,1
237329,received,0,1
237330,diethylcarbamazine,0,0
237331,6,0,0
237332,mg/kg,0,0
237333,plus,0,0
237334,ivermectin,0,0
237335,400,0,0
237336,micrograms/kg,0,0
237337,.,0,1
237338,We,0,0
237339,made,0,0
237340,physical,0,0
237341,examinations,0,1
237342,for,0,1
237343,hydroceles,0,1
237344,and,0,0
237345,leg,0,0
237346,oedema,0,0
237347,and,0,0
237348,investigated,0,0
237349,microfilarial,0,0
237350,densities,0,0
237351,by,0,0
237352,membrane,0,0
237353,filtration,0,0
237354,before,0,0
237355,and,0,0
237356,after,0,0
237357,treatment,0,0
237358,.,0,1
237359,We,0,0
237360,selected,0,1
237361,five,1,1
237362,communities,1,1
237363,for,0,1
237364,monthly,0,0
237365,entomological,0,1
237366,surveys,0,1
237367,between,0,0
237368,September,0,1
237369,",",0,0
237370,1993,0,1
237371,",",0,0
237372,and,0,0
237373,September,0,1
237374,",",0,0
237375,1995,0,1
237376,.,0,1
237377,Mosquitoes,0,0
237378,were,0,0
237379,collected,0,0
237380,in,0,0
237381,these,0,0
237382,communities,0,0
237383,by,0,0
237384,the,0,0
237385,all-night,0,1
237386,landing,0,0
237387,catch,0,0
237388,method,0,0
237389,and,0,0
237390,were,0,0
237391,individually,0,0
237392,dissected,0,0
237393,to,0,0
237394,identify,0,0
237395,rates,0,0
237396,of,0,0
237397,infection,0,1
237398,and,0,0
237399,infectiveness,0,0
237400,.,0,1
237401,FINDINGS,0,0
237402,2219,1,1
237403,(,1,1
237404,87.6,1,0
237405,%,1,0
237406,),1,0
237407,of,1,0
237408,2534,1,1
237409,eligible,1,1
237410,people,1,1
237411,received,1,1
237412,treatment,1,0
237413,.,1,0
237414,Microfilarial,0,0
237415,rate,0,0
237416,and,0,0
237417,density,0,0
237418,had,0,1
237419,decreased,0,0
237420,1,0,0
237421,year,0,0
237422,after,0,0
237423,treatment,0,0
237424,in,0,0
237425,all,0,0
237426,14,0,1
237427,communities,0,1
237428,;,0,1
237429,this,0,0
237430,decrease,0,0
237431,was,0,0
237432,significantly,0,0
237433,higher,0,0
237434,in,0,0
237435,communities,0,1
237436,given,0,0
237437,combined,0,0
237438,therapy,0,0
237439,than,0,0
237440,in,0,0
237441,those,0,0
237442,given,0,0
237443,diethylcarbamazine,0,0
237444,alone,0,0
237445,(,0,0
237446,mean,0,0
237447,decreases,0,0
237448,57.5,0,0
237449,%,0,0
237450,and,0,0
237451,30.6,0,0
237452,%,0,0
237453,",",0,0
237454,respectively,0,0
237455,;,0,0
237456,p,0,0
237457,=,0,0
237458,0.0013,0,0
237459,),0,0
237460,.,0,1
237461,Greater,0,0
237462,decreases,0,0
237463,were,0,0
237464,also,0,0
237465,seen,0,0
237466,in,0,0
237467,community-specific,0,0
237468,microfilarial,0,0
237469,intensity,0,0
237470,with,0,1
237471,combined,0,0
237472,therapy,0,0
237473,(,0,0
237474,mean,0,1
237475,reductions,0,0
237476,91.1,0,1
237477,%,0,0
237478,and,0,0
237479,69.8,0,0
237480,%,0,0
237481,",",0,0
237482,respectively,0,0
237483,;,0,0
237484,p,0,0
237485,=,0,0
237486,0.0047,0,0
237487,),0,0
237488,.,0,0
237489,The,0,0
237490,rate,0,0
237491,of,0,0
237492,leg,0,0
237493,oedema,0,0
237494,was,0,0
237495,not,0,0
237496,altered,0,0
237497,",",0,0
237498,but,0,0
237499,the,0,0
237500,frequency,0,0
237501,of,0,0
237502,advanced,0,1
237503,hydroceles,0,1
237504,decreased,0,0
237505,by,0,0
237506,47,0,1
237507,%,0,0
237508,with,0,1
237509,combined,0,0
237510,therapy,0,0
237511,and,0,0
237512,56,0,1
237513,%,0,0
237514,with,0,1
237515,diethylcarbamazine,0,0
237516,alone,0,0
237517,.,0,1
237518,"26,641",0,0
237519,Anopheles,0,1
237520,punctulatus,0,1
237521,mosquitoes,0,1
237522,were,0,0
237523,caught,0,1
237524,during,0,0
237525,499,0,1
237526,person-nights,0,0
237527,of,0,0
237528,landing,0,1
237529,catches,0,0
237530,.,0,1
237531,Exposure,0,0
237532,to,0,0
237533,infective,0,0
237534,third-stage,0,1
237535,larvae,0,0
237536,decreased,0,0
237537,in,0,0
237538,all,0,0
237539,monitored,0,0
237540,five,0,1
237541,communities,0,1
237542,.,0,1
237543,Annual,0,0
237544,transmission,0,0
237545,potential,0,0
237546,decreased,0,0
237547,by,0,0
237548,between,0,0
237549,75.7,0,0
237550,%,0,0
237551,and,0,0
237552,98.8,0,0
237553,%,0,0
237554,in,0,0
237555,combined-therapy,0,0
237556,communities,0,1
237557,and,0,1
237558,between,0,0
237559,75.6,0,0
237560,%,0,0
237561,and,0,0
237562,79.4,0,0
237563,%,0,0
237564,in,0,0
237565,communities,0,1
237566,given,0,0
237567,diethylcarbamazine,0,0
237568,alone,0,0
237569,.,0,0
237570,Transmission,0,0
237571,was,0,0
237572,almost,0,0
237573,interrupted,0,0
237574,in,0,0
237575,two,0,0
237576,communities,0,1
237577,treated,0,1
237578,with,0,1
237579,combined,0,0
237580,therapy,0,0
237581,.,0,1
237582,INTERPRETATION,0,0
237583,Annual,0,0
237584,single-dose,0,0
237585,community-wide,0,0
237586,treatment,0,0
237587,with,0,1
237588,diethylcarbamazine,0,0
237589,alone,0,0
237590,or,0,1
237591,with,0,0
237592,ivermectin,0,0
237593,is,0,0
237594,effective,0,0
237595,for,0,0
237596,the,0,0
237597,control,0,0
237598,of,0,0
237599,lymphatic,0,0
237600,filariasis,0,1
237601,in,0,0
237602,highly,0,0
237603,endemic,0,1
237604,areas,0,0
237605,",",0,0
237606,but,0,0
237607,combination,0,0
237608,therapy,0,0
237609,brings,0,0
237610,about,0,0
237611,greater,0,0
237612,decreases,0,0
237613,in,0,0
237614,rates,0,0
237615,and,0,0
237616,intensity,0,0
237617,of,0,0
237618,microfilaraemia,0,1
237619,.,0,1
237620,Effect,0,0
237621,of,0,0
237622,indomethacin,0,0
237623,phonophoresis,0,0
237624,on,0,0
237625,the,0,0
237626,relief,0,0
237627,of,0,0
237628,temporomandibular,1,1
237629,joint,1,1
237630,pain,1,1
237631,.,1,0
237632,The,0,0
237633,pain-relieving,0,0
237634,effect,0,0
237635,of,0,0
237636,indomethacin,0,0
237637,phonophoresis,0,0
237638,on,0,0
237639,temporomandibular,0,1
237640,(,0,0
237641,TMJ,0,0
237642,),0,0
237643,joint,0,0
237644,pain,0,1
237645,was,0,0
237646,evaluated,0,0
237647,in,0,0
237648,a,0,0
237649,double-blind,0,0
237650,",",0,0
237651,placebo-controlled,0,0
237652,clinical,0,0
237653,trial,0,1
237654,.,0,1
237655,Twenty,1,1
237656,subjects,1,1
237657,",",1,1
237658,who,1,1
237659,have,1,1
237660,TMJ,1,1
237661,pain,1,0
237662,",",0,0
237663,were,0,0
237664,included,0,0
237665,for,0,0
237666,this,0,0
237667,study,0,0
237668,and,0,0
237669,randomly,0,1
237670,assigned,0,0
237671,to,0,0
237672,either,0,0
237673,the,0,0
237674,experimental,0,0
237675,group,0,0
237676,(,0,0
237677,n,0,1
237678,=,0,0
237679,10,0,1
237680,),0,0
237681,or,0,0
237682,the,0,0
237683,control,0,0
237684,group,0,0
237685,(,0,0
237686,n,0,1
237687,=,0,0
237688,10,0,1
237689,),0,0
237690,.,0,0
237691,Each,0,0
237692,treatment,0,0
237693,consisted,0,0
237694,of,0,0
237695,the,0,0
237696,application,0,0
237697,of,0,0
237698,ultrasound,0,0
237699,massage,0,0
237700,(,0,0
237701,1.0,0,0
237702,MHz,0,0
237703,",",0,0
237704,0.8,0,0
237705,to,0,0
237706,1.5,0,0
237707,W/cm2,0,0
237708,continuous,0,0
237709,output,0,0
237710,),0,0
237711,for,0,0
237712,15,0,1
237713,minutes,0,0
237714,to,0,0
237715,the,0,0
237716,painful,0,0
237717,temporomandibular,0,1
237718,joint,0,1
237719,.,0,0
237720,As,0,0
237721,a,0,0
237722,conducting,0,0
237723,medium,0,0
237724,",",0,0
237725,1,0,0
237726,%,0,0
237727,indomethacin,0,0
237728,cream,0,0
237729,was,0,0
237730,used,0,0
237731,for,0,0
237732,the,0,0
237733,experimental,0,0
237734,group,0,0
237735,and,0,0
237736,placebo,0,0
237737,cream,0,0
237738,for,0,0
237739,the,0,0
237740,control,0,0
237741,group,0,0
237742,respectively,0,0
237743,.,0,0
237744,Pre-,0,0
237745,and,0,0
237746,post-treatment,0,0
237747,pain,0,1
237748,levels,0,0
237749,and,0,0
237750,pain,0,1
237751,sensitivity,0,0
237752,were,0,0
237753,assessed,0,0
237754,with,0,1
237755,visual,0,0
237756,analogue,0,0
237757,scales,0,0
237758,(,0,1
237759,VAS,0,1
237760,),0,0
237761,and,0,0
237762,pressure,0,0
237763,pain,0,0
237764,threshold,0,0
237765,(,0,0
237766,PPT,0,0
237767,),0,1
237768,.,0,1
237769,Mean,0,1
237770,data,0,0
237771,indicated,0,0
237772,that,0,0
237773,post-treatment,0,0
237774,VAS,0,1
237775,was,0,0
237776,significantly,0,0
237777,decreased,0,0
237778,and,0,0
237779,post-treatment,0,0
237780,PPT,0,0
237781,was,0,0
237782,significantly,0,0
237783,increased,0,0
237784,in,0,0
237785,the,0,0
237786,experimental,0,0
237787,group,0,0
237788,",",0,0
237789,not,0,0
237790,in,0,0
237791,the,0,0
237792,control,0,0
237793,group,0,0
237794,.,0,0
237795,The,0,0
237796,results,0,0
237797,of,0,0
237798,this,0,0
237799,study,0,0
237800,suggest,0,0
237801,that,0,0
237802,indomethacin,0,0
237803,phonophoresis,0,0
237804,provides,0,0
237805,significant,0,0
237806,pain,0,0
237807,relieving,0,0
237808,effect,0,0
237809,over,0,0
237810,the,0,0
237811,TMJ,0,0
237812,pain,0,1
237813,.,0,1
237814,Efficacy,0,0
237815,of,0,0
237816,intravenous,0,0
237817,granisetron,0,0
237818,to,0,0
237819,control,0,0
237820,nausea,0,0
237821,and,0,0
237822,vomiting,0,0
237823,during,0,0
237824,multiple,0,0
237825,cycles,0,0
237826,of,0,0
237827,cisplatin-based,0,0
237828,chemotherapy,0,1
237829,.,0,0
237830,The,0,0
237831,safety,0,0
237832,and,0,0
237833,efficacy,0,0
237834,of,0,0
237835,granisetron,0,0
237836,(,0,0
237837,10,0,0
237838,micrograms/kg,0,0
237839,and,0,0
237840,40,0,1
237841,micrograms/kg,0,0
237842,),0,0
237843,were,0,0
237844,evaluated,0,0
237845,during,0,0
237846,a,0,0
237847,second,0,0
237848,(,0,0
237849,n,0,1
237850,=,0,0
237851,393,0,1
237852,),0,0
237853,and,0,0
237854,third,0,1
237855,(,0,0
237856,n,0,1
237857,=,0,0
237858,200,0,1
237859,),0,0
237860,cycle,0,0
237861,of,0,0
237862,chemotherapy,0,0
237863,in,0,0
237864,this,0,0
237865,multicenter,1,0
237866,",",1,0
237867,double-blind,1,0
237868,",",1,0
237869,randomized,1,0
237870,",",1,0
237871,parallel-group,1,0
237872,study,1,0
237873,.,1,1
237874,Granisetron,0,0
237875,was,0,0
237876,administered,0,0
237877,as,0,0
237878,a,0,0
237879,single,0,0
237880,intravenous,0,0
237881,dose,0,0
237882,before,0,0
237883,the,0,0
237884,start,0,0
237885,of,0,0
237886,cisplatin,1,0
237887,chemotherapy,1,1
237888,(,1,0
237889,>,1,0
237890,or,1,1
237891,=,1,0
237892,60,1,1
237893,mg/m2,1,0
237894,),1,0
237895,.,1,0
237896,Total,0,0
237897,control,0,0
237898,(,0,0
237899,no,0,0
237900,vomiting,0,0
237901,",",0,0
237902,no,0,0
237903,retching,0,0
237904,",",0,0
237905,no,0,0
237906,nausea,0,0
237907,",",0,0
237908,and,0,0
237909,no,0,0
237910,use,0,0
237911,of,0,0
237912,antiemetic,0,0
237913,rescue,0,0
237914,medication,0,0
237915,),0,0
237916,after,0,0
237917,the,0,0
237918,first,0,0
237919,24,0,0
237920,hr,0,0
237921,following,0,0
237922,chemotherapy,0,0
237923,was,0,0
237924,achieved,0,0
237925,in,0,0
237926,40,1,1
237927,%,1,0
237928,and,1,0
237929,49,1,1
237930,%,1,0
237931,of,1,0
237932,patients,1,1
237933,in,1,1
237934,Cycles,1,1
237935,2,1,1
237936,and,1,0
237937,3,1,0
237938,",",1,0
237939,respectively,1,0
237940,",",1,0
237941,for,1,0
237942,the,1,0
237943,10,1,0
237944,micrograms/kg,1,0
237945,group,1,0
237946,",",1,0
237947,and,1,0
237948,in,1,0
237949,42,1,1
237950,%,1,0
237951,and,1,0
237952,38,1,1
237953,%,1,0
237954,of,1,0
237955,patients,1,1
237956,in,1,1
237957,Cycles,1,1
237958,2,1,1
237959,and,1,0
237960,3,1,0
237961,",",1,0
237962,respectively,1,0
237963,",",1,0
237964,for,1,0
237965,the,1,0
237966,40,1,1
237967,micrograms/kg,1,0
237968,group,1,0
237969,.,1,0
237970,Both,0,0
237971,dose,0,0
237972,levels,0,0
237973,of,0,0
237974,granisetron,0,0
237975,were,0,0
237976,well,0,0
237977,tolerated,0,0
237978,.,0,0
237979,The,0,0
237980,results,0,0
237981,demonstrate,0,0
237982,comparable,0,0
237983,efficacy,0,0
237984,between,0,0
237985,the,0,0
237986,10,0,0
237987,micrograms/kg,0,0
237988,and,0,0
237989,40,0,1
237990,micrograms/kg,0,0
237991,doses,0,0
237992,of,0,0
237993,granisetron,0,0
237994,in,0,0
237995,preventing,0,0
237996,nausea,0,0
237997,and,0,0
237998,vomiting,0,0
237999,during,0,0
238000,repeat,0,1
238001,cycles,0,0
238002,of,0,0
238003,high-dose,1,1
238004,cisplatin-based,1,0
238005,chemotherapy,1,1
238006,.,1,0
238007,The,0,0
238008,results,0,0
238009,of,0,0
238010,this,0,0
238011,study,0,0
238012,show,0,0
238013,that,0,0
238014,granisetron,0,0
238015,10,0,0
238016,micrograms/kg,0,0
238017,is,0,0
238018,safe,0,0
238019,and,0,0
238020,well,0,0
238021,tolerated,0,0
238022,",",0,0
238023,and,0,0
238024,remains,0,0
238025,effective,0,0
238026,with,0,0
238027,repeat,0,0
238028,cycle,0,0
238029,use,0,0
238030,.,0,1
238031,Comparative,0,0
238032,dose,0,0
238033,efficacy,0,0
238034,study,0,0
238035,of,0,0
238036,atorvastatin,0,0
238037,versus,0,0
238038,simvastatin,0,0
238039,",",0,0
238040,pravastatin,0,0
238041,",",0,0
238042,lovastatin,0,0
238043,",",0,0
238044,and,0,0
238045,fluvastatin,0,0
238046,in,0,0
238047,patients,1,1
238048,with,1,1
238049,hypercholesterolemia,1,1
238050,(,0,0
238051,the,0,0
238052,CURVES,0,0
238053,study,0,0
238054,),0,0
238055,The,0,0
238056,objective,0,0
238057,of,0,0
238058,this,0,0
238059,multicenter,1,0
238060,",",0,0
238061,randomized,0,0
238062,",",0,0
238063,open-label,0,0
238064,",",0,0
238065,parallel-group,0,0
238066,",",0,0
238067,8-week,0,0
238068,study,0,0
238069,was,0,0
238070,to,0,0
238071,evaluate,0,0
238072,the,0,0
238073,comparative,0,0
238074,dose,0,0
238075,efficacy,0,0
238076,of,0,0
238077,the,0,0
238078,3-hydroxy-3-methylglutaryl,0,0
238079,coenzyme,0,0
238080,A,0,1
238081,(,0,0
238082,HMG-CoA,0,0
238083,),0,0
238084,reductase,0,0
238085,inhibitor,0,0
238086,atorvastatin,0,0
238087,10,0,0
238088,",",0,0
238089,20,0,0
238090,",",0,0
238091,40,0,0
238092,",",0,0
238093,and,0,0
238094,80,0,1
238095,mg,0,0
238096,compared,0,0
238097,with,0,1
238098,simvastatin,0,0
238099,10,0,0
238100,",",0,0
238101,20,0,0
238102,",",0,0
238103,and,0,0
238104,40,0,0
238105,mg,0,0
238106,",",0,0
238107,pravastatin,0,0
238108,10,0,0
238109,",",0,0
238110,20,0,0
238111,",",0,0
238112,and,0,0
238113,40,0,0
238114,mg,0,0
238115,",",0,0
238116,lovastatin,0,0
238117,20,0,0
238118,",",0,0
238119,40,0,0
238120,",",0,0
238121,and,0,0
238122,80,0,1
238123,mg,0,0
238124,",",0,0
238125,and,0,0
238126,fluvastatin,0,0
238127,20,0,1
238128,and,0,0
238129,40,0,1
238130,mg.,0,0
238131,Investigators,0,1
238132,enrolled,0,1
238133,534,1,1
238134,hypercholesterolemic,1,1
238135,patients,1,1
238136,(,1,1
238137,low-density,1,0
238138,lipoprotein,1,0
238139,[,1,0
238140,LDL,1,1
238141,],1,1
238142,cholesterol,1,0
238143,>,1,1
238144,or,1,1
238145,=,1,0
238146,160,1,1
238147,mg/dl,1,0
238148,[,1,0
238149,4.2,1,0
238150,mmol/L,1,0
238151,],1,0
238152,and,1,0
238153,triglycerides,1,0
238154,<,1,0
238155,or,1,1
238156,=,1,0
238157,400,1,0
238158,mg/dl,1,0
238159,[,1,0
238160,4.5,1,0
238161,mmol/L,1,0
238162,],1,1
238163,),1,0
238164,.,1,0
238165,The,0,0
238166,efficacy,0,0
238167,end,0,0
238168,points,0,0
238169,were,0,1
238170,mean,0,1
238171,percent,0,0
238172,change,0,0
238173,in,0,0
238174,plasma,0,0
238175,LDL,0,0
238176,cholesterol,0,0
238177,(,0,0
238178,primary,0,1
238179,),0,0
238180,",",0,0
238181,total,0,1
238182,cholesterol,0,0
238183,",",0,0
238184,triglycerides,0,0
238185,",",0,0
238186,and,0,0
238187,high-density,0,0
238188,lipoprotein,0,0
238189,cholesterol,0,0
238190,concentrations,0,0
238191,from,0,1
238192,baseline,0,0
238193,to,0,0
238194,the,0,0
238195,end,0,0
238196,of,0,0
238197,treatment,0,0
238198,(,0,0
238199,week,0,0
238200,8,0,0
238201,),0,0
238202,.,0,1
238203,Atorvastatin,0,0
238204,10,0,0
238205,",",0,0
238206,20,0,0
238207,",",0,0
238208,and,0,0
238209,40,0,1
238210,mg,0,0
238211,produced,0,0
238212,greater,0,0
238213,(,0,0
238214,p,0,0
238215,<,0,0
238216,or,0,1
238217,=,0,0
238218,0.01,0,0
238219,),0,0
238220,reductions,0,0
238221,in,0,0
238222,LDL,0,1
238223,cholesterol,0,0
238224,",",0,0
238225,-38,0,0
238226,%,0,0
238227,",",0,0
238228,-46,0,0
238229,%,0,0
238230,",",0,0
238231,and,0,0
238232,-51,0,0
238233,%,0,0
238234,",",0,0
238235,respectively,0,0
238236,",",0,0
238237,than,0,0
238238,the,0,0
238239,milligram,0,0
238240,equivalent,0,0
238241,doses,0,0
238242,of,0,0
238243,simvastatin,0,0
238244,",",0,0
238245,pravastatin,0,0
238246,",",0,0
238247,lovastatin,0,0
238248,",",0,0
238249,and,0,0
238250,fluvastatin,0,0
238251,.,0,0
238252,Atorvastatin,0,0
238253,10,0,0
238254,mg,0,0
238255,produced,0,0
238256,LDL,0,0
238257,cholesterol,0,0
238258,reductions,0,0
238259,comparable,0,0
238260,to,0,0
238261,or,0,0
238262,greater,0,0
238263,than,0,0
238264,(,0,0
238265,p,0,0
238266,<,0,0
238267,or,0,1
238268,=,0,0
238269,0.02,0,0
238270,),0,0
238271,simvastatin,0,0
238272,10,0,0
238273,",",0,0
238274,20,0,0
238275,",",0,0
238276,and,0,0
238277,40,0,0
238278,mg,0,0
238279,",",0,0
238280,pravastatin,0,0
238281,10,0,0
238282,",",0,0
238283,20,0,0
238284,",",0,0
238285,and,0,0
238286,40,0,0
238287,mg,0,0
238288,",",0,0
238289,lovastatin,0,0
238290,20,0,0
238291,and,0,0
238292,40,0,1
238293,mg,0,0
238294,",",0,0
238295,and,0,0
238296,fluvastatin,0,0
238297,20,0,1
238298,and,0,0
238299,40,0,1
238300,mg.,0,0
238301,Atorvastatin,0,0
238302,10,0,0
238303,",",0,0
238304,20,0,0
238305,",",0,0
238306,and,0,0
238307,40,0,1
238308,mg,0,0
238309,produced,0,0
238310,greater,0,0
238311,(,0,0
238312,p,0,0
238313,<,0,0
238314,or,0,1
238315,=,0,0
238316,0.01,0,0
238317,),0,0
238318,reductions,0,0
238319,in,0,0
238320,total,0,1
238321,cholesterol,0,0
238322,than,0,0
238323,the,0,0
238324,milligram,0,0
238325,equivalent,0,0
238326,doses,0,0
238327,of,0,0
238328,simvastatin,0,0
238329,",",0,0
238330,pravastatin,0,0
238331,",",0,0
238332,lovastatin,0,0
238333,",",0,0
238334,and,0,0
238335,fluvastatin,0,0
238336,.,0,0
238337,All,0,0
238338,reductase,0,0
238339,inhibitors,0,0
238340,studied,0,1
238341,had,0,1
238342,similar,0,0
238343,tolerability,0,0
238344,.,0,0
238345,There,0,0
238346,were,0,0
238347,no,0,0
238348,incidences,0,0
238349,of,0,0
238350,persistent,0,1
238351,elevations,0,0
238352,in,0,0
238353,serum,0,0
238354,transaminases,0,0
238355,or,0,1
238356,myositis,0,1
238357,.,0,1
238358,Amoxicillin/metronidazole/omeprazole/clarithromycin,0,0
238359,:,0,1
238360,a,0,0
238361,new,0,0
238362,",",0,0
238363,short,0,0
238364,quadruple,0,0
238365,therapy,1,0
238366,for,1,0
238367,Helicobacter,1,1
238368,pylori,1,1
238369,eradication,1,0
238370,.,1,1
238371,BACKGROUND,0,0
238372,Triple,0,0
238373,therapy,0,0
238374,regimens,0,0
238375,including,0,0
238376,two,0,0
238377,antibiotics,0,0
238378,plus,0,0
238379,acid,0,0
238380,suppression,0,0
238381,have,0,0
238382,become,0,0
238383,the,0,0
238384,new,0,0
238385,standard,0,0
238386,therapy,0,0
238387,in,0,0
238388,Helicobacter,0,1
238389,pylori,0,0
238390,eradication,0,0
238391,because,0,0
238392,of,0,0
238393,success,0,0
238394,rates,0,0
238395,of,0,0
238396,about,0,0
238397,90,0,0
238398,%,0,0
238399,.,0,0
238400,However,0,0
238401,",",0,0
238402,these,0,0
238403,regimens,0,0
238404,are,0,0
238405,still,0,0
238406,costly,0,0
238407,",",0,0
238408,duration,0,0
238409,is,0,0
238410,about,0,0
238411,one,0,0
238412,week,0,0
238413,or,0,0
238414,less,0,0
238415,",",0,0
238416,and,0,0
238417,side-effects,0,0
238418,are,0,0
238419,not,0,0
238420,negligible,0,0
238421,.,0,0
238422,We,0,0
238423,therefore,0,0
238424,evaluated,0,0
238425,a,0,0
238426,new,0,0
238427,quadruple,0,0
238428,therapy,0,0
238429,",",0,0
238430,because,0,0
238431,theoretically,0,0
238432,a,0,0
238433,shorter,0,0
238434,duration,0,0
238435,of,0,0
238436,treatment,0,0
238437,may,0,0
238438,result,0,0
238439,in,0,0
238440,reduced,0,0
238441,costs,0,0
238442,",",0,0
238443,fewer,0,0
238444,side-effects,0,0
238445,",",0,0
238446,and,0,0
238447,possibly,0,0
238448,in,0,0
238449,a,0,0
238450,lower,0,0
238451,potential,0,0
238452,for,0,0
238453,antibiotic,0,0
238454,resistances,0,0
238455,.,0,1
238456,METHODS,0,0
238457,Controlled,0,0
238458,",",0,0
238459,prospective,0,0
238460,pilot,0,0
238461,study,0,0
238462,including,0,0
238463,H.,1,1
238464,pylori-positive,1,1
238465,patients,1,1
238466,with,1,1
238467,gastric,1,1
238468,or,1,1
238469,duodenal,1,1
238470,ulcers,1,1
238471,or,1,1
238472,erosive,1,1
238473,gastritis,1,1
238474,",",1,0
238475,treated,1,0
238476,after,1,0
238477,failure,1,1
238478,of,1,0
238479,dual,1,1
238480,therapy,1,0
238481,(,1,0
238482,proton-pump-inhibitors,1,0
238483,or,1,1
238484,ranitidine,1,0
238485,plus,1,0
238486,amoxicillin,1,0
238487,),1,0
238488,or,1,0
238489,for,1,0
238490,the,1,0
238491,first,1,0
238492,time,1,0
238493,.,1,1
238494,They,0,0
238495,were,0,0
238496,assigned,0,0
238497,to,0,0
238498,a,0,0
238499,one,0,0
238500,week,0,0
238501,triple,0,0
238502,standard,0,0
238503,therapy,0,0
238504,",",0,0
238505,consisting,0,0
238506,of,0,0
238507,metronidazole,0,0
238508,400,0,0
238509,mg,0,0
238510,bid,0,0
238511,+,0,0
238512,omeprazole,0,0
238513,20,0,0
238514,mg,0,0
238515,bid,0,0
238516,+,0,0
238517,clarithromycin,0,0
238518,250,0,0
238519,mg,0,0
238520,bid,0,0
238521,",",0,0
238522,or,0,0
238523,a,0,0
238524,newly,0,1
238525,created,0,0
238526,quadruple-regimen,0,0
238527,",",0,0
238528,which,0,0
238529,adds,0,0
238530,amoxicillin,0,0
238531,(,0,0
238532,1,0,0
238533,g,0,1
238534,bid,0,0
238535,),0,0
238536,to,0,0
238537,the,0,0
238538,above,0,0
238539,triple,0,0
238540,regimen,0,0
238541,.,0,0
238542,Each,0,0
238543,of,0,0
238544,the,0,0
238545,four,0,1
238546,drugs,0,0
238547,was,0,0
238548,given,0,0
238549,for,0,0
238550,5,0,1
238551,days,0,0
238552,.,0,1
238553,H.,0,0
238554,pylori,0,0
238555,status,0,0
238556,was,0,0
238557,checked,0,0
238558,by,0,0
238559,13C,0,1
238560,urea,0,0
238561,breath,0,0
238562,test,0,0
238563,before,0,0
238564,and,0,0
238565,after,0,0
238566,four,0,1
238567,weeks,0,0
238568,of,0,1
238569,therapy,0,0
238570,.,0,0
238571,RESULTS,0,0
238572,A,0,0
238573,total,1,1
238574,of,1,0
238575,71,1,1
238576,patients,1,1
238577,were,1,1
238578,treated,1,1
238579,by,1,0
238580,quadruple,1,0
238581,therapy,1,0
238582,",",1,0
238583,and,1,0
238584,42,1,1
238585,patients,1,1
238586,were,1,1
238587,treated,1,1
238588,by,1,0
238589,triple,1,0
238590,therapy,1,0
238591,.,1,0
238592,The,0,0
238593,eradication,0,0
238594,rate,0,0
238595,of,0,0
238596,H.,0,1
238597,pylori,0,1
238598,for,0,0
238599,patients,0,1
238600,under,0,0
238601,quadruple,0,0
238602,treatment,0,0
238603,",",0,0
238604,without,0,0
238605,vs.,0,0
238606,with,0,1
238607,previous,0,0
238608,dual,0,1
238609,therapy,0,0
238610,",",0,0
238611,were,0,0
238612,96,0,1
238613,%,0,0
238614,vs.,0,0
238615,92,0,1
238616,%,0,0
238617,(,0,0
238618,42/44,0,0
238619,vs.,0,0
238620,22/24,0,0
238621,),0,0
238622,by,0,0
238623,per,0,0
238624,protocol,0,0
238625,and,0,0
238626,91,0,0
238627,%,0,0
238628,vs.,0,0
238629,88,0,0
238630,%,0,0
238631,(,0,0
238632,42/46,0,0
238633,vs.,0,0
238634,22/25,0,0
238635,),0,0
238636,by,0,0
238637,intention,0,0
238638,to,0,0
238639,treat,0,0
238640,analysis,0,0
238641,(,0,0
238642,comparisons,0,0
238643,not,0,0
238644,significant,0,0
238645,),0,0
238646,.,0,0
238647,No,0,0
238648,major,0,0
238649,side-effects,0,0
238650,were,0,1
238651,reported,0,0
238652,.,0,1
238653,CONCLUSIONS,0,0
238654,Five-day,0,0
238655,quadruple,0,0
238656,therapy,0,0
238657,(,0,0
238658,with,0,1
238659,omeprazole,0,0
238660,",",0,0
238661,metronidazole,0,0
238662,",",0,0
238663,clarithromycin,0,0
238664,and,0,0
238665,amoxicillin,0,0
238666,),0,0
238667,represents,0,0
238668,an,0,0
238669,effective,0,0
238670,and,0,0
238671,safe,0,0
238672,new,0,0
238673,regimen,0,0
238674,for,0,1
238675,H.,0,1
238676,pylori,0,1
238677,eradication,0,0
238678,.,0,1
238679,Simulating,0,0
238680,a,0,0
238681,memory,0,0
238682,impairment,0,0
238683,:,0,0
238684,can,0,0
238685,amnesics,1,1
238686,implicitly,0,0
238687,outperform,0,0
238688,simulators,0,0
238689,?,0,1
238690,OBJECTIVES,0,0
238691,The,0,0
238692,purpose,0,0
238693,of,0,0
238694,this,0,0
238695,study,0,0
238696,was,0,0
238697,to,0,0
238698,examine,0,0
238699,the,0,0
238700,effectiveness,0,0
238701,of,0,0
238702,a,0,0
238703,variety,0,0
238704,of,0,0
238705,tests,0,0
238706,in,0,0
238707,differentiating,0,0
238708,simulating,0,0
238709,test,0,0
238710,performances,0,0
238711,from,0,1
238712,genuine,0,1
238713,memory-impaired,1,1
238714,and,0,0
238715,normal,0,1
238716,(,0,0
238717,control,0,1
238718,),0,0
238719,test,0,0
238720,performances,0,0
238721,.,0,0
238722,DESIGN,0,0
238723,A,0,0
238724,simulation,0,0
238725,design,0,0
238726,was,0,0
238727,implemented,0,0
238728,",",0,0
238729,based,0,0
238730,on,0,0
238731,an,0,0
238732,analogue,0,0
238733,design,0,0
238734,in,0,0
238735,which,0,0
238736,normal,0,1
238737,participants,0,1
238738,were,0,1
238739,given,0,0
238740,experimental,0,0
238741,instructions,0,0
238742,to,0,0
238743,feign,0,1
238744,a,0,0
238745,mental,0,0
238746,impairment,0,0
238747,and,0,0
238748,are,0,0
238749,compared,0,0
238750,to,0,0
238751,(,0,0
238752,a,0,0
238753,),0,0
238754,other,0,0
238755,normal,0,1
238756,participants,0,1
238757,with,0,1
238758,instructions,0,0
238759,to,0,0
238760,perform,0,0
238761,honestly,0,0
238762,",",0,0
238763,and,0,0
238764,(,0,0
238765,b,0,0
238766,),0,0
238767,a,0,0
238768,comparison,0,0
238769,group,0,0
238770,",",0,0
238771,for,0,0
238772,example,0,0
238773,",",0,0
238774,acquired,1,0
238775,brain-injured,1,1
238776,persons,1,1
238777,",",0,0
238778,with,0,1
238779,similar,0,0
238780,instructions,0,0
238781,.,0,1
238782,METHOD,0,0
238783,Forty,1,1
238784,individuals,1,1
238785,comprised,1,1
238786,the,1,0
238787,simulating,1,0
238788,and,1,0
238789,control,1,0
238790,group,1,0
238791,and,0,0
238792,all,0,0
238793,participants,0,1
238794,were,0,0
238795,randomly,0,1
238796,assigned,0,0
238797,to,0,0
238798,the,0,0
238799,simulating,0,0
238800,and,0,0
238801,control,0,1
238802,groups,0,0
238803,.,0,1
238804,Twenty,1,1
238805,memory-impaired,1,1
238806,patients,1,1
238807,",",1,0
238808,all,1,1
238809,of,1,0
238810,whom,1,1
238811,had,1,1
238812,been,1,1
238813,diagnosed,1,1
238814,as,1,0
238815,suffering,1,1
238816,from,1,0
238817,a,1,0
238818,memory,1,0
238819,impairment,1,0
238820,following,1,0
238821,acquired,1,0
238822,brain,1,0
238823,damage,1,0
238824,",",1,0
238825,participated,1,1
238826,as,1,0
238827,the,1,0
238828,memory-impaired,1,0
238829,control,1,0
238830,group,1,0
238831,.,1,0
238832,The,0,0
238833,simulation,0,0
238834,group,0,0
238835,was,0,0
238836,directed,0,0
238837,to,0,0
238838,imitate,0,0
238839,a,0,0
238840,person,0,0
238841,with,0,0
238842,a,0,0
238843,memory,0,0
238844,impairment,0,0
238845,.,0,0
238846,The,0,0
238847,primary,0,0
238848,outcome,0,0
238849,measure,0,0
238850,involved,0,0
238851,identifying,0,0
238852,those,0,0
238853,tests,0,0
238854,",",0,0
238855,if,0,0
238856,any,0,0
238857,",",0,0
238858,where,0,0
238859,simulators,0,0
238860,were,0,0
238861,significantly,0,0
238862,different,0,0
238863,from,0,0
238864,normal,0,1
238865,and,0,1
238866,memory-impaired,0,1
238867,participants,0,1
238868,.,0,1
238869,RESULTS,0,0
238870,On,0,0
238871,5,0,0
238872,of,0,0
238873,the,0,0
238874,15,0,1
238875,tasks,0,0
238876,administered,0,0
238877,",",0,0
238878,simulators,0,0
238879,performed,0,0
238880,significantly,0,0
238881,differently,0,0
238882,from,0,0
238883,normal,0,1
238884,and,0,1
238885,memory-impaired,0,1
238886,participants,0,1
238887,.,0,1
238888,Of,0,0
238889,these,0,0
238890,5,0,0
238891,tasks,0,0
238892,",",0,0
238893,the,0,0
238894,coin-in-the-hand,0,0
238895,",",0,0
238896,when,0,0
238897,administered,0,0
238898,in,0,0
238899,conjunction,0,0
238900,with,0,1
238901,the,0,0
238902,autobiographical,0,0
238903,interview,0,0
238904,",",0,0
238905,identified,0,0
238906,95,0,0
238907,per,0,0
238908,cent,0,0
238909,of,0,0
238910,the,0,0
238911,simulators,0,0
238912,without,0,1
238913,misclassifying,0,0
238914,any,0,0
238915,of,0,0
238916,the,0,0
238917,memory-impaired,0,0
238918,or,0,1
238919,normal,0,1
238920,participants,0,1
238921,.,0,1
238922,CONCLUSION,0,0
238923,It,0,0
238924,is,0,0
238925,suggested,0,0
238926,that,0,0
238927,these,0,0
238928,two,0,0
238929,tests,0,0
238930,",",0,0
238931,when,0,0
238932,administered,0,0
238933,jointly,0,0
238934,",",0,0
238935,might,0,0
238936,be,0,0
238937,of,0,0
238938,use,0,0
238939,in,0,0
238940,clinical,0,0
238941,settings,0,0
238942,to,0,0
238943,assist,0,0
238944,in,0,0
238945,the,0,0
238946,detection,0,0
238947,of,0,0
238948,malingerers,0,1
238949,.,0,1
238950,Comparison,0,0
238951,of,0,0
238952,single-,0,0
238953,and,0,1
238954,dual-coil,0,1
238955,active,0,1
238956,pectoral,0,1
238957,defibrillation,0,0
238958,lead,0,0
238959,systems,0,0
238960,.,0,1
238961,OBJECTIVES,0,0
238962,The,0,0
238963,purpose,0,0
238964,of,0,0
238965,this,0,0
238966,study,0,0
238967,was,0,0
238968,to,0,0
238969,compare,0,0
238970,defibrillation,0,0
238971,thresholds,0,0
238972,with,0,1
238973,lead,0,0
238974,systems,0,0
238975,consisting,0,1
238976,of,0,0
238977,an,0,0
238978,active,0,1
238979,left,0,1
238980,pectoral,0,1
238981,electrode,0,0
238982,and,0,0
238983,either,0,0
238984,single,0,0
238985,or,0,1
238986,dual,0,1
238987,transvenous,0,1
238988,coils,0,0
238989,.,0,1
238990,BACKGROUND,0,0
238991,Lead,0,0
238992,systems,0,0
238993,that,0,0
238994,include,0,0
238995,an,0,0
238996,active,0,0
238997,pectoral,0,0
238998,pulse,0,0
238999,generator,0,0
239000,reduce,0,0
239001,defibrillation,0,0
239002,thresholds,0,0
239003,and,0,0
239004,permit,0,0
239005,transvenous,0,0
239006,defibrillation,0,0
239007,in,0,0
239008,nearly,0,0
239009,all,0,0
239010,patients,0,1
239011,.,0,0
239012,A,0,0
239013,further,0,0
239014,improvement,0,0
239015,in,0,0
239016,defibrillation,0,0
239017,efficacy,0,0
239018,is,0,0
239019,desirable,0,0
239020,to,0,0
239021,allow,0,0
239022,for,0,0
239023,smaller,0,0
239024,pulse,0,0
239025,generators,0,0
239026,with,0,1
239027,a,0,0
239028,reduced,0,0
239029,maximal,0,0
239030,output,0,0
239031,.,0,0
239032,METHODS,0,0
239033,This,0,0
239034,prospective,0,0
239035,study,0,0
239036,was,0,0
239037,performed,0,0
239038,in,0,0
239039,50,1,1
239040,consecutive,1,1
239041,patients,1,1
239042,.,1,1
239043,Each,1,0
239044,patient,1,0
239045,was,0,0
239046,evaluated,0,0
239047,with,0,1
239048,two,0,0
239049,lead,0,0
239050,configurations,0,0
239051,with,0,1
239052,the,0,0
239053,order,0,0
239054,of,0,0
239055,testing,0,0
239056,randomized,0,1
239057,.,0,1
239058,Shocks,0,0
239059,were,0,0
239060,delivered,0,0
239061,between,0,0
239062,the,0,0
239063,right,0,0
239064,ventricular,0,0
239065,coil,0,0
239066,and,0,0
239067,either,0,0
239068,an,0,0
239069,active,0,0
239070,can,0,0
239071,alone,0,0
239072,(,0,0
239073,single,0,0
239074,coil,0,1
239075,),0,0
239076,or,0,0
239077,an,0,0
239078,active,0,0
239079,can,0,0
239080,with,0,1
239081,the,0,0
239082,proximal,0,1
239083,atrial,0,1
239084,coil,0,1
239085,(,0,0
239086,dual,0,1
239087,coil,0,1
239088,),0,0
239089,.,0,0
239090,The,0,0
239091,right,0,0
239092,ventricular,0,0
239093,coil,0,0
239094,was,0,0
239095,the,0,0
239096,cathode,0,0
239097,for,0,0
239098,the,0,0
239099,first,0,0
239100,phase,0,0
239101,of,0,0
239102,the,0,0
239103,biphasic,0,0
239104,defibrillation,0,0
239105,waveform,0,0
239106,.,0,1
239107,RESULTS,0,0
239108,Delivered,0,0
239109,energy,0,0
239110,at,0,0
239111,the,0,0
239112,defibrillation,0,0
239113,threshold,0,0
239114,was,0,0
239115,10.1+/-5.0,0,0
239116,J,0,0
239117,for,0,0
239118,the,0,0
239119,single-coil,0,0
239120,configuration,0,1
239121,and,0,0
239122,8.7+/-4.0,0,0
239123,J,0,0
239124,for,0,0
239125,the,0,0
239126,dual-coil,0,0
239127,configuration,0,1
239128,(,0,0
239129,p,0,0
239130,<,0,0
239131,0.02,0,0
239132,),0,0
239133,.,0,0
239134,Moreover,0,0
239135,",",0,0
239136,98,1,0
239137,%,1,0
239138,of,1,0
239139,patients,1,1
239140,had,1,1
239141,low,1,1
239142,(,1,1
239143,<,1,0
239144,15,1,1
239145,J,1,0
239146,),1,0
239147,thresholds,1,0
239148,with,0,0
239149,the,0,0
239150,dual-coil,1,0
239151,lead,1,0
239152,system,1,0
239153,",",0,0
239154,compared,0,0
239155,with,0,1
239156,88,1,0
239157,%,1,0
239158,of,1,0
239159,patients,1,1
239160,with,1,1
239161,the,1,0
239162,single-coil,1,0
239163,configuration,1,1
239164,(,0,0
239165,p=0.05,0,0
239166,),0,0
239167,.,0,0
239168,Leading,0,0
239169,edge,0,0
239170,voltage,0,0
239171,(,0,0
239172,p,0,0
239173,<,0,0
239174,0.001,0,0
239175,),0,0
239176,and,0,0
239177,shock,0,1
239178,impedance,0,0
239179,(,0,0
239180,p,0,0
239181,<,0,0
239182,0.001,0,0
239183,),0,0
239184,were,0,0
239185,also,0,0
239186,decreased,0,0
239187,with,0,0
239188,the,0,0
239189,dual-coil,0,0
239190,configuration,0,0
239191,",",0,0
239192,although,0,0
239193,peak,0,0
239194,current,0,0
239195,was,0,0
239196,increased,0,0
239197,(,0,0
239198,p,0,0
239199,<,0,0
239200,0.001,0,0
239201,),0,0
239202,.,0,0
239203,CONCLUSIONS,0,0
239204,A,0,0
239205,dual-coil,0,0
239206,",",0,0
239207,active,0,1
239208,pectoral,0,0
239209,lead,0,0
239210,system,0,0
239211,reduces,0,0
239212,defibrillation,0,0
239213,energy,0,0
239214,requirements,0,0
239215,compared,0,0
239216,with,0,1
239217,a,0,0
239218,single-coil,0,0
239219,",",0,0
239220,unipolar,0,1
239221,configuration,0,1
239222,.,0,1
239223,Randomised,0,0
239224,trial,0,0
239225,of,0,0
239226,laparoscopic,0,1
239227,versus,0,0
239228,open,0,1
239229,cholecystectomy,0,1
239230,for,0,0
239231,acute,1,1
239232,and,1,0
239233,gangrenous,1,1
239234,cholecystitis,1,1
239235,.,1,1
239236,BACKGROUND,0,0
239237,Laparoscopic,0,0
239238,cholecystectomy,0,1
239239,(,0,0
239240,LC,0,0
239241,),0,0
239242,has,0,0
239243,become,0,0
239244,the,0,0
239245,treatment,0,0
239246,of,0,0
239247,choice,0,0
239248,for,0,0
239249,elective,0,1
239250,cholecystectomy,0,1
239251,",",0,0
239252,but,0,0
239253,controversy,0,0
239254,persists,0,0
239255,over,0,0
239256,use,0,0
239257,of,0,0
239258,this,0,0
239259,approach,0,0
239260,in,0,0
239261,the,0,0
239262,treatment,0,0
239263,of,0,0
239264,acute,1,1
239265,cholecystitis,1,1
239266,.,1,1
239267,We,0,0
239268,undertook,0,0
239269,a,0,0
239270,randomised,0,0
239271,comparison,0,0
239272,of,0,0
239273,the,0,0
239274,safety,0,0
239275,and,0,0
239276,outcome,0,0
239277,of,0,0
239278,LC,0,0
239279,and,0,0
239280,open,0,1
239281,cholecystectomy,0,1
239282,(,0,0
239283,OC,0,1
239284,),0,0
239285,in,0,0
239286,patients,1,1
239287,with,1,1
239288,acute,1,1
239289,cholecystitis,1,1
239290,.,1,1
239291,METHODS,0,0
239292,63,1,1
239293,of,1,0
239294,68,1,1
239295,consecutive,1,1
239296,patients,1,1
239297,who,1,1
239298,met,1,1
239299,criteria,1,1
239300,for,1,0
239301,acute,1,1
239302,cholecystitis,1,1
239303,were,1,0
239304,randomly,1,1
239305,assigned,1,0
239306,OC,1,0
239307,(,1,1
239308,31,1,1
239309,patients,1,1
239310,),1,1
239311,or,1,1
239312,LC,1,0
239313,(,1,1
239314,32,1,1
239315,patients,1,1
239316,),1,1
239317,.,1,1
239318,The,0,0
239319,primary,0,0
239320,endpoints,0,0
239321,were,0,1
239322,hospital,0,1
239323,mortality,0,0
239324,and,0,0
239325,morbidity,0,0
239326,",",0,0
239327,length,0,0
239328,of,0,0
239329,hospital,0,1
239330,stay,0,0
239331,",",0,0
239332,and,0,0
239333,length,0,0
239334,of,0,0
239335,sick,0,1
239336,leave,0,0
239337,from,0,0
239338,work,0,0
239339,.,0,1
239340,Analysis,0,0
239341,was,0,0
239342,by,0,0
239343,intention,0,0
239344,to,0,0
239345,treat,0,0
239346,.,0,0
239347,Suspected,0,0
239348,bile-duct,0,1
239349,stones,0,1
239350,were,0,0
239351,investigated,0,0
239352,by,0,0
239353,preoperative,0,0
239354,endoscopic,0,0
239355,retrograde,0,1
239356,cholangiography,0,0
239357,(,0,0
239358,LC,0,0
239359,group,0,1
239360,),0,0
239361,or,0,1
239362,intraoperative,0,0
239363,cholangiography,0,0
239364,(,0,0
239365,OC,0,1
239366,group,0,1
239367,),0,0
239368,.,0,0
239369,FINDINGS,0,0
239370,The,0,0
239371,two,0,0
239372,randomised,0,0
239373,groups,0,0
239374,were,0,1
239375,similar,0,0
239376,in,0,0
239377,demographic,0,0
239378,",",0,0
239379,physical,0,0
239380,",",0,0
239381,and,0,0
239382,clinical,0,0
239383,characteristics,0,0
239384,.,0,1
239385,48,0,0
239386,%,0,0
239387,of,0,0
239388,the,0,0
239389,patients,0,1
239390,in,0,0
239391,the,0,0
239392,OC,0,0
239393,group,0,0
239394,and,0,0
239395,59,0,1
239396,%,0,0
239397,in,0,0
239398,the,0,0
239399,LC,0,0
239400,group,0,0
239401,were,0,0
239402,older,0,1
239403,than,0,0
239404,60,0,1
239405,years,0,1
239406,.,0,1
239407,13,0,1
239408,patients,0,1
239409,in,0,0
239410,each,0,0
239411,group,0,0
239412,had,0,0
239413,gangrene,0,1
239414,or,0,0
239415,empyema,0,0
239416,",",0,0
239417,and,0,0
239418,one,0,0
239419,in,0,0
239420,each,0,0
239421,group,0,0
239422,had,0,0
239423,perforation,0,1
239424,of,0,0
239425,the,0,0
239426,gallbladder,0,1
239427,causing,0,0
239428,diffuse,0,1
239429,peritonitis,0,1
239430,.,0,0
239431,Five,0,0
239432,(,0,0
239433,16,0,1
239434,%,0,0
239435,),0,0
239436,patients,0,1
239437,in,0,0
239438,the,0,0
239439,LC,0,0
239440,group,0,0
239441,required,0,0
239442,conversion,0,0
239443,to,0,0
239444,OC,0,0
239445,",",0,0
239446,in,0,0
239447,most,0,0
239448,because,0,0
239449,severe,0,1
239450,inflammation,0,0
239451,distorted,0,0
239452,the,0,0
239453,anatomy,0,0
239454,of,0,0
239455,Calot,0,0
239456,'s,0,1
239457,triangle,0,0
239458,.,0,0
239459,There,0,0
239460,were,0,0
239461,no,0,0
239462,deaths,0,0
239463,or,0,1
239464,bile-duct,0,1
239465,lesions,0,0
239466,in,0,0
239467,either,0,0
239468,group,0,0
239469,",",0,0
239470,but,0,0
239471,the,0,0
239472,postoperative,0,0
239473,complication,0,0
239474,rate,0,0
239475,was,0,0
239476,significantly,0,0
239477,(,0,0
239478,p=0.0048,0,0
239479,),0,0
239480,higher,0,0
239481,in,0,0
239482,the,0,0
239483,OC,0,0
239484,than,0,0
239485,in,0,0
239486,the,0,0
239487,LC,0,0
239488,group,0,1
239489,:,0,1
239490,seven,0,1
239491,(,0,0
239492,23,0,1
239493,%,0,0
239494,),0,1
239495,patients,0,1
239496,had,0,1
239497,major,0,1
239498,and,0,0
239499,six,0,1
239500,(,0,0
239501,19,0,1
239502,%,0,0
239503,),0,0
239504,minor,0,0
239505,complications,0,0
239506,after,0,0
239507,OC,0,1
239508,",",0,0
239509,whereas,0,0
239510,only,0,0
239511,one,0,1
239512,(,0,0
239513,3,0,0
239514,%,0,0
239515,),0,0
239516,minor,0,0
239517,complication,0,0
239518,occurred,0,0
239519,after,0,0
239520,LC,0,0
239521,.,0,1
239522,The,0,0
239523,postoperative,0,0
239524,hospital,0,1
239525,stay,0,0
239526,was,0,0
239527,significantly,0,0
239528,shorter,0,0
239529,in,0,0
239530,the,0,0
239531,LC,0,0
239532,than,0,0
239533,the,0,0
239534,OC,0,0
239535,group,0,0
239536,(,0,0
239537,median,0,1
239538,4,0,0
239539,[,0,0
239540,IQR,0,1
239541,2-5,0,0
239542,],0,1
239543,vs,0,0
239544,6,0,0
239545,[,0,0
239546,5-8,0,1
239547,],0,1
239548,days,0,0
239549,;,0,1
239550,p=0.0063,0,0
239551,),0,0
239552,.,0,0
239553,Mean,0,0
239554,length,0,0
239555,of,0,0
239556,sick,0,1
239557,leave,0,0
239558,was,0,0
239559,shorter,0,0
239560,in,0,0
239561,the,0,0
239562,LC,0,0
239563,group,0,0
239564,(,0,0
239565,13.9,0,0
239566,vs,0,0
239567,30.1,0,1
239568,days,0,0
239569,;,0,1
239570,95,0,0
239571,%,0,0
239572,CI,0,0
239573,for,0,0
239574,difference,0,0
239575,10.9-21.7,0,0
239576,),0,0
239577,.,0,0
239578,INTERPRETATION,0,0
239579,Even,0,1
239580,though,0,0
239581,LC,0,0
239582,for,0,0
239583,acute,0,1
239584,and,0,0
239585,gangrenous,0,1
239586,cholecystitis,0,1
239587,is,0,0
239588,technically,0,0
239589,demanding,0,0
239590,",",0,0
239591,in,0,0
239592,experienced,0,0
239593,hands,0,0
239594,it,0,0
239595,is,0,0
239596,safe,0,0
239597,and,0,0
239598,effective,0,0
239599,.,0,0
239600,It,0,0
239601,does,0,0
239602,not,0,0
239603,increase,0,0
239604,the,0,0
239605,mortality,0,0
239606,rate,0,0
239607,",",0,0
239608,and,0,0
239609,the,0,0
239610,morbidity,0,0
239611,rate,0,0
239612,seems,0,0
239613,to,0,0
239614,be,0,0
239615,even,0,0
239616,lower,0,0
239617,than,0,0
239618,that,0,0
239619,in,0,0
239620,OC,0,0
239621,.,0,0
239622,However,0,0
239623,",",0,0
239624,a,0,0
239625,moderately,0,0
239626,high,0,0
239627,conversion,0,0
239628,rate,0,0
239629,must,0,0
239630,be,0,0
239631,accepted,0,0
239632,.,0,0
239633,Effects,0,0
239634,of,0,0
239635,formoterol,0,0
239636,",",0,0
239637,salmeterol,0,0
239638,or,0,0
239639,oxitropium,0,0
239640,bromide,0,0
239641,on,0,0
239642,airway,0,1
239643,responses,0,0
239644,to,0,0
239645,salbutamol,0,0
239646,in,0,0
239647,COPD,1,0
239648,.,1,1
239649,We,0,0
239650,examined,0,0
239651,whether,0,0
239652,a,0,0
239653,pretreatment,0,0
239654,with,0,0
239655,formoterol,0,0
239656,",",0,0
239657,oxitropium,0,0
239658,bromide,0,0
239659,",",0,0
239660,or,0,0
239661,salmeterol,0,0
239662,might,0,0
239663,modify,0,0
239664,the,0,0
239665,dose-response,0,0
239666,curves,0,0
239667,to,0,0
239668,inhaled,0,0
239669,salbutamol,0,0
239670,in,0,0
239671,patients,1,1
239672,with,1,1
239673,stable,1,1
239674,and,1,0
239675,partially,1,0
239676,reversible,1,0
239677,chronic,1,1
239678,obstructive,1,1
239679,pulmonary,1,1
239680,disease,1,1
239681,(,1,0
239682,COPD,1,1
239683,),1,1
239684,.,1,1
239685,Sixteen,1,1
239686,outpatients,1,1
239687,with,1,1
239688,partially,1,0
239689,reversible,1,0
239690,",",1,0
239691,stable,1,1
239692,COPD,1,1
239693,received,0,1
239694,24,0,0
239695,microg,0,0
239696,formoterol,0,0
239697,",",0,0
239698,50,0,0
239699,microg,0,0
239700,salmeterol,0,0
239701,",",0,0
239702,200,0,0
239703,microg,0,0
239704,oxitropium,0,0
239705,bromide,0,0
239706,",",0,0
239707,or,0,0
239708,placebo,0,0
239709,on,0,0
239710,four,0,1
239711,non-consecutive,0,1
239712,days,0,0
239713,.,0,1
239714,Spirometric,0,0
239715,testing,0,0
239716,was,0,0
239717,performed,0,0
239718,immediately,0,0
239719,before,0,0
239720,inhalation,0,0
239721,of,0,0
239722,treatment,0,0
239723,and,0,0
239724,after,0,0
239725,2,0,0
239726,h.,0,1
239727,A,0,0
239728,dose-response,0,0
239729,curve,0,0
239730,to,0,0
239731,inhaled,0,0
239732,salbutamol,0,0
239733,was,0,0
239734,then,0,0
239735,constructed,0,0
239736,using,0,0
239737,doses,0,0
239738,of,0,0
239739,100,0,0
239740,",",0,0
239741,100,0,0
239742,",",0,0
239743,200,0,0
239744,microg,0,0
239745,and,0,0
239746,400,0,0
239747,microg,0,0
239748,--,0,0
239749,that,0,0
239750,is,0,0
239751,",",0,0
239752,a,0,0
239753,total,0,1
239754,cumulative,0,0
239755,dose,0,0
239756,of,0,0
239757,800,0,0
239758,microg,0,0
239759,.,0,1
239760,Dose,0,0
239761,increments,0,0
239762,were,0,1
239763,given,0,0
239764,at,0,0
239765,20,0,1
239766,min,0,0
239767,intervals,0,0
239768,with,0,1
239769,measurements,0,0
239770,being,0,1
239771,made,0,0
239772,15,0,1
239773,min,0,0
239774,after,0,0
239775,each,0,1
239776,dose,0,0
239777,.,0,0
239778,Formoterol,0,0
239779,",",0,0
239780,salmeterol,0,0
239781,",",0,0
239782,or,0,0
239783,oxitropium,0,0
239784,bromide,0,0
239785,elicited,0,0
239786,a,0,0
239787,significant,0,0
239788,increase,0,0
239789,in,0,0
239790,forced,0,1
239791,expiratory,0,0
239792,volume,0,0
239793,in,0,0
239794,one,0,0
239795,second,0,0
239796,(,0,0
239797,FEV1,0,0
239798,),0,0
239799,compared,0,0
239800,with,0,1
239801,placebo,0,0
239802,(,0,0
239803,mean,0,1
239804,differences,0,0
239805,(,0,1
239806,L,0,0
239807,),0,0
239808,=,0,0
239809,placebo,0,0
239810,0.05,0,0
239811,;,0,0
239812,formoterol,0,0
239813,0.34,0,0
239814,;,0,0
239815,salmeterol,0,0
239816,0.27,0,0
239817,;,0,0
239818,oxitropium,0,0
239819,bromide,0,0
239820,0.23,0,0
239821,),0,1
239822,.,0,1
239823,Dose-dependent,0,0
239824,increases,0,0
239825,in,0,1
239826,FEV1,0,1
239827,were,0,0
239828,seen,0,0
239829,(,0,0
239830,mean,0,1
239831,values,0,0
239832,(,0,1
239833,L,0,0
239834,),0,0
239835,before,0,0
239836,salbutamol,0,0
239837,and,0,0
239838,after,0,0
239839,a,0,0
239840,cumulative,0,0
239841,dose,0,0
239842,of,0,0
239843,100,0,0
239844,",",0,0
239845,200,0,0
239846,",",0,0
239847,400,0,0
239848,",",0,0
239849,and,0,0
239850,800,0,0
239851,microg,0,0
239852,=,0,0
239853,placebo,0,0
239854,:,0,1
239855,1.06,0,0
239856,",",0,0
239857,1.28,0,0
239858,",",0,0
239859,1.35,0,0
239860,",",0,0
239861,1.39,0,0
239862,",",0,0
239863,1.41,0,0
239864,;,0,0
239865,formoterol,0,0
239866,:,0,1
239867,1.33,0,0
239868,",",0,0
239869,1.37,0,0
239870,",",0,0
239871,1.41,0,0
239872,",",0,0
239873,1.44,0,0
239874,",",0,0
239875,1.44,0,0
239876,;,0,0
239877,salmeterol,0,0
239878,:,0,1
239879,1.30,0,0
239880,",",0,0
239881,1.33,0,0
239882,",",0,0
239883,1.36,0,0
239884,",",0,0
239885,1.39,0,0
239886,",",0,0
239887,1.42,0,0
239888,;,0,0
239889,oxitropium,0,0
239890,bromide,0,0
239891,:,0,1
239892,1.27,0,0
239893,",",0,0
239894,1.34,0,0
239895,",",0,0
239896,1.37,0,0
239897,",",0,0
239898,1.41,0,0
239899,",",0,0
239900,1.40,0,0
239901,),0,0
239902,.,0,1
239903,Statistical,0,0
239904,analysis,0,0
239905,revealed,0,0
239906,no,0,0
239907,significant,0,0
239908,differences,0,0
239909,in,0,0
239910,FEV1,0,1
239911,and,0,0
239912,forced,0,1
239913,vital,0,0
239914,capacity,0,0
239915,(,0,0
239916,FVC,0,0
239917,),0,0
239918,responses,0,0
239919,to,0,0
239920,salbutamol,0,0
239921,after,0,0
239922,therapy,0,0
239923,with,0,1
239924,formoterol,0,0
239925,",",0,0
239926,salmeterol,0,0
239927,",",0,0
239928,or,0,0
239929,oxitropium,0,0
239930,bromide,0,0
239931,compared,0,0
239932,with,0,1
239933,placebo,0,0
239934,.,0,0
239935,This,0,0
239936,study,0,0
239937,clearly,0,0
239938,shows,0,0
239939,that,0,0
239940,a,0,0
239941,pretreatment,0,0
239942,with,0,0
239943,a,0,0
239944,conventional,0,0
239945,dose,0,0
239946,of,0,0
239947,formoterol,0,0
239948,",",0,0
239949,salmeterol,0,0
239950,",",0,0
239951,or,0,0
239952,oxitropium,0,0
239953,bromide,0,0
239954,does,0,0
239955,not,0,0
239956,preclude,0,0
239957,the,0,0
239958,possibility,0,0
239959,of,0,0
239960,inducing,0,0
239961,a,0,0
239962,further,0,0
239963,bronchodilation,0,0
239964,with,0,1
239965,salbutamol,0,0
239966,in,0,0
239967,patients,1,1
239968,suffering,1,1
239969,from,1,1
239970,partially,1,1
239971,reversible,1,0
239972,chronic,1,1
239973,obstructive,1,1
239974,pulmonary,1,1
239975,disease,1,1
239976,.,1,1
239977,Zolmitriptan,0,0
239978,(,0,1
239979,311C90,0,0
239980,),0,0
239981,does,0,0
239982,not,0,0
239983,interact,0,0
239984,with,0,0
239985,fluoxetine,0,0
239986,in,0,0
239987,healthy,1,1
239988,volunteers,1,1
239989,.,1,1
239990,Zolmitriptan,0,0
239991,(,0,0
239992,Zomig,0,1
239993,",",0,0
239994,formerly,0,1
239995,311C90,0,0
239996,),0,0
239997,is,0,0
239998,a,0,0
239999,selective,0,0
240000,5-hydroxytryptamine,0,0
240001,(,0,1
240002,5-HT,0,0
240003,),0,0
240004,1B/1D-receptor,0,0
240005,agonist,0,0
240006,with,0,1
240007,central,0,0
240008,and,0,0
240009,peripheral,0,0
240010,activity,0,0
240011,for,0,0
240012,the,0,0
240013,acute,0,1
240014,treatment,0,0
240015,of,0,0
240016,migraine,0,1
240017,.,0,0
240018,This,0,0
240019,randomized,0,0
240020,",",0,0
240021,placebo-controlled,0,0
240022,",",0,0
240023,crossover,0,0
240024,study,0,0
240025,investigated,0,0
240026,the,0,0
240027,effects,0,0
240028,of,0,0
240029,fluoxetine,0,0
240030,administration,0,0
240031,on,0,0
240032,the,0,0
240033,pharmacokinetics,0,0
240034,and,0,0
240035,pharmacodynamics,0,0
240036,of,0,0
240037,zolmitriptan,0,0
240038,.,0,1
240039,Twenty,1,1
240040,volunteers,1,1
240041,were,1,1
240042,given,1,0
240043,single,1,0
240044,doses,1,0
240045,of,1,1
240046,fluoxetine,1,0
240047,20,1,1
240048,mg,1,0
240049,or,1,1
240050,an,1,0
240051,identical,1,0
240052,placebo,1,0
240053,daily,1,0
240054,for,1,0
240055,28,1,1
240056,days,1,0
240057,prior,1,1
240058,to,1,0
240059,receiving,1,0
240060,a,1,0
240061,single,1,0
240062,10,1,1
240063,mg,1,0
240064,oral,1,0
240065,dose,1,0
240066,of,1,0
240067,zolmitriptan,1,0
240068,.,1,1
240069,Sixteen,1,1
240070,volunteers,1,1
240071,completed,1,1
240072,the,1,0
240073,two,1,0
240074,treatment,1,0
240075,phases,1,0
240076,.,1,1
240077,The,0,0
240078,pharmacokinetic,0,0
240079,parameters,0,0
240080,of,0,0
240081,zolmitriptan,0,0
240082,and,0,0
240083,its,0,0
240084,metabolites,0,0
240085,were,0,0
240086,not,0,0
240087,significantly,0,0
240088,affected,0,0
240089,by,0,0
240090,fluoxetine,0,0
240091,pretreatment,0,0
240092,.,0,0
240093,The,0,0
240094,pharmacodynamic,0,0
240095,effects,0,0
240096,of,0,0
240097,zolmitriptan,0,0
240098,were,0,0
240099,also,0,0
240100,unaffected,0,0
240101,by,0,0
240102,fluoxetine,0,0
240103,pretreatment,0,0
240104,.,0,0
240105,There,0,0
240106,were,0,0
240107,small,0,0
240108,",",0,0
240109,clinically,0,0
240110,insignificant,0,0
240111,increases,0,0
240112,in,0,0
240113,blood,0,0
240114,pressure,0,0
240115,following,0,0
240116,zolmitriptan,0,0
240117,which,0,0
240118,were,0,0
240119,unaltered,0,0
240120,by,0,0
240121,fluoxetine,0,0
240122,.,0,1
240123,Zolmitriptan,0,0
240124,was,0,0
240125,well,0,0
240126,tolerated,0,0
240127,when,0,0
240128,given,0,0
240129,alone,0,0
240130,or,0,0
240131,concomitantly,0,0
240132,with,0,1
240133,fluoxetine,0,0
240134,.,0,0
240135,These,0,0
240136,results,0,0
240137,indicate,0,0
240138,that,0,0
240139,there,0,0
240140,is,0,0
240141,no,0,0
240142,contraindication,0,0
240143,to,0,0
240144,the,0,0
240145,use,0,0
240146,of,0,0
240147,zolmitriptan,0,0
240148,in,0,0
240149,patients,1,1
240150,treated,1,1
240151,concurrently,1,0
240152,with,1,1
240153,selective,1,1
240154,serotonin,1,0
240155,reuptake,1,0
240156,inhibitors,1,0
240157,and,0,0
240158,that,0,0
240159,no,0,0
240160,adjustment,0,0
240161,of,0,0
240162,the,0,0
240163,zolmitriptan,0,0
240164,dose,0,0
240165,is,0,0
240166,required,0,0
240167,in,0,0
240168,these,0,0
240169,circumstances,0,0
240170,.,0,1
240171,Glucosamine,0,0
240172,in,0,0
240173,serum,0,0
240174,of,0,0
240175,patients,1,1
240176,after,1,0
240177,myocardial,1,1
240178,infarction,1,1
240179,subjected,0,0
240180,to,0,0
240181,rehabilitation,0,0
240182,training,0,0
240183,.,0,0
240184,This,0,0
240185,paper,0,0
240186,presents,0,0
240187,results,0,0
240188,of,0,0
240189,3,0,1
240190,weeks,0,0
240191,physical,0,0
240192,training,0,0
240193,on,0,0
240194,glucosamine,0,0
240195,level,0,0
240196,in,0,0
240197,serum,0,0
240198,of,0,0
240199,male,1,1
240200,patients,1,1
240201,after,1,0
240202,myocardial,1,1
240203,infarction,1,1
240204,(,1,0
240205,MI,1,1
240206,),1,0
240207,aged,1,1
240208,between,1,0
240209,38,1,1
240210,and,1,1
240211,61,1,1
240212,.,1,1
240213,Patients,0,1
240214,were,0,0
240215,randomised,0,1
240216,in,0,0
240217,two,0,1
240218,groups,0,0
240219,:,0,1
240220,the,1,0
240221,training,1,0
240222,group,1,0
240223,(,1,0
240224,n,1,1
240225,=,1,0
240226,21,1,1
240227,),1,0
240228,",",1,0
240229,staying,1,0
240230,in,1,0
240231,Cardiac,1,1
240232,Rehabilitation,1,1
240233,Department,1,1
240234,and,1,0
240235,the,1,0
240236,control,1,0
240237,group,1,0
240238,(,1,0
240239,n,1,1
240240,=,1,0
240241,11,1,1
240242,),1,0
240243,",",0,0
240244,discharged,0,0
240245,home,0,0
240246,for,0,0
240247,3,0,0
240248,weeks,0,0
240249,.,0,1
240250,Each,0,0
240251,group,0,0
240252,received,0,0
240253,identical,0,0
240254,dietary,0,0
240255,instructions,0,0
240256,.,0,1
240257,The,1,0
240258,training,1,0
240259,group,1,0
240260,performed,0,0
240261,exercises,0,0
240262,every,0,0
240263,day,0,0
240264,:,0,1
240265,on,0,0
240266,bicycle,0,0
240267,ergometer,0,0
240268,during,0,0
240269,30,0,1
240270,minutes,0,0
240271,(,0,1
240272,5,0,1
240273,times,0,0
240274,a,0,0
240275,week,0,0
240276,),0,0
240277,",",0,0
240278,overall-conditioning,0,0
240279,exercises,0,0
240280,for,0,1
240281,30,0,1
240282,minutes,0,0
240283,daily,0,0
240284,and,0,0
240285,30,0,0
240286,to,0,0
240287,60,0,1
240288,minutes,0,0
240289,of,0,0
240290,walking,0,0
240291,each,0,0
240292,day,0,0
240293,.,0,0
240294,Before,0,0
240295,administering,0,0
240296,of,0,0
240297,the,0,0
240298,therapy,0,0
240299,and,0,0
240300,3,0,0
240301,weeks,0,0
240302,later,0,1
240303,all,0,0
240304,MI,1,0
240305,patients,1,1
240306,performed,0,0
240307,the,0,0
240308,bicycle,0,0
240309,ergometer,0,0
240310,exercise,0,0
240311,test,0,0
240312,until,0,0
240313,the,0,0
240314,ventilatory,0,0
240315,threshold,0,0
240316,was,0,0
240317,reached,0,0
240318,.,0,0
240319,Before,0,0
240320,that,0,0
240321,test,0,0
240322,and,0,0
240323,3,0,0
240324,minutes,0,0
240325,after,0,0
240326,its,0,0
240327,termination,0,0
240328,capillary,0,0
240329,and,0,0
240330,venous,0,0
240331,blood,0,0
240332,samples,0,0
240333,were,0,1
240334,drawn,0,0
240335,.,0,0
240336,In,0,0
240337,the,0,0
240338,capillary,0,0
240339,blood,0,0
240340,samples,0,0
240341,indices,0,0
240342,of,0,1
240343,acid-base,0,0
240344,balance,0,0
240345,",",0,0
240346,lactate,0,0
240347,level,0,0
240348,",",0,0
240349,and,0,0
240350,glucose,0,0
240351,level,0,0
240352,were,0,0
240353,determined,0,0
240354,.,0,0
240355,In,0,0
240356,venous,0,0
240357,blood,0,0
240358,samples,0,0
240359,the,0,0
240360,serum,0,0
240361,levels,0,0
240362,of,0,0
240363,immunoreactive,0,0
240364,insulin,0,0
240365,",",0,0
240366,C-peptide,0,0
240367,and,0,0
240368,glucosamine,0,0
240369,were,0,0
240370,determined,0,0
240371,as,0,0
240372,well,0,0
240373,as,0,0
240374,binding,0,0
240375,of,0,0
240376,125I-insulin,0,0
240377,to,0,0
240378,erythrocyte,0,0
240379,receptors,0,0
240380,.,0,1
240381,Obtained,0,0
240382,results,0,0
240383,show,0,0
240384,that,0,0
240385,administered,0,0
240386,therapy,0,0
240387,increased,0,0
240388,physical,0,0
240389,fitness,0,1
240390,and,0,0
240391,decreased,0,0
240392,of,0,0
240393,glucosamine,0,0
240394,concentration,0,0
240395,",",0,0
240396,insulinaemia,0,0
240397,and,0,0
240398,insulin,0,0
240399,resistance,0,0
240400,.,0,1
240401,A,0,0
240402,prospective,0,0
240403,randomized,0,0
240404,study,0,0
240405,of,0,0
240406,transurethral,0,1
240407,resection,0,1
240408,of,0,0
240409,the,0,0
240410,prostate,0,1
240411,and,0,0
240412,transurethral,0,1
240413,vaporization,0,0
240414,of,0,0
240415,the,0,0
240416,prostate,0,1
240417,as,0,0
240418,a,0,0
240419,therapeutic,0,0
240420,alternative,0,0
240421,in,0,0
240422,the,0,0
240423,management,0,0
240424,of,0,0
240425,men,1,1
240426,with,1,1
240427,BPH,1,0
240428,.,1,1
240429,OBJECTIVE,0,0
240430,The,0,0
240431,common,0,0
240432,goals,0,0
240433,of,0,1
240434,new,0,1
240435,surgical,0,0
240436,treatment,0,0
240437,for,0,0
240438,benign,1,1
240439,prostatic,1,1
240440,hyperplasia,1,1
240441,(,1,0
240442,BPH,1,0
240443,),1,0
240444,are,0,0
240445,to,0,0
240446,improve,0,0
240447,subjective,0,0
240448,and,0,0
240449,objective,0,0
240450,symptoms,0,0
240451,",",0,0
240452,to,0,0
240453,decrease,0,0
240454,the,0,0
240455,risk,0,0
240456,of,0,0
240457,postoperative,0,0
240458,complications,0,0
240459,and,0,1
240460,short,0,0
240461,hospitalization,0,1
240462,.,0,1
240463,Transurethral,0,0
240464,electrovaporization,0,0
240465,of,0,0
240466,the,0,0
240467,prostate,0,1
240468,(,0,0
240469,TUVP,0,0
240470,),0,0
240471,is,0,0
240472,a,0,0
240473,new,0,0
240474,",",0,0
240475,minimally,0,0
240476,invasive,0,0
240477,and,0,0
240478,a,0,0
240479,promising,0,0
240480,alternative,0,0
240481,to,0,0
240482,standard,0,0
240483,transurethral,0,1
240484,resection,0,1
240485,of,0,0
240486,the,0,0
240487,prostate,0,1
240488,(,0,0
240489,TURP,0,0
240490,),0,0
240491,in,0,0
240492,the,0,0
240493,treatment,0,0
240494,of,0,0
240495,BPH,0,0
240496,.,0,0
240497,The,0,0
240498,aim,0,0
240499,of,0,0
240500,this,0,0
240501,study,0,0
240502,is,0,0
240503,to,0,0
240504,compare,0,0
240505,the,0,0
240506,efficacy,0,0
240507,and,0,0
240508,safety,0,0
240509,of,0,0
240510,these,0,0
240511,two,0,0
240512,treatment,0,0
240513,alternatives,0,0
240514,.,0,1
240515,METHODS,0,0
240516,A,0,0
240517,prospective,0,0
240518,randomized,0,0
240519,trial,0,0
240520,of,0,0
240521,60,1,1
240522,patients,1,1
240523,with,1,1
240524,symptomatic,1,1
240525,BPH,1,0
240526,was,1,0
240527,performed,1,0
240528,.,1,0
240529,Preoperative,0,0
240530,and,0,0
240531,postoperative,0,0
240532,International,0,1
240533,Prostate,0,1
240534,Symptom,0,1
240535,Score,0,1
240536,(,0,0
240537,IPSS,0,0
240538,),0,0
240539,",",0,0
240540,maximum,0,0
240541,flow,0,0
240542,rates,0,0
240543,(,0,1
240544,Qmax,0,0
240545,),0,0
240546,and,0,0
240547,complications,0,0
240548,were,0,0
240549,recorded,0,0
240550,in,0,0
240551,each,0,0
240552,patient,0,0
240553,.,0,0
240554,The,0,0
240555,volume,0,0
240556,of,0,0
240557,the,0,0
240558,prostate,0,1
240559,was,0,0
240560,measured,0,0
240561,preoperatively,0,0
240562,and,0,0
240563,postoperatively,0,0
240564,using,0,0
240565,transrectal,0,0
240566,ultrasound,0,0
240567,.,0,0
240568,RESULTS,0,0
240569,Of,0,0
240570,the,0,0
240571,30,0,1
240572,patients,0,1
240573,who,0,1
240574,underwent,0,1
240575,TURP,0,1
240576,",",0,0
240577,mean,0,0
240578,hospital,0,1
240579,stay,0,0
240580,was,0,0
240581,4.5,0,0
240582,days,0,0
240583,.,0,1
240584,The,0,0
240585,Foley,0,0
240586,catheter,0,0
240587,was,0,0
240588,removed,0,0
240589,on,0,0
240590,postoperative,0,0
240591,day,0,0
240592,4,0,0
240593,following,0,0
240594,surgery,0,1
240595,.,0,1
240596,IPSS,0,0
240597,decreased,0,0
240598,from,0,1
240599,21.6,0,1
240600,to,0,0
240601,5.2,0,0
240602,",",0,0
240603,Qmax,0,0
240604,increased,0,0
240605,from,0,1
240606,9.2,0,0
240607,to,0,1
240608,19.2,0,0
240609,ml/s,0,0
240610,at,0,1
240611,3,0,1
240612,months,0,0
240613,.,0,1
240614,Mean,0,1
240615,prostatic,0,1
240616,volume,0,0
240617,at,0,0
240618,3,0,0
240619,months,0,0
240620,decreased,0,0
240621,from,0,1
240622,51.7,0,1
240623,to,0,0
240624,26.2,0,0
240625,g,0,0
240626,",",0,0
240627,a,0,0
240628,49.3,0,0
240629,%,0,0
240630,reduction,0,0
240631,.,0,0
240632,Of,0,0
240633,30,0,1
240634,patients,0,1
240635,undergoing,0,1
240636,TUVP,0,0
240637,",",0,0
240638,mean,0,0
240639,hospital,0,1
240640,stay,0,0
240641,was,0,0
240642,2.5,0,0
240643,days,0,0
240644,and,0,0
240645,the,0,0
240646,catheter,0,0
240647,was,0,0
240648,removed,0,0
240649,within,0,0
240650,2,0,0
240651,days,0,0
240652,following,0,0
240653,surgery,0,1
240654,.,0,1
240655,Postoperative,0,0
240656,urinary,0,0
240657,retention,0,0
240658,did,0,0
240659,not,0,0
240660,occur,0,0
240661,in,0,0
240662,any,0,0
240663,patient,0,0
240664,.,0,0
240665,IPSS,0,0
240666,decreased,0,0
240667,from,0,1
240668,19.4,0,0
240669,to,0,0
240670,4.1,0,0
240671,and,0,0
240672,Qmax,0,0
240673,increased,0,0
240674,from,0,1
240675,7.9,0,1
240676,to,0,1
240677,17.7,0,0
240678,ml/s,0,0
240679,at,0,1
240680,3,0,1
240681,months,0,0
240682,.,0,1
240683,Mean,0,1
240684,prostatic,0,1
240685,volume,0,0
240686,decreased,0,0
240687,from,0,0
240688,48.9,0,1
240689,to,0,0
240690,27.8,0,0
240691,g,0,0
240692,",",0,0
240693,a,0,0
240694,43.1,0,0
240695,%,0,0
240696,reduction,0,0
240697,at,0,0
240698,3,0,0
240699,months,0,0
240700,.,0,1
240701,In,0,0
240702,the,0,0
240703,TUVP,0,0
240704,group,0,0
240705,",",0,0
240706,none,0,0
240707,of,0,0
240708,the,0,0
240709,patients,0,1
240710,required,0,0
240711,blood,0,0
240712,transfusions,0,0
240713,or,0,1
240714,developed,0,1
240715,clinical,0,0
240716,transurethral,0,1
240717,resection,0,1
240718,syndrome,0,1
240719,.,0,0
240720,There,0,0
240721,were,0,0
240722,no,0,0
240723,major,0,1
240724,complications,0,0
240725,.,0,1
240726,Sphincteric,0,0
240727,incontinence,0,0
240728,",",0,0
240729,urethral,0,1
240730,strictures,0,1
240731,or,0,1
240732,bladder,0,1
240733,neck,0,1
240734,contractures,0,0
240735,were,0,0
240736,not,0,0
240737,recorded,0,0
240738,.,0,0
240739,At,0,0
240740,3,0,0
240741,months,0,0
240742,postoperatively,0,0
240743,",",0,0
240744,13,0,1
240745,patients,0,1
240746,in,0,0
240747,the,0,0
240748,TURP,0,0
240749,group,0,0
240750,and,0,0
240751,7,0,1
240752,patients,0,1
240753,in,0,0
240754,the,0,0
240755,TUVP,0,0
240756,group,0,0
240757,had,0,0
240758,retrograde,0,1
240759,ejaculation,0,1
240760,.,0,0
240761,CONCLUSION,0,0
240762,Our,0,0
240763,initial,0,0
240764,experience,0,0
240765,of,0,0
240766,TUVP,0,0
240767,suggests,0,0
240768,advantages,0,0
240769,over,0,0
240770,conventional,0,1
240771,TURP,0,1
240772,through,0,0
240773,reduced,0,0
240774,blood,0,0
240775,loss,0,0
240776,and,0,0
240777,shorter,0,0
240778,hospital,0,1
240779,stay,0,0
240780,.,0,0
240781,It,0,0
240782,appears,0,0
240783,to,0,0
240784,be,0,0
240785,an,0,0
240786,effective,0,0
240787,treatment,0,0
240788,for,0,0
240789,BPH,0,0
240790,;,0,0
240791,however,0,0
240792,",",0,0
240793,long-term,0,0
240794,results,0,0
240795,should,0,0
240796,be,0,0
240797,evaluated,0,0
240798,.,0,0
240799,The,0,0
240800,Treatment,0,0
240801,of,0,0
240802,Lead-exposed,1,1
240803,Children,1,1
240804,(,1,1
240805,TLC,1,0
240806,),1,1
240807,trial,0,0
240808,:,0,1
240809,design,0,0
240810,and,0,0
240811,recruitment,0,0
240812,for,0,0
240813,a,0,0
240814,study,0,0
240815,of,0,0
240816,the,0,0
240817,effect,0,0
240818,of,0,0
240819,oral,0,0
240820,chelation,0,0
240821,on,0,0
240822,growth,0,0
240823,and,0,0
240824,development,0,0
240825,in,0,0
240826,toddlers,1,1
240827,.,1,1
240828,Exposure,0,0
240829,to,0,0
240830,lead,0,0
240831,impairs,0,0
240832,cognitive,0,0
240833,development,0,0
240834,in,0,0
240835,young,1,1
240836,children,1,1
240837,",",0,0
240838,but,0,0
240839,the,0,0
240840,benefits,0,0
240841,of,0,0
240842,lowering,0,0
240843,blood,0,0
240844,lead,0,0
240845,pharmacologically,0,0
240846,are,0,0
240847,not,0,0
240848,clear,0,0
240849,.,0,0
240850,This,0,0
240851,report,0,0
240852,describes,0,0
240853,the,0,0
240854,design,0,0
240855,",",0,0
240856,recruitment,0,0
240857,",",0,0
240858,enrolment,0,0
240859,and,0,0
240860,baseline,0,0
240861,results,0,0
240862,of,0,0
240863,the,0,0
240864,Treatment,0,0
240865,of,0,0
240866,Lead-Exposed,1,0
240867,Children,1,1
240868,(,0,1
240869,TLC,0,0
240870,),0,0
240871,trial,0,0
240872,",",0,0
240873,a,0,0
240874,randomised,0,0
240875,",",0,0
240876,multicentre,0,0
240877,",",0,0
240878,placebo-controlled,0,0
240879,",",0,0
240880,double-blind,0,0
240881,clinical,0,0
240882,trial,0,0
240883,of,0,0
240884,the,0,0
240885,effects,0,0
240886,of,0,0
240887,treating,0,1
240888,lead-exposed,1,1
240889,children,1,1
240890,with,0,1
240891,succimer,0,0
240892,",",0,0
240893,a,0,0
240894,drug,0,0
240895,that,0,0
240896,enhances,0,0
240897,urinary,0,0
240898,excretion,0,0
240899,of,0,0
240900,lead,0,0
240901,",",0,0
240902,on,0,0
240903,cognitive,0,0
240904,",",0,0
240905,behavioural,0,0
240906,and,0,0
240907,physical,0,0
240908,development,0,0
240909,.,0,1
240910,TLC,0,0
240911,clinical,0,0
240912,sites,0,0
240913,were,0,1
240914,in,0,0
240915,Baltimore,1,1
240916,",",1,0
240917,Cincinnati,1,1
240918,and,1,0
240919,Columbus,1,1
240920,",",1,0
240921,Newark,1,1
240922,and,1,0
240923,Philadelphia,1,1
240924,.,1,1
240925,Children,1,1
240926,were,1,0
240927,eligible,1,1
240928,for,1,0
240929,TLC,1,0
240930,if,1,0
240931,they,1,0
240932,were,1,0
240933,between,1,0
240934,12,1,0
240935,and,1,1
240936,33,1,1
240937,months,1,0
240938,of,1,0
240939,age,1,1
240940,",",1,0
240941,had,1,0
240942,a,1,0
240943,confirmed,1,0
240944,blood,1,0
240945,lead,1,0
240946,concentration,1,0
240947,between,1,0
240948,20,1,1
240949,and,1,0
240950,44,1,1
240951,micrograms/dL,1,0
240952,and,1,0
240953,lived,1,1
240954,in,1,0
240955,a,1,0
240956,residence,1,0
240957,suitable,1,0
240958,for,1,0
240959,lead,1,0
240960,dust,1,1
240961,reduction,1,0
240962,.,1,1
240963,Randomised,0,0
240964,children,1,1
240965,received,0,0
240966,up,0,0
240967,to,0,0
240968,three,0,0
240969,26-day,0,1
240970,courses,0,0
240971,of,0,0
240972,succimer,0,0
240973,or,0,0
240974,placebo,0,0
240975,",",0,0
240976,and,0,0
240977,were,0,0
240978,then,0,0
240979,followed,0,0
240980,for,0,0
240981,3,0,0
240982,years,0,1
240983,.,0,1
240984,The,0,0
240985,study,0,0
240986,can,0,0
240987,detect,0,0
240988,a,0,0
240989,three-point,0,0
240990,difference,0,0
240991,in,0,0
240992,full-scale,0,0
240993,IQ,0,1
240994,at,0,0
240995,3-year,0,0
240996,follow-up,0,0
240997,.,0,1
240998,Statistical,0,0
240999,power,0,0
241000,for,0,0
241001,the,0,0
241002,other,0,0
241003,end,0,0
241004,points,0,0
241005,is,0,0
241006,more,0,0
241007,difficult,0,0
241008,to,0,0
241009,estimate,0,0
241010,.,0,0
241011,A,1,0
241012,total,1,1
241013,of,1,0
241014,1854,1,1
241015,children,1,1
241016,were,1,1
241017,evaluated,1,0
241018,and,1,0
241019,780,1,1
241020,children,1,1
241021,were,1,1
241022,randomised,1,1
241023,between,1,0
241024,August,1,1
241025,1994,1,1
241026,and,1,0
241027,January,1,1
241028,1997,1,1
241029,.,1,0
241030,The,1,0
241031,mean,1,0
241032,age,1,1
241033,of,1,0
241034,randomised,1,1
241035,children,1,1
241036,was,1,0
241037,24,1,1
241038,months,1,0
241039,and,1,0
241040,mean,1,1
241041,blood,1,0
241042,lead,1,0
241043,level,1,0
241044,26,1,1
241045,micrograms/dL,1,0
241046,.,1,1
241047,Three-quarters,1,0
241048,were,1,1
241049,African-American,1,1
241050,.,1,1
241051,Most,1,0
241052,children,1,1
241053,had,1,1
241054,poor,1,1
241055,",",1,0
241056,single,1,1
241057,mothers,1,1
241058,who,1,1
241059,had,1,1
241060,completed,1,1
241061,12,1,0
241062,or,1,1
241063,fewer,1,0
241064,years,1,1
241065,of,1,0
241066,school,1,1
241067,and,1,1
241068,who,1,1
241069,lived,1,1
241070,in,1,1
241071,older,1,1
241072,",",1,0
241073,poorly,1,0
241074,maintained,1,0
241075,residences,1,1
241076,.,1,1
241077,Comparison,0,0
241078,of,0,0
241079,prostate-specific,0,1
241080,antigen,0,0
241081,corrected,0,0
241082,for,0,0
241083,total,0,1
241084,prostate,0,1
241085,volume,0,0
241086,and,0,0
241087,transition,0,0
241088,zone,0,0
241089,volume,0,0
241090,in,0,0
241091,a,0,0
241092,population-based,1,1
241093,screening,1,1
241094,study,1,1
241095,.,1,0
241096,OBJECTIVES,0,0
241097,To,0,0
241098,compare,0,0
241099,the,0,0
241100,discriminatory,0,0
241101,potential,0,0
241102,between,0,0
241103,prostate,1,1
241104,cancer,1,1
241105,and,1,0
241106,benign,1,1
241107,conditions,1,0
241108,of,1,0
241109,the,1,0
241110,prostate,1,1
241111,in,0,0
241112,a,0,0
241113,population-based,0,1
241114,screening,0,0
241115,study,0,0
241116,",",0,0
241117,of,0,0
241118,serum,0,0
241119,prostate-specific,0,1
241120,antigen,0,0
241121,levels,0,0
241122,(,0,1
241123,PSA,0,1
241124,),0,0
241125,and,0,0
241126,PSA,0,0
241127,corrected,0,0
241128,for,0,0
241129,both,0,0
241130,the,0,0
241131,total,0,0
241132,prostate,0,1
241133,volume,0,0
241134,(,0,0
241135,PSA-D,0,0
241136,),0,0
241137,and,0,0
241138,the,0,0
241139,transition,0,0
241140,zone,0,0
241141,volume,0,0
241142,(,0,0
241143,PSA-T,0,1
241144,),0,1
241145,.,0,0
241146,METHODS,0,0
241147,In,0,0
241148,a,0,0
241149,randomized,0,0
241150,population-based,0,1
241151,screening,0,1
241152,study,0,0
241153,(,1,0
241154,Rotterdam,1,1
241155,section,1,0
241156,of,1,0
241157,the,1,0
241158,European,1,1
241159,Randomized,1,0
241160,Study,1,0
241161,of,1,0
241162,Screening,1,1
241163,for,1,0
241164,Prostate,1,1
241165,Cancer,1,1
241166,),1,0
241167,",",0,0
241168,in,0,0
241169,which,0,0
241170,"10,865",1,1
241171,men,1,1
241172,have,1,1
241173,been,1,0
241174,screened,1,1
241175,",",0,0
241176,the,0,0
241177,biopsy,1,0
241178,results,1,0
241179,of,1,1
241180,1202,1,1
241181,men,1,1
241182,with,1,1
241183,PSA,1,1
241184,levels,1,0
241185,of,1,1
241186,4,1,0
241187,ng/mL,1,0
241188,or,1,1
241189,more,1,0
241190,were,0,0
241191,evaluated,0,0
241192,.,0,0
241193,Planimetric,0,0
241194,and,0,0
241195,prolate,0,0
241196,ellipsoid,0,0
241197,volumes,0,0
241198,of,0,0
241199,the,0,0
241200,total,0,1
241201,prostate,0,1
241202,as,0,0
241203,well,0,0
241204,as,0,0
241205,of,0,0
241206,the,0,0
241207,transition,0,0
241208,zone,0,0
241209,were,0,0
241210,measured,0,0
241211,.,0,0
241212,The,0,0
241213,measured,0,0
241214,volumes,0,0
241215,were,0,1
241216,compared,0,0
241217,with,0,1
241218,the,0,0
241219,volumes,0,0
241220,of,0,0
241221,57,0,1
241222,radical,0,1
241223,prostatectomy,0,1
241224,specimens,0,1
241225,through,0,0
241226,Spearman,0,0
241227,'s,0,1
241228,rank,0,0
241229,correlation,0,0
241230,coefficient,0,0
241231,and,0,0
241232,agreement,0,0
241233,tests,0,0
241234,.,0,0
241235,A,0,0
241236,receiver,0,0
241237,operating,0,0
241238,characteristic,0,0
241239,(,0,1
241240,ROC,0,1
241241,),0,0
241242,curve,0,0
241243,analysis,0,0
241244,was,0,0
241245,done,0,0
241246,of,0,0
241247,sensitivity,0,0
241248,and,0,0
241249,specificity,0,0
241250,of,0,0
241251,biopsy,0,1
241252,indications,0,0
241253,through,0,0
241254,PSA,0,1
241255,and,0,1
241256,PSA,0,0
241257,corrected,0,0
241258,for,0,0
241259,the,0,0
241260,volumes,0,0
241261,measured,0,0
241262,with,0,1
241263,transrectal,0,1
241264,ultrasound,0,0
241265,.,0,0
241266,RESULTS,0,0
241267,In,0,0
241268,the,0,0
241269,1202,1,1
241270,men,1,1
241271,studied,1,1
241272,",",1,0
241273,361,1,1
241274,cases,1,1
241275,of,1,0
241276,prostate,1,1
241277,cancer,1,1
241278,were,0,0
241279,diagnosed,0,1
241280,.,0,0
241281,Both,0,0
241282,PSA-D,0,0
241283,and,0,0
241284,PSA-T,0,0
241285,showed,0,0
241286,a,0,0
241287,significantly,0,0
241288,higher,0,0
241289,area,0,0
241290,under,0,0
241291,the,0,0
241292,ROC,0,1
241293,curve,0,0
241294,(,0,0
241295,0.77,0,0
241296,and,0,0
241297,0.79,0,0
241298,",",0,0
241299,respectively,0,0
241300,),0,0
241301,than,0,0
241302,PSA,0,0
241303,alone,0,0
241304,(,0,0
241305,area,0,0
241306,0.65,0,0
241307,),0,0
241308,.,0,0
241309,There,0,0
241310,was,0,0
241311,no,0,0
241312,significant,0,0
241313,difference,0,0
241314,between,0,0
241315,PSA-D,0,0
241316,and,0,1
241317,PSA-T,0,0
241318,.,0,0
241319,The,0,0
241320,use,0,0
241321,of,0,0
241322,a,0,0
241323,PSA-D,0,0
241324,threshold,0,0
241325,value,0,0
241326,of,0,0
241327,0,0,0
241328,.,0,1
241329,10,0,0
241330,ng/mL/cc,0,0
241331,would,0,0
241332,have,0,0
241333,avoided,0,0
241334,28,0,0
241335,%,0,0
241336,of,0,0
241337,biopsies,0,0
241338,at,0,0
241339,the,0,0
241340,cost,0,0
241341,of,0,0
241342,10,0,0
241343,%,0,0
241344,of,0,0
241345,detectable,0,0
241346,cancers,0,1
241347,.,0,1
241348,A,0,0
241349,PSA-D,0,0
241350,threshold,0,0
241351,of,0,0
241352,0.15,0,0
241353,ng/mL/cc,0,0
241354,would,0,0
241355,have,0,0
241356,avoided,0,0
241357,73.8,0,0
241358,%,0,0
241359,of,0,0
241360,biopsies,0,0
241361,at,0,0
241362,the,0,0
241363,cost,0,0
241364,of,0,0
241365,not,0,0
241366,diagnosing,0,0
241367,43.8,0,0
241368,%,0,0
241369,of,0,0
241370,detectable,0,0
241371,cancers,0,1
241372,.,0,1
241373,CONCLUSIONS,0,0
241374,The,0,0
241375,planimetrically,0,0
241376,obtained,0,0
241377,prostate,0,1
241378,volume,0,0
241379,showed,0,0
241380,a,0,0
241381,more,0,0
241382,favorable,0,0
241383,agreement,0,0
241384,with,0,1
241385,the,0,0
241386,radical,0,0
241387,prostatectomy,0,1
241388,volume,0,0
241389,than,0,0
241390,the,0,0
241391,prolate,0,0
241392,ellipsoid,0,0
241393,volume,0,0
241394,.,0,0
241395,The,0,0
241396,discriminatory,0,0
241397,potential,0,0
241398,of,0,0
241399,the,0,0
241400,corrected,0,0
241401,PSA,0,0
241402,value,0,0
241403,is,0,0
241404,better,0,0
241405,at,0,0
241406,predicting,0,0
241407,the,0,0
241408,results,0,0
241409,of,0,0
241410,needle,0,0
241411,biopsy,0,1
241412,of,0,0
241413,the,0,0
241414,prostate,0,1
241415,when,0,0
241416,compared,0,0
241417,with,0,0
241418,PSA,0,1
241419,alone,0,0
241420,.,0,0
241421,The,0,0
241422,use,0,0
241423,of,0,0
241424,the,0,0
241425,transition,0,0
241426,zone,0,0
241427,volume,0,0
241428,for,0,0
241429,this,0,0
241430,correction,0,0
241431,results,0,0
241432,in,0,0
241433,a,0,0
241434,higher,0,0
241435,discriminatory,0,0
241436,potential,0,0
241437,when,0,0
241438,compared,0,0
241439,to,0,0
241440,the,0,0
241441,use,0,0
241442,of,0,0
241443,the,0,0
241444,total,0,1
241445,prostate,0,1
241446,volume,0,0
241447,;,0,0
241448,however,0,0
241449,",",0,0
241450,the,0,0
241451,observed,0,0
241452,difference,0,0
241453,was,0,0
241454,not,0,0
241455,statistically,0,0
241456,significant,0,0
241457,.,0,1
241458,Incidence,0,0
241459,and,0,0
241460,time,0,0
241461,course,0,0
241462,of,0,0
241463,cardiovascular,0,1
241464,side,0,0
241465,effects,0,0
241466,during,0,0
241467,spinal,1,1
241468,anesthesia,1,1
241469,after,1,0
241470,prophylactic,1,0
241471,administration,1,0
241472,of,1,0
241473,intravenous,1,0
241474,fluids,1,0
241475,or,1,1
241476,vasoconstrictors,1,0
241477,.,1,1
241478,UNLABELLED,0,0
241479,We,0,0
241480,studied,0,0
241481,the,0,0
241482,time,0,0
241483,course,0,0
241484,of,0,0
241485,arterial,0,1
241486,hypotension,0,0
241487,and/or,0,0
241488,bradycardia,0,0
241489,requiring,0,0
241490,treatment,0,0
241491,during,0,0
241492,spinal,1,1
241493,anesthesia,1,1
241494,and,0,0
241495,compared,0,0
241496,the,0,0
241497,efficacy,0,0
241498,of,0,0
241499,i.v,0,0
241500,.,0,0
241501,fluid,0,0
241502,or,0,0
241503,vasoconstrictor,0,0
241504,administration,0,0
241505,for,0,0
241506,the,0,0
241507,prevention,0,0
241508,of,0,0
241509,these,0,0
241510,side,0,0
241511,effects,0,0
241512,.,0,1
241513,Patients,1,1
241514,(,1,0
241515,n,1,1
241516,=,1,0
241517,1066,1,1
241518,),1,0
241519,were,0,0
241520,randomly,0,1
241521,allocated,0,0
241522,to,0,0
241523,either,0,0
241524,a,0,0
241525,volume,0,0
241526,group,0,0
241527,(,0,0
241528,lactated,0,0
241529,Ringer,0,1
241530,'s,0,1
241531,solution,0,0
241532,15,0,1
241533,mL/kg,0,1
241534,within,0,0
241535,15,0,0
241536,min,0,0
241537,before,0,0
241538,spinal,0,1
241539,anesthesia,0,1
241540,),0,0
241541,",",0,0
241542,a,0,0
241543,dihydroergotamine,0,0
241544,group,0,0
241545,(,0,0
241546,10,0,0
241547,microg/kg,0,0
241548,i.m,0,0
241549,.,0,0
241550,15,0,0
241551,min,0,0
241552,before,0,0
241553,anesthesia,0,1
241554,),0,0
241555,",",0,0
241556,or,0,0
241557,a,0,0
241558,placebo,0,0
241559,group,0,0
241560,.,0,0
241561,All,1,0
241562,patients,1,1
241563,breathed,1,1
241564,O2-enriched,1,1
241565,air,1,1
241566,during,1,0
241567,spinal,1,1
241568,anesthesia,1,1
241569,(,1,0
241570,4,1,0
241571,mL,1,0
241572,of,1,0
241573,plain,1,0
241574,0.5,1,0
241575,%,1,0
241576,bupivacaine,1,0
241577,),1,0
241578,.,1,0
241579,With,0,0
241580,the,0,0
241581,placebo,0,0
241582,",",0,0
241583,there,0,0
241584,were,0,0
241585,side,0,0
241586,effects,0,0
241587,(,0,1
241588,mean,0,1
241589,incidence,0,0
241590,22.9,0,1
241591,%,0,0
241592,),0,0
241593,for,0,0
241594,up,0,0
241595,to,0,0
241596,45,0,1
241597,min,0,0
241598,after,0,0
241599,the,0,0
241600,start,0,0
241601,of,0,0
241602,anesthesia,0,1
241603,.,0,1
241604,Dihydroergotamine,0,0
241605,reduced,0,0
241606,the,0,0
241607,incidence,0,0
241608,of,0,0
241609,side,0,0
241610,effects,0,0
241611,",",0,0
241612,preferentially,0,0
241613,the,0,0
241614,late,0,0
241615,ones,0,0
241616,",",0,0
241617,more,0,0
241618,(,0,0
241619,mean,0,0
241620,incidence,0,0
241621,11.8,0,0
241622,%,0,0
241623,),0,0
241624,than,0,0
241625,fluid,0,0
241626,administration,0,0
241627,(,0,0
241628,mean,0,1
241629,incidence,0,0
241630,16.9,0,0
241631,%,0,0
241632,),0,0
241633,",",0,0
241634,which,0,0
241635,was,0,0
241636,effective,0,0
241637,only,0,0
241638,during,0,0
241639,the,0,0
241640,first,0,0
241641,15,0,0
241642,min,0,0
241643,of,0,0
241644,anesthesia,0,1
241645,.,0,0
241646,Both,0,0
241647,heart,0,0
241648,rate,0,0
241649,and,0,0
241650,arterial,0,1
241651,pressure,0,0
241652,decreased,0,0
241653,within,0,0
241654,15,0,1
241655,min,0,0
241656,before,0,0
241657,the,0,0
241658,manifestation,0,1
241659,of,0,0
241660,symptoms,0,0
241661,.,0,1
241662,In,0,0
241663,a,0,0
241664,subgroup,0,1
241665,of,0,0
241666,patients,0,1
241667,",",0,0
241668,the,0,0
241669,incidence,0,0
241670,of,0,0
241671,side,0,0
241672,effects,0,0
241673,(,0,1
241674,8,0,0
241675,%,0,0
241676,),0,0
241677,was,0,0
241678,greatly,0,0
241679,reduced,0,0
241680,by,0,0
241681,the,0,0
241682,intraoperative,0,0
241683,application,0,0
241684,of,0,0
241685,both,0,0
241686,sedatives,0,0
241687,and,0,1
241688,opioids,0,0
241689,.,0,1
241690,We,0,0
241691,conclude,0,0
241692,that,0,0
241693,cardiovascular,0,1
241694,side,0,0
241695,effects,0,0
241696,may,0,0
241697,occur,0,0
241698,at,0,0
241699,any,0,0
241700,time,0,0
241701,during,0,0
241702,spinal,0,1
241703,anesthesia,0,1
241704,.,0,1
241705,Fluid,0,0
241706,administration,0,0
241707,reduced,0,0
241708,the,0,0
241709,incidence,0,0
241710,of,0,0
241711,early,0,1
241712,events,0,0
241713,",",0,0
241714,but,0,0
241715,dihydroergotamine,0,0
241716,the,0,0
241717,late,0,0
241718,events,0,0
241719,.,0,1
241720,IMPLICATIONS,0,0
241721,Cardiovascular,0,0
241722,side,0,0
241723,effects,0,0
241724,requiring,0,1
241725,treatment,0,0
241726,occurred,0,0
241727,at,0,0
241728,any,0,0
241729,time,0,0
241730,during,0,0
241731,spinal,0,1
241732,anesthesia,0,1
241733,in,0,0
241734,our,0,0
241735,placebo-controlled,0,0
241736,study,0,0
241737,",",0,0
241738,regardless,0,0
241739,of,0,0
241740,the,0,0
241741,prophylactic,0,0
241742,regimen,0,0
241743,(,0,1
241744,fluid,0,0
241745,infusions,0,0
241746,versus,0,0
241747,dihydroergotamine,0,0
241748,),0,0
241749,.,0,1
241750,Epileptogenic,0,0
241751,activity,0,0
241752,of,0,0
241753,folic,0,0
241754,acid,0,0
241755,after,0,0
241756,drug,0,0
241757,induces,0,0
241758,SLE,0,0
241759,(,0,1
241760,folic,0,0
241761,acid,0,0
241762,and,0,0
241763,epilepsy,0,1
241764,),0,0
241765,OBJECTIVE,0,0
241766,To,0,0
241767,study,0,0
241768,the,0,0
241769,effect,0,0
241770,of,0,0
241771,folic,0,0
241772,acid-containing,0,0
241773,multivitamin,0,0
241774,supplementation,0,0
241775,in,0,0
241776,epileptic,1,1
241777,women,1,1
241778,before,1,0
241779,and,1,0
241780,during,1,0
241781,pregnancy,1,1
241782,in,0,0
241783,order,0,0
241784,to,0,0
241785,determine,0,0
241786,the,0,0
241787,rate,0,0
241788,of,0,0
241789,structural,0,0
241790,birth,0,1
241791,defects,0,1
241792,and,0,0
241793,epilepsy-related,0,1
241794,side,0,0
241795,effects,0,0
241796,.,0,1
241797,STUDY,0,0
241798,DESIGN,0,0
241799,First,0,0
241800,a,0,0
241801,randomised,0,0
241802,trial,0,0
241803,",",0,0
241804,later,0,0
241805,periconception,0,0
241806,care,0,0
241807,including,0,0
241808,in,0,0
241809,total,0,1
241810,12225,1,1
241811,females,1,1
241812,.,1,1
241813,RESULTS,0,0
241814,Of,0,1
241815,60,1,1
241816,epileptic,1,1
241817,women,1,1
241818,with,1,1
241819,periconceptional,1,0
241820,folic,1,0
241821,acid,1,0
241822,(,0,0
241823,0.8,0,0
241824,mg,0,0
241825,),0,0
241826,-containing,0,0
241827,multivitamin,0,0
241828,supplementation,0,0
241829,",",0,0
241830,no,0,0
241831,one,0,0
241832,developed,0,0
241833,epilepsy-related,0,1
241834,side,0,0
241835,effects,0,0
241836,during,0,0
241837,the,0,0
241838,periconception,0,0
241839,period,0,0
241840,.,0,1
241841,One,0,1
241842,epileptic,0,1
241843,woman,0,1
241844,delivered,0,0
241845,a,0,0
241846,newborn,0,1
241847,with,0,1
241848,cleft,0,1
241849,lip,0,0
241850,and,0,0
241851,palate,0,1
241852,.,0,0
241853,Another,0,0
241854,patient,0,0
241855,exhibited,0,0
241856,with,0,1
241857,a,0,0
241858,cluster,0,0
241859,of,0,0
241860,seizures,0,1
241861,after,0,0
241862,the,0,0
241863,periconception,0,0
241864,period,0,0
241865,using,0,0
241866,another,0,0
241867,multivitamin,0,0
241868,.,0,0
241869,This,0,0
241870,22-year-old,0,1
241871,epileptic,0,1
241872,woman,0,1
241873,was,0,0
241874,treated,0,0
241875,continuously,0,0
241876,by,0,0
241877,carbamazepine,0,0
241878,and,0,0
241879,a,0,0
241880,folic,0,0
241881,acid,0,0
241882,(,0,0
241883,1,0,0
241884,mg,0,0
241885,),0,0
241886,-containing,0,0
241887,multivitamin,0,0
241888,from,0,0
241889,the,0,0
241890,20th,0,0
241891,week,0,0
241892,of,0,0
241893,gestation,0,1
241894,.,0,1
241895,She,0,0
241896,developed,0,0
241897,status,0,0
241898,epilepticus,0,1
241899,and,0,0
241900,later,0,0
241901,symptoms,0,0
241902,of,0,0
241903,systemic,0,0
241904,lupus,0,1
241905,erythematodes,0,1
241906,.,0,1
241907,Her,0,0
241908,pregnancy,0,0
241909,ended,0,0
241910,with,0,1
241911,stillbirth,0,1
241912,.,0,0
241913,CONCLUSIONS,0,0
241914,The,0,0
241915,epileptic,0,1
241916,pregnant,0,1
241917,patient,0,1
241918,'s,0,1
241919,autoimmune,0,1
241920,disease,0,1
241921,(,0,0
241922,probably,0,0
241923,drug-induced,0,0
241924,lupus,0,1
241925,),0,0
241926,could,0,0
241927,damage,0,0
241928,the,0,0
241929,blood-brain,0,0
241930,barrier,0,0
241931,",",0,0
241932,therefore,0,0
241933,the,0,0
241934,therapeutic,0,0
241935,dose,0,0
241936,(,0,0
241937,>,0,0
241938,or,0,0
241939,=1,0,0
241940,mg,0,0
241941,),0,0
241942,of,0,0
241943,folic,0,0
241944,acid,0,0
241945,triggered,0,0
241946,a,0,0
241947,cluster,0,0
241948,of,0,0
241949,seizures,0,1
241950,.,0,1
241951,Physiological,0,0
241952,dose,0,0
241953,(,0,0
241954,<,0,0
241955,1,0,0
241956,mg,0,0
241957,),0,0
241958,of,0,0
241959,folic,0,0
241960,acid,0,0
241961,both,0,0
241962,in,0,0
241963,healthy,0,1
241964,and,0,1
241965,60,0,1
241966,epileptic,0,1
241967,women,0,1
241968,",",0,0
241969,all,0,0
241970,without,0,0
241971,any,0,0
241972,autoimmune,0,1
241973,disease,0,1
241974,",",0,0
241975,did,0,0
241976,not,0,0
241977,increase,0,0
241978,the,0,0
241979,risk,0,0
241980,for,0,0
241981,epileptic,0,1
241982,seizures,0,1
241983,.,0,1
241984,Efficacy,0,0
241985,of,0,0
241986,dose-intensified,0,0
241987,MEC,0,0
241988,(,0,0
241989,methotrexate,0,0
241990,",",0,0
241991,epirubicin,0,0
241992,and,0,0
241993,cisplatin,0,0
241994,),0,0
241995,chemotherapy,0,0
241996,for,0,0
241997,advanced,1,1
241998,urothelial,1,1
241999,carcinoma,1,1
242000,:,1,1
242001,a,0,0
242002,prospective,0,0
242003,randomized,0,0
242004,trial,0,0
242005,comparing,0,0
242006,MEC,0,0
242007,and,0,0
242008,M-VAC,0,0
242009,(,0,0
242010,methotrexate,0,0
242011,",",0,0
242012,vinblastine,0,0
242013,",",0,0
242014,doxorubicin,0,0
242015,and,0,0
242016,cisplatin,0,0
242017,),0,0
242018,.,0,0
242019,Japanese,1,1
242020,Urothelial,1,1
242021,Cancer,1,1
242022,Research,1,1
242023,Group,1,1
242024,.,1,1
242025,BACKGROUND,0,0
242026,To,0,0
242027,evaluate,0,0
242028,the,0,0
242029,antitumor,0,0
242030,activity,0,0
242031,in,0,0
242032,patients,1,1
242033,with,1,1
242034,T3b,1,0
242035,",",1,0
242036,T4,1,0
242037,or,1,1
242038,metastatic,1,1
242039,urothelial,1,1
242040,carcinoma,1,1
242041,treated,1,1
242042,with,1,1
242043,MEC,1,0
242044,or,1,1
242045,M-VAC,1,0
242046,chemotherapy,1,0
242047,",",0,0
242048,by,0,0
242049,performing,0,0
242050,a,0,0
242051,multi-center,0,0
242052,randomized,0,1
242053,prospective,0,1
242054,study,0,1
242055,.,0,0
242056,METHODS,0,0
242057,From,1,1
242058,1991,1,1
242059,to,1,0
242060,1995,1,1
242061,",",1,0
242062,89,1,1
242063,patients,1,1
242064,with,1,1
242065,T3b,1,0
242066,",",1,0
242067,T4,1,0
242068,or,1,1
242069,metastatic,1,1
242070,urothelial,1,1
242071,carcinoma,1,1
242072,were,0,0
242073,randomly,0,1
242074,allocated,0,0
242075,to,0,0
242076,a,0,0
242077,methotrexate,0,0
242078,",",0,0
242079,epirubicin,0,0
242080,and,0,0
242081,cisplatin,0,0
242082,chemotherapy,0,0
242083,group,0,0
242084,(,0,0
242085,arm,0,1
242086,1,0,1
242087,:,0,1
242088,S-MEC,0,0
242089,therapy,0,0
242090,;,0,0
242091,n,0,1
242092,=,0,0
242093,29,0,1
242094,),0,0
242095,",",0,0
242096,a,0,0
242097,dose-intensified,0,0
242098,MEC,0,0
242099,therapy,0,0
242100,combined,0,0
242101,with,0,1
242102,G-CSF,0,0
242103,group,0,0
242104,(,0,0
242105,arm,0,1
242106,2,0,1
242107,:,0,1
242108,I-MEC,0,1
242109,therapy,0,0
242110,;,0,0
242111,n,0,1
242112,=,0,0
242113,30,0,1
242114,),0,0
242115,or,0,0
242116,a,0,0
242117,methotrexate,0,0
242118,",",0,0
242119,vinblastine,0,0
242120,",",0,0
242121,doxorubicin,0,0
242122,and,0,0
242123,cisplatin,0,0
242124,chemotherapy,0,0
242125,(,0,0
242126,arm,0,1
242127,3,0,1
242128,:,0,1
242129,M-VAC,0,0
242130,therapy,0,0
242131,;,0,0
242132,n,0,1
242133,=,0,0
242134,30,0,1
242135,),0,0
242136,.,0,0
242137,At,0,0
242138,the,0,0
242139,registration,0,0
242140,center,0,1
242141,",",0,0
242142,the,0,0
242143,patients,0,1
242144,were,0,0
242145,stratified,0,1
242146,into,0,0
242147,previously,0,1
242148,untreated,0,1
242149,patients,0,1
242150,and,0,1
242151,patients,0,1
242152,with,0,1
242153,recurrence,0,0
242154,after,0,0
242155,radical,0,0
242156,operation,0,0
242157,and,0,0
242158,then,0,0
242159,randomly,0,0
242160,allocated,0,0
242161,to,0,0
242162,the,0,0
242163,treatment,0,0
242164,groups,0,0
242165,.,0,1
242166,In,0,0
242167,each,0,0
242168,arm,0,0
242169,",",0,0
242170,two,0,0
242171,or,0,1
242172,more,0,0
242173,courses,0,0
242174,of,0,0
242175,chemotherapy,0,1
242176,(,0,0
242177,4-week,0,0
242178,cycles,0,0
242179,),0,1
242180,were,0,1
242181,performed,0,0
242182,.,0,0
242183,RESULTS,0,0
242184,Of,0,0
242185,the,0,0
242186,88,0,0
242187,eligible,0,1
242188,patients,0,1
242189,",",0,1
242190,four,0,0
242191,treated,0,1
242192,with,0,1
242193,S-MEC,0,0
242194,therapy,0,0
242195,and,0,0
242196,two,0,0
242197,treated,0,1
242198,with,0,1
242199,I-MEC,0,1
242200,therapy,0,0
242201,showed,0,0
242202,CR,0,0
242203,.,0,0
242204,The,0,0
242205,response,0,0
242206,rates,0,0
242207,(,0,1
242208,CR,0,1
242209,+,0,0
242210,PR,0,0
242211,),0,0
242212,were,0,0
242213,52,0,1
242214,%,0,0
242215,(,0,1
242216,15/29,0,0
242217,),0,0
242218,with,0,1
242219,S-MEC,0,0
242220,therapy,0,0
242221,",",0,0
242222,76,0,1
242223,%,0,0
242224,(,0,1
242225,22/29,0,0
242226,),0,0
242227,with,0,1
242228,I-MEC,0,1
242229,therapy,0,0
242230,and,0,0
242231,47,0,1
242232,%,0,0
242233,(,0,1
242234,14/30,0,0
242235,),0,0
242236,with,0,1
242237,M-VAC,0,0
242238,therapy,0,0
242239,.,0,0
242240,The,0,0
242241,response,0,0
242242,rate,0,0
242243,with,0,1
242244,I-MEC,0,1
242245,therapy,0,0
242246,was,0,0
242247,significantly,0,0
242248,higher,0,0
242249,than,0,0
242250,that,0,0
242251,with,0,1
242252,M-VAC,0,0
242253,therapy,0,0
242254,(,0,0
242255,P,0,0
242256,=,0,0
242257,0.02,0,0
242258,),0,0
242259,.,0,0
242260,Although,0,0
242261,the,0,0
242262,incidence,0,0
242263,of,0,0
242264,leukopenia,0,0
242265,was,0,0
242266,low,0,0
242267,with,0,1
242268,I-MEC,0,1
242269,therapy,0,0
242270,",",0,0
242271,the,0,0
242272,incidence,0,0
242273,of,0,0
242274,thrombocytopenia,0,1
242275,was,0,0
242276,high,0,0
242277,with,0,1
242278,this,0,0
242279,therapy,0,0
242280,.,0,0
242281,CONCLUSION,0,0
242282,MEC,0,0
242283,therapy,0,0
242284,used,0,0
242285,in,0,0
242286,this,0,0
242287,study,0,0
242288,is,0,0
242289,promising,0,0
242290,in,0,0
242291,terms,0,0
242292,of,0,0
242293,the,0,0
242294,antitumor,0,0
242295,effects,0,0
242296,.,0,1
242297,Evaluation,0,0
242298,of,0,0
242299,the,0,0
242300,safety,0,0
242301,",",0,0
242302,immunogenicity,0,0
242303,",",0,0
242304,and,0,0
242305,pharmacokinetic,0,0
242306,profile,0,0
242307,of,0,0
242308,a,0,0
242309,new,0,0
242310,",",0,0
242311,highly,0,0
242312,purified,0,0
242313,",",0,0
242314,heat-treated,0,0
242315,equine,0,1
242316,rabies,0,1
242317,immunoglobulin,0,1
242318,",",0,0
242319,administered,0,0
242320,either,0,0
242321,alone,0,0
242322,or,0,0
242323,in,0,0
242324,association,0,0
242325,with,0,1
242326,a,0,0
242327,purified,0,0
242328,",",0,0
242329,Vero-cell,0,0
242330,rabies,0,1
242331,vaccine,0,0
242332,.,0,0
242333,A,0,0
242334,clinical,0,0
242335,evaluation,0,0
242336,of,0,0
242337,a,0,0
242338,new,0,0
242339,",",0,0
242340,purified,0,0
242341,",",0,0
242342,heat-treated,0,0
242343,equine,0,1
242344,rabies,0,1
242345,immunoglobulin,0,1
242346,(,0,0
242347,PHT-Erig,0,0
242348,),0,0
242349,",",0,0
242350,F,0,0
242351,(,0,0
242352,ab,0,0
242353,',0,1
242354,),0,0
242355,2,0,0
242356,preparation,0,0
242357,",",0,0
242358,was,0,0
242359,carried,0,0
242360,out,0,0
242361,in,0,0
242362,Thailand,1,1
242363,and,0,0
242364,in,0,0
242365,the,0,0
242366,Philippines-two,1,1
242367,countries,0,0
242368,where,0,1
242369,rabies,0,1
242370,is,0,0
242371,endemic,0,1
242372,.,0,0
242373,An,0,0
242374,initial,0,0
242375,prospective,0,0
242376,",",0,0
242377,randomised,0,0
242378,",",0,0
242379,controlled,0,0
242380,trial,0,0
242381,(,0,0
242382,Study,0,0
242383,1,0,0
242384,),0,0
242385,",",0,0
242386,compared,0,0
242387,the,0,0
242388,safety,0,0
242389,and,0,0
242390,pharmacokinetics,0,0
242391,(,0,1
242392,serum,0,0
242393,concentrations,0,0
242394,of,0,1
242395,rabies,0,1
242396,antibodies,0,0
242397,),0,1
242398,after,0,0
242399,administration,0,0
242400,either,0,0
242401,of,0,0
242402,PHT-Erig,0,0
242403,or,0,1
242404,of,0,0
242405,a,0,0
242406,commercially-available,0,0
242407,",",0,0
242408,equine,0,1
242409,rabies,0,1
242410,immune,0,0
242411,globulin,0,0
242412,(,0,0
242413,Erig,0,0
242414,PMC,0,0
242415,),0,0
242416,.,0,0
242417,A,0,0
242418,second,0,0
242419,trial,0,0
242420,(,0,1
242421,Study,0,0
242422,2,0,1
242423,),0,0
242424,simulated,0,0
242425,post-exposure,0,0
242426,rabies,0,1
242427,prophylaxis,0,1
242428,by,0,0
242429,using,0,0
242430,a,0,0
242431,reference,0,0
242432,cell,0,0
242433,culture,0,0
242434,vaccine,0,0
242435,",",0,0
242436,the,0,0
242437,purified,0,0
242438,Vero-cell,0,1
242439,rabies,0,1
242440,vaccine,0,0
242441,(,0,1
242442,PVRV,0,1
242443,),0,0
242444,",",0,0
242445,administered,0,0
242446,in,0,0
242447,association,0,0
242448,with,0,1
242449,either,0,0
242450,Erig,0,0
242451,PMC,0,0
242452,or,0,1
242453,PHT-Erig,0,0
242454,.,0,0
242455,In,0,0
242456,Study,0,0
242457,1,0,0
242458,",",0,0
242459,27,1,1
242460,healthy,1,1
242461,",",1,0
242462,Thai,1,1
242463,adults,1,1
242464,received,1,1
242465,a,1,1
242466,40,1,1
242467,IU,1,0
242468,kg,1,1
242469,(,1,0
242470,-1,1,0
242471,),1,0
242472,dose,1,0
242473,of,1,0
242474,either,1,0
242475,Erig,1,0
242476,PMC,1,0
242477,(,1,0
242478,n,1,1
242479,=,1,0
242480,12,1,1
242481,),1,0
242482,or,1,1
242483,PHT-Erig,1,0
242484,(,1,0
242485,n,1,1
242486,=,1,0
242487,15,1,1
242488,),1,0
242489,via,1,0
242490,the,1,0
242491,intramuscular,1,0
242492,(,1,0
242493,i.m,1,0
242494,.,1,1
242495,),1,0
242496,route,1,0
242497,;,1,0
242498,half,0,1
242499,of,0,0
242500,the,0,0
242501,dose,0,0
242502,was,0,0
242503,injected,0,0
242504,into,0,0
242505,the,0,0
242506,deltoid,0,1
242507,area,0,0
242508,and,0,0
242509,the,0,0
242510,other,0,0
242511,half,0,1
242512,into,0,0
242513,the,0,0
242514,buttocks,0,0
242515,.,0,0
242516,Serum,0,1
242517,for,0,0
242518,rabies,0,1
242519,antibody,0,0
242520,determination,0,0
242521,and,0,0
242522,F,0,0
242523,(,0,0
242524,ab,0,0
242525,',0,1
242526,),0,0
242527,2,0,1
242528,concentration,0,0
242529,was,0,0
242530,collected,0,0
242531,at,0,0
242532,hours,0,0
242533,(,0,1
242534,H,0,1
242535,),0,0
242536,0,0,0
242537,",",0,0
242538,6,0,0
242539,and,0,0
242540,12,0,0
242541,",",0,0
242542,and,0,0
242543,on,0,0
242544,day,0,0
242545,(,0,0
242546,D,0,0
242547,),0,0
242548,2,0,0
242549,",",0,0
242550,3,0,0
242551,",",0,0
242552,4,0,0
242553,",",0,0
242554,6,0,0
242555,",",0,0
242556,8,0,0
242557,",",0,0
242558,10,0,0
242559,",",0,0
242560,12,0,0
242561,and,0,0
242562,15,0,1
242563,.,0,0
242564,Both,0,0
242565,products,0,0
242566,were,0,0
242567,safe,0,0
242568,",",0,0
242569,with,0,1
242570,no,0,0
242571,serious,0,0
242572,adverse,0,0
242573,events,0,0
242574,",",0,0
242575,and,0,0
242576,in,0,0
242577,particular,0,0
242578,",",0,0
242579,no,0,0
242580,anaphylactic,0,0
242581,reactions,0,0
242582,or,0,1
242583,serum,0,0
242584,sickness,0,1
242585,was,0,0
242586,reported,0,0
242587,.,0,0
242588,A,0,0
242589,statistical,0,0
242590,comparison,0,0
242591,of,0,0
242592,the,0,0
242593,pharmacokinetic,0,0
242594,parameters,0,0
242595,did,0,0
242596,not,0,0
242597,demonstrate,0,0
242598,bioequivalence,0,0
242599,of,0,0
242600,the,0,0
242601,two,0,0
242602,products,0,0
242603,.,0,1
242604,Nonetheless,0,0
242605,",",0,0
242606,the,0,0
242607,relative,0,0
242608,bioavailability,0,0
242609,of,0,0
242610,93,0,1
242611,%,0,0
242612,and,0,0
242613,the,0,0
242614,similar,0,0
242615,absorption,0,0
242616,rates,0,0
242617,suggest,0,0
242618,the,0,0
242619,pharmacokinetic,0,0
242620,profiles,0,0
242621,of,0,0
242622,Erig,0,1
242623,and,0,0
242624,PHT-Erig,0,0
242625,are,0,0
242626,similar,0,0
242627,.,0,0
242628,The,0,0
242629,antibody,0,0
242630,level,0,0
242631,in,0,0
242632,either,0,0
242633,group,0,0
242634,were,0,0
242635,low,0,0
242636,throughout,0,0
242637,the,0,0
242638,15-day,0,0
242639,study,0,0
242640,period,0,0
242641,.,0,0
242642,The,0,0
242643,geometric,0,0
242644,mean,0,0
242645,titer,0,0
242646,(,0,0
242647,GMT,0,1
242648,),0,1
242649,values,0,0
242650,ranged,0,0
242651,from,0,1
242652,group,0,1
242653,0.027-0.117,0,0
242654,IU,0,0
242655,ml,0,0
242656,(,0,0
242657,-1,0,0
242658,),0,0
242659,in,0,0
242660,the,0,0
242661,Erig,0,0
242662,group,0,0
242663,and,0,0
242664,from,0,0
242665,0.029,0,0
242666,to,0,1
242667,0.072,0,0
242668,IU,0,0
242669,ml,0,0
242670,(,0,0
242671,-1,0,0
242672,),0,0
242673,in,0,0
242674,the,0,0
242675,PHT-Erig,0,0
242676,.,0,0
242677,There,0,0
242678,was,0,0
242679,no,0,0
242680,significant,0,0
242681,difference,0,0
242682,between,0,0
242683,the,0,0
242684,evolution,0,0
242685,of,0,0
242686,GMT,0,0
242687,values,0,0
242688,for,0,0
242689,the,0,0
242690,two,0,0
242691,groups,0,0
242692,.,0,1
242693,In,0,0
242694,Study,0,0
242695,2,0,0
242696,",",0,0
242697,71,1,1
242698,healthy,1,1
242699,volunteers,1,1
242700,received,0,1
242701,40,0,1
242702,IU,0,0
242703,kg,0,1
242704,(,0,0
242705,-1,0,0
242706,),0,0
242707,via,0,0
242708,the,0,0
242709,intramuscular,0,0
242710,route,0,0
242711,of,0,0
242712,either,0,0
242713,Erig,0,0
242714,PMC,0,0
242715,(,0,0
242716,n,0,1
242717,=,0,0
242718,36,0,1
242719,),0,0
242720,or,0,1
242721,PHT-Erig,0,0
242722,(,0,0
242723,n,0,1
242724,=,0,0
242725,35,0,1
242726,),0,0
242727,on,0,0
242728,D0,0,0
242729,",",0,0
242730,in,0,0
242731,association,0,0
242732,with,0,1
242733,five,0,1
242734,doses,0,0
242735,of,0,0
242736,PVRV,0,1
242737,on,0,0
242738,D0,0,0
242739,",",0,0
242740,D3,0,0
242741,",",0,0
242742,D7,0,0
242743,",",0,0
242744,D14,0,0
242745,and,0,0
242746,D28,0,0
242747,.,0,0
242748,The,0,0
242749,safety,0,0
242750,evaluation,0,0
242751,was,0,0
242752,performed,0,0
242753,during,0,0
242754,the,0,0
242755,28-day,0,0
242756,follow-up,0,0
242757,and,0,0
242758,serum,0,0
242759,samples,0,0
242760,for,0,0
242761,anti-rabies,0,1
242762,antibody,0,0
242763,titration,0,0
242764,were,0,0
242765,collected,0,0
242766,on,0,0
242767,D0,0,0
242768,(,0,0
242769,before,0,0
242770,injection,0,0
242771,),0,0
242772,D3,0,0
242773,",",0,0
242774,D7,0,0
242775,",",0,0
242776,D14,0,0
242777,and,0,0
242778,D28,0,0
242779,.,0,1
242780,No,0,0
242781,serious,0,0
242782,reactions,0,0
242783,were,0,1
242784,reported,0,0
242785,in,0,0
242786,either,0,0
242787,group,0,0
242788,.,0,0
242789,In,0,0
242790,particular,0,0
242791,",",0,0
242792,no,0,0
242793,immediate,0,0
242794,(,0,0
242795,anaphylactic,0,0
242796,type,0,1
242797,),0,0
242798,or,0,0
242799,delayed,0,0
242800,(,0,0
242801,serum,0,0
242802,sickness,0,1
242803,),0,0
242804,allergic,0,1
242805,reactions,0,0
242806,were,0,1
242807,observed,0,0
242808,.,0,0
242809,Over,0,0
242810,the,0,0
242811,28-day,0,0
242812,follow-up,0,0
242813,period,0,0
242814,",",0,0
242815,GMT,0,0
242816,profiles,0,0
242817,of,0,0
242818,the,0,0
242819,two,0,0
242820,groups,0,0
242821,were,0,1
242822,statistically,0,0
242823,equivalent,0,0
242824,.,0,0
242825,On,0,0
242826,D14,0,0
242827,",",0,0
242828,100,0,0
242829,%,0,0
242830,of,0,0
242831,the,0,0
242832,subjects,0,1
242833,had,0,1
242834,protective,0,0
242835,antibody,0,0
242836,titers,0,0
242837,(,0,1
242838,anti-rabies,0,1
242839,antibodies,0,0
242840,>,0,1
242841,or,0,1
242842,=,0,0
242843,0.5,0,0
242844,IU,0,0
242845,ml,0,0
242846,(,0,0
242847,-1,0,0
242848,),0,0
242849,",",0,0
242850,which,0,0
242851,is,0,0
242852,the,0,0
242853,WHO-recommended,0,0
242854,level,0,0
242855,of,0,0
242856,seroconversion,0,1
242857,),0,0
242858,",",0,0
242859,and,0,0
242860,Erig,0,0
242861,PMC,0,0
242862,and,0,0
242863,PHT-Erig,0,0
242864,were,0,0
242865,indistinguishable,0,0
242866,according,0,1
242867,to,0,0
242868,the,0,0
242869,clinical,0,0
242870,definition,0,0
242871,chosen,0,0
242872,.,0,0
242873,On,0,0
242874,D28,0,0
242875,",",0,0
242876,the,0,0
242877,GMT,0,0
242878,values,0,0
242879,were,0,1
242880,33.2,0,1
242881,IU,0,0
242882,ml,0,0
242883,(,0,0
242884,-1,0,0
242885,),0,0
242886,(,0,0
242887,95,0,0
242888,%,0,0
242889,CI,0,0
242890,",",0,0
242891,23.8-46.1,0,0
242892,IU,0,0
242893,ml,0,0
242894,(,0,0
242895,-1,0,0
242896,),0,0
242897,),0,0
242898,in,0,0
242899,the,0,0
242900,Erig,0,0
242901,PMC/PVRV,0,0
242902,group,0,0
242903,and,0,0
242904,31.4,0,0
242905,IU,0,0
242906,ml,0,0
242907,(,0,0
242908,-1,0,0
242909,),0,0
242910,(,0,0
242911,95,0,0
242912,%,0,0
242913,confidence,0,0
242914,interval,0,0
242915,",",0,0
242916,CI,0,0
242917,",",0,0
242918,23.4-42.2,0,0
242919,IU,0,0
242920,ml,0,0
242921,(,0,0
242922,-1,0,0
242923,),0,0
242924,),0,0
242925,in,0,0
242926,the,0,0
242927,PHT-Erig/PVRV,0,0
242928,group,0,0
242929,",",0,0
242930,showing,0,0
242931,evidence,0,0
242932,of,0,0
242933,adequate,0,0
242934,vaccine-induced,0,0
242935,antibody,0,0
242936,responses,0,0
242937,in,0,0
242938,both,0,0
242939,groups,0,0
242940,.,0,0
242941,The,0,0
242942,increased,0,0
242943,purity,0,0
242944,",",0,0
242945,the,0,0
242946,heat-treatment,0,0
242947,step,0,0
242948,introduced,0,0
242949,in,0,0
242950,the,0,0
242951,manufacturing,0,0
242952,process,0,0
242953,of,0,0
242954,PHT-Erig,0,0
242955,",",0,0
242956,and,0,0
242957,the,0,0
242958,good,0,0
242959,clinical,0,0
242960,results,0,0
242961,substantiate,0,0
242962,the,0,0
242963,use,0,0
242964,of,0,0
242965,this,0,0
242966,new,0,0
242967,generation,0,0
242968,",",0,0
242969,purified,0,0
242970,equine,0,1
242971,F,0,1
242972,(,0,0
242973,ab,0,0
242974,',0,1
242975,),0,0
242976,2,0,0
242977,preparation,0,0
242978,in,0,0
242979,the,0,0
242980,post-exposure,0,0
242981,prophylaxis,0,0
242982,of,0,0
242983,rabies,0,1
242984,.,0,1
242985,Preventing,0,0
242986,disability,0,0
242987,and,0,0
242988,managing,0,0
242989,chronic,0,1
242990,illness,0,1
242991,in,0,0
242992,frail,1,1
242993,older,1,1
242994,adults,1,1
242995,:,1,1
242996,a,0,0
242997,randomized,0,0
242998,trial,0,0
242999,of,0,0
243000,a,0,0
243001,community-based,0,1
243002,partnership,0,0
243003,with,0,1
243004,primary,0,1
243005,care,0,1
243006,.,0,1
243007,BACKGROUND,0,0
243008,Effective,0,0
243009,new,0,1
243010,strategies,0,0
243011,that,0,0
243012,complement,0,0
243013,primary,0,0
243014,care,0,1
243015,are,0,0
243016,needed,0,0
243017,to,0,0
243018,reduce,0,0
243019,disability,0,0
243020,risks,0,0
243021,and,0,0
243022,improve,0,0
243023,self-management,0,0
243024,of,0,0
243025,chronic,0,1
243026,illness,0,1
243027,in,0,0
243028,frail,1,1
243029,older,1,1
243030,people,1,1
243031,living,1,1
243032,in,1,0
243033,the,1,0
243034,community,1,0
243035,.,1,0
243036,OBJECTIVE,0,0
243037,To,0,0
243038,evaluate,0,0
243039,the,0,0
243040,impact,0,0
243041,of,0,0
243042,a,0,0
243043,1-year,0,0
243044,",",0,0
243045,senior,0,1
243046,center-based,0,0
243047,chronic,0,1
243048,illness,0,1
243049,self-management,0,0
243050,and,0,0
243051,disability,0,0
243052,prevention,0,0
243053,program,0,0
243054,on,0,0
243055,health,0,0
243056,",",0,0
243057,functioning,0,0
243058,",",0,0
243059,and,0,0
243060,healthcare,0,0
243061,utilization,0,0
243062,in,0,0
243063,frail,0,1
243064,older,0,1
243065,adults,0,1
243066,.,0,0
243067,DESIGN,0,0
243068,A,0,0
243069,randomized,0,0
243070,controlled,0,0
243071,trial,0,0
243072,.,0,0
243073,SETTING,0,0
243074,A,0,0
243075,large,0,1
243076,senior,0,1
243077,center,0,1
243078,located,0,1
243079,in,0,0
243080,a,0,0
243081,northeast,0,1
243082,Seattle,1,0
243083,suburb,0,1
243084,.,0,0
243085,The,0,0
243086,trial,0,0
243087,was,0,0
243088,conducted,0,0
243089,in,0,0
243090,collaboration,0,0
243091,with,0,1
243092,primary,0,1
243093,care,0,1
243094,providers,0,1
243095,of,0,0
243096,two,0,1
243097,large,0,1
243098,managed,0,1
243099,care,0,1
243100,organizations,0,1
243101,.,0,0
243102,PARTICIPANTS,0,0
243103,A,0,0
243104,total,1,1
243105,of,1,0
243106,201,1,1
243107,chronically,1,1
243108,ill,1,1
243109,older,1,1
243110,adults,1,1
243111,seniors,1,1
243112,aged,1,1
243113,70,1,1
243114,and,1,0
243115,older,1,1
243116,recruited,1,1
243117,through,1,0
243118,medical,1,1
243119,practices,1,1
243120,.,1,1
243121,INTERVENTION,0,0
243122,A,0,0
243123,targeted,0,0
243124,",",0,0
243125,multi-component,0,0
243126,disability,0,0
243127,prevention,0,0
243128,and,0,0
243129,disease,0,1
243130,self-management,0,0
243131,program,0,0
243132,led,0,0
243133,by,0,0
243134,a,0,0
243135,geriatric,0,1
243136,nurse,0,0
243137,practitioner,0,1
243138,(,0,0
243139,GNP,0,1
243140,),0,1
243141,.,0,1
243142,MEASUREMENTS,0,0
243143,Self-reported,0,0
243144,Physical,0,0
243145,function,0,0
243146,",",0,0
243147,physical,0,0
243148,performance,0,0
243149,tests,0,0
243150,",",0,0
243151,health,0,1
243152,care,0,0
243153,utilization,0,0
243154,",",0,0
243155,and,0,0
243156,health,0,1
243157,behaviors,0,0
243158,.,0,1
243159,RESULTS,0,0
243160,Each,0,0
243161,of,0,0
243162,101,1,1
243163,intervention,1,1
243164,participants,1,1
243165,met,0,1
243166,with,0,1
243167,the,0,0
243168,GNP,0,0
243169,from,0,0
243170,1,0,0
243171,to,0,1
243172,8,0,0
243173,times,0,0
243174,(,0,1
243175,median,0,1
243176,=,0,0
243177,3,0,0
243178,),0,0
243179,during,0,0
243180,the,0,0
243181,study,0,0
243182,year,0,0
243183,.,0,0
243184,The,0,0
243185,intervention,0,0
243186,group,0,0
243187,showed,0,0
243188,less,0,0
243189,decline,0,0
243190,in,0,0
243191,function,0,0
243192,",",0,0
243193,as,0,0
243194,measured,0,0
243195,by,0,0
243196,disability,0,1
243197,days,0,0
243198,and,0,0
243199,lower,0,0
243200,scores,0,0
243201,on,0,0
243202,the,0,0
243203,Health,0,0
243204,Assessment,0,0
243205,Questionnaire,0,0
243206,.,0,1
243207,Other,0,0
243208,measures,0,0
243209,of,0,0
243210,function,0,0
243211,",",0,0
243212,including,0,0
243213,the,0,0
243214,SF-36,0,0
243215,and,0,0
243216,a,0,0
243217,battery,0,0
243218,of,0,0
243219,physical,0,0
243220,performance,0,0
243221,tests,0,0
243222,",",0,0
243223,did,0,0
243224,not,0,0
243225,change,0,0
243226,with,0,0
243227,the,0,0
243228,intervention,0,0
243229,.,0,0
243230,The,0,0
243231,number,0,0
243232,of,0,0
243233,hospitalized,0,1
243234,participants,0,1
243235,increased,0,0
243236,by,0,0
243237,69,0,1
243238,%,0,0
243239,among,0,0
243240,the,0,0
243241,controls,0,1
243242,and,0,0
243243,decreased,0,0
243244,by,0,0
243245,38,0,1
243246,%,0,0
243247,in,0,0
243248,the,0,0
243249,intervention,0,0
243250,group,0,0
243251,(,0,0
243252,P,0,0
243253,=,0,0
243254,.083,0,0
243255,),0,0
243256,.,0,0
243257,The,0,0
243258,total,0,0
243259,number,0,0
243260,of,0,0
243261,inpatient,0,1
243262,hospital,0,1
243263,days,0,0
243264,during,0,0
243265,the,0,0
243266,study,0,0
243267,year,0,0
243268,was,0,0
243269,significantly,0,0
243270,less,0,0
243271,in,0,0
243272,the,0,0
243273,intervention,0,0
243274,group,0,0
243275,compared,0,0
243276,with,0,1
243277,controls,0,1
243278,(,0,1
243279,total,0,1
243280,days,0,0
243281,=,0,0
243282,33,0,1
243283,vs,0,0
243284,116,0,1
243285,",",0,0
243286,P,0,0
243287,=,0,0
243288,.049,0,0
243289,),0,0
243290,.,0,0
243291,The,0,0
243292,intervention,0,0
243293,led,0,0
243294,to,0,0
243295,significantly,0,0
243296,higher,0,0
243297,levels,0,0
243298,of,0,0
243299,physical,0,0
243300,activity,0,0
243301,and,0,0
243302,senior,0,1
243303,center,0,1
243304,participation,0,0
243305,and,0,0
243306,significant,0,0
243307,reductions,0,0
243308,in,0,0
243309,the,0,0
243310,use,0,0
243311,of,0,0
243312,psychoactive,0,1
243313,medications,0,0
243314,.,0,1
243315,CONCLUSIONS,0,0
243316,This,0,0
243317,project,0,0
243318,provides,0,0
243319,evidence,0,0
243320,that,0,0
243321,a,0,0
243322,community-based,0,1
243323,collaboration,0,0
243324,with,0,1
243325,primary,0,1
243326,care,0,1
243327,providers,0,0
243328,can,0,0
243329,improve,0,0
243330,function,0,0
243331,and,0,0
243332,reduce,0,0
243333,inpatient,0,1
243334,utilization,0,0
243335,in,0,0
243336,chronically,1,1
243337,ill,1,1
243338,older,1,1
243339,adults,1,1
243340,.,1,0
243341,Linking,0,0
243342,organized,0,0
243343,medical,0,1
243344,care,0,1
243345,with,0,1
243346,complementary,0,0
243347,community-based,0,1
243348,interventions,0,0
243349,may,0,0
243350,be,0,0
243351,a,0,0
243352,promising,0,0
243353,direction,0,0
243354,for,0,0
243355,research,0,0
243356,and,0,0
243357,practice,0,0
243358,.,0,1
243359,[,0,0
243360,Radiotherapy,0,1
243361,for,0,0
243362,choroidal,0,1
243363,neovascularization,0,1
243364,in,0,0
243365,age-related,0,0
243366,macular,0,1
243367,degeneration,0,1
243368,.,0,0
243369,A,0,0
243370,pilot,0,0
243371,study,0,0
243372,using,0,0
243373,low-,0,0
243374,versus,0,0
243375,high-dose,0,0
243376,photon,0,0
243377,bean,0,0
243378,radiation,0,0
243379,],0,0
243380,.,0,0
243381,PURPOSE,0,0
243382,Several,0,0
243383,pilot,0,0
243384,studies,0,0
243385,have,0,0
243386,indicated,0,0
243387,that,0,0
243388,low-dose,0,0
243389,radiation,0,0
243390,therapy,0,0
243391,might,0,0
243392,have,0,0
243393,a,0,0
243394,beneficial,0,0
243395,effect,0,0
243396,on,0,0
243397,the,0,0
243398,course,0,0
243399,of,0,0
243400,choroidal,0,1
243401,neovascularization,0,1
243402,(,0,0
243403,CNV,0,0
243404,),0,0
243405,in,0,0
243406,age-related,1,0
243407,macular,1,1
243408,degeneration,1,1
243409,(,1,0
243410,AMD,1,0
243411,),1,0
243412,.,1,0
243413,This,0,0
243414,study,0,0
243415,aimed,0,0
243416,to,0,0
243417,ascertain,0,0
243418,whether,0,0
243419,such,0,0
243420,treatment,0,0
243421,might,0,0
243422,halt,0,0
243423,the,0,0
243424,progression,0,0
243425,of,0,0
243426,neovascular,0,1
243427,AMD,0,0
243428,and,0,0
243429,whether,0,0
243430,a,0,0
243431,low,0,0
243432,or,0,0
243433,a,0,0
243434,high,0,0
243435,radiation,0,0
243436,dose,0,0
243437,should,0,0
243438,be,0,0
243439,applied,0,0
243440,.,0,0
243441,PATIENTS,0,0
243442,The,0,0
243443,patients,1,1
243444,comprised,1,1
243445,some,1,0
243446,randomized,1,0
243447,to,1,0
243448,0,1,0
243449,vs,1,0
243450,10,1,1
243451,vs,1,0
243452,36,1,1
243453,Gy,1,1
243454,of,1,0
243455,radiation,1,0
243456,and,1,0
243457,(,1,0
243458,after,1,0
243459,a,1,0
243460,change,1,0
243461,of,1,0
243462,the,1,0
243463,study,1,0
243464,protocol,1,0
243465,became,1,0
243466,necessary,1,0
243467,),1,1
243468,others,1,1
243469,who,1,1
243470,participated,1,1
243471,in,1,1
243472,a,1,0
243473,prospective,1,0
243474,",",1,0
243475,controlled,1,0
243476,non-randomized,1,0
243477,pilot,1,0
243478,study,1,1
243479,.,1,0
243480,Enclosed,0,0
243481,were,0,0
243482,eyes,1,1
243483,with,1,1
243484,visual,1,0
243485,acuity,1,0
243486,of,1,0
243487,>,1,1
243488,or,1,1
243489,=,1,0
243490,0.1,1,0
243491,and,1,0
243492,<,1,0
243493,or,1,1
243494,=,1,0
243495,0.6,1,0
243496,revealing,1,0
243497,a,1,0
243498,juxta-subfoveal,1,1
243499,CNV,1,0
243500,either,1,0
243501,of,1,0
243502,the,1,0
243503,occult,1,1
243504,type,1,1
243505,(,1,0
243506,type,1,1
243507,1,1,0
243508,),1,0
243509,or,1,1
243510,the,1,0
243511,classic,1,0
243512,type,1,1
243513,(,1,0
243514,isolated,1,0
243515,or,1,1
243516,as,1,0
243517,part,1,0
243518,of,1,0
243519,a,1,0
243520,predominantly,1,1
243521,occult,1,1
243522,lesion,1,0
243523,),1,0
243524,.,1,1
243525,RESULTS,0,0
243526,Eyes,0,1
243527,treated,0,1
243528,with,0,1
243529,10,0,1
243530,Gy,0,1
243531,for,0,0
243532,occult,0,1
243533,CNV,0,0
243534,(,0,0
243535,n,0,1
243536,=,0,0
243537,12,0,1
243538,),0,0
243539,were,0,0
243540,subject,0,0
243541,to,0,0
243542,severe,0,1
243543,visual,0,0
243544,loss,0,0
243545,in,0,0
243546,41.6,0,0
243547,%,0,0
243548,of,0,0
243549,the,0,0
243550,cases,0,0
243551,compared,0,0
243552,to,0,0
243553,38.5,0,0
243554,%,0,0
243555,in,0,0
243556,the,0,0
243557,control,0,0
243558,group,0,0
243559,(,0,0
243560,n,0,1
243561,=,0,0
243562,13,0,1
243563,),0,0
243564,at,0,0
243565,12,0,1
243566,months,0,0
243567,of,0,1
243568,follow-up,0,0
243569,.,0,1
243570,For,0,0
243571,eyes,0,1
243572,treated,0,1
243573,with,0,1
243574,10,0,0
243575,Gy,0,1
243576,because,0,0
243577,of,0,0
243578,classic,0,1
243579,CNV,0,0
243580,",",0,0
243581,the,0,0
243582,corresponding,0,0
243583,figures,0,0
243584,were,0,1
243585,33,0,1
243586,%,0,0
243587,(,0,0
243588,n,0,1
243589,=,0,0
243590,18,0,1
243591,),0,0
243592,and,0,0
243593,57,0,1
243594,%,0,0
243595,(,0,0
243596,n,0,1
243597,=,0,0
243598,14,0,1
243599,),0,0
243600,respectively,0,0
243601,.,0,0
243602,At,0,0
243603,18,0,1
243604,months,0,0
243605,of,0,0
243606,follow-up,0,0
243607,",",0,0
243608,the,0,0
243609,percentages,0,0
243610,were,0,1
243611,63,0,1
243612,%,0,0
243613,and,0,0
243614,75,0,0
243615,%,0,0
243616,respectively,0,0
243617,.,0,0
243618,Fluorescein,0,0
243619,angiographic,0,0
243620,growth,0,0
243621,of,0,0
243622,classic,0,1
243623,and,0,0
243624,occult,0,1
243625,CNV,0,0
243626,could,0,0
243627,not,0,0
243628,be,0,0
243629,halted,0,0
243630,by,0,0
243631,10,0,0
243632,Gy,0,0
243633,",",0,0
243634,while,0,0
243635,a,0,0
243636,temporary,0,0
243637,growth,0,0
243638,retardation,0,1
243639,was,0,0
243640,observed,0,0
243641,in,0,0
243642,cases,0,1
243643,irradiated,0,1
243644,with,0,1
243645,36,0,1
243646,Gy,0,1
243647,.,0,1
243648,CONCLUSION,0,0
243649,In,0,0
243650,the,0,0
243651,study,0,0
243652,presented,0,0
243653,",",0,0
243654,the,0,0
243655,natural,0,0
243656,course,0,0
243657,of,0,0
243658,occult,0,1
243659,CNV,0,0
243660,could,0,0
243661,not,0,0
243662,be,0,0
243663,improved,0,0
243664,by,0,0
243665,irradiation,0,0
243666,with,0,1
243667,10,0,1
243668,or,0,1
243669,36,0,1
243670,Gy,0,0
243671,.,0,1
243672,In,0,0
243673,cases,0,1
243674,of,0,1
243675,classic,0,1
243676,CNV,0,0
243677,",",0,0
243678,low-dose,0,0
243679,irradiation,0,0
243680,with,0,1
243681,10,0,1
243682,Gy,0,1
243683,postponed,0,0
243684,severe,0,1
243685,visual,0,0
243686,loss,0,0
243687,by,0,0
243688,a,0,0
243689,maximum,0,0
243690,of,0,0
243691,18,0,1
243692,months,0,0
243693,.,0,1
243694,A,0,0
243695,positive,0,0
243696,treatment,0,0
243697,effect,0,0
243698,was,0,0
243699,also,0,0
243700,observed,0,0
243701,in,0,0
243702,cases,0,1
243703,irradiated,0,1
243704,with,0,1
243705,36,0,1
243706,Gy,0,1
243707,;,0,0
243708,however,0,0
243709,",",0,0
243710,a,0,0
243711,25,0,0
243712,%,0,0
243713,incidence,0,0
243714,of,0,0
243715,radiation,0,0
243716,retinopathy,0,1
243717,seems,0,0
243718,unacceptable,0,0
243719,.,0,0
243720,Marginal,0,0
243721,benefit/disadvantage,0,0
243722,of,0,0
243723,granulocyte,1,0
243724,colony-stimulating,1,0
243725,factor,1,0
243726,therapy,1,0
243727,after,1,0
243728,autologous,1,0
243729,blood,1,0
243730,stem,1,1
243731,cell,1,0
243732,transplantation,1,1
243733,in,1,0
243734,children,1,1
243735,:,1,1
243736,results,0,0
243737,of,0,0
243738,a,0,1
243739,prospective,0,0
243740,randomized,0,0
243741,trial,0,0
243742,.,0,0
243743,The,0,0
243744,Japanese,1,1
243745,Cooperative,1,1
243746,Study,1,0
243747,Group,1,1
243748,of,1,0
243749,PBSCT,1,1
243750,.,1,1
243751,In,0,0
243752,this,0,0
243753,prospective,0,0
243754,trial,0,0
243755,",",0,0
243756,a,0,0
243757,total,0,1
243758,of,0,0
243759,74,1,1
243760,children,1,1
243761,who,1,1
243762,were,1,1
243763,scheduled,1,1
243764,to,1,0
243765,undergo,1,1
243766,high-dose,1,0
243767,chemotherapy,1,0
243768,followed,1,0
243769,by,1,0
243770,autologous,1,1
243771,peripheral,1,1
243772,blood,1,0
243773,stem,1,1
243774,cell,1,0
243775,transplantation,1,1
243776,(,1,0
243777,PBSCT,1,1
243778,),1,0
243779,were,0,0
243780,prospectively,0,0
243781,randomized,0,0
243782,at,0,0
243783,diagnosis,0,1
243784,to,0,0
243785,evaluate,0,0
243786,the,0,0
243787,effectiveness,0,0
243788,of,0,0
243789,exogenous,0,0
243790,granulocyte,0,0
243791,colony-stimulating,0,0
243792,factor,0,0
243793,(,0,0
243794,G-CSF,0,0
243795,),0,0
243796,treatment,0,0
243797,in,0,0
243798,accelerating,0,0
243799,hematopoietic,0,0
243800,recovery,0,0
243801,after,0,0
243802,PBSCT,0,1
243803,.,0,0
243804,The,1,0
243805,diagnosis,1,1
243806,included,1,1
243807,acute,1,1
243808,lymphoblastic,1,1
243809,leukemia,1,1
243810,(,1,0
243811,ALL,1,0
243812,),1,0
243813,(,1,0
243814,n,1,1
243815,=,1,0
243816,27,1,1
243817,),1,0
243818,",",1,0
243819,neuroblastoma,1,1
243820,(,1,0
243821,n,1,1
243822,=,1,0
243823,29,1,1
243824,),1,0
243825,",",1,0
243826,and,1,0
243827,miscellaneous,1,1
243828,solid,1,1
243829,tumors,1,1
243830,(,1,1
243831,n,1,1
243832,=,1,0
243833,18,1,1
243834,),1,1
243835,.,1,1
243836,Eligibility,1,0
243837,criteria,1,1
243838,included,1,1
243839,(,1,1
243840,1,1,0
243841,),1,0
243842,primary,1,1
243843,PBSCT,1,1
243844,",",1,0
243845,(,1,0
243846,2,1,0
243847,),1,0
243848,chemotherapy-responsive,1,1
243849,disease,1,1
243850,",",1,0
243851,and,1,0
243852,(,1,0
243853,3,1,0
243854,),1,0
243855,collected,1,0
243856,cell,1,0
243857,number,1,0
243858,>,1,1
243859,1,1,0
243860,x,1,0
243861,10,1,1
243862,(,1,0
243863,5,1,0
243864,),1,0
243865,colony-forming,1,0
243866,unit-granulocyte-macrophage,1,0
243867,(,1,0
243868,CFU-GM,1,1
243869,),1,0
243870,/kg,1,0
243871,and,1,0
243872,>,1,1
243873,1,1,0
243874,x,1,0
243875,10,1,1
243876,(,1,0
243877,6,1,0
243878,),1,0
243879,CD34,1,0
243880,(,1,0
243881,+,1,0
243882,),1,0
243883,cells/kg,1,0
243884,patient,1,0
243885,'s,1,1
243886,body,1,1
243887,weight,1,1
243888,.,1,0
243889,After,0,0
243890,applying,0,0
243891,the,0,0
243892,above,0,0
243893,criteria,0,1
243894,",",0,0
243895,11,1,0
243896,patients,1,1
243897,were,1,1
243898,excluded,1,1
243899,due,1,0
243900,to,1,0
243901,disease,1,1
243902,progression,1,0
243903,before,1,0
243904,PBSCT,1,1
243905,(,1,1
243906,n,1,1
243907,=,1,0
243908,6,1,0
243909,),1,0
243910,or,1,1
243911,a,1,0
243912,low,1,0
243913,number,1,0
243914,of,1,0
243915,harvested,1,1
243916,cells,1,0
243917,(,1,1
243918,n,1,1
243919,=,1,0
243920,5,1,1
243921,),1,0
243922,",",1,0
243923,leaving,1,0
243924,63,1,1
243925,patients,1,1
243926,for,1,1
243927,analysis,1,0
243928,;,1,1
243929,32,1,1
243930,patients,1,1
243931,in,0,0
243932,the,0,0
243933,treatment,0,0
243934,group,0,0
243935,(,0,0
243936,300,0,0
243937,microg/m2,0,1
243938,of,0,0
243939,G-CSF,0,0
243940,intravenously,0,1
243941,over,0,0
243942,1,0,0
243943,hour,0,0
243944,from,0,1
243945,day,0,0
243946,1,0,0
243947,of,0,0
243948,PBSCT,0,1
243949,),0,1
243950,and,0,0
243951,31,0,1
243952,in,0,0
243953,the,0,0
243954,control,0,0
243955,group,0,0
243956,without,0,1
243957,treatment,0,0
243958,.,0,1
243959,Two,0,0
243960,distinct,0,0
243961,disease-oriented,0,1
243962,high-dose,0,1
243963,regimens,0,0
243964,without,0,1
243965,total,0,1
243966,body,0,1
243967,irradiation,0,0
243968,consisted,0,1
243969,of,0,0
243970,the,0,0
243971,MCVAC,0,1
243972,regimen,0,0
243973,using,0,0
243974,ranimustine,0,0
243975,(,0,0
243976,MCNU,0,1
243977,",",0,0
243978,450,0,0
243979,mg/m2,0,0
243980,),0,0
243981,",",0,0
243982,cytosine,0,0
243983,arabinoside,0,1
243984,(,0,0
243985,16,0,1
243986,g/m2,0,0
243987,),0,0
243988,",",0,0
243989,etoposide,0,0
243990,(,0,0
243991,1.6,0,0
243992,g/m2,0,0
243993,),0,0
243994,",",0,0
243995,and,0,0
243996,cyclophosphamide,0,0
243997,(,0,0
243998,100,0,0
243999,mg/kg,0,0
244000,),0,0
244001,for,0,0
244002,patients,0,1
244003,with,0,1
244004,ALL,0,0
244005,",",0,0
244006,and,0,0
244007,the,0,0
244008,Hi-MEC,0,0
244009,regimen,0,0
244010,using,0,0
244011,melphalan,0,1
244012,(,0,0
244013,180,0,1
244014,mg/m2,0,0
244015,),0,0
244016,",",0,0
244017,etoposide,0,0
244018,(,0,0
244019,1.6,0,0
244020,g/m2,0,0
244021,),0,0
244022,",",0,0
244023,and,0,0
244024,carboplatinum,0,0
244025,(,0,0
244026,1.6,0,0
244027,g/m2,0,0
244028,),0,0
244029,for,0,0
244030,those,0,0
244031,with,0,1
244032,solid,0,1
244033,tumors,0,1
244034,.,0,1
244035,Five,1,0
244036,patients,1,1
244037,(,1,1
244038,two,1,0
244039,in,1,0
244040,the,1,0
244041,treatment,1,0
244042,group,1,0
244043,and,1,0
244044,three,1,0
244045,in,1,0
244046,the,1,0
244047,control,1,0
244048,group,1,0
244049,),1,0
244050,were,1,0
244051,subsequently,1,0
244052,removed,1,0
244053,due,1,0
244054,to,1,0
244055,protocol,1,1
244056,violations,1,0
244057,.,1,0
244058,All,0,1
244059,patients,0,1
244060,survived,0,1
244061,PBSCT,1,1
244062,.,1,0
244063,The,0,0
244064,median,0,0
244065,numbers,0,0
244066,of,0,1
244067,transfused,0,1
244068,mononuclear,0,0
244069,cells,0,0
244070,(,0,1
244071,MNC,0,1
244072,),0,0
244073,",",0,0
244074,CD34,0,0
244075,(,0,0
244076,+,0,0
244077,),0,0
244078,cells,0,0
244079,",",0,0
244080,and,0,0
244081,CFU-GM,0,0
244082,were,0,0
244083,",",0,0
244084,respectively,0,0
244085,",",0,0
244086,4.5,0,0
244087,(,0,0
244088,range,0,0
244089,",",0,0
244090,1,0,0
244091,to,0,0
244092,19,0,1
244093,),0,0
244094,x,0,0
244095,10,0,1
244096,(,0,0
244097,8,0,0
244098,),0,0
244099,/kg,0,0
244100,",",0,0
244101,8.0,0,0
244102,(,0,0
244103,1.1,0,0
244104,to,0,0
244105,25,0,1
244106,),0,0
244107,x,0,0
244108,10,0,1
244109,(,0,0
244110,6,0,0
244111,),0,0
244112,/kg,0,0
244113,",",0,0
244114,and,0,0
244115,3.7,0,0
244116,(,0,0
244117,1.2,0,0
244118,to,0,0
244119,23,0,1
244120,),0,0
244121,x,0,0
244122,10,0,1
244123,(,0,0
244124,5,0,0
244125,),0,0
244126,/kg,0,0
244127,in,0,0
244128,the,0,0
244129,treatment,0,0
244130,group,0,0
244131,(,0,0
244132,n,0,1
244133,=,0,0
244134,30,0,1
244135,),0,0
244136,and,0,0
244137,2.9,0,0
244138,(,0,0
244139,0.8,0,1
244140,to,0,0
244141,21,0,1
244142,),0,0
244143,x,0,0
244144,10,0,1
244145,(,0,0
244146,8,0,0
244147,),0,0
244148,/kg,0,0
244149,",",0,0
244150,6.3,0,0
244151,(,0,0
244152,1.1,0,0
244153,to,0,0
244154,34,0,1
244155,),0,0
244156,x,0,0
244157,10,0,1
244158,(,0,0
244159,6,0,0
244160,),0,0
244161,/kg,0,0
244162,",",0,0
244163,and,0,0
244164,5.5,0,0
244165,(,0,0
244166,1.3,0,0
244167,to,0,0
244168,37,0,1
244169,),0,0
244170,x,0,0
244171,10,0,1
244172,(,0,0
244173,5,0,0
244174,),0,0
244175,/kg,0,0
244176,",",0,0
244177,respectively,0,0
244178,",",0,0
244179,in,0,0
244180,the,0,0
244181,control,0,0
244182,group,0,0
244183,(,0,0
244184,n,0,1
244185,=,0,0
244186,28,0,1
244187,),0,0
244188,",",0,0
244189,with,0,1
244190,no,0,0
244191,significant,0,0
244192,difference,0,0
244193,.,0,1
244194,After,0,0
244195,PBSCT,0,0
244196,",",0,0
244197,the,0,0
244198,time,0,0
244199,to,0,0
244200,achieve,0,0
244201,an,0,0
244202,absolute,0,0
244203,neutrophil,0,0
244204,count,0,0
244205,(,0,0
244206,ANC,0,0
244207,),0,0
244208,of,0,0
244209,>,0,1
244210,0.5,0,0
244211,x,0,0
244212,10,0,1
244213,(,0,0
244214,9,0,0
244215,),0,0
244216,/L,0,0
244217,in,0,0
244218,the,0,0
244219,treatment,0,0
244220,group,0,0
244221,was,0,0
244222,less,0,0
244223,than,0,0
244224,that,0,0
244225,in,0,0
244226,the,0,0
244227,control,0,0
244228,group,0,0
244229,(,0,0
244230,median,0,0
244231,",",0,0
244232,11,0,0
244233,v,0,0
244234,12,0,1
244235,days,0,0
244236,;,0,1
244237,the,0,0
244238,log-rank,0,0
244239,test,0,0
244240,",",0,0
244241,P,0,0
244242,=.046,0,0
244243,),0,0
244244,",",0,0
244245,although,0,0
244246,the,0,0
244247,last,0,0
244248,day,0,0
244249,of,0,0
244250,red,0,1
244251,blood,0,0
244252,cell,0,1
244253,(,0,0
244254,RBC,0,0
244255,),0,0
244256,transfusion,0,0
244257,(,0,0
244258,day,0,0
244259,11,0,0
244260,v,0,0
244261,day,0,0
244262,10,0,0
244263,),0,0
244264,and,0,0
244265,the,0,0
244266,duration,0,0
244267,of,0,0
244268,febrile,0,1
244269,days,0,0
244270,(,0,1
244271,>,0,1
244272,38,0,1
244273,degrees,0,0
244274,C,0,0
244275,),0,1
244276,after,0,0
244277,PBSCT,0,1
244278,(,0,0
244279,4,0,0
244280,v,0,0
244281,4,0,0
244282,days,0,0
244283,),0,1
244284,were,0,1
244285,identical,0,0
244286,in,0,0
244287,both,0,0
244288,groups,0,0
244289,.,0,0
244290,However,0,0
244291,",",0,0
244292,platelet,0,0
244293,recovery,0,0
244294,to,0,0
244295,>,0,1
244296,20,0,1
244297,x,0,0
244298,10,0,1
244299,(,0,1
244300,9,0,0
244301,),0,0
244302,/L,0,0
244303,was,0,0
244304,significantly,0,0
244305,longer,0,0
244306,in,0,0
244307,treatment,0,0
244308,group,0,0
244309,than,0,0
244310,control,0,0
244311,group,0,0
244312,(,0,0
244313,26,0,1
244314,v,0,0
244315,16,0,1
244316,days,0,0
244317,;,0,1
244318,P,0,0
244319,=.009,0,0
244320,),0,0
244321,and,0,0
244322,>,0,1
244323,50,0,1
244324,x,0,0
244325,10,0,1
244326,(,0,0
244327,9,0,0
244328,),0,0
244329,/L,0,0
244330,tended,0,0
244331,to,0,0
244332,take,0,0
244333,longer,0,0
244334,in,0,0
244335,the,0,0
244336,treatment,0,0
244337,group,0,0
244338,(,0,0
244339,29,0,1
244340,v,0,0
244341,26,0,1
244342,days,0,0
244343,;,0,1
244344,P,0,0
244345,=.126,0,0
244346,),0,0
244347,",",0,0
244348,with,0,0
244349,significantly,0,0
244350,more,0,0
244351,platelet,0,0
244352,transfusion-dependent,0,1
244353,days,0,0
244354,(,0,1
244355,27,0,1
244356,v,0,0
244357,13,0,1
244358,days,0,0
244359,;,0,1
244360,t-test,0,0
244361,",",0,0
244362,P,0,0
244363,=.037,0,0
244364,),0,0
244365,.,0,0
244366,When,0,0
244367,patients,0,1
244368,were,0,0
244369,divided,0,1
244370,into,0,1
244371,two,0,0
244372,different,0,0
244373,disease,0,1
244374,cohorts,0,0
244375,",",0,0
244376,ALL,0,1
244377,patients,0,1
244378,showed,0,0
244379,no,0,0
244380,difference,0,0
244381,in,0,0
244382,engraftment,0,0
244383,kinetics,0,0
244384,between,0,0
244385,the,0,0
244386,G-CSF,0,0
244387,treatment,0,0
244388,and,0,0
244389,control,0,0
244390,groups,0,0
244391,",",0,0
244392,while,0,0
244393,differences,0,0
244394,were,0,1
244395,seen,0,0
244396,in,0,0
244397,those,0,0
244398,with,0,1
244399,solid,0,1
244400,tumors,0,1
244401,.,0,1
244402,We,0,0
244403,concluded,0,0
244404,that,0,0
244405,the,0,0
244406,marginal,0,0
244407,clinical,0,0
244408,benefit,0,0
244409,of,0,0
244410,1,0,0
244411,day,0,0
244412,earlier,0,0
244413,recovery,0,0
244414,of,0,0
244415,granulocytes,0,0
244416,could,0,0
244417,be,0,0
244418,offset,0,0
244419,by,0,0
244420,the,0,0
244421,delayed,0,0
244422,recovery,0,0
244423,of,0,0
244424,platelets,0,1
244425,.,0,1
244426,We,0,0
244427,recommend,0,0
244428,that,0,0
244429,the,0,0
244430,routine,0,0
244431,application,0,0
244432,of,0,0
244433,costly,0,0
244434,G-CSF,1,1
244435,therapy,1,0
244436,in,1,0
244437,children,1,1
244438,undergoing,1,1
244439,PBSCT,1,1
244440,should,0,0
244441,be,0,0
244442,seriously,0,0
244443,reconsidered,0,0
244444,.,0,0
244445,Ten-year,0,1
244446,results,0,0
244447,of,0,0
244448,a,0,0
244449,randomised,0,0
244450,trial,0,0
244451,comparing,0,0
244452,cisplatin,0,0
244453,with,0,1
244454,cisplatin,0,0
244455,and,0,0
244456,cyclophosphamide,0,0
244457,in,0,0
244458,advanced,1,1
244459,",",1,0
244460,suboptimally,1,1
244461,debulked,1,0
244462,ovarian,1,1
244463,cancer,1,1
244464,.,1,1
244465,176,1,1
244466,eligible,1,1
244467,patients,1,1
244468,with,1,1
244469,advanced,1,1
244470,suboptimally,1,1
244471,operated,1,1
244472,ovarian,1,1
244473,carcinoma,1,1
244474,were,0,0
244475,randomly,0,1
244476,allocated,0,0
244477,to,0,0
244478,receive,0,0
244479,either,0,0
244480,cisplatin,0,0
244481,75,0,0
244482,mg/m2,0,0
244483,or,0,1
244484,cisplatin,0,0
244485,50,0,1
244486,mg/m2,0,0
244487,and,0,0
244488,cyclophosphamide,0,0
244489,500,0,0
244490,mg/m2,0,0
244491,(,0,0
244492,CP,0,0
244493,),0,0
244494,every,0,0
244495,28,0,1
244496,days,0,0
244497,for,0,1
244498,six,0,1
244499,courses,0,0
244500,.,0,1
244501,The,0,0
244502,overall,0,0
244503,clinical,0,0
244504,response,0,0
244505,rates,0,0
244506,(,0,0
244507,complete,0,1
244508,response,0,0
244509,plus,0,0
244510,partial,0,0
244511,response,0,0
244512,),0,0
244513,were,0,0
244514,52,0,1
244515,and,0,0
244516,63,0,1
244517,%,0,0
244518,for,0,0
244519,CP,0,0
244520,and,0,0
244521,cisplatin,0,0
244522,",",0,0
244523,respectively,0,0
244524,(,0,0
244525,non-significant,0,0
244526,),0,0
244527,.,0,1
244528,Including,0,0
244529,results,0,0
244530,obtained,0,0
244531,by,0,0
244532,second-look,0,0
244533,laparotomy,0,1
244534,",",0,0
244535,we,0,0
244536,did,0,0
244537,not,0,0
244538,observe,0,0
244539,a,0,0
244540,statistically,0,0
244541,significant,0,0
244542,difference,0,0
244543,in,0,0
244544,response,0,0
244545,rates,0,0
244546,in,0,0
244547,the,0,0
244548,two,0,0
244549,treatment,0,0
244550,groups,0,0
244551,.,0,1
244552,Median,0,0
244553,progression-free,0,0
244554,survival,0,0
244555,was,0,0
244556,10,0,0
244557,and,0,1
244558,11.9,0,1
244559,months,0,0
244560,for,0,0
244561,CP,0,1
244562,and,0,0
244563,cisplatin,0,0
244564,",",0,0
244565,respectively,0,0
244566,(,0,0
244567,non-significant,0,0
244568,),0,0
244569,.,0,0
244570,No,0,0
244571,significant,0,0
244572,difference,0,0
244573,was,0,0
244574,observed,0,0
244575,in,0,0
244576,overall,0,0
244577,survival,0,0
244578,",",0,0
244579,with,0,0
244580,a,0,0
244581,median,0,0
244582,of,0,0
244583,19.4,0,0
244584,and,0,1
244585,21.5,0,0
244586,months,0,0
244587,for,0,0
244588,CP,0,1
244589,and,0,0
244590,cisplatin,0,0
244591,",",0,0
244592,respectively,0,0
244593,.,0,0
244594,Thirty-seven,1,1
244595,platinum-resistant,1,1
244596,and,1,1
244597,27,1,1
244598,platinum-sensitive,1,1
244599,tumours,1,1
244600,were,0,1
244601,treated,0,1
244602,with,0,1
244603,carboplatin,0,0
244604,or,0,0
244605,cisplatin,0,0
244606,as,0,0
244607,second-line,0,0
244608,therapy,0,0
244609,.,0,1
244610,Response,0,0
244611,rates,0,0
244612,to,0,0
244613,platinum,0,0
244614,second-line,0,0
244615,therapy,0,0
244616,were,0,0
244617,6,0,0
244618,and,0,0
244619,50,0,1
244620,%,0,0
244621,for,0,0
244622,resistant,0,1
244623,and,0,0
244624,sensitive,0,0
244625,tumours,0,1
244626,",",0,0
244627,respectively,0,0
244628,(,0,0
244629,P,0,0
244630,<,0,0
244631,0.001,0,0
244632,),0,0
244633,.,0,0
244634,This,0,0
244635,difference,0,0
244636,in,0,0
244637,response,0,0
244638,rate,0,0
244639,was,0,0
244640,also,0,0
244641,confirmed,0,0
244642,by,0,0
244643,survival,0,0
244644,analysis,0,0
244645,.,0,0
244646,Patients,1,1
244647,with,1,1
244648,platinum-sensitive,1,1
244649,tumours,1,1
244650,survived,0,1
244651,longer,0,0
244652,when,0,0
244653,they,0,0
244654,were,0,0
244655,treated,0,1
244656,with,0,1
244657,platinum-containing,0,0
244658,chemotherapy,0,1
244659,(,0,0
244660,P,0,0
244661,=,0,0
244662,0.005,0,0
244663,),0,1
244664,.,0,1
244665,Median,0,0
244666,survival,0,0
244667,was,0,0
244668,22.8,0,0
244669,and,0,1
244670,8.5,0,0
244671,months,0,0
244672,after,0,0
244673,initiation,0,0
244674,of,0,0
244675,second-line,0,0
244676,treatment,0,0
244677,for,0,0
244678,the,0,0
244679,platinum-containing,0,0
244680,and,0,0
244681,platinum-free,0,0
244682,regimens,0,0
244683,",",0,0
244684,respectively,0,0
244685,.,0,0
244686,In,0,0
244687,summary,0,0
244688,",",0,0
244689,we,0,0
244690,observed,0,0
244691,in,0,0
244692,suboptimally,1,1
244693,operated,1,1
244694,ovarian,1,1
244695,carcinoma,1,1
244696,patients,1,1
244697,similar,0,0
244698,response,0,0
244699,rates,0,0
244700,",",0,0
244701,progression-free,0,0
244702,interval,0,0
244703,",",0,0
244704,and,0,0
244705,overall,0,0
244706,survival,0,0
244707,for,0,0
244708,equitoxic,0,0
244709,cisplatin,0,0
244710,and,0,0
244711,CP,0,0
244712,.,0,0
244713,However,0,0
244714,",",0,0
244715,the,0,0
244716,doses,0,0
244717,of,0,0
244718,cisplatin,0,0
244719,and,0,0
244720,cyclophosphamide,0,0
244721,chosen,0,0
244722,were,0,0
244723,substantially,0,0
244724,lower,0,0
244725,than,0,0
244726,current,0,0
244727,standard,0,1
244728,doses,0,0
244729,of,0,1
244730,CP,0,1
244731,.,0,1
244732,Our,0,0
244733,study,0,0
244734,demonstrates,0,0
244735,",",0,0
244736,therefore,0,0
244737,",",0,0
244738,that,0,0
244739,a,0,0
244740,suboptimal,0,0
244741,dose,0,0
244742,of,0,0
244743,CP,0,0
244744,is,0,0
244745,as,0,0
244746,effective,0,0
244747,as,0,0
244748,optimal,0,0
244749,dose,0,0
244750,monotherapy,0,1
244751,cisplatin,0,0
244752,.,0,0
244753,Patients,1,1
244754,with,1,1
244755,recurrences,1,1
244756,considered,1,1
244757,as,1,0
244758,platinum-sensitive,1,1
244759,had,0,0
244760,a,0,0
244761,significantly,0,0
244762,higher,0,0
244763,response,0,0
244764,rate,0,0
244765,and,0,0
244766,improved,0,0
244767,survival,0,0
244768,when,0,0
244769,retreated,0,0
244770,with,0,0
244771,platinum-containing,0,0
244772,therapy,0,0
244773,.,0,1
244774,Optimization,0,0
244775,of,0,0
244776,acid,0,0
244777,suppression,0,0
244778,for,0,0
244779,patients,1,1
244780,with,1,1
244781,peptic,1,1
244782,ulcer,1,1
244783,bleeding,1,1
244784,:,1,1
244785,an,0,0
244786,intragastric,0,0
244787,pH-metry,0,0
244788,study,0,0
244789,with,0,1
244790,omeprazole,0,0
244791,.,0,0
244792,OBJECTIVE,0,0
244793,To,0,0
244794,study,0,0
244795,whether,0,0
244796,an,0,0
244797,intravenous,0,0
244798,infusion,0,0
244799,dose,0,0
244800,of,0,0
244801,omeprazole,0,0
244802,(,0,0
244803,80,0,1
244804,mg,0,0
244805,+,0,0
244806,8,0,0
244807,mg/h,0,0
244808,),0,0
244809,during,0,0
244810,24,0,0
244811,h,0,0
244812,can,0,0
244813,be,0,0
244814,subsequently,0,0
244815,reduced,0,0
244816,with,0,1
244817,maintained,0,0
244818,effect,0,0
244819,.,0,0
244820,Second,0,0
244821,",",0,0
244822,to,0,0
244823,study,0,0
244824,the,0,0
244825,effect,0,0
244826,of,0,0
244827,oral,0,0
244828,omeprazole,0,0
244829,20,0,1
244830,mg,0,0
244831,given,0,0
244832,once,0,0
244833,or,0,0
244834,twice,0,0
244835,daily,0,0
244836,up,0,0
244837,to,0,0
244838,day,0,0
244839,10,0,0
244840,",",0,0
244841,after,0,0
244842,cessation,0,0
244843,of,0,0
244844,a,0,0
244845,3-day,0,0
244846,intravenous,0,0
244847,infusion,0,0
244848,(,0,0
244849,80,0,1
244850,mg,0,0
244851,+,0,0
244852,8,0,0
244853,mg/h,0,0
244854,),0,1
244855,.,0,1
244856,DESIGN,0,0
244857,Prospective,0,0
244858,",",0,0
244859,randomized,0,0
244860,",",0,0
244861,partly,0,0
244862,blinded,0,0
244863,study,0,0
244864,.,0,1
244865,METHODS,0,0
244866,Twelve,1,1
244867,Helicobacter,1,1
244868,pylori,1,0
244869,(,1,0
244870,+,1,0
244871,),1,1
244872,patients,1,1
244873,and,1,1
244874,12,1,1
244875,H.,1,1
244876,pylori,1,1
244877,(,1,0
244878,-,1,0
244879,),1,1
244880,subjects,1,1
244881,were,1,1
244882,included,1,1
244883,.,1,0
244884,In,0,0
244885,part,0,0
244886,I,0,1
244887,the,0,0
244888,patients,0,1
244889,received,0,0
244890,omeprazole,0,0
244891,",",0,0
244892,80,0,1
244893,mg,0,0
244894,+,0,0
244895,8,0,0
244896,mg/h,0,0
244897,",",0,0
244898,during,0,0
244899,24,0,0
244900,h,0,0
244901,followed,0,0
244902,by,0,0
244903,8,0,0
244904,",",0,0
244905,4,0,0
244906,or,0,1
244907,2,0,0
244908,mg/h,0,0
244909,.,0,0
244910,In,0,0
244911,part,0,0
244912,II,0,1
244913,the,0,0
244914,subjects,0,1
244915,received,0,1
244916,80,0,1
244917,mg,0,0
244918,+,0,0
244919,8,0,0
244920,mg/h,0,0
244921,during,0,0
244922,3,0,0
244923,days,0,0
244924,followed,0,0
244925,by,0,0
244926,20,0,1
244927,mg,0,0
244928,omeprazole,0,0
244929,orally,0,0
244930,",",0,0
244931,once,0,0
244932,or,0,0
244933,twice,0,0
244934,daily,0,0
244935,until,0,0
244936,day,0,0
244937,10,0,1
244938,.,0,1
244939,Intragastric,0,0
244940,pH,0,0
244941,was,0,0
244942,measured,0,0
244943,.,0,1
244944,RESULTS,0,0
244945,All,0,1
244946,H.,0,1
244947,pylori,0,0
244948,(,0,0
244949,+,0,0
244950,),0,1
244951,patients,0,1
244952,showed,0,0
244953,a,0,0
244954,rapid,0,0
244955,increase,0,0
244956,of,0,0
244957,intragastric,0,0
244958,pH,0,0
244959,with,0,1
244960,a,0,0
244961,mean,0,0
244962,intragastric,0,0
244963,pH,0,0
244964,of,0,0
244965,6.7,0,0
244966,during,0,0
244967,the,0,0
244968,second,0,0
244969,half,0,1
244970,of,0,0
244971,the,0,0
244972,first,0,0
244973,day,0,0
244974,.,0,0
244975,After,0,0
244976,the,0,0
244977,subsequent,0,0
244978,dose,0,0
244979,reduction,0,0
244980,",",0,0
244981,the,0,0
244982,mean,0,0
244983,pH,0,0
244984,decreased,0,0
244985,to,0,0
244986,6.1-6.2,0,0
244987,.,0,0
244988,Patients,0,1
244989,continuing,0,0
244990,on,0,0
244991,8,0,0
244992,mg/h,0,0
244993,showed,0,0
244994,the,0,0
244995,best,0,0
244996,results,0,0
244997,.,0,1
244998,Likewise,0,0
244999,",",0,0
245000,all,0,0
245001,H.,0,0
245002,pylori,0,0
245003,(,0,0
245004,-,0,0
245005,),0,0
245006,subjects,0,1
245007,showed,0,0
245008,a,0,0
245009,rapid,0,0
245010,and,0,0
245011,sustained,0,0
245012,reduction,0,0
245013,of,0,0
245014,intragastric,0,0
245015,acidity,0,0
245016,during,0,0
245017,the,0,0
245018,infusion,0,0
245019,.,0,0
245020,Subsequent,0,0
245021,dose,0,0
245022,reduction,0,0
245023,to,0,0
245024,20,0,1
245025,mg,0,0
245026,once,0,0
245027,daily,0,0
245028,led,0,0
245029,to,0,0
245030,a,0,0
245031,stable,0,1
245032,fraction,0,0
245033,of,0,0
245034,time,0,0
245035,with,0,1
245036,pH,0,0
245037,>,0,1
245038,3,0,0
245039,of,0,0
245040,72,0,1
245041,%,0,0
245042,.,0,1
245043,CONCLUSIONS,0,0
245044,Omeprazole,0,0
245045,given,0,0
245046,as,0,0
245047,a,0,0
245048,continuous,0,0
245049,infusion,0,0
245050,of,0,0
245051,80,0,1
245052,mg,0,0
245053,+,0,0
245054,8,0,0
245055,mg/h,0,0
245056,for,0,0
245057,72,0,1
245058,h,0,0
245059,followed,0,0
245060,by,0,0
245061,omeprazole,0,0
245062,20,0,1
245063,mg,0,0
245064,once,0,0
245065,daily,0,0
245066,raised,0,0
245067,the,0,0
245068,intragastric,0,0
245069,pH,0,0
245070,to,0,0
245071,and,0,0
245072,above,0,0
245073,levels,0,0
245074,alleged,0,1
245075,to,0,0
245076,allow,0,0
245077,haemostasis,0,1
245078,in,0,0
245079,patients,0,1
245080,with,0,1
245081,peptic,1,1
245082,ulcer,1,1
245083,bleeding,1,1
245084,and,0,0
245085,subsequent,0,0
245086,healing,0,0
245087,of,0,0
245088,the,0,0
245089,ulcer,0,1
245090,.,0,0
